diff --git "a/raw/parallel_extract/table.jsonl" "b/raw/parallel_extract/table.jsonl" new file mode 100644--- /dev/null +++ "b/raw/parallel_extract/table.jsonl" @@ -0,0 +1,503 @@ +{"completed_at":"2026-11-04T19:47:45.981136","latency_in_ms":3094,"output":{"example_id":"table/0000027_page1","grounded_pages":[],"layout_pages":[],"markdown":"135 134\n\nReport on operations at 30 June 2024 Condensed Consolidated Interim Financial Statements at 30 June 2024 The Fincantieri Group **Notes to the Condensed Consolidated Interim Financial Statements**\n\n**Business activity Registered office Countries in which they operate Share Capital % interest held % consolidated by Group**\n\n**JOINT VENTURES CONSOLIDATED USING THE EQUITY METHOD**\n\n**ORIZZONTE SISTEMI NAVALI S.p.A.** Provision of naval surface vessels equipped with weapons systems Genoa Italy Algeria EUR 20,000,000 51.00 Fincantieri S.p.A. 51.00\n\n**ETIHAD SHIP BUILDING LLC** Design, production and sale of civilian and naval ships United Arab Emirates United Arab Emirates AED 2,500,000 35.00 Fincantieri S.p.A. 35.00\n\n**NAVIRIS S.p.A.** Design and manufacture of ships for naval or government use Genoa Italy EUR 5,000,000 50.00 Fincantieri S.p.A. 50.00\n\n**NAVIRIS FRANCE SAS** Shipbuilding France France EUR 100,000 100.00 Naviris S.p.A. 50.00\n\n**CSSC - FINCANTIERI CRUISE INDUSTRY DEVELOPMENT LIMITED** Design and marketing of cruise ships China China EUR 140,000,000 40.00 Fincantieri S.p.A. 40.00\n\n**CSSC - FINCANTIERI (SHANGHAI) CRUISE DESIGN LIMITED** Engineering, Project Management and Supply Chain Management China China RMB 1,000,000 100.00 CSSC - Fincantieri Cruise Industry Development Limited 40.00\n\n**CONSORZIO F.S.B.** Building construction Marghera (VE) Italy EUR 15,000 58.36 Fincantieri S.p.A 58.36\n\n**BUSBAR4F S.c.a.r.l.** Complete execution of contract ITER BUSBARF4 Trieste Italy France EUR 40,000 10.00 50.00 Fincantieri S.p.A. Fincantieri SI S.p.A. 60.00\n\n**4TCC1 - S.c.a.r.l.** Complete execution of the Tokamak Complex Contract Trieste Italy France EUR 100,000 5.00 75.00 Fincantieri S.p.A. Fincantieri SI S.p.A. 80.00\n\n**4B3 S.c.a.r.l.** Complete execution of contract BOP3 Trieste Italy France EUR 50,000 2.50 52.50 Fincantieri S.p.A. Fincantieri SI S.p.A. 55.00\n\n**4TB13 S.c.a.r.l.** _Inactive_ Trieste Italy France EUR 50,000 55.00 Fincantieri SI S.p.A. 55.00\n\n**FINMESA S.c.a.r.l. in liquidazione** _In liquidation_ Milan Italy EUR 20,000 50.00 Fincantieri SI S.p.A. 50.00\n\n**ERSMA 2026 S.c.a.r.l.** Demolition and dismantling of buildings and other structures Piacenza Italy EUR 10,000 20.00 Fincantieri SI S.p.A. 20.00\n\n**FINCANTIERI CLEA BUILDINGS S.c.a.r.l. in liquidazione** _In liquidation_ Milan Italy EUR 10,000 51.00 Fincantieri Infrastructure S.p.A. 51.00\n\n**DARSENA EUROPA S.c.a.r.l.** Execution of the Europa Platform of the Port of Livorno Rome Italy EUR 10,000 26.00 Fincantieri Infrastructure Opere Marittime S.p.A. 26.00\n\n**NUOVO SANTA CHIARA HOSPITAL S.c.a r.l.** Construction of hospital buildings Florence Italy EUR 300,000 50.00 Fincantieri INfrastrutture SOciali S.p.A. 45.00\n\n**VIMERCATE SALUTE GESTIONI S.c.a.r.l.** Other business support service activities n.e.c. Milan Italy EUR 10,000 3.65 49.10 SOF S.p.A. Fincantieri INfrastrutture SOciali S.p.A. 47.48\n\n**4TB21 S.c.a.r.l.** Unitary execution of the framework agreement for the TOKAMAK Complex Contract - TB21 Trieste Italy EUR 10,000 51.00 Fincantieri S.p.A. 51.00\n\n**TCM S.c.a.r.l.** Design and execution of works relating to the contract for the \"Construction of the offshore platform at the Port of Venice - Terminal Container \"Montesyndial\" - 1st section\"\n\nRome Italy EUR 10,000 41.56 Fincantieri Infrastructure Opere Marittime S.p.A. 41.56\n\n**CONSORZIO RAVENNA DIGA OFFSHORE S.c.a.r.l.** _Inactive_ Genoa Italy EUR 10,000 31.50 Fincantieri Infrastructure Opere Marittime S.p.A. 31.50\n\n**Business activity Registered office Countries in which they operate Share Capital % interest held % consolidated by Group**\n\n**ASSOCIATES CONSOLIDATED USING THE EQUITY METHOD**\n\n**CENTRO SERVIZI NAVALI S.p.A.** Processing and production of metal products\n\nSan Giorgio di Nogaro (UD) Italy EUR 5,620,618 10.93 Fincantieri S.p.A. 10.93\n\n**GRUPPO PSC S.p.A.** Design and installation of systems Maratea (PZ) Italy Denmark EUR 1,431,112 10.00 Fincantieri S.p.A. 10.00\n\n**DECOMAR S.p.A.** Development of innovative solutions for environmental restoration Massa (MS) Italy EUR 2,500,000 20.00 Fincantieri S.p.A. 20.00\n\n**DIDO S.r.l.** Activities in the field of decision intelligence Milan Italy EUR 142,801 30.00 Fincantieri S.p.A. 30.00\n\n**PRELIOS SOLUTIONS & TECHNOLOGIES S.r.l.** Realization and management of technological installations in the industrial, civil and defence sectors Milan Italy EUR 50,000 49.00 Fincantieri NexTech S.p.A 49.00\n\n**STARS RAILWAY SYSTEMS** Production of radar products for railway safety Rome Italy EUR 300,000 48.00 2.00 IDS Ingegneria Dei Sistemi S.p.A. TRS Sistemi S.r.l. 50.00\n\n**ITS INTEGRATED TECH SYSTEM S.r.l.** _Inactive_ La Spezia Italy EUR 10,000 51.00 Rob.Int S.r.l. 51.00\n\n**MC4COM - MISSION CRITICAL FOR COMMUNICATIONS SOCIETÀ CONSORTILE S.r.l.** Implementation of integrated telecommunications systems\n\nMilan Italy EUR 10,000 50.00 HMS IT S.p.A. 50.00\n\n**UNIFER NAVALE S.r.l. in liquidazione** _In liquidation_ Finale Emilia (MO) Italy EUR 150,000 20.00 Società per l'Esercizio di Attività Finanziarie - S.E.A.F. S.p.A. 20.00\n\n**2F PER VADO S.c.a.r.l.** Execution of works for the construction of the \"New Vado Ligure Breakwater\" Genoa Italy EUR 10,000 49.00 Fincantieri Infrastructure Opere Marittime S.p.A. 49.00\n\n**CITTÀ SALUTE RICERCA MILANO S.p.A.** Construction activities and other civil engineering works n.e.c. Milan Italy EUR 5,000,000 30.00 Fincantieri INfrastrutture SOciali S.p.A. 27.00\n\n**CISAR COSTRUZIONI S.c.a.r.l.** Design and execution activities Milan Italy EUR 100,000 30.00 Fincantieri INfrastrutture SOciali S.p.A. 27.00\n\n**NOTE GESTIONE S.c.a.r.l.** Installation of plumbing in buildings Reggio Emilia Italy EUR 20,000 34.00 SOF S.p.A. 30.60\n\n**S.ENE.CA GESTIONI S.c.a.r.l.** Other business support service activities Florence Italy EUR 10,000 49.00 SOF S.p.A. 44.10\n\n**HOSPITAL BUILDING TECHNOLOGIES S.c.a.r.l.** Sale and purchase of real estate on own goods Florence Italy EUR 10,000 20.00 SOF S.p.A. 18.00\n\n**BIOTECA S.c.a.r.l.** Execution of contracts for the supply and installation of furniture and furnishings\n\nCarpi (MO) Italy EUR 100,000 33.33 SOF S.p.A. 30.00\n\n**ENERGETIKA S.c.a.r.l.** _Inactive_ Florence Italy EUR 10,000 40.00 SOF S.p.A. 36.00\n\n**PERGENOVA BREAKWATER** Construction of the new breakwater for the port of Genoa within the Sampierdarena basin Genoa Italy EUR 10,000 25.00 Fincantieri Infrastructure Opere Marittime S.p.A. 25.00\n\n**BREVIK TECHNOLOGY AS** Technology licences and patents Norway Norway NOK 1,050,000 34.00 Vard Group AS 33.45\n\n**SOLSTAD SUPPLY AS** Shipowner Norway Norway NOK 345,003,000 26.66 Vard Group AS 26.23\n\n**ISLAND OFFSHORE XII SHIP AS** Shipowner Norway Norway NOK 404,097,000 42.20 Vard Group AS 41.52\n\n**CASTOR DRILLING SOLUTION AS** Offshore drilling technology Norway Norway NOK 229,710 34.13 Seaonics AS 33.58\n\n**CSS DESIGN LIMITED** Design and engineering United Kingdom United Kingdom GBP 100 31.00 Vard Marine Inc. 30.50\n\n**REMAC S.r.l.** Machinery construction activities Trieste Italy EUR 200,000 49.00 Remazel Engineering S.p.A. 49.00\n\n**VBF NAUTICA S.r.l.** Business, administrative and management consulting, planning and digital and innovative IT services with high technological value in the marine, maritime and port segments\n\nGenoa Italy EUR 50,000 12.50 Fincantieri S.p.A. 12.50","pages":[{"line_numbers":[],"markdown":"135 134\n\nReport on operations at 30 June 2024 Condensed Consolidated Interim Financial Statements at 30 June 2024 The Fincantieri Group **Notes to the Condensed Consolidated Interim Financial Statements**\n\n**Business activity Registered office Countries in which they operate Share Capital % interest held % consolidated by Group**\n\n**JOINT VENTURES CONSOLIDATED USING THE EQUITY METHOD**\n\n**ORIZZONTE SISTEMI NAVALI S.p.A.** Provision of naval surface vessels equipped with weapons systems Genoa Italy Algeria EUR 20,000,000 51.00 Fincantieri S.p.A. 51.00\n\n**ETIHAD SHIP BUILDING LLC** Design, production and sale of civilian and naval ships United Arab Emirates United Arab Emirates AED 2,500,000 35.00 Fincantieri S.p.A. 35.00\n\n**NAVIRIS S.p.A.** Design and manufacture of ships for naval or government use Genoa Italy EUR 5,000,000 50.00 Fincantieri S.p.A. 50.00\n\n**NAVIRIS FRANCE SAS** Shipbuilding France France EUR 100,000 100.00 Naviris S.p.A. 50.00\n\n**CSSC - FINCANTIERI CRUISE INDUSTRY DEVELOPMENT LIMITED** Design and marketing of cruise ships China China EUR 140,000,000 40.00 Fincantieri S.p.A. 40.00\n\n**CSSC - FINCANTIERI (SHANGHAI) CRUISE DESIGN LIMITED** Engineering, Project Management and Supply Chain Management China China RMB 1,000,000 100.00 CSSC - Fincantieri Cruise Industry Development Limited 40.00\n\n**CONSORZIO F.S.B.** Building construction Marghera (VE) Italy EUR 15,000 58.36 Fincantieri S.p.A 58.36\n\n**BUSBAR4F S.c.a.r.l.** Complete execution of contract ITER BUSBARF4 Trieste Italy France EUR 40,000 10.00 50.00 Fincantieri S.p.A. Fincantieri SI S.p.A. 60.00\n\n**4TCC1 - S.c.a.r.l.** Complete execution of the Tokamak Complex Contract Trieste Italy France EUR 100,000 5.00 75.00 Fincantieri S.p.A. Fincantieri SI S.p.A. 80.00\n\n**4B3 S.c.a.r.l.** Complete execution of contract BOP3 Trieste Italy France EUR 50,000 2.50 52.50 Fincantieri S.p.A. Fincantieri SI S.p.A. 55.00\n\n**4TB13 S.c.a.r.l.** _Inactive_ Trieste Italy France EUR 50,000 55.00 Fincantieri SI S.p.A. 55.00\n\n**FINMESA S.c.a.r.l. in liquidazione** _In liquidation_ Milan Italy EUR 20,000 50.00 Fincantieri SI S.p.A. 50.00\n\n**ERSMA 2026 S.c.a.r.l.** Demolition and dismantling of buildings and other structures Piacenza Italy EUR 10,000 20.00 Fincantieri SI S.p.A. 20.00\n\n**FINCANTIERI CLEA BUILDINGS S.c.a.r.l. in liquidazione** _In liquidation_ Milan Italy EUR 10,000 51.00 Fincantieri Infrastructure S.p.A. 51.00\n\n**DARSENA EUROPA S.c.a.r.l.** Execution of the Europa Platform of the Port of Livorno Rome Italy EUR 10,000 26.00 Fincantieri Infrastructure Opere Marittime S.p.A. 26.00\n\n**NUOVO SANTA CHIARA HOSPITAL S.c.a r.l.** Construction of hospital buildings Florence Italy EUR 300,000 50.00 Fincantieri INfrastrutture SOciali S.p.A. 45.00\n\n**VIMERCATE SALUTE GESTIONI S.c.a.r.l.** Other business support service activities n.e.c. Milan Italy EUR 10,000 3.65 49.10 SOF S.p.A. Fincantieri INfrastrutture SOciali S.p.A. 47.48\n\n**4TB21 S.c.a.r.l.** Unitary execution of the framework agreement for the TOKAMAK Complex Contract - TB21 Trieste Italy EUR 10,000 51.00 Fincantieri S.p.A. 51.00\n\n**TCM S.c.a.r.l.** Design and execution of works relating to the contract for the \"Construction of the offshore platform at the Port of Venice - Terminal Container \"Montesyndial\" - 1st section\"\n\nRome Italy EUR 10,000 41.56 Fincantieri Infrastructure Opere Marittime S.p.A. 41.56\n\n**CONSORZIO RAVENNA DIGA OFFSHORE S.c.a.r.l.** _Inactive_ Genoa Italy EUR 10,000 31.50 Fincantieri Infrastructure Opere Marittime S.p.A. 31.50\n\n**Business activity Registered office Countries in which they operate Share Capital % interest held % consolidated by Group**\n\n**ASSOCIATES CONSOLIDATED USING THE EQUITY METHOD**\n\n**CENTRO SERVIZI NAVALI S.p.A.** Processing and production of metal products\n\nSan Giorgio di Nogaro (UD) Italy EUR 5,620,618 10.93 Fincantieri S.p.A. 10.93\n\n**GRUPPO PSC S.p.A.** Design and installation of systems Maratea (PZ) Italy Denmark EUR 1,431,112 10.00 Fincantieri S.p.A. 10.00\n\n**DECOMAR S.p.A.** Development of innovative solutions for environmental restoration Massa (MS) Italy EUR 2,500,000 20.00 Fincantieri S.p.A. 20.00\n\n**DIDO S.r.l.** Activities in the field of decision intelligence Milan Italy EUR 142,801 30.00 Fincantieri S.p.A. 30.00\n\n**PRELIOS SOLUTIONS & TECHNOLOGIES S.r.l.** Realization and management of technological installations in the industrial, civil and defence sectors Milan Italy EUR 50,000 49.00 Fincantieri NexTech S.p.A 49.00\n\n**STARS RAILWAY SYSTEMS** Production of radar products for railway safety Rome Italy EUR 300,000 48.00 2.00 IDS Ingegneria Dei Sistemi S.p.A. TRS Sistemi S.r.l. 50.00\n\n**ITS INTEGRATED TECH SYSTEM S.r.l.** _Inactive_ La Spezia Italy EUR 10,000 51.00 Rob.Int S.r.l. 51.00\n\n**MC4COM - MISSION CRITICAL FOR COMMUNICATIONS SOCIETÀ CONSORTILE S.r.l.** Implementation of integrated telecommunications systems\n\nMilan Italy EUR 10,000 50.00 HMS IT S.p.A. 50.00\n\n**UNIFER NAVALE S.r.l. in liquidazione** _In liquidation_ Finale Emilia (MO) Italy EUR 150,000 20.00 Società per l'Esercizio di Attività Finanziarie - S.E.A.F. S.p.A. 20.00\n\n**2F PER VADO S.c.a.r.l.** Execution of works for the construction of the \"New Vado Ligure Breakwater\" Genoa Italy EUR 10,000 49.00 Fincantieri Infrastructure Opere Marittime S.p.A. 49.00\n\n**CITTÀ SALUTE RICERCA MILANO S.p.A.** Construction activities and other civil engineering works n.e.c. Milan Italy EUR 5,000,000 30.00 Fincantieri INfrastrutture SOciali S.p.A. 27.00\n\n**CISAR COSTRUZIONI S.c.a.r.l.** Design and execution activities Milan Italy EUR 100,000 30.00 Fincantieri INfrastrutture SOciali S.p.A. 27.00\n\n**NOTE GESTIONE S.c.a.r.l.** Installation of plumbing in buildings Reggio Emilia Italy EUR 20,000 34.00 SOF S.p.A. 30.60\n\n**S.ENE.CA GESTIONI S.c.a.r.l.** Other business support service activities Florence Italy EUR 10,000 49.00 SOF S.p.A. 44.10\n\n**HOSPITAL BUILDING TECHNOLOGIES S.c.a.r.l.** Sale and purchase of real estate on own goods Florence Italy EUR 10,000 20.00 SOF S.p.A. 18.00\n\n**BIOTECA S.c.a.r.l.** Execution of contracts for the supply and installation of furniture and furnishings\n\nCarpi (MO) Italy EUR 100,000 33.33 SOF S.p.A. 30.00\n\n**ENERGETIKA S.c.a.r.l.** _Inactive_ Florence Italy EUR 10,000 40.00 SOF S.p.A. 36.00\n\n**PERGENOVA BREAKWATER** Construction of the new breakwater for the port of Genoa within the Sampierdarena basin Genoa Italy EUR 10,000 25.00 Fincantieri Infrastructure Opere Marittime S.p.A. 25.00\n\n**BREVIK TECHNOLOGY AS** Technology licences and patents Norway Norway NOK 1,050,000 34.00 Vard Group AS 33.45\n\n**SOLSTAD SUPPLY AS** Shipowner Norway Norway NOK 345,003,000 26.66 Vard Group AS 26.23\n\n**ISLAND OFFSHORE XII SHIP AS** Shipowner Norway Norway NOK 404,097,000 42.20 Vard Group AS 41.52\n\n**CASTOR DRILLING SOLUTION AS** Offshore drilling technology Norway Norway NOK 229,710 34.13 Seaonics AS 33.58\n\n**CSS DESIGN LIMITED** Design and engineering United Kingdom United Kingdom GBP 100 31.00 Vard Marine Inc. 30.50\n\n**REMAC S.r.l.** Machinery construction activities Trieste Italy EUR 200,000 49.00 Remazel Engineering S.p.A. 49.00\n\n**VBF NAUTICA S.r.l.** Business, administrative and management consulting, planning and digital and innovative IT services with high technological value in the marine, maritime and port segments\n\nGenoa Italy EUR 50,000 12.50 Fincantieri S.p.A. 12.50","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"135 134\n\nReport on operations at 30 June 2024 Condensed Consolidated Interim Financial Statements at 30 June 2024 The Fincantieri Group **Notes to the Condensed Consolidated Interim Financial Statements**\n\n**Business activity Registered office Countries in which they operate Share Capital % interest held % consolidated by Group**\n\n**JOINT VENTURES CONSOLIDATED USING THE EQUITY METHOD**\n\n**ORIZZONTE SISTEMI NAVALI S.p.A.** Provision of naval surface vessels equipped with weapons systems Genoa Italy Algeria EUR 20,000,000 51.00 Fincantieri S.p.A. 51.00\n\n**ETIHAD SHIP BUILDING LLC** Design, production and sale of civilian and naval ships United Arab Emirates United Arab Emirates AED 2,500,000 35.00 Fincantieri S.p.A. 35.00\n\n**NAVIRIS S.p.A.** Design and manufacture of ships for naval or government use Genoa Italy EUR 5,000,000 50.00 Fincantieri S.p.A. 50.00\n\n**NAVIRIS FRANCE SAS** Shipbuilding France France EUR 100,000 100.00 Naviris S.p.A. 50.00\n\n**CSSC - FINCANTIERI CRUISE INDUSTRY DEVELOPMENT LIMITED** Design and marketing of cruise ships China China EUR 140,000,000 40.00 Fincantieri S.p.A. 40.00\n\n**CSSC - FINCANTIERI (SHANGHAI) CRUISE DESIGN LIMITED** Engineering, Project Management and Supply Chain Management China China RMB 1,000,000 100.00 CSSC - Fincantieri Cruise Industry Development Limited 40.00\n\n**CONSORZIO F.S.B.** Building construction Marghera (VE) Italy EUR 15,000 58.36 Fincantieri S.p.A 58.36\n\n**BUSBAR4F S.c.a.r.l.** Complete execution of contract ITER BUSBARF4 Trieste Italy France EUR 40,000 10.00 50.00 Fincantieri S.p.A. Fincantieri SI S.p.A. 60.00\n\n**4TCC1 - S.c.a.r.l.** Complete execution of the Tokamak Complex Contract Trieste Italy France EUR 100,000 5.00 75.00 Fincantieri S.p.A. Fincantieri SI S.p.A. 80.00\n\n**4B3 S.c.a.r.l.** Complete execution of contract BOP3 Trieste Italy France EUR 50,000 2.50 52.50 Fincantieri S.p.A. Fincantieri SI S.p.A. 55.00\n\n**4TB13 S.c.a.r.l.** _Inactive_ Trieste Italy France EUR 50,000 55.00 Fincantieri SI S.p.A. 55.00\n\n**FINMESA S.c.a.r.l. in liquidazione** _In liquidation_ Milan Italy EUR 20,000 50.00 Fincantieri SI S.p.A. 50.00\n\n**ERSMA 2026 S.c.a.r.l.** Demolition and dismantling of buildings and other structures Piacenza Italy EUR 10,000 20.00 Fincantieri SI S.p.A. 20.00\n\n**FINCANTIERI CLEA BUILDINGS S.c.a.r.l. in liquidazione** _In liquidation_ Milan Italy EUR 10,000 51.00 Fincantieri Infrastructure S.p.A. 51.00\n\n**DARSENA EUROPA S.c.a.r.l.** Execution of the Europa Platform of the Port of Livorno Rome Italy EUR 10,000 26.00 Fincantieri Infrastructure Opere Marittime S.p.A. 26.00\n\n**NUOVO SANTA CHIARA HOSPITAL S.c.a r.l.** Construction of hospital buildings Florence Italy EUR 300,000 50.00 Fincantieri INfrastrutture SOciali S.p.A. 45.00\n\n**VIMERCATE SALUTE GESTIONI S.c.a.r.l.** Other business support service activities n.e.c. Milan Italy EUR 10,000 3.65 49.10 SOF S.p.A. Fincantieri INfrastrutture SOciali S.p.A. 47.48\n\n**4TB21 S.c.a.r.l.** Unitary execution of the framework agreement for the TOKAMAK Complex Contract - TB21 Trieste Italy EUR 10,000 51.00 Fincantieri S.p.A. 51.00\n\n**TCM S.c.a.r.l.** Design and execution of works relating to the contract for the \"Construction of the offshore platform at the Port of Venice - Terminal Container \"Montesyndial\" - 1st section\"\n\nRome Italy EUR 10,000 41.56 Fincantieri Infrastructure Opere Marittime S.p.A. 41.56\n\n**CONSORZIO RAVENNA DIGA OFFSHORE S.c.a.r.l.** _Inactive_ Genoa Italy EUR 10,000 31.50 Fincantieri Infrastructure Opere Marittime S.p.A. 31.50\n\n**Business activity Registered office Countries in which they operate Share Capital % interest held % consolidated by Group**\n\n**ASSOCIATES CONSOLIDATED USING THE EQUITY METHOD**\n\n**CENTRO SERVIZI NAVALI S.p.A.** Processing and production of metal products\n\nSan Giorgio di Nogaro (UD) Italy EUR 5,620,618 10.93 Fincantieri S.p.A. 10.93\n\n**GRUPPO PSC S.p.A.** Design and installation of systems Maratea (PZ) Italy Denmark EUR 1,431,112 10.00 Fincantieri S.p.A. 10.00\n\n**DECOMAR S.p.A.** Development of innovative solutions for environmental restoration Massa (MS) Italy EUR 2,500,000 20.00 Fincantieri S.p.A. 20.00\n\n**DIDO S.r.l.** Activities in the field of decision intelligence Milan Italy EUR 142,801 30.00 Fincantieri S.p.A. 30.00\n\n**PRELIOS SOLUTIONS & TECHNOLOGIES S.r.l.** Realization and management of technological installations in the industrial, civil and defence sectors Milan Italy EUR 50,000 49.00 Fincantieri NexTech S.p.A 49.00\n\n**STARS RAILWAY SYSTEMS** Production of radar products for railway safety Rome Italy EUR 300,000 48.00 2.00 IDS Ingegneria Dei Sistemi S.p.A. TRS Sistemi S.r.l. 50.00\n\n**ITS INTEGRATED TECH SYSTEM S.r.l.** _Inactive_ La Spezia Italy EUR 10,000 51.00 Rob.Int S.r.l. 51.00\n\n**MC4COM - MISSION CRITICAL FOR COMMUNICATIONS SOCIETÀ CONSORTILE S.r.l.** Implementation of integrated telecommunications systems\n\nMilan Italy EUR 10,000 50.00 HMS IT S.p.A. 50.00\n\n**UNIFER NAVALE S.r.l. in liquidazione** _In liquidation_ Finale Emilia (MO) Italy EUR 150,000 20.00 Società per l'Esercizio di Attività Finanziarie - S.E.A.F. S.p.A. 20.00\n\n**2F PER VADO S.c.a.r.l.** Execution of works for the construction of the \"New Vado Ligure Breakwater\" Genoa Italy EUR 10,000 49.00 Fincantieri Infrastructure Opere Marittime S.p.A. 49.00\n\n**CITTÀ SALUTE RICERCA MILANO S.p.A.** Construction activities and other civil engineering works n.e.c. Milan Italy EUR 5,000,000 30.00 Fincantieri INfrastrutture SOciali S.p.A. 27.00\n\n**CISAR COSTRUZIONI S.c.a.r.l.** Design and execution activities Milan Italy EUR 100,000 30.00 Fincantieri INfrastrutture SOciali S.p.A. 27.00\n\n**NOTE GESTIONE S.c.a.r.l.** Installation of plumbing in buildings Reggio Emilia Italy EUR 20,000 34.00 SOF S.p.A. 30.60\n\n**S.ENE.CA GESTIONI S.c.a.r.l.** Other business support service activities Florence Italy EUR 10,000 49.00 SOF S.p.A. 44.10\n\n**HOSPITAL BUILDING TECHNOLOGIES S.c.a.r.l.** Sale and purchase of real estate on own goods Florence Italy EUR 10,000 20.00 SOF S.p.A. 18.00\n\n**BIOTECA S.c.a.r.l.** Execution of contracts for the supply and installation of furniture and furnishings\n\nCarpi (MO) Italy EUR 100,000 33.33 SOF S.p.A. 30.00\n\n**ENERGETIKA S.c.a.r.l.** _Inactive_ Florence Italy EUR 10,000 40.00 SOF S.p.A. 36.00\n\n**PERGENOVA BREAKWATER** Construction of the new breakwater for the port of Genoa within the Sampierdarena basin Genoa Italy EUR 10,000 25.00 Fincantieri Infrastructure Opere Marittime S.p.A. 25.00\n\n**BREVIK TECHNOLOGY AS** Technology licences and patents Norway Norway NOK 1,050,000 34.00 Vard Group AS 33.45\n\n**SOLSTAD SUPPLY AS** Shipowner Norway Norway NOK 345,003,000 26.66 Vard Group AS 26.23\n\n**ISLAND OFFSHORE XII SHIP AS** Shipowner Norway Norway NOK 404,097,000 42.20 Vard Group AS 41.52\n\n**CASTOR DRILLING SOLUTION AS** Offshore drilling technology Norway Norway NOK 229,710 34.13 Seaonics AS 33.58\n\n**CSS DESIGN LIMITED** Design and engineering United Kingdom United Kingdom GBP 100 31.00 Vard Marine Inc. 30.50\n\n**REMAC S.r.l.** Machinery construction activities Trieste Italy EUR 200,000 49.00 Remazel Engineering S.p.A. 49.00\n\n**VBF NAUTICA S.r.l.** Business, administrative and management consulting, planning and digital and innovative IT services with high technological value in the marine, maritime and port segments\n\nGenoa Italy EUR 50,000 12.50 Fincantieri S.p.A. 12.50","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/0000027_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_d13cab7cdd3f997285c75ad6caf90cfa","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["135 134\n\nReport on operations at 30 June 2024 Condensed Consolidated Interim Financial Statements at 30 June 2024 The Fincantieri Group **Notes to the Condensed Consolidated Interim Financial Statements**\n\n**Business activity Registered office Countries in which they operate Share Capital % interest held % consolidated by Group**\n\n**JOINT VENTURES CONSOLIDATED USING THE EQUITY METHOD**\n\n**ORIZZONTE SISTEMI NAVALI S.p.A.** Provision of naval surface vessels equipped with weapons systems Genoa Italy Algeria EUR 20,000,000 51.00 Fincantieri S.p.A. 51.00\n\n**ETIHAD SHIP BUILDING LLC** Design, production and sale of civilian and naval ships United Arab Emirates United Arab Emirates AED 2,500,000 35.00 Fincantieri S.p.A. 35.00\n\n**NAVIRIS S.p.A.** Design and manufacture of ships for naval or government use Genoa Italy EUR 5,000,000 50.00 Fincantieri S.p.A. 50.00\n\n**NAVIRIS FRANCE SAS** Shipbuilding France France EUR 100,000 100.00 Naviris S.p.A. 50.00\n\n**CSSC - FINCANTIERI CRUISE INDUSTRY DEVELOPMENT LIMITED** Design and marketing of cruise ships China China EUR 140,000,000 40.00 Fincantieri S.p.A. 40.00\n\n**CSSC - FINCANTIERI (SHANGHAI) CRUISE DESIGN LIMITED** Engineering, Project Management and Supply Chain Management China China RMB 1,000,000 100.00 CSSC - Fincantieri Cruise Industry Development Limited 40.00\n\n**CONSORZIO F.S.B.** Building construction Marghera (VE) Italy EUR 15,000 58.36 Fincantieri S.p.A 58.36\n\n**BUSBAR4F S.c.a.r.l.** Complete execution of contract ITER BUSBARF4 Trieste Italy France EUR 40,000 10.00 50.00 Fincantieri S.p.A. Fincantieri SI S.p.A. 60.00\n\n**4TCC1 - S.c.a.r.l.** Complete execution of the Tokamak Complex Contract Trieste Italy France EUR 100,000 5.00 75.00 Fincantieri S.p.A. Fincantieri SI S.p.A. 80.00\n\n**4B3 S.c.a.r.l.** Complete execution of contract BOP3 Trieste Italy France EUR 50,000 2.50 52.50 Fincantieri S.p.A. Fincantieri SI S.p.A. 55.00\n\n**4TB13 S.c.a.r.l.** _Inactive_ Trieste Italy France EUR 50,000 55.00 Fincantieri SI S.p.A. 55.00\n\n**FINMESA S.c.a.r.l. in liquidazione** _In liquidation_ Milan Italy EUR 20,000 50.00 Fincantieri SI S.p.A. 50.00\n\n**ERSMA 2026 S.c.a.r.l.** Demolition and dismantling of buildings and other structures Piacenza Italy EUR 10,000 20.00 Fincantieri SI S.p.A. 20.00\n\n**FINCANTIERI CLEA BUILDINGS S.c.a.r.l. in liquidazione** _In liquidation_ Milan Italy EUR 10,000 51.00 Fincantieri Infrastructure S.p.A. 51.00\n\n**DARSENA EUROPA S.c.a.r.l.** Execution of the Europa Platform of the Port of Livorno Rome Italy EUR 10,000 26.00 Fincantieri Infrastructure Opere Marittime S.p.A. 26.00\n\n**NUOVO SANTA CHIARA HOSPITAL S.c.a r.l.** Construction of hospital buildings Florence Italy EUR 300,000 50.00 Fincantieri INfrastrutture SOciali S.p.A. 45.00\n\n**VIMERCATE SALUTE GESTIONI S.c.a.r.l.** Other business support service activities n.e.c. Milan Italy EUR 10,000 3.65 49.10 SOF S.p.A. Fincantieri INfrastrutture SOciali S.p.A. 47.48\n\n**4TB21 S.c.a.r.l.** Unitary execution of the framework agreement for the TOKAMAK Complex Contract - TB21 Trieste Italy EUR 10,000 51.00 Fincantieri S.p.A. 51.00\n\n**TCM S.c.a.r.l.** Design and execution of works relating to the contract for the \"Construction of the offshore platform at the Port of Venice - Terminal Container \"Montesyndial\" - 1st section\"\n\nRome Italy EUR 10,000 41.56 Fincantieri Infrastructure Opere Marittime S.p.A. 41.56\n\n**CONSORZIO RAVENNA DIGA OFFSHORE S.c.a.r.l.** _Inactive_ Genoa Italy EUR 10,000 31.50 Fincantieri Infrastructure Opere Marittime S.p.A. 31.50\n\n**Business activity Registered office Countries in which they operate Share Capital % interest held % consolidated by Group**\n\n**ASSOCIATES CONSOLIDATED USING THE EQUITY METHOD**\n\n**CENTRO SERVIZI NAVALI S.p.A.** Processing and production of metal products\n\nSan Giorgio di Nogaro (UD) Italy EUR 5,620,618 10.93 Fincantieri S.p.A. 10.93\n\n**GRUPPO PSC S.p.A.** Design and installation of systems Maratea (PZ) Italy Denmark EUR 1,431,112 10.00 Fincantieri S.p.A. 10.00\n\n**DECOMAR S.p.A.** Development of innovative solutions for environmental restoration Massa (MS) Italy EUR 2,500,000 20.00 Fincantieri S.p.A. 20.00\n\n**DIDO S.r.l.** Activities in the field of decision intelligence Milan Italy EUR 142,801 30.00 Fincantieri S.p.A. 30.00\n\n**PRELIOS SOLUTIONS & TECHNOLOGIES S.r.l.** Realization and management of technological installations in the industrial, civil and defence sectors Milan Italy EUR 50,000 49.00 Fincantieri NexTech S.p.A 49.00\n\n**STARS RAILWAY SYSTEMS** Production of radar products for railway safety Rome Italy EUR 300,000 48.00 2.00 IDS Ingegneria Dei Sistemi S.p.A. TRS Sistemi S.r.l. 50.00\n\n**ITS INTEGRATED TECH SYSTEM S.r.l.** _Inactive_ La Spezia Italy EUR 10,000 51.00 Rob.Int S.r.l. 51.00\n\n**MC4COM - MISSION CRITICAL FOR COMMUNICATIONS SOCIETÀ CONSORTILE S.r.l.** Implementation of integrated telecommunications systems\n\nMilan Italy EUR 10,000 50.00 HMS IT S.p.A. 50.00\n\n**UNIFER NAVALE S.r.l. in liquidazione** _In liquidation_ Finale Emilia (MO) Italy EUR 150,000 20.00 Società per l'Esercizio di Attività Finanziarie - S.E.A.F. S.p.A. 20.00\n\n**2F PER VADO S.c.a.r.l.** Execution of works for the construction of the \"New Vado Ligure Breakwater\" Genoa Italy EUR 10,000 49.00 Fincantieri Infrastructure Opere Marittime S.p.A. 49.00\n\n**CITTÀ SALUTE RICERCA MILANO S.p.A.** Construction activities and other civil engineering works n.e.c. Milan Italy EUR 5,000,000 30.00 Fincantieri INfrastrutture SOciali S.p.A. 27.00\n\n**CISAR COSTRUZIONI S.c.a.r.l.** Design and execution activities Milan Italy EUR 100,000 30.00 Fincantieri INfrastrutture SOciali S.p.A. 27.00\n\n**NOTE GESTIONE S.c.a.r.l.** Installation of plumbing in buildings Reggio Emilia Italy EUR 20,000 34.00 SOF S.p.A. 30.60\n\n**S.ENE.CA GESTIONI S.c.a.r.l.** Other business support service activities Florence Italy EUR 10,000 49.00 SOF S.p.A. 44.10\n\n**HOSPITAL BUILDING TECHNOLOGIES S.c.a.r.l.** Sale and purchase of real estate on own goods Florence Italy EUR 10,000 20.00 SOF S.p.A. 18.00\n\n**BIOTECA S.c.a.r.l.** Execution of contracts for the supply and installation of furniture and furnishings\n\nCarpi (MO) Italy EUR 100,000 33.33 SOF S.p.A. 30.00\n\n**ENERGETIKA S.c.a.r.l.** _Inactive_ Florence Italy EUR 10,000 40.00 SOF S.p.A. 36.00\n\n**PERGENOVA BREAKWATER** Construction of the new breakwater for the port of Genoa within the Sampierdarena basin Genoa Italy EUR 10,000 25.00 Fincantieri Infrastructure Opere Marittime S.p.A. 25.00\n\n**BREVIK TECHNOLOGY AS** Technology licences and patents Norway Norway NOK 1,050,000 34.00 Vard Group AS 33.45\n\n**SOLSTAD SUPPLY AS** Shipowner Norway Norway NOK 345,003,000 26.66 Vard Group AS 26.23\n\n**ISLAND OFFSHORE XII SHIP AS** Shipowner Norway Norway NOK 404,097,000 42.20 Vard Group AS 41.52\n\n**CASTOR DRILLING SOLUTION AS** Offshore drilling technology Norway Norway NOK 229,710 34.13 Seaonics AS 33.58\n\n**CSS DESIGN LIMITED** Design and engineering United Kingdom United Kingdom GBP 100 31.00 Vard Marine Inc. 30.50\n\n**REMAC S.r.l.** Machinery construction activities Trieste Italy EUR 200,000 49.00 Remazel Engineering S.p.A. 49.00\n\n**VBF NAUTICA S.r.l.** Business, administrative and management consulting, planning and digital and innovative IT services with high technological value in the marine, maritime and port segments\n\nGenoa Italy EUR 50,000 12.50 Fincantieri S.p.A. 12.50"],"full_content":"135 134\n\nReport on operations at 30 June 2024 Condensed Consolidated Interim Financial Statements at 30 June 2024 The Fincantieri Group **Notes to the Condensed Consolidated Interim Financial Statements**\n\n**Business activity Registered office Countries in which they operate Share Capital % interest held % consolidated by Group**\n\n**JOINT VENTURES CONSOLIDATED USING THE EQUITY METHOD**\n\n**ORIZZONTE SISTEMI NAVALI S.p.A.** Provision of naval surface vessels equipped with weapons systems Genoa Italy Algeria EUR 20,000,000 51.00 Fincantieri S.p.A. 51.00\n\n**ETIHAD SHIP BUILDING LLC** Design, production and sale of civilian and naval ships United Arab Emirates United Arab Emirates AED 2,500,000 35.00 Fincantieri S.p.A. 35.00\n\n**NAVIRIS S.p.A.** Design and manufacture of ships for naval or government use Genoa Italy EUR 5,000,000 50.00 Fincantieri S.p.A. 50.00\n\n**NAVIRIS FRANCE SAS** Shipbuilding France France EUR 100,000 100.00 Naviris S.p.A. 50.00\n\n**CSSC - FINCANTIERI CRUISE INDUSTRY DEVELOPMENT LIMITED** Design and marketing of cruise ships China China EUR 140,000,000 40.00 Fincantieri S.p.A. 40.00\n\n**CSSC - FINCANTIERI (SHANGHAI) CRUISE DESIGN LIMITED** Engineering, Project Management and Supply Chain Management China China RMB 1,000,000 100.00 CSSC - Fincantieri Cruise Industry Development Limited 40.00\n\n**CONSORZIO F.S.B.** Building construction Marghera (VE) Italy EUR 15,000 58.36 Fincantieri S.p.A 58.36\n\n**BUSBAR4F S.c.a.r.l.** Complete execution of contract ITER BUSBARF4 Trieste Italy France EUR 40,000 10.00 50.00 Fincantieri S.p.A. Fincantieri SI S.p.A. 60.00\n\n**4TCC1 - S.c.a.r.l.** Complete execution of the Tokamak Complex Contract Trieste Italy France EUR 100,000 5.00 75.00 Fincantieri S.p.A. Fincantieri SI S.p.A. 80.00\n\n**4B3 S.c.a.r.l.** Complete execution of contract BOP3 Trieste Italy France EUR 50,000 2.50 52.50 Fincantieri S.p.A. Fincantieri SI S.p.A. 55.00\n\n**4TB13 S.c.a.r.l.** _Inactive_ Trieste Italy France EUR 50,000 55.00 Fincantieri SI S.p.A. 55.00\n\n**FINMESA S.c.a.r.l. in liquidazione** _In liquidation_ Milan Italy EUR 20,000 50.00 Fincantieri SI S.p.A. 50.00\n\n**ERSMA 2026 S.c.a.r.l.** Demolition and dismantling of buildings and other structures Piacenza Italy EUR 10,000 20.00 Fincantieri SI S.p.A. 20.00\n\n**FINCANTIERI CLEA BUILDINGS S.c.a.r.l. in liquidazione** _In liquidation_ Milan Italy EUR 10,000 51.00 Fincantieri Infrastructure S.p.A. 51.00\n\n**DARSENA EUROPA S.c.a.r.l.** Execution of the Europa Platform of the Port of Livorno Rome Italy EUR 10,000 26.00 Fincantieri Infrastructure Opere Marittime S.p.A. 26.00\n\n**NUOVO SANTA CHIARA HOSPITAL S.c.a r.l.** Construction of hospital buildings Florence Italy EUR 300,000 50.00 Fincantieri INfrastrutture SOciali S.p.A. 45.00\n\n**VIMERCATE SALUTE GESTIONI S.c.a.r.l.** Other business support service activities n.e.c. Milan Italy EUR 10,000 3.65 49.10 SOF S.p.A. Fincantieri INfrastrutture SOciali S.p.A. 47.48\n\n**4TB21 S.c.a.r.l.** Unitary execution of the framework agreement for the TOKAMAK Complex Contract - TB21 Trieste Italy EUR 10,000 51.00 Fincantieri S.p.A. 51.00\n\n**TCM S.c.a.r.l.** Design and execution of works relating to the contract for the \"Construction of the offshore platform at the Port of Venice - Terminal Container \"Montesyndial\" - 1st section\"\n\nRome Italy EUR 10,000 41.56 Fincantieri Infrastructure Opere Marittime S.p.A. 41.56\n\n**CONSORZIO RAVENNA DIGA OFFSHORE S.c.a.r.l.** _Inactive_ Genoa Italy EUR 10,000 31.50 Fincantieri Infrastructure Opere Marittime S.p.A. 31.50\n\n**Business activity Registered office Countries in which they operate Share Capital % interest held % consolidated by Group**\n\n**ASSOCIATES CONSOLIDATED USING THE EQUITY METHOD**\n\n**CENTRO SERVIZI NAVALI S.p.A.** Processing and production of metal products\n\nSan Giorgio di Nogaro (UD) Italy EUR 5,620,618 10.93 Fincantieri S.p.A. 10.93\n\n**GRUPPO PSC S.p.A.** Design and installation of systems Maratea (PZ) Italy Denmark EUR 1,431,112 10.00 Fincantieri S.p.A. 10.00\n\n**DECOMAR S.p.A.** Development of innovative solutions for environmental restoration Massa (MS) Italy EUR 2,500,000 20.00 Fincantieri S.p.A. 20.00\n\n**DIDO S.r.l.** Activities in the field of decision intelligence Milan Italy EUR 142,801 30.00 Fincantieri S.p.A. 30.00\n\n**PRELIOS SOLUTIONS & TECHNOLOGIES S.r.l.** Realization and management of technological installations in the industrial, civil and defence sectors Milan Italy EUR 50,000 49.00 Fincantieri NexTech S.p.A 49.00\n\n**STARS RAILWAY SYSTEMS** Production of radar products for railway safety Rome Italy EUR 300,000 48.00 2.00 IDS Ingegneria Dei Sistemi S.p.A. TRS Sistemi S.r.l. 50.00\n\n**ITS INTEGRATED TECH SYSTEM S.r.l.** _Inactive_ La Spezia Italy EUR 10,000 51.00 Rob.Int S.r.l. 51.00\n\n**MC4COM - MISSION CRITICAL FOR COMMUNICATIONS SOCIETÀ CONSORTILE S.r.l.** Implementation of integrated telecommunications systems\n\nMilan Italy EUR 10,000 50.00 HMS IT S.p.A. 50.00\n\n**UNIFER NAVALE S.r.l. in liquidazione** _In liquidation_ Finale Emilia (MO) Italy EUR 150,000 20.00 Società per l'Esercizio di Attività Finanziarie - S.E.A.F. S.p.A. 20.00\n\n**2F PER VADO S.c.a.r.l.** Execution of works for the construction of the \"New Vado Ligure Breakwater\" Genoa Italy EUR 10,000 49.00 Fincantieri Infrastructure Opere Marittime S.p.A. 49.00\n\n**CITTÀ SALUTE RICERCA MILANO S.p.A.** Construction activities and other civil engineering works n.e.c. Milan Italy EUR 5,000,000 30.00 Fincantieri INfrastrutture SOciali S.p.A. 27.00\n\n**CISAR COSTRUZIONI S.c.a.r.l.** Design and execution activities Milan Italy EUR 100,000 30.00 Fincantieri INfrastrutture SOciali S.p.A. 27.00\n\n**NOTE GESTIONE S.c.a.r.l.** Installation of plumbing in buildings Reggio Emilia Italy EUR 20,000 34.00 SOF S.p.A. 30.60\n\n**S.ENE.CA GESTIONI S.c.a.r.l.** Other business support service activities Florence Italy EUR 10,000 49.00 SOF S.p.A. 44.10\n\n**HOSPITAL BUILDING TECHNOLOGIES S.c.a.r.l.** Sale and purchase of real estate on own goods Florence Italy EUR 10,000 20.00 SOF S.p.A. 18.00\n\n**BIOTECA S.c.a.r.l.** Execution of contracts for the supply and installation of furniture and furnishings\n\nCarpi (MO) Italy EUR 100,000 33.33 SOF S.p.A. 30.00\n\n**ENERGETIKA S.c.a.r.l.** _Inactive_ Florence Italy EUR 10,000 40.00 SOF S.p.A. 36.00\n\n**PERGENOVA BREAKWATER** Construction of the new breakwater for the port of Genoa within the Sampierdarena basin Genoa Italy EUR 10,000 25.00 Fincantieri Infrastructure Opere Marittime S.p.A. 25.00\n\n**BREVIK TECHNOLOGY AS** Technology licences and patents Norway Norway NOK 1,050,000 34.00 Vard Group AS 33.45\n\n**SOLSTAD SUPPLY AS** Shipowner Norway Norway NOK 345,003,000 26.66 Vard Group AS 26.23\n\n**ISLAND OFFSHORE XII SHIP AS** Shipowner Norway Norway NOK 404,097,000 42.20 Vard Group AS 41.52\n\n**CASTOR DRILLING SOLUTION AS** Offshore drilling technology Norway Norway NOK 229,710 34.13 Seaonics AS 33.58\n\n**CSS DESIGN LIMITED** Design and engineering United Kingdom United Kingdom GBP 100 31.00 Vard Marine Inc. 30.50\n\n**REMAC S.r.l.** Machinery construction activities Trieste Italy EUR 200,000 49.00 Remazel Engineering S.p.A. 49.00\n\n**VBF NAUTICA S.r.l.** Business, administrative and management consulting, planning and digital and innovative IT services with high technological value in the marine, maritime and port segments\n\nGenoa Italy EUR 50,000 12.50 Fincantieri S.p.A. 12.50","publish_date":null,"title":"Report on operations at 30 June 2024","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/0000027_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/0000027_page1.pdf"},"request":{"example_id":"table/0000027_page1","product_type":"parse","source_file_path":"0000027_page1.pdf"},"started_at":"2026-11-04T19:47:42.886183"} +{"completed_at":"2026-11-04T19:47:45.085341","latency_in_ms":1407,"output":{"example_id":"table/1 timetable (1)_page2","grounded_pages":[],"layout_pages":[],"markdown":"### **Weekdays to The Bronx**\n\n**Notes**\n\n**South Ferry**\n\n**Chambers St**\n\n**Times Sq**\n\n**42 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**96 St**\n\n**103 St**\n\n**137 St**\n\n**City College**\n\n**168 St**\n\n**Washington Hts**\n\n**Dyckman St**\n\n**215 St**\n\n**238 St**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**Mon** 12:00 12:04 12:17 12:23 12:28 12:30 12:36 12:42 12:46 12:49 12:56 12:57\n\n**xMon** 12:09 12:13 12:26 12:31 12:36 12:38 12:44 12:49 12:54 12:57 1:05 1:07\n\n**Mon** 12:14 12:18 12:31 12:37 12:42 12:44 12:50 12:56 1:00 1:03 1:10 1:11\n\n**xMon** 12:19 12:23 12:36 12:41 12:46 12:48 12:54 12:59 1:04 1:07 1:15 1:17\n\n**Mon** 12:28 12:32 12:45 12:51 12:56 12:58 1:04 1:10 1:14 1:17 1:24 1:25\n\n**xMon** 12:32 12:36 12:49 12:54 12:59 1:01 1:07 1:12 1:17 1:20 1:28 1:30\n\n**xMon** 12:45 12:49 1:02 1:07 1:13 1:14 1:20 1:25 1:30 1:33 1:41 1:43\n\n**Mon** 12:45 12:49 1:02 1:08 1:13 1:15 1:21 1:27 1:31 1:34 1:41 1:42\n\n**xMon** 12:59 1:03 1:16 1:21 1:26 1:28 1:34 1:39 1:44 1:47 1:55 1:57\n\n**Mon** 1:00 1:04 1:17 1:23 1:28 1:30 1:36 1:42 1:46 1:49 1:56 1:57\n\n1:14 1:18 1:31 1:36 1:42 1:43 1:49 1:54 1:59 2:02 2:10 2:12\n\n1:34 1:38 1:51 1:56 2:02 2:03 2:09 2:14 2:19 2:22 2:30 2:32\n\n1:54 1:58 2:11 2:16 2:22 2:23 2:29 2:34 2:39 2:42 2:50 2:52\n\n2:14 2:18 2:31 2:36 2:42 2:43 2:49 2:54 2:59 3:02 3:10 3:12\n\n2:34 2:38 2:51 2:56 3:02 3:03 3:09 3:14 3:19 3:22 3:30 3:32\n\n2:54 2:58 3:11 3:16 3:22 3:23 3:29 3:34 3:39 3:42 3:50 3:52\n\n3:14 3:18 3:31 3:36 3:42 3:43 3:49 3:54 3:59 4:02 4:10 4:12\n\n3:34 3:38 3:51 3:56 4:02 4:03 4:09 4:14 4:19 4:22 4:30 4:32\n\n3:54 3:58 4:11 4:16 4:22 4:23 4:29 4:34 4:39 4:42 4:50 4:52\n\n4:14 4:18 4:31 4:36 4:42 4:43 4:49 4:54 4:59 5:02 5:10 5:12\n\n4:34 4:38 4:51 4:56 5:02 5:03 5:09 5:14 5:19 5:22 5:29 5:31\n\n4:54 4:58 5:11 5:16 5:22 5:23 5:29 5:34 5:39 5:42 5:47 5:49\n\n5:14 5:18 5:31 5:36 5:42 5:43 5:49 5:54 5:59 6:02 6:07 6:09\n\n5:34 5:38 5:51 5:56 6:02 6:03 6:09 6:14 6:19 6:22 6:27 6:29\n\n5:48 5:52 6:05 6:10 6:16 6:17 6:23 6:28 6:33 6:36 6:41 6:43\n\n6:01 6:05 6:18 6:23 6:28 6:30 6:36 6:41 6:46 6:49 6:53 6:55\n\n6:11 6:15 6:28 6:33 6:38 6:40 6:46 6:51 6:56 6:59 7:03 7:05\n\n6:21 6:25 6:38 6:43 6:48 6:50 6:56 7:01 7:06 7:09 7:14 7:16\n\n6:31 6:35 6:48 6:53 6:58 7:00 7:06 7:11 7:16 7:19 7:25 7:27\n\n6:39 6:43 6:56 7:01 7:06 7:08 7:14 7:19 7:24 7:27 7:31 7:33\n\n6:47 6:51 7:04 7:09 7:14 7:16 7:22 7:27 7:32 7:35 7:40 7:42\n\n6:55 6:59 7:12 7:17 7:22 7:24 7:30 7:36 7:41 7:44 7:48 7:50\n\n7:03 7:07 7:20 7:25 7:31 7:32 7:39 7:44 7:49 7:52 7:57 7:59\n\n7:11 7:15 7:28 7:33 7:39 7:40 7:47 7:52 7:57 8:00 8:06 8:08\n\n7:19 7:23 7:36 7:41 7:47 7:49 7:55 8:01 8:06 8:09 8:13 8:15\n\n7:26 7:30 7:43 7:48 7:54 7:56 8:02 8:08 8:13 8:16 8:20 8:22\n\n7:32 7:36 7:49 7:54 8:00 8:02 8:08 8:14 8:19 8:22 8:26 8:28\n\n7:38 7:42 7:55 8:00 8:06 8:08 8:14 8:20 8:25 8:28 8:32 8:34\n\n7:44 7:48 8:01 8:06 8:12 8:14 8:20 8:26 8:31 8:34 8:38 8:40\n\n7:50 7:54 8:07 8:12 8:18 8:20 8:26\n\n7:55 7:59 8:12 8:17 8:23 8:25 8:31 8:37 8:42 8:45 8:49 8:51\n\n8:00 8:04 8:17 8:22 8:28 8:30 8:36 8:42 8:47 8:50 8:54 8:56\n\n8:05 8:09 8:22 8:27 8:34 8:35 8:42\n\n8:10 8:14 8:27 8:32 8:38 8:40 8:46 8:52 8:57 9:00 9:04 9:06\n\n8:14 8:18 8:31 8:36 8:42 8:44 8:50 8:56 9:01 9:04 9:08 9:10\n\n8:18 8:22 8:35 8:40 8:46 8:48 8:54\n\n8:22 8:27 8:40 8:45 8:51 8:52 8:59 9:04 9:09 9:12 9:17 9:19\n\n8:26 8:31 8:44 8:49 8:55 8:56 9:03 9:08 9:13 9:16 9:20 9:22\n\n8:29 8:34 8:47 8:52 8:58 9:00 9:06 9:11 9:16 9:19 9:24 9:26\n\n8:33 8:38 8:51 8:56 9:02 9:04 9:10\n\nPage 2 of 28","pages":[{"line_numbers":[],"markdown":"### **Weekdays to The Bronx**\n\n**Notes**\n\n**South Ferry**\n\n**Chambers St**\n\n**Times Sq**\n\n**42 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**96 St**\n\n**103 St**\n\n**137 St**\n\n**City College**\n\n**168 St**\n\n**Washington Hts**\n\n**Dyckman St**\n\n**215 St**\n\n**238 St**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**Mon** 12:00 12:04 12:17 12:23 12:28 12:30 12:36 12:42 12:46 12:49 12:56 12:57\n\n**xMon** 12:09 12:13 12:26 12:31 12:36 12:38 12:44 12:49 12:54 12:57 1:05 1:07\n\n**Mon** 12:14 12:18 12:31 12:37 12:42 12:44 12:50 12:56 1:00 1:03 1:10 1:11\n\n**xMon** 12:19 12:23 12:36 12:41 12:46 12:48 12:54 12:59 1:04 1:07 1:15 1:17\n\n**Mon** 12:28 12:32 12:45 12:51 12:56 12:58 1:04 1:10 1:14 1:17 1:24 1:25\n\n**xMon** 12:32 12:36 12:49 12:54 12:59 1:01 1:07 1:12 1:17 1:20 1:28 1:30\n\n**xMon** 12:45 12:49 1:02 1:07 1:13 1:14 1:20 1:25 1:30 1:33 1:41 1:43\n\n**Mon** 12:45 12:49 1:02 1:08 1:13 1:15 1:21 1:27 1:31 1:34 1:41 1:42\n\n**xMon** 12:59 1:03 1:16 1:21 1:26 1:28 1:34 1:39 1:44 1:47 1:55 1:57\n\n**Mon** 1:00 1:04 1:17 1:23 1:28 1:30 1:36 1:42 1:46 1:49 1:56 1:57\n\n1:14 1:18 1:31 1:36 1:42 1:43 1:49 1:54 1:59 2:02 2:10 2:12\n\n1:34 1:38 1:51 1:56 2:02 2:03 2:09 2:14 2:19 2:22 2:30 2:32\n\n1:54 1:58 2:11 2:16 2:22 2:23 2:29 2:34 2:39 2:42 2:50 2:52\n\n2:14 2:18 2:31 2:36 2:42 2:43 2:49 2:54 2:59 3:02 3:10 3:12\n\n2:34 2:38 2:51 2:56 3:02 3:03 3:09 3:14 3:19 3:22 3:30 3:32\n\n2:54 2:58 3:11 3:16 3:22 3:23 3:29 3:34 3:39 3:42 3:50 3:52\n\n3:14 3:18 3:31 3:36 3:42 3:43 3:49 3:54 3:59 4:02 4:10 4:12\n\n3:34 3:38 3:51 3:56 4:02 4:03 4:09 4:14 4:19 4:22 4:30 4:32\n\n3:54 3:58 4:11 4:16 4:22 4:23 4:29 4:34 4:39 4:42 4:50 4:52\n\n4:14 4:18 4:31 4:36 4:42 4:43 4:49 4:54 4:59 5:02 5:10 5:12\n\n4:34 4:38 4:51 4:56 5:02 5:03 5:09 5:14 5:19 5:22 5:29 5:31\n\n4:54 4:58 5:11 5:16 5:22 5:23 5:29 5:34 5:39 5:42 5:47 5:49\n\n5:14 5:18 5:31 5:36 5:42 5:43 5:49 5:54 5:59 6:02 6:07 6:09\n\n5:34 5:38 5:51 5:56 6:02 6:03 6:09 6:14 6:19 6:22 6:27 6:29\n\n5:48 5:52 6:05 6:10 6:16 6:17 6:23 6:28 6:33 6:36 6:41 6:43\n\n6:01 6:05 6:18 6:23 6:28 6:30 6:36 6:41 6:46 6:49 6:53 6:55\n\n6:11 6:15 6:28 6:33 6:38 6:40 6:46 6:51 6:56 6:59 7:03 7:05\n\n6:21 6:25 6:38 6:43 6:48 6:50 6:56 7:01 7:06 7:09 7:14 7:16\n\n6:31 6:35 6:48 6:53 6:58 7:00 7:06 7:11 7:16 7:19 7:25 7:27\n\n6:39 6:43 6:56 7:01 7:06 7:08 7:14 7:19 7:24 7:27 7:31 7:33\n\n6:47 6:51 7:04 7:09 7:14 7:16 7:22 7:27 7:32 7:35 7:40 7:42\n\n6:55 6:59 7:12 7:17 7:22 7:24 7:30 7:36 7:41 7:44 7:48 7:50\n\n7:03 7:07 7:20 7:25 7:31 7:32 7:39 7:44 7:49 7:52 7:57 7:59\n\n7:11 7:15 7:28 7:33 7:39 7:40 7:47 7:52 7:57 8:00 8:06 8:08\n\n7:19 7:23 7:36 7:41 7:47 7:49 7:55 8:01 8:06 8:09 8:13 8:15\n\n7:26 7:30 7:43 7:48 7:54 7:56 8:02 8:08 8:13 8:16 8:20 8:22\n\n7:32 7:36 7:49 7:54 8:00 8:02 8:08 8:14 8:19 8:22 8:26 8:28\n\n7:38 7:42 7:55 8:00 8:06 8:08 8:14 8:20 8:25 8:28 8:32 8:34\n\n7:44 7:48 8:01 8:06 8:12 8:14 8:20 8:26 8:31 8:34 8:38 8:40\n\n7:50 7:54 8:07 8:12 8:18 8:20 8:26\n\n7:55 7:59 8:12 8:17 8:23 8:25 8:31 8:37 8:42 8:45 8:49 8:51\n\n8:00 8:04 8:17 8:22 8:28 8:30 8:36 8:42 8:47 8:50 8:54 8:56\n\n8:05 8:09 8:22 8:27 8:34 8:35 8:42\n\n8:10 8:14 8:27 8:32 8:38 8:40 8:46 8:52 8:57 9:00 9:04 9:06\n\n8:14 8:18 8:31 8:36 8:42 8:44 8:50 8:56 9:01 9:04 9:08 9:10\n\n8:18 8:22 8:35 8:40 8:46 8:48 8:54\n\n8:22 8:27 8:40 8:45 8:51 8:52 8:59 9:04 9:09 9:12 9:17 9:19\n\n8:26 8:31 8:44 8:49 8:55 8:56 9:03 9:08 9:13 9:16 9:20 9:22\n\n8:29 8:34 8:47 8:52 8:58 9:00 9:06 9:11 9:16 9:19 9:24 9:26\n\n8:33 8:38 8:51 8:56 9:02 9:04 9:10\n\nPage 2 of 28","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Weekdays to The Bronx**\n\n**Notes**\n\n**South Ferry**\n\n**Chambers St**\n\n**Times Sq**\n\n**42 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**96 St**\n\n**103 St**\n\n**137 St**\n\n**City College**\n\n**168 St**\n\n**Washington Hts**\n\n**Dyckman St**\n\n**215 St**\n\n**238 St**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**Mon** 12:00 12:04 12:17 12:23 12:28 12:30 12:36 12:42 12:46 12:49 12:56 12:57\n\n**xMon** 12:09 12:13 12:26 12:31 12:36 12:38 12:44 12:49 12:54 12:57 1:05 1:07\n\n**Mon** 12:14 12:18 12:31 12:37 12:42 12:44 12:50 12:56 1:00 1:03 1:10 1:11\n\n**xMon** 12:19 12:23 12:36 12:41 12:46 12:48 12:54 12:59 1:04 1:07 1:15 1:17\n\n**Mon** 12:28 12:32 12:45 12:51 12:56 12:58 1:04 1:10 1:14 1:17 1:24 1:25\n\n**xMon** 12:32 12:36 12:49 12:54 12:59 1:01 1:07 1:12 1:17 1:20 1:28 1:30\n\n**xMon** 12:45 12:49 1:02 1:07 1:13 1:14 1:20 1:25 1:30 1:33 1:41 1:43\n\n**Mon** 12:45 12:49 1:02 1:08 1:13 1:15 1:21 1:27 1:31 1:34 1:41 1:42\n\n**xMon** 12:59 1:03 1:16 1:21 1:26 1:28 1:34 1:39 1:44 1:47 1:55 1:57\n\n**Mon** 1:00 1:04 1:17 1:23 1:28 1:30 1:36 1:42 1:46 1:49 1:56 1:57\n\n1:14 1:18 1:31 1:36 1:42 1:43 1:49 1:54 1:59 2:02 2:10 2:12\n\n1:34 1:38 1:51 1:56 2:02 2:03 2:09 2:14 2:19 2:22 2:30 2:32\n\n1:54 1:58 2:11 2:16 2:22 2:23 2:29 2:34 2:39 2:42 2:50 2:52\n\n2:14 2:18 2:31 2:36 2:42 2:43 2:49 2:54 2:59 3:02 3:10 3:12\n\n2:34 2:38 2:51 2:56 3:02 3:03 3:09 3:14 3:19 3:22 3:30 3:32\n\n2:54 2:58 3:11 3:16 3:22 3:23 3:29 3:34 3:39 3:42 3:50 3:52\n\n3:14 3:18 3:31 3:36 3:42 3:43 3:49 3:54 3:59 4:02 4:10 4:12\n\n3:34 3:38 3:51 3:56 4:02 4:03 4:09 4:14 4:19 4:22 4:30 4:32\n\n3:54 3:58 4:11 4:16 4:22 4:23 4:29 4:34 4:39 4:42 4:50 4:52\n\n4:14 4:18 4:31 4:36 4:42 4:43 4:49 4:54 4:59 5:02 5:10 5:12\n\n4:34 4:38 4:51 4:56 5:02 5:03 5:09 5:14 5:19 5:22 5:29 5:31\n\n4:54 4:58 5:11 5:16 5:22 5:23 5:29 5:34 5:39 5:42 5:47 5:49\n\n5:14 5:18 5:31 5:36 5:42 5:43 5:49 5:54 5:59 6:02 6:07 6:09\n\n5:34 5:38 5:51 5:56 6:02 6:03 6:09 6:14 6:19 6:22 6:27 6:29\n\n5:48 5:52 6:05 6:10 6:16 6:17 6:23 6:28 6:33 6:36 6:41 6:43\n\n6:01 6:05 6:18 6:23 6:28 6:30 6:36 6:41 6:46 6:49 6:53 6:55\n\n6:11 6:15 6:28 6:33 6:38 6:40 6:46 6:51 6:56 6:59 7:03 7:05\n\n6:21 6:25 6:38 6:43 6:48 6:50 6:56 7:01 7:06 7:09 7:14 7:16\n\n6:31 6:35 6:48 6:53 6:58 7:00 7:06 7:11 7:16 7:19 7:25 7:27\n\n6:39 6:43 6:56 7:01 7:06 7:08 7:14 7:19 7:24 7:27 7:31 7:33\n\n6:47 6:51 7:04 7:09 7:14 7:16 7:22 7:27 7:32 7:35 7:40 7:42\n\n6:55 6:59 7:12 7:17 7:22 7:24 7:30 7:36 7:41 7:44 7:48 7:50\n\n7:03 7:07 7:20 7:25 7:31 7:32 7:39 7:44 7:49 7:52 7:57 7:59\n\n7:11 7:15 7:28 7:33 7:39 7:40 7:47 7:52 7:57 8:00 8:06 8:08\n\n7:19 7:23 7:36 7:41 7:47 7:49 7:55 8:01 8:06 8:09 8:13 8:15\n\n7:26 7:30 7:43 7:48 7:54 7:56 8:02 8:08 8:13 8:16 8:20 8:22\n\n7:32 7:36 7:49 7:54 8:00 8:02 8:08 8:14 8:19 8:22 8:26 8:28\n\n7:38 7:42 7:55 8:00 8:06 8:08 8:14 8:20 8:25 8:28 8:32 8:34\n\n7:44 7:48 8:01 8:06 8:12 8:14 8:20 8:26 8:31 8:34 8:38 8:40\n\n7:50 7:54 8:07 8:12 8:18 8:20 8:26\n\n7:55 7:59 8:12 8:17 8:23 8:25 8:31 8:37 8:42 8:45 8:49 8:51\n\n8:00 8:04 8:17 8:22 8:28 8:30 8:36 8:42 8:47 8:50 8:54 8:56\n\n8:05 8:09 8:22 8:27 8:34 8:35 8:42\n\n8:10 8:14 8:27 8:32 8:38 8:40 8:46 8:52 8:57 9:00 9:04 9:06\n\n8:14 8:18 8:31 8:36 8:42 8:44 8:50 8:56 9:01 9:04 9:08 9:10\n\n8:18 8:22 8:35 8:40 8:46 8:48 8:54\n\n8:22 8:27 8:40 8:45 8:51 8:52 8:59 9:04 9:09 9:12 9:17 9:19\n\n8:26 8:31 8:44 8:49 8:55 8:56 9:03 9:08 9:13 9:16 9:20 9:22\n\n8:29 8:34 8:47 8:52 8:58 9:00 9:06 9:11 9:16 9:19 9:24 9:26\n\n8:33 8:38 8:51 8:56 9:02 9:04 9:10\n\nPage 2 of 28","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_bf993feaeeb3bad74a99c35d0ba4fcd3","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Weekdays to The Bronx**\n\n**Notes**\n\n**South Ferry**\n\n**Chambers St**\n\n**Times Sq**\n\n**42 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**96 St**\n\n**103 St**\n\n**137 St**\n\n**City College**\n\n**168 St**\n\n**Washington Hts**\n\n**Dyckman St**\n\n**215 St**\n\n**238 St**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**Mon** 12:00 12:04 12:17 12:23 12:28 12:30 12:36 12:42 12:46 12:49 12:56 12:57\n\n**xMon** 12:09 12:13 12:26 12:31 12:36 12:38 12:44 12:49 12:54 12:57 1:05 1:07\n\n**Mon** 12:14 12:18 12:31 12:37 12:42 12:44 12:50 12:56 1:00 1:03 1:10 1:11\n\n**xMon** 12:19 12:23 12:36 12:41 12:46 12:48 12:54 12:59 1:04 1:07 1:15 1:17\n\n**Mon** 12:28 12:32 12:45 12:51 12:56 12:58 1:04 1:10 1:14 1:17 1:24 1:25\n\n**xMon** 12:32 12:36 12:49 12:54 12:59 1:01 1:07 1:12 1:17 1:20 1:28 1:30\n\n**xMon** 12:45 12:49 1:02 1:07 1:13 1:14 1:20 1:25 1:30 1:33 1:41 1:43\n\n**Mon** 12:45 12:49 1:02 1:08 1:13 1:15 1:21 1:27 1:31 1:34 1:41 1:42\n\n**xMon** 12:59 1:03 1:16 1:21 1:26 1:28 1:34 1:39 1:44 1:47 1:55 1:57\n\n**Mon** 1:00 1:04 1:17 1:23 1:28 1:30 1:36 1:42 1:46 1:49 1:56 1:57\n\n1:14 1:18 1:31 1:36 1:42 1:43 1:49 1:54 1:59 2:02 2:10 2:12\n\n1:34 1:38 1:51 1:56 2:02 2:03 2:09 2:14 2:19 2:22 2:30 2:32\n\n1:54 1:58 2:11 2:16 2:22 2:23 2:29 2:34 2:39 2:42 2:50 2:52\n\n2:14 2:18 2:31 2:36 2:42 2:43 2:49 2:54 2:59 3:02 3:10 3:12\n\n2:34 2:38 2:51 2:56 3:02 3:03 3:09 3:14 3:19 3:22 3:30 3:32\n\n2:54 2:58 3:11 3:16 3:22 3:23 3:29 3:34 3:39 3:42 3:50 3:52\n\n3:14 3:18 3:31 3:36 3:42 3:43 3:49 3:54 3:59 4:02 4:10 4:12\n\n3:34 3:38 3:51 3:56 4:02 4:03 4:09 4:14 4:19 4:22 4:30 4:32\n\n3:54 3:58 4:11 4:16 4:22 4:23 4:29 4:34 4:39 4:42 4:50 4:52\n\n4:14 4:18 4:31 4:36 4:42 4:43 4:49 4:54 4:59 5:02 5:10 5:12\n\n4:34 4:38 4:51 4:56 5:02 5:03 5:09 5:14 5:19 5:22 5:29 5:31\n\n4:54 4:58 5:11 5:16 5:22 5:23 5:29 5:34 5:39 5:42 5:47 5:49\n\n5:14 5:18 5:31 5:36 5:42 5:43 5:49 5:54 5:59 6:02 6:07 6:09\n\n5:34 5:38 5:51 5:56 6:02 6:03 6:09 6:14 6:19 6:22 6:27 6:29\n\n5:48 5:52 6:05 6:10 6:16 6:17 6:23 6:28 6:33 6:36 6:41 6:43\n\n6:01 6:05 6:18 6:23 6:28 6:30 6:36 6:41 6:46 6:49 6:53 6:55\n\n6:11 6:15 6:28 6:33 6:38 6:40 6:46 6:51 6:56 6:59 7:03 7:05\n\n6:21 6:25 6:38 6:43 6:48 6:50 6:56 7:01 7:06 7:09 7:14 7:16\n\n6:31 6:35 6:48 6:53 6:58 7:00 7:06 7:11 7:16 7:19 7:25 7:27\n\n6:39 6:43 6:56 7:01 7:06 7:08 7:14 7:19 7:24 7:27 7:31 7:33\n\n6:47 6:51 7:04 7:09 7:14 7:16 7:22 7:27 7:32 7:35 7:40 7:42\n\n6:55 6:59 7:12 7:17 7:22 7:24 7:30 7:36 7:41 7:44 7:48 7:50\n\n7:03 7:07 7:20 7:25 7:31 7:32 7:39 7:44 7:49 7:52 7:57 7:59\n\n7:11 7:15 7:28 7:33 7:39 7:40 7:47 7:52 7:57 8:00 8:06 8:08\n\n7:19 7:23 7:36 7:41 7:47 7:49 7:55 8:01 8:06 8:09 8:13 8:15\n\n7:26 7:30 7:43 7:48 7:54 7:56 8:02 8:08 8:13 8:16 8:20 8:22\n\n7:32 7:36 7:49 7:54 8:00 8:02 8:08 8:14 8:19 8:22 8:26 8:28\n\n7:38 7:42 7:55 8:00 8:06 8:08 8:14 8:20 8:25 8:28 8:32 8:34\n\n7:44 7:48 8:01 8:06 8:12 8:14 8:20 8:26 8:31 8:34 8:38 8:40\n\n7:50 7:54 8:07 8:12 8:18 8:20 8:26\n\n7:55 7:59 8:12 8:17 8:23 8:25 8:31 8:37 8:42 8:45 8:49 8:51\n\n8:00 8:04 8:17 8:22 8:28 8:30 8:36 8:42 8:47 8:50 8:54 8:56\n\n8:05 8:09 8:22 8:27 8:34 8:35 8:42\n\n8:10 8:14 8:27 8:32 8:38 8:40 8:46 8:52 8:57 9:00 9:04 9:06\n\n8:14 8:18 8:31 8:36 8:42 8:44 8:50 8:56 9:01 9:04 9:08 9:10\n\n8:18 8:22 8:35 8:40 8:46 8:48 8:54\n\n8:22 8:27 8:40 8:45 8:51 8:52 8:59 9:04 9:09 9:12 9:17 9:19\n\n8:26 8:31 8:44 8:49 8:55 8:56 9:03 9:08 9:13 9:16 9:20 9:22\n\n8:29 8:34 8:47 8:52 8:58 9:00 9:06 9:11 9:16 9:19 9:24 9:26\n\n8:33 8:38 8:51 8:56 9:02 9:04 9:10\n\nPage 2 of 28"],"full_content":"### **Weekdays to The Bronx**\n\n**Notes**\n\n**South Ferry**\n\n**Chambers St**\n\n**Times Sq**\n\n**42 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**96 St**\n\n**103 St**\n\n**137 St**\n\n**City College**\n\n**168 St**\n\n**Washington Hts**\n\n**Dyckman St**\n\n**215 St**\n\n**238 St**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**Mon** 12:00 12:04 12:17 12:23 12:28 12:30 12:36 12:42 12:46 12:49 12:56 12:57\n\n**xMon** 12:09 12:13 12:26 12:31 12:36 12:38 12:44 12:49 12:54 12:57 1:05 1:07\n\n**Mon** 12:14 12:18 12:31 12:37 12:42 12:44 12:50 12:56 1:00 1:03 1:10 1:11\n\n**xMon** 12:19 12:23 12:36 12:41 12:46 12:48 12:54 12:59 1:04 1:07 1:15 1:17\n\n**Mon** 12:28 12:32 12:45 12:51 12:56 12:58 1:04 1:10 1:14 1:17 1:24 1:25\n\n**xMon** 12:32 12:36 12:49 12:54 12:59 1:01 1:07 1:12 1:17 1:20 1:28 1:30\n\n**xMon** 12:45 12:49 1:02 1:07 1:13 1:14 1:20 1:25 1:30 1:33 1:41 1:43\n\n**Mon** 12:45 12:49 1:02 1:08 1:13 1:15 1:21 1:27 1:31 1:34 1:41 1:42\n\n**xMon** 12:59 1:03 1:16 1:21 1:26 1:28 1:34 1:39 1:44 1:47 1:55 1:57\n\n**Mon** 1:00 1:04 1:17 1:23 1:28 1:30 1:36 1:42 1:46 1:49 1:56 1:57\n\n1:14 1:18 1:31 1:36 1:42 1:43 1:49 1:54 1:59 2:02 2:10 2:12\n\n1:34 1:38 1:51 1:56 2:02 2:03 2:09 2:14 2:19 2:22 2:30 2:32\n\n1:54 1:58 2:11 2:16 2:22 2:23 2:29 2:34 2:39 2:42 2:50 2:52\n\n2:14 2:18 2:31 2:36 2:42 2:43 2:49 2:54 2:59 3:02 3:10 3:12\n\n2:34 2:38 2:51 2:56 3:02 3:03 3:09 3:14 3:19 3:22 3:30 3:32\n\n2:54 2:58 3:11 3:16 3:22 3:23 3:29 3:34 3:39 3:42 3:50 3:52\n\n3:14 3:18 3:31 3:36 3:42 3:43 3:49 3:54 3:59 4:02 4:10 4:12\n\n3:34 3:38 3:51 3:56 4:02 4:03 4:09 4:14 4:19 4:22 4:30 4:32\n\n3:54 3:58 4:11 4:16 4:22 4:23 4:29 4:34 4:39 4:42 4:50 4:52\n\n4:14 4:18 4:31 4:36 4:42 4:43 4:49 4:54 4:59 5:02 5:10 5:12\n\n4:34 4:38 4:51 4:56 5:02 5:03 5:09 5:14 5:19 5:22 5:29 5:31\n\n4:54 4:58 5:11 5:16 5:22 5:23 5:29 5:34 5:39 5:42 5:47 5:49\n\n5:14 5:18 5:31 5:36 5:42 5:43 5:49 5:54 5:59 6:02 6:07 6:09\n\n5:34 5:38 5:51 5:56 6:02 6:03 6:09 6:14 6:19 6:22 6:27 6:29\n\n5:48 5:52 6:05 6:10 6:16 6:17 6:23 6:28 6:33 6:36 6:41 6:43\n\n6:01 6:05 6:18 6:23 6:28 6:30 6:36 6:41 6:46 6:49 6:53 6:55\n\n6:11 6:15 6:28 6:33 6:38 6:40 6:46 6:51 6:56 6:59 7:03 7:05\n\n6:21 6:25 6:38 6:43 6:48 6:50 6:56 7:01 7:06 7:09 7:14 7:16\n\n6:31 6:35 6:48 6:53 6:58 7:00 7:06 7:11 7:16 7:19 7:25 7:27\n\n6:39 6:43 6:56 7:01 7:06 7:08 7:14 7:19 7:24 7:27 7:31 7:33\n\n6:47 6:51 7:04 7:09 7:14 7:16 7:22 7:27 7:32 7:35 7:40 7:42\n\n6:55 6:59 7:12 7:17 7:22 7:24 7:30 7:36 7:41 7:44 7:48 7:50\n\n7:03 7:07 7:20 7:25 7:31 7:32 7:39 7:44 7:49 7:52 7:57 7:59\n\n7:11 7:15 7:28 7:33 7:39 7:40 7:47 7:52 7:57 8:00 8:06 8:08\n\n7:19 7:23 7:36 7:41 7:47 7:49 7:55 8:01 8:06 8:09 8:13 8:15\n\n7:26 7:30 7:43 7:48 7:54 7:56 8:02 8:08 8:13 8:16 8:20 8:22\n\n7:32 7:36 7:49 7:54 8:00 8:02 8:08 8:14 8:19 8:22 8:26 8:28\n\n7:38 7:42 7:55 8:00 8:06 8:08 8:14 8:20 8:25 8:28 8:32 8:34\n\n7:44 7:48 8:01 8:06 8:12 8:14 8:20 8:26 8:31 8:34 8:38 8:40\n\n7:50 7:54 8:07 8:12 8:18 8:20 8:26\n\n7:55 7:59 8:12 8:17 8:23 8:25 8:31 8:37 8:42 8:45 8:49 8:51\n\n8:00 8:04 8:17 8:22 8:28 8:30 8:36 8:42 8:47 8:50 8:54 8:56\n\n8:05 8:09 8:22 8:27 8:34 8:35 8:42\n\n8:10 8:14 8:27 8:32 8:38 8:40 8:46 8:52 8:57 9:00 9:04 9:06\n\n8:14 8:18 8:31 8:36 8:42 8:44 8:50 8:56 9:01 9:04 9:08 9:10\n\n8:18 8:22 8:35 8:40 8:46 8:48 8:54\n\n8:22 8:27 8:40 8:45 8:51 8:52 8:59 9:04 9:09 9:12 9:17 9:19\n\n8:26 8:31 8:44 8:49 8:55 8:56 9:03 9:08 9:13 9:16 9:20 9:22\n\n8:29 8:34 8:47 8:52 8:58 9:00 9:06 9:11 9:16 9:19 9:24 9:26\n\n8:33 8:38 8:51 8:56 9:02 9:04 9:10\n\nPage 2 of 28","publish_date":null,"title":"Weekdays to The Bronx","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page2.pdf"},"request":{"example_id":"table/1 timetable (1)_page2","product_type":"parse","source_file_path":"1 timetable (1)_page2.pdf"},"started_at":"2026-11-04T19:47:43.678340"} +{"completed_at":"2026-11-04T19:47:47.992296","latency_in_ms":1164,"output":{"example_id":"table/1 timetable (1)_page27","grounded_pages":[],"layout_pages":[],"markdown":"### **Sundays to Manhattan**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**238 St**\n\n**Dyckman St**\n\n**168 St**\n\n**Washington Hts**\n\n**137 St**\n\n**City College**\n\n**103 St**\n\n**96 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**Times Sq**\n\n**42 St**\n\n**Chambers St**\n\n**South Ferry**\n\n**11:05 11:07 11:14 11:19 11:24 11:30 11:32 11:38 11:43 11:57** 12:02\n\n**11:20 11:22 11:29 11:34 11:39 11:45 11:47 11:53 11:58** 12:12 12:17\n\n**11:35 11:37 11:44 11:49 11:54** 12:00 12:02 12:08 12:13 12:27 12:32\n\n**11:52 11:54** 12:01 12:06 12:11 12:17 12:19 12:25 12:30 12:44 12:49\n\nPage 27 of 28","pages":[{"line_numbers":[],"markdown":"### **Sundays to Manhattan**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**238 St**\n\n**Dyckman St**\n\n**168 St**\n\n**Washington Hts**\n\n**137 St**\n\n**City College**\n\n**103 St**\n\n**96 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**Times Sq**\n\n**42 St**\n\n**Chambers St**\n\n**South Ferry**\n\n**11:05 11:07 11:14 11:19 11:24 11:30 11:32 11:38 11:43 11:57** 12:02\n\n**11:20 11:22 11:29 11:34 11:39 11:45 11:47 11:53 11:58** 12:12 12:17\n\n**11:35 11:37 11:44 11:49 11:54** 12:00 12:02 12:08 12:13 12:27 12:32\n\n**11:52 11:54** 12:01 12:06 12:11 12:17 12:19 12:25 12:30 12:44 12:49\n\nPage 27 of 28","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Sundays to Manhattan**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**238 St**\n\n**Dyckman St**\n\n**168 St**\n\n**Washington Hts**\n\n**137 St**\n\n**City College**\n\n**103 St**\n\n**96 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**Times Sq**\n\n**42 St**\n\n**Chambers St**\n\n**South Ferry**\n\n**11:05 11:07 11:14 11:19 11:24 11:30 11:32 11:38 11:43 11:57** 12:02\n\n**11:20 11:22 11:29 11:34 11:39 11:45 11:47 11:53 11:58** 12:12 12:17\n\n**11:35 11:37 11:44 11:49 11:54** 12:00 12:02 12:08 12:13 12:27 12:32\n\n**11:52 11:54** 12:01 12:06 12:11 12:17 12:19 12:25 12:30 12:44 12:49\n\nPage 27 of 28","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page27.pdf"]},"response":{"errors":[],"extract_id":"extract_46daebe9c90b385c81c8987157349ba8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Sundays to Manhattan**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**238 St**\n\n**Dyckman St**\n\n**168 St**\n\n**Washington Hts**\n\n**137 St**\n\n**City College**\n\n**103 St**\n\n**96 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**Times Sq**\n\n**42 St**\n\n**Chambers St**\n\n**South Ferry**\n\n**11:05 11:07 11:14 11:19 11:24 11:30 11:32 11:38 11:43 11:57** 12:02\n\n**11:20 11:22 11:29 11:34 11:39 11:45 11:47 11:53 11:58** 12:12 12:17\n\n**11:35 11:37 11:44 11:49 11:54** 12:00 12:02 12:08 12:13 12:27 12:32\n\n**11:52 11:54** 12:01 12:06 12:11 12:17 12:19 12:25 12:30 12:44 12:49\n\nPage 27 of 28"],"full_content":"### **Sundays to Manhattan**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**238 St**\n\n**Dyckman St**\n\n**168 St**\n\n**Washington Hts**\n\n**137 St**\n\n**City College**\n\n**103 St**\n\n**96 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**Times Sq**\n\n**42 St**\n\n**Chambers St**\n\n**South Ferry**\n\n**11:05 11:07 11:14 11:19 11:24 11:30 11:32 11:38 11:43 11:57** 12:02\n\n**11:20 11:22 11:29 11:34 11:39 11:45 11:47 11:53 11:58** 12:12 12:17\n\n**11:35 11:37 11:44 11:49 11:54** 12:00 12:02 12:08 12:13 12:27 12:32\n\n**11:52 11:54** 12:01 12:06 12:11 12:17 12:19 12:25 12:30 12:44 12:49\n\nPage 27 of 28","publish_date":null,"title":"Sundays to Manhattan","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page27.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page27.pdf"},"request":{"example_id":"table/1 timetable (1)_page27","product_type":"parse","source_file_path":"1 timetable (1)_page27.pdf"},"started_at":"2026-11-04T19:47:46.827326"} +{"completed_at":"2026-11-04T19:47:49.270994","latency_in_ms":1277,"output":{"example_id":"table/1 timetable (1)_page6","grounded_pages":[],"layout_pages":[],"markdown":"### **Weekdays to The Bronx**\n\n**Notes**\n\n**South Ferry**\n\n**Chambers St**\n\n**Times Sq**\n\n**42 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**96 St**\n\n**103 St**\n\n**137 St**\n\n**City College**\n\n**168 St**\n\n**Washington Hts**\n\n**Dyckman St**\n\n**215 St**\n\n**238 St**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**8:24 8:28 8:41 8:46 8:52 8:53 8:59 9:04 9:09 9:12 9:17 9:19**\n\n**8:29 8:33 8:46 8:51 8:56 8:58 9:04 9:09 9:14 9:17 9:21 9:23**\n\n**8:33 8:37 8:50 8:55 9:01 9:02 9:08 9:13 9:18 9:21 9:26 9:28**\n\n**8:38 8:42 8:55 9:00 9:05 9:07 9:13 9:18 9:23 9:26 9:30 9:32**\n\n**8:42 8:46 8:59 9:04 9:10 9:11 9:17 9:22 9:27 9:30 9:35 9:37**\n\n**8:47 8:51 9:04 9:09 9:14 9:16 9:22 9:27 9:32 9:35 9:39 9:41**\n\n**8:51 8:55 9:08 9:13 9:19 9:20 9:26 9:31 9:36 9:39 9:44 9:46**\n\n**8:56 9:00 9:13 9:18 9:23 9:25 9:31 9:37 9:42 9:45 9:49 9:51**\n\n**9:00 9:04 9:17 9:22 9:28 9:29 9:35 9:40 9:45 9:48**\n\n**9:05 9:09 9:22 9:27 9:32 9:34 9:40 9:45 9:50 9:53 9:57 9:59**\n\n**9:09 9:13 9:26 9:31 9:37 9:38 9:44 9:49 9:54 9:57 10:02 10:04**\n\n**9:14 9:18 9:31 9:36 9:41 9:43 9:49 9:54 9:59 10:02 10:06 10:08**\n\n**9:18 9:22 9:35 9:40 9:46 9:47 9:53 9:58 10:03 10:06 10:11 10:13**\n\n**9:23 9:27 9:40 9:45 9:50 9:52 9:58 10:03 10:08 10:11 10:16 10:18**\n\n**9:27 9:31 9:44 9:49 9:55 9:56 10:02 10:07 10:12 10:15 10:21 10:23**\n\n**9:32 9:36 9:49 9:54 9:59 10:01 10:07 10:12 10:17 10:20 10:26 10:28**\n\n**9:37 9:41 9:54 9:59 10:04 10:06 10:12 10:17 10:22 10:25 10:31 10:33**\n\n**9:42 9:46 9:59 10:04 10:09 10:11 10:17 10:22 10:27 10:30 10:37 10:39**\n\n**9:48 9:52 10:05 10:10 10:15 10:17 10:23 10:28 10:33 10:36 10:43 10:45**\n\n**9:54 9:58 10:11 10:16 10:21 10:23 10:29 10:34 10:39 10:42 10:49 10:51**\n\n**10:00 10:04 10:17 10:22 10:27 10:29 10:35 10:40 10:45 10:48 10:55 10:57**\n\n**10:06 10:10 10:23 10:28 10:33 10:35 10:41 10:46 10:51 10:54 11:01 11:03**\n\n**10:12 10:16 10:29 10:34 10:39 10:41 10:47 10:52 10:57 11:00 11:07 11:09**\n\n**10:18 10:22 10:35 10:40 10:45 10:47 10:53 10:58 11:03 11:06 11:13 11:15**\n\n**10:24 10:28 10:41 10:46 10:51 10:53 10:59 11:04 11:09 11:12 11:19 11:21**\n\n**10:30 10:34 10:47 10:52 10:57 10:59 11:05 11:10 11:15 11:18 11:25 11:27**\n\n**10:36 10:40 10:53 10:58 11:03 11:05 11:11 11:16 11:21 11:24 11:31 11:33**\n\n**10:43 10:47 11:00 11:05 11:10 11:12 11:18 11:23 11:28 11:31 11:38 11:40**\n\n**10:51 10:55 11:08 11:13 11:18 11:20 11:26 11:31 11:36 11:39 11:46 11:48**\n\n**10:59 11:03 11:16 11:21 11:26 11:28 11:34 11:39 11:44 11:47 11:54 11:56**\n\n**11:09 11:13 11:26 11:31 11:36 11:38 11:44 11:49 11:54 11:57** 12:04 12:06\n\n**11:19 11:23 11:36 11:41 11:46 11:48 11:54 11:59** 12:04 12:07 12:14 12:16\n\n**11:29 11:33 11:46 11:51 11:56 11:58** 12:04 12:09 12:14 12:17 12:25 12:27\n\n**11:39 11:43 11:56** 12:01 12:06 12:08 12:14 12:19 12:24 12:27 12:35 12:37\n\n**11:49 11:53** 12:06 12:11 12:16 12:18 12:24 12:29 12:34 12:37 12:45 12:47\n\n**11:59** 12:03 12:16 12:21 12:26 12:28 12:34 12:39 12:44 12:47 12:55 12:57\n\nPage 6 of 28","pages":[{"line_numbers":[],"markdown":"### **Weekdays to The Bronx**\n\n**Notes**\n\n**South Ferry**\n\n**Chambers St**\n\n**Times Sq**\n\n**42 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**96 St**\n\n**103 St**\n\n**137 St**\n\n**City College**\n\n**168 St**\n\n**Washington Hts**\n\n**Dyckman St**\n\n**215 St**\n\n**238 St**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**8:24 8:28 8:41 8:46 8:52 8:53 8:59 9:04 9:09 9:12 9:17 9:19**\n\n**8:29 8:33 8:46 8:51 8:56 8:58 9:04 9:09 9:14 9:17 9:21 9:23**\n\n**8:33 8:37 8:50 8:55 9:01 9:02 9:08 9:13 9:18 9:21 9:26 9:28**\n\n**8:38 8:42 8:55 9:00 9:05 9:07 9:13 9:18 9:23 9:26 9:30 9:32**\n\n**8:42 8:46 8:59 9:04 9:10 9:11 9:17 9:22 9:27 9:30 9:35 9:37**\n\n**8:47 8:51 9:04 9:09 9:14 9:16 9:22 9:27 9:32 9:35 9:39 9:41**\n\n**8:51 8:55 9:08 9:13 9:19 9:20 9:26 9:31 9:36 9:39 9:44 9:46**\n\n**8:56 9:00 9:13 9:18 9:23 9:25 9:31 9:37 9:42 9:45 9:49 9:51**\n\n**9:00 9:04 9:17 9:22 9:28 9:29 9:35 9:40 9:45 9:48**\n\n**9:05 9:09 9:22 9:27 9:32 9:34 9:40 9:45 9:50 9:53 9:57 9:59**\n\n**9:09 9:13 9:26 9:31 9:37 9:38 9:44 9:49 9:54 9:57 10:02 10:04**\n\n**9:14 9:18 9:31 9:36 9:41 9:43 9:49 9:54 9:59 10:02 10:06 10:08**\n\n**9:18 9:22 9:35 9:40 9:46 9:47 9:53 9:58 10:03 10:06 10:11 10:13**\n\n**9:23 9:27 9:40 9:45 9:50 9:52 9:58 10:03 10:08 10:11 10:16 10:18**\n\n**9:27 9:31 9:44 9:49 9:55 9:56 10:02 10:07 10:12 10:15 10:21 10:23**\n\n**9:32 9:36 9:49 9:54 9:59 10:01 10:07 10:12 10:17 10:20 10:26 10:28**\n\n**9:37 9:41 9:54 9:59 10:04 10:06 10:12 10:17 10:22 10:25 10:31 10:33**\n\n**9:42 9:46 9:59 10:04 10:09 10:11 10:17 10:22 10:27 10:30 10:37 10:39**\n\n**9:48 9:52 10:05 10:10 10:15 10:17 10:23 10:28 10:33 10:36 10:43 10:45**\n\n**9:54 9:58 10:11 10:16 10:21 10:23 10:29 10:34 10:39 10:42 10:49 10:51**\n\n**10:00 10:04 10:17 10:22 10:27 10:29 10:35 10:40 10:45 10:48 10:55 10:57**\n\n**10:06 10:10 10:23 10:28 10:33 10:35 10:41 10:46 10:51 10:54 11:01 11:03**\n\n**10:12 10:16 10:29 10:34 10:39 10:41 10:47 10:52 10:57 11:00 11:07 11:09**\n\n**10:18 10:22 10:35 10:40 10:45 10:47 10:53 10:58 11:03 11:06 11:13 11:15**\n\n**10:24 10:28 10:41 10:46 10:51 10:53 10:59 11:04 11:09 11:12 11:19 11:21**\n\n**10:30 10:34 10:47 10:52 10:57 10:59 11:05 11:10 11:15 11:18 11:25 11:27**\n\n**10:36 10:40 10:53 10:58 11:03 11:05 11:11 11:16 11:21 11:24 11:31 11:33**\n\n**10:43 10:47 11:00 11:05 11:10 11:12 11:18 11:23 11:28 11:31 11:38 11:40**\n\n**10:51 10:55 11:08 11:13 11:18 11:20 11:26 11:31 11:36 11:39 11:46 11:48**\n\n**10:59 11:03 11:16 11:21 11:26 11:28 11:34 11:39 11:44 11:47 11:54 11:56**\n\n**11:09 11:13 11:26 11:31 11:36 11:38 11:44 11:49 11:54 11:57** 12:04 12:06\n\n**11:19 11:23 11:36 11:41 11:46 11:48 11:54 11:59** 12:04 12:07 12:14 12:16\n\n**11:29 11:33 11:46 11:51 11:56 11:58** 12:04 12:09 12:14 12:17 12:25 12:27\n\n**11:39 11:43 11:56** 12:01 12:06 12:08 12:14 12:19 12:24 12:27 12:35 12:37\n\n**11:49 11:53** 12:06 12:11 12:16 12:18 12:24 12:29 12:34 12:37 12:45 12:47\n\n**11:59** 12:03 12:16 12:21 12:26 12:28 12:34 12:39 12:44 12:47 12:55 12:57\n\nPage 6 of 28","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Weekdays to The Bronx**\n\n**Notes**\n\n**South Ferry**\n\n**Chambers St**\n\n**Times Sq**\n\n**42 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**96 St**\n\n**103 St**\n\n**137 St**\n\n**City College**\n\n**168 St**\n\n**Washington Hts**\n\n**Dyckman St**\n\n**215 St**\n\n**238 St**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**8:24 8:28 8:41 8:46 8:52 8:53 8:59 9:04 9:09 9:12 9:17 9:19**\n\n**8:29 8:33 8:46 8:51 8:56 8:58 9:04 9:09 9:14 9:17 9:21 9:23**\n\n**8:33 8:37 8:50 8:55 9:01 9:02 9:08 9:13 9:18 9:21 9:26 9:28**\n\n**8:38 8:42 8:55 9:00 9:05 9:07 9:13 9:18 9:23 9:26 9:30 9:32**\n\n**8:42 8:46 8:59 9:04 9:10 9:11 9:17 9:22 9:27 9:30 9:35 9:37**\n\n**8:47 8:51 9:04 9:09 9:14 9:16 9:22 9:27 9:32 9:35 9:39 9:41**\n\n**8:51 8:55 9:08 9:13 9:19 9:20 9:26 9:31 9:36 9:39 9:44 9:46**\n\n**8:56 9:00 9:13 9:18 9:23 9:25 9:31 9:37 9:42 9:45 9:49 9:51**\n\n**9:00 9:04 9:17 9:22 9:28 9:29 9:35 9:40 9:45 9:48**\n\n**9:05 9:09 9:22 9:27 9:32 9:34 9:40 9:45 9:50 9:53 9:57 9:59**\n\n**9:09 9:13 9:26 9:31 9:37 9:38 9:44 9:49 9:54 9:57 10:02 10:04**\n\n**9:14 9:18 9:31 9:36 9:41 9:43 9:49 9:54 9:59 10:02 10:06 10:08**\n\n**9:18 9:22 9:35 9:40 9:46 9:47 9:53 9:58 10:03 10:06 10:11 10:13**\n\n**9:23 9:27 9:40 9:45 9:50 9:52 9:58 10:03 10:08 10:11 10:16 10:18**\n\n**9:27 9:31 9:44 9:49 9:55 9:56 10:02 10:07 10:12 10:15 10:21 10:23**\n\n**9:32 9:36 9:49 9:54 9:59 10:01 10:07 10:12 10:17 10:20 10:26 10:28**\n\n**9:37 9:41 9:54 9:59 10:04 10:06 10:12 10:17 10:22 10:25 10:31 10:33**\n\n**9:42 9:46 9:59 10:04 10:09 10:11 10:17 10:22 10:27 10:30 10:37 10:39**\n\n**9:48 9:52 10:05 10:10 10:15 10:17 10:23 10:28 10:33 10:36 10:43 10:45**\n\n**9:54 9:58 10:11 10:16 10:21 10:23 10:29 10:34 10:39 10:42 10:49 10:51**\n\n**10:00 10:04 10:17 10:22 10:27 10:29 10:35 10:40 10:45 10:48 10:55 10:57**\n\n**10:06 10:10 10:23 10:28 10:33 10:35 10:41 10:46 10:51 10:54 11:01 11:03**\n\n**10:12 10:16 10:29 10:34 10:39 10:41 10:47 10:52 10:57 11:00 11:07 11:09**\n\n**10:18 10:22 10:35 10:40 10:45 10:47 10:53 10:58 11:03 11:06 11:13 11:15**\n\n**10:24 10:28 10:41 10:46 10:51 10:53 10:59 11:04 11:09 11:12 11:19 11:21**\n\n**10:30 10:34 10:47 10:52 10:57 10:59 11:05 11:10 11:15 11:18 11:25 11:27**\n\n**10:36 10:40 10:53 10:58 11:03 11:05 11:11 11:16 11:21 11:24 11:31 11:33**\n\n**10:43 10:47 11:00 11:05 11:10 11:12 11:18 11:23 11:28 11:31 11:38 11:40**\n\n**10:51 10:55 11:08 11:13 11:18 11:20 11:26 11:31 11:36 11:39 11:46 11:48**\n\n**10:59 11:03 11:16 11:21 11:26 11:28 11:34 11:39 11:44 11:47 11:54 11:56**\n\n**11:09 11:13 11:26 11:31 11:36 11:38 11:44 11:49 11:54 11:57** 12:04 12:06\n\n**11:19 11:23 11:36 11:41 11:46 11:48 11:54 11:59** 12:04 12:07 12:14 12:16\n\n**11:29 11:33 11:46 11:51 11:56 11:58** 12:04 12:09 12:14 12:17 12:25 12:27\n\n**11:39 11:43 11:56** 12:01 12:06 12:08 12:14 12:19 12:24 12:27 12:35 12:37\n\n**11:49 11:53** 12:06 12:11 12:16 12:18 12:24 12:29 12:34 12:37 12:45 12:47\n\n**11:59** 12:03 12:16 12:21 12:26 12:28 12:34 12:39 12:44 12:47 12:55 12:57\n\nPage 6 of 28","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_d1c77bf7eec93b1869dd754dbb28fdce","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Weekdays to The Bronx**\n\n**Notes**\n\n**South Ferry**\n\n**Chambers St**\n\n**Times Sq**\n\n**42 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**96 St**\n\n**103 St**\n\n**137 St**\n\n**City College**\n\n**168 St**\n\n**Washington Hts**\n\n**Dyckman St**\n\n**215 St**\n\n**238 St**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**8:24 8:28 8:41 8:46 8:52 8:53 8:59 9:04 9:09 9:12 9:17 9:19**\n\n**8:29 8:33 8:46 8:51 8:56 8:58 9:04 9:09 9:14 9:17 9:21 9:23**\n\n**8:33 8:37 8:50 8:55 9:01 9:02 9:08 9:13 9:18 9:21 9:26 9:28**\n\n**8:38 8:42 8:55 9:00 9:05 9:07 9:13 9:18 9:23 9:26 9:30 9:32**\n\n**8:42 8:46 8:59 9:04 9:10 9:11 9:17 9:22 9:27 9:30 9:35 9:37**\n\n**8:47 8:51 9:04 9:09 9:14 9:16 9:22 9:27 9:32 9:35 9:39 9:41**\n\n**8:51 8:55 9:08 9:13 9:19 9:20 9:26 9:31 9:36 9:39 9:44 9:46**\n\n**8:56 9:00 9:13 9:18 9:23 9:25 9:31 9:37 9:42 9:45 9:49 9:51**\n\n**9:00 9:04 9:17 9:22 9:28 9:29 9:35 9:40 9:45 9:48**\n\n**9:05 9:09 9:22 9:27 9:32 9:34 9:40 9:45 9:50 9:53 9:57 9:59**\n\n**9:09 9:13 9:26 9:31 9:37 9:38 9:44 9:49 9:54 9:57 10:02 10:04**\n\n**9:14 9:18 9:31 9:36 9:41 9:43 9:49 9:54 9:59 10:02 10:06 10:08**\n\n**9:18 9:22 9:35 9:40 9:46 9:47 9:53 9:58 10:03 10:06 10:11 10:13**\n\n**9:23 9:27 9:40 9:45 9:50 9:52 9:58 10:03 10:08 10:11 10:16 10:18**\n\n**9:27 9:31 9:44 9:49 9:55 9:56 10:02 10:07 10:12 10:15 10:21 10:23**\n\n**9:32 9:36 9:49 9:54 9:59 10:01 10:07 10:12 10:17 10:20 10:26 10:28**\n\n**9:37 9:41 9:54 9:59 10:04 10:06 10:12 10:17 10:22 10:25 10:31 10:33**\n\n**9:42 9:46 9:59 10:04 10:09 10:11 10:17 10:22 10:27 10:30 10:37 10:39**\n\n**9:48 9:52 10:05 10:10 10:15 10:17 10:23 10:28 10:33 10:36 10:43 10:45**\n\n**9:54 9:58 10:11 10:16 10:21 10:23 10:29 10:34 10:39 10:42 10:49 10:51**\n\n**10:00 10:04 10:17 10:22 10:27 10:29 10:35 10:40 10:45 10:48 10:55 10:57**\n\n**10:06 10:10 10:23 10:28 10:33 10:35 10:41 10:46 10:51 10:54 11:01 11:03**\n\n**10:12 10:16 10:29 10:34 10:39 10:41 10:47 10:52 10:57 11:00 11:07 11:09**\n\n**10:18 10:22 10:35 10:40 10:45 10:47 10:53 10:58 11:03 11:06 11:13 11:15**\n\n**10:24 10:28 10:41 10:46 10:51 10:53 10:59 11:04 11:09 11:12 11:19 11:21**\n\n**10:30 10:34 10:47 10:52 10:57 10:59 11:05 11:10 11:15 11:18 11:25 11:27**\n\n**10:36 10:40 10:53 10:58 11:03 11:05 11:11 11:16 11:21 11:24 11:31 11:33**\n\n**10:43 10:47 11:00 11:05 11:10 11:12 11:18 11:23 11:28 11:31 11:38 11:40**\n\n**10:51 10:55 11:08 11:13 11:18 11:20 11:26 11:31 11:36 11:39 11:46 11:48**\n\n**10:59 11:03 11:16 11:21 11:26 11:28 11:34 11:39 11:44 11:47 11:54 11:56**\n\n**11:09 11:13 11:26 11:31 11:36 11:38 11:44 11:49 11:54 11:57** 12:04 12:06\n\n**11:19 11:23 11:36 11:41 11:46 11:48 11:54 11:59** 12:04 12:07 12:14 12:16\n\n**11:29 11:33 11:46 11:51 11:56 11:58** 12:04 12:09 12:14 12:17 12:25 12:27\n\n**11:39 11:43 11:56** 12:01 12:06 12:08 12:14 12:19 12:24 12:27 12:35 12:37\n\n**11:49 11:53** 12:06 12:11 12:16 12:18 12:24 12:29 12:34 12:37 12:45 12:47\n\n**11:59** 12:03 12:16 12:21 12:26 12:28 12:34 12:39 12:44 12:47 12:55 12:57\n\nPage 6 of 28"],"full_content":"### **Weekdays to The Bronx**\n\n**Notes**\n\n**South Ferry**\n\n**Chambers St**\n\n**Times Sq**\n\n**42 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**96 St**\n\n**103 St**\n\n**137 St**\n\n**City College**\n\n**168 St**\n\n**Washington Hts**\n\n**Dyckman St**\n\n**215 St**\n\n**238 St**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**8:24 8:28 8:41 8:46 8:52 8:53 8:59 9:04 9:09 9:12 9:17 9:19**\n\n**8:29 8:33 8:46 8:51 8:56 8:58 9:04 9:09 9:14 9:17 9:21 9:23**\n\n**8:33 8:37 8:50 8:55 9:01 9:02 9:08 9:13 9:18 9:21 9:26 9:28**\n\n**8:38 8:42 8:55 9:00 9:05 9:07 9:13 9:18 9:23 9:26 9:30 9:32**\n\n**8:42 8:46 8:59 9:04 9:10 9:11 9:17 9:22 9:27 9:30 9:35 9:37**\n\n**8:47 8:51 9:04 9:09 9:14 9:16 9:22 9:27 9:32 9:35 9:39 9:41**\n\n**8:51 8:55 9:08 9:13 9:19 9:20 9:26 9:31 9:36 9:39 9:44 9:46**\n\n**8:56 9:00 9:13 9:18 9:23 9:25 9:31 9:37 9:42 9:45 9:49 9:51**\n\n**9:00 9:04 9:17 9:22 9:28 9:29 9:35 9:40 9:45 9:48**\n\n**9:05 9:09 9:22 9:27 9:32 9:34 9:40 9:45 9:50 9:53 9:57 9:59**\n\n**9:09 9:13 9:26 9:31 9:37 9:38 9:44 9:49 9:54 9:57 10:02 10:04**\n\n**9:14 9:18 9:31 9:36 9:41 9:43 9:49 9:54 9:59 10:02 10:06 10:08**\n\n**9:18 9:22 9:35 9:40 9:46 9:47 9:53 9:58 10:03 10:06 10:11 10:13**\n\n**9:23 9:27 9:40 9:45 9:50 9:52 9:58 10:03 10:08 10:11 10:16 10:18**\n\n**9:27 9:31 9:44 9:49 9:55 9:56 10:02 10:07 10:12 10:15 10:21 10:23**\n\n**9:32 9:36 9:49 9:54 9:59 10:01 10:07 10:12 10:17 10:20 10:26 10:28**\n\n**9:37 9:41 9:54 9:59 10:04 10:06 10:12 10:17 10:22 10:25 10:31 10:33**\n\n**9:42 9:46 9:59 10:04 10:09 10:11 10:17 10:22 10:27 10:30 10:37 10:39**\n\n**9:48 9:52 10:05 10:10 10:15 10:17 10:23 10:28 10:33 10:36 10:43 10:45**\n\n**9:54 9:58 10:11 10:16 10:21 10:23 10:29 10:34 10:39 10:42 10:49 10:51**\n\n**10:00 10:04 10:17 10:22 10:27 10:29 10:35 10:40 10:45 10:48 10:55 10:57**\n\n**10:06 10:10 10:23 10:28 10:33 10:35 10:41 10:46 10:51 10:54 11:01 11:03**\n\n**10:12 10:16 10:29 10:34 10:39 10:41 10:47 10:52 10:57 11:00 11:07 11:09**\n\n**10:18 10:22 10:35 10:40 10:45 10:47 10:53 10:58 11:03 11:06 11:13 11:15**\n\n**10:24 10:28 10:41 10:46 10:51 10:53 10:59 11:04 11:09 11:12 11:19 11:21**\n\n**10:30 10:34 10:47 10:52 10:57 10:59 11:05 11:10 11:15 11:18 11:25 11:27**\n\n**10:36 10:40 10:53 10:58 11:03 11:05 11:11 11:16 11:21 11:24 11:31 11:33**\n\n**10:43 10:47 11:00 11:05 11:10 11:12 11:18 11:23 11:28 11:31 11:38 11:40**\n\n**10:51 10:55 11:08 11:13 11:18 11:20 11:26 11:31 11:36 11:39 11:46 11:48**\n\n**10:59 11:03 11:16 11:21 11:26 11:28 11:34 11:39 11:44 11:47 11:54 11:56**\n\n**11:09 11:13 11:26 11:31 11:36 11:38 11:44 11:49 11:54 11:57** 12:04 12:06\n\n**11:19 11:23 11:36 11:41 11:46 11:48 11:54 11:59** 12:04 12:07 12:14 12:16\n\n**11:29 11:33 11:46 11:51 11:56 11:58** 12:04 12:09 12:14 12:17 12:25 12:27\n\n**11:39 11:43 11:56** 12:01 12:06 12:08 12:14 12:19 12:24 12:27 12:35 12:37\n\n**11:49 11:53** 12:06 12:11 12:16 12:18 12:24 12:29 12:34 12:37 12:45 12:47\n\n**11:59** 12:03 12:16 12:21 12:26 12:28 12:34 12:39 12:44 12:47 12:55 12:57\n\nPage 6 of 28","publish_date":null,"title":"Weekdays to The Bronx","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page6.pdf"},"request":{"example_id":"table/1 timetable (1)_page6","product_type":"parse","source_file_path":"1 timetable (1)_page6.pdf"},"started_at":"2026-11-04T19:47:47.993975"} +{"completed_at":"2026-11-04T19:47:50.807253","latency_in_ms":2031,"output":{"example_id":"table/1 timetable (1)_page7","grounded_pages":[],"layout_pages":[],"markdown":"### **Weekdays to Manhattan**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**238 St**\n\n**Dyckman St**\n\n**168 St**\n\n**Washington Hts**\n\n**137 St**\n\n**City College**\n\n**103 St**\n\n**96 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**Times Sq**\n\n**42 St**\n\n**Chambers St**\n\n**South Ferry**\n\n12:06 12:08 12:15 12:21 12:26 12:31 12:33 12:39 12:44 12:59 1:03\n\n12:25 12:27 12:34 12:40 12:45 12:50 12:52 12:58 1:03 1:18 1:22\n\n12:45 12:47 12:54 1:00 1:05 1:10 1:12 1:18 1:23 1:38 1:42\n\n1:05 1:07 1:14 1:20 1:25 1:30 1:32 1:38 1:43 1:58 2:02\n\n1:25 1:27 1:34 1:40 1:45 1:50 1:52 1:58 2:03 2:18 2:22\n\n1:45 1:47 1:54 2:00 2:05 2:10 2:12 2:18 2:23 2:38 2:42\n\n2:05 2:07 2:14 2:20 2:25 2:30 2:32 2:38 2:43 2:58 3:02\n\n2:25 2:27 2:34 2:40 2:45 2:50 2:52 2:58 3:03 3:18 3:22\n\n2:45 2:47 2:54 3:00 3:05 3:10 3:12 3:18 3:23 3:38 3:42\n\n3:05 3:07 3:14 3:20 3:25 3:30 3:32 3:38 3:43 3:58 4:02\n\n3:25 3:27 3:34 3:40 3:45 3:50 3:52 3:58 4:03 4:18 4:22\n\n3:45 3:47 3:54 4:00 4:05 4:10 4:12 4:18 4:23 4:38 4:42\n\n4:05 4:07 4:14 4:20 4:25 4:30 4:32 4:38 4:43 4:58 5:02\n\n4:25 4:27 4:34 4:40 4:45 4:50 4:52 4:58 5:03 5:18 5:22\n\n4:42 4:44 4:51 4:57 5:02 5:07 5:09 5:15 5:20 5:35 5:39\n\n4:57 4:59 5:06 5:12 5:17 5:22 5:24 5:30 5:35 5:48 5:52\n\n5:09 5:10 5:17 5:23 5:28 5:34 5:36 5:42 5:47 5:59 6:04\n\n5:17 5:18 5:25 5:31 5:36 5:42 5:44 5:50 5:55 6:07 6:12\n\n5:25 5:26 5:33 5:39 5:44 5:50 5:52 5:58 6:03 6:15 6:20\n\n5:33 5:34 5:41 5:47 5:52 5:58 6:00 6:06 6:11 6:23 6:28\n\n5:41 5:42 5:49 5:55 6:00 6:06 6:08 6:14 6:19 6:31 6:36\n\n5:49 5:50 5:57 6:03 6:08 6:14 6:16 6:22 6:27 6:39 6:44\n\n5:57 5:58 6:05 6:10 6:15 6:21 6:23 6:29 6:34 6:46 6:51\n\n6:05 6:06 6:13 6:18 6:23 6:29 6:31 6:37 6:42 6:54 6:59\n\n6:13 6:14 6:21 6:26 6:31 6:37 6:39 6:45 6:50 7:02 7:07\n\n6:21 6:22 6:29 6:34 6:39 6:45 6:47 6:53 6:58 7:10 7:15\n\n6:29 6:30 6:37 6:42 6:47 6:53 6:55 7:01 7:06 7:18 7:23\n\n6:35 6:36 6:43 6:48 6:53 6:59 7:01 7:07 7:12 7:24 7:29\n\n6:42 6:49 6:54 6:59 7:05 7:07 7:13 7:18 7:30 7:36\n\n6:46 6:47 6:54 6:59 7:04 7:10 7:12 7:18 7:23 7:37 7:41\n\n6:52 6:59 7:04 7:09 7:15 7:17 7:23 7:28 7:41 7:47\n\n6:55 6:57 7:04 7:09 7:14 7:20 7:22 7:28 7:33 7:48 7:53\n\n7:02 7:09 7:14 7:19 7:25 7:27 7:33 7:38 7:53 7:58\n\n7:05 7:07 7:14 7:19 7:24 7:30 7:32 7:38 7:43 7:58 8:03\n\n7:12 7:19 7:24 7:29 7:35 7:37 7:43 7:48 8:03 8:09\n\n7:14 7:16 7:23 7:28 7:33 7:39 7:41 7:47 7:52 8:08 8:13\n\n7:18 7:20 7:27 7:32 7:37 7:43 7:45 7:51 7:57 8:12 8:17\n\n7:23 7:30 7:35 7:40 7:46 7:48 7:54 8:00 8:16 8:21\n\n7:25 7:26 7:33 7:38 7:44 7:50 7:52 7:58 8:03 8:20 8:25\n\n7:28 7:30 7:37 7:42 7:47 7:53 7:55 8:01 8:07 8:23 8:28\n\n7:34 7:41 7:46 7:51 7:57 7:59 8:05 8:11 8:27 8:32\n\n7:37 7:38 7:45 7:50 7:56 8:02 8:04 8:10 8:15 8:30 8:35\n\n7:41 7:42 7:49 7:55 8:00 8:06 8:08 8:14 8:20 8:35 8:40\n\n7:46 7:53 7:59 8:04 8:10 8:12 8:18 8:24 8:38 8:44\n\n7:48 7:49 7:56 8:02 8:08 8:14 8:16 8:22 8:28 8:42 8:47\n\n7:52 7:53 8:00 8:06 8:11 8:17 8:19 8:25 8:31 8:45 8:50\n\n8:14 8:20 8:22 8:28 8:33 8:47 8:53\n\n7:56 7:57 8:04 8:10 8:17 8:23 8:25 8:31 8:37 8:51 8:56\n\n8:01 8:08 8:14 8:20 8:26 8:28 8:34 8:40 8:53 8:59\n\n8:02 8:05 8:12 8:18 8:23 8:29 8:31 8:37 8:43 8:57 9:02\n\nPage 7 of 28","pages":[{"line_numbers":[],"markdown":"### **Weekdays to Manhattan**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**238 St**\n\n**Dyckman St**\n\n**168 St**\n\n**Washington Hts**\n\n**137 St**\n\n**City College**\n\n**103 St**\n\n**96 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**Times Sq**\n\n**42 St**\n\n**Chambers St**\n\n**South Ferry**\n\n12:06 12:08 12:15 12:21 12:26 12:31 12:33 12:39 12:44 12:59 1:03\n\n12:25 12:27 12:34 12:40 12:45 12:50 12:52 12:58 1:03 1:18 1:22\n\n12:45 12:47 12:54 1:00 1:05 1:10 1:12 1:18 1:23 1:38 1:42\n\n1:05 1:07 1:14 1:20 1:25 1:30 1:32 1:38 1:43 1:58 2:02\n\n1:25 1:27 1:34 1:40 1:45 1:50 1:52 1:58 2:03 2:18 2:22\n\n1:45 1:47 1:54 2:00 2:05 2:10 2:12 2:18 2:23 2:38 2:42\n\n2:05 2:07 2:14 2:20 2:25 2:30 2:32 2:38 2:43 2:58 3:02\n\n2:25 2:27 2:34 2:40 2:45 2:50 2:52 2:58 3:03 3:18 3:22\n\n2:45 2:47 2:54 3:00 3:05 3:10 3:12 3:18 3:23 3:38 3:42\n\n3:05 3:07 3:14 3:20 3:25 3:30 3:32 3:38 3:43 3:58 4:02\n\n3:25 3:27 3:34 3:40 3:45 3:50 3:52 3:58 4:03 4:18 4:22\n\n3:45 3:47 3:54 4:00 4:05 4:10 4:12 4:18 4:23 4:38 4:42\n\n4:05 4:07 4:14 4:20 4:25 4:30 4:32 4:38 4:43 4:58 5:02\n\n4:25 4:27 4:34 4:40 4:45 4:50 4:52 4:58 5:03 5:18 5:22\n\n4:42 4:44 4:51 4:57 5:02 5:07 5:09 5:15 5:20 5:35 5:39\n\n4:57 4:59 5:06 5:12 5:17 5:22 5:24 5:30 5:35 5:48 5:52\n\n5:09 5:10 5:17 5:23 5:28 5:34 5:36 5:42 5:47 5:59 6:04\n\n5:17 5:18 5:25 5:31 5:36 5:42 5:44 5:50 5:55 6:07 6:12\n\n5:25 5:26 5:33 5:39 5:44 5:50 5:52 5:58 6:03 6:15 6:20\n\n5:33 5:34 5:41 5:47 5:52 5:58 6:00 6:06 6:11 6:23 6:28\n\n5:41 5:42 5:49 5:55 6:00 6:06 6:08 6:14 6:19 6:31 6:36\n\n5:49 5:50 5:57 6:03 6:08 6:14 6:16 6:22 6:27 6:39 6:44\n\n5:57 5:58 6:05 6:10 6:15 6:21 6:23 6:29 6:34 6:46 6:51\n\n6:05 6:06 6:13 6:18 6:23 6:29 6:31 6:37 6:42 6:54 6:59\n\n6:13 6:14 6:21 6:26 6:31 6:37 6:39 6:45 6:50 7:02 7:07\n\n6:21 6:22 6:29 6:34 6:39 6:45 6:47 6:53 6:58 7:10 7:15\n\n6:29 6:30 6:37 6:42 6:47 6:53 6:55 7:01 7:06 7:18 7:23\n\n6:35 6:36 6:43 6:48 6:53 6:59 7:01 7:07 7:12 7:24 7:29\n\n6:42 6:49 6:54 6:59 7:05 7:07 7:13 7:18 7:30 7:36\n\n6:46 6:47 6:54 6:59 7:04 7:10 7:12 7:18 7:23 7:37 7:41\n\n6:52 6:59 7:04 7:09 7:15 7:17 7:23 7:28 7:41 7:47\n\n6:55 6:57 7:04 7:09 7:14 7:20 7:22 7:28 7:33 7:48 7:53\n\n7:02 7:09 7:14 7:19 7:25 7:27 7:33 7:38 7:53 7:58\n\n7:05 7:07 7:14 7:19 7:24 7:30 7:32 7:38 7:43 7:58 8:03\n\n7:12 7:19 7:24 7:29 7:35 7:37 7:43 7:48 8:03 8:09\n\n7:14 7:16 7:23 7:28 7:33 7:39 7:41 7:47 7:52 8:08 8:13\n\n7:18 7:20 7:27 7:32 7:37 7:43 7:45 7:51 7:57 8:12 8:17\n\n7:23 7:30 7:35 7:40 7:46 7:48 7:54 8:00 8:16 8:21\n\n7:25 7:26 7:33 7:38 7:44 7:50 7:52 7:58 8:03 8:20 8:25\n\n7:28 7:30 7:37 7:42 7:47 7:53 7:55 8:01 8:07 8:23 8:28\n\n7:34 7:41 7:46 7:51 7:57 7:59 8:05 8:11 8:27 8:32\n\n7:37 7:38 7:45 7:50 7:56 8:02 8:04 8:10 8:15 8:30 8:35\n\n7:41 7:42 7:49 7:55 8:00 8:06 8:08 8:14 8:20 8:35 8:40\n\n7:46 7:53 7:59 8:04 8:10 8:12 8:18 8:24 8:38 8:44\n\n7:48 7:49 7:56 8:02 8:08 8:14 8:16 8:22 8:28 8:42 8:47\n\n7:52 7:53 8:00 8:06 8:11 8:17 8:19 8:25 8:31 8:45 8:50\n\n8:14 8:20 8:22 8:28 8:33 8:47 8:53\n\n7:56 7:57 8:04 8:10 8:17 8:23 8:25 8:31 8:37 8:51 8:56\n\n8:01 8:08 8:14 8:20 8:26 8:28 8:34 8:40 8:53 8:59\n\n8:02 8:05 8:12 8:18 8:23 8:29 8:31 8:37 8:43 8:57 9:02\n\nPage 7 of 28","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Weekdays to Manhattan**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**238 St**\n\n**Dyckman St**\n\n**168 St**\n\n**Washington Hts**\n\n**137 St**\n\n**City College**\n\n**103 St**\n\n**96 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**Times Sq**\n\n**42 St**\n\n**Chambers St**\n\n**South Ferry**\n\n12:06 12:08 12:15 12:21 12:26 12:31 12:33 12:39 12:44 12:59 1:03\n\n12:25 12:27 12:34 12:40 12:45 12:50 12:52 12:58 1:03 1:18 1:22\n\n12:45 12:47 12:54 1:00 1:05 1:10 1:12 1:18 1:23 1:38 1:42\n\n1:05 1:07 1:14 1:20 1:25 1:30 1:32 1:38 1:43 1:58 2:02\n\n1:25 1:27 1:34 1:40 1:45 1:50 1:52 1:58 2:03 2:18 2:22\n\n1:45 1:47 1:54 2:00 2:05 2:10 2:12 2:18 2:23 2:38 2:42\n\n2:05 2:07 2:14 2:20 2:25 2:30 2:32 2:38 2:43 2:58 3:02\n\n2:25 2:27 2:34 2:40 2:45 2:50 2:52 2:58 3:03 3:18 3:22\n\n2:45 2:47 2:54 3:00 3:05 3:10 3:12 3:18 3:23 3:38 3:42\n\n3:05 3:07 3:14 3:20 3:25 3:30 3:32 3:38 3:43 3:58 4:02\n\n3:25 3:27 3:34 3:40 3:45 3:50 3:52 3:58 4:03 4:18 4:22\n\n3:45 3:47 3:54 4:00 4:05 4:10 4:12 4:18 4:23 4:38 4:42\n\n4:05 4:07 4:14 4:20 4:25 4:30 4:32 4:38 4:43 4:58 5:02\n\n4:25 4:27 4:34 4:40 4:45 4:50 4:52 4:58 5:03 5:18 5:22\n\n4:42 4:44 4:51 4:57 5:02 5:07 5:09 5:15 5:20 5:35 5:39\n\n4:57 4:59 5:06 5:12 5:17 5:22 5:24 5:30 5:35 5:48 5:52\n\n5:09 5:10 5:17 5:23 5:28 5:34 5:36 5:42 5:47 5:59 6:04\n\n5:17 5:18 5:25 5:31 5:36 5:42 5:44 5:50 5:55 6:07 6:12\n\n5:25 5:26 5:33 5:39 5:44 5:50 5:52 5:58 6:03 6:15 6:20\n\n5:33 5:34 5:41 5:47 5:52 5:58 6:00 6:06 6:11 6:23 6:28\n\n5:41 5:42 5:49 5:55 6:00 6:06 6:08 6:14 6:19 6:31 6:36\n\n5:49 5:50 5:57 6:03 6:08 6:14 6:16 6:22 6:27 6:39 6:44\n\n5:57 5:58 6:05 6:10 6:15 6:21 6:23 6:29 6:34 6:46 6:51\n\n6:05 6:06 6:13 6:18 6:23 6:29 6:31 6:37 6:42 6:54 6:59\n\n6:13 6:14 6:21 6:26 6:31 6:37 6:39 6:45 6:50 7:02 7:07\n\n6:21 6:22 6:29 6:34 6:39 6:45 6:47 6:53 6:58 7:10 7:15\n\n6:29 6:30 6:37 6:42 6:47 6:53 6:55 7:01 7:06 7:18 7:23\n\n6:35 6:36 6:43 6:48 6:53 6:59 7:01 7:07 7:12 7:24 7:29\n\n6:42 6:49 6:54 6:59 7:05 7:07 7:13 7:18 7:30 7:36\n\n6:46 6:47 6:54 6:59 7:04 7:10 7:12 7:18 7:23 7:37 7:41\n\n6:52 6:59 7:04 7:09 7:15 7:17 7:23 7:28 7:41 7:47\n\n6:55 6:57 7:04 7:09 7:14 7:20 7:22 7:28 7:33 7:48 7:53\n\n7:02 7:09 7:14 7:19 7:25 7:27 7:33 7:38 7:53 7:58\n\n7:05 7:07 7:14 7:19 7:24 7:30 7:32 7:38 7:43 7:58 8:03\n\n7:12 7:19 7:24 7:29 7:35 7:37 7:43 7:48 8:03 8:09\n\n7:14 7:16 7:23 7:28 7:33 7:39 7:41 7:47 7:52 8:08 8:13\n\n7:18 7:20 7:27 7:32 7:37 7:43 7:45 7:51 7:57 8:12 8:17\n\n7:23 7:30 7:35 7:40 7:46 7:48 7:54 8:00 8:16 8:21\n\n7:25 7:26 7:33 7:38 7:44 7:50 7:52 7:58 8:03 8:20 8:25\n\n7:28 7:30 7:37 7:42 7:47 7:53 7:55 8:01 8:07 8:23 8:28\n\n7:34 7:41 7:46 7:51 7:57 7:59 8:05 8:11 8:27 8:32\n\n7:37 7:38 7:45 7:50 7:56 8:02 8:04 8:10 8:15 8:30 8:35\n\n7:41 7:42 7:49 7:55 8:00 8:06 8:08 8:14 8:20 8:35 8:40\n\n7:46 7:53 7:59 8:04 8:10 8:12 8:18 8:24 8:38 8:44\n\n7:48 7:49 7:56 8:02 8:08 8:14 8:16 8:22 8:28 8:42 8:47\n\n7:52 7:53 8:00 8:06 8:11 8:17 8:19 8:25 8:31 8:45 8:50\n\n8:14 8:20 8:22 8:28 8:33 8:47 8:53\n\n7:56 7:57 8:04 8:10 8:17 8:23 8:25 8:31 8:37 8:51 8:56\n\n8:01 8:08 8:14 8:20 8:26 8:28 8:34 8:40 8:53 8:59\n\n8:02 8:05 8:12 8:18 8:23 8:29 8:31 8:37 8:43 8:57 9:02\n\nPage 7 of 28","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page7.pdf"]},"response":{"errors":[],"extract_id":"extract_1fd604ff205441a0b407c454bff49be8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Weekdays to Manhattan**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**238 St**\n\n**Dyckman St**\n\n**168 St**\n\n**Washington Hts**\n\n**137 St**\n\n**City College**\n\n**103 St**\n\n**96 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**Times Sq**\n\n**42 St**\n\n**Chambers St**\n\n**South Ferry**\n\n12:06 12:08 12:15 12:21 12:26 12:31 12:33 12:39 12:44 12:59 1:03\n\n12:25 12:27 12:34 12:40 12:45 12:50 12:52 12:58 1:03 1:18 1:22\n\n12:45 12:47 12:54 1:00 1:05 1:10 1:12 1:18 1:23 1:38 1:42\n\n1:05 1:07 1:14 1:20 1:25 1:30 1:32 1:38 1:43 1:58 2:02\n\n1:25 1:27 1:34 1:40 1:45 1:50 1:52 1:58 2:03 2:18 2:22\n\n1:45 1:47 1:54 2:00 2:05 2:10 2:12 2:18 2:23 2:38 2:42\n\n2:05 2:07 2:14 2:20 2:25 2:30 2:32 2:38 2:43 2:58 3:02\n\n2:25 2:27 2:34 2:40 2:45 2:50 2:52 2:58 3:03 3:18 3:22\n\n2:45 2:47 2:54 3:00 3:05 3:10 3:12 3:18 3:23 3:38 3:42\n\n3:05 3:07 3:14 3:20 3:25 3:30 3:32 3:38 3:43 3:58 4:02\n\n3:25 3:27 3:34 3:40 3:45 3:50 3:52 3:58 4:03 4:18 4:22\n\n3:45 3:47 3:54 4:00 4:05 4:10 4:12 4:18 4:23 4:38 4:42\n\n4:05 4:07 4:14 4:20 4:25 4:30 4:32 4:38 4:43 4:58 5:02\n\n4:25 4:27 4:34 4:40 4:45 4:50 4:52 4:58 5:03 5:18 5:22\n\n4:42 4:44 4:51 4:57 5:02 5:07 5:09 5:15 5:20 5:35 5:39\n\n4:57 4:59 5:06 5:12 5:17 5:22 5:24 5:30 5:35 5:48 5:52\n\n5:09 5:10 5:17 5:23 5:28 5:34 5:36 5:42 5:47 5:59 6:04\n\n5:17 5:18 5:25 5:31 5:36 5:42 5:44 5:50 5:55 6:07 6:12\n\n5:25 5:26 5:33 5:39 5:44 5:50 5:52 5:58 6:03 6:15 6:20\n\n5:33 5:34 5:41 5:47 5:52 5:58 6:00 6:06 6:11 6:23 6:28\n\n5:41 5:42 5:49 5:55 6:00 6:06 6:08 6:14 6:19 6:31 6:36\n\n5:49 5:50 5:57 6:03 6:08 6:14 6:16 6:22 6:27 6:39 6:44\n\n5:57 5:58 6:05 6:10 6:15 6:21 6:23 6:29 6:34 6:46 6:51\n\n6:05 6:06 6:13 6:18 6:23 6:29 6:31 6:37 6:42 6:54 6:59\n\n6:13 6:14 6:21 6:26 6:31 6:37 6:39 6:45 6:50 7:02 7:07\n\n6:21 6:22 6:29 6:34 6:39 6:45 6:47 6:53 6:58 7:10 7:15\n\n6:29 6:30 6:37 6:42 6:47 6:53 6:55 7:01 7:06 7:18 7:23\n\n6:35 6:36 6:43 6:48 6:53 6:59 7:01 7:07 7:12 7:24 7:29\n\n6:42 6:49 6:54 6:59 7:05 7:07 7:13 7:18 7:30 7:36\n\n6:46 6:47 6:54 6:59 7:04 7:10 7:12 7:18 7:23 7:37 7:41\n\n6:52 6:59 7:04 7:09 7:15 7:17 7:23 7:28 7:41 7:47\n\n6:55 6:57 7:04 7:09 7:14 7:20 7:22 7:28 7:33 7:48 7:53\n\n7:02 7:09 7:14 7:19 7:25 7:27 7:33 7:38 7:53 7:58\n\n7:05 7:07 7:14 7:19 7:24 7:30 7:32 7:38 7:43 7:58 8:03\n\n7:12 7:19 7:24 7:29 7:35 7:37 7:43 7:48 8:03 8:09\n\n7:14 7:16 7:23 7:28 7:33 7:39 7:41 7:47 7:52 8:08 8:13\n\n7:18 7:20 7:27 7:32 7:37 7:43 7:45 7:51 7:57 8:12 8:17\n\n7:23 7:30 7:35 7:40 7:46 7:48 7:54 8:00 8:16 8:21\n\n7:25 7:26 7:33 7:38 7:44 7:50 7:52 7:58 8:03 8:20 8:25\n\n7:28 7:30 7:37 7:42 7:47 7:53 7:55 8:01 8:07 8:23 8:28\n\n7:34 7:41 7:46 7:51 7:57 7:59 8:05 8:11 8:27 8:32\n\n7:37 7:38 7:45 7:50 7:56 8:02 8:04 8:10 8:15 8:30 8:35\n\n7:41 7:42 7:49 7:55 8:00 8:06 8:08 8:14 8:20 8:35 8:40\n\n7:46 7:53 7:59 8:04 8:10 8:12 8:18 8:24 8:38 8:44\n\n7:48 7:49 7:56 8:02 8:08 8:14 8:16 8:22 8:28 8:42 8:47\n\n7:52 7:53 8:00 8:06 8:11 8:17 8:19 8:25 8:31 8:45 8:50\n\n8:14 8:20 8:22 8:28 8:33 8:47 8:53\n\n7:56 7:57 8:04 8:10 8:17 8:23 8:25 8:31 8:37 8:51 8:56\n\n8:01 8:08 8:14 8:20 8:26 8:28 8:34 8:40 8:53 8:59\n\n8:02 8:05 8:12 8:18 8:23 8:29 8:31 8:37 8:43 8:57 9:02\n\nPage 7 of 28"],"full_content":"### **Weekdays to Manhattan**\n\n**Van Cortlandt Park**\n\n**242 St**\n\n**238 St**\n\n**Dyckman St**\n\n**168 St**\n\n**Washington Hts**\n\n**137 St**\n\n**City College**\n\n**103 St**\n\n**96 St**\n\n**66 St**\n\n**Lincoln Center**\n\n**Times Sq**\n\n**42 St**\n\n**Chambers St**\n\n**South Ferry**\n\n12:06 12:08 12:15 12:21 12:26 12:31 12:33 12:39 12:44 12:59 1:03\n\n12:25 12:27 12:34 12:40 12:45 12:50 12:52 12:58 1:03 1:18 1:22\n\n12:45 12:47 12:54 1:00 1:05 1:10 1:12 1:18 1:23 1:38 1:42\n\n1:05 1:07 1:14 1:20 1:25 1:30 1:32 1:38 1:43 1:58 2:02\n\n1:25 1:27 1:34 1:40 1:45 1:50 1:52 1:58 2:03 2:18 2:22\n\n1:45 1:47 1:54 2:00 2:05 2:10 2:12 2:18 2:23 2:38 2:42\n\n2:05 2:07 2:14 2:20 2:25 2:30 2:32 2:38 2:43 2:58 3:02\n\n2:25 2:27 2:34 2:40 2:45 2:50 2:52 2:58 3:03 3:18 3:22\n\n2:45 2:47 2:54 3:00 3:05 3:10 3:12 3:18 3:23 3:38 3:42\n\n3:05 3:07 3:14 3:20 3:25 3:30 3:32 3:38 3:43 3:58 4:02\n\n3:25 3:27 3:34 3:40 3:45 3:50 3:52 3:58 4:03 4:18 4:22\n\n3:45 3:47 3:54 4:00 4:05 4:10 4:12 4:18 4:23 4:38 4:42\n\n4:05 4:07 4:14 4:20 4:25 4:30 4:32 4:38 4:43 4:58 5:02\n\n4:25 4:27 4:34 4:40 4:45 4:50 4:52 4:58 5:03 5:18 5:22\n\n4:42 4:44 4:51 4:57 5:02 5:07 5:09 5:15 5:20 5:35 5:39\n\n4:57 4:59 5:06 5:12 5:17 5:22 5:24 5:30 5:35 5:48 5:52\n\n5:09 5:10 5:17 5:23 5:28 5:34 5:36 5:42 5:47 5:59 6:04\n\n5:17 5:18 5:25 5:31 5:36 5:42 5:44 5:50 5:55 6:07 6:12\n\n5:25 5:26 5:33 5:39 5:44 5:50 5:52 5:58 6:03 6:15 6:20\n\n5:33 5:34 5:41 5:47 5:52 5:58 6:00 6:06 6:11 6:23 6:28\n\n5:41 5:42 5:49 5:55 6:00 6:06 6:08 6:14 6:19 6:31 6:36\n\n5:49 5:50 5:57 6:03 6:08 6:14 6:16 6:22 6:27 6:39 6:44\n\n5:57 5:58 6:05 6:10 6:15 6:21 6:23 6:29 6:34 6:46 6:51\n\n6:05 6:06 6:13 6:18 6:23 6:29 6:31 6:37 6:42 6:54 6:59\n\n6:13 6:14 6:21 6:26 6:31 6:37 6:39 6:45 6:50 7:02 7:07\n\n6:21 6:22 6:29 6:34 6:39 6:45 6:47 6:53 6:58 7:10 7:15\n\n6:29 6:30 6:37 6:42 6:47 6:53 6:55 7:01 7:06 7:18 7:23\n\n6:35 6:36 6:43 6:48 6:53 6:59 7:01 7:07 7:12 7:24 7:29\n\n6:42 6:49 6:54 6:59 7:05 7:07 7:13 7:18 7:30 7:36\n\n6:46 6:47 6:54 6:59 7:04 7:10 7:12 7:18 7:23 7:37 7:41\n\n6:52 6:59 7:04 7:09 7:15 7:17 7:23 7:28 7:41 7:47\n\n6:55 6:57 7:04 7:09 7:14 7:20 7:22 7:28 7:33 7:48 7:53\n\n7:02 7:09 7:14 7:19 7:25 7:27 7:33 7:38 7:53 7:58\n\n7:05 7:07 7:14 7:19 7:24 7:30 7:32 7:38 7:43 7:58 8:03\n\n7:12 7:19 7:24 7:29 7:35 7:37 7:43 7:48 8:03 8:09\n\n7:14 7:16 7:23 7:28 7:33 7:39 7:41 7:47 7:52 8:08 8:13\n\n7:18 7:20 7:27 7:32 7:37 7:43 7:45 7:51 7:57 8:12 8:17\n\n7:23 7:30 7:35 7:40 7:46 7:48 7:54 8:00 8:16 8:21\n\n7:25 7:26 7:33 7:38 7:44 7:50 7:52 7:58 8:03 8:20 8:25\n\n7:28 7:30 7:37 7:42 7:47 7:53 7:55 8:01 8:07 8:23 8:28\n\n7:34 7:41 7:46 7:51 7:57 7:59 8:05 8:11 8:27 8:32\n\n7:37 7:38 7:45 7:50 7:56 8:02 8:04 8:10 8:15 8:30 8:35\n\n7:41 7:42 7:49 7:55 8:00 8:06 8:08 8:14 8:20 8:35 8:40\n\n7:46 7:53 7:59 8:04 8:10 8:12 8:18 8:24 8:38 8:44\n\n7:48 7:49 7:56 8:02 8:08 8:14 8:16 8:22 8:28 8:42 8:47\n\n7:52 7:53 8:00 8:06 8:11 8:17 8:19 8:25 8:31 8:45 8:50\n\n8:14 8:20 8:22 8:28 8:33 8:47 8:53\n\n7:56 7:57 8:04 8:10 8:17 8:23 8:25 8:31 8:37 8:51 8:56\n\n8:01 8:08 8:14 8:20 8:26 8:28 8:34 8:40 8:53 8:59\n\n8:02 8:05 8:12 8:18 8:23 8:29 8:31 8:37 8:43 8:57 9:02\n\nPage 7 of 28","publish_date":null,"title":"Weekdays to Manhattan","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page7.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1%20timetable%20%281%29_page7.pdf"},"request":{"example_id":"table/1 timetable (1)_page7","product_type":"parse","source_file_path":"1 timetable (1)_page7.pdf"},"started_at":"2026-11-04T19:47:48.776077"} +{"completed_at":"2026-11-04T19:47:51.112184","latency_in_ms":1445,"output":{"example_id":"table/1212.1661v1_page7","grounded_pages":[],"layout_pages":[],"markdown":"7\n\n### August _F_ 4 -1.861 _ORPR_ 2 1.018 6.898 112.917 2.914\n\n### July _F_ 4 -1.863 _ORPR_ 2 1.024 6.873 112.112 2.912\n\n### June _F_ 4 -1.865 _ORPR_ 2 1.024 6.883 112.342 2.912\n\n### May _F_ 4 -1.863 _ORPR_ 2 1.024 6.877 112.182 2.912\n\n### April _FH_ 4 -1.254 _FAB_ 2 1.770 10.219 -12.460 2.905\n\n### March _F_ 4 -1.878 _ORPR_ 2 1.051 6.791 109.260 2.839\n\n### Table 6. The monthly models for BEN.\n\n### **_Month_**\n\n**_C1 t1 b1 C2 t2 b2_**\n\n### **_c d_** **sterr,$**\n\n### October _FB_ 4 -7.333 _O_ 9 -1.519 69.578 1536.224 7.365\n\n### September _FB_ 4 -7.319 _O_ 9 -1.515 69.428 1533.079 7.361\n\n### August _FB_ 4 -7.301 _O_ 9 -1.513 69.275 1529.960 7.353\n\n### July _FB_ 4 -7.299 _O_ 9 -1.515 69.286 1530.175 7.353\n\n### June _FB_ 4 -7.311 _O_ 9 -1.515 69.375 1532.037 7.350\n\n### May _FB_ 4 -7.301 _O_ 9 -1.513 69.304 1529.705 7.343\n\n### April _FB_ 4 -7.303 _O_ 9 -1.515 69.361 1530.410 7.337\n\n### March _FB_ 4 -7.309 _O_ 9 -1.513 69.312 1531.360 7.270\n\n### Table 7. Cross correlation coefficients for six CPI time series and their first differences. Original series include 124 readings, and their first differences – 123 readings.\n\n**_F FB SEFV ORPR RSH O_**\n\n**_F_** 1\n\n**_FB_** 0\\.99998 1\n\n**_SEFV_** 0\\.99714 0.99671 1\n\n**_ORPR_** 0\\.98356 0.98295 0.98702 1\n\n**_RSH_** 0\\.97533 0.97478 0.97736 0.99698 1\n\n**_O_** 0\\.97752 0.97661 0.98664 0.95629 0.93924 1\n\n**d** **_F_** **d** **_FB_** **d** **_SEFV_** **d** **_ORPR_** **d** **_RSH_** **d** **_O_**\n\n**d** **_F_** 1\n\n**d** **_FB_** 0\\.994 1\n\n**d** **_SEFV_** 0\\.47 [0.49] 0.48 [0.49] 1\n\n**d** **_ORPR_** 0\\.12 [0.26] 0.12 [0.26] 0.31 [0.35] 1\n\n**d** **_RSH_** 0\\.13 [0.30] 0.12 [0.28] 0.10 [0.29] 0.31 [0.37] 1\n\n**d** **_O_** \\-0.18 [030] -0.18 [0.28] 0.06 [0.29] 0.002 [-0.21] 0.04 [-0.29] 1\n\n### **Discussion**\n\n### The stock prices of BAC and MS are well correlated. This observation is supported by the similarity of defining CPIs with equal time lags. It is worth noting that the level of correlation may cease quickly for two models with the same defining CPIs but with increasing difference in time lags. For the same CPIs and lags, the level of correlation depends on the ratio of CPI\n\ncoefficients. This ratio ( _b1/b2_ ) is -2.23 for BAC and -1.65 for MS. The closeness of the ratios\n\n### guarantees similar evolution of their prices. It is important to stress, however, that _SEFV_ has a","pages":[{"line_numbers":[],"markdown":"7\n\n### August _F_ 4 -1.861 _ORPR_ 2 1.018 6.898 112.917 2.914\n\n### July _F_ 4 -1.863 _ORPR_ 2 1.024 6.873 112.112 2.912\n\n### June _F_ 4 -1.865 _ORPR_ 2 1.024 6.883 112.342 2.912\n\n### May _F_ 4 -1.863 _ORPR_ 2 1.024 6.877 112.182 2.912\n\n### April _FH_ 4 -1.254 _FAB_ 2 1.770 10.219 -12.460 2.905\n\n### March _F_ 4 -1.878 _ORPR_ 2 1.051 6.791 109.260 2.839\n\n### Table 6. The monthly models for BEN.\n\n### **_Month_**\n\n**_C1 t1 b1 C2 t2 b2_**\n\n### **_c d_** **sterr,$**\n\n### October _FB_ 4 -7.333 _O_ 9 -1.519 69.578 1536.224 7.365\n\n### September _FB_ 4 -7.319 _O_ 9 -1.515 69.428 1533.079 7.361\n\n### August _FB_ 4 -7.301 _O_ 9 -1.513 69.275 1529.960 7.353\n\n### July _FB_ 4 -7.299 _O_ 9 -1.515 69.286 1530.175 7.353\n\n### June _FB_ 4 -7.311 _O_ 9 -1.515 69.375 1532.037 7.350\n\n### May _FB_ 4 -7.301 _O_ 9 -1.513 69.304 1529.705 7.343\n\n### April _FB_ 4 -7.303 _O_ 9 -1.515 69.361 1530.410 7.337\n\n### March _FB_ 4 -7.309 _O_ 9 -1.513 69.312 1531.360 7.270\n\n### Table 7. Cross correlation coefficients for six CPI time series and their first differences. Original series include 124 readings, and their first differences – 123 readings.\n\n**_F FB SEFV ORPR RSH O_**\n\n**_F_** 1\n\n**_FB_** 0\\.99998 1\n\n**_SEFV_** 0\\.99714 0.99671 1\n\n**_ORPR_** 0\\.98356 0.98295 0.98702 1\n\n**_RSH_** 0\\.97533 0.97478 0.97736 0.99698 1\n\n**_O_** 0\\.97752 0.97661 0.98664 0.95629 0.93924 1\n\n**d** **_F_** **d** **_FB_** **d** **_SEFV_** **d** **_ORPR_** **d** **_RSH_** **d** **_O_**\n\n**d** **_F_** 1\n\n**d** **_FB_** 0\\.994 1\n\n**d** **_SEFV_** 0\\.47 [0.49] 0.48 [0.49] 1\n\n**d** **_ORPR_** 0\\.12 [0.26] 0.12 [0.26] 0.31 [0.35] 1\n\n**d** **_RSH_** 0\\.13 [0.30] 0.12 [0.28] 0.10 [0.29] 0.31 [0.37] 1\n\n**d** **_O_** \\-0.18 [030] -0.18 [0.28] 0.06 [0.29] 0.002 [-0.21] 0.04 [-0.29] 1\n\n### **Discussion**\n\n### The stock prices of BAC and MS are well correlated. This observation is supported by the similarity of defining CPIs with equal time lags. It is worth noting that the level of correlation may cease quickly for two models with the same defining CPIs but with increasing difference in time lags. For the same CPIs and lags, the level of correlation depends on the ratio of CPI\n\ncoefficients. This ratio ( _b1/b2_ ) is -2.23 for BAC and -1.65 for MS. The closeness of the ratios\n\n### guarantees similar evolution of their prices. It is important to stress, however, that _SEFV_ has a","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"7\n\n### August _F_ 4 -1.861 _ORPR_ 2 1.018 6.898 112.917 2.914\n\n### July _F_ 4 -1.863 _ORPR_ 2 1.024 6.873 112.112 2.912\n\n### June _F_ 4 -1.865 _ORPR_ 2 1.024 6.883 112.342 2.912\n\n### May _F_ 4 -1.863 _ORPR_ 2 1.024 6.877 112.182 2.912\n\n### April _FH_ 4 -1.254 _FAB_ 2 1.770 10.219 -12.460 2.905\n\n### March _F_ 4 -1.878 _ORPR_ 2 1.051 6.791 109.260 2.839\n\n### Table 6. The monthly models for BEN.\n\n### **_Month_**\n\n**_C1 t1 b1 C2 t2 b2_**\n\n### **_c d_** **sterr,$**\n\n### October _FB_ 4 -7.333 _O_ 9 -1.519 69.578 1536.224 7.365\n\n### September _FB_ 4 -7.319 _O_ 9 -1.515 69.428 1533.079 7.361\n\n### August _FB_ 4 -7.301 _O_ 9 -1.513 69.275 1529.960 7.353\n\n### July _FB_ 4 -7.299 _O_ 9 -1.515 69.286 1530.175 7.353\n\n### June _FB_ 4 -7.311 _O_ 9 -1.515 69.375 1532.037 7.350\n\n### May _FB_ 4 -7.301 _O_ 9 -1.513 69.304 1529.705 7.343\n\n### April _FB_ 4 -7.303 _O_ 9 -1.515 69.361 1530.410 7.337\n\n### March _FB_ 4 -7.309 _O_ 9 -1.513 69.312 1531.360 7.270\n\n### Table 7. Cross correlation coefficients for six CPI time series and their first differences. Original series include 124 readings, and their first differences – 123 readings.\n\n**_F FB SEFV ORPR RSH O_**\n\n**_F_** 1\n\n**_FB_** 0\\.99998 1\n\n**_SEFV_** 0\\.99714 0.99671 1\n\n**_ORPR_** 0\\.98356 0.98295 0.98702 1\n\n**_RSH_** 0\\.97533 0.97478 0.97736 0.99698 1\n\n**_O_** 0\\.97752 0.97661 0.98664 0.95629 0.93924 1\n\n**d** **_F_** **d** **_FB_** **d** **_SEFV_** **d** **_ORPR_** **d** **_RSH_** **d** **_O_**\n\n**d** **_F_** 1\n\n**d** **_FB_** 0\\.994 1\n\n**d** **_SEFV_** 0\\.47 [0.49] 0.48 [0.49] 1\n\n**d** **_ORPR_** 0\\.12 [0.26] 0.12 [0.26] 0.31 [0.35] 1\n\n**d** **_RSH_** 0\\.13 [0.30] 0.12 [0.28] 0.10 [0.29] 0.31 [0.37] 1\n\n**d** **_O_** \\-0.18 [030] -0.18 [0.28] 0.06 [0.29] 0.002 [-0.21] 0.04 [-0.29] 1\n\n### **Discussion**\n\n### The stock prices of BAC and MS are well correlated. This observation is supported by the similarity of defining CPIs with equal time lags. It is worth noting that the level of correlation may cease quickly for two models with the same defining CPIs but with increasing difference in time lags. For the same CPIs and lags, the level of correlation depends on the ratio of CPI\n\ncoefficients. This ratio ( _b1/b2_ ) is -2.23 for BAC and -1.65 for MS. The closeness of the ratios\n\n### guarantees similar evolution of their prices. It is important to stress, however, that _SEFV_ has a","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1212.1661v1_page7.pdf"]},"response":{"errors":[],"extract_id":"extract_6e6357993f005afb6d2e17afb8545528","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["7\n\n### August _F_ 4 -1.861 _ORPR_ 2 1.018 6.898 112.917 2.914\n\n### July _F_ 4 -1.863 _ORPR_ 2 1.024 6.873 112.112 2.912\n\n### June _F_ 4 -1.865 _ORPR_ 2 1.024 6.883 112.342 2.912\n\n### May _F_ 4 -1.863 _ORPR_ 2 1.024 6.877 112.182 2.912\n\n### April _FH_ 4 -1.254 _FAB_ 2 1.770 10.219 -12.460 2.905\n\n### March _F_ 4 -1.878 _ORPR_ 2 1.051 6.791 109.260 2.839\n\n### Table 6. The monthly models for BEN.\n\n### **_Month_**\n\n**_C1 t1 b1 C2 t2 b2_**\n\n### **_c d_** **sterr,$**\n\n### October _FB_ 4 -7.333 _O_ 9 -1.519 69.578 1536.224 7.365\n\n### September _FB_ 4 -7.319 _O_ 9 -1.515 69.428 1533.079 7.361\n\n### August _FB_ 4 -7.301 _O_ 9 -1.513 69.275 1529.960 7.353\n\n### July _FB_ 4 -7.299 _O_ 9 -1.515 69.286 1530.175 7.353\n\n### June _FB_ 4 -7.311 _O_ 9 -1.515 69.375 1532.037 7.350\n\n### May _FB_ 4 -7.301 _O_ 9 -1.513 69.304 1529.705 7.343\n\n### April _FB_ 4 -7.303 _O_ 9 -1.515 69.361 1530.410 7.337\n\n### March _FB_ 4 -7.309 _O_ 9 -1.513 69.312 1531.360 7.270\n\n### Table 7. Cross correlation coefficients for six CPI time series and their first differences. Original series include 124 readings, and their first differences – 123 readings.\n\n**_F FB SEFV ORPR RSH O_**\n\n**_F_** 1\n\n**_FB_** 0\\.99998 1\n\n**_SEFV_** 0\\.99714 0.99671 1\n\n**_ORPR_** 0\\.98356 0.98295 0.98702 1\n\n**_RSH_** 0\\.97533 0.97478 0.97736 0.99698 1\n\n**_O_** 0\\.97752 0.97661 0.98664 0.95629 0.93924 1\n\n**d** **_F_** **d** **_FB_** **d** **_SEFV_** **d** **_ORPR_** **d** **_RSH_** **d** **_O_**\n\n**d** **_F_** 1\n\n**d** **_FB_** 0\\.994 1\n\n**d** **_SEFV_** 0\\.47 [0.49] 0.48 [0.49] 1\n\n**d** **_ORPR_** 0\\.12 [0.26] 0.12 [0.26] 0.31 [0.35] 1\n\n**d** **_RSH_** 0\\.13 [0.30] 0.12 [0.28] 0.10 [0.29] 0.31 [0.37] 1\n\n**d** **_O_** \\-0.18 [030] -0.18 [0.28] 0.06 [0.29] 0.002 [-0.21] 0.04 [-0.29] 1\n\n### **Discussion**\n\n### The stock prices of BAC and MS are well correlated. This observation is supported by the similarity of defining CPIs with equal time lags. It is worth noting that the level of correlation may cease quickly for two models with the same defining CPIs but with increasing difference in time lags. For the same CPIs and lags, the level of correlation depends on the ratio of CPI\n\ncoefficients. This ratio ( _b1/b2_ ) is -2.23 for BAC and -1.65 for MS. The closeness of the ratios\n\n### guarantees similar evolution of their prices. It is important to stress, however, that _SEFV_ has a"],"full_content":"7\n\n### August _F_ 4 -1.861 _ORPR_ 2 1.018 6.898 112.917 2.914\n\n### July _F_ 4 -1.863 _ORPR_ 2 1.024 6.873 112.112 2.912\n\n### June _F_ 4 -1.865 _ORPR_ 2 1.024 6.883 112.342 2.912\n\n### May _F_ 4 -1.863 _ORPR_ 2 1.024 6.877 112.182 2.912\n\n### April _FH_ 4 -1.254 _FAB_ 2 1.770 10.219 -12.460 2.905\n\n### March _F_ 4 -1.878 _ORPR_ 2 1.051 6.791 109.260 2.839\n\n### Table 6. The monthly models for BEN.\n\n### **_Month_**\n\n**_C1 t1 b1 C2 t2 b2_**\n\n### **_c d_** **sterr,$**\n\n### October _FB_ 4 -7.333 _O_ 9 -1.519 69.578 1536.224 7.365\n\n### September _FB_ 4 -7.319 _O_ 9 -1.515 69.428 1533.079 7.361\n\n### August _FB_ 4 -7.301 _O_ 9 -1.513 69.275 1529.960 7.353\n\n### July _FB_ 4 -7.299 _O_ 9 -1.515 69.286 1530.175 7.353\n\n### June _FB_ 4 -7.311 _O_ 9 -1.515 69.375 1532.037 7.350\n\n### May _FB_ 4 -7.301 _O_ 9 -1.513 69.304 1529.705 7.343\n\n### April _FB_ 4 -7.303 _O_ 9 -1.515 69.361 1530.410 7.337\n\n### March _FB_ 4 -7.309 _O_ 9 -1.513 69.312 1531.360 7.270\n\n### Table 7. Cross correlation coefficients for six CPI time series and their first differences. Original series include 124 readings, and their first differences – 123 readings.\n\n**_F FB SEFV ORPR RSH O_**\n\n**_F_** 1\n\n**_FB_** 0\\.99998 1\n\n**_SEFV_** 0\\.99714 0.99671 1\n\n**_ORPR_** 0\\.98356 0.98295 0.98702 1\n\n**_RSH_** 0\\.97533 0.97478 0.97736 0.99698 1\n\n**_O_** 0\\.97752 0.97661 0.98664 0.95629 0.93924 1\n\n**d** **_F_** **d** **_FB_** **d** **_SEFV_** **d** **_ORPR_** **d** **_RSH_** **d** **_O_**\n\n**d** **_F_** 1\n\n**d** **_FB_** 0\\.994 1\n\n**d** **_SEFV_** 0\\.47 [0.49] 0.48 [0.49] 1\n\n**d** **_ORPR_** 0\\.12 [0.26] 0.12 [0.26] 0.31 [0.35] 1\n\n**d** **_RSH_** 0\\.13 [0.30] 0.12 [0.28] 0.10 [0.29] 0.31 [0.37] 1\n\n**d** **_O_** \\-0.18 [030] -0.18 [0.28] 0.06 [0.29] 0.002 [-0.21] 0.04 [-0.29] 1\n\n### **Discussion**\n\n### The stock prices of BAC and MS are well correlated. This observation is supported by the similarity of defining CPIs with equal time lags. It is worth noting that the level of correlation may cease quickly for two models with the same defining CPIs but with increasing difference in time lags. For the same CPIs and lags, the level of correlation depends on the ratio of CPI\n\ncoefficients. This ratio ( _b1/b2_ ) is -2.23 for BAC and -1.65 for MS. The closeness of the ratios\n\n### guarantees similar evolution of their prices. It is important to stress, however, that _SEFV_ has a","publish_date":null,"title":"August F 4 -1.861 ORPR 2 1.018 6.898 112.917 2.914 July F 4 -1.863 ORPR 2 1.024 6.873 112.112 2.912","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1212.1661v1_page7.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1212.1661v1_page7.pdf"},"request":{"example_id":"table/1212.1661v1_page7","product_type":"parse","source_file_path":"1212.1661v1_page7.pdf"},"started_at":"2026-11-04T19:47:49.666877"} +{"completed_at":"2026-11-04T19:47:52.089163","latency_in_ms":1280,"output":{"example_id":"table/13_axa_world_funds_page59","grounded_pages":[],"layout_pages":[],"markdown":"AXA World Funds\n\n## Statement of Operations and Changes in Net Assets for the year ended 31 December 2024\n\nCombined AXA World Funds AXA World Funds\n\nACT Biodiversity ACT Clean Economy\n\nEUR USD USD\n\nNET ASSET VALUE AT THE BEGINNING OF THE YEAR 34,071,185,342 \\* 203,829,100 158,452,467\n\nINCOME\n\nDividends (note 2k) 237,359,932 1,516,976 1,912,244\n\nInterest on investment portfolio (note 2l) 975,255,720 - -\n\nInterest on bank accounts 36 - -\n\nSecurities lending income (note 16) 8,149,542 - 2,472\n\nIncome on swaps 6,159,866 - -\n\nOther income 685,053 34 125\n\nTotal income 1,227,610,149 1,517,010 1,914,841\n\nEXPENSES\n\nExpense on swaps 13,740,558 - -\n\nProfessional fees 25,854 - -\n\nDistribution fees (note 4) 7,187,163 482 6,597\n\nManagement fees (note 5) 206,687,506 535,377 1,709,958\n\nPerformance fees (note 6) 1,024,321 - -\n\nWithholding tax reclaim fees (note 8) 82,568 - -\n\nRedex fees (note 7) 21,388 - -\n\nApplied service fee (note 9) 59,251,360 352,030 406,957\n\nTransaction fees (note 11) 1,709,387 8,727 21,341\n\nSecurities lending expenses (note 16) 2,852,338 - 865\n\nOther expenses 602,465 - -\n\nTotal expenses 293,184,908 896,616 2,145,718\n\nNET INCOME/(LOSS) FROM INVESTMENTS FOR THE YEAR 934,425,241 620,394 (230,877)\n\nNet realised gain/(loss)\n\n\\- on sales of investments (note 2f) 460,503,890 (60,804) 15,248,984\n\n\\- on spot foreign exchange (74,534,072) 675,573 152,302\n\n\\- on forward foreign exchange contracts (349,497,206) (577,466) (5,886,188)\n\n\\- on futures 109,223,840 - -\n\n\\- on swaps (66,915,228) - -\n\n\\- on options (9,489,285) - -\n\nNet realised gain/(loss) for the year 69,291,939 37,303 9,515,098\n\nNet change in unrealised appreciation/(depreciation)\n\n\\- on investments (note 2f) 864,230,851 10,669,684 (807,176)\n\n\\- on forward foreign exchange contracts (133,903,216) (155,430) (1,512,986)\n\n\\- on futures (14,184,453) - -\n\n\\- on swaps 41,638,577 - -\n\n\\- on options (10,355,009) - -\n\nNet change in net assets for the year resulting from operations 1,751,143,930 11,171,951 6,964,059\n\nNet proceeds from subscriptions/(redemptions) 763,875,754 12,064,555 (14,444,720)\n\nDividends paid and payable (note 15) (173,352,062) - (25,087)\n\nNET ASSET VALUE AT THE END OF THE YEAR 36,412,852,964 227,065,606 150,946,719\n\n\\*The opening balance was combined at the exchange ruling used at Year end. With the exchange rates prevailing as at 31 December 2023, this amount was equal to 33,227,246,527 EUR. Please refer to note 2b) for more details.","pages":[{"line_numbers":[],"markdown":"AXA World Funds\n\n## Statement of Operations and Changes in Net Assets for the year ended 31 December 2024\n\nCombined AXA World Funds AXA World Funds\n\nACT Biodiversity ACT Clean Economy\n\nEUR USD USD\n\nNET ASSET VALUE AT THE BEGINNING OF THE YEAR 34,071,185,342 \\* 203,829,100 158,452,467\n\nINCOME\n\nDividends (note 2k) 237,359,932 1,516,976 1,912,244\n\nInterest on investment portfolio (note 2l) 975,255,720 - -\n\nInterest on bank accounts 36 - -\n\nSecurities lending income (note 16) 8,149,542 - 2,472\n\nIncome on swaps 6,159,866 - -\n\nOther income 685,053 34 125\n\nTotal income 1,227,610,149 1,517,010 1,914,841\n\nEXPENSES\n\nExpense on swaps 13,740,558 - -\n\nProfessional fees 25,854 - -\n\nDistribution fees (note 4) 7,187,163 482 6,597\n\nManagement fees (note 5) 206,687,506 535,377 1,709,958\n\nPerformance fees (note 6) 1,024,321 - -\n\nWithholding tax reclaim fees (note 8) 82,568 - -\n\nRedex fees (note 7) 21,388 - -\n\nApplied service fee (note 9) 59,251,360 352,030 406,957\n\nTransaction fees (note 11) 1,709,387 8,727 21,341\n\nSecurities lending expenses (note 16) 2,852,338 - 865\n\nOther expenses 602,465 - -\n\nTotal expenses 293,184,908 896,616 2,145,718\n\nNET INCOME/(LOSS) FROM INVESTMENTS FOR THE YEAR 934,425,241 620,394 (230,877)\n\nNet realised gain/(loss)\n\n\\- on sales of investments (note 2f) 460,503,890 (60,804) 15,248,984\n\n\\- on spot foreign exchange (74,534,072) 675,573 152,302\n\n\\- on forward foreign exchange contracts (349,497,206) (577,466) (5,886,188)\n\n\\- on futures 109,223,840 - -\n\n\\- on swaps (66,915,228) - -\n\n\\- on options (9,489,285) - -\n\nNet realised gain/(loss) for the year 69,291,939 37,303 9,515,098\n\nNet change in unrealised appreciation/(depreciation)\n\n\\- on investments (note 2f) 864,230,851 10,669,684 (807,176)\n\n\\- on forward foreign exchange contracts (133,903,216) (155,430) (1,512,986)\n\n\\- on futures (14,184,453) - -\n\n\\- on swaps 41,638,577 - -\n\n\\- on options (10,355,009) - -\n\nNet change in net assets for the year resulting from operations 1,751,143,930 11,171,951 6,964,059\n\nNet proceeds from subscriptions/(redemptions) 763,875,754 12,064,555 (14,444,720)\n\nDividends paid and payable (note 15) (173,352,062) - (25,087)\n\nNET ASSET VALUE AT THE END OF THE YEAR 36,412,852,964 227,065,606 150,946,719\n\n\\*The opening balance was combined at the exchange ruling used at Year end. With the exchange rates prevailing as at 31 December 2023, this amount was equal to 33,227,246,527 EUR. Please refer to note 2b) for more details.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"AXA World Funds\n\n## Statement of Operations and Changes in Net Assets for the year ended 31 December 2024\n\nCombined AXA World Funds AXA World Funds\n\nACT Biodiversity ACT Clean Economy\n\nEUR USD USD\n\nNET ASSET VALUE AT THE BEGINNING OF THE YEAR 34,071,185,342 \\* 203,829,100 158,452,467\n\nINCOME\n\nDividends (note 2k) 237,359,932 1,516,976 1,912,244\n\nInterest on investment portfolio (note 2l) 975,255,720 - -\n\nInterest on bank accounts 36 - -\n\nSecurities lending income (note 16) 8,149,542 - 2,472\n\nIncome on swaps 6,159,866 - -\n\nOther income 685,053 34 125\n\nTotal income 1,227,610,149 1,517,010 1,914,841\n\nEXPENSES\n\nExpense on swaps 13,740,558 - -\n\nProfessional fees 25,854 - -\n\nDistribution fees (note 4) 7,187,163 482 6,597\n\nManagement fees (note 5) 206,687,506 535,377 1,709,958\n\nPerformance fees (note 6) 1,024,321 - -\n\nWithholding tax reclaim fees (note 8) 82,568 - -\n\nRedex fees (note 7) 21,388 - -\n\nApplied service fee (note 9) 59,251,360 352,030 406,957\n\nTransaction fees (note 11) 1,709,387 8,727 21,341\n\nSecurities lending expenses (note 16) 2,852,338 - 865\n\nOther expenses 602,465 - -\n\nTotal expenses 293,184,908 896,616 2,145,718\n\nNET INCOME/(LOSS) FROM INVESTMENTS FOR THE YEAR 934,425,241 620,394 (230,877)\n\nNet realised gain/(loss)\n\n\\- on sales of investments (note 2f) 460,503,890 (60,804) 15,248,984\n\n\\- on spot foreign exchange (74,534,072) 675,573 152,302\n\n\\- on forward foreign exchange contracts (349,497,206) (577,466) (5,886,188)\n\n\\- on futures 109,223,840 - -\n\n\\- on swaps (66,915,228) - -\n\n\\- on options (9,489,285) - -\n\nNet realised gain/(loss) for the year 69,291,939 37,303 9,515,098\n\nNet change in unrealised appreciation/(depreciation)\n\n\\- on investments (note 2f) 864,230,851 10,669,684 (807,176)\n\n\\- on forward foreign exchange contracts (133,903,216) (155,430) (1,512,986)\n\n\\- on futures (14,184,453) - -\n\n\\- on swaps 41,638,577 - -\n\n\\- on options (10,355,009) - -\n\nNet change in net assets for the year resulting from operations 1,751,143,930 11,171,951 6,964,059\n\nNet proceeds from subscriptions/(redemptions) 763,875,754 12,064,555 (14,444,720)\n\nDividends paid and payable (note 15) (173,352,062) - (25,087)\n\nNET ASSET VALUE AT THE END OF THE YEAR 36,412,852,964 227,065,606 150,946,719\n\n\\*The opening balance was combined at the exchange ruling used at Year end. With the exchange rates prevailing as at 31 December 2023, this amount was equal to 33,227,246,527 EUR. Please refer to note 2b) for more details.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/13_axa_world_funds_page59.pdf"]},"response":{"errors":[],"extract_id":"extract_453709ace21bf0a28239d90dc93045ae","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["AXA World Funds\n\n## Statement of Operations and Changes in Net Assets for the year ended 31 December 2024\n\nCombined AXA World Funds AXA World Funds\n\nACT Biodiversity ACT Clean Economy\n\nEUR USD USD\n\nNET ASSET VALUE AT THE BEGINNING OF THE YEAR 34,071,185,342 \\* 203,829,100 158,452,467\n\nINCOME\n\nDividends (note 2k) 237,359,932 1,516,976 1,912,244\n\nInterest on investment portfolio (note 2l) 975,255,720 - -\n\nInterest on bank accounts 36 - -\n\nSecurities lending income (note 16) 8,149,542 - 2,472\n\nIncome on swaps 6,159,866 - -\n\nOther income 685,053 34 125\n\nTotal income 1,227,610,149 1,517,010 1,914,841\n\nEXPENSES\n\nExpense on swaps 13,740,558 - -\n\nProfessional fees 25,854 - -\n\nDistribution fees (note 4) 7,187,163 482 6,597\n\nManagement fees (note 5) 206,687,506 535,377 1,709,958\n\nPerformance fees (note 6) 1,024,321 - -\n\nWithholding tax reclaim fees (note 8) 82,568 - -\n\nRedex fees (note 7) 21,388 - -\n\nApplied service fee (note 9) 59,251,360 352,030 406,957\n\nTransaction fees (note 11) 1,709,387 8,727 21,341\n\nSecurities lending expenses (note 16) 2,852,338 - 865\n\nOther expenses 602,465 - -\n\nTotal expenses 293,184,908 896,616 2,145,718\n\nNET INCOME/(LOSS) FROM INVESTMENTS FOR THE YEAR 934,425,241 620,394 (230,877)\n\nNet realised gain/(loss)\n\n\\- on sales of investments (note 2f) 460,503,890 (60,804) 15,248,984\n\n\\- on spot foreign exchange (74,534,072) 675,573 152,302\n\n\\- on forward foreign exchange contracts (349,497,206) (577,466) (5,886,188)\n\n\\- on futures 109,223,840 - -\n\n\\- on swaps (66,915,228) - -\n\n\\- on options (9,489,285) - -\n\nNet realised gain/(loss) for the year 69,291,939 37,303 9,515,098\n\nNet change in unrealised appreciation/(depreciation)\n\n\\- on investments (note 2f) 864,230,851 10,669,684 (807,176)\n\n\\- on forward foreign exchange contracts (133,903,216) (155,430) (1,512,986)\n\n\\- on futures (14,184,453) - -\n\n\\- on swaps 41,638,577 - -\n\n\\- on options (10,355,009) - -\n\nNet change in net assets for the year resulting from operations 1,751,143,930 11,171,951 6,964,059\n\nNet proceeds from subscriptions/(redemptions) 763,875,754 12,064,555 (14,444,720)\n\nDividends paid and payable (note 15) (173,352,062) - (25,087)\n\nNET ASSET VALUE AT THE END OF THE YEAR 36,412,852,964 227,065,606 150,946,719\n\n\\*The opening balance was combined at the exchange ruling used at Year end. With the exchange rates prevailing as at 31 December 2023, this amount was equal to 33,227,246,527 EUR. Please refer to note 2b) for more details."],"full_content":"AXA World Funds\n\n## Statement of Operations and Changes in Net Assets for the year ended 31 December 2024\n\nCombined AXA World Funds AXA World Funds\n\nACT Biodiversity ACT Clean Economy\n\nEUR USD USD\n\nNET ASSET VALUE AT THE BEGINNING OF THE YEAR 34,071,185,342 \\* 203,829,100 158,452,467\n\nINCOME\n\nDividends (note 2k) 237,359,932 1,516,976 1,912,244\n\nInterest on investment portfolio (note 2l) 975,255,720 - -\n\nInterest on bank accounts 36 - -\n\nSecurities lending income (note 16) 8,149,542 - 2,472\n\nIncome on swaps 6,159,866 - -\n\nOther income 685,053 34 125\n\nTotal income 1,227,610,149 1,517,010 1,914,841\n\nEXPENSES\n\nExpense on swaps 13,740,558 - -\n\nProfessional fees 25,854 - -\n\nDistribution fees (note 4) 7,187,163 482 6,597\n\nManagement fees (note 5) 206,687,506 535,377 1,709,958\n\nPerformance fees (note 6) 1,024,321 - -\n\nWithholding tax reclaim fees (note 8) 82,568 - -\n\nRedex fees (note 7) 21,388 - -\n\nApplied service fee (note 9) 59,251,360 352,030 406,957\n\nTransaction fees (note 11) 1,709,387 8,727 21,341\n\nSecurities lending expenses (note 16) 2,852,338 - 865\n\nOther expenses 602,465 - -\n\nTotal expenses 293,184,908 896,616 2,145,718\n\nNET INCOME/(LOSS) FROM INVESTMENTS FOR THE YEAR 934,425,241 620,394 (230,877)\n\nNet realised gain/(loss)\n\n\\- on sales of investments (note 2f) 460,503,890 (60,804) 15,248,984\n\n\\- on spot foreign exchange (74,534,072) 675,573 152,302\n\n\\- on forward foreign exchange contracts (349,497,206) (577,466) (5,886,188)\n\n\\- on futures 109,223,840 - -\n\n\\- on swaps (66,915,228) - -\n\n\\- on options (9,489,285) - -\n\nNet realised gain/(loss) for the year 69,291,939 37,303 9,515,098\n\nNet change in unrealised appreciation/(depreciation)\n\n\\- on investments (note 2f) 864,230,851 10,669,684 (807,176)\n\n\\- on forward foreign exchange contracts (133,903,216) (155,430) (1,512,986)\n\n\\- on futures (14,184,453) - -\n\n\\- on swaps 41,638,577 - -\n\n\\- on options (10,355,009) - -\n\nNet change in net assets for the year resulting from operations 1,751,143,930 11,171,951 6,964,059\n\nNet proceeds from subscriptions/(redemptions) 763,875,754 12,064,555 (14,444,720)\n\nDividends paid and payable (note 15) (173,352,062) - (25,087)\n\nNET ASSET VALUE AT THE END OF THE YEAR 36,412,852,964 227,065,606 150,946,719\n\n\\*The opening balance was combined at the exchange ruling used at Year end. With the exchange rates prevailing as at 31 December 2023, this amount was equal to 33,227,246,527 EUR. Please refer to note 2b) for more details.","publish_date":null,"title":"Statement of Operations and Changes in Net Assets for the year ended 31 December 2024","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/13_axa_world_funds_page59.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/13_axa_world_funds_page59.pdf"},"request":{"example_id":"table/13_axa_world_funds_page59","product_type":"parse","source_file_path":"13_axa_world_funds_page59.pdf"},"started_at":"2026-11-04T19:47:50.808831"} +{"completed_at":"2026-11-04T19:47:53.415574","latency_in_ms":1322,"output":{"example_id":"table/15_blackrock_strategic_funds_page29","grounded_pages":[],"layout_pages":[],"markdown":"**BlackRock Systematic Asia Pacific Equity Absolute Return Fund** **(2)** **BlackRock Systematic ESG World Equity Fund**\n\n**BlackRock Systematic Global Equity Absolute Return Fund** **(2)** **BlackRock Systematic Style Factor Fund** **(2)**\n\n**Note USD USD USD USD**\n\n**Assets**\n\nSecurities portfolio at cost 139,646,696 1,021,504,793 20,901,267 116,506,042\n\nUnrealised appreciation/(depreciation) 1,576,979 137,906,684 11,470 (25,848)\n\nSecurities portfolio at market value 2(a) 141,223,675 1,159,411,477 20,912,737 116,480,194\n\nCash at bank 2(a) 3,269,850 13,211,976 657,340 26,622,769\n\nDue from broker 15 891,996 858,205 379,580 15,167,959\n\nInterest and dividends receivable 2(a),2(d) 996,388 1,954,230 28,188 628,679\n\nReceivable for investments sold 2(a),2(d) 25,940,393 — 3,800,387 11,680,232\n\nReceivable for Fund shares subscribed 2(a) 1,899,214 4,260,071 62,726 43,036\n\nUnrealised appreciation on:\n\nFutures contracts 2(d) 171,370 — 167,026 2,017,556\n\nOpen forward foreign exchange transactions 2(d) 767,752 5,562 151,224 3,819,095\n\nContracts for difference 2(d) 15,126,803 — 2,116,749 8,284,252\n\nTo Be Announced securities contracts 2(d) — — — —\n\nSwaps at market value 2(d) — — — 2,538,671\n\nPurchased options/swaptions at market value 2(d) — — — —\n\nOther assets 2(a) 20,293 15,328 — 15\n\n**Total assets 190,307,734 1,179,716,849 28,275,957 187,282,458**\n\n**Liabilities**\n\nCash owed to bank 2(a) — 6,326 5,813 25\n\nDue to broker 15 1,539,045 5 450,249 2,285,265\n\nInterest and dividends payable 2(a),2(d) 535,564 — 44,916 182,374\n\nPayable for investments purchased 2(a),2(d) 23,397,936 — 3,564,773 13,419,458\n\nPayable for Fund shares redeemed 2(a) 18,029 972,760 2,250 70,410\n\nIncome distribution payable 2(a),11 — — — 4,453\n\nUnrealised depreciation on:\n\nFutures contracts 2(d) 68,696 127,571 — 1,661,425\n\nOpen forward foreign exchange transactions 2(d) 12,530 93,837 2,663 4,066,352\n\nContracts for difference 2(d) 14,807,084 — 2,077,854 6,970,909\n\nTo Be Announced securities contracts 2(d) — — — —\n\nSwaps at market value 2(d) — — — 1,740,294\n\nWritten options/swaptions at market value 2(d) — — — —\n\nAccrued expenses and other liabilities 2(a),4,5,6,7,8 1,751,493 2,170,956 250,546 515,583\n\n**Total liabilities 42,130,377 3,371,455 6,399,064 30,916,548**\n\n**Total net assets 148,177,357 1,176,345,394 21,876,893 156,365,910**\n\n(2) Fund name changed during the year, see Note 1 for further details.\n\n## Statement of Net Assets\n\nas at 31 May 2024 continued\n\nThe notes on pages 543 to 565 form an integral part of these financial statements.\n\n**Annual report and audited financial statements [27]**\n\nNM0924U-3899602-29/772","pages":[{"line_numbers":[],"markdown":"**BlackRock Systematic Asia Pacific Equity Absolute Return Fund** **(2)** **BlackRock Systematic ESG World Equity Fund**\n\n**BlackRock Systematic Global Equity Absolute Return Fund** **(2)** **BlackRock Systematic Style Factor Fund** **(2)**\n\n**Note USD USD USD USD**\n\n**Assets**\n\nSecurities portfolio at cost 139,646,696 1,021,504,793 20,901,267 116,506,042\n\nUnrealised appreciation/(depreciation) 1,576,979 137,906,684 11,470 (25,848)\n\nSecurities portfolio at market value 2(a) 141,223,675 1,159,411,477 20,912,737 116,480,194\n\nCash at bank 2(a) 3,269,850 13,211,976 657,340 26,622,769\n\nDue from broker 15 891,996 858,205 379,580 15,167,959\n\nInterest and dividends receivable 2(a),2(d) 996,388 1,954,230 28,188 628,679\n\nReceivable for investments sold 2(a),2(d) 25,940,393 — 3,800,387 11,680,232\n\nReceivable for Fund shares subscribed 2(a) 1,899,214 4,260,071 62,726 43,036\n\nUnrealised appreciation on:\n\nFutures contracts 2(d) 171,370 — 167,026 2,017,556\n\nOpen forward foreign exchange transactions 2(d) 767,752 5,562 151,224 3,819,095\n\nContracts for difference 2(d) 15,126,803 — 2,116,749 8,284,252\n\nTo Be Announced securities contracts 2(d) — — — —\n\nSwaps at market value 2(d) — — — 2,538,671\n\nPurchased options/swaptions at market value 2(d) — — — —\n\nOther assets 2(a) 20,293 15,328 — 15\n\n**Total assets 190,307,734 1,179,716,849 28,275,957 187,282,458**\n\n**Liabilities**\n\nCash owed to bank 2(a) — 6,326 5,813 25\n\nDue to broker 15 1,539,045 5 450,249 2,285,265\n\nInterest and dividends payable 2(a),2(d) 535,564 — 44,916 182,374\n\nPayable for investments purchased 2(a),2(d) 23,397,936 — 3,564,773 13,419,458\n\nPayable for Fund shares redeemed 2(a) 18,029 972,760 2,250 70,410\n\nIncome distribution payable 2(a),11 — — — 4,453\n\nUnrealised depreciation on:\n\nFutures contracts 2(d) 68,696 127,571 — 1,661,425\n\nOpen forward foreign exchange transactions 2(d) 12,530 93,837 2,663 4,066,352\n\nContracts for difference 2(d) 14,807,084 — 2,077,854 6,970,909\n\nTo Be Announced securities contracts 2(d) — — — —\n\nSwaps at market value 2(d) — — — 1,740,294\n\nWritten options/swaptions at market value 2(d) — — — —\n\nAccrued expenses and other liabilities 2(a),4,5,6,7,8 1,751,493 2,170,956 250,546 515,583\n\n**Total liabilities 42,130,377 3,371,455 6,399,064 30,916,548**\n\n**Total net assets 148,177,357 1,176,345,394 21,876,893 156,365,910**\n\n(2) Fund name changed during the year, see Note 1 for further details.\n\n## Statement of Net Assets\n\nas at 31 May 2024 continued\n\nThe notes on pages 543 to 565 form an integral part of these financial statements.\n\n**Annual report and audited financial statements [27]**\n\nNM0924U-3899602-29/772","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**BlackRock Systematic Asia Pacific Equity Absolute Return Fund** **(2)** **BlackRock Systematic ESG World Equity Fund**\n\n**BlackRock Systematic Global Equity Absolute Return Fund** **(2)** **BlackRock Systematic Style Factor Fund** **(2)**\n\n**Note USD USD USD USD**\n\n**Assets**\n\nSecurities portfolio at cost 139,646,696 1,021,504,793 20,901,267 116,506,042\n\nUnrealised appreciation/(depreciation) 1,576,979 137,906,684 11,470 (25,848)\n\nSecurities portfolio at market value 2(a) 141,223,675 1,159,411,477 20,912,737 116,480,194\n\nCash at bank 2(a) 3,269,850 13,211,976 657,340 26,622,769\n\nDue from broker 15 891,996 858,205 379,580 15,167,959\n\nInterest and dividends receivable 2(a),2(d) 996,388 1,954,230 28,188 628,679\n\nReceivable for investments sold 2(a),2(d) 25,940,393 — 3,800,387 11,680,232\n\nReceivable for Fund shares subscribed 2(a) 1,899,214 4,260,071 62,726 43,036\n\nUnrealised appreciation on:\n\nFutures contracts 2(d) 171,370 — 167,026 2,017,556\n\nOpen forward foreign exchange transactions 2(d) 767,752 5,562 151,224 3,819,095\n\nContracts for difference 2(d) 15,126,803 — 2,116,749 8,284,252\n\nTo Be Announced securities contracts 2(d) — — — —\n\nSwaps at market value 2(d) — — — 2,538,671\n\nPurchased options/swaptions at market value 2(d) — — — —\n\nOther assets 2(a) 20,293 15,328 — 15\n\n**Total assets 190,307,734 1,179,716,849 28,275,957 187,282,458**\n\n**Liabilities**\n\nCash owed to bank 2(a) — 6,326 5,813 25\n\nDue to broker 15 1,539,045 5 450,249 2,285,265\n\nInterest and dividends payable 2(a),2(d) 535,564 — 44,916 182,374\n\nPayable for investments purchased 2(a),2(d) 23,397,936 — 3,564,773 13,419,458\n\nPayable for Fund shares redeemed 2(a) 18,029 972,760 2,250 70,410\n\nIncome distribution payable 2(a),11 — — — 4,453\n\nUnrealised depreciation on:\n\nFutures contracts 2(d) 68,696 127,571 — 1,661,425\n\nOpen forward foreign exchange transactions 2(d) 12,530 93,837 2,663 4,066,352\n\nContracts for difference 2(d) 14,807,084 — 2,077,854 6,970,909\n\nTo Be Announced securities contracts 2(d) — — — —\n\nSwaps at market value 2(d) — — — 1,740,294\n\nWritten options/swaptions at market value 2(d) — — — —\n\nAccrued expenses and other liabilities 2(a),4,5,6,7,8 1,751,493 2,170,956 250,546 515,583\n\n**Total liabilities 42,130,377 3,371,455 6,399,064 30,916,548**\n\n**Total net assets 148,177,357 1,176,345,394 21,876,893 156,365,910**\n\n(2) Fund name changed during the year, see Note 1 for further details.\n\n## Statement of Net Assets\n\nas at 31 May 2024 continued\n\nThe notes on pages 543 to 565 form an integral part of these financial statements.\n\n**Annual report and audited financial statements [27]**\n\nNM0924U-3899602-29/772","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/15_blackrock_strategic_funds_page29.pdf"]},"response":{"errors":[],"extract_id":"extract_a60175b967b68460fa8a9d3b8393e084","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**BlackRock Systematic Asia Pacific Equity Absolute Return Fund** **(2)** **BlackRock Systematic ESG World Equity Fund**\n\n**BlackRock Systematic Global Equity Absolute Return Fund** **(2)** **BlackRock Systematic Style Factor Fund** **(2)**\n\n**Note USD USD USD USD**\n\n**Assets**\n\nSecurities portfolio at cost 139,646,696 1,021,504,793 20,901,267 116,506,042\n\nUnrealised appreciation/(depreciation) 1,576,979 137,906,684 11,470 (25,848)\n\nSecurities portfolio at market value 2(a) 141,223,675 1,159,411,477 20,912,737 116,480,194\n\nCash at bank 2(a) 3,269,850 13,211,976 657,340 26,622,769\n\nDue from broker 15 891,996 858,205 379,580 15,167,959\n\nInterest and dividends receivable 2(a),2(d) 996,388 1,954,230 28,188 628,679\n\nReceivable for investments sold 2(a),2(d) 25,940,393 — 3,800,387 11,680,232\n\nReceivable for Fund shares subscribed 2(a) 1,899,214 4,260,071 62,726 43,036\n\nUnrealised appreciation on:\n\nFutures contracts 2(d) 171,370 — 167,026 2,017,556\n\nOpen forward foreign exchange transactions 2(d) 767,752 5,562 151,224 3,819,095\n\nContracts for difference 2(d) 15,126,803 — 2,116,749 8,284,252\n\nTo Be Announced securities contracts 2(d) — — — —\n\nSwaps at market value 2(d) — — — 2,538,671\n\nPurchased options/swaptions at market value 2(d) — — — —\n\nOther assets 2(a) 20,293 15,328 — 15\n\n**Total assets 190,307,734 1,179,716,849 28,275,957 187,282,458**\n\n**Liabilities**\n\nCash owed to bank 2(a) — 6,326 5,813 25\n\nDue to broker 15 1,539,045 5 450,249 2,285,265\n\nInterest and dividends payable 2(a),2(d) 535,564 — 44,916 182,374\n\nPayable for investments purchased 2(a),2(d) 23,397,936 — 3,564,773 13,419,458\n\nPayable for Fund shares redeemed 2(a) 18,029 972,760 2,250 70,410\n\nIncome distribution payable 2(a),11 — — — 4,453\n\nUnrealised depreciation on:\n\nFutures contracts 2(d) 68,696 127,571 — 1,661,425\n\nOpen forward foreign exchange transactions 2(d) 12,530 93,837 2,663 4,066,352\n\nContracts for difference 2(d) 14,807,084 — 2,077,854 6,970,909\n\nTo Be Announced securities contracts 2(d) — — — —\n\nSwaps at market value 2(d) — — — 1,740,294\n\nWritten options/swaptions at market value 2(d) — — — —\n\nAccrued expenses and other liabilities 2(a),4,5,6,7,8 1,751,493 2,170,956 250,546 515,583\n\n**Total liabilities 42,130,377 3,371,455 6,399,064 30,916,548**\n\n**Total net assets 148,177,357 1,176,345,394 21,876,893 156,365,910**\n\n(2) Fund name changed during the year, see Note 1 for further details.\n\n## Statement of Net Assets\n\nas at 31 May 2024 continued\n\nThe notes on pages 543 to 565 form an integral part of these financial statements.\n\n**Annual report and audited financial statements [27]**\n\nNM0924U-3899602-29/772"],"full_content":"**BlackRock Systematic Asia Pacific Equity Absolute Return Fund** **(2)** **BlackRock Systematic ESG World Equity Fund**\n\n**BlackRock Systematic Global Equity Absolute Return Fund** **(2)** **BlackRock Systematic Style Factor Fund** **(2)**\n\n**Note USD USD USD USD**\n\n**Assets**\n\nSecurities portfolio at cost 139,646,696 1,021,504,793 20,901,267 116,506,042\n\nUnrealised appreciation/(depreciation) 1,576,979 137,906,684 11,470 (25,848)\n\nSecurities portfolio at market value 2(a) 141,223,675 1,159,411,477 20,912,737 116,480,194\n\nCash at bank 2(a) 3,269,850 13,211,976 657,340 26,622,769\n\nDue from broker 15 891,996 858,205 379,580 15,167,959\n\nInterest and dividends receivable 2(a),2(d) 996,388 1,954,230 28,188 628,679\n\nReceivable for investments sold 2(a),2(d) 25,940,393 — 3,800,387 11,680,232\n\nReceivable for Fund shares subscribed 2(a) 1,899,214 4,260,071 62,726 43,036\n\nUnrealised appreciation on:\n\nFutures contracts 2(d) 171,370 — 167,026 2,017,556\n\nOpen forward foreign exchange transactions 2(d) 767,752 5,562 151,224 3,819,095\n\nContracts for difference 2(d) 15,126,803 — 2,116,749 8,284,252\n\nTo Be Announced securities contracts 2(d) — — — —\n\nSwaps at market value 2(d) — — — 2,538,671\n\nPurchased options/swaptions at market value 2(d) — — — —\n\nOther assets 2(a) 20,293 15,328 — 15\n\n**Total assets 190,307,734 1,179,716,849 28,275,957 187,282,458**\n\n**Liabilities**\n\nCash owed to bank 2(a) — 6,326 5,813 25\n\nDue to broker 15 1,539,045 5 450,249 2,285,265\n\nInterest and dividends payable 2(a),2(d) 535,564 — 44,916 182,374\n\nPayable for investments purchased 2(a),2(d) 23,397,936 — 3,564,773 13,419,458\n\nPayable for Fund shares redeemed 2(a) 18,029 972,760 2,250 70,410\n\nIncome distribution payable 2(a),11 — — — 4,453\n\nUnrealised depreciation on:\n\nFutures contracts 2(d) 68,696 127,571 — 1,661,425\n\nOpen forward foreign exchange transactions 2(d) 12,530 93,837 2,663 4,066,352\n\nContracts for difference 2(d) 14,807,084 — 2,077,854 6,970,909\n\nTo Be Announced securities contracts 2(d) — — — —\n\nSwaps at market value 2(d) — — — 1,740,294\n\nWritten options/swaptions at market value 2(d) — — — —\n\nAccrued expenses and other liabilities 2(a),4,5,6,7,8 1,751,493 2,170,956 250,546 515,583\n\n**Total liabilities 42,130,377 3,371,455 6,399,064 30,916,548**\n\n**Total net assets 148,177,357 1,176,345,394 21,876,893 156,365,910**\n\n(2) Fund name changed during the year, see Note 1 for further details.\n\n## Statement of Net Assets\n\nas at 31 May 2024 continued\n\nThe notes on pages 543 to 565 form an integral part of these financial statements.\n\n**Annual report and audited financial statements [27]**\n\nNM0924U-3899602-29/772","publish_date":null,"title":"Statement of Net Assets","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/15_blackrock_strategic_funds_page29.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/15_blackrock_strategic_funds_page29.pdf"},"request":{"example_id":"table/15_blackrock_strategic_funds_page29","product_type":"parse","source_file_path":"15_blackrock_strategic_funds_page29.pdf"},"started_at":"2026-11-04T19:47:52.093570"} +{"completed_at":"2026-11-04T19:47:55.224921","latency_in_ms":2371,"output":{"example_id":"table/1634690602_page1","grounded_pages":[],"layout_pages":[],"markdown":"**Official address** Domenico Scarlattilaan 6 **●** 1083 HS Amsterdam **●** The Netherlands\n\nAn agency of the European Union\n\n**Address for visits and deliveries** Refer to www.ema.europa.eu/how-to-find-us\n\n**Send us a question** Go to www.ema.europa.eu/contact **Telephone** \\+31 (0)88 781 6000\n\n© European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged.\n\n15 October 2021 EMA/CVMP/PhVWP/105691/2021 Veterinary Medicines Division\n\n## Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2021 (Updated monthly)\n\nPlease note that the recommendations shown in this document may not reflect the exact final wording that will appear in the actual package leaflet that still needs to be implemented by the marketing authorisation holders. Previous regulatory recommendations and ongoing procedures are outlined in Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2020 (EMA/112926/2020)\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**Advocate** (imidacloprid/moxidectin)\n\n**13-15 July 2021 Section 4.6 of SPC for Advocate spot-on solution for dogs** :\n\n**Vomiting can occur on rare occasions.** Use of the product may result in transient\n\npruritus in dogs. Vomiting can occur on rare occasions. Transient local skin sensitivity\n\nreactions including increased itching, hair loss, greasy fur and redness at application site\n\nhave been reported in very rare cases in spontaneous (pharmacovigilance) reports. These\n\nsigns disappear without further treatment. If the animal licks the application site after\n\ntreatment, n **N** eurological signs, (most of which are transient) **such as ataxia and**\n\n**muscle tremor (most of which are transient)** may be observed in very rare cases","pages":[{"line_numbers":[],"markdown":"**Official address** Domenico Scarlattilaan 6 **●** 1083 HS Amsterdam **●** The Netherlands\n\nAn agency of the European Union\n\n**Address for visits and deliveries** Refer to www.ema.europa.eu/how-to-find-us\n\n**Send us a question** Go to www.ema.europa.eu/contact **Telephone** \\+31 (0)88 781 6000\n\n© European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged.\n\n15 October 2021 EMA/CVMP/PhVWP/105691/2021 Veterinary Medicines Division\n\n## Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2021 (Updated monthly)\n\nPlease note that the recommendations shown in this document may not reflect the exact final wording that will appear in the actual package leaflet that still needs to be implemented by the marketing authorisation holders. Previous regulatory recommendations and ongoing procedures are outlined in Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2020 (EMA/112926/2020)\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**Advocate** (imidacloprid/moxidectin)\n\n**13-15 July 2021 Section 4.6 of SPC for Advocate spot-on solution for dogs** :\n\n**Vomiting can occur on rare occasions.** Use of the product may result in transient\n\npruritus in dogs. Vomiting can occur on rare occasions. Transient local skin sensitivity\n\nreactions including increased itching, hair loss, greasy fur and redness at application site\n\nhave been reported in very rare cases in spontaneous (pharmacovigilance) reports. These\n\nsigns disappear without further treatment. If the animal licks the application site after\n\ntreatment, n **N** eurological signs, (most of which are transient) **such as ataxia and**\n\n**muscle tremor (most of which are transient)** may be observed in very rare cases","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Official address** Domenico Scarlattilaan 6 **●** 1083 HS Amsterdam **●** The Netherlands\n\nAn agency of the European Union\n\n**Address for visits and deliveries** Refer to www.ema.europa.eu/how-to-find-us\n\n**Send us a question** Go to www.ema.europa.eu/contact **Telephone** \\+31 (0)88 781 6000\n\n© European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged.\n\n15 October 2021 EMA/CVMP/PhVWP/105691/2021 Veterinary Medicines Division\n\n## Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2021 (Updated monthly)\n\nPlease note that the recommendations shown in this document may not reflect the exact final wording that will appear in the actual package leaflet that still needs to be implemented by the marketing authorisation holders. Previous regulatory recommendations and ongoing procedures are outlined in Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2020 (EMA/112926/2020)\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**Advocate** (imidacloprid/moxidectin)\n\n**13-15 July 2021 Section 4.6 of SPC for Advocate spot-on solution for dogs** :\n\n**Vomiting can occur on rare occasions.** Use of the product may result in transient\n\npruritus in dogs. Vomiting can occur on rare occasions. Transient local skin sensitivity\n\nreactions including increased itching, hair loss, greasy fur and redness at application site\n\nhave been reported in very rare cases in spontaneous (pharmacovigilance) reports. These\n\nsigns disappear without further treatment. If the animal licks the application site after\n\ntreatment, n **N** eurological signs, (most of which are transient) **such as ataxia and**\n\n**muscle tremor (most of which are transient)** may be observed in very rare cases","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_ec674c6fd65cc5908f3261764b973776","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Official address** Domenico Scarlattilaan 6 **●** 1083 HS Amsterdam **●** The Netherlands\n\nAn agency of the European Union\n\n**Address for visits and deliveries** Refer to www.ema.europa.eu/how-to-find-us\n\n**Send us a question** Go to www.ema.europa.eu/contact **Telephone** \\+31 (0)88 781 6000\n\n© European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged.\n\n15 October 2021 EMA/CVMP/PhVWP/105691/2021 Veterinary Medicines Division\n\n## Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2021 (Updated monthly)\n\nPlease note that the recommendations shown in this document may not reflect the exact final wording that will appear in the actual package leaflet that still needs to be implemented by the marketing authorisation holders. Previous regulatory recommendations and ongoing procedures are outlined in Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2020 (EMA/112926/2020)\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**Advocate** (imidacloprid/moxidectin)\n\n**13-15 July 2021 Section 4.6 of SPC for Advocate spot-on solution for dogs** :\n\n**Vomiting can occur on rare occasions.** Use of the product may result in transient\n\npruritus in dogs. Vomiting can occur on rare occasions. Transient local skin sensitivity\n\nreactions including increased itching, hair loss, greasy fur and redness at application site\n\nhave been reported in very rare cases in spontaneous (pharmacovigilance) reports. These\n\nsigns disappear without further treatment. If the animal licks the application site after\n\ntreatment, n **N** eurological signs, (most of which are transient) **such as ataxia and**\n\n**muscle tremor (most of which are transient)** may be observed in very rare cases"],"full_content":"**Official address** Domenico Scarlattilaan 6 **●** 1083 HS Amsterdam **●** The Netherlands\n\nAn agency of the European Union\n\n**Address for visits and deliveries** Refer to www.ema.europa.eu/how-to-find-us\n\n**Send us a question** Go to www.ema.europa.eu/contact **Telephone** \\+31 (0)88 781 6000\n\n© European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged.\n\n15 October 2021 EMA/CVMP/PhVWP/105691/2021 Veterinary Medicines Division\n\n## Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2021 (Updated monthly)\n\nPlease note that the recommendations shown in this document may not reflect the exact final wording that will appear in the actual package leaflet that still needs to be implemented by the marketing authorisation holders. Previous regulatory recommendations and ongoing procedures are outlined in Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2020 (EMA/112926/2020)\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**Advocate** (imidacloprid/moxidectin)\n\n**13-15 July 2021 Section 4.6 of SPC for Advocate spot-on solution for dogs** :\n\n**Vomiting can occur on rare occasions.** Use of the product may result in transient\n\npruritus in dogs. Vomiting can occur on rare occasions. Transient local skin sensitivity\n\nreactions including increased itching, hair loss, greasy fur and redness at application site\n\nhave been reported in very rare cases in spontaneous (pharmacovigilance) reports. These\n\nsigns disappear without further treatment. If the animal licks the application site after\n\ntreatment, n **N** eurological signs, (most of which are transient) **such as ataxia and**\n\n**muscle tremor (most of which are transient)** may be observed in very rare cases","publish_date":null,"title":"Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2021 (Updated monthly)","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page1.pdf"},"request":{"example_id":"table/1634690602_page1","product_type":"parse","source_file_path":"1634690602_page1.pdf"},"started_at":"2026-11-04T19:47:52.853801"} +{"completed_at":"2026-11-04T19:47:54.883336","latency_in_ms":937,"output":{"example_id":"table/1634690602_page10","grounded_pages":[],"layout_pages":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 10 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**Vectra 3D** (pyriproxyfen/dinotefuran/permethrin)\n\n**13-15 July 2021** **Section 4.5 of SPC for Vectra 3D, under ‘Special precautions to be taken by**\n\n**the person administering the veterinary medicinal product to animals** **’** :\n\nDo not eat, drink or smoke while handling the veterinary medicinal product.\n\nPeople with known hypersensitivity to any of the ingredients should avoid contact with the\n\nveterinary medicinal product.\n\n**Because the excipient N-methylpyrrolidone has shown evidence of foetal**\n\n**malformations in rabbits and rats in laboratory studies, pregnant women and**\n\n**women suspected of being pregnant should not administer the product and**\n\n**should avoid direct contact with the application site until the application site is**\n\n**no longer noticeable.**\n\n**Vepured** (Recombinant verotoxin 2e of E. coli)\n\n**7-9 September 2021 Section 4.6 of SPC for Vepured** :\n\nVery common adverse reactions:\n\n\\- Mild inflammation at the injection site (< 5 cm in diameter) that typically resolves within\n\nthree days post-vaccination without treatment.\n\n\\- Mild depression during the day of vaccination.\n\n\\- Temperature rise of maximum 1.1 °C was observed. Temperatures returned to normal\n\nwithin 24 hrs.\n\n**Emesis, recumbency, convulsion, lethargy and loss of consciousness occur in**\n\n**very rare cases within a few minutes after vaccination. The animals mostly start**\n\n**to recover within around 15 minutes. In case of severe anaphylactic-type**\n\n**reactions appropriate treatment is recommended.**","pages":[{"line_numbers":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 10 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**Vectra 3D** (pyriproxyfen/dinotefuran/permethrin)\n\n**13-15 July 2021** **Section 4.5 of SPC for Vectra 3D, under ‘Special precautions to be taken by**\n\n**the person administering the veterinary medicinal product to animals** **’** :\n\nDo not eat, drink or smoke while handling the veterinary medicinal product.\n\nPeople with known hypersensitivity to any of the ingredients should avoid contact with the\n\nveterinary medicinal product.\n\n**Because the excipient N-methylpyrrolidone has shown evidence of foetal**\n\n**malformations in rabbits and rats in laboratory studies, pregnant women and**\n\n**women suspected of being pregnant should not administer the product and**\n\n**should avoid direct contact with the application site until the application site is**\n\n**no longer noticeable.**\n\n**Vepured** (Recombinant verotoxin 2e of E. coli)\n\n**7-9 September 2021 Section 4.6 of SPC for Vepured** :\n\nVery common adverse reactions:\n\n\\- Mild inflammation at the injection site (< 5 cm in diameter) that typically resolves within\n\nthree days post-vaccination without treatment.\n\n\\- Mild depression during the day of vaccination.\n\n\\- Temperature rise of maximum 1.1 °C was observed. Temperatures returned to normal\n\nwithin 24 hrs.\n\n**Emesis, recumbency, convulsion, lethargy and loss of consciousness occur in**\n\n**very rare cases within a few minutes after vaccination. The animals mostly start**\n\n**to recover within around 15 minutes. In case of severe anaphylactic-type**\n\n**reactions appropriate treatment is recommended.**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 10 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**Vectra 3D** (pyriproxyfen/dinotefuran/permethrin)\n\n**13-15 July 2021** **Section 4.5 of SPC for Vectra 3D, under ‘Special precautions to be taken by**\n\n**the person administering the veterinary medicinal product to animals** **’** :\n\nDo not eat, drink or smoke while handling the veterinary medicinal product.\n\nPeople with known hypersensitivity to any of the ingredients should avoid contact with the\n\nveterinary medicinal product.\n\n**Because the excipient N-methylpyrrolidone has shown evidence of foetal**\n\n**malformations in rabbits and rats in laboratory studies, pregnant women and**\n\n**women suspected of being pregnant should not administer the product and**\n\n**should avoid direct contact with the application site until the application site is**\n\n**no longer noticeable.**\n\n**Vepured** (Recombinant verotoxin 2e of E. coli)\n\n**7-9 September 2021 Section 4.6 of SPC for Vepured** :\n\nVery common adverse reactions:\n\n\\- Mild inflammation at the injection site (< 5 cm in diameter) that typically resolves within\n\nthree days post-vaccination without treatment.\n\n\\- Mild depression during the day of vaccination.\n\n\\- Temperature rise of maximum 1.1 °C was observed. Temperatures returned to normal\n\nwithin 24 hrs.\n\n**Emesis, recumbency, convulsion, lethargy and loss of consciousness occur in**\n\n**very rare cases within a few minutes after vaccination. The animals mostly start**\n\n**to recover within around 15 minutes. In case of severe anaphylactic-type**\n\n**reactions appropriate treatment is recommended.**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page10.pdf"]},"response":{"errors":[],"extract_id":"extract_03a5d17779319740593a53f4c2f04cfc","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 10 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**Vectra 3D** (pyriproxyfen/dinotefuran/permethrin)\n\n**13-15 July 2021** **Section 4.5 of SPC for Vectra 3D, under ‘Special precautions to be taken by**\n\n**the person administering the veterinary medicinal product to animals** **’** :\n\nDo not eat, drink or smoke while handling the veterinary medicinal product.\n\nPeople with known hypersensitivity to any of the ingredients should avoid contact with the\n\nveterinary medicinal product.\n\n**Because the excipient N-methylpyrrolidone has shown evidence of foetal**\n\n**malformations in rabbits and rats in laboratory studies, pregnant women and**\n\n**women suspected of being pregnant should not administer the product and**\n\n**should avoid direct contact with the application site until the application site is**\n\n**no longer noticeable.**\n\n**Vepured** (Recombinant verotoxin 2e of E. coli)\n\n**7-9 September 2021 Section 4.6 of SPC for Vepured** :\n\nVery common adverse reactions:\n\n\\- Mild inflammation at the injection site (< 5 cm in diameter) that typically resolves within\n\nthree days post-vaccination without treatment.\n\n\\- Mild depression during the day of vaccination.\n\n\\- Temperature rise of maximum 1.1 °C was observed. Temperatures returned to normal\n\nwithin 24 hrs.\n\n**Emesis, recumbency, convulsion, lethargy and loss of consciousness occur in**\n\n**very rare cases within a few minutes after vaccination. The animals mostly start**\n\n**to recover within around 15 minutes. In case of severe anaphylactic-type**\n\n**reactions appropriate treatment is recommended.**"],"full_content":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 10 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**Vectra 3D** (pyriproxyfen/dinotefuran/permethrin)\n\n**13-15 July 2021** **Section 4.5 of SPC for Vectra 3D, under ‘Special precautions to be taken by**\n\n**the person administering the veterinary medicinal product to animals** **’** :\n\nDo not eat, drink or smoke while handling the veterinary medicinal product.\n\nPeople with known hypersensitivity to any of the ingredients should avoid contact with the\n\nveterinary medicinal product.\n\n**Because the excipient N-methylpyrrolidone has shown evidence of foetal**\n\n**malformations in rabbits and rats in laboratory studies, pregnant women and**\n\n**women suspected of being pregnant should not administer the product and**\n\n**should avoid direct contact with the application site until the application site is**\n\n**no longer noticeable.**\n\n**Vepured** (Recombinant verotoxin 2e of E. coli)\n\n**7-9 September 2021 Section 4.6 of SPC for Vepured** :\n\nVery common adverse reactions:\n\n\\- Mild inflammation at the injection site (< 5 cm in diameter) that typically resolves within\n\nthree days post-vaccination without treatment.\n\n\\- Mild depression during the day of vaccination.\n\n\\- Temperature rise of maximum 1.1 °C was observed. Temperatures returned to normal\n\nwithin 24 hrs.\n\n**Emesis, recumbency, convulsion, lethargy and loss of consciousness occur in**\n\n**very rare cases within a few minutes after vaccination. The animals mostly start**\n\n**to recover within around 15 minutes. In case of severe anaphylactic-type**\n\n**reactions appropriate treatment is recommended.**","publish_date":null,"title":"Product CVMP meeting date Recommendation - SPC change (active substance(s)) (additions to text in bold, deletions in strikethrough) Vectra 3D","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page10.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page10.pdf"},"request":{"example_id":"table/1634690602_page10","product_type":"parse","source_file_path":"1634690602_page10.pdf"},"started_at":"2026-11-04T19:47:53.946251"} +{"completed_at":"2026-11-04T19:47:55.794580","latency_in_ms":909,"output":{"example_id":"table/1634690602_page2","grounded_pages":[],"layout_pages":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 2 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n(see section 4.10).\n\n**Bravecto** (fluralaner)\n\n**15-17 June 2021 Section 4.6 of SPC for Bravecto spot-on solution for cats** :\n\nMild and transient skin reactions at the application site, such as erythema and pruritus or\n\nalopecia were commonly observed in clinical trials (2.2% of treated cats).\n\nThe following other signs shortly after administration were uncommonly observed:\n\napathy/tremors/anorexia (0.9% of treated cats) or vomiting/hypersalivation (0.4% of\n\ntreated cats).\n\n**Convulsions have been reported very rarely based on post marketing safety**\n\n**experience (pharmacovigilance).**\n\n**Bravecto Plus** (fluralaner/moxidectin)\n\n**5-7 October 2021 Section 4.5 of SPC for Bravecto Plus (under Special precautions for use in**\n\n**animals):**\n\nCare should be taken to avoid contact with the eyes of the animal.\n\nDo not use directly on skin lesions.\n\nIn the absence of available data, treatment of kittens less than 9 weeks of age and cats\n\nless than 1.2 kg bodyweight is not recommended.\n\nTreatment of male breeding animals is not recommended.\n\nThis product is for topical use and should not be administered orally.\n\nOral uptake of the product at the maximum recommended dose of 93 mg fluralaner + 4.65\n\nmg moxidectin/kg body weight induced some self-limiting salivation or single incidences\n\nof vomiting immediately after administration.\n\nIt is important to apply the dose as indicated to prevent the animal from licking and\n\ningesting the product **(see sections 4.6 and 4.9)** .\n\nDo not allow recently treated animals to groom each other.\n\n**NEW**","pages":[{"line_numbers":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 2 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n(see section 4.10).\n\n**Bravecto** (fluralaner)\n\n**15-17 June 2021 Section 4.6 of SPC for Bravecto spot-on solution for cats** :\n\nMild and transient skin reactions at the application site, such as erythema and pruritus or\n\nalopecia were commonly observed in clinical trials (2.2% of treated cats).\n\nThe following other signs shortly after administration were uncommonly observed:\n\napathy/tremors/anorexia (0.9% of treated cats) or vomiting/hypersalivation (0.4% of\n\ntreated cats).\n\n**Convulsions have been reported very rarely based on post marketing safety**\n\n**experience (pharmacovigilance).**\n\n**Bravecto Plus** (fluralaner/moxidectin)\n\n**5-7 October 2021 Section 4.5 of SPC for Bravecto Plus (under Special precautions for use in**\n\n**animals):**\n\nCare should be taken to avoid contact with the eyes of the animal.\n\nDo not use directly on skin lesions.\n\nIn the absence of available data, treatment of kittens less than 9 weeks of age and cats\n\nless than 1.2 kg bodyweight is not recommended.\n\nTreatment of male breeding animals is not recommended.\n\nThis product is for topical use and should not be administered orally.\n\nOral uptake of the product at the maximum recommended dose of 93 mg fluralaner + 4.65\n\nmg moxidectin/kg body weight induced some self-limiting salivation or single incidences\n\nof vomiting immediately after administration.\n\nIt is important to apply the dose as indicated to prevent the animal from licking and\n\ningesting the product **(see sections 4.6 and 4.9)** .\n\nDo not allow recently treated animals to groom each other.\n\n**NEW**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 2 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n(see section 4.10).\n\n**Bravecto** (fluralaner)\n\n**15-17 June 2021 Section 4.6 of SPC for Bravecto spot-on solution for cats** :\n\nMild and transient skin reactions at the application site, such as erythema and pruritus or\n\nalopecia were commonly observed in clinical trials (2.2% of treated cats).\n\nThe following other signs shortly after administration were uncommonly observed:\n\napathy/tremors/anorexia (0.9% of treated cats) or vomiting/hypersalivation (0.4% of\n\ntreated cats).\n\n**Convulsions have been reported very rarely based on post marketing safety**\n\n**experience (pharmacovigilance).**\n\n**Bravecto Plus** (fluralaner/moxidectin)\n\n**5-7 October 2021 Section 4.5 of SPC for Bravecto Plus (under Special precautions for use in**\n\n**animals):**\n\nCare should be taken to avoid contact with the eyes of the animal.\n\nDo not use directly on skin lesions.\n\nIn the absence of available data, treatment of kittens less than 9 weeks of age and cats\n\nless than 1.2 kg bodyweight is not recommended.\n\nTreatment of male breeding animals is not recommended.\n\nThis product is for topical use and should not be administered orally.\n\nOral uptake of the product at the maximum recommended dose of 93 mg fluralaner + 4.65\n\nmg moxidectin/kg body weight induced some self-limiting salivation or single incidences\n\nof vomiting immediately after administration.\n\nIt is important to apply the dose as indicated to prevent the animal from licking and\n\ningesting the product **(see sections 4.6 and 4.9)** .\n\nDo not allow recently treated animals to groom each other.\n\n**NEW**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_5df87f248dea434db1f125cb99904134","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 2 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n(see section 4.10).\n\n**Bravecto** (fluralaner)\n\n**15-17 June 2021 Section 4.6 of SPC for Bravecto spot-on solution for cats** :\n\nMild and transient skin reactions at the application site, such as erythema and pruritus or\n\nalopecia were commonly observed in clinical trials (2.2% of treated cats).\n\nThe following other signs shortly after administration were uncommonly observed:\n\napathy/tremors/anorexia (0.9% of treated cats) or vomiting/hypersalivation (0.4% of\n\ntreated cats).\n\n**Convulsions have been reported very rarely based on post marketing safety**\n\n**experience (pharmacovigilance).**\n\n**Bravecto Plus** (fluralaner/moxidectin)\n\n**5-7 October 2021 Section 4.5 of SPC for Bravecto Plus (under Special precautions for use in**\n\n**animals):**\n\nCare should be taken to avoid contact with the eyes of the animal.\n\nDo not use directly on skin lesions.\n\nIn the absence of available data, treatment of kittens less than 9 weeks of age and cats\n\nless than 1.2 kg bodyweight is not recommended.\n\nTreatment of male breeding animals is not recommended.\n\nThis product is for topical use and should not be administered orally.\n\nOral uptake of the product at the maximum recommended dose of 93 mg fluralaner + 4.65\n\nmg moxidectin/kg body weight induced some self-limiting salivation or single incidences\n\nof vomiting immediately after administration.\n\nIt is important to apply the dose as indicated to prevent the animal from licking and\n\ningesting the product **(see sections 4.6 and 4.9)** .\n\nDo not allow recently treated animals to groom each other.\n\n**NEW**"],"full_content":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 2 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n(see section 4.10).\n\n**Bravecto** (fluralaner)\n\n**15-17 June 2021 Section 4.6 of SPC for Bravecto spot-on solution for cats** :\n\nMild and transient skin reactions at the application site, such as erythema and pruritus or\n\nalopecia were commonly observed in clinical trials (2.2% of treated cats).\n\nThe following other signs shortly after administration were uncommonly observed:\n\napathy/tremors/anorexia (0.9% of treated cats) or vomiting/hypersalivation (0.4% of\n\ntreated cats).\n\n**Convulsions have been reported very rarely based on post marketing safety**\n\n**experience (pharmacovigilance).**\n\n**Bravecto Plus** (fluralaner/moxidectin)\n\n**5-7 October 2021 Section 4.5 of SPC for Bravecto Plus (under Special precautions for use in**\n\n**animals):**\n\nCare should be taken to avoid contact with the eyes of the animal.\n\nDo not use directly on skin lesions.\n\nIn the absence of available data, treatment of kittens less than 9 weeks of age and cats\n\nless than 1.2 kg bodyweight is not recommended.\n\nTreatment of male breeding animals is not recommended.\n\nThis product is for topical use and should not be administered orally.\n\nOral uptake of the product at the maximum recommended dose of 93 mg fluralaner + 4.65\n\nmg moxidectin/kg body weight induced some self-limiting salivation or single incidences\n\nof vomiting immediately after administration.\n\nIt is important to apply the dose as indicated to prevent the animal from licking and\n\ningesting the product **(see sections 4.6 and 4.9)** .\n\nDo not allow recently treated animals to groom each other.\n\n**NEW**","publish_date":null,"title":"Product CVMP meeting date Recommendation - SPC change (active substance(s)) (additions to text in bold, deletions in strikethrough) (see section","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page2.pdf"},"request":{"example_id":"table/1634690602_page2","product_type":"parse","source_file_path":"1634690602_page2.pdf"},"started_at":"2026-11-04T19:47:54.884791"} +{"completed_at":"2026-11-04T19:47:56.953451","latency_in_ms":1157,"output":{"example_id":"table/1634690602_page4","grounded_pages":[],"layout_pages":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 4 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\ncollapse, dyspnoea, pale mucous membranes) may occur **in very rare cases** .\n\n**Lethargy has been reported in very rare cases, based on post-marketing safety**\n\n**experience.**\n\n**Comfortis** (spinosad)\n\n**16-18 March 2021 Section 4.6 of SPC for Comfortis (under subsection for cats)** :\n\nCats\n\nOther commonly observed adverse reactions in cats were diarrhoea and anorexia.\n\nLethargy, loss of condition and salivation were uncommon. Seizures **, ataxia and muscle**\n\n**tremor** were rare adverse reactions.\n\n**Cytopoint** (lokivetmab)\n\n**10-12 May 2021 Section 4.6 of SPC for Cytopoint** :\n\nHypersensitivity reactions (anaphylaxis, facial oedema, urticaria) have been reported to\n\noccur in rare cases from spontaneous reports. In such cases appropriate treatment should\n\nbe administered immediately.\n\nVomiting and/or diarrhoea have been reported to occur in rare cases from spontaneous\n\nreports and may occur in connection with hypersensitivity reactions. Treatment should be\n\nadministered as needed.\n\nNeurological signs (seizure, convulsion or ataxia) have been rarely observed in\n\nspontaneous reports following use of the veterinary medicinal product.\n\n**Application site disorders (injection site pain, injection site swelling) have been**\n\n**reported very rarely in spontaneous reports.**\n\n**Clinical signs of immune-mediated diseases, such as haemolytic anaemia or**\n\n**thrombocytopenia, have been reported very rarely in spontaneous reports.**\n\n**Draxxin** (tulathromycin)\n\n**10-12 May 2021 Section 4.5 of SPC for Draxxin** :\n\nTulathromycin is irritating to eyes. In case of accidental eye exposure, flush the eyes","pages":[{"line_numbers":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 4 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\ncollapse, dyspnoea, pale mucous membranes) may occur **in very rare cases** .\n\n**Lethargy has been reported in very rare cases, based on post-marketing safety**\n\n**experience.**\n\n**Comfortis** (spinosad)\n\n**16-18 March 2021 Section 4.6 of SPC for Comfortis (under subsection for cats)** :\n\nCats\n\nOther commonly observed adverse reactions in cats were diarrhoea and anorexia.\n\nLethargy, loss of condition and salivation were uncommon. Seizures **, ataxia and muscle**\n\n**tremor** were rare adverse reactions.\n\n**Cytopoint** (lokivetmab)\n\n**10-12 May 2021 Section 4.6 of SPC for Cytopoint** :\n\nHypersensitivity reactions (anaphylaxis, facial oedema, urticaria) have been reported to\n\noccur in rare cases from spontaneous reports. In such cases appropriate treatment should\n\nbe administered immediately.\n\nVomiting and/or diarrhoea have been reported to occur in rare cases from spontaneous\n\nreports and may occur in connection with hypersensitivity reactions. Treatment should be\n\nadministered as needed.\n\nNeurological signs (seizure, convulsion or ataxia) have been rarely observed in\n\nspontaneous reports following use of the veterinary medicinal product.\n\n**Application site disorders (injection site pain, injection site swelling) have been**\n\n**reported very rarely in spontaneous reports.**\n\n**Clinical signs of immune-mediated diseases, such as haemolytic anaemia or**\n\n**thrombocytopenia, have been reported very rarely in spontaneous reports.**\n\n**Draxxin** (tulathromycin)\n\n**10-12 May 2021 Section 4.5 of SPC for Draxxin** :\n\nTulathromycin is irritating to eyes. In case of accidental eye exposure, flush the eyes","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 4 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\ncollapse, dyspnoea, pale mucous membranes) may occur **in very rare cases** .\n\n**Lethargy has been reported in very rare cases, based on post-marketing safety**\n\n**experience.**\n\n**Comfortis** (spinosad)\n\n**16-18 March 2021 Section 4.6 of SPC for Comfortis (under subsection for cats)** :\n\nCats\n\nOther commonly observed adverse reactions in cats were diarrhoea and anorexia.\n\nLethargy, loss of condition and salivation were uncommon. Seizures **, ataxia and muscle**\n\n**tremor** were rare adverse reactions.\n\n**Cytopoint** (lokivetmab)\n\n**10-12 May 2021 Section 4.6 of SPC for Cytopoint** :\n\nHypersensitivity reactions (anaphylaxis, facial oedema, urticaria) have been reported to\n\noccur in rare cases from spontaneous reports. In such cases appropriate treatment should\n\nbe administered immediately.\n\nVomiting and/or diarrhoea have been reported to occur in rare cases from spontaneous\n\nreports and may occur in connection with hypersensitivity reactions. Treatment should be\n\nadministered as needed.\n\nNeurological signs (seizure, convulsion or ataxia) have been rarely observed in\n\nspontaneous reports following use of the veterinary medicinal product.\n\n**Application site disorders (injection site pain, injection site swelling) have been**\n\n**reported very rarely in spontaneous reports.**\n\n**Clinical signs of immune-mediated diseases, such as haemolytic anaemia or**\n\n**thrombocytopenia, have been reported very rarely in spontaneous reports.**\n\n**Draxxin** (tulathromycin)\n\n**10-12 May 2021 Section 4.5 of SPC for Draxxin** :\n\nTulathromycin is irritating to eyes. In case of accidental eye exposure, flush the eyes","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page4.pdf"]},"response":{"errors":[],"extract_id":"extract_0f829efb9947eb73367d263c65ccde38","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 4 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\ncollapse, dyspnoea, pale mucous membranes) may occur **in very rare cases** .\n\n**Lethargy has been reported in very rare cases, based on post-marketing safety**\n\n**experience.**\n\n**Comfortis** (spinosad)\n\n**16-18 March 2021 Section 4.6 of SPC for Comfortis (under subsection for cats)** :\n\nCats\n\nOther commonly observed adverse reactions in cats were diarrhoea and anorexia.\n\nLethargy, loss of condition and salivation were uncommon. Seizures **, ataxia and muscle**\n\n**tremor** were rare adverse reactions.\n\n**Cytopoint** (lokivetmab)\n\n**10-12 May 2021 Section 4.6 of SPC for Cytopoint** :\n\nHypersensitivity reactions (anaphylaxis, facial oedema, urticaria) have been reported to\n\noccur in rare cases from spontaneous reports. In such cases appropriate treatment should\n\nbe administered immediately.\n\nVomiting and/or diarrhoea have been reported to occur in rare cases from spontaneous\n\nreports and may occur in connection with hypersensitivity reactions. Treatment should be\n\nadministered as needed.\n\nNeurological signs (seizure, convulsion or ataxia) have been rarely observed in\n\nspontaneous reports following use of the veterinary medicinal product.\n\n**Application site disorders (injection site pain, injection site swelling) have been**\n\n**reported very rarely in spontaneous reports.**\n\n**Clinical signs of immune-mediated diseases, such as haemolytic anaemia or**\n\n**thrombocytopenia, have been reported very rarely in spontaneous reports.**\n\n**Draxxin** (tulathromycin)\n\n**10-12 May 2021 Section 4.5 of SPC for Draxxin** :\n\nTulathromycin is irritating to eyes. In case of accidental eye exposure, flush the eyes"],"full_content":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 4 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\ncollapse, dyspnoea, pale mucous membranes) may occur **in very rare cases** .\n\n**Lethargy has been reported in very rare cases, based on post-marketing safety**\n\n**experience.**\n\n**Comfortis** (spinosad)\n\n**16-18 March 2021 Section 4.6 of SPC for Comfortis (under subsection for cats)** :\n\nCats\n\nOther commonly observed adverse reactions in cats were diarrhoea and anorexia.\n\nLethargy, loss of condition and salivation were uncommon. Seizures **, ataxia and muscle**\n\n**tremor** were rare adverse reactions.\n\n**Cytopoint** (lokivetmab)\n\n**10-12 May 2021 Section 4.6 of SPC for Cytopoint** :\n\nHypersensitivity reactions (anaphylaxis, facial oedema, urticaria) have been reported to\n\noccur in rare cases from spontaneous reports. In such cases appropriate treatment should\n\nbe administered immediately.\n\nVomiting and/or diarrhoea have been reported to occur in rare cases from spontaneous\n\nreports and may occur in connection with hypersensitivity reactions. Treatment should be\n\nadministered as needed.\n\nNeurological signs (seizure, convulsion or ataxia) have been rarely observed in\n\nspontaneous reports following use of the veterinary medicinal product.\n\n**Application site disorders (injection site pain, injection site swelling) have been**\n\n**reported very rarely in spontaneous reports.**\n\n**Clinical signs of immune-mediated diseases, such as haemolytic anaemia or**\n\n**thrombocytopenia, have been reported very rarely in spontaneous reports.**\n\n**Draxxin** (tulathromycin)\n\n**10-12 May 2021 Section 4.5 of SPC for Draxxin** :\n\nTulathromycin is irritating to eyes. In case of accidental eye exposure, flush the eyes","publish_date":null,"title":"Product CVMP meeting date Recommendation - SPC change (active substance(s)) (additions to text in bold, deletions in strikethrough) collapse, dyspnoea,","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page4.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page4.pdf"},"request":{"example_id":"table/1634690602_page4","product_type":"parse","source_file_path":"1634690602_page4.pdf"},"started_at":"2026-11-04T19:47:55.796013"} +{"completed_at":"2026-11-04T19:47:58.493675","latency_in_ms":1147,"output":{"example_id":"table/1634690602_page5","grounded_pages":[],"layout_pages":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 5 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nimmediately with clean water.\n\nTulathromycin may cause sensitisation by skin contact **resulting in e.g. reddening of**\n\n**the skin (erythema) and/or dermatitis** . In case of accidental spillage onto skin, wash\n\nthe skin immediately with soap and water.\n\nWash hands after use.\n\nIn case of accidental self-injection, seek medical advice immediately and show the\n\npackage leaflet or the label to the physician.\n\n**If there is suspicion of a hypersensitivity reaction following accidental exposure**\n\n**(recognised** **by e.g. itching, difficulty in breathing, hives, swelling on the face,**\n\n**nausea, vomiting) appropriate treatment should be administered.**\n\n**Seek medical advice immediately and show the package leaflet or the label to**\n\n**the physician.**\n\n**Felisecto Plus** (selamectin/sarolaner)\n\n**15-17 February 2021 Section 4.6 of SPC for Felisecto Plus** :\n\nUse of the veterinary medicinal product may result in mild and transient pruritus at the\n\napplication site. Mild to moderate alopecia at the application site, erythema and drooling\n\nhave been uncommonly observed.\n\n**Neurological signs (convulsions, ataxia) and gastrointestinal signs (emesis,**\n\n**diarrhoea) have been reported very rarely based on post-marketing safety**\n\n**experience. In most cases these signs are transient.**\n\n**Galliprant** (grapiprant)\n\n**13-15 April 2021 Section 4.6 of SPC for Galliprant** :\n\nIn clinical studies, the following mild and generally transient adverse reactions have\n\nbeen observed: vomiting, soft-formed faeces, diarrhoea and inappetence. Vomiting\n\nwas observed very commonly **in clinical studies.** whereas s Soft-formed faeces,\n\ndiarrhoea and inappetence were commonly observed **in clinical studies. These**","pages":[{"line_numbers":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 5 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nimmediately with clean water.\n\nTulathromycin may cause sensitisation by skin contact **resulting in e.g. reddening of**\n\n**the skin (erythema) and/or dermatitis** . In case of accidental spillage onto skin, wash\n\nthe skin immediately with soap and water.\n\nWash hands after use.\n\nIn case of accidental self-injection, seek medical advice immediately and show the\n\npackage leaflet or the label to the physician.\n\n**If there is suspicion of a hypersensitivity reaction following accidental exposure**\n\n**(recognised** **by e.g. itching, difficulty in breathing, hives, swelling on the face,**\n\n**nausea, vomiting) appropriate treatment should be administered.**\n\n**Seek medical advice immediately and show the package leaflet or the label to**\n\n**the physician.**\n\n**Felisecto Plus** (selamectin/sarolaner)\n\n**15-17 February 2021 Section 4.6 of SPC for Felisecto Plus** :\n\nUse of the veterinary medicinal product may result in mild and transient pruritus at the\n\napplication site. Mild to moderate alopecia at the application site, erythema and drooling\n\nhave been uncommonly observed.\n\n**Neurological signs (convulsions, ataxia) and gastrointestinal signs (emesis,**\n\n**diarrhoea) have been reported very rarely based on post-marketing safety**\n\n**experience. In most cases these signs are transient.**\n\n**Galliprant** (grapiprant)\n\n**13-15 April 2021 Section 4.6 of SPC for Galliprant** :\n\nIn clinical studies, the following mild and generally transient adverse reactions have\n\nbeen observed: vomiting, soft-formed faeces, diarrhoea and inappetence. Vomiting\n\nwas observed very commonly **in clinical studies.** whereas s Soft-formed faeces,\n\ndiarrhoea and inappetence were commonly observed **in clinical studies. These**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 5 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nimmediately with clean water.\n\nTulathromycin may cause sensitisation by skin contact **resulting in e.g. reddening of**\n\n**the skin (erythema) and/or dermatitis** . In case of accidental spillage onto skin, wash\n\nthe skin immediately with soap and water.\n\nWash hands after use.\n\nIn case of accidental self-injection, seek medical advice immediately and show the\n\npackage leaflet or the label to the physician.\n\n**If there is suspicion of a hypersensitivity reaction following accidental exposure**\n\n**(recognised** **by e.g. itching, difficulty in breathing, hives, swelling on the face,**\n\n**nausea, vomiting) appropriate treatment should be administered.**\n\n**Seek medical advice immediately and show the package leaflet or the label to**\n\n**the physician.**\n\n**Felisecto Plus** (selamectin/sarolaner)\n\n**15-17 February 2021 Section 4.6 of SPC for Felisecto Plus** :\n\nUse of the veterinary medicinal product may result in mild and transient pruritus at the\n\napplication site. Mild to moderate alopecia at the application site, erythema and drooling\n\nhave been uncommonly observed.\n\n**Neurological signs (convulsions, ataxia) and gastrointestinal signs (emesis,**\n\n**diarrhoea) have been reported very rarely based on post-marketing safety**\n\n**experience. In most cases these signs are transient.**\n\n**Galliprant** (grapiprant)\n\n**13-15 April 2021 Section 4.6 of SPC for Galliprant** :\n\nIn clinical studies, the following mild and generally transient adverse reactions have\n\nbeen observed: vomiting, soft-formed faeces, diarrhoea and inappetence. Vomiting\n\nwas observed very commonly **in clinical studies.** whereas s Soft-formed faeces,\n\ndiarrhoea and inappetence were commonly observed **in clinical studies. These**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page5.pdf"]},"response":{"errors":[],"extract_id":"extract_579e2a0ab23a473defc6602e661a3e96","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 5 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nimmediately with clean water.\n\nTulathromycin may cause sensitisation by skin contact **resulting in e.g. reddening of**\n\n**the skin (erythema) and/or dermatitis** . In case of accidental spillage onto skin, wash\n\nthe skin immediately with soap and water.\n\nWash hands after use.\n\nIn case of accidental self-injection, seek medical advice immediately and show the\n\npackage leaflet or the label to the physician.\n\n**If there is suspicion of a hypersensitivity reaction following accidental exposure**\n\n**(recognised** **by e.g. itching, difficulty in breathing, hives, swelling on the face,**\n\n**nausea, vomiting) appropriate treatment should be administered.**\n\n**Seek medical advice immediately and show the package leaflet or the label to**\n\n**the physician.**\n\n**Felisecto Plus** (selamectin/sarolaner)\n\n**15-17 February 2021 Section 4.6 of SPC for Felisecto Plus** :\n\nUse of the veterinary medicinal product may result in mild and transient pruritus at the\n\napplication site. Mild to moderate alopecia at the application site, erythema and drooling\n\nhave been uncommonly observed.\n\n**Neurological signs (convulsions, ataxia) and gastrointestinal signs (emesis,**\n\n**diarrhoea) have been reported very rarely based on post-marketing safety**\n\n**experience. In most cases these signs are transient.**\n\n**Galliprant** (grapiprant)\n\n**13-15 April 2021 Section 4.6 of SPC for Galliprant** :\n\nIn clinical studies, the following mild and generally transient adverse reactions have\n\nbeen observed: vomiting, soft-formed faeces, diarrhoea and inappetence. Vomiting\n\nwas observed very commonly **in clinical studies.** whereas s Soft-formed faeces,\n\ndiarrhoea and inappetence were commonly observed **in clinical studies. These**"],"full_content":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 5 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nimmediately with clean water.\n\nTulathromycin may cause sensitisation by skin contact **resulting in e.g. reddening of**\n\n**the skin (erythema) and/or dermatitis** . In case of accidental spillage onto skin, wash\n\nthe skin immediately with soap and water.\n\nWash hands after use.\n\nIn case of accidental self-injection, seek medical advice immediately and show the\n\npackage leaflet or the label to the physician.\n\n**If there is suspicion of a hypersensitivity reaction following accidental exposure**\n\n**(recognised** **by e.g. itching, difficulty in breathing, hives, swelling on the face,**\n\n**nausea, vomiting) appropriate treatment should be administered.**\n\n**Seek medical advice immediately and show the package leaflet or the label to**\n\n**the physician.**\n\n**Felisecto Plus** (selamectin/sarolaner)\n\n**15-17 February 2021 Section 4.6 of SPC for Felisecto Plus** :\n\nUse of the veterinary medicinal product may result in mild and transient pruritus at the\n\napplication site. Mild to moderate alopecia at the application site, erythema and drooling\n\nhave been uncommonly observed.\n\n**Neurological signs (convulsions, ataxia) and gastrointestinal signs (emesis,**\n\n**diarrhoea) have been reported very rarely based on post-marketing safety**\n\n**experience. In most cases these signs are transient.**\n\n**Galliprant** (grapiprant)\n\n**13-15 April 2021 Section 4.6 of SPC for Galliprant** :\n\nIn clinical studies, the following mild and generally transient adverse reactions have\n\nbeen observed: vomiting, soft-formed faeces, diarrhoea and inappetence. Vomiting\n\nwas observed very commonly **in clinical studies.** whereas s Soft-formed faeces,\n\ndiarrhoea and inappetence were commonly observed **in clinical studies. These**","publish_date":null,"title":"Product CVMP meeting date Recommendation - SPC change (active substance(s)) (additions to text in bold, deletions in strikethrough) immediately with","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page5.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page5.pdf"},"request":{"example_id":"table/1634690602_page5","product_type":"parse","source_file_path":"1634690602_page5.pdf"},"started_at":"2026-11-04T19:47:57.346469"} +{"completed_at":"2026-11-04T19:47:59.633688","latency_in_ms":1138,"output":{"example_id":"table/1634690602_page6","grounded_pages":[],"layout_pages":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 6 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**signs were generally transient.**\n\nIn very rare cases, haematemesis or haemorrhagic diarrhoea was reported following\n\nclinical use post authorisation **Elevated liver enzymes, elevated BUN, elevated**\n\n**creatinine, haematemesis and haemorrhagic diarrhoea have been reported**\n\n**very rarely following use post authorisation.**\n\n**Kexxtone** (monensin)\n\n**13-15 April 2021 Section 4.5 of SPC for Kexxtone, under** **‘** **Other precautions** **’** :\n\nIngestion or oral exposure to monensin can be fatal in dogs, horses, other equines or\n\nguinea fowl. Do not allow dogs, horses, other equines or guinea fowl access to veterinary\n\nmedicinal products containing monensin.\n\nDue to the risk of bolus regurgitation, do not allow these species access to areas where\n\ntreated cattle have been kept.\n\n**Keep dogs away from treated animals. Accidental ingestion of active ingredient**\n\n**by dogs has resulted in fatal consequences. In case of suspected ingestion by**\n\n**dogs, seek veterinary advice immediately.**\n\n**Kriptazen** (halofuginone)\n\n**13-15 July 2021 Section 4.6 of SPC for Kriptazen** :\n\nAn increase in the level of diarrhoea has been observed in very rare cases, in treated\n\nanimals.\n\n**Letifend** (Recombinant protein Q from Leishmania infantum MON-1)\n\n**5-7 October 2021 Section 4.6 of SPC for Letifend:**\n\nAfter vaccination, scratching at the injection site has been observed very commonly in\n\ndogs. Spontaneous resolution of such reaction was observed within 4 hours.\n\n**Hypersensitivity reactions (e.g. anaphylaxis, skin manifestations such as**\n\n**oedema, urticaria, pruritus) have been reported in very rare cases. In case of**\n\n**such an allergic or anaphylactic reaction, appropriate symptomatic treatment**\n\n**should be administered.**\n\n**NEW**","pages":[{"line_numbers":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 6 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**signs were generally transient.**\n\nIn very rare cases, haematemesis or haemorrhagic diarrhoea was reported following\n\nclinical use post authorisation **Elevated liver enzymes, elevated BUN, elevated**\n\n**creatinine, haematemesis and haemorrhagic diarrhoea have been reported**\n\n**very rarely following use post authorisation.**\n\n**Kexxtone** (monensin)\n\n**13-15 April 2021 Section 4.5 of SPC for Kexxtone, under** **‘** **Other precautions** **’** :\n\nIngestion or oral exposure to monensin can be fatal in dogs, horses, other equines or\n\nguinea fowl. Do not allow dogs, horses, other equines or guinea fowl access to veterinary\n\nmedicinal products containing monensin.\n\nDue to the risk of bolus regurgitation, do not allow these species access to areas where\n\ntreated cattle have been kept.\n\n**Keep dogs away from treated animals. Accidental ingestion of active ingredient**\n\n**by dogs has resulted in fatal consequences. In case of suspected ingestion by**\n\n**dogs, seek veterinary advice immediately.**\n\n**Kriptazen** (halofuginone)\n\n**13-15 July 2021 Section 4.6 of SPC for Kriptazen** :\n\nAn increase in the level of diarrhoea has been observed in very rare cases, in treated\n\nanimals.\n\n**Letifend** (Recombinant protein Q from Leishmania infantum MON-1)\n\n**5-7 October 2021 Section 4.6 of SPC for Letifend:**\n\nAfter vaccination, scratching at the injection site has been observed very commonly in\n\ndogs. Spontaneous resolution of such reaction was observed within 4 hours.\n\n**Hypersensitivity reactions (e.g. anaphylaxis, skin manifestations such as**\n\n**oedema, urticaria, pruritus) have been reported in very rare cases. In case of**\n\n**such an allergic or anaphylactic reaction, appropriate symptomatic treatment**\n\n**should be administered.**\n\n**NEW**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 6 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**signs were generally transient.**\n\nIn very rare cases, haematemesis or haemorrhagic diarrhoea was reported following\n\nclinical use post authorisation **Elevated liver enzymes, elevated BUN, elevated**\n\n**creatinine, haematemesis and haemorrhagic diarrhoea have been reported**\n\n**very rarely following use post authorisation.**\n\n**Kexxtone** (monensin)\n\n**13-15 April 2021 Section 4.5 of SPC for Kexxtone, under** **‘** **Other precautions** **’** :\n\nIngestion or oral exposure to monensin can be fatal in dogs, horses, other equines or\n\nguinea fowl. Do not allow dogs, horses, other equines or guinea fowl access to veterinary\n\nmedicinal products containing monensin.\n\nDue to the risk of bolus regurgitation, do not allow these species access to areas where\n\ntreated cattle have been kept.\n\n**Keep dogs away from treated animals. Accidental ingestion of active ingredient**\n\n**by dogs has resulted in fatal consequences. In case of suspected ingestion by**\n\n**dogs, seek veterinary advice immediately.**\n\n**Kriptazen** (halofuginone)\n\n**13-15 July 2021 Section 4.6 of SPC for Kriptazen** :\n\nAn increase in the level of diarrhoea has been observed in very rare cases, in treated\n\nanimals.\n\n**Letifend** (Recombinant protein Q from Leishmania infantum MON-1)\n\n**5-7 October 2021 Section 4.6 of SPC for Letifend:**\n\nAfter vaccination, scratching at the injection site has been observed very commonly in\n\ndogs. Spontaneous resolution of such reaction was observed within 4 hours.\n\n**Hypersensitivity reactions (e.g. anaphylaxis, skin manifestations such as**\n\n**oedema, urticaria, pruritus) have been reported in very rare cases. In case of**\n\n**such an allergic or anaphylactic reaction, appropriate symptomatic treatment**\n\n**should be administered.**\n\n**NEW**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_dc70fb6e7c256e4dd71fef9772750a35","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 6 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**signs were generally transient.**\n\nIn very rare cases, haematemesis or haemorrhagic diarrhoea was reported following\n\nclinical use post authorisation **Elevated liver enzymes, elevated BUN, elevated**\n\n**creatinine, haematemesis and haemorrhagic diarrhoea have been reported**\n\n**very rarely following use post authorisation.**\n\n**Kexxtone** (monensin)\n\n**13-15 April 2021 Section 4.5 of SPC for Kexxtone, under** **‘** **Other precautions** **’** :\n\nIngestion or oral exposure to monensin can be fatal in dogs, horses, other equines or\n\nguinea fowl. Do not allow dogs, horses, other equines or guinea fowl access to veterinary\n\nmedicinal products containing monensin.\n\nDue to the risk of bolus regurgitation, do not allow these species access to areas where\n\ntreated cattle have been kept.\n\n**Keep dogs away from treated animals. Accidental ingestion of active ingredient**\n\n**by dogs has resulted in fatal consequences. In case of suspected ingestion by**\n\n**dogs, seek veterinary advice immediately.**\n\n**Kriptazen** (halofuginone)\n\n**13-15 July 2021 Section 4.6 of SPC for Kriptazen** :\n\nAn increase in the level of diarrhoea has been observed in very rare cases, in treated\n\nanimals.\n\n**Letifend** (Recombinant protein Q from Leishmania infantum MON-1)\n\n**5-7 October 2021 Section 4.6 of SPC for Letifend:**\n\nAfter vaccination, scratching at the injection site has been observed very commonly in\n\ndogs. Spontaneous resolution of such reaction was observed within 4 hours.\n\n**Hypersensitivity reactions (e.g. anaphylaxis, skin manifestations such as**\n\n**oedema, urticaria, pruritus) have been reported in very rare cases. In case of**\n\n**such an allergic or anaphylactic reaction, appropriate symptomatic treatment**\n\n**should be administered.**\n\n**NEW**"],"full_content":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 6 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**signs were generally transient.**\n\nIn very rare cases, haematemesis or haemorrhagic diarrhoea was reported following\n\nclinical use post authorisation **Elevated liver enzymes, elevated BUN, elevated**\n\n**creatinine, haematemesis and haemorrhagic diarrhoea have been reported**\n\n**very rarely following use post authorisation.**\n\n**Kexxtone** (monensin)\n\n**13-15 April 2021 Section 4.5 of SPC for Kexxtone, under** **‘** **Other precautions** **’** :\n\nIngestion or oral exposure to monensin can be fatal in dogs, horses, other equines or\n\nguinea fowl. Do not allow dogs, horses, other equines or guinea fowl access to veterinary\n\nmedicinal products containing monensin.\n\nDue to the risk of bolus regurgitation, do not allow these species access to areas where\n\ntreated cattle have been kept.\n\n**Keep dogs away from treated animals. Accidental ingestion of active ingredient**\n\n**by dogs has resulted in fatal consequences. In case of suspected ingestion by**\n\n**dogs, seek veterinary advice immediately.**\n\n**Kriptazen** (halofuginone)\n\n**13-15 July 2021 Section 4.6 of SPC for Kriptazen** :\n\nAn increase in the level of diarrhoea has been observed in very rare cases, in treated\n\nanimals.\n\n**Letifend** (Recombinant protein Q from Leishmania infantum MON-1)\n\n**5-7 October 2021 Section 4.6 of SPC for Letifend:**\n\nAfter vaccination, scratching at the injection site has been observed very commonly in\n\ndogs. Spontaneous resolution of such reaction was observed within 4 hours.\n\n**Hypersensitivity reactions (e.g. anaphylaxis, skin manifestations such as**\n\n**oedema, urticaria, pruritus) have been reported in very rare cases. In case of**\n\n**such an allergic or anaphylactic reaction, appropriate symptomatic treatment**\n\n**should be administered.**\n\n**NEW**","publish_date":null,"title":"Product CVMP meeting date Recommendation - SPC change (active substance(s)) (additions to text in bold, deletions in strikethrough) signs were","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page6.pdf"},"request":{"example_id":"table/1634690602_page6","product_type":"parse","source_file_path":"1634690602_page6.pdf"},"started_at":"2026-11-04T19:47:58.495497"} +{"completed_at":"2026-11-04T19:48:00.913063","latency_in_ms":1277,"output":{"example_id":"table/1634690602_page7","grounded_pages":[],"layout_pages":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 7 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nLethargy, vomiting, diarrhoea and hyperthermia following vaccination have each been\n\nreported to occur very rarely based on post-marketing safety experience. Treatment\n\nshould be administered as needed.\n\n**Osurnia** (terbinafine/florfenicol/betamethasone)\n\n**10-12 May 2021 Section 4.6 of SPC for Osurnia** :\n\nDeafness or impaired hearing, usually temporary, have been reported after use in very\n\nrare cases in dogs, mainly in elderly animals, in post authorisation experience.\n\n**Application site reactions (i.e. erythema, pain, pruritus, oedema and ulcer)**\n\n**have been reported in very rare cases, in post authorisation experience.**\n\n**Hypersensitivity reactions including facial oedema, urticaria and shock have**\n\n**been reported in very rare cases, in post authorisation experience.**\n\n**Prevomax** (maropitant)\n\n**15-17 June 2021 Section 4.6 of SPC for Prevomax** :\n\nPain at injection site may occur when injected subcutaneously. In cats, moderate to\n\nsevere response to injection is very commonly observed (in approximately one third of\n\ncats).\n\nIn very rare cases, aAnaphylactic type reactions (allergic oedema, urticaria, erythema,\n\ncollapse, dyspnoea, pale mucous membranes) may occur **in very rare cases.**\n\n**Lethargy has been reported in very rare cases, based on post-marketing safety**\n\n**experience.**\n\n**Purevax RC** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens)\n\n**Purevax RCP** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1\n\n**5-7 October 2021 Section 4.6 of SPC for Purevax RC, Purevax RCP, Purevax RCP FeLV:**\n\nTransient apathy and anorexia as well as hyperthermia (lasting usually for 1 or 2 days)\n\nwere commonly observed during safety and field studies. A local reaction (slight pain at\n\npalpation, itching or limited oedema) that disappears within 1 or 2 weeks at most was\n\ncommonly observed during safety and field studies.\n\nA hypersensitivity reaction has been observed uncommonly in field studies, which may\n\n**NEW**","pages":[{"line_numbers":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 7 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nLethargy, vomiting, diarrhoea and hyperthermia following vaccination have each been\n\nreported to occur very rarely based on post-marketing safety experience. Treatment\n\nshould be administered as needed.\n\n**Osurnia** (terbinafine/florfenicol/betamethasone)\n\n**10-12 May 2021 Section 4.6 of SPC for Osurnia** :\n\nDeafness or impaired hearing, usually temporary, have been reported after use in very\n\nrare cases in dogs, mainly in elderly animals, in post authorisation experience.\n\n**Application site reactions (i.e. erythema, pain, pruritus, oedema and ulcer)**\n\n**have been reported in very rare cases, in post authorisation experience.**\n\n**Hypersensitivity reactions including facial oedema, urticaria and shock have**\n\n**been reported in very rare cases, in post authorisation experience.**\n\n**Prevomax** (maropitant)\n\n**15-17 June 2021 Section 4.6 of SPC for Prevomax** :\n\nPain at injection site may occur when injected subcutaneously. In cats, moderate to\n\nsevere response to injection is very commonly observed (in approximately one third of\n\ncats).\n\nIn very rare cases, aAnaphylactic type reactions (allergic oedema, urticaria, erythema,\n\ncollapse, dyspnoea, pale mucous membranes) may occur **in very rare cases.**\n\n**Lethargy has been reported in very rare cases, based on post-marketing safety**\n\n**experience.**\n\n**Purevax RC** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens)\n\n**Purevax RCP** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1\n\n**5-7 October 2021 Section 4.6 of SPC for Purevax RC, Purevax RCP, Purevax RCP FeLV:**\n\nTransient apathy and anorexia as well as hyperthermia (lasting usually for 1 or 2 days)\n\nwere commonly observed during safety and field studies. A local reaction (slight pain at\n\npalpation, itching or limited oedema) that disappears within 1 or 2 weeks at most was\n\ncommonly observed during safety and field studies.\n\nA hypersensitivity reaction has been observed uncommonly in field studies, which may\n\n**NEW**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 7 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nLethargy, vomiting, diarrhoea and hyperthermia following vaccination have each been\n\nreported to occur very rarely based on post-marketing safety experience. Treatment\n\nshould be administered as needed.\n\n**Osurnia** (terbinafine/florfenicol/betamethasone)\n\n**10-12 May 2021 Section 4.6 of SPC for Osurnia** :\n\nDeafness or impaired hearing, usually temporary, have been reported after use in very\n\nrare cases in dogs, mainly in elderly animals, in post authorisation experience.\n\n**Application site reactions (i.e. erythema, pain, pruritus, oedema and ulcer)**\n\n**have been reported in very rare cases, in post authorisation experience.**\n\n**Hypersensitivity reactions including facial oedema, urticaria and shock have**\n\n**been reported in very rare cases, in post authorisation experience.**\n\n**Prevomax** (maropitant)\n\n**15-17 June 2021 Section 4.6 of SPC for Prevomax** :\n\nPain at injection site may occur when injected subcutaneously. In cats, moderate to\n\nsevere response to injection is very commonly observed (in approximately one third of\n\ncats).\n\nIn very rare cases, aAnaphylactic type reactions (allergic oedema, urticaria, erythema,\n\ncollapse, dyspnoea, pale mucous membranes) may occur **in very rare cases.**\n\n**Lethargy has been reported in very rare cases, based on post-marketing safety**\n\n**experience.**\n\n**Purevax RC** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens)\n\n**Purevax RCP** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1\n\n**5-7 October 2021 Section 4.6 of SPC for Purevax RC, Purevax RCP, Purevax RCP FeLV:**\n\nTransient apathy and anorexia as well as hyperthermia (lasting usually for 1 or 2 days)\n\nwere commonly observed during safety and field studies. A local reaction (slight pain at\n\npalpation, itching or limited oedema) that disappears within 1 or 2 weeks at most was\n\ncommonly observed during safety and field studies.\n\nA hypersensitivity reaction has been observed uncommonly in field studies, which may\n\n**NEW**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page7.pdf"]},"response":{"errors":[],"extract_id":"extract_d2d54137b8a91d58b2cc93b22d5cd911","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 7 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nLethargy, vomiting, diarrhoea and hyperthermia following vaccination have each been\n\nreported to occur very rarely based on post-marketing safety experience. Treatment\n\nshould be administered as needed.\n\n**Osurnia** (terbinafine/florfenicol/betamethasone)\n\n**10-12 May 2021 Section 4.6 of SPC for Osurnia** :\n\nDeafness or impaired hearing, usually temporary, have been reported after use in very\n\nrare cases in dogs, mainly in elderly animals, in post authorisation experience.\n\n**Application site reactions (i.e. erythema, pain, pruritus, oedema and ulcer)**\n\n**have been reported in very rare cases, in post authorisation experience.**\n\n**Hypersensitivity reactions including facial oedema, urticaria and shock have**\n\n**been reported in very rare cases, in post authorisation experience.**\n\n**Prevomax** (maropitant)\n\n**15-17 June 2021 Section 4.6 of SPC for Prevomax** :\n\nPain at injection site may occur when injected subcutaneously. In cats, moderate to\n\nsevere response to injection is very commonly observed (in approximately one third of\n\ncats).\n\nIn very rare cases, aAnaphylactic type reactions (allergic oedema, urticaria, erythema,\n\ncollapse, dyspnoea, pale mucous membranes) may occur **in very rare cases.**\n\n**Lethargy has been reported in very rare cases, based on post-marketing safety**\n\n**experience.**\n\n**Purevax RC** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens)\n\n**Purevax RCP** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1\n\n**5-7 October 2021 Section 4.6 of SPC for Purevax RC, Purevax RCP, Purevax RCP FeLV:**\n\nTransient apathy and anorexia as well as hyperthermia (lasting usually for 1 or 2 days)\n\nwere commonly observed during safety and field studies. A local reaction (slight pain at\n\npalpation, itching or limited oedema) that disappears within 1 or 2 weeks at most was\n\ncommonly observed during safety and field studies.\n\nA hypersensitivity reaction has been observed uncommonly in field studies, which may\n\n**NEW**"],"full_content":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 7 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nLethargy, vomiting, diarrhoea and hyperthermia following vaccination have each been\n\nreported to occur very rarely based on post-marketing safety experience. Treatment\n\nshould be administered as needed.\n\n**Osurnia** (terbinafine/florfenicol/betamethasone)\n\n**10-12 May 2021 Section 4.6 of SPC for Osurnia** :\n\nDeafness or impaired hearing, usually temporary, have been reported after use in very\n\nrare cases in dogs, mainly in elderly animals, in post authorisation experience.\n\n**Application site reactions (i.e. erythema, pain, pruritus, oedema and ulcer)**\n\n**have been reported in very rare cases, in post authorisation experience.**\n\n**Hypersensitivity reactions including facial oedema, urticaria and shock have**\n\n**been reported in very rare cases, in post authorisation experience.**\n\n**Prevomax** (maropitant)\n\n**15-17 June 2021 Section 4.6 of SPC for Prevomax** :\n\nPain at injection site may occur when injected subcutaneously. In cats, moderate to\n\nsevere response to injection is very commonly observed (in approximately one third of\n\ncats).\n\nIn very rare cases, aAnaphylactic type reactions (allergic oedema, urticaria, erythema,\n\ncollapse, dyspnoea, pale mucous membranes) may occur **in very rare cases.**\n\n**Lethargy has been reported in very rare cases, based on post-marketing safety**\n\n**experience.**\n\n**Purevax RC** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens)\n\n**Purevax RCP** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1\n\n**5-7 October 2021 Section 4.6 of SPC for Purevax RC, Purevax RCP, Purevax RCP FeLV:**\n\nTransient apathy and anorexia as well as hyperthermia (lasting usually for 1 or 2 days)\n\nwere commonly observed during safety and field studies. A local reaction (slight pain at\n\npalpation, itching or limited oedema) that disappears within 1 or 2 weeks at most was\n\ncommonly observed during safety and field studies.\n\nA hypersensitivity reaction has been observed uncommonly in field studies, which may\n\n**NEW**","publish_date":null,"title":"Product CVMP meeting date Recommendation - SPC change (active substance(s)) (additions to text in bold, deletions in strikethrough) Lethargy, vomiting,","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page7.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page7.pdf"},"request":{"example_id":"table/1634690602_page7","product_type":"parse","source_file_path":"1634690602_page7.pdf"},"started_at":"2026-11-04T19:47:59.635875"} +{"completed_at":"2026-11-04T19:48:02.205175","latency_in_ms":1149,"output":{"example_id":"table/1634690602_page8","grounded_pages":[],"layout_pages":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 8 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nstrains) antigens)/Attenuated feline panleucopenia virus (PLI IV))\n\n**Purevax RCP FeLV** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens/Attenuated feline panleucopenia virus (PLI IV)/FELV recombinant canarypox virus (vCP97)\n\nrequire appropriate symptomatic treatment.\n\n**Emesis (mostly within 24 to 48 hours) has been observed in very rare cases**\n\n**based on post-marketing safety experience.**\n\n**Purevax RCPCh** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens/Attenuated Chlamydophila felis (905 strain)/Attenuated feline panleucopenia virus (PLI IV)\n\n**Purevax RCPCh FeLV** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirosis (FCV 431 and G1 strains) antigens/Attenuated Chlamydophila felis (905 strain)/Attenuated feline panleucopenia virus (PLI IV)/FeLV recombinant canarypox virus (vCP97)\n\n**5-7 October 2021 Section 4.6 of SPC for Purevax RCPCh, Purevax RCPCh FeLV:**\n\nTransient apathy and anorexia as well as hyperthermia (lasting usually for 1 or 2 days)\n\nwere commonly observed during safety and field studies. A local reaction (slight pain at\n\npalpation, itching or limited oedema) that disappears within 1 or 2 weeks at most was\n\ncommonly observed during safety and field studies.\n\nA hypersensitivity reaction has been observed uncommonly in field studies, which may\n\nrequire appropriate symptomatic treatment.\n\n**Emesis (mostly within 24 to 48 hours) has been observed in very rare cases**\n\n**based on post-marketing safety experience.**\n\nTransient hyperthermia and lethargy, sometimes associated with lameness, have been\n\nobserved 1 to 3 weeks following booster vaccination in adult cats, in very rare cases,\n\nbased on post marketing safety experience.\n\n**Simparica Trio** (moxidectin/sarolaner/pyrantel embonate)\n\n**13-15 April 2021 Section 4.6 of SPC for Simparica Trio** :\n\nNone known. **Gastrointestinal signs such as vomiting and diarrhoea, and systemic**\n\n**disorders such as lethargy, anorexia/inappetence may occur in very rare cases**\n\n**based on post-marketing safety experience. In most cases these signs are mild**\n\n**and transient.**\n\n**Neurological signs such as tremor, ataxia or convulsion may occur in very rare**\n\n**cases based on post-marketing safety experience. In most cases these signs are**\n\n**NEW**","pages":[{"line_numbers":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 8 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nstrains) antigens)/Attenuated feline panleucopenia virus (PLI IV))\n\n**Purevax RCP FeLV** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens/Attenuated feline panleucopenia virus (PLI IV)/FELV recombinant canarypox virus (vCP97)\n\nrequire appropriate symptomatic treatment.\n\n**Emesis (mostly within 24 to 48 hours) has been observed in very rare cases**\n\n**based on post-marketing safety experience.**\n\n**Purevax RCPCh** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens/Attenuated Chlamydophila felis (905 strain)/Attenuated feline panleucopenia virus (PLI IV)\n\n**Purevax RCPCh FeLV** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirosis (FCV 431 and G1 strains) antigens/Attenuated Chlamydophila felis (905 strain)/Attenuated feline panleucopenia virus (PLI IV)/FeLV recombinant canarypox virus (vCP97)\n\n**5-7 October 2021 Section 4.6 of SPC for Purevax RCPCh, Purevax RCPCh FeLV:**\n\nTransient apathy and anorexia as well as hyperthermia (lasting usually for 1 or 2 days)\n\nwere commonly observed during safety and field studies. A local reaction (slight pain at\n\npalpation, itching or limited oedema) that disappears within 1 or 2 weeks at most was\n\ncommonly observed during safety and field studies.\n\nA hypersensitivity reaction has been observed uncommonly in field studies, which may\n\nrequire appropriate symptomatic treatment.\n\n**Emesis (mostly within 24 to 48 hours) has been observed in very rare cases**\n\n**based on post-marketing safety experience.**\n\nTransient hyperthermia and lethargy, sometimes associated with lameness, have been\n\nobserved 1 to 3 weeks following booster vaccination in adult cats, in very rare cases,\n\nbased on post marketing safety experience.\n\n**Simparica Trio** (moxidectin/sarolaner/pyrantel embonate)\n\n**13-15 April 2021 Section 4.6 of SPC for Simparica Trio** :\n\nNone known. **Gastrointestinal signs such as vomiting and diarrhoea, and systemic**\n\n**disorders such as lethargy, anorexia/inappetence may occur in very rare cases**\n\n**based on post-marketing safety experience. In most cases these signs are mild**\n\n**and transient.**\n\n**Neurological signs such as tremor, ataxia or convulsion may occur in very rare**\n\n**cases based on post-marketing safety experience. In most cases these signs are**\n\n**NEW**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 8 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nstrains) antigens)/Attenuated feline panleucopenia virus (PLI IV))\n\n**Purevax RCP FeLV** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens/Attenuated feline panleucopenia virus (PLI IV)/FELV recombinant canarypox virus (vCP97)\n\nrequire appropriate symptomatic treatment.\n\n**Emesis (mostly within 24 to 48 hours) has been observed in very rare cases**\n\n**based on post-marketing safety experience.**\n\n**Purevax RCPCh** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens/Attenuated Chlamydophila felis (905 strain)/Attenuated feline panleucopenia virus (PLI IV)\n\n**Purevax RCPCh FeLV** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirosis (FCV 431 and G1 strains) antigens/Attenuated Chlamydophila felis (905 strain)/Attenuated feline panleucopenia virus (PLI IV)/FeLV recombinant canarypox virus (vCP97)\n\n**5-7 October 2021 Section 4.6 of SPC for Purevax RCPCh, Purevax RCPCh FeLV:**\n\nTransient apathy and anorexia as well as hyperthermia (lasting usually for 1 or 2 days)\n\nwere commonly observed during safety and field studies. A local reaction (slight pain at\n\npalpation, itching or limited oedema) that disappears within 1 or 2 weeks at most was\n\ncommonly observed during safety and field studies.\n\nA hypersensitivity reaction has been observed uncommonly in field studies, which may\n\nrequire appropriate symptomatic treatment.\n\n**Emesis (mostly within 24 to 48 hours) has been observed in very rare cases**\n\n**based on post-marketing safety experience.**\n\nTransient hyperthermia and lethargy, sometimes associated with lameness, have been\n\nobserved 1 to 3 weeks following booster vaccination in adult cats, in very rare cases,\n\nbased on post marketing safety experience.\n\n**Simparica Trio** (moxidectin/sarolaner/pyrantel embonate)\n\n**13-15 April 2021 Section 4.6 of SPC for Simparica Trio** :\n\nNone known. **Gastrointestinal signs such as vomiting and diarrhoea, and systemic**\n\n**disorders such as lethargy, anorexia/inappetence may occur in very rare cases**\n\n**based on post-marketing safety experience. In most cases these signs are mild**\n\n**and transient.**\n\n**Neurological signs such as tremor, ataxia or convulsion may occur in very rare**\n\n**cases based on post-marketing safety experience. In most cases these signs are**\n\n**NEW**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page8.pdf"]},"response":{"errors":[],"extract_id":"extract_54a9c14ae34d8c2a653e402db3e47343","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 8 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nstrains) antigens)/Attenuated feline panleucopenia virus (PLI IV))\n\n**Purevax RCP FeLV** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens/Attenuated feline panleucopenia virus (PLI IV)/FELV recombinant canarypox virus (vCP97)\n\nrequire appropriate symptomatic treatment.\n\n**Emesis (mostly within 24 to 48 hours) has been observed in very rare cases**\n\n**based on post-marketing safety experience.**\n\n**Purevax RCPCh** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens/Attenuated Chlamydophila felis (905 strain)/Attenuated feline panleucopenia virus (PLI IV)\n\n**Purevax RCPCh FeLV** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirosis (FCV 431 and G1 strains) antigens/Attenuated Chlamydophila felis (905 strain)/Attenuated feline panleucopenia virus (PLI IV)/FeLV recombinant canarypox virus (vCP97)\n\n**5-7 October 2021 Section 4.6 of SPC for Purevax RCPCh, Purevax RCPCh FeLV:**\n\nTransient apathy and anorexia as well as hyperthermia (lasting usually for 1 or 2 days)\n\nwere commonly observed during safety and field studies. A local reaction (slight pain at\n\npalpation, itching or limited oedema) that disappears within 1 or 2 weeks at most was\n\ncommonly observed during safety and field studies.\n\nA hypersensitivity reaction has been observed uncommonly in field studies, which may\n\nrequire appropriate symptomatic treatment.\n\n**Emesis (mostly within 24 to 48 hours) has been observed in very rare cases**\n\n**based on post-marketing safety experience.**\n\nTransient hyperthermia and lethargy, sometimes associated with lameness, have been\n\nobserved 1 to 3 weeks following booster vaccination in adult cats, in very rare cases,\n\nbased on post marketing safety experience.\n\n**Simparica Trio** (moxidectin/sarolaner/pyrantel embonate)\n\n**13-15 April 2021 Section 4.6 of SPC for Simparica Trio** :\n\nNone known. **Gastrointestinal signs such as vomiting and diarrhoea, and systemic**\n\n**disorders such as lethargy, anorexia/inappetence may occur in very rare cases**\n\n**based on post-marketing safety experience. In most cases these signs are mild**\n\n**and transient.**\n\n**Neurological signs such as tremor, ataxia or convulsion may occur in very rare**\n\n**cases based on post-marketing safety experience. In most cases these signs are**\n\n**NEW**"],"full_content":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 8 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\nstrains) antigens)/Attenuated feline panleucopenia virus (PLI IV))\n\n**Purevax RCP FeLV** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens/Attenuated feline panleucopenia virus (PLI IV)/FELV recombinant canarypox virus (vCP97)\n\nrequire appropriate symptomatic treatment.\n\n**Emesis (mostly within 24 to 48 hours) has been observed in very rare cases**\n\n**based on post-marketing safety experience.**\n\n**Purevax RCPCh** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirus (FCV 431 and G1 strains) antigens/Attenuated Chlamydophila felis (905 strain)/Attenuated feline panleucopenia virus (PLI IV)\n\n**Purevax RCPCh FeLV** (Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain)/Inactivated feline calicivirosis (FCV 431 and G1 strains) antigens/Attenuated Chlamydophila felis (905 strain)/Attenuated feline panleucopenia virus (PLI IV)/FeLV recombinant canarypox virus (vCP97)\n\n**5-7 October 2021 Section 4.6 of SPC for Purevax RCPCh, Purevax RCPCh FeLV:**\n\nTransient apathy and anorexia as well as hyperthermia (lasting usually for 1 or 2 days)\n\nwere commonly observed during safety and field studies. A local reaction (slight pain at\n\npalpation, itching or limited oedema) that disappears within 1 or 2 weeks at most was\n\ncommonly observed during safety and field studies.\n\nA hypersensitivity reaction has been observed uncommonly in field studies, which may\n\nrequire appropriate symptomatic treatment.\n\n**Emesis (mostly within 24 to 48 hours) has been observed in very rare cases**\n\n**based on post-marketing safety experience.**\n\nTransient hyperthermia and lethargy, sometimes associated with lameness, have been\n\nobserved 1 to 3 weeks following booster vaccination in adult cats, in very rare cases,\n\nbased on post marketing safety experience.\n\n**Simparica Trio** (moxidectin/sarolaner/pyrantel embonate)\n\n**13-15 April 2021 Section 4.6 of SPC for Simparica Trio** :\n\nNone known. **Gastrointestinal signs such as vomiting and diarrhoea, and systemic**\n\n**disorders such as lethargy, anorexia/inappetence may occur in very rare cases**\n\n**based on post-marketing safety experience. In most cases these signs are mild**\n\n**and transient.**\n\n**Neurological signs such as tremor, ataxia or convulsion may occur in very rare**\n\n**cases based on post-marketing safety experience. In most cases these signs are**\n\n**NEW**","publish_date":null,"title":"Product CVMP meeting date Recommendation - SPC change (active substance(s)) (additions to text in bold, deletions in strikethrough) strains) antigens)/Attenuated","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page8.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page8.pdf"},"request":{"example_id":"table/1634690602_page8","product_type":"parse","source_file_path":"1634690602_page8.pdf"},"started_at":"2026-11-04T19:48:01.055246"} +{"completed_at":"2026-11-04T19:48:04.289610","latency_in_ms":1387,"output":{"example_id":"table/1634690602_page9","grounded_pages":[],"layout_pages":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 9 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**transient.**\n\n**Stronghold Plus** (selamectin/sarolaner)\n\n**15-17 February 2021 Section 4.6 of SPC for Stronghold Plus** :\n\nUse of the veterinary medicinal product may result in mild and transient pruritus at the\n\napplication site. Mild to moderate alopecia at the application site, erythema and drooling\n\nhave been uncommonly observed.\n\n**Neurological signs (convulsions, ataxia) and gastrointestinal signs (emesis,**\n\n**diarrhoea) have been reported very rarely based on post-marketing safety**\n\n**experience. In most cases these signs are transient.**\n\n**Ubac** (Lipoteichoic acid (LTA) from Biofilm Adhesion Component (BAC) of Streptococcus uberis, strain 5616)\n\n**5-7 October 2021 Section 4.6 of SPC for Ubac:**\n\nLocal swelling more than 5 cm in diameter at the injection site is a very common reaction\n\nafter administration of the vaccine. This swelling will have disappeared or be clearly\n\nreduced in size by 17 days post vaccination. However, in some cases, swelling may persist\n\nfor up to 4 weeks.\n\nA transient increase in rectal temperature (mean increase of 1 °C but may be up to 2 °C\n\nin individual animals) may very commonly occur in the first 24 hours after injection.\n\n**Anaphylactic-type reactions (e.g. oedema) which might be life-threatening,**\n\n**may occur very rarely in some sensitive animals based on post-marketing**\n\n**safety experience. Under these circumstances, appropriate symptomatic**\n\n**treatment should be administered.**\n\n**Vectra Felis** (pyriproxyfen/dinotefuran)\n\n**15-17 June 2021 Section 4.6 of SPC for Vectra Felis** :\n\nSlight scales, transient erythema and alopecia can be observed in rare cases, which\n\nusually disappear spontaneously without treatment.\n\n**Transient neurological signs such as muscle tremors or lethargy may occur very**\n\n**rarely and in particular after application site licking.**\n\n**NEW**","pages":[{"line_numbers":[],"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 9 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**transient.**\n\n**Stronghold Plus** (selamectin/sarolaner)\n\n**15-17 February 2021 Section 4.6 of SPC for Stronghold Plus** :\n\nUse of the veterinary medicinal product may result in mild and transient pruritus at the\n\napplication site. Mild to moderate alopecia at the application site, erythema and drooling\n\nhave been uncommonly observed.\n\n**Neurological signs (convulsions, ataxia) and gastrointestinal signs (emesis,**\n\n**diarrhoea) have been reported very rarely based on post-marketing safety**\n\n**experience. In most cases these signs are transient.**\n\n**Ubac** (Lipoteichoic acid (LTA) from Biofilm Adhesion Component (BAC) of Streptococcus uberis, strain 5616)\n\n**5-7 October 2021 Section 4.6 of SPC for Ubac:**\n\nLocal swelling more than 5 cm in diameter at the injection site is a very common reaction\n\nafter administration of the vaccine. This swelling will have disappeared or be clearly\n\nreduced in size by 17 days post vaccination. However, in some cases, swelling may persist\n\nfor up to 4 weeks.\n\nA transient increase in rectal temperature (mean increase of 1 °C but may be up to 2 °C\n\nin individual animals) may very commonly occur in the first 24 hours after injection.\n\n**Anaphylactic-type reactions (e.g. oedema) which might be life-threatening,**\n\n**may occur very rarely in some sensitive animals based on post-marketing**\n\n**safety experience. Under these circumstances, appropriate symptomatic**\n\n**treatment should be administered.**\n\n**Vectra Felis** (pyriproxyfen/dinotefuran)\n\n**15-17 June 2021 Section 4.6 of SPC for Vectra Felis** :\n\nSlight scales, transient erythema and alopecia can be observed in rare cases, which\n\nusually disappear spontaneously without treatment.\n\n**Transient neurological signs such as muscle tremors or lethargy may occur very**\n\n**rarely and in particular after application site licking.**\n\n**NEW**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 9 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**transient.**\n\n**Stronghold Plus** (selamectin/sarolaner)\n\n**15-17 February 2021 Section 4.6 of SPC for Stronghold Plus** :\n\nUse of the veterinary medicinal product may result in mild and transient pruritus at the\n\napplication site. Mild to moderate alopecia at the application site, erythema and drooling\n\nhave been uncommonly observed.\n\n**Neurological signs (convulsions, ataxia) and gastrointestinal signs (emesis,**\n\n**diarrhoea) have been reported very rarely based on post-marketing safety**\n\n**experience. In most cases these signs are transient.**\n\n**Ubac** (Lipoteichoic acid (LTA) from Biofilm Adhesion Component (BAC) of Streptococcus uberis, strain 5616)\n\n**5-7 October 2021 Section 4.6 of SPC for Ubac:**\n\nLocal swelling more than 5 cm in diameter at the injection site is a very common reaction\n\nafter administration of the vaccine. This swelling will have disappeared or be clearly\n\nreduced in size by 17 days post vaccination. However, in some cases, swelling may persist\n\nfor up to 4 weeks.\n\nA transient increase in rectal temperature (mean increase of 1 °C but may be up to 2 °C\n\nin individual animals) may very commonly occur in the first 24 hours after injection.\n\n**Anaphylactic-type reactions (e.g. oedema) which might be life-threatening,**\n\n**may occur very rarely in some sensitive animals based on post-marketing**\n\n**safety experience. Under these circumstances, appropriate symptomatic**\n\n**treatment should be administered.**\n\n**Vectra Felis** (pyriproxyfen/dinotefuran)\n\n**15-17 June 2021 Section 4.6 of SPC for Vectra Felis** :\n\nSlight scales, transient erythema and alopecia can be observed in rare cases, which\n\nusually disappear spontaneously without treatment.\n\n**Transient neurological signs such as muscle tremors or lethargy may occur very**\n\n**rarely and in particular after application site licking.**\n\n**NEW**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page9.pdf"]},"response":{"errors":[],"extract_id":"extract_2ae5e69a77388ab7d87e20348f1648df","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 9 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**transient.**\n\n**Stronghold Plus** (selamectin/sarolaner)\n\n**15-17 February 2021 Section 4.6 of SPC for Stronghold Plus** :\n\nUse of the veterinary medicinal product may result in mild and transient pruritus at the\n\napplication site. Mild to moderate alopecia at the application site, erythema and drooling\n\nhave been uncommonly observed.\n\n**Neurological signs (convulsions, ataxia) and gastrointestinal signs (emesis,**\n\n**diarrhoea) have been reported very rarely based on post-marketing safety**\n\n**experience. In most cases these signs are transient.**\n\n**Ubac** (Lipoteichoic acid (LTA) from Biofilm Adhesion Component (BAC) of Streptococcus uberis, strain 5616)\n\n**5-7 October 2021 Section 4.6 of SPC for Ubac:**\n\nLocal swelling more than 5 cm in diameter at the injection site is a very common reaction\n\nafter administration of the vaccine. This swelling will have disappeared or be clearly\n\nreduced in size by 17 days post vaccination. However, in some cases, swelling may persist\n\nfor up to 4 weeks.\n\nA transient increase in rectal temperature (mean increase of 1 °C but may be up to 2 °C\n\nin individual animals) may very commonly occur in the first 24 hours after injection.\n\n**Anaphylactic-type reactions (e.g. oedema) which might be life-threatening,**\n\n**may occur very rarely in some sensitive animals based on post-marketing**\n\n**safety experience. Under these circumstances, appropriate symptomatic**\n\n**treatment should be administered.**\n\n**Vectra Felis** (pyriproxyfen/dinotefuran)\n\n**15-17 June 2021 Section 4.6 of SPC for Vectra Felis** :\n\nSlight scales, transient erythema and alopecia can be observed in rare cases, which\n\nusually disappear spontaneously without treatment.\n\n**Transient neurological signs such as muscle tremors or lethargy may occur very**\n\n**rarely and in particular after application site licking.**\n\n**NEW**"],"full_content":"Pharmacovigilance regulatory recommendations for centrally authorised veterinary medicinal products during 2021 EMA/CVMP/PhVWP/105691/2021 Page 9 of 10\n\n**Product (active substance(s))**\n\n**CVMP meeting date Recommendation - SPC change** (additions to text **in bold** , deletions in strikethrough **)**\n\n**transient.**\n\n**Stronghold Plus** (selamectin/sarolaner)\n\n**15-17 February 2021 Section 4.6 of SPC for Stronghold Plus** :\n\nUse of the veterinary medicinal product may result in mild and transient pruritus at the\n\napplication site. Mild to moderate alopecia at the application site, erythema and drooling\n\nhave been uncommonly observed.\n\n**Neurological signs (convulsions, ataxia) and gastrointestinal signs (emesis,**\n\n**diarrhoea) have been reported very rarely based on post-marketing safety**\n\n**experience. In most cases these signs are transient.**\n\n**Ubac** (Lipoteichoic acid (LTA) from Biofilm Adhesion Component (BAC) of Streptococcus uberis, strain 5616)\n\n**5-7 October 2021 Section 4.6 of SPC for Ubac:**\n\nLocal swelling more than 5 cm in diameter at the injection site is a very common reaction\n\nafter administration of the vaccine. This swelling will have disappeared or be clearly\n\nreduced in size by 17 days post vaccination. However, in some cases, swelling may persist\n\nfor up to 4 weeks.\n\nA transient increase in rectal temperature (mean increase of 1 °C but may be up to 2 °C\n\nin individual animals) may very commonly occur in the first 24 hours after injection.\n\n**Anaphylactic-type reactions (e.g. oedema) which might be life-threatening,**\n\n**may occur very rarely in some sensitive animals based on post-marketing**\n\n**safety experience. Under these circumstances, appropriate symptomatic**\n\n**treatment should be administered.**\n\n**Vectra Felis** (pyriproxyfen/dinotefuran)\n\n**15-17 June 2021 Section 4.6 of SPC for Vectra Felis** :\n\nSlight scales, transient erythema and alopecia can be observed in rare cases, which\n\nusually disappear spontaneously without treatment.\n\n**Transient neurological signs such as muscle tremors or lethargy may occur very**\n\n**rarely and in particular after application site licking.**\n\n**NEW**","publish_date":null,"title":"Product CVMP meeting date Recommendation - SPC change (active substance(s)) (additions to text in bold, deletions in strikethrough) transient. Stronghold","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page9.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1634690602_page9.pdf"},"request":{"example_id":"table/1634690602_page9","product_type":"parse","source_file_path":"1634690602_page9.pdf"},"started_at":"2026-11-04T19:48:02.902511"} +{"completed_at":"2026-11-04T19:48:07.188635","latency_in_ms":2896,"output":{"example_id":"table/1653739079_page2","grounded_pages":[],"layout_pages":[],"markdown":"**32247 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n2 The initial draft of the RIA for the SUNSET final rule was prepared by an outside economist. _See_ 86 FR 5737 n. 210. As far as the Department is currently aware, no Department economist participated in considering, drafting, or revising the economic evaluation of the SUNSET proposed or final rule. These deviations from usual practice in developing the original SUNSET rule may help explain why our current RIA differs so greatly from the previous RIA. We also note that the Department, in developing the original SUNSET rule, did not follow other routine internal review procedures, such as distributing the draft proposed and final rules to the relevant HHS agencies to solicit their review, comments, and concurrences. These irregularities may have also contributed to the flawed execution and analysis in the original SUNSET rule.\n\n_D. Costs and Benefits_\n\nThis regulatory action will reduce the time spent by the Department performing retrospective assessments and reviews of its regulations that would have been required by the SUNSET final rule, and time spent by regulated entities and other stakeholders, including the general public, small and large businesses, non- governmental organizations, Tribes and state and local governments, on comments related to these assessments\n\nand reviews. The impact of the withdrawal is analyzed in the final Regulatory Impact Analysis (RIA) for this final rule. _See_ Section VI below. In that section, we monetize the likely reductions in time spent by the Department and the general public as cost savings. Our primary estimate of these cost savings in 2020 dollars, annualized over 10 years, using a 3% discount rate, totals $69.9 million. Using a 7% discount rate, we estimate $75.5 million in annualized cost savings. Table 1 in Section VI reports\n\nthese primary estimates alongside a range of estimates that capture uncertainty in the amount of time it would have taken the Department to perform each regulatory assessment and review, and uncertainty in the amount of time the public would have spent on comments.\n\n**II. Table of Abbreviations/Commonly Used Acronyms in This Document**\n\nAs used in this preamble, the following terms and abbreviations have the meanings noted below.\n\nTerm Meaning\n\nACA .......................................................................................... Affordable Care Act.\n\nACF .......................................................................................... Administration for Children and Families.\n\nAI/ANs ...................................................................................... American Indian and Alaska Native people.\n\nAI .............................................................................................. Artificial intelligence.\n\nAPA .......................................................................................... Administrative Procedure Act.\n\nCDC .......................................................................................... Centers for Disease Control and Prevention.\n\nCFR .......................................................................................... Code of Federal Regulations.\n\nCHIP ......................................................................................... Children’s Health Insurance Program.\n\nCMS .......................................................................................... Centers for Medicare & Medicaid Services.\n\nCOVID–19 ................................................................................ Coronavirus Disease 2019.\n\nE.O. .......................................................................................... Executive Order.\n\nFD&C Act ................................................................................. Federal Food, Drug, and Cosmetic Act.\n\nFDA .......................................................................................... Food and Drug Administration.\n\nFSMA ........................................................................................ FDA Food Safety Modernization Act.\n\nHHS or Department .................................................................. U.S. Department of Health and Human Services.\n\nIHS ............................................................................................ Indian Health Service.\n\nOCR .......................................................................................... Office for Civil Rights.\n\nOIRA ......................................................................................... Office of Information and Regulatory Affairs.\n\nPDV .......................................................................................... Present Daily Value.\n\nPHS Act .................................................................................... Public Health Service Act.\n\nRFA .......................................................................................... Regulatory Flexibility Act.\n\nRIA ............................................................................................ Regulatory Impact Analysis.\n\nSAMHSA .................................................................................. Substance Abuse and Mental Health Services Administration.\n\nSBA .......................................................................................... Small Business Administration.\n\nSEISNOSE ............................................................................... Significant Economic Impact Upon a Substantial Number of Small Entities.\n\nSECG ....................................................................................... Small Entity Compliance Guide.\n\nSSA .......................................................................................... Social Security Act.\n\nSUNSET ................................................................................... Securing Updated and Necessary Statutory Evaluations Timely.\n\nUnified Agenda ......................................................................... Unified Agenda of Regulatory and Deregulatory Actions.\n\n**III. Background** The SUNSET final rule, if implemented, would have significantly altered the operations of HHS with considerable negative repercussions for a diverse array of stakeholders. We now conclude that these significant repercussions were not adequately considered in issuing the SUNSET final rule in part because the process to promulgate the rule was extremely unusual, if not unprecedented. We note a few of the key considerations here. The SUNSET final rule is expansive in scope and impact, faced considerable opposition from stakeholders (and very little support), and lacked a public health or welfare rationale for expediting rulemaking. In contrast to the Department’s historical approach to rulemaking in these circumstances, HHS completed the rulemaking—from the publication of the proposal to\n\npublication of the final rule—in less than three months. In issuing the Withdrawal NPRM, we explained that, given the lack of a public health or welfare reason to expedite the rulemaking and other procedural shortcomings, we were reconsidering the commenters’ significant objections to the SUNSET proposed rule. As summarized and discussed in the Withdrawal NPRM, we found that those comments raised compelling concerns that the SUNSET final rule would harm the public health and welfare, but were given insufficient weight in issuing the SUNSET final rule. Many of those same concerns have been further confirmed in the comments on the Withdrawal NPRM. We also conducted a reanalysis of the regulatory impact of the SUNSET final rule, and found that the rule rested on\n\nflawed assumptions and analysis. ² We now conclude that the SUNSET final rule likely underestimated to a significant degree the resources needed for the required undertaking. In particular, because the implementation of the SUNSET final rule would have required a significant expenditure of\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00003 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","pages":[{"line_numbers":[],"markdown":"**32247 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n2 The initial draft of the RIA for the SUNSET final rule was prepared by an outside economist. _See_ 86 FR 5737 n. 210. As far as the Department is currently aware, no Department economist participated in considering, drafting, or revising the economic evaluation of the SUNSET proposed or final rule. These deviations from usual practice in developing the original SUNSET rule may help explain why our current RIA differs so greatly from the previous RIA. We also note that the Department, in developing the original SUNSET rule, did not follow other routine internal review procedures, such as distributing the draft proposed and final rules to the relevant HHS agencies to solicit their review, comments, and concurrences. These irregularities may have also contributed to the flawed execution and analysis in the original SUNSET rule.\n\n_D. Costs and Benefits_\n\nThis regulatory action will reduce the time spent by the Department performing retrospective assessments and reviews of its regulations that would have been required by the SUNSET final rule, and time spent by regulated entities and other stakeholders, including the general public, small and large businesses, non- governmental organizations, Tribes and state and local governments, on comments related to these assessments\n\nand reviews. The impact of the withdrawal is analyzed in the final Regulatory Impact Analysis (RIA) for this final rule. _See_ Section VI below. In that section, we monetize the likely reductions in time spent by the Department and the general public as cost savings. Our primary estimate of these cost savings in 2020 dollars, annualized over 10 years, using a 3% discount rate, totals $69.9 million. Using a 7% discount rate, we estimate $75.5 million in annualized cost savings. Table 1 in Section VI reports\n\nthese primary estimates alongside a range of estimates that capture uncertainty in the amount of time it would have taken the Department to perform each regulatory assessment and review, and uncertainty in the amount of time the public would have spent on comments.\n\n**II. Table of Abbreviations/Commonly Used Acronyms in This Document**\n\nAs used in this preamble, the following terms and abbreviations have the meanings noted below.\n\nTerm Meaning\n\nACA .......................................................................................... Affordable Care Act.\n\nACF .......................................................................................... Administration for Children and Families.\n\nAI/ANs ...................................................................................... American Indian and Alaska Native people.\n\nAI .............................................................................................. Artificial intelligence.\n\nAPA .......................................................................................... Administrative Procedure Act.\n\nCDC .......................................................................................... Centers for Disease Control and Prevention.\n\nCFR .......................................................................................... Code of Federal Regulations.\n\nCHIP ......................................................................................... Children’s Health Insurance Program.\n\nCMS .......................................................................................... Centers for Medicare & Medicaid Services.\n\nCOVID–19 ................................................................................ Coronavirus Disease 2019.\n\nE.O. .......................................................................................... Executive Order.\n\nFD&C Act ................................................................................. Federal Food, Drug, and Cosmetic Act.\n\nFDA .......................................................................................... Food and Drug Administration.\n\nFSMA ........................................................................................ FDA Food Safety Modernization Act.\n\nHHS or Department .................................................................. U.S. Department of Health and Human Services.\n\nIHS ............................................................................................ Indian Health Service.\n\nOCR .......................................................................................... Office for Civil Rights.\n\nOIRA ......................................................................................... Office of Information and Regulatory Affairs.\n\nPDV .......................................................................................... Present Daily Value.\n\nPHS Act .................................................................................... Public Health Service Act.\n\nRFA .......................................................................................... Regulatory Flexibility Act.\n\nRIA ............................................................................................ Regulatory Impact Analysis.\n\nSAMHSA .................................................................................. Substance Abuse and Mental Health Services Administration.\n\nSBA .......................................................................................... Small Business Administration.\n\nSEISNOSE ............................................................................... Significant Economic Impact Upon a Substantial Number of Small Entities.\n\nSECG ....................................................................................... Small Entity Compliance Guide.\n\nSSA .......................................................................................... Social Security Act.\n\nSUNSET ................................................................................... Securing Updated and Necessary Statutory Evaluations Timely.\n\nUnified Agenda ......................................................................... Unified Agenda of Regulatory and Deregulatory Actions.\n\n**III. Background** The SUNSET final rule, if implemented, would have significantly altered the operations of HHS with considerable negative repercussions for a diverse array of stakeholders. We now conclude that these significant repercussions were not adequately considered in issuing the SUNSET final rule in part because the process to promulgate the rule was extremely unusual, if not unprecedented. We note a few of the key considerations here. The SUNSET final rule is expansive in scope and impact, faced considerable opposition from stakeholders (and very little support), and lacked a public health or welfare rationale for expediting rulemaking. In contrast to the Department’s historical approach to rulemaking in these circumstances, HHS completed the rulemaking—from the publication of the proposal to\n\npublication of the final rule—in less than three months. In issuing the Withdrawal NPRM, we explained that, given the lack of a public health or welfare reason to expedite the rulemaking and other procedural shortcomings, we were reconsidering the commenters’ significant objections to the SUNSET proposed rule. As summarized and discussed in the Withdrawal NPRM, we found that those comments raised compelling concerns that the SUNSET final rule would harm the public health and welfare, but were given insufficient weight in issuing the SUNSET final rule. Many of those same concerns have been further confirmed in the comments on the Withdrawal NPRM. We also conducted a reanalysis of the regulatory impact of the SUNSET final rule, and found that the rule rested on\n\nflawed assumptions and analysis. ² We now conclude that the SUNSET final rule likely underestimated to a significant degree the resources needed for the required undertaking. In particular, because the implementation of the SUNSET final rule would have required a significant expenditure of\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00003 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**32247 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n2 The initial draft of the RIA for the SUNSET final rule was prepared by an outside economist. _See_ 86 FR 5737 n. 210. As far as the Department is currently aware, no Department economist participated in considering, drafting, or revising the economic evaluation of the SUNSET proposed or final rule. These deviations from usual practice in developing the original SUNSET rule may help explain why our current RIA differs so greatly from the previous RIA. We also note that the Department, in developing the original SUNSET rule, did not follow other routine internal review procedures, such as distributing the draft proposed and final rules to the relevant HHS agencies to solicit their review, comments, and concurrences. These irregularities may have also contributed to the flawed execution and analysis in the original SUNSET rule.\n\n_D. Costs and Benefits_\n\nThis regulatory action will reduce the time spent by the Department performing retrospective assessments and reviews of its regulations that would have been required by the SUNSET final rule, and time spent by regulated entities and other stakeholders, including the general public, small and large businesses, non- governmental organizations, Tribes and state and local governments, on comments related to these assessments\n\nand reviews. The impact of the withdrawal is analyzed in the final Regulatory Impact Analysis (RIA) for this final rule. _See_ Section VI below. In that section, we monetize the likely reductions in time spent by the Department and the general public as cost savings. Our primary estimate of these cost savings in 2020 dollars, annualized over 10 years, using a 3% discount rate, totals $69.9 million. Using a 7% discount rate, we estimate $75.5 million in annualized cost savings. Table 1 in Section VI reports\n\nthese primary estimates alongside a range of estimates that capture uncertainty in the amount of time it would have taken the Department to perform each regulatory assessment and review, and uncertainty in the amount of time the public would have spent on comments.\n\n**II. Table of Abbreviations/Commonly Used Acronyms in This Document**\n\nAs used in this preamble, the following terms and abbreviations have the meanings noted below.\n\nTerm Meaning\n\nACA .......................................................................................... Affordable Care Act.\n\nACF .......................................................................................... Administration for Children and Families.\n\nAI/ANs ...................................................................................... American Indian and Alaska Native people.\n\nAI .............................................................................................. Artificial intelligence.\n\nAPA .......................................................................................... Administrative Procedure Act.\n\nCDC .......................................................................................... Centers for Disease Control and Prevention.\n\nCFR .......................................................................................... Code of Federal Regulations.\n\nCHIP ......................................................................................... Children’s Health Insurance Program.\n\nCMS .......................................................................................... Centers for Medicare & Medicaid Services.\n\nCOVID–19 ................................................................................ Coronavirus Disease 2019.\n\nE.O. .......................................................................................... Executive Order.\n\nFD&C Act ................................................................................. Federal Food, Drug, and Cosmetic Act.\n\nFDA .......................................................................................... Food and Drug Administration.\n\nFSMA ........................................................................................ FDA Food Safety Modernization Act.\n\nHHS or Department .................................................................. U.S. Department of Health and Human Services.\n\nIHS ............................................................................................ Indian Health Service.\n\nOCR .......................................................................................... Office for Civil Rights.\n\nOIRA ......................................................................................... Office of Information and Regulatory Affairs.\n\nPDV .......................................................................................... Present Daily Value.\n\nPHS Act .................................................................................... Public Health Service Act.\n\nRFA .......................................................................................... Regulatory Flexibility Act.\n\nRIA ............................................................................................ Regulatory Impact Analysis.\n\nSAMHSA .................................................................................. Substance Abuse and Mental Health Services Administration.\n\nSBA .......................................................................................... Small Business Administration.\n\nSEISNOSE ............................................................................... Significant Economic Impact Upon a Substantial Number of Small Entities.\n\nSECG ....................................................................................... Small Entity Compliance Guide.\n\nSSA .......................................................................................... Social Security Act.\n\nSUNSET ................................................................................... Securing Updated and Necessary Statutory Evaluations Timely.\n\nUnified Agenda ......................................................................... Unified Agenda of Regulatory and Deregulatory Actions.\n\n**III. Background** The SUNSET final rule, if implemented, would have significantly altered the operations of HHS with considerable negative repercussions for a diverse array of stakeholders. We now conclude that these significant repercussions were not adequately considered in issuing the SUNSET final rule in part because the process to promulgate the rule was extremely unusual, if not unprecedented. We note a few of the key considerations here. The SUNSET final rule is expansive in scope and impact, faced considerable opposition from stakeholders (and very little support), and lacked a public health or welfare rationale for expediting rulemaking. In contrast to the Department’s historical approach to rulemaking in these circumstances, HHS completed the rulemaking—from the publication of the proposal to\n\npublication of the final rule—in less than three months. In issuing the Withdrawal NPRM, we explained that, given the lack of a public health or welfare reason to expedite the rulemaking and other procedural shortcomings, we were reconsidering the commenters’ significant objections to the SUNSET proposed rule. As summarized and discussed in the Withdrawal NPRM, we found that those comments raised compelling concerns that the SUNSET final rule would harm the public health and welfare, but were given insufficient weight in issuing the SUNSET final rule. Many of those same concerns have been further confirmed in the comments on the Withdrawal NPRM. We also conducted a reanalysis of the regulatory impact of the SUNSET final rule, and found that the rule rested on\n\nflawed assumptions and analysis. ² We now conclude that the SUNSET final rule likely underestimated to a significant degree the resources needed for the required undertaking. In particular, because the implementation of the SUNSET final rule would have required a significant expenditure of\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00003 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_8b774aa14375e1dcb6abedfebce668b5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**32247 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n2 The initial draft of the RIA for the SUNSET final rule was prepared by an outside economist. _See_ 86 FR 5737 n. 210. As far as the Department is currently aware, no Department economist participated in considering, drafting, or revising the economic evaluation of the SUNSET proposed or final rule. These deviations from usual practice in developing the original SUNSET rule may help explain why our current RIA differs so greatly from the previous RIA. We also note that the Department, in developing the original SUNSET rule, did not follow other routine internal review procedures, such as distributing the draft proposed and final rules to the relevant HHS agencies to solicit their review, comments, and concurrences. These irregularities may have also contributed to the flawed execution and analysis in the original SUNSET rule.\n\n_D. Costs and Benefits_\n\nThis regulatory action will reduce the time spent by the Department performing retrospective assessments and reviews of its regulations that would have been required by the SUNSET final rule, and time spent by regulated entities and other stakeholders, including the general public, small and large businesses, non- governmental organizations, Tribes and state and local governments, on comments related to these assessments\n\nand reviews. The impact of the withdrawal is analyzed in the final Regulatory Impact Analysis (RIA) for this final rule. _See_ Section VI below. In that section, we monetize the likely reductions in time spent by the Department and the general public as cost savings. Our primary estimate of these cost savings in 2020 dollars, annualized over 10 years, using a 3% discount rate, totals $69.9 million. Using a 7% discount rate, we estimate $75.5 million in annualized cost savings. Table 1 in Section VI reports\n\nthese primary estimates alongside a range of estimates that capture uncertainty in the amount of time it would have taken the Department to perform each regulatory assessment and review, and uncertainty in the amount of time the public would have spent on comments.\n\n**II. Table of Abbreviations/Commonly Used Acronyms in This Document**\n\nAs used in this preamble, the following terms and abbreviations have the meanings noted below.\n\nTerm Meaning\n\nACA .......................................................................................... Affordable Care Act.\n\nACF .......................................................................................... Administration for Children and Families.\n\nAI/ANs ...................................................................................... American Indian and Alaska Native people.\n\nAI .............................................................................................. Artificial intelligence.\n\nAPA .......................................................................................... Administrative Procedure Act.\n\nCDC .......................................................................................... Centers for Disease Control and Prevention.\n\nCFR .......................................................................................... Code of Federal Regulations.\n\nCHIP ......................................................................................... Children’s Health Insurance Program.\n\nCMS .......................................................................................... Centers for Medicare & Medicaid Services.\n\nCOVID–19 ................................................................................ Coronavirus Disease 2019.\n\nE.O. .......................................................................................... Executive Order.\n\nFD&C Act ................................................................................. Federal Food, Drug, and Cosmetic Act.\n\nFDA .......................................................................................... Food and Drug Administration.\n\nFSMA ........................................................................................ FDA Food Safety Modernization Act.\n\nHHS or Department .................................................................. U.S. Department of Health and Human Services.\n\nIHS ............................................................................................ Indian Health Service.\n\nOCR .......................................................................................... Office for Civil Rights.\n\nOIRA ......................................................................................... Office of Information and Regulatory Affairs.\n\nPDV .......................................................................................... Present Daily Value.\n\nPHS Act .................................................................................... Public Health Service Act.\n\nRFA .......................................................................................... Regulatory Flexibility Act.\n\nRIA ............................................................................................ Regulatory Impact Analysis.\n\nSAMHSA .................................................................................. Substance Abuse and Mental Health Services Administration.\n\nSBA .......................................................................................... Small Business Administration.\n\nSEISNOSE ............................................................................... Significant Economic Impact Upon a Substantial Number of Small Entities.\n\nSECG ....................................................................................... Small Entity Compliance Guide.\n\nSSA .......................................................................................... Social Security Act.\n\nSUNSET ................................................................................... Securing Updated and Necessary Statutory Evaluations Timely.\n\nUnified Agenda ......................................................................... Unified Agenda of Regulatory and Deregulatory Actions.\n\n**III. Background** The SUNSET final rule, if implemented, would have significantly altered the operations of HHS with considerable negative repercussions for a diverse array of stakeholders. We now conclude that these significant repercussions were not adequately considered in issuing the SUNSET final rule in part because the process to promulgate the rule was extremely unusual, if not unprecedented. We note a few of the key considerations here. The SUNSET final rule is expansive in scope and impact, faced considerable opposition from stakeholders (and very little support), and lacked a public health or welfare rationale for expediting rulemaking. In contrast to the Department’s historical approach to rulemaking in these circumstances, HHS completed the rulemaking—from the publication of the proposal to\n\npublication of the final rule—in less than three months. In issuing the Withdrawal NPRM, we explained that, given the lack of a public health or welfare reason to expedite the rulemaking and other procedural shortcomings, we were reconsidering the commenters’ significant objections to the SUNSET proposed rule. As summarized and discussed in the Withdrawal NPRM, we found that those comments raised compelling concerns that the SUNSET final rule would harm the public health and welfare, but were given insufficient weight in issuing the SUNSET final rule. Many of those same concerns have been further confirmed in the comments on the Withdrawal NPRM. We also conducted a reanalysis of the regulatory impact of the SUNSET final rule, and found that the rule rested on\n\nflawed assumptions and analysis. ² We now conclude that the SUNSET final rule likely underestimated to a significant degree the resources needed for the required undertaking. In particular, because the implementation of the SUNSET final rule would have required a significant expenditure of\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00003 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2"],"full_content":"**32247 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n2 The initial draft of the RIA for the SUNSET final rule was prepared by an outside economist. _See_ 86 FR 5737 n. 210. As far as the Department is currently aware, no Department economist participated in considering, drafting, or revising the economic evaluation of the SUNSET proposed or final rule. These deviations from usual practice in developing the original SUNSET rule may help explain why our current RIA differs so greatly from the previous RIA. We also note that the Department, in developing the original SUNSET rule, did not follow other routine internal review procedures, such as distributing the draft proposed and final rules to the relevant HHS agencies to solicit their review, comments, and concurrences. These irregularities may have also contributed to the flawed execution and analysis in the original SUNSET rule.\n\n_D. Costs and Benefits_\n\nThis regulatory action will reduce the time spent by the Department performing retrospective assessments and reviews of its regulations that would have been required by the SUNSET final rule, and time spent by regulated entities and other stakeholders, including the general public, small and large businesses, non- governmental organizations, Tribes and state and local governments, on comments related to these assessments\n\nand reviews. The impact of the withdrawal is analyzed in the final Regulatory Impact Analysis (RIA) for this final rule. _See_ Section VI below. In that section, we monetize the likely reductions in time spent by the Department and the general public as cost savings. Our primary estimate of these cost savings in 2020 dollars, annualized over 10 years, using a 3% discount rate, totals $69.9 million. Using a 7% discount rate, we estimate $75.5 million in annualized cost savings. Table 1 in Section VI reports\n\nthese primary estimates alongside a range of estimates that capture uncertainty in the amount of time it would have taken the Department to perform each regulatory assessment and review, and uncertainty in the amount of time the public would have spent on comments.\n\n**II. Table of Abbreviations/Commonly Used Acronyms in This Document**\n\nAs used in this preamble, the following terms and abbreviations have the meanings noted below.\n\nTerm Meaning\n\nACA .......................................................................................... Affordable Care Act.\n\nACF .......................................................................................... Administration for Children and Families.\n\nAI/ANs ...................................................................................... American Indian and Alaska Native people.\n\nAI .............................................................................................. Artificial intelligence.\n\nAPA .......................................................................................... Administrative Procedure Act.\n\nCDC .......................................................................................... Centers for Disease Control and Prevention.\n\nCFR .......................................................................................... Code of Federal Regulations.\n\nCHIP ......................................................................................... Children’s Health Insurance Program.\n\nCMS .......................................................................................... Centers for Medicare & Medicaid Services.\n\nCOVID–19 ................................................................................ Coronavirus Disease 2019.\n\nE.O. .......................................................................................... Executive Order.\n\nFD&C Act ................................................................................. Federal Food, Drug, and Cosmetic Act.\n\nFDA .......................................................................................... Food and Drug Administration.\n\nFSMA ........................................................................................ FDA Food Safety Modernization Act.\n\nHHS or Department .................................................................. U.S. Department of Health and Human Services.\n\nIHS ............................................................................................ Indian Health Service.\n\nOCR .......................................................................................... Office for Civil Rights.\n\nOIRA ......................................................................................... Office of Information and Regulatory Affairs.\n\nPDV .......................................................................................... Present Daily Value.\n\nPHS Act .................................................................................... Public Health Service Act.\n\nRFA .......................................................................................... Regulatory Flexibility Act.\n\nRIA ............................................................................................ Regulatory Impact Analysis.\n\nSAMHSA .................................................................................. Substance Abuse and Mental Health Services Administration.\n\nSBA .......................................................................................... Small Business Administration.\n\nSEISNOSE ............................................................................... Significant Economic Impact Upon a Substantial Number of Small Entities.\n\nSECG ....................................................................................... Small Entity Compliance Guide.\n\nSSA .......................................................................................... Social Security Act.\n\nSUNSET ................................................................................... Securing Updated and Necessary Statutory Evaluations Timely.\n\nUnified Agenda ......................................................................... Unified Agenda of Regulatory and Deregulatory Actions.\n\n**III. Background** The SUNSET final rule, if implemented, would have significantly altered the operations of HHS with considerable negative repercussions for a diverse array of stakeholders. We now conclude that these significant repercussions were not adequately considered in issuing the SUNSET final rule in part because the process to promulgate the rule was extremely unusual, if not unprecedented. We note a few of the key considerations here. The SUNSET final rule is expansive in scope and impact, faced considerable opposition from stakeholders (and very little support), and lacked a public health or welfare rationale for expediting rulemaking. In contrast to the Department’s historical approach to rulemaking in these circumstances, HHS completed the rulemaking—from the publication of the proposal to\n\npublication of the final rule—in less than three months. In issuing the Withdrawal NPRM, we explained that, given the lack of a public health or welfare reason to expedite the rulemaking and other procedural shortcomings, we were reconsidering the commenters’ significant objections to the SUNSET proposed rule. As summarized and discussed in the Withdrawal NPRM, we found that those comments raised compelling concerns that the SUNSET final rule would harm the public health and welfare, but were given insufficient weight in issuing the SUNSET final rule. Many of those same concerns have been further confirmed in the comments on the Withdrawal NPRM. We also conducted a reanalysis of the regulatory impact of the SUNSET final rule, and found that the rule rested on\n\nflawed assumptions and analysis. ² We now conclude that the SUNSET final rule likely underestimated to a significant degree the resources needed for the required undertaking. In particular, because the implementation of the SUNSET final rule would have required a significant expenditure of\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00003 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","publish_date":null,"title":"32247","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page2.pdf"},"request":{"example_id":"table/1653739079_page2","product_type":"parse","source_file_path":"1653739079_page2.pdf"},"started_at":"2026-11-04T19:48:04.291909"} +{"completed_at":"2026-11-04T19:48:07.969527","latency_in_ms":1987,"output":{"example_id":"table/1653739079_page34","grounded_pages":[],"layout_pages":[],"markdown":"**32279 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nusing the most current (2021) Implicit Price Deflator for the Gross Domestic Product. This final withdrawal rule will result in an expenditure in at least one year that meets or exceeds this amount.\n\n2\\. Summary of Costs and Benefits The final withdrawal rule will withdraw the SUNSET final rule. This regulatory action will reduce the time spent by the Department performing retrospective assessments and reviews of its regulations, and time spent by the general public on comments related to these assessments and reviews anticipated under the SUNSET final rule. We monetize the likely reductions in time spent by the Department and the general public and report these impacts as cost savings. Our primary estimate of\n\nthese cost savings in 2020 dollars, annualized over 10 years, using a 3% discount rate, totals $69.9 million. Using a 7% discount rate, we estimate $75.5 million in annualized cost savings. Table 1 reports these primary estimates alongside a range of estimates that capture uncertainty in the amount of time it will take the Department to perform each assessment and review, and uncertainty in the amount of time the public will spend on comments. In addition to these monetized effects, the final withdrawal rule will also reduce regulatory uncertainty and regulatory confusion anticipated under the SUNSET final rule. Given the scope of the SUNSET final rule, these impacts would have been experienced by small\n\nbusinesses but also the general public, larger businesses, Tribes, States, non- governmental organizations, and other regulated entities and stakeholders across a wide range of industrial sectors. The final withdrawal rule will also reduce the time spent by the Department on other activities that we have not monetized or quantified, such as the time developing Small Entity Compliance Guides (SECGs), and it will reduce the time spent by the public monitoring regulations undergoing assessment or review and set to expire. The final withdrawal rule will also result in a disbenefit with respect to forgone information as a result of not performing the assessments and reviews.\n\nTABLE 1—SUMMARY OF BENEFITS, COSTS AND DISTRIBUTIONAL EFFECTS OF THE FINAL WITHDRAWAL RULE\n\nCategory Primary estimate Low estimate High estimate\n\nUnits\n\nNotes Year dollars Discount rate (%) Period covered\n\nBenefits:\n\nAnnualized Monetized $millions/year .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nAnnualized Quantified ...................... .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nQualitative ........................................ —Reduction in regulatory uncertainty and confusion. —Disbenefits from the information foregone from not performing assessments and reviews.\n\nCosts:\n\nAnnualized Monetized $millions/year ¥$75.5 ¥69.9 ¥$40.1 ¥37.2 ¥$110.9 ¥102.7 2020 2020 7 3 2022–2031 2022–2031 Cost savings from not performing as- sessments and reviews, and time spent by the public on comments.\n\nAnnualized Quantified ...................... .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nQualitative.\n\nTransfers:\n\nFederal Annualized Monetized $millions/year. .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nFrom/To ............................................ From: To:\n\nOther Annualized Monetized $millions/year. .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nFrom/To ............................................ From: To:\n\nEffects: State, Local or Tribal Government: Small Business: Wages: Growth:\n\n3\\. Summary of Changes\n\nCompared to the preliminary regulatory impact analysis, this final regulatory impact analysis expands the discussion of regulatory alternatives, including a quantitative analysis of two additional alternatives recommended in public comments. Specifically, we analyze a policy option that would maintain the general framework of the SUNSET final rule but limit its scope to\n\nregulations that the Department previously identified as having a significant economic impact on a substantial number of small entities. We also analyze a policy option that would maintain the SUNSET final rule’s requirements related to the timeline for assessing and reviewing all of the Department’s existing regulations, but without the automatic expiration\n\nprovision contained in the SUNSET final rule. We have revised the discussion and estimates contained in this regulatory impact analysis to reflect regulatory action that administratively postponed the effective date of the SUNSET final rule. This analysis now states that the regulatory action will withdraw the SUNSET final rule, whereas the preliminary regulatory impact analysis\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00035 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","pages":[{"line_numbers":[],"markdown":"**32279 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nusing the most current (2021) Implicit Price Deflator for the Gross Domestic Product. This final withdrawal rule will result in an expenditure in at least one year that meets or exceeds this amount.\n\n2\\. Summary of Costs and Benefits The final withdrawal rule will withdraw the SUNSET final rule. This regulatory action will reduce the time spent by the Department performing retrospective assessments and reviews of its regulations, and time spent by the general public on comments related to these assessments and reviews anticipated under the SUNSET final rule. We monetize the likely reductions in time spent by the Department and the general public and report these impacts as cost savings. Our primary estimate of\n\nthese cost savings in 2020 dollars, annualized over 10 years, using a 3% discount rate, totals $69.9 million. Using a 7% discount rate, we estimate $75.5 million in annualized cost savings. Table 1 reports these primary estimates alongside a range of estimates that capture uncertainty in the amount of time it will take the Department to perform each assessment and review, and uncertainty in the amount of time the public will spend on comments. In addition to these monetized effects, the final withdrawal rule will also reduce regulatory uncertainty and regulatory confusion anticipated under the SUNSET final rule. Given the scope of the SUNSET final rule, these impacts would have been experienced by small\n\nbusinesses but also the general public, larger businesses, Tribes, States, non- governmental organizations, and other regulated entities and stakeholders across a wide range of industrial sectors. The final withdrawal rule will also reduce the time spent by the Department on other activities that we have not monetized or quantified, such as the time developing Small Entity Compliance Guides (SECGs), and it will reduce the time spent by the public monitoring regulations undergoing assessment or review and set to expire. The final withdrawal rule will also result in a disbenefit with respect to forgone information as a result of not performing the assessments and reviews.\n\nTABLE 1—SUMMARY OF BENEFITS, COSTS AND DISTRIBUTIONAL EFFECTS OF THE FINAL WITHDRAWAL RULE\n\nCategory Primary estimate Low estimate High estimate\n\nUnits\n\nNotes Year dollars Discount rate (%) Period covered\n\nBenefits:\n\nAnnualized Monetized $millions/year .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nAnnualized Quantified ...................... .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nQualitative ........................................ —Reduction in regulatory uncertainty and confusion. —Disbenefits from the information foregone from not performing assessments and reviews.\n\nCosts:\n\nAnnualized Monetized $millions/year ¥$75.5 ¥69.9 ¥$40.1 ¥37.2 ¥$110.9 ¥102.7 2020 2020 7 3 2022–2031 2022–2031 Cost savings from not performing as- sessments and reviews, and time spent by the public on comments.\n\nAnnualized Quantified ...................... .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nQualitative.\n\nTransfers:\n\nFederal Annualized Monetized $millions/year. .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nFrom/To ............................................ From: To:\n\nOther Annualized Monetized $millions/year. .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nFrom/To ............................................ From: To:\n\nEffects: State, Local or Tribal Government: Small Business: Wages: Growth:\n\n3\\. Summary of Changes\n\nCompared to the preliminary regulatory impact analysis, this final regulatory impact analysis expands the discussion of regulatory alternatives, including a quantitative analysis of two additional alternatives recommended in public comments. Specifically, we analyze a policy option that would maintain the general framework of the SUNSET final rule but limit its scope to\n\nregulations that the Department previously identified as having a significant economic impact on a substantial number of small entities. We also analyze a policy option that would maintain the SUNSET final rule’s requirements related to the timeline for assessing and reviewing all of the Department’s existing regulations, but without the automatic expiration\n\nprovision contained in the SUNSET final rule. We have revised the discussion and estimates contained in this regulatory impact analysis to reflect regulatory action that administratively postponed the effective date of the SUNSET final rule. This analysis now states that the regulatory action will withdraw the SUNSET final rule, whereas the preliminary regulatory impact analysis\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00035 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**32279 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nusing the most current (2021) Implicit Price Deflator for the Gross Domestic Product. This final withdrawal rule will result in an expenditure in at least one year that meets or exceeds this amount.\n\n2\\. Summary of Costs and Benefits The final withdrawal rule will withdraw the SUNSET final rule. This regulatory action will reduce the time spent by the Department performing retrospective assessments and reviews of its regulations, and time spent by the general public on comments related to these assessments and reviews anticipated under the SUNSET final rule. We monetize the likely reductions in time spent by the Department and the general public and report these impacts as cost savings. Our primary estimate of\n\nthese cost savings in 2020 dollars, annualized over 10 years, using a 3% discount rate, totals $69.9 million. Using a 7% discount rate, we estimate $75.5 million in annualized cost savings. Table 1 reports these primary estimates alongside a range of estimates that capture uncertainty in the amount of time it will take the Department to perform each assessment and review, and uncertainty in the amount of time the public will spend on comments. In addition to these monetized effects, the final withdrawal rule will also reduce regulatory uncertainty and regulatory confusion anticipated under the SUNSET final rule. Given the scope of the SUNSET final rule, these impacts would have been experienced by small\n\nbusinesses but also the general public, larger businesses, Tribes, States, non- governmental organizations, and other regulated entities and stakeholders across a wide range of industrial sectors. The final withdrawal rule will also reduce the time spent by the Department on other activities that we have not monetized or quantified, such as the time developing Small Entity Compliance Guides (SECGs), and it will reduce the time spent by the public monitoring regulations undergoing assessment or review and set to expire. The final withdrawal rule will also result in a disbenefit with respect to forgone information as a result of not performing the assessments and reviews.\n\nTABLE 1—SUMMARY OF BENEFITS, COSTS AND DISTRIBUTIONAL EFFECTS OF THE FINAL WITHDRAWAL RULE\n\nCategory Primary estimate Low estimate High estimate\n\nUnits\n\nNotes Year dollars Discount rate (%) Period covered\n\nBenefits:\n\nAnnualized Monetized $millions/year .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nAnnualized Quantified ...................... .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nQualitative ........................................ —Reduction in regulatory uncertainty and confusion. —Disbenefits from the information foregone from not performing assessments and reviews.\n\nCosts:\n\nAnnualized Monetized $millions/year ¥$75.5 ¥69.9 ¥$40.1 ¥37.2 ¥$110.9 ¥102.7 2020 2020 7 3 2022–2031 2022–2031 Cost savings from not performing as- sessments and reviews, and time spent by the public on comments.\n\nAnnualized Quantified ...................... .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nQualitative.\n\nTransfers:\n\nFederal Annualized Monetized $millions/year. .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nFrom/To ............................................ From: To:\n\nOther Annualized Monetized $millions/year. .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nFrom/To ............................................ From: To:\n\nEffects: State, Local or Tribal Government: Small Business: Wages: Growth:\n\n3\\. Summary of Changes\n\nCompared to the preliminary regulatory impact analysis, this final regulatory impact analysis expands the discussion of regulatory alternatives, including a quantitative analysis of two additional alternatives recommended in public comments. Specifically, we analyze a policy option that would maintain the general framework of the SUNSET final rule but limit its scope to\n\nregulations that the Department previously identified as having a significant economic impact on a substantial number of small entities. We also analyze a policy option that would maintain the SUNSET final rule’s requirements related to the timeline for assessing and reviewing all of the Department’s existing regulations, but without the automatic expiration\n\nprovision contained in the SUNSET final rule. We have revised the discussion and estimates contained in this regulatory impact analysis to reflect regulatory action that administratively postponed the effective date of the SUNSET final rule. This analysis now states that the regulatory action will withdraw the SUNSET final rule, whereas the preliminary regulatory impact analysis\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00035 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page34.pdf"]},"response":{"errors":[],"extract_id":"extract_928d40e43e80073a2c24ced330534f97","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**32279 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nusing the most current (2021) Implicit Price Deflator for the Gross Domestic Product. This final withdrawal rule will result in an expenditure in at least one year that meets or exceeds this amount.\n\n2\\. Summary of Costs and Benefits The final withdrawal rule will withdraw the SUNSET final rule. This regulatory action will reduce the time spent by the Department performing retrospective assessments and reviews of its regulations, and time spent by the general public on comments related to these assessments and reviews anticipated under the SUNSET final rule. We monetize the likely reductions in time spent by the Department and the general public and report these impacts as cost savings. Our primary estimate of\n\nthese cost savings in 2020 dollars, annualized over 10 years, using a 3% discount rate, totals $69.9 million. Using a 7% discount rate, we estimate $75.5 million in annualized cost savings. Table 1 reports these primary estimates alongside a range of estimates that capture uncertainty in the amount of time it will take the Department to perform each assessment and review, and uncertainty in the amount of time the public will spend on comments. In addition to these monetized effects, the final withdrawal rule will also reduce regulatory uncertainty and regulatory confusion anticipated under the SUNSET final rule. Given the scope of the SUNSET final rule, these impacts would have been experienced by small\n\nbusinesses but also the general public, larger businesses, Tribes, States, non- governmental organizations, and other regulated entities and stakeholders across a wide range of industrial sectors. The final withdrawal rule will also reduce the time spent by the Department on other activities that we have not monetized or quantified, such as the time developing Small Entity Compliance Guides (SECGs), and it will reduce the time spent by the public monitoring regulations undergoing assessment or review and set to expire. The final withdrawal rule will also result in a disbenefit with respect to forgone information as a result of not performing the assessments and reviews.\n\nTABLE 1—SUMMARY OF BENEFITS, COSTS AND DISTRIBUTIONAL EFFECTS OF THE FINAL WITHDRAWAL RULE\n\nCategory Primary estimate Low estimate High estimate\n\nUnits\n\nNotes Year dollars Discount rate (%) Period covered\n\nBenefits:\n\nAnnualized Monetized $millions/year .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nAnnualized Quantified ...................... .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nQualitative ........................................ —Reduction in regulatory uncertainty and confusion. —Disbenefits from the information foregone from not performing assessments and reviews.\n\nCosts:\n\nAnnualized Monetized $millions/year ¥$75.5 ¥69.9 ¥$40.1 ¥37.2 ¥$110.9 ¥102.7 2020 2020 7 3 2022–2031 2022–2031 Cost savings from not performing as- sessments and reviews, and time spent by the public on comments.\n\nAnnualized Quantified ...................... .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nQualitative.\n\nTransfers:\n\nFederal Annualized Monetized $millions/year. .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nFrom/To ............................................ From: To:\n\nOther Annualized Monetized $millions/year. .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nFrom/To ............................................ From: To:\n\nEffects: State, Local or Tribal Government: Small Business: Wages: Growth:\n\n3\\. Summary of Changes\n\nCompared to the preliminary regulatory impact analysis, this final regulatory impact analysis expands the discussion of regulatory alternatives, including a quantitative analysis of two additional alternatives recommended in public comments. Specifically, we analyze a policy option that would maintain the general framework of the SUNSET final rule but limit its scope to\n\nregulations that the Department previously identified as having a significant economic impact on a substantial number of small entities. We also analyze a policy option that would maintain the SUNSET final rule’s requirements related to the timeline for assessing and reviewing all of the Department’s existing regulations, but without the automatic expiration\n\nprovision contained in the SUNSET final rule. We have revised the discussion and estimates contained in this regulatory impact analysis to reflect regulatory action that administratively postponed the effective date of the SUNSET final rule. This analysis now states that the regulatory action will withdraw the SUNSET final rule, whereas the preliminary regulatory impact analysis\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00035 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2"],"full_content":"**32279 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nusing the most current (2021) Implicit Price Deflator for the Gross Domestic Product. This final withdrawal rule will result in an expenditure in at least one year that meets or exceeds this amount.\n\n2\\. Summary of Costs and Benefits The final withdrawal rule will withdraw the SUNSET final rule. This regulatory action will reduce the time spent by the Department performing retrospective assessments and reviews of its regulations, and time spent by the general public on comments related to these assessments and reviews anticipated under the SUNSET final rule. We monetize the likely reductions in time spent by the Department and the general public and report these impacts as cost savings. Our primary estimate of\n\nthese cost savings in 2020 dollars, annualized over 10 years, using a 3% discount rate, totals $69.9 million. Using a 7% discount rate, we estimate $75.5 million in annualized cost savings. Table 1 reports these primary estimates alongside a range of estimates that capture uncertainty in the amount of time it will take the Department to perform each assessment and review, and uncertainty in the amount of time the public will spend on comments. In addition to these monetized effects, the final withdrawal rule will also reduce regulatory uncertainty and regulatory confusion anticipated under the SUNSET final rule. Given the scope of the SUNSET final rule, these impacts would have been experienced by small\n\nbusinesses but also the general public, larger businesses, Tribes, States, non- governmental organizations, and other regulated entities and stakeholders across a wide range of industrial sectors. The final withdrawal rule will also reduce the time spent by the Department on other activities that we have not monetized or quantified, such as the time developing Small Entity Compliance Guides (SECGs), and it will reduce the time spent by the public monitoring regulations undergoing assessment or review and set to expire. The final withdrawal rule will also result in a disbenefit with respect to forgone information as a result of not performing the assessments and reviews.\n\nTABLE 1—SUMMARY OF BENEFITS, COSTS AND DISTRIBUTIONAL EFFECTS OF THE FINAL WITHDRAWAL RULE\n\nCategory Primary estimate Low estimate High estimate\n\nUnits\n\nNotes Year dollars Discount rate (%) Period covered\n\nBenefits:\n\nAnnualized Monetized $millions/year .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nAnnualized Quantified ...................... .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nQualitative ........................................ —Reduction in regulatory uncertainty and confusion. —Disbenefits from the information foregone from not performing assessments and reviews.\n\nCosts:\n\nAnnualized Monetized $millions/year ¥$75.5 ¥69.9 ¥$40.1 ¥37.2 ¥$110.9 ¥102.7 2020 2020 7 3 2022–2031 2022–2031 Cost savings from not performing as- sessments and reviews, and time spent by the public on comments.\n\nAnnualized Quantified ...................... .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nQualitative.\n\nTransfers:\n\nFederal Annualized Monetized $millions/year. .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nFrom/To ............................................ From: To:\n\nOther Annualized Monetized $millions/year. .................. .................. .................. .................. .................. .................. .................. .................. 7 3 .................. ..................\n\nFrom/To ............................................ From: To:\n\nEffects: State, Local or Tribal Government: Small Business: Wages: Growth:\n\n3\\. Summary of Changes\n\nCompared to the preliminary regulatory impact analysis, this final regulatory impact analysis expands the discussion of regulatory alternatives, including a quantitative analysis of two additional alternatives recommended in public comments. Specifically, we analyze a policy option that would maintain the general framework of the SUNSET final rule but limit its scope to\n\nregulations that the Department previously identified as having a significant economic impact on a substantial number of small entities. We also analyze a policy option that would maintain the SUNSET final rule’s requirements related to the timeline for assessing and reviewing all of the Department’s existing regulations, but without the automatic expiration\n\nprovision contained in the SUNSET final rule. We have revised the discussion and estimates contained in this regulatory impact analysis to reflect regulatory action that administratively postponed the effective date of the SUNSET final rule. This analysis now states that the regulatory action will withdraw the SUNSET final rule, whereas the preliminary regulatory impact analysis\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00035 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","publish_date":null,"title":"32279","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page34.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page34.pdf"},"request":{"example_id":"table/1653739079_page34","product_type":"parse","source_file_path":"1653739079_page34.pdf"},"started_at":"2026-11-04T19:48:05.981744"} +{"completed_at":"2026-11-04T19:48:08.495550","latency_in_ms":1302,"output":{"example_id":"table/1653739079_page36","grounded_pages":[],"layout_pages":[],"markdown":"**32281 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n68 Available at _https://cdn.advocacy.sba.gov/wp- content/uploads/2019/06/21110349/How-to- Comply-with-the-RFA.pdf._\n\nassessments. The SUNSET final rule RIA assumes that 11% of these assessments, or 396, are for regulations previously determined to have a significant economic impact on a substantial number of small entities, but reduces this figure to 370 to account for rulemakings that are likely to be reviewed for reasons other than the SUNSET final rule. This adjustment similarly reduces the estimate of the number of rulemakings impacted by the SUNSET final rule to 3,574 [=3600¥(396–370)]. For each of these 370 rulemakings, the Department will need to perform a review, which includes a retrospective regulatory flexibility analysis. The SUNSET final rule RIA distinguishes between the 44 rulemakings that predate the RFA and are unlikely to have an existing prospective regulatory flexibility analysis, and the remaining 326 rulemakings that are assumed to have an existing prospective analysis.\n\nThe SUNSET final rule RIA also estimates there will be an additional 160 rulemakings assessed to have a significant impact on a substantial number of small entities that have not previously been identified as having a significant economic impact. The Department will need to perform a review of these rulemakings under the SUNSET final rule. The SUNSET final rule provides for an initial five-year period for the Department to address regulations older than ten years. We maintain the assumption in the SUNSET final rule RIA that assessments and reviews required in the first five years will be completed evenly across this time period, and that the remaining assessments and reviews will be completed evenly across the next five- year time period. Of the 3,574 total assessments anticipated under the SUNSET final rule, 3,415 would occur during the first five-year period, an\n\naverage of 683.0 assessments per year; while 159 assessments would occur during the second five-year period, an average of 31.8 assessments per year. Of the total reviews anticipated under the SUNSET final rule, 506 would occur during the first five-year period, an average of 101.2 reviews per year; while 24 assessments would occur during the second five-year period, an average of 4.8 reviews per year. Table D1 presents yearly counts of assessments and reviews anticipated under the baseline scenario. These figures are broadly consistent with the figures contained in the SUNSET final rule RIA; however, unlike that analysis, we do not reduce the number of assessments under the SUNSET final rule by the number of reviews performed, since these assessments occur first and serve to identify those regulations requiring review.\n\nTABLE D1—BASELINE ASSESSMENTS AND REVIEWS UNDER THE SUNSET FINAL RULE\n\nYear Total assessments Reviews\n\nPre-RFA Post-RFA Not specified Total\n\n2022 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2023 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2024 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2025 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2026 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2027 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2028 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2029 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2030 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2031 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\nTotal .............................................................................. 3574.0 44.0 326.0 160.0 530.0\n\nTime per Assessment and per Review The SUNSET final rule RIA contains estimates of the time per assessment and time per review performed under the SUNSET final rule. For each assessment, the SUNSET final rule RIA assumes that it will require between 3 and 10 hours to assess a rulemaking. For each review, the SUNSET RIA assumes that it will require between 250 and 500 hours to review rulemakings that predate the RFA, and between 40 and 100 hours to review rulemakings that postdate the RFA. For the 160 rulemakings newly found to have a significant impact, the SUNSET RIA assumes that it will take between 40 and 100 hours to complete a review. The Department now concludes the SUNSET RIA likely underestimates the time necessary to credibly assess whether a regulation imposes a significant economic impact on a substantial number of small entities by\n\na significant degree. The Small Business Administration (SBA) Office of Advocacy published ‘‘A Guide for Government Agencies: How to Comply with The Regulatory Flexibility Act,’’ detailing a step-by-step approach for analysts. ⁶⁸ For each of the 3,574 rulemakings requiring an assessment under the SUNSET final rule, the Department will need to define the problem and describe the regulated entities, estimate economic impacts by size categories, and determine which size categories incur significant impacts. The SBA guide presents a two-page checklist containing the elements of an adequate certification. In practice, when performing a threshold analysis, analysts will face novel conceptual issues and data challenges, both of which require thoughtful consideration\n\nand professional judgement. The SUNSET final rule also requires HHS to open a docket and review public comments on each rulemaking being assessed. Furthermore, SBA indicates that it is not sufficient to rely on an assessment made at the time a regulation was published:\n\nIn some cases, even if an agency was originally able to certify properly under section 605 of the RFA that a rule would not have a significant economic impact on a substantial number of small entities, changed conditions may mean that the rule now does have a significant impact and therefore should be reviewed under section 610. For example, many more small businesses may be subject to the rule now than when the rule was promulgated. The cost of compliance with a current rule may have increased sharply because of a required new technology. (SBA, pp. 80–81) We assume that, under the baseline scenario of the SUNSET final rule, the Department will follow the\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00037 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","pages":[{"line_numbers":[],"markdown":"**32281 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n68 Available at _https://cdn.advocacy.sba.gov/wp- content/uploads/2019/06/21110349/How-to- Comply-with-the-RFA.pdf._\n\nassessments. The SUNSET final rule RIA assumes that 11% of these assessments, or 396, are for regulations previously determined to have a significant economic impact on a substantial number of small entities, but reduces this figure to 370 to account for rulemakings that are likely to be reviewed for reasons other than the SUNSET final rule. This adjustment similarly reduces the estimate of the number of rulemakings impacted by the SUNSET final rule to 3,574 [=3600¥(396–370)]. For each of these 370 rulemakings, the Department will need to perform a review, which includes a retrospective regulatory flexibility analysis. The SUNSET final rule RIA distinguishes between the 44 rulemakings that predate the RFA and are unlikely to have an existing prospective regulatory flexibility analysis, and the remaining 326 rulemakings that are assumed to have an existing prospective analysis.\n\nThe SUNSET final rule RIA also estimates there will be an additional 160 rulemakings assessed to have a significant impact on a substantial number of small entities that have not previously been identified as having a significant economic impact. The Department will need to perform a review of these rulemakings under the SUNSET final rule. The SUNSET final rule provides for an initial five-year period for the Department to address regulations older than ten years. We maintain the assumption in the SUNSET final rule RIA that assessments and reviews required in the first five years will be completed evenly across this time period, and that the remaining assessments and reviews will be completed evenly across the next five- year time period. Of the 3,574 total assessments anticipated under the SUNSET final rule, 3,415 would occur during the first five-year period, an\n\naverage of 683.0 assessments per year; while 159 assessments would occur during the second five-year period, an average of 31.8 assessments per year. Of the total reviews anticipated under the SUNSET final rule, 506 would occur during the first five-year period, an average of 101.2 reviews per year; while 24 assessments would occur during the second five-year period, an average of 4.8 reviews per year. Table D1 presents yearly counts of assessments and reviews anticipated under the baseline scenario. These figures are broadly consistent with the figures contained in the SUNSET final rule RIA; however, unlike that analysis, we do not reduce the number of assessments under the SUNSET final rule by the number of reviews performed, since these assessments occur first and serve to identify those regulations requiring review.\n\nTABLE D1—BASELINE ASSESSMENTS AND REVIEWS UNDER THE SUNSET FINAL RULE\n\nYear Total assessments Reviews\n\nPre-RFA Post-RFA Not specified Total\n\n2022 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2023 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2024 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2025 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2026 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2027 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2028 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2029 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2030 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2031 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\nTotal .............................................................................. 3574.0 44.0 326.0 160.0 530.0\n\nTime per Assessment and per Review The SUNSET final rule RIA contains estimates of the time per assessment and time per review performed under the SUNSET final rule. For each assessment, the SUNSET final rule RIA assumes that it will require between 3 and 10 hours to assess a rulemaking. For each review, the SUNSET RIA assumes that it will require between 250 and 500 hours to review rulemakings that predate the RFA, and between 40 and 100 hours to review rulemakings that postdate the RFA. For the 160 rulemakings newly found to have a significant impact, the SUNSET RIA assumes that it will take between 40 and 100 hours to complete a review. The Department now concludes the SUNSET RIA likely underestimates the time necessary to credibly assess whether a regulation imposes a significant economic impact on a substantial number of small entities by\n\na significant degree. The Small Business Administration (SBA) Office of Advocacy published ‘‘A Guide for Government Agencies: How to Comply with The Regulatory Flexibility Act,’’ detailing a step-by-step approach for analysts. ⁶⁸ For each of the 3,574 rulemakings requiring an assessment under the SUNSET final rule, the Department will need to define the problem and describe the regulated entities, estimate economic impacts by size categories, and determine which size categories incur significant impacts. The SBA guide presents a two-page checklist containing the elements of an adequate certification. In practice, when performing a threshold analysis, analysts will face novel conceptual issues and data challenges, both of which require thoughtful consideration\n\nand professional judgement. The SUNSET final rule also requires HHS to open a docket and review public comments on each rulemaking being assessed. Furthermore, SBA indicates that it is not sufficient to rely on an assessment made at the time a regulation was published:\n\nIn some cases, even if an agency was originally able to certify properly under section 605 of the RFA that a rule would not have a significant economic impact on a substantial number of small entities, changed conditions may mean that the rule now does have a significant impact and therefore should be reviewed under section 610. For example, many more small businesses may be subject to the rule now than when the rule was promulgated. The cost of compliance with a current rule may have increased sharply because of a required new technology. (SBA, pp. 80–81) We assume that, under the baseline scenario of the SUNSET final rule, the Department will follow the\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00037 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**32281 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n68 Available at _https://cdn.advocacy.sba.gov/wp- content/uploads/2019/06/21110349/How-to- Comply-with-the-RFA.pdf._\n\nassessments. The SUNSET final rule RIA assumes that 11% of these assessments, or 396, are for regulations previously determined to have a significant economic impact on a substantial number of small entities, but reduces this figure to 370 to account for rulemakings that are likely to be reviewed for reasons other than the SUNSET final rule. This adjustment similarly reduces the estimate of the number of rulemakings impacted by the SUNSET final rule to 3,574 [=3600¥(396–370)]. For each of these 370 rulemakings, the Department will need to perform a review, which includes a retrospective regulatory flexibility analysis. The SUNSET final rule RIA distinguishes between the 44 rulemakings that predate the RFA and are unlikely to have an existing prospective regulatory flexibility analysis, and the remaining 326 rulemakings that are assumed to have an existing prospective analysis.\n\nThe SUNSET final rule RIA also estimates there will be an additional 160 rulemakings assessed to have a significant impact on a substantial number of small entities that have not previously been identified as having a significant economic impact. The Department will need to perform a review of these rulemakings under the SUNSET final rule. The SUNSET final rule provides for an initial five-year period for the Department to address regulations older than ten years. We maintain the assumption in the SUNSET final rule RIA that assessments and reviews required in the first five years will be completed evenly across this time period, and that the remaining assessments and reviews will be completed evenly across the next five- year time period. Of the 3,574 total assessments anticipated under the SUNSET final rule, 3,415 would occur during the first five-year period, an\n\naverage of 683.0 assessments per year; while 159 assessments would occur during the second five-year period, an average of 31.8 assessments per year. Of the total reviews anticipated under the SUNSET final rule, 506 would occur during the first five-year period, an average of 101.2 reviews per year; while 24 assessments would occur during the second five-year period, an average of 4.8 reviews per year. Table D1 presents yearly counts of assessments and reviews anticipated under the baseline scenario. These figures are broadly consistent with the figures contained in the SUNSET final rule RIA; however, unlike that analysis, we do not reduce the number of assessments under the SUNSET final rule by the number of reviews performed, since these assessments occur first and serve to identify those regulations requiring review.\n\nTABLE D1—BASELINE ASSESSMENTS AND REVIEWS UNDER THE SUNSET FINAL RULE\n\nYear Total assessments Reviews\n\nPre-RFA Post-RFA Not specified Total\n\n2022 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2023 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2024 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2025 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2026 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2027 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2028 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2029 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2030 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2031 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\nTotal .............................................................................. 3574.0 44.0 326.0 160.0 530.0\n\nTime per Assessment and per Review The SUNSET final rule RIA contains estimates of the time per assessment and time per review performed under the SUNSET final rule. For each assessment, the SUNSET final rule RIA assumes that it will require between 3 and 10 hours to assess a rulemaking. For each review, the SUNSET RIA assumes that it will require between 250 and 500 hours to review rulemakings that predate the RFA, and between 40 and 100 hours to review rulemakings that postdate the RFA. For the 160 rulemakings newly found to have a significant impact, the SUNSET RIA assumes that it will take between 40 and 100 hours to complete a review. The Department now concludes the SUNSET RIA likely underestimates the time necessary to credibly assess whether a regulation imposes a significant economic impact on a substantial number of small entities by\n\na significant degree. The Small Business Administration (SBA) Office of Advocacy published ‘‘A Guide for Government Agencies: How to Comply with The Regulatory Flexibility Act,’’ detailing a step-by-step approach for analysts. ⁶⁸ For each of the 3,574 rulemakings requiring an assessment under the SUNSET final rule, the Department will need to define the problem and describe the regulated entities, estimate economic impacts by size categories, and determine which size categories incur significant impacts. The SBA guide presents a two-page checklist containing the elements of an adequate certification. In practice, when performing a threshold analysis, analysts will face novel conceptual issues and data challenges, both of which require thoughtful consideration\n\nand professional judgement. The SUNSET final rule also requires HHS to open a docket and review public comments on each rulemaking being assessed. Furthermore, SBA indicates that it is not sufficient to rely on an assessment made at the time a regulation was published:\n\nIn some cases, even if an agency was originally able to certify properly under section 605 of the RFA that a rule would not have a significant economic impact on a substantial number of small entities, changed conditions may mean that the rule now does have a significant impact and therefore should be reviewed under section 610. For example, many more small businesses may be subject to the rule now than when the rule was promulgated. The cost of compliance with a current rule may have increased sharply because of a required new technology. (SBA, pp. 80–81) We assume that, under the baseline scenario of the SUNSET final rule, the Department will follow the\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00037 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page36.pdf"]},"response":{"errors":[],"extract_id":"extract_e11dad259863cf8dd312726fda6867e5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**32281 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n68 Available at _https://cdn.advocacy.sba.gov/wp- content/uploads/2019/06/21110349/How-to- Comply-with-the-RFA.pdf._\n\nassessments. The SUNSET final rule RIA assumes that 11% of these assessments, or 396, are for regulations previously determined to have a significant economic impact on a substantial number of small entities, but reduces this figure to 370 to account for rulemakings that are likely to be reviewed for reasons other than the SUNSET final rule. This adjustment similarly reduces the estimate of the number of rulemakings impacted by the SUNSET final rule to 3,574 [=3600¥(396–370)]. For each of these 370 rulemakings, the Department will need to perform a review, which includes a retrospective regulatory flexibility analysis. The SUNSET final rule RIA distinguishes between the 44 rulemakings that predate the RFA and are unlikely to have an existing prospective regulatory flexibility analysis, and the remaining 326 rulemakings that are assumed to have an existing prospective analysis.\n\nThe SUNSET final rule RIA also estimates there will be an additional 160 rulemakings assessed to have a significant impact on a substantial number of small entities that have not previously been identified as having a significant economic impact. The Department will need to perform a review of these rulemakings under the SUNSET final rule. The SUNSET final rule provides for an initial five-year period for the Department to address regulations older than ten years. We maintain the assumption in the SUNSET final rule RIA that assessments and reviews required in the first five years will be completed evenly across this time period, and that the remaining assessments and reviews will be completed evenly across the next five- year time period. Of the 3,574 total assessments anticipated under the SUNSET final rule, 3,415 would occur during the first five-year period, an\n\naverage of 683.0 assessments per year; while 159 assessments would occur during the second five-year period, an average of 31.8 assessments per year. Of the total reviews anticipated under the SUNSET final rule, 506 would occur during the first five-year period, an average of 101.2 reviews per year; while 24 assessments would occur during the second five-year period, an average of 4.8 reviews per year. Table D1 presents yearly counts of assessments and reviews anticipated under the baseline scenario. These figures are broadly consistent with the figures contained in the SUNSET final rule RIA; however, unlike that analysis, we do not reduce the number of assessments under the SUNSET final rule by the number of reviews performed, since these assessments occur first and serve to identify those regulations requiring review.\n\nTABLE D1—BASELINE ASSESSMENTS AND REVIEWS UNDER THE SUNSET FINAL RULE\n\nYear Total assessments Reviews\n\nPre-RFA Post-RFA Not specified Total\n\n2022 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2023 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2024 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2025 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2026 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2027 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2028 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2029 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2030 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2031 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\nTotal .............................................................................. 3574.0 44.0 326.0 160.0 530.0\n\nTime per Assessment and per Review The SUNSET final rule RIA contains estimates of the time per assessment and time per review performed under the SUNSET final rule. For each assessment, the SUNSET final rule RIA assumes that it will require between 3 and 10 hours to assess a rulemaking. For each review, the SUNSET RIA assumes that it will require between 250 and 500 hours to review rulemakings that predate the RFA, and between 40 and 100 hours to review rulemakings that postdate the RFA. For the 160 rulemakings newly found to have a significant impact, the SUNSET RIA assumes that it will take between 40 and 100 hours to complete a review. The Department now concludes the SUNSET RIA likely underestimates the time necessary to credibly assess whether a regulation imposes a significant economic impact on a substantial number of small entities by\n\na significant degree. The Small Business Administration (SBA) Office of Advocacy published ‘‘A Guide for Government Agencies: How to Comply with The Regulatory Flexibility Act,’’ detailing a step-by-step approach for analysts. ⁶⁸ For each of the 3,574 rulemakings requiring an assessment under the SUNSET final rule, the Department will need to define the problem and describe the regulated entities, estimate economic impacts by size categories, and determine which size categories incur significant impacts. The SBA guide presents a two-page checklist containing the elements of an adequate certification. In practice, when performing a threshold analysis, analysts will face novel conceptual issues and data challenges, both of which require thoughtful consideration\n\nand professional judgement. The SUNSET final rule also requires HHS to open a docket and review public comments on each rulemaking being assessed. Furthermore, SBA indicates that it is not sufficient to rely on an assessment made at the time a regulation was published:\n\nIn some cases, even if an agency was originally able to certify properly under section 605 of the RFA that a rule would not have a significant economic impact on a substantial number of small entities, changed conditions may mean that the rule now does have a significant impact and therefore should be reviewed under section 610. For example, many more small businesses may be subject to the rule now than when the rule was promulgated. The cost of compliance with a current rule may have increased sharply because of a required new technology. (SBA, pp. 80–81) We assume that, under the baseline scenario of the SUNSET final rule, the Department will follow the\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00037 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2"],"full_content":"**32281 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n68 Available at _https://cdn.advocacy.sba.gov/wp- content/uploads/2019/06/21110349/How-to- Comply-with-the-RFA.pdf._\n\nassessments. The SUNSET final rule RIA assumes that 11% of these assessments, or 396, are for regulations previously determined to have a significant economic impact on a substantial number of small entities, but reduces this figure to 370 to account for rulemakings that are likely to be reviewed for reasons other than the SUNSET final rule. This adjustment similarly reduces the estimate of the number of rulemakings impacted by the SUNSET final rule to 3,574 [=3600¥(396–370)]. For each of these 370 rulemakings, the Department will need to perform a review, which includes a retrospective regulatory flexibility analysis. The SUNSET final rule RIA distinguishes between the 44 rulemakings that predate the RFA and are unlikely to have an existing prospective regulatory flexibility analysis, and the remaining 326 rulemakings that are assumed to have an existing prospective analysis.\n\nThe SUNSET final rule RIA also estimates there will be an additional 160 rulemakings assessed to have a significant impact on a substantial number of small entities that have not previously been identified as having a significant economic impact. The Department will need to perform a review of these rulemakings under the SUNSET final rule. The SUNSET final rule provides for an initial five-year period for the Department to address regulations older than ten years. We maintain the assumption in the SUNSET final rule RIA that assessments and reviews required in the first five years will be completed evenly across this time period, and that the remaining assessments and reviews will be completed evenly across the next five- year time period. Of the 3,574 total assessments anticipated under the SUNSET final rule, 3,415 would occur during the first five-year period, an\n\naverage of 683.0 assessments per year; while 159 assessments would occur during the second five-year period, an average of 31.8 assessments per year. Of the total reviews anticipated under the SUNSET final rule, 506 would occur during the first five-year period, an average of 101.2 reviews per year; while 24 assessments would occur during the second five-year period, an average of 4.8 reviews per year. Table D1 presents yearly counts of assessments and reviews anticipated under the baseline scenario. These figures are broadly consistent with the figures contained in the SUNSET final rule RIA; however, unlike that analysis, we do not reduce the number of assessments under the SUNSET final rule by the number of reviews performed, since these assessments occur first and serve to identify those regulations requiring review.\n\nTABLE D1—BASELINE ASSESSMENTS AND REVIEWS UNDER THE SUNSET FINAL RULE\n\nYear Total assessments Reviews\n\nPre-RFA Post-RFA Not specified Total\n\n2022 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2023 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2024 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2025 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2026 ..................................................................................... 683.0 8.8 61.8 30.6 101.2\n\n2027 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2028 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2029 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2030 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\n2031 ..................................................................................... 31.8 0.0 3.4 1.4 4.8\n\nTotal .............................................................................. 3574.0 44.0 326.0 160.0 530.0\n\nTime per Assessment and per Review The SUNSET final rule RIA contains estimates of the time per assessment and time per review performed under the SUNSET final rule. For each assessment, the SUNSET final rule RIA assumes that it will require between 3 and 10 hours to assess a rulemaking. For each review, the SUNSET RIA assumes that it will require between 250 and 500 hours to review rulemakings that predate the RFA, and between 40 and 100 hours to review rulemakings that postdate the RFA. For the 160 rulemakings newly found to have a significant impact, the SUNSET RIA assumes that it will take between 40 and 100 hours to complete a review. The Department now concludes the SUNSET RIA likely underestimates the time necessary to credibly assess whether a regulation imposes a significant economic impact on a substantial number of small entities by\n\na significant degree. The Small Business Administration (SBA) Office of Advocacy published ‘‘A Guide for Government Agencies: How to Comply with The Regulatory Flexibility Act,’’ detailing a step-by-step approach for analysts. ⁶⁸ For each of the 3,574 rulemakings requiring an assessment under the SUNSET final rule, the Department will need to define the problem and describe the regulated entities, estimate economic impacts by size categories, and determine which size categories incur significant impacts. The SBA guide presents a two-page checklist containing the elements of an adequate certification. In practice, when performing a threshold analysis, analysts will face novel conceptual issues and data challenges, both of which require thoughtful consideration\n\nand professional judgement. The SUNSET final rule also requires HHS to open a docket and review public comments on each rulemaking being assessed. Furthermore, SBA indicates that it is not sufficient to rely on an assessment made at the time a regulation was published:\n\nIn some cases, even if an agency was originally able to certify properly under section 605 of the RFA that a rule would not have a significant economic impact on a substantial number of small entities, changed conditions may mean that the rule now does have a significant impact and therefore should be reviewed under section 610. For example, many more small businesses may be subject to the rule now than when the rule was promulgated. The cost of compliance with a current rule may have increased sharply because of a required new technology. (SBA, pp. 80–81) We assume that, under the baseline scenario of the SUNSET final rule, the Department will follow the\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00037 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","publish_date":null,"title":"32281","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page36.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page36.pdf"},"request":{"example_id":"table/1653739079_page36","product_type":"parse","source_file_path":"1653739079_page36.pdf"},"started_at":"2026-11-04T19:48:07.192885"} +{"completed_at":"2026-11-04T19:48:10.463341","latency_in_ms":2591,"output":{"example_id":"table/1653739079_page37","grounded_pages":[],"layout_pages":[],"markdown":"**32282 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nrecommendations in the SBA guidance, and will perform a credible threshold analysis for each rulemaking to assess whether it imposes a significant economic impact on a substantial number of small entities. Each assessment will likely require time by an economist or other analyst to perform and document the threshold analysis, with input from at least one subject matter expert on the area of the regulation. Recognizing the need to fully respond to all the requirements, we modify the assumption in the SUNSET final rule RIA and adopt an estimate of 40 to 100 hours to complete a credible threshold analysis for each rulemaking requiring an assessment. As described earlier, the SUNSET final rule RIA contains two estimates for the time necessary to perform a retrospective analysis as part of a review. For rulemakings published before the RFA was enacted, the SUNSET final rule RIA assumes between 250 and 500 hours per review. For rulemakings published after the RFA was enacted, the SUNSET final rule RIA assumes that a prospective regulatory flexibility analysis is available and further assumes that this will reduce the time necessary to complete a review, adopting a range of 40 and 100 hours per review. For the 160 rulemakings newly found to have a significant impact, the SUNSET RIA assumes that it will take between 40 and 100 hours to complete a review. The Sensitivity Analysis Section of the SUNSET final rule RIA acknowledges that ‘‘[o]ne commenter noted that conducting a retrospective analysis can\n\nbe as time-consuming and expensive as a prospective regulatory analysis, suggesting the Department’s estimates of the time and expense of Reviews may be understated.’’ Upon further consideration, the Department agrees that the commenter is likely correct. For the analysis of this final withdrawal rule, we adopt the SUNSET final rule RIA estimate of 250 to 500 hours for all retrospective analyses performed as part of a review, regardless of when the underlying rulemaking was published, and regardless of whether the rulemaking was previously found to have a significant impact on a substantial number of small entities. If previously published prospective or retrospective regulatory flexibility analyses are generally available, analysts may be able to build off of these previous analytic efforts when developing a retrospective analysis under the SUNSET final rule. All else equal, this would suggest the average time per retrospective analysis may be closer to the lower-bound estimate of 250 hours. If these analyses are not generally available, this would suggest an average time per retrospective analysis closer to the upper-bound estimate of 500 hours. We do not address the assumption in the SUNSET final rule RIA that a prospective regulatory flexibility analysis is available for every rulemaking published after the RFA was enacted, because it does not impact the estimate of the overall time spent on reviews under the baseline scenario. Our approach also allows us to ignore the apparent internal inconsistency in the\n\nSUNSET final rule RIA underlying the time per review of the 160 rulemakings that are newly assessed to have a significant impact. The SUNSET final rule RIA is not clear on what activities are included in its estimates of the time per review other than the time spent developing a retrospective analysis. We interpret the magnitudes of these estimates to exclude consideration of time spent on activities other than drafting the retrospective analysis. For example, the Department may need to conduct a study or survey to gather data to inform its analyses. We therefore include an additional 250 hours to 500 hours per review to account for this omission. This estimate reflects time spent by Department subject matter experts, lawyers, and other reviewers informing the retrospective analysis and providing feedback on draft analyses. It also reflects time spent by economists and other analysts developing the retrospective analysis to respond to this feedback, and time spent reading and incorporating evidence from other sources, including public comments. Table D2 summarizes the assumptions in the SUNSET final rule RIA and our revised assumptions for the final withdrawal rule of the time per assessment and time per review performed under the baseline scenario of the SUNSET final rule. Combining the time spent on retrospective analysis and on other related activities, we estimate that each review will take between 500 and 1,000 hours to complete.\n\nTABLE D2—HOURS PER ASSESSMENT AND REVIEW\n\nBaseline requirement SUNSET final rule RIA Final withdrawal rule\n\nLow High Low High\n\nAssessment ..................................................................................................... 3 10 40 100\n\nReview: Retrospective Analysis, pre-RFA regulation ...................................... 250 500 250 500\n\nReview: Retrospective Analysis, post-RFA regulation .................................... 40 100 250 500\n\nReview: Retrospective Analysis, Not Specified ............................................... 40 100 250 500\n\nReview: Other Activities ................................................................................... 0 0 250 500\n\nTime Spent by the Public To Monitor and Comment\n\nUnder the SUNSET final rule, the Department would create a docket on _www.Regulations.gov_ for each assessment or review that the Department is conducting. The public would then be able to submit comments to the dockets of each rulemaking being assessed or reviewed. The SUNSET final rule RIA includes a discussion of the costs to the stakeholders to monitor and comment on regulations as these are\n\nundergoing assessment and review; however, the analysis assigns no costs to the Department associated with setting up these dockets or engaging with the comments. The analysis also does not monetize any other costs associated with operationalization of the SUNSET final rule, which also requires developing a schedule for activities associated with the SUNSET final rule, publishing monthly updates on the commencement of assessments and reviews, publishing the results of\n\nassessments and review (‘‘including the full underlying analyses and data used to support the results’’) once a year, and establishing a website dashboard to help the public monitor the Department’s progress. When estimating the impact on the public, the SUNSET final rule RIA assumes the public will wait until the assessments and reviews are complete and the Department has announced it intends to rescind or amend a rulemaking before commenting. Thus,\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00038 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","pages":[{"line_numbers":[],"markdown":"**32282 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nrecommendations in the SBA guidance, and will perform a credible threshold analysis for each rulemaking to assess whether it imposes a significant economic impact on a substantial number of small entities. Each assessment will likely require time by an economist or other analyst to perform and document the threshold analysis, with input from at least one subject matter expert on the area of the regulation. Recognizing the need to fully respond to all the requirements, we modify the assumption in the SUNSET final rule RIA and adopt an estimate of 40 to 100 hours to complete a credible threshold analysis for each rulemaking requiring an assessment. As described earlier, the SUNSET final rule RIA contains two estimates for the time necessary to perform a retrospective analysis as part of a review. For rulemakings published before the RFA was enacted, the SUNSET final rule RIA assumes between 250 and 500 hours per review. For rulemakings published after the RFA was enacted, the SUNSET final rule RIA assumes that a prospective regulatory flexibility analysis is available and further assumes that this will reduce the time necessary to complete a review, adopting a range of 40 and 100 hours per review. For the 160 rulemakings newly found to have a significant impact, the SUNSET RIA assumes that it will take between 40 and 100 hours to complete a review. The Sensitivity Analysis Section of the SUNSET final rule RIA acknowledges that ‘‘[o]ne commenter noted that conducting a retrospective analysis can\n\nbe as time-consuming and expensive as a prospective regulatory analysis, suggesting the Department’s estimates of the time and expense of Reviews may be understated.’’ Upon further consideration, the Department agrees that the commenter is likely correct. For the analysis of this final withdrawal rule, we adopt the SUNSET final rule RIA estimate of 250 to 500 hours for all retrospective analyses performed as part of a review, regardless of when the underlying rulemaking was published, and regardless of whether the rulemaking was previously found to have a significant impact on a substantial number of small entities. If previously published prospective or retrospective regulatory flexibility analyses are generally available, analysts may be able to build off of these previous analytic efforts when developing a retrospective analysis under the SUNSET final rule. All else equal, this would suggest the average time per retrospective analysis may be closer to the lower-bound estimate of 250 hours. If these analyses are not generally available, this would suggest an average time per retrospective analysis closer to the upper-bound estimate of 500 hours. We do not address the assumption in the SUNSET final rule RIA that a prospective regulatory flexibility analysis is available for every rulemaking published after the RFA was enacted, because it does not impact the estimate of the overall time spent on reviews under the baseline scenario. Our approach also allows us to ignore the apparent internal inconsistency in the\n\nSUNSET final rule RIA underlying the time per review of the 160 rulemakings that are newly assessed to have a significant impact. The SUNSET final rule RIA is not clear on what activities are included in its estimates of the time per review other than the time spent developing a retrospective analysis. We interpret the magnitudes of these estimates to exclude consideration of time spent on activities other than drafting the retrospective analysis. For example, the Department may need to conduct a study or survey to gather data to inform its analyses. We therefore include an additional 250 hours to 500 hours per review to account for this omission. This estimate reflects time spent by Department subject matter experts, lawyers, and other reviewers informing the retrospective analysis and providing feedback on draft analyses. It also reflects time spent by economists and other analysts developing the retrospective analysis to respond to this feedback, and time spent reading and incorporating evidence from other sources, including public comments. Table D2 summarizes the assumptions in the SUNSET final rule RIA and our revised assumptions for the final withdrawal rule of the time per assessment and time per review performed under the baseline scenario of the SUNSET final rule. Combining the time spent on retrospective analysis and on other related activities, we estimate that each review will take between 500 and 1,000 hours to complete.\n\nTABLE D2—HOURS PER ASSESSMENT AND REVIEW\n\nBaseline requirement SUNSET final rule RIA Final withdrawal rule\n\nLow High Low High\n\nAssessment ..................................................................................................... 3 10 40 100\n\nReview: Retrospective Analysis, pre-RFA regulation ...................................... 250 500 250 500\n\nReview: Retrospective Analysis, post-RFA regulation .................................... 40 100 250 500\n\nReview: Retrospective Analysis, Not Specified ............................................... 40 100 250 500\n\nReview: Other Activities ................................................................................... 0 0 250 500\n\nTime Spent by the Public To Monitor and Comment\n\nUnder the SUNSET final rule, the Department would create a docket on _www.Regulations.gov_ for each assessment or review that the Department is conducting. The public would then be able to submit comments to the dockets of each rulemaking being assessed or reviewed. The SUNSET final rule RIA includes a discussion of the costs to the stakeholders to monitor and comment on regulations as these are\n\nundergoing assessment and review; however, the analysis assigns no costs to the Department associated with setting up these dockets or engaging with the comments. The analysis also does not monetize any other costs associated with operationalization of the SUNSET final rule, which also requires developing a schedule for activities associated with the SUNSET final rule, publishing monthly updates on the commencement of assessments and reviews, publishing the results of\n\nassessments and review (‘‘including the full underlying analyses and data used to support the results’’) once a year, and establishing a website dashboard to help the public monitor the Department’s progress. When estimating the impact on the public, the SUNSET final rule RIA assumes the public will wait until the assessments and reviews are complete and the Department has announced it intends to rescind or amend a rulemaking before commenting. Thus,\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00038 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**32282 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nrecommendations in the SBA guidance, and will perform a credible threshold analysis for each rulemaking to assess whether it imposes a significant economic impact on a substantial number of small entities. Each assessment will likely require time by an economist or other analyst to perform and document the threshold analysis, with input from at least one subject matter expert on the area of the regulation. Recognizing the need to fully respond to all the requirements, we modify the assumption in the SUNSET final rule RIA and adopt an estimate of 40 to 100 hours to complete a credible threshold analysis for each rulemaking requiring an assessment. As described earlier, the SUNSET final rule RIA contains two estimates for the time necessary to perform a retrospective analysis as part of a review. For rulemakings published before the RFA was enacted, the SUNSET final rule RIA assumes between 250 and 500 hours per review. For rulemakings published after the RFA was enacted, the SUNSET final rule RIA assumes that a prospective regulatory flexibility analysis is available and further assumes that this will reduce the time necessary to complete a review, adopting a range of 40 and 100 hours per review. For the 160 rulemakings newly found to have a significant impact, the SUNSET RIA assumes that it will take between 40 and 100 hours to complete a review. The Sensitivity Analysis Section of the SUNSET final rule RIA acknowledges that ‘‘[o]ne commenter noted that conducting a retrospective analysis can\n\nbe as time-consuming and expensive as a prospective regulatory analysis, suggesting the Department’s estimates of the time and expense of Reviews may be understated.’’ Upon further consideration, the Department agrees that the commenter is likely correct. For the analysis of this final withdrawal rule, we adopt the SUNSET final rule RIA estimate of 250 to 500 hours for all retrospective analyses performed as part of a review, regardless of when the underlying rulemaking was published, and regardless of whether the rulemaking was previously found to have a significant impact on a substantial number of small entities. If previously published prospective or retrospective regulatory flexibility analyses are generally available, analysts may be able to build off of these previous analytic efforts when developing a retrospective analysis under the SUNSET final rule. All else equal, this would suggest the average time per retrospective analysis may be closer to the lower-bound estimate of 250 hours. If these analyses are not generally available, this would suggest an average time per retrospective analysis closer to the upper-bound estimate of 500 hours. We do not address the assumption in the SUNSET final rule RIA that a prospective regulatory flexibility analysis is available for every rulemaking published after the RFA was enacted, because it does not impact the estimate of the overall time spent on reviews under the baseline scenario. Our approach also allows us to ignore the apparent internal inconsistency in the\n\nSUNSET final rule RIA underlying the time per review of the 160 rulemakings that are newly assessed to have a significant impact. The SUNSET final rule RIA is not clear on what activities are included in its estimates of the time per review other than the time spent developing a retrospective analysis. We interpret the magnitudes of these estimates to exclude consideration of time spent on activities other than drafting the retrospective analysis. For example, the Department may need to conduct a study or survey to gather data to inform its analyses. We therefore include an additional 250 hours to 500 hours per review to account for this omission. This estimate reflects time spent by Department subject matter experts, lawyers, and other reviewers informing the retrospective analysis and providing feedback on draft analyses. It also reflects time spent by economists and other analysts developing the retrospective analysis to respond to this feedback, and time spent reading and incorporating evidence from other sources, including public comments. Table D2 summarizes the assumptions in the SUNSET final rule RIA and our revised assumptions for the final withdrawal rule of the time per assessment and time per review performed under the baseline scenario of the SUNSET final rule. Combining the time spent on retrospective analysis and on other related activities, we estimate that each review will take between 500 and 1,000 hours to complete.\n\nTABLE D2—HOURS PER ASSESSMENT AND REVIEW\n\nBaseline requirement SUNSET final rule RIA Final withdrawal rule\n\nLow High Low High\n\nAssessment ..................................................................................................... 3 10 40 100\n\nReview: Retrospective Analysis, pre-RFA regulation ...................................... 250 500 250 500\n\nReview: Retrospective Analysis, post-RFA regulation .................................... 40 100 250 500\n\nReview: Retrospective Analysis, Not Specified ............................................... 40 100 250 500\n\nReview: Other Activities ................................................................................... 0 0 250 500\n\nTime Spent by the Public To Monitor and Comment\n\nUnder the SUNSET final rule, the Department would create a docket on _www.Regulations.gov_ for each assessment or review that the Department is conducting. The public would then be able to submit comments to the dockets of each rulemaking being assessed or reviewed. The SUNSET final rule RIA includes a discussion of the costs to the stakeholders to monitor and comment on regulations as these are\n\nundergoing assessment and review; however, the analysis assigns no costs to the Department associated with setting up these dockets or engaging with the comments. The analysis also does not monetize any other costs associated with operationalization of the SUNSET final rule, which also requires developing a schedule for activities associated with the SUNSET final rule, publishing monthly updates on the commencement of assessments and reviews, publishing the results of\n\nassessments and review (‘‘including the full underlying analyses and data used to support the results’’) once a year, and establishing a website dashboard to help the public monitor the Department’s progress. When estimating the impact on the public, the SUNSET final rule RIA assumes the public will wait until the assessments and reviews are complete and the Department has announced it intends to rescind or amend a rulemaking before commenting. Thus,\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00038 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page37.pdf"]},"response":{"errors":[],"extract_id":"extract_0926c30c30be9da615a3ea5217f2bd0c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**32282 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nrecommendations in the SBA guidance, and will perform a credible threshold analysis for each rulemaking to assess whether it imposes a significant economic impact on a substantial number of small entities. Each assessment will likely require time by an economist or other analyst to perform and document the threshold analysis, with input from at least one subject matter expert on the area of the regulation. Recognizing the need to fully respond to all the requirements, we modify the assumption in the SUNSET final rule RIA and adopt an estimate of 40 to 100 hours to complete a credible threshold analysis for each rulemaking requiring an assessment. As described earlier, the SUNSET final rule RIA contains two estimates for the time necessary to perform a retrospective analysis as part of a review. For rulemakings published before the RFA was enacted, the SUNSET final rule RIA assumes between 250 and 500 hours per review. For rulemakings published after the RFA was enacted, the SUNSET final rule RIA assumes that a prospective regulatory flexibility analysis is available and further assumes that this will reduce the time necessary to complete a review, adopting a range of 40 and 100 hours per review. For the 160 rulemakings newly found to have a significant impact, the SUNSET RIA assumes that it will take between 40 and 100 hours to complete a review. The Sensitivity Analysis Section of the SUNSET final rule RIA acknowledges that ‘‘[o]ne commenter noted that conducting a retrospective analysis can\n\nbe as time-consuming and expensive as a prospective regulatory analysis, suggesting the Department’s estimates of the time and expense of Reviews may be understated.’’ Upon further consideration, the Department agrees that the commenter is likely correct. For the analysis of this final withdrawal rule, we adopt the SUNSET final rule RIA estimate of 250 to 500 hours for all retrospective analyses performed as part of a review, regardless of when the underlying rulemaking was published, and regardless of whether the rulemaking was previously found to have a significant impact on a substantial number of small entities. If previously published prospective or retrospective regulatory flexibility analyses are generally available, analysts may be able to build off of these previous analytic efforts when developing a retrospective analysis under the SUNSET final rule. All else equal, this would suggest the average time per retrospective analysis may be closer to the lower-bound estimate of 250 hours. If these analyses are not generally available, this would suggest an average time per retrospective analysis closer to the upper-bound estimate of 500 hours. We do not address the assumption in the SUNSET final rule RIA that a prospective regulatory flexibility analysis is available for every rulemaking published after the RFA was enacted, because it does not impact the estimate of the overall time spent on reviews under the baseline scenario. Our approach also allows us to ignore the apparent internal inconsistency in the\n\nSUNSET final rule RIA underlying the time per review of the 160 rulemakings that are newly assessed to have a significant impact. The SUNSET final rule RIA is not clear on what activities are included in its estimates of the time per review other than the time spent developing a retrospective analysis. We interpret the magnitudes of these estimates to exclude consideration of time spent on activities other than drafting the retrospective analysis. For example, the Department may need to conduct a study or survey to gather data to inform its analyses. We therefore include an additional 250 hours to 500 hours per review to account for this omission. This estimate reflects time spent by Department subject matter experts, lawyers, and other reviewers informing the retrospective analysis and providing feedback on draft analyses. It also reflects time spent by economists and other analysts developing the retrospective analysis to respond to this feedback, and time spent reading and incorporating evidence from other sources, including public comments. Table D2 summarizes the assumptions in the SUNSET final rule RIA and our revised assumptions for the final withdrawal rule of the time per assessment and time per review performed under the baseline scenario of the SUNSET final rule. Combining the time spent on retrospective analysis and on other related activities, we estimate that each review will take between 500 and 1,000 hours to complete.\n\nTABLE D2—HOURS PER ASSESSMENT AND REVIEW\n\nBaseline requirement SUNSET final rule RIA Final withdrawal rule\n\nLow High Low High\n\nAssessment ..................................................................................................... 3 10 40 100\n\nReview: Retrospective Analysis, pre-RFA regulation ...................................... 250 500 250 500\n\nReview: Retrospective Analysis, post-RFA regulation .................................... 40 100 250 500\n\nReview: Retrospective Analysis, Not Specified ............................................... 40 100 250 500\n\nReview: Other Activities ................................................................................... 0 0 250 500\n\nTime Spent by the Public To Monitor and Comment\n\nUnder the SUNSET final rule, the Department would create a docket on _www.Regulations.gov_ for each assessment or review that the Department is conducting. The public would then be able to submit comments to the dockets of each rulemaking being assessed or reviewed. The SUNSET final rule RIA includes a discussion of the costs to the stakeholders to monitor and comment on regulations as these are\n\nundergoing assessment and review; however, the analysis assigns no costs to the Department associated with setting up these dockets or engaging with the comments. The analysis also does not monetize any other costs associated with operationalization of the SUNSET final rule, which also requires developing a schedule for activities associated with the SUNSET final rule, publishing monthly updates on the commencement of assessments and reviews, publishing the results of\n\nassessments and review (‘‘including the full underlying analyses and data used to support the results’’) once a year, and establishing a website dashboard to help the public monitor the Department’s progress. When estimating the impact on the public, the SUNSET final rule RIA assumes the public will wait until the assessments and reviews are complete and the Department has announced it intends to rescind or amend a rulemaking before commenting. Thus,\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00038 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2"],"full_content":"**32282 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nrecommendations in the SBA guidance, and will perform a credible threshold analysis for each rulemaking to assess whether it imposes a significant economic impact on a substantial number of small entities. Each assessment will likely require time by an economist or other analyst to perform and document the threshold analysis, with input from at least one subject matter expert on the area of the regulation. Recognizing the need to fully respond to all the requirements, we modify the assumption in the SUNSET final rule RIA and adopt an estimate of 40 to 100 hours to complete a credible threshold analysis for each rulemaking requiring an assessment. As described earlier, the SUNSET final rule RIA contains two estimates for the time necessary to perform a retrospective analysis as part of a review. For rulemakings published before the RFA was enacted, the SUNSET final rule RIA assumes between 250 and 500 hours per review. For rulemakings published after the RFA was enacted, the SUNSET final rule RIA assumes that a prospective regulatory flexibility analysis is available and further assumes that this will reduce the time necessary to complete a review, adopting a range of 40 and 100 hours per review. For the 160 rulemakings newly found to have a significant impact, the SUNSET RIA assumes that it will take between 40 and 100 hours to complete a review. The Sensitivity Analysis Section of the SUNSET final rule RIA acknowledges that ‘‘[o]ne commenter noted that conducting a retrospective analysis can\n\nbe as time-consuming and expensive as a prospective regulatory analysis, suggesting the Department’s estimates of the time and expense of Reviews may be understated.’’ Upon further consideration, the Department agrees that the commenter is likely correct. For the analysis of this final withdrawal rule, we adopt the SUNSET final rule RIA estimate of 250 to 500 hours for all retrospective analyses performed as part of a review, regardless of when the underlying rulemaking was published, and regardless of whether the rulemaking was previously found to have a significant impact on a substantial number of small entities. If previously published prospective or retrospective regulatory flexibility analyses are generally available, analysts may be able to build off of these previous analytic efforts when developing a retrospective analysis under the SUNSET final rule. All else equal, this would suggest the average time per retrospective analysis may be closer to the lower-bound estimate of 250 hours. If these analyses are not generally available, this would suggest an average time per retrospective analysis closer to the upper-bound estimate of 500 hours. We do not address the assumption in the SUNSET final rule RIA that a prospective regulatory flexibility analysis is available for every rulemaking published after the RFA was enacted, because it does not impact the estimate of the overall time spent on reviews under the baseline scenario. Our approach also allows us to ignore the apparent internal inconsistency in the\n\nSUNSET final rule RIA underlying the time per review of the 160 rulemakings that are newly assessed to have a significant impact. The SUNSET final rule RIA is not clear on what activities are included in its estimates of the time per review other than the time spent developing a retrospective analysis. We interpret the magnitudes of these estimates to exclude consideration of time spent on activities other than drafting the retrospective analysis. For example, the Department may need to conduct a study or survey to gather data to inform its analyses. We therefore include an additional 250 hours to 500 hours per review to account for this omission. This estimate reflects time spent by Department subject matter experts, lawyers, and other reviewers informing the retrospective analysis and providing feedback on draft analyses. It also reflects time spent by economists and other analysts developing the retrospective analysis to respond to this feedback, and time spent reading and incorporating evidence from other sources, including public comments. Table D2 summarizes the assumptions in the SUNSET final rule RIA and our revised assumptions for the final withdrawal rule of the time per assessment and time per review performed under the baseline scenario of the SUNSET final rule. Combining the time spent on retrospective analysis and on other related activities, we estimate that each review will take between 500 and 1,000 hours to complete.\n\nTABLE D2—HOURS PER ASSESSMENT AND REVIEW\n\nBaseline requirement SUNSET final rule RIA Final withdrawal rule\n\nLow High Low High\n\nAssessment ..................................................................................................... 3 10 40 100\n\nReview: Retrospective Analysis, pre-RFA regulation ...................................... 250 500 250 500\n\nReview: Retrospective Analysis, post-RFA regulation .................................... 40 100 250 500\n\nReview: Retrospective Analysis, Not Specified ............................................... 40 100 250 500\n\nReview: Other Activities ................................................................................... 0 0 250 500\n\nTime Spent by the Public To Monitor and Comment\n\nUnder the SUNSET final rule, the Department would create a docket on _www.Regulations.gov_ for each assessment or review that the Department is conducting. The public would then be able to submit comments to the dockets of each rulemaking being assessed or reviewed. The SUNSET final rule RIA includes a discussion of the costs to the stakeholders to monitor and comment on regulations as these are\n\nundergoing assessment and review; however, the analysis assigns no costs to the Department associated with setting up these dockets or engaging with the comments. The analysis also does not monetize any other costs associated with operationalization of the SUNSET final rule, which also requires developing a schedule for activities associated with the SUNSET final rule, publishing monthly updates on the commencement of assessments and reviews, publishing the results of\n\nassessments and review (‘‘including the full underlying analyses and data used to support the results’’) once a year, and establishing a website dashboard to help the public monitor the Department’s progress. When estimating the impact on the public, the SUNSET final rule RIA assumes the public will wait until the assessments and reviews are complete and the Department has announced it intends to rescind or amend a rulemaking before commenting. Thus,\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00038 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","publish_date":null,"title":"32282","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page37.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page37.pdf"},"request":{"example_id":"table/1653739079_page37","product_type":"parse","source_file_path":"1653739079_page37.pdf"},"started_at":"2026-11-04T19:48:07.871432"} +{"completed_at":"2026-11-04T19:48:10.462677","latency_in_ms":1142,"output":{"example_id":"table/1653739079_page39","grounded_pages":[],"layout_pages":[],"markdown":"**32284 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nSUNSET final rule to the Department and the public. Table D5 presents comparable figures related to reviews. Table D6 presents the total time anticipated under the SUNSET final rule related to assessments and reviews.\n\nTABLE D4—HOURS RELATED TO ASSESSMENTS UNDER THE SUNSET FINAL RULE\n\nYear Assessments Department Public\n\nLow High Low High\n\n2022 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2023 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2024 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2025 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2026 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2027 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2028 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2029 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2030 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2031 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\nTABLE D5—HOURS RELATED TO REVIEWS UNDER THE SUNSET FINAL RULE\n\nYear Reviews Department Public\n\nLow High Low High\n\n2022 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2023 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2024 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2025 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2026 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2027 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2028 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2029 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2030 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2031 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\nTABLE D6—TOTAL HOURS RELATED TO THE SUNSET FINAL RULE\n\nYear Department Public\n\nLow High Low High\n\n2022 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2023 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2024 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2025 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2026 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2027 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2028 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2029 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2030 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2031 ................................................................................................................. 3,672 7,980 15,639 46,917\n\nWhile these time estimates are significant, they are not inclusive of all costs expected under the SUNSET final rule. In addition to the quantified estimates above, we expect that the Department will experience other costs related to the requirements of the SUNSET final rule under the baseline scenario. For example, the estimates above do not include time spent reviewing guidance documents related to rulemaking undergoing assessment and review. They also do not include the time associated with developing SECGs for the 160 rulemakings newly found to have a significant impact on a substantial number of small entities, or\n\nthe time associated with updating existing guidances for the same or related rulemakings. The figures above also omit the monetary costs to purchase data and data subscriptions that we anticipate will serve as critical inputs for the assessments and reviews, and costs associated with conducting formal evaluations to understand the impact of the rules. In addition, the estimates do not include the costs of resolving and communicating the meaning of ambiguous provisions in the SUNSET final rule. For example, HHS anticipates that it will take considerable work to determine when regulations must be assessed and reviewed as part\n\nof a particular rulemaking and when regulations fall within an exception. Even after that work is complete, additional resources are required to share those interpretations with the public. Furthermore, the figures do not account for the time and costs associated with HHS’s efforts to reevaluate and redirect resources to support assessments and reviews and thereby preserve regulations. As an additional consideration, we estimate that assessing and reviewing regulations will require the equivalent of 67 and 146 full-time employees in each of the first five years of the analysis, adopting the SUNSET final\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00040 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","pages":[{"line_numbers":[],"markdown":"**32284 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nSUNSET final rule to the Department and the public. Table D5 presents comparable figures related to reviews. Table D6 presents the total time anticipated under the SUNSET final rule related to assessments and reviews.\n\nTABLE D4—HOURS RELATED TO ASSESSMENTS UNDER THE SUNSET FINAL RULE\n\nYear Assessments Department Public\n\nLow High Low High\n\n2022 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2023 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2024 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2025 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2026 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2027 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2028 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2029 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2030 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2031 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\nTABLE D5—HOURS RELATED TO REVIEWS UNDER THE SUNSET FINAL RULE\n\nYear Reviews Department Public\n\nLow High Low High\n\n2022 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2023 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2024 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2025 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2026 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2027 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2028 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2029 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2030 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2031 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\nTABLE D6—TOTAL HOURS RELATED TO THE SUNSET FINAL RULE\n\nYear Department Public\n\nLow High Low High\n\n2022 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2023 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2024 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2025 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2026 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2027 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2028 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2029 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2030 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2031 ................................................................................................................. 3,672 7,980 15,639 46,917\n\nWhile these time estimates are significant, they are not inclusive of all costs expected under the SUNSET final rule. In addition to the quantified estimates above, we expect that the Department will experience other costs related to the requirements of the SUNSET final rule under the baseline scenario. For example, the estimates above do not include time spent reviewing guidance documents related to rulemaking undergoing assessment and review. They also do not include the time associated with developing SECGs for the 160 rulemakings newly found to have a significant impact on a substantial number of small entities, or\n\nthe time associated with updating existing guidances for the same or related rulemakings. The figures above also omit the monetary costs to purchase data and data subscriptions that we anticipate will serve as critical inputs for the assessments and reviews, and costs associated with conducting formal evaluations to understand the impact of the rules. In addition, the estimates do not include the costs of resolving and communicating the meaning of ambiguous provisions in the SUNSET final rule. For example, HHS anticipates that it will take considerable work to determine when regulations must be assessed and reviewed as part\n\nof a particular rulemaking and when regulations fall within an exception. Even after that work is complete, additional resources are required to share those interpretations with the public. Furthermore, the figures do not account for the time and costs associated with HHS’s efforts to reevaluate and redirect resources to support assessments and reviews and thereby preserve regulations. As an additional consideration, we estimate that assessing and reviewing regulations will require the equivalent of 67 and 146 full-time employees in each of the first five years of the analysis, adopting the SUNSET final\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00040 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**32284 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nSUNSET final rule to the Department and the public. Table D5 presents comparable figures related to reviews. Table D6 presents the total time anticipated under the SUNSET final rule related to assessments and reviews.\n\nTABLE D4—HOURS RELATED TO ASSESSMENTS UNDER THE SUNSET FINAL RULE\n\nYear Assessments Department Public\n\nLow High Low High\n\n2022 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2023 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2024 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2025 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2026 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2027 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2028 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2029 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2030 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2031 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\nTABLE D5—HOURS RELATED TO REVIEWS UNDER THE SUNSET FINAL RULE\n\nYear Reviews Department Public\n\nLow High Low High\n\n2022 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2023 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2024 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2025 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2026 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2027 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2028 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2029 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2030 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2031 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\nTABLE D6—TOTAL HOURS RELATED TO THE SUNSET FINAL RULE\n\nYear Department Public\n\nLow High Low High\n\n2022 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2023 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2024 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2025 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2026 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2027 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2028 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2029 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2030 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2031 ................................................................................................................. 3,672 7,980 15,639 46,917\n\nWhile these time estimates are significant, they are not inclusive of all costs expected under the SUNSET final rule. In addition to the quantified estimates above, we expect that the Department will experience other costs related to the requirements of the SUNSET final rule under the baseline scenario. For example, the estimates above do not include time spent reviewing guidance documents related to rulemaking undergoing assessment and review. They also do not include the time associated with developing SECGs for the 160 rulemakings newly found to have a significant impact on a substantial number of small entities, or\n\nthe time associated with updating existing guidances for the same or related rulemakings. The figures above also omit the monetary costs to purchase data and data subscriptions that we anticipate will serve as critical inputs for the assessments and reviews, and costs associated with conducting formal evaluations to understand the impact of the rules. In addition, the estimates do not include the costs of resolving and communicating the meaning of ambiguous provisions in the SUNSET final rule. For example, HHS anticipates that it will take considerable work to determine when regulations must be assessed and reviewed as part\n\nof a particular rulemaking and when regulations fall within an exception. Even after that work is complete, additional resources are required to share those interpretations with the public. Furthermore, the figures do not account for the time and costs associated with HHS’s efforts to reevaluate and redirect resources to support assessments and reviews and thereby preserve regulations. As an additional consideration, we estimate that assessing and reviewing regulations will require the equivalent of 67 and 146 full-time employees in each of the first five years of the analysis, adopting the SUNSET final\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00040 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page39.pdf"]},"response":{"errors":[],"extract_id":"extract_e8cb933d7055e6c943731ab1e8b6b859","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**32284 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nSUNSET final rule to the Department and the public. Table D5 presents comparable figures related to reviews. Table D6 presents the total time anticipated under the SUNSET final rule related to assessments and reviews.\n\nTABLE D4—HOURS RELATED TO ASSESSMENTS UNDER THE SUNSET FINAL RULE\n\nYear Assessments Department Public\n\nLow High Low High\n\n2022 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2023 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2024 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2025 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2026 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2027 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2028 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2029 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2030 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2031 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\nTABLE D5—HOURS RELATED TO REVIEWS UNDER THE SUNSET FINAL RULE\n\nYear Reviews Department Public\n\nLow High Low High\n\n2022 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2023 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2024 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2025 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2026 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2027 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2028 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2029 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2030 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2031 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\nTABLE D6—TOTAL HOURS RELATED TO THE SUNSET FINAL RULE\n\nYear Department Public\n\nLow High Low High\n\n2022 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2023 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2024 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2025 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2026 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2027 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2028 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2029 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2030 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2031 ................................................................................................................. 3,672 7,980 15,639 46,917\n\nWhile these time estimates are significant, they are not inclusive of all costs expected under the SUNSET final rule. In addition to the quantified estimates above, we expect that the Department will experience other costs related to the requirements of the SUNSET final rule under the baseline scenario. For example, the estimates above do not include time spent reviewing guidance documents related to rulemaking undergoing assessment and review. They also do not include the time associated with developing SECGs for the 160 rulemakings newly found to have a significant impact on a substantial number of small entities, or\n\nthe time associated with updating existing guidances for the same or related rulemakings. The figures above also omit the monetary costs to purchase data and data subscriptions that we anticipate will serve as critical inputs for the assessments and reviews, and costs associated with conducting formal evaluations to understand the impact of the rules. In addition, the estimates do not include the costs of resolving and communicating the meaning of ambiguous provisions in the SUNSET final rule. For example, HHS anticipates that it will take considerable work to determine when regulations must be assessed and reviewed as part\n\nof a particular rulemaking and when regulations fall within an exception. Even after that work is complete, additional resources are required to share those interpretations with the public. Furthermore, the figures do not account for the time and costs associated with HHS’s efforts to reevaluate and redirect resources to support assessments and reviews and thereby preserve regulations. As an additional consideration, we estimate that assessing and reviewing regulations will require the equivalent of 67 and 146 full-time employees in each of the first five years of the analysis, adopting the SUNSET final\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00040 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2"],"full_content":"**32284 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\nSUNSET final rule to the Department and the public. Table D5 presents comparable figures related to reviews. Table D6 presents the total time anticipated under the SUNSET final rule related to assessments and reviews.\n\nTABLE D4—HOURS RELATED TO ASSESSMENTS UNDER THE SUNSET FINAL RULE\n\nYear Assessments Department Public\n\nLow High Low High\n\n2022 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2023 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2024 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2025 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2026 ..................................................................................... 683.0 27,320 68,300 85,375 256,125\n\n2027 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2028 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2029 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2030 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\n2031 ..................................................................................... 31.8 1,272 3,180 3,975 11,925\n\nTABLE D5—HOURS RELATED TO REVIEWS UNDER THE SUNSET FINAL RULE\n\nYear Reviews Department Public\n\nLow High Low High\n\n2022 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2023 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2024 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2025 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2026 ..................................................................................... 101.2 50,600 101,200 245,916 737,748\n\n2027 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2028 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2029 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2030 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\n2031 ..................................................................................... 4.8 2,400 4,800 11,664 34,992\n\nTABLE D6—TOTAL HOURS RELATED TO THE SUNSET FINAL RULE\n\nYear Department Public\n\nLow High Low High\n\n2022 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2023 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2024 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2025 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2026 ................................................................................................................. 77,920 169,500 331,291 993,873\n\n2027 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2028 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2029 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2030 ................................................................................................................. 3,672 7,980 15,639 46,917\n\n2031 ................................................................................................................. 3,672 7,980 15,639 46,917\n\nWhile these time estimates are significant, they are not inclusive of all costs expected under the SUNSET final rule. In addition to the quantified estimates above, we expect that the Department will experience other costs related to the requirements of the SUNSET final rule under the baseline scenario. For example, the estimates above do not include time spent reviewing guidance documents related to rulemaking undergoing assessment and review. They also do not include the time associated with developing SECGs for the 160 rulemakings newly found to have a significant impact on a substantial number of small entities, or\n\nthe time associated with updating existing guidances for the same or related rulemakings. The figures above also omit the monetary costs to purchase data and data subscriptions that we anticipate will serve as critical inputs for the assessments and reviews, and costs associated with conducting formal evaluations to understand the impact of the rules. In addition, the estimates do not include the costs of resolving and communicating the meaning of ambiguous provisions in the SUNSET final rule. For example, HHS anticipates that it will take considerable work to determine when regulations must be assessed and reviewed as part\n\nof a particular rulemaking and when regulations fall within an exception. Even after that work is complete, additional resources are required to share those interpretations with the public. Furthermore, the figures do not account for the time and costs associated with HHS’s efforts to reevaluate and redirect resources to support assessments and reviews and thereby preserve regulations. As an additional consideration, we estimate that assessing and reviewing regulations will require the equivalent of 67 and 146 full-time employees in each of the first five years of the analysis, adopting the SUNSET final\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00040 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","publish_date":null,"title":"32284","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page39.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page39.pdf"},"request":{"example_id":"table/1653739079_page39","product_type":"parse","source_file_path":"1653739079_page39.pdf"},"started_at":"2026-11-04T19:48:09.320451"} +{"completed_at":"2026-11-04T19:31:12.358882","latency_in_ms":3774,"output":{"example_id":"table/1653739079_page40","grounded_pages":[],"layout_pages":[],"markdown":"**32285 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n70 This 1,160-hour estimate corresponds to a measure of the ‘‘Net Supported Direct FDA Work Hours Available for Assignments’’ (86 FR 5743).\n\n71 86 FR 5743.\n\n72 86 FR 5745.\n\nrule RIA’s estimate of 1,160 hours of work per year per employee. ⁷⁰ Given current staffing and other Departmental needs and priorities, we anticipate the need to hire non-government experts to perform a share of the retrospective work. This approach will likely result in additional overhead costs that we have not quantified. We also anticipate the need to spend Departmental resources to find, hire, train, and transfer personnel with technical expertise to conduct the analyses, the costs of which have not been quantified in this analysis.\n\n_E. Benefits of the Final Withdrawal Rule_ The monetized benefits of this regulatory action to withdraw the\n\nSUNSET final rule are the cost savings to the Department from not completing the assessments and reviews required under the baseline scenario, and the cost savings to the public from not commenting on these assessments and reviews. To monetize these cost savings, we multiply the hours related to the SUNSET final rule in Table D6 by the cost per hour of these activities. We adopt the SUNSET final rule RIA’s ‘‘estimates that the fully-loaded cost per hour to the Department to employ a person to conduct a Review or Assessment is $244.98 per hour’’ ⁷¹ and ‘‘fully loaded cost per hour of writing comments is $143.20.’’ ⁷² Table E1 presents the yearly cost savings to the\n\nDepartment and the public expected under the final withdrawal rule compared to the baseline scenario. We combine the low estimates for the Department and the public to generate an overall low estimate, and similarly combine the high estimates for the Department and the public to generate an overall high estimate. We also report an overall primary estimate, which is the midpoint between the low and high estimates. Finally, we report the present discounted value (PDV) and annualized cost savings under the final withdrawal rule for both a 3% and 7% discount rate. All figures are reported in 2020 dollars, in millions.\n\nTABLE E1—COST SAVINGS UNDER THE FINAL WITHDRAWAL RULE [Millions of $]\n\nYear Department Public Overall\n\nLow High Low High Low Central High\n\n2022 ............................. $19.1 $41.5 $47.4 $142.3 $66.5 $125.2 $183.8\n\n2023 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2024 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2025 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2026 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2027 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2028 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2029 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2030 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2031 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\nPDV, 3% ...................... 91.0 197.9 226.1 678.3 317.1 596.7 876.2\n\nPDV, 7% ...................... 80.9 176.0 201.1 603.2 282.0 530.6 779.2\n\nAnnualized, 3% ............ 10.7 23.2 26.5 79.5 37.2 69.9 102.7\n\nAnnualized, 7% ............ 11.5 25.1 28.6 85.9 40.1 75.5 110.9\n\nFor comparison, in present value terms, these estimates of annualized cost savings are more than four times the size of the annualized cost estimates included in the SUNSET final rule RIA. This reflects what the Department has now concluded are more reasonable assumptions about the effect of the SUNSET final rule rather than a claim that the combination of these two regulatory actions will generate net cost savings. These cost savings estimates attributed to the final withdrawal rule are consistent with a scenario that the Department returns to its approach to Section 610 reviews that immediately predate the publication of the SUNSET final rule on January 19, 2021. We believe that this represents a credible and appropriate approach for estimating the likely cost savings that will be attributable to the final withdrawal rule. Other considerations relating to the\n\nappropriate frequency or nature of retrospective economic analyses of existing Departmental regulations are beyond the scope of this final rule RIA. In the previous section, we discussed concerns about potential costs of the SUNSET final rule that were overlooked in the SUNSET final rule RIA. To the extent that we are unable to quantify or monetize these costs, such as the purchase of data, conducting studies to evaluate the impacts of rules, additional overhead costs associated with contracting with non-government entities to perform a share of the retrospective work, and other personnel costs, the cost savings anticipated under the final withdrawal rule are equally underestimated. In addition to cost savings, the final withdrawal rule will generate non- quantified benefits from reduced regulatory uncertainty. Although we calculate the cost savings estimates in\n\nthis analysis by adopting an assumption that the Department will fulfill the requirements of the SUNSET final rule rather than to let any regulation expire automatically, it is highly likely that some regulations will automatically expire. Withdrawing the SUNSET final rule will remove the expiration provisions, which will also remove the likelihood of any automatic expiration of regulatory requirements. The final withdrawal rule will also eliminate the potential for regulatory confusion among stakeholders, and harm to the public health related to the actuality of having regulations expire automatically.\n\n_F. Costs of the Final Withdrawal Rule_ The costs of the final withdrawal rule will be the forgone benefits of the information learned from the assessments and reviews completed under the baseline scenario. We adopt the approach taken in the SUNSET final\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00041 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","pages":[{"line_numbers":[],"markdown":"**32285 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n70 This 1,160-hour estimate corresponds to a measure of the ‘‘Net Supported Direct FDA Work Hours Available for Assignments’’ (86 FR 5743).\n\n71 86 FR 5743.\n\n72 86 FR 5745.\n\nrule RIA’s estimate of 1,160 hours of work per year per employee. ⁷⁰ Given current staffing and other Departmental needs and priorities, we anticipate the need to hire non-government experts to perform a share of the retrospective work. This approach will likely result in additional overhead costs that we have not quantified. We also anticipate the need to spend Departmental resources to find, hire, train, and transfer personnel with technical expertise to conduct the analyses, the costs of which have not been quantified in this analysis.\n\n_E. Benefits of the Final Withdrawal Rule_ The monetized benefits of this regulatory action to withdraw the\n\nSUNSET final rule are the cost savings to the Department from not completing the assessments and reviews required under the baseline scenario, and the cost savings to the public from not commenting on these assessments and reviews. To monetize these cost savings, we multiply the hours related to the SUNSET final rule in Table D6 by the cost per hour of these activities. We adopt the SUNSET final rule RIA’s ‘‘estimates that the fully-loaded cost per hour to the Department to employ a person to conduct a Review or Assessment is $244.98 per hour’’ ⁷¹ and ‘‘fully loaded cost per hour of writing comments is $143.20.’’ ⁷² Table E1 presents the yearly cost savings to the\n\nDepartment and the public expected under the final withdrawal rule compared to the baseline scenario. We combine the low estimates for the Department and the public to generate an overall low estimate, and similarly combine the high estimates for the Department and the public to generate an overall high estimate. We also report an overall primary estimate, which is the midpoint between the low and high estimates. Finally, we report the present discounted value (PDV) and annualized cost savings under the final withdrawal rule for both a 3% and 7% discount rate. All figures are reported in 2020 dollars, in millions.\n\nTABLE E1—COST SAVINGS UNDER THE FINAL WITHDRAWAL RULE [Millions of $]\n\nYear Department Public Overall\n\nLow High Low High Low Central High\n\n2022 ............................. $19.1 $41.5 $47.4 $142.3 $66.5 $125.2 $183.8\n\n2023 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2024 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2025 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2026 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2027 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2028 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2029 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2030 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2031 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\nPDV, 3% ...................... 91.0 197.9 226.1 678.3 317.1 596.7 876.2\n\nPDV, 7% ...................... 80.9 176.0 201.1 603.2 282.0 530.6 779.2\n\nAnnualized, 3% ............ 10.7 23.2 26.5 79.5 37.2 69.9 102.7\n\nAnnualized, 7% ............ 11.5 25.1 28.6 85.9 40.1 75.5 110.9\n\nFor comparison, in present value terms, these estimates of annualized cost savings are more than four times the size of the annualized cost estimates included in the SUNSET final rule RIA. This reflects what the Department has now concluded are more reasonable assumptions about the effect of the SUNSET final rule rather than a claim that the combination of these two regulatory actions will generate net cost savings. These cost savings estimates attributed to the final withdrawal rule are consistent with a scenario that the Department returns to its approach to Section 610 reviews that immediately predate the publication of the SUNSET final rule on January 19, 2021. We believe that this represents a credible and appropriate approach for estimating the likely cost savings that will be attributable to the final withdrawal rule. Other considerations relating to the\n\nappropriate frequency or nature of retrospective economic analyses of existing Departmental regulations are beyond the scope of this final rule RIA. In the previous section, we discussed concerns about potential costs of the SUNSET final rule that were overlooked in the SUNSET final rule RIA. To the extent that we are unable to quantify or monetize these costs, such as the purchase of data, conducting studies to evaluate the impacts of rules, additional overhead costs associated with contracting with non-government entities to perform a share of the retrospective work, and other personnel costs, the cost savings anticipated under the final withdrawal rule are equally underestimated. In addition to cost savings, the final withdrawal rule will generate non- quantified benefits from reduced regulatory uncertainty. Although we calculate the cost savings estimates in\n\nthis analysis by adopting an assumption that the Department will fulfill the requirements of the SUNSET final rule rather than to let any regulation expire automatically, it is highly likely that some regulations will automatically expire. Withdrawing the SUNSET final rule will remove the expiration provisions, which will also remove the likelihood of any automatic expiration of regulatory requirements. The final withdrawal rule will also eliminate the potential for regulatory confusion among stakeholders, and harm to the public health related to the actuality of having regulations expire automatically.\n\n_F. Costs of the Final Withdrawal Rule_ The costs of the final withdrawal rule will be the forgone benefits of the information learned from the assessments and reviews completed under the baseline scenario. We adopt the approach taken in the SUNSET final\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00041 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**32285 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n70 This 1,160-hour estimate corresponds to a measure of the ‘‘Net Supported Direct FDA Work Hours Available for Assignments’’ (86 FR 5743).\n\n71 86 FR 5743.\n\n72 86 FR 5745.\n\nrule RIA’s estimate of 1,160 hours of work per year per employee. ⁷⁰ Given current staffing and other Departmental needs and priorities, we anticipate the need to hire non-government experts to perform a share of the retrospective work. This approach will likely result in additional overhead costs that we have not quantified. We also anticipate the need to spend Departmental resources to find, hire, train, and transfer personnel with technical expertise to conduct the analyses, the costs of which have not been quantified in this analysis.\n\n_E. Benefits of the Final Withdrawal Rule_ The monetized benefits of this regulatory action to withdraw the\n\nSUNSET final rule are the cost savings to the Department from not completing the assessments and reviews required under the baseline scenario, and the cost savings to the public from not commenting on these assessments and reviews. To monetize these cost savings, we multiply the hours related to the SUNSET final rule in Table D6 by the cost per hour of these activities. We adopt the SUNSET final rule RIA’s ‘‘estimates that the fully-loaded cost per hour to the Department to employ a person to conduct a Review or Assessment is $244.98 per hour’’ ⁷¹ and ‘‘fully loaded cost per hour of writing comments is $143.20.’’ ⁷² Table E1 presents the yearly cost savings to the\n\nDepartment and the public expected under the final withdrawal rule compared to the baseline scenario. We combine the low estimates for the Department and the public to generate an overall low estimate, and similarly combine the high estimates for the Department and the public to generate an overall high estimate. We also report an overall primary estimate, which is the midpoint between the low and high estimates. Finally, we report the present discounted value (PDV) and annualized cost savings under the final withdrawal rule for both a 3% and 7% discount rate. All figures are reported in 2020 dollars, in millions.\n\nTABLE E1—COST SAVINGS UNDER THE FINAL WITHDRAWAL RULE [Millions of $]\n\nYear Department Public Overall\n\nLow High Low High Low Central High\n\n2022 ............................. $19.1 $41.5 $47.4 $142.3 $66.5 $125.2 $183.8\n\n2023 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2024 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2025 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2026 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2027 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2028 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2029 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2030 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2031 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\nPDV, 3% ...................... 91.0 197.9 226.1 678.3 317.1 596.7 876.2\n\nPDV, 7% ...................... 80.9 176.0 201.1 603.2 282.0 530.6 779.2\n\nAnnualized, 3% ............ 10.7 23.2 26.5 79.5 37.2 69.9 102.7\n\nAnnualized, 7% ............ 11.5 25.1 28.6 85.9 40.1 75.5 110.9\n\nFor comparison, in present value terms, these estimates of annualized cost savings are more than four times the size of the annualized cost estimates included in the SUNSET final rule RIA. This reflects what the Department has now concluded are more reasonable assumptions about the effect of the SUNSET final rule rather than a claim that the combination of these two regulatory actions will generate net cost savings. These cost savings estimates attributed to the final withdrawal rule are consistent with a scenario that the Department returns to its approach to Section 610 reviews that immediately predate the publication of the SUNSET final rule on January 19, 2021. We believe that this represents a credible and appropriate approach for estimating the likely cost savings that will be attributable to the final withdrawal rule. Other considerations relating to the\n\nappropriate frequency or nature of retrospective economic analyses of existing Departmental regulations are beyond the scope of this final rule RIA. In the previous section, we discussed concerns about potential costs of the SUNSET final rule that were overlooked in the SUNSET final rule RIA. To the extent that we are unable to quantify or monetize these costs, such as the purchase of data, conducting studies to evaluate the impacts of rules, additional overhead costs associated with contracting with non-government entities to perform a share of the retrospective work, and other personnel costs, the cost savings anticipated under the final withdrawal rule are equally underestimated. In addition to cost savings, the final withdrawal rule will generate non- quantified benefits from reduced regulatory uncertainty. Although we calculate the cost savings estimates in\n\nthis analysis by adopting an assumption that the Department will fulfill the requirements of the SUNSET final rule rather than to let any regulation expire automatically, it is highly likely that some regulations will automatically expire. Withdrawing the SUNSET final rule will remove the expiration provisions, which will also remove the likelihood of any automatic expiration of regulatory requirements. The final withdrawal rule will also eliminate the potential for regulatory confusion among stakeholders, and harm to the public health related to the actuality of having regulations expire automatically.\n\n_F. Costs of the Final Withdrawal Rule_ The costs of the final withdrawal rule will be the forgone benefits of the information learned from the assessments and reviews completed under the baseline scenario. We adopt the approach taken in the SUNSET final\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00041 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page40.pdf"]},"response":{"errors":[],"extract_id":"extract_80304b5d9e4226c7e71ea7095b056da8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**32285 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n70 This 1,160-hour estimate corresponds to a measure of the ‘‘Net Supported Direct FDA Work Hours Available for Assignments’’ (86 FR 5743).\n\n71 86 FR 5743.\n\n72 86 FR 5745.\n\nrule RIA’s estimate of 1,160 hours of work per year per employee. ⁷⁰ Given current staffing and other Departmental needs and priorities, we anticipate the need to hire non-government experts to perform a share of the retrospective work. This approach will likely result in additional overhead costs that we have not quantified. We also anticipate the need to spend Departmental resources to find, hire, train, and transfer personnel with technical expertise to conduct the analyses, the costs of which have not been quantified in this analysis.\n\n_E. Benefits of the Final Withdrawal Rule_ The monetized benefits of this regulatory action to withdraw the\n\nSUNSET final rule are the cost savings to the Department from not completing the assessments and reviews required under the baseline scenario, and the cost savings to the public from not commenting on these assessments and reviews. To monetize these cost savings, we multiply the hours related to the SUNSET final rule in Table D6 by the cost per hour of these activities. We adopt the SUNSET final rule RIA’s ‘‘estimates that the fully-loaded cost per hour to the Department to employ a person to conduct a Review or Assessment is $244.98 per hour’’ ⁷¹ and ‘‘fully loaded cost per hour of writing comments is $143.20.’’ ⁷² Table E1 presents the yearly cost savings to the\n\nDepartment and the public expected under the final withdrawal rule compared to the baseline scenario. We combine the low estimates for the Department and the public to generate an overall low estimate, and similarly combine the high estimates for the Department and the public to generate an overall high estimate. We also report an overall primary estimate, which is the midpoint between the low and high estimates. Finally, we report the present discounted value (PDV) and annualized cost savings under the final withdrawal rule for both a 3% and 7% discount rate. All figures are reported in 2020 dollars, in millions.\n\nTABLE E1—COST SAVINGS UNDER THE FINAL WITHDRAWAL RULE [Millions of $]\n\nYear Department Public Overall\n\nLow High Low High Low Central High\n\n2022 ............................. $19.1 $41.5 $47.4 $142.3 $66.5 $125.2 $183.8\n\n2023 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2024 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2025 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2026 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2027 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2028 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2029 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2030 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2031 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\nPDV, 3% ...................... 91.0 197.9 226.1 678.3 317.1 596.7 876.2\n\nPDV, 7% ...................... 80.9 176.0 201.1 603.2 282.0 530.6 779.2\n\nAnnualized, 3% ............ 10.7 23.2 26.5 79.5 37.2 69.9 102.7\n\nAnnualized, 7% ............ 11.5 25.1 28.6 85.9 40.1 75.5 110.9\n\nFor comparison, in present value terms, these estimates of annualized cost savings are more than four times the size of the annualized cost estimates included in the SUNSET final rule RIA. This reflects what the Department has now concluded are more reasonable assumptions about the effect of the SUNSET final rule rather than a claim that the combination of these two regulatory actions will generate net cost savings. These cost savings estimates attributed to the final withdrawal rule are consistent with a scenario that the Department returns to its approach to Section 610 reviews that immediately predate the publication of the SUNSET final rule on January 19, 2021. We believe that this represents a credible and appropriate approach for estimating the likely cost savings that will be attributable to the final withdrawal rule. Other considerations relating to the\n\nappropriate frequency or nature of retrospective economic analyses of existing Departmental regulations are beyond the scope of this final rule RIA. In the previous section, we discussed concerns about potential costs of the SUNSET final rule that were overlooked in the SUNSET final rule RIA. To the extent that we are unable to quantify or monetize these costs, such as the purchase of data, conducting studies to evaluate the impacts of rules, additional overhead costs associated with contracting with non-government entities to perform a share of the retrospective work, and other personnel costs, the cost savings anticipated under the final withdrawal rule are equally underestimated. In addition to cost savings, the final withdrawal rule will generate non- quantified benefits from reduced regulatory uncertainty. Although we calculate the cost savings estimates in\n\nthis analysis by adopting an assumption that the Department will fulfill the requirements of the SUNSET final rule rather than to let any regulation expire automatically, it is highly likely that some regulations will automatically expire. Withdrawing the SUNSET final rule will remove the expiration provisions, which will also remove the likelihood of any automatic expiration of regulatory requirements. The final withdrawal rule will also eliminate the potential for regulatory confusion among stakeholders, and harm to the public health related to the actuality of having regulations expire automatically.\n\n_F. Costs of the Final Withdrawal Rule_ The costs of the final withdrawal rule will be the forgone benefits of the information learned from the assessments and reviews completed under the baseline scenario. We adopt the approach taken in the SUNSET final\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00041 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2"],"full_content":"**32285 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n70 This 1,160-hour estimate corresponds to a measure of the ‘‘Net Supported Direct FDA Work Hours Available for Assignments’’ (86 FR 5743).\n\n71 86 FR 5743.\n\n72 86 FR 5745.\n\nrule RIA’s estimate of 1,160 hours of work per year per employee. ⁷⁰ Given current staffing and other Departmental needs and priorities, we anticipate the need to hire non-government experts to perform a share of the retrospective work. This approach will likely result in additional overhead costs that we have not quantified. We also anticipate the need to spend Departmental resources to find, hire, train, and transfer personnel with technical expertise to conduct the analyses, the costs of which have not been quantified in this analysis.\n\n_E. Benefits of the Final Withdrawal Rule_ The monetized benefits of this regulatory action to withdraw the\n\nSUNSET final rule are the cost savings to the Department from not completing the assessments and reviews required under the baseline scenario, and the cost savings to the public from not commenting on these assessments and reviews. To monetize these cost savings, we multiply the hours related to the SUNSET final rule in Table D6 by the cost per hour of these activities. We adopt the SUNSET final rule RIA’s ‘‘estimates that the fully-loaded cost per hour to the Department to employ a person to conduct a Review or Assessment is $244.98 per hour’’ ⁷¹ and ‘‘fully loaded cost per hour of writing comments is $143.20.’’ ⁷² Table E1 presents the yearly cost savings to the\n\nDepartment and the public expected under the final withdrawal rule compared to the baseline scenario. We combine the low estimates for the Department and the public to generate an overall low estimate, and similarly combine the high estimates for the Department and the public to generate an overall high estimate. We also report an overall primary estimate, which is the midpoint between the low and high estimates. Finally, we report the present discounted value (PDV) and annualized cost savings under the final withdrawal rule for both a 3% and 7% discount rate. All figures are reported in 2020 dollars, in millions.\n\nTABLE E1—COST SAVINGS UNDER THE FINAL WITHDRAWAL RULE [Millions of $]\n\nYear Department Public Overall\n\nLow High Low High Low Central High\n\n2022 ............................. $19.1 $41.5 $47.4 $142.3 $66.5 $125.2 $183.8\n\n2023 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2024 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2025 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2026 ............................. 19.1 41.5 47.4 142.3 66.5 125.2 183.8\n\n2027 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2028 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2029 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2030 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\n2031 ............................. 0.9 2.0 2.2 6.7 3.1 5.9 8.7\n\nPDV, 3% ...................... 91.0 197.9 226.1 678.3 317.1 596.7 876.2\n\nPDV, 7% ...................... 80.9 176.0 201.1 603.2 282.0 530.6 779.2\n\nAnnualized, 3% ............ 10.7 23.2 26.5 79.5 37.2 69.9 102.7\n\nAnnualized, 7% ............ 11.5 25.1 28.6 85.9 40.1 75.5 110.9\n\nFor comparison, in present value terms, these estimates of annualized cost savings are more than four times the size of the annualized cost estimates included in the SUNSET final rule RIA. This reflects what the Department has now concluded are more reasonable assumptions about the effect of the SUNSET final rule rather than a claim that the combination of these two regulatory actions will generate net cost savings. These cost savings estimates attributed to the final withdrawal rule are consistent with a scenario that the Department returns to its approach to Section 610 reviews that immediately predate the publication of the SUNSET final rule on January 19, 2021. We believe that this represents a credible and appropriate approach for estimating the likely cost savings that will be attributable to the final withdrawal rule. Other considerations relating to the\n\nappropriate frequency or nature of retrospective economic analyses of existing Departmental regulations are beyond the scope of this final rule RIA. In the previous section, we discussed concerns about potential costs of the SUNSET final rule that were overlooked in the SUNSET final rule RIA. To the extent that we are unable to quantify or monetize these costs, such as the purchase of data, conducting studies to evaluate the impacts of rules, additional overhead costs associated with contracting with non-government entities to perform a share of the retrospective work, and other personnel costs, the cost savings anticipated under the final withdrawal rule are equally underestimated. In addition to cost savings, the final withdrawal rule will generate non- quantified benefits from reduced regulatory uncertainty. Although we calculate the cost savings estimates in\n\nthis analysis by adopting an assumption that the Department will fulfill the requirements of the SUNSET final rule rather than to let any regulation expire automatically, it is highly likely that some regulations will automatically expire. Withdrawing the SUNSET final rule will remove the expiration provisions, which will also remove the likelihood of any automatic expiration of regulatory requirements. The final withdrawal rule will also eliminate the potential for regulatory confusion among stakeholders, and harm to the public health related to the actuality of having regulations expire automatically.\n\n_F. Costs of the Final Withdrawal Rule_ The costs of the final withdrawal rule will be the forgone benefits of the information learned from the assessments and reviews completed under the baseline scenario. We adopt the approach taken in the SUNSET final\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00041 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","publish_date":null,"title":"32285","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page40.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page40.pdf"},"request":{"example_id":"table/1653739079_page40","product_type":"parse","source_file_path":"1653739079_page40.pdf"},"started_at":"2026-11-04T19:31:08.584848"} +{"completed_at":"2026-11-04T19:48:13.211546","latency_in_ms":1563,"output":{"example_id":"table/1653739079_page41","grounded_pages":[],"layout_pages":[],"markdown":"**32286 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n73 85 FR 70096.\n\nrule RIA and make no attempt to quantify or monetize the value of this information. The SUNSET final rule RIA also describes potential benefits from subsequent regulatory actions to rescind or amend existing regulations as a result of the SUNSET final rule; however, the Department now believes that any effects associated with future regulatory actions raise challenging questions of attribution (entirely to those regulatory actions themselves, or at least partially to the SUNSET final rule). We therefore do not unambiguously identify these as a source of foregone benefits under the final withdrawal rule.\n\n_G. Analysis of Regulatory Alternatives to the Final Withdrawal Rule_ We quantitatively analyze four alternative options to the final withdrawal rule. First, we consider an option to maintain the general approach of the SUNSET final rule, but adopt a two-year period following the effective\n\ndate to assess and review all regulations older than ten years. This option, Alternative 1, follows the timeline envisioned under the November 4, 2020, proposed SUNSET rule. ⁷³ Second, we consider an option to maintain the general approach of the SUNSET final rule, but adopt an initial ten-year period following the effective date to assess and review all regulations, regardless of when these were first published. This option, Alternative 2, evenly distributes the time spent by the Department assessing and reviewing existing regulations. Third, we consider an option to maintain the general framework of the SUNSET final rule but limit its scope to regulations that the Department previously identified as having a significant economic impact on a substantial number of small entities. This option, Alternative 3, would include the 326 Reviews of Post-RFA rulemakings identified in Table D1.\n\nFourth, we consider an option, Alternative 4, that would maintain the SUNSET final rule’s requirements related to the timeline for assessing and reviewing all of the Department’s existing regulations, but without the automatic expiration provision contained in the SUNSET final rule. Table G1 presents the primary estimates of yearly cost savings under the final withdrawal rule and under the four policy alternatives described above. Each of these policy options are compared to the common baseline scenario described in section D. We report the PDV and annualized cost savings under the final withdrawal rule and two policy alternatives for both a 3% and 7% discount rate. All figures are reported in 2020 dollars, in millions. Negative cost-savings estimates indicate that a policy alternative would likely result in net cost increases compared to the baseline scenario.\n\nTABLE G1—PRIMARY ESTIMATE OF COST SAVINGS UNDER THE FINAL WITHDRAWAL RULE AND ALTERNATIVES [$M]\n\nYear Final rule Alternative 1 Alternative 2 Alternative 3 Alternative 4\n\n2022 ..................................................................................... $125.2 ¥$187.8 $59.6 $70.8 $0.0\n\n2023 ..................................................................................... 125.2 ¥187.8 59.6 70.8 0.0\n\n2024 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2025 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2026 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2027 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2028 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2029 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2030 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2031 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\nPDV, 3% .............................................................................. 596.7 ¥26.6 37.5 335.9 0.0\n\nPDV, 7% .............................................................................. 530.6 ¥54.5 70.2 298.9 0.0\n\nAnnualized, 3% .................................................................... 69.9 ¥3.1 4.4 39.4 0.0\n\nAnnualized, 7% .................................................................... 75.5 ¥7.8 10.0 42.6 0.0\n\nThe cost savings reported for the Sunset final rule match the estimates contained in Table E1 of this analysis. For Alternative 1, we estimate annualized cost savings of ¥$3.1 million using a 3% discount rate. This indicates that Alternative 1 would result in incremental annualized costs of $3.1 million above the baseline scenario of the SUNSET final rule. In addition to this quantified impact on cost savings, Alternative 1 would increase the likelihood that the Department would need to hire non-government experts to perform a share of the retrospective work, resulting in additional overhead costs that we have not monetized. Alternative 1 would also result in additional unquantified benefits associated with earlier completion of some of the retrospectives, and therefore\n\nearlier access to information from these assessments and reviews. For Alternatives 2 and 3, we estimate annualized cost savings of $4.4 million and $335.9 million, respectively. Compared to the SUNSET final rule, Alternatives 2 and 3 would reduce the likelihood that the Department would need to hire non-government experts to perform a share of the retrospective work, and thus reduce the potential for additional overhead costs. Compared to the SUNSET final rule, Alternative 2 would result in non-quantified forgone benefits associated with later completion of some of the retrospective analyses, and therefore later access to information from these assessments and reviews. Alternative 3 would reduce the number of retrospective analyses and result in more foregone information.\n\nFor Alternative 4, we do not identify any incremental costs or cost savings compared to the baseline scenario of the SUNSET final rule, maintaining the assumption in the main analysis that the Department will fulfill the analytic requirements of the SUNSET final rule. However, compared to SUNSET final rule, Alternative 4 would generate non- quantified benefits from reduced regulatory uncertainty associated with the automatic expiration provision of the SUNSET final rule. Alternative 4 would, therefore, result in non- quantified benefits from reduced regulatory confusion among stakeholders, and non-quantified benefits from reduced harm to the public health related to the actuality of having regulations expire automatically.\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00042 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","pages":[{"line_numbers":[],"markdown":"**32286 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n73 85 FR 70096.\n\nrule RIA and make no attempt to quantify or monetize the value of this information. The SUNSET final rule RIA also describes potential benefits from subsequent regulatory actions to rescind or amend existing regulations as a result of the SUNSET final rule; however, the Department now believes that any effects associated with future regulatory actions raise challenging questions of attribution (entirely to those regulatory actions themselves, or at least partially to the SUNSET final rule). We therefore do not unambiguously identify these as a source of foregone benefits under the final withdrawal rule.\n\n_G. Analysis of Regulatory Alternatives to the Final Withdrawal Rule_ We quantitatively analyze four alternative options to the final withdrawal rule. First, we consider an option to maintain the general approach of the SUNSET final rule, but adopt a two-year period following the effective\n\ndate to assess and review all regulations older than ten years. This option, Alternative 1, follows the timeline envisioned under the November 4, 2020, proposed SUNSET rule. ⁷³ Second, we consider an option to maintain the general approach of the SUNSET final rule, but adopt an initial ten-year period following the effective date to assess and review all regulations, regardless of when these were first published. This option, Alternative 2, evenly distributes the time spent by the Department assessing and reviewing existing regulations. Third, we consider an option to maintain the general framework of the SUNSET final rule but limit its scope to regulations that the Department previously identified as having a significant economic impact on a substantial number of small entities. This option, Alternative 3, would include the 326 Reviews of Post-RFA rulemakings identified in Table D1.\n\nFourth, we consider an option, Alternative 4, that would maintain the SUNSET final rule’s requirements related to the timeline for assessing and reviewing all of the Department’s existing regulations, but without the automatic expiration provision contained in the SUNSET final rule. Table G1 presents the primary estimates of yearly cost savings under the final withdrawal rule and under the four policy alternatives described above. Each of these policy options are compared to the common baseline scenario described in section D. We report the PDV and annualized cost savings under the final withdrawal rule and two policy alternatives for both a 3% and 7% discount rate. All figures are reported in 2020 dollars, in millions. Negative cost-savings estimates indicate that a policy alternative would likely result in net cost increases compared to the baseline scenario.\n\nTABLE G1—PRIMARY ESTIMATE OF COST SAVINGS UNDER THE FINAL WITHDRAWAL RULE AND ALTERNATIVES [$M]\n\nYear Final rule Alternative 1 Alternative 2 Alternative 3 Alternative 4\n\n2022 ..................................................................................... $125.2 ¥$187.8 $59.6 $70.8 $0.0\n\n2023 ..................................................................................... 125.2 ¥187.8 59.6 70.8 0.0\n\n2024 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2025 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2026 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2027 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2028 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2029 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2030 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2031 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\nPDV, 3% .............................................................................. 596.7 ¥26.6 37.5 335.9 0.0\n\nPDV, 7% .............................................................................. 530.6 ¥54.5 70.2 298.9 0.0\n\nAnnualized, 3% .................................................................... 69.9 ¥3.1 4.4 39.4 0.0\n\nAnnualized, 7% .................................................................... 75.5 ¥7.8 10.0 42.6 0.0\n\nThe cost savings reported for the Sunset final rule match the estimates contained in Table E1 of this analysis. For Alternative 1, we estimate annualized cost savings of ¥$3.1 million using a 3% discount rate. This indicates that Alternative 1 would result in incremental annualized costs of $3.1 million above the baseline scenario of the SUNSET final rule. In addition to this quantified impact on cost savings, Alternative 1 would increase the likelihood that the Department would need to hire non-government experts to perform a share of the retrospective work, resulting in additional overhead costs that we have not monetized. Alternative 1 would also result in additional unquantified benefits associated with earlier completion of some of the retrospectives, and therefore\n\nearlier access to information from these assessments and reviews. For Alternatives 2 and 3, we estimate annualized cost savings of $4.4 million and $335.9 million, respectively. Compared to the SUNSET final rule, Alternatives 2 and 3 would reduce the likelihood that the Department would need to hire non-government experts to perform a share of the retrospective work, and thus reduce the potential for additional overhead costs. Compared to the SUNSET final rule, Alternative 2 would result in non-quantified forgone benefits associated with later completion of some of the retrospective analyses, and therefore later access to information from these assessments and reviews. Alternative 3 would reduce the number of retrospective analyses and result in more foregone information.\n\nFor Alternative 4, we do not identify any incremental costs or cost savings compared to the baseline scenario of the SUNSET final rule, maintaining the assumption in the main analysis that the Department will fulfill the analytic requirements of the SUNSET final rule. However, compared to SUNSET final rule, Alternative 4 would generate non- quantified benefits from reduced regulatory uncertainty associated with the automatic expiration provision of the SUNSET final rule. Alternative 4 would, therefore, result in non- quantified benefits from reduced regulatory confusion among stakeholders, and non-quantified benefits from reduced harm to the public health related to the actuality of having regulations expire automatically.\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00042 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**32286 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n73 85 FR 70096.\n\nrule RIA and make no attempt to quantify or monetize the value of this information. The SUNSET final rule RIA also describes potential benefits from subsequent regulatory actions to rescind or amend existing regulations as a result of the SUNSET final rule; however, the Department now believes that any effects associated with future regulatory actions raise challenging questions of attribution (entirely to those regulatory actions themselves, or at least partially to the SUNSET final rule). We therefore do not unambiguously identify these as a source of foregone benefits under the final withdrawal rule.\n\n_G. Analysis of Regulatory Alternatives to the Final Withdrawal Rule_ We quantitatively analyze four alternative options to the final withdrawal rule. First, we consider an option to maintain the general approach of the SUNSET final rule, but adopt a two-year period following the effective\n\ndate to assess and review all regulations older than ten years. This option, Alternative 1, follows the timeline envisioned under the November 4, 2020, proposed SUNSET rule. ⁷³ Second, we consider an option to maintain the general approach of the SUNSET final rule, but adopt an initial ten-year period following the effective date to assess and review all regulations, regardless of when these were first published. This option, Alternative 2, evenly distributes the time spent by the Department assessing and reviewing existing regulations. Third, we consider an option to maintain the general framework of the SUNSET final rule but limit its scope to regulations that the Department previously identified as having a significant economic impact on a substantial number of small entities. This option, Alternative 3, would include the 326 Reviews of Post-RFA rulemakings identified in Table D1.\n\nFourth, we consider an option, Alternative 4, that would maintain the SUNSET final rule’s requirements related to the timeline for assessing and reviewing all of the Department’s existing regulations, but without the automatic expiration provision contained in the SUNSET final rule. Table G1 presents the primary estimates of yearly cost savings under the final withdrawal rule and under the four policy alternatives described above. Each of these policy options are compared to the common baseline scenario described in section D. We report the PDV and annualized cost savings under the final withdrawal rule and two policy alternatives for both a 3% and 7% discount rate. All figures are reported in 2020 dollars, in millions. Negative cost-savings estimates indicate that a policy alternative would likely result in net cost increases compared to the baseline scenario.\n\nTABLE G1—PRIMARY ESTIMATE OF COST SAVINGS UNDER THE FINAL WITHDRAWAL RULE AND ALTERNATIVES [$M]\n\nYear Final rule Alternative 1 Alternative 2 Alternative 3 Alternative 4\n\n2022 ..................................................................................... $125.2 ¥$187.8 $59.6 $70.8 $0.0\n\n2023 ..................................................................................... 125.2 ¥187.8 59.6 70.8 0.0\n\n2024 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2025 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2026 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2027 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2028 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2029 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2030 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2031 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\nPDV, 3% .............................................................................. 596.7 ¥26.6 37.5 335.9 0.0\n\nPDV, 7% .............................................................................. 530.6 ¥54.5 70.2 298.9 0.0\n\nAnnualized, 3% .................................................................... 69.9 ¥3.1 4.4 39.4 0.0\n\nAnnualized, 7% .................................................................... 75.5 ¥7.8 10.0 42.6 0.0\n\nThe cost savings reported for the Sunset final rule match the estimates contained in Table E1 of this analysis. For Alternative 1, we estimate annualized cost savings of ¥$3.1 million using a 3% discount rate. This indicates that Alternative 1 would result in incremental annualized costs of $3.1 million above the baseline scenario of the SUNSET final rule. In addition to this quantified impact on cost savings, Alternative 1 would increase the likelihood that the Department would need to hire non-government experts to perform a share of the retrospective work, resulting in additional overhead costs that we have not monetized. Alternative 1 would also result in additional unquantified benefits associated with earlier completion of some of the retrospectives, and therefore\n\nearlier access to information from these assessments and reviews. For Alternatives 2 and 3, we estimate annualized cost savings of $4.4 million and $335.9 million, respectively. Compared to the SUNSET final rule, Alternatives 2 and 3 would reduce the likelihood that the Department would need to hire non-government experts to perform a share of the retrospective work, and thus reduce the potential for additional overhead costs. Compared to the SUNSET final rule, Alternative 2 would result in non-quantified forgone benefits associated with later completion of some of the retrospective analyses, and therefore later access to information from these assessments and reviews. Alternative 3 would reduce the number of retrospective analyses and result in more foregone information.\n\nFor Alternative 4, we do not identify any incremental costs or cost savings compared to the baseline scenario of the SUNSET final rule, maintaining the assumption in the main analysis that the Department will fulfill the analytic requirements of the SUNSET final rule. However, compared to SUNSET final rule, Alternative 4 would generate non- quantified benefits from reduced regulatory uncertainty associated with the automatic expiration provision of the SUNSET final rule. Alternative 4 would, therefore, result in non- quantified benefits from reduced regulatory confusion among stakeholders, and non-quantified benefits from reduced harm to the public health related to the actuality of having regulations expire automatically.\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00042 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page41.pdf"]},"response":{"errors":[],"extract_id":"extract_96842e16565c7ef131f4668d8f75daa8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**32286 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n73 85 FR 70096.\n\nrule RIA and make no attempt to quantify or monetize the value of this information. The SUNSET final rule RIA also describes potential benefits from subsequent regulatory actions to rescind or amend existing regulations as a result of the SUNSET final rule; however, the Department now believes that any effects associated with future regulatory actions raise challenging questions of attribution (entirely to those regulatory actions themselves, or at least partially to the SUNSET final rule). We therefore do not unambiguously identify these as a source of foregone benefits under the final withdrawal rule.\n\n_G. Analysis of Regulatory Alternatives to the Final Withdrawal Rule_ We quantitatively analyze four alternative options to the final withdrawal rule. First, we consider an option to maintain the general approach of the SUNSET final rule, but adopt a two-year period following the effective\n\ndate to assess and review all regulations older than ten years. This option, Alternative 1, follows the timeline envisioned under the November 4, 2020, proposed SUNSET rule. ⁷³ Second, we consider an option to maintain the general approach of the SUNSET final rule, but adopt an initial ten-year period following the effective date to assess and review all regulations, regardless of when these were first published. This option, Alternative 2, evenly distributes the time spent by the Department assessing and reviewing existing regulations. Third, we consider an option to maintain the general framework of the SUNSET final rule but limit its scope to regulations that the Department previously identified as having a significant economic impact on a substantial number of small entities. This option, Alternative 3, would include the 326 Reviews of Post-RFA rulemakings identified in Table D1.\n\nFourth, we consider an option, Alternative 4, that would maintain the SUNSET final rule’s requirements related to the timeline for assessing and reviewing all of the Department’s existing regulations, but without the automatic expiration provision contained in the SUNSET final rule. Table G1 presents the primary estimates of yearly cost savings under the final withdrawal rule and under the four policy alternatives described above. Each of these policy options are compared to the common baseline scenario described in section D. We report the PDV and annualized cost savings under the final withdrawal rule and two policy alternatives for both a 3% and 7% discount rate. All figures are reported in 2020 dollars, in millions. Negative cost-savings estimates indicate that a policy alternative would likely result in net cost increases compared to the baseline scenario.\n\nTABLE G1—PRIMARY ESTIMATE OF COST SAVINGS UNDER THE FINAL WITHDRAWAL RULE AND ALTERNATIVES [$M]\n\nYear Final rule Alternative 1 Alternative 2 Alternative 3 Alternative 4\n\n2022 ..................................................................................... $125.2 ¥$187.8 $59.6 $70.8 $0.0\n\n2023 ..................................................................................... 125.2 ¥187.8 59.6 70.8 0.0\n\n2024 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2025 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2026 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2027 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2028 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2029 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2030 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2031 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\nPDV, 3% .............................................................................. 596.7 ¥26.6 37.5 335.9 0.0\n\nPDV, 7% .............................................................................. 530.6 ¥54.5 70.2 298.9 0.0\n\nAnnualized, 3% .................................................................... 69.9 ¥3.1 4.4 39.4 0.0\n\nAnnualized, 7% .................................................................... 75.5 ¥7.8 10.0 42.6 0.0\n\nThe cost savings reported for the Sunset final rule match the estimates contained in Table E1 of this analysis. For Alternative 1, we estimate annualized cost savings of ¥$3.1 million using a 3% discount rate. This indicates that Alternative 1 would result in incremental annualized costs of $3.1 million above the baseline scenario of the SUNSET final rule. In addition to this quantified impact on cost savings, Alternative 1 would increase the likelihood that the Department would need to hire non-government experts to perform a share of the retrospective work, resulting in additional overhead costs that we have not monetized. Alternative 1 would also result in additional unquantified benefits associated with earlier completion of some of the retrospectives, and therefore\n\nearlier access to information from these assessments and reviews. For Alternatives 2 and 3, we estimate annualized cost savings of $4.4 million and $335.9 million, respectively. Compared to the SUNSET final rule, Alternatives 2 and 3 would reduce the likelihood that the Department would need to hire non-government experts to perform a share of the retrospective work, and thus reduce the potential for additional overhead costs. Compared to the SUNSET final rule, Alternative 2 would result in non-quantified forgone benefits associated with later completion of some of the retrospective analyses, and therefore later access to information from these assessments and reviews. Alternative 3 would reduce the number of retrospective analyses and result in more foregone information.\n\nFor Alternative 4, we do not identify any incremental costs or cost savings compared to the baseline scenario of the SUNSET final rule, maintaining the assumption in the main analysis that the Department will fulfill the analytic requirements of the SUNSET final rule. However, compared to SUNSET final rule, Alternative 4 would generate non- quantified benefits from reduced regulatory uncertainty associated with the automatic expiration provision of the SUNSET final rule. Alternative 4 would, therefore, result in non- quantified benefits from reduced regulatory confusion among stakeholders, and non-quantified benefits from reduced harm to the public health related to the actuality of having regulations expire automatically.\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00042 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2"],"full_content":"**32286 Federal Register** / Vol. 87, No. 103 / Friday, May 27, 2022 / Rules and Regulations\n\n73 85 FR 70096.\n\nrule RIA and make no attempt to quantify or monetize the value of this information. The SUNSET final rule RIA also describes potential benefits from subsequent regulatory actions to rescind or amend existing regulations as a result of the SUNSET final rule; however, the Department now believes that any effects associated with future regulatory actions raise challenging questions of attribution (entirely to those regulatory actions themselves, or at least partially to the SUNSET final rule). We therefore do not unambiguously identify these as a source of foregone benefits under the final withdrawal rule.\n\n_G. Analysis of Regulatory Alternatives to the Final Withdrawal Rule_ We quantitatively analyze four alternative options to the final withdrawal rule. First, we consider an option to maintain the general approach of the SUNSET final rule, but adopt a two-year period following the effective\n\ndate to assess and review all regulations older than ten years. This option, Alternative 1, follows the timeline envisioned under the November 4, 2020, proposed SUNSET rule. ⁷³ Second, we consider an option to maintain the general approach of the SUNSET final rule, but adopt an initial ten-year period following the effective date to assess and review all regulations, regardless of when these were first published. This option, Alternative 2, evenly distributes the time spent by the Department assessing and reviewing existing regulations. Third, we consider an option to maintain the general framework of the SUNSET final rule but limit its scope to regulations that the Department previously identified as having a significant economic impact on a substantial number of small entities. This option, Alternative 3, would include the 326 Reviews of Post-RFA rulemakings identified in Table D1.\n\nFourth, we consider an option, Alternative 4, that would maintain the SUNSET final rule’s requirements related to the timeline for assessing and reviewing all of the Department’s existing regulations, but without the automatic expiration provision contained in the SUNSET final rule. Table G1 presents the primary estimates of yearly cost savings under the final withdrawal rule and under the four policy alternatives described above. Each of these policy options are compared to the common baseline scenario described in section D. We report the PDV and annualized cost savings under the final withdrawal rule and two policy alternatives for both a 3% and 7% discount rate. All figures are reported in 2020 dollars, in millions. Negative cost-savings estimates indicate that a policy alternative would likely result in net cost increases compared to the baseline scenario.\n\nTABLE G1—PRIMARY ESTIMATE OF COST SAVINGS UNDER THE FINAL WITHDRAWAL RULE AND ALTERNATIVES [$M]\n\nYear Final rule Alternative 1 Alternative 2 Alternative 3 Alternative 4\n\n2022 ..................................................................................... $125.2 ¥$187.8 $59.6 $70.8 $0.0\n\n2023 ..................................................................................... 125.2 ¥187.8 59.6 70.8 0.0\n\n2024 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2025 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2026 ..................................................................................... 125.2 121.5 59.6 70.8 0.0\n\n2027 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2028 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2029 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2030 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\n2031 ..................................................................................... 5.9 2.2 ¥59.6 2.9 0.0\n\nPDV, 3% .............................................................................. 596.7 ¥26.6 37.5 335.9 0.0\n\nPDV, 7% .............................................................................. 530.6 ¥54.5 70.2 298.9 0.0\n\nAnnualized, 3% .................................................................... 69.9 ¥3.1 4.4 39.4 0.0\n\nAnnualized, 7% .................................................................... 75.5 ¥7.8 10.0 42.6 0.0\n\nThe cost savings reported for the Sunset final rule match the estimates contained in Table E1 of this analysis. For Alternative 1, we estimate annualized cost savings of ¥$3.1 million using a 3% discount rate. This indicates that Alternative 1 would result in incremental annualized costs of $3.1 million above the baseline scenario of the SUNSET final rule. In addition to this quantified impact on cost savings, Alternative 1 would increase the likelihood that the Department would need to hire non-government experts to perform a share of the retrospective work, resulting in additional overhead costs that we have not monetized. Alternative 1 would also result in additional unquantified benefits associated with earlier completion of some of the retrospectives, and therefore\n\nearlier access to information from these assessments and reviews. For Alternatives 2 and 3, we estimate annualized cost savings of $4.4 million and $335.9 million, respectively. Compared to the SUNSET final rule, Alternatives 2 and 3 would reduce the likelihood that the Department would need to hire non-government experts to perform a share of the retrospective work, and thus reduce the potential for additional overhead costs. Compared to the SUNSET final rule, Alternative 2 would result in non-quantified forgone benefits associated with later completion of some of the retrospective analyses, and therefore later access to information from these assessments and reviews. Alternative 3 would reduce the number of retrospective analyses and result in more foregone information.\n\nFor Alternative 4, we do not identify any incremental costs or cost savings compared to the baseline scenario of the SUNSET final rule, maintaining the assumption in the main analysis that the Department will fulfill the analytic requirements of the SUNSET final rule. However, compared to SUNSET final rule, Alternative 4 would generate non- quantified benefits from reduced regulatory uncertainty associated with the automatic expiration provision of the SUNSET final rule. Alternative 4 would, therefore, result in non- quantified benefits from reduced regulatory confusion among stakeholders, and non-quantified benefits from reduced harm to the public health related to the actuality of having regulations expire automatically.\n\nVerDate Sep<11>2014 18:33 May 26, 2022 Jkt 256001 PO 00000 Frm 00042 Fmt 4701 Sfmt 4700 E:\\\\FR\\\\FM\\\\27MYR2.SGM 27MYR2\n\njspears on DSK121TN23PROD with RULES2","publish_date":null,"title":"32286","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page41.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1653739079_page41.pdf"},"request":{"example_id":"table/1653739079_page41","product_type":"parse","source_file_path":"1653739079_page41.pdf"},"started_at":"2026-11-04T19:48:11.647808"} +{"completed_at":"2026-11-04T19:48:15.326410","latency_in_ms":2258,"output":{"example_id":"table/1657221585_page14","grounded_pages":[],"layout_pages":[],"markdown":"1\\.2.17 **Crushed degerminated (degermed) maize** ( ³ )\n\nProduct obtained by degermination of crushed maize. It consists principally of endosperm fragments and may contain some maize germ and outer skin particles\n\nCrude fibre Starch\n\n1\\.2.18 **Maize grits** ( ³ ) Hard, flinty portions of ground maize containing little or no bran or germs\n\nCrude fibre Starch\n\n1\\.2.19 **Maize germ meal feed** ( ³ ) Product of oil manufacture, obtained by extraction of processed maize germ. Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % of crude lecithins — 2 % of soap stocks\n\nCrude protein\n\n1\\.2.20 **Corn cob mix** Grains and cobs of maize\n\n1\\.2.21 **Corn cob mix with husks** Grains, cobs and husks of maize\n\n1\\.3.1 **Millet** Grains of _Panicum miliaceum_ L.\n\n1\\.4.1 **Oats** Grains of _Avena sativa_ L. and other cultivars of oats\n\n1\\.4.2 **Dehulled oats** Dehulled grains of oats\n\n1\\.4.3 **Oat flakes** Product obtained by steaming or infra red micronising and rolling dehusked oats. It may contain a small proportion of oat husks.\n\nStarch\n\n1\\.4.4 **Oat middlings** Product obtained during the processing of screened, dehusked oats into oat groats and flour. It consists principally of oat bran and some endosperm\n\nCrude fibre Starch\n\n1\\.4.5 **Oat bran** Product of flour manufacture, obtained from screened grains of dehusked oat. It consists principally of fragments of the outer skins and particles of grain from which the greater part of the endosperm has been removed.\n\nCrude fibre\n\n1\\.4.6 **Oat hulls** Product obtained during dehulling of oat grains Crude fibre\n\n1\\.4.7 **Oat, puffed** Product obtained from milled or broken oat by means of a treatment in humid, warm conditions and under pressure\n\nStarch\n\n1\\.4.8 **Oat groats** Cleaned oats with the hull removed Crude fibre Starch\n\n1\\.4.9 **Oat flour** Product obtained by milling of oat grains Crude fibre Starch\n\nEN Official Journal of the European Union 4.7.2022 L 177/17","pages":[{"line_numbers":[],"markdown":"1\\.2.17 **Crushed degerminated (degermed) maize** ( ³ )\n\nProduct obtained by degermination of crushed maize. It consists principally of endosperm fragments and may contain some maize germ and outer skin particles\n\nCrude fibre Starch\n\n1\\.2.18 **Maize grits** ( ³ ) Hard, flinty portions of ground maize containing little or no bran or germs\n\nCrude fibre Starch\n\n1\\.2.19 **Maize germ meal feed** ( ³ ) Product of oil manufacture, obtained by extraction of processed maize germ. Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % of crude lecithins — 2 % of soap stocks\n\nCrude protein\n\n1\\.2.20 **Corn cob mix** Grains and cobs of maize\n\n1\\.2.21 **Corn cob mix with husks** Grains, cobs and husks of maize\n\n1\\.3.1 **Millet** Grains of _Panicum miliaceum_ L.\n\n1\\.4.1 **Oats** Grains of _Avena sativa_ L. and other cultivars of oats\n\n1\\.4.2 **Dehulled oats** Dehulled grains of oats\n\n1\\.4.3 **Oat flakes** Product obtained by steaming or infra red micronising and rolling dehusked oats. It may contain a small proportion of oat husks.\n\nStarch\n\n1\\.4.4 **Oat middlings** Product obtained during the processing of screened, dehusked oats into oat groats and flour. It consists principally of oat bran and some endosperm\n\nCrude fibre Starch\n\n1\\.4.5 **Oat bran** Product of flour manufacture, obtained from screened grains of dehusked oat. It consists principally of fragments of the outer skins and particles of grain from which the greater part of the endosperm has been removed.\n\nCrude fibre\n\n1\\.4.6 **Oat hulls** Product obtained during dehulling of oat grains Crude fibre\n\n1\\.4.7 **Oat, puffed** Product obtained from milled or broken oat by means of a treatment in humid, warm conditions and under pressure\n\nStarch\n\n1\\.4.8 **Oat groats** Cleaned oats with the hull removed Crude fibre Starch\n\n1\\.4.9 **Oat flour** Product obtained by milling of oat grains Crude fibre Starch\n\nEN Official Journal of the European Union 4.7.2022 L 177/17","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"1\\.2.17 **Crushed degerminated (degermed) maize** ( ³ )\n\nProduct obtained by degermination of crushed maize. It consists principally of endosperm fragments and may contain some maize germ and outer skin particles\n\nCrude fibre Starch\n\n1\\.2.18 **Maize grits** ( ³ ) Hard, flinty portions of ground maize containing little or no bran or germs\n\nCrude fibre Starch\n\n1\\.2.19 **Maize germ meal feed** ( ³ ) Product of oil manufacture, obtained by extraction of processed maize germ. Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % of crude lecithins — 2 % of soap stocks\n\nCrude protein\n\n1\\.2.20 **Corn cob mix** Grains and cobs of maize\n\n1\\.2.21 **Corn cob mix with husks** Grains, cobs and husks of maize\n\n1\\.3.1 **Millet** Grains of _Panicum miliaceum_ L.\n\n1\\.4.1 **Oats** Grains of _Avena sativa_ L. and other cultivars of oats\n\n1\\.4.2 **Dehulled oats** Dehulled grains of oats\n\n1\\.4.3 **Oat flakes** Product obtained by steaming or infra red micronising and rolling dehusked oats. It may contain a small proportion of oat husks.\n\nStarch\n\n1\\.4.4 **Oat middlings** Product obtained during the processing of screened, dehusked oats into oat groats and flour. It consists principally of oat bran and some endosperm\n\nCrude fibre Starch\n\n1\\.4.5 **Oat bran** Product of flour manufacture, obtained from screened grains of dehusked oat. It consists principally of fragments of the outer skins and particles of grain from which the greater part of the endosperm has been removed.\n\nCrude fibre\n\n1\\.4.6 **Oat hulls** Product obtained during dehulling of oat grains Crude fibre\n\n1\\.4.7 **Oat, puffed** Product obtained from milled or broken oat by means of a treatment in humid, warm conditions and under pressure\n\nStarch\n\n1\\.4.8 **Oat groats** Cleaned oats with the hull removed Crude fibre Starch\n\n1\\.4.9 **Oat flour** Product obtained by milling of oat grains Crude fibre Starch\n\nEN Official Journal of the European Union 4.7.2022 L 177/17","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page14.pdf"]},"response":{"errors":[],"extract_id":"extract_402605b40c5d384ac8254e0e798774e6","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["1\\.2.17 **Crushed degerminated (degermed) maize** ( ³ )\n\nProduct obtained by degermination of crushed maize. It consists principally of endosperm fragments and may contain some maize germ and outer skin particles\n\nCrude fibre Starch\n\n1\\.2.18 **Maize grits** ( ³ ) Hard, flinty portions of ground maize containing little or no bran or germs\n\nCrude fibre Starch\n\n1\\.2.19 **Maize germ meal feed** ( ³ ) Product of oil manufacture, obtained by extraction of processed maize germ. Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % of crude lecithins — 2 % of soap stocks\n\nCrude protein\n\n1\\.2.20 **Corn cob mix** Grains and cobs of maize\n\n1\\.2.21 **Corn cob mix with husks** Grains, cobs and husks of maize\n\n1\\.3.1 **Millet** Grains of _Panicum miliaceum_ L.\n\n1\\.4.1 **Oats** Grains of _Avena sativa_ L. and other cultivars of oats\n\n1\\.4.2 **Dehulled oats** Dehulled grains of oats\n\n1\\.4.3 **Oat flakes** Product obtained by steaming or infra red micronising and rolling dehusked oats. It may contain a small proportion of oat husks.\n\nStarch\n\n1\\.4.4 **Oat middlings** Product obtained during the processing of screened, dehusked oats into oat groats and flour. It consists principally of oat bran and some endosperm\n\nCrude fibre Starch\n\n1\\.4.5 **Oat bran** Product of flour manufacture, obtained from screened grains of dehusked oat. It consists principally of fragments of the outer skins and particles of grain from which the greater part of the endosperm has been removed.\n\nCrude fibre\n\n1\\.4.6 **Oat hulls** Product obtained during dehulling of oat grains Crude fibre\n\n1\\.4.7 **Oat, puffed** Product obtained from milled or broken oat by means of a treatment in humid, warm conditions and under pressure\n\nStarch\n\n1\\.4.8 **Oat groats** Cleaned oats with the hull removed Crude fibre Starch\n\n1\\.4.9 **Oat flour** Product obtained by milling of oat grains Crude fibre Starch\n\nEN Official Journal of the European Union 4.7.2022 L 177/17"],"full_content":"1\\.2.17 **Crushed degerminated (degermed) maize** ( ³ )\n\nProduct obtained by degermination of crushed maize. It consists principally of endosperm fragments and may contain some maize germ and outer skin particles\n\nCrude fibre Starch\n\n1\\.2.18 **Maize grits** ( ³ ) Hard, flinty portions of ground maize containing little or no bran or germs\n\nCrude fibre Starch\n\n1\\.2.19 **Maize germ meal feed** ( ³ ) Product of oil manufacture, obtained by extraction of processed maize germ. Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % of crude lecithins — 2 % of soap stocks\n\nCrude protein\n\n1\\.2.20 **Corn cob mix** Grains and cobs of maize\n\n1\\.2.21 **Corn cob mix with husks** Grains, cobs and husks of maize\n\n1\\.3.1 **Millet** Grains of _Panicum miliaceum_ L.\n\n1\\.4.1 **Oats** Grains of _Avena sativa_ L. and other cultivars of oats\n\n1\\.4.2 **Dehulled oats** Dehulled grains of oats\n\n1\\.4.3 **Oat flakes** Product obtained by steaming or infra red micronising and rolling dehusked oats. It may contain a small proportion of oat husks.\n\nStarch\n\n1\\.4.4 **Oat middlings** Product obtained during the processing of screened, dehusked oats into oat groats and flour. It consists principally of oat bran and some endosperm\n\nCrude fibre Starch\n\n1\\.4.5 **Oat bran** Product of flour manufacture, obtained from screened grains of dehusked oat. It consists principally of fragments of the outer skins and particles of grain from which the greater part of the endosperm has been removed.\n\nCrude fibre\n\n1\\.4.6 **Oat hulls** Product obtained during dehulling of oat grains Crude fibre\n\n1\\.4.7 **Oat, puffed** Product obtained from milled or broken oat by means of a treatment in humid, warm conditions and under pressure\n\nStarch\n\n1\\.4.8 **Oat groats** Cleaned oats with the hull removed Crude fibre Starch\n\n1\\.4.9 **Oat flour** Product obtained by milling of oat grains Crude fibre Starch\n\nEN Official Journal of the European Union 4.7.2022 L 177/17","publish_date":null,"title":"EN Official Journal of the European Union 4.7.2022 L 177/17 1.2.17 Crushed degerminated Product obtained by degermination of crushed Crude","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page14.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page14.pdf"},"request":{"example_id":"table/1657221585_page14","product_type":"parse","source_file_path":"1657221585_page14.pdf"},"started_at":"2026-11-04T19:48:13.067849"} +{"completed_at":"2026-11-04T19:48:17.244638","latency_in_ms":2609,"output":{"example_id":"table/1657221585_page19","grounded_pages":[],"layout_pages":[],"markdown":"1\\.11.19 **Liquid wheat starch** Product obtained from the production of starch/glucose and gluten from wheat\n\nMoisture, if < 65 % or > 85 % If moisture < 65 %: — Starch\n\n1\\.11.20 **Wheat starch containing protein, partially de-sugared**\n\nProduct obtained during the production of wheat starch mainly comprising partially sugared starch, the soluble proteins and other soluble parts of the endosperm\n\nCrude protein Starch Total sugars calculated as sucrose\n\n1\\.11.21 **Wheat solubles** Product of wheat obtained after wet protein and starch extraction. May be hydrolysed\n\nMoisture if < 55 % or > 85 % If moisture < 55 %: — Crude protein\n\n1\\.11.22 **Wheat yeast concentrate** Wet co-product that is released after the fermentation of wheat starch for alcohol production\n\nMoisture, if < 60 % or > 80 % If moisture < 60 %: — Crude protein\n\n1\\.11.23 **Malting wheat screenings** Product from mechanical screening (size fractionation) consisting of undersized wheat kernels and fractions of wheat kernels separated before the malting process\n\nCrude fibre\n\n1\\.11.24 **Malting wheat and malt fines**\n\nProduct consisting of fractions of wheat kernels and malt separated during the production of malt\n\nCrude fibre\n\n1\\.11.25 **Malting wheat husks** Product from malting wheat cleaning consisting of fractions of husk and fines\n\nCrude fibre\n\n1\\.11.26 **Wheat aleurone** Product obtained by splitting the layer of aleurone from wheat bran\n\nCrude protein Crude fiber\n\n1\\.12.2 **Grain flour** ( ² ) Flour from milling grains Starch Crude fibre\n\n1\\.12.3 **Grain protein concentrate** ( ² )\n\nConcentrate and dried product obtained from grain after starch removal through yeast fermentation\n\nCrude protein\n\n1\\.12.4 **Cereal grains screenings** ( ² )\n\nProducts from mechanical screening (size fractionation) consisting of small grains and fractions of grain kernels, which may be germinated, separated before further processing of the grain. The products contain more crude fibre (e. g. hulls) than the unfractionated cereals\n\nCrude fibre\n\n1\\.12.5 **Grain germ** ( ² ) Product of flour milling and the manufacture of starch consisting principally of grain germ, rolled or otherwise, to which fragments of endosperm and outer skin may still adhere\n\nCrude protein, Crude fat\n\nEN Official Journal of the European Union L 177/22 4.7.2022","pages":[{"line_numbers":[],"markdown":"1\\.11.19 **Liquid wheat starch** Product obtained from the production of starch/glucose and gluten from wheat\n\nMoisture, if < 65 % or > 85 % If moisture < 65 %: — Starch\n\n1\\.11.20 **Wheat starch containing protein, partially de-sugared**\n\nProduct obtained during the production of wheat starch mainly comprising partially sugared starch, the soluble proteins and other soluble parts of the endosperm\n\nCrude protein Starch Total sugars calculated as sucrose\n\n1\\.11.21 **Wheat solubles** Product of wheat obtained after wet protein and starch extraction. May be hydrolysed\n\nMoisture if < 55 % or > 85 % If moisture < 55 %: — Crude protein\n\n1\\.11.22 **Wheat yeast concentrate** Wet co-product that is released after the fermentation of wheat starch for alcohol production\n\nMoisture, if < 60 % or > 80 % If moisture < 60 %: — Crude protein\n\n1\\.11.23 **Malting wheat screenings** Product from mechanical screening (size fractionation) consisting of undersized wheat kernels and fractions of wheat kernels separated before the malting process\n\nCrude fibre\n\n1\\.11.24 **Malting wheat and malt fines**\n\nProduct consisting of fractions of wheat kernels and malt separated during the production of malt\n\nCrude fibre\n\n1\\.11.25 **Malting wheat husks** Product from malting wheat cleaning consisting of fractions of husk and fines\n\nCrude fibre\n\n1\\.11.26 **Wheat aleurone** Product obtained by splitting the layer of aleurone from wheat bran\n\nCrude protein Crude fiber\n\n1\\.12.2 **Grain flour** ( ² ) Flour from milling grains Starch Crude fibre\n\n1\\.12.3 **Grain protein concentrate** ( ² )\n\nConcentrate and dried product obtained from grain after starch removal through yeast fermentation\n\nCrude protein\n\n1\\.12.4 **Cereal grains screenings** ( ² )\n\nProducts from mechanical screening (size fractionation) consisting of small grains and fractions of grain kernels, which may be germinated, separated before further processing of the grain. The products contain more crude fibre (e. g. hulls) than the unfractionated cereals\n\nCrude fibre\n\n1\\.12.5 **Grain germ** ( ² ) Product of flour milling and the manufacture of starch consisting principally of grain germ, rolled or otherwise, to which fragments of endosperm and outer skin may still adhere\n\nCrude protein, Crude fat\n\nEN Official Journal of the European Union L 177/22 4.7.2022","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"1\\.11.19 **Liquid wheat starch** Product obtained from the production of starch/glucose and gluten from wheat\n\nMoisture, if < 65 % or > 85 % If moisture < 65 %: — Starch\n\n1\\.11.20 **Wheat starch containing protein, partially de-sugared**\n\nProduct obtained during the production of wheat starch mainly comprising partially sugared starch, the soluble proteins and other soluble parts of the endosperm\n\nCrude protein Starch Total sugars calculated as sucrose\n\n1\\.11.21 **Wheat solubles** Product of wheat obtained after wet protein and starch extraction. May be hydrolysed\n\nMoisture if < 55 % or > 85 % If moisture < 55 %: — Crude protein\n\n1\\.11.22 **Wheat yeast concentrate** Wet co-product that is released after the fermentation of wheat starch for alcohol production\n\nMoisture, if < 60 % or > 80 % If moisture < 60 %: — Crude protein\n\n1\\.11.23 **Malting wheat screenings** Product from mechanical screening (size fractionation) consisting of undersized wheat kernels and fractions of wheat kernels separated before the malting process\n\nCrude fibre\n\n1\\.11.24 **Malting wheat and malt fines**\n\nProduct consisting of fractions of wheat kernels and malt separated during the production of malt\n\nCrude fibre\n\n1\\.11.25 **Malting wheat husks** Product from malting wheat cleaning consisting of fractions of husk and fines\n\nCrude fibre\n\n1\\.11.26 **Wheat aleurone** Product obtained by splitting the layer of aleurone from wheat bran\n\nCrude protein Crude fiber\n\n1\\.12.2 **Grain flour** ( ² ) Flour from milling grains Starch Crude fibre\n\n1\\.12.3 **Grain protein concentrate** ( ² )\n\nConcentrate and dried product obtained from grain after starch removal through yeast fermentation\n\nCrude protein\n\n1\\.12.4 **Cereal grains screenings** ( ² )\n\nProducts from mechanical screening (size fractionation) consisting of small grains and fractions of grain kernels, which may be germinated, separated before further processing of the grain. The products contain more crude fibre (e. g. hulls) than the unfractionated cereals\n\nCrude fibre\n\n1\\.12.5 **Grain germ** ( ² ) Product of flour milling and the manufacture of starch consisting principally of grain germ, rolled or otherwise, to which fragments of endosperm and outer skin may still adhere\n\nCrude protein, Crude fat\n\nEN Official Journal of the European Union L 177/22 4.7.2022","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page19.pdf"]},"response":{"errors":[],"extract_id":"extract_6bfe106342022b30c6405cdc6d39d54a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["1\\.11.19 **Liquid wheat starch** Product obtained from the production of starch/glucose and gluten from wheat\n\nMoisture, if < 65 % or > 85 % If moisture < 65 %: — Starch\n\n1\\.11.20 **Wheat starch containing protein, partially de-sugared**\n\nProduct obtained during the production of wheat starch mainly comprising partially sugared starch, the soluble proteins and other soluble parts of the endosperm\n\nCrude protein Starch Total sugars calculated as sucrose\n\n1\\.11.21 **Wheat solubles** Product of wheat obtained after wet protein and starch extraction. May be hydrolysed\n\nMoisture if < 55 % or > 85 % If moisture < 55 %: — Crude protein\n\n1\\.11.22 **Wheat yeast concentrate** Wet co-product that is released after the fermentation of wheat starch for alcohol production\n\nMoisture, if < 60 % or > 80 % If moisture < 60 %: — Crude protein\n\n1\\.11.23 **Malting wheat screenings** Product from mechanical screening (size fractionation) consisting of undersized wheat kernels and fractions of wheat kernels separated before the malting process\n\nCrude fibre\n\n1\\.11.24 **Malting wheat and malt fines**\n\nProduct consisting of fractions of wheat kernels and malt separated during the production of malt\n\nCrude fibre\n\n1\\.11.25 **Malting wheat husks** Product from malting wheat cleaning consisting of fractions of husk and fines\n\nCrude fibre\n\n1\\.11.26 **Wheat aleurone** Product obtained by splitting the layer of aleurone from wheat bran\n\nCrude protein Crude fiber\n\n1\\.12.2 **Grain flour** ( ² ) Flour from milling grains Starch Crude fibre\n\n1\\.12.3 **Grain protein concentrate** ( ² )\n\nConcentrate and dried product obtained from grain after starch removal through yeast fermentation\n\nCrude protein\n\n1\\.12.4 **Cereal grains screenings** ( ² )\n\nProducts from mechanical screening (size fractionation) consisting of small grains and fractions of grain kernels, which may be germinated, separated before further processing of the grain. The products contain more crude fibre (e. g. hulls) than the unfractionated cereals\n\nCrude fibre\n\n1\\.12.5 **Grain germ** ( ² ) Product of flour milling and the manufacture of starch consisting principally of grain germ, rolled or otherwise, to which fragments of endosperm and outer skin may still adhere\n\nCrude protein, Crude fat\n\nEN Official Journal of the European Union L 177/22 4.7.2022"],"full_content":"1\\.11.19 **Liquid wheat starch** Product obtained from the production of starch/glucose and gluten from wheat\n\nMoisture, if < 65 % or > 85 % If moisture < 65 %: — Starch\n\n1\\.11.20 **Wheat starch containing protein, partially de-sugared**\n\nProduct obtained during the production of wheat starch mainly comprising partially sugared starch, the soluble proteins and other soluble parts of the endosperm\n\nCrude protein Starch Total sugars calculated as sucrose\n\n1\\.11.21 **Wheat solubles** Product of wheat obtained after wet protein and starch extraction. May be hydrolysed\n\nMoisture if < 55 % or > 85 % If moisture < 55 %: — Crude protein\n\n1\\.11.22 **Wheat yeast concentrate** Wet co-product that is released after the fermentation of wheat starch for alcohol production\n\nMoisture, if < 60 % or > 80 % If moisture < 60 %: — Crude protein\n\n1\\.11.23 **Malting wheat screenings** Product from mechanical screening (size fractionation) consisting of undersized wheat kernels and fractions of wheat kernels separated before the malting process\n\nCrude fibre\n\n1\\.11.24 **Malting wheat and malt fines**\n\nProduct consisting of fractions of wheat kernels and malt separated during the production of malt\n\nCrude fibre\n\n1\\.11.25 **Malting wheat husks** Product from malting wheat cleaning consisting of fractions of husk and fines\n\nCrude fibre\n\n1\\.11.26 **Wheat aleurone** Product obtained by splitting the layer of aleurone from wheat bran\n\nCrude protein Crude fiber\n\n1\\.12.2 **Grain flour** ( ² ) Flour from milling grains Starch Crude fibre\n\n1\\.12.3 **Grain protein concentrate** ( ² )\n\nConcentrate and dried product obtained from grain after starch removal through yeast fermentation\n\nCrude protein\n\n1\\.12.4 **Cereal grains screenings** ( ² )\n\nProducts from mechanical screening (size fractionation) consisting of small grains and fractions of grain kernels, which may be germinated, separated before further processing of the grain. The products contain more crude fibre (e. g. hulls) than the unfractionated cereals\n\nCrude fibre\n\n1\\.12.5 **Grain germ** ( ² ) Product of flour milling and the manufacture of starch consisting principally of grain germ, rolled or otherwise, to which fragments of endosperm and outer skin may still adhere\n\nCrude protein, Crude fat\n\nEN Official Journal of the European Union L 177/22 4.7.2022","publish_date":null,"title":"EN Official Journal of the European Union L 177/22 4.7.2022 1.11.19 Liquid wheat starch Product obtained from the production of","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page19.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page19.pdf"},"request":{"example_id":"table/1657221585_page19","product_type":"parse","source_file_path":"1657221585_page19.pdf"},"started_at":"2026-11-04T19:48:14.634830"} +{"completed_at":"2026-11-04T19:48:17.359165","latency_in_ms":1330,"output":{"example_id":"table/1657221585_page26","grounded_pages":[],"layout_pages":[],"markdown":"2\\.18.7 **Soya (bean) protein concentrate**\n\nProduct obtained from dehulled, fat extracted soya beans, after a second extraction or enzymatic treatment to reduce the level of nitrogen-free extract. May contain inactivated enzymes\n\nCrude protein\n\n2\\.18.8 **Soya bean pulp [Soya bean paste]**\n\nProduct obtained during extraction of soya beans for food preparation\n\nCrude protein\n\n2\\.18.9 **Soya bean molasses** Product obtained during the processing of soya bean Crude protein Crude fat\n\n2\\.18.10 **Co-product from soybean preparation**\n\nProducts obtained when processing soybeans to obtain soybean food preparations\n\nCrude protein\n\n2\\.18.11 **Soya (beans)** Soya beans ( _Glycine max_ L. Merr.) Urease activity if > 0,4 mg N/g × min\n\n2\\.18.12 **Soybean, flakes** Product obtained by steaming or infrared micronising and rolling dehulled soya beans (Urease activity maximum 0,4 mg N/g × min.)\n\nCrude protein\n\n2\\.18.13 **Soya (bean) meal feed** Product of oil manufacture, obtained from soya beans after extraction and appropriate heat treatment. (Urease activity maximum 0,4 mg N/g × min.). Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % crude lecithins — 1,5 % soap stocks\n\nCrude protein Crude fibre if > 8 % in dry matter\n\n2\\.18.14 **Soya (bean) meal feed, dehulled**\n\nProduct of oil manufacture, obtained from dehulled soya beans after extraction and appropriate heat treatment. (Urease activity maximum 0,5 mg N/g × min.). Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % crude lecithins — 1,5 % soap stocks\n\nCrude protein\n\n2\\.18.15 **Fermented soya (bean) protein (concentrate)**\n\nProduct obtained from dehulled, fat extracted soya beans, after microbial fermentation to reduce the level of nitrogen-free extract. It may also include dead cells and/or parts thereof of the fermentation micro-organisms used\n\nCrude protein\n\nEN Official Journal of the European Union 4.7.2022 L 177/29","pages":[{"line_numbers":[],"markdown":"2\\.18.7 **Soya (bean) protein concentrate**\n\nProduct obtained from dehulled, fat extracted soya beans, after a second extraction or enzymatic treatment to reduce the level of nitrogen-free extract. May contain inactivated enzymes\n\nCrude protein\n\n2\\.18.8 **Soya bean pulp [Soya bean paste]**\n\nProduct obtained during extraction of soya beans for food preparation\n\nCrude protein\n\n2\\.18.9 **Soya bean molasses** Product obtained during the processing of soya bean Crude protein Crude fat\n\n2\\.18.10 **Co-product from soybean preparation**\n\nProducts obtained when processing soybeans to obtain soybean food preparations\n\nCrude protein\n\n2\\.18.11 **Soya (beans)** Soya beans ( _Glycine max_ L. Merr.) Urease activity if > 0,4 mg N/g × min\n\n2\\.18.12 **Soybean, flakes** Product obtained by steaming or infrared micronising and rolling dehulled soya beans (Urease activity maximum 0,4 mg N/g × min.)\n\nCrude protein\n\n2\\.18.13 **Soya (bean) meal feed** Product of oil manufacture, obtained from soya beans after extraction and appropriate heat treatment. (Urease activity maximum 0,4 mg N/g × min.). Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % crude lecithins — 1,5 % soap stocks\n\nCrude protein Crude fibre if > 8 % in dry matter\n\n2\\.18.14 **Soya (bean) meal feed, dehulled**\n\nProduct of oil manufacture, obtained from dehulled soya beans after extraction and appropriate heat treatment. (Urease activity maximum 0,5 mg N/g × min.). Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % crude lecithins — 1,5 % soap stocks\n\nCrude protein\n\n2\\.18.15 **Fermented soya (bean) protein (concentrate)**\n\nProduct obtained from dehulled, fat extracted soya beans, after microbial fermentation to reduce the level of nitrogen-free extract. It may also include dead cells and/or parts thereof of the fermentation micro-organisms used\n\nCrude protein\n\nEN Official Journal of the European Union 4.7.2022 L 177/29","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"2\\.18.7 **Soya (bean) protein concentrate**\n\nProduct obtained from dehulled, fat extracted soya beans, after a second extraction or enzymatic treatment to reduce the level of nitrogen-free extract. May contain inactivated enzymes\n\nCrude protein\n\n2\\.18.8 **Soya bean pulp [Soya bean paste]**\n\nProduct obtained during extraction of soya beans for food preparation\n\nCrude protein\n\n2\\.18.9 **Soya bean molasses** Product obtained during the processing of soya bean Crude protein Crude fat\n\n2\\.18.10 **Co-product from soybean preparation**\n\nProducts obtained when processing soybeans to obtain soybean food preparations\n\nCrude protein\n\n2\\.18.11 **Soya (beans)** Soya beans ( _Glycine max_ L. Merr.) Urease activity if > 0,4 mg N/g × min\n\n2\\.18.12 **Soybean, flakes** Product obtained by steaming or infrared micronising and rolling dehulled soya beans (Urease activity maximum 0,4 mg N/g × min.)\n\nCrude protein\n\n2\\.18.13 **Soya (bean) meal feed** Product of oil manufacture, obtained from soya beans after extraction and appropriate heat treatment. (Urease activity maximum 0,4 mg N/g × min.). Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % crude lecithins — 1,5 % soap stocks\n\nCrude protein Crude fibre if > 8 % in dry matter\n\n2\\.18.14 **Soya (bean) meal feed, dehulled**\n\nProduct of oil manufacture, obtained from dehulled soya beans after extraction and appropriate heat treatment. (Urease activity maximum 0,5 mg N/g × min.). Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % crude lecithins — 1,5 % soap stocks\n\nCrude protein\n\n2\\.18.15 **Fermented soya (bean) protein (concentrate)**\n\nProduct obtained from dehulled, fat extracted soya beans, after microbial fermentation to reduce the level of nitrogen-free extract. It may also include dead cells and/or parts thereof of the fermentation micro-organisms used\n\nCrude protein\n\nEN Official Journal of the European Union 4.7.2022 L 177/29","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page26.pdf"]},"response":{"errors":[],"extract_id":"extract_bee1dc015f36896e97256195ea6d5d74","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["2\\.18.7 **Soya (bean) protein concentrate**\n\nProduct obtained from dehulled, fat extracted soya beans, after a second extraction or enzymatic treatment to reduce the level of nitrogen-free extract. May contain inactivated enzymes\n\nCrude protein\n\n2\\.18.8 **Soya bean pulp [Soya bean paste]**\n\nProduct obtained during extraction of soya beans for food preparation\n\nCrude protein\n\n2\\.18.9 **Soya bean molasses** Product obtained during the processing of soya bean Crude protein Crude fat\n\n2\\.18.10 **Co-product from soybean preparation**\n\nProducts obtained when processing soybeans to obtain soybean food preparations\n\nCrude protein\n\n2\\.18.11 **Soya (beans)** Soya beans ( _Glycine max_ L. Merr.) Urease activity if > 0,4 mg N/g × min\n\n2\\.18.12 **Soybean, flakes** Product obtained by steaming or infrared micronising and rolling dehulled soya beans (Urease activity maximum 0,4 mg N/g × min.)\n\nCrude protein\n\n2\\.18.13 **Soya (bean) meal feed** Product of oil manufacture, obtained from soya beans after extraction and appropriate heat treatment. (Urease activity maximum 0,4 mg N/g × min.). Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % crude lecithins — 1,5 % soap stocks\n\nCrude protein Crude fibre if > 8 % in dry matter\n\n2\\.18.14 **Soya (bean) meal feed, dehulled**\n\nProduct of oil manufacture, obtained from dehulled soya beans after extraction and appropriate heat treatment. (Urease activity maximum 0,5 mg N/g × min.). Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % crude lecithins — 1,5 % soap stocks\n\nCrude protein\n\n2\\.18.15 **Fermented soya (bean) protein (concentrate)**\n\nProduct obtained from dehulled, fat extracted soya beans, after microbial fermentation to reduce the level of nitrogen-free extract. It may also include dead cells and/or parts thereof of the fermentation micro-organisms used\n\nCrude protein\n\nEN Official Journal of the European Union 4.7.2022 L 177/29"],"full_content":"2\\.18.7 **Soya (bean) protein concentrate**\n\nProduct obtained from dehulled, fat extracted soya beans, after a second extraction or enzymatic treatment to reduce the level of nitrogen-free extract. May contain inactivated enzymes\n\nCrude protein\n\n2\\.18.8 **Soya bean pulp [Soya bean paste]**\n\nProduct obtained during extraction of soya beans for food preparation\n\nCrude protein\n\n2\\.18.9 **Soya bean molasses** Product obtained during the processing of soya bean Crude protein Crude fat\n\n2\\.18.10 **Co-product from soybean preparation**\n\nProducts obtained when processing soybeans to obtain soybean food preparations\n\nCrude protein\n\n2\\.18.11 **Soya (beans)** Soya beans ( _Glycine max_ L. Merr.) Urease activity if > 0,4 mg N/g × min\n\n2\\.18.12 **Soybean, flakes** Product obtained by steaming or infrared micronising and rolling dehulled soya beans (Urease activity maximum 0,4 mg N/g × min.)\n\nCrude protein\n\n2\\.18.13 **Soya (bean) meal feed** Product of oil manufacture, obtained from soya beans after extraction and appropriate heat treatment. (Urease activity maximum 0,4 mg N/g × min.). Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % crude lecithins — 1,5 % soap stocks\n\nCrude protein Crude fibre if > 8 % in dry matter\n\n2\\.18.14 **Soya (bean) meal feed, dehulled**\n\nProduct of oil manufacture, obtained from dehulled soya beans after extraction and appropriate heat treatment. (Urease activity maximum 0,5 mg N/g × min.). Only when produced at an integrated crushing and refining site, the product may contain up to: — 1 % of the sum of used bleaching earth and filter aid (e.g. diatomaceous earth, amorphous sili­ cates and silica, phyllosilicates and cellulosic or wood fibres)\n\n— 1,3 % crude lecithins — 1,5 % soap stocks\n\nCrude protein\n\n2\\.18.15 **Fermented soya (bean) protein (concentrate)**\n\nProduct obtained from dehulled, fat extracted soya beans, after microbial fermentation to reduce the level of nitrogen-free extract. It may also include dead cells and/or parts thereof of the fermentation micro-organisms used\n\nCrude protein\n\nEN Official Journal of the European Union 4.7.2022 L 177/29","publish_date":null,"title":"EN Official Journal of the European Union 4.7.2022 L 177/29 2.18.7 Soya (bean) protein Product obtained from dehulled, fat extracted","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page26.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page26.pdf"},"request":{"example_id":"table/1657221585_page26","product_type":"parse","source_file_path":"1657221585_page26.pdf"},"started_at":"2026-11-04T19:48:16.028382"} +{"completed_at":"2026-11-04T19:48:18.988596","latency_in_ms":1739,"output":{"example_id":"table/1657221585_page40","grounded_pages":[],"layout_pages":[],"markdown":"6\\. **Forages and roughage, and products derived thereof**\n\nNumber Name ¹ Description Compulsory declarations\n\n6\\.1.1 **Beet leaves** Leaves of _Beta_ spp.\n\n6\\.2.1 **Cereal plants** **11** Whole plants of cereal species or parts thereof Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.3.1 **Cereals straw** **11** Straw of cereals\n\n6\\.3.2 **Cereal straw, treated** **11** Product obtained by an appropriate treatment of cereal straw\n\nSodium, if treated with NaOH\n\n6\\.4.1 **Clover meal** Product obtained by drying and milling clover _Trifolium_ spp. It may contain up to 20 % lucerne ( _Medicago sativa_ L. and _Medicago_ var. _Martyn_ ) or other forage crops dried and milled at the same time as the clover\n\nCrude protein Crude fibre Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.5.1 **Forage meal** ( ¹ ) **[grass meal** ( ¹ ) **]; [green meal** ( ¹ )]\n\nProduct obtained by drying and milling and in some cases compacting forage plants ( ² )\n\nCrude protein Crude fibre Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.1 **Hay** Species of any grass or legumes plants or herbs, field dried or artificially dried\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.2 **Grass; herbs; legume plants, dried**\n\nProduct obtained from grass, herbs or legume plants that has been artificially dehydrated (in any form)\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.3 **Grass; herbs; legume plants; [green forage]**\n\nFresh biomass consisting of grass, legume plants or herbs\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.4 **Green silage** Ensiled biomass from arable land and grassland consisting of any grass, legume plants or herbs\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.5 **Haylage** Ensiled or dried arable crops consisting of grass, legume plants or herbs with a minimum of 50 % dry matter content, wrapped in bales or stored in silos\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.7.1 **Hemp flour** Flour ground from stems from hemp from varieties of _Cannabis sativa_ L. with a tetrahydrocannabinol content < 0,2 % according to the quantification method established in Regulation (EU) No 639/2014\n\nCrude protein\n\n6\\.7.2 **Hemp fibre** Product obtained during the mechanical processing of hemp stems from varieties of _Cannabis sativa_ L. with a tetrahydrocannabinol content < 0,2 % according to the quantification method established in Regulation (EU) No 639/2014\n\nCrude fibre\n\n6\\.8.1 **Horse bean straw** Straw of horse bean ( _Vicia faba_ L. ssp. _faba_ var. _equina_ Pers. and var. _minuta_ (Alef.) Mansf.)\n\nEN Official Journal of the European Union 4.7.2022 L 177/43","pages":[{"line_numbers":[],"markdown":"6\\. **Forages and roughage, and products derived thereof**\n\nNumber Name ¹ Description Compulsory declarations\n\n6\\.1.1 **Beet leaves** Leaves of _Beta_ spp.\n\n6\\.2.1 **Cereal plants** **11** Whole plants of cereal species or parts thereof Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.3.1 **Cereals straw** **11** Straw of cereals\n\n6\\.3.2 **Cereal straw, treated** **11** Product obtained by an appropriate treatment of cereal straw\n\nSodium, if treated with NaOH\n\n6\\.4.1 **Clover meal** Product obtained by drying and milling clover _Trifolium_ spp. It may contain up to 20 % lucerne ( _Medicago sativa_ L. and _Medicago_ var. _Martyn_ ) or other forage crops dried and milled at the same time as the clover\n\nCrude protein Crude fibre Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.5.1 **Forage meal** ( ¹ ) **[grass meal** ( ¹ ) **]; [green meal** ( ¹ )]\n\nProduct obtained by drying and milling and in some cases compacting forage plants ( ² )\n\nCrude protein Crude fibre Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.1 **Hay** Species of any grass or legumes plants or herbs, field dried or artificially dried\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.2 **Grass; herbs; legume plants, dried**\n\nProduct obtained from grass, herbs or legume plants that has been artificially dehydrated (in any form)\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.3 **Grass; herbs; legume plants; [green forage]**\n\nFresh biomass consisting of grass, legume plants or herbs\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.4 **Green silage** Ensiled biomass from arable land and grassland consisting of any grass, legume plants or herbs\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.5 **Haylage** Ensiled or dried arable crops consisting of grass, legume plants or herbs with a minimum of 50 % dry matter content, wrapped in bales or stored in silos\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.7.1 **Hemp flour** Flour ground from stems from hemp from varieties of _Cannabis sativa_ L. with a tetrahydrocannabinol content < 0,2 % according to the quantification method established in Regulation (EU) No 639/2014\n\nCrude protein\n\n6\\.7.2 **Hemp fibre** Product obtained during the mechanical processing of hemp stems from varieties of _Cannabis sativa_ L. with a tetrahydrocannabinol content < 0,2 % according to the quantification method established in Regulation (EU) No 639/2014\n\nCrude fibre\n\n6\\.8.1 **Horse bean straw** Straw of horse bean ( _Vicia faba_ L. ssp. _faba_ var. _equina_ Pers. and var. _minuta_ (Alef.) Mansf.)\n\nEN Official Journal of the European Union 4.7.2022 L 177/43","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"6\\. **Forages and roughage, and products derived thereof**\n\nNumber Name ¹ Description Compulsory declarations\n\n6\\.1.1 **Beet leaves** Leaves of _Beta_ spp.\n\n6\\.2.1 **Cereal plants** **11** Whole plants of cereal species or parts thereof Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.3.1 **Cereals straw** **11** Straw of cereals\n\n6\\.3.2 **Cereal straw, treated** **11** Product obtained by an appropriate treatment of cereal straw\n\nSodium, if treated with NaOH\n\n6\\.4.1 **Clover meal** Product obtained by drying and milling clover _Trifolium_ spp. It may contain up to 20 % lucerne ( _Medicago sativa_ L. and _Medicago_ var. _Martyn_ ) or other forage crops dried and milled at the same time as the clover\n\nCrude protein Crude fibre Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.5.1 **Forage meal** ( ¹ ) **[grass meal** ( ¹ ) **]; [green meal** ( ¹ )]\n\nProduct obtained by drying and milling and in some cases compacting forage plants ( ² )\n\nCrude protein Crude fibre Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.1 **Hay** Species of any grass or legumes plants or herbs, field dried or artificially dried\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.2 **Grass; herbs; legume plants, dried**\n\nProduct obtained from grass, herbs or legume plants that has been artificially dehydrated (in any form)\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.3 **Grass; herbs; legume plants; [green forage]**\n\nFresh biomass consisting of grass, legume plants or herbs\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.4 **Green silage** Ensiled biomass from arable land and grassland consisting of any grass, legume plants or herbs\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.5 **Haylage** Ensiled or dried arable crops consisting of grass, legume plants or herbs with a minimum of 50 % dry matter content, wrapped in bales or stored in silos\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.7.1 **Hemp flour** Flour ground from stems from hemp from varieties of _Cannabis sativa_ L. with a tetrahydrocannabinol content < 0,2 % according to the quantification method established in Regulation (EU) No 639/2014\n\nCrude protein\n\n6\\.7.2 **Hemp fibre** Product obtained during the mechanical processing of hemp stems from varieties of _Cannabis sativa_ L. with a tetrahydrocannabinol content < 0,2 % according to the quantification method established in Regulation (EU) No 639/2014\n\nCrude fibre\n\n6\\.8.1 **Horse bean straw** Straw of horse bean ( _Vicia faba_ L. ssp. _faba_ var. _equina_ Pers. and var. _minuta_ (Alef.) Mansf.)\n\nEN Official Journal of the European Union 4.7.2022 L 177/43","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page40.pdf"]},"response":{"errors":[],"extract_id":"extract_4857b52dad410384c5a95494446233ff","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["6\\. **Forages and roughage, and products derived thereof**\n\nNumber Name ¹ Description Compulsory declarations\n\n6\\.1.1 **Beet leaves** Leaves of _Beta_ spp.\n\n6\\.2.1 **Cereal plants** **11** Whole plants of cereal species or parts thereof Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.3.1 **Cereals straw** **11** Straw of cereals\n\n6\\.3.2 **Cereal straw, treated** **11** Product obtained by an appropriate treatment of cereal straw\n\nSodium, if treated with NaOH\n\n6\\.4.1 **Clover meal** Product obtained by drying and milling clover _Trifolium_ spp. It may contain up to 20 % lucerne ( _Medicago sativa_ L. and _Medicago_ var. _Martyn_ ) or other forage crops dried and milled at the same time as the clover\n\nCrude protein Crude fibre Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.5.1 **Forage meal** ( ¹ ) **[grass meal** ( ¹ ) **]; [green meal** ( ¹ )]\n\nProduct obtained by drying and milling and in some cases compacting forage plants ( ² )\n\nCrude protein Crude fibre Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.1 **Hay** Species of any grass or legumes plants or herbs, field dried or artificially dried\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.2 **Grass; herbs; legume plants, dried**\n\nProduct obtained from grass, herbs or legume plants that has been artificially dehydrated (in any form)\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.3 **Grass; herbs; legume plants; [green forage]**\n\nFresh biomass consisting of grass, legume plants or herbs\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.4 **Green silage** Ensiled biomass from arable land and grassland consisting of any grass, legume plants or herbs\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.5 **Haylage** Ensiled or dried arable crops consisting of grass, legume plants or herbs with a minimum of 50 % dry matter content, wrapped in bales or stored in silos\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.7.1 **Hemp flour** Flour ground from stems from hemp from varieties of _Cannabis sativa_ L. with a tetrahydrocannabinol content < 0,2 % according to the quantification method established in Regulation (EU) No 639/2014\n\nCrude protein\n\n6\\.7.2 **Hemp fibre** Product obtained during the mechanical processing of hemp stems from varieties of _Cannabis sativa_ L. with a tetrahydrocannabinol content < 0,2 % according to the quantification method established in Regulation (EU) No 639/2014\n\nCrude fibre\n\n6\\.8.1 **Horse bean straw** Straw of horse bean ( _Vicia faba_ L. ssp. _faba_ var. _equina_ Pers. and var. _minuta_ (Alef.) Mansf.)\n\nEN Official Journal of the European Union 4.7.2022 L 177/43"],"full_content":"6\\. **Forages and roughage, and products derived thereof**\n\nNumber Name ¹ Description Compulsory declarations\n\n6\\.1.1 **Beet leaves** Leaves of _Beta_ spp.\n\n6\\.2.1 **Cereal plants** **11** Whole plants of cereal species or parts thereof Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.3.1 **Cereals straw** **11** Straw of cereals\n\n6\\.3.2 **Cereal straw, treated** **11** Product obtained by an appropriate treatment of cereal straw\n\nSodium, if treated with NaOH\n\n6\\.4.1 **Clover meal** Product obtained by drying and milling clover _Trifolium_ spp. It may contain up to 20 % lucerne ( _Medicago sativa_ L. and _Medicago_ var. _Martyn_ ) or other forage crops dried and milled at the same time as the clover\n\nCrude protein Crude fibre Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.5.1 **Forage meal** ( ¹ ) **[grass meal** ( ¹ ) **]; [green meal** ( ¹ )]\n\nProduct obtained by drying and milling and in some cases compacting forage plants ( ² )\n\nCrude protein Crude fibre Ash insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.1 **Hay** Species of any grass or legumes plants or herbs, field dried or artificially dried\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.2 **Grass; herbs; legume plants, dried**\n\nProduct obtained from grass, herbs or legume plants that has been artificially dehydrated (in any form)\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.3 **Grass; herbs; legume plants; [green forage]**\n\nFresh biomass consisting of grass, legume plants or herbs\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.4 **Green silage** Ensiled biomass from arable land and grassland consisting of any grass, legume plants or herbs\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.6.5 **Haylage** Ensiled or dried arable crops consisting of grass, legume plants or herbs with a minimum of 50 % dry matter content, wrapped in bales or stored in silos\n\nAsh insoluble, in HCl, if > 3,5 % of dry matter\n\n6\\.7.1 **Hemp flour** Flour ground from stems from hemp from varieties of _Cannabis sativa_ L. with a tetrahydrocannabinol content < 0,2 % according to the quantification method established in Regulation (EU) No 639/2014\n\nCrude protein\n\n6\\.7.2 **Hemp fibre** Product obtained during the mechanical processing of hemp stems from varieties of _Cannabis sativa_ L. with a tetrahydrocannabinol content < 0,2 % according to the quantification method established in Regulation (EU) No 639/2014\n\nCrude fibre\n\n6\\.8.1 **Horse bean straw** Straw of horse bean ( _Vicia faba_ L. ssp. _faba_ var. _equina_ Pers. and var. _minuta_ (Alef.) Mansf.)\n\nEN Official Journal of the European Union 4.7.2022 L 177/43","publish_date":null,"title":"EN Official Journal of the European Union 4.7.2022 L 177/43 6. Forages and roughage, and products derived thereof 6.1.1 Beet","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page40.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page40.pdf"},"request":{"example_id":"table/1657221585_page40","product_type":"parse","source_file_path":"1657221585_page40.pdf"},"started_at":"2026-11-04T19:48:17.248929"} +{"completed_at":"2026-11-04T19:48:21.606834","latency_in_ms":3289,"output":{"example_id":"table/1657221585_page6","grounded_pages":[],"layout_pages":[],"markdown":"(16) If a feed material listed in part C, for which it is required in a footnote that the name shall be supplemented with the species, consists of several species, it can only be considered as a feed material, when the characteristics and the origin of the plants or the animals used for the feed materials, or parts thereof, are the same.\n\nPART B\n\n**Glossary of processes**\n\nProcess Definition Common name/qualifier\n\n1 **Air fractionation** Separation of particles by means of an air stream Air fractionated\n\n2 **Aspiration** Process to remove dust, fine particles and other particulates with suspended grain fines from bulk grain during transfer by means of an air-flow\n\nAspirated\n\n3 **Blanching** Process consisting of heat treatment of an organic substance by boiling or steaming in order to denature natural enzymes, soften tissue and remove raw flavouring, followed by immersion in cold water to halt the cooking process\n\nBlanched\n\n4 **Bleaching** Removing naturally occurring colour by chemical or physical processes or by the use of bleaching earth\n\nBleached\n\n5 **Chilling** Lowering the temperature below ambient but above freezing point to aid preservation.\n\nChilled\n\n6 **Chopping** Reduction of particle size using one or more knives Chopped\n\n7 **Cleaning** Removal of objects (contaminants, e.g. stones) or vegetative parts of the plant e.g. unattached particles of straw or husks or weeds\n\nCleaned/sorted\n\n8 **Concentration** ( ¹ ) Removal of water and/or other constituents ( ² ) Concentrate\n\n9 **Condensation** Transition of a substance from a gaseous to a liquid phase\n\nCondensed\n\n10 **Cooking** The application of heat to change the physical and chemical characteristics of feed materials\n\nCooked\n\n11 **Crushing** Reduction of particle size using a crusher Crushed\n\n12 **Crystallisation** Purification by the formation of solid crystals from a liquid solution. Impurities in the liquid are usually not incorporated into the lattice structure of the crystal\n\nCrystallised\n\n13 **Decortication** ( ³ ) Complete or partial removal of outer layers from grains, seeds, fruits, nuts and others\n\nDecorticated, partially decorticated\n\n14 **Dehulling/dehusking** Removal of the outer skins of beans, grains and seeds usually by physical means\n\nDehulled or dehusked ( ⁴ )\n\nEN Official Journal of the European Union 4.7.2022 L 177/9","pages":[{"line_numbers":[],"markdown":"(16) If a feed material listed in part C, for which it is required in a footnote that the name shall be supplemented with the species, consists of several species, it can only be considered as a feed material, when the characteristics and the origin of the plants or the animals used for the feed materials, or parts thereof, are the same.\n\nPART B\n\n**Glossary of processes**\n\nProcess Definition Common name/qualifier\n\n1 **Air fractionation** Separation of particles by means of an air stream Air fractionated\n\n2 **Aspiration** Process to remove dust, fine particles and other particulates with suspended grain fines from bulk grain during transfer by means of an air-flow\n\nAspirated\n\n3 **Blanching** Process consisting of heat treatment of an organic substance by boiling or steaming in order to denature natural enzymes, soften tissue and remove raw flavouring, followed by immersion in cold water to halt the cooking process\n\nBlanched\n\n4 **Bleaching** Removing naturally occurring colour by chemical or physical processes or by the use of bleaching earth\n\nBleached\n\n5 **Chilling** Lowering the temperature below ambient but above freezing point to aid preservation.\n\nChilled\n\n6 **Chopping** Reduction of particle size using one or more knives Chopped\n\n7 **Cleaning** Removal of objects (contaminants, e.g. stones) or vegetative parts of the plant e.g. unattached particles of straw or husks or weeds\n\nCleaned/sorted\n\n8 **Concentration** ( ¹ ) Removal of water and/or other constituents ( ² ) Concentrate\n\n9 **Condensation** Transition of a substance from a gaseous to a liquid phase\n\nCondensed\n\n10 **Cooking** The application of heat to change the physical and chemical characteristics of feed materials\n\nCooked\n\n11 **Crushing** Reduction of particle size using a crusher Crushed\n\n12 **Crystallisation** Purification by the formation of solid crystals from a liquid solution. Impurities in the liquid are usually not incorporated into the lattice structure of the crystal\n\nCrystallised\n\n13 **Decortication** ( ³ ) Complete or partial removal of outer layers from grains, seeds, fruits, nuts and others\n\nDecorticated, partially decorticated\n\n14 **Dehulling/dehusking** Removal of the outer skins of beans, grains and seeds usually by physical means\n\nDehulled or dehusked ( ⁴ )\n\nEN Official Journal of the European Union 4.7.2022 L 177/9","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"(16) If a feed material listed in part C, for which it is required in a footnote that the name shall be supplemented with the species, consists of several species, it can only be considered as a feed material, when the characteristics and the origin of the plants or the animals used for the feed materials, or parts thereof, are the same.\n\nPART B\n\n**Glossary of processes**\n\nProcess Definition Common name/qualifier\n\n1 **Air fractionation** Separation of particles by means of an air stream Air fractionated\n\n2 **Aspiration** Process to remove dust, fine particles and other particulates with suspended grain fines from bulk grain during transfer by means of an air-flow\n\nAspirated\n\n3 **Blanching** Process consisting of heat treatment of an organic substance by boiling or steaming in order to denature natural enzymes, soften tissue and remove raw flavouring, followed by immersion in cold water to halt the cooking process\n\nBlanched\n\n4 **Bleaching** Removing naturally occurring colour by chemical or physical processes or by the use of bleaching earth\n\nBleached\n\n5 **Chilling** Lowering the temperature below ambient but above freezing point to aid preservation.\n\nChilled\n\n6 **Chopping** Reduction of particle size using one or more knives Chopped\n\n7 **Cleaning** Removal of objects (contaminants, e.g. stones) or vegetative parts of the plant e.g. unattached particles of straw or husks or weeds\n\nCleaned/sorted\n\n8 **Concentration** ( ¹ ) Removal of water and/or other constituents ( ² ) Concentrate\n\n9 **Condensation** Transition of a substance from a gaseous to a liquid phase\n\nCondensed\n\n10 **Cooking** The application of heat to change the physical and chemical characteristics of feed materials\n\nCooked\n\n11 **Crushing** Reduction of particle size using a crusher Crushed\n\n12 **Crystallisation** Purification by the formation of solid crystals from a liquid solution. Impurities in the liquid are usually not incorporated into the lattice structure of the crystal\n\nCrystallised\n\n13 **Decortication** ( ³ ) Complete or partial removal of outer layers from grains, seeds, fruits, nuts and others\n\nDecorticated, partially decorticated\n\n14 **Dehulling/dehusking** Removal of the outer skins of beans, grains and seeds usually by physical means\n\nDehulled or dehusked ( ⁴ )\n\nEN Official Journal of the European Union 4.7.2022 L 177/9","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_024d9d653997ca4f359a95474480be30","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["(16) If a feed material listed in part C, for which it is required in a footnote that the name shall be supplemented with the species, consists of several species, it can only be considered as a feed material, when the characteristics and the origin of the plants or the animals used for the feed materials, or parts thereof, are the same.\n\nPART B\n\n**Glossary of processes**\n\nProcess Definition Common name/qualifier\n\n1 **Air fractionation** Separation of particles by means of an air stream Air fractionated\n\n2 **Aspiration** Process to remove dust, fine particles and other particulates with suspended grain fines from bulk grain during transfer by means of an air-flow\n\nAspirated\n\n3 **Blanching** Process consisting of heat treatment of an organic substance by boiling or steaming in order to denature natural enzymes, soften tissue and remove raw flavouring, followed by immersion in cold water to halt the cooking process\n\nBlanched\n\n4 **Bleaching** Removing naturally occurring colour by chemical or physical processes or by the use of bleaching earth\n\nBleached\n\n5 **Chilling** Lowering the temperature below ambient but above freezing point to aid preservation.\n\nChilled\n\n6 **Chopping** Reduction of particle size using one or more knives Chopped\n\n7 **Cleaning** Removal of objects (contaminants, e.g. stones) or vegetative parts of the plant e.g. unattached particles of straw or husks or weeds\n\nCleaned/sorted\n\n8 **Concentration** ( ¹ ) Removal of water and/or other constituents ( ² ) Concentrate\n\n9 **Condensation** Transition of a substance from a gaseous to a liquid phase\n\nCondensed\n\n10 **Cooking** The application of heat to change the physical and chemical characteristics of feed materials\n\nCooked\n\n11 **Crushing** Reduction of particle size using a crusher Crushed\n\n12 **Crystallisation** Purification by the formation of solid crystals from a liquid solution. Impurities in the liquid are usually not incorporated into the lattice structure of the crystal\n\nCrystallised\n\n13 **Decortication** ( ³ ) Complete or partial removal of outer layers from grains, seeds, fruits, nuts and others\n\nDecorticated, partially decorticated\n\n14 **Dehulling/dehusking** Removal of the outer skins of beans, grains and seeds usually by physical means\n\nDehulled or dehusked ( ⁴ )\n\nEN Official Journal of the European Union 4.7.2022 L 177/9"],"full_content":"(16) If a feed material listed in part C, for which it is required in a footnote that the name shall be supplemented with the species, consists of several species, it can only be considered as a feed material, when the characteristics and the origin of the plants or the animals used for the feed materials, or parts thereof, are the same.\n\nPART B\n\n**Glossary of processes**\n\nProcess Definition Common name/qualifier\n\n1 **Air fractionation** Separation of particles by means of an air stream Air fractionated\n\n2 **Aspiration** Process to remove dust, fine particles and other particulates with suspended grain fines from bulk grain during transfer by means of an air-flow\n\nAspirated\n\n3 **Blanching** Process consisting of heat treatment of an organic substance by boiling or steaming in order to denature natural enzymes, soften tissue and remove raw flavouring, followed by immersion in cold water to halt the cooking process\n\nBlanched\n\n4 **Bleaching** Removing naturally occurring colour by chemical or physical processes or by the use of bleaching earth\n\nBleached\n\n5 **Chilling** Lowering the temperature below ambient but above freezing point to aid preservation.\n\nChilled\n\n6 **Chopping** Reduction of particle size using one or more knives Chopped\n\n7 **Cleaning** Removal of objects (contaminants, e.g. stones) or vegetative parts of the plant e.g. unattached particles of straw or husks or weeds\n\nCleaned/sorted\n\n8 **Concentration** ( ¹ ) Removal of water and/or other constituents ( ² ) Concentrate\n\n9 **Condensation** Transition of a substance from a gaseous to a liquid phase\n\nCondensed\n\n10 **Cooking** The application of heat to change the physical and chemical characteristics of feed materials\n\nCooked\n\n11 **Crushing** Reduction of particle size using a crusher Crushed\n\n12 **Crystallisation** Purification by the formation of solid crystals from a liquid solution. Impurities in the liquid are usually not incorporated into the lattice structure of the crystal\n\nCrystallised\n\n13 **Decortication** ( ³ ) Complete or partial removal of outer layers from grains, seeds, fruits, nuts and others\n\nDecorticated, partially decorticated\n\n14 **Dehulling/dehusking** Removal of the outer skins of beans, grains and seeds usually by physical means\n\nDehulled or dehusked ( ⁴ )\n\nEN Official Journal of the European Union 4.7.2022 L 177/9","publish_date":null,"title":"EN Official Journal of the European Union 4.7.2022 L 177/9 (16) If a feed material listed in part C, for","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page6.pdf"},"request":{"example_id":"table/1657221585_page6","product_type":"parse","source_file_path":"1657221585_page6.pdf"},"started_at":"2026-11-04T19:48:18.317827"} +{"completed_at":"2026-11-04T19:48:22.258292","latency_in_ms":2413,"output":{"example_id":"table/1657221585_page62","grounded_pages":[],"layout_pages":[],"markdown":"12\\.1.12 **Yeasts products** All yeasts ³² and parts ( ¹ ) thereof obtained by cracking and/or fractionation of yeast cells from _Saccharomyces bayanus, Saccharomyces cerevisiae, Saccharomyces pastorianus, Saccharomyces carlsbergensis, Kluyveromyces lactis, Kluyveromyces marxianus, Metschnikowia pulcherrima, Metschnikowia fructicola, Torulaspora delbrueckii, Cyberlindnera jadinii_ ( ² ), _Saccharomycodes ludwigii, Wickerhamomyces anomalus_ , _Debaryomyces hansenii, Pichia guilliermondii, Yarrowia lypolitica_ or _Brettanomyces_ ssp. on substrate/ culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nMoisture if < 75 % or > 97 %\n\n12\\.1.13 **Single cell proteins from bacteria** ( ⁴ )\n\nProtein products obtained by fermentation with bacteria on a substrate/culture medium consisting of methanol (fermented with _Methylophilus methylotrophus_ ) or natural gas (fermented with _Methylococcus capsulatus_ , _Alcaligenes acidovorans_ , _Aneurinibacillus danicus_ (previously known as _Bacillus brevis_ ) and/or _Bacillus firmus_ ) as carbon source, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nCrude protein Crude ash\n\n12\\.1.14 **Inactivated bacteria and parts thereof** ( ⁴ )\n\nWhole bacteria or their parts ( ¹ ) obtained from _Bifidobacterium spp._ , _Lactobacillus acidophilus_ , _Lactobacillus delbrueckii ssp. bulgaricus_ , _Lacticaseibacillus casei_ , _Limosilactobacillus fermentum (_ formerly known as _Lactobacillus fermentum)_ , _Lacticaseibacillus paracasei (_ formerly known as _Lactobacillus paracasei)_ , _Lactiplantibacillus plantarum_ (formerly known as _Lactobacillus plantarum)_ , _Limosilactobacillus_ reuteri (formerly known as _Lactobacillus reuteri)_ , _Lacticaseibacillus rhamnosus (_ formerly known as _Lactobacillus rhamnosus)_ , _Lactobacillus helveticus_ or _Streptococcus thermophiles_ or other species of bacteria authorised as feed additives fermented on substrate/culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nCrude ash\n\n12\\.2.8 **Bacterial biomass rich in protein** ( ⁴ )\n\nProtein rich co-products obtained from the production of amino acids, vitamins, organic acids, enzymes and/or their salts obtained by fermentation with _Bacillus coagulans, Bacillus subtilis, Bacillus velezensis, Bacillus licheniformis, Bacillus smithii, Corynebacterium casei_ , _Corynebacterium glutamicum_ , _Corynebacterium melassecola, Ensifer adhaerens, Enterococcus faecium, Escherichia coli_ K12 or _Lactobacillaceae_ on substrate/culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals. The product may be hydrolysed\n\nCrude protein Crude ash\n\nEN Official Journal of the European Union 4.7.2022 L 177/65","pages":[{"line_numbers":[],"markdown":"12\\.1.12 **Yeasts products** All yeasts ³² and parts ( ¹ ) thereof obtained by cracking and/or fractionation of yeast cells from _Saccharomyces bayanus, Saccharomyces cerevisiae, Saccharomyces pastorianus, Saccharomyces carlsbergensis, Kluyveromyces lactis, Kluyveromyces marxianus, Metschnikowia pulcherrima, Metschnikowia fructicola, Torulaspora delbrueckii, Cyberlindnera jadinii_ ( ² ), _Saccharomycodes ludwigii, Wickerhamomyces anomalus_ , _Debaryomyces hansenii, Pichia guilliermondii, Yarrowia lypolitica_ or _Brettanomyces_ ssp. on substrate/ culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nMoisture if < 75 % or > 97 %\n\n12\\.1.13 **Single cell proteins from bacteria** ( ⁴ )\n\nProtein products obtained by fermentation with bacteria on a substrate/culture medium consisting of methanol (fermented with _Methylophilus methylotrophus_ ) or natural gas (fermented with _Methylococcus capsulatus_ , _Alcaligenes acidovorans_ , _Aneurinibacillus danicus_ (previously known as _Bacillus brevis_ ) and/or _Bacillus firmus_ ) as carbon source, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nCrude protein Crude ash\n\n12\\.1.14 **Inactivated bacteria and parts thereof** ( ⁴ )\n\nWhole bacteria or their parts ( ¹ ) obtained from _Bifidobacterium spp._ , _Lactobacillus acidophilus_ , _Lactobacillus delbrueckii ssp. bulgaricus_ , _Lacticaseibacillus casei_ , _Limosilactobacillus fermentum (_ formerly known as _Lactobacillus fermentum)_ , _Lacticaseibacillus paracasei (_ formerly known as _Lactobacillus paracasei)_ , _Lactiplantibacillus plantarum_ (formerly known as _Lactobacillus plantarum)_ , _Limosilactobacillus_ reuteri (formerly known as _Lactobacillus reuteri)_ , _Lacticaseibacillus rhamnosus (_ formerly known as _Lactobacillus rhamnosus)_ , _Lactobacillus helveticus_ or _Streptococcus thermophiles_ or other species of bacteria authorised as feed additives fermented on substrate/culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nCrude ash\n\n12\\.2.8 **Bacterial biomass rich in protein** ( ⁴ )\n\nProtein rich co-products obtained from the production of amino acids, vitamins, organic acids, enzymes and/or their salts obtained by fermentation with _Bacillus coagulans, Bacillus subtilis, Bacillus velezensis, Bacillus licheniformis, Bacillus smithii, Corynebacterium casei_ , _Corynebacterium glutamicum_ , _Corynebacterium melassecola, Ensifer adhaerens, Enterococcus faecium, Escherichia coli_ K12 or _Lactobacillaceae_ on substrate/culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals. The product may be hydrolysed\n\nCrude protein Crude ash\n\nEN Official Journal of the European Union 4.7.2022 L 177/65","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"12\\.1.12 **Yeasts products** All yeasts ³² and parts ( ¹ ) thereof obtained by cracking and/or fractionation of yeast cells from _Saccharomyces bayanus, Saccharomyces cerevisiae, Saccharomyces pastorianus, Saccharomyces carlsbergensis, Kluyveromyces lactis, Kluyveromyces marxianus, Metschnikowia pulcherrima, Metschnikowia fructicola, Torulaspora delbrueckii, Cyberlindnera jadinii_ ( ² ), _Saccharomycodes ludwigii, Wickerhamomyces anomalus_ , _Debaryomyces hansenii, Pichia guilliermondii, Yarrowia lypolitica_ or _Brettanomyces_ ssp. on substrate/ culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nMoisture if < 75 % or > 97 %\n\n12\\.1.13 **Single cell proteins from bacteria** ( ⁴ )\n\nProtein products obtained by fermentation with bacteria on a substrate/culture medium consisting of methanol (fermented with _Methylophilus methylotrophus_ ) or natural gas (fermented with _Methylococcus capsulatus_ , _Alcaligenes acidovorans_ , _Aneurinibacillus danicus_ (previously known as _Bacillus brevis_ ) and/or _Bacillus firmus_ ) as carbon source, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nCrude protein Crude ash\n\n12\\.1.14 **Inactivated bacteria and parts thereof** ( ⁴ )\n\nWhole bacteria or their parts ( ¹ ) obtained from _Bifidobacterium spp._ , _Lactobacillus acidophilus_ , _Lactobacillus delbrueckii ssp. bulgaricus_ , _Lacticaseibacillus casei_ , _Limosilactobacillus fermentum (_ formerly known as _Lactobacillus fermentum)_ , _Lacticaseibacillus paracasei (_ formerly known as _Lactobacillus paracasei)_ , _Lactiplantibacillus plantarum_ (formerly known as _Lactobacillus plantarum)_ , _Limosilactobacillus_ reuteri (formerly known as _Lactobacillus reuteri)_ , _Lacticaseibacillus rhamnosus (_ formerly known as _Lactobacillus rhamnosus)_ , _Lactobacillus helveticus_ or _Streptococcus thermophiles_ or other species of bacteria authorised as feed additives fermented on substrate/culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nCrude ash\n\n12\\.2.8 **Bacterial biomass rich in protein** ( ⁴ )\n\nProtein rich co-products obtained from the production of amino acids, vitamins, organic acids, enzymes and/or their salts obtained by fermentation with _Bacillus coagulans, Bacillus subtilis, Bacillus velezensis, Bacillus licheniformis, Bacillus smithii, Corynebacterium casei_ , _Corynebacterium glutamicum_ , _Corynebacterium melassecola, Ensifer adhaerens, Enterococcus faecium, Escherichia coli_ K12 or _Lactobacillaceae_ on substrate/culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals. The product may be hydrolysed\n\nCrude protein Crude ash\n\nEN Official Journal of the European Union 4.7.2022 L 177/65","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page62.pdf"]},"response":{"errors":[],"extract_id":"extract_91af1cc86500f90aedbb0fc062a6030c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["12\\.1.12 **Yeasts products** All yeasts ³² and parts ( ¹ ) thereof obtained by cracking and/or fractionation of yeast cells from _Saccharomyces bayanus, Saccharomyces cerevisiae, Saccharomyces pastorianus, Saccharomyces carlsbergensis, Kluyveromyces lactis, Kluyveromyces marxianus, Metschnikowia pulcherrima, Metschnikowia fructicola, Torulaspora delbrueckii, Cyberlindnera jadinii_ ( ² ), _Saccharomycodes ludwigii, Wickerhamomyces anomalus_ , _Debaryomyces hansenii, Pichia guilliermondii, Yarrowia lypolitica_ or _Brettanomyces_ ssp. on substrate/ culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nMoisture if < 75 % or > 97 %\n\n12\\.1.13 **Single cell proteins from bacteria** ( ⁴ )\n\nProtein products obtained by fermentation with bacteria on a substrate/culture medium consisting of methanol (fermented with _Methylophilus methylotrophus_ ) or natural gas (fermented with _Methylococcus capsulatus_ , _Alcaligenes acidovorans_ , _Aneurinibacillus danicus_ (previously known as _Bacillus brevis_ ) and/or _Bacillus firmus_ ) as carbon source, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nCrude protein Crude ash\n\n12\\.1.14 **Inactivated bacteria and parts thereof** ( ⁴ )\n\nWhole bacteria or their parts ( ¹ ) obtained from _Bifidobacterium spp._ , _Lactobacillus acidophilus_ , _Lactobacillus delbrueckii ssp. bulgaricus_ , _Lacticaseibacillus casei_ , _Limosilactobacillus fermentum (_ formerly known as _Lactobacillus fermentum)_ , _Lacticaseibacillus paracasei (_ formerly known as _Lactobacillus paracasei)_ , _Lactiplantibacillus plantarum_ (formerly known as _Lactobacillus plantarum)_ , _Limosilactobacillus_ reuteri (formerly known as _Lactobacillus reuteri)_ , _Lacticaseibacillus rhamnosus (_ formerly known as _Lactobacillus rhamnosus)_ , _Lactobacillus helveticus_ or _Streptococcus thermophiles_ or other species of bacteria authorised as feed additives fermented on substrate/culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nCrude ash\n\n12\\.2.8 **Bacterial biomass rich in protein** ( ⁴ )\n\nProtein rich co-products obtained from the production of amino acids, vitamins, organic acids, enzymes and/or their salts obtained by fermentation with _Bacillus coagulans, Bacillus subtilis, Bacillus velezensis, Bacillus licheniformis, Bacillus smithii, Corynebacterium casei_ , _Corynebacterium glutamicum_ , _Corynebacterium melassecola, Ensifer adhaerens, Enterococcus faecium, Escherichia coli_ K12 or _Lactobacillaceae_ on substrate/culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals. The product may be hydrolysed\n\nCrude protein Crude ash\n\nEN Official Journal of the European Union 4.7.2022 L 177/65"],"full_content":"12\\.1.12 **Yeasts products** All yeasts ³² and parts ( ¹ ) thereof obtained by cracking and/or fractionation of yeast cells from _Saccharomyces bayanus, Saccharomyces cerevisiae, Saccharomyces pastorianus, Saccharomyces carlsbergensis, Kluyveromyces lactis, Kluyveromyces marxianus, Metschnikowia pulcherrima, Metschnikowia fructicola, Torulaspora delbrueckii, Cyberlindnera jadinii_ ( ² ), _Saccharomycodes ludwigii, Wickerhamomyces anomalus_ , _Debaryomyces hansenii, Pichia guilliermondii, Yarrowia lypolitica_ or _Brettanomyces_ ssp. on substrate/ culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nMoisture if < 75 % or > 97 %\n\n12\\.1.13 **Single cell proteins from bacteria** ( ⁴ )\n\nProtein products obtained by fermentation with bacteria on a substrate/culture medium consisting of methanol (fermented with _Methylophilus methylotrophus_ ) or natural gas (fermented with _Methylococcus capsulatus_ , _Alcaligenes acidovorans_ , _Aneurinibacillus danicus_ (previously known as _Bacillus brevis_ ) and/or _Bacillus firmus_ ) as carbon source, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nCrude protein Crude ash\n\n12\\.1.14 **Inactivated bacteria and parts thereof** ( ⁴ )\n\nWhole bacteria or their parts ( ¹ ) obtained from _Bifidobacterium spp._ , _Lactobacillus acidophilus_ , _Lactobacillus delbrueckii ssp. bulgaricus_ , _Lacticaseibacillus casei_ , _Limosilactobacillus fermentum (_ formerly known as _Lactobacillus fermentum)_ , _Lacticaseibacillus paracasei (_ formerly known as _Lactobacillus paracasei)_ , _Lactiplantibacillus plantarum_ (formerly known as _Lactobacillus plantarum)_ , _Limosilactobacillus_ reuteri (formerly known as _Lactobacillus reuteri)_ , _Lacticaseibacillus rhamnosus (_ formerly known as _Lactobacillus rhamnosus)_ , _Lactobacillus helveticus_ or _Streptococcus thermophiles_ or other species of bacteria authorised as feed additives fermented on substrate/culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals\n\nCrude ash\n\n12\\.2.8 **Bacterial biomass rich in protein** ( ⁴ )\n\nProtein rich co-products obtained from the production of amino acids, vitamins, organic acids, enzymes and/or their salts obtained by fermentation with _Bacillus coagulans, Bacillus subtilis, Bacillus velezensis, Bacillus licheniformis, Bacillus smithii, Corynebacterium casei_ , _Corynebacterium glutamicum_ , _Corynebacterium melassecola, Ensifer adhaerens, Enterococcus faecium, Escherichia coli_ K12 or _Lactobacillaceae_ on substrate/culture medium consisting of a carbon source mostly of vegetal origin, a nitrogen source of vegetal or chemical origin, vitamins and minerals. The product may be hydrolysed\n\nCrude protein Crude ash\n\nEN Official Journal of the European Union 4.7.2022 L 177/65","publish_date":null,"title":"EN Official Journal of the European Union 4.7.2022 L 177/65 12.1.12 Yeasts products All yeasts and parts( )thereof obtained by","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page62.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1657221585_page62.pdf"},"request":{"example_id":"table/1657221585_page62","product_type":"parse","source_file_path":"1657221585_page62.pdf"},"started_at":"2026-11-04T19:48:19.844649"} +{"completed_at":"2026-11-04T19:48:24.265715","latency_in_ms":2973,"output":{"example_id":"table/1948bb0c-01f1-aa67-a1bd-4d54323f4f0d_page2","grounded_pages":[],"layout_pages":[],"markdown":"125 West 55th St New York, NY 10019\n\n**Contract #** 26834871 **Changes as of:** 3/23/2020 at 1:33 PM **Version:** Original Order\n\n**CPE:** 218/473/5192 **Flight:** 9/8/20 - 9/14/20 **Station:** WTVQ **Con Type:** POLITICAL/VOTE\n\n**Agency:** MAIN STREET MEDIA\n\nGRP\n\n**Advertiser:** Keep Kentucky Great **Market:** Lexington-Fayette **Total $:** $13,360.00\n\nPO BOX 25093 **Product:** Kentucky **Office:** PHILADELPHIA **Total Spots:** 35\n\nAlexandria, VA 22314 **Agency Order #:** 9484151 **Service:** Nielsen **Total CPP:** $0.00\n\n**Buyer:** Maroney, Stephanie **Primary Demo: Total GRP:**\n\n**Salesperson:** SUSANA RENDINA\n\n212-424-6190\n\n**Assistant:** SUSANA RENDINA\n\n212-424-6190\n\n**Separation:**\n\n**9/8 - 9/14 Total Total**\n\n**_\\#_** **Day/Time DP Program Rate Len 9/8 9/9 9/10 9/11 9/12 9/13 9/14 Spots $ CPP\\* GRP\\***\n\n14\n\nTh 10p-11p »Reef Break-ABC $400.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 123. Nielsen: 0.85104453772608_\n\n15\n\nF 8p-9p »Marvel's Agents of Shield-ABC $350.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 115. Nielsen: 1.353552827747626_\n\n16\n\nF 9p-10p »What Would You Do?-ABC $340.00 30 0 0 0 1 0 0 0 1 $340.00 $0.00 0.0\n\n_302 Index: 127. Nielsen: 1.562687731131522_\n\n17\n\nF 10p-11p »20/20-ABC $400.00 30 0 0 0 1 0 0 0 1 $400.00 $0.00 0.0\n\n_302 Index: 124. Nielsen: 2.2479706460727704_\n\n18\n\nSa 8a-9a »Good Morning America $125.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 124. Nielsen: 1.3624095596069425_\n\n19\n\nSa 12n-3:30p »ABC College Football Early Game $350.00 30 0 0 0 0 1 0 0 1 $350.00 $0.00 0.0\n\n_302 Index: 109. Nielsen: 2.681653954082014_\n\n20\n\nSa 3:30p-7p »ABC College Football Late Game $400.00 30 0 0 0 0 1 0 0 1 $400.00 $0.00 0.0\n\n_302 Index: 105. Nielsen: 3.2439346042170847_\n\n21\n\nSa 7:30p-11p\n\n»ABC Saturday Night College Football $700.00 30 0 0 0 0 1 0 0 1 $700.00 $0.00 0.0\n\n_302 Index: 104. Nielsen: 3.0405066960853704_\n\n22\n\nSa 11p-11:30p »ABC 36 News At 11 $120.00 30 0 0 0 0 1 0 0 1 $120.00 $0.00 0.0\n\n_302 Index: 103. Nielsen: 2.055146983615481_\n\n23\n\nSu 8a-9a »Good Morning America $125.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 123. Nielsen: 1.2919224768907855_\n\n24\n\nSu 9a-10a »This Week-ABC $120.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 129. Nielsen: 1.1287489933900707_\n\n25\n\nSu 7p-8p\n\n»America's Funniest Home Videos- ABC $800.00 30 0 0 0 0 0 1 0 1 $800.00 $0.00 0.0\n\n_302 Index: 129. Nielsen: 3.1189113211922432_\n\n26\n\nSu 8p-9p »Celebrity Family Feud-ABC $700.00 30 0 0 0 0 0 1 0 1 $700.00 $0.00 0.0\n\n_302 Index: 134. Nielsen: 3.5871598054636693_\n\n**Printed on 03/23/2020 at 03:46 PM | \\* Stats based on Primary Demo Page 2 of 4**","pages":[{"line_numbers":[],"markdown":"125 West 55th St New York, NY 10019\n\n**Contract #** 26834871 **Changes as of:** 3/23/2020 at 1:33 PM **Version:** Original Order\n\n**CPE:** 218/473/5192 **Flight:** 9/8/20 - 9/14/20 **Station:** WTVQ **Con Type:** POLITICAL/VOTE\n\n**Agency:** MAIN STREET MEDIA\n\nGRP\n\n**Advertiser:** Keep Kentucky Great **Market:** Lexington-Fayette **Total $:** $13,360.00\n\nPO BOX 25093 **Product:** Kentucky **Office:** PHILADELPHIA **Total Spots:** 35\n\nAlexandria, VA 22314 **Agency Order #:** 9484151 **Service:** Nielsen **Total CPP:** $0.00\n\n**Buyer:** Maroney, Stephanie **Primary Demo: Total GRP:**\n\n**Salesperson:** SUSANA RENDINA\n\n212-424-6190\n\n**Assistant:** SUSANA RENDINA\n\n212-424-6190\n\n**Separation:**\n\n**9/8 - 9/14 Total Total**\n\n**_\\#_** **Day/Time DP Program Rate Len 9/8 9/9 9/10 9/11 9/12 9/13 9/14 Spots $ CPP\\* GRP\\***\n\n14\n\nTh 10p-11p »Reef Break-ABC $400.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 123. Nielsen: 0.85104453772608_\n\n15\n\nF 8p-9p »Marvel's Agents of Shield-ABC $350.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 115. Nielsen: 1.353552827747626_\n\n16\n\nF 9p-10p »What Would You Do?-ABC $340.00 30 0 0 0 1 0 0 0 1 $340.00 $0.00 0.0\n\n_302 Index: 127. Nielsen: 1.562687731131522_\n\n17\n\nF 10p-11p »20/20-ABC $400.00 30 0 0 0 1 0 0 0 1 $400.00 $0.00 0.0\n\n_302 Index: 124. Nielsen: 2.2479706460727704_\n\n18\n\nSa 8a-9a »Good Morning America $125.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 124. Nielsen: 1.3624095596069425_\n\n19\n\nSa 12n-3:30p »ABC College Football Early Game $350.00 30 0 0 0 0 1 0 0 1 $350.00 $0.00 0.0\n\n_302 Index: 109. Nielsen: 2.681653954082014_\n\n20\n\nSa 3:30p-7p »ABC College Football Late Game $400.00 30 0 0 0 0 1 0 0 1 $400.00 $0.00 0.0\n\n_302 Index: 105. Nielsen: 3.2439346042170847_\n\n21\n\nSa 7:30p-11p\n\n»ABC Saturday Night College Football $700.00 30 0 0 0 0 1 0 0 1 $700.00 $0.00 0.0\n\n_302 Index: 104. Nielsen: 3.0405066960853704_\n\n22\n\nSa 11p-11:30p »ABC 36 News At 11 $120.00 30 0 0 0 0 1 0 0 1 $120.00 $0.00 0.0\n\n_302 Index: 103. Nielsen: 2.055146983615481_\n\n23\n\nSu 8a-9a »Good Morning America $125.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 123. Nielsen: 1.2919224768907855_\n\n24\n\nSu 9a-10a »This Week-ABC $120.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 129. Nielsen: 1.1287489933900707_\n\n25\n\nSu 7p-8p\n\n»America's Funniest Home Videos- ABC $800.00 30 0 0 0 0 0 1 0 1 $800.00 $0.00 0.0\n\n_302 Index: 129. Nielsen: 3.1189113211922432_\n\n26\n\nSu 8p-9p »Celebrity Family Feud-ABC $700.00 30 0 0 0 0 0 1 0 1 $700.00 $0.00 0.0\n\n_302 Index: 134. Nielsen: 3.5871598054636693_\n\n**Printed on 03/23/2020 at 03:46 PM | \\* Stats based on Primary Demo Page 2 of 4**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"125 West 55th St New York, NY 10019\n\n**Contract #** 26834871 **Changes as of:** 3/23/2020 at 1:33 PM **Version:** Original Order\n\n**CPE:** 218/473/5192 **Flight:** 9/8/20 - 9/14/20 **Station:** WTVQ **Con Type:** POLITICAL/VOTE\n\n**Agency:** MAIN STREET MEDIA\n\nGRP\n\n**Advertiser:** Keep Kentucky Great **Market:** Lexington-Fayette **Total $:** $13,360.00\n\nPO BOX 25093 **Product:** Kentucky **Office:** PHILADELPHIA **Total Spots:** 35\n\nAlexandria, VA 22314 **Agency Order #:** 9484151 **Service:** Nielsen **Total CPP:** $0.00\n\n**Buyer:** Maroney, Stephanie **Primary Demo: Total GRP:**\n\n**Salesperson:** SUSANA RENDINA\n\n212-424-6190\n\n**Assistant:** SUSANA RENDINA\n\n212-424-6190\n\n**Separation:**\n\n**9/8 - 9/14 Total Total**\n\n**_\\#_** **Day/Time DP Program Rate Len 9/8 9/9 9/10 9/11 9/12 9/13 9/14 Spots $ CPP\\* GRP\\***\n\n14\n\nTh 10p-11p »Reef Break-ABC $400.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 123. Nielsen: 0.85104453772608_\n\n15\n\nF 8p-9p »Marvel's Agents of Shield-ABC $350.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 115. Nielsen: 1.353552827747626_\n\n16\n\nF 9p-10p »What Would You Do?-ABC $340.00 30 0 0 0 1 0 0 0 1 $340.00 $0.00 0.0\n\n_302 Index: 127. Nielsen: 1.562687731131522_\n\n17\n\nF 10p-11p »20/20-ABC $400.00 30 0 0 0 1 0 0 0 1 $400.00 $0.00 0.0\n\n_302 Index: 124. Nielsen: 2.2479706460727704_\n\n18\n\nSa 8a-9a »Good Morning America $125.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 124. Nielsen: 1.3624095596069425_\n\n19\n\nSa 12n-3:30p »ABC College Football Early Game $350.00 30 0 0 0 0 1 0 0 1 $350.00 $0.00 0.0\n\n_302 Index: 109. Nielsen: 2.681653954082014_\n\n20\n\nSa 3:30p-7p »ABC College Football Late Game $400.00 30 0 0 0 0 1 0 0 1 $400.00 $0.00 0.0\n\n_302 Index: 105. Nielsen: 3.2439346042170847_\n\n21\n\nSa 7:30p-11p\n\n»ABC Saturday Night College Football $700.00 30 0 0 0 0 1 0 0 1 $700.00 $0.00 0.0\n\n_302 Index: 104. Nielsen: 3.0405066960853704_\n\n22\n\nSa 11p-11:30p »ABC 36 News At 11 $120.00 30 0 0 0 0 1 0 0 1 $120.00 $0.00 0.0\n\n_302 Index: 103. Nielsen: 2.055146983615481_\n\n23\n\nSu 8a-9a »Good Morning America $125.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 123. Nielsen: 1.2919224768907855_\n\n24\n\nSu 9a-10a »This Week-ABC $120.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 129. Nielsen: 1.1287489933900707_\n\n25\n\nSu 7p-8p\n\n»America's Funniest Home Videos- ABC $800.00 30 0 0 0 0 0 1 0 1 $800.00 $0.00 0.0\n\n_302 Index: 129. Nielsen: 3.1189113211922432_\n\n26\n\nSu 8p-9p »Celebrity Family Feud-ABC $700.00 30 0 0 0 0 0 1 0 1 $700.00 $0.00 0.0\n\n_302 Index: 134. Nielsen: 3.5871598054636693_\n\n**Printed on 03/23/2020 at 03:46 PM | \\* Stats based on Primary Demo Page 2 of 4**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1948bb0c-01f1-aa67-a1bd-4d54323f4f0d_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_9b5094ace60e19882c262f69b97464da","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["125 West 55th St New York, NY 10019\n\n**Contract #** 26834871 **Changes as of:** 3/23/2020 at 1:33 PM **Version:** Original Order\n\n**CPE:** 218/473/5192 **Flight:** 9/8/20 - 9/14/20 **Station:** WTVQ **Con Type:** POLITICAL/VOTE\n\n**Agency:** MAIN STREET MEDIA\n\nGRP\n\n**Advertiser:** Keep Kentucky Great **Market:** Lexington-Fayette **Total $:** $13,360.00\n\nPO BOX 25093 **Product:** Kentucky **Office:** PHILADELPHIA **Total Spots:** 35\n\nAlexandria, VA 22314 **Agency Order #:** 9484151 **Service:** Nielsen **Total CPP:** $0.00\n\n**Buyer:** Maroney, Stephanie **Primary Demo: Total GRP:**\n\n**Salesperson:** SUSANA RENDINA\n\n212-424-6190\n\n**Assistant:** SUSANA RENDINA\n\n212-424-6190\n\n**Separation:**\n\n**9/8 - 9/14 Total Total**\n\n**_\\#_** **Day/Time DP Program Rate Len 9/8 9/9 9/10 9/11 9/12 9/13 9/14 Spots $ CPP\\* GRP\\***\n\n14\n\nTh 10p-11p »Reef Break-ABC $400.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 123. Nielsen: 0.85104453772608_\n\n15\n\nF 8p-9p »Marvel's Agents of Shield-ABC $350.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 115. Nielsen: 1.353552827747626_\n\n16\n\nF 9p-10p »What Would You Do?-ABC $340.00 30 0 0 0 1 0 0 0 1 $340.00 $0.00 0.0\n\n_302 Index: 127. Nielsen: 1.562687731131522_\n\n17\n\nF 10p-11p »20/20-ABC $400.00 30 0 0 0 1 0 0 0 1 $400.00 $0.00 0.0\n\n_302 Index: 124. Nielsen: 2.2479706460727704_\n\n18\n\nSa 8a-9a »Good Morning America $125.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 124. Nielsen: 1.3624095596069425_\n\n19\n\nSa 12n-3:30p »ABC College Football Early Game $350.00 30 0 0 0 0 1 0 0 1 $350.00 $0.00 0.0\n\n_302 Index: 109. Nielsen: 2.681653954082014_\n\n20\n\nSa 3:30p-7p »ABC College Football Late Game $400.00 30 0 0 0 0 1 0 0 1 $400.00 $0.00 0.0\n\n_302 Index: 105. Nielsen: 3.2439346042170847_\n\n21\n\nSa 7:30p-11p\n\n»ABC Saturday Night College Football $700.00 30 0 0 0 0 1 0 0 1 $700.00 $0.00 0.0\n\n_302 Index: 104. Nielsen: 3.0405066960853704_\n\n22\n\nSa 11p-11:30p »ABC 36 News At 11 $120.00 30 0 0 0 0 1 0 0 1 $120.00 $0.00 0.0\n\n_302 Index: 103. Nielsen: 2.055146983615481_\n\n23\n\nSu 8a-9a »Good Morning America $125.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 123. Nielsen: 1.2919224768907855_\n\n24\n\nSu 9a-10a »This Week-ABC $120.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 129. Nielsen: 1.1287489933900707_\n\n25\n\nSu 7p-8p\n\n»America's Funniest Home Videos- ABC $800.00 30 0 0 0 0 0 1 0 1 $800.00 $0.00 0.0\n\n_302 Index: 129. Nielsen: 3.1189113211922432_\n\n26\n\nSu 8p-9p »Celebrity Family Feud-ABC $700.00 30 0 0 0 0 0 1 0 1 $700.00 $0.00 0.0\n\n_302 Index: 134. Nielsen: 3.5871598054636693_\n\n**Printed on 03/23/2020 at 03:46 PM | \\* Stats based on Primary Demo Page 2 of 4**"],"full_content":"125 West 55th St New York, NY 10019\n\n**Contract #** 26834871 **Changes as of:** 3/23/2020 at 1:33 PM **Version:** Original Order\n\n**CPE:** 218/473/5192 **Flight:** 9/8/20 - 9/14/20 **Station:** WTVQ **Con Type:** POLITICAL/VOTE\n\n**Agency:** MAIN STREET MEDIA\n\nGRP\n\n**Advertiser:** Keep Kentucky Great **Market:** Lexington-Fayette **Total $:** $13,360.00\n\nPO BOX 25093 **Product:** Kentucky **Office:** PHILADELPHIA **Total Spots:** 35\n\nAlexandria, VA 22314 **Agency Order #:** 9484151 **Service:** Nielsen **Total CPP:** $0.00\n\n**Buyer:** Maroney, Stephanie **Primary Demo: Total GRP:**\n\n**Salesperson:** SUSANA RENDINA\n\n212-424-6190\n\n**Assistant:** SUSANA RENDINA\n\n212-424-6190\n\n**Separation:**\n\n**9/8 - 9/14 Total Total**\n\n**_\\#_** **Day/Time DP Program Rate Len 9/8 9/9 9/10 9/11 9/12 9/13 9/14 Spots $ CPP\\* GRP\\***\n\n14\n\nTh 10p-11p »Reef Break-ABC $400.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 123. Nielsen: 0.85104453772608_\n\n15\n\nF 8p-9p »Marvel's Agents of Shield-ABC $350.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 115. Nielsen: 1.353552827747626_\n\n16\n\nF 9p-10p »What Would You Do?-ABC $340.00 30 0 0 0 1 0 0 0 1 $340.00 $0.00 0.0\n\n_302 Index: 127. Nielsen: 1.562687731131522_\n\n17\n\nF 10p-11p »20/20-ABC $400.00 30 0 0 0 1 0 0 0 1 $400.00 $0.00 0.0\n\n_302 Index: 124. Nielsen: 2.2479706460727704_\n\n18\n\nSa 8a-9a »Good Morning America $125.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 124. Nielsen: 1.3624095596069425_\n\n19\n\nSa 12n-3:30p »ABC College Football Early Game $350.00 30 0 0 0 0 1 0 0 1 $350.00 $0.00 0.0\n\n_302 Index: 109. Nielsen: 2.681653954082014_\n\n20\n\nSa 3:30p-7p »ABC College Football Late Game $400.00 30 0 0 0 0 1 0 0 1 $400.00 $0.00 0.0\n\n_302 Index: 105. Nielsen: 3.2439346042170847_\n\n21\n\nSa 7:30p-11p\n\n»ABC Saturday Night College Football $700.00 30 0 0 0 0 1 0 0 1 $700.00 $0.00 0.0\n\n_302 Index: 104. Nielsen: 3.0405066960853704_\n\n22\n\nSa 11p-11:30p »ABC 36 News At 11 $120.00 30 0 0 0 0 1 0 0 1 $120.00 $0.00 0.0\n\n_302 Index: 103. Nielsen: 2.055146983615481_\n\n23\n\nSu 8a-9a »Good Morning America $125.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 123. Nielsen: 1.2919224768907855_\n\n24\n\nSu 9a-10a »This Week-ABC $120.00 30 0 0 0 0 0 0 0 0 $0.00 $0.00 0.0\n\n_302 Index: 129. Nielsen: 1.1287489933900707_\n\n25\n\nSu 7p-8p\n\n»America's Funniest Home Videos- ABC $800.00 30 0 0 0 0 0 1 0 1 $800.00 $0.00 0.0\n\n_302 Index: 129. Nielsen: 3.1189113211922432_\n\n26\n\nSu 8p-9p »Celebrity Family Feud-ABC $700.00 30 0 0 0 0 0 1 0 1 $700.00 $0.00 0.0\n\n_302 Index: 134. Nielsen: 3.5871598054636693_\n\n**Printed on 03/23/2020 at 03:46 PM | \\* Stats based on Primary Demo Page 2 of 4**","publish_date":null,"title":"Printed on 03/23/2020 at 03:46 PM | * Stats based on Primary Demo Page 2 of 4","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1948bb0c-01f1-aa67-a1bd-4d54323f4f0d_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1948bb0c-01f1-aa67-a1bd-4d54323f4f0d_page2.pdf"},"request":{"example_id":"table/1948bb0c-01f1-aa67-a1bd-4d54323f4f0d_page2","product_type":"parse","source_file_path":"1948bb0c-01f1-aa67-a1bd-4d54323f4f0d_page2.pdf"},"started_at":"2026-11-04T19:48:21.292194"} +{"completed_at":"2026-11-04T19:48:23.604908","latency_in_ms":1528,"output":{"example_id":"table/1H-2025-Global-Catastrophe-Recap_page7","grounded_pages":[],"layout_pages":[],"markdown":"1H 2025 Global Catastrophe Recap 7\n\nInsured losses were driven by the destructive California wildfires in January, with total insured losses to be estimated at more than $40 billion. At least 19 events, 18 of which occurred in the United States, surpassed $1 billion in insured losses. Outside the U.S. region, European SCS outbreak in late June was the only event that exceeded this threshold. Cyclone Alfred in Australia resulted in the insured losses of approximately $900 million (AUD1.4 billion). É w in Ireland and the UK followed with $690 million (€ ).\n\n**EXHIBIT 7: Top 5 Costliest Insured Loss Events in 1H 2025**\n\nNatural catastrophes in the United States accounted for more than 90 percent of global insured losses in the first half of 2025, reaching approximately $92 billion. Meanwhile, 1H insured losses in all other regions were significantly lower compared to their long-term averages.\n\n**EXHIBIT 8: 1H Insured Losses by Region (2025 $B)**\n\n**er cas C**\n\n**Date(s) Event Location Fatalities Insured Loss ($B)**\n\n01/07-01/28 Palisades Fire United States 12 23.0\n\n01/07-01/28 Eaton Fire United States 18 17.5\n\n03/14-03/16 Severe Convective Storm United States 43 8.0\n\n05/14-05/16 Severe Convective Storm United States 30 8.0\n\n05/17-05/20 Severe Convective Storm United States 0 4.0","pages":[{"line_numbers":[],"markdown":"1H 2025 Global Catastrophe Recap 7\n\nInsured losses were driven by the destructive California wildfires in January, with total insured losses to be estimated at more than $40 billion. At least 19 events, 18 of which occurred in the United States, surpassed $1 billion in insured losses. Outside the U.S. region, European SCS outbreak in late June was the only event that exceeded this threshold. Cyclone Alfred in Australia resulted in the insured losses of approximately $900 million (AUD1.4 billion). É w in Ireland and the UK followed with $690 million (€ ).\n\n**EXHIBIT 7: Top 5 Costliest Insured Loss Events in 1H 2025**\n\nNatural catastrophes in the United States accounted for more than 90 percent of global insured losses in the first half of 2025, reaching approximately $92 billion. Meanwhile, 1H insured losses in all other regions were significantly lower compared to their long-term averages.\n\n**EXHIBIT 8: 1H Insured Losses by Region (2025 $B)**\n\n**er cas C**\n\n**Date(s) Event Location Fatalities Insured Loss ($B)**\n\n01/07-01/28 Palisades Fire United States 12 23.0\n\n01/07-01/28 Eaton Fire United States 18 17.5\n\n03/14-03/16 Severe Convective Storm United States 43 8.0\n\n05/14-05/16 Severe Convective Storm United States 30 8.0\n\n05/17-05/20 Severe Convective Storm United States 0 4.0","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"1H 2025 Global Catastrophe Recap 7\n\nInsured losses were driven by the destructive California wildfires in January, with total insured losses to be estimated at more than $40 billion. At least 19 events, 18 of which occurred in the United States, surpassed $1 billion in insured losses. Outside the U.S. region, European SCS outbreak in late June was the only event that exceeded this threshold. Cyclone Alfred in Australia resulted in the insured losses of approximately $900 million (AUD1.4 billion). É w in Ireland and the UK followed with $690 million (€ ).\n\n**EXHIBIT 7: Top 5 Costliest Insured Loss Events in 1H 2025**\n\nNatural catastrophes in the United States accounted for more than 90 percent of global insured losses in the first half of 2025, reaching approximately $92 billion. Meanwhile, 1H insured losses in all other regions were significantly lower compared to their long-term averages.\n\n**EXHIBIT 8: 1H Insured Losses by Region (2025 $B)**\n\n**er cas C**\n\n**Date(s) Event Location Fatalities Insured Loss ($B)**\n\n01/07-01/28 Palisades Fire United States 12 23.0\n\n01/07-01/28 Eaton Fire United States 18 17.5\n\n03/14-03/16 Severe Convective Storm United States 43 8.0\n\n05/14-05/16 Severe Convective Storm United States 30 8.0\n\n05/17-05/20 Severe Convective Storm United States 0 4.0","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1H-2025-Global-Catastrophe-Recap_page7.pdf"]},"response":{"errors":[],"extract_id":"extract_bc99b966a08af5f6a58a82915427382d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["1H 2025 Global Catastrophe Recap 7\n\nInsured losses were driven by the destructive California wildfires in January, with total insured losses to be estimated at more than $40 billion. At least 19 events, 18 of which occurred in the United States, surpassed $1 billion in insured losses. Outside the U.S. region, European SCS outbreak in late June was the only event that exceeded this threshold. Cyclone Alfred in Australia resulted in the insured losses of approximately $900 million (AUD1.4 billion). É w in Ireland and the UK followed with $690 million (€ ).\n\n**EXHIBIT 7: Top 5 Costliest Insured Loss Events in 1H 2025**\n\nNatural catastrophes in the United States accounted for more than 90 percent of global insured losses in the first half of 2025, reaching approximately $92 billion. Meanwhile, 1H insured losses in all other regions were significantly lower compared to their long-term averages.\n\n**EXHIBIT 8: 1H Insured Losses by Region (2025 $B)**\n\n**er cas C**\n\n**Date(s) Event Location Fatalities Insured Loss ($B)**\n\n01/07-01/28 Palisades Fire United States 12 23.0\n\n01/07-01/28 Eaton Fire United States 18 17.5\n\n03/14-03/16 Severe Convective Storm United States 43 8.0\n\n05/14-05/16 Severe Convective Storm United States 30 8.0\n\n05/17-05/20 Severe Convective Storm United States 0 4.0"],"full_content":"1H 2025 Global Catastrophe Recap 7\n\nInsured losses were driven by the destructive California wildfires in January, with total insured losses to be estimated at more than $40 billion. At least 19 events, 18 of which occurred in the United States, surpassed $1 billion in insured losses. Outside the U.S. region, European SCS outbreak in late June was the only event that exceeded this threshold. Cyclone Alfred in Australia resulted in the insured losses of approximately $900 million (AUD1.4 billion). É w in Ireland and the UK followed with $690 million (€ ).\n\n**EXHIBIT 7: Top 5 Costliest Insured Loss Events in 1H 2025**\n\nNatural catastrophes in the United States accounted for more than 90 percent of global insured losses in the first half of 2025, reaching approximately $92 billion. Meanwhile, 1H insured losses in all other regions were significantly lower compared to their long-term averages.\n\n**EXHIBIT 8: 1H Insured Losses by Region (2025 $B)**\n\n**er cas C**\n\n**Date(s) Event Location Fatalities Insured Loss ($B)**\n\n01/07-01/28 Palisades Fire United States 12 23.0\n\n01/07-01/28 Eaton Fire United States 18 17.5\n\n03/14-03/16 Severe Convective Storm United States 43 8.0\n\n05/14-05/16 Severe Convective Storm United States 30 8.0\n\n05/17-05/20 Severe Convective Storm United States 0 4.0","publish_date":null,"title":"Insured losses were driven by the destructive California wildfires in January, with total insured losses to be estimated at more","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1H-2025-Global-Catastrophe-Recap_page7.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/1H-2025-Global-Catastrophe-Recap_page7.pdf"},"request":{"example_id":"table/1H-2025-Global-Catastrophe-Recap_page7","product_type":"parse","source_file_path":"1H-2025-Global-Catastrophe-Recap_page7.pdf"},"started_at":"2026-11-04T19:48:22.076647"} +{"completed_at":"2026-11-04T19:48:28.875781","latency_in_ms":5966,"output":{"example_id":"table/2023-conocophillips-aim-presentation (1)_page7","grounded_pages":[],"layout_pages":[],"markdown":"We Are Continuously Improving Ww\n\n2016 2019 2022 Foundational\n$43/BBL WTI $57/BBL WTI $94/BBL WTI Princ ples\nReturn on\n= ~ BA Satin\nReturn of Capital’ $1.11/share $4.45/share $11.73/share (OPA and Returns\nNet Debt $24B $7B $7B Sz | =<\nCash From Operations |\nBras Caen) Flaw $5B | $0B $12B | $5B $29B | $18B\nResource Fant Disciplined\n<$40/BBL WTI ~10 BBOE ~15 BBOE ~20 BBOE ineeasnanseres\nProduction 1.6 MMBOED 1.3 MMBOED 1.7 MMBOED\nEmissions Intensity? ~39 26 ~22 (S ESG\n(kg CO,e/BOE) mown Excellence\n\n'Defined in the Appendix and presented on a per-share basis using average outstanding diluted shares. \\*Gross operated GHG emissions (Scope 1 and 2), 2022 is a preliminary estimate.\n\nCash from operations (CFO), free cash flow (FCF), net debt and return on capital employed (ROCE) are non-GAAP measures. Definitions and reconciliations are included in the Appendix. ConocoPhillips 7","pages":[{"line_numbers":[],"markdown":"We Are Continuously Improving Ww\n\n2016 2019 2022 Foundational\n$43/BBL WTI $57/BBL WTI $94/BBL WTI Princ ples\nReturn on\n= ~ BA Satin\nReturn of Capital’ $1.11/share $4.45/share $11.73/share (OPA and Returns\nNet Debt $24B $7B $7B Sz | =<\nCash From Operations |\nBras Caen) Flaw $5B | $0B $12B | $5B $29B | $18B\nResource Fant Disciplined\n<$40/BBL WTI ~10 BBOE ~15 BBOE ~20 BBOE ineeasnanseres\nProduction 1.6 MMBOED 1.3 MMBOED 1.7 MMBOED\nEmissions Intensity? ~39 26 ~22 (S ESG\n(kg CO,e/BOE) mown Excellence\n\n'Defined in the Appendix and presented on a per-share basis using average outstanding diluted shares. \\*Gross operated GHG emissions (Scope 1 and 2), 2022 is a preliminary estimate.\n\nCash from operations (CFO), free cash flow (FCF), net debt and return on capital employed (ROCE) are non-GAAP measures. Definitions and reconciliations are included in the Appendix. ConocoPhillips 7","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"We Are Continuously Improving Ww\n\n2016 2019 2022 Foundational\n$43/BBL WTI $57/BBL WTI $94/BBL WTI Princ ples\nReturn on\n= ~ BA Satin\nReturn of Capital’ $1.11/share $4.45/share $11.73/share (OPA and Returns\nNet Debt $24B $7B $7B Sz | =<\nCash From Operations |\nBras Caen) Flaw $5B | $0B $12B | $5B $29B | $18B\nResource Fant Disciplined\n<$40/BBL WTI ~10 BBOE ~15 BBOE ~20 BBOE ineeasnanseres\nProduction 1.6 MMBOED 1.3 MMBOED 1.7 MMBOED\nEmissions Intensity? ~39 26 ~22 (S ESG\n(kg CO,e/BOE) mown Excellence\n\n'Defined in the Appendix and presented on a per-share basis using average outstanding diluted shares. \\*Gross operated GHG emissions (Scope 1 and 2), 2022 is a preliminary estimate.\n\nCash from operations (CFO), free cash flow (FCF), net debt and return on capital employed (ROCE) are non-GAAP measures. Definitions and reconciliations are included in the Appendix. ConocoPhillips 7","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/2023-conocophillips-aim-presentation%20%281%29_page7.pdf"]},"response":{"errors":[],"extract_id":"extract_95e0890ec68c3f6333434e00aa7bd991","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["We Are Continuously Improving Ww\n\n2016 2019 2022 Foundational\n$43/BBL WTI $57/BBL WTI $94/BBL WTI Princ ples\nReturn on\n= ~ BA Satin\nReturn of Capital’ $1.11/share $4.45/share $11.73/share (OPA and Returns\nNet Debt $24B $7B $7B Sz | =<\nCash From Operations |\nBras Caen) Flaw $5B | $0B $12B | $5B $29B | $18B\nResource Fant Disciplined\n<$40/BBL WTI ~10 BBOE ~15 BBOE ~20 BBOE ineeasnanseres\nProduction 1.6 MMBOED 1.3 MMBOED 1.7 MMBOED\nEmissions Intensity? ~39 26 ~22 (S ESG\n(kg CO,e/BOE) mown Excellence\n\n'Defined in the Appendix and presented on a per-share basis using average outstanding diluted shares. \\*Gross operated GHG emissions (Scope 1 and 2), 2022 is a preliminary estimate.\n\nCash from operations (CFO), free cash flow (FCF), net debt and return on capital employed (ROCE) are non-GAAP measures. Definitions and reconciliations are included in the Appendix. ConocoPhillips 7"],"full_content":"We Are Continuously Improving Ww\n\n2016 2019 2022 Foundational\n$43/BBL WTI $57/BBL WTI $94/BBL WTI Princ ples\nReturn on\n= ~ BA Satin\nReturn of Capital’ $1.11/share $4.45/share $11.73/share (OPA and Returns\nNet Debt $24B $7B $7B Sz | =<\nCash From Operations |\nBras Caen) Flaw $5B | $0B $12B | $5B $29B | $18B\nResource Fant Disciplined\n<$40/BBL WTI ~10 BBOE ~15 BBOE ~20 BBOE ineeasnanseres\nProduction 1.6 MMBOED 1.3 MMBOED 1.7 MMBOED\nEmissions Intensity? ~39 26 ~22 (S ESG\n(kg CO,e/BOE) mown Excellence\n\n'Defined in the Appendix and presented on a per-share basis using average outstanding diluted shares. \\*Gross operated GHG emissions (Scope 1 and 2), 2022 is a preliminary estimate.\n\nCash from operations (CFO), free cash flow (FCF), net debt and return on capital employed (ROCE) are non-GAAP measures. Definitions and reconciliations are included in the Appendix. ConocoPhillips 7","publish_date":null,"title":"2023 Conocophillips Aim Presentation (1) Page7","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/2023-conocophillips-aim-presentation%20%281%29_page7.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/2023-conocophillips-aim-presentation%20%281%29_page7.pdf"},"request":{"example_id":"table/2023-conocophillips-aim-presentation (1)_page7","product_type":"parse","source_file_path":"2023-conocophillips-aim-presentation (1)_page7.pdf"},"started_at":"2026-11-04T19:48:22.909356"} +{"completed_at":"2026-11-04T19:48:27.000851","latency_in_ms":2733,"output":{"example_id":"table/2023.02.07 Walmart Settlement Agreement_page27","grounded_pages":[],"layout_pages":[],"markdown":"### 24\n\n### Incentive BC Subdivision Population achieved by the Settling State as of the Third Subdivision Participation Date. Incentive Payment D shall be equal to between three percent (3%) and fifteen percent (15%) of the of the Settling State’s Overall Allocation Percentage of the Global Settlement Remediation Amount. The Incentive Payment D may be earned in each of Payment Years 3 through 6. Eligibility for Incentive Payment D is as follows:\n\n### a. A Settling State is eligible for Incentive Payment D if there has been no Later Litigating Subdivision (for purposes of Incentive Payment D, Later Litigating Subdivisions are limited to (i) a Primary Subdivision; (ii) a school district with a K-12 student enrollment of at least 25,000 or 0.10% of the State’s population, whichever is greater; (iii) a health district or hospital district that has at least one hundred twenty-five (125) hospital beds in one or more hospitals rendering services in that district; and (iv) Primary Fire Districts) in that State that has had a Claim against a Released Entity survive more than six (6) months after denial in whole or in part of a Threshold Motion as of July 15 of Payment Years 3 to 6 (each, an “ _Incentive Payment D Look-Back Date_ ”).\n\n### b. To the extent a Settling State achieves a Percentage of Incentive BC Subdivision Population of 95% or above as of the Third Subdivision Participation Date, the level of Incentive Payment D is reduced according to the schedule below. The following portions of Incentive Payment D are paid in equal installments in Payment Years 3 through 6:\n\n### c. The Settlement Fund Administrator shall determine a Settling State’s eligibility for Incentive Payment D as of the Incentive Payment D Look- Back Date in Payment Years 3 through 6. If a Later Litigating Subdivision’s lawsuit in that Settling State survives more than six (6) months after denial in whole or in part of a Threshold Motion, that State shall not be eligible for Incentive Payment D for the Payment Year in which that occurs and any subsequent Payment Year. Prior to the Incentive Payment D Look-Back Date in Payment Years 3 through 6, Walmart may provide the Settlement Fund Administrator and the\n\n### **Percentage of Incentive BC Subdivision Population as of the Third Subdivision Participation Date**\n\n### **Incentive Payment D Amount as a Percentage of Settling State’s Overall Allocation Percentage of the Global Settlement Remediation Amount**\n\n### Participation below 95% 15%\n\n### Participation of 95% but less than 96% 13%\n\n### Participation of 96% but less than 97% 11%\n\n### Participation of 97% but less than 98% 9%\n\n### Participation of 98% but less than 99% 7%\n\n### Participation of 99% but less than 100% 5%\n\n### Participation of 100% 3%","pages":[{"line_numbers":[],"markdown":"### 24\n\n### Incentive BC Subdivision Population achieved by the Settling State as of the Third Subdivision Participation Date. Incentive Payment D shall be equal to between three percent (3%) and fifteen percent (15%) of the of the Settling State’s Overall Allocation Percentage of the Global Settlement Remediation Amount. The Incentive Payment D may be earned in each of Payment Years 3 through 6. Eligibility for Incentive Payment D is as follows:\n\n### a. A Settling State is eligible for Incentive Payment D if there has been no Later Litigating Subdivision (for purposes of Incentive Payment D, Later Litigating Subdivisions are limited to (i) a Primary Subdivision; (ii) a school district with a K-12 student enrollment of at least 25,000 or 0.10% of the State’s population, whichever is greater; (iii) a health district or hospital district that has at least one hundred twenty-five (125) hospital beds in one or more hospitals rendering services in that district; and (iv) Primary Fire Districts) in that State that has had a Claim against a Released Entity survive more than six (6) months after denial in whole or in part of a Threshold Motion as of July 15 of Payment Years 3 to 6 (each, an “ _Incentive Payment D Look-Back Date_ ”).\n\n### b. To the extent a Settling State achieves a Percentage of Incentive BC Subdivision Population of 95% or above as of the Third Subdivision Participation Date, the level of Incentive Payment D is reduced according to the schedule below. The following portions of Incentive Payment D are paid in equal installments in Payment Years 3 through 6:\n\n### c. The Settlement Fund Administrator shall determine a Settling State’s eligibility for Incentive Payment D as of the Incentive Payment D Look- Back Date in Payment Years 3 through 6. If a Later Litigating Subdivision’s lawsuit in that Settling State survives more than six (6) months after denial in whole or in part of a Threshold Motion, that State shall not be eligible for Incentive Payment D for the Payment Year in which that occurs and any subsequent Payment Year. Prior to the Incentive Payment D Look-Back Date in Payment Years 3 through 6, Walmart may provide the Settlement Fund Administrator and the\n\n### **Percentage of Incentive BC Subdivision Population as of the Third Subdivision Participation Date**\n\n### **Incentive Payment D Amount as a Percentage of Settling State’s Overall Allocation Percentage of the Global Settlement Remediation Amount**\n\n### Participation below 95% 15%\n\n### Participation of 95% but less than 96% 13%\n\n### Participation of 96% but less than 97% 11%\n\n### Participation of 97% but less than 98% 9%\n\n### Participation of 98% but less than 99% 7%\n\n### Participation of 99% but less than 100% 5%\n\n### Participation of 100% 3%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### 24\n\n### Incentive BC Subdivision Population achieved by the Settling State as of the Third Subdivision Participation Date. Incentive Payment D shall be equal to between three percent (3%) and fifteen percent (15%) of the of the Settling State’s Overall Allocation Percentage of the Global Settlement Remediation Amount. The Incentive Payment D may be earned in each of Payment Years 3 through 6. Eligibility for Incentive Payment D is as follows:\n\n### a. A Settling State is eligible for Incentive Payment D if there has been no Later Litigating Subdivision (for purposes of Incentive Payment D, Later Litigating Subdivisions are limited to (i) a Primary Subdivision; (ii) a school district with a K-12 student enrollment of at least 25,000 or 0.10% of the State’s population, whichever is greater; (iii) a health district or hospital district that has at least one hundred twenty-five (125) hospital beds in one or more hospitals rendering services in that district; and (iv) Primary Fire Districts) in that State that has had a Claim against a Released Entity survive more than six (6) months after denial in whole or in part of a Threshold Motion as of July 15 of Payment Years 3 to 6 (each, an “ _Incentive Payment D Look-Back Date_ ”).\n\n### b. To the extent a Settling State achieves a Percentage of Incentive BC Subdivision Population of 95% or above as of the Third Subdivision Participation Date, the level of Incentive Payment D is reduced according to the schedule below. The following portions of Incentive Payment D are paid in equal installments in Payment Years 3 through 6:\n\n### c. The Settlement Fund Administrator shall determine a Settling State’s eligibility for Incentive Payment D as of the Incentive Payment D Look- Back Date in Payment Years 3 through 6. If a Later Litigating Subdivision’s lawsuit in that Settling State survives more than six (6) months after denial in whole or in part of a Threshold Motion, that State shall not be eligible for Incentive Payment D for the Payment Year in which that occurs and any subsequent Payment Year. Prior to the Incentive Payment D Look-Back Date in Payment Years 3 through 6, Walmart may provide the Settlement Fund Administrator and the\n\n### **Percentage of Incentive BC Subdivision Population as of the Third Subdivision Participation Date**\n\n### **Incentive Payment D Amount as a Percentage of Settling State’s Overall Allocation Percentage of the Global Settlement Remediation Amount**\n\n### Participation below 95% 15%\n\n### Participation of 95% but less than 96% 13%\n\n### Participation of 96% but less than 97% 11%\n\n### Participation of 97% but less than 98% 9%\n\n### Participation of 98% but less than 99% 7%\n\n### Participation of 99% but less than 100% 5%\n\n### Participation of 100% 3%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/2023.02.07%20Walmart%20Settlement%20Agreement_page27.pdf"]},"response":{"errors":[],"extract_id":"extract_e4112127e8b3e9cc0bced4023a2aaf58","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### 24\n\n### Incentive BC Subdivision Population achieved by the Settling State as of the Third Subdivision Participation Date. Incentive Payment D shall be equal to between three percent (3%) and fifteen percent (15%) of the of the Settling State’s Overall Allocation Percentage of the Global Settlement Remediation Amount. The Incentive Payment D may be earned in each of Payment Years 3 through 6. Eligibility for Incentive Payment D is as follows:\n\n### a. A Settling State is eligible for Incentive Payment D if there has been no Later Litigating Subdivision (for purposes of Incentive Payment D, Later Litigating Subdivisions are limited to (i) a Primary Subdivision; (ii) a school district with a K-12 student enrollment of at least 25,000 or 0.10% of the State’s population, whichever is greater; (iii) a health district or hospital district that has at least one hundred twenty-five (125) hospital beds in one or more hospitals rendering services in that district; and (iv) Primary Fire Districts) in that State that has had a Claim against a Released Entity survive more than six (6) months after denial in whole or in part of a Threshold Motion as of July 15 of Payment Years 3 to 6 (each, an “ _Incentive Payment D Look-Back Date_ ”).\n\n### b. To the extent a Settling State achieves a Percentage of Incentive BC Subdivision Population of 95% or above as of the Third Subdivision Participation Date, the level of Incentive Payment D is reduced according to the schedule below. The following portions of Incentive Payment D are paid in equal installments in Payment Years 3 through 6:\n\n### c. The Settlement Fund Administrator shall determine a Settling State’s eligibility for Incentive Payment D as of the Incentive Payment D Look- Back Date in Payment Years 3 through 6. If a Later Litigating Subdivision’s lawsuit in that Settling State survives more than six (6) months after denial in whole or in part of a Threshold Motion, that State shall not be eligible for Incentive Payment D for the Payment Year in which that occurs and any subsequent Payment Year. Prior to the Incentive Payment D Look-Back Date in Payment Years 3 through 6, Walmart may provide the Settlement Fund Administrator and the\n\n### **Percentage of Incentive BC Subdivision Population as of the Third Subdivision Participation Date**\n\n### **Incentive Payment D Amount as a Percentage of Settling State’s Overall Allocation Percentage of the Global Settlement Remediation Amount**\n\n### Participation below 95% 15%\n\n### Participation of 95% but less than 96% 13%\n\n### Participation of 96% but less than 97% 11%\n\n### Participation of 97% but less than 98% 9%\n\n### Participation of 98% but less than 99% 7%\n\n### Participation of 99% but less than 100% 5%\n\n### Participation of 100% 3%"],"full_content":"### 24\n\n### Incentive BC Subdivision Population achieved by the Settling State as of the Third Subdivision Participation Date. Incentive Payment D shall be equal to between three percent (3%) and fifteen percent (15%) of the of the Settling State’s Overall Allocation Percentage of the Global Settlement Remediation Amount. The Incentive Payment D may be earned in each of Payment Years 3 through 6. Eligibility for Incentive Payment D is as follows:\n\n### a. A Settling State is eligible for Incentive Payment D if there has been no Later Litigating Subdivision (for purposes of Incentive Payment D, Later Litigating Subdivisions are limited to (i) a Primary Subdivision; (ii) a school district with a K-12 student enrollment of at least 25,000 or 0.10% of the State’s population, whichever is greater; (iii) a health district or hospital district that has at least one hundred twenty-five (125) hospital beds in one or more hospitals rendering services in that district; and (iv) Primary Fire Districts) in that State that has had a Claim against a Released Entity survive more than six (6) months after denial in whole or in part of a Threshold Motion as of July 15 of Payment Years 3 to 6 (each, an “ _Incentive Payment D Look-Back Date_ ”).\n\n### b. To the extent a Settling State achieves a Percentage of Incentive BC Subdivision Population of 95% or above as of the Third Subdivision Participation Date, the level of Incentive Payment D is reduced according to the schedule below. The following portions of Incentive Payment D are paid in equal installments in Payment Years 3 through 6:\n\n### c. The Settlement Fund Administrator shall determine a Settling State’s eligibility for Incentive Payment D as of the Incentive Payment D Look- Back Date in Payment Years 3 through 6. If a Later Litigating Subdivision’s lawsuit in that Settling State survives more than six (6) months after denial in whole or in part of a Threshold Motion, that State shall not be eligible for Incentive Payment D for the Payment Year in which that occurs and any subsequent Payment Year. Prior to the Incentive Payment D Look-Back Date in Payment Years 3 through 6, Walmart may provide the Settlement Fund Administrator and the\n\n### **Percentage of Incentive BC Subdivision Population as of the Third Subdivision Participation Date**\n\n### **Incentive Payment D Amount as a Percentage of Settling State’s Overall Allocation Percentage of the Global Settlement Remediation Amount**\n\n### Participation below 95% 15%\n\n### Participation of 95% but less than 96% 13%\n\n### Participation of 96% but less than 97% 11%\n\n### Participation of 97% but less than 98% 9%\n\n### Participation of 98% but less than 99% 7%\n\n### Participation of 99% but less than 100% 5%\n\n### Participation of 100% 3%","publish_date":null,"title":"Incentive BC Subdivision Population achieved by the Settling State as of the Third Subdivision Participation Date. Incentive Payment D shall","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/2023.02.07%20Walmart%20Settlement%20Agreement_page27.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/2023.02.07%20Walmart%20Settlement%20Agreement_page27.pdf"},"request":{"example_id":"table/2023.02.07 Walmart Settlement Agreement_page27","product_type":"parse","source_file_path":"2023.02.07 Walmart Settlement Agreement_page27.pdf"},"started_at":"2026-11-04T19:48:24.267024"} +{"completed_at":"2026-11-04T19:48:26.998260","latency_in_ms":1189,"output":{"example_id":"table/2023.02.07 Walmart Settlement Agreement_page300","grounded_pages":[],"layout_pages":[],"markdown":"### G-186\n\n### _revised January 14, 2023_\n\n**State ID Qualifying Subdivision**\n\n**Consolidated State**\n\n**Allocation**\n\nOH1778 The Village of Indian Hill City, Ohio\n\n0\\.0264202950%\n\nOH1779 Thompson Township, Delaware County, Ohio\n\n0\\.0002474656%\n\nOH1780 Thompson Township, Geauga County, Ohio\n\n0\\.0022491568%\n\nOH1781 Thorn Township, Ohio 0.0007422882%\n\nOH1782 Thornville Village, Ohio 0.0006131946%\n\nOH1783 Thurston Village, Ohio 0.0013688400%\n\nOH1784 Tiffin City, Ohio 0.0703803061%\n\nOH1785 Tiffin Township, Ohio 0.0005075927%\n\nOH1786 Tiltonsville Village, Ohio 0.0016575735%\n\nOH1787 Timberlake Village, Ohio 0.0023312243%\n\nOH1788 Tipp City, Ohio 0.0376479790%\n\nOH1789 Tiro Village, Ohio 0.0000326285%\n\nOH1790 Toledo City, Ohio 1.0197706186%\n\nOH1791 Tontogany Village, Ohio 0.0001897924%\n\nOH1792 Toronto City, Ohio 0.0279077997%\n\nOH1793 Townsend Township, Huron County, Ohio\n\n0\\.0006177098%\n\nOH1794 Townsend Township, Sandusky County, Ohio\n\n0\\.0000271274%\n\nOH1795 Tremont City Village, Ohio 0.0006396354%\n\nOH1796 Trenton City, Ohio 0.0416371797%\n\nOH1797 Trenton Township, Ohio 0.0000577420%\n\nOH1798 Trimble Township, Ohio 0.0023032365%\n\nOH1799 Trimble Village, Ohio 0.0004320101%\n\nOH1800 Trotwood City, Ohio 0.0811683100%\n\nOH1801 Troy City, Ohio 0.0899917302%\n\nOH1802 Troy Township, Ashland County, Ohio\n\n0\\.0002358826%\n\nOH1803 Troy Township, Athens County, Ohio\n\n0\\.0008754383%\n\nOH1804 Troy Township, Geauga County, Ohio\n\n0\\.0026032794%\n\nOH1805 Troy Township, Richland County, Ohio\n\n0\\.0034790294%\n\nOH1806 Troy Township, Wood County, Ohio\n\n0\\.0027734180%\n\nOH1807 Trumbull County, Ohio 2.0203599712%\n\nOH1808 Trumbull Township, Ohio 0.0006457459%\n\nOH1809 Truro Township, Ohio 0.0493339720%\n\nOH1810 Tully Township, Ohio 0.0007929647%\n\nOH1811 Turtle Creek Township, Ohio 0.0003372090%\n\nOH1812 Turtlecreek Township, Ohio 0.0071325956%\n\nOH1813 Tuscarawas County, Ohio 0.3721703206%\n\nOH1814 Tuscarawas Township, Ohio 0.0020979323%\n\nOH1815 Tuscarawas Village, Ohio 0.0003842902%","pages":[{"line_numbers":[],"markdown":"### G-186\n\n### _revised January 14, 2023_\n\n**State ID Qualifying Subdivision**\n\n**Consolidated State**\n\n**Allocation**\n\nOH1778 The Village of Indian Hill City, Ohio\n\n0\\.0264202950%\n\nOH1779 Thompson Township, Delaware County, Ohio\n\n0\\.0002474656%\n\nOH1780 Thompson Township, Geauga County, Ohio\n\n0\\.0022491568%\n\nOH1781 Thorn Township, Ohio 0.0007422882%\n\nOH1782 Thornville Village, Ohio 0.0006131946%\n\nOH1783 Thurston Village, Ohio 0.0013688400%\n\nOH1784 Tiffin City, Ohio 0.0703803061%\n\nOH1785 Tiffin Township, Ohio 0.0005075927%\n\nOH1786 Tiltonsville Village, Ohio 0.0016575735%\n\nOH1787 Timberlake Village, Ohio 0.0023312243%\n\nOH1788 Tipp City, Ohio 0.0376479790%\n\nOH1789 Tiro Village, Ohio 0.0000326285%\n\nOH1790 Toledo City, Ohio 1.0197706186%\n\nOH1791 Tontogany Village, Ohio 0.0001897924%\n\nOH1792 Toronto City, Ohio 0.0279077997%\n\nOH1793 Townsend Township, Huron County, Ohio\n\n0\\.0006177098%\n\nOH1794 Townsend Township, Sandusky County, Ohio\n\n0\\.0000271274%\n\nOH1795 Tremont City Village, Ohio 0.0006396354%\n\nOH1796 Trenton City, Ohio 0.0416371797%\n\nOH1797 Trenton Township, Ohio 0.0000577420%\n\nOH1798 Trimble Township, Ohio 0.0023032365%\n\nOH1799 Trimble Village, Ohio 0.0004320101%\n\nOH1800 Trotwood City, Ohio 0.0811683100%\n\nOH1801 Troy City, Ohio 0.0899917302%\n\nOH1802 Troy Township, Ashland County, Ohio\n\n0\\.0002358826%\n\nOH1803 Troy Township, Athens County, Ohio\n\n0\\.0008754383%\n\nOH1804 Troy Township, Geauga County, Ohio\n\n0\\.0026032794%\n\nOH1805 Troy Township, Richland County, Ohio\n\n0\\.0034790294%\n\nOH1806 Troy Township, Wood County, Ohio\n\n0\\.0027734180%\n\nOH1807 Trumbull County, Ohio 2.0203599712%\n\nOH1808 Trumbull Township, Ohio 0.0006457459%\n\nOH1809 Truro Township, Ohio 0.0493339720%\n\nOH1810 Tully Township, Ohio 0.0007929647%\n\nOH1811 Turtle Creek Township, Ohio 0.0003372090%\n\nOH1812 Turtlecreek Township, Ohio 0.0071325956%\n\nOH1813 Tuscarawas County, Ohio 0.3721703206%\n\nOH1814 Tuscarawas Township, Ohio 0.0020979323%\n\nOH1815 Tuscarawas Village, Ohio 0.0003842902%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### G-186\n\n### _revised January 14, 2023_\n\n**State ID Qualifying Subdivision**\n\n**Consolidated State**\n\n**Allocation**\n\nOH1778 The Village of Indian Hill City, Ohio\n\n0\\.0264202950%\n\nOH1779 Thompson Township, Delaware County, Ohio\n\n0\\.0002474656%\n\nOH1780 Thompson Township, Geauga County, Ohio\n\n0\\.0022491568%\n\nOH1781 Thorn Township, Ohio 0.0007422882%\n\nOH1782 Thornville Village, Ohio 0.0006131946%\n\nOH1783 Thurston Village, Ohio 0.0013688400%\n\nOH1784 Tiffin City, Ohio 0.0703803061%\n\nOH1785 Tiffin Township, Ohio 0.0005075927%\n\nOH1786 Tiltonsville Village, Ohio 0.0016575735%\n\nOH1787 Timberlake Village, Ohio 0.0023312243%\n\nOH1788 Tipp City, Ohio 0.0376479790%\n\nOH1789 Tiro Village, Ohio 0.0000326285%\n\nOH1790 Toledo City, Ohio 1.0197706186%\n\nOH1791 Tontogany Village, Ohio 0.0001897924%\n\nOH1792 Toronto City, Ohio 0.0279077997%\n\nOH1793 Townsend Township, Huron County, Ohio\n\n0\\.0006177098%\n\nOH1794 Townsend Township, Sandusky County, Ohio\n\n0\\.0000271274%\n\nOH1795 Tremont City Village, Ohio 0.0006396354%\n\nOH1796 Trenton City, Ohio 0.0416371797%\n\nOH1797 Trenton Township, Ohio 0.0000577420%\n\nOH1798 Trimble Township, Ohio 0.0023032365%\n\nOH1799 Trimble Village, Ohio 0.0004320101%\n\nOH1800 Trotwood City, Ohio 0.0811683100%\n\nOH1801 Troy City, Ohio 0.0899917302%\n\nOH1802 Troy Township, Ashland County, Ohio\n\n0\\.0002358826%\n\nOH1803 Troy Township, Athens County, Ohio\n\n0\\.0008754383%\n\nOH1804 Troy Township, Geauga County, Ohio\n\n0\\.0026032794%\n\nOH1805 Troy Township, Richland County, Ohio\n\n0\\.0034790294%\n\nOH1806 Troy Township, Wood County, Ohio\n\n0\\.0027734180%\n\nOH1807 Trumbull County, Ohio 2.0203599712%\n\nOH1808 Trumbull Township, Ohio 0.0006457459%\n\nOH1809 Truro Township, Ohio 0.0493339720%\n\nOH1810 Tully Township, Ohio 0.0007929647%\n\nOH1811 Turtle Creek Township, Ohio 0.0003372090%\n\nOH1812 Turtlecreek Township, Ohio 0.0071325956%\n\nOH1813 Tuscarawas County, Ohio 0.3721703206%\n\nOH1814 Tuscarawas Township, Ohio 0.0020979323%\n\nOH1815 Tuscarawas Village, Ohio 0.0003842902%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/2023.02.07%20Walmart%20Settlement%20Agreement_page300.pdf"]},"response":{"errors":[],"extract_id":"extract_ed4618fe588936932e0deb0a221b34f2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### G-186\n\n### _revised January 14, 2023_\n\n**State ID Qualifying Subdivision**\n\n**Consolidated State**\n\n**Allocation**\n\nOH1778 The Village of Indian Hill City, Ohio\n\n0\\.0264202950%\n\nOH1779 Thompson Township, Delaware County, Ohio\n\n0\\.0002474656%\n\nOH1780 Thompson Township, Geauga County, Ohio\n\n0\\.0022491568%\n\nOH1781 Thorn Township, Ohio 0.0007422882%\n\nOH1782 Thornville Village, Ohio 0.0006131946%\n\nOH1783 Thurston Village, Ohio 0.0013688400%\n\nOH1784 Tiffin City, Ohio 0.0703803061%\n\nOH1785 Tiffin Township, Ohio 0.0005075927%\n\nOH1786 Tiltonsville Village, Ohio 0.0016575735%\n\nOH1787 Timberlake Village, Ohio 0.0023312243%\n\nOH1788 Tipp City, Ohio 0.0376479790%\n\nOH1789 Tiro Village, Ohio 0.0000326285%\n\nOH1790 Toledo City, Ohio 1.0197706186%\n\nOH1791 Tontogany Village, Ohio 0.0001897924%\n\nOH1792 Toronto City, Ohio 0.0279077997%\n\nOH1793 Townsend Township, Huron County, Ohio\n\n0\\.0006177098%\n\nOH1794 Townsend Township, Sandusky County, Ohio\n\n0\\.0000271274%\n\nOH1795 Tremont City Village, Ohio 0.0006396354%\n\nOH1796 Trenton City, Ohio 0.0416371797%\n\nOH1797 Trenton Township, Ohio 0.0000577420%\n\nOH1798 Trimble Township, Ohio 0.0023032365%\n\nOH1799 Trimble Village, Ohio 0.0004320101%\n\nOH1800 Trotwood City, Ohio 0.0811683100%\n\nOH1801 Troy City, Ohio 0.0899917302%\n\nOH1802 Troy Township, Ashland County, Ohio\n\n0\\.0002358826%\n\nOH1803 Troy Township, Athens County, Ohio\n\n0\\.0008754383%\n\nOH1804 Troy Township, Geauga County, Ohio\n\n0\\.0026032794%\n\nOH1805 Troy Township, Richland County, Ohio\n\n0\\.0034790294%\n\nOH1806 Troy Township, Wood County, Ohio\n\n0\\.0027734180%\n\nOH1807 Trumbull County, Ohio 2.0203599712%\n\nOH1808 Trumbull Township, Ohio 0.0006457459%\n\nOH1809 Truro Township, Ohio 0.0493339720%\n\nOH1810 Tully Township, Ohio 0.0007929647%\n\nOH1811 Turtle Creek Township, Ohio 0.0003372090%\n\nOH1812 Turtlecreek Township, Ohio 0.0071325956%\n\nOH1813 Tuscarawas County, Ohio 0.3721703206%\n\nOH1814 Tuscarawas Township, Ohio 0.0020979323%\n\nOH1815 Tuscarawas Village, Ohio 0.0003842902%"],"full_content":"### G-186\n\n### _revised January 14, 2023_\n\n**State ID Qualifying Subdivision**\n\n**Consolidated State**\n\n**Allocation**\n\nOH1778 The Village of Indian Hill City, Ohio\n\n0\\.0264202950%\n\nOH1779 Thompson Township, Delaware County, Ohio\n\n0\\.0002474656%\n\nOH1780 Thompson Township, Geauga County, Ohio\n\n0\\.0022491568%\n\nOH1781 Thorn Township, Ohio 0.0007422882%\n\nOH1782 Thornville Village, Ohio 0.0006131946%\n\nOH1783 Thurston Village, Ohio 0.0013688400%\n\nOH1784 Tiffin City, Ohio 0.0703803061%\n\nOH1785 Tiffin Township, Ohio 0.0005075927%\n\nOH1786 Tiltonsville Village, Ohio 0.0016575735%\n\nOH1787 Timberlake Village, Ohio 0.0023312243%\n\nOH1788 Tipp City, Ohio 0.0376479790%\n\nOH1789 Tiro Village, Ohio 0.0000326285%\n\nOH1790 Toledo City, Ohio 1.0197706186%\n\nOH1791 Tontogany Village, Ohio 0.0001897924%\n\nOH1792 Toronto City, Ohio 0.0279077997%\n\nOH1793 Townsend Township, Huron County, Ohio\n\n0\\.0006177098%\n\nOH1794 Townsend Township, Sandusky County, Ohio\n\n0\\.0000271274%\n\nOH1795 Tremont City Village, Ohio 0.0006396354%\n\nOH1796 Trenton City, Ohio 0.0416371797%\n\nOH1797 Trenton Township, Ohio 0.0000577420%\n\nOH1798 Trimble Township, Ohio 0.0023032365%\n\nOH1799 Trimble Village, Ohio 0.0004320101%\n\nOH1800 Trotwood City, Ohio 0.0811683100%\n\nOH1801 Troy City, Ohio 0.0899917302%\n\nOH1802 Troy Township, Ashland County, Ohio\n\n0\\.0002358826%\n\nOH1803 Troy Township, Athens County, Ohio\n\n0\\.0008754383%\n\nOH1804 Troy Township, Geauga County, Ohio\n\n0\\.0026032794%\n\nOH1805 Troy Township, Richland County, Ohio\n\n0\\.0034790294%\n\nOH1806 Troy Township, Wood County, Ohio\n\n0\\.0027734180%\n\nOH1807 Trumbull County, Ohio 2.0203599712%\n\nOH1808 Trumbull Township, Ohio 0.0006457459%\n\nOH1809 Truro Township, Ohio 0.0493339720%\n\nOH1810 Tully Township, Ohio 0.0007929647%\n\nOH1811 Turtle Creek Township, Ohio 0.0003372090%\n\nOH1812 Turtlecreek Township, Ohio 0.0071325956%\n\nOH1813 Tuscarawas County, Ohio 0.3721703206%\n\nOH1814 Tuscarawas Township, Ohio 0.0020979323%\n\nOH1815 Tuscarawas Village, Ohio 0.0003842902%","publish_date":null,"title":"G-186","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/2023.02.07%20Walmart%20Settlement%20Agreement_page300.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/2023.02.07%20Walmart%20Settlement%20Agreement_page300.pdf"},"request":{"example_id":"table/2023.02.07 Walmart Settlement Agreement_page300","product_type":"parse","source_file_path":"2023.02.07 Walmart Settlement Agreement_page300.pdf"},"started_at":"2026-11-04T19:48:25.808935"} +{"completed_at":"2026-11-04T19:48:27.998113","latency_in_ms":993,"output":{"example_id":"table/20230125-weather-climate-catastrophe-insight_page9","grounded_pages":[],"layout_pages":[],"markdown":"## 9\n\n## 2022 Natural Disaster Events and Loss Trends\n\n# **Exhibit 2: Top 10 2022 Global Economic Loss Events**\n\n## **Date Event Location Deaths Economic Loss ($ billion) Insured Loss ($ billion)**\n\n## 09/27 – 10/01 **Hurricane Ian** United States, Cuba 157 **95\\.5** 52\\.5\n\n## Annual **European Drought** Southern, Western and Central Europe N/A **22\\.0** 3\\.0\n\n## Annual **U.S. Drought** United States N/A **16\\.0** 8\\.0\n\n## 06/14 – 10/30 **Pakistan Seasonal Floods** Pakistan 1,739 **15\\.0** 0\\.1\n\n## 06/01 – 09/30 **China Seasonal Floods** China 195 **15\\.0** 0\\.4\n\n## 03/16 **Fukushima Earthquake** Japan 4 **9\\.1** 2\\.9\n\n## 02/23 – 03/31 **QLD & NSW Floods** Australia 22 **8\\.0** 4\\.0\n\n## Annual **China Drought** China N/A **7\\.6** 0\\.2\n\n## 02/18 – 02/19 **Windstorm Eunice** Western and Central Europe 17 **4\\.5** 3\\.4\n\n## 05/17 – 10/31 **India Seasonal Floods** India 2,135 **4\\.2** 0\\.1\n\n## All other events ~27,100 **115\\.6** 57\\.4\n\n## **Totals ~31,300 313 billion** **132 billion**\n\n## At least five events topped the economic loss threshold of $10 billion. Hurricane Ian dominated the ranking with an aggregated toll of approximately $95.5 billion — more than the next seven events combined. Three drought events in the table of 10 costliest events underline the growing significance of the peril on a global scale. Particularly, cumulative drought losses in European countries were at their highest since the historic summer of 2003, while the U.S. had the worst drought since 2012 in terms of overall economic losses. Floods in Pakistan were the costliest event for the peril, tied with seasonal flood losses in China, which were at their lowest since 2015. All but one event in the table were weather- and climate-related; the only two geophysical disasters that topped $1 billion in economic losses in 2022 were the March Fukushima Earthquake in Japan and September Sichuan Earthquake in China.","pages":[{"line_numbers":[],"markdown":"## 9\n\n## 2022 Natural Disaster Events and Loss Trends\n\n# **Exhibit 2: Top 10 2022 Global Economic Loss Events**\n\n## **Date Event Location Deaths Economic Loss ($ billion) Insured Loss ($ billion)**\n\n## 09/27 – 10/01 **Hurricane Ian** United States, Cuba 157 **95\\.5** 52\\.5\n\n## Annual **European Drought** Southern, Western and Central Europe N/A **22\\.0** 3\\.0\n\n## Annual **U.S. Drought** United States N/A **16\\.0** 8\\.0\n\n## 06/14 – 10/30 **Pakistan Seasonal Floods** Pakistan 1,739 **15\\.0** 0\\.1\n\n## 06/01 – 09/30 **China Seasonal Floods** China 195 **15\\.0** 0\\.4\n\n## 03/16 **Fukushima Earthquake** Japan 4 **9\\.1** 2\\.9\n\n## 02/23 – 03/31 **QLD & NSW Floods** Australia 22 **8\\.0** 4\\.0\n\n## Annual **China Drought** China N/A **7\\.6** 0\\.2\n\n## 02/18 – 02/19 **Windstorm Eunice** Western and Central Europe 17 **4\\.5** 3\\.4\n\n## 05/17 – 10/31 **India Seasonal Floods** India 2,135 **4\\.2** 0\\.1\n\n## All other events ~27,100 **115\\.6** 57\\.4\n\n## **Totals ~31,300 313 billion** **132 billion**\n\n## At least five events topped the economic loss threshold of $10 billion. Hurricane Ian dominated the ranking with an aggregated toll of approximately $95.5 billion — more than the next seven events combined. Three drought events in the table of 10 costliest events underline the growing significance of the peril on a global scale. Particularly, cumulative drought losses in European countries were at their highest since the historic summer of 2003, while the U.S. had the worst drought since 2012 in terms of overall economic losses. Floods in Pakistan were the costliest event for the peril, tied with seasonal flood losses in China, which were at their lowest since 2015. All but one event in the table were weather- and climate-related; the only two geophysical disasters that topped $1 billion in economic losses in 2022 were the March Fukushima Earthquake in Japan and September Sichuan Earthquake in China.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## 9\n\n## 2022 Natural Disaster Events and Loss Trends\n\n# **Exhibit 2: Top 10 2022 Global Economic Loss Events**\n\n## **Date Event Location Deaths Economic Loss ($ billion) Insured Loss ($ billion)**\n\n## 09/27 – 10/01 **Hurricane Ian** United States, Cuba 157 **95\\.5** 52\\.5\n\n## Annual **European Drought** Southern, Western and Central Europe N/A **22\\.0** 3\\.0\n\n## Annual **U.S. Drought** United States N/A **16\\.0** 8\\.0\n\n## 06/14 – 10/30 **Pakistan Seasonal Floods** Pakistan 1,739 **15\\.0** 0\\.1\n\n## 06/01 – 09/30 **China Seasonal Floods** China 195 **15\\.0** 0\\.4\n\n## 03/16 **Fukushima Earthquake** Japan 4 **9\\.1** 2\\.9\n\n## 02/23 – 03/31 **QLD & NSW Floods** Australia 22 **8\\.0** 4\\.0\n\n## Annual **China Drought** China N/A **7\\.6** 0\\.2\n\n## 02/18 – 02/19 **Windstorm Eunice** Western and Central Europe 17 **4\\.5** 3\\.4\n\n## 05/17 – 10/31 **India Seasonal Floods** India 2,135 **4\\.2** 0\\.1\n\n## All other events ~27,100 **115\\.6** 57\\.4\n\n## **Totals ~31,300 313 billion** **132 billion**\n\n## At least five events topped the economic loss threshold of $10 billion. Hurricane Ian dominated the ranking with an aggregated toll of approximately $95.5 billion — more than the next seven events combined. Three drought events in the table of 10 costliest events underline the growing significance of the peril on a global scale. Particularly, cumulative drought losses in European countries were at their highest since the historic summer of 2003, while the U.S. had the worst drought since 2012 in terms of overall economic losses. Floods in Pakistan were the costliest event for the peril, tied with seasonal flood losses in China, which were at their lowest since 2015. All but one event in the table were weather- and climate-related; the only two geophysical disasters that topped $1 billion in economic losses in 2022 were the March Fukushima Earthquake in Japan and September Sichuan Earthquake in China.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/20230125-weather-climate-catastrophe-insight_page9.pdf"]},"response":{"errors":[],"extract_id":"extract_fa10a6bec4eabcfffd5436d0a6dc1eca","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## 9\n\n## 2022 Natural Disaster Events and Loss Trends\n\n# **Exhibit 2: Top 10 2022 Global Economic Loss Events**\n\n## **Date Event Location Deaths Economic Loss ($ billion) Insured Loss ($ billion)**\n\n## 09/27 – 10/01 **Hurricane Ian** United States, Cuba 157 **95\\.5** 52\\.5\n\n## Annual **European Drought** Southern, Western and Central Europe N/A **22\\.0** 3\\.0\n\n## Annual **U.S. Drought** United States N/A **16\\.0** 8\\.0\n\n## 06/14 – 10/30 **Pakistan Seasonal Floods** Pakistan 1,739 **15\\.0** 0\\.1\n\n## 06/01 – 09/30 **China Seasonal Floods** China 195 **15\\.0** 0\\.4\n\n## 03/16 **Fukushima Earthquake** Japan 4 **9\\.1** 2\\.9\n\n## 02/23 – 03/31 **QLD & NSW Floods** Australia 22 **8\\.0** 4\\.0\n\n## Annual **China Drought** China N/A **7\\.6** 0\\.2\n\n## 02/18 – 02/19 **Windstorm Eunice** Western and Central Europe 17 **4\\.5** 3\\.4\n\n## 05/17 – 10/31 **India Seasonal Floods** India 2,135 **4\\.2** 0\\.1\n\n## All other events ~27,100 **115\\.6** 57\\.4\n\n## **Totals ~31,300 313 billion** **132 billion**\n\n## At least five events topped the economic loss threshold of $10 billion. Hurricane Ian dominated the ranking with an aggregated toll of approximately $95.5 billion — more than the next seven events combined. Three drought events in the table of 10 costliest events underline the growing significance of the peril on a global scale. Particularly, cumulative drought losses in European countries were at their highest since the historic summer of 2003, while the U.S. had the worst drought since 2012 in terms of overall economic losses. Floods in Pakistan were the costliest event for the peril, tied with seasonal flood losses in China, which were at their lowest since 2015. All but one event in the table were weather- and climate-related; the only two geophysical disasters that topped $1 billion in economic losses in 2022 were the March Fukushima Earthquake in Japan and September Sichuan Earthquake in China."],"full_content":"## 9\n\n## 2022 Natural Disaster Events and Loss Trends\n\n# **Exhibit 2: Top 10 2022 Global Economic Loss Events**\n\n## **Date Event Location Deaths Economic Loss ($ billion) Insured Loss ($ billion)**\n\n## 09/27 – 10/01 **Hurricane Ian** United States, Cuba 157 **95\\.5** 52\\.5\n\n## Annual **European Drought** Southern, Western and Central Europe N/A **22\\.0** 3\\.0\n\n## Annual **U.S. Drought** United States N/A **16\\.0** 8\\.0\n\n## 06/14 – 10/30 **Pakistan Seasonal Floods** Pakistan 1,739 **15\\.0** 0\\.1\n\n## 06/01 – 09/30 **China Seasonal Floods** China 195 **15\\.0** 0\\.4\n\n## 03/16 **Fukushima Earthquake** Japan 4 **9\\.1** 2\\.9\n\n## 02/23 – 03/31 **QLD & NSW Floods** Australia 22 **8\\.0** 4\\.0\n\n## Annual **China Drought** China N/A **7\\.6** 0\\.2\n\n## 02/18 – 02/19 **Windstorm Eunice** Western and Central Europe 17 **4\\.5** 3\\.4\n\n## 05/17 – 10/31 **India Seasonal Floods** India 2,135 **4\\.2** 0\\.1\n\n## All other events ~27,100 **115\\.6** 57\\.4\n\n## **Totals ~31,300 313 billion** **132 billion**\n\n## At least five events topped the economic loss threshold of $10 billion. Hurricane Ian dominated the ranking with an aggregated toll of approximately $95.5 billion — more than the next seven events combined. Three drought events in the table of 10 costliest events underline the growing significance of the peril on a global scale. Particularly, cumulative drought losses in European countries were at their highest since the historic summer of 2003, while the U.S. had the worst drought since 2012 in terms of overall economic losses. Floods in Pakistan were the costliest event for the peril, tied with seasonal flood losses in China, which were at their lowest since 2015. All but one event in the table were weather- and climate-related; the only two geophysical disasters that topped $1 billion in economic losses in 2022 were the March Fukushima Earthquake in Japan and September Sichuan Earthquake in China.","publish_date":null,"title":"Exhibit 2: Top 10 2022 Global Economic Loss Events","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/20230125-weather-climate-catastrophe-insight_page9.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/20230125-weather-climate-catastrophe-insight_page9.pdf"},"request":{"example_id":"table/20230125-weather-climate-catastrophe-insight_page9","product_type":"parse","source_file_path":"20230125-weather-climate-catastrophe-insight_page9.pdf"},"started_at":"2026-11-04T19:48:27.004947"} +{"completed_at":"2026-11-04T19:48:30.046003","latency_in_ms":2045,"output":{"example_id":"table/20250401_Axos_Bank_SFR_Correspondent_Rate_Sheet_page1","grounded_pages":[],"layout_pages":[],"markdown":"**Base Rate 21 Day 30 Day 45 Day 60 Day Base Rate 21 Day 30 Day 45 Day 60 Day Base Rate 21 Day 30 Day 45 Day 60 Day**\n\n8\\.000 103.000 102.875 102.750 102.625 8.000 102.500 102.375 102.250 102.125 8.250 102.500 102.375 102.250 102.125\n\n7\\.875 102.750 102.625 102.500 102.375 7.875 102.250 102.125 102.000 101.875 8.125 102.250 102.125 102.000 101.875\n\n7\\.750 102.500 102.375 102.250 102.125 7.750 102.000 101.875 101.750 101.625 8.000 102.000 101.875 101.750 101.625\n\n7\\.625 102.250 102.125 102.000 101.875 7.625 101.750 101.625 101.500 101.375 7.875 101.750 101.625 101.500 101.375\n\n7\\.500 102.000 101.875 101.750 101.625 7.500 101.500 101.375 101.250 101.125 7.750 101.500 101.375 101.250 101.125\n\n7\\.375 101.750 101.625 101.500 101.375 7.375 101.250 101.125 101.000 100.875 7.625 101.250 101.125 101.000 100.875\n\n7\\.250 101.500 101.375 101.250 101.125 7.250 101.000 100.875 100.750 100.625 7.500 101.000 100.875 100.750 100.625\n\n7\\.125 101.250 101.125 101.000 100.875 7.125 100.750 100.625 100.500 100.375 7.375 100.750 100.625 100.500 100.375\n\n7\\.000 101.000 100.875 100.750 100.625 7.000 100.500 100.375 100.250 100.125 7.250 100.500 100.375 100.250 100.125\n\n6\\.875 100.750 100.625 100.500 100.375 6.875 100.250 100.125 100.000 99.875 7.125 100.250 100.125 100.000 99.875\n\n6\\.750 100.500 100.375 100.250 100.125 6.750 100.000 99.875 99.750 99.625 7.000 100.000 99.875 99.750 99.625\n\n6\\.625 100.375 100.250 100.125 100.000 6.625 99.875 99.750 99.625 99.500 6.875 99.875 99.750 99.625 99.500\n\n6\\.500 100.000 99.875 99.750 99.625 6.500 99.500 99.375 99.250 99.125 6.750 99.500 99.375 99.250 99.125\n\n0\\.125 0.250 0.125\n\n0\\.250 0.250\n\n0\\.250 0.500\n\n\\-0.125 **0\\.250**\n\n0\\.000 0.125 0.500 0.875 1.250 0.000 0.125 0.250 0.375 -0.250 0.500 0.125 0.250 0.500 0.125 0.250\n\n50 / 55 50 / 55 50 / 55 45 / 50\n\n50 / 55 50 / 55 50 / 55 50 / 55 45 / 50\n\n40 / 45\n\n50 / 55 45 / 50\n\n60 / 60 60 / 60 60 / 60 55 / 60 50 / 55 45 / 50\n\n50 / 55\n\n40 / 45\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n50 / 55 50 / 55 45 / 50 40 / 45\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n55 / 60 50 / 55\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n60 / 60 55 / 55 50 / 50 45 / 45\n\n50 / 55 50 / 55 50 / 55 50 / 55 45 / 50 40 / 45\n\n55 / 60 50 / 55 45 / 50 40 / 45\n\n50 / 50 45 / 45\n\n55 / 60 50 / 55\n\n65 / 70 65 / 70 65 / 70 60 / 65 55 / 60 50 / 55\n\n65 / 65 60 / 65 55 / 60 50 / 55\n\n55 / 60 55 / 60 55 / 60 50 / 55 45 / 50 40 / 45\n\n55 / 55 50 / 50 45 / 45 40 / 40\n\n55 / 60 50 / 55\n\n55 / 55 50 / 50\n\n65 / 70 65 / 70 65 / 65 60 / 60 55 / 55 50 / 50\n\n65 / 70 60 / 65 55 / 60 50 / 55\n\n60 / 65 60 / 65 55 / 60 55 / 60 50 / 55 45 / 50\n\n60 / 65 55 / 60 50 / 55 45 / 50\n\n60 / 60 55 / 55\n\n>$5MM - ≤$10MM\n\nLTV/CLTV\n\n>$10MM - ≤$20MM\n\nLTV/CLTV\n\n60 / 60 55 / 55\n\n65 / 70 65 / 70 65 / 70 60 / 65 55 / 60 50 / 55\n\n**Correspondent SFR Ratesheet Lock Desk**\n\nTel: 1-858-764-6597 x 1550\n\nEmail: lockdesk@axosbank.com\n\nSales Inquiries Tuesday, April 01, 2025 Lock Requests:\n\nhttps://thirdpartylending.axosbank.com\n\n**PORTFOLIO ARM - Correspondent**\n\n2-4 Unit Property 15 Day Lock Extension\n\n**10/6 SOFR ARM 5/1/5 (JP106)**\n\nInvestment (18 mo. Pre-Payment Penalty)\n\n_Max of 2 extensions - Not to exceed original lock term_\n\nTel: 1-888-585-4869\n\n**Bank Statement Income LTV Max 65%**\n\n**Bank Statement - Interest Only Max LTV 60%**\n\nFICO 740+\n\n**5/6 SOFR ARM 5/1/5 (JP56, JP56IO) 7/6 SOFR ARM 5/1/5 (JP76, JP76IO)**\n\n30 Day Lock Extension\n\n2nd Home\n\n**Information** FICO 700-739\n\nLoan Amount $2,500,000 - $3,499,999\n\n**Portfolio Correspondent Fees** FICO 680-699\n\n**Rate Adjustments Price Adjustments ARM Features**\n\nRefinance\n\n**Rate Floor = Note Rate**\n\n**Margin = 3.25 Caps = 5/1/5**\n\n7 Day Lock Extension\n\n**NY Loans (Correspondent Only)**\n\nFICO <640 (Exception)\n\nTrust/Entity Review $350.00\n\nLender Fee $1,695.00 FICO 679-660 (Exception) FICO 659-640 (Exception)\n\nTX Doc Review $150.00\n\nLoan Amount $3,500,000 - $5,000,000 Loan Amount $5,000,001 - $10,000,000\n\nLoan To Value (LTV) ≤ 50%\n\nCondo (Condotel Max 50% LTV)\n\nCross-Collateralization\n\nInterest Only ( **Max 60% LTV/CLTV** ) 5/1 and 7/1 only Cash Out ≤ $500,000 Cash Out >$500,000\n\nLoan Amount $10,000,001 - $20,000,000\n\n**Max Pricing**\n\nCo-Op (New York Only)\n\n**LTV Eligibility Matrix**\n\nProperty Type / Loan Amount\n\n**Loans ≤$1MM: 5% LTV reduction in the following states:**\n\n**NY, NJ, CT - Applicable to LTVs >55% on grid below** Max Correspondent Pricing 102.000\n\n≤$1MM\n\nLTV/CLTV\n\n>$1MM - ≤$2MM\n\nLTV/CLTV\n\n>$2MM - ≤$3MM\n\nLTV/CLTV\n\n>$3MM - ≤$5MM\n\nLTV/CLTV\n\n**Primary Residence - Purchase**\n\n1 Unit 70 / 75 70 / 75 65 / 70 65 / 65\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Primary Residence - Rate & Term**\n\n1 Unit 70 / 75 70 / 75 65 / 70 65 / 65\n\n60 / 65 60 / 65\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Primary Residence - Cash Out**\n\n1 Unit 65 / 70 65 / 70 65 / 65 60 / 60\n\n65 / 70 65 / 70\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Purchase**\n\n1 Unit 65 / 70 65 / 70 65 / 65 60 / 65\n\n55 / 60 55 / 60\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Refinance (Rate/Term)**\n\n1 Unit 65 / 70 65 / 70 65 / 70 60 / 65\n\n65 / 70 65 / 70\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Refinance (Cash Out)**\n\n1 Unit 60 / 60 60 / 60 60 / 60 55 / 55\n\n55 / 60 55 / 60\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Investment - Purchase**\n\n1 Unit 65 / 65 65 / 65 65 / 65 60 / 65\n\n60 / 60 60 / 60\n\nCondo/Co-Op\n\n**Investment - Refinance (Rate/Term)**\n\n1 Unit\n\n1 Unit 60 / 60 60 / 60 60 / 60 55 / 60\n\n50 / 55 50 / 55\n\n**Minimum Loan Amount $500,000**\n\n**Minimum Rate 6.5%**\n\n**Foreign National - Not Eligible**\n\n**_See Foreign National Specific Program_**\n\n**TX (a6) \"Home Equity\" ELIGIBLE**\n\n**Investment - Refinance (Cash Out)**\n\n**12 Months Personal or Business Bank Statements**\n\n**ELIGIBLE**\n\nCondo/Co-Op\n\n2-4 Unit\n\n_This information is prepared as an advertisement for real estate and mortgage professionals only. It is not intended for public distribution or consumer information as it is not presented within the guidelines required by the Truth-In-Lending Act or other pertinent federal regulations._\n\n2-4 Unit\n\nCondo/Co-Op\n\nPrivacy Mortgage $350.00\n\n2-4 Unit\n\nCorr. Doc Service (optional) \\* _Cross-Collateralization & Entity Vesting require doc. services_\n\n$450.00","pages":[{"line_numbers":[],"markdown":"**Base Rate 21 Day 30 Day 45 Day 60 Day Base Rate 21 Day 30 Day 45 Day 60 Day Base Rate 21 Day 30 Day 45 Day 60 Day**\n\n8\\.000 103.000 102.875 102.750 102.625 8.000 102.500 102.375 102.250 102.125 8.250 102.500 102.375 102.250 102.125\n\n7\\.875 102.750 102.625 102.500 102.375 7.875 102.250 102.125 102.000 101.875 8.125 102.250 102.125 102.000 101.875\n\n7\\.750 102.500 102.375 102.250 102.125 7.750 102.000 101.875 101.750 101.625 8.000 102.000 101.875 101.750 101.625\n\n7\\.625 102.250 102.125 102.000 101.875 7.625 101.750 101.625 101.500 101.375 7.875 101.750 101.625 101.500 101.375\n\n7\\.500 102.000 101.875 101.750 101.625 7.500 101.500 101.375 101.250 101.125 7.750 101.500 101.375 101.250 101.125\n\n7\\.375 101.750 101.625 101.500 101.375 7.375 101.250 101.125 101.000 100.875 7.625 101.250 101.125 101.000 100.875\n\n7\\.250 101.500 101.375 101.250 101.125 7.250 101.000 100.875 100.750 100.625 7.500 101.000 100.875 100.750 100.625\n\n7\\.125 101.250 101.125 101.000 100.875 7.125 100.750 100.625 100.500 100.375 7.375 100.750 100.625 100.500 100.375\n\n7\\.000 101.000 100.875 100.750 100.625 7.000 100.500 100.375 100.250 100.125 7.250 100.500 100.375 100.250 100.125\n\n6\\.875 100.750 100.625 100.500 100.375 6.875 100.250 100.125 100.000 99.875 7.125 100.250 100.125 100.000 99.875\n\n6\\.750 100.500 100.375 100.250 100.125 6.750 100.000 99.875 99.750 99.625 7.000 100.000 99.875 99.750 99.625\n\n6\\.625 100.375 100.250 100.125 100.000 6.625 99.875 99.750 99.625 99.500 6.875 99.875 99.750 99.625 99.500\n\n6\\.500 100.000 99.875 99.750 99.625 6.500 99.500 99.375 99.250 99.125 6.750 99.500 99.375 99.250 99.125\n\n0\\.125 0.250 0.125\n\n0\\.250 0.250\n\n0\\.250 0.500\n\n\\-0.125 **0\\.250**\n\n0\\.000 0.125 0.500 0.875 1.250 0.000 0.125 0.250 0.375 -0.250 0.500 0.125 0.250 0.500 0.125 0.250\n\n50 / 55 50 / 55 50 / 55 45 / 50\n\n50 / 55 50 / 55 50 / 55 50 / 55 45 / 50\n\n40 / 45\n\n50 / 55 45 / 50\n\n60 / 60 60 / 60 60 / 60 55 / 60 50 / 55 45 / 50\n\n50 / 55\n\n40 / 45\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n50 / 55 50 / 55 45 / 50 40 / 45\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n55 / 60 50 / 55\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n60 / 60 55 / 55 50 / 50 45 / 45\n\n50 / 55 50 / 55 50 / 55 50 / 55 45 / 50 40 / 45\n\n55 / 60 50 / 55 45 / 50 40 / 45\n\n50 / 50 45 / 45\n\n55 / 60 50 / 55\n\n65 / 70 65 / 70 65 / 70 60 / 65 55 / 60 50 / 55\n\n65 / 65 60 / 65 55 / 60 50 / 55\n\n55 / 60 55 / 60 55 / 60 50 / 55 45 / 50 40 / 45\n\n55 / 55 50 / 50 45 / 45 40 / 40\n\n55 / 60 50 / 55\n\n55 / 55 50 / 50\n\n65 / 70 65 / 70 65 / 65 60 / 60 55 / 55 50 / 50\n\n65 / 70 60 / 65 55 / 60 50 / 55\n\n60 / 65 60 / 65 55 / 60 55 / 60 50 / 55 45 / 50\n\n60 / 65 55 / 60 50 / 55 45 / 50\n\n60 / 60 55 / 55\n\n>$5MM - ≤$10MM\n\nLTV/CLTV\n\n>$10MM - ≤$20MM\n\nLTV/CLTV\n\n60 / 60 55 / 55\n\n65 / 70 65 / 70 65 / 70 60 / 65 55 / 60 50 / 55\n\n**Correspondent SFR Ratesheet Lock Desk**\n\nTel: 1-858-764-6597 x 1550\n\nEmail: lockdesk@axosbank.com\n\nSales Inquiries Tuesday, April 01, 2025 Lock Requests:\n\nhttps://thirdpartylending.axosbank.com\n\n**PORTFOLIO ARM - Correspondent**\n\n2-4 Unit Property 15 Day Lock Extension\n\n**10/6 SOFR ARM 5/1/5 (JP106)**\n\nInvestment (18 mo. Pre-Payment Penalty)\n\n_Max of 2 extensions - Not to exceed original lock term_\n\nTel: 1-888-585-4869\n\n**Bank Statement Income LTV Max 65%**\n\n**Bank Statement - Interest Only Max LTV 60%**\n\nFICO 740+\n\n**5/6 SOFR ARM 5/1/5 (JP56, JP56IO) 7/6 SOFR ARM 5/1/5 (JP76, JP76IO)**\n\n30 Day Lock Extension\n\n2nd Home\n\n**Information** FICO 700-739\n\nLoan Amount $2,500,000 - $3,499,999\n\n**Portfolio Correspondent Fees** FICO 680-699\n\n**Rate Adjustments Price Adjustments ARM Features**\n\nRefinance\n\n**Rate Floor = Note Rate**\n\n**Margin = 3.25 Caps = 5/1/5**\n\n7 Day Lock Extension\n\n**NY Loans (Correspondent Only)**\n\nFICO <640 (Exception)\n\nTrust/Entity Review $350.00\n\nLender Fee $1,695.00 FICO 679-660 (Exception) FICO 659-640 (Exception)\n\nTX Doc Review $150.00\n\nLoan Amount $3,500,000 - $5,000,000 Loan Amount $5,000,001 - $10,000,000\n\nLoan To Value (LTV) ≤ 50%\n\nCondo (Condotel Max 50% LTV)\n\nCross-Collateralization\n\nInterest Only ( **Max 60% LTV/CLTV** ) 5/1 and 7/1 only Cash Out ≤ $500,000 Cash Out >$500,000\n\nLoan Amount $10,000,001 - $20,000,000\n\n**Max Pricing**\n\nCo-Op (New York Only)\n\n**LTV Eligibility Matrix**\n\nProperty Type / Loan Amount\n\n**Loans ≤$1MM: 5% LTV reduction in the following states:**\n\n**NY, NJ, CT - Applicable to LTVs >55% on grid below** Max Correspondent Pricing 102.000\n\n≤$1MM\n\nLTV/CLTV\n\n>$1MM - ≤$2MM\n\nLTV/CLTV\n\n>$2MM - ≤$3MM\n\nLTV/CLTV\n\n>$3MM - ≤$5MM\n\nLTV/CLTV\n\n**Primary Residence - Purchase**\n\n1 Unit 70 / 75 70 / 75 65 / 70 65 / 65\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Primary Residence - Rate & Term**\n\n1 Unit 70 / 75 70 / 75 65 / 70 65 / 65\n\n60 / 65 60 / 65\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Primary Residence - Cash Out**\n\n1 Unit 65 / 70 65 / 70 65 / 65 60 / 60\n\n65 / 70 65 / 70\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Purchase**\n\n1 Unit 65 / 70 65 / 70 65 / 65 60 / 65\n\n55 / 60 55 / 60\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Refinance (Rate/Term)**\n\n1 Unit 65 / 70 65 / 70 65 / 70 60 / 65\n\n65 / 70 65 / 70\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Refinance (Cash Out)**\n\n1 Unit 60 / 60 60 / 60 60 / 60 55 / 55\n\n55 / 60 55 / 60\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Investment - Purchase**\n\n1 Unit 65 / 65 65 / 65 65 / 65 60 / 65\n\n60 / 60 60 / 60\n\nCondo/Co-Op\n\n**Investment - Refinance (Rate/Term)**\n\n1 Unit\n\n1 Unit 60 / 60 60 / 60 60 / 60 55 / 60\n\n50 / 55 50 / 55\n\n**Minimum Loan Amount $500,000**\n\n**Minimum Rate 6.5%**\n\n**Foreign National - Not Eligible**\n\n**_See Foreign National Specific Program_**\n\n**TX (a6) \"Home Equity\" ELIGIBLE**\n\n**Investment - Refinance (Cash Out)**\n\n**12 Months Personal or Business Bank Statements**\n\n**ELIGIBLE**\n\nCondo/Co-Op\n\n2-4 Unit\n\n_This information is prepared as an advertisement for real estate and mortgage professionals only. It is not intended for public distribution or consumer information as it is not presented within the guidelines required by the Truth-In-Lending Act or other pertinent federal regulations._\n\n2-4 Unit\n\nCondo/Co-Op\n\nPrivacy Mortgage $350.00\n\n2-4 Unit\n\nCorr. Doc Service (optional) \\* _Cross-Collateralization & Entity Vesting require doc. services_\n\n$450.00","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Base Rate 21 Day 30 Day 45 Day 60 Day Base Rate 21 Day 30 Day 45 Day 60 Day Base Rate 21 Day 30 Day 45 Day 60 Day**\n\n8\\.000 103.000 102.875 102.750 102.625 8.000 102.500 102.375 102.250 102.125 8.250 102.500 102.375 102.250 102.125\n\n7\\.875 102.750 102.625 102.500 102.375 7.875 102.250 102.125 102.000 101.875 8.125 102.250 102.125 102.000 101.875\n\n7\\.750 102.500 102.375 102.250 102.125 7.750 102.000 101.875 101.750 101.625 8.000 102.000 101.875 101.750 101.625\n\n7\\.625 102.250 102.125 102.000 101.875 7.625 101.750 101.625 101.500 101.375 7.875 101.750 101.625 101.500 101.375\n\n7\\.500 102.000 101.875 101.750 101.625 7.500 101.500 101.375 101.250 101.125 7.750 101.500 101.375 101.250 101.125\n\n7\\.375 101.750 101.625 101.500 101.375 7.375 101.250 101.125 101.000 100.875 7.625 101.250 101.125 101.000 100.875\n\n7\\.250 101.500 101.375 101.250 101.125 7.250 101.000 100.875 100.750 100.625 7.500 101.000 100.875 100.750 100.625\n\n7\\.125 101.250 101.125 101.000 100.875 7.125 100.750 100.625 100.500 100.375 7.375 100.750 100.625 100.500 100.375\n\n7\\.000 101.000 100.875 100.750 100.625 7.000 100.500 100.375 100.250 100.125 7.250 100.500 100.375 100.250 100.125\n\n6\\.875 100.750 100.625 100.500 100.375 6.875 100.250 100.125 100.000 99.875 7.125 100.250 100.125 100.000 99.875\n\n6\\.750 100.500 100.375 100.250 100.125 6.750 100.000 99.875 99.750 99.625 7.000 100.000 99.875 99.750 99.625\n\n6\\.625 100.375 100.250 100.125 100.000 6.625 99.875 99.750 99.625 99.500 6.875 99.875 99.750 99.625 99.500\n\n6\\.500 100.000 99.875 99.750 99.625 6.500 99.500 99.375 99.250 99.125 6.750 99.500 99.375 99.250 99.125\n\n0\\.125 0.250 0.125\n\n0\\.250 0.250\n\n0\\.250 0.500\n\n\\-0.125 **0\\.250**\n\n0\\.000 0.125 0.500 0.875 1.250 0.000 0.125 0.250 0.375 -0.250 0.500 0.125 0.250 0.500 0.125 0.250\n\n50 / 55 50 / 55 50 / 55 45 / 50\n\n50 / 55 50 / 55 50 / 55 50 / 55 45 / 50\n\n40 / 45\n\n50 / 55 45 / 50\n\n60 / 60 60 / 60 60 / 60 55 / 60 50 / 55 45 / 50\n\n50 / 55\n\n40 / 45\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n50 / 55 50 / 55 45 / 50 40 / 45\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n55 / 60 50 / 55\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n60 / 60 55 / 55 50 / 50 45 / 45\n\n50 / 55 50 / 55 50 / 55 50 / 55 45 / 50 40 / 45\n\n55 / 60 50 / 55 45 / 50 40 / 45\n\n50 / 50 45 / 45\n\n55 / 60 50 / 55\n\n65 / 70 65 / 70 65 / 70 60 / 65 55 / 60 50 / 55\n\n65 / 65 60 / 65 55 / 60 50 / 55\n\n55 / 60 55 / 60 55 / 60 50 / 55 45 / 50 40 / 45\n\n55 / 55 50 / 50 45 / 45 40 / 40\n\n55 / 60 50 / 55\n\n55 / 55 50 / 50\n\n65 / 70 65 / 70 65 / 65 60 / 60 55 / 55 50 / 50\n\n65 / 70 60 / 65 55 / 60 50 / 55\n\n60 / 65 60 / 65 55 / 60 55 / 60 50 / 55 45 / 50\n\n60 / 65 55 / 60 50 / 55 45 / 50\n\n60 / 60 55 / 55\n\n>$5MM - ≤$10MM\n\nLTV/CLTV\n\n>$10MM - ≤$20MM\n\nLTV/CLTV\n\n60 / 60 55 / 55\n\n65 / 70 65 / 70 65 / 70 60 / 65 55 / 60 50 / 55\n\n**Correspondent SFR Ratesheet Lock Desk**\n\nTel: 1-858-764-6597 x 1550\n\nEmail: lockdesk@axosbank.com\n\nSales Inquiries Tuesday, April 01, 2025 Lock Requests:\n\nhttps://thirdpartylending.axosbank.com\n\n**PORTFOLIO ARM - Correspondent**\n\n2-4 Unit Property 15 Day Lock Extension\n\n**10/6 SOFR ARM 5/1/5 (JP106)**\n\nInvestment (18 mo. Pre-Payment Penalty)\n\n_Max of 2 extensions - Not to exceed original lock term_\n\nTel: 1-888-585-4869\n\n**Bank Statement Income LTV Max 65%**\n\n**Bank Statement - Interest Only Max LTV 60%**\n\nFICO 740+\n\n**5/6 SOFR ARM 5/1/5 (JP56, JP56IO) 7/6 SOFR ARM 5/1/5 (JP76, JP76IO)**\n\n30 Day Lock Extension\n\n2nd Home\n\n**Information** FICO 700-739\n\nLoan Amount $2,500,000 - $3,499,999\n\n**Portfolio Correspondent Fees** FICO 680-699\n\n**Rate Adjustments Price Adjustments ARM Features**\n\nRefinance\n\n**Rate Floor = Note Rate**\n\n**Margin = 3.25 Caps = 5/1/5**\n\n7 Day Lock Extension\n\n**NY Loans (Correspondent Only)**\n\nFICO <640 (Exception)\n\nTrust/Entity Review $350.00\n\nLender Fee $1,695.00 FICO 679-660 (Exception) FICO 659-640 (Exception)\n\nTX Doc Review $150.00\n\nLoan Amount $3,500,000 - $5,000,000 Loan Amount $5,000,001 - $10,000,000\n\nLoan To Value (LTV) ≤ 50%\n\nCondo (Condotel Max 50% LTV)\n\nCross-Collateralization\n\nInterest Only ( **Max 60% LTV/CLTV** ) 5/1 and 7/1 only Cash Out ≤ $500,000 Cash Out >$500,000\n\nLoan Amount $10,000,001 - $20,000,000\n\n**Max Pricing**\n\nCo-Op (New York Only)\n\n**LTV Eligibility Matrix**\n\nProperty Type / Loan Amount\n\n**Loans ≤$1MM: 5% LTV reduction in the following states:**\n\n**NY, NJ, CT - Applicable to LTVs >55% on grid below** Max Correspondent Pricing 102.000\n\n≤$1MM\n\nLTV/CLTV\n\n>$1MM - ≤$2MM\n\nLTV/CLTV\n\n>$2MM - ≤$3MM\n\nLTV/CLTV\n\n>$3MM - ≤$5MM\n\nLTV/CLTV\n\n**Primary Residence - Purchase**\n\n1 Unit 70 / 75 70 / 75 65 / 70 65 / 65\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Primary Residence - Rate & Term**\n\n1 Unit 70 / 75 70 / 75 65 / 70 65 / 65\n\n60 / 65 60 / 65\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Primary Residence - Cash Out**\n\n1 Unit 65 / 70 65 / 70 65 / 65 60 / 60\n\n65 / 70 65 / 70\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Purchase**\n\n1 Unit 65 / 70 65 / 70 65 / 65 60 / 65\n\n55 / 60 55 / 60\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Refinance (Rate/Term)**\n\n1 Unit 65 / 70 65 / 70 65 / 70 60 / 65\n\n65 / 70 65 / 70\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Refinance (Cash Out)**\n\n1 Unit 60 / 60 60 / 60 60 / 60 55 / 55\n\n55 / 60 55 / 60\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Investment - Purchase**\n\n1 Unit 65 / 65 65 / 65 65 / 65 60 / 65\n\n60 / 60 60 / 60\n\nCondo/Co-Op\n\n**Investment - Refinance (Rate/Term)**\n\n1 Unit\n\n1 Unit 60 / 60 60 / 60 60 / 60 55 / 60\n\n50 / 55 50 / 55\n\n**Minimum Loan Amount $500,000**\n\n**Minimum Rate 6.5%**\n\n**Foreign National - Not Eligible**\n\n**_See Foreign National Specific Program_**\n\n**TX (a6) \"Home Equity\" ELIGIBLE**\n\n**Investment - Refinance (Cash Out)**\n\n**12 Months Personal or Business Bank Statements**\n\n**ELIGIBLE**\n\nCondo/Co-Op\n\n2-4 Unit\n\n_This information is prepared as an advertisement for real estate and mortgage professionals only. It is not intended for public distribution or consumer information as it is not presented within the guidelines required by the Truth-In-Lending Act or other pertinent federal regulations._\n\n2-4 Unit\n\nCondo/Co-Op\n\nPrivacy Mortgage $350.00\n\n2-4 Unit\n\nCorr. Doc Service (optional) \\* _Cross-Collateralization & Entity Vesting require doc. services_\n\n$450.00","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/20250401_Axos_Bank_SFR_Correspondent_Rate_Sheet_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_bfa4e7c4af41c8db77b2bd689859c983","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Base Rate 21 Day 30 Day 45 Day 60 Day Base Rate 21 Day 30 Day 45 Day 60 Day Base Rate 21 Day 30 Day 45 Day 60 Day**\n\n8\\.000 103.000 102.875 102.750 102.625 8.000 102.500 102.375 102.250 102.125 8.250 102.500 102.375 102.250 102.125\n\n7\\.875 102.750 102.625 102.500 102.375 7.875 102.250 102.125 102.000 101.875 8.125 102.250 102.125 102.000 101.875\n\n7\\.750 102.500 102.375 102.250 102.125 7.750 102.000 101.875 101.750 101.625 8.000 102.000 101.875 101.750 101.625\n\n7\\.625 102.250 102.125 102.000 101.875 7.625 101.750 101.625 101.500 101.375 7.875 101.750 101.625 101.500 101.375\n\n7\\.500 102.000 101.875 101.750 101.625 7.500 101.500 101.375 101.250 101.125 7.750 101.500 101.375 101.250 101.125\n\n7\\.375 101.750 101.625 101.500 101.375 7.375 101.250 101.125 101.000 100.875 7.625 101.250 101.125 101.000 100.875\n\n7\\.250 101.500 101.375 101.250 101.125 7.250 101.000 100.875 100.750 100.625 7.500 101.000 100.875 100.750 100.625\n\n7\\.125 101.250 101.125 101.000 100.875 7.125 100.750 100.625 100.500 100.375 7.375 100.750 100.625 100.500 100.375\n\n7\\.000 101.000 100.875 100.750 100.625 7.000 100.500 100.375 100.250 100.125 7.250 100.500 100.375 100.250 100.125\n\n6\\.875 100.750 100.625 100.500 100.375 6.875 100.250 100.125 100.000 99.875 7.125 100.250 100.125 100.000 99.875\n\n6\\.750 100.500 100.375 100.250 100.125 6.750 100.000 99.875 99.750 99.625 7.000 100.000 99.875 99.750 99.625\n\n6\\.625 100.375 100.250 100.125 100.000 6.625 99.875 99.750 99.625 99.500 6.875 99.875 99.750 99.625 99.500\n\n6\\.500 100.000 99.875 99.750 99.625 6.500 99.500 99.375 99.250 99.125 6.750 99.500 99.375 99.250 99.125\n\n0\\.125 0.250 0.125\n\n0\\.250 0.250\n\n0\\.250 0.500\n\n\\-0.125 **0\\.250**\n\n0\\.000 0.125 0.500 0.875 1.250 0.000 0.125 0.250 0.375 -0.250 0.500 0.125 0.250 0.500 0.125 0.250\n\n50 / 55 50 / 55 50 / 55 45 / 50\n\n50 / 55 50 / 55 50 / 55 50 / 55 45 / 50\n\n40 / 45\n\n50 / 55 45 / 50\n\n60 / 60 60 / 60 60 / 60 55 / 60 50 / 55 45 / 50\n\n50 / 55\n\n40 / 45\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n50 / 55 50 / 55 45 / 50 40 / 45\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n55 / 60 50 / 55\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n60 / 60 55 / 55 50 / 50 45 / 45\n\n50 / 55 50 / 55 50 / 55 50 / 55 45 / 50 40 / 45\n\n55 / 60 50 / 55 45 / 50 40 / 45\n\n50 / 50 45 / 45\n\n55 / 60 50 / 55\n\n65 / 70 65 / 70 65 / 70 60 / 65 55 / 60 50 / 55\n\n65 / 65 60 / 65 55 / 60 50 / 55\n\n55 / 60 55 / 60 55 / 60 50 / 55 45 / 50 40 / 45\n\n55 / 55 50 / 50 45 / 45 40 / 40\n\n55 / 60 50 / 55\n\n55 / 55 50 / 50\n\n65 / 70 65 / 70 65 / 65 60 / 60 55 / 55 50 / 50\n\n65 / 70 60 / 65 55 / 60 50 / 55\n\n60 / 65 60 / 65 55 / 60 55 / 60 50 / 55 45 / 50\n\n60 / 65 55 / 60 50 / 55 45 / 50\n\n60 / 60 55 / 55\n\n>$5MM - ≤$10MM\n\nLTV/CLTV\n\n>$10MM - ≤$20MM\n\nLTV/CLTV\n\n60 / 60 55 / 55\n\n65 / 70 65 / 70 65 / 70 60 / 65 55 / 60 50 / 55\n\n**Correspondent SFR Ratesheet Lock Desk**\n\nTel: 1-858-764-6597 x 1550\n\nEmail: lockdesk@axosbank.com\n\nSales Inquiries Tuesday, April 01, 2025 Lock Requests:\n\nhttps://thirdpartylending.axosbank.com\n\n**PORTFOLIO ARM - Correspondent**\n\n2-4 Unit Property 15 Day Lock Extension\n\n**10/6 SOFR ARM 5/1/5 (JP106)**\n\nInvestment (18 mo. Pre-Payment Penalty)\n\n_Max of 2 extensions - Not to exceed original lock term_\n\nTel: 1-888-585-4869\n\n**Bank Statement Income LTV Max 65%**\n\n**Bank Statement - Interest Only Max LTV 60%**\n\nFICO 740+\n\n**5/6 SOFR ARM 5/1/5 (JP56, JP56IO) 7/6 SOFR ARM 5/1/5 (JP76, JP76IO)**\n\n30 Day Lock Extension\n\n2nd Home\n\n**Information** FICO 700-739\n\nLoan Amount $2,500,000 - $3,499,999\n\n**Portfolio Correspondent Fees** FICO 680-699\n\n**Rate Adjustments Price Adjustments ARM Features**\n\nRefinance\n\n**Rate Floor = Note Rate**\n\n**Margin = 3.25 Caps = 5/1/5**\n\n7 Day Lock Extension\n\n**NY Loans (Correspondent Only)**\n\nFICO <640 (Exception)\n\nTrust/Entity Review $350.00\n\nLender Fee $1,695.00 FICO 679-660 (Exception) FICO 659-640 (Exception)\n\nTX Doc Review $150.00\n\nLoan Amount $3,500,000 - $5,000,000 Loan Amount $5,000,001 - $10,000,000\n\nLoan To Value (LTV) ≤ 50%\n\nCondo (Condotel Max 50% LTV)\n\nCross-Collateralization\n\nInterest Only ( **Max 60% LTV/CLTV** ) 5/1 and 7/1 only Cash Out ≤ $500,000 Cash Out >$500,000\n\nLoan Amount $10,000,001 - $20,000,000\n\n**Max Pricing**\n\nCo-Op (New York Only)\n\n**LTV Eligibility Matrix**\n\nProperty Type / Loan Amount\n\n**Loans ≤$1MM: 5% LTV reduction in the following states:**\n\n**NY, NJ, CT - Applicable to LTVs >55% on grid below** Max Correspondent Pricing 102.000\n\n≤$1MM\n\nLTV/CLTV\n\n>$1MM - ≤$2MM\n\nLTV/CLTV\n\n>$2MM - ≤$3MM\n\nLTV/CLTV\n\n>$3MM - ≤$5MM\n\nLTV/CLTV\n\n**Primary Residence - Purchase**\n\n1 Unit 70 / 75 70 / 75 65 / 70 65 / 65\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Primary Residence - Rate & Term**\n\n1 Unit 70 / 75 70 / 75 65 / 70 65 / 65\n\n60 / 65 60 / 65\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Primary Residence - Cash Out**\n\n1 Unit 65 / 70 65 / 70 65 / 65 60 / 60\n\n65 / 70 65 / 70\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Purchase**\n\n1 Unit 65 / 70 65 / 70 65 / 65 60 / 65\n\n55 / 60 55 / 60\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Refinance (Rate/Term)**\n\n1 Unit 65 / 70 65 / 70 65 / 70 60 / 65\n\n65 / 70 65 / 70\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Refinance (Cash Out)**\n\n1 Unit 60 / 60 60 / 60 60 / 60 55 / 55\n\n55 / 60 55 / 60\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Investment - Purchase**\n\n1 Unit 65 / 65 65 / 65 65 / 65 60 / 65\n\n60 / 60 60 / 60\n\nCondo/Co-Op\n\n**Investment - Refinance (Rate/Term)**\n\n1 Unit\n\n1 Unit 60 / 60 60 / 60 60 / 60 55 / 60\n\n50 / 55 50 / 55\n\n**Minimum Loan Amount $500,000**\n\n**Minimum Rate 6.5%**\n\n**Foreign National - Not Eligible**\n\n**_See Foreign National Specific Program_**\n\n**TX (a6) \"Home Equity\" ELIGIBLE**\n\n**Investment - Refinance (Cash Out)**\n\n**12 Months Personal or Business Bank Statements**\n\n**ELIGIBLE**\n\nCondo/Co-Op\n\n2-4 Unit\n\n_This information is prepared as an advertisement for real estate and mortgage professionals only. It is not intended for public distribution or consumer information as it is not presented within the guidelines required by the Truth-In-Lending Act or other pertinent federal regulations._\n\n2-4 Unit\n\nCondo/Co-Op\n\nPrivacy Mortgage $350.00\n\n2-4 Unit\n\nCorr. Doc Service (optional) \\* _Cross-Collateralization & Entity Vesting require doc. services_\n\n$450.00"],"full_content":"**Base Rate 21 Day 30 Day 45 Day 60 Day Base Rate 21 Day 30 Day 45 Day 60 Day Base Rate 21 Day 30 Day 45 Day 60 Day**\n\n8\\.000 103.000 102.875 102.750 102.625 8.000 102.500 102.375 102.250 102.125 8.250 102.500 102.375 102.250 102.125\n\n7\\.875 102.750 102.625 102.500 102.375 7.875 102.250 102.125 102.000 101.875 8.125 102.250 102.125 102.000 101.875\n\n7\\.750 102.500 102.375 102.250 102.125 7.750 102.000 101.875 101.750 101.625 8.000 102.000 101.875 101.750 101.625\n\n7\\.625 102.250 102.125 102.000 101.875 7.625 101.750 101.625 101.500 101.375 7.875 101.750 101.625 101.500 101.375\n\n7\\.500 102.000 101.875 101.750 101.625 7.500 101.500 101.375 101.250 101.125 7.750 101.500 101.375 101.250 101.125\n\n7\\.375 101.750 101.625 101.500 101.375 7.375 101.250 101.125 101.000 100.875 7.625 101.250 101.125 101.000 100.875\n\n7\\.250 101.500 101.375 101.250 101.125 7.250 101.000 100.875 100.750 100.625 7.500 101.000 100.875 100.750 100.625\n\n7\\.125 101.250 101.125 101.000 100.875 7.125 100.750 100.625 100.500 100.375 7.375 100.750 100.625 100.500 100.375\n\n7\\.000 101.000 100.875 100.750 100.625 7.000 100.500 100.375 100.250 100.125 7.250 100.500 100.375 100.250 100.125\n\n6\\.875 100.750 100.625 100.500 100.375 6.875 100.250 100.125 100.000 99.875 7.125 100.250 100.125 100.000 99.875\n\n6\\.750 100.500 100.375 100.250 100.125 6.750 100.000 99.875 99.750 99.625 7.000 100.000 99.875 99.750 99.625\n\n6\\.625 100.375 100.250 100.125 100.000 6.625 99.875 99.750 99.625 99.500 6.875 99.875 99.750 99.625 99.500\n\n6\\.500 100.000 99.875 99.750 99.625 6.500 99.500 99.375 99.250 99.125 6.750 99.500 99.375 99.250 99.125\n\n0\\.125 0.250 0.125\n\n0\\.250 0.250\n\n0\\.250 0.500\n\n\\-0.125 **0\\.250**\n\n0\\.000 0.125 0.500 0.875 1.250 0.000 0.125 0.250 0.375 -0.250 0.500 0.125 0.250 0.500 0.125 0.250\n\n50 / 55 50 / 55 50 / 55 45 / 50\n\n50 / 55 50 / 55 50 / 55 50 / 55 45 / 50\n\n40 / 45\n\n50 / 55 45 / 50\n\n60 / 60 60 / 60 60 / 60 55 / 60 50 / 55 45 / 50\n\n50 / 55\n\n40 / 45\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n50 / 55 50 / 55 45 / 50 40 / 45\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n55 / 60 50 / 55\n\n65 / 65 65 / 65 65 / 65 60 / 65 55 / 60 50 / 55\n\n60 / 60 55 / 55 50 / 50 45 / 45\n\n50 / 55 50 / 55 50 / 55 50 / 55 45 / 50 40 / 45\n\n55 / 60 50 / 55 45 / 50 40 / 45\n\n50 / 50 45 / 45\n\n55 / 60 50 / 55\n\n65 / 70 65 / 70 65 / 70 60 / 65 55 / 60 50 / 55\n\n65 / 65 60 / 65 55 / 60 50 / 55\n\n55 / 60 55 / 60 55 / 60 50 / 55 45 / 50 40 / 45\n\n55 / 55 50 / 50 45 / 45 40 / 40\n\n55 / 60 50 / 55\n\n55 / 55 50 / 50\n\n65 / 70 65 / 70 65 / 65 60 / 60 55 / 55 50 / 50\n\n65 / 70 60 / 65 55 / 60 50 / 55\n\n60 / 65 60 / 65 55 / 60 55 / 60 50 / 55 45 / 50\n\n60 / 65 55 / 60 50 / 55 45 / 50\n\n60 / 60 55 / 55\n\n>$5MM - ≤$10MM\n\nLTV/CLTV\n\n>$10MM - ≤$20MM\n\nLTV/CLTV\n\n60 / 60 55 / 55\n\n65 / 70 65 / 70 65 / 70 60 / 65 55 / 60 50 / 55\n\n**Correspondent SFR Ratesheet Lock Desk**\n\nTel: 1-858-764-6597 x 1550\n\nEmail: lockdesk@axosbank.com\n\nSales Inquiries Tuesday, April 01, 2025 Lock Requests:\n\nhttps://thirdpartylending.axosbank.com\n\n**PORTFOLIO ARM - Correspondent**\n\n2-4 Unit Property 15 Day Lock Extension\n\n**10/6 SOFR ARM 5/1/5 (JP106)**\n\nInvestment (18 mo. Pre-Payment Penalty)\n\n_Max of 2 extensions - Not to exceed original lock term_\n\nTel: 1-888-585-4869\n\n**Bank Statement Income LTV Max 65%**\n\n**Bank Statement - Interest Only Max LTV 60%**\n\nFICO 740+\n\n**5/6 SOFR ARM 5/1/5 (JP56, JP56IO) 7/6 SOFR ARM 5/1/5 (JP76, JP76IO)**\n\n30 Day Lock Extension\n\n2nd Home\n\n**Information** FICO 700-739\n\nLoan Amount $2,500,000 - $3,499,999\n\n**Portfolio Correspondent Fees** FICO 680-699\n\n**Rate Adjustments Price Adjustments ARM Features**\n\nRefinance\n\n**Rate Floor = Note Rate**\n\n**Margin = 3.25 Caps = 5/1/5**\n\n7 Day Lock Extension\n\n**NY Loans (Correspondent Only)**\n\nFICO <640 (Exception)\n\nTrust/Entity Review $350.00\n\nLender Fee $1,695.00 FICO 679-660 (Exception) FICO 659-640 (Exception)\n\nTX Doc Review $150.00\n\nLoan Amount $3,500,000 - $5,000,000 Loan Amount $5,000,001 - $10,000,000\n\nLoan To Value (LTV) ≤ 50%\n\nCondo (Condotel Max 50% LTV)\n\nCross-Collateralization\n\nInterest Only ( **Max 60% LTV/CLTV** ) 5/1 and 7/1 only Cash Out ≤ $500,000 Cash Out >$500,000\n\nLoan Amount $10,000,001 - $20,000,000\n\n**Max Pricing**\n\nCo-Op (New York Only)\n\n**LTV Eligibility Matrix**\n\nProperty Type / Loan Amount\n\n**Loans ≤$1MM: 5% LTV reduction in the following states:**\n\n**NY, NJ, CT - Applicable to LTVs >55% on grid below** Max Correspondent Pricing 102.000\n\n≤$1MM\n\nLTV/CLTV\n\n>$1MM - ≤$2MM\n\nLTV/CLTV\n\n>$2MM - ≤$3MM\n\nLTV/CLTV\n\n>$3MM - ≤$5MM\n\nLTV/CLTV\n\n**Primary Residence - Purchase**\n\n1 Unit 70 / 75 70 / 75 65 / 70 65 / 65\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Primary Residence - Rate & Term**\n\n1 Unit 70 / 75 70 / 75 65 / 70 65 / 65\n\n60 / 65 60 / 65\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Primary Residence - Cash Out**\n\n1 Unit 65 / 70 65 / 70 65 / 65 60 / 60\n\n65 / 70 65 / 70\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Purchase**\n\n1 Unit 65 / 70 65 / 70 65 / 65 60 / 65\n\n55 / 60 55 / 60\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Refinance (Rate/Term)**\n\n1 Unit 65 / 70 65 / 70 65 / 70 60 / 65\n\n65 / 70 65 / 70\n\n2-4 Unit\n\nCondo/Co-Op\n\n**2nd Home - Refinance (Cash Out)**\n\n1 Unit 60 / 60 60 / 60 60 / 60 55 / 55\n\n55 / 60 55 / 60\n\n2-4 Unit\n\nCondo/Co-Op\n\n**Investment - Purchase**\n\n1 Unit 65 / 65 65 / 65 65 / 65 60 / 65\n\n60 / 60 60 / 60\n\nCondo/Co-Op\n\n**Investment - Refinance (Rate/Term)**\n\n1 Unit\n\n1 Unit 60 / 60 60 / 60 60 / 60 55 / 60\n\n50 / 55 50 / 55\n\n**Minimum Loan Amount $500,000**\n\n**Minimum Rate 6.5%**\n\n**Foreign National - Not Eligible**\n\n**_See Foreign National Specific Program_**\n\n**TX (a6) \"Home Equity\" ELIGIBLE**\n\n**Investment - Refinance (Cash Out)**\n\n**12 Months Personal or Business Bank Statements**\n\n**ELIGIBLE**\n\nCondo/Co-Op\n\n2-4 Unit\n\n_This information is prepared as an advertisement for real estate and mortgage professionals only. It is not intended for public distribution or consumer information as it is not presented within the guidelines required by the Truth-In-Lending Act or other pertinent federal regulations._\n\n2-4 Unit\n\nCondo/Co-Op\n\nPrivacy Mortgage $350.00\n\n2-4 Unit\n\nCorr. Doc Service (optional) \\* _Cross-Collateralization & Entity Vesting require doc. services_\n\n$450.00","publish_date":null,"title":"Lock Desk","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/20250401_Axos_Bank_SFR_Correspondent_Rate_Sheet_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/20250401_Axos_Bank_SFR_Correspondent_Rate_Sheet_page1.pdf"},"request":{"example_id":"table/20250401_Axos_Bank_SFR_Correspondent_Rate_Sheet_page1","product_type":"parse","source_file_path":"20250401_Axos_Bank_SFR_Correspondent_Rate_Sheet_page1.pdf"},"started_at":"2026-11-04T19:48:28.000105"} +{"completed_at":"2026-11-04T19:48:31.385684","latency_in_ms":2014,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page10","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 10/31\n\nThe following Table 1 provides an overview as counts of research needs and their priority topics within\n\nthe respective needs section.\n\nTable 1: Overview of 2025 updated RSRNs\n\n**Sections with Research needs to …** **Number of**\n\n**research needs**\n\n**Number of**\n\n**priority topics**\n\n2\\.2. …improve clinical research 9 25\n\n2\\.3. …improve regulatory system evolution 11 35\n\n2\\.4. … foster technologies for development of\n\nspecific types of medicines 14 35\n\n2\\.5. … advance specifically animal health and the\n\nregulation of veterinary medicines\n\n15\n\n27\n\n**Total** 49 122\n\nThe following Figure 2 indicates the relative frequencies of keywords that characterise the research needs in this 2025 update.\n\nFigure 2: Word cloud of priority topics","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 10/31\n\nThe following Table 1 provides an overview as counts of research needs and their priority topics within\n\nthe respective needs section.\n\nTable 1: Overview of 2025 updated RSRNs\n\n**Sections with Research needs to …** **Number of**\n\n**research needs**\n\n**Number of**\n\n**priority topics**\n\n2\\.2. …improve clinical research 9 25\n\n2\\.3. …improve regulatory system evolution 11 35\n\n2\\.4. … foster technologies for development of\n\nspecific types of medicines 14 35\n\n2\\.5. … advance specifically animal health and the\n\nregulation of veterinary medicines\n\n15\n\n27\n\n**Total** 49 122\n\nThe following Figure 2 indicates the relative frequencies of keywords that characterise the research needs in this 2025 update.\n\nFigure 2: Word cloud of priority topics","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 10/31\n\nThe following Table 1 provides an overview as counts of research needs and their priority topics within\n\nthe respective needs section.\n\nTable 1: Overview of 2025 updated RSRNs\n\n**Sections with Research needs to …** **Number of**\n\n**research needs**\n\n**Number of**\n\n**priority topics**\n\n2\\.2. …improve clinical research 9 25\n\n2\\.3. …improve regulatory system evolution 11 35\n\n2\\.4. … foster technologies for development of\n\nspecific types of medicines 14 35\n\n2\\.5. … advance specifically animal health and the\n\nregulation of veterinary medicines\n\n15\n\n27\n\n**Total** 49 122\n\nThe following Figure 2 indicates the relative frequencies of keywords that characterise the research needs in this 2025 update.\n\nFigure 2: Word cloud of priority topics","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page10.pdf"]},"response":{"errors":[],"extract_id":"extract_8292f75eb342b9c207678cff3e14a9a1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 10/31\n\nThe following Table 1 provides an overview as counts of research needs and their priority topics within\n\nthe respective needs section.\n\nTable 1: Overview of 2025 updated RSRNs\n\n**Sections with Research needs to …** **Number of**\n\n**research needs**\n\n**Number of**\n\n**priority topics**\n\n2\\.2. …improve clinical research 9 25\n\n2\\.3. …improve regulatory system evolution 11 35\n\n2\\.4. … foster technologies for development of\n\nspecific types of medicines 14 35\n\n2\\.5. … advance specifically animal health and the\n\nregulation of veterinary medicines\n\n15\n\n27\n\n**Total** 49 122\n\nThe following Figure 2 indicates the relative frequencies of keywords that characterise the research needs in this 2025 update.\n\nFigure 2: Word cloud of priority topics"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 10/31\n\nThe following Table 1 provides an overview as counts of research needs and their priority topics within\n\nthe respective needs section.\n\nTable 1: Overview of 2025 updated RSRNs\n\n**Sections with Research needs to …** **Number of**\n\n**research needs**\n\n**Number of**\n\n**priority topics**\n\n2\\.2. …improve clinical research 9 25\n\n2\\.3. …improve regulatory system evolution 11 35\n\n2\\.4. … foster technologies for development of\n\nspecific types of medicines 14 35\n\n2\\.5. … advance specifically animal health and the\n\nregulation of veterinary medicines\n\n15\n\n27\n\n**Total** 49 122\n\nThe following Figure 2 indicates the relative frequencies of keywords that characterise the research needs in this 2025 update.\n\nFigure 2: Word cloud of priority topics","publish_date":null,"title":"The following Table 1 provides an overview as counts of research needs and their priority topics within the respective needs","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page10.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page10.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page10","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page10.pdf"},"started_at":"2026-11-04T19:48:29.370697"} +{"completed_at":"2026-11-04T19:48:32.619615","latency_in_ms":2466,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page11","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 11/31\n\n**_2\\.2._** **_Research needs to improve clinical research_**\n\nThis section includes 9 research needs and 25 priority topics to develop clinical trial\n\nmethodologies and advance clinical trial design, thereby enhancing the flexibility, speed,\n\nand quality of clinical trials.\n\nThe needs in this list touch upon statistical analysis in clinical trials, innovative approaches in clinical\n\ntrial design and the optimisation of clinical trials in specific therapeutic areas.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Impacted domain**\n\n**_Focus area: Statistical analysis in clinical trials_** **CT1** Research on use of the estimand framework ICH E9(R1)\n\n1\\. Develop principles for aligning estimation methods with targeted estimands for intercurrent event strategies, including hypothetical scenarios (C; D; F)\n\n2\\. Develop principles for applying causal inference approaches to clinical trials in the estimand framework (C; D; F)\n\n3\\. Identify commonalities between the estimand framework and frameworks for HTA assessment (e.g., PICO) and generate recommendations on how they could be aligned based on methodological principles (C; D; G)\n\n• Study design • Statistical analysis • Estimands\n\nHuman and Veterinary medicines Health technology assessment\n\n**CT2** Research to enhance robustness of non- randomised studies\n\n1\\. Develop a framework of multiple dimensions and criteria for the rigor and quality of non-randomised clinical trials including contextual considerations (e.g. challenges with rare diseases or certain technologies) (C; D; G)\n\n• Statistical analysis • non-randomised clinical trials\n\n• Clinical trials\n\nHuman medicine\n\n**CT3** Research on analytical methods for clinical trials\n\n1\\. Perform a review of elicitation and data-driven methods for priors for Bayesian analyses of clinical trial results to inform clinical and regulatory decision-making, and identify use-cases that would particularly benefit from using such priors (focus on rare and ultra-rare diseases, special populations and other areas of high unmet medical needs) (B; C; G)\n\n2\\. Research multiple bias modelling in evidence synthesis and analysis, to inform regulatory decisions (C; G)\n\n• Statistical design • Statistical analysis • Rare diseases • Several therapeutics areas\n\n• Orphan medicines • Clinical trials\n\nHuman medicine","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 11/31\n\n**_2\\.2._** **_Research needs to improve clinical research_**\n\nThis section includes 9 research needs and 25 priority topics to develop clinical trial\n\nmethodologies and advance clinical trial design, thereby enhancing the flexibility, speed,\n\nand quality of clinical trials.\n\nThe needs in this list touch upon statistical analysis in clinical trials, innovative approaches in clinical\n\ntrial design and the optimisation of clinical trials in specific therapeutic areas.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Impacted domain**\n\n**_Focus area: Statistical analysis in clinical trials_** **CT1** Research on use of the estimand framework ICH E9(R1)\n\n1\\. Develop principles for aligning estimation methods with targeted estimands for intercurrent event strategies, including hypothetical scenarios (C; D; F)\n\n2\\. Develop principles for applying causal inference approaches to clinical trials in the estimand framework (C; D; F)\n\n3\\. Identify commonalities between the estimand framework and frameworks for HTA assessment (e.g., PICO) and generate recommendations on how they could be aligned based on methodological principles (C; D; G)\n\n• Study design • Statistical analysis • Estimands\n\nHuman and Veterinary medicines Health technology assessment\n\n**CT2** Research to enhance robustness of non- randomised studies\n\n1\\. Develop a framework of multiple dimensions and criteria for the rigor and quality of non-randomised clinical trials including contextual considerations (e.g. challenges with rare diseases or certain technologies) (C; D; G)\n\n• Statistical analysis • non-randomised clinical trials\n\n• Clinical trials\n\nHuman medicine\n\n**CT3** Research on analytical methods for clinical trials\n\n1\\. Perform a review of elicitation and data-driven methods for priors for Bayesian analyses of clinical trial results to inform clinical and regulatory decision-making, and identify use-cases that would particularly benefit from using such priors (focus on rare and ultra-rare diseases, special populations and other areas of high unmet medical needs) (B; C; G)\n\n2\\. Research multiple bias modelling in evidence synthesis and analysis, to inform regulatory decisions (C; G)\n\n• Statistical design • Statistical analysis • Rare diseases • Several therapeutics areas\n\n• Orphan medicines • Clinical trials\n\nHuman medicine","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 11/31\n\n**_2\\.2._** **_Research needs to improve clinical research_**\n\nThis section includes 9 research needs and 25 priority topics to develop clinical trial\n\nmethodologies and advance clinical trial design, thereby enhancing the flexibility, speed,\n\nand quality of clinical trials.\n\nThe needs in this list touch upon statistical analysis in clinical trials, innovative approaches in clinical\n\ntrial design and the optimisation of clinical trials in specific therapeutic areas.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Impacted domain**\n\n**_Focus area: Statistical analysis in clinical trials_** **CT1** Research on use of the estimand framework ICH E9(R1)\n\n1\\. Develop principles for aligning estimation methods with targeted estimands for intercurrent event strategies, including hypothetical scenarios (C; D; F)\n\n2\\. Develop principles for applying causal inference approaches to clinical trials in the estimand framework (C; D; F)\n\n3\\. Identify commonalities between the estimand framework and frameworks for HTA assessment (e.g., PICO) and generate recommendations on how they could be aligned based on methodological principles (C; D; G)\n\n• Study design • Statistical analysis • Estimands\n\nHuman and Veterinary medicines Health technology assessment\n\n**CT2** Research to enhance robustness of non- randomised studies\n\n1\\. Develop a framework of multiple dimensions and criteria for the rigor and quality of non-randomised clinical trials including contextual considerations (e.g. challenges with rare diseases or certain technologies) (C; D; G)\n\n• Statistical analysis • non-randomised clinical trials\n\n• Clinical trials\n\nHuman medicine\n\n**CT3** Research on analytical methods for clinical trials\n\n1\\. Perform a review of elicitation and data-driven methods for priors for Bayesian analyses of clinical trial results to inform clinical and regulatory decision-making, and identify use-cases that would particularly benefit from using such priors (focus on rare and ultra-rare diseases, special populations and other areas of high unmet medical needs) (B; C; G)\n\n2\\. Research multiple bias modelling in evidence synthesis and analysis, to inform regulatory decisions (C; G)\n\n• Statistical design • Statistical analysis • Rare diseases • Several therapeutics areas\n\n• Orphan medicines • Clinical trials\n\nHuman medicine","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page11.pdf"]},"response":{"errors":[],"extract_id":"extract_52f4f1aa11e6994545388b478287f25a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 11/31\n\n**_2\\.2._** **_Research needs to improve clinical research_**\n\nThis section includes 9 research needs and 25 priority topics to develop clinical trial\n\nmethodologies and advance clinical trial design, thereby enhancing the flexibility, speed,\n\nand quality of clinical trials.\n\nThe needs in this list touch upon statistical analysis in clinical trials, innovative approaches in clinical\n\ntrial design and the optimisation of clinical trials in specific therapeutic areas.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Impacted domain**\n\n**_Focus area: Statistical analysis in clinical trials_** **CT1** Research on use of the estimand framework ICH E9(R1)\n\n1\\. Develop principles for aligning estimation methods with targeted estimands for intercurrent event strategies, including hypothetical scenarios (C; D; F)\n\n2\\. Develop principles for applying causal inference approaches to clinical trials in the estimand framework (C; D; F)\n\n3\\. Identify commonalities between the estimand framework and frameworks for HTA assessment (e.g., PICO) and generate recommendations on how they could be aligned based on methodological principles (C; D; G)\n\n• Study design • Statistical analysis • Estimands\n\nHuman and Veterinary medicines Health technology assessment\n\n**CT2** Research to enhance robustness of non- randomised studies\n\n1\\. Develop a framework of multiple dimensions and criteria for the rigor and quality of non-randomised clinical trials including contextual considerations (e.g. challenges with rare diseases or certain technologies) (C; D; G)\n\n• Statistical analysis • non-randomised clinical trials\n\n• Clinical trials\n\nHuman medicine\n\n**CT3** Research on analytical methods for clinical trials\n\n1\\. Perform a review of elicitation and data-driven methods for priors for Bayesian analyses of clinical trial results to inform clinical and regulatory decision-making, and identify use-cases that would particularly benefit from using such priors (focus on rare and ultra-rare diseases, special populations and other areas of high unmet medical needs) (B; C; G)\n\n2\\. Research multiple bias modelling in evidence synthesis and analysis, to inform regulatory decisions (C; G)\n\n• Statistical design • Statistical analysis • Rare diseases • Several therapeutics areas\n\n• Orphan medicines • Clinical trials\n\nHuman medicine"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 11/31\n\n**_2\\.2._** **_Research needs to improve clinical research_**\n\nThis section includes 9 research needs and 25 priority topics to develop clinical trial\n\nmethodologies and advance clinical trial design, thereby enhancing the flexibility, speed,\n\nand quality of clinical trials.\n\nThe needs in this list touch upon statistical analysis in clinical trials, innovative approaches in clinical\n\ntrial design and the optimisation of clinical trials in specific therapeutic areas.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Impacted domain**\n\n**_Focus area: Statistical analysis in clinical trials_** **CT1** Research on use of the estimand framework ICH E9(R1)\n\n1\\. Develop principles for aligning estimation methods with targeted estimands for intercurrent event strategies, including hypothetical scenarios (C; D; F)\n\n2\\. Develop principles for applying causal inference approaches to clinical trials in the estimand framework (C; D; F)\n\n3\\. Identify commonalities between the estimand framework and frameworks for HTA assessment (e.g., PICO) and generate recommendations on how they could be aligned based on methodological principles (C; D; G)\n\n• Study design • Statistical analysis • Estimands\n\nHuman and Veterinary medicines Health technology assessment\n\n**CT2** Research to enhance robustness of non- randomised studies\n\n1\\. Develop a framework of multiple dimensions and criteria for the rigor and quality of non-randomised clinical trials including contextual considerations (e.g. challenges with rare diseases or certain technologies) (C; D; G)\n\n• Statistical analysis • non-randomised clinical trials\n\n• Clinical trials\n\nHuman medicine\n\n**CT3** Research on analytical methods for clinical trials\n\n1\\. Perform a review of elicitation and data-driven methods for priors for Bayesian analyses of clinical trial results to inform clinical and regulatory decision-making, and identify use-cases that would particularly benefit from using such priors (focus on rare and ultra-rare diseases, special populations and other areas of high unmet medical needs) (B; C; G)\n\n2\\. Research multiple bias modelling in evidence synthesis and analysis, to inform regulatory decisions (C; G)\n\n• Statistical design • Statistical analysis • Rare diseases • Several therapeutics areas\n\n• Orphan medicines • Clinical trials\n\nHuman medicine","publish_date":null,"title":"2.2. Research needs to improve clinical research This section includes 9 research needs and 25 priority topics to develop clinical","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page11.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page11.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page11","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page11.pdf"},"started_at":"2026-11-04T19:48:30.152920"} +{"completed_at":"2026-11-04T19:46:55.512649","latency_in_ms":3647,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page12","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 12/31\n\n**_Focus area: Innovative approaches in clinical trial design_** **CT4** Research on methods to improve efficiency of design and analysis methodologies for trials\n\n1\\. Perform a comparison of methods to use non-concurrent arms, including handling time trends, in platform trials (G)\n\n2\\. Research hierarchical / multi- level modelling approaches for analyses of efficacy endpoints in complex or personalised treatment trials (C; D; G)\n\n3\\. Conduct a review of features of medicines and of trial participants that are relevant for expressing their independency with respect to considerations for “type 1 error control” (e.g., when included in arms, periods, groups or other elements of platform trials) (G)\n\n4\\. Develop with stakeholders a protocol for, and prepare the conduct of a multi-stage or platform trial that establishes a new early efficacy endpoint(s) and uses this endpoint in future participants in the trial to investigate the efficacy of an investigational product(s) (e.g. vaccines targeting low incidence, high risk nosocomial infections) (G)\n\n5\\. Research ways of constructing ordinal endpoints that include functional improvements or impairments and favourable or detrimental events, and simulate its impact on trial efficiency using past trials (F; G)\n\n6\\. Perform an analytical and simulation-based comparison of designs for first-in-man oncology studies in terms of efficiency and patient benefit- risk (A; C; F; G)\n\n7\\. Review stakeholder positions and arguments (covering ethics, policies, pharma- cology, medicine) concerning diversity, equity and inclusion, analyse the impact and implications for various activities in particular clinical research and medicine development (B; G)\n\n• Clinical trials • Platform trial • Complex trials • Oncology • First-in-man studies\n\nHuman medicine","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 12/31\n\n**_Focus area: Innovative approaches in clinical trial design_** **CT4** Research on methods to improve efficiency of design and analysis methodologies for trials\n\n1\\. Perform a comparison of methods to use non-concurrent arms, including handling time trends, in platform trials (G)\n\n2\\. Research hierarchical / multi- level modelling approaches for analyses of efficacy endpoints in complex or personalised treatment trials (C; D; G)\n\n3\\. Conduct a review of features of medicines and of trial participants that are relevant for expressing their independency with respect to considerations for “type 1 error control” (e.g., when included in arms, periods, groups or other elements of platform trials) (G)\n\n4\\. Develop with stakeholders a protocol for, and prepare the conduct of a multi-stage or platform trial that establishes a new early efficacy endpoint(s) and uses this endpoint in future participants in the trial to investigate the efficacy of an investigational product(s) (e.g. vaccines targeting low incidence, high risk nosocomial infections) (G)\n\n5\\. Research ways of constructing ordinal endpoints that include functional improvements or impairments and favourable or detrimental events, and simulate its impact on trial efficiency using past trials (F; G)\n\n6\\. Perform an analytical and simulation-based comparison of designs for first-in-man oncology studies in terms of efficiency and patient benefit- risk (A; C; F; G)\n\n7\\. Review stakeholder positions and arguments (covering ethics, policies, pharma- cology, medicine) concerning diversity, equity and inclusion, analyse the impact and implications for various activities in particular clinical research and medicine development (B; G)\n\n• Clinical trials • Platform trial • Complex trials • Oncology • First-in-man studies\n\nHuman medicine","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 12/31\n\n**_Focus area: Innovative approaches in clinical trial design_** **CT4** Research on methods to improve efficiency of design and analysis methodologies for trials\n\n1\\. Perform a comparison of methods to use non-concurrent arms, including handling time trends, in platform trials (G)\n\n2\\. Research hierarchical / multi- level modelling approaches for analyses of efficacy endpoints in complex or personalised treatment trials (C; D; G)\n\n3\\. Conduct a review of features of medicines and of trial participants that are relevant for expressing their independency with respect to considerations for “type 1 error control” (e.g., when included in arms, periods, groups or other elements of platform trials) (G)\n\n4\\. Develop with stakeholders a protocol for, and prepare the conduct of a multi-stage or platform trial that establishes a new early efficacy endpoint(s) and uses this endpoint in future participants in the trial to investigate the efficacy of an investigational product(s) (e.g. vaccines targeting low incidence, high risk nosocomial infections) (G)\n\n5\\. Research ways of constructing ordinal endpoints that include functional improvements or impairments and favourable or detrimental events, and simulate its impact on trial efficiency using past trials (F; G)\n\n6\\. Perform an analytical and simulation-based comparison of designs for first-in-man oncology studies in terms of efficiency and patient benefit- risk (A; C; F; G)\n\n7\\. Review stakeholder positions and arguments (covering ethics, policies, pharma- cology, medicine) concerning diversity, equity and inclusion, analyse the impact and implications for various activities in particular clinical research and medicine development (B; G)\n\n• Clinical trials • Platform trial • Complex trials • Oncology • First-in-man studies\n\nHuman medicine","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page12.pdf"]},"response":{"errors":[],"extract_id":"extract_bff088c607e804a010b4b10c5806611d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 12/31\n\n**_Focus area: Innovative approaches in clinical trial design_** **CT4** Research on methods to improve efficiency of design and analysis methodologies for trials\n\n1\\. Perform a comparison of methods to use non-concurrent arms, including handling time trends, in platform trials (G)\n\n2\\. Research hierarchical / multi- level modelling approaches for analyses of efficacy endpoints in complex or personalised treatment trials (C; D; G)\n\n3\\. Conduct a review of features of medicines and of trial participants that are relevant for expressing their independency with respect to considerations for “type 1 error control” (e.g., when included in arms, periods, groups or other elements of platform trials) (G)\n\n4\\. Develop with stakeholders a protocol for, and prepare the conduct of a multi-stage or platform trial that establishes a new early efficacy endpoint(s) and uses this endpoint in future participants in the trial to investigate the efficacy of an investigational product(s) (e.g. vaccines targeting low incidence, high risk nosocomial infections) (G)\n\n5\\. Research ways of constructing ordinal endpoints that include functional improvements or impairments and favourable or detrimental events, and simulate its impact on trial efficiency using past trials (F; G)\n\n6\\. Perform an analytical and simulation-based comparison of designs for first-in-man oncology studies in terms of efficiency and patient benefit- risk (A; C; F; G)\n\n7\\. Review stakeholder positions and arguments (covering ethics, policies, pharma- cology, medicine) concerning diversity, equity and inclusion, analyse the impact and implications for various activities in particular clinical research and medicine development (B; G)\n\n• Clinical trials • Platform trial • Complex trials • Oncology • First-in-man studies\n\nHuman medicine"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 12/31\n\n**_Focus area: Innovative approaches in clinical trial design_** **CT4** Research on methods to improve efficiency of design and analysis methodologies for trials\n\n1\\. Perform a comparison of methods to use non-concurrent arms, including handling time trends, in platform trials (G)\n\n2\\. Research hierarchical / multi- level modelling approaches for analyses of efficacy endpoints in complex or personalised treatment trials (C; D; G)\n\n3\\. Conduct a review of features of medicines and of trial participants that are relevant for expressing their independency with respect to considerations for “type 1 error control” (e.g., when included in arms, periods, groups or other elements of platform trials) (G)\n\n4\\. Develop with stakeholders a protocol for, and prepare the conduct of a multi-stage or platform trial that establishes a new early efficacy endpoint(s) and uses this endpoint in future participants in the trial to investigate the efficacy of an investigational product(s) (e.g. vaccines targeting low incidence, high risk nosocomial infections) (G)\n\n5\\. Research ways of constructing ordinal endpoints that include functional improvements or impairments and favourable or detrimental events, and simulate its impact on trial efficiency using past trials (F; G)\n\n6\\. Perform an analytical and simulation-based comparison of designs for first-in-man oncology studies in terms of efficiency and patient benefit- risk (A; C; F; G)\n\n7\\. Review stakeholder positions and arguments (covering ethics, policies, pharma- cology, medicine) concerning diversity, equity and inclusion, analyse the impact and implications for various activities in particular clinical research and medicine development (B; G)\n\n• Clinical trials • Platform trial • Complex trials • Oncology • First-in-man studies\n\nHuman medicine","publish_date":null,"title":"• 1. • • • • 2. 3. 4. 5. 6. 7.","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page12.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page12.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page12","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page12.pdf"},"started_at":"2026-11-04T19:46:51.865470"} +{"completed_at":"2026-11-04T19:31:11.890221","latency_in_ms":2420,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page13","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 13/31\n\n**CT5** Research on EU capacity and operational aspects of clinical trials\n\n1\\. Develop a mapping and quantification of key challenges for sponsors (commercial and non-commercial) to efficiently plan, resource, set-up and conduct multinational clinical trials in the EU (and beyond) (B; G)\n\n2\\. Perform gap analysis and quantify capacities and competencies (e.g., researchers, organisations, infrastructure) in the EU for carrying out master protocol- based trials, large, simple pragmatic or low interventional clinical trials in the EU (and beyond; to include aspects of health care systems, health professionals formation etc.) (B; G)\n\n3\\. Map clinical trials with decentralised elements (e.g., over time, geography, therapeutic area, types of elements) and perform trend analyses to describe challenges and opportunities (if possible, including the impact of the EU DCT recommendations ²⁷ ; B; G)\n\n4\\. Research including a survey and interviews into the local, regional and country-specific availability and usability of existing electronic health care record, hospital and medical practice IT systems for screening persons and recruiting subjects into clinical trials (B; G)\n\n• Clinical trials • Network capacity • Decentralised clinical trials\n\nHuman medicine\n\n**_Focus area: Clinical trials optimisation in specific therapeutic areas_** **CT6** Research on innovative clinical trial designs to support medicines development\n\n1\\. Review complex clinical trials in rare diseases and perform analyses to evaluate design choices, opportunities and avenues to address challenges of drawing conclusions from them (B; G)\n\n2\\. Research into efficiency of broader options for clinical trial design, broader inclusion of study populations, stratification approaches and analyses, e.g. in obesity and diabetes (G)\n\n3\\. Research into efficient options for organising and designing clinical research in pre- symptomatic stages of neuro- degenerative diseases for documenting clinical benefits (B; D; F; G)\n\n4\\. Research to develop non- invasive markers for MASH\n\n• Clinical trials • Advanced therapy medicinal products\n\n• Rare disease • Platform trials • Complex trials • Obesity • Neurology\n\nHuman medicine\n\n27 Facilitating Decentralised Clinical Trials in the EU | European Medicines Agency (EMA)","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 13/31\n\n**CT5** Research on EU capacity and operational aspects of clinical trials\n\n1\\. Develop a mapping and quantification of key challenges for sponsors (commercial and non-commercial) to efficiently plan, resource, set-up and conduct multinational clinical trials in the EU (and beyond) (B; G)\n\n2\\. Perform gap analysis and quantify capacities and competencies (e.g., researchers, organisations, infrastructure) in the EU for carrying out master protocol- based trials, large, simple pragmatic or low interventional clinical trials in the EU (and beyond; to include aspects of health care systems, health professionals formation etc.) (B; G)\n\n3\\. Map clinical trials with decentralised elements (e.g., over time, geography, therapeutic area, types of elements) and perform trend analyses to describe challenges and opportunities (if possible, including the impact of the EU DCT recommendations ²⁷ ; B; G)\n\n4\\. Research including a survey and interviews into the local, regional and country-specific availability and usability of existing electronic health care record, hospital and medical practice IT systems for screening persons and recruiting subjects into clinical trials (B; G)\n\n• Clinical trials • Network capacity • Decentralised clinical trials\n\nHuman medicine\n\n**_Focus area: Clinical trials optimisation in specific therapeutic areas_** **CT6** Research on innovative clinical trial designs to support medicines development\n\n1\\. Review complex clinical trials in rare diseases and perform analyses to evaluate design choices, opportunities and avenues to address challenges of drawing conclusions from them (B; G)\n\n2\\. Research into efficiency of broader options for clinical trial design, broader inclusion of study populations, stratification approaches and analyses, e.g. in obesity and diabetes (G)\n\n3\\. Research into efficient options for organising and designing clinical research in pre- symptomatic stages of neuro- degenerative diseases for documenting clinical benefits (B; D; F; G)\n\n4\\. Research to develop non- invasive markers for MASH\n\n• Clinical trials • Advanced therapy medicinal products\n\n• Rare disease • Platform trials • Complex trials • Obesity • Neurology\n\nHuman medicine\n\n27 Facilitating Decentralised Clinical Trials in the EU | European Medicines Agency (EMA)","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 13/31\n\n**CT5** Research on EU capacity and operational aspects of clinical trials\n\n1\\. Develop a mapping and quantification of key challenges for sponsors (commercial and non-commercial) to efficiently plan, resource, set-up and conduct multinational clinical trials in the EU (and beyond) (B; G)\n\n2\\. Perform gap analysis and quantify capacities and competencies (e.g., researchers, organisations, infrastructure) in the EU for carrying out master protocol- based trials, large, simple pragmatic or low interventional clinical trials in the EU (and beyond; to include aspects of health care systems, health professionals formation etc.) (B; G)\n\n3\\. Map clinical trials with decentralised elements (e.g., over time, geography, therapeutic area, types of elements) and perform trend analyses to describe challenges and opportunities (if possible, including the impact of the EU DCT recommendations ²⁷ ; B; G)\n\n4\\. Research including a survey and interviews into the local, regional and country-specific availability and usability of existing electronic health care record, hospital and medical practice IT systems for screening persons and recruiting subjects into clinical trials (B; G)\n\n• Clinical trials • Network capacity • Decentralised clinical trials\n\nHuman medicine\n\n**_Focus area: Clinical trials optimisation in specific therapeutic areas_** **CT6** Research on innovative clinical trial designs to support medicines development\n\n1\\. Review complex clinical trials in rare diseases and perform analyses to evaluate design choices, opportunities and avenues to address challenges of drawing conclusions from them (B; G)\n\n2\\. Research into efficiency of broader options for clinical trial design, broader inclusion of study populations, stratification approaches and analyses, e.g. in obesity and diabetes (G)\n\n3\\. Research into efficient options for organising and designing clinical research in pre- symptomatic stages of neuro- degenerative diseases for documenting clinical benefits (B; D; F; G)\n\n4\\. Research to develop non- invasive markers for MASH\n\n• Clinical trials • Advanced therapy medicinal products\n\n• Rare disease • Platform trials • Complex trials • Obesity • Neurology\n\nHuman medicine\n\n27 Facilitating Decentralised Clinical Trials in the EU | European Medicines Agency (EMA)","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page13.pdf"]},"response":{"errors":[],"extract_id":"extract_226ed004d03150c4e9301369da0c9f21","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 13/31\n\n**CT5** Research on EU capacity and operational aspects of clinical trials\n\n1\\. Develop a mapping and quantification of key challenges for sponsors (commercial and non-commercial) to efficiently plan, resource, set-up and conduct multinational clinical trials in the EU (and beyond) (B; G)\n\n2\\. Perform gap analysis and quantify capacities and competencies (e.g., researchers, organisations, infrastructure) in the EU for carrying out master protocol- based trials, large, simple pragmatic or low interventional clinical trials in the EU (and beyond; to include aspects of health care systems, health professionals formation etc.) (B; G)\n\n3\\. Map clinical trials with decentralised elements (e.g., over time, geography, therapeutic area, types of elements) and perform trend analyses to describe challenges and opportunities (if possible, including the impact of the EU DCT recommendations ²⁷ ; B; G)\n\n4\\. Research including a survey and interviews into the local, regional and country-specific availability and usability of existing electronic health care record, hospital and medical practice IT systems for screening persons and recruiting subjects into clinical trials (B; G)\n\n• Clinical trials • Network capacity • Decentralised clinical trials\n\nHuman medicine\n\n**_Focus area: Clinical trials optimisation in specific therapeutic areas_** **CT6** Research on innovative clinical trial designs to support medicines development\n\n1\\. Review complex clinical trials in rare diseases and perform analyses to evaluate design choices, opportunities and avenues to address challenges of drawing conclusions from them (B; G)\n\n2\\. Research into efficiency of broader options for clinical trial design, broader inclusion of study populations, stratification approaches and analyses, e.g. in obesity and diabetes (G)\n\n3\\. Research into efficient options for organising and designing clinical research in pre- symptomatic stages of neuro- degenerative diseases for documenting clinical benefits (B; D; F; G)\n\n4\\. Research to develop non- invasive markers for MASH\n\n• Clinical trials • Advanced therapy medicinal products\n\n• Rare disease • Platform trials • Complex trials • Obesity • Neurology\n\nHuman medicine\n\n27 Facilitating Decentralised Clinical Trials in the EU | European Medicines Agency (EMA)"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 13/31\n\n**CT5** Research on EU capacity and operational aspects of clinical trials\n\n1\\. Develop a mapping and quantification of key challenges for sponsors (commercial and non-commercial) to efficiently plan, resource, set-up and conduct multinational clinical trials in the EU (and beyond) (B; G)\n\n2\\. Perform gap analysis and quantify capacities and competencies (e.g., researchers, organisations, infrastructure) in the EU for carrying out master protocol- based trials, large, simple pragmatic or low interventional clinical trials in the EU (and beyond; to include aspects of health care systems, health professionals formation etc.) (B; G)\n\n3\\. Map clinical trials with decentralised elements (e.g., over time, geography, therapeutic area, types of elements) and perform trend analyses to describe challenges and opportunities (if possible, including the impact of the EU DCT recommendations ²⁷ ; B; G)\n\n4\\. Research including a survey and interviews into the local, regional and country-specific availability and usability of existing electronic health care record, hospital and medical practice IT systems for screening persons and recruiting subjects into clinical trials (B; G)\n\n• Clinical trials • Network capacity • Decentralised clinical trials\n\nHuman medicine\n\n**_Focus area: Clinical trials optimisation in specific therapeutic areas_** **CT6** Research on innovative clinical trial designs to support medicines development\n\n1\\. Review complex clinical trials in rare diseases and perform analyses to evaluate design choices, opportunities and avenues to address challenges of drawing conclusions from them (B; G)\n\n2\\. Research into efficiency of broader options for clinical trial design, broader inclusion of study populations, stratification approaches and analyses, e.g. in obesity and diabetes (G)\n\n3\\. Research into efficient options for organising and designing clinical research in pre- symptomatic stages of neuro- degenerative diseases for documenting clinical benefits (B; D; F; G)\n\n4\\. Research to develop non- invasive markers for MASH\n\n• Clinical trials • Advanced therapy medicinal products\n\n• Rare disease • Platform trials • Complex trials • Obesity • Neurology\n\nHuman medicine\n\n27 Facilitating Decentralised Clinical Trials in the EU | European Medicines Agency (EMA)","publish_date":null,"title":"• 1. • • 2. 3. 4. • 1. • • • • 2. • 3. 4. Facilitating Decentralised Clinical","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page13.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page13.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page13","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page13.pdf"},"started_at":"2026-11-04T19:31:09.469288"} +{"completed_at":"2026-11-04T19:46:57.398153","latency_in_ms":3333,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page14","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 14/31\n\nsuitable for clinical trials for regulatory purposes (D; E; G)\n\n**CT7** Research on safety documentation in clinical trials\n\n1\\. Perform an analysis of clinical trials to inform principles and requirements for collecting and reporting cardiovascular toxicities ensuring scientific strength while reducing burden on clinical trial sites and patients, by using case studies from the following therapeutic areas: 1) oncology; 2) neurology; 3) psychiatry (B; D; G)\n\n• Clinical trials • Side effects • Cardiovascular toxicity\n\nHuman medicine\n\n**CT8** Research on natural history studies to support medicines development for rare diseases\n\n1\\. Design protocols and conduct natural history studies to 1) propose and define endpoints for clinical trials in rare diseases lacking authorised medicines and 2) explore their use as comparative groups for clinical trials in understudied rare diseases without internal control, exploring options to handle changes over time in aspects of endpoint definition or documentation (D)\n\n2\\. Develop approaches that model measurement uncertainty, random and systematic fluctuation (C; F)\n\n• Clinical trials • Natural history • Rare diseases • Orphan medicines\n\nHuman medicine\n\n**CT9** Research to optimise evidence generation\n\n1\\. Review clinical trials conducted to support marketing authorisation of medicines to treat solid cancers or malignant haematological conditions to gauge inclusiveness of the concerned populations and identify approaches for effective inclusiveness (including but not limited to factors such as age, ethnicity, sex; B; G)\n\n• Clinical trials • Age • Haemato-oncology • Representation\n\nHuman medicine\n\n**_2\\.3._** **_Research needs to improve regulatory system evolution_**\n\nThis section includes 11 research needs and 35 priority topics that aim to improve the\n\nAgency’s regulatory methodologies, standards and practices, thereby optimising the\n\nprocesses and oversight needed to ensure efficiency of the medicines regulatory system. This is\n\nexpected to help maintain an adaptive and dynamic regulatory system that fosters growth and\n\ninnovation, while ensuring public trust and reliability.\n\nThe needs in this list touch upon research that goes beyond current regulatory pathways, as well as\n\nresearch into the handling of shortages of medicines and medical devices, communication strategies\n\nand data management.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 14/31\n\nsuitable for clinical trials for regulatory purposes (D; E; G)\n\n**CT7** Research on safety documentation in clinical trials\n\n1\\. Perform an analysis of clinical trials to inform principles and requirements for collecting and reporting cardiovascular toxicities ensuring scientific strength while reducing burden on clinical trial sites and patients, by using case studies from the following therapeutic areas: 1) oncology; 2) neurology; 3) psychiatry (B; D; G)\n\n• Clinical trials • Side effects • Cardiovascular toxicity\n\nHuman medicine\n\n**CT8** Research on natural history studies to support medicines development for rare diseases\n\n1\\. Design protocols and conduct natural history studies to 1) propose and define endpoints for clinical trials in rare diseases lacking authorised medicines and 2) explore their use as comparative groups for clinical trials in understudied rare diseases without internal control, exploring options to handle changes over time in aspects of endpoint definition or documentation (D)\n\n2\\. Develop approaches that model measurement uncertainty, random and systematic fluctuation (C; F)\n\n• Clinical trials • Natural history • Rare diseases • Orphan medicines\n\nHuman medicine\n\n**CT9** Research to optimise evidence generation\n\n1\\. Review clinical trials conducted to support marketing authorisation of medicines to treat solid cancers or malignant haematological conditions to gauge inclusiveness of the concerned populations and identify approaches for effective inclusiveness (including but not limited to factors such as age, ethnicity, sex; B; G)\n\n• Clinical trials • Age • Haemato-oncology • Representation\n\nHuman medicine\n\n**_2\\.3._** **_Research needs to improve regulatory system evolution_**\n\nThis section includes 11 research needs and 35 priority topics that aim to improve the\n\nAgency’s regulatory methodologies, standards and practices, thereby optimising the\n\nprocesses and oversight needed to ensure efficiency of the medicines regulatory system. This is\n\nexpected to help maintain an adaptive and dynamic regulatory system that fosters growth and\n\ninnovation, while ensuring public trust and reliability.\n\nThe needs in this list touch upon research that goes beyond current regulatory pathways, as well as\n\nresearch into the handling of shortages of medicines and medical devices, communication strategies\n\nand data management.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 14/31\n\nsuitable for clinical trials for regulatory purposes (D; E; G)\n\n**CT7** Research on safety documentation in clinical trials\n\n1\\. Perform an analysis of clinical trials to inform principles and requirements for collecting and reporting cardiovascular toxicities ensuring scientific strength while reducing burden on clinical trial sites and patients, by using case studies from the following therapeutic areas: 1) oncology; 2) neurology; 3) psychiatry (B; D; G)\n\n• Clinical trials • Side effects • Cardiovascular toxicity\n\nHuman medicine\n\n**CT8** Research on natural history studies to support medicines development for rare diseases\n\n1\\. Design protocols and conduct natural history studies to 1) propose and define endpoints for clinical trials in rare diseases lacking authorised medicines and 2) explore their use as comparative groups for clinical trials in understudied rare diseases without internal control, exploring options to handle changes over time in aspects of endpoint definition or documentation (D)\n\n2\\. Develop approaches that model measurement uncertainty, random and systematic fluctuation (C; F)\n\n• Clinical trials • Natural history • Rare diseases • Orphan medicines\n\nHuman medicine\n\n**CT9** Research to optimise evidence generation\n\n1\\. Review clinical trials conducted to support marketing authorisation of medicines to treat solid cancers or malignant haematological conditions to gauge inclusiveness of the concerned populations and identify approaches for effective inclusiveness (including but not limited to factors such as age, ethnicity, sex; B; G)\n\n• Clinical trials • Age • Haemato-oncology • Representation\n\nHuman medicine\n\n**_2\\.3._** **_Research needs to improve regulatory system evolution_**\n\nThis section includes 11 research needs and 35 priority topics that aim to improve the\n\nAgency’s regulatory methodologies, standards and practices, thereby optimising the\n\nprocesses and oversight needed to ensure efficiency of the medicines regulatory system. This is\n\nexpected to help maintain an adaptive and dynamic regulatory system that fosters growth and\n\ninnovation, while ensuring public trust and reliability.\n\nThe needs in this list touch upon research that goes beyond current regulatory pathways, as well as\n\nresearch into the handling of shortages of medicines and medical devices, communication strategies\n\nand data management.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page14.pdf"]},"response":{"errors":[],"extract_id":"extract_20138f1c2a816e62d1224c900023f88f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 14/31\n\nsuitable for clinical trials for regulatory purposes (D; E; G)\n\n**CT7** Research on safety documentation in clinical trials\n\n1\\. Perform an analysis of clinical trials to inform principles and requirements for collecting and reporting cardiovascular toxicities ensuring scientific strength while reducing burden on clinical trial sites and patients, by using case studies from the following therapeutic areas: 1) oncology; 2) neurology; 3) psychiatry (B; D; G)\n\n• Clinical trials • Side effects • Cardiovascular toxicity\n\nHuman medicine\n\n**CT8** Research on natural history studies to support medicines development for rare diseases\n\n1\\. Design protocols and conduct natural history studies to 1) propose and define endpoints for clinical trials in rare diseases lacking authorised medicines and 2) explore their use as comparative groups for clinical trials in understudied rare diseases without internal control, exploring options to handle changes over time in aspects of endpoint definition or documentation (D)\n\n2\\. Develop approaches that model measurement uncertainty, random and systematic fluctuation (C; F)\n\n• Clinical trials • Natural history • Rare diseases • Orphan medicines\n\nHuman medicine\n\n**CT9** Research to optimise evidence generation\n\n1\\. Review clinical trials conducted to support marketing authorisation of medicines to treat solid cancers or malignant haematological conditions to gauge inclusiveness of the concerned populations and identify approaches for effective inclusiveness (including but not limited to factors such as age, ethnicity, sex; B; G)\n\n• Clinical trials • Age • Haemato-oncology • Representation\n\nHuman medicine\n\n**_2\\.3._** **_Research needs to improve regulatory system evolution_**\n\nThis section includes 11 research needs and 35 priority topics that aim to improve the\n\nAgency’s regulatory methodologies, standards and practices, thereby optimising the\n\nprocesses and oversight needed to ensure efficiency of the medicines regulatory system. This is\n\nexpected to help maintain an adaptive and dynamic regulatory system that fosters growth and\n\ninnovation, while ensuring public trust and reliability.\n\nThe needs in this list touch upon research that goes beyond current regulatory pathways, as well as\n\nresearch into the handling of shortages of medicines and medical devices, communication strategies\n\nand data management.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu."],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 14/31\n\nsuitable for clinical trials for regulatory purposes (D; E; G)\n\n**CT7** Research on safety documentation in clinical trials\n\n1\\. Perform an analysis of clinical trials to inform principles and requirements for collecting and reporting cardiovascular toxicities ensuring scientific strength while reducing burden on clinical trial sites and patients, by using case studies from the following therapeutic areas: 1) oncology; 2) neurology; 3) psychiatry (B; D; G)\n\n• Clinical trials • Side effects • Cardiovascular toxicity\n\nHuman medicine\n\n**CT8** Research on natural history studies to support medicines development for rare diseases\n\n1\\. Design protocols and conduct natural history studies to 1) propose and define endpoints for clinical trials in rare diseases lacking authorised medicines and 2) explore their use as comparative groups for clinical trials in understudied rare diseases without internal control, exploring options to handle changes over time in aspects of endpoint definition or documentation (D)\n\n2\\. Develop approaches that model measurement uncertainty, random and systematic fluctuation (C; F)\n\n• Clinical trials • Natural history • Rare diseases • Orphan medicines\n\nHuman medicine\n\n**CT9** Research to optimise evidence generation\n\n1\\. Review clinical trials conducted to support marketing authorisation of medicines to treat solid cancers or malignant haematological conditions to gauge inclusiveness of the concerned populations and identify approaches for effective inclusiveness (including but not limited to factors such as age, ethnicity, sex; B; G)\n\n• Clinical trials • Age • Haemato-oncology • Representation\n\nHuman medicine\n\n**_2\\.3._** **_Research needs to improve regulatory system evolution_**\n\nThis section includes 11 research needs and 35 priority topics that aim to improve the\n\nAgency’s regulatory methodologies, standards and practices, thereby optimising the\n\nprocesses and oversight needed to ensure efficiency of the medicines regulatory system. This is\n\nexpected to help maintain an adaptive and dynamic regulatory system that fosters growth and\n\ninnovation, while ensuring public trust and reliability.\n\nThe needs in this list touch upon research that goes beyond current regulatory pathways, as well as\n\nresearch into the handling of shortages of medicines and medical devices, communication strategies\n\nand data management.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.","publish_date":null,"title":"• • • • 2.3. Research needs to improve regulatory system evolution This section includes 11 research needs and 35","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page14.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page14.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page14","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page14.pdf"},"started_at":"2026-11-04T19:46:54.064701"} +{"completed_at":"2026-11-04T19:46:57.705198","latency_in_ms":2441,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page21","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 21/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\nadverse events for mRNA vaccines and novel vaccines technologies (A; D; E)\n\n**NT5** Research on potential modifiers of treatment effects\n\n1\\. Perform appropriately designed clinical trial(s) using different types of vaccines to robustly evaluate and quantitively estimate if and how their treatment effect on immunogenicity depends on and varies with potential factors such as: 1) gut microbiome; 2) time of the day for administration; 3) age; 4) ethnicity; 5) pharmacogenomics; 6) epidemiology of circulating pathogens (A; D; E)\n\n• Vaccines\n\n• Immunogenicity\n\nHuman medicine\n\n**NT6** Research on optimisation of post-authorisation study design\n\n1\\. Perform a comparison of a set of possible vaccine study designs in the post- authorisation setting with respect to efficiency and robustness (G)\n\n• Vaccines\n\n• Post-authorisation studies\n\n• Infectious diseases\n\nHuman and veterinary medicine\n\n**_Focus area: Antimicrobial resistance_** **NT7** Research to establish standards for phage-based therapies\n\n1\\. Perform studies to identify elements that determine the potency of phage- based therapies (A; D; E)\n\n2\\. Perform studies to develop quality standards for phage-based therapies, including to compare and address fixed mixtures as well as mixtures adapted to different therapeutic targets) (A; D; E; F)\n\n3\\. Perform studies to define manufacturing standards of phage-based therapies (G)\n\n• Bacteriophages\n\n• Antimicrobial resistance\n\nHuman and Veterinary medicine","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 21/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\nadverse events for mRNA vaccines and novel vaccines technologies (A; D; E)\n\n**NT5** Research on potential modifiers of treatment effects\n\n1\\. Perform appropriately designed clinical trial(s) using different types of vaccines to robustly evaluate and quantitively estimate if and how their treatment effect on immunogenicity depends on and varies with potential factors such as: 1) gut microbiome; 2) time of the day for administration; 3) age; 4) ethnicity; 5) pharmacogenomics; 6) epidemiology of circulating pathogens (A; D; E)\n\n• Vaccines\n\n• Immunogenicity\n\nHuman medicine\n\n**NT6** Research on optimisation of post-authorisation study design\n\n1\\. Perform a comparison of a set of possible vaccine study designs in the post- authorisation setting with respect to efficiency and robustness (G)\n\n• Vaccines\n\n• Post-authorisation studies\n\n• Infectious diseases\n\nHuman and veterinary medicine\n\n**_Focus area: Antimicrobial resistance_** **NT7** Research to establish standards for phage-based therapies\n\n1\\. Perform studies to identify elements that determine the potency of phage- based therapies (A; D; E)\n\n2\\. Perform studies to develop quality standards for phage-based therapies, including to compare and address fixed mixtures as well as mixtures adapted to different therapeutic targets) (A; D; E; F)\n\n3\\. Perform studies to define manufacturing standards of phage-based therapies (G)\n\n• Bacteriophages\n\n• Antimicrobial resistance\n\nHuman and Veterinary medicine","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 21/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\nadverse events for mRNA vaccines and novel vaccines technologies (A; D; E)\n\n**NT5** Research on potential modifiers of treatment effects\n\n1\\. Perform appropriately designed clinical trial(s) using different types of vaccines to robustly evaluate and quantitively estimate if and how their treatment effect on immunogenicity depends on and varies with potential factors such as: 1) gut microbiome; 2) time of the day for administration; 3) age; 4) ethnicity; 5) pharmacogenomics; 6) epidemiology of circulating pathogens (A; D; E)\n\n• Vaccines\n\n• Immunogenicity\n\nHuman medicine\n\n**NT6** Research on optimisation of post-authorisation study design\n\n1\\. Perform a comparison of a set of possible vaccine study designs in the post- authorisation setting with respect to efficiency and robustness (G)\n\n• Vaccines\n\n• Post-authorisation studies\n\n• Infectious diseases\n\nHuman and veterinary medicine\n\n**_Focus area: Antimicrobial resistance_** **NT7** Research to establish standards for phage-based therapies\n\n1\\. Perform studies to identify elements that determine the potency of phage- based therapies (A; D; E)\n\n2\\. Perform studies to develop quality standards for phage-based therapies, including to compare and address fixed mixtures as well as mixtures adapted to different therapeutic targets) (A; D; E; F)\n\n3\\. Perform studies to define manufacturing standards of phage-based therapies (G)\n\n• Bacteriophages\n\n• Antimicrobial resistance\n\nHuman and Veterinary medicine","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page21.pdf"]},"response":{"errors":[],"extract_id":"extract_2111592488ec7003673ddfd5b0fd513d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 21/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\nadverse events for mRNA vaccines and novel vaccines technologies (A; D; E)\n\n**NT5** Research on potential modifiers of treatment effects\n\n1\\. Perform appropriately designed clinical trial(s) using different types of vaccines to robustly evaluate and quantitively estimate if and how their treatment effect on immunogenicity depends on and varies with potential factors such as: 1) gut microbiome; 2) time of the day for administration; 3) age; 4) ethnicity; 5) pharmacogenomics; 6) epidemiology of circulating pathogens (A; D; E)\n\n• Vaccines\n\n• Immunogenicity\n\nHuman medicine\n\n**NT6** Research on optimisation of post-authorisation study design\n\n1\\. Perform a comparison of a set of possible vaccine study designs in the post- authorisation setting with respect to efficiency and robustness (G)\n\n• Vaccines\n\n• Post-authorisation studies\n\n• Infectious diseases\n\nHuman and veterinary medicine\n\n**_Focus area: Antimicrobial resistance_** **NT7** Research to establish standards for phage-based therapies\n\n1\\. Perform studies to identify elements that determine the potency of phage- based therapies (A; D; E)\n\n2\\. Perform studies to develop quality standards for phage-based therapies, including to compare and address fixed mixtures as well as mixtures adapted to different therapeutic targets) (A; D; E; F)\n\n3\\. Perform studies to define manufacturing standards of phage-based therapies (G)\n\n• Bacteriophages\n\n• Antimicrobial resistance\n\nHuman and Veterinary medicine"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 21/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\nadverse events for mRNA vaccines and novel vaccines technologies (A; D; E)\n\n**NT5** Research on potential modifiers of treatment effects\n\n1\\. Perform appropriately designed clinical trial(s) using different types of vaccines to robustly evaluate and quantitively estimate if and how their treatment effect on immunogenicity depends on and varies with potential factors such as: 1) gut microbiome; 2) time of the day for administration; 3) age; 4) ethnicity; 5) pharmacogenomics; 6) epidemiology of circulating pathogens (A; D; E)\n\n• Vaccines\n\n• Immunogenicity\n\nHuman medicine\n\n**NT6** Research on optimisation of post-authorisation study design\n\n1\\. Perform a comparison of a set of possible vaccine study designs in the post- authorisation setting with respect to efficiency and robustness (G)\n\n• Vaccines\n\n• Post-authorisation studies\n\n• Infectious diseases\n\nHuman and veterinary medicine\n\n**_Focus area: Antimicrobial resistance_** **NT7** Research to establish standards for phage-based therapies\n\n1\\. Perform studies to identify elements that determine the potency of phage- based therapies (A; D; E)\n\n2\\. Perform studies to develop quality standards for phage-based therapies, including to compare and address fixed mixtures as well as mixtures adapted to different therapeutic targets) (A; D; E; F)\n\n3\\. Perform studies to define manufacturing standards of phage-based therapies (G)\n\n• Bacteriophages\n\n• Antimicrobial resistance\n\nHuman and Veterinary medicine","publish_date":null,"title":"• 1. • • 1. • • • 1. • 2. 3.","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page21.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page21.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page21","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page21.pdf"},"started_at":"2026-11-04T19:46:55.263512"} +{"completed_at":"2026-11-04T19:46:59.058412","latency_in_ms":2242,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page22","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 22/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\n**NT8** Research on development of novel antibiotics\n\n1\\. Using a multistakeholder approach, develop standards for assays to allow high-throughput screening libraries for new antibiotics (E; G)\n\n2\\. Using a multistakeholder approach, develop methods to identify potential candidate antibiotics from novel sources such as human and animal “microbiomes” (E)\n\n• Antimicrobial resistance\n\n• Antibiotics\n\nHuman and Veterinary medicine\n\n**_Focus area: New approach methodologies (NAMs) / Non-animal models / 3Rs_** **NT9** Research to improve regulatory acceptance of 3R methods / NAMs\n\n1\\. Conduct an analytical comparison of approaches and criteria used by regulators (e.g., EDQM, EMA) to evaluate approval for NAMs, and identify key elements that could support regulatory harmonisation in validation and qualification processes. (G)\n\n2\\. Develop scientific evidence of clinical predictivity of NAMs for _in vivo_ pathophysiology (A; E; F)\n\n• 3Rs\n\n• Non-clinical models\n\n• _In vitro_ models\n\n• Modelling and simulation\n\nHuman and Veterinary medicine EU regulatory system\n\n**NT10** Research on impact of medicines in pregnancy, breast-feeding, neonates\n\n1\\. Develop non-clinical models to predict transfer of medicines to human breast milk and uptake by the neonate (A; D; E; F)\n\n2\\. Develop modelling approaches including physiologically based pharmacokinetic (PBPK) models to predict transfer of medicines to human breast milk and uptake by the neonate (A; D; E; F)\n\n3\\. Review and provide an analytical comparison of the available non-animal models that fit the purpose of measuring the impact on pregnancy, breast feeding, neonates (G)\n\n4\\. Conduct studies to better understand the effects of using HIV anti-retrovirals during pregnancy and breastfeeding on the foetus and newborn (including a better understanding of U=U levels on breastfeeding) (E; F; G)\n\n5\\. Conduct a scoping review of methods and strength of evidence concerning pharmacological\n\n• 3Rs\n\n• Non-clinical models\n\n• Pregnancy\n\n• Neonatal medicine\n\n• Breast-feeding\n\n• _In vitro_ models\n\n• HIV\n\n• Modelling and simulation\n\nHuman medicine","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 22/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\n**NT8** Research on development of novel antibiotics\n\n1\\. Using a multistakeholder approach, develop standards for assays to allow high-throughput screening libraries for new antibiotics (E; G)\n\n2\\. Using a multistakeholder approach, develop methods to identify potential candidate antibiotics from novel sources such as human and animal “microbiomes” (E)\n\n• Antimicrobial resistance\n\n• Antibiotics\n\nHuman and Veterinary medicine\n\n**_Focus area: New approach methodologies (NAMs) / Non-animal models / 3Rs_** **NT9** Research to improve regulatory acceptance of 3R methods / NAMs\n\n1\\. Conduct an analytical comparison of approaches and criteria used by regulators (e.g., EDQM, EMA) to evaluate approval for NAMs, and identify key elements that could support regulatory harmonisation in validation and qualification processes. (G)\n\n2\\. Develop scientific evidence of clinical predictivity of NAMs for _in vivo_ pathophysiology (A; E; F)\n\n• 3Rs\n\n• Non-clinical models\n\n• _In vitro_ models\n\n• Modelling and simulation\n\nHuman and Veterinary medicine EU regulatory system\n\n**NT10** Research on impact of medicines in pregnancy, breast-feeding, neonates\n\n1\\. Develop non-clinical models to predict transfer of medicines to human breast milk and uptake by the neonate (A; D; E; F)\n\n2\\. Develop modelling approaches including physiologically based pharmacokinetic (PBPK) models to predict transfer of medicines to human breast milk and uptake by the neonate (A; D; E; F)\n\n3\\. Review and provide an analytical comparison of the available non-animal models that fit the purpose of measuring the impact on pregnancy, breast feeding, neonates (G)\n\n4\\. Conduct studies to better understand the effects of using HIV anti-retrovirals during pregnancy and breastfeeding on the foetus and newborn (including a better understanding of U=U levels on breastfeeding) (E; F; G)\n\n5\\. Conduct a scoping review of methods and strength of evidence concerning pharmacological\n\n• 3Rs\n\n• Non-clinical models\n\n• Pregnancy\n\n• Neonatal medicine\n\n• Breast-feeding\n\n• _In vitro_ models\n\n• HIV\n\n• Modelling and simulation\n\nHuman medicine","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 22/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\n**NT8** Research on development of novel antibiotics\n\n1\\. Using a multistakeholder approach, develop standards for assays to allow high-throughput screening libraries for new antibiotics (E; G)\n\n2\\. Using a multistakeholder approach, develop methods to identify potential candidate antibiotics from novel sources such as human and animal “microbiomes” (E)\n\n• Antimicrobial resistance\n\n• Antibiotics\n\nHuman and Veterinary medicine\n\n**_Focus area: New approach methodologies (NAMs) / Non-animal models / 3Rs_** **NT9** Research to improve regulatory acceptance of 3R methods / NAMs\n\n1\\. Conduct an analytical comparison of approaches and criteria used by regulators (e.g., EDQM, EMA) to evaluate approval for NAMs, and identify key elements that could support regulatory harmonisation in validation and qualification processes. (G)\n\n2\\. Develop scientific evidence of clinical predictivity of NAMs for _in vivo_ pathophysiology (A; E; F)\n\n• 3Rs\n\n• Non-clinical models\n\n• _In vitro_ models\n\n• Modelling and simulation\n\nHuman and Veterinary medicine EU regulatory system\n\n**NT10** Research on impact of medicines in pregnancy, breast-feeding, neonates\n\n1\\. Develop non-clinical models to predict transfer of medicines to human breast milk and uptake by the neonate (A; D; E; F)\n\n2\\. Develop modelling approaches including physiologically based pharmacokinetic (PBPK) models to predict transfer of medicines to human breast milk and uptake by the neonate (A; D; E; F)\n\n3\\. Review and provide an analytical comparison of the available non-animal models that fit the purpose of measuring the impact on pregnancy, breast feeding, neonates (G)\n\n4\\. Conduct studies to better understand the effects of using HIV anti-retrovirals during pregnancy and breastfeeding on the foetus and newborn (including a better understanding of U=U levels on breastfeeding) (E; F; G)\n\n5\\. Conduct a scoping review of methods and strength of evidence concerning pharmacological\n\n• 3Rs\n\n• Non-clinical models\n\n• Pregnancy\n\n• Neonatal medicine\n\n• Breast-feeding\n\n• _In vitro_ models\n\n• HIV\n\n• Modelling and simulation\n\nHuman medicine","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page22.pdf"]},"response":{"errors":[],"extract_id":"extract_fca5c5a85d6b33ed70a9625509f466e9","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 22/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\n**NT8** Research on development of novel antibiotics\n\n1\\. Using a multistakeholder approach, develop standards for assays to allow high-throughput screening libraries for new antibiotics (E; G)\n\n2\\. Using a multistakeholder approach, develop methods to identify potential candidate antibiotics from novel sources such as human and animal “microbiomes” (E)\n\n• Antimicrobial resistance\n\n• Antibiotics\n\nHuman and Veterinary medicine\n\n**_Focus area: New approach methodologies (NAMs) / Non-animal models / 3Rs_** **NT9** Research to improve regulatory acceptance of 3R methods / NAMs\n\n1\\. Conduct an analytical comparison of approaches and criteria used by regulators (e.g., EDQM, EMA) to evaluate approval for NAMs, and identify key elements that could support regulatory harmonisation in validation and qualification processes. (G)\n\n2\\. Develop scientific evidence of clinical predictivity of NAMs for _in vivo_ pathophysiology (A; E; F)\n\n• 3Rs\n\n• Non-clinical models\n\n• _In vitro_ models\n\n• Modelling and simulation\n\nHuman and Veterinary medicine EU regulatory system\n\n**NT10** Research on impact of medicines in pregnancy, breast-feeding, neonates\n\n1\\. Develop non-clinical models to predict transfer of medicines to human breast milk and uptake by the neonate (A; D; E; F)\n\n2\\. Develop modelling approaches including physiologically based pharmacokinetic (PBPK) models to predict transfer of medicines to human breast milk and uptake by the neonate (A; D; E; F)\n\n3\\. Review and provide an analytical comparison of the available non-animal models that fit the purpose of measuring the impact on pregnancy, breast feeding, neonates (G)\n\n4\\. Conduct studies to better understand the effects of using HIV anti-retrovirals during pregnancy and breastfeeding on the foetus and newborn (including a better understanding of U=U levels on breastfeeding) (E; F; G)\n\n5\\. Conduct a scoping review of methods and strength of evidence concerning pharmacological\n\n• 3Rs\n\n• Non-clinical models\n\n• Pregnancy\n\n• Neonatal medicine\n\n• Breast-feeding\n\n• _In vitro_ models\n\n• HIV\n\n• Modelling and simulation\n\nHuman medicine"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 22/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\n**NT8** Research on development of novel antibiotics\n\n1\\. Using a multistakeholder approach, develop standards for assays to allow high-throughput screening libraries for new antibiotics (E; G)\n\n2\\. Using a multistakeholder approach, develop methods to identify potential candidate antibiotics from novel sources such as human and animal “microbiomes” (E)\n\n• Antimicrobial resistance\n\n• Antibiotics\n\nHuman and Veterinary medicine\n\n**_Focus area: New approach methodologies (NAMs) / Non-animal models / 3Rs_** **NT9** Research to improve regulatory acceptance of 3R methods / NAMs\n\n1\\. Conduct an analytical comparison of approaches and criteria used by regulators (e.g., EDQM, EMA) to evaluate approval for NAMs, and identify key elements that could support regulatory harmonisation in validation and qualification processes. (G)\n\n2\\. Develop scientific evidence of clinical predictivity of NAMs for _in vivo_ pathophysiology (A; E; F)\n\n• 3Rs\n\n• Non-clinical models\n\n• _In vitro_ models\n\n• Modelling and simulation\n\nHuman and Veterinary medicine EU regulatory system\n\n**NT10** Research on impact of medicines in pregnancy, breast-feeding, neonates\n\n1\\. Develop non-clinical models to predict transfer of medicines to human breast milk and uptake by the neonate (A; D; E; F)\n\n2\\. Develop modelling approaches including physiologically based pharmacokinetic (PBPK) models to predict transfer of medicines to human breast milk and uptake by the neonate (A; D; E; F)\n\n3\\. Review and provide an analytical comparison of the available non-animal models that fit the purpose of measuring the impact on pregnancy, breast feeding, neonates (G)\n\n4\\. Conduct studies to better understand the effects of using HIV anti-retrovirals during pregnancy and breastfeeding on the foetus and newborn (including a better understanding of U=U levels on breastfeeding) (E; F; G)\n\n5\\. Conduct a scoping review of methods and strength of evidence concerning pharmacological\n\n• 3Rs\n\n• Non-clinical models\n\n• Pregnancy\n\n• Neonatal medicine\n\n• Breast-feeding\n\n• _In vitro_ models\n\n• HIV\n\n• Modelling and simulation\n\nHuman medicine","publish_date":null,"title":"• 1. • 2. • • • • • 1. • • • 2. • • • • 3. 4.","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page22.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page22.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page22","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page22.pdf"},"started_at":"2026-11-04T19:46:56.816321"} +{"completed_at":"2026-11-04T19:46:59.049442","latency_in_ms":1340,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page23","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 23/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\nmechanisms and factors influencing (aggravating or protecting) embryo and foetal impact of exposure to selected classes of medicines during pregnancy (B; G)\n\n**NT11** Research on modelling and simulation methods to support regulatory decisions\n\n1\\. Develop models and designs for characterisation of exposure response throughout drug development to support dose selection and posology claims in SmPC, with a focus on special populations (F; G)\n\n2\\. Perform studies to develop optimal PK (and PD) designs in children to support extrapolation from adults (A; D; E; F)\n\n3\\. Develop modelling approaches including PBPK for renal/hepatic impairment in elderly patients (A; D; E; F)\n\n4\\. Develop methods to quantify and report uncertainties in complex models, such as diagnostic and reporting tools to facilitate regulatory decision based on these models (D; F)\n\n• Modelling and simulation\n\n• Dose selection\n\n• Posology\n\n• Special populations\n\nHuman medicine\n\n**_Focus area: Non-clinical models / ATMPs_** **NT12** Research on methods to improve regulatory acceptance of ATMPs\n\n1\\. Perform studies to develop non-clinical efficacy models for therapies based on genome editing (A; E; F)\n\n2\\. Develop methods to validate predicted or observed off-target effects of genome editing, especially effects on regions with unknown functions (A; E; F)\n\n• 3Rs\n\n• Non-clinical models\n\n• ATMPs\n\n• Genome editing\n\n• Side effects\n\nHuman and veterinary medicine\n\n**_Focus area: Real-world data (RWD) / Real-world evidence (RWE)_**\n\n**NT13** Research on methods to improve use of RWE in decision-making\n\n1\\. Perform studies on the application of causal inference methods to RWE for medicines, contributing to effective and efficient decision-making (C; D; F; G)\n\n2\\. Develop/explore methods to assess the robustness of RWE-derived claims for centrally authorised medicinal products and in consideration of products authorised by other regulators (F)\n\n• RWD, RWE\n\n• Causal inference\n\nHuman and Veterinary medicine","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 23/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\nmechanisms and factors influencing (aggravating or protecting) embryo and foetal impact of exposure to selected classes of medicines during pregnancy (B; G)\n\n**NT11** Research on modelling and simulation methods to support regulatory decisions\n\n1\\. Develop models and designs for characterisation of exposure response throughout drug development to support dose selection and posology claims in SmPC, with a focus on special populations (F; G)\n\n2\\. Perform studies to develop optimal PK (and PD) designs in children to support extrapolation from adults (A; D; E; F)\n\n3\\. Develop modelling approaches including PBPK for renal/hepatic impairment in elderly patients (A; D; E; F)\n\n4\\. Develop methods to quantify and report uncertainties in complex models, such as diagnostic and reporting tools to facilitate regulatory decision based on these models (D; F)\n\n• Modelling and simulation\n\n• Dose selection\n\n• Posology\n\n• Special populations\n\nHuman medicine\n\n**_Focus area: Non-clinical models / ATMPs_** **NT12** Research on methods to improve regulatory acceptance of ATMPs\n\n1\\. Perform studies to develop non-clinical efficacy models for therapies based on genome editing (A; E; F)\n\n2\\. Develop methods to validate predicted or observed off-target effects of genome editing, especially effects on regions with unknown functions (A; E; F)\n\n• 3Rs\n\n• Non-clinical models\n\n• ATMPs\n\n• Genome editing\n\n• Side effects\n\nHuman and veterinary medicine\n\n**_Focus area: Real-world data (RWD) / Real-world evidence (RWE)_**\n\n**NT13** Research on methods to improve use of RWE in decision-making\n\n1\\. Perform studies on the application of causal inference methods to RWE for medicines, contributing to effective and efficient decision-making (C; D; F; G)\n\n2\\. Develop/explore methods to assess the robustness of RWE-derived claims for centrally authorised medicinal products and in consideration of products authorised by other regulators (F)\n\n• RWD, RWE\n\n• Causal inference\n\nHuman and Veterinary medicine","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 23/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\nmechanisms and factors influencing (aggravating or protecting) embryo and foetal impact of exposure to selected classes of medicines during pregnancy (B; G)\n\n**NT11** Research on modelling and simulation methods to support regulatory decisions\n\n1\\. Develop models and designs for characterisation of exposure response throughout drug development to support dose selection and posology claims in SmPC, with a focus on special populations (F; G)\n\n2\\. Perform studies to develop optimal PK (and PD) designs in children to support extrapolation from adults (A; D; E; F)\n\n3\\. Develop modelling approaches including PBPK for renal/hepatic impairment in elderly patients (A; D; E; F)\n\n4\\. Develop methods to quantify and report uncertainties in complex models, such as diagnostic and reporting tools to facilitate regulatory decision based on these models (D; F)\n\n• Modelling and simulation\n\n• Dose selection\n\n• Posology\n\n• Special populations\n\nHuman medicine\n\n**_Focus area: Non-clinical models / ATMPs_** **NT12** Research on methods to improve regulatory acceptance of ATMPs\n\n1\\. Perform studies to develop non-clinical efficacy models for therapies based on genome editing (A; E; F)\n\n2\\. Develop methods to validate predicted or observed off-target effects of genome editing, especially effects on regions with unknown functions (A; E; F)\n\n• 3Rs\n\n• Non-clinical models\n\n• ATMPs\n\n• Genome editing\n\n• Side effects\n\nHuman and veterinary medicine\n\n**_Focus area: Real-world data (RWD) / Real-world evidence (RWE)_**\n\n**NT13** Research on methods to improve use of RWE in decision-making\n\n1\\. Perform studies on the application of causal inference methods to RWE for medicines, contributing to effective and efficient decision-making (C; D; F; G)\n\n2\\. Develop/explore methods to assess the robustness of RWE-derived claims for centrally authorised medicinal products and in consideration of products authorised by other regulators (F)\n\n• RWD, RWE\n\n• Causal inference\n\nHuman and Veterinary medicine","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page23.pdf"]},"response":{"errors":[],"extract_id":"extract_6d712cc186313c501cba39fcd4214cc3","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 23/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\nmechanisms and factors influencing (aggravating or protecting) embryo and foetal impact of exposure to selected classes of medicines during pregnancy (B; G)\n\n**NT11** Research on modelling and simulation methods to support regulatory decisions\n\n1\\. Develop models and designs for characterisation of exposure response throughout drug development to support dose selection and posology claims in SmPC, with a focus on special populations (F; G)\n\n2\\. Perform studies to develop optimal PK (and PD) designs in children to support extrapolation from adults (A; D; E; F)\n\n3\\. Develop modelling approaches including PBPK for renal/hepatic impairment in elderly patients (A; D; E; F)\n\n4\\. Develop methods to quantify and report uncertainties in complex models, such as diagnostic and reporting tools to facilitate regulatory decision based on these models (D; F)\n\n• Modelling and simulation\n\n• Dose selection\n\n• Posology\n\n• Special populations\n\nHuman medicine\n\n**_Focus area: Non-clinical models / ATMPs_** **NT12** Research on methods to improve regulatory acceptance of ATMPs\n\n1\\. Perform studies to develop non-clinical efficacy models for therapies based on genome editing (A; E; F)\n\n2\\. Develop methods to validate predicted or observed off-target effects of genome editing, especially effects on regions with unknown functions (A; E; F)\n\n• 3Rs\n\n• Non-clinical models\n\n• ATMPs\n\n• Genome editing\n\n• Side effects\n\nHuman and veterinary medicine\n\n**_Focus area: Real-world data (RWD) / Real-world evidence (RWE)_**\n\n**NT13** Research on methods to improve use of RWE in decision-making\n\n1\\. Perform studies on the application of causal inference methods to RWE for medicines, contributing to effective and efficient decision-making (C; D; F; G)\n\n2\\. Develop/explore methods to assess the robustness of RWE-derived claims for centrally authorised medicinal products and in consideration of products authorised by other regulators (F)\n\n• RWD, RWE\n\n• Causal inference\n\nHuman and Veterinary medicine"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 23/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\nmechanisms and factors influencing (aggravating or protecting) embryo and foetal impact of exposure to selected classes of medicines during pregnancy (B; G)\n\n**NT11** Research on modelling and simulation methods to support regulatory decisions\n\n1\\. Develop models and designs for characterisation of exposure response throughout drug development to support dose selection and posology claims in SmPC, with a focus on special populations (F; G)\n\n2\\. Perform studies to develop optimal PK (and PD) designs in children to support extrapolation from adults (A; D; E; F)\n\n3\\. Develop modelling approaches including PBPK for renal/hepatic impairment in elderly patients (A; D; E; F)\n\n4\\. Develop methods to quantify and report uncertainties in complex models, such as diagnostic and reporting tools to facilitate regulatory decision based on these models (D; F)\n\n• Modelling and simulation\n\n• Dose selection\n\n• Posology\n\n• Special populations\n\nHuman medicine\n\n**_Focus area: Non-clinical models / ATMPs_** **NT12** Research on methods to improve regulatory acceptance of ATMPs\n\n1\\. Perform studies to develop non-clinical efficacy models for therapies based on genome editing (A; E; F)\n\n2\\. Develop methods to validate predicted or observed off-target effects of genome editing, especially effects on regions with unknown functions (A; E; F)\n\n• 3Rs\n\n• Non-clinical models\n\n• ATMPs\n\n• Genome editing\n\n• Side effects\n\nHuman and veterinary medicine\n\n**_Focus area: Real-world data (RWD) / Real-world evidence (RWE)_**\n\n**NT13** Research on methods to improve use of RWE in decision-making\n\n1\\. Perform studies on the application of causal inference methods to RWE for medicines, contributing to effective and efficient decision-making (C; D; F; G)\n\n2\\. Develop/explore methods to assess the robustness of RWE-derived claims for centrally authorised medicinal products and in consideration of products authorised by other regulators (F)\n\n• RWD, RWE\n\n• Causal inference\n\nHuman and Veterinary medicine","publish_date":null,"title":"• • • • • 1. • • • 2. • • 1. • 2.","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page23.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page23.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page23","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page23.pdf"},"started_at":"2026-11-04T19:46:57.708563"} +{"completed_at":"2026-11-04T19:47:01.788372","latency_in_ms":1593,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page24","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 24/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\n3\\. Develop methods to understand and possibly mitigate the impact of heterogeneity between RWD sources on the choice of analytical approaches and designs used to take into account this heterogeneity, with a focus on: sample composition; prognostic / risk factors specific to therapeutic areas; nature / type of the data source (C; D; F; G)\n\n4\\. Perform mapping of medical ontologies and develop cross-dictionary phenotyping to assess the impact of their differences on RWE use and value (G)\n\n**_Focus area: Biomarkers_** **NT14** Research on predictive biomarkers for patient-tailored treatment of frequent diseases\n\n1\\. Develop studies for\n\ndiscovering, confirming and validating biomarkers (including multi-modal biomarkers, and AI-based predictive biomarkers) that may predict response to a medicine, with a focus on frequent or chronic diseases such as cardiovascular diseases (A; E; F)\n\n• Biomarkers\n\n• Personalised medicine\n\n• Cardiovascular diseases\n\nHuman medicine\n\n**_2\\.5._** **_Research needs to advance specifically animal health and the regulation of veterinary medicines_**\n\nThis section includes 15 research needs and 27 priority topics that aim to ensure the safety\n\nand efficacy of veterinary medicines, safeguarding both animal and public health.\n\nThe needs in this list include research on non-animal models and 3Rs-related\n\ndevelopments, environmental risk assessment, antiparasitic and antimicrobial resistance,\n\npharmacovigilance methods, novel therapies and innovation, vaccines and veterinary big data.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain of impact**\n\n**_Focus area: New approach methodologies (NAMs) / Non-animal models / 3Rs_** **VET1** Research to develop 3Rs-compliant methods for regulatory testing of veterinary medicines and establishment of maximum residue limits\n\n1\\. Develop methods for quantitative _in vitro/in vivo_ extrapolation modelling (A; E; F)\n\n2\\. Develop _in silico_ models specifically for\n\n• 3Rs • Non-clinical models • _In vitro_ models • Maximum residue limit • Computational biology • Nanoparticles\n\nVeterinary medicine","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 24/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\n3\\. Develop methods to understand and possibly mitigate the impact of heterogeneity between RWD sources on the choice of analytical approaches and designs used to take into account this heterogeneity, with a focus on: sample composition; prognostic / risk factors specific to therapeutic areas; nature / type of the data source (C; D; F; G)\n\n4\\. Perform mapping of medical ontologies and develop cross-dictionary phenotyping to assess the impact of their differences on RWE use and value (G)\n\n**_Focus area: Biomarkers_** **NT14** Research on predictive biomarkers for patient-tailored treatment of frequent diseases\n\n1\\. Develop studies for\n\ndiscovering, confirming and validating biomarkers (including multi-modal biomarkers, and AI-based predictive biomarkers) that may predict response to a medicine, with a focus on frequent or chronic diseases such as cardiovascular diseases (A; E; F)\n\n• Biomarkers\n\n• Personalised medicine\n\n• Cardiovascular diseases\n\nHuman medicine\n\n**_2\\.5._** **_Research needs to advance specifically animal health and the regulation of veterinary medicines_**\n\nThis section includes 15 research needs and 27 priority topics that aim to ensure the safety\n\nand efficacy of veterinary medicines, safeguarding both animal and public health.\n\nThe needs in this list include research on non-animal models and 3Rs-related\n\ndevelopments, environmental risk assessment, antiparasitic and antimicrobial resistance,\n\npharmacovigilance methods, novel therapies and innovation, vaccines and veterinary big data.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain of impact**\n\n**_Focus area: New approach methodologies (NAMs) / Non-animal models / 3Rs_** **VET1** Research to develop 3Rs-compliant methods for regulatory testing of veterinary medicines and establishment of maximum residue limits\n\n1\\. Develop methods for quantitative _in vitro/in vivo_ extrapolation modelling (A; E; F)\n\n2\\. Develop _in silico_ models specifically for\n\n• 3Rs • Non-clinical models • _In vitro_ models • Maximum residue limit • Computational biology • Nanoparticles\n\nVeterinary medicine","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 24/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\n3\\. Develop methods to understand and possibly mitigate the impact of heterogeneity between RWD sources on the choice of analytical approaches and designs used to take into account this heterogeneity, with a focus on: sample composition; prognostic / risk factors specific to therapeutic areas; nature / type of the data source (C; D; F; G)\n\n4\\. Perform mapping of medical ontologies and develop cross-dictionary phenotyping to assess the impact of their differences on RWE use and value (G)\n\n**_Focus area: Biomarkers_** **NT14** Research on predictive biomarkers for patient-tailored treatment of frequent diseases\n\n1\\. Develop studies for\n\ndiscovering, confirming and validating biomarkers (including multi-modal biomarkers, and AI-based predictive biomarkers) that may predict response to a medicine, with a focus on frequent or chronic diseases such as cardiovascular diseases (A; E; F)\n\n• Biomarkers\n\n• Personalised medicine\n\n• Cardiovascular diseases\n\nHuman medicine\n\n**_2\\.5._** **_Research needs to advance specifically animal health and the regulation of veterinary medicines_**\n\nThis section includes 15 research needs and 27 priority topics that aim to ensure the safety\n\nand efficacy of veterinary medicines, safeguarding both animal and public health.\n\nThe needs in this list include research on non-animal models and 3Rs-related\n\ndevelopments, environmental risk assessment, antiparasitic and antimicrobial resistance,\n\npharmacovigilance methods, novel therapies and innovation, vaccines and veterinary big data.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain of impact**\n\n**_Focus area: New approach methodologies (NAMs) / Non-animal models / 3Rs_** **VET1** Research to develop 3Rs-compliant methods for regulatory testing of veterinary medicines and establishment of maximum residue limits\n\n1\\. Develop methods for quantitative _in vitro/in vivo_ extrapolation modelling (A; E; F)\n\n2\\. Develop _in silico_ models specifically for\n\n• 3Rs • Non-clinical models • _In vitro_ models • Maximum residue limit • Computational biology • Nanoparticles\n\nVeterinary medicine","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page24.pdf"]},"response":{"errors":[],"extract_id":"extract_67d356e2d51d3abf8af453c8f7f74884","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 24/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\n3\\. Develop methods to understand and possibly mitigate the impact of heterogeneity between RWD sources on the choice of analytical approaches and designs used to take into account this heterogeneity, with a focus on: sample composition; prognostic / risk factors specific to therapeutic areas; nature / type of the data source (C; D; F; G)\n\n4\\. Perform mapping of medical ontologies and develop cross-dictionary phenotyping to assess the impact of their differences on RWE use and value (G)\n\n**_Focus area: Biomarkers_** **NT14** Research on predictive biomarkers for patient-tailored treatment of frequent diseases\n\n1\\. Develop studies for\n\ndiscovering, confirming and validating biomarkers (including multi-modal biomarkers, and AI-based predictive biomarkers) that may predict response to a medicine, with a focus on frequent or chronic diseases such as cardiovascular diseases (A; E; F)\n\n• Biomarkers\n\n• Personalised medicine\n\n• Cardiovascular diseases\n\nHuman medicine\n\n**_2\\.5._** **_Research needs to advance specifically animal health and the regulation of veterinary medicines_**\n\nThis section includes 15 research needs and 27 priority topics that aim to ensure the safety\n\nand efficacy of veterinary medicines, safeguarding both animal and public health.\n\nThe needs in this list include research on non-animal models and 3Rs-related\n\ndevelopments, environmental risk assessment, antiparasitic and antimicrobial resistance,\n\npharmacovigilance methods, novel therapies and innovation, vaccines and veterinary big data.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain of impact**\n\n**_Focus area: New approach methodologies (NAMs) / Non-animal models / 3Rs_** **VET1** Research to develop 3Rs-compliant methods for regulatory testing of veterinary medicines and establishment of maximum residue limits\n\n1\\. Develop methods for quantitative _in vitro/in vivo_ extrapolation modelling (A; E; F)\n\n2\\. Develop _in silico_ models specifically for\n\n• 3Rs • Non-clinical models • _In vitro_ models • Maximum residue limit • Computational biology • Nanoparticles\n\nVeterinary medicine"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 24/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain**\n\n3\\. Develop methods to understand and possibly mitigate the impact of heterogeneity between RWD sources on the choice of analytical approaches and designs used to take into account this heterogeneity, with a focus on: sample composition; prognostic / risk factors specific to therapeutic areas; nature / type of the data source (C; D; F; G)\n\n4\\. Perform mapping of medical ontologies and develop cross-dictionary phenotyping to assess the impact of their differences on RWE use and value (G)\n\n**_Focus area: Biomarkers_** **NT14** Research on predictive biomarkers for patient-tailored treatment of frequent diseases\n\n1\\. Develop studies for\n\ndiscovering, confirming and validating biomarkers (including multi-modal biomarkers, and AI-based predictive biomarkers) that may predict response to a medicine, with a focus on frequent or chronic diseases such as cardiovascular diseases (A; E; F)\n\n• Biomarkers\n\n• Personalised medicine\n\n• Cardiovascular diseases\n\nHuman medicine\n\n**_2\\.5._** **_Research needs to advance specifically animal health and the regulation of veterinary medicines_**\n\nThis section includes 15 research needs and 27 priority topics that aim to ensure the safety\n\nand efficacy of veterinary medicines, safeguarding both animal and public health.\n\nThe needs in this list include research on non-animal models and 3Rs-related\n\ndevelopments, environmental risk assessment, antiparasitic and antimicrobial resistance,\n\npharmacovigilance methods, novel therapies and innovation, vaccines and veterinary big data.\n\nResearchers working on these RSRN topics or interested in working on RSRN can engage with EMA via\n\ndirect contact with the Regulatory Science and Academia Workstream at\n\nregulatory.science@ema.europa.eu.\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain of impact**\n\n**_Focus area: New approach methodologies (NAMs) / Non-animal models / 3Rs_** **VET1** Research to develop 3Rs-compliant methods for regulatory testing of veterinary medicines and establishment of maximum residue limits\n\n1\\. Develop methods for quantitative _in vitro/in vivo_ extrapolation modelling (A; E; F)\n\n2\\. Develop _in silico_ models specifically for\n\n• 3Rs • Non-clinical models • _In vitro_ models • Maximum residue limit • Computational biology • Nanoparticles\n\nVeterinary medicine","publish_date":null,"title":"3. 4. • • • 2.5. Research needs to advance specifically animal health and the regulation of veterinary medicines This","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page24.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page24.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page24","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page24.pdf"},"started_at":"2026-11-04T19:47:00.194642"} +{"completed_at":"2026-11-04T19:47:01.991112","latency_in_ms":1185,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page25","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 25/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain of impact**\n\nveterinary medicines (F)\n\n3\\. Develop microphysio- logical / cellular models specifically for veterinary medicines (A; E; F)\n\n4\\. Develop _in vitro_ models for the assessment of toxicity and potency of novel therapies, particularly nanoparticles and RNA-based veterinary medicinal products (A; E; F)\n\n**_Focus area: Environmental risk assessment_** **VET2** Research to generate data for regulatory decisions on environmental safety of veterinary medicinal products\n\n1\\. Develop methods to reliably estimate, measure and analyse environmental concentrations of substances used in veterinary medicinal products (A; D; E; F)\n\n2\\. Develop methods/ produce data to inform the assessment of public health risks related to antimicrobial resistance acquired via the environment resulting from the use of a veterinary medicinal product (A; D; E; F; G)\n\n3\\. Conduct a gap analysis of the availability of environmental risk assessment (ERA) data for veterinary medicinal products and propose new models to update ERAs (e.g., addressing water pollution effects of veterinary products) (G)\n\n• Environmental risk\n\nassessment\n\n• Veterinary medicinal products\n\nVeterinary medicine\n\n**VET3** Research on approaches to monitor environmental risk\n\n1\\. Develop tools and strategies to monitor environmental risks arising from the release of bacteriophages used to treat food-producing animals (including in aquaculture). This includes validation of methods to detect interactions between antibiotics and bacteriophages that might affect antibiotic activity (C; D; F; G)\n\n• Environmental risk\n\nassessment\n\n• Bacteriophages • Antibiotics • Antimicrobial resistance\n\nVeterinary medicine","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 25/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain of impact**\n\nveterinary medicines (F)\n\n3\\. Develop microphysio- logical / cellular models specifically for veterinary medicines (A; E; F)\n\n4\\. Develop _in vitro_ models for the assessment of toxicity and potency of novel therapies, particularly nanoparticles and RNA-based veterinary medicinal products (A; E; F)\n\n**_Focus area: Environmental risk assessment_** **VET2** Research to generate data for regulatory decisions on environmental safety of veterinary medicinal products\n\n1\\. Develop methods to reliably estimate, measure and analyse environmental concentrations of substances used in veterinary medicinal products (A; D; E; F)\n\n2\\. Develop methods/ produce data to inform the assessment of public health risks related to antimicrobial resistance acquired via the environment resulting from the use of a veterinary medicinal product (A; D; E; F; G)\n\n3\\. Conduct a gap analysis of the availability of environmental risk assessment (ERA) data for veterinary medicinal products and propose new models to update ERAs (e.g., addressing water pollution effects of veterinary products) (G)\n\n• Environmental risk\n\nassessment\n\n• Veterinary medicinal products\n\nVeterinary medicine\n\n**VET3** Research on approaches to monitor environmental risk\n\n1\\. Develop tools and strategies to monitor environmental risks arising from the release of bacteriophages used to treat food-producing animals (including in aquaculture). This includes validation of methods to detect interactions between antibiotics and bacteriophages that might affect antibiotic activity (C; D; F; G)\n\n• Environmental risk\n\nassessment\n\n• Bacteriophages • Antibiotics • Antimicrobial resistance\n\nVeterinary medicine","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 25/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain of impact**\n\nveterinary medicines (F)\n\n3\\. Develop microphysio- logical / cellular models specifically for veterinary medicines (A; E; F)\n\n4\\. Develop _in vitro_ models for the assessment of toxicity and potency of novel therapies, particularly nanoparticles and RNA-based veterinary medicinal products (A; E; F)\n\n**_Focus area: Environmental risk assessment_** **VET2** Research to generate data for regulatory decisions on environmental safety of veterinary medicinal products\n\n1\\. Develop methods to reliably estimate, measure and analyse environmental concentrations of substances used in veterinary medicinal products (A; D; E; F)\n\n2\\. Develop methods/ produce data to inform the assessment of public health risks related to antimicrobial resistance acquired via the environment resulting from the use of a veterinary medicinal product (A; D; E; F; G)\n\n3\\. Conduct a gap analysis of the availability of environmental risk assessment (ERA) data for veterinary medicinal products and propose new models to update ERAs (e.g., addressing water pollution effects of veterinary products) (G)\n\n• Environmental risk\n\nassessment\n\n• Veterinary medicinal products\n\nVeterinary medicine\n\n**VET3** Research on approaches to monitor environmental risk\n\n1\\. Develop tools and strategies to monitor environmental risks arising from the release of bacteriophages used to treat food-producing animals (including in aquaculture). This includes validation of methods to detect interactions between antibiotics and bacteriophages that might affect antibiotic activity (C; D; F; G)\n\n• Environmental risk\n\nassessment\n\n• Bacteriophages • Antibiotics • Antimicrobial resistance\n\nVeterinary medicine","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page25.pdf"]},"response":{"errors":[],"extract_id":"extract_1c411c94287fb70ca87b13d8cc88bbd5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 25/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain of impact**\n\nveterinary medicines (F)\n\n3\\. Develop microphysio- logical / cellular models specifically for veterinary medicines (A; E; F)\n\n4\\. Develop _in vitro_ models for the assessment of toxicity and potency of novel therapies, particularly nanoparticles and RNA-based veterinary medicinal products (A; E; F)\n\n**_Focus area: Environmental risk assessment_** **VET2** Research to generate data for regulatory decisions on environmental safety of veterinary medicinal products\n\n1\\. Develop methods to reliably estimate, measure and analyse environmental concentrations of substances used in veterinary medicinal products (A; D; E; F)\n\n2\\. Develop methods/ produce data to inform the assessment of public health risks related to antimicrobial resistance acquired via the environment resulting from the use of a veterinary medicinal product (A; D; E; F; G)\n\n3\\. Conduct a gap analysis of the availability of environmental risk assessment (ERA) data for veterinary medicinal products and propose new models to update ERAs (e.g., addressing water pollution effects of veterinary products) (G)\n\n• Environmental risk\n\nassessment\n\n• Veterinary medicinal products\n\nVeterinary medicine\n\n**VET3** Research on approaches to monitor environmental risk\n\n1\\. Develop tools and strategies to monitor environmental risks arising from the release of bacteriophages used to treat food-producing animals (including in aquaculture). This includes validation of methods to detect interactions between antibiotics and bacteriophages that might affect antibiotic activity (C; D; F; G)\n\n• Environmental risk\n\nassessment\n\n• Bacteriophages • Antibiotics • Antimicrobial resistance\n\nVeterinary medicine"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 25/31\n\n**RSRN ID**\n\n**Research need Priority topic Keywords Domain of impact**\n\nveterinary medicines (F)\n\n3\\. Develop microphysio- logical / cellular models specifically for veterinary medicines (A; E; F)\n\n4\\. Develop _in vitro_ models for the assessment of toxicity and potency of novel therapies, particularly nanoparticles and RNA-based veterinary medicinal products (A; E; F)\n\n**_Focus area: Environmental risk assessment_** **VET2** Research to generate data for regulatory decisions on environmental safety of veterinary medicinal products\n\n1\\. Develop methods to reliably estimate, measure and analyse environmental concentrations of substances used in veterinary medicinal products (A; D; E; F)\n\n2\\. Develop methods/ produce data to inform the assessment of public health risks related to antimicrobial resistance acquired via the environment resulting from the use of a veterinary medicinal product (A; D; E; F; G)\n\n3\\. Conduct a gap analysis of the availability of environmental risk assessment (ERA) data for veterinary medicinal products and propose new models to update ERAs (e.g., addressing water pollution effects of veterinary products) (G)\n\n• Environmental risk\n\nassessment\n\n• Veterinary medicinal products\n\nVeterinary medicine\n\n**VET3** Research on approaches to monitor environmental risk\n\n1\\. Develop tools and strategies to monitor environmental risks arising from the release of bacteriophages used to treat food-producing animals (including in aquaculture). This includes validation of methods to detect interactions between antibiotics and bacteriophages that might affect antibiotic activity (C; D; F; G)\n\n• Environmental risk\n\nassessment\n\n• Bacteriophages • Antibiotics • Antimicrobial resistance\n\nVeterinary medicine","publish_date":null,"title":"RSRN Research need Priority topic Keywords Domain of ID impact veterinary medicines (F) 3. Develop microphysio- logical / cellular models","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page25.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page25.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page25","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page25.pdf"},"started_at":"2026-11-04T19:47:00.805216"} +{"completed_at":"2026-11-04T19:31:14.461667","latency_in_ms":3462,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page26","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 26/31\n\n**_Focus area: Antiparasitic resistance_** **VET4** Research to increase scientific knowledge on antiparasitic resistance\n\n1\\. Perform studies to identify the mechanisms of antiparasitic resistance development and transmission (A; E)\n\n2\\. Develop methods to estimate and accurately predict the level of antiparasitic resistance depending on parasite and antiparasitic substance class (A; C; E; F)\n\n• Antiparasitic resistance • Risk assessment\n\nVeterinary medicine\n\n**VET5** Research to ensure control and prevention of antiparasitic resistance\n\n1\\. Perform studies to determine the types of data and the minimum level of evidence necessary to ensure reliable assessment of antiparasitic resistance (F; G)\n\n2\\. Perform mapping and gap analysis of measures necessary for the control and prevention of antiparasitic resistance globally (G)\n\n• Antiparasitic resistance • Risk assessment\n\nVeterinary medicine\n\n**_Focus area: Pharmacovigilance_** **VET6** Research on approaches to leverage data for improved pharmacovigilance\n\n1\\. Perform studies to establish the data landscape of pharmacovigilance- related information (including species population, data on treatment) at the level of veterinary practice and husbandry in the different Member States (G)\n\n2\\. Perform an analysis of data in the union pharmacovigilance database to identify potential biases in terms of product type population that may affect data warehouse analyses and suggest appropriate measures to improve the robustness and consistency for signal management (C; F; G)\n\n• Pharmacovigilance • Data management • Union pharmacovigilance database\n\nVeterinary medicine\n\n**VET7** Research on approaches to facilitate and improve reporting of adverse events related to veterinary medicines\n\n1\\. Perform analysis on the sales data relative to the reporting of adverse event in the different Member States\n\n2\\. Develop new methods (and review relevant existing methods) to increase the reporting rates of adverse events\n\n• Adverse drug reaction • Adverse event\n\nVeterinary medicine","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 26/31\n\n**_Focus area: Antiparasitic resistance_** **VET4** Research to increase scientific knowledge on antiparasitic resistance\n\n1\\. Perform studies to identify the mechanisms of antiparasitic resistance development and transmission (A; E)\n\n2\\. Develop methods to estimate and accurately predict the level of antiparasitic resistance depending on parasite and antiparasitic substance class (A; C; E; F)\n\n• Antiparasitic resistance • Risk assessment\n\nVeterinary medicine\n\n**VET5** Research to ensure control and prevention of antiparasitic resistance\n\n1\\. Perform studies to determine the types of data and the minimum level of evidence necessary to ensure reliable assessment of antiparasitic resistance (F; G)\n\n2\\. Perform mapping and gap analysis of measures necessary for the control and prevention of antiparasitic resistance globally (G)\n\n• Antiparasitic resistance • Risk assessment\n\nVeterinary medicine\n\n**_Focus area: Pharmacovigilance_** **VET6** Research on approaches to leverage data for improved pharmacovigilance\n\n1\\. Perform studies to establish the data landscape of pharmacovigilance- related information (including species population, data on treatment) at the level of veterinary practice and husbandry in the different Member States (G)\n\n2\\. Perform an analysis of data in the union pharmacovigilance database to identify potential biases in terms of product type population that may affect data warehouse analyses and suggest appropriate measures to improve the robustness and consistency for signal management (C; F; G)\n\n• Pharmacovigilance • Data management • Union pharmacovigilance database\n\nVeterinary medicine\n\n**VET7** Research on approaches to facilitate and improve reporting of adverse events related to veterinary medicines\n\n1\\. Perform analysis on the sales data relative to the reporting of adverse event in the different Member States\n\n2\\. Develop new methods (and review relevant existing methods) to increase the reporting rates of adverse events\n\n• Adverse drug reaction • Adverse event\n\nVeterinary medicine","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 26/31\n\n**_Focus area: Antiparasitic resistance_** **VET4** Research to increase scientific knowledge on antiparasitic resistance\n\n1\\. Perform studies to identify the mechanisms of antiparasitic resistance development and transmission (A; E)\n\n2\\. Develop methods to estimate and accurately predict the level of antiparasitic resistance depending on parasite and antiparasitic substance class (A; C; E; F)\n\n• Antiparasitic resistance • Risk assessment\n\nVeterinary medicine\n\n**VET5** Research to ensure control and prevention of antiparasitic resistance\n\n1\\. Perform studies to determine the types of data and the minimum level of evidence necessary to ensure reliable assessment of antiparasitic resistance (F; G)\n\n2\\. Perform mapping and gap analysis of measures necessary for the control and prevention of antiparasitic resistance globally (G)\n\n• Antiparasitic resistance • Risk assessment\n\nVeterinary medicine\n\n**_Focus area: Pharmacovigilance_** **VET6** Research on approaches to leverage data for improved pharmacovigilance\n\n1\\. Perform studies to establish the data landscape of pharmacovigilance- related information (including species population, data on treatment) at the level of veterinary practice and husbandry in the different Member States (G)\n\n2\\. Perform an analysis of data in the union pharmacovigilance database to identify potential biases in terms of product type population that may affect data warehouse analyses and suggest appropriate measures to improve the robustness and consistency for signal management (C; F; G)\n\n• Pharmacovigilance • Data management • Union pharmacovigilance database\n\nVeterinary medicine\n\n**VET7** Research on approaches to facilitate and improve reporting of adverse events related to veterinary medicines\n\n1\\. Perform analysis on the sales data relative to the reporting of adverse event in the different Member States\n\n2\\. Develop new methods (and review relevant existing methods) to increase the reporting rates of adverse events\n\n• Adverse drug reaction • Adverse event\n\nVeterinary medicine","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page26.pdf"]},"response":{"errors":[],"extract_id":"extract_bf0de56b1d30a8819c12f7a5f22418bd","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 26/31\n\n**_Focus area: Antiparasitic resistance_** **VET4** Research to increase scientific knowledge on antiparasitic resistance\n\n1\\. Perform studies to identify the mechanisms of antiparasitic resistance development and transmission (A; E)\n\n2\\. Develop methods to estimate and accurately predict the level of antiparasitic resistance depending on parasite and antiparasitic substance class (A; C; E; F)\n\n• Antiparasitic resistance • Risk assessment\n\nVeterinary medicine\n\n**VET5** Research to ensure control and prevention of antiparasitic resistance\n\n1\\. Perform studies to determine the types of data and the minimum level of evidence necessary to ensure reliable assessment of antiparasitic resistance (F; G)\n\n2\\. Perform mapping and gap analysis of measures necessary for the control and prevention of antiparasitic resistance globally (G)\n\n• Antiparasitic resistance • Risk assessment\n\nVeterinary medicine\n\n**_Focus area: Pharmacovigilance_** **VET6** Research on approaches to leverage data for improved pharmacovigilance\n\n1\\. Perform studies to establish the data landscape of pharmacovigilance- related information (including species population, data on treatment) at the level of veterinary practice and husbandry in the different Member States (G)\n\n2\\. Perform an analysis of data in the union pharmacovigilance database to identify potential biases in terms of product type population that may affect data warehouse analyses and suggest appropriate measures to improve the robustness and consistency for signal management (C; F; G)\n\n• Pharmacovigilance • Data management • Union pharmacovigilance database\n\nVeterinary medicine\n\n**VET7** Research on approaches to facilitate and improve reporting of adverse events related to veterinary medicines\n\n1\\. Perform analysis on the sales data relative to the reporting of adverse event in the different Member States\n\n2\\. Develop new methods (and review relevant existing methods) to increase the reporting rates of adverse events\n\n• Adverse drug reaction • Adverse event\n\nVeterinary medicine"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 26/31\n\n**_Focus area: Antiparasitic resistance_** **VET4** Research to increase scientific knowledge on antiparasitic resistance\n\n1\\. Perform studies to identify the mechanisms of antiparasitic resistance development and transmission (A; E)\n\n2\\. Develop methods to estimate and accurately predict the level of antiparasitic resistance depending on parasite and antiparasitic substance class (A; C; E; F)\n\n• Antiparasitic resistance • Risk assessment\n\nVeterinary medicine\n\n**VET5** Research to ensure control and prevention of antiparasitic resistance\n\n1\\. Perform studies to determine the types of data and the minimum level of evidence necessary to ensure reliable assessment of antiparasitic resistance (F; G)\n\n2\\. Perform mapping and gap analysis of measures necessary for the control and prevention of antiparasitic resistance globally (G)\n\n• Antiparasitic resistance • Risk assessment\n\nVeterinary medicine\n\n**_Focus area: Pharmacovigilance_** **VET6** Research on approaches to leverage data for improved pharmacovigilance\n\n1\\. Perform studies to establish the data landscape of pharmacovigilance- related information (including species population, data on treatment) at the level of veterinary practice and husbandry in the different Member States (G)\n\n2\\. Perform an analysis of data in the union pharmacovigilance database to identify potential biases in terms of product type population that may affect data warehouse analyses and suggest appropriate measures to improve the robustness and consistency for signal management (C; F; G)\n\n• Pharmacovigilance • Data management • Union pharmacovigilance database\n\nVeterinary medicine\n\n**VET7** Research on approaches to facilitate and improve reporting of adverse events related to veterinary medicines\n\n1\\. Perform analysis on the sales data relative to the reporting of adverse event in the different Member States\n\n2\\. Develop new methods (and review relevant existing methods) to increase the reporting rates of adverse events\n\n• Adverse drug reaction • Adverse event\n\nVeterinary medicine","publish_date":null,"title":"Focus area: Antiparasitic resistance • VET4 Research to increase 1. Perform studies to Antiparasitic resistance Veterinary • scientific knowledge on","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page26.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page26.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page26","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page26.pdf"},"started_at":"2026-11-04T19:31:10.999402"} +{"completed_at":"2026-11-04T19:47:05.420863","latency_in_ms":2101,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page27","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 27/31\n\nfor veterinary medicinal products (to cover technologies such as mobile devices and apps) (D; F)\n\n3\\. Investigate and develop methods to optimise the dissemination of updated safety information to practising veterinarians and animal owners (food- producing animals and companion animals) (B; G)\n\n**_Focus area: Novel therapies and innovation_** **VET8** Research on identification of regulatory bottlenecks for novel manufacturing\n\n1\\. Review novel manufacturing methods and delivery approaches (including devices) with a focus on related regulatory limitations and bottlenecks (G)\n\n2\\. Review and perform an analysis on the approach underpinning novel manufacturing regulation in the devices field, highlighting learnings that could translate into medicine regulation (G)\n\n• Advanced manufacturing Veterinary medicine\n\n**VET9** Research on novel methodologies for quality control of veterinary medicines\n\n1\\. Develop or optimise methods entailing deep sequencing for testing of contaminants, to inform limit-setting for veterinary use, such as blood products, cell products (D; E; F)\n\n• Quality control\n\n• Pharmaceutical quality\n\n• Product quality issue\n\n• Deep sequencing\n\nVeterinary medicine\n\n**_Focus area: Vaccines_** **VET10** Research on vaccines for priority diseases\n\n1\\. Perform an analysis to identify challenges, opportunities and potential synergies to foster the development of veterinary vaccines for therapeutic gaps in the market (e.g., specific target species, limited markets, zoonotic and emerging diseases) (G)\n\n• Vaccines\n\n• Priority diseases\n\n• Limited market\n\n• Zoonosis\n\n• Emerging diseases\n\nVeterinary medicine","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 27/31\n\nfor veterinary medicinal products (to cover technologies such as mobile devices and apps) (D; F)\n\n3\\. Investigate and develop methods to optimise the dissemination of updated safety information to practising veterinarians and animal owners (food- producing animals and companion animals) (B; G)\n\n**_Focus area: Novel therapies and innovation_** **VET8** Research on identification of regulatory bottlenecks for novel manufacturing\n\n1\\. Review novel manufacturing methods and delivery approaches (including devices) with a focus on related regulatory limitations and bottlenecks (G)\n\n2\\. Review and perform an analysis on the approach underpinning novel manufacturing regulation in the devices field, highlighting learnings that could translate into medicine regulation (G)\n\n• Advanced manufacturing Veterinary medicine\n\n**VET9** Research on novel methodologies for quality control of veterinary medicines\n\n1\\. Develop or optimise methods entailing deep sequencing for testing of contaminants, to inform limit-setting for veterinary use, such as blood products, cell products (D; E; F)\n\n• Quality control\n\n• Pharmaceutical quality\n\n• Product quality issue\n\n• Deep sequencing\n\nVeterinary medicine\n\n**_Focus area: Vaccines_** **VET10** Research on vaccines for priority diseases\n\n1\\. Perform an analysis to identify challenges, opportunities and potential synergies to foster the development of veterinary vaccines for therapeutic gaps in the market (e.g., specific target species, limited markets, zoonotic and emerging diseases) (G)\n\n• Vaccines\n\n• Priority diseases\n\n• Limited market\n\n• Zoonosis\n\n• Emerging diseases\n\nVeterinary medicine","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 27/31\n\nfor veterinary medicinal products (to cover technologies such as mobile devices and apps) (D; F)\n\n3\\. Investigate and develop methods to optimise the dissemination of updated safety information to practising veterinarians and animal owners (food- producing animals and companion animals) (B; G)\n\n**_Focus area: Novel therapies and innovation_** **VET8** Research on identification of regulatory bottlenecks for novel manufacturing\n\n1\\. Review novel manufacturing methods and delivery approaches (including devices) with a focus on related regulatory limitations and bottlenecks (G)\n\n2\\. Review and perform an analysis on the approach underpinning novel manufacturing regulation in the devices field, highlighting learnings that could translate into medicine regulation (G)\n\n• Advanced manufacturing Veterinary medicine\n\n**VET9** Research on novel methodologies for quality control of veterinary medicines\n\n1\\. Develop or optimise methods entailing deep sequencing for testing of contaminants, to inform limit-setting for veterinary use, such as blood products, cell products (D; E; F)\n\n• Quality control\n\n• Pharmaceutical quality\n\n• Product quality issue\n\n• Deep sequencing\n\nVeterinary medicine\n\n**_Focus area: Vaccines_** **VET10** Research on vaccines for priority diseases\n\n1\\. Perform an analysis to identify challenges, opportunities and potential synergies to foster the development of veterinary vaccines for therapeutic gaps in the market (e.g., specific target species, limited markets, zoonotic and emerging diseases) (G)\n\n• Vaccines\n\n• Priority diseases\n\n• Limited market\n\n• Zoonosis\n\n• Emerging diseases\n\nVeterinary medicine","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page27.pdf"]},"response":{"errors":[],"extract_id":"extract_46387dfe4681dd5c38a2e39987fdc72a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 27/31\n\nfor veterinary medicinal products (to cover technologies such as mobile devices and apps) (D; F)\n\n3\\. Investigate and develop methods to optimise the dissemination of updated safety information to practising veterinarians and animal owners (food- producing animals and companion animals) (B; G)\n\n**_Focus area: Novel therapies and innovation_** **VET8** Research on identification of regulatory bottlenecks for novel manufacturing\n\n1\\. Review novel manufacturing methods and delivery approaches (including devices) with a focus on related regulatory limitations and bottlenecks (G)\n\n2\\. Review and perform an analysis on the approach underpinning novel manufacturing regulation in the devices field, highlighting learnings that could translate into medicine regulation (G)\n\n• Advanced manufacturing Veterinary medicine\n\n**VET9** Research on novel methodologies for quality control of veterinary medicines\n\n1\\. Develop or optimise methods entailing deep sequencing for testing of contaminants, to inform limit-setting for veterinary use, such as blood products, cell products (D; E; F)\n\n• Quality control\n\n• Pharmaceutical quality\n\n• Product quality issue\n\n• Deep sequencing\n\nVeterinary medicine\n\n**_Focus area: Vaccines_** **VET10** Research on vaccines for priority diseases\n\n1\\. Perform an analysis to identify challenges, opportunities and potential synergies to foster the development of veterinary vaccines for therapeutic gaps in the market (e.g., specific target species, limited markets, zoonotic and emerging diseases) (G)\n\n• Vaccines\n\n• Priority diseases\n\n• Limited market\n\n• Zoonosis\n\n• Emerging diseases\n\nVeterinary medicine"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 27/31\n\nfor veterinary medicinal products (to cover technologies such as mobile devices and apps) (D; F)\n\n3\\. Investigate and develop methods to optimise the dissemination of updated safety information to practising veterinarians and animal owners (food- producing animals and companion animals) (B; G)\n\n**_Focus area: Novel therapies and innovation_** **VET8** Research on identification of regulatory bottlenecks for novel manufacturing\n\n1\\. Review novel manufacturing methods and delivery approaches (including devices) with a focus on related regulatory limitations and bottlenecks (G)\n\n2\\. Review and perform an analysis on the approach underpinning novel manufacturing regulation in the devices field, highlighting learnings that could translate into medicine regulation (G)\n\n• Advanced manufacturing Veterinary medicine\n\n**VET9** Research on novel methodologies for quality control of veterinary medicines\n\n1\\. Develop or optimise methods entailing deep sequencing for testing of contaminants, to inform limit-setting for veterinary use, such as blood products, cell products (D; E; F)\n\n• Quality control\n\n• Pharmaceutical quality\n\n• Product quality issue\n\n• Deep sequencing\n\nVeterinary medicine\n\n**_Focus area: Vaccines_** **VET10** Research on vaccines for priority diseases\n\n1\\. Perform an analysis to identify challenges, opportunities and potential synergies to foster the development of veterinary vaccines for therapeutic gaps in the market (e.g., specific target species, limited markets, zoonotic and emerging diseases) (G)\n\n• Vaccines\n\n• Priority diseases\n\n• Limited market\n\n• Zoonosis\n\n• Emerging diseases\n\nVeterinary medicine","publish_date":null,"title":"• • • • • • • • • •","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page27.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page27.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page27","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page27.pdf"},"started_at":"2026-11-04T19:47:03.319000"} +{"completed_at":"2026-11-04T19:31:13.417548","latency_in_ms":1014,"output":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page28","grounded_pages":[],"layout_pages":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 28/31\n\n**VET11** Research on methods to ensure highest quality of vaccines\n\n1\\. Perform an analysis to discover opportunities offered by novel methods for the detection of nucleic acids applied to the quality control of veterinary vaccines (e.g., in the detection of contaminating material and vaccine strain characterisation) (G)\n\n2\\. Develop approaches to investigate process- and product-related impurities in veterinary vaccines (D, E, F)\n\n• Quality control\n\n• Vaccines\n\nVeterinary medicine\n\n**_Focus area: Antimicrobial resistance_** **VET12** Research on data generation for regulatory decisions on antimicrobials\n\n1\\. Develop models to support the initial or the maintained marketing authorisation of antimicrobials of public health relevance. The models might take into account the following elements: 1) off-patent veterinary antimicrobials; 2) modelling and extrapolation using PK/PD; 3) dose optimisation (B; F; G)\n\n• Antimicrobial resistance\n\n• Dose optimisation\n\n• Pharmacokinetic study\n\n• Pharmacodynamic study\n\nVeterinary medicine\n\n**VET13** Research on methods for reporting data on antimicrobial use\n\n1\\. Develop methodologies to establish defined daily dose and defined course dose (DDDvet/DCDvet) for reporting of antimicrobial use in different animal species (A; D; E; F)\n\n• Defined daily dose\n\n• Defined course dose\n\n• Antimicrobial resistance\n\n**VET14** Research on diagnostics to support prudent use of antimicrobials\n\n1\\. Develop and establish/validate point- of-care/ companion diagnostics for veterinary antimicrobial sensitivity tests (D)\n\n• Antimicrobial resistance\n\n• Point-of-care testing\n\n• Diagnostics\n\nVeterinary medicine Notified bodies\n\n**_Focus area: Veterinary big data_** **VET15** Research on big data activities on the veterinary domain\n\n2\\. Perform a review and highlight differences and opportunities of big data initiatives (e.g., to further explore availability of data sources on animal health, data integration and analytics solutions) to support the Veterinary Big Data strategy (B; G)\n\n• Veterinary Big Data strategy\n\nVeterinary medicine","pages":[{"line_numbers":[],"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 28/31\n\n**VET11** Research on methods to ensure highest quality of vaccines\n\n1\\. Perform an analysis to discover opportunities offered by novel methods for the detection of nucleic acids applied to the quality control of veterinary vaccines (e.g., in the detection of contaminating material and vaccine strain characterisation) (G)\n\n2\\. Develop approaches to investigate process- and product-related impurities in veterinary vaccines (D, E, F)\n\n• Quality control\n\n• Vaccines\n\nVeterinary medicine\n\n**_Focus area: Antimicrobial resistance_** **VET12** Research on data generation for regulatory decisions on antimicrobials\n\n1\\. Develop models to support the initial or the maintained marketing authorisation of antimicrobials of public health relevance. The models might take into account the following elements: 1) off-patent veterinary antimicrobials; 2) modelling and extrapolation using PK/PD; 3) dose optimisation (B; F; G)\n\n• Antimicrobial resistance\n\n• Dose optimisation\n\n• Pharmacokinetic study\n\n• Pharmacodynamic study\n\nVeterinary medicine\n\n**VET13** Research on methods for reporting data on antimicrobial use\n\n1\\. Develop methodologies to establish defined daily dose and defined course dose (DDDvet/DCDvet) for reporting of antimicrobial use in different animal species (A; D; E; F)\n\n• Defined daily dose\n\n• Defined course dose\n\n• Antimicrobial resistance\n\n**VET14** Research on diagnostics to support prudent use of antimicrobials\n\n1\\. Develop and establish/validate point- of-care/ companion diagnostics for veterinary antimicrobial sensitivity tests (D)\n\n• Antimicrobial resistance\n\n• Point-of-care testing\n\n• Diagnostics\n\nVeterinary medicine Notified bodies\n\n**_Focus area: Veterinary big data_** **VET15** Research on big data activities on the veterinary domain\n\n2\\. Perform a review and highlight differences and opportunities of big data initiatives (e.g., to further explore availability of data sources on animal health, data integration and analytics solutions) to support the Veterinary Big Data strategy (B; G)\n\n• Veterinary Big Data strategy\n\nVeterinary medicine","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 28/31\n\n**VET11** Research on methods to ensure highest quality of vaccines\n\n1\\. Perform an analysis to discover opportunities offered by novel methods for the detection of nucleic acids applied to the quality control of veterinary vaccines (e.g., in the detection of contaminating material and vaccine strain characterisation) (G)\n\n2\\. Develop approaches to investigate process- and product-related impurities in veterinary vaccines (D, E, F)\n\n• Quality control\n\n• Vaccines\n\nVeterinary medicine\n\n**_Focus area: Antimicrobial resistance_** **VET12** Research on data generation for regulatory decisions on antimicrobials\n\n1\\. Develop models to support the initial or the maintained marketing authorisation of antimicrobials of public health relevance. The models might take into account the following elements: 1) off-patent veterinary antimicrobials; 2) modelling and extrapolation using PK/PD; 3) dose optimisation (B; F; G)\n\n• Antimicrobial resistance\n\n• Dose optimisation\n\n• Pharmacokinetic study\n\n• Pharmacodynamic study\n\nVeterinary medicine\n\n**VET13** Research on methods for reporting data on antimicrobial use\n\n1\\. Develop methodologies to establish defined daily dose and defined course dose (DDDvet/DCDvet) for reporting of antimicrobial use in different animal species (A; D; E; F)\n\n• Defined daily dose\n\n• Defined course dose\n\n• Antimicrobial resistance\n\n**VET14** Research on diagnostics to support prudent use of antimicrobials\n\n1\\. Develop and establish/validate point- of-care/ companion diagnostics for veterinary antimicrobial sensitivity tests (D)\n\n• Antimicrobial resistance\n\n• Point-of-care testing\n\n• Diagnostics\n\nVeterinary medicine Notified bodies\n\n**_Focus area: Veterinary big data_** **VET15** Research on big data activities on the veterinary domain\n\n2\\. Perform a review and highlight differences and opportunities of big data initiatives (e.g., to further explore availability of data sources on animal health, data integration and analytics solutions) to support the Veterinary Big Data strategy (B; G)\n\n• Veterinary Big Data strategy\n\nVeterinary medicine","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page28.pdf"]},"response":{"errors":[],"extract_id":"extract_0a7861ab2f5b36c183d94b5cbebf6ad6","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Regulatory Science Research Needs\n\nEMA/510633/2024 Page 28/31\n\n**VET11** Research on methods to ensure highest quality of vaccines\n\n1\\. Perform an analysis to discover opportunities offered by novel methods for the detection of nucleic acids applied to the quality control of veterinary vaccines (e.g., in the detection of contaminating material and vaccine strain characterisation) (G)\n\n2\\. Develop approaches to investigate process- and product-related impurities in veterinary vaccines (D, E, F)\n\n• Quality control\n\n• Vaccines\n\nVeterinary medicine\n\n**_Focus area: Antimicrobial resistance_** **VET12** Research on data generation for regulatory decisions on antimicrobials\n\n1\\. Develop models to support the initial or the maintained marketing authorisation of antimicrobials of public health relevance. The models might take into account the following elements: 1) off-patent veterinary antimicrobials; 2) modelling and extrapolation using PK/PD; 3) dose optimisation (B; F; G)\n\n• Antimicrobial resistance\n\n• Dose optimisation\n\n• Pharmacokinetic study\n\n• Pharmacodynamic study\n\nVeterinary medicine\n\n**VET13** Research on methods for reporting data on antimicrobial use\n\n1\\. Develop methodologies to establish defined daily dose and defined course dose (DDDvet/DCDvet) for reporting of antimicrobial use in different animal species (A; D; E; F)\n\n• Defined daily dose\n\n• Defined course dose\n\n• Antimicrobial resistance\n\n**VET14** Research on diagnostics to support prudent use of antimicrobials\n\n1\\. Develop and establish/validate point- of-care/ companion diagnostics for veterinary antimicrobial sensitivity tests (D)\n\n• Antimicrobial resistance\n\n• Point-of-care testing\n\n• Diagnostics\n\nVeterinary medicine Notified bodies\n\n**_Focus area: Veterinary big data_** **VET15** Research on big data activities on the veterinary domain\n\n2\\. Perform a review and highlight differences and opportunities of big data initiatives (e.g., to further explore availability of data sources on animal health, data integration and analytics solutions) to support the Veterinary Big Data strategy (B; G)\n\n• Veterinary Big Data strategy\n\nVeterinary medicine"],"full_content":"Regulatory Science Research Needs\n\nEMA/510633/2024 Page 28/31\n\n**VET11** Research on methods to ensure highest quality of vaccines\n\n1\\. Perform an analysis to discover opportunities offered by novel methods for the detection of nucleic acids applied to the quality control of veterinary vaccines (e.g., in the detection of contaminating material and vaccine strain characterisation) (G)\n\n2\\. Develop approaches to investigate process- and product-related impurities in veterinary vaccines (D, E, F)\n\n• Quality control\n\n• Vaccines\n\nVeterinary medicine\n\n**_Focus area: Antimicrobial resistance_** **VET12** Research on data generation for regulatory decisions on antimicrobials\n\n1\\. Develop models to support the initial or the maintained marketing authorisation of antimicrobials of public health relevance. The models might take into account the following elements: 1) off-patent veterinary antimicrobials; 2) modelling and extrapolation using PK/PD; 3) dose optimisation (B; F; G)\n\n• Antimicrobial resistance\n\n• Dose optimisation\n\n• Pharmacokinetic study\n\n• Pharmacodynamic study\n\nVeterinary medicine\n\n**VET13** Research on methods for reporting data on antimicrobial use\n\n1\\. Develop methodologies to establish defined daily dose and defined course dose (DDDvet/DCDvet) for reporting of antimicrobial use in different animal species (A; D; E; F)\n\n• Defined daily dose\n\n• Defined course dose\n\n• Antimicrobial resistance\n\n**VET14** Research on diagnostics to support prudent use of antimicrobials\n\n1\\. Develop and establish/validate point- of-care/ companion diagnostics for veterinary antimicrobial sensitivity tests (D)\n\n• Antimicrobial resistance\n\n• Point-of-care testing\n\n• Diagnostics\n\nVeterinary medicine Notified bodies\n\n**_Focus area: Veterinary big data_** **VET15** Research on big data activities on the veterinary domain\n\n2\\. Perform a review and highlight differences and opportunities of big data initiatives (e.g., to further explore availability of data sources on animal health, data integration and analytics solutions) to support the Veterinary Big Data strategy (B; G)\n\n• Veterinary Big Data strategy\n\nVeterinary medicine","publish_date":null,"title":"• • • • • • • • • • • • •","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page28.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/203924_fb04e77929bf4bbc93dbd659653a4f01_page28.pdf"},"request":{"example_id":"table/203924_fb04e77929bf4bbc93dbd659653a4f01_page28","product_type":"parse","source_file_path":"203924_fb04e77929bf4bbc93dbd659653a4f01_page28.pdf"},"started_at":"2026-11-04T19:31:12.402906"} +{"completed_at":"2026-11-04T19:47:07.488452","latency_in_ms":1121,"output":{"example_id":"table/222876fb_page2","grounded_pages":[],"layout_pages":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 2\n\n222876fb\n\n## **PIN CONFIGURATION ABSOLUTE MAXIMUM RATINGS**\n\nSupply Voltage (VDD) ..................................................4V Digital Output Ground Voltage (OGND) ........ –0.3V to 1V Analog Input Voltage (Note 3) .......–0.3V to (VDD + 0.3V) Digital Input Voltage ......................–0.3V to (VDD + 0.3V) Digital Output Voltage ................ –0.3V to (OVDD + 0.3V) Power Dissipation .............................................1500mW Operating Temperature Range LTC2228C, LTC2227C, LTC2226C............. 0°C to 70°C LTC2228I, LTC2227I, LTC2226I ............ –40°C to 85°C Storage Temperature Range ................... –65°C to 125°C\n\n**OVDD = VDD (Notes 1, 2)**\n\n32 31 30 29 28 27 26 25\n\n9 10 11 12\n\nTOP VIEW\n\nUH PACKAGE 32-LEAD (5mm 5mm) PLASTIC QFN\n\n13 14 15 16\n\n17\n\n18\n\n19\n\n20\n\n21\n\n22\n\n23\n\n24\n\n8\n\n7\n\n6\n\n5\n\n4\n\n3\n\n2\n\n1 AIN \\+\n\nAIN –\n\nREFH\n\nREFH\n\nREFL\n\nREFL\n\nVDD\n\nGND\n\nD8\n\nD7\n\nD6\n\nOVDD\n\nOGND\n\nD5\n\nD4\n\nD3\n\nVDD\n\nVCM\n\nSENSE\n\nMODE\n\nOF\n\nD11\n\nD10\n\nD9\n\nCLK\n\nSHDN\n\nOE\n\nNC\n\nNC\n\nD0\n\nD1\n\nD2\n\n33\n\nTJMAX = 125°C, θJA = 34°C/W EXPOSED PAD (PIN 33) IS GND, MUST BE SOLDERED TO PCB\n\n## **ORDER INFORMATION**\n\n**LEAD FREE FINISH TAPE AND REEL PART MARKING\\* PACKAGE DESCRIPTION TEMPERATURE RANGE**\n\nLTC2228CUH LTC2228CUH 2228 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2228IUH LTC2228IUH 2228 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2227CUH LTC2227CUH 2227 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2227IUH LTC2227IUH 2227 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2226CUH LTC2226CUH 2226 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2226IUH LTC2226IUH 2226 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\n**LEAD BASED FINISH TAPE AND REEL PART MARKING\\* PACKAGE DESCRIPTION TEMPERATURE RANGE**\n\nLTC2228CUH LTC2228CUH 2228 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2228IUH LTC2228IUH 2228 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2227CUH LTC2227CUH 2227 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2227IUH LTC2227IUH 2227 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2226CUH LTC2226CUH 2226 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2226IUH LTC2226IUH 2226 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nConsult LTC Marketing for parts specifi ed with wider operating temperature ranges. \\*The temperature grade is identifi ed by a label on the shipping container.\n\nFor more information on lead free part marking, go to: http://www.linear.com/leadfree/ For more information on tape and reel specifi cations, go to: http://www.linear.com/tapeandreel/","pages":[{"line_numbers":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 2\n\n222876fb\n\n## **PIN CONFIGURATION ABSOLUTE MAXIMUM RATINGS**\n\nSupply Voltage (VDD) ..................................................4V Digital Output Ground Voltage (OGND) ........ –0.3V to 1V Analog Input Voltage (Note 3) .......–0.3V to (VDD + 0.3V) Digital Input Voltage ......................–0.3V to (VDD + 0.3V) Digital Output Voltage ................ –0.3V to (OVDD + 0.3V) Power Dissipation .............................................1500mW Operating Temperature Range LTC2228C, LTC2227C, LTC2226C............. 0°C to 70°C LTC2228I, LTC2227I, LTC2226I ............ –40°C to 85°C Storage Temperature Range ................... –65°C to 125°C\n\n**OVDD = VDD (Notes 1, 2)**\n\n32 31 30 29 28 27 26 25\n\n9 10 11 12\n\nTOP VIEW\n\nUH PACKAGE 32-LEAD (5mm 5mm) PLASTIC QFN\n\n13 14 15 16\n\n17\n\n18\n\n19\n\n20\n\n21\n\n22\n\n23\n\n24\n\n8\n\n7\n\n6\n\n5\n\n4\n\n3\n\n2\n\n1 AIN \\+\n\nAIN –\n\nREFH\n\nREFH\n\nREFL\n\nREFL\n\nVDD\n\nGND\n\nD8\n\nD7\n\nD6\n\nOVDD\n\nOGND\n\nD5\n\nD4\n\nD3\n\nVDD\n\nVCM\n\nSENSE\n\nMODE\n\nOF\n\nD11\n\nD10\n\nD9\n\nCLK\n\nSHDN\n\nOE\n\nNC\n\nNC\n\nD0\n\nD1\n\nD2\n\n33\n\nTJMAX = 125°C, θJA = 34°C/W EXPOSED PAD (PIN 33) IS GND, MUST BE SOLDERED TO PCB\n\n## **ORDER INFORMATION**\n\n**LEAD FREE FINISH TAPE AND REEL PART MARKING\\* PACKAGE DESCRIPTION TEMPERATURE RANGE**\n\nLTC2228CUH LTC2228CUH 2228 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2228IUH LTC2228IUH 2228 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2227CUH LTC2227CUH 2227 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2227IUH LTC2227IUH 2227 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2226CUH LTC2226CUH 2226 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2226IUH LTC2226IUH 2226 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\n**LEAD BASED FINISH TAPE AND REEL PART MARKING\\* PACKAGE DESCRIPTION TEMPERATURE RANGE**\n\nLTC2228CUH LTC2228CUH 2228 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2228IUH LTC2228IUH 2228 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2227CUH LTC2227CUH 2227 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2227IUH LTC2227IUH 2227 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2226CUH LTC2226CUH 2226 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2226IUH LTC2226IUH 2226 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nConsult LTC Marketing for parts specifi ed with wider operating temperature ranges. \\*The temperature grade is identifi ed by a label on the shipping container.\n\nFor more information on lead free part marking, go to: http://www.linear.com/leadfree/ For more information on tape and reel specifi cations, go to: http://www.linear.com/tapeandreel/","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 2\n\n222876fb\n\n## **PIN CONFIGURATION ABSOLUTE MAXIMUM RATINGS**\n\nSupply Voltage (VDD) ..................................................4V Digital Output Ground Voltage (OGND) ........ –0.3V to 1V Analog Input Voltage (Note 3) .......–0.3V to (VDD + 0.3V) Digital Input Voltage ......................–0.3V to (VDD + 0.3V) Digital Output Voltage ................ –0.3V to (OVDD + 0.3V) Power Dissipation .............................................1500mW Operating Temperature Range LTC2228C, LTC2227C, LTC2226C............. 0°C to 70°C LTC2228I, LTC2227I, LTC2226I ............ –40°C to 85°C Storage Temperature Range ................... –65°C to 125°C\n\n**OVDD = VDD (Notes 1, 2)**\n\n32 31 30 29 28 27 26 25\n\n9 10 11 12\n\nTOP VIEW\n\nUH PACKAGE 32-LEAD (5mm 5mm) PLASTIC QFN\n\n13 14 15 16\n\n17\n\n18\n\n19\n\n20\n\n21\n\n22\n\n23\n\n24\n\n8\n\n7\n\n6\n\n5\n\n4\n\n3\n\n2\n\n1 AIN \\+\n\nAIN –\n\nREFH\n\nREFH\n\nREFL\n\nREFL\n\nVDD\n\nGND\n\nD8\n\nD7\n\nD6\n\nOVDD\n\nOGND\n\nD5\n\nD4\n\nD3\n\nVDD\n\nVCM\n\nSENSE\n\nMODE\n\nOF\n\nD11\n\nD10\n\nD9\n\nCLK\n\nSHDN\n\nOE\n\nNC\n\nNC\n\nD0\n\nD1\n\nD2\n\n33\n\nTJMAX = 125°C, θJA = 34°C/W EXPOSED PAD (PIN 33) IS GND, MUST BE SOLDERED TO PCB\n\n## **ORDER INFORMATION**\n\n**LEAD FREE FINISH TAPE AND REEL PART MARKING\\* PACKAGE DESCRIPTION TEMPERATURE RANGE**\n\nLTC2228CUH LTC2228CUH 2228 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2228IUH LTC2228IUH 2228 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2227CUH LTC2227CUH 2227 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2227IUH LTC2227IUH 2227 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2226CUH LTC2226CUH 2226 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2226IUH LTC2226IUH 2226 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\n**LEAD BASED FINISH TAPE AND REEL PART MARKING\\* PACKAGE DESCRIPTION TEMPERATURE RANGE**\n\nLTC2228CUH LTC2228CUH 2228 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2228IUH LTC2228IUH 2228 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2227CUH LTC2227CUH 2227 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2227IUH LTC2227IUH 2227 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2226CUH LTC2226CUH 2226 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2226IUH LTC2226IUH 2226 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nConsult LTC Marketing for parts specifi ed with wider operating temperature ranges. \\*The temperature grade is identifi ed by a label on the shipping container.\n\nFor more information on lead free part marking, go to: http://www.linear.com/leadfree/ For more information on tape and reel specifi cations, go to: http://www.linear.com/tapeandreel/","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_66aa1dac16e2735f8348031def62a1a8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## LTC2228/LTC2227/LTC2226\n\n# 2\n\n222876fb\n\n## **PIN CONFIGURATION ABSOLUTE MAXIMUM RATINGS**\n\nSupply Voltage (VDD) ..................................................4V Digital Output Ground Voltage (OGND) ........ –0.3V to 1V Analog Input Voltage (Note 3) .......–0.3V to (VDD + 0.3V) Digital Input Voltage ......................–0.3V to (VDD + 0.3V) Digital Output Voltage ................ –0.3V to (OVDD + 0.3V) Power Dissipation .............................................1500mW Operating Temperature Range LTC2228C, LTC2227C, LTC2226C............. 0°C to 70°C LTC2228I, LTC2227I, LTC2226I ............ –40°C to 85°C Storage Temperature Range ................... –65°C to 125°C\n\n**OVDD = VDD (Notes 1, 2)**\n\n32 31 30 29 28 27 26 25\n\n9 10 11 12\n\nTOP VIEW\n\nUH PACKAGE 32-LEAD (5mm 5mm) PLASTIC QFN\n\n13 14 15 16\n\n17\n\n18\n\n19\n\n20\n\n21\n\n22\n\n23\n\n24\n\n8\n\n7\n\n6\n\n5\n\n4\n\n3\n\n2\n\n1 AIN \\+\n\nAIN –\n\nREFH\n\nREFH\n\nREFL\n\nREFL\n\nVDD\n\nGND\n\nD8\n\nD7\n\nD6\n\nOVDD\n\nOGND\n\nD5\n\nD4\n\nD3\n\nVDD\n\nVCM\n\nSENSE\n\nMODE\n\nOF\n\nD11\n\nD10\n\nD9\n\nCLK\n\nSHDN\n\nOE\n\nNC\n\nNC\n\nD0\n\nD1\n\nD2\n\n33\n\nTJMAX = 125°C, θJA = 34°C/W EXPOSED PAD (PIN 33) IS GND, MUST BE SOLDERED TO PCB\n\n## **ORDER INFORMATION**\n\n**LEAD FREE FINISH TAPE AND REEL PART MARKING\\* PACKAGE DESCRIPTION TEMPERATURE RANGE**\n\nLTC2228CUH LTC2228CUH 2228 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2228IUH LTC2228IUH 2228 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2227CUH LTC2227CUH 2227 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2227IUH LTC2227IUH 2227 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2226CUH LTC2226CUH 2226 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2226IUH LTC2226IUH 2226 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\n**LEAD BASED FINISH TAPE AND REEL PART MARKING\\* PACKAGE DESCRIPTION TEMPERATURE RANGE**\n\nLTC2228CUH LTC2228CUH 2228 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2228IUH LTC2228IUH 2228 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2227CUH LTC2227CUH 2227 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2227IUH LTC2227IUH 2227 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2226CUH LTC2226CUH 2226 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2226IUH LTC2226IUH 2226 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nConsult LTC Marketing for parts specifi ed with wider operating temperature ranges. \\*The temperature grade is identifi ed by a label on the shipping container.\n\nFor more information on lead free part marking, go to: http://www.linear.com/leadfree/ For more information on tape and reel specifi cations, go to: http://www.linear.com/tapeandreel/"],"full_content":"## LTC2228/LTC2227/LTC2226\n\n# 2\n\n222876fb\n\n## **PIN CONFIGURATION ABSOLUTE MAXIMUM RATINGS**\n\nSupply Voltage (VDD) ..................................................4V Digital Output Ground Voltage (OGND) ........ –0.3V to 1V Analog Input Voltage (Note 3) .......–0.3V to (VDD + 0.3V) Digital Input Voltage ......................–0.3V to (VDD + 0.3V) Digital Output Voltage ................ –0.3V to (OVDD + 0.3V) Power Dissipation .............................................1500mW Operating Temperature Range LTC2228C, LTC2227C, LTC2226C............. 0°C to 70°C LTC2228I, LTC2227I, LTC2226I ............ –40°C to 85°C Storage Temperature Range ................... –65°C to 125°C\n\n**OVDD = VDD (Notes 1, 2)**\n\n32 31 30 29 28 27 26 25\n\n9 10 11 12\n\nTOP VIEW\n\nUH PACKAGE 32-LEAD (5mm 5mm) PLASTIC QFN\n\n13 14 15 16\n\n17\n\n18\n\n19\n\n20\n\n21\n\n22\n\n23\n\n24\n\n8\n\n7\n\n6\n\n5\n\n4\n\n3\n\n2\n\n1 AIN \\+\n\nAIN –\n\nREFH\n\nREFH\n\nREFL\n\nREFL\n\nVDD\n\nGND\n\nD8\n\nD7\n\nD6\n\nOVDD\n\nOGND\n\nD5\n\nD4\n\nD3\n\nVDD\n\nVCM\n\nSENSE\n\nMODE\n\nOF\n\nD11\n\nD10\n\nD9\n\nCLK\n\nSHDN\n\nOE\n\nNC\n\nNC\n\nD0\n\nD1\n\nD2\n\n33\n\nTJMAX = 125°C, θJA = 34°C/W EXPOSED PAD (PIN 33) IS GND, MUST BE SOLDERED TO PCB\n\n## **ORDER INFORMATION**\n\n**LEAD FREE FINISH TAPE AND REEL PART MARKING\\* PACKAGE DESCRIPTION TEMPERATURE RANGE**\n\nLTC2228CUH LTC2228CUH 2228 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2228IUH LTC2228IUH 2228 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2227CUH LTC2227CUH 2227 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2227IUH LTC2227IUH 2227 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2226CUH LTC2226CUH 2226 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2226IUH LTC2226IUH 2226 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\n**LEAD BASED FINISH TAPE AND REEL PART MARKING\\* PACKAGE DESCRIPTION TEMPERATURE RANGE**\n\nLTC2228CUH LTC2228CUH 2228 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2228IUH LTC2228IUH 2228 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2227CUH LTC2227CUH 2227 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2227IUH LTC2227IUH 2227 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nLTC2226CUH LTC2226CUH 2226 32-Lead (5mm × 5mm) Plastic QFN 0°C to 70°C\n\nLTC2226IUH LTC2226IUH 2226 32-Lead (5mm × 5mm) Plastic QFN –40°C to 85°C\n\nConsult LTC Marketing for parts specifi ed with wider operating temperature ranges. \\*The temperature grade is identifi ed by a label on the shipping container.\n\nFor more information on lead free part marking, go to: http://www.linear.com/leadfree/ For more information on tape and reel specifi cations, go to: http://www.linear.com/tapeandreel/","publish_date":null,"title":"2","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page2.pdf"},"request":{"example_id":"table/222876fb_page2","product_type":"parse","source_file_path":"222876fb_page2.pdf"},"started_at":"2026-11-04T19:47:06.367209"} +{"completed_at":"2026-11-04T19:47:08.580474","latency_in_ms":1106,"output":{"example_id":"table/222876fb_page21","grounded_pages":[],"layout_pages":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 21\n\n222876fb\n\n## **APPLICATIONS INFORMATION**\n\n**Maximum and Minimum Conversion Rates**\n\nThe maximum conversion rate for the LTC2228/LTC2227/ LTC2226 is 65Msps (LTC2228), 40Msps (LTC2227), and 25Msps (LTC2226). For the ADC to operate properly, the CLK signal should have a 50% (±5%) duty cycle. Each half cycle must have at least 7.3ns (LTC2228), 11.8ns (LTC2227), and 18.9ns (LTC2226) for the ADC internal cir- cuitry to have enough settling time for proper operation.\n\nAn optional clock duty cycle stabilizer circuit can be used if the input clock has a non 50% duty cycle. This circuit uses the rising edge of the CLK pin to sample the analog input. The falling edge of CLK is ignored and the internal falling edge is generated by a phase-locked loop. The input clock duty cycle can vary from 40% to 60% and the clock duty cycle stabilizer will maintain a constant 50% internal duty cycle. If the clock is turned off for a long period of time, the duty cycle stabilizer circuit will require a hundred clock cycles for the PLL to lock onto the input clock. To use the clock duty cycle stabilizer, the MODE pin should be connected to 1/3VDD or 2/3VDD using external resistors.\n\nThe lower limit of the LTC2228/LTC2227/LTC2226 sample rate is determined by droop of the sample-and-hold circuits. The pipelined architecture of this ADC relies on storing analog signals on small-valued capacitors. Junction leak- age will discharge the capacitors. The specifi ed minimum operating frequency for the LTC2228/LTC2227/LTC2226 is 1Msps.\n\nLTC2228/27/26\n\n222876 F14\n\nOVDD\n\nVDD VDD\n\n0\\.1μF\n\n43Ω TYPICAL DATA OUTPUT\n\nOGND\n\nOVDD 0.5V TO 3.6V\n\nPREDRIVER LOGIC\n\nDATA FROM LATCH\n\nOE\n\n**Figure 14. Digital Output Buffer**\n\n**DIGITAL OUTPUTS**\n\nTable 1 shows the relationship between the analog input voltage, the digital data bits and the overfl ow bit.\n\n**Table 1. Output Codes vs Input Voltage**\n\n**AIN** **\\+** **– AIN** **–** **(2V RANGE) OF D11-D0 (OFFSET BINARY) D11-D0 (2’s COMPLEMENT)**\n\n>+1.000000V +0.999512V +0.999024V\n\n1 0 0\n\n1111 1111 1111 1111 1111 1111 1111 1111 1110\n\n0111 1111 1111 0111 1111 1111 0111 1111 1110\n\n\\+0.000488V 0.000000V –0.000488V –0.000976V\n\n0 0 0 0\n\n1000 0000 0001 1000 0000 0000 0111 1111 1111 0111 1111 1110\n\n0000 0000 0001 0000 0000 0000 1111 1111 1111 1111 1111 1110\n\n–0.999512V –1.000000V <–1.000000V\n\n0 0 1\n\n0000 0000 0001 0000 0000 0000 0000 0000 0000\n\n1000 0000 0001 1000 0000 0000 1000 0000 0000\n\n**Digital Output Buffers**\n\nFigure 14 shows an equivalent circuit for a single output buffer. Each buffer is powered by OVDD and OGND, isolated from the ADC power and ground. The additional\n\nN-channel transistor in the output driver allows operation down to low voltages. The internal resistor in series with the output makes the output appear as 50Ω to external circuitry and may eliminate the need for external damping resistors.\n\nAs with all high speed/high resolution converters, the digital output loading can affect the performance. The","pages":[{"line_numbers":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 21\n\n222876fb\n\n## **APPLICATIONS INFORMATION**\n\n**Maximum and Minimum Conversion Rates**\n\nThe maximum conversion rate for the LTC2228/LTC2227/ LTC2226 is 65Msps (LTC2228), 40Msps (LTC2227), and 25Msps (LTC2226). For the ADC to operate properly, the CLK signal should have a 50% (±5%) duty cycle. Each half cycle must have at least 7.3ns (LTC2228), 11.8ns (LTC2227), and 18.9ns (LTC2226) for the ADC internal cir- cuitry to have enough settling time for proper operation.\n\nAn optional clock duty cycle stabilizer circuit can be used if the input clock has a non 50% duty cycle. This circuit uses the rising edge of the CLK pin to sample the analog input. The falling edge of CLK is ignored and the internal falling edge is generated by a phase-locked loop. The input clock duty cycle can vary from 40% to 60% and the clock duty cycle stabilizer will maintain a constant 50% internal duty cycle. If the clock is turned off for a long period of time, the duty cycle stabilizer circuit will require a hundred clock cycles for the PLL to lock onto the input clock. To use the clock duty cycle stabilizer, the MODE pin should be connected to 1/3VDD or 2/3VDD using external resistors.\n\nThe lower limit of the LTC2228/LTC2227/LTC2226 sample rate is determined by droop of the sample-and-hold circuits. The pipelined architecture of this ADC relies on storing analog signals on small-valued capacitors. Junction leak- age will discharge the capacitors. The specifi ed minimum operating frequency for the LTC2228/LTC2227/LTC2226 is 1Msps.\n\nLTC2228/27/26\n\n222876 F14\n\nOVDD\n\nVDD VDD\n\n0\\.1μF\n\n43Ω TYPICAL DATA OUTPUT\n\nOGND\n\nOVDD 0.5V TO 3.6V\n\nPREDRIVER LOGIC\n\nDATA FROM LATCH\n\nOE\n\n**Figure 14. Digital Output Buffer**\n\n**DIGITAL OUTPUTS**\n\nTable 1 shows the relationship between the analog input voltage, the digital data bits and the overfl ow bit.\n\n**Table 1. Output Codes vs Input Voltage**\n\n**AIN** **\\+** **– AIN** **–** **(2V RANGE) OF D11-D0 (OFFSET BINARY) D11-D0 (2’s COMPLEMENT)**\n\n>+1.000000V +0.999512V +0.999024V\n\n1 0 0\n\n1111 1111 1111 1111 1111 1111 1111 1111 1110\n\n0111 1111 1111 0111 1111 1111 0111 1111 1110\n\n\\+0.000488V 0.000000V –0.000488V –0.000976V\n\n0 0 0 0\n\n1000 0000 0001 1000 0000 0000 0111 1111 1111 0111 1111 1110\n\n0000 0000 0001 0000 0000 0000 1111 1111 1111 1111 1111 1110\n\n–0.999512V –1.000000V <–1.000000V\n\n0 0 1\n\n0000 0000 0001 0000 0000 0000 0000 0000 0000\n\n1000 0000 0001 1000 0000 0000 1000 0000 0000\n\n**Digital Output Buffers**\n\nFigure 14 shows an equivalent circuit for a single output buffer. Each buffer is powered by OVDD and OGND, isolated from the ADC power and ground. The additional\n\nN-channel transistor in the output driver allows operation down to low voltages. The internal resistor in series with the output makes the output appear as 50Ω to external circuitry and may eliminate the need for external damping resistors.\n\nAs with all high speed/high resolution converters, the digital output loading can affect the performance. The","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 21\n\n222876fb\n\n## **APPLICATIONS INFORMATION**\n\n**Maximum and Minimum Conversion Rates**\n\nThe maximum conversion rate for the LTC2228/LTC2227/ LTC2226 is 65Msps (LTC2228), 40Msps (LTC2227), and 25Msps (LTC2226). For the ADC to operate properly, the CLK signal should have a 50% (±5%) duty cycle. Each half cycle must have at least 7.3ns (LTC2228), 11.8ns (LTC2227), and 18.9ns (LTC2226) for the ADC internal cir- cuitry to have enough settling time for proper operation.\n\nAn optional clock duty cycle stabilizer circuit can be used if the input clock has a non 50% duty cycle. This circuit uses the rising edge of the CLK pin to sample the analog input. The falling edge of CLK is ignored and the internal falling edge is generated by a phase-locked loop. The input clock duty cycle can vary from 40% to 60% and the clock duty cycle stabilizer will maintain a constant 50% internal duty cycle. If the clock is turned off for a long period of time, the duty cycle stabilizer circuit will require a hundred clock cycles for the PLL to lock onto the input clock. To use the clock duty cycle stabilizer, the MODE pin should be connected to 1/3VDD or 2/3VDD using external resistors.\n\nThe lower limit of the LTC2228/LTC2227/LTC2226 sample rate is determined by droop of the sample-and-hold circuits. The pipelined architecture of this ADC relies on storing analog signals on small-valued capacitors. Junction leak- age will discharge the capacitors. The specifi ed minimum operating frequency for the LTC2228/LTC2227/LTC2226 is 1Msps.\n\nLTC2228/27/26\n\n222876 F14\n\nOVDD\n\nVDD VDD\n\n0\\.1μF\n\n43Ω TYPICAL DATA OUTPUT\n\nOGND\n\nOVDD 0.5V TO 3.6V\n\nPREDRIVER LOGIC\n\nDATA FROM LATCH\n\nOE\n\n**Figure 14. Digital Output Buffer**\n\n**DIGITAL OUTPUTS**\n\nTable 1 shows the relationship between the analog input voltage, the digital data bits and the overfl ow bit.\n\n**Table 1. Output Codes vs Input Voltage**\n\n**AIN** **\\+** **– AIN** **–** **(2V RANGE) OF D11-D0 (OFFSET BINARY) D11-D0 (2’s COMPLEMENT)**\n\n>+1.000000V +0.999512V +0.999024V\n\n1 0 0\n\n1111 1111 1111 1111 1111 1111 1111 1111 1110\n\n0111 1111 1111 0111 1111 1111 0111 1111 1110\n\n\\+0.000488V 0.000000V –0.000488V –0.000976V\n\n0 0 0 0\n\n1000 0000 0001 1000 0000 0000 0111 1111 1111 0111 1111 1110\n\n0000 0000 0001 0000 0000 0000 1111 1111 1111 1111 1111 1110\n\n–0.999512V –1.000000V <–1.000000V\n\n0 0 1\n\n0000 0000 0001 0000 0000 0000 0000 0000 0000\n\n1000 0000 0001 1000 0000 0000 1000 0000 0000\n\n**Digital Output Buffers**\n\nFigure 14 shows an equivalent circuit for a single output buffer. Each buffer is powered by OVDD and OGND, isolated from the ADC power and ground. The additional\n\nN-channel transistor in the output driver allows operation down to low voltages. The internal resistor in series with the output makes the output appear as 50Ω to external circuitry and may eliminate the need for external damping resistors.\n\nAs with all high speed/high resolution converters, the digital output loading can affect the performance. The","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page21.pdf"]},"response":{"errors":[],"extract_id":"extract_7d89b5784c48105755ad7c02548504bd","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## LTC2228/LTC2227/LTC2226\n\n# 21\n\n222876fb\n\n## **APPLICATIONS INFORMATION**\n\n**Maximum and Minimum Conversion Rates**\n\nThe maximum conversion rate for the LTC2228/LTC2227/ LTC2226 is 65Msps (LTC2228), 40Msps (LTC2227), and 25Msps (LTC2226). For the ADC to operate properly, the CLK signal should have a 50% (±5%) duty cycle. Each half cycle must have at least 7.3ns (LTC2228), 11.8ns (LTC2227), and 18.9ns (LTC2226) for the ADC internal cir- cuitry to have enough settling time for proper operation.\n\nAn optional clock duty cycle stabilizer circuit can be used if the input clock has a non 50% duty cycle. This circuit uses the rising edge of the CLK pin to sample the analog input. The falling edge of CLK is ignored and the internal falling edge is generated by a phase-locked loop. The input clock duty cycle can vary from 40% to 60% and the clock duty cycle stabilizer will maintain a constant 50% internal duty cycle. If the clock is turned off for a long period of time, the duty cycle stabilizer circuit will require a hundred clock cycles for the PLL to lock onto the input clock. To use the clock duty cycle stabilizer, the MODE pin should be connected to 1/3VDD or 2/3VDD using external resistors.\n\nThe lower limit of the LTC2228/LTC2227/LTC2226 sample rate is determined by droop of the sample-and-hold circuits. The pipelined architecture of this ADC relies on storing analog signals on small-valued capacitors. Junction leak- age will discharge the capacitors. The specifi ed minimum operating frequency for the LTC2228/LTC2227/LTC2226 is 1Msps.\n\nLTC2228/27/26\n\n222876 F14\n\nOVDD\n\nVDD VDD\n\n0\\.1μF\n\n43Ω TYPICAL DATA OUTPUT\n\nOGND\n\nOVDD 0.5V TO 3.6V\n\nPREDRIVER LOGIC\n\nDATA FROM LATCH\n\nOE\n\n**Figure 14. Digital Output Buffer**\n\n**DIGITAL OUTPUTS**\n\nTable 1 shows the relationship between the analog input voltage, the digital data bits and the overfl ow bit.\n\n**Table 1. Output Codes vs Input Voltage**\n\n**AIN** **\\+** **– AIN** **–** **(2V RANGE) OF D11-D0 (OFFSET BINARY) D11-D0 (2’s COMPLEMENT)**\n\n>+1.000000V +0.999512V +0.999024V\n\n1 0 0\n\n1111 1111 1111 1111 1111 1111 1111 1111 1110\n\n0111 1111 1111 0111 1111 1111 0111 1111 1110\n\n\\+0.000488V 0.000000V –0.000488V –0.000976V\n\n0 0 0 0\n\n1000 0000 0001 1000 0000 0000 0111 1111 1111 0111 1111 1110\n\n0000 0000 0001 0000 0000 0000 1111 1111 1111 1111 1111 1110\n\n–0.999512V –1.000000V <–1.000000V\n\n0 0 1\n\n0000 0000 0001 0000 0000 0000 0000 0000 0000\n\n1000 0000 0001 1000 0000 0000 1000 0000 0000\n\n**Digital Output Buffers**\n\nFigure 14 shows an equivalent circuit for a single output buffer. Each buffer is powered by OVDD and OGND, isolated from the ADC power and ground. The additional\n\nN-channel transistor in the output driver allows operation down to low voltages. The internal resistor in series with the output makes the output appear as 50Ω to external circuitry and may eliminate the need for external damping resistors.\n\nAs with all high speed/high resolution converters, the digital output loading can affect the performance. The"],"full_content":"## LTC2228/LTC2227/LTC2226\n\n# 21\n\n222876fb\n\n## **APPLICATIONS INFORMATION**\n\n**Maximum and Minimum Conversion Rates**\n\nThe maximum conversion rate for the LTC2228/LTC2227/ LTC2226 is 65Msps (LTC2228), 40Msps (LTC2227), and 25Msps (LTC2226). For the ADC to operate properly, the CLK signal should have a 50% (±5%) duty cycle. Each half cycle must have at least 7.3ns (LTC2228), 11.8ns (LTC2227), and 18.9ns (LTC2226) for the ADC internal cir- cuitry to have enough settling time for proper operation.\n\nAn optional clock duty cycle stabilizer circuit can be used if the input clock has a non 50% duty cycle. This circuit uses the rising edge of the CLK pin to sample the analog input. The falling edge of CLK is ignored and the internal falling edge is generated by a phase-locked loop. The input clock duty cycle can vary from 40% to 60% and the clock duty cycle stabilizer will maintain a constant 50% internal duty cycle. If the clock is turned off for a long period of time, the duty cycle stabilizer circuit will require a hundred clock cycles for the PLL to lock onto the input clock. To use the clock duty cycle stabilizer, the MODE pin should be connected to 1/3VDD or 2/3VDD using external resistors.\n\nThe lower limit of the LTC2228/LTC2227/LTC2226 sample rate is determined by droop of the sample-and-hold circuits. The pipelined architecture of this ADC relies on storing analog signals on small-valued capacitors. Junction leak- age will discharge the capacitors. The specifi ed minimum operating frequency for the LTC2228/LTC2227/LTC2226 is 1Msps.\n\nLTC2228/27/26\n\n222876 F14\n\nOVDD\n\nVDD VDD\n\n0\\.1μF\n\n43Ω TYPICAL DATA OUTPUT\n\nOGND\n\nOVDD 0.5V TO 3.6V\n\nPREDRIVER LOGIC\n\nDATA FROM LATCH\n\nOE\n\n**Figure 14. Digital Output Buffer**\n\n**DIGITAL OUTPUTS**\n\nTable 1 shows the relationship between the analog input voltage, the digital data bits and the overfl ow bit.\n\n**Table 1. Output Codes vs Input Voltage**\n\n**AIN** **\\+** **– AIN** **–** **(2V RANGE) OF D11-D0 (OFFSET BINARY) D11-D0 (2’s COMPLEMENT)**\n\n>+1.000000V +0.999512V +0.999024V\n\n1 0 0\n\n1111 1111 1111 1111 1111 1111 1111 1111 1110\n\n0111 1111 1111 0111 1111 1111 0111 1111 1110\n\n\\+0.000488V 0.000000V –0.000488V –0.000976V\n\n0 0 0 0\n\n1000 0000 0001 1000 0000 0000 0111 1111 1111 0111 1111 1110\n\n0000 0000 0001 0000 0000 0000 1111 1111 1111 1111 1111 1110\n\n–0.999512V –1.000000V <–1.000000V\n\n0 0 1\n\n0000 0000 0001 0000 0000 0000 0000 0000 0000\n\n1000 0000 0001 1000 0000 0000 1000 0000 0000\n\n**Digital Output Buffers**\n\nFigure 14 shows an equivalent circuit for a single output buffer. Each buffer is powered by OVDD and OGND, isolated from the ADC power and ground. The additional\n\nN-channel transistor in the output driver allows operation down to low voltages. The internal resistor in series with the output makes the output appear as 50Ω to external circuitry and may eliminate the need for external damping resistors.\n\nAs with all high speed/high resolution converters, the digital output loading can affect the performance. The","publish_date":null,"title":"21","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page21.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page21.pdf"},"request":{"example_id":"table/222876fb_page21","product_type":"parse","source_file_path":"222876fb_page21.pdf"},"started_at":"2026-11-04T19:47:07.474397"} +{"completed_at":"2026-11-04T19:31:14.549818","latency_in_ms":1130,"output":{"example_id":"table/222876fb_page22","grounded_pages":[],"layout_pages":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 22\n\n222876fb\n\n## **APPLICATIONS INFORMATION**\n\ndigital outputs of the LTC2228/LTC2227/LTC2226 should drive a minimal capacitive load to avoid possible interaction between the digital outputs and sensitive input circuitry. The output should be buffered with a device such as an ALVCH16373 CMOS latch. For full speed operation the capacitive load should be kept under 10pF.\n\nLower OVDD voltages will also help reduce interference from the digital outputs.\n\n**Data Format**\n\nUsing the MODE pin, the LTC2228/LTC2227/LTC2226 parallel digital output can be selected for offset binary or 2’s complement format. Connecting MODE to GND or 1/3VDD selects offset binary output format. Connecting MODE to 2/3VDD or VDD selects 2’s complement output format. An external resistor divider can be used to set the 1/3VDD or 2/3VDD logic values. Table 2 shows the logic states for the MODE pin.\n\n**Table 2. MODE Pin Function**\n\n**MODE PIN OUTPUT FORMAT CLOCK DUTY CYCLE STABILIZER**\n\n0 Offset Binary Off\n\n1/3VDD Offset Binary On\n\n2/3VDD 2’s Complement On\n\nVDD 2’s Complement Off\n\n**Overfl ow Bit**\n\nWhen OF outputs a logic high the converter is either over- ranged or underranged.\n\n**Output Driver Power**\n\nSeparate output power and ground pins allow the output drivers to be isolated from the analog circuitry. The power supply for the digital output buffers, OVDD, should be tied to the same power supply as for the logic being driven. For example if the converter is driving a DSP powered by a 1.8V supply, then OVDD should be tied to that same 1.8V supply.\n\nOVDD can be powered with any voltage from 500mV up to 3.6V. OGND can be powered with any voltage from GND up to 1V and must be less than OVDD. The logic outputs will swing between OGND and OVDD.\n\n**Output Enable**\n\nThe outputs may be disabled with the output enable pin, OE. OE high disables all data outputs including OF. The data access and bus relinquish times are too slow to allow the outputs to be enabled and disabled during full speed operation. The output Hi-Z state is intended for use during long periods of inactivity.\n\n**Sleep and Nap Modes**\n\nThe converter may be placed in shutdown or nap modes to conserve power. Connecting SHDN to GND results in normal operation. Connecting SHDN to VDD and OE to VDD results in sleep mode, which powers down all circuitry including the reference and typically dissipates 1mW. When exiting sleep mode it will take milliseconds for the output data to become valid because the reference capacitors have to recharge and stabilize. Connecting SHDN to VDD and OE to GND results in nap mode, which typically dis- sipates 15mW. In nap mode, the on-chip reference circuit is kept on, so that recovery from nap mode is faster than that from sleep mode, typically taking 100 clock cycles. In both sleep and nap modes, all digital outputs are disabled and enter the Hi-Z state.\n\n**Grounding and Bypassing**\n\nThe LTC2228/LTC2227/LTC2226 require a printed circuit board with a clean, unbroken ground plane. A multilayer board with an internal ground plane is recommended. Layout for the printed circuit board should ensure that digital and analog signal lines are separated as much as possible. In particular, care should be taken not to run any digital track alongside an analog signal track or underneath the ADC.\n\nHigh quality ceramic bypass capacitors should be used at the VDD, OVDD, VCM, REFH, and REFL pins. Bypass capaci- tors must be located as close to the pins as possible. Of particular importance is the 0.1μF capacitor between REFH and REFL. This capacitor should be placed as close to the device as possible (1.5mm or less). A size 0402 ceramic capacitor is recommended. The large 2.2μF capacitor be- tween REFH and REFL can be somewhat further away. The traces connecting the pins and bypass capacitors must be kept short and should be made as wide as possible.","pages":[{"line_numbers":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 22\n\n222876fb\n\n## **APPLICATIONS INFORMATION**\n\ndigital outputs of the LTC2228/LTC2227/LTC2226 should drive a minimal capacitive load to avoid possible interaction between the digital outputs and sensitive input circuitry. The output should be buffered with a device such as an ALVCH16373 CMOS latch. For full speed operation the capacitive load should be kept under 10pF.\n\nLower OVDD voltages will also help reduce interference from the digital outputs.\n\n**Data Format**\n\nUsing the MODE pin, the LTC2228/LTC2227/LTC2226 parallel digital output can be selected for offset binary or 2’s complement format. Connecting MODE to GND or 1/3VDD selects offset binary output format. Connecting MODE to 2/3VDD or VDD selects 2’s complement output format. An external resistor divider can be used to set the 1/3VDD or 2/3VDD logic values. Table 2 shows the logic states for the MODE pin.\n\n**Table 2. MODE Pin Function**\n\n**MODE PIN OUTPUT FORMAT CLOCK DUTY CYCLE STABILIZER**\n\n0 Offset Binary Off\n\n1/3VDD Offset Binary On\n\n2/3VDD 2’s Complement On\n\nVDD 2’s Complement Off\n\n**Overfl ow Bit**\n\nWhen OF outputs a logic high the converter is either over- ranged or underranged.\n\n**Output Driver Power**\n\nSeparate output power and ground pins allow the output drivers to be isolated from the analog circuitry. The power supply for the digital output buffers, OVDD, should be tied to the same power supply as for the logic being driven. For example if the converter is driving a DSP powered by a 1.8V supply, then OVDD should be tied to that same 1.8V supply.\n\nOVDD can be powered with any voltage from 500mV up to 3.6V. OGND can be powered with any voltage from GND up to 1V and must be less than OVDD. The logic outputs will swing between OGND and OVDD.\n\n**Output Enable**\n\nThe outputs may be disabled with the output enable pin, OE. OE high disables all data outputs including OF. The data access and bus relinquish times are too slow to allow the outputs to be enabled and disabled during full speed operation. The output Hi-Z state is intended for use during long periods of inactivity.\n\n**Sleep and Nap Modes**\n\nThe converter may be placed in shutdown or nap modes to conserve power. Connecting SHDN to GND results in normal operation. Connecting SHDN to VDD and OE to VDD results in sleep mode, which powers down all circuitry including the reference and typically dissipates 1mW. When exiting sleep mode it will take milliseconds for the output data to become valid because the reference capacitors have to recharge and stabilize. Connecting SHDN to VDD and OE to GND results in nap mode, which typically dis- sipates 15mW. In nap mode, the on-chip reference circuit is kept on, so that recovery from nap mode is faster than that from sleep mode, typically taking 100 clock cycles. In both sleep and nap modes, all digital outputs are disabled and enter the Hi-Z state.\n\n**Grounding and Bypassing**\n\nThe LTC2228/LTC2227/LTC2226 require a printed circuit board with a clean, unbroken ground plane. A multilayer board with an internal ground plane is recommended. Layout for the printed circuit board should ensure that digital and analog signal lines are separated as much as possible. In particular, care should be taken not to run any digital track alongside an analog signal track or underneath the ADC.\n\nHigh quality ceramic bypass capacitors should be used at the VDD, OVDD, VCM, REFH, and REFL pins. Bypass capaci- tors must be located as close to the pins as possible. Of particular importance is the 0.1μF capacitor between REFH and REFL. This capacitor should be placed as close to the device as possible (1.5mm or less). A size 0402 ceramic capacitor is recommended. The large 2.2μF capacitor be- tween REFH and REFL can be somewhat further away. The traces connecting the pins and bypass capacitors must be kept short and should be made as wide as possible.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 22\n\n222876fb\n\n## **APPLICATIONS INFORMATION**\n\ndigital outputs of the LTC2228/LTC2227/LTC2226 should drive a minimal capacitive load to avoid possible interaction between the digital outputs and sensitive input circuitry. The output should be buffered with a device such as an ALVCH16373 CMOS latch. For full speed operation the capacitive load should be kept under 10pF.\n\nLower OVDD voltages will also help reduce interference from the digital outputs.\n\n**Data Format**\n\nUsing the MODE pin, the LTC2228/LTC2227/LTC2226 parallel digital output can be selected for offset binary or 2’s complement format. Connecting MODE to GND or 1/3VDD selects offset binary output format. Connecting MODE to 2/3VDD or VDD selects 2’s complement output format. An external resistor divider can be used to set the 1/3VDD or 2/3VDD logic values. Table 2 shows the logic states for the MODE pin.\n\n**Table 2. MODE Pin Function**\n\n**MODE PIN OUTPUT FORMAT CLOCK DUTY CYCLE STABILIZER**\n\n0 Offset Binary Off\n\n1/3VDD Offset Binary On\n\n2/3VDD 2’s Complement On\n\nVDD 2’s Complement Off\n\n**Overfl ow Bit**\n\nWhen OF outputs a logic high the converter is either over- ranged or underranged.\n\n**Output Driver Power**\n\nSeparate output power and ground pins allow the output drivers to be isolated from the analog circuitry. The power supply for the digital output buffers, OVDD, should be tied to the same power supply as for the logic being driven. For example if the converter is driving a DSP powered by a 1.8V supply, then OVDD should be tied to that same 1.8V supply.\n\nOVDD can be powered with any voltage from 500mV up to 3.6V. OGND can be powered with any voltage from GND up to 1V and must be less than OVDD. The logic outputs will swing between OGND and OVDD.\n\n**Output Enable**\n\nThe outputs may be disabled with the output enable pin, OE. OE high disables all data outputs including OF. The data access and bus relinquish times are too slow to allow the outputs to be enabled and disabled during full speed operation. The output Hi-Z state is intended for use during long periods of inactivity.\n\n**Sleep and Nap Modes**\n\nThe converter may be placed in shutdown or nap modes to conserve power. Connecting SHDN to GND results in normal operation. Connecting SHDN to VDD and OE to VDD results in sleep mode, which powers down all circuitry including the reference and typically dissipates 1mW. When exiting sleep mode it will take milliseconds for the output data to become valid because the reference capacitors have to recharge and stabilize. Connecting SHDN to VDD and OE to GND results in nap mode, which typically dis- sipates 15mW. In nap mode, the on-chip reference circuit is kept on, so that recovery from nap mode is faster than that from sleep mode, typically taking 100 clock cycles. In both sleep and nap modes, all digital outputs are disabled and enter the Hi-Z state.\n\n**Grounding and Bypassing**\n\nThe LTC2228/LTC2227/LTC2226 require a printed circuit board with a clean, unbroken ground plane. A multilayer board with an internal ground plane is recommended. Layout for the printed circuit board should ensure that digital and analog signal lines are separated as much as possible. In particular, care should be taken not to run any digital track alongside an analog signal track or underneath the ADC.\n\nHigh quality ceramic bypass capacitors should be used at the VDD, OVDD, VCM, REFH, and REFL pins. Bypass capaci- tors must be located as close to the pins as possible. Of particular importance is the 0.1μF capacitor between REFH and REFL. This capacitor should be placed as close to the device as possible (1.5mm or less). A size 0402 ceramic capacitor is recommended. The large 2.2μF capacitor be- tween REFH and REFL can be somewhat further away. The traces connecting the pins and bypass capacitors must be kept short and should be made as wide as possible.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page22.pdf"]},"response":{"errors":[],"extract_id":"extract_ae1488249b7ce6328362820341270958","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## LTC2228/LTC2227/LTC2226\n\n# 22\n\n222876fb\n\n## **APPLICATIONS INFORMATION**\n\ndigital outputs of the LTC2228/LTC2227/LTC2226 should drive a minimal capacitive load to avoid possible interaction between the digital outputs and sensitive input circuitry. The output should be buffered with a device such as an ALVCH16373 CMOS latch. For full speed operation the capacitive load should be kept under 10pF.\n\nLower OVDD voltages will also help reduce interference from the digital outputs.\n\n**Data Format**\n\nUsing the MODE pin, the LTC2228/LTC2227/LTC2226 parallel digital output can be selected for offset binary or 2’s complement format. Connecting MODE to GND or 1/3VDD selects offset binary output format. Connecting MODE to 2/3VDD or VDD selects 2’s complement output format. An external resistor divider can be used to set the 1/3VDD or 2/3VDD logic values. Table 2 shows the logic states for the MODE pin.\n\n**Table 2. MODE Pin Function**\n\n**MODE PIN OUTPUT FORMAT CLOCK DUTY CYCLE STABILIZER**\n\n0 Offset Binary Off\n\n1/3VDD Offset Binary On\n\n2/3VDD 2’s Complement On\n\nVDD 2’s Complement Off\n\n**Overfl ow Bit**\n\nWhen OF outputs a logic high the converter is either over- ranged or underranged.\n\n**Output Driver Power**\n\nSeparate output power and ground pins allow the output drivers to be isolated from the analog circuitry. The power supply for the digital output buffers, OVDD, should be tied to the same power supply as for the logic being driven. For example if the converter is driving a DSP powered by a 1.8V supply, then OVDD should be tied to that same 1.8V supply.\n\nOVDD can be powered with any voltage from 500mV up to 3.6V. OGND can be powered with any voltage from GND up to 1V and must be less than OVDD. The logic outputs will swing between OGND and OVDD.\n\n**Output Enable**\n\nThe outputs may be disabled with the output enable pin, OE. OE high disables all data outputs including OF. The data access and bus relinquish times are too slow to allow the outputs to be enabled and disabled during full speed operation. The output Hi-Z state is intended for use during long periods of inactivity.\n\n**Sleep and Nap Modes**\n\nThe converter may be placed in shutdown or nap modes to conserve power. Connecting SHDN to GND results in normal operation. Connecting SHDN to VDD and OE to VDD results in sleep mode, which powers down all circuitry including the reference and typically dissipates 1mW. When exiting sleep mode it will take milliseconds for the output data to become valid because the reference capacitors have to recharge and stabilize. Connecting SHDN to VDD and OE to GND results in nap mode, which typically dis- sipates 15mW. In nap mode, the on-chip reference circuit is kept on, so that recovery from nap mode is faster than that from sleep mode, typically taking 100 clock cycles. In both sleep and nap modes, all digital outputs are disabled and enter the Hi-Z state.\n\n**Grounding and Bypassing**\n\nThe LTC2228/LTC2227/LTC2226 require a printed circuit board with a clean, unbroken ground plane. A multilayer board with an internal ground plane is recommended. Layout for the printed circuit board should ensure that digital and analog signal lines are separated as much as possible. In particular, care should be taken not to run any digital track alongside an analog signal track or underneath the ADC.\n\nHigh quality ceramic bypass capacitors should be used at the VDD, OVDD, VCM, REFH, and REFL pins. Bypass capaci- tors must be located as close to the pins as possible. Of particular importance is the 0.1μF capacitor between REFH and REFL. This capacitor should be placed as close to the device as possible (1.5mm or less). A size 0402 ceramic capacitor is recommended. The large 2.2μF capacitor be- tween REFH and REFL can be somewhat further away. The traces connecting the pins and bypass capacitors must be kept short and should be made as wide as possible."],"full_content":"## LTC2228/LTC2227/LTC2226\n\n# 22\n\n222876fb\n\n## **APPLICATIONS INFORMATION**\n\ndigital outputs of the LTC2228/LTC2227/LTC2226 should drive a minimal capacitive load to avoid possible interaction between the digital outputs and sensitive input circuitry. The output should be buffered with a device such as an ALVCH16373 CMOS latch. For full speed operation the capacitive load should be kept under 10pF.\n\nLower OVDD voltages will also help reduce interference from the digital outputs.\n\n**Data Format**\n\nUsing the MODE pin, the LTC2228/LTC2227/LTC2226 parallel digital output can be selected for offset binary or 2’s complement format. Connecting MODE to GND or 1/3VDD selects offset binary output format. Connecting MODE to 2/3VDD or VDD selects 2’s complement output format. An external resistor divider can be used to set the 1/3VDD or 2/3VDD logic values. Table 2 shows the logic states for the MODE pin.\n\n**Table 2. MODE Pin Function**\n\n**MODE PIN OUTPUT FORMAT CLOCK DUTY CYCLE STABILIZER**\n\n0 Offset Binary Off\n\n1/3VDD Offset Binary On\n\n2/3VDD 2’s Complement On\n\nVDD 2’s Complement Off\n\n**Overfl ow Bit**\n\nWhen OF outputs a logic high the converter is either over- ranged or underranged.\n\n**Output Driver Power**\n\nSeparate output power and ground pins allow the output drivers to be isolated from the analog circuitry. The power supply for the digital output buffers, OVDD, should be tied to the same power supply as for the logic being driven. For example if the converter is driving a DSP powered by a 1.8V supply, then OVDD should be tied to that same 1.8V supply.\n\nOVDD can be powered with any voltage from 500mV up to 3.6V. OGND can be powered with any voltage from GND up to 1V and must be less than OVDD. The logic outputs will swing between OGND and OVDD.\n\n**Output Enable**\n\nThe outputs may be disabled with the output enable pin, OE. OE high disables all data outputs including OF. The data access and bus relinquish times are too slow to allow the outputs to be enabled and disabled during full speed operation. The output Hi-Z state is intended for use during long periods of inactivity.\n\n**Sleep and Nap Modes**\n\nThe converter may be placed in shutdown or nap modes to conserve power. Connecting SHDN to GND results in normal operation. Connecting SHDN to VDD and OE to VDD results in sleep mode, which powers down all circuitry including the reference and typically dissipates 1mW. When exiting sleep mode it will take milliseconds for the output data to become valid because the reference capacitors have to recharge and stabilize. Connecting SHDN to VDD and OE to GND results in nap mode, which typically dis- sipates 15mW. In nap mode, the on-chip reference circuit is kept on, so that recovery from nap mode is faster than that from sleep mode, typically taking 100 clock cycles. In both sleep and nap modes, all digital outputs are disabled and enter the Hi-Z state.\n\n**Grounding and Bypassing**\n\nThe LTC2228/LTC2227/LTC2226 require a printed circuit board with a clean, unbroken ground plane. A multilayer board with an internal ground plane is recommended. Layout for the printed circuit board should ensure that digital and analog signal lines are separated as much as possible. In particular, care should be taken not to run any digital track alongside an analog signal track or underneath the ADC.\n\nHigh quality ceramic bypass capacitors should be used at the VDD, OVDD, VCM, REFH, and REFL pins. Bypass capaci- tors must be located as close to the pins as possible. Of particular importance is the 0.1μF capacitor between REFH and REFL. This capacitor should be placed as close to the device as possible (1.5mm or less). A size 0402 ceramic capacitor is recommended. The large 2.2μF capacitor be- tween REFH and REFL can be somewhat further away. The traces connecting the pins and bypass capacitors must be kept short and should be made as wide as possible.","publish_date":null,"title":"22","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page22.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page22.pdf"},"request":{"example_id":"table/222876fb_page22","product_type":"parse","source_file_path":"222876fb_page22.pdf"},"started_at":"2026-11-04T19:31:13.419563"} +{"completed_at":"2026-11-04T19:47:12.211713","latency_in_ms":2849,"output":{"example_id":"table/222876fb_page28","grounded_pages":[],"layout_pages":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 28\n\n222876fb\n\n### Linear Technology Corporation\n\n1630 McCarthy Blvd., Milpitas, CA 95035-7417 (408) 432-1900 ● FAX: (408) 434-0507 ● www.linear.com © LINEAR TECHNOLOGY CORPORATION 2004\n\nLT 0608 REV B • PRINTED IN USA\n\n## **RELATED PARTS**\n\n**PART NUMBER DESCRIPTION COMMENTS**\n\nLTC1748 14-Bit, 80Msps, 5V ADC 76.3dB SNR, 90dB SFDR, 48-Pin TSSOP Package\n\nLTC1750 14-Bit, 80Msps, 5V Wideband ADC Up to 500MHz IF Undersampling, 90dB SFDR\n\nLT1993-2 High Speed Differential Op Amp 800MHz BW, 70dBc Distortion at 70MHz, 6dB Gain\n\nLT1994 Low Noise, Low Distortion Fully Differential Input/Output Amplifi er/Driver Low Distortion: –94dBc at 1MHz\n\nLTC2202 16-Bit, 10Msps, 3V ADC, Lowest Power 150mW, 81.6dB SNR, 100dB SFDR, 48-Pin QFN\n\nLTC2208 16-Bit, 130Msps, 3V ADC, LVDS Outputs 1250mW, 78dB SNR, 100dB SFDR, 64-Pin QFN\n\nLTC2220-1 12-Bit, 185Msps, 3V ADC, LVDS Outputs 910mW, 67.7dB SNR, 80dB SFDR, 64-Pin QFN\n\nLTC2224 12-Bit, 135Msps, 3V ADC, High IF Sampling 630mW, 67.6dB SNR, 84dB SFDR, 48-Pin QFN\n\nLTC2225 12-Bit, 10Msps, 3V ADC, Lowest Power 60mW, 71.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2226 12-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 71.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2227 12-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 71.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2228 12-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 71.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2229 12-Bit, 80Msps, 3V ADC, Lowest Power 211mW, 70.6dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2236 10-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2237 10-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2238 10-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2239 10-Bit, 80Msps, 3V ADC, Lowest Power 211mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2245 14-Bit, 10Msps, 3V ADC, Lowest Power 60mW, 74.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2246 14-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 74.5dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2247 14-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 74.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2248 14-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 74.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2249 14-Bit, 80Msps, 3V ADC, Lowest Power 222mW, 73dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2250 10-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2251 10-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2252 12-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 70.2dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2253 12-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 70.2dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2254 14-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 72.4dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2255 14-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 72.5dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2284 14-Bit, Dual, 105Msps, 3V ADC, Low Crosstalk 540mW, 72.4dB SNR, 88dB SFDR, 64-Pin QFN\n\nLT5512 DC-3GHz High Signal Level Downconverting Mixer DC to 3GHz, 21dBm IIP3, Integrated LO Buffer\n\nLT5514 Ultralow Distortion IF Amplifi er/ADC Driver with Digitally Controlled Gain 450MHz to 1dB BW, 47dB OIP3, Digital Gain Control 10.5dB to 33dB in 1.5dB/Step\n\nLT5515 1.5GHz to 2.5GHz Direct Conversion High IIP3: 20dBm at 1.9GHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5516 800MHz to 1.5GHz Direct Conversion High IIP3: 21.5dBm at 900MHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5517 40MHz to 900MHz Direct Conversion High IIP3: 21dBm at 800MHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5522 600MHz to 2.7GHz High Linearity Downconverting Mixer 4.5V to 5.25V Supply, 25dBm IIP3 at 900MHz. NF = 12.5dB, 50W Single-Ended RF and LO Ports","pages":[{"line_numbers":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 28\n\n222876fb\n\n### Linear Technology Corporation\n\n1630 McCarthy Blvd., Milpitas, CA 95035-7417 (408) 432-1900 ● FAX: (408) 434-0507 ● www.linear.com © LINEAR TECHNOLOGY CORPORATION 2004\n\nLT 0608 REV B • PRINTED IN USA\n\n## **RELATED PARTS**\n\n**PART NUMBER DESCRIPTION COMMENTS**\n\nLTC1748 14-Bit, 80Msps, 5V ADC 76.3dB SNR, 90dB SFDR, 48-Pin TSSOP Package\n\nLTC1750 14-Bit, 80Msps, 5V Wideband ADC Up to 500MHz IF Undersampling, 90dB SFDR\n\nLT1993-2 High Speed Differential Op Amp 800MHz BW, 70dBc Distortion at 70MHz, 6dB Gain\n\nLT1994 Low Noise, Low Distortion Fully Differential Input/Output Amplifi er/Driver Low Distortion: –94dBc at 1MHz\n\nLTC2202 16-Bit, 10Msps, 3V ADC, Lowest Power 150mW, 81.6dB SNR, 100dB SFDR, 48-Pin QFN\n\nLTC2208 16-Bit, 130Msps, 3V ADC, LVDS Outputs 1250mW, 78dB SNR, 100dB SFDR, 64-Pin QFN\n\nLTC2220-1 12-Bit, 185Msps, 3V ADC, LVDS Outputs 910mW, 67.7dB SNR, 80dB SFDR, 64-Pin QFN\n\nLTC2224 12-Bit, 135Msps, 3V ADC, High IF Sampling 630mW, 67.6dB SNR, 84dB SFDR, 48-Pin QFN\n\nLTC2225 12-Bit, 10Msps, 3V ADC, Lowest Power 60mW, 71.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2226 12-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 71.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2227 12-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 71.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2228 12-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 71.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2229 12-Bit, 80Msps, 3V ADC, Lowest Power 211mW, 70.6dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2236 10-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2237 10-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2238 10-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2239 10-Bit, 80Msps, 3V ADC, Lowest Power 211mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2245 14-Bit, 10Msps, 3V ADC, Lowest Power 60mW, 74.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2246 14-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 74.5dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2247 14-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 74.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2248 14-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 74.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2249 14-Bit, 80Msps, 3V ADC, Lowest Power 222mW, 73dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2250 10-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2251 10-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2252 12-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 70.2dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2253 12-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 70.2dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2254 14-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 72.4dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2255 14-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 72.5dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2284 14-Bit, Dual, 105Msps, 3V ADC, Low Crosstalk 540mW, 72.4dB SNR, 88dB SFDR, 64-Pin QFN\n\nLT5512 DC-3GHz High Signal Level Downconverting Mixer DC to 3GHz, 21dBm IIP3, Integrated LO Buffer\n\nLT5514 Ultralow Distortion IF Amplifi er/ADC Driver with Digitally Controlled Gain 450MHz to 1dB BW, 47dB OIP3, Digital Gain Control 10.5dB to 33dB in 1.5dB/Step\n\nLT5515 1.5GHz to 2.5GHz Direct Conversion High IIP3: 20dBm at 1.9GHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5516 800MHz to 1.5GHz Direct Conversion High IIP3: 21.5dBm at 900MHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5517 40MHz to 900MHz Direct Conversion High IIP3: 21dBm at 800MHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5522 600MHz to 2.7GHz High Linearity Downconverting Mixer 4.5V to 5.25V Supply, 25dBm IIP3 at 900MHz. NF = 12.5dB, 50W Single-Ended RF and LO Ports","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 28\n\n222876fb\n\n### Linear Technology Corporation\n\n1630 McCarthy Blvd., Milpitas, CA 95035-7417 (408) 432-1900 ● FAX: (408) 434-0507 ● www.linear.com © LINEAR TECHNOLOGY CORPORATION 2004\n\nLT 0608 REV B • PRINTED IN USA\n\n## **RELATED PARTS**\n\n**PART NUMBER DESCRIPTION COMMENTS**\n\nLTC1748 14-Bit, 80Msps, 5V ADC 76.3dB SNR, 90dB SFDR, 48-Pin TSSOP Package\n\nLTC1750 14-Bit, 80Msps, 5V Wideband ADC Up to 500MHz IF Undersampling, 90dB SFDR\n\nLT1993-2 High Speed Differential Op Amp 800MHz BW, 70dBc Distortion at 70MHz, 6dB Gain\n\nLT1994 Low Noise, Low Distortion Fully Differential Input/Output Amplifi er/Driver Low Distortion: –94dBc at 1MHz\n\nLTC2202 16-Bit, 10Msps, 3V ADC, Lowest Power 150mW, 81.6dB SNR, 100dB SFDR, 48-Pin QFN\n\nLTC2208 16-Bit, 130Msps, 3V ADC, LVDS Outputs 1250mW, 78dB SNR, 100dB SFDR, 64-Pin QFN\n\nLTC2220-1 12-Bit, 185Msps, 3V ADC, LVDS Outputs 910mW, 67.7dB SNR, 80dB SFDR, 64-Pin QFN\n\nLTC2224 12-Bit, 135Msps, 3V ADC, High IF Sampling 630mW, 67.6dB SNR, 84dB SFDR, 48-Pin QFN\n\nLTC2225 12-Bit, 10Msps, 3V ADC, Lowest Power 60mW, 71.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2226 12-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 71.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2227 12-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 71.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2228 12-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 71.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2229 12-Bit, 80Msps, 3V ADC, Lowest Power 211mW, 70.6dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2236 10-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2237 10-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2238 10-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2239 10-Bit, 80Msps, 3V ADC, Lowest Power 211mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2245 14-Bit, 10Msps, 3V ADC, Lowest Power 60mW, 74.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2246 14-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 74.5dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2247 14-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 74.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2248 14-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 74.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2249 14-Bit, 80Msps, 3V ADC, Lowest Power 222mW, 73dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2250 10-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2251 10-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2252 12-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 70.2dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2253 12-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 70.2dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2254 14-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 72.4dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2255 14-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 72.5dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2284 14-Bit, Dual, 105Msps, 3V ADC, Low Crosstalk 540mW, 72.4dB SNR, 88dB SFDR, 64-Pin QFN\n\nLT5512 DC-3GHz High Signal Level Downconverting Mixer DC to 3GHz, 21dBm IIP3, Integrated LO Buffer\n\nLT5514 Ultralow Distortion IF Amplifi er/ADC Driver with Digitally Controlled Gain 450MHz to 1dB BW, 47dB OIP3, Digital Gain Control 10.5dB to 33dB in 1.5dB/Step\n\nLT5515 1.5GHz to 2.5GHz Direct Conversion High IIP3: 20dBm at 1.9GHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5516 800MHz to 1.5GHz Direct Conversion High IIP3: 21.5dBm at 900MHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5517 40MHz to 900MHz Direct Conversion High IIP3: 21dBm at 800MHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5522 600MHz to 2.7GHz High Linearity Downconverting Mixer 4.5V to 5.25V Supply, 25dBm IIP3 at 900MHz. NF = 12.5dB, 50W Single-Ended RF and LO Ports","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page28.pdf"]},"response":{"errors":[],"extract_id":"extract_d73b9f69bdcb0be6e8137268da464206","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## LTC2228/LTC2227/LTC2226\n\n# 28\n\n222876fb\n\n### Linear Technology Corporation\n\n1630 McCarthy Blvd., Milpitas, CA 95035-7417 (408) 432-1900 ● FAX: (408) 434-0507 ● www.linear.com © LINEAR TECHNOLOGY CORPORATION 2004\n\nLT 0608 REV B • PRINTED IN USA\n\n## **RELATED PARTS**\n\n**PART NUMBER DESCRIPTION COMMENTS**\n\nLTC1748 14-Bit, 80Msps, 5V ADC 76.3dB SNR, 90dB SFDR, 48-Pin TSSOP Package\n\nLTC1750 14-Bit, 80Msps, 5V Wideband ADC Up to 500MHz IF Undersampling, 90dB SFDR\n\nLT1993-2 High Speed Differential Op Amp 800MHz BW, 70dBc Distortion at 70MHz, 6dB Gain\n\nLT1994 Low Noise, Low Distortion Fully Differential Input/Output Amplifi er/Driver Low Distortion: –94dBc at 1MHz\n\nLTC2202 16-Bit, 10Msps, 3V ADC, Lowest Power 150mW, 81.6dB SNR, 100dB SFDR, 48-Pin QFN\n\nLTC2208 16-Bit, 130Msps, 3V ADC, LVDS Outputs 1250mW, 78dB SNR, 100dB SFDR, 64-Pin QFN\n\nLTC2220-1 12-Bit, 185Msps, 3V ADC, LVDS Outputs 910mW, 67.7dB SNR, 80dB SFDR, 64-Pin QFN\n\nLTC2224 12-Bit, 135Msps, 3V ADC, High IF Sampling 630mW, 67.6dB SNR, 84dB SFDR, 48-Pin QFN\n\nLTC2225 12-Bit, 10Msps, 3V ADC, Lowest Power 60mW, 71.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2226 12-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 71.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2227 12-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 71.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2228 12-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 71.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2229 12-Bit, 80Msps, 3V ADC, Lowest Power 211mW, 70.6dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2236 10-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2237 10-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2238 10-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2239 10-Bit, 80Msps, 3V ADC, Lowest Power 211mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2245 14-Bit, 10Msps, 3V ADC, Lowest Power 60mW, 74.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2246 14-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 74.5dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2247 14-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 74.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2248 14-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 74.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2249 14-Bit, 80Msps, 3V ADC, Lowest Power 222mW, 73dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2250 10-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2251 10-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2252 12-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 70.2dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2253 12-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 70.2dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2254 14-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 72.4dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2255 14-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 72.5dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2284 14-Bit, Dual, 105Msps, 3V ADC, Low Crosstalk 540mW, 72.4dB SNR, 88dB SFDR, 64-Pin QFN\n\nLT5512 DC-3GHz High Signal Level Downconverting Mixer DC to 3GHz, 21dBm IIP3, Integrated LO Buffer\n\nLT5514 Ultralow Distortion IF Amplifi er/ADC Driver with Digitally Controlled Gain 450MHz to 1dB BW, 47dB OIP3, Digital Gain Control 10.5dB to 33dB in 1.5dB/Step\n\nLT5515 1.5GHz to 2.5GHz Direct Conversion High IIP3: 20dBm at 1.9GHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5516 800MHz to 1.5GHz Direct Conversion High IIP3: 21.5dBm at 900MHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5517 40MHz to 900MHz Direct Conversion High IIP3: 21dBm at 800MHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5522 600MHz to 2.7GHz High Linearity Downconverting Mixer 4.5V to 5.25V Supply, 25dBm IIP3 at 900MHz. NF = 12.5dB, 50W Single-Ended RF and LO Ports"],"full_content":"## LTC2228/LTC2227/LTC2226\n\n# 28\n\n222876fb\n\n### Linear Technology Corporation\n\n1630 McCarthy Blvd., Milpitas, CA 95035-7417 (408) 432-1900 ● FAX: (408) 434-0507 ● www.linear.com © LINEAR TECHNOLOGY CORPORATION 2004\n\nLT 0608 REV B • PRINTED IN USA\n\n## **RELATED PARTS**\n\n**PART NUMBER DESCRIPTION COMMENTS**\n\nLTC1748 14-Bit, 80Msps, 5V ADC 76.3dB SNR, 90dB SFDR, 48-Pin TSSOP Package\n\nLTC1750 14-Bit, 80Msps, 5V Wideband ADC Up to 500MHz IF Undersampling, 90dB SFDR\n\nLT1993-2 High Speed Differential Op Amp 800MHz BW, 70dBc Distortion at 70MHz, 6dB Gain\n\nLT1994 Low Noise, Low Distortion Fully Differential Input/Output Amplifi er/Driver Low Distortion: –94dBc at 1MHz\n\nLTC2202 16-Bit, 10Msps, 3V ADC, Lowest Power 150mW, 81.6dB SNR, 100dB SFDR, 48-Pin QFN\n\nLTC2208 16-Bit, 130Msps, 3V ADC, LVDS Outputs 1250mW, 78dB SNR, 100dB SFDR, 64-Pin QFN\n\nLTC2220-1 12-Bit, 185Msps, 3V ADC, LVDS Outputs 910mW, 67.7dB SNR, 80dB SFDR, 64-Pin QFN\n\nLTC2224 12-Bit, 135Msps, 3V ADC, High IF Sampling 630mW, 67.6dB SNR, 84dB SFDR, 48-Pin QFN\n\nLTC2225 12-Bit, 10Msps, 3V ADC, Lowest Power 60mW, 71.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2226 12-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 71.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2227 12-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 71.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2228 12-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 71.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2229 12-Bit, 80Msps, 3V ADC, Lowest Power 211mW, 70.6dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2236 10-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2237 10-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2238 10-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 61.8dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2239 10-Bit, 80Msps, 3V ADC, Lowest Power 211mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2245 14-Bit, 10Msps, 3V ADC, Lowest Power 60mW, 74.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2246 14-Bit, 25Msps, 3V ADC, Lowest Power 75mW, 74.5dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2247 14-Bit, 40Msps, 3V ADC, Lowest Power 120mW, 74.4dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2248 14-Bit, 65Msps, 3V ADC, Lowest Power 205mW, 74.3dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2249 14-Bit, 80Msps, 3V ADC, Lowest Power 222mW, 73dB SNR, 90dB SFDR, 32-Pin QFN\n\nLTC2250 10-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2251 10-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 61.6dB SNR, 85dB SFDR, 32-Pin QFN\n\nLTC2252 12-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 70.2dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2253 12-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 70.2dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2254 14-Bit, 105Msps, 3V ADC, Lowest Power 320mW, 72.4dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2255 14-Bit, 125Msps, 3V ADC, Lowest Power 395mW, 72.5dB SNR, 88dB SFDR, 32-Pin QFN\n\nLTC2284 14-Bit, Dual, 105Msps, 3V ADC, Low Crosstalk 540mW, 72.4dB SNR, 88dB SFDR, 64-Pin QFN\n\nLT5512 DC-3GHz High Signal Level Downconverting Mixer DC to 3GHz, 21dBm IIP3, Integrated LO Buffer\n\nLT5514 Ultralow Distortion IF Amplifi er/ADC Driver with Digitally Controlled Gain 450MHz to 1dB BW, 47dB OIP3, Digital Gain Control 10.5dB to 33dB in 1.5dB/Step\n\nLT5515 1.5GHz to 2.5GHz Direct Conversion High IIP3: 20dBm at 1.9GHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5516 800MHz to 1.5GHz Direct Conversion High IIP3: 21.5dBm at 900MHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5517 40MHz to 900MHz Direct Conversion High IIP3: 21dBm at 800MHz, Quadrature Demodulator Integrated LO Quadrature Generator\n\nLT5522 600MHz to 2.7GHz High Linearity Downconverting Mixer 4.5V to 5.25V Supply, 25dBm IIP3 at 900MHz. NF = 12.5dB, 50W Single-Ended RF and LO Ports","publish_date":null,"title":"28","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page28.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page28.pdf"},"request":{"example_id":"table/222876fb_page28","product_type":"parse","source_file_path":"222876fb_page28.pdf"},"started_at":"2026-11-04T19:47:09.362470"} +{"completed_at":"2026-11-04T19:47:13.072785","latency_in_ms":2503,"output":{"example_id":"table/222876fb_page3","grounded_pages":[],"layout_pages":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 3\n\n222876fb\n\n## **CONVERTER CHARACTERISTICS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nResolution (No Missing Codes)\n\nl 12 12 12 Bits\n\nIntegral Linearity Error Differential Analog Input (Note 5) l –1.1 ±0.3 1.1 –1 ±0.3 1 –1 ±0.3 1 LSB\n\nDifferential Linearity Error Differential Analog Input l –0.8 ±0.15 0.8 –0.7 ±0.15 0.7 –0.7 ±0.15 0.7 LSB\n\nOffset Error (Note 6) l –12 ±2 12 –12 ±2 12 –12 ±2 12 mV\n\nGain Error External Reference l –2.5 ±0.5 2.5 –2.5 ±0.5 2.5 –2.5 ±0.5 2.5 %FS\n\nOffset Drift ±10 ±10 ±10 μV/°C\n\nFull-Scale Drift Internal Reference ±30 ±30 ±30 ppm/°C\n\nExternal Reference ±5 ±5 ±5 ppm/°C\n\nTransition Noise SENSE = 1V 0.25 0.25 0.25 LSBRMS\n\n## **ANALOG INPUT**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\nVIN Analog Input Range (AIN \\+ – AIN – ) 2.7V < VDD < 3.4V (Note 7) l ±0.5V to ±1V V\n\nVIN,CM Analog Input Common Mode (AIN \\+ \\+ AIN – )/2 Differential Input (Note 7) Single-Ended Input (Note 7)\n\nl l\n\n1 0.5 1.5 1.5 1.9 2 V V\n\nIIN Analog Input Leakage Current 0V < AIN \\+ , AIN – < VDD l –1 1 μA\n\nISENSE SENSE Input Leakage 0V < SENSE < 1V l –3 3 μA\n\nIMODE MODE Pin Leakage l –3 3 μA\n\ntAP Sample-and-Hold Acquisition Delay Time 0 ns\n\ntJITTER Sample-and-Hold Acquisition Delay Time Jitter 0.2 psRMS CMRR Analog Input Common Mode Rejection Ratio 80 dB\n\nFull Power Bandwidth Figure 8 Test Circuit 575 MHz\n\n## **DYNAMIC ACCURACY**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. AIN = –1dBFS. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nSNR Signal-to-Noise Ratio 5MHz Input 71.3 71.4 71.4 dB\n\n12\\.5MHz Input l 70.2 71.2 dB\n\n20MHz Input l 70.1 71.3 dB\n\n30MHz Input l 70 71.3 dB\n\n70MHz Input 71.3 71.1 70.9 dB\n\n140MHz Input 71 70.7 70.6 dB\n\nSFDR Spurious Free Dynamic Range 2nd or 3rd Harmonic\n\n5MHz Input 90 90 90 dB\n\n12\\.5MHz Input l 76 90 dB\n\n20MHz Input l 76 90 dB\n\n30MHz Input l 75 90 dB\n\n70MHz Input 85 85 85 dB\n\n140MHz Input 80 80 80 dB","pages":[{"line_numbers":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 3\n\n222876fb\n\n## **CONVERTER CHARACTERISTICS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nResolution (No Missing Codes)\n\nl 12 12 12 Bits\n\nIntegral Linearity Error Differential Analog Input (Note 5) l –1.1 ±0.3 1.1 –1 ±0.3 1 –1 ±0.3 1 LSB\n\nDifferential Linearity Error Differential Analog Input l –0.8 ±0.15 0.8 –0.7 ±0.15 0.7 –0.7 ±0.15 0.7 LSB\n\nOffset Error (Note 6) l –12 ±2 12 –12 ±2 12 –12 ±2 12 mV\n\nGain Error External Reference l –2.5 ±0.5 2.5 –2.5 ±0.5 2.5 –2.5 ±0.5 2.5 %FS\n\nOffset Drift ±10 ±10 ±10 μV/°C\n\nFull-Scale Drift Internal Reference ±30 ±30 ±30 ppm/°C\n\nExternal Reference ±5 ±5 ±5 ppm/°C\n\nTransition Noise SENSE = 1V 0.25 0.25 0.25 LSBRMS\n\n## **ANALOG INPUT**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\nVIN Analog Input Range (AIN \\+ – AIN – ) 2.7V < VDD < 3.4V (Note 7) l ±0.5V to ±1V V\n\nVIN,CM Analog Input Common Mode (AIN \\+ \\+ AIN – )/2 Differential Input (Note 7) Single-Ended Input (Note 7)\n\nl l\n\n1 0.5 1.5 1.5 1.9 2 V V\n\nIIN Analog Input Leakage Current 0V < AIN \\+ , AIN – < VDD l –1 1 μA\n\nISENSE SENSE Input Leakage 0V < SENSE < 1V l –3 3 μA\n\nIMODE MODE Pin Leakage l –3 3 μA\n\ntAP Sample-and-Hold Acquisition Delay Time 0 ns\n\ntJITTER Sample-and-Hold Acquisition Delay Time Jitter 0.2 psRMS CMRR Analog Input Common Mode Rejection Ratio 80 dB\n\nFull Power Bandwidth Figure 8 Test Circuit 575 MHz\n\n## **DYNAMIC ACCURACY**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. AIN = –1dBFS. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nSNR Signal-to-Noise Ratio 5MHz Input 71.3 71.4 71.4 dB\n\n12\\.5MHz Input l 70.2 71.2 dB\n\n20MHz Input l 70.1 71.3 dB\n\n30MHz Input l 70 71.3 dB\n\n70MHz Input 71.3 71.1 70.9 dB\n\n140MHz Input 71 70.7 70.6 dB\n\nSFDR Spurious Free Dynamic Range 2nd or 3rd Harmonic\n\n5MHz Input 90 90 90 dB\n\n12\\.5MHz Input l 76 90 dB\n\n20MHz Input l 76 90 dB\n\n30MHz Input l 75 90 dB\n\n70MHz Input 85 85 85 dB\n\n140MHz Input 80 80 80 dB","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 3\n\n222876fb\n\n## **CONVERTER CHARACTERISTICS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nResolution (No Missing Codes)\n\nl 12 12 12 Bits\n\nIntegral Linearity Error Differential Analog Input (Note 5) l –1.1 ±0.3 1.1 –1 ±0.3 1 –1 ±0.3 1 LSB\n\nDifferential Linearity Error Differential Analog Input l –0.8 ±0.15 0.8 –0.7 ±0.15 0.7 –0.7 ±0.15 0.7 LSB\n\nOffset Error (Note 6) l –12 ±2 12 –12 ±2 12 –12 ±2 12 mV\n\nGain Error External Reference l –2.5 ±0.5 2.5 –2.5 ±0.5 2.5 –2.5 ±0.5 2.5 %FS\n\nOffset Drift ±10 ±10 ±10 μV/°C\n\nFull-Scale Drift Internal Reference ±30 ±30 ±30 ppm/°C\n\nExternal Reference ±5 ±5 ±5 ppm/°C\n\nTransition Noise SENSE = 1V 0.25 0.25 0.25 LSBRMS\n\n## **ANALOG INPUT**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\nVIN Analog Input Range (AIN \\+ – AIN – ) 2.7V < VDD < 3.4V (Note 7) l ±0.5V to ±1V V\n\nVIN,CM Analog Input Common Mode (AIN \\+ \\+ AIN – )/2 Differential Input (Note 7) Single-Ended Input (Note 7)\n\nl l\n\n1 0.5 1.5 1.5 1.9 2 V V\n\nIIN Analog Input Leakage Current 0V < AIN \\+ , AIN – < VDD l –1 1 μA\n\nISENSE SENSE Input Leakage 0V < SENSE < 1V l –3 3 μA\n\nIMODE MODE Pin Leakage l –3 3 μA\n\ntAP Sample-and-Hold Acquisition Delay Time 0 ns\n\ntJITTER Sample-and-Hold Acquisition Delay Time Jitter 0.2 psRMS CMRR Analog Input Common Mode Rejection Ratio 80 dB\n\nFull Power Bandwidth Figure 8 Test Circuit 575 MHz\n\n## **DYNAMIC ACCURACY**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. AIN = –1dBFS. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nSNR Signal-to-Noise Ratio 5MHz Input 71.3 71.4 71.4 dB\n\n12\\.5MHz Input l 70.2 71.2 dB\n\n20MHz Input l 70.1 71.3 dB\n\n30MHz Input l 70 71.3 dB\n\n70MHz Input 71.3 71.1 70.9 dB\n\n140MHz Input 71 70.7 70.6 dB\n\nSFDR Spurious Free Dynamic Range 2nd or 3rd Harmonic\n\n5MHz Input 90 90 90 dB\n\n12\\.5MHz Input l 76 90 dB\n\n20MHz Input l 76 90 dB\n\n30MHz Input l 75 90 dB\n\n70MHz Input 85 85 85 dB\n\n140MHz Input 80 80 80 dB","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page3.pdf"]},"response":{"errors":[],"extract_id":"extract_420a493ace340617ff1ed760a12f157b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## LTC2228/LTC2227/LTC2226\n\n# 3\n\n222876fb\n\n## **CONVERTER CHARACTERISTICS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nResolution (No Missing Codes)\n\nl 12 12 12 Bits\n\nIntegral Linearity Error Differential Analog Input (Note 5) l –1.1 ±0.3 1.1 –1 ±0.3 1 –1 ±0.3 1 LSB\n\nDifferential Linearity Error Differential Analog Input l –0.8 ±0.15 0.8 –0.7 ±0.15 0.7 –0.7 ±0.15 0.7 LSB\n\nOffset Error (Note 6) l –12 ±2 12 –12 ±2 12 –12 ±2 12 mV\n\nGain Error External Reference l –2.5 ±0.5 2.5 –2.5 ±0.5 2.5 –2.5 ±0.5 2.5 %FS\n\nOffset Drift ±10 ±10 ±10 μV/°C\n\nFull-Scale Drift Internal Reference ±30 ±30 ±30 ppm/°C\n\nExternal Reference ±5 ±5 ±5 ppm/°C\n\nTransition Noise SENSE = 1V 0.25 0.25 0.25 LSBRMS\n\n## **ANALOG INPUT**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\nVIN Analog Input Range (AIN \\+ – AIN – ) 2.7V < VDD < 3.4V (Note 7) l ±0.5V to ±1V V\n\nVIN,CM Analog Input Common Mode (AIN \\+ \\+ AIN – )/2 Differential Input (Note 7) Single-Ended Input (Note 7)\n\nl l\n\n1 0.5 1.5 1.5 1.9 2 V V\n\nIIN Analog Input Leakage Current 0V < AIN \\+ , AIN – < VDD l –1 1 μA\n\nISENSE SENSE Input Leakage 0V < SENSE < 1V l –3 3 μA\n\nIMODE MODE Pin Leakage l –3 3 μA\n\ntAP Sample-and-Hold Acquisition Delay Time 0 ns\n\ntJITTER Sample-and-Hold Acquisition Delay Time Jitter 0.2 psRMS CMRR Analog Input Common Mode Rejection Ratio 80 dB\n\nFull Power Bandwidth Figure 8 Test Circuit 575 MHz\n\n## **DYNAMIC ACCURACY**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. AIN = –1dBFS. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nSNR Signal-to-Noise Ratio 5MHz Input 71.3 71.4 71.4 dB\n\n12\\.5MHz Input l 70.2 71.2 dB\n\n20MHz Input l 70.1 71.3 dB\n\n30MHz Input l 70 71.3 dB\n\n70MHz Input 71.3 71.1 70.9 dB\n\n140MHz Input 71 70.7 70.6 dB\n\nSFDR Spurious Free Dynamic Range 2nd or 3rd Harmonic\n\n5MHz Input 90 90 90 dB\n\n12\\.5MHz Input l 76 90 dB\n\n20MHz Input l 76 90 dB\n\n30MHz Input l 75 90 dB\n\n70MHz Input 85 85 85 dB\n\n140MHz Input 80 80 80 dB"],"full_content":"## LTC2228/LTC2227/LTC2226\n\n# 3\n\n222876fb\n\n## **CONVERTER CHARACTERISTICS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nResolution (No Missing Codes)\n\nl 12 12 12 Bits\n\nIntegral Linearity Error Differential Analog Input (Note 5) l –1.1 ±0.3 1.1 –1 ±0.3 1 –1 ±0.3 1 LSB\n\nDifferential Linearity Error Differential Analog Input l –0.8 ±0.15 0.8 –0.7 ±0.15 0.7 –0.7 ±0.15 0.7 LSB\n\nOffset Error (Note 6) l –12 ±2 12 –12 ±2 12 –12 ±2 12 mV\n\nGain Error External Reference l –2.5 ±0.5 2.5 –2.5 ±0.5 2.5 –2.5 ±0.5 2.5 %FS\n\nOffset Drift ±10 ±10 ±10 μV/°C\n\nFull-Scale Drift Internal Reference ±30 ±30 ±30 ppm/°C\n\nExternal Reference ±5 ±5 ±5 ppm/°C\n\nTransition Noise SENSE = 1V 0.25 0.25 0.25 LSBRMS\n\n## **ANALOG INPUT**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\nVIN Analog Input Range (AIN \\+ – AIN – ) 2.7V < VDD < 3.4V (Note 7) l ±0.5V to ±1V V\n\nVIN,CM Analog Input Common Mode (AIN \\+ \\+ AIN – )/2 Differential Input (Note 7) Single-Ended Input (Note 7)\n\nl l\n\n1 0.5 1.5 1.5 1.9 2 V V\n\nIIN Analog Input Leakage Current 0V < AIN \\+ , AIN ��� < VDD l –1 1 μA\n\nISENSE SENSE Input Leakage 0V < SENSE < 1V l –3 3 μA\n\nIMODE MODE Pin Leakage l –3 3 μA\n\ntAP Sample-and-Hold Acquisition Delay Time 0 ns\n\ntJITTER Sample-and-Hold Acquisition Delay Time Jitter 0.2 psRMS CMRR Analog Input Common Mode Rejection Ratio 80 dB\n\nFull Power Bandwidth Figure 8 Test Circuit 575 MHz\n\n## **DYNAMIC ACCURACY**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. AIN = –1dBFS. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nSNR Signal-to-Noise Ratio 5MHz Input 71.3 71.4 71.4 dB\n\n12\\.5MHz Input l 70.2 71.2 dB\n\n20MHz Input l 70.1 71.3 dB\n\n30MHz Input l 70 71.3 dB\n\n70MHz Input 71.3 71.1 70.9 dB\n\n140MHz Input 71 70.7 70.6 dB\n\nSFDR Spurious Free Dynamic Range 2nd or 3rd Harmonic\n\n5MHz Input 90 90 90 dB\n\n12\\.5MHz Input l 76 90 dB\n\n20MHz Input l 76 90 dB\n\n30MHz Input l 75 90 dB\n\n70MHz Input 85 85 85 dB\n\n140MHz Input 80 80 80 dB","publish_date":null,"title":"3","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page3.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page3.pdf"},"request":{"example_id":"table/222876fb_page3","product_type":"parse","source_file_path":"222876fb_page3.pdf"},"started_at":"2026-11-04T19:47:10.569513"} +{"completed_at":"2026-11-04T19:47:12.884841","latency_in_ms":1052,"output":{"example_id":"table/222876fb_page4","grounded_pages":[],"layout_pages":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 4\n\n222876fb\n\n## **DYNAMIC ACCURACY**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. AIN = –1dBFS. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nSFDR Spurious Free Dynamic Range 4th Harmonic or Higher\n\n5MHz Input 95 95 95 dB\n\n12\\.5MHz Input l 82 95 dB\n\n20MHz Input l 82 95 dB\n\n30MHz Input l 82 95 dB\n\n70MHz Input 95 95 95 dB\n\n140MHz Input 90 90 90 dB\n\nS/(N+D) Signal-to-Noise Plus Distortion Ratio\n\n5MHz Input 71.3 71.4 71.4 dB\n\n12\\.5MHz Input l 69.8 71.2 dB\n\n20MHz Input l 69.7 71.2 dB\n\n30MHz Input l 69.6 71.2 dB\n\n70MHz Input 71.1 70.9 70.8 dB\n\n140MHz Input 69.9 69.9 69.8 dB\n\nIMD Intermodulation Distortion fIN1 = 28.2MHz, fIN2 = 26.8MHz\n\n90 90 90 dB\n\n**PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\nVCM Output Voltage IOUT = 0 1.475 1.500 1.525 V\n\nVCM Output Tempco ±25 ppm/°C\n\nVCM Line Regulation 2.7V < VDD < 3.4V 3 mV/V\n\nVCM Output Resistance –1mA < IOUT < 1mA 4 Ω\n\n## **INTERNAL REFERENCE CHARACTERISTICS**\n\n**(Note 4)**\n\n## **DIGITAL INPUTS AND DIGITAL OUTPUTS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\n**LOGIC INPUTS (CLK,** **OE** **, SHDN)**\n\nVIH High Level Input Voltage VDD = 3V l 2 V\n\nVIL Low Level Input Voltage VDD = 3V l 0.8 V\n\nIIN Input Current VIN = 0V to VDD l –10 10 μA\n\nCIN Input Capacitance (Note 7) 3 pF\n\n**LOGIC OUTPUTS**\n\n**OVDD = 3V**\n\nCOZ Hi-Z Output Capacitance OE = High (Note 7) 3 pF\n\nISOURCE Output Source Current VOUT = 0V 50 mA\n\nISINK Output Sink Current VOUT = 3V 50 mA\n\nVOH High Level Output Voltage IO = –10μA IO = –200μA l 2.7 2.995 2.99 V V\n\nVOL Low Level Output Voltage IO = 10μA IO = 1.6mA l\n\n0\\.005 0.09 0.4 V V\n\n**OVDD = 2.5V**\n\nVOH High Level Output Voltage IO = –200μA 2.49 V\n\nVOL Low Level Output Voltage IO = 1.6mA 0.09 V\n\n**OVDD = 1.8V**\n\nVOH High Level Output Voltage IO = –200μA 1.79 V\n\nVOL Low Level Output Voltage IO = 1.6mA 0.09 V","pages":[{"line_numbers":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 4\n\n222876fb\n\n## **DYNAMIC ACCURACY**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. AIN = –1dBFS. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nSFDR Spurious Free Dynamic Range 4th Harmonic or Higher\n\n5MHz Input 95 95 95 dB\n\n12\\.5MHz Input l 82 95 dB\n\n20MHz Input l 82 95 dB\n\n30MHz Input l 82 95 dB\n\n70MHz Input 95 95 95 dB\n\n140MHz Input 90 90 90 dB\n\nS/(N+D) Signal-to-Noise Plus Distortion Ratio\n\n5MHz Input 71.3 71.4 71.4 dB\n\n12\\.5MHz Input l 69.8 71.2 dB\n\n20MHz Input l 69.7 71.2 dB\n\n30MHz Input l 69.6 71.2 dB\n\n70MHz Input 71.1 70.9 70.8 dB\n\n140MHz Input 69.9 69.9 69.8 dB\n\nIMD Intermodulation Distortion fIN1 = 28.2MHz, fIN2 = 26.8MHz\n\n90 90 90 dB\n\n**PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\nVCM Output Voltage IOUT = 0 1.475 1.500 1.525 V\n\nVCM Output Tempco ±25 ppm/°C\n\nVCM Line Regulation 2.7V < VDD < 3.4V 3 mV/V\n\nVCM Output Resistance –1mA < IOUT < 1mA 4 Ω\n\n## **INTERNAL REFERENCE CHARACTERISTICS**\n\n**(Note 4)**\n\n## **DIGITAL INPUTS AND DIGITAL OUTPUTS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\n**LOGIC INPUTS (CLK,** **OE** **, SHDN)**\n\nVIH High Level Input Voltage VDD = 3V l 2 V\n\nVIL Low Level Input Voltage VDD = 3V l 0.8 V\n\nIIN Input Current VIN = 0V to VDD l –10 10 μA\n\nCIN Input Capacitance (Note 7) 3 pF\n\n**LOGIC OUTPUTS**\n\n**OVDD = 3V**\n\nCOZ Hi-Z Output Capacitance OE = High (Note 7) 3 pF\n\nISOURCE Output Source Current VOUT = 0V 50 mA\n\nISINK Output Sink Current VOUT = 3V 50 mA\n\nVOH High Level Output Voltage IO = –10μA IO = –200μA l 2.7 2.995 2.99 V V\n\nVOL Low Level Output Voltage IO = 10μA IO = 1.6mA l\n\n0\\.005 0.09 0.4 V V\n\n**OVDD = 2.5V**\n\nVOH High Level Output Voltage IO = –200μA 2.49 V\n\nVOL Low Level Output Voltage IO = 1.6mA 0.09 V\n\n**OVDD = 1.8V**\n\nVOH High Level Output Voltage IO = –200μA 1.79 V\n\nVOL Low Level Output Voltage IO = 1.6mA 0.09 V","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 4\n\n222876fb\n\n## **DYNAMIC ACCURACY**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. AIN = –1dBFS. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nSFDR Spurious Free Dynamic Range 4th Harmonic or Higher\n\n5MHz Input 95 95 95 dB\n\n12\\.5MHz Input l 82 95 dB\n\n20MHz Input l 82 95 dB\n\n30MHz Input l 82 95 dB\n\n70MHz Input 95 95 95 dB\n\n140MHz Input 90 90 90 dB\n\nS/(N+D) Signal-to-Noise Plus Distortion Ratio\n\n5MHz Input 71.3 71.4 71.4 dB\n\n12\\.5MHz Input l 69.8 71.2 dB\n\n20MHz Input l 69.7 71.2 dB\n\n30MHz Input l 69.6 71.2 dB\n\n70MHz Input 71.1 70.9 70.8 dB\n\n140MHz Input 69.9 69.9 69.8 dB\n\nIMD Intermodulation Distortion fIN1 = 28.2MHz, fIN2 = 26.8MHz\n\n90 90 90 dB\n\n**PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\nVCM Output Voltage IOUT = 0 1.475 1.500 1.525 V\n\nVCM Output Tempco ±25 ppm/°C\n\nVCM Line Regulation 2.7V < VDD < 3.4V 3 mV/V\n\nVCM Output Resistance –1mA < IOUT < 1mA 4 Ω\n\n## **INTERNAL REFERENCE CHARACTERISTICS**\n\n**(Note 4)**\n\n## **DIGITAL INPUTS AND DIGITAL OUTPUTS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\n**LOGIC INPUTS (CLK,** **OE** **, SHDN)**\n\nVIH High Level Input Voltage VDD = 3V l 2 V\n\nVIL Low Level Input Voltage VDD = 3V l 0.8 V\n\nIIN Input Current VIN = 0V to VDD l –10 10 μA\n\nCIN Input Capacitance (Note 7) 3 pF\n\n**LOGIC OUTPUTS**\n\n**OVDD = 3V**\n\nCOZ Hi-Z Output Capacitance OE = High (Note 7) 3 pF\n\nISOURCE Output Source Current VOUT = 0V 50 mA\n\nISINK Output Sink Current VOUT = 3V 50 mA\n\nVOH High Level Output Voltage IO = –10μA IO = –200μA l 2.7 2.995 2.99 V V\n\nVOL Low Level Output Voltage IO = 10μA IO = 1.6mA l\n\n0\\.005 0.09 0.4 V V\n\n**OVDD = 2.5V**\n\nVOH High Level Output Voltage IO = –200μA 2.49 V\n\nVOL Low Level Output Voltage IO = 1.6mA 0.09 V\n\n**OVDD = 1.8V**\n\nVOH High Level Output Voltage IO = –200μA 1.79 V\n\nVOL Low Level Output Voltage IO = 1.6mA 0.09 V","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page4.pdf"]},"response":{"errors":[],"extract_id":"extract_38ff3ae6617e7a9940ae25886bf809ed","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## LTC2228/LTC2227/LTC2226\n\n# 4\n\n222876fb\n\n## **DYNAMIC ACCURACY**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. AIN = –1dBFS. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nSFDR Spurious Free Dynamic Range 4th Harmonic or Higher\n\n5MHz Input 95 95 95 dB\n\n12\\.5MHz Input l 82 95 dB\n\n20MHz Input l 82 95 dB\n\n30MHz Input l 82 95 dB\n\n70MHz Input 95 95 95 dB\n\n140MHz Input 90 90 90 dB\n\nS/(N+D) Signal-to-Noise Plus Distortion Ratio\n\n5MHz Input 71.3 71.4 71.4 dB\n\n12\\.5MHz Input l 69.8 71.2 dB\n\n20MHz Input l 69.7 71.2 dB\n\n30MHz Input l 69.6 71.2 dB\n\n70MHz Input 71.1 70.9 70.8 dB\n\n140MHz Input 69.9 69.9 69.8 dB\n\nIMD Intermodulation Distortion fIN1 = 28.2MHz, fIN2 = 26.8MHz\n\n90 90 90 dB\n\n**PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\nVCM Output Voltage IOUT = 0 1.475 1.500 1.525 V\n\nVCM Output Tempco ±25 ppm/°C\n\nVCM Line Regulation 2.7V < VDD < 3.4V 3 mV/V\n\nVCM Output Resistance –1mA < IOUT < 1mA 4 Ω\n\n## **INTERNAL REFERENCE CHARACTERISTICS**\n\n**(Note 4)**\n\n## **DIGITAL INPUTS AND DIGITAL OUTPUTS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\n**LOGIC INPUTS (CLK,** **OE** **, SHDN)**\n\nVIH High Level Input Voltage VDD = 3V l 2 V\n\nVIL Low Level Input Voltage VDD = 3V l 0.8 V\n\nIIN Input Current VIN = 0V to VDD l –10 10 μA\n\nCIN Input Capacitance (Note 7) 3 pF\n\n**LOGIC OUTPUTS**\n\n**OVDD = 3V**\n\nCOZ Hi-Z Output Capacitance OE = High (Note 7) 3 pF\n\nISOURCE Output Source Current VOUT = 0V 50 mA\n\nISINK Output Sink Current VOUT = 3V 50 mA\n\nVOH High Level Output Voltage IO = –10μA IO = –200μA l 2.7 2.995 2.99 V V\n\nVOL Low Level Output Voltage IO = 10μA IO = 1.6mA l\n\n0\\.005 0.09 0.4 V V\n\n**OVDD = 2.5V**\n\nVOH High Level Output Voltage IO = –200μA 2.49 V\n\nVOL Low Level Output Voltage IO = 1.6mA 0.09 V\n\n**OVDD = 1.8V**\n\nVOH High Level Output Voltage IO = –200μA 1.79 V\n\nVOL Low Level Output Voltage IO = 1.6mA 0.09 V"],"full_content":"## LTC2228/LTC2227/LTC2226\n\n# 4\n\n222876fb\n\n## **DYNAMIC ACCURACY**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. AIN = –1dBFS. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nSFDR Spurious Free Dynamic Range 4th Harmonic or Higher\n\n5MHz Input 95 95 95 dB\n\n12\\.5MHz Input l 82 95 dB\n\n20MHz Input l 82 95 dB\n\n30MHz Input l 82 95 dB\n\n70MHz Input 95 95 95 dB\n\n140MHz Input 90 90 90 dB\n\nS/(N+D) Signal-to-Noise Plus Distortion Ratio\n\n5MHz Input 71.3 71.4 71.4 dB\n\n12\\.5MHz Input l 69.8 71.2 dB\n\n20MHz Input l 69.7 71.2 dB\n\n30MHz Input l 69.6 71.2 dB\n\n70MHz Input 71.1 70.9 70.8 dB\n\n140MHz Input 69.9 69.9 69.8 dB\n\nIMD Intermodulation Distortion fIN1 = 28.2MHz, fIN2 = 26.8MHz\n\n90 90 90 dB\n\n**PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\nVCM Output Voltage IOUT = 0 1.475 1.500 1.525 V\n\nVCM Output Tempco ±25 ppm/°C\n\nVCM Line Regulation 2.7V < VDD < 3.4V 3 mV/V\n\nVCM Output Resistance –1mA < IOUT < 1mA 4 Ω\n\n## **INTERNAL REFERENCE CHARACTERISTICS**\n\n**(Note 4)**\n\n## **DIGITAL INPUTS AND DIGITAL OUTPUTS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS MIN TYP MAX UNITS**\n\n**LOGIC INPUTS (CLK,** **OE** **, SHDN)**\n\nVIH High Level Input Voltage VDD = 3V l 2 V\n\nVIL Low Level Input Voltage VDD = 3V l 0.8 V\n\nIIN Input Current VIN = 0V to VDD l –10 10 μA\n\nCIN Input Capacitance (Note 7) 3 pF\n\n**LOGIC OUTPUTS**\n\n**OVDD = 3V**\n\nCOZ Hi-Z Output Capacitance OE = High (Note 7) 3 pF\n\nISOURCE Output Source Current VOUT = 0V 50 mA\n\nISINK Output Sink Current VOUT = 3V 50 mA\n\nVOH High Level Output Voltage IO = –10μA IO = –200μA l 2.7 2.995 2.99 V V\n\nVOL Low Level Output Voltage IO = 10μA IO = 1.6mA l\n\n0\\.005 0.09 0.4 V V\n\n**OVDD = 2.5V**\n\nVOH High Level Output Voltage IO = –200μA 2.49 V\n\nVOL Low Level Output Voltage IO = 1.6mA 0.09 V\n\n**OVDD = 1.8V**\n\nVOH High Level Output Voltage IO = –200μA 1.79 V\n\nVOL Low Level Output Voltage IO = 1.6mA 0.09 V","publish_date":null,"title":"4","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page4.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page4.pdf"},"request":{"example_id":"table/222876fb_page4","product_type":"parse","source_file_path":"222876fb_page4.pdf"},"started_at":"2026-11-04T19:47:11.832056"} +{"completed_at":"2026-11-04T19:47:14.512429","latency_in_ms":1437,"output":{"example_id":"table/222876fb_page5","grounded_pages":[],"layout_pages":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 5\n\n222876fb\n\n## **POWER REQUIREMENTS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 8)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nVDD Analog Supply Voltage (Note 9) l 2.7 3 3.4 2.7 3 3.4 2.7 3 3.4 V\n\nOVDD Output Supply Voltage (Note 9) l 0.5 3 3.6 0.5 3 3.6 0.5 3 3.6 V\n\nIVDD Supply Current l 68.3 80 40 48 25 30 mA\n\nPDISS Power Dissipation l 205 240 120 144 75 90 mW\n\nPSHDN Shutdown Power SHDN = H, OE = H, No CLK 2 2 2 mW\n\nPNAP Nap Mode Power SHDN = H, OE = L, No CLK 15 15 15 mW\n\n## **TIMING CHARACTERISTICS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nfS Sampling Frequency (Note 9) l 1 65 1 40 1 25 MHz\n\ntL CLK Low Time Duty Cycle Stabilizer Off Duty Cycle Stabilizer On (Note 7)\n\nl l\n\n7\\.3 5 7.7 7.7 500 500 11.8 5 12.5 500 500 18.9 5 20 20 500 500 ns ns\n\ntH CLK High Time Duty Cycle Stabilizer Off Duty Cycle Stabilizer On (Note 7)\n\nl l\n\n7\\.3 5 7.7 7.7 500 500 11.8 5 12.5 12.5 500 500 18.9 5 20 20 500 500 ns ns\n\ntAP Sample-and-Hold Aperture Delay 0 0 0 ns\n\ntD CLK to DATA Delay CL = 5pF (Note 7) l 1.4 2.7 5.4 1.4 2.7 5.4 1.4 2.7 5.4 ns\n\nData Access Time After OE↓ CL = 5pF (Note 7) l 4.3 10 4.3 10 4.3 10 ns\n\nBUS Relinquish Time (Note 7) l 3.3 8.5 3.3 8.5 3.3 8.5 ns\n\nPipeline Latency 5 5 5 Cycles\n\n**Note 1:** Stresses beyond those listed under Absolute Maximum Ratings may cause permanent damage to the device. Exposure to any Absolute Maximum Rating condition for extended periods may affect device reliability and lifetime. **Note 2:** All voltage values are with respect to ground with GND and OGND wired together (unless otherwise noted). **Note 3:** When these pin voltages are taken below GND or above VDD, they will be clamped by internal diodes. This product can handle input currents of greater than 100mA below GND or above VDD without latchup. **Note 4:** VDD = 3V, fSAMPLE = 65MHz (LTC2228), 40MHz (LTC2227), or 25MHz (LTC2226), input range = 2VP-P with differential drive, unless otherwise noted.\n\n**Note 5:** Integral nonlinearity is defi ned as the deviation of a code from a straight line passing through the actual endpoints of the transfer curve. The deviation is measured from the center of the quantization band. **Note 6:** Offset error is the offset voltage measured from –0.5 LSB when the output code fl ickers between 0000 0000 0000 and 1111 1111 1111. **Note 7:** Guaranteed by design, not subject to test. **Note 8:** VDD = 3V, fSAMPLE = 65MHz (LTC2228), 40MHz (LTC2227), or 25MHz (LTC2226), input range = 1VP-P with differential drive. **Note 9:** Recommend operating conditions.","pages":[{"line_numbers":[],"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 5\n\n222876fb\n\n## **POWER REQUIREMENTS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 8)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nVDD Analog Supply Voltage (Note 9) l 2.7 3 3.4 2.7 3 3.4 2.7 3 3.4 V\n\nOVDD Output Supply Voltage (Note 9) l 0.5 3 3.6 0.5 3 3.6 0.5 3 3.6 V\n\nIVDD Supply Current l 68.3 80 40 48 25 30 mA\n\nPDISS Power Dissipation l 205 240 120 144 75 90 mW\n\nPSHDN Shutdown Power SHDN = H, OE = H, No CLK 2 2 2 mW\n\nPNAP Nap Mode Power SHDN = H, OE = L, No CLK 15 15 15 mW\n\n## **TIMING CHARACTERISTICS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nfS Sampling Frequency (Note 9) l 1 65 1 40 1 25 MHz\n\ntL CLK Low Time Duty Cycle Stabilizer Off Duty Cycle Stabilizer On (Note 7)\n\nl l\n\n7\\.3 5 7.7 7.7 500 500 11.8 5 12.5 500 500 18.9 5 20 20 500 500 ns ns\n\ntH CLK High Time Duty Cycle Stabilizer Off Duty Cycle Stabilizer On (Note 7)\n\nl l\n\n7\\.3 5 7.7 7.7 500 500 11.8 5 12.5 12.5 500 500 18.9 5 20 20 500 500 ns ns\n\ntAP Sample-and-Hold Aperture Delay 0 0 0 ns\n\ntD CLK to DATA Delay CL = 5pF (Note 7) l 1.4 2.7 5.4 1.4 2.7 5.4 1.4 2.7 5.4 ns\n\nData Access Time After OE↓ CL = 5pF (Note 7) l 4.3 10 4.3 10 4.3 10 ns\n\nBUS Relinquish Time (Note 7) l 3.3 8.5 3.3 8.5 3.3 8.5 ns\n\nPipeline Latency 5 5 5 Cycles\n\n**Note 1:** Stresses beyond those listed under Absolute Maximum Ratings may cause permanent damage to the device. Exposure to any Absolute Maximum Rating condition for extended periods may affect device reliability and lifetime. **Note 2:** All voltage values are with respect to ground with GND and OGND wired together (unless otherwise noted). **Note 3:** When these pin voltages are taken below GND or above VDD, they will be clamped by internal diodes. This product can handle input currents of greater than 100mA below GND or above VDD without latchup. **Note 4:** VDD = 3V, fSAMPLE = 65MHz (LTC2228), 40MHz (LTC2227), or 25MHz (LTC2226), input range = 2VP-P with differential drive, unless otherwise noted.\n\n**Note 5:** Integral nonlinearity is defi ned as the deviation of a code from a straight line passing through the actual endpoints of the transfer curve. The deviation is measured from the center of the quantization band. **Note 6:** Offset error is the offset voltage measured from –0.5 LSB when the output code fl ickers between 0000 0000 0000 and 1111 1111 1111. **Note 7:** Guaranteed by design, not subject to test. **Note 8:** VDD = 3V, fSAMPLE = 65MHz (LTC2228), 40MHz (LTC2227), or 25MHz (LTC2226), input range = 1VP-P with differential drive. **Note 9:** Recommend operating conditions.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## LTC2228/LTC2227/LTC2226\n\n# 5\n\n222876fb\n\n## **POWER REQUIREMENTS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 8)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nVDD Analog Supply Voltage (Note 9) l 2.7 3 3.4 2.7 3 3.4 2.7 3 3.4 V\n\nOVDD Output Supply Voltage (Note 9) l 0.5 3 3.6 0.5 3 3.6 0.5 3 3.6 V\n\nIVDD Supply Current l 68.3 80 40 48 25 30 mA\n\nPDISS Power Dissipation l 205 240 120 144 75 90 mW\n\nPSHDN Shutdown Power SHDN = H, OE = H, No CLK 2 2 2 mW\n\nPNAP Nap Mode Power SHDN = H, OE = L, No CLK 15 15 15 mW\n\n## **TIMING CHARACTERISTICS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nfS Sampling Frequency (Note 9) l 1 65 1 40 1 25 MHz\n\ntL CLK Low Time Duty Cycle Stabilizer Off Duty Cycle Stabilizer On (Note 7)\n\nl l\n\n7\\.3 5 7.7 7.7 500 500 11.8 5 12.5 500 500 18.9 5 20 20 500 500 ns ns\n\ntH CLK High Time Duty Cycle Stabilizer Off Duty Cycle Stabilizer On (Note 7)\n\nl l\n\n7\\.3 5 7.7 7.7 500 500 11.8 5 12.5 12.5 500 500 18.9 5 20 20 500 500 ns ns\n\ntAP Sample-and-Hold Aperture Delay 0 0 0 ns\n\ntD CLK to DATA Delay CL = 5pF (Note 7) l 1.4 2.7 5.4 1.4 2.7 5.4 1.4 2.7 5.4 ns\n\nData Access Time After OE↓ CL = 5pF (Note 7) l 4.3 10 4.3 10 4.3 10 ns\n\nBUS Relinquish Time (Note 7) l 3.3 8.5 3.3 8.5 3.3 8.5 ns\n\nPipeline Latency 5 5 5 Cycles\n\n**Note 1:** Stresses beyond those listed under Absolute Maximum Ratings may cause permanent damage to the device. Exposure to any Absolute Maximum Rating condition for extended periods may affect device reliability and lifetime. **Note 2:** All voltage values are with respect to ground with GND and OGND wired together (unless otherwise noted). **Note 3:** When these pin voltages are taken below GND or above VDD, they will be clamped by internal diodes. This product can handle input currents of greater than 100mA below GND or above VDD without latchup. **Note 4:** VDD = 3V, fSAMPLE = 65MHz (LTC2228), 40MHz (LTC2227), or 25MHz (LTC2226), input range = 2VP-P with differential drive, unless otherwise noted.\n\n**Note 5:** Integral nonlinearity is defi ned as the deviation of a code from a straight line passing through the actual endpoints of the transfer curve. The deviation is measured from the center of the quantization band. **Note 6:** Offset error is the offset voltage measured from –0.5 LSB when the output code fl ickers between 0000 0000 0000 and 1111 1111 1111. **Note 7:** Guaranteed by design, not subject to test. **Note 8:** VDD = 3V, fSAMPLE = 65MHz (LTC2228), 40MHz (LTC2227), or 25MHz (LTC2226), input range = 1VP-P with differential drive. **Note 9:** Recommend operating conditions.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page5.pdf"]},"response":{"errors":[],"extract_id":"extract_8bd1a686936af46ec30c48983ec18580","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## LTC2228/LTC2227/LTC2226\n\n# 5\n\n222876fb\n\n## **POWER REQUIREMENTS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 8)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nVDD Analog Supply Voltage (Note 9) l 2.7 3 3.4 2.7 3 3.4 2.7 3 3.4 V\n\nOVDD Output Supply Voltage (Note 9) l 0.5 3 3.6 0.5 3 3.6 0.5 3 3.6 V\n\nIVDD Supply Current l 68.3 80 40 48 25 30 mA\n\nPDISS Power Dissipation l 205 240 120 144 75 90 mW\n\nPSHDN Shutdown Power SHDN = H, OE = H, No CLK 2 2 2 mW\n\nPNAP Nap Mode Power SHDN = H, OE = L, No CLK 15 15 15 mW\n\n## **TIMING CHARACTERISTICS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nfS Sampling Frequency (Note 9) l 1 65 1 40 1 25 MHz\n\ntL CLK Low Time Duty Cycle Stabilizer Off Duty Cycle Stabilizer On (Note 7)\n\nl l\n\n7\\.3 5 7.7 7.7 500 500 11.8 5 12.5 500 500 18.9 5 20 20 500 500 ns ns\n\ntH CLK High Time Duty Cycle Stabilizer Off Duty Cycle Stabilizer On (Note 7)\n\nl l\n\n7\\.3 5 7.7 7.7 500 500 11.8 5 12.5 12.5 500 500 18.9 5 20 20 500 500 ns ns\n\ntAP Sample-and-Hold Aperture Delay 0 0 0 ns\n\ntD CLK to DATA Delay CL = 5pF (Note 7) l 1.4 2.7 5.4 1.4 2.7 5.4 1.4 2.7 5.4 ns\n\nData Access Time After OE↓ CL = 5pF (Note 7) l 4.3 10 4.3 10 4.3 10 ns\n\nBUS Relinquish Time (Note 7) l 3.3 8.5 3.3 8.5 3.3 8.5 ns\n\nPipeline Latency 5 5 5 Cycles\n\n**Note 1:** Stresses beyond those listed under Absolute Maximum Ratings may cause permanent damage to the device. Exposure to any Absolute Maximum Rating condition for extended periods may affect device reliability and lifetime. **Note 2:** All voltage values are with respect to ground with GND and OGND wired together (unless otherwise noted). **Note 3:** When these pin voltages are taken below GND or above VDD, they will be clamped by internal diodes. This product can handle input currents of greater than 100mA below GND or above VDD without latchup. **Note 4:** VDD = 3V, fSAMPLE = 65MHz (LTC2228), 40MHz (LTC2227), or 25MHz (LTC2226), input range = 2VP-P with differential drive, unless otherwise noted.\n\n**Note 5:** Integral nonlinearity is defi ned as the deviation of a code from a straight line passing through the actual endpoints of the transfer curve. The deviation is measured from the center of the quantization band. **Note 6:** Offset error is the offset voltage measured from –0.5 LSB when the output code fl ickers between 0000 0000 0000 and 1111 1111 1111. **Note 7:** Guaranteed by design, not subject to test. **Note 8:** VDD = 3V, fSAMPLE = 65MHz (LTC2228), 40MHz (LTC2227), or 25MHz (LTC2226), input range = 1VP-P with differential drive. **Note 9:** Recommend operating conditions."],"full_content":"## LTC2228/LTC2227/LTC2226\n\n# 5\n\n222876fb\n\n## **POWER REQUIREMENTS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 8)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nVDD Analog Supply Voltage (Note 9) l 2.7 3 3.4 2.7 3 3.4 2.7 3 3.4 V\n\nOVDD Output Supply Voltage (Note 9) l 0.5 3 3.6 0.5 3 3.6 0.5 3 3.6 V\n\nIVDD Supply Current l 68.3 80 40 48 25 30 mA\n\nPDISS Power Dissipation l 205 240 120 144 75 90 mW\n\nPSHDN Shutdown Power SHDN = H, OE = H, No CLK 2 2 2 mW\n\nPNAP Nap Mode Power SHDN = H, OE = L, No CLK 15 15 15 mW\n\n## **TIMING CHARACTERISTICS**\n\n**The** l **denotes the specifi cations which apply over the full operating temperature range, otherwise specifi cations are at TA = 25°C. (Note 4)**\n\n**SYMBOL PARAMETER CONDITIONS LTC2228 LTC2227 LTC2226 UNITS MIN TYP MAX MIN TYP MAX MIN TYP MAX**\n\nfS Sampling Frequency (Note 9) l 1 65 1 40 1 25 MHz\n\ntL CLK Low Time Duty Cycle Stabilizer Off Duty Cycle Stabilizer On (Note 7)\n\nl l\n\n7\\.3 5 7.7 7.7 500 500 11.8 5 12.5 500 500 18.9 5 20 20 500 500 ns ns\n\ntH CLK High Time Duty Cycle Stabilizer Off Duty Cycle Stabilizer On (Note 7)\n\nl l\n\n7\\.3 5 7.7 7.7 500 500 11.8 5 12.5 12.5 500 500 18.9 5 20 20 500 500 ns ns\n\ntAP Sample-and-Hold Aperture Delay 0 0 0 ns\n\ntD CLK to DATA Delay CL = 5pF (Note 7) l 1.4 2.7 5.4 1.4 2.7 5.4 1.4 2.7 5.4 ns\n\nData Access Time After OE↓ CL = 5pF (Note 7) l 4.3 10 4.3 10 4.3 10 ns\n\nBUS Relinquish Time (Note 7) l 3.3 8.5 3.3 8.5 3.3 8.5 ns\n\nPipeline Latency 5 5 5 Cycles\n\n**Note 1:** Stresses beyond those listed under Absolute Maximum Ratings may cause permanent damage to the device. Exposure to any Absolute Maximum Rating condition for extended periods may affect device reliability and lifetime. **Note 2:** All voltage values are with respect to ground with GND and OGND wired together (unless otherwise noted). **Note 3:** When these pin voltages are taken below GND or above VDD, they will be clamped by internal diodes. This product can handle input currents of greater than 100mA below GND or above VDD without latchup. **Note 4:** VDD = 3V, fSAMPLE = 65MHz (LTC2228), 40MHz (LTC2227), or 25MHz (LTC2226), input range = 2VP-P with differential drive, unless otherwise noted.\n\n**Note 5:** Integral nonlinearity is defi ned as the deviation of a code from a straight line passing through the actual endpoints of the transfer curve. The deviation is measured from the center of the quantization band. **Note 6:** Offset error is the offset voltage measured from –0.5 LSB when the output code fl ickers between 0000 0000 0000 and 1111 1111 1111. **Note 7:** Guaranteed by design, not subject to test. **Note 8:** VDD = 3V, fSAMPLE = 65MHz (LTC2228), 40MHz (LTC2227), or 25MHz (LTC2226), input range = 1VP-P with differential drive. **Note 9:** Recommend operating conditions.","publish_date":null,"title":"5","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page5.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/222876fb_page5.pdf"},"request":{"example_id":"table/222876fb_page5","product_type":"parse","source_file_path":"222876fb_page5.pdf"},"started_at":"2026-11-04T19:47:13.074741"} +{"completed_at":"2026-11-04T22:55:45.762555","latency_in_ms":1375,"output":{"example_id":"table/245804406-CV-Nevers-signé-EX_page10","grounded_pages":[],"layout_pages":[],"markdown":"10\n\n## **1\\.1.** **La géographie des quartiers prioritaires**\n\nSuite au décret du 28 décembre 2023, modifiant la liste des quartiers prioritaires de la politique de la ville, l’agglomération de Nevers compte désormais 3 quartiers prioritaires, tous situés sur la commune de Nevers :\n\n• Grande Pâture – Les Montôts (QN05801M)\n\n• Le Banlay (QN05802M)\n\n• Bords de Loire – Courlis – La Baratte (QN05803M)\n\nLa population des quartiers prioritaires résultant de la nouvelle géographie est de 5 700 habitants (données FILOSOFI 2019 arrondies à la centaine supérieure).\n\nQuartiers prioritaires\n\nNombre\n\nd’habitants (FILOSOFI\n\n2019)\n\nRevenu médian (FILOSOFI 2019)\n\nTaux de pauvreté (FILOSOFI\n\n2019)\n\nTaux\n\nd’emploi (recensem ent 2019)\n\nFamilles\n\nmonoparentales\n\n(recensement\n\n2019)\n\nPart des 16-25 ans non scolarisés et\n\nsans emploi (recensement\n\n2018)\n\nGrande Pâture – Les Montôts 1600 7 723 € 51,4 % 32,6 % 26,7 % 27,2 %\n\nLe Banlay 1700 7 193 € 51,7 % 31,8 % 40,8 % 38,5 %\n\nBords de Loire – Courlis – La Baratte 2400\n\n6 734 €\n\n(Bords de Loire) 50,7 % 27,2 % 41,5 % 51,5 %\n\n8 275 € (Baratte- Courlis) 45,9 % 33,5 % 26,6 % 30,6 %","pages":[{"line_numbers":[],"markdown":"10\n\n## **1\\.1.** **La géographie des quartiers prioritaires**\n\nSuite au décret du 28 décembre 2023, modifiant la liste des quartiers prioritaires de la politique de la ville, l’agglomération de Nevers compte désormais 3 quartiers prioritaires, tous situés sur la commune de Nevers :\n\n• Grande Pâture – Les Montôts (QN05801M)\n\n• Le Banlay (QN05802M)\n\n• Bords de Loire – Courlis – La Baratte (QN05803M)\n\nLa population des quartiers prioritaires résultant de la nouvelle géographie est de 5 700 habitants (données FILOSOFI 2019 arrondies à la centaine supérieure).\n\nQuartiers prioritaires\n\nNombre\n\nd’habitants (FILOSOFI\n\n2019)\n\nRevenu médian (FILOSOFI 2019)\n\nTaux de pauvreté (FILOSOFI\n\n2019)\n\nTaux\n\nd’emploi (recensem ent 2019)\n\nFamilles\n\nmonoparentales\n\n(recensement\n\n2019)\n\nPart des 16-25 ans non scolarisés et\n\nsans emploi (recensement\n\n2018)\n\nGrande Pâture – Les Montôts 1600 7 723 € 51,4 % 32,6 % 26,7 % 27,2 %\n\nLe Banlay 1700 7 193 € 51,7 % 31,8 % 40,8 % 38,5 %\n\nBords de Loire – Courlis – La Baratte 2400\n\n6 734 €\n\n(Bords de Loire) 50,7 % 27,2 % 41,5 % 51,5 %\n\n8 275 € (Baratte- Courlis) 45,9 % 33,5 % 26,6 % 30,6 %","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"10\n\n## **1\\.1.** **La géographie des quartiers prioritaires**\n\nSuite au décret du 28 décembre 2023, modifiant la liste des quartiers prioritaires de la politique de la ville, l’agglomération de Nevers compte désormais 3 quartiers prioritaires, tous situés sur la commune de Nevers :\n\n• Grande Pâture – Les Montôts (QN05801M)\n\n• Le Banlay (QN05802M)\n\n• Bords de Loire – Courlis – La Baratte (QN05803M)\n\nLa population des quartiers prioritaires résultant de la nouvelle géographie est de 5 700 habitants (données FILOSOFI 2019 arrondies à la centaine supérieure).\n\nQuartiers prioritaires\n\nNombre\n\nd’habitants (FILOSOFI\n\n2019)\n\nRevenu médian (FILOSOFI 2019)\n\nTaux de pauvreté (FILOSOFI\n\n2019)\n\nTaux\n\nd’emploi (recensem ent 2019)\n\nFamilles\n\nmonoparentales\n\n(recensement\n\n2019)\n\nPart des 16-25 ans non scolarisés et\n\nsans emploi (recensement\n\n2018)\n\nGrande Pâture – Les Montôts 1600 7 723 € 51,4 % 32,6 % 26,7 % 27,2 %\n\nLe Banlay 1700 7 193 € 51,7 % 31,8 % 40,8 % 38,5 %\n\nBords de Loire – Courlis – La Baratte 2400\n\n6 734 €\n\n(Bords de Loire) 50,7 % 27,2 % 41,5 % 51,5 %\n\n8 275 € (Baratte- Courlis) 45,9 % 33,5 % 26,6 % 30,6 %","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/245804406-CV-Nevers-signe%CC%81-EX_page10.pdf"]},"response":{"errors":[],"extract_id":"extract_cf7a074b2cec40f255f01044e9074def","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["10\n\n## **1\\.1.** **La géographie des quartiers prioritaires**\n\nSuite au décret du 28 décembre 2023, modifiant la liste des quartiers prioritaires de la politique de la ville, l’agglomération de Nevers compte désormais 3 quartiers prioritaires, tous situés sur la commune de Nevers :\n\n• Grande Pâture – Les Montôts (QN05801M)\n\n• Le Banlay (QN05802M)\n\n• Bords de Loire – Courlis – La Baratte (QN05803M)\n\nLa population des quartiers prioritaires résultant de la nouvelle géographie est de 5 700 habitants (données FILOSOFI 2019 arrondies à la centaine supérieure).\n\nQuartiers prioritaires\n\nNombre\n\nd’habitants (FILOSOFI\n\n2019)\n\nRevenu médian (FILOSOFI 2019)\n\nTaux de pauvreté (FILOSOFI\n\n2019)\n\nTaux\n\nd’emploi (recensem ent 2019)\n\nFamilles\n\nmonoparentales\n\n(recensement\n\n2019)\n\nPart des 16-25 ans non scolarisés et\n\nsans emploi (recensement\n\n2018)\n\nGrande Pâture – Les Montôts 1600 7 723 € 51,4 % 32,6 % 26,7 % 27,2 %\n\nLe Banlay 1700 7 193 € 51,7 % 31,8 % 40,8 % 38,5 %\n\nBords de Loire – Courlis – La Baratte 2400\n\n6 734 €\n\n(Bords de Loire) 50,7 % 27,2 % 41,5 % 51,5 %\n\n8 275 € (Baratte- Courlis) 45,9 % 33,5 % 26,6 % 30,6 %"],"full_content":"10\n\n## **1\\.1.** **La géographie des quartiers prioritaires**\n\nSuite au décret du 28 décembre 2023, modifiant la liste des quartiers prioritaires de la politique de la ville, l’agglomération de Nevers compte désormais 3 quartiers prioritaires, tous situés sur la commune de Nevers :\n\n• Grande Pâture – Les Montôts (QN05801M)\n\n• Le Banlay (QN05802M)\n\n• Bords de Loire – Courlis – La Baratte (QN05803M)\n\nLa population des quartiers prioritaires résultant de la nouvelle géographie est de 5 700 habitants (données FILOSOFI 2019 arrondies à la centaine supérieure).\n\nQuartiers prioritaires\n\nNombre\n\nd’habitants (FILOSOFI\n\n2019)\n\nRevenu médian (FILOSOFI 2019)\n\nTaux de pauvreté (FILOSOFI\n\n2019)\n\nTaux\n\nd’emploi (recensem ent 2019)\n\nFamilles\n\nmonoparentales\n\n(recensement\n\n2019)\n\nPart des 16-25 ans non scolarisés et\n\nsans emploi (recensement\n\n2018)\n\nGrande Pâture – Les Montôts 1600 7 723 € 51,4 % 32,6 % 26,7 % 27,2 %\n\nLe Banlay 1700 7 193 € 51,7 % 31,8 % 40,8 % 38,5 %\n\nBords de Loire – Courlis – La Baratte 2400\n\n6 734 €\n\n(Bords de Loire) 50,7 % 27,2 % 41,5 % 51,5 %\n\n8 275 € (Baratte- Courlis) 45,9 % 33,5 % 26,6 % 30,6 %","publish_date":null,"title":"1.1. La géographie des quartiers prioritaires","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/245804406-CV-Nevers-signe%CC%81-EX_page10.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/245804406-CV-Nevers-signe%CC%81-EX_page10.pdf"},"request":{"example_id":"table/245804406-CV-Nevers-signé-EX_page10","product_type":"parse","source_file_path":"245804406-CV-Nevers-signé-EX_page10.pdf"},"started_at":"2026-11-04T22:55:44.387114"} +{"completed_at":"2026-11-04T22:55:47.541467","latency_in_ms":3150,"output":{"example_id":"table/245804406-CV-Nevers-signé-EX_page60","grounded_pages":[],"layout_pages":[],"markdown":"Tableau de bord\\_Contrat de Ville Nevers\\_2024 -2030\\_VDEF Contrat de ville - Engagements quartiers 2030\n\n**Priorités** **Enjeux** **Déclinaison des objectifs opérationnels** **Pilote de l'objectif Contributeurs Indicateurs /**\n\n**Impacts recherchés (non exhaustifs)** **Pistes de financement (non exhaustives) Cadre/contractualisations**\n\nFaciliter l’accès des habitants à la formation et aux différents dispositifs d'accompagnement pour l'insertion professionnelle\n\nNevers Agglomération (Cité de\n\nl'Emploi) / France Travail Opérateur et opérateurs spécialisés (CAP Emploi,\n\nMILO)\n\nEtat (DETSPP) CD58 Nevers Agglomération (PLIE) SIAE Entreprises (Les entreprises s'engagent) CRBFC Bailleur Nièvre Habitat\n\nAmélioration de la coordination des différents acteurs Mobilisation des structures intermédiaires, mobilisation des entreprises Nombre d’actions de promotion Nombre d’actions « d’aller-vers » Nombre de personnes des quartiers ayant intégré une formation ou un dispositif d’accompagnement\n\nCRBFC Bailleurs en lien avec l'abattement TFPB Pacte local des solidarités Contrat de ville\n\nCité de l'emploi Pacte local des solidarités Démarche France travail\n\nPrévenir la marginalisation de certains jeunes en travaillant les compétences de savoir-être en lien avec le réseau France Travail\n\nNevers Agglomération (Cité de\n\nl'Emploi) / France Travail Opérateur et opérateurs spécialisés (CAP Emploi,\n\nMILO)\n\nAssociations CRBFC\n\nNombre de personnes des quartiers ayant intégré des ateliers Amélioration de la coordination des différents acteurs Nombre d’actions spécifiques aux quartiers\n\nCRBFC Crédits Politique de la ville\n\nCité de l'emploi Démarche France travail Pacte local des solidarités\n\nLutter contre l’illettrisme Nevers Agglomération (Cité de\n\nl'Emploi) / CD58\n\nEtat (DETSPP) AFPLI FOL DEFL CRBFC Education Nationale ANLCI\n\nNombre de personnes du quartier repérées et accompagnées Nombre de personnes du quartier ayant développé leurs compétences dans le cadre d’un accompagnement\n\nPacte local des solidarités CRBFC SDJES Contrat de ville\n\nPacte local des solidarités Plan départemental de lutte contre l'illettrisme Education Nationale\n\nLever les freins liés à la mobilité Nevers Agglomération (Cité de\n\nl'Emploi) / CD58\n\nEtat (DETSPP) CRBFC CCAS Associations\n\nNombre d’actions de promotion des solutions alternatives de mobilité : aide au permis, prêt de voitures solidaires, covoiturage Nombre de diagnostics mobilités (Opérateur France travail notamment) Nombre de personnes du quartier ayant fait appel à la plateforme mobilité de l’ASEM\n\nCRBFC Opérateur France travail Pacte local des solidarités\n\nSoutenir les parents dans leur rôle éducatif CAF / CD58\n\nFédération des centres sociaux CCAS-PRE Centres sociaux FDCS Ville de Nevers\n\nNombre d’actions mises en place Nombre de parents touchés Retours des familles\n\nREAAP CLAS Crédits Politique de la ville\n\nPacte local des solidarités comité départemental des services aux familles Comités REAPP, CLAS Contrat de ville, Cité éducative\n\nRenforcer les liens parents/école Ville de Nevers / Etat (Education\n\nNationale)\n\nFédération des centres sociaux CCAS-PRE Associations (dont Centres sociaux) CD58 CAF\n\nNombre de parents présents aux réunions parents/professeurs Nombre de parents élu Sréation d’associations de parents d’élèves\n\nREAAP CLAS Crédits Politique de la ville\n\nProjets d’écoles et d’établissements Comités REAPP, CLAS Contrat de ville\n\nRenforcer les partenariats entre les professionnels de l’éducation (Éducation nationale, ville, associations)\n\nNevers Agglomération CD58 CCAS-PRE Associations CAF\n\nNombre de projets co-construits entre partenaires (l’école, la ville, les associations, le CD) Crédits Politique de la ville : Cité éducative Projets d’écoles et d’établissements Contrat de ville, Cité éducative\n\nAgir dès le plus jeune âge en prévention (harcèlement, lutte contre les stéréotypes…)\n\nAgglomération CCAS-PRE CD58 Associations CAF\n\nNombre d’actions mises en place, baisse du nombre de situations de harcèlement sur les 6 ans, bien être et climat scolaire, réussite éducative\n\nAgence nationale du sport : Plan sportif territorial Éducation Nationale (SDJES et projet pHARe) Politique de la ville\n\nProjets d’écoles et d’établissements (dont projet pHARe) Contrat de ville, Cité éducative\n\nDévelopper l’accès aux activités artistiques, culturelles et sportives qui contribuent à l’épanouissement et à la réussite\n\nNevers Agglomération Associations CRBFC CD58 DRAC CCAS-PRE\n\nAméliorer l'implication des jeunes de quartiers dans la vie culturelle et associative de l'agglomération Nombre d’actions Nombre de participants, nouveaux participants % filles-garçons\n\nAgence nationale du sport : Plan sportif territorial SDJES DRAC Contrat de ville\n\nContrat de ville, Cité éducative Autres appels à projets\n\nFavoriser l’engagement et l’implication des jeunes : service civique, bénévolat, engagement associatif, Ville de Nevers / Etat ( SDJES)\n\nCD58 Asssociations CRBFC DMD SDIS FOL CCAS-PRE\n\nNombre de jeunes en service civique Nombre de bénévoles Nombre de participants dans les instances démocratiques Nombre de junior associations crées\n\nAgence nationale du sport : Plan sportif territorial SDJES\n\nPacte local des solidarités Contrat de ville\n\n**Favoriser la coordination et le travail partenarial**\n\nEn lien avec le CLSP, installer et mettre en œuvre des cellules de coordination favorisant les échanges d’informations entre les partenaires dans le respect du secret partagé\n\nVille de Nevers / Etat (Préfecture)\n\nCD58 CCAS CMP Bailleurs Associations Nevers Agglomération\n\nFocus QPV dans les CLSPD Diagnostic local de sécurité aboutissant à des orientations partagées Mise en place de groupes thématiques ou par quartier favoriser l'accessibilité et la fluidité des connaissances interprofessionnelles et des informations partagées Conventions partenariales, outils mutualisés\n\nFIPD MILDECA Politique de la ville\n\nCLSPD Contrat de ville\n\nRenforcer la présence humaine : médiateurs formés, éducateurs spécialisés, sportifs Ville de Nevers / CD58\n\nBailleurs Associations Nevers Agglomération PJJ Etat (Préfecture, SDJES)\n\nAboutir à une équipe pluridisciplinaire et formée en capacité de couvrir les 3 QPV\n\nFIPD MILDECA Pacte local des solidarités Politique de la ville Agence nationale du sport : plan sportif territorial\n\nContrat de ville (adultes-relais) Pacte local des solidarités\n\nAccompagner les familles dans l’exercice de la parentalité CD58 / CAF\n\nVille de Nevers CCAS-PRE PJJ Associations FDCS Bailleurs\n\nNombres d'actions collectives Accompagnements individuels\n\nREAAP CLAS Politique de la ville\n\nPacte local des solidarités comité départemental des services aux familles Comités REAPP, CLAS Contrat de ville\n\nRenforcer le lien police/population en favorisant des temps de rencontre et des espaces de dialogue\n\nAssociations CD58 PJJ SPIP\n\nActivation de la GUP, création de nouveaux service aux usagers, mise en place de marches exploratoires Rencontres institutionnelles, et implication des implications dans la constitution des groupes d'échange\n\nPolitique de la ville\n\nContrat de sécurité intégrée CLSPD Contrat de ville\n\nPrévenir les actes de délinquance ou d’incivilités à travers des actions éducatives, citoyennes, sportives\n\nAssociations CD58 PJJ SPIP\n\nNombre d’actions mises en place Diminution des actes de délinquance ou d’incivilités\n\nFIPD MILDECA Politique de la Ville Agence nationale du sport : Plan sportif territorial\n\nContrat de sécurité intégrée Contrat de ville Autres appels à projets\n\nLutter contre les trafics de drogue Etat (Préfecture) Ville de Nevers Tribunal Judiciaire Baisse du trafic, des points de deal et de leur fréquentation FIPD Contrat de sécurité intégrée\n\nDévelopper des actions de prévention et de lutte contre les violences intrafamiliales et/ou faites aux femmes\n\nEtat (Déléguée aux droits des femmes,\n\nDDETSPP)\n\nCIDFF CD58 France Victimes 58 AFHED CAF CDAD CMP Nevers Agglomération\n\nNombre d’actions mises en place Diminution des actes de violence\n\nDroit commun : Agence nationale du sport (Plan sportif territorial), FIPD, crédits DDFE Politique de la Ville\n\nDéclinaison départementale du plan interministériel pour l’égalité entre les femmes et les hommes Contrat de ville Autres appels à projets\n\n**Favoriser l'accès à l'emploi et**\n\n**développer l'activité**\n\n**économique**\n\n**Coordonner l'accompagnement pour le retour à l'emploi**\n\n**Améliorer la sécurité, prévenir**\n\n**la délinquance**\n\n**Développer l'axe de prévention**\n\nVille de Nevers / Etat (Préfecture)\n\n**Favoriser la réussite éducative**\n\n**Soutien aux actions de parentalité**\n\n**Créer les conditions favorables à la réussite**\n\nVille de Nevers / État (Éducation\n\nNationale)\n\nMàJ\\_29/03/2024","pages":[{"line_numbers":[],"markdown":"Tableau de bord\\_Contrat de Ville Nevers\\_2024 -2030\\_VDEF Contrat de ville - Engagements quartiers 2030\n\n**Priorités** **Enjeux** **Déclinaison des objectifs opérationnels** **Pilote de l'objectif Contributeurs Indicateurs /**\n\n**Impacts recherchés (non exhaustifs)** **Pistes de financement (non exhaustives) Cadre/contractualisations**\n\nFaciliter l’accès des habitants à la formation et aux différents dispositifs d'accompagnement pour l'insertion professionnelle\n\nNevers Agglomération (Cité de\n\nl'Emploi) / France Travail Opérateur et opérateurs spécialisés (CAP Emploi,\n\nMILO)\n\nEtat (DETSPP) CD58 Nevers Agglomération (PLIE) SIAE Entreprises (Les entreprises s'engagent) CRBFC Bailleur Nièvre Habitat\n\nAmélioration de la coordination des différents acteurs Mobilisation des structures intermédiaires, mobilisation des entreprises Nombre d’actions de promotion Nombre d’actions « d’aller-vers » Nombre de personnes des quartiers ayant intégré une formation ou un dispositif d’accompagnement\n\nCRBFC Bailleurs en lien avec l'abattement TFPB Pacte local des solidarités Contrat de ville\n\nCité de l'emploi Pacte local des solidarités Démarche France travail\n\nPrévenir la marginalisation de certains jeunes en travaillant les compétences de savoir-être en lien avec le réseau France Travail\n\nNevers Agglomération (Cité de\n\nl'Emploi) / France Travail Opérateur et opérateurs spécialisés (CAP Emploi,\n\nMILO)\n\nAssociations CRBFC\n\nNombre de personnes des quartiers ayant intégré des ateliers Amélioration de la coordination des différents acteurs Nombre d’actions spécifiques aux quartiers\n\nCRBFC Crédits Politique de la ville\n\nCité de l'emploi Démarche France travail Pacte local des solidarités\n\nLutter contre l’illettrisme Nevers Agglomération (Cité de\n\nl'Emploi) / CD58\n\nEtat (DETSPP) AFPLI FOL DEFL CRBFC Education Nationale ANLCI\n\nNombre de personnes du quartier repérées et accompagnées Nombre de personnes du quartier ayant développé leurs compétences dans le cadre d’un accompagnement\n\nPacte local des solidarités CRBFC SDJES Contrat de ville\n\nPacte local des solidarités Plan départemental de lutte contre l'illettrisme Education Nationale\n\nLever les freins liés à la mobilité Nevers Agglomération (Cité de\n\nl'Emploi) / CD58\n\nEtat (DETSPP) CRBFC CCAS Associations\n\nNombre d’actions de promotion des solutions alternatives de mobilité : aide au permis, prêt de voitures solidaires, covoiturage Nombre de diagnostics mobilités (Opérateur France travail notamment) Nombre de personnes du quartier ayant fait appel à la plateforme mobilité de l’ASEM\n\nCRBFC Opérateur France travail Pacte local des solidarités\n\nSoutenir les parents dans leur rôle éducatif CAF / CD58\n\nFédération des centres sociaux CCAS-PRE Centres sociaux FDCS Ville de Nevers\n\nNombre d’actions mises en place Nombre de parents touchés Retours des familles\n\nREAAP CLAS Crédits Politique de la ville\n\nPacte local des solidarités comité départemental des services aux familles Comités REAPP, CLAS Contrat de ville, Cité éducative\n\nRenforcer les liens parents/école Ville de Nevers / Etat (Education\n\nNationale)\n\nFédération des centres sociaux CCAS-PRE Associations (dont Centres sociaux) CD58 CAF\n\nNombre de parents présents aux réunions parents/professeurs Nombre de parents élu Sréation d’associations de parents d’élèves\n\nREAAP CLAS Crédits Politique de la ville\n\nProjets d’écoles et d’établissements Comités REAPP, CLAS Contrat de ville\n\nRenforcer les partenariats entre les professionnels de l’éducation (Éducation nationale, ville, associations)\n\nNevers Agglomération CD58 CCAS-PRE Associations CAF\n\nNombre de projets co-construits entre partenaires (l’école, la ville, les associations, le CD) Crédits Politique de la ville : Cité éducative Projets d’écoles et d’établissements Contrat de ville, Cité éducative\n\nAgir dès le plus jeune âge en prévention (harcèlement, lutte contre les stéréotypes…)\n\nAgglomération CCAS-PRE CD58 Associations CAF\n\nNombre d’actions mises en place, baisse du nombre de situations de harcèlement sur les 6 ans, bien être et climat scolaire, réussite éducative\n\nAgence nationale du sport : Plan sportif territorial Éducation Nationale (SDJES et projet pHARe) Politique de la ville\n\nProjets d’écoles et d’établissements (dont projet pHARe) Contrat de ville, Cité éducative\n\nDévelopper l’accès aux activités artistiques, culturelles et sportives qui contribuent à l’épanouissement et à la réussite\n\nNevers Agglomération Associations CRBFC CD58 DRAC CCAS-PRE\n\nAméliorer l'implication des jeunes de quartiers dans la vie culturelle et associative de l'agglomération Nombre d’actions Nombre de participants, nouveaux participants % filles-garçons\n\nAgence nationale du sport : Plan sportif territorial SDJES DRAC Contrat de ville\n\nContrat de ville, Cité éducative Autres appels à projets\n\nFavoriser l’engagement et l’implication des jeunes : service civique, bénévolat, engagement associatif, Ville de Nevers / Etat ( SDJES)\n\nCD58 Asssociations CRBFC DMD SDIS FOL CCAS-PRE\n\nNombre de jeunes en service civique Nombre de bénévoles Nombre de participants dans les instances démocratiques Nombre de junior associations crées\n\nAgence nationale du sport : Plan sportif territorial SDJES\n\nPacte local des solidarités Contrat de ville\n\n**Favoriser la coordination et le travail partenarial**\n\nEn lien avec le CLSP, installer et mettre en œuvre des cellules de coordination favorisant les échanges d’informations entre les partenaires dans le respect du secret partagé\n\nVille de Nevers / Etat (Préfecture)\n\nCD58 CCAS CMP Bailleurs Associations Nevers Agglomération\n\nFocus QPV dans les CLSPD Diagnostic local de sécurité aboutissant à des orientations partagées Mise en place de groupes thématiques ou par quartier favoriser l'accessibilité et la fluidité des connaissances interprofessionnelles et des informations partagées Conventions partenariales, outils mutualisés\n\nFIPD MILDECA Politique de la ville\n\nCLSPD Contrat de ville\n\nRenforcer la présence humaine : médiateurs formés, éducateurs spécialisés, sportifs Ville de Nevers / CD58\n\nBailleurs Associations Nevers Agglomération PJJ Etat (Préfecture, SDJES)\n\nAboutir à une équipe pluridisciplinaire et formée en capacité de couvrir les 3 QPV\n\nFIPD MILDECA Pacte local des solidarités Politique de la ville Agence nationale du sport : plan sportif territorial\n\nContrat de ville (adultes-relais) Pacte local des solidarités\n\nAccompagner les familles dans l’exercice de la parentalité CD58 / CAF\n\nVille de Nevers CCAS-PRE PJJ Associations FDCS Bailleurs\n\nNombres d'actions collectives Accompagnements individuels\n\nREAAP CLAS Politique de la ville\n\nPacte local des solidarités comité départemental des services aux familles Comités REAPP, CLAS Contrat de ville\n\nRenforcer le lien police/population en favorisant des temps de rencontre et des espaces de dialogue\n\nAssociations CD58 PJJ SPIP\n\nActivation de la GUP, création de nouveaux service aux usagers, mise en place de marches exploratoires Rencontres institutionnelles, et implication des implications dans la constitution des groupes d'échange\n\nPolitique de la ville\n\nContrat de sécurité intégrée CLSPD Contrat de ville\n\nPrévenir les actes de délinquance ou d’incivilités à travers des actions éducatives, citoyennes, sportives\n\nAssociations CD58 PJJ SPIP\n\nNombre d’actions mises en place Diminution des actes de délinquance ou d’incivilités\n\nFIPD MILDECA Politique de la Ville Agence nationale du sport : Plan sportif territorial\n\nContrat de sécurité intégrée Contrat de ville Autres appels à projets\n\nLutter contre les trafics de drogue Etat (Préfecture) Ville de Nevers Tribunal Judiciaire Baisse du trafic, des points de deal et de leur fréquentation FIPD Contrat de sécurité intégrée\n\nDévelopper des actions de prévention et de lutte contre les violences intrafamiliales et/ou faites aux femmes\n\nEtat (Déléguée aux droits des femmes,\n\nDDETSPP)\n\nCIDFF CD58 France Victimes 58 AFHED CAF CDAD CMP Nevers Agglomération\n\nNombre d’actions mises en place Diminution des actes de violence\n\nDroit commun : Agence nationale du sport (Plan sportif territorial), FIPD, crédits DDFE Politique de la Ville\n\nDéclinaison départementale du plan interministériel pour l’égalité entre les femmes et les hommes Contrat de ville Autres appels à projets\n\n**Favoriser l'accès à l'emploi et**\n\n**développer l'activité**\n\n**économique**\n\n**Coordonner l'accompagnement pour le retour à l'emploi**\n\n**Améliorer la sécurité, prévenir**\n\n**la délinquance**\n\n**Développer l'axe de prévention**\n\nVille de Nevers / Etat (Préfecture)\n\n**Favoriser la réussite éducative**\n\n**Soutien aux actions de parentalité**\n\n**Créer les conditions favorables à la réussite**\n\nVille de Nevers / État (Éducation\n\nNationale)\n\nMàJ\\_29/03/2024","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Tableau de bord\\_Contrat de Ville Nevers\\_2024 -2030\\_VDEF Contrat de ville - Engagements quartiers 2030\n\n**Priorités** **Enjeux** **Déclinaison des objectifs opérationnels** **Pilote de l'objectif Contributeurs Indicateurs /**\n\n**Impacts recherchés (non exhaustifs)** **Pistes de financement (non exhaustives) Cadre/contractualisations**\n\nFaciliter l’accès des habitants à la formation et aux différents dispositifs d'accompagnement pour l'insertion professionnelle\n\nNevers Agglomération (Cité de\n\nl'Emploi) / France Travail Opérateur et opérateurs spécialisés (CAP Emploi,\n\nMILO)\n\nEtat (DETSPP) CD58 Nevers Agglomération (PLIE) SIAE Entreprises (Les entreprises s'engagent) CRBFC Bailleur Nièvre Habitat\n\nAmélioration de la coordination des différents acteurs Mobilisation des structures intermédiaires, mobilisation des entreprises Nombre d’actions de promotion Nombre d’actions « d’aller-vers » Nombre de personnes des quartiers ayant intégré une formation ou un dispositif d’accompagnement\n\nCRBFC Bailleurs en lien avec l'abattement TFPB Pacte local des solidarités Contrat de ville\n\nCité de l'emploi Pacte local des solidarités Démarche France travail\n\nPrévenir la marginalisation de certains jeunes en travaillant les compétences de savoir-être en lien avec le réseau France Travail\n\nNevers Agglomération (Cité de\n\nl'Emploi) / France Travail Opérateur et opérateurs spécialisés (CAP Emploi,\n\nMILO)\n\nAssociations CRBFC\n\nNombre de personnes des quartiers ayant intégré des ateliers Amélioration de la coordination des différents acteurs Nombre d’actions spécifiques aux quartiers\n\nCRBFC Crédits Politique de la ville\n\nCité de l'emploi Démarche France travail Pacte local des solidarités\n\nLutter contre l’illettrisme Nevers Agglomération (Cité de\n\nl'Emploi) / CD58\n\nEtat (DETSPP) AFPLI FOL DEFL CRBFC Education Nationale ANLCI\n\nNombre de personnes du quartier repérées et accompagnées Nombre de personnes du quartier ayant développé leurs compétences dans le cadre d’un accompagnement\n\nPacte local des solidarités CRBFC SDJES Contrat de ville\n\nPacte local des solidarités Plan départemental de lutte contre l'illettrisme Education Nationale\n\nLever les freins liés à la mobilité Nevers Agglomération (Cité de\n\nl'Emploi) / CD58\n\nEtat (DETSPP) CRBFC CCAS Associations\n\nNombre d’actions de promotion des solutions alternatives de mobilité : aide au permis, prêt de voitures solidaires, covoiturage Nombre de diagnostics mobilités (Opérateur France travail notamment) Nombre de personnes du quartier ayant fait appel à la plateforme mobilité de l’ASEM\n\nCRBFC Opérateur France travail Pacte local des solidarités\n\nSoutenir les parents dans leur rôle éducatif CAF / CD58\n\nFédération des centres sociaux CCAS-PRE Centres sociaux FDCS Ville de Nevers\n\nNombre d’actions mises en place Nombre de parents touchés Retours des familles\n\nREAAP CLAS Crédits Politique de la ville\n\nPacte local des solidarités comité départemental des services aux familles Comités REAPP, CLAS Contrat de ville, Cité éducative\n\nRenforcer les liens parents/école Ville de Nevers / Etat (Education\n\nNationale)\n\nFédération des centres sociaux CCAS-PRE Associations (dont Centres sociaux) CD58 CAF\n\nNombre de parents présents aux réunions parents/professeurs Nombre de parents élu Sréation d’associations de parents d’élèves\n\nREAAP CLAS Crédits Politique de la ville\n\nProjets d’écoles et d’établissements Comités REAPP, CLAS Contrat de ville\n\nRenforcer les partenariats entre les professionnels de l’éducation (Éducation nationale, ville, associations)\n\nNevers Agglomération CD58 CCAS-PRE Associations CAF\n\nNombre de projets co-construits entre partenaires (l’école, la ville, les associations, le CD) Crédits Politique de la ville : Cité éducative Projets d’écoles et d’établissements Contrat de ville, Cité éducative\n\nAgir dès le plus jeune âge en prévention (harcèlement, lutte contre les stéréotypes…)\n\nAgglomération CCAS-PRE CD58 Associations CAF\n\nNombre d’actions mises en place, baisse du nombre de situations de harcèlement sur les 6 ans, bien être et climat scolaire, réussite éducative\n\nAgence nationale du sport : Plan sportif territorial Éducation Nationale (SDJES et projet pHARe) Politique de la ville\n\nProjets d’écoles et d’établissements (dont projet pHARe) Contrat de ville, Cité éducative\n\nDévelopper l’accès aux activités artistiques, culturelles et sportives qui contribuent à l’épanouissement et à la réussite\n\nNevers Agglomération Associations CRBFC CD58 DRAC CCAS-PRE\n\nAméliorer l'implication des jeunes de quartiers dans la vie culturelle et associative de l'agglomération Nombre d’actions Nombre de participants, nouveaux participants % filles-garçons\n\nAgence nationale du sport : Plan sportif territorial SDJES DRAC Contrat de ville\n\nContrat de ville, Cité éducative Autres appels à projets\n\nFavoriser l’engagement et l’implication des jeunes : service civique, bénévolat, engagement associatif, Ville de Nevers / Etat ( SDJES)\n\nCD58 Asssociations CRBFC DMD SDIS FOL CCAS-PRE\n\nNombre de jeunes en service civique Nombre de bénévoles Nombre de participants dans les instances démocratiques Nombre de junior associations crées\n\nAgence nationale du sport : Plan sportif territorial SDJES\n\nPacte local des solidarités Contrat de ville\n\n**Favoriser la coordination et le travail partenarial**\n\nEn lien avec le CLSP, installer et mettre en œuvre des cellules de coordination favorisant les échanges d’informations entre les partenaires dans le respect du secret partagé\n\nVille de Nevers / Etat (Préfecture)\n\nCD58 CCAS CMP Bailleurs Associations Nevers Agglomération\n\nFocus QPV dans les CLSPD Diagnostic local de sécurité aboutissant à des orientations partagées Mise en place de groupes thématiques ou par quartier favoriser l'accessibilité et la fluidité des connaissances interprofessionnelles et des informations partagées Conventions partenariales, outils mutualisés\n\nFIPD MILDECA Politique de la ville\n\nCLSPD Contrat de ville\n\nRenforcer la présence humaine : médiateurs formés, éducateurs spécialisés, sportifs Ville de Nevers / CD58\n\nBailleurs Associations Nevers Agglomération PJJ Etat (Préfecture, SDJES)\n\nAboutir à une équipe pluridisciplinaire et formée en capacité de couvrir les 3 QPV\n\nFIPD MILDECA Pacte local des solidarités Politique de la ville Agence nationale du sport : plan sportif territorial\n\nContrat de ville (adultes-relais) Pacte local des solidarités\n\nAccompagner les familles dans l’exercice de la parentalité CD58 / CAF\n\nVille de Nevers CCAS-PRE PJJ Associations FDCS Bailleurs\n\nNombres d'actions collectives Accompagnements individuels\n\nREAAP CLAS Politique de la ville\n\nPacte local des solidarités comité départemental des services aux familles Comités REAPP, CLAS Contrat de ville\n\nRenforcer le lien police/population en favorisant des temps de rencontre et des espaces de dialogue\n\nAssociations CD58 PJJ SPIP\n\nActivation de la GUP, création de nouveaux service aux usagers, mise en place de marches exploratoires Rencontres institutionnelles, et implication des implications dans la constitution des groupes d'échange\n\nPolitique de la ville\n\nContrat de sécurité intégrée CLSPD Contrat de ville\n\nPrévenir les actes de délinquance ou d’incivilités à travers des actions éducatives, citoyennes, sportives\n\nAssociations CD58 PJJ SPIP\n\nNombre d’actions mises en place Diminution des actes de délinquance ou d’incivilités\n\nFIPD MILDECA Politique de la Ville Agence nationale du sport : Plan sportif territorial\n\nContrat de sécurité intégrée Contrat de ville Autres appels à projets\n\nLutter contre les trafics de drogue Etat (Préfecture) Ville de Nevers Tribunal Judiciaire Baisse du trafic, des points de deal et de leur fréquentation FIPD Contrat de sécurité intégrée\n\nDévelopper des actions de prévention et de lutte contre les violences intrafamiliales et/ou faites aux femmes\n\nEtat (Déléguée aux droits des femmes,\n\nDDETSPP)\n\nCIDFF CD58 France Victimes 58 AFHED CAF CDAD CMP Nevers Agglomération\n\nNombre d’actions mises en place Diminution des actes de violence\n\nDroit commun : Agence nationale du sport (Plan sportif territorial), FIPD, crédits DDFE Politique de la Ville\n\nDéclinaison départementale du plan interministériel pour l’égalité entre les femmes et les hommes Contrat de ville Autres appels à projets\n\n**Favoriser l'accès à l'emploi et**\n\n**développer l'activité**\n\n**économique**\n\n**Coordonner l'accompagnement pour le retour à l'emploi**\n\n**Améliorer la sécurité, prévenir**\n\n**la délinquance**\n\n**Développer l'axe de prévention**\n\nVille de Nevers / Etat (Préfecture)\n\n**Favoriser la réussite éducative**\n\n**Soutien aux actions de parentalité**\n\n**Créer les conditions favorables à la réussite**\n\nVille de Nevers / État (Éducation\n\nNationale)\n\nMàJ\\_29/03/2024","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/245804406-CV-Nevers-signe%CC%81-EX_page60.pdf"]},"response":{"errors":[],"extract_id":"extract_a626b564506fe7e12d4ef0db2094b3b8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Tableau de bord\\_Contrat de Ville Nevers\\_2024 -2030\\_VDEF Contrat de ville - Engagements quartiers 2030\n\n**Priorités** **Enjeux** **Déclinaison des objectifs opérationnels** **Pilote de l'objectif Contributeurs Indicateurs /**\n\n**Impacts recherchés (non exhaustifs)** **Pistes de financement (non exhaustives) Cadre/contractualisations**\n\nFaciliter l’accès des habitants à la formation et aux différents dispositifs d'accompagnement pour l'insertion professionnelle\n\nNevers Agglomération (Cité de\n\nl'Emploi) / France Travail Opérateur et opérateurs spécialisés (CAP Emploi,\n\nMILO)\n\nEtat (DETSPP) CD58 Nevers Agglomération (PLIE) SIAE Entreprises (Les entreprises s'engagent) CRBFC Bailleur Nièvre Habitat\n\nAmélioration de la coordination des différents acteurs Mobilisation des structures intermédiaires, mobilisation des entreprises Nombre d’actions de promotion Nombre d’actions « d’aller-vers » Nombre de personnes des quartiers ayant intégré une formation ou un dispositif d’accompagnement\n\nCRBFC Bailleurs en lien avec l'abattement TFPB Pacte local des solidarités Contrat de ville\n\nCité de l'emploi Pacte local des solidarités Démarche France travail\n\nPrévenir la marginalisation de certains jeunes en travaillant les compétences de savoir-être en lien avec le réseau France Travail\n\nNevers Agglomération (Cité de\n\nl'Emploi) / France Travail Opérateur et opérateurs spécialisés (CAP Emploi,\n\nMILO)\n\nAssociations CRBFC\n\nNombre de personnes des quartiers ayant intégré des ateliers Amélioration de la coordination des différents acteurs Nombre d’actions spécifiques aux quartiers\n\nCRBFC Crédits Politique de la ville\n\nCité de l'emploi Démarche France travail Pacte local des solidarités\n\nLutter contre l’illettrisme Nevers Agglomération (Cité de\n\nl'Emploi) / CD58\n\nEtat (DETSPP) AFPLI FOL DEFL CRBFC Education Nationale ANLCI\n\nNombre de personnes du quartier repérées et accompagnées Nombre de personnes du quartier ayant développé leurs compétences dans le cadre d’un accompagnement\n\nPacte local des solidarités CRBFC SDJES Contrat de ville\n\nPacte local des solidarités Plan départemental de lutte contre l'illettrisme Education Nationale\n\nLever les freins liés à la mobilité Nevers Agglomération (Cité de\n\nl'Emploi) / CD58\n\nEtat (DETSPP) CRBFC CCAS Associations\n\nNombre d’actions de promotion des solutions alternatives de mobilité : aide au permis, prêt de voitures solidaires, covoiturage Nombre de diagnostics mobilités (Opérateur France travail notamment) Nombre de personnes du quartier ayant fait appel à la plateforme mobilité de l’ASEM\n\nCRBFC Opérateur France travail Pacte local des solidarités\n\nSoutenir les parents dans leur rôle éducatif CAF / CD58\n\nFédération des centres sociaux CCAS-PRE Centres sociaux FDCS Ville de Nevers\n\nNombre d’actions mises en place Nombre de parents touchés Retours des familles\n\nREAAP CLAS Crédits Politique de la ville\n\nPacte local des solidarités comité départemental des services aux familles Comités REAPP, CLAS Contrat de ville, Cité éducative\n\nRenforcer les liens parents/école Ville de Nevers / Etat (Education\n\nNationale)\n\nFédération des centres sociaux CCAS-PRE Associations (dont Centres sociaux) CD58 CAF\n\nNombre de parents présents aux réunions parents/professeurs Nombre de parents élu Sréation d’associations de parents d’élèves\n\nREAAP CLAS Crédits Politique de la ville\n\nProjets d’écoles et d’établissements Comités REAPP, CLAS Contrat de ville\n\nRenforcer les partenariats entre les professionnels de l’éducation (Éducation nationale, ville, associations)\n\nNevers Agglomération CD58 CCAS-PRE Associations CAF\n\nNombre de projets co-construits entre partenaires (l’école, la ville, les associations, le CD) Crédits Politique de la ville : Cité éducative Projets d’écoles et d’établissements Contrat de ville, Cité éducative\n\nAgir dès le plus jeune âge en prévention (harcèlement, lutte contre les stéréotypes…)\n\nAgglomération CCAS-PRE CD58 Associations CAF\n\nNombre d’actions mises en place, baisse du nombre de situations de harcèlement sur les 6 ans, bien être et climat scolaire, réussite éducative\n\nAgence nationale du sport : Plan sportif territorial Éducation Nationale (SDJES et projet pHARe) Politique de la ville\n\nProjets d’écoles et d’établissements (dont projet pHARe) Contrat de ville, Cité éducative\n\nDévelopper l’accès aux activités artistiques, culturelles et sportives qui contribuent à l’épanouissement et à la réussite\n\nNevers Agglomération Associations CRBFC CD58 DRAC CCAS-PRE\n\nAméliorer l'implication des jeunes de quartiers dans la vie culturelle et associative de l'agglomération Nombre d’actions Nombre de participants, nouveaux participants % filles-garçons\n\nAgence nationale du sport : Plan sportif territorial SDJES DRAC Contrat de ville\n\nContrat de ville, Cité éducative Autres appels à projets\n\nFavoriser l’engagement et l’implication des jeunes : service civique, bénévolat, engagement associatif, Ville de Nevers / Etat ( SDJES)\n\nCD58 Asssociations CRBFC DMD SDIS FOL CCAS-PRE\n\nNombre de jeunes en service civique Nombre de bénévoles Nombre de participants dans les instances démocratiques Nombre de junior associations crées\n\nAgence nationale du sport : Plan sportif territorial SDJES\n\nPacte local des solidarités Contrat de ville\n\n**Favoriser la coordination et le travail partenarial**\n\nEn lien avec le CLSP, installer et mettre en œuvre des cellules de coordination favorisant les échanges d’informations entre les partenaires dans le respect du secret partagé\n\nVille de Nevers / Etat (Préfecture)\n\nCD58 CCAS CMP Bailleurs Associations Nevers Agglomération\n\nFocus QPV dans les CLSPD Diagnostic local de sécurité aboutissant à des orientations partagées Mise en place de groupes thématiques ou par quartier favoriser l'accessibilité et la fluidité des connaissances interprofessionnelles et des informations partagées Conventions partenariales, outils mutualisés\n\nFIPD MILDECA Politique de la ville\n\nCLSPD Contrat de ville\n\nRenforcer la présence humaine : médiateurs formés, éducateurs spécialisés, sportifs Ville de Nevers / CD58\n\nBailleurs Associations Nevers Agglomération PJJ Etat (Préfecture, SDJES)\n\nAboutir à une équipe pluridisciplinaire et formée en capacité de couvrir les 3 QPV\n\nFIPD MILDECA Pacte local des solidarités Politique de la ville Agence nationale du sport : plan sportif territorial\n\nContrat de ville (adultes-relais) Pacte local des solidarités\n\nAccompagner les familles dans l’exercice de la parentalité CD58 / CAF\n\nVille de Nevers CCAS-PRE PJJ Associations FDCS Bailleurs\n\nNombres d'actions collectives Accompagnements individuels\n\nREAAP CLAS Politique de la ville\n\nPacte local des solidarités comité départemental des services aux familles Comités REAPP, CLAS Contrat de ville\n\nRenforcer le lien police/population en favorisant des temps de rencontre et des espaces de dialogue\n\nAssociations CD58 PJJ SPIP\n\nActivation de la GUP, création de nouveaux service aux usagers, mise en place de marches exploratoires Rencontres institutionnelles, et implication des implications dans la constitution des groupes d'échange\n\nPolitique de la ville\n\nContrat de sécurité intégrée CLSPD Contrat de ville\n\nPrévenir les actes de délinquance ou d’incivilités à travers des actions éducatives, citoyennes, sportives\n\nAssociations CD58 PJJ SPIP\n\nNombre d’actions mises en place Diminution des actes de délinquance ou d’incivilités\n\nFIPD MILDECA Politique de la Ville Agence nationale du sport : Plan sportif territorial\n\nContrat de sécurité intégrée Contrat de ville Autres appels à projets\n\nLutter contre les trafics de drogue Etat (Préfecture) Ville de Nevers Tribunal Judiciaire Baisse du trafic, des points de deal et de leur fréquentation FIPD Contrat de sécurité intégrée\n\nDévelopper des actions de prévention et de lutte contre les violences intrafamiliales et/ou faites aux femmes\n\nEtat (Déléguée aux droits des femmes,\n\nDDETSPP)\n\nCIDFF CD58 France Victimes 58 AFHED CAF CDAD CMP Nevers Agglomération\n\nNombre d’actions mises en place Diminution des actes de violence\n\nDroit commun : Agence nationale du sport (Plan sportif territorial), FIPD, crédits DDFE Politique de la Ville\n\nDéclinaison départementale du plan interministériel pour l’égalité entre les femmes et les hommes Contrat de ville Autres appels à projets\n\n**Favoriser l'accès à l'emploi et**\n\n**développer l'activité**\n\n**économique**\n\n**Coordonner l'accompagnement pour le retour à l'emploi**\n\n**Améliorer la sécurité, prévenir**\n\n**la délinquance**\n\n**Développer l'axe de prévention**\n\nVille de Nevers / Etat (Préfecture)\n\n**Favoriser la réussite éducative**\n\n**Soutien aux actions de parentalité**\n\n**Créer les conditions favorables à la réussite**\n\nVille de Nevers / État (Éducation\n\nNationale)\n\nMàJ\\_29/03/2024"],"full_content":"Tableau de bord\\_Contrat de Ville Nevers\\_2024 -2030\\_VDEF Contrat de ville - Engagements quartiers 2030\n\n**Priorités** **Enjeux** **Déclinaison des objectifs opérationnels** **Pilote de l'objectif Contributeurs Indicateurs /**\n\n**Impacts recherchés (non exhaustifs)** **Pistes de financement (non exhaustives) Cadre/contractualisations**\n\nFaciliter l’accès des habitants à la formation et aux différents dispositifs d'accompagnement pour l'insertion professionnelle\n\nNevers Agglomération (Cité de\n\nl'Emploi) / France Travail Opérateur et opérateurs spécialisés (CAP Emploi,\n\nMILO)\n\nEtat (DETSPP) CD58 Nevers Agglomération (PLIE) SIAE Entreprises (Les entreprises s'engagent) CRBFC Bailleur Nièvre Habitat\n\nAmélioration de la coordination des différents acteurs Mobilisation des structures intermédiaires, mobilisation des entreprises Nombre d’actions de promotion Nombre d’actions « d’aller-vers » Nombre de personnes des quartiers ayant intégré une formation ou un dispositif d’accompagnement\n\nCRBFC Bailleurs en lien avec l'abattement TFPB Pacte local des solidarités Contrat de ville\n\nCité de l'emploi Pacte local des solidarités Démarche France travail\n\nPrévenir la marginalisation de certains jeunes en travaillant les compétences de savoir-être en lien avec le réseau France Travail\n\nNevers Agglomération (Cité de\n\nl'Emploi) / France Travail Opérateur et opérateurs spécialisés (CAP Emploi,\n\nMILO)\n\nAssociations CRBFC\n\nNombre de personnes des quartiers ayant intégré des ateliers Amélioration de la coordination des différents acteurs Nombre d’actions spécifiques aux quartiers\n\nCRBFC Crédits Politique de la ville\n\nCité de l'emploi Démarche France travail Pacte local des solidarités\n\nLutter contre l’illettrisme Nevers Agglomération (Cité de\n\nl'Emploi) / CD58\n\nEtat (DETSPP) AFPLI FOL DEFL CRBFC Education Nationale ANLCI\n\nNombre de personnes du quartier repérées et accompagnées Nombre de personnes du quartier ayant développé leurs compétences dans le cadre d’un accompagnement\n\nPacte local des solidarités CRBFC SDJES Contrat de ville\n\nPacte local des solidarités Plan départemental de lutte contre l'illettrisme Education Nationale\n\nLever les freins liés à la mobilité Nevers Agglomération (Cité de\n\nl'Emploi) / CD58\n\nEtat (DETSPP) CRBFC CCAS Associations\n\nNombre d’actions de promotion des solutions alternatives de mobilité : aide au permis, prêt de voitures solidaires, covoiturage Nombre de diagnostics mobilités (Opérateur France travail notamment) Nombre de personnes du quartier ayant fait appel à la plateforme mobilité de l’ASEM\n\nCRBFC Opérateur France travail Pacte local des solidarités\n\nSoutenir les parents dans leur rôle éducatif CAF / CD58\n\nFédération des centres sociaux CCAS-PRE Centres sociaux FDCS Ville de Nevers\n\nNombre d’actions mises en place Nombre de parents touchés Retours des familles\n\nREAAP CLAS Crédits Politique de la ville\n\nPacte local des solidarités comité départemental des services aux familles Comités REAPP, CLAS Contrat de ville, Cité éducative\n\nRenforcer les liens parents/école Ville de Nevers / Etat (Education\n\nNationale)\n\nFédération des centres sociaux CCAS-PRE Associations (dont Centres sociaux) CD58 CAF\n\nNombre de parents présents aux réunions parents/professeurs Nombre de parents élu Sréation d’associations de parents d’élèves\n\nREAAP CLAS Crédits Politique de la ville\n\nProjets d’écoles et d’établissements Comités REAPP, CLAS Contrat de ville\n\nRenforcer les partenariats entre les professionnels de l’éducation (Éducation nationale, ville, associations)\n\nNevers Agglomération CD58 CCAS-PRE Associations CAF\n\nNombre de projets co-construits entre partenaires (l’école, la ville, les associations, le CD) Crédits Politique de la ville : Cité éducative Projets d’écoles et d’établissements Contrat de ville, Cité éducative\n\nAgir dès le plus jeune âge en prévention (harcèlement, lutte contre les stéréotypes…)\n\nAgglomération CCAS-PRE CD58 Associations CAF\n\nNombre d’actions mises en place, baisse du nombre de situations de harcèlement sur les 6 ans, bien être et climat scolaire, réussite éducative\n\nAgence nationale du sport : Plan sportif territorial Éducation Nationale (SDJES et projet pHARe) Politique de la ville\n\nProjets d’écoles et d’établissements (dont projet pHARe) Contrat de ville, Cité éducative\n\nDévelopper l’accès aux activités artistiques, culturelles et sportives qui contribuent à l’épanouissement et à la réussite\n\nNevers Agglomération Associations CRBFC CD58 DRAC CCAS-PRE\n\nAméliorer l'implication des jeunes de quartiers dans la vie culturelle et associative de l'agglomération Nombre d’actions Nombre de participants, nouveaux participants % filles-garçons\n\nAgence nationale du sport : Plan sportif territorial SDJES DRAC Contrat de ville\n\nContrat de ville, Cité éducative Autres appels à projets\n\nFavoriser l’engagement et l’implication des jeunes : service civique, bénévolat, engagement associatif, Ville de Nevers / Etat ( SDJES)\n\nCD58 Asssociations CRBFC DMD SDIS FOL CCAS-PRE\n\nNombre de jeunes en service civique Nombre de bénévoles Nombre de participants dans les instances démocratiques Nombre de junior associations crées\n\nAgence nationale du sport : Plan sportif territorial SDJES\n\nPacte local des solidarités Contrat de ville\n\n**Favoriser la coordination et le travail partenarial**\n\nEn lien avec le CLSP, installer et mettre en œuvre des cellules de coordination favorisant les échanges d’informations entre les partenaires dans le respect du secret partagé\n\nVille de Nevers / Etat (Préfecture)\n\nCD58 CCAS CMP Bailleurs Associations Nevers Agglomération\n\nFocus QPV dans les CLSPD Diagnostic local de sécurité aboutissant à des orientations partagées Mise en place de groupes thématiques ou par quartier favoriser l'accessibilité et la fluidité des connaissances interprofessionnelles et des informations partagées Conventions partenariales, outils mutualisés\n\nFIPD MILDECA Politique de la ville\n\nCLSPD Contrat de ville\n\nRenforcer la présence humaine : médiateurs formés, éducateurs spécialisés, sportifs Ville de Nevers / CD58\n\nBailleurs Associations Nevers Agglomération PJJ Etat (Préfecture, SDJES)\n\nAboutir à une équipe pluridisciplinaire et formée en capacité de couvrir les 3 QPV\n\nFIPD MILDECA Pacte local des solidarités Politique de la ville Agence nationale du sport : plan sportif territorial\n\nContrat de ville (adultes-relais) Pacte local des solidarités\n\nAccompagner les familles dans l’exercice de la parentalité CD58 / CAF\n\nVille de Nevers CCAS-PRE PJJ Associations FDCS Bailleurs\n\nNombres d'actions collectives Accompagnements individuels\n\nREAAP CLAS Politique de la ville\n\nPacte local des solidarités comité départemental des services aux familles Comités REAPP, CLAS Contrat de ville\n\nRenforcer le lien police/population en favorisant des temps de rencontre et des espaces de dialogue\n\nAssociations CD58 PJJ SPIP\n\nActivation de la GUP, création de nouveaux service aux usagers, mise en place de marches exploratoires Rencontres institutionnelles, et implication des implications dans la constitution des groupes d'échange\n\nPolitique de la ville\n\nContrat de sécurité intégrée CLSPD Contrat de ville\n\nPrévenir les actes de délinquance ou d’incivilités à travers des actions éducatives, citoyennes, sportives\n\nAssociations CD58 PJJ SPIP\n\nNombre d’actions mises en place Diminution des actes de délinquance ou d’incivilités\n\nFIPD MILDECA Politique de la Ville Agence nationale du sport : Plan sportif territorial\n\nContrat de sécurité intégrée Contrat de ville Autres appels à projets\n\nLutter contre les trafics de drogue Etat (Préfecture) Ville de Nevers Tribunal Judiciaire Baisse du trafic, des points de deal et de leur fréquentation FIPD Contrat de sécurité intégrée\n\nDévelopper des actions de prévention et de lutte contre les violences intrafamiliales et/ou faites aux femmes\n\nEtat (Déléguée aux droits des femmes,\n\nDDETSPP)\n\nCIDFF CD58 France Victimes 58 AFHED CAF CDAD CMP Nevers Agglomération\n\nNombre d’actions mises en place Diminution des actes de violence\n\nDroit commun : Agence nationale du sport (Plan sportif territorial), FIPD, crédits DDFE Politique de la Ville\n\nDéclinaison départementale du plan interministériel pour l’égalité entre les femmes et les hommes Contrat de ville Autres appels à projets\n\n**Favoriser l'accès à l'emploi et**\n\n**développer l'activité**\n\n**économique**\n\n**Coordonner l'accompagnement pour le retour à l'emploi**\n\n**Améliorer la sécurité, prévenir**\n\n**la délinquance**\n\n**Développer l'axe de prévention**\n\nVille de Nevers / Etat (Préfecture)\n\n**Favoriser la réussite éducative**\n\n**Soutien aux actions de parentalité**\n\n**Créer les conditions favorables à la réussite**\n\nVille de Nevers / État (Éducation\n\nNationale)\n\nMàJ\\_29/03/2024","publish_date":null,"title":"Contrat de ville - Engagements quartiers 2030","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/245804406-CV-Nevers-signe%CC%81-EX_page60.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/245804406-CV-Nevers-signe%CC%81-EX_page60.pdf"},"request":{"example_id":"table/245804406-CV-Nevers-signé-EX_page60","product_type":"parse","source_file_path":"245804406-CV-Nevers-signé-EX_page60.pdf"},"started_at":"2026-11-04T22:55:44.391058"} +{"completed_at":"2026-11-04T19:47:18.206260","latency_in_ms":1703,"output":{"example_id":"table/637951191e7b35ae07dbd4c76a2e6690c370_pg2_pg1_page1","grounded_pages":[],"layout_pages":[],"markdown":"**_Table 2. Control of volunteer RR 2Xtend alfalfa with dicamba, 2,4-D and glufosinate systems in no-till soybean at Rochester, MN in 2018._** Pest Name **VOLUNTEER ALFALFA**\n\nRating Date **Jun-14-2018 Jun-22-2018 Jun-27-2018 Jul-6-2018 Jul-11-2018 Jul-17-2018**\n\nTrt Treatment Rate Appl **PERCENT CONTROL (%)**\n\n**_PRE (6/4/18) / POST II (6/23/18)_**\n\n1 SONIC 6.4 oz wt/a A **24 d 13 g 78 d 68 e 60 c 58 d**\n\nFLEXSTAR GT 3.5 3 pt/a C\n\nN-PAK AMS 2.5 % v/v C\n\nNIS 0.5 % v/v C\n\n2 SONIC 6.4 oz wt/a A **24 d 13 g 60 e 95 abc 98 a 99 a**\n\nENLIST DUO 75 fl oz/a C\n\nN-PAK AMS 2.5 % v/v C\n\n6 LIBERTY 280 32 fl oz/a A **82 c 80 e 96 a 93 bcd 92 b 92 c**\n\nWARRANT ULTRA 3 pt/a A\n\nN-PAK AMS 2.5 % v/v A\n\nLIBERTY 280 32 fl oz/a C\n\nN-PAK AMS 2.5 % v/v C\n\n**_PRE (6/4/18) / POST III (6/29/18)_**\n\n3 SONIC 6.4 oz wt/a A **87 b 86 d 81 c 94 bcd 97 a 99 a**\n\nENLIST DUO 75 fl oz/a A\n\nENLIST DUO 75 fl oz/a D\n\nN-PAK AMS 2.5 % v/v D\n\n4 ENLIST DUO 75 fl oz/a A **88 b 89 c 86 b 99 a 99 a 99 a**\n\nEVERPREX 16 fl oz/a D\n\n2,4-D CHOLINE SALT 32 fl oz/a D\n\nLIBERTY 280 32 fl oz/a D\n\nN-PAK AMS 2.5 % v/v D\n\n**_PRE (6/4/18) / POST IV (7/6/18)_**\n\n9 FEXAPAN 44 fl oz/a A **94 a 95 b 95 a 90 d 93 b 97 b**\n\nABUNDIT EDGE 32 fl oz/a A\n\nDRA 0.5 % v/v A\n\nCLASS ACT RIDION 1.0 % v/v A\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n10 SONIC 6.4 oz wt/a A **94 a 96 ab 96 a 92 cd 93 b 97 b**\n\nFEXAPAN 44 fl oz/a A\n\nABUNDIT EDGE 32 fl oz/a A\n\nDRA 0.5 % v/v A\n\nCLASS ACT RIDION 1.0 % v/v A\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n**_POST I (6/15/18) / POST IV (7/6/18)_**\n\n5 ENLIST DUO 75 fl oz/a B **0 e 70 f 96 a 99 a 99 a 99 a**\n\nN-PAK AMS 2.5 % v/v B\n\nEVERPREX 16 fl oz/a B\n\n2,4-D CHOLINE SALT 32 fl oz/a E\n\nLIBERTY 280 32 fl oz/a E\n\nN-PAK AMS 2.5 % v/v E\n\n7 LIBERTY 280 32 fl oz/a B **0 e 97 a 97 a 96 ab 99 a 99 a**\n\nN-PAK AMS 2.5 % v/v B\n\nWARRANT ULTRA 3 pt/a E\n\nLIBERTY 280 32 fl oz/a E\n\nN-PAK AMS 2.5 % v/v E\n\n11 FEXAPAN 22 fl oz/a B **0 e 70 f 86 b 97 ab 98 a 98 ab**\n\nABUNDIT EDGE 32 fl oz/a B\n\nDRA 0.5 % v/v B\n\nCLASS ACT RIDION 1.0 % v/v B\n\nWARRANT 3 pt/a E\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n**LSD P=.10 2.7 2.1 2.5 4.2 2.5 1.5**\n\nTreatments 8 and 12, untreated checks, are not shown in table. Means followed by same letter or symbol do not significantly differ (P=.10, LSD).","pages":[{"line_numbers":[],"markdown":"**_Table 2. Control of volunteer RR 2Xtend alfalfa with dicamba, 2,4-D and glufosinate systems in no-till soybean at Rochester, MN in 2018._** Pest Name **VOLUNTEER ALFALFA**\n\nRating Date **Jun-14-2018 Jun-22-2018 Jun-27-2018 Jul-6-2018 Jul-11-2018 Jul-17-2018**\n\nTrt Treatment Rate Appl **PERCENT CONTROL (%)**\n\n**_PRE (6/4/18) / POST II (6/23/18)_**\n\n1 SONIC 6.4 oz wt/a A **24 d 13 g 78 d 68 e 60 c 58 d**\n\nFLEXSTAR GT 3.5 3 pt/a C\n\nN-PAK AMS 2.5 % v/v C\n\nNIS 0.5 % v/v C\n\n2 SONIC 6.4 oz wt/a A **24 d 13 g 60 e 95 abc 98 a 99 a**\n\nENLIST DUO 75 fl oz/a C\n\nN-PAK AMS 2.5 % v/v C\n\n6 LIBERTY 280 32 fl oz/a A **82 c 80 e 96 a 93 bcd 92 b 92 c**\n\nWARRANT ULTRA 3 pt/a A\n\nN-PAK AMS 2.5 % v/v A\n\nLIBERTY 280 32 fl oz/a C\n\nN-PAK AMS 2.5 % v/v C\n\n**_PRE (6/4/18) / POST III (6/29/18)_**\n\n3 SONIC 6.4 oz wt/a A **87 b 86 d 81 c 94 bcd 97 a 99 a**\n\nENLIST DUO 75 fl oz/a A\n\nENLIST DUO 75 fl oz/a D\n\nN-PAK AMS 2.5 % v/v D\n\n4 ENLIST DUO 75 fl oz/a A **88 b 89 c 86 b 99 a 99 a 99 a**\n\nEVERPREX 16 fl oz/a D\n\n2,4-D CHOLINE SALT 32 fl oz/a D\n\nLIBERTY 280 32 fl oz/a D\n\nN-PAK AMS 2.5 % v/v D\n\n**_PRE (6/4/18) / POST IV (7/6/18)_**\n\n9 FEXAPAN 44 fl oz/a A **94 a 95 b 95 a 90 d 93 b 97 b**\n\nABUNDIT EDGE 32 fl oz/a A\n\nDRA 0.5 % v/v A\n\nCLASS ACT RIDION 1.0 % v/v A\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n10 SONIC 6.4 oz wt/a A **94 a 96 ab 96 a 92 cd 93 b 97 b**\n\nFEXAPAN 44 fl oz/a A\n\nABUNDIT EDGE 32 fl oz/a A\n\nDRA 0.5 % v/v A\n\nCLASS ACT RIDION 1.0 % v/v A\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n**_POST I (6/15/18) / POST IV (7/6/18)_**\n\n5 ENLIST DUO 75 fl oz/a B **0 e 70 f 96 a 99 a 99 a 99 a**\n\nN-PAK AMS 2.5 % v/v B\n\nEVERPREX 16 fl oz/a B\n\n2,4-D CHOLINE SALT 32 fl oz/a E\n\nLIBERTY 280 32 fl oz/a E\n\nN-PAK AMS 2.5 % v/v E\n\n7 LIBERTY 280 32 fl oz/a B **0 e 97 a 97 a 96 ab 99 a 99 a**\n\nN-PAK AMS 2.5 % v/v B\n\nWARRANT ULTRA 3 pt/a E\n\nLIBERTY 280 32 fl oz/a E\n\nN-PAK AMS 2.5 % v/v E\n\n11 FEXAPAN 22 fl oz/a B **0 e 70 f 86 b 97 ab 98 a 98 ab**\n\nABUNDIT EDGE 32 fl oz/a B\n\nDRA 0.5 % v/v B\n\nCLASS ACT RIDION 1.0 % v/v B\n\nWARRANT 3 pt/a E\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n**LSD P=.10 2.7 2.1 2.5 4.2 2.5 1.5**\n\nTreatments 8 and 12, untreated checks, are not shown in table. Means followed by same letter or symbol do not significantly differ (P=.10, LSD).","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**_Table 2. Control of volunteer RR 2Xtend alfalfa with dicamba, 2,4-D and glufosinate systems in no-till soybean at Rochester, MN in 2018._** Pest Name **VOLUNTEER ALFALFA**\n\nRating Date **Jun-14-2018 Jun-22-2018 Jun-27-2018 Jul-6-2018 Jul-11-2018 Jul-17-2018**\n\nTrt Treatment Rate Appl **PERCENT CONTROL (%)**\n\n**_PRE (6/4/18) / POST II (6/23/18)_**\n\n1 SONIC 6.4 oz wt/a A **24 d 13 g 78 d 68 e 60 c 58 d**\n\nFLEXSTAR GT 3.5 3 pt/a C\n\nN-PAK AMS 2.5 % v/v C\n\nNIS 0.5 % v/v C\n\n2 SONIC 6.4 oz wt/a A **24 d 13 g 60 e 95 abc 98 a 99 a**\n\nENLIST DUO 75 fl oz/a C\n\nN-PAK AMS 2.5 % v/v C\n\n6 LIBERTY 280 32 fl oz/a A **82 c 80 e 96 a 93 bcd 92 b 92 c**\n\nWARRANT ULTRA 3 pt/a A\n\nN-PAK AMS 2.5 % v/v A\n\nLIBERTY 280 32 fl oz/a C\n\nN-PAK AMS 2.5 % v/v C\n\n**_PRE (6/4/18) / POST III (6/29/18)_**\n\n3 SONIC 6.4 oz wt/a A **87 b 86 d 81 c 94 bcd 97 a 99 a**\n\nENLIST DUO 75 fl oz/a A\n\nENLIST DUO 75 fl oz/a D\n\nN-PAK AMS 2.5 % v/v D\n\n4 ENLIST DUO 75 fl oz/a A **88 b 89 c 86 b 99 a 99 a 99 a**\n\nEVERPREX 16 fl oz/a D\n\n2,4-D CHOLINE SALT 32 fl oz/a D\n\nLIBERTY 280 32 fl oz/a D\n\nN-PAK AMS 2.5 % v/v D\n\n**_PRE (6/4/18) / POST IV (7/6/18)_**\n\n9 FEXAPAN 44 fl oz/a A **94 a 95 b 95 a 90 d 93 b 97 b**\n\nABUNDIT EDGE 32 fl oz/a A\n\nDRA 0.5 % v/v A\n\nCLASS ACT RIDION 1.0 % v/v A\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n10 SONIC 6.4 oz wt/a A **94 a 96 ab 96 a 92 cd 93 b 97 b**\n\nFEXAPAN 44 fl oz/a A\n\nABUNDIT EDGE 32 fl oz/a A\n\nDRA 0.5 % v/v A\n\nCLASS ACT RIDION 1.0 % v/v A\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n**_POST I (6/15/18) / POST IV (7/6/18)_**\n\n5 ENLIST DUO 75 fl oz/a B **0 e 70 f 96 a 99 a 99 a 99 a**\n\nN-PAK AMS 2.5 % v/v B\n\nEVERPREX 16 fl oz/a B\n\n2,4-D CHOLINE SALT 32 fl oz/a E\n\nLIBERTY 280 32 fl oz/a E\n\nN-PAK AMS 2.5 % v/v E\n\n7 LIBERTY 280 32 fl oz/a B **0 e 97 a 97 a 96 ab 99 a 99 a**\n\nN-PAK AMS 2.5 % v/v B\n\nWARRANT ULTRA 3 pt/a E\n\nLIBERTY 280 32 fl oz/a E\n\nN-PAK AMS 2.5 % v/v E\n\n11 FEXAPAN 22 fl oz/a B **0 e 70 f 86 b 97 ab 98 a 98 ab**\n\nABUNDIT EDGE 32 fl oz/a B\n\nDRA 0.5 % v/v B\n\nCLASS ACT RIDION 1.0 % v/v B\n\nWARRANT 3 pt/a E\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n**LSD P=.10 2.7 2.1 2.5 4.2 2.5 1.5**\n\nTreatments 8 and 12, untreated checks, are not shown in table. Means followed by same letter or symbol do not significantly differ (P=.10, LSD).","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/637951191e7b35ae07dbd4c76a2e6690c370_pg2_pg1_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_0a34e8adc1b7cb2cdda21a4c942ff4a1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**_Table 2. Control of volunteer RR 2Xtend alfalfa with dicamba, 2,4-D and glufosinate systems in no-till soybean at Rochester, MN in 2018._** Pest Name **VOLUNTEER ALFALFA**\n\nRating Date **Jun-14-2018 Jun-22-2018 Jun-27-2018 Jul-6-2018 Jul-11-2018 Jul-17-2018**\n\nTrt Treatment Rate Appl **PERCENT CONTROL (%)**\n\n**_PRE (6/4/18) / POST II (6/23/18)_**\n\n1 SONIC 6.4 oz wt/a A **24 d 13 g 78 d 68 e 60 c 58 d**\n\nFLEXSTAR GT 3.5 3 pt/a C\n\nN-PAK AMS 2.5 % v/v C\n\nNIS 0.5 % v/v C\n\n2 SONIC 6.4 oz wt/a A **24 d 13 g 60 e 95 abc 98 a 99 a**\n\nENLIST DUO 75 fl oz/a C\n\nN-PAK AMS 2.5 % v/v C\n\n6 LIBERTY 280 32 fl oz/a A **82 c 80 e 96 a 93 bcd 92 b 92 c**\n\nWARRANT ULTRA 3 pt/a A\n\nN-PAK AMS 2.5 % v/v A\n\nLIBERTY 280 32 fl oz/a C\n\nN-PAK AMS 2.5 % v/v C\n\n**_PRE (6/4/18) / POST III (6/29/18)_**\n\n3 SONIC 6.4 oz wt/a A **87 b 86 d 81 c 94 bcd 97 a 99 a**\n\nENLIST DUO 75 fl oz/a A\n\nENLIST DUO 75 fl oz/a D\n\nN-PAK AMS 2.5 % v/v D\n\n4 ENLIST DUO 75 fl oz/a A **88 b 89 c 86 b 99 a 99 a 99 a**\n\nEVERPREX 16 fl oz/a D\n\n2,4-D CHOLINE SALT 32 fl oz/a D\n\nLIBERTY 280 32 fl oz/a D\n\nN-PAK AMS 2.5 % v/v D\n\n**_PRE (6/4/18) / POST IV (7/6/18)_**\n\n9 FEXAPAN 44 fl oz/a A **94 a 95 b 95 a 90 d 93 b 97 b**\n\nABUNDIT EDGE 32 fl oz/a A\n\nDRA 0.5 % v/v A\n\nCLASS ACT RIDION 1.0 % v/v A\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n10 SONIC 6.4 oz wt/a A **94 a 96 ab 96 a 92 cd 93 b 97 b**\n\nFEXAPAN 44 fl oz/a A\n\nABUNDIT EDGE 32 fl oz/a A\n\nDRA 0.5 % v/v A\n\nCLASS ACT RIDION 1.0 % v/v A\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n**_POST I (6/15/18) / POST IV (7/6/18)_**\n\n5 ENLIST DUO 75 fl oz/a B **0 e 70 f 96 a 99 a 99 a 99 a**\n\nN-PAK AMS 2.5 % v/v B\n\nEVERPREX 16 fl oz/a B\n\n2,4-D CHOLINE SALT 32 fl oz/a E\n\nLIBERTY 280 32 fl oz/a E\n\nN-PAK AMS 2.5 % v/v E\n\n7 LIBERTY 280 32 fl oz/a B **0 e 97 a 97 a 96 ab 99 a 99 a**\n\nN-PAK AMS 2.5 % v/v B\n\nWARRANT ULTRA 3 pt/a E\n\nLIBERTY 280 32 fl oz/a E\n\nN-PAK AMS 2.5 % v/v E\n\n11 FEXAPAN 22 fl oz/a B **0 e 70 f 86 b 97 ab 98 a 98 ab**\n\nABUNDIT EDGE 32 fl oz/a B\n\nDRA 0.5 % v/v B\n\nCLASS ACT RIDION 1.0 % v/v B\n\nWARRANT 3 pt/a E\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n**LSD P=.10 2.7 2.1 2.5 4.2 2.5 1.5**\n\nTreatments 8 and 12, untreated checks, are not shown in table. Means followed by same letter or symbol do not significantly differ (P=.10, LSD)."],"full_content":"**_Table 2. Control of volunteer RR 2Xtend alfalfa with dicamba, 2,4-D and glufosinate systems in no-till soybean at Rochester, MN in 2018._** Pest Name **VOLUNTEER ALFALFA**\n\nRating Date **Jun-14-2018 Jun-22-2018 Jun-27-2018 Jul-6-2018 Jul-11-2018 Jul-17-2018**\n\nTrt Treatment Rate Appl **PERCENT CONTROL (%)**\n\n**_PRE (6/4/18) / POST II (6/23/18)_**\n\n1 SONIC 6.4 oz wt/a A **24 d 13 g 78 d 68 e 60 c 58 d**\n\nFLEXSTAR GT 3.5 3 pt/a C\n\nN-PAK AMS 2.5 % v/v C\n\nNIS 0.5 % v/v C\n\n2 SONIC 6.4 oz wt/a A **24 d 13 g 60 e 95 abc 98 a 99 a**\n\nENLIST DUO 75 fl oz/a C\n\nN-PAK AMS 2.5 % v/v C\n\n6 LIBERTY 280 32 fl oz/a A **82 c 80 e 96 a 93 bcd 92 b 92 c**\n\nWARRANT ULTRA 3 pt/a A\n\nN-PAK AMS 2.5 % v/v A\n\nLIBERTY 280 32 fl oz/a C\n\nN-PAK AMS 2.5 % v/v C\n\n**_PRE (6/4/18) / POST III (6/29/18)_**\n\n3 SONIC 6.4 oz wt/a A **87 b 86 d 81 c 94 bcd 97 a 99 a**\n\nENLIST DUO 75 fl oz/a A\n\nENLIST DUO 75 fl oz/a D\n\nN-PAK AMS 2.5 % v/v D\n\n4 ENLIST DUO 75 fl oz/a A **88 b 89 c 86 b 99 a 99 a 99 a**\n\nEVERPREX 16 fl oz/a D\n\n2,4-D CHOLINE SALT 32 fl oz/a D\n\nLIBERTY 280 32 fl oz/a D\n\nN-PAK AMS 2.5 % v/v D\n\n**_PRE (6/4/18) / POST IV (7/6/18)_**\n\n9 FEXAPAN 44 fl oz/a A **94 a 95 b 95 a 90 d 93 b 97 b**\n\nABUNDIT EDGE 32 fl oz/a A\n\nDRA 0.5 % v/v A\n\nCLASS ACT RIDION 1.0 % v/v A\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n10 SONIC 6.4 oz wt/a A **94 a 96 ab 96 a 92 cd 93 b 97 b**\n\nFEXAPAN 44 fl oz/a A\n\nABUNDIT EDGE 32 fl oz/a A\n\nDRA 0.5 % v/v A\n\nCLASS ACT RIDION 1.0 % v/v A\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n**_POST I (6/15/18) / POST IV (7/6/18)_**\n\n5 ENLIST DUO 75 fl oz/a B **0 e 70 f 96 a 99 a 99 a 99 a**\n\nN-PAK AMS 2.5 % v/v B\n\nEVERPREX 16 fl oz/a B\n\n2,4-D CHOLINE SALT 32 fl oz/a E\n\nLIBERTY 280 32 fl oz/a E\n\nN-PAK AMS 2.5 % v/v E\n\n7 LIBERTY 280 32 fl oz/a B **0 e 97 a 97 a 96 ab 99 a 99 a**\n\nN-PAK AMS 2.5 % v/v B\n\nWARRANT ULTRA 3 pt/a E\n\nLIBERTY 280 32 fl oz/a E\n\nN-PAK AMS 2.5 % v/v E\n\n11 FEXAPAN 22 fl oz/a B **0 e 70 f 86 b 97 ab 98 a 98 ab**\n\nABUNDIT EDGE 32 fl oz/a B\n\nDRA 0.5 % v/v B\n\nCLASS ACT RIDION 1.0 % v/v B\n\nWARRANT 3 pt/a E\n\nFEXAPAN 22 fl oz/a E\n\nABUNDIT EDGE 32 fl oz/a E\n\nDRA 0.5 % v/v E\n\nCLASS ACT RIDION 1.0 % v/v E\n\n**LSD P=.10 2.7 2.1 2.5 4.2 2.5 1.5**\n\nTreatments 8 and 12, untreated checks, are not shown in table. Means followed by same letter or symbol do not significantly differ (P=.10, LSD).","publish_date":null,"title":"Table 2. Control of volunteer RR 2Xtend alfalfa with dicamba, 2,4-D and glufosinate systems in no-till soybean at Rochester, MN","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/637951191e7b35ae07dbd4c76a2e6690c370_pg2_pg1_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/637951191e7b35ae07dbd4c76a2e6690c370_pg2_pg1_page1.pdf"},"request":{"example_id":"table/637951191e7b35ae07dbd4c76a2e6690c370_pg2_pg1_page1","product_type":"parse","source_file_path":"637951191e7b35ae07dbd4c76a2e6690c370_pg2_pg1_page1.pdf"},"started_at":"2026-11-04T19:47:16.502363"} +{"completed_at":"2026-11-04T19:47:19.579174","latency_in_ms":1023,"output":{"example_id":"table/7b9c8208-d2be-2a81-8a15-215a9a5a26e8_page1","grounded_pages":[],"layout_pages":[],"markdown":"_Rep:_ HRP **_REP BUYLINES_** _Page:_ 1\n\n_Run On:_ Feb19/20 at 17:35 _Requested by:_ KC\n\n_Dare#:_ 94783 (Rev 0) _Hdln#:_ 9755368 (Mod 0.2) _Traffic#:_ 662617\n\n_Station:_ EFOX-TV JACKSONVILLE _Dates:_ Feb15/20 - Feb21/20 _Salesperson:_ IAN AMBRON\n\n_Agency:_ ASSEMBLY _Prod1:_ BLOOMBERG 4 PRES _Est#:_ 0129\n\n_Advertiser:_ POLI/M BLOOMBERG/D/PRE/US _Prod2: Demo:_ RA35+\n\n_Buyer:_ HEATHER GOLDSMITH _Tel #:_ 917-344-5386 (ext 000000)\n\n**Mod Code**\n\n**Buy Line Day/Time Length Rate**\n\n**Starting Date**\n\n**Ending Date**\n\n**\\# of**\n\n**Wks**\n\n**Spt/**\n\n**Week**\n\n**Total Spots**\n\n**Total**\n\n**Dollars Program Name**\n\n**Rep:**\n\n**RA35+**\n\n**Last Activity Last Mod/Rev**\n\n\\# # MICHAEL BLOOMBERG FOR PRESIDENT\n\n1 M-F/3-4P 30S $30 Feb17/20 Feb21/20 1 1 1 $30 THE RIFLEMAN 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: THE RIFLEMAN\n\n2 Sun/2-3P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 GILLIGAN'S ISLAND 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: GILLIGAN'S ISLAND\n\n5 W-F/9-10A 30S $40 Feb19/20 Feb21/20 1 1 1 $40 PERRY MASON 0.0 Feb19/20 Mod #0.1: A\n\nThis is a make-good for Feb16 on line-2 for 1 spot/wk This is a make-good for Feb16 on line-3 for 1 spot/wk This is a make-good for Feb16 on line-4 for 1 spot/wk This is a make-good for Feb17 on line-1 for 3 spots/wk Order Comment: MG\n\n6 Th-F/2-3P 30S $40 Feb20/20 Feb21/20 1 2 2 $80 BONANZA 0.0 Feb19/20 Mod #0.1: A\n\nPart of a makegood made up of lines 5-7 Order Comment: MG\n\n7 W-F/2-259A 30S $5 Feb19/20 Feb21/20 1 3 3 $15 OVERNIGHT 0.0 Feb19/20 Mod #0.1: A\n\nPart of a makegood made up of lines 5-7 Order Comment: MG\n\n3 Sun/4-5P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 GILLIGAN'S ISLAND 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: GILLIGAN'S ISLAND\n\n4 Sun/6-7P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 THE LOVE BOAT 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: THE LOVE BOAT\n\n**Total 7 Spots for: $165 7 $165 0.0**\n\nMonthly Estimate Dollars:\n\n$165 Feb/20 0.0 Feb/20","pages":[{"line_numbers":[],"markdown":"_Rep:_ HRP **_REP BUYLINES_** _Page:_ 1\n\n_Run On:_ Feb19/20 at 17:35 _Requested by:_ KC\n\n_Dare#:_ 94783 (Rev 0) _Hdln#:_ 9755368 (Mod 0.2) _Traffic#:_ 662617\n\n_Station:_ EFOX-TV JACKSONVILLE _Dates:_ Feb15/20 - Feb21/20 _Salesperson:_ IAN AMBRON\n\n_Agency:_ ASSEMBLY _Prod1:_ BLOOMBERG 4 PRES _Est#:_ 0129\n\n_Advertiser:_ POLI/M BLOOMBERG/D/PRE/US _Prod2: Demo:_ RA35+\n\n_Buyer:_ HEATHER GOLDSMITH _Tel #:_ 917-344-5386 (ext 000000)\n\n**Mod Code**\n\n**Buy Line Day/Time Length Rate**\n\n**Starting Date**\n\n**Ending Date**\n\n**\\# of**\n\n**Wks**\n\n**Spt/**\n\n**Week**\n\n**Total Spots**\n\n**Total**\n\n**Dollars Program Name**\n\n**Rep:**\n\n**RA35+**\n\n**Last Activity Last Mod/Rev**\n\n\\# # MICHAEL BLOOMBERG FOR PRESIDENT\n\n1 M-F/3-4P 30S $30 Feb17/20 Feb21/20 1 1 1 $30 THE RIFLEMAN 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: THE RIFLEMAN\n\n2 Sun/2-3P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 GILLIGAN'S ISLAND 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: GILLIGAN'S ISLAND\n\n5 W-F/9-10A 30S $40 Feb19/20 Feb21/20 1 1 1 $40 PERRY MASON 0.0 Feb19/20 Mod #0.1: A\n\nThis is a make-good for Feb16 on line-2 for 1 spot/wk This is a make-good for Feb16 on line-3 for 1 spot/wk This is a make-good for Feb16 on line-4 for 1 spot/wk This is a make-good for Feb17 on line-1 for 3 spots/wk Order Comment: MG\n\n6 Th-F/2-3P 30S $40 Feb20/20 Feb21/20 1 2 2 $80 BONANZA 0.0 Feb19/20 Mod #0.1: A\n\nPart of a makegood made up of lines 5-7 Order Comment: MG\n\n7 W-F/2-259A 30S $5 Feb19/20 Feb21/20 1 3 3 $15 OVERNIGHT 0.0 Feb19/20 Mod #0.1: A\n\nPart of a makegood made up of lines 5-7 Order Comment: MG\n\n3 Sun/4-5P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 GILLIGAN'S ISLAND 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: GILLIGAN'S ISLAND\n\n4 Sun/6-7P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 THE LOVE BOAT 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: THE LOVE BOAT\n\n**Total 7 Spots for: $165 7 $165 0.0**\n\nMonthly Estimate Dollars:\n\n$165 Feb/20 0.0 Feb/20","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"_Rep:_ HRP **_REP BUYLINES_** _Page:_ 1\n\n_Run On:_ Feb19/20 at 17:35 _Requested by:_ KC\n\n_Dare#:_ 94783 (Rev 0) _Hdln#:_ 9755368 (Mod 0.2) _Traffic#:_ 662617\n\n_Station:_ EFOX-TV JACKSONVILLE _Dates:_ Feb15/20 - Feb21/20 _Salesperson:_ IAN AMBRON\n\n_Agency:_ ASSEMBLY _Prod1:_ BLOOMBERG 4 PRES _Est#:_ 0129\n\n_Advertiser:_ POLI/M BLOOMBERG/D/PRE/US _Prod2: Demo:_ RA35+\n\n_Buyer:_ HEATHER GOLDSMITH _Tel #:_ 917-344-5386 (ext 000000)\n\n**Mod Code**\n\n**Buy Line Day/Time Length Rate**\n\n**Starting Date**\n\n**Ending Date**\n\n**\\# of**\n\n**Wks**\n\n**Spt/**\n\n**Week**\n\n**Total Spots**\n\n**Total**\n\n**Dollars Program Name**\n\n**Rep:**\n\n**RA35+**\n\n**Last Activity Last Mod/Rev**\n\n\\# # MICHAEL BLOOMBERG FOR PRESIDENT\n\n1 M-F/3-4P 30S $30 Feb17/20 Feb21/20 1 1 1 $30 THE RIFLEMAN 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: THE RIFLEMAN\n\n2 Sun/2-3P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 GILLIGAN'S ISLAND 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: GILLIGAN'S ISLAND\n\n5 W-F/9-10A 30S $40 Feb19/20 Feb21/20 1 1 1 $40 PERRY MASON 0.0 Feb19/20 Mod #0.1: A\n\nThis is a make-good for Feb16 on line-2 for 1 spot/wk This is a make-good for Feb16 on line-3 for 1 spot/wk This is a make-good for Feb16 on line-4 for 1 spot/wk This is a make-good for Feb17 on line-1 for 3 spots/wk Order Comment: MG\n\n6 Th-F/2-3P 30S $40 Feb20/20 Feb21/20 1 2 2 $80 BONANZA 0.0 Feb19/20 Mod #0.1: A\n\nPart of a makegood made up of lines 5-7 Order Comment: MG\n\n7 W-F/2-259A 30S $5 Feb19/20 Feb21/20 1 3 3 $15 OVERNIGHT 0.0 Feb19/20 Mod #0.1: A\n\nPart of a makegood made up of lines 5-7 Order Comment: MG\n\n3 Sun/4-5P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 GILLIGAN'S ISLAND 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: GILLIGAN'S ISLAND\n\n4 Sun/6-7P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 THE LOVE BOAT 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: THE LOVE BOAT\n\n**Total 7 Spots for: $165 7 $165 0.0**\n\nMonthly Estimate Dollars:\n\n$165 Feb/20 0.0 Feb/20","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/7b9c8208-d2be-2a81-8a15-215a9a5a26e8_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_aeb8bf94176f4104949cc76bed727dd1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["_Rep:_ HRP **_REP BUYLINES_** _Page:_ 1\n\n_Run On:_ Feb19/20 at 17:35 _Requested by:_ KC\n\n_Dare#:_ 94783 (Rev 0) _Hdln#:_ 9755368 (Mod 0.2) _Traffic#:_ 662617\n\n_Station:_ EFOX-TV JACKSONVILLE _Dates:_ Feb15/20 - Feb21/20 _Salesperson:_ IAN AMBRON\n\n_Agency:_ ASSEMBLY _Prod1:_ BLOOMBERG 4 PRES _Est#:_ 0129\n\n_Advertiser:_ POLI/M BLOOMBERG/D/PRE/US _Prod2: Demo:_ RA35+\n\n_Buyer:_ HEATHER GOLDSMITH _Tel #:_ 917-344-5386 (ext 000000)\n\n**Mod Code**\n\n**Buy Line Day/Time Length Rate**\n\n**Starting Date**\n\n**Ending Date**\n\n**\\# of**\n\n**Wks**\n\n**Spt/**\n\n**Week**\n\n**Total Spots**\n\n**Total**\n\n**Dollars Program Name**\n\n**Rep:**\n\n**RA35+**\n\n**Last Activity Last Mod/Rev**\n\n\\# # MICHAEL BLOOMBERG FOR PRESIDENT\n\n1 M-F/3-4P 30S $30 Feb17/20 Feb21/20 1 1 1 $30 THE RIFLEMAN 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: THE RIFLEMAN\n\n2 Sun/2-3P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 GILLIGAN'S ISLAND 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: GILLIGAN'S ISLAND\n\n5 W-F/9-10A 30S $40 Feb19/20 Feb21/20 1 1 1 $40 PERRY MASON 0.0 Feb19/20 Mod #0.1: A\n\nThis is a make-good for Feb16 on line-2 for 1 spot/wk This is a make-good for Feb16 on line-3 for 1 spot/wk This is a make-good for Feb16 on line-4 for 1 spot/wk This is a make-good for Feb17 on line-1 for 3 spots/wk Order Comment: MG\n\n6 Th-F/2-3P 30S $40 Feb20/20 Feb21/20 1 2 2 $80 BONANZA 0.0 Feb19/20 Mod #0.1: A\n\nPart of a makegood made up of lines 5-7 Order Comment: MG\n\n7 W-F/2-259A 30S $5 Feb19/20 Feb21/20 1 3 3 $15 OVERNIGHT 0.0 Feb19/20 Mod #0.1: A\n\nPart of a makegood made up of lines 5-7 Order Comment: MG\n\n3 Sun/4-5P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 GILLIGAN'S ISLAND 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: GILLIGAN'S ISLAND\n\n4 Sun/6-7P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 THE LOVE BOAT 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: THE LOVE BOAT\n\n**Total 7 Spots for: $165 7 $165 0.0**\n\nMonthly Estimate Dollars:\n\n$165 Feb/20 0.0 Feb/20"],"full_content":"_Rep:_ HRP **_REP BUYLINES_** _Page:_ 1\n\n_Run On:_ Feb19/20 at 17:35 _Requested by:_ KC\n\n_Dare#:_ 94783 (Rev 0) _Hdln#:_ 9755368 (Mod 0.2) _Traffic#:_ 662617\n\n_Station:_ EFOX-TV JACKSONVILLE _Dates:_ Feb15/20 - Feb21/20 _Salesperson:_ IAN AMBRON\n\n_Agency:_ ASSEMBLY _Prod1:_ BLOOMBERG 4 PRES _Est#:_ 0129\n\n_Advertiser:_ POLI/M BLOOMBERG/D/PRE/US _Prod2: Demo:_ RA35+\n\n_Buyer:_ HEATHER GOLDSMITH _Tel #:_ 917-344-5386 (ext 000000)\n\n**Mod Code**\n\n**Buy Line Day/Time Length Rate**\n\n**Starting Date**\n\n**Ending Date**\n\n**\\# of**\n\n**Wks**\n\n**Spt/**\n\n**Week**\n\n**Total Spots**\n\n**Total**\n\n**Dollars Program Name**\n\n**Rep:**\n\n**RA35+**\n\n**Last Activity Last Mod/Rev**\n\n\\# # MICHAEL BLOOMBERG FOR PRESIDENT\n\n1 M-F/3-4P 30S $30 Feb17/20 Feb21/20 1 1 1 $30 THE RIFLEMAN 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: THE RIFLEMAN\n\n2 Sun/2-3P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 GILLIGAN'S ISLAND 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: GILLIGAN'S ISLAND\n\n5 W-F/9-10A 30S $40 Feb19/20 Feb21/20 1 1 1 $40 PERRY MASON 0.0 Feb19/20 Mod #0.1: A\n\nThis is a make-good for Feb16 on line-2 for 1 spot/wk This is a make-good for Feb16 on line-3 for 1 spot/wk This is a make-good for Feb16 on line-4 for 1 spot/wk This is a make-good for Feb17 on line-1 for 3 spots/wk Order Comment: MG\n\n6 Th-F/2-3P 30S $40 Feb20/20 Feb21/20 1 2 2 $80 BONANZA 0.0 Feb19/20 Mod #0.1: A\n\nPart of a makegood made up of lines 5-7 Order Comment: MG\n\n7 W-F/2-259A 30S $5 Feb19/20 Feb21/20 1 3 3 $15 OVERNIGHT 0.0 Feb19/20 Mod #0.1: A\n\nPart of a makegood made up of lines 5-7 Order Comment: MG\n\n3 Sun/4-5P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 GILLIGAN'S ISLAND 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: GILLIGAN'S ISLAND\n\n4 Sun/6-7P 30S $15 Feb16/20 Feb16/20 1 0 0 $0 THE LOVE BOAT 0.0 Feb19/20 Mod #0.1: S\n\nContract Comment: THE LOVE BOAT\n\n**Total 7 Spots for: $165 7 $165 0.0**\n\nMonthly Estimate Dollars:\n\n$165 Feb/20 0.0 Feb/20","publish_date":null,"title":"REP BUYLINES","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/7b9c8208-d2be-2a81-8a15-215a9a5a26e8_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/7b9c8208-d2be-2a81-8a15-215a9a5a26e8_page1.pdf"},"request":{"example_id":"table/7b9c8208-d2be-2a81-8a15-215a9a5a26e8_page1","product_type":"parse","source_file_path":"7b9c8208-d2be-2a81-8a15-215a9a5a26e8_page1.pdf"},"started_at":"2026-11-04T19:47:18.555388"} +{"completed_at":"2026-11-04T19:47:22.577058","latency_in_ms":3123,"output":{"example_id":"table/7bbe366d-1e09-b2c3-e969-c45940fc5d71_page2","grounded_pages":[],"layout_pages":[],"markdown":"ECR26914929 External #\n\nComments\n\nBuyer Name\n\nCPE\n\nSalesperson\n\nContract #\n\n05/05/20-05/15/20 Schedule Dates\n\nMIL/CHICAGO - KEZI, MIL/CHICAGO - KEZI (1033)\n\nPolitical-LOCAL CANDIDATE (1208) Product\n\nCandidate (15669) Brand\n\nStandard Billing Type National/Political Account Types\n\n05/04/20\n\n05/08/20 Lisa Vanderveen\n\nDate Entered\n\nLast Modified\n\nEntered By\n\nNo CO-OP\n\nCommission\n\nPackage Deal\n\nNet Total $3,812.25\n\n$672.75\n\n15\\.00 Commission % AL MEDIA 222 W. ONTARIO ST SUITE 600 CHICAGO, IL 60654\n\nKEZI EUGENE Sales Office\n\nSales Tax\n\nA35+ Demo\n\nOrder Type Normal\n\n(312) 832-6620 / Phone/Fax\n\nROSENTH,ALLISON\n\nCOMMITTEE TO ELECT SHEMIA FAGAN (5673)\n\nAL MEDIA (1992)\n\nAdvertiser\n\nAgency\n\n90171\n\n1324\n\nCOMMITTEE TO ELECT S RYAN LANGLANDS - MIL CHI 5/4 - NEW ORDER, POLITICAL CANDIDATE: COMMITTEE TO ELECT SHEMIA FAGAN, PLS CONFIRM,THANKS!Separation: Min minutes between spots: 30.\n\nEugene COMBO (KEZI) By Broadcast Month Spots Rate\n\nMay. 2020 39 $4,485.00\n\n$4,485.00 Grand Total: 39 Eugene COMBO KEZI P. O. BOX 7009 EUGENE, OR 97401\n\nEntered Comments Station Total Rate Spots Su Sa Fr Th We Tu Mo SPW Run Times Length Sec Dates Line Type / Break Type (Ref #) Line\n\n05/05/20-05/08/20 6P- 7P (PST) 4 $660.00 Eugene COMBO (KEZI) KEZI NEWS AT 6 5/4/20 Normal Line / SPOT 5 13.0 $165.00 1 1 1 1 :30\n\n05/11/20-05/15/20 6P- 7P (PST) 2 $330.00 Eugene COMBO (KEZI) KEZI NEWS AT 6 5/4/20 Normal Line / SPOT 5 2 14.0 $165.00 X X X X X :30\n\n05/10/20-05/10/20 6P- 7P (PST) 1 $85.00 Eugene COMBO (KEZI) KEZI NEWS 5/4/20 Normal Line / SPOT 5 1 15.0 $85.00 X :30\n\n05/11/20-05/11/20 10P- 11P (PST) 1 $275.00 Eugene COMBO (KEZI) BAKER AND THE BEAUTY 5/4/20 Normal Line / SPOT 5 1 16.0 $275.00 X :30\n\n05/09/20-05/09/20 8P- 9P (PST) Eugene COMBO (KEZI) SHARK TANK 5/4/20 Normal Line / SPOT 4 1 17.0 $135.00 X :30\n\n05/09/20 Eugene COMBO (KEZI) Schedule Change/Spot - Closed Preempt 17.0.1\n\n05/10/20-05/10/20 8P- 10P (PST) 1 $500.00 Eugene COMBO (KEZI) AMERICAN IDOL 5/4/20 Normal Line / SPOT 5 1 18.0 $500.00 X :30\n\n05/05/20-05/08/20 11P- 11:35P (PST) 4 $320.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 19.0 $80.00 1 1 1 1 :30\n\n05/11/20-05/15/20 11P- 11:35P (PST) 1 $80.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 20.0 $80.00 X X X X X :30\n\n05/09/20-05/09/20 11P- 11:30P (PST) 1 $65.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 21.0 $65.00 X :30\n\n05/10/20-05/10/20 11P- 11:30P (PST) 1 $65.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 22.0 $65.00 X :30\n\n05/09/20-05/09/20 8P- 11P (PST) 1 $135.00 Eugene COMBO (KEZI) CLASSIC NBA - mg 5/8/20 M/G For 17.0.1 / SPOT 4 1 23.0 $135.00 X :30\n\n### CONFIRMATION CONTRACT\n\nAccepted-Agency/Advertiser: Date: Accepted-Station: Date: Comments:\n\nPrinted At: 05:03 PM on Friday, May 8 2020\n\nB/E Bookend P/B Piggy Back Page 2 of 2\n\nKEZI does not discriminate in the sale of advertising time and will not accept advertising that is placed with the intent to discriminate on the basis of race or gender.","pages":[{"line_numbers":[],"markdown":"ECR26914929 External #\n\nComments\n\nBuyer Name\n\nCPE\n\nSalesperson\n\nContract #\n\n05/05/20-05/15/20 Schedule Dates\n\nMIL/CHICAGO - KEZI, MIL/CHICAGO - KEZI (1033)\n\nPolitical-LOCAL CANDIDATE (1208) Product\n\nCandidate (15669) Brand\n\nStandard Billing Type National/Political Account Types\n\n05/04/20\n\n05/08/20 Lisa Vanderveen\n\nDate Entered\n\nLast Modified\n\nEntered By\n\nNo CO-OP\n\nCommission\n\nPackage Deal\n\nNet Total $3,812.25\n\n$672.75\n\n15\\.00 Commission % AL MEDIA 222 W. ONTARIO ST SUITE 600 CHICAGO, IL 60654\n\nKEZI EUGENE Sales Office\n\nSales Tax\n\nA35+ Demo\n\nOrder Type Normal\n\n(312) 832-6620 / Phone/Fax\n\nROSENTH,ALLISON\n\nCOMMITTEE TO ELECT SHEMIA FAGAN (5673)\n\nAL MEDIA (1992)\n\nAdvertiser\n\nAgency\n\n90171\n\n1324\n\nCOMMITTEE TO ELECT S RYAN LANGLANDS - MIL CHI 5/4 - NEW ORDER, POLITICAL CANDIDATE: COMMITTEE TO ELECT SHEMIA FAGAN, PLS CONFIRM,THANKS!Separation: Min minutes between spots: 30.\n\nEugene COMBO (KEZI) By Broadcast Month Spots Rate\n\nMay. 2020 39 $4,485.00\n\n$4,485.00 Grand Total: 39 Eugene COMBO KEZI P. O. BOX 7009 EUGENE, OR 97401\n\nEntered Comments Station Total Rate Spots Su Sa Fr Th We Tu Mo SPW Run Times Length Sec Dates Line Type / Break Type (Ref #) Line\n\n05/05/20-05/08/20 6P- 7P (PST) 4 $660.00 Eugene COMBO (KEZI) KEZI NEWS AT 6 5/4/20 Normal Line / SPOT 5 13.0 $165.00 1 1 1 1 :30\n\n05/11/20-05/15/20 6P- 7P (PST) 2 $330.00 Eugene COMBO (KEZI) KEZI NEWS AT 6 5/4/20 Normal Line / SPOT 5 2 14.0 $165.00 X X X X X :30\n\n05/10/20-05/10/20 6P- 7P (PST) 1 $85.00 Eugene COMBO (KEZI) KEZI NEWS 5/4/20 Normal Line / SPOT 5 1 15.0 $85.00 X :30\n\n05/11/20-05/11/20 10P- 11P (PST) 1 $275.00 Eugene COMBO (KEZI) BAKER AND THE BEAUTY 5/4/20 Normal Line / SPOT 5 1 16.0 $275.00 X :30\n\n05/09/20-05/09/20 8P- 9P (PST) Eugene COMBO (KEZI) SHARK TANK 5/4/20 Normal Line / SPOT 4 1 17.0 $135.00 X :30\n\n05/09/20 Eugene COMBO (KEZI) Schedule Change/Spot - Closed Preempt 17.0.1\n\n05/10/20-05/10/20 8P- 10P (PST) 1 $500.00 Eugene COMBO (KEZI) AMERICAN IDOL 5/4/20 Normal Line / SPOT 5 1 18.0 $500.00 X :30\n\n05/05/20-05/08/20 11P- 11:35P (PST) 4 $320.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 19.0 $80.00 1 1 1 1 :30\n\n05/11/20-05/15/20 11P- 11:35P (PST) 1 $80.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 20.0 $80.00 X X X X X :30\n\n05/09/20-05/09/20 11P- 11:30P (PST) 1 $65.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 21.0 $65.00 X :30\n\n05/10/20-05/10/20 11P- 11:30P (PST) 1 $65.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 22.0 $65.00 X :30\n\n05/09/20-05/09/20 8P- 11P (PST) 1 $135.00 Eugene COMBO (KEZI) CLASSIC NBA - mg 5/8/20 M/G For 17.0.1 / SPOT 4 1 23.0 $135.00 X :30\n\n### CONFIRMATION CONTRACT\n\nAccepted-Agency/Advertiser: Date: Accepted-Station: Date: Comments:\n\nPrinted At: 05:03 PM on Friday, May 8 2020\n\nB/E Bookend P/B Piggy Back Page 2 of 2\n\nKEZI does not discriminate in the sale of advertising time and will not accept advertising that is placed with the intent to discriminate on the basis of race or gender.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"ECR26914929 External #\n\nComments\n\nBuyer Name\n\nCPE\n\nSalesperson\n\nContract #\n\n05/05/20-05/15/20 Schedule Dates\n\nMIL/CHICAGO - KEZI, MIL/CHICAGO - KEZI (1033)\n\nPolitical-LOCAL CANDIDATE (1208) Product\n\nCandidate (15669) Brand\n\nStandard Billing Type National/Political Account Types\n\n05/04/20\n\n05/08/20 Lisa Vanderveen\n\nDate Entered\n\nLast Modified\n\nEntered By\n\nNo CO-OP\n\nCommission\n\nPackage Deal\n\nNet Total $3,812.25\n\n$672.75\n\n15\\.00 Commission % AL MEDIA 222 W. ONTARIO ST SUITE 600 CHICAGO, IL 60654\n\nKEZI EUGENE Sales Office\n\nSales Tax\n\nA35+ Demo\n\nOrder Type Normal\n\n(312) 832-6620 / Phone/Fax\n\nROSENTH,ALLISON\n\nCOMMITTEE TO ELECT SHEMIA FAGAN (5673)\n\nAL MEDIA (1992)\n\nAdvertiser\n\nAgency\n\n90171\n\n1324\n\nCOMMITTEE TO ELECT S RYAN LANGLANDS - MIL CHI 5/4 - NEW ORDER, POLITICAL CANDIDATE: COMMITTEE TO ELECT SHEMIA FAGAN, PLS CONFIRM,THANKS!Separation: Min minutes between spots: 30.\n\nEugene COMBO (KEZI) By Broadcast Month Spots Rate\n\nMay. 2020 39 $4,485.00\n\n$4,485.00 Grand Total: 39 Eugene COMBO KEZI P. O. BOX 7009 EUGENE, OR 97401\n\nEntered Comments Station Total Rate Spots Su Sa Fr Th We Tu Mo SPW Run Times Length Sec Dates Line Type / Break Type (Ref #) Line\n\n05/05/20-05/08/20 6P- 7P (PST) 4 $660.00 Eugene COMBO (KEZI) KEZI NEWS AT 6 5/4/20 Normal Line / SPOT 5 13.0 $165.00 1 1 1 1 :30\n\n05/11/20-05/15/20 6P- 7P (PST) 2 $330.00 Eugene COMBO (KEZI) KEZI NEWS AT 6 5/4/20 Normal Line / SPOT 5 2 14.0 $165.00 X X X X X :30\n\n05/10/20-05/10/20 6P- 7P (PST) 1 $85.00 Eugene COMBO (KEZI) KEZI NEWS 5/4/20 Normal Line / SPOT 5 1 15.0 $85.00 X :30\n\n05/11/20-05/11/20 10P- 11P (PST) 1 $275.00 Eugene COMBO (KEZI) BAKER AND THE BEAUTY 5/4/20 Normal Line / SPOT 5 1 16.0 $275.00 X :30\n\n05/09/20-05/09/20 8P- 9P (PST) Eugene COMBO (KEZI) SHARK TANK 5/4/20 Normal Line / SPOT 4 1 17.0 $135.00 X :30\n\n05/09/20 Eugene COMBO (KEZI) Schedule Change/Spot - Closed Preempt 17.0.1\n\n05/10/20-05/10/20 8P- 10P (PST) 1 $500.00 Eugene COMBO (KEZI) AMERICAN IDOL 5/4/20 Normal Line / SPOT 5 1 18.0 $500.00 X :30\n\n05/05/20-05/08/20 11P- 11:35P (PST) 4 $320.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 19.0 $80.00 1 1 1 1 :30\n\n05/11/20-05/15/20 11P- 11:35P (PST) 1 $80.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 20.0 $80.00 X X X X X :30\n\n05/09/20-05/09/20 11P- 11:30P (PST) 1 $65.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 21.0 $65.00 X :30\n\n05/10/20-05/10/20 11P- 11:30P (PST) 1 $65.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 22.0 $65.00 X :30\n\n05/09/20-05/09/20 8P- 11P (PST) 1 $135.00 Eugene COMBO (KEZI) CLASSIC NBA - mg 5/8/20 M/G For 17.0.1 / SPOT 4 1 23.0 $135.00 X :30\n\n### CONFIRMATION CONTRACT\n\nAccepted-Agency/Advertiser: Date: Accepted-Station: Date: Comments:\n\nPrinted At: 05:03 PM on Friday, May 8 2020\n\nB/E Bookend P/B Piggy Back Page 2 of 2\n\nKEZI does not discriminate in the sale of advertising time and will not accept advertising that is placed with the intent to discriminate on the basis of race or gender.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/7bbe366d-1e09-b2c3-e969-c45940fc5d71_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_41a77b45599fe9a281e822d721cb4657","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["ECR26914929 External #\n\nComments\n\nBuyer Name\n\nCPE\n\nSalesperson\n\nContract #\n\n05/05/20-05/15/20 Schedule Dates\n\nMIL/CHICAGO - KEZI, MIL/CHICAGO - KEZI (1033)\n\nPolitical-LOCAL CANDIDATE (1208) Product\n\nCandidate (15669) Brand\n\nStandard Billing Type National/Political Account Types\n\n05/04/20\n\n05/08/20 Lisa Vanderveen\n\nDate Entered\n\nLast Modified\n\nEntered By\n\nNo CO-OP\n\nCommission\n\nPackage Deal\n\nNet Total $3,812.25\n\n$672.75\n\n15\\.00 Commission % AL MEDIA 222 W. ONTARIO ST SUITE 600 CHICAGO, IL 60654\n\nKEZI EUGENE Sales Office\n\nSales Tax\n\nA35+ Demo\n\nOrder Type Normal\n\n(312) 832-6620 / Phone/Fax\n\nROSENTH,ALLISON\n\nCOMMITTEE TO ELECT SHEMIA FAGAN (5673)\n\nAL MEDIA (1992)\n\nAdvertiser\n\nAgency\n\n90171\n\n1324\n\nCOMMITTEE TO ELECT S RYAN LANGLANDS - MIL CHI 5/4 - NEW ORDER, POLITICAL CANDIDATE: COMMITTEE TO ELECT SHEMIA FAGAN, PLS CONFIRM,THANKS!Separation: Min minutes between spots: 30.\n\nEugene COMBO (KEZI) By Broadcast Month Spots Rate\n\nMay. 2020 39 $4,485.00\n\n$4,485.00 Grand Total: 39 Eugene COMBO KEZI P. O. BOX 7009 EUGENE, OR 97401\n\nEntered Comments Station Total Rate Spots Su Sa Fr Th We Tu Mo SPW Run Times Length Sec Dates Line Type / Break Type (Ref #) Line\n\n05/05/20-05/08/20 6P- 7P (PST) 4 $660.00 Eugene COMBO (KEZI) KEZI NEWS AT 6 5/4/20 Normal Line / SPOT 5 13.0 $165.00 1 1 1 1 :30\n\n05/11/20-05/15/20 6P- 7P (PST) 2 $330.00 Eugene COMBO (KEZI) KEZI NEWS AT 6 5/4/20 Normal Line / SPOT 5 2 14.0 $165.00 X X X X X :30\n\n05/10/20-05/10/20 6P- 7P (PST) 1 $85.00 Eugene COMBO (KEZI) KEZI NEWS 5/4/20 Normal Line / SPOT 5 1 15.0 $85.00 X :30\n\n05/11/20-05/11/20 10P- 11P (PST) 1 $275.00 Eugene COMBO (KEZI) BAKER AND THE BEAUTY 5/4/20 Normal Line / SPOT 5 1 16.0 $275.00 X :30\n\n05/09/20-05/09/20 8P- 9P (PST) Eugene COMBO (KEZI) SHARK TANK 5/4/20 Normal Line / SPOT 4 1 17.0 $135.00 X :30\n\n05/09/20 Eugene COMBO (KEZI) Schedule Change/Spot - Closed Preempt 17.0.1\n\n05/10/20-05/10/20 8P- 10P (PST) 1 $500.00 Eugene COMBO (KEZI) AMERICAN IDOL 5/4/20 Normal Line / SPOT 5 1 18.0 $500.00 X :30\n\n05/05/20-05/08/20 11P- 11:35P (PST) 4 $320.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 19.0 $80.00 1 1 1 1 :30\n\n05/11/20-05/15/20 11P- 11:35P (PST) 1 $80.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 20.0 $80.00 X X X X X :30\n\n05/09/20-05/09/20 11P- 11:30P (PST) 1 $65.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 21.0 $65.00 X :30\n\n05/10/20-05/10/20 11P- 11:30P (PST) 1 $65.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 22.0 $65.00 X :30\n\n05/09/20-05/09/20 8P- 11P (PST) 1 $135.00 Eugene COMBO (KEZI) CLASSIC NBA - mg 5/8/20 M/G For 17.0.1 / SPOT 4 1 23.0 $135.00 X :30\n\n### CONFIRMATION CONTRACT\n\nAccepted-Agency/Advertiser: Date: Accepted-Station: Date: Comments:\n\nPrinted At: 05:03 PM on Friday, May 8 2020\n\nB/E Bookend P/B Piggy Back Page 2 of 2\n\nKEZI does not discriminate in the sale of advertising time and will not accept advertising that is placed with the intent to discriminate on the basis of race or gender."],"full_content":"ECR26914929 External #\n\nComments\n\nBuyer Name\n\nCPE\n\nSalesperson\n\nContract #\n\n05/05/20-05/15/20 Schedule Dates\n\nMIL/CHICAGO - KEZI, MIL/CHICAGO - KEZI (1033)\n\nPolitical-LOCAL CANDIDATE (1208) Product\n\nCandidate (15669) Brand\n\nStandard Billing Type National/Political Account Types\n\n05/04/20\n\n05/08/20 Lisa Vanderveen\n\nDate Entered\n\nLast Modified\n\nEntered By\n\nNo CO-OP\n\nCommission\n\nPackage Deal\n\nNet Total $3,812.25\n\n$672.75\n\n15\\.00 Commission % AL MEDIA 222 W. ONTARIO ST SUITE 600 CHICAGO, IL 60654\n\nKEZI EUGENE Sales Office\n\nSales Tax\n\nA35+ Demo\n\nOrder Type Normal\n\n(312) 832-6620 / Phone/Fax\n\nROSENTH,ALLISON\n\nCOMMITTEE TO ELECT SHEMIA FAGAN (5673)\n\nAL MEDIA (1992)\n\nAdvertiser\n\nAgency\n\n90171\n\n1324\n\nCOMMITTEE TO ELECT S RYAN LANGLANDS - MIL CHI 5/4 - NEW ORDER, POLITICAL CANDIDATE: COMMITTEE TO ELECT SHEMIA FAGAN, PLS CONFIRM,THANKS!Separation: Min minutes between spots: 30.\n\nEugene COMBO (KEZI) By Broadcast Month Spots Rate\n\nMay. 2020 39 $4,485.00\n\n$4,485.00 Grand Total: 39 Eugene COMBO KEZI P. O. BOX 7009 EUGENE, OR 97401\n\nEntered Comments Station Total Rate Spots Su Sa Fr Th We Tu Mo SPW Run Times Length Sec Dates Line Type / Break Type (Ref #) Line\n\n05/05/20-05/08/20 6P- 7P (PST) 4 $660.00 Eugene COMBO (KEZI) KEZI NEWS AT 6 5/4/20 Normal Line / SPOT 5 13.0 $165.00 1 1 1 1 :30\n\n05/11/20-05/15/20 6P- 7P (PST) 2 $330.00 Eugene COMBO (KEZI) KEZI NEWS AT 6 5/4/20 Normal Line / SPOT 5 2 14.0 $165.00 X X X X X :30\n\n05/10/20-05/10/20 6P- 7P (PST) 1 $85.00 Eugene COMBO (KEZI) KEZI NEWS 5/4/20 Normal Line / SPOT 5 1 15.0 $85.00 X :30\n\n05/11/20-05/11/20 10P- 11P (PST) 1 $275.00 Eugene COMBO (KEZI) BAKER AND THE BEAUTY 5/4/20 Normal Line / SPOT 5 1 16.0 $275.00 X :30\n\n05/09/20-05/09/20 8P- 9P (PST) Eugene COMBO (KEZI) SHARK TANK 5/4/20 Normal Line / SPOT 4 1 17.0 $135.00 X :30\n\n05/09/20 Eugene COMBO (KEZI) Schedule Change/Spot - Closed Preempt 17.0.1\n\n05/10/20-05/10/20 8P- 10P (PST) 1 $500.00 Eugene COMBO (KEZI) AMERICAN IDOL 5/4/20 Normal Line / SPOT 5 1 18.0 $500.00 X :30\n\n05/05/20-05/08/20 11P- 11:35P (PST) 4 $320.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 19.0 $80.00 1 1 1 1 :30\n\n05/11/20-05/15/20 11P- 11:35P (PST) 1 $80.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 20.0 $80.00 X X X X X :30\n\n05/09/20-05/09/20 11P- 11:30P (PST) 1 $65.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 21.0 $65.00 X :30\n\n05/10/20-05/10/20 11P- 11:30P (PST) 1 $65.00 Eugene COMBO (KEZI) KEZI NEWS AT 11 5/4/20 Normal Line / SPOT 5 1 22.0 $65.00 X :30\n\n05/09/20-05/09/20 8P- 11P (PST) 1 $135.00 Eugene COMBO (KEZI) CLASSIC NBA - mg 5/8/20 M/G For 17.0.1 / SPOT 4 1 23.0 $135.00 X :30\n\n### CONFIRMATION CONTRACT\n\nAccepted-Agency/Advertiser: Date: Accepted-Station: Date: Comments:\n\nPrinted At: 05:03 PM on Friday, May 8 2020\n\nB/E Bookend P/B Piggy Back Page 2 of 2\n\nKEZI does not discriminate in the sale of advertising time and will not accept advertising that is placed with the intent to discriminate on the basis of race or gender.","publish_date":null,"title":"CONFIRMATION CONTRACT","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/7bbe366d-1e09-b2c3-e969-c45940fc5d71_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/7bbe366d-1e09-b2c3-e969-c45940fc5d71_page2.pdf"},"request":{"example_id":"table/7bbe366d-1e09-b2c3-e969-c45940fc5d71_page2","product_type":"parse","source_file_path":"7bbe366d-1e09-b2c3-e969-c45940fc5d71_page2.pdf"},"started_at":"2026-11-04T19:47:19.453840"} +{"completed_at":"2026-11-04T19:47:21.950122","latency_in_ms":1051,"output":{"example_id":"table/AMZN.2005.page_32.pdf_61783_page1","grounded_pages":[],"layout_pages":[],"markdown":"**Item 6.** **_Selected Consolidated Financial Data_**\n\nThe following selected consolidated financial data should be read in conjunction with the consolidated financial statements and the notes thereto in Item 8 of Part II, “Financial Statements and Supplementary Data,” and the information contained in Item 7 of Part II, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Historical results are not necessarily indicative of future results.\n\n**Year Ended December 31,**\n\n**2005 2004 2003 2002 2001**\n\n**(in millions, except per share data) Income Statement:** Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $8,490 $6,921 $5,264 $3,933 $3,122 Income (loss) before change in accounting principle . . . . . . . . . . . 333 588 35 (150) (557) Cumulative effect of change in accounting principle . . . . . . . . . . . 26 — — 1 (11) Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 359 588 35 (149) (567) Basic earnings (loss) per share (1): Prior to cumulative effect of change in accounting principle . . . . . $ 0.81 $ 1.45 $ 0.09 $ (0.40) $ (1.53) Cumulative effect of change in accounting principle . . . . . . . . . . . 0.06 — — 0.01 (0.03)\n\nBasic earnings (loss) per share (1) . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.87 $ 1.45 $ 0.09 $ (0.39) $ (1.56)\n\nDiluted earnings (loss) per share (1): Prior to cumulative effect of change in accounting principle . . . . . $ 0.78 $ 1.39 $ 0.08 $ (0.40) $ (1.53) Cumulative effect of change in accounting principle . . . . . . . . . . . 0.06 — — 0.01 (0.03)\n\nDiluted earnings (loss) per share (1) . . . . . . . . . . . . . . . . . . . . . . . . $ 0.84 $ 1.39 $ 0.08 $ (0.39) $ (1.56)\n\nWeighted average shares used in computation of earnings (loss) per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 412 406 395 378 364 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 426 425 419 378 364\n\n**December 31,**\n\n**2005 2004 2003 2002 2001**\n\n**(in millions) Balance Sheet:** Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,696 $3,248 $2,162 $1,990 $1,638 Long-term debt and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,521 $1,855 $1,945 $2,277 $2,156\n\n(1) For further discussion of earnings (loss) per share, see Item 8 of Part II, “Financial Statements and Supplementary Data—Note 1—Description of Business and Accounting Policies.”\n\n**Item 7.** **_Management’s Discussion and Analysis of Financial Condition and Results of Operations_**\n\n**Forward-Looking Statements**\n\nThis Annual Report on Form 10-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including statements regarding guidance, industry prospects or future results of operations or financial position, made in this Annual Report on Form 10-K are forward-looking. We use words such as anticipates, believes, expects, future, intends, and similar expressions to identify forward-looking statements. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Actual results could differ materially for a variety of reasons, including, among others, fluctuations in foreign exchange rates, changes in global economic conditions and consumer spending, world events, the rate of growth of the Internet and online commerce, the amount that Amazon.com invests in new business opportunities and the timing of those investments, the mix of products sold to customers, the mix of net sales derived from products as compared with services, competition, management of growth, potential fluctuations in operating results, international growth and expansion,\n\n24","pages":[{"line_numbers":[],"markdown":"**Item 6.** **_Selected Consolidated Financial Data_**\n\nThe following selected consolidated financial data should be read in conjunction with the consolidated financial statements and the notes thereto in Item 8 of Part II, “Financial Statements and Supplementary Data,” and the information contained in Item 7 of Part II, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Historical results are not necessarily indicative of future results.\n\n**Year Ended December 31,**\n\n**2005 2004 2003 2002 2001**\n\n**(in millions, except per share data) Income Statement:** Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $8,490 $6,921 $5,264 $3,933 $3,122 Income (loss) before change in accounting principle . . . . . . . . . . . 333 588 35 (150) (557) Cumulative effect of change in accounting principle . . . . . . . . . . . 26 — — 1 (11) Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 359 588 35 (149) (567) Basic earnings (loss) per share (1): Prior to cumulative effect of change in accounting principle . . . . . $ 0.81 $ 1.45 $ 0.09 $ (0.40) $ (1.53) Cumulative effect of change in accounting principle . . . . . . . . . . . 0.06 — — 0.01 (0.03)\n\nBasic earnings (loss) per share (1) . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.87 $ 1.45 $ 0.09 $ (0.39) $ (1.56)\n\nDiluted earnings (loss) per share (1): Prior to cumulative effect of change in accounting principle . . . . . $ 0.78 $ 1.39 $ 0.08 $ (0.40) $ (1.53) Cumulative effect of change in accounting principle . . . . . . . . . . . 0.06 — — 0.01 (0.03)\n\nDiluted earnings (loss) per share (1) . . . . . . . . . . . . . . . . . . . . . . . . $ 0.84 $ 1.39 $ 0.08 $ (0.39) $ (1.56)\n\nWeighted average shares used in computation of earnings (loss) per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 412 406 395 378 364 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 426 425 419 378 364\n\n**December 31,**\n\n**2005 2004 2003 2002 2001**\n\n**(in millions) Balance Sheet:** Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,696 $3,248 $2,162 $1,990 $1,638 Long-term debt and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,521 $1,855 $1,945 $2,277 $2,156\n\n(1) For further discussion of earnings (loss) per share, see Item 8 of Part II, “Financial Statements and Supplementary Data—Note 1—Description of Business and Accounting Policies.”\n\n**Item 7.** **_Management’s Discussion and Analysis of Financial Condition and Results of Operations_**\n\n**Forward-Looking Statements**\n\nThis Annual Report on Form 10-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including statements regarding guidance, industry prospects or future results of operations or financial position, made in this Annual Report on Form 10-K are forward-looking. We use words such as anticipates, believes, expects, future, intends, and similar expressions to identify forward-looking statements. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Actual results could differ materially for a variety of reasons, including, among others, fluctuations in foreign exchange rates, changes in global economic conditions and consumer spending, world events, the rate of growth of the Internet and online commerce, the amount that Amazon.com invests in new business opportunities and the timing of those investments, the mix of products sold to customers, the mix of net sales derived from products as compared with services, competition, management of growth, potential fluctuations in operating results, international growth and expansion,\n\n24","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Item 6.** **_Selected Consolidated Financial Data_**\n\nThe following selected consolidated financial data should be read in conjunction with the consolidated financial statements and the notes thereto in Item 8 of Part II, “Financial Statements and Supplementary Data,” and the information contained in Item 7 of Part II, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Historical results are not necessarily indicative of future results.\n\n**Year Ended December 31,**\n\n**2005 2004 2003 2002 2001**\n\n**(in millions, except per share data) Income Statement:** Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $8,490 $6,921 $5,264 $3,933 $3,122 Income (loss) before change in accounting principle . . . . . . . . . . . 333 588 35 (150) (557) Cumulative effect of change in accounting principle . . . . . . . . . . . 26 — — 1 (11) Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 359 588 35 (149) (567) Basic earnings (loss) per share (1): Prior to cumulative effect of change in accounting principle . . . . . $ 0.81 $ 1.45 $ 0.09 $ (0.40) $ (1.53) Cumulative effect of change in accounting principle . . . . . . . . . . . 0.06 — — 0.01 (0.03)\n\nBasic earnings (loss) per share (1) . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.87 $ 1.45 $ 0.09 $ (0.39) $ (1.56)\n\nDiluted earnings (loss) per share (1): Prior to cumulative effect of change in accounting principle . . . . . $ 0.78 $ 1.39 $ 0.08 $ (0.40) $ (1.53) Cumulative effect of change in accounting principle . . . . . . . . . . . 0.06 — — 0.01 (0.03)\n\nDiluted earnings (loss) per share (1) . . . . . . . . . . . . . . . . . . . . . . . . $ 0.84 $ 1.39 $ 0.08 $ (0.39) $ (1.56)\n\nWeighted average shares used in computation of earnings (loss) per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 412 406 395 378 364 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 426 425 419 378 364\n\n**December 31,**\n\n**2005 2004 2003 2002 2001**\n\n**(in millions) Balance Sheet:** Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,696 $3,248 $2,162 $1,990 $1,638 Long-term debt and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,521 $1,855 $1,945 $2,277 $2,156\n\n(1) For further discussion of earnings (loss) per share, see Item 8 of Part II, “Financial Statements and Supplementary Data—Note 1—Description of Business and Accounting Policies.”\n\n**Item 7.** **_Management’s Discussion and Analysis of Financial Condition and Results of Operations_**\n\n**Forward-Looking Statements**\n\nThis Annual Report on Form 10-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including statements regarding guidance, industry prospects or future results of operations or financial position, made in this Annual Report on Form 10-K are forward-looking. We use words such as anticipates, believes, expects, future, intends, and similar expressions to identify forward-looking statements. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Actual results could differ materially for a variety of reasons, including, among others, fluctuations in foreign exchange rates, changes in global economic conditions and consumer spending, world events, the rate of growth of the Internet and online commerce, the amount that Amazon.com invests in new business opportunities and the timing of those investments, the mix of products sold to customers, the mix of net sales derived from products as compared with services, competition, management of growth, potential fluctuations in operating results, international growth and expansion,\n\n24","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AMZN.2005.page_32.pdf_61783_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_df52281330216a46947c093c693f5b12","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Item 6.** **_Selected Consolidated Financial Data_**\n\nThe following selected consolidated financial data should be read in conjunction with the consolidated financial statements and the notes thereto in Item 8 of Part II, “Financial Statements and Supplementary Data,” and the information contained in Item 7 of Part II, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Historical results are not necessarily indicative of future results.\n\n**Year Ended December 31,**\n\n**2005 2004 2003 2002 2001**\n\n**(in millions, except per share data) Income Statement:** Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $8,490 $6,921 $5,264 $3,933 $3,122 Income (loss) before change in accounting principle . . . . . . . . . . . 333 588 35 (150) (557) Cumulative effect of change in accounting principle . . . . . . . . . . . 26 — — 1 (11) Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 359 588 35 (149) (567) Basic earnings (loss) per share (1): Prior to cumulative effect of change in accounting principle . . . . . $ 0.81 $ 1.45 $ 0.09 $ (0.40) $ (1.53) Cumulative effect of change in accounting principle . . . . . . . . . . . 0.06 — — 0.01 (0.03)\n\nBasic earnings (loss) per share (1) . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.87 $ 1.45 $ 0.09 $ (0.39) $ (1.56)\n\nDiluted earnings (loss) per share (1): Prior to cumulative effect of change in accounting principle . . . . . $ 0.78 $ 1.39 $ 0.08 $ (0.40) $ (1.53) Cumulative effect of change in accounting principle . . . . . . . . . . . 0.06 — — 0.01 (0.03)\n\nDiluted earnings (loss) per share (1) . . . . . . . . . . . . . . . . . . . . . . . . $ 0.84 $ 1.39 $ 0.08 $ (0.39) $ (1.56)\n\nWeighted average shares used in computation of earnings (loss) per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 412 406 395 378 364 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 426 425 419 378 364\n\n**December 31,**\n\n**2005 2004 2003 2002 2001**\n\n**(in millions) Balance Sheet:** Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,696 $3,248 $2,162 $1,990 $1,638 Long-term debt and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,521 $1,855 $1,945 $2,277 $2,156\n\n(1) For further discussion of earnings (loss) per share, see Item 8 of Part II, “Financial Statements and Supplementary Data—Note 1—Description of Business and Accounting Policies.”\n\n**Item 7.** **_Management’s Discussion and Analysis of Financial Condition and Results of Operations_**\n\n**Forward-Looking Statements**\n\nThis Annual Report on Form 10-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including statements regarding guidance, industry prospects or future results of operations or financial position, made in this Annual Report on Form 10-K are forward-looking. We use words such as anticipates, believes, expects, future, intends, and similar expressions to identify forward-looking statements. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Actual results could differ materially for a variety of reasons, including, among others, fluctuations in foreign exchange rates, changes in global economic conditions and consumer spending, world events, the rate of growth of the Internet and online commerce, the amount that Amazon.com invests in new business opportunities and the timing of those investments, the mix of products sold to customers, the mix of net sales derived from products as compared with services, competition, management of growth, potential fluctuations in operating results, international growth and expansion,\n\n24"],"full_content":"**Item 6.** **_Selected Consolidated Financial Data_**\n\nThe following selected consolidated financial data should be read in conjunction with the consolidated financial statements and the notes thereto in Item 8 of Part II, “Financial Statements and Supplementary Data,” and the information contained in Item 7 of Part II, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Historical results are not necessarily indicative of future results.\n\n**Year Ended December 31,**\n\n**2005 2004 2003 2002 2001**\n\n**(in millions, except per share data) Income Statement:** Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $8,490 $6,921 $5,264 $3,933 $3,122 Income (loss) before change in accounting principle . . . . . . . . . . . 333 588 35 (150) (557) Cumulative effect of change in accounting principle . . . . . . . . . . . 26 — — 1 (11) Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 359 588 35 (149) (567) Basic earnings (loss) per share (1): Prior to cumulative effect of change in accounting principle . . . . . $ 0.81 $ 1.45 $ 0.09 $ (0.40) $ (1.53) Cumulative effect of change in accounting principle . . . . . . . . . . . 0.06 — — 0.01 (0.03)\n\nBasic earnings (loss) per share (1) . . . . . . . . . . . . . . . . . . . . . . . . . . $ 0.87 $ 1.45 $ 0.09 $ (0.39) $ (1.56)\n\nDiluted earnings (loss) per share (1): Prior to cumulative effect of change in accounting principle . . . . . $ 0.78 $ 1.39 $ 0.08 $ (0.40) $ (1.53) Cumulative effect of change in accounting principle . . . . . . . . . . . 0.06 — — 0.01 (0.03)\n\nDiluted earnings (loss) per share (1) . . . . . . . . . . . . . . . . . . . . . . . . $ 0.84 $ 1.39 $ 0.08 $ (0.39) $ (1.56)\n\nWeighted average shares used in computation of earnings (loss) per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 412 406 395 378 364 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 426 425 419 378 364\n\n**December 31,**\n\n**2005 2004 2003 2002 2001**\n\n**(in millions) Balance Sheet:** Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $3,696 $3,248 $2,162 $1,990 $1,638 Long-term debt and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $1,521 $1,855 $1,945 $2,277 $2,156\n\n(1) For further discussion of earnings (loss) per share, see Item 8 of Part II, “Financial Statements and Supplementary Data—Note 1—Description of Business and Accounting Policies.”\n\n**Item 7.** **_Management’s Discussion and Analysis of Financial Condition and Results of Operations_**\n\n**Forward-Looking Statements**\n\nThis Annual Report on Form 10-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including statements regarding guidance, industry prospects or future results of operations or financial position, made in this Annual Report on Form 10-K are forward-looking. We use words such as anticipates, believes, expects, future, intends, and similar expressions to identify forward-looking statements. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Actual results could differ materially for a variety of reasons, including, among others, fluctuations in foreign exchange rates, changes in global economic conditions and consumer spending, world events, the rate of growth of the Internet and online commerce, the amount that Amazon.com invests in new business opportunities and the timing of those investments, the mix of products sold to customers, the mix of net sales derived from products as compared with services, competition, management of growth, potential fluctuations in operating results, international growth and expansion,\n\n24","publish_date":null,"title":"Item6. SelectedConsolidatedFinancialData Thefollowingselectedconsolidatedfinancialdatashouldbereadinconjunctionwiththeconsolidated financialstatementsandthenotestheretoinItem8ofPartII,“FinancialStatementsandSupplementaryData,” andtheinformationcontainedinItem7ofPartII,“Management’sDiscussionandAnalysisofFinancial ConditionandResultsofOperations.”Historicalresultsarenotnecessarilyindicativeoffutureresults. IncomeStatement: Netsales .............................................. $8,490 $6,921 $5,264 $3,933 $3,122 Income(loss)beforechangeinaccountingprinciple ........... 333 588 35 (150)","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AMZN.2005.page_32.pdf_61783_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AMZN.2005.page_32.pdf_61783_page1.pdf"},"request":{"example_id":"table/AMZN.2005.page_32.pdf_61783_page1","product_type":"parse","source_file_path":"AMZN.2005.page_32.pdf_61783_page1.pdf"},"started_at":"2026-11-04T19:47:20.898485"} +{"completed_at":"2026-11-04T19:31:15.802462","latency_in_ms":1250,"output":{"example_id":"table/AONR32314_page1","grounded_pages":[],"layout_pages":[],"markdown":"## **_AONR32314_**\n\n**General Description Product Summary**\n\nVDS\n\nID (at VGS=10V) 30A\n\nRDS(ON) (at VGS=10V) < 8.7mΩ\n\nRDS(ON) (at VGS=4.5V) < 12.3mΩ\n\n**Applications** 100% UIS Tested 100% Rg Tested\n\n**Symbol** VDS VGS\n\nIDM\n\nIAS\n\nAvalanche energy L=0.05mH C EAS\n\nTJ, TSTG\n\n**Symbol**\n\nt ≤ 10s\n\nSteady-State\n\nSteady-State RqJC\n\n**_30V N-Channel MOSFET_**\n\n**Orderable Part Number Package Type Form Minimum Order Quantity**\n\n30V • Latest advanced trench technology • Low RDS(ON) • High Current capability • RoHS and Halogen-Free Compliant\n\nTA=25°C\n\nTA=70°C\n\nTC=25°C\n\nTC=100°C\n\nTC=25°C\n\nAvalanche Current C\n\nContinuous Drain Current\n\n**Thermal Characteristics Parameter Max**\n\nTA=70°C 2.6\n\n°C\n\n**Units**\n\nJunction and Storage Temperature Range -55 to 150\n\n**Typ**\n\nPDSM W TA=25°C 4.1\n\nPower Dissipation A\n\nMaximum Junction-to-Ambient A °C/W RqJA 24 47\n\n30\n\nW\n\nID\n\nA 33\n\nA\n\n90\n\nIDSM 13.5\n\nmJ 27\n\n17\n\n30\n\nAONR32314 DFN 3X3 Tape & Reel 3000\n\nV\n\nA\n\n**Absolute Maximum Ratings TA=25°C unless otherwise noted**\n\n±20\n\nV\n\n**Maximum Units**\n\nMaximum Junction-to-Case °C/W °C/W Maximum Junction-to-Ambient A D\n\n4\\.2\n\n60 5.2\n\n• Notebook AC-in load switch • Battery protection charge/discharge\n\nPower Dissipation B 9\\.6 TC=100°C PD\n\n30\n\n24\n\nGate-Source Voltage\n\nPulsed Drain Current C\n\n25\\.5\n\n**Parameter** Drain-Source Voltage\n\nContinuous Drain Current G\n\nG\n\nD\n\nS\n\n**Top View**\n\nS\n\nS\n\nS\n\nG\n\nD\n\nD D\n\nD\n\n1\n\n2\n\n3\n\n4\n\n8\n\n7\n\n6\n\n5\n\n**DFN 3x3\\_EP**\n\n**Top View Bottom View**\n\nPIN1\n\nPIN1\n\nRev.2.0: March 2018 **_www.aosmd.com_** Page 1 of 6","pages":[{"line_numbers":[],"markdown":"## **_AONR32314_**\n\n**General Description Product Summary**\n\nVDS\n\nID (at VGS=10V) 30A\n\nRDS(ON) (at VGS=10V) < 8.7mΩ\n\nRDS(ON) (at VGS=4.5V) < 12.3mΩ\n\n**Applications** 100% UIS Tested 100% Rg Tested\n\n**Symbol** VDS VGS\n\nIDM\n\nIAS\n\nAvalanche energy L=0.05mH C EAS\n\nTJ, TSTG\n\n**Symbol**\n\nt ≤ 10s\n\nSteady-State\n\nSteady-State RqJC\n\n**_30V N-Channel MOSFET_**\n\n**Orderable Part Number Package Type Form Minimum Order Quantity**\n\n30V • Latest advanced trench technology • Low RDS(ON) • High Current capability • RoHS and Halogen-Free Compliant\n\nTA=25°C\n\nTA=70°C\n\nTC=25°C\n\nTC=100°C\n\nTC=25°C\n\nAvalanche Current C\n\nContinuous Drain Current\n\n**Thermal Characteristics Parameter Max**\n\nTA=70°C 2.6\n\n°C\n\n**Units**\n\nJunction and Storage Temperature Range -55 to 150\n\n**Typ**\n\nPDSM W TA=25°C 4.1\n\nPower Dissipation A\n\nMaximum Junction-to-Ambient A °C/W RqJA 24 47\n\n30\n\nW\n\nID\n\nA 33\n\nA\n\n90\n\nIDSM 13.5\n\nmJ 27\n\n17\n\n30\n\nAONR32314 DFN 3X3 Tape & Reel 3000\n\nV\n\nA\n\n**Absolute Maximum Ratings TA=25°C unless otherwise noted**\n\n±20\n\nV\n\n**Maximum Units**\n\nMaximum Junction-to-Case °C/W °C/W Maximum Junction-to-Ambient A D\n\n4\\.2\n\n60 5.2\n\n• Notebook AC-in load switch • Battery protection charge/discharge\n\nPower Dissipation B 9\\.6 TC=100°C PD\n\n30\n\n24\n\nGate-Source Voltage\n\nPulsed Drain Current C\n\n25\\.5\n\n**Parameter** Drain-Source Voltage\n\nContinuous Drain Current G\n\nG\n\nD\n\nS\n\n**Top View**\n\nS\n\nS\n\nS\n\nG\n\nD\n\nD D\n\nD\n\n1\n\n2\n\n3\n\n4\n\n8\n\n7\n\n6\n\n5\n\n**DFN 3x3\\_EP**\n\n**Top View Bottom View**\n\nPIN1\n\nPIN1\n\nRev.2.0: March 2018 **_www.aosmd.com_** Page 1 of 6","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## **_AONR32314_**\n\n**General Description Product Summary**\n\nVDS\n\nID (at VGS=10V) 30A\n\nRDS(ON) (at VGS=10V) < 8.7mΩ\n\nRDS(ON) (at VGS=4.5V) < 12.3mΩ\n\n**Applications** 100% UIS Tested 100% Rg Tested\n\n**Symbol** VDS VGS\n\nIDM\n\nIAS\n\nAvalanche energy L=0.05mH C EAS\n\nTJ, TSTG\n\n**Symbol**\n\nt ≤ 10s\n\nSteady-State\n\nSteady-State RqJC\n\n**_30V N-Channel MOSFET_**\n\n**Orderable Part Number Package Type Form Minimum Order Quantity**\n\n30V • Latest advanced trench technology • Low RDS(ON) • High Current capability • RoHS and Halogen-Free Compliant\n\nTA=25°C\n\nTA=70°C\n\nTC=25°C\n\nTC=100°C\n\nTC=25°C\n\nAvalanche Current C\n\nContinuous Drain Current\n\n**Thermal Characteristics Parameter Max**\n\nTA=70°C 2.6\n\n°C\n\n**Units**\n\nJunction and Storage Temperature Range -55 to 150\n\n**Typ**\n\nPDSM W TA=25°C 4.1\n\nPower Dissipation A\n\nMaximum Junction-to-Ambient A °C/W RqJA 24 47\n\n30\n\nW\n\nID\n\nA 33\n\nA\n\n90\n\nIDSM 13.5\n\nmJ 27\n\n17\n\n30\n\nAONR32314 DFN 3X3 Tape & Reel 3000\n\nV\n\nA\n\n**Absolute Maximum Ratings TA=25°C unless otherwise noted**\n\n±20\n\nV\n\n**Maximum Units**\n\nMaximum Junction-to-Case °C/W °C/W Maximum Junction-to-Ambient A D\n\n4\\.2\n\n60 5.2\n\n• Notebook AC-in load switch • Battery protection charge/discharge\n\nPower Dissipation B 9\\.6 TC=100°C PD\n\n30\n\n24\n\nGate-Source Voltage\n\nPulsed Drain Current C\n\n25\\.5\n\n**Parameter** Drain-Source Voltage\n\nContinuous Drain Current G\n\nG\n\nD\n\nS\n\n**Top View**\n\nS\n\nS\n\nS\n\nG\n\nD\n\nD D\n\nD\n\n1\n\n2\n\n3\n\n4\n\n8\n\n7\n\n6\n\n5\n\n**DFN 3x3\\_EP**\n\n**Top View Bottom View**\n\nPIN1\n\nPIN1\n\nRev.2.0: March 2018 **_www.aosmd.com_** Page 1 of 6","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AONR32314_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_cb2a01bb327004f9d9a1a0dd3a64ea57","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## **_AONR32314_**\n\n**General Description Product Summary**\n\nVDS\n\nID (at VGS=10V) 30A\n\nRDS(ON) (at VGS=10V) < 8.7mΩ\n\nRDS(ON) (at VGS=4.5V) < 12.3mΩ\n\n**Applications** 100% UIS Tested 100% Rg Tested\n\n**Symbol** VDS VGS\n\nIDM\n\nIAS\n\nAvalanche energy L=0.05mH C EAS\n\nTJ, TSTG\n\n**Symbol**\n\nt ≤ 10s\n\nSteady-State\n\nSteady-State RqJC\n\n**_30V N-Channel MOSFET_**\n\n**Orderable Part Number Package Type Form Minimum Order Quantity**\n\n30V • Latest advanced trench technology • Low RDS(ON) • High Current capability • RoHS and Halogen-Free Compliant\n\nTA=25°C\n\nTA=70°C\n\nTC=25°C\n\nTC=100°C\n\nTC=25°C\n\nAvalanche Current C\n\nContinuous Drain Current\n\n**Thermal Characteristics Parameter Max**\n\nTA=70°C 2.6\n\n°C\n\n**Units**\n\nJunction and Storage Temperature Range -55 to 150\n\n**Typ**\n\nPDSM W TA=25°C 4.1\n\nPower Dissipation A\n\nMaximum Junction-to-Ambient A °C/W RqJA 24 47\n\n30\n\nW\n\nID\n\nA 33\n\nA\n\n90\n\nIDSM 13.5\n\nmJ 27\n\n17\n\n30\n\nAONR32314 DFN 3X3 Tape & Reel 3000\n\nV\n\nA\n\n**Absolute Maximum Ratings TA=25°C unless otherwise noted**\n\n±20\n\nV\n\n**Maximum Units**\n\nMaximum Junction-to-Case °C/W °C/W Maximum Junction-to-Ambient A D\n\n4\\.2\n\n60 5.2\n\n• Notebook AC-in load switch • Battery protection charge/discharge\n\nPower Dissipation B 9\\.6 TC=100°C PD\n\n30\n\n24\n\nGate-Source Voltage\n\nPulsed Drain Current C\n\n25\\.5\n\n**Parameter** Drain-Source Voltage\n\nContinuous Drain Current G\n\nG\n\nD\n\nS\n\n**Top View**\n\nS\n\nS\n\nS\n\nG\n\nD\n\nD D\n\nD\n\n1\n\n2\n\n3\n\n4\n\n8\n\n7\n\n6\n\n5\n\n**DFN 3x3\\_EP**\n\n**Top View Bottom View**\n\nPIN1\n\nPIN1\n\nRev.2.0: March 2018 **_www.aosmd.com_** Page 1 of 6"],"full_content":"## **_AONR32314_**\n\n**General Description Product Summary**\n\nVDS\n\nID (at VGS=10V) 30A\n\nRDS(ON) (at VGS=10V) < 8.7mΩ\n\nRDS(ON) (at VGS=4.5V) < 12.3mΩ\n\n**Applications** 100% UIS Tested 100% Rg Tested\n\n**Symbol** VDS VGS\n\nIDM\n\nIAS\n\nAvalanche energy L=0.05mH C EAS\n\nTJ, TSTG\n\n**Symbol**\n\nt ≤ 10s\n\nSteady-State\n\nSteady-State RqJC\n\n**_30V N-Channel MOSFET_**\n\n**Orderable Part Number Package Type Form Minimum Order Quantity**\n\n30V • Latest advanced trench technology • Low RDS(ON) • High Current capability • RoHS and Halogen-Free Compliant\n\nTA=25°C\n\nTA=70°C\n\nTC=25°C\n\nTC=100°C\n\nTC=25°C\n\nAvalanche Current C\n\nContinuous Drain Current\n\n**Thermal Characteristics Parameter Max**\n\nTA=70°C 2.6\n\n°C\n\n**Units**\n\nJunction and Storage Temperature Range -55 to 150\n\n**Typ**\n\nPDSM W TA=25°C 4.1\n\nPower Dissipation A\n\nMaximum Junction-to-Ambient A °C/W RqJA 24 47\n\n30\n\nW\n\nID\n\nA 33\n\nA\n\n90\n\nIDSM 13.5\n\nmJ 27\n\n17\n\n30\n\nAONR32314 DFN 3X3 Tape & Reel 3000\n\nV\n\nA\n\n**Absolute Maximum Ratings TA=25°C unless otherwise noted**\n\n±20\n\nV\n\n**Maximum Units**\n\nMaximum Junction-to-Case °C/W °C/W Maximum Junction-to-Ambient A D\n\n4\\.2\n\n60 5.2\n\n• Notebook AC-in load switch • Battery protection charge/discharge\n\nPower Dissipation B 9\\.6 TC=100°C PD\n\n30\n\n24\n\nGate-Source Voltage\n\nPulsed Drain Current C\n\n25\\.5\n\n**Parameter** Drain-Source Voltage\n\nContinuous Drain Current G\n\nG\n\nD\n\nS\n\n**Top View**\n\nS\n\nS\n\nS\n\nG\n\nD\n\nD D\n\nD\n\n1\n\n2\n\n3\n\n4\n\n8\n\n7\n\n6\n\n5\n\n**DFN 3x3\\_EP**\n\n**Top View Bottom View**\n\nPIN1\n\nPIN1\n\nRev.2.0: March 2018 **_www.aosmd.com_** Page 1 of 6","publish_date":null,"title":"AONR32314","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AONR32314_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AONR32314_page1.pdf"},"request":{"example_id":"table/AONR32314_page1","product_type":"parse","source_file_path":"AONR32314_page1.pdf"},"started_at":"2026-11-04T19:31:14.552053"} +{"completed_at":"2026-11-04T19:47:25.364594","latency_in_ms":2116,"output":{"example_id":"table/AONR32314_page2","grounded_pages":[],"layout_pages":[],"markdown":"**_AONR32314_**\n\n**Symbol Min Typ Max Units**\n\nBVDSS 30 V\n\nVDS=30V, VGS=0V 1\n\nTJ=55°C 5\n\nIGSS ±100 nA\n\nVGS(th) Gate Threshold Voltage 1.25 1.75 2.25 V\n\n7\\.2 8.7\n\nTJ=125°C 11.2 13.5\n\n9\\.8 12.3 mΩ\n\ngFS 53 S\n\nVSD 0.7 1 V\n\nIS 30 A\n\nCiss 1420 pF\n\nCoss 150 pF\n\nCrss 95 pF\n\nRg 1 2 3 Ω\n\nQg(10V) 22 32 nC\n\nQg(4.5V) 10 15 nC\n\nQgs 4.7 nC\n\nQgd 4 nC\n\ntD(on) 6.5 ns\n\ntr 2.5 ns\n\ntD(off) 22.5 ns\n\ntf 3 ns\n\ntrr 7.5 ns\n\nQrr 9.0 nC\n\nAPPLICATIONS OR USE AS CRITICAL COMPONENTS IN LIFE SUPPORT DEVICES OR SYSTEMS ARE NOT AUTHORIZED. AOS DOES NOT\n\nASSUME ANY LIABILITY ARISING OUT OF SUCH APPLICATIONS OR USES OF ITS PRODUCTS. AOS RESERVES THE RIGHT TO IMPROVE\n\nPRODUCT DESIGN,FUNCTIONS AND RELIABILITY WITHOUT NOTICE.\n\nmΩ\n\nVGS=10V, VDS=15V, ID=17A\n\nTotal Gate Charge\n\n**Electrical Characteristics (TJ=25°C unless otherwise noted)**\n\n**STATIC PARAMETERS**\n\n**Parameter Conditions**\n\nGate resistance f=1MHz\n\nIDSS μA Zero Gate Voltage Drain Current\n\nDrain-Source Breakdown Voltage ID=250mA, VGS=0V\n\nRDS(ON) Static Drain-Source On-Resistance\n\nGate Source Charge\n\nGate Drain Charge\n\nTotal Gate Charge\n\n**SWITCHING PARAMETERS**\n\nTurn-On DelayTime\n\nVDS=0V, VGS=±20V\n\nMaximum Body-Diode Continuous Current G\n\nInput Capacitance\n\nGate-Body leakage current\n\nBody Diode Reverse Recovery Charge\n\nBody Diode Reverse Recovery Time\n\nIF=17A, di/dt=500A/ms\n\nTurn-Off DelayTime\n\nTurn-Off Fall Time\n\nVGS=10V, VDS=15V, RL=0.75W, RGEN=3W\n\nDiode Forward Voltage\n\n**DYNAMIC PARAMETERS**\n\nVGS=4.5V, ID=14A\n\nIF=17A, di/dt=500A/ms\n\nTurn-On Rise Time\n\nReverse Transfer Capacitance\n\nVGS=0V, VDS=15V, f=1MHz\n\nVDS=VGS, ID=250mA\n\nOutput Capacitance\n\nForward Transconductance\n\nIS=1A, VGS=0V\n\nVDS=5V, ID=17A\n\nVGS=10V, ID=17A\n\nA. The value of RqJA is measured with the device mounted on 1in ² FR-4 board with 2oz. Copper, in a still air environment with T A =25°C. The Power dissipation PDSM is based on R qJA t≤ 10s and the maximum allowed junction temperature of 150°C. The value in any given application depends on the user's specific board design. B. The power dissipation PD is based on TJ(MAX)=150°C, using junction-to-case thermal resistance, and is more useful in setting the upper dissipation limit for cases where additional heatsinking is used. C. Single pulse width limited by junction temperature T J(MAX)=150°C. D. The RqJA is the sum of the thermal impedance from junction to case R qJC and case to ambient. E. The static characteristics in Figures 1 to 6 are obtained using <300 ms pulses, duty cycle 0.5% max. F. These curves are based on the junction-to-case thermal impedance which is measured with the device mounted to a large heatsin k, assuming a maximum junction temperature of TJ(MAX)=150°C. The SOA curve provides a single pulse rating. G. The maximum current rating is package limited. H. These tests are performed with the device mounted on 1 in ² FR-4 board with 2oz. Copper, in a still air environment with T A=25°C.\n\nRev.2.0: March 2018 **_www.aosmd.com_** Page 2 of 6","pages":[{"line_numbers":[],"markdown":"**_AONR32314_**\n\n**Symbol Min Typ Max Units**\n\nBVDSS 30 V\n\nVDS=30V, VGS=0V 1\n\nTJ=55°C 5\n\nIGSS ±100 nA\n\nVGS(th) Gate Threshold Voltage 1.25 1.75 2.25 V\n\n7\\.2 8.7\n\nTJ=125°C 11.2 13.5\n\n9\\.8 12.3 mΩ\n\ngFS 53 S\n\nVSD 0.7 1 V\n\nIS 30 A\n\nCiss 1420 pF\n\nCoss 150 pF\n\nCrss 95 pF\n\nRg 1 2 3 Ω\n\nQg(10V) 22 32 nC\n\nQg(4.5V) 10 15 nC\n\nQgs 4.7 nC\n\nQgd 4 nC\n\ntD(on) 6.5 ns\n\ntr 2.5 ns\n\ntD(off) 22.5 ns\n\ntf 3 ns\n\ntrr 7.5 ns\n\nQrr 9.0 nC\n\nAPPLICATIONS OR USE AS CRITICAL COMPONENTS IN LIFE SUPPORT DEVICES OR SYSTEMS ARE NOT AUTHORIZED. AOS DOES NOT\n\nASSUME ANY LIABILITY ARISING OUT OF SUCH APPLICATIONS OR USES OF ITS PRODUCTS. AOS RESERVES THE RIGHT TO IMPROVE\n\nPRODUCT DESIGN,FUNCTIONS AND RELIABILITY WITHOUT NOTICE.\n\nmΩ\n\nVGS=10V, VDS=15V, ID=17A\n\nTotal Gate Charge\n\n**Electrical Characteristics (TJ=25°C unless otherwise noted)**\n\n**STATIC PARAMETERS**\n\n**Parameter Conditions**\n\nGate resistance f=1MHz\n\nIDSS μA Zero Gate Voltage Drain Current\n\nDrain-Source Breakdown Voltage ID=250mA, VGS=0V\n\nRDS(ON) Static Drain-Source On-Resistance\n\nGate Source Charge\n\nGate Drain Charge\n\nTotal Gate Charge\n\n**SWITCHING PARAMETERS**\n\nTurn-On DelayTime\n\nVDS=0V, VGS=±20V\n\nMaximum Body-Diode Continuous Current G\n\nInput Capacitance\n\nGate-Body leakage current\n\nBody Diode Reverse Recovery Charge\n\nBody Diode Reverse Recovery Time\n\nIF=17A, di/dt=500A/ms\n\nTurn-Off DelayTime\n\nTurn-Off Fall Time\n\nVGS=10V, VDS=15V, RL=0.75W, RGEN=3W\n\nDiode Forward Voltage\n\n**DYNAMIC PARAMETERS**\n\nVGS=4.5V, ID=14A\n\nIF=17A, di/dt=500A/ms\n\nTurn-On Rise Time\n\nReverse Transfer Capacitance\n\nVGS=0V, VDS=15V, f=1MHz\n\nVDS=VGS, ID=250mA\n\nOutput Capacitance\n\nForward Transconductance\n\nIS=1A, VGS=0V\n\nVDS=5V, ID=17A\n\nVGS=10V, ID=17A\n\nA. The value of RqJA is measured with the device mounted on 1in ² FR-4 board with 2oz. Copper, in a still air environment with T A =25°C. The Power dissipation PDSM is based on R qJA t≤ 10s and the maximum allowed junction temperature of 150°C. The value in any given application depends on the user's specific board design. B. The power dissipation PD is based on TJ(MAX)=150°C, using junction-to-case thermal resistance, and is more useful in setting the upper dissipation limit for cases where additional heatsinking is used. C. Single pulse width limited by junction temperature T J(MAX)=150°C. D. The RqJA is the sum of the thermal impedance from junction to case R qJC and case to ambient. E. The static characteristics in Figures 1 to 6 are obtained using <300 ms pulses, duty cycle 0.5% max. F. These curves are based on the junction-to-case thermal impedance which is measured with the device mounted to a large heatsin k, assuming a maximum junction temperature of TJ(MAX)=150°C. The SOA curve provides a single pulse rating. G. The maximum current rating is package limited. H. These tests are performed with the device mounted on 1 in ² FR-4 board with 2oz. Copper, in a still air environment with T A=25°C.\n\nRev.2.0: March 2018 **_www.aosmd.com_** Page 2 of 6","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**_AONR32314_**\n\n**Symbol Min Typ Max Units**\n\nBVDSS 30 V\n\nVDS=30V, VGS=0V 1\n\nTJ=55°C 5\n\nIGSS ±100 nA\n\nVGS(th) Gate Threshold Voltage 1.25 1.75 2.25 V\n\n7\\.2 8.7\n\nTJ=125°C 11.2 13.5\n\n9\\.8 12.3 mΩ\n\ngFS 53 S\n\nVSD 0.7 1 V\n\nIS 30 A\n\nCiss 1420 pF\n\nCoss 150 pF\n\nCrss 95 pF\n\nRg 1 2 3 Ω\n\nQg(10V) 22 32 nC\n\nQg(4.5V) 10 15 nC\n\nQgs 4.7 nC\n\nQgd 4 nC\n\ntD(on) 6.5 ns\n\ntr 2.5 ns\n\ntD(off) 22.5 ns\n\ntf 3 ns\n\ntrr 7.5 ns\n\nQrr 9.0 nC\n\nAPPLICATIONS OR USE AS CRITICAL COMPONENTS IN LIFE SUPPORT DEVICES OR SYSTEMS ARE NOT AUTHORIZED. AOS DOES NOT\n\nASSUME ANY LIABILITY ARISING OUT OF SUCH APPLICATIONS OR USES OF ITS PRODUCTS. AOS RESERVES THE RIGHT TO IMPROVE\n\nPRODUCT DESIGN,FUNCTIONS AND RELIABILITY WITHOUT NOTICE.\n\nmΩ\n\nVGS=10V, VDS=15V, ID=17A\n\nTotal Gate Charge\n\n**Electrical Characteristics (TJ=25°C unless otherwise noted)**\n\n**STATIC PARAMETERS**\n\n**Parameter Conditions**\n\nGate resistance f=1MHz\n\nIDSS μA Zero Gate Voltage Drain Current\n\nDrain-Source Breakdown Voltage ID=250mA, VGS=0V\n\nRDS(ON) Static Drain-Source On-Resistance\n\nGate Source Charge\n\nGate Drain Charge\n\nTotal Gate Charge\n\n**SWITCHING PARAMETERS**\n\nTurn-On DelayTime\n\nVDS=0V, VGS=±20V\n\nMaximum Body-Diode Continuous Current G\n\nInput Capacitance\n\nGate-Body leakage current\n\nBody Diode Reverse Recovery Charge\n\nBody Diode Reverse Recovery Time\n\nIF=17A, di/dt=500A/ms\n\nTurn-Off DelayTime\n\nTurn-Off Fall Time\n\nVGS=10V, VDS=15V, RL=0.75W, RGEN=3W\n\nDiode Forward Voltage\n\n**DYNAMIC PARAMETERS**\n\nVGS=4.5V, ID=14A\n\nIF=17A, di/dt=500A/ms\n\nTurn-On Rise Time\n\nReverse Transfer Capacitance\n\nVGS=0V, VDS=15V, f=1MHz\n\nVDS=VGS, ID=250mA\n\nOutput Capacitance\n\nForward Transconductance\n\nIS=1A, VGS=0V\n\nVDS=5V, ID=17A\n\nVGS=10V, ID=17A\n\nA. The value of RqJA is measured with the device mounted on 1in ² FR-4 board with 2oz. Copper, in a still air environment with T A =25°C. The Power dissipation PDSM is based on R qJA t≤ 10s and the maximum allowed junction temperature of 150°C. The value in any given application depends on the user's specific board design. B. The power dissipation PD is based on TJ(MAX)=150°C, using junction-to-case thermal resistance, and is more useful in setting the upper dissipation limit for cases where additional heatsinking is used. C. Single pulse width limited by junction temperature T J(MAX)=150°C. D. The RqJA is the sum of the thermal impedance from junction to case R qJC and case to ambient. E. The static characteristics in Figures 1 to 6 are obtained using <300 ms pulses, duty cycle 0.5% max. F. These curves are based on the junction-to-case thermal impedance which is measured with the device mounted to a large heatsin k, assuming a maximum junction temperature of TJ(MAX)=150°C. The SOA curve provides a single pulse rating. G. The maximum current rating is package limited. H. These tests are performed with the device mounted on 1 in ² FR-4 board with 2oz. Copper, in a still air environment with T A=25°C.\n\nRev.2.0: March 2018 **_www.aosmd.com_** Page 2 of 6","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AONR32314_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_26492b162411fc8d28bbd13590c3a63c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**_AONR32314_**\n\n**Symbol Min Typ Max Units**\n\nBVDSS 30 V\n\nVDS=30V, VGS=0V 1\n\nTJ=55°C 5\n\nIGSS ±100 nA\n\nVGS(th) Gate Threshold Voltage 1.25 1.75 2.25 V\n\n7\\.2 8.7\n\nTJ=125°C 11.2 13.5\n\n9\\.8 12.3 mΩ\n\ngFS 53 S\n\nVSD 0.7 1 V\n\nIS 30 A\n\nCiss 1420 pF\n\nCoss 150 pF\n\nCrss 95 pF\n\nRg 1 2 3 Ω\n\nQg(10V) 22 32 nC\n\nQg(4.5V) 10 15 nC\n\nQgs 4.7 nC\n\nQgd 4 nC\n\ntD(on) 6.5 ns\n\ntr 2.5 ns\n\ntD(off) 22.5 ns\n\ntf 3 ns\n\ntrr 7.5 ns\n\nQrr 9.0 nC\n\nAPPLICATIONS OR USE AS CRITICAL COMPONENTS IN LIFE SUPPORT DEVICES OR SYSTEMS ARE NOT AUTHORIZED. AOS DOES NOT\n\nASSUME ANY LIABILITY ARISING OUT OF SUCH APPLICATIONS OR USES OF ITS PRODUCTS. AOS RESERVES THE RIGHT TO IMPROVE\n\nPRODUCT DESIGN,FUNCTIONS AND RELIABILITY WITHOUT NOTICE.\n\nmΩ\n\nVGS=10V, VDS=15V, ID=17A\n\nTotal Gate Charge\n\n**Electrical Characteristics (TJ=25°C unless otherwise noted)**\n\n**STATIC PARAMETERS**\n\n**Parameter Conditions**\n\nGate resistance f=1MHz\n\nIDSS μA Zero Gate Voltage Drain Current\n\nDrain-Source Breakdown Voltage ID=250mA, VGS=0V\n\nRDS(ON) Static Drain-Source On-Resistance\n\nGate Source Charge\n\nGate Drain Charge\n\nTotal Gate Charge\n\n**SWITCHING PARAMETERS**\n\nTurn-On DelayTime\n\nVDS=0V, VGS=±20V\n\nMaximum Body-Diode Continuous Current G\n\nInput Capacitance\n\nGate-Body leakage current\n\nBody Diode Reverse Recovery Charge\n\nBody Diode Reverse Recovery Time\n\nIF=17A, di/dt=500A/ms\n\nTurn-Off DelayTime\n\nTurn-Off Fall Time\n\nVGS=10V, VDS=15V, RL=0.75W, RGEN=3W\n\nDiode Forward Voltage\n\n**DYNAMIC PARAMETERS**\n\nVGS=4.5V, ID=14A\n\nIF=17A, di/dt=500A/ms\n\nTurn-On Rise Time\n\nReverse Transfer Capacitance\n\nVGS=0V, VDS=15V, f=1MHz\n\nVDS=VGS, ID=250mA\n\nOutput Capacitance\n\nForward Transconductance\n\nIS=1A, VGS=0V\n\nVDS=5V, ID=17A\n\nVGS=10V, ID=17A\n\nA. The value of RqJA is measured with the device mounted on 1in ² FR-4 board with 2oz. Copper, in a still air environment with T A =25°C. The Power dissipation PDSM is based on R qJA t≤ 10s and the maximum allowed junction temperature of 150°C. The value in any given application depends on the user's specific board design. B. The power dissipation PD is based on TJ(MAX)=150°C, using junction-to-case thermal resistance, and is more useful in setting the upper dissipation limit for cases where additional heatsinking is used. C. Single pulse width limited by junction temperature T J(MAX)=150°C. D. The RqJA is the sum of the thermal impedance from junction to case R qJC and case to ambient. E. The static characteristics in Figures 1 to 6 are obtained using <300 ms pulses, duty cycle 0.5% max. F. These curves are based on the junction-to-case thermal impedance which is measured with the device mounted to a large heatsin k, assuming a maximum junction temperature of TJ(MAX)=150°C. The SOA curve provides a single pulse rating. G. The maximum current rating is package limited. H. These tests are performed with the device mounted on 1 in ² FR-4 board with 2oz. Copper, in a still air environment with T A=25°C.\n\nRev.2.0: March 2018 **_www.aosmd.com_** Page 2 of 6"],"full_content":"**_AONR32314_**\n\n**Symbol Min Typ Max Units**\n\nBVDSS 30 V\n\nVDS=30V, VGS=0V 1\n\nTJ=55°C 5\n\nIGSS ±100 nA\n\nVGS(th) Gate Threshold Voltage 1.25 1.75 2.25 V\n\n7\\.2 8.7\n\nTJ=125°C 11.2 13.5\n\n9\\.8 12.3 mΩ\n\ngFS 53 S\n\nVSD 0.7 1 V\n\nIS 30 A\n\nCiss 1420 pF\n\nCoss 150 pF\n\nCrss 95 pF\n\nRg 1 2 3 Ω\n\nQg(10V) 22 32 nC\n\nQg(4.5V) 10 15 nC\n\nQgs 4.7 nC\n\nQgd 4 nC\n\ntD(on) 6.5 ns\n\ntr 2.5 ns\n\ntD(off) 22.5 ns\n\ntf 3 ns\n\ntrr 7.5 ns\n\nQrr 9.0 nC\n\nAPPLICATIONS OR USE AS CRITICAL COMPONENTS IN LIFE SUPPORT DEVICES OR SYSTEMS ARE NOT AUTHORIZED. AOS DOES NOT\n\nASSUME ANY LIABILITY ARISING OUT OF SUCH APPLICATIONS OR USES OF ITS PRODUCTS. AOS RESERVES THE RIGHT TO IMPROVE\n\nPRODUCT DESIGN,FUNCTIONS AND RELIABILITY WITHOUT NOTICE.\n\nmΩ\n\nVGS=10V, VDS=15V, ID=17A\n\nTotal Gate Charge\n\n**Electrical Characteristics (TJ=25°C unless otherwise noted)**\n\n**STATIC PARAMETERS**\n\n**Parameter Conditions**\n\nGate resistance f=1MHz\n\nIDSS μA Zero Gate Voltage Drain Current\n\nDrain-Source Breakdown Voltage ID=250mA, VGS=0V\n\nRDS(ON) Static Drain-Source On-Resistance\n\nGate Source Charge\n\nGate Drain Charge\n\nTotal Gate Charge\n\n**SWITCHING PARAMETERS**\n\nTurn-On DelayTime\n\nVDS=0V, VGS=±20V\n\nMaximum Body-Diode Continuous Current G\n\nInput Capacitance\n\nGate-Body leakage current\n\nBody Diode Reverse Recovery Charge\n\nBody Diode Reverse Recovery Time\n\nIF=17A, di/dt=500A/ms\n\nTurn-Off DelayTime\n\nTurn-Off Fall Time\n\nVGS=10V, VDS=15V, RL=0.75W, RGEN=3W\n\nDiode Forward Voltage\n\n**DYNAMIC PARAMETERS**\n\nVGS=4.5V, ID=14A\n\nIF=17A, di/dt=500A/ms\n\nTurn-On Rise Time\n\nReverse Transfer Capacitance\n\nVGS=0V, VDS=15V, f=1MHz\n\nVDS=VGS, ID=250mA\n\nOutput Capacitance\n\nForward Transconductance\n\nIS=1A, VGS=0V\n\nVDS=5V, ID=17A\n\nVGS=10V, ID=17A\n\nA. The value of RqJA is measured with the device mounted on 1in ² FR-4 board with 2oz. Copper, in a still air environment with T A =25°C. The Power dissipation PDSM is based on R qJA t≤ 10s and the maximum allowed junction temperature of 150°C. The value in any given application depends on the user's specific board design. B. The power dissipation PD is based on TJ(MAX)=150°C, using junction-to-case thermal resistance, and is more useful in setting the upper dissipation limit for cases where additional heatsinking is used. C. Single pulse width limited by junction temperature T J(MAX)=150°C. D. The RqJA is the sum of the thermal impedance from junction to case R qJC and case to ambient. E. The static characteristics in Figures 1 to 6 are obtained using <300 ms pulses, duty cycle 0.5% max. F. These curves are based on the junction-to-case thermal impedance which is measured with the device mounted to a large heatsin k, assuming a maximum junction temperature of TJ(MAX)=150°C. The SOA curve provides a single pulse rating. G. The maximum current rating is package limited. H. These tests are performed with the device mounted on 1 in ² FR-4 board with 2oz. Copper, in a still air environment with T A=25°C.\n\nRev.2.0: March 2018 **_www.aosmd.com_** Page 2 of 6","publish_date":null,"title":"AONR32314","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AONR32314_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AONR32314_page2.pdf"},"request":{"example_id":"table/AONR32314_page2","product_type":"parse","source_file_path":"AONR32314_page2.pdf"},"started_at":"2026-11-04T19:47:23.247857"} +{"completed_at":"2026-11-04T19:47:25.355643","latency_in_ms":889,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page100","grounded_pages":[],"layout_pages":[],"markdown":"100\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Additional Insured - Manager or Lessor**\n\n**Rate**\n\nPer Each Location/ Each Additional Insured $12.86","pages":[{"line_numbers":[],"markdown":"100\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Additional Insured - Manager or Lessor**\n\n**Rate**\n\nPer Each Location/ Each Additional Insured $12.86","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"100\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Additional Insured - Manager or Lessor**\n\n**Rate**\n\nPer Each Location/ Each Additional Insured $12.86","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page100.pdf"]},"response":{"errors":[],"extract_id":"extract_07caea549cea0f92249125e55012c3ff","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["100\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Additional Insured - Manager or Lessor**\n\n**Rate**\n\nPer Each Location/ Each Additional Insured $12.86"],"full_content":"100\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Additional Insured - Manager or Lessor**\n\n**Rate**\n\nPer Each Location/ Each Additional Insured $12.86","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Additional Insured - Manager or Lessor Rate Per Each Location/ Each","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page100.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page100.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page100","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page100.pdf"},"started_at":"2026-11-04T19:47:24.466050"} +{"completed_at":"2026-11-04T19:47:27.566783","latency_in_ms":1977,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page101","grounded_pages":[],"layout_pages":[],"markdown":"101\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Coverage E Limit (Personal Liability)**\n\n**All Forms**\n\n**Limit 1 2 3 4**\n\n**$100,000** \\- - - -\n\n**$200,000** $11.00 $19.00 $24.00 $29.00\n\n**$300,000** $16.00 $28.00 $36.00 $44.00\n\n**$400,000** $20.00 $35.00 $45.00 $55.00\n\n**$500,000** $22.00 $39.00 $50.00 $61.00\n\n**$1,000,000** $30.00 $53.00 $68.00 $83.00\n\n**Number of Families**","pages":[{"line_numbers":[],"markdown":"101\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Coverage E Limit (Personal Liability)**\n\n**All Forms**\n\n**Limit 1 2 3 4**\n\n**$100,000** \\- - - -\n\n**$200,000** $11.00 $19.00 $24.00 $29.00\n\n**$300,000** $16.00 $28.00 $36.00 $44.00\n\n**$400,000** $20.00 $35.00 $45.00 $55.00\n\n**$500,000** $22.00 $39.00 $50.00 $61.00\n\n**$1,000,000** $30.00 $53.00 $68.00 $83.00\n\n**Number of Families**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"101\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Coverage E Limit (Personal Liability)**\n\n**All Forms**\n\n**Limit 1 2 3 4**\n\n**$100,000** \\- - - -\n\n**$200,000** $11.00 $19.00 $24.00 $29.00\n\n**$300,000** $16.00 $28.00 $36.00 $44.00\n\n**$400,000** $20.00 $35.00 $45.00 $55.00\n\n**$500,000** $22.00 $39.00 $50.00 $61.00\n\n**$1,000,000** $30.00 $53.00 $68.00 $83.00\n\n**Number of Families**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page101.pdf"]},"response":{"errors":[],"extract_id":"extract_acf1f354a1d84fa42158001f92d30210","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["101\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Coverage E Limit (Personal Liability)**\n\n**All Forms**\n\n**Limit 1 2 3 4**\n\n**$100,000** \\- - - -\n\n**$200,000** $11.00 $19.00 $24.00 $29.00\n\n**$300,000** $16.00 $28.00 $36.00 $44.00\n\n**$400,000** $20.00 $35.00 $45.00 $55.00\n\n**$500,000** $22.00 $39.00 $50.00 $61.00\n\n**$1,000,000** $30.00 $53.00 $68.00 $83.00\n\n**Number of Families**"],"full_content":"101\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Coverage E Limit (Personal Liability)**\n\n**All Forms**\n\n**Limit 1 2 3 4**\n\n**$100,000** \\- - - -\n\n**$200,000** $11.00 $19.00 $24.00 $29.00\n\n**$300,000** $16.00 $28.00 $36.00 $44.00\n\n**$400,000** $20.00 $35.00 $45.00 $55.00\n\n**$500,000** $22.00 $39.00 $50.00 $61.00\n\n**$1,000,000** $30.00 $53.00 $68.00 $83.00\n\n**Number of Families**","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Coverage E Limit (Personal Liability) All Forms Number of Families Limit","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page101.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page101.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page101","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page101.pdf"},"started_at":"2026-11-04T19:47:25.589459"} +{"completed_at":"2026-11-04T19:47:27.762646","latency_in_ms":1446,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page103","grounded_pages":[],"layout_pages":[],"markdown":"103\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Personal Injury Coverage All Forms**\n\n**Type Rate**\n\nPer Policy (per offense) $11.52","pages":[{"line_numbers":[],"markdown":"103\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Personal Injury Coverage All Forms**\n\n**Type Rate**\n\nPer Policy (per offense) $11.52","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"103\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Personal Injury Coverage All Forms**\n\n**Type Rate**\n\nPer Policy (per offense) $11.52","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page103.pdf"]},"response":{"errors":[],"extract_id":"extract_d8b079145b3b58839ffc9c20f241d9ce","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["103\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Personal Injury Coverage All Forms**\n\n**Type Rate**\n\nPer Policy (per offense) $11.52"],"full_content":"103\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Personal Injury Coverage All Forms**\n\n**Type Rate**\n\nPer Policy (per offense) $11.52","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Personal Injury Coverage All Forms Type Rate Per Policy (per offense)","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page103.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page103.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page103","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page103.pdf"},"started_at":"2026-11-04T19:47:26.316272"} +{"completed_at":"2026-11-04T19:47:29.598802","latency_in_ms":2055,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page105","grounded_pages":[],"layout_pages":[],"markdown":"105\n\nLemonade Insurance Company\n\nHomeowners Program\n\nArizona Edition April 2024\n\n**Other Exposures - Increased Coverage F Limits**\n\n**All Forms**\n\n**$2,000 $3,000 $4,000 $5,000**\n\n$0.89 $1.77 $2.66 $3.54\n\n**Rule Name Basic Limit**\n\nOther Members of an Insured's","pages":[{"line_numbers":[],"markdown":"105\n\nLemonade Insurance Company\n\nHomeowners Program\n\nArizona Edition April 2024\n\n**Other Exposures - Increased Coverage F Limits**\n\n**All Forms**\n\n**$2,000 $3,000 $4,000 $5,000**\n\n$0.89 $1.77 $2.66 $3.54\n\n**Rule Name Basic Limit**\n\nOther Members of an Insured's","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"105\n\nLemonade Insurance Company\n\nHomeowners Program\n\nArizona Edition April 2024\n\n**Other Exposures - Increased Coverage F Limits**\n\n**All Forms**\n\n**$2,000 $3,000 $4,000 $5,000**\n\n$0.89 $1.77 $2.66 $3.54\n\n**Rule Name Basic Limit**\n\nOther Members of an Insured's","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page105.pdf"]},"response":{"errors":[],"extract_id":"extract_7a4a90fa24d8aa5d180ead221cfe188a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["105\n\nLemonade Insurance Company\n\nHomeowners Program\n\nArizona Edition April 2024\n\n**Other Exposures - Increased Coverage F Limits**\n\n**All Forms**\n\n**$2,000 $3,000 $4,000 $5,000**\n\n$0.89 $1.77 $2.66 $3.54\n\n**Rule Name Basic Limit**\n\nOther Members of an Insured's"],"full_content":"105\n\nLemonade Insurance Company\n\nHomeowners Program\n\nArizona Edition April 2024\n\n**Other Exposures - Increased Coverage F Limits**\n\n**All Forms**\n\n**$2,000 $3,000 $4,000 $5,000**\n\n$0.89 $1.77 $2.66 $3.54\n\n**Rule Name Basic Limit**\n\nOther Members of an Insured's","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Other Exposures - Increased Coverage F Limits All Forms Basic Limit","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page105.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page105.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page105","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page105.pdf"},"started_at":"2026-11-04T19:47:27.543613"} +{"completed_at":"2026-11-04T19:47:30.706563","latency_in_ms":2645,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page47","grounded_pages":[],"layout_pages":[],"markdown":"47\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Protection Class**\n\n46 44-45, 47, 49-\n\n51, 55, 57\n\n40, 42-43, 48,\n\n52-54, 56 41\n\n1 0.870 0.840 0.810 0.790\n\n2 0.880 0.850 0.830 0.800\n\n3 0.880 0.860 0.840 0.820\n\n4 0.880 0.870 0.850 0.840\n\n5 0.890 0.880 0.860 0.850\n\n6 0.900 0.900 0.900 0.890\n\n7 0.910 0.910 0.920 0.930\n\n8 0.910 0.920 0.930 0.940\n\n8B 0.910 0.930 0.940 0.950\n\n9 0.920 0.930 0.950 0.960\n\n10 0.960 1.010 1.070 1.120\n\n1X - 4X 1Y - 4Y 0.890 0.890 0.880 0.880\n\n5X-5Y 0.900 0.890 0.880 0.880\n\n6X-7X 6Y-7Y 0.910 0.920 0.930 0.940\n\n8Y 0.910 0.930 0.940 0.950\n\n8X 0.920 0.930 0.950 0.960\n\n10W 0.950 1.000 1.050 1.090\n\n**Construction PPC**\n\nTerritory\n\nMasonry\n\n**Protection - Construction Factors**","pages":[{"line_numbers":[],"markdown":"47\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Protection Class**\n\n46 44-45, 47, 49-\n\n51, 55, 57\n\n40, 42-43, 48,\n\n52-54, 56 41\n\n1 0.870 0.840 0.810 0.790\n\n2 0.880 0.850 0.830 0.800\n\n3 0.880 0.860 0.840 0.820\n\n4 0.880 0.870 0.850 0.840\n\n5 0.890 0.880 0.860 0.850\n\n6 0.900 0.900 0.900 0.890\n\n7 0.910 0.910 0.920 0.930\n\n8 0.910 0.920 0.930 0.940\n\n8B 0.910 0.930 0.940 0.950\n\n9 0.920 0.930 0.950 0.960\n\n10 0.960 1.010 1.070 1.120\n\n1X - 4X 1Y - 4Y 0.890 0.890 0.880 0.880\n\n5X-5Y 0.900 0.890 0.880 0.880\n\n6X-7X 6Y-7Y 0.910 0.920 0.930 0.940\n\n8Y 0.910 0.930 0.940 0.950\n\n8X 0.920 0.930 0.950 0.960\n\n10W 0.950 1.000 1.050 1.090\n\n**Construction PPC**\n\nTerritory\n\nMasonry\n\n**Protection - Construction Factors**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"47\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Protection Class**\n\n46 44-45, 47, 49-\n\n51, 55, 57\n\n40, 42-43, 48,\n\n52-54, 56 41\n\n1 0.870 0.840 0.810 0.790\n\n2 0.880 0.850 0.830 0.800\n\n3 0.880 0.860 0.840 0.820\n\n4 0.880 0.870 0.850 0.840\n\n5 0.890 0.880 0.860 0.850\n\n6 0.900 0.900 0.900 0.890\n\n7 0.910 0.910 0.920 0.930\n\n8 0.910 0.920 0.930 0.940\n\n8B 0.910 0.930 0.940 0.950\n\n9 0.920 0.930 0.950 0.960\n\n10 0.960 1.010 1.070 1.120\n\n1X - 4X 1Y - 4Y 0.890 0.890 0.880 0.880\n\n5X-5Y 0.900 0.890 0.880 0.880\n\n6X-7X 6Y-7Y 0.910 0.920 0.930 0.940\n\n8Y 0.910 0.930 0.940 0.950\n\n8X 0.920 0.930 0.950 0.960\n\n10W 0.950 1.000 1.050 1.090\n\n**Construction PPC**\n\nTerritory\n\nMasonry\n\n**Protection - Construction Factors**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page47.pdf"]},"response":{"errors":[],"extract_id":"extract_a3c47c00a46be582e09f3eed71a0b015","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["47\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Protection Class**\n\n46 44-45, 47, 49-\n\n51, 55, 57\n\n40, 42-43, 48,\n\n52-54, 56 41\n\n1 0.870 0.840 0.810 0.790\n\n2 0.880 0.850 0.830 0.800\n\n3 0.880 0.860 0.840 0.820\n\n4 0.880 0.870 0.850 0.840\n\n5 0.890 0.880 0.860 0.850\n\n6 0.900 0.900 0.900 0.890\n\n7 0.910 0.910 0.920 0.930\n\n8 0.910 0.920 0.930 0.940\n\n8B 0.910 0.930 0.940 0.950\n\n9 0.920 0.930 0.950 0.960\n\n10 0.960 1.010 1.070 1.120\n\n1X - 4X 1Y - 4Y 0.890 0.890 0.880 0.880\n\n5X-5Y 0.900 0.890 0.880 0.880\n\n6X-7X 6Y-7Y 0.910 0.920 0.930 0.940\n\n8Y 0.910 0.930 0.940 0.950\n\n8X 0.920 0.930 0.950 0.960\n\n10W 0.950 1.000 1.050 1.090\n\n**Construction PPC**\n\nTerritory\n\nMasonry\n\n**Protection - Construction Factors**"],"full_content":"47\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Protection Class**\n\n46 44-45, 47, 49-\n\n51, 55, 57\n\n40, 42-43, 48,\n\n52-54, 56 41\n\n1 0.870 0.840 0.810 0.790\n\n2 0.880 0.850 0.830 0.800\n\n3 0.880 0.860 0.840 0.820\n\n4 0.880 0.870 0.850 0.840\n\n5 0.890 0.880 0.860 0.850\n\n6 0.900 0.900 0.900 0.890\n\n7 0.910 0.910 0.920 0.930\n\n8 0.910 0.920 0.930 0.940\n\n8B 0.910 0.930 0.940 0.950\n\n9 0.920 0.930 0.950 0.960\n\n10 0.960 1.010 1.070 1.120\n\n1X - 4X 1Y - 4Y 0.890 0.890 0.880 0.880\n\n5X-5Y 0.900 0.890 0.880 0.880\n\n6X-7X 6Y-7Y 0.910 0.920 0.930 0.940\n\n8Y 0.910 0.930 0.940 0.950\n\n8X 0.920 0.930 0.950 0.960\n\n10W 0.950 1.000 1.050 1.090\n\n**Construction PPC**\n\nTerritory\n\nMasonry\n\n**Protection - Construction Factors**","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Protection Class Protection - Construction Factors Territory Construction PPC 44-45, 47,","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page47.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page47.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page47","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page47.pdf"},"started_at":"2026-11-04T19:47:28.061273"} +{"completed_at":"2026-11-04T19:47:30.747975","latency_in_ms":1147,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page48","grounded_pages":[],"layout_pages":[],"markdown":"48\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Protection Class**\n\n**LEM 04**\n\n**Construction**\n\n**Type Frame**\n\n1 0.930\n\n2 0.960\n\n3 0.990\n\n4 0.990\n\n5 1.000\n\n6 1.080\n\n7 1.280\n\n8 1.290\n\n8B 1.290\n\n9 1.300\n\n10 1.510\n\n1X – 5X, 1Y –\n\n5Y 1.170\n\n6X, 6Y 1.270\n\n7X, 7Y, 8Y 1.290\n\n8X 1.30\n\n10W 1.47\n\n**Protection**\n\n**Class**\n\n**Protection – Construction**\n\n**Factors\\***","pages":[{"line_numbers":[],"markdown":"48\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Protection Class**\n\n**LEM 04**\n\n**Construction**\n\n**Type Frame**\n\n1 0.930\n\n2 0.960\n\n3 0.990\n\n4 0.990\n\n5 1.000\n\n6 1.080\n\n7 1.280\n\n8 1.290\n\n8B 1.290\n\n9 1.300\n\n10 1.510\n\n1X – 5X, 1Y –\n\n5Y 1.170\n\n6X, 6Y 1.270\n\n7X, 7Y, 8Y 1.290\n\n8X 1.30\n\n10W 1.47\n\n**Protection**\n\n**Class**\n\n**Protection – Construction**\n\n**Factors\\***","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"48\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Protection Class**\n\n**LEM 04**\n\n**Construction**\n\n**Type Frame**\n\n1 0.930\n\n2 0.960\n\n3 0.990\n\n4 0.990\n\n5 1.000\n\n6 1.080\n\n7 1.280\n\n8 1.290\n\n8B 1.290\n\n9 1.300\n\n10 1.510\n\n1X – 5X, 1Y –\n\n5Y 1.170\n\n6X, 6Y 1.270\n\n7X, 7Y, 8Y 1.290\n\n8X 1.30\n\n10W 1.47\n\n**Protection**\n\n**Class**\n\n**Protection – Construction**\n\n**Factors\\***","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page48.pdf"]},"response":{"errors":[],"extract_id":"extract_16305b39b11f083562dca7d821f91477","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["48\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Protection Class**\n\n**LEM 04**\n\n**Construction**\n\n**Type Frame**\n\n1 0.930\n\n2 0.960\n\n3 0.990\n\n4 0.990\n\n5 1.000\n\n6 1.080\n\n7 1.280\n\n8 1.290\n\n8B 1.290\n\n9 1.300\n\n10 1.510\n\n1X – 5X, 1Y –\n\n5Y 1.170\n\n6X, 6Y 1.270\n\n7X, 7Y, 8Y 1.290\n\n8X 1.30\n\n10W 1.47\n\n**Protection**\n\n**Class**\n\n**Protection – Construction**\n\n**Factors\\***"],"full_content":"48\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Protection Class**\n\n**LEM 04**\n\n**Construction**\n\n**Type Frame**\n\n1 0.930\n\n2 0.960\n\n3 0.990\n\n4 0.990\n\n5 1.000\n\n6 1.080\n\n7 1.280\n\n8 1.290\n\n8B 1.290\n\n9 1.300\n\n10 1.510\n\n1X – 5X, 1Y –\n\n5Y 1.170\n\n6X, 6Y 1.270\n\n7X, 7Y, 8Y 1.290\n\n8X 1.30\n\n10W 1.47\n\n**Protection**\n\n**Class**\n\n**Protection – Construction**\n\n**Factors\\***","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Protection Class LEM 04 Protection – Construction Factors* Construction Protection Type","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page48.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page48.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page48","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page48.pdf"},"started_at":"2026-11-04T19:47:29.600605"} +{"completed_at":"2026-11-04T19:47:31.626896","latency_in_ms":910,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page57","grounded_pages":[],"layout_pages":[],"markdown":"57\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Loss Settlement Options - Personal Property**\n\n**Personal Property at**\n\n**Replacement Cost Factor**\n\nNo 1.000\n\nYes: LEM 03 1.150\n\nYes: LEM 04 1.350\n\nYes: LEM 06 1.350","pages":[{"line_numbers":[],"markdown":"57\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Loss Settlement Options - Personal Property**\n\n**Personal Property at**\n\n**Replacement Cost Factor**\n\nNo 1.000\n\nYes: LEM 03 1.150\n\nYes: LEM 04 1.350\n\nYes: LEM 06 1.350","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"57\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Loss Settlement Options - Personal Property**\n\n**Personal Property at**\n\n**Replacement Cost Factor**\n\nNo 1.000\n\nYes: LEM 03 1.150\n\nYes: LEM 04 1.350\n\nYes: LEM 06 1.350","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page57.pdf"]},"response":{"errors":[],"extract_id":"extract_06bb8fbe0d6fec2149d64b0a38df3fcd","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["57\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Loss Settlement Options - Personal Property**\n\n**Personal Property at**\n\n**Replacement Cost Factor**\n\nNo 1.000\n\nYes: LEM 03 1.150\n\nYes: LEM 04 1.350\n\nYes: LEM 06 1.350"],"full_content":"57\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Loss Settlement Options - Personal Property**\n\n**Personal Property at**\n\n**Replacement Cost Factor**\n\nNo 1.000\n\nYes: LEM 03 1.150\n\nYes: LEM 04 1.350\n\nYes: LEM 06 1.350","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Loss Settlement Options - Personal Property Personal Property at Factor Replacement","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page57.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page57.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page57","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page57.pdf"},"started_at":"2026-11-04T19:47:30.716071"} +{"completed_at":"2026-11-04T19:47:32.616193","latency_in_ms":925,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page60","grounded_pages":[],"layout_pages":[],"markdown":"60\n\nLemonade Insurance Company Homeowners Program\n\nArizona Edition April 2024\n\n**Deductibles**\n\n**A. Optional Lower Deductibles**\n\n**Deductible**\n\n**Form** $250\n\nLEM 04 1.090\n\n**B. Optional Higher Deductibles**\n\n**Coverage A Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $99,999** 0\\.920 0.800 0.700 0.630 0.590\n\n**$100,000 to $199,999** 0\\.930 0.810 0.710 0.640 0.600\n\n**$200,000 to $299,999** 0\\.940 0.820 0.720 0.650 0.610\n\n**$300,000 and Over** 0\\.960 0.860 0.770 0.710 0.670\n\n**Coverage C Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $25,000** 0\\.880 0.690 - - -\n\n**$25,001 and Over** 0\\.910 0.780 - - -\n\n**Coverage C Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $40,000** 0\\.890 0.700 - - -\n\n**$40,001 and Over** 0\\.910 0.750 - - -\n\n**Deductible Amount**\n\n**Form LEM 03**\n\n**Deductible Amount**\n\n**Form LEM 04**\n\n**Deductible Amount**\n\n**Form LEM 06**","pages":[{"line_numbers":[],"markdown":"60\n\nLemonade Insurance Company Homeowners Program\n\nArizona Edition April 2024\n\n**Deductibles**\n\n**A. Optional Lower Deductibles**\n\n**Deductible**\n\n**Form** $250\n\nLEM 04 1.090\n\n**B. Optional Higher Deductibles**\n\n**Coverage A Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $99,999** 0\\.920 0.800 0.700 0.630 0.590\n\n**$100,000 to $199,999** 0\\.930 0.810 0.710 0.640 0.600\n\n**$200,000 to $299,999** 0\\.940 0.820 0.720 0.650 0.610\n\n**$300,000 and Over** 0\\.960 0.860 0.770 0.710 0.670\n\n**Coverage C Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $25,000** 0\\.880 0.690 - - -\n\n**$25,001 and Over** 0\\.910 0.780 - - -\n\n**Coverage C Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $40,000** 0\\.890 0.700 - - -\n\n**$40,001 and Over** 0\\.910 0.750 - - -\n\n**Deductible Amount**\n\n**Form LEM 03**\n\n**Deductible Amount**\n\n**Form LEM 04**\n\n**Deductible Amount**\n\n**Form LEM 06**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"60\n\nLemonade Insurance Company Homeowners Program\n\nArizona Edition April 2024\n\n**Deductibles**\n\n**A. Optional Lower Deductibles**\n\n**Deductible**\n\n**Form** $250\n\nLEM 04 1.090\n\n**B. Optional Higher Deductibles**\n\n**Coverage A Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $99,999** 0\\.920 0.800 0.700 0.630 0.590\n\n**$100,000 to $199,999** 0\\.930 0.810 0.710 0.640 0.600\n\n**$200,000 to $299,999** 0\\.940 0.820 0.720 0.650 0.610\n\n**$300,000 and Over** 0\\.960 0.860 0.770 0.710 0.670\n\n**Coverage C Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $25,000** 0\\.880 0.690 - - -\n\n**$25,001 and Over** 0\\.910 0.780 - - -\n\n**Coverage C Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $40,000** 0\\.890 0.700 - - -\n\n**$40,001 and Over** 0\\.910 0.750 - - -\n\n**Deductible Amount**\n\n**Form LEM 03**\n\n**Deductible Amount**\n\n**Form LEM 04**\n\n**Deductible Amount**\n\n**Form LEM 06**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page60.pdf"]},"response":{"errors":[],"extract_id":"extract_6ab0e3bad7256d12cb14d525d47fffa5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["60\n\nLemonade Insurance Company Homeowners Program\n\nArizona Edition April 2024\n\n**Deductibles**\n\n**A. Optional Lower Deductibles**\n\n**Deductible**\n\n**Form** $250\n\nLEM 04 1.090\n\n**B. Optional Higher Deductibles**\n\n**Coverage A Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $99,999** 0\\.920 0.800 0.700 0.630 0.590\n\n**$100,000 to $199,999** 0\\.930 0.810 0.710 0.640 0.600\n\n**$200,000 to $299,999** 0\\.940 0.820 0.720 0.650 0.610\n\n**$300,000 and Over** 0\\.960 0.860 0.770 0.710 0.670\n\n**Coverage C Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $25,000** 0\\.880 0.690 - - -\n\n**$25,001 and Over** 0\\.910 0.780 - - -\n\n**Coverage C Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $40,000** 0\\.890 0.700 - - -\n\n**$40,001 and Over** 0\\.910 0.750 - - -\n\n**Deductible Amount**\n\n**Form LEM 03**\n\n**Deductible Amount**\n\n**Form LEM 04**\n\n**Deductible Amount**\n\n**Form LEM 06**"],"full_content":"60\n\nLemonade Insurance Company Homeowners Program\n\nArizona Edition April 2024\n\n**Deductibles**\n\n**A. Optional Lower Deductibles**\n\n**Deductible**\n\n**Form** $250\n\nLEM 04 1.090\n\n**B. Optional Higher Deductibles**\n\n**Coverage A Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $99,999** 0\\.920 0.800 0.700 0.630 0.590\n\n**$100,000 to $199,999** 0\\.930 0.810 0.710 0.640 0.600\n\n**$200,000 to $299,999** 0\\.940 0.820 0.720 0.650 0.610\n\n**$300,000 and Over** 0\\.960 0.860 0.770 0.710 0.670\n\n**Coverage C Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $25,000** 0\\.880 0.690 - - -\n\n**$25,001 and Over** 0\\.910 0.780 - - -\n\n**Coverage C Limit**\n\n$1,000 $2,500 $5,000 $7,500 $10,000\n\n**Up to $40,000** 0\\.890 0.700 - - -\n\n**$40,001 and Over** 0\\.910 0.750 - - -\n\n**Deductible Amount**\n\n**Form LEM 03**\n\n**Deductible Amount**\n\n**Form LEM 04**\n\n**Deductible Amount**\n\n**Form LEM 06**","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Deductibles A. Optional Lower Deductibles Deductible Form $250 LEM 04 1.090","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page60.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page60.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page60","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page60.pdf"},"started_at":"2026-11-04T19:47:31.690902"} +{"completed_at":"2026-11-04T19:47:33.669888","latency_in_ms":1052,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page62","grounded_pages":[],"layout_pages":[],"markdown":"62\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Roof Age**\n\n**LEM 03**\n\n**Roof Age Factor**\n\n0 0.894\n\n1 0.906\n\n2 0.918\n\n3 0.930\n\n4 0.943\n\n5 0.952\n\n6 0.963\n\n7 0.973\n\n8 0.983\n\n9 0.992\n\n10 1.000\n\n11 1.010\n\n12 1.019\n\n13 1.029\n\n14 1.038\n\n15 1.048\n\n16 1.058\n\n17 1.067\n\n18 1.077\n\n19 1.086\n\n20 1.096\n\n21 1.105\n\n22 1.115\n\n23 1.124\n\n24 1.134\n\n25 1.144\n\n26 1.153\n\n27 1.163\n\n28 1.172\n\n29 1.182\n\n30+ 1.191\n\nMissing 1.000","pages":[{"line_numbers":[],"markdown":"62\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Roof Age**\n\n**LEM 03**\n\n**Roof Age Factor**\n\n0 0.894\n\n1 0.906\n\n2 0.918\n\n3 0.930\n\n4 0.943\n\n5 0.952\n\n6 0.963\n\n7 0.973\n\n8 0.983\n\n9 0.992\n\n10 1.000\n\n11 1.010\n\n12 1.019\n\n13 1.029\n\n14 1.038\n\n15 1.048\n\n16 1.058\n\n17 1.067\n\n18 1.077\n\n19 1.086\n\n20 1.096\n\n21 1.105\n\n22 1.115\n\n23 1.124\n\n24 1.134\n\n25 1.144\n\n26 1.153\n\n27 1.163\n\n28 1.172\n\n29 1.182\n\n30+ 1.191\n\nMissing 1.000","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"62\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Roof Age**\n\n**LEM 03**\n\n**Roof Age Factor**\n\n0 0.894\n\n1 0.906\n\n2 0.918\n\n3 0.930\n\n4 0.943\n\n5 0.952\n\n6 0.963\n\n7 0.973\n\n8 0.983\n\n9 0.992\n\n10 1.000\n\n11 1.010\n\n12 1.019\n\n13 1.029\n\n14 1.038\n\n15 1.048\n\n16 1.058\n\n17 1.067\n\n18 1.077\n\n19 1.086\n\n20 1.096\n\n21 1.105\n\n22 1.115\n\n23 1.124\n\n24 1.134\n\n25 1.144\n\n26 1.153\n\n27 1.163\n\n28 1.172\n\n29 1.182\n\n30+ 1.191\n\nMissing 1.000","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page62.pdf"]},"response":{"errors":[],"extract_id":"extract_fa6632ff9b302b390f0037c3ba7289a6","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["62\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Roof Age**\n\n**LEM 03**\n\n**Roof Age Factor**\n\n0 0.894\n\n1 0.906\n\n2 0.918\n\n3 0.930\n\n4 0.943\n\n5 0.952\n\n6 0.963\n\n7 0.973\n\n8 0.983\n\n9 0.992\n\n10 1.000\n\n11 1.010\n\n12 1.019\n\n13 1.029\n\n14 1.038\n\n15 1.048\n\n16 1.058\n\n17 1.067\n\n18 1.077\n\n19 1.086\n\n20 1.096\n\n21 1.105\n\n22 1.115\n\n23 1.124\n\n24 1.134\n\n25 1.144\n\n26 1.153\n\n27 1.163\n\n28 1.172\n\n29 1.182\n\n30+ 1.191\n\nMissing 1.000"],"full_content":"62\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Roof Age**\n\n**LEM 03**\n\n**Roof Age Factor**\n\n0 0.894\n\n1 0.906\n\n2 0.918\n\n3 0.930\n\n4 0.943\n\n5 0.952\n\n6 0.963\n\n7 0.973\n\n8 0.983\n\n9 0.992\n\n10 1.000\n\n11 1.010\n\n12 1.019\n\n13 1.029\n\n14 1.038\n\n15 1.048\n\n16 1.058\n\n17 1.067\n\n18 1.077\n\n19 1.086\n\n20 1.096\n\n21 1.105\n\n22 1.115\n\n23 1.124\n\n24 1.134\n\n25 1.144\n\n26 1.153\n\n27 1.163\n\n28 1.172\n\n29 1.182\n\n30+ 1.191\n\nMissing 1.000","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Roof Age LEM 03 Roof Age Factor 0 0.894 1 0.906","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page62.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page62.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page62","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page62.pdf"},"started_at":"2026-11-04T19:47:32.617304"} +{"completed_at":"2026-11-04T19:47:34.865532","latency_in_ms":1190,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page78","grounded_pages":[],"layout_pages":[],"markdown":"78\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Bundle Credit**\n\n**All Forms**\n\n**Car Other Factor**\n\n0 0 1.000\n\n1+ 0 0.900\n\n0 1+ 0.900\n\n1+ 1+ 0.900\n\n**Number of Additional Policies**","pages":[{"line_numbers":[],"markdown":"78\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Bundle Credit**\n\n**All Forms**\n\n**Car Other Factor**\n\n0 0 1.000\n\n1+ 0 0.900\n\n0 1+ 0.900\n\n1+ 1+ 0.900\n\n**Number of Additional Policies**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"78\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Bundle Credit**\n\n**All Forms**\n\n**Car Other Factor**\n\n0 0 1.000\n\n1+ 0 0.900\n\n0 1+ 0.900\n\n1+ 1+ 0.900\n\n**Number of Additional Policies**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page78.pdf"]},"response":{"errors":[],"extract_id":"extract_acc7bd109ff4eaa5d599345d8b300dc3","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["78\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Bundle Credit**\n\n**All Forms**\n\n**Car Other Factor**\n\n0 0 1.000\n\n1+ 0 0.900\n\n0 1+ 0.900\n\n1+ 1+ 0.900\n\n**Number of Additional Policies**"],"full_content":"78\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Bundle Credit**\n\n**All Forms**\n\n**Car Other Factor**\n\n0 0 1.000\n\n1+ 0 0.900\n\n0 1+ 0.900\n\n1+ 1+ 0.900\n\n**Number of Additional Policies**","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Bundle Credit All Forms Number of Additional Policies Car Other Factor","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page78.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page78.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page78","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page78.pdf"},"started_at":"2026-11-04T19:47:33.675242"} +{"completed_at":"2026-11-04T19:47:36.015967","latency_in_ms":1058,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page80","grounded_pages":[],"layout_pages":[],"markdown":"80\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Type of Residence**\n\n**All Forms**\n\n**Type Factor**\n\nPrimary 1.000\n\nSecondary 1.100\n\nSeasonal 1.100","pages":[{"line_numbers":[],"markdown":"80\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Type of Residence**\n\n**All Forms**\n\n**Type Factor**\n\nPrimary 1.000\n\nSecondary 1.100\n\nSeasonal 1.100","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"80\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Type of Residence**\n\n**All Forms**\n\n**Type Factor**\n\nPrimary 1.000\n\nSecondary 1.100\n\nSeasonal 1.100","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page80.pdf"]},"response":{"errors":[],"extract_id":"extract_c2f19c3da7f82b074c6bb40d006e052b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["80\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Type of Residence**\n\n**All Forms**\n\n**Type Factor**\n\nPrimary 1.000\n\nSecondary 1.100\n\nSeasonal 1.100"],"full_content":"80\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Type of Residence**\n\n**All Forms**\n\n**Type Factor**\n\nPrimary 1.000\n\nSecondary 1.100\n\nSeasonal 1.100","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Type of Residence All Forms Type Factor Primary 1.000 Secondary 1.100","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page80.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page80.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page80","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page80.pdf"},"started_at":"2026-11-04T19:47:34.957054"} +{"completed_at":"2026-11-04T19:47:38.729981","latency_in_ms":2544,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page89","grounded_pages":[],"layout_pages":[],"markdown":"89\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Personal Property LEM 03**\n\n**Per Rate**\n\nIncrease in Limit $1,000 $1.77\n\n**Per Credit**\n\nDecrease in Limit $1,000 $0.89","pages":[{"line_numbers":[],"markdown":"89\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Personal Property LEM 03**\n\n**Per Rate**\n\nIncrease in Limit $1,000 $1.77\n\n**Per Credit**\n\nDecrease in Limit $1,000 $0.89","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"89\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Personal Property LEM 03**\n\n**Per Rate**\n\nIncrease in Limit $1,000 $1.77\n\n**Per Credit**\n\nDecrease in Limit $1,000 $0.89","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page89.pdf"]},"response":{"errors":[],"extract_id":"extract_9d5423c1cda7c98f0a53a14ded02160f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["89\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Personal Property LEM 03**\n\n**Per Rate**\n\nIncrease in Limit $1,000 $1.77\n\n**Per Credit**\n\nDecrease in Limit $1,000 $0.89"],"full_content":"89\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Personal Property LEM 03**\n\n**Per Rate**\n\nIncrease in Limit $1,000 $1.77\n\n**Per Credit**\n\nDecrease in Limit $1,000 $0.89","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Personal Property LEM 03 Per Rate $1,000 $1.77 Increase in Limit","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page89.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page89.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page89","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page89.pdf"},"started_at":"2026-11-04T19:47:36.185661"} +{"completed_at":"2026-11-04T19:47:37.917345","latency_in_ms":912,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page90","grounded_pages":[],"layout_pages":[],"markdown":"90\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Coverage D Increased Limit (Loss of Use) All Forms**\n\n**Per Rate**\n\n$1,000 $2.66","pages":[{"line_numbers":[],"markdown":"90\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Coverage D Increased Limit (Loss of Use) All Forms**\n\n**Per Rate**\n\n$1,000 $2.66","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"90\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Coverage D Increased Limit (Loss of Use) All Forms**\n\n**Per Rate**\n\n$1,000 $2.66","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page90.pdf"]},"response":{"errors":[],"extract_id":"extract_3891495873417ef59968f446d3d24a0d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["90\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Coverage D Increased Limit (Loss of Use) All Forms**\n\n**Per Rate**\n\n$1,000 $2.66"],"full_content":"90\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Coverage D Increased Limit (Loss of Use) All Forms**\n\n**Per Rate**\n\n$1,000 $2.66","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Coverage D Increased Limit (Loss of Use) All Forms Per Rate","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page90.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page90.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page90","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page90.pdf"},"started_at":"2026-11-04T19:47:37.004597"} +{"completed_at":"2026-11-04T19:47:39.582302","latency_in_ms":1621,"output":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page93","grounded_pages":[],"layout_pages":[],"markdown":"93\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Buried Utility Lines Coverage**\n\n**LEM 03** A. Premium - Buried Utility Lines Coverage\n\n**Deductible** $500\n\nLEM 03 $39.00\n\nB. Premium - Buried Utility Lines Coverage if EBC is attached to the policy.\n\n**Deductible** $500\n\nLEM 03 $33.00","pages":[{"line_numbers":[],"markdown":"93\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Buried Utility Lines Coverage**\n\n**LEM 03** A. Premium - Buried Utility Lines Coverage\n\n**Deductible** $500\n\nLEM 03 $39.00\n\nB. Premium - Buried Utility Lines Coverage if EBC is attached to the policy.\n\n**Deductible** $500\n\nLEM 03 $33.00","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"93\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Buried Utility Lines Coverage**\n\n**LEM 03** A. Premium - Buried Utility Lines Coverage\n\n**Deductible** $500\n\nLEM 03 $39.00\n\nB. Premium - Buried Utility Lines Coverage if EBC is attached to the policy.\n\n**Deductible** $500\n\nLEM 03 $33.00","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page93.pdf"]},"response":{"errors":[],"extract_id":"extract_ac5b5c366a6e7401c74e63f642d0eea1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["93\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Buried Utility Lines Coverage**\n\n**LEM 03** A. Premium - Buried Utility Lines Coverage\n\n**Deductible** $500\n\nLEM 03 $39.00\n\nB. Premium - Buried Utility Lines Coverage if EBC is attached to the policy.\n\n**Deductible** $500\n\nLEM 03 $33.00"],"full_content":"93\n\nLemonade Insurance Company Homeowners Program Arizona Edition April 2024\n\n**Buried Utility Lines Coverage**\n\n**LEM 03** A. Premium - Buried Utility Lines Coverage\n\n**Deductible** $500\n\nLEM 03 $39.00\n\nB. Premium - Buried Utility Lines Coverage if EBC is attached to the policy.\n\n**Deductible** $500\n\nLEM 03 $33.00","publish_date":null,"title":"Lemonade Insurance Company Homeowners Program Arizona Edition April 2024 Buried Utility Lines Coverage LEM 03 A. Premium - Buried Utility","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page93.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/AZ%20LIC%20Rate%20Tables%202.0.v2_page93.pdf"},"request":{"example_id":"table/AZ LIC Rate Tables 2.0.v2_page93","product_type":"parse","source_file_path":"AZ LIC Rate Tables 2.0.v2_page93.pdf"},"started_at":"2026-11-04T19:47:37.960927"} +{"completed_at":"2026-11-04T19:31:17.594006","latency_in_ms":1788,"output":{"example_id":"table/Apple 10-k_page1","grounded_pages":[],"layout_pages":[],"markdown":"### **UNITED STATES**\n\n### **SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n## **FORM 10-K**\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the fiscal year ended September 27, 2025\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the transition period from to .\n\nCommission File Number: **001-36743**\n\n# **Apple Inc.**\n\n(Exact name of Registrant as specified in its charter)\n\n**California 94-2404110**\n\n(State or other jurisdiction\n\nof incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n**One Apple Park Way Cupertino, California 95014**\n\n(Address of principal executive offices) (Zip Code)\n\n**(408) 996-1010**\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading symbol(s) Name of each exchange on which registered\n\n**Common Stock, $0.00001 par value per share AAPL The Nasdaq Stock Market LLC**\n\n**0\\.000% Notes due 2025 — The Nasdaq Stock Market LLC**\n\n**1\\.625% Notes due 2026 — The Nasdaq Stock Market LLC**\n\n**2\\.000% Notes due 2027 — The Nasdaq Stock Market LLC**\n\n**1\\.375% Notes due 2029 — The Nasdaq Stock Market LLC**\n\n**3\\.050% Notes due 2029 — The Nasdaq Stock Market LLC**\n\n**0\\.500% Notes due 2031 — The Nasdaq Stock Market LLC**\n\n**3\\.600% Notes due 2042 — The Nasdaq Stock Market LLC**\n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\nIndicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.\n\nYes ☒ No ☐\n\nIndicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.\n\nYes ☐ No ☒","pages":[{"line_numbers":[],"markdown":"### **UNITED STATES**\n\n### **SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n## **FORM 10-K**\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the fiscal year ended September 27, 2025\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the transition period from to .\n\nCommission File Number: **001-36743**\n\n# **Apple Inc.**\n\n(Exact name of Registrant as specified in its charter)\n\n**California 94-2404110**\n\n(State or other jurisdiction\n\nof incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n**One Apple Park Way Cupertino, California 95014**\n\n(Address of principal executive offices) (Zip Code)\n\n**(408) 996-1010**\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading symbol(s) Name of each exchange on which registered\n\n**Common Stock, $0.00001 par value per share AAPL The Nasdaq Stock Market LLC**\n\n**0\\.000% Notes due 2025 — The Nasdaq Stock Market LLC**\n\n**1\\.625% Notes due 2026 — The Nasdaq Stock Market LLC**\n\n**2\\.000% Notes due 2027 — The Nasdaq Stock Market LLC**\n\n**1\\.375% Notes due 2029 — The Nasdaq Stock Market LLC**\n\n**3\\.050% Notes due 2029 — The Nasdaq Stock Market LLC**\n\n**0\\.500% Notes due 2031 — The Nasdaq Stock Market LLC**\n\n**3\\.600% Notes due 2042 — The Nasdaq Stock Market LLC**\n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\nIndicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.\n\nYes ☒ No ☐\n\nIndicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.\n\nYes ☐ No ☒","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **UNITED STATES**\n\n### **SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n## **FORM 10-K**\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the fiscal year ended September 27, 2025\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the transition period from to .\n\nCommission File Number: **001-36743**\n\n# **Apple Inc.**\n\n(Exact name of Registrant as specified in its charter)\n\n**California 94-2404110**\n\n(State or other jurisdiction\n\nof incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n**One Apple Park Way Cupertino, California 95014**\n\n(Address of principal executive offices) (Zip Code)\n\n**(408) 996-1010**\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading symbol(s) Name of each exchange on which registered\n\n**Common Stock, $0.00001 par value per share AAPL The Nasdaq Stock Market LLC**\n\n**0\\.000% Notes due 2025 — The Nasdaq Stock Market LLC**\n\n**1\\.625% Notes due 2026 — The Nasdaq Stock Market LLC**\n\n**2\\.000% Notes due 2027 — The Nasdaq Stock Market LLC**\n\n**1\\.375% Notes due 2029 — The Nasdaq Stock Market LLC**\n\n**3\\.050% Notes due 2029 — The Nasdaq Stock Market LLC**\n\n**0\\.500% Notes due 2031 — The Nasdaq Stock Market LLC**\n\n**3\\.600% Notes due 2042 — The Nasdaq Stock Market LLC**\n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\nIndicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.\n\nYes ☒ No ☐\n\nIndicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.\n\nYes ☐ No ☒","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_0fc0327865f8652972ac9f5bcd85e535","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **UNITED STATES**\n\n### **SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n## **FORM 10-K**\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the fiscal year ended September 27, 2025\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the transition period from to .\n\nCommission File Number: **001-36743**\n\n# **Apple Inc.**\n\n(Exact name of Registrant as specified in its charter)\n\n**California 94-2404110**\n\n(State or other jurisdiction\n\nof incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n**One Apple Park Way Cupertino, California 95014**\n\n(Address of principal executive offices) (Zip Code)\n\n**(408) 996-1010**\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading symbol(s) Name of each exchange on which registered\n\n**Common Stock, $0.00001 par value per share AAPL The Nasdaq Stock Market LLC**\n\n**0\\.000% Notes due 2025 — The Nasdaq Stock Market LLC**\n\n**1\\.625% Notes due 2026 — The Nasdaq Stock Market LLC**\n\n**2\\.000% Notes due 2027 — The Nasdaq Stock Market LLC**\n\n**1\\.375% Notes due 2029 — The Nasdaq Stock Market LLC**\n\n**3\\.050% Notes due 2029 — The Nasdaq Stock Market LLC**\n\n**0\\.500% Notes due 2031 — The Nasdaq Stock Market LLC**\n\n**3\\.600% Notes due 2042 — The Nasdaq Stock Market LLC**\n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\nIndicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.\n\nYes ☒ No ☐\n\nIndicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.\n\nYes ☐ No ☒"],"full_content":"### **UNITED STATES**\n\n### **SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n## **FORM 10-K**\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the fiscal year ended September 27, 2025\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the transition period from to .\n\nCommission File Number: **001-36743**\n\n# **Apple Inc.**\n\n(Exact name of Registrant as specified in its charter)\n\n**California 94-2404110**\n\n(State or other jurisdiction\n\nof incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n**One Apple Park Way Cupertino, California 95014**\n\n(Address of principal executive offices) (Zip Code)\n\n**(408) 996-1010**\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading symbol(s) Name of each exchange on which registered\n\n**Common Stock, $0.00001 par value per share AAPL The Nasdaq Stock Market LLC**\n\n**0\\.000% Notes due 2025 — The Nasdaq Stock Market LLC**\n\n**1\\.625% Notes due 2026 — The Nasdaq Stock Market LLC**\n\n**2\\.000% Notes due 2027 — The Nasdaq Stock Market LLC**\n\n**1\\.375% Notes due 2029 — The Nasdaq Stock Market LLC**\n\n**3\\.050% Notes due 2029 — The Nasdaq Stock Market LLC**\n\n**0\\.500% Notes due 2031 — The Nasdaq Stock Market LLC**\n\n**3\\.600% Notes due 2042 — The Nasdaq Stock Market LLC**\n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\nIndicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.\n\nYes ☒ No ☐\n\nIndicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.\n\nYes ☐ No ☒","publish_date":null,"title":"Apple Inc. — FORM 10-K, fiscal year ended September 27, 2025","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page1.pdf"},"request":{"example_id":"table/Apple 10-k_page1","product_type":"parse","source_file_path":"Apple 10-k_page1.pdf"},"started_at":"2026-11-04T19:31:15.805739"} +{"completed_at":"2026-11-04T19:47:41.665844","latency_in_ms":1128,"output":{"example_id":"table/Apple 10-k_page22","grounded_pages":[],"layout_pages":[],"markdown":"**PART II**\n\n**Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities**\n\nThe Company’s common stock is traded on The Nasdaq Stock Market LLC under the symbol AAPL.\n\n**Holders**\n\nAs of October 17, 2025, there were 22,429 shareholders of record.\n\n**Purchases of Equity Securities by the Issuer and Affiliated Purchasers**\n\nShare repurchase activity during the three months ended September 27, 2025, was as follows (in millions, except number of shares, which are reflected in thousands, and per-share amounts):\n\n**Periods**\n\n**Total Number**\n\n**of Shares Purchased**\n\n**Average**\n\n**Price**\n\n**Paid Per**\n\n**Share**\n\n**Total Number**\n\n**of Shares**\n\n**Purchased as Part of Publicly**\n\n**Announced**\n\n**Plans or Programs**\n\n**Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs** **(1)**\n\nJune 29, 2025 to August 2, 2025:\n\nOpen market and privately negotiated purchases 33,265 $ 210.43 33,265\n\nAugust 3, 2025 to August 30, 2025:\n\nOpen market and privately negotiated purchases 28,986 $ 224.25 28,986\n\nAugust 31, 2025 to September 27, 2025:\n\nOpen market and privately negotiated purchases 27,247 $ 238.56 27,247\n\nTotal 89,498 $ 99,779\n\n(1) On May 2, 2024, the Company announced a program to repurchase up to $110 billion of the Company’s common stock. During the fourth quarter of 2025, the Company utilized the final $19.8 billion under the May 2024 program. On May 1, 2025, the Company announced an additional program to repurchase up to $100 billion of the Company’s common stock. As of September 27, 2025, $221 million of the May 2025 program had been utilized. The programs do not obligate the Company to acquire a minimum amount of shares. Under the programs, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act.\n\nApple Inc. | 2025 Form 10-K | 19","pages":[{"line_numbers":[],"markdown":"**PART II**\n\n**Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities**\n\nThe Company’s common stock is traded on The Nasdaq Stock Market LLC under the symbol AAPL.\n\n**Holders**\n\nAs of October 17, 2025, there were 22,429 shareholders of record.\n\n**Purchases of Equity Securities by the Issuer and Affiliated Purchasers**\n\nShare repurchase activity during the three months ended September 27, 2025, was as follows (in millions, except number of shares, which are reflected in thousands, and per-share amounts):\n\n**Periods**\n\n**Total Number**\n\n**of Shares Purchased**\n\n**Average**\n\n**Price**\n\n**Paid Per**\n\n**Share**\n\n**Total Number**\n\n**of Shares**\n\n**Purchased as Part of Publicly**\n\n**Announced**\n\n**Plans or Programs**\n\n**Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs** **(1)**\n\nJune 29, 2025 to August 2, 2025:\n\nOpen market and privately negotiated purchases 33,265 $ 210.43 33,265\n\nAugust 3, 2025 to August 30, 2025:\n\nOpen market and privately negotiated purchases 28,986 $ 224.25 28,986\n\nAugust 31, 2025 to September 27, 2025:\n\nOpen market and privately negotiated purchases 27,247 $ 238.56 27,247\n\nTotal 89,498 $ 99,779\n\n(1) On May 2, 2024, the Company announced a program to repurchase up to $110 billion of the Company’s common stock. During the fourth quarter of 2025, the Company utilized the final $19.8 billion under the May 2024 program. On May 1, 2025, the Company announced an additional program to repurchase up to $100 billion of the Company’s common stock. As of September 27, 2025, $221 million of the May 2025 program had been utilized. The programs do not obligate the Company to acquire a minimum amount of shares. Under the programs, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act.\n\nApple Inc. | 2025 Form 10-K | 19","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**PART II**\n\n**Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities**\n\nThe Company’s common stock is traded on The Nasdaq Stock Market LLC under the symbol AAPL.\n\n**Holders**\n\nAs of October 17, 2025, there were 22,429 shareholders of record.\n\n**Purchases of Equity Securities by the Issuer and Affiliated Purchasers**\n\nShare repurchase activity during the three months ended September 27, 2025, was as follows (in millions, except number of shares, which are reflected in thousands, and per-share amounts):\n\n**Periods**\n\n**Total Number**\n\n**of Shares Purchased**\n\n**Average**\n\n**Price**\n\n**Paid Per**\n\n**Share**\n\n**Total Number**\n\n**of Shares**\n\n**Purchased as Part of Publicly**\n\n**Announced**\n\n**Plans or Programs**\n\n**Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs** **(1)**\n\nJune 29, 2025 to August 2, 2025:\n\nOpen market and privately negotiated purchases 33,265 $ 210.43 33,265\n\nAugust 3, 2025 to August 30, 2025:\n\nOpen market and privately negotiated purchases 28,986 $ 224.25 28,986\n\nAugust 31, 2025 to September 27, 2025:\n\nOpen market and privately negotiated purchases 27,247 $ 238.56 27,247\n\nTotal 89,498 $ 99,779\n\n(1) On May 2, 2024, the Company announced a program to repurchase up to $110 billion of the Company’s common stock. During the fourth quarter of 2025, the Company utilized the final $19.8 billion under the May 2024 program. On May 1, 2025, the Company announced an additional program to repurchase up to $100 billion of the Company’s common stock. As of September 27, 2025, $221 million of the May 2025 program had been utilized. The programs do not obligate the Company to acquire a minimum amount of shares. Under the programs, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act.\n\nApple Inc. | 2025 Form 10-K | 19","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page22.pdf"]},"response":{"errors":[],"extract_id":"extract_6b89fb7ceb08284a533604d3592f3011","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**PART II**\n\n**Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities**\n\nThe Company’s common stock is traded on The Nasdaq Stock Market LLC under the symbol AAPL.\n\n**Holders**\n\nAs of October 17, 2025, there were 22,429 shareholders of record.\n\n**Purchases of Equity Securities by the Issuer and Affiliated Purchasers**\n\nShare repurchase activity during the three months ended September 27, 2025, was as follows (in millions, except number of shares, which are reflected in thousands, and per-share amounts):\n\n**Periods**\n\n**Total Number**\n\n**of Shares Purchased**\n\n**Average**\n\n**Price**\n\n**Paid Per**\n\n**Share**\n\n**Total Number**\n\n**of Shares**\n\n**Purchased as Part of Publicly**\n\n**Announced**\n\n**Plans or Programs**\n\n**Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs** **(1)**\n\nJune 29, 2025 to August 2, 2025:\n\nOpen market and privately negotiated purchases 33,265 $ 210.43 33,265\n\nAugust 3, 2025 to August 30, 2025:\n\nOpen market and privately negotiated purchases 28,986 $ 224.25 28,986\n\nAugust 31, 2025 to September 27, 2025:\n\nOpen market and privately negotiated purchases 27,247 $ 238.56 27,247\n\nTotal 89,498 $ 99,779\n\n(1) On May 2, 2024, the Company announced a program to repurchase up to $110 billion of the Company’s common stock. During the fourth quarter of 2025, the Company utilized the final $19.8 billion under the May 2024 program. On May 1, 2025, the Company announced an additional program to repurchase up to $100 billion of the Company’s common stock. As of September 27, 2025, $221 million of the May 2025 program had been utilized. The programs do not obligate the Company to acquire a minimum amount of shares. Under the programs, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act.\n\nApple Inc. | 2025 Form 10-K | 19"],"full_content":"**PART II**\n\n**Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities**\n\nThe Company’s common stock is traded on The Nasdaq Stock Market LLC under the symbol AAPL.\n\n**Holders**\n\nAs of October 17, 2025, there were 22,429 shareholders of record.\n\n**Purchases of Equity Securities by the Issuer and Affiliated Purchasers**\n\nShare repurchase activity during the three months ended September 27, 2025, was as follows (in millions, except number of shares, which are reflected in thousands, and per-share amounts):\n\n**Periods**\n\n**Total Number**\n\n**of Shares Purchased**\n\n**Average**\n\n**Price**\n\n**Paid Per**\n\n**Share**\n\n**Total Number**\n\n**of Shares**\n\n**Purchased as Part of Publicly**\n\n**Announced**\n\n**Plans or Programs**\n\n**Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs** **(1)**\n\nJune 29, 2025 to August 2, 2025:\n\nOpen market and privately negotiated purchases 33,265 $ 210.43 33,265\n\nAugust 3, 2025 to August 30, 2025:\n\nOpen market and privately negotiated purchases 28,986 $ 224.25 28,986\n\nAugust 31, 2025 to September 27, 2025:\n\nOpen market and privately negotiated purchases 27,247 $ 238.56 27,247\n\nTotal 89,498 $ 99,779\n\n(1) On May 2, 2024, the Company announced a program to repurchase up to $110 billion of the Company’s common stock. During the fourth quarter of 2025, the Company utilized the final $19.8 billion under the May 2024 program. On May 1, 2025, the Company announced an additional program to repurchase up to $100 billion of the Company’s common stock. As of September 27, 2025, $221 million of the May 2025 program had been utilized. The programs do not obligate the Company to acquire a minimum amount of shares. Under the programs, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act.\n\nApple Inc. | 2025 Form 10-K | 19","publish_date":null,"title":"PART II Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities The Company’s","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page22.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page22.pdf"},"request":{"example_id":"table/Apple 10-k_page22","product_type":"parse","source_file_path":"Apple 10-k_page22.pdf"},"started_at":"2026-11-04T19:47:40.536847"} +{"completed_at":"2026-11-04T19:47:43.558653","latency_in_ms":1665,"output":{"example_id":"table/Apple 10-k_page23","grounded_pages":[],"layout_pages":[],"markdown":"**Company Stock Performance**\n\nThe following graph shows a comparison of five-year cumulative total shareholder return, calculated on a dividend-reinvested basis, for the Company, the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index. The graph assumes $100 was invested in each of the Company’s common stock, the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index as of the market close on September 25, 2020. Past stock price performance is not necessarily indicative of future stock price performance.\n\n**COMPARISON OF 5-YEAR CUMULATIVE TOTAL RETURN**\n\n**Among Apple Inc., the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index**\n\nApple Inc. S&P 500 Index Dow Jones U.S. Technology Total Stock Market Index\n\n9/25/20 9/25/21 9/24/22 9/30/23 9/28/24 9/27/25\n\n$0\n\n$100\n\n$200\n\n$300\n\n**September**\n\n**2020**\n\n**September**\n\n**2021**\n\n**September**\n\n**2022**\n\n**September**\n\n**2023**\n\n**September**\n\n**2024**\n\n**September**\n\n**2025**\n\nApple Inc. $ 100 $ 132 $ 136 $ 155 $ 208 $ 234\n\nS&P 500 Index $ 100 $ 137 $ 115 $ 136 $ 185 $ 217\n\nDow Jones U.S. Technology Total Stock\n\nMarket Index $ 100 $ 147 $ 107 $ 147 $ 220 $ 287\n\n**Item 6. [Reserved]**\n\nApple Inc. | 2025 Form 10-K | 20","pages":[{"line_numbers":[],"markdown":"**Company Stock Performance**\n\nThe following graph shows a comparison of five-year cumulative total shareholder return, calculated on a dividend-reinvested basis, for the Company, the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index. The graph assumes $100 was invested in each of the Company’s common stock, the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index as of the market close on September 25, 2020. Past stock price performance is not necessarily indicative of future stock price performance.\n\n**COMPARISON OF 5-YEAR CUMULATIVE TOTAL RETURN**\n\n**Among Apple Inc., the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index**\n\nApple Inc. S&P 500 Index Dow Jones U.S. Technology Total Stock Market Index\n\n9/25/20 9/25/21 9/24/22 9/30/23 9/28/24 9/27/25\n\n$0\n\n$100\n\n$200\n\n$300\n\n**September**\n\n**2020**\n\n**September**\n\n**2021**\n\n**September**\n\n**2022**\n\n**September**\n\n**2023**\n\n**September**\n\n**2024**\n\n**September**\n\n**2025**\n\nApple Inc. $ 100 $ 132 $ 136 $ 155 $ 208 $ 234\n\nS&P 500 Index $ 100 $ 137 $ 115 $ 136 $ 185 $ 217\n\nDow Jones U.S. Technology Total Stock\n\nMarket Index $ 100 $ 147 $ 107 $ 147 $ 220 $ 287\n\n**Item 6. [Reserved]**\n\nApple Inc. | 2025 Form 10-K | 20","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Company Stock Performance**\n\nThe following graph shows a comparison of five-year cumulative total shareholder return, calculated on a dividend-reinvested basis, for the Company, the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index. The graph assumes $100 was invested in each of the Company’s common stock, the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index as of the market close on September 25, 2020. Past stock price performance is not necessarily indicative of future stock price performance.\n\n**COMPARISON OF 5-YEAR CUMULATIVE TOTAL RETURN**\n\n**Among Apple Inc., the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index**\n\nApple Inc. S&P 500 Index Dow Jones U.S. Technology Total Stock Market Index\n\n9/25/20 9/25/21 9/24/22 9/30/23 9/28/24 9/27/25\n\n$0\n\n$100\n\n$200\n\n$300\n\n**September**\n\n**2020**\n\n**September**\n\n**2021**\n\n**September**\n\n**2022**\n\n**September**\n\n**2023**\n\n**September**\n\n**2024**\n\n**September**\n\n**2025**\n\nApple Inc. $ 100 $ 132 $ 136 $ 155 $ 208 $ 234\n\nS&P 500 Index $ 100 $ 137 $ 115 $ 136 $ 185 $ 217\n\nDow Jones U.S. Technology Total Stock\n\nMarket Index $ 100 $ 147 $ 107 $ 147 $ 220 $ 287\n\n**Item 6. [Reserved]**\n\nApple Inc. | 2025 Form 10-K | 20","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page23.pdf"]},"response":{"errors":[],"extract_id":"extract_8e23818b35ea774660210bc051dd9501","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Company Stock Performance**\n\nThe following graph shows a comparison of five-year cumulative total shareholder return, calculated on a dividend-reinvested basis, for the Company, the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index. The graph assumes $100 was invested in each of the Company’s common stock, the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index as of the market close on September 25, 2020. Past stock price performance is not necessarily indicative of future stock price performance.\n\n**COMPARISON OF 5-YEAR CUMULATIVE TOTAL RETURN**\n\n**Among Apple Inc., the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index**\n\nApple Inc. S&P 500 Index Dow Jones U.S. Technology Total Stock Market Index\n\n9/25/20 9/25/21 9/24/22 9/30/23 9/28/24 9/27/25\n\n$0\n\n$100\n\n$200\n\n$300\n\n**September**\n\n**2020**\n\n**September**\n\n**2021**\n\n**September**\n\n**2022**\n\n**September**\n\n**2023**\n\n**September**\n\n**2024**\n\n**September**\n\n**2025**\n\nApple Inc. $ 100 $ 132 $ 136 $ 155 $ 208 $ 234\n\nS&P 500 Index $ 100 $ 137 $ 115 $ 136 $ 185 $ 217\n\nDow Jones U.S. Technology Total Stock\n\nMarket Index $ 100 $ 147 $ 107 $ 147 $ 220 $ 287\n\n**Item 6. [Reserved]**\n\nApple Inc. | 2025 Form 10-K | 20"],"full_content":"**Company Stock Performance**\n\nThe following graph shows a comparison of five-year cumulative total shareholder return, calculated on a dividend-reinvested basis, for the Company, the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index. The graph assumes $100 was invested in each of the Company’s common stock, the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index as of the market close on September 25, 2020. Past stock price performance is not necessarily indicative of future stock price performance.\n\n**COMPARISON OF 5-YEAR CUMULATIVE TOTAL RETURN**\n\n**Among Apple Inc., the S&P 500 Index and the Dow Jones U.S. Technology Total Stock Market Index**\n\nApple Inc. S&P 500 Index Dow Jones U.S. Technology Total Stock Market Index\n\n9/25/20 9/25/21 9/24/22 9/30/23 9/28/24 9/27/25\n\n$0\n\n$100\n\n$200\n\n$300\n\n**September**\n\n**2020**\n\n**September**\n\n**2021**\n\n**September**\n\n**2022**\n\n**September**\n\n**2023**\n\n**September**\n\n**2024**\n\n**September**\n\n**2025**\n\nApple Inc. $ 100 $ 132 $ 136 $ 155 $ 208 $ 234\n\nS&P 500 Index $ 100 $ 137 $ 115 $ 136 $ 185 $ 217\n\nDow Jones U.S. Technology Total Stock\n\nMarket Index $ 100 $ 147 $ 107 $ 147 $ 220 $ 287\n\n**Item 6. [Reserved]**\n\nApple Inc. | 2025 Form 10-K | 20","publish_date":null,"title":"Company Stock Performance The following graph shows a comparison of five-year cumulative total shareholder return, calculated on a dividend-reinvested basis,","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page23.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page23.pdf"},"request":{"example_id":"table/Apple 10-k_page23","product_type":"parse","source_file_path":"Apple 10-k_page23.pdf"},"started_at":"2026-11-04T19:47:41.892841"} +{"completed_at":"2026-11-04T19:47:44.744436","latency_in_ms":1857,"output":{"example_id":"table/Apple 10-k_page25","grounded_pages":[],"layout_pages":[],"markdown":"**Tariffs and Other Measures**\n\nBeginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others. In response, several countries have imposed, or threatened to impose, reciprocal tariffs on imports from the U.S. and other retaliatory measures. Various modifications to the U.S. Tariffs have been announced and further changes could be made in the future, which may include additional sector-based tariffs or other measures. For example, the U.S. Department of Commerce has initiated an investigation under Section 232 of the Trade Expansion Act of 1962, as amended, into, among other things, imports of semiconductors, semiconductor manufacturing equipment, and their derivative products, including downstream products that contain semiconductors. Tariffs and other measures that are applied to the Company’s products or their components can have a material adverse impact on the Company’s business, results of operations and financial condition, including impacting the Company’s supply chain, the availability of rare earths and other raw materials and components, pricing and gross margin. The ultimate impact remains uncertain and will depend on several factors, including whether additional or incremental U.S. Tariffs or other measures are announced or imposed, to what extent other countries implement tariffs or other retaliatory measures in response, and the overall magnitude and duration of these measures. Trade and other international disputes can have an adverse impact on the overall macroeconomic environment and result in shifts and reductions in consumer spending and negative consumer sentiment for the Company’s products and services, all of which can further adversely affect the Company’s business and results of operations.\n\n**Segment Operating Performance**\n\nThe following table shows net sales by reportable segment for 2025, 2024 and 2023 (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\nAmericas $ 178,353 7 % $ 167,045 3 % $ 162,560\n\nEurope 111,032 10 % 101,328 7 % 94,294\n\nGreater China 64,377 (4) % 66,952 (8) % 72,559\n\nJapan 28,703 15 % 25,052 3 % 24,257\n\nRest of Asia Pacific 33,696 10 % 30,658 4 % 29,615\n\nTotal net sales $ 416,161 6 % $ 391,035 2 % $ 383,285\n\n_Americas_\n\nAmericas net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone and Services. The weakness in foreign currencies relative to the U.S. dollar had an unfavorable year-over-year impact on Americas net sales during 2025.\n\n_Europe_\n\nEurope net sales increased during 2025 compared to 2024 primarily due to higher net sales of Services, iPhone and Mac.\n\n_Greater China_\n\nGreater China net sales decreased during 2025 compared to 2024 primarily due to lower net sales of iPhone, partially offset by higher net sales of Mac.\n\n_Japan_\n\nJapan net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone, Services and iPad.\n\n_Rest of Asia Pacific_\n\nRest of Asia Pacific net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone, Services and Mac.\n\nApple Inc. | 2025 Form 10-K | 22","pages":[{"line_numbers":[],"markdown":"**Tariffs and Other Measures**\n\nBeginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others. In response, several countries have imposed, or threatened to impose, reciprocal tariffs on imports from the U.S. and other retaliatory measures. Various modifications to the U.S. Tariffs have been announced and further changes could be made in the future, which may include additional sector-based tariffs or other measures. For example, the U.S. Department of Commerce has initiated an investigation under Section 232 of the Trade Expansion Act of 1962, as amended, into, among other things, imports of semiconductors, semiconductor manufacturing equipment, and their derivative products, including downstream products that contain semiconductors. Tariffs and other measures that are applied to the Company’s products or their components can have a material adverse impact on the Company’s business, results of operations and financial condition, including impacting the Company’s supply chain, the availability of rare earths and other raw materials and components, pricing and gross margin. The ultimate impact remains uncertain and will depend on several factors, including whether additional or incremental U.S. Tariffs or other measures are announced or imposed, to what extent other countries implement tariffs or other retaliatory measures in response, and the overall magnitude and duration of these measures. Trade and other international disputes can have an adverse impact on the overall macroeconomic environment and result in shifts and reductions in consumer spending and negative consumer sentiment for the Company’s products and services, all of which can further adversely affect the Company’s business and results of operations.\n\n**Segment Operating Performance**\n\nThe following table shows net sales by reportable segment for 2025, 2024 and 2023 (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\nAmericas $ 178,353 7 % $ 167,045 3 % $ 162,560\n\nEurope 111,032 10 % 101,328 7 % 94,294\n\nGreater China 64,377 (4) % 66,952 (8) % 72,559\n\nJapan 28,703 15 % 25,052 3 % 24,257\n\nRest of Asia Pacific 33,696 10 % 30,658 4 % 29,615\n\nTotal net sales $ 416,161 6 % $ 391,035 2 % $ 383,285\n\n_Americas_\n\nAmericas net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone and Services. The weakness in foreign currencies relative to the U.S. dollar had an unfavorable year-over-year impact on Americas net sales during 2025.\n\n_Europe_\n\nEurope net sales increased during 2025 compared to 2024 primarily due to higher net sales of Services, iPhone and Mac.\n\n_Greater China_\n\nGreater China net sales decreased during 2025 compared to 2024 primarily due to lower net sales of iPhone, partially offset by higher net sales of Mac.\n\n_Japan_\n\nJapan net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone, Services and iPad.\n\n_Rest of Asia Pacific_\n\nRest of Asia Pacific net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone, Services and Mac.\n\nApple Inc. | 2025 Form 10-K | 22","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Tariffs and Other Measures**\n\nBeginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others. In response, several countries have imposed, or threatened to impose, reciprocal tariffs on imports from the U.S. and other retaliatory measures. Various modifications to the U.S. Tariffs have been announced and further changes could be made in the future, which may include additional sector-based tariffs or other measures. For example, the U.S. Department of Commerce has initiated an investigation under Section 232 of the Trade Expansion Act of 1962, as amended, into, among other things, imports of semiconductors, semiconductor manufacturing equipment, and their derivative products, including downstream products that contain semiconductors. Tariffs and other measures that are applied to the Company’s products or their components can have a material adverse impact on the Company’s business, results of operations and financial condition, including impacting the Company’s supply chain, the availability of rare earths and other raw materials and components, pricing and gross margin. The ultimate impact remains uncertain and will depend on several factors, including whether additional or incremental U.S. Tariffs or other measures are announced or imposed, to what extent other countries implement tariffs or other retaliatory measures in response, and the overall magnitude and duration of these measures. Trade and other international disputes can have an adverse impact on the overall macroeconomic environment and result in shifts and reductions in consumer spending and negative consumer sentiment for the Company’s products and services, all of which can further adversely affect the Company’s business and results of operations.\n\n**Segment Operating Performance**\n\nThe following table shows net sales by reportable segment for 2025, 2024 and 2023 (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\nAmericas $ 178,353 7 % $ 167,045 3 % $ 162,560\n\nEurope 111,032 10 % 101,328 7 % 94,294\n\nGreater China 64,377 (4) % 66,952 (8) % 72,559\n\nJapan 28,703 15 % 25,052 3 % 24,257\n\nRest of Asia Pacific 33,696 10 % 30,658 4 % 29,615\n\nTotal net sales $ 416,161 6 % $ 391,035 2 % $ 383,285\n\n_Americas_\n\nAmericas net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone and Services. The weakness in foreign currencies relative to the U.S. dollar had an unfavorable year-over-year impact on Americas net sales during 2025.\n\n_Europe_\n\nEurope net sales increased during 2025 compared to 2024 primarily due to higher net sales of Services, iPhone and Mac.\n\n_Greater China_\n\nGreater China net sales decreased during 2025 compared to 2024 primarily due to lower net sales of iPhone, partially offset by higher net sales of Mac.\n\n_Japan_\n\nJapan net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone, Services and iPad.\n\n_Rest of Asia Pacific_\n\nRest of Asia Pacific net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone, Services and Mac.\n\nApple Inc. | 2025 Form 10-K | 22","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page25.pdf"]},"response":{"errors":[],"extract_id":"extract_85aa69acfc7af069a9c47bf6cb3f46fa","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Tariffs and Other Measures**\n\nBeginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others. In response, several countries have imposed, or threatened to impose, reciprocal tariffs on imports from the U.S. and other retaliatory measures. Various modifications to the U.S. Tariffs have been announced and further changes could be made in the future, which may include additional sector-based tariffs or other measures. For example, the U.S. Department of Commerce has initiated an investigation under Section 232 of the Trade Expansion Act of 1962, as amended, into, among other things, imports of semiconductors, semiconductor manufacturing equipment, and their derivative products, including downstream products that contain semiconductors. Tariffs and other measures that are applied to the Company’s products or their components can have a material adverse impact on the Company’s business, results of operations and financial condition, including impacting the Company’s supply chain, the availability of rare earths and other raw materials and components, pricing and gross margin. The ultimate impact remains uncertain and will depend on several factors, including whether additional or incremental U.S. Tariffs or other measures are announced or imposed, to what extent other countries implement tariffs or other retaliatory measures in response, and the overall magnitude and duration of these measures. Trade and other international disputes can have an adverse impact on the overall macroeconomic environment and result in shifts and reductions in consumer spending and negative consumer sentiment for the Company’s products and services, all of which can further adversely affect the Company’s business and results of operations.\n\n**Segment Operating Performance**\n\nThe following table shows net sales by reportable segment for 2025, 2024 and 2023 (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\nAmericas $ 178,353 7 % $ 167,045 3 % $ 162,560\n\nEurope 111,032 10 % 101,328 7 % 94,294\n\nGreater China 64,377 (4) % 66,952 (8) % 72,559\n\nJapan 28,703 15 % 25,052 3 % 24,257\n\nRest of Asia Pacific 33,696 10 % 30,658 4 % 29,615\n\nTotal net sales $ 416,161 6 % $ 391,035 2 % $ 383,285\n\n_Americas_\n\nAmericas net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone and Services. The weakness in foreign currencies relative to the U.S. dollar had an unfavorable year-over-year impact on Americas net sales during 2025.\n\n_Europe_\n\nEurope net sales increased during 2025 compared to 2024 primarily due to higher net sales of Services, iPhone and Mac.\n\n_Greater China_\n\nGreater China net sales decreased during 2025 compared to 2024 primarily due to lower net sales of iPhone, partially offset by higher net sales of Mac.\n\n_Japan_\n\nJapan net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone, Services and iPad.\n\n_Rest of Asia Pacific_\n\nRest of Asia Pacific net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone, Services and Mac.\n\nApple Inc. | 2025 Form 10-K | 22"],"full_content":"**Tariffs and Other Measures**\n\nBeginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others. In response, several countries have imposed, or threatened to impose, reciprocal tariffs on imports from the U.S. and other retaliatory measures. Various modifications to the U.S. Tariffs have been announced and further changes could be made in the future, which may include additional sector-based tariffs or other measures. For example, the U.S. Department of Commerce has initiated an investigation under Section 232 of the Trade Expansion Act of 1962, as amended, into, among other things, imports of semiconductors, semiconductor manufacturing equipment, and their derivative products, including downstream products that contain semiconductors. Tariffs and other measures that are applied to the Company’s products or their components can have a material adverse impact on the Company’s business, results of operations and financial condition, including impacting the Company’s supply chain, the availability of rare earths and other raw materials and components, pricing and gross margin. The ultimate impact remains uncertain and will depend on several factors, including whether additional or incremental U.S. Tariffs or other measures are announced or imposed, to what extent other countries implement tariffs or other retaliatory measures in response, and the overall magnitude and duration of these measures. Trade and other international disputes can have an adverse impact on the overall macroeconomic environment and result in shifts and reductions in consumer spending and negative consumer sentiment for the Company’s products and services, all of which can further adversely affect the Company’s business and results of operations.\n\n**Segment Operating Performance**\n\nThe following table shows net sales by reportable segment for 2025, 2024 and 2023 (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\nAmericas $ 178,353 7 % $ 167,045 3 % $ 162,560\n\nEurope 111,032 10 % 101,328 7 % 94,294\n\nGreater China 64,377 (4) % 66,952 (8) % 72,559\n\nJapan 28,703 15 % 25,052 3 % 24,257\n\nRest of Asia Pacific 33,696 10 % 30,658 4 % 29,615\n\nTotal net sales $ 416,161 6 % $ 391,035 2 % $ 383,285\n\n_Americas_\n\nAmericas net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone and Services. The weakness in foreign currencies relative to the U.S. dollar had an unfavorable year-over-year impact on Americas net sales during 2025.\n\n_Europe_\n\nEurope net sales increased during 2025 compared to 2024 primarily due to higher net sales of Services, iPhone and Mac.\n\n_Greater China_\n\nGreater China net sales decreased during 2025 compared to 2024 primarily due to lower net sales of iPhone, partially offset by higher net sales of Mac.\n\n_Japan_\n\nJapan net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone, Services and iPad.\n\n_Rest of Asia Pacific_\n\nRest of Asia Pacific net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPhone, Services and Mac.\n\nApple Inc. | 2025 Form 10-K | 22","publish_date":null,"title":"Tariffs and Other Measures Beginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page25.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page25.pdf"},"request":{"example_id":"table/Apple 10-k_page25","product_type":"parse","source_file_path":"Apple 10-k_page25.pdf"},"started_at":"2026-11-04T19:47:42.887353"} +{"completed_at":"2026-11-04T19:47:46.671206","latency_in_ms":2362,"output":{"example_id":"table/Apple 10-k_page26","grounded_pages":[],"layout_pages":[],"markdown":"**Products and Services Performance**\n\nThe following table shows net sales by category for 2025, 2024 and 2023 (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\niPhone $ 209,586 4 % $ 201,183 — % $ 200,583\n\nMac 33,708 12 % 29,984 2 % 29,357\n\niPad 28,023 5 % 26,694 (6) % 28,300\n\nWearables, Home and Accessories 35,686 (4) % 37,005 (7) % 39,845\n\nServices (1) 109,158 14 % 96,169 13 % 85,200\n\nTotal net sales $ 416,161 6 % $ 391,035 2 % $ 383,285\n\n(1) Services net sales include amortization of the deferred value of services bundled in the sales price of certain products.\n\n_iPhone_\n\niPhone net sales increased during 2025 compared to 2024 due to higher net sales of Pro models.\n\n_Mac_\n\nMac net sales increased during 2025 compared to 2024 primarily due to higher net sales of laptops and desktops.\n\n_iPad_\n\niPad net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPad Air, iPad mini and iPad, partially offset by lower net sales of iPad Pro.\n\n_Wearables, Home and Accessories_\n\nWearables, Home and Accessories net sales decreased during 2025 compared to 2024 primarily due to lower net sales of Accessories and Wearables.\n\n_Services_\n\nServices net sales increased during 2025 compared to 2024 primarily due to higher net sales from advertising, the App Store and cloud services.\n\nApple Inc. | 2025 Form 10-K | 23","pages":[{"line_numbers":[],"markdown":"**Products and Services Performance**\n\nThe following table shows net sales by category for 2025, 2024 and 2023 (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\niPhone $ 209,586 4 % $ 201,183 — % $ 200,583\n\nMac 33,708 12 % 29,984 2 % 29,357\n\niPad 28,023 5 % 26,694 (6) % 28,300\n\nWearables, Home and Accessories 35,686 (4) % 37,005 (7) % 39,845\n\nServices (1) 109,158 14 % 96,169 13 % 85,200\n\nTotal net sales $ 416,161 6 % $ 391,035 2 % $ 383,285\n\n(1) Services net sales include amortization of the deferred value of services bundled in the sales price of certain products.\n\n_iPhone_\n\niPhone net sales increased during 2025 compared to 2024 due to higher net sales of Pro models.\n\n_Mac_\n\nMac net sales increased during 2025 compared to 2024 primarily due to higher net sales of laptops and desktops.\n\n_iPad_\n\niPad net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPad Air, iPad mini and iPad, partially offset by lower net sales of iPad Pro.\n\n_Wearables, Home and Accessories_\n\nWearables, Home and Accessories net sales decreased during 2025 compared to 2024 primarily due to lower net sales of Accessories and Wearables.\n\n_Services_\n\nServices net sales increased during 2025 compared to 2024 primarily due to higher net sales from advertising, the App Store and cloud services.\n\nApple Inc. | 2025 Form 10-K | 23","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Products and Services Performance**\n\nThe following table shows net sales by category for 2025, 2024 and 2023 (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\niPhone $ 209,586 4 % $ 201,183 — % $ 200,583\n\nMac 33,708 12 % 29,984 2 % 29,357\n\niPad 28,023 5 % 26,694 (6) % 28,300\n\nWearables, Home and Accessories 35,686 (4) % 37,005 (7) % 39,845\n\nServices (1) 109,158 14 % 96,169 13 % 85,200\n\nTotal net sales $ 416,161 6 % $ 391,035 2 % $ 383,285\n\n(1) Services net sales include amortization of the deferred value of services bundled in the sales price of certain products.\n\n_iPhone_\n\niPhone net sales increased during 2025 compared to 2024 due to higher net sales of Pro models.\n\n_Mac_\n\nMac net sales increased during 2025 compared to 2024 primarily due to higher net sales of laptops and desktops.\n\n_iPad_\n\niPad net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPad Air, iPad mini and iPad, partially offset by lower net sales of iPad Pro.\n\n_Wearables, Home and Accessories_\n\nWearables, Home and Accessories net sales decreased during 2025 compared to 2024 primarily due to lower net sales of Accessories and Wearables.\n\n_Services_\n\nServices net sales increased during 2025 compared to 2024 primarily due to higher net sales from advertising, the App Store and cloud services.\n\nApple Inc. | 2025 Form 10-K | 23","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page26.pdf"]},"response":{"errors":[],"extract_id":"extract_55d8cd1f182951b5ce0fe905c1c44c98","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Products and Services Performance**\n\nThe following table shows net sales by category for 2025, 2024 and 2023 (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\niPhone $ 209,586 4 % $ 201,183 — % $ 200,583\n\nMac 33,708 12 % 29,984 2 % 29,357\n\niPad 28,023 5 % 26,694 (6) % 28,300\n\nWearables, Home and Accessories 35,686 (4) % 37,005 (7) % 39,845\n\nServices (1) 109,158 14 % 96,169 13 % 85,200\n\nTotal net sales $ 416,161 6 % $ 391,035 2 % $ 383,285\n\n(1) Services net sales include amortization of the deferred value of services bundled in the sales price of certain products.\n\n_iPhone_\n\niPhone net sales increased during 2025 compared to 2024 due to higher net sales of Pro models.\n\n_Mac_\n\nMac net sales increased during 2025 compared to 2024 primarily due to higher net sales of laptops and desktops.\n\n_iPad_\n\niPad net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPad Air, iPad mini and iPad, partially offset by lower net sales of iPad Pro.\n\n_Wearables, Home and Accessories_\n\nWearables, Home and Accessories net sales decreased during 2025 compared to 2024 primarily due to lower net sales of Accessories and Wearables.\n\n_Services_\n\nServices net sales increased during 2025 compared to 2024 primarily due to higher net sales from advertising, the App Store and cloud services.\n\nApple Inc. | 2025 Form 10-K | 23"],"full_content":"**Products and Services Performance**\n\nThe following table shows net sales by category for 2025, 2024 and 2023 (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\niPhone $ 209,586 4 % $ 201,183 — % $ 200,583\n\nMac 33,708 12 % 29,984 2 % 29,357\n\niPad 28,023 5 % 26,694 (6) % 28,300\n\nWearables, Home and Accessories 35,686 (4) % 37,005 (7) % 39,845\n\nServices (1) 109,158 14 % 96,169 13 % 85,200\n\nTotal net sales $ 416,161 6 % $ 391,035 2 % $ 383,285\n\n(1) Services net sales include amortization of the deferred value of services bundled in the sales price of certain products.\n\n_iPhone_\n\niPhone net sales increased during 2025 compared to 2024 due to higher net sales of Pro models.\n\n_Mac_\n\nMac net sales increased during 2025 compared to 2024 primarily due to higher net sales of laptops and desktops.\n\n_iPad_\n\niPad net sales increased during 2025 compared to 2024 primarily due to higher net sales of iPad Air, iPad mini and iPad, partially offset by lower net sales of iPad Pro.\n\n_Wearables, Home and Accessories_\n\nWearables, Home and Accessories net sales decreased during 2025 compared to 2024 primarily due to lower net sales of Accessories and Wearables.\n\n_Services_\n\nServices net sales increased during 2025 compared to 2024 primarily due to higher net sales from advertising, the App Store and cloud services.\n\nApple Inc. | 2025 Form 10-K | 23","publish_date":null,"title":"Products and Services Performance The following table shows net sales by category for 2025, 2024 and 2023 (dollars in millions):","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page26.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page26.pdf"},"request":{"example_id":"table/Apple 10-k_page26","product_type":"parse","source_file_path":"Apple 10-k_page26.pdf"},"started_at":"2026-11-04T19:47:44.308445"} +{"completed_at":"2026-11-04T19:47:46.222122","latency_in_ms":1375,"output":{"example_id":"table/Apple 10-k_page27","grounded_pages":[],"layout_pages":[],"markdown":"**Gross Margin**\n\nProducts and Services gross margin and gross margin percentage for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 2024 2023**\n\nGross margin:\n\nProducts $ 112,887 $ 109,633 $ 108,803\n\nServices 82,314 71,050 60,345\n\nTotal gross margin $ 195,201 $ 180,683 $ 169,148\n\nGross margin percentage:\n\nProducts 36.8% 37.2% 36.5%\n\nServices 75.4% 73.9% 70.8%\n\nTotal gross margin percentage 46.9% 46.2% 44.1%\n\n_Products Gross Margin_\n\nProducts gross margin increased during 2025 compared to 2024 primarily due to favorable costs and a different mix of products, partially offset by tariff costs.\n\nProducts gross margin percentage decreased during 2025 compared to 2024 primarily due to a different mix of products and tariff costs, partially offset by other favorable costs.\n\n_Services Gross Margin_\n\nServices gross margin increased during 2025 compared to 2024 primarily due to higher Services net sales and a different mix of services.\n\nServices gross margin percentage increased during 2025 compared to 2024 primarily due to a different mix of services, partially offset by higher costs.\n\nThe Company’s future gross margins can be impacted by a variety of factors, as discussed in Part I, Item 1A of this Form 10-K under the heading “Risk Factors.” As a result, the Company believes, in general, gross margins will be subject to volatility and downward pressure.\n\n**Operating Expenses**\n\nOperating expenses for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\nResearch and development $ 34,550 10 % $ 31,370 5 % $ 29,915\n\nPercentage of total net sales 8% 8% 8%\n\nSelling, general and administrative $ 27,601 6 % $ 26,097 5 % $ 24,932\n\nPercentage of total net sales 7% 7% 7%\n\nTotal operating expenses $ 62,151 8 % $ 57,467 5 % $ 54,847\n\nPercentage of total net sales 15% 15% 14%\n\n_Research and Development_\n\nThe growth in R&D expense during 2025 compared to 2024 was primarily driven by increases in headcount-related expenses and infrastructure-related costs.\n\n_Selling, General and Administrative_\n\nThe growth in selling, general and administrative expense during 2025 compared to 2024 was primarily driven by increases in headcount-related expenses and variable selling expenses.\n\nApple Inc. | 2025 Form 10-K | 24","pages":[{"line_numbers":[],"markdown":"**Gross Margin**\n\nProducts and Services gross margin and gross margin percentage for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 2024 2023**\n\nGross margin:\n\nProducts $ 112,887 $ 109,633 $ 108,803\n\nServices 82,314 71,050 60,345\n\nTotal gross margin $ 195,201 $ 180,683 $ 169,148\n\nGross margin percentage:\n\nProducts 36.8% 37.2% 36.5%\n\nServices 75.4% 73.9% 70.8%\n\nTotal gross margin percentage 46.9% 46.2% 44.1%\n\n_Products Gross Margin_\n\nProducts gross margin increased during 2025 compared to 2024 primarily due to favorable costs and a different mix of products, partially offset by tariff costs.\n\nProducts gross margin percentage decreased during 2025 compared to 2024 primarily due to a different mix of products and tariff costs, partially offset by other favorable costs.\n\n_Services Gross Margin_\n\nServices gross margin increased during 2025 compared to 2024 primarily due to higher Services net sales and a different mix of services.\n\nServices gross margin percentage increased during 2025 compared to 2024 primarily due to a different mix of services, partially offset by higher costs.\n\nThe Company’s future gross margins can be impacted by a variety of factors, as discussed in Part I, Item 1A of this Form 10-K under the heading “Risk Factors.” As a result, the Company believes, in general, gross margins will be subject to volatility and downward pressure.\n\n**Operating Expenses**\n\nOperating expenses for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\nResearch and development $ 34,550 10 % $ 31,370 5 % $ 29,915\n\nPercentage of total net sales 8% 8% 8%\n\nSelling, general and administrative $ 27,601 6 % $ 26,097 5 % $ 24,932\n\nPercentage of total net sales 7% 7% 7%\n\nTotal operating expenses $ 62,151 8 % $ 57,467 5 % $ 54,847\n\nPercentage of total net sales 15% 15% 14%\n\n_Research and Development_\n\nThe growth in R&D expense during 2025 compared to 2024 was primarily driven by increases in headcount-related expenses and infrastructure-related costs.\n\n_Selling, General and Administrative_\n\nThe growth in selling, general and administrative expense during 2025 compared to 2024 was primarily driven by increases in headcount-related expenses and variable selling expenses.\n\nApple Inc. | 2025 Form 10-K | 24","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Gross Margin**\n\nProducts and Services gross margin and gross margin percentage for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 2024 2023**\n\nGross margin:\n\nProducts $ 112,887 $ 109,633 $ 108,803\n\nServices 82,314 71,050 60,345\n\nTotal gross margin $ 195,201 $ 180,683 $ 169,148\n\nGross margin percentage:\n\nProducts 36.8% 37.2% 36.5%\n\nServices 75.4% 73.9% 70.8%\n\nTotal gross margin percentage 46.9% 46.2% 44.1%\n\n_Products Gross Margin_\n\nProducts gross margin increased during 2025 compared to 2024 primarily due to favorable costs and a different mix of products, partially offset by tariff costs.\n\nProducts gross margin percentage decreased during 2025 compared to 2024 primarily due to a different mix of products and tariff costs, partially offset by other favorable costs.\n\n_Services Gross Margin_\n\nServices gross margin increased during 2025 compared to 2024 primarily due to higher Services net sales and a different mix of services.\n\nServices gross margin percentage increased during 2025 compared to 2024 primarily due to a different mix of services, partially offset by higher costs.\n\nThe Company’s future gross margins can be impacted by a variety of factors, as discussed in Part I, Item 1A of this Form 10-K under the heading “Risk Factors.” As a result, the Company believes, in general, gross margins will be subject to volatility and downward pressure.\n\n**Operating Expenses**\n\nOperating expenses for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\nResearch and development $ 34,550 10 % $ 31,370 5 % $ 29,915\n\nPercentage of total net sales 8% 8% 8%\n\nSelling, general and administrative $ 27,601 6 % $ 26,097 5 % $ 24,932\n\nPercentage of total net sales 7% 7% 7%\n\nTotal operating expenses $ 62,151 8 % $ 57,467 5 % $ 54,847\n\nPercentage of total net sales 15% 15% 14%\n\n_Research and Development_\n\nThe growth in R&D expense during 2025 compared to 2024 was primarily driven by increases in headcount-related expenses and infrastructure-related costs.\n\n_Selling, General and Administrative_\n\nThe growth in selling, general and administrative expense during 2025 compared to 2024 was primarily driven by increases in headcount-related expenses and variable selling expenses.\n\nApple Inc. | 2025 Form 10-K | 24","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page27.pdf"]},"response":{"errors":[],"extract_id":"extract_71c29b91be99514b2a0c03c0c3a2ac0a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Gross Margin**\n\nProducts and Services gross margin and gross margin percentage for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 2024 2023**\n\nGross margin:\n\nProducts $ 112,887 $ 109,633 $ 108,803\n\nServices 82,314 71,050 60,345\n\nTotal gross margin $ 195,201 $ 180,683 $ 169,148\n\nGross margin percentage:\n\nProducts 36.8% 37.2% 36.5%\n\nServices 75.4% 73.9% 70.8%\n\nTotal gross margin percentage 46.9% 46.2% 44.1%\n\n_Products Gross Margin_\n\nProducts gross margin increased during 2025 compared to 2024 primarily due to favorable costs and a different mix of products, partially offset by tariff costs.\n\nProducts gross margin percentage decreased during 2025 compared to 2024 primarily due to a different mix of products and tariff costs, partially offset by other favorable costs.\n\n_Services Gross Margin_\n\nServices gross margin increased during 2025 compared to 2024 primarily due to higher Services net sales and a different mix of services.\n\nServices gross margin percentage increased during 2025 compared to 2024 primarily due to a different mix of services, partially offset by higher costs.\n\nThe Company’s future gross margins can be impacted by a variety of factors, as discussed in Part I, Item 1A of this Form 10-K under the heading “Risk Factors.” As a result, the Company believes, in general, gross margins will be subject to volatility and downward pressure.\n\n**Operating Expenses**\n\nOperating expenses for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\nResearch and development $ 34,550 10 % $ 31,370 5 % $ 29,915\n\nPercentage of total net sales 8% 8% 8%\n\nSelling, general and administrative $ 27,601 6 % $ 26,097 5 % $ 24,932\n\nPercentage of total net sales 7% 7% 7%\n\nTotal operating expenses $ 62,151 8 % $ 57,467 5 % $ 54,847\n\nPercentage of total net sales 15% 15% 14%\n\n_Research and Development_\n\nThe growth in R&D expense during 2025 compared to 2024 was primarily driven by increases in headcount-related expenses and infrastructure-related costs.\n\n_Selling, General and Administrative_\n\nThe growth in selling, general and administrative expense during 2025 compared to 2024 was primarily driven by increases in headcount-related expenses and variable selling expenses.\n\nApple Inc. | 2025 Form 10-K | 24"],"full_content":"**Gross Margin**\n\nProducts and Services gross margin and gross margin percentage for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 2024 2023**\n\nGross margin:\n\nProducts $ 112,887 $ 109,633 $ 108,803\n\nServices 82,314 71,050 60,345\n\nTotal gross margin $ 195,201 $ 180,683 $ 169,148\n\nGross margin percentage:\n\nProducts 36.8% 37.2% 36.5%\n\nServices 75.4% 73.9% 70.8%\n\nTotal gross margin percentage 46.9% 46.2% 44.1%\n\n_Products Gross Margin_\n\nProducts gross margin increased during 2025 compared to 2024 primarily due to favorable costs and a different mix of products, partially offset by tariff costs.\n\nProducts gross margin percentage decreased during 2025 compared to 2024 primarily due to a different mix of products and tariff costs, partially offset by other favorable costs.\n\n_Services Gross Margin_\n\nServices gross margin increased during 2025 compared to 2024 primarily due to higher Services net sales and a different mix of services.\n\nServices gross margin percentage increased during 2025 compared to 2024 primarily due to a different mix of services, partially offset by higher costs.\n\nThe Company’s future gross margins can be impacted by a variety of factors, as discussed in Part I, Item 1A of this Form 10-K under the heading “Risk Factors.” As a result, the Company believes, in general, gross margins will be subject to volatility and downward pressure.\n\n**Operating Expenses**\n\nOperating expenses for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 Change 2024 Change 2023**\n\nResearch and development $ 34,550 10 % $ 31,370 5 % $ 29,915\n\nPercentage of total net sales 8% 8% 8%\n\nSelling, general and administrative $ 27,601 6 % $ 26,097 5 % $ 24,932\n\nPercentage of total net sales 7% 7% 7%\n\nTotal operating expenses $ 62,151 8 % $ 57,467 5 % $ 54,847\n\nPercentage of total net sales 15% 15% 14%\n\n_Research and Development_\n\nThe growth in R&D expense during 2025 compared to 2024 was primarily driven by increases in headcount-related expenses and infrastructure-related costs.\n\n_Selling, General and Administrative_\n\nThe growth in selling, general and administrative expense during 2025 compared to 2024 was primarily driven by increases in headcount-related expenses and variable selling expenses.\n\nApple Inc. | 2025 Form 10-K | 24","publish_date":null,"title":"Gross Margin Products and Services gross margin and gross margin percentage for 2025, 2024 and 2023 were as follows (dollars","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page27.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page27.pdf"},"request":{"example_id":"table/Apple 10-k_page27","product_type":"parse","source_file_path":"Apple 10-k_page27.pdf"},"started_at":"2026-11-04T19:47:44.846456"} +{"completed_at":"2026-11-04T19:47:47.035775","latency_in_ms":1052,"output":{"example_id":"table/Apple 10-k_page28","grounded_pages":[],"layout_pages":[],"markdown":"**Provision for Income Taxes**\n\nProvision for income taxes, effective tax rate and statutory federal income tax rate for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 2024 2023**\n\nProvision for income taxes $ 20,719 $ 29,749 $ 16,741\n\nEffective tax rate 15.6% 24.1% 14.7%\n\nStatutory federal income tax rate 21% 21% 21%\n\nThe Company’s effective tax rate for 2025 was lower than the statutory federal income tax rate primarily due to a lower effective tax rate on foreign earnings, including the impact of changes in unrecognized tax benefits, the impact of the U.S. federal R&D credit, and tax benefits from share-based compensation, partially offset by a change in valuation allowance and state income taxes.\n\nThe Company’s effective tax rate for 2025 was lower compared to 2024 due to a $10.7 billion year-over-year decrease in the provision for income taxes related to the State Aid Decision (refer to Note 7, “Income Taxes” in the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K) and the impact of changes in unrecognized tax benefits, partially offset by a change in valuation allowance and a higher effective tax rate on foreign earnings.\n\n**Liquidity and Capital Resources**\n\nThe Company believes its balances of cash, cash equivalents and marketable securities, which totaled $132.4 billion as of September 27, 2025, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.\n\nThe Company’s material cash requirements include the following contractual obligations:\n\n_Debt_\n\nAs of September 27, 2025, the Company had outstanding fixed-rate notes with varying maturities for an aggregate principal amount of $91.3 billion (collectively the “Notes”), with $12.4 billion payable within 12 months. Future interest payments associated with the Notes total $37.0 billion, with $2.6 billion payable within 12 months.\n\nThe Company also issues unsecured short-term promissory notes pursuant to a commercial paper program. As of September 27, 2025, the Company had $8.0 billion of commercial paper outstanding, which was payable within 12 months.\n\n_Leases_\n\nThe Company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. As of September 27, 2025, the Company had fixed lease payment obligations of $16.8 billion, with $2.6 billion payable within 12 months.\n\n_Manufacturing Purchase Obligations_\n\nThe Company utilizes several outsourcing partners to manufacture subassemblies for the Company’s products and to perform final assembly and testing of finished products. The Company also obtains individual components for its products from a wide variety of individual suppliers. As of September 27, 2025, the Company had manufacturing purchase obligations of $56.2 billion, with $55.4 billion payable within 12 months.\n\n_Other Purchase Obligations_\n\nThe Company’s other purchase obligations primarily consist of noncancelable obligations to acquire capital assets, including assets related to product manufacturing, and noncancelable obligations related to supplier arrangements, licensed intellectual property and content, and distribution rights. As of September 27, 2025, the Company had other purchase obligations of $14.8 billion, with $7.0 billion payable within 12 months.\n\n_Deemed Repatriation Tax Payable_\n\nAs of September 27, 2025, the balance of the deemed repatriation tax payable imposed by the U.S. Tax Cuts and Jobs Act of 2017 (“TCJA”) was $8.8 billion, which was payable within 12 months.\n\nApple Inc. | 2025 Form 10-K | 25","pages":[{"line_numbers":[],"markdown":"**Provision for Income Taxes**\n\nProvision for income taxes, effective tax rate and statutory federal income tax rate for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 2024 2023**\n\nProvision for income taxes $ 20,719 $ 29,749 $ 16,741\n\nEffective tax rate 15.6% 24.1% 14.7%\n\nStatutory federal income tax rate 21% 21% 21%\n\nThe Company’s effective tax rate for 2025 was lower than the statutory federal income tax rate primarily due to a lower effective tax rate on foreign earnings, including the impact of changes in unrecognized tax benefits, the impact of the U.S. federal R&D credit, and tax benefits from share-based compensation, partially offset by a change in valuation allowance and state income taxes.\n\nThe Company’s effective tax rate for 2025 was lower compared to 2024 due to a $10.7 billion year-over-year decrease in the provision for income taxes related to the State Aid Decision (refer to Note 7, “Income Taxes” in the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K) and the impact of changes in unrecognized tax benefits, partially offset by a change in valuation allowance and a higher effective tax rate on foreign earnings.\n\n**Liquidity and Capital Resources**\n\nThe Company believes its balances of cash, cash equivalents and marketable securities, which totaled $132.4 billion as of September 27, 2025, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.\n\nThe Company’s material cash requirements include the following contractual obligations:\n\n_Debt_\n\nAs of September 27, 2025, the Company had outstanding fixed-rate notes with varying maturities for an aggregate principal amount of $91.3 billion (collectively the “Notes”), with $12.4 billion payable within 12 months. Future interest payments associated with the Notes total $37.0 billion, with $2.6 billion payable within 12 months.\n\nThe Company also issues unsecured short-term promissory notes pursuant to a commercial paper program. As of September 27, 2025, the Company had $8.0 billion of commercial paper outstanding, which was payable within 12 months.\n\n_Leases_\n\nThe Company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. As of September 27, 2025, the Company had fixed lease payment obligations of $16.8 billion, with $2.6 billion payable within 12 months.\n\n_Manufacturing Purchase Obligations_\n\nThe Company utilizes several outsourcing partners to manufacture subassemblies for the Company’s products and to perform final assembly and testing of finished products. The Company also obtains individual components for its products from a wide variety of individual suppliers. As of September 27, 2025, the Company had manufacturing purchase obligations of $56.2 billion, with $55.4 billion payable within 12 months.\n\n_Other Purchase Obligations_\n\nThe Company’s other purchase obligations primarily consist of noncancelable obligations to acquire capital assets, including assets related to product manufacturing, and noncancelable obligations related to supplier arrangements, licensed intellectual property and content, and distribution rights. As of September 27, 2025, the Company had other purchase obligations of $14.8 billion, with $7.0 billion payable within 12 months.\n\n_Deemed Repatriation Tax Payable_\n\nAs of September 27, 2025, the balance of the deemed repatriation tax payable imposed by the U.S. Tax Cuts and Jobs Act of 2017 (“TCJA”) was $8.8 billion, which was payable within 12 months.\n\nApple Inc. | 2025 Form 10-K | 25","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Provision for Income Taxes**\n\nProvision for income taxes, effective tax rate and statutory federal income tax rate for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 2024 2023**\n\nProvision for income taxes $ 20,719 $ 29,749 $ 16,741\n\nEffective tax rate 15.6% 24.1% 14.7%\n\nStatutory federal income tax rate 21% 21% 21%\n\nThe Company’s effective tax rate for 2025 was lower than the statutory federal income tax rate primarily due to a lower effective tax rate on foreign earnings, including the impact of changes in unrecognized tax benefits, the impact of the U.S. federal R&D credit, and tax benefits from share-based compensation, partially offset by a change in valuation allowance and state income taxes.\n\nThe Company’s effective tax rate for 2025 was lower compared to 2024 due to a $10.7 billion year-over-year decrease in the provision for income taxes related to the State Aid Decision (refer to Note 7, “Income Taxes” in the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K) and the impact of changes in unrecognized tax benefits, partially offset by a change in valuation allowance and a higher effective tax rate on foreign earnings.\n\n**Liquidity and Capital Resources**\n\nThe Company believes its balances of cash, cash equivalents and marketable securities, which totaled $132.4 billion as of September 27, 2025, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.\n\nThe Company’s material cash requirements include the following contractual obligations:\n\n_Debt_\n\nAs of September 27, 2025, the Company had outstanding fixed-rate notes with varying maturities for an aggregate principal amount of $91.3 billion (collectively the “Notes”), with $12.4 billion payable within 12 months. Future interest payments associated with the Notes total $37.0 billion, with $2.6 billion payable within 12 months.\n\nThe Company also issues unsecured short-term promissory notes pursuant to a commercial paper program. As of September 27, 2025, the Company had $8.0 billion of commercial paper outstanding, which was payable within 12 months.\n\n_Leases_\n\nThe Company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. As of September 27, 2025, the Company had fixed lease payment obligations of $16.8 billion, with $2.6 billion payable within 12 months.\n\n_Manufacturing Purchase Obligations_\n\nThe Company utilizes several outsourcing partners to manufacture subassemblies for the Company’s products and to perform final assembly and testing of finished products. The Company also obtains individual components for its products from a wide variety of individual suppliers. As of September 27, 2025, the Company had manufacturing purchase obligations of $56.2 billion, with $55.4 billion payable within 12 months.\n\n_Other Purchase Obligations_\n\nThe Company’s other purchase obligations primarily consist of noncancelable obligations to acquire capital assets, including assets related to product manufacturing, and noncancelable obligations related to supplier arrangements, licensed intellectual property and content, and distribution rights. As of September 27, 2025, the Company had other purchase obligations of $14.8 billion, with $7.0 billion payable within 12 months.\n\n_Deemed Repatriation Tax Payable_\n\nAs of September 27, 2025, the balance of the deemed repatriation tax payable imposed by the U.S. Tax Cuts and Jobs Act of 2017 (“TCJA”) was $8.8 billion, which was payable within 12 months.\n\nApple Inc. | 2025 Form 10-K | 25","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page28.pdf"]},"response":{"errors":[],"extract_id":"extract_89f92313eb663f4acabbeb2557478103","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Provision for Income Taxes**\n\nProvision for income taxes, effective tax rate and statutory federal income tax rate for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 2024 2023**\n\nProvision for income taxes $ 20,719 $ 29,749 $ 16,741\n\nEffective tax rate 15.6% 24.1% 14.7%\n\nStatutory federal income tax rate 21% 21% 21%\n\nThe Company’s effective tax rate for 2025 was lower than the statutory federal income tax rate primarily due to a lower effective tax rate on foreign earnings, including the impact of changes in unrecognized tax benefits, the impact of the U.S. federal R&D credit, and tax benefits from share-based compensation, partially offset by a change in valuation allowance and state income taxes.\n\nThe Company’s effective tax rate for 2025 was lower compared to 2024 due to a $10.7 billion year-over-year decrease in the provision for income taxes related to the State Aid Decision (refer to Note 7, “Income Taxes” in the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K) and the impact of changes in unrecognized tax benefits, partially offset by a change in valuation allowance and a higher effective tax rate on foreign earnings.\n\n**Liquidity and Capital Resources**\n\nThe Company believes its balances of cash, cash equivalents and marketable securities, which totaled $132.4 billion as of September 27, 2025, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.\n\nThe Company’s material cash requirements include the following contractual obligations:\n\n_Debt_\n\nAs of September 27, 2025, the Company had outstanding fixed-rate notes with varying maturities for an aggregate principal amount of $91.3 billion (collectively the “Notes”), with $12.4 billion payable within 12 months. Future interest payments associated with the Notes total $37.0 billion, with $2.6 billion payable within 12 months.\n\nThe Company also issues unsecured short-term promissory notes pursuant to a commercial paper program. As of September 27, 2025, the Company had $8.0 billion of commercial paper outstanding, which was payable within 12 months.\n\n_Leases_\n\nThe Company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. As of September 27, 2025, the Company had fixed lease payment obligations of $16.8 billion, with $2.6 billion payable within 12 months.\n\n_Manufacturing Purchase Obligations_\n\nThe Company utilizes several outsourcing partners to manufacture subassemblies for the Company’s products and to perform final assembly and testing of finished products. The Company also obtains individual components for its products from a wide variety of individual suppliers. As of September 27, 2025, the Company had manufacturing purchase obligations of $56.2 billion, with $55.4 billion payable within 12 months.\n\n_Other Purchase Obligations_\n\nThe Company’s other purchase obligations primarily consist of noncancelable obligations to acquire capital assets, including assets related to product manufacturing, and noncancelable obligations related to supplier arrangements, licensed intellectual property and content, and distribution rights. As of September 27, 2025, the Company had other purchase obligations of $14.8 billion, with $7.0 billion payable within 12 months.\n\n_Deemed Repatriation Tax Payable_\n\nAs of September 27, 2025, the balance of the deemed repatriation tax payable imposed by the U.S. Tax Cuts and Jobs Act of 2017 (“TCJA”) was $8.8 billion, which was payable within 12 months.\n\nApple Inc. | 2025 Form 10-K | 25"],"full_content":"**Provision for Income Taxes**\n\nProvision for income taxes, effective tax rate and statutory federal income tax rate for 2025, 2024 and 2023 were as follows (dollars in millions):\n\n**2025 2024 2023**\n\nProvision for income taxes $ 20,719 $ 29,749 $ 16,741\n\nEffective tax rate 15.6% 24.1% 14.7%\n\nStatutory federal income tax rate 21% 21% 21%\n\nThe Company’s effective tax rate for 2025 was lower than the statutory federal income tax rate primarily due to a lower effective tax rate on foreign earnings, including the impact of changes in unrecognized tax benefits, the impact of the U.S. federal R&D credit, and tax benefits from share-based compensation, partially offset by a change in valuation allowance and state income taxes.\n\nThe Company’s effective tax rate for 2025 was lower compared to 2024 due to a $10.7 billion year-over-year decrease in the provision for income taxes related to the State Aid Decision (refer to Note 7, “Income Taxes” in the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K) and the impact of changes in unrecognized tax benefits, partially offset by a change in valuation allowance and a higher effective tax rate on foreign earnings.\n\n**Liquidity and Capital Resources**\n\nThe Company believes its balances of cash, cash equivalents and marketable securities, which totaled $132.4 billion as of September 27, 2025, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.\n\nThe Company’s material cash requirements include the following contractual obligations:\n\n_Debt_\n\nAs of September 27, 2025, the Company had outstanding fixed-rate notes with varying maturities for an aggregate principal amount of $91.3 billion (collectively the “Notes”), with $12.4 billion payable within 12 months. Future interest payments associated with the Notes total $37.0 billion, with $2.6 billion payable within 12 months.\n\nThe Company also issues unsecured short-term promissory notes pursuant to a commercial paper program. As of September 27, 2025, the Company had $8.0 billion of commercial paper outstanding, which was payable within 12 months.\n\n_Leases_\n\nThe Company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. As of September 27, 2025, the Company had fixed lease payment obligations of $16.8 billion, with $2.6 billion payable within 12 months.\n\n_Manufacturing Purchase Obligations_\n\nThe Company utilizes several outsourcing partners to manufacture subassemblies for the Company’s products and to perform final assembly and testing of finished products. The Company also obtains individual components for its products from a wide variety of individual suppliers. As of September 27, 2025, the Company had manufacturing purchase obligations of $56.2 billion, with $55.4 billion payable within 12 months.\n\n_Other Purchase Obligations_\n\nThe Company’s other purchase obligations primarily consist of noncancelable obligations to acquire capital assets, including assets related to product manufacturing, and noncancelable obligations related to supplier arrangements, licensed intellectual property and content, and distribution rights. As of September 27, 2025, the Company had other purchase obligations of $14.8 billion, with $7.0 billion payable within 12 months.\n\n_Deemed Repatriation Tax Payable_\n\nAs of September 27, 2025, the balance of the deemed repatriation tax payable imposed by the U.S. Tax Cuts and Jobs Act of 2017 (“TCJA”) was $8.8 billion, which was payable within 12 months.\n\nApple Inc. | 2025 Form 10-K | 25","publish_date":null,"title":"Provision for Income Taxes Provision for income taxes, effective tax rate and statutory federal income tax rate for 2025, 2024","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page28.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page28.pdf"},"request":{"example_id":"table/Apple 10-k_page28","product_type":"parse","source_file_path":"Apple 10-k_page28.pdf"},"started_at":"2026-11-04T19:47:45.983602"} +{"completed_at":"2026-11-04T19:47:48.006564","latency_in_ms":1178,"output":{"example_id":"table/Apple 10-k_page3","grounded_pages":[],"layout_pages":[],"markdown":"**Apple Inc.**\n\n**Form 10-K**\n\n**For the Fiscal Year Ended September 27, 2025**\n\n**TABLE OF CONTENTS**\n\n**Page**\n\n**Part I**\n\nItem 1. Business 1\n\nItem 1A. Risk Factors 5\n\nItem 1B. Unresolved Staff Comments 17\n\nItem 1C. Cybersecurity 17\n\nItem 2. Properties 17\n\nItem 3. Legal Proceedings 18\n\nItem 4. Mine Safety Disclosures 18\n\n**Part II**\n\nItem 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity\n\nSecurities\n\n19\n\nItem 6. [Reserved] 20\n\nItem 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21\n\nItem 7A. Quantitative and Qualitative Disclosures About Market Risk 27\n\nItem 8. Financial Statements and Supplementary Data 28\n\nItem 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 52\n\nItem 9A. Controls and Procedures 52\n\nItem 9B. Other Information 53\n\nItem 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 53\n\n**Part III**\n\nItem 10. Directors, Executive Officers and Corporate Governance 53\n\nItem 11. Executive Compensation 53\n\nItem 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 53\n\nItem 13. Certain Relationships and Related Transactions, and Director Independence 53\n\nItem 14. Principal Accountant Fees and Services 53\n\n**Part IV**\n\nItem 15. Exhibit and Financial Statement Schedules 54\n\nItem 16. Form 10-K Summary 57","pages":[{"line_numbers":[],"markdown":"**Apple Inc.**\n\n**Form 10-K**\n\n**For the Fiscal Year Ended September 27, 2025**\n\n**TABLE OF CONTENTS**\n\n**Page**\n\n**Part I**\n\nItem 1. Business 1\n\nItem 1A. Risk Factors 5\n\nItem 1B. Unresolved Staff Comments 17\n\nItem 1C. Cybersecurity 17\n\nItem 2. Properties 17\n\nItem 3. Legal Proceedings 18\n\nItem 4. Mine Safety Disclosures 18\n\n**Part II**\n\nItem 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity\n\nSecurities\n\n19\n\nItem 6. [Reserved] 20\n\nItem 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21\n\nItem 7A. Quantitative and Qualitative Disclosures About Market Risk 27\n\nItem 8. Financial Statements and Supplementary Data 28\n\nItem 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 52\n\nItem 9A. Controls and Procedures 52\n\nItem 9B. Other Information 53\n\nItem 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 53\n\n**Part III**\n\nItem 10. Directors, Executive Officers and Corporate Governance 53\n\nItem 11. Executive Compensation 53\n\nItem 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 53\n\nItem 13. Certain Relationships and Related Transactions, and Director Independence 53\n\nItem 14. Principal Accountant Fees and Services 53\n\n**Part IV**\n\nItem 15. Exhibit and Financial Statement Schedules 54\n\nItem 16. Form 10-K Summary 57","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Apple Inc.**\n\n**Form 10-K**\n\n**For the Fiscal Year Ended September 27, 2025**\n\n**TABLE OF CONTENTS**\n\n**Page**\n\n**Part I**\n\nItem 1. Business 1\n\nItem 1A. Risk Factors 5\n\nItem 1B. Unresolved Staff Comments 17\n\nItem 1C. Cybersecurity 17\n\nItem 2. Properties 17\n\nItem 3. Legal Proceedings 18\n\nItem 4. Mine Safety Disclosures 18\n\n**Part II**\n\nItem 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity\n\nSecurities\n\n19\n\nItem 6. [Reserved] 20\n\nItem 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21\n\nItem 7A. Quantitative and Qualitative Disclosures About Market Risk 27\n\nItem 8. Financial Statements and Supplementary Data 28\n\nItem 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 52\n\nItem 9A. Controls and Procedures 52\n\nItem 9B. Other Information 53\n\nItem 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 53\n\n**Part III**\n\nItem 10. Directors, Executive Officers and Corporate Governance 53\n\nItem 11. Executive Compensation 53\n\nItem 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 53\n\nItem 13. Certain Relationships and Related Transactions, and Director Independence 53\n\nItem 14. Principal Accountant Fees and Services 53\n\n**Part IV**\n\nItem 15. Exhibit and Financial Statement Schedules 54\n\nItem 16. Form 10-K Summary 57","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page3.pdf"]},"response":{"errors":[],"extract_id":"extract_4b67d0d15f840d30f2cda815b1868f43","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Apple Inc.**\n\n**Form 10-K**\n\n**For the Fiscal Year Ended September 27, 2025**\n\n**TABLE OF CONTENTS**\n\n**Page**\n\n**Part I**\n\nItem 1. Business 1\n\nItem 1A. Risk Factors 5\n\nItem 1B. Unresolved Staff Comments 17\n\nItem 1C. Cybersecurity 17\n\nItem 2. Properties 17\n\nItem 3. Legal Proceedings 18\n\nItem 4. Mine Safety Disclosures 18\n\n**Part II**\n\nItem 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity\n\nSecurities\n\n19\n\nItem 6. [Reserved] 20\n\nItem 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21\n\nItem 7A. Quantitative and Qualitative Disclosures About Market Risk 27\n\nItem 8. Financial Statements and Supplementary Data 28\n\nItem 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 52\n\nItem 9A. Controls and Procedures 52\n\nItem 9B. Other Information 53\n\nItem 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 53\n\n**Part III**\n\nItem 10. Directors, Executive Officers and Corporate Governance 53\n\nItem 11. Executive Compensation 53\n\nItem 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 53\n\nItem 13. Certain Relationships and Related Transactions, and Director Independence 53\n\nItem 14. Principal Accountant Fees and Services 53\n\n**Part IV**\n\nItem 15. Exhibit and Financial Statement Schedules 54\n\nItem 16. Form 10-K Summary 57"],"full_content":"**Apple Inc.**\n\n**Form 10-K**\n\n**For the Fiscal Year Ended September 27, 2025**\n\n**TABLE OF CONTENTS**\n\n**Page**\n\n**Part I**\n\nItem 1. Business 1\n\nItem 1A. Risk Factors 5\n\nItem 1B. Unresolved Staff Comments 17\n\nItem 1C. Cybersecurity 17\n\nItem 2. Properties 17\n\nItem 3. Legal Proceedings 18\n\nItem 4. Mine Safety Disclosures 18\n\n**Part II**\n\nItem 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity\n\nSecurities\n\n19\n\nItem 6. [Reserved] 20\n\nItem 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21\n\nItem 7A. Quantitative and Qualitative Disclosures About Market Risk 27\n\nItem 8. Financial Statements and Supplementary Data 28\n\nItem 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 52\n\nItem 9A. Controls and Procedures 52\n\nItem 9B. Other Information 53\n\nItem 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 53\n\n**Part III**\n\nItem 10. Directors, Executive Officers and Corporate Governance 53\n\nItem 11. Executive Compensation 53\n\nItem 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 53\n\nItem 13. Certain Relationships and Related Transactions, and Director Independence 53\n\nItem 14. Principal Accountant Fees and Services 53\n\n**Part IV**\n\nItem 15. Exhibit and Financial Statement Schedules 54\n\nItem 16. Form 10-K Summary 57","publish_date":null,"title":"Apple Inc. Form 10-K For the Fiscal Year Ended September 27, 2025 TABLE OF CONTENTS Part I Item 1. Business","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page3.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page3.pdf"},"request":{"example_id":"table/Apple 10-k_page3","product_type":"parse","source_file_path":"Apple 10-k_page3.pdf"},"started_at":"2026-11-04T19:47:46.827950"} +{"completed_at":"2026-11-04T19:47:49.058557","latency_in_ms":1048,"output":{"example_id":"table/Apple 10-k_page30","grounded_pages":[],"layout_pages":[],"markdown":"_Legal and Other Contingencies_\n\nThe Company is subject to various legal proceedings and claims that arise in the ordinary course of business, the outcomes of which are inherently uncertain. The Company records a liability when it is probable a loss has been incurred and the amount is reasonably estimable, the determination of which requires significant judgment. Resolution of legal matters in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.\n\n**Item 7A. Quantitative and Qualitative Disclosures About Market Risk**\n\nThe Company is exposed to economic risk from interest rates and foreign exchange rates. The Company uses various strategies to manage these risks; however, they may still impact the Company’s consolidated financial statements.\n\n**Interest Rate Risk**\n\nThe Company is primarily exposed to fluctuations in U.S. interest rates and their impact on the Company’s investment portfolio and term debt. Increases in interest rates will negatively affect the fair value of the Company’s investment portfolio and increase the interest expense on the Company’s term debt. To protect against interest rate risk, the Company may use derivative instruments, offset interest rate–sensitive assets and liabilities, or control duration of the investment and term debt portfolios.\n\nThe following table sets forth potential impacts on the Company’s investment portfolio and term debt, including the effects of any associated derivatives, that would result from a hypothetical increase in relevant interest rates as of September 27, 2025 and September 28, 2024 (dollars in millions):\n\n**Interest Rate Sensitive Instrument**\n\n**Hypothetical Interest Rate Increase Potential Impact 2025 2024**\n\nInvestment portfolio 100 basis points, all tenors Decline in fair value $ 2,416 $ 2,755\n\nTerm debt 100 basis points, all tenors Increase in annual interest expense $ 129 $ 139\n\n**Foreign Exchange Rate Risk**\n\nThe Company’s exposure to foreign exchange rate risk relates primarily to the Company being a net receiver of currencies other than the U.S. dollar. Changes in exchange rates, and in particular a strengthening of the U.S. dollar, will negatively affect the Company’s net sales and gross margins as expressed in U.S. dollars. Fluctuations in exchange rates may also affect the fair values of certain of the Company’s assets and liabilities. To protect against foreign exchange rate risk, the Company may use derivative instruments, offset exposures, or adjust local currency pricing of its products and services. However, the Company may choose to not hedge certain foreign currency exposures for a variety of reasons, including accounting considerations or prohibitive cost.\n\nThe Company applied a value-at-risk (“VAR”) model to its foreign currency derivative positions to assess the potential impact of fluctuations in exchange rates. The VAR model used a Monte Carlo simulation. The VAR is the maximum expected loss in fair value, for a given confidence interval, to the Company’s foreign currency derivative positions due to adverse movements in rates. Based on the results of the model, the Company estimates, with 95% confidence, a maximum one-day loss in fair value of $590 million and $538 million as of September 27, 2025 and September 28, 2024, respectively. Changes in the Company’s underlying foreign currency exposures, which were excluded from the assessment, generally offset changes in the fair values of the Company’s foreign currency derivatives.\n\nApple Inc. | 2025 Form 10-K | 27","pages":[{"line_numbers":[],"markdown":"_Legal and Other Contingencies_\n\nThe Company is subject to various legal proceedings and claims that arise in the ordinary course of business, the outcomes of which are inherently uncertain. The Company records a liability when it is probable a loss has been incurred and the amount is reasonably estimable, the determination of which requires significant judgment. Resolution of legal matters in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.\n\n**Item 7A. Quantitative and Qualitative Disclosures About Market Risk**\n\nThe Company is exposed to economic risk from interest rates and foreign exchange rates. The Company uses various strategies to manage these risks; however, they may still impact the Company’s consolidated financial statements.\n\n**Interest Rate Risk**\n\nThe Company is primarily exposed to fluctuations in U.S. interest rates and their impact on the Company’s investment portfolio and term debt. Increases in interest rates will negatively affect the fair value of the Company’s investment portfolio and increase the interest expense on the Company’s term debt. To protect against interest rate risk, the Company may use derivative instruments, offset interest rate–sensitive assets and liabilities, or control duration of the investment and term debt portfolios.\n\nThe following table sets forth potential impacts on the Company’s investment portfolio and term debt, including the effects of any associated derivatives, that would result from a hypothetical increase in relevant interest rates as of September 27, 2025 and September 28, 2024 (dollars in millions):\n\n**Interest Rate Sensitive Instrument**\n\n**Hypothetical Interest Rate Increase Potential Impact 2025 2024**\n\nInvestment portfolio 100 basis points, all tenors Decline in fair value $ 2,416 $ 2,755\n\nTerm debt 100 basis points, all tenors Increase in annual interest expense $ 129 $ 139\n\n**Foreign Exchange Rate Risk**\n\nThe Company’s exposure to foreign exchange rate risk relates primarily to the Company being a net receiver of currencies other than the U.S. dollar. Changes in exchange rates, and in particular a strengthening of the U.S. dollar, will negatively affect the Company’s net sales and gross margins as expressed in U.S. dollars. Fluctuations in exchange rates may also affect the fair values of certain of the Company’s assets and liabilities. To protect against foreign exchange rate risk, the Company may use derivative instruments, offset exposures, or adjust local currency pricing of its products and services. However, the Company may choose to not hedge certain foreign currency exposures for a variety of reasons, including accounting considerations or prohibitive cost.\n\nThe Company applied a value-at-risk (“VAR”) model to its foreign currency derivative positions to assess the potential impact of fluctuations in exchange rates. The VAR model used a Monte Carlo simulation. The VAR is the maximum expected loss in fair value, for a given confidence interval, to the Company’s foreign currency derivative positions due to adverse movements in rates. Based on the results of the model, the Company estimates, with 95% confidence, a maximum one-day loss in fair value of $590 million and $538 million as of September 27, 2025 and September 28, 2024, respectively. Changes in the Company’s underlying foreign currency exposures, which were excluded from the assessment, generally offset changes in the fair values of the Company’s foreign currency derivatives.\n\nApple Inc. | 2025 Form 10-K | 27","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"_Legal and Other Contingencies_\n\nThe Company is subject to various legal proceedings and claims that arise in the ordinary course of business, the outcomes of which are inherently uncertain. The Company records a liability when it is probable a loss has been incurred and the amount is reasonably estimable, the determination of which requires significant judgment. Resolution of legal matters in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.\n\n**Item 7A. Quantitative and Qualitative Disclosures About Market Risk**\n\nThe Company is exposed to economic risk from interest rates and foreign exchange rates. The Company uses various strategies to manage these risks; however, they may still impact the Company’s consolidated financial statements.\n\n**Interest Rate Risk**\n\nThe Company is primarily exposed to fluctuations in U.S. interest rates and their impact on the Company’s investment portfolio and term debt. Increases in interest rates will negatively affect the fair value of the Company’s investment portfolio and increase the interest expense on the Company’s term debt. To protect against interest rate risk, the Company may use derivative instruments, offset interest rate–sensitive assets and liabilities, or control duration of the investment and term debt portfolios.\n\nThe following table sets forth potential impacts on the Company’s investment portfolio and term debt, including the effects of any associated derivatives, that would result from a hypothetical increase in relevant interest rates as of September 27, 2025 and September 28, 2024 (dollars in millions):\n\n**Interest Rate Sensitive Instrument**\n\n**Hypothetical Interest Rate Increase Potential Impact 2025 2024**\n\nInvestment portfolio 100 basis points, all tenors Decline in fair value $ 2,416 $ 2,755\n\nTerm debt 100 basis points, all tenors Increase in annual interest expense $ 129 $ 139\n\n**Foreign Exchange Rate Risk**\n\nThe Company’s exposure to foreign exchange rate risk relates primarily to the Company being a net receiver of currencies other than the U.S. dollar. Changes in exchange rates, and in particular a strengthening of the U.S. dollar, will negatively affect the Company’s net sales and gross margins as expressed in U.S. dollars. Fluctuations in exchange rates may also affect the fair values of certain of the Company’s assets and liabilities. To protect against foreign exchange rate risk, the Company may use derivative instruments, offset exposures, or adjust local currency pricing of its products and services. However, the Company may choose to not hedge certain foreign currency exposures for a variety of reasons, including accounting considerations or prohibitive cost.\n\nThe Company applied a value-at-risk (“VAR”) model to its foreign currency derivative positions to assess the potential impact of fluctuations in exchange rates. The VAR model used a Monte Carlo simulation. The VAR is the maximum expected loss in fair value, for a given confidence interval, to the Company’s foreign currency derivative positions due to adverse movements in rates. Based on the results of the model, the Company estimates, with 95% confidence, a maximum one-day loss in fair value of $590 million and $538 million as of September 27, 2025 and September 28, 2024, respectively. Changes in the Company’s underlying foreign currency exposures, which were excluded from the assessment, generally offset changes in the fair values of the Company’s foreign currency derivatives.\n\nApple Inc. | 2025 Form 10-K | 27","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page30.pdf"]},"response":{"errors":[],"extract_id":"extract_ed0054f5795b3ab61f6fa1b61aabec54","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["_Legal and Other Contingencies_\n\nThe Company is subject to various legal proceedings and claims that arise in the ordinary course of business, the outcomes of which are inherently uncertain. The Company records a liability when it is probable a loss has been incurred and the amount is reasonably estimable, the determination of which requires significant judgment. Resolution of legal matters in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.\n\n**Item 7A. Quantitative and Qualitative Disclosures About Market Risk**\n\nThe Company is exposed to economic risk from interest rates and foreign exchange rates. The Company uses various strategies to manage these risks; however, they may still impact the Company’s consolidated financial statements.\n\n**Interest Rate Risk**\n\nThe Company is primarily exposed to fluctuations in U.S. interest rates and their impact on the Company’s investment portfolio and term debt. Increases in interest rates will negatively affect the fair value of the Company’s investment portfolio and increase the interest expense on the Company’s term debt. To protect against interest rate risk, the Company may use derivative instruments, offset interest rate–sensitive assets and liabilities, or control duration of the investment and term debt portfolios.\n\nThe following table sets forth potential impacts on the Company’s investment portfolio and term debt, including the effects of any associated derivatives, that would result from a hypothetical increase in relevant interest rates as of September 27, 2025 and September 28, 2024 (dollars in millions):\n\n**Interest Rate Sensitive Instrument**\n\n**Hypothetical Interest Rate Increase Potential Impact 2025 2024**\n\nInvestment portfolio 100 basis points, all tenors Decline in fair value $ 2,416 $ 2,755\n\nTerm debt 100 basis points, all tenors Increase in annual interest expense $ 129 $ 139\n\n**Foreign Exchange Rate Risk**\n\nThe Company’s exposure to foreign exchange rate risk relates primarily to the Company being a net receiver of currencies other than the U.S. dollar. Changes in exchange rates, and in particular a strengthening of the U.S. dollar, will negatively affect the Company’s net sales and gross margins as expressed in U.S. dollars. Fluctuations in exchange rates may also affect the fair values of certain of the Company’s assets and liabilities. To protect against foreign exchange rate risk, the Company may use derivative instruments, offset exposures, or adjust local currency pricing of its products and services. However, the Company may choose to not hedge certain foreign currency exposures for a variety of reasons, including accounting considerations or prohibitive cost.\n\nThe Company applied a value-at-risk (“VAR”) model to its foreign currency derivative positions to assess the potential impact of fluctuations in exchange rates. The VAR model used a Monte Carlo simulation. The VAR is the maximum expected loss in fair value, for a given confidence interval, to the Company’s foreign currency derivative positions due to adverse movements in rates. Based on the results of the model, the Company estimates, with 95% confidence, a maximum one-day loss in fair value of $590 million and $538 million as of September 27, 2025 and September 28, 2024, respectively. Changes in the Company’s underlying foreign currency exposures, which were excluded from the assessment, generally offset changes in the fair values of the Company’s foreign currency derivatives.\n\nApple Inc. | 2025 Form 10-K | 27"],"full_content":"_Legal and Other Contingencies_\n\nThe Company is subject to various legal proceedings and claims that arise in the ordinary course of business, the outcomes of which are inherently uncertain. The Company records a liability when it is probable a loss has been incurred and the amount is reasonably estimable, the determination of which requires significant judgment. Resolution of legal matters in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.\n\n**Item 7A. Quantitative and Qualitative Disclosures About Market Risk**\n\nThe Company is exposed to economic risk from interest rates and foreign exchange rates. The Company uses various strategies to manage these risks; however, they may still impact the Company’s consolidated financial statements.\n\n**Interest Rate Risk**\n\nThe Company is primarily exposed to fluctuations in U.S. interest rates and their impact on the Company’s investment portfolio and term debt. Increases in interest rates will negatively affect the fair value of the Company’s investment portfolio and increase the interest expense on the Company’s term debt. To protect against interest rate risk, the Company may use derivative instruments, offset interest rate–sensitive assets and liabilities, or control duration of the investment and term debt portfolios.\n\nThe following table sets forth potential impacts on the Company’s investment portfolio and term debt, including the effects of any associated derivatives, that would result from a hypothetical increase in relevant interest rates as of September 27, 2025 and September 28, 2024 (dollars in millions):\n\n**Interest Rate Sensitive Instrument**\n\n**Hypothetical Interest Rate Increase Potential Impact 2025 2024**\n\nInvestment portfolio 100 basis points, all tenors Decline in fair value $ 2,416 $ 2,755\n\nTerm debt 100 basis points, all tenors Increase in annual interest expense $ 129 $ 139\n\n**Foreign Exchange Rate Risk**\n\nThe Company’s exposure to foreign exchange rate risk relates primarily to the Company being a net receiver of currencies other than the U.S. dollar. Changes in exchange rates, and in particular a strengthening of the U.S. dollar, will negatively affect the Company’s net sales and gross margins as expressed in U.S. dollars. Fluctuations in exchange rates may also affect the fair values of certain of the Company’s assets and liabilities. To protect against foreign exchange rate risk, the Company may use derivative instruments, offset exposures, or adjust local currency pricing of its products and services. However, the Company may choose to not hedge certain foreign currency exposures for a variety of reasons, including accounting considerations or prohibitive cost.\n\nThe Company applied a value-at-risk (“VAR”) model to its foreign currency derivative positions to assess the potential impact of fluctuations in exchange rates. The VAR model used a Monte Carlo simulation. The VAR is the maximum expected loss in fair value, for a given confidence interval, to the Company’s foreign currency derivative positions due to adverse movements in rates. Based on the results of the model, the Company estimates, with 95% confidence, a maximum one-day loss in fair value of $590 million and $538 million as of September 27, 2025 and September 28, 2024, respectively. Changes in the Company’s underlying foreign currency exposures, which were excluded from the assessment, generally offset changes in the fair values of the Company’s foreign currency derivatives.\n\nApple Inc. | 2025 Form 10-K | 27","publish_date":null,"title":"Legal and Other Contingencies The Company is subject to various legal proceedings and claims that arise in the ordinary course","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page30.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page30.pdf"},"request":{"example_id":"table/Apple 10-k_page30","product_type":"parse","source_file_path":"Apple 10-k_page30.pdf"},"started_at":"2026-11-04T19:47:48.010405"} +{"completed_at":"2026-11-04T19:47:50.157361","latency_in_ms":1171,"output":{"example_id":"table/Apple 10-k_page43","grounded_pages":[],"layout_pages":[],"markdown":"**Note 6 – Consolidated Financial Statement Details**\n\nThe following tables show the Company’s consolidated financial statement details as of September 27, 2025 and September 28, 2024 (in millions):\n\n**Other Non-Current Assets**\n\n**2025 2024**\n\nDeferred tax assets $ 20,777 $ 19,499\n\nOther non-current assets 62,950 55,335\n\nTotal other non-current assets $ 83,727 $ 74,834\n\n**Other Current Liabilities**\n\n**2025 2024**\n\nIncome taxes payable $ 13,016 $ 26,601\n\nAccrued distribution and marketing 8,919 7,679\n\nOther current liabilities 44,452 44,024\n\nTotal other current liabilities $ 66,387 $ 78,304\n\n**Note 7 – Income Taxes**\n\n**European Commission State Aid Decision**\n\nOn August 30, 2016, the Commission announced its decision that Ireland granted state aid to the Company by providing tax opinions in 1991 and 2007 concerning the tax allocation of profits of the Irish branches of two subsidiaries of the Company (“State Aid Decision”). The State Aid Decision ordered Ireland to calculate and recover additional taxes from the Company for the period June 2003 through December 2014. Irish legislative changes, effective as of January 2015, eliminated the application of the tax opinions from that date forward.\n\nThe Company and Ireland appealed the State Aid Decision to the General Court of the Court of Justice of the European Union (“General Court”). On July 15, 2020, the General Court annulled the State Aid Decision. On September 25, 2020, the Commission appealed the General Court’s decision to the European Court of Justice (“ECJ”). On September 10, 2024, the ECJ announced that it had set aside the 2020 judgment of the General Court and confirmed the Commission’s 2016 State Aid Decision. As a result, during the fourth quarter of 2024 the Company recorded a one-time income tax charge of $10.2 billion, net, which represented $15.8 billion payable to Ireland via release of amounts held in escrow, partially offset by a U.S. foreign tax credit of $4.8 billion and a decrease in unrecognized tax benefits of $823 million.\n\n**Provision for Income Taxes and Effective Tax Rate**\n\nThe provision for income taxes for 2025, 2024 and 2023, consisted of the following (in millions):\n\n**2025 2024 2023**\n\nFederal:\n\nCurrent $ 11,487 $ 5,571 $ 9,445\n\nDeferred (1,804) (3,080) (3,644)\n\nTotal 9,683 2,491 5,801\n\nState:\n\nCurrent 1,680 1,726 1,570\n\nDeferred (139) (298) (49)\n\nTotal 1,541 1,428 1,521\n\nForeign:\n\nCurrent 8,891 25,483 8,750\n\nDeferred 604 347 669\n\nTotal 9,495 25,830 9,419\n\nProvision for income taxes $ 20,719 $ 29,749 $ 16,741\n\nForeign pretax earnings were $82.0 billion, $77.3 billion and $72.9 billion in 2025, 2024 and 2023, respectively.\n\nApple Inc. | 2025 Form 10-K | 40","pages":[{"line_numbers":[],"markdown":"**Note 6 – Consolidated Financial Statement Details**\n\nThe following tables show the Company’s consolidated financial statement details as of September 27, 2025 and September 28, 2024 (in millions):\n\n**Other Non-Current Assets**\n\n**2025 2024**\n\nDeferred tax assets $ 20,777 $ 19,499\n\nOther non-current assets 62,950 55,335\n\nTotal other non-current assets $ 83,727 $ 74,834\n\n**Other Current Liabilities**\n\n**2025 2024**\n\nIncome taxes payable $ 13,016 $ 26,601\n\nAccrued distribution and marketing 8,919 7,679\n\nOther current liabilities 44,452 44,024\n\nTotal other current liabilities $ 66,387 $ 78,304\n\n**Note 7 – Income Taxes**\n\n**European Commission State Aid Decision**\n\nOn August 30, 2016, the Commission announced its decision that Ireland granted state aid to the Company by providing tax opinions in 1991 and 2007 concerning the tax allocation of profits of the Irish branches of two subsidiaries of the Company (“State Aid Decision”). The State Aid Decision ordered Ireland to calculate and recover additional taxes from the Company for the period June 2003 through December 2014. Irish legislative changes, effective as of January 2015, eliminated the application of the tax opinions from that date forward.\n\nThe Company and Ireland appealed the State Aid Decision to the General Court of the Court of Justice of the European Union (“General Court”). On July 15, 2020, the General Court annulled the State Aid Decision. On September 25, 2020, the Commission appealed the General Court’s decision to the European Court of Justice (“ECJ”). On September 10, 2024, the ECJ announced that it had set aside the 2020 judgment of the General Court and confirmed the Commission’s 2016 State Aid Decision. As a result, during the fourth quarter of 2024 the Company recorded a one-time income tax charge of $10.2 billion, net, which represented $15.8 billion payable to Ireland via release of amounts held in escrow, partially offset by a U.S. foreign tax credit of $4.8 billion and a decrease in unrecognized tax benefits of $823 million.\n\n**Provision for Income Taxes and Effective Tax Rate**\n\nThe provision for income taxes for 2025, 2024 and 2023, consisted of the following (in millions):\n\n**2025 2024 2023**\n\nFederal:\n\nCurrent $ 11,487 $ 5,571 $ 9,445\n\nDeferred (1,804) (3,080) (3,644)\n\nTotal 9,683 2,491 5,801\n\nState:\n\nCurrent 1,680 1,726 1,570\n\nDeferred (139) (298) (49)\n\nTotal 1,541 1,428 1,521\n\nForeign:\n\nCurrent 8,891 25,483 8,750\n\nDeferred 604 347 669\n\nTotal 9,495 25,830 9,419\n\nProvision for income taxes $ 20,719 $ 29,749 $ 16,741\n\nForeign pretax earnings were $82.0 billion, $77.3 billion and $72.9 billion in 2025, 2024 and 2023, respectively.\n\nApple Inc. | 2025 Form 10-K | 40","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Note 6 – Consolidated Financial Statement Details**\n\nThe following tables show the Company’s consolidated financial statement details as of September 27, 2025 and September 28, 2024 (in millions):\n\n**Other Non-Current Assets**\n\n**2025 2024**\n\nDeferred tax assets $ 20,777 $ 19,499\n\nOther non-current assets 62,950 55,335\n\nTotal other non-current assets $ 83,727 $ 74,834\n\n**Other Current Liabilities**\n\n**2025 2024**\n\nIncome taxes payable $ 13,016 $ 26,601\n\nAccrued distribution and marketing 8,919 7,679\n\nOther current liabilities 44,452 44,024\n\nTotal other current liabilities $ 66,387 $ 78,304\n\n**Note 7 – Income Taxes**\n\n**European Commission State Aid Decision**\n\nOn August 30, 2016, the Commission announced its decision that Ireland granted state aid to the Company by providing tax opinions in 1991 and 2007 concerning the tax allocation of profits of the Irish branches of two subsidiaries of the Company (“State Aid Decision”). The State Aid Decision ordered Ireland to calculate and recover additional taxes from the Company for the period June 2003 through December 2014. Irish legislative changes, effective as of January 2015, eliminated the application of the tax opinions from that date forward.\n\nThe Company and Ireland appealed the State Aid Decision to the General Court of the Court of Justice of the European Union (“General Court”). On July 15, 2020, the General Court annulled the State Aid Decision. On September 25, 2020, the Commission appealed the General Court’s decision to the European Court of Justice (“ECJ”). On September 10, 2024, the ECJ announced that it had set aside the 2020 judgment of the General Court and confirmed the Commission’s 2016 State Aid Decision. As a result, during the fourth quarter of 2024 the Company recorded a one-time income tax charge of $10.2 billion, net, which represented $15.8 billion payable to Ireland via release of amounts held in escrow, partially offset by a U.S. foreign tax credit of $4.8 billion and a decrease in unrecognized tax benefits of $823 million.\n\n**Provision for Income Taxes and Effective Tax Rate**\n\nThe provision for income taxes for 2025, 2024 and 2023, consisted of the following (in millions):\n\n**2025 2024 2023**\n\nFederal:\n\nCurrent $ 11,487 $ 5,571 $ 9,445\n\nDeferred (1,804) (3,080) (3,644)\n\nTotal 9,683 2,491 5,801\n\nState:\n\nCurrent 1,680 1,726 1,570\n\nDeferred (139) (298) (49)\n\nTotal 1,541 1,428 1,521\n\nForeign:\n\nCurrent 8,891 25,483 8,750\n\nDeferred 604 347 669\n\nTotal 9,495 25,830 9,419\n\nProvision for income taxes $ 20,719 $ 29,749 $ 16,741\n\nForeign pretax earnings were $82.0 billion, $77.3 billion and $72.9 billion in 2025, 2024 and 2023, respectively.\n\nApple Inc. | 2025 Form 10-K | 40","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page43.pdf"]},"response":{"errors":[],"extract_id":"extract_ba4b2c11338c5ec89b30a7f6bf4b4add","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Note 6 – Consolidated Financial Statement Details**\n\nThe following tables show the Company’s consolidated financial statement details as of September 27, 2025 and September 28, 2024 (in millions):\n\n**Other Non-Current Assets**\n\n**2025 2024**\n\nDeferred tax assets $ 20,777 $ 19,499\n\nOther non-current assets 62,950 55,335\n\nTotal other non-current assets $ 83,727 $ 74,834\n\n**Other Current Liabilities**\n\n**2025 2024**\n\nIncome taxes payable $ 13,016 $ 26,601\n\nAccrued distribution and marketing 8,919 7,679\n\nOther current liabilities 44,452 44,024\n\nTotal other current liabilities $ 66,387 $ 78,304\n\n**Note 7 – Income Taxes**\n\n**European Commission State Aid Decision**\n\nOn August 30, 2016, the Commission announced its decision that Ireland granted state aid to the Company by providing tax opinions in 1991 and 2007 concerning the tax allocation of profits of the Irish branches of two subsidiaries of the Company (“State Aid Decision”). The State Aid Decision ordered Ireland to calculate and recover additional taxes from the Company for the period June 2003 through December 2014. Irish legislative changes, effective as of January 2015, eliminated the application of the tax opinions from that date forward.\n\nThe Company and Ireland appealed the State Aid Decision to the General Court of the Court of Justice of the European Union (“General Court”). On July 15, 2020, the General Court annulled the State Aid Decision. On September 25, 2020, the Commission appealed the General Court’s decision to the European Court of Justice (“ECJ”). On September 10, 2024, the ECJ announced that it had set aside the 2020 judgment of the General Court and confirmed the Commission’s 2016 State Aid Decision. As a result, during the fourth quarter of 2024 the Company recorded a one-time income tax charge of $10.2 billion, net, which represented $15.8 billion payable to Ireland via release of amounts held in escrow, partially offset by a U.S. foreign tax credit of $4.8 billion and a decrease in unrecognized tax benefits of $823 million.\n\n**Provision for Income Taxes and Effective Tax Rate**\n\nThe provision for income taxes for 2025, 2024 and 2023, consisted of the following (in millions):\n\n**2025 2024 2023**\n\nFederal:\n\nCurrent $ 11,487 $ 5,571 $ 9,445\n\nDeferred (1,804) (3,080) (3,644)\n\nTotal 9,683 2,491 5,801\n\nState:\n\nCurrent 1,680 1,726 1,570\n\nDeferred (139) (298) (49)\n\nTotal 1,541 1,428 1,521\n\nForeign:\n\nCurrent 8,891 25,483 8,750\n\nDeferred 604 347 669\n\nTotal 9,495 25,830 9,419\n\nProvision for income taxes $ 20,719 $ 29,749 $ 16,741\n\nForeign pretax earnings were $82.0 billion, $77.3 billion and $72.9 billion in 2025, 2024 and 2023, respectively.\n\nApple Inc. | 2025 Form 10-K | 40"],"full_content":"**Note 6 – Consolidated Financial Statement Details**\n\nThe following tables show the Company’s consolidated financial statement details as of September 27, 2025 and September 28, 2024 (in millions):\n\n**Other Non-Current Assets**\n\n**2025 2024**\n\nDeferred tax assets $ 20,777 $ 19,499\n\nOther non-current assets 62,950 55,335\n\nTotal other non-current assets $ 83,727 $ 74,834\n\n**Other Current Liabilities**\n\n**2025 2024**\n\nIncome taxes payable $ 13,016 $ 26,601\n\nAccrued distribution and marketing 8,919 7,679\n\nOther current liabilities 44,452 44,024\n\nTotal other current liabilities $ 66,387 $ 78,304\n\n**Note 7 – Income Taxes**\n\n**European Commission State Aid Decision**\n\nOn August 30, 2016, the Commission announced its decision that Ireland granted state aid to the Company by providing tax opinions in 1991 and 2007 concerning the tax allocation of profits of the Irish branches of two subsidiaries of the Company (“State Aid Decision”). The State Aid Decision ordered Ireland to calculate and recover additional taxes from the Company for the period June 2003 through December 2014. Irish legislative changes, effective as of January 2015, eliminated the application of the tax opinions from that date forward.\n\nThe Company and Ireland appealed the State Aid Decision to the General Court of the Court of Justice of the European Union (“General Court”). On July 15, 2020, the General Court annulled the State Aid Decision. On September 25, 2020, the Commission appealed the General Court’s decision to the European Court of Justice (“ECJ”). On September 10, 2024, the ECJ announced that it had set aside the 2020 judgment of the General Court and confirmed the Commission’s 2016 State Aid Decision. As a result, during the fourth quarter of 2024 the Company recorded a one-time income tax charge of $10.2 billion, net, which represented $15.8 billion payable to Ireland via release of amounts held in escrow, partially offset by a U.S. foreign tax credit of $4.8 billion and a decrease in unrecognized tax benefits of $823 million.\n\n**Provision for Income Taxes and Effective Tax Rate**\n\nThe provision for income taxes for 2025, 2024 and 2023, consisted of the following (in millions):\n\n**2025 2024 2023**\n\nFederal:\n\nCurrent $ 11,487 $ 5,571 $ 9,445\n\nDeferred (1,804) (3,080) (3,644)\n\nTotal 9,683 2,491 5,801\n\nState:\n\nCurrent 1,680 1,726 1,570\n\nDeferred (139) (298) (49)\n\nTotal 1,541 1,428 1,521\n\nForeign:\n\nCurrent 8,891 25,483 8,750\n\nDeferred 604 347 669\n\nTotal 9,495 25,830 9,419\n\nProvision for income taxes $ 20,719 $ 29,749 $ 16,741\n\nForeign pretax earnings were $82.0 billion, $77.3 billion and $72.9 billion in 2025, 2024 and 2023, respectively.\n\nApple Inc. | 2025 Form 10-K | 40","publish_date":null,"title":"Note 6 – Consolidated Financial Statement Details The following tables show the Company’s consolidated financial statement details as of September","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page43.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page43.pdf"},"request":{"example_id":"table/Apple 10-k_page43","product_type":"parse","source_file_path":"Apple 10-k_page43.pdf"},"started_at":"2026-11-04T19:47:48.986200"} +{"completed_at":"2026-11-04T19:47:51.015654","latency_in_ms":1035,"output":{"example_id":"table/Apple 10-k_page45","grounded_pages":[],"layout_pages":[],"markdown":"**Uncertain Tax Positions**\n\nAs of September 27, 2025, the total amount of gross unrecognized tax benefits was $23.2 billion, of which $10.6 billion, if recognized, would impact the Company’s effective tax rate. As of September 28, 2024, the total amount of gross unrecognized tax benefits was $22.0 billion, of which $10.8 billion, if recognized, would have impacted the Company’s effective tax rate.\n\nThe aggregate change in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for 2025, 2024 and 2023 is as follows (in millions):\n\n**2025 2024 2023**\n\nBeginning balances $ 22,038 $ 19,454 $ 16,758\n\nIncreases related to tax positions taken during a prior year 1,971 1,727 2,044\n\nDecreases related to tax positions taken during a prior year (71) (386) (1,463)\n\nIncreases related to tax positions taken during the current year 3,795 2,542 2,628\n\nDecreases related to settlements with taxing authorities (2,939) (1,070) (19)\n\nDecreases related to expiration of the statute of limitations (1,552) (229) (494)\n\nEnding balances $ 23,242 $ 22,038 $ 19,454\n\nThe Company is subject to taxation and files income tax returns in the U.S. federal jurisdiction and many state and foreign jurisdictions. Tax years 2018 and after 2021 for the U.S. federal jurisdiction, and after 2014 in certain major foreign jurisdictions, remain subject to examination. Although the timing of resolution or closure of examinations is not certain, the Company believes it is reasonably possible that its gross unrecognized tax benefits could decrease as much as $6 billion in the next 12 months.\n\n**Note 8 – Leases**\n\nThe Company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. These leases typically have original terms not exceeding 10 years and generally contain multiyear renewal options, some of which are reasonably certain of exercise.\n\nPayments under the Company’s lease arrangements may be fixed or variable, and variable lease payments are primarily based on purchases of output of the underlying leased assets. Lease costs associated with fixed payments on the Company’s operating leases were $2.1 billion for 2025 and $2.0 billion for both 2024 and 2023. Lease costs associated with variable payments on the Company’s leases were $16.1 billion, $13.8 billion and $13.9 billion for 2025, 2024 and 2023, respectively.\n\nThe Company made fixed cash payments related to operating leases of $2.1 billion in 2025 and $1.9 billion in both 2024 and 2023. Noncash activities involving right-of-use (“ROU”) assets obtained in exchange for lease liabilities were $2.8 billion, $1.0 billion and $2.1 billion for 2025, 2024 and 2023, respectively.\n\nThe following table shows ROU assets and lease liabilities, and the associated financial statement line items, as of September 27, 2025 and September 28, 2024 (in millions):\n\n**Lease-Related Assets and Liabilities Financial Statement Line Items 2025 2024**\n\nRight-of-use assets:\n\nOperating leases Other non-current assets $ 11,205 $ 10,234\n\nFinance leases Property, plant and equipment, net 1,033 1,069\n\nTotal right-of-use assets $ 12,238 $ 11,303\n\nLease liabilities:\n\nOperating leases Other current liabilities $ 1,579 $ 1,488\n\nOther non-current liabilities 10,911 10,046\n\nFinance leases Other current liabilities 538 144\n\nOther non-current liabilities 692 752\n\nTotal lease liabilities $ 13,720 $ 12,430\n\nApple Inc. | 2025 Form 10-K | 42","pages":[{"line_numbers":[],"markdown":"**Uncertain Tax Positions**\n\nAs of September 27, 2025, the total amount of gross unrecognized tax benefits was $23.2 billion, of which $10.6 billion, if recognized, would impact the Company’s effective tax rate. As of September 28, 2024, the total amount of gross unrecognized tax benefits was $22.0 billion, of which $10.8 billion, if recognized, would have impacted the Company’s effective tax rate.\n\nThe aggregate change in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for 2025, 2024 and 2023 is as follows (in millions):\n\n**2025 2024 2023**\n\nBeginning balances $ 22,038 $ 19,454 $ 16,758\n\nIncreases related to tax positions taken during a prior year 1,971 1,727 2,044\n\nDecreases related to tax positions taken during a prior year (71) (386) (1,463)\n\nIncreases related to tax positions taken during the current year 3,795 2,542 2,628\n\nDecreases related to settlements with taxing authorities (2,939) (1,070) (19)\n\nDecreases related to expiration of the statute of limitations (1,552) (229) (494)\n\nEnding balances $ 23,242 $ 22,038 $ 19,454\n\nThe Company is subject to taxation and files income tax returns in the U.S. federal jurisdiction and many state and foreign jurisdictions. Tax years 2018 and after 2021 for the U.S. federal jurisdiction, and after 2014 in certain major foreign jurisdictions, remain subject to examination. Although the timing of resolution or closure of examinations is not certain, the Company believes it is reasonably possible that its gross unrecognized tax benefits could decrease as much as $6 billion in the next 12 months.\n\n**Note 8 – Leases**\n\nThe Company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. These leases typically have original terms not exceeding 10 years and generally contain multiyear renewal options, some of which are reasonably certain of exercise.\n\nPayments under the Company’s lease arrangements may be fixed or variable, and variable lease payments are primarily based on purchases of output of the underlying leased assets. Lease costs associated with fixed payments on the Company’s operating leases were $2.1 billion for 2025 and $2.0 billion for both 2024 and 2023. Lease costs associated with variable payments on the Company’s leases were $16.1 billion, $13.8 billion and $13.9 billion for 2025, 2024 and 2023, respectively.\n\nThe Company made fixed cash payments related to operating leases of $2.1 billion in 2025 and $1.9 billion in both 2024 and 2023. Noncash activities involving right-of-use (“ROU”) assets obtained in exchange for lease liabilities were $2.8 billion, $1.0 billion and $2.1 billion for 2025, 2024 and 2023, respectively.\n\nThe following table shows ROU assets and lease liabilities, and the associated financial statement line items, as of September 27, 2025 and September 28, 2024 (in millions):\n\n**Lease-Related Assets and Liabilities Financial Statement Line Items 2025 2024**\n\nRight-of-use assets:\n\nOperating leases Other non-current assets $ 11,205 $ 10,234\n\nFinance leases Property, plant and equipment, net 1,033 1,069\n\nTotal right-of-use assets $ 12,238 $ 11,303\n\nLease liabilities:\n\nOperating leases Other current liabilities $ 1,579 $ 1,488\n\nOther non-current liabilities 10,911 10,046\n\nFinance leases Other current liabilities 538 144\n\nOther non-current liabilities 692 752\n\nTotal lease liabilities $ 13,720 $ 12,430\n\nApple Inc. | 2025 Form 10-K | 42","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Uncertain Tax Positions**\n\nAs of September 27, 2025, the total amount of gross unrecognized tax benefits was $23.2 billion, of which $10.6 billion, if recognized, would impact the Company’s effective tax rate. As of September 28, 2024, the total amount of gross unrecognized tax benefits was $22.0 billion, of which $10.8 billion, if recognized, would have impacted the Company’s effective tax rate.\n\nThe aggregate change in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for 2025, 2024 and 2023 is as follows (in millions):\n\n**2025 2024 2023**\n\nBeginning balances $ 22,038 $ 19,454 $ 16,758\n\nIncreases related to tax positions taken during a prior year 1,971 1,727 2,044\n\nDecreases related to tax positions taken during a prior year (71) (386) (1,463)\n\nIncreases related to tax positions taken during the current year 3,795 2,542 2,628\n\nDecreases related to settlements with taxing authorities (2,939) (1,070) (19)\n\nDecreases related to expiration of the statute of limitations (1,552) (229) (494)\n\nEnding balances $ 23,242 $ 22,038 $ 19,454\n\nThe Company is subject to taxation and files income tax returns in the U.S. federal jurisdiction and many state and foreign jurisdictions. Tax years 2018 and after 2021 for the U.S. federal jurisdiction, and after 2014 in certain major foreign jurisdictions, remain subject to examination. Although the timing of resolution or closure of examinations is not certain, the Company believes it is reasonably possible that its gross unrecognized tax benefits could decrease as much as $6 billion in the next 12 months.\n\n**Note 8 – Leases**\n\nThe Company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. These leases typically have original terms not exceeding 10 years and generally contain multiyear renewal options, some of which are reasonably certain of exercise.\n\nPayments under the Company’s lease arrangements may be fixed or variable, and variable lease payments are primarily based on purchases of output of the underlying leased assets. Lease costs associated with fixed payments on the Company’s operating leases were $2.1 billion for 2025 and $2.0 billion for both 2024 and 2023. Lease costs associated with variable payments on the Company’s leases were $16.1 billion, $13.8 billion and $13.9 billion for 2025, 2024 and 2023, respectively.\n\nThe Company made fixed cash payments related to operating leases of $2.1 billion in 2025 and $1.9 billion in both 2024 and 2023. Noncash activities involving right-of-use (“ROU”) assets obtained in exchange for lease liabilities were $2.8 billion, $1.0 billion and $2.1 billion for 2025, 2024 and 2023, respectively.\n\nThe following table shows ROU assets and lease liabilities, and the associated financial statement line items, as of September 27, 2025 and September 28, 2024 (in millions):\n\n**Lease-Related Assets and Liabilities Financial Statement Line Items 2025 2024**\n\nRight-of-use assets:\n\nOperating leases Other non-current assets $ 11,205 $ 10,234\n\nFinance leases Property, plant and equipment, net 1,033 1,069\n\nTotal right-of-use assets $ 12,238 $ 11,303\n\nLease liabilities:\n\nOperating leases Other current liabilities $ 1,579 $ 1,488\n\nOther non-current liabilities 10,911 10,046\n\nFinance leases Other current liabilities 538 144\n\nOther non-current liabilities 692 752\n\nTotal lease liabilities $ 13,720 $ 12,430\n\nApple Inc. | 2025 Form 10-K | 42","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page45.pdf"]},"response":{"errors":[],"extract_id":"extract_00e114e3af0b306f02175ea3c8290c4d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Uncertain Tax Positions**\n\nAs of September 27, 2025, the total amount of gross unrecognized tax benefits was $23.2 billion, of which $10.6 billion, if recognized, would impact the Company’s effective tax rate. As of September 28, 2024, the total amount of gross unrecognized tax benefits was $22.0 billion, of which $10.8 billion, if recognized, would have impacted the Company’s effective tax rate.\n\nThe aggregate change in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for 2025, 2024 and 2023 is as follows (in millions):\n\n**2025 2024 2023**\n\nBeginning balances $ 22,038 $ 19,454 $ 16,758\n\nIncreases related to tax positions taken during a prior year 1,971 1,727 2,044\n\nDecreases related to tax positions taken during a prior year (71) (386) (1,463)\n\nIncreases related to tax positions taken during the current year 3,795 2,542 2,628\n\nDecreases related to settlements with taxing authorities (2,939) (1,070) (19)\n\nDecreases related to expiration of the statute of limitations (1,552) (229) (494)\n\nEnding balances $ 23,242 $ 22,038 $ 19,454\n\nThe Company is subject to taxation and files income tax returns in the U.S. federal jurisdiction and many state and foreign jurisdictions. Tax years 2018 and after 2021 for the U.S. federal jurisdiction, and after 2014 in certain major foreign jurisdictions, remain subject to examination. Although the timing of resolution or closure of examinations is not certain, the Company believes it is reasonably possible that its gross unrecognized tax benefits could decrease as much as $6 billion in the next 12 months.\n\n**Note 8 – Leases**\n\nThe Company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. These leases typically have original terms not exceeding 10 years and generally contain multiyear renewal options, some of which are reasonably certain of exercise.\n\nPayments under the Company’s lease arrangements may be fixed or variable, and variable lease payments are primarily based on purchases of output of the underlying leased assets. Lease costs associated with fixed payments on the Company’s operating leases were $2.1 billion for 2025 and $2.0 billion for both 2024 and 2023. Lease costs associated with variable payments on the Company’s leases were $16.1 billion, $13.8 billion and $13.9 billion for 2025, 2024 and 2023, respectively.\n\nThe Company made fixed cash payments related to operating leases of $2.1 billion in 2025 and $1.9 billion in both 2024 and 2023. Noncash activities involving right-of-use (“ROU”) assets obtained in exchange for lease liabilities were $2.8 billion, $1.0 billion and $2.1 billion for 2025, 2024 and 2023, respectively.\n\nThe following table shows ROU assets and lease liabilities, and the associated financial statement line items, as of September 27, 2025 and September 28, 2024 (in millions):\n\n**Lease-Related Assets and Liabilities Financial Statement Line Items 2025 2024**\n\nRight-of-use assets:\n\nOperating leases Other non-current assets $ 11,205 $ 10,234\n\nFinance leases Property, plant and equipment, net 1,033 1,069\n\nTotal right-of-use assets $ 12,238 $ 11,303\n\nLease liabilities:\n\nOperating leases Other current liabilities $ 1,579 $ 1,488\n\nOther non-current liabilities 10,911 10,046\n\nFinance leases Other current liabilities 538 144\n\nOther non-current liabilities 692 752\n\nTotal lease liabilities $ 13,720 $ 12,430\n\nApple Inc. | 2025 Form 10-K | 42"],"full_content":"**Uncertain Tax Positions**\n\nAs of September 27, 2025, the total amount of gross unrecognized tax benefits was $23.2 billion, of which $10.6 billion, if recognized, would impact the Company’s effective tax rate. As of September 28, 2024, the total amount of gross unrecognized tax benefits was $22.0 billion, of which $10.8 billion, if recognized, would have impacted the Company’s effective tax rate.\n\nThe aggregate change in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for 2025, 2024 and 2023 is as follows (in millions):\n\n**2025 2024 2023**\n\nBeginning balances $ 22,038 $ 19,454 $ 16,758\n\nIncreases related to tax positions taken during a prior year 1,971 1,727 2,044\n\nDecreases related to tax positions taken during a prior year (71) (386) (1,463)\n\nIncreases related to tax positions taken during the current year 3,795 2,542 2,628\n\nDecreases related to settlements with taxing authorities (2,939) (1,070) (19)\n\nDecreases related to expiration of the statute of limitations (1,552) (229) (494)\n\nEnding balances $ 23,242 $ 22,038 $ 19,454\n\nThe Company is subject to taxation and files income tax returns in the U.S. federal jurisdiction and many state and foreign jurisdictions. Tax years 2018 and after 2021 for the U.S. federal jurisdiction, and after 2014 in certain major foreign jurisdictions, remain subject to examination. Although the timing of resolution or closure of examinations is not certain, the Company believes it is reasonably possible that its gross unrecognized tax benefits could decrease as much as $6 billion in the next 12 months.\n\n**Note 8 – Leases**\n\nThe Company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. These leases typically have original terms not exceeding 10 years and generally contain multiyear renewal options, some of which are reasonably certain of exercise.\n\nPayments under the Company’s lease arrangements may be fixed or variable, and variable lease payments are primarily based on purchases of output of the underlying leased assets. Lease costs associated with fixed payments on the Company’s operating leases were $2.1 billion for 2025 and $2.0 billion for both 2024 and 2023. Lease costs associated with variable payments on the Company’s leases were $16.1 billion, $13.8 billion and $13.9 billion for 2025, 2024 and 2023, respectively.\n\nThe Company made fixed cash payments related to operating leases of $2.1 billion in 2025 and $1.9 billion in both 2024 and 2023. Noncash activities involving right-of-use (“ROU”) assets obtained in exchange for lease liabilities were $2.8 billion, $1.0 billion and $2.1 billion for 2025, 2024 and 2023, respectively.\n\nThe following table shows ROU assets and lease liabilities, and the associated financial statement line items, as of September 27, 2025 and September 28, 2024 (in millions):\n\n**Lease-Related Assets and Liabilities Financial Statement Line Items 2025 2024**\n\nRight-of-use assets:\n\nOperating leases Other non-current assets $ 11,205 $ 10,234\n\nFinance leases Property, plant and equipment, net 1,033 1,069\n\nTotal right-of-use assets $ 12,238 $ 11,303\n\nLease liabilities:\n\nOperating leases Other current liabilities $ 1,579 $ 1,488\n\nOther non-current liabilities 10,911 10,046\n\nFinance leases Other current liabilities 538 144\n\nOther non-current liabilities 692 752\n\nTotal lease liabilities $ 13,720 $ 12,430\n\nApple Inc. | 2025 Form 10-K | 42","publish_date":null,"title":"Uncertain Tax Positions As of September 27, 2025, the total amount of gross unrecognized tax benefits was $23.2 billion, of","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page45.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page45.pdf"},"request":{"example_id":"table/Apple 10-k_page45","product_type":"parse","source_file_path":"Apple 10-k_page45.pdf"},"started_at":"2026-11-04T19:47:49.980203"} +{"completed_at":"2026-11-04T19:47:52.090053","latency_in_ms":1072,"output":{"example_id":"table/Apple 10-k_page50","grounded_pages":[],"layout_pages":[],"markdown":"**Note 13 – Segment Information and Geographic Data**\n\nThe Company manages its business primarily on a geographic basis. The Company’s CEO is its CODM.\n\nThe Company’s reportable segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. Americas includes both North and South America. Europe includes European countries, as well as India, the Middle East and Africa. Greater China includes China mainland, Hong Kong and Taiwan. Rest of Asia Pacific includes Australia, New Zealand and those Asian countries not included in the Company’s other reportable segments. Although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the Company’s customers and distribution partners and the unique market dynamics of each geographic region.\n\nThe CODM uses segment net sales and operating income information to make certain decisions, such as product and service pricing, and to decide how to allocate resources related to sales activities and marketing investments. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment consists of net sales to third parties, related cost of sales, and operating expenses directly attributable to the segment. The information provided to the CODM for purposes of making decisions and assessing segment performance excludes asset information.\n\nThe following tables show information by reportable segment for 2025, 2024 and 2023 (in millions):\n\n**2025**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 178,353 $ 111,032 $ 64,377 $ 28,703 $ 33,696 $ — $ 416,161\n\nCost of sales (95,699) (58,617) (35,141) (13,779) (17,724) — (220,960)\n\nResearch and development — — — — — (34,550) (34,550)\n\nSelling and marketing (10,174) (4,676) (2,319) (969) (1,386) — (19,524)\n\nGeneral and administrative — — — — — (8,077) (8,077)\n\nOperating income/(loss) $ 72,480 $ 47,739 $ 26,917 $ 13,955 $ 14,586 $ (42,627) $ 133,050\n\n**2024**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 167,045 $ 101,328 $ 66,952 $ 25,052 $ 30,658 $ — $ 391,035\n\nCost of sales (89,587) (55,197) (37,519) (11,744) (16,305) — (210,352)\n\nResearch and development — — — — — (31,370) (31,370)\n\nSelling and marketing (9,802) (4,341) (2,351) (854) (1,291) — (18,639)\n\nGeneral and administrative — — — — — (7,458) (7,458)\n\nOperating income/(loss) $ 67,656 $ 41,790 $ 27,082 $ 12,454 $ 13,062 $ (38,828) $ 123,216\n\n**2023**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 162,560 $ 94,294 $ 72,559 $ 24,257 $ 29,615 $ — $ 383,285\n\nCost of sales (92,394) (54,101) (39,787) (11,542) (16,313) — (214,137)\n\nResearch and development — — — — — (29,915) (29,915)\n\nSelling and marketing (9,658) (4,095) (2,444) (827) (1,236) — (18,260)\n\nGeneral and administrative — — — — — (6,672) (6,672)\n\nOperating income/(loss) $ 60,508 $ 36,098 $ 30,328 $ 11,888 $ 12,066 $ (36,587) $ 114,301\n\nApple Inc. | 2025 Form 10-K | 47","pages":[{"line_numbers":[],"markdown":"**Note 13 – Segment Information and Geographic Data**\n\nThe Company manages its business primarily on a geographic basis. The Company’s CEO is its CODM.\n\nThe Company’s reportable segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. Americas includes both North and South America. Europe includes European countries, as well as India, the Middle East and Africa. Greater China includes China mainland, Hong Kong and Taiwan. Rest of Asia Pacific includes Australia, New Zealand and those Asian countries not included in the Company’s other reportable segments. Although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the Company’s customers and distribution partners and the unique market dynamics of each geographic region.\n\nThe CODM uses segment net sales and operating income information to make certain decisions, such as product and service pricing, and to decide how to allocate resources related to sales activities and marketing investments. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment consists of net sales to third parties, related cost of sales, and operating expenses directly attributable to the segment. The information provided to the CODM for purposes of making decisions and assessing segment performance excludes asset information.\n\nThe following tables show information by reportable segment for 2025, 2024 and 2023 (in millions):\n\n**2025**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 178,353 $ 111,032 $ 64,377 $ 28,703 $ 33,696 $ — $ 416,161\n\nCost of sales (95,699) (58,617) (35,141) (13,779) (17,724) — (220,960)\n\nResearch and development — — — — — (34,550) (34,550)\n\nSelling and marketing (10,174) (4,676) (2,319) (969) (1,386) — (19,524)\n\nGeneral and administrative — — — — — (8,077) (8,077)\n\nOperating income/(loss) $ 72,480 $ 47,739 $ 26,917 $ 13,955 $ 14,586 $ (42,627) $ 133,050\n\n**2024**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 167,045 $ 101,328 $ 66,952 $ 25,052 $ 30,658 $ — $ 391,035\n\nCost of sales (89,587) (55,197) (37,519) (11,744) (16,305) — (210,352)\n\nResearch and development — — — — — (31,370) (31,370)\n\nSelling and marketing (9,802) (4,341) (2,351) (854) (1,291) — (18,639)\n\nGeneral and administrative — — — — — (7,458) (7,458)\n\nOperating income/(loss) $ 67,656 $ 41,790 $ 27,082 $ 12,454 $ 13,062 $ (38,828) $ 123,216\n\n**2023**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 162,560 $ 94,294 $ 72,559 $ 24,257 $ 29,615 $ — $ 383,285\n\nCost of sales (92,394) (54,101) (39,787) (11,542) (16,313) — (214,137)\n\nResearch and development — — — — — (29,915) (29,915)\n\nSelling and marketing (9,658) (4,095) (2,444) (827) (1,236) — (18,260)\n\nGeneral and administrative — — — — — (6,672) (6,672)\n\nOperating income/(loss) $ 60,508 $ 36,098 $ 30,328 $ 11,888 $ 12,066 $ (36,587) $ 114,301\n\nApple Inc. | 2025 Form 10-K | 47","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Note 13 – Segment Information and Geographic Data**\n\nThe Company manages its business primarily on a geographic basis. The Company’s CEO is its CODM.\n\nThe Company’s reportable segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. Americas includes both North and South America. Europe includes European countries, as well as India, the Middle East and Africa. Greater China includes China mainland, Hong Kong and Taiwan. Rest of Asia Pacific includes Australia, New Zealand and those Asian countries not included in the Company’s other reportable segments. Although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the Company’s customers and distribution partners and the unique market dynamics of each geographic region.\n\nThe CODM uses segment net sales and operating income information to make certain decisions, such as product and service pricing, and to decide how to allocate resources related to sales activities and marketing investments. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment consists of net sales to third parties, related cost of sales, and operating expenses directly attributable to the segment. The information provided to the CODM for purposes of making decisions and assessing segment performance excludes asset information.\n\nThe following tables show information by reportable segment for 2025, 2024 and 2023 (in millions):\n\n**2025**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 178,353 $ 111,032 $ 64,377 $ 28,703 $ 33,696 $ — $ 416,161\n\nCost of sales (95,699) (58,617) (35,141) (13,779) (17,724) — (220,960)\n\nResearch and development — — — — — (34,550) (34,550)\n\nSelling and marketing (10,174) (4,676) (2,319) (969) (1,386) — (19,524)\n\nGeneral and administrative — — — — — (8,077) (8,077)\n\nOperating income/(loss) $ 72,480 $ 47,739 $ 26,917 $ 13,955 $ 14,586 $ (42,627) $ 133,050\n\n**2024**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 167,045 $ 101,328 $ 66,952 $ 25,052 $ 30,658 $ — $ 391,035\n\nCost of sales (89,587) (55,197) (37,519) (11,744) (16,305) — (210,352)\n\nResearch and development — — — — — (31,370) (31,370)\n\nSelling and marketing (9,802) (4,341) (2,351) (854) (1,291) — (18,639)\n\nGeneral and administrative — — — — — (7,458) (7,458)\n\nOperating income/(loss) $ 67,656 $ 41,790 $ 27,082 $ 12,454 $ 13,062 $ (38,828) $ 123,216\n\n**2023**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 162,560 $ 94,294 $ 72,559 $ 24,257 $ 29,615 $ — $ 383,285\n\nCost of sales (92,394) (54,101) (39,787) (11,542) (16,313) — (214,137)\n\nResearch and development — — — — — (29,915) (29,915)\n\nSelling and marketing (9,658) (4,095) (2,444) (827) (1,236) — (18,260)\n\nGeneral and administrative — — — — — (6,672) (6,672)\n\nOperating income/(loss) $ 60,508 $ 36,098 $ 30,328 $ 11,888 $ 12,066 $ (36,587) $ 114,301\n\nApple Inc. | 2025 Form 10-K | 47","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page50.pdf"]},"response":{"errors":[],"extract_id":"extract_2115fc378edba58b413119d7a0f31e4f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Note 13 – Segment Information and Geographic Data**\n\nThe Company manages its business primarily on a geographic basis. The Company’s CEO is its CODM.\n\nThe Company’s reportable segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. Americas includes both North and South America. Europe includes European countries, as well as India, the Middle East and Africa. Greater China includes China mainland, Hong Kong and Taiwan. Rest of Asia Pacific includes Australia, New Zealand and those Asian countries not included in the Company’s other reportable segments. Although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the Company’s customers and distribution partners and the unique market dynamics of each geographic region.\n\nThe CODM uses segment net sales and operating income information to make certain decisions, such as product and service pricing, and to decide how to allocate resources related to sales activities and marketing investments. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment consists of net sales to third parties, related cost of sales, and operating expenses directly attributable to the segment. The information provided to the CODM for purposes of making decisions and assessing segment performance excludes asset information.\n\nThe following tables show information by reportable segment for 2025, 2024 and 2023 (in millions):\n\n**2025**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 178,353 $ 111,032 $ 64,377 $ 28,703 $ 33,696 $ — $ 416,161\n\nCost of sales (95,699) (58,617) (35,141) (13,779) (17,724) — (220,960)\n\nResearch and development — — — — — (34,550) (34,550)\n\nSelling and marketing (10,174) (4,676) (2,319) (969) (1,386) — (19,524)\n\nGeneral and administrative — — — — — (8,077) (8,077)\n\nOperating income/(loss) $ 72,480 $ 47,739 $ 26,917 $ 13,955 $ 14,586 $ (42,627) $ 133,050\n\n**2024**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 167,045 $ 101,328 $ 66,952 $ 25,052 $ 30,658 $ — $ 391,035\n\nCost of sales (89,587) (55,197) (37,519) (11,744) (16,305) — (210,352)\n\nResearch and development — — — — — (31,370) (31,370)\n\nSelling and marketing (9,802) (4,341) (2,351) (854) (1,291) — (18,639)\n\nGeneral and administrative — — — — — (7,458) (7,458)\n\nOperating income/(loss) $ 67,656 $ 41,790 $ 27,082 $ 12,454 $ 13,062 $ (38,828) $ 123,216\n\n**2023**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 162,560 $ 94,294 $ 72,559 $ 24,257 $ 29,615 $ — $ 383,285\n\nCost of sales (92,394) (54,101) (39,787) (11,542) (16,313) — (214,137)\n\nResearch and development — — — — — (29,915) (29,915)\n\nSelling and marketing (9,658) (4,095) (2,444) (827) (1,236) — (18,260)\n\nGeneral and administrative — — — — — (6,672) (6,672)\n\nOperating income/(loss) $ 60,508 $ 36,098 $ 30,328 $ 11,888 $ 12,066 $ (36,587) $ 114,301\n\nApple Inc. | 2025 Form 10-K | 47"],"full_content":"**Note 13 – Segment Information and Geographic Data**\n\nThe Company manages its business primarily on a geographic basis. The Company’s CEO is its CODM.\n\nThe Company’s reportable segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. Americas includes both North and South America. Europe includes European countries, as well as India, the Middle East and Africa. Greater China includes China mainland, Hong Kong and Taiwan. Rest of Asia Pacific includes Australia, New Zealand and those Asian countries not included in the Company’s other reportable segments. Although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the Company’s customers and distribution partners and the unique market dynamics of each geographic region.\n\nThe CODM uses segment net sales and operating income information to make certain decisions, such as product and service pricing, and to decide how to allocate resources related to sales activities and marketing investments. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment consists of net sales to third parties, related cost of sales, and operating expenses directly attributable to the segment. The information provided to the CODM for purposes of making decisions and assessing segment performance excludes asset information.\n\nThe following tables show information by reportable segment for 2025, 2024 and 2023 (in millions):\n\n**2025**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 178,353 $ 111,032 $ 64,377 $ 28,703 $ 33,696 $ — $ 416,161\n\nCost of sales (95,699) (58,617) (35,141) (13,779) (17,724) — (220,960)\n\nResearch and development — — — — — (34,550) (34,550)\n\nSelling and marketing (10,174) (4,676) (2,319) (969) (1,386) — (19,524)\n\nGeneral and administrative — — — — — (8,077) (8,077)\n\nOperating income/(loss) $ 72,480 $ 47,739 $ 26,917 $ 13,955 $ 14,586 $ (42,627) $ 133,050\n\n**2024**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 167,045 $ 101,328 $ 66,952 $ 25,052 $ 30,658 $ — $ 391,035\n\nCost of sales (89,587) (55,197) (37,519) (11,744) (16,305) — (210,352)\n\nResearch and development — — — — — (31,370) (31,370)\n\nSelling and marketing (9,802) (4,341) (2,351) (854) (1,291) — (18,639)\n\nGeneral and administrative — — — — — (7,458) (7,458)\n\nOperating income/(loss) $ 67,656 $ 41,790 $ 27,082 $ 12,454 $ 13,062 $ (38,828) $ 123,216\n\n**2023**\n\n**Americas Europe**\n\n**Greater China Japan**\n\n**Rest of**\n\n**Asia Pacific Corporate Total**\n\nNet sales $ 162,560 $ 94,294 $ 72,559 $ 24,257 $ 29,615 $ — $ 383,285\n\nCost of sales (92,394) (54,101) (39,787) (11,542) (16,313) — (214,137)\n\nResearch and development — — — — — (29,915) (29,915)\n\nSelling and marketing (9,658) (4,095) (2,444) (827) (1,236) — (18,260)\n\nGeneral and administrative — — — — — (6,672) (6,672)\n\nOperating income/(loss) $ 60,508 $ 36,098 $ 30,328 $ 11,888 $ 12,066 $ (36,587) $ 114,301\n\nApple Inc. | 2025 Form 10-K | 47","publish_date":null,"title":"Note 13 – Segment Information and Geographic Data The Company manages its business primarily on a geographic basis. The Company’s","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page50.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page50.pdf"},"request":{"example_id":"table/Apple 10-k_page50","product_type":"parse","source_file_path":"Apple 10-k_page50.pdf"},"started_at":"2026-11-04T19:47:51.017804"} +{"completed_at":"2026-11-04T19:47:53.382662","latency_in_ms":1287,"output":{"example_id":"table/Apple 10-k_page51","grounded_pages":[],"layout_pages":[],"markdown":"The following tables show net sales for 2025, 2024 and 2023 and long-lived assets as of September 27, 2025 and September 28, 2024 for countries that individually accounted for 10% or more of the respective totals, as well as aggregate amounts for the remaining countries (in millions):\n\n**2025 2024 2023**\n\nNet sales:\n\nU.S. $ 151,790 $ 142,196 $ 138,573\n\nChina (1) 64,377 66,952 72,559\n\nOther countries 199,994 181,887 172,153\n\nTotal net sales $ 416,161 $ 391,035 $ 383,285\n\n**2025 2024**\n\nLong-lived assets:\n\nU.S. $ 40,274 $ 35,664\n\nChina (1) 3,617 4,797\n\nOther countries 5,943 5,219\n\nTotal long-lived assets $ 49,834 $ 45,680\n\n(1) China includes Hong Kong and Taiwan.\n\nApple Inc. | 2025 Form 10-K | 48","pages":[{"line_numbers":[],"markdown":"The following tables show net sales for 2025, 2024 and 2023 and long-lived assets as of September 27, 2025 and September 28, 2024 for countries that individually accounted for 10% or more of the respective totals, as well as aggregate amounts for the remaining countries (in millions):\n\n**2025 2024 2023**\n\nNet sales:\n\nU.S. $ 151,790 $ 142,196 $ 138,573\n\nChina (1) 64,377 66,952 72,559\n\nOther countries 199,994 181,887 172,153\n\nTotal net sales $ 416,161 $ 391,035 $ 383,285\n\n**2025 2024**\n\nLong-lived assets:\n\nU.S. $ 40,274 $ 35,664\n\nChina (1) 3,617 4,797\n\nOther countries 5,943 5,219\n\nTotal long-lived assets $ 49,834 $ 45,680\n\n(1) China includes Hong Kong and Taiwan.\n\nApple Inc. | 2025 Form 10-K | 48","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"The following tables show net sales for 2025, 2024 and 2023 and long-lived assets as of September 27, 2025 and September 28, 2024 for countries that individually accounted for 10% or more of the respective totals, as well as aggregate amounts for the remaining countries (in millions):\n\n**2025 2024 2023**\n\nNet sales:\n\nU.S. $ 151,790 $ 142,196 $ 138,573\n\nChina (1) 64,377 66,952 72,559\n\nOther countries 199,994 181,887 172,153\n\nTotal net sales $ 416,161 $ 391,035 $ 383,285\n\n**2025 2024**\n\nLong-lived assets:\n\nU.S. $ 40,274 $ 35,664\n\nChina (1) 3,617 4,797\n\nOther countries 5,943 5,219\n\nTotal long-lived assets $ 49,834 $ 45,680\n\n(1) China includes Hong Kong and Taiwan.\n\nApple Inc. | 2025 Form 10-K | 48","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page51.pdf"]},"response":{"errors":[],"extract_id":"extract_40da74155978e1c4b5beaa6a4caadfc7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["The following tables show net sales for 2025, 2024 and 2023 and long-lived assets as of September 27, 2025 and September 28, 2024 for countries that individually accounted for 10% or more of the respective totals, as well as aggregate amounts for the remaining countries (in millions):\n\n**2025 2024 2023**\n\nNet sales:\n\nU.S. $ 151,790 $ 142,196 $ 138,573\n\nChina (1) 64,377 66,952 72,559\n\nOther countries 199,994 181,887 172,153\n\nTotal net sales $ 416,161 $ 391,035 $ 383,285\n\n**2025 2024**\n\nLong-lived assets:\n\nU.S. $ 40,274 $ 35,664\n\nChina (1) 3,617 4,797\n\nOther countries 5,943 5,219\n\nTotal long-lived assets $ 49,834 $ 45,680\n\n(1) China includes Hong Kong and Taiwan.\n\nApple Inc. | 2025 Form 10-K | 48"],"full_content":"The following tables show net sales for 2025, 2024 and 2023 and long-lived assets as of September 27, 2025 and September 28, 2024 for countries that individually accounted for 10% or more of the respective totals, as well as aggregate amounts for the remaining countries (in millions):\n\n**2025 2024 2023**\n\nNet sales:\n\nU.S. $ 151,790 $ 142,196 $ 138,573\n\nChina (1) 64,377 66,952 72,559\n\nOther countries 199,994 181,887 172,153\n\nTotal net sales $ 416,161 $ 391,035 $ 383,285\n\n**2025 2024**\n\nLong-lived assets:\n\nU.S. $ 40,274 $ 35,664\n\nChina (1) 3,617 4,797\n\nOther countries 5,943 5,219\n\nTotal long-lived assets $ 49,834 $ 45,680\n\n(1) China includes Hong Kong and Taiwan.\n\nApple Inc. | 2025 Form 10-K | 48","publish_date":null,"title":"The following tables show net sales for 2025, 2024 and 2023 and long-lived assets as of September 27, 2025 and","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page51.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page51.pdf"},"request":{"example_id":"table/Apple 10-k_page51","product_type":"parse","source_file_path":"Apple 10-k_page51.pdf"},"started_at":"2026-11-04T19:47:52.094801"} +{"completed_at":"2026-11-04T19:47:53.942202","latency_in_ms":1070,"output":{"example_id":"table/Apple 10-k_page57","grounded_pages":[],"layout_pages":[],"markdown":"**PART IV**\n\n**Item 15. Exhibit and Financial Statement Schedules**\n\n**(a) Documents filed as part of this report**\n\n**(1) All financial statements**\n\n**Index to Consolidated Financial Statements Page**\n\nConsolidated Statements of Operations for the years ended September 27, 2025, September 28, 2024 and\n\nSeptember 30, 2023 29\n\nConsolidated Statements of Comprehensive Income for the years ended September 27, 2025, September 28,\n\n2024 and September 30, 2023 30\n\nConsolidated Balance Sheets as of September 27, 2025 and September 28, 2024 31\n\nConsolidated Statements of Shareholders’ Equity for the years ended September 27, 2025, September 28, 2024\n\nand September 30, 2023 32\n\nConsolidated Statements of Cash Flows for the years ended September 27, 2025, September 28, 2024 and\n\nSeptember 30, 2023 33\n\nNotes to Consolidated Financial Statements 34\n\nReports of Independent Registered Public Accounting Firm\\* 49\n\n\\* Ernst & Young LLP, PCAOB Firm ID No. 00042.\n\n**(2) Financial Statement Schedules**\n\nAll financial statement schedules have been omitted, since the required information is not applicable or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements and accompanying notes included in this Form 10-K.\n\n**(3) Exhibits required by Item 601 of Regulation S-K** **(1)**\n\n**Incorporated by Reference**\n\n**Exhibit Number Exhibit Description Form Exhibit**\n\n**Filing Date/ Period End Date**\n\n3\\.1 Restated Articles of Incorporation of the Registrant filed on August 3, 2020. 8-K 3.1 8/7/20\n\n3\\.2 Amended and Restated Bylaws of the Registrant effective as of August 20, 2024. 8-K 3.2 8/23/24\n\n4\\.1\\*\\* Description of Securities of the Registrant.\n\n4\\.2 Indenture, dated as of April 29, 2013, between the Registrant and The Bank of\n\nNew York Mellon Trust Company, N.A., as Trustee.\n\nS-3 4.1 4/29/13\n\n4\\.3 Officer’s Certificate of the Registrant, dated as of May 3, 2013, including forms of\n\nglobal notes representing the Floating Rate Notes due 2016, Floating Rate Notes due 2018, 0.45% Notes due 2016, 1.00% Notes due 2018, 2.40% Notes due 2023 and 3.85% Notes due 2043.\n\n8-K 4.1 5/3/13\n\n4\\.4 Officer’s Certificate of the Registrant, dated as of May 6, 2014, including forms of\n\nglobal notes representing the Floating Rate Notes due 2017, Floating Rate Notes due 2019, 1.05% Notes due 2017, 2.10% Notes due 2019, 2.85% Notes due 2021, 3.45% Notes due 2024 and 4.45% Notes due 2044.\n\n8-K 4.1 5/6/14\n\n4\\.5 Officer’s Certificate of the Registrant, dated as of November 10, 2014, including\n\nforms of global notes representing the 1.000% Notes due 2022 and 1.625% Notes due 2026.\n\n8-K 4.1 11/10/14\n\n4\\.6 Officer’s Certificate of the Registrant, dated as of February 9, 2015, including\n\nforms of global notes representing the Floating Rate Notes due 2020, 1.55% Notes due 2020, 2.15% Notes due 2022, 2.50% Notes due 2025 and 3.45% Notes due 2045.\n\n8-K 4.1 2/9/15\n\n4\\.7 Officer’s Certificate of the Registrant, dated as of May 13, 2015, including forms\n\nof global notes representing the Floating Rate Notes due 2017, Floating Rate Notes due 2020, 0.900% Notes due 2017, 2.000% Notes due 2020, 2.700% Notes due 2022, 3.200% Notes due 2025, and 4.375% Notes due 2045.\n\n8-K 4.1 5/13/15\n\n4\\.8 Officer’s Certificate of the Registrant, dated as of July 31, 2015, including forms\n\nof global notes representing the 3.05% Notes due 2029 and 3.60% Notes due 2042.\n\n8-K 4.1 7/31/15\n\nApple Inc. | 2025 Form 10-K | 54","pages":[{"line_numbers":[],"markdown":"**PART IV**\n\n**Item 15. Exhibit and Financial Statement Schedules**\n\n**(a) Documents filed as part of this report**\n\n**(1) All financial statements**\n\n**Index to Consolidated Financial Statements Page**\n\nConsolidated Statements of Operations for the years ended September 27, 2025, September 28, 2024 and\n\nSeptember 30, 2023 29\n\nConsolidated Statements of Comprehensive Income for the years ended September 27, 2025, September 28,\n\n2024 and September 30, 2023 30\n\nConsolidated Balance Sheets as of September 27, 2025 and September 28, 2024 31\n\nConsolidated Statements of Shareholders’ Equity for the years ended September 27, 2025, September 28, 2024\n\nand September 30, 2023 32\n\nConsolidated Statements of Cash Flows for the years ended September 27, 2025, September 28, 2024 and\n\nSeptember 30, 2023 33\n\nNotes to Consolidated Financial Statements 34\n\nReports of Independent Registered Public Accounting Firm\\* 49\n\n\\* Ernst & Young LLP, PCAOB Firm ID No. 00042.\n\n**(2) Financial Statement Schedules**\n\nAll financial statement schedules have been omitted, since the required information is not applicable or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements and accompanying notes included in this Form 10-K.\n\n**(3) Exhibits required by Item 601 of Regulation S-K** **(1)**\n\n**Incorporated by Reference**\n\n**Exhibit Number Exhibit Description Form Exhibit**\n\n**Filing Date/ Period End Date**\n\n3\\.1 Restated Articles of Incorporation of the Registrant filed on August 3, 2020. 8-K 3.1 8/7/20\n\n3\\.2 Amended and Restated Bylaws of the Registrant effective as of August 20, 2024. 8-K 3.2 8/23/24\n\n4\\.1\\*\\* Description of Securities of the Registrant.\n\n4\\.2 Indenture, dated as of April 29, 2013, between the Registrant and The Bank of\n\nNew York Mellon Trust Company, N.A., as Trustee.\n\nS-3 4.1 4/29/13\n\n4\\.3 Officer’s Certificate of the Registrant, dated as of May 3, 2013, including forms of\n\nglobal notes representing the Floating Rate Notes due 2016, Floating Rate Notes due 2018, 0.45% Notes due 2016, 1.00% Notes due 2018, 2.40% Notes due 2023 and 3.85% Notes due 2043.\n\n8-K 4.1 5/3/13\n\n4\\.4 Officer’s Certificate of the Registrant, dated as of May 6, 2014, including forms of\n\nglobal notes representing the Floating Rate Notes due 2017, Floating Rate Notes due 2019, 1.05% Notes due 2017, 2.10% Notes due 2019, 2.85% Notes due 2021, 3.45% Notes due 2024 and 4.45% Notes due 2044.\n\n8-K 4.1 5/6/14\n\n4\\.5 Officer’s Certificate of the Registrant, dated as of November 10, 2014, including\n\nforms of global notes representing the 1.000% Notes due 2022 and 1.625% Notes due 2026.\n\n8-K 4.1 11/10/14\n\n4\\.6 Officer’s Certificate of the Registrant, dated as of February 9, 2015, including\n\nforms of global notes representing the Floating Rate Notes due 2020, 1.55% Notes due 2020, 2.15% Notes due 2022, 2.50% Notes due 2025 and 3.45% Notes due 2045.\n\n8-K 4.1 2/9/15\n\n4\\.7 Officer’s Certificate of the Registrant, dated as of May 13, 2015, including forms\n\nof global notes representing the Floating Rate Notes due 2017, Floating Rate Notes due 2020, 0.900% Notes due 2017, 2.000% Notes due 2020, 2.700% Notes due 2022, 3.200% Notes due 2025, and 4.375% Notes due 2045.\n\n8-K 4.1 5/13/15\n\n4\\.8 Officer’s Certificate of the Registrant, dated as of July 31, 2015, including forms\n\nof global notes representing the 3.05% Notes due 2029 and 3.60% Notes due 2042.\n\n8-K 4.1 7/31/15\n\nApple Inc. | 2025 Form 10-K | 54","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**PART IV**\n\n**Item 15. Exhibit and Financial Statement Schedules**\n\n**(a) Documents filed as part of this report**\n\n**(1) All financial statements**\n\n**Index to Consolidated Financial Statements Page**\n\nConsolidated Statements of Operations for the years ended September 27, 2025, September 28, 2024 and\n\nSeptember 30, 2023 29\n\nConsolidated Statements of Comprehensive Income for the years ended September 27, 2025, September 28,\n\n2024 and September 30, 2023 30\n\nConsolidated Balance Sheets as of September 27, 2025 and September 28, 2024 31\n\nConsolidated Statements of Shareholders’ Equity for the years ended September 27, 2025, September 28, 2024\n\nand September 30, 2023 32\n\nConsolidated Statements of Cash Flows for the years ended September 27, 2025, September 28, 2024 and\n\nSeptember 30, 2023 33\n\nNotes to Consolidated Financial Statements 34\n\nReports of Independent Registered Public Accounting Firm\\* 49\n\n\\* Ernst & Young LLP, PCAOB Firm ID No. 00042.\n\n**(2) Financial Statement Schedules**\n\nAll financial statement schedules have been omitted, since the required information is not applicable or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements and accompanying notes included in this Form 10-K.\n\n**(3) Exhibits required by Item 601 of Regulation S-K** **(1)**\n\n**Incorporated by Reference**\n\n**Exhibit Number Exhibit Description Form Exhibit**\n\n**Filing Date/ Period End Date**\n\n3\\.1 Restated Articles of Incorporation of the Registrant filed on August 3, 2020. 8-K 3.1 8/7/20\n\n3\\.2 Amended and Restated Bylaws of the Registrant effective as of August 20, 2024. 8-K 3.2 8/23/24\n\n4\\.1\\*\\* Description of Securities of the Registrant.\n\n4\\.2 Indenture, dated as of April 29, 2013, between the Registrant and The Bank of\n\nNew York Mellon Trust Company, N.A., as Trustee.\n\nS-3 4.1 4/29/13\n\n4\\.3 Officer’s Certificate of the Registrant, dated as of May 3, 2013, including forms of\n\nglobal notes representing the Floating Rate Notes due 2016, Floating Rate Notes due 2018, 0.45% Notes due 2016, 1.00% Notes due 2018, 2.40% Notes due 2023 and 3.85% Notes due 2043.\n\n8-K 4.1 5/3/13\n\n4\\.4 Officer’s Certificate of the Registrant, dated as of May 6, 2014, including forms of\n\nglobal notes representing the Floating Rate Notes due 2017, Floating Rate Notes due 2019, 1.05% Notes due 2017, 2.10% Notes due 2019, 2.85% Notes due 2021, 3.45% Notes due 2024 and 4.45% Notes due 2044.\n\n8-K 4.1 5/6/14\n\n4\\.5 Officer’s Certificate of the Registrant, dated as of November 10, 2014, including\n\nforms of global notes representing the 1.000% Notes due 2022 and 1.625% Notes due 2026.\n\n8-K 4.1 11/10/14\n\n4\\.6 Officer’s Certificate of the Registrant, dated as of February 9, 2015, including\n\nforms of global notes representing the Floating Rate Notes due 2020, 1.55% Notes due 2020, 2.15% Notes due 2022, 2.50% Notes due 2025 and 3.45% Notes due 2045.\n\n8-K 4.1 2/9/15\n\n4\\.7 Officer’s Certificate of the Registrant, dated as of May 13, 2015, including forms\n\nof global notes representing the Floating Rate Notes due 2017, Floating Rate Notes due 2020, 0.900% Notes due 2017, 2.000% Notes due 2020, 2.700% Notes due 2022, 3.200% Notes due 2025, and 4.375% Notes due 2045.\n\n8-K 4.1 5/13/15\n\n4\\.8 Officer’s Certificate of the Registrant, dated as of July 31, 2015, including forms\n\nof global notes representing the 3.05% Notes due 2029 and 3.60% Notes due 2042.\n\n8-K 4.1 7/31/15\n\nApple Inc. | 2025 Form 10-K | 54","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page57.pdf"]},"response":{"errors":[],"extract_id":"extract_a7b7c0efe47fa6eceac924893af06ae8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**PART IV**\n\n**Item 15. Exhibit and Financial Statement Schedules**\n\n**(a) Documents filed as part of this report**\n\n**(1) All financial statements**\n\n**Index to Consolidated Financial Statements Page**\n\nConsolidated Statements of Operations for the years ended September 27, 2025, September 28, 2024 and\n\nSeptember 30, 2023 29\n\nConsolidated Statements of Comprehensive Income for the years ended September 27, 2025, September 28,\n\n2024 and September 30, 2023 30\n\nConsolidated Balance Sheets as of September 27, 2025 and September 28, 2024 31\n\nConsolidated Statements of Shareholders’ Equity for the years ended September 27, 2025, September 28, 2024\n\nand September 30, 2023 32\n\nConsolidated Statements of Cash Flows for the years ended September 27, 2025, September 28, 2024 and\n\nSeptember 30, 2023 33\n\nNotes to Consolidated Financial Statements 34\n\nReports of Independent Registered Public Accounting Firm\\* 49\n\n\\* Ernst & Young LLP, PCAOB Firm ID No. 00042.\n\n**(2) Financial Statement Schedules**\n\nAll financial statement schedules have been omitted, since the required information is not applicable or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements and accompanying notes included in this Form 10-K.\n\n**(3) Exhibits required by Item 601 of Regulation S-K** **(1)**\n\n**Incorporated by Reference**\n\n**Exhibit Number Exhibit Description Form Exhibit**\n\n**Filing Date/ Period End Date**\n\n3\\.1 Restated Articles of Incorporation of the Registrant filed on August 3, 2020. 8-K 3.1 8/7/20\n\n3\\.2 Amended and Restated Bylaws of the Registrant effective as of August 20, 2024. 8-K 3.2 8/23/24\n\n4\\.1\\*\\* Description of Securities of the Registrant.\n\n4\\.2 Indenture, dated as of April 29, 2013, between the Registrant and The Bank of\n\nNew York Mellon Trust Company, N.A., as Trustee.\n\nS-3 4.1 4/29/13\n\n4\\.3 Officer’s Certificate of the Registrant, dated as of May 3, 2013, including forms of\n\nglobal notes representing the Floating Rate Notes due 2016, Floating Rate Notes due 2018, 0.45% Notes due 2016, 1.00% Notes due 2018, 2.40% Notes due 2023 and 3.85% Notes due 2043.\n\n8-K 4.1 5/3/13\n\n4\\.4 Officer’s Certificate of the Registrant, dated as of May 6, 2014, including forms of\n\nglobal notes representing the Floating Rate Notes due 2017, Floating Rate Notes due 2019, 1.05% Notes due 2017, 2.10% Notes due 2019, 2.85% Notes due 2021, 3.45% Notes due 2024 and 4.45% Notes due 2044.\n\n8-K 4.1 5/6/14\n\n4\\.5 Officer’s Certificate of the Registrant, dated as of November 10, 2014, including\n\nforms of global notes representing the 1.000% Notes due 2022 and 1.625% Notes due 2026.\n\n8-K 4.1 11/10/14\n\n4\\.6 Officer’s Certificate of the Registrant, dated as of February 9, 2015, including\n\nforms of global notes representing the Floating Rate Notes due 2020, 1.55% Notes due 2020, 2.15% Notes due 2022, 2.50% Notes due 2025 and 3.45% Notes due 2045.\n\n8-K 4.1 2/9/15\n\n4\\.7 Officer’s Certificate of the Registrant, dated as of May 13, 2015, including forms\n\nof global notes representing the Floating Rate Notes due 2017, Floating Rate Notes due 2020, 0.900% Notes due 2017, 2.000% Notes due 2020, 2.700% Notes due 2022, 3.200% Notes due 2025, and 4.375% Notes due 2045.\n\n8-K 4.1 5/13/15\n\n4\\.8 Officer’s Certificate of the Registrant, dated as of July 31, 2015, including forms\n\nof global notes representing the 3.05% Notes due 2029 and 3.60% Notes due 2042.\n\n8-K 4.1 7/31/15\n\nApple Inc. | 2025 Form 10-K | 54"],"full_content":"**PART IV**\n\n**Item 15. Exhibit and Financial Statement Schedules**\n\n**(a) Documents filed as part of this report**\n\n**(1) All financial statements**\n\n**Index to Consolidated Financial Statements Page**\n\nConsolidated Statements of Operations for the years ended September 27, 2025, September 28, 2024 and\n\nSeptember 30, 2023 29\n\nConsolidated Statements of Comprehensive Income for the years ended September 27, 2025, September 28,\n\n2024 and September 30, 2023 30\n\nConsolidated Balance Sheets as of September 27, 2025 and September 28, 2024 31\n\nConsolidated Statements of Shareholders’ Equity for the years ended September 27, 2025, September 28, 2024\n\nand September 30, 2023 32\n\nConsolidated Statements of Cash Flows for the years ended September 27, 2025, September 28, 2024 and\n\nSeptember 30, 2023 33\n\nNotes to Consolidated Financial Statements 34\n\nReports of Independent Registered Public Accounting Firm\\* 49\n\n\\* Ernst & Young LLP, PCAOB Firm ID No. 00042.\n\n**(2) Financial Statement Schedules**\n\nAll financial statement schedules have been omitted, since the required information is not applicable or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements and accompanying notes included in this Form 10-K.\n\n**(3) Exhibits required by Item 601 of Regulation S-K** **(1)**\n\n**Incorporated by Reference**\n\n**Exhibit Number Exhibit Description Form Exhibit**\n\n**Filing Date/ Period End Date**\n\n3\\.1 Restated Articles of Incorporation of the Registrant filed on August 3, 2020. 8-K 3.1 8/7/20\n\n3\\.2 Amended and Restated Bylaws of the Registrant effective as of August 20, 2024. 8-K 3.2 8/23/24\n\n4\\.1\\*\\* Description of Securities of the Registrant.\n\n4\\.2 Indenture, dated as of April 29, 2013, between the Registrant and The Bank of\n\nNew York Mellon Trust Company, N.A., as Trustee.\n\nS-3 4.1 4/29/13\n\n4\\.3 Officer’s Certificate of the Registrant, dated as of May 3, 2013, including forms of\n\nglobal notes representing the Floating Rate Notes due 2016, Floating Rate Notes due 2018, 0.45% Notes due 2016, 1.00% Notes due 2018, 2.40% Notes due 2023 and 3.85% Notes due 2043.\n\n8-K 4.1 5/3/13\n\n4\\.4 Officer’s Certificate of the Registrant, dated as of May 6, 2014, including forms of\n\nglobal notes representing the Floating Rate Notes due 2017, Floating Rate Notes due 2019, 1.05% Notes due 2017, 2.10% Notes due 2019, 2.85% Notes due 2021, 3.45% Notes due 2024 and 4.45% Notes due 2044.\n\n8-K 4.1 5/6/14\n\n4\\.5 Officer’s Certificate of the Registrant, dated as of November 10, 2014, including\n\nforms of global notes representing the 1.000% Notes due 2022 and 1.625% Notes due 2026.\n\n8-K 4.1 11/10/14\n\n4\\.6 Officer’s Certificate of the Registrant, dated as of February 9, 2015, including\n\nforms of global notes representing the Floating Rate Notes due 2020, 1.55% Notes due 2020, 2.15% Notes due 2022, 2.50% Notes due 2025 and 3.45% Notes due 2045.\n\n8-K 4.1 2/9/15\n\n4\\.7 Officer’s Certificate of the Registrant, dated as of May 13, 2015, including forms\n\nof global notes representing the Floating Rate Notes due 2017, Floating Rate Notes due 2020, 0.900% Notes due 2017, 2.000% Notes due 2020, 2.700% Notes due 2022, 3.200% Notes due 2025, and 4.375% Notes due 2045.\n\n8-K 4.1 5/13/15\n\n4\\.8 Officer’s Certificate of the Registrant, dated as of July 31, 2015, including forms\n\nof global notes representing the 3.05% Notes due 2029 and 3.60% Notes due 2042.\n\n8-K 4.1 7/31/15\n\nApple Inc. | 2025 Form 10-K | 54","publish_date":null,"title":"PART IV Item 15. Exhibit and Financial Statement Schedules (a) Documents filed as part of this report (1) All financial","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page57.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page57.pdf"},"request":{"example_id":"table/Apple 10-k_page57","product_type":"parse","source_file_path":"Apple 10-k_page57.pdf"},"started_at":"2026-11-04T19:47:52.871588"} +{"completed_at":"2026-11-04T19:47:55.639265","latency_in_ms":1337,"output":{"example_id":"table/Apple 10-k_page59","grounded_pages":[],"layout_pages":[],"markdown":"**Incorporated by Reference**\n\n**Exhibit Number Exhibit Description Form Exhibit**\n\n**Filing Date/ Period End Date**\n\n4\\.26 Indenture, dated as of October 28, 2021, between the Registrant and The Bank\n\nof New York Mellon Trust Company, N.A., as Trustee.\n\nS-3 4.1 10/29/21\n\n4\\.27 Officer’s Certificate of the Registrant, dated as of August 8, 2022, including forms\n\nof global notes representing the 3.250% Notes due 2029, 3.350% Notes due 2032, 3.950% Notes due 2052 and 4.100% Notes due 2062.\n\n8-K 4.1 8/8/22\n\n4\\.28 Officer’s Certificate of the Registrant, dated as of May 10, 2023, including forms\n\nof global notes representing the 4.421% Notes due 2026, 4.000% Notes due 2028, 4.150% Notes due 2030, 4.300% Notes due 2033 and 4.850% Notes due 2053.\n\n8-K 4.1 5/10/23\n\n4\\.29 Officer’s Certificate of the Registrant, dated as of May 12, 2025, including forms\n\nof global notes representing the 4.000% Notes due 2028, 4.200% Notes due 2030, 4.500% Notes due 2032 and 4.750% Notes due 2035.\n\n8-K 4.1 5/12/25\n\n4\\.30\\* Apple Inc. Deferred Compensation Plan. S-8 4.1 8/23/18\n\n10\\.1\\* Apple Inc. Employee Stock Purchase Plan, as amended as of November 6, 2024. 10-Q 10.1 12/28/24\n\n10\\.2\\* Form of Indemnification Agreement between the Registrant and each director\n\nand executive officer of the Registrant.\n\n10-Q 10.2 6/27/09\n\n10\\.3\\* Apple Inc. Non-Employee Director Stock Plan, as amended November 6, 2024. 10-Q 10.2 12/28/24\n\n10\\.4\\* Apple Inc. 2014 Employee Stock Plan, as amended and restated as of October 1,\n\n2017\\.\n\n10-K 10.8 9/30/17\n\n10\\.5\\* Form of Restricted Stock Unit Award Agreement under 2014 Employee Stock\n\nPlan effective as of August 18, 2020.\n\n10-K 10.16 9/26/20\n\n10\\.6\\* Apple Inc. 2022 Employee Stock Plan. 8-K 10.1 3/4/22\n\n10\\.7\\* Form of Restricted Stock Unit Award Agreement under 2022 Employee Stock\n\nPlan effective as of March 4, 2022.\n\n8-K 10.2 3/4/22\n\n10\\.8\\* Form of Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of March 4, 2022.\n\n8-K 10.3 3/4/22\n\n10\\.9\\* Apple Inc. Executive Cash Incentive Plan. 8-K 10.1 8/19/22\n\n10\\.10\\* Form of CEO Restricted Stock Unit Award Agreement under 2022 Employee\n\nStock Plan effective as of September 25, 2022.\n\n10-Q 10.1 12/31/22\n\n10\\.11\\* Form of CEO Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 25, 2022.\n\n10-Q 10.2 12/31/22\n\n10\\.12\\* Form of Restricted Stock Unit Award Agreement under 2022 Employee Stock\n\nPlan effective as of September 29, 2024.\n\n10-K 10.19 9/28/24\n\n10\\.13\\* Form of Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 29, 2024.\n\n10-K 10.20 9/28/24\n\n10\\.14\\* Form of CEO Restricted Stock Unit Award Agreement under 2022 Employee\n\nStock Plan effective as of September 29, 2024.\n\n10-K 10.21 9/28/24\n\n10\\.15\\* Form of CEO Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 29, 2024.\n\n10-K 10.22 9/28/24\n\n19\\.1 Insider Trading Policy. 10-K 19.1 9/28/24\n\n21\\.1\\*\\* Subsidiaries of the Registrant.\n\n23\\.1\\*\\* Consent of Independent Registered Public Accounting Firm.\n\n24\\.1\\*\\* Power of Attorney (included on the Signatures page of this Annual Report on\n\nForm 10-K).\n\n31\\.1\\*\\* Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.\n\n31\\.2\\*\\* Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.\n\n32\\.1\\*\\*\\* Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer.\n\n97\\.1\\* Rule 10D-1 Recovery Policy 10-K 97.1 9/28/24\n\nApple Inc. | 2025 Form 10-K | 56","pages":[{"line_numbers":[],"markdown":"**Incorporated by Reference**\n\n**Exhibit Number Exhibit Description Form Exhibit**\n\n**Filing Date/ Period End Date**\n\n4\\.26 Indenture, dated as of October 28, 2021, between the Registrant and The Bank\n\nof New York Mellon Trust Company, N.A., as Trustee.\n\nS-3 4.1 10/29/21\n\n4\\.27 Officer’s Certificate of the Registrant, dated as of August 8, 2022, including forms\n\nof global notes representing the 3.250% Notes due 2029, 3.350% Notes due 2032, 3.950% Notes due 2052 and 4.100% Notes due 2062.\n\n8-K 4.1 8/8/22\n\n4\\.28 Officer’s Certificate of the Registrant, dated as of May 10, 2023, including forms\n\nof global notes representing the 4.421% Notes due 2026, 4.000% Notes due 2028, 4.150% Notes due 2030, 4.300% Notes due 2033 and 4.850% Notes due 2053.\n\n8-K 4.1 5/10/23\n\n4\\.29 Officer’s Certificate of the Registrant, dated as of May 12, 2025, including forms\n\nof global notes representing the 4.000% Notes due 2028, 4.200% Notes due 2030, 4.500% Notes due 2032 and 4.750% Notes due 2035.\n\n8-K 4.1 5/12/25\n\n4\\.30\\* Apple Inc. Deferred Compensation Plan. S-8 4.1 8/23/18\n\n10\\.1\\* Apple Inc. Employee Stock Purchase Plan, as amended as of November 6, 2024. 10-Q 10.1 12/28/24\n\n10\\.2\\* Form of Indemnification Agreement between the Registrant and each director\n\nand executive officer of the Registrant.\n\n10-Q 10.2 6/27/09\n\n10\\.3\\* Apple Inc. Non-Employee Director Stock Plan, as amended November 6, 2024. 10-Q 10.2 12/28/24\n\n10\\.4\\* Apple Inc. 2014 Employee Stock Plan, as amended and restated as of October 1,\n\n2017\\.\n\n10-K 10.8 9/30/17\n\n10\\.5\\* Form of Restricted Stock Unit Award Agreement under 2014 Employee Stock\n\nPlan effective as of August 18, 2020.\n\n10-K 10.16 9/26/20\n\n10\\.6\\* Apple Inc. 2022 Employee Stock Plan. 8-K 10.1 3/4/22\n\n10\\.7\\* Form of Restricted Stock Unit Award Agreement under 2022 Employee Stock\n\nPlan effective as of March 4, 2022.\n\n8-K 10.2 3/4/22\n\n10\\.8\\* Form of Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of March 4, 2022.\n\n8-K 10.3 3/4/22\n\n10\\.9\\* Apple Inc. Executive Cash Incentive Plan. 8-K 10.1 8/19/22\n\n10\\.10\\* Form of CEO Restricted Stock Unit Award Agreement under 2022 Employee\n\nStock Plan effective as of September 25, 2022.\n\n10-Q 10.1 12/31/22\n\n10\\.11\\* Form of CEO Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 25, 2022.\n\n10-Q 10.2 12/31/22\n\n10\\.12\\* Form of Restricted Stock Unit Award Agreement under 2022 Employee Stock\n\nPlan effective as of September 29, 2024.\n\n10-K 10.19 9/28/24\n\n10\\.13\\* Form of Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 29, 2024.\n\n10-K 10.20 9/28/24\n\n10\\.14\\* Form of CEO Restricted Stock Unit Award Agreement under 2022 Employee\n\nStock Plan effective as of September 29, 2024.\n\n10-K 10.21 9/28/24\n\n10\\.15\\* Form of CEO Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 29, 2024.\n\n10-K 10.22 9/28/24\n\n19\\.1 Insider Trading Policy. 10-K 19.1 9/28/24\n\n21\\.1\\*\\* Subsidiaries of the Registrant.\n\n23\\.1\\*\\* Consent of Independent Registered Public Accounting Firm.\n\n24\\.1\\*\\* Power of Attorney (included on the Signatures page of this Annual Report on\n\nForm 10-K).\n\n31\\.1\\*\\* Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.\n\n31\\.2\\*\\* Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.\n\n32\\.1\\*\\*\\* Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer.\n\n97\\.1\\* Rule 10D-1 Recovery Policy 10-K 97.1 9/28/24\n\nApple Inc. | 2025 Form 10-K | 56","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Incorporated by Reference**\n\n**Exhibit Number Exhibit Description Form Exhibit**\n\n**Filing Date/ Period End Date**\n\n4\\.26 Indenture, dated as of October 28, 2021, between the Registrant and The Bank\n\nof New York Mellon Trust Company, N.A., as Trustee.\n\nS-3 4.1 10/29/21\n\n4\\.27 Officer’s Certificate of the Registrant, dated as of August 8, 2022, including forms\n\nof global notes representing the 3.250% Notes due 2029, 3.350% Notes due 2032, 3.950% Notes due 2052 and 4.100% Notes due 2062.\n\n8-K 4.1 8/8/22\n\n4\\.28 Officer’s Certificate of the Registrant, dated as of May 10, 2023, including forms\n\nof global notes representing the 4.421% Notes due 2026, 4.000% Notes due 2028, 4.150% Notes due 2030, 4.300% Notes due 2033 and 4.850% Notes due 2053.\n\n8-K 4.1 5/10/23\n\n4\\.29 Officer’s Certificate of the Registrant, dated as of May 12, 2025, including forms\n\nof global notes representing the 4.000% Notes due 2028, 4.200% Notes due 2030, 4.500% Notes due 2032 and 4.750% Notes due 2035.\n\n8-K 4.1 5/12/25\n\n4\\.30\\* Apple Inc. Deferred Compensation Plan. S-8 4.1 8/23/18\n\n10\\.1\\* Apple Inc. Employee Stock Purchase Plan, as amended as of November 6, 2024. 10-Q 10.1 12/28/24\n\n10\\.2\\* Form of Indemnification Agreement between the Registrant and each director\n\nand executive officer of the Registrant.\n\n10-Q 10.2 6/27/09\n\n10\\.3\\* Apple Inc. Non-Employee Director Stock Plan, as amended November 6, 2024. 10-Q 10.2 12/28/24\n\n10\\.4\\* Apple Inc. 2014 Employee Stock Plan, as amended and restated as of October 1,\n\n2017\\.\n\n10-K 10.8 9/30/17\n\n10\\.5\\* Form of Restricted Stock Unit Award Agreement under 2014 Employee Stock\n\nPlan effective as of August 18, 2020.\n\n10-K 10.16 9/26/20\n\n10\\.6\\* Apple Inc. 2022 Employee Stock Plan. 8-K 10.1 3/4/22\n\n10\\.7\\* Form of Restricted Stock Unit Award Agreement under 2022 Employee Stock\n\nPlan effective as of March 4, 2022.\n\n8-K 10.2 3/4/22\n\n10\\.8\\* Form of Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of March 4, 2022.\n\n8-K 10.3 3/4/22\n\n10\\.9\\* Apple Inc. Executive Cash Incentive Plan. 8-K 10.1 8/19/22\n\n10\\.10\\* Form of CEO Restricted Stock Unit Award Agreement under 2022 Employee\n\nStock Plan effective as of September 25, 2022.\n\n10-Q 10.1 12/31/22\n\n10\\.11\\* Form of CEO Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 25, 2022.\n\n10-Q 10.2 12/31/22\n\n10\\.12\\* Form of Restricted Stock Unit Award Agreement under 2022 Employee Stock\n\nPlan effective as of September 29, 2024.\n\n10-K 10.19 9/28/24\n\n10\\.13\\* Form of Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 29, 2024.\n\n10-K 10.20 9/28/24\n\n10\\.14\\* Form of CEO Restricted Stock Unit Award Agreement under 2022 Employee\n\nStock Plan effective as of September 29, 2024.\n\n10-K 10.21 9/28/24\n\n10\\.15\\* Form of CEO Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 29, 2024.\n\n10-K 10.22 9/28/24\n\n19\\.1 Insider Trading Policy. 10-K 19.1 9/28/24\n\n21\\.1\\*\\* Subsidiaries of the Registrant.\n\n23\\.1\\*\\* Consent of Independent Registered Public Accounting Firm.\n\n24\\.1\\*\\* Power of Attorney (included on the Signatures page of this Annual Report on\n\nForm 10-K).\n\n31\\.1\\*\\* Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.\n\n31\\.2\\*\\* Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.\n\n32\\.1\\*\\*\\* Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer.\n\n97\\.1\\* Rule 10D-1 Recovery Policy 10-K 97.1 9/28/24\n\nApple Inc. | 2025 Form 10-K | 56","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page59.pdf"]},"response":{"errors":[],"extract_id":"extract_f6b1356f65892b1aaa802782d75024c4","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Incorporated by Reference**\n\n**Exhibit Number Exhibit Description Form Exhibit**\n\n**Filing Date/ Period End Date**\n\n4\\.26 Indenture, dated as of October 28, 2021, between the Registrant and The Bank\n\nof New York Mellon Trust Company, N.A., as Trustee.\n\nS-3 4.1 10/29/21\n\n4\\.27 Officer’s Certificate of the Registrant, dated as of August 8, 2022, including forms\n\nof global notes representing the 3.250% Notes due 2029, 3.350% Notes due 2032, 3.950% Notes due 2052 and 4.100% Notes due 2062.\n\n8-K 4.1 8/8/22\n\n4\\.28 Officer’s Certificate of the Registrant, dated as of May 10, 2023, including forms\n\nof global notes representing the 4.421% Notes due 2026, 4.000% Notes due 2028, 4.150% Notes due 2030, 4.300% Notes due 2033 and 4.850% Notes due 2053.\n\n8-K 4.1 5/10/23\n\n4\\.29 Officer’s Certificate of the Registrant, dated as of May 12, 2025, including forms\n\nof global notes representing the 4.000% Notes due 2028, 4.200% Notes due 2030, 4.500% Notes due 2032 and 4.750% Notes due 2035.\n\n8-K 4.1 5/12/25\n\n4\\.30\\* Apple Inc. Deferred Compensation Plan. S-8 4.1 8/23/18\n\n10\\.1\\* Apple Inc. Employee Stock Purchase Plan, as amended as of November 6, 2024. 10-Q 10.1 12/28/24\n\n10\\.2\\* Form of Indemnification Agreement between the Registrant and each director\n\nand executive officer of the Registrant.\n\n10-Q 10.2 6/27/09\n\n10\\.3\\* Apple Inc. Non-Employee Director Stock Plan, as amended November 6, 2024. 10-Q 10.2 12/28/24\n\n10\\.4\\* Apple Inc. 2014 Employee Stock Plan, as amended and restated as of October 1,\n\n2017\\.\n\n10-K 10.8 9/30/17\n\n10\\.5\\* Form of Restricted Stock Unit Award Agreement under 2014 Employee Stock\n\nPlan effective as of August 18, 2020.\n\n10-K 10.16 9/26/20\n\n10\\.6\\* Apple Inc. 2022 Employee Stock Plan. 8-K 10.1 3/4/22\n\n10\\.7\\* Form of Restricted Stock Unit Award Agreement under 2022 Employee Stock\n\nPlan effective as of March 4, 2022.\n\n8-K 10.2 3/4/22\n\n10\\.8\\* Form of Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of March 4, 2022.\n\n8-K 10.3 3/4/22\n\n10\\.9\\* Apple Inc. Executive Cash Incentive Plan. 8-K 10.1 8/19/22\n\n10\\.10\\* Form of CEO Restricted Stock Unit Award Agreement under 2022 Employee\n\nStock Plan effective as of September 25, 2022.\n\n10-Q 10.1 12/31/22\n\n10\\.11\\* Form of CEO Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 25, 2022.\n\n10-Q 10.2 12/31/22\n\n10\\.12\\* Form of Restricted Stock Unit Award Agreement under 2022 Employee Stock\n\nPlan effective as of September 29, 2024.\n\n10-K 10.19 9/28/24\n\n10\\.13\\* Form of Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 29, 2024.\n\n10-K 10.20 9/28/24\n\n10\\.14\\* Form of CEO Restricted Stock Unit Award Agreement under 2022 Employee\n\nStock Plan effective as of September 29, 2024.\n\n10-K 10.21 9/28/24\n\n10\\.15\\* Form of CEO Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 29, 2024.\n\n10-K 10.22 9/28/24\n\n19\\.1 Insider Trading Policy. 10-K 19.1 9/28/24\n\n21\\.1\\*\\* Subsidiaries of the Registrant.\n\n23\\.1\\*\\* Consent of Independent Registered Public Accounting Firm.\n\n24\\.1\\*\\* Power of Attorney (included on the Signatures page of this Annual Report on\n\nForm 10-K).\n\n31\\.1\\*\\* Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.\n\n31\\.2\\*\\* Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.\n\n32\\.1\\*\\*\\* Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer.\n\n97\\.1\\* Rule 10D-1 Recovery Policy 10-K 97.1 9/28/24\n\nApple Inc. | 2025 Form 10-K | 56"],"full_content":"**Incorporated by Reference**\n\n**Exhibit Number Exhibit Description Form Exhibit**\n\n**Filing Date/ Period End Date**\n\n4\\.26 Indenture, dated as of October 28, 2021, between the Registrant and The Bank\n\nof New York Mellon Trust Company, N.A., as Trustee.\n\nS-3 4.1 10/29/21\n\n4\\.27 Officer’s Certificate of the Registrant, dated as of August 8, 2022, including forms\n\nof global notes representing the 3.250% Notes due 2029, 3.350% Notes due 2032, 3.950% Notes due 2052 and 4.100% Notes due 2062.\n\n8-K 4.1 8/8/22\n\n4\\.28 Officer’s Certificate of the Registrant, dated as of May 10, 2023, including forms\n\nof global notes representing the 4.421% Notes due 2026, 4.000% Notes due 2028, 4.150% Notes due 2030, 4.300% Notes due 2033 and 4.850% Notes due 2053.\n\n8-K 4.1 5/10/23\n\n4\\.29 Officer’s Certificate of the Registrant, dated as of May 12, 2025, including forms\n\nof global notes representing the 4.000% Notes due 2028, 4.200% Notes due 2030, 4.500% Notes due 2032 and 4.750% Notes due 2035.\n\n8-K 4.1 5/12/25\n\n4\\.30\\* Apple Inc. Deferred Compensation Plan. S-8 4.1 8/23/18\n\n10\\.1\\* Apple Inc. Employee Stock Purchase Plan, as amended as of November 6, 2024. 10-Q 10.1 12/28/24\n\n10\\.2\\* Form of Indemnification Agreement between the Registrant and each director\n\nand executive officer of the Registrant.\n\n10-Q 10.2 6/27/09\n\n10\\.3\\* Apple Inc. Non-Employee Director Stock Plan, as amended November 6, 2024. 10-Q 10.2 12/28/24\n\n10\\.4\\* Apple Inc. 2014 Employee Stock Plan, as amended and restated as of October 1,\n\n2017\\.\n\n10-K 10.8 9/30/17\n\n10\\.5\\* Form of Restricted Stock Unit Award Agreement under 2014 Employee Stock\n\nPlan effective as of August 18, 2020.\n\n10-K 10.16 9/26/20\n\n10\\.6\\* Apple Inc. 2022 Employee Stock Plan. 8-K 10.1 3/4/22\n\n10\\.7\\* Form of Restricted Stock Unit Award Agreement under 2022 Employee Stock\n\nPlan effective as of March 4, 2022.\n\n8-K 10.2 3/4/22\n\n10\\.8\\* Form of Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of March 4, 2022.\n\n8-K 10.3 3/4/22\n\n10\\.9\\* Apple Inc. Executive Cash Incentive Plan. 8-K 10.1 8/19/22\n\n10\\.10\\* Form of CEO Restricted Stock Unit Award Agreement under 2022 Employee\n\nStock Plan effective as of September 25, 2022.\n\n10-Q 10.1 12/31/22\n\n10\\.11\\* Form of CEO Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 25, 2022.\n\n10-Q 10.2 12/31/22\n\n10\\.12\\* Form of Restricted Stock Unit Award Agreement under 2022 Employee Stock\n\nPlan effective as of September 29, 2024.\n\n10-K 10.19 9/28/24\n\n10\\.13\\* Form of Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 29, 2024.\n\n10-K 10.20 9/28/24\n\n10\\.14\\* Form of CEO Restricted Stock Unit Award Agreement under 2022 Employee\n\nStock Plan effective as of September 29, 2024.\n\n10-K 10.21 9/28/24\n\n10\\.15\\* Form of CEO Performance Award Agreement under 2022 Employee Stock Plan\n\neffective as of September 29, 2024.\n\n10-K 10.22 9/28/24\n\n19\\.1 Insider Trading Policy. 10-K 19.1 9/28/24\n\n21\\.1\\*\\* Subsidiaries of the Registrant.\n\n23\\.1\\*\\* Consent of Independent Registered Public Accounting Firm.\n\n24\\.1\\*\\* Power of Attorney (included on the Signatures page of this Annual Report on\n\nForm 10-K).\n\n31\\.1\\*\\* Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.\n\n31\\.2\\*\\* Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.\n\n32\\.1\\*\\*\\* Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer.\n\n97\\.1\\* Rule 10D-1 Recovery Policy 10-K 97.1 9/28/24\n\nApple Inc. | 2025 Form 10-K | 56","publish_date":null,"title":"4.26 Indenture, dated as of October 28, 2021, between the Registrant and The Bank S-3 4.1 10/29/21 of New York","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page59.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page59.pdf"},"request":{"example_id":"table/Apple 10-k_page59","product_type":"parse","source_file_path":"Apple 10-k_page59.pdf"},"started_at":"2026-11-04T19:47:54.301903"} +{"completed_at":"2026-11-04T19:47:56.018225","latency_in_ms":1091,"output":{"example_id":"table/Apple 10-k_page76","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit 21.1**\n\n**Subsidiaries of**\n\n**Apple Inc.\\***\n\n**Jurisdiction**\n\n**of Incorporation**\n\nApple Asia Limited Hong Kong\n\nApple Asia LLC Delaware, U.S.\n\nApple Canada Inc. Canada\n\nApple Computer Trading (Shanghai) Co., Ltd. China\n\nApple Distribution International Limited Ireland\n\nApple India Private Limited India\n\nApple Insurance Company, Inc. Arizona, U.S.\n\nApple Japan, Inc. Japan\n\nApple Korea Limited South Korea\n\nApple Operations International Limited Ireland\n\nApple Operations Limited Ireland\n\nApple Operations Mexico, S.A. de C.V. Mexico\n\nApple Pty Limited Australia\n\nApple Services Pte. Ltd. Singapore\n\nApple South Asia (Thailand) Limited Thailand\n\nApple South Asia Pte. Ltd. Singapore\n\nApple Vietnam Limited Liability Company Vietnam\n\nBraeburn Capital, Inc. Nevada, U.S.\n\niTunes K.K. Japan\n\n\\* Pursuant to Item 601(b)(21)(ii) of Regulation S-K, the names of other subsidiaries of Apple Inc. are omitted because, considered in the aggregate, they would not constitute a significant subsidiary as of the end of the year covered by this report.","pages":[{"line_numbers":[],"markdown":"**Exhibit 21.1**\n\n**Subsidiaries of**\n\n**Apple Inc.\\***\n\n**Jurisdiction**\n\n**of Incorporation**\n\nApple Asia Limited Hong Kong\n\nApple Asia LLC Delaware, U.S.\n\nApple Canada Inc. Canada\n\nApple Computer Trading (Shanghai) Co., Ltd. China\n\nApple Distribution International Limited Ireland\n\nApple India Private Limited India\n\nApple Insurance Company, Inc. Arizona, U.S.\n\nApple Japan, Inc. Japan\n\nApple Korea Limited South Korea\n\nApple Operations International Limited Ireland\n\nApple Operations Limited Ireland\n\nApple Operations Mexico, S.A. de C.V. Mexico\n\nApple Pty Limited Australia\n\nApple Services Pte. Ltd. Singapore\n\nApple South Asia (Thailand) Limited Thailand\n\nApple South Asia Pte. Ltd. Singapore\n\nApple Vietnam Limited Liability Company Vietnam\n\nBraeburn Capital, Inc. Nevada, U.S.\n\niTunes K.K. Japan\n\n\\* Pursuant to Item 601(b)(21)(ii) of Regulation S-K, the names of other subsidiaries of Apple Inc. are omitted because, considered in the aggregate, they would not constitute a significant subsidiary as of the end of the year covered by this report.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit 21.1**\n\n**Subsidiaries of**\n\n**Apple Inc.\\***\n\n**Jurisdiction**\n\n**of Incorporation**\n\nApple Asia Limited Hong Kong\n\nApple Asia LLC Delaware, U.S.\n\nApple Canada Inc. Canada\n\nApple Computer Trading (Shanghai) Co., Ltd. China\n\nApple Distribution International Limited Ireland\n\nApple India Private Limited India\n\nApple Insurance Company, Inc. Arizona, U.S.\n\nApple Japan, Inc. Japan\n\nApple Korea Limited South Korea\n\nApple Operations International Limited Ireland\n\nApple Operations Limited Ireland\n\nApple Operations Mexico, S.A. de C.V. Mexico\n\nApple Pty Limited Australia\n\nApple Services Pte. Ltd. Singapore\n\nApple South Asia (Thailand) Limited Thailand\n\nApple South Asia Pte. Ltd. Singapore\n\nApple Vietnam Limited Liability Company Vietnam\n\nBraeburn Capital, Inc. Nevada, U.S.\n\niTunes K.K. Japan\n\n\\* Pursuant to Item 601(b)(21)(ii) of Regulation S-K, the names of other subsidiaries of Apple Inc. are omitted because, considered in the aggregate, they would not constitute a significant subsidiary as of the end of the year covered by this report.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page76.pdf"]},"response":{"errors":[],"extract_id":"extract_99f63c4d9b6898539469502b5410ab9d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit 21.1**\n\n**Subsidiaries of**\n\n**Apple Inc.\\***\n\n**Jurisdiction**\n\n**of Incorporation**\n\nApple Asia Limited Hong Kong\n\nApple Asia LLC Delaware, U.S.\n\nApple Canada Inc. Canada\n\nApple Computer Trading (Shanghai) Co., Ltd. China\n\nApple Distribution International Limited Ireland\n\nApple India Private Limited India\n\nApple Insurance Company, Inc. Arizona, U.S.\n\nApple Japan, Inc. Japan\n\nApple Korea Limited South Korea\n\nApple Operations International Limited Ireland\n\nApple Operations Limited Ireland\n\nApple Operations Mexico, S.A. de C.V. Mexico\n\nApple Pty Limited Australia\n\nApple Services Pte. Ltd. Singapore\n\nApple South Asia (Thailand) Limited Thailand\n\nApple South Asia Pte. Ltd. Singapore\n\nApple Vietnam Limited Liability Company Vietnam\n\nBraeburn Capital, Inc. Nevada, U.S.\n\niTunes K.K. Japan\n\n\\* Pursuant to Item 601(b)(21)(ii) of Regulation S-K, the names of other subsidiaries of Apple Inc. are omitted because, considered in the aggregate, they would not constitute a significant subsidiary as of the end of the year covered by this report."],"full_content":"**Exhibit 21.1**\n\n**Subsidiaries of**\n\n**Apple Inc.\\***\n\n**Jurisdiction**\n\n**of Incorporation**\n\nApple Asia Limited Hong Kong\n\nApple Asia LLC Delaware, U.S.\n\nApple Canada Inc. Canada\n\nApple Computer Trading (Shanghai) Co., Ltd. China\n\nApple Distribution International Limited Ireland\n\nApple India Private Limited India\n\nApple Insurance Company, Inc. Arizona, U.S.\n\nApple Japan, Inc. Japan\n\nApple Korea Limited South Korea\n\nApple Operations International Limited Ireland\n\nApple Operations Limited Ireland\n\nApple Operations Mexico, S.A. de C.V. Mexico\n\nApple Pty Limited Australia\n\nApple Services Pte. Ltd. Singapore\n\nApple South Asia (Thailand) Limited Thailand\n\nApple South Asia Pte. Ltd. Singapore\n\nApple Vietnam Limited Liability Company Vietnam\n\nBraeburn Capital, Inc. Nevada, U.S.\n\niTunes K.K. Japan\n\n\\* Pursuant to Item 601(b)(21)(ii) of Regulation S-K, the names of other subsidiaries of Apple Inc. are omitted because, considered in the aggregate, they would not constitute a significant subsidiary as of the end of the year covered by this report.","publish_date":null,"title":"Exhibit 21.1 Subsidiaries of Apple Inc.* Apple Asia Limited Hong Kong Apple Asia LLC Delaware, U.S. Apple Canada Inc. Canada","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page76.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Apple%2010-k_page76.pdf"},"request":{"example_id":"table/Apple 10-k_page76","product_type":"parse","source_file_path":"Apple 10-k_page76.pdf"},"started_at":"2026-11-04T19:47:54.926301"} +{"completed_at":"2026-11-04T19:47:57.344280","latency_in_ms":1322,"output":{"example_id":"table/BRWS-134565917_page1002","grounded_pages":[],"layout_pages":[],"markdown":"Named Operator & Pre-1981 Veh\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Named Operator & Pre-1981 Vehicles**\n\n**BI BI PD PD PIP/MP/UM PIP/MP/UM COMP COMP COLL/UMPD COLL/UMPD**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nNamed Operator 0.7519 0.7519 0.8911 0.8911 0.8010 0.8010\n\nPre-1981 Vehicles 0.2346 0.2560 0.2960 0.2888 0.2228 0.2257\n\n\\# Proprietary Named Operator & Pre-1981 Veh Page 70","pages":[{"line_numbers":[],"markdown":"Named Operator & Pre-1981 Veh\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Named Operator & Pre-1981 Vehicles**\n\n**BI BI PD PD PIP/MP/UM PIP/MP/UM COMP COMP COLL/UMPD COLL/UMPD**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nNamed Operator 0.7519 0.7519 0.8911 0.8911 0.8010 0.8010\n\nPre-1981 Vehicles 0.2346 0.2560 0.2960 0.2888 0.2228 0.2257\n\n\\# Proprietary Named Operator & Pre-1981 Veh Page 70","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Named Operator & Pre-1981 Veh\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Named Operator & Pre-1981 Vehicles**\n\n**BI BI PD PD PIP/MP/UM PIP/MP/UM COMP COMP COLL/UMPD COLL/UMPD**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nNamed Operator 0.7519 0.7519 0.8911 0.8911 0.8010 0.8010\n\nPre-1981 Vehicles 0.2346 0.2560 0.2960 0.2888 0.2228 0.2257\n\n\\# Proprietary Named Operator & Pre-1981 Veh Page 70","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1002.pdf"]},"response":{"errors":[],"extract_id":"extract_105030fecb8c216db860fe9207b60dee","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Named Operator & Pre-1981 Veh\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Named Operator & Pre-1981 Vehicles**\n\n**BI BI PD PD PIP/MP/UM PIP/MP/UM COMP COMP COLL/UMPD COLL/UMPD**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nNamed Operator 0.7519 0.7519 0.8911 0.8911 0.8010 0.8010\n\nPre-1981 Vehicles 0.2346 0.2560 0.2960 0.2888 0.2228 0.2257\n\n\\# Proprietary Named Operator & Pre-1981 Veh Page 70"],"full_content":"Named Operator & Pre-1981 Veh\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Named Operator & Pre-1981 Vehicles**\n\n**BI BI PD PD PIP/MP/UM PIP/MP/UM COMP COMP COLL/UMPD COLL/UMPD**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nNamed Operator 0.7519 0.7519 0.8911 0.8911 0.8010 0.8010\n\nPre-1981 Vehicles 0.2346 0.2560 0.2960 0.2888 0.2228 0.2257\n\n\\# Proprietary Named Operator & Pre-1981 Veh Page 70","publish_date":null,"title":"Named Operator & Pre-1981 Veh Named Operator & Pre-1981 Veh Page 70","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1002.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1002.pdf"},"request":{"example_id":"table/BRWS-134565917_page1002","product_type":"parse","source_file_path":"BRWS-134565917_page1002.pdf"},"started_at":"2026-11-04T19:47:56.021347"} +{"completed_at":"2026-11-04T19:48:00.194122","latency_in_ms":2663,"output":{"example_id":"table/BRWS-134565917_page1017","grounded_pages":[],"layout_pages":[],"markdown":"EFT\\_Tenure\n\n**EFT||Tenure**\n\nN||00-06M N||06-12M N||12-24M N||>=24+M Y||00-06M Y||06-12M Y||12-24M Y||>=24+M\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - EFT by Tenure**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n108,985 54,948,344 10,649 9.77% 5,160 504 1.0778 1.0000\n\n44,501 17,830,757 3,676 8.26% 4,850 401 1.0880 1.0000\n\n93,895 30,601,301 6,438 6.86% 4,753 326 1.0331 1.0000\n\n134,943 32,738,028 6,972 5.17% 4,696 243 0.9140 1.0000\n\n285,847 160,848,153 30,797 10.77% 5,223 563 1.0306 0.9746\n\n100,618 45,767,819 8,937 8.88% 5,121 455 1.0231 0.9776\n\n177,397 73,202,583 14,223 8.02% 5,147 413 0.9776 0.9821\n\n246,818 79,039,252 15,737 6.38% 5,023 320 0.9554 0.9882\n\n\\# Proprietary EFT\\_Tenure Page 85","pages":[{"line_numbers":[],"markdown":"EFT\\_Tenure\n\n**EFT||Tenure**\n\nN||00-06M N||06-12M N||12-24M N||>=24+M Y||00-06M Y||06-12M Y||12-24M Y||>=24+M\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - EFT by Tenure**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n108,985 54,948,344 10,649 9.77% 5,160 504 1.0778 1.0000\n\n44,501 17,830,757 3,676 8.26% 4,850 401 1.0880 1.0000\n\n93,895 30,601,301 6,438 6.86% 4,753 326 1.0331 1.0000\n\n134,943 32,738,028 6,972 5.17% 4,696 243 0.9140 1.0000\n\n285,847 160,848,153 30,797 10.77% 5,223 563 1.0306 0.9746\n\n100,618 45,767,819 8,937 8.88% 5,121 455 1.0231 0.9776\n\n177,397 73,202,583 14,223 8.02% 5,147 413 0.9776 0.9821\n\n246,818 79,039,252 15,737 6.38% 5,023 320 0.9554 0.9882\n\n\\# Proprietary EFT\\_Tenure Page 85","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"EFT\\_Tenure\n\n**EFT||Tenure**\n\nN||00-06M N||06-12M N||12-24M N||>=24+M Y||00-06M Y||06-12M Y||12-24M Y||>=24+M\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - EFT by Tenure**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n108,985 54,948,344 10,649 9.77% 5,160 504 1.0778 1.0000\n\n44,501 17,830,757 3,676 8.26% 4,850 401 1.0880 1.0000\n\n93,895 30,601,301 6,438 6.86% 4,753 326 1.0331 1.0000\n\n134,943 32,738,028 6,972 5.17% 4,696 243 0.9140 1.0000\n\n285,847 160,848,153 30,797 10.77% 5,223 563 1.0306 0.9746\n\n100,618 45,767,819 8,937 8.88% 5,121 455 1.0231 0.9776\n\n177,397 73,202,583 14,223 8.02% 5,147 413 0.9776 0.9821\n\n246,818 79,039,252 15,737 6.38% 5,023 320 0.9554 0.9882\n\n\\# Proprietary EFT\\_Tenure Page 85","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1017.pdf"]},"response":{"errors":[],"extract_id":"extract_6587f7575970f99b72b194c00d2c3279","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["EFT\\_Tenure\n\n**EFT||Tenure**\n\nN||00-06M N||06-12M N||12-24M N||>=24+M Y||00-06M Y||06-12M Y||12-24M Y||>=24+M\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - EFT by Tenure**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n108,985 54,948,344 10,649 9.77% 5,160 504 1.0778 1.0000\n\n44,501 17,830,757 3,676 8.26% 4,850 401 1.0880 1.0000\n\n93,895 30,601,301 6,438 6.86% 4,753 326 1.0331 1.0000\n\n134,943 32,738,028 6,972 5.17% 4,696 243 0.9140 1.0000\n\n285,847 160,848,153 30,797 10.77% 5,223 563 1.0306 0.9746\n\n100,618 45,767,819 8,937 8.88% 5,121 455 1.0231 0.9776\n\n177,397 73,202,583 14,223 8.02% 5,147 413 0.9776 0.9821\n\n246,818 79,039,252 15,737 6.38% 5,023 320 0.9554 0.9882\n\n\\# Proprietary EFT\\_Tenure Page 85"],"full_content":"EFT\\_Tenure\n\n**EFT||Tenure**\n\nN||00-06M N||06-12M N||12-24M N||>=24+M Y||00-06M Y||06-12M Y||12-24M Y||>=24+M\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - EFT by Tenure**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n108,985 54,948,344 10,649 9.77% 5,160 504 1.0778 1.0000\n\n44,501 17,830,757 3,676 8.26% 4,850 401 1.0880 1.0000\n\n93,895 30,601,301 6,438 6.86% 4,753 326 1.0331 1.0000\n\n134,943 32,738,028 6,972 5.17% 4,696 243 0.9140 1.0000\n\n285,847 160,848,153 30,797 10.77% 5,223 563 1.0306 0.9746\n\n100,618 45,767,819 8,937 8.88% 5,121 455 1.0231 0.9776\n\n177,397 73,202,583 14,223 8.02% 5,147 413 0.9776 0.9821\n\n246,818 79,039,252 15,737 6.38% 5,023 320 0.9554 0.9882\n\n\\# Proprietary EFT\\_Tenure Page 85","publish_date":null,"title":"EFT_Tenure State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - EFT by Tenure COLL/UMPD COLL/UMPD","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1017.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1017.pdf"},"request":{"example_id":"table/BRWS-134565917_page1017","product_type":"parse","source_file_path":"BRWS-134565917_page1017.pdf"},"started_at":"2026-11-04T19:47:57.530735"} +{"completed_at":"2026-11-04T19:48:00.075383","latency_in_ms":1333,"output":{"example_id":"table/BRWS-134565917_page1028","grounded_pages":[],"layout_pages":[],"markdown":"Safe Driver Discount\n\n**Safe Driver**\n\n**Discount**\n\nNN NG NL NO NA YN YG YL YO YA\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Safe Driver Discount**\n\n**PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM COMP COMP**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss**\n\n452,925 137,740,785 27,092 5.98% 5,084 304 1.0000 1.0000 391,648 52,378,563\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n782,792 179,341,420 34,451 4.40% 5,206 229 1.0399 1.0000 850,886 91,397,638\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n\\# Proprietary Safe Driver Discount Page 96","pages":[{"line_numbers":[],"markdown":"Safe Driver Discount\n\n**Safe Driver**\n\n**Discount**\n\nNN NG NL NO NA YN YG YL YO YA\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Safe Driver Discount**\n\n**PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM COMP COMP**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss**\n\n452,925 137,740,785 27,092 5.98% 5,084 304 1.0000 1.0000 391,648 52,378,563\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n782,792 179,341,420 34,451 4.40% 5,206 229 1.0399 1.0000 850,886 91,397,638\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n\\# Proprietary Safe Driver Discount Page 96","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Safe Driver Discount\n\n**Safe Driver**\n\n**Discount**\n\nNN NG NL NO NA YN YG YL YO YA\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Safe Driver Discount**\n\n**PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM COMP COMP**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss**\n\n452,925 137,740,785 27,092 5.98% 5,084 304 1.0000 1.0000 391,648 52,378,563\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n782,792 179,341,420 34,451 4.40% 5,206 229 1.0399 1.0000 850,886 91,397,638\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n\\# Proprietary Safe Driver Discount Page 96","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1028.pdf"]},"response":{"errors":[],"extract_id":"extract_71f16c964ff980108382c0d9b3bfafe4","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Safe Driver Discount\n\n**Safe Driver**\n\n**Discount**\n\nNN NG NL NO NA YN YG YL YO YA\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Safe Driver Discount**\n\n**PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM COMP COMP**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss**\n\n452,925 137,740,785 27,092 5.98% 5,084 304 1.0000 1.0000 391,648 52,378,563\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n782,792 179,341,420 34,451 4.40% 5,206 229 1.0399 1.0000 850,886 91,397,638\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n\\# Proprietary Safe Driver Discount Page 96"],"full_content":"Safe Driver Discount\n\n**Safe Driver**\n\n**Discount**\n\nNN NG NL NO NA YN YG YL YO YA\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Safe Driver Discount**\n\n**PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM COMP COMP**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss**\n\n452,925 137,740,785 27,092 5.98% 5,084 304 1.0000 1.0000 391,648 52,378,563\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n782,792 179,341,420 34,451 4.40% 5,206 229 1.0399 1.0000 850,886 91,397,638\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n1\\.0399 1.0000\n\n\\# Proprietary Safe Driver Discount Page 96","publish_date":null,"title":"Safe Driver Discount State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Safe Driver Discount","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1028.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1028.pdf"},"request":{"example_id":"table/BRWS-134565917_page1028","product_type":"parse","source_file_path":"BRWS-134565917_page1028.pdf"},"started_at":"2026-11-04T19:47:58.741385"} +{"completed_at":"2026-11-04T19:48:01.369928","latency_in_ms":1323,"output":{"example_id":"table/BRWS-134565917_page1087","grounded_pages":[],"layout_pages":[],"markdown":"Full Coverage by Tow\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Full Coverage Factor**\n\n**BI BI BI BI BI BI BI BI PD PD PD PD PD PD PD PD**\n\n**Full Coverage Factor**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nN || -2-2 || N 50,331 9,761,230 965 1.92% 10,114 194 1.0146 1.0191 58,456 11,605,496 3,520 6.02% 3,297 199 0.9612 0.9663\n\nN || -2-2 || Y 0 0 0 0.00% 0 0 1.0146 1.0191 0 0 0 0.00% 0 0 0.9612 0.9663\n\nN || 3-5 || N 91,359 20,584,303 2,089 2.29% 9,854 225 0.9834 0.9769 107,745 25,887,351 7,911 7.34% 3,272 240 0.9562 0.9641\n\nN || 3-5 || Y 0 0 0 0.00% 0 0 0.9834 0.9769 0 0 0 0.00% 0 0 0.9562 0.9641\n\nN || 6-8 || N 124,273 28,533,412 2,842 2.29% 10,040 230 0.9539 0.9743 150,313 38,862,176 11,524 7.67% 3,372 259 0.9616 0.9707\n\nN || 6-8 || Y 0 0 0 0.00% 0 0 0.9539 0.9743 0 0 0 0.00% 0 0 0.9616 0.9707\n\nN || 9-11 || N 161,967 39,285,005 3,839 2.37% 10,234 243 0.9656 0.9836 198,101 52,044,877 16,005 8.08% 3,252 263 0.9425 0.9577\n\nN || 9-11 || Y 0 0 0 0.00% 0 0 0.9656 0.9836 0 0 0 0.00% 0 0 0.9425 0.9577\n\nN || 12-14 || N 240,711 54,510,520 5,594 2.32% 9,744 226 0.9674 0.9812 290,346 76,974,856 23,711 8.17% 3,246 265 0.9925 0.9803\n\nN || 12-14 || Y 0 0 0 0.00% 0 0 0.9674 0.9812 0 0 0 0.00% 0 0 0.9925 0.9803\n\nN || 15-17 || N 252,808 54,333,422 5,487 2.17% 9,902 215 0.9896 0.9656 305,988 76,395,269 23,293 7.61% 3,280 250 0.9869 0.9817\n\nN || 15-17 || Y 0 0 0 0.00% 0 0 0.9896 0.9656 0 0 0 0.00% 0 0 0.9869 0.9817\n\nN || 18+ || N 459,612 76,626,240 7,585 1.65% 10,102 167 1.0047 0.9907 530,528 110,003,108 32,003 6.03% 3,437 207 0.9978 0.9888\n\nN || 18+ || Y 0 0 0 0.00% 0 0 1.0047 0.9907 0 0 0 0.00% 0 0 0.9978 0.9888\n\nY || -2-2 || N 145,257 29,562,841 3,072 2.11% 9,625 204 0.9890 0.9934 160,609 37,829,382 11,499 7.16% 3,290 236 1.0069 1.0123\n\nY || -2-2 || Y 0 0 0 0.00% 0 0 0.9890 0.9934 0 0 0 0.00% 0 0 1.0069 1.0123\n\nY || 3-5 || N 190,297 45,301,215 4,605 2.42% 9,836 238 1.0177 1.0111 213,537 58,724,802 17,349 8.12% 3,385 275 1.0098 1.0181\n\nY || 3-5 || Y 0 0 0 0.00% 0 0 1.0177 1.0111 0 0 0 0.00% 0 0 1.0098 1.0181\n\nY || 6-8 || N 168,423 39,256,208 4,087 2.43% 9,605 233 0.9976 1.0189 188,642 52,764,263 15,575 8.26% 3,388 280 1.0138 1.0234\n\nY || 6-8 || Y 0 0 0 0.00% 0 0 0.9976 1.0189 0 0 0 0.00% 0 0 1.0138 1.0234\n\nY || 9-11 || N 121,437 28,117,097 2,923 2.41% 9,620 232 1.0031 1.0218 132,994 37,664,613 11,348 8.53% 3,319 283 1.0462 1.0630\n\nY || 9-11 || Y 0 0 0 0.00% 0 0 1.0031 1.0218 0 0 0 0.00% 0 0 1.0462 1.0630\n\nY || 12-14 || N 95,871 20,598,229 2,112 2.20% 9,753 215 1.0326 1.0473 102,199 27,516,822 8,166 7.99% 3,370 269 1.0691 1.0559\n\nY || 12-14 || Y 0 0 0 0.00% 0 0 1.0326 1.0473 0 0 0 0.00% 0 0 1.0691 1.0559\n\nY || 15-17 || N 63,416 14,046,080 1,448 2.28% 9,698 221 1.1653 1.1371 67,022 17,202,762 5,011 7.48% 3,433 257 1.0892 1.0835\n\nY || 15-17 || Y 0 0 0 0.00% 0 0 1.1653 1.1371 0 0 0 0.00% 0 0 1.0892 1.0835\n\nY || 18+ || N 52,881 8,777,640 943 1.78% 9,307 166 1.0961 1.0808 55,044 12,545,865 3,439 6.25% 3,648 228 1.1177 1.1076\n\nY || 18+ || Y 0 0 0 0.00% 0 0 1.0961 1.0808 0 0 0 0.00% 0 0 1.1177 1.1076\n\n\\# Proprietary Full Coverage by Tow Page 155","pages":[{"line_numbers":[],"markdown":"Full Coverage by Tow\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Full Coverage Factor**\n\n**BI BI BI BI BI BI BI BI PD PD PD PD PD PD PD PD**\n\n**Full Coverage Factor**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nN || -2-2 || N 50,331 9,761,230 965 1.92% 10,114 194 1.0146 1.0191 58,456 11,605,496 3,520 6.02% 3,297 199 0.9612 0.9663\n\nN || -2-2 || Y 0 0 0 0.00% 0 0 1.0146 1.0191 0 0 0 0.00% 0 0 0.9612 0.9663\n\nN || 3-5 || N 91,359 20,584,303 2,089 2.29% 9,854 225 0.9834 0.9769 107,745 25,887,351 7,911 7.34% 3,272 240 0.9562 0.9641\n\nN || 3-5 || Y 0 0 0 0.00% 0 0 0.9834 0.9769 0 0 0 0.00% 0 0 0.9562 0.9641\n\nN || 6-8 || N 124,273 28,533,412 2,842 2.29% 10,040 230 0.9539 0.9743 150,313 38,862,176 11,524 7.67% 3,372 259 0.9616 0.9707\n\nN || 6-8 || Y 0 0 0 0.00% 0 0 0.9539 0.9743 0 0 0 0.00% 0 0 0.9616 0.9707\n\nN || 9-11 || N 161,967 39,285,005 3,839 2.37% 10,234 243 0.9656 0.9836 198,101 52,044,877 16,005 8.08% 3,252 263 0.9425 0.9577\n\nN || 9-11 || Y 0 0 0 0.00% 0 0 0.9656 0.9836 0 0 0 0.00% 0 0 0.9425 0.9577\n\nN || 12-14 || N 240,711 54,510,520 5,594 2.32% 9,744 226 0.9674 0.9812 290,346 76,974,856 23,711 8.17% 3,246 265 0.9925 0.9803\n\nN || 12-14 || Y 0 0 0 0.00% 0 0 0.9674 0.9812 0 0 0 0.00% 0 0 0.9925 0.9803\n\nN || 15-17 || N 252,808 54,333,422 5,487 2.17% 9,902 215 0.9896 0.9656 305,988 76,395,269 23,293 7.61% 3,280 250 0.9869 0.9817\n\nN || 15-17 || Y 0 0 0 0.00% 0 0 0.9896 0.9656 0 0 0 0.00% 0 0 0.9869 0.9817\n\nN || 18+ || N 459,612 76,626,240 7,585 1.65% 10,102 167 1.0047 0.9907 530,528 110,003,108 32,003 6.03% 3,437 207 0.9978 0.9888\n\nN || 18+ || Y 0 0 0 0.00% 0 0 1.0047 0.9907 0 0 0 0.00% 0 0 0.9978 0.9888\n\nY || -2-2 || N 145,257 29,562,841 3,072 2.11% 9,625 204 0.9890 0.9934 160,609 37,829,382 11,499 7.16% 3,290 236 1.0069 1.0123\n\nY || -2-2 || Y 0 0 0 0.00% 0 0 0.9890 0.9934 0 0 0 0.00% 0 0 1.0069 1.0123\n\nY || 3-5 || N 190,297 45,301,215 4,605 2.42% 9,836 238 1.0177 1.0111 213,537 58,724,802 17,349 8.12% 3,385 275 1.0098 1.0181\n\nY || 3-5 || Y 0 0 0 0.00% 0 0 1.0177 1.0111 0 0 0 0.00% 0 0 1.0098 1.0181\n\nY || 6-8 || N 168,423 39,256,208 4,087 2.43% 9,605 233 0.9976 1.0189 188,642 52,764,263 15,575 8.26% 3,388 280 1.0138 1.0234\n\nY || 6-8 || Y 0 0 0 0.00% 0 0 0.9976 1.0189 0 0 0 0.00% 0 0 1.0138 1.0234\n\nY || 9-11 || N 121,437 28,117,097 2,923 2.41% 9,620 232 1.0031 1.0218 132,994 37,664,613 11,348 8.53% 3,319 283 1.0462 1.0630\n\nY || 9-11 || Y 0 0 0 0.00% 0 0 1.0031 1.0218 0 0 0 0.00% 0 0 1.0462 1.0630\n\nY || 12-14 || N 95,871 20,598,229 2,112 2.20% 9,753 215 1.0326 1.0473 102,199 27,516,822 8,166 7.99% 3,370 269 1.0691 1.0559\n\nY || 12-14 || Y 0 0 0 0.00% 0 0 1.0326 1.0473 0 0 0 0.00% 0 0 1.0691 1.0559\n\nY || 15-17 || N 63,416 14,046,080 1,448 2.28% 9,698 221 1.1653 1.1371 67,022 17,202,762 5,011 7.48% 3,433 257 1.0892 1.0835\n\nY || 15-17 || Y 0 0 0 0.00% 0 0 1.1653 1.1371 0 0 0 0.00% 0 0 1.0892 1.0835\n\nY || 18+ || N 52,881 8,777,640 943 1.78% 9,307 166 1.0961 1.0808 55,044 12,545,865 3,439 6.25% 3,648 228 1.1177 1.1076\n\nY || 18+ || Y 0 0 0 0.00% 0 0 1.0961 1.0808 0 0 0 0.00% 0 0 1.1177 1.1076\n\n\\# Proprietary Full Coverage by Tow Page 155","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Full Coverage by Tow\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Full Coverage Factor**\n\n**BI BI BI BI BI BI BI BI PD PD PD PD PD PD PD PD**\n\n**Full Coverage Factor**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nN || -2-2 || N 50,331 9,761,230 965 1.92% 10,114 194 1.0146 1.0191 58,456 11,605,496 3,520 6.02% 3,297 199 0.9612 0.9663\n\nN || -2-2 || Y 0 0 0 0.00% 0 0 1.0146 1.0191 0 0 0 0.00% 0 0 0.9612 0.9663\n\nN || 3-5 || N 91,359 20,584,303 2,089 2.29% 9,854 225 0.9834 0.9769 107,745 25,887,351 7,911 7.34% 3,272 240 0.9562 0.9641\n\nN || 3-5 || Y 0 0 0 0.00% 0 0 0.9834 0.9769 0 0 0 0.00% 0 0 0.9562 0.9641\n\nN || 6-8 || N 124,273 28,533,412 2,842 2.29% 10,040 230 0.9539 0.9743 150,313 38,862,176 11,524 7.67% 3,372 259 0.9616 0.9707\n\nN || 6-8 || Y 0 0 0 0.00% 0 0 0.9539 0.9743 0 0 0 0.00% 0 0 0.9616 0.9707\n\nN || 9-11 || N 161,967 39,285,005 3,839 2.37% 10,234 243 0.9656 0.9836 198,101 52,044,877 16,005 8.08% 3,252 263 0.9425 0.9577\n\nN || 9-11 || Y 0 0 0 0.00% 0 0 0.9656 0.9836 0 0 0 0.00% 0 0 0.9425 0.9577\n\nN || 12-14 || N 240,711 54,510,520 5,594 2.32% 9,744 226 0.9674 0.9812 290,346 76,974,856 23,711 8.17% 3,246 265 0.9925 0.9803\n\nN || 12-14 || Y 0 0 0 0.00% 0 0 0.9674 0.9812 0 0 0 0.00% 0 0 0.9925 0.9803\n\nN || 15-17 || N 252,808 54,333,422 5,487 2.17% 9,902 215 0.9896 0.9656 305,988 76,395,269 23,293 7.61% 3,280 250 0.9869 0.9817\n\nN || 15-17 || Y 0 0 0 0.00% 0 0 0.9896 0.9656 0 0 0 0.00% 0 0 0.9869 0.9817\n\nN || 18+ || N 459,612 76,626,240 7,585 1.65% 10,102 167 1.0047 0.9907 530,528 110,003,108 32,003 6.03% 3,437 207 0.9978 0.9888\n\nN || 18+ || Y 0 0 0 0.00% 0 0 1.0047 0.9907 0 0 0 0.00% 0 0 0.9978 0.9888\n\nY || -2-2 || N 145,257 29,562,841 3,072 2.11% 9,625 204 0.9890 0.9934 160,609 37,829,382 11,499 7.16% 3,290 236 1.0069 1.0123\n\nY || -2-2 || Y 0 0 0 0.00% 0 0 0.9890 0.9934 0 0 0 0.00% 0 0 1.0069 1.0123\n\nY || 3-5 || N 190,297 45,301,215 4,605 2.42% 9,836 238 1.0177 1.0111 213,537 58,724,802 17,349 8.12% 3,385 275 1.0098 1.0181\n\nY || 3-5 || Y 0 0 0 0.00% 0 0 1.0177 1.0111 0 0 0 0.00% 0 0 1.0098 1.0181\n\nY || 6-8 || N 168,423 39,256,208 4,087 2.43% 9,605 233 0.9976 1.0189 188,642 52,764,263 15,575 8.26% 3,388 280 1.0138 1.0234\n\nY || 6-8 || Y 0 0 0 0.00% 0 0 0.9976 1.0189 0 0 0 0.00% 0 0 1.0138 1.0234\n\nY || 9-11 || N 121,437 28,117,097 2,923 2.41% 9,620 232 1.0031 1.0218 132,994 37,664,613 11,348 8.53% 3,319 283 1.0462 1.0630\n\nY || 9-11 || Y 0 0 0 0.00% 0 0 1.0031 1.0218 0 0 0 0.00% 0 0 1.0462 1.0630\n\nY || 12-14 || N 95,871 20,598,229 2,112 2.20% 9,753 215 1.0326 1.0473 102,199 27,516,822 8,166 7.99% 3,370 269 1.0691 1.0559\n\nY || 12-14 || Y 0 0 0 0.00% 0 0 1.0326 1.0473 0 0 0 0.00% 0 0 1.0691 1.0559\n\nY || 15-17 || N 63,416 14,046,080 1,448 2.28% 9,698 221 1.1653 1.1371 67,022 17,202,762 5,011 7.48% 3,433 257 1.0892 1.0835\n\nY || 15-17 || Y 0 0 0 0.00% 0 0 1.1653 1.1371 0 0 0 0.00% 0 0 1.0892 1.0835\n\nY || 18+ || N 52,881 8,777,640 943 1.78% 9,307 166 1.0961 1.0808 55,044 12,545,865 3,439 6.25% 3,648 228 1.1177 1.1076\n\nY || 18+ || Y 0 0 0 0.00% 0 0 1.0961 1.0808 0 0 0 0.00% 0 0 1.1177 1.1076\n\n\\# Proprietary Full Coverage by Tow Page 155","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1087.pdf"]},"response":{"errors":[],"extract_id":"extract_81e242eb093a42ae848aa2c143056e8b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Full Coverage by Tow\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Full Coverage Factor**\n\n**BI BI BI BI BI BI BI BI PD PD PD PD PD PD PD PD**\n\n**Full Coverage Factor**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nN || -2-2 || N 50,331 9,761,230 965 1.92% 10,114 194 1.0146 1.0191 58,456 11,605,496 3,520 6.02% 3,297 199 0.9612 0.9663\n\nN || -2-2 || Y 0 0 0 0.00% 0 0 1.0146 1.0191 0 0 0 0.00% 0 0 0.9612 0.9663\n\nN || 3-5 || N 91,359 20,584,303 2,089 2.29% 9,854 225 0.9834 0.9769 107,745 25,887,351 7,911 7.34% 3,272 240 0.9562 0.9641\n\nN || 3-5 || Y 0 0 0 0.00% 0 0 0.9834 0.9769 0 0 0 0.00% 0 0 0.9562 0.9641\n\nN || 6-8 || N 124,273 28,533,412 2,842 2.29% 10,040 230 0.9539 0.9743 150,313 38,862,176 11,524 7.67% 3,372 259 0.9616 0.9707\n\nN || 6-8 || Y 0 0 0 0.00% 0 0 0.9539 0.9743 0 0 0 0.00% 0 0 0.9616 0.9707\n\nN || 9-11 || N 161,967 39,285,005 3,839 2.37% 10,234 243 0.9656 0.9836 198,101 52,044,877 16,005 8.08% 3,252 263 0.9425 0.9577\n\nN || 9-11 || Y 0 0 0 0.00% 0 0 0.9656 0.9836 0 0 0 0.00% 0 0 0.9425 0.9577\n\nN || 12-14 || N 240,711 54,510,520 5,594 2.32% 9,744 226 0.9674 0.9812 290,346 76,974,856 23,711 8.17% 3,246 265 0.9925 0.9803\n\nN || 12-14 || Y 0 0 0 0.00% 0 0 0.9674 0.9812 0 0 0 0.00% 0 0 0.9925 0.9803\n\nN || 15-17 || N 252,808 54,333,422 5,487 2.17% 9,902 215 0.9896 0.9656 305,988 76,395,269 23,293 7.61% 3,280 250 0.9869 0.9817\n\nN || 15-17 || Y 0 0 0 0.00% 0 0 0.9896 0.9656 0 0 0 0.00% 0 0 0.9869 0.9817\n\nN || 18+ || N 459,612 76,626,240 7,585 1.65% 10,102 167 1.0047 0.9907 530,528 110,003,108 32,003 6.03% 3,437 207 0.9978 0.9888\n\nN || 18+ || Y 0 0 0 0.00% 0 0 1.0047 0.9907 0 0 0 0.00% 0 0 0.9978 0.9888\n\nY || -2-2 || N 145,257 29,562,841 3,072 2.11% 9,625 204 0.9890 0.9934 160,609 37,829,382 11,499 7.16% 3,290 236 1.0069 1.0123\n\nY || -2-2 || Y 0 0 0 0.00% 0 0 0.9890 0.9934 0 0 0 0.00% 0 0 1.0069 1.0123\n\nY || 3-5 || N 190,297 45,301,215 4,605 2.42% 9,836 238 1.0177 1.0111 213,537 58,724,802 17,349 8.12% 3,385 275 1.0098 1.0181\n\nY || 3-5 || Y 0 0 0 0.00% 0 0 1.0177 1.0111 0 0 0 0.00% 0 0 1.0098 1.0181\n\nY || 6-8 || N 168,423 39,256,208 4,087 2.43% 9,605 233 0.9976 1.0189 188,642 52,764,263 15,575 8.26% 3,388 280 1.0138 1.0234\n\nY || 6-8 || Y 0 0 0 0.00% 0 0 0.9976 1.0189 0 0 0 0.00% 0 0 1.0138 1.0234\n\nY || 9-11 || N 121,437 28,117,097 2,923 2.41% 9,620 232 1.0031 1.0218 132,994 37,664,613 11,348 8.53% 3,319 283 1.0462 1.0630\n\nY || 9-11 || Y 0 0 0 0.00% 0 0 1.0031 1.0218 0 0 0 0.00% 0 0 1.0462 1.0630\n\nY || 12-14 || N 95,871 20,598,229 2,112 2.20% 9,753 215 1.0326 1.0473 102,199 27,516,822 8,166 7.99% 3,370 269 1.0691 1.0559\n\nY || 12-14 || Y 0 0 0 0.00% 0 0 1.0326 1.0473 0 0 0 0.00% 0 0 1.0691 1.0559\n\nY || 15-17 || N 63,416 14,046,080 1,448 2.28% 9,698 221 1.1653 1.1371 67,022 17,202,762 5,011 7.48% 3,433 257 1.0892 1.0835\n\nY || 15-17 || Y 0 0 0 0.00% 0 0 1.1653 1.1371 0 0 0 0.00% 0 0 1.0892 1.0835\n\nY || 18+ || N 52,881 8,777,640 943 1.78% 9,307 166 1.0961 1.0808 55,044 12,545,865 3,439 6.25% 3,648 228 1.1177 1.1076\n\nY || 18+ || Y 0 0 0 0.00% 0 0 1.0961 1.0808 0 0 0 0.00% 0 0 1.1177 1.1076\n\n\\# Proprietary Full Coverage by Tow Page 155"],"full_content":"Full Coverage by Tow\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Full Coverage Factor**\n\n**BI BI BI BI BI BI BI BI PD PD PD PD PD PD PD PD**\n\n**Full Coverage Factor**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nN || -2-2 || N 50,331 9,761,230 965 1.92% 10,114 194 1.0146 1.0191 58,456 11,605,496 3,520 6.02% 3,297 199 0.9612 0.9663\n\nN || -2-2 || Y 0 0 0 0.00% 0 0 1.0146 1.0191 0 0 0 0.00% 0 0 0.9612 0.9663\n\nN || 3-5 || N 91,359 20,584,303 2,089 2.29% 9,854 225 0.9834 0.9769 107,745 25,887,351 7,911 7.34% 3,272 240 0.9562 0.9641\n\nN || 3-5 || Y 0 0 0 0.00% 0 0 0.9834 0.9769 0 0 0 0.00% 0 0 0.9562 0.9641\n\nN || 6-8 || N 124,273 28,533,412 2,842 2.29% 10,040 230 0.9539 0.9743 150,313 38,862,176 11,524 7.67% 3,372 259 0.9616 0.9707\n\nN || 6-8 || Y 0 0 0 0.00% 0 0 0.9539 0.9743 0 0 0 0.00% 0 0 0.9616 0.9707\n\nN || 9-11 || N 161,967 39,285,005 3,839 2.37% 10,234 243 0.9656 0.9836 198,101 52,044,877 16,005 8.08% 3,252 263 0.9425 0.9577\n\nN || 9-11 || Y 0 0 0 0.00% 0 0 0.9656 0.9836 0 0 0 0.00% 0 0 0.9425 0.9577\n\nN || 12-14 || N 240,711 54,510,520 5,594 2.32% 9,744 226 0.9674 0.9812 290,346 76,974,856 23,711 8.17% 3,246 265 0.9925 0.9803\n\nN || 12-14 || Y 0 0 0 0.00% 0 0 0.9674 0.9812 0 0 0 0.00% 0 0 0.9925 0.9803\n\nN || 15-17 || N 252,808 54,333,422 5,487 2.17% 9,902 215 0.9896 0.9656 305,988 76,395,269 23,293 7.61% 3,280 250 0.9869 0.9817\n\nN || 15-17 || Y 0 0 0 0.00% 0 0 0.9896 0.9656 0 0 0 0.00% 0 0 0.9869 0.9817\n\nN || 18+ || N 459,612 76,626,240 7,585 1.65% 10,102 167 1.0047 0.9907 530,528 110,003,108 32,003 6.03% 3,437 207 0.9978 0.9888\n\nN || 18+ || Y 0 0 0 0.00% 0 0 1.0047 0.9907 0 0 0 0.00% 0 0 0.9978 0.9888\n\nY || -2-2 || N 145,257 29,562,841 3,072 2.11% 9,625 204 0.9890 0.9934 160,609 37,829,382 11,499 7.16% 3,290 236 1.0069 1.0123\n\nY || -2-2 || Y 0 0 0 0.00% 0 0 0.9890 0.9934 0 0 0 0.00% 0 0 1.0069 1.0123\n\nY || 3-5 || N 190,297 45,301,215 4,605 2.42% 9,836 238 1.0177 1.0111 213,537 58,724,802 17,349 8.12% 3,385 275 1.0098 1.0181\n\nY || 3-5 || Y 0 0 0 0.00% 0 0 1.0177 1.0111 0 0 0 0.00% 0 0 1.0098 1.0181\n\nY || 6-8 || N 168,423 39,256,208 4,087 2.43% 9,605 233 0.9976 1.0189 188,642 52,764,263 15,575 8.26% 3,388 280 1.0138 1.0234\n\nY || 6-8 || Y 0 0 0 0.00% 0 0 0.9976 1.0189 0 0 0 0.00% 0 0 1.0138 1.0234\n\nY || 9-11 || N 121,437 28,117,097 2,923 2.41% 9,620 232 1.0031 1.0218 132,994 37,664,613 11,348 8.53% 3,319 283 1.0462 1.0630\n\nY || 9-11 || Y 0 0 0 0.00% 0 0 1.0031 1.0218 0 0 0 0.00% 0 0 1.0462 1.0630\n\nY || 12-14 || N 95,871 20,598,229 2,112 2.20% 9,753 215 1.0326 1.0473 102,199 27,516,822 8,166 7.99% 3,370 269 1.0691 1.0559\n\nY || 12-14 || Y 0 0 0 0.00% 0 0 1.0326 1.0473 0 0 0 0.00% 0 0 1.0691 1.0559\n\nY || 15-17 || N 63,416 14,046,080 1,448 2.28% 9,698 221 1.1653 1.1371 67,022 17,202,762 5,011 7.48% 3,433 257 1.0892 1.0835\n\nY || 15-17 || Y 0 0 0 0.00% 0 0 1.1653 1.1371 0 0 0 0.00% 0 0 1.0892 1.0835\n\nY || 18+ || N 52,881 8,777,640 943 1.78% 9,307 166 1.0961 1.0808 55,044 12,545,865 3,439 6.25% 3,648 228 1.1177 1.1076\n\nY || 18+ || Y 0 0 0 0.00% 0 0 1.0961 1.0808 0 0 0 0.00% 0 0 1.1177 1.1076\n\n\\# Proprietary Full Coverage by Tow Page 155","publish_date":null,"title":"Full Coverage by Tow Full Coverage by Tow Page 155","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1087.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1087.pdf"},"request":{"example_id":"table/BRWS-134565917_page1087","product_type":"parse","source_file_path":"BRWS-134565917_page1087.pdf"},"started_at":"2026-11-04T19:48:00.046255"} +{"completed_at":"2026-11-04T19:48:02.899725","latency_in_ms":1523,"output":{"example_id":"table/BRWS-134565917_page1100","grounded_pages":[],"layout_pages":[],"markdown":"In this filing, we are proposing an overall rate change of -1.9%. The actuarial exhibits and this memorandum will provide support for the proposed rate change.\n\nCredibility The amount of credibility for each coverage indication is determined by the square root of the ultimate claim count in the experience period divided by the standard below.\n\nThe credibility standards vary by coverage as shown in the following table. A classical credibility method is used to determine the claim frequency in which there is a 95% probability that the standard is within 7.5% of the actual underlying frequency. This is then multiplied by a factor that measures the variance of the underlying distribution of claim costs.\n\nCoverage Standard\n\nBodily Injury 1876\n\nProperty Damage 1735\n\nUninsured Motorists Bodily Injury 2097\n\nUninsured Motorists Property Damage 1882\n\nComprehensive 3876\n\nCollision 1613\n\nMedical Payments 2536\n\nPersonal Injury Protection 1330\n\nThe complement of credibility for the coverage indications is based on the future net trend and is adjusted to reflect the time period from the last rate change to the effective date of the proposed rates. This time period can be capped if significant time has passed since the last rate change.\n\nThe formula is: (1 + Future Net Trend)^(Years between current approved rates and proposed effective date)\n\nRate Level Adjustment Factor The methodology to calculate the Rate Level Adjustment Factors is similar to the parallelogram method described in the \"Basic Ratemaking\" paper by Geoff Werner and Claudine Modlin. The difference is instead of assuming a uniform earning of the premium, we use the actual proportion of earned premium associated with each of the various rate levels.\n\nPremium Trend The premium trend factor is comprised of a historical trend factor and future trend factor. The historical trend period is from the midpoint of each quarter in the experience period to the midpoint of the most recent quarter. The future trend period is from the midpoint of the current quarter to the midpoint of the proposed effective period.\n\n**Actuarial Memorandum**\n\nBristol West Insurance Company\n\nMissouri - Select 2.0\n\n\\# Proprietary","pages":[{"line_numbers":[],"markdown":"In this filing, we are proposing an overall rate change of -1.9%. The actuarial exhibits and this memorandum will provide support for the proposed rate change.\n\nCredibility The amount of credibility for each coverage indication is determined by the square root of the ultimate claim count in the experience period divided by the standard below.\n\nThe credibility standards vary by coverage as shown in the following table. A classical credibility method is used to determine the claim frequency in which there is a 95% probability that the standard is within 7.5% of the actual underlying frequency. This is then multiplied by a factor that measures the variance of the underlying distribution of claim costs.\n\nCoverage Standard\n\nBodily Injury 1876\n\nProperty Damage 1735\n\nUninsured Motorists Bodily Injury 2097\n\nUninsured Motorists Property Damage 1882\n\nComprehensive 3876\n\nCollision 1613\n\nMedical Payments 2536\n\nPersonal Injury Protection 1330\n\nThe complement of credibility for the coverage indications is based on the future net trend and is adjusted to reflect the time period from the last rate change to the effective date of the proposed rates. This time period can be capped if significant time has passed since the last rate change.\n\nThe formula is: (1 + Future Net Trend)^(Years between current approved rates and proposed effective date)\n\nRate Level Adjustment Factor The methodology to calculate the Rate Level Adjustment Factors is similar to the parallelogram method described in the \"Basic Ratemaking\" paper by Geoff Werner and Claudine Modlin. The difference is instead of assuming a uniform earning of the premium, we use the actual proportion of earned premium associated with each of the various rate levels.\n\nPremium Trend The premium trend factor is comprised of a historical trend factor and future trend factor. The historical trend period is from the midpoint of each quarter in the experience period to the midpoint of the most recent quarter. The future trend period is from the midpoint of the current quarter to the midpoint of the proposed effective period.\n\n**Actuarial Memorandum**\n\nBristol West Insurance Company\n\nMissouri - Select 2.0\n\n\\# Proprietary","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"In this filing, we are proposing an overall rate change of -1.9%. The actuarial exhibits and this memorandum will provide support for the proposed rate change.\n\nCredibility The amount of credibility for each coverage indication is determined by the square root of the ultimate claim count in the experience period divided by the standard below.\n\nThe credibility standards vary by coverage as shown in the following table. A classical credibility method is used to determine the claim frequency in which there is a 95% probability that the standard is within 7.5% of the actual underlying frequency. This is then multiplied by a factor that measures the variance of the underlying distribution of claim costs.\n\nCoverage Standard\n\nBodily Injury 1876\n\nProperty Damage 1735\n\nUninsured Motorists Bodily Injury 2097\n\nUninsured Motorists Property Damage 1882\n\nComprehensive 3876\n\nCollision 1613\n\nMedical Payments 2536\n\nPersonal Injury Protection 1330\n\nThe complement of credibility for the coverage indications is based on the future net trend and is adjusted to reflect the time period from the last rate change to the effective date of the proposed rates. This time period can be capped if significant time has passed since the last rate change.\n\nThe formula is: (1 + Future Net Trend)^(Years between current approved rates and proposed effective date)\n\nRate Level Adjustment Factor The methodology to calculate the Rate Level Adjustment Factors is similar to the parallelogram method described in the \"Basic Ratemaking\" paper by Geoff Werner and Claudine Modlin. The difference is instead of assuming a uniform earning of the premium, we use the actual proportion of earned premium associated with each of the various rate levels.\n\nPremium Trend The premium trend factor is comprised of a historical trend factor and future trend factor. The historical trend period is from the midpoint of each quarter in the experience period to the midpoint of the most recent quarter. The future trend period is from the midpoint of the current quarter to the midpoint of the proposed effective period.\n\n**Actuarial Memorandum**\n\nBristol West Insurance Company\n\nMissouri - Select 2.0\n\n\\# Proprietary","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1100.pdf"]},"response":{"errors":[],"extract_id":"extract_ff804ea099c7e806d5923e274434be42","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["In this filing, we are proposing an overall rate change of -1.9%. The actuarial exhibits and this memorandum will provide support for the proposed rate change.\n\nCredibility The amount of credibility for each coverage indication is determined by the square root of the ultimate claim count in the experience period divided by the standard below.\n\nThe credibility standards vary by coverage as shown in the following table. A classical credibility method is used to determine the claim frequency in which there is a 95% probability that the standard is within 7.5% of the actual underlying frequency. This is then multiplied by a factor that measures the variance of the underlying distribution of claim costs.\n\nCoverage Standard\n\nBodily Injury 1876\n\nProperty Damage 1735\n\nUninsured Motorists Bodily Injury 2097\n\nUninsured Motorists Property Damage 1882\n\nComprehensive 3876\n\nCollision 1613\n\nMedical Payments 2536\n\nPersonal Injury Protection 1330\n\nThe complement of credibility for the coverage indications is based on the future net trend and is adjusted to reflect the time period from the last rate change to the effective date of the proposed rates. This time period can be capped if significant time has passed since the last rate change.\n\nThe formula is: (1 + Future Net Trend)^(Years between current approved rates and proposed effective date)\n\nRate Level Adjustment Factor The methodology to calculate the Rate Level Adjustment Factors is similar to the parallelogram method described in the \"Basic Ratemaking\" paper by Geoff Werner and Claudine Modlin. The difference is instead of assuming a uniform earning of the premium, we use the actual proportion of earned premium associated with each of the various rate levels.\n\nPremium Trend The premium trend factor is comprised of a historical trend factor and future trend factor. The historical trend period is from the midpoint of each quarter in the experience period to the midpoint of the most recent quarter. The future trend period is from the midpoint of the current quarter to the midpoint of the proposed effective period.\n\n**Actuarial Memorandum**\n\nBristol West Insurance Company\n\nMissouri - Select 2.0\n\n\\# Proprietary"],"full_content":"In this filing, we are proposing an overall rate change of -1.9%. The actuarial exhibits and this memorandum will provide support for the proposed rate change.\n\nCredibility The amount of credibility for each coverage indication is determined by the square root of the ultimate claim count in the experience period divided by the standard below.\n\nThe credibility standards vary by coverage as shown in the following table. A classical credibility method is used to determine the claim frequency in which there is a 95% probability that the standard is within 7.5% of the actual underlying frequency. This is then multiplied by a factor that measures the variance of the underlying distribution of claim costs.\n\nCoverage Standard\n\nBodily Injury 1876\n\nProperty Damage 1735\n\nUninsured Motorists Bodily Injury 2097\n\nUninsured Motorists Property Damage 1882\n\nComprehensive 3876\n\nCollision 1613\n\nMedical Payments 2536\n\nPersonal Injury Protection 1330\n\nThe complement of credibility for the coverage indications is based on the future net trend and is adjusted to reflect the time period from the last rate change to the effective date of the proposed rates. This time period can be capped if significant time has passed since the last rate change.\n\nThe formula is: (1 + Future Net Trend)^(Years between current approved rates and proposed effective date)\n\nRate Level Adjustment Factor The methodology to calculate the Rate Level Adjustment Factors is similar to the parallelogram method described in the \"Basic Ratemaking\" paper by Geoff Werner and Claudine Modlin. The difference is instead of assuming a uniform earning of the premium, we use the actual proportion of earned premium associated with each of the various rate levels.\n\nPremium Trend The premium trend factor is comprised of a historical trend factor and future trend factor. The historical trend period is from the midpoint of each quarter in the experience period to the midpoint of the most recent quarter. The future trend period is from the midpoint of the current quarter to the midpoint of the proposed effective period.\n\n**Actuarial Memorandum**\n\nBristol West Insurance Company\n\nMissouri - Select 2.0\n\n\\# Proprietary","publish_date":null,"title":"Actuarial Memorandum Bristol West Insurance Company Missouri - Select 2.0 In this filing, we are proposing an overall rate change","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1100.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1100.pdf"},"request":{"example_id":"table/BRWS-134565917_page1100","product_type":"parse","source_file_path":"BRWS-134565917_page1100.pdf"},"started_at":"2026-11-04T19:48:01.376130"} +{"completed_at":"2026-11-04T19:48:04.357743","latency_in_ms":1439,"output":{"example_id":"table/BRWS-134565917_page1103","grounded_pages":[],"layout_pages":[],"markdown":"**Rate Indication Summary**\n\n**Coverage**\n\n**Trended Earned**\n\n**Premium at Current Rate**\n\n**Level**\n\n**Indicated Rate**\n\n**Change Credibility**\n\n**Credibility**\n\n**Complement**\n\n**Credibility Weighted**\n\n**Indicated Rate**\n\n**Change**\n\n**Selected Rate**\n\n**Change**\n\nBodily Injury 7,989,906 -16.6% 54.3% 1.8% -8.2% -14.5%\n\nProperty Damage 7,281,780 4.2% 100.0% 2.0% 4.2% 4.2%\n\nMedical Payments 203,743 -2.7% 17.7% 3.3% 2.3% -0.1%\n\nUninsured Motorist (Bodily Injury) 3,885,169 5.1% 28.9% 6.0% 5.7% 5.1%\n\nCollision 4,351,159 1.5% 63.8% 2.6% 1.9% 1.5%\n\nComprehensive 2,544,138 3.0% 39.4% 1.4% 2.0% 2.4%\n\n**Total 26,255,895 -2.6% 0.0% -1.9%**\n\n**Rate Indication Summary**\n\n**Bristol West Insurance Company**\n\n**Missouri - Select 2.0**\n\n**Date Valued as of 3/31/2025**\n\n\\# Proprietary","pages":[{"line_numbers":[],"markdown":"**Rate Indication Summary**\n\n**Coverage**\n\n**Trended Earned**\n\n**Premium at Current Rate**\n\n**Level**\n\n**Indicated Rate**\n\n**Change Credibility**\n\n**Credibility**\n\n**Complement**\n\n**Credibility Weighted**\n\n**Indicated Rate**\n\n**Change**\n\n**Selected Rate**\n\n**Change**\n\nBodily Injury 7,989,906 -16.6% 54.3% 1.8% -8.2% -14.5%\n\nProperty Damage 7,281,780 4.2% 100.0% 2.0% 4.2% 4.2%\n\nMedical Payments 203,743 -2.7% 17.7% 3.3% 2.3% -0.1%\n\nUninsured Motorist (Bodily Injury) 3,885,169 5.1% 28.9% 6.0% 5.7% 5.1%\n\nCollision 4,351,159 1.5% 63.8% 2.6% 1.9% 1.5%\n\nComprehensive 2,544,138 3.0% 39.4% 1.4% 2.0% 2.4%\n\n**Total 26,255,895 -2.6% 0.0% -1.9%**\n\n**Rate Indication Summary**\n\n**Bristol West Insurance Company**\n\n**Missouri - Select 2.0**\n\n**Date Valued as of 3/31/2025**\n\n\\# Proprietary","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Rate Indication Summary**\n\n**Coverage**\n\n**Trended Earned**\n\n**Premium at Current Rate**\n\n**Level**\n\n**Indicated Rate**\n\n**Change Credibility**\n\n**Credibility**\n\n**Complement**\n\n**Credibility Weighted**\n\n**Indicated Rate**\n\n**Change**\n\n**Selected Rate**\n\n**Change**\n\nBodily Injury 7,989,906 -16.6% 54.3% 1.8% -8.2% -14.5%\n\nProperty Damage 7,281,780 4.2% 100.0% 2.0% 4.2% 4.2%\n\nMedical Payments 203,743 -2.7% 17.7% 3.3% 2.3% -0.1%\n\nUninsured Motorist (Bodily Injury) 3,885,169 5.1% 28.9% 6.0% 5.7% 5.1%\n\nCollision 4,351,159 1.5% 63.8% 2.6% 1.9% 1.5%\n\nComprehensive 2,544,138 3.0% 39.4% 1.4% 2.0% 2.4%\n\n**Total 26,255,895 -2.6% 0.0% -1.9%**\n\n**Rate Indication Summary**\n\n**Bristol West Insurance Company**\n\n**Missouri - Select 2.0**\n\n**Date Valued as of 3/31/2025**\n\n\\# Proprietary","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1103.pdf"]},"response":{"errors":[],"extract_id":"extract_53d528b253151ef9b2364158fd079751","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Rate Indication Summary**\n\n**Coverage**\n\n**Trended Earned**\n\n**Premium at Current Rate**\n\n**Level**\n\n**Indicated Rate**\n\n**Change Credibility**\n\n**Credibility**\n\n**Complement**\n\n**Credibility Weighted**\n\n**Indicated Rate**\n\n**Change**\n\n**Selected Rate**\n\n**Change**\n\nBodily Injury 7,989,906 -16.6% 54.3% 1.8% -8.2% -14.5%\n\nProperty Damage 7,281,780 4.2% 100.0% 2.0% 4.2% 4.2%\n\nMedical Payments 203,743 -2.7% 17.7% 3.3% 2.3% -0.1%\n\nUninsured Motorist (Bodily Injury) 3,885,169 5.1% 28.9% 6.0% 5.7% 5.1%\n\nCollision 4,351,159 1.5% 63.8% 2.6% 1.9% 1.5%\n\nComprehensive 2,544,138 3.0% 39.4% 1.4% 2.0% 2.4%\n\n**Total 26,255,895 -2.6% 0.0% -1.9%**\n\n**Rate Indication Summary**\n\n**Bristol West Insurance Company**\n\n**Missouri - Select 2.0**\n\n**Date Valued as of 3/31/2025**\n\n\\# Proprietary"],"full_content":"**Rate Indication Summary**\n\n**Coverage**\n\n**Trended Earned**\n\n**Premium at Current Rate**\n\n**Level**\n\n**Indicated Rate**\n\n**Change Credibility**\n\n**Credibility**\n\n**Complement**\n\n**Credibility Weighted**\n\n**Indicated Rate**\n\n**Change**\n\n**Selected Rate**\n\n**Change**\n\nBodily Injury 7,989,906 -16.6% 54.3% 1.8% -8.2% -14.5%\n\nProperty Damage 7,281,780 4.2% 100.0% 2.0% 4.2% 4.2%\n\nMedical Payments 203,743 -2.7% 17.7% 3.3% 2.3% -0.1%\n\nUninsured Motorist (Bodily Injury) 3,885,169 5.1% 28.9% 6.0% 5.7% 5.1%\n\nCollision 4,351,159 1.5% 63.8% 2.6% 1.9% 1.5%\n\nComprehensive 2,544,138 3.0% 39.4% 1.4% 2.0% 2.4%\n\n**Total 26,255,895 -2.6% 0.0% -1.9%**\n\n**Rate Indication Summary**\n\n**Bristol West Insurance Company**\n\n**Missouri - Select 2.0**\n\n**Date Valued as of 3/31/2025**\n\n\\# Proprietary","publish_date":null,"title":"Rate Indication Summary Bristol West Insurance Company Missouri - Select 2.0 Date Valued as of 3/31/2025 Rate Indication Summary Trended","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1103.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1103.pdf"},"request":{"example_id":"table/BRWS-134565917_page1103","product_type":"parse","source_file_path":"BRWS-134565917_page1103.pdf"},"started_at":"2026-11-04T19:48:02.918403"} +{"completed_at":"2026-11-04T19:48:05.862568","latency_in_ms":1503,"output":{"example_id":"table/BRWS-134565917_page1110","grounded_pages":[],"layout_pages":[],"markdown":"Proprietary\n\nObjection 1 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Core Tiers Could you please detail how each UW Tier Group is determined?\n\nResponse: UW Tier Group determination was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.","pages":[{"line_numbers":[],"markdown":"Proprietary\n\nObjection 1 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Core Tiers Could you please detail how each UW Tier Group is determined?\n\nResponse: UW Tier Group determination was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Proprietary\n\nObjection 1 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Core Tiers Could you please detail how each UW Tier Group is determined?\n\nResponse: UW Tier Group determination was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1110.pdf"]},"response":{"errors":[],"extract_id":"extract_d156a06751de9a5528b985e8069c0fe7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Proprietary\n\nObjection 1 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Core Tiers Could you please detail how each UW Tier Group is determined?\n\nResponse: UW Tier Group determination was not revised with this revision. Below is the mapping previously filed with BRWS-134207257."],"full_content":"Proprietary\n\nObjection 1 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Core Tiers Could you please detail how each UW Tier Group is determined?\n\nResponse: UW Tier Group determination was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.","publish_date":null,"title":"Objection 1 Applies To: Rates, Rate Manual (Rate) Comments: Regarding: Core Tiers Could you please detail how each UW Tier","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1110.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1110.pdf"},"request":{"example_id":"table/BRWS-134565917_page1110","product_type":"parse","source_file_path":"BRWS-134565917_page1110.pdf"},"started_at":"2026-11-04T19:48:04.359520"} +{"completed_at":"2026-11-04T19:48:07.185123","latency_in_ms":1700,"output":{"example_id":"table/BRWS-134565917_page1112","grounded_pages":[],"layout_pages":[],"markdown":"Proprietary\n\nObjection 2 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Core Tiers Regarding: Mean Bad Debt Could you please detail how each Credit Teir is determined?\n\nResponse: The Credit Tier determination was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.\n\nObjection 3 Applies To:\n\n Rates, Rate Manual (Rate)","pages":[{"line_numbers":[],"markdown":"Proprietary\n\nObjection 2 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Core Tiers Regarding: Mean Bad Debt Could you please detail how each Credit Teir is determined?\n\nResponse: The Credit Tier determination was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.\n\nObjection 3 Applies To:\n\n Rates, Rate Manual (Rate)","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Proprietary\n\nObjection 2 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Core Tiers Regarding: Mean Bad Debt Could you please detail how each Credit Teir is determined?\n\nResponse: The Credit Tier determination was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.\n\nObjection 3 Applies To:\n\n Rates, Rate Manual (Rate)","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1112.pdf"]},"response":{"errors":[],"extract_id":"extract_bb0b2f03b752f869de6c8531488d5e15","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Proprietary\n\nObjection 2 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Core Tiers Regarding: Mean Bad Debt Could you please detail how each Credit Teir is determined?\n\nResponse: The Credit Tier determination was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.\n\nObjection 3 Applies To:\n\n Rates, Rate Manual (Rate)"],"full_content":"Proprietary\n\nObjection 2 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Core Tiers Regarding: Mean Bad Debt Could you please detail how each Credit Teir is determined?\n\nResponse: The Credit Tier determination was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.\n\nObjection 3 Applies To:\n\n Rates, Rate Manual (Rate)","publish_date":null,"title":"Objection 2 Applies To: Rates, Rate Manual (Rate) Comments: Regarding: Core Tiers Regarding: Mean Bad Debt Could you please detail","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1112.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1112.pdf"},"request":{"example_id":"table/BRWS-134565917_page1112","product_type":"parse","source_file_path":"BRWS-134565917_page1112.pdf"},"started_at":"2026-11-04T19:48:05.484290"} +{"completed_at":"2026-11-04T19:48:08.419509","latency_in_ms":1226,"output":{"example_id":"table/BRWS-134565917_page1113","grounded_pages":[],"layout_pages":[],"markdown":"Proprietary\n\n**Comments:**\n\nRegarding: Driver Class Factors Could you please detail how each Driver Class Factors is determined?\n\nResponse: Driver Class is a matrix of marital status, gender and age. There are 4 marital status categories: Married (M), Single (S), Domestic Partnership (P) and Widow(er) (W). Gender categories are Male (M), Female (F) and Not Specified (X).\n\nObjection 4 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Points Factors Points Group Could you please detail how each point factor/ point group are determined?\n\nResponse: The points mapping and grouping was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.","pages":[{"line_numbers":[],"markdown":"Proprietary\n\n**Comments:**\n\nRegarding: Driver Class Factors Could you please detail how each Driver Class Factors is determined?\n\nResponse: Driver Class is a matrix of marital status, gender and age. There are 4 marital status categories: Married (M), Single (S), Domestic Partnership (P) and Widow(er) (W). Gender categories are Male (M), Female (F) and Not Specified (X).\n\nObjection 4 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Points Factors Points Group Could you please detail how each point factor/ point group are determined?\n\nResponse: The points mapping and grouping was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Proprietary\n\n**Comments:**\n\nRegarding: Driver Class Factors Could you please detail how each Driver Class Factors is determined?\n\nResponse: Driver Class is a matrix of marital status, gender and age. There are 4 marital status categories: Married (M), Single (S), Domestic Partnership (P) and Widow(er) (W). Gender categories are Male (M), Female (F) and Not Specified (X).\n\nObjection 4 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Points Factors Points Group Could you please detail how each point factor/ point group are determined?\n\nResponse: The points mapping and grouping was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1113.pdf"]},"response":{"errors":[],"extract_id":"extract_f50ab61d743c90b1a241b7915ab27577","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Proprietary\n\n**Comments:**\n\nRegarding: Driver Class Factors Could you please detail how each Driver Class Factors is determined?\n\nResponse: Driver Class is a matrix of marital status, gender and age. There are 4 marital status categories: Married (M), Single (S), Domestic Partnership (P) and Widow(er) (W). Gender categories are Male (M), Female (F) and Not Specified (X).\n\nObjection 4 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Points Factors Points Group Could you please detail how each point factor/ point group are determined?\n\nResponse: The points mapping and grouping was not revised with this revision. Below is the mapping previously filed with BRWS-134207257."],"full_content":"Proprietary\n\n**Comments:**\n\nRegarding: Driver Class Factors Could you please detail how each Driver Class Factors is determined?\n\nResponse: Driver Class is a matrix of marital status, gender and age. There are 4 marital status categories: Married (M), Single (S), Domestic Partnership (P) and Widow(er) (W). Gender categories are Male (M), Female (F) and Not Specified (X).\n\nObjection 4 Applies To:\n\n Rates, Rate Manual (Rate)\n\n**Comments:**\n\nRegarding: Points Factors Points Group Could you please detail how each point factor/ point group are determined?\n\nResponse: The points mapping and grouping was not revised with this revision. Below is the mapping previously filed with BRWS-134207257.","publish_date":null,"title":"Comments: Regarding: Driver Class Factors Could you please detail how each Driver Class Factors is determined? Response: Driver Class is","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1113.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1113.pdf"},"request":{"example_id":"table/BRWS-134565917_page1113","product_type":"parse","source_file_path":"BRWS-134565917_page1113.pdf"},"started_at":"2026-11-04T19:48:07.193409"} +{"completed_at":"2026-11-04T19:48:09.317019","latency_in_ms":1345,"output":{"example_id":"table/BRWS-134565917_page1121","grounded_pages":[],"layout_pages":[],"markdown":"**Rate Order of Calculation** **BI PD MP UIM UMBI COMP LOAN COLL Rental Towing**\n\n**Roadside Assistance AOE**\n\n**Factor Description BI PD MP UIM UMBI OTC ALL COL EXTR TL RA CEQ**\n\nAverage Driver (see tab) x x x x x x x x\n\nBase Rate $ $ $ $ $ $ $ $ $ $ $ $\n\nHousehold Structure Factor x x x x x x x x\n\nVehicle - Driver Exposure x x x x x x x x\n\nUW Rate Matrix Tier x x x x x x x x x x x\n\nTerritory x x x x x x x x\n\nSymbol x x x x x x x x\n\nVTI x x x x x x x x\n\nModel Year x x x x x x x x x x\n\nLimit x x x x x x x x x x x x\n\nDeductible x x x x x x x\n\nVehicle Adjustment Factor x x x x x x x x\n\nFull Coverage Factor x x x x x x x x x x\n\nPNI Age - Model Year Factor x x x x x x x x\n\n1 - Safe Driver Discount x x x x x x x x\n\n1 - Preferred Driver Discount x x x x x x x x\n\nMulti Car - Model Year Factor x x x x x x x x\n\nContinuous Insurance Discount x x x x x x x x\n\nFDL Factor x x x x x x x x\n\nAddress Matrix Factor x x x x x x x x\n\nExcluded Driver Factor x x x x x x x x\n\nOwnership/Policy Tenure Factor x x x x x x x x\n\nLeased Factor x x x x x x x x\n\nPrior Damage x x x x x x x x\n\nNumber of Prior Owners x x x x x x x x\n\nAdditional Driver Factor x x x x x x x x\n\nISI Score Factor x x x x x x x x\n\nVerified Mileage Factor x x x x x x x x\n\nPrior Insurance Activity x x x x x x x x\n\nDriver Background Tier x x x x x x x x\n\nPermissive User Accidents x x x x x x x x\n\n1 - Multipolicy Discount x x x x x x x x\n\n1 + Vehicle Use Surcharge x x x x x x x x x\n\n1 + Comp without Coll Surcharge x x x x x x x\n\n1 + SR22 Surcharge x x x x x x x x\n\nPolicy Term Factor x x x x x x x x x x x x\n\nChannel Factor x x x x x x x x\n\nCore Discount x x x x x x x x\n\nSDP Tier x x x x x x x x\n\nRate Capping Factor x x x x x x x x x x x x\n\nRate Level Adjustment Factor x x x x x x x x x x x x\n\nReturned Payment Factor x x x x x x x x\n\nReinstatement Factor x x x x x x x x\n\nEndorsement Factor x x x x x x x x\n\nMonthly Trend x x x x x x x x\n\n**Initial Premium = = = = = = = = = = = =**\n\nBad Debt Factor (see tab) x x x x x x x x x x x x\n\n1 - EFT/PIF Discount x x x x x x x x x x x\n\nPay Plan Factor x x x x x x x x **x**\n\n**Final Premium = = = = = = = = = = = =**\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Rate Order of Calculation** **BI PD MP UIM UMBI COMP LOAN COLL Rental Towing**\n\n**Roadside Assistance AOE**\n\n**Factor Description BI PD MP UIM UMBI OTC ALL COL EXTR TL RA CEQ**\n\nAverage Driver (see tab) x x x x x x x x\n\nBase Rate $ $ $ $ $ $ $ $ $ $ $ $\n\nHousehold Structure Factor x x x x x x x x\n\nVehicle - Driver Exposure x x x x x x x x\n\nUW Rate Matrix Tier x x x x x x x x x x x\n\nTerritory x x x x x x x x\n\nSymbol x x x x x x x x\n\nVTI x x x x x x x x\n\nModel Year x x x x x x x x x x\n\nLimit x x x x x x x x x x x x\n\nDeductible x x x x x x x\n\nVehicle Adjustment Factor x x x x x x x x\n\nFull Coverage Factor x x x x x x x x x x\n\nPNI Age - Model Year Factor x x x x x x x x\n\n1 - Safe Driver Discount x x x x x x x x\n\n1 - Preferred Driver Discount x x x x x x x x\n\nMulti Car - Model Year Factor x x x x x x x x\n\nContinuous Insurance Discount x x x x x x x x\n\nFDL Factor x x x x x x x x\n\nAddress Matrix Factor x x x x x x x x\n\nExcluded Driver Factor x x x x x x x x\n\nOwnership/Policy Tenure Factor x x x x x x x x\n\nLeased Factor x x x x x x x x\n\nPrior Damage x x x x x x x x\n\nNumber of Prior Owners x x x x x x x x\n\nAdditional Driver Factor x x x x x x x x\n\nISI Score Factor x x x x x x x x\n\nVerified Mileage Factor x x x x x x x x\n\nPrior Insurance Activity x x x x x x x x\n\nDriver Background Tier x x x x x x x x\n\nPermissive User Accidents x x x x x x x x\n\n1 - Multipolicy Discount x x x x x x x x\n\n1 + Vehicle Use Surcharge x x x x x x x x x\n\n1 + Comp without Coll Surcharge x x x x x x x\n\n1 + SR22 Surcharge x x x x x x x x\n\nPolicy Term Factor x x x x x x x x x x x x\n\nChannel Factor x x x x x x x x\n\nCore Discount x x x x x x x x\n\nSDP Tier x x x x x x x x\n\nRate Capping Factor x x x x x x x x x x x x\n\nRate Level Adjustment Factor x x x x x x x x x x x x\n\nReturned Payment Factor x x x x x x x x\n\nReinstatement Factor x x x x x x x x\n\nEndorsement Factor x x x x x x x x\n\nMonthly Trend x x x x x x x x\n\n**Initial Premium = = = = = = = = = = = =**\n\nBad Debt Factor (see tab) x x x x x x x x x x x x\n\n1 - EFT/PIF Discount x x x x x x x x x x x\n\nPay Plan Factor x x x x x x x x **x**\n\n**Final Premium = = = = = = = = = = = =**\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Rate Order of Calculation** **BI PD MP UIM UMBI COMP LOAN COLL Rental Towing**\n\n**Roadside Assistance AOE**\n\n**Factor Description BI PD MP UIM UMBI OTC ALL COL EXTR TL RA CEQ**\n\nAverage Driver (see tab) x x x x x x x x\n\nBase Rate $ $ $ $ $ $ $ $ $ $ $ $\n\nHousehold Structure Factor x x x x x x x x\n\nVehicle - Driver Exposure x x x x x x x x\n\nUW Rate Matrix Tier x x x x x x x x x x x\n\nTerritory x x x x x x x x\n\nSymbol x x x x x x x x\n\nVTI x x x x x x x x\n\nModel Year x x x x x x x x x x\n\nLimit x x x x x x x x x x x x\n\nDeductible x x x x x x x\n\nVehicle Adjustment Factor x x x x x x x x\n\nFull Coverage Factor x x x x x x x x x x\n\nPNI Age - Model Year Factor x x x x x x x x\n\n1 - Safe Driver Discount x x x x x x x x\n\n1 - Preferred Driver Discount x x x x x x x x\n\nMulti Car - Model Year Factor x x x x x x x x\n\nContinuous Insurance Discount x x x x x x x x\n\nFDL Factor x x x x x x x x\n\nAddress Matrix Factor x x x x x x x x\n\nExcluded Driver Factor x x x x x x x x\n\nOwnership/Policy Tenure Factor x x x x x x x x\n\nLeased Factor x x x x x x x x\n\nPrior Damage x x x x x x x x\n\nNumber of Prior Owners x x x x x x x x\n\nAdditional Driver Factor x x x x x x x x\n\nISI Score Factor x x x x x x x x\n\nVerified Mileage Factor x x x x x x x x\n\nPrior Insurance Activity x x x x x x x x\n\nDriver Background Tier x x x x x x x x\n\nPermissive User Accidents x x x x x x x x\n\n1 - Multipolicy Discount x x x x x x x x\n\n1 + Vehicle Use Surcharge x x x x x x x x x\n\n1 + Comp without Coll Surcharge x x x x x x x\n\n1 + SR22 Surcharge x x x x x x x x\n\nPolicy Term Factor x x x x x x x x x x x x\n\nChannel Factor x x x x x x x x\n\nCore Discount x x x x x x x x\n\nSDP Tier x x x x x x x x\n\nRate Capping Factor x x x x x x x x x x x x\n\nRate Level Adjustment Factor x x x x x x x x x x x x\n\nReturned Payment Factor x x x x x x x x\n\nReinstatement Factor x x x x x x x x\n\nEndorsement Factor x x x x x x x x\n\nMonthly Trend x x x x x x x x\n\n**Initial Premium = = = = = = = = = = = =**\n\nBad Debt Factor (see tab) x x x x x x x x x x x x\n\n1 - EFT/PIF Discount x x x x x x x x x x x\n\nPay Plan Factor x x x x x x x x **x**\n\n**Final Premium = = = = = = = = = = = =**\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1121.pdf"]},"response":{"errors":[],"extract_id":"extract_3454adfaa75866423f0341ba7a190176","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Rate Order of Calculation** **BI PD MP UIM UMBI COMP LOAN COLL Rental Towing**\n\n**Roadside Assistance AOE**\n\n**Factor Description BI PD MP UIM UMBI OTC ALL COL EXTR TL RA CEQ**\n\nAverage Driver (see tab) x x x x x x x x\n\nBase Rate $ $ $ $ $ $ $ $ $ $ $ $\n\nHousehold Structure Factor x x x x x x x x\n\nVehicle - Driver Exposure x x x x x x x x\n\nUW Rate Matrix Tier x x x x x x x x x x x\n\nTerritory x x x x x x x x\n\nSymbol x x x x x x x x\n\nVTI x x x x x x x x\n\nModel Year x x x x x x x x x x\n\nLimit x x x x x x x x x x x x\n\nDeductible x x x x x x x\n\nVehicle Adjustment Factor x x x x x x x x\n\nFull Coverage Factor x x x x x x x x x x\n\nPNI Age - Model Year Factor x x x x x x x x\n\n1 - Safe Driver Discount x x x x x x x x\n\n1 - Preferred Driver Discount x x x x x x x x\n\nMulti Car - Model Year Factor x x x x x x x x\n\nContinuous Insurance Discount x x x x x x x x\n\nFDL Factor x x x x x x x x\n\nAddress Matrix Factor x x x x x x x x\n\nExcluded Driver Factor x x x x x x x x\n\nOwnership/Policy Tenure Factor x x x x x x x x\n\nLeased Factor x x x x x x x x\n\nPrior Damage x x x x x x x x\n\nNumber of Prior Owners x x x x x x x x\n\nAdditional Driver Factor x x x x x x x x\n\nISI Score Factor x x x x x x x x\n\nVerified Mileage Factor x x x x x x x x\n\nPrior Insurance Activity x x x x x x x x\n\nDriver Background Tier x x x x x x x x\n\nPermissive User Accidents x x x x x x x x\n\n1 - Multipolicy Discount x x x x x x x x\n\n1 + Vehicle Use Surcharge x x x x x x x x x\n\n1 + Comp without Coll Surcharge x x x x x x x\n\n1 + SR22 Surcharge x x x x x x x x\n\nPolicy Term Factor x x x x x x x x x x x x\n\nChannel Factor x x x x x x x x\n\nCore Discount x x x x x x x x\n\nSDP Tier x x x x x x x x\n\nRate Capping Factor x x x x x x x x x x x x\n\nRate Level Adjustment Factor x x x x x x x x x x x x\n\nReturned Payment Factor x x x x x x x x\n\nReinstatement Factor x x x x x x x x\n\nEndorsement Factor x x x x x x x x\n\nMonthly Trend x x x x x x x x\n\n**Initial Premium = = = = = = = = = = = =**\n\nBad Debt Factor (see tab) x x x x x x x x x x x x\n\n1 - EFT/PIF Discount x x x x x x x x x x x\n\nPay Plan Factor x x x x x x x x **x**\n\n**Final Premium = = = = = = = = = = = =**\n\n**Proposed**"],"full_content":"**Rate Order of Calculation** **BI PD MP UIM UMBI COMP LOAN COLL Rental Towing**\n\n**Roadside Assistance AOE**\n\n**Factor Description BI PD MP UIM UMBI OTC ALL COL EXTR TL RA CEQ**\n\nAverage Driver (see tab) x x x x x x x x\n\nBase Rate $ $ $ $ $ $ $ $ $ $ $ $\n\nHousehold Structure Factor x x x x x x x x\n\nVehicle - Driver Exposure x x x x x x x x\n\nUW Rate Matrix Tier x x x x x x x x x x x\n\nTerritory x x x x x x x x\n\nSymbol x x x x x x x x\n\nVTI x x x x x x x x\n\nModel Year x x x x x x x x x x\n\nLimit x x x x x x x x x x x x\n\nDeductible x x x x x x x\n\nVehicle Adjustment Factor x x x x x x x x\n\nFull Coverage Factor x x x x x x x x x x\n\nPNI Age - Model Year Factor x x x x x x x x\n\n1 - Safe Driver Discount x x x x x x x x\n\n1 - Preferred Driver Discount x x x x x x x x\n\nMulti Car - Model Year Factor x x x x x x x x\n\nContinuous Insurance Discount x x x x x x x x\n\nFDL Factor x x x x x x x x\n\nAddress Matrix Factor x x x x x x x x\n\nExcluded Driver Factor x x x x x x x x\n\nOwnership/Policy Tenure Factor x x x x x x x x\n\nLeased Factor x x x x x x x x\n\nPrior Damage x x x x x x x x\n\nNumber of Prior Owners x x x x x x x x\n\nAdditional Driver Factor x x x x x x x x\n\nISI Score Factor x x x x x x x x\n\nVerified Mileage Factor x x x x x x x x\n\nPrior Insurance Activity x x x x x x x x\n\nDriver Background Tier x x x x x x x x\n\nPermissive User Accidents x x x x x x x x\n\n1 - Multipolicy Discount x x x x x x x x\n\n1 + Vehicle Use Surcharge x x x x x x x x x\n\n1 + Comp without Coll Surcharge x x x x x x x\n\n1 + SR22 Surcharge x x x x x x x x\n\nPolicy Term Factor x x x x x x x x x x x x\n\nChannel Factor x x x x x x x x\n\nCore Discount x x x x x x x x\n\nSDP Tier x x x x x x x x\n\nRate Capping Factor x x x x x x x x x x x x\n\nRate Level Adjustment Factor x x x x x x x x x x x x\n\nReturned Payment Factor x x x x x x x x\n\nReinstatement Factor x x x x x x x x\n\nEndorsement Factor x x x x x x x x\n\nMonthly Trend x x x x x x x x\n\n**Initial Premium = = = = = = = = = = = =**\n\nBad Debt Factor (see tab) x x x x x x x x x x x x\n\n1 - EFT/PIF Discount x x x x x x x x x x x\n\nPay Plan Factor x x x x x x x x **x**\n\n**Final Premium = = = = = = = = = = = =**\n\n**Proposed**","publish_date":null,"title":"Proposed Roadside MP UIM UMBI COMP LOAN COLL Rental Towing Assistance BI PD AOE Rate Order of Calculation UIM UMBI","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1121.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1121.pdf"},"request":{"example_id":"table/BRWS-134565917_page1121","product_type":"parse","source_file_path":"BRWS-134565917_page1121.pdf"},"started_at":"2026-11-04T19:48:07.971106"} +{"completed_at":"2026-11-04T19:48:11.643801","latency_in_ms":2075,"output":{"example_id":"table/BRWS-134565917_page1123","grounded_pages":[],"layout_pages":[],"markdown":"**Core Tiers**\n\n**UW Tier Group Credit Tier BI Core Tier**\n\n**UW Tier Group Credit Tier PD Core Tier**\n\n**UW Tier Group Credit Tier PI Core Tier**\n\n**UW Tier Group Credit Tier CM Core Tier**\n\n**UW Tier Group Credit Tier CL Core Tier**\n\n1 A B1 1 A P1 1 A F1 1 A O1 1 A C1\n\n1 B B1 1 B P1 1 B F1 1 B O1 1 B C1\n\n1 C B1 1 C P1 1 C F1 1 C O1 1 C C1\n\n1 D B1 1 D P1 1 D F1 1 D O1 1 D C1\n\n1 E B1 1 E P1 1 E F1 1 E O1 1 E C1\n\n1 F B1 1 F P1 1 F F1 1 F O1 1 F C1\n\n1 G B1 1 G P1 1 G F1 1 G O2 1 G C1\n\n1 H B1 1 H P2 1 H F1 1 H O2 1 H C2\n\n1 I B1 1 I P2 1 I F2 1 I O2 1 I C2\n\n1 J B2 1 J P2 1 J F2 1 J O2 1 J C2\n\n1 K B2 1 K P2 1 K F2 1 K O2 1 K C2\n\n1 L B2 1 L P2 1 L F2 1 L O2 1 L C2\n\n1 M B2 1 M P2 1 M F2 1 M O2 1 M C2\n\n1 N B2 1 N P2 1 N F2 1 N O2 1 N C2\n\n1 O B2 1 O P2 1 O F2 1 O O3 1 O C3\n\n1 P B2 1 P P3 1 P F2 1 P O3 1 P C3\n\n1 Q B3 1 Q P3 1 Q F2 1 Q O3 1 Q C3\n\n1 R B3 1 R P3 1 R F2 1 R O3 1 R C3\n\n1 S B3 1 S P3 1 S F2 1 S O4 1 S C3\n\n1 T B3 1 T P3 1 T F3 1 T O4 1 T C4\n\n1 U B4 1 U P3 1 U F3 1 U O4 1 U C4\n\n1 V B4 1 V P3 1 V F3 1 V O4 1 V C4\n\n1 W B4 1 W P4 1 W F3 1 W O4 1 W C5\n\n1 X B4 1 X P4 1 X F3 1 X O4 1 X C5\n\n1 Y B4 1 Y P4 1 Y F5 1 Y O5 1 Y C5\n\n1 ZD B4 1 ZD P4 1 ZD F3 1 ZD O4 1 ZD C5\n\n1 ZE B4 1 ZE P4 1 ZE F3 1 ZE O4 1 ZE C5\n\n1 ZF B4 1 ZF P4 1 ZF F5 1 ZF O5 1 ZF C5\n\n1 ZG B4 1 ZG P4 1 ZG F5 1 ZG O5 1 ZG C5\n\n1 ZH B4 1 ZH P4 1 ZH F5 1 ZH O5 1 ZH C5\n\n1 ZJ B4 1 ZJ P4 1 ZJ F5 1 ZJ O5 1 ZJ C5\n\n1 ZK B4 1 ZK P4 1 ZK F5 1 ZK O5 1 ZK C5\n\n1 ZL B4 1 ZL P4 1 ZL F5 1 ZL O5 1 ZL C5\n\n2 A B1 2 A P2 2 A F1 2 A O1 2 A C1\n\n2 B B1 2 B P2 2 B F2 2 B O2 2 B C2\n\n2 C B1 2 C P2 2 C F2 2 C O2 2 C C2\n\n2 D B2 2 D P2 2 D F3 2 D O2 2 D C2\n\n2 E B2 2 E P2 2 E F3 2 E O2 2 E C3\n\n2 F B2 2 F P2 2 F F3 2 F O3 2 F C3\n\n2 G B2 2 G P2 2 G F3 2 G O3 2 G C3\n\n2 H B2 2 H P3 2 H F3 2 H O3 2 H C3\n\n2 I B2 2 I P3 2 I F3 2 I O3 2 I C3\n\n2 J B3 2 J P3 2 J F3 2 J O3 2 J C3\n\n2 K B3 2 K P3 2 K F4 2 K O3 2 K C3\n\n2 L B3 2 L P3 2 L F4 2 L O3 2 L C4\n\n2 M B4 2 M P3 2 M F4 2 M O3 2 M C4\n\n2 N B4 2 N P3 2 N F4 2 N O3 2 N C4\n\n2 O B4 2 O P4 2 O F4 2 O O4 2 O C4\n\n2 P B4 2 P P4 2 P F4 2 P O4 2 P C4\n\n2 Q B4 2 Q P4 2 Q F5 2 Q O4 2 Q C5\n\n2 R B4 2 R P4 2 R F5 2 R O5 2 R C5\n\n2 S B4 2 S P4 2 S F5 2 S O5 2 S C5\n\n2 T B4 2 T P5 2 T F5 2 T O5 2 T C5\n\n2 U B5 2 U P5 2 U F5 2 U O5 2 U C5\n\n2 V B5 2 V P5 2 V F5 2 V O5 2 V C5\n\n2 W B5 2 W P5 2 W F5 2 W O5 2 W C5\n\n2 X B5 2 X P5 2 X F5 2 X O5 2 X C5\n\n2 Y B5 2 Y P5 2 Y F5 2 Y O5 2 Y C5\n\n2 ZD B5 2 ZD P5 2 ZD F5 2 ZD O5 2 ZD C5\n\n2 ZE B5 2 ZE P5 2 ZE F5 2 ZE O5 2 ZE C5\n\n2 ZF B5 2 ZF P5 2 ZF F5 2 ZF O5 2 ZF C5\n\n2 ZG B5 2 ZG P5 2 ZG F5 2 ZG O5 2 ZG C5\n\n2 ZH B5 2 ZH P5 2 ZH F5 2 ZH O5 2 ZH C5\n\n2 ZJ B5 2 ZJ P5 2 ZJ F5 2 ZJ O5 2 ZJ C5\n\n2 ZK B5 2 ZK P5 2 ZK F5 2 ZK O5 2 ZK C5\n\n2 ZL B5 2 ZL P5 2 ZL F5 2 ZL O5 2 ZL C5\n\n3 A B1 3 A P1 3 A F1 3 A O1 3 A C1\n\n3 B B1 3 B P1 3 B F1 3 B O1 3 B C1\n\n3 C B1 3 C P1 3 C F1 3 C O1 3 C C1\n\n3 D B1 3 D P1 3 D F1 3 D O1 3 D C1\n\n3 E B2 3 E P1 3 E F1 3 E O2 3 E C2\n\n3 F B2 3 F P1 3 F F1 3 F O2 3 F C2\n\n3 G B2 3 G P1 3 G F1 3 G O2 3 G C2\n\n3 H B2 3 H P2 3 H F2 3 H O2 3 H C2\n\n3 I B2 3 I P2 3 I F2 3 I O2 3 I C2\n\n3 J B2 3 J P2 3 J F2 3 J O2 3 J C2\n\n3 K B2 3 K P2 3 K F2 3 K O2 3 K C3\n\n3 L B3 3 L P2 3 L F2 3 L O2 3 L C3\n\n3 M B3 3 M P3 3 M F3 3 M O3 3 M C3\n\n3 N B3 3 N P3 3 N F3 3 N O3 3 N C3\n\n3 O B3 3 O P3 3 O F3 3 O O3 3 O C3\n\n3 P B3 3 P P3 3 P F3 3 P O4 3 P C3\n\n3 Q B3 3 Q P3 3 Q F3 3 Q O4 3 Q C4\n\n3 R B3 3 R P3 3 R F3 3 R O4 3 R C4\n\n3 S B4 3 S P3 3 S F3 3 S O4 3 S C4\n\n3 T B4 3 T P3 3 T F3 3 T O4 3 T C4\n\n3 U B4 3 U P4 3 U F3 3 U O4 3 U C4\n\n3 V B4 3 V P4 3 V F4 3 V O5 3 V C4\n\n3 W B4 3 W P4 3 W F4 3 W O5 3 W C5\n\n3 X B4 3 X P4 3 X F5 3 X O5 3 X C5\n\n3 Y B4 3 Y P4 3 Y F5 3 Y O5 3 Y C5\n\n3 ZD B4 3 ZD P4 3 ZD F4 3 ZD O5 3 ZD C5\n\n3 ZE B4 3 ZE P4 3 ZE F5 3 ZE O5 3 ZE C5\n\n3 ZF B4 3 ZF P4 3 ZF F5 3 ZF O5 3 ZF C5\n\n3 ZG B4 3 ZG P4 3 ZG F5 3 ZG O5 3 ZG C5\n\n3 ZH B4 3 ZH P4 3 ZH F5 3 ZH O5 3 ZH C5\n\n3 ZJ B4 3 ZJ P4 3 ZJ F5 3 ZJ O5 3 ZJ C5\n\n3 ZK B4 3 ZK P4 3 ZK F5 3 ZK O5 3 ZK C5\n\n3 ZL B4 3 ZL P4 3 ZL F5 3 ZL O5 3 ZL C5\n\n4 A B1 4 A P2 4 A F1 4 A O1 4 A C1\n\n4 B B1 4 B P2 4 B F2 4 B O2 4 B C2\n\n4 C B1 4 C P2 4 C F2 4 C O2 4 C C2\n\n4 D B2 4 D P2 4 D F3 4 D O2 4 D C2\n\n4 E B2 4 E P2 4 E F3 4 E O2 4 E C3\n\n4 F B2 4 F P2 4 F F3 4 F O3 4 F C3\n\n4 G B2 4 G P2 4 G F3 4 G O3 4 G C3\n\n4 H B2 4 H P3 4 H F3 4 H O3 4 H C3\n\n4 I B2 4 I P3 4 I F3 4 I O3 4 I C3\n\n4 J B3 4 J P3 4 J F3 4 J O3 4 J C3\n\n4 K B3 4 K P3 4 K F4 4 K O3 4 K C3\n\n4 L B3 4 L P3 4 L F4 4 L O3 4 L C4\n\n4 M B4 4 M P3 4 M F4 4 M O3 4 M C4\n\n4 N B4 4 N P3 4 N F4 4 N O3 4 N C4\n\n4 O B4 4 O P4 4 O F4 4 O O4 4 O C4\n\n4 P B4 4 P P4 4 P F4 4 P O4 4 P C4\n\n4 Q B4 4 Q P4 4 Q F5 4 Q O4 4 Q C5\n\n4 R B4 4 R P4 4 R F5 4 R O5 4 R C5\n\n4 S B4 4 S P4 4 S F5 4 S O5 4 S C5\n\n4 T B4 4 T P5 4 T F5 4 T O5 4 T C5\n\n4 U B5 4 U P5 4 U F5 4 U O5 4 U C5\n\n4 V B5 4 V P5 4 V F5 4 V O5 4 V C5\n\n4 W B5 4 W P5 4 W F5 4 W O5 4 W C5\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Core Tiers**\n\n**UW Tier Group Credit Tier BI Core Tier**\n\n**UW Tier Group Credit Tier PD Core Tier**\n\n**UW Tier Group Credit Tier PI Core Tier**\n\n**UW Tier Group Credit Tier CM Core Tier**\n\n**UW Tier Group Credit Tier CL Core Tier**\n\n1 A B1 1 A P1 1 A F1 1 A O1 1 A C1\n\n1 B B1 1 B P1 1 B F1 1 B O1 1 B C1\n\n1 C B1 1 C P1 1 C F1 1 C O1 1 C C1\n\n1 D B1 1 D P1 1 D F1 1 D O1 1 D C1\n\n1 E B1 1 E P1 1 E F1 1 E O1 1 E C1\n\n1 F B1 1 F P1 1 F F1 1 F O1 1 F C1\n\n1 G B1 1 G P1 1 G F1 1 G O2 1 G C1\n\n1 H B1 1 H P2 1 H F1 1 H O2 1 H C2\n\n1 I B1 1 I P2 1 I F2 1 I O2 1 I C2\n\n1 J B2 1 J P2 1 J F2 1 J O2 1 J C2\n\n1 K B2 1 K P2 1 K F2 1 K O2 1 K C2\n\n1 L B2 1 L P2 1 L F2 1 L O2 1 L C2\n\n1 M B2 1 M P2 1 M F2 1 M O2 1 M C2\n\n1 N B2 1 N P2 1 N F2 1 N O2 1 N C2\n\n1 O B2 1 O P2 1 O F2 1 O O3 1 O C3\n\n1 P B2 1 P P3 1 P F2 1 P O3 1 P C3\n\n1 Q B3 1 Q P3 1 Q F2 1 Q O3 1 Q C3\n\n1 R B3 1 R P3 1 R F2 1 R O3 1 R C3\n\n1 S B3 1 S P3 1 S F2 1 S O4 1 S C3\n\n1 T B3 1 T P3 1 T F3 1 T O4 1 T C4\n\n1 U B4 1 U P3 1 U F3 1 U O4 1 U C4\n\n1 V B4 1 V P3 1 V F3 1 V O4 1 V C4\n\n1 W B4 1 W P4 1 W F3 1 W O4 1 W C5\n\n1 X B4 1 X P4 1 X F3 1 X O4 1 X C5\n\n1 Y B4 1 Y P4 1 Y F5 1 Y O5 1 Y C5\n\n1 ZD B4 1 ZD P4 1 ZD F3 1 ZD O4 1 ZD C5\n\n1 ZE B4 1 ZE P4 1 ZE F3 1 ZE O4 1 ZE C5\n\n1 ZF B4 1 ZF P4 1 ZF F5 1 ZF O5 1 ZF C5\n\n1 ZG B4 1 ZG P4 1 ZG F5 1 ZG O5 1 ZG C5\n\n1 ZH B4 1 ZH P4 1 ZH F5 1 ZH O5 1 ZH C5\n\n1 ZJ B4 1 ZJ P4 1 ZJ F5 1 ZJ O5 1 ZJ C5\n\n1 ZK B4 1 ZK P4 1 ZK F5 1 ZK O5 1 ZK C5\n\n1 ZL B4 1 ZL P4 1 ZL F5 1 ZL O5 1 ZL C5\n\n2 A B1 2 A P2 2 A F1 2 A O1 2 A C1\n\n2 B B1 2 B P2 2 B F2 2 B O2 2 B C2\n\n2 C B1 2 C P2 2 C F2 2 C O2 2 C C2\n\n2 D B2 2 D P2 2 D F3 2 D O2 2 D C2\n\n2 E B2 2 E P2 2 E F3 2 E O2 2 E C3\n\n2 F B2 2 F P2 2 F F3 2 F O3 2 F C3\n\n2 G B2 2 G P2 2 G F3 2 G O3 2 G C3\n\n2 H B2 2 H P3 2 H F3 2 H O3 2 H C3\n\n2 I B2 2 I P3 2 I F3 2 I O3 2 I C3\n\n2 J B3 2 J P3 2 J F3 2 J O3 2 J C3\n\n2 K B3 2 K P3 2 K F4 2 K O3 2 K C3\n\n2 L B3 2 L P3 2 L F4 2 L O3 2 L C4\n\n2 M B4 2 M P3 2 M F4 2 M O3 2 M C4\n\n2 N B4 2 N P3 2 N F4 2 N O3 2 N C4\n\n2 O B4 2 O P4 2 O F4 2 O O4 2 O C4\n\n2 P B4 2 P P4 2 P F4 2 P O4 2 P C4\n\n2 Q B4 2 Q P4 2 Q F5 2 Q O4 2 Q C5\n\n2 R B4 2 R P4 2 R F5 2 R O5 2 R C5\n\n2 S B4 2 S P4 2 S F5 2 S O5 2 S C5\n\n2 T B4 2 T P5 2 T F5 2 T O5 2 T C5\n\n2 U B5 2 U P5 2 U F5 2 U O5 2 U C5\n\n2 V B5 2 V P5 2 V F5 2 V O5 2 V C5\n\n2 W B5 2 W P5 2 W F5 2 W O5 2 W C5\n\n2 X B5 2 X P5 2 X F5 2 X O5 2 X C5\n\n2 Y B5 2 Y P5 2 Y F5 2 Y O5 2 Y C5\n\n2 ZD B5 2 ZD P5 2 ZD F5 2 ZD O5 2 ZD C5\n\n2 ZE B5 2 ZE P5 2 ZE F5 2 ZE O5 2 ZE C5\n\n2 ZF B5 2 ZF P5 2 ZF F5 2 ZF O5 2 ZF C5\n\n2 ZG B5 2 ZG P5 2 ZG F5 2 ZG O5 2 ZG C5\n\n2 ZH B5 2 ZH P5 2 ZH F5 2 ZH O5 2 ZH C5\n\n2 ZJ B5 2 ZJ P5 2 ZJ F5 2 ZJ O5 2 ZJ C5\n\n2 ZK B5 2 ZK P5 2 ZK F5 2 ZK O5 2 ZK C5\n\n2 ZL B5 2 ZL P5 2 ZL F5 2 ZL O5 2 ZL C5\n\n3 A B1 3 A P1 3 A F1 3 A O1 3 A C1\n\n3 B B1 3 B P1 3 B F1 3 B O1 3 B C1\n\n3 C B1 3 C P1 3 C F1 3 C O1 3 C C1\n\n3 D B1 3 D P1 3 D F1 3 D O1 3 D C1\n\n3 E B2 3 E P1 3 E F1 3 E O2 3 E C2\n\n3 F B2 3 F P1 3 F F1 3 F O2 3 F C2\n\n3 G B2 3 G P1 3 G F1 3 G O2 3 G C2\n\n3 H B2 3 H P2 3 H F2 3 H O2 3 H C2\n\n3 I B2 3 I P2 3 I F2 3 I O2 3 I C2\n\n3 J B2 3 J P2 3 J F2 3 J O2 3 J C2\n\n3 K B2 3 K P2 3 K F2 3 K O2 3 K C3\n\n3 L B3 3 L P2 3 L F2 3 L O2 3 L C3\n\n3 M B3 3 M P3 3 M F3 3 M O3 3 M C3\n\n3 N B3 3 N P3 3 N F3 3 N O3 3 N C3\n\n3 O B3 3 O P3 3 O F3 3 O O3 3 O C3\n\n3 P B3 3 P P3 3 P F3 3 P O4 3 P C3\n\n3 Q B3 3 Q P3 3 Q F3 3 Q O4 3 Q C4\n\n3 R B3 3 R P3 3 R F3 3 R O4 3 R C4\n\n3 S B4 3 S P3 3 S F3 3 S O4 3 S C4\n\n3 T B4 3 T P3 3 T F3 3 T O4 3 T C4\n\n3 U B4 3 U P4 3 U F3 3 U O4 3 U C4\n\n3 V B4 3 V P4 3 V F4 3 V O5 3 V C4\n\n3 W B4 3 W P4 3 W F4 3 W O5 3 W C5\n\n3 X B4 3 X P4 3 X F5 3 X O5 3 X C5\n\n3 Y B4 3 Y P4 3 Y F5 3 Y O5 3 Y C5\n\n3 ZD B4 3 ZD P4 3 ZD F4 3 ZD O5 3 ZD C5\n\n3 ZE B4 3 ZE P4 3 ZE F5 3 ZE O5 3 ZE C5\n\n3 ZF B4 3 ZF P4 3 ZF F5 3 ZF O5 3 ZF C5\n\n3 ZG B4 3 ZG P4 3 ZG F5 3 ZG O5 3 ZG C5\n\n3 ZH B4 3 ZH P4 3 ZH F5 3 ZH O5 3 ZH C5\n\n3 ZJ B4 3 ZJ P4 3 ZJ F5 3 ZJ O5 3 ZJ C5\n\n3 ZK B4 3 ZK P4 3 ZK F5 3 ZK O5 3 ZK C5\n\n3 ZL B4 3 ZL P4 3 ZL F5 3 ZL O5 3 ZL C5\n\n4 A B1 4 A P2 4 A F1 4 A O1 4 A C1\n\n4 B B1 4 B P2 4 B F2 4 B O2 4 B C2\n\n4 C B1 4 C P2 4 C F2 4 C O2 4 C C2\n\n4 D B2 4 D P2 4 D F3 4 D O2 4 D C2\n\n4 E B2 4 E P2 4 E F3 4 E O2 4 E C3\n\n4 F B2 4 F P2 4 F F3 4 F O3 4 F C3\n\n4 G B2 4 G P2 4 G F3 4 G O3 4 G C3\n\n4 H B2 4 H P3 4 H F3 4 H O3 4 H C3\n\n4 I B2 4 I P3 4 I F3 4 I O3 4 I C3\n\n4 J B3 4 J P3 4 J F3 4 J O3 4 J C3\n\n4 K B3 4 K P3 4 K F4 4 K O3 4 K C3\n\n4 L B3 4 L P3 4 L F4 4 L O3 4 L C4\n\n4 M B4 4 M P3 4 M F4 4 M O3 4 M C4\n\n4 N B4 4 N P3 4 N F4 4 N O3 4 N C4\n\n4 O B4 4 O P4 4 O F4 4 O O4 4 O C4\n\n4 P B4 4 P P4 4 P F4 4 P O4 4 P C4\n\n4 Q B4 4 Q P4 4 Q F5 4 Q O4 4 Q C5\n\n4 R B4 4 R P4 4 R F5 4 R O5 4 R C5\n\n4 S B4 4 S P4 4 S F5 4 S O5 4 S C5\n\n4 T B4 4 T P5 4 T F5 4 T O5 4 T C5\n\n4 U B5 4 U P5 4 U F5 4 U O5 4 U C5\n\n4 V B5 4 V P5 4 V F5 4 V O5 4 V C5\n\n4 W B5 4 W P5 4 W F5 4 W O5 4 W C5\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Core Tiers**\n\n**UW Tier Group Credit Tier BI Core Tier**\n\n**UW Tier Group Credit Tier PD Core Tier**\n\n**UW Tier Group Credit Tier PI Core Tier**\n\n**UW Tier Group Credit Tier CM Core Tier**\n\n**UW Tier Group Credit Tier CL Core Tier**\n\n1 A B1 1 A P1 1 A F1 1 A O1 1 A C1\n\n1 B B1 1 B P1 1 B F1 1 B O1 1 B C1\n\n1 C B1 1 C P1 1 C F1 1 C O1 1 C C1\n\n1 D B1 1 D P1 1 D F1 1 D O1 1 D C1\n\n1 E B1 1 E P1 1 E F1 1 E O1 1 E C1\n\n1 F B1 1 F P1 1 F F1 1 F O1 1 F C1\n\n1 G B1 1 G P1 1 G F1 1 G O2 1 G C1\n\n1 H B1 1 H P2 1 H F1 1 H O2 1 H C2\n\n1 I B1 1 I P2 1 I F2 1 I O2 1 I C2\n\n1 J B2 1 J P2 1 J F2 1 J O2 1 J C2\n\n1 K B2 1 K P2 1 K F2 1 K O2 1 K C2\n\n1 L B2 1 L P2 1 L F2 1 L O2 1 L C2\n\n1 M B2 1 M P2 1 M F2 1 M O2 1 M C2\n\n1 N B2 1 N P2 1 N F2 1 N O2 1 N C2\n\n1 O B2 1 O P2 1 O F2 1 O O3 1 O C3\n\n1 P B2 1 P P3 1 P F2 1 P O3 1 P C3\n\n1 Q B3 1 Q P3 1 Q F2 1 Q O3 1 Q C3\n\n1 R B3 1 R P3 1 R F2 1 R O3 1 R C3\n\n1 S B3 1 S P3 1 S F2 1 S O4 1 S C3\n\n1 T B3 1 T P3 1 T F3 1 T O4 1 T C4\n\n1 U B4 1 U P3 1 U F3 1 U O4 1 U C4\n\n1 V B4 1 V P3 1 V F3 1 V O4 1 V C4\n\n1 W B4 1 W P4 1 W F3 1 W O4 1 W C5\n\n1 X B4 1 X P4 1 X F3 1 X O4 1 X C5\n\n1 Y B4 1 Y P4 1 Y F5 1 Y O5 1 Y C5\n\n1 ZD B4 1 ZD P4 1 ZD F3 1 ZD O4 1 ZD C5\n\n1 ZE B4 1 ZE P4 1 ZE F3 1 ZE O4 1 ZE C5\n\n1 ZF B4 1 ZF P4 1 ZF F5 1 ZF O5 1 ZF C5\n\n1 ZG B4 1 ZG P4 1 ZG F5 1 ZG O5 1 ZG C5\n\n1 ZH B4 1 ZH P4 1 ZH F5 1 ZH O5 1 ZH C5\n\n1 ZJ B4 1 ZJ P4 1 ZJ F5 1 ZJ O5 1 ZJ C5\n\n1 ZK B4 1 ZK P4 1 ZK F5 1 ZK O5 1 ZK C5\n\n1 ZL B4 1 ZL P4 1 ZL F5 1 ZL O5 1 ZL C5\n\n2 A B1 2 A P2 2 A F1 2 A O1 2 A C1\n\n2 B B1 2 B P2 2 B F2 2 B O2 2 B C2\n\n2 C B1 2 C P2 2 C F2 2 C O2 2 C C2\n\n2 D B2 2 D P2 2 D F3 2 D O2 2 D C2\n\n2 E B2 2 E P2 2 E F3 2 E O2 2 E C3\n\n2 F B2 2 F P2 2 F F3 2 F O3 2 F C3\n\n2 G B2 2 G P2 2 G F3 2 G O3 2 G C3\n\n2 H B2 2 H P3 2 H F3 2 H O3 2 H C3\n\n2 I B2 2 I P3 2 I F3 2 I O3 2 I C3\n\n2 J B3 2 J P3 2 J F3 2 J O3 2 J C3\n\n2 K B3 2 K P3 2 K F4 2 K O3 2 K C3\n\n2 L B3 2 L P3 2 L F4 2 L O3 2 L C4\n\n2 M B4 2 M P3 2 M F4 2 M O3 2 M C4\n\n2 N B4 2 N P3 2 N F4 2 N O3 2 N C4\n\n2 O B4 2 O P4 2 O F4 2 O O4 2 O C4\n\n2 P B4 2 P P4 2 P F4 2 P O4 2 P C4\n\n2 Q B4 2 Q P4 2 Q F5 2 Q O4 2 Q C5\n\n2 R B4 2 R P4 2 R F5 2 R O5 2 R C5\n\n2 S B4 2 S P4 2 S F5 2 S O5 2 S C5\n\n2 T B4 2 T P5 2 T F5 2 T O5 2 T C5\n\n2 U B5 2 U P5 2 U F5 2 U O5 2 U C5\n\n2 V B5 2 V P5 2 V F5 2 V O5 2 V C5\n\n2 W B5 2 W P5 2 W F5 2 W O5 2 W C5\n\n2 X B5 2 X P5 2 X F5 2 X O5 2 X C5\n\n2 Y B5 2 Y P5 2 Y F5 2 Y O5 2 Y C5\n\n2 ZD B5 2 ZD P5 2 ZD F5 2 ZD O5 2 ZD C5\n\n2 ZE B5 2 ZE P5 2 ZE F5 2 ZE O5 2 ZE C5\n\n2 ZF B5 2 ZF P5 2 ZF F5 2 ZF O5 2 ZF C5\n\n2 ZG B5 2 ZG P5 2 ZG F5 2 ZG O5 2 ZG C5\n\n2 ZH B5 2 ZH P5 2 ZH F5 2 ZH O5 2 ZH C5\n\n2 ZJ B5 2 ZJ P5 2 ZJ F5 2 ZJ O5 2 ZJ C5\n\n2 ZK B5 2 ZK P5 2 ZK F5 2 ZK O5 2 ZK C5\n\n2 ZL B5 2 ZL P5 2 ZL F5 2 ZL O5 2 ZL C5\n\n3 A B1 3 A P1 3 A F1 3 A O1 3 A C1\n\n3 B B1 3 B P1 3 B F1 3 B O1 3 B C1\n\n3 C B1 3 C P1 3 C F1 3 C O1 3 C C1\n\n3 D B1 3 D P1 3 D F1 3 D O1 3 D C1\n\n3 E B2 3 E P1 3 E F1 3 E O2 3 E C2\n\n3 F B2 3 F P1 3 F F1 3 F O2 3 F C2\n\n3 G B2 3 G P1 3 G F1 3 G O2 3 G C2\n\n3 H B2 3 H P2 3 H F2 3 H O2 3 H C2\n\n3 I B2 3 I P2 3 I F2 3 I O2 3 I C2\n\n3 J B2 3 J P2 3 J F2 3 J O2 3 J C2\n\n3 K B2 3 K P2 3 K F2 3 K O2 3 K C3\n\n3 L B3 3 L P2 3 L F2 3 L O2 3 L C3\n\n3 M B3 3 M P3 3 M F3 3 M O3 3 M C3\n\n3 N B3 3 N P3 3 N F3 3 N O3 3 N C3\n\n3 O B3 3 O P3 3 O F3 3 O O3 3 O C3\n\n3 P B3 3 P P3 3 P F3 3 P O4 3 P C3\n\n3 Q B3 3 Q P3 3 Q F3 3 Q O4 3 Q C4\n\n3 R B3 3 R P3 3 R F3 3 R O4 3 R C4\n\n3 S B4 3 S P3 3 S F3 3 S O4 3 S C4\n\n3 T B4 3 T P3 3 T F3 3 T O4 3 T C4\n\n3 U B4 3 U P4 3 U F3 3 U O4 3 U C4\n\n3 V B4 3 V P4 3 V F4 3 V O5 3 V C4\n\n3 W B4 3 W P4 3 W F4 3 W O5 3 W C5\n\n3 X B4 3 X P4 3 X F5 3 X O5 3 X C5\n\n3 Y B4 3 Y P4 3 Y F5 3 Y O5 3 Y C5\n\n3 ZD B4 3 ZD P4 3 ZD F4 3 ZD O5 3 ZD C5\n\n3 ZE B4 3 ZE P4 3 ZE F5 3 ZE O5 3 ZE C5\n\n3 ZF B4 3 ZF P4 3 ZF F5 3 ZF O5 3 ZF C5\n\n3 ZG B4 3 ZG P4 3 ZG F5 3 ZG O5 3 ZG C5\n\n3 ZH B4 3 ZH P4 3 ZH F5 3 ZH O5 3 ZH C5\n\n3 ZJ B4 3 ZJ P4 3 ZJ F5 3 ZJ O5 3 ZJ C5\n\n3 ZK B4 3 ZK P4 3 ZK F5 3 ZK O5 3 ZK C5\n\n3 ZL B4 3 ZL P4 3 ZL F5 3 ZL O5 3 ZL C5\n\n4 A B1 4 A P2 4 A F1 4 A O1 4 A C1\n\n4 B B1 4 B P2 4 B F2 4 B O2 4 B C2\n\n4 C B1 4 C P2 4 C F2 4 C O2 4 C C2\n\n4 D B2 4 D P2 4 D F3 4 D O2 4 D C2\n\n4 E B2 4 E P2 4 E F3 4 E O2 4 E C3\n\n4 F B2 4 F P2 4 F F3 4 F O3 4 F C3\n\n4 G B2 4 G P2 4 G F3 4 G O3 4 G C3\n\n4 H B2 4 H P3 4 H F3 4 H O3 4 H C3\n\n4 I B2 4 I P3 4 I F3 4 I O3 4 I C3\n\n4 J B3 4 J P3 4 J F3 4 J O3 4 J C3\n\n4 K B3 4 K P3 4 K F4 4 K O3 4 K C3\n\n4 L B3 4 L P3 4 L F4 4 L O3 4 L C4\n\n4 M B4 4 M P3 4 M F4 4 M O3 4 M C4\n\n4 N B4 4 N P3 4 N F4 4 N O3 4 N C4\n\n4 O B4 4 O P4 4 O F4 4 O O4 4 O C4\n\n4 P B4 4 P P4 4 P F4 4 P O4 4 P C4\n\n4 Q B4 4 Q P4 4 Q F5 4 Q O4 4 Q C5\n\n4 R B4 4 R P4 4 R F5 4 R O5 4 R C5\n\n4 S B4 4 S P4 4 S F5 4 S O5 4 S C5\n\n4 T B4 4 T P5 4 T F5 4 T O5 4 T C5\n\n4 U B5 4 U P5 4 U F5 4 U O5 4 U C5\n\n4 V B5 4 V P5 4 V F5 4 V O5 4 V C5\n\n4 W B5 4 W P5 4 W F5 4 W O5 4 W C5\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1123.pdf"]},"response":{"errors":[],"extract_id":"extract_5192be550d9ca5099a9870de2829935c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Core Tiers**\n\n**UW Tier Group Credit Tier BI Core Tier**\n\n**UW Tier Group Credit Tier PD Core Tier**\n\n**UW Tier Group Credit Tier PI Core Tier**\n\n**UW Tier Group Credit Tier CM Core Tier**\n\n**UW Tier Group Credit Tier CL Core Tier**\n\n1 A B1 1 A P1 1 A F1 1 A O1 1 A C1\n\n1 B B1 1 B P1 1 B F1 1 B O1 1 B C1\n\n1 C B1 1 C P1 1 C F1 1 C O1 1 C C1\n\n1 D B1 1 D P1 1 D F1 1 D O1 1 D C1\n\n1 E B1 1 E P1 1 E F1 1 E O1 1 E C1\n\n1 F B1 1 F P1 1 F F1 1 F O1 1 F C1\n\n1 G B1 1 G P1 1 G F1 1 G O2 1 G C1\n\n1 H B1 1 H P2 1 H F1 1 H O2 1 H C2\n\n1 I B1 1 I P2 1 I F2 1 I O2 1 I C2\n\n1 J B2 1 J P2 1 J F2 1 J O2 1 J C2\n\n1 K B2 1 K P2 1 K F2 1 K O2 1 K C2\n\n1 L B2 1 L P2 1 L F2 1 L O2 1 L C2\n\n1 M B2 1 M P2 1 M F2 1 M O2 1 M C2\n\n1 N B2 1 N P2 1 N F2 1 N O2 1 N C2\n\n1 O B2 1 O P2 1 O F2 1 O O3 1 O C3\n\n1 P B2 1 P P3 1 P F2 1 P O3 1 P C3\n\n1 Q B3 1 Q P3 1 Q F2 1 Q O3 1 Q C3\n\n1 R B3 1 R P3 1 R F2 1 R O3 1 R C3\n\n1 S B3 1 S P3 1 S F2 1 S O4 1 S C3\n\n1 T B3 1 T P3 1 T F3 1 T O4 1 T C4\n\n1 U B4 1 U P3 1 U F3 1 U O4 1 U C4\n\n1 V B4 1 V P3 1 V F3 1 V O4 1 V C4\n\n1 W B4 1 W P4 1 W F3 1 W O4 1 W C5\n\n1 X B4 1 X P4 1 X F3 1 X O4 1 X C5\n\n1 Y B4 1 Y P4 1 Y F5 1 Y O5 1 Y C5\n\n1 ZD B4 1 ZD P4 1 ZD F3 1 ZD O4 1 ZD C5\n\n1 ZE B4 1 ZE P4 1 ZE F3 1 ZE O4 1 ZE C5\n\n1 ZF B4 1 ZF P4 1 ZF F5 1 ZF O5 1 ZF C5\n\n1 ZG B4 1 ZG P4 1 ZG F5 1 ZG O5 1 ZG C5\n\n1 ZH B4 1 ZH P4 1 ZH F5 1 ZH O5 1 ZH C5\n\n1 ZJ B4 1 ZJ P4 1 ZJ F5 1 ZJ O5 1 ZJ C5\n\n1 ZK B4 1 ZK P4 1 ZK F5 1 ZK O5 1 ZK C5\n\n1 ZL B4 1 ZL P4 1 ZL F5 1 ZL O5 1 ZL C5\n\n2 A B1 2 A P2 2 A F1 2 A O1 2 A C1\n\n2 B B1 2 B P2 2 B F2 2 B O2 2 B C2\n\n2 C B1 2 C P2 2 C F2 2 C O2 2 C C2\n\n2 D B2 2 D P2 2 D F3 2 D O2 2 D C2\n\n2 E B2 2 E P2 2 E F3 2 E O2 2 E C3\n\n2 F B2 2 F P2 2 F F3 2 F O3 2 F C3\n\n2 G B2 2 G P2 2 G F3 2 G O3 2 G C3\n\n2 H B2 2 H P3 2 H F3 2 H O3 2 H C3\n\n2 I B2 2 I P3 2 I F3 2 I O3 2 I C3\n\n2 J B3 2 J P3 2 J F3 2 J O3 2 J C3\n\n2 K B3 2 K P3 2 K F4 2 K O3 2 K C3\n\n2 L B3 2 L P3 2 L F4 2 L O3 2 L C4\n\n2 M B4 2 M P3 2 M F4 2 M O3 2 M C4\n\n2 N B4 2 N P3 2 N F4 2 N O3 2 N C4\n\n2 O B4 2 O P4 2 O F4 2 O O4 2 O C4\n\n2 P B4 2 P P4 2 P F4 2 P O4 2 P C4\n\n2 Q B4 2 Q P4 2 Q F5 2 Q O4 2 Q C5\n\n2 R B4 2 R P4 2 R F5 2 R O5 2 R C5\n\n2 S B4 2 S P4 2 S F5 2 S O5 2 S C5\n\n2 T B4 2 T P5 2 T F5 2 T O5 2 T C5\n\n2 U B5 2 U P5 2 U F5 2 U O5 2 U C5\n\n2 V B5 2 V P5 2 V F5 2 V O5 2 V C5\n\n2 W B5 2 W P5 2 W F5 2 W O5 2 W C5\n\n2 X B5 2 X P5 2 X F5 2 X O5 2 X C5\n\n2 Y B5 2 Y P5 2 Y F5 2 Y O5 2 Y C5\n\n2 ZD B5 2 ZD P5 2 ZD F5 2 ZD O5 2 ZD C5\n\n2 ZE B5 2 ZE P5 2 ZE F5 2 ZE O5 2 ZE C5\n\n2 ZF B5 2 ZF P5 2 ZF F5 2 ZF O5 2 ZF C5\n\n2 ZG B5 2 ZG P5 2 ZG F5 2 ZG O5 2 ZG C5\n\n2 ZH B5 2 ZH P5 2 ZH F5 2 ZH O5 2 ZH C5\n\n2 ZJ B5 2 ZJ P5 2 ZJ F5 2 ZJ O5 2 ZJ C5\n\n2 ZK B5 2 ZK P5 2 ZK F5 2 ZK O5 2 ZK C5\n\n2 ZL B5 2 ZL P5 2 ZL F5 2 ZL O5 2 ZL C5\n\n3 A B1 3 A P1 3 A F1 3 A O1 3 A C1\n\n3 B B1 3 B P1 3 B F1 3 B O1 3 B C1\n\n3 C B1 3 C P1 3 C F1 3 C O1 3 C C1\n\n3 D B1 3 D P1 3 D F1 3 D O1 3 D C1\n\n3 E B2 3 E P1 3 E F1 3 E O2 3 E C2\n\n3 F B2 3 F P1 3 F F1 3 F O2 3 F C2\n\n3 G B2 3 G P1 3 G F1 3 G O2 3 G C2\n\n3 H B2 3 H P2 3 H F2 3 H O2 3 H C2\n\n3 I B2 3 I P2 3 I F2 3 I O2 3 I C2\n\n3 J B2 3 J P2 3 J F2 3 J O2 3 J C2\n\n3 K B2 3 K P2 3 K F2 3 K O2 3 K C3\n\n3 L B3 3 L P2 3 L F2 3 L O2 3 L C3\n\n3 M B3 3 M P3 3 M F3 3 M O3 3 M C3\n\n3 N B3 3 N P3 3 N F3 3 N O3 3 N C3\n\n3 O B3 3 O P3 3 O F3 3 O O3 3 O C3\n\n3 P B3 3 P P3 3 P F3 3 P O4 3 P C3\n\n3 Q B3 3 Q P3 3 Q F3 3 Q O4 3 Q C4\n\n3 R B3 3 R P3 3 R F3 3 R O4 3 R C4\n\n3 S B4 3 S P3 3 S F3 3 S O4 3 S C4\n\n3 T B4 3 T P3 3 T F3 3 T O4 3 T C4\n\n3 U B4 3 U P4 3 U F3 3 U O4 3 U C4\n\n3 V B4 3 V P4 3 V F4 3 V O5 3 V C4\n\n3 W B4 3 W P4 3 W F4 3 W O5 3 W C5\n\n3 X B4 3 X P4 3 X F5 3 X O5 3 X C5\n\n3 Y B4 3 Y P4 3 Y F5 3 Y O5 3 Y C5\n\n3 ZD B4 3 ZD P4 3 ZD F4 3 ZD O5 3 ZD C5\n\n3 ZE B4 3 ZE P4 3 ZE F5 3 ZE O5 3 ZE C5\n\n3 ZF B4 3 ZF P4 3 ZF F5 3 ZF O5 3 ZF C5\n\n3 ZG B4 3 ZG P4 3 ZG F5 3 ZG O5 3 ZG C5\n\n3 ZH B4 3 ZH P4 3 ZH F5 3 ZH O5 3 ZH C5\n\n3 ZJ B4 3 ZJ P4 3 ZJ F5 3 ZJ O5 3 ZJ C5\n\n3 ZK B4 3 ZK P4 3 ZK F5 3 ZK O5 3 ZK C5\n\n3 ZL B4 3 ZL P4 3 ZL F5 3 ZL O5 3 ZL C5\n\n4 A B1 4 A P2 4 A F1 4 A O1 4 A C1\n\n4 B B1 4 B P2 4 B F2 4 B O2 4 B C2\n\n4 C B1 4 C P2 4 C F2 4 C O2 4 C C2\n\n4 D B2 4 D P2 4 D F3 4 D O2 4 D C2\n\n4 E B2 4 E P2 4 E F3 4 E O2 4 E C3\n\n4 F B2 4 F P2 4 F F3 4 F O3 4 F C3\n\n4 G B2 4 G P2 4 G F3 4 G O3 4 G C3\n\n4 H B2 4 H P3 4 H F3 4 H O3 4 H C3\n\n4 I B2 4 I P3 4 I F3 4 I O3 4 I C3\n\n4 J B3 4 J P3 4 J F3 4 J O3 4 J C3\n\n4 K B3 4 K P3 4 K F4 4 K O3 4 K C3\n\n4 L B3 4 L P3 4 L F4 4 L O3 4 L C4\n\n4 M B4 4 M P3 4 M F4 4 M O3 4 M C4\n\n4 N B4 4 N P3 4 N F4 4 N O3 4 N C4\n\n4 O B4 4 O P4 4 O F4 4 O O4 4 O C4\n\n4 P B4 4 P P4 4 P F4 4 P O4 4 P C4\n\n4 Q B4 4 Q P4 4 Q F5 4 Q O4 4 Q C5\n\n4 R B4 4 R P4 4 R F5 4 R O5 4 R C5\n\n4 S B4 4 S P4 4 S F5 4 S O5 4 S C5\n\n4 T B4 4 T P5 4 T F5 4 T O5 4 T C5\n\n4 U B5 4 U P5 4 U F5 4 U O5 4 U C5\n\n4 V B5 4 V P5 4 V F5 4 V O5 4 V C5\n\n4 W B5 4 W P5 4 W F5 4 W O5 4 W C5\n\n**Proposed**"],"full_content":"**Core Tiers**\n\n**UW Tier Group Credit Tier BI Core Tier**\n\n**UW Tier Group Credit Tier PD Core Tier**\n\n**UW Tier Group Credit Tier PI Core Tier**\n\n**UW Tier Group Credit Tier CM Core Tier**\n\n**UW Tier Group Credit Tier CL Core Tier**\n\n1 A B1 1 A P1 1 A F1 1 A O1 1 A C1\n\n1 B B1 1 B P1 1 B F1 1 B O1 1 B C1\n\n1 C B1 1 C P1 1 C F1 1 C O1 1 C C1\n\n1 D B1 1 D P1 1 D F1 1 D O1 1 D C1\n\n1 E B1 1 E P1 1 E F1 1 E O1 1 E C1\n\n1 F B1 1 F P1 1 F F1 1 F O1 1 F C1\n\n1 G B1 1 G P1 1 G F1 1 G O2 1 G C1\n\n1 H B1 1 H P2 1 H F1 1 H O2 1 H C2\n\n1 I B1 1 I P2 1 I F2 1 I O2 1 I C2\n\n1 J B2 1 J P2 1 J F2 1 J O2 1 J C2\n\n1 K B2 1 K P2 1 K F2 1 K O2 1 K C2\n\n1 L B2 1 L P2 1 L F2 1 L O2 1 L C2\n\n1 M B2 1 M P2 1 M F2 1 M O2 1 M C2\n\n1 N B2 1 N P2 1 N F2 1 N O2 1 N C2\n\n1 O B2 1 O P2 1 O F2 1 O O3 1 O C3\n\n1 P B2 1 P P3 1 P F2 1 P O3 1 P C3\n\n1 Q B3 1 Q P3 1 Q F2 1 Q O3 1 Q C3\n\n1 R B3 1 R P3 1 R F2 1 R O3 1 R C3\n\n1 S B3 1 S P3 1 S F2 1 S O4 1 S C3\n\n1 T B3 1 T P3 1 T F3 1 T O4 1 T C4\n\n1 U B4 1 U P3 1 U F3 1 U O4 1 U C4\n\n1 V B4 1 V P3 1 V F3 1 V O4 1 V C4\n\n1 W B4 1 W P4 1 W F3 1 W O4 1 W C5\n\n1 X B4 1 X P4 1 X F3 1 X O4 1 X C5\n\n1 Y B4 1 Y P4 1 Y F5 1 Y O5 1 Y C5\n\n1 ZD B4 1 ZD P4 1 ZD F3 1 ZD O4 1 ZD C5\n\n1 ZE B4 1 ZE P4 1 ZE F3 1 ZE O4 1 ZE C5\n\n1 ZF B4 1 ZF P4 1 ZF F5 1 ZF O5 1 ZF C5\n\n1 ZG B4 1 ZG P4 1 ZG F5 1 ZG O5 1 ZG C5\n\n1 ZH B4 1 ZH P4 1 ZH F5 1 ZH O5 1 ZH C5\n\n1 ZJ B4 1 ZJ P4 1 ZJ F5 1 ZJ O5 1 ZJ C5\n\n1 ZK B4 1 ZK P4 1 ZK F5 1 ZK O5 1 ZK C5\n\n1 ZL B4 1 ZL P4 1 ZL F5 1 ZL O5 1 ZL C5\n\n2 A B1 2 A P2 2 A F1 2 A O1 2 A C1\n\n2 B B1 2 B P2 2 B F2 2 B O2 2 B C2\n\n2 C B1 2 C P2 2 C F2 2 C O2 2 C C2\n\n2 D B2 2 D P2 2 D F3 2 D O2 2 D C2\n\n2 E B2 2 E P2 2 E F3 2 E O2 2 E C3\n\n2 F B2 2 F P2 2 F F3 2 F O3 2 F C3\n\n2 G B2 2 G P2 2 G F3 2 G O3 2 G C3\n\n2 H B2 2 H P3 2 H F3 2 H O3 2 H C3\n\n2 I B2 2 I P3 2 I F3 2 I O3 2 I C3\n\n2 J B3 2 J P3 2 J F3 2 J O3 2 J C3\n\n2 K B3 2 K P3 2 K F4 2 K O3 2 K C3\n\n2 L B3 2 L P3 2 L F4 2 L O3 2 L C4\n\n2 M B4 2 M P3 2 M F4 2 M O3 2 M C4\n\n2 N B4 2 N P3 2 N F4 2 N O3 2 N C4\n\n2 O B4 2 O P4 2 O F4 2 O O4 2 O C4\n\n2 P B4 2 P P4 2 P F4 2 P O4 2 P C4\n\n2 Q B4 2 Q P4 2 Q F5 2 Q O4 2 Q C5\n\n2 R B4 2 R P4 2 R F5 2 R O5 2 R C5\n\n2 S B4 2 S P4 2 S F5 2 S O5 2 S C5\n\n2 T B4 2 T P5 2 T F5 2 T O5 2 T C5\n\n2 U B5 2 U P5 2 U F5 2 U O5 2 U C5\n\n2 V B5 2 V P5 2 V F5 2 V O5 2 V C5\n\n2 W B5 2 W P5 2 W F5 2 W O5 2 W C5\n\n2 X B5 2 X P5 2 X F5 2 X O5 2 X C5\n\n2 Y B5 2 Y P5 2 Y F5 2 Y O5 2 Y C5\n\n2 ZD B5 2 ZD P5 2 ZD F5 2 ZD O5 2 ZD C5\n\n2 ZE B5 2 ZE P5 2 ZE F5 2 ZE O5 2 ZE C5\n\n2 ZF B5 2 ZF P5 2 ZF F5 2 ZF O5 2 ZF C5\n\n2 ZG B5 2 ZG P5 2 ZG F5 2 ZG O5 2 ZG C5\n\n2 ZH B5 2 ZH P5 2 ZH F5 2 ZH O5 2 ZH C5\n\n2 ZJ B5 2 ZJ P5 2 ZJ F5 2 ZJ O5 2 ZJ C5\n\n2 ZK B5 2 ZK P5 2 ZK F5 2 ZK O5 2 ZK C5\n\n2 ZL B5 2 ZL P5 2 ZL F5 2 ZL O5 2 ZL C5\n\n3 A B1 3 A P1 3 A F1 3 A O1 3 A C1\n\n3 B B1 3 B P1 3 B F1 3 B O1 3 B C1\n\n3 C B1 3 C P1 3 C F1 3 C O1 3 C C1\n\n3 D B1 3 D P1 3 D F1 3 D O1 3 D C1\n\n3 E B2 3 E P1 3 E F1 3 E O2 3 E C2\n\n3 F B2 3 F P1 3 F F1 3 F O2 3 F C2\n\n3 G B2 3 G P1 3 G F1 3 G O2 3 G C2\n\n3 H B2 3 H P2 3 H F2 3 H O2 3 H C2\n\n3 I B2 3 I P2 3 I F2 3 I O2 3 I C2\n\n3 J B2 3 J P2 3 J F2 3 J O2 3 J C2\n\n3 K B2 3 K P2 3 K F2 3 K O2 3 K C3\n\n3 L B3 3 L P2 3 L F2 3 L O2 3 L C3\n\n3 M B3 3 M P3 3 M F3 3 M O3 3 M C3\n\n3 N B3 3 N P3 3 N F3 3 N O3 3 N C3\n\n3 O B3 3 O P3 3 O F3 3 O O3 3 O C3\n\n3 P B3 3 P P3 3 P F3 3 P O4 3 P C3\n\n3 Q B3 3 Q P3 3 Q F3 3 Q O4 3 Q C4\n\n3 R B3 3 R P3 3 R F3 3 R O4 3 R C4\n\n3 S B4 3 S P3 3 S F3 3 S O4 3 S C4\n\n3 T B4 3 T P3 3 T F3 3 T O4 3 T C4\n\n3 U B4 3 U P4 3 U F3 3 U O4 3 U C4\n\n3 V B4 3 V P4 3 V F4 3 V O5 3 V C4\n\n3 W B4 3 W P4 3 W F4 3 W O5 3 W C5\n\n3 X B4 3 X P4 3 X F5 3 X O5 3 X C5\n\n3 Y B4 3 Y P4 3 Y F5 3 Y O5 3 Y C5\n\n3 ZD B4 3 ZD P4 3 ZD F4 3 ZD O5 3 ZD C5\n\n3 ZE B4 3 ZE P4 3 ZE F5 3 ZE O5 3 ZE C5\n\n3 ZF B4 3 ZF P4 3 ZF F5 3 ZF O5 3 ZF C5\n\n3 ZG B4 3 ZG P4 3 ZG F5 3 ZG O5 3 ZG C5\n\n3 ZH B4 3 ZH P4 3 ZH F5 3 ZH O5 3 ZH C5\n\n3 ZJ B4 3 ZJ P4 3 ZJ F5 3 ZJ O5 3 ZJ C5\n\n3 ZK B4 3 ZK P4 3 ZK F5 3 ZK O5 3 ZK C5\n\n3 ZL B4 3 ZL P4 3 ZL F5 3 ZL O5 3 ZL C5\n\n4 A B1 4 A P2 4 A F1 4 A O1 4 A C1\n\n4 B B1 4 B P2 4 B F2 4 B O2 4 B C2\n\n4 C B1 4 C P2 4 C F2 4 C O2 4 C C2\n\n4 D B2 4 D P2 4 D F3 4 D O2 4 D C2\n\n4 E B2 4 E P2 4 E F3 4 E O2 4 E C3\n\n4 F B2 4 F P2 4 F F3 4 F O3 4 F C3\n\n4 G B2 4 G P2 4 G F3 4 G O3 4 G C3\n\n4 H B2 4 H P3 4 H F3 4 H O3 4 H C3\n\n4 I B2 4 I P3 4 I F3 4 I O3 4 I C3\n\n4 J B3 4 J P3 4 J F3 4 J O3 4 J C3\n\n4 K B3 4 K P3 4 K F4 4 K O3 4 K C3\n\n4 L B3 4 L P3 4 L F4 4 L O3 4 L C4\n\n4 M B4 4 M P3 4 M F4 4 M O3 4 M C4\n\n4 N B4 4 N P3 4 N F4 4 N O3 4 N C4\n\n4 O B4 4 O P4 4 O F4 4 O O4 4 O C4\n\n4 P B4 4 P P4 4 P F4 4 P O4 4 P C4\n\n4 Q B4 4 Q P4 4 Q F5 4 Q O4 4 Q C5\n\n4 R B4 4 R P4 4 R F5 4 R O5 4 R C5\n\n4 S B4 4 S P4 4 S F5 4 S O5 4 S C5\n\n4 T B4 4 T P5 4 T F5 4 T O5 4 T C5\n\n4 U B5 4 U P5 4 U F5 4 U O5 4 U C5\n\n4 V B5 4 V P5 4 V F5 4 V O5 4 V C5\n\n4 W B5 4 W P5 4 W F5 4 W O5 4 W C5\n\n**Proposed**","publish_date":null,"title":"Proposed Core Tiers","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1123.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1123.pdf"},"request":{"example_id":"table/BRWS-134565917_page1123","product_type":"parse","source_file_path":"BRWS-134565917_page1123.pdf"},"started_at":"2026-11-04T19:48:09.567977"} +{"completed_at":"2026-11-04T19:48:13.062527","latency_in_ms":2595,"output":{"example_id":"table/BRWS-134565917_page1171","grounded_pages":[],"layout_pages":[],"markdown":"**AAF Violation Aging**\n\n**0 - 12 Month AAF Violation**\n\n**Count**\n\n**13 - 24 Month AAF**\n\n**Violation Count**\n\n**25 - 35 Month AAF Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0206 -0.1344 -0.0863 0.0000 0.0000 -0.0898 0.0000 0.0000\n\n0 0 2 0.0524 -0.1473 -0.0811 0.0000 0.0000 -0.1425 0.0000 0.0000\n\n0 1 0 0.0319 -0.0129 0.0262 0.0000 0.0000 -0.0527 0.0000 0.0000\n\n0 1 1 0.0559 -0.1489 -0.0596 0.0000 0.0000 -0.1488 0.0000 0.0000\n\n0 2 0 0.1447 0.3041 0.0265 0.0000 0.0000 -0.0915 0.0000 0.0000\n\n1 0 0 0.1072 0.3481 0.2279 0.0000 0.0000 0.2251 0.0000 0.0000\n\n1 0 1 0.1313 0.2121 0.1421 0.0000 0.0000 0.1290 0.0000 0.0000\n\n1 1 0 0.1608 0.3643 0.2397 0.0000 0.0000 0.1497 0.0000 0.0000\n\n2 0 0 0.5151 0.4898 0.9462 0.0000 0.0000 0.8133 0.0000 0.0000\n\n**DUI Violation Aging**\n\n**0 - 12 Month DUI Violation**\n\n**Count**\n\n**13 - 24 Month DUI**\n\n**Violation Count**\n\n**25 - 35 Month DUI Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0250 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 2 0.0250 0.0000 0.0000 0.0000 0.0000 -0.0300 0.0000 0.0000\n\n0 1 0 0.0500 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 1 1 0.0750 0.0000 0.0000 0.0000 0.0000 -0.0012 0.0000 0.0000\n\n0 2 0 0.1008 0.3010 0.0000 0.0000 0.0000 -0.0001 0.0000 0.0000\n\n1 0 0 0.0750 0.3010 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 0 1 0.1000 0.3010 0.0000 0.0000 0.0000 -0.0009 0.0000 0.0000\n\n1 1 0 0.1255 0.3121 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n2 0 0 0.1524 0.3016 0.3396 0.0000 0.0000 0.3000 0.0000 0.0000\n\n**MAJ Violation Aging**\n\n**0 - 12 Month MAJ Violation**\n\n**Count**\n\n**13 - 24 Month MAJ Violation**\n\n**Count**\n\n**25 - 35 Month MAJ Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.2325 0.0065 0.0264 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.4454 -0.0112 0.0529 0.0000 0.0000 0.2475 0.0000 0.0000\n\n0 1 0 0.2325 0.0065 0.0264 0.0000 0.0000 0.1744 0.0000 0.0000\n\n0 1 1 0.4776 0.0108 0.0542 0.0000 0.0000 0.2660 0.0000 0.0000\n\n0 2 0 0.5858 0.2090 0.0558 0.0000 0.0000 0.3073 0.0000 0.0000\n\n1 0 0 0.3252 0.2194 0.1054 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.5640 0.2242 0.1325 0.0000 0.0000 0.2991 0.0000 0.0000\n\n1 1 0 0.6008 0.2526 0.1360 0.0000 0.0000 0.4101 0.0000 0.0000\n\n2 0 0 0.6326 0.5140 0.4030 0.0000 0.0000 0.5452 0.0000 0.0000\n\n**MIN Violation Aging**\n\n**0 - 12 Month MIN Violation**\n\n**Count**\n\n**13 - 24 Month MIN Violation**\n\n**Count**\n\n**25 - 35 Month MIN Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.1020 0.0065 -0.1079 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.0983 -0.0112 -0.1383 0.0000 0.0000 -0.0280 0.0000 0.0000\n\n0 1 0 0.1020 0.0065 0.0264 0.0000 0.0000 0.1009 0.0000 0.0000\n\n0 1 1 0.2036 0.0111 -0.0841 0.0000 0.0000 0.1629 0.0000 0.0000\n\n0 2 0 0.2174 0.2091 0.1172 0.0000 0.0000 0.2978 0.0000 0.0000\n\n1 0 0 0.1020 0.2194 0.1846 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.2037 0.2245 0.0750 0.0000 0.0000 0.2744 0.0000 0.0000\n\n1 1 0 0.2264 0.2534 0.2073 0.0000 0.0000 0.3443 0.0000 0.0000\n\n2 0 0 0.6342 0.5108 0.2020 0.0000 0.0000 0.5378 0.0000 0.0000\n\n**SPD Violation Aging**\n\n**0 - 12 Month SPD Violation**\n\n**Count**\n\n**13 - 24 Month SPD**\n\n**Violation Count**\n\n**25 - 35 Month SPD Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0000 -0.0875 -0.0960 0.0000 0.0000 -0.1920 0.0000 0.0000\n\n0 0 2 0.0000 -0.0875 -0.1293 0.0000 0.0000 -0.2543 0.0000 0.0000\n\n0 1 0 0.0292 0.0000 -0.0333 0.0000 0.0000 -0.0351 0.0000 0.0000\n\n0 1 1 0.0292 -0.0875 -0.1333 0.0000 0.0000 -0.2349 0.0000 0.0000\n\n0 2 0 0.0814 -0.1062 -0.1084 0.0000 0.0000 -0.2701 0.0000 0.0000\n\n1 0 0 0.0522 0.1586 0.1382 0.0000 0.0000 0.0821 0.0000 0.0000\n\n1 0 1 0.0522 0.0711 0.0386 0.0000 0.0000 -0.1169 0.0000 0.0000\n\n1 1 0 0.0890 0.1293 0.0799 0.0000 0.0000 -0.0179 0.0000 0.0000\n\n2 0 0 0.0911 0.1387 0.3783 0.0000 0.0000 0.3221 0.0000 0.0000\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**AAF Violation Aging**\n\n**0 - 12 Month AAF Violation**\n\n**Count**\n\n**13 - 24 Month AAF**\n\n**Violation Count**\n\n**25 - 35 Month AAF Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0206 -0.1344 -0.0863 0.0000 0.0000 -0.0898 0.0000 0.0000\n\n0 0 2 0.0524 -0.1473 -0.0811 0.0000 0.0000 -0.1425 0.0000 0.0000\n\n0 1 0 0.0319 -0.0129 0.0262 0.0000 0.0000 -0.0527 0.0000 0.0000\n\n0 1 1 0.0559 -0.1489 -0.0596 0.0000 0.0000 -0.1488 0.0000 0.0000\n\n0 2 0 0.1447 0.3041 0.0265 0.0000 0.0000 -0.0915 0.0000 0.0000\n\n1 0 0 0.1072 0.3481 0.2279 0.0000 0.0000 0.2251 0.0000 0.0000\n\n1 0 1 0.1313 0.2121 0.1421 0.0000 0.0000 0.1290 0.0000 0.0000\n\n1 1 0 0.1608 0.3643 0.2397 0.0000 0.0000 0.1497 0.0000 0.0000\n\n2 0 0 0.5151 0.4898 0.9462 0.0000 0.0000 0.8133 0.0000 0.0000\n\n**DUI Violation Aging**\n\n**0 - 12 Month DUI Violation**\n\n**Count**\n\n**13 - 24 Month DUI**\n\n**Violation Count**\n\n**25 - 35 Month DUI Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0250 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 2 0.0250 0.0000 0.0000 0.0000 0.0000 -0.0300 0.0000 0.0000\n\n0 1 0 0.0500 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 1 1 0.0750 0.0000 0.0000 0.0000 0.0000 -0.0012 0.0000 0.0000\n\n0 2 0 0.1008 0.3010 0.0000 0.0000 0.0000 -0.0001 0.0000 0.0000\n\n1 0 0 0.0750 0.3010 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 0 1 0.1000 0.3010 0.0000 0.0000 0.0000 -0.0009 0.0000 0.0000\n\n1 1 0 0.1255 0.3121 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n2 0 0 0.1524 0.3016 0.3396 0.0000 0.0000 0.3000 0.0000 0.0000\n\n**MAJ Violation Aging**\n\n**0 - 12 Month MAJ Violation**\n\n**Count**\n\n**13 - 24 Month MAJ Violation**\n\n**Count**\n\n**25 - 35 Month MAJ Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.2325 0.0065 0.0264 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.4454 -0.0112 0.0529 0.0000 0.0000 0.2475 0.0000 0.0000\n\n0 1 0 0.2325 0.0065 0.0264 0.0000 0.0000 0.1744 0.0000 0.0000\n\n0 1 1 0.4776 0.0108 0.0542 0.0000 0.0000 0.2660 0.0000 0.0000\n\n0 2 0 0.5858 0.2090 0.0558 0.0000 0.0000 0.3073 0.0000 0.0000\n\n1 0 0 0.3252 0.2194 0.1054 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.5640 0.2242 0.1325 0.0000 0.0000 0.2991 0.0000 0.0000\n\n1 1 0 0.6008 0.2526 0.1360 0.0000 0.0000 0.4101 0.0000 0.0000\n\n2 0 0 0.6326 0.5140 0.4030 0.0000 0.0000 0.5452 0.0000 0.0000\n\n**MIN Violation Aging**\n\n**0 - 12 Month MIN Violation**\n\n**Count**\n\n**13 - 24 Month MIN Violation**\n\n**Count**\n\n**25 - 35 Month MIN Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.1020 0.0065 -0.1079 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.0983 -0.0112 -0.1383 0.0000 0.0000 -0.0280 0.0000 0.0000\n\n0 1 0 0.1020 0.0065 0.0264 0.0000 0.0000 0.1009 0.0000 0.0000\n\n0 1 1 0.2036 0.0111 -0.0841 0.0000 0.0000 0.1629 0.0000 0.0000\n\n0 2 0 0.2174 0.2091 0.1172 0.0000 0.0000 0.2978 0.0000 0.0000\n\n1 0 0 0.1020 0.2194 0.1846 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.2037 0.2245 0.0750 0.0000 0.0000 0.2744 0.0000 0.0000\n\n1 1 0 0.2264 0.2534 0.2073 0.0000 0.0000 0.3443 0.0000 0.0000\n\n2 0 0 0.6342 0.5108 0.2020 0.0000 0.0000 0.5378 0.0000 0.0000\n\n**SPD Violation Aging**\n\n**0 - 12 Month SPD Violation**\n\n**Count**\n\n**13 - 24 Month SPD**\n\n**Violation Count**\n\n**25 - 35 Month SPD Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0000 -0.0875 -0.0960 0.0000 0.0000 -0.1920 0.0000 0.0000\n\n0 0 2 0.0000 -0.0875 -0.1293 0.0000 0.0000 -0.2543 0.0000 0.0000\n\n0 1 0 0.0292 0.0000 -0.0333 0.0000 0.0000 -0.0351 0.0000 0.0000\n\n0 1 1 0.0292 -0.0875 -0.1333 0.0000 0.0000 -0.2349 0.0000 0.0000\n\n0 2 0 0.0814 -0.1062 -0.1084 0.0000 0.0000 -0.2701 0.0000 0.0000\n\n1 0 0 0.0522 0.1586 0.1382 0.0000 0.0000 0.0821 0.0000 0.0000\n\n1 0 1 0.0522 0.0711 0.0386 0.0000 0.0000 -0.1169 0.0000 0.0000\n\n1 1 0 0.0890 0.1293 0.0799 0.0000 0.0000 -0.0179 0.0000 0.0000\n\n2 0 0 0.0911 0.1387 0.3783 0.0000 0.0000 0.3221 0.0000 0.0000\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**AAF Violation Aging**\n\n**0 - 12 Month AAF Violation**\n\n**Count**\n\n**13 - 24 Month AAF**\n\n**Violation Count**\n\n**25 - 35 Month AAF Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0206 -0.1344 -0.0863 0.0000 0.0000 -0.0898 0.0000 0.0000\n\n0 0 2 0.0524 -0.1473 -0.0811 0.0000 0.0000 -0.1425 0.0000 0.0000\n\n0 1 0 0.0319 -0.0129 0.0262 0.0000 0.0000 -0.0527 0.0000 0.0000\n\n0 1 1 0.0559 -0.1489 -0.0596 0.0000 0.0000 -0.1488 0.0000 0.0000\n\n0 2 0 0.1447 0.3041 0.0265 0.0000 0.0000 -0.0915 0.0000 0.0000\n\n1 0 0 0.1072 0.3481 0.2279 0.0000 0.0000 0.2251 0.0000 0.0000\n\n1 0 1 0.1313 0.2121 0.1421 0.0000 0.0000 0.1290 0.0000 0.0000\n\n1 1 0 0.1608 0.3643 0.2397 0.0000 0.0000 0.1497 0.0000 0.0000\n\n2 0 0 0.5151 0.4898 0.9462 0.0000 0.0000 0.8133 0.0000 0.0000\n\n**DUI Violation Aging**\n\n**0 - 12 Month DUI Violation**\n\n**Count**\n\n**13 - 24 Month DUI**\n\n**Violation Count**\n\n**25 - 35 Month DUI Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0250 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 2 0.0250 0.0000 0.0000 0.0000 0.0000 -0.0300 0.0000 0.0000\n\n0 1 0 0.0500 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 1 1 0.0750 0.0000 0.0000 0.0000 0.0000 -0.0012 0.0000 0.0000\n\n0 2 0 0.1008 0.3010 0.0000 0.0000 0.0000 -0.0001 0.0000 0.0000\n\n1 0 0 0.0750 0.3010 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 0 1 0.1000 0.3010 0.0000 0.0000 0.0000 -0.0009 0.0000 0.0000\n\n1 1 0 0.1255 0.3121 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n2 0 0 0.1524 0.3016 0.3396 0.0000 0.0000 0.3000 0.0000 0.0000\n\n**MAJ Violation Aging**\n\n**0 - 12 Month MAJ Violation**\n\n**Count**\n\n**13 - 24 Month MAJ Violation**\n\n**Count**\n\n**25 - 35 Month MAJ Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.2325 0.0065 0.0264 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.4454 -0.0112 0.0529 0.0000 0.0000 0.2475 0.0000 0.0000\n\n0 1 0 0.2325 0.0065 0.0264 0.0000 0.0000 0.1744 0.0000 0.0000\n\n0 1 1 0.4776 0.0108 0.0542 0.0000 0.0000 0.2660 0.0000 0.0000\n\n0 2 0 0.5858 0.2090 0.0558 0.0000 0.0000 0.3073 0.0000 0.0000\n\n1 0 0 0.3252 0.2194 0.1054 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.5640 0.2242 0.1325 0.0000 0.0000 0.2991 0.0000 0.0000\n\n1 1 0 0.6008 0.2526 0.1360 0.0000 0.0000 0.4101 0.0000 0.0000\n\n2 0 0 0.6326 0.5140 0.4030 0.0000 0.0000 0.5452 0.0000 0.0000\n\n**MIN Violation Aging**\n\n**0 - 12 Month MIN Violation**\n\n**Count**\n\n**13 - 24 Month MIN Violation**\n\n**Count**\n\n**25 - 35 Month MIN Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.1020 0.0065 -0.1079 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.0983 -0.0112 -0.1383 0.0000 0.0000 -0.0280 0.0000 0.0000\n\n0 1 0 0.1020 0.0065 0.0264 0.0000 0.0000 0.1009 0.0000 0.0000\n\n0 1 1 0.2036 0.0111 -0.0841 0.0000 0.0000 0.1629 0.0000 0.0000\n\n0 2 0 0.2174 0.2091 0.1172 0.0000 0.0000 0.2978 0.0000 0.0000\n\n1 0 0 0.1020 0.2194 0.1846 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.2037 0.2245 0.0750 0.0000 0.0000 0.2744 0.0000 0.0000\n\n1 1 0 0.2264 0.2534 0.2073 0.0000 0.0000 0.3443 0.0000 0.0000\n\n2 0 0 0.6342 0.5108 0.2020 0.0000 0.0000 0.5378 0.0000 0.0000\n\n**SPD Violation Aging**\n\n**0 - 12 Month SPD Violation**\n\n**Count**\n\n**13 - 24 Month SPD**\n\n**Violation Count**\n\n**25 - 35 Month SPD Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0000 -0.0875 -0.0960 0.0000 0.0000 -0.1920 0.0000 0.0000\n\n0 0 2 0.0000 -0.0875 -0.1293 0.0000 0.0000 -0.2543 0.0000 0.0000\n\n0 1 0 0.0292 0.0000 -0.0333 0.0000 0.0000 -0.0351 0.0000 0.0000\n\n0 1 1 0.0292 -0.0875 -0.1333 0.0000 0.0000 -0.2349 0.0000 0.0000\n\n0 2 0 0.0814 -0.1062 -0.1084 0.0000 0.0000 -0.2701 0.0000 0.0000\n\n1 0 0 0.0522 0.1586 0.1382 0.0000 0.0000 0.0821 0.0000 0.0000\n\n1 0 1 0.0522 0.0711 0.0386 0.0000 0.0000 -0.1169 0.0000 0.0000\n\n1 1 0 0.0890 0.1293 0.0799 0.0000 0.0000 -0.0179 0.0000 0.0000\n\n2 0 0 0.0911 0.1387 0.3783 0.0000 0.0000 0.3221 0.0000 0.0000\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1171.pdf"]},"response":{"errors":[],"extract_id":"extract_2359365eb65e3424590def8403a43706","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**AAF Violation Aging**\n\n**0 - 12 Month AAF Violation**\n\n**Count**\n\n**13 - 24 Month AAF**\n\n**Violation Count**\n\n**25 - 35 Month AAF Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0206 -0.1344 -0.0863 0.0000 0.0000 -0.0898 0.0000 0.0000\n\n0 0 2 0.0524 -0.1473 -0.0811 0.0000 0.0000 -0.1425 0.0000 0.0000\n\n0 1 0 0.0319 -0.0129 0.0262 0.0000 0.0000 -0.0527 0.0000 0.0000\n\n0 1 1 0.0559 -0.1489 -0.0596 0.0000 0.0000 -0.1488 0.0000 0.0000\n\n0 2 0 0.1447 0.3041 0.0265 0.0000 0.0000 -0.0915 0.0000 0.0000\n\n1 0 0 0.1072 0.3481 0.2279 0.0000 0.0000 0.2251 0.0000 0.0000\n\n1 0 1 0.1313 0.2121 0.1421 0.0000 0.0000 0.1290 0.0000 0.0000\n\n1 1 0 0.1608 0.3643 0.2397 0.0000 0.0000 0.1497 0.0000 0.0000\n\n2 0 0 0.5151 0.4898 0.9462 0.0000 0.0000 0.8133 0.0000 0.0000\n\n**DUI Violation Aging**\n\n**0 - 12 Month DUI Violation**\n\n**Count**\n\n**13 - 24 Month DUI**\n\n**Violation Count**\n\n**25 - 35 Month DUI Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0250 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 2 0.0250 0.0000 0.0000 0.0000 0.0000 -0.0300 0.0000 0.0000\n\n0 1 0 0.0500 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 1 1 0.0750 0.0000 0.0000 0.0000 0.0000 -0.0012 0.0000 0.0000\n\n0 2 0 0.1008 0.3010 0.0000 0.0000 0.0000 -0.0001 0.0000 0.0000\n\n1 0 0 0.0750 0.3010 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 0 1 0.1000 0.3010 0.0000 0.0000 0.0000 -0.0009 0.0000 0.0000\n\n1 1 0 0.1255 0.3121 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n2 0 0 0.1524 0.3016 0.3396 0.0000 0.0000 0.3000 0.0000 0.0000\n\n**MAJ Violation Aging**\n\n**0 - 12 Month MAJ Violation**\n\n**Count**\n\n**13 - 24 Month MAJ Violation**\n\n**Count**\n\n**25 - 35 Month MAJ Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.2325 0.0065 0.0264 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.4454 -0.0112 0.0529 0.0000 0.0000 0.2475 0.0000 0.0000\n\n0 1 0 0.2325 0.0065 0.0264 0.0000 0.0000 0.1744 0.0000 0.0000\n\n0 1 1 0.4776 0.0108 0.0542 0.0000 0.0000 0.2660 0.0000 0.0000\n\n0 2 0 0.5858 0.2090 0.0558 0.0000 0.0000 0.3073 0.0000 0.0000\n\n1 0 0 0.3252 0.2194 0.1054 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.5640 0.2242 0.1325 0.0000 0.0000 0.2991 0.0000 0.0000\n\n1 1 0 0.6008 0.2526 0.1360 0.0000 0.0000 0.4101 0.0000 0.0000\n\n2 0 0 0.6326 0.5140 0.4030 0.0000 0.0000 0.5452 0.0000 0.0000\n\n**MIN Violation Aging**\n\n**0 - 12 Month MIN Violation**\n\n**Count**\n\n**13 - 24 Month MIN Violation**\n\n**Count**\n\n**25 - 35 Month MIN Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.1020 0.0065 -0.1079 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.0983 -0.0112 -0.1383 0.0000 0.0000 -0.0280 0.0000 0.0000\n\n0 1 0 0.1020 0.0065 0.0264 0.0000 0.0000 0.1009 0.0000 0.0000\n\n0 1 1 0.2036 0.0111 -0.0841 0.0000 0.0000 0.1629 0.0000 0.0000\n\n0 2 0 0.2174 0.2091 0.1172 0.0000 0.0000 0.2978 0.0000 0.0000\n\n1 0 0 0.1020 0.2194 0.1846 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.2037 0.2245 0.0750 0.0000 0.0000 0.2744 0.0000 0.0000\n\n1 1 0 0.2264 0.2534 0.2073 0.0000 0.0000 0.3443 0.0000 0.0000\n\n2 0 0 0.6342 0.5108 0.2020 0.0000 0.0000 0.5378 0.0000 0.0000\n\n**SPD Violation Aging**\n\n**0 - 12 Month SPD Violation**\n\n**Count**\n\n**13 - 24 Month SPD**\n\n**Violation Count**\n\n**25 - 35 Month SPD Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0000 -0.0875 -0.0960 0.0000 0.0000 -0.1920 0.0000 0.0000\n\n0 0 2 0.0000 -0.0875 -0.1293 0.0000 0.0000 -0.2543 0.0000 0.0000\n\n0 1 0 0.0292 0.0000 -0.0333 0.0000 0.0000 -0.0351 0.0000 0.0000\n\n0 1 1 0.0292 -0.0875 -0.1333 0.0000 0.0000 -0.2349 0.0000 0.0000\n\n0 2 0 0.0814 -0.1062 -0.1084 0.0000 0.0000 -0.2701 0.0000 0.0000\n\n1 0 0 0.0522 0.1586 0.1382 0.0000 0.0000 0.0821 0.0000 0.0000\n\n1 0 1 0.0522 0.0711 0.0386 0.0000 0.0000 -0.1169 0.0000 0.0000\n\n1 1 0 0.0890 0.1293 0.0799 0.0000 0.0000 -0.0179 0.0000 0.0000\n\n2 0 0 0.0911 0.1387 0.3783 0.0000 0.0000 0.3221 0.0000 0.0000\n\n**Proposed**"],"full_content":"**AAF Violation Aging**\n\n**0 - 12 Month AAF Violation**\n\n**Count**\n\n**13 - 24 Month AAF**\n\n**Violation Count**\n\n**25 - 35 Month AAF Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0206 -0.1344 -0.0863 0.0000 0.0000 -0.0898 0.0000 0.0000\n\n0 0 2 0.0524 -0.1473 -0.0811 0.0000 0.0000 -0.1425 0.0000 0.0000\n\n0 1 0 0.0319 -0.0129 0.0262 0.0000 0.0000 -0.0527 0.0000 0.0000\n\n0 1 1 0.0559 -0.1489 -0.0596 0.0000 0.0000 -0.1488 0.0000 0.0000\n\n0 2 0 0.1447 0.3041 0.0265 0.0000 0.0000 -0.0915 0.0000 0.0000\n\n1 0 0 0.1072 0.3481 0.2279 0.0000 0.0000 0.2251 0.0000 0.0000\n\n1 0 1 0.1313 0.2121 0.1421 0.0000 0.0000 0.1290 0.0000 0.0000\n\n1 1 0 0.1608 0.3643 0.2397 0.0000 0.0000 0.1497 0.0000 0.0000\n\n2 0 0 0.5151 0.4898 0.9462 0.0000 0.0000 0.8133 0.0000 0.0000\n\n**DUI Violation Aging**\n\n**0 - 12 Month DUI Violation**\n\n**Count**\n\n**13 - 24 Month DUI**\n\n**Violation Count**\n\n**25 - 35 Month DUI Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0250 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 2 0.0250 0.0000 0.0000 0.0000 0.0000 -0.0300 0.0000 0.0000\n\n0 1 0 0.0500 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 1 1 0.0750 0.0000 0.0000 0.0000 0.0000 -0.0012 0.0000 0.0000\n\n0 2 0 0.1008 0.3010 0.0000 0.0000 0.0000 -0.0001 0.0000 0.0000\n\n1 0 0 0.0750 0.3010 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 0 1 0.1000 0.3010 0.0000 0.0000 0.0000 -0.0009 0.0000 0.0000\n\n1 1 0 0.1255 0.3121 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n2 0 0 0.1524 0.3016 0.3396 0.0000 0.0000 0.3000 0.0000 0.0000\n\n**MAJ Violation Aging**\n\n**0 - 12 Month MAJ Violation**\n\n**Count**\n\n**13 - 24 Month MAJ Violation**\n\n**Count**\n\n**25 - 35 Month MAJ Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.2325 0.0065 0.0264 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.4454 -0.0112 0.0529 0.0000 0.0000 0.2475 0.0000 0.0000\n\n0 1 0 0.2325 0.0065 0.0264 0.0000 0.0000 0.1744 0.0000 0.0000\n\n0 1 1 0.4776 0.0108 0.0542 0.0000 0.0000 0.2660 0.0000 0.0000\n\n0 2 0 0.5858 0.2090 0.0558 0.0000 0.0000 0.3073 0.0000 0.0000\n\n1 0 0 0.3252 0.2194 0.1054 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.5640 0.2242 0.1325 0.0000 0.0000 0.2991 0.0000 0.0000\n\n1 1 0 0.6008 0.2526 0.1360 0.0000 0.0000 0.4101 0.0000 0.0000\n\n2 0 0 0.6326 0.5140 0.4030 0.0000 0.0000 0.5452 0.0000 0.0000\n\n**MIN Violation Aging**\n\n**0 - 12 Month MIN Violation**\n\n**Count**\n\n**13 - 24 Month MIN Violation**\n\n**Count**\n\n**25 - 35 Month MIN Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.1020 0.0065 -0.1079 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.0983 -0.0112 -0.1383 0.0000 0.0000 -0.0280 0.0000 0.0000\n\n0 1 0 0.1020 0.0065 0.0264 0.0000 0.0000 0.1009 0.0000 0.0000\n\n0 1 1 0.2036 0.0111 -0.0841 0.0000 0.0000 0.1629 0.0000 0.0000\n\n0 2 0 0.2174 0.2091 0.1172 0.0000 0.0000 0.2978 0.0000 0.0000\n\n1 0 0 0.1020 0.2194 0.1846 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.2037 0.2245 0.0750 0.0000 0.0000 0.2744 0.0000 0.0000\n\n1 1 0 0.2264 0.2534 0.2073 0.0000 0.0000 0.3443 0.0000 0.0000\n\n2 0 0 0.6342 0.5108 0.2020 0.0000 0.0000 0.5378 0.0000 0.0000\n\n**SPD Violation Aging**\n\n**0 - 12 Month SPD Violation**\n\n**Count**\n\n**13 - 24 Month SPD**\n\n**Violation Count**\n\n**25 - 35 Month SPD Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0000 -0.0875 -0.0960 0.0000 0.0000 -0.1920 0.0000 0.0000\n\n0 0 2 0.0000 -0.0875 -0.1293 0.0000 0.0000 -0.2543 0.0000 0.0000\n\n0 1 0 0.0292 0.0000 -0.0333 0.0000 0.0000 -0.0351 0.0000 0.0000\n\n0 1 1 0.0292 -0.0875 -0.1333 0.0000 0.0000 -0.2349 0.0000 0.0000\n\n0 2 0 0.0814 -0.1062 -0.1084 0.0000 0.0000 -0.2701 0.0000 0.0000\n\n1 0 0 0.0522 0.1586 0.1382 0.0000 0.0000 0.0821 0.0000 0.0000\n\n1 0 1 0.0522 0.0711 0.0386 0.0000 0.0000 -0.1169 0.0000 0.0000\n\n1 1 0 0.0890 0.1293 0.0799 0.0000 0.0000 -0.0179 0.0000 0.0000\n\n2 0 0 0.0911 0.1387 0.3783 0.0000 0.0000 0.3221 0.0000 0.0000\n\n**Proposed**","publish_date":null,"title":"AAF Violation Aging DUI Violation Aging MAJ Violation Aging MIN Violation Aging SPD Violation Aging","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1171.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1171.pdf"},"request":{"example_id":"table/BRWS-134565917_page1171","product_type":"parse","source_file_path":"BRWS-134565917_page1171.pdf"},"started_at":"2026-11-04T19:48:10.466586"} +{"completed_at":"2026-11-04T19:48:14.397089","latency_in_ms":2500,"output":{"example_id":"table/BRWS-134565917_page1210","grounded_pages":[],"layout_pages":[],"markdown":"**Model Year Factor Model Year Groups Model Year group Vehicle Age Group**\n\n**Model Year ALL BI COL EXTR MP OTC PD RA UIM UMBI** 2023-2027+ A\n\n1995 & older 0.4320 0.7485 0.3144 0.3144 0.6826 0.4320 0.7480 2.1400 0.6826 0.6826 2020-2022 B\n\n1996 0.4320 0.7618 0.3144 0.3144 0.6933 0.4320 0.7577 2.1400 0.6933 0.6933 2017-2019 C\n\n1997 0.4320 0.7750 0.3144 0.3144 0.7041 0.4320 0.7674 2.1400 0.7041 0.7041 2014-2016 D\n\n1998 0.4320 0.7883 0.3144 0.3144 0.7149 0.4320 0.7771 2.1400 0.7149 0.7149 2011-2013 E\n\n1999 0.4320 0.8016 0.3144 0.3144 0.7257 0.4320 0.7868 2.1400 0.7257 0.7257 2008-2010 F\n\n2000 0.4320 0.8148 0.3144 0.3144 0.7364 0.4320 0.7965 2.1400 0.7364 0.7364 2007 & older G\n\n2001 0.4320 0.8281 0.3144 0.3144 0.7472 0.4320 0.8062 2.1400 0.7472 0.7472 9999 Z\n\n2002 0.4320 0.8414 0.3144 0.3144 0.7580 0.4320 0.8159 2.1400 0.7580 0.7580\n\n2003 0.4320 0.8546 0.3144 0.3144 0.7688 0.4320 0.8255 2.1400 0.7688 0.7688\n\n2004 0.4320 0.8804 0.3144 0.3144 0.8537 0.4320 0.8399 2.1400 0.8537 0.8537\n\n2005 0.4320 0.8831 0.3144 0.3144 0.8576 0.4320 0.9030 2.1400 0.8576 0.8576\n\n2006 0.4320 0.8845 0.3144 0.3144 0.8576 0.4320 0.9060 2.1400 0.8576 0.8576\n\n2007 0.4692 0.9787 0.3601 0.3601 0.8576 0.4692 0.9347 2.1400 0.8576 0.8576\n\n2008 0.4766 0.9929 0.4001 0.4001 0.8791 0.4766 0.9399 2.1400 0.8791 0.8791\n\n2009 0.5413 0.9976 0.4756 0.4756 0.9080 0.5413 0.9578 1.9700 0.9080 0.9080\n\n2010 0.5413 0.9976 0.4798 0.4798 0.9281 0.5413 0.9578 1.8600 0.9281 0.9281\n\n2011 0.5733 0.9976 0.4871 0.4871 0.9281 0.5733 0.9853 1.7900 0.9281 0.9281\n\n2012 0.6135 1.0322 0.5452 0.5452 1.0065 0.6135 1.0294 1.7500 1.0065 1.0065\n\n2013 0.7267 1.0829 0.6377 0.6377 1.0386 0.7267 1.0517 1.7200 1.0386 1.0386\n\n2014 0.7349 1.0829 0.6823 0.6823 1.0386 0.7349 1.0517 1.6900 1.0386 1.0386\n\n2015 0.8241 1.0982 0.7460 0.7460 1.0386 0.8241 1.0517 1.6600 1.0386 1.0386\n\n2016 0.9480 1.0568 0.8815 0.8815 1.0386 0.9480 1.0517 1.6100 1.0386 1.0386\n\n2017 0.9830 1.0568 0.9302 0.9302 1.0386 0.9830 1.0741 1.5300 1.0386 1.0386\n\n2018 0.9845 1.0568 0.9876 0.9876 1.0597 0.9845 1.0741 1.4200 1.0597 1.0597\n\n2019 1.1636 1.0568 1.1318 1.1318 1.0998 1.1636 1.1187 1.2900 1.0998 1.0998\n\n2020 1.1718 1.0568 1.2571 1.2571 1.1398 1.1718 1.1426 1.1200 1.1398 1.1398\n\n2021 1.2814 1.0568 1.2753 1.2753 1.1664 1.2814 1.1084 0.9300 1.1664 1.1664\n\n2022 1.3349 1.0568 1.4005 1.4005 1.1887 1.3349 1.0892 0.7600 1.1887 1.1887\n\n2023 1.4089 1.0076 1.4288 1.4288 1.2427 1.4089 1.0570 0.5900 1.2427 1.2427\n\n2024 1.4089 0.9572 1.4378 1.4378 1.2149 1.4089 0.9718 0.4200 1.2149 1.2149\n\n2025 1.4158 0.9572 1.5760 1.5760 1.2060 1.4158 0.9699 0.2600 1.2060 1.2060\n\n2026 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n2027+ 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n9999 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Model Year Factor Model Year Groups Model Year group Vehicle Age Group**\n\n**Model Year ALL BI COL EXTR MP OTC PD RA UIM UMBI** 2023-2027+ A\n\n1995 & older 0.4320 0.7485 0.3144 0.3144 0.6826 0.4320 0.7480 2.1400 0.6826 0.6826 2020-2022 B\n\n1996 0.4320 0.7618 0.3144 0.3144 0.6933 0.4320 0.7577 2.1400 0.6933 0.6933 2017-2019 C\n\n1997 0.4320 0.7750 0.3144 0.3144 0.7041 0.4320 0.7674 2.1400 0.7041 0.7041 2014-2016 D\n\n1998 0.4320 0.7883 0.3144 0.3144 0.7149 0.4320 0.7771 2.1400 0.7149 0.7149 2011-2013 E\n\n1999 0.4320 0.8016 0.3144 0.3144 0.7257 0.4320 0.7868 2.1400 0.7257 0.7257 2008-2010 F\n\n2000 0.4320 0.8148 0.3144 0.3144 0.7364 0.4320 0.7965 2.1400 0.7364 0.7364 2007 & older G\n\n2001 0.4320 0.8281 0.3144 0.3144 0.7472 0.4320 0.8062 2.1400 0.7472 0.7472 9999 Z\n\n2002 0.4320 0.8414 0.3144 0.3144 0.7580 0.4320 0.8159 2.1400 0.7580 0.7580\n\n2003 0.4320 0.8546 0.3144 0.3144 0.7688 0.4320 0.8255 2.1400 0.7688 0.7688\n\n2004 0.4320 0.8804 0.3144 0.3144 0.8537 0.4320 0.8399 2.1400 0.8537 0.8537\n\n2005 0.4320 0.8831 0.3144 0.3144 0.8576 0.4320 0.9030 2.1400 0.8576 0.8576\n\n2006 0.4320 0.8845 0.3144 0.3144 0.8576 0.4320 0.9060 2.1400 0.8576 0.8576\n\n2007 0.4692 0.9787 0.3601 0.3601 0.8576 0.4692 0.9347 2.1400 0.8576 0.8576\n\n2008 0.4766 0.9929 0.4001 0.4001 0.8791 0.4766 0.9399 2.1400 0.8791 0.8791\n\n2009 0.5413 0.9976 0.4756 0.4756 0.9080 0.5413 0.9578 1.9700 0.9080 0.9080\n\n2010 0.5413 0.9976 0.4798 0.4798 0.9281 0.5413 0.9578 1.8600 0.9281 0.9281\n\n2011 0.5733 0.9976 0.4871 0.4871 0.9281 0.5733 0.9853 1.7900 0.9281 0.9281\n\n2012 0.6135 1.0322 0.5452 0.5452 1.0065 0.6135 1.0294 1.7500 1.0065 1.0065\n\n2013 0.7267 1.0829 0.6377 0.6377 1.0386 0.7267 1.0517 1.7200 1.0386 1.0386\n\n2014 0.7349 1.0829 0.6823 0.6823 1.0386 0.7349 1.0517 1.6900 1.0386 1.0386\n\n2015 0.8241 1.0982 0.7460 0.7460 1.0386 0.8241 1.0517 1.6600 1.0386 1.0386\n\n2016 0.9480 1.0568 0.8815 0.8815 1.0386 0.9480 1.0517 1.6100 1.0386 1.0386\n\n2017 0.9830 1.0568 0.9302 0.9302 1.0386 0.9830 1.0741 1.5300 1.0386 1.0386\n\n2018 0.9845 1.0568 0.9876 0.9876 1.0597 0.9845 1.0741 1.4200 1.0597 1.0597\n\n2019 1.1636 1.0568 1.1318 1.1318 1.0998 1.1636 1.1187 1.2900 1.0998 1.0998\n\n2020 1.1718 1.0568 1.2571 1.2571 1.1398 1.1718 1.1426 1.1200 1.1398 1.1398\n\n2021 1.2814 1.0568 1.2753 1.2753 1.1664 1.2814 1.1084 0.9300 1.1664 1.1664\n\n2022 1.3349 1.0568 1.4005 1.4005 1.1887 1.3349 1.0892 0.7600 1.1887 1.1887\n\n2023 1.4089 1.0076 1.4288 1.4288 1.2427 1.4089 1.0570 0.5900 1.2427 1.2427\n\n2024 1.4089 0.9572 1.4378 1.4378 1.2149 1.4089 0.9718 0.4200 1.2149 1.2149\n\n2025 1.4158 0.9572 1.5760 1.5760 1.2060 1.4158 0.9699 0.2600 1.2060 1.2060\n\n2026 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n2027+ 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n9999 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Model Year Factor Model Year Groups Model Year group Vehicle Age Group**\n\n**Model Year ALL BI COL EXTR MP OTC PD RA UIM UMBI** 2023-2027+ A\n\n1995 & older 0.4320 0.7485 0.3144 0.3144 0.6826 0.4320 0.7480 2.1400 0.6826 0.6826 2020-2022 B\n\n1996 0.4320 0.7618 0.3144 0.3144 0.6933 0.4320 0.7577 2.1400 0.6933 0.6933 2017-2019 C\n\n1997 0.4320 0.7750 0.3144 0.3144 0.7041 0.4320 0.7674 2.1400 0.7041 0.7041 2014-2016 D\n\n1998 0.4320 0.7883 0.3144 0.3144 0.7149 0.4320 0.7771 2.1400 0.7149 0.7149 2011-2013 E\n\n1999 0.4320 0.8016 0.3144 0.3144 0.7257 0.4320 0.7868 2.1400 0.7257 0.7257 2008-2010 F\n\n2000 0.4320 0.8148 0.3144 0.3144 0.7364 0.4320 0.7965 2.1400 0.7364 0.7364 2007 & older G\n\n2001 0.4320 0.8281 0.3144 0.3144 0.7472 0.4320 0.8062 2.1400 0.7472 0.7472 9999 Z\n\n2002 0.4320 0.8414 0.3144 0.3144 0.7580 0.4320 0.8159 2.1400 0.7580 0.7580\n\n2003 0.4320 0.8546 0.3144 0.3144 0.7688 0.4320 0.8255 2.1400 0.7688 0.7688\n\n2004 0.4320 0.8804 0.3144 0.3144 0.8537 0.4320 0.8399 2.1400 0.8537 0.8537\n\n2005 0.4320 0.8831 0.3144 0.3144 0.8576 0.4320 0.9030 2.1400 0.8576 0.8576\n\n2006 0.4320 0.8845 0.3144 0.3144 0.8576 0.4320 0.9060 2.1400 0.8576 0.8576\n\n2007 0.4692 0.9787 0.3601 0.3601 0.8576 0.4692 0.9347 2.1400 0.8576 0.8576\n\n2008 0.4766 0.9929 0.4001 0.4001 0.8791 0.4766 0.9399 2.1400 0.8791 0.8791\n\n2009 0.5413 0.9976 0.4756 0.4756 0.9080 0.5413 0.9578 1.9700 0.9080 0.9080\n\n2010 0.5413 0.9976 0.4798 0.4798 0.9281 0.5413 0.9578 1.8600 0.9281 0.9281\n\n2011 0.5733 0.9976 0.4871 0.4871 0.9281 0.5733 0.9853 1.7900 0.9281 0.9281\n\n2012 0.6135 1.0322 0.5452 0.5452 1.0065 0.6135 1.0294 1.7500 1.0065 1.0065\n\n2013 0.7267 1.0829 0.6377 0.6377 1.0386 0.7267 1.0517 1.7200 1.0386 1.0386\n\n2014 0.7349 1.0829 0.6823 0.6823 1.0386 0.7349 1.0517 1.6900 1.0386 1.0386\n\n2015 0.8241 1.0982 0.7460 0.7460 1.0386 0.8241 1.0517 1.6600 1.0386 1.0386\n\n2016 0.9480 1.0568 0.8815 0.8815 1.0386 0.9480 1.0517 1.6100 1.0386 1.0386\n\n2017 0.9830 1.0568 0.9302 0.9302 1.0386 0.9830 1.0741 1.5300 1.0386 1.0386\n\n2018 0.9845 1.0568 0.9876 0.9876 1.0597 0.9845 1.0741 1.4200 1.0597 1.0597\n\n2019 1.1636 1.0568 1.1318 1.1318 1.0998 1.1636 1.1187 1.2900 1.0998 1.0998\n\n2020 1.1718 1.0568 1.2571 1.2571 1.1398 1.1718 1.1426 1.1200 1.1398 1.1398\n\n2021 1.2814 1.0568 1.2753 1.2753 1.1664 1.2814 1.1084 0.9300 1.1664 1.1664\n\n2022 1.3349 1.0568 1.4005 1.4005 1.1887 1.3349 1.0892 0.7600 1.1887 1.1887\n\n2023 1.4089 1.0076 1.4288 1.4288 1.2427 1.4089 1.0570 0.5900 1.2427 1.2427\n\n2024 1.4089 0.9572 1.4378 1.4378 1.2149 1.4089 0.9718 0.4200 1.2149 1.2149\n\n2025 1.4158 0.9572 1.5760 1.5760 1.2060 1.4158 0.9699 0.2600 1.2060 1.2060\n\n2026 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n2027+ 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n9999 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1210.pdf"]},"response":{"errors":[],"extract_id":"extract_ff405e0cd33ee796df1778593a0fc7e2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Model Year Factor Model Year Groups Model Year group Vehicle Age Group**\n\n**Model Year ALL BI COL EXTR MP OTC PD RA UIM UMBI** 2023-2027+ A\n\n1995 & older 0.4320 0.7485 0.3144 0.3144 0.6826 0.4320 0.7480 2.1400 0.6826 0.6826 2020-2022 B\n\n1996 0.4320 0.7618 0.3144 0.3144 0.6933 0.4320 0.7577 2.1400 0.6933 0.6933 2017-2019 C\n\n1997 0.4320 0.7750 0.3144 0.3144 0.7041 0.4320 0.7674 2.1400 0.7041 0.7041 2014-2016 D\n\n1998 0.4320 0.7883 0.3144 0.3144 0.7149 0.4320 0.7771 2.1400 0.7149 0.7149 2011-2013 E\n\n1999 0.4320 0.8016 0.3144 0.3144 0.7257 0.4320 0.7868 2.1400 0.7257 0.7257 2008-2010 F\n\n2000 0.4320 0.8148 0.3144 0.3144 0.7364 0.4320 0.7965 2.1400 0.7364 0.7364 2007 & older G\n\n2001 0.4320 0.8281 0.3144 0.3144 0.7472 0.4320 0.8062 2.1400 0.7472 0.7472 9999 Z\n\n2002 0.4320 0.8414 0.3144 0.3144 0.7580 0.4320 0.8159 2.1400 0.7580 0.7580\n\n2003 0.4320 0.8546 0.3144 0.3144 0.7688 0.4320 0.8255 2.1400 0.7688 0.7688\n\n2004 0.4320 0.8804 0.3144 0.3144 0.8537 0.4320 0.8399 2.1400 0.8537 0.8537\n\n2005 0.4320 0.8831 0.3144 0.3144 0.8576 0.4320 0.9030 2.1400 0.8576 0.8576\n\n2006 0.4320 0.8845 0.3144 0.3144 0.8576 0.4320 0.9060 2.1400 0.8576 0.8576\n\n2007 0.4692 0.9787 0.3601 0.3601 0.8576 0.4692 0.9347 2.1400 0.8576 0.8576\n\n2008 0.4766 0.9929 0.4001 0.4001 0.8791 0.4766 0.9399 2.1400 0.8791 0.8791\n\n2009 0.5413 0.9976 0.4756 0.4756 0.9080 0.5413 0.9578 1.9700 0.9080 0.9080\n\n2010 0.5413 0.9976 0.4798 0.4798 0.9281 0.5413 0.9578 1.8600 0.9281 0.9281\n\n2011 0.5733 0.9976 0.4871 0.4871 0.9281 0.5733 0.9853 1.7900 0.9281 0.9281\n\n2012 0.6135 1.0322 0.5452 0.5452 1.0065 0.6135 1.0294 1.7500 1.0065 1.0065\n\n2013 0.7267 1.0829 0.6377 0.6377 1.0386 0.7267 1.0517 1.7200 1.0386 1.0386\n\n2014 0.7349 1.0829 0.6823 0.6823 1.0386 0.7349 1.0517 1.6900 1.0386 1.0386\n\n2015 0.8241 1.0982 0.7460 0.7460 1.0386 0.8241 1.0517 1.6600 1.0386 1.0386\n\n2016 0.9480 1.0568 0.8815 0.8815 1.0386 0.9480 1.0517 1.6100 1.0386 1.0386\n\n2017 0.9830 1.0568 0.9302 0.9302 1.0386 0.9830 1.0741 1.5300 1.0386 1.0386\n\n2018 0.9845 1.0568 0.9876 0.9876 1.0597 0.9845 1.0741 1.4200 1.0597 1.0597\n\n2019 1.1636 1.0568 1.1318 1.1318 1.0998 1.1636 1.1187 1.2900 1.0998 1.0998\n\n2020 1.1718 1.0568 1.2571 1.2571 1.1398 1.1718 1.1426 1.1200 1.1398 1.1398\n\n2021 1.2814 1.0568 1.2753 1.2753 1.1664 1.2814 1.1084 0.9300 1.1664 1.1664\n\n2022 1.3349 1.0568 1.4005 1.4005 1.1887 1.3349 1.0892 0.7600 1.1887 1.1887\n\n2023 1.4089 1.0076 1.4288 1.4288 1.2427 1.4089 1.0570 0.5900 1.2427 1.2427\n\n2024 1.4089 0.9572 1.4378 1.4378 1.2149 1.4089 0.9718 0.4200 1.2149 1.2149\n\n2025 1.4158 0.9572 1.5760 1.5760 1.2060 1.4158 0.9699 0.2600 1.2060 1.2060\n\n2026 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n2027+ 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n9999 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**"],"full_content":"**Model Year Factor Model Year Groups Model Year group Vehicle Age Group**\n\n**Model Year ALL BI COL EXTR MP OTC PD RA UIM UMBI** 2023-2027+ A\n\n1995 & older 0.4320 0.7485 0.3144 0.3144 0.6826 0.4320 0.7480 2.1400 0.6826 0.6826 2020-2022 B\n\n1996 0.4320 0.7618 0.3144 0.3144 0.6933 0.4320 0.7577 2.1400 0.6933 0.6933 2017-2019 C\n\n1997 0.4320 0.7750 0.3144 0.3144 0.7041 0.4320 0.7674 2.1400 0.7041 0.7041 2014-2016 D\n\n1998 0.4320 0.7883 0.3144 0.3144 0.7149 0.4320 0.7771 2.1400 0.7149 0.7149 2011-2013 E\n\n1999 0.4320 0.8016 0.3144 0.3144 0.7257 0.4320 0.7868 2.1400 0.7257 0.7257 2008-2010 F\n\n2000 0.4320 0.8148 0.3144 0.3144 0.7364 0.4320 0.7965 2.1400 0.7364 0.7364 2007 & older G\n\n2001 0.4320 0.8281 0.3144 0.3144 0.7472 0.4320 0.8062 2.1400 0.7472 0.7472 9999 Z\n\n2002 0.4320 0.8414 0.3144 0.3144 0.7580 0.4320 0.8159 2.1400 0.7580 0.7580\n\n2003 0.4320 0.8546 0.3144 0.3144 0.7688 0.4320 0.8255 2.1400 0.7688 0.7688\n\n2004 0.4320 0.8804 0.3144 0.3144 0.8537 0.4320 0.8399 2.1400 0.8537 0.8537\n\n2005 0.4320 0.8831 0.3144 0.3144 0.8576 0.4320 0.9030 2.1400 0.8576 0.8576\n\n2006 0.4320 0.8845 0.3144 0.3144 0.8576 0.4320 0.9060 2.1400 0.8576 0.8576\n\n2007 0.4692 0.9787 0.3601 0.3601 0.8576 0.4692 0.9347 2.1400 0.8576 0.8576\n\n2008 0.4766 0.9929 0.4001 0.4001 0.8791 0.4766 0.9399 2.1400 0.8791 0.8791\n\n2009 0.5413 0.9976 0.4756 0.4756 0.9080 0.5413 0.9578 1.9700 0.9080 0.9080\n\n2010 0.5413 0.9976 0.4798 0.4798 0.9281 0.5413 0.9578 1.8600 0.9281 0.9281\n\n2011 0.5733 0.9976 0.4871 0.4871 0.9281 0.5733 0.9853 1.7900 0.9281 0.9281\n\n2012 0.6135 1.0322 0.5452 0.5452 1.0065 0.6135 1.0294 1.7500 1.0065 1.0065\n\n2013 0.7267 1.0829 0.6377 0.6377 1.0386 0.7267 1.0517 1.7200 1.0386 1.0386\n\n2014 0.7349 1.0829 0.6823 0.6823 1.0386 0.7349 1.0517 1.6900 1.0386 1.0386\n\n2015 0.8241 1.0982 0.7460 0.7460 1.0386 0.8241 1.0517 1.6600 1.0386 1.0386\n\n2016 0.9480 1.0568 0.8815 0.8815 1.0386 0.9480 1.0517 1.6100 1.0386 1.0386\n\n2017 0.9830 1.0568 0.9302 0.9302 1.0386 0.9830 1.0741 1.5300 1.0386 1.0386\n\n2018 0.9845 1.0568 0.9876 0.9876 1.0597 0.9845 1.0741 1.4200 1.0597 1.0597\n\n2019 1.1636 1.0568 1.1318 1.1318 1.0998 1.1636 1.1187 1.2900 1.0998 1.0998\n\n2020 1.1718 1.0568 1.2571 1.2571 1.1398 1.1718 1.1426 1.1200 1.1398 1.1398\n\n2021 1.2814 1.0568 1.2753 1.2753 1.1664 1.2814 1.1084 0.9300 1.1664 1.1664\n\n2022 1.3349 1.0568 1.4005 1.4005 1.1887 1.3349 1.0892 0.7600 1.1887 1.1887\n\n2023 1.4089 1.0076 1.4288 1.4288 1.2427 1.4089 1.0570 0.5900 1.2427 1.2427\n\n2024 1.4089 0.9572 1.4378 1.4378 1.2149 1.4089 0.9718 0.4200 1.2149 1.2149\n\n2025 1.4158 0.9572 1.5760 1.5760 1.2060 1.4158 0.9699 0.2600 1.2060 1.2060\n\n2026 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n2027+ 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n9999 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","publish_date":null,"title":"Proposed Model Year Factor Model Year Groups Model Year group Vehicle Age Group Model Year ALL BI COL EXTR MP","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1210.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1210.pdf"},"request":{"example_id":"table/BRWS-134565917_page1210","product_type":"parse","source_file_path":"BRWS-134565917_page1210.pdf"},"started_at":"2026-11-04T19:48:11.896667"} +{"completed_at":"2026-11-04T19:48:15.579554","latency_in_ms":2419,"output":{"example_id":"table/BRWS-134565917_page1240","grounded_pages":[],"layout_pages":[],"markdown":"**UIM UMBI**\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9399 0.9399\n\n0\\.9399 0.9399","pages":[{"line_numbers":[],"markdown":"**UIM UMBI**\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9399 0.9399\n\n0\\.9399 0.9399","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**UIM UMBI**\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9399 0.9399\n\n0\\.9399 0.9399","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1240.pdf"]},"response":{"errors":[],"extract_id":"extract_19c3439480ebd1ace44144ce97841623","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**UIM UMBI**\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9399 0.9399\n\n0\\.9399 0.9399"],"full_content":"**UIM UMBI**\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n0\\.9928 0.9928\n\n1\\.0000 1.0000\n\n1\\.0000 1.0000\n\n0\\.9399 0.9399\n\n0\\.9399 0.9399","publish_date":null,"title":"UIM UMBI","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1240.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1240.pdf"},"request":{"example_id":"table/BRWS-134565917_page1240","product_type":"parse","source_file_path":"BRWS-134565917_page1240.pdf"},"started_at":"2026-11-04T19:48:13.159843"} +{"completed_at":"2026-11-04T19:48:18.314824","latency_in_ms":3427,"output":{"example_id":"table/BRWS-134565917_page1419","grounded_pages":[],"layout_pages":[],"markdown":"**Calculation of Bad Debt Factor**\n\n**Factor**\n\nMean Bad Debt XX\n\nCredit Tier x\n\nUW Tier x\n\nDownpay/Number of Payments x\n\nAdditional Driver x\n\nInstallment Type x\n\nISI Tier x\n\nFDL Factor x\n\nAddition of Unity 1\n\nBad Debt Factor =\n\n**Mean Bad Debt** 0\\.0411 \\*\\*MEAN BAD DEBT FACTOR NEEDS UPDATED IN BOB\\*\\*\n\n**Credit Tier Factor Additional Driver**\n\n**Count Group Factor ISI Factor UW Tier Factor**\n\nFDL Full Coverage\n\n**Factor**\n\nPAID IN FULL EFT Installment Type\n\n**Factor Pay Plan Code Factor**\n\nA 0.3848 0 0.9124 1\\_BEST 0.5732 1 0.3435 N N 1.0216 N N 0.8932 D0 0.0408\n\nB 0.4017 1+ 1.5689 2\\_GOOD 0.7460 2 0.9169 N Y 1.0124 N Y 0.6830 D1 1.1492\n\nC 0.4365 2.4813 3\\_AVER 0.9370 3 0.4146 I N 0.5464 N C 1.0797 D2 0.0408\n\nD 0.4995 4\\_MEDI 1.0382 4 0.9169 I Y 0.6702 N D 1.0797 D3 0.4830\n\nE 0.5475 5\\_POOR 1.2803 5 0.5295 Y N 2.3364 D4 0.7152\n\nF 0.5840 6\\_NHTF 1.0747 6 0.9169 3.2506 Y Y 2.3364 D5 0.7152\n\nG 0.6143 7\\_NO 1.0747 7 1.5962 Y C 2.3364 D6 1.1492\n\nH 0.6568 G\\_GRANDFATHERED 1.0000 5.6345 Y D 2.3364 D7 0.7152\n\nI 0.6791 7.7241 D8 1.1492\n\nJ 0.7333 13.0812 D9 1.1974\n\nK 0.7873 DA 0.2752\n\nL 0.8421 DB 1.1974\n\nM 0.8759 DC 1.1974\n\nN 0.9143 DD 1.1492\n\nO 0.9886 DE 1.1974\n\nP 0.9972 DF 1.1492\n\nQ 1.0433 DG 1.1492\n\nR 1.1212 DH 1.1974\n\nS 1.1955 DI 1.1974\n\nT 1.2391 DJ 0.7152\n\nU 1.3443 DK 1.1974\n\nV 1.4362 DL 0.8534\n\nW 1.5883 DM 0.8534\n\nX 1.7819 DN 0.483\n\nY 2.1535 DO 1.1974\n\nZD 1.1996 DP 0.483\n\nZE 1.1996 DQ 0.0408\n\nZF 1.1996 DR 1.1974\n\nZG 1.1996 DS 1.1974\n\nZH 2.1535 DU 1.1492\n\nZJ 1.3073 DV 1.1974\n\nZK 1.3073 DW 1.1974\n\nZL 1.3073 DX 1.1492\n\nDY 0.2752\n\n34\\.7200 DZ 1.1492\n\nO0 1.1974\n\nO1 1.1974\n\nO2 1.1974\n\nO3 1.1974\n\nO4 1.1974\n\nO5 0.483\n\nO6 0.483\n\nO7 0.483\n\nO8 0.483\n\nO9 0.0408\n\nOA 0.0408\n\nOB 2.5631\n\nOC 1.1974\n\nOD 2.5631\n\nOE 1.1974\n\nOF 1.1974\n\nOG 0.0408\n\nOH 2.5631\n\nOI 0.2752\n\nOJ 0.2752\n\nOK 0.2752\n\nOL 0.2752\n\nOM 2.5631\n\nON 3.2959\n\nOO 3.2959\n\nOP 3.2959\n\nOQ 1.1492\n\nOR 1.1492\n\nOS 1.1492\n\nOU 1.1974\n\nOV 1.1974\n\nOW 2.5631\n\nOX 1.1974\n\nOY 1.1974\n\nOZ 1.1974\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Calculation of Bad Debt Factor**\n\n**Factor**\n\nMean Bad Debt XX\n\nCredit Tier x\n\nUW Tier x\n\nDownpay/Number of Payments x\n\nAdditional Driver x\n\nInstallment Type x\n\nISI Tier x\n\nFDL Factor x\n\nAddition of Unity 1\n\nBad Debt Factor =\n\n**Mean Bad Debt** 0\\.0411 \\*\\*MEAN BAD DEBT FACTOR NEEDS UPDATED IN BOB\\*\\*\n\n**Credit Tier Factor Additional Driver**\n\n**Count Group Factor ISI Factor UW Tier Factor**\n\nFDL Full Coverage\n\n**Factor**\n\nPAID IN FULL EFT Installment Type\n\n**Factor Pay Plan Code Factor**\n\nA 0.3848 0 0.9124 1\\_BEST 0.5732 1 0.3435 N N 1.0216 N N 0.8932 D0 0.0408\n\nB 0.4017 1+ 1.5689 2\\_GOOD 0.7460 2 0.9169 N Y 1.0124 N Y 0.6830 D1 1.1492\n\nC 0.4365 2.4813 3\\_AVER 0.9370 3 0.4146 I N 0.5464 N C 1.0797 D2 0.0408\n\nD 0.4995 4\\_MEDI 1.0382 4 0.9169 I Y 0.6702 N D 1.0797 D3 0.4830\n\nE 0.5475 5\\_POOR 1.2803 5 0.5295 Y N 2.3364 D4 0.7152\n\nF 0.5840 6\\_NHTF 1.0747 6 0.9169 3.2506 Y Y 2.3364 D5 0.7152\n\nG 0.6143 7\\_NO 1.0747 7 1.5962 Y C 2.3364 D6 1.1492\n\nH 0.6568 G\\_GRANDFATHERED 1.0000 5.6345 Y D 2.3364 D7 0.7152\n\nI 0.6791 7.7241 D8 1.1492\n\nJ 0.7333 13.0812 D9 1.1974\n\nK 0.7873 DA 0.2752\n\nL 0.8421 DB 1.1974\n\nM 0.8759 DC 1.1974\n\nN 0.9143 DD 1.1492\n\nO 0.9886 DE 1.1974\n\nP 0.9972 DF 1.1492\n\nQ 1.0433 DG 1.1492\n\nR 1.1212 DH 1.1974\n\nS 1.1955 DI 1.1974\n\nT 1.2391 DJ 0.7152\n\nU 1.3443 DK 1.1974\n\nV 1.4362 DL 0.8534\n\nW 1.5883 DM 0.8534\n\nX 1.7819 DN 0.483\n\nY 2.1535 DO 1.1974\n\nZD 1.1996 DP 0.483\n\nZE 1.1996 DQ 0.0408\n\nZF 1.1996 DR 1.1974\n\nZG 1.1996 DS 1.1974\n\nZH 2.1535 DU 1.1492\n\nZJ 1.3073 DV 1.1974\n\nZK 1.3073 DW 1.1974\n\nZL 1.3073 DX 1.1492\n\nDY 0.2752\n\n34\\.7200 DZ 1.1492\n\nO0 1.1974\n\nO1 1.1974\n\nO2 1.1974\n\nO3 1.1974\n\nO4 1.1974\n\nO5 0.483\n\nO6 0.483\n\nO7 0.483\n\nO8 0.483\n\nO9 0.0408\n\nOA 0.0408\n\nOB 2.5631\n\nOC 1.1974\n\nOD 2.5631\n\nOE 1.1974\n\nOF 1.1974\n\nOG 0.0408\n\nOH 2.5631\n\nOI 0.2752\n\nOJ 0.2752\n\nOK 0.2752\n\nOL 0.2752\n\nOM 2.5631\n\nON 3.2959\n\nOO 3.2959\n\nOP 3.2959\n\nOQ 1.1492\n\nOR 1.1492\n\nOS 1.1492\n\nOU 1.1974\n\nOV 1.1974\n\nOW 2.5631\n\nOX 1.1974\n\nOY 1.1974\n\nOZ 1.1974\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Calculation of Bad Debt Factor**\n\n**Factor**\n\nMean Bad Debt XX\n\nCredit Tier x\n\nUW Tier x\n\nDownpay/Number of Payments x\n\nAdditional Driver x\n\nInstallment Type x\n\nISI Tier x\n\nFDL Factor x\n\nAddition of Unity 1\n\nBad Debt Factor =\n\n**Mean Bad Debt** 0\\.0411 \\*\\*MEAN BAD DEBT FACTOR NEEDS UPDATED IN BOB\\*\\*\n\n**Credit Tier Factor Additional Driver**\n\n**Count Group Factor ISI Factor UW Tier Factor**\n\nFDL Full Coverage\n\n**Factor**\n\nPAID IN FULL EFT Installment Type\n\n**Factor Pay Plan Code Factor**\n\nA 0.3848 0 0.9124 1\\_BEST 0.5732 1 0.3435 N N 1.0216 N N 0.8932 D0 0.0408\n\nB 0.4017 1+ 1.5689 2\\_GOOD 0.7460 2 0.9169 N Y 1.0124 N Y 0.6830 D1 1.1492\n\nC 0.4365 2.4813 3\\_AVER 0.9370 3 0.4146 I N 0.5464 N C 1.0797 D2 0.0408\n\nD 0.4995 4\\_MEDI 1.0382 4 0.9169 I Y 0.6702 N D 1.0797 D3 0.4830\n\nE 0.5475 5\\_POOR 1.2803 5 0.5295 Y N 2.3364 D4 0.7152\n\nF 0.5840 6\\_NHTF 1.0747 6 0.9169 3.2506 Y Y 2.3364 D5 0.7152\n\nG 0.6143 7\\_NO 1.0747 7 1.5962 Y C 2.3364 D6 1.1492\n\nH 0.6568 G\\_GRANDFATHERED 1.0000 5.6345 Y D 2.3364 D7 0.7152\n\nI 0.6791 7.7241 D8 1.1492\n\nJ 0.7333 13.0812 D9 1.1974\n\nK 0.7873 DA 0.2752\n\nL 0.8421 DB 1.1974\n\nM 0.8759 DC 1.1974\n\nN 0.9143 DD 1.1492\n\nO 0.9886 DE 1.1974\n\nP 0.9972 DF 1.1492\n\nQ 1.0433 DG 1.1492\n\nR 1.1212 DH 1.1974\n\nS 1.1955 DI 1.1974\n\nT 1.2391 DJ 0.7152\n\nU 1.3443 DK 1.1974\n\nV 1.4362 DL 0.8534\n\nW 1.5883 DM 0.8534\n\nX 1.7819 DN 0.483\n\nY 2.1535 DO 1.1974\n\nZD 1.1996 DP 0.483\n\nZE 1.1996 DQ 0.0408\n\nZF 1.1996 DR 1.1974\n\nZG 1.1996 DS 1.1974\n\nZH 2.1535 DU 1.1492\n\nZJ 1.3073 DV 1.1974\n\nZK 1.3073 DW 1.1974\n\nZL 1.3073 DX 1.1492\n\nDY 0.2752\n\n34\\.7200 DZ 1.1492\n\nO0 1.1974\n\nO1 1.1974\n\nO2 1.1974\n\nO3 1.1974\n\nO4 1.1974\n\nO5 0.483\n\nO6 0.483\n\nO7 0.483\n\nO8 0.483\n\nO9 0.0408\n\nOA 0.0408\n\nOB 2.5631\n\nOC 1.1974\n\nOD 2.5631\n\nOE 1.1974\n\nOF 1.1974\n\nOG 0.0408\n\nOH 2.5631\n\nOI 0.2752\n\nOJ 0.2752\n\nOK 0.2752\n\nOL 0.2752\n\nOM 2.5631\n\nON 3.2959\n\nOO 3.2959\n\nOP 3.2959\n\nOQ 1.1492\n\nOR 1.1492\n\nOS 1.1492\n\nOU 1.1974\n\nOV 1.1974\n\nOW 2.5631\n\nOX 1.1974\n\nOY 1.1974\n\nOZ 1.1974\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1419.pdf"]},"response":{"errors":[],"extract_id":"extract_f85d94735a0578cc0d48e73100753522","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Calculation of Bad Debt Factor**\n\n**Factor**\n\nMean Bad Debt XX\n\nCredit Tier x\n\nUW Tier x\n\nDownpay/Number of Payments x\n\nAdditional Driver x\n\nInstallment Type x\n\nISI Tier x\n\nFDL Factor x\n\nAddition of Unity 1\n\nBad Debt Factor =\n\n**Mean Bad Debt** 0\\.0411 \\*\\*MEAN BAD DEBT FACTOR NEEDS UPDATED IN BOB\\*\\*\n\n**Credit Tier Factor Additional Driver**\n\n**Count Group Factor ISI Factor UW Tier Factor**\n\nFDL Full Coverage\n\n**Factor**\n\nPAID IN FULL EFT Installment Type\n\n**Factor Pay Plan Code Factor**\n\nA 0.3848 0 0.9124 1\\_BEST 0.5732 1 0.3435 N N 1.0216 N N 0.8932 D0 0.0408\n\nB 0.4017 1+ 1.5689 2\\_GOOD 0.7460 2 0.9169 N Y 1.0124 N Y 0.6830 D1 1.1492\n\nC 0.4365 2.4813 3\\_AVER 0.9370 3 0.4146 I N 0.5464 N C 1.0797 D2 0.0408\n\nD 0.4995 4\\_MEDI 1.0382 4 0.9169 I Y 0.6702 N D 1.0797 D3 0.4830\n\nE 0.5475 5\\_POOR 1.2803 5 0.5295 Y N 2.3364 D4 0.7152\n\nF 0.5840 6\\_NHTF 1.0747 6 0.9169 3.2506 Y Y 2.3364 D5 0.7152\n\nG 0.6143 7\\_NO 1.0747 7 1.5962 Y C 2.3364 D6 1.1492\n\nH 0.6568 G\\_GRANDFATHERED 1.0000 5.6345 Y D 2.3364 D7 0.7152\n\nI 0.6791 7.7241 D8 1.1492\n\nJ 0.7333 13.0812 D9 1.1974\n\nK 0.7873 DA 0.2752\n\nL 0.8421 DB 1.1974\n\nM 0.8759 DC 1.1974\n\nN 0.9143 DD 1.1492\n\nO 0.9886 DE 1.1974\n\nP 0.9972 DF 1.1492\n\nQ 1.0433 DG 1.1492\n\nR 1.1212 DH 1.1974\n\nS 1.1955 DI 1.1974\n\nT 1.2391 DJ 0.7152\n\nU 1.3443 DK 1.1974\n\nV 1.4362 DL 0.8534\n\nW 1.5883 DM 0.8534\n\nX 1.7819 DN 0.483\n\nY 2.1535 DO 1.1974\n\nZD 1.1996 DP 0.483\n\nZE 1.1996 DQ 0.0408\n\nZF 1.1996 DR 1.1974\n\nZG 1.1996 DS 1.1974\n\nZH 2.1535 DU 1.1492\n\nZJ 1.3073 DV 1.1974\n\nZK 1.3073 DW 1.1974\n\nZL 1.3073 DX 1.1492\n\nDY 0.2752\n\n34\\.7200 DZ 1.1492\n\nO0 1.1974\n\nO1 1.1974\n\nO2 1.1974\n\nO3 1.1974\n\nO4 1.1974\n\nO5 0.483\n\nO6 0.483\n\nO7 0.483\n\nO8 0.483\n\nO9 0.0408\n\nOA 0.0408\n\nOB 2.5631\n\nOC 1.1974\n\nOD 2.5631\n\nOE 1.1974\n\nOF 1.1974\n\nOG 0.0408\n\nOH 2.5631\n\nOI 0.2752\n\nOJ 0.2752\n\nOK 0.2752\n\nOL 0.2752\n\nOM 2.5631\n\nON 3.2959\n\nOO 3.2959\n\nOP 3.2959\n\nOQ 1.1492\n\nOR 1.1492\n\nOS 1.1492\n\nOU 1.1974\n\nOV 1.1974\n\nOW 2.5631\n\nOX 1.1974\n\nOY 1.1974\n\nOZ 1.1974\n\n**Proposed**"],"full_content":"**Calculation of Bad Debt Factor**\n\n**Factor**\n\nMean Bad Debt XX\n\nCredit Tier x\n\nUW Tier x\n\nDownpay/Number of Payments x\n\nAdditional Driver x\n\nInstallment Type x\n\nISI Tier x\n\nFDL Factor x\n\nAddition of Unity 1\n\nBad Debt Factor =\n\n**Mean Bad Debt** 0\\.0411 \\*\\*MEAN BAD DEBT FACTOR NEEDS UPDATED IN BOB\\*\\*\n\n**Credit Tier Factor Additional Driver**\n\n**Count Group Factor ISI Factor UW Tier Factor**\n\nFDL Full Coverage\n\n**Factor**\n\nPAID IN FULL EFT Installment Type\n\n**Factor Pay Plan Code Factor**\n\nA 0.3848 0 0.9124 1\\_BEST 0.5732 1 0.3435 N N 1.0216 N N 0.8932 D0 0.0408\n\nB 0.4017 1+ 1.5689 2\\_GOOD 0.7460 2 0.9169 N Y 1.0124 N Y 0.6830 D1 1.1492\n\nC 0.4365 2.4813 3\\_AVER 0.9370 3 0.4146 I N 0.5464 N C 1.0797 D2 0.0408\n\nD 0.4995 4\\_MEDI 1.0382 4 0.9169 I Y 0.6702 N D 1.0797 D3 0.4830\n\nE 0.5475 5\\_POOR 1.2803 5 0.5295 Y N 2.3364 D4 0.7152\n\nF 0.5840 6\\_NHTF 1.0747 6 0.9169 3.2506 Y Y 2.3364 D5 0.7152\n\nG 0.6143 7\\_NO 1.0747 7 1.5962 Y C 2.3364 D6 1.1492\n\nH 0.6568 G\\_GRANDFATHERED 1.0000 5.6345 Y D 2.3364 D7 0.7152\n\nI 0.6791 7.7241 D8 1.1492\n\nJ 0.7333 13.0812 D9 1.1974\n\nK 0.7873 DA 0.2752\n\nL 0.8421 DB 1.1974\n\nM 0.8759 DC 1.1974\n\nN 0.9143 DD 1.1492\n\nO 0.9886 DE 1.1974\n\nP 0.9972 DF 1.1492\n\nQ 1.0433 DG 1.1492\n\nR 1.1212 DH 1.1974\n\nS 1.1955 DI 1.1974\n\nT 1.2391 DJ 0.7152\n\nU 1.3443 DK 1.1974\n\nV 1.4362 DL 0.8534\n\nW 1.5883 DM 0.8534\n\nX 1.7819 DN 0.483\n\nY 2.1535 DO 1.1974\n\nZD 1.1996 DP 0.483\n\nZE 1.1996 DQ 0.0408\n\nZF 1.1996 DR 1.1974\n\nZG 1.1996 DS 1.1974\n\nZH 2.1535 DU 1.1492\n\nZJ 1.3073 DV 1.1974\n\nZK 1.3073 DW 1.1974\n\nZL 1.3073 DX 1.1492\n\nDY 0.2752\n\n34\\.7200 DZ 1.1492\n\nO0 1.1974\n\nO1 1.1974\n\nO2 1.1974\n\nO3 1.1974\n\nO4 1.1974\n\nO5 0.483\n\nO6 0.483\n\nO7 0.483\n\nO8 0.483\n\nO9 0.0408\n\nOA 0.0408\n\nOB 2.5631\n\nOC 1.1974\n\nOD 2.5631\n\nOE 1.1974\n\nOF 1.1974\n\nOG 0.0408\n\nOH 2.5631\n\nOI 0.2752\n\nOJ 0.2752\n\nOK 0.2752\n\nOL 0.2752\n\nOM 2.5631\n\nON 3.2959\n\nOO 3.2959\n\nOP 3.2959\n\nOQ 1.1492\n\nOR 1.1492\n\nOS 1.1492\n\nOU 1.1974\n\nOV 1.1974\n\nOW 2.5631\n\nOX 1.1974\n\nOY 1.1974\n\nOZ 1.1974\n\n**Proposed**","publish_date":null,"title":"Proposed Calculation of Bad Debt Factor Factor Mean Bad Debt XX Credit Tier x UW Tier x Downpay/Number of Payments","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1419.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1419.pdf"},"request":{"example_id":"table/BRWS-134565917_page1419","product_type":"parse","source_file_path":"BRWS-134565917_page1419.pdf"},"started_at":"2026-11-04T19:48:14.886849"} +{"completed_at":"2026-11-04T19:31:18.921376","latency_in_ms":2698,"output":{"example_id":"table/BRWS-134565917_page1420","grounded_pages":[],"layout_pages":[],"markdown":"**Calculation of Bad Debt Factor**\n\n**Factor**\n\nMean Bad Debt XX\n\nCredit Tier x\n\nUW Tier x\n\nDownpay/Number of Payments x\n\nAdditional Driver x\n\nInstallment Type x\n\nISI Tier x\n\nFDL Factor x\n\nAddition of Unity 1\n\nBad Debt Factor =\n\n**Mean Bad Debt** 0\\.0424 \\*\\*MEAN BAD DEBT FACTOR NEEDS UPDATED IN BOB\\*\\*\n\n**Credit Tier Factor Additional Driver**\n\n**Count Group Factor ISI Factor UW Tier Factor**\n\nFDL Full Coverage\n\n**Factor**\n\nPAID IN FULL EFT Installment Type\n\n**Factor Pay Plan Code Factor**\n\nA 0.3848 0 0.9124 1\\_BEST 0.5732 1 0.3435 N N 1.0216 N N 0.8932 D0 0.0408\n\nB 0.4017 1+ 1.5689 2\\_GOOD 0.7460 2 0.9169 N Y 1.0124 N Y 0.6830 D1 1.1492\n\nC 0.4365 2.4813 3\\_AVER 0.9370 3 0.4146 I N 0.5464 N C 1.0797 D2 0.0408\n\nD 0.4995 4\\_MEDI 1.0382 4 0.9169 I Y 0.6702 N D 1.0797 D3 0.4830\n\nE 0.5475 5\\_POOR 1.2803 5 0.5295 Y N 2.3364 D4 0.7152\n\nF 0.5840 6\\_NHTF 1.0747 6 0.9169 Y Y 2.3364 D5 0.7152\n\nG 0.6143 7\\_NO 1.0747 7 1.5962 Y C 2.3364 D6 1.1492\n\nH 0.6568 G\\_GRANDFATHERED 1.0000 Y D 2.3364 D7 1.1974\n\nI 0.6791 D8 1.1974\n\nJ 0.7333 13.0812 D9 1.1974\n\nK 0.7873 DA 0.2752\n\nL 0.8421 DB 1.1974\n\nM 0.8759 DC 1.1974\n\nN 0.9143 DD 1.1492\n\nO 0.9886 DE 1.1974\n\nP 0.9972 DF 1.1492\n\nQ 1.0433 DG 1.1492\n\nR 1.1212 DH 1.1974\n\nS 1.1955 DI 1.1974\n\nT 1.2391 DJ 1.1974\n\nU 1.3443 DK 1.1974\n\nV 1.4362 DL 0.8534\n\nW 1.5883 DM 0.8534\n\nX 1.7819 DN 0.483\n\nY 2.1535 DO 1.1974\n\nZD 1.1996 DP 1.1974\n\nZE 1.1996 DQ 0.0408\n\nZF 1.1996 DR 1.1974\n\nZG 1.1996 DS 1.1974\n\nZH 2.1535 DU 1.1492\n\nZJ 1.3073 DV 1.1974\n\nZK 1.3073 DW 1.1974\n\nZL 1.3073 DX 1.1492\n\nDY 1.1492\n\nDZ 1.1974\n\nO1 0.0408\n\nO2 0.2752\n\nO3 1.1492\n\nO4 1.1974\n\nO5 1.1974\n\nO6 1.1974\n\nO7 1.1974\n\nO8 1.1974\n\nO9 1.1974\n\nOA 0.0408\n\nOB 0.2752\n\nOC 1.1492\n\nOD 0.8534\n\nOE 0.8534\n\nOF 1.1974\n\nOG 1.1974\n\nOH 1.1492\n\nOI 0.8534\n\nOJ 0.8534\n\nOK 0.8534\n\nOL 0.8534\n\nOM 0.8534\n\nON 0.8534\n\nOO 1.1492\n\nOP 1.1492\n\nOQ 1.1492\n\nOR 1.1492\n\nOS 1.1492\n\nOU 1.1974\n\nOV 1.1974\n\nOW 1.1974\n\nOX 1.1974\n\nOY 1.1974\n\nOZ 1.1974\n\n**Current**","pages":[{"line_numbers":[],"markdown":"**Calculation of Bad Debt Factor**\n\n**Factor**\n\nMean Bad Debt XX\n\nCredit Tier x\n\nUW Tier x\n\nDownpay/Number of Payments x\n\nAdditional Driver x\n\nInstallment Type x\n\nISI Tier x\n\nFDL Factor x\n\nAddition of Unity 1\n\nBad Debt Factor =\n\n**Mean Bad Debt** 0\\.0424 \\*\\*MEAN BAD DEBT FACTOR NEEDS UPDATED IN BOB\\*\\*\n\n**Credit Tier Factor Additional Driver**\n\n**Count Group Factor ISI Factor UW Tier Factor**\n\nFDL Full Coverage\n\n**Factor**\n\nPAID IN FULL EFT Installment Type\n\n**Factor Pay Plan Code Factor**\n\nA 0.3848 0 0.9124 1\\_BEST 0.5732 1 0.3435 N N 1.0216 N N 0.8932 D0 0.0408\n\nB 0.4017 1+ 1.5689 2\\_GOOD 0.7460 2 0.9169 N Y 1.0124 N Y 0.6830 D1 1.1492\n\nC 0.4365 2.4813 3\\_AVER 0.9370 3 0.4146 I N 0.5464 N C 1.0797 D2 0.0408\n\nD 0.4995 4\\_MEDI 1.0382 4 0.9169 I Y 0.6702 N D 1.0797 D3 0.4830\n\nE 0.5475 5\\_POOR 1.2803 5 0.5295 Y N 2.3364 D4 0.7152\n\nF 0.5840 6\\_NHTF 1.0747 6 0.9169 Y Y 2.3364 D5 0.7152\n\nG 0.6143 7\\_NO 1.0747 7 1.5962 Y C 2.3364 D6 1.1492\n\nH 0.6568 G\\_GRANDFATHERED 1.0000 Y D 2.3364 D7 1.1974\n\nI 0.6791 D8 1.1974\n\nJ 0.7333 13.0812 D9 1.1974\n\nK 0.7873 DA 0.2752\n\nL 0.8421 DB 1.1974\n\nM 0.8759 DC 1.1974\n\nN 0.9143 DD 1.1492\n\nO 0.9886 DE 1.1974\n\nP 0.9972 DF 1.1492\n\nQ 1.0433 DG 1.1492\n\nR 1.1212 DH 1.1974\n\nS 1.1955 DI 1.1974\n\nT 1.2391 DJ 1.1974\n\nU 1.3443 DK 1.1974\n\nV 1.4362 DL 0.8534\n\nW 1.5883 DM 0.8534\n\nX 1.7819 DN 0.483\n\nY 2.1535 DO 1.1974\n\nZD 1.1996 DP 1.1974\n\nZE 1.1996 DQ 0.0408\n\nZF 1.1996 DR 1.1974\n\nZG 1.1996 DS 1.1974\n\nZH 2.1535 DU 1.1492\n\nZJ 1.3073 DV 1.1974\n\nZK 1.3073 DW 1.1974\n\nZL 1.3073 DX 1.1492\n\nDY 1.1492\n\nDZ 1.1974\n\nO1 0.0408\n\nO2 0.2752\n\nO3 1.1492\n\nO4 1.1974\n\nO5 1.1974\n\nO6 1.1974\n\nO7 1.1974\n\nO8 1.1974\n\nO9 1.1974\n\nOA 0.0408\n\nOB 0.2752\n\nOC 1.1492\n\nOD 0.8534\n\nOE 0.8534\n\nOF 1.1974\n\nOG 1.1974\n\nOH 1.1492\n\nOI 0.8534\n\nOJ 0.8534\n\nOK 0.8534\n\nOL 0.8534\n\nOM 0.8534\n\nON 0.8534\n\nOO 1.1492\n\nOP 1.1492\n\nOQ 1.1492\n\nOR 1.1492\n\nOS 1.1492\n\nOU 1.1974\n\nOV 1.1974\n\nOW 1.1974\n\nOX 1.1974\n\nOY 1.1974\n\nOZ 1.1974\n\n**Current**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Calculation of Bad Debt Factor**\n\n**Factor**\n\nMean Bad Debt XX\n\nCredit Tier x\n\nUW Tier x\n\nDownpay/Number of Payments x\n\nAdditional Driver x\n\nInstallment Type x\n\nISI Tier x\n\nFDL Factor x\n\nAddition of Unity 1\n\nBad Debt Factor =\n\n**Mean Bad Debt** 0\\.0424 \\*\\*MEAN BAD DEBT FACTOR NEEDS UPDATED IN BOB\\*\\*\n\n**Credit Tier Factor Additional Driver**\n\n**Count Group Factor ISI Factor UW Tier Factor**\n\nFDL Full Coverage\n\n**Factor**\n\nPAID IN FULL EFT Installment Type\n\n**Factor Pay Plan Code Factor**\n\nA 0.3848 0 0.9124 1\\_BEST 0.5732 1 0.3435 N N 1.0216 N N 0.8932 D0 0.0408\n\nB 0.4017 1+ 1.5689 2\\_GOOD 0.7460 2 0.9169 N Y 1.0124 N Y 0.6830 D1 1.1492\n\nC 0.4365 2.4813 3\\_AVER 0.9370 3 0.4146 I N 0.5464 N C 1.0797 D2 0.0408\n\nD 0.4995 4\\_MEDI 1.0382 4 0.9169 I Y 0.6702 N D 1.0797 D3 0.4830\n\nE 0.5475 5\\_POOR 1.2803 5 0.5295 Y N 2.3364 D4 0.7152\n\nF 0.5840 6\\_NHTF 1.0747 6 0.9169 Y Y 2.3364 D5 0.7152\n\nG 0.6143 7\\_NO 1.0747 7 1.5962 Y C 2.3364 D6 1.1492\n\nH 0.6568 G\\_GRANDFATHERED 1.0000 Y D 2.3364 D7 1.1974\n\nI 0.6791 D8 1.1974\n\nJ 0.7333 13.0812 D9 1.1974\n\nK 0.7873 DA 0.2752\n\nL 0.8421 DB 1.1974\n\nM 0.8759 DC 1.1974\n\nN 0.9143 DD 1.1492\n\nO 0.9886 DE 1.1974\n\nP 0.9972 DF 1.1492\n\nQ 1.0433 DG 1.1492\n\nR 1.1212 DH 1.1974\n\nS 1.1955 DI 1.1974\n\nT 1.2391 DJ 1.1974\n\nU 1.3443 DK 1.1974\n\nV 1.4362 DL 0.8534\n\nW 1.5883 DM 0.8534\n\nX 1.7819 DN 0.483\n\nY 2.1535 DO 1.1974\n\nZD 1.1996 DP 1.1974\n\nZE 1.1996 DQ 0.0408\n\nZF 1.1996 DR 1.1974\n\nZG 1.1996 DS 1.1974\n\nZH 2.1535 DU 1.1492\n\nZJ 1.3073 DV 1.1974\n\nZK 1.3073 DW 1.1974\n\nZL 1.3073 DX 1.1492\n\nDY 1.1492\n\nDZ 1.1974\n\nO1 0.0408\n\nO2 0.2752\n\nO3 1.1492\n\nO4 1.1974\n\nO5 1.1974\n\nO6 1.1974\n\nO7 1.1974\n\nO8 1.1974\n\nO9 1.1974\n\nOA 0.0408\n\nOB 0.2752\n\nOC 1.1492\n\nOD 0.8534\n\nOE 0.8534\n\nOF 1.1974\n\nOG 1.1974\n\nOH 1.1492\n\nOI 0.8534\n\nOJ 0.8534\n\nOK 0.8534\n\nOL 0.8534\n\nOM 0.8534\n\nON 0.8534\n\nOO 1.1492\n\nOP 1.1492\n\nOQ 1.1492\n\nOR 1.1492\n\nOS 1.1492\n\nOU 1.1974\n\nOV 1.1974\n\nOW 1.1974\n\nOX 1.1974\n\nOY 1.1974\n\nOZ 1.1974\n\n**Current**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1420.pdf"]},"response":{"errors":[],"extract_id":"extract_4b5bb81e6bb528fa76e46c43612edf43","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Calculation of Bad Debt Factor**\n\n**Factor**\n\nMean Bad Debt XX\n\nCredit Tier x\n\nUW Tier x\n\nDownpay/Number of Payments x\n\nAdditional Driver x\n\nInstallment Type x\n\nISI Tier x\n\nFDL Factor x\n\nAddition of Unity 1\n\nBad Debt Factor =\n\n**Mean Bad Debt** 0\\.0424 \\*\\*MEAN BAD DEBT FACTOR NEEDS UPDATED IN BOB\\*\\*\n\n**Credit Tier Factor Additional Driver**\n\n**Count Group Factor ISI Factor UW Tier Factor**\n\nFDL Full Coverage\n\n**Factor**\n\nPAID IN FULL EFT Installment Type\n\n**Factor Pay Plan Code Factor**\n\nA 0.3848 0 0.9124 1\\_BEST 0.5732 1 0.3435 N N 1.0216 N N 0.8932 D0 0.0408\n\nB 0.4017 1+ 1.5689 2\\_GOOD 0.7460 2 0.9169 N Y 1.0124 N Y 0.6830 D1 1.1492\n\nC 0.4365 2.4813 3\\_AVER 0.9370 3 0.4146 I N 0.5464 N C 1.0797 D2 0.0408\n\nD 0.4995 4\\_MEDI 1.0382 4 0.9169 I Y 0.6702 N D 1.0797 D3 0.4830\n\nE 0.5475 5\\_POOR 1.2803 5 0.5295 Y N 2.3364 D4 0.7152\n\nF 0.5840 6\\_NHTF 1.0747 6 0.9169 Y Y 2.3364 D5 0.7152\n\nG 0.6143 7\\_NO 1.0747 7 1.5962 Y C 2.3364 D6 1.1492\n\nH 0.6568 G\\_GRANDFATHERED 1.0000 Y D 2.3364 D7 1.1974\n\nI 0.6791 D8 1.1974\n\nJ 0.7333 13.0812 D9 1.1974\n\nK 0.7873 DA 0.2752\n\nL 0.8421 DB 1.1974\n\nM 0.8759 DC 1.1974\n\nN 0.9143 DD 1.1492\n\nO 0.9886 DE 1.1974\n\nP 0.9972 DF 1.1492\n\nQ 1.0433 DG 1.1492\n\nR 1.1212 DH 1.1974\n\nS 1.1955 DI 1.1974\n\nT 1.2391 DJ 1.1974\n\nU 1.3443 DK 1.1974\n\nV 1.4362 DL 0.8534\n\nW 1.5883 DM 0.8534\n\nX 1.7819 DN 0.483\n\nY 2.1535 DO 1.1974\n\nZD 1.1996 DP 1.1974\n\nZE 1.1996 DQ 0.0408\n\nZF 1.1996 DR 1.1974\n\nZG 1.1996 DS 1.1974\n\nZH 2.1535 DU 1.1492\n\nZJ 1.3073 DV 1.1974\n\nZK 1.3073 DW 1.1974\n\nZL 1.3073 DX 1.1492\n\nDY 1.1492\n\nDZ 1.1974\n\nO1 0.0408\n\nO2 0.2752\n\nO3 1.1492\n\nO4 1.1974\n\nO5 1.1974\n\nO6 1.1974\n\nO7 1.1974\n\nO8 1.1974\n\nO9 1.1974\n\nOA 0.0408\n\nOB 0.2752\n\nOC 1.1492\n\nOD 0.8534\n\nOE 0.8534\n\nOF 1.1974\n\nOG 1.1974\n\nOH 1.1492\n\nOI 0.8534\n\nOJ 0.8534\n\nOK 0.8534\n\nOL 0.8534\n\nOM 0.8534\n\nON 0.8534\n\nOO 1.1492\n\nOP 1.1492\n\nOQ 1.1492\n\nOR 1.1492\n\nOS 1.1492\n\nOU 1.1974\n\nOV 1.1974\n\nOW 1.1974\n\nOX 1.1974\n\nOY 1.1974\n\nOZ 1.1974\n\n**Current**"],"full_content":"**Calculation of Bad Debt Factor**\n\n**Factor**\n\nMean Bad Debt XX\n\nCredit Tier x\n\nUW Tier x\n\nDownpay/Number of Payments x\n\nAdditional Driver x\n\nInstallment Type x\n\nISI Tier x\n\nFDL Factor x\n\nAddition of Unity 1\n\nBad Debt Factor =\n\n**Mean Bad Debt** 0\\.0424 \\*\\*MEAN BAD DEBT FACTOR NEEDS UPDATED IN BOB\\*\\*\n\n**Credit Tier Factor Additional Driver**\n\n**Count Group Factor ISI Factor UW Tier Factor**\n\nFDL Full Coverage\n\n**Factor**\n\nPAID IN FULL EFT Installment Type\n\n**Factor Pay Plan Code Factor**\n\nA 0.3848 0 0.9124 1\\_BEST 0.5732 1 0.3435 N N 1.0216 N N 0.8932 D0 0.0408\n\nB 0.4017 1+ 1.5689 2\\_GOOD 0.7460 2 0.9169 N Y 1.0124 N Y 0.6830 D1 1.1492\n\nC 0.4365 2.4813 3\\_AVER 0.9370 3 0.4146 I N 0.5464 N C 1.0797 D2 0.0408\n\nD 0.4995 4\\_MEDI 1.0382 4 0.9169 I Y 0.6702 N D 1.0797 D3 0.4830\n\nE 0.5475 5\\_POOR 1.2803 5 0.5295 Y N 2.3364 D4 0.7152\n\nF 0.5840 6\\_NHTF 1.0747 6 0.9169 Y Y 2.3364 D5 0.7152\n\nG 0.6143 7\\_NO 1.0747 7 1.5962 Y C 2.3364 D6 1.1492\n\nH 0.6568 G\\_GRANDFATHERED 1.0000 Y D 2.3364 D7 1.1974\n\nI 0.6791 D8 1.1974\n\nJ 0.7333 13.0812 D9 1.1974\n\nK 0.7873 DA 0.2752\n\nL 0.8421 DB 1.1974\n\nM 0.8759 DC 1.1974\n\nN 0.9143 DD 1.1492\n\nO 0.9886 DE 1.1974\n\nP 0.9972 DF 1.1492\n\nQ 1.0433 DG 1.1492\n\nR 1.1212 DH 1.1974\n\nS 1.1955 DI 1.1974\n\nT 1.2391 DJ 1.1974\n\nU 1.3443 DK 1.1974\n\nV 1.4362 DL 0.8534\n\nW 1.5883 DM 0.8534\n\nX 1.7819 DN 0.483\n\nY 2.1535 DO 1.1974\n\nZD 1.1996 DP 1.1974\n\nZE 1.1996 DQ 0.0408\n\nZF 1.1996 DR 1.1974\n\nZG 1.1996 DS 1.1974\n\nZH 2.1535 DU 1.1492\n\nZJ 1.3073 DV 1.1974\n\nZK 1.3073 DW 1.1974\n\nZL 1.3073 DX 1.1492\n\nDY 1.1492\n\nDZ 1.1974\n\nO1 0.0408\n\nO2 0.2752\n\nO3 1.1492\n\nO4 1.1974\n\nO5 1.1974\n\nO6 1.1974\n\nO7 1.1974\n\nO8 1.1974\n\nO9 1.1974\n\nOA 0.0408\n\nOB 0.2752\n\nOC 1.1492\n\nOD 0.8534\n\nOE 0.8534\n\nOF 1.1974\n\nOG 1.1974\n\nOH 1.1492\n\nOI 0.8534\n\nOJ 0.8534\n\nOK 0.8534\n\nOL 0.8534\n\nOM 0.8534\n\nON 0.8534\n\nOO 1.1492\n\nOP 1.1492\n\nOQ 1.1492\n\nOR 1.1492\n\nOS 1.1492\n\nOU 1.1974\n\nOV 1.1974\n\nOW 1.1974\n\nOX 1.1974\n\nOY 1.1974\n\nOZ 1.1974\n\n**Current**","publish_date":null,"title":"Current Calculation of Bad Debt Factor Factor Mean Bad Debt XX Credit Tier x UW Tier x Downpay/Number of Payments","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1420.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page1420.pdf"},"request":{"example_id":"table/BRWS-134565917_page1420","product_type":"parse","source_file_path":"BRWS-134565917_page1420.pdf"},"started_at":"2026-11-04T19:31:16.222727"} +{"completed_at":"2026-11-04T19:48:18.314087","latency_in_ms":953,"output":{"example_id":"table/BRWS-134565917_page6","grounded_pages":[],"layout_pages":[],"markdown":"### **Disposition**\n\nDisposition Date: 07/16/2025 Effective Date (New): 06/13/2025 Effective Date (Renewal): 07/18/2025 Status: REVIEWED\n\nComment: Thank you for your filing submission. At this point in time, I do not have any further questions and am concluding my review of this filing. Please note that the closure of this filing does not constitute an approval by the Department and does not mean the Department is precluded from initiating future inquiries or from taking further administrative or legal action. Ultimately, the insurance company is responsible for ensuring it is in compliance with Missouri insurance law through its administration of insurance policies and handling of claims.\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nBristol West Insurance Company\n\n0\\.000% -1.900% $-346,989 7,007 $18,262,617 163.000% -33.000%\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate (revised)** Rates REVIEWED Yes\n\n**Rate** Rates SUPERSEDED Yes\n\n**Rate** Rules REVIEWED Yes\n\n**Rate** Select 4.0 Symbol Set REVIEWED Yes\n\n**Supporting Document** Filing Memorandum REVIEWED Yes\n\n**Supporting Document** Exhibit A, B, & C (20 CSR 500-4.200) REVIEWED Yes\n\n**Supporting Document** Actuarial Justification REVIEWED Yes\n\n**Supporting Document** Actuarial Support for Factor Updates REVIEWED Yes\n\n**Supporting Document** Current v Proposed Factors REVIEWED Yes\n\n**Supporting Document** Rate Stabilization Disclosure REVIEWED Yes\n\n**Supporting Document** Objection Response 07 01 25 REVIEWED Yes\n\n**_SERFF Tracking #:_** _BRWS-134565917_ **_State Tracking #:_** _1535_ **_Company Tracking #:_**\n\n**_State:_** _Missouri_ **_Filing Company:_** _Bristol West Insurance Company_\n\n**_TOI/Sub-TOI:_** _19\\.0 Personal Auto/19.0001 Private Passenger Auto (PPA)_\n\n**_Product Name:_** _Select 4.0_\n\n**_Project Name/Number:_** _4\\.24 Refresh/_\n\n_PDF Pipeline for SERFF Tracking Number BRWS-134565917 Generated 07/20/2025 06:34 PM_","pages":[{"line_numbers":[],"markdown":"### **Disposition**\n\nDisposition Date: 07/16/2025 Effective Date (New): 06/13/2025 Effective Date (Renewal): 07/18/2025 Status: REVIEWED\n\nComment: Thank you for your filing submission. At this point in time, I do not have any further questions and am concluding my review of this filing. Please note that the closure of this filing does not constitute an approval by the Department and does not mean the Department is precluded from initiating future inquiries or from taking further administrative or legal action. Ultimately, the insurance company is responsible for ensuring it is in compliance with Missouri insurance law through its administration of insurance policies and handling of claims.\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nBristol West Insurance Company\n\n0\\.000% -1.900% $-346,989 7,007 $18,262,617 163.000% -33.000%\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate (revised)** Rates REVIEWED Yes\n\n**Rate** Rates SUPERSEDED Yes\n\n**Rate** Rules REVIEWED Yes\n\n**Rate** Select 4.0 Symbol Set REVIEWED Yes\n\n**Supporting Document** Filing Memorandum REVIEWED Yes\n\n**Supporting Document** Exhibit A, B, & C (20 CSR 500-4.200) REVIEWED Yes\n\n**Supporting Document** Actuarial Justification REVIEWED Yes\n\n**Supporting Document** Actuarial Support for Factor Updates REVIEWED Yes\n\n**Supporting Document** Current v Proposed Factors REVIEWED Yes\n\n**Supporting Document** Rate Stabilization Disclosure REVIEWED Yes\n\n**Supporting Document** Objection Response 07 01 25 REVIEWED Yes\n\n**_SERFF Tracking #:_** _BRWS-134565917_ **_State Tracking #:_** _1535_ **_Company Tracking #:_**\n\n**_State:_** _Missouri_ **_Filing Company:_** _Bristol West Insurance Company_\n\n**_TOI/Sub-TOI:_** _19\\.0 Personal Auto/19.0001 Private Passenger Auto (PPA)_\n\n**_Product Name:_** _Select 4.0_\n\n**_Project Name/Number:_** _4\\.24 Refresh/_\n\n_PDF Pipeline for SERFF Tracking Number BRWS-134565917 Generated 07/20/2025 06:34 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Disposition**\n\nDisposition Date: 07/16/2025 Effective Date (New): 06/13/2025 Effective Date (Renewal): 07/18/2025 Status: REVIEWED\n\nComment: Thank you for your filing submission. At this point in time, I do not have any further questions and am concluding my review of this filing. Please note that the closure of this filing does not constitute an approval by the Department and does not mean the Department is precluded from initiating future inquiries or from taking further administrative or legal action. Ultimately, the insurance company is responsible for ensuring it is in compliance with Missouri insurance law through its administration of insurance policies and handling of claims.\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nBristol West Insurance Company\n\n0\\.000% -1.900% $-346,989 7,007 $18,262,617 163.000% -33.000%\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate (revised)** Rates REVIEWED Yes\n\n**Rate** Rates SUPERSEDED Yes\n\n**Rate** Rules REVIEWED Yes\n\n**Rate** Select 4.0 Symbol Set REVIEWED Yes\n\n**Supporting Document** Filing Memorandum REVIEWED Yes\n\n**Supporting Document** Exhibit A, B, & C (20 CSR 500-4.200) REVIEWED Yes\n\n**Supporting Document** Actuarial Justification REVIEWED Yes\n\n**Supporting Document** Actuarial Support for Factor Updates REVIEWED Yes\n\n**Supporting Document** Current v Proposed Factors REVIEWED Yes\n\n**Supporting Document** Rate Stabilization Disclosure REVIEWED Yes\n\n**Supporting Document** Objection Response 07 01 25 REVIEWED Yes\n\n**_SERFF Tracking #:_** _BRWS-134565917_ **_State Tracking #:_** _1535_ **_Company Tracking #:_**\n\n**_State:_** _Missouri_ **_Filing Company:_** _Bristol West Insurance Company_\n\n**_TOI/Sub-TOI:_** _19\\.0 Personal Auto/19.0001 Private Passenger Auto (PPA)_\n\n**_Product Name:_** _Select 4.0_\n\n**_Project Name/Number:_** _4\\.24 Refresh/_\n\n_PDF Pipeline for SERFF Tracking Number BRWS-134565917 Generated 07/20/2025 06:34 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_01031bf6b40bcee1f0924c1829b45d25","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Disposition**\n\nDisposition Date: 07/16/2025 Effective Date (New): 06/13/2025 Effective Date (Renewal): 07/18/2025 Status: REVIEWED\n\nComment: Thank you for your filing submission. At this point in time, I do not have any further questions and am concluding my review of this filing. Please note that the closure of this filing does not constitute an approval by the Department and does not mean the Department is precluded from initiating future inquiries or from taking further administrative or legal action. Ultimately, the insurance company is responsible for ensuring it is in compliance with Missouri insurance law through its administration of insurance policies and handling of claims.\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nBristol West Insurance Company\n\n0\\.000% -1.900% $-346,989 7,007 $18,262,617 163.000% -33.000%\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate (revised)** Rates REVIEWED Yes\n\n**Rate** Rates SUPERSEDED Yes\n\n**Rate** Rules REVIEWED Yes\n\n**Rate** Select 4.0 Symbol Set REVIEWED Yes\n\n**Supporting Document** Filing Memorandum REVIEWED Yes\n\n**Supporting Document** Exhibit A, B, & C (20 CSR 500-4.200) REVIEWED Yes\n\n**Supporting Document** Actuarial Justification REVIEWED Yes\n\n**Supporting Document** Actuarial Support for Factor Updates REVIEWED Yes\n\n**Supporting Document** Current v Proposed Factors REVIEWED Yes\n\n**Supporting Document** Rate Stabilization Disclosure REVIEWED Yes\n\n**Supporting Document** Objection Response 07 01 25 REVIEWED Yes\n\n**_SERFF Tracking #:_** _BRWS-134565917_ **_State Tracking #:_** _1535_ **_Company Tracking #:_**\n\n**_State:_** _Missouri_ **_Filing Company:_** _Bristol West Insurance Company_\n\n**_TOI/Sub-TOI:_** _19\\.0 Personal Auto/19.0001 Private Passenger Auto (PPA)_\n\n**_Product Name:_** _Select 4.0_\n\n**_Project Name/Number:_** _4\\.24 Refresh/_\n\n_PDF Pipeline for SERFF Tracking Number BRWS-134565917 Generated 07/20/2025 06:34 PM_"],"full_content":"### **Disposition**\n\nDisposition Date: 07/16/2025 Effective Date (New): 06/13/2025 Effective Date (Renewal): 07/18/2025 Status: REVIEWED\n\nComment: Thank you for your filing submission. At this point in time, I do not have any further questions and am concluding my review of this filing. Please note that the closure of this filing does not constitute an approval by the Department and does not mean the Department is precluded from initiating future inquiries or from taking further administrative or legal action. Ultimately, the insurance company is responsible for ensuring it is in compliance with Missouri insurance law through its administration of insurance policies and handling of claims.\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nBristol West Insurance Company\n\n0\\.000% -1.900% $-346,989 7,007 $18,262,617 163.000% -33.000%\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate (revised)** Rates REVIEWED Yes\n\n**Rate** Rates SUPERSEDED Yes\n\n**Rate** Rules REVIEWED Yes\n\n**Rate** Select 4.0 Symbol Set REVIEWED Yes\n\n**Supporting Document** Filing Memorandum REVIEWED Yes\n\n**Supporting Document** Exhibit A, B, & C (20 CSR 500-4.200) REVIEWED Yes\n\n**Supporting Document** Actuarial Justification REVIEWED Yes\n\n**Supporting Document** Actuarial Support for Factor Updates REVIEWED Yes\n\n**Supporting Document** Current v Proposed Factors REVIEWED Yes\n\n**Supporting Document** Rate Stabilization Disclosure REVIEWED Yes\n\n**Supporting Document** Objection Response 07 01 25 REVIEWED Yes\n\n**_SERFF Tracking #:_** _BRWS-134565917_ **_State Tracking #:_** _1535_ **_Company Tracking #:_**\n\n**_State:_** _Missouri_ **_Filing Company:_** _Bristol West Insurance Company_\n\n**_TOI/Sub-TOI:_** _19\\.0 Personal Auto/19.0001 Private Passenger Auto (PPA)_\n\n**_Product Name:_** _Select 4.0_\n\n**_Project Name/Number:_** _4\\.24 Refresh/_\n\n_PDF Pipeline for SERFF Tracking Number BRWS-134565917 Generated 07/20/2025 06:34 PM_","publish_date":null,"title":"Disposition","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page6.pdf"},"request":{"example_id":"table/BRWS-134565917_page6","product_type":"parse","source_file_path":"BRWS-134565917_page6.pdf"},"started_at":"2026-11-04T19:48:17.360799"} +{"completed_at":"2026-11-04T19:48:19.841976","latency_in_ms":1523,"output":{"example_id":"table/BRWS-134565917_page834","grounded_pages":[],"layout_pages":[],"markdown":"**Points Factors**\n\n**Points** **ALL BI COL MP OTC PD UIM UMBI**\n\n0 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n1 1.0649 1.0232 1.0972 1.1200 1.0649 1.0667 1.1200 1.1200\n\n2 1.1006 1.2095 1.1944 1.1829 1.1006 1.2273 1.1829 1.1829\n\n3 1.2079 1.3341 1.3497 1.2198 1.2079 1.4686 1.2198 1.2198\n\n4 1.2821 1.4428 1.3612 1.3485 1.2821 1.5686 1.3485 1.3485\n\n5 1.3253 1.6155 1.4439 1.6219 1.3253 1.8628 1.6219 1.6219\n\n6 1.3685 1.7918 1.7469 1.6417 1.3685 2.1950 1.6417 1.6417\n\n7 1.4117 1.9270 1.8147 1.6690 1.4117 2.2783 1.6690 1.6690\n\n8 1.4549 2.2426 1.9353 1.9471 1.4549 2.5611 1.9471 1.9471\n\n9 1.4981 2.6761 2.2619 1.9561 1.4981 2.9632 1.9561 1.9561\n\n10 1.5414 2.6852 2.2795 2.1250 1.5414 2.9727 2.1250 2.1250\n\n11 1.5846 2.8842 2.2971 2.2939 1.5846 3.1939 2.2939 2.2939\n\n12 1.6278 3.0833 2.3147 2.4629 1.6278 3.4152 2.4629 2.4629\n\n13 1.6710 3.2804 2.4761 2.6318 1.6710 3.7363 2.6318 2.6318\n\n14 1.7142 3.4532 2.6460 2.8007 1.7142 4.0659 2.8007 2.8007\n\n15 1.7574 3.6259 2.8160 2.9696 1.7574 4.3954 2.9696 2.9696\n\n16 1.8007 3.7987 2.9860 3.1385 1.8007 4.7250 3.1385 3.1385\n\n17 1.8439 3.9714 3.1560 3.3075 1.8439 5.0545 3.3075 3.3075\n\n18 1.8871 4.1442 3.3259 3.4764 1.8871 5.3841 3.4764 3.4764\n\n19 1.9303 4.3169 3.4959 3.6453 1.9303 5.8730 3.6453 3.6453\n\n20 1.9735 4.3848 3.6134 3.8142 1.9735 6.3904 3.8142 3.8142\n\n21 2.0167 4.4285 3.7056 3.9832 2.0167 6.9079 3.9832 3.9832\n\n22 2.0599 4.4723 3.7978 4.1521 2.0599 7.4253 4.1521 4.1521\n\n23 2.1032 4.5160 3.8900 4.3210 2.1032 7.9428 4.3210 4.3210\n\n24 2.1464 4.5598 3.9821 4.4899 2.1464 8.4602 4.4899 4.4899\n\n25 2.1896 4.6036 4.0743 4.6588 2.1896 8.9777 4.6588 4.6588\n\n26 2.2328 4.6473 4.1665 4.8278 2.2328 9.4951 4.8278 4.8278\n\n27 2.2756 4.6923 4.2594 4.9961 2.2756 10.0114 4.9961 4.9961\n\n28 2.3188 4.7361 4.3516 5.1650 2.3188 10.5288 5.1650 5.1650\n\n29 2.3620 4.7799 4.4438 5.3339 2.3620 11.0462 5.3339 5.3339\n\n30 2.4052 4.8237 4.5360 5.5028 2.4052 11.5636 5.5028 5.5028\n\n31 2.4484 4.8675 4.6282 5.6717 2.4484 12.0810 5.6717 5.6717\n\n32 2.4916 4.9113 4.7204 5.8406 2.4916 12.5984 5.8406 5.8406\n\n33 2.5348 4.9551 4.8126 6.0095 2.5348 13.1158 6.0095 6.0095\n\n34 2.5780 4.9989 4.9048 6.1784 2.5780 13.6332 6.1784 6.1784\n\n35 2.6212 5.0427 4.9970 6.3473 2.6212 14.1506 6.3473 6.3473\n\n36 2.6644 5.0865 5.0892 6.5162 2.6644 14.6680 6.5162 6.5162\n\n37 2.7076 5.1303 5.1814 6.6851 2.7076 15.1854 6.6851 6.6851\n\n38 2.7508 5.1741 5.2736 6.8540 2.7508 15.7028 6.8540 6.8540\n\n39 2.7940 5.2179 5.3658 7.0229 2.7940 16.2202 7.0229 7.0229\n\n40 2.8372 5.2617 5.4580 7.1918 2.8372 16.7376 7.1918 7.1918\n\n41 2.8804 5.3055 5.5502 7.3607 2.8804 17.2550 7.3607 7.3607\n\n42 2.9236 5.3493 5.6424 7.5296 2.9236 17.7724 7.5296 7.5296\n\n43 2.9668 5.3931 5.7346 7.6985 2.9668 18.2898 7.6985 7.6985\n\n44 3.0100 5.4369 5.8268 7.8674 3.0100 18.8072 7.8674 7.8674\n\n45 3.0532 5.4807 5.9190 8.0363 3.0532 19.3246 8.0363 8.0363\n\n46 3.0964 5.5245 6.0112 8.2052 3.0964 19.8420 8.2052 8.2052\n\n47 3.1396 5.5683 6.1034 8.3741 3.1396 20.3594 8.3741 8.3741\n\n48 3.1828 5.6121 6.1956 8.5430 3.1828 20.8768 8.5430 8.5430\n\n49 3.2260 5.6559 6.2878 8.7119 3.2260 21.3942 8.7119 8.7119\n\n50 3.2692 5.6997 6.3800 8.8808 3.2692 21.9116 8.8808 8.8808\n\n51 3.3124 5.7435 6.4722 9.0497 3.3124 22.4290 9.0497 9.0497\n\n52 3.3556 5.7873 6.5644 9.2186 3.3556 22.9464 9.2186 9.2186\n\n53 3.3988 5.8311 6.6566 9.3875 3.3988 23.4638 9.3875 9.3875\n\n54 3.4420 5.8749 6.7488 9.5564 3.4420 23.9812 9.5564 9.5564\n\n55 3.4852 5.9187 6.8410 9.7253 3.4852 24.4986 9.7253 9.7253\n\n56 3.5284 5.9625 6.9332 9.8942 3.5284 25.0160 9.8942 9.8942\n\n57 3.5716 6.0063 7.0254 10.0631 3.5716 25.5334 10.0631 10.0631\n\n58 3.6148 6.0501 7.1176 10.2320 3.6148 26.0508 10.2320 10.2320\n\n59 3.6580 6.0939 7.2098 10.4009 3.6580 26.5682 10.4009 10.4009\n\n60 3.7012 6.1377 7.3020 10.5698 3.7012 27.0856 10.5698 10.5698\n\n61 3.7444 6.1815 7.3942 10.7387 3.7444 27.6030 10.7387 10.7387\n\n62 3.7876 6.2253 7.4864 10.9076 3.7876 28.1204 10.9076 10.9076\n\n63 3.8308 6.2691 7.5786 11.0765 3.8308 28.6378 11.0765 11.0765\n\n64 3.8740 6.3129 7.6708 11.2454 3.8740 29.1552 11.2454 11.2454\n\n65 3.9172 6.3567 7.7630 11.4143 3.9172 29.6726 11.4143 11.4143\n\n66 3.9604 6.4005 7.8552 11.5832 3.9604 30.1900 11.5832 11.5832\n\n67 4.0036 6.4443 7.9474 11.7521 4.0036 30.7074 11.7521 11.7521\n\n68 4.0468 6.4881 8.0396 11.9210 4.0468 31.2248 11.9210 11.9210\n\n69 4.0900 6.5319 8.1318 12.0899 4.0900 31.7422 12.0899 12.0899\n\n70 4.1332 6.5757 8.2240 12.2588 4.1332 32.2596 12.2588 12.2588\n\n71 4.1764 6.6195 8.3162 12.4277 4.1764 32.7770 12.4277 12.4277\n\n72 4.2196 6.6633 8.4084 12.5966 4.2196 33.2944 12.5966 12.5966\n\n73 4.2628 6.7071 8.5006 12.7655 4.2628 33.8118 12.7655 12.7655\n\n74 4.3060 6.7509 8.5928 12.9344 4.3060 34.3292 12.9344 12.9344\n\n75 4.3492 6.7947 8.6850 13.1033 4.3492 34.8466 13.1033 13.1033\n\n76 4.3924 6.8385 8.7772 13.2722 4.3924 35.3640 13.2722 13.2722\n\n77 4.4356 6.8823 8.8694 13.4411 4.4356 35.8814 13.4411 13.4411\n\n78 4.4788 6.9261 8.9616 13.6100 4.4788 36.3988 13.6100 13.6100\n\n79 4.5220 6.9699 9.0538 13.7789 4.5220 36.9162 13.7789 13.7789\n\n80 4.5652 7.0137 9.1460 13.9478 4.5652 37.4336 13.9478 13.9478\n\n81 4.6084 7.0575 9.2382 14.1167 4.6084 37.9510 14.1167 14.1167\n\n82 4.6516 7.1013 9.3304 14.2856 4.6516 38.4684 14.2856 14.2856\n\n83 4.6948 7.1451 9.4226 14.4545 4.6948 38.9858 14.4545 14.4545\n\n84 4.7380 7.1889 9.5148 14.6234 4.7380 39.5032 14.6234 14.6234\n\n85 4.7812 7.2327 9.6070 14.7923 4.7812 40.0206 14.7923 14.7923\n\n86 4.8244 7.2765 9.6992 14.9612 4.8244 40.5380 14.9612 14.9612\n\n87 4.8676 7.3203 9.7914 15.1301 4.8676 41.0554 15.1301 15.1301\n\n88 4.9108 7.3641 9.8836 15.2990 4.9108 41.5728 15.2990 15.2990\n\n89 4.9540 7.4079 9.9758 15.4679 4.9540 42.0902 15.4679 15.4679\n\n90 4.9972 7.4517 10.0680 15.6368 4.9972 42.6076 15.6368 15.6368\n\n91 5.0404 7.4955 10.1602 15.8057 5.0404 43.1250 15.8057 15.8057\n\n92 5.0836 7.5393 10.2524 15.9746 5.0836 43.6424 15.9746 15.9746\n\n93 5.1268 7.5831 10.3446 16.1435 5.1268 44.1598 16.1435 16.1435\n\n94 5.1700 7.6269 10.4368 16.3124 5.1700 44.6772 16.3124 16.3124\n\n95 5.2132 7.6707 10.5290 16.4813 5.2132 45.1946 16.4813 16.4813\n\n96 5.2564 7.7145 10.6212 16.6502 5.2564 45.7120 16.6502 16.6502\n\n97 5.2996 7.7583 10.7134 16.8191 5.2996 46.2294 16.8191 16.8191\n\n98 5.3428 7.8021 10.8056 16.9880 5.3428 46.7468 16.9880 16.9880\n\n99 5.3860 7.8459 10.8978 17.1569 5.3860 47.2642 17.1569 17.1569\n\n100+ 5.4292 7.8897 10.9900 17.3258 5.4292 47.7816 17.3258 17.3258\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Points Factors**\n\n**Points** **ALL BI COL MP OTC PD UIM UMBI**\n\n0 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n1 1.0649 1.0232 1.0972 1.1200 1.0649 1.0667 1.1200 1.1200\n\n2 1.1006 1.2095 1.1944 1.1829 1.1006 1.2273 1.1829 1.1829\n\n3 1.2079 1.3341 1.3497 1.2198 1.2079 1.4686 1.2198 1.2198\n\n4 1.2821 1.4428 1.3612 1.3485 1.2821 1.5686 1.3485 1.3485\n\n5 1.3253 1.6155 1.4439 1.6219 1.3253 1.8628 1.6219 1.6219\n\n6 1.3685 1.7918 1.7469 1.6417 1.3685 2.1950 1.6417 1.6417\n\n7 1.4117 1.9270 1.8147 1.6690 1.4117 2.2783 1.6690 1.6690\n\n8 1.4549 2.2426 1.9353 1.9471 1.4549 2.5611 1.9471 1.9471\n\n9 1.4981 2.6761 2.2619 1.9561 1.4981 2.9632 1.9561 1.9561\n\n10 1.5414 2.6852 2.2795 2.1250 1.5414 2.9727 2.1250 2.1250\n\n11 1.5846 2.8842 2.2971 2.2939 1.5846 3.1939 2.2939 2.2939\n\n12 1.6278 3.0833 2.3147 2.4629 1.6278 3.4152 2.4629 2.4629\n\n13 1.6710 3.2804 2.4761 2.6318 1.6710 3.7363 2.6318 2.6318\n\n14 1.7142 3.4532 2.6460 2.8007 1.7142 4.0659 2.8007 2.8007\n\n15 1.7574 3.6259 2.8160 2.9696 1.7574 4.3954 2.9696 2.9696\n\n16 1.8007 3.7987 2.9860 3.1385 1.8007 4.7250 3.1385 3.1385\n\n17 1.8439 3.9714 3.1560 3.3075 1.8439 5.0545 3.3075 3.3075\n\n18 1.8871 4.1442 3.3259 3.4764 1.8871 5.3841 3.4764 3.4764\n\n19 1.9303 4.3169 3.4959 3.6453 1.9303 5.8730 3.6453 3.6453\n\n20 1.9735 4.3848 3.6134 3.8142 1.9735 6.3904 3.8142 3.8142\n\n21 2.0167 4.4285 3.7056 3.9832 2.0167 6.9079 3.9832 3.9832\n\n22 2.0599 4.4723 3.7978 4.1521 2.0599 7.4253 4.1521 4.1521\n\n23 2.1032 4.5160 3.8900 4.3210 2.1032 7.9428 4.3210 4.3210\n\n24 2.1464 4.5598 3.9821 4.4899 2.1464 8.4602 4.4899 4.4899\n\n25 2.1896 4.6036 4.0743 4.6588 2.1896 8.9777 4.6588 4.6588\n\n26 2.2328 4.6473 4.1665 4.8278 2.2328 9.4951 4.8278 4.8278\n\n27 2.2756 4.6923 4.2594 4.9961 2.2756 10.0114 4.9961 4.9961\n\n28 2.3188 4.7361 4.3516 5.1650 2.3188 10.5288 5.1650 5.1650\n\n29 2.3620 4.7799 4.4438 5.3339 2.3620 11.0462 5.3339 5.3339\n\n30 2.4052 4.8237 4.5360 5.5028 2.4052 11.5636 5.5028 5.5028\n\n31 2.4484 4.8675 4.6282 5.6717 2.4484 12.0810 5.6717 5.6717\n\n32 2.4916 4.9113 4.7204 5.8406 2.4916 12.5984 5.8406 5.8406\n\n33 2.5348 4.9551 4.8126 6.0095 2.5348 13.1158 6.0095 6.0095\n\n34 2.5780 4.9989 4.9048 6.1784 2.5780 13.6332 6.1784 6.1784\n\n35 2.6212 5.0427 4.9970 6.3473 2.6212 14.1506 6.3473 6.3473\n\n36 2.6644 5.0865 5.0892 6.5162 2.6644 14.6680 6.5162 6.5162\n\n37 2.7076 5.1303 5.1814 6.6851 2.7076 15.1854 6.6851 6.6851\n\n38 2.7508 5.1741 5.2736 6.8540 2.7508 15.7028 6.8540 6.8540\n\n39 2.7940 5.2179 5.3658 7.0229 2.7940 16.2202 7.0229 7.0229\n\n40 2.8372 5.2617 5.4580 7.1918 2.8372 16.7376 7.1918 7.1918\n\n41 2.8804 5.3055 5.5502 7.3607 2.8804 17.2550 7.3607 7.3607\n\n42 2.9236 5.3493 5.6424 7.5296 2.9236 17.7724 7.5296 7.5296\n\n43 2.9668 5.3931 5.7346 7.6985 2.9668 18.2898 7.6985 7.6985\n\n44 3.0100 5.4369 5.8268 7.8674 3.0100 18.8072 7.8674 7.8674\n\n45 3.0532 5.4807 5.9190 8.0363 3.0532 19.3246 8.0363 8.0363\n\n46 3.0964 5.5245 6.0112 8.2052 3.0964 19.8420 8.2052 8.2052\n\n47 3.1396 5.5683 6.1034 8.3741 3.1396 20.3594 8.3741 8.3741\n\n48 3.1828 5.6121 6.1956 8.5430 3.1828 20.8768 8.5430 8.5430\n\n49 3.2260 5.6559 6.2878 8.7119 3.2260 21.3942 8.7119 8.7119\n\n50 3.2692 5.6997 6.3800 8.8808 3.2692 21.9116 8.8808 8.8808\n\n51 3.3124 5.7435 6.4722 9.0497 3.3124 22.4290 9.0497 9.0497\n\n52 3.3556 5.7873 6.5644 9.2186 3.3556 22.9464 9.2186 9.2186\n\n53 3.3988 5.8311 6.6566 9.3875 3.3988 23.4638 9.3875 9.3875\n\n54 3.4420 5.8749 6.7488 9.5564 3.4420 23.9812 9.5564 9.5564\n\n55 3.4852 5.9187 6.8410 9.7253 3.4852 24.4986 9.7253 9.7253\n\n56 3.5284 5.9625 6.9332 9.8942 3.5284 25.0160 9.8942 9.8942\n\n57 3.5716 6.0063 7.0254 10.0631 3.5716 25.5334 10.0631 10.0631\n\n58 3.6148 6.0501 7.1176 10.2320 3.6148 26.0508 10.2320 10.2320\n\n59 3.6580 6.0939 7.2098 10.4009 3.6580 26.5682 10.4009 10.4009\n\n60 3.7012 6.1377 7.3020 10.5698 3.7012 27.0856 10.5698 10.5698\n\n61 3.7444 6.1815 7.3942 10.7387 3.7444 27.6030 10.7387 10.7387\n\n62 3.7876 6.2253 7.4864 10.9076 3.7876 28.1204 10.9076 10.9076\n\n63 3.8308 6.2691 7.5786 11.0765 3.8308 28.6378 11.0765 11.0765\n\n64 3.8740 6.3129 7.6708 11.2454 3.8740 29.1552 11.2454 11.2454\n\n65 3.9172 6.3567 7.7630 11.4143 3.9172 29.6726 11.4143 11.4143\n\n66 3.9604 6.4005 7.8552 11.5832 3.9604 30.1900 11.5832 11.5832\n\n67 4.0036 6.4443 7.9474 11.7521 4.0036 30.7074 11.7521 11.7521\n\n68 4.0468 6.4881 8.0396 11.9210 4.0468 31.2248 11.9210 11.9210\n\n69 4.0900 6.5319 8.1318 12.0899 4.0900 31.7422 12.0899 12.0899\n\n70 4.1332 6.5757 8.2240 12.2588 4.1332 32.2596 12.2588 12.2588\n\n71 4.1764 6.6195 8.3162 12.4277 4.1764 32.7770 12.4277 12.4277\n\n72 4.2196 6.6633 8.4084 12.5966 4.2196 33.2944 12.5966 12.5966\n\n73 4.2628 6.7071 8.5006 12.7655 4.2628 33.8118 12.7655 12.7655\n\n74 4.3060 6.7509 8.5928 12.9344 4.3060 34.3292 12.9344 12.9344\n\n75 4.3492 6.7947 8.6850 13.1033 4.3492 34.8466 13.1033 13.1033\n\n76 4.3924 6.8385 8.7772 13.2722 4.3924 35.3640 13.2722 13.2722\n\n77 4.4356 6.8823 8.8694 13.4411 4.4356 35.8814 13.4411 13.4411\n\n78 4.4788 6.9261 8.9616 13.6100 4.4788 36.3988 13.6100 13.6100\n\n79 4.5220 6.9699 9.0538 13.7789 4.5220 36.9162 13.7789 13.7789\n\n80 4.5652 7.0137 9.1460 13.9478 4.5652 37.4336 13.9478 13.9478\n\n81 4.6084 7.0575 9.2382 14.1167 4.6084 37.9510 14.1167 14.1167\n\n82 4.6516 7.1013 9.3304 14.2856 4.6516 38.4684 14.2856 14.2856\n\n83 4.6948 7.1451 9.4226 14.4545 4.6948 38.9858 14.4545 14.4545\n\n84 4.7380 7.1889 9.5148 14.6234 4.7380 39.5032 14.6234 14.6234\n\n85 4.7812 7.2327 9.6070 14.7923 4.7812 40.0206 14.7923 14.7923\n\n86 4.8244 7.2765 9.6992 14.9612 4.8244 40.5380 14.9612 14.9612\n\n87 4.8676 7.3203 9.7914 15.1301 4.8676 41.0554 15.1301 15.1301\n\n88 4.9108 7.3641 9.8836 15.2990 4.9108 41.5728 15.2990 15.2990\n\n89 4.9540 7.4079 9.9758 15.4679 4.9540 42.0902 15.4679 15.4679\n\n90 4.9972 7.4517 10.0680 15.6368 4.9972 42.6076 15.6368 15.6368\n\n91 5.0404 7.4955 10.1602 15.8057 5.0404 43.1250 15.8057 15.8057\n\n92 5.0836 7.5393 10.2524 15.9746 5.0836 43.6424 15.9746 15.9746\n\n93 5.1268 7.5831 10.3446 16.1435 5.1268 44.1598 16.1435 16.1435\n\n94 5.1700 7.6269 10.4368 16.3124 5.1700 44.6772 16.3124 16.3124\n\n95 5.2132 7.6707 10.5290 16.4813 5.2132 45.1946 16.4813 16.4813\n\n96 5.2564 7.7145 10.6212 16.6502 5.2564 45.7120 16.6502 16.6502\n\n97 5.2996 7.7583 10.7134 16.8191 5.2996 46.2294 16.8191 16.8191\n\n98 5.3428 7.8021 10.8056 16.9880 5.3428 46.7468 16.9880 16.9880\n\n99 5.3860 7.8459 10.8978 17.1569 5.3860 47.2642 17.1569 17.1569\n\n100+ 5.4292 7.8897 10.9900 17.3258 5.4292 47.7816 17.3258 17.3258\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Points Factors**\n\n**Points** **ALL BI COL MP OTC PD UIM UMBI**\n\n0 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n1 1.0649 1.0232 1.0972 1.1200 1.0649 1.0667 1.1200 1.1200\n\n2 1.1006 1.2095 1.1944 1.1829 1.1006 1.2273 1.1829 1.1829\n\n3 1.2079 1.3341 1.3497 1.2198 1.2079 1.4686 1.2198 1.2198\n\n4 1.2821 1.4428 1.3612 1.3485 1.2821 1.5686 1.3485 1.3485\n\n5 1.3253 1.6155 1.4439 1.6219 1.3253 1.8628 1.6219 1.6219\n\n6 1.3685 1.7918 1.7469 1.6417 1.3685 2.1950 1.6417 1.6417\n\n7 1.4117 1.9270 1.8147 1.6690 1.4117 2.2783 1.6690 1.6690\n\n8 1.4549 2.2426 1.9353 1.9471 1.4549 2.5611 1.9471 1.9471\n\n9 1.4981 2.6761 2.2619 1.9561 1.4981 2.9632 1.9561 1.9561\n\n10 1.5414 2.6852 2.2795 2.1250 1.5414 2.9727 2.1250 2.1250\n\n11 1.5846 2.8842 2.2971 2.2939 1.5846 3.1939 2.2939 2.2939\n\n12 1.6278 3.0833 2.3147 2.4629 1.6278 3.4152 2.4629 2.4629\n\n13 1.6710 3.2804 2.4761 2.6318 1.6710 3.7363 2.6318 2.6318\n\n14 1.7142 3.4532 2.6460 2.8007 1.7142 4.0659 2.8007 2.8007\n\n15 1.7574 3.6259 2.8160 2.9696 1.7574 4.3954 2.9696 2.9696\n\n16 1.8007 3.7987 2.9860 3.1385 1.8007 4.7250 3.1385 3.1385\n\n17 1.8439 3.9714 3.1560 3.3075 1.8439 5.0545 3.3075 3.3075\n\n18 1.8871 4.1442 3.3259 3.4764 1.8871 5.3841 3.4764 3.4764\n\n19 1.9303 4.3169 3.4959 3.6453 1.9303 5.8730 3.6453 3.6453\n\n20 1.9735 4.3848 3.6134 3.8142 1.9735 6.3904 3.8142 3.8142\n\n21 2.0167 4.4285 3.7056 3.9832 2.0167 6.9079 3.9832 3.9832\n\n22 2.0599 4.4723 3.7978 4.1521 2.0599 7.4253 4.1521 4.1521\n\n23 2.1032 4.5160 3.8900 4.3210 2.1032 7.9428 4.3210 4.3210\n\n24 2.1464 4.5598 3.9821 4.4899 2.1464 8.4602 4.4899 4.4899\n\n25 2.1896 4.6036 4.0743 4.6588 2.1896 8.9777 4.6588 4.6588\n\n26 2.2328 4.6473 4.1665 4.8278 2.2328 9.4951 4.8278 4.8278\n\n27 2.2756 4.6923 4.2594 4.9961 2.2756 10.0114 4.9961 4.9961\n\n28 2.3188 4.7361 4.3516 5.1650 2.3188 10.5288 5.1650 5.1650\n\n29 2.3620 4.7799 4.4438 5.3339 2.3620 11.0462 5.3339 5.3339\n\n30 2.4052 4.8237 4.5360 5.5028 2.4052 11.5636 5.5028 5.5028\n\n31 2.4484 4.8675 4.6282 5.6717 2.4484 12.0810 5.6717 5.6717\n\n32 2.4916 4.9113 4.7204 5.8406 2.4916 12.5984 5.8406 5.8406\n\n33 2.5348 4.9551 4.8126 6.0095 2.5348 13.1158 6.0095 6.0095\n\n34 2.5780 4.9989 4.9048 6.1784 2.5780 13.6332 6.1784 6.1784\n\n35 2.6212 5.0427 4.9970 6.3473 2.6212 14.1506 6.3473 6.3473\n\n36 2.6644 5.0865 5.0892 6.5162 2.6644 14.6680 6.5162 6.5162\n\n37 2.7076 5.1303 5.1814 6.6851 2.7076 15.1854 6.6851 6.6851\n\n38 2.7508 5.1741 5.2736 6.8540 2.7508 15.7028 6.8540 6.8540\n\n39 2.7940 5.2179 5.3658 7.0229 2.7940 16.2202 7.0229 7.0229\n\n40 2.8372 5.2617 5.4580 7.1918 2.8372 16.7376 7.1918 7.1918\n\n41 2.8804 5.3055 5.5502 7.3607 2.8804 17.2550 7.3607 7.3607\n\n42 2.9236 5.3493 5.6424 7.5296 2.9236 17.7724 7.5296 7.5296\n\n43 2.9668 5.3931 5.7346 7.6985 2.9668 18.2898 7.6985 7.6985\n\n44 3.0100 5.4369 5.8268 7.8674 3.0100 18.8072 7.8674 7.8674\n\n45 3.0532 5.4807 5.9190 8.0363 3.0532 19.3246 8.0363 8.0363\n\n46 3.0964 5.5245 6.0112 8.2052 3.0964 19.8420 8.2052 8.2052\n\n47 3.1396 5.5683 6.1034 8.3741 3.1396 20.3594 8.3741 8.3741\n\n48 3.1828 5.6121 6.1956 8.5430 3.1828 20.8768 8.5430 8.5430\n\n49 3.2260 5.6559 6.2878 8.7119 3.2260 21.3942 8.7119 8.7119\n\n50 3.2692 5.6997 6.3800 8.8808 3.2692 21.9116 8.8808 8.8808\n\n51 3.3124 5.7435 6.4722 9.0497 3.3124 22.4290 9.0497 9.0497\n\n52 3.3556 5.7873 6.5644 9.2186 3.3556 22.9464 9.2186 9.2186\n\n53 3.3988 5.8311 6.6566 9.3875 3.3988 23.4638 9.3875 9.3875\n\n54 3.4420 5.8749 6.7488 9.5564 3.4420 23.9812 9.5564 9.5564\n\n55 3.4852 5.9187 6.8410 9.7253 3.4852 24.4986 9.7253 9.7253\n\n56 3.5284 5.9625 6.9332 9.8942 3.5284 25.0160 9.8942 9.8942\n\n57 3.5716 6.0063 7.0254 10.0631 3.5716 25.5334 10.0631 10.0631\n\n58 3.6148 6.0501 7.1176 10.2320 3.6148 26.0508 10.2320 10.2320\n\n59 3.6580 6.0939 7.2098 10.4009 3.6580 26.5682 10.4009 10.4009\n\n60 3.7012 6.1377 7.3020 10.5698 3.7012 27.0856 10.5698 10.5698\n\n61 3.7444 6.1815 7.3942 10.7387 3.7444 27.6030 10.7387 10.7387\n\n62 3.7876 6.2253 7.4864 10.9076 3.7876 28.1204 10.9076 10.9076\n\n63 3.8308 6.2691 7.5786 11.0765 3.8308 28.6378 11.0765 11.0765\n\n64 3.8740 6.3129 7.6708 11.2454 3.8740 29.1552 11.2454 11.2454\n\n65 3.9172 6.3567 7.7630 11.4143 3.9172 29.6726 11.4143 11.4143\n\n66 3.9604 6.4005 7.8552 11.5832 3.9604 30.1900 11.5832 11.5832\n\n67 4.0036 6.4443 7.9474 11.7521 4.0036 30.7074 11.7521 11.7521\n\n68 4.0468 6.4881 8.0396 11.9210 4.0468 31.2248 11.9210 11.9210\n\n69 4.0900 6.5319 8.1318 12.0899 4.0900 31.7422 12.0899 12.0899\n\n70 4.1332 6.5757 8.2240 12.2588 4.1332 32.2596 12.2588 12.2588\n\n71 4.1764 6.6195 8.3162 12.4277 4.1764 32.7770 12.4277 12.4277\n\n72 4.2196 6.6633 8.4084 12.5966 4.2196 33.2944 12.5966 12.5966\n\n73 4.2628 6.7071 8.5006 12.7655 4.2628 33.8118 12.7655 12.7655\n\n74 4.3060 6.7509 8.5928 12.9344 4.3060 34.3292 12.9344 12.9344\n\n75 4.3492 6.7947 8.6850 13.1033 4.3492 34.8466 13.1033 13.1033\n\n76 4.3924 6.8385 8.7772 13.2722 4.3924 35.3640 13.2722 13.2722\n\n77 4.4356 6.8823 8.8694 13.4411 4.4356 35.8814 13.4411 13.4411\n\n78 4.4788 6.9261 8.9616 13.6100 4.4788 36.3988 13.6100 13.6100\n\n79 4.5220 6.9699 9.0538 13.7789 4.5220 36.9162 13.7789 13.7789\n\n80 4.5652 7.0137 9.1460 13.9478 4.5652 37.4336 13.9478 13.9478\n\n81 4.6084 7.0575 9.2382 14.1167 4.6084 37.9510 14.1167 14.1167\n\n82 4.6516 7.1013 9.3304 14.2856 4.6516 38.4684 14.2856 14.2856\n\n83 4.6948 7.1451 9.4226 14.4545 4.6948 38.9858 14.4545 14.4545\n\n84 4.7380 7.1889 9.5148 14.6234 4.7380 39.5032 14.6234 14.6234\n\n85 4.7812 7.2327 9.6070 14.7923 4.7812 40.0206 14.7923 14.7923\n\n86 4.8244 7.2765 9.6992 14.9612 4.8244 40.5380 14.9612 14.9612\n\n87 4.8676 7.3203 9.7914 15.1301 4.8676 41.0554 15.1301 15.1301\n\n88 4.9108 7.3641 9.8836 15.2990 4.9108 41.5728 15.2990 15.2990\n\n89 4.9540 7.4079 9.9758 15.4679 4.9540 42.0902 15.4679 15.4679\n\n90 4.9972 7.4517 10.0680 15.6368 4.9972 42.6076 15.6368 15.6368\n\n91 5.0404 7.4955 10.1602 15.8057 5.0404 43.1250 15.8057 15.8057\n\n92 5.0836 7.5393 10.2524 15.9746 5.0836 43.6424 15.9746 15.9746\n\n93 5.1268 7.5831 10.3446 16.1435 5.1268 44.1598 16.1435 16.1435\n\n94 5.1700 7.6269 10.4368 16.3124 5.1700 44.6772 16.3124 16.3124\n\n95 5.2132 7.6707 10.5290 16.4813 5.2132 45.1946 16.4813 16.4813\n\n96 5.2564 7.7145 10.6212 16.6502 5.2564 45.7120 16.6502 16.6502\n\n97 5.2996 7.7583 10.7134 16.8191 5.2996 46.2294 16.8191 16.8191\n\n98 5.3428 7.8021 10.8056 16.9880 5.3428 46.7468 16.9880 16.9880\n\n99 5.3860 7.8459 10.8978 17.1569 5.3860 47.2642 17.1569 17.1569\n\n100+ 5.4292 7.8897 10.9900 17.3258 5.4292 47.7816 17.3258 17.3258\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page834.pdf"]},"response":{"errors":[],"extract_id":"extract_340da3f4b9d44b64b88bdf3bc5e9ca90","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Points Factors**\n\n**Points** **ALL BI COL MP OTC PD UIM UMBI**\n\n0 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n1 1.0649 1.0232 1.0972 1.1200 1.0649 1.0667 1.1200 1.1200\n\n2 1.1006 1.2095 1.1944 1.1829 1.1006 1.2273 1.1829 1.1829\n\n3 1.2079 1.3341 1.3497 1.2198 1.2079 1.4686 1.2198 1.2198\n\n4 1.2821 1.4428 1.3612 1.3485 1.2821 1.5686 1.3485 1.3485\n\n5 1.3253 1.6155 1.4439 1.6219 1.3253 1.8628 1.6219 1.6219\n\n6 1.3685 1.7918 1.7469 1.6417 1.3685 2.1950 1.6417 1.6417\n\n7 1.4117 1.9270 1.8147 1.6690 1.4117 2.2783 1.6690 1.6690\n\n8 1.4549 2.2426 1.9353 1.9471 1.4549 2.5611 1.9471 1.9471\n\n9 1.4981 2.6761 2.2619 1.9561 1.4981 2.9632 1.9561 1.9561\n\n10 1.5414 2.6852 2.2795 2.1250 1.5414 2.9727 2.1250 2.1250\n\n11 1.5846 2.8842 2.2971 2.2939 1.5846 3.1939 2.2939 2.2939\n\n12 1.6278 3.0833 2.3147 2.4629 1.6278 3.4152 2.4629 2.4629\n\n13 1.6710 3.2804 2.4761 2.6318 1.6710 3.7363 2.6318 2.6318\n\n14 1.7142 3.4532 2.6460 2.8007 1.7142 4.0659 2.8007 2.8007\n\n15 1.7574 3.6259 2.8160 2.9696 1.7574 4.3954 2.9696 2.9696\n\n16 1.8007 3.7987 2.9860 3.1385 1.8007 4.7250 3.1385 3.1385\n\n17 1.8439 3.9714 3.1560 3.3075 1.8439 5.0545 3.3075 3.3075\n\n18 1.8871 4.1442 3.3259 3.4764 1.8871 5.3841 3.4764 3.4764\n\n19 1.9303 4.3169 3.4959 3.6453 1.9303 5.8730 3.6453 3.6453\n\n20 1.9735 4.3848 3.6134 3.8142 1.9735 6.3904 3.8142 3.8142\n\n21 2.0167 4.4285 3.7056 3.9832 2.0167 6.9079 3.9832 3.9832\n\n22 2.0599 4.4723 3.7978 4.1521 2.0599 7.4253 4.1521 4.1521\n\n23 2.1032 4.5160 3.8900 4.3210 2.1032 7.9428 4.3210 4.3210\n\n24 2.1464 4.5598 3.9821 4.4899 2.1464 8.4602 4.4899 4.4899\n\n25 2.1896 4.6036 4.0743 4.6588 2.1896 8.9777 4.6588 4.6588\n\n26 2.2328 4.6473 4.1665 4.8278 2.2328 9.4951 4.8278 4.8278\n\n27 2.2756 4.6923 4.2594 4.9961 2.2756 10.0114 4.9961 4.9961\n\n28 2.3188 4.7361 4.3516 5.1650 2.3188 10.5288 5.1650 5.1650\n\n29 2.3620 4.7799 4.4438 5.3339 2.3620 11.0462 5.3339 5.3339\n\n30 2.4052 4.8237 4.5360 5.5028 2.4052 11.5636 5.5028 5.5028\n\n31 2.4484 4.8675 4.6282 5.6717 2.4484 12.0810 5.6717 5.6717\n\n32 2.4916 4.9113 4.7204 5.8406 2.4916 12.5984 5.8406 5.8406\n\n33 2.5348 4.9551 4.8126 6.0095 2.5348 13.1158 6.0095 6.0095\n\n34 2.5780 4.9989 4.9048 6.1784 2.5780 13.6332 6.1784 6.1784\n\n35 2.6212 5.0427 4.9970 6.3473 2.6212 14.1506 6.3473 6.3473\n\n36 2.6644 5.0865 5.0892 6.5162 2.6644 14.6680 6.5162 6.5162\n\n37 2.7076 5.1303 5.1814 6.6851 2.7076 15.1854 6.6851 6.6851\n\n38 2.7508 5.1741 5.2736 6.8540 2.7508 15.7028 6.8540 6.8540\n\n39 2.7940 5.2179 5.3658 7.0229 2.7940 16.2202 7.0229 7.0229\n\n40 2.8372 5.2617 5.4580 7.1918 2.8372 16.7376 7.1918 7.1918\n\n41 2.8804 5.3055 5.5502 7.3607 2.8804 17.2550 7.3607 7.3607\n\n42 2.9236 5.3493 5.6424 7.5296 2.9236 17.7724 7.5296 7.5296\n\n43 2.9668 5.3931 5.7346 7.6985 2.9668 18.2898 7.6985 7.6985\n\n44 3.0100 5.4369 5.8268 7.8674 3.0100 18.8072 7.8674 7.8674\n\n45 3.0532 5.4807 5.9190 8.0363 3.0532 19.3246 8.0363 8.0363\n\n46 3.0964 5.5245 6.0112 8.2052 3.0964 19.8420 8.2052 8.2052\n\n47 3.1396 5.5683 6.1034 8.3741 3.1396 20.3594 8.3741 8.3741\n\n48 3.1828 5.6121 6.1956 8.5430 3.1828 20.8768 8.5430 8.5430\n\n49 3.2260 5.6559 6.2878 8.7119 3.2260 21.3942 8.7119 8.7119\n\n50 3.2692 5.6997 6.3800 8.8808 3.2692 21.9116 8.8808 8.8808\n\n51 3.3124 5.7435 6.4722 9.0497 3.3124 22.4290 9.0497 9.0497\n\n52 3.3556 5.7873 6.5644 9.2186 3.3556 22.9464 9.2186 9.2186\n\n53 3.3988 5.8311 6.6566 9.3875 3.3988 23.4638 9.3875 9.3875\n\n54 3.4420 5.8749 6.7488 9.5564 3.4420 23.9812 9.5564 9.5564\n\n55 3.4852 5.9187 6.8410 9.7253 3.4852 24.4986 9.7253 9.7253\n\n56 3.5284 5.9625 6.9332 9.8942 3.5284 25.0160 9.8942 9.8942\n\n57 3.5716 6.0063 7.0254 10.0631 3.5716 25.5334 10.0631 10.0631\n\n58 3.6148 6.0501 7.1176 10.2320 3.6148 26.0508 10.2320 10.2320\n\n59 3.6580 6.0939 7.2098 10.4009 3.6580 26.5682 10.4009 10.4009\n\n60 3.7012 6.1377 7.3020 10.5698 3.7012 27.0856 10.5698 10.5698\n\n61 3.7444 6.1815 7.3942 10.7387 3.7444 27.6030 10.7387 10.7387\n\n62 3.7876 6.2253 7.4864 10.9076 3.7876 28.1204 10.9076 10.9076\n\n63 3.8308 6.2691 7.5786 11.0765 3.8308 28.6378 11.0765 11.0765\n\n64 3.8740 6.3129 7.6708 11.2454 3.8740 29.1552 11.2454 11.2454\n\n65 3.9172 6.3567 7.7630 11.4143 3.9172 29.6726 11.4143 11.4143\n\n66 3.9604 6.4005 7.8552 11.5832 3.9604 30.1900 11.5832 11.5832\n\n67 4.0036 6.4443 7.9474 11.7521 4.0036 30.7074 11.7521 11.7521\n\n68 4.0468 6.4881 8.0396 11.9210 4.0468 31.2248 11.9210 11.9210\n\n69 4.0900 6.5319 8.1318 12.0899 4.0900 31.7422 12.0899 12.0899\n\n70 4.1332 6.5757 8.2240 12.2588 4.1332 32.2596 12.2588 12.2588\n\n71 4.1764 6.6195 8.3162 12.4277 4.1764 32.7770 12.4277 12.4277\n\n72 4.2196 6.6633 8.4084 12.5966 4.2196 33.2944 12.5966 12.5966\n\n73 4.2628 6.7071 8.5006 12.7655 4.2628 33.8118 12.7655 12.7655\n\n74 4.3060 6.7509 8.5928 12.9344 4.3060 34.3292 12.9344 12.9344\n\n75 4.3492 6.7947 8.6850 13.1033 4.3492 34.8466 13.1033 13.1033\n\n76 4.3924 6.8385 8.7772 13.2722 4.3924 35.3640 13.2722 13.2722\n\n77 4.4356 6.8823 8.8694 13.4411 4.4356 35.8814 13.4411 13.4411\n\n78 4.4788 6.9261 8.9616 13.6100 4.4788 36.3988 13.6100 13.6100\n\n79 4.5220 6.9699 9.0538 13.7789 4.5220 36.9162 13.7789 13.7789\n\n80 4.5652 7.0137 9.1460 13.9478 4.5652 37.4336 13.9478 13.9478\n\n81 4.6084 7.0575 9.2382 14.1167 4.6084 37.9510 14.1167 14.1167\n\n82 4.6516 7.1013 9.3304 14.2856 4.6516 38.4684 14.2856 14.2856\n\n83 4.6948 7.1451 9.4226 14.4545 4.6948 38.9858 14.4545 14.4545\n\n84 4.7380 7.1889 9.5148 14.6234 4.7380 39.5032 14.6234 14.6234\n\n85 4.7812 7.2327 9.6070 14.7923 4.7812 40.0206 14.7923 14.7923\n\n86 4.8244 7.2765 9.6992 14.9612 4.8244 40.5380 14.9612 14.9612\n\n87 4.8676 7.3203 9.7914 15.1301 4.8676 41.0554 15.1301 15.1301\n\n88 4.9108 7.3641 9.8836 15.2990 4.9108 41.5728 15.2990 15.2990\n\n89 4.9540 7.4079 9.9758 15.4679 4.9540 42.0902 15.4679 15.4679\n\n90 4.9972 7.4517 10.0680 15.6368 4.9972 42.6076 15.6368 15.6368\n\n91 5.0404 7.4955 10.1602 15.8057 5.0404 43.1250 15.8057 15.8057\n\n92 5.0836 7.5393 10.2524 15.9746 5.0836 43.6424 15.9746 15.9746\n\n93 5.1268 7.5831 10.3446 16.1435 5.1268 44.1598 16.1435 16.1435\n\n94 5.1700 7.6269 10.4368 16.3124 5.1700 44.6772 16.3124 16.3124\n\n95 5.2132 7.6707 10.5290 16.4813 5.2132 45.1946 16.4813 16.4813\n\n96 5.2564 7.7145 10.6212 16.6502 5.2564 45.7120 16.6502 16.6502\n\n97 5.2996 7.7583 10.7134 16.8191 5.2996 46.2294 16.8191 16.8191\n\n98 5.3428 7.8021 10.8056 16.9880 5.3428 46.7468 16.9880 16.9880\n\n99 5.3860 7.8459 10.8978 17.1569 5.3860 47.2642 17.1569 17.1569\n\n100+ 5.4292 7.8897 10.9900 17.3258 5.4292 47.7816 17.3258 17.3258\n\n**Proposed**"],"full_content":"**Points Factors**\n\n**Points** **ALL BI COL MP OTC PD UIM UMBI**\n\n0 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n1 1.0649 1.0232 1.0972 1.1200 1.0649 1.0667 1.1200 1.1200\n\n2 1.1006 1.2095 1.1944 1.1829 1.1006 1.2273 1.1829 1.1829\n\n3 1.2079 1.3341 1.3497 1.2198 1.2079 1.4686 1.2198 1.2198\n\n4 1.2821 1.4428 1.3612 1.3485 1.2821 1.5686 1.3485 1.3485\n\n5 1.3253 1.6155 1.4439 1.6219 1.3253 1.8628 1.6219 1.6219\n\n6 1.3685 1.7918 1.7469 1.6417 1.3685 2.1950 1.6417 1.6417\n\n7 1.4117 1.9270 1.8147 1.6690 1.4117 2.2783 1.6690 1.6690\n\n8 1.4549 2.2426 1.9353 1.9471 1.4549 2.5611 1.9471 1.9471\n\n9 1.4981 2.6761 2.2619 1.9561 1.4981 2.9632 1.9561 1.9561\n\n10 1.5414 2.6852 2.2795 2.1250 1.5414 2.9727 2.1250 2.1250\n\n11 1.5846 2.8842 2.2971 2.2939 1.5846 3.1939 2.2939 2.2939\n\n12 1.6278 3.0833 2.3147 2.4629 1.6278 3.4152 2.4629 2.4629\n\n13 1.6710 3.2804 2.4761 2.6318 1.6710 3.7363 2.6318 2.6318\n\n14 1.7142 3.4532 2.6460 2.8007 1.7142 4.0659 2.8007 2.8007\n\n15 1.7574 3.6259 2.8160 2.9696 1.7574 4.3954 2.9696 2.9696\n\n16 1.8007 3.7987 2.9860 3.1385 1.8007 4.7250 3.1385 3.1385\n\n17 1.8439 3.9714 3.1560 3.3075 1.8439 5.0545 3.3075 3.3075\n\n18 1.8871 4.1442 3.3259 3.4764 1.8871 5.3841 3.4764 3.4764\n\n19 1.9303 4.3169 3.4959 3.6453 1.9303 5.8730 3.6453 3.6453\n\n20 1.9735 4.3848 3.6134 3.8142 1.9735 6.3904 3.8142 3.8142\n\n21 2.0167 4.4285 3.7056 3.9832 2.0167 6.9079 3.9832 3.9832\n\n22 2.0599 4.4723 3.7978 4.1521 2.0599 7.4253 4.1521 4.1521\n\n23 2.1032 4.5160 3.8900 4.3210 2.1032 7.9428 4.3210 4.3210\n\n24 2.1464 4.5598 3.9821 4.4899 2.1464 8.4602 4.4899 4.4899\n\n25 2.1896 4.6036 4.0743 4.6588 2.1896 8.9777 4.6588 4.6588\n\n26 2.2328 4.6473 4.1665 4.8278 2.2328 9.4951 4.8278 4.8278\n\n27 2.2756 4.6923 4.2594 4.9961 2.2756 10.0114 4.9961 4.9961\n\n28 2.3188 4.7361 4.3516 5.1650 2.3188 10.5288 5.1650 5.1650\n\n29 2.3620 4.7799 4.4438 5.3339 2.3620 11.0462 5.3339 5.3339\n\n30 2.4052 4.8237 4.5360 5.5028 2.4052 11.5636 5.5028 5.5028\n\n31 2.4484 4.8675 4.6282 5.6717 2.4484 12.0810 5.6717 5.6717\n\n32 2.4916 4.9113 4.7204 5.8406 2.4916 12.5984 5.8406 5.8406\n\n33 2.5348 4.9551 4.8126 6.0095 2.5348 13.1158 6.0095 6.0095\n\n34 2.5780 4.9989 4.9048 6.1784 2.5780 13.6332 6.1784 6.1784\n\n35 2.6212 5.0427 4.9970 6.3473 2.6212 14.1506 6.3473 6.3473\n\n36 2.6644 5.0865 5.0892 6.5162 2.6644 14.6680 6.5162 6.5162\n\n37 2.7076 5.1303 5.1814 6.6851 2.7076 15.1854 6.6851 6.6851\n\n38 2.7508 5.1741 5.2736 6.8540 2.7508 15.7028 6.8540 6.8540\n\n39 2.7940 5.2179 5.3658 7.0229 2.7940 16.2202 7.0229 7.0229\n\n40 2.8372 5.2617 5.4580 7.1918 2.8372 16.7376 7.1918 7.1918\n\n41 2.8804 5.3055 5.5502 7.3607 2.8804 17.2550 7.3607 7.3607\n\n42 2.9236 5.3493 5.6424 7.5296 2.9236 17.7724 7.5296 7.5296\n\n43 2.9668 5.3931 5.7346 7.6985 2.9668 18.2898 7.6985 7.6985\n\n44 3.0100 5.4369 5.8268 7.8674 3.0100 18.8072 7.8674 7.8674\n\n45 3.0532 5.4807 5.9190 8.0363 3.0532 19.3246 8.0363 8.0363\n\n46 3.0964 5.5245 6.0112 8.2052 3.0964 19.8420 8.2052 8.2052\n\n47 3.1396 5.5683 6.1034 8.3741 3.1396 20.3594 8.3741 8.3741\n\n48 3.1828 5.6121 6.1956 8.5430 3.1828 20.8768 8.5430 8.5430\n\n49 3.2260 5.6559 6.2878 8.7119 3.2260 21.3942 8.7119 8.7119\n\n50 3.2692 5.6997 6.3800 8.8808 3.2692 21.9116 8.8808 8.8808\n\n51 3.3124 5.7435 6.4722 9.0497 3.3124 22.4290 9.0497 9.0497\n\n52 3.3556 5.7873 6.5644 9.2186 3.3556 22.9464 9.2186 9.2186\n\n53 3.3988 5.8311 6.6566 9.3875 3.3988 23.4638 9.3875 9.3875\n\n54 3.4420 5.8749 6.7488 9.5564 3.4420 23.9812 9.5564 9.5564\n\n55 3.4852 5.9187 6.8410 9.7253 3.4852 24.4986 9.7253 9.7253\n\n56 3.5284 5.9625 6.9332 9.8942 3.5284 25.0160 9.8942 9.8942\n\n57 3.5716 6.0063 7.0254 10.0631 3.5716 25.5334 10.0631 10.0631\n\n58 3.6148 6.0501 7.1176 10.2320 3.6148 26.0508 10.2320 10.2320\n\n59 3.6580 6.0939 7.2098 10.4009 3.6580 26.5682 10.4009 10.4009\n\n60 3.7012 6.1377 7.3020 10.5698 3.7012 27.0856 10.5698 10.5698\n\n61 3.7444 6.1815 7.3942 10.7387 3.7444 27.6030 10.7387 10.7387\n\n62 3.7876 6.2253 7.4864 10.9076 3.7876 28.1204 10.9076 10.9076\n\n63 3.8308 6.2691 7.5786 11.0765 3.8308 28.6378 11.0765 11.0765\n\n64 3.8740 6.3129 7.6708 11.2454 3.8740 29.1552 11.2454 11.2454\n\n65 3.9172 6.3567 7.7630 11.4143 3.9172 29.6726 11.4143 11.4143\n\n66 3.9604 6.4005 7.8552 11.5832 3.9604 30.1900 11.5832 11.5832\n\n67 4.0036 6.4443 7.9474 11.7521 4.0036 30.7074 11.7521 11.7521\n\n68 4.0468 6.4881 8.0396 11.9210 4.0468 31.2248 11.9210 11.9210\n\n69 4.0900 6.5319 8.1318 12.0899 4.0900 31.7422 12.0899 12.0899\n\n70 4.1332 6.5757 8.2240 12.2588 4.1332 32.2596 12.2588 12.2588\n\n71 4.1764 6.6195 8.3162 12.4277 4.1764 32.7770 12.4277 12.4277\n\n72 4.2196 6.6633 8.4084 12.5966 4.2196 33.2944 12.5966 12.5966\n\n73 4.2628 6.7071 8.5006 12.7655 4.2628 33.8118 12.7655 12.7655\n\n74 4.3060 6.7509 8.5928 12.9344 4.3060 34.3292 12.9344 12.9344\n\n75 4.3492 6.7947 8.6850 13.1033 4.3492 34.8466 13.1033 13.1033\n\n76 4.3924 6.8385 8.7772 13.2722 4.3924 35.3640 13.2722 13.2722\n\n77 4.4356 6.8823 8.8694 13.4411 4.4356 35.8814 13.4411 13.4411\n\n78 4.4788 6.9261 8.9616 13.6100 4.4788 36.3988 13.6100 13.6100\n\n79 4.5220 6.9699 9.0538 13.7789 4.5220 36.9162 13.7789 13.7789\n\n80 4.5652 7.0137 9.1460 13.9478 4.5652 37.4336 13.9478 13.9478\n\n81 4.6084 7.0575 9.2382 14.1167 4.6084 37.9510 14.1167 14.1167\n\n82 4.6516 7.1013 9.3304 14.2856 4.6516 38.4684 14.2856 14.2856\n\n83 4.6948 7.1451 9.4226 14.4545 4.6948 38.9858 14.4545 14.4545\n\n84 4.7380 7.1889 9.5148 14.6234 4.7380 39.5032 14.6234 14.6234\n\n85 4.7812 7.2327 9.6070 14.7923 4.7812 40.0206 14.7923 14.7923\n\n86 4.8244 7.2765 9.6992 14.9612 4.8244 40.5380 14.9612 14.9612\n\n87 4.8676 7.3203 9.7914 15.1301 4.8676 41.0554 15.1301 15.1301\n\n88 4.9108 7.3641 9.8836 15.2990 4.9108 41.5728 15.2990 15.2990\n\n89 4.9540 7.4079 9.9758 15.4679 4.9540 42.0902 15.4679 15.4679\n\n90 4.9972 7.4517 10.0680 15.6368 4.9972 42.6076 15.6368 15.6368\n\n91 5.0404 7.4955 10.1602 15.8057 5.0404 43.1250 15.8057 15.8057\n\n92 5.0836 7.5393 10.2524 15.9746 5.0836 43.6424 15.9746 15.9746\n\n93 5.1268 7.5831 10.3446 16.1435 5.1268 44.1598 16.1435 16.1435\n\n94 5.1700 7.6269 10.4368 16.3124 5.1700 44.6772 16.3124 16.3124\n\n95 5.2132 7.6707 10.5290 16.4813 5.2132 45.1946 16.4813 16.4813\n\n96 5.2564 7.7145 10.6212 16.6502 5.2564 45.7120 16.6502 16.6502\n\n97 5.2996 7.7583 10.7134 16.8191 5.2996 46.2294 16.8191 16.8191\n\n98 5.3428 7.8021 10.8056 16.9880 5.3428 46.7468 16.9880 16.9880\n\n99 5.3860 7.8459 10.8978 17.1569 5.3860 47.2642 17.1569 17.1569\n\n100+ 5.4292 7.8897 10.9900 17.3258 5.4292 47.7816 17.3258 17.3258\n\n**Proposed**","publish_date":null,"title":"Proposed","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page834.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page834.pdf"},"request":{"example_id":"table/BRWS-134565917_page834","product_type":"parse","source_file_path":"BRWS-134565917_page834.pdf"},"started_at":"2026-11-04T19:48:18.318735"} +{"completed_at":"2026-11-04T19:48:23.644910","latency_in_ms":3408,"output":{"example_id":"table/BRWS-134565917_page835","grounded_pages":[],"layout_pages":[],"markdown":"**AAF Violation Aging**\n\n**0 - 12 Month AAF Violation**\n\n**Count**\n\n**13 - 24 Month AAF Violation**\n\n**Count**\n\n**25 - 35 Month AAF Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0206 -0.1344 -0.0863 0.0000 0.0000 -0.0898 0.0000 0.0000\n\n0 0 2 0.0524 -0.1473 -0.0811 0.0000 0.0000 -0.1425 0.0000 0.0000\n\n0 1 0 0.0319 -0.0129 0.0262 0.0000 0.0000 -0.0527 0.0000 0.0000\n\n0 1 1 0.0559 -0.1489 -0.0596 0.0000 0.0000 -0.1488 0.0000 0.0000\n\n0 2 0 0.1447 0.3041 0.0265 0.0000 0.0000 -0.0915 0.0000 0.0000\n\n1 0 0 0.1072 0.3481 0.2279 0.0000 0.0000 0.2251 0.0000 0.0000\n\n1 0 1 0.1313 0.2121 0.1421 0.0000 0.0000 0.1290 0.0000 0.0000\n\n1 1 0 0.1608 0.3643 0.2397 0.0000 0.0000 0.1497 0.0000 0.0000\n\n2 0 0 0.5151 0.4898 0.9462 0.0000 0.0000 0.8133 0.0000 0.0000\n\n**DUI Violation Aging**\n\n**0 - 12 Month DUI Violation**\n\n**Count**\n\n**13 - 24 Month DUI**\n\n**Violation Count**\n\n**25 - 35 Month DUI Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0250 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 2 0.0250 0.0000 0.0000 0.0000 0.0000 -0.0300 0.0000 0.0000\n\n0 1 0 0.0500 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 1 1 0.0750 0.0000 0.0000 0.0000 0.0000 -0.0012 0.0000 0.0000\n\n0 2 0 0.1008 0.3010 0.0000 0.0000 0.0000 -0.0001 0.0000 0.0000\n\n1 0 0 0.0750 0.3010 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 0 1 0.1000 0.3010 0.0000 0.0000 0.0000 -0.0009 0.0000 0.0000\n\n1 1 0 0.1255 0.3121 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n2 0 0 0.1524 0.3016 0.3396 0.0000 0.0000 0.3000 0.0000 0.0000\n\n**MAJ Violation Aging**\n\n**0 - 12 Month MAJ Violation**\n\n**Count**\n\n**13 - 24 Month MAJ Violation**\n\n**Count**\n\n**25 - 35 Month MAJ Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.2325 0.0065 0.0264 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.4454 -0.0112 0.0529 0.0000 0.0000 0.2475 0.0000 0.0000\n\n0 1 0 0.2325 0.0065 0.0264 0.0000 0.0000 0.1744 0.0000 0.0000\n\n0 1 1 0.4776 0.0108 0.0542 0.0000 0.0000 0.2660 0.0000 0.0000\n\n0 2 0 0.5858 0.2090 0.0558 0.0000 0.0000 0.3073 0.0000 0.0000\n\n1 0 0 0.3252 0.2194 0.1054 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.5640 0.2242 0.1325 0.0000 0.0000 0.2991 0.0000 0.0000\n\n1 1 0 0.6008 0.2526 0.1360 0.0000 0.0000 0.4101 0.0000 0.0000\n\n2 0 0 0.6326 0.5140 0.4030 0.0000 0.0000 0.5452 0.0000 0.0000\n\n**MIN Violation Aging**\n\n**0 - 12 Month MIN Violation**\n\n**Count**\n\n**13 - 24 Month MIN Violation**\n\n**Count**\n\n**25 - 35 Month MIN Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.1020 0.0065 -0.1079 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.0983 -0.0112 -0.1383 0.0000 0.0000 -0.0280 0.0000 0.0000\n\n0 1 0 0.1020 0.0065 0.0264 0.0000 0.0000 0.1009 0.0000 0.0000\n\n0 1 1 0.2036 0.0111 -0.0841 0.0000 0.0000 0.1629 0.0000 0.0000\n\n0 2 0 0.2174 0.2091 0.1172 0.0000 0.0000 0.2978 0.0000 0.0000\n\n1 0 0 0.1020 0.2194 0.1846 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.2037 0.2245 0.0750 0.0000 0.0000 0.2744 0.0000 0.0000\n\n1 1 0 0.2264 0.2534 0.2073 0.0000 0.0000 0.3443 0.0000 0.0000\n\n2 0 0 0.6342 0.5108 0.2020 0.0000 0.0000 0.5378 0.0000 0.0000\n\n**SPD Violation Aging**\n\n**0 - 12 Month SPD Violation**\n\n**Count**\n\n**13 - 24 Month SPD Violation**\n\n**Count**\n\n**25 - 35 Month SPD Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0000 -0.0875 -0.0960 0.0000 0.0000 -0.1920 0.0000 0.0000\n\n0 0 2 0.0000 -0.0875 -0.1293 0.0000 0.0000 -0.2543 0.0000 0.0000\n\n0 1 0 0.0292 0.0000 -0.0333 0.0000 0.0000 -0.0351 0.0000 0.0000\n\n0 1 1 0.0292 -0.0875 -0.1333 0.0000 0.0000 -0.2349 0.0000 0.0000\n\n0 2 0 0.0814 -0.1062 -0.1084 0.0000 0.0000 -0.2701 0.0000 0.0000\n\n1 0 0 0.0522 0.1586 0.1382 0.0000 0.0000 0.0821 0.0000 0.0000\n\n1 0 1 0.0522 0.0711 0.0386 0.0000 0.0000 -0.1169 0.0000 0.0000\n\n1 1 0 0.0890 0.1293 0.0799 0.0000 0.0000 -0.0179 0.0000 0.0000\n\n2 0 0 0.0911 0.1387 0.3783 0.0000 0.0000 0.3221 0.0000 0.0000\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**AAF Violation Aging**\n\n**0 - 12 Month AAF Violation**\n\n**Count**\n\n**13 - 24 Month AAF Violation**\n\n**Count**\n\n**25 - 35 Month AAF Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0206 -0.1344 -0.0863 0.0000 0.0000 -0.0898 0.0000 0.0000\n\n0 0 2 0.0524 -0.1473 -0.0811 0.0000 0.0000 -0.1425 0.0000 0.0000\n\n0 1 0 0.0319 -0.0129 0.0262 0.0000 0.0000 -0.0527 0.0000 0.0000\n\n0 1 1 0.0559 -0.1489 -0.0596 0.0000 0.0000 -0.1488 0.0000 0.0000\n\n0 2 0 0.1447 0.3041 0.0265 0.0000 0.0000 -0.0915 0.0000 0.0000\n\n1 0 0 0.1072 0.3481 0.2279 0.0000 0.0000 0.2251 0.0000 0.0000\n\n1 0 1 0.1313 0.2121 0.1421 0.0000 0.0000 0.1290 0.0000 0.0000\n\n1 1 0 0.1608 0.3643 0.2397 0.0000 0.0000 0.1497 0.0000 0.0000\n\n2 0 0 0.5151 0.4898 0.9462 0.0000 0.0000 0.8133 0.0000 0.0000\n\n**DUI Violation Aging**\n\n**0 - 12 Month DUI Violation**\n\n**Count**\n\n**13 - 24 Month DUI**\n\n**Violation Count**\n\n**25 - 35 Month DUI Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0250 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 2 0.0250 0.0000 0.0000 0.0000 0.0000 -0.0300 0.0000 0.0000\n\n0 1 0 0.0500 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 1 1 0.0750 0.0000 0.0000 0.0000 0.0000 -0.0012 0.0000 0.0000\n\n0 2 0 0.1008 0.3010 0.0000 0.0000 0.0000 -0.0001 0.0000 0.0000\n\n1 0 0 0.0750 0.3010 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 0 1 0.1000 0.3010 0.0000 0.0000 0.0000 -0.0009 0.0000 0.0000\n\n1 1 0 0.1255 0.3121 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n2 0 0 0.1524 0.3016 0.3396 0.0000 0.0000 0.3000 0.0000 0.0000\n\n**MAJ Violation Aging**\n\n**0 - 12 Month MAJ Violation**\n\n**Count**\n\n**13 - 24 Month MAJ Violation**\n\n**Count**\n\n**25 - 35 Month MAJ Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.2325 0.0065 0.0264 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.4454 -0.0112 0.0529 0.0000 0.0000 0.2475 0.0000 0.0000\n\n0 1 0 0.2325 0.0065 0.0264 0.0000 0.0000 0.1744 0.0000 0.0000\n\n0 1 1 0.4776 0.0108 0.0542 0.0000 0.0000 0.2660 0.0000 0.0000\n\n0 2 0 0.5858 0.2090 0.0558 0.0000 0.0000 0.3073 0.0000 0.0000\n\n1 0 0 0.3252 0.2194 0.1054 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.5640 0.2242 0.1325 0.0000 0.0000 0.2991 0.0000 0.0000\n\n1 1 0 0.6008 0.2526 0.1360 0.0000 0.0000 0.4101 0.0000 0.0000\n\n2 0 0 0.6326 0.5140 0.4030 0.0000 0.0000 0.5452 0.0000 0.0000\n\n**MIN Violation Aging**\n\n**0 - 12 Month MIN Violation**\n\n**Count**\n\n**13 - 24 Month MIN Violation**\n\n**Count**\n\n**25 - 35 Month MIN Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.1020 0.0065 -0.1079 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.0983 -0.0112 -0.1383 0.0000 0.0000 -0.0280 0.0000 0.0000\n\n0 1 0 0.1020 0.0065 0.0264 0.0000 0.0000 0.1009 0.0000 0.0000\n\n0 1 1 0.2036 0.0111 -0.0841 0.0000 0.0000 0.1629 0.0000 0.0000\n\n0 2 0 0.2174 0.2091 0.1172 0.0000 0.0000 0.2978 0.0000 0.0000\n\n1 0 0 0.1020 0.2194 0.1846 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.2037 0.2245 0.0750 0.0000 0.0000 0.2744 0.0000 0.0000\n\n1 1 0 0.2264 0.2534 0.2073 0.0000 0.0000 0.3443 0.0000 0.0000\n\n2 0 0 0.6342 0.5108 0.2020 0.0000 0.0000 0.5378 0.0000 0.0000\n\n**SPD Violation Aging**\n\n**0 - 12 Month SPD Violation**\n\n**Count**\n\n**13 - 24 Month SPD Violation**\n\n**Count**\n\n**25 - 35 Month SPD Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0000 -0.0875 -0.0960 0.0000 0.0000 -0.1920 0.0000 0.0000\n\n0 0 2 0.0000 -0.0875 -0.1293 0.0000 0.0000 -0.2543 0.0000 0.0000\n\n0 1 0 0.0292 0.0000 -0.0333 0.0000 0.0000 -0.0351 0.0000 0.0000\n\n0 1 1 0.0292 -0.0875 -0.1333 0.0000 0.0000 -0.2349 0.0000 0.0000\n\n0 2 0 0.0814 -0.1062 -0.1084 0.0000 0.0000 -0.2701 0.0000 0.0000\n\n1 0 0 0.0522 0.1586 0.1382 0.0000 0.0000 0.0821 0.0000 0.0000\n\n1 0 1 0.0522 0.0711 0.0386 0.0000 0.0000 -0.1169 0.0000 0.0000\n\n1 1 0 0.0890 0.1293 0.0799 0.0000 0.0000 -0.0179 0.0000 0.0000\n\n2 0 0 0.0911 0.1387 0.3783 0.0000 0.0000 0.3221 0.0000 0.0000\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**AAF Violation Aging**\n\n**0 - 12 Month AAF Violation**\n\n**Count**\n\n**13 - 24 Month AAF Violation**\n\n**Count**\n\n**25 - 35 Month AAF Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0206 -0.1344 -0.0863 0.0000 0.0000 -0.0898 0.0000 0.0000\n\n0 0 2 0.0524 -0.1473 -0.0811 0.0000 0.0000 -0.1425 0.0000 0.0000\n\n0 1 0 0.0319 -0.0129 0.0262 0.0000 0.0000 -0.0527 0.0000 0.0000\n\n0 1 1 0.0559 -0.1489 -0.0596 0.0000 0.0000 -0.1488 0.0000 0.0000\n\n0 2 0 0.1447 0.3041 0.0265 0.0000 0.0000 -0.0915 0.0000 0.0000\n\n1 0 0 0.1072 0.3481 0.2279 0.0000 0.0000 0.2251 0.0000 0.0000\n\n1 0 1 0.1313 0.2121 0.1421 0.0000 0.0000 0.1290 0.0000 0.0000\n\n1 1 0 0.1608 0.3643 0.2397 0.0000 0.0000 0.1497 0.0000 0.0000\n\n2 0 0 0.5151 0.4898 0.9462 0.0000 0.0000 0.8133 0.0000 0.0000\n\n**DUI Violation Aging**\n\n**0 - 12 Month DUI Violation**\n\n**Count**\n\n**13 - 24 Month DUI**\n\n**Violation Count**\n\n**25 - 35 Month DUI Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0250 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 2 0.0250 0.0000 0.0000 0.0000 0.0000 -0.0300 0.0000 0.0000\n\n0 1 0 0.0500 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 1 1 0.0750 0.0000 0.0000 0.0000 0.0000 -0.0012 0.0000 0.0000\n\n0 2 0 0.1008 0.3010 0.0000 0.0000 0.0000 -0.0001 0.0000 0.0000\n\n1 0 0 0.0750 0.3010 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 0 1 0.1000 0.3010 0.0000 0.0000 0.0000 -0.0009 0.0000 0.0000\n\n1 1 0 0.1255 0.3121 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n2 0 0 0.1524 0.3016 0.3396 0.0000 0.0000 0.3000 0.0000 0.0000\n\n**MAJ Violation Aging**\n\n**0 - 12 Month MAJ Violation**\n\n**Count**\n\n**13 - 24 Month MAJ Violation**\n\n**Count**\n\n**25 - 35 Month MAJ Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.2325 0.0065 0.0264 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.4454 -0.0112 0.0529 0.0000 0.0000 0.2475 0.0000 0.0000\n\n0 1 0 0.2325 0.0065 0.0264 0.0000 0.0000 0.1744 0.0000 0.0000\n\n0 1 1 0.4776 0.0108 0.0542 0.0000 0.0000 0.2660 0.0000 0.0000\n\n0 2 0 0.5858 0.2090 0.0558 0.0000 0.0000 0.3073 0.0000 0.0000\n\n1 0 0 0.3252 0.2194 0.1054 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.5640 0.2242 0.1325 0.0000 0.0000 0.2991 0.0000 0.0000\n\n1 1 0 0.6008 0.2526 0.1360 0.0000 0.0000 0.4101 0.0000 0.0000\n\n2 0 0 0.6326 0.5140 0.4030 0.0000 0.0000 0.5452 0.0000 0.0000\n\n**MIN Violation Aging**\n\n**0 - 12 Month MIN Violation**\n\n**Count**\n\n**13 - 24 Month MIN Violation**\n\n**Count**\n\n**25 - 35 Month MIN Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.1020 0.0065 -0.1079 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.0983 -0.0112 -0.1383 0.0000 0.0000 -0.0280 0.0000 0.0000\n\n0 1 0 0.1020 0.0065 0.0264 0.0000 0.0000 0.1009 0.0000 0.0000\n\n0 1 1 0.2036 0.0111 -0.0841 0.0000 0.0000 0.1629 0.0000 0.0000\n\n0 2 0 0.2174 0.2091 0.1172 0.0000 0.0000 0.2978 0.0000 0.0000\n\n1 0 0 0.1020 0.2194 0.1846 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.2037 0.2245 0.0750 0.0000 0.0000 0.2744 0.0000 0.0000\n\n1 1 0 0.2264 0.2534 0.2073 0.0000 0.0000 0.3443 0.0000 0.0000\n\n2 0 0 0.6342 0.5108 0.2020 0.0000 0.0000 0.5378 0.0000 0.0000\n\n**SPD Violation Aging**\n\n**0 - 12 Month SPD Violation**\n\n**Count**\n\n**13 - 24 Month SPD Violation**\n\n**Count**\n\n**25 - 35 Month SPD Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0000 -0.0875 -0.0960 0.0000 0.0000 -0.1920 0.0000 0.0000\n\n0 0 2 0.0000 -0.0875 -0.1293 0.0000 0.0000 -0.2543 0.0000 0.0000\n\n0 1 0 0.0292 0.0000 -0.0333 0.0000 0.0000 -0.0351 0.0000 0.0000\n\n0 1 1 0.0292 -0.0875 -0.1333 0.0000 0.0000 -0.2349 0.0000 0.0000\n\n0 2 0 0.0814 -0.1062 -0.1084 0.0000 0.0000 -0.2701 0.0000 0.0000\n\n1 0 0 0.0522 0.1586 0.1382 0.0000 0.0000 0.0821 0.0000 0.0000\n\n1 0 1 0.0522 0.0711 0.0386 0.0000 0.0000 -0.1169 0.0000 0.0000\n\n1 1 0 0.0890 0.1293 0.0799 0.0000 0.0000 -0.0179 0.0000 0.0000\n\n2 0 0 0.0911 0.1387 0.3783 0.0000 0.0000 0.3221 0.0000 0.0000\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page835.pdf"]},"response":{"errors":[],"extract_id":"extract_31430584fa7553373bcc037d72ef51da","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**AAF Violation Aging**\n\n**0 - 12 Month AAF Violation**\n\n**Count**\n\n**13 - 24 Month AAF Violation**\n\n**Count**\n\n**25 - 35 Month AAF Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0206 -0.1344 -0.0863 0.0000 0.0000 -0.0898 0.0000 0.0000\n\n0 0 2 0.0524 -0.1473 -0.0811 0.0000 0.0000 -0.1425 0.0000 0.0000\n\n0 1 0 0.0319 -0.0129 0.0262 0.0000 0.0000 -0.0527 0.0000 0.0000\n\n0 1 1 0.0559 -0.1489 -0.0596 0.0000 0.0000 -0.1488 0.0000 0.0000\n\n0 2 0 0.1447 0.3041 0.0265 0.0000 0.0000 -0.0915 0.0000 0.0000\n\n1 0 0 0.1072 0.3481 0.2279 0.0000 0.0000 0.2251 0.0000 0.0000\n\n1 0 1 0.1313 0.2121 0.1421 0.0000 0.0000 0.1290 0.0000 0.0000\n\n1 1 0 0.1608 0.3643 0.2397 0.0000 0.0000 0.1497 0.0000 0.0000\n\n2 0 0 0.5151 0.4898 0.9462 0.0000 0.0000 0.8133 0.0000 0.0000\n\n**DUI Violation Aging**\n\n**0 - 12 Month DUI Violation**\n\n**Count**\n\n**13 - 24 Month DUI**\n\n**Violation Count**\n\n**25 - 35 Month DUI Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0250 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 2 0.0250 0.0000 0.0000 0.0000 0.0000 -0.0300 0.0000 0.0000\n\n0 1 0 0.0500 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 1 1 0.0750 0.0000 0.0000 0.0000 0.0000 -0.0012 0.0000 0.0000\n\n0 2 0 0.1008 0.3010 0.0000 0.0000 0.0000 -0.0001 0.0000 0.0000\n\n1 0 0 0.0750 0.3010 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 0 1 0.1000 0.3010 0.0000 0.0000 0.0000 -0.0009 0.0000 0.0000\n\n1 1 0 0.1255 0.3121 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n2 0 0 0.1524 0.3016 0.3396 0.0000 0.0000 0.3000 0.0000 0.0000\n\n**MAJ Violation Aging**\n\n**0 - 12 Month MAJ Violation**\n\n**Count**\n\n**13 - 24 Month MAJ Violation**\n\n**Count**\n\n**25 - 35 Month MAJ Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.2325 0.0065 0.0264 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.4454 -0.0112 0.0529 0.0000 0.0000 0.2475 0.0000 0.0000\n\n0 1 0 0.2325 0.0065 0.0264 0.0000 0.0000 0.1744 0.0000 0.0000\n\n0 1 1 0.4776 0.0108 0.0542 0.0000 0.0000 0.2660 0.0000 0.0000\n\n0 2 0 0.5858 0.2090 0.0558 0.0000 0.0000 0.3073 0.0000 0.0000\n\n1 0 0 0.3252 0.2194 0.1054 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.5640 0.2242 0.1325 0.0000 0.0000 0.2991 0.0000 0.0000\n\n1 1 0 0.6008 0.2526 0.1360 0.0000 0.0000 0.4101 0.0000 0.0000\n\n2 0 0 0.6326 0.5140 0.4030 0.0000 0.0000 0.5452 0.0000 0.0000\n\n**MIN Violation Aging**\n\n**0 - 12 Month MIN Violation**\n\n**Count**\n\n**13 - 24 Month MIN Violation**\n\n**Count**\n\n**25 - 35 Month MIN Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.1020 0.0065 -0.1079 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.0983 -0.0112 -0.1383 0.0000 0.0000 -0.0280 0.0000 0.0000\n\n0 1 0 0.1020 0.0065 0.0264 0.0000 0.0000 0.1009 0.0000 0.0000\n\n0 1 1 0.2036 0.0111 -0.0841 0.0000 0.0000 0.1629 0.0000 0.0000\n\n0 2 0 0.2174 0.2091 0.1172 0.0000 0.0000 0.2978 0.0000 0.0000\n\n1 0 0 0.1020 0.2194 0.1846 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.2037 0.2245 0.0750 0.0000 0.0000 0.2744 0.0000 0.0000\n\n1 1 0 0.2264 0.2534 0.2073 0.0000 0.0000 0.3443 0.0000 0.0000\n\n2 0 0 0.6342 0.5108 0.2020 0.0000 0.0000 0.5378 0.0000 0.0000\n\n**SPD Violation Aging**\n\n**0 - 12 Month SPD Violation**\n\n**Count**\n\n**13 - 24 Month SPD Violation**\n\n**Count**\n\n**25 - 35 Month SPD Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0000 -0.0875 -0.0960 0.0000 0.0000 -0.1920 0.0000 0.0000\n\n0 0 2 0.0000 -0.0875 -0.1293 0.0000 0.0000 -0.2543 0.0000 0.0000\n\n0 1 0 0.0292 0.0000 -0.0333 0.0000 0.0000 -0.0351 0.0000 0.0000\n\n0 1 1 0.0292 -0.0875 -0.1333 0.0000 0.0000 -0.2349 0.0000 0.0000\n\n0 2 0 0.0814 -0.1062 -0.1084 0.0000 0.0000 -0.2701 0.0000 0.0000\n\n1 0 0 0.0522 0.1586 0.1382 0.0000 0.0000 0.0821 0.0000 0.0000\n\n1 0 1 0.0522 0.0711 0.0386 0.0000 0.0000 -0.1169 0.0000 0.0000\n\n1 1 0 0.0890 0.1293 0.0799 0.0000 0.0000 -0.0179 0.0000 0.0000\n\n2 0 0 0.0911 0.1387 0.3783 0.0000 0.0000 0.3221 0.0000 0.0000\n\n**Proposed**"],"full_content":"**AAF Violation Aging**\n\n**0 - 12 Month AAF Violation**\n\n**Count**\n\n**13 - 24 Month AAF Violation**\n\n**Count**\n\n**25 - 35 Month AAF Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0206 -0.1344 -0.0863 0.0000 0.0000 -0.0898 0.0000 0.0000\n\n0 0 2 0.0524 -0.1473 -0.0811 0.0000 0.0000 -0.1425 0.0000 0.0000\n\n0 1 0 0.0319 -0.0129 0.0262 0.0000 0.0000 -0.0527 0.0000 0.0000\n\n0 1 1 0.0559 -0.1489 -0.0596 0.0000 0.0000 -0.1488 0.0000 0.0000\n\n0 2 0 0.1447 0.3041 0.0265 0.0000 0.0000 -0.0915 0.0000 0.0000\n\n1 0 0 0.1072 0.3481 0.2279 0.0000 0.0000 0.2251 0.0000 0.0000\n\n1 0 1 0.1313 0.2121 0.1421 0.0000 0.0000 0.1290 0.0000 0.0000\n\n1 1 0 0.1608 0.3643 0.2397 0.0000 0.0000 0.1497 0.0000 0.0000\n\n2 0 0 0.5151 0.4898 0.9462 0.0000 0.0000 0.8133 0.0000 0.0000\n\n**DUI Violation Aging**\n\n**0 - 12 Month DUI Violation**\n\n**Count**\n\n**13 - 24 Month DUI**\n\n**Violation Count**\n\n**25 - 35 Month DUI Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0250 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 2 0.0250 0.0000 0.0000 0.0000 0.0000 -0.0300 0.0000 0.0000\n\n0 1 0 0.0500 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 1 1 0.0750 0.0000 0.0000 0.0000 0.0000 -0.0012 0.0000 0.0000\n\n0 2 0 0.1008 0.3010 0.0000 0.0000 0.0000 -0.0001 0.0000 0.0000\n\n1 0 0 0.0750 0.3010 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 0 1 0.1000 0.3010 0.0000 0.0000 0.0000 -0.0009 0.0000 0.0000\n\n1 1 0 0.1255 0.3121 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n2 0 0 0.1524 0.3016 0.3396 0.0000 0.0000 0.3000 0.0000 0.0000\n\n**MAJ Violation Aging**\n\n**0 - 12 Month MAJ Violation**\n\n**Count**\n\n**13 - 24 Month MAJ Violation**\n\n**Count**\n\n**25 - 35 Month MAJ Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.2325 0.0065 0.0264 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.4454 -0.0112 0.0529 0.0000 0.0000 0.2475 0.0000 0.0000\n\n0 1 0 0.2325 0.0065 0.0264 0.0000 0.0000 0.1744 0.0000 0.0000\n\n0 1 1 0.4776 0.0108 0.0542 0.0000 0.0000 0.2660 0.0000 0.0000\n\n0 2 0 0.5858 0.2090 0.0558 0.0000 0.0000 0.3073 0.0000 0.0000\n\n1 0 0 0.3252 0.2194 0.1054 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.5640 0.2242 0.1325 0.0000 0.0000 0.2991 0.0000 0.0000\n\n1 1 0 0.6008 0.2526 0.1360 0.0000 0.0000 0.4101 0.0000 0.0000\n\n2 0 0 0.6326 0.5140 0.4030 0.0000 0.0000 0.5452 0.0000 0.0000\n\n**MIN Violation Aging**\n\n**0 - 12 Month MIN Violation**\n\n**Count**\n\n**13 - 24 Month MIN Violation**\n\n**Count**\n\n**25 - 35 Month MIN Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.1020 0.0065 -0.1079 0.0000 0.0000 0.0731 0.0000 0.0000\n\n0 0 2 0.0983 -0.0112 -0.1383 0.0000 0.0000 -0.0280 0.0000 0.0000\n\n0 1 0 0.1020 0.0065 0.0264 0.0000 0.0000 0.1009 0.0000 0.0000\n\n0 1 1 0.2036 0.0111 -0.0841 0.0000 0.0000 0.1629 0.0000 0.0000\n\n0 2 0 0.2174 0.2091 0.1172 0.0000 0.0000 0.2978 0.0000 0.0000\n\n1 0 0 0.1020 0.2194 0.1846 0.0000 0.0000 0.2098 0.0000 0.0000\n\n1 0 1 0.2037 0.2245 0.0750 0.0000 0.0000 0.2744 0.0000 0.0000\n\n1 1 0 0.2264 0.2534 0.2073 0.0000 0.0000 0.3443 0.0000 0.0000\n\n2 0 0 0.6342 0.5108 0.2020 0.0000 0.0000 0.5378 0.0000 0.0000\n\n**SPD Violation Aging**\n\n**0 - 12 Month SPD Violation**\n\n**Count**\n\n**13 - 24 Month SPD Violation**\n\n**Count**\n\n**25 - 35 Month SPD Violation**\n\n**Count ALL BI COL MP OTC PD UIM UMBI**\n\n0 0 0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n0 0 1 0.0000 -0.0875 -0.0960 0.0000 0.0000 -0.1920 0.0000 0.0000\n\n0 0 2 0.0000 -0.0875 -0.1293 0.0000 0.0000 -0.2543 0.0000 0.0000\n\n0 1 0 0.0292 0.0000 -0.0333 0.0000 0.0000 -0.0351 0.0000 0.0000\n\n0 1 1 0.0292 -0.0875 -0.1333 0.0000 0.0000 -0.2349 0.0000 0.0000\n\n0 2 0 0.0814 -0.1062 -0.1084 0.0000 0.0000 -0.2701 0.0000 0.0000\n\n1 0 0 0.0522 0.1586 0.1382 0.0000 0.0000 0.0821 0.0000 0.0000\n\n1 0 1 0.0522 0.0711 0.0386 0.0000 0.0000 -0.1169 0.0000 0.0000\n\n1 1 0 0.0890 0.1293 0.0799 0.0000 0.0000 -0.0179 0.0000 0.0000\n\n2 0 0 0.0911 0.1387 0.3783 0.0000 0.0000 0.3221 0.0000 0.0000\n\n**Proposed**","publish_date":null,"title":"AAF Violation Aging DUI Violation Aging MAJ Violation Aging MIN Violation Aging SPD Violation Aging","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page835.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page835.pdf"},"request":{"example_id":"table/BRWS-134565917_page835","product_type":"parse","source_file_path":"BRWS-134565917_page835.pdf"},"started_at":"2026-11-04T19:48:20.236894"} +{"completed_at":"2026-11-04T19:48:22.904234","latency_in_ms":1611,"output":{"example_id":"table/BRWS-134565917_page836","grounded_pages":[],"layout_pages":[],"markdown":"**Driver Age Group Points Group - BI Points Group - PD Points Group - MP / UMBI/UIM**\n\n**Driver Age Range Driver Age Group BI Points Group PD Points Group**\n\n**MP/ UM/UIM Points**\n\n**Group**\n\n1 - 24 A Low High Low High Low High\n\n25 - 49 B 0 0 A 0 0 A 0 0 A\n\n50 - 64 C 1 3 B 1 2 B 1 1 B\n\n65 - 74 D 4 4 C 3 3 C 2 2 C\n\n75 + E 5 6 D 4 5 D 3 4 D\n\n7 E 6 E 5 E\n\n**Points Group - ALL/OTC Points Group - COL**\n\n**ALL/OTC Points**\n\n**Group COL Points Group**\n\nLow High Low High\n\n0 0 A 0 0 A\n\n1 1 B 1 3 B\n\n2 2 C 4 4 C\n\n3 D 5 6 D\n\n7 E\n\n**Age Points Factor Driver Age Group Points Group ALL BI COL MP OTC PD UIM UMBI**\n\nA A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nB A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nC A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nD A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nD B 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD C 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD D 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD E 0.0000 1.1673 1.0420 1.0000 0.0000 1.1079 1.0000 1.0000\n\nE A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nE B 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE C 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE D 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE E 0.0000 1.1871 1.0447 1.0000 0.0000 1.1843 1.0000 1.0000\n\n**ALL/OTC Points COL Points**\n\n**Proposed**\n\n**BI Points PD Points MP/ UM/UIM Points**","pages":[{"line_numbers":[],"markdown":"**Driver Age Group Points Group - BI Points Group - PD Points Group - MP / UMBI/UIM**\n\n**Driver Age Range Driver Age Group BI Points Group PD Points Group**\n\n**MP/ UM/UIM Points**\n\n**Group**\n\n1 - 24 A Low High Low High Low High\n\n25 - 49 B 0 0 A 0 0 A 0 0 A\n\n50 - 64 C 1 3 B 1 2 B 1 1 B\n\n65 - 74 D 4 4 C 3 3 C 2 2 C\n\n75 + E 5 6 D 4 5 D 3 4 D\n\n7 E 6 E 5 E\n\n**Points Group - ALL/OTC Points Group - COL**\n\n**ALL/OTC Points**\n\n**Group COL Points Group**\n\nLow High Low High\n\n0 0 A 0 0 A\n\n1 1 B 1 3 B\n\n2 2 C 4 4 C\n\n3 D 5 6 D\n\n7 E\n\n**Age Points Factor Driver Age Group Points Group ALL BI COL MP OTC PD UIM UMBI**\n\nA A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nB A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nC A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nD A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nD B 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD C 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD D 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD E 0.0000 1.1673 1.0420 1.0000 0.0000 1.1079 1.0000 1.0000\n\nE A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nE B 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE C 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE D 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE E 0.0000 1.1871 1.0447 1.0000 0.0000 1.1843 1.0000 1.0000\n\n**ALL/OTC Points COL Points**\n\n**Proposed**\n\n**BI Points PD Points MP/ UM/UIM Points**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Driver Age Group Points Group - BI Points Group - PD Points Group - MP / UMBI/UIM**\n\n**Driver Age Range Driver Age Group BI Points Group PD Points Group**\n\n**MP/ UM/UIM Points**\n\n**Group**\n\n1 - 24 A Low High Low High Low High\n\n25 - 49 B 0 0 A 0 0 A 0 0 A\n\n50 - 64 C 1 3 B 1 2 B 1 1 B\n\n65 - 74 D 4 4 C 3 3 C 2 2 C\n\n75 + E 5 6 D 4 5 D 3 4 D\n\n7 E 6 E 5 E\n\n**Points Group - ALL/OTC Points Group - COL**\n\n**ALL/OTC Points**\n\n**Group COL Points Group**\n\nLow High Low High\n\n0 0 A 0 0 A\n\n1 1 B 1 3 B\n\n2 2 C 4 4 C\n\n3 D 5 6 D\n\n7 E\n\n**Age Points Factor Driver Age Group Points Group ALL BI COL MP OTC PD UIM UMBI**\n\nA A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nB A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nC A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nD A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nD B 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD C 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD D 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD E 0.0000 1.1673 1.0420 1.0000 0.0000 1.1079 1.0000 1.0000\n\nE A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nE B 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE C 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE D 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE E 0.0000 1.1871 1.0447 1.0000 0.0000 1.1843 1.0000 1.0000\n\n**ALL/OTC Points COL Points**\n\n**Proposed**\n\n**BI Points PD Points MP/ UM/UIM Points**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page836.pdf"]},"response":{"errors":[],"extract_id":"extract_6a482a89bf2bcc88dcc3b8ae80f4c2f2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Driver Age Group Points Group - BI Points Group - PD Points Group - MP / UMBI/UIM**\n\n**Driver Age Range Driver Age Group BI Points Group PD Points Group**\n\n**MP/ UM/UIM Points**\n\n**Group**\n\n1 - 24 A Low High Low High Low High\n\n25 - 49 B 0 0 A 0 0 A 0 0 A\n\n50 - 64 C 1 3 B 1 2 B 1 1 B\n\n65 - 74 D 4 4 C 3 3 C 2 2 C\n\n75 + E 5 6 D 4 5 D 3 4 D\n\n7 E 6 E 5 E\n\n**Points Group - ALL/OTC Points Group - COL**\n\n**ALL/OTC Points**\n\n**Group COL Points Group**\n\nLow High Low High\n\n0 0 A 0 0 A\n\n1 1 B 1 3 B\n\n2 2 C 4 4 C\n\n3 D 5 6 D\n\n7 E\n\n**Age Points Factor Driver Age Group Points Group ALL BI COL MP OTC PD UIM UMBI**\n\nA A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nB A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nC A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nD A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nD B 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD C 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD D 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD E 0.0000 1.1673 1.0420 1.0000 0.0000 1.1079 1.0000 1.0000\n\nE A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nE B 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE C 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE D 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE E 0.0000 1.1871 1.0447 1.0000 0.0000 1.1843 1.0000 1.0000\n\n**ALL/OTC Points COL Points**\n\n**Proposed**\n\n**BI Points PD Points MP/ UM/UIM Points**"],"full_content":"**Driver Age Group Points Group - BI Points Group - PD Points Group - MP / UMBI/UIM**\n\n**Driver Age Range Driver Age Group BI Points Group PD Points Group**\n\n**MP/ UM/UIM Points**\n\n**Group**\n\n1 - 24 A Low High Low High Low High\n\n25 - 49 B 0 0 A 0 0 A 0 0 A\n\n50 - 64 C 1 3 B 1 2 B 1 1 B\n\n65 - 74 D 4 4 C 3 3 C 2 2 C\n\n75 + E 5 6 D 4 5 D 3 4 D\n\n7 E 6 E 5 E\n\n**Points Group - ALL/OTC Points Group - COL**\n\n**ALL/OTC Points**\n\n**Group COL Points Group**\n\nLow High Low High\n\n0 0 A 0 0 A\n\n1 1 B 1 3 B\n\n2 2 C 4 4 C\n\n3 D 5 6 D\n\n7 E\n\n**Age Points Factor Driver Age Group Points Group ALL BI COL MP OTC PD UIM UMBI**\n\nA A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nA E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nB A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nB E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nC A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC B 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC C 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC D 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nC E 0.0000 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 1.0000\n\nD A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nD B 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD C 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD D 1.0000 1.1673 1.0420 1.0000 1.0000 1.1079 1.0000 1.0000\n\nD E 0.0000 1.1673 1.0420 1.0000 0.0000 1.1079 1.0000 1.0000\n\nE A 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nE B 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE C 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE D 1.0000 1.1871 1.0447 1.0000 1.0000 1.1843 1.0000 1.0000\n\nE E 0.0000 1.1871 1.0447 1.0000 0.0000 1.1843 1.0000 1.0000\n\n**ALL/OTC Points COL Points**\n\n**Proposed**\n\n**BI Points PD Points MP/ UM/UIM Points**","publish_date":null,"title":"Proposed Driver Age Group Points Group - BI Points Group - PD Points Group - MP / UMBI/UIM MP/ UM/UIM","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page836.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page836.pdf"},"request":{"example_id":"table/BRWS-134565917_page836","product_type":"parse","source_file_path":"BRWS-134565917_page836.pdf"},"started_at":"2026-11-04T19:48:21.292892"} +{"completed_at":"2026-11-04T19:48:25.136321","latency_in_ms":2874,"output":{"example_id":"table/BRWS-134565917_page837","grounded_pages":[],"layout_pages":[],"markdown":"**Base Rate**\n\n**Coverage Channel ALL BI CEQ COL EXTR MP OTC PD RA TL UIM UMBI**\n\n**Base Rate D** 37\\.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Base Rate** E 37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Base Rate** I 37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Base Rate**\n\n**Coverage Channel ALL BI CEQ COL EXTR MP OTC PD RA TL UIM UMBI**\n\n**Base Rate D** 37\\.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Base Rate** E 37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Base Rate** I 37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Base Rate**\n\n**Coverage Channel ALL BI CEQ COL EXTR MP OTC PD RA TL UIM UMBI**\n\n**Base Rate D** 37\\.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Base Rate** E 37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Base Rate** I 37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page837.pdf"]},"response":{"errors":[],"extract_id":"extract_80b5ee69e6447d23987ce18c8571449c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Base Rate**\n\n**Coverage Channel ALL BI CEQ COL EXTR MP OTC PD RA TL UIM UMBI**\n\n**Base Rate D** 37\\.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Base Rate** E 37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Base Rate** I 37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Proposed**"],"full_content":"**Base Rate**\n\n**Coverage Channel ALL BI CEQ COL EXTR MP OTC PD RA TL UIM UMBI**\n\n**Base Rate D** 37\\.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Base Rate** E 37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Base Rate** I 37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 6.31 $ 8.84 $ 21.43 $ 76.72 $\n\n**Proposed**","publish_date":null,"title":"37.43 $ 117.70 $ 9.68 $ 433.38 $ 25.75 $ 29.13 $ 297.84 $ 160.98 $ 21.43 $ 76.72 $","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page837.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page837.pdf"},"request":{"example_id":"table/BRWS-134565917_page837","product_type":"parse","source_file_path":"BRWS-134565917_page837.pdf"},"started_at":"2026-11-04T19:48:22.262071"} +{"completed_at":"2026-11-04T19:48:25.133094","latency_in_ms":1522,"output":{"example_id":"table/BRWS-134565917_page838","grounded_pages":[],"layout_pages":[],"markdown":"**Household Type Code Descriptions**\n\n**Household Type**\n\n**Code Household Type Household Type Description**\n\n**1** Youthful Married PNI PNI < 21 and Marital Status = Married/Domestic Partner Widow(er) (ignore the relationship of any other driver in the household)\n\n**2** Youthful Single PNI If household is not Group 1, and PNI < 21 and PNI Marital Status = Single (ignore the relationship of any other driver in the household)\n\n**3** Child in Household If household is not Group 1 or 2 and if any rated driver is a Child ² of the PNI, has an age < 25 and is single.\n\n**4** Senior in Household If household is not Group 1, 2 or 3 and if any rated driver who is not the PNI or Spouse ¹ age > 64\n\n**5** Senior PNI Household If household is not Group 1, 2, 3 or 4 and either PNI or Spouse ¹ age > 64\n\n**6** Married Household If household is not Group 1, 2, 3, 4 or 5 and marital status of all rated drivers in household = Married/Widow(er)/Domestic Partner\n\n**7** Single Household If household is not Group 1, 2, 3, 4, 5 or 6 and marital status of all rated drivers in household = Single\n\n**8** Other Household If household is not Group 1, 2, 3, 4, 5, 6 or 7\n\n**Household Structure Factor**\n\n**Household Type**\n\n**Code Description ALL BI COL MP OTC PD UIM UMBI**\n\n1 Youthful Married PNI 1.0592 1.0500 1.2023 1.0056 1.0592 1.1041 1.0056 1.0056\n\n2 Youthful Single PNI 1.0592 1.0500 1.2023 1.0056 1.0592 1.1041 1.0056 1.0056\n\n3 Child in Household 1.0455 1.0150 1.0173 0.9999 1.0455 1.0423 0.9999 0.9999\n\n4 Senior in Household 0.9491 0.9003 0.9891 0.9819 0.9491 0.9322 0.9819 0.9819\n\n5 Senior PNI Household 0.9514 1.0806 1.0180 1.0983 0.9514 1.0539 1.0983 1.0983\n\n6 Married Household 1.0132 1.0046 1.0087 1.0281 1.0132 0.9925 1.0281 1.0281\n\n7 Single Household 0.9993 0.9692 0.9809 0.9669 0.9993 0.9810 0.9669 0.9669\n\n8 Other Household 0.9729 1.0028 0.9534 0.9349 0.9729 0.9259 0.9349 0.9349\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Household Type Code Descriptions**\n\n**Household Type**\n\n**Code Household Type Household Type Description**\n\n**1** Youthful Married PNI PNI < 21 and Marital Status = Married/Domestic Partner Widow(er) (ignore the relationship of any other driver in the household)\n\n**2** Youthful Single PNI If household is not Group 1, and PNI < 21 and PNI Marital Status = Single (ignore the relationship of any other driver in the household)\n\n**3** Child in Household If household is not Group 1 or 2 and if any rated driver is a Child ² of the PNI, has an age < 25 and is single.\n\n**4** Senior in Household If household is not Group 1, 2 or 3 and if any rated driver who is not the PNI or Spouse ¹ age > 64\n\n**5** Senior PNI Household If household is not Group 1, 2, 3 or 4 and either PNI or Spouse ¹ age > 64\n\n**6** Married Household If household is not Group 1, 2, 3, 4 or 5 and marital status of all rated drivers in household = Married/Widow(er)/Domestic Partner\n\n**7** Single Household If household is not Group 1, 2, 3, 4, 5 or 6 and marital status of all rated drivers in household = Single\n\n**8** Other Household If household is not Group 1, 2, 3, 4, 5, 6 or 7\n\n**Household Structure Factor**\n\n**Household Type**\n\n**Code Description ALL BI COL MP OTC PD UIM UMBI**\n\n1 Youthful Married PNI 1.0592 1.0500 1.2023 1.0056 1.0592 1.1041 1.0056 1.0056\n\n2 Youthful Single PNI 1.0592 1.0500 1.2023 1.0056 1.0592 1.1041 1.0056 1.0056\n\n3 Child in Household 1.0455 1.0150 1.0173 0.9999 1.0455 1.0423 0.9999 0.9999\n\n4 Senior in Household 0.9491 0.9003 0.9891 0.9819 0.9491 0.9322 0.9819 0.9819\n\n5 Senior PNI Household 0.9514 1.0806 1.0180 1.0983 0.9514 1.0539 1.0983 1.0983\n\n6 Married Household 1.0132 1.0046 1.0087 1.0281 1.0132 0.9925 1.0281 1.0281\n\n7 Single Household 0.9993 0.9692 0.9809 0.9669 0.9993 0.9810 0.9669 0.9669\n\n8 Other Household 0.9729 1.0028 0.9534 0.9349 0.9729 0.9259 0.9349 0.9349\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Household Type Code Descriptions**\n\n**Household Type**\n\n**Code Household Type Household Type Description**\n\n**1** Youthful Married PNI PNI < 21 and Marital Status = Married/Domestic Partner Widow(er) (ignore the relationship of any other driver in the household)\n\n**2** Youthful Single PNI If household is not Group 1, and PNI < 21 and PNI Marital Status = Single (ignore the relationship of any other driver in the household)\n\n**3** Child in Household If household is not Group 1 or 2 and if any rated driver is a Child ² of the PNI, has an age < 25 and is single.\n\n**4** Senior in Household If household is not Group 1, 2 or 3 and if any rated driver who is not the PNI or Spouse ¹ age > 64\n\n**5** Senior PNI Household If household is not Group 1, 2, 3 or 4 and either PNI or Spouse ¹ age > 64\n\n**6** Married Household If household is not Group 1, 2, 3, 4 or 5 and marital status of all rated drivers in household = Married/Widow(er)/Domestic Partner\n\n**7** Single Household If household is not Group 1, 2, 3, 4, 5 or 6 and marital status of all rated drivers in household = Single\n\n**8** Other Household If household is not Group 1, 2, 3, 4, 5, 6 or 7\n\n**Household Structure Factor**\n\n**Household Type**\n\n**Code Description ALL BI COL MP OTC PD UIM UMBI**\n\n1 Youthful Married PNI 1.0592 1.0500 1.2023 1.0056 1.0592 1.1041 1.0056 1.0056\n\n2 Youthful Single PNI 1.0592 1.0500 1.2023 1.0056 1.0592 1.1041 1.0056 1.0056\n\n3 Child in Household 1.0455 1.0150 1.0173 0.9999 1.0455 1.0423 0.9999 0.9999\n\n4 Senior in Household 0.9491 0.9003 0.9891 0.9819 0.9491 0.9322 0.9819 0.9819\n\n5 Senior PNI Household 0.9514 1.0806 1.0180 1.0983 0.9514 1.0539 1.0983 1.0983\n\n6 Married Household 1.0132 1.0046 1.0087 1.0281 1.0132 0.9925 1.0281 1.0281\n\n7 Single Household 0.9993 0.9692 0.9809 0.9669 0.9993 0.9810 0.9669 0.9669\n\n8 Other Household 0.9729 1.0028 0.9534 0.9349 0.9729 0.9259 0.9349 0.9349\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page838.pdf"]},"response":{"errors":[],"extract_id":"extract_dd6234e4b7e2107f1713c00a6a4df117","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Household Type Code Descriptions**\n\n**Household Type**\n\n**Code Household Type Household Type Description**\n\n**1** Youthful Married PNI PNI < 21 and Marital Status = Married/Domestic Partner Widow(er) (ignore the relationship of any other driver in the household)\n\n**2** Youthful Single PNI If household is not Group 1, and PNI < 21 and PNI Marital Status = Single (ignore the relationship of any other driver in the household)\n\n**3** Child in Household If household is not Group 1 or 2 and if any rated driver is a Child ² of the PNI, has an age < 25 and is single.\n\n**4** Senior in Household If household is not Group 1, 2 or 3 and if any rated driver who is not the PNI or Spouse ¹ age > 64\n\n**5** Senior PNI Household If household is not Group 1, 2, 3 or 4 and either PNI or Spouse ¹ age > 64\n\n**6** Married Household If household is not Group 1, 2, 3, 4 or 5 and marital status of all rated drivers in household = Married/Widow(er)/Domestic Partner\n\n**7** Single Household If household is not Group 1, 2, 3, 4, 5 or 6 and marital status of all rated drivers in household = Single\n\n**8** Other Household If household is not Group 1, 2, 3, 4, 5, 6 or 7\n\n**Household Structure Factor**\n\n**Household Type**\n\n**Code Description ALL BI COL MP OTC PD UIM UMBI**\n\n1 Youthful Married PNI 1.0592 1.0500 1.2023 1.0056 1.0592 1.1041 1.0056 1.0056\n\n2 Youthful Single PNI 1.0592 1.0500 1.2023 1.0056 1.0592 1.1041 1.0056 1.0056\n\n3 Child in Household 1.0455 1.0150 1.0173 0.9999 1.0455 1.0423 0.9999 0.9999\n\n4 Senior in Household 0.9491 0.9003 0.9891 0.9819 0.9491 0.9322 0.9819 0.9819\n\n5 Senior PNI Household 0.9514 1.0806 1.0180 1.0983 0.9514 1.0539 1.0983 1.0983\n\n6 Married Household 1.0132 1.0046 1.0087 1.0281 1.0132 0.9925 1.0281 1.0281\n\n7 Single Household 0.9993 0.9692 0.9809 0.9669 0.9993 0.9810 0.9669 0.9669\n\n8 Other Household 0.9729 1.0028 0.9534 0.9349 0.9729 0.9259 0.9349 0.9349\n\n**Proposed**"],"full_content":"**Household Type Code Descriptions**\n\n**Household Type**\n\n**Code Household Type Household Type Description**\n\n**1** Youthful Married PNI PNI < 21 and Marital Status = Married/Domestic Partner Widow(er) (ignore the relationship of any other driver in the household)\n\n**2** Youthful Single PNI If household is not Group 1, and PNI < 21 and PNI Marital Status = Single (ignore the relationship of any other driver in the household)\n\n**3** Child in Household If household is not Group 1 or 2 and if any rated driver is a Child ² of the PNI, has an age < 25 and is single.\n\n**4** Senior in Household If household is not Group 1, 2 or 3 and if any rated driver who is not the PNI or Spouse ¹ age > 64\n\n**5** Senior PNI Household If household is not Group 1, 2, 3 or 4 and either PNI or Spouse ¹ age > 64\n\n**6** Married Household If household is not Group 1, 2, 3, 4 or 5 and marital status of all rated drivers in household = Married/Widow(er)/Domestic Partner\n\n**7** Single Household If household is not Group 1, 2, 3, 4, 5 or 6 and marital status of all rated drivers in household = Single\n\n**8** Other Household If household is not Group 1, 2, 3, 4, 5, 6 or 7\n\n**Household Structure Factor**\n\n**Household Type**\n\n**Code Description ALL BI COL MP OTC PD UIM UMBI**\n\n1 Youthful Married PNI 1.0592 1.0500 1.2023 1.0056 1.0592 1.1041 1.0056 1.0056\n\n2 Youthful Single PNI 1.0592 1.0500 1.2023 1.0056 1.0592 1.1041 1.0056 1.0056\n\n3 Child in Household 1.0455 1.0150 1.0173 0.9999 1.0455 1.0423 0.9999 0.9999\n\n4 Senior in Household 0.9491 0.9003 0.9891 0.9819 0.9491 0.9322 0.9819 0.9819\n\n5 Senior PNI Household 0.9514 1.0806 1.0180 1.0983 0.9514 1.0539 1.0983 1.0983\n\n6 Married Household 1.0132 1.0046 1.0087 1.0281 1.0132 0.9925 1.0281 1.0281\n\n7 Single Household 0.9993 0.9692 0.9809 0.9669 0.9993 0.9810 0.9669 0.9669\n\n8 Other Household 0.9729 1.0028 0.9534 0.9349 0.9729 0.9259 0.9349 0.9349\n\n**Proposed**","publish_date":null,"title":"Proposed Household Type Code Descriptions Household Type Household Type Household Type Description Code 1 Youthful Married PNI PNI < 21","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page838.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page838.pdf"},"request":{"example_id":"table/BRWS-134565917_page838","product_type":"parse","source_file_path":"BRWS-134565917_page838.pdf"},"started_at":"2026-11-04T19:48:23.610204"} +{"completed_at":"2026-11-04T19:48:27.238591","latency_in_ms":2499,"output":{"example_id":"table/BRWS-134565917_page839","grounded_pages":[],"layout_pages":[],"markdown":"**Vehicle - Driver Exposure Factor**\n\n**\\# Vehicles # Drivers V / D ALL BI COL MP OTC PD UIM UMBI**\n\n0 1 **=** 1\\.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n1 1 = 0.9928 1.1026 1.1283 1.0950 0.9928 1.1479 1.0950 1.0950\n\n1 2 < 0.9549 1.0538 1.0768 1.1589 0.9549 1.0660 1.1589 1.1589\n\n1 3 < 1.0098 1.1329 1.1138 1.1500 1.0098 1.1475 1.1500 1.1500\n\n1 4 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 5 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 6 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 7 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 8 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 9 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 10 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 11 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 12 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 13 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 14 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 15 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n2 1 > 1.0764 0.9100 0.9519 0.8876 1.0764 0.8695 0.8876 0.8876\n\n2 2 = 1.0299 0.9427 0.9432 0.9974 1.0299 0.9482 0.9974 0.9974\n\n2 3 < 0.9704 0.9662 0.9714 1.0929 0.9704 0.9911 1.0929 1.0929\n\n2 4 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 5 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 6 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 7 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 8 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 9 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 10 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 11 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 12 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 13 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 14 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 15 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n3 1 > 1.0561 0.8874 0.8526 0.8000 1.0561 0.7725 0.8000 0.8000\n\n3 2 > 1.0173 0.8857 0.8777 0.8700 1.0173 0.8556 0.8700 0.8700\n\n3 3 = 0.9702 0.9589 1.0055 0.9393 0.9702 0.9598 0.9393 0.9393\n\n3 4 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 5 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 6 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 7 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 8 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 9 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 10 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 11 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 12 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 13 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 14 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 15 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n4 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n4 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n4 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n4 4 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 5 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 6 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n5 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n5 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n5 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 5 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 6 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n6 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n6 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n6 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 6 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n7 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n7 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n7 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 6 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 7 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n8 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n8 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n8 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 6 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 7 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 8 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Vehicle - Driver Exposure Factor**\n\n**\\# Vehicles # Drivers V / D ALL BI COL MP OTC PD UIM UMBI**\n\n0 1 **=** 1\\.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n1 1 = 0.9928 1.1026 1.1283 1.0950 0.9928 1.1479 1.0950 1.0950\n\n1 2 < 0.9549 1.0538 1.0768 1.1589 0.9549 1.0660 1.1589 1.1589\n\n1 3 < 1.0098 1.1329 1.1138 1.1500 1.0098 1.1475 1.1500 1.1500\n\n1 4 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 5 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 6 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 7 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 8 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 9 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 10 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 11 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 12 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 13 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 14 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 15 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n2 1 > 1.0764 0.9100 0.9519 0.8876 1.0764 0.8695 0.8876 0.8876\n\n2 2 = 1.0299 0.9427 0.9432 0.9974 1.0299 0.9482 0.9974 0.9974\n\n2 3 < 0.9704 0.9662 0.9714 1.0929 0.9704 0.9911 1.0929 1.0929\n\n2 4 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 5 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 6 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 7 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 8 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 9 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 10 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 11 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 12 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 13 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 14 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 15 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n3 1 > 1.0561 0.8874 0.8526 0.8000 1.0561 0.7725 0.8000 0.8000\n\n3 2 > 1.0173 0.8857 0.8777 0.8700 1.0173 0.8556 0.8700 0.8700\n\n3 3 = 0.9702 0.9589 1.0055 0.9393 0.9702 0.9598 0.9393 0.9393\n\n3 4 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 5 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 6 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 7 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 8 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 9 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 10 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 11 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 12 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 13 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 14 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 15 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n4 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n4 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n4 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n4 4 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 5 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 6 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n5 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n5 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n5 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 5 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 6 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n6 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n6 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n6 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 6 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n7 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n7 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n7 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 6 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 7 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n8 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n8 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n8 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 6 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 7 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 8 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Vehicle - Driver Exposure Factor**\n\n**\\# Vehicles # Drivers V / D ALL BI COL MP OTC PD UIM UMBI**\n\n0 1 **=** 1\\.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n1 1 = 0.9928 1.1026 1.1283 1.0950 0.9928 1.1479 1.0950 1.0950\n\n1 2 < 0.9549 1.0538 1.0768 1.1589 0.9549 1.0660 1.1589 1.1589\n\n1 3 < 1.0098 1.1329 1.1138 1.1500 1.0098 1.1475 1.1500 1.1500\n\n1 4 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 5 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 6 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 7 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 8 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 9 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 10 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 11 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 12 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 13 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 14 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 15 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n2 1 > 1.0764 0.9100 0.9519 0.8876 1.0764 0.8695 0.8876 0.8876\n\n2 2 = 1.0299 0.9427 0.9432 0.9974 1.0299 0.9482 0.9974 0.9974\n\n2 3 < 0.9704 0.9662 0.9714 1.0929 0.9704 0.9911 1.0929 1.0929\n\n2 4 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 5 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 6 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 7 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 8 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 9 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 10 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 11 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 12 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 13 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 14 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 15 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n3 1 > 1.0561 0.8874 0.8526 0.8000 1.0561 0.7725 0.8000 0.8000\n\n3 2 > 1.0173 0.8857 0.8777 0.8700 1.0173 0.8556 0.8700 0.8700\n\n3 3 = 0.9702 0.9589 1.0055 0.9393 0.9702 0.9598 0.9393 0.9393\n\n3 4 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 5 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 6 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 7 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 8 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 9 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 10 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 11 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 12 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 13 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 14 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 15 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n4 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n4 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n4 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n4 4 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 5 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 6 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n5 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n5 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n5 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 5 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 6 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n6 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n6 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n6 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 6 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n7 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n7 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n7 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 6 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 7 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n8 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n8 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n8 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 6 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 7 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 8 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page839.pdf"]},"response":{"errors":[],"extract_id":"extract_7f3cecb4a58d0c96b05aece48b5c344c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Vehicle - Driver Exposure Factor**\n\n**\\# Vehicles # Drivers V / D ALL BI COL MP OTC PD UIM UMBI**\n\n0 1 **=** 1\\.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n1 1 = 0.9928 1.1026 1.1283 1.0950 0.9928 1.1479 1.0950 1.0950\n\n1 2 < 0.9549 1.0538 1.0768 1.1589 0.9549 1.0660 1.1589 1.1589\n\n1 3 < 1.0098 1.1329 1.1138 1.1500 1.0098 1.1475 1.1500 1.1500\n\n1 4 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 5 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 6 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 7 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 8 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 9 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 10 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 11 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 12 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 13 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 14 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 15 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n2 1 > 1.0764 0.9100 0.9519 0.8876 1.0764 0.8695 0.8876 0.8876\n\n2 2 = 1.0299 0.9427 0.9432 0.9974 1.0299 0.9482 0.9974 0.9974\n\n2 3 < 0.9704 0.9662 0.9714 1.0929 0.9704 0.9911 1.0929 1.0929\n\n2 4 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 5 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 6 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 7 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 8 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 9 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 10 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 11 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 12 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 13 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 14 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 15 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n3 1 > 1.0561 0.8874 0.8526 0.8000 1.0561 0.7725 0.8000 0.8000\n\n3 2 > 1.0173 0.8857 0.8777 0.8700 1.0173 0.8556 0.8700 0.8700\n\n3 3 = 0.9702 0.9589 1.0055 0.9393 0.9702 0.9598 0.9393 0.9393\n\n3 4 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 5 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 6 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 7 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 8 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 9 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 10 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 11 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 12 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 13 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 14 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 15 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n4 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n4 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n4 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n4 4 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 5 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 6 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n5 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n5 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n5 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 5 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 6 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n6 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n6 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n6 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 6 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n7 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n7 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n7 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 6 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 7 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n8 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n8 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n8 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 6 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 7 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 8 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n**Proposed**"],"full_content":"**Vehicle - Driver Exposure Factor**\n\n**\\# Vehicles # Drivers V / D ALL BI COL MP OTC PD UIM UMBI**\n\n0 1 **=** 1\\.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n1 1 = 0.9928 1.1026 1.1283 1.0950 0.9928 1.1479 1.0950 1.0950\n\n1 2 < 0.9549 1.0538 1.0768 1.1589 0.9549 1.0660 1.1589 1.1589\n\n1 3 < 1.0098 1.1329 1.1138 1.1500 1.0098 1.1475 1.1500 1.1500\n\n1 4 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 5 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 6 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 7 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 8 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 9 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 10 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 11 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 12 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 13 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 14 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n1 15 < 1.0404 1.0896 1.0500 1.1500 1.0404 1.2085 1.1500 1.1500\n\n2 1 > 1.0764 0.9100 0.9519 0.8876 1.0764 0.8695 0.8876 0.8876\n\n2 2 = 1.0299 0.9427 0.9432 0.9974 1.0299 0.9482 0.9974 0.9974\n\n2 3 < 0.9704 0.9662 0.9714 1.0929 0.9704 0.9911 1.0929 1.0929\n\n2 4 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 5 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 6 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 7 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 8 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 9 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 10 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 11 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 12 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 13 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 14 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n2 15 < 1.0710 1.0530 0.9563 1.0679 1.0710 0.9310 1.0679 1.0679\n\n3 1 > 1.0561 0.8874 0.8526 0.8000 1.0561 0.7725 0.8000 0.8000\n\n3 2 > 1.0173 0.8857 0.8777 0.8700 1.0173 0.8556 0.8700 0.8700\n\n3 3 = 0.9702 0.9589 1.0055 0.9393 0.9702 0.9598 0.9393 0.9393\n\n3 4 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 5 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 6 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 7 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 8 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 9 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 10 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 11 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 12 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 13 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 14 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n3 15 < 0.8428 0.9691 0.9563 0.9723 0.8428 0.9700 0.9723 0.9723\n\n4 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n4 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n4 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n4 4 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 5 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 6 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n4 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n5 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n5 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n5 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 5 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 6 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n5 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n6 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n6 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n6 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 6 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 7 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n6 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n7 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n7 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n7 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 6 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 7 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 8 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 12 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 13 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 14 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n7 15 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 1 > 0.9801 0.9161 0.8526 0.7200 0.9801 0.7680 0.7200 0.7200\n\n8 2 > 1.0031 1.0192 0.8959 0.7900 1.0031 0.8788 0.7900 0.7900\n\n8 3 > 0.8910 0.8628 0.8588 0.7687 0.8910 0.8770 0.7687 0.7687\n\n8 4 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 5 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 6 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 7 > 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 8 = 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 9 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 10 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n8 11 < 0.9588 1.0462 0.8656 0.8399 0.9588 0.9441 0.8399 0.8399\n\n**Proposed**","publish_date":null,"title":"Proposed Vehicle - Driver Exposure Factor # Vehicles # Drivers V / D ALL BI COL MP OTC PD UIM","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page839.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page839.pdf"},"request":{"example_id":"table/BRWS-134565917_page839","product_type":"parse","source_file_path":"BRWS-134565917_page839.pdf"},"started_at":"2026-11-04T19:48:24.739144"} +{"completed_at":"2026-11-04T19:48:30.487500","latency_in_ms":4211,"output":{"example_id":"table/BRWS-134565917_page841","grounded_pages":[],"layout_pages":[],"markdown":"**UW Rate Matrix Tier**\n\n**UW Tier Group Credit Tier NAF/OCG TIER UW Rate Matrix Tier ALL BI CEQ COL EXTR MP OTC PD RA UIM UMBI**\n\n1 A A 1 0.5348 0.5540 0.5348 0.5494 0.5494 0.2905 0.5348 0.5480 0.5494 0.2905 0.2905\n\n1 B A 2 0.6828 0.6085 0.6828 0.6262 0.6262 0.3460 0.6828 0.6190 0.6262 0.3460 0.3460\n\n1 C A 3 0.6848 0.6265 0.6848 0.6282 0.6282 0.3998 0.6848 0.6366 0.6282 0.3998 0.3998\n\n1 D A 4 0.6868 0.6285 0.6868 0.6604 0.6604 0.4018 0.6868 0.6386 0.6604 0.4018 0.4018\n\n1 E A 5 0.6888 0.6475 0.6888 0.7189 0.7189 0.4369 0.6888 0.6926 0.7189 0.4369 0.4369\n\n1 F A 6 0.6908 0.7008 0.6908 0.7486 0.7486 0.4389 0.6908 0.6956 0.7486 0.4389 0.4389\n\n1 G A 7 0.6928 0.7028 0.6928 0.7506 0.7506 0.4665 0.6928 0.7156 0.7506 0.4665 0.4665\n\n1 H A 8 0.7843 0.7048 0.7843 0.7526 0.7526 0.4685 0.7843 0.7675 0.7526 0.4685 0.4685\n\n1 I A 9 0.7863 0.7068 0.7863 0.7546 0.7546 0.5161 0.7863 0.7695 0.7546 0.5161 0.5161\n\n1 J A 10 0.7991 0.7088 0.7991 0.8464 0.8464 0.5181 0.7991 0.7867 0.8464 0.5181 0.5181\n\n1 K A 11 0.8272 0.7108 0.8272 0.8484 0.8484 0.6021 0.8272 0.8204 0.8484 0.6021 0.6021\n\n1 L A 12 0.8292 0.8176 0.8292 0.8671 0.8671 0.6041 0.8292 0.8442 0.8671 0.6041 0.6041\n\n1 M A 13 0.8717 0.8196 0.8717 0.8691 0.8691 0.6061 0.8717 0.8462 0.8691 0.6061 0.6061\n\n1 N A 14 0.8851 0.8348 0.8851 0.8711 0.8711 0.8334 0.8851 0.8482 0.8711 0.8334 0.8334\n\n1 O A 15 0.8871 0.8368 0.8871 0.8731 0.8731 0.8354 0.8871 0.8502 0.8731 0.8354 0.8354\n\n1 P A 16 0.8891 0.8388 0.8891 0.8751 0.8751 0.8374 0.8891 0.8845 0.8751 0.8374 0.8374\n\n1 Q A 17 0.8911 0.8408 0.8911 0.8771 0.8771 0.8394 0.8911 0.8865 0.8771 0.8394 0.8394\n\n1 R A 18 0.8931 0.8428 0.8931 0.8791 0.8791 0.8414 0.8931 0.8885 0.8791 0.8414 0.8414\n\n1 S A 19 1.0180 0.9545 1.0180 0.9299 0.9299 0.8434 1.0180 0.9199 0.9299 0.8434 0.8434\n\n1 T A 20 1.1006 0.9565 1.1006 0.9971 0.9971 0.8454 1.1006 0.9219 0.9971 0.8454 0.8454\n\n1 U A 21 1.1026 0.9585 1.1026 1.0017 1.0017 0.8642 1.1026 0.9239 1.0017 0.8642 0.8642\n\n1 V A 22 1.1046 0.9605 1.1046 1.0659 1.0659 0.9368 1.1046 0.9259 1.0659 0.9368 0.9368\n\n1 W A 23 1.1159 0.9625 1.1159 1.0679 1.0679 0.9388 1.1159 1.0703 1.0679 0.9388 0.9388\n\n1 X A 24 1.1179 1.0945 1.1179 1.0699 1.0699 0.9408 1.1179 1.0723 1.0699 0.9408 0.9408\n\n1 Y A 25 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZD A 26 1.1159 0.9625 1.1159 1.0679 1.0679 0.9388 1.1159 1.0703 1.0679 0.9388 0.9388\n\n1 ZE A 27 1.1179 1.0945 1.1179 1.0699 1.0699 0.9408 1.1179 1.0723 1.0699 0.9408 0.9408\n\n1 ZF A 28 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZG A 29 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZH A 30 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZJ A 31 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZK A 32 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZL A 33 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n2 A A 34 0.6783 0.7510 0.6783 0.6547 0.6547 0.5043 0.6783 0.7347 0.6547 0.5043 0.5043\n\n2 B A 35 0.7565 0.7530 0.7565 0.7963 0.7963 0.7751 0.7565 0.8326 0.7963 0.7751 0.7751\n\n2 C A 36 0.7815 0.7550 0.7815 0.8166 0.8166 0.7771 0.7815 0.8346 0.8166 0.7771 0.7771\n\n2 D A 37 0.8063 0.8639 0.8063 0.8711 0.8711 0.7791 0.8063 0.9208 0.8711 0.7791 0.7791\n\n2 E A 38 0.8339 0.8659 0.8339 0.8754 0.8754 0.8114 0.8339 0.9228 0.8754 0.8114 0.8114\n\n2 F A 39 0.8649 0.8679 0.8649 0.9343 0.9343 0.8134 0.8649 0.9248 0.9343 0.8134 0.8134\n\n2 G A 40 0.8669 0.8699 0.8669 0.9363 0.9363 0.8154 0.8669 0.9268 0.9363 0.8154 0.8154\n\n2 H A 41 0.9852 0.8719 0.9852 0.9505 0.9505 0.8269 0.9852 0.9288 0.9505 0.8269 0.8269\n\n2 I A 42 0.9872 0.8739 0.9872 1.0008 1.0008 0.8429 0.9872 0.9829 1.0008 0.8429 0.8429\n\n2 J A 43 0.9892 1.0389 0.9892 1.0028 1.0028 0.9423 0.9892 0.9854 1.0028 0.9423 0.9423\n\n2 K A 44 0.9912 1.0570 0.9912 1.0048 1.0048 0.9443 0.9912 0.9874 1.0048 0.9443 0.9443\n\n2 L A 45 0.9932 1.0590 0.9932 1.0068 1.0068 1.0395 0.9932 0.9894 1.0068 1.0395 1.0395\n\n2 M A 46 1.0185 1.0610 1.0185 1.0657 1.0657 1.0415 1.0185 0.9914 1.0657 1.0415 1.0415\n\n2 N A 47 1.0205 1.0630 1.0205 1.0677 1.0677 1.0435 1.0205 0.9934 1.0677 1.0435 1.0435\n\n2 O A 48 1.0275 1.0650 1.0275 1.0931 1.0931 1.0455 1.0275 1.0618 1.0931 1.0455 1.0455\n\n2 P A 49 1.1085 1.0670 1.1085 1.0951 1.0951 1.0475 1.1085 1.0681 1.0951 1.0475 1.0475\n\n2 Q A 50 1.2461 1.1469 1.2461 1.0971 1.0971 1.0495 1.2461 1.1111 1.0971 1.0495 1.0495\n\n2 R A 51 1.2481 1.1489 1.2481 1.0991 1.0991 1.0515 1.2481 1.1131 1.0991 1.0515 1.0515\n\n2 S A 52 1.2501 1.1509 1.2501 1.1923 1.1923 1.0535 1.2501 1.1151 1.1923 1.0535 1.0535\n\n2 T A 53 1.2521 1.1529 1.2521 1.2299 1.2299 1.2289 1.2521 1.1171 1.2299 1.2289 1.2289\n\n2 U A 54 1.2541 1.1549 1.2541 1.2319 1.2319 1.2309 1.2541 1.1191 1.2319 1.2309 1.2309\n\n2 V A 55 1.3190 1.1569 1.3190 1.2339 1.2339 1.3279 1.3190 1.1211 1.2339 1.3279 1.3279\n\n2 W A 56 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n2 X A 57 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n2 Y A 58 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZD A 59 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n2 ZE A 60 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n2 ZF A 61 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZG A 62 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZH A 63 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZJ A 64 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZK A 65 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZL A 66 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n3 A A 67 0.6227 0.6165 0.6227 0.6153 0.6153 0.3005 0.6227 0.6207 0.6153 0.3005 0.3005\n\n3 B A 68 0.6928 0.6185 0.6928 0.7095 0.7095 0.4921 0.6928 0.6290 0.7095 0.4921 0.4921\n\n3 C A 69 0.7615 0.6365 0.7615 0.7250 0.7250 0.4941 0.7615 0.6466 0.7250 0.4941 0.4941\n\n3 D A 70 0.7635 0.6385 0.7635 0.7270 0.7270 0.5602 0.7635 0.7012 0.7270 0.5602 0.5602\n\n3 E A 71 0.7655 0.6863 0.7655 0.7736 0.7736 0.5622 0.7655 0.7032 0.7736 0.5622 0.5622\n\n3 F A 72 0.7675 0.7108 0.7675 0.8232 0.8232 0.5642 0.7675 0.7056 0.8232 0.5642 0.5642\n\n3 G A 73 0.7923 0.7157 0.7923 0.8252 0.8252 0.5662 0.7923 0.7448 0.8252 0.5662 0.5662\n\n3 H A 74 0.7943 0.7795 0.7943 0.8691 0.8691 0.5682 0.7943 0.7848 0.8691 0.5682 0.5682\n\n3 I A 75 0.8071 0.7815 0.8071 0.8711 0.8711 0.7498 0.8071 0.7947 0.8711 0.7498 0.7498\n\n3 J A 76 0.8091 0.7835 0.8091 0.8731 0.8731 0.7518 0.8091 0.7967 0.8731 0.7518 0.7518\n\n3 K A 77 0.8372 0.8256 0.8372 0.8751 0.8751 0.7538 0.8372 0.8522 0.8751 0.7538 0.7538\n\n3 L A 78 0.8392 0.8276 0.8392 0.8771 0.8771 0.7558 0.8392 0.8542 0.8771 0.7558 0.7558\n\n3 M A 79 0.8978 0.8998 0.8978 0.9213 0.9213 0.8786 0.8978 0.8562 0.9213 0.8786 0.8786\n\n3 N A 80 0.9845 0.9018 0.9845 0.9233 0.9233 0.8806 0.9845 0.8704 0.9233 0.8806 0.8806\n\n3 O A 81 0.9865 0.9038 0.9865 0.9253 0.9253 0.8826 0.9865 0.8775 0.9253 0.8826 0.8826\n\n3 P A 82 0.9885 0.9058 0.9885 0.9273 0.9273 0.8846 0.9885 0.8945 0.9273 0.8846 0.8846\n\n3 Q A 83 0.9905 0.9078 0.9905 0.9293 0.9293 0.8866 0.9905 0.8965 0.9293 0.8866 0.8866\n\n3 R A 84 1.0174 0.9098 1.0174 0.9313 0.9313 0.8886 1.0174 0.8985 0.9313 0.8886 0.8886\n\n3 S A 85 1.0280 0.9645 1.0280 1.0469 1.0469 0.8906 1.0280 0.9299 1.0469 0.8906 0.8906\n\n3 T A 86 1.1106 0.9665 1.1106 1.0489 1.0489 0.8926 1.1106 0.9319 1.0489 0.8926 0.8926\n\n3 U A 87 1.1126 0.9685 1.1126 1.0509 1.0509 1.0517 1.1126 0.9339 1.0509 1.0517 1.0517\n\n3 V A 88 1.1146 1.0264 1.1146 1.0759 1.0759 1.1055 1.1146 1.0070 1.0759 1.1055 1.1055\n\n3 W A 89 1.1259 1.0856 1.1259 1.0779 1.0779 1.1075 1.1259 1.0803 1.0779 1.1075 1.1075\n\n3 X A 90 1.1279 1.1045 1.1279 1.0799 1.0799 1.2316 1.1279 1.0823 1.0799 1.2316 1.2316\n\n3 Y A 91 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZD A 92 1.1259 1.0856 1.1259 1.0779 1.0779 1.1075 1.1259 1.0803 1.0779 1.1075 1.1075\n\n3 ZE A 93 1.1279 1.1045 1.1279 1.0799 1.0799 1.2316 1.1279 1.0823 1.0799 1.2316 1.2316\n\n3 ZF A 94 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZG A 95 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZH A 96 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZJ A 97 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZK A 98 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZL A 99 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n4 A A 100 0.6783 0.7510 0.6783 0.6547 0.6547 0.5043 0.6783 0.7347 0.6547 0.5043 0.5043\n\n4 B A 101 0.7565 0.7530 0.7565 0.7963 0.7963 0.7751 0.7565 0.8326 0.7963 0.7751 0.7751\n\n4 C A 102 0.7815 0.7550 0.7815 0.8166 0.8166 0.7771 0.7815 0.8346 0.8166 0.7771 0.7771\n\n4 D A 103 0.8063 0.8639 0.8063 0.8711 0.8711 0.7791 0.8063 0.9208 0.8711 0.7791 0.7791\n\n4 E A 104 0.8339 0.8659 0.8339 0.8754 0.8754 0.8114 0.8339 0.9228 0.8754 0.8114 0.8114\n\n4 F A 105 0.8649 0.8679 0.8649 0.9343 0.9343 0.8134 0.8649 0.9248 0.9343 0.8134 0.8134\n\n4 G A 106 0.8669 0.8699 0.8669 0.9363 0.9363 0.8154 0.8669 0.9268 0.9363 0.8154 0.8154\n\n4 H A 107 0.9852 0.8719 0.9852 0.9505 0.9505 0.8269 0.9852 0.9288 0.9505 0.8269 0.8269\n\n4 I A 108 0.9872 0.8739 0.9872 1.0008 1.0008 0.8429 0.9872 0.9829 1.0008 0.8429 0.8429\n\n4 J A 109 0.9892 1.0389 0.9892 1.0028 1.0028 0.9423 0.9892 0.9854 1.0028 0.9423 0.9423\n\n4 K A 110 0.9912 1.0570 0.9912 1.0048 1.0048 0.9443 0.9912 0.9874 1.0048 0.9443 0.9443\n\n4 L A 111 0.9932 1.0590 0.9932 1.0068 1.0068 1.0395 0.9932 0.9894 1.0068 1.0395 1.0395\n\n4 M A 112 1.0185 1.0610 1.0185 1.0657 1.0657 1.0415 1.0185 0.9914 1.0657 1.0415 1.0415\n\n4 N A 113 1.0205 1.0630 1.0205 1.0677 1.0677 1.0435 1.0205 0.9934 1.0677 1.0435 1.0435\n\n4 O A 114 1.0275 1.0650 1.0275 1.0931 1.0931 1.0455 1.0275 1.0618 1.0931 1.0455 1.0455\n\n4 P A 115 1.1085 1.0670 1.1085 1.0951 1.0951 1.0475 1.1085 1.0681 1.0951 1.0475 1.0475\n\n4 Q A 116 1.2461 1.1469 1.2461 1.0971 1.0971 1.0495 1.2461 1.1111 1.0971 1.0495 1.0495\n\n4 R A 117 1.2481 1.1489 1.2481 1.0991 1.0991 1.0515 1.2481 1.1131 1.0991 1.0515 1.0515\n\n4 S A 118 1.2501 1.1509 1.2501 1.1923 1.1923 1.0535 1.2501 1.1151 1.1923 1.0535 1.0535\n\n4 T A 119 1.2521 1.1529 1.2521 1.2299 1.2299 1.2289 1.2521 1.1171 1.2299 1.2289 1.2289\n\n4 U A 120 1.2541 1.1549 1.2541 1.2319 1.2319 1.2309 1.2541 1.1191 1.2319 1.2309 1.2309\n\n4 V A 121 1.3190 1.1569 1.3190 1.2339 1.2339 1.3279 1.3190 1.1211 1.2339 1.3279 1.3279\n\n4 W A 122 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n4 X A 123 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n4 Y A 124 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZD A 125 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n4 ZE A 126 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n4 ZF A 127 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZG A 128 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZH A 129 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZJ A 130 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZK A 131 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZL A 132 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n5 A A 133 0.6327 0.6841 0.6327 0.6447 0.6447 0.4777 0.6327 0.6307 0.6447 0.4777 0.4777\n\n5 B A 134 0.7028 0.7275 0.7028 0.7195 0.7195 0.5021 0.7028 0.6734 0.7195 0.5021 0.5021\n\n5 C A 135 0.7715 0.7295 0.7715 0.7451 0.7451 0.6684 0.7715 0.7092 0.7451 0.6684 0.6684\n\n5 D A 136 0.7963 0.7315 0.7963 0.7471 0.7471 0.7373 0.7963 0.7112 0.7471 0.7373 0.7373\n\n5 E A 137 0.7983 0.7623 0.7983 0.8654 0.8654 0.7393 0.7983 0.7481 0.8654 0.7393 0.7393\n\n5 F A 138 0.8003 0.7643 0.8003 0.8727 0.8727 0.7413 0.8003 0.7501 0.8727 0.7413 0.7413\n\n5 G A 139 0.8023 0.7663 0.8023 0.8891 0.8891 0.7433 0.8023 0.7811 0.8891 0.7433 0.7433\n\n5 H A 140 0.8043 0.7895 0.8043 0.8911 0.8911 0.8041 0.8043 0.8027 0.8911 0.8041 0.8041\n\n5 I A 141 0.8171 0.8187 0.8171 0.8931 0.8931 0.8061 0.8171 0.8047 0.8931 0.8061 0.8061\n\n5 J A 142 0.8191 0.8996 0.8191 0.9593 0.9593 0.9219 0.8191 0.8775 0.9593 0.9219 0.9219\n\n5 K A 143 0.8472 0.9409 0.8472 0.9613 0.9613 0.9239 0.8472 0.8795 0.9613 0.9239 0.9239\n\n5 L A 144 0.8492 0.9429 0.8492 0.9633 0.9633 0.9259 0.8492 0.8815 0.9633 0.9259 0.9259\n\n5 M A 145 1.0085 0.9449 1.0085 0.9708 0.9708 0.9279 1.0085 0.8835 0.9708 0.9279 0.9279\n\n5 N A 146 1.0105 0.9469 1.0105 0.9728 0.9728 0.9299 1.0105 0.8855 0.9728 0.9299 0.9299\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**UW Rate Matrix Tier**\n\n**UW Tier Group Credit Tier NAF/OCG TIER UW Rate Matrix Tier ALL BI CEQ COL EXTR MP OTC PD RA UIM UMBI**\n\n1 A A 1 0.5348 0.5540 0.5348 0.5494 0.5494 0.2905 0.5348 0.5480 0.5494 0.2905 0.2905\n\n1 B A 2 0.6828 0.6085 0.6828 0.6262 0.6262 0.3460 0.6828 0.6190 0.6262 0.3460 0.3460\n\n1 C A 3 0.6848 0.6265 0.6848 0.6282 0.6282 0.3998 0.6848 0.6366 0.6282 0.3998 0.3998\n\n1 D A 4 0.6868 0.6285 0.6868 0.6604 0.6604 0.4018 0.6868 0.6386 0.6604 0.4018 0.4018\n\n1 E A 5 0.6888 0.6475 0.6888 0.7189 0.7189 0.4369 0.6888 0.6926 0.7189 0.4369 0.4369\n\n1 F A 6 0.6908 0.7008 0.6908 0.7486 0.7486 0.4389 0.6908 0.6956 0.7486 0.4389 0.4389\n\n1 G A 7 0.6928 0.7028 0.6928 0.7506 0.7506 0.4665 0.6928 0.7156 0.7506 0.4665 0.4665\n\n1 H A 8 0.7843 0.7048 0.7843 0.7526 0.7526 0.4685 0.7843 0.7675 0.7526 0.4685 0.4685\n\n1 I A 9 0.7863 0.7068 0.7863 0.7546 0.7546 0.5161 0.7863 0.7695 0.7546 0.5161 0.5161\n\n1 J A 10 0.7991 0.7088 0.7991 0.8464 0.8464 0.5181 0.7991 0.7867 0.8464 0.5181 0.5181\n\n1 K A 11 0.8272 0.7108 0.8272 0.8484 0.8484 0.6021 0.8272 0.8204 0.8484 0.6021 0.6021\n\n1 L A 12 0.8292 0.8176 0.8292 0.8671 0.8671 0.6041 0.8292 0.8442 0.8671 0.6041 0.6041\n\n1 M A 13 0.8717 0.8196 0.8717 0.8691 0.8691 0.6061 0.8717 0.8462 0.8691 0.6061 0.6061\n\n1 N A 14 0.8851 0.8348 0.8851 0.8711 0.8711 0.8334 0.8851 0.8482 0.8711 0.8334 0.8334\n\n1 O A 15 0.8871 0.8368 0.8871 0.8731 0.8731 0.8354 0.8871 0.8502 0.8731 0.8354 0.8354\n\n1 P A 16 0.8891 0.8388 0.8891 0.8751 0.8751 0.8374 0.8891 0.8845 0.8751 0.8374 0.8374\n\n1 Q A 17 0.8911 0.8408 0.8911 0.8771 0.8771 0.8394 0.8911 0.8865 0.8771 0.8394 0.8394\n\n1 R A 18 0.8931 0.8428 0.8931 0.8791 0.8791 0.8414 0.8931 0.8885 0.8791 0.8414 0.8414\n\n1 S A 19 1.0180 0.9545 1.0180 0.9299 0.9299 0.8434 1.0180 0.9199 0.9299 0.8434 0.8434\n\n1 T A 20 1.1006 0.9565 1.1006 0.9971 0.9971 0.8454 1.1006 0.9219 0.9971 0.8454 0.8454\n\n1 U A 21 1.1026 0.9585 1.1026 1.0017 1.0017 0.8642 1.1026 0.9239 1.0017 0.8642 0.8642\n\n1 V A 22 1.1046 0.9605 1.1046 1.0659 1.0659 0.9368 1.1046 0.9259 1.0659 0.9368 0.9368\n\n1 W A 23 1.1159 0.9625 1.1159 1.0679 1.0679 0.9388 1.1159 1.0703 1.0679 0.9388 0.9388\n\n1 X A 24 1.1179 1.0945 1.1179 1.0699 1.0699 0.9408 1.1179 1.0723 1.0699 0.9408 0.9408\n\n1 Y A 25 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZD A 26 1.1159 0.9625 1.1159 1.0679 1.0679 0.9388 1.1159 1.0703 1.0679 0.9388 0.9388\n\n1 ZE A 27 1.1179 1.0945 1.1179 1.0699 1.0699 0.9408 1.1179 1.0723 1.0699 0.9408 0.9408\n\n1 ZF A 28 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZG A 29 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZH A 30 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZJ A 31 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZK A 32 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZL A 33 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n2 A A 34 0.6783 0.7510 0.6783 0.6547 0.6547 0.5043 0.6783 0.7347 0.6547 0.5043 0.5043\n\n2 B A 35 0.7565 0.7530 0.7565 0.7963 0.7963 0.7751 0.7565 0.8326 0.7963 0.7751 0.7751\n\n2 C A 36 0.7815 0.7550 0.7815 0.8166 0.8166 0.7771 0.7815 0.8346 0.8166 0.7771 0.7771\n\n2 D A 37 0.8063 0.8639 0.8063 0.8711 0.8711 0.7791 0.8063 0.9208 0.8711 0.7791 0.7791\n\n2 E A 38 0.8339 0.8659 0.8339 0.8754 0.8754 0.8114 0.8339 0.9228 0.8754 0.8114 0.8114\n\n2 F A 39 0.8649 0.8679 0.8649 0.9343 0.9343 0.8134 0.8649 0.9248 0.9343 0.8134 0.8134\n\n2 G A 40 0.8669 0.8699 0.8669 0.9363 0.9363 0.8154 0.8669 0.9268 0.9363 0.8154 0.8154\n\n2 H A 41 0.9852 0.8719 0.9852 0.9505 0.9505 0.8269 0.9852 0.9288 0.9505 0.8269 0.8269\n\n2 I A 42 0.9872 0.8739 0.9872 1.0008 1.0008 0.8429 0.9872 0.9829 1.0008 0.8429 0.8429\n\n2 J A 43 0.9892 1.0389 0.9892 1.0028 1.0028 0.9423 0.9892 0.9854 1.0028 0.9423 0.9423\n\n2 K A 44 0.9912 1.0570 0.9912 1.0048 1.0048 0.9443 0.9912 0.9874 1.0048 0.9443 0.9443\n\n2 L A 45 0.9932 1.0590 0.9932 1.0068 1.0068 1.0395 0.9932 0.9894 1.0068 1.0395 1.0395\n\n2 M A 46 1.0185 1.0610 1.0185 1.0657 1.0657 1.0415 1.0185 0.9914 1.0657 1.0415 1.0415\n\n2 N A 47 1.0205 1.0630 1.0205 1.0677 1.0677 1.0435 1.0205 0.9934 1.0677 1.0435 1.0435\n\n2 O A 48 1.0275 1.0650 1.0275 1.0931 1.0931 1.0455 1.0275 1.0618 1.0931 1.0455 1.0455\n\n2 P A 49 1.1085 1.0670 1.1085 1.0951 1.0951 1.0475 1.1085 1.0681 1.0951 1.0475 1.0475\n\n2 Q A 50 1.2461 1.1469 1.2461 1.0971 1.0971 1.0495 1.2461 1.1111 1.0971 1.0495 1.0495\n\n2 R A 51 1.2481 1.1489 1.2481 1.0991 1.0991 1.0515 1.2481 1.1131 1.0991 1.0515 1.0515\n\n2 S A 52 1.2501 1.1509 1.2501 1.1923 1.1923 1.0535 1.2501 1.1151 1.1923 1.0535 1.0535\n\n2 T A 53 1.2521 1.1529 1.2521 1.2299 1.2299 1.2289 1.2521 1.1171 1.2299 1.2289 1.2289\n\n2 U A 54 1.2541 1.1549 1.2541 1.2319 1.2319 1.2309 1.2541 1.1191 1.2319 1.2309 1.2309\n\n2 V A 55 1.3190 1.1569 1.3190 1.2339 1.2339 1.3279 1.3190 1.1211 1.2339 1.3279 1.3279\n\n2 W A 56 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n2 X A 57 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n2 Y A 58 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZD A 59 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n2 ZE A 60 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n2 ZF A 61 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZG A 62 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZH A 63 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZJ A 64 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZK A 65 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZL A 66 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n3 A A 67 0.6227 0.6165 0.6227 0.6153 0.6153 0.3005 0.6227 0.6207 0.6153 0.3005 0.3005\n\n3 B A 68 0.6928 0.6185 0.6928 0.7095 0.7095 0.4921 0.6928 0.6290 0.7095 0.4921 0.4921\n\n3 C A 69 0.7615 0.6365 0.7615 0.7250 0.7250 0.4941 0.7615 0.6466 0.7250 0.4941 0.4941\n\n3 D A 70 0.7635 0.6385 0.7635 0.7270 0.7270 0.5602 0.7635 0.7012 0.7270 0.5602 0.5602\n\n3 E A 71 0.7655 0.6863 0.7655 0.7736 0.7736 0.5622 0.7655 0.7032 0.7736 0.5622 0.5622\n\n3 F A 72 0.7675 0.7108 0.7675 0.8232 0.8232 0.5642 0.7675 0.7056 0.8232 0.5642 0.5642\n\n3 G A 73 0.7923 0.7157 0.7923 0.8252 0.8252 0.5662 0.7923 0.7448 0.8252 0.5662 0.5662\n\n3 H A 74 0.7943 0.7795 0.7943 0.8691 0.8691 0.5682 0.7943 0.7848 0.8691 0.5682 0.5682\n\n3 I A 75 0.8071 0.7815 0.8071 0.8711 0.8711 0.7498 0.8071 0.7947 0.8711 0.7498 0.7498\n\n3 J A 76 0.8091 0.7835 0.8091 0.8731 0.8731 0.7518 0.8091 0.7967 0.8731 0.7518 0.7518\n\n3 K A 77 0.8372 0.8256 0.8372 0.8751 0.8751 0.7538 0.8372 0.8522 0.8751 0.7538 0.7538\n\n3 L A 78 0.8392 0.8276 0.8392 0.8771 0.8771 0.7558 0.8392 0.8542 0.8771 0.7558 0.7558\n\n3 M A 79 0.8978 0.8998 0.8978 0.9213 0.9213 0.8786 0.8978 0.8562 0.9213 0.8786 0.8786\n\n3 N A 80 0.9845 0.9018 0.9845 0.9233 0.9233 0.8806 0.9845 0.8704 0.9233 0.8806 0.8806\n\n3 O A 81 0.9865 0.9038 0.9865 0.9253 0.9253 0.8826 0.9865 0.8775 0.9253 0.8826 0.8826\n\n3 P A 82 0.9885 0.9058 0.9885 0.9273 0.9273 0.8846 0.9885 0.8945 0.9273 0.8846 0.8846\n\n3 Q A 83 0.9905 0.9078 0.9905 0.9293 0.9293 0.8866 0.9905 0.8965 0.9293 0.8866 0.8866\n\n3 R A 84 1.0174 0.9098 1.0174 0.9313 0.9313 0.8886 1.0174 0.8985 0.9313 0.8886 0.8886\n\n3 S A 85 1.0280 0.9645 1.0280 1.0469 1.0469 0.8906 1.0280 0.9299 1.0469 0.8906 0.8906\n\n3 T A 86 1.1106 0.9665 1.1106 1.0489 1.0489 0.8926 1.1106 0.9319 1.0489 0.8926 0.8926\n\n3 U A 87 1.1126 0.9685 1.1126 1.0509 1.0509 1.0517 1.1126 0.9339 1.0509 1.0517 1.0517\n\n3 V A 88 1.1146 1.0264 1.1146 1.0759 1.0759 1.1055 1.1146 1.0070 1.0759 1.1055 1.1055\n\n3 W A 89 1.1259 1.0856 1.1259 1.0779 1.0779 1.1075 1.1259 1.0803 1.0779 1.1075 1.1075\n\n3 X A 90 1.1279 1.1045 1.1279 1.0799 1.0799 1.2316 1.1279 1.0823 1.0799 1.2316 1.2316\n\n3 Y A 91 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZD A 92 1.1259 1.0856 1.1259 1.0779 1.0779 1.1075 1.1259 1.0803 1.0779 1.1075 1.1075\n\n3 ZE A 93 1.1279 1.1045 1.1279 1.0799 1.0799 1.2316 1.1279 1.0823 1.0799 1.2316 1.2316\n\n3 ZF A 94 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZG A 95 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZH A 96 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZJ A 97 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZK A 98 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZL A 99 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n4 A A 100 0.6783 0.7510 0.6783 0.6547 0.6547 0.5043 0.6783 0.7347 0.6547 0.5043 0.5043\n\n4 B A 101 0.7565 0.7530 0.7565 0.7963 0.7963 0.7751 0.7565 0.8326 0.7963 0.7751 0.7751\n\n4 C A 102 0.7815 0.7550 0.7815 0.8166 0.8166 0.7771 0.7815 0.8346 0.8166 0.7771 0.7771\n\n4 D A 103 0.8063 0.8639 0.8063 0.8711 0.8711 0.7791 0.8063 0.9208 0.8711 0.7791 0.7791\n\n4 E A 104 0.8339 0.8659 0.8339 0.8754 0.8754 0.8114 0.8339 0.9228 0.8754 0.8114 0.8114\n\n4 F A 105 0.8649 0.8679 0.8649 0.9343 0.9343 0.8134 0.8649 0.9248 0.9343 0.8134 0.8134\n\n4 G A 106 0.8669 0.8699 0.8669 0.9363 0.9363 0.8154 0.8669 0.9268 0.9363 0.8154 0.8154\n\n4 H A 107 0.9852 0.8719 0.9852 0.9505 0.9505 0.8269 0.9852 0.9288 0.9505 0.8269 0.8269\n\n4 I A 108 0.9872 0.8739 0.9872 1.0008 1.0008 0.8429 0.9872 0.9829 1.0008 0.8429 0.8429\n\n4 J A 109 0.9892 1.0389 0.9892 1.0028 1.0028 0.9423 0.9892 0.9854 1.0028 0.9423 0.9423\n\n4 K A 110 0.9912 1.0570 0.9912 1.0048 1.0048 0.9443 0.9912 0.9874 1.0048 0.9443 0.9443\n\n4 L A 111 0.9932 1.0590 0.9932 1.0068 1.0068 1.0395 0.9932 0.9894 1.0068 1.0395 1.0395\n\n4 M A 112 1.0185 1.0610 1.0185 1.0657 1.0657 1.0415 1.0185 0.9914 1.0657 1.0415 1.0415\n\n4 N A 113 1.0205 1.0630 1.0205 1.0677 1.0677 1.0435 1.0205 0.9934 1.0677 1.0435 1.0435\n\n4 O A 114 1.0275 1.0650 1.0275 1.0931 1.0931 1.0455 1.0275 1.0618 1.0931 1.0455 1.0455\n\n4 P A 115 1.1085 1.0670 1.1085 1.0951 1.0951 1.0475 1.1085 1.0681 1.0951 1.0475 1.0475\n\n4 Q A 116 1.2461 1.1469 1.2461 1.0971 1.0971 1.0495 1.2461 1.1111 1.0971 1.0495 1.0495\n\n4 R A 117 1.2481 1.1489 1.2481 1.0991 1.0991 1.0515 1.2481 1.1131 1.0991 1.0515 1.0515\n\n4 S A 118 1.2501 1.1509 1.2501 1.1923 1.1923 1.0535 1.2501 1.1151 1.1923 1.0535 1.0535\n\n4 T A 119 1.2521 1.1529 1.2521 1.2299 1.2299 1.2289 1.2521 1.1171 1.2299 1.2289 1.2289\n\n4 U A 120 1.2541 1.1549 1.2541 1.2319 1.2319 1.2309 1.2541 1.1191 1.2319 1.2309 1.2309\n\n4 V A 121 1.3190 1.1569 1.3190 1.2339 1.2339 1.3279 1.3190 1.1211 1.2339 1.3279 1.3279\n\n4 W A 122 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n4 X A 123 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n4 Y A 124 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZD A 125 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n4 ZE A 126 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n4 ZF A 127 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZG A 128 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZH A 129 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZJ A 130 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZK A 131 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZL A 132 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n5 A A 133 0.6327 0.6841 0.6327 0.6447 0.6447 0.4777 0.6327 0.6307 0.6447 0.4777 0.4777\n\n5 B A 134 0.7028 0.7275 0.7028 0.7195 0.7195 0.5021 0.7028 0.6734 0.7195 0.5021 0.5021\n\n5 C A 135 0.7715 0.7295 0.7715 0.7451 0.7451 0.6684 0.7715 0.7092 0.7451 0.6684 0.6684\n\n5 D A 136 0.7963 0.7315 0.7963 0.7471 0.7471 0.7373 0.7963 0.7112 0.7471 0.7373 0.7373\n\n5 E A 137 0.7983 0.7623 0.7983 0.8654 0.8654 0.7393 0.7983 0.7481 0.8654 0.7393 0.7393\n\n5 F A 138 0.8003 0.7643 0.8003 0.8727 0.8727 0.7413 0.8003 0.7501 0.8727 0.7413 0.7413\n\n5 G A 139 0.8023 0.7663 0.8023 0.8891 0.8891 0.7433 0.8023 0.7811 0.8891 0.7433 0.7433\n\n5 H A 140 0.8043 0.7895 0.8043 0.8911 0.8911 0.8041 0.8043 0.8027 0.8911 0.8041 0.8041\n\n5 I A 141 0.8171 0.8187 0.8171 0.8931 0.8931 0.8061 0.8171 0.8047 0.8931 0.8061 0.8061\n\n5 J A 142 0.8191 0.8996 0.8191 0.9593 0.9593 0.9219 0.8191 0.8775 0.9593 0.9219 0.9219\n\n5 K A 143 0.8472 0.9409 0.8472 0.9613 0.9613 0.9239 0.8472 0.8795 0.9613 0.9239 0.9239\n\n5 L A 144 0.8492 0.9429 0.8492 0.9633 0.9633 0.9259 0.8492 0.8815 0.9633 0.9259 0.9259\n\n5 M A 145 1.0085 0.9449 1.0085 0.9708 0.9708 0.9279 1.0085 0.8835 0.9708 0.9279 0.9279\n\n5 N A 146 1.0105 0.9469 1.0105 0.9728 0.9728 0.9299 1.0105 0.8855 0.9728 0.9299 0.9299\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**UW Rate Matrix Tier**\n\n**UW Tier Group Credit Tier NAF/OCG TIER UW Rate Matrix Tier ALL BI CEQ COL EXTR MP OTC PD RA UIM UMBI**\n\n1 A A 1 0.5348 0.5540 0.5348 0.5494 0.5494 0.2905 0.5348 0.5480 0.5494 0.2905 0.2905\n\n1 B A 2 0.6828 0.6085 0.6828 0.6262 0.6262 0.3460 0.6828 0.6190 0.6262 0.3460 0.3460\n\n1 C A 3 0.6848 0.6265 0.6848 0.6282 0.6282 0.3998 0.6848 0.6366 0.6282 0.3998 0.3998\n\n1 D A 4 0.6868 0.6285 0.6868 0.6604 0.6604 0.4018 0.6868 0.6386 0.6604 0.4018 0.4018\n\n1 E A 5 0.6888 0.6475 0.6888 0.7189 0.7189 0.4369 0.6888 0.6926 0.7189 0.4369 0.4369\n\n1 F A 6 0.6908 0.7008 0.6908 0.7486 0.7486 0.4389 0.6908 0.6956 0.7486 0.4389 0.4389\n\n1 G A 7 0.6928 0.7028 0.6928 0.7506 0.7506 0.4665 0.6928 0.7156 0.7506 0.4665 0.4665\n\n1 H A 8 0.7843 0.7048 0.7843 0.7526 0.7526 0.4685 0.7843 0.7675 0.7526 0.4685 0.4685\n\n1 I A 9 0.7863 0.7068 0.7863 0.7546 0.7546 0.5161 0.7863 0.7695 0.7546 0.5161 0.5161\n\n1 J A 10 0.7991 0.7088 0.7991 0.8464 0.8464 0.5181 0.7991 0.7867 0.8464 0.5181 0.5181\n\n1 K A 11 0.8272 0.7108 0.8272 0.8484 0.8484 0.6021 0.8272 0.8204 0.8484 0.6021 0.6021\n\n1 L A 12 0.8292 0.8176 0.8292 0.8671 0.8671 0.6041 0.8292 0.8442 0.8671 0.6041 0.6041\n\n1 M A 13 0.8717 0.8196 0.8717 0.8691 0.8691 0.6061 0.8717 0.8462 0.8691 0.6061 0.6061\n\n1 N A 14 0.8851 0.8348 0.8851 0.8711 0.8711 0.8334 0.8851 0.8482 0.8711 0.8334 0.8334\n\n1 O A 15 0.8871 0.8368 0.8871 0.8731 0.8731 0.8354 0.8871 0.8502 0.8731 0.8354 0.8354\n\n1 P A 16 0.8891 0.8388 0.8891 0.8751 0.8751 0.8374 0.8891 0.8845 0.8751 0.8374 0.8374\n\n1 Q A 17 0.8911 0.8408 0.8911 0.8771 0.8771 0.8394 0.8911 0.8865 0.8771 0.8394 0.8394\n\n1 R A 18 0.8931 0.8428 0.8931 0.8791 0.8791 0.8414 0.8931 0.8885 0.8791 0.8414 0.8414\n\n1 S A 19 1.0180 0.9545 1.0180 0.9299 0.9299 0.8434 1.0180 0.9199 0.9299 0.8434 0.8434\n\n1 T A 20 1.1006 0.9565 1.1006 0.9971 0.9971 0.8454 1.1006 0.9219 0.9971 0.8454 0.8454\n\n1 U A 21 1.1026 0.9585 1.1026 1.0017 1.0017 0.8642 1.1026 0.9239 1.0017 0.8642 0.8642\n\n1 V A 22 1.1046 0.9605 1.1046 1.0659 1.0659 0.9368 1.1046 0.9259 1.0659 0.9368 0.9368\n\n1 W A 23 1.1159 0.9625 1.1159 1.0679 1.0679 0.9388 1.1159 1.0703 1.0679 0.9388 0.9388\n\n1 X A 24 1.1179 1.0945 1.1179 1.0699 1.0699 0.9408 1.1179 1.0723 1.0699 0.9408 0.9408\n\n1 Y A 25 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZD A 26 1.1159 0.9625 1.1159 1.0679 1.0679 0.9388 1.1159 1.0703 1.0679 0.9388 0.9388\n\n1 ZE A 27 1.1179 1.0945 1.1179 1.0699 1.0699 0.9408 1.1179 1.0723 1.0699 0.9408 0.9408\n\n1 ZF A 28 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZG A 29 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZH A 30 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZJ A 31 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZK A 32 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZL A 33 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n2 A A 34 0.6783 0.7510 0.6783 0.6547 0.6547 0.5043 0.6783 0.7347 0.6547 0.5043 0.5043\n\n2 B A 35 0.7565 0.7530 0.7565 0.7963 0.7963 0.7751 0.7565 0.8326 0.7963 0.7751 0.7751\n\n2 C A 36 0.7815 0.7550 0.7815 0.8166 0.8166 0.7771 0.7815 0.8346 0.8166 0.7771 0.7771\n\n2 D A 37 0.8063 0.8639 0.8063 0.8711 0.8711 0.7791 0.8063 0.9208 0.8711 0.7791 0.7791\n\n2 E A 38 0.8339 0.8659 0.8339 0.8754 0.8754 0.8114 0.8339 0.9228 0.8754 0.8114 0.8114\n\n2 F A 39 0.8649 0.8679 0.8649 0.9343 0.9343 0.8134 0.8649 0.9248 0.9343 0.8134 0.8134\n\n2 G A 40 0.8669 0.8699 0.8669 0.9363 0.9363 0.8154 0.8669 0.9268 0.9363 0.8154 0.8154\n\n2 H A 41 0.9852 0.8719 0.9852 0.9505 0.9505 0.8269 0.9852 0.9288 0.9505 0.8269 0.8269\n\n2 I A 42 0.9872 0.8739 0.9872 1.0008 1.0008 0.8429 0.9872 0.9829 1.0008 0.8429 0.8429\n\n2 J A 43 0.9892 1.0389 0.9892 1.0028 1.0028 0.9423 0.9892 0.9854 1.0028 0.9423 0.9423\n\n2 K A 44 0.9912 1.0570 0.9912 1.0048 1.0048 0.9443 0.9912 0.9874 1.0048 0.9443 0.9443\n\n2 L A 45 0.9932 1.0590 0.9932 1.0068 1.0068 1.0395 0.9932 0.9894 1.0068 1.0395 1.0395\n\n2 M A 46 1.0185 1.0610 1.0185 1.0657 1.0657 1.0415 1.0185 0.9914 1.0657 1.0415 1.0415\n\n2 N A 47 1.0205 1.0630 1.0205 1.0677 1.0677 1.0435 1.0205 0.9934 1.0677 1.0435 1.0435\n\n2 O A 48 1.0275 1.0650 1.0275 1.0931 1.0931 1.0455 1.0275 1.0618 1.0931 1.0455 1.0455\n\n2 P A 49 1.1085 1.0670 1.1085 1.0951 1.0951 1.0475 1.1085 1.0681 1.0951 1.0475 1.0475\n\n2 Q A 50 1.2461 1.1469 1.2461 1.0971 1.0971 1.0495 1.2461 1.1111 1.0971 1.0495 1.0495\n\n2 R A 51 1.2481 1.1489 1.2481 1.0991 1.0991 1.0515 1.2481 1.1131 1.0991 1.0515 1.0515\n\n2 S A 52 1.2501 1.1509 1.2501 1.1923 1.1923 1.0535 1.2501 1.1151 1.1923 1.0535 1.0535\n\n2 T A 53 1.2521 1.1529 1.2521 1.2299 1.2299 1.2289 1.2521 1.1171 1.2299 1.2289 1.2289\n\n2 U A 54 1.2541 1.1549 1.2541 1.2319 1.2319 1.2309 1.2541 1.1191 1.2319 1.2309 1.2309\n\n2 V A 55 1.3190 1.1569 1.3190 1.2339 1.2339 1.3279 1.3190 1.1211 1.2339 1.3279 1.3279\n\n2 W A 56 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n2 X A 57 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n2 Y A 58 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZD A 59 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n2 ZE A 60 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n2 ZF A 61 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZG A 62 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZH A 63 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZJ A 64 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZK A 65 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZL A 66 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n3 A A 67 0.6227 0.6165 0.6227 0.6153 0.6153 0.3005 0.6227 0.6207 0.6153 0.3005 0.3005\n\n3 B A 68 0.6928 0.6185 0.6928 0.7095 0.7095 0.4921 0.6928 0.6290 0.7095 0.4921 0.4921\n\n3 C A 69 0.7615 0.6365 0.7615 0.7250 0.7250 0.4941 0.7615 0.6466 0.7250 0.4941 0.4941\n\n3 D A 70 0.7635 0.6385 0.7635 0.7270 0.7270 0.5602 0.7635 0.7012 0.7270 0.5602 0.5602\n\n3 E A 71 0.7655 0.6863 0.7655 0.7736 0.7736 0.5622 0.7655 0.7032 0.7736 0.5622 0.5622\n\n3 F A 72 0.7675 0.7108 0.7675 0.8232 0.8232 0.5642 0.7675 0.7056 0.8232 0.5642 0.5642\n\n3 G A 73 0.7923 0.7157 0.7923 0.8252 0.8252 0.5662 0.7923 0.7448 0.8252 0.5662 0.5662\n\n3 H A 74 0.7943 0.7795 0.7943 0.8691 0.8691 0.5682 0.7943 0.7848 0.8691 0.5682 0.5682\n\n3 I A 75 0.8071 0.7815 0.8071 0.8711 0.8711 0.7498 0.8071 0.7947 0.8711 0.7498 0.7498\n\n3 J A 76 0.8091 0.7835 0.8091 0.8731 0.8731 0.7518 0.8091 0.7967 0.8731 0.7518 0.7518\n\n3 K A 77 0.8372 0.8256 0.8372 0.8751 0.8751 0.7538 0.8372 0.8522 0.8751 0.7538 0.7538\n\n3 L A 78 0.8392 0.8276 0.8392 0.8771 0.8771 0.7558 0.8392 0.8542 0.8771 0.7558 0.7558\n\n3 M A 79 0.8978 0.8998 0.8978 0.9213 0.9213 0.8786 0.8978 0.8562 0.9213 0.8786 0.8786\n\n3 N A 80 0.9845 0.9018 0.9845 0.9233 0.9233 0.8806 0.9845 0.8704 0.9233 0.8806 0.8806\n\n3 O A 81 0.9865 0.9038 0.9865 0.9253 0.9253 0.8826 0.9865 0.8775 0.9253 0.8826 0.8826\n\n3 P A 82 0.9885 0.9058 0.9885 0.9273 0.9273 0.8846 0.9885 0.8945 0.9273 0.8846 0.8846\n\n3 Q A 83 0.9905 0.9078 0.9905 0.9293 0.9293 0.8866 0.9905 0.8965 0.9293 0.8866 0.8866\n\n3 R A 84 1.0174 0.9098 1.0174 0.9313 0.9313 0.8886 1.0174 0.8985 0.9313 0.8886 0.8886\n\n3 S A 85 1.0280 0.9645 1.0280 1.0469 1.0469 0.8906 1.0280 0.9299 1.0469 0.8906 0.8906\n\n3 T A 86 1.1106 0.9665 1.1106 1.0489 1.0489 0.8926 1.1106 0.9319 1.0489 0.8926 0.8926\n\n3 U A 87 1.1126 0.9685 1.1126 1.0509 1.0509 1.0517 1.1126 0.9339 1.0509 1.0517 1.0517\n\n3 V A 88 1.1146 1.0264 1.1146 1.0759 1.0759 1.1055 1.1146 1.0070 1.0759 1.1055 1.1055\n\n3 W A 89 1.1259 1.0856 1.1259 1.0779 1.0779 1.1075 1.1259 1.0803 1.0779 1.1075 1.1075\n\n3 X A 90 1.1279 1.1045 1.1279 1.0799 1.0799 1.2316 1.1279 1.0823 1.0799 1.2316 1.2316\n\n3 Y A 91 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZD A 92 1.1259 1.0856 1.1259 1.0779 1.0779 1.1075 1.1259 1.0803 1.0779 1.1075 1.1075\n\n3 ZE A 93 1.1279 1.1045 1.1279 1.0799 1.0799 1.2316 1.1279 1.0823 1.0799 1.2316 1.2316\n\n3 ZF A 94 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZG A 95 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZH A 96 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZJ A 97 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZK A 98 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZL A 99 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n4 A A 100 0.6783 0.7510 0.6783 0.6547 0.6547 0.5043 0.6783 0.7347 0.6547 0.5043 0.5043\n\n4 B A 101 0.7565 0.7530 0.7565 0.7963 0.7963 0.7751 0.7565 0.8326 0.7963 0.7751 0.7751\n\n4 C A 102 0.7815 0.7550 0.7815 0.8166 0.8166 0.7771 0.7815 0.8346 0.8166 0.7771 0.7771\n\n4 D A 103 0.8063 0.8639 0.8063 0.8711 0.8711 0.7791 0.8063 0.9208 0.8711 0.7791 0.7791\n\n4 E A 104 0.8339 0.8659 0.8339 0.8754 0.8754 0.8114 0.8339 0.9228 0.8754 0.8114 0.8114\n\n4 F A 105 0.8649 0.8679 0.8649 0.9343 0.9343 0.8134 0.8649 0.9248 0.9343 0.8134 0.8134\n\n4 G A 106 0.8669 0.8699 0.8669 0.9363 0.9363 0.8154 0.8669 0.9268 0.9363 0.8154 0.8154\n\n4 H A 107 0.9852 0.8719 0.9852 0.9505 0.9505 0.8269 0.9852 0.9288 0.9505 0.8269 0.8269\n\n4 I A 108 0.9872 0.8739 0.9872 1.0008 1.0008 0.8429 0.9872 0.9829 1.0008 0.8429 0.8429\n\n4 J A 109 0.9892 1.0389 0.9892 1.0028 1.0028 0.9423 0.9892 0.9854 1.0028 0.9423 0.9423\n\n4 K A 110 0.9912 1.0570 0.9912 1.0048 1.0048 0.9443 0.9912 0.9874 1.0048 0.9443 0.9443\n\n4 L A 111 0.9932 1.0590 0.9932 1.0068 1.0068 1.0395 0.9932 0.9894 1.0068 1.0395 1.0395\n\n4 M A 112 1.0185 1.0610 1.0185 1.0657 1.0657 1.0415 1.0185 0.9914 1.0657 1.0415 1.0415\n\n4 N A 113 1.0205 1.0630 1.0205 1.0677 1.0677 1.0435 1.0205 0.9934 1.0677 1.0435 1.0435\n\n4 O A 114 1.0275 1.0650 1.0275 1.0931 1.0931 1.0455 1.0275 1.0618 1.0931 1.0455 1.0455\n\n4 P A 115 1.1085 1.0670 1.1085 1.0951 1.0951 1.0475 1.1085 1.0681 1.0951 1.0475 1.0475\n\n4 Q A 116 1.2461 1.1469 1.2461 1.0971 1.0971 1.0495 1.2461 1.1111 1.0971 1.0495 1.0495\n\n4 R A 117 1.2481 1.1489 1.2481 1.0991 1.0991 1.0515 1.2481 1.1131 1.0991 1.0515 1.0515\n\n4 S A 118 1.2501 1.1509 1.2501 1.1923 1.1923 1.0535 1.2501 1.1151 1.1923 1.0535 1.0535\n\n4 T A 119 1.2521 1.1529 1.2521 1.2299 1.2299 1.2289 1.2521 1.1171 1.2299 1.2289 1.2289\n\n4 U A 120 1.2541 1.1549 1.2541 1.2319 1.2319 1.2309 1.2541 1.1191 1.2319 1.2309 1.2309\n\n4 V A 121 1.3190 1.1569 1.3190 1.2339 1.2339 1.3279 1.3190 1.1211 1.2339 1.3279 1.3279\n\n4 W A 122 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n4 X A 123 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n4 Y A 124 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZD A 125 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n4 ZE A 126 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n4 ZF A 127 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZG A 128 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZH A 129 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZJ A 130 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZK A 131 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZL A 132 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n5 A A 133 0.6327 0.6841 0.6327 0.6447 0.6447 0.4777 0.6327 0.6307 0.6447 0.4777 0.4777\n\n5 B A 134 0.7028 0.7275 0.7028 0.7195 0.7195 0.5021 0.7028 0.6734 0.7195 0.5021 0.5021\n\n5 C A 135 0.7715 0.7295 0.7715 0.7451 0.7451 0.6684 0.7715 0.7092 0.7451 0.6684 0.6684\n\n5 D A 136 0.7963 0.7315 0.7963 0.7471 0.7471 0.7373 0.7963 0.7112 0.7471 0.7373 0.7373\n\n5 E A 137 0.7983 0.7623 0.7983 0.8654 0.8654 0.7393 0.7983 0.7481 0.8654 0.7393 0.7393\n\n5 F A 138 0.8003 0.7643 0.8003 0.8727 0.8727 0.7413 0.8003 0.7501 0.8727 0.7413 0.7413\n\n5 G A 139 0.8023 0.7663 0.8023 0.8891 0.8891 0.7433 0.8023 0.7811 0.8891 0.7433 0.7433\n\n5 H A 140 0.8043 0.7895 0.8043 0.8911 0.8911 0.8041 0.8043 0.8027 0.8911 0.8041 0.8041\n\n5 I A 141 0.8171 0.8187 0.8171 0.8931 0.8931 0.8061 0.8171 0.8047 0.8931 0.8061 0.8061\n\n5 J A 142 0.8191 0.8996 0.8191 0.9593 0.9593 0.9219 0.8191 0.8775 0.9593 0.9219 0.9219\n\n5 K A 143 0.8472 0.9409 0.8472 0.9613 0.9613 0.9239 0.8472 0.8795 0.9613 0.9239 0.9239\n\n5 L A 144 0.8492 0.9429 0.8492 0.9633 0.9633 0.9259 0.8492 0.8815 0.9633 0.9259 0.9259\n\n5 M A 145 1.0085 0.9449 1.0085 0.9708 0.9708 0.9279 1.0085 0.8835 0.9708 0.9279 0.9279\n\n5 N A 146 1.0105 0.9469 1.0105 0.9728 0.9728 0.9299 1.0105 0.8855 0.9728 0.9299 0.9299\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page841.pdf"]},"response":{"errors":[],"extract_id":"extract_a15d6b2a650b5fffb81faedb83f21f73","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**UW Rate Matrix Tier**\n\n**UW Tier Group Credit Tier NAF/OCG TIER UW Rate Matrix Tier ALL BI CEQ COL EXTR MP OTC PD RA UIM UMBI**\n\n1 A A 1 0.5348 0.5540 0.5348 0.5494 0.5494 0.2905 0.5348 0.5480 0.5494 0.2905 0.2905\n\n1 B A 2 0.6828 0.6085 0.6828 0.6262 0.6262 0.3460 0.6828 0.6190 0.6262 0.3460 0.3460\n\n1 C A 3 0.6848 0.6265 0.6848 0.6282 0.6282 0.3998 0.6848 0.6366 0.6282 0.3998 0.3998\n\n1 D A 4 0.6868 0.6285 0.6868 0.6604 0.6604 0.4018 0.6868 0.6386 0.6604 0.4018 0.4018\n\n1 E A 5 0.6888 0.6475 0.6888 0.7189 0.7189 0.4369 0.6888 0.6926 0.7189 0.4369 0.4369\n\n1 F A 6 0.6908 0.7008 0.6908 0.7486 0.7486 0.4389 0.6908 0.6956 0.7486 0.4389 0.4389\n\n1 G A 7 0.6928 0.7028 0.6928 0.7506 0.7506 0.4665 0.6928 0.7156 0.7506 0.4665 0.4665\n\n1 H A 8 0.7843 0.7048 0.7843 0.7526 0.7526 0.4685 0.7843 0.7675 0.7526 0.4685 0.4685\n\n1 I A 9 0.7863 0.7068 0.7863 0.7546 0.7546 0.5161 0.7863 0.7695 0.7546 0.5161 0.5161\n\n1 J A 10 0.7991 0.7088 0.7991 0.8464 0.8464 0.5181 0.7991 0.7867 0.8464 0.5181 0.5181\n\n1 K A 11 0.8272 0.7108 0.8272 0.8484 0.8484 0.6021 0.8272 0.8204 0.8484 0.6021 0.6021\n\n1 L A 12 0.8292 0.8176 0.8292 0.8671 0.8671 0.6041 0.8292 0.8442 0.8671 0.6041 0.6041\n\n1 M A 13 0.8717 0.8196 0.8717 0.8691 0.8691 0.6061 0.8717 0.8462 0.8691 0.6061 0.6061\n\n1 N A 14 0.8851 0.8348 0.8851 0.8711 0.8711 0.8334 0.8851 0.8482 0.8711 0.8334 0.8334\n\n1 O A 15 0.8871 0.8368 0.8871 0.8731 0.8731 0.8354 0.8871 0.8502 0.8731 0.8354 0.8354\n\n1 P A 16 0.8891 0.8388 0.8891 0.8751 0.8751 0.8374 0.8891 0.8845 0.8751 0.8374 0.8374\n\n1 Q A 17 0.8911 0.8408 0.8911 0.8771 0.8771 0.8394 0.8911 0.8865 0.8771 0.8394 0.8394\n\n1 R A 18 0.8931 0.8428 0.8931 0.8791 0.8791 0.8414 0.8931 0.8885 0.8791 0.8414 0.8414\n\n1 S A 19 1.0180 0.9545 1.0180 0.9299 0.9299 0.8434 1.0180 0.9199 0.9299 0.8434 0.8434\n\n1 T A 20 1.1006 0.9565 1.1006 0.9971 0.9971 0.8454 1.1006 0.9219 0.9971 0.8454 0.8454\n\n1 U A 21 1.1026 0.9585 1.1026 1.0017 1.0017 0.8642 1.1026 0.9239 1.0017 0.8642 0.8642\n\n1 V A 22 1.1046 0.9605 1.1046 1.0659 1.0659 0.9368 1.1046 0.9259 1.0659 0.9368 0.9368\n\n1 W A 23 1.1159 0.9625 1.1159 1.0679 1.0679 0.9388 1.1159 1.0703 1.0679 0.9388 0.9388\n\n1 X A 24 1.1179 1.0945 1.1179 1.0699 1.0699 0.9408 1.1179 1.0723 1.0699 0.9408 0.9408\n\n1 Y A 25 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZD A 26 1.1159 0.9625 1.1159 1.0679 1.0679 0.9388 1.1159 1.0703 1.0679 0.9388 0.9388\n\n1 ZE A 27 1.1179 1.0945 1.1179 1.0699 1.0699 0.9408 1.1179 1.0723 1.0699 0.9408 0.9408\n\n1 ZF A 28 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZG A 29 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZH A 30 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZJ A 31 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZK A 32 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZL A 33 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n2 A A 34 0.6783 0.7510 0.6783 0.6547 0.6547 0.5043 0.6783 0.7347 0.6547 0.5043 0.5043\n\n2 B A 35 0.7565 0.7530 0.7565 0.7963 0.7963 0.7751 0.7565 0.8326 0.7963 0.7751 0.7751\n\n2 C A 36 0.7815 0.7550 0.7815 0.8166 0.8166 0.7771 0.7815 0.8346 0.8166 0.7771 0.7771\n\n2 D A 37 0.8063 0.8639 0.8063 0.8711 0.8711 0.7791 0.8063 0.9208 0.8711 0.7791 0.7791\n\n2 E A 38 0.8339 0.8659 0.8339 0.8754 0.8754 0.8114 0.8339 0.9228 0.8754 0.8114 0.8114\n\n2 F A 39 0.8649 0.8679 0.8649 0.9343 0.9343 0.8134 0.8649 0.9248 0.9343 0.8134 0.8134\n\n2 G A 40 0.8669 0.8699 0.8669 0.9363 0.9363 0.8154 0.8669 0.9268 0.9363 0.8154 0.8154\n\n2 H A 41 0.9852 0.8719 0.9852 0.9505 0.9505 0.8269 0.9852 0.9288 0.9505 0.8269 0.8269\n\n2 I A 42 0.9872 0.8739 0.9872 1.0008 1.0008 0.8429 0.9872 0.9829 1.0008 0.8429 0.8429\n\n2 J A 43 0.9892 1.0389 0.9892 1.0028 1.0028 0.9423 0.9892 0.9854 1.0028 0.9423 0.9423\n\n2 K A 44 0.9912 1.0570 0.9912 1.0048 1.0048 0.9443 0.9912 0.9874 1.0048 0.9443 0.9443\n\n2 L A 45 0.9932 1.0590 0.9932 1.0068 1.0068 1.0395 0.9932 0.9894 1.0068 1.0395 1.0395\n\n2 M A 46 1.0185 1.0610 1.0185 1.0657 1.0657 1.0415 1.0185 0.9914 1.0657 1.0415 1.0415\n\n2 N A 47 1.0205 1.0630 1.0205 1.0677 1.0677 1.0435 1.0205 0.9934 1.0677 1.0435 1.0435\n\n2 O A 48 1.0275 1.0650 1.0275 1.0931 1.0931 1.0455 1.0275 1.0618 1.0931 1.0455 1.0455\n\n2 P A 49 1.1085 1.0670 1.1085 1.0951 1.0951 1.0475 1.1085 1.0681 1.0951 1.0475 1.0475\n\n2 Q A 50 1.2461 1.1469 1.2461 1.0971 1.0971 1.0495 1.2461 1.1111 1.0971 1.0495 1.0495\n\n2 R A 51 1.2481 1.1489 1.2481 1.0991 1.0991 1.0515 1.2481 1.1131 1.0991 1.0515 1.0515\n\n2 S A 52 1.2501 1.1509 1.2501 1.1923 1.1923 1.0535 1.2501 1.1151 1.1923 1.0535 1.0535\n\n2 T A 53 1.2521 1.1529 1.2521 1.2299 1.2299 1.2289 1.2521 1.1171 1.2299 1.2289 1.2289\n\n2 U A 54 1.2541 1.1549 1.2541 1.2319 1.2319 1.2309 1.2541 1.1191 1.2319 1.2309 1.2309\n\n2 V A 55 1.3190 1.1569 1.3190 1.2339 1.2339 1.3279 1.3190 1.1211 1.2339 1.3279 1.3279\n\n2 W A 56 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n2 X A 57 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n2 Y A 58 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZD A 59 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n2 ZE A 60 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n2 ZF A 61 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZG A 62 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZH A 63 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZJ A 64 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZK A 65 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZL A 66 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n3 A A 67 0.6227 0.6165 0.6227 0.6153 0.6153 0.3005 0.6227 0.6207 0.6153 0.3005 0.3005\n\n3 B A 68 0.6928 0.6185 0.6928 0.7095 0.7095 0.4921 0.6928 0.6290 0.7095 0.4921 0.4921\n\n3 C A 69 0.7615 0.6365 0.7615 0.7250 0.7250 0.4941 0.7615 0.6466 0.7250 0.4941 0.4941\n\n3 D A 70 0.7635 0.6385 0.7635 0.7270 0.7270 0.5602 0.7635 0.7012 0.7270 0.5602 0.5602\n\n3 E A 71 0.7655 0.6863 0.7655 0.7736 0.7736 0.5622 0.7655 0.7032 0.7736 0.5622 0.5622\n\n3 F A 72 0.7675 0.7108 0.7675 0.8232 0.8232 0.5642 0.7675 0.7056 0.8232 0.5642 0.5642\n\n3 G A 73 0.7923 0.7157 0.7923 0.8252 0.8252 0.5662 0.7923 0.7448 0.8252 0.5662 0.5662\n\n3 H A 74 0.7943 0.7795 0.7943 0.8691 0.8691 0.5682 0.7943 0.7848 0.8691 0.5682 0.5682\n\n3 I A 75 0.8071 0.7815 0.8071 0.8711 0.8711 0.7498 0.8071 0.7947 0.8711 0.7498 0.7498\n\n3 J A 76 0.8091 0.7835 0.8091 0.8731 0.8731 0.7518 0.8091 0.7967 0.8731 0.7518 0.7518\n\n3 K A 77 0.8372 0.8256 0.8372 0.8751 0.8751 0.7538 0.8372 0.8522 0.8751 0.7538 0.7538\n\n3 L A 78 0.8392 0.8276 0.8392 0.8771 0.8771 0.7558 0.8392 0.8542 0.8771 0.7558 0.7558\n\n3 M A 79 0.8978 0.8998 0.8978 0.9213 0.9213 0.8786 0.8978 0.8562 0.9213 0.8786 0.8786\n\n3 N A 80 0.9845 0.9018 0.9845 0.9233 0.9233 0.8806 0.9845 0.8704 0.9233 0.8806 0.8806\n\n3 O A 81 0.9865 0.9038 0.9865 0.9253 0.9253 0.8826 0.9865 0.8775 0.9253 0.8826 0.8826\n\n3 P A 82 0.9885 0.9058 0.9885 0.9273 0.9273 0.8846 0.9885 0.8945 0.9273 0.8846 0.8846\n\n3 Q A 83 0.9905 0.9078 0.9905 0.9293 0.9293 0.8866 0.9905 0.8965 0.9293 0.8866 0.8866\n\n3 R A 84 1.0174 0.9098 1.0174 0.9313 0.9313 0.8886 1.0174 0.8985 0.9313 0.8886 0.8886\n\n3 S A 85 1.0280 0.9645 1.0280 1.0469 1.0469 0.8906 1.0280 0.9299 1.0469 0.8906 0.8906\n\n3 T A 86 1.1106 0.9665 1.1106 1.0489 1.0489 0.8926 1.1106 0.9319 1.0489 0.8926 0.8926\n\n3 U A 87 1.1126 0.9685 1.1126 1.0509 1.0509 1.0517 1.1126 0.9339 1.0509 1.0517 1.0517\n\n3 V A 88 1.1146 1.0264 1.1146 1.0759 1.0759 1.1055 1.1146 1.0070 1.0759 1.1055 1.1055\n\n3 W A 89 1.1259 1.0856 1.1259 1.0779 1.0779 1.1075 1.1259 1.0803 1.0779 1.1075 1.1075\n\n3 X A 90 1.1279 1.1045 1.1279 1.0799 1.0799 1.2316 1.1279 1.0823 1.0799 1.2316 1.2316\n\n3 Y A 91 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZD A 92 1.1259 1.0856 1.1259 1.0779 1.0779 1.1075 1.1259 1.0803 1.0779 1.1075 1.1075\n\n3 ZE A 93 1.1279 1.1045 1.1279 1.0799 1.0799 1.2316 1.1279 1.0823 1.0799 1.2316 1.2316\n\n3 ZF A 94 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZG A 95 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZH A 96 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZJ A 97 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZK A 98 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZL A 99 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n4 A A 100 0.6783 0.7510 0.6783 0.6547 0.6547 0.5043 0.6783 0.7347 0.6547 0.5043 0.5043\n\n4 B A 101 0.7565 0.7530 0.7565 0.7963 0.7963 0.7751 0.7565 0.8326 0.7963 0.7751 0.7751\n\n4 C A 102 0.7815 0.7550 0.7815 0.8166 0.8166 0.7771 0.7815 0.8346 0.8166 0.7771 0.7771\n\n4 D A 103 0.8063 0.8639 0.8063 0.8711 0.8711 0.7791 0.8063 0.9208 0.8711 0.7791 0.7791\n\n4 E A 104 0.8339 0.8659 0.8339 0.8754 0.8754 0.8114 0.8339 0.9228 0.8754 0.8114 0.8114\n\n4 F A 105 0.8649 0.8679 0.8649 0.9343 0.9343 0.8134 0.8649 0.9248 0.9343 0.8134 0.8134\n\n4 G A 106 0.8669 0.8699 0.8669 0.9363 0.9363 0.8154 0.8669 0.9268 0.9363 0.8154 0.8154\n\n4 H A 107 0.9852 0.8719 0.9852 0.9505 0.9505 0.8269 0.9852 0.9288 0.9505 0.8269 0.8269\n\n4 I A 108 0.9872 0.8739 0.9872 1.0008 1.0008 0.8429 0.9872 0.9829 1.0008 0.8429 0.8429\n\n4 J A 109 0.9892 1.0389 0.9892 1.0028 1.0028 0.9423 0.9892 0.9854 1.0028 0.9423 0.9423\n\n4 K A 110 0.9912 1.0570 0.9912 1.0048 1.0048 0.9443 0.9912 0.9874 1.0048 0.9443 0.9443\n\n4 L A 111 0.9932 1.0590 0.9932 1.0068 1.0068 1.0395 0.9932 0.9894 1.0068 1.0395 1.0395\n\n4 M A 112 1.0185 1.0610 1.0185 1.0657 1.0657 1.0415 1.0185 0.9914 1.0657 1.0415 1.0415\n\n4 N A 113 1.0205 1.0630 1.0205 1.0677 1.0677 1.0435 1.0205 0.9934 1.0677 1.0435 1.0435\n\n4 O A 114 1.0275 1.0650 1.0275 1.0931 1.0931 1.0455 1.0275 1.0618 1.0931 1.0455 1.0455\n\n4 P A 115 1.1085 1.0670 1.1085 1.0951 1.0951 1.0475 1.1085 1.0681 1.0951 1.0475 1.0475\n\n4 Q A 116 1.2461 1.1469 1.2461 1.0971 1.0971 1.0495 1.2461 1.1111 1.0971 1.0495 1.0495\n\n4 R A 117 1.2481 1.1489 1.2481 1.0991 1.0991 1.0515 1.2481 1.1131 1.0991 1.0515 1.0515\n\n4 S A 118 1.2501 1.1509 1.2501 1.1923 1.1923 1.0535 1.2501 1.1151 1.1923 1.0535 1.0535\n\n4 T A 119 1.2521 1.1529 1.2521 1.2299 1.2299 1.2289 1.2521 1.1171 1.2299 1.2289 1.2289\n\n4 U A 120 1.2541 1.1549 1.2541 1.2319 1.2319 1.2309 1.2541 1.1191 1.2319 1.2309 1.2309\n\n4 V A 121 1.3190 1.1569 1.3190 1.2339 1.2339 1.3279 1.3190 1.1211 1.2339 1.3279 1.3279\n\n4 W A 122 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n4 X A 123 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n4 Y A 124 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZD A 125 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n4 ZE A 126 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n4 ZF A 127 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZG A 128 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZH A 129 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZJ A 130 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZK A 131 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZL A 132 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n5 A A 133 0.6327 0.6841 0.6327 0.6447 0.6447 0.4777 0.6327 0.6307 0.6447 0.4777 0.4777\n\n5 B A 134 0.7028 0.7275 0.7028 0.7195 0.7195 0.5021 0.7028 0.6734 0.7195 0.5021 0.5021\n\n5 C A 135 0.7715 0.7295 0.7715 0.7451 0.7451 0.6684 0.7715 0.7092 0.7451 0.6684 0.6684\n\n5 D A 136 0.7963 0.7315 0.7963 0.7471 0.7471 0.7373 0.7963 0.7112 0.7471 0.7373 0.7373\n\n5 E A 137 0.7983 0.7623 0.7983 0.8654 0.8654 0.7393 0.7983 0.7481 0.8654 0.7393 0.7393\n\n5 F A 138 0.8003 0.7643 0.8003 0.8727 0.8727 0.7413 0.8003 0.7501 0.8727 0.7413 0.7413\n\n5 G A 139 0.8023 0.7663 0.8023 0.8891 0.8891 0.7433 0.8023 0.7811 0.8891 0.7433 0.7433\n\n5 H A 140 0.8043 0.7895 0.8043 0.8911 0.8911 0.8041 0.8043 0.8027 0.8911 0.8041 0.8041\n\n5 I A 141 0.8171 0.8187 0.8171 0.8931 0.8931 0.8061 0.8171 0.8047 0.8931 0.8061 0.8061\n\n5 J A 142 0.8191 0.8996 0.8191 0.9593 0.9593 0.9219 0.8191 0.8775 0.9593 0.9219 0.9219\n\n5 K A 143 0.8472 0.9409 0.8472 0.9613 0.9613 0.9239 0.8472 0.8795 0.9613 0.9239 0.9239\n\n5 L A 144 0.8492 0.9429 0.8492 0.9633 0.9633 0.9259 0.8492 0.8815 0.9633 0.9259 0.9259\n\n5 M A 145 1.0085 0.9449 1.0085 0.9708 0.9708 0.9279 1.0085 0.8835 0.9708 0.9279 0.9279\n\n5 N A 146 1.0105 0.9469 1.0105 0.9728 0.9728 0.9299 1.0105 0.8855 0.9728 0.9299 0.9299\n\n**Proposed**"],"full_content":"**UW Rate Matrix Tier**\n\n**UW Tier Group Credit Tier NAF/OCG TIER UW Rate Matrix Tier ALL BI CEQ COL EXTR MP OTC PD RA UIM UMBI**\n\n1 A A 1 0.5348 0.5540 0.5348 0.5494 0.5494 0.2905 0.5348 0.5480 0.5494 0.2905 0.2905\n\n1 B A 2 0.6828 0.6085 0.6828 0.6262 0.6262 0.3460 0.6828 0.6190 0.6262 0.3460 0.3460\n\n1 C A 3 0.6848 0.6265 0.6848 0.6282 0.6282 0.3998 0.6848 0.6366 0.6282 0.3998 0.3998\n\n1 D A 4 0.6868 0.6285 0.6868 0.6604 0.6604 0.4018 0.6868 0.6386 0.6604 0.4018 0.4018\n\n1 E A 5 0.6888 0.6475 0.6888 0.7189 0.7189 0.4369 0.6888 0.6926 0.7189 0.4369 0.4369\n\n1 F A 6 0.6908 0.7008 0.6908 0.7486 0.7486 0.4389 0.6908 0.6956 0.7486 0.4389 0.4389\n\n1 G A 7 0.6928 0.7028 0.6928 0.7506 0.7506 0.4665 0.6928 0.7156 0.7506 0.4665 0.4665\n\n1 H A 8 0.7843 0.7048 0.7843 0.7526 0.7526 0.4685 0.7843 0.7675 0.7526 0.4685 0.4685\n\n1 I A 9 0.7863 0.7068 0.7863 0.7546 0.7546 0.5161 0.7863 0.7695 0.7546 0.5161 0.5161\n\n1 J A 10 0.7991 0.7088 0.7991 0.8464 0.8464 0.5181 0.7991 0.7867 0.8464 0.5181 0.5181\n\n1 K A 11 0.8272 0.7108 0.8272 0.8484 0.8484 0.6021 0.8272 0.8204 0.8484 0.6021 0.6021\n\n1 L A 12 0.8292 0.8176 0.8292 0.8671 0.8671 0.6041 0.8292 0.8442 0.8671 0.6041 0.6041\n\n1 M A 13 0.8717 0.8196 0.8717 0.8691 0.8691 0.6061 0.8717 0.8462 0.8691 0.6061 0.6061\n\n1 N A 14 0.8851 0.8348 0.8851 0.8711 0.8711 0.8334 0.8851 0.8482 0.8711 0.8334 0.8334\n\n1 O A 15 0.8871 0.8368 0.8871 0.8731 0.8731 0.8354 0.8871 0.8502 0.8731 0.8354 0.8354\n\n1 P A 16 0.8891 0.8388 0.8891 0.8751 0.8751 0.8374 0.8891 0.8845 0.8751 0.8374 0.8374\n\n1 Q A 17 0.8911 0.8408 0.8911 0.8771 0.8771 0.8394 0.8911 0.8865 0.8771 0.8394 0.8394\n\n1 R A 18 0.8931 0.8428 0.8931 0.8791 0.8791 0.8414 0.8931 0.8885 0.8791 0.8414 0.8414\n\n1 S A 19 1.0180 0.9545 1.0180 0.9299 0.9299 0.8434 1.0180 0.9199 0.9299 0.8434 0.8434\n\n1 T A 20 1.1006 0.9565 1.1006 0.9971 0.9971 0.8454 1.1006 0.9219 0.9971 0.8454 0.8454\n\n1 U A 21 1.1026 0.9585 1.1026 1.0017 1.0017 0.8642 1.1026 0.9239 1.0017 0.8642 0.8642\n\n1 V A 22 1.1046 0.9605 1.1046 1.0659 1.0659 0.9368 1.1046 0.9259 1.0659 0.9368 0.9368\n\n1 W A 23 1.1159 0.9625 1.1159 1.0679 1.0679 0.9388 1.1159 1.0703 1.0679 0.9388 0.9388\n\n1 X A 24 1.1179 1.0945 1.1179 1.0699 1.0699 0.9408 1.1179 1.0723 1.0699 0.9408 0.9408\n\n1 Y A 25 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZD A 26 1.1159 0.9625 1.1159 1.0679 1.0679 0.9388 1.1159 1.0703 1.0679 0.9388 0.9388\n\n1 ZE A 27 1.1179 1.0945 1.1179 1.0699 1.0699 0.9408 1.1179 1.0723 1.0699 0.9408 0.9408\n\n1 ZF A 28 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZG A 29 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZH A 30 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZJ A 31 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZK A 32 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n1 ZL A 33 1.1199 1.0965 1.1199 1.2228 1.2228 0.9428 1.1199 1.0743 1.2228 0.9428 0.9428\n\n2 A A 34 0.6783 0.7510 0.6783 0.6547 0.6547 0.5043 0.6783 0.7347 0.6547 0.5043 0.5043\n\n2 B A 35 0.7565 0.7530 0.7565 0.7963 0.7963 0.7751 0.7565 0.8326 0.7963 0.7751 0.7751\n\n2 C A 36 0.7815 0.7550 0.7815 0.8166 0.8166 0.7771 0.7815 0.8346 0.8166 0.7771 0.7771\n\n2 D A 37 0.8063 0.8639 0.8063 0.8711 0.8711 0.7791 0.8063 0.9208 0.8711 0.7791 0.7791\n\n2 E A 38 0.8339 0.8659 0.8339 0.8754 0.8754 0.8114 0.8339 0.9228 0.8754 0.8114 0.8114\n\n2 F A 39 0.8649 0.8679 0.8649 0.9343 0.9343 0.8134 0.8649 0.9248 0.9343 0.8134 0.8134\n\n2 G A 40 0.8669 0.8699 0.8669 0.9363 0.9363 0.8154 0.8669 0.9268 0.9363 0.8154 0.8154\n\n2 H A 41 0.9852 0.8719 0.9852 0.9505 0.9505 0.8269 0.9852 0.9288 0.9505 0.8269 0.8269\n\n2 I A 42 0.9872 0.8739 0.9872 1.0008 1.0008 0.8429 0.9872 0.9829 1.0008 0.8429 0.8429\n\n2 J A 43 0.9892 1.0389 0.9892 1.0028 1.0028 0.9423 0.9892 0.9854 1.0028 0.9423 0.9423\n\n2 K A 44 0.9912 1.0570 0.9912 1.0048 1.0048 0.9443 0.9912 0.9874 1.0048 0.9443 0.9443\n\n2 L A 45 0.9932 1.0590 0.9932 1.0068 1.0068 1.0395 0.9932 0.9894 1.0068 1.0395 1.0395\n\n2 M A 46 1.0185 1.0610 1.0185 1.0657 1.0657 1.0415 1.0185 0.9914 1.0657 1.0415 1.0415\n\n2 N A 47 1.0205 1.0630 1.0205 1.0677 1.0677 1.0435 1.0205 0.9934 1.0677 1.0435 1.0435\n\n2 O A 48 1.0275 1.0650 1.0275 1.0931 1.0931 1.0455 1.0275 1.0618 1.0931 1.0455 1.0455\n\n2 P A 49 1.1085 1.0670 1.1085 1.0951 1.0951 1.0475 1.1085 1.0681 1.0951 1.0475 1.0475\n\n2 Q A 50 1.2461 1.1469 1.2461 1.0971 1.0971 1.0495 1.2461 1.1111 1.0971 1.0495 1.0495\n\n2 R A 51 1.2481 1.1489 1.2481 1.0991 1.0991 1.0515 1.2481 1.1131 1.0991 1.0515 1.0515\n\n2 S A 52 1.2501 1.1509 1.2501 1.1923 1.1923 1.0535 1.2501 1.1151 1.1923 1.0535 1.0535\n\n2 T A 53 1.2521 1.1529 1.2521 1.2299 1.2299 1.2289 1.2521 1.1171 1.2299 1.2289 1.2289\n\n2 U A 54 1.2541 1.1549 1.2541 1.2319 1.2319 1.2309 1.2541 1.1191 1.2319 1.2309 1.2309\n\n2 V A 55 1.3190 1.1569 1.3190 1.2339 1.2339 1.3279 1.3190 1.1211 1.2339 1.3279 1.3279\n\n2 W A 56 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n2 X A 57 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n2 Y A 58 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZD A 59 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n2 ZE A 60 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n2 ZF A 61 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZG A 62 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZH A 63 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZJ A 64 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZK A 65 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n2 ZL A 66 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n3 A A 67 0.6227 0.6165 0.6227 0.6153 0.6153 0.3005 0.6227 0.6207 0.6153 0.3005 0.3005\n\n3 B A 68 0.6928 0.6185 0.6928 0.7095 0.7095 0.4921 0.6928 0.6290 0.7095 0.4921 0.4921\n\n3 C A 69 0.7615 0.6365 0.7615 0.7250 0.7250 0.4941 0.7615 0.6466 0.7250 0.4941 0.4941\n\n3 D A 70 0.7635 0.6385 0.7635 0.7270 0.7270 0.5602 0.7635 0.7012 0.7270 0.5602 0.5602\n\n3 E A 71 0.7655 0.6863 0.7655 0.7736 0.7736 0.5622 0.7655 0.7032 0.7736 0.5622 0.5622\n\n3 F A 72 0.7675 0.7108 0.7675 0.8232 0.8232 0.5642 0.7675 0.7056 0.8232 0.5642 0.5642\n\n3 G A 73 0.7923 0.7157 0.7923 0.8252 0.8252 0.5662 0.7923 0.7448 0.8252 0.5662 0.5662\n\n3 H A 74 0.7943 0.7795 0.7943 0.8691 0.8691 0.5682 0.7943 0.7848 0.8691 0.5682 0.5682\n\n3 I A 75 0.8071 0.7815 0.8071 0.8711 0.8711 0.7498 0.8071 0.7947 0.8711 0.7498 0.7498\n\n3 J A 76 0.8091 0.7835 0.8091 0.8731 0.8731 0.7518 0.8091 0.7967 0.8731 0.7518 0.7518\n\n3 K A 77 0.8372 0.8256 0.8372 0.8751 0.8751 0.7538 0.8372 0.8522 0.8751 0.7538 0.7538\n\n3 L A 78 0.8392 0.8276 0.8392 0.8771 0.8771 0.7558 0.8392 0.8542 0.8771 0.7558 0.7558\n\n3 M A 79 0.8978 0.8998 0.8978 0.9213 0.9213 0.8786 0.8978 0.8562 0.9213 0.8786 0.8786\n\n3 N A 80 0.9845 0.9018 0.9845 0.9233 0.9233 0.8806 0.9845 0.8704 0.9233 0.8806 0.8806\n\n3 O A 81 0.9865 0.9038 0.9865 0.9253 0.9253 0.8826 0.9865 0.8775 0.9253 0.8826 0.8826\n\n3 P A 82 0.9885 0.9058 0.9885 0.9273 0.9273 0.8846 0.9885 0.8945 0.9273 0.8846 0.8846\n\n3 Q A 83 0.9905 0.9078 0.9905 0.9293 0.9293 0.8866 0.9905 0.8965 0.9293 0.8866 0.8866\n\n3 R A 84 1.0174 0.9098 1.0174 0.9313 0.9313 0.8886 1.0174 0.8985 0.9313 0.8886 0.8886\n\n3 S A 85 1.0280 0.9645 1.0280 1.0469 1.0469 0.8906 1.0280 0.9299 1.0469 0.8906 0.8906\n\n3 T A 86 1.1106 0.9665 1.1106 1.0489 1.0489 0.8926 1.1106 0.9319 1.0489 0.8926 0.8926\n\n3 U A 87 1.1126 0.9685 1.1126 1.0509 1.0509 1.0517 1.1126 0.9339 1.0509 1.0517 1.0517\n\n3 V A 88 1.1146 1.0264 1.1146 1.0759 1.0759 1.1055 1.1146 1.0070 1.0759 1.1055 1.1055\n\n3 W A 89 1.1259 1.0856 1.1259 1.0779 1.0779 1.1075 1.1259 1.0803 1.0779 1.1075 1.1075\n\n3 X A 90 1.1279 1.1045 1.1279 1.0799 1.0799 1.2316 1.1279 1.0823 1.0799 1.2316 1.2316\n\n3 Y A 91 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZD A 92 1.1259 1.0856 1.1259 1.0779 1.0779 1.1075 1.1259 1.0803 1.0779 1.1075 1.1075\n\n3 ZE A 93 1.1279 1.1045 1.1279 1.0799 1.0799 1.2316 1.1279 1.0823 1.0799 1.2316 1.2316\n\n3 ZF A 94 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZG A 95 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZH A 96 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZJ A 97 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZK A 98 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n3 ZL A 99 1.1299 1.1065 1.1299 1.2328 1.2328 1.2336 1.1299 1.0843 1.2328 1.2336 1.2336\n\n4 A A 100 0.6783 0.7510 0.6783 0.6547 0.6547 0.5043 0.6783 0.7347 0.6547 0.5043 0.5043\n\n4 B A 101 0.7565 0.7530 0.7565 0.7963 0.7963 0.7751 0.7565 0.8326 0.7963 0.7751 0.7751\n\n4 C A 102 0.7815 0.7550 0.7815 0.8166 0.8166 0.7771 0.7815 0.8346 0.8166 0.7771 0.7771\n\n4 D A 103 0.8063 0.8639 0.8063 0.8711 0.8711 0.7791 0.8063 0.9208 0.8711 0.7791 0.7791\n\n4 E A 104 0.8339 0.8659 0.8339 0.8754 0.8754 0.8114 0.8339 0.9228 0.8754 0.8114 0.8114\n\n4 F A 105 0.8649 0.8679 0.8649 0.9343 0.9343 0.8134 0.8649 0.9248 0.9343 0.8134 0.8134\n\n4 G A 106 0.8669 0.8699 0.8669 0.9363 0.9363 0.8154 0.8669 0.9268 0.9363 0.8154 0.8154\n\n4 H A 107 0.9852 0.8719 0.9852 0.9505 0.9505 0.8269 0.9852 0.9288 0.9505 0.8269 0.8269\n\n4 I A 108 0.9872 0.8739 0.9872 1.0008 1.0008 0.8429 0.9872 0.9829 1.0008 0.8429 0.8429\n\n4 J A 109 0.9892 1.0389 0.9892 1.0028 1.0028 0.9423 0.9892 0.9854 1.0028 0.9423 0.9423\n\n4 K A 110 0.9912 1.0570 0.9912 1.0048 1.0048 0.9443 0.9912 0.9874 1.0048 0.9443 0.9443\n\n4 L A 111 0.9932 1.0590 0.9932 1.0068 1.0068 1.0395 0.9932 0.9894 1.0068 1.0395 1.0395\n\n4 M A 112 1.0185 1.0610 1.0185 1.0657 1.0657 1.0415 1.0185 0.9914 1.0657 1.0415 1.0415\n\n4 N A 113 1.0205 1.0630 1.0205 1.0677 1.0677 1.0435 1.0205 0.9934 1.0677 1.0435 1.0435\n\n4 O A 114 1.0275 1.0650 1.0275 1.0931 1.0931 1.0455 1.0275 1.0618 1.0931 1.0455 1.0455\n\n4 P A 115 1.1085 1.0670 1.1085 1.0951 1.0951 1.0475 1.1085 1.0681 1.0951 1.0475 1.0475\n\n4 Q A 116 1.2461 1.1469 1.2461 1.0971 1.0971 1.0495 1.2461 1.1111 1.0971 1.0495 1.0495\n\n4 R A 117 1.2481 1.1489 1.2481 1.0991 1.0991 1.0515 1.2481 1.1131 1.0991 1.0515 1.0515\n\n4 S A 118 1.2501 1.1509 1.2501 1.1923 1.1923 1.0535 1.2501 1.1151 1.1923 1.0535 1.0535\n\n4 T A 119 1.2521 1.1529 1.2521 1.2299 1.2299 1.2289 1.2521 1.1171 1.2299 1.2289 1.2289\n\n4 U A 120 1.2541 1.1549 1.2541 1.2319 1.2319 1.2309 1.2541 1.1191 1.2319 1.2309 1.2309\n\n4 V A 121 1.3190 1.1569 1.3190 1.2339 1.2339 1.3279 1.3190 1.1211 1.2339 1.3279 1.3279\n\n4 W A 122 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n4 X A 123 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n4 Y A 124 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZD A 125 1.3210 1.1589 1.3210 1.2359 1.2359 1.3299 1.3210 1.1231 1.2359 1.3299 1.3299\n\n4 ZE A 126 1.3230 1.2932 1.3230 1.2379 1.2379 1.3319 1.3230 1.1251 1.2379 1.3319 1.3319\n\n4 ZF A 127 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZG A 128 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZH A 129 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZJ A 130 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZK A 131 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n4 ZL A 132 1.4109 1.2952 1.4109 1.2528 1.2528 1.5221 1.4109 1.1271 1.2528 1.5221 1.5221\n\n5 A A 133 0.6327 0.6841 0.6327 0.6447 0.6447 0.4777 0.6327 0.6307 0.6447 0.4777 0.4777\n\n5 B A 134 0.7028 0.7275 0.7028 0.7195 0.7195 0.5021 0.7028 0.6734 0.7195 0.5021 0.5021\n\n5 C A 135 0.7715 0.7295 0.7715 0.7451 0.7451 0.6684 0.7715 0.7092 0.7451 0.6684 0.6684\n\n5 D A 136 0.7963 0.7315 0.7963 0.7471 0.7471 0.7373 0.7963 0.7112 0.7471 0.7373 0.7373\n\n5 E A 137 0.7983 0.7623 0.7983 0.8654 0.8654 0.7393 0.7983 0.7481 0.8654 0.7393 0.7393\n\n5 F A 138 0.8003 0.7643 0.8003 0.8727 0.8727 0.7413 0.8003 0.7501 0.8727 0.7413 0.7413\n\n5 G A 139 0.8023 0.7663 0.8023 0.8891 0.8891 0.7433 0.8023 0.7811 0.8891 0.7433 0.7433\n\n5 H A 140 0.8043 0.7895 0.8043 0.8911 0.8911 0.8041 0.8043 0.8027 0.8911 0.8041 0.8041\n\n5 I A 141 0.8171 0.8187 0.8171 0.8931 0.8931 0.8061 0.8171 0.8047 0.8931 0.8061 0.8061\n\n5 J A 142 0.8191 0.8996 0.8191 0.9593 0.9593 0.9219 0.8191 0.8775 0.9593 0.9219 0.9219\n\n5 K A 143 0.8472 0.9409 0.8472 0.9613 0.9613 0.9239 0.8472 0.8795 0.9613 0.9239 0.9239\n\n5 L A 144 0.8492 0.9429 0.8492 0.9633 0.9633 0.9259 0.8492 0.8815 0.9633 0.9259 0.9259\n\n5 M A 145 1.0085 0.9449 1.0085 0.9708 0.9708 0.9279 1.0085 0.8835 0.9708 0.9279 0.9279\n\n5 N A 146 1.0105 0.9469 1.0105 0.9728 0.9728 0.9299 1.0105 0.8855 0.9728 0.9299 0.9299\n\n**Proposed**","publish_date":null,"title":"Proposed UW Rate Matrix Tier UW Tier Group Credit Tier NAF/OCG TIER UW Rate Matrix Tier ALL BI CEQ COL","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page841.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page841.pdf"},"request":{"example_id":"table/BRWS-134565917_page841","product_type":"parse","source_file_path":"BRWS-134565917_page841.pdf"},"started_at":"2026-11-04T19:48:26.276224"} +{"completed_at":"2026-11-04T19:48:28.412261","latency_in_ms":1406,"output":{"example_id":"table/BRWS-134565917_page851","grounded_pages":[],"layout_pages":[],"markdown":"**Symbol Factors**\n\n**Symbol ALL BI COL MP OTC PD UIM UMBI**\n\n1 0.4588 0.7326 0.6353 0.5174 0.4588 0.5490 0.5174 0.5174\n\n2 0.6746 0.8306 0.6825 0.7075 0.6746 0.7828 0.7075 0.7075\n\n3 0.7963 0.9192 0.7584 0.7497 0.7963 0.8539 0.7497 0.7497\n\n4 0.9221 0.9225 0.8031 0.7549 0.9221 0.8865 0.7549 0.7549\n\n5 1.0715 0.9225 0.8313 0.7933 1.0715 0.9126 0.7933 0.7933\n\n6 1.0908 0.9769 0.8765 0.8219 1.0908 0.9354 0.8219 0.8219\n\n7 1.2372 0.9984 0.9375 0.8440 1.2372 0.9637 0.8440 0.8440\n\n8 1.2957 1.0721 0.9539 0.9656 1.2957 1.0041 0.9656 0.9656\n\n9 1.6452 1.0802 1.0159 1.0002 1.6452 1.0409 1.0002 1.0002\n\n10 1.6665 1.1116 1.0483 1.0195 1.6665 1.0409 1.0195 1.0195\n\n11 1.6665 1.1213 1.0827 1.0856 1.6665 1.0720 1.0856 1.0856\n\n12 1.8263 1.1353 1.1580 1.8263 1.1236 1.1580 1.1580\n\n13 2.5046 1.2709 1.2018 2.5046 1.1729 1.2018 1.2018\n\n14 3.3948 1.4120 1.2985 3.3948 1.3513 1.2985 1.2985\n\n15 1.5397 1.2985 1.2985 1.2985\n\n\\# 16 1.6087 1.2985 1.2985 1.2985\n\n17 1.8084 1.2985 1.2985 1.2985\n\n18 1.9565 1.2985 1.2985 1.2985\n\n19 2.5572\n\n20 21 22 23 24 25 26 45 5.8298 2.2426 5.1144 2.5970 6.7896 2.7026 2.5970 2.5970\n\n65 0.630 0.812 0.630 0.812 0.812\n\n66 0.630 0.812 0.630 0.812 0.812\n\n69 0.860 0.810 0.860 0.810 0.810\n\n71 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n72 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n73 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n74 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n75 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n76 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n**Symbol Description**\n\n65 Broad Form Named Operator Policy - offered for Liability coverages (BI, PD, MP, UM/UIM) (only available in select states)\n\n66 Named Operator Policy - offered for Liability coverages (BI, PD, MP, UM/UIM)\n\n69 This is for vehicles not appearing on symbol list. Physical Damage coverage is not available. (BI, PD, MP, UM/UIM)\n\n4\\. Conversion Van symbols for are based on the stated amount of the vehicle. The maximum stated amount allowed is $70,000.\n\n**Symbol Description**\n\n71 $1 - $10,000\n\n72 $10,001 - $20,000\n\n73 $20,001 - $30,000\n\n74 $30,001 - $40,000\n\n75 $40,001 - $50,000\n\n76 $50,000 - $70,000\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Symbol Factors**\n\n**Symbol ALL BI COL MP OTC PD UIM UMBI**\n\n1 0.4588 0.7326 0.6353 0.5174 0.4588 0.5490 0.5174 0.5174\n\n2 0.6746 0.8306 0.6825 0.7075 0.6746 0.7828 0.7075 0.7075\n\n3 0.7963 0.9192 0.7584 0.7497 0.7963 0.8539 0.7497 0.7497\n\n4 0.9221 0.9225 0.8031 0.7549 0.9221 0.8865 0.7549 0.7549\n\n5 1.0715 0.9225 0.8313 0.7933 1.0715 0.9126 0.7933 0.7933\n\n6 1.0908 0.9769 0.8765 0.8219 1.0908 0.9354 0.8219 0.8219\n\n7 1.2372 0.9984 0.9375 0.8440 1.2372 0.9637 0.8440 0.8440\n\n8 1.2957 1.0721 0.9539 0.9656 1.2957 1.0041 0.9656 0.9656\n\n9 1.6452 1.0802 1.0159 1.0002 1.6452 1.0409 1.0002 1.0002\n\n10 1.6665 1.1116 1.0483 1.0195 1.6665 1.0409 1.0195 1.0195\n\n11 1.6665 1.1213 1.0827 1.0856 1.6665 1.0720 1.0856 1.0856\n\n12 1.8263 1.1353 1.1580 1.8263 1.1236 1.1580 1.1580\n\n13 2.5046 1.2709 1.2018 2.5046 1.1729 1.2018 1.2018\n\n14 3.3948 1.4120 1.2985 3.3948 1.3513 1.2985 1.2985\n\n15 1.5397 1.2985 1.2985 1.2985\n\n\\# 16 1.6087 1.2985 1.2985 1.2985\n\n17 1.8084 1.2985 1.2985 1.2985\n\n18 1.9565 1.2985 1.2985 1.2985\n\n19 2.5572\n\n20 21 22 23 24 25 26 45 5.8298 2.2426 5.1144 2.5970 6.7896 2.7026 2.5970 2.5970\n\n65 0.630 0.812 0.630 0.812 0.812\n\n66 0.630 0.812 0.630 0.812 0.812\n\n69 0.860 0.810 0.860 0.810 0.810\n\n71 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n72 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n73 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n74 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n75 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n76 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n**Symbol Description**\n\n65 Broad Form Named Operator Policy - offered for Liability coverages (BI, PD, MP, UM/UIM) (only available in select states)\n\n66 Named Operator Policy - offered for Liability coverages (BI, PD, MP, UM/UIM)\n\n69 This is for vehicles not appearing on symbol list. Physical Damage coverage is not available. (BI, PD, MP, UM/UIM)\n\n4\\. Conversion Van symbols for are based on the stated amount of the vehicle. The maximum stated amount allowed is $70,000.\n\n**Symbol Description**\n\n71 $1 - $10,000\n\n72 $10,001 - $20,000\n\n73 $20,001 - $30,000\n\n74 $30,001 - $40,000\n\n75 $40,001 - $50,000\n\n76 $50,000 - $70,000\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Symbol Factors**\n\n**Symbol ALL BI COL MP OTC PD UIM UMBI**\n\n1 0.4588 0.7326 0.6353 0.5174 0.4588 0.5490 0.5174 0.5174\n\n2 0.6746 0.8306 0.6825 0.7075 0.6746 0.7828 0.7075 0.7075\n\n3 0.7963 0.9192 0.7584 0.7497 0.7963 0.8539 0.7497 0.7497\n\n4 0.9221 0.9225 0.8031 0.7549 0.9221 0.8865 0.7549 0.7549\n\n5 1.0715 0.9225 0.8313 0.7933 1.0715 0.9126 0.7933 0.7933\n\n6 1.0908 0.9769 0.8765 0.8219 1.0908 0.9354 0.8219 0.8219\n\n7 1.2372 0.9984 0.9375 0.8440 1.2372 0.9637 0.8440 0.8440\n\n8 1.2957 1.0721 0.9539 0.9656 1.2957 1.0041 0.9656 0.9656\n\n9 1.6452 1.0802 1.0159 1.0002 1.6452 1.0409 1.0002 1.0002\n\n10 1.6665 1.1116 1.0483 1.0195 1.6665 1.0409 1.0195 1.0195\n\n11 1.6665 1.1213 1.0827 1.0856 1.6665 1.0720 1.0856 1.0856\n\n12 1.8263 1.1353 1.1580 1.8263 1.1236 1.1580 1.1580\n\n13 2.5046 1.2709 1.2018 2.5046 1.1729 1.2018 1.2018\n\n14 3.3948 1.4120 1.2985 3.3948 1.3513 1.2985 1.2985\n\n15 1.5397 1.2985 1.2985 1.2985\n\n\\# 16 1.6087 1.2985 1.2985 1.2985\n\n17 1.8084 1.2985 1.2985 1.2985\n\n18 1.9565 1.2985 1.2985 1.2985\n\n19 2.5572\n\n20 21 22 23 24 25 26 45 5.8298 2.2426 5.1144 2.5970 6.7896 2.7026 2.5970 2.5970\n\n65 0.630 0.812 0.630 0.812 0.812\n\n66 0.630 0.812 0.630 0.812 0.812\n\n69 0.860 0.810 0.860 0.810 0.810\n\n71 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n72 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n73 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n74 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n75 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n76 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n**Symbol Description**\n\n65 Broad Form Named Operator Policy - offered for Liability coverages (BI, PD, MP, UM/UIM) (only available in select states)\n\n66 Named Operator Policy - offered for Liability coverages (BI, PD, MP, UM/UIM)\n\n69 This is for vehicles not appearing on symbol list. Physical Damage coverage is not available. (BI, PD, MP, UM/UIM)\n\n4\\. Conversion Van symbols for are based on the stated amount of the vehicle. The maximum stated amount allowed is $70,000.\n\n**Symbol Description**\n\n71 $1 - $10,000\n\n72 $10,001 - $20,000\n\n73 $20,001 - $30,000\n\n74 $30,001 - $40,000\n\n75 $40,001 - $50,000\n\n76 $50,000 - $70,000\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page851.pdf"]},"response":{"errors":[],"extract_id":"extract_544b2318b4f3f96ddf3cee52043fef3b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Symbol Factors**\n\n**Symbol ALL BI COL MP OTC PD UIM UMBI**\n\n1 0.4588 0.7326 0.6353 0.5174 0.4588 0.5490 0.5174 0.5174\n\n2 0.6746 0.8306 0.6825 0.7075 0.6746 0.7828 0.7075 0.7075\n\n3 0.7963 0.9192 0.7584 0.7497 0.7963 0.8539 0.7497 0.7497\n\n4 0.9221 0.9225 0.8031 0.7549 0.9221 0.8865 0.7549 0.7549\n\n5 1.0715 0.9225 0.8313 0.7933 1.0715 0.9126 0.7933 0.7933\n\n6 1.0908 0.9769 0.8765 0.8219 1.0908 0.9354 0.8219 0.8219\n\n7 1.2372 0.9984 0.9375 0.8440 1.2372 0.9637 0.8440 0.8440\n\n8 1.2957 1.0721 0.9539 0.9656 1.2957 1.0041 0.9656 0.9656\n\n9 1.6452 1.0802 1.0159 1.0002 1.6452 1.0409 1.0002 1.0002\n\n10 1.6665 1.1116 1.0483 1.0195 1.6665 1.0409 1.0195 1.0195\n\n11 1.6665 1.1213 1.0827 1.0856 1.6665 1.0720 1.0856 1.0856\n\n12 1.8263 1.1353 1.1580 1.8263 1.1236 1.1580 1.1580\n\n13 2.5046 1.2709 1.2018 2.5046 1.1729 1.2018 1.2018\n\n14 3.3948 1.4120 1.2985 3.3948 1.3513 1.2985 1.2985\n\n15 1.5397 1.2985 1.2985 1.2985\n\n\\# 16 1.6087 1.2985 1.2985 1.2985\n\n17 1.8084 1.2985 1.2985 1.2985\n\n18 1.9565 1.2985 1.2985 1.2985\n\n19 2.5572\n\n20 21 22 23 24 25 26 45 5.8298 2.2426 5.1144 2.5970 6.7896 2.7026 2.5970 2.5970\n\n65 0.630 0.812 0.630 0.812 0.812\n\n66 0.630 0.812 0.630 0.812 0.812\n\n69 0.860 0.810 0.860 0.810 0.810\n\n71 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n72 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n73 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n74 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n75 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n76 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n**Symbol Description**\n\n65 Broad Form Named Operator Policy - offered for Liability coverages (BI, PD, MP, UM/UIM) (only available in select states)\n\n66 Named Operator Policy - offered for Liability coverages (BI, PD, MP, UM/UIM)\n\n69 This is for vehicles not appearing on symbol list. Physical Damage coverage is not available. (BI, PD, MP, UM/UIM)\n\n4\\. Conversion Van symbols for are based on the stated amount of the vehicle. The maximum stated amount allowed is $70,000.\n\n**Symbol Description**\n\n71 $1 - $10,000\n\n72 $10,001 - $20,000\n\n73 $20,001 - $30,000\n\n74 $30,001 - $40,000\n\n75 $40,001 - $50,000\n\n76 $50,000 - $70,000\n\n**Proposed**"],"full_content":"**Symbol Factors**\n\n**Symbol ALL BI COL MP OTC PD UIM UMBI**\n\n1 0.4588 0.7326 0.6353 0.5174 0.4588 0.5490 0.5174 0.5174\n\n2 0.6746 0.8306 0.6825 0.7075 0.6746 0.7828 0.7075 0.7075\n\n3 0.7963 0.9192 0.7584 0.7497 0.7963 0.8539 0.7497 0.7497\n\n4 0.9221 0.9225 0.8031 0.7549 0.9221 0.8865 0.7549 0.7549\n\n5 1.0715 0.9225 0.8313 0.7933 1.0715 0.9126 0.7933 0.7933\n\n6 1.0908 0.9769 0.8765 0.8219 1.0908 0.9354 0.8219 0.8219\n\n7 1.2372 0.9984 0.9375 0.8440 1.2372 0.9637 0.8440 0.8440\n\n8 1.2957 1.0721 0.9539 0.9656 1.2957 1.0041 0.9656 0.9656\n\n9 1.6452 1.0802 1.0159 1.0002 1.6452 1.0409 1.0002 1.0002\n\n10 1.6665 1.1116 1.0483 1.0195 1.6665 1.0409 1.0195 1.0195\n\n11 1.6665 1.1213 1.0827 1.0856 1.6665 1.0720 1.0856 1.0856\n\n12 1.8263 1.1353 1.1580 1.8263 1.1236 1.1580 1.1580\n\n13 2.5046 1.2709 1.2018 2.5046 1.1729 1.2018 1.2018\n\n14 3.3948 1.4120 1.2985 3.3948 1.3513 1.2985 1.2985\n\n15 1.5397 1.2985 1.2985 1.2985\n\n\\# 16 1.6087 1.2985 1.2985 1.2985\n\n17 1.8084 1.2985 1.2985 1.2985\n\n18 1.9565 1.2985 1.2985 1.2985\n\n19 2.5572\n\n20 21 22 23 24 25 26 45 5.8298 2.2426 5.1144 2.5970 6.7896 2.7026 2.5970 2.5970\n\n65 0.630 0.812 0.630 0.812 0.812\n\n66 0.630 0.812 0.630 0.812 0.812\n\n69 0.860 0.810 0.860 0.810 0.810\n\n71 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n72 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n73 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n74 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n75 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n76 0.970 0.970 0.970 0.800 0.970 0.970 0.800 0.800\n\n**Symbol Description**\n\n65 Broad Form Named Operator Policy - offered for Liability coverages (BI, PD, MP, UM/UIM) (only available in select states)\n\n66 Named Operator Policy - offered for Liability coverages (BI, PD, MP, UM/UIM)\n\n69 This is for vehicles not appearing on symbol list. Physical Damage coverage is not available. (BI, PD, MP, UM/UIM)\n\n4\\. Conversion Van symbols for are based on the stated amount of the vehicle. The maximum stated amount allowed is $70,000.\n\n**Symbol Description**\n\n71 $1 - $10,000\n\n72 $10,001 - $20,000\n\n73 $20,001 - $30,000\n\n74 $30,001 - $40,000\n\n75 $40,001 - $50,000\n\n76 $50,000 - $70,000\n\n**Proposed**","publish_date":null,"title":"Proposed #","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page851.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page851.pdf"},"request":{"example_id":"table/BRWS-134565917_page851","product_type":"parse","source_file_path":"BRWS-134565917_page851.pdf"},"started_at":"2026-11-04T19:48:27.005850"} +{"completed_at":"2026-11-04T19:48:30.035193","latency_in_ms":1956,"output":{"example_id":"table/BRWS-134565917_page852","grounded_pages":[],"layout_pages":[],"markdown":"**Vehicle Type Indicator**\n\n**Vehicle Type VTI Code** **ALL BI COL MP OTC PD UIM UMBI**\n\nCoupe C 1.0242 0.9070 1.2006 0.9641 1.0242 0.9353 0.9641 0.9641\n\n4WD Truck K 1.0401 1.0374 1.0914 0.7693 1.0401 1.0758 0.7693 0.7693\n\nRoadster/Convertible R 1.1257 1.0522 1.1674 0.9410 1.1257 1.0821 0.9410 0.9410\n\nSedan S 1.0049 0.9826 1.0269 1.1120 1.0049 0.9705 1.1120 1.1120\n\n2WD Truck T 1.0033 1.1100 1.0952 0.7964 1.0033 1.1319 0.7964 0.7964\n\n2WD SUV U 0.9488 1.0261 0.9472 1.0254 0.9488 0.9748 1.0254 1.0254\n\nVan V 0.8070 0.9088 0.7868 0.8421 0.8070 0.9008 0.8421 0.8421\n\nWagon W 0.8889 0.9437 0.9162 1.0212 0.8889 0.9076 1.0212 1.0212\n\n4WD SUV Y 1.0611 0.9198 0.9216 1.0441 1.0611 0.9659 1.0441 1.0441\n\nZ 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Vehicle Type Indicator**\n\n**Vehicle Type VTI Code** **ALL BI COL MP OTC PD UIM UMBI**\n\nCoupe C 1.0242 0.9070 1.2006 0.9641 1.0242 0.9353 0.9641 0.9641\n\n4WD Truck K 1.0401 1.0374 1.0914 0.7693 1.0401 1.0758 0.7693 0.7693\n\nRoadster/Convertible R 1.1257 1.0522 1.1674 0.9410 1.1257 1.0821 0.9410 0.9410\n\nSedan S 1.0049 0.9826 1.0269 1.1120 1.0049 0.9705 1.1120 1.1120\n\n2WD Truck T 1.0033 1.1100 1.0952 0.7964 1.0033 1.1319 0.7964 0.7964\n\n2WD SUV U 0.9488 1.0261 0.9472 1.0254 0.9488 0.9748 1.0254 1.0254\n\nVan V 0.8070 0.9088 0.7868 0.8421 0.8070 0.9008 0.8421 0.8421\n\nWagon W 0.8889 0.9437 0.9162 1.0212 0.8889 0.9076 1.0212 1.0212\n\n4WD SUV Y 1.0611 0.9198 0.9216 1.0441 1.0611 0.9659 1.0441 1.0441\n\nZ 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Vehicle Type Indicator**\n\n**Vehicle Type VTI Code** **ALL BI COL MP OTC PD UIM UMBI**\n\nCoupe C 1.0242 0.9070 1.2006 0.9641 1.0242 0.9353 0.9641 0.9641\n\n4WD Truck K 1.0401 1.0374 1.0914 0.7693 1.0401 1.0758 0.7693 0.7693\n\nRoadster/Convertible R 1.1257 1.0522 1.1674 0.9410 1.1257 1.0821 0.9410 0.9410\n\nSedan S 1.0049 0.9826 1.0269 1.1120 1.0049 0.9705 1.1120 1.1120\n\n2WD Truck T 1.0033 1.1100 1.0952 0.7964 1.0033 1.1319 0.7964 0.7964\n\n2WD SUV U 0.9488 1.0261 0.9472 1.0254 0.9488 0.9748 1.0254 1.0254\n\nVan V 0.8070 0.9088 0.7868 0.8421 0.8070 0.9008 0.8421 0.8421\n\nWagon W 0.8889 0.9437 0.9162 1.0212 0.8889 0.9076 1.0212 1.0212\n\n4WD SUV Y 1.0611 0.9198 0.9216 1.0441 1.0611 0.9659 1.0441 1.0441\n\nZ 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page852.pdf"]},"response":{"errors":[],"extract_id":"extract_fd2b7926f4a2aae7a06f1179b5031c5c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Vehicle Type Indicator**\n\n**Vehicle Type VTI Code** **ALL BI COL MP OTC PD UIM UMBI**\n\nCoupe C 1.0242 0.9070 1.2006 0.9641 1.0242 0.9353 0.9641 0.9641\n\n4WD Truck K 1.0401 1.0374 1.0914 0.7693 1.0401 1.0758 0.7693 0.7693\n\nRoadster/Convertible R 1.1257 1.0522 1.1674 0.9410 1.1257 1.0821 0.9410 0.9410\n\nSedan S 1.0049 0.9826 1.0269 1.1120 1.0049 0.9705 1.1120 1.1120\n\n2WD Truck T 1.0033 1.1100 1.0952 0.7964 1.0033 1.1319 0.7964 0.7964\n\n2WD SUV U 0.9488 1.0261 0.9472 1.0254 0.9488 0.9748 1.0254 1.0254\n\nVan V 0.8070 0.9088 0.7868 0.8421 0.8070 0.9008 0.8421 0.8421\n\nWagon W 0.8889 0.9437 0.9162 1.0212 0.8889 0.9076 1.0212 1.0212\n\n4WD SUV Y 1.0611 0.9198 0.9216 1.0441 1.0611 0.9659 1.0441 1.0441\n\nZ 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**"],"full_content":"**Vehicle Type Indicator**\n\n**Vehicle Type VTI Code** **ALL BI COL MP OTC PD UIM UMBI**\n\nCoupe C 1.0242 0.9070 1.2006 0.9641 1.0242 0.9353 0.9641 0.9641\n\n4WD Truck K 1.0401 1.0374 1.0914 0.7693 1.0401 1.0758 0.7693 0.7693\n\nRoadster/Convertible R 1.1257 1.0522 1.1674 0.9410 1.1257 1.0821 0.9410 0.9410\n\nSedan S 1.0049 0.9826 1.0269 1.1120 1.0049 0.9705 1.1120 1.1120\n\n2WD Truck T 1.0033 1.1100 1.0952 0.7964 1.0033 1.1319 0.7964 0.7964\n\n2WD SUV U 0.9488 1.0261 0.9472 1.0254 0.9488 0.9748 1.0254 1.0254\n\nVan V 0.8070 0.9088 0.7868 0.8421 0.8070 0.9008 0.8421 0.8421\n\nWagon W 0.8889 0.9437 0.9162 1.0212 0.8889 0.9076 1.0212 1.0212\n\n4WD SUV Y 1.0611 0.9198 0.9216 1.0441 1.0611 0.9659 1.0441 1.0441\n\nZ 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","publish_date":null,"title":"Proposed Vehicle Type Indicator ALL BI COL MP OTC PD UIM UMBI Vehicle Type VTI Code Coupe C 1.02420.9070 1.2006","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page852.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page852.pdf"},"request":{"example_id":"table/BRWS-134565917_page852","product_type":"parse","source_file_path":"BRWS-134565917_page852.pdf"},"started_at":"2026-11-04T19:48:28.078550"} +{"completed_at":"2026-11-04T19:48:31.960243","latency_in_ms":2125,"output":{"example_id":"table/BRWS-134565917_page853","grounded_pages":[],"layout_pages":[],"markdown":"**Model Year Factor Model Year Groups Model Year group Vehicle Age Group**\n\n**Model Year ALL BI COL EXTR MP OTC PD RA UIM UMBI** 2023-2027+ A\n\n1995 & older 0.4320 0.7485 0.3144 0.3144 0.6826 0.4320 0.7480 2.1400 0.6826 0.6826 2020-2022 B\n\n1996 0.4320 0.7618 0.3144 0.3144 0.6933 0.4320 0.7577 2.1400 0.6933 0.6933 2017-2019 C\n\n1997 0.4320 0.7750 0.3144 0.3144 0.7041 0.4320 0.7674 2.1400 0.7041 0.7041 2014-2016 D\n\n1998 0.4320 0.7883 0.3144 0.3144 0.7149 0.4320 0.7771 2.1400 0.7149 0.7149 2011-2013 E\n\n1999 0.4320 0.8016 0.3144 0.3144 0.7257 0.4320 0.7868 2.1400 0.7257 0.7257 2008-2010 F\n\n2000 0.4320 0.8148 0.3144 0.3144 0.7364 0.4320 0.7965 2.1400 0.7364 0.7364 2007 & older G\n\n2001 0.4320 0.8281 0.3144 0.3144 0.7472 0.4320 0.8062 2.1400 0.7472 0.7472 9999 Z\n\n2002 0.4320 0.8414 0.3144 0.3144 0.7580 0.4320 0.8159 2.1400 0.7580 0.7580\n\n2003 0.4320 0.8546 0.3144 0.3144 0.7688 0.4320 0.8255 2.1400 0.7688 0.7688\n\n2004 0.4320 0.8804 0.3144 0.3144 0.8537 0.4320 0.8399 2.1400 0.8537 0.8537\n\n2005 0.4320 0.8831 0.3144 0.3144 0.8576 0.4320 0.9030 2.1400 0.8576 0.8576\n\n2006 0.4320 0.8845 0.3144 0.3144 0.8576 0.4320 0.9060 2.1400 0.8576 0.8576\n\n2007 0.4692 0.9787 0.3601 0.3601 0.8576 0.4692 0.9347 2.1400 0.8576 0.8576\n\n2008 0.4766 0.9929 0.4001 0.4001 0.8791 0.4766 0.9399 2.1400 0.8791 0.8791\n\n2009 0.5413 0.9976 0.4756 0.4756 0.9080 0.5413 0.9578 1.9700 0.9080 0.9080\n\n2010 0.5413 0.9976 0.4798 0.4798 0.9281 0.5413 0.9578 1.8600 0.9281 0.9281\n\n2011 0.5733 0.9976 0.4871 0.4871 0.9281 0.5733 0.9853 1.7900 0.9281 0.9281\n\n2012 0.6135 1.0322 0.5452 0.5452 1.0065 0.6135 1.0294 1.7500 1.0065 1.0065\n\n2013 0.7267 1.0829 0.6377 0.6377 1.0386 0.7267 1.0517 1.7200 1.0386 1.0386\n\n2014 0.7349 1.0829 0.6823 0.6823 1.0386 0.7349 1.0517 1.6900 1.0386 1.0386\n\n2015 0.8241 1.0982 0.7460 0.7460 1.0386 0.8241 1.0517 1.6600 1.0386 1.0386\n\n2016 0.9480 1.0568 0.8815 0.8815 1.0386 0.9480 1.0517 1.6100 1.0386 1.0386\n\n2017 0.9830 1.0568 0.9302 0.9302 1.0386 0.9830 1.0741 1.5300 1.0386 1.0386\n\n2018 0.9845 1.0568 0.9876 0.9876 1.0597 0.9845 1.0741 1.4200 1.0597 1.0597\n\n2019 1.1636 1.0568 1.1318 1.1318 1.0998 1.1636 1.1187 1.2900 1.0998 1.0998\n\n2020 1.1718 1.0568 1.2571 1.2571 1.1398 1.1718 1.1426 1.1200 1.1398 1.1398\n\n2021 1.2814 1.0568 1.2753 1.2753 1.1664 1.2814 1.1084 0.9300 1.1664 1.1664\n\n2022 1.3349 1.0568 1.4005 1.4005 1.1887 1.3349 1.0892 0.7600 1.1887 1.1887\n\n2023 1.4089 1.0076 1.4288 1.4288 1.2427 1.4089 1.0570 0.5900 1.2427 1.2427\n\n2024 1.4089 0.9572 1.4378 1.4378 1.2149 1.4089 0.9718 0.4200 1.2149 1.2149\n\n2025 1.4158 0.9572 1.5760 1.5760 1.2060 1.4158 0.9699 0.2600 1.2060 1.2060\n\n2026 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n2027+ 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n9999 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Model Year Factor Model Year Groups Model Year group Vehicle Age Group**\n\n**Model Year ALL BI COL EXTR MP OTC PD RA UIM UMBI** 2023-2027+ A\n\n1995 & older 0.4320 0.7485 0.3144 0.3144 0.6826 0.4320 0.7480 2.1400 0.6826 0.6826 2020-2022 B\n\n1996 0.4320 0.7618 0.3144 0.3144 0.6933 0.4320 0.7577 2.1400 0.6933 0.6933 2017-2019 C\n\n1997 0.4320 0.7750 0.3144 0.3144 0.7041 0.4320 0.7674 2.1400 0.7041 0.7041 2014-2016 D\n\n1998 0.4320 0.7883 0.3144 0.3144 0.7149 0.4320 0.7771 2.1400 0.7149 0.7149 2011-2013 E\n\n1999 0.4320 0.8016 0.3144 0.3144 0.7257 0.4320 0.7868 2.1400 0.7257 0.7257 2008-2010 F\n\n2000 0.4320 0.8148 0.3144 0.3144 0.7364 0.4320 0.7965 2.1400 0.7364 0.7364 2007 & older G\n\n2001 0.4320 0.8281 0.3144 0.3144 0.7472 0.4320 0.8062 2.1400 0.7472 0.7472 9999 Z\n\n2002 0.4320 0.8414 0.3144 0.3144 0.7580 0.4320 0.8159 2.1400 0.7580 0.7580\n\n2003 0.4320 0.8546 0.3144 0.3144 0.7688 0.4320 0.8255 2.1400 0.7688 0.7688\n\n2004 0.4320 0.8804 0.3144 0.3144 0.8537 0.4320 0.8399 2.1400 0.8537 0.8537\n\n2005 0.4320 0.8831 0.3144 0.3144 0.8576 0.4320 0.9030 2.1400 0.8576 0.8576\n\n2006 0.4320 0.8845 0.3144 0.3144 0.8576 0.4320 0.9060 2.1400 0.8576 0.8576\n\n2007 0.4692 0.9787 0.3601 0.3601 0.8576 0.4692 0.9347 2.1400 0.8576 0.8576\n\n2008 0.4766 0.9929 0.4001 0.4001 0.8791 0.4766 0.9399 2.1400 0.8791 0.8791\n\n2009 0.5413 0.9976 0.4756 0.4756 0.9080 0.5413 0.9578 1.9700 0.9080 0.9080\n\n2010 0.5413 0.9976 0.4798 0.4798 0.9281 0.5413 0.9578 1.8600 0.9281 0.9281\n\n2011 0.5733 0.9976 0.4871 0.4871 0.9281 0.5733 0.9853 1.7900 0.9281 0.9281\n\n2012 0.6135 1.0322 0.5452 0.5452 1.0065 0.6135 1.0294 1.7500 1.0065 1.0065\n\n2013 0.7267 1.0829 0.6377 0.6377 1.0386 0.7267 1.0517 1.7200 1.0386 1.0386\n\n2014 0.7349 1.0829 0.6823 0.6823 1.0386 0.7349 1.0517 1.6900 1.0386 1.0386\n\n2015 0.8241 1.0982 0.7460 0.7460 1.0386 0.8241 1.0517 1.6600 1.0386 1.0386\n\n2016 0.9480 1.0568 0.8815 0.8815 1.0386 0.9480 1.0517 1.6100 1.0386 1.0386\n\n2017 0.9830 1.0568 0.9302 0.9302 1.0386 0.9830 1.0741 1.5300 1.0386 1.0386\n\n2018 0.9845 1.0568 0.9876 0.9876 1.0597 0.9845 1.0741 1.4200 1.0597 1.0597\n\n2019 1.1636 1.0568 1.1318 1.1318 1.0998 1.1636 1.1187 1.2900 1.0998 1.0998\n\n2020 1.1718 1.0568 1.2571 1.2571 1.1398 1.1718 1.1426 1.1200 1.1398 1.1398\n\n2021 1.2814 1.0568 1.2753 1.2753 1.1664 1.2814 1.1084 0.9300 1.1664 1.1664\n\n2022 1.3349 1.0568 1.4005 1.4005 1.1887 1.3349 1.0892 0.7600 1.1887 1.1887\n\n2023 1.4089 1.0076 1.4288 1.4288 1.2427 1.4089 1.0570 0.5900 1.2427 1.2427\n\n2024 1.4089 0.9572 1.4378 1.4378 1.2149 1.4089 0.9718 0.4200 1.2149 1.2149\n\n2025 1.4158 0.9572 1.5760 1.5760 1.2060 1.4158 0.9699 0.2600 1.2060 1.2060\n\n2026 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n2027+ 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n9999 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Model Year Factor Model Year Groups Model Year group Vehicle Age Group**\n\n**Model Year ALL BI COL EXTR MP OTC PD RA UIM UMBI** 2023-2027+ A\n\n1995 & older 0.4320 0.7485 0.3144 0.3144 0.6826 0.4320 0.7480 2.1400 0.6826 0.6826 2020-2022 B\n\n1996 0.4320 0.7618 0.3144 0.3144 0.6933 0.4320 0.7577 2.1400 0.6933 0.6933 2017-2019 C\n\n1997 0.4320 0.7750 0.3144 0.3144 0.7041 0.4320 0.7674 2.1400 0.7041 0.7041 2014-2016 D\n\n1998 0.4320 0.7883 0.3144 0.3144 0.7149 0.4320 0.7771 2.1400 0.7149 0.7149 2011-2013 E\n\n1999 0.4320 0.8016 0.3144 0.3144 0.7257 0.4320 0.7868 2.1400 0.7257 0.7257 2008-2010 F\n\n2000 0.4320 0.8148 0.3144 0.3144 0.7364 0.4320 0.7965 2.1400 0.7364 0.7364 2007 & older G\n\n2001 0.4320 0.8281 0.3144 0.3144 0.7472 0.4320 0.8062 2.1400 0.7472 0.7472 9999 Z\n\n2002 0.4320 0.8414 0.3144 0.3144 0.7580 0.4320 0.8159 2.1400 0.7580 0.7580\n\n2003 0.4320 0.8546 0.3144 0.3144 0.7688 0.4320 0.8255 2.1400 0.7688 0.7688\n\n2004 0.4320 0.8804 0.3144 0.3144 0.8537 0.4320 0.8399 2.1400 0.8537 0.8537\n\n2005 0.4320 0.8831 0.3144 0.3144 0.8576 0.4320 0.9030 2.1400 0.8576 0.8576\n\n2006 0.4320 0.8845 0.3144 0.3144 0.8576 0.4320 0.9060 2.1400 0.8576 0.8576\n\n2007 0.4692 0.9787 0.3601 0.3601 0.8576 0.4692 0.9347 2.1400 0.8576 0.8576\n\n2008 0.4766 0.9929 0.4001 0.4001 0.8791 0.4766 0.9399 2.1400 0.8791 0.8791\n\n2009 0.5413 0.9976 0.4756 0.4756 0.9080 0.5413 0.9578 1.9700 0.9080 0.9080\n\n2010 0.5413 0.9976 0.4798 0.4798 0.9281 0.5413 0.9578 1.8600 0.9281 0.9281\n\n2011 0.5733 0.9976 0.4871 0.4871 0.9281 0.5733 0.9853 1.7900 0.9281 0.9281\n\n2012 0.6135 1.0322 0.5452 0.5452 1.0065 0.6135 1.0294 1.7500 1.0065 1.0065\n\n2013 0.7267 1.0829 0.6377 0.6377 1.0386 0.7267 1.0517 1.7200 1.0386 1.0386\n\n2014 0.7349 1.0829 0.6823 0.6823 1.0386 0.7349 1.0517 1.6900 1.0386 1.0386\n\n2015 0.8241 1.0982 0.7460 0.7460 1.0386 0.8241 1.0517 1.6600 1.0386 1.0386\n\n2016 0.9480 1.0568 0.8815 0.8815 1.0386 0.9480 1.0517 1.6100 1.0386 1.0386\n\n2017 0.9830 1.0568 0.9302 0.9302 1.0386 0.9830 1.0741 1.5300 1.0386 1.0386\n\n2018 0.9845 1.0568 0.9876 0.9876 1.0597 0.9845 1.0741 1.4200 1.0597 1.0597\n\n2019 1.1636 1.0568 1.1318 1.1318 1.0998 1.1636 1.1187 1.2900 1.0998 1.0998\n\n2020 1.1718 1.0568 1.2571 1.2571 1.1398 1.1718 1.1426 1.1200 1.1398 1.1398\n\n2021 1.2814 1.0568 1.2753 1.2753 1.1664 1.2814 1.1084 0.9300 1.1664 1.1664\n\n2022 1.3349 1.0568 1.4005 1.4005 1.1887 1.3349 1.0892 0.7600 1.1887 1.1887\n\n2023 1.4089 1.0076 1.4288 1.4288 1.2427 1.4089 1.0570 0.5900 1.2427 1.2427\n\n2024 1.4089 0.9572 1.4378 1.4378 1.2149 1.4089 0.9718 0.4200 1.2149 1.2149\n\n2025 1.4158 0.9572 1.5760 1.5760 1.2060 1.4158 0.9699 0.2600 1.2060 1.2060\n\n2026 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n2027+ 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n9999 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page853.pdf"]},"response":{"errors":[],"extract_id":"extract_eb1efca28aebda7edeabb575c2afed99","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Model Year Factor Model Year Groups Model Year group Vehicle Age Group**\n\n**Model Year ALL BI COL EXTR MP OTC PD RA UIM UMBI** 2023-2027+ A\n\n1995 & older 0.4320 0.7485 0.3144 0.3144 0.6826 0.4320 0.7480 2.1400 0.6826 0.6826 2020-2022 B\n\n1996 0.4320 0.7618 0.3144 0.3144 0.6933 0.4320 0.7577 2.1400 0.6933 0.6933 2017-2019 C\n\n1997 0.4320 0.7750 0.3144 0.3144 0.7041 0.4320 0.7674 2.1400 0.7041 0.7041 2014-2016 D\n\n1998 0.4320 0.7883 0.3144 0.3144 0.7149 0.4320 0.7771 2.1400 0.7149 0.7149 2011-2013 E\n\n1999 0.4320 0.8016 0.3144 0.3144 0.7257 0.4320 0.7868 2.1400 0.7257 0.7257 2008-2010 F\n\n2000 0.4320 0.8148 0.3144 0.3144 0.7364 0.4320 0.7965 2.1400 0.7364 0.7364 2007 & older G\n\n2001 0.4320 0.8281 0.3144 0.3144 0.7472 0.4320 0.8062 2.1400 0.7472 0.7472 9999 Z\n\n2002 0.4320 0.8414 0.3144 0.3144 0.7580 0.4320 0.8159 2.1400 0.7580 0.7580\n\n2003 0.4320 0.8546 0.3144 0.3144 0.7688 0.4320 0.8255 2.1400 0.7688 0.7688\n\n2004 0.4320 0.8804 0.3144 0.3144 0.8537 0.4320 0.8399 2.1400 0.8537 0.8537\n\n2005 0.4320 0.8831 0.3144 0.3144 0.8576 0.4320 0.9030 2.1400 0.8576 0.8576\n\n2006 0.4320 0.8845 0.3144 0.3144 0.8576 0.4320 0.9060 2.1400 0.8576 0.8576\n\n2007 0.4692 0.9787 0.3601 0.3601 0.8576 0.4692 0.9347 2.1400 0.8576 0.8576\n\n2008 0.4766 0.9929 0.4001 0.4001 0.8791 0.4766 0.9399 2.1400 0.8791 0.8791\n\n2009 0.5413 0.9976 0.4756 0.4756 0.9080 0.5413 0.9578 1.9700 0.9080 0.9080\n\n2010 0.5413 0.9976 0.4798 0.4798 0.9281 0.5413 0.9578 1.8600 0.9281 0.9281\n\n2011 0.5733 0.9976 0.4871 0.4871 0.9281 0.5733 0.9853 1.7900 0.9281 0.9281\n\n2012 0.6135 1.0322 0.5452 0.5452 1.0065 0.6135 1.0294 1.7500 1.0065 1.0065\n\n2013 0.7267 1.0829 0.6377 0.6377 1.0386 0.7267 1.0517 1.7200 1.0386 1.0386\n\n2014 0.7349 1.0829 0.6823 0.6823 1.0386 0.7349 1.0517 1.6900 1.0386 1.0386\n\n2015 0.8241 1.0982 0.7460 0.7460 1.0386 0.8241 1.0517 1.6600 1.0386 1.0386\n\n2016 0.9480 1.0568 0.8815 0.8815 1.0386 0.9480 1.0517 1.6100 1.0386 1.0386\n\n2017 0.9830 1.0568 0.9302 0.9302 1.0386 0.9830 1.0741 1.5300 1.0386 1.0386\n\n2018 0.9845 1.0568 0.9876 0.9876 1.0597 0.9845 1.0741 1.4200 1.0597 1.0597\n\n2019 1.1636 1.0568 1.1318 1.1318 1.0998 1.1636 1.1187 1.2900 1.0998 1.0998\n\n2020 1.1718 1.0568 1.2571 1.2571 1.1398 1.1718 1.1426 1.1200 1.1398 1.1398\n\n2021 1.2814 1.0568 1.2753 1.2753 1.1664 1.2814 1.1084 0.9300 1.1664 1.1664\n\n2022 1.3349 1.0568 1.4005 1.4005 1.1887 1.3349 1.0892 0.7600 1.1887 1.1887\n\n2023 1.4089 1.0076 1.4288 1.4288 1.2427 1.4089 1.0570 0.5900 1.2427 1.2427\n\n2024 1.4089 0.9572 1.4378 1.4378 1.2149 1.4089 0.9718 0.4200 1.2149 1.2149\n\n2025 1.4158 0.9572 1.5760 1.5760 1.2060 1.4158 0.9699 0.2600 1.2060 1.2060\n\n2026 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n2027+ 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n9999 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**"],"full_content":"**Model Year Factor Model Year Groups Model Year group Vehicle Age Group**\n\n**Model Year ALL BI COL EXTR MP OTC PD RA UIM UMBI** 2023-2027+ A\n\n1995 & older 0.4320 0.7485 0.3144 0.3144 0.6826 0.4320 0.7480 2.1400 0.6826 0.6826 2020-2022 B\n\n1996 0.4320 0.7618 0.3144 0.3144 0.6933 0.4320 0.7577 2.1400 0.6933 0.6933 2017-2019 C\n\n1997 0.4320 0.7750 0.3144 0.3144 0.7041 0.4320 0.7674 2.1400 0.7041 0.7041 2014-2016 D\n\n1998 0.4320 0.7883 0.3144 0.3144 0.7149 0.4320 0.7771 2.1400 0.7149 0.7149 2011-2013 E\n\n1999 0.4320 0.8016 0.3144 0.3144 0.7257 0.4320 0.7868 2.1400 0.7257 0.7257 2008-2010 F\n\n2000 0.4320 0.8148 0.3144 0.3144 0.7364 0.4320 0.7965 2.1400 0.7364 0.7364 2007 & older G\n\n2001 0.4320 0.8281 0.3144 0.3144 0.7472 0.4320 0.8062 2.1400 0.7472 0.7472 9999 Z\n\n2002 0.4320 0.8414 0.3144 0.3144 0.7580 0.4320 0.8159 2.1400 0.7580 0.7580\n\n2003 0.4320 0.8546 0.3144 0.3144 0.7688 0.4320 0.8255 2.1400 0.7688 0.7688\n\n2004 0.4320 0.8804 0.3144 0.3144 0.8537 0.4320 0.8399 2.1400 0.8537 0.8537\n\n2005 0.4320 0.8831 0.3144 0.3144 0.8576 0.4320 0.9030 2.1400 0.8576 0.8576\n\n2006 0.4320 0.8845 0.3144 0.3144 0.8576 0.4320 0.9060 2.1400 0.8576 0.8576\n\n2007 0.4692 0.9787 0.3601 0.3601 0.8576 0.4692 0.9347 2.1400 0.8576 0.8576\n\n2008 0.4766 0.9929 0.4001 0.4001 0.8791 0.4766 0.9399 2.1400 0.8791 0.8791\n\n2009 0.5413 0.9976 0.4756 0.4756 0.9080 0.5413 0.9578 1.9700 0.9080 0.9080\n\n2010 0.5413 0.9976 0.4798 0.4798 0.9281 0.5413 0.9578 1.8600 0.9281 0.9281\n\n2011 0.5733 0.9976 0.4871 0.4871 0.9281 0.5733 0.9853 1.7900 0.9281 0.9281\n\n2012 0.6135 1.0322 0.5452 0.5452 1.0065 0.6135 1.0294 1.7500 1.0065 1.0065\n\n2013 0.7267 1.0829 0.6377 0.6377 1.0386 0.7267 1.0517 1.7200 1.0386 1.0386\n\n2014 0.7349 1.0829 0.6823 0.6823 1.0386 0.7349 1.0517 1.6900 1.0386 1.0386\n\n2015 0.8241 1.0982 0.7460 0.7460 1.0386 0.8241 1.0517 1.6600 1.0386 1.0386\n\n2016 0.9480 1.0568 0.8815 0.8815 1.0386 0.9480 1.0517 1.6100 1.0386 1.0386\n\n2017 0.9830 1.0568 0.9302 0.9302 1.0386 0.9830 1.0741 1.5300 1.0386 1.0386\n\n2018 0.9845 1.0568 0.9876 0.9876 1.0597 0.9845 1.0741 1.4200 1.0597 1.0597\n\n2019 1.1636 1.0568 1.1318 1.1318 1.0998 1.1636 1.1187 1.2900 1.0998 1.0998\n\n2020 1.1718 1.0568 1.2571 1.2571 1.1398 1.1718 1.1426 1.1200 1.1398 1.1398\n\n2021 1.2814 1.0568 1.2753 1.2753 1.1664 1.2814 1.1084 0.9300 1.1664 1.1664\n\n2022 1.3349 1.0568 1.4005 1.4005 1.1887 1.3349 1.0892 0.7600 1.1887 1.1887\n\n2023 1.4089 1.0076 1.4288 1.4288 1.2427 1.4089 1.0570 0.5900 1.2427 1.2427\n\n2024 1.4089 0.9572 1.4378 1.4378 1.2149 1.4089 0.9718 0.4200 1.2149 1.2149\n\n2025 1.4158 0.9572 1.5760 1.5760 1.2060 1.4158 0.9699 0.2600 1.2060 1.2060\n\n2026 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n2027+ 1.4158 0.9000 1.5760 1.5760 1.2060 1.4158 0.8245 0.2600 1.2060 1.2060\n\n9999 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\n**Proposed**","publish_date":null,"title":"Proposed Model Year Factor Model Year Groups Model Year group Vehicle Age Group Model Year ALL BI COL EXTR MP","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page853.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page853.pdf"},"request":{"example_id":"table/BRWS-134565917_page853","product_type":"parse","source_file_path":"BRWS-134565917_page853.pdf"},"started_at":"2026-11-04T19:48:29.834468"} +{"completed_at":"2026-11-04T19:48:31.375583","latency_in_ms":1149,"output":{"example_id":"table/BRWS-134565917_page874","grounded_pages":[],"layout_pages":[],"markdown":"**Comp without Collision Surcharge**\n\n**Vehicle Use Code NRE COL ON VEHICLE** **OTC Surcharge**\n\nA N 0.2313\n\nA Y 0.0000\n\nB N 0.2313\n\nB Y 0.0000\n\nO N 0.0000\n\nO Y 0.0000\n\nP N 0.2313\n\nP Y 0.0000\n\nR N 0.2313\n\nR Y 0.0000\n\nS N 0.2313\n\nS Y 0.0000\n\n**Proposed**","pages":[{"line_numbers":[],"markdown":"**Comp without Collision Surcharge**\n\n**Vehicle Use Code NRE COL ON VEHICLE** **OTC Surcharge**\n\nA N 0.2313\n\nA Y 0.0000\n\nB N 0.2313\n\nB Y 0.0000\n\nO N 0.0000\n\nO Y 0.0000\n\nP N 0.2313\n\nP Y 0.0000\n\nR N 0.2313\n\nR Y 0.0000\n\nS N 0.2313\n\nS Y 0.0000\n\n**Proposed**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Comp without Collision Surcharge**\n\n**Vehicle Use Code NRE COL ON VEHICLE** **OTC Surcharge**\n\nA N 0.2313\n\nA Y 0.0000\n\nB N 0.2313\n\nB Y 0.0000\n\nO N 0.0000\n\nO Y 0.0000\n\nP N 0.2313\n\nP Y 0.0000\n\nR N 0.2313\n\nR Y 0.0000\n\nS N 0.2313\n\nS Y 0.0000\n\n**Proposed**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page874.pdf"]},"response":{"errors":[],"extract_id":"extract_5a24426b7544914846bfa5e106fcc146","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Comp without Collision Surcharge**\n\n**Vehicle Use Code NRE COL ON VEHICLE** **OTC Surcharge**\n\nA N 0.2313\n\nA Y 0.0000\n\nB N 0.2313\n\nB Y 0.0000\n\nO N 0.0000\n\nO Y 0.0000\n\nP N 0.2313\n\nP Y 0.0000\n\nR N 0.2313\n\nR Y 0.0000\n\nS N 0.2313\n\nS Y 0.0000\n\n**Proposed**"],"full_content":"**Comp without Collision Surcharge**\n\n**Vehicle Use Code NRE COL ON VEHICLE** **OTC Surcharge**\n\nA N 0.2313\n\nA Y 0.0000\n\nB N 0.2313\n\nB Y 0.0000\n\nO N 0.0000\n\nO Y 0.0000\n\nP N 0.2313\n\nP Y 0.0000\n\nR N 0.2313\n\nR Y 0.0000\n\nS N 0.2313\n\nS Y 0.0000\n\n**Proposed**","publish_date":null,"title":"Proposed Vehicle Use Code NRE COL ON VEHICLE A N A Y B N B Y O N O Y","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page874.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page874.pdf"},"request":{"example_id":"table/BRWS-134565917_page874","product_type":"parse","source_file_path":"BRWS-134565917_page874.pdf"},"started_at":"2026-11-04T19:48:30.225748"} +{"completed_at":"2026-11-04T19:46:54.062831","latency_in_ms":2197,"output":{"example_id":"table/BRWS-134565917_page875","grounded_pages":[],"layout_pages":[],"markdown":"**SR22 Surcharge SR22 ALL BI COLL MP OTC PD UIM UMBI**\n\n**Y** 0\\.1139 0.0577 0.1139 0.0577 0.1139 0.0577 0.0577 0.0577\n\nN 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\nProposed","pages":[{"line_numbers":[],"markdown":"**SR22 Surcharge SR22 ALL BI COLL MP OTC PD UIM UMBI**\n\n**Y** 0\\.1139 0.0577 0.1139 0.0577 0.1139 0.0577 0.0577 0.0577\n\nN 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\nProposed","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**SR22 Surcharge SR22 ALL BI COLL MP OTC PD UIM UMBI**\n\n**Y** 0\\.1139 0.0577 0.1139 0.0577 0.1139 0.0577 0.0577 0.0577\n\nN 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\nProposed","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page875.pdf"]},"response":{"errors":[],"extract_id":"extract_9381a748a34faf785c50c72a439c2c54","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**SR22 Surcharge SR22 ALL BI COLL MP OTC PD UIM UMBI**\n\n**Y** 0\\.1139 0.0577 0.1139 0.0577 0.1139 0.0577 0.0577 0.0577\n\nN 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\nProposed"],"full_content":"**SR22 Surcharge SR22 ALL BI COLL MP OTC PD UIM UMBI**\n\n**Y** 0\\.1139 0.0577 0.1139 0.0577 0.1139 0.0577 0.0577 0.0577\n\nN 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\nProposed","publish_date":null,"title":"Proposed SR22 Surcharge SR22 ALL BI COLL MP OTC PD UIM UMBI Y 0.1139 0.0577 0.1139 0.0577 0.1139 0.0577 0.0577","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page875.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page875.pdf"},"request":{"example_id":"table/BRWS-134565917_page875","product_type":"parse","source_file_path":"BRWS-134565917_page875.pdf"},"started_at":"2026-11-04T19:46:51.865741"} +{"completed_at":"2026-11-04T19:46:53.999299","latency_in_ms":2130,"output":{"example_id":"table/BRWS-134565917_page877","grounded_pages":[],"layout_pages":[],"markdown":"**EFT ALR Code**\n\n**Down Payment Method**\n\n**EFT Installment**\n\n**Method Installment ALR Code**\n\n**EFT Discount**\n\n**Applied\\* Lifetime Tenure Codes**\n\nProducer Sweep None N N 0 to < 6 months A C\n\nChecking/Savings None N N 6 to < 12 months B D\n\nCredit Card None N N 12 to < 18 months C N\n\nDebit Card None N N 18 to < 24 months D Y\n\nProducer Sweep Checking/Savings Y Y 24 to < 30 months E\n\nChecking/Savings Checking/Savings Y Y 30 to < 36 months F E\n\nCredit Card Checking/Savings Y Y 36 to < 42 months G X\n\nDebit Card Checking/Savings Y Y 42 to < 48 months H\n\nProducer Sweep Credit Card C Y 48 to < 54 months I\n\nChecking/Savings Credit Card C Y 54 to < 60 months J\n\nCredit Card Credit Card C Y >= 60 months K\n\nDebit Card Credit Card C Y\n\nProducer Sweep Debit Card D N\n\nChecking/Savings Debit Card D N\n\nCredit Card Debit Card D N\n\nDebit Card Debit Card D N\n\n**EFT-PIF-GPL Discount**\n\n**UW Tier Group**\n\n**Downpayment ALR**\n\n**Code EFT Installment ALR Code Paid In Full Go Paperless Lifetime Tenure ALL BI COL EXTR MP OTC PD RA TL UIM UMBI**\n\n1 C C N E A 0.0273 0.0999 0.0573 0.0573 0.1484 0.0273 0.1211 0.0573 0.0573 0.1484 0.1484\n\n1 C C N E B 0.0262 0.0793 0.0497 0.0497 0.1391 0.0262 0.1036 0.0497 0.0497 0.1391 0.1391\n\n1 C C N E C 0.0251 0.0582 0.0420 0.0420 0.1297 0.0251 0.0858 0.0420 0.0420 0.1297 0.1297\n\n1 C C N E D 0.0240 0.0366 0.0342 0.0342 0.1202 0.0240 0.0676 0.0342 0.0342 0.1202 0.1202\n\n1 C C N E E 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E F 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E G 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E H 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E I 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E J 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E K 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N X A 0.0273 0.0652 0.0301 0.0301 0.1300 0.0273 0.0816 0.0301 0.0301 0.1300 0.1300\n\n1 C C N X B 0.0262 0.0504 0.0267 0.0267 0.1229 0.0262 0.0712 0.0267 0.0267 0.1229 0.1229\n\n1 C C N X C 0.0251 0.0354 0.0233 0.0233 0.1158 0.0251 0.0607 0.0233 0.0233 0.1158 0.1158\n\n1 C C N X D 0.0240 0.0201 0.0199 0.0199 0.1086 0.0240 0.0501 0.0199 0.0199 0.1086 0.1086\n\n1 C C N X E 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X F 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X G 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X H 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X I 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X J 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X K 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C C Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C C Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C C Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C C Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E H 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E I 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E J 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E K 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y X A 0.1621 0.1324 0.1027 0.1027 0.2784 0.1621 0.1048 0.1027 0.1027 0.2784 0.2784\n\n1 C C Y X B 0.1501 0.1150 0.0883 0.0883 0.2590 0.1501 0.0897 0.0883 0.0883 0.2590 0.2590\n\n1 C C Y X C 0.1380 0.0973 0.0737 0.0737 0.2391 0.1380 0.0744 0.0737 0.0737 0.2391 0.2391\n\n1 C C Y X D 0.1257 0.0792 0.0588 0.0588 0.2187 0.1257 0.0588 0.0588 0.0588 0.2187 0.2187\n\n1 C C Y X E 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X F 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X G 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X H 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X I 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X J 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X K 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D N E A 0.0000 0.0371 0.0281 0.0281 0.0211 0.0000 0.0430 0.0281 0.0281 0.0211 0.0211\n\n1 C D N E B 0.0000 0.0304 0.0236 0.0236 0.0183 0.0000 0.0349 0.0236 0.0236 0.0183 0.0183\n\n1 C D N E C 0.0000 0.0236 0.0191 0.0191 0.0155 0.0000 0.0267 0.0191 0.0191 0.0155 0.0155\n\n1 C D N E D 0.0000 0.0168 0.0146 0.0146 0.0127 0.0000 0.0184 0.0146 0.0146 0.0127 0.0127\n\n1 C D N E E 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E F 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E G 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E H 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E I 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E J 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E K 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N X A 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X B 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X C 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X D 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X E 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X G 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X H 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X I 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X J 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X K 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C D Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C D Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C D Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C D Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E H 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E I 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E J 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E K 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y X A 0.1621 0.1324 0.1027 0.1027 0.2784 0.1621 0.1048 0.1027 0.1027 0.2784 0.2784\n\n1 C D Y X B 0.1501 0.1150 0.0883 0.0883 0.2590 0.1501 0.0897 0.0883 0.0883 0.2590 0.2590\n\n1 C D Y X C 0.1380 0.0973 0.0737 0.0737 0.2391 0.1380 0.0744 0.0737 0.0737 0.2391 0.2391\n\n1 C D Y X D 0.1257 0.0792 0.0588 0.0588 0.2187 0.1257 0.0588 0.0588 0.0588 0.2187 0.2187\n\n1 C D Y X E 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X F 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X G 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X H 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X I 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X J 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X K 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C N N E A 0.0000 0.0371 0.0281 0.0281 0.0211 0.0000 0.0430 0.0281 0.0281 0.0211 0.0211\n\n1 C N N E B 0.0000 0.0304 0.0236 0.0236 0.0183 0.0000 0.0349 0.0236 0.0236 0.0183 0.0183\n\n1 C N N E C 0.0000 0.0236 0.0191 0.0191 0.0155 0.0000 0.0267 0.0191 0.0191 0.0155 0.0155\n\n1 C N N E D 0.0000 0.0168 0.0146 0.0146 0.0127 0.0000 0.0184 0.0146 0.0146 0.0127 0.0127\n\n1 C N N E E 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E F 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E G 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E H 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E I 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E J 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E K 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N X A 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X B 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X C 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X D 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X E 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X G 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X H 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X I 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X J 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X K 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C N Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C N Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C N Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C N Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C N Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C N Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n**Go Paperless Key**\n\nGo Paperless\n\nNo Go Paperless\n\nCredit Card\n\n**Proposed**\n\n**EFT Key**\n\nChecking/ Saving\n\nDebit Card\n\nNo EFT","pages":[{"line_numbers":[],"markdown":"**EFT ALR Code**\n\n**Down Payment Method**\n\n**EFT Installment**\n\n**Method Installment ALR Code**\n\n**EFT Discount**\n\n**Applied\\* Lifetime Tenure Codes**\n\nProducer Sweep None N N 0 to < 6 months A C\n\nChecking/Savings None N N 6 to < 12 months B D\n\nCredit Card None N N 12 to < 18 months C N\n\nDebit Card None N N 18 to < 24 months D Y\n\nProducer Sweep Checking/Savings Y Y 24 to < 30 months E\n\nChecking/Savings Checking/Savings Y Y 30 to < 36 months F E\n\nCredit Card Checking/Savings Y Y 36 to < 42 months G X\n\nDebit Card Checking/Savings Y Y 42 to < 48 months H\n\nProducer Sweep Credit Card C Y 48 to < 54 months I\n\nChecking/Savings Credit Card C Y 54 to < 60 months J\n\nCredit Card Credit Card C Y >= 60 months K\n\nDebit Card Credit Card C Y\n\nProducer Sweep Debit Card D N\n\nChecking/Savings Debit Card D N\n\nCredit Card Debit Card D N\n\nDebit Card Debit Card D N\n\n**EFT-PIF-GPL Discount**\n\n**UW Tier Group**\n\n**Downpayment ALR**\n\n**Code EFT Installment ALR Code Paid In Full Go Paperless Lifetime Tenure ALL BI COL EXTR MP OTC PD RA TL UIM UMBI**\n\n1 C C N E A 0.0273 0.0999 0.0573 0.0573 0.1484 0.0273 0.1211 0.0573 0.0573 0.1484 0.1484\n\n1 C C N E B 0.0262 0.0793 0.0497 0.0497 0.1391 0.0262 0.1036 0.0497 0.0497 0.1391 0.1391\n\n1 C C N E C 0.0251 0.0582 0.0420 0.0420 0.1297 0.0251 0.0858 0.0420 0.0420 0.1297 0.1297\n\n1 C C N E D 0.0240 0.0366 0.0342 0.0342 0.1202 0.0240 0.0676 0.0342 0.0342 0.1202 0.1202\n\n1 C C N E E 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E F 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E G 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E H 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E I 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E J 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E K 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N X A 0.0273 0.0652 0.0301 0.0301 0.1300 0.0273 0.0816 0.0301 0.0301 0.1300 0.1300\n\n1 C C N X B 0.0262 0.0504 0.0267 0.0267 0.1229 0.0262 0.0712 0.0267 0.0267 0.1229 0.1229\n\n1 C C N X C 0.0251 0.0354 0.0233 0.0233 0.1158 0.0251 0.0607 0.0233 0.0233 0.1158 0.1158\n\n1 C C N X D 0.0240 0.0201 0.0199 0.0199 0.1086 0.0240 0.0501 0.0199 0.0199 0.1086 0.1086\n\n1 C C N X E 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X F 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X G 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X H 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X I 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X J 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X K 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C C Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C C Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C C Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C C Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E H 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E I 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E J 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E K 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y X A 0.1621 0.1324 0.1027 0.1027 0.2784 0.1621 0.1048 0.1027 0.1027 0.2784 0.2784\n\n1 C C Y X B 0.1501 0.1150 0.0883 0.0883 0.2590 0.1501 0.0897 0.0883 0.0883 0.2590 0.2590\n\n1 C C Y X C 0.1380 0.0973 0.0737 0.0737 0.2391 0.1380 0.0744 0.0737 0.0737 0.2391 0.2391\n\n1 C C Y X D 0.1257 0.0792 0.0588 0.0588 0.2187 0.1257 0.0588 0.0588 0.0588 0.2187 0.2187\n\n1 C C Y X E 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X F 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X G 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X H 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X I 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X J 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X K 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D N E A 0.0000 0.0371 0.0281 0.0281 0.0211 0.0000 0.0430 0.0281 0.0281 0.0211 0.0211\n\n1 C D N E B 0.0000 0.0304 0.0236 0.0236 0.0183 0.0000 0.0349 0.0236 0.0236 0.0183 0.0183\n\n1 C D N E C 0.0000 0.0236 0.0191 0.0191 0.0155 0.0000 0.0267 0.0191 0.0191 0.0155 0.0155\n\n1 C D N E D 0.0000 0.0168 0.0146 0.0146 0.0127 0.0000 0.0184 0.0146 0.0146 0.0127 0.0127\n\n1 C D N E E 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E F 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E G 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E H 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E I 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E J 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E K 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N X A 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X B 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X C 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X D 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X E 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X G 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X H 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X I 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X J 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X K 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C D Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C D Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C D Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C D Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E H 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E I 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E J 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E K 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y X A 0.1621 0.1324 0.1027 0.1027 0.2784 0.1621 0.1048 0.1027 0.1027 0.2784 0.2784\n\n1 C D Y X B 0.1501 0.1150 0.0883 0.0883 0.2590 0.1501 0.0897 0.0883 0.0883 0.2590 0.2590\n\n1 C D Y X C 0.1380 0.0973 0.0737 0.0737 0.2391 0.1380 0.0744 0.0737 0.0737 0.2391 0.2391\n\n1 C D Y X D 0.1257 0.0792 0.0588 0.0588 0.2187 0.1257 0.0588 0.0588 0.0588 0.2187 0.2187\n\n1 C D Y X E 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X F 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X G 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X H 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X I 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X J 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X K 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C N N E A 0.0000 0.0371 0.0281 0.0281 0.0211 0.0000 0.0430 0.0281 0.0281 0.0211 0.0211\n\n1 C N N E B 0.0000 0.0304 0.0236 0.0236 0.0183 0.0000 0.0349 0.0236 0.0236 0.0183 0.0183\n\n1 C N N E C 0.0000 0.0236 0.0191 0.0191 0.0155 0.0000 0.0267 0.0191 0.0191 0.0155 0.0155\n\n1 C N N E D 0.0000 0.0168 0.0146 0.0146 0.0127 0.0000 0.0184 0.0146 0.0146 0.0127 0.0127\n\n1 C N N E E 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E F 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E G 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E H 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E I 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E J 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E K 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N X A 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X B 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X C 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X D 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X E 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X G 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X H 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X I 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X J 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X K 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C N Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C N Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C N Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C N Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C N Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C N Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n**Go Paperless Key**\n\nGo Paperless\n\nNo Go Paperless\n\nCredit Card\n\n**Proposed**\n\n**EFT Key**\n\nChecking/ Saving\n\nDebit Card\n\nNo EFT","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**EFT ALR Code**\n\n**Down Payment Method**\n\n**EFT Installment**\n\n**Method Installment ALR Code**\n\n**EFT Discount**\n\n**Applied\\* Lifetime Tenure Codes**\n\nProducer Sweep None N N 0 to < 6 months A C\n\nChecking/Savings None N N 6 to < 12 months B D\n\nCredit Card None N N 12 to < 18 months C N\n\nDebit Card None N N 18 to < 24 months D Y\n\nProducer Sweep Checking/Savings Y Y 24 to < 30 months E\n\nChecking/Savings Checking/Savings Y Y 30 to < 36 months F E\n\nCredit Card Checking/Savings Y Y 36 to < 42 months G X\n\nDebit Card Checking/Savings Y Y 42 to < 48 months H\n\nProducer Sweep Credit Card C Y 48 to < 54 months I\n\nChecking/Savings Credit Card C Y 54 to < 60 months J\n\nCredit Card Credit Card C Y >= 60 months K\n\nDebit Card Credit Card C Y\n\nProducer Sweep Debit Card D N\n\nChecking/Savings Debit Card D N\n\nCredit Card Debit Card D N\n\nDebit Card Debit Card D N\n\n**EFT-PIF-GPL Discount**\n\n**UW Tier Group**\n\n**Downpayment ALR**\n\n**Code EFT Installment ALR Code Paid In Full Go Paperless Lifetime Tenure ALL BI COL EXTR MP OTC PD RA TL UIM UMBI**\n\n1 C C N E A 0.0273 0.0999 0.0573 0.0573 0.1484 0.0273 0.1211 0.0573 0.0573 0.1484 0.1484\n\n1 C C N E B 0.0262 0.0793 0.0497 0.0497 0.1391 0.0262 0.1036 0.0497 0.0497 0.1391 0.1391\n\n1 C C N E C 0.0251 0.0582 0.0420 0.0420 0.1297 0.0251 0.0858 0.0420 0.0420 0.1297 0.1297\n\n1 C C N E D 0.0240 0.0366 0.0342 0.0342 0.1202 0.0240 0.0676 0.0342 0.0342 0.1202 0.1202\n\n1 C C N E E 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E F 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E G 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E H 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E I 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E J 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E K 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N X A 0.0273 0.0652 0.0301 0.0301 0.1300 0.0273 0.0816 0.0301 0.0301 0.1300 0.1300\n\n1 C C N X B 0.0262 0.0504 0.0267 0.0267 0.1229 0.0262 0.0712 0.0267 0.0267 0.1229 0.1229\n\n1 C C N X C 0.0251 0.0354 0.0233 0.0233 0.1158 0.0251 0.0607 0.0233 0.0233 0.1158 0.1158\n\n1 C C N X D 0.0240 0.0201 0.0199 0.0199 0.1086 0.0240 0.0501 0.0199 0.0199 0.1086 0.1086\n\n1 C C N X E 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X F 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X G 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X H 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X I 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X J 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X K 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C C Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C C Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C C Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C C Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E H 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E I 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E J 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E K 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y X A 0.1621 0.1324 0.1027 0.1027 0.2784 0.1621 0.1048 0.1027 0.1027 0.2784 0.2784\n\n1 C C Y X B 0.1501 0.1150 0.0883 0.0883 0.2590 0.1501 0.0897 0.0883 0.0883 0.2590 0.2590\n\n1 C C Y X C 0.1380 0.0973 0.0737 0.0737 0.2391 0.1380 0.0744 0.0737 0.0737 0.2391 0.2391\n\n1 C C Y X D 0.1257 0.0792 0.0588 0.0588 0.2187 0.1257 0.0588 0.0588 0.0588 0.2187 0.2187\n\n1 C C Y X E 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X F 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X G 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X H 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X I 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X J 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X K 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D N E A 0.0000 0.0371 0.0281 0.0281 0.0211 0.0000 0.0430 0.0281 0.0281 0.0211 0.0211\n\n1 C D N E B 0.0000 0.0304 0.0236 0.0236 0.0183 0.0000 0.0349 0.0236 0.0236 0.0183 0.0183\n\n1 C D N E C 0.0000 0.0236 0.0191 0.0191 0.0155 0.0000 0.0267 0.0191 0.0191 0.0155 0.0155\n\n1 C D N E D 0.0000 0.0168 0.0146 0.0146 0.0127 0.0000 0.0184 0.0146 0.0146 0.0127 0.0127\n\n1 C D N E E 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E F 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E G 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E H 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E I 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E J 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E K 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N X A 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X B 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X C 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X D 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X E 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X G 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X H 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X I 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X J 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X K 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C D Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C D Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C D Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C D Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E H 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E I 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E J 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E K 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y X A 0.1621 0.1324 0.1027 0.1027 0.2784 0.1621 0.1048 0.1027 0.1027 0.2784 0.2784\n\n1 C D Y X B 0.1501 0.1150 0.0883 0.0883 0.2590 0.1501 0.0897 0.0883 0.0883 0.2590 0.2590\n\n1 C D Y X C 0.1380 0.0973 0.0737 0.0737 0.2391 0.1380 0.0744 0.0737 0.0737 0.2391 0.2391\n\n1 C D Y X D 0.1257 0.0792 0.0588 0.0588 0.2187 0.1257 0.0588 0.0588 0.0588 0.2187 0.2187\n\n1 C D Y X E 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X F 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X G 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X H 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X I 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X J 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X K 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C N N E A 0.0000 0.0371 0.0281 0.0281 0.0211 0.0000 0.0430 0.0281 0.0281 0.0211 0.0211\n\n1 C N N E B 0.0000 0.0304 0.0236 0.0236 0.0183 0.0000 0.0349 0.0236 0.0236 0.0183 0.0183\n\n1 C N N E C 0.0000 0.0236 0.0191 0.0191 0.0155 0.0000 0.0267 0.0191 0.0191 0.0155 0.0155\n\n1 C N N E D 0.0000 0.0168 0.0146 0.0146 0.0127 0.0000 0.0184 0.0146 0.0146 0.0127 0.0127\n\n1 C N N E E 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E F 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E G 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E H 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E I 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E J 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E K 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N X A 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X B 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X C 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X D 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X E 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X G 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X H 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X I 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X J 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X K 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C N Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C N Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C N Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C N Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C N Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C N Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n**Go Paperless Key**\n\nGo Paperless\n\nNo Go Paperless\n\nCredit Card\n\n**Proposed**\n\n**EFT Key**\n\nChecking/ Saving\n\nDebit Card\n\nNo EFT","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page877.pdf"]},"response":{"errors":[],"extract_id":"extract_a9cdb5547a9b82069dd485c70cdba2aa","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**EFT ALR Code**\n\n**Down Payment Method**\n\n**EFT Installment**\n\n**Method Installment ALR Code**\n\n**EFT Discount**\n\n**Applied\\* Lifetime Tenure Codes**\n\nProducer Sweep None N N 0 to < 6 months A C\n\nChecking/Savings None N N 6 to < 12 months B D\n\nCredit Card None N N 12 to < 18 months C N\n\nDebit Card None N N 18 to < 24 months D Y\n\nProducer Sweep Checking/Savings Y Y 24 to < 30 months E\n\nChecking/Savings Checking/Savings Y Y 30 to < 36 months F E\n\nCredit Card Checking/Savings Y Y 36 to < 42 months G X\n\nDebit Card Checking/Savings Y Y 42 to < 48 months H\n\nProducer Sweep Credit Card C Y 48 to < 54 months I\n\nChecking/Savings Credit Card C Y 54 to < 60 months J\n\nCredit Card Credit Card C Y >= 60 months K\n\nDebit Card Credit Card C Y\n\nProducer Sweep Debit Card D N\n\nChecking/Savings Debit Card D N\n\nCredit Card Debit Card D N\n\nDebit Card Debit Card D N\n\n**EFT-PIF-GPL Discount**\n\n**UW Tier Group**\n\n**Downpayment ALR**\n\n**Code EFT Installment ALR Code Paid In Full Go Paperless Lifetime Tenure ALL BI COL EXTR MP OTC PD RA TL UIM UMBI**\n\n1 C C N E A 0.0273 0.0999 0.0573 0.0573 0.1484 0.0273 0.1211 0.0573 0.0573 0.1484 0.1484\n\n1 C C N E B 0.0262 0.0793 0.0497 0.0497 0.1391 0.0262 0.1036 0.0497 0.0497 0.1391 0.1391\n\n1 C C N E C 0.0251 0.0582 0.0420 0.0420 0.1297 0.0251 0.0858 0.0420 0.0420 0.1297 0.1297\n\n1 C C N E D 0.0240 0.0366 0.0342 0.0342 0.1202 0.0240 0.0676 0.0342 0.0342 0.1202 0.1202\n\n1 C C N E E 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E F 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E G 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E H 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E I 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E J 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E K 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N X A 0.0273 0.0652 0.0301 0.0301 0.1300 0.0273 0.0816 0.0301 0.0301 0.1300 0.1300\n\n1 C C N X B 0.0262 0.0504 0.0267 0.0267 0.1229 0.0262 0.0712 0.0267 0.0267 0.1229 0.1229\n\n1 C C N X C 0.0251 0.0354 0.0233 0.0233 0.1158 0.0251 0.0607 0.0233 0.0233 0.1158 0.1158\n\n1 C C N X D 0.0240 0.0201 0.0199 0.0199 0.1086 0.0240 0.0501 0.0199 0.0199 0.1086 0.1086\n\n1 C C N X E 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X F 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X G 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X H 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X I 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X J 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X K 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C C Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C C Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C C Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C C Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E H 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E I 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E J 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E K 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y X A 0.1621 0.1324 0.1027 0.1027 0.2784 0.1621 0.1048 0.1027 0.1027 0.2784 0.2784\n\n1 C C Y X B 0.1501 0.1150 0.0883 0.0883 0.2590 0.1501 0.0897 0.0883 0.0883 0.2590 0.2590\n\n1 C C Y X C 0.1380 0.0973 0.0737 0.0737 0.2391 0.1380 0.0744 0.0737 0.0737 0.2391 0.2391\n\n1 C C Y X D 0.1257 0.0792 0.0588 0.0588 0.2187 0.1257 0.0588 0.0588 0.0588 0.2187 0.2187\n\n1 C C Y X E 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X F 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X G 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X H 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X I 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X J 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X K 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D N E A 0.0000 0.0371 0.0281 0.0281 0.0211 0.0000 0.0430 0.0281 0.0281 0.0211 0.0211\n\n1 C D N E B 0.0000 0.0304 0.0236 0.0236 0.0183 0.0000 0.0349 0.0236 0.0236 0.0183 0.0183\n\n1 C D N E C 0.0000 0.0236 0.0191 0.0191 0.0155 0.0000 0.0267 0.0191 0.0191 0.0155 0.0155\n\n1 C D N E D 0.0000 0.0168 0.0146 0.0146 0.0127 0.0000 0.0184 0.0146 0.0146 0.0127 0.0127\n\n1 C D N E E 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E F 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E G 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E H 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E I 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E J 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E K 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N X A 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X B 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X C 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X D 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X E 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X G 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X H 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X I 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X J 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X K 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C D Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C D Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C D Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C D Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E H 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E I 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E J 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E K 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y X A 0.1621 0.1324 0.1027 0.1027 0.2784 0.1621 0.1048 0.1027 0.1027 0.2784 0.2784\n\n1 C D Y X B 0.1501 0.1150 0.0883 0.0883 0.2590 0.1501 0.0897 0.0883 0.0883 0.2590 0.2590\n\n1 C D Y X C 0.1380 0.0973 0.0737 0.0737 0.2391 0.1380 0.0744 0.0737 0.0737 0.2391 0.2391\n\n1 C D Y X D 0.1257 0.0792 0.0588 0.0588 0.2187 0.1257 0.0588 0.0588 0.0588 0.2187 0.2187\n\n1 C D Y X E 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X F 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X G 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X H 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X I 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X J 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X K 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C N N E A 0.0000 0.0371 0.0281 0.0281 0.0211 0.0000 0.0430 0.0281 0.0281 0.0211 0.0211\n\n1 C N N E B 0.0000 0.0304 0.0236 0.0236 0.0183 0.0000 0.0349 0.0236 0.0236 0.0183 0.0183\n\n1 C N N E C 0.0000 0.0236 0.0191 0.0191 0.0155 0.0000 0.0267 0.0191 0.0191 0.0155 0.0155\n\n1 C N N E D 0.0000 0.0168 0.0146 0.0146 0.0127 0.0000 0.0184 0.0146 0.0146 0.0127 0.0127\n\n1 C N N E E 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E F 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E G 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E H 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E I 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E J 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E K 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N X A 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X B 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X C 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X D 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X E 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X G 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X H 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X I 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X J 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X K 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C N Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C N Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C N Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C N Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C N Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C N Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n**Go Paperless Key**\n\nGo Paperless\n\nNo Go Paperless\n\nCredit Card\n\n**Proposed**\n\n**EFT Key**\n\nChecking/ Saving\n\nDebit Card\n\nNo EFT"],"full_content":"**EFT ALR Code**\n\n**Down Payment Method**\n\n**EFT Installment**\n\n**Method Installment ALR Code**\n\n**EFT Discount**\n\n**Applied\\* Lifetime Tenure Codes**\n\nProducer Sweep None N N 0 to < 6 months A C\n\nChecking/Savings None N N 6 to < 12 months B D\n\nCredit Card None N N 12 to < 18 months C N\n\nDebit Card None N N 18 to < 24 months D Y\n\nProducer Sweep Checking/Savings Y Y 24 to < 30 months E\n\nChecking/Savings Checking/Savings Y Y 30 to < 36 months F E\n\nCredit Card Checking/Savings Y Y 36 to < 42 months G X\n\nDebit Card Checking/Savings Y Y 42 to < 48 months H\n\nProducer Sweep Credit Card C Y 48 to < 54 months I\n\nChecking/Savings Credit Card C Y 54 to < 60 months J\n\nCredit Card Credit Card C Y >= 60 months K\n\nDebit Card Credit Card C Y\n\nProducer Sweep Debit Card D N\n\nChecking/Savings Debit Card D N\n\nCredit Card Debit Card D N\n\nDebit Card Debit Card D N\n\n**EFT-PIF-GPL Discount**\n\n**UW Tier Group**\n\n**Downpayment ALR**\n\n**Code EFT Installment ALR Code Paid In Full Go Paperless Lifetime Tenure ALL BI COL EXTR MP OTC PD RA TL UIM UMBI**\n\n1 C C N E A 0.0273 0.0999 0.0573 0.0573 0.1484 0.0273 0.1211 0.0573 0.0573 0.1484 0.1484\n\n1 C C N E B 0.0262 0.0793 0.0497 0.0497 0.1391 0.0262 0.1036 0.0497 0.0497 0.1391 0.1391\n\n1 C C N E C 0.0251 0.0582 0.0420 0.0420 0.1297 0.0251 0.0858 0.0420 0.0420 0.1297 0.1297\n\n1 C C N E D 0.0240 0.0366 0.0342 0.0342 0.1202 0.0240 0.0676 0.0342 0.0342 0.1202 0.1202\n\n1 C C N E E 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E F 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E G 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E H 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E I 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E J 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N E K 0.0228 0.0145 0.0264 0.0264 0.1105 0.0228 0.0490 0.0264 0.0264 0.1105 0.1105\n\n1 C C N X A 0.0273 0.0652 0.0301 0.0301 0.1300 0.0273 0.0816 0.0301 0.0301 0.1300 0.1300\n\n1 C C N X B 0.0262 0.0504 0.0267 0.0267 0.1229 0.0262 0.0712 0.0267 0.0267 0.1229 0.1229\n\n1 C C N X C 0.0251 0.0354 0.0233 0.0233 0.1158 0.0251 0.0607 0.0233 0.0233 0.1158 0.1158\n\n1 C C N X D 0.0240 0.0201 0.0199 0.0199 0.1086 0.0240 0.0501 0.0199 0.0199 0.1086 0.1086\n\n1 C C N X E 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X F 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X G 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X H 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X I 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X J 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C N X K 0.0228 0.0046 0.0165 0.0165 0.1015 0.0228 0.0394 0.0165 0.0165 0.1015 0.1015\n\n1 C C Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C C Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C C Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C C Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C C Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E H 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E I 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E J 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y E K 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C C Y X A 0.1621 0.1324 0.1027 0.1027 0.2784 0.1621 0.1048 0.1027 0.1027 0.2784 0.2784\n\n1 C C Y X B 0.1501 0.1150 0.0883 0.0883 0.2590 0.1501 0.0897 0.0883 0.0883 0.2590 0.2590\n\n1 C C Y X C 0.1380 0.0973 0.0737 0.0737 0.2391 0.1380 0.0744 0.0737 0.0737 0.2391 0.2391\n\n1 C C Y X D 0.1257 0.0792 0.0588 0.0588 0.2187 0.1257 0.0588 0.0588 0.0588 0.2187 0.2187\n\n1 C C Y X E 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X F 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X G 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X H 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X I 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X J 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C C Y X K 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D N E A 0.0000 0.0371 0.0281 0.0281 0.0211 0.0000 0.0430 0.0281 0.0281 0.0211 0.0211\n\n1 C D N E B 0.0000 0.0304 0.0236 0.0236 0.0183 0.0000 0.0349 0.0236 0.0236 0.0183 0.0183\n\n1 C D N E C 0.0000 0.0236 0.0191 0.0191 0.0155 0.0000 0.0267 0.0191 0.0191 0.0155 0.0155\n\n1 C D N E D 0.0000 0.0168 0.0146 0.0146 0.0127 0.0000 0.0184 0.0146 0.0146 0.0127 0.0127\n\n1 C D N E E 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E F 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E G 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E H 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E I 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E J 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N E K 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C D N X A 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X B 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X C 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X D 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X E 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X G 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X H 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X I 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X J 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D N X K 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C D Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C D Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C D Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C D Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C D Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E H 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E I 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E J 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y E K 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C D Y X A 0.1621 0.1324 0.1027 0.1027 0.2784 0.1621 0.1048 0.1027 0.1027 0.2784 0.2784\n\n1 C D Y X B 0.1501 0.1150 0.0883 0.0883 0.2590 0.1501 0.0897 0.0883 0.0883 0.2590 0.2590\n\n1 C D Y X C 0.1380 0.0973 0.0737 0.0737 0.2391 0.1380 0.0744 0.0737 0.0737 0.2391 0.2391\n\n1 C D Y X D 0.1257 0.0792 0.0588 0.0588 0.2187 0.1257 0.0588 0.0588 0.0588 0.2187 0.2187\n\n1 C D Y X E 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X F 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X G 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X H 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X I 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X J 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C D Y X K 0.1132 0.0608 0.0437 0.0437 0.1978 0.1132 0.0429 0.0437 0.0437 0.1978 0.1978\n\n1 C N N E A 0.0000 0.0371 0.0281 0.0281 0.0211 0.0000 0.0430 0.0281 0.0281 0.0211 0.0211\n\n1 C N N E B 0.0000 0.0304 0.0236 0.0236 0.0183 0.0000 0.0349 0.0236 0.0236 0.0183 0.0183\n\n1 C N N E C 0.0000 0.0236 0.0191 0.0191 0.0155 0.0000 0.0267 0.0191 0.0191 0.0155 0.0155\n\n1 C N N E D 0.0000 0.0168 0.0146 0.0146 0.0127 0.0000 0.0184 0.0146 0.0146 0.0127 0.0127\n\n1 C N N E E 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E F 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E G 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E H 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E I 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E J 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N E K 0.0000 0.0100 0.0100 0.0100 0.0100 0.0000 0.0100 0.0100 0.0100 0.0100 0.0100\n\n1 C N N X A 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X B 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X C 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X D 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X E 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X F 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X G 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X H 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X I 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X J 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N N X K 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000\n\n1 C N Y E A 0.1621 0.1646 0.1279 0.1279 0.2936 0.1621 0.1433 0.1279 0.1279 0.2936 0.2936\n\n1 C N Y E B 0.1501 0.1419 0.1098 0.1098 0.2726 0.1501 0.1214 0.1098 0.1098 0.2726 0.2726\n\n1 C N Y E C 0.1380 0.1186 0.0913 0.0913 0.2510 0.1380 0.0990 0.0913 0.0913 0.2510 0.2510\n\n1 C N Y E D 0.1257 0.0947 0.0725 0.0725 0.2287 0.1257 0.0760 0.0725 0.0725 0.2287 0.2287\n\n1 C N Y E E 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C N Y E F 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n1 C N Y E G 0.1132 0.0702 0.0533 0.0533 0.2058 0.1132 0.0525 0.0533 0.0533 0.2058 0.2058\n\n**Go Paperless Key**\n\nGo Paperless\n\nNo Go Paperless\n\nCredit Card\n\n**Proposed**\n\n**EFT Key**\n\nChecking/ Saving\n\nDebit Card\n\nNo EFT","publish_date":null,"title":"EFT Key C Checking/ Saving D Debit Card N No EFT Y Credit Card Go Paperless Key E Go Paperless","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page877.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page877.pdf"},"request":{"example_id":"table/BRWS-134565917_page877","product_type":"parse","source_file_path":"BRWS-134565917_page877.pdf"},"started_at":"2026-11-04T19:46:51.868545"} +{"completed_at":"2026-11-04T19:46:55.660945","latency_in_ms":1566,"output":{"example_id":"table/BRWS-134565917_page938","grounded_pages":[],"layout_pages":[],"markdown":"Driver Class\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class**\n\n**BI BI BI BI BI BI BI BI PD PD PD PD PD PD PD PD**\n\n**Driver Class**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nSM41 1.2607 1.1458 1.2465 1.1947\n\nSM42 1.2607 1.1415 1.2465 1.1846\n\nSM43 1.2607 1.1372 1.2465 1.1745\n\nSM44 1.2607 1.1329 1.2465 1.1644\n\nSM45 1.2607 1.1253 1.2465 1.1586\n\nSM46 1.2607 1.1166 1.2465 1.1543\n\nSM47 1.2607 1.1079 1.2465 1.1500\n\nSM48 1.2607 1.0993 1.2465 1.1457\n\nSM49 1.2607 1.0906 1.2465 1.1414\n\n**SM50** 62,540 12,491,387 1,221 1.95% 10,229 200 1.1662 1.0675 74,600 17,799,486 5,151 6.90% 3,456 239 1.2049 1.1394\n\nSM51 1.1662 1.0588 1.2049 1.1351\n\nSM52 1.1662 1.0501 1.2049 1.1309\n\nSM53 1.1662 1.0562 1.2049 1.1348\n\nSM54 1.1662 1.0624 1.2049 1.1387\n\n**SM55** 124,570 23,767,332 2,398 1.92% 9,913 191 1.1956 1.0888 146,123 33,779,990 10,035 6.87% 3,366 231 1.2254 1.1538\n\nSM56 1.1956 1.0949 1.2254 1.1577\n\nSM57 1.1956 1.1010 1.2254 1.1616\n\nSM58 1.1956 1.1071 1.2254 1.1655\n\nSM59 1.1956 1.1133 1.2254 1.1694\n\nSM60 1.1956 1.1126 1.2254 1.1695\n\nSM61 1.1956 1.1094 1.2254 1.1683\n\nSM62 1.1956 1.1061 1.2254 1.1670\n\nSM63 1.1956 1.1029 1.2254 1.1657\n\nSM64 1.1956 1.0996 1.2254 1.1645\n\n**SM65** 60,647 11,192,339 1,147 1.89% 9,762 185 1.2638 1.0525 69,040 15,021,880 4,636 6.72% 3,240 218 1.2559 1.1174\n\nSM66 1.2638 1.0492 1.2559 1.1161\n\nSM67 1.2638 1.0460 1.2559 1.1149\n\nSM68 1.2638 1.0427 1.2559 1.1136\n\nSM69 1.2638 1.0470 1.2559 1.1221\n\nSM70 1.2638 1.0704 1.2559 1.1534\n\nSM71 1.2638 1.0939 1.2559 1.1847\n\nSM72 1.2638 1.1173 1.2559 1.2160\n\nSM73 1.2638 1.1408 1.2559 1.2473\n\nSM74 1.2638 1.1642 1.2559 1.2786\n\n**SM75** 29,032 6,111,615 606 2.09% 10,078 211 1.6198 1.2202 32,500 8,017,135 2,527 7.78% 3,173 247 1.6060 1.3494\n\nSM76 1.6198 1.2436 1.6060 1.3807\n\nSM77 1.6198 1.2671 1.6060 1.4120\n\nSM78 1.6198 1.2905 1.6060 1.4433\n\nSM79 1.6198 1.3140 1.6060 1.4746\n\nSM80 1.6198 1.3374 1.6060 1.5059\n\nSM81 1.6198 1.3608 1.6060 1.5372\n\nSM82 1.6198 1.3843 1.6060 1.5685\n\nSM83 1.6198 1.4077 1.6060 1.5998\n\nSM84 1.6198 1.4312 1.6060 1.6311\n\nSM85 1.6198 1.4546 1.6060 1.6624\n\nSM86 1.6198 1.4781 1.6060 1.6937\n\nSM87 1.6198 1.5015 1.6060 1.7250\n\nSM88 1.6198 1.5250 1.6060 1.7563\n\nSM89 1.6198 1.5484 1.6060 1.7876\n\nSM90 1.6198 1.5719 1.6060 1.8189\n\nSM91 1.6198 1.5953 1.6060 1.8502\n\nSM92 1.6198 1.6188 1.6060 1.8815\n\nSM93 1.6198 1.6422 1.6060 1.9128\n\nSM94 1.6198 1.6657 1.6060 1.9441\n\nSM95 1.6198 1.6891 1.6060 1.9754\n\nSM96 1.6198 1.7125 1.6060 2.0067\n\nSM97 1.6198 1.7360 1.6060 2.0380\n\n\\# Proprietary Driver Class Page 6","pages":[{"line_numbers":[],"markdown":"Driver Class\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class**\n\n**BI BI BI BI BI BI BI BI PD PD PD PD PD PD PD PD**\n\n**Driver Class**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nSM41 1.2607 1.1458 1.2465 1.1947\n\nSM42 1.2607 1.1415 1.2465 1.1846\n\nSM43 1.2607 1.1372 1.2465 1.1745\n\nSM44 1.2607 1.1329 1.2465 1.1644\n\nSM45 1.2607 1.1253 1.2465 1.1586\n\nSM46 1.2607 1.1166 1.2465 1.1543\n\nSM47 1.2607 1.1079 1.2465 1.1500\n\nSM48 1.2607 1.0993 1.2465 1.1457\n\nSM49 1.2607 1.0906 1.2465 1.1414\n\n**SM50** 62,540 12,491,387 1,221 1.95% 10,229 200 1.1662 1.0675 74,600 17,799,486 5,151 6.90% 3,456 239 1.2049 1.1394\n\nSM51 1.1662 1.0588 1.2049 1.1351\n\nSM52 1.1662 1.0501 1.2049 1.1309\n\nSM53 1.1662 1.0562 1.2049 1.1348\n\nSM54 1.1662 1.0624 1.2049 1.1387\n\n**SM55** 124,570 23,767,332 2,398 1.92% 9,913 191 1.1956 1.0888 146,123 33,779,990 10,035 6.87% 3,366 231 1.2254 1.1538\n\nSM56 1.1956 1.0949 1.2254 1.1577\n\nSM57 1.1956 1.1010 1.2254 1.1616\n\nSM58 1.1956 1.1071 1.2254 1.1655\n\nSM59 1.1956 1.1133 1.2254 1.1694\n\nSM60 1.1956 1.1126 1.2254 1.1695\n\nSM61 1.1956 1.1094 1.2254 1.1683\n\nSM62 1.1956 1.1061 1.2254 1.1670\n\nSM63 1.1956 1.1029 1.2254 1.1657\n\nSM64 1.1956 1.0996 1.2254 1.1645\n\n**SM65** 60,647 11,192,339 1,147 1.89% 9,762 185 1.2638 1.0525 69,040 15,021,880 4,636 6.72% 3,240 218 1.2559 1.1174\n\nSM66 1.2638 1.0492 1.2559 1.1161\n\nSM67 1.2638 1.0460 1.2559 1.1149\n\nSM68 1.2638 1.0427 1.2559 1.1136\n\nSM69 1.2638 1.0470 1.2559 1.1221\n\nSM70 1.2638 1.0704 1.2559 1.1534\n\nSM71 1.2638 1.0939 1.2559 1.1847\n\nSM72 1.2638 1.1173 1.2559 1.2160\n\nSM73 1.2638 1.1408 1.2559 1.2473\n\nSM74 1.2638 1.1642 1.2559 1.2786\n\n**SM75** 29,032 6,111,615 606 2.09% 10,078 211 1.6198 1.2202 32,500 8,017,135 2,527 7.78% 3,173 247 1.6060 1.3494\n\nSM76 1.6198 1.2436 1.6060 1.3807\n\nSM77 1.6198 1.2671 1.6060 1.4120\n\nSM78 1.6198 1.2905 1.6060 1.4433\n\nSM79 1.6198 1.3140 1.6060 1.4746\n\nSM80 1.6198 1.3374 1.6060 1.5059\n\nSM81 1.6198 1.3608 1.6060 1.5372\n\nSM82 1.6198 1.3843 1.6060 1.5685\n\nSM83 1.6198 1.4077 1.6060 1.5998\n\nSM84 1.6198 1.4312 1.6060 1.6311\n\nSM85 1.6198 1.4546 1.6060 1.6624\n\nSM86 1.6198 1.4781 1.6060 1.6937\n\nSM87 1.6198 1.5015 1.6060 1.7250\n\nSM88 1.6198 1.5250 1.6060 1.7563\n\nSM89 1.6198 1.5484 1.6060 1.7876\n\nSM90 1.6198 1.5719 1.6060 1.8189\n\nSM91 1.6198 1.5953 1.6060 1.8502\n\nSM92 1.6198 1.6188 1.6060 1.8815\n\nSM93 1.6198 1.6422 1.6060 1.9128\n\nSM94 1.6198 1.6657 1.6060 1.9441\n\nSM95 1.6198 1.6891 1.6060 1.9754\n\nSM96 1.6198 1.7125 1.6060 2.0067\n\nSM97 1.6198 1.7360 1.6060 2.0380\n\n\\# Proprietary Driver Class Page 6","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Driver Class\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class**\n\n**BI BI BI BI BI BI BI BI PD PD PD PD PD PD PD PD**\n\n**Driver Class**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nSM41 1.2607 1.1458 1.2465 1.1947\n\nSM42 1.2607 1.1415 1.2465 1.1846\n\nSM43 1.2607 1.1372 1.2465 1.1745\n\nSM44 1.2607 1.1329 1.2465 1.1644\n\nSM45 1.2607 1.1253 1.2465 1.1586\n\nSM46 1.2607 1.1166 1.2465 1.1543\n\nSM47 1.2607 1.1079 1.2465 1.1500\n\nSM48 1.2607 1.0993 1.2465 1.1457\n\nSM49 1.2607 1.0906 1.2465 1.1414\n\n**SM50** 62,540 12,491,387 1,221 1.95% 10,229 200 1.1662 1.0675 74,600 17,799,486 5,151 6.90% 3,456 239 1.2049 1.1394\n\nSM51 1.1662 1.0588 1.2049 1.1351\n\nSM52 1.1662 1.0501 1.2049 1.1309\n\nSM53 1.1662 1.0562 1.2049 1.1348\n\nSM54 1.1662 1.0624 1.2049 1.1387\n\n**SM55** 124,570 23,767,332 2,398 1.92% 9,913 191 1.1956 1.0888 146,123 33,779,990 10,035 6.87% 3,366 231 1.2254 1.1538\n\nSM56 1.1956 1.0949 1.2254 1.1577\n\nSM57 1.1956 1.1010 1.2254 1.1616\n\nSM58 1.1956 1.1071 1.2254 1.1655\n\nSM59 1.1956 1.1133 1.2254 1.1694\n\nSM60 1.1956 1.1126 1.2254 1.1695\n\nSM61 1.1956 1.1094 1.2254 1.1683\n\nSM62 1.1956 1.1061 1.2254 1.1670\n\nSM63 1.1956 1.1029 1.2254 1.1657\n\nSM64 1.1956 1.0996 1.2254 1.1645\n\n**SM65** 60,647 11,192,339 1,147 1.89% 9,762 185 1.2638 1.0525 69,040 15,021,880 4,636 6.72% 3,240 218 1.2559 1.1174\n\nSM66 1.2638 1.0492 1.2559 1.1161\n\nSM67 1.2638 1.0460 1.2559 1.1149\n\nSM68 1.2638 1.0427 1.2559 1.1136\n\nSM69 1.2638 1.0470 1.2559 1.1221\n\nSM70 1.2638 1.0704 1.2559 1.1534\n\nSM71 1.2638 1.0939 1.2559 1.1847\n\nSM72 1.2638 1.1173 1.2559 1.2160\n\nSM73 1.2638 1.1408 1.2559 1.2473\n\nSM74 1.2638 1.1642 1.2559 1.2786\n\n**SM75** 29,032 6,111,615 606 2.09% 10,078 211 1.6198 1.2202 32,500 8,017,135 2,527 7.78% 3,173 247 1.6060 1.3494\n\nSM76 1.6198 1.2436 1.6060 1.3807\n\nSM77 1.6198 1.2671 1.6060 1.4120\n\nSM78 1.6198 1.2905 1.6060 1.4433\n\nSM79 1.6198 1.3140 1.6060 1.4746\n\nSM80 1.6198 1.3374 1.6060 1.5059\n\nSM81 1.6198 1.3608 1.6060 1.5372\n\nSM82 1.6198 1.3843 1.6060 1.5685\n\nSM83 1.6198 1.4077 1.6060 1.5998\n\nSM84 1.6198 1.4312 1.6060 1.6311\n\nSM85 1.6198 1.4546 1.6060 1.6624\n\nSM86 1.6198 1.4781 1.6060 1.6937\n\nSM87 1.6198 1.5015 1.6060 1.7250\n\nSM88 1.6198 1.5250 1.6060 1.7563\n\nSM89 1.6198 1.5484 1.6060 1.7876\n\nSM90 1.6198 1.5719 1.6060 1.8189\n\nSM91 1.6198 1.5953 1.6060 1.8502\n\nSM92 1.6198 1.6188 1.6060 1.8815\n\nSM93 1.6198 1.6422 1.6060 1.9128\n\nSM94 1.6198 1.6657 1.6060 1.9441\n\nSM95 1.6198 1.6891 1.6060 1.9754\n\nSM96 1.6198 1.7125 1.6060 2.0067\n\nSM97 1.6198 1.7360 1.6060 2.0380\n\n\\# Proprietary Driver Class Page 6","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page938.pdf"]},"response":{"errors":[],"extract_id":"extract_e87140c43b485a132b6d0fdf48bc8f73","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Driver Class\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class**\n\n**BI BI BI BI BI BI BI BI PD PD PD PD PD PD PD PD**\n\n**Driver Class**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nSM41 1.2607 1.1458 1.2465 1.1947\n\nSM42 1.2607 1.1415 1.2465 1.1846\n\nSM43 1.2607 1.1372 1.2465 1.1745\n\nSM44 1.2607 1.1329 1.2465 1.1644\n\nSM45 1.2607 1.1253 1.2465 1.1586\n\nSM46 1.2607 1.1166 1.2465 1.1543\n\nSM47 1.2607 1.1079 1.2465 1.1500\n\nSM48 1.2607 1.0993 1.2465 1.1457\n\nSM49 1.2607 1.0906 1.2465 1.1414\n\n**SM50** 62,540 12,491,387 1,221 1.95% 10,229 200 1.1662 1.0675 74,600 17,799,486 5,151 6.90% 3,456 239 1.2049 1.1394\n\nSM51 1.1662 1.0588 1.2049 1.1351\n\nSM52 1.1662 1.0501 1.2049 1.1309\n\nSM53 1.1662 1.0562 1.2049 1.1348\n\nSM54 1.1662 1.0624 1.2049 1.1387\n\n**SM55** 124,570 23,767,332 2,398 1.92% 9,913 191 1.1956 1.0888 146,123 33,779,990 10,035 6.87% 3,366 231 1.2254 1.1538\n\nSM56 1.1956 1.0949 1.2254 1.1577\n\nSM57 1.1956 1.1010 1.2254 1.1616\n\nSM58 1.1956 1.1071 1.2254 1.1655\n\nSM59 1.1956 1.1133 1.2254 1.1694\n\nSM60 1.1956 1.1126 1.2254 1.1695\n\nSM61 1.1956 1.1094 1.2254 1.1683\n\nSM62 1.1956 1.1061 1.2254 1.1670\n\nSM63 1.1956 1.1029 1.2254 1.1657\n\nSM64 1.1956 1.0996 1.2254 1.1645\n\n**SM65** 60,647 11,192,339 1,147 1.89% 9,762 185 1.2638 1.0525 69,040 15,021,880 4,636 6.72% 3,240 218 1.2559 1.1174\n\nSM66 1.2638 1.0492 1.2559 1.1161\n\nSM67 1.2638 1.0460 1.2559 1.1149\n\nSM68 1.2638 1.0427 1.2559 1.1136\n\nSM69 1.2638 1.0470 1.2559 1.1221\n\nSM70 1.2638 1.0704 1.2559 1.1534\n\nSM71 1.2638 1.0939 1.2559 1.1847\n\nSM72 1.2638 1.1173 1.2559 1.2160\n\nSM73 1.2638 1.1408 1.2559 1.2473\n\nSM74 1.2638 1.1642 1.2559 1.2786\n\n**SM75** 29,032 6,111,615 606 2.09% 10,078 211 1.6198 1.2202 32,500 8,017,135 2,527 7.78% 3,173 247 1.6060 1.3494\n\nSM76 1.6198 1.2436 1.6060 1.3807\n\nSM77 1.6198 1.2671 1.6060 1.4120\n\nSM78 1.6198 1.2905 1.6060 1.4433\n\nSM79 1.6198 1.3140 1.6060 1.4746\n\nSM80 1.6198 1.3374 1.6060 1.5059\n\nSM81 1.6198 1.3608 1.6060 1.5372\n\nSM82 1.6198 1.3843 1.6060 1.5685\n\nSM83 1.6198 1.4077 1.6060 1.5998\n\nSM84 1.6198 1.4312 1.6060 1.6311\n\nSM85 1.6198 1.4546 1.6060 1.6624\n\nSM86 1.6198 1.4781 1.6060 1.6937\n\nSM87 1.6198 1.5015 1.6060 1.7250\n\nSM88 1.6198 1.5250 1.6060 1.7563\n\nSM89 1.6198 1.5484 1.6060 1.7876\n\nSM90 1.6198 1.5719 1.6060 1.8189\n\nSM91 1.6198 1.5953 1.6060 1.8502\n\nSM92 1.6198 1.6188 1.6060 1.8815\n\nSM93 1.6198 1.6422 1.6060 1.9128\n\nSM94 1.6198 1.6657 1.6060 1.9441\n\nSM95 1.6198 1.6891 1.6060 1.9754\n\nSM96 1.6198 1.7125 1.6060 2.0067\n\nSM97 1.6198 1.7360 1.6060 2.0380\n\n\\# Proprietary Driver Class Page 6"],"full_content":"Driver Class\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class**\n\n**BI BI BI BI BI BI BI BI PD PD PD PD PD PD PD PD**\n\n**Driver Class**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\nSM41 1.2607 1.1458 1.2465 1.1947\n\nSM42 1.2607 1.1415 1.2465 1.1846\n\nSM43 1.2607 1.1372 1.2465 1.1745\n\nSM44 1.2607 1.1329 1.2465 1.1644\n\nSM45 1.2607 1.1253 1.2465 1.1586\n\nSM46 1.2607 1.1166 1.2465 1.1543\n\nSM47 1.2607 1.1079 1.2465 1.1500\n\nSM48 1.2607 1.0993 1.2465 1.1457\n\nSM49 1.2607 1.0906 1.2465 1.1414\n\n**SM50** 62,540 12,491,387 1,221 1.95% 10,229 200 1.1662 1.0675 74,600 17,799,486 5,151 6.90% 3,456 239 1.2049 1.1394\n\nSM51 1.1662 1.0588 1.2049 1.1351\n\nSM52 1.1662 1.0501 1.2049 1.1309\n\nSM53 1.1662 1.0562 1.2049 1.1348\n\nSM54 1.1662 1.0624 1.2049 1.1387\n\n**SM55** 124,570 23,767,332 2,398 1.92% 9,913 191 1.1956 1.0888 146,123 33,779,990 10,035 6.87% 3,366 231 1.2254 1.1538\n\nSM56 1.1956 1.0949 1.2254 1.1577\n\nSM57 1.1956 1.1010 1.2254 1.1616\n\nSM58 1.1956 1.1071 1.2254 1.1655\n\nSM59 1.1956 1.1133 1.2254 1.1694\n\nSM60 1.1956 1.1126 1.2254 1.1695\n\nSM61 1.1956 1.1094 1.2254 1.1683\n\nSM62 1.1956 1.1061 1.2254 1.1670\n\nSM63 1.1956 1.1029 1.2254 1.1657\n\nSM64 1.1956 1.0996 1.2254 1.1645\n\n**SM65** 60,647 11,192,339 1,147 1.89% 9,762 185 1.2638 1.0525 69,040 15,021,880 4,636 6.72% 3,240 218 1.2559 1.1174\n\nSM66 1.2638 1.0492 1.2559 1.1161\n\nSM67 1.2638 1.0460 1.2559 1.1149\n\nSM68 1.2638 1.0427 1.2559 1.1136\n\nSM69 1.2638 1.0470 1.2559 1.1221\n\nSM70 1.2638 1.0704 1.2559 1.1534\n\nSM71 1.2638 1.0939 1.2559 1.1847\n\nSM72 1.2638 1.1173 1.2559 1.2160\n\nSM73 1.2638 1.1408 1.2559 1.2473\n\nSM74 1.2638 1.1642 1.2559 1.2786\n\n**SM75** 29,032 6,111,615 606 2.09% 10,078 211 1.6198 1.2202 32,500 8,017,135 2,527 7.78% 3,173 247 1.6060 1.3494\n\nSM76 1.6198 1.2436 1.6060 1.3807\n\nSM77 1.6198 1.2671 1.6060 1.4120\n\nSM78 1.6198 1.2905 1.6060 1.4433\n\nSM79 1.6198 1.3140 1.6060 1.4746\n\nSM80 1.6198 1.3374 1.6060 1.5059\n\nSM81 1.6198 1.3608 1.6060 1.5372\n\nSM82 1.6198 1.3843 1.6060 1.5685\n\nSM83 1.6198 1.4077 1.6060 1.5998\n\nSM84 1.6198 1.4312 1.6060 1.6311\n\nSM85 1.6198 1.4546 1.6060 1.6624\n\nSM86 1.6198 1.4781 1.6060 1.6937\n\nSM87 1.6198 1.5015 1.6060 1.7250\n\nSM88 1.6198 1.5250 1.6060 1.7563\n\nSM89 1.6198 1.5484 1.6060 1.7876\n\nSM90 1.6198 1.5719 1.6060 1.8189\n\nSM91 1.6198 1.5953 1.6060 1.8502\n\nSM92 1.6198 1.6188 1.6060 1.8815\n\nSM93 1.6198 1.6422 1.6060 1.9128\n\nSM94 1.6198 1.6657 1.6060 1.9441\n\nSM95 1.6198 1.6891 1.6060 1.9754\n\nSM96 1.6198 1.7125 1.6060 2.0067\n\nSM97 1.6198 1.7360 1.6060 2.0380\n\n\\# Proprietary Driver Class Page 6","publish_date":null,"title":"Driver Class State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class BI BI","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page938.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page938.pdf"},"request":{"example_id":"table/BRWS-134565917_page938","product_type":"parse","source_file_path":"BRWS-134565917_page938.pdf"},"started_at":"2026-11-04T19:46:54.094842"} +{"completed_at":"2026-11-04T19:46:56.813680","latency_in_ms":1299,"output":{"example_id":"table/BRWS-134565917_page953","grounded_pages":[],"layout_pages":[],"markdown":"Driver Class\n\n**Driver Class**\n\nSM98 SM99\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n1\\.4970 1.5990\n\n1\\.4970 1.6134\n\n1,193,003 494,976,237 97,429\n\n\\# Proprietary Driver Class Page 21","pages":[{"line_numbers":[],"markdown":"Driver Class\n\n**Driver Class**\n\nSM98 SM99\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n1\\.4970 1.5990\n\n1\\.4970 1.6134\n\n1,193,003 494,976,237 97,429\n\n\\# Proprietary Driver Class Page 21","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Driver Class\n\n**Driver Class**\n\nSM98 SM99\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n1\\.4970 1.5990\n\n1\\.4970 1.6134\n\n1,193,003 494,976,237 97,429\n\n\\# Proprietary Driver Class Page 21","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page953.pdf"]},"response":{"errors":[],"extract_id":"extract_cdcd177b1b0e0e08154fa984566b42ec","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Driver Class\n\n**Driver Class**\n\nSM98 SM99\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n1\\.4970 1.5990\n\n1\\.4970 1.6134\n\n1,193,003 494,976,237 97,429\n\n\\# Proprietary Driver Class Page 21"],"full_content":"Driver Class\n\n**Driver Class**\n\nSM98 SM99\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n1\\.4970 1.5990\n\n1\\.4970 1.6134\n\n1,193,003 494,976,237 97,429\n\n\\# Proprietary Driver Class Page 21","publish_date":null,"title":"Driver Class State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Driver Class COLL/UMPD COLL/UMPD","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page953.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page953.pdf"},"request":{"example_id":"table/BRWS-134565917_page953","product_type":"parse","source_file_path":"BRWS-134565917_page953.pdf"},"started_at":"2026-11-04T19:46:55.514500"} +{"completed_at":"2026-11-04T19:47:00.211844","latency_in_ms":3023,"output":{"example_id":"table/BRWS-134565917_page987","grounded_pages":[],"layout_pages":[],"markdown":"Rate Matrix\n\n**Rate Matrix**\n\nJ K L M N O P Q R S T U V W X Y\n\n**UW Tier 6**\n\nA B C D E F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 7**\n\nA B C D E F G H I J K L M N\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix**\n\n**PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM COMP COMP COMP COMP COMP COMP COMP COMP**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n10,094 3,051,123 572 5.66% 5,338 302 1.0403 0.9219 12,072 1,044,358 626 5.18% 1,669 87 0.7650 0.8191\n\n9,135 2,584,671 474 5.19% 5,453 283 0.9578 0.9239 10,932 1,177,703 648 5.93% 1,816 108 0.9206 0.8472\n\n10,003 2,449,684 479 4.79% 5,111 245 0.8248 0.9259 12,057 989,928 641 5.32% 1,544 82 0.7140 0.8492\n\n10,112 2,893,186 557 5.51% 5,193 286 0.9911 0.9279 11,290 1,400,084 668 5.92% 2,096 124 1.0625 1.0085\n\n9,926 2,650,038 517 5.21% 5,128 267 0.9365 0.9299 11,464 1,350,700 712 6.21% 1,897 118 1.0069 1.0105\n\n9,765 2,251,841 447 4.58% 5,032 231 0.8092 0.9319 10,902 1,197,554 646 5.93% 1,854 110 0.9252 1.0175\n\n9,821 2,872,621 557 5.67% 5,154 292 0.9950 0.9534 11,537 1,466,780 755 6.54% 1,943 127 1.0812 1.0745\n\n8,689 2,591,614 480 5.52% 5,401 298 1.0078 0.9554 10,177 1,365,884 688 6.76% 1,986 134 1.1248 1.1146\n\n8,688 2,395,720 485 5.59% 4,935 276 0.9274 0.9574 10,068 1,451,149 725 7.20% 2,001 144 1.2223 1.1166\n\n8,227 2,191,364 412 5.00% 5,322 266 0.8862 0.9594 9,535 1,158,860 598 6.27% 1,938 122 1.0408 1.1186\n\n8,054 2,547,125 511 6.34% 4,988 316 1.0597 1.0597 9,415 1,208,249 673 7.14% 1,796 128 1.0778 1.1206\n\n7,637 2,733,688 545 7.14% 5,013 358 1.2431 1.2109 8,966 1,276,252 620 6.92% 2,057 142 1.1615 1.1301\n\n7,188 2,565,770 487 6.77% 5,274 357 1.1786 1.2129 8,306 1,241,088 573 6.90% 2,167 149 1.2588 1.2673\n\n6,426 2,714,811 509 7.92% 5,333 422 1.4147 1.3199 7,735 1,207,795 606 7.83% 1,994 156 1.3113 1.2693\n\n6,053 2,332,488 490 8.09% 4,760 385 1.3017 1.3219 7,050 1,016,800 508 7.21% 2,001 144 1.2212 1.2713\n\n4,374 1,662,313 329 7.51% 5,058 380 1.2735 1.3239 5,008 861,761 399 7.96% 2,161 172 1.4661 1.4009\n\n301 42,236 9 2.86% 4,903 140 0.5040 0.5043 350 29,572 9 2.60% 3,249 85 0.8610 0.6783\n\n509 144,211 29 5.63% 5,029 283 0.7767 0.7751 698 97,594 34 4.89% 2,860 140 1.0163 0.7565\n\n702 213,277 38 5.47% 5,555 304 1.0218 0.7771 895 92,372 59 6.61% 1,562 103 0.8385 0.7815\n\n744 155,169 28 3.80% 5,495 209 0.5599 0.7791 960 85,648 57 5.95% 1,500 89 0.8112 0.8063\n\n946 265,329 53 5.61% 4,995 280 1.1006 0.8114 1,054 118,388 58 5.52% 2,035 112 0.8636 0.8339\n\n1,133 301,545 58 5.15% 5,171 266 0.8207 0.8134 1,271 138,748 63 4.98% 2,194 109 0.8994 0.8649\n\n1,256 296,741 58 4.60% 5,135 236 0.7138 0.8154 1,408 160,218 72 5.12% 2,222 114 0.8893 0.8669\n\n1,225 367,563 79 6.47% 4,642 300 0.8269 0.8269 1,342 216,944 80 5.98% 2,702 162 1.3080 0.9852\n\n1,075 288,462 63 5.84% 4,591 268 0.8429 0.8429 1,299 132,453 74 5.71% 1,786 102 0.8347 0.9872\n\n1,338 338,176 76 5.67% 4,455 253 0.9555 0.9423 1,379 156,744 76 5.53% 2,056 114 1.1980 0.9892\n\n1,276 387,919 74 5.77% 5,269 304 0.9300 0.9443 1,323 129,544 77 5.84% 1,678 98 0.8507 0.9912\n\n1,459 541,510 79 5.44% 6,821 371 1.1869 1.0395 1,440 170,827 110 7.66% 1,548 119 0.8891 0.9932\n\n1,274 391,742 85 6.70% 4,592 307 1.0968 1.0415 1,406 189,253 88 6.27% 2,146 135 1.0371 1.0185\n\n1,350 392,055 70 5.22% 5,563 291 0.9749 1.0435 1,353 130,524 83 6.15% 1,568 96 0.8484 1.0205\n\n1,373 407,621 89 6.52% 4,557 297 1.0663 1.0455 1,490 150,119 85 5.72% 1,762 101 0.9509 1.0275\n\n1,485 439,214 88 5.94% 4,981 296 0.9391 1.0475 1,512 195,286 102 6.77% 1,907 129 1.1539 1.1085\n\n1,402 521,932 95 6.79% 5,487 372 1.0695 1.0495 1,484 250,301 114 7.71% 2,188 169 1.3976 1.2461\n\n1,405 479,754 94 6.68% 5,107 341 1.1436 1.0515 1,393 256,974 113 8.13% 2,270 184 1.4724 1.2481\n\n1,602 438,153 94 5.89% 4,644 274 0.9180 1.0535 1,366 150,478 105 7.71% 1,429 110 1.1407 1.2501\n\n1,364 610,764 123 9.03% 4,961 448 1.3187 1.2289 1,217 163,119 94 7.74% 1,731 134 1.1457 1.2521\n\n1,316 448,909 95 7.22% 4,723 341 1.1373 1.2309 1,272 193,002 94 7.40% 2,049 152 1.2263 1.2541\n\n1,389 584,418 109 7.88% 5,341 421 1.3367 1.3279 1,312 258,997 119 9.09% 2,174 197 1.5954 1.3190\n\n1,221 499,063 102 8.40% 4,869 409 1.4786 1.3299 1,158 217,178 102 8.82% 2,127 188 1.3606 1.3210\n\n1,134 389,038 76 6.68% 5,137 343 1.0021 1.3319 1,044 128,185 68 6.54% 1,878 123 1.1196 1.3230\n\n947 368,978 67 7.07% 5,516 390 1.5221 1.5221 863 178,552 76 8.82% 2,345 207 1.3705 1.4109\n\n6,017 704,050 135 2.24% 5,218 117 0.5855 0.5855 7,249 484,825 308 4.25% 1,574 67 0.6615 0.6883\n\n8,418 1,574,496 293 3.48% 5,379 187 0.8173 0.7855 10,309 811,821 475 4.61% 1,709 79 0.7076 0.7665\n\n10,175 1,984,958 363 3.56% 5,475 195 0.8135 0.7875 11,416 989,451 565 4.95% 1,751 87 0.7601 0.7915\n\n11,785 2,215,969 407 3.45% 5,447 188 0.7442 0.7895 12,378 1,364,125 650 5.25% 2,100 110 0.9621 0.9691\n\n12,836 2,689,180 535 4.17% 5,025 209 0.7959 0.8214 13,303 1,559,333 759 5.71% 2,054 117 0.9899 0.9711\n\n14,733 3,854,442 741 5.03% 5,201 262 0.9687 0.9359 14,903 1,652,528 845 5.67% 1,955 111 0.9465 0.9731\n\n18,325 4,659,343 927 5.06% 5,025 254 0.9115 0.9379 16,535 2,031,221 971 5.87% 2,091 123 1.0608 1.0374\n\n17,843 4,809,918 949 5.32% 5,069 270 0.9671 0.9671 16,113 1,936,825 953 5.92% 2,031 120 1.0258 1.0394\n\n18,446 5,272,168 1,018 5.52% 5,179 286 1.0237 1.0237 16,093 2,235,130 974 6.05% 2,294 139 1.1829 1.1321\n\n21,135 6,170,286 1,227 5.80% 5,030 292 1.0439 1.0439 18,139 2,550,213 1,153 6.36% 2,212 141 1.2006 1.1341\n\n20,705 6,224,600 1,272 6.14% 4,893 301 1.0644 1.0644 17,050 2,103,064 1,072 6.29% 1,961 123 1.0756 1.1361\n\n22,563 7,293,057 1,408 6.24% 5,181 323 1.1265 1.1265 18,524 2,444,774 1,203 6.49% 2,032 132 1.1294 1.1381\n\n23,021 7,714,763 1,529 6.64% 5,047 335 1.1716 1.1360 18,733 2,482,762 1,174 6.27% 2,115 133 1.1223 1.1401\n\n23,213 7,085,855 1,355 5.84% 5,228 305 1.1273 1.1380 18,423 2,901,087 1,266 6.87% 2,292 157 1.3378 1.2592\n\n\\# Proprietary Rate Matrix Page 55","pages":[{"line_numbers":[],"markdown":"Rate Matrix\n\n**Rate Matrix**\n\nJ K L M N O P Q R S T U V W X Y\n\n**UW Tier 6**\n\nA B C D E F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 7**\n\nA B C D E F G H I J K L M N\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix**\n\n**PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM COMP COMP COMP COMP COMP COMP COMP COMP**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n10,094 3,051,123 572 5.66% 5,338 302 1.0403 0.9219 12,072 1,044,358 626 5.18% 1,669 87 0.7650 0.8191\n\n9,135 2,584,671 474 5.19% 5,453 283 0.9578 0.9239 10,932 1,177,703 648 5.93% 1,816 108 0.9206 0.8472\n\n10,003 2,449,684 479 4.79% 5,111 245 0.8248 0.9259 12,057 989,928 641 5.32% 1,544 82 0.7140 0.8492\n\n10,112 2,893,186 557 5.51% 5,193 286 0.9911 0.9279 11,290 1,400,084 668 5.92% 2,096 124 1.0625 1.0085\n\n9,926 2,650,038 517 5.21% 5,128 267 0.9365 0.9299 11,464 1,350,700 712 6.21% 1,897 118 1.0069 1.0105\n\n9,765 2,251,841 447 4.58% 5,032 231 0.8092 0.9319 10,902 1,197,554 646 5.93% 1,854 110 0.9252 1.0175\n\n9,821 2,872,621 557 5.67% 5,154 292 0.9950 0.9534 11,537 1,466,780 755 6.54% 1,943 127 1.0812 1.0745\n\n8,689 2,591,614 480 5.52% 5,401 298 1.0078 0.9554 10,177 1,365,884 688 6.76% 1,986 134 1.1248 1.1146\n\n8,688 2,395,720 485 5.59% 4,935 276 0.9274 0.9574 10,068 1,451,149 725 7.20% 2,001 144 1.2223 1.1166\n\n8,227 2,191,364 412 5.00% 5,322 266 0.8862 0.9594 9,535 1,158,860 598 6.27% 1,938 122 1.0408 1.1186\n\n8,054 2,547,125 511 6.34% 4,988 316 1.0597 1.0597 9,415 1,208,249 673 7.14% 1,796 128 1.0778 1.1206\n\n7,637 2,733,688 545 7.14% 5,013 358 1.2431 1.2109 8,966 1,276,252 620 6.92% 2,057 142 1.1615 1.1301\n\n7,188 2,565,770 487 6.77% 5,274 357 1.1786 1.2129 8,306 1,241,088 573 6.90% 2,167 149 1.2588 1.2673\n\n6,426 2,714,811 509 7.92% 5,333 422 1.4147 1.3199 7,735 1,207,795 606 7.83% 1,994 156 1.3113 1.2693\n\n6,053 2,332,488 490 8.09% 4,760 385 1.3017 1.3219 7,050 1,016,800 508 7.21% 2,001 144 1.2212 1.2713\n\n4,374 1,662,313 329 7.51% 5,058 380 1.2735 1.3239 5,008 861,761 399 7.96% 2,161 172 1.4661 1.4009\n\n301 42,236 9 2.86% 4,903 140 0.5040 0.5043 350 29,572 9 2.60% 3,249 85 0.8610 0.6783\n\n509 144,211 29 5.63% 5,029 283 0.7767 0.7751 698 97,594 34 4.89% 2,860 140 1.0163 0.7565\n\n702 213,277 38 5.47% 5,555 304 1.0218 0.7771 895 92,372 59 6.61% 1,562 103 0.8385 0.7815\n\n744 155,169 28 3.80% 5,495 209 0.5599 0.7791 960 85,648 57 5.95% 1,500 89 0.8112 0.8063\n\n946 265,329 53 5.61% 4,995 280 1.1006 0.8114 1,054 118,388 58 5.52% 2,035 112 0.8636 0.8339\n\n1,133 301,545 58 5.15% 5,171 266 0.8207 0.8134 1,271 138,748 63 4.98% 2,194 109 0.8994 0.8649\n\n1,256 296,741 58 4.60% 5,135 236 0.7138 0.8154 1,408 160,218 72 5.12% 2,222 114 0.8893 0.8669\n\n1,225 367,563 79 6.47% 4,642 300 0.8269 0.8269 1,342 216,944 80 5.98% 2,702 162 1.3080 0.9852\n\n1,075 288,462 63 5.84% 4,591 268 0.8429 0.8429 1,299 132,453 74 5.71% 1,786 102 0.8347 0.9872\n\n1,338 338,176 76 5.67% 4,455 253 0.9555 0.9423 1,379 156,744 76 5.53% 2,056 114 1.1980 0.9892\n\n1,276 387,919 74 5.77% 5,269 304 0.9300 0.9443 1,323 129,544 77 5.84% 1,678 98 0.8507 0.9912\n\n1,459 541,510 79 5.44% 6,821 371 1.1869 1.0395 1,440 170,827 110 7.66% 1,548 119 0.8891 0.9932\n\n1,274 391,742 85 6.70% 4,592 307 1.0968 1.0415 1,406 189,253 88 6.27% 2,146 135 1.0371 1.0185\n\n1,350 392,055 70 5.22% 5,563 291 0.9749 1.0435 1,353 130,524 83 6.15% 1,568 96 0.8484 1.0205\n\n1,373 407,621 89 6.52% 4,557 297 1.0663 1.0455 1,490 150,119 85 5.72% 1,762 101 0.9509 1.0275\n\n1,485 439,214 88 5.94% 4,981 296 0.9391 1.0475 1,512 195,286 102 6.77% 1,907 129 1.1539 1.1085\n\n1,402 521,932 95 6.79% 5,487 372 1.0695 1.0495 1,484 250,301 114 7.71% 2,188 169 1.3976 1.2461\n\n1,405 479,754 94 6.68% 5,107 341 1.1436 1.0515 1,393 256,974 113 8.13% 2,270 184 1.4724 1.2481\n\n1,602 438,153 94 5.89% 4,644 274 0.9180 1.0535 1,366 150,478 105 7.71% 1,429 110 1.1407 1.2501\n\n1,364 610,764 123 9.03% 4,961 448 1.3187 1.2289 1,217 163,119 94 7.74% 1,731 134 1.1457 1.2521\n\n1,316 448,909 95 7.22% 4,723 341 1.1373 1.2309 1,272 193,002 94 7.40% 2,049 152 1.2263 1.2541\n\n1,389 584,418 109 7.88% 5,341 421 1.3367 1.3279 1,312 258,997 119 9.09% 2,174 197 1.5954 1.3190\n\n1,221 499,063 102 8.40% 4,869 409 1.4786 1.3299 1,158 217,178 102 8.82% 2,127 188 1.3606 1.3210\n\n1,134 389,038 76 6.68% 5,137 343 1.0021 1.3319 1,044 128,185 68 6.54% 1,878 123 1.1196 1.3230\n\n947 368,978 67 7.07% 5,516 390 1.5221 1.5221 863 178,552 76 8.82% 2,345 207 1.3705 1.4109\n\n6,017 704,050 135 2.24% 5,218 117 0.5855 0.5855 7,249 484,825 308 4.25% 1,574 67 0.6615 0.6883\n\n8,418 1,574,496 293 3.48% 5,379 187 0.8173 0.7855 10,309 811,821 475 4.61% 1,709 79 0.7076 0.7665\n\n10,175 1,984,958 363 3.56% 5,475 195 0.8135 0.7875 11,416 989,451 565 4.95% 1,751 87 0.7601 0.7915\n\n11,785 2,215,969 407 3.45% 5,447 188 0.7442 0.7895 12,378 1,364,125 650 5.25% 2,100 110 0.9621 0.9691\n\n12,836 2,689,180 535 4.17% 5,025 209 0.7959 0.8214 13,303 1,559,333 759 5.71% 2,054 117 0.9899 0.9711\n\n14,733 3,854,442 741 5.03% 5,201 262 0.9687 0.9359 14,903 1,652,528 845 5.67% 1,955 111 0.9465 0.9731\n\n18,325 4,659,343 927 5.06% 5,025 254 0.9115 0.9379 16,535 2,031,221 971 5.87% 2,091 123 1.0608 1.0374\n\n17,843 4,809,918 949 5.32% 5,069 270 0.9671 0.9671 16,113 1,936,825 953 5.92% 2,031 120 1.0258 1.0394\n\n18,446 5,272,168 1,018 5.52% 5,179 286 1.0237 1.0237 16,093 2,235,130 974 6.05% 2,294 139 1.1829 1.1321\n\n21,135 6,170,286 1,227 5.80% 5,030 292 1.0439 1.0439 18,139 2,550,213 1,153 6.36% 2,212 141 1.2006 1.1341\n\n20,705 6,224,600 1,272 6.14% 4,893 301 1.0644 1.0644 17,050 2,103,064 1,072 6.29% 1,961 123 1.0756 1.1361\n\n22,563 7,293,057 1,408 6.24% 5,181 323 1.1265 1.1265 18,524 2,444,774 1,203 6.49% 2,032 132 1.1294 1.1381\n\n23,021 7,714,763 1,529 6.64% 5,047 335 1.1716 1.1360 18,733 2,482,762 1,174 6.27% 2,115 133 1.1223 1.1401\n\n23,213 7,085,855 1,355 5.84% 5,228 305 1.1273 1.1380 18,423 2,901,087 1,266 6.87% 2,292 157 1.3378 1.2592\n\n\\# Proprietary Rate Matrix Page 55","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Rate Matrix\n\n**Rate Matrix**\n\nJ K L M N O P Q R S T U V W X Y\n\n**UW Tier 6**\n\nA B C D E F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 7**\n\nA B C D E F G H I J K L M N\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix**\n\n**PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM COMP COMP COMP COMP COMP COMP COMP COMP**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n10,094 3,051,123 572 5.66% 5,338 302 1.0403 0.9219 12,072 1,044,358 626 5.18% 1,669 87 0.7650 0.8191\n\n9,135 2,584,671 474 5.19% 5,453 283 0.9578 0.9239 10,932 1,177,703 648 5.93% 1,816 108 0.9206 0.8472\n\n10,003 2,449,684 479 4.79% 5,111 245 0.8248 0.9259 12,057 989,928 641 5.32% 1,544 82 0.7140 0.8492\n\n10,112 2,893,186 557 5.51% 5,193 286 0.9911 0.9279 11,290 1,400,084 668 5.92% 2,096 124 1.0625 1.0085\n\n9,926 2,650,038 517 5.21% 5,128 267 0.9365 0.9299 11,464 1,350,700 712 6.21% 1,897 118 1.0069 1.0105\n\n9,765 2,251,841 447 4.58% 5,032 231 0.8092 0.9319 10,902 1,197,554 646 5.93% 1,854 110 0.9252 1.0175\n\n9,821 2,872,621 557 5.67% 5,154 292 0.9950 0.9534 11,537 1,466,780 755 6.54% 1,943 127 1.0812 1.0745\n\n8,689 2,591,614 480 5.52% 5,401 298 1.0078 0.9554 10,177 1,365,884 688 6.76% 1,986 134 1.1248 1.1146\n\n8,688 2,395,720 485 5.59% 4,935 276 0.9274 0.9574 10,068 1,451,149 725 7.20% 2,001 144 1.2223 1.1166\n\n8,227 2,191,364 412 5.00% 5,322 266 0.8862 0.9594 9,535 1,158,860 598 6.27% 1,938 122 1.0408 1.1186\n\n8,054 2,547,125 511 6.34% 4,988 316 1.0597 1.0597 9,415 1,208,249 673 7.14% 1,796 128 1.0778 1.1206\n\n7,637 2,733,688 545 7.14% 5,013 358 1.2431 1.2109 8,966 1,276,252 620 6.92% 2,057 142 1.1615 1.1301\n\n7,188 2,565,770 487 6.77% 5,274 357 1.1786 1.2129 8,306 1,241,088 573 6.90% 2,167 149 1.2588 1.2673\n\n6,426 2,714,811 509 7.92% 5,333 422 1.4147 1.3199 7,735 1,207,795 606 7.83% 1,994 156 1.3113 1.2693\n\n6,053 2,332,488 490 8.09% 4,760 385 1.3017 1.3219 7,050 1,016,800 508 7.21% 2,001 144 1.2212 1.2713\n\n4,374 1,662,313 329 7.51% 5,058 380 1.2735 1.3239 5,008 861,761 399 7.96% 2,161 172 1.4661 1.4009\n\n301 42,236 9 2.86% 4,903 140 0.5040 0.5043 350 29,572 9 2.60% 3,249 85 0.8610 0.6783\n\n509 144,211 29 5.63% 5,029 283 0.7767 0.7751 698 97,594 34 4.89% 2,860 140 1.0163 0.7565\n\n702 213,277 38 5.47% 5,555 304 1.0218 0.7771 895 92,372 59 6.61% 1,562 103 0.8385 0.7815\n\n744 155,169 28 3.80% 5,495 209 0.5599 0.7791 960 85,648 57 5.95% 1,500 89 0.8112 0.8063\n\n946 265,329 53 5.61% 4,995 280 1.1006 0.8114 1,054 118,388 58 5.52% 2,035 112 0.8636 0.8339\n\n1,133 301,545 58 5.15% 5,171 266 0.8207 0.8134 1,271 138,748 63 4.98% 2,194 109 0.8994 0.8649\n\n1,256 296,741 58 4.60% 5,135 236 0.7138 0.8154 1,408 160,218 72 5.12% 2,222 114 0.8893 0.8669\n\n1,225 367,563 79 6.47% 4,642 300 0.8269 0.8269 1,342 216,944 80 5.98% 2,702 162 1.3080 0.9852\n\n1,075 288,462 63 5.84% 4,591 268 0.8429 0.8429 1,299 132,453 74 5.71% 1,786 102 0.8347 0.9872\n\n1,338 338,176 76 5.67% 4,455 253 0.9555 0.9423 1,379 156,744 76 5.53% 2,056 114 1.1980 0.9892\n\n1,276 387,919 74 5.77% 5,269 304 0.9300 0.9443 1,323 129,544 77 5.84% 1,678 98 0.8507 0.9912\n\n1,459 541,510 79 5.44% 6,821 371 1.1869 1.0395 1,440 170,827 110 7.66% 1,548 119 0.8891 0.9932\n\n1,274 391,742 85 6.70% 4,592 307 1.0968 1.0415 1,406 189,253 88 6.27% 2,146 135 1.0371 1.0185\n\n1,350 392,055 70 5.22% 5,563 291 0.9749 1.0435 1,353 130,524 83 6.15% 1,568 96 0.8484 1.0205\n\n1,373 407,621 89 6.52% 4,557 297 1.0663 1.0455 1,490 150,119 85 5.72% 1,762 101 0.9509 1.0275\n\n1,485 439,214 88 5.94% 4,981 296 0.9391 1.0475 1,512 195,286 102 6.77% 1,907 129 1.1539 1.1085\n\n1,402 521,932 95 6.79% 5,487 372 1.0695 1.0495 1,484 250,301 114 7.71% 2,188 169 1.3976 1.2461\n\n1,405 479,754 94 6.68% 5,107 341 1.1436 1.0515 1,393 256,974 113 8.13% 2,270 184 1.4724 1.2481\n\n1,602 438,153 94 5.89% 4,644 274 0.9180 1.0535 1,366 150,478 105 7.71% 1,429 110 1.1407 1.2501\n\n1,364 610,764 123 9.03% 4,961 448 1.3187 1.2289 1,217 163,119 94 7.74% 1,731 134 1.1457 1.2521\n\n1,316 448,909 95 7.22% 4,723 341 1.1373 1.2309 1,272 193,002 94 7.40% 2,049 152 1.2263 1.2541\n\n1,389 584,418 109 7.88% 5,341 421 1.3367 1.3279 1,312 258,997 119 9.09% 2,174 197 1.5954 1.3190\n\n1,221 499,063 102 8.40% 4,869 409 1.4786 1.3299 1,158 217,178 102 8.82% 2,127 188 1.3606 1.3210\n\n1,134 389,038 76 6.68% 5,137 343 1.0021 1.3319 1,044 128,185 68 6.54% 1,878 123 1.1196 1.3230\n\n947 368,978 67 7.07% 5,516 390 1.5221 1.5221 863 178,552 76 8.82% 2,345 207 1.3705 1.4109\n\n6,017 704,050 135 2.24% 5,218 117 0.5855 0.5855 7,249 484,825 308 4.25% 1,574 67 0.6615 0.6883\n\n8,418 1,574,496 293 3.48% 5,379 187 0.8173 0.7855 10,309 811,821 475 4.61% 1,709 79 0.7076 0.7665\n\n10,175 1,984,958 363 3.56% 5,475 195 0.8135 0.7875 11,416 989,451 565 4.95% 1,751 87 0.7601 0.7915\n\n11,785 2,215,969 407 3.45% 5,447 188 0.7442 0.7895 12,378 1,364,125 650 5.25% 2,100 110 0.9621 0.9691\n\n12,836 2,689,180 535 4.17% 5,025 209 0.7959 0.8214 13,303 1,559,333 759 5.71% 2,054 117 0.9899 0.9711\n\n14,733 3,854,442 741 5.03% 5,201 262 0.9687 0.9359 14,903 1,652,528 845 5.67% 1,955 111 0.9465 0.9731\n\n18,325 4,659,343 927 5.06% 5,025 254 0.9115 0.9379 16,535 2,031,221 971 5.87% 2,091 123 1.0608 1.0374\n\n17,843 4,809,918 949 5.32% 5,069 270 0.9671 0.9671 16,113 1,936,825 953 5.92% 2,031 120 1.0258 1.0394\n\n18,446 5,272,168 1,018 5.52% 5,179 286 1.0237 1.0237 16,093 2,235,130 974 6.05% 2,294 139 1.1829 1.1321\n\n21,135 6,170,286 1,227 5.80% 5,030 292 1.0439 1.0439 18,139 2,550,213 1,153 6.36% 2,212 141 1.2006 1.1341\n\n20,705 6,224,600 1,272 6.14% 4,893 301 1.0644 1.0644 17,050 2,103,064 1,072 6.29% 1,961 123 1.0756 1.1361\n\n22,563 7,293,057 1,408 6.24% 5,181 323 1.1265 1.1265 18,524 2,444,774 1,203 6.49% 2,032 132 1.1294 1.1381\n\n23,021 7,714,763 1,529 6.64% 5,047 335 1.1716 1.1360 18,733 2,482,762 1,174 6.27% 2,115 133 1.1223 1.1401\n\n23,213 7,085,855 1,355 5.84% 5,228 305 1.1273 1.1380 18,423 2,901,087 1,266 6.87% 2,292 157 1.3378 1.2592\n\n\\# Proprietary Rate Matrix Page 55","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page987.pdf"]},"response":{"errors":[],"extract_id":"extract_77fb627ad18eae921904030cc2a47a5d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Rate Matrix\n\n**Rate Matrix**\n\nJ K L M N O P Q R S T U V W X Y\n\n**UW Tier 6**\n\nA B C D E F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 7**\n\nA B C D E F G H I J K L M N\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix**\n\n**PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM COMP COMP COMP COMP COMP COMP COMP COMP**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n10,094 3,051,123 572 5.66% 5,338 302 1.0403 0.9219 12,072 1,044,358 626 5.18% 1,669 87 0.7650 0.8191\n\n9,135 2,584,671 474 5.19% 5,453 283 0.9578 0.9239 10,932 1,177,703 648 5.93% 1,816 108 0.9206 0.8472\n\n10,003 2,449,684 479 4.79% 5,111 245 0.8248 0.9259 12,057 989,928 641 5.32% 1,544 82 0.7140 0.8492\n\n10,112 2,893,186 557 5.51% 5,193 286 0.9911 0.9279 11,290 1,400,084 668 5.92% 2,096 124 1.0625 1.0085\n\n9,926 2,650,038 517 5.21% 5,128 267 0.9365 0.9299 11,464 1,350,700 712 6.21% 1,897 118 1.0069 1.0105\n\n9,765 2,251,841 447 4.58% 5,032 231 0.8092 0.9319 10,902 1,197,554 646 5.93% 1,854 110 0.9252 1.0175\n\n9,821 2,872,621 557 5.67% 5,154 292 0.9950 0.9534 11,537 1,466,780 755 6.54% 1,943 127 1.0812 1.0745\n\n8,689 2,591,614 480 5.52% 5,401 298 1.0078 0.9554 10,177 1,365,884 688 6.76% 1,986 134 1.1248 1.1146\n\n8,688 2,395,720 485 5.59% 4,935 276 0.9274 0.9574 10,068 1,451,149 725 7.20% 2,001 144 1.2223 1.1166\n\n8,227 2,191,364 412 5.00% 5,322 266 0.8862 0.9594 9,535 1,158,860 598 6.27% 1,938 122 1.0408 1.1186\n\n8,054 2,547,125 511 6.34% 4,988 316 1.0597 1.0597 9,415 1,208,249 673 7.14% 1,796 128 1.0778 1.1206\n\n7,637 2,733,688 545 7.14% 5,013 358 1.2431 1.2109 8,966 1,276,252 620 6.92% 2,057 142 1.1615 1.1301\n\n7,188 2,565,770 487 6.77% 5,274 357 1.1786 1.2129 8,306 1,241,088 573 6.90% 2,167 149 1.2588 1.2673\n\n6,426 2,714,811 509 7.92% 5,333 422 1.4147 1.3199 7,735 1,207,795 606 7.83% 1,994 156 1.3113 1.2693\n\n6,053 2,332,488 490 8.09% 4,760 385 1.3017 1.3219 7,050 1,016,800 508 7.21% 2,001 144 1.2212 1.2713\n\n4,374 1,662,313 329 7.51% 5,058 380 1.2735 1.3239 5,008 861,761 399 7.96% 2,161 172 1.4661 1.4009\n\n301 42,236 9 2.86% 4,903 140 0.5040 0.5043 350 29,572 9 2.60% 3,249 85 0.8610 0.6783\n\n509 144,211 29 5.63% 5,029 283 0.7767 0.7751 698 97,594 34 4.89% 2,860 140 1.0163 0.7565\n\n702 213,277 38 5.47% 5,555 304 1.0218 0.7771 895 92,372 59 6.61% 1,562 103 0.8385 0.7815\n\n744 155,169 28 3.80% 5,495 209 0.5599 0.7791 960 85,648 57 5.95% 1,500 89 0.8112 0.8063\n\n946 265,329 53 5.61% 4,995 280 1.1006 0.8114 1,054 118,388 58 5.52% 2,035 112 0.8636 0.8339\n\n1,133 301,545 58 5.15% 5,171 266 0.8207 0.8134 1,271 138,748 63 4.98% 2,194 109 0.8994 0.8649\n\n1,256 296,741 58 4.60% 5,135 236 0.7138 0.8154 1,408 160,218 72 5.12% 2,222 114 0.8893 0.8669\n\n1,225 367,563 79 6.47% 4,642 300 0.8269 0.8269 1,342 216,944 80 5.98% 2,702 162 1.3080 0.9852\n\n1,075 288,462 63 5.84% 4,591 268 0.8429 0.8429 1,299 132,453 74 5.71% 1,786 102 0.8347 0.9872\n\n1,338 338,176 76 5.67% 4,455 253 0.9555 0.9423 1,379 156,744 76 5.53% 2,056 114 1.1980 0.9892\n\n1,276 387,919 74 5.77% 5,269 304 0.9300 0.9443 1,323 129,544 77 5.84% 1,678 98 0.8507 0.9912\n\n1,459 541,510 79 5.44% 6,821 371 1.1869 1.0395 1,440 170,827 110 7.66% 1,548 119 0.8891 0.9932\n\n1,274 391,742 85 6.70% 4,592 307 1.0968 1.0415 1,406 189,253 88 6.27% 2,146 135 1.0371 1.0185\n\n1,350 392,055 70 5.22% 5,563 291 0.9749 1.0435 1,353 130,524 83 6.15% 1,568 96 0.8484 1.0205\n\n1,373 407,621 89 6.52% 4,557 297 1.0663 1.0455 1,490 150,119 85 5.72% 1,762 101 0.9509 1.0275\n\n1,485 439,214 88 5.94% 4,981 296 0.9391 1.0475 1,512 195,286 102 6.77% 1,907 129 1.1539 1.1085\n\n1,402 521,932 95 6.79% 5,487 372 1.0695 1.0495 1,484 250,301 114 7.71% 2,188 169 1.3976 1.2461\n\n1,405 479,754 94 6.68% 5,107 341 1.1436 1.0515 1,393 256,974 113 8.13% 2,270 184 1.4724 1.2481\n\n1,602 438,153 94 5.89% 4,644 274 0.9180 1.0535 1,366 150,478 105 7.71% 1,429 110 1.1407 1.2501\n\n1,364 610,764 123 9.03% 4,961 448 1.3187 1.2289 1,217 163,119 94 7.74% 1,731 134 1.1457 1.2521\n\n1,316 448,909 95 7.22% 4,723 341 1.1373 1.2309 1,272 193,002 94 7.40% 2,049 152 1.2263 1.2541\n\n1,389 584,418 109 7.88% 5,341 421 1.3367 1.3279 1,312 258,997 119 9.09% 2,174 197 1.5954 1.3190\n\n1,221 499,063 102 8.40% 4,869 409 1.4786 1.3299 1,158 217,178 102 8.82% 2,127 188 1.3606 1.3210\n\n1,134 389,038 76 6.68% 5,137 343 1.0021 1.3319 1,044 128,185 68 6.54% 1,878 123 1.1196 1.3230\n\n947 368,978 67 7.07% 5,516 390 1.5221 1.5221 863 178,552 76 8.82% 2,345 207 1.3705 1.4109\n\n6,017 704,050 135 2.24% 5,218 117 0.5855 0.5855 7,249 484,825 308 4.25% 1,574 67 0.6615 0.6883\n\n8,418 1,574,496 293 3.48% 5,379 187 0.8173 0.7855 10,309 811,821 475 4.61% 1,709 79 0.7076 0.7665\n\n10,175 1,984,958 363 3.56% 5,475 195 0.8135 0.7875 11,416 989,451 565 4.95% 1,751 87 0.7601 0.7915\n\n11,785 2,215,969 407 3.45% 5,447 188 0.7442 0.7895 12,378 1,364,125 650 5.25% 2,100 110 0.9621 0.9691\n\n12,836 2,689,180 535 4.17% 5,025 209 0.7959 0.8214 13,303 1,559,333 759 5.71% 2,054 117 0.9899 0.9711\n\n14,733 3,854,442 741 5.03% 5,201 262 0.9687 0.9359 14,903 1,652,528 845 5.67% 1,955 111 0.9465 0.9731\n\n18,325 4,659,343 927 5.06% 5,025 254 0.9115 0.9379 16,535 2,031,221 971 5.87% 2,091 123 1.0608 1.0374\n\n17,843 4,809,918 949 5.32% 5,069 270 0.9671 0.9671 16,113 1,936,825 953 5.92% 2,031 120 1.0258 1.0394\n\n18,446 5,272,168 1,018 5.52% 5,179 286 1.0237 1.0237 16,093 2,235,130 974 6.05% 2,294 139 1.1829 1.1321\n\n21,135 6,170,286 1,227 5.80% 5,030 292 1.0439 1.0439 18,139 2,550,213 1,153 6.36% 2,212 141 1.2006 1.1341\n\n20,705 6,224,600 1,272 6.14% 4,893 301 1.0644 1.0644 17,050 2,103,064 1,072 6.29% 1,961 123 1.0756 1.1361\n\n22,563 7,293,057 1,408 6.24% 5,181 323 1.1265 1.1265 18,524 2,444,774 1,203 6.49% 2,032 132 1.1294 1.1381\n\n23,021 7,714,763 1,529 6.64% 5,047 335 1.1716 1.1360 18,733 2,482,762 1,174 6.27% 2,115 133 1.1223 1.1401\n\n23,213 7,085,855 1,355 5.84% 5,228 305 1.1273 1.1380 18,423 2,901,087 1,266 6.87% 2,292 157 1.3378 1.2592\n\n\\# Proprietary Rate Matrix Page 55"],"full_content":"Rate Matrix\n\n**Rate Matrix**\n\nJ K L M N O P Q R S T U V W X Y\n\n**UW Tier 6**\n\nA B C D E F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 7**\n\nA B C D E F G H I J K L M N\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix**\n\n**PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM PIP/MP/UM COMP COMP COMP COMP COMP COMP COMP COMP**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n10,094 3,051,123 572 5.66% 5,338 302 1.0403 0.9219 12,072 1,044,358 626 5.18% 1,669 87 0.7650 0.8191\n\n9,135 2,584,671 474 5.19% 5,453 283 0.9578 0.9239 10,932 1,177,703 648 5.93% 1,816 108 0.9206 0.8472\n\n10,003 2,449,684 479 4.79% 5,111 245 0.8248 0.9259 12,057 989,928 641 5.32% 1,544 82 0.7140 0.8492\n\n10,112 2,893,186 557 5.51% 5,193 286 0.9911 0.9279 11,290 1,400,084 668 5.92% 2,096 124 1.0625 1.0085\n\n9,926 2,650,038 517 5.21% 5,128 267 0.9365 0.9299 11,464 1,350,700 712 6.21% 1,897 118 1.0069 1.0105\n\n9,765 2,251,841 447 4.58% 5,032 231 0.8092 0.9319 10,902 1,197,554 646 5.93% 1,854 110 0.9252 1.0175\n\n9,821 2,872,621 557 5.67% 5,154 292 0.9950 0.9534 11,537 1,466,780 755 6.54% 1,943 127 1.0812 1.0745\n\n8,689 2,591,614 480 5.52% 5,401 298 1.0078 0.9554 10,177 1,365,884 688 6.76% 1,986 134 1.1248 1.1146\n\n8,688 2,395,720 485 5.59% 4,935 276 0.9274 0.9574 10,068 1,451,149 725 7.20% 2,001 144 1.2223 1.1166\n\n8,227 2,191,364 412 5.00% 5,322 266 0.8862 0.9594 9,535 1,158,860 598 6.27% 1,938 122 1.0408 1.1186\n\n8,054 2,547,125 511 6.34% 4,988 316 1.0597 1.0597 9,415 1,208,249 673 7.14% 1,796 128 1.0778 1.1206\n\n7,637 2,733,688 545 7.14% 5,013 358 1.2431 1.2109 8,966 1,276,252 620 6.92% 2,057 142 1.1615 1.1301\n\n7,188 2,565,770 487 6.77% 5,274 357 1.1786 1.2129 8,306 1,241,088 573 6.90% 2,167 149 1.2588 1.2673\n\n6,426 2,714,811 509 7.92% 5,333 422 1.4147 1.3199 7,735 1,207,795 606 7.83% 1,994 156 1.3113 1.2693\n\n6,053 2,332,488 490 8.09% 4,760 385 1.3017 1.3219 7,050 1,016,800 508 7.21% 2,001 144 1.2212 1.2713\n\n4,374 1,662,313 329 7.51% 5,058 380 1.2735 1.3239 5,008 861,761 399 7.96% 2,161 172 1.4661 1.4009\n\n301 42,236 9 2.86% 4,903 140 0.5040 0.5043 350 29,572 9 2.60% 3,249 85 0.8610 0.6783\n\n509 144,211 29 5.63% 5,029 283 0.7767 0.7751 698 97,594 34 4.89% 2,860 140 1.0163 0.7565\n\n702 213,277 38 5.47% 5,555 304 1.0218 0.7771 895 92,372 59 6.61% 1,562 103 0.8385 0.7815\n\n744 155,169 28 3.80% 5,495 209 0.5599 0.7791 960 85,648 57 5.95% 1,500 89 0.8112 0.8063\n\n946 265,329 53 5.61% 4,995 280 1.1006 0.8114 1,054 118,388 58 5.52% 2,035 112 0.8636 0.8339\n\n1,133 301,545 58 5.15% 5,171 266 0.8207 0.8134 1,271 138,748 63 4.98% 2,194 109 0.8994 0.8649\n\n1,256 296,741 58 4.60% 5,135 236 0.7138 0.8154 1,408 160,218 72 5.12% 2,222 114 0.8893 0.8669\n\n1,225 367,563 79 6.47% 4,642 300 0.8269 0.8269 1,342 216,944 80 5.98% 2,702 162 1.3080 0.9852\n\n1,075 288,462 63 5.84% 4,591 268 0.8429 0.8429 1,299 132,453 74 5.71% 1,786 102 0.8347 0.9872\n\n1,338 338,176 76 5.67% 4,455 253 0.9555 0.9423 1,379 156,744 76 5.53% 2,056 114 1.1980 0.9892\n\n1,276 387,919 74 5.77% 5,269 304 0.9300 0.9443 1,323 129,544 77 5.84% 1,678 98 0.8507 0.9912\n\n1,459 541,510 79 5.44% 6,821 371 1.1869 1.0395 1,440 170,827 110 7.66% 1,548 119 0.8891 0.9932\n\n1,274 391,742 85 6.70% 4,592 307 1.0968 1.0415 1,406 189,253 88 6.27% 2,146 135 1.0371 1.0185\n\n1,350 392,055 70 5.22% 5,563 291 0.9749 1.0435 1,353 130,524 83 6.15% 1,568 96 0.8484 1.0205\n\n1,373 407,621 89 6.52% 4,557 297 1.0663 1.0455 1,490 150,119 85 5.72% 1,762 101 0.9509 1.0275\n\n1,485 439,214 88 5.94% 4,981 296 0.9391 1.0475 1,512 195,286 102 6.77% 1,907 129 1.1539 1.1085\n\n1,402 521,932 95 6.79% 5,487 372 1.0695 1.0495 1,484 250,301 114 7.71% 2,188 169 1.3976 1.2461\n\n1,405 479,754 94 6.68% 5,107 341 1.1436 1.0515 1,393 256,974 113 8.13% 2,270 184 1.4724 1.2481\n\n1,602 438,153 94 5.89% 4,644 274 0.9180 1.0535 1,366 150,478 105 7.71% 1,429 110 1.1407 1.2501\n\n1,364 610,764 123 9.03% 4,961 448 1.3187 1.2289 1,217 163,119 94 7.74% 1,731 134 1.1457 1.2521\n\n1,316 448,909 95 7.22% 4,723 341 1.1373 1.2309 1,272 193,002 94 7.40% 2,049 152 1.2263 1.2541\n\n1,389 584,418 109 7.88% 5,341 421 1.3367 1.3279 1,312 258,997 119 9.09% 2,174 197 1.5954 1.3190\n\n1,221 499,063 102 8.40% 4,869 409 1.4786 1.3299 1,158 217,178 102 8.82% 2,127 188 1.3606 1.3210\n\n1,134 389,038 76 6.68% 5,137 343 1.0021 1.3319 1,044 128,185 68 6.54% 1,878 123 1.1196 1.3230\n\n947 368,978 67 7.07% 5,516 390 1.5221 1.5221 863 178,552 76 8.82% 2,345 207 1.3705 1.4109\n\n6,017 704,050 135 2.24% 5,218 117 0.5855 0.5855 7,249 484,825 308 4.25% 1,574 67 0.6615 0.6883\n\n8,418 1,574,496 293 3.48% 5,379 187 0.8173 0.7855 10,309 811,821 475 4.61% 1,709 79 0.7076 0.7665\n\n10,175 1,984,958 363 3.56% 5,475 195 0.8135 0.7875 11,416 989,451 565 4.95% 1,751 87 0.7601 0.7915\n\n11,785 2,215,969 407 3.45% 5,447 188 0.7442 0.7895 12,378 1,364,125 650 5.25% 2,100 110 0.9621 0.9691\n\n12,836 2,689,180 535 4.17% 5,025 209 0.7959 0.8214 13,303 1,559,333 759 5.71% 2,054 117 0.9899 0.9711\n\n14,733 3,854,442 741 5.03% 5,201 262 0.9687 0.9359 14,903 1,652,528 845 5.67% 1,955 111 0.9465 0.9731\n\n18,325 4,659,343 927 5.06% 5,025 254 0.9115 0.9379 16,535 2,031,221 971 5.87% 2,091 123 1.0608 1.0374\n\n17,843 4,809,918 949 5.32% 5,069 270 0.9671 0.9671 16,113 1,936,825 953 5.92% 2,031 120 1.0258 1.0394\n\n18,446 5,272,168 1,018 5.52% 5,179 286 1.0237 1.0237 16,093 2,235,130 974 6.05% 2,294 139 1.1829 1.1321\n\n21,135 6,170,286 1,227 5.80% 5,030 292 1.0439 1.0439 18,139 2,550,213 1,153 6.36% 2,212 141 1.2006 1.1341\n\n20,705 6,224,600 1,272 6.14% 4,893 301 1.0644 1.0644 17,050 2,103,064 1,072 6.29% 1,961 123 1.0756 1.1361\n\n22,563 7,293,057 1,408 6.24% 5,181 323 1.1265 1.1265 18,524 2,444,774 1,203 6.49% 2,032 132 1.1294 1.1381\n\n23,021 7,714,763 1,529 6.64% 5,047 335 1.1716 1.1360 18,733 2,482,762 1,174 6.27% 2,115 133 1.1223 1.1401\n\n23,213 7,085,855 1,355 5.84% 5,228 305 1.1273 1.1380 18,423 2,901,087 1,266 6.87% 2,292 157 1.3378 1.2592\n\n\\# Proprietary Rate Matrix Page 55","publish_date":null,"title":"Rate Matrix State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix PIP/MP/UM PIP/MP/UM","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page987.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page987.pdf"},"request":{"example_id":"table/BRWS-134565917_page987","product_type":"parse","source_file_path":"BRWS-134565917_page987.pdf"},"started_at":"2026-11-04T19:46:57.188098"} +{"completed_at":"2026-11-04T19:47:04.463575","latency_in_ms":6599,"output":{"example_id":"table/BRWS-134565917_page990","grounded_pages":[],"layout_pages":[],"markdown":"Rate Matrix\n\n**Rate Matrix**\n\nE F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 4**\n\nA B C D E F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 5**\n\nA B C D E F G H I\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n10,127 2,991,798 601 5.94% 4,977 295 0.7665 0.7736\n\n9,475 3,048,625 565 5.96% 5,396 322 0.8217 0.8232\n\n9,781 3,070,947 625 6.39% 4,914 314 0.7848 0.8252\n\n8,955 3,285,528 587 6.56% 5,597 367 0.9098 0.8691\n\n8,451 2,915,340 544 6.44% 5,360 345 0.8813 0.8711\n\n8,546 2,938,763 592 6.93% 4,965 344 0.8254 0.8731\n\n7,125 2,656,616 510 7.16% 5,210 373 0.9084 0.8751\n\n7,744 2,636,114 541 6.99% 4,873 340 0.8242 0.8771\n\n7,359 2,913,827 544 7.39% 5,357 396 0.9417 0.9213\n\n6,829 2,698,371 485 7.10% 5,565 395 0.9334 0.9233\n\n6,380 2,777,702 512 8.02% 5,425 435 1.0236 0.9253\n\n6,522 2,301,296 462 7.08% 4,984 353 0.8372 0.9273\n\n5,816 2,297,282 475 8.17% 4,838 395 0.9123 0.9293\n\n5,182 1,990,658 412 7.95% 4,835 384 0.8983 0.9313\n\n4,813 2,239,381 414 8.60% 5,413 465 1.0929 1.0469\n\n4,504 2,134,870 379 8.41% 5,638 474 1.0920 1.0489\n\n4,138 1,875,933 367 8.86% 5,118 453 1.0481 1.0509\n\n3,877 1,836,272 375 9.66% 4,902 474 1.0807 1.0759\n\n3,388 1,522,050 298 8.81% 5,100 449 1.0310 1.0779\n\n3,238 1,546,380 314 9.71% 4,918 478 1.0710 1.0799\n\n2,322 1,368,483 256 11.04% 5,337 589 1.3412 1.2328\n\n288 99,179 19 6.61% 5,208 344 0.6707 0.6547\n\n480 221,607 34 7.11% 6,500 462 0.8587 0.7963\n\n564 228,958 39 6.93% 5,863 406 0.9035 0.8166\n\n529 232,022 41 7.76% 5,650 439 0.9520 0.8711\n\n615 204,420 34 5.54% 6,002 332 0.8281 0.8754\n\n641 330,537 58 9.07% 5,689 516 1.0717 0.9343\n\n619 248,124 45 7.28% 5,504 401 0.8206 0.9363\n\n671 273,037 63 9.40% 4,327 407 0.9621 0.9505\n\n659 170,248 52 7.90% 3,268 258 1.0262 1.0008\n\n649 284,923 45 6.95% 6,320 439 1.1003 1.0028\n\n528 231,745 36 6.83% 6,427 439 1.0237 1.0048\n\n549 223,674 44 8.02% 5,077 407 0.9492 1.0068\n\n547 294,148 56 10.25% 5,242 537 1.1201 1.0657\n\n568 250,065 49 8.64% 5,094 440 0.9891 1.0677\n\n562 270,606 59 10.52% 4,577 482 1.1686 1.0931\n\n607 280,192 58 9.57% 4,823 461 1.2962 1.0951\n\n554 223,709 47 8.50% 4,750 404 0.9825 1.0971\n\n493 238,296 40 8.12% 5,949 483 1.0904 1.0991\n\n546 347,748 58 10.63% 5,986 637 1.2206 1.1923\n\n467 225,576 35 7.51% 6,434 483 1.3529 1.2299\n\n488 276,127 52 10.66% 5,304 565 1.3374 1.2319\n\n485 190,810 40 8.26% 4,763 393 1.1586 1.2339\n\n417 245,053 46 11.04% 5,322 588 1.5169 1.2359\n\n413 149,064 41 9.94% 3,631 361 1.0298 1.2379\n\n261 147,493 26 9.98% 5,663 565 1.3085 1.2528\n\n5,332 1,174,213 258 4.85% 4,543 220 0.6448 0.6447\n\n8,753 2,268,193 477 5.45% 4,757 259 0.7127 0.7195\n\n9,905 3,075,362 620 6.26% 4,960 310 0.8271 0.7451\n\n10,389 2,792,867 592 5.70% 4,718 269 0.6843 0.7471\n\n10,724 3,605,356 723 6.74% 4,986 336 0.8672 0.8654\n\n10,918 3,798,813 756 6.92% 5,024 348 0.8704 0.8727\n\n11,978 4,351,866 858 7.17% 5,070 363 0.9077 0.8891\n\n11,497 4,124,629 846 7.36% 4,873 359 0.8733 0.8911\n\n11,013 3,979,907 754 6.85% 5,276 361 0.8948 0.8931\n\n\\# Proprietary Rate Matrix Page 58","pages":[{"line_numbers":[],"markdown":"Rate Matrix\n\n**Rate Matrix**\n\nE F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 4**\n\nA B C D E F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 5**\n\nA B C D E F G H I\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n10,127 2,991,798 601 5.94% 4,977 295 0.7665 0.7736\n\n9,475 3,048,625 565 5.96% 5,396 322 0.8217 0.8232\n\n9,781 3,070,947 625 6.39% 4,914 314 0.7848 0.8252\n\n8,955 3,285,528 587 6.56% 5,597 367 0.9098 0.8691\n\n8,451 2,915,340 544 6.44% 5,360 345 0.8813 0.8711\n\n8,546 2,938,763 592 6.93% 4,965 344 0.8254 0.8731\n\n7,125 2,656,616 510 7.16% 5,210 373 0.9084 0.8751\n\n7,744 2,636,114 541 6.99% 4,873 340 0.8242 0.8771\n\n7,359 2,913,827 544 7.39% 5,357 396 0.9417 0.9213\n\n6,829 2,698,371 485 7.10% 5,565 395 0.9334 0.9233\n\n6,380 2,777,702 512 8.02% 5,425 435 1.0236 0.9253\n\n6,522 2,301,296 462 7.08% 4,984 353 0.8372 0.9273\n\n5,816 2,297,282 475 8.17% 4,838 395 0.9123 0.9293\n\n5,182 1,990,658 412 7.95% 4,835 384 0.8983 0.9313\n\n4,813 2,239,381 414 8.60% 5,413 465 1.0929 1.0469\n\n4,504 2,134,870 379 8.41% 5,638 474 1.0920 1.0489\n\n4,138 1,875,933 367 8.86% 5,118 453 1.0481 1.0509\n\n3,877 1,836,272 375 9.66% 4,902 474 1.0807 1.0759\n\n3,388 1,522,050 298 8.81% 5,100 449 1.0310 1.0779\n\n3,238 1,546,380 314 9.71% 4,918 478 1.0710 1.0799\n\n2,322 1,368,483 256 11.04% 5,337 589 1.3412 1.2328\n\n288 99,179 19 6.61% 5,208 344 0.6707 0.6547\n\n480 221,607 34 7.11% 6,500 462 0.8587 0.7963\n\n564 228,958 39 6.93% 5,863 406 0.9035 0.8166\n\n529 232,022 41 7.76% 5,650 439 0.9520 0.8711\n\n615 204,420 34 5.54% 6,002 332 0.8281 0.8754\n\n641 330,537 58 9.07% 5,689 516 1.0717 0.9343\n\n619 248,124 45 7.28% 5,504 401 0.8206 0.9363\n\n671 273,037 63 9.40% 4,327 407 0.9621 0.9505\n\n659 170,248 52 7.90% 3,268 258 1.0262 1.0008\n\n649 284,923 45 6.95% 6,320 439 1.1003 1.0028\n\n528 231,745 36 6.83% 6,427 439 1.0237 1.0048\n\n549 223,674 44 8.02% 5,077 407 0.9492 1.0068\n\n547 294,148 56 10.25% 5,242 537 1.1201 1.0657\n\n568 250,065 49 8.64% 5,094 440 0.9891 1.0677\n\n562 270,606 59 10.52% 4,577 482 1.1686 1.0931\n\n607 280,192 58 9.57% 4,823 461 1.2962 1.0951\n\n554 223,709 47 8.50% 4,750 404 0.9825 1.0971\n\n493 238,296 40 8.12% 5,949 483 1.0904 1.0991\n\n546 347,748 58 10.63% 5,986 637 1.2206 1.1923\n\n467 225,576 35 7.51% 6,434 483 1.3529 1.2299\n\n488 276,127 52 10.66% 5,304 565 1.3374 1.2319\n\n485 190,810 40 8.26% 4,763 393 1.1586 1.2339\n\n417 245,053 46 11.04% 5,322 588 1.5169 1.2359\n\n413 149,064 41 9.94% 3,631 361 1.0298 1.2379\n\n261 147,493 26 9.98% 5,663 565 1.3085 1.2528\n\n5,332 1,174,213 258 4.85% 4,543 220 0.6448 0.6447\n\n8,753 2,268,193 477 5.45% 4,757 259 0.7127 0.7195\n\n9,905 3,075,362 620 6.26% 4,960 310 0.8271 0.7451\n\n10,389 2,792,867 592 5.70% 4,718 269 0.6843 0.7471\n\n10,724 3,605,356 723 6.74% 4,986 336 0.8672 0.8654\n\n10,918 3,798,813 756 6.92% 5,024 348 0.8704 0.8727\n\n11,978 4,351,866 858 7.17% 5,070 363 0.9077 0.8891\n\n11,497 4,124,629 846 7.36% 4,873 359 0.8733 0.8911\n\n11,013 3,979,907 754 6.85% 5,276 361 0.8948 0.8931\n\n\\# Proprietary Rate Matrix Page 58","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Rate Matrix\n\n**Rate Matrix**\n\nE F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 4**\n\nA B C D E F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 5**\n\nA B C D E F G H I\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n10,127 2,991,798 601 5.94% 4,977 295 0.7665 0.7736\n\n9,475 3,048,625 565 5.96% 5,396 322 0.8217 0.8232\n\n9,781 3,070,947 625 6.39% 4,914 314 0.7848 0.8252\n\n8,955 3,285,528 587 6.56% 5,597 367 0.9098 0.8691\n\n8,451 2,915,340 544 6.44% 5,360 345 0.8813 0.8711\n\n8,546 2,938,763 592 6.93% 4,965 344 0.8254 0.8731\n\n7,125 2,656,616 510 7.16% 5,210 373 0.9084 0.8751\n\n7,744 2,636,114 541 6.99% 4,873 340 0.8242 0.8771\n\n7,359 2,913,827 544 7.39% 5,357 396 0.9417 0.9213\n\n6,829 2,698,371 485 7.10% 5,565 395 0.9334 0.9233\n\n6,380 2,777,702 512 8.02% 5,425 435 1.0236 0.9253\n\n6,522 2,301,296 462 7.08% 4,984 353 0.8372 0.9273\n\n5,816 2,297,282 475 8.17% 4,838 395 0.9123 0.9293\n\n5,182 1,990,658 412 7.95% 4,835 384 0.8983 0.9313\n\n4,813 2,239,381 414 8.60% 5,413 465 1.0929 1.0469\n\n4,504 2,134,870 379 8.41% 5,638 474 1.0920 1.0489\n\n4,138 1,875,933 367 8.86% 5,118 453 1.0481 1.0509\n\n3,877 1,836,272 375 9.66% 4,902 474 1.0807 1.0759\n\n3,388 1,522,050 298 8.81% 5,100 449 1.0310 1.0779\n\n3,238 1,546,380 314 9.71% 4,918 478 1.0710 1.0799\n\n2,322 1,368,483 256 11.04% 5,337 589 1.3412 1.2328\n\n288 99,179 19 6.61% 5,208 344 0.6707 0.6547\n\n480 221,607 34 7.11% 6,500 462 0.8587 0.7963\n\n564 228,958 39 6.93% 5,863 406 0.9035 0.8166\n\n529 232,022 41 7.76% 5,650 439 0.9520 0.8711\n\n615 204,420 34 5.54% 6,002 332 0.8281 0.8754\n\n641 330,537 58 9.07% 5,689 516 1.0717 0.9343\n\n619 248,124 45 7.28% 5,504 401 0.8206 0.9363\n\n671 273,037 63 9.40% 4,327 407 0.9621 0.9505\n\n659 170,248 52 7.90% 3,268 258 1.0262 1.0008\n\n649 284,923 45 6.95% 6,320 439 1.1003 1.0028\n\n528 231,745 36 6.83% 6,427 439 1.0237 1.0048\n\n549 223,674 44 8.02% 5,077 407 0.9492 1.0068\n\n547 294,148 56 10.25% 5,242 537 1.1201 1.0657\n\n568 250,065 49 8.64% 5,094 440 0.9891 1.0677\n\n562 270,606 59 10.52% 4,577 482 1.1686 1.0931\n\n607 280,192 58 9.57% 4,823 461 1.2962 1.0951\n\n554 223,709 47 8.50% 4,750 404 0.9825 1.0971\n\n493 238,296 40 8.12% 5,949 483 1.0904 1.0991\n\n546 347,748 58 10.63% 5,986 637 1.2206 1.1923\n\n467 225,576 35 7.51% 6,434 483 1.3529 1.2299\n\n488 276,127 52 10.66% 5,304 565 1.3374 1.2319\n\n485 190,810 40 8.26% 4,763 393 1.1586 1.2339\n\n417 245,053 46 11.04% 5,322 588 1.5169 1.2359\n\n413 149,064 41 9.94% 3,631 361 1.0298 1.2379\n\n261 147,493 26 9.98% 5,663 565 1.3085 1.2528\n\n5,332 1,174,213 258 4.85% 4,543 220 0.6448 0.6447\n\n8,753 2,268,193 477 5.45% 4,757 259 0.7127 0.7195\n\n9,905 3,075,362 620 6.26% 4,960 310 0.8271 0.7451\n\n10,389 2,792,867 592 5.70% 4,718 269 0.6843 0.7471\n\n10,724 3,605,356 723 6.74% 4,986 336 0.8672 0.8654\n\n10,918 3,798,813 756 6.92% 5,024 348 0.8704 0.8727\n\n11,978 4,351,866 858 7.17% 5,070 363 0.9077 0.8891\n\n11,497 4,124,629 846 7.36% 4,873 359 0.8733 0.8911\n\n11,013 3,979,907 754 6.85% 5,276 361 0.8948 0.8931\n\n\\# Proprietary Rate Matrix Page 58","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page990.pdf"]},"response":{"errors":[],"extract_id":"extract_2e13a0f045c3b467537bbe56c6eace2a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Rate Matrix\n\n**Rate Matrix**\n\nE F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 4**\n\nA B C D E F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 5**\n\nA B C D E F G H I\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n10,127 2,991,798 601 5.94% 4,977 295 0.7665 0.7736\n\n9,475 3,048,625 565 5.96% 5,396 322 0.8217 0.8232\n\n9,781 3,070,947 625 6.39% 4,914 314 0.7848 0.8252\n\n8,955 3,285,528 587 6.56% 5,597 367 0.9098 0.8691\n\n8,451 2,915,340 544 6.44% 5,360 345 0.8813 0.8711\n\n8,546 2,938,763 592 6.93% 4,965 344 0.8254 0.8731\n\n7,125 2,656,616 510 7.16% 5,210 373 0.9084 0.8751\n\n7,744 2,636,114 541 6.99% 4,873 340 0.8242 0.8771\n\n7,359 2,913,827 544 7.39% 5,357 396 0.9417 0.9213\n\n6,829 2,698,371 485 7.10% 5,565 395 0.9334 0.9233\n\n6,380 2,777,702 512 8.02% 5,425 435 1.0236 0.9253\n\n6,522 2,301,296 462 7.08% 4,984 353 0.8372 0.9273\n\n5,816 2,297,282 475 8.17% 4,838 395 0.9123 0.9293\n\n5,182 1,990,658 412 7.95% 4,835 384 0.8983 0.9313\n\n4,813 2,239,381 414 8.60% 5,413 465 1.0929 1.0469\n\n4,504 2,134,870 379 8.41% 5,638 474 1.0920 1.0489\n\n4,138 1,875,933 367 8.86% 5,118 453 1.0481 1.0509\n\n3,877 1,836,272 375 9.66% 4,902 474 1.0807 1.0759\n\n3,388 1,522,050 298 8.81% 5,100 449 1.0310 1.0779\n\n3,238 1,546,380 314 9.71% 4,918 478 1.0710 1.0799\n\n2,322 1,368,483 256 11.04% 5,337 589 1.3412 1.2328\n\n288 99,179 19 6.61% 5,208 344 0.6707 0.6547\n\n480 221,607 34 7.11% 6,500 462 0.8587 0.7963\n\n564 228,958 39 6.93% 5,863 406 0.9035 0.8166\n\n529 232,022 41 7.76% 5,650 439 0.9520 0.8711\n\n615 204,420 34 5.54% 6,002 332 0.8281 0.8754\n\n641 330,537 58 9.07% 5,689 516 1.0717 0.9343\n\n619 248,124 45 7.28% 5,504 401 0.8206 0.9363\n\n671 273,037 63 9.40% 4,327 407 0.9621 0.9505\n\n659 170,248 52 7.90% 3,268 258 1.0262 1.0008\n\n649 284,923 45 6.95% 6,320 439 1.1003 1.0028\n\n528 231,745 36 6.83% 6,427 439 1.0237 1.0048\n\n549 223,674 44 8.02% 5,077 407 0.9492 1.0068\n\n547 294,148 56 10.25% 5,242 537 1.1201 1.0657\n\n568 250,065 49 8.64% 5,094 440 0.9891 1.0677\n\n562 270,606 59 10.52% 4,577 482 1.1686 1.0931\n\n607 280,192 58 9.57% 4,823 461 1.2962 1.0951\n\n554 223,709 47 8.50% 4,750 404 0.9825 1.0971\n\n493 238,296 40 8.12% 5,949 483 1.0904 1.0991\n\n546 347,748 58 10.63% 5,986 637 1.2206 1.1923\n\n467 225,576 35 7.51% 6,434 483 1.3529 1.2299\n\n488 276,127 52 10.66% 5,304 565 1.3374 1.2319\n\n485 190,810 40 8.26% 4,763 393 1.1586 1.2339\n\n417 245,053 46 11.04% 5,322 588 1.5169 1.2359\n\n413 149,064 41 9.94% 3,631 361 1.0298 1.2379\n\n261 147,493 26 9.98% 5,663 565 1.3085 1.2528\n\n5,332 1,174,213 258 4.85% 4,543 220 0.6448 0.6447\n\n8,753 2,268,193 477 5.45% 4,757 259 0.7127 0.7195\n\n9,905 3,075,362 620 6.26% 4,960 310 0.8271 0.7451\n\n10,389 2,792,867 592 5.70% 4,718 269 0.6843 0.7471\n\n10,724 3,605,356 723 6.74% 4,986 336 0.8672 0.8654\n\n10,918 3,798,813 756 6.92% 5,024 348 0.8704 0.8727\n\n11,978 4,351,866 858 7.17% 5,070 363 0.9077 0.8891\n\n11,497 4,124,629 846 7.36% 4,873 359 0.8733 0.8911\n\n11,013 3,979,907 754 6.85% 5,276 361 0.8948 0.8931\n\n\\# Proprietary Rate Matrix Page 58"],"full_content":"Rate Matrix\n\n**Rate Matrix**\n\nE F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 4**\n\nA B C D E F G H I J K L M N O P Q R S T U V W X Y\n\n**UW Tier 5**\n\nA B C D E F G H I\n\n**State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix**\n\n**COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD COLL/UMPD**\n\n**Earned Car**\n\n**Years Incurred Loss Incurred Count Frequency Severity Pure Premium**\n\n**Indicated Relativity**\n\n**Proposed Relativity**\n\n10,127 2,991,798 601 5.94% 4,977 295 0.7665 0.7736\n\n9,475 3,048,625 565 5.96% 5,396 322 0.8217 0.8232\n\n9,781 3,070,947 625 6.39% 4,914 314 0.7848 0.8252\n\n8,955 3,285,528 587 6.56% 5,597 367 0.9098 0.8691\n\n8,451 2,915,340 544 6.44% 5,360 345 0.8813 0.8711\n\n8,546 2,938,763 592 6.93% 4,965 344 0.8254 0.8731\n\n7,125 2,656,616 510 7.16% 5,210 373 0.9084 0.8751\n\n7,744 2,636,114 541 6.99% 4,873 340 0.8242 0.8771\n\n7,359 2,913,827 544 7.39% 5,357 396 0.9417 0.9213\n\n6,829 2,698,371 485 7.10% 5,565 395 0.9334 0.9233\n\n6,380 2,777,702 512 8.02% 5,425 435 1.0236 0.9253\n\n6,522 2,301,296 462 7.08% 4,984 353 0.8372 0.9273\n\n5,816 2,297,282 475 8.17% 4,838 395 0.9123 0.9293\n\n5,182 1,990,658 412 7.95% 4,835 384 0.8983 0.9313\n\n4,813 2,239,381 414 8.60% 5,413 465 1.0929 1.0469\n\n4,504 2,134,870 379 8.41% 5,638 474 1.0920 1.0489\n\n4,138 1,875,933 367 8.86% 5,118 453 1.0481 1.0509\n\n3,877 1,836,272 375 9.66% 4,902 474 1.0807 1.0759\n\n3,388 1,522,050 298 8.81% 5,100 449 1.0310 1.0779\n\n3,238 1,546,380 314 9.71% 4,918 478 1.0710 1.0799\n\n2,322 1,368,483 256 11.04% 5,337 589 1.3412 1.2328\n\n288 99,179 19 6.61% 5,208 344 0.6707 0.6547\n\n480 221,607 34 7.11% 6,500 462 0.8587 0.7963\n\n564 228,958 39 6.93% 5,863 406 0.9035 0.8166\n\n529 232,022 41 7.76% 5,650 439 0.9520 0.8711\n\n615 204,420 34 5.54% 6,002 332 0.8281 0.8754\n\n641 330,537 58 9.07% 5,689 516 1.0717 0.9343\n\n619 248,124 45 7.28% 5,504 401 0.8206 0.9363\n\n671 273,037 63 9.40% 4,327 407 0.9621 0.9505\n\n659 170,248 52 7.90% 3,268 258 1.0262 1.0008\n\n649 284,923 45 6.95% 6,320 439 1.1003 1.0028\n\n528 231,745 36 6.83% 6,427 439 1.0237 1.0048\n\n549 223,674 44 8.02% 5,077 407 0.9492 1.0068\n\n547 294,148 56 10.25% 5,242 537 1.1201 1.0657\n\n568 250,065 49 8.64% 5,094 440 0.9891 1.0677\n\n562 270,606 59 10.52% 4,577 482 1.1686 1.0931\n\n607 280,192 58 9.57% 4,823 461 1.2962 1.0951\n\n554 223,709 47 8.50% 4,750 404 0.9825 1.0971\n\n493 238,296 40 8.12% 5,949 483 1.0904 1.0991\n\n546 347,748 58 10.63% 5,986 637 1.2206 1.1923\n\n467 225,576 35 7.51% 6,434 483 1.3529 1.2299\n\n488 276,127 52 10.66% 5,304 565 1.3374 1.2319\n\n485 190,810 40 8.26% 4,763 393 1.1586 1.2339\n\n417 245,053 46 11.04% 5,322 588 1.5169 1.2359\n\n413 149,064 41 9.94% 3,631 361 1.0298 1.2379\n\n261 147,493 26 9.98% 5,663 565 1.3085 1.2528\n\n5,332 1,174,213 258 4.85% 4,543 220 0.6448 0.6447\n\n8,753 2,268,193 477 5.45% 4,757 259 0.7127 0.7195\n\n9,905 3,075,362 620 6.26% 4,960 310 0.8271 0.7451\n\n10,389 2,792,867 592 5.70% 4,718 269 0.6843 0.7471\n\n10,724 3,605,356 723 6.74% 4,986 336 0.8672 0.8654\n\n10,918 3,798,813 756 6.92% 5,024 348 0.8704 0.8727\n\n11,978 4,351,866 858 7.17% 5,070 363 0.9077 0.8891\n\n11,497 4,124,629 846 7.36% 4,873 359 0.8733 0.8911\n\n11,013 3,979,907 754 6.85% 5,276 361 0.8948 0.8931\n\n\\# Proprietary Rate Matrix Page 58","publish_date":null,"title":"Rate Matrix State of: Missouri Bristol West Insurance Company Private Passenger Automobile Insurance Relativity Support - Rate Matrix COLL/UMPD COLL/UMPD","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page990.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BRWS-134565917_page990.pdf"},"request":{"example_id":"table/BRWS-134565917_page990","product_type":"parse","source_file_path":"BRWS-134565917_page990.pdf"},"started_at":"2026-11-04T19:46:57.863613"} +{"completed_at":"2026-11-04T19:47:24.462713","latency_in_ms":24264,"output":{"example_id":"table/BSC-Hospital-List-by-County (2)_page1","grounded_pages":[],"layout_pages":[],"markdown":"Network Comparison prepared for:\n\nBroad Networks\n\nAccess+ HMO\nPPO\n\nNarrow Networks\n\nTrio HMO\n\nLocal Access+ / SaveNet [x] Tandem PPO\n\nBlueHPN PPO\n\nHospital List by County - Hospital data below is a snapshot of the network as of 12/2023\n\nServices\n\nblue &\n\ncaliforn\n\nte\n\nHospital\n\nAlameda Hospital\n\nAlta Bates Med Ctr Herrick Campus\n\nAlta Bates Summit Med Ctr Alta\n\nBates Campus\n\nAlta Bates Summit Med Ctr Summit\n\nCampus\n\nAlta Bates Summit Medical Center\n\nBHC Fremont Hospital\n\nCentre For Neuro Skills San\n\nFrancisco\n\nEden Medical Center\nFairmont Hospital\nHighland Hospital\n\nKindred Hospital San Francisco Bay\n\nArea\n\nMpi Chemical Dependency Recovery\n\nHospital\n\nSan Leandro Hospital\n\nSt Rose Hospital\n\nStanford Health Care Tri-Valley\n\nUCSF Benioff Children's Hospital\nOakland\n\nValley Memorial Hospital\nWashington Hospital\n\nSutter Amador Hospital\n\nEnloe Medical Center Cohasset\nEnloe Medical Center Esplanade\nEnloe Rehabilitation Center\nOrchard Hospital\n\nOroville Hospital\n\nMark Twain Medical Center\nColusa Medical Center\n\nJohn Muir Behavioral Health Ctr\n\nJohn Muir Medical Center Concord\n\nCampus\n\nJohn Muir Medical Center Walnut\n\nCreek Campus\n\nSan Ramon Regional Med Ctr\nSutter Delta Medical Center\nSutter Coast Hospital\n\nBarton Memorial Hosp\n\nCounty\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\nAmador\nButte\nButte\nButte\nButte\nButte\nCalaveras\nColusa\n\nContra Costa\n\nContra Costa\n\nContra Costa\n\nContra Costa\nContra Costa\nDel Norte\n\nEl Dorado\n\nTrio HMO\n\nLocal Access+ /\n\nSaveNet\n\nPage 1 of 12\n\nAccess+ HMO\n\nBlueHPN PPO\n\nTandem PPO\n\nPPO","pages":[{"line_numbers":[],"markdown":"Network Comparison prepared for:\n\nBroad Networks\n\nAccess+ HMO\nPPO\n\nNarrow Networks\n\nTrio HMO\n\nLocal Access+ / SaveNet [x] Tandem PPO\n\nBlueHPN PPO\n\nHospital List by County - Hospital data below is a snapshot of the network as of 12/2023\n\nServices\n\nblue &\n\ncaliforn\n\nte\n\nHospital\n\nAlameda Hospital\n\nAlta Bates Med Ctr Herrick Campus\n\nAlta Bates Summit Med Ctr Alta\n\nBates Campus\n\nAlta Bates Summit Med Ctr Summit\n\nCampus\n\nAlta Bates Summit Medical Center\n\nBHC Fremont Hospital\n\nCentre For Neuro Skills San\n\nFrancisco\n\nEden Medical Center\nFairmont Hospital\nHighland Hospital\n\nKindred Hospital San Francisco Bay\n\nArea\n\nMpi Chemical Dependency Recovery\n\nHospital\n\nSan Leandro Hospital\n\nSt Rose Hospital\n\nStanford Health Care Tri-Valley\n\nUCSF Benioff Children's Hospital\nOakland\n\nValley Memorial Hospital\nWashington Hospital\n\nSutter Amador Hospital\n\nEnloe Medical Center Cohasset\nEnloe Medical Center Esplanade\nEnloe Rehabilitation Center\nOrchard Hospital\n\nOroville Hospital\n\nMark Twain Medical Center\nColusa Medical Center\n\nJohn Muir Behavioral Health Ctr\n\nJohn Muir Medical Center Concord\n\nCampus\n\nJohn Muir Medical Center Walnut\n\nCreek Campus\n\nSan Ramon Regional Med Ctr\nSutter Delta Medical Center\nSutter Coast Hospital\n\nBarton Memorial Hosp\n\nCounty\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\nAmador\nButte\nButte\nButte\nButte\nButte\nCalaveras\nColusa\n\nContra Costa\n\nContra Costa\n\nContra Costa\n\nContra Costa\nContra Costa\nDel Norte\n\nEl Dorado\n\nTrio HMO\n\nLocal Access+ /\n\nSaveNet\n\nPage 1 of 12\n\nAccess+ HMO\n\nBlueHPN PPO\n\nTandem PPO\n\nPPO","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Network Comparison prepared for:\n\nBroad Networks\n\nAccess+ HMO\nPPO\n\nNarrow Networks\n\nTrio HMO\n\nLocal Access+ / SaveNet [x] Tandem PPO\n\nBlueHPN PPO\n\nHospital List by County - Hospital data below is a snapshot of the network as of 12/2023\n\nServices\n\nblue &\n\ncaliforn\n\nte\n\nHospital\n\nAlameda Hospital\n\nAlta Bates Med Ctr Herrick Campus\n\nAlta Bates Summit Med Ctr Alta\n\nBates Campus\n\nAlta Bates Summit Med Ctr Summit\n\nCampus\n\nAlta Bates Summit Medical Center\n\nBHC Fremont Hospital\n\nCentre For Neuro Skills San\n\nFrancisco\n\nEden Medical Center\nFairmont Hospital\nHighland Hospital\n\nKindred Hospital San Francisco Bay\n\nArea\n\nMpi Chemical Dependency Recovery\n\nHospital\n\nSan Leandro Hospital\n\nSt Rose Hospital\n\nStanford Health Care Tri-Valley\n\nUCSF Benioff Children's Hospital\nOakland\n\nValley Memorial Hospital\nWashington Hospital\n\nSutter Amador Hospital\n\nEnloe Medical Center Cohasset\nEnloe Medical Center Esplanade\nEnloe Rehabilitation Center\nOrchard Hospital\n\nOroville Hospital\n\nMark Twain Medical Center\nColusa Medical Center\n\nJohn Muir Behavioral Health Ctr\n\nJohn Muir Medical Center Concord\n\nCampus\n\nJohn Muir Medical Center Walnut\n\nCreek Campus\n\nSan Ramon Regional Med Ctr\nSutter Delta Medical Center\nSutter Coast Hospital\n\nBarton Memorial Hosp\n\nCounty\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\nAmador\nButte\nButte\nButte\nButte\nButte\nCalaveras\nColusa\n\nContra Costa\n\nContra Costa\n\nContra Costa\n\nContra Costa\nContra Costa\nDel Norte\n\nEl Dorado\n\nTrio HMO\n\nLocal Access+ /\n\nSaveNet\n\nPage 1 of 12\n\nAccess+ HMO\n\nBlueHPN PPO\n\nTandem PPO\n\nPPO","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BSC-Hospital-List-by-County%20%282%29_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_daf87f679e94c852628f8af93b11c96e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Network Comparison prepared for:\n\nBroad Networks\n\nAccess+ HMO\nPPO\n\nNarrow Networks\n\nTrio HMO\n\nLocal Access+ / SaveNet [x] Tandem PPO\n\nBlueHPN PPO\n\nHospital List by County - Hospital data below is a snapshot of the network as of 12/2023\n\nServices\n\nblue &\n\ncaliforn\n\nte\n\nHospital\n\nAlameda Hospital\n\nAlta Bates Med Ctr Herrick Campus\n\nAlta Bates Summit Med Ctr Alta\n\nBates Campus\n\nAlta Bates Summit Med Ctr Summit\n\nCampus\n\nAlta Bates Summit Medical Center\n\nBHC Fremont Hospital\n\nCentre For Neuro Skills San\n\nFrancisco\n\nEden Medical Center\nFairmont Hospital\nHighland Hospital\n\nKindred Hospital San Francisco Bay\n\nArea\n\nMpi Chemical Dependency Recovery\n\nHospital\n\nSan Leandro Hospital\n\nSt Rose Hospital\n\nStanford Health Care Tri-Valley\n\nUCSF Benioff Children's Hospital\nOakland\n\nValley Memorial Hospital\nWashington Hospital\n\nSutter Amador Hospital\n\nEnloe Medical Center Cohasset\nEnloe Medical Center Esplanade\nEnloe Rehabilitation Center\nOrchard Hospital\n\nOroville Hospital\n\nMark Twain Medical Center\nColusa Medical Center\n\nJohn Muir Behavioral Health Ctr\n\nJohn Muir Medical Center Concord\n\nCampus\n\nJohn Muir Medical Center Walnut\n\nCreek Campus\n\nSan Ramon Regional Med Ctr\nSutter Delta Medical Center\nSutter Coast Hospital\n\nBarton Memorial Hosp\n\nCounty\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\nAmador\nButte\nButte\nButte\nButte\nButte\nCalaveras\nColusa\n\nContra Costa\n\nContra Costa\n\nContra Costa\n\nContra Costa\nContra Costa\nDel Norte\n\nEl Dorado\n\nTrio HMO\n\nLocal Access+ /\n\nSaveNet\n\nPage 1 of 12\n\nAccess+ HMO\n\nBlueHPN PPO\n\nTandem PPO\n\nPPO"],"full_content":"Network Comparison prepared for:\n\nBroad Networks\n\nAccess+ HMO\nPPO\n\nNarrow Networks\n\nTrio HMO\n\nLocal Access+ / SaveNet [x] Tandem PPO\n\nBlueHPN PPO\n\nHospital List by County - Hospital data below is a snapshot of the network as of 12/2023\n\nServices\n\nblue &\n\ncaliforn\n\nte\n\nHospital\n\nAlameda Hospital\n\nAlta Bates Med Ctr Herrick Campus\n\nAlta Bates Summit Med Ctr Alta\n\nBates Campus\n\nAlta Bates Summit Med Ctr Summit\n\nCampus\n\nAlta Bates Summit Medical Center\n\nBHC Fremont Hospital\n\nCentre For Neuro Skills San\n\nFrancisco\n\nEden Medical Center\nFairmont Hospital\nHighland Hospital\n\nKindred Hospital San Francisco Bay\n\nArea\n\nMpi Chemical Dependency Recovery\n\nHospital\n\nSan Leandro Hospital\n\nSt Rose Hospital\n\nStanford Health Care Tri-Valley\n\nUCSF Benioff Children's Hospital\nOakland\n\nValley Memorial Hospital\nWashington Hospital\n\nSutter Amador Hospital\n\nEnloe Medical Center Cohasset\nEnloe Medical Center Esplanade\nEnloe Rehabilitation Center\nOrchard Hospital\n\nOroville Hospital\n\nMark Twain Medical Center\nColusa Medical Center\n\nJohn Muir Behavioral Health Ctr\n\nJohn Muir Medical Center Concord\n\nCampus\n\nJohn Muir Medical Center Walnut\n\nCreek Campus\n\nSan Ramon Regional Med Ctr\nSutter Delta Medical Center\nSutter Coast Hospital\n\nBarton Memorial Hosp\n\nCounty\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\n\nAlameda\n\nAlameda\n\nAlameda\nAlameda\nAmador\nButte\nButte\nButte\nButte\nButte\nCalaveras\nColusa\n\nContra Costa\n\nContra Costa\n\nContra Costa\n\nContra Costa\nContra Costa\nDel Norte\n\nEl Dorado\n\nTrio HMO\n\nLocal Access+ /\n\nSaveNet\n\nPage 1 of 12\n\nAccess+ HMO\n\nBlueHPN PPO\n\nTandem PPO\n\nPPO","publish_date":null,"title":"Bsc Hospital List By County (2) Page1","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BSC-Hospital-List-by-County%20%282%29_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BSC-Hospital-List-by-County%20%282%29_page1.pdf"},"request":{"example_id":"table/BSC-Hospital-List-by-County (2)_page1","product_type":"parse","source_file_path":"BSC-Hospital-List-by-County (2)_page1.pdf"},"started_at":"2026-11-04T19:47:00.198532"} +{"completed_at":"2026-11-04T19:47:02.310485","latency_in_ms":911,"output":{"example_id":"table/BXP.2008.page_112.pdf_57116_page1","grounded_pages":[],"layout_pages":[],"markdown":"**Item 7A.** **_Quantitative and Qualitative Disclosures about Market Risk_**\n\nAs of December 31, 2008, approximately $5.9 billion of our borrowings bore interest at fixed rates, and therefore the fair value of these instruments is affected by changes in the market interest rates. The following table presents our aggregate fixed rate debt obligations as of December 31, 2008 with corresponding weighted- average interest rates sorted by maturity date and our aggregate variable rate debt obligations sorted by maturity date. The GAAP weighted average interest rate on the variable rate debt as of December 31, 2008 was 3.62% per annum.\n\n**2009 2010 2011 2012 2013 2014+ Total Fair Value**\n\n**(dollars in thousands) Secured debt** Fixed Rate . . . . . . . . . . . . $ 95,685 $134,803 $551,720 $106,642 $ 101,068 $1,385,232 $2,375,150 $2,239,309 Average Interest Rate . . . 6.38% 7.83% 7.02% 5.68% 6.03% 5.97% 6.33% Variable Rate . . . . . . . . . . 183,125 30,674 71,693 — — — $ 285,492 $ 282,263 **Unsecured debt** Fixed Rate . . . . . . . . . . . . — — — — $ 923,580 $ 548,795 $1,472,375 $1,202,875 Average Interest Rate . . . — — — — 6.36% 5.47% 5.95% Variable Rate . . . . . . . . . . — 100,000 — — — — $ 100,000 $ 100,111 **Unsecured exchangeable debt** Fixed Rate . . . . . . . . . . . . — — — $848,410 $ 450,000 $ 740,489 $2,038,899 $1,571,536 Average Interest Rate . . . — — — 3.46% 3.79% 4.04% 3.65% Variable Rate . . . . . . . . . . — — — — — — — —\n\n**Total Debt** . . . . . . . . . . . **$278,810 $265,477 $623,413 $955,052 $1,474,648 $2,674,516 $6,271,916 $5,396,094**\n\nAdditional disclosure about market risk is incorporated herein by reference from “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Market Risk.”\n\n100","pages":[{"line_numbers":[],"markdown":"**Item 7A.** **_Quantitative and Qualitative Disclosures about Market Risk_**\n\nAs of December 31, 2008, approximately $5.9 billion of our borrowings bore interest at fixed rates, and therefore the fair value of these instruments is affected by changes in the market interest rates. The following table presents our aggregate fixed rate debt obligations as of December 31, 2008 with corresponding weighted- average interest rates sorted by maturity date and our aggregate variable rate debt obligations sorted by maturity date. The GAAP weighted average interest rate on the variable rate debt as of December 31, 2008 was 3.62% per annum.\n\n**2009 2010 2011 2012 2013 2014+ Total Fair Value**\n\n**(dollars in thousands) Secured debt** Fixed Rate . . . . . . . . . . . . $ 95,685 $134,803 $551,720 $106,642 $ 101,068 $1,385,232 $2,375,150 $2,239,309 Average Interest Rate . . . 6.38% 7.83% 7.02% 5.68% 6.03% 5.97% 6.33% Variable Rate . . . . . . . . . . 183,125 30,674 71,693 — — — $ 285,492 $ 282,263 **Unsecured debt** Fixed Rate . . . . . . . . . . . . — — — — $ 923,580 $ 548,795 $1,472,375 $1,202,875 Average Interest Rate . . . — — — — 6.36% 5.47% 5.95% Variable Rate . . . . . . . . . . — 100,000 — — — — $ 100,000 $ 100,111 **Unsecured exchangeable debt** Fixed Rate . . . . . . . . . . . . — — — $848,410 $ 450,000 $ 740,489 $2,038,899 $1,571,536 Average Interest Rate . . . — — — 3.46% 3.79% 4.04% 3.65% Variable Rate . . . . . . . . . . — — — — — — — —\n\n**Total Debt** . . . . . . . . . . . **$278,810 $265,477 $623,413 $955,052 $1,474,648 $2,674,516 $6,271,916 $5,396,094**\n\nAdditional disclosure about market risk is incorporated herein by reference from “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Market Risk.”\n\n100","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Item 7A.** **_Quantitative and Qualitative Disclosures about Market Risk_**\n\nAs of December 31, 2008, approximately $5.9 billion of our borrowings bore interest at fixed rates, and therefore the fair value of these instruments is affected by changes in the market interest rates. The following table presents our aggregate fixed rate debt obligations as of December 31, 2008 with corresponding weighted- average interest rates sorted by maturity date and our aggregate variable rate debt obligations sorted by maturity date. The GAAP weighted average interest rate on the variable rate debt as of December 31, 2008 was 3.62% per annum.\n\n**2009 2010 2011 2012 2013 2014+ Total Fair Value**\n\n**(dollars in thousands) Secured debt** Fixed Rate . . . . . . . . . . . . $ 95,685 $134,803 $551,720 $106,642 $ 101,068 $1,385,232 $2,375,150 $2,239,309 Average Interest Rate . . . 6.38% 7.83% 7.02% 5.68% 6.03% 5.97% 6.33% Variable Rate . . . . . . . . . . 183,125 30,674 71,693 — — — $ 285,492 $ 282,263 **Unsecured debt** Fixed Rate . . . . . . . . . . . . — — — — $ 923,580 $ 548,795 $1,472,375 $1,202,875 Average Interest Rate . . . — — — — 6.36% 5.47% 5.95% Variable Rate . . . . . . . . . . — 100,000 — — — — $ 100,000 $ 100,111 **Unsecured exchangeable debt** Fixed Rate . . . . . . . . . . . . — — — $848,410 $ 450,000 $ 740,489 $2,038,899 $1,571,536 Average Interest Rate . . . — — — 3.46% 3.79% 4.04% 3.65% Variable Rate . . . . . . . . . . — — — — — — — —\n\n**Total Debt** . . . . . . . . . . . **$278,810 $265,477 $623,413 $955,052 $1,474,648 $2,674,516 $6,271,916 $5,396,094**\n\nAdditional disclosure about market risk is incorporated herein by reference from “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Market Risk.”\n\n100","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BXP.2008.page_112.pdf_57116_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_c67671f2358370e96d0b04a055e98580","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Item 7A.** **_Quantitative and Qualitative Disclosures about Market Risk_**\n\nAs of December 31, 2008, approximately $5.9 billion of our borrowings bore interest at fixed rates, and therefore the fair value of these instruments is affected by changes in the market interest rates. The following table presents our aggregate fixed rate debt obligations as of December 31, 2008 with corresponding weighted- average interest rates sorted by maturity date and our aggregate variable rate debt obligations sorted by maturity date. The GAAP weighted average interest rate on the variable rate debt as of December 31, 2008 was 3.62% per annum.\n\n**2009 2010 2011 2012 2013 2014+ Total Fair Value**\n\n**(dollars in thousands) Secured debt** Fixed Rate . . . . . . . . . . . . $ 95,685 $134,803 $551,720 $106,642 $ 101,068 $1,385,232 $2,375,150 $2,239,309 Average Interest Rate . . . 6.38% 7.83% 7.02% 5.68% 6.03% 5.97% 6.33% Variable Rate . . . . . . . . . . 183,125 30,674 71,693 — — — $ 285,492 $ 282,263 **Unsecured debt** Fixed Rate . . . . . . . . . . . . — — — — $ 923,580 $ 548,795 $1,472,375 $1,202,875 Average Interest Rate . . . — — — — 6.36% 5.47% 5.95% Variable Rate . . . . . . . . . . — 100,000 — — — — $ 100,000 $ 100,111 **Unsecured exchangeable debt** Fixed Rate . . . . . . . . . . . . — — — $848,410 $ 450,000 $ 740,489 $2,038,899 $1,571,536 Average Interest Rate . . . — — — 3.46% 3.79% 4.04% 3.65% Variable Rate . . . . . . . . . . — — — — — — — —\n\n**Total Debt** . . . . . . . . . . . **$278,810 $265,477 $623,413 $955,052 $1,474,648 $2,674,516 $6,271,916 $5,396,094**\n\nAdditional disclosure about market risk is incorporated herein by reference from “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Market Risk.”\n\n100"],"full_content":"**Item 7A.** **_Quantitative and Qualitative Disclosures about Market Risk_**\n\nAs of December 31, 2008, approximately $5.9 billion of our borrowings bore interest at fixed rates, and therefore the fair value of these instruments is affected by changes in the market interest rates. The following table presents our aggregate fixed rate debt obligations as of December 31, 2008 with corresponding weighted- average interest rates sorted by maturity date and our aggregate variable rate debt obligations sorted by maturity date. The GAAP weighted average interest rate on the variable rate debt as of December 31, 2008 was 3.62% per annum.\n\n**2009 2010 2011 2012 2013 2014+ Total Fair Value**\n\n**(dollars in thousands) Secured debt** Fixed Rate . . . . . . . . . . . . $ 95,685 $134,803 $551,720 $106,642 $ 101,068 $1,385,232 $2,375,150 $2,239,309 Average Interest Rate . . . 6.38% 7.83% 7.02% 5.68% 6.03% 5.97% 6.33% Variable Rate . . . . . . . . . . 183,125 30,674 71,693 — — — $ 285,492 $ 282,263 **Unsecured debt** Fixed Rate . . . . . . . . . . . . — — — — $ 923,580 $ 548,795 $1,472,375 $1,202,875 Average Interest Rate . . . — — — — 6.36% 5.47% 5.95% Variable Rate . . . . . . . . . . — 100,000 — — — — $ 100,000 $ 100,111 **Unsecured exchangeable debt** Fixed Rate . . . . . . . . . . . . — — — $848,410 $ 450,000 $ 740,489 $2,038,899 $1,571,536 Average Interest Rate . . . — — — 3.46% 3.79% 4.04% 3.65% Variable Rate . . . . . . . . . . — — — — — — — —\n\n**Total Debt** . . . . . . . . . . . **$278,810 $265,477 $623,413 $955,052 $1,474,648 $2,674,516 $6,271,916 $5,396,094**\n\nAdditional disclosure about market risk is incorporated herein by reference from “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Market Risk.”\n\n100","publish_date":null,"title":"Item7A.QuantitativeandQualitativeDisclosuresaboutMarketRisk AsofDecember31,2008,approximately$5.9billionofourborrowingsboreinterestatfixedrates,and thereforethefairvalueoftheseinstrumentsisaffectedbychangesinthemarketinterestrates.Thefollowing tablepresentsouraggregatefixedratedebtobligationsasofDecember31,2008withcorrespondingweighted- averageinterestratessortedbymaturitydateandouraggregatevariableratedebtobligationssortedbymaturity date.TheGAAPweightedaverageinterestrateonthevariableratedebtasofDecember31,2008was3.62%per annum. Additionaldisclosureaboutmarketriskisincorporatedhereinbyreferencefrom“Management’sDiscussion andAnalysisofFinancialConditionandResultsofOperations—LiquidityandCapitalResources—Market Risk.” 100","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BXP.2008.page_112.pdf_57116_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/BXP.2008.page_112.pdf_57116_page1.pdf"},"request":{"example_id":"table/BXP.2008.page_112.pdf_57116_page1","product_type":"parse","source_file_path":"BXP.2008.page_112.pdf_57116_page1.pdf"},"started_at":"2026-11-04T19:47:01.398838"} +{"completed_at":"2026-11-04T19:47:03.317368","latency_in_ms":1324,"output":{"example_id":"table/CINF.2006.page_93.pdf_140594_page1","grounded_pages":[],"layout_pages":[],"markdown":"2006 10-K Page 65\n\n(In millions) 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 **2006** A. Originally reported reserves for unpaid loss and loss expenses:\n\nGross of reinsurance $ 1,824 $ 1,889 $ 1,978 $ 2,093 $ 2,401 $ 2,865 $ 3,150 $ 3,386 $ 3,514 $ 3,629 $ **3,860** Reinsurance recoverable 122 112 138 161 219 513 542 541 537 518 **504** Net of reinsurance $ 1,702 $ 1,777 $ 1,840 $ 1,932 $ 2,182 $ 2,352 $ 2,608 $ 2,845 $ 2,977 $ 3,111 $ **3,356**\n\nB. Cumulative net paid as of: One year later $ 453 $ 499 $ 522 $ 591 $ 697 $ 758 $ 799 $ 817 $ 907 $ **944** Two years later 732 761 833 943 1,116 1,194 1,235 1,293 **1,426** Three years later 884 965 1,067 1,195 1,378 1,455 1,519 **1,626** Four years later 992 1,075 1,207 1,327 1,526 1,614 **1,716** Five years later 1,049 1,152 1,283 1,412 1,623 **1,717** Six years later 1,093 1,205 1,333 1,464 **1,680** Seven years later 1,123 1,239 1,366 **1,496** Eight years later 1,146 1,260 **1,390** Nine years later 1,159 **1,279** Ten years later **1,175**\n\nC. Net reserves re-estimated as of: One year later $ 1,582 $ 1,623 $ 1,724 $ 1,912 $ 2,120 $ 2,307 $ 2,528 $ 2,649 $ 2,817 $ **2,995** Two years later 1,470 1,551 1,728 1,833 2,083 2,263 2,377 2,546 **2,743** Three years later 1,405 1,520 1,636 1,802 2,052 2,178 2,336 **2,489** Four years later 1,380 1,465 1,615 1,771 2,010 2,153 **2,299** Five years later 1,326 1,466 1,608 1,757 1,999 **2,127** Six years later 1,333 1,463 1,602 1,733 **1,992** Seven years later 1,333 1,460 1,577 **1,739** Eight years later 1,332 1,435 **1,593** Nine years later 1,305 **1,456** Ten years later **1,323**\n\nD. Cumulative net redundancy as of: One year later $ (120) $ (154) $ (116) $ (20) $ (62) $ (45) $ (80) $ (196) $ (160) $ **(116)** Two years later (232) (226) (112) (99) (99) (89) (231) (299) **(234)** Three years later (297) (257) (204) (130) (130) (174) (272) **(356)** Four years later (322) (312) (225) (161) (172) (199) **(309)** Five years later (376) (311) (232) (175) (183) **(225)** Six years later (369) (314) (238) (199) **(190)** Seven years later (369) (317) (263) **(193)** Eight years later (370) (342) **(247)** Nine years later (397) **(321)** Ten years later **(379)**\n\nNet liability re-estimated—latest $ 1,323 $ 1,456 $ 1,593 $ 1,739 $ 1,992 $ 2,127 $ 2,299 $ 2,489 **$** 2,743 **$ 2,995** Re-estimated recoverable—latest 183 198 224 230 259 532 568 547 551 **517** Gross liability re-estimated—latest $ 1,506 $ 1,654 $ 1,817 $ 1,969 $ 2,251 $ 2,659 $ 2,867 $ 3,036 **$** 3,294 **$ 3,512**\n\nCumulative gross redundancy $ (318) $ (235) $ (161) $ (124) $ (150) $ (206) $ (283) $ (350) **$** (220) **$ (117)**\n\nCalendar year ended December 31,\n\n• Section C shows the re-estimated amount of the previously reported reserves based on experience as of the end of each succeeding year. The estimate is increased or decreased as we learn more about the frequency and severity of claims.\n\n• Section D, cumulative net redundancy, represents the aggregate change in the estimates for all years subsequent to the year the reserves were initially established. For example, reserves established at December 31, 1996, had developed a $379 million redundancy over 10 years, net of reinsurance, which was reflected in income over the 10 years. The table shows redundant reserves as a negative number. The effects on income in 2006, 2005 and 2004 of changes in estimates of the reserves for loss and loss expenses for all accident years are shown in the reconciliation below. In evaluating the development of our estimated reserves for loss and loss expenses for the past 10 years, note that each amount includes the effects of all changes in amounts for prior periods. For example, payments or reserve adjustments related to losses settled in 2006 but incurred in 2000 are included in the cumulative deficiency or redundancy amount for 2000 and each subsequent year. In addition, this table presents calendar year data, not accident or policy year development data, which readers may be more accustomed to analyzing. Conditions and trends that have affected development of the reserves in the past may not necessarily occur in the future. Accordingly, it may not be appropriate to extrapolate future redundancies or deficiencies based on this data. Differences between the property casualty reserves reported in the accompanying consolidated balance sheets (prepared in accordance with GAAP) and those same reserves reported in the annual statements (filed with state insurance departments in accordance with statutory accounting practices – SAP), relate principally to the reporting of reinsurance recoverables, which are recognized as receivables for GAAP and as an offset to reserves for SAP.","pages":[{"line_numbers":[],"markdown":"2006 10-K Page 65\n\n(In millions) 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 **2006** A. Originally reported reserves for unpaid loss and loss expenses:\n\nGross of reinsurance $ 1,824 $ 1,889 $ 1,978 $ 2,093 $ 2,401 $ 2,865 $ 3,150 $ 3,386 $ 3,514 $ 3,629 $ **3,860** Reinsurance recoverable 122 112 138 161 219 513 542 541 537 518 **504** Net of reinsurance $ 1,702 $ 1,777 $ 1,840 $ 1,932 $ 2,182 $ 2,352 $ 2,608 $ 2,845 $ 2,977 $ 3,111 $ **3,356**\n\nB. Cumulative net paid as of: One year later $ 453 $ 499 $ 522 $ 591 $ 697 $ 758 $ 799 $ 817 $ 907 $ **944** Two years later 732 761 833 943 1,116 1,194 1,235 1,293 **1,426** Three years later 884 965 1,067 1,195 1,378 1,455 1,519 **1,626** Four years later 992 1,075 1,207 1,327 1,526 1,614 **1,716** Five years later 1,049 1,152 1,283 1,412 1,623 **1,717** Six years later 1,093 1,205 1,333 1,464 **1,680** Seven years later 1,123 1,239 1,366 **1,496** Eight years later 1,146 1,260 **1,390** Nine years later 1,159 **1,279** Ten years later **1,175**\n\nC. Net reserves re-estimated as of: One year later $ 1,582 $ 1,623 $ 1,724 $ 1,912 $ 2,120 $ 2,307 $ 2,528 $ 2,649 $ 2,817 $ **2,995** Two years later 1,470 1,551 1,728 1,833 2,083 2,263 2,377 2,546 **2,743** Three years later 1,405 1,520 1,636 1,802 2,052 2,178 2,336 **2,489** Four years later 1,380 1,465 1,615 1,771 2,010 2,153 **2,299** Five years later 1,326 1,466 1,608 1,757 1,999 **2,127** Six years later 1,333 1,463 1,602 1,733 **1,992** Seven years later 1,333 1,460 1,577 **1,739** Eight years later 1,332 1,435 **1,593** Nine years later 1,305 **1,456** Ten years later **1,323**\n\nD. Cumulative net redundancy as of: One year later $ (120) $ (154) $ (116) $ (20) $ (62) $ (45) $ (80) $ (196) $ (160) $ **(116)** Two years later (232) (226) (112) (99) (99) (89) (231) (299) **(234)** Three years later (297) (257) (204) (130) (130) (174) (272) **(356)** Four years later (322) (312) (225) (161) (172) (199) **(309)** Five years later (376) (311) (232) (175) (183) **(225)** Six years later (369) (314) (238) (199) **(190)** Seven years later (369) (317) (263) **(193)** Eight years later (370) (342) **(247)** Nine years later (397) **(321)** Ten years later **(379)**\n\nNet liability re-estimated—latest $ 1,323 $ 1,456 $ 1,593 $ 1,739 $ 1,992 $ 2,127 $ 2,299 $ 2,489 **$** 2,743 **$ 2,995** Re-estimated recoverable—latest 183 198 224 230 259 532 568 547 551 **517** Gross liability re-estimated—latest $ 1,506 $ 1,654 $ 1,817 $ 1,969 $ 2,251 $ 2,659 $ 2,867 $ 3,036 **$** 3,294 **$ 3,512**\n\nCumulative gross redundancy $ (318) $ (235) $ (161) $ (124) $ (150) $ (206) $ (283) $ (350) **$** (220) **$ (117)**\n\nCalendar year ended December 31,\n\n• Section C shows the re-estimated amount of the previously reported reserves based on experience as of the end of each succeeding year. The estimate is increased or decreased as we learn more about the frequency and severity of claims.\n\n• Section D, cumulative net redundancy, represents the aggregate change in the estimates for all years subsequent to the year the reserves were initially established. For example, reserves established at December 31, 1996, had developed a $379 million redundancy over 10 years, net of reinsurance, which was reflected in income over the 10 years. The table shows redundant reserves as a negative number. The effects on income in 2006, 2005 and 2004 of changes in estimates of the reserves for loss and loss expenses for all accident years are shown in the reconciliation below. In evaluating the development of our estimated reserves for loss and loss expenses for the past 10 years, note that each amount includes the effects of all changes in amounts for prior periods. For example, payments or reserve adjustments related to losses settled in 2006 but incurred in 2000 are included in the cumulative deficiency or redundancy amount for 2000 and each subsequent year. In addition, this table presents calendar year data, not accident or policy year development data, which readers may be more accustomed to analyzing. Conditions and trends that have affected development of the reserves in the past may not necessarily occur in the future. Accordingly, it may not be appropriate to extrapolate future redundancies or deficiencies based on this data. Differences between the property casualty reserves reported in the accompanying consolidated balance sheets (prepared in accordance with GAAP) and those same reserves reported in the annual statements (filed with state insurance departments in accordance with statutory accounting practices – SAP), relate principally to the reporting of reinsurance recoverables, which are recognized as receivables for GAAP and as an offset to reserves for SAP.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"2006 10-K Page 65\n\n(In millions) 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 **2006** A. Originally reported reserves for unpaid loss and loss expenses:\n\nGross of reinsurance $ 1,824 $ 1,889 $ 1,978 $ 2,093 $ 2,401 $ 2,865 $ 3,150 $ 3,386 $ 3,514 $ 3,629 $ **3,860** Reinsurance recoverable 122 112 138 161 219 513 542 541 537 518 **504** Net of reinsurance $ 1,702 $ 1,777 $ 1,840 $ 1,932 $ 2,182 $ 2,352 $ 2,608 $ 2,845 $ 2,977 $ 3,111 $ **3,356**\n\nB. Cumulative net paid as of: One year later $ 453 $ 499 $ 522 $ 591 $ 697 $ 758 $ 799 $ 817 $ 907 $ **944** Two years later 732 761 833 943 1,116 1,194 1,235 1,293 **1,426** Three years later 884 965 1,067 1,195 1,378 1,455 1,519 **1,626** Four years later 992 1,075 1,207 1,327 1,526 1,614 **1,716** Five years later 1,049 1,152 1,283 1,412 1,623 **1,717** Six years later 1,093 1,205 1,333 1,464 **1,680** Seven years later 1,123 1,239 1,366 **1,496** Eight years later 1,146 1,260 **1,390** Nine years later 1,159 **1,279** Ten years later **1,175**\n\nC. Net reserves re-estimated as of: One year later $ 1,582 $ 1,623 $ 1,724 $ 1,912 $ 2,120 $ 2,307 $ 2,528 $ 2,649 $ 2,817 $ **2,995** Two years later 1,470 1,551 1,728 1,833 2,083 2,263 2,377 2,546 **2,743** Three years later 1,405 1,520 1,636 1,802 2,052 2,178 2,336 **2,489** Four years later 1,380 1,465 1,615 1,771 2,010 2,153 **2,299** Five years later 1,326 1,466 1,608 1,757 1,999 **2,127** Six years later 1,333 1,463 1,602 1,733 **1,992** Seven years later 1,333 1,460 1,577 **1,739** Eight years later 1,332 1,435 **1,593** Nine years later 1,305 **1,456** Ten years later **1,323**\n\nD. Cumulative net redundancy as of: One year later $ (120) $ (154) $ (116) $ (20) $ (62) $ (45) $ (80) $ (196) $ (160) $ **(116)** Two years later (232) (226) (112) (99) (99) (89) (231) (299) **(234)** Three years later (297) (257) (204) (130) (130) (174) (272) **(356)** Four years later (322) (312) (225) (161) (172) (199) **(309)** Five years later (376) (311) (232) (175) (183) **(225)** Six years later (369) (314) (238) (199) **(190)** Seven years later (369) (317) (263) **(193)** Eight years later (370) (342) **(247)** Nine years later (397) **(321)** Ten years later **(379)**\n\nNet liability re-estimated—latest $ 1,323 $ 1,456 $ 1,593 $ 1,739 $ 1,992 $ 2,127 $ 2,299 $ 2,489 **$** 2,743 **$ 2,995** Re-estimated recoverable—latest 183 198 224 230 259 532 568 547 551 **517** Gross liability re-estimated—latest $ 1,506 $ 1,654 $ 1,817 $ 1,969 $ 2,251 $ 2,659 $ 2,867 $ 3,036 **$** 3,294 **$ 3,512**\n\nCumulative gross redundancy $ (318) $ (235) $ (161) $ (124) $ (150) $ (206) $ (283) $ (350) **$** (220) **$ (117)**\n\nCalendar year ended December 31,\n\n• Section C shows the re-estimated amount of the previously reported reserves based on experience as of the end of each succeeding year. The estimate is increased or decreased as we learn more about the frequency and severity of claims.\n\n• Section D, cumulative net redundancy, represents the aggregate change in the estimates for all years subsequent to the year the reserves were initially established. For example, reserves established at December 31, 1996, had developed a $379 million redundancy over 10 years, net of reinsurance, which was reflected in income over the 10 years. The table shows redundant reserves as a negative number. The effects on income in 2006, 2005 and 2004 of changes in estimates of the reserves for loss and loss expenses for all accident years are shown in the reconciliation below. In evaluating the development of our estimated reserves for loss and loss expenses for the past 10 years, note that each amount includes the effects of all changes in amounts for prior periods. For example, payments or reserve adjustments related to losses settled in 2006 but incurred in 2000 are included in the cumulative deficiency or redundancy amount for 2000 and each subsequent year. In addition, this table presents calendar year data, not accident or policy year development data, which readers may be more accustomed to analyzing. Conditions and trends that have affected development of the reserves in the past may not necessarily occur in the future. Accordingly, it may not be appropriate to extrapolate future redundancies or deficiencies based on this data. Differences between the property casualty reserves reported in the accompanying consolidated balance sheets (prepared in accordance with GAAP) and those same reserves reported in the annual statements (filed with state insurance departments in accordance with statutory accounting practices – SAP), relate principally to the reporting of reinsurance recoverables, which are recognized as receivables for GAAP and as an offset to reserves for SAP.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/CINF.2006.page_93.pdf_140594_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_f083d848007c974c4a8e97327c958c08","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["2006 10-K Page 65\n\n(In millions) 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 **2006** A. Originally reported reserves for unpaid loss and loss expenses:\n\nGross of reinsurance $ 1,824 $ 1,889 $ 1,978 $ 2,093 $ 2,401 $ 2,865 $ 3,150 $ 3,386 $ 3,514 $ 3,629 $ **3,860** Reinsurance recoverable 122 112 138 161 219 513 542 541 537 518 **504** Net of reinsurance $ 1,702 $ 1,777 $ 1,840 $ 1,932 $ 2,182 $ 2,352 $ 2,608 $ 2,845 $ 2,977 $ 3,111 $ **3,356**\n\nB. Cumulative net paid as of: One year later $ 453 $ 499 $ 522 $ 591 $ 697 $ 758 $ 799 $ 817 $ 907 $ **944** Two years later 732 761 833 943 1,116 1,194 1,235 1,293 **1,426** Three years later 884 965 1,067 1,195 1,378 1,455 1,519 **1,626** Four years later 992 1,075 1,207 1,327 1,526 1,614 **1,716** Five years later 1,049 1,152 1,283 1,412 1,623 **1,717** Six years later 1,093 1,205 1,333 1,464 **1,680** Seven years later 1,123 1,239 1,366 **1,496** Eight years later 1,146 1,260 **1,390** Nine years later 1,159 **1,279** Ten years later **1,175**\n\nC. Net reserves re-estimated as of: One year later $ 1,582 $ 1,623 $ 1,724 $ 1,912 $ 2,120 $ 2,307 $ 2,528 $ 2,649 $ 2,817 $ **2,995** Two years later 1,470 1,551 1,728 1,833 2,083 2,263 2,377 2,546 **2,743** Three years later 1,405 1,520 1,636 1,802 2,052 2,178 2,336 **2,489** Four years later 1,380 1,465 1,615 1,771 2,010 2,153 **2,299** Five years later 1,326 1,466 1,608 1,757 1,999 **2,127** Six years later 1,333 1,463 1,602 1,733 **1,992** Seven years later 1,333 1,460 1,577 **1,739** Eight years later 1,332 1,435 **1,593** Nine years later 1,305 **1,456** Ten years later **1,323**\n\nD. Cumulative net redundancy as of: One year later $ (120) $ (154) $ (116) $ (20) $ (62) $ (45) $ (80) $ (196) $ (160) $ **(116)** Two years later (232) (226) (112) (99) (99) (89) (231) (299) **(234)** Three years later (297) (257) (204) (130) (130) (174) (272) **(356)** Four years later (322) (312) (225) (161) (172) (199) **(309)** Five years later (376) (311) (232) (175) (183) **(225)** Six years later (369) (314) (238) (199) **(190)** Seven years later (369) (317) (263) **(193)** Eight years later (370) (342) **(247)** Nine years later (397) **(321)** Ten years later **(379)**\n\nNet liability re-estimated—latest $ 1,323 $ 1,456 $ 1,593 $ 1,739 $ 1,992 $ 2,127 $ 2,299 $ 2,489 **$** 2,743 **$ 2,995** Re-estimated recoverable—latest 183 198 224 230 259 532 568 547 551 **517** Gross liability re-estimated—latest $ 1,506 $ 1,654 $ 1,817 $ 1,969 $ 2,251 $ 2,659 $ 2,867 $ 3,036 **$** 3,294 **$ 3,512**\n\nCumulative gross redundancy $ (318) $ (235) $ (161) $ (124) $ (150) $ (206) $ (283) $ (350) **$** (220) **$ (117)**\n\nCalendar year ended December 31,\n\n• Section C shows the re-estimated amount of the previously reported reserves based on experience as of the end of each succeeding year. The estimate is increased or decreased as we learn more about the frequency and severity of claims.\n\n• Section D, cumulative net redundancy, represents the aggregate change in the estimates for all years subsequent to the year the reserves were initially established. For example, reserves established at December 31, 1996, had developed a $379 million redundancy over 10 years, net of reinsurance, which was reflected in income over the 10 years. The table shows redundant reserves as a negative number. The effects on income in 2006, 2005 and 2004 of changes in estimates of the reserves for loss and loss expenses for all accident years are shown in the reconciliation below. In evaluating the development of our estimated reserves for loss and loss expenses for the past 10 years, note that each amount includes the effects of all changes in amounts for prior periods. For example, payments or reserve adjustments related to losses settled in 2006 but incurred in 2000 are included in the cumulative deficiency or redundancy amount for 2000 and each subsequent year. In addition, this table presents calendar year data, not accident or policy year development data, which readers may be more accustomed to analyzing. Conditions and trends that have affected development of the reserves in the past may not necessarily occur in the future. Accordingly, it may not be appropriate to extrapolate future redundancies or deficiencies based on this data. Differences between the property casualty reserves reported in the accompanying consolidated balance sheets (prepared in accordance with GAAP) and those same reserves reported in the annual statements (filed with state insurance departments in accordance with statutory accounting practices – SAP), relate principally to the reporting of reinsurance recoverables, which are recognized as receivables for GAAP and as an offset to reserves for SAP."],"full_content":"2006 10-K Page 65\n\n(In millions) 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 **2006** A. Originally reported reserves for unpaid loss and loss expenses:\n\nGross of reinsurance $ 1,824 $ 1,889 $ 1,978 $ 2,093 $ 2,401 $ 2,865 $ 3,150 $ 3,386 $ 3,514 $ 3,629 $ **3,860** Reinsurance recoverable 122 112 138 161 219 513 542 541 537 518 **504** Net of reinsurance $ 1,702 $ 1,777 $ 1,840 $ 1,932 $ 2,182 $ 2,352 $ 2,608 $ 2,845 $ 2,977 $ 3,111 $ **3,356**\n\nB. Cumulative net paid as of: One year later $ 453 $ 499 $ 522 $ 591 $ 697 $ 758 $ 799 $ 817 $ 907 $ **944** Two years later 732 761 833 943 1,116 1,194 1,235 1,293 **1,426** Three years later 884 965 1,067 1,195 1,378 1,455 1,519 **1,626** Four years later 992 1,075 1,207 1,327 1,526 1,614 **1,716** Five years later 1,049 1,152 1,283 1,412 1,623 **1,717** Six years later 1,093 1,205 1,333 1,464 **1,680** Seven years later 1,123 1,239 1,366 **1,496** Eight years later 1,146 1,260 **1,390** Nine years later 1,159 **1,279** Ten years later **1,175**\n\nC. Net reserves re-estimated as of: One year later $ 1,582 $ 1,623 $ 1,724 $ 1,912 $ 2,120 $ 2,307 $ 2,528 $ 2,649 $ 2,817 $ **2,995** Two years later 1,470 1,551 1,728 1,833 2,083 2,263 2,377 2,546 **2,743** Three years later 1,405 1,520 1,636 1,802 2,052 2,178 2,336 **2,489** Four years later 1,380 1,465 1,615 1,771 2,010 2,153 **2,299** Five years later 1,326 1,466 1,608 1,757 1,999 **2,127** Six years later 1,333 1,463 1,602 1,733 **1,992** Seven years later 1,333 1,460 1,577 **1,739** Eight years later 1,332 1,435 **1,593** Nine years later 1,305 **1,456** Ten years later **1,323**\n\nD. Cumulative net redundancy as of: One year later $ (120) $ (154) $ (116) $ (20) $ (62) $ (45) $ (80) $ (196) $ (160) $ **(116)** Two years later (232) (226) (112) (99) (99) (89) (231) (299) **(234)** Three years later (297) (257) (204) (130) (130) (174) (272) **(356)** Four years later (322) (312) (225) (161) (172) (199) **(309)** Five years later (376) (311) (232) (175) (183) **(225)** Six years later (369) (314) (238) (199) **(190)** Seven years later (369) (317) (263) **(193)** Eight years later (370) (342) **(247)** Nine years later (397) **(321)** Ten years later **(379)**\n\nNet liability re-estimated—latest $ 1,323 $ 1,456 $ 1,593 $ 1,739 $ 1,992 $ 2,127 $ 2,299 $ 2,489 **$** 2,743 **$ 2,995** Re-estimated recoverable—latest 183 198 224 230 259 532 568 547 551 **517** Gross liability re-estimated—latest $ 1,506 $ 1,654 $ 1,817 $ 1,969 $ 2,251 $ 2,659 $ 2,867 $ 3,036 **$** 3,294 **$ 3,512**\n\nCumulative gross redundancy $ (318) $ (235) $ (161) $ (124) $ (150) $ (206) $ (283) $ (350) **$** (220) **$ (117)**\n\nCalendar year ended December 31,\n\n• Section C shows the re-estimated amount of the previously reported reserves based on experience as of the end of each succeeding year. The estimate is increased or decreased as we learn more about the frequency and severity of claims.\n\n• Section D, cumulative net redundancy, represents the aggregate change in the estimates for all years subsequent to the year the reserves were initially established. For example, reserves established at December 31, 1996, had developed a $379 million redundancy over 10 years, net of reinsurance, which was reflected in income over the 10 years. The table shows redundant reserves as a negative number. The effects on income in 2006, 2005 and 2004 of changes in estimates of the reserves for loss and loss expenses for all accident years are shown in the reconciliation below. In evaluating the development of our estimated reserves for loss and loss expenses for the past 10 years, note that each amount includes the effects of all changes in amounts for prior periods. For example, payments or reserve adjustments related to losses settled in 2006 but incurred in 2000 are included in the cumulative deficiency or redundancy amount for 2000 and each subsequent year. In addition, this table presents calendar year data, not accident or policy year development data, which readers may be more accustomed to analyzing. Conditions and trends that have affected development of the reserves in the past may not necessarily occur in the future. Accordingly, it may not be appropriate to extrapolate future redundancies or deficiencies based on this data. Differences between the property casualty reserves reported in the accompanying consolidated balance sheets (prepared in accordance with GAAP) and those same reserves reported in the annual statements (filed with state insurance departments in accordance with statutory accounting practices – SAP), relate principally to the reporting of reinsurance recoverables, which are recognized as receivables for GAAP and as an offset to reserves for SAP.","publish_date":null,"title":"Section C shows the re-estimated amount of the previously reported reserves based on experience as of • the end of","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/CINF.2006.page_93.pdf_140594_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/CINF.2006.page_93.pdf_140594_page1.pdf"},"request":{"example_id":"table/CINF.2006.page_93.pdf_140594_page1","product_type":"parse","source_file_path":"CINF.2006.page_93.pdf_140594_page1.pdf"},"started_at":"2026-11-04T19:47:01.993117"} +{"completed_at":"2026-11-04T19:47:07.108992","latency_in_ms":3780,"output":{"example_id":"table/Coca Cola 10-k_page1","grounded_pages":[],"layout_pages":[],"markdown":"### **UNITED STATES**\n\n### **SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n### **FORM 10-K**\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the fiscal year ended December 31, 2024**\n\n**OR**\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the transition period from to**\n\n**Commission File Number 001-02217**\n\nCOCA COLA CO\n\n(Exact name of Registrant as specified in its charter)\n\n**Delaware 58-0628465**\n\n(State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)\n\n**One Coca-Cola Plaza**\n\n**Atlanta, Georgia 30313**\n\n(Address of principal executive offices) (Zip Code)\n\n**Registrant’s telephone number, including area code: (404) 676-2121**\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n**Title of each class Trading Symbol(s) Name of each exchange on which registered**\n\n**Common Stock, $0.25 Par Value KO New York Stock Exchange**\n\n**1\\.875% Notes Due 2026 KO26 New York Stock Exchange**\n\n**0\\.750% Notes Due 2026 KO26C New York Stock Exchange**\n\n**1\\.125% Notes Due 2027 KO27 New York Stock Exchange**\n\n**0\\.125% Notes Due 2029 KO29A New York Stock Exchange**\n\n**0\\.125% Notes Due 2029 KO29B New York Stock Exchange**\n\n**0\\.400% Notes Due 2030 KO30B New York Stock Exchange**\n\n**1\\.250% Notes Due 2031 KO31 New York Stock Exchange**\n\n**3\\.125% Notes Due 2032 KO32 New York Stock Exchange**\n\n**0\\.375% Notes Due 2033 KO33 New York Stock Exchange**\n\n**0\\.500% Notes Due 2033 KO33A New York Stock Exchange**\n\n**1\\.625% Notes Due 2035 KO35 New York Stock Exchange**\n\n**1\\.100% Notes Due 2036 KO36 New York Stock Exchange**\n\n**0\\.950% Notes Due 2036 KO36A New York Stock Exchange**\n\n**3\\.375% Notes Due 2037 KO37 New York Stock Exchange**\n\n**0\\.800% Notes Due 2040 KO40B New York Stock Exchange**\n\n**1\\.000% Notes Due 2041 KO41 New York Stock Exchange**\n\n**3\\.500% Notes Due 2044 KO44 New York Stock Exchange**\n\n**3\\.750% Notes Due 2053 KO53 New York Stock Exchange**\n\n**Securities registered pursuant to Section 12(g) of the Act: None**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_","pages":[{"line_numbers":[],"markdown":"### **UNITED STATES**\n\n### **SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n### **FORM 10-K**\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the fiscal year ended December 31, 2024**\n\n**OR**\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the transition period from to**\n\n**Commission File Number 001-02217**\n\nCOCA COLA CO\n\n(Exact name of Registrant as specified in its charter)\n\n**Delaware 58-0628465**\n\n(State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)\n\n**One Coca-Cola Plaza**\n\n**Atlanta, Georgia 30313**\n\n(Address of principal executive offices) (Zip Code)\n\n**Registrant’s telephone number, including area code: (404) 676-2121**\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n**Title of each class Trading Symbol(s) Name of each exchange on which registered**\n\n**Common Stock, $0.25 Par Value KO New York Stock Exchange**\n\n**1\\.875% Notes Due 2026 KO26 New York Stock Exchange**\n\n**0\\.750% Notes Due 2026 KO26C New York Stock Exchange**\n\n**1\\.125% Notes Due 2027 KO27 New York Stock Exchange**\n\n**0\\.125% Notes Due 2029 KO29A New York Stock Exchange**\n\n**0\\.125% Notes Due 2029 KO29B New York Stock Exchange**\n\n**0\\.400% Notes Due 2030 KO30B New York Stock Exchange**\n\n**1\\.250% Notes Due 2031 KO31 New York Stock Exchange**\n\n**3\\.125% Notes Due 2032 KO32 New York Stock Exchange**\n\n**0\\.375% Notes Due 2033 KO33 New York Stock Exchange**\n\n**0\\.500% Notes Due 2033 KO33A New York Stock Exchange**\n\n**1\\.625% Notes Due 2035 KO35 New York Stock Exchange**\n\n**1\\.100% Notes Due 2036 KO36 New York Stock Exchange**\n\n**0\\.950% Notes Due 2036 KO36A New York Stock Exchange**\n\n**3\\.375% Notes Due 2037 KO37 New York Stock Exchange**\n\n**0\\.800% Notes Due 2040 KO40B New York Stock Exchange**\n\n**1\\.000% Notes Due 2041 KO41 New York Stock Exchange**\n\n**3\\.500% Notes Due 2044 KO44 New York Stock Exchange**\n\n**3\\.750% Notes Due 2053 KO53 New York Stock Exchange**\n\n**Securities registered pursuant to Section 12(g) of the Act: None**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **UNITED STATES**\n\n### **SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n### **FORM 10-K**\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the fiscal year ended December 31, 2024**\n\n**OR**\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the transition period from to**\n\n**Commission File Number 001-02217**\n\nCOCA COLA CO\n\n(Exact name of Registrant as specified in its charter)\n\n**Delaware 58-0628465**\n\n(State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)\n\n**One Coca-Cola Plaza**\n\n**Atlanta, Georgia 30313**\n\n(Address of principal executive offices) (Zip Code)\n\n**Registrant’s telephone number, including area code: (404) 676-2121**\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n**Title of each class Trading Symbol(s) Name of each exchange on which registered**\n\n**Common Stock, $0.25 Par Value KO New York Stock Exchange**\n\n**1\\.875% Notes Due 2026 KO26 New York Stock Exchange**\n\n**0\\.750% Notes Due 2026 KO26C New York Stock Exchange**\n\n**1\\.125% Notes Due 2027 KO27 New York Stock Exchange**\n\n**0\\.125% Notes Due 2029 KO29A New York Stock Exchange**\n\n**0\\.125% Notes Due 2029 KO29B New York Stock Exchange**\n\n**0\\.400% Notes Due 2030 KO30B New York Stock Exchange**\n\n**1\\.250% Notes Due 2031 KO31 New York Stock Exchange**\n\n**3\\.125% Notes Due 2032 KO32 New York Stock Exchange**\n\n**0\\.375% Notes Due 2033 KO33 New York Stock Exchange**\n\n**0\\.500% Notes Due 2033 KO33A New York Stock Exchange**\n\n**1\\.625% Notes Due 2035 KO35 New York Stock Exchange**\n\n**1\\.100% Notes Due 2036 KO36 New York Stock Exchange**\n\n**0\\.950% Notes Due 2036 KO36A New York Stock Exchange**\n\n**3\\.375% Notes Due 2037 KO37 New York Stock Exchange**\n\n**0\\.800% Notes Due 2040 KO40B New York Stock Exchange**\n\n**1\\.000% Notes Due 2041 KO41 New York Stock Exchange**\n\n**3\\.500% Notes Due 2044 KO44 New York Stock Exchange**\n\n**3\\.750% Notes Due 2053 KO53 New York Stock Exchange**\n\n**Securities registered pursuant to Section 12(g) of the Act: None**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_5c97c2e0c2eb648954234bb0bcfcacb2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **UNITED STATES**\n\n### **SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n### **FORM 10-K**\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the fiscal year ended December 31, 2024**\n\n**OR**\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the transition period from to**\n\n**Commission File Number 001-02217**\n\nCOCA COLA CO\n\n(Exact name of Registrant as specified in its charter)\n\n**Delaware 58-0628465**\n\n(State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)\n\n**One Coca-Cola Plaza**\n\n**Atlanta, Georgia 30313**\n\n(Address of principal executive offices) (Zip Code)\n\n**Registrant’s telephone number, including area code: (404) 676-2121**\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n**Title of each class Trading Symbol(s) Name of each exchange on which registered**\n\n**Common Stock, $0.25 Par Value KO New York Stock Exchange**\n\n**1\\.875% Notes Due 2026 KO26 New York Stock Exchange**\n\n**0\\.750% Notes Due 2026 KO26C New York Stock Exchange**\n\n**1\\.125% Notes Due 2027 KO27 New York Stock Exchange**\n\n**0\\.125% Notes Due 2029 KO29A New York Stock Exchange**\n\n**0\\.125% Notes Due 2029 KO29B New York Stock Exchange**\n\n**0\\.400% Notes Due 2030 KO30B New York Stock Exchange**\n\n**1\\.250% Notes Due 2031 KO31 New York Stock Exchange**\n\n**3\\.125% Notes Due 2032 KO32 New York Stock Exchange**\n\n**0\\.375% Notes Due 2033 KO33 New York Stock Exchange**\n\n**0\\.500% Notes Due 2033 KO33A New York Stock Exchange**\n\n**1\\.625% Notes Due 2035 KO35 New York Stock Exchange**\n\n**1\\.100% Notes Due 2036 KO36 New York Stock Exchange**\n\n**0\\.950% Notes Due 2036 KO36A New York Stock Exchange**\n\n**3\\.375% Notes Due 2037 KO37 New York Stock Exchange**\n\n**0\\.800% Notes Due 2040 KO40B New York Stock Exchange**\n\n**1\\.000% Notes Due 2041 KO41 New York Stock Exchange**\n\n**3\\.500% Notes Due 2044 KO44 New York Stock Exchange**\n\n**3\\.750% Notes Due 2053 KO53 New York Stock Exchange**\n\n**Securities registered pursuant to Section 12(g) of the Act: None**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_"],"full_content":"### **UNITED STATES**\n\n### **SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n### **FORM 10-K**\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the fiscal year ended December 31, 2024**\n\n**OR**\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n**For the transition period from to**\n\n**Commission File Number 001-02217**\n\nCOCA COLA CO\n\n(Exact name of Registrant as specified in its charter)\n\n**Delaware 58-0628465**\n\n(State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)\n\n**One Coca-Cola Plaza**\n\n**Atlanta, Georgia 30313**\n\n(Address of principal executive offices) (Zip Code)\n\n**Registrant’s telephone number, including area code: (404) 676-2121**\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n**Title of each class Trading Symbol(s) Name of each exchange on which registered**\n\n**Common Stock, $0.25 Par Value KO New York Stock Exchange**\n\n**1\\.875% Notes Due 2026 KO26 New York Stock Exchange**\n\n**0\\.750% Notes Due 2026 KO26C New York Stock Exchange**\n\n**1\\.125% Notes Due 2027 KO27 New York Stock Exchange**\n\n**0\\.125% Notes Due 2029 KO29A New York Stock Exchange**\n\n**0\\.125% Notes Due 2029 KO29B New York Stock Exchange**\n\n**0\\.400% Notes Due 2030 KO30B New York Stock Exchange**\n\n**1\\.250% Notes Due 2031 KO31 New York Stock Exchange**\n\n**3\\.125% Notes Due 2032 KO32 New York Stock Exchange**\n\n**0\\.375% Notes Due 2033 KO33 New York Stock Exchange**\n\n**0\\.500% Notes Due 2033 KO33A New York Stock Exchange**\n\n**1\\.625% Notes Due 2035 KO35 New York Stock Exchange**\n\n**1\\.100% Notes Due 2036 KO36 New York Stock Exchange**\n\n**0\\.950% Notes Due 2036 KO36A New York Stock Exchange**\n\n**3\\.375% Notes Due 2037 KO37 New York Stock Exchange**\n\n**0\\.800% Notes Due 2040 KO40B New York Stock Exchange**\n\n**1\\.000% Notes Due 2041 KO41 New York Stock Exchange**\n\n**3\\.500% Notes Due 2044 KO44 New York Stock Exchange**\n\n**3\\.750% Notes Due 2053 KO53 New York Stock Exchange**\n\n**Securities registered pursuant to Section 12(g) of the Act: None**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_","publish_date":null,"title":"COCA COLA CO — FORM 10-K, fiscal year ended December 31, 2024","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page1.pdf"},"request":{"example_id":"table/Coca Cola 10-k_page1","product_type":"parse","source_file_path":"Coca Cola 10-k_page1.pdf"},"started_at":"2026-11-04T19:47:03.328481"} +{"completed_at":"2026-11-04T19:47:07.472815","latency_in_ms":2784,"output":{"example_id":"table/Coca Cola 10-k_page107","grounded_pages":[],"layout_pages":[],"markdown":"and related valuation allowances on a certain equity method investment and the changes in net operating losses in the normal course of business.\n\nIn 2023, the Company recognized a net decrease of $28 million in its valuation allowances, primarily due to net decreases in the deferred tax assets and related valuation allowances on a certain equity method investment, certain excess foreign tax credit carryforwards and the changes in net operating losses in the normal course of business.\n\nIn 2022, the Company recognized a net increase of $23 million in its valuation allowances. The increase was primarily due to significant negative evidence on the utilization of excess foreign tax credits generated in the current year. The increase was also due to net increases in the deferred tax assets and related valuation allowances on certain equity method investments and the changes in net operating losses in the normal course of business.\n\n**NOTE 16: OTHER COMPREHENSIVE INCOME**\n\nAOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a component of The Coca-Cola Company’s shareowners’ equity, which also includes our proportionate share of equity method investees’ AOCI. OCI attributable to noncontrolling interests is allocated to, and included in, our consolidated balance sheet as part of the line item equity attributable to noncontrolling interests.\n\nAOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):\n\nDecember 31, **2024** 2023\n\nNet foreign currency translation adjustments **$ (15,610)** $ (12,726)\n\nAccumulated net gains (losses) on derivatives **116** (154)\n\nUnrealized net gains (losses) on available-for-sale debt securities **(64)** (1)\n\nAdjustments to pension and other postretirement benefit liabilities **(1,285)** (1,394)\n\nAccumulated other comprehensive income (loss) **$ (16,843)** $ (14,275)\n\nThe following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):\n\nYear Ended December 31, 2024\n\nShareowners of\n\nThe Coca-Cola Company\n\nNoncontrolling\n\nInterests Total\n\nConsolidated net income $ 10,631 $ 18 $ 10,649\n\nOther comprehensive income:\n\nNet foreign currency translation adjustments (2,884) (9) (2,893)\n\nNet gains (losses) on derivatives 270 — 270\n\nNet change in unrealized gains (losses) on available-for-sale debt securities (63) — (63)\n\nNet change in pension and other postretirement benefit liabilities 109 — 109\n\nTotal comprehensive income $ 8,063 $ 9 $ 8,072\n\nRefer to Note 5 for additional information related to the net gains or losses on derivative instruments. Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities. Refer to Note 14 for additional information related to the Company’s pension and other postretirement benefit liabilities.\n\n1\n\n2\n\n3\n\n1\n\n2\n\n3\n\n104","pages":[{"line_numbers":[],"markdown":"and related valuation allowances on a certain equity method investment and the changes in net operating losses in the normal course of business.\n\nIn 2023, the Company recognized a net decrease of $28 million in its valuation allowances, primarily due to net decreases in the deferred tax assets and related valuation allowances on a certain equity method investment, certain excess foreign tax credit carryforwards and the changes in net operating losses in the normal course of business.\n\nIn 2022, the Company recognized a net increase of $23 million in its valuation allowances. The increase was primarily due to significant negative evidence on the utilization of excess foreign tax credits generated in the current year. The increase was also due to net increases in the deferred tax assets and related valuation allowances on certain equity method investments and the changes in net operating losses in the normal course of business.\n\n**NOTE 16: OTHER COMPREHENSIVE INCOME**\n\nAOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a component of The Coca-Cola Company’s shareowners’ equity, which also includes our proportionate share of equity method investees’ AOCI. OCI attributable to noncontrolling interests is allocated to, and included in, our consolidated balance sheet as part of the line item equity attributable to noncontrolling interests.\n\nAOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):\n\nDecember 31, **2024** 2023\n\nNet foreign currency translation adjustments **$ (15,610)** $ (12,726)\n\nAccumulated net gains (losses) on derivatives **116** (154)\n\nUnrealized net gains (losses) on available-for-sale debt securities **(64)** (1)\n\nAdjustments to pension and other postretirement benefit liabilities **(1,285)** (1,394)\n\nAccumulated other comprehensive income (loss) **$ (16,843)** $ (14,275)\n\nThe following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):\n\nYear Ended December 31, 2024\n\nShareowners of\n\nThe Coca-Cola Company\n\nNoncontrolling\n\nInterests Total\n\nConsolidated net income $ 10,631 $ 18 $ 10,649\n\nOther comprehensive income:\n\nNet foreign currency translation adjustments (2,884) (9) (2,893)\n\nNet gains (losses) on derivatives 270 — 270\n\nNet change in unrealized gains (losses) on available-for-sale debt securities (63) — (63)\n\nNet change in pension and other postretirement benefit liabilities 109 — 109\n\nTotal comprehensive income $ 8,063 $ 9 $ 8,072\n\nRefer to Note 5 for additional information related to the net gains or losses on derivative instruments. Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities. Refer to Note 14 for additional information related to the Company’s pension and other postretirement benefit liabilities.\n\n1\n\n2\n\n3\n\n1\n\n2\n\n3\n\n104","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"and related valuation allowances on a certain equity method investment and the changes in net operating losses in the normal course of business.\n\nIn 2023, the Company recognized a net decrease of $28 million in its valuation allowances, primarily due to net decreases in the deferred tax assets and related valuation allowances on a certain equity method investment, certain excess foreign tax credit carryforwards and the changes in net operating losses in the normal course of business.\n\nIn 2022, the Company recognized a net increase of $23 million in its valuation allowances. The increase was primarily due to significant negative evidence on the utilization of excess foreign tax credits generated in the current year. The increase was also due to net increases in the deferred tax assets and related valuation allowances on certain equity method investments and the changes in net operating losses in the normal course of business.\n\n**NOTE 16: OTHER COMPREHENSIVE INCOME**\n\nAOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a component of The Coca-Cola Company’s shareowners’ equity, which also includes our proportionate share of equity method investees’ AOCI. OCI attributable to noncontrolling interests is allocated to, and included in, our consolidated balance sheet as part of the line item equity attributable to noncontrolling interests.\n\nAOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):\n\nDecember 31, **2024** 2023\n\nNet foreign currency translation adjustments **$ (15,610)** $ (12,726)\n\nAccumulated net gains (losses) on derivatives **116** (154)\n\nUnrealized net gains (losses) on available-for-sale debt securities **(64)** (1)\n\nAdjustments to pension and other postretirement benefit liabilities **(1,285)** (1,394)\n\nAccumulated other comprehensive income (loss) **$ (16,843)** $ (14,275)\n\nThe following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):\n\nYear Ended December 31, 2024\n\nShareowners of\n\nThe Coca-Cola Company\n\nNoncontrolling\n\nInterests Total\n\nConsolidated net income $ 10,631 $ 18 $ 10,649\n\nOther comprehensive income:\n\nNet foreign currency translation adjustments (2,884) (9) (2,893)\n\nNet gains (losses) on derivatives 270 — 270\n\nNet change in unrealized gains (losses) on available-for-sale debt securities (63) — (63)\n\nNet change in pension and other postretirement benefit liabilities 109 — 109\n\nTotal comprehensive income $ 8,063 $ 9 $ 8,072\n\nRefer to Note 5 for additional information related to the net gains or losses on derivative instruments. Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities. Refer to Note 14 for additional information related to the Company’s pension and other postretirement benefit liabilities.\n\n1\n\n2\n\n3\n\n1\n\n2\n\n3\n\n104","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page107.pdf"]},"response":{"errors":[],"extract_id":"extract_fe7411d8fde13b1a7ab7b42e278e2ad5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["and related valuation allowances on a certain equity method investment and the changes in net operating losses in the normal course of business.\n\nIn 2023, the Company recognized a net decrease of $28 million in its valuation allowances, primarily due to net decreases in the deferred tax assets and related valuation allowances on a certain equity method investment, certain excess foreign tax credit carryforwards and the changes in net operating losses in the normal course of business.\n\nIn 2022, the Company recognized a net increase of $23 million in its valuation allowances. The increase was primarily due to significant negative evidence on the utilization of excess foreign tax credits generated in the current year. The increase was also due to net increases in the deferred tax assets and related valuation allowances on certain equity method investments and the changes in net operating losses in the normal course of business.\n\n**NOTE 16: OTHER COMPREHENSIVE INCOME**\n\nAOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a component of The Coca-Cola Company’s shareowners’ equity, which also includes our proportionate share of equity method investees’ AOCI. OCI attributable to noncontrolling interests is allocated to, and included in, our consolidated balance sheet as part of the line item equity attributable to noncontrolling interests.\n\nAOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):\n\nDecember 31, **2024** 2023\n\nNet foreign currency translation adjustments **$ (15,610)** $ (12,726)\n\nAccumulated net gains (losses) on derivatives **116** (154)\n\nUnrealized net gains (losses) on available-for-sale debt securities **(64)** (1)\n\nAdjustments to pension and other postretirement benefit liabilities **(1,285)** (1,394)\n\nAccumulated other comprehensive income (loss) **$ (16,843)** $ (14,275)\n\nThe following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):\n\nYear Ended December 31, 2024\n\nShareowners of\n\nThe Coca-Cola Company\n\nNoncontrolling\n\nInterests Total\n\nConsolidated net income $ 10,631 $ 18 $ 10,649\n\nOther comprehensive income:\n\nNet foreign currency translation adjustments (2,884) (9) (2,893)\n\nNet gains (losses) on derivatives 270 — 270\n\nNet change in unrealized gains (losses) on available-for-sale debt securities (63) — (63)\n\nNet change in pension and other postretirement benefit liabilities 109 — 109\n\nTotal comprehensive income $ 8,063 $ 9 $ 8,072\n\nRefer to Note 5 for additional information related to the net gains or losses on derivative instruments. Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities. Refer to Note 14 for additional information related to the Company’s pension and other postretirement benefit liabilities.\n\n1\n\n2\n\n3\n\n1\n\n2\n\n3\n\n104"],"full_content":"and related valuation allowances on a certain equity method investment and the changes in net operating losses in the normal course of business.\n\nIn 2023, the Company recognized a net decrease of $28 million in its valuation allowances, primarily due to net decreases in the deferred tax assets and related valuation allowances on a certain equity method investment, certain excess foreign tax credit carryforwards and the changes in net operating losses in the normal course of business.\n\nIn 2022, the Company recognized a net increase of $23 million in its valuation allowances. The increase was primarily due to significant negative evidence on the utilization of excess foreign tax credits generated in the current year. The increase was also due to net increases in the deferred tax assets and related valuation allowances on certain equity method investments and the changes in net operating losses in the normal course of business.\n\n**NOTE 16: OTHER COMPREHENSIVE INCOME**\n\nAOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a component of The Coca-Cola Company’s shareowners’ equity, which also includes our proportionate share of equity method investees’ AOCI. OCI attributable to noncontrolling interests is allocated to, and included in, our consolidated balance sheet as part of the line item equity attributable to noncontrolling interests.\n\nAOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):\n\nDecember 31, **2024** 2023\n\nNet foreign currency translation adjustments **$ (15,610)** $ (12,726)\n\nAccumulated net gains (losses) on derivatives **116** (154)\n\nUnrealized net gains (losses) on available-for-sale debt securities **(64)** (1)\n\nAdjustments to pension and other postretirement benefit liabilities **(1,285)** (1,394)\n\nAccumulated other comprehensive income (loss) **$ (16,843)** $ (14,275)\n\nThe following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):\n\nYear Ended December 31, 2024\n\nShareowners of\n\nThe Coca-Cola Company\n\nNoncontrolling\n\nInterests Total\n\nConsolidated net income $ 10,631 $ 18 $ 10,649\n\nOther comprehensive income:\n\nNet foreign currency translation adjustments (2,884) (9) (2,893)\n\nNet gains (losses) on derivatives 270 — 270\n\nNet change in unrealized gains (losses) on available-for-sale debt securities (63) — (63)\n\nNet change in pension and other postretirement benefit liabilities 109 — 109\n\nTotal comprehensive income $ 8,063 $ 9 $ 8,072\n\nRefer to Note 5 for additional information related to the net gains or losses on derivative instruments. Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities. Refer to Note 14 for additional information related to the Company’s pension and other postretirement benefit liabilities.\n\n1\n\n2\n\n3\n\n1\n\n2\n\n3\n\n104","publish_date":null,"title":"and related valuation allowances on a certain equity method investment and the changes in net operating losses in the normal","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page107.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page107.pdf"},"request":{"example_id":"table/Coca Cola 10-k_page107","product_type":"parse","source_file_path":"Coca Cola 10-k_page107.pdf"},"started_at":"2026-11-04T19:47:04.687940"} +{"completed_at":"2026-11-04T19:47:07.728461","latency_in_ms":1188,"output":{"example_id":"table/Coca Cola 10-k_page30","grounded_pages":[],"layout_pages":[],"markdown":"The following table summarizes our principal production facilities, distribution and storage facilities, and retail stores by operating segment and Corporate as of December 31, 2024:\n\nPrincipal Concentrate and/or\n\nSyrup Plants\n\nPrincipal Beverage\n\nManufacturing/Bottling Plants\n\nPrincipal Distribution and\n\nStorage Facilities Principal Retail Stores\n\nOwned Leased Owned Leased Owned Leased Owned Leased\n\nEurope, Middle East & Africa 5 — 2 — 7 27 — 13\n\nLatin America 5 — — — 2 5 — —\n\nNorth America 10 — 6 3 — 29 — 5\n\nAsia Pacific 6 1 3 — 3 4 — —\n\nGlobal Ventures 1 — 2 — — 8 — 1,508\n\nBottling Investments — — 61 4 51 79 — —\n\nCorporate 3 — — — — 5 — —\n\nTotal 30 1 74 7 63 157 — 1,526\n\nManagement believes that our Company’s facilities used for the production of our products are suitable and adequate, that they are being appropriately utilized in line with past experience, and that they have sufficient production capacity for their present intended purposes. The extent of utilization of our production facilities varies based upon seasonal demand for our products. However, management believes that, with the exception of certain dairy products that require specialized equipment, additional production can be achieved at the existing facilities by adding personnel and capital equipment or, at some facilities, by adding shifts of personnel or expanding the facilities. The Company is in the process of increasing our dairy production capacity. We continuously review our anticipated requirements for facilities and, on the basis of that review, may from time to time acquire or lease additional facilities and/or dispose of existing facilities.\n\n**ITEM 3. LEGAL PROCEEDINGS**\n\nThe Company is involved in various legal proceedings, including the proceedings specifically discussed below. Management believes that, except as disclosed in “U.S. Federal Income Tax Dispute” below, the total liabilities of the Company that may arise as a result of currently pending legal proceedings will not have a material adverse effect on the Company taken as a whole.\n\n_Aqua-Chem Litigation_\n\nOn December 20, 2002, the Company filed a lawsuit (The Coca-Cola Company v. Aqua-Chem, Inc., Civil Action No. 2002CV631-50) in the Superior Court of Fulton County, Georgia (“Georgia Case”), seeking a declaratory judgment that the Company has no obligation to its former subsidiary, Aqua-Chem, Inc., now known as Cleaver-Brooks, Inc. (“Aqua-Chem”), for any past, present or future liabilities or expenses in connection with any claims or lawsuits against Aqua-Chem. Subsequent to the Company’s filing but on the same day, Aqua-Chem filed a lawsuit (Aqua-Chem, Inc. v. The Coca-Cola Company, Civil Action No. 02CV012179) in the Circuit Court, Civil Division of Milwaukee County, Wisconsin (“Wisconsin Case”). In the Wisconsin Case, Aqua-Chem sought a declaratory judgment that the Company is responsible for all liabilities and expenses not covered by insurance in connection with certain of Aqua-Chem’s general and product liability claims arising from occurrences prior to the Company’s sale of Aqua-Chem in 1981, and a judgment for breach of contract in an amount exceeding $9 million for costs incurred by Aqua-Chem to date in connection with such claims. The Wisconsin Case initially was stayed, pending final resolution of the Georgia Case, and later was voluntarily dismissed without prejudice by Aqua-Chem.\n\nThe Company owned Aqua-Chem from 1970 to 1981. During that time, the Company purchased over $400 million of insurance coverage, which also insures Aqua-Chem for some of its prior and future costs for certain product liability and other claims. The Company sold Aqua-Chem to Lyonnaise American Holding, Inc., in 1981 under the terms of a stock sale agreement. The 1981 agreement, and a subsequent 1983 settlement agreement, outlined the parties’ rights and obligations concerning past and future claims and lawsuits involving Aqua-Chem. Cleaver-Brooks, a division of Aqua-Chem, manufactured boilers, some of which contained asbestos gaskets. Aqua-Chem was first named as a defendant in asbestos lawsuits in or around 1985 and currently has approximately 15,000 active claims pending against it.\n\nThe parties agreed in 2004 to stay the Georgia Case pending the outcome of insurance coverage litigation filed by certain Aqua-Chem insurers on March 26, 2004. In the coverage action, five plaintiff insurance companies filed suit (Century Indemnity Company, et al. v. Aqua-Chem, Inc., The Coca-Cola Company, et al., Case No. 04CV002852) in the Circuit Court, Civil Division of Milwaukee County, Wisconsin, against the Company, Aqua-Chem and 16 insurance companies. Several of the policies that were the subject of the coverage action had been issued to the Company during the period (1970 to 1981) when the Company owned Aqua-Chem. The complaint sought a determination of the respective rights and obligations under the insurance policies issued with regard to asbestos-related claims against Aqua-Chem. The action also sought a monetary judgment reimbursing any amounts paid by the plaintiffs in excess of their obligations. Two of the insurers, one with a\n\n28","pages":[{"line_numbers":[],"markdown":"The following table summarizes our principal production facilities, distribution and storage facilities, and retail stores by operating segment and Corporate as of December 31, 2024:\n\nPrincipal Concentrate and/or\n\nSyrup Plants\n\nPrincipal Beverage\n\nManufacturing/Bottling Plants\n\nPrincipal Distribution and\n\nStorage Facilities Principal Retail Stores\n\nOwned Leased Owned Leased Owned Leased Owned Leased\n\nEurope, Middle East & Africa 5 — 2 — 7 27 — 13\n\nLatin America 5 — — — 2 5 — —\n\nNorth America 10 — 6 3 — 29 — 5\n\nAsia Pacific 6 1 3 — 3 4 — —\n\nGlobal Ventures 1 — 2 — — 8 — 1,508\n\nBottling Investments — — 61 4 51 79 — —\n\nCorporate 3 — — — — 5 — —\n\nTotal 30 1 74 7 63 157 — 1,526\n\nManagement believes that our Company’s facilities used for the production of our products are suitable and adequate, that they are being appropriately utilized in line with past experience, and that they have sufficient production capacity for their present intended purposes. The extent of utilization of our production facilities varies based upon seasonal demand for our products. However, management believes that, with the exception of certain dairy products that require specialized equipment, additional production can be achieved at the existing facilities by adding personnel and capital equipment or, at some facilities, by adding shifts of personnel or expanding the facilities. The Company is in the process of increasing our dairy production capacity. We continuously review our anticipated requirements for facilities and, on the basis of that review, may from time to time acquire or lease additional facilities and/or dispose of existing facilities.\n\n**ITEM 3. LEGAL PROCEEDINGS**\n\nThe Company is involved in various legal proceedings, including the proceedings specifically discussed below. Management believes that, except as disclosed in “U.S. Federal Income Tax Dispute” below, the total liabilities of the Company that may arise as a result of currently pending legal proceedings will not have a material adverse effect on the Company taken as a whole.\n\n_Aqua-Chem Litigation_\n\nOn December 20, 2002, the Company filed a lawsuit (The Coca-Cola Company v. Aqua-Chem, Inc., Civil Action No. 2002CV631-50) in the Superior Court of Fulton County, Georgia (“Georgia Case”), seeking a declaratory judgment that the Company has no obligation to its former subsidiary, Aqua-Chem, Inc., now known as Cleaver-Brooks, Inc. (“Aqua-Chem”), for any past, present or future liabilities or expenses in connection with any claims or lawsuits against Aqua-Chem. Subsequent to the Company’s filing but on the same day, Aqua-Chem filed a lawsuit (Aqua-Chem, Inc. v. The Coca-Cola Company, Civil Action No. 02CV012179) in the Circuit Court, Civil Division of Milwaukee County, Wisconsin (“Wisconsin Case”). In the Wisconsin Case, Aqua-Chem sought a declaratory judgment that the Company is responsible for all liabilities and expenses not covered by insurance in connection with certain of Aqua-Chem’s general and product liability claims arising from occurrences prior to the Company’s sale of Aqua-Chem in 1981, and a judgment for breach of contract in an amount exceeding $9 million for costs incurred by Aqua-Chem to date in connection with such claims. The Wisconsin Case initially was stayed, pending final resolution of the Georgia Case, and later was voluntarily dismissed without prejudice by Aqua-Chem.\n\nThe Company owned Aqua-Chem from 1970 to 1981. During that time, the Company purchased over $400 million of insurance coverage, which also insures Aqua-Chem for some of its prior and future costs for certain product liability and other claims. The Company sold Aqua-Chem to Lyonnaise American Holding, Inc., in 1981 under the terms of a stock sale agreement. The 1981 agreement, and a subsequent 1983 settlement agreement, outlined the parties’ rights and obligations concerning past and future claims and lawsuits involving Aqua-Chem. Cleaver-Brooks, a division of Aqua-Chem, manufactured boilers, some of which contained asbestos gaskets. Aqua-Chem was first named as a defendant in asbestos lawsuits in or around 1985 and currently has approximately 15,000 active claims pending against it.\n\nThe parties agreed in 2004 to stay the Georgia Case pending the outcome of insurance coverage litigation filed by certain Aqua-Chem insurers on March 26, 2004. In the coverage action, five plaintiff insurance companies filed suit (Century Indemnity Company, et al. v. Aqua-Chem, Inc., The Coca-Cola Company, et al., Case No. 04CV002852) in the Circuit Court, Civil Division of Milwaukee County, Wisconsin, against the Company, Aqua-Chem and 16 insurance companies. Several of the policies that were the subject of the coverage action had been issued to the Company during the period (1970 to 1981) when the Company owned Aqua-Chem. The complaint sought a determination of the respective rights and obligations under the insurance policies issued with regard to asbestos-related claims against Aqua-Chem. The action also sought a monetary judgment reimbursing any amounts paid by the plaintiffs in excess of their obligations. Two of the insurers, one with a\n\n28","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"The following table summarizes our principal production facilities, distribution and storage facilities, and retail stores by operating segment and Corporate as of December 31, 2024:\n\nPrincipal Concentrate and/or\n\nSyrup Plants\n\nPrincipal Beverage\n\nManufacturing/Bottling Plants\n\nPrincipal Distribution and\n\nStorage Facilities Principal Retail Stores\n\nOwned Leased Owned Leased Owned Leased Owned Leased\n\nEurope, Middle East & Africa 5 — 2 — 7 27 — 13\n\nLatin America 5 — — — 2 5 — —\n\nNorth America 10 — 6 3 — 29 — 5\n\nAsia Pacific 6 1 3 — 3 4 — —\n\nGlobal Ventures 1 — 2 — — 8 — 1,508\n\nBottling Investments — — 61 4 51 79 — —\n\nCorporate 3 — — — — 5 — —\n\nTotal 30 1 74 7 63 157 — 1,526\n\nManagement believes that our Company’s facilities used for the production of our products are suitable and adequate, that they are being appropriately utilized in line with past experience, and that they have sufficient production capacity for their present intended purposes. The extent of utilization of our production facilities varies based upon seasonal demand for our products. However, management believes that, with the exception of certain dairy products that require specialized equipment, additional production can be achieved at the existing facilities by adding personnel and capital equipment or, at some facilities, by adding shifts of personnel or expanding the facilities. The Company is in the process of increasing our dairy production capacity. We continuously review our anticipated requirements for facilities and, on the basis of that review, may from time to time acquire or lease additional facilities and/or dispose of existing facilities.\n\n**ITEM 3. LEGAL PROCEEDINGS**\n\nThe Company is involved in various legal proceedings, including the proceedings specifically discussed below. Management believes that, except as disclosed in “U.S. Federal Income Tax Dispute” below, the total liabilities of the Company that may arise as a result of currently pending legal proceedings will not have a material adverse effect on the Company taken as a whole.\n\n_Aqua-Chem Litigation_\n\nOn December 20, 2002, the Company filed a lawsuit (The Coca-Cola Company v. Aqua-Chem, Inc., Civil Action No. 2002CV631-50) in the Superior Court of Fulton County, Georgia (“Georgia Case”), seeking a declaratory judgment that the Company has no obligation to its former subsidiary, Aqua-Chem, Inc., now known as Cleaver-Brooks, Inc. (“Aqua-Chem”), for any past, present or future liabilities or expenses in connection with any claims or lawsuits against Aqua-Chem. Subsequent to the Company’s filing but on the same day, Aqua-Chem filed a lawsuit (Aqua-Chem, Inc. v. The Coca-Cola Company, Civil Action No. 02CV012179) in the Circuit Court, Civil Division of Milwaukee County, Wisconsin (“Wisconsin Case”). In the Wisconsin Case, Aqua-Chem sought a declaratory judgment that the Company is responsible for all liabilities and expenses not covered by insurance in connection with certain of Aqua-Chem’s general and product liability claims arising from occurrences prior to the Company’s sale of Aqua-Chem in 1981, and a judgment for breach of contract in an amount exceeding $9 million for costs incurred by Aqua-Chem to date in connection with such claims. The Wisconsin Case initially was stayed, pending final resolution of the Georgia Case, and later was voluntarily dismissed without prejudice by Aqua-Chem.\n\nThe Company owned Aqua-Chem from 1970 to 1981. During that time, the Company purchased over $400 million of insurance coverage, which also insures Aqua-Chem for some of its prior and future costs for certain product liability and other claims. The Company sold Aqua-Chem to Lyonnaise American Holding, Inc., in 1981 under the terms of a stock sale agreement. The 1981 agreement, and a subsequent 1983 settlement agreement, outlined the parties’ rights and obligations concerning past and future claims and lawsuits involving Aqua-Chem. Cleaver-Brooks, a division of Aqua-Chem, manufactured boilers, some of which contained asbestos gaskets. Aqua-Chem was first named as a defendant in asbestos lawsuits in or around 1985 and currently has approximately 15,000 active claims pending against it.\n\nThe parties agreed in 2004 to stay the Georgia Case pending the outcome of insurance coverage litigation filed by certain Aqua-Chem insurers on March 26, 2004. In the coverage action, five plaintiff insurance companies filed suit (Century Indemnity Company, et al. v. Aqua-Chem, Inc., The Coca-Cola Company, et al., Case No. 04CV002852) in the Circuit Court, Civil Division of Milwaukee County, Wisconsin, against the Company, Aqua-Chem and 16 insurance companies. Several of the policies that were the subject of the coverage action had been issued to the Company during the period (1970 to 1981) when the Company owned Aqua-Chem. The complaint sought a determination of the respective rights and obligations under the insurance policies issued with regard to asbestos-related claims against Aqua-Chem. The action also sought a monetary judgment reimbursing any amounts paid by the plaintiffs in excess of their obligations. Two of the insurers, one with a\n\n28","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page30.pdf"]},"response":{"errors":[],"extract_id":"extract_a6ae13b6cd5f09a88b7dfc7b331be4ec","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["The following table summarizes our principal production facilities, distribution and storage facilities, and retail stores by operating segment and Corporate as of December 31, 2024:\n\nPrincipal Concentrate and/or\n\nSyrup Plants\n\nPrincipal Beverage\n\nManufacturing/Bottling Plants\n\nPrincipal Distribution and\n\nStorage Facilities Principal Retail Stores\n\nOwned Leased Owned Leased Owned Leased Owned Leased\n\nEurope, Middle East & Africa 5 — 2 — 7 27 — 13\n\nLatin America 5 — — — 2 5 — —\n\nNorth America 10 — 6 3 — 29 — 5\n\nAsia Pacific 6 1 3 — 3 4 — —\n\nGlobal Ventures 1 — 2 — — 8 — 1,508\n\nBottling Investments — — 61 4 51 79 — —\n\nCorporate 3 — — — — 5 — —\n\nTotal 30 1 74 7 63 157 — 1,526\n\nManagement believes that our Company’s facilities used for the production of our products are suitable and adequate, that they are being appropriately utilized in line with past experience, and that they have sufficient production capacity for their present intended purposes. The extent of utilization of our production facilities varies based upon seasonal demand for our products. However, management believes that, with the exception of certain dairy products that require specialized equipment, additional production can be achieved at the existing facilities by adding personnel and capital equipment or, at some facilities, by adding shifts of personnel or expanding the facilities. The Company is in the process of increasing our dairy production capacity. We continuously review our anticipated requirements for facilities and, on the basis of that review, may from time to time acquire or lease additional facilities and/or dispose of existing facilities.\n\n**ITEM 3. LEGAL PROCEEDINGS**\n\nThe Company is involved in various legal proceedings, including the proceedings specifically discussed below. Management believes that, except as disclosed in “U.S. Federal Income Tax Dispute” below, the total liabilities of the Company that may arise as a result of currently pending legal proceedings will not have a material adverse effect on the Company taken as a whole.\n\n_Aqua-Chem Litigation_\n\nOn December 20, 2002, the Company filed a lawsuit (The Coca-Cola Company v. Aqua-Chem, Inc., Civil Action No. 2002CV631-50) in the Superior Court of Fulton County, Georgia (“Georgia Case”), seeking a declaratory judgment that the Company has no obligation to its former subsidiary, Aqua-Chem, Inc., now known as Cleaver-Brooks, Inc. (“Aqua-Chem”), for any past, present or future liabilities or expenses in connection with any claims or lawsuits against Aqua-Chem. Subsequent to the Company’s filing but on the same day, Aqua-Chem filed a lawsuit (Aqua-Chem, Inc. v. The Coca-Cola Company, Civil Action No. 02CV012179) in the Circuit Court, Civil Division of Milwaukee County, Wisconsin (“Wisconsin Case”). In the Wisconsin Case, Aqua-Chem sought a declaratory judgment that the Company is responsible for all liabilities and expenses not covered by insurance in connection with certain of Aqua-Chem’s general and product liability claims arising from occurrences prior to the Company’s sale of Aqua-Chem in 1981, and a judgment for breach of contract in an amount exceeding $9 million for costs incurred by Aqua-Chem to date in connection with such claims. The Wisconsin Case initially was stayed, pending final resolution of the Georgia Case, and later was voluntarily dismissed without prejudice by Aqua-Chem.\n\nThe Company owned Aqua-Chem from 1970 to 1981. During that time, the Company purchased over $400 million of insurance coverage, which also insures Aqua-Chem for some of its prior and future costs for certain product liability and other claims. The Company sold Aqua-Chem to Lyonnaise American Holding, Inc., in 1981 under the terms of a stock sale agreement. The 1981 agreement, and a subsequent 1983 settlement agreement, outlined the parties’ rights and obligations concerning past and future claims and lawsuits involving Aqua-Chem. Cleaver-Brooks, a division of Aqua-Chem, manufactured boilers, some of which contained asbestos gaskets. Aqua-Chem was first named as a defendant in asbestos lawsuits in or around 1985 and currently has approximately 15,000 active claims pending against it.\n\nThe parties agreed in 2004 to stay the Georgia Case pending the outcome of insurance coverage litigation filed by certain Aqua-Chem insurers on March 26, 2004. In the coverage action, five plaintiff insurance companies filed suit (Century Indemnity Company, et al. v. Aqua-Chem, Inc., The Coca-Cola Company, et al., Case No. 04CV002852) in the Circuit Court, Civil Division of Milwaukee County, Wisconsin, against the Company, Aqua-Chem and 16 insurance companies. Several of the policies that were the subject of the coverage action had been issued to the Company during the period (1970 to 1981) when the Company owned Aqua-Chem. The complaint sought a determination of the respective rights and obligations under the insurance policies issued with regard to asbestos-related claims against Aqua-Chem. The action also sought a monetary judgment reimbursing any amounts paid by the plaintiffs in excess of their obligations. Two of the insurers, one with a\n\n28"],"full_content":"The following table summarizes our principal production facilities, distribution and storage facilities, and retail stores by operating segment and Corporate as of December 31, 2024:\n\nPrincipal Concentrate and/or\n\nSyrup Plants\n\nPrincipal Beverage\n\nManufacturing/Bottling Plants\n\nPrincipal Distribution and\n\nStorage Facilities Principal Retail Stores\n\nOwned Leased Owned Leased Owned Leased Owned Leased\n\nEurope, Middle East & Africa 5 — 2 — 7 27 — 13\n\nLatin America 5 — — — 2 5 — —\n\nNorth America 10 — 6 3 — 29 — 5\n\nAsia Pacific 6 1 3 — 3 4 — —\n\nGlobal Ventures 1 — 2 — — 8 — 1,508\n\nBottling Investments — — 61 4 51 79 — —\n\nCorporate 3 — — — — 5 — —\n\nTotal 30 1 74 7 63 157 — 1,526\n\nManagement believes that our Company’s facilities used for the production of our products are suitable and adequate, that they are being appropriately utilized in line with past experience, and that they have sufficient production capacity for their present intended purposes. The extent of utilization of our production facilities varies based upon seasonal demand for our products. However, management believes that, with the exception of certain dairy products that require specialized equipment, additional production can be achieved at the existing facilities by adding personnel and capital equipment or, at some facilities, by adding shifts of personnel or expanding the facilities. The Company is in the process of increasing our dairy production capacity. We continuously review our anticipated requirements for facilities and, on the basis of that review, may from time to time acquire or lease additional facilities and/or dispose of existing facilities.\n\n**ITEM 3. LEGAL PROCEEDINGS**\n\nThe Company is involved in various legal proceedings, including the proceedings specifically discussed below. Management believes that, except as disclosed in “U.S. Federal Income Tax Dispute” below, the total liabilities of the Company that may arise as a result of currently pending legal proceedings will not have a material adverse effect on the Company taken as a whole.\n\n_Aqua-Chem Litigation_\n\nOn December 20, 2002, the Company filed a lawsuit (The Coca-Cola Company v. Aqua-Chem, Inc., Civil Action No. 2002CV631-50) in the Superior Court of Fulton County, Georgia (“Georgia Case”), seeking a declaratory judgment that the Company has no obligation to its former subsidiary, Aqua-Chem, Inc., now known as Cleaver-Brooks, Inc. (“Aqua-Chem”), for any past, present or future liabilities or expenses in connection with any claims or lawsuits against Aqua-Chem. Subsequent to the Company’s filing but on the same day, Aqua-Chem filed a lawsuit (Aqua-Chem, Inc. v. The Coca-Cola Company, Civil Action No. 02CV012179) in the Circuit Court, Civil Division of Milwaukee County, Wisconsin (“Wisconsin Case”). In the Wisconsin Case, Aqua-Chem sought a declaratory judgment that the Company is responsible for all liabilities and expenses not covered by insurance in connection with certain of Aqua-Chem’s general and product liability claims arising from occurrences prior to the Company’s sale of Aqua-Chem in 1981, and a judgment for breach of contract in an amount exceeding $9 million for costs incurred by Aqua-Chem to date in connection with such claims. The Wisconsin Case initially was stayed, pending final resolution of the Georgia Case, and later was voluntarily dismissed without prejudice by Aqua-Chem.\n\nThe Company owned Aqua-Chem from 1970 to 1981. During that time, the Company purchased over $400 million of insurance coverage, which also insures Aqua-Chem for some of its prior and future costs for certain product liability and other claims. The Company sold Aqua-Chem to Lyonnaise American Holding, Inc., in 1981 under the terms of a stock sale agreement. The 1981 agreement, and a subsequent 1983 settlement agreement, outlined the parties’ rights and obligations concerning past and future claims and lawsuits involving Aqua-Chem. Cleaver-Brooks, a division of Aqua-Chem, manufactured boilers, some of which contained asbestos gaskets. Aqua-Chem was first named as a defendant in asbestos lawsuits in or around 1985 and currently has approximately 15,000 active claims pending against it.\n\nThe parties agreed in 2004 to stay the Georgia Case pending the outcome of insurance coverage litigation filed by certain Aqua-Chem insurers on March 26, 2004. In the coverage action, five plaintiff insurance companies filed suit (Century Indemnity Company, et al. v. Aqua-Chem, Inc., The Coca-Cola Company, et al., Case No. 04CV002852) in the Circuit Court, Civil Division of Milwaukee County, Wisconsin, against the Company, Aqua-Chem and 16 insurance companies. Several of the policies that were the subject of the coverage action had been issued to the Company during the period (1970 to 1981) when the Company owned Aqua-Chem. The complaint sought a determination of the respective rights and obligations under the insurance policies issued with regard to asbestos-related claims against Aqua-Chem. The action also sought a monetary judgment reimbursing any amounts paid by the plaintiffs in excess of their obligations. Two of the insurers, one with a\n\n28","publish_date":null,"title":"The following table summarizes our principal production facilities, distribution and storage facilities, and retail stores by operating segment and Corporate","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page30.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page30.pdf"},"request":{"example_id":"table/Coca Cola 10-k_page30","product_type":"parse","source_file_path":"Coca Cola 10-k_page30.pdf"},"started_at":"2026-11-04T19:47:06.539644"} +{"completed_at":"2026-11-04T19:31:23.311918","latency_in_ms":5394,"output":{"example_id":"table/Coca Cola 10-k_page39","grounded_pages":[],"layout_pages":[],"markdown":"The following table sets forth the percentage of total net operating revenues attributable to concentrate operations and finished product operations:\n\nYear Ended December 31, **2024** 2023\n\nConcentrate operations **59** **%** 58 %\n\nFinished product operations **41** 42\n\nTotal **100** **%** 100 %\n\nThe following table sets forth the percentage of total worldwide unit case volume attributable to concentrate operations and finished product operations:\n\nYear Ended December 31, **2024** 2023\n\nConcentrate operations **85** **%** 83 %\n\nFinished product operations **15** 17\n\nTotal **100** **%** 100 %\n\nWe operate in the highly competitive commercial beverage industry. We face strong competition from numerous other general and specialty beverage companies. We, along with other beverage companies, are affected by a number of factors, including, but not limited to, the cost to manufacture and distribute products, consumer spending, economic conditions, availability and quality of water, consumer preferences, inflation, geopolitical conditions (including international conflicts), local and national laws and regulations, foreign currency exchange rate fluctuations, fuel prices, weather patterns and health crises.\n\nDespite the dynamic world in which we are currently operating, we believe we are well positioned to create value for our Company and our stakeholders. In an effort to support our future growth, we are continuing to invest in our portfolio of brands, our strategic capabilities and our people. We are focused on the following strategic priorities: shaping a portfolio of loved brands; transforming our marketing and innovation agenda; optimizing the Coca-Cola ecosystem; building talent and capabilities; and enhancing our license to operate.\n\n**_Challenges and Risks_**\n\nBeing a global enterprise provides unique opportunities for our Company. Challenges and risks accompany those opportunities. Our management has identified certain challenges and risks that demand the attention of our Company and the commercial beverage industry. Of these, six key strategic business challenges and risks are discussed below.\n\n_Obesity_\n\nObesity continues to impact individuals, communities and countries worldwide. There is concern among consumers, public health professionals and governments about the health problems associated with obesity, which may present a challenge to our industry. We understand that obesity is a complex public health challenge, and we are committed to being a part of the solution.\n\nWe recognize the uniqueness of consumers’ lifestyles and dietary choices. Therefore, we continue to do the following:\n\n• offer an expanded portfolio of beverage choices, including reduced-, low- and no-calorie beverage options;\n\n• provide transparent nutrition information, featuring calories on the front of most of our packages;\n\n• provide our beverages in a range of packaging sizes, including small sizes to enable portion control; and\n\n• market responsibly, including no advertising targeted to children under 13.\n\nThe heritage of our Company is to lead, and innovation is critical for leadership. As such, we are resolute in continuing to innovate and are committed to partnering with suppliers to invest in research and development of new noncaloric sweeteners and flavors that help us create the best tasting beverages, including options with low or no calories. We want to be a helpful and credible partner in the fight against obesity.\n\n_Evolving Consumer Product Preferences_\n\nWe are impacted by shifting consumer demographics and needs, on-the-go lifestyles and consumers who are empowered with more information than ever. As a consequence of these changes, many consumers want more beverage choices, personalization, a focus on sustainability, and transparency related to our products and packaging. We are committed to meeting changing consumer needs and to generating growth through our evolving portfolio of beverage brands and products (including numerous low- and no- calorie products); selectively expanding into other profitable categories of the commercial beverage industry; investing in innovative and sustainable packaging; and including easy-to-access information about our beverages on our website.\n\n37","pages":[{"line_numbers":[],"markdown":"The following table sets forth the percentage of total net operating revenues attributable to concentrate operations and finished product operations:\n\nYear Ended December 31, **2024** 2023\n\nConcentrate operations **59** **%** 58 %\n\nFinished product operations **41** 42\n\nTotal **100** **%** 100 %\n\nThe following table sets forth the percentage of total worldwide unit case volume attributable to concentrate operations and finished product operations:\n\nYear Ended December 31, **2024** 2023\n\nConcentrate operations **85** **%** 83 %\n\nFinished product operations **15** 17\n\nTotal **100** **%** 100 %\n\nWe operate in the highly competitive commercial beverage industry. We face strong competition from numerous other general and specialty beverage companies. We, along with other beverage companies, are affected by a number of factors, including, but not limited to, the cost to manufacture and distribute products, consumer spending, economic conditions, availability and quality of water, consumer preferences, inflation, geopolitical conditions (including international conflicts), local and national laws and regulations, foreign currency exchange rate fluctuations, fuel prices, weather patterns and health crises.\n\nDespite the dynamic world in which we are currently operating, we believe we are well positioned to create value for our Company and our stakeholders. In an effort to support our future growth, we are continuing to invest in our portfolio of brands, our strategic capabilities and our people. We are focused on the following strategic priorities: shaping a portfolio of loved brands; transforming our marketing and innovation agenda; optimizing the Coca-Cola ecosystem; building talent and capabilities; and enhancing our license to operate.\n\n**_Challenges and Risks_**\n\nBeing a global enterprise provides unique opportunities for our Company. Challenges and risks accompany those opportunities. Our management has identified certain challenges and risks that demand the attention of our Company and the commercial beverage industry. Of these, six key strategic business challenges and risks are discussed below.\n\n_Obesity_\n\nObesity continues to impact individuals, communities and countries worldwide. There is concern among consumers, public health professionals and governments about the health problems associated with obesity, which may present a challenge to our industry. We understand that obesity is a complex public health challenge, and we are committed to being a part of the solution.\n\nWe recognize the uniqueness of consumers’ lifestyles and dietary choices. Therefore, we continue to do the following:\n\n• offer an expanded portfolio of beverage choices, including reduced-, low- and no-calorie beverage options;\n\n• provide transparent nutrition information, featuring calories on the front of most of our packages;\n\n• provide our beverages in a range of packaging sizes, including small sizes to enable portion control; and\n\n• market responsibly, including no advertising targeted to children under 13.\n\nThe heritage of our Company is to lead, and innovation is critical for leadership. As such, we are resolute in continuing to innovate and are committed to partnering with suppliers to invest in research and development of new noncaloric sweeteners and flavors that help us create the best tasting beverages, including options with low or no calories. We want to be a helpful and credible partner in the fight against obesity.\n\n_Evolving Consumer Product Preferences_\n\nWe are impacted by shifting consumer demographics and needs, on-the-go lifestyles and consumers who are empowered with more information than ever. As a consequence of these changes, many consumers want more beverage choices, personalization, a focus on sustainability, and transparency related to our products and packaging. We are committed to meeting changing consumer needs and to generating growth through our evolving portfolio of beverage brands and products (including numerous low- and no- calorie products); selectively expanding into other profitable categories of the commercial beverage industry; investing in innovative and sustainable packaging; and including easy-to-access information about our beverages on our website.\n\n37","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"The following table sets forth the percentage of total net operating revenues attributable to concentrate operations and finished product operations:\n\nYear Ended December 31, **2024** 2023\n\nConcentrate operations **59** **%** 58 %\n\nFinished product operations **41** 42\n\nTotal **100** **%** 100 %\n\nThe following table sets forth the percentage of total worldwide unit case volume attributable to concentrate operations and finished product operations:\n\nYear Ended December 31, **2024** 2023\n\nConcentrate operations **85** **%** 83 %\n\nFinished product operations **15** 17\n\nTotal **100** **%** 100 %\n\nWe operate in the highly competitive commercial beverage industry. We face strong competition from numerous other general and specialty beverage companies. We, along with other beverage companies, are affected by a number of factors, including, but not limited to, the cost to manufacture and distribute products, consumer spending, economic conditions, availability and quality of water, consumer preferences, inflation, geopolitical conditions (including international conflicts), local and national laws and regulations, foreign currency exchange rate fluctuations, fuel prices, weather patterns and health crises.\n\nDespite the dynamic world in which we are currently operating, we believe we are well positioned to create value for our Company and our stakeholders. In an effort to support our future growth, we are continuing to invest in our portfolio of brands, our strategic capabilities and our people. We are focused on the following strategic priorities: shaping a portfolio of loved brands; transforming our marketing and innovation agenda; optimizing the Coca-Cola ecosystem; building talent and capabilities; and enhancing our license to operate.\n\n**_Challenges and Risks_**\n\nBeing a global enterprise provides unique opportunities for our Company. Challenges and risks accompany those opportunities. Our management has identified certain challenges and risks that demand the attention of our Company and the commercial beverage industry. Of these, six key strategic business challenges and risks are discussed below.\n\n_Obesity_\n\nObesity continues to impact individuals, communities and countries worldwide. There is concern among consumers, public health professionals and governments about the health problems associated with obesity, which may present a challenge to our industry. We understand that obesity is a complex public health challenge, and we are committed to being a part of the solution.\n\nWe recognize the uniqueness of consumers’ lifestyles and dietary choices. Therefore, we continue to do the following:\n\n• offer an expanded portfolio of beverage choices, including reduced-, low- and no-calorie beverage options;\n\n• provide transparent nutrition information, featuring calories on the front of most of our packages;\n\n• provide our beverages in a range of packaging sizes, including small sizes to enable portion control; and\n\n• market responsibly, including no advertising targeted to children under 13.\n\nThe heritage of our Company is to lead, and innovation is critical for leadership. As such, we are resolute in continuing to innovate and are committed to partnering with suppliers to invest in research and development of new noncaloric sweeteners and flavors that help us create the best tasting beverages, including options with low or no calories. We want to be a helpful and credible partner in the fight against obesity.\n\n_Evolving Consumer Product Preferences_\n\nWe are impacted by shifting consumer demographics and needs, on-the-go lifestyles and consumers who are empowered with more information than ever. As a consequence of these changes, many consumers want more beverage choices, personalization, a focus on sustainability, and transparency related to our products and packaging. We are committed to meeting changing consumer needs and to generating growth through our evolving portfolio of beverage brands and products (including numerous low- and no- calorie products); selectively expanding into other profitable categories of the commercial beverage industry; investing in innovative and sustainable packaging; and including easy-to-access information about our beverages on our website.\n\n37","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page39.pdf"]},"response":{"errors":[],"extract_id":"extract_a998674b2f175e50a7206cb7867c7b2c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["The following table sets forth the percentage of total net operating revenues attributable to concentrate operations and finished product operations:\n\nYear Ended December 31, **2024** 2023\n\nConcentrate operations **59** **%** 58 %\n\nFinished product operations **41** 42\n\nTotal **100** **%** 100 %\n\nThe following table sets forth the percentage of total worldwide unit case volume attributable to concentrate operations and finished product operations:\n\nYear Ended December 31, **2024** 2023\n\nConcentrate operations **85** **%** 83 %\n\nFinished product operations **15** 17\n\nTotal **100** **%** 100 %\n\nWe operate in the highly competitive commercial beverage industry. We face strong competition from numerous other general and specialty beverage companies. We, along with other beverage companies, are affected by a number of factors, including, but not limited to, the cost to manufacture and distribute products, consumer spending, economic conditions, availability and quality of water, consumer preferences, inflation, geopolitical conditions (including international conflicts), local and national laws and regulations, foreign currency exchange rate fluctuations, fuel prices, weather patterns and health crises.\n\nDespite the dynamic world in which we are currently operating, we believe we are well positioned to create value for our Company and our stakeholders. In an effort to support our future growth, we are continuing to invest in our portfolio of brands, our strategic capabilities and our people. We are focused on the following strategic priorities: shaping a portfolio of loved brands; transforming our marketing and innovation agenda; optimizing the Coca-Cola ecosystem; building talent and capabilities; and enhancing our license to operate.\n\n**_Challenges and Risks_**\n\nBeing a global enterprise provides unique opportunities for our Company. Challenges and risks accompany those opportunities. Our management has identified certain challenges and risks that demand the attention of our Company and the commercial beverage industry. Of these, six key strategic business challenges and risks are discussed below.\n\n_Obesity_\n\nObesity continues to impact individuals, communities and countries worldwide. There is concern among consumers, public health professionals and governments about the health problems associated with obesity, which may present a challenge to our industry. We understand that obesity is a complex public health challenge, and we are committed to being a part of the solution.\n\nWe recognize the uniqueness of consumers’ lifestyles and dietary choices. Therefore, we continue to do the following:\n\n• offer an expanded portfolio of beverage choices, including reduced-, low- and no-calorie beverage options;\n\n• provide transparent nutrition information, featuring calories on the front of most of our packages;\n\n• provide our beverages in a range of packaging sizes, including small sizes to enable portion control; and\n\n• market responsibly, including no advertising targeted to children under 13.\n\nThe heritage of our Company is to lead, and innovation is critical for leadership. As such, we are resolute in continuing to innovate and are committed to partnering with suppliers to invest in research and development of new noncaloric sweeteners and flavors that help us create the best tasting beverages, including options with low or no calories. We want to be a helpful and credible partner in the fight against obesity.\n\n_Evolving Consumer Product Preferences_\n\nWe are impacted by shifting consumer demographics and needs, on-the-go lifestyles and consumers who are empowered with more information than ever. As a consequence of these changes, many consumers want more beverage choices, personalization, a focus on sustainability, and transparency related to our products and packaging. We are committed to meeting changing consumer needs and to generating growth through our evolving portfolio of beverage brands and products (including numerous low- and no- calorie products); selectively expanding into other profitable categories of the commercial beverage industry; investing in innovative and sustainable packaging; and including easy-to-access information about our beverages on our website.\n\n37"],"full_content":"The following table sets forth the percentage of total net operating revenues attributable to concentrate operations and finished product operations:\n\nYear Ended December 31, **2024** 2023\n\nConcentrate operations **59** **%** 58 %\n\nFinished product operations **41** 42\n\nTotal **100** **%** 100 %\n\nThe following table sets forth the percentage of total worldwide unit case volume attributable to concentrate operations and finished product operations:\n\nYear Ended December 31, **2024** 2023\n\nConcentrate operations **85** **%** 83 %\n\nFinished product operations **15** 17\n\nTotal **100** **%** 100 %\n\nWe operate in the highly competitive commercial beverage industry. We face strong competition from numerous other general and specialty beverage companies. We, along with other beverage companies, are affected by a number of factors, including, but not limited to, the cost to manufacture and distribute products, consumer spending, economic conditions, availability and quality of water, consumer preferences, inflation, geopolitical conditions (including international conflicts), local and national laws and regulations, foreign currency exchange rate fluctuations, fuel prices, weather patterns and health crises.\n\nDespite the dynamic world in which we are currently operating, we believe we are well positioned to create value for our Company and our stakeholders. In an effort to support our future growth, we are continuing to invest in our portfolio of brands, our strategic capabilities and our people. We are focused on the following strategic priorities: shaping a portfolio of loved brands; transforming our marketing and innovation agenda; optimizing the Coca-Cola ecosystem; building talent and capabilities; and enhancing our license to operate.\n\n**_Challenges and Risks_**\n\nBeing a global enterprise provides unique opportunities for our Company. Challenges and risks accompany those opportunities. Our management has identified certain challenges and risks that demand the attention of our Company and the commercial beverage industry. Of these, six key strategic business challenges and risks are discussed below.\n\n_Obesity_\n\nObesity continues to impact individuals, communities and countries worldwide. There is concern among consumers, public health professionals and governments about the health problems associated with obesity, which may present a challenge to our industry. We understand that obesity is a complex public health challenge, and we are committed to being a part of the solution.\n\nWe recognize the uniqueness of consumers’ lifestyles and dietary choices. Therefore, we continue to do the following:\n\n• offer an expanded portfolio of beverage choices, including reduced-, low- and no-calorie beverage options;\n\n• provide transparent nutrition information, featuring calories on the front of most of our packages;\n\n• provide our beverages in a range of packaging sizes, including small sizes to enable portion control; and\n\n• market responsibly, including no advertising targeted to children under 13.\n\nThe heritage of our Company is to lead, and innovation is critical for leadership. As such, we are resolute in continuing to innovate and are committed to partnering with suppliers to invest in research and development of new noncaloric sweeteners and flavors that help us create the best tasting beverages, including options with low or no calories. We want to be a helpful and credible partner in the fight against obesity.\n\n_Evolving Consumer Product Preferences_\n\nWe are impacted by shifting consumer demographics and needs, on-the-go lifestyles and consumers who are empowered with more information than ever. As a consequence of these changes, many consumers want more beverage choices, personalization, a focus on sustainability, and transparency related to our products and packaging. We are committed to meeting changing consumer needs and to generating growth through our evolving portfolio of beverage brands and products (including numerous low- and no- calorie products); selectively expanding into other profitable categories of the commercial beverage industry; investing in innovative and sustainable packaging; and including easy-to-access information about our beverages on our website.\n\n37","publish_date":null,"title":"The following table sets forth the percentage of total net operating revenues attributable to concentrate operations and finished product operations:","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page39.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page39.pdf"},"request":{"example_id":"table/Coca Cola 10-k_page39","product_type":"parse","source_file_path":"Coca Cola 10-k_page39.pdf"},"started_at":"2026-11-04T19:31:17.917878"} +{"completed_at":"2026-11-04T19:47:11.401891","latency_in_ms":2877,"output":{"example_id":"table/Coca Cola 10-k_page48","grounded_pages":[],"layout_pages":[],"markdown":"**_Net Operating Revenues_**\n\nNet operating revenues were $47,061 million in 2024, compared to $45,754 million in 2023, an increase of $1,307 million, or 3%.\n\nThe following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis and for each of our operating segments:\n\nPercent Change 2024 versus 2023\n\nVolume\n\nPrice, Product & Geographic Mix\n\nForeign Currency Exchange\n\nRate Fluctuations\n\nAcquisitions &\n\nDivestitures **Total**\n\nConsolidated 2 % 11 % (5)% (4)% **3** **%**\n\nEurope, Middle East & Africa (1) 17 (16) — **1**\n\nLatin America 3 21 (14) — **11**\n\nNorth America 1 10 — — **11**\n\nAsia Pacific 2 2 (3) — **2**\n\nGlobal Ventures 4 (3) 2 — **2**\n\nBottling Investments 5 5 (2) (28) **(21)**\n\nNote: Certain rows may not add due to rounding. Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments and our Global Ventures operating segment (expressed in unit case equivalents) after considering the impact of acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating revenues attributable to the increase (decrease) in unit case volume after considering the impact of structural changes, if any. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural changes, if any. Refer to the heading “Beverage Volume” above. Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.\n\nRefer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.\n\n“Price, product and geographic mix” refers to the change in net operating revenues caused by factors such as pricing actions taken by the Company and, where applicable, our bottling partners; the mix of categories, products and packages sold; and the mix of channels and geographic territories where the sales occurred. Management believes that providing investors with price, product and geographic mix enhances their understanding about the combined impact that these items had on the Company’s net operating revenues. The impact of price, product and geographic mix is calculated by subtracting the change in net operating revenues resulting from volume increases or decreases, fluctuations in foreign currency exchange rates, and acquisitions and divestitures from the total change in net operating revenues. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nPrice, product and geographic mix had an 11% favorable impact on our consolidated net operating revenues. Price, product and geographic mix was impacted by a variety of factors and events, including, but not limited to, the following:\n\n• Europe, Middle East and Africa — favorable pricing initiatives, including inflationary pricing in Türkiye and Zimbabwe, and favorable geographic mix, partially offset\n\nby increased funding for promotional and marketing support;\n\n• Latin America — favorable pricing initiatives, including inflationary pricing in Argentina, partially offset by increased funding for promotional and marketing support;\n\n• North America — favorable pricing initiatives and package and category mix, partially offset by unfavorable channel mix and increased funding for promotional and\n\nmarketing support;\n\n• Asia Pacific — favorable pricing initiatives and favorable geographic mix, partially offset by unfavorable channel, category and package mix and increased funding for\n\npromotional and marketing support;\n\n• Global Ventures — unfavorable product mix, partially offset by favorable pricing initiatives; and\n\n• Bottling Investments — favorable pricing initiatives across most markets, partially offset by unfavorable geographic mix.\n\nThe favorable pricing initiatives for the year ended December 31, 2024 in all operating segments included both new and carryover pricing increases from the prior year.\n\n1 2\n\n1\n\n2\n\n46","pages":[{"line_numbers":[],"markdown":"**_Net Operating Revenues_**\n\nNet operating revenues were $47,061 million in 2024, compared to $45,754 million in 2023, an increase of $1,307 million, or 3%.\n\nThe following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis and for each of our operating segments:\n\nPercent Change 2024 versus 2023\n\nVolume\n\nPrice, Product & Geographic Mix\n\nForeign Currency Exchange\n\nRate Fluctuations\n\nAcquisitions &\n\nDivestitures **Total**\n\nConsolidated 2 % 11 % (5)% (4)% **3** **%**\n\nEurope, Middle East & Africa (1) 17 (16) — **1**\n\nLatin America 3 21 (14) — **11**\n\nNorth America 1 10 — — **11**\n\nAsia Pacific 2 2 (3) — **2**\n\nGlobal Ventures 4 (3) 2 — **2**\n\nBottling Investments 5 5 (2) (28) **(21)**\n\nNote: Certain rows may not add due to rounding. Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments and our Global Ventures operating segment (expressed in unit case equivalents) after considering the impact of acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating revenues attributable to the increase (decrease) in unit case volume after considering the impact of structural changes, if any. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural changes, if any. Refer to the heading “Beverage Volume” above. Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.\n\nRefer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.\n\n“Price, product and geographic mix” refers to the change in net operating revenues caused by factors such as pricing actions taken by the Company and, where applicable, our bottling partners; the mix of categories, products and packages sold; and the mix of channels and geographic territories where the sales occurred. Management believes that providing investors with price, product and geographic mix enhances their understanding about the combined impact that these items had on the Company’s net operating revenues. The impact of price, product and geographic mix is calculated by subtracting the change in net operating revenues resulting from volume increases or decreases, fluctuations in foreign currency exchange rates, and acquisitions and divestitures from the total change in net operating revenues. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nPrice, product and geographic mix had an 11% favorable impact on our consolidated net operating revenues. Price, product and geographic mix was impacted by a variety of factors and events, including, but not limited to, the following:\n\n• Europe, Middle East and Africa — favorable pricing initiatives, including inflationary pricing in Türkiye and Zimbabwe, and favorable geographic mix, partially offset\n\nby increased funding for promotional and marketing support;\n\n• Latin America — favorable pricing initiatives, including inflationary pricing in Argentina, partially offset by increased funding for promotional and marketing support;\n\n• North America — favorable pricing initiatives and package and category mix, partially offset by unfavorable channel mix and increased funding for promotional and\n\nmarketing support;\n\n• Asia Pacific — favorable pricing initiatives and favorable geographic mix, partially offset by unfavorable channel, category and package mix and increased funding for\n\npromotional and marketing support;\n\n• Global Ventures — unfavorable product mix, partially offset by favorable pricing initiatives; and\n\n• Bottling Investments — favorable pricing initiatives across most markets, partially offset by unfavorable geographic mix.\n\nThe favorable pricing initiatives for the year ended December 31, 2024 in all operating segments included both new and carryover pricing increases from the prior year.\n\n1 2\n\n1\n\n2\n\n46","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**_Net Operating Revenues_**\n\nNet operating revenues were $47,061 million in 2024, compared to $45,754 million in 2023, an increase of $1,307 million, or 3%.\n\nThe following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis and for each of our operating segments:\n\nPercent Change 2024 versus 2023\n\nVolume\n\nPrice, Product & Geographic Mix\n\nForeign Currency Exchange\n\nRate Fluctuations\n\nAcquisitions &\n\nDivestitures **Total**\n\nConsolidated 2 % 11 % (5)% (4)% **3** **%**\n\nEurope, Middle East & Africa (1) 17 (16) — **1**\n\nLatin America 3 21 (14) — **11**\n\nNorth America 1 10 — — **11**\n\nAsia Pacific 2 2 (3) — **2**\n\nGlobal Ventures 4 (3) 2 — **2**\n\nBottling Investments 5 5 (2) (28) **(21)**\n\nNote: Certain rows may not add due to rounding. Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments and our Global Ventures operating segment (expressed in unit case equivalents) after considering the impact of acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating revenues attributable to the increase (decrease) in unit case volume after considering the impact of structural changes, if any. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural changes, if any. Refer to the heading “Beverage Volume” above. Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.\n\nRefer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.\n\n“Price, product and geographic mix” refers to the change in net operating revenues caused by factors such as pricing actions taken by the Company and, where applicable, our bottling partners; the mix of categories, products and packages sold; and the mix of channels and geographic territories where the sales occurred. Management believes that providing investors with price, product and geographic mix enhances their understanding about the combined impact that these items had on the Company’s net operating revenues. The impact of price, product and geographic mix is calculated by subtracting the change in net operating revenues resulting from volume increases or decreases, fluctuations in foreign currency exchange rates, and acquisitions and divestitures from the total change in net operating revenues. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nPrice, product and geographic mix had an 11% favorable impact on our consolidated net operating revenues. Price, product and geographic mix was impacted by a variety of factors and events, including, but not limited to, the following:\n\n• Europe, Middle East and Africa — favorable pricing initiatives, including inflationary pricing in Türkiye and Zimbabwe, and favorable geographic mix, partially offset\n\nby increased funding for promotional and marketing support;\n\n• Latin America — favorable pricing initiatives, including inflationary pricing in Argentina, partially offset by increased funding for promotional and marketing support;\n\n• North America — favorable pricing initiatives and package and category mix, partially offset by unfavorable channel mix and increased funding for promotional and\n\nmarketing support;\n\n• Asia Pacific — favorable pricing initiatives and favorable geographic mix, partially offset by unfavorable channel, category and package mix and increased funding for\n\npromotional and marketing support;\n\n• Global Ventures — unfavorable product mix, partially offset by favorable pricing initiatives; and\n\n• Bottling Investments — favorable pricing initiatives across most markets, partially offset by unfavorable geographic mix.\n\nThe favorable pricing initiatives for the year ended December 31, 2024 in all operating segments included both new and carryover pricing increases from the prior year.\n\n1 2\n\n1\n\n2\n\n46","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page48.pdf"]},"response":{"errors":[],"extract_id":"extract_5a8521e02a76370aba371f3aff264807","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**_Net Operating Revenues_**\n\nNet operating revenues were $47,061 million in 2024, compared to $45,754 million in 2023, an increase of $1,307 million, or 3%.\n\nThe following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis and for each of our operating segments:\n\nPercent Change 2024 versus 2023\n\nVolume\n\nPrice, Product & Geographic Mix\n\nForeign Currency Exchange\n\nRate Fluctuations\n\nAcquisitions &\n\nDivestitures **Total**\n\nConsolidated 2 % 11 % (5)% (4)% **3** **%**\n\nEurope, Middle East & Africa (1) 17 (16) — **1**\n\nLatin America 3 21 (14) — **11**\n\nNorth America 1 10 — — **11**\n\nAsia Pacific 2 2 (3) — **2**\n\nGlobal Ventures 4 (3) 2 — **2**\n\nBottling Investments 5 5 (2) (28) **(21)**\n\nNote: Certain rows may not add due to rounding. Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments and our Global Ventures operating segment (expressed in unit case equivalents) after considering the impact of acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating revenues attributable to the increase (decrease) in unit case volume after considering the impact of structural changes, if any. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural changes, if any. Refer to the heading “Beverage Volume” above. Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.\n\nRefer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.\n\n“Price, product and geographic mix” refers to the change in net operating revenues caused by factors such as pricing actions taken by the Company and, where applicable, our bottling partners; the mix of categories, products and packages sold; and the mix of channels and geographic territories where the sales occurred. Management believes that providing investors with price, product and geographic mix enhances their understanding about the combined impact that these items had on the Company’s net operating revenues. The impact of price, product and geographic mix is calculated by subtracting the change in net operating revenues resulting from volume increases or decreases, fluctuations in foreign currency exchange rates, and acquisitions and divestitures from the total change in net operating revenues. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nPrice, product and geographic mix had an 11% favorable impact on our consolidated net operating revenues. Price, product and geographic mix was impacted by a variety of factors and events, including, but not limited to, the following:\n\n• Europe, Middle East and Africa — favorable pricing initiatives, including inflationary pricing in Türkiye and Zimbabwe, and favorable geographic mix, partially offset\n\nby increased funding for promotional and marketing support;\n\n• Latin America — favorable pricing initiatives, including inflationary pricing in Argentina, partially offset by increased funding for promotional and marketing support;\n\n• North America — favorable pricing initiatives and package and category mix, partially offset by unfavorable channel mix and increased funding for promotional and\n\nmarketing support;\n\n• Asia Pacific — favorable pricing initiatives and favorable geographic mix, partially offset by unfavorable channel, category and package mix and increased funding for\n\npromotional and marketing support;\n\n• Global Ventures — unfavorable product mix, partially offset by favorable pricing initiatives; and\n\n• Bottling Investments — favorable pricing initiatives across most markets, partially offset by unfavorable geographic mix.\n\nThe favorable pricing initiatives for the year ended December 31, 2024 in all operating segments included both new and carryover pricing increases from the prior year.\n\n1 2\n\n1\n\n2\n\n46"],"full_content":"**_Net Operating Revenues_**\n\nNet operating revenues were $47,061 million in 2024, compared to $45,754 million in 2023, an increase of $1,307 million, or 3%.\n\nThe following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis and for each of our operating segments:\n\nPercent Change 2024 versus 2023\n\nVolume\n\nPrice, Product & Geographic Mix\n\nForeign Currency Exchange\n\nRate Fluctuations\n\nAcquisitions &\n\nDivestitures **Total**\n\nConsolidated 2 % 11 % (5)% (4)% **3** **%**\n\nEurope, Middle East & Africa (1) 17 (16) — **1**\n\nLatin America 3 21 (14) — **11**\n\nNorth America 1 10 — — **11**\n\nAsia Pacific 2 2 (3) — **2**\n\nGlobal Ventures 4 (3) 2 — **2**\n\nBottling Investments 5 5 (2) (28) **(21)**\n\nNote: Certain rows may not add due to rounding. Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments and our Global Ventures operating segment (expressed in unit case equivalents) after considering the impact of acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating revenues attributable to the increase (decrease) in unit case volume after considering the impact of structural changes, if any. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural changes, if any. Refer to the heading “Beverage Volume” above. Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.\n\nRefer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.\n\n“Price, product and geographic mix” refers to the change in net operating revenues caused by factors such as pricing actions taken by the Company and, where applicable, our bottling partners; the mix of categories, products and packages sold; and the mix of channels and geographic territories where the sales occurred. Management believes that providing investors with price, product and geographic mix enhances their understanding about the combined impact that these items had on the Company’s net operating revenues. The impact of price, product and geographic mix is calculated by subtracting the change in net operating revenues resulting from volume increases or decreases, fluctuations in foreign currency exchange rates, and acquisitions and divestitures from the total change in net operating revenues. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nPrice, product and geographic mix had an 11% favorable impact on our consolidated net operating revenues. Price, product and geographic mix was impacted by a variety of factors and events, including, but not limited to, the following:\n\n• Europe, Middle East and Africa — favorable pricing initiatives, including inflationary pricing in Türkiye and Zimbabwe, and favorable geographic mix, partially offset\n\nby increased funding for promotional and marketing support;\n\n• Latin America — favorable pricing initiatives, including inflationary pricing in Argentina, partially offset by increased funding for promotional and marketing support;\n\n• North America — favorable pricing initiatives and package and category mix, partially offset by unfavorable channel mix and increased funding for promotional and\n\nmarketing support;\n\n• Asia Pacific — favorable pricing initiatives and favorable geographic mix, partially offset by unfavorable channel, category and package mix and increased funding for\n\npromotional and marketing support;\n\n• Global Ventures — unfavorable product mix, partially offset by favorable pricing initiatives; and\n\n• Bottling Investments — favorable pricing initiatives across most markets, partially offset by unfavorable geographic mix.\n\nThe favorable pricing initiatives for the year ended December 31, 2024 in all operating segments included both new and carryover pricing increases from the prior year.\n\n1 2\n\n1\n\n2\n\n46","publish_date":null,"title":"Net Operating Revenues Net operating revenues were $47,061 million in 2024, compared to $45,754 million in 2023, an increase of","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page48.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page48.pdf"},"request":{"example_id":"table/Coca Cola 10-k_page48","product_type":"parse","source_file_path":"Coca Cola 10-k_page48.pdf"},"started_at":"2026-11-04T19:47:08.524180"} +{"completed_at":"2026-11-04T19:47:12.035874","latency_in_ms":2672,"output":{"example_id":"table/Coca Cola 10-k_page49","grounded_pages":[],"layout_pages":[],"markdown":"Fluctuations in foreign currency exchange rates decreased our consolidated net operating revenues by 5%. This unfavorable impact was primarily due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine peso, Nigerian naira, Zimbabwean dollar, Turkish lira and Japanese yen, which had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Asia Pacific operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the British pound and euro, which had a favorable impact on our Europe, Middle East and Africa and Global Ventures operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below for additional information about the impact of foreign currency exchange rate fluctuations.\n\n“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the Company considers to be structural changes. The impact of acquisitions and divestitures is the difference between the change in net operating revenues and the change in what our net operating revenues would have been if we removed the net operating revenues associated with an acquisition or a divestiture from either the current year or the prior year, as applicable. Management believes that quantifying the impact that acquisitions and divestitures had on the Company’s net operating revenues provides investors with useful information to enhance their understanding of the Company’s net operating revenue performance by improving their ability to compare our year-to-year results. Management considers the impact of acquisitions and divestitures when evaluating the Company’s performance. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above for additional information related to acquisitions and divestitures.\n\nNet operating revenue growth rates are impacted by sales volume; price, product and geographic mix; foreign currency exchange rate fluctuations; and acquisitions and divestitures. The size and timing of acquisitions and divestitures are not consistent from period to period. Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have an unfavorable impact on our full year 2025 net operating revenues.\n\nInformation about our net operating revenues by operating segment and Corporate as a percentage of Company net operating revenues is as follows:\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **15\\.8** **%** 16\\.2 %\n\nLatin America **13\\.7** 12\\.7\n\nNorth America **39\\.6** 36\\.6\n\nAsia Pacific **10\\.8** 10\\.3\n\nGlobal Ventures **6\\.7** 6\\.7\n\nBottling Investments **13\\.2** 17\\.2\n\nCorporate **0\\.2** 0\\.3\n\nTotal **100\\.0** **%** 100\\.0 %\n\nThe percentage contribution of each operating segment fluctuates over time due to net operating revenues in some operating segments growing at a faster rate compared to other operating segments. In addition, foreign currency exchange rate fluctuations impact the percentage contribution of each operating segment. For additional information about the impact of foreign currency exchange rate fluctuations, refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.\n\n**_Gross Profit Margin_**\n\nGross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit margin provides investors with useful information related to the profitability of our business prior to considering all of the selling, general and administrative expenses and other operating charges incurred. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nOur gross profit margin increased to 61.1% in 2024 from 59.5% in 2023. This increase was primarily due to the impact of favorable pricing initiatives and the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by the unfavorable impact of foreign currency exchange rate fluctuations and higher commodity costs.\n\n47","pages":[{"line_numbers":[],"markdown":"Fluctuations in foreign currency exchange rates decreased our consolidated net operating revenues by 5%. This unfavorable impact was primarily due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine peso, Nigerian naira, Zimbabwean dollar, Turkish lira and Japanese yen, which had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Asia Pacific operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the British pound and euro, which had a favorable impact on our Europe, Middle East and Africa and Global Ventures operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below for additional information about the impact of foreign currency exchange rate fluctuations.\n\n“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the Company considers to be structural changes. The impact of acquisitions and divestitures is the difference between the change in net operating revenues and the change in what our net operating revenues would have been if we removed the net operating revenues associated with an acquisition or a divestiture from either the current year or the prior year, as applicable. Management believes that quantifying the impact that acquisitions and divestitures had on the Company’s net operating revenues provides investors with useful information to enhance their understanding of the Company’s net operating revenue performance by improving their ability to compare our year-to-year results. Management considers the impact of acquisitions and divestitures when evaluating the Company’s performance. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above for additional information related to acquisitions and divestitures.\n\nNet operating revenue growth rates are impacted by sales volume; price, product and geographic mix; foreign currency exchange rate fluctuations; and acquisitions and divestitures. The size and timing of acquisitions and divestitures are not consistent from period to period. Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have an unfavorable impact on our full year 2025 net operating revenues.\n\nInformation about our net operating revenues by operating segment and Corporate as a percentage of Company net operating revenues is as follows:\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **15\\.8** **%** 16\\.2 %\n\nLatin America **13\\.7** 12\\.7\n\nNorth America **39\\.6** 36\\.6\n\nAsia Pacific **10\\.8** 10\\.3\n\nGlobal Ventures **6\\.7** 6\\.7\n\nBottling Investments **13\\.2** 17\\.2\n\nCorporate **0\\.2** 0\\.3\n\nTotal **100\\.0** **%** 100\\.0 %\n\nThe percentage contribution of each operating segment fluctuates over time due to net operating revenues in some operating segments growing at a faster rate compared to other operating segments. In addition, foreign currency exchange rate fluctuations impact the percentage contribution of each operating segment. For additional information about the impact of foreign currency exchange rate fluctuations, refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.\n\n**_Gross Profit Margin_**\n\nGross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit margin provides investors with useful information related to the profitability of our business prior to considering all of the selling, general and administrative expenses and other operating charges incurred. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nOur gross profit margin increased to 61.1% in 2024 from 59.5% in 2023. This increase was primarily due to the impact of favorable pricing initiatives and the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by the unfavorable impact of foreign currency exchange rate fluctuations and higher commodity costs.\n\n47","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Fluctuations in foreign currency exchange rates decreased our consolidated net operating revenues by 5%. This unfavorable impact was primarily due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine peso, Nigerian naira, Zimbabwean dollar, Turkish lira and Japanese yen, which had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Asia Pacific operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the British pound and euro, which had a favorable impact on our Europe, Middle East and Africa and Global Ventures operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below for additional information about the impact of foreign currency exchange rate fluctuations.\n\n“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the Company considers to be structural changes. The impact of acquisitions and divestitures is the difference between the change in net operating revenues and the change in what our net operating revenues would have been if we removed the net operating revenues associated with an acquisition or a divestiture from either the current year or the prior year, as applicable. Management believes that quantifying the impact that acquisitions and divestitures had on the Company’s net operating revenues provides investors with useful information to enhance their understanding of the Company’s net operating revenue performance by improving their ability to compare our year-to-year results. Management considers the impact of acquisitions and divestitures when evaluating the Company’s performance. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above for additional information related to acquisitions and divestitures.\n\nNet operating revenue growth rates are impacted by sales volume; price, product and geographic mix; foreign currency exchange rate fluctuations; and acquisitions and divestitures. The size and timing of acquisitions and divestitures are not consistent from period to period. Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have an unfavorable impact on our full year 2025 net operating revenues.\n\nInformation about our net operating revenues by operating segment and Corporate as a percentage of Company net operating revenues is as follows:\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **15\\.8** **%** 16\\.2 %\n\nLatin America **13\\.7** 12\\.7\n\nNorth America **39\\.6** 36\\.6\n\nAsia Pacific **10\\.8** 10\\.3\n\nGlobal Ventures **6\\.7** 6\\.7\n\nBottling Investments **13\\.2** 17\\.2\n\nCorporate **0\\.2** 0\\.3\n\nTotal **100\\.0** **%** 100\\.0 %\n\nThe percentage contribution of each operating segment fluctuates over time due to net operating revenues in some operating segments growing at a faster rate compared to other operating segments. In addition, foreign currency exchange rate fluctuations impact the percentage contribution of each operating segment. For additional information about the impact of foreign currency exchange rate fluctuations, refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.\n\n**_Gross Profit Margin_**\n\nGross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit margin provides investors with useful information related to the profitability of our business prior to considering all of the selling, general and administrative expenses and other operating charges incurred. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nOur gross profit margin increased to 61.1% in 2024 from 59.5% in 2023. This increase was primarily due to the impact of favorable pricing initiatives and the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by the unfavorable impact of foreign currency exchange rate fluctuations and higher commodity costs.\n\n47","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page49.pdf"]},"response":{"errors":[],"extract_id":"extract_30d103fb6c4b93770c7e3f51668c68d1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Fluctuations in foreign currency exchange rates decreased our consolidated net operating revenues by 5%. This unfavorable impact was primarily due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine peso, Nigerian naira, Zimbabwean dollar, Turkish lira and Japanese yen, which had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Asia Pacific operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the British pound and euro, which had a favorable impact on our Europe, Middle East and Africa and Global Ventures operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below for additional information about the impact of foreign currency exchange rate fluctuations.\n\n“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the Company considers to be structural changes. The impact of acquisitions and divestitures is the difference between the change in net operating revenues and the change in what our net operating revenues would have been if we removed the net operating revenues associated with an acquisition or a divestiture from either the current year or the prior year, as applicable. Management believes that quantifying the impact that acquisitions and divestitures had on the Company’s net operating revenues provides investors with useful information to enhance their understanding of the Company’s net operating revenue performance by improving their ability to compare our year-to-year results. Management considers the impact of acquisitions and divestitures when evaluating the Company’s performance. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above for additional information related to acquisitions and divestitures.\n\nNet operating revenue growth rates are impacted by sales volume; price, product and geographic mix; foreign currency exchange rate fluctuations; and acquisitions and divestitures. The size and timing of acquisitions and divestitures are not consistent from period to period. Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have an unfavorable impact on our full year 2025 net operating revenues.\n\nInformation about our net operating revenues by operating segment and Corporate as a percentage of Company net operating revenues is as follows:\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **15\\.8** **%** 16\\.2 %\n\nLatin America **13\\.7** 12\\.7\n\nNorth America **39\\.6** 36\\.6\n\nAsia Pacific **10\\.8** 10\\.3\n\nGlobal Ventures **6\\.7** 6\\.7\n\nBottling Investments **13\\.2** 17\\.2\n\nCorporate **0\\.2** 0\\.3\n\nTotal **100\\.0** **%** 100\\.0 %\n\nThe percentage contribution of each operating segment fluctuates over time due to net operating revenues in some operating segments growing at a faster rate compared to other operating segments. In addition, foreign currency exchange rate fluctuations impact the percentage contribution of each operating segment. For additional information about the impact of foreign currency exchange rate fluctuations, refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.\n\n**_Gross Profit Margin_**\n\nGross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit margin provides investors with useful information related to the profitability of our business prior to considering all of the selling, general and administrative expenses and other operating charges incurred. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nOur gross profit margin increased to 61.1% in 2024 from 59.5% in 2023. This increase was primarily due to the impact of favorable pricing initiatives and the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by the unfavorable impact of foreign currency exchange rate fluctuations and higher commodity costs.\n\n47"],"full_content":"Fluctuations in foreign currency exchange rates decreased our consolidated net operating revenues by 5%. This unfavorable impact was primarily due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine peso, Nigerian naira, Zimbabwean dollar, Turkish lira and Japanese yen, which had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Asia Pacific operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the British pound and euro, which had a favorable impact on our Europe, Middle East and Africa and Global Ventures operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below for additional information about the impact of foreign currency exchange rate fluctuations.\n\n“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the Company considers to be structural changes. The impact of acquisitions and divestitures is the difference between the change in net operating revenues and the change in what our net operating revenues would have been if we removed the net operating revenues associated with an acquisition or a divestiture from either the current year or the prior year, as applicable. Management believes that quantifying the impact that acquisitions and divestitures had on the Company’s net operating revenues provides investors with useful information to enhance their understanding of the Company’s net operating revenue performance by improving their ability to compare our year-to-year results. Management considers the impact of acquisitions and divestitures when evaluating the Company’s performance. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above for additional information related to acquisitions and divestitures.\n\nNet operating revenue growth rates are impacted by sales volume; price, product and geographic mix; foreign currency exchange rate fluctuations; and acquisitions and divestitures. The size and timing of acquisitions and divestitures are not consistent from period to period. Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have an unfavorable impact on our full year 2025 net operating revenues.\n\nInformation about our net operating revenues by operating segment and Corporate as a percentage of Company net operating revenues is as follows:\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **15\\.8** **%** 16\\.2 %\n\nLatin America **13\\.7** 12\\.7\n\nNorth America **39\\.6** 36\\.6\n\nAsia Pacific **10\\.8** 10\\.3\n\nGlobal Ventures **6\\.7** 6\\.7\n\nBottling Investments **13\\.2** 17\\.2\n\nCorporate **0\\.2** 0\\.3\n\nTotal **100\\.0** **%** 100\\.0 %\n\nThe percentage contribution of each operating segment fluctuates over time due to net operating revenues in some operating segments growing at a faster rate compared to other operating segments. In addition, foreign currency exchange rate fluctuations impact the percentage contribution of each operating segment. For additional information about the impact of foreign currency exchange rate fluctuations, refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.\n\n**_Gross Profit Margin_**\n\nGross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit margin provides investors with useful information related to the profitability of our business prior to considering all of the selling, general and administrative expenses and other operating charges incurred. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nOur gross profit margin increased to 61.1% in 2024 from 59.5% in 2023. This increase was primarily due to the impact of favorable pricing initiatives and the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by the unfavorable impact of foreign currency exchange rate fluctuations and higher commodity costs.\n\n47","publish_date":null,"title":"Fluctuations in foreign currency exchange rates decreased our consolidated net operating revenues by 5%. This unfavorable impact was primarily due","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page49.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page49.pdf"},"request":{"example_id":"table/Coca Cola 10-k_page49","product_type":"parse","source_file_path":"Coca Cola 10-k_page49.pdf"},"started_at":"2026-11-04T19:47:09.362907"} +{"completed_at":"2026-11-04T19:47:13.314088","latency_in_ms":2580,"output":{"example_id":"table/Coca Cola 10-k_page50","grounded_pages":[],"layout_pages":[],"markdown":"**_Selling, General and Administrative Expenses_**\n\nThe following table sets forth the components of selling, general and administrative expenses (in millions):\n\nYear Ended December 31, **2024** 2023\n\nSelling and distribution expenses **$ 2,525** $ 2,599\n\nAdvertising expenses **5,146** 5,010\n\nStock-based compensation expense **286** 254\n\nOther operating expenses **6,625** 6,109\n\nSelling, general and administrative expenses **$ 14,582** $ 13,972\n\nSelling, general and administrative expenses increased $610 million, or 4%, in 2024. This increase was primarily due to higher advertising expenses, stock-based compensation expense and other operating expenses, partially offset by a decrease in selling and distribution expenses. The increase in other operating expenses was primarily due to increased charitable donations, higher employee costs, higher other marketing expenses and an asset impairment charge related to certain prototypes. The decrease in selling and distribution expenses was primarily due to the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by increases in Costa expenses. In 2024, foreign currency exchange rate fluctuations decreased selling, general and administrative expenses by 4%. Refer to Note 17 of Notes to Consolidated Financial Statements for more information on the impairment charge.\n\nAs of December 31, 2024, we had $234 million of total unrecognized compensation cost related to nonvested stock-based compensation awards granted under our plans, which we expect to recognize over a weighted-average period of 1.6 years as stock-based compensation expense. This expected cost does not include the impact of any future stock- based compensation awards. Refer to Note 13 of Notes to Consolidated Financial Statements.\n\n**_Other Operating Charges_**\n\nOther operating charges incurred by operating segment and Corporate were as follows (in millions):\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **$ —** $ —\n\nLatin America **126** —\n\nNorth America **760** 26\n\nAsia Pacific **—** 35\n\nGlobal Ventures **—** —\n\nBottling Investments **—** —\n\nCorporate **3,277** 1,890\n\nTotal **$ 4,163** $ 1,951\n\nIn 2024, the Company recorded other operating charges of $4,163 million. These charges consisted of $3,109 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife in 2020, $760 million related to the impairment of our BodyArmor trademark, $133 million related to the Company’s productivity and reinvestment program and $126 million related to the impairment of a trademark in Latin America. In addition, other operating charges included $15 million for the amortization of noncompete agreements related to the BodyArmor acquisition in 2021, $13 million related to an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $7 million of transaction costs related to the refranchising of our bottling operations in certain territories in India and $2 million of transaction costs related to the sale of a portion of our interest in Coca-Cola Consolidated, Inc. (“Coke Consolidated”), an equity method investee. These charges were partially offset by a net benefit of $2 million related to a revision of management’s estimates for tax litigation expense.\n\nIn 2023, the Company recorded other operating charges of $1,951 million. These charges consisted of $1,702 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition, $164 million related to the Company’s productivity and reinvestment program and $35 million related to the discontinuation of certain manufacturing operations in Asia Pacific. In addition, other operating charges included $27 million related to the restructuring of our North America operating unit, $15 million for the amortization of noncompete agreements related to the BodyArmor acquisition and $8 million related to tax litigation expense.\n\nRefer to Note 2 of Notes to Consolidated Financial Statements for additional information on the refranchising of our bottling operations and the sale of a portion of our interest in Coke Consolidated. Refer to Note 12 of Notes to Consolidated Financial\n\n48","pages":[{"line_numbers":[],"markdown":"**_Selling, General and Administrative Expenses_**\n\nThe following table sets forth the components of selling, general and administrative expenses (in millions):\n\nYear Ended December 31, **2024** 2023\n\nSelling and distribution expenses **$ 2,525** $ 2,599\n\nAdvertising expenses **5,146** 5,010\n\nStock-based compensation expense **286** 254\n\nOther operating expenses **6,625** 6,109\n\nSelling, general and administrative expenses **$ 14,582** $ 13,972\n\nSelling, general and administrative expenses increased $610 million, or 4%, in 2024. This increase was primarily due to higher advertising expenses, stock-based compensation expense and other operating expenses, partially offset by a decrease in selling and distribution expenses. The increase in other operating expenses was primarily due to increased charitable donations, higher employee costs, higher other marketing expenses and an asset impairment charge related to certain prototypes. The decrease in selling and distribution expenses was primarily due to the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by increases in Costa expenses. In 2024, foreign currency exchange rate fluctuations decreased selling, general and administrative expenses by 4%. Refer to Note 17 of Notes to Consolidated Financial Statements for more information on the impairment charge.\n\nAs of December 31, 2024, we had $234 million of total unrecognized compensation cost related to nonvested stock-based compensation awards granted under our plans, which we expect to recognize over a weighted-average period of 1.6 years as stock-based compensation expense. This expected cost does not include the impact of any future stock- based compensation awards. Refer to Note 13 of Notes to Consolidated Financial Statements.\n\n**_Other Operating Charges_**\n\nOther operating charges incurred by operating segment and Corporate were as follows (in millions):\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **$ —** $ —\n\nLatin America **126** —\n\nNorth America **760** 26\n\nAsia Pacific **—** 35\n\nGlobal Ventures **—** —\n\nBottling Investments **—** —\n\nCorporate **3,277** 1,890\n\nTotal **$ 4,163** $ 1,951\n\nIn 2024, the Company recorded other operating charges of $4,163 million. These charges consisted of $3,109 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife in 2020, $760 million related to the impairment of our BodyArmor trademark, $133 million related to the Company’s productivity and reinvestment program and $126 million related to the impairment of a trademark in Latin America. In addition, other operating charges included $15 million for the amortization of noncompete agreements related to the BodyArmor acquisition in 2021, $13 million related to an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $7 million of transaction costs related to the refranchising of our bottling operations in certain territories in India and $2 million of transaction costs related to the sale of a portion of our interest in Coca-Cola Consolidated, Inc. (“Coke Consolidated”), an equity method investee. These charges were partially offset by a net benefit of $2 million related to a revision of management’s estimates for tax litigation expense.\n\nIn 2023, the Company recorded other operating charges of $1,951 million. These charges consisted of $1,702 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition, $164 million related to the Company’s productivity and reinvestment program and $35 million related to the discontinuation of certain manufacturing operations in Asia Pacific. In addition, other operating charges included $27 million related to the restructuring of our North America operating unit, $15 million for the amortization of noncompete agreements related to the BodyArmor acquisition and $8 million related to tax litigation expense.\n\nRefer to Note 2 of Notes to Consolidated Financial Statements for additional information on the refranchising of our bottling operations and the sale of a portion of our interest in Coke Consolidated. Refer to Note 12 of Notes to Consolidated Financial\n\n48","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**_Selling, General and Administrative Expenses_**\n\nThe following table sets forth the components of selling, general and administrative expenses (in millions):\n\nYear Ended December 31, **2024** 2023\n\nSelling and distribution expenses **$ 2,525** $ 2,599\n\nAdvertising expenses **5,146** 5,010\n\nStock-based compensation expense **286** 254\n\nOther operating expenses **6,625** 6,109\n\nSelling, general and administrative expenses **$ 14,582** $ 13,972\n\nSelling, general and administrative expenses increased $610 million, or 4%, in 2024. This increase was primarily due to higher advertising expenses, stock-based compensation expense and other operating expenses, partially offset by a decrease in selling and distribution expenses. The increase in other operating expenses was primarily due to increased charitable donations, higher employee costs, higher other marketing expenses and an asset impairment charge related to certain prototypes. The decrease in selling and distribution expenses was primarily due to the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by increases in Costa expenses. In 2024, foreign currency exchange rate fluctuations decreased selling, general and administrative expenses by 4%. Refer to Note 17 of Notes to Consolidated Financial Statements for more information on the impairment charge.\n\nAs of December 31, 2024, we had $234 million of total unrecognized compensation cost related to nonvested stock-based compensation awards granted under our plans, which we expect to recognize over a weighted-average period of 1.6 years as stock-based compensation expense. This expected cost does not include the impact of any future stock- based compensation awards. Refer to Note 13 of Notes to Consolidated Financial Statements.\n\n**_Other Operating Charges_**\n\nOther operating charges incurred by operating segment and Corporate were as follows (in millions):\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **$ —** $ —\n\nLatin America **126** —\n\nNorth America **760** 26\n\nAsia Pacific **—** 35\n\nGlobal Ventures **—** —\n\nBottling Investments **—** —\n\nCorporate **3,277** 1,890\n\nTotal **$ 4,163** $ 1,951\n\nIn 2024, the Company recorded other operating charges of $4,163 million. These charges consisted of $3,109 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife in 2020, $760 million related to the impairment of our BodyArmor trademark, $133 million related to the Company’s productivity and reinvestment program and $126 million related to the impairment of a trademark in Latin America. In addition, other operating charges included $15 million for the amortization of noncompete agreements related to the BodyArmor acquisition in 2021, $13 million related to an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $7 million of transaction costs related to the refranchising of our bottling operations in certain territories in India and $2 million of transaction costs related to the sale of a portion of our interest in Coca-Cola Consolidated, Inc. (“Coke Consolidated”), an equity method investee. These charges were partially offset by a net benefit of $2 million related to a revision of management’s estimates for tax litigation expense.\n\nIn 2023, the Company recorded other operating charges of $1,951 million. These charges consisted of $1,702 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition, $164 million related to the Company’s productivity and reinvestment program and $35 million related to the discontinuation of certain manufacturing operations in Asia Pacific. In addition, other operating charges included $27 million related to the restructuring of our North America operating unit, $15 million for the amortization of noncompete agreements related to the BodyArmor acquisition and $8 million related to tax litigation expense.\n\nRefer to Note 2 of Notes to Consolidated Financial Statements for additional information on the refranchising of our bottling operations and the sale of a portion of our interest in Coke Consolidated. Refer to Note 12 of Notes to Consolidated Financial\n\n48","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page50.pdf"]},"response":{"errors":[],"extract_id":"extract_b5e506c888cff01a9ce37e2f9d4f5cd3","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**_Selling, General and Administrative Expenses_**\n\nThe following table sets forth the components of selling, general and administrative expenses (in millions):\n\nYear Ended December 31, **2024** 2023\n\nSelling and distribution expenses **$ 2,525** $ 2,599\n\nAdvertising expenses **5,146** 5,010\n\nStock-based compensation expense **286** 254\n\nOther operating expenses **6,625** 6,109\n\nSelling, general and administrative expenses **$ 14,582** $ 13,972\n\nSelling, general and administrative expenses increased $610 million, or 4%, in 2024. This increase was primarily due to higher advertising expenses, stock-based compensation expense and other operating expenses, partially offset by a decrease in selling and distribution expenses. The increase in other operating expenses was primarily due to increased charitable donations, higher employee costs, higher other marketing expenses and an asset impairment charge related to certain prototypes. The decrease in selling and distribution expenses was primarily due to the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by increases in Costa expenses. In 2024, foreign currency exchange rate fluctuations decreased selling, general and administrative expenses by 4%. Refer to Note 17 of Notes to Consolidated Financial Statements for more information on the impairment charge.\n\nAs of December 31, 2024, we had $234 million of total unrecognized compensation cost related to nonvested stock-based compensation awards granted under our plans, which we expect to recognize over a weighted-average period of 1.6 years as stock-based compensation expense. This expected cost does not include the impact of any future stock- based compensation awards. Refer to Note 13 of Notes to Consolidated Financial Statements.\n\n**_Other Operating Charges_**\n\nOther operating charges incurred by operating segment and Corporate were as follows (in millions):\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **$ —** $ —\n\nLatin America **126** —\n\nNorth America **760** 26\n\nAsia Pacific **—** 35\n\nGlobal Ventures **—** —\n\nBottling Investments **—** —\n\nCorporate **3,277** 1,890\n\nTotal **$ 4,163** $ 1,951\n\nIn 2024, the Company recorded other operating charges of $4,163 million. These charges consisted of $3,109 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife in 2020, $760 million related to the impairment of our BodyArmor trademark, $133 million related to the Company’s productivity and reinvestment program and $126 million related to the impairment of a trademark in Latin America. In addition, other operating charges included $15 million for the amortization of noncompete agreements related to the BodyArmor acquisition in 2021, $13 million related to an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $7 million of transaction costs related to the refranchising of our bottling operations in certain territories in India and $2 million of transaction costs related to the sale of a portion of our interest in Coca-Cola Consolidated, Inc. (“Coke Consolidated”), an equity method investee. These charges were partially offset by a net benefit of $2 million related to a revision of management’s estimates for tax litigation expense.\n\nIn 2023, the Company recorded other operating charges of $1,951 million. These charges consisted of $1,702 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition, $164 million related to the Company’s productivity and reinvestment program and $35 million related to the discontinuation of certain manufacturing operations in Asia Pacific. In addition, other operating charges included $27 million related to the restructuring of our North America operating unit, $15 million for the amortization of noncompete agreements related to the BodyArmor acquisition and $8 million related to tax litigation expense.\n\nRefer to Note 2 of Notes to Consolidated Financial Statements for additional information on the refranchising of our bottling operations and the sale of a portion of our interest in Coke Consolidated. Refer to Note 12 of Notes to Consolidated Financial\n\n48"],"full_content":"**_Selling, General and Administrative Expenses_**\n\nThe following table sets forth the components of selling, general and administrative expenses (in millions):\n\nYear Ended December 31, **2024** 2023\n\nSelling and distribution expenses **$ 2,525** $ 2,599\n\nAdvertising expenses **5,146** 5,010\n\nStock-based compensation expense **286** 254\n\nOther operating expenses **6,625** 6,109\n\nSelling, general and administrative expenses **$ 14,582** $ 13,972\n\nSelling, general and administrative expenses increased $610 million, or 4%, in 2024. This increase was primarily due to higher advertising expenses, stock-based compensation expense and other operating expenses, partially offset by a decrease in selling and distribution expenses. The increase in other operating expenses was primarily due to increased charitable donations, higher employee costs, higher other marketing expenses and an asset impairment charge related to certain prototypes. The decrease in selling and distribution expenses was primarily due to the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by increases in Costa expenses. In 2024, foreign currency exchange rate fluctuations decreased selling, general and administrative expenses by 4%. Refer to Note 17 of Notes to Consolidated Financial Statements for more information on the impairment charge.\n\nAs of December 31, 2024, we had $234 million of total unrecognized compensation cost related to nonvested stock-based compensation awards granted under our plans, which we expect to recognize over a weighted-average period of 1.6 years as stock-based compensation expense. This expected cost does not include the impact of any future stock- based compensation awards. Refer to Note 13 of Notes to Consolidated Financial Statements.\n\n**_Other Operating Charges_**\n\nOther operating charges incurred by operating segment and Corporate were as follows (in millions):\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **$ —** $ —\n\nLatin America **126** —\n\nNorth America **760** 26\n\nAsia Pacific **—** 35\n\nGlobal Ventures **—** —\n\nBottling Investments **—** —\n\nCorporate **3,277** 1,890\n\nTotal **$ 4,163** $ 1,951\n\nIn 2024, the Company recorded other operating charges of $4,163 million. These charges consisted of $3,109 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife in 2020, $760 million related to the impairment of our BodyArmor trademark, $133 million related to the Company’s productivity and reinvestment program and $126 million related to the impairment of a trademark in Latin America. In addition, other operating charges included $15 million for the amortization of noncompete agreements related to the BodyArmor acquisition in 2021, $13 million related to an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $7 million of transaction costs related to the refranchising of our bottling operations in certain territories in India and $2 million of transaction costs related to the sale of a portion of our interest in Coca-Cola Consolidated, Inc. (“Coke Consolidated”), an equity method investee. These charges were partially offset by a net benefit of $2 million related to a revision of management’s estimates for tax litigation expense.\n\nIn 2023, the Company recorded other operating charges of $1,951 million. These charges consisted of $1,702 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition, $164 million related to the Company’s productivity and reinvestment program and $35 million related to the discontinuation of certain manufacturing operations in Asia Pacific. In addition, other operating charges included $27 million related to the restructuring of our North America operating unit, $15 million for the amortization of noncompete agreements related to the BodyArmor acquisition and $8 million related to tax litigation expense.\n\nRefer to Note 2 of Notes to Consolidated Financial Statements for additional information on the refranchising of our bottling operations and the sale of a portion of our interest in Coke Consolidated. Refer to Note 12 of Notes to Consolidated Financial\n\n48","publish_date":null,"title":"Selling, General and Administrative Expenses The following table sets forth the components of selling, general and administrative expenses (in millions):","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page50.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page50.pdf"},"request":{"example_id":"table/Coca Cola 10-k_page50","product_type":"parse","source_file_path":"Coca Cola 10-k_page50.pdf"},"started_at":"2026-11-04T19:47:10.733854"} +{"completed_at":"2026-11-04T19:47:14.345062","latency_in_ms":2372,"output":{"example_id":"table/Coca Cola 10-k_page51","grounded_pages":[],"layout_pages":[],"markdown":"Statements for additional information related to the tax litigation. Refer to Note 17 of Notes to Consolidated Financial Statements for additional information on the fairlife contingent consideration and the impairment charges. Refer to Note 19 of Notes to Consolidated Financial Statements for additional information on the Company’s restructuring initiatives. Refer to Note 20 of Notes to Consolidated Financial Statements for the impact these charges had on our operating segments and Corporate.\n\n**_Operating Income and Operating Margin_**\n\nInformation about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **41\\.3** **%** 37\\.2 %\n\nLatin America **37\\.8** 30\\.3\n\nNorth America **43\\.4** 39\\.2\n\nAsia Pacific **21\\.5** 18\\.0\n\nGlobal Ventures **3\\.6** 2\\.9\n\nBottling Investments **5\\.0** 5\\.1\n\nCorporate **(52.6)** (32.7)\n\nTotal **100\\.0** **%** 100\\.0 %\n\nOperating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating margin provides investors with useful information related to the profitability of our business after considering selling, general and administrative expenses and other operating charges. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nInformation about our operating margin on a consolidated basis and by operating segment and Corporate is as follows:\n\nYear Ended December 31, **2024** 2023\n\nConsolidated **21\\.2** **%** 24\\.7 %\n\nEurope, Middle East & Africa **55\\.4** 56\\.8\n\nLatin America **58\\.5** 58\\.9\n\nNorth America **23\\.3** 26\\.4\n\nAsia Pacific **42\\.3** 43\\.2\n\nGlobal Ventures **11\\.5** 10\\.7\n\nBottling Investments **8\\.0** 7\\.4\n\nCorporate \\* \\*\n\n\\* Calculation is not meaningful.\n\nOperating income was $9,992 million in 2024, compared to $11,311 million in 2023, a decrease of $1,319 million, or 12%. The decrease in operating income was primarily driven by higher commodity costs; higher selling, general and administrative expenses; higher other operating charges; the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India; and an unfavorable foreign currency exchange rate impact of 11%. These items were partially offset by concentrate sales volume growth of 2% and favorable pricing initiatives.\n\nThe decrease in our operating margin on a consolidated basis was primarily due to higher commodity costs; higher selling, general and administrative expenses; higher other operating charges; and an unfavorable foreign currency exchange rate impact. The impact of these items was partially offset by favorable pricing initiatives and the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India.\n\nIn 2024, fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine peso, Mexican peso, Brazilian real, Zimbabwean dollar, Turkish lira, Nigerian naira and Japanese yen, which had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Asia Pacific operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the euro and British pound, which had a favorable impact on our Europe, Middle East and Africa and Global Ventures operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.\n\n49","pages":[{"line_numbers":[],"markdown":"Statements for additional information related to the tax litigation. Refer to Note 17 of Notes to Consolidated Financial Statements for additional information on the fairlife contingent consideration and the impairment charges. Refer to Note 19 of Notes to Consolidated Financial Statements for additional information on the Company’s restructuring initiatives. Refer to Note 20 of Notes to Consolidated Financial Statements for the impact these charges had on our operating segments and Corporate.\n\n**_Operating Income and Operating Margin_**\n\nInformation about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **41\\.3** **%** 37\\.2 %\n\nLatin America **37\\.8** 30\\.3\n\nNorth America **43\\.4** 39\\.2\n\nAsia Pacific **21\\.5** 18\\.0\n\nGlobal Ventures **3\\.6** 2\\.9\n\nBottling Investments **5\\.0** 5\\.1\n\nCorporate **(52.6)** (32.7)\n\nTotal **100\\.0** **%** 100\\.0 %\n\nOperating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating margin provides investors with useful information related to the profitability of our business after considering selling, general and administrative expenses and other operating charges. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nInformation about our operating margin on a consolidated basis and by operating segment and Corporate is as follows:\n\nYear Ended December 31, **2024** 2023\n\nConsolidated **21\\.2** **%** 24\\.7 %\n\nEurope, Middle East & Africa **55\\.4** 56\\.8\n\nLatin America **58\\.5** 58\\.9\n\nNorth America **23\\.3** 26\\.4\n\nAsia Pacific **42\\.3** 43\\.2\n\nGlobal Ventures **11\\.5** 10\\.7\n\nBottling Investments **8\\.0** 7\\.4\n\nCorporate \\* \\*\n\n\\* Calculation is not meaningful.\n\nOperating income was $9,992 million in 2024, compared to $11,311 million in 2023, a decrease of $1,319 million, or 12%. The decrease in operating income was primarily driven by higher commodity costs; higher selling, general and administrative expenses; higher other operating charges; the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India; and an unfavorable foreign currency exchange rate impact of 11%. These items were partially offset by concentrate sales volume growth of 2% and favorable pricing initiatives.\n\nThe decrease in our operating margin on a consolidated basis was primarily due to higher commodity costs; higher selling, general and administrative expenses; higher other operating charges; and an unfavorable foreign currency exchange rate impact. The impact of these items was partially offset by favorable pricing initiatives and the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India.\n\nIn 2024, fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine peso, Mexican peso, Brazilian real, Zimbabwean dollar, Turkish lira, Nigerian naira and Japanese yen, which had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Asia Pacific operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the euro and British pound, which had a favorable impact on our Europe, Middle East and Africa and Global Ventures operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.\n\n49","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Statements for additional information related to the tax litigation. Refer to Note 17 of Notes to Consolidated Financial Statements for additional information on the fairlife contingent consideration and the impairment charges. Refer to Note 19 of Notes to Consolidated Financial Statements for additional information on the Company’s restructuring initiatives. Refer to Note 20 of Notes to Consolidated Financial Statements for the impact these charges had on our operating segments and Corporate.\n\n**_Operating Income and Operating Margin_**\n\nInformation about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **41\\.3** **%** 37\\.2 %\n\nLatin America **37\\.8** 30\\.3\n\nNorth America **43\\.4** 39\\.2\n\nAsia Pacific **21\\.5** 18\\.0\n\nGlobal Ventures **3\\.6** 2\\.9\n\nBottling Investments **5\\.0** 5\\.1\n\nCorporate **(52.6)** (32.7)\n\nTotal **100\\.0** **%** 100\\.0 %\n\nOperating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating margin provides investors with useful information related to the profitability of our business after considering selling, general and administrative expenses and other operating charges. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nInformation about our operating margin on a consolidated basis and by operating segment and Corporate is as follows:\n\nYear Ended December 31, **2024** 2023\n\nConsolidated **21\\.2** **%** 24\\.7 %\n\nEurope, Middle East & Africa **55\\.4** 56\\.8\n\nLatin America **58\\.5** 58\\.9\n\nNorth America **23\\.3** 26\\.4\n\nAsia Pacific **42\\.3** 43\\.2\n\nGlobal Ventures **11\\.5** 10\\.7\n\nBottling Investments **8\\.0** 7\\.4\n\nCorporate \\* \\*\n\n\\* Calculation is not meaningful.\n\nOperating income was $9,992 million in 2024, compared to $11,311 million in 2023, a decrease of $1,319 million, or 12%. The decrease in operating income was primarily driven by higher commodity costs; higher selling, general and administrative expenses; higher other operating charges; the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India; and an unfavorable foreign currency exchange rate impact of 11%. These items were partially offset by concentrate sales volume growth of 2% and favorable pricing initiatives.\n\nThe decrease in our operating margin on a consolidated basis was primarily due to higher commodity costs; higher selling, general and administrative expenses; higher other operating charges; and an unfavorable foreign currency exchange rate impact. The impact of these items was partially offset by favorable pricing initiatives and the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India.\n\nIn 2024, fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine peso, Mexican peso, Brazilian real, Zimbabwean dollar, Turkish lira, Nigerian naira and Japanese yen, which had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Asia Pacific operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the euro and British pound, which had a favorable impact on our Europe, Middle East and Africa and Global Ventures operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.\n\n49","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page51.pdf"]},"response":{"errors":[],"extract_id":"extract_59fe5267bd87876b53fd41c147411402","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Statements for additional information related to the tax litigation. Refer to Note 17 of Notes to Consolidated Financial Statements for additional information on the fairlife contingent consideration and the impairment charges. Refer to Note 19 of Notes to Consolidated Financial Statements for additional information on the Company’s restructuring initiatives. Refer to Note 20 of Notes to Consolidated Financial Statements for the impact these charges had on our operating segments and Corporate.\n\n**_Operating Income and Operating Margin_**\n\nInformation about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **41\\.3** **%** 37\\.2 %\n\nLatin America **37\\.8** 30\\.3\n\nNorth America **43\\.4** 39\\.2\n\nAsia Pacific **21\\.5** 18\\.0\n\nGlobal Ventures **3\\.6** 2\\.9\n\nBottling Investments **5\\.0** 5\\.1\n\nCorporate **(52.6)** (32.7)\n\nTotal **100\\.0** **%** 100\\.0 %\n\nOperating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating margin provides investors with useful information related to the profitability of our business after considering selling, general and administrative expenses and other operating charges. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nInformation about our operating margin on a consolidated basis and by operating segment and Corporate is as follows:\n\nYear Ended December 31, **2024** 2023\n\nConsolidated **21\\.2** **%** 24\\.7 %\n\nEurope, Middle East & Africa **55\\.4** 56\\.8\n\nLatin America **58\\.5** 58\\.9\n\nNorth America **23\\.3** 26\\.4\n\nAsia Pacific **42\\.3** 43\\.2\n\nGlobal Ventures **11\\.5** 10\\.7\n\nBottling Investments **8\\.0** 7\\.4\n\nCorporate \\* \\*\n\n\\* Calculation is not meaningful.\n\nOperating income was $9,992 million in 2024, compared to $11,311 million in 2023, a decrease of $1,319 million, or 12%. The decrease in operating income was primarily driven by higher commodity costs; higher selling, general and administrative expenses; higher other operating charges; the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India; and an unfavorable foreign currency exchange rate impact of 11%. These items were partially offset by concentrate sales volume growth of 2% and favorable pricing initiatives.\n\nThe decrease in our operating margin on a consolidated basis was primarily due to higher commodity costs; higher selling, general and administrative expenses; higher other operating charges; and an unfavorable foreign currency exchange rate impact. The impact of these items was partially offset by favorable pricing initiatives and the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India.\n\nIn 2024, fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine peso, Mexican peso, Brazilian real, Zimbabwean dollar, Turkish lira, Nigerian naira and Japanese yen, which had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Asia Pacific operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the euro and British pound, which had a favorable impact on our Europe, Middle East and Africa and Global Ventures operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.\n\n49"],"full_content":"Statements for additional information related to the tax litigation. Refer to Note 17 of Notes to Consolidated Financial Statements for additional information on the fairlife contingent consideration and the impairment charges. Refer to Note 19 of Notes to Consolidated Financial Statements for additional information on the Company’s restructuring initiatives. Refer to Note 20 of Notes to Consolidated Financial Statements for the impact these charges had on our operating segments and Corporate.\n\n**_Operating Income and Operating Margin_**\n\nInformation about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:\n\nYear Ended December 31, **2024** 2023\n\nEurope, Middle East & Africa **41\\.3** **%** 37\\.2 %\n\nLatin America **37\\.8** 30\\.3\n\nNorth America **43\\.4** 39\\.2\n\nAsia Pacific **21\\.5** 18\\.0\n\nGlobal Ventures **3\\.6** 2\\.9\n\nBottling Investments **5\\.0** 5\\.1\n\nCorporate **(52.6)** (32.7)\n\nTotal **100\\.0** **%** 100\\.0 %\n\nOperating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating margin provides investors with useful information related to the profitability of our business after considering selling, general and administrative expenses and other operating charges. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.\n\nInformation about our operating margin on a consolidated basis and by operating segment and Corporate is as follows:\n\nYear Ended December 31, **2024** 2023\n\nConsolidated **21\\.2** **%** 24\\.7 %\n\nEurope, Middle East & Africa **55\\.4** 56\\.8\n\nLatin America **58\\.5** 58\\.9\n\nNorth America **23\\.3** 26\\.4\n\nAsia Pacific **42\\.3** 43\\.2\n\nGlobal Ventures **11\\.5** 10\\.7\n\nBottling Investments **8\\.0** 7\\.4\n\nCorporate \\* \\*\n\n\\* Calculation is not meaningful.\n\nOperating income was $9,992 million in 2024, compared to $11,311 million in 2023, a decrease of $1,319 million, or 12%. The decrease in operating income was primarily driven by higher commodity costs; higher selling, general and administrative expenses; higher other operating charges; the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India; and an unfavorable foreign currency exchange rate impact of 11%. These items were partially offset by concentrate sales volume growth of 2% and favorable pricing initiatives.\n\nThe decrease in our operating margin on a consolidated basis was primarily due to higher commodity costs; higher selling, general and administrative expenses; higher other operating charges; and an unfavorable foreign currency exchange rate impact. The impact of these items was partially offset by favorable pricing initiatives and the impact of refranchising our bottling operations in the Philippines, Bangladesh and certain territories in India.\n\nIn 2024, fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine peso, Mexican peso, Brazilian real, Zimbabwean dollar, Turkish lira, Nigerian naira and Japanese yen, which had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Asia Pacific operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the euro and British pound, which had a favorable impact on our Europe, Middle East and Africa and Global Ventures operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.\n\n49","publish_date":null,"title":"Statements for additional information related to the tax litigation. Refer to Note 17 of Notes to Consolidated Financial Statements for","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page51.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page51.pdf"},"request":{"example_id":"table/Coca Cola 10-k_page51","product_type":"parse","source_file_path":"Coca Cola 10-k_page51.pdf"},"started_at":"2026-11-04T19:47:11.972373"} +{"completed_at":"2026-11-04T19:47:16.301524","latency_in_ms":2983,"output":{"example_id":"table/Coca Cola 10-k_page68","grounded_pages":[],"layout_pages":[],"markdown":"**THE COCA-COLA COMPANY AND SUBSIDIARIES**\n\n**CONSOLIDATED STATEMENTS OF SHAREOWNERS’ EQUITY**\n\n(In millions except per share data)\n\n**2024** 2023 2022\n\n**Equity Attributable to Shareowners of The Coca-Cola Company**\n\n**Number of Common Shares Outstanding**\n\nBalance at beginning of year **4,308** 4,328 4,325\n\nTreasury stock issued to employees related to stock-based compensation plans **21** 17 24\n\nPurchases of stock for treasury **(27)** (37) (21)\n\nBalance at end of year **4,302** 4,308 4,328\n\n**Common Stock $ 1,760** $ 1,760 $ 1,760\n\n**Capital Surplus**\n\nBalance at beginning of year **19,209** 18,822 18,116\n\nStock issued to employees related to stock-based compensation plans **319** 177 373\n\nStock-based compensation expense **273** 233 332\n\nAcquisition of interests held by noncontrolling owners **—** (20) —\n\nOther activities **—** (3) 1\n\nBalance at end of year **19,801** 19,209 18,822\n\n**Reinvested Earnings**\n\nBalance at beginning of year **73,782** 71,019 69,094\n\nNet income attributable to shareowners of The Coca-Cola Company **10,631** 10,714 9,542\n\nDividends (per share — $1.94, $1.84 and $1.76 in 2024, 2023 and 2022, respectively) **(8,359)** (7,951) (7,617)\n\nBalance at end of year **76,054** 73,782 71,019\n\n**Accumulated Other Comprehensive Income (Loss)**\n\nBalance at beginning of year **(14,275)** (14,895) (14,330)\n\nNet other comprehensive income (loss) **(2,568)** 620 (565)\n\nBalance at end of year **(16,843)** (14,275) (14,895)\n\n**Treasury Stock**\n\nBalance at beginning of year **(54,535)** (52,601) (51,641)\n\nTreasury stock issued to employees related to stock-based compensation plans **321** 255 376\n\nPurchases of stock for treasury **(1,702)** (2,189) (1,336)\n\nBalance at end of year **(55,916)** (54,535) (52,601)\n\n**Total Equity Attributable to Shareowners of The Coca-Cola Company $ 24,856** $ 25,941 $ 24,105\n\n**Equity Attributable to Noncontrolling Interests**\n\nBalance at beginning of year **$ 1,539** $ 1,721 $ 1,861\n\nNet income attributable to noncontrolling interests **18** (11) 29\n\nNet foreign currency translation adjustments **(9)** (147) (118)\n\nDividends paid to noncontrolling interests **(28)** (25) (51)\n\nAcquisition of interests held by noncontrolling owners **—** (2) —\n\nDivestitures **(4)** — —\n\nOther activities **—** 3 —\n\n**Total Equity Attributable to Noncontrolling Interests $ 1,516** $ 1,539 $ 1,721\n\nRefer to Notes to Consolidated Financial Statements.\n\n66","pages":[{"line_numbers":[],"markdown":"**THE COCA-COLA COMPANY AND SUBSIDIARIES**\n\n**CONSOLIDATED STATEMENTS OF SHAREOWNERS’ EQUITY**\n\n(In millions except per share data)\n\n**2024** 2023 2022\n\n**Equity Attributable to Shareowners of The Coca-Cola Company**\n\n**Number of Common Shares Outstanding**\n\nBalance at beginning of year **4,308** 4,328 4,325\n\nTreasury stock issued to employees related to stock-based compensation plans **21** 17 24\n\nPurchases of stock for treasury **(27)** (37) (21)\n\nBalance at end of year **4,302** 4,308 4,328\n\n**Common Stock $ 1,760** $ 1,760 $ 1,760\n\n**Capital Surplus**\n\nBalance at beginning of year **19,209** 18,822 18,116\n\nStock issued to employees related to stock-based compensation plans **319** 177 373\n\nStock-based compensation expense **273** 233 332\n\nAcquisition of interests held by noncontrolling owners **—** (20) —\n\nOther activities **—** (3) 1\n\nBalance at end of year **19,801** 19,209 18,822\n\n**Reinvested Earnings**\n\nBalance at beginning of year **73,782** 71,019 69,094\n\nNet income attributable to shareowners of The Coca-Cola Company **10,631** 10,714 9,542\n\nDividends (per share — $1.94, $1.84 and $1.76 in 2024, 2023 and 2022, respectively) **(8,359)** (7,951) (7,617)\n\nBalance at end of year **76,054** 73,782 71,019\n\n**Accumulated Other Comprehensive Income (Loss)**\n\nBalance at beginning of year **(14,275)** (14,895) (14,330)\n\nNet other comprehensive income (loss) **(2,568)** 620 (565)\n\nBalance at end of year **(16,843)** (14,275) (14,895)\n\n**Treasury Stock**\n\nBalance at beginning of year **(54,535)** (52,601) (51,641)\n\nTreasury stock issued to employees related to stock-based compensation plans **321** 255 376\n\nPurchases of stock for treasury **(1,702)** (2,189) (1,336)\n\nBalance at end of year **(55,916)** (54,535) (52,601)\n\n**Total Equity Attributable to Shareowners of The Coca-Cola Company $ 24,856** $ 25,941 $ 24,105\n\n**Equity Attributable to Noncontrolling Interests**\n\nBalance at beginning of year **$ 1,539** $ 1,721 $ 1,861\n\nNet income attributable to noncontrolling interests **18** (11) 29\n\nNet foreign currency translation adjustments **(9)** (147) (118)\n\nDividends paid to noncontrolling interests **(28)** (25) (51)\n\nAcquisition of interests held by noncontrolling owners **—** (2) —\n\nDivestitures **(4)** — —\n\nOther activities **—** 3 —\n\n**Total Equity Attributable to Noncontrolling Interests $ 1,516** $ 1,539 $ 1,721\n\nRefer to Notes to Consolidated Financial Statements.\n\n66","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**THE COCA-COLA COMPANY AND SUBSIDIARIES**\n\n**CONSOLIDATED STATEMENTS OF SHAREOWNERS’ EQUITY**\n\n(In millions except per share data)\n\n**2024** 2023 2022\n\n**Equity Attributable to Shareowners of The Coca-Cola Company**\n\n**Number of Common Shares Outstanding**\n\nBalance at beginning of year **4,308** 4,328 4,325\n\nTreasury stock issued to employees related to stock-based compensation plans **21** 17 24\n\nPurchases of stock for treasury **(27)** (37) (21)\n\nBalance at end of year **4,302** 4,308 4,328\n\n**Common Stock $ 1,760** $ 1,760 $ 1,760\n\n**Capital Surplus**\n\nBalance at beginning of year **19,209** 18,822 18,116\n\nStock issued to employees related to stock-based compensation plans **319** 177 373\n\nStock-based compensation expense **273** 233 332\n\nAcquisition of interests held by noncontrolling owners **—** (20) —\n\nOther activities **—** (3) 1\n\nBalance at end of year **19,801** 19,209 18,822\n\n**Reinvested Earnings**\n\nBalance at beginning of year **73,782** 71,019 69,094\n\nNet income attributable to shareowners of The Coca-Cola Company **10,631** 10,714 9,542\n\nDividends (per share — $1.94, $1.84 and $1.76 in 2024, 2023 and 2022, respectively) **(8,359)** (7,951) (7,617)\n\nBalance at end of year **76,054** 73,782 71,019\n\n**Accumulated Other Comprehensive Income (Loss)**\n\nBalance at beginning of year **(14,275)** (14,895) (14,330)\n\nNet other comprehensive income (loss) **(2,568)** 620 (565)\n\nBalance at end of year **(16,843)** (14,275) (14,895)\n\n**Treasury Stock**\n\nBalance at beginning of year **(54,535)** (52,601) (51,641)\n\nTreasury stock issued to employees related to stock-based compensation plans **321** 255 376\n\nPurchases of stock for treasury **(1,702)** (2,189) (1,336)\n\nBalance at end of year **(55,916)** (54,535) (52,601)\n\n**Total Equity Attributable to Shareowners of The Coca-Cola Company $ 24,856** $ 25,941 $ 24,105\n\n**Equity Attributable to Noncontrolling Interests**\n\nBalance at beginning of year **$ 1,539** $ 1,721 $ 1,861\n\nNet income attributable to noncontrolling interests **18** (11) 29\n\nNet foreign currency translation adjustments **(9)** (147) (118)\n\nDividends paid to noncontrolling interests **(28)** (25) (51)\n\nAcquisition of interests held by noncontrolling owners **—** (2) —\n\nDivestitures **(4)** — —\n\nOther activities **—** 3 —\n\n**Total Equity Attributable to Noncontrolling Interests $ 1,516** $ 1,539 $ 1,721\n\nRefer to Notes to Consolidated Financial Statements.\n\n66","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page68.pdf"]},"response":{"errors":[],"extract_id":"extract_36cbab0cbc428bdd82826f556bfcf93d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**THE COCA-COLA COMPANY AND SUBSIDIARIES**\n\n**CONSOLIDATED STATEMENTS OF SHAREOWNERS’ EQUITY**\n\n(In millions except per share data)\n\n**2024** 2023 2022\n\n**Equity Attributable to Shareowners of The Coca-Cola Company**\n\n**Number of Common Shares Outstanding**\n\nBalance at beginning of year **4,308** 4,328 4,325\n\nTreasury stock issued to employees related to stock-based compensation plans **21** 17 24\n\nPurchases of stock for treasury **(27)** (37) (21)\n\nBalance at end of year **4,302** 4,308 4,328\n\n**Common Stock $ 1,760** $ 1,760 $ 1,760\n\n**Capital Surplus**\n\nBalance at beginning of year **19,209** 18,822 18,116\n\nStock issued to employees related to stock-based compensation plans **319** 177 373\n\nStock-based compensation expense **273** 233 332\n\nAcquisition of interests held by noncontrolling owners **—** (20) —\n\nOther activities **—** (3) 1\n\nBalance at end of year **19,801** 19,209 18,822\n\n**Reinvested Earnings**\n\nBalance at beginning of year **73,782** 71,019 69,094\n\nNet income attributable to shareowners of The Coca-Cola Company **10,631** 10,714 9,542\n\nDividends (per share — $1.94, $1.84 and $1.76 in 2024, 2023 and 2022, respectively) **(8,359)** (7,951) (7,617)\n\nBalance at end of year **76,054** 73,782 71,019\n\n**Accumulated Other Comprehensive Income (Loss)**\n\nBalance at beginning of year **(14,275)** (14,895) (14,330)\n\nNet other comprehensive income (loss) **(2,568)** 620 (565)\n\nBalance at end of year **(16,843)** (14,275) (14,895)\n\n**Treasury Stock**\n\nBalance at beginning of year **(54,535)** (52,601) (51,641)\n\nTreasury stock issued to employees related to stock-based compensation plans **321** 255 376\n\nPurchases of stock for treasury **(1,702)** (2,189) (1,336)\n\nBalance at end of year **(55,916)** (54,535) (52,601)\n\n**Total Equity Attributable to Shareowners of The Coca-Cola Company $ 24,856** $ 25,941 $ 24,105\n\n**Equity Attributable to Noncontrolling Interests**\n\nBalance at beginning of year **$ 1,539** $ 1,721 $ 1,861\n\nNet income attributable to noncontrolling interests **18** (11) 29\n\nNet foreign currency translation adjustments **(9)** (147) (118)\n\nDividends paid to noncontrolling interests **(28)** (25) (51)\n\nAcquisition of interests held by noncontrolling owners **—** (2) —\n\nDivestitures **(4)** — —\n\nOther activities **—** 3 —\n\n**Total Equity Attributable to Noncontrolling Interests $ 1,516** $ 1,539 $ 1,721\n\nRefer to Notes to Consolidated Financial Statements.\n\n66"],"full_content":"**THE COCA-COLA COMPANY AND SUBSIDIARIES**\n\n**CONSOLIDATED STATEMENTS OF SHAREOWNERS’ EQUITY**\n\n(In millions except per share data)\n\n**2024** 2023 2022\n\n**Equity Attributable to Shareowners of The Coca-Cola Company**\n\n**Number of Common Shares Outstanding**\n\nBalance at beginning of year **4,308** 4,328 4,325\n\nTreasury stock issued to employees related to stock-based compensation plans **21** 17 24\n\nPurchases of stock for treasury **(27)** (37) (21)\n\nBalance at end of year **4,302** 4,308 4,328\n\n**Common Stock $ 1,760** $ 1,760 $ 1,760\n\n**Capital Surplus**\n\nBalance at beginning of year **19,209** 18,822 18,116\n\nStock issued to employees related to stock-based compensation plans **319** 177 373\n\nStock-based compensation expense **273** 233 332\n\nAcquisition of interests held by noncontrolling owners **—** (20) —\n\nOther activities **—** (3) 1\n\nBalance at end of year **19,801** 19,209 18,822\n\n**Reinvested Earnings**\n\nBalance at beginning of year **73,782** 71,019 69,094\n\nNet income attributable to shareowners of The Coca-Cola Company **10,631** 10,714 9,542\n\nDividends (per share — $1.94, $1.84 and $1.76 in 2024, 2023 and 2022, respectively) **(8,359)** (7,951) (7,617)\n\nBalance at end of year **76,054** 73,782 71,019\n\n**Accumulated Other Comprehensive Income (Loss)**\n\nBalance at beginning of year **(14,275)** (14,895) (14,330)\n\nNet other comprehensive income (loss) **(2,568)** 620 (565)\n\nBalance at end of year **(16,843)** (14,275) (14,895)\n\n**Treasury Stock**\n\nBalance at beginning of year **(54,535)** (52,601) (51,641)\n\nTreasury stock issued to employees related to stock-based compensation plans **321** 255 376\n\nPurchases of stock for treasury **(1,702)** (2,189) (1,336)\n\nBalance at end of year **(55,916)** (54,535) (52,601)\n\n**Total Equity Attributable to Shareowners of The Coca-Cola Company $ 24,856** $ 25,941 $ 24,105\n\n**Equity Attributable to Noncontrolling Interests**\n\nBalance at beginning of year **$ 1,539** $ 1,721 $ 1,861\n\nNet income attributable to noncontrolling interests **18** (11) 29\n\nNet foreign currency translation adjustments **(9)** (147) (118)\n\nDividends paid to noncontrolling interests **(28)** (25) (51)\n\nAcquisition of interests held by noncontrolling owners **—** (2) —\n\nDivestitures **(4)** — —\n\nOther activities **—** 3 —\n\n**Total Equity Attributable to Noncontrolling Interests $ 1,516** $ 1,539 $ 1,721\n\nRefer to Notes to Consolidated Financial Statements.\n\n66","publish_date":null,"title":"THE COCA-COLA COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF SHAREOWNERS’ EQUITY (In millions except per share data) Refer to Notes to","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page68.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Coca%20Cola%2010-k_page68.pdf"},"request":{"example_id":"table/Coca Cola 10-k_page68","product_type":"parse","source_file_path":"Coca Cola 10-k_page68.pdf"},"started_at":"2026-11-04T19:47:13.317804"} +{"completed_at":"2026-11-04T19:47:17.520200","latency_in_ms":2716,"output":{"example_id":"table/Cost_Estimating_Guideline (1)_page1","grounded_pages":[],"layout_pages":[],"markdown":"8\n\n**Construction Cost Estimating Table**\n\n**Other Project Types**\n\n(Values updated in year 2016)\n\nProject Category Units Used for Calculations\n\nMedian Cost\n\nper Unit Low Cost Average Cost High Cost\n\nSign Structure Replacement\n\nSign Structure (Overhead or Cantilever)\n\n$278,000 $233,000 $291,000 $387,000\n\nInterchange Construction Interchange $34,640,000 $18,620,000 $29,840,000 $36,270,000\n\nIntersection Widening Intersection $4,740,000 $4,020,000 $5,010,000 $6,540,000\n\nSignalizing an Intersection\n\n4-leg, “T” or “Y”\n\nIntersection $445,000 $290,000 $486,000 $690,000\n\n**Estimate the construction cost for a sign structure replacement project.**\n\nExample: A proposed project to replace eight existing sign structures (overhead and/or cantilever).\n\nEstimate the project’s construction costs as a range.\n\n$233,000/sign structure X 8 sign structures = $1,864,000 (low end)\n\n$387,000/sign structure X 8 sign structures = $3,096,000 (high end)\n\n$278,000/sign structure X 8 sign structures = $2,224,000 (median)\n\n**Estimate the construction cost for a project to eliminate an existing at-grade intersection.**\n\nExample: A proposed project to replace the existing at-grade intersection with a grade-separated interchange.\n\nThe estimated construction cost for this interchange construction project ranges from $18,620,000 to\n\n$36,270,000 with a median price of $34,640,000.\n\n**Estimate the construction cost of adding left-turn lanes at an intersection.**\n\nExample: A proposed operation improvement project to add left-turn lanes at two existing intersections.\n\nEstimate the project’s construction costs as a range.\n\n$4,020,000/intersection X 2 improved intersections = $8,040,000 (low end)\n\n$6,540,000/intersection X 2 improved intersections = $13,080,000 (high end)\n\n$4,740,000/intersection X 2 improved intersections = $9,480,000 (median)\n\n**Concept Development Phase**\n\nFor the scoping stage, the goal is for the Designer to review the order of magnitude construction cost estimate developed during the TIP development and determine what additional information is now known regarding the project scope.","pages":[{"line_numbers":[],"markdown":"8\n\n**Construction Cost Estimating Table**\n\n**Other Project Types**\n\n(Values updated in year 2016)\n\nProject Category Units Used for Calculations\n\nMedian Cost\n\nper Unit Low Cost Average Cost High Cost\n\nSign Structure Replacement\n\nSign Structure (Overhead or Cantilever)\n\n$278,000 $233,000 $291,000 $387,000\n\nInterchange Construction Interchange $34,640,000 $18,620,000 $29,840,000 $36,270,000\n\nIntersection Widening Intersection $4,740,000 $4,020,000 $5,010,000 $6,540,000\n\nSignalizing an Intersection\n\n4-leg, “T” or “Y”\n\nIntersection $445,000 $290,000 $486,000 $690,000\n\n**Estimate the construction cost for a sign structure replacement project.**\n\nExample: A proposed project to replace eight existing sign structures (overhead and/or cantilever).\n\nEstimate the project’s construction costs as a range.\n\n$233,000/sign structure X 8 sign structures = $1,864,000 (low end)\n\n$387,000/sign structure X 8 sign structures = $3,096,000 (high end)\n\n$278,000/sign structure X 8 sign structures = $2,224,000 (median)\n\n**Estimate the construction cost for a project to eliminate an existing at-grade intersection.**\n\nExample: A proposed project to replace the existing at-grade intersection with a grade-separated interchange.\n\nThe estimated construction cost for this interchange construction project ranges from $18,620,000 to\n\n$36,270,000 with a median price of $34,640,000.\n\n**Estimate the construction cost of adding left-turn lanes at an intersection.**\n\nExample: A proposed operation improvement project to add left-turn lanes at two existing intersections.\n\nEstimate the project’s construction costs as a range.\n\n$4,020,000/intersection X 2 improved intersections = $8,040,000 (low end)\n\n$6,540,000/intersection X 2 improved intersections = $13,080,000 (high end)\n\n$4,740,000/intersection X 2 improved intersections = $9,480,000 (median)\n\n**Concept Development Phase**\n\nFor the scoping stage, the goal is for the Designer to review the order of magnitude construction cost estimate developed during the TIP development and determine what additional information is now known regarding the project scope.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"8\n\n**Construction Cost Estimating Table**\n\n**Other Project Types**\n\n(Values updated in year 2016)\n\nProject Category Units Used for Calculations\n\nMedian Cost\n\nper Unit Low Cost Average Cost High Cost\n\nSign Structure Replacement\n\nSign Structure (Overhead or Cantilever)\n\n$278,000 $233,000 $291,000 $387,000\n\nInterchange Construction Interchange $34,640,000 $18,620,000 $29,840,000 $36,270,000\n\nIntersection Widening Intersection $4,740,000 $4,020,000 $5,010,000 $6,540,000\n\nSignalizing an Intersection\n\n4-leg, “T” or “Y”\n\nIntersection $445,000 $290,000 $486,000 $690,000\n\n**Estimate the construction cost for a sign structure replacement project.**\n\nExample: A proposed project to replace eight existing sign structures (overhead and/or cantilever).\n\nEstimate the project’s construction costs as a range.\n\n$233,000/sign structure X 8 sign structures = $1,864,000 (low end)\n\n$387,000/sign structure X 8 sign structures = $3,096,000 (high end)\n\n$278,000/sign structure X 8 sign structures = $2,224,000 (median)\n\n**Estimate the construction cost for a project to eliminate an existing at-grade intersection.**\n\nExample: A proposed project to replace the existing at-grade intersection with a grade-separated interchange.\n\nThe estimated construction cost for this interchange construction project ranges from $18,620,000 to\n\n$36,270,000 with a median price of $34,640,000.\n\n**Estimate the construction cost of adding left-turn lanes at an intersection.**\n\nExample: A proposed operation improvement project to add left-turn lanes at two existing intersections.\n\nEstimate the project’s construction costs as a range.\n\n$4,020,000/intersection X 2 improved intersections = $8,040,000 (low end)\n\n$6,540,000/intersection X 2 improved intersections = $13,080,000 (high end)\n\n$4,740,000/intersection X 2 improved intersections = $9,480,000 (median)\n\n**Concept Development Phase**\n\nFor the scoping stage, the goal is for the Designer to review the order of magnitude construction cost estimate developed during the TIP development and determine what additional information is now known regarding the project scope.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Cost_Estimating_Guideline%20%281%29_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_a95f4519f4d62f48b7843214b397d7d5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["8\n\n**Construction Cost Estimating Table**\n\n**Other Project Types**\n\n(Values updated in year 2016)\n\nProject Category Units Used for Calculations\n\nMedian Cost\n\nper Unit Low Cost Average Cost High Cost\n\nSign Structure Replacement\n\nSign Structure (Overhead or Cantilever)\n\n$278,000 $233,000 $291,000 $387,000\n\nInterchange Construction Interchange $34,640,000 $18,620,000 $29,840,000 $36,270,000\n\nIntersection Widening Intersection $4,740,000 $4,020,000 $5,010,000 $6,540,000\n\nSignalizing an Intersection\n\n4-leg, “T” or “Y”\n\nIntersection $445,000 $290,000 $486,000 $690,000\n\n**Estimate the construction cost for a sign structure replacement project.**\n\nExample: A proposed project to replace eight existing sign structures (overhead and/or cantilever).\n\nEstimate the project’s construction costs as a range.\n\n$233,000/sign structure X 8 sign structures = $1,864,000 (low end)\n\n$387,000/sign structure X 8 sign structures = $3,096,000 (high end)\n\n$278,000/sign structure X 8 sign structures = $2,224,000 (median)\n\n**Estimate the construction cost for a project to eliminate an existing at-grade intersection.**\n\nExample: A proposed project to replace the existing at-grade intersection with a grade-separated interchange.\n\nThe estimated construction cost for this interchange construction project ranges from $18,620,000 to\n\n$36,270,000 with a median price of $34,640,000.\n\n**Estimate the construction cost of adding left-turn lanes at an intersection.**\n\nExample: A proposed operation improvement project to add left-turn lanes at two existing intersections.\n\nEstimate the project’s construction costs as a range.\n\n$4,020,000/intersection X 2 improved intersections = $8,040,000 (low end)\n\n$6,540,000/intersection X 2 improved intersections = $13,080,000 (high end)\n\n$4,740,000/intersection X 2 improved intersections = $9,480,000 (median)\n\n**Concept Development Phase**\n\nFor the scoping stage, the goal is for the Designer to review the order of magnitude construction cost estimate developed during the TIP development and determine what additional information is now known regarding the project scope."],"full_content":"8\n\n**Construction Cost Estimating Table**\n\n**Other Project Types**\n\n(Values updated in year 2016)\n\nProject Category Units Used for Calculations\n\nMedian Cost\n\nper Unit Low Cost Average Cost High Cost\n\nSign Structure Replacement\n\nSign Structure (Overhead or Cantilever)\n\n$278,000 $233,000 $291,000 $387,000\n\nInterchange Construction Interchange $34,640,000 $18,620,000 $29,840,000 $36,270,000\n\nIntersection Widening Intersection $4,740,000 $4,020,000 $5,010,000 $6,540,000\n\nSignalizing an Intersection\n\n4-leg, “T” or “Y”\n\nIntersection $445,000 $290,000 $486,000 $690,000\n\n**Estimate the construction cost for a sign structure replacement project.**\n\nExample: A proposed project to replace eight existing sign structures (overhead and/or cantilever).\n\nEstimate the project’s construction costs as a range.\n\n$233,000/sign structure X 8 sign structures = $1,864,000 (low end)\n\n$387,000/sign structure X 8 sign structures = $3,096,000 (high end)\n\n$278,000/sign structure X 8 sign structures = $2,224,000 (median)\n\n**Estimate the construction cost for a project to eliminate an existing at-grade intersection.**\n\nExample: A proposed project to replace the existing at-grade intersection with a grade-separated interchange.\n\nThe estimated construction cost for this interchange construction project ranges from $18,620,000 to\n\n$36,270,000 with a median price of $34,640,000.\n\n**Estimate the construction cost of adding left-turn lanes at an intersection.**\n\nExample: A proposed operation improvement project to add left-turn lanes at two existing intersections.\n\nEstimate the project’s construction costs as a range.\n\n$4,020,000/intersection X 2 improved intersections = $8,040,000 (low end)\n\n$6,540,000/intersection X 2 improved intersections = $13,080,000 (high end)\n\n$4,740,000/intersection X 2 improved intersections = $9,480,000 (median)\n\n**Concept Development Phase**\n\nFor the scoping stage, the goal is for the Designer to review the order of magnitude construction cost estimate developed during the TIP development and determine what additional information is now known regarding the project scope.","publish_date":null,"title":"Construction Cost Estimating Table Other Project Types (Values updated in year 2016) Units Used for Median Cost Project Category Low","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Cost_Estimating_Guideline%20%281%29_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Cost_Estimating_Guideline%20%281%29_page1.pdf"},"request":{"example_id":"table/Cost_Estimating_Guideline (1)_page1","product_type":"parse","source_file_path":"Cost_Estimating_Guideline (1)_page1.pdf"},"started_at":"2026-11-04T19:47:14.804181"} +{"completed_at":"2026-11-04T19:31:20.030882","latency_in_ms":1137,"output":{"example_id":"table/Cost_Estimating_Guideline (1)_page3","grounded_pages":[],"layout_pages":[],"markdown":"10\n\n**Final Design Phase** Several cost estimates are prepared during the FD phase. Near the beginning of the FD phase a comprehensive utility estimate is prepared under the activity, _Prepare Utility Agreement Plans, Specifications and Estimates_ . The estimate is prepared utilizing the approved utility relocation checklists and the utility agreement plans.\n\nToward the end of the FD phase and just prior to the preparation of the Final Design Submission, the Department utilizes estimating software to _Develop Construction Cost Estimate_ . This estimate is a detailed itemized estimate utilizing contract qualities and historical bid item prices.\n\n**PS&E Development** The Designer prepares and submits the Cost Estimate package to the Project Manager. This estimate is an itemized estimate utilizing contract quantities adjusted as per the Final Design Submission review comments. The construction cost estimate is to be developed using AASHTOWare software and Historical bid-based Estimating, Historical Percentages Estimating, or Cost-based Estimating, as needed.\n\n**2\\.2 NJDOT Cost Estimating Process Summary**\n\nThe following summary is meant to provide an overview for the NJDOT project cost estimation process:\n\n**Table 2.2** **–** **Summary**\n\n**Estimating Stages**\n\n**Estimating Phases**\n\n**Estimate Estimate developed or Updated**\n\n**Estimate developed by**\n\n**Where Estimate is published Type Method**\n\nProgramming and Planning\n\nProblem Screening Phase\n\nConceptual/ planning level estimate\n\nSimilar Projects and Historical Percentages\n\n TIP estimate\n\nCapital Project Management\n\nSTIP and PRS, Budget Info tab\n\nScoping\n\nConcept Development Phase\n\nBaseline estimate\n\nSimilar Projects and Historical Percentages\n\nPreliminary Construction Cost Estimate\n\nDesigner PRS, Budget Info tab\n\nConcept Development ROW and Access Cost Estimate\n\nROW PRS, Budget Info tab\n\nDesign Development\n\nPreliminary Engineering\n\nMid-level estimate\n\nCost Estimation System (CES) software\n\nConstruction Cost Estimate Designer PRS, Budget Info tab\n\nFinal Design Phases\n\nDetailed itemized estimate\n\nCost Estimation System (CES) software\n\nConstruction Cost Estimate Designer PRS, Budget Info tab","pages":[{"line_numbers":[],"markdown":"10\n\n**Final Design Phase** Several cost estimates are prepared during the FD phase. Near the beginning of the FD phase a comprehensive utility estimate is prepared under the activity, _Prepare Utility Agreement Plans, Specifications and Estimates_ . The estimate is prepared utilizing the approved utility relocation checklists and the utility agreement plans.\n\nToward the end of the FD phase and just prior to the preparation of the Final Design Submission, the Department utilizes estimating software to _Develop Construction Cost Estimate_ . This estimate is a detailed itemized estimate utilizing contract qualities and historical bid item prices.\n\n**PS&E Development** The Designer prepares and submits the Cost Estimate package to the Project Manager. This estimate is an itemized estimate utilizing contract quantities adjusted as per the Final Design Submission review comments. The construction cost estimate is to be developed using AASHTOWare software and Historical bid-based Estimating, Historical Percentages Estimating, or Cost-based Estimating, as needed.\n\n**2\\.2 NJDOT Cost Estimating Process Summary**\n\nThe following summary is meant to provide an overview for the NJDOT project cost estimation process:\n\n**Table 2.2** **–** **Summary**\n\n**Estimating Stages**\n\n**Estimating Phases**\n\n**Estimate Estimate developed or Updated**\n\n**Estimate developed by**\n\n**Where Estimate is published Type Method**\n\nProgramming and Planning\n\nProblem Screening Phase\n\nConceptual/ planning level estimate\n\nSimilar Projects and Historical Percentages\n\n TIP estimate\n\nCapital Project Management\n\nSTIP and PRS, Budget Info tab\n\nScoping\n\nConcept Development Phase\n\nBaseline estimate\n\nSimilar Projects and Historical Percentages\n\nPreliminary Construction Cost Estimate\n\nDesigner PRS, Budget Info tab\n\nConcept Development ROW and Access Cost Estimate\n\nROW PRS, Budget Info tab\n\nDesign Development\n\nPreliminary Engineering\n\nMid-level estimate\n\nCost Estimation System (CES) software\n\nConstruction Cost Estimate Designer PRS, Budget Info tab\n\nFinal Design Phases\n\nDetailed itemized estimate\n\nCost Estimation System (CES) software\n\nConstruction Cost Estimate Designer PRS, Budget Info tab","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"10\n\n**Final Design Phase** Several cost estimates are prepared during the FD phase. Near the beginning of the FD phase a comprehensive utility estimate is prepared under the activity, _Prepare Utility Agreement Plans, Specifications and Estimates_ . The estimate is prepared utilizing the approved utility relocation checklists and the utility agreement plans.\n\nToward the end of the FD phase and just prior to the preparation of the Final Design Submission, the Department utilizes estimating software to _Develop Construction Cost Estimate_ . This estimate is a detailed itemized estimate utilizing contract qualities and historical bid item prices.\n\n**PS&E Development** The Designer prepares and submits the Cost Estimate package to the Project Manager. This estimate is an itemized estimate utilizing contract quantities adjusted as per the Final Design Submission review comments. The construction cost estimate is to be developed using AASHTOWare software and Historical bid-based Estimating, Historical Percentages Estimating, or Cost-based Estimating, as needed.\n\n**2\\.2 NJDOT Cost Estimating Process Summary**\n\nThe following summary is meant to provide an overview for the NJDOT project cost estimation process:\n\n**Table 2.2** **–** **Summary**\n\n**Estimating Stages**\n\n**Estimating Phases**\n\n**Estimate Estimate developed or Updated**\n\n**Estimate developed by**\n\n**Where Estimate is published Type Method**\n\nProgramming and Planning\n\nProblem Screening Phase\n\nConceptual/ planning level estimate\n\nSimilar Projects and Historical Percentages\n\n TIP estimate\n\nCapital Project Management\n\nSTIP and PRS, Budget Info tab\n\nScoping\n\nConcept Development Phase\n\nBaseline estimate\n\nSimilar Projects and Historical Percentages\n\nPreliminary Construction Cost Estimate\n\nDesigner PRS, Budget Info tab\n\nConcept Development ROW and Access Cost Estimate\n\nROW PRS, Budget Info tab\n\nDesign Development\n\nPreliminary Engineering\n\nMid-level estimate\n\nCost Estimation System (CES) software\n\nConstruction Cost Estimate Designer PRS, Budget Info tab\n\nFinal Design Phases\n\nDetailed itemized estimate\n\nCost Estimation System (CES) software\n\nConstruction Cost Estimate Designer PRS, Budget Info tab","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Cost_Estimating_Guideline%20%281%29_page3.pdf"]},"response":{"errors":[],"extract_id":"extract_6812d7c3efd13ca9d4b119d8a5247995","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["10\n\n**Final Design Phase** Several cost estimates are prepared during the FD phase. Near the beginning of the FD phase a comprehensive utility estimate is prepared under the activity, _Prepare Utility Agreement Plans, Specifications and Estimates_ . The estimate is prepared utilizing the approved utility relocation checklists and the utility agreement plans.\n\nToward the end of the FD phase and just prior to the preparation of the Final Design Submission, the Department utilizes estimating software to _Develop Construction Cost Estimate_ . This estimate is a detailed itemized estimate utilizing contract qualities and historical bid item prices.\n\n**PS&E Development** The Designer prepares and submits the Cost Estimate package to the Project Manager. This estimate is an itemized estimate utilizing contract quantities adjusted as per the Final Design Submission review comments. The construction cost estimate is to be developed using AASHTOWare software and Historical bid-based Estimating, Historical Percentages Estimating, or Cost-based Estimating, as needed.\n\n**2\\.2 NJDOT Cost Estimating Process Summary**\n\nThe following summary is meant to provide an overview for the NJDOT project cost estimation process:\n\n**Table 2.2** **–** **Summary**\n\n**Estimating Stages**\n\n**Estimating Phases**\n\n**Estimate Estimate developed or Updated**\n\n**Estimate developed by**\n\n**Where Estimate is published Type Method**\n\nProgramming and Planning\n\nProblem Screening Phase\n\nConceptual/ planning level estimate\n\nSimilar Projects and Historical Percentages\n\n TIP estimate\n\nCapital Project Management\n\nSTIP and PRS, Budget Info tab\n\nScoping\n\nConcept Development Phase\n\nBaseline estimate\n\nSimilar Projects and Historical Percentages\n\nPreliminary Construction Cost Estimate\n\nDesigner PRS, Budget Info tab\n\nConcept Development ROW and Access Cost Estimate\n\nROW PRS, Budget Info tab\n\nDesign Development\n\nPreliminary Engineering\n\nMid-level estimate\n\nCost Estimation System (CES) software\n\nConstruction Cost Estimate Designer PRS, Budget Info tab\n\nFinal Design Phases\n\nDetailed itemized estimate\n\nCost Estimation System (CES) software\n\nConstruction Cost Estimate Designer PRS, Budget Info tab"],"full_content":"10\n\n**Final Design Phase** Several cost estimates are prepared during the FD phase. Near the beginning of the FD phase a comprehensive utility estimate is prepared under the activity, _Prepare Utility Agreement Plans, Specifications and Estimates_ . The estimate is prepared utilizing the approved utility relocation checklists and the utility agreement plans.\n\nToward the end of the FD phase and just prior to the preparation of the Final Design Submission, the Department utilizes estimating software to _Develop Construction Cost Estimate_ . This estimate is a detailed itemized estimate utilizing contract qualities and historical bid item prices.\n\n**PS&E Development** The Designer prepares and submits the Cost Estimate package to the Project Manager. This estimate is an itemized estimate utilizing contract quantities adjusted as per the Final Design Submission review comments. The construction cost estimate is to be developed using AASHTOWare software and Historical bid-based Estimating, Historical Percentages Estimating, or Cost-based Estimating, as needed.\n\n**2\\.2 NJDOT Cost Estimating Process Summary**\n\nThe following summary is meant to provide an overview for the NJDOT project cost estimation process:\n\n**Table 2.2** **–** **Summary**\n\n**Estimating Stages**\n\n**Estimating Phases**\n\n**Estimate Estimate developed or Updated**\n\n**Estimate developed by**\n\n**Where Estimate is published Type Method**\n\nProgramming and Planning\n\nProblem Screening Phase\n\nConceptual/ planning level estimate\n\nSimilar Projects and Historical Percentages\n\n TIP estimate\n\nCapital Project Management\n\nSTIP and PRS, Budget Info tab\n\nScoping\n\nConcept Development Phase\n\nBaseline estimate\n\nSimilar Projects and Historical Percentages\n\nPreliminary Construction Cost Estimate\n\nDesigner PRS, Budget Info tab\n\nConcept Development ROW and Access Cost Estimate\n\nROW PRS, Budget Info tab\n\nDesign Development\n\nPreliminary Engineering\n\nMid-level estimate\n\nCost Estimation System (CES) software\n\nConstruction Cost Estimate Designer PRS, Budget Info tab\n\nFinal Design Phases\n\nDetailed itemized estimate\n\nCost Estimation System (CES) software\n\nConstruction Cost Estimate Designer PRS, Budget Info tab","publish_date":null,"title":"Several cost estimates are prepared during the FD phase. Near the beginning of the FD phase a comprehensive utility estimate","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Cost_Estimating_Guideline%20%281%29_page3.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Cost_Estimating_Guideline%20%281%29_page3.pdf"},"request":{"example_id":"table/Cost_Estimating_Guideline (1)_page3","product_type":"parse","source_file_path":"Cost_Estimating_Guideline (1)_page3.pdf"},"started_at":"2026-11-04T19:31:18.893674"} +{"completed_at":"2026-11-04T19:47:18.124270","latency_in_ms":1450,"output":{"example_id":"table/Cost_Estimating_Guideline (1)_page6","grounded_pages":[],"layout_pages":[],"markdown":"13\n\nObtain appropriate approvals\n\nObtain authorization to proceed by:  Review of current project scope and estimate basis\n\n Securing approvals from appropriate management levels\n\n Approval of current estimates, including any changes from previous estimates\n\n Release of estimate for its intended purpose and use\n\n**2\\.5 Project Estimate File**\n\nEstimates are created by the collaborative effort of many units (e.g., highway, structures, traffic). To be able to follow the assumptions upon which the construction cost estimate is based and to preserve the information for future projects, all estimates and their supporting documentation must be stored in the project estimate file that can be easily accessed by hard-copy or electronically as a folder within the general project file. The Project Manager is responsible for the creation and maintenance of the project estimate file.\n\nA project estimate file provides a record that documents the basic reasons behind the original estimated construction cost, as well as reasons for subsequent construction cost revisions. The project estimate file should, at a minimum, contain the Cost Driver Analysis Form of appropriate categories of work at each project milestone for each cost estimate developed including any assumptions that have been made, the current project scope, and a copy of or reference to the cost data that were used to develop the construction cost estimate. This information should be included in the project estimate file regardless of project development stage—the creation of the file begins with the very first estimate. When items are estimated by percentages or other costs, as is often done for miscellaneous and utility costs, the percentage should also be documented in the project estimate file.\n\nDepending on the point in time in the project development cycle, the amount and type of documentation contained in the project estimate file will vary. Information used to develop the funding estimate, such as cost-per-mile factors or other parametric estimates, should be well documented, and included in the project estimation file. Additionally, any line item prices that are higher or lower from the bid item history costs must be well documented in the project estimate file. Information that may be included in the project estimate file may consist of references to bid tabulation data, unit bid price book data, or some other reputable resources. The estimate file can also provide other project descriptive information, such as trends that affect item(s) cost, cost from similar past projects, and external factors that limit construction operations.\n\nGood documentation supports the cost estimate's credibility, aids in the analysis of changes in project cost, enables reviewers to effectively assess the construction estimate, and contributes to the collection of information for estimating the cost of future projects. Each project's construction cost estimate will be a well-documented history of the assumptions, methods, and procedures used to estimate the costs associated with the project's specific scope of work.\n\n**Other Estimate Documentation** At each project development milestone, the level of information must be documented regarding how the estimated cost was obtained to allow an independent reviewer to determine whether the estimate is complete, accurate, and realistic. The following information should be provided at each milestone:","pages":[{"line_numbers":[],"markdown":"13\n\nObtain appropriate approvals\n\nObtain authorization to proceed by:  Review of current project scope and estimate basis\n\n Securing approvals from appropriate management levels\n\n Approval of current estimates, including any changes from previous estimates\n\n Release of estimate for its intended purpose and use\n\n**2\\.5 Project Estimate File**\n\nEstimates are created by the collaborative effort of many units (e.g., highway, structures, traffic). To be able to follow the assumptions upon which the construction cost estimate is based and to preserve the information for future projects, all estimates and their supporting documentation must be stored in the project estimate file that can be easily accessed by hard-copy or electronically as a folder within the general project file. The Project Manager is responsible for the creation and maintenance of the project estimate file.\n\nA project estimate file provides a record that documents the basic reasons behind the original estimated construction cost, as well as reasons for subsequent construction cost revisions. The project estimate file should, at a minimum, contain the Cost Driver Analysis Form of appropriate categories of work at each project milestone for each cost estimate developed including any assumptions that have been made, the current project scope, and a copy of or reference to the cost data that were used to develop the construction cost estimate. This information should be included in the project estimate file regardless of project development stage—the creation of the file begins with the very first estimate. When items are estimated by percentages or other costs, as is often done for miscellaneous and utility costs, the percentage should also be documented in the project estimate file.\n\nDepending on the point in time in the project development cycle, the amount and type of documentation contained in the project estimate file will vary. Information used to develop the funding estimate, such as cost-per-mile factors or other parametric estimates, should be well documented, and included in the project estimation file. Additionally, any line item prices that are higher or lower from the bid item history costs must be well documented in the project estimate file. Information that may be included in the project estimate file may consist of references to bid tabulation data, unit bid price book data, or some other reputable resources. The estimate file can also provide other project descriptive information, such as trends that affect item(s) cost, cost from similar past projects, and external factors that limit construction operations.\n\nGood documentation supports the cost estimate's credibility, aids in the analysis of changes in project cost, enables reviewers to effectively assess the construction estimate, and contributes to the collection of information for estimating the cost of future projects. Each project's construction cost estimate will be a well-documented history of the assumptions, methods, and procedures used to estimate the costs associated with the project's specific scope of work.\n\n**Other Estimate Documentation** At each project development milestone, the level of information must be documented regarding how the estimated cost was obtained to allow an independent reviewer to determine whether the estimate is complete, accurate, and realistic. The following information should be provided at each milestone:","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"13\n\nObtain appropriate approvals\n\nObtain authorization to proceed by:  Review of current project scope and estimate basis\n\n Securing approvals from appropriate management levels\n\n Approval of current estimates, including any changes from previous estimates\n\n Release of estimate for its intended purpose and use\n\n**2\\.5 Project Estimate File**\n\nEstimates are created by the collaborative effort of many units (e.g., highway, structures, traffic). To be able to follow the assumptions upon which the construction cost estimate is based and to preserve the information for future projects, all estimates and their supporting documentation must be stored in the project estimate file that can be easily accessed by hard-copy or electronically as a folder within the general project file. The Project Manager is responsible for the creation and maintenance of the project estimate file.\n\nA project estimate file provides a record that documents the basic reasons behind the original estimated construction cost, as well as reasons for subsequent construction cost revisions. The project estimate file should, at a minimum, contain the Cost Driver Analysis Form of appropriate categories of work at each project milestone for each cost estimate developed including any assumptions that have been made, the current project scope, and a copy of or reference to the cost data that were used to develop the construction cost estimate. This information should be included in the project estimate file regardless of project development stage—the creation of the file begins with the very first estimate. When items are estimated by percentages or other costs, as is often done for miscellaneous and utility costs, the percentage should also be documented in the project estimate file.\n\nDepending on the point in time in the project development cycle, the amount and type of documentation contained in the project estimate file will vary. Information used to develop the funding estimate, such as cost-per-mile factors or other parametric estimates, should be well documented, and included in the project estimation file. Additionally, any line item prices that are higher or lower from the bid item history costs must be well documented in the project estimate file. Information that may be included in the project estimate file may consist of references to bid tabulation data, unit bid price book data, or some other reputable resources. The estimate file can also provide other project descriptive information, such as trends that affect item(s) cost, cost from similar past projects, and external factors that limit construction operations.\n\nGood documentation supports the cost estimate's credibility, aids in the analysis of changes in project cost, enables reviewers to effectively assess the construction estimate, and contributes to the collection of information for estimating the cost of future projects. Each project's construction cost estimate will be a well-documented history of the assumptions, methods, and procedures used to estimate the costs associated with the project's specific scope of work.\n\n**Other Estimate Documentation** At each project development milestone, the level of information must be documented regarding how the estimated cost was obtained to allow an independent reviewer to determine whether the estimate is complete, accurate, and realistic. The following information should be provided at each milestone:","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Cost_Estimating_Guideline%20%281%29_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_1d86e89f007c733b93a0e5762d2b5759","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["13\n\nObtain appropriate approvals\n\nObtain authorization to proceed by:  Review of current project scope and estimate basis\n\n Securing approvals from appropriate management levels\n\n Approval of current estimates, including any changes from previous estimates\n\n Release of estimate for its intended purpose and use\n\n**2\\.5 Project Estimate File**\n\nEstimates are created by the collaborative effort of many units (e.g., highway, structures, traffic). To be able to follow the assumptions upon which the construction cost estimate is based and to preserve the information for future projects, all estimates and their supporting documentation must be stored in the project estimate file that can be easily accessed by hard-copy or electronically as a folder within the general project file. The Project Manager is responsible for the creation and maintenance of the project estimate file.\n\nA project estimate file provides a record that documents the basic reasons behind the original estimated construction cost, as well as reasons for subsequent construction cost revisions. The project estimate file should, at a minimum, contain the Cost Driver Analysis Form of appropriate categories of work at each project milestone for each cost estimate developed including any assumptions that have been made, the current project scope, and a copy of or reference to the cost data that were used to develop the construction cost estimate. This information should be included in the project estimate file regardless of project development stage—the creation of the file begins with the very first estimate. When items are estimated by percentages or other costs, as is often done for miscellaneous and utility costs, the percentage should also be documented in the project estimate file.\n\nDepending on the point in time in the project development cycle, the amount and type of documentation contained in the project estimate file will vary. Information used to develop the funding estimate, such as cost-per-mile factors or other parametric estimates, should be well documented, and included in the project estimation file. Additionally, any line item prices that are higher or lower from the bid item history costs must be well documented in the project estimate file. Information that may be included in the project estimate file may consist of references to bid tabulation data, unit bid price book data, or some other reputable resources. The estimate file can also provide other project descriptive information, such as trends that affect item(s) cost, cost from similar past projects, and external factors that limit construction operations.\n\nGood documentation supports the cost estimate's credibility, aids in the analysis of changes in project cost, enables reviewers to effectively assess the construction estimate, and contributes to the collection of information for estimating the cost of future projects. Each project's construction cost estimate will be a well-documented history of the assumptions, methods, and procedures used to estimate the costs associated with the project's specific scope of work.\n\n**Other Estimate Documentation** At each project development milestone, the level of information must be documented regarding how the estimated cost was obtained to allow an independent reviewer to determine whether the estimate is complete, accurate, and realistic. The following information should be provided at each milestone:"],"full_content":"13\n\nObtain appropriate approvals\n\nObtain authorization to proceed by:  Review of current project scope and estimate basis\n\n Securing approvals from appropriate management levels\n\n Approval of current estimates, including any changes from previous estimates\n\n Release of estimate for its intended purpose and use\n\n**2\\.5 Project Estimate File**\n\nEstimates are created by the collaborative effort of many units (e.g., highway, structures, traffic). To be able to follow the assumptions upon which the construction cost estimate is based and to preserve the information for future projects, all estimates and their supporting documentation must be stored in the project estimate file that can be easily accessed by hard-copy or electronically as a folder within the general project file. The Project Manager is responsible for the creation and maintenance of the project estimate file.\n\nA project estimate file provides a record that documents the basic reasons behind the original estimated construction cost, as well as reasons for subsequent construction cost revisions. The project estimate file should, at a minimum, contain the Cost Driver Analysis Form of appropriate categories of work at each project milestone for each cost estimate developed including any assumptions that have been made, the current project scope, and a copy of or reference to the cost data that were used to develop the construction cost estimate. This information should be included in the project estimate file regardless of project development stage—the creation of the file begins with the very first estimate. When items are estimated by percentages or other costs, as is often done for miscellaneous and utility costs, the percentage should also be documented in the project estimate file.\n\nDepending on the point in time in the project development cycle, the amount and type of documentation contained in the project estimate file will vary. Information used to develop the funding estimate, such as cost-per-mile factors or other parametric estimates, should be well documented, and included in the project estimation file. Additionally, any line item prices that are higher or lower from the bid item history costs must be well documented in the project estimate file. Information that may be included in the project estimate file may consist of references to bid tabulation data, unit bid price book data, or some other reputable resources. The estimate file can also provide other project descriptive information, such as trends that affect item(s) cost, cost from similar past projects, and external factors that limit construction operations.\n\nGood documentation supports the cost estimate's credibility, aids in the analysis of changes in project cost, enables reviewers to effectively assess the construction estimate, and contributes to the collection of information for estimating the cost of future projects. Each project's construction cost estimate will be a well-documented history of the assumptions, methods, and procedures used to estimate the costs associated with the project's specific scope of work.\n\n**Other Estimate Documentation** At each project development milestone, the level of information must be documented regarding how the estimated cost was obtained to allow an independent reviewer to determine whether the estimate is complete, accurate, and realistic. The following information should be provided at each milestone:","publish_date":null,"title":"Obtain authorization to proceed by:  Review of current project scope and estimate basis  Securing approvals from appropriate management","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Cost_Estimating_Guideline%20%281%29_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Cost_Estimating_Guideline%20%281%29_page6.pdf"},"request":{"example_id":"table/Cost_Estimating_Guideline (1)_page6","product_type":"parse","source_file_path":"Cost_Estimating_Guideline (1)_page6.pdf"},"started_at":"2026-11-04T19:47:16.673842"} +{"completed_at":"2026-11-04T19:47:21.745759","latency_in_ms":3618,"output":{"example_id":"table/DLR.2004.page_61.pdf_21918_page1","grounded_pages":[],"layout_pages":[],"markdown":"**DIGITAL REALTY TRUST, INC. AND DIGITAL REALTY TRUST, INC. PREDECESSOR**\n\n**CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS’ AND OWNERS’ EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (in thousands, except share data)**\n\n**Number of Common Shares**\n\n**Common Stock**\n\n**Additional Paid-in Capital**\n\n**Dividends In Excess of Earnings**\n\n**Accumulated Other Comprehensive Income, net**\n\n**Owner’s Equity Total**\n\n**Balance at December 31, 2001** . . **— $— $ — $ — $ — $ 990 $ 990** Contributions . . . . . . . . . . . . . . . . . — — — — — 86,090 86,090 Distributions . . . . . . . . . . . . . . . . . . — — — — — (4,305) (4,305) Net loss . . . . . . . . . . . . . . . . . . . . . . — — — — — (61) (61) Other Comprehensive Income—Foreign currency translation adjustments . . . . . . . . — — — — 463 — 463\n\nComprehensive income . . . . . . . . . 402\n\n**Balance at December 31, 2002** . . **— — — — 463 82,714 83,177** Contributions . . . . . . . . . . . . . . . . . — — — — — 131,181 131,181 Distributions . . . . . . . . . . . . . . . . . . — — — — — (82,891) (82,891) Net income . . . . . . . . . . . . . . . . . . . — — — — — 16,642 16,642 Other Comprehensive Income—Foreign currency translation adjustments . . . . . . . . — — — — (158) — (158)\n\nComprehensive income . . . . . . . . . 16,484\n\n**Balance at December 31, 2003** . . **— — — — 305 147,646 147,951** Contributions . . . . . . . . . . . . . . . . . — — — — — 130,264 130,264 Distributions . . . . . . . . . . . . . . . . . . — — — — — (68,971) (68,971) Net income . . . . . . . . . . . . . . . . . . . — — — — — 10,726 10,726 Other comprehensive income—Foreign currency translation adjustments . . . . . . . . — — — — 33 — 33\n\nComprehensive income . . . . . . . . . 10,759\n\n**Balance at November 2, 2004** . . . **— — — — 338 219,665 220,003 The Company** Reclassify Predecessor owner’s equity . . . . . . . . . . . . . . . . . . . . . — — 219,665 — — (219,665) — Net proceeds from sale of common stock . . . . . . . . . . . . . . . . . . . . . . 21,421,300 214 230,584 — — — 230,798 Record minority interests . . . . . . . . — — (267,851) — (201) — (268,052) Amortization of fair market value of stock options, net of minority interests . . . . . . . . . . . . . . . . . . . — — 13 — — — 13 Dividends . . . . . . . . . . . . . . . . . . . . — — — (3,348) — — (3,348) Net loss . . . . . . . . . . . . . . . . . . . . . . — — — (6,169) — — (6,169) Other comprehensive loss—Fair value of interest rate swaps, net of minority interests . . . . . . . . . . — — — — (11) — (11) Other comprehensive loss—Foreign currency translation adjustments, net of minority interests . . . . . . . . . . . . — — — — (35) — (35)\n\nComprehensive loss . . . . . . . . . . . . (6,215)\n\n**Balance at December 31, 2004** . . **21,421,300 $214 $ 182,411 $(9,517) $ 91 $ — $ 173,199**\n\nSee accompanying notes to the consolidated and combined financial statements.\n\n51","pages":[{"line_numbers":[],"markdown":"**DIGITAL REALTY TRUST, INC. AND DIGITAL REALTY TRUST, INC. PREDECESSOR**\n\n**CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS’ AND OWNERS’ EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (in thousands, except share data)**\n\n**Number of Common Shares**\n\n**Common Stock**\n\n**Additional Paid-in Capital**\n\n**Dividends In Excess of Earnings**\n\n**Accumulated Other Comprehensive Income, net**\n\n**Owner’s Equity Total**\n\n**Balance at December 31, 2001** . . **— $— $ — $ — $ — $ 990 $ 990** Contributions . . . . . . . . . . . . . . . . . — — — — — 86,090 86,090 Distributions . . . . . . . . . . . . . . . . . . — — — — — (4,305) (4,305) Net loss . . . . . . . . . . . . . . . . . . . . . . — — — — — (61) (61) Other Comprehensive Income—Foreign currency translation adjustments . . . . . . . . — — — — 463 — 463\n\nComprehensive income . . . . . . . . . 402\n\n**Balance at December 31, 2002** . . **— — — — 463 82,714 83,177** Contributions . . . . . . . . . . . . . . . . . — — — — — 131,181 131,181 Distributions . . . . . . . . . . . . . . . . . . — — — — — (82,891) (82,891) Net income . . . . . . . . . . . . . . . . . . . — — — — — 16,642 16,642 Other Comprehensive Income—Foreign currency translation adjustments . . . . . . . . — — — — (158) — (158)\n\nComprehensive income . . . . . . . . . 16,484\n\n**Balance at December 31, 2003** . . **— — — — 305 147,646 147,951** Contributions . . . . . . . . . . . . . . . . . — — — — — 130,264 130,264 Distributions . . . . . . . . . . . . . . . . . . — — — — — (68,971) (68,971) Net income . . . . . . . . . . . . . . . . . . . — — — — — 10,726 10,726 Other comprehensive income—Foreign currency translation adjustments . . . . . . . . — — — — 33 — 33\n\nComprehensive income . . . . . . . . . 10,759\n\n**Balance at November 2, 2004** . . . **— — — — 338 219,665 220,003 The Company** Reclassify Predecessor owner’s equity . . . . . . . . . . . . . . . . . . . . . — — 219,665 — — (219,665) — Net proceeds from sale of common stock . . . . . . . . . . . . . . . . . . . . . . 21,421,300 214 230,584 — — — 230,798 Record minority interests . . . . . . . . — — (267,851) — (201) — (268,052) Amortization of fair market value of stock options, net of minority interests . . . . . . . . . . . . . . . . . . . — — 13 — — — 13 Dividends . . . . . . . . . . . . . . . . . . . . — — — (3,348) — — (3,348) Net loss . . . . . . . . . . . . . . . . . . . . . . — — — (6,169) — — (6,169) Other comprehensive loss—Fair value of interest rate swaps, net of minority interests . . . . . . . . . . — — — — (11) — (11) Other comprehensive loss—Foreign currency translation adjustments, net of minority interests . . . . . . . . . . . . — — — — (35) — (35)\n\nComprehensive loss . . . . . . . . . . . . (6,215)\n\n**Balance at December 31, 2004** . . **21,421,300 $214 $ 182,411 $(9,517) $ 91 $ — $ 173,199**\n\nSee accompanying notes to the consolidated and combined financial statements.\n\n51","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**DIGITAL REALTY TRUST, INC. AND DIGITAL REALTY TRUST, INC. PREDECESSOR**\n\n**CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS’ AND OWNERS’ EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (in thousands, except share data)**\n\n**Number of Common Shares**\n\n**Common Stock**\n\n**Additional Paid-in Capital**\n\n**Dividends In Excess of Earnings**\n\n**Accumulated Other Comprehensive Income, net**\n\n**Owner’s Equity Total**\n\n**Balance at December 31, 2001** . . **— $— $ — $ — $ — $ 990 $ 990** Contributions . . . . . . . . . . . . . . . . . — — — — — 86,090 86,090 Distributions . . . . . . . . . . . . . . . . . . — — — — — (4,305) (4,305) Net loss . . . . . . . . . . . . . . . . . . . . . . — — — — — (61) (61) Other Comprehensive Income—Foreign currency translation adjustments . . . . . . . . — — — — 463 — 463\n\nComprehensive income . . . . . . . . . 402\n\n**Balance at December 31, 2002** . . **— — — — 463 82,714 83,177** Contributions . . . . . . . . . . . . . . . . . — — — — — 131,181 131,181 Distributions . . . . . . . . . . . . . . . . . . — — — — — (82,891) (82,891) Net income . . . . . . . . . . . . . . . . . . . — — — — — 16,642 16,642 Other Comprehensive Income—Foreign currency translation adjustments . . . . . . . . — — — — (158) — (158)\n\nComprehensive income . . . . . . . . . 16,484\n\n**Balance at December 31, 2003** . . **— — — — 305 147,646 147,951** Contributions . . . . . . . . . . . . . . . . . — — — — — 130,264 130,264 Distributions . . . . . . . . . . . . . . . . . . — — — — — (68,971) (68,971) Net income . . . . . . . . . . . . . . . . . . . — — — — — 10,726 10,726 Other comprehensive income—Foreign currency translation adjustments . . . . . . . . — — — — 33 — 33\n\nComprehensive income . . . . . . . . . 10,759\n\n**Balance at November 2, 2004** . . . **— — — — 338 219,665 220,003 The Company** Reclassify Predecessor owner’s equity . . . . . . . . . . . . . . . . . . . . . — — 219,665 — — (219,665) — Net proceeds from sale of common stock . . . . . . . . . . . . . . . . . . . . . . 21,421,300 214 230,584 — — — 230,798 Record minority interests . . . . . . . . — — (267,851) — (201) — (268,052) Amortization of fair market value of stock options, net of minority interests . . . . . . . . . . . . . . . . . . . — — 13 — — — 13 Dividends . . . . . . . . . . . . . . . . . . . . — — — (3,348) — — (3,348) Net loss . . . . . . . . . . . . . . . . . . . . . . — — — (6,169) — — (6,169) Other comprehensive loss—Fair value of interest rate swaps, net of minority interests . . . . . . . . . . — — — — (11) — (11) Other comprehensive loss—Foreign currency translation adjustments, net of minority interests . . . . . . . . . . . . — — — — (35) — (35)\n\nComprehensive loss . . . . . . . . . . . . (6,215)\n\n**Balance at December 31, 2004** . . **21,421,300 $214 $ 182,411 $(9,517) $ 91 $ — $ 173,199**\n\nSee accompanying notes to the consolidated and combined financial statements.\n\n51","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DLR.2004.page_61.pdf_21918_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_c97a90550327e2cf8a581a79b28117db","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**DIGITAL REALTY TRUST, INC. AND DIGITAL REALTY TRUST, INC. PREDECESSOR**\n\n**CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS’ AND OWNERS’ EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (in thousands, except share data)**\n\n**Number of Common Shares**\n\n**Common Stock**\n\n**Additional Paid-in Capital**\n\n**Dividends In Excess of Earnings**\n\n**Accumulated Other Comprehensive Income, net**\n\n**Owner’s Equity Total**\n\n**Balance at December 31, 2001** . . **— $— $ — $ — $ — $ 990 $ 990** Contributions . . . . . . . . . . . . . . . . . — — — — — 86,090 86,090 Distributions . . . . . . . . . . . . . . . . . . — — — — — (4,305) (4,305) Net loss . . . . . . . . . . . . . . . . . . . . . . — — — — — (61) (61) Other Comprehensive Income—Foreign currency translation adjustments . . . . . . . . — — — — 463 — 463\n\nComprehensive income . . . . . . . . . 402\n\n**Balance at December 31, 2002** . . **— — — — 463 82,714 83,177** Contributions . . . . . . . . . . . . . . . . . — — — — — 131,181 131,181 Distributions . . . . . . . . . . . . . . . . . . — — — — — (82,891) (82,891) Net income . . . . . . . . . . . . . . . . . . . — — — — — 16,642 16,642 Other Comprehensive Income—Foreign currency translation adjustments . . . . . . . . — — — — (158) — (158)\n\nComprehensive income . . . . . . . . . 16,484\n\n**Balance at December 31, 2003** . . **— — — — 305 147,646 147,951** Contributions . . . . . . . . . . . . . . . . . — — — — — 130,264 130,264 Distributions . . . . . . . . . . . . . . . . . . — — — — — (68,971) (68,971) Net income . . . . . . . . . . . . . . . . . . . — — — — — 10,726 10,726 Other comprehensive income—Foreign currency translation adjustments . . . . . . . . — — — — 33 — 33\n\nComprehensive income . . . . . . . . . 10,759\n\n**Balance at November 2, 2004** . . . **— — — — 338 219,665 220,003 The Company** Reclassify Predecessor owner’s equity . . . . . . . . . . . . . . . . . . . . . — — 219,665 — — (219,665) — Net proceeds from sale of common stock . . . . . . . . . . . . . . . . . . . . . . 21,421,300 214 230,584 — — — 230,798 Record minority interests . . . . . . . . — — (267,851) — (201) — (268,052) Amortization of fair market value of stock options, net of minority interests . . . . . . . . . . . . . . . . . . . — — 13 — — — 13 Dividends . . . . . . . . . . . . . . . . . . . . — — — (3,348) — — (3,348) Net loss . . . . . . . . . . . . . . . . . . . . . . — — — (6,169) — — (6,169) Other comprehensive loss—Fair value of interest rate swaps, net of minority interests . . . . . . . . . . — — — — (11) — (11) Other comprehensive loss—Foreign currency translation adjustments, net of minority interests . . . . . . . . . . . . — — — — (35) — (35)\n\nComprehensive loss . . . . . . . . . . . . (6,215)\n\n**Balance at December 31, 2004** . . **21,421,300 $214 $ 182,411 $(9,517) $ 91 $ — $ 173,199**\n\nSee accompanying notes to the consolidated and combined financial statements.\n\n51"],"full_content":"**DIGITAL REALTY TRUST, INC. AND DIGITAL REALTY TRUST, INC. PREDECESSOR**\n\n**CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS’ AND OWNERS’ EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (in thousands, except share data)**\n\n**Number of Common Shares**\n\n**Common Stock**\n\n**Additional Paid-in Capital**\n\n**Dividends In Excess of Earnings**\n\n**Accumulated Other Comprehensive Income, net**\n\n**Owner’s Equity Total**\n\n**Balance at December 31, 2001** . . **— $— $ — $ — $ — $ 990 $ 990** Contributions . . . . . . . . . . . . . . . . . — — — — — 86,090 86,090 Distributions . . . . . . . . . . . . . . . . . . — — — — — (4,305) (4,305) Net loss . . . . . . . . . . . . . . . . . . . . . . — — — — — (61) (61) Other Comprehensive Income—Foreign currency translation adjustments . . . . . . . . — — — — 463 — 463\n\nComprehensive income . . . . . . . . . 402\n\n**Balance at December 31, 2002** . . **— — — — 463 82,714 83,177** Contributions . . . . . . . . . . . . . . . . . — — — — — 131,181 131,181 Distributions . . . . . . . . . . . . . . . . . . — — — — — (82,891) (82,891) Net income . . . . . . . . . . . . . . . . . . . — — — — — 16,642 16,642 Other Comprehensive Income—Foreign currency translation adjustments . . . . . . . . — — — — (158) — (158)\n\nComprehensive income . . . . . . . . . 16,484\n\n**Balance at December 31, 2003** . . **— — — — 305 147,646 147,951** Contributions . . . . . . . . . . . . . . . . . — — — — — 130,264 130,264 Distributions . . . . . . . . . . . . . . . . . . — — — — — (68,971) (68,971) Net income . . . . . . . . . . . . . . . . . . . — — — — — 10,726 10,726 Other comprehensive income—Foreign currency translation adjustments . . . . . . . . — — — — 33 — 33\n\nComprehensive income . . . . . . . . . 10,759\n\n**Balance at November 2, 2004** . . . **— — — — 338 219,665 220,003 The Company** Reclassify Predecessor owner’s equity . . . . . . . . . . . . . . . . . . . . . — — 219,665 — — (219,665) — Net proceeds from sale of common stock . . . . . . . . . . . . . . . . . . . . . . 21,421,300 214 230,584 — — — 230,798 Record minority interests . . . . . . . . — — (267,851) — (201) — (268,052) Amortization of fair market value of stock options, net of minority interests . . . . . . . . . . . . . . . . . . . — — 13 — — — 13 Dividends . . . . . . . . . . . . . . . . . . . . — — — (3,348) — — (3,348) Net loss . . . . . . . . . . . . . . . . . . . . . . — — — (6,169) — — (6,169) Other comprehensive loss—Fair value of interest rate swaps, net of minority interests . . . . . . . . . . — — — — (11) — (11) Other comprehensive loss—Foreign currency translation adjustments, net of minority interests . . . . . . . . . . . . — — — — (35) — (35)\n\nComprehensive loss . . . . . . . . . . . . (6,215)\n\n**Balance at December 31, 2004** . . **21,421,300 $214 $ 182,411 $(9,517) $ 91 $ — $ 173,199**\n\nSee accompanying notes to the consolidated and combined financial statements.\n\n51","publish_date":null,"title":"DIGITALREALTYTRUST,INC.AND DIGITALREALTYTRUST,INC.PREDECESSOR CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERS’AND OWNERS’EQUITY(DEFICIT)ANDCOMPREHENSIVEINCOME(LOSS) (inthousands,exceptsharedata) Seeaccompanyingnotestotheconsolidatedandcombinedfinancialstatements. 51","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DLR.2004.page_61.pdf_21918_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DLR.2004.page_61.pdf_21918_page1.pdf"},"request":{"example_id":"table/DLR.2004.page_61.pdf_21918_page1","product_type":"parse","source_file_path":"DLR.2004.page_61.pdf_21918_page1.pdf"},"started_at":"2026-11-04T19:47:18.127048"} +{"completed_at":"2026-11-04T19:47:22.136740","latency_in_ms":2575,"output":{"example_id":"table/DS5795A-06_page13","grounded_pages":[],"layout_pages":[],"markdown":"13 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\nThe output ripple is highest at maximum input voltage since ΔIL increases with input voltage. Multiple capacitors placed in parallel may be needed to meet the ESR and RMS current handling requirements. Dry tantalum, special polymer, aluminum electrolytic and ceramic capacitors are all available in surface mount packages. Special polymer capacitors offer very low ESR, but have lower capacitance density than other types. Tantalum capacitors have the highest capacitance density, but it is important to only use types that have been surge tested for use in switching power supplies. Aluminum electrolytic capacitors have significantly higher ESR, but can be used in cost-sensitive applications provided that consideration is given to ripple current ratings and long term reliability. Ceramic capacitors have excellent low ESR characteristics, but can have a high voltage coefficient and audible piezoelectric effects.\n\nThe high Q of ceramic capacitors with trace inductance can also lead to significant ringing.\n\n**Using Ceramic Input and Output Capacitors**\n\nHigher value, lower cost ceramic capacitors are now becoming available in smaller case sizes. Their high ripple current, high voltage rating and low ESR make them ideal\n\nfor switching regulator applications. However, care must be taken when these capacitors are used at the input and output. When a ceramic capacitor is used at the input and the power is supplied by a wall adapter through long wires, a load step at the output can induce ringing at the input, VIN. At best, this ringing can couple to the output and be mistaken as loop instability. At worst, a sudden inrush of current through the long wires can potentially cause a voltage spike at VIN large enough to damage the part.\n\n**Table 2. Capacitors for CIN and COUT**\n\n**Thermal Considerations**\n\nFor continuous operation, do not exceed absolute maximum junction temperature. The maximum power dissipation depends on the thermal resistance of the IC package, PCB layout, rate of surrounding airflow, and difference between junction and ambient temperature. The maximum power dissipation can be calculated by the following formula :\n\nPD(MAX) = (TJ(MAX) − TA) / θJA\n\nwhere TJ(MAX) is the maximum junction temperature, TA is the ambient temperature, and θJA is the junction to ambient thermal resistance.\n\nFor recommended operating condition specifications, the maximum junction temperature is 125°C. The junction to ambient thermal resistance, θJA, is layout dependent. The junction to ambient thermal resistance, θJA, is layout dependent. For WDFN-8SL 2x2 packages, the thermal resistance, θJA, is 65°C/W on a standard JEDEC 51-7 four-layer thermal test board. The maximum power dissipation at TA = 25°C can be calculated by the following formula :\n\nPD(MAX) = (125°C − 25°C) / (65°C/W) = 1.538W for WDFN-8SL 2x2 package\n\nThe maximum power dissipation depends on the operating ambient temperature for fixed TJ(MAX) and thermal resistance, θJA. The derating curve in Figure 2 allows the designer to see the effect of rising ambient temperature on the maximum power dissipation.\n\nFigure 2. Derating Curve of Maximum Power Dissipation\n\n0\\.0\n\n0\\.4\n\n0\\.8\n\n1\\.2\n\n1\\.6\n\n2\\.0\n\n0 25 50 75 100 125\n\nAmbient Temperature (°C)\n\nMaximum Power Dissipation (W) 1\n\nFour-Layer PCB\n\n**Component Supplier Part No. Capacitance (**  **F) Case Size**\n\nMuRata GRM31CR71A106KA01 10F 1206\n\nMuRata GRM31CR71A226KA01 22F 1206","pages":[{"line_numbers":[],"markdown":"13 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\nThe output ripple is highest at maximum input voltage since ΔIL increases with input voltage. Multiple capacitors placed in parallel may be needed to meet the ESR and RMS current handling requirements. Dry tantalum, special polymer, aluminum electrolytic and ceramic capacitors are all available in surface mount packages. Special polymer capacitors offer very low ESR, but have lower capacitance density than other types. Tantalum capacitors have the highest capacitance density, but it is important to only use types that have been surge tested for use in switching power supplies. Aluminum electrolytic capacitors have significantly higher ESR, but can be used in cost-sensitive applications provided that consideration is given to ripple current ratings and long term reliability. Ceramic capacitors have excellent low ESR characteristics, but can have a high voltage coefficient and audible piezoelectric effects.\n\nThe high Q of ceramic capacitors with trace inductance can also lead to significant ringing.\n\n**Using Ceramic Input and Output Capacitors**\n\nHigher value, lower cost ceramic capacitors are now becoming available in smaller case sizes. Their high ripple current, high voltage rating and low ESR make them ideal\n\nfor switching regulator applications. However, care must be taken when these capacitors are used at the input and output. When a ceramic capacitor is used at the input and the power is supplied by a wall adapter through long wires, a load step at the output can induce ringing at the input, VIN. At best, this ringing can couple to the output and be mistaken as loop instability. At worst, a sudden inrush of current through the long wires can potentially cause a voltage spike at VIN large enough to damage the part.\n\n**Table 2. Capacitors for CIN and COUT**\n\n**Thermal Considerations**\n\nFor continuous operation, do not exceed absolute maximum junction temperature. The maximum power dissipation depends on the thermal resistance of the IC package, PCB layout, rate of surrounding airflow, and difference between junction and ambient temperature. The maximum power dissipation can be calculated by the following formula :\n\nPD(MAX) = (TJ(MAX) − TA) / θJA\n\nwhere TJ(MAX) is the maximum junction temperature, TA is the ambient temperature, and θJA is the junction to ambient thermal resistance.\n\nFor recommended operating condition specifications, the maximum junction temperature is 125°C. The junction to ambient thermal resistance, θJA, is layout dependent. The junction to ambient thermal resistance, θJA, is layout dependent. For WDFN-8SL 2x2 packages, the thermal resistance, θJA, is 65°C/W on a standard JEDEC 51-7 four-layer thermal test board. The maximum power dissipation at TA = 25°C can be calculated by the following formula :\n\nPD(MAX) = (125°C − 25°C) / (65°C/W) = 1.538W for WDFN-8SL 2x2 package\n\nThe maximum power dissipation depends on the operating ambient temperature for fixed TJ(MAX) and thermal resistance, θJA. The derating curve in Figure 2 allows the designer to see the effect of rising ambient temperature on the maximum power dissipation.\n\nFigure 2. Derating Curve of Maximum Power Dissipation\n\n0\\.0\n\n0\\.4\n\n0\\.8\n\n1\\.2\n\n1\\.6\n\n2\\.0\n\n0 25 50 75 100 125\n\nAmbient Temperature (°C)\n\nMaximum Power Dissipation (W) 1\n\nFour-Layer PCB\n\n**Component Supplier Part No. Capacitance (**  **F) Case Size**\n\nMuRata GRM31CR71A106KA01 10F 1206\n\nMuRata GRM31CR71A226KA01 22F 1206","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"13 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\nThe output ripple is highest at maximum input voltage since ΔIL increases with input voltage. Multiple capacitors placed in parallel may be needed to meet the ESR and RMS current handling requirements. Dry tantalum, special polymer, aluminum electrolytic and ceramic capacitors are all available in surface mount packages. Special polymer capacitors offer very low ESR, but have lower capacitance density than other types. Tantalum capacitors have the highest capacitance density, but it is important to only use types that have been surge tested for use in switching power supplies. Aluminum electrolytic capacitors have significantly higher ESR, but can be used in cost-sensitive applications provided that consideration is given to ripple current ratings and long term reliability. Ceramic capacitors have excellent low ESR characteristics, but can have a high voltage coefficient and audible piezoelectric effects.\n\nThe high Q of ceramic capacitors with trace inductance can also lead to significant ringing.\n\n**Using Ceramic Input and Output Capacitors**\n\nHigher value, lower cost ceramic capacitors are now becoming available in smaller case sizes. Their high ripple current, high voltage rating and low ESR make them ideal\n\nfor switching regulator applications. However, care must be taken when these capacitors are used at the input and output. When a ceramic capacitor is used at the input and the power is supplied by a wall adapter through long wires, a load step at the output can induce ringing at the input, VIN. At best, this ringing can couple to the output and be mistaken as loop instability. At worst, a sudden inrush of current through the long wires can potentially cause a voltage spike at VIN large enough to damage the part.\n\n**Table 2. Capacitors for CIN and COUT**\n\n**Thermal Considerations**\n\nFor continuous operation, do not exceed absolute maximum junction temperature. The maximum power dissipation depends on the thermal resistance of the IC package, PCB layout, rate of surrounding airflow, and difference between junction and ambient temperature. The maximum power dissipation can be calculated by the following formula :\n\nPD(MAX) = (TJ(MAX) − TA) / θJA\n\nwhere TJ(MAX) is the maximum junction temperature, TA is the ambient temperature, and θJA is the junction to ambient thermal resistance.\n\nFor recommended operating condition specifications, the maximum junction temperature is 125°C. The junction to ambient thermal resistance, θJA, is layout dependent. The junction to ambient thermal resistance, θJA, is layout dependent. For WDFN-8SL 2x2 packages, the thermal resistance, θJA, is 65°C/W on a standard JEDEC 51-7 four-layer thermal test board. The maximum power dissipation at TA = 25°C can be calculated by the following formula :\n\nPD(MAX) = (125°C − 25°C) / (65°C/W) = 1.538W for WDFN-8SL 2x2 package\n\nThe maximum power dissipation depends on the operating ambient temperature for fixed TJ(MAX) and thermal resistance, θJA. The derating curve in Figure 2 allows the designer to see the effect of rising ambient temperature on the maximum power dissipation.\n\nFigure 2. Derating Curve of Maximum Power Dissipation\n\n0\\.0\n\n0\\.4\n\n0\\.8\n\n1\\.2\n\n1\\.6\n\n2\\.0\n\n0 25 50 75 100 125\n\nAmbient Temperature (°C)\n\nMaximum Power Dissipation (W) 1\n\nFour-Layer PCB\n\n**Component Supplier Part No. Capacitance (**  **F) Case Size**\n\nMuRata GRM31CR71A106KA01 10F 1206\n\nMuRata GRM31CR71A226KA01 22F 1206","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page13.pdf"]},"response":{"errors":[],"extract_id":"extract_5a967daaf410eaf633e3356ad8fdf8cd","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["13 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\nThe output ripple is highest at maximum input voltage since ΔIL increases with input voltage. Multiple capacitors placed in parallel may be needed to meet the ESR and RMS current handling requirements. Dry tantalum, special polymer, aluminum electrolytic and ceramic capacitors are all available in surface mount packages. Special polymer capacitors offer very low ESR, but have lower capacitance density than other types. Tantalum capacitors have the highest capacitance density, but it is important to only use types that have been surge tested for use in switching power supplies. Aluminum electrolytic capacitors have significantly higher ESR, but can be used in cost-sensitive applications provided that consideration is given to ripple current ratings and long term reliability. Ceramic capacitors have excellent low ESR characteristics, but can have a high voltage coefficient and audible piezoelectric effects.\n\nThe high Q of ceramic capacitors with trace inductance can also lead to significant ringing.\n\n**Using Ceramic Input and Output Capacitors**\n\nHigher value, lower cost ceramic capacitors are now becoming available in smaller case sizes. Their high ripple current, high voltage rating and low ESR make them ideal\n\nfor switching regulator applications. However, care must be taken when these capacitors are used at the input and output. When a ceramic capacitor is used at the input and the power is supplied by a wall adapter through long wires, a load step at the output can induce ringing at the input, VIN. At best, this ringing can couple to the output and be mistaken as loop instability. At worst, a sudden inrush of current through the long wires can potentially cause a voltage spike at VIN large enough to damage the part.\n\n**Table 2. Capacitors for CIN and COUT**\n\n**Thermal Considerations**\n\nFor continuous operation, do not exceed absolute maximum junction temperature. The maximum power dissipation depends on the thermal resistance of the IC package, PCB layout, rate of surrounding airflow, and difference between junction and ambient temperature. The maximum power dissipation can be calculated by the following formula :\n\nPD(MAX) = (TJ(MAX) − TA) / θJA\n\nwhere TJ(MAX) is the maximum junction temperature, TA is the ambient temperature, and θJA is the junction to ambient thermal resistance.\n\nFor recommended operating condition specifications, the maximum junction temperature is 125°C. The junction to ambient thermal resistance, θJA, is layout dependent. The junction to ambient thermal resistance, θJA, is layout dependent. For WDFN-8SL 2x2 packages, the thermal resistance, θJA, is 65°C/W on a standard JEDEC 51-7 four-layer thermal test board. The maximum power dissipation at TA = 25°C can be calculated by the following formula :\n\nPD(MAX) = (125°C − 25°C) / (65°C/W) = 1.538W for WDFN-8SL 2x2 package\n\nThe maximum power dissipation depends on the operating ambient temperature for fixed TJ(MAX) and thermal resistance, θJA. The derating curve in Figure 2 allows the designer to see the effect of rising ambient temperature on the maximum power dissipation.\n\nFigure 2. Derating Curve of Maximum Power Dissipation\n\n0\\.0\n\n0\\.4\n\n0\\.8\n\n1\\.2\n\n1\\.6\n\n2\\.0\n\n0 25 50 75 100 125\n\nAmbient Temperature (°C)\n\nMaximum Power Dissipation (W) 1\n\nFour-Layer PCB\n\n**Component Supplier Part No. Capacitance (**  **F) Case Size**\n\nMuRata GRM31CR71A106KA01 10F 1206\n\nMuRata GRM31CR71A226KA01 22F 1206"],"full_content":"13 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\nThe output ripple is highest at maximum input voltage since ΔIL increases with input voltage. Multiple capacitors placed in parallel may be needed to meet the ESR and RMS current handling requirements. Dry tantalum, special polymer, aluminum electrolytic and ceramic capacitors are all available in surface mount packages. Special polymer capacitors offer very low ESR, but have lower capacitance density than other types. Tantalum capacitors have the highest capacitance density, but it is important to only use types that have been surge tested for use in switching power supplies. Aluminum electrolytic capacitors have significantly higher ESR, but can be used in cost-sensitive applications provided that consideration is given to ripple current ratings and long term reliability. Ceramic capacitors have excellent low ESR characteristics, but can have a high voltage coefficient and audible piezoelectric effects.\n\nThe high Q of ceramic capacitors with trace inductance can also lead to significant ringing.\n\n**Using Ceramic Input and Output Capacitors**\n\nHigher value, lower cost ceramic capacitors are now becoming available in smaller case sizes. Their high ripple current, high voltage rating and low ESR make them ideal\n\nfor switching regulator applications. However, care must be taken when these capacitors are used at the input and output. When a ceramic capacitor is used at the input and the power is supplied by a wall adapter through long wires, a load step at the output can induce ringing at the input, VIN. At best, this ringing can couple to the output and be mistaken as loop instability. At worst, a sudden inrush of current through the long wires can potentially cause a voltage spike at VIN large enough to damage the part.\n\n**Table 2. Capacitors for CIN and COUT**\n\n**Thermal Considerations**\n\nFor continuous operation, do not exceed absolute maximum junction temperature. The maximum power dissipation depends on the thermal resistance of the IC package, PCB layout, rate of surrounding airflow, and difference between junction and ambient temperature. The maximum power dissipation can be calculated by the following formula :\n\nPD(MAX) = (TJ(MAX) − TA) / θJA\n\nwhere TJ(MAX) is the maximum junction temperature, TA is the ambient temperature, and θJA is the junction to ambient thermal resistance.\n\nFor recommended operating condition specifications, the maximum junction temperature is 125°C. The junction to ambient thermal resistance, θJA, is layout dependent. The junction to ambient thermal resistance, θJA, is layout dependent. For WDFN-8SL 2x2 packages, the thermal resistance, θJA, is 65°C/W on a standard JEDEC 51-7 four-layer thermal test board. The maximum power dissipation at TA = 25°C can be calculated by the following formula :\n\nPD(MAX) = (125°C − 25°C) / (65°C/W) = 1.538W for WDFN-8SL 2x2 package\n\nThe maximum power dissipation depends on the operating ambient temperature for fixed TJ(MAX) and thermal resistance, θJA. The derating curve in Figure 2 allows the designer to see the effect of rising ambient temperature on the maximum power dissipation.\n\nFigure 2. Derating Curve of Maximum Power Dissipation\n\n0\\.0\n\n0\\.4\n\n0\\.8\n\n1\\.2\n\n1\\.6\n\n2\\.0\n\n0 25 50 75 100 125\n\nAmbient Temperature (°C)\n\nMaximum Power Dissipation (W) 1\n\nFour-Layer PCB\n\n**Component Supplier Part No. Capacitance (**  **F) Case Size**\n\nMuRata GRM31CR71A106KA01 10F 1206\n\nMuRata GRM31CR71A226KA01 22F 1206","publish_date":null,"title":"RT5795A","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page13.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page13.pdf"},"request":{"example_id":"table/DS5795A-06_page13","product_type":"parse","source_file_path":"DS5795A-06_page13.pdf"},"started_at":"2026-11-04T19:47:19.561026"} +{"completed_at":"2026-11-04T19:47:22.702563","latency_in_ms":1643,"output":{"example_id":"table/DS5795A-06_page15","grounded_pages":[],"layout_pages":[],"markdown":"15 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Richtek Technology Corporation**\n\n14F, No. 8, Tai Yuen 1 st Street, Chupei City\n\nHsinchu, Taiwan, R.O.C.\n\nTel: (8863)5526789\n\nRichtek products are sold by description only. Customers should obtain the latest relevant information and data sheets before placing orders and should verify that such information is current and complete. Richtek cannot assume responsibility for use of any circuitry other than circuitry entirely embodied in a Richtek product. Information furnished by Richtek is believed to be accurate and reliable. However, no responsibility is assumed by Richtek or its subsidiaries for its use; nor for any infringements of patents or other rights of third parties which may result from its use. No license is granted by implication or otherwise under any patent or patent rights of Richtek or its subsidiaries.\n\n### **Outline Dimension**\n\n**W-Type 8SL DFN 2x2 Package**\n\n**Min. Max. Min. Max.**\n\n0\\.700 0.800 0.028 0.031\n\n0\\.000 0.050 0.000 0.002\n\n0\\.175 0.250 0.007 0.010\n\n0\\.200 0.300 0.008 0.012\n\n1\\.900 2.100 0.075 0.083\n\nOption1 1.150 1.250 0.045 0.049\n\nOption2 1.550 1.650 0.061 0.065\n\n1\\.900 2.100 0.075 0.083\n\nOption1 0.750 0.850 0.030 0.033\n\nOption2 0.850 0.950 0.033 0.037\n\n0\\.250 0.350 0.010 0.014\n\n0\\.500 0.020\n\nL\n\nb\n\nD\n\nD2\n\nE\n\nE2\n\ne\n\n**Symbol Dimensions In Millimeters Dimensions In Inches**\n\nA\n\nA1\n\nA3\n\n1 1 2 2\n\nNote : The configuration of the Pin #1 identifier is optional, but must be located within the zone indicated.\n\n**DETAIL A** Pin #1 ID and Tie Bar Mark Options","pages":[{"line_numbers":[],"markdown":"15 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Richtek Technology Corporation**\n\n14F, No. 8, Tai Yuen 1 st Street, Chupei City\n\nHsinchu, Taiwan, R.O.C.\n\nTel: (8863)5526789\n\nRichtek products are sold by description only. Customers should obtain the latest relevant information and data sheets before placing orders and should verify that such information is current and complete. Richtek cannot assume responsibility for use of any circuitry other than circuitry entirely embodied in a Richtek product. Information furnished by Richtek is believed to be accurate and reliable. However, no responsibility is assumed by Richtek or its subsidiaries for its use; nor for any infringements of patents or other rights of third parties which may result from its use. No license is granted by implication or otherwise under any patent or patent rights of Richtek or its subsidiaries.\n\n### **Outline Dimension**\n\n**W-Type 8SL DFN 2x2 Package**\n\n**Min. Max. Min. Max.**\n\n0\\.700 0.800 0.028 0.031\n\n0\\.000 0.050 0.000 0.002\n\n0\\.175 0.250 0.007 0.010\n\n0\\.200 0.300 0.008 0.012\n\n1\\.900 2.100 0.075 0.083\n\nOption1 1.150 1.250 0.045 0.049\n\nOption2 1.550 1.650 0.061 0.065\n\n1\\.900 2.100 0.075 0.083\n\nOption1 0.750 0.850 0.030 0.033\n\nOption2 0.850 0.950 0.033 0.037\n\n0\\.250 0.350 0.010 0.014\n\n0\\.500 0.020\n\nL\n\nb\n\nD\n\nD2\n\nE\n\nE2\n\ne\n\n**Symbol Dimensions In Millimeters Dimensions In Inches**\n\nA\n\nA1\n\nA3\n\n1 1 2 2\n\nNote : The configuration of the Pin #1 identifier is optional, but must be located within the zone indicated.\n\n**DETAIL A** Pin #1 ID and Tie Bar Mark Options","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"15 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Richtek Technology Corporation**\n\n14F, No. 8, Tai Yuen 1 st Street, Chupei City\n\nHsinchu, Taiwan, R.O.C.\n\nTel: (8863)5526789\n\nRichtek products are sold by description only. Customers should obtain the latest relevant information and data sheets before placing orders and should verify that such information is current and complete. Richtek cannot assume responsibility for use of any circuitry other than circuitry entirely embodied in a Richtek product. Information furnished by Richtek is believed to be accurate and reliable. However, no responsibility is assumed by Richtek or its subsidiaries for its use; nor for any infringements of patents or other rights of third parties which may result from its use. No license is granted by implication or otherwise under any patent or patent rights of Richtek or its subsidiaries.\n\n### **Outline Dimension**\n\n**W-Type 8SL DFN 2x2 Package**\n\n**Min. Max. Min. Max.**\n\n0\\.700 0.800 0.028 0.031\n\n0\\.000 0.050 0.000 0.002\n\n0\\.175 0.250 0.007 0.010\n\n0\\.200 0.300 0.008 0.012\n\n1\\.900 2.100 0.075 0.083\n\nOption1 1.150 1.250 0.045 0.049\n\nOption2 1.550 1.650 0.061 0.065\n\n1\\.900 2.100 0.075 0.083\n\nOption1 0.750 0.850 0.030 0.033\n\nOption2 0.850 0.950 0.033 0.037\n\n0\\.250 0.350 0.010 0.014\n\n0\\.500 0.020\n\nL\n\nb\n\nD\n\nD2\n\nE\n\nE2\n\ne\n\n**Symbol Dimensions In Millimeters Dimensions In Inches**\n\nA\n\nA1\n\nA3\n\n1 1 2 2\n\nNote : The configuration of the Pin #1 identifier is optional, but must be located within the zone indicated.\n\n**DETAIL A** Pin #1 ID and Tie Bar Mark Options","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page15.pdf"]},"response":{"errors":[],"extract_id":"extract_6630b34d5efffcf8eb7355665f525456","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["15 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Richtek Technology Corporation**\n\n14F, No. 8, Tai Yuen 1 st Street, Chupei City\n\nHsinchu, Taiwan, R.O.C.\n\nTel: (8863)5526789\n\nRichtek products are sold by description only. Customers should obtain the latest relevant information and data sheets before placing orders and should verify that such information is current and complete. Richtek cannot assume responsibility for use of any circuitry other than circuitry entirely embodied in a Richtek product. Information furnished by Richtek is believed to be accurate and reliable. However, no responsibility is assumed by Richtek or its subsidiaries for its use; nor for any infringements of patents or other rights of third parties which may result from its use. No license is granted by implication or otherwise under any patent or patent rights of Richtek or its subsidiaries.\n\n### **Outline Dimension**\n\n**W-Type 8SL DFN 2x2 Package**\n\n**Min. Max. Min. Max.**\n\n0\\.700 0.800 0.028 0.031\n\n0\\.000 0.050 0.000 0.002\n\n0\\.175 0.250 0.007 0.010\n\n0\\.200 0.300 0.008 0.012\n\n1\\.900 2.100 0.075 0.083\n\nOption1 1.150 1.250 0.045 0.049\n\nOption2 1.550 1.650 0.061 0.065\n\n1\\.900 2.100 0.075 0.083\n\nOption1 0.750 0.850 0.030 0.033\n\nOption2 0.850 0.950 0.033 0.037\n\n0\\.250 0.350 0.010 0.014\n\n0\\.500 0.020\n\nL\n\nb\n\nD\n\nD2\n\nE\n\nE2\n\ne\n\n**Symbol Dimensions In Millimeters Dimensions In Inches**\n\nA\n\nA1\n\nA3\n\n1 1 2 2\n\nNote : The configuration of the Pin #1 identifier is optional, but must be located within the zone indicated.\n\n**DETAIL A** Pin #1 ID and Tie Bar Mark Options"],"full_content":"15 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Richtek Technology Corporation**\n\n14F, No. 8, Tai Yuen 1 st Street, Chupei City\n\nHsinchu, Taiwan, R.O.C.\n\nTel: (8863)5526789\n\nRichtek products are sold by description only. Customers should obtain the latest relevant information and data sheets before placing orders and should verify that such information is current and complete. Richtek cannot assume responsibility for use of any circuitry other than circuitry entirely embodied in a Richtek product. Information furnished by Richtek is believed to be accurate and reliable. However, no responsibility is assumed by Richtek or its subsidiaries for its use; nor for any infringements of patents or other rights of third parties which may result from its use. No license is granted by implication or otherwise under any patent or patent rights of Richtek or its subsidiaries.\n\n### **Outline Dimension**\n\n**W-Type 8SL DFN 2x2 Package**\n\n**Min. Max. Min. Max.**\n\n0\\.700 0.800 0.028 0.031\n\n0\\.000 0.050 0.000 0.002\n\n0\\.175 0.250 0.007 0.010\n\n0\\.200 0.300 0.008 0.012\n\n1\\.900 2.100 0.075 0.083\n\nOption1 1.150 1.250 0.045 0.049\n\nOption2 1.550 1.650 0.061 0.065\n\n1\\.900 2.100 0.075 0.083\n\nOption1 0.750 0.850 0.030 0.033\n\nOption2 0.850 0.950 0.033 0.037\n\n0\\.250 0.350 0.010 0.014\n\n0\\.500 0.020\n\nL\n\nb\n\nD\n\nD2\n\nE\n\nE2\n\ne\n\n**Symbol Dimensions In Millimeters Dimensions In Inches**\n\nA\n\nA1\n\nA3\n\n1 1 2 2\n\nNote : The configuration of the Pin #1 identifier is optional, but must be located within the zone indicated.\n\n**DETAIL A** Pin #1 ID and Tie Bar Mark Options","publish_date":null,"title":"RT5795A","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page15.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page15.pdf"},"request":{"example_id":"table/DS5795A-06_page15","product_type":"parse","source_file_path":"DS5795A-06_page15.pdf"},"started_at":"2026-11-04T19:47:21.059037"} +{"completed_at":"2026-11-04T19:47:23.742851","latency_in_ms":1162,"output":{"example_id":"table/DS5795A-06_page2","grounded_pages":[],"layout_pages":[],"markdown":"2 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Functional Block Diagram**\n\n### **Functional Pin Description**\n\n**Pin No.** **Pin Name Pin Function**\n\n1 EN Enable control input. Pull High to Enable.\n\n2, 9 (Exposed Pad) PGND Power ground. The exposed pad must be soldered to a large PCB and connected to PGND for maximum power dissipation.\n\n3 AGND Analog ground. Should be electrically connected to GND close to the device.\n\n4 FB Feedback voltage input.\n\n5 VOS Output voltage sense pin for the internal control loop. Must be connected to output.\n\n6 PGOOD Power good open-drain output. This pin is pulled to low if the output voltage is below regulation limits. Can be left floating if not used.\n\n7 LX Switch node. The Source of the internal high-side power MOSFET, and Drain of the internal low-side (synchronous) rectifier MOSFET.\n\n8 VIN Power input supply voltage, 2.5V to 5.5V.\n\nVIN\n\nAGND\n\nPGND\n\nEN\n\n\\+\n\n\\-\n\nVREF\n\nShutdown Control\n\nLX FB Driver\n\nTON\n\nLogic Control\n\nLX\n\nCurrent Limit Detector\n\nAZC LX\n\nComparator \\+-+\n\nVOS\n\nError Amplifier\n\nUVLO\n\nOTP\n\nLX\n\n\\+\n\n\\-\n\nVFB\n\nPGOOD\n\nRamp Generator\n\nLX","pages":[{"line_numbers":[],"markdown":"2 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Functional Block Diagram**\n\n### **Functional Pin Description**\n\n**Pin No.** **Pin Name Pin Function**\n\n1 EN Enable control input. Pull High to Enable.\n\n2, 9 (Exposed Pad) PGND Power ground. The exposed pad must be soldered to a large PCB and connected to PGND for maximum power dissipation.\n\n3 AGND Analog ground. Should be electrically connected to GND close to the device.\n\n4 FB Feedback voltage input.\n\n5 VOS Output voltage sense pin for the internal control loop. Must be connected to output.\n\n6 PGOOD Power good open-drain output. This pin is pulled to low if the output voltage is below regulation limits. Can be left floating if not used.\n\n7 LX Switch node. The Source of the internal high-side power MOSFET, and Drain of the internal low-side (synchronous) rectifier MOSFET.\n\n8 VIN Power input supply voltage, 2.5V to 5.5V.\n\nVIN\n\nAGND\n\nPGND\n\nEN\n\n\\+\n\n\\-\n\nVREF\n\nShutdown Control\n\nLX FB Driver\n\nTON\n\nLogic Control\n\nLX\n\nCurrent Limit Detector\n\nAZC LX\n\nComparator \\+-+\n\nVOS\n\nError Amplifier\n\nUVLO\n\nOTP\n\nLX\n\n\\+\n\n\\-\n\nVFB\n\nPGOOD\n\nRamp Generator\n\nLX","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"2 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Functional Block Diagram**\n\n### **Functional Pin Description**\n\n**Pin No.** **Pin Name Pin Function**\n\n1 EN Enable control input. Pull High to Enable.\n\n2, 9 (Exposed Pad) PGND Power ground. The exposed pad must be soldered to a large PCB and connected to PGND for maximum power dissipation.\n\n3 AGND Analog ground. Should be electrically connected to GND close to the device.\n\n4 FB Feedback voltage input.\n\n5 VOS Output voltage sense pin for the internal control loop. Must be connected to output.\n\n6 PGOOD Power good open-drain output. This pin is pulled to low if the output voltage is below regulation limits. Can be left floating if not used.\n\n7 LX Switch node. The Source of the internal high-side power MOSFET, and Drain of the internal low-side (synchronous) rectifier MOSFET.\n\n8 VIN Power input supply voltage, 2.5V to 5.5V.\n\nVIN\n\nAGND\n\nPGND\n\nEN\n\n\\+\n\n\\-\n\nVREF\n\nShutdown Control\n\nLX FB Driver\n\nTON\n\nLogic Control\n\nLX\n\nCurrent Limit Detector\n\nAZC LX\n\nComparator \\+-+\n\nVOS\n\nError Amplifier\n\nUVLO\n\nOTP\n\nLX\n\n\\+\n\n\\-\n\nVFB\n\nPGOOD\n\nRamp Generator\n\nLX","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_36966b62c7dfe587e32d719a50cd0d07","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["2 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Functional Block Diagram**\n\n### **Functional Pin Description**\n\n**Pin No.** **Pin Name Pin Function**\n\n1 EN Enable control input. Pull High to Enable.\n\n2, 9 (Exposed Pad) PGND Power ground. The exposed pad must be soldered to a large PCB and connected to PGND for maximum power dissipation.\n\n3 AGND Analog ground. Should be electrically connected to GND close to the device.\n\n4 FB Feedback voltage input.\n\n5 VOS Output voltage sense pin for the internal control loop. Must be connected to output.\n\n6 PGOOD Power good open-drain output. This pin is pulled to low if the output voltage is below regulation limits. Can be left floating if not used.\n\n7 LX Switch node. The Source of the internal high-side power MOSFET, and Drain of the internal low-side (synchronous) rectifier MOSFET.\n\n8 VIN Power input supply voltage, 2.5V to 5.5V.\n\nVIN\n\nAGND\n\nPGND\n\nEN\n\n\\+\n\n\\-\n\nVREF\n\nShutdown Control\n\nLX FB Driver\n\nTON\n\nLogic Control\n\nLX\n\nCurrent Limit Detector\n\nAZC LX\n\nComparator \\+-+\n\nVOS\n\nError Amplifier\n\nUVLO\n\nOTP\n\nLX\n\n\\+\n\n\\-\n\nVFB\n\nPGOOD\n\nRamp Generator\n\nLX"],"full_content":"2 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Functional Block Diagram**\n\n### **Functional Pin Description**\n\n**Pin No.** **Pin Name Pin Function**\n\n1 EN Enable control input. Pull High to Enable.\n\n2, 9 (Exposed Pad) PGND Power ground. The exposed pad must be soldered to a large PCB and connected to PGND for maximum power dissipation.\n\n3 AGND Analog ground. Should be electrically connected to GND close to the device.\n\n4 FB Feedback voltage input.\n\n5 VOS Output voltage sense pin for the internal control loop. Must be connected to output.\n\n6 PGOOD Power good open-drain output. This pin is pulled to low if the output voltage is below regulation limits. Can be left floating if not used.\n\n7 LX Switch node. The Source of the internal high-side power MOSFET, and Drain of the internal low-side (synchronous) rectifier MOSFET.\n\n8 VIN Power input supply voltage, 2.5V to 5.5V.\n\nVIN\n\nAGND\n\nPGND\n\nEN\n\n\\+\n\n\\-\n\nVREF\n\nShutdown Control\n\nLX FB Driver\n\nTON\n\nLogic Control\n\nLX\n\nCurrent Limit Detector\n\nAZC LX\n\nComparator \\+-+\n\nVOS\n\nError Amplifier\n\nUVLO\n\nOTP\n\nLX\n\n\\+\n\n\\-\n\nVFB\n\nPGOOD\n\nRamp Generator\n\nLX","publish_date":null,"title":"RT5795A","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page2.pdf"},"request":{"example_id":"table/DS5795A-06_page2","product_type":"parse","source_file_path":"DS5795A-06_page2.pdf"},"started_at":"2026-11-04T19:47:22.580426"} +{"completed_at":"2026-11-04T19:47:25.862483","latency_in_ms":2564,"output":{"example_id":"table/DS5795A-06_page4","grounded_pages":[],"layout_pages":[],"markdown":"4 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Recommended Operating Conditions** (Note 4)\n\n Supply Input Voltage, VIN ----------------------------------------------------------------------------------------------- 2.5V to 5.5V\n\n Junction Temperature Range-------------------------------------------------------------------------------------------- −40°C to 125°C\n\n Ambient Temperature Range-------------------------------------------------------------------------------------------- −40°C to 85°C\n\n### **Electrical Characteristics**\n\n(VIN = 3.6V, TA = 25°C, unless otherwise specified)\n\n### **Absolute Maximum Ratings** (Note 1)\n\n Supply Input Voltage, VIN ----------------------------------------------------------------------------------------------- −0.3V to 6V\n\n Switch Voltage, LX -------------------------------------------------------------------------------------------------------- −0.3V to 6V < 50ns------------------------------------------------------------------------------------------------------------------------ −2.5V to 7V\n\n Other Pins------------------------------------------------------------------------------------------------------------------- −0.3V to 6V\n\n Power Dissipation, PD @ TA = 25°C WDFN-8SL 2x2 ------------------------------------------------------------------------------------------------------------ 1.538W\n\n Package Thermal Resistance (Note 2) WDFN-8SL 2x2, θJA ------------------------------------------------------------------------------------------------------- 65°C/W WDFN-8SL 2x2, θJC ------------------------------------------------------------------------------------------------------ 8°C/W\n\n Junction Temperature ----------------------------------------------------------------------------------------------------- 150°C\n\n Lead Temperature (Soldering, 10 sec.)------------------------------------------------------------------------------- 260°C\n\n Storage Temperature Range -------------------------------------------------------------------------------------------- −65°C to 150°C\n\n ESD Susceptibility (Note 3) HBM (Human Body Model)---------------------------------------------------------------------------------------------- 2kV\n\n**Parameter Symbol Test Conditions Min Typ Max Unit**\n\nUnder-Voltage Lockout Threshold VUVLO VCC rising 2.28 2.35 2.48 V\n\nUnder-Voltage Lockout Hysteresis VUVLOHY -- 400 -- mV\n\nShutdown Supply Current ISHDN EN = 0V -- -- 1 A\n\nQuiescent Current IQ Active, VFB = 0.5V, no switching -- 30 -- A\n\nVoltage Reference VREF 0.441 0.45 0.459 V\n\nCurrent Limit High-Side ILIM Peak current 2.5 3.2 4 A\n\nLow-Side Valley current 2 2.4 2.9\n\nPower Good Threshold VPGTH VOUT falling referenced to VOUT nominal 15 10 5 %\n\nPower Good Hysteresis VPGHY Hysteresis referenced to VOUT nominal -- 5 -- %\n\nPower Good Leakage Current IPG VPG = 5V -- 0.01 0.1 A\n\nPower Good Low Level Voltage VPGL Isink = 500A -- -- 0.3 V\n\nEnable Rising Threshold VENR Rising 1 -- -- V\n\nEnable Falling Threshold VENF Falling -- -- 0.4 V","pages":[{"line_numbers":[],"markdown":"4 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Recommended Operating Conditions** (Note 4)\n\n Supply Input Voltage, VIN ----------------------------------------------------------------------------------------------- 2.5V to 5.5V\n\n Junction Temperature Range-------------------------------------------------------------------------------------------- −40°C to 125°C\n\n Ambient Temperature Range-------------------------------------------------------------------------------------------- −40°C to 85°C\n\n### **Electrical Characteristics**\n\n(VIN = 3.6V, TA = 25°C, unless otherwise specified)\n\n### **Absolute Maximum Ratings** (Note 1)\n\n Supply Input Voltage, VIN ----------------------------------------------------------------------------------------------- −0.3V to 6V\n\n Switch Voltage, LX -------------------------------------------------------------------------------------------------------- −0.3V to 6V < 50ns------------------------------------------------------------------------------------------------------------------------ −2.5V to 7V\n\n Other Pins------------------------------------------------------------------------------------------------------------------- −0.3V to 6V\n\n Power Dissipation, PD @ TA = 25°C WDFN-8SL 2x2 ------------------------------------------------------------------------------------------------------------ 1.538W\n\n Package Thermal Resistance (Note 2) WDFN-8SL 2x2, θJA ------------------------------------------------------------------------------------------------------- 65°C/W WDFN-8SL 2x2, θJC ------------------------------------------------------------------------------------------------------ 8°C/W\n\n Junction Temperature ----------------------------------------------------------------------------------------------------- 150°C\n\n Lead Temperature (Soldering, 10 sec.)------------------------------------------------------------------------------- 260°C\n\n Storage Temperature Range -------------------------------------------------------------------------------------------- −65°C to 150°C\n\n ESD Susceptibility (Note 3) HBM (Human Body Model)---------------------------------------------------------------------------------------------- 2kV\n\n**Parameter Symbol Test Conditions Min Typ Max Unit**\n\nUnder-Voltage Lockout Threshold VUVLO VCC rising 2.28 2.35 2.48 V\n\nUnder-Voltage Lockout Hysteresis VUVLOHY -- 400 -- mV\n\nShutdown Supply Current ISHDN EN = 0V -- -- 1 A\n\nQuiescent Current IQ Active, VFB = 0.5V, no switching -- 30 -- A\n\nVoltage Reference VREF 0.441 0.45 0.459 V\n\nCurrent Limit High-Side ILIM Peak current 2.5 3.2 4 A\n\nLow-Side Valley current 2 2.4 2.9\n\nPower Good Threshold VPGTH VOUT falling referenced to VOUT nominal 15 10 5 %\n\nPower Good Hysteresis VPGHY Hysteresis referenced to VOUT nominal -- 5 -- %\n\nPower Good Leakage Current IPG VPG = 5V -- 0.01 0.1 A\n\nPower Good Low Level Voltage VPGL Isink = 500A -- -- 0.3 V\n\nEnable Rising Threshold VENR Rising 1 -- -- V\n\nEnable Falling Threshold VENF Falling -- -- 0.4 V","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"4 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Recommended Operating Conditions** (Note 4)\n\n Supply Input Voltage, VIN ----------------------------------------------------------------------------------------------- 2.5V to 5.5V\n\n Junction Temperature Range-------------------------------------------------------------------------------------------- −40°C to 125°C\n\n Ambient Temperature Range-------------------------------------------------------------------------------------------- −40°C to 85°C\n\n### **Electrical Characteristics**\n\n(VIN = 3.6V, TA = 25°C, unless otherwise specified)\n\n### **Absolute Maximum Ratings** (Note 1)\n\n Supply Input Voltage, VIN ----------------------------------------------------------------------------------------------- −0.3V to 6V\n\n Switch Voltage, LX -------------------------------------------------------------------------------------------------------- −0.3V to 6V < 50ns------------------------------------------------------------------------------------------------------------------------ −2.5V to 7V\n\n Other Pins------------------------------------------------------------------------------------------------------------------- −0.3V to 6V\n\n Power Dissipation, PD @ TA = 25°C WDFN-8SL 2x2 ------------------------------------------------------------------------------------------------------------ 1.538W\n\n Package Thermal Resistance (Note 2) WDFN-8SL 2x2, θJA ------------------------------------------------------------------------------------------------------- 65°C/W WDFN-8SL 2x2, θJC ------------------------------------------------------------------------------------------------------ 8°C/W\n\n Junction Temperature ----------------------------------------------------------------------------------------------------- 150°C\n\n Lead Temperature (Soldering, 10 sec.)------------------------------------------------------------------------------- 260°C\n\n Storage Temperature Range -------------------------------------------------------------------------------------------- −65°C to 150°C\n\n ESD Susceptibility (Note 3) HBM (Human Body Model)---------------------------------------------------------------------------------------------- 2kV\n\n**Parameter Symbol Test Conditions Min Typ Max Unit**\n\nUnder-Voltage Lockout Threshold VUVLO VCC rising 2.28 2.35 2.48 V\n\nUnder-Voltage Lockout Hysteresis VUVLOHY -- 400 -- mV\n\nShutdown Supply Current ISHDN EN = 0V -- -- 1 A\n\nQuiescent Current IQ Active, VFB = 0.5V, no switching -- 30 -- A\n\nVoltage Reference VREF 0.441 0.45 0.459 V\n\nCurrent Limit High-Side ILIM Peak current 2.5 3.2 4 A\n\nLow-Side Valley current 2 2.4 2.9\n\nPower Good Threshold VPGTH VOUT falling referenced to VOUT nominal 15 10 5 %\n\nPower Good Hysteresis VPGHY Hysteresis referenced to VOUT nominal -- 5 -- %\n\nPower Good Leakage Current IPG VPG = 5V -- 0.01 0.1 A\n\nPower Good Low Level Voltage VPGL Isink = 500A -- -- 0.3 V\n\nEnable Rising Threshold VENR Rising 1 -- -- V\n\nEnable Falling Threshold VENF Falling -- -- 0.4 V","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page4.pdf"]},"response":{"errors":[],"extract_id":"extract_9c85f94268d695196fc375f2cca91b95","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["4 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Recommended Operating Conditions** (Note 4)\n\n Supply Input Voltage, VIN ----------------------------------------------------------------------------------------------- 2.5V to 5.5V\n\n Junction Temperature Range-------------------------------------------------------------------------------------------- −40°C to 125°C\n\n Ambient Temperature Range-------------------------------------------------------------------------------------------- −40°C to 85°C\n\n### **Electrical Characteristics**\n\n(VIN = 3.6V, TA = 25°C, unless otherwise specified)\n\n### **Absolute Maximum Ratings** (Note 1)\n\n Supply Input Voltage, VIN ----------------------------------------------------------------------------------------------- −0.3V to 6V\n\n Switch Voltage, LX -------------------------------------------------------------------------------------------------------- −0.3V to 6V < 50ns------------------------------------------------------------------------------------------------------------------------ −2.5V to 7V\n\n Other Pins------------------------------------------------------------------------------------------------------------------- −0.3V to 6V\n\n Power Dissipation, PD @ TA = 25°C WDFN-8SL 2x2 ------------------------------------------------------------------------------------------------------------ 1.538W\n\n Package Thermal Resistance (Note 2) WDFN-8SL 2x2, θJA ------------------------------------------------------------------------------------------------------- 65°C/W WDFN-8SL 2x2, θJC ------------------------------------------------------------------------------------------------------ 8°C/W\n\n Junction Temperature ----------------------------------------------------------------------------------------------------- 150°C\n\n Lead Temperature (Soldering, 10 sec.)------------------------------------------------------------------------------- 260°C\n\n Storage Temperature Range -------------------------------------------------------------------------------------------- −65°C to 150°C\n\n ESD Susceptibility (Note 3) HBM (Human Body Model)---------------------------------------------------------------------------------------------- 2kV\n\n**Parameter Symbol Test Conditions Min Typ Max Unit**\n\nUnder-Voltage Lockout Threshold VUVLO VCC rising 2.28 2.35 2.48 V\n\nUnder-Voltage Lockout Hysteresis VUVLOHY -- 400 -- mV\n\nShutdown Supply Current ISHDN EN = 0V -- -- 1 A\n\nQuiescent Current IQ Active, VFB = 0.5V, no switching -- 30 -- A\n\nVoltage Reference VREF 0.441 0.45 0.459 V\n\nCurrent Limit High-Side ILIM Peak current 2.5 3.2 4 A\n\nLow-Side Valley current 2 2.4 2.9\n\nPower Good Threshold VPGTH VOUT falling referenced to VOUT nominal 15 10 5 %\n\nPower Good Hysteresis VPGHY Hysteresis referenced to VOUT nominal -- 5 -- %\n\nPower Good Leakage Current IPG VPG = 5V -- 0.01 0.1 A\n\nPower Good Low Level Voltage VPGL Isink = 500A -- -- 0.3 V\n\nEnable Rising Threshold VENR Rising 1 -- -- V\n\nEnable Falling Threshold VENF Falling -- -- 0.4 V"],"full_content":"4 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Recommended Operating Conditions** (Note 4)\n\n Supply Input Voltage, VIN ----------------------------------------------------------------------------------------------- 2.5V to 5.5V\n\n Junction Temperature Range-------------------------------------------------------------------------------------------- −40°C to 125°C\n\n Ambient Temperature Range-------------------------------------------------------------------------------------------- −40°C to 85°C\n\n### **Electrical Characteristics**\n\n(VIN = 3.6V, TA = 25°C, unless otherwise specified)\n\n### **Absolute Maximum Ratings** (Note 1)\n\n Supply Input Voltage, VIN ----------------------------------------------------------------------------------------------- −0.3V to 6V\n\n Switch Voltage, LX -------------------------------------------------------------------------------------------------------- −0.3V to 6V < 50ns------------------------------------------------------------------------------------------------------------------------ −2.5V to 7V\n\n Other Pins------------------------------------------------------------------------------------------------------------------- −0.3V to 6V\n\n Power Dissipation, PD @ TA = 25°C WDFN-8SL 2x2 ------------------------------------------------------------------------------------------------------------ 1.538W\n\n Package Thermal Resistance (Note 2) WDFN-8SL 2x2, θJA ------------------------------------------------------------------------------------------------------- 65°C/W WDFN-8SL 2x2, θJC ------------------------------------------------------------------------------------------------------ 8°C/W\n\n Junction Temperature ----------------------------------------------------------------------------------------------------- 150°C\n\n Lead Temperature (Soldering, 10 sec.)------------------------------------------------------------------------------- 260°C\n\n Storage Temperature Range -------------------------------------------------------------------------------------------- −65°C to 150°C\n\n ESD Susceptibility (Note 3) HBM (Human Body Model)---------------------------------------------------------------------------------------------- 2kV\n\n**Parameter Symbol Test Conditions Min Typ Max Unit**\n\nUnder-Voltage Lockout Threshold VUVLO VCC rising 2.28 2.35 2.48 V\n\nUnder-Voltage Lockout Hysteresis VUVLOHY -- 400 -- mV\n\nShutdown Supply Current ISHDN EN = 0V -- -- 1 A\n\nQuiescent Current IQ Active, VFB = 0.5V, no switching -- 30 -- A\n\nVoltage Reference VREF 0.441 0.45 0.459 V\n\nCurrent Limit High-Side ILIM Peak current 2.5 3.2 4 A\n\nLow-Side Valley current 2 2.4 2.9\n\nPower Good Threshold VPGTH VOUT falling referenced to VOUT nominal 15 10 5 %\n\nPower Good Hysteresis VPGHY Hysteresis referenced to VOUT nominal -- 5 -- %\n\nPower Good Leakage Current IPG VPG = 5V -- 0.01 0.1 A\n\nPower Good Low Level Voltage VPGL Isink = 500A -- -- 0.3 V\n\nEnable Rising Threshold VENR Rising 1 -- -- V\n\nEnable Falling Threshold VENF Falling -- -- 0.4 V","publish_date":null,"title":"RT5795A","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page4.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page4.pdf"},"request":{"example_id":"table/DS5795A-06_page4","product_type":"parse","source_file_path":"DS5795A-06_page4.pdf"},"started_at":"2026-11-04T19:47:23.297934"} +{"completed_at":"2026-11-04T19:47:26.167181","latency_in_ms":1572,"output":{"example_id":"table/DS5795A-06_page5","grounded_pages":[],"layout_pages":[],"markdown":"5 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n**Parameter Symbol Test Conditions Min Typ Max Unit**\n\nSwitch On-Resistance High-Side RP-MOSFET -- 100 -- m\n\nLow-Side RN-MOSFET -- 80 --\n\nThermal Shutdown Temperature -- 150 -- C\n\nThermal Shutdown Hysteresis -- 20 -- C\n\nSwitching Frequency fOSC -- 2.7 -- MHz\n\nOutput Discharge Resistor -- 1 -- k\n\n**Note 1.** Stresses beyond those listed under “Absolute Maximum Ratings” may cause permanent damage to the device.\n\nThese are stress ratings only, and functional operation of the device at these or any other conditions beyond those\n\nindicated in the operational sections of the specifications is not implied. Exposure to absolute maximum rating\n\nconditions may affect device reliability.\n\n**Note 2.** θJA is measured at TA = 25°C on a high effective thermal conductivity four-layer test board per JEDEC 51-7. θJC is\n\nmeasured at the exposed pad of the package. The copper area is 70mm ² connected with IC exposed pad.\n\n**Note 3.** Devices are ESD sensitive. Handling precaution is recommended.\n\n**Note 4.** The device is not guaranteed to function outside its operating conditions.","pages":[{"line_numbers":[],"markdown":"5 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n**Parameter Symbol Test Conditions Min Typ Max Unit**\n\nSwitch On-Resistance High-Side RP-MOSFET -- 100 -- m\n\nLow-Side RN-MOSFET -- 80 --\n\nThermal Shutdown Temperature -- 150 -- C\n\nThermal Shutdown Hysteresis -- 20 -- C\n\nSwitching Frequency fOSC -- 2.7 -- MHz\n\nOutput Discharge Resistor -- 1 -- k\n\n**Note 1.** Stresses beyond those listed under “Absolute Maximum Ratings” may cause permanent damage to the device.\n\nThese are stress ratings only, and functional operation of the device at these or any other conditions beyond those\n\nindicated in the operational sections of the specifications is not implied. Exposure to absolute maximum rating\n\nconditions may affect device reliability.\n\n**Note 2.** θJA is measured at TA = 25°C on a high effective thermal conductivity four-layer test board per JEDEC 51-7. θJC is\n\nmeasured at the exposed pad of the package. The copper area is 70mm ² connected with IC exposed pad.\n\n**Note 3.** Devices are ESD sensitive. Handling precaution is recommended.\n\n**Note 4.** The device is not guaranteed to function outside its operating conditions.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"5 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n**Parameter Symbol Test Conditions Min Typ Max Unit**\n\nSwitch On-Resistance High-Side RP-MOSFET -- 100 -- m\n\nLow-Side RN-MOSFET -- 80 --\n\nThermal Shutdown Temperature -- 150 -- C\n\nThermal Shutdown Hysteresis -- 20 -- C\n\nSwitching Frequency fOSC -- 2.7 -- MHz\n\nOutput Discharge Resistor -- 1 -- k\n\n**Note 1.** Stresses beyond those listed under “Absolute Maximum Ratings” may cause permanent damage to the device.\n\nThese are stress ratings only, and functional operation of the device at these or any other conditions beyond those\n\nindicated in the operational sections of the specifications is not implied. Exposure to absolute maximum rating\n\nconditions may affect device reliability.\n\n**Note 2.** θJA is measured at TA = 25°C on a high effective thermal conductivity four-layer test board per JEDEC 51-7. θJC is\n\nmeasured at the exposed pad of the package. The copper area is 70mm ² connected with IC exposed pad.\n\n**Note 3.** Devices are ESD sensitive. Handling precaution is recommended.\n\n**Note 4.** The device is not guaranteed to function outside its operating conditions.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page5.pdf"]},"response":{"errors":[],"extract_id":"extract_fc7a85cc2c1106d3291db98f12858f4c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["5 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n**Parameter Symbol Test Conditions Min Typ Max Unit**\n\nSwitch On-Resistance High-Side RP-MOSFET -- 100 -- m\n\nLow-Side RN-MOSFET -- 80 --\n\nThermal Shutdown Temperature -- 150 -- C\n\nThermal Shutdown Hysteresis -- 20 -- C\n\nSwitching Frequency fOSC -- 2.7 -- MHz\n\nOutput Discharge Resistor -- 1 -- k\n\n**Note 1.** Stresses beyond those listed under “Absolute Maximum Ratings” may cause permanent damage to the device.\n\nThese are stress ratings only, and functional operation of the device at these or any other conditions beyond those\n\nindicated in the operational sections of the specifications is not implied. Exposure to absolute maximum rating\n\nconditions may affect device reliability.\n\n**Note 2.** θJA is measured at TA = 25°C on a high effective thermal conductivity four-layer test board per JEDEC 51-7. θJC is\n\nmeasured at the exposed pad of the package. The copper area is 70mm ² connected with IC exposed pad.\n\n**Note 3.** Devices are ESD sensitive. Handling precaution is recommended.\n\n**Note 4.** The device is not guaranteed to function outside its operating conditions."],"full_content":"5 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n**Parameter Symbol Test Conditions Min Typ Max Unit**\n\nSwitch On-Resistance High-Side RP-MOSFET -- 100 -- m\n\nLow-Side RN-MOSFET -- 80 --\n\nThermal Shutdown Temperature -- 150 -- C\n\nThermal Shutdown Hysteresis -- 20 -- C\n\nSwitching Frequency fOSC -- 2.7 -- MHz\n\nOutput Discharge Resistor -- 1 -- k\n\n**Note 1.** Stresses beyond those listed under “Absolute Maximum Ratings” may cause permanent damage to the device.\n\nThese are stress ratings only, and functional operation of the device at these or any other conditions beyond those\n\nindicated in the operational sections of the specifications is not implied. Exposure to absolute maximum rating\n\nconditions may affect device reliability.\n\n**Note 2.** θJA is measured at TA = 25°C on a high effective thermal conductivity four-layer test board per JEDEC 51-7. θJC is\n\nmeasured at the exposed pad of the package. The copper area is 70mm ² connected with IC exposed pad.\n\n**Note 3.** Devices are ESD sensitive. Handling precaution is recommended.\n\n**Note 4.** The device is not guaranteed to function outside its operating conditions.","publish_date":null,"title":"RT5795A","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page5.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page5.pdf"},"request":{"example_id":"table/DS5795A-06_page5","product_type":"parse","source_file_path":"DS5795A-06_page5.pdf"},"started_at":"2026-11-04T19:47:24.594683"} +{"completed_at":"2026-11-04T19:47:28.058707","latency_in_ms":2194,"output":{"example_id":"table/DS5795A-06_page6","grounded_pages":[],"layout_pages":[],"markdown":"6 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Typical Application Circuit**\n\n**Table 1. Suggested Component Values**\n\n**VOUT (V) R1 (k**  **) R2 (k**  **) L (**  **H) COUT (**  **F)**\n\n1\\.2V 65.3 39.2 0.47 22\n\n1\\.8V 117.6 39.2 1 22\n\n2\\.5V 178.6 39.2 1 22\n\n3\\.3V 248.3 39.2 1 22\n\nVIN\n\n**RT5795A**\n\nEN\n\nPGND\n\nAGND\n\nPGOOD\n\nLX\n\nVOS FB\n\n180k\n\nR1\n\nR2\n\nL\n\nCOUT\n\nVOUT\n\nPower Good\n\n10µF\n\nVIN\n\n6\n\n7\n\n5\n\n4 3\n\n2, 9 (Exposed Pad)\n\n1\n\n8","pages":[{"line_numbers":[],"markdown":"6 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Typical Application Circuit**\n\n**Table 1. Suggested Component Values**\n\n**VOUT (V) R1 (k**  **) R2 (k**  **) L (**  **H) COUT (**  **F)**\n\n1\\.2V 65.3 39.2 0.47 22\n\n1\\.8V 117.6 39.2 1 22\n\n2\\.5V 178.6 39.2 1 22\n\n3\\.3V 248.3 39.2 1 22\n\nVIN\n\n**RT5795A**\n\nEN\n\nPGND\n\nAGND\n\nPGOOD\n\nLX\n\nVOS FB\n\n180k\n\nR1\n\nR2\n\nL\n\nCOUT\n\nVOUT\n\nPower Good\n\n10µF\n\nVIN\n\n6\n\n7\n\n5\n\n4 3\n\n2, 9 (Exposed Pad)\n\n1\n\n8","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"6 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Typical Application Circuit**\n\n**Table 1. Suggested Component Values**\n\n**VOUT (V) R1 (k**  **) R2 (k**  **) L (**  **H) COUT (**  **F)**\n\n1\\.2V 65.3 39.2 0.47 22\n\n1\\.8V 117.6 39.2 1 22\n\n2\\.5V 178.6 39.2 1 22\n\n3\\.3V 248.3 39.2 1 22\n\nVIN\n\n**RT5795A**\n\nEN\n\nPGND\n\nAGND\n\nPGOOD\n\nLX\n\nVOS FB\n\n180k\n\nR1\n\nR2\n\nL\n\nCOUT\n\nVOUT\n\nPower Good\n\n10µF\n\nVIN\n\n6\n\n7\n\n5\n\n4 3\n\n2, 9 (Exposed Pad)\n\n1\n\n8","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_0d58f92bff356ff81f550036dc534dec","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["6 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Typical Application Circuit**\n\n**Table 1. Suggested Component Values**\n\n**VOUT (V) R1 (k**  **) R2 (k**  **) L (**  **H) COUT (**  **F)**\n\n1\\.2V 65.3 39.2 0.47 22\n\n1\\.8V 117.6 39.2 1 22\n\n2\\.5V 178.6 39.2 1 22\n\n3\\.3V 248.3 39.2 1 22\n\nVIN\n\n**RT5795A**\n\nEN\n\nPGND\n\nAGND\n\nPGOOD\n\nLX\n\nVOS FB\n\n180k\n\nR1\n\nR2\n\nL\n\nCOUT\n\nVOUT\n\nPower Good\n\n10µF\n\nVIN\n\n6\n\n7\n\n5\n\n4 3\n\n2, 9 (Exposed Pad)\n\n1\n\n8"],"full_content":"6 DS5795A-06 November 2019 www.richtek.com\n\n# **RT5795A**\n\n### **Typical Application Circuit**\n\n**Table 1. Suggested Component Values**\n\n**VOUT (V) R1 (k**  **) R2 (k**  **) L (**  **H) COUT (**  **F)**\n\n1\\.2V 65.3 39.2 0.47 22\n\n1\\.8V 117.6 39.2 1 22\n\n2\\.5V 178.6 39.2 1 22\n\n3\\.3V 248.3 39.2 1 22\n\nVIN\n\n**RT5795A**\n\nEN\n\nPGND\n\nAGND\n\nPGOOD\n\nLX\n\nVOS FB\n\n180k\n\nR1\n\nR2\n\nL\n\nCOUT\n\nVOUT\n\nPower Good\n\n10µF\n\nVIN\n\n6\n\n7\n\n5\n\n4 3\n\n2, 9 (Exposed Pad)\n\n1\n\n8","publish_date":null,"title":"RT5795A","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/DS5795A-06_page6.pdf"},"request":{"example_id":"table/DS5795A-06_page6","product_type":"parse","source_file_path":"DS5795A-06_page6.pdf"},"started_at":"2026-11-04T19:47:25.864095"} +{"completed_at":"2026-11-04T19:47:27.541922","latency_in_ms":1134,"output":{"example_id":"table/Earnings Presentation (FY26 Q2)_page22","grounded_pages":[],"layout_pages":[],"markdown":"# Supplemental Information - FY26 and FY27 Comparable Sales 4-5-4 Reporting Calendars\n\nWe report U.S. comparable sales on a 13-week and 52-week retail calendar — commonly referred to as a \"4-5-4\" calendar — which uses 364 days in a year. In certain years, it becomes necessary to add a 53rd week to our comparable sales reporting calendar, which occurred in fiscal 2025. The following tables reflect our period ending dates for the reporting of U.S. comparable sales throughout fiscal 2026 and fiscal 2027. The additional week only affects 4-5-4 comparable sales; all other measures remain unaffected.\n\nFY26 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nBase: FY25 (52 weeks) May 03, 2024 August 02, 2024 November 01, 2024 January 31, 2025 January 31, 2025\n\nComparison Period: FY25 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 14 Weeks Ended Full Year 53 Weeks Ended\n\nFY25 (53 weeks) ¹ April 26, 2024 July 26, 2024 October 25, 2024 January 31, 2025 January 31, 2025\n\nBase: FY24 (53 weeks) April 28, 2023 July 28, 2023 October 27, 2023 February 02, 2024 February 02, 2024\n\n# FY26 Reporting\n\nFY27 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY27 (52 weeks) May 01, 2026 July 31, 2026 October 30, 2026 January 29, 2027 January 29, 2027\n\nBase: FY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nComparison Period: FY26 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nBase: FY25 (52 weeks) May 03, 2024 August 02, 2024 November 01, 2024 January 31, 2025 January 31, 2025\n\n# FY27 Reporting\n\n1 Our comparable sales calculations are based on periods of equal lengths and comparison periods are presented as they were originally reported. If the comparison periods were recast to align to the same number of weeks as the reporting period, any changes to the previously reported comparable sales would be inconsequential. 22","pages":[{"line_numbers":[],"markdown":"# Supplemental Information - FY26 and FY27 Comparable Sales 4-5-4 Reporting Calendars\n\nWe report U.S. comparable sales on a 13-week and 52-week retail calendar — commonly referred to as a \"4-5-4\" calendar — which uses 364 days in a year. In certain years, it becomes necessary to add a 53rd week to our comparable sales reporting calendar, which occurred in fiscal 2025. The following tables reflect our period ending dates for the reporting of U.S. comparable sales throughout fiscal 2026 and fiscal 2027. The additional week only affects 4-5-4 comparable sales; all other measures remain unaffected.\n\nFY26 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nBase: FY25 (52 weeks) May 03, 2024 August 02, 2024 November 01, 2024 January 31, 2025 January 31, 2025\n\nComparison Period: FY25 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 14 Weeks Ended Full Year 53 Weeks Ended\n\nFY25 (53 weeks) ¹ April 26, 2024 July 26, 2024 October 25, 2024 January 31, 2025 January 31, 2025\n\nBase: FY24 (53 weeks) April 28, 2023 July 28, 2023 October 27, 2023 February 02, 2024 February 02, 2024\n\n# FY26 Reporting\n\nFY27 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY27 (52 weeks) May 01, 2026 July 31, 2026 October 30, 2026 January 29, 2027 January 29, 2027\n\nBase: FY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nComparison Period: FY26 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nBase: FY25 (52 weeks) May 03, 2024 August 02, 2024 November 01, 2024 January 31, 2025 January 31, 2025\n\n# FY27 Reporting\n\n1 Our comparable sales calculations are based on periods of equal lengths and comparison periods are presented as they were originally reported. If the comparison periods were recast to align to the same number of weeks as the reporting period, any changes to the previously reported comparable sales would be inconsequential. 22","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"# Supplemental Information - FY26 and FY27 Comparable Sales 4-5-4 Reporting Calendars\n\nWe report U.S. comparable sales on a 13-week and 52-week retail calendar — commonly referred to as a \"4-5-4\" calendar — which uses 364 days in a year. In certain years, it becomes necessary to add a 53rd week to our comparable sales reporting calendar, which occurred in fiscal 2025. The following tables reflect our period ending dates for the reporting of U.S. comparable sales throughout fiscal 2026 and fiscal 2027. The additional week only affects 4-5-4 comparable sales; all other measures remain unaffected.\n\nFY26 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nBase: FY25 (52 weeks) May 03, 2024 August 02, 2024 November 01, 2024 January 31, 2025 January 31, 2025\n\nComparison Period: FY25 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 14 Weeks Ended Full Year 53 Weeks Ended\n\nFY25 (53 weeks) ¹ April 26, 2024 July 26, 2024 October 25, 2024 January 31, 2025 January 31, 2025\n\nBase: FY24 (53 weeks) April 28, 2023 July 28, 2023 October 27, 2023 February 02, 2024 February 02, 2024\n\n# FY26 Reporting\n\nFY27 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY27 (52 weeks) May 01, 2026 July 31, 2026 October 30, 2026 January 29, 2027 January 29, 2027\n\nBase: FY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nComparison Period: FY26 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nBase: FY25 (52 weeks) May 03, 2024 August 02, 2024 November 01, 2024 January 31, 2025 January 31, 2025\n\n# FY27 Reporting\n\n1 Our comparable sales calculations are based on periods of equal lengths and comparison periods are presented as they were originally reported. If the comparison periods were recast to align to the same number of weeks as the reporting period, any changes to the previously reported comparable sales would be inconsequential. 22","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Earnings%20Presentation%20%28FY26%20Q2%29_page22.pdf"]},"response":{"errors":[],"extract_id":"extract_7f7b5faae4c636eb907a49f4ebf3cef4","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["# Supplemental Information - FY26 and FY27 Comparable Sales 4-5-4 Reporting Calendars\n\nWe report U.S. comparable sales on a 13-week and 52-week retail calendar — commonly referred to as a \"4-5-4\" calendar — which uses 364 days in a year. In certain years, it becomes necessary to add a 53rd week to our comparable sales reporting calendar, which occurred in fiscal 2025. The following tables reflect our period ending dates for the reporting of U.S. comparable sales throughout fiscal 2026 and fiscal 2027. The additional week only affects 4-5-4 comparable sales; all other measures remain unaffected.\n\nFY26 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nBase: FY25 (52 weeks) May 03, 2024 August 02, 2024 November 01, 2024 January 31, 2025 January 31, 2025\n\nComparison Period: FY25 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 14 Weeks Ended Full Year 53 Weeks Ended\n\nFY25 (53 weeks) ¹ April 26, 2024 July 26, 2024 October 25, 2024 January 31, 2025 January 31, 2025\n\nBase: FY24 (53 weeks) April 28, 2023 July 28, 2023 October 27, 2023 February 02, 2024 February 02, 2024\n\n# FY26 Reporting\n\nFY27 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY27 (52 weeks) May 01, 2026 July 31, 2026 October 30, 2026 January 29, 2027 January 29, 2027\n\nBase: FY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nComparison Period: FY26 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nBase: FY25 (52 weeks) May 03, 2024 August 02, 2024 November 01, 2024 January 31, 2025 January 31, 2025\n\n# FY27 Reporting\n\n1 Our comparable sales calculations are based on periods of equal lengths and comparison periods are presented as they were originally reported. If the comparison periods were recast to align to the same number of weeks as the reporting period, any changes to the previously reported comparable sales would be inconsequential. 22"],"full_content":"# Supplemental Information - FY26 and FY27 Comparable Sales 4-5-4 Reporting Calendars\n\nWe report U.S. comparable sales on a 13-week and 52-week retail calendar — commonly referred to as a \"4-5-4\" calendar — which uses 364 days in a year. In certain years, it becomes necessary to add a 53rd week to our comparable sales reporting calendar, which occurred in fiscal 2025. The following tables reflect our period ending dates for the reporting of U.S. comparable sales throughout fiscal 2026 and fiscal 2027. The additional week only affects 4-5-4 comparable sales; all other measures remain unaffected.\n\nFY26 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nBase: FY25 (52 weeks) May 03, 2024 August 02, 2024 November 01, 2024 January 31, 2025 January 31, 2025\n\nComparison Period: FY25 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 14 Weeks Ended Full Year 53 Weeks Ended\n\nFY25 (53 weeks) ¹ April 26, 2024 July 26, 2024 October 25, 2024 January 31, 2025 January 31, 2025\n\nBase: FY24 (53 weeks) April 28, 2023 July 28, 2023 October 27, 2023 February 02, 2024 February 02, 2024\n\n# FY26 Reporting\n\nFY27 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY27 (52 weeks) May 01, 2026 July 31, 2026 October 30, 2026 January 29, 2027 January 29, 2027\n\nBase: FY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nComparison Period: FY26 Comparable Sales\n\nQ1 13 Weeks Ended Q2 13 Weeks Ended Q3 13 Weeks Ended Q4 13 Weeks Ended Full Year 52 Weeks Ended\n\nFY26 (52 weeks) May 02, 2025 August 01, 2025 October 31, 2025 January 30, 2026 January 30, 2026\n\nBase: FY25 (52 weeks) May 03, 2024 August 02, 2024 November 01, 2024 January 31, 2025 January 31, 2025\n\n# FY27 Reporting\n\n1 Our comparable sales calculations are based on periods of equal lengths and comparison periods are presented as they were originally reported. If the comparison periods were recast to align to the same number of weeks as the reporting period, any changes to the previously reported comparable sales would be inconsequential. 22","publish_date":null,"title":"Supplemental Information - FY26 and FY27 Comparable Sales 4-5-4 Reporting Calendars","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Earnings%20Presentation%20%28FY26%20Q2%29_page22.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Earnings%20Presentation%20%28FY26%20Q2%29_page22.pdf"},"request":{"example_id":"table/Earnings Presentation (FY26 Q2)_page22","product_type":"parse","source_file_path":"Earnings Presentation (FY26 Q2)_page22.pdf"},"started_at":"2026-11-04T19:47:26.407150"} +{"completed_at":"2026-11-04T19:47:30.268173","latency_in_ms":2700,"output":{"example_id":"table/FBLB-134215544_page10","grounded_pages":[],"layout_pages":[],"markdown":"### **Rate Information** Rate data applies to filing.\n\n**Filing Method:** Use and File\n\n**Rate Change Type:** Increase\n\n**Overall Percentage of Last Rate Revision:** 8\\.400%\n\n**Effective Date of Last Rate Revision:** 09/30/2024\n\n**Filing Method of Last Filing:** Use and File\n\n**SERFF Tracking Number of Last Filing:** FBLB-134101344\n\n### **Company Rate Information**\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nFarm Bureau Property & Casualty Insurance Company\n\n5\\.500% 4.400% $5,258,723 25,392 $119,944,088 245.000% -12.100%\n\nWestern Agricultural Insurance Company\n\n5\\.300% 4.000% $1,073,338 6,085 $27,091,793 164.100% -0.200%\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","pages":[{"line_numbers":[],"markdown":"### **Rate Information** Rate data applies to filing.\n\n**Filing Method:** Use and File\n\n**Rate Change Type:** Increase\n\n**Overall Percentage of Last Rate Revision:** 8\\.400%\n\n**Effective Date of Last Rate Revision:** 09/30/2024\n\n**Filing Method of Last Filing:** Use and File\n\n**SERFF Tracking Number of Last Filing:** FBLB-134101344\n\n### **Company Rate Information**\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nFarm Bureau Property & Casualty Insurance Company\n\n5\\.500% 4.400% $5,258,723 25,392 $119,944,088 245.000% -12.100%\n\nWestern Agricultural Insurance Company\n\n5\\.300% 4.000% $1,073,338 6,085 $27,091,793 164.100% -0.200%\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Rate Information** Rate data applies to filing.\n\n**Filing Method:** Use and File\n\n**Rate Change Type:** Increase\n\n**Overall Percentage of Last Rate Revision:** 8\\.400%\n\n**Effective Date of Last Rate Revision:** 09/30/2024\n\n**Filing Method of Last Filing:** Use and File\n\n**SERFF Tracking Number of Last Filing:** FBLB-134101344\n\n### **Company Rate Information**\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nFarm Bureau Property & Casualty Insurance Company\n\n5\\.500% 4.400% $5,258,723 25,392 $119,944,088 245.000% -12.100%\n\nWestern Agricultural Insurance Company\n\n5\\.300% 4.000% $1,073,338 6,085 $27,091,793 164.100% -0.200%\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page10.pdf"]},"response":{"errors":[],"extract_id":"extract_7fca2779e9055e46d0b90ff9851737f8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Rate Information** Rate data applies to filing.\n\n**Filing Method:** Use and File\n\n**Rate Change Type:** Increase\n\n**Overall Percentage of Last Rate Revision:** 8\\.400%\n\n**Effective Date of Last Rate Revision:** 09/30/2024\n\n**Filing Method of Last Filing:** Use and File\n\n**SERFF Tracking Number of Last Filing:** FBLB-134101344\n\n### **Company Rate Information**\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nFarm Bureau Property & Casualty Insurance Company\n\n5\\.500% 4.400% $5,258,723 25,392 $119,944,088 245.000% -12.100%\n\nWestern Agricultural Insurance Company\n\n5\\.300% 4.000% $1,073,338 6,085 $27,091,793 164.100% -0.200%\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_"],"full_content":"### **Rate Information** Rate data applies to filing.\n\n**Filing Method:** Use and File\n\n**Rate Change Type:** Increase\n\n**Overall Percentage of Last Rate Revision:** 8\\.400%\n\n**Effective Date of Last Rate Revision:** 09/30/2024\n\n**Filing Method of Last Filing:** Use and File\n\n**SERFF Tracking Number of Last Filing:** FBLB-134101344\n\n### **Company Rate Information**\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nFarm Bureau Property & Casualty Insurance Company\n\n5\\.500% 4.400% $5,258,723 25,392 $119,944,088 245.000% -12.100%\n\nWestern Agricultural Insurance Company\n\n5\\.300% 4.000% $1,073,338 6,085 $27,091,793 164.100% -0.200%\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","publish_date":null,"title":"Rate Information","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page10.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page10.pdf"},"request":{"example_id":"table/FBLB-134215544_page10","product_type":"parse","source_file_path":"FBLB-134215544_page10.pdf"},"started_at":"2026-11-04T19:47:27.567975"} +{"completed_at":"2026-11-04T19:47:30.714355","latency_in_ms":2425,"output":{"example_id":"table/FBLB-134215544_page106","grounded_pages":[],"layout_pages":[],"markdown":"Name of Company: Western Agricultural Insurance Company Premiums and Losses Reported Are:\n\nLine of Business: Homeowners Experience Current As Of 20 23 Basic Limits: Total Limits: X\n\nYear: 2019 Year: 2020 Year: 2021 Year: 2022 Year: 2023\n\nUTAH Amount % Amount % Amount % Amount % Amount % Amount %\n\n1\\. Direct Premiums Earned 3,544,873 100 3,820,470 100 4,064,437 100 4,636,245 100 5,452,743 100 21,518,768 100\n\n2\\. Direct Losses Incurred 4,679,285 132 5,181,870 136 3,501,155 86 2,328,208 50 3,445,662 63 19,136,180 89\n\n3\\. Loss Adjustment Expense Incurred 275,406 8 245,540 6 180,949 4 282,465 6 293,485 5 1,277,845 6\n\n4\\. Loss & Loss Adjustment Expenses Incurred (2+3) 4,954,691 140 5,427,410 142 3,682,104 91 2,610,673 56 3,739,147 69 20,414,025 95\n\n5\\. Direct Premiums Written 3,649,317 100 3,945,502 100 4,249,205 100 5,019,695 100 5,979,384 100 22,843,103 100\n\n6\\. Commission and Brokerage Paid 496,541 14 522,070 13 582,456 14 682,221 14 896,242 15 3,179,530 14\n\n7\\. Other Acquisition, Field Supervision & Collection Expenses Pd. 319,998 9 318,433 8 326,968 8 372,481 7 434,343 7 1,772,223 8\n\n8\\. General Expenses Paid 137,222 4 143,374 4 156,527 4 178,281 4 193,208 3 808,612 4\n\n9\\. Taxes, Licenses & Fees Paid 87,819 2 91,656 2 97,425 2 110,334 2 132,951 2 520,185 2\n\n10\\. Total Expenses Paid (6+7+8+9) 1,041,580 29 1,075,533 27 1,163,376 27 1,343,317 27 1,656,744 28 6,280,550 27\n\nYear: 2019 Year: 2020 Year: 2021 Year: 2022 Year: 2023\n\nCOUNTRYWIDE Amount % Amount % Amount % Amount % Amount % Amount %\n\n1\\. Direct Premiums Earned 37,788,000 100 40,965,000 100 44,073,000 100 50,088,000 100 59,721,000 100 232,635,000 100\n\n2\\. Direct Losses Incurred 36,018,000 95 36,884,000 90 27,577,000 63 46,340,000 93 47,649,000 80 194,468,000 84\n\n3\\. Loss Adjustment Expense Incurred 2,305,000 6 2,458,000 6 1,798,000 4 2,861,000 6 2,831,000 5 12,253,000 5\n\n4\\. Loss & Loss Adjustment Expenses Incurred (2+3) 38,323,000 101 39,342,000 96 29,375,000 67 49,201,000 98 50,480,000 85 206,721,000 89\n\n5\\. Direct Premiums Written 39,333,000 100 42,214,000 100 46,421,000 100 53,919,000 100 67,745,000 100 249,632,000 100\n\n6\\. Commission and Brokerage Paid 5,103,000 13 5,420,000 13 6,193,000 13 7,492,000 14 10,250,000 15 34,458,000 14\n\n7\\. Other Acquisition, Field Supervision & Collection Expenses Pd. 3,449,000 9 3,407,000 8 3,572,000 8 4,001,000 7 4,921,000 7 19,350,000 8\n\n8\\. General Expenses Paid 1,479,000 4 1,534,000 4 1,710,000 4 1,915,000 4 2,189,000 3 8,827,000 4\n\n9\\. Taxes, Licenses & Fees Paid 714,000 2 792,000 2 957,000 2 1,049,000 2 1,274,000 2 4,786,000 2\n\n10\\. Total Expenses Paid (6+7+8+9) 10,745,000 27 11,153,000 26 12,432,000 27 14,457,000 27 18,634,000 28 67,421,000 27\n\nNotes: \\*% of Line 1 (Same for each year and total) Statistical Agent for this Line of Business:\n\n\\*\\*% of Line 5 (Same for each year and total) Rating Bureau Affiliation for this Line of Business:\n\nCompany Notes: - Used Annual Statement Statutory Page 14 for Utah data and Part III of the IEE Exhibit for Countrywide data, except as noted below. - Countrywide items 6, 7, 8, and 9, as in the IEE, and are on an incurred basis (not paid). - Calculated Utah items 3 (Adjusting & Other Expenses only), 7, and 8 using Countrywide IEE data by line of business allocated to Utah using premium weights (earned premium for item 3, written premium for items 7 and 8).\n\n### **UTAH PREMIUM AND LOSS EXPERIENCE EXHIBIT**\n\nTOTAL\n\nTOTAL","pages":[{"line_numbers":[],"markdown":"Name of Company: Western Agricultural Insurance Company Premiums and Losses Reported Are:\n\nLine of Business: Homeowners Experience Current As Of 20 23 Basic Limits: Total Limits: X\n\nYear: 2019 Year: 2020 Year: 2021 Year: 2022 Year: 2023\n\nUTAH Amount % Amount % Amount % Amount % Amount % Amount %\n\n1\\. Direct Premiums Earned 3,544,873 100 3,820,470 100 4,064,437 100 4,636,245 100 5,452,743 100 21,518,768 100\n\n2\\. Direct Losses Incurred 4,679,285 132 5,181,870 136 3,501,155 86 2,328,208 50 3,445,662 63 19,136,180 89\n\n3\\. Loss Adjustment Expense Incurred 275,406 8 245,540 6 180,949 4 282,465 6 293,485 5 1,277,845 6\n\n4\\. Loss & Loss Adjustment Expenses Incurred (2+3) 4,954,691 140 5,427,410 142 3,682,104 91 2,610,673 56 3,739,147 69 20,414,025 95\n\n5\\. Direct Premiums Written 3,649,317 100 3,945,502 100 4,249,205 100 5,019,695 100 5,979,384 100 22,843,103 100\n\n6\\. Commission and Brokerage Paid 496,541 14 522,070 13 582,456 14 682,221 14 896,242 15 3,179,530 14\n\n7\\. Other Acquisition, Field Supervision & Collection Expenses Pd. 319,998 9 318,433 8 326,968 8 372,481 7 434,343 7 1,772,223 8\n\n8\\. General Expenses Paid 137,222 4 143,374 4 156,527 4 178,281 4 193,208 3 808,612 4\n\n9\\. Taxes, Licenses & Fees Paid 87,819 2 91,656 2 97,425 2 110,334 2 132,951 2 520,185 2\n\n10\\. Total Expenses Paid (6+7+8+9) 1,041,580 29 1,075,533 27 1,163,376 27 1,343,317 27 1,656,744 28 6,280,550 27\n\nYear: 2019 Year: 2020 Year: 2021 Year: 2022 Year: 2023\n\nCOUNTRYWIDE Amount % Amount % Amount % Amount % Amount % Amount %\n\n1\\. Direct Premiums Earned 37,788,000 100 40,965,000 100 44,073,000 100 50,088,000 100 59,721,000 100 232,635,000 100\n\n2\\. Direct Losses Incurred 36,018,000 95 36,884,000 90 27,577,000 63 46,340,000 93 47,649,000 80 194,468,000 84\n\n3\\. Loss Adjustment Expense Incurred 2,305,000 6 2,458,000 6 1,798,000 4 2,861,000 6 2,831,000 5 12,253,000 5\n\n4\\. Loss & Loss Adjustment Expenses Incurred (2+3) 38,323,000 101 39,342,000 96 29,375,000 67 49,201,000 98 50,480,000 85 206,721,000 89\n\n5\\. Direct Premiums Written 39,333,000 100 42,214,000 100 46,421,000 100 53,919,000 100 67,745,000 100 249,632,000 100\n\n6\\. Commission and Brokerage Paid 5,103,000 13 5,420,000 13 6,193,000 13 7,492,000 14 10,250,000 15 34,458,000 14\n\n7\\. Other Acquisition, Field Supervision & Collection Expenses Pd. 3,449,000 9 3,407,000 8 3,572,000 8 4,001,000 7 4,921,000 7 19,350,000 8\n\n8\\. General Expenses Paid 1,479,000 4 1,534,000 4 1,710,000 4 1,915,000 4 2,189,000 3 8,827,000 4\n\n9\\. Taxes, Licenses & Fees Paid 714,000 2 792,000 2 957,000 2 1,049,000 2 1,274,000 2 4,786,000 2\n\n10\\. Total Expenses Paid (6+7+8+9) 10,745,000 27 11,153,000 26 12,432,000 27 14,457,000 27 18,634,000 28 67,421,000 27\n\nNotes: \\*% of Line 1 (Same for each year and total) Statistical Agent for this Line of Business:\n\n\\*\\*% of Line 5 (Same for each year and total) Rating Bureau Affiliation for this Line of Business:\n\nCompany Notes: - Used Annual Statement Statutory Page 14 for Utah data and Part III of the IEE Exhibit for Countrywide data, except as noted below. - Countrywide items 6, 7, 8, and 9, as in the IEE, and are on an incurred basis (not paid). - Calculated Utah items 3 (Adjusting & Other Expenses only), 7, and 8 using Countrywide IEE data by line of business allocated to Utah using premium weights (earned premium for item 3, written premium for items 7 and 8).\n\n### **UTAH PREMIUM AND LOSS EXPERIENCE EXHIBIT**\n\nTOTAL\n\nTOTAL","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Name of Company: Western Agricultural Insurance Company Premiums and Losses Reported Are:\n\nLine of Business: Homeowners Experience Current As Of 20 23 Basic Limits: Total Limits: X\n\nYear: 2019 Year: 2020 Year: 2021 Year: 2022 Year: 2023\n\nUTAH Amount % Amount % Amount % Amount % Amount % Amount %\n\n1\\. Direct Premiums Earned 3,544,873 100 3,820,470 100 4,064,437 100 4,636,245 100 5,452,743 100 21,518,768 100\n\n2\\. Direct Losses Incurred 4,679,285 132 5,181,870 136 3,501,155 86 2,328,208 50 3,445,662 63 19,136,180 89\n\n3\\. Loss Adjustment Expense Incurred 275,406 8 245,540 6 180,949 4 282,465 6 293,485 5 1,277,845 6\n\n4\\. Loss & Loss Adjustment Expenses Incurred (2+3) 4,954,691 140 5,427,410 142 3,682,104 91 2,610,673 56 3,739,147 69 20,414,025 95\n\n5\\. Direct Premiums Written 3,649,317 100 3,945,502 100 4,249,205 100 5,019,695 100 5,979,384 100 22,843,103 100\n\n6\\. Commission and Brokerage Paid 496,541 14 522,070 13 582,456 14 682,221 14 896,242 15 3,179,530 14\n\n7\\. Other Acquisition, Field Supervision & Collection Expenses Pd. 319,998 9 318,433 8 326,968 8 372,481 7 434,343 7 1,772,223 8\n\n8\\. General Expenses Paid 137,222 4 143,374 4 156,527 4 178,281 4 193,208 3 808,612 4\n\n9\\. Taxes, Licenses & Fees Paid 87,819 2 91,656 2 97,425 2 110,334 2 132,951 2 520,185 2\n\n10\\. Total Expenses Paid (6+7+8+9) 1,041,580 29 1,075,533 27 1,163,376 27 1,343,317 27 1,656,744 28 6,280,550 27\n\nYear: 2019 Year: 2020 Year: 2021 Year: 2022 Year: 2023\n\nCOUNTRYWIDE Amount % Amount % Amount % Amount % Amount % Amount %\n\n1\\. Direct Premiums Earned 37,788,000 100 40,965,000 100 44,073,000 100 50,088,000 100 59,721,000 100 232,635,000 100\n\n2\\. Direct Losses Incurred 36,018,000 95 36,884,000 90 27,577,000 63 46,340,000 93 47,649,000 80 194,468,000 84\n\n3\\. Loss Adjustment Expense Incurred 2,305,000 6 2,458,000 6 1,798,000 4 2,861,000 6 2,831,000 5 12,253,000 5\n\n4\\. Loss & Loss Adjustment Expenses Incurred (2+3) 38,323,000 101 39,342,000 96 29,375,000 67 49,201,000 98 50,480,000 85 206,721,000 89\n\n5\\. Direct Premiums Written 39,333,000 100 42,214,000 100 46,421,000 100 53,919,000 100 67,745,000 100 249,632,000 100\n\n6\\. Commission and Brokerage Paid 5,103,000 13 5,420,000 13 6,193,000 13 7,492,000 14 10,250,000 15 34,458,000 14\n\n7\\. Other Acquisition, Field Supervision & Collection Expenses Pd. 3,449,000 9 3,407,000 8 3,572,000 8 4,001,000 7 4,921,000 7 19,350,000 8\n\n8\\. General Expenses Paid 1,479,000 4 1,534,000 4 1,710,000 4 1,915,000 4 2,189,000 3 8,827,000 4\n\n9\\. Taxes, Licenses & Fees Paid 714,000 2 792,000 2 957,000 2 1,049,000 2 1,274,000 2 4,786,000 2\n\n10\\. Total Expenses Paid (6+7+8+9) 10,745,000 27 11,153,000 26 12,432,000 27 14,457,000 27 18,634,000 28 67,421,000 27\n\nNotes: \\*% of Line 1 (Same for each year and total) Statistical Agent for this Line of Business:\n\n\\*\\*% of Line 5 (Same for each year and total) Rating Bureau Affiliation for this Line of Business:\n\nCompany Notes: - Used Annual Statement Statutory Page 14 for Utah data and Part III of the IEE Exhibit for Countrywide data, except as noted below. - Countrywide items 6, 7, 8, and 9, as in the IEE, and are on an incurred basis (not paid). - Calculated Utah items 3 (Adjusting & Other Expenses only), 7, and 8 using Countrywide IEE data by line of business allocated to Utah using premium weights (earned premium for item 3, written premium for items 7 and 8).\n\n### **UTAH PREMIUM AND LOSS EXPERIENCE EXHIBIT**\n\nTOTAL\n\nTOTAL","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page106.pdf"]},"response":{"errors":[],"extract_id":"extract_6789c0be2ccb43303dc34164f17bc03c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Name of Company: Western Agricultural Insurance Company Premiums and Losses Reported Are:\n\nLine of Business: Homeowners Experience Current As Of 20 23 Basic Limits: Total Limits: X\n\nYear: 2019 Year: 2020 Year: 2021 Year: 2022 Year: 2023\n\nUTAH Amount % Amount % Amount % Amount % Amount % Amount %\n\n1\\. Direct Premiums Earned 3,544,873 100 3,820,470 100 4,064,437 100 4,636,245 100 5,452,743 100 21,518,768 100\n\n2\\. Direct Losses Incurred 4,679,285 132 5,181,870 136 3,501,155 86 2,328,208 50 3,445,662 63 19,136,180 89\n\n3\\. Loss Adjustment Expense Incurred 275,406 8 245,540 6 180,949 4 282,465 6 293,485 5 1,277,845 6\n\n4\\. Loss & Loss Adjustment Expenses Incurred (2+3) 4,954,691 140 5,427,410 142 3,682,104 91 2,610,673 56 3,739,147 69 20,414,025 95\n\n5\\. Direct Premiums Written 3,649,317 100 3,945,502 100 4,249,205 100 5,019,695 100 5,979,384 100 22,843,103 100\n\n6\\. Commission and Brokerage Paid 496,541 14 522,070 13 582,456 14 682,221 14 896,242 15 3,179,530 14\n\n7\\. Other Acquisition, Field Supervision & Collection Expenses Pd. 319,998 9 318,433 8 326,968 8 372,481 7 434,343 7 1,772,223 8\n\n8\\. General Expenses Paid 137,222 4 143,374 4 156,527 4 178,281 4 193,208 3 808,612 4\n\n9\\. Taxes, Licenses & Fees Paid 87,819 2 91,656 2 97,425 2 110,334 2 132,951 2 520,185 2\n\n10\\. Total Expenses Paid (6+7+8+9) 1,041,580 29 1,075,533 27 1,163,376 27 1,343,317 27 1,656,744 28 6,280,550 27\n\nYear: 2019 Year: 2020 Year: 2021 Year: 2022 Year: 2023\n\nCOUNTRYWIDE Amount % Amount % Amount % Amount % Amount % Amount %\n\n1\\. Direct Premiums Earned 37,788,000 100 40,965,000 100 44,073,000 100 50,088,000 100 59,721,000 100 232,635,000 100\n\n2\\. Direct Losses Incurred 36,018,000 95 36,884,000 90 27,577,000 63 46,340,000 93 47,649,000 80 194,468,000 84\n\n3\\. Loss Adjustment Expense Incurred 2,305,000 6 2,458,000 6 1,798,000 4 2,861,000 6 2,831,000 5 12,253,000 5\n\n4\\. Loss & Loss Adjustment Expenses Incurred (2+3) 38,323,000 101 39,342,000 96 29,375,000 67 49,201,000 98 50,480,000 85 206,721,000 89\n\n5\\. Direct Premiums Written 39,333,000 100 42,214,000 100 46,421,000 100 53,919,000 100 67,745,000 100 249,632,000 100\n\n6\\. Commission and Brokerage Paid 5,103,000 13 5,420,000 13 6,193,000 13 7,492,000 14 10,250,000 15 34,458,000 14\n\n7\\. Other Acquisition, Field Supervision & Collection Expenses Pd. 3,449,000 9 3,407,000 8 3,572,000 8 4,001,000 7 4,921,000 7 19,350,000 8\n\n8\\. General Expenses Paid 1,479,000 4 1,534,000 4 1,710,000 4 1,915,000 4 2,189,000 3 8,827,000 4\n\n9\\. Taxes, Licenses & Fees Paid 714,000 2 792,000 2 957,000 2 1,049,000 2 1,274,000 2 4,786,000 2\n\n10\\. Total Expenses Paid (6+7+8+9) 10,745,000 27 11,153,000 26 12,432,000 27 14,457,000 27 18,634,000 28 67,421,000 27\n\nNotes: \\*% of Line 1 (Same for each year and total) Statistical Agent for this Line of Business:\n\n\\*\\*% of Line 5 (Same for each year and total) Rating Bureau Affiliation for this Line of Business:\n\nCompany Notes: - Used Annual Statement Statutory Page 14 for Utah data and Part III of the IEE Exhibit for Countrywide data, except as noted below. - Countrywide items 6, 7, 8, and 9, as in the IEE, and are on an incurred basis (not paid). - Calculated Utah items 3 (Adjusting & Other Expenses only), 7, and 8 using Countrywide IEE data by line of business allocated to Utah using premium weights (earned premium for item 3, written premium for items 7 and 8).\n\n### **UTAH PREMIUM AND LOSS EXPERIENCE EXHIBIT**\n\nTOTAL\n\nTOTAL"],"full_content":"Name of Company: Western Agricultural Insurance Company Premiums and Losses Reported Are:\n\nLine of Business: Homeowners Experience Current As Of 20 23 Basic Limits: Total Limits: X\n\nYear: 2019 Year: 2020 Year: 2021 Year: 2022 Year: 2023\n\nUTAH Amount % Amount % Amount % Amount % Amount % Amount %\n\n1\\. Direct Premiums Earned 3,544,873 100 3,820,470 100 4,064,437 100 4,636,245 100 5,452,743 100 21,518,768 100\n\n2\\. Direct Losses Incurred 4,679,285 132 5,181,870 136 3,501,155 86 2,328,208 50 3,445,662 63 19,136,180 89\n\n3\\. Loss Adjustment Expense Incurred 275,406 8 245,540 6 180,949 4 282,465 6 293,485 5 1,277,845 6\n\n4\\. Loss & Loss Adjustment Expenses Incurred (2+3) 4,954,691 140 5,427,410 142 3,682,104 91 2,610,673 56 3,739,147 69 20,414,025 95\n\n5\\. Direct Premiums Written 3,649,317 100 3,945,502 100 4,249,205 100 5,019,695 100 5,979,384 100 22,843,103 100\n\n6\\. Commission and Brokerage Paid 496,541 14 522,070 13 582,456 14 682,221 14 896,242 15 3,179,530 14\n\n7\\. Other Acquisition, Field Supervision & Collection Expenses Pd. 319,998 9 318,433 8 326,968 8 372,481 7 434,343 7 1,772,223 8\n\n8\\. General Expenses Paid 137,222 4 143,374 4 156,527 4 178,281 4 193,208 3 808,612 4\n\n9\\. Taxes, Licenses & Fees Paid 87,819 2 91,656 2 97,425 2 110,334 2 132,951 2 520,185 2\n\n10\\. Total Expenses Paid (6+7+8+9) 1,041,580 29 1,075,533 27 1,163,376 27 1,343,317 27 1,656,744 28 6,280,550 27\n\nYear: 2019 Year: 2020 Year: 2021 Year: 2022 Year: 2023\n\nCOUNTRYWIDE Amount % Amount % Amount % Amount % Amount % Amount %\n\n1\\. Direct Premiums Earned 37,788,000 100 40,965,000 100 44,073,000 100 50,088,000 100 59,721,000 100 232,635,000 100\n\n2\\. Direct Losses Incurred 36,018,000 95 36,884,000 90 27,577,000 63 46,340,000 93 47,649,000 80 194,468,000 84\n\n3\\. Loss Adjustment Expense Incurred 2,305,000 6 2,458,000 6 1,798,000 4 2,861,000 6 2,831,000 5 12,253,000 5\n\n4\\. Loss & Loss Adjustment Expenses Incurred (2+3) 38,323,000 101 39,342,000 96 29,375,000 67 49,201,000 98 50,480,000 85 206,721,000 89\n\n5\\. Direct Premiums Written 39,333,000 100 42,214,000 100 46,421,000 100 53,919,000 100 67,745,000 100 249,632,000 100\n\n6\\. Commission and Brokerage Paid 5,103,000 13 5,420,000 13 6,193,000 13 7,492,000 14 10,250,000 15 34,458,000 14\n\n7\\. Other Acquisition, Field Supervision & Collection Expenses Pd. 3,449,000 9 3,407,000 8 3,572,000 8 4,001,000 7 4,921,000 7 19,350,000 8\n\n8\\. General Expenses Paid 1,479,000 4 1,534,000 4 1,710,000 4 1,915,000 4 2,189,000 3 8,827,000 4\n\n9\\. Taxes, Licenses & Fees Paid 714,000 2 792,000 2 957,000 2 1,049,000 2 1,274,000 2 4,786,000 2\n\n10\\. Total Expenses Paid (6+7+8+9) 10,745,000 27 11,153,000 26 12,432,000 27 14,457,000 27 18,634,000 28 67,421,000 27\n\nNotes: \\*% of Line 1 (Same for each year and total) Statistical Agent for this Line of Business:\n\n\\*\\*% of Line 5 (Same for each year and total) Rating Bureau Affiliation for this Line of Business:\n\nCompany Notes: - Used Annual Statement Statutory Page 14 for Utah data and Part III of the IEE Exhibit for Countrywide data, except as noted below. - Countrywide items 6, 7, 8, and 9, as in the IEE, and are on an incurred basis (not paid). - Calculated Utah items 3 (Adjusting & Other Expenses only), 7, and 8 using Countrywide IEE data by line of business allocated to Utah using premium weights (earned premium for item 3, written premium for items 7 and 8).\n\n### **UTAH PREMIUM AND LOSS EXPERIENCE EXHIBIT**\n\nTOTAL\n\nTOTAL","publish_date":null,"title":"UTAH PREMIUM AND LOSS EXPERIENCE EXHIBIT","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page106.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page106.pdf"},"request":{"example_id":"table/FBLB-134215544_page106","product_type":"parse","source_file_path":"FBLB-134215544_page106.pdf"},"started_at":"2026-11-04T19:47:28.289004"} +{"completed_at":"2026-11-04T19:47:30.785334","latency_in_ms":974,"output":{"example_id":"table/FBLB-134215544_page11","grounded_pages":[],"layout_pages":[],"markdown":"### **Rate/Rule Schedule**\n\n**Item No.**\n\n**Schedule Item Status Exhibit Name Rule # or Page # Rate Action**\n\n**Previous State Filing Number Attachments**\n\n1 UT FBPCIC Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB- 134101344, FBLB- 133683724, FBLB- 133989630\n\nUT FBPCIC Filed Pages 2025-01-23-rev.pdf\n\n2 UT WAIC Express Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB- 134101344, FBLB- 133683724, FBLB- 133989630\n\nUT WAIC Express Filed Pages 2025-01-23-rev.pdf\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","pages":[{"line_numbers":[],"markdown":"### **Rate/Rule Schedule**\n\n**Item No.**\n\n**Schedule Item Status Exhibit Name Rule # or Page # Rate Action**\n\n**Previous State Filing Number Attachments**\n\n1 UT FBPCIC Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB- 134101344, FBLB- 133683724, FBLB- 133989630\n\nUT FBPCIC Filed Pages 2025-01-23-rev.pdf\n\n2 UT WAIC Express Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB- 134101344, FBLB- 133683724, FBLB- 133989630\n\nUT WAIC Express Filed Pages 2025-01-23-rev.pdf\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Rate/Rule Schedule**\n\n**Item No.**\n\n**Schedule Item Status Exhibit Name Rule # or Page # Rate Action**\n\n**Previous State Filing Number Attachments**\n\n1 UT FBPCIC Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB- 134101344, FBLB- 133683724, FBLB- 133989630\n\nUT FBPCIC Filed Pages 2025-01-23-rev.pdf\n\n2 UT WAIC Express Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB- 134101344, FBLB- 133683724, FBLB- 133989630\n\nUT WAIC Express Filed Pages 2025-01-23-rev.pdf\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page11.pdf"]},"response":{"errors":[],"extract_id":"extract_63024a500a9ee982f41cbd82623858f7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Rate/Rule Schedule**\n\n**Item No.**\n\n**Schedule Item Status Exhibit Name Rule # or Page # Rate Action**\n\n**Previous State Filing Number Attachments**\n\n1 UT FBPCIC Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB- 134101344, FBLB- 133683724, FBLB- 133989630\n\nUT FBPCIC Filed Pages 2025-01-23-rev.pdf\n\n2 UT WAIC Express Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB- 134101344, FBLB- 133683724, FBLB- 133989630\n\nUT WAIC Express Filed Pages 2025-01-23-rev.pdf\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_"],"full_content":"### **Rate/Rule Schedule**\n\n**Item No.**\n\n**Schedule Item Status Exhibit Name Rule # or Page # Rate Action**\n\n**Previous State Filing Number Attachments**\n\n1 UT FBPCIC Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB- 134101344, FBLB- 133683724, FBLB- 133989630\n\nUT FBPCIC Filed Pages 2025-01-23-rev.pdf\n\n2 UT WAIC Express Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB- 134101344, FBLB- 133683724, FBLB- 133989630\n\nUT WAIC Express Filed Pages 2025-01-23-rev.pdf\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","publish_date":null,"title":"Rate/Rule Schedule","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page11.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page11.pdf"},"request":{"example_id":"table/FBLB-134215544_page11","product_type":"parse","source_file_path":"FBLB-134215544_page11.pdf"},"started_at":"2026-11-04T19:47:29.810988"} +{"completed_at":"2026-11-04T19:47:32.801090","latency_in_ms":2051,"output":{"example_id":"table/FBLB-134215544_page110","grounded_pages":[],"layout_pages":[],"markdown":"**UTAH – WESTERN AGRICULTURAL INSURANCE COMPANY FARM BUREAU MEMBER’S CHOICE PERSONAL PACKAGE POLICY**\n\n### **AGENTS MANUAL PAGE CHANGES EFFECTIVE 01/23/2025 Exhibit A**\n\nPage **1** of **2**\n\n**SECTION/PART PAGE(S)**\n\n**CHANGE** **_Instructions and information are italicized. Only the actual agent’s manual wording is non-italics. New wording is underlined. Deleted wording is crossed out. The pages are highlighted on the manual pages._**\n\n**LIABILITY SECTION** 529W-550W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Liability Base Rates Updated Medical Base Rates_\n\n586W-600W 01/23/2025 Prior Edition 01/23/2024\n\n_Updated Rate Capping Factors_\n\n**PROPERTY SECTION** 603W 01/23/2025 Prior Edition 09/30/2023\n\n_Adjusted layers for Property Loss Assessment_\n\n651W thru 656W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n658W thru 663W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n665W thru 670W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n726W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Property Loss Assessment Coverage Base Rates_\n\n753W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Base Rates Updated Amount of Insurance Factors_\n\n766W 01/23/2025 Prior Edition 09/30/2022\n\n_Updated Account Discount Factors_\n\n779W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Base Rates Updated Roofing Limitation Factors_\n\n780W thru 786W 01/23/2025 Prior Edition 06/23/2015\n\n_Added Roofing Limitation Factor Tables_","pages":[{"line_numbers":[],"markdown":"**UTAH – WESTERN AGRICULTURAL INSURANCE COMPANY FARM BUREAU MEMBER’S CHOICE PERSONAL PACKAGE POLICY**\n\n### **AGENTS MANUAL PAGE CHANGES EFFECTIVE 01/23/2025 Exhibit A**\n\nPage **1** of **2**\n\n**SECTION/PART PAGE(S)**\n\n**CHANGE** **_Instructions and information are italicized. Only the actual agent’s manual wording is non-italics. New wording is underlined. Deleted wording is crossed out. The pages are highlighted on the manual pages._**\n\n**LIABILITY SECTION** 529W-550W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Liability Base Rates Updated Medical Base Rates_\n\n586W-600W 01/23/2025 Prior Edition 01/23/2024\n\n_Updated Rate Capping Factors_\n\n**PROPERTY SECTION** 603W 01/23/2025 Prior Edition 09/30/2023\n\n_Adjusted layers for Property Loss Assessment_\n\n651W thru 656W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n658W thru 663W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n665W thru 670W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n726W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Property Loss Assessment Coverage Base Rates_\n\n753W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Base Rates Updated Amount of Insurance Factors_\n\n766W 01/23/2025 Prior Edition 09/30/2022\n\n_Updated Account Discount Factors_\n\n779W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Base Rates Updated Roofing Limitation Factors_\n\n780W thru 786W 01/23/2025 Prior Edition 06/23/2015\n\n_Added Roofing Limitation Factor Tables_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**UTAH – WESTERN AGRICULTURAL INSURANCE COMPANY FARM BUREAU MEMBER’S CHOICE PERSONAL PACKAGE POLICY**\n\n### **AGENTS MANUAL PAGE CHANGES EFFECTIVE 01/23/2025 Exhibit A**\n\nPage **1** of **2**\n\n**SECTION/PART PAGE(S)**\n\n**CHANGE** **_Instructions and information are italicized. Only the actual agent’s manual wording is non-italics. New wording is underlined. Deleted wording is crossed out. The pages are highlighted on the manual pages._**\n\n**LIABILITY SECTION** 529W-550W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Liability Base Rates Updated Medical Base Rates_\n\n586W-600W 01/23/2025 Prior Edition 01/23/2024\n\n_Updated Rate Capping Factors_\n\n**PROPERTY SECTION** 603W 01/23/2025 Prior Edition 09/30/2023\n\n_Adjusted layers for Property Loss Assessment_\n\n651W thru 656W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n658W thru 663W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n665W thru 670W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n726W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Property Loss Assessment Coverage Base Rates_\n\n753W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Base Rates Updated Amount of Insurance Factors_\n\n766W 01/23/2025 Prior Edition 09/30/2022\n\n_Updated Account Discount Factors_\n\n779W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Base Rates Updated Roofing Limitation Factors_\n\n780W thru 786W 01/23/2025 Prior Edition 06/23/2015\n\n_Added Roofing Limitation Factor Tables_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page110.pdf"]},"response":{"errors":[],"extract_id":"extract_df6e8c7ba4414be0757c0c1e0eb66276","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**UTAH – WESTERN AGRICULTURAL INSURANCE COMPANY FARM BUREAU MEMBER’S CHOICE PERSONAL PACKAGE POLICY**\n\n### **AGENTS MANUAL PAGE CHANGES EFFECTIVE 01/23/2025 Exhibit A**\n\nPage **1** of **2**\n\n**SECTION/PART PAGE(S)**\n\n**CHANGE** **_Instructions and information are italicized. Only the actual agent’s manual wording is non-italics. New wording is underlined. Deleted wording is crossed out. The pages are highlighted on the manual pages._**\n\n**LIABILITY SECTION** 529W-550W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Liability Base Rates Updated Medical Base Rates_\n\n586W-600W 01/23/2025 Prior Edition 01/23/2024\n\n_Updated Rate Capping Factors_\n\n**PROPERTY SECTION** 603W 01/23/2025 Prior Edition 09/30/2023\n\n_Adjusted layers for Property Loss Assessment_\n\n651W thru 656W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n658W thru 663W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n665W thru 670W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n726W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Property Loss Assessment Coverage Base Rates_\n\n753W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Base Rates Updated Amount of Insurance Factors_\n\n766W 01/23/2025 Prior Edition 09/30/2022\n\n_Updated Account Discount Factors_\n\n779W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Base Rates Updated Roofing Limitation Factors_\n\n780W thru 786W 01/23/2025 Prior Edition 06/23/2015\n\n_Added Roofing Limitation Factor Tables_"],"full_content":"**UTAH – WESTERN AGRICULTURAL INSURANCE COMPANY FARM BUREAU MEMBER’S CHOICE PERSONAL PACKAGE POLICY**\n\n### **AGENTS MANUAL PAGE CHANGES EFFECTIVE 01/23/2025 Exhibit A**\n\nPage **1** of **2**\n\n**SECTION/PART PAGE(S)**\n\n**CHANGE** **_Instructions and information are italicized. Only the actual agent’s manual wording is non-italics. New wording is underlined. Deleted wording is crossed out. The pages are highlighted on the manual pages._**\n\n**LIABILITY SECTION** 529W-550W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Liability Base Rates Updated Medical Base Rates_\n\n586W-600W 01/23/2025 Prior Edition 01/23/2024\n\n_Updated Rate Capping Factors_\n\n**PROPERTY SECTION** 603W 01/23/2025 Prior Edition 09/30/2023\n\n_Adjusted layers for Property Loss Assessment_\n\n651W thru 656W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n658W thru 663W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n665W thru 670W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Zip Code Factors_\n\n726W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Property Loss Assessment Coverage Base Rates_\n\n753W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Base Rates Updated Amount of Insurance Factors_\n\n766W 01/23/2025 Prior Edition 09/30/2022\n\n_Updated Account Discount Factors_\n\n779W 01/23/2025 Prior Edition 09/30/2024\n\n_Updated Base Rates Updated Roofing Limitation Factors_\n\n780W thru 786W 01/23/2025 Prior Edition 06/23/2015\n\n_Added Roofing Limitation Factor Tables_","publish_date":null,"title":"AGENTS MANUAL PAGE CHANGES EFFECTIVE 01/23/2025 Exhibit A","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page110.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page110.pdf"},"request":{"example_id":"table/FBLB-134215544_page110","product_type":"parse","source_file_path":"FBLB-134215544_page110.pdf"},"started_at":"2026-11-04T19:47:30.749525"} +{"completed_at":"2026-11-04T19:47:32.881571","latency_in_ms":992,"output":{"example_id":"table/FBLB-134215544_page112","grounded_pages":[],"layout_pages":[],"markdown":"**Liability Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Primary Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 Years Y N Y N 1 Year Non-Farm 1.000 1.000 0 Years 2 Years Non-Farm 0.980 0.980 1 Year 3 Years Non-Farm 0.980 0.980 2 Years 4 Years Non-Farm 0.970 0.970 3 Years 5 Years Non-Farm 0.970 0.970 4 Years 6 Years Non-Farm 0.960 0.960 5 Years 7 Years Non-Farm 0.960 0.960 6 Years 8 Years Non-Farm 0.950 0.950 7 Years 9 Years Non-Farm 0.950 0.950 8 Years 10 Years Non-Farm 0.940 0.940 9 Years 11 Years Non-Farm 0.940 0.940 10+ Years 12 Years Non-Farm 0.940 0.940 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\n**Factors Used in Determining the Liability/Medical Multiplier - Continued**\n\n88 1.550 38 0.970\n\n**Ag Advantage Factors**\n\n98 1.660 99\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n19 0.950 0.950\n\n0\\.950 12\n\n14\n\n17 0.950 18\n\n43 1.000\n\n36\n\n50\n\nLevel Factors **Underwriting Level Factors Underwriting Level Factors** Level Factors\n\n0\\.960 33\n\n29 0.950 30 31 32 0.950 0.950\n\n26\n\n21\n\n23\n\n0\\.950\n\n24\n\n22\n\n20\n\n0\\.950\n\n70 1.160 71 1.200 72\n\n52 1.000\n\n1\\.000\n\n37\n\n9\n\n0\\.910 5 0.900\n\n1 0.860\n\n3\n\n28\n\n0\\.960 35\n\n0\\.950\n\n27 0.950 0.950\n\n74 1.270 75 1.290\n\n89 1.560 0.970\n\n0\\.980\n\n34 0.960\n\n45 1.000\n\n94 1.600 95 1.610\n\n41\n\n82 1.450\n\n86\n\n90 1.560 40 0.980 91 1.560 39 0.970\n\n0\\.920 8 0.930\n\n0\\.950\n\n10\n\n0\\.950\n\n0\\.940\n\n6\n\n83 1.500 84 1.510\n\n25 0.950\n\n1\\.210\n\n68\n\n80 1.430 81 1.440\n\n0\\.950 11\n\n13 0.950\n\n15 0.950 0.950\n\n0\\.950\n\n2\n\n4 0.880 0.870\n\n0\\.890\n\n60\n\n76 1.340 77 1.360 78 1.400\n\n1\\.000 54 1.000 53\n\n1\\.040 64 1.000\n\n55 1.000 56 1.000\n\n1\\.000\n\n61 1.000 62 1.000\n\n59 1.000\n\n66 1.060 67 1.090\n\n79 1.420\n\n65\n\n51 1.000\n\n1\\.000 48 1.000 47\n\n96 1.620 46 1.000 97 1.640\n\n85 1.520\n\n63\n\n100 1.700 998 1.000\n\n87 1.540\n\n1\\.110 69 1.140\n\n1\\.000 Factor Date Prior to 06/23/15\n\n**Policy Inception Date Factor**\n\n06/23/15 or Later 1.000\n\n999 1.000\n\n49 1.000\n\n92 1.570 42 0.990 93 1.580\n\n44 1.000\n\n1\\.530\n\n1\\.680\n\n16\n\n0\\.950\n\n1\\.000\n\n57 1.000 58 1.000\n\n73 1.220\n\n7\n\nSmall Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000 0.990 0.990 1.000 1.000 0.980 0.980\n\n1\\.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\n1\\.000 1.000 0.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2302 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Liability Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Primary Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 Years Y N Y N 1 Year Non-Farm 1.000 1.000 0 Years 2 Years Non-Farm 0.980 0.980 1 Year 3 Years Non-Farm 0.980 0.980 2 Years 4 Years Non-Farm 0.970 0.970 3 Years 5 Years Non-Farm 0.970 0.970 4 Years 6 Years Non-Farm 0.960 0.960 5 Years 7 Years Non-Farm 0.960 0.960 6 Years 8 Years Non-Farm 0.950 0.950 7 Years 9 Years Non-Farm 0.950 0.950 8 Years 10 Years Non-Farm 0.940 0.940 9 Years 11 Years Non-Farm 0.940 0.940 10+ Years 12 Years Non-Farm 0.940 0.940 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\n**Factors Used in Determining the Liability/Medical Multiplier - Continued**\n\n88 1.550 38 0.970\n\n**Ag Advantage Factors**\n\n98 1.660 99\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n19 0.950 0.950\n\n0\\.950 12\n\n14\n\n17 0.950 18\n\n43 1.000\n\n36\n\n50\n\nLevel Factors **Underwriting Level Factors Underwriting Level Factors** Level Factors\n\n0\\.960 33\n\n29 0.950 30 31 32 0.950 0.950\n\n26\n\n21\n\n23\n\n0\\.950\n\n24\n\n22\n\n20\n\n0\\.950\n\n70 1.160 71 1.200 72\n\n52 1.000\n\n1\\.000\n\n37\n\n9\n\n0\\.910 5 0.900\n\n1 0.860\n\n3\n\n28\n\n0\\.960 35\n\n0\\.950\n\n27 0.950 0.950\n\n74 1.270 75 1.290\n\n89 1.560 0.970\n\n0\\.980\n\n34 0.960\n\n45 1.000\n\n94 1.600 95 1.610\n\n41\n\n82 1.450\n\n86\n\n90 1.560 40 0.980 91 1.560 39 0.970\n\n0\\.920 8 0.930\n\n0\\.950\n\n10\n\n0\\.950\n\n0\\.940\n\n6\n\n83 1.500 84 1.510\n\n25 0.950\n\n1\\.210\n\n68\n\n80 1.430 81 1.440\n\n0\\.950 11\n\n13 0.950\n\n15 0.950 0.950\n\n0\\.950\n\n2\n\n4 0.880 0.870\n\n0\\.890\n\n60\n\n76 1.340 77 1.360 78 1.400\n\n1\\.000 54 1.000 53\n\n1\\.040 64 1.000\n\n55 1.000 56 1.000\n\n1\\.000\n\n61 1.000 62 1.000\n\n59 1.000\n\n66 1.060 67 1.090\n\n79 1.420\n\n65\n\n51 1.000\n\n1\\.000 48 1.000 47\n\n96 1.620 46 1.000 97 1.640\n\n85 1.520\n\n63\n\n100 1.700 998 1.000\n\n87 1.540\n\n1\\.110 69 1.140\n\n1\\.000 Factor Date Prior to 06/23/15\n\n**Policy Inception Date Factor**\n\n06/23/15 or Later 1.000\n\n999 1.000\n\n49 1.000\n\n92 1.570 42 0.990 93 1.580\n\n44 1.000\n\n1\\.530\n\n1\\.680\n\n16\n\n0\\.950\n\n1\\.000\n\n57 1.000 58 1.000\n\n73 1.220\n\n7\n\nSmall Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000 0.990 0.990 1.000 1.000 0.980 0.980\n\n1\\.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\n1\\.000 1.000 0.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2302 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Liability Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Primary Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 Years Y N Y N 1 Year Non-Farm 1.000 1.000 0 Years 2 Years Non-Farm 0.980 0.980 1 Year 3 Years Non-Farm 0.980 0.980 2 Years 4 Years Non-Farm 0.970 0.970 3 Years 5 Years Non-Farm 0.970 0.970 4 Years 6 Years Non-Farm 0.960 0.960 5 Years 7 Years Non-Farm 0.960 0.960 6 Years 8 Years Non-Farm 0.950 0.950 7 Years 9 Years Non-Farm 0.950 0.950 8 Years 10 Years Non-Farm 0.940 0.940 9 Years 11 Years Non-Farm 0.940 0.940 10+ Years 12 Years Non-Farm 0.940 0.940 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\n**Factors Used in Determining the Liability/Medical Multiplier - Continued**\n\n88 1.550 38 0.970\n\n**Ag Advantage Factors**\n\n98 1.660 99\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n19 0.950 0.950\n\n0\\.950 12\n\n14\n\n17 0.950 18\n\n43 1.000\n\n36\n\n50\n\nLevel Factors **Underwriting Level Factors Underwriting Level Factors** Level Factors\n\n0\\.960 33\n\n29 0.950 30 31 32 0.950 0.950\n\n26\n\n21\n\n23\n\n0\\.950\n\n24\n\n22\n\n20\n\n0\\.950\n\n70 1.160 71 1.200 72\n\n52 1.000\n\n1\\.000\n\n37\n\n9\n\n0\\.910 5 0.900\n\n1 0.860\n\n3\n\n28\n\n0\\.960 35\n\n0\\.950\n\n27 0.950 0.950\n\n74 1.270 75 1.290\n\n89 1.560 0.970\n\n0\\.980\n\n34 0.960\n\n45 1.000\n\n94 1.600 95 1.610\n\n41\n\n82 1.450\n\n86\n\n90 1.560 40 0.980 91 1.560 39 0.970\n\n0\\.920 8 0.930\n\n0\\.950\n\n10\n\n0\\.950\n\n0\\.940\n\n6\n\n83 1.500 84 1.510\n\n25 0.950\n\n1\\.210\n\n68\n\n80 1.430 81 1.440\n\n0\\.950 11\n\n13 0.950\n\n15 0.950 0.950\n\n0\\.950\n\n2\n\n4 0.880 0.870\n\n0\\.890\n\n60\n\n76 1.340 77 1.360 78 1.400\n\n1\\.000 54 1.000 53\n\n1\\.040 64 1.000\n\n55 1.000 56 1.000\n\n1\\.000\n\n61 1.000 62 1.000\n\n59 1.000\n\n66 1.060 67 1.090\n\n79 1.420\n\n65\n\n51 1.000\n\n1\\.000 48 1.000 47\n\n96 1.620 46 1.000 97 1.640\n\n85 1.520\n\n63\n\n100 1.700 998 1.000\n\n87 1.540\n\n1\\.110 69 1.140\n\n1\\.000 Factor Date Prior to 06/23/15\n\n**Policy Inception Date Factor**\n\n06/23/15 or Later 1.000\n\n999 1.000\n\n49 1.000\n\n92 1.570 42 0.990 93 1.580\n\n44 1.000\n\n1\\.530\n\n1\\.680\n\n16\n\n0\\.950\n\n1\\.000\n\n57 1.000 58 1.000\n\n73 1.220\n\n7\n\nSmall Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000 0.990 0.990 1.000 1.000 0.980 0.980\n\n1\\.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\n1\\.000 1.000 0.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2302 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page112.pdf"]},"response":{"errors":[],"extract_id":"extract_89799bdaf66a6c3fd631055a066c91f1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Liability Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Primary Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 Years Y N Y N 1 Year Non-Farm 1.000 1.000 0 Years 2 Years Non-Farm 0.980 0.980 1 Year 3 Years Non-Farm 0.980 0.980 2 Years 4 Years Non-Farm 0.970 0.970 3 Years 5 Years Non-Farm 0.970 0.970 4 Years 6 Years Non-Farm 0.960 0.960 5 Years 7 Years Non-Farm 0.960 0.960 6 Years 8 Years Non-Farm 0.950 0.950 7 Years 9 Years Non-Farm 0.950 0.950 8 Years 10 Years Non-Farm 0.940 0.940 9 Years 11 Years Non-Farm 0.940 0.940 10+ Years 12 Years Non-Farm 0.940 0.940 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\n**Factors Used in Determining the Liability/Medical Multiplier - Continued**\n\n88 1.550 38 0.970\n\n**Ag Advantage Factors**\n\n98 1.660 99\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n19 0.950 0.950\n\n0\\.950 12\n\n14\n\n17 0.950 18\n\n43 1.000\n\n36\n\n50\n\nLevel Factors **Underwriting Level Factors Underwriting Level Factors** Level Factors\n\n0\\.960 33\n\n29 0.950 30 31 32 0.950 0.950\n\n26\n\n21\n\n23\n\n0\\.950\n\n24\n\n22\n\n20\n\n0\\.950\n\n70 1.160 71 1.200 72\n\n52 1.000\n\n1\\.000\n\n37\n\n9\n\n0\\.910 5 0.900\n\n1 0.860\n\n3\n\n28\n\n0\\.960 35\n\n0\\.950\n\n27 0.950 0.950\n\n74 1.270 75 1.290\n\n89 1.560 0.970\n\n0\\.980\n\n34 0.960\n\n45 1.000\n\n94 1.600 95 1.610\n\n41\n\n82 1.450\n\n86\n\n90 1.560 40 0.980 91 1.560 39 0.970\n\n0\\.920 8 0.930\n\n0\\.950\n\n10\n\n0\\.950\n\n0\\.940\n\n6\n\n83 1.500 84 1.510\n\n25 0.950\n\n1\\.210\n\n68\n\n80 1.430 81 1.440\n\n0\\.950 11\n\n13 0.950\n\n15 0.950 0.950\n\n0\\.950\n\n2\n\n4 0.880 0.870\n\n0\\.890\n\n60\n\n76 1.340 77 1.360 78 1.400\n\n1\\.000 54 1.000 53\n\n1\\.040 64 1.000\n\n55 1.000 56 1.000\n\n1\\.000\n\n61 1.000 62 1.000\n\n59 1.000\n\n66 1.060 67 1.090\n\n79 1.420\n\n65\n\n51 1.000\n\n1\\.000 48 1.000 47\n\n96 1.620 46 1.000 97 1.640\n\n85 1.520\n\n63\n\n100 1.700 998 1.000\n\n87 1.540\n\n1\\.110 69 1.140\n\n1\\.000 Factor Date Prior to 06/23/15\n\n**Policy Inception Date Factor**\n\n06/23/15 or Later 1.000\n\n999 1.000\n\n49 1.000\n\n92 1.570 42 0.990 93 1.580\n\n44 1.000\n\n1\\.530\n\n1\\.680\n\n16\n\n0\\.950\n\n1\\.000\n\n57 1.000 58 1.000\n\n73 1.220\n\n7\n\nSmall Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000 0.990 0.990 1.000 1.000 0.980 0.980\n\n1\\.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\n1\\.000 1.000 0.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2302 Rates and Factors"],"full_content":"**Liability Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Primary Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 Years Y N Y N 1 Year Non-Farm 1.000 1.000 0 Years 2 Years Non-Farm 0.980 0.980 1 Year 3 Years Non-Farm 0.980 0.980 2 Years 4 Years Non-Farm 0.970 0.970 3 Years 5 Years Non-Farm 0.970 0.970 4 Years 6 Years Non-Farm 0.960 0.960 5 Years 7 Years Non-Farm 0.960 0.960 6 Years 8 Years Non-Farm 0.950 0.950 7 Years 9 Years Non-Farm 0.950 0.950 8 Years 10 Years Non-Farm 0.940 0.940 9 Years 11 Years Non-Farm 0.940 0.940 10+ Years 12 Years Non-Farm 0.940 0.940 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\n**Factors Used in Determining the Liability/Medical Multiplier - Continued**\n\n88 1.550 38 0.970\n\n**Ag Advantage Factors**\n\n98 1.660 99\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n19 0.950 0.950\n\n0\\.950 12\n\n14\n\n17 0.950 18\n\n43 1.000\n\n36\n\n50\n\nLevel Factors **Underwriting Level Factors Underwriting Level Factors** Level Factors\n\n0\\.960 33\n\n29 0.950 30 31 32 0.950 0.950\n\n26\n\n21\n\n23\n\n0\\.950\n\n24\n\n22\n\n20\n\n0\\.950\n\n70 1.160 71 1.200 72\n\n52 1.000\n\n1\\.000\n\n37\n\n9\n\n0\\.910 5 0.900\n\n1 0.860\n\n3\n\n28\n\n0\\.960 35\n\n0\\.950\n\n27 0.950 0.950\n\n74 1.270 75 1.290\n\n89 1.560 0.970\n\n0\\.980\n\n34 0.960\n\n45 1.000\n\n94 1.600 95 1.610\n\n41\n\n82 1.450\n\n86\n\n90 1.560 40 0.980 91 1.560 39 0.970\n\n0\\.920 8 0.930\n\n0\\.950\n\n10\n\n0\\.950\n\n0\\.940\n\n6\n\n83 1.500 84 1.510\n\n25 0.950\n\n1\\.210\n\n68\n\n80 1.430 81 1.440\n\n0\\.950 11\n\n13 0.950\n\n15 0.950 0.950\n\n0\\.950\n\n2\n\n4 0.880 0.870\n\n0\\.890\n\n60\n\n76 1.340 77 1.360 78 1.400\n\n1\\.000 54 1.000 53\n\n1\\.040 64 1.000\n\n55 1.000 56 1.000\n\n1\\.000\n\n61 1.000 62 1.000\n\n59 1.000\n\n66 1.060 67 1.090\n\n79 1.420\n\n65\n\n51 1.000\n\n1\\.000 48 1.000 47\n\n96 1.620 46 1.000 97 1.640\n\n85 1.520\n\n63\n\n100 1.700 998 1.000\n\n87 1.540\n\n1\\.110 69 1.140\n\n1\\.000 Factor Date Prior to 06/23/15\n\n**Policy Inception Date Factor**\n\n06/23/15 or Later 1.000\n\n999 1.000\n\n49 1.000\n\n92 1.570 42 0.990 93 1.580\n\n44 1.000\n\n1\\.530\n\n1\\.680\n\n16\n\n0\\.950\n\n1\\.000\n\n57 1.000 58 1.000\n\n73 1.220\n\n7\n\nSmall Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000 0.990 0.990 1.000 1.000 0.980 0.980\n\n1\\.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\n1\\.000 1.000 0.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2302 Rates and Factors","publish_date":null,"title":"Liability Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page112.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page112.pdf"},"request":{"example_id":"table/FBLB-134215544_page112","product_type":"parse","source_file_path":"FBLB-134215544_page112.pdf"},"started_at":"2026-11-04T19:47:31.888623"} +{"completed_at":"2026-11-04T19:47:35.011226","latency_in_ms":2208,"output":{"example_id":"table/FBLB-134215544_page113","grounded_pages":[],"layout_pages":[],"markdown":"**Liability Section Rates and Factors**\n\nFactor\n\n1\\.333 $750\n\nAcres (0 - 160)\n\nInsured is Owner\n\n1\\.00\n\n1\\.29\n\n1\\.35\n\n3\\.50 2.20\n\n**Increased Borrowed F/R PP Limit Factors**\n\n1\\.167\n\n**Increased Employer Medical Limit Factors**\n\n1\\.56\n\n$25,000\n\n1\\.000\n\n$2,000\n\n$21.75\n\nHousehold/Organizational Medical Household/Organizational Liability\n\nInsured is Tenant $32.75\n\n$21.75 Residence Medical\n\n$3.00 $4.69 Per Household/Organization\n\n$2.90 Insured is Tenant\n\nFarm/Ranch Acres Liability\n\n$12.50\n\n$42.00\n\n$5.82\n\n1 - 10 $9.50 Farm/Ranch Livestock Liability\n\n4 - 6\n\n**Liability Base Rates**\n\nInsured is Owner\n\n**Medical Base Rates**\n\nPer F/R Household/Organization $30.50 Per Household/Organization Per F/R Household/Organization\n\n$2.90 Residence Liability\n\n**Personal and Farm/Ranch (F/R) Liability and Medical Base Rate Tables**\n\n$52.00\n\nFarm/Ranch Acres Medical\n\n11 - 100\n\n**Farm/Ranch Employer Base Rates**\n\n$30.00 $64.00\n\n$3.45 Acres (0 - 160)\n\n$3.15\n\n$2.65\n\n100 +\n\nInsured is Tenant\n\n$3.36\n\n$1.05\n\nDairy\n\nExcess of 1, up to 8\n\n$75.00\n\n$27.25\n\n$170.00 Additional Locations 1 - 10 $25.25\n\nDairy\n\n$20.00\n\nF/R Additional Locations Excess of 1, up to 8 $39.75\n\nAnimal Liability\n\n$1.05\n\n100 + 11 - 100\n\nNamed Persons Medical\n\n**Optional Coverages Base Rates**\n\n1 - 3\n\nPersonal Injury Liability\n\nFarm/Ranch Livestock Medical\n\nAnimal Medical\n\nFarm/Ranch Employer Liability\n\n2\\.10\n\n2\\.80\n\n$1,000\n\n5\\.25\n\n1\\.00 1.00 $2,000 $5,000\n\n2\\.30 $1,000,000\n\n0\\.60\n\n3\\.45 $10,000 For Each Additional $1,000 Add\n\n$500\n\nLimit\n\nFarm/Ranch Employer Medical Non-Dairy\n\nNon-Dairy\n\n$65,000 0.94 $65,000\n\n$25,000\n\n0\\.90\n\n**Personal and Farm/Ranch Liability and Medical Increased Limit Factors**\n\n$300,000 1.00 1.00 $300,000 1.40\n\n**Increased Liability Limit Factors Increased Personal Injury Limit Factors**\n\n$100,000 $100,000\n\nFactor Factor Limit\n\n0\\.167\n\nLimit\n\n$10,000\n\n2\\.06\n\n$25,000\n\n$500\n\n$5,000 1.30\n\n$500,000 2.10 1.90\n\n$10,000 $5,000\n\nFactor\n\n6\\.30\n\nLimit\n\n$1,000\n\n$2,000\n\n$0.42\n\n$2.20 4 - 6 1 - 3\n\n$2.20 7 + $2.20\n\n$500,000 $750,000\n\n2\\.50\n\n**Increased Named Persons Medical Limit Factors**\n\n0\\.70 Limit Factor\n\n1\\.58\n\n$300\n\n3\\.70\n\n$750,000\n\n$0.42\n\nBorrowed F/R PP\n\n$1,000\n\nLimit 0.70\n\nInsured is Tenant\n\nLivestock/Animal Collision\n\nF/R Residence Liability Insured is Owner $32.75\n\n**Increased Medical Limit Factors**\n\n2\\.35\n\nWaterbed Liability\n\n$500\n\n$1,000,000\n\n$1,000\n\nFactor\n\nF/R Residence Medical Insured is Owner $3.36\n\n7 + $48.50\n\n$2.70\n\n$37.75\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2406 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Liability Section Rates and Factors**\n\nFactor\n\n1\\.333 $750\n\nAcres (0 - 160)\n\nInsured is Owner\n\n1\\.00\n\n1\\.29\n\n1\\.35\n\n3\\.50 2.20\n\n**Increased Borrowed F/R PP Limit Factors**\n\n1\\.167\n\n**Increased Employer Medical Limit Factors**\n\n1\\.56\n\n$25,000\n\n1\\.000\n\n$2,000\n\n$21.75\n\nHousehold/Organizational Medical Household/Organizational Liability\n\nInsured is Tenant $32.75\n\n$21.75 Residence Medical\n\n$3.00 $4.69 Per Household/Organization\n\n$2.90 Insured is Tenant\n\nFarm/Ranch Acres Liability\n\n$12.50\n\n$42.00\n\n$5.82\n\n1 - 10 $9.50 Farm/Ranch Livestock Liability\n\n4 - 6\n\n**Liability Base Rates**\n\nInsured is Owner\n\n**Medical Base Rates**\n\nPer F/R Household/Organization $30.50 Per Household/Organization Per F/R Household/Organization\n\n$2.90 Residence Liability\n\n**Personal and Farm/Ranch (F/R) Liability and Medical Base Rate Tables**\n\n$52.00\n\nFarm/Ranch Acres Medical\n\n11 - 100\n\n**Farm/Ranch Employer Base Rates**\n\n$30.00 $64.00\n\n$3.45 Acres (0 - 160)\n\n$3.15\n\n$2.65\n\n100 +\n\nInsured is Tenant\n\n$3.36\n\n$1.05\n\nDairy\n\nExcess of 1, up to 8\n\n$75.00\n\n$27.25\n\n$170.00 Additional Locations 1 - 10 $25.25\n\nDairy\n\n$20.00\n\nF/R Additional Locations Excess of 1, up to 8 $39.75\n\nAnimal Liability\n\n$1.05\n\n100 + 11 - 100\n\nNamed Persons Medical\n\n**Optional Coverages Base Rates**\n\n1 - 3\n\nPersonal Injury Liability\n\nFarm/Ranch Livestock Medical\n\nAnimal Medical\n\nFarm/Ranch Employer Liability\n\n2\\.10\n\n2\\.80\n\n$1,000\n\n5\\.25\n\n1\\.00 1.00 $2,000 $5,000\n\n2\\.30 $1,000,000\n\n0\\.60\n\n3\\.45 $10,000 For Each Additional $1,000 Add\n\n$500\n\nLimit\n\nFarm/Ranch Employer Medical Non-Dairy\n\nNon-Dairy\n\n$65,000 0.94 $65,000\n\n$25,000\n\n0\\.90\n\n**Personal and Farm/Ranch Liability and Medical Increased Limit Factors**\n\n$300,000 1.00 1.00 $300,000 1.40\n\n**Increased Liability Limit Factors Increased Personal Injury Limit Factors**\n\n$100,000 $100,000\n\nFactor Factor Limit\n\n0\\.167\n\nLimit\n\n$10,000\n\n2\\.06\n\n$25,000\n\n$500\n\n$5,000 1.30\n\n$500,000 2.10 1.90\n\n$10,000 $5,000\n\nFactor\n\n6\\.30\n\nLimit\n\n$1,000\n\n$2,000\n\n$0.42\n\n$2.20 4 - 6 1 - 3\n\n$2.20 7 + $2.20\n\n$500,000 $750,000\n\n2\\.50\n\n**Increased Named Persons Medical Limit Factors**\n\n0\\.70 Limit Factor\n\n1\\.58\n\n$300\n\n3\\.70\n\n$750,000\n\n$0.42\n\nBorrowed F/R PP\n\n$1,000\n\nLimit 0.70\n\nInsured is Tenant\n\nLivestock/Animal Collision\n\nF/R Residence Liability Insured is Owner $32.75\n\n**Increased Medical Limit Factors**\n\n2\\.35\n\nWaterbed Liability\n\n$500\n\n$1,000,000\n\n$1,000\n\nFactor\n\nF/R Residence Medical Insured is Owner $3.36\n\n7 + $48.50\n\n$2.70\n\n$37.75\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2406 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Liability Section Rates and Factors**\n\nFactor\n\n1\\.333 $750\n\nAcres (0 - 160)\n\nInsured is Owner\n\n1\\.00\n\n1\\.29\n\n1\\.35\n\n3\\.50 2.20\n\n**Increased Borrowed F/R PP Limit Factors**\n\n1\\.167\n\n**Increased Employer Medical Limit Factors**\n\n1\\.56\n\n$25,000\n\n1\\.000\n\n$2,000\n\n$21.75\n\nHousehold/Organizational Medical Household/Organizational Liability\n\nInsured is Tenant $32.75\n\n$21.75 Residence Medical\n\n$3.00 $4.69 Per Household/Organization\n\n$2.90 Insured is Tenant\n\nFarm/Ranch Acres Liability\n\n$12.50\n\n$42.00\n\n$5.82\n\n1 - 10 $9.50 Farm/Ranch Livestock Liability\n\n4 - 6\n\n**Liability Base Rates**\n\nInsured is Owner\n\n**Medical Base Rates**\n\nPer F/R Household/Organization $30.50 Per Household/Organization Per F/R Household/Organization\n\n$2.90 Residence Liability\n\n**Personal and Farm/Ranch (F/R) Liability and Medical Base Rate Tables**\n\n$52.00\n\nFarm/Ranch Acres Medical\n\n11 - 100\n\n**Farm/Ranch Employer Base Rates**\n\n$30.00 $64.00\n\n$3.45 Acres (0 - 160)\n\n$3.15\n\n$2.65\n\n100 +\n\nInsured is Tenant\n\n$3.36\n\n$1.05\n\nDairy\n\nExcess of 1, up to 8\n\n$75.00\n\n$27.25\n\n$170.00 Additional Locations 1 - 10 $25.25\n\nDairy\n\n$20.00\n\nF/R Additional Locations Excess of 1, up to 8 $39.75\n\nAnimal Liability\n\n$1.05\n\n100 + 11 - 100\n\nNamed Persons Medical\n\n**Optional Coverages Base Rates**\n\n1 - 3\n\nPersonal Injury Liability\n\nFarm/Ranch Livestock Medical\n\nAnimal Medical\n\nFarm/Ranch Employer Liability\n\n2\\.10\n\n2\\.80\n\n$1,000\n\n5\\.25\n\n1\\.00 1.00 $2,000 $5,000\n\n2\\.30 $1,000,000\n\n0\\.60\n\n3\\.45 $10,000 For Each Additional $1,000 Add\n\n$500\n\nLimit\n\nFarm/Ranch Employer Medical Non-Dairy\n\nNon-Dairy\n\n$65,000 0.94 $65,000\n\n$25,000\n\n0\\.90\n\n**Personal and Farm/Ranch Liability and Medical Increased Limit Factors**\n\n$300,000 1.00 1.00 $300,000 1.40\n\n**Increased Liability Limit Factors Increased Personal Injury Limit Factors**\n\n$100,000 $100,000\n\nFactor Factor Limit\n\n0\\.167\n\nLimit\n\n$10,000\n\n2\\.06\n\n$25,000\n\n$500\n\n$5,000 1.30\n\n$500,000 2.10 1.90\n\n$10,000 $5,000\n\nFactor\n\n6\\.30\n\nLimit\n\n$1,000\n\n$2,000\n\n$0.42\n\n$2.20 4 - 6 1 - 3\n\n$2.20 7 + $2.20\n\n$500,000 $750,000\n\n2\\.50\n\n**Increased Named Persons Medical Limit Factors**\n\n0\\.70 Limit Factor\n\n1\\.58\n\n$300\n\n3\\.70\n\n$750,000\n\n$0.42\n\nBorrowed F/R PP\n\n$1,000\n\nLimit 0.70\n\nInsured is Tenant\n\nLivestock/Animal Collision\n\nF/R Residence Liability Insured is Owner $32.75\n\n**Increased Medical Limit Factors**\n\n2\\.35\n\nWaterbed Liability\n\n$500\n\n$1,000,000\n\n$1,000\n\nFactor\n\nF/R Residence Medical Insured is Owner $3.36\n\n7 + $48.50\n\n$2.70\n\n$37.75\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2406 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page113.pdf"]},"response":{"errors":[],"extract_id":"extract_0b41fabef510828cd3bc7ac809f51497","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Liability Section Rates and Factors**\n\nFactor\n\n1\\.333 $750\n\nAcres (0 - 160)\n\nInsured is Owner\n\n1\\.00\n\n1\\.29\n\n1\\.35\n\n3\\.50 2.20\n\n**Increased Borrowed F/R PP Limit Factors**\n\n1\\.167\n\n**Increased Employer Medical Limit Factors**\n\n1\\.56\n\n$25,000\n\n1\\.000\n\n$2,000\n\n$21.75\n\nHousehold/Organizational Medical Household/Organizational Liability\n\nInsured is Tenant $32.75\n\n$21.75 Residence Medical\n\n$3.00 $4.69 Per Household/Organization\n\n$2.90 Insured is Tenant\n\nFarm/Ranch Acres Liability\n\n$12.50\n\n$42.00\n\n$5.82\n\n1 - 10 $9.50 Farm/Ranch Livestock Liability\n\n4 - 6\n\n**Liability Base Rates**\n\nInsured is Owner\n\n**Medical Base Rates**\n\nPer F/R Household/Organization $30.50 Per Household/Organization Per F/R Household/Organization\n\n$2.90 Residence Liability\n\n**Personal and Farm/Ranch (F/R) Liability and Medical Base Rate Tables**\n\n$52.00\n\nFarm/Ranch Acres Medical\n\n11 - 100\n\n**Farm/Ranch Employer Base Rates**\n\n$30.00 $64.00\n\n$3.45 Acres (0 - 160)\n\n$3.15\n\n$2.65\n\n100 +\n\nInsured is Tenant\n\n$3.36\n\n$1.05\n\nDairy\n\nExcess of 1, up to 8\n\n$75.00\n\n$27.25\n\n$170.00 Additional Locations 1 - 10 $25.25\n\nDairy\n\n$20.00\n\nF/R Additional Locations Excess of 1, up to 8 $39.75\n\nAnimal Liability\n\n$1.05\n\n100 + 11 - 100\n\nNamed Persons Medical\n\n**Optional Coverages Base Rates**\n\n1 - 3\n\nPersonal Injury Liability\n\nFarm/Ranch Livestock Medical\n\nAnimal Medical\n\nFarm/Ranch Employer Liability\n\n2\\.10\n\n2\\.80\n\n$1,000\n\n5\\.25\n\n1\\.00 1.00 $2,000 $5,000\n\n2\\.30 $1,000,000\n\n0\\.60\n\n3\\.45 $10,000 For Each Additional $1,000 Add\n\n$500\n\nLimit\n\nFarm/Ranch Employer Medical Non-Dairy\n\nNon-Dairy\n\n$65,000 0.94 $65,000\n\n$25,000\n\n0\\.90\n\n**Personal and Farm/Ranch Liability and Medical Increased Limit Factors**\n\n$300,000 1.00 1.00 $300,000 1.40\n\n**Increased Liability Limit Factors Increased Personal Injury Limit Factors**\n\n$100,000 $100,000\n\nFactor Factor Limit\n\n0\\.167\n\nLimit\n\n$10,000\n\n2\\.06\n\n$25,000\n\n$500\n\n$5,000 1.30\n\n$500,000 2.10 1.90\n\n$10,000 $5,000\n\nFactor\n\n6\\.30\n\nLimit\n\n$1,000\n\n$2,000\n\n$0.42\n\n$2.20 4 - 6 1 - 3\n\n$2.20 7 + $2.20\n\n$500,000 $750,000\n\n2\\.50\n\n**Increased Named Persons Medical Limit Factors**\n\n0\\.70 Limit Factor\n\n1\\.58\n\n$300\n\n3\\.70\n\n$750,000\n\n$0.42\n\nBorrowed F/R PP\n\n$1,000\n\nLimit 0.70\n\nInsured is Tenant\n\nLivestock/Animal Collision\n\nF/R Residence Liability Insured is Owner $32.75\n\n**Increased Medical Limit Factors**\n\n2\\.35\n\nWaterbed Liability\n\n$500\n\n$1,000,000\n\n$1,000\n\nFactor\n\nF/R Residence Medical Insured is Owner $3.36\n\n7 + $48.50\n\n$2.70\n\n$37.75\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2406 Rates and Factors"],"full_content":"**Liability Section Rates and Factors**\n\nFactor\n\n1\\.333 $750\n\nAcres (0 - 160)\n\nInsured is Owner\n\n1\\.00\n\n1\\.29\n\n1\\.35\n\n3\\.50 2.20\n\n**Increased Borrowed F/R PP Limit Factors**\n\n1\\.167\n\n**Increased Employer Medical Limit Factors**\n\n1\\.56\n\n$25,000\n\n1\\.000\n\n$2,000\n\n$21.75\n\nHousehold/Organizational Medical Household/Organizational Liability\n\nInsured is Tenant $32.75\n\n$21.75 Residence Medical\n\n$3.00 $4.69 Per Household/Organization\n\n$2.90 Insured is Tenant\n\nFarm/Ranch Acres Liability\n\n$12.50\n\n$42.00\n\n$5.82\n\n1 - 10 $9.50 Farm/Ranch Livestock Liability\n\n4 - 6\n\n**Liability Base Rates**\n\nInsured is Owner\n\n**Medical Base Rates**\n\nPer F/R Household/Organization $30.50 Per Household/Organization Per F/R Household/Organization\n\n$2.90 Residence Liability\n\n**Personal and Farm/Ranch (F/R) Liability and Medical Base Rate Tables**\n\n$52.00\n\nFarm/Ranch Acres Medical\n\n11 - 100\n\n**Farm/Ranch Employer Base Rates**\n\n$30.00 $64.00\n\n$3.45 Acres (0 - 160)\n\n$3.15\n\n$2.65\n\n100 +\n\nInsured is Tenant\n\n$3.36\n\n$1.05\n\nDairy\n\nExcess of 1, up to 8\n\n$75.00\n\n$27.25\n\n$170.00 Additional Locations 1 - 10 $25.25\n\nDairy\n\n$20.00\n\nF/R Additional Locations Excess of 1, up to 8 $39.75\n\nAnimal Liability\n\n$1.05\n\n100 + 11 - 100\n\nNamed Persons Medical\n\n**Optional Coverages Base Rates**\n\n1 - 3\n\nPersonal Injury Liability\n\nFarm/Ranch Livestock Medical\n\nAnimal Medical\n\nFarm/Ranch Employer Liability\n\n2\\.10\n\n2\\.80\n\n$1,000\n\n5\\.25\n\n1\\.00 1.00 $2,000 $5,000\n\n2\\.30 $1,000,000\n\n0\\.60\n\n3\\.45 $10,000 For Each Additional $1,000 Add\n\n$500\n\nLimit\n\nFarm/Ranch Employer Medical Non-Dairy\n\nNon-Dairy\n\n$65,000 0.94 $65,000\n\n$25,000\n\n0\\.90\n\n**Personal and Farm/Ranch Liability and Medical Increased Limit Factors**\n\n$300,000 1.00 1.00 $300,000 1.40\n\n**Increased Liability Limit Factors Increased Personal Injury Limit Factors**\n\n$100,000 $100,000\n\nFactor Factor Limit\n\n0\\.167\n\nLimit\n\n$10,000\n\n2\\.06\n\n$25,000\n\n$500\n\n$5,000 1.30\n\n$500,000 2.10 1.90\n\n$10,000 $5,000\n\nFactor\n\n6\\.30\n\nLimit\n\n$1,000\n\n$2,000\n\n$0.42\n\n$2.20 4 - 6 1 - 3\n\n$2.20 7 + $2.20\n\n$500,000 $750,000\n\n2\\.50\n\n**Increased Named Persons Medical Limit Factors**\n\n0\\.70 Limit Factor\n\n1\\.58\n\n$300\n\n3\\.70\n\n$750,000\n\n$0.42\n\nBorrowed F/R PP\n\n$1,000\n\nLimit 0.70\n\nInsured is Tenant\n\nLivestock/Animal Collision\n\nF/R Residence Liability Insured is Owner $32.75\n\n**Increased Medical Limit Factors**\n\n2\\.35\n\nWaterbed Liability\n\n$500\n\n$1,000,000\n\n$1,000\n\nFactor\n\nF/R Residence Medical Insured is Owner $3.36\n\n7 + $48.50\n\n$2.70\n\n$37.75\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2406 Rates and Factors","publish_date":null,"title":"Liability Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page113.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page113.pdf"},"request":{"example_id":"table/FBLB-134215544_page113","product_type":"parse","source_file_path":"FBLB-134215544_page113.pdf"},"started_at":"2026-11-04T19:47:32.802915"} +{"completed_at":"2026-11-04T19:47:35.021752","latency_in_ms":1345,"output":{"example_id":"table/FBLB-134215544_page114","grounded_pages":[],"layout_pages":[],"markdown":"### **Liability Section Rates and Factors**\n\nUtah\n\nLower $ Threshold -$100.00 -$100.00 Upper $ Threshold $100.00 $100.00\n\nNo Cap\n\n\\-75% 75% -75% 75% Upper % Threshold\n\nLower % Threshold\n\n**Personal and Farm/Ranch Liability and Medical Additional Factors Used in Rating**\n\nLiability Type Non Farm/Ranch\n\nFarm/Ranch Small Farm/Ranch Indicator = N Small Farm/Ranch Indicator = Y\n\n**Maximum and Minimum Changes for Calculation of Rate Capping Factor**\n\n**Upper & Lower Thresholds**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2024 2601- 2700 Rates and Factors","pages":[{"line_numbers":[],"markdown":"### **Liability Section Rates and Factors**\n\nUtah\n\nLower $ Threshold -$100.00 -$100.00 Upper $ Threshold $100.00 $100.00\n\nNo Cap\n\n\\-75% 75% -75% 75% Upper % Threshold\n\nLower % Threshold\n\n**Personal and Farm/Ranch Liability and Medical Additional Factors Used in Rating**\n\nLiability Type Non Farm/Ranch\n\nFarm/Ranch Small Farm/Ranch Indicator = N Small Farm/Ranch Indicator = Y\n\n**Maximum and Minimum Changes for Calculation of Rate Capping Factor**\n\n**Upper & Lower Thresholds**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2024 2601- 2700 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Liability Section Rates and Factors**\n\nUtah\n\nLower $ Threshold -$100.00 -$100.00 Upper $ Threshold $100.00 $100.00\n\nNo Cap\n\n\\-75% 75% -75% 75% Upper % Threshold\n\nLower % Threshold\n\n**Personal and Farm/Ranch Liability and Medical Additional Factors Used in Rating**\n\nLiability Type Non Farm/Ranch\n\nFarm/Ranch Small Farm/Ranch Indicator = N Small Farm/Ranch Indicator = Y\n\n**Maximum and Minimum Changes for Calculation of Rate Capping Factor**\n\n**Upper & Lower Thresholds**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2024 2601- 2700 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page114.pdf"]},"response":{"errors":[],"extract_id":"extract_43accdc249ca1809131cf89c1a9cb72e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Liability Section Rates and Factors**\n\nUtah\n\nLower $ Threshold -$100.00 -$100.00 Upper $ Threshold $100.00 $100.00\n\nNo Cap\n\n\\-75% 75% -75% 75% Upper % Threshold\n\nLower % Threshold\n\n**Personal and Farm/Ranch Liability and Medical Additional Factors Used in Rating**\n\nLiability Type Non Farm/Ranch\n\nFarm/Ranch Small Farm/Ranch Indicator = N Small Farm/Ranch Indicator = Y\n\n**Maximum and Minimum Changes for Calculation of Rate Capping Factor**\n\n**Upper & Lower Thresholds**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2024 2601- 2700 Rates and Factors"],"full_content":"### **Liability Section Rates and Factors**\n\nUtah\n\nLower $ Threshold -$100.00 -$100.00 Upper $ Threshold $100.00 $100.00\n\nNo Cap\n\n\\-75% 75% -75% 75% Upper % Threshold\n\nLower % Threshold\n\n**Personal and Farm/Ranch Liability and Medical Additional Factors Used in Rating**\n\nLiability Type Non Farm/Ranch\n\nFarm/Ranch Small Farm/Ranch Indicator = N Small Farm/Ranch Indicator = Y\n\n**Maximum and Minimum Changes for Calculation of Rate Capping Factor**\n\n**Upper & Lower Thresholds**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2024 2601- 2700 Rates and Factors","publish_date":null,"title":"Liability Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page114.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page114.pdf"},"request":{"example_id":"table/FBLB-134215544_page114","product_type":"parse","source_file_path":"FBLB-134215544_page114.pdf"},"started_at":"2026-11-04T19:47:33.675886"} +{"completed_at":"2026-11-04T19:47:36.514437","latency_in_ms":1501,"output":{"example_id":"table/FBLB-134215544_page115","grounded_pages":[],"layout_pages":[],"markdown":"**PROPERTY SECTION PREMIUM DETERMINATION**\n\n**OPP2.15** **_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.14_** **=**\n\n**OPP2.19** _Subtotal_ **=**\n\n**Layer** **4** **‐** **Use** **only** **if** **Limit** **exceeds** **$26,000 OPP2.16 Subtract** **$26,000** **from** **the** **Limit $ # OPP2.17 Divide** **by** **100** **and** **enter** **the** **amount ÷ OPP2.18** **Layer** **4** **Property** **Assessment** **Base** **Rate X**\n\n**Layer** **1** **‐** **Use** **only** **if** **Limit** **exceeds** **$1,000**\n\n**Policy** **Inception** **Date** **Factor X X**\n\n**\\# #**\n\n**OPP2.21 Property** **Multiplier** **(Value** **of** **OPP1) X**\n\n**OPP1**\n\n**\\#**\n\n**X**\n\n**$**\n\n**OPP2.15**\n\n**OPP2.10**\n\n**OPP2.08 OPP2.07**\n\n**OPP2.04**\n\n**OPP2.20**\n\n**Layer** **1** **Property** **Assessment** **Base** **Rate**\n\n**Layer** **2** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.14 OPP2.13**\n\n**\\#**\n\n**OPP2.12 Take** **the** **lesser** **of** **Step** **OPP2.11** **and** **$15,000 =**\n\n**Subtract** **$6,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.06** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Subtract** **$11,000** **from** **the** **Limit**\n\n**_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.15_** **_\\+_** **_OPP2.19_** **=**\n\n**Rate** **Capping** **Factor X**\n\n**X X =**\n\n**Layer** **3** **‐** **Use** **only** **if** **Limit** **exceeds** **$11,000 $**\n\n_Subtotal_\n\n_Subtotal_\n\n**Layer** **3** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.22**\n\n**Fire** **Department** **Service** **Charge** **Coverage** **(for** **limits** **exceeding** **$1,000) OPP2** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nTotal Insured Value is equal to the sum of the Amounts of Insurance for the following: Outbuilding Types 2‐8, 10‐11, 13‐15, 17‐24, 27, 30‐34, & 36‐37, Tools/Miscellaneous insured under Blanket Farm/Ranch Personal Property, and Tools/Miscellaneous and Irrigation insured under Scheduled Farm/Ranch Personal Property. Note: Leased Irrigation Equipment amounts of insurance are included in the Total Insured Value for Farm Ranch Equipment Breakdown. Amounts of insurance for Cab Glass, Peak Season, Livestock Freezing or Smothering, Livestock Suffocation, Earthquake, Farm/Ranch Operation Records, Agricultural Earnings and Extra Expense Coverage, & Farm/Ranch Refrigerated Contents are excluded from the Total Insured Value.\n\n**OPP3.02 OPP3.01**\n\n**Farm** **Ranch** **(F/R)** **Equipment** **Breakdown**\n\n**Divide** **by** **100** **$ ÷ $ Fire** **Department** **Service** **Charge** **Amount** **of** **Insurance** **‐** **1,000**\n\n**OPP3.03 Fire** **Department** **Service** **Charge** **Rate X**\n\n**OPP3.05 OPP3**\n\n**OPP3.04 Property** **Multiplier** **(Value** **of** **OPP1) Rate** **Capping** **Factor** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**OPP4.04 OPP4.03 #**\n\n**OPP4.02** _Subtotal_ _1_ _‐_ _Round_ _to_ _2_ _decimals_ **F/R** **Equipment** **Breakdown** **Minimum** **Premium**\n\n**OPP4.01 Total** **Insured** **Value** **divided** **by** **1000 F/R** **Equipment** **Breakdown** **Rate # X**\n\n**= Identity** **Services** **and** **Fraud** **Expense** **Coverage OPP4** _Subtotal_ _‐_ _(Greater_ _of_ _OPP4.03_ _&_ _OPP4.04)_ **=**\n\n**=**\n\n**F/R** **Ag** **Earnings OPP6.01 F/R** **Ag** **Earnings** **Base** **Rate**\n\n**OPP2.11**\n\n**Property** **Loss** **Assessment** **($100** **increments)**\n\n**PLA FDSC FREB OPP1.01 Claim** **Frequency** **Factor** **1**\n\n**Sum** **of** **Ag** **Factors** **‐** **1\\.00**\n\n**ID**\n\n_Subtotal_ **= =**\n\n**OPP1.09**\n\n**Step**\n\n**OPP2.06 Layer** **2** **‐** **Use** **only** **if** **Limit** **exceeds** **$6,000 OPP2.05** _Subtotal_ **=**\n\n**=**\n\n**=**\n\n**=**\n\n**÷ X #**\n\n**OPP2.09**\n\n**OPP1.10 Underwriting** **Level** **Factor X X**\n\n**OPP2.03 OPP2.02 OPP2.01 Subtract** **$1,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.01** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Divide** **by** **100** **and** **enter** **the** **amount**\n\n**$ = ÷**\n\n**OPP1.06 Ag** **\\+** **Rewards** **Factor + OPP1.07 Sum** **of** **Ag** **Factors =**\n\n**\\#**\n\n**OPP1.02 Claim** **Frequency** **Factor** **2 X X**\n\n**÷ X**\n\n**OPP1.03 Claim** **Free** **Discount** **Factor OPP1.04 Continued** **in** **Force** **Factor OPP1.05 Ag** **Advantage** **Factor**\n\n**OPP1.08**\n\n**Rating** **Algorithm AGE # X X X**\n\n**X X =**\n\n**Component**\n\n**X X X X**\n\n**X X**\n\n**=**\n\n**OPP5** _Subtotal_ **Ag** **Earnings**\n\n**\\# OPP6.02 (Ag** **Earnings** **Limit\\*** **of** **Insurance** **/** **1000)** **X OPP6.03 Ag** **Earnings** **Operation** **Type** **Factors X OPP6.04 Ag** **Earnings** **Structure** **Count** **Factors X OPP6.05 Property** **Multiplier** **(Value** **of** **OPP1) X OPP6.06 Extended** **Earnings** **Factor X OPP6.07 Individual** **Risk** **Premium** **Modification** **Factor X OPP6.08 Rate** **Capping** **Factor X OPP6** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER’S CHOICE POLICY – PROPERTY SECTION – 01/23/2025 3253 Premium Determination","pages":[{"line_numbers":[],"markdown":"**PROPERTY SECTION PREMIUM DETERMINATION**\n\n**OPP2.15** **_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.14_** **=**\n\n**OPP2.19** _Subtotal_ **=**\n\n**Layer** **4** **‐** **Use** **only** **if** **Limit** **exceeds** **$26,000 OPP2.16 Subtract** **$26,000** **from** **the** **Limit $ # OPP2.17 Divide** **by** **100** **and** **enter** **the** **amount ÷ OPP2.18** **Layer** **4** **Property** **Assessment** **Base** **Rate X**\n\n**Layer** **1** **‐** **Use** **only** **if** **Limit** **exceeds** **$1,000**\n\n**Policy** **Inception** **Date** **Factor X X**\n\n**\\# #**\n\n**OPP2.21 Property** **Multiplier** **(Value** **of** **OPP1) X**\n\n**OPP1**\n\n**\\#**\n\n**X**\n\n**$**\n\n**OPP2.15**\n\n**OPP2.10**\n\n**OPP2.08 OPP2.07**\n\n**OPP2.04**\n\n**OPP2.20**\n\n**Layer** **1** **Property** **Assessment** **Base** **Rate**\n\n**Layer** **2** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.14 OPP2.13**\n\n**\\#**\n\n**OPP2.12 Take** **the** **lesser** **of** **Step** **OPP2.11** **and** **$15,000 =**\n\n**Subtract** **$6,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.06** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Subtract** **$11,000** **from** **the** **Limit**\n\n**_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.15_** **_\\+_** **_OPP2.19_** **=**\n\n**Rate** **Capping** **Factor X**\n\n**X X =**\n\n**Layer** **3** **‐** **Use** **only** **if** **Limit** **exceeds** **$11,000 $**\n\n_Subtotal_\n\n_Subtotal_\n\n**Layer** **3** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.22**\n\n**Fire** **Department** **Service** **Charge** **Coverage** **(for** **limits** **exceeding** **$1,000) OPP2** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nTotal Insured Value is equal to the sum of the Amounts of Insurance for the following: Outbuilding Types 2‐8, 10‐11, 13‐15, 17‐24, 27, 30‐34, & 36‐37, Tools/Miscellaneous insured under Blanket Farm/Ranch Personal Property, and Tools/Miscellaneous and Irrigation insured under Scheduled Farm/Ranch Personal Property. Note: Leased Irrigation Equipment amounts of insurance are included in the Total Insured Value for Farm Ranch Equipment Breakdown. Amounts of insurance for Cab Glass, Peak Season, Livestock Freezing or Smothering, Livestock Suffocation, Earthquake, Farm/Ranch Operation Records, Agricultural Earnings and Extra Expense Coverage, & Farm/Ranch Refrigerated Contents are excluded from the Total Insured Value.\n\n**OPP3.02 OPP3.01**\n\n**Farm** **Ranch** **(F/R)** **Equipment** **Breakdown**\n\n**Divide** **by** **100** **$ ÷ $ Fire** **Department** **Service** **Charge** **Amount** **of** **Insurance** **‐** **1,000**\n\n**OPP3.03 Fire** **Department** **Service** **Charge** **Rate X**\n\n**OPP3.05 OPP3**\n\n**OPP3.04 Property** **Multiplier** **(Value** **of** **OPP1) Rate** **Capping** **Factor** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**OPP4.04 OPP4.03 #**\n\n**OPP4.02** _Subtotal_ _1_ _‐_ _Round_ _to_ _2_ _decimals_ **F/R** **Equipment** **Breakdown** **Minimum** **Premium**\n\n**OPP4.01 Total** **Insured** **Value** **divided** **by** **1000 F/R** **Equipment** **Breakdown** **Rate # X**\n\n**= Identity** **Services** **and** **Fraud** **Expense** **Coverage OPP4** _Subtotal_ _‐_ _(Greater_ _of_ _OPP4.03_ _&_ _OPP4.04)_ **=**\n\n**=**\n\n**F/R** **Ag** **Earnings OPP6.01 F/R** **Ag** **Earnings** **Base** **Rate**\n\n**OPP2.11**\n\n**Property** **Loss** **Assessment** **($100** **increments)**\n\n**PLA FDSC FREB OPP1.01 Claim** **Frequency** **Factor** **1**\n\n**Sum** **of** **Ag** **Factors** **‐** **1\\.00**\n\n**ID**\n\n_Subtotal_ **= =**\n\n**OPP1.09**\n\n**Step**\n\n**OPP2.06 Layer** **2** **‐** **Use** **only** **if** **Limit** **exceeds** **$6,000 OPP2.05** _Subtotal_ **=**\n\n**=**\n\n**=**\n\n**=**\n\n**÷ X #**\n\n**OPP2.09**\n\n**OPP1.10 Underwriting** **Level** **Factor X X**\n\n**OPP2.03 OPP2.02 OPP2.01 Subtract** **$1,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.01** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Divide** **by** **100** **and** **enter** **the** **amount**\n\n**$ = ÷**\n\n**OPP1.06 Ag** **\\+** **Rewards** **Factor + OPP1.07 Sum** **of** **Ag** **Factors =**\n\n**\\#**\n\n**OPP1.02 Claim** **Frequency** **Factor** **2 X X**\n\n**÷ X**\n\n**OPP1.03 Claim** **Free** **Discount** **Factor OPP1.04 Continued** **in** **Force** **Factor OPP1.05 Ag** **Advantage** **Factor**\n\n**OPP1.08**\n\n**Rating** **Algorithm AGE # X X X**\n\n**X X =**\n\n**Component**\n\n**X X X X**\n\n**X X**\n\n**=**\n\n**OPP5** _Subtotal_ **Ag** **Earnings**\n\n**\\# OPP6.02 (Ag** **Earnings** **Limit\\*** **of** **Insurance** **/** **1000)** **X OPP6.03 Ag** **Earnings** **Operation** **Type** **Factors X OPP6.04 Ag** **Earnings** **Structure** **Count** **Factors X OPP6.05 Property** **Multiplier** **(Value** **of** **OPP1) X OPP6.06 Extended** **Earnings** **Factor X OPP6.07 Individual** **Risk** **Premium** **Modification** **Factor X OPP6.08 Rate** **Capping** **Factor X OPP6** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER’S CHOICE POLICY – PROPERTY SECTION – 01/23/2025 3253 Premium Determination","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**PROPERTY SECTION PREMIUM DETERMINATION**\n\n**OPP2.15** **_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.14_** **=**\n\n**OPP2.19** _Subtotal_ **=**\n\n**Layer** **4** **‐** **Use** **only** **if** **Limit** **exceeds** **$26,000 OPP2.16 Subtract** **$26,000** **from** **the** **Limit $ # OPP2.17 Divide** **by** **100** **and** **enter** **the** **amount ÷ OPP2.18** **Layer** **4** **Property** **Assessment** **Base** **Rate X**\n\n**Layer** **1** **‐** **Use** **only** **if** **Limit** **exceeds** **$1,000**\n\n**Policy** **Inception** **Date** **Factor X X**\n\n**\\# #**\n\n**OPP2.21 Property** **Multiplier** **(Value** **of** **OPP1) X**\n\n**OPP1**\n\n**\\#**\n\n**X**\n\n**$**\n\n**OPP2.15**\n\n**OPP2.10**\n\n**OPP2.08 OPP2.07**\n\n**OPP2.04**\n\n**OPP2.20**\n\n**Layer** **1** **Property** **Assessment** **Base** **Rate**\n\n**Layer** **2** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.14 OPP2.13**\n\n**\\#**\n\n**OPP2.12 Take** **the** **lesser** **of** **Step** **OPP2.11** **and** **$15,000 =**\n\n**Subtract** **$6,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.06** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Subtract** **$11,000** **from** **the** **Limit**\n\n**_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.15_** **_\\+_** **_OPP2.19_** **=**\n\n**Rate** **Capping** **Factor X**\n\n**X X =**\n\n**Layer** **3** **‐** **Use** **only** **if** **Limit** **exceeds** **$11,000 $**\n\n_Subtotal_\n\n_Subtotal_\n\n**Layer** **3** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.22**\n\n**Fire** **Department** **Service** **Charge** **Coverage** **(for** **limits** **exceeding** **$1,000) OPP2** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nTotal Insured Value is equal to the sum of the Amounts of Insurance for the following: Outbuilding Types 2‐8, 10‐11, 13‐15, 17‐24, 27, 30‐34, & 36‐37, Tools/Miscellaneous insured under Blanket Farm/Ranch Personal Property, and Tools/Miscellaneous and Irrigation insured under Scheduled Farm/Ranch Personal Property. Note: Leased Irrigation Equipment amounts of insurance are included in the Total Insured Value for Farm Ranch Equipment Breakdown. Amounts of insurance for Cab Glass, Peak Season, Livestock Freezing or Smothering, Livestock Suffocation, Earthquake, Farm/Ranch Operation Records, Agricultural Earnings and Extra Expense Coverage, & Farm/Ranch Refrigerated Contents are excluded from the Total Insured Value.\n\n**OPP3.02 OPP3.01**\n\n**Farm** **Ranch** **(F/R)** **Equipment** **Breakdown**\n\n**Divide** **by** **100** **$ ÷ $ Fire** **Department** **Service** **Charge** **Amount** **of** **Insurance** **‐** **1,000**\n\n**OPP3.03 Fire** **Department** **Service** **Charge** **Rate X**\n\n**OPP3.05 OPP3**\n\n**OPP3.04 Property** **Multiplier** **(Value** **of** **OPP1) Rate** **Capping** **Factor** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**OPP4.04 OPP4.03 #**\n\n**OPP4.02** _Subtotal_ _1_ _‐_ _Round_ _to_ _2_ _decimals_ **F/R** **Equipment** **Breakdown** **Minimum** **Premium**\n\n**OPP4.01 Total** **Insured** **Value** **divided** **by** **1000 F/R** **Equipment** **Breakdown** **Rate # X**\n\n**= Identity** **Services** **and** **Fraud** **Expense** **Coverage OPP4** _Subtotal_ _‐_ _(Greater_ _of_ _OPP4.03_ _&_ _OPP4.04)_ **=**\n\n**=**\n\n**F/R** **Ag** **Earnings OPP6.01 F/R** **Ag** **Earnings** **Base** **Rate**\n\n**OPP2.11**\n\n**Property** **Loss** **Assessment** **($100** **increments)**\n\n**PLA FDSC FREB OPP1.01 Claim** **Frequency** **Factor** **1**\n\n**Sum** **of** **Ag** **Factors** **‐** **1\\.00**\n\n**ID**\n\n_Subtotal_ **= =**\n\n**OPP1.09**\n\n**Step**\n\n**OPP2.06 Layer** **2** **‐** **Use** **only** **if** **Limit** **exceeds** **$6,000 OPP2.05** _Subtotal_ **=**\n\n**=**\n\n**=**\n\n**=**\n\n**÷ X #**\n\n**OPP2.09**\n\n**OPP1.10 Underwriting** **Level** **Factor X X**\n\n**OPP2.03 OPP2.02 OPP2.01 Subtract** **$1,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.01** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Divide** **by** **100** **and** **enter** **the** **amount**\n\n**$ = ÷**\n\n**OPP1.06 Ag** **\\+** **Rewards** **Factor + OPP1.07 Sum** **of** **Ag** **Factors =**\n\n**\\#**\n\n**OPP1.02 Claim** **Frequency** **Factor** **2 X X**\n\n**÷ X**\n\n**OPP1.03 Claim** **Free** **Discount** **Factor OPP1.04 Continued** **in** **Force** **Factor OPP1.05 Ag** **Advantage** **Factor**\n\n**OPP1.08**\n\n**Rating** **Algorithm AGE # X X X**\n\n**X X =**\n\n**Component**\n\n**X X X X**\n\n**X X**\n\n**=**\n\n**OPP5** _Subtotal_ **Ag** **Earnings**\n\n**\\# OPP6.02 (Ag** **Earnings** **Limit\\*** **of** **Insurance** **/** **1000)** **X OPP6.03 Ag** **Earnings** **Operation** **Type** **Factors X OPP6.04 Ag** **Earnings** **Structure** **Count** **Factors X OPP6.05 Property** **Multiplier** **(Value** **of** **OPP1) X OPP6.06 Extended** **Earnings** **Factor X OPP6.07 Individual** **Risk** **Premium** **Modification** **Factor X OPP6.08 Rate** **Capping** **Factor X OPP6** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER’S CHOICE POLICY – PROPERTY SECTION – 01/23/2025 3253 Premium Determination","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page115.pdf"]},"response":{"errors":[],"extract_id":"extract_2b668ce6b9631bc2ee5c5dbe7c042d8d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**PROPERTY SECTION PREMIUM DETERMINATION**\n\n**OPP2.15** **_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.14_** **=**\n\n**OPP2.19** _Subtotal_ **=**\n\n**Layer** **4** **‐** **Use** **only** **if** **Limit** **exceeds** **$26,000 OPP2.16 Subtract** **$26,000** **from** **the** **Limit $ # OPP2.17 Divide** **by** **100** **and** **enter** **the** **amount ÷ OPP2.18** **Layer** **4** **Property** **Assessment** **Base** **Rate X**\n\n**Layer** **1** **‐** **Use** **only** **if** **Limit** **exceeds** **$1,000**\n\n**Policy** **Inception** **Date** **Factor X X**\n\n**\\# #**\n\n**OPP2.21 Property** **Multiplier** **(Value** **of** **OPP1) X**\n\n**OPP1**\n\n**\\#**\n\n**X**\n\n**$**\n\n**OPP2.15**\n\n**OPP2.10**\n\n**OPP2.08 OPP2.07**\n\n**OPP2.04**\n\n**OPP2.20**\n\n**Layer** **1** **Property** **Assessment** **Base** **Rate**\n\n**Layer** **2** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.14 OPP2.13**\n\n**\\#**\n\n**OPP2.12 Take** **the** **lesser** **of** **Step** **OPP2.11** **and** **$15,000 =**\n\n**Subtract** **$6,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.06** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Subtract** **$11,000** **from** **the** **Limit**\n\n**_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.15_** **_\\+_** **_OPP2.19_** **=**\n\n**Rate** **Capping** **Factor X**\n\n**X X =**\n\n**Layer** **3** **‐** **Use** **only** **if** **Limit** **exceeds** **$11,000 $**\n\n_Subtotal_\n\n_Subtotal_\n\n**Layer** **3** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.22**\n\n**Fire** **Department** **Service** **Charge** **Coverage** **(for** **limits** **exceeding** **$1,000) OPP2** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nTotal Insured Value is equal to the sum of the Amounts of Insurance for the following: Outbuilding Types 2‐8, 10‐11, 13‐15, 17‐24, 27, 30‐34, & 36‐37, Tools/Miscellaneous insured under Blanket Farm/Ranch Personal Property, and Tools/Miscellaneous and Irrigation insured under Scheduled Farm/Ranch Personal Property. Note: Leased Irrigation Equipment amounts of insurance are included in the Total Insured Value for Farm Ranch Equipment Breakdown. Amounts of insurance for Cab Glass, Peak Season, Livestock Freezing or Smothering, Livestock Suffocation, Earthquake, Farm/Ranch Operation Records, Agricultural Earnings and Extra Expense Coverage, & Farm/Ranch Refrigerated Contents are excluded from the Total Insured Value.\n\n**OPP3.02 OPP3.01**\n\n**Farm** **Ranch** **(F/R)** **Equipment** **Breakdown**\n\n**Divide** **by** **100** **$ ÷ $ Fire** **Department** **Service** **Charge** **Amount** **of** **Insurance** **‐** **1,000**\n\n**OPP3.03 Fire** **Department** **Service** **Charge** **Rate X**\n\n**OPP3.05 OPP3**\n\n**OPP3.04 Property** **Multiplier** **(Value** **of** **OPP1) Rate** **Capping** **Factor** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**OPP4.04 OPP4.03 #**\n\n**OPP4.02** _Subtotal_ _1_ _‐_ _Round_ _to_ _2_ _decimals_ **F/R** **Equipment** **Breakdown** **Minimum** **Premium**\n\n**OPP4.01 Total** **Insured** **Value** **divided** **by** **1000 F/R** **Equipment** **Breakdown** **Rate # X**\n\n**= Identity** **Services** **and** **Fraud** **Expense** **Coverage OPP4** _Subtotal_ _‐_ _(Greater_ _of_ _OPP4.03_ _&_ _OPP4.04)_ **=**\n\n**=**\n\n**F/R** **Ag** **Earnings OPP6.01 F/R** **Ag** **Earnings** **Base** **Rate**\n\n**OPP2.11**\n\n**Property** **Loss** **Assessment** **($100** **increments)**\n\n**PLA FDSC FREB OPP1.01 Claim** **Frequency** **Factor** **1**\n\n**Sum** **of** **Ag** **Factors** **‐** **1\\.00**\n\n**ID**\n\n_Subtotal_ **= =**\n\n**OPP1.09**\n\n**Step**\n\n**OPP2.06 Layer** **2** **‐** **Use** **only** **if** **Limit** **exceeds** **$6,000 OPP2.05** _Subtotal_ **=**\n\n**=**\n\n**=**\n\n**=**\n\n**÷ X #**\n\n**OPP2.09**\n\n**OPP1.10 Underwriting** **Level** **Factor X X**\n\n**OPP2.03 OPP2.02 OPP2.01 Subtract** **$1,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.01** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Divide** **by** **100** **and** **enter** **the** **amount**\n\n**$ = ÷**\n\n**OPP1.06 Ag** **\\+** **Rewards** **Factor + OPP1.07 Sum** **of** **Ag** **Factors =**\n\n**\\#**\n\n**OPP1.02 Claim** **Frequency** **Factor** **2 X X**\n\n**÷ X**\n\n**OPP1.03 Claim** **Free** **Discount** **Factor OPP1.04 Continued** **in** **Force** **Factor OPP1.05 Ag** **Advantage** **Factor**\n\n**OPP1.08**\n\n**Rating** **Algorithm AGE # X X X**\n\n**X X =**\n\n**Component**\n\n**X X X X**\n\n**X X**\n\n**=**\n\n**OPP5** _Subtotal_ **Ag** **Earnings**\n\n**\\# OPP6.02 (Ag** **Earnings** **Limit\\*** **of** **Insurance** **/** **1000)** **X OPP6.03 Ag** **Earnings** **Operation** **Type** **Factors X OPP6.04 Ag** **Earnings** **Structure** **Count** **Factors X OPP6.05 Property** **Multiplier** **(Value** **of** **OPP1) X OPP6.06 Extended** **Earnings** **Factor X OPP6.07 Individual** **Risk** **Premium** **Modification** **Factor X OPP6.08 Rate** **Capping** **Factor X OPP6** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER’S CHOICE POLICY – PROPERTY SECTION – 01/23/2025 3253 Premium Determination"],"full_content":"**PROPERTY SECTION PREMIUM DETERMINATION**\n\n**OPP2.15** **_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.14_** **=**\n\n**OPP2.19** _Subtotal_ **=**\n\n**Layer** **4** **‐** **Use** **only** **if** **Limit** **exceeds** **$26,000 OPP2.16 Subtract** **$26,000** **from** **the** **Limit $ # OPP2.17 Divide** **by** **100** **and** **enter** **the** **amount ÷ OPP2.18** **Layer** **4** **Property** **Assessment** **Base** **Rate X**\n\n**Layer** **1** **‐** **Use** **only** **if** **Limit** **exceeds** **$1,000**\n\n**Policy** **Inception** **Date** **Factor X X**\n\n**\\# #**\n\n**OPP2.21 Property** **Multiplier** **(Value** **of** **OPP1) X**\n\n**OPP1**\n\n**\\#**\n\n**X**\n\n**$**\n\n**OPP2.15**\n\n**OPP2.10**\n\n**OPP2.08 OPP2.07**\n\n**OPP2.04**\n\n**OPP2.20**\n\n**Layer** **1** **Property** **Assessment** **Base** **Rate**\n\n**Layer** **2** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.14 OPP2.13**\n\n**\\#**\n\n**OPP2.12 Take** **the** **lesser** **of** **Step** **OPP2.11** **and** **$15,000 =**\n\n**Subtract** **$6,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.06** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Subtract** **$11,000** **from** **the** **Limit**\n\n**_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.15_** **_\\+_** **_OPP2.19_** **=**\n\n**Rate** **Capping** **Factor X**\n\n**X X =**\n\n**Layer** **3** **‐** **Use** **only** **if** **Limit** **exceeds** **$11,000 $**\n\n_Subtotal_\n\n_Subtotal_\n\n**Layer** **3** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.22**\n\n**Fire** **Department** **Service** **Charge** **Coverage** **(for** **limits** **exceeding** **$1,000) OPP2** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nTotal Insured Value is equal to the sum of the Amounts of Insurance for the following: Outbuilding Types 2‐8, 10‐11, 13‐15, 17‐24, 27, 30‐34, & 36‐37, Tools/Miscellaneous insured under Blanket Farm/Ranch Personal Property, and Tools/Miscellaneous and Irrigation insured under Scheduled Farm/Ranch Personal Property. Note: Leased Irrigation Equipment amounts of insurance are included in the Total Insured Value for Farm Ranch Equipment Breakdown. Amounts of insurance for Cab Glass, Peak Season, Livestock Freezing or Smothering, Livestock Suffocation, Earthquake, Farm/Ranch Operation Records, Agricultural Earnings and Extra Expense Coverage, & Farm/Ranch Refrigerated Contents are excluded from the Total Insured Value.\n\n**OPP3.02 OPP3.01**\n\n**Farm** **Ranch** **(F/R)** **Equipment** **Breakdown**\n\n**Divide** **by** **100** **$ ÷ $ Fire** **Department** **Service** **Charge** **Amount** **of** **Insurance** **‐** **1,000**\n\n**OPP3.03 Fire** **Department** **Service** **Charge** **Rate X**\n\n**OPP3.05 OPP3**\n\n**OPP3.04 Property** **Multiplier** **(Value** **of** **OPP1) Rate** **Capping** **Factor** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**OPP4.04 OPP4.03 #**\n\n**OPP4.02** _Subtotal_ _1_ _‐_ _Round_ _to_ _2_ _decimals_ **F/R** **Equipment** **Breakdown** **Minimum** **Premium**\n\n**OPP4.01 Total** **Insured** **Value** **divided** **by** **1000 F/R** **Equipment** **Breakdown** **Rate # X**\n\n**= Identity** **Services** **and** **Fraud** **Expense** **Coverage OPP4** _Subtotal_ _‐_ _(Greater_ _of_ _OPP4.03_ _&_ _OPP4.04)_ **=**\n\n**=**\n\n**F/R** **Ag** **Earnings OPP6.01 F/R** **Ag** **Earnings** **Base** **Rate**\n\n**OPP2.11**\n\n**Property** **Loss** **Assessment** **($100** **increments)**\n\n**PLA FDSC FREB OPP1.01 Claim** **Frequency** **Factor** **1**\n\n**Sum** **of** **Ag** **Factors** **‐** **1\\.00**\n\n**ID**\n\n_Subtotal_ **= =**\n\n**OPP1.09**\n\n**Step**\n\n**OPP2.06 Layer** **2** **‐** **Use** **only** **if** **Limit** **exceeds** **$6,000 OPP2.05** _Subtotal_ **=**\n\n**=**\n\n**=**\n\n**=**\n\n**÷ X #**\n\n**OPP2.09**\n\n**OPP1.10 Underwriting** **Level** **Factor X X**\n\n**OPP2.03 OPP2.02 OPP2.01 Subtract** **$1,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.01** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Divide** **by** **100** **and** **enter** **the** **amount**\n\n**$ = ÷**\n\n**OPP1.06 Ag** **\\+** **Rewards** **Factor + OPP1.07 Sum** **of** **Ag** **Factors =**\n\n**\\#**\n\n**OPP1.02 Claim** **Frequency** **Factor** **2 X X**\n\n**÷ X**\n\n**OPP1.03 Claim** **Free** **Discount** **Factor OPP1.04 Continued** **in** **Force** **Factor OPP1.05 Ag** **Advantage** **Factor**\n\n**OPP1.08**\n\n**Rating** **Algorithm AGE # X X X**\n\n**X X =**\n\n**Component**\n\n**X X X X**\n\n**X X**\n\n**=**\n\n**OPP5** _Subtotal_ **Ag** **Earnings**\n\n**\\# OPP6.02 (Ag** **Earnings** **Limit\\*** **of** **Insurance** **/** **1000)** **X OPP6.03 Ag** **Earnings** **Operation** **Type** **Factors X OPP6.04 Ag** **Earnings** **Structure** **Count** **Factors X OPP6.05 Property** **Multiplier** **(Value** **of** **OPP1) X OPP6.06 Extended** **Earnings** **Factor X OPP6.07 Individual** **Risk** **Premium** **Modification** **Factor X OPP6.08 Rate** **Capping** **Factor X OPP6** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER’S CHOICE POLICY – PROPERTY SECTION – 01/23/2025 3253 Premium Determination","publish_date":null,"title":"PROPERTY SECTION PREMIUM DETERMINATION ÷ ÷ ÷ ÷ ÷","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page115.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page115.pdf"},"request":{"example_id":"table/FBLB-134215544_page115","product_type":"parse","source_file_path":"FBLB-134215544_page115.pdf"},"started_at":"2026-11-04T19:47:35.013239"} +{"completed_at":"2026-11-04T19:47:37.959673","latency_in_ms":1622,"output":{"example_id":"table/FBLB-134215544_page122","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\n**Utah Property ZC Factors** HPP, HPPO, MHPP, MHPPO, Condo **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84001 1.157 0.712 0.919 1.112 0.908 0.857 0.801 NA 84002 3.804 0.712 0.946 1.112 0.908 0.857 0.754 NA 84003 1.463 0.902 0.919 0.973 0.938 0.961 1.064 NA 84004 2.222 0.902 0.919 1.027 1.012 0.995 1.136 NA 84005 5.000 0.825 0.887 0.903 0.838 0.890 0.922 NA 84006 4.858 1.132 0.919 0.999 0.938 1.084 1.064 NA 84007 1.184 0.712 0.919 1.112 0.908 0.857 0.754 NA 84008 1.018 0.785 1.028 1.087 0.938 0.890 0.801 NA 84009 1.018 1.038 0.919 0.946 0.908 0.961 1.547 NA 84010 1.154 1.464 0.982 1.027 1.292 1.208 1.313 NA 84011 0.766 1.464 0.982 1.027 1.292 1.208 1.313 NA 84013 5.000 0.902 0.887 0.946 0.838 0.890 0.866 NA 84014 1.724 1.661 1.060 0.999 1.049 1.084 1.064 NA 84015 1.073 1.132 1.123 0.946 0.938 0.995 0.866 NA 84016 1.046 1.132 1.123 0.946 0.938 0.995 0.866 NA 84017 2.608 0.862 0.946 1.165 1.049 0.995 0.801 NA 84018 4.554 0.940 0.946 1.165 1.099 0.961 0.922 NA 84020 4.363 0.902 0.919 0.999 0.938 0.933 1.424 NA 84021 1.245 0.753 0.919 1.112 0.938 0.913 0.801 NA 84022 1.252 1.075 0.887 0.999 0.977 1.138 0.866 NA 84023 2.620 0.785 1.060 1.112 0.938 0.890 0.703 NA 84024 1.018 0.978 0.946 1.165 1.049 1.047 0.922 NA 84025 1.516 1.661 1.565 1.165 1.134 1.138 0.866 NA 84026 1.129 0.753 0.982 1.137 0.908 0.857 0.754 NA 84027 1.667 0.862 0.887 1.137 0.938 0.913 0.922 NA 84028 1.481 0.940 1.123 1.027 1.099 1.047 1.313 NA 84029 1.288 1.038 0.919 0.946 0.938 1.047 1.064 NA 84031 1.061 0.753 0.946 1.165 1.012 0.913 0.801 NA 84032 1.245 0.785 0.946 1.087 1.012 0.995 1.002 NA 84033 1.324 0.940 0.982 1.189 1.099 1.047 0.922 NA 84034 1.131 0.825 0.919 0.999 1.049 1.047 1.002 NA 84035 1.044 0.785 1.028 1.087 0.938 0.890 0.801 NA 84036 1.794 0.825 0.946 1.165 1.049 0.995 0.866 NA 84037 1.376 1.661 1.237 0.999 0.977 0.961 0.922 NA 84038 1.280 0.862 1.060 1.042 1.099 0.995 0.703 NA 84039 1.691 0.825 1.060 1.137 0.977 0.961 0.754 NA 84040 1.044 1.661 1.321 1.054 1.012 0.995 1.002 NA 84041 1.172 1.327 1.123 0.946 0.977 0.961 0.922 NA 84042 1.270 0.940 0.919 0.999 0.938 0.961 1.002 NA 84043 1.362 0.862 0.887 0.946 0.876 0.913 1.002 NA 84044 1.008 1.132 0.887 0.999 0.977 1.047 2.038 NA 84045 4.626 0.825 0.887 0.903 0.838 0.890 0.922 NA 84046 1.152 0.785 1.028 1.112 0.938 0.857 0.703 NA 84047 0.931 0.978 0.919 0.973 0.977 0.933 1.708 NA 84049 2.317 0.862 0.982 1.248 1.099 1.084 1.064 NA 84050 2.011 1.038 0.982 1.165 1.134 1.084 1.002 NA 84051 1.322 0.712 0.887 1.137 0.938 0.890 0.866 NA 84052 1.251 0.753 0.919 1.087 0.876 0.814 0.754 NA 84053 1.369 0.753 0.982 1.112 0.876 0.857 0.801 NA 84054 1.245 1.265 0.919 0.973 1.049 1.047 1.547 NA 84055 1.317 0.862 0.919 1.248 1.012 0.933 0.922 NA 84056 0.898 1.190 1.123 0.946 1.012 1.018 0.922 NA 84057 1.277 0.902 0.919 0.973 0.938 0.961 0.922 NA 84058 1.620 0.902 0.946 0.973 0.938 0.961 0.922 NA 84059 1.466 0.902 0.919 0.973 0.938 0.961 0.922 NA 84060 1.987 0.862 0.919 1.112 1.012 0.961 1.313 NA 84061 2.134 0.825 0.946 1.189 1.049 0.961 0.922 NA 84062 2.372 0.902 0.946 1.027 1.012 0.995 1.002 NA 84063 1.310 0.825 0.982 1.112 0.908 0.890 0.801 NA 84064 1.155 0.785 0.982 0.903 0.977 0.913 1.064 NA 84065 1.768 0.902 0.887 0.946 0.876 0.890 1.064 NA 84066 1.246 0.753 0.946 1.112 0.876 0.890 0.801 NA 84067 1.018 1.265 1.060 1.054 1.198 1.208 1.064 NA\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3358 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\n**Utah Property ZC Factors** HPP, HPPO, MHPP, MHPPO, Condo **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84001 1.157 0.712 0.919 1.112 0.908 0.857 0.801 NA 84002 3.804 0.712 0.946 1.112 0.908 0.857 0.754 NA 84003 1.463 0.902 0.919 0.973 0.938 0.961 1.064 NA 84004 2.222 0.902 0.919 1.027 1.012 0.995 1.136 NA 84005 5.000 0.825 0.887 0.903 0.838 0.890 0.922 NA 84006 4.858 1.132 0.919 0.999 0.938 1.084 1.064 NA 84007 1.184 0.712 0.919 1.112 0.908 0.857 0.754 NA 84008 1.018 0.785 1.028 1.087 0.938 0.890 0.801 NA 84009 1.018 1.038 0.919 0.946 0.908 0.961 1.547 NA 84010 1.154 1.464 0.982 1.027 1.292 1.208 1.313 NA 84011 0.766 1.464 0.982 1.027 1.292 1.208 1.313 NA 84013 5.000 0.902 0.887 0.946 0.838 0.890 0.866 NA 84014 1.724 1.661 1.060 0.999 1.049 1.084 1.064 NA 84015 1.073 1.132 1.123 0.946 0.938 0.995 0.866 NA 84016 1.046 1.132 1.123 0.946 0.938 0.995 0.866 NA 84017 2.608 0.862 0.946 1.165 1.049 0.995 0.801 NA 84018 4.554 0.940 0.946 1.165 1.099 0.961 0.922 NA 84020 4.363 0.902 0.919 0.999 0.938 0.933 1.424 NA 84021 1.245 0.753 0.919 1.112 0.938 0.913 0.801 NA 84022 1.252 1.075 0.887 0.999 0.977 1.138 0.866 NA 84023 2.620 0.785 1.060 1.112 0.938 0.890 0.703 NA 84024 1.018 0.978 0.946 1.165 1.049 1.047 0.922 NA 84025 1.516 1.661 1.565 1.165 1.134 1.138 0.866 NA 84026 1.129 0.753 0.982 1.137 0.908 0.857 0.754 NA 84027 1.667 0.862 0.887 1.137 0.938 0.913 0.922 NA 84028 1.481 0.940 1.123 1.027 1.099 1.047 1.313 NA 84029 1.288 1.038 0.919 0.946 0.938 1.047 1.064 NA 84031 1.061 0.753 0.946 1.165 1.012 0.913 0.801 NA 84032 1.245 0.785 0.946 1.087 1.012 0.995 1.002 NA 84033 1.324 0.940 0.982 1.189 1.099 1.047 0.922 NA 84034 1.131 0.825 0.919 0.999 1.049 1.047 1.002 NA 84035 1.044 0.785 1.028 1.087 0.938 0.890 0.801 NA 84036 1.794 0.825 0.946 1.165 1.049 0.995 0.866 NA 84037 1.376 1.661 1.237 0.999 0.977 0.961 0.922 NA 84038 1.280 0.862 1.060 1.042 1.099 0.995 0.703 NA 84039 1.691 0.825 1.060 1.137 0.977 0.961 0.754 NA 84040 1.044 1.661 1.321 1.054 1.012 0.995 1.002 NA 84041 1.172 1.327 1.123 0.946 0.977 0.961 0.922 NA 84042 1.270 0.940 0.919 0.999 0.938 0.961 1.002 NA 84043 1.362 0.862 0.887 0.946 0.876 0.913 1.002 NA 84044 1.008 1.132 0.887 0.999 0.977 1.047 2.038 NA 84045 4.626 0.825 0.887 0.903 0.838 0.890 0.922 NA 84046 1.152 0.785 1.028 1.112 0.938 0.857 0.703 NA 84047 0.931 0.978 0.919 0.973 0.977 0.933 1.708 NA 84049 2.317 0.862 0.982 1.248 1.099 1.084 1.064 NA 84050 2.011 1.038 0.982 1.165 1.134 1.084 1.002 NA 84051 1.322 0.712 0.887 1.137 0.938 0.890 0.866 NA 84052 1.251 0.753 0.919 1.087 0.876 0.814 0.754 NA 84053 1.369 0.753 0.982 1.112 0.876 0.857 0.801 NA 84054 1.245 1.265 0.919 0.973 1.049 1.047 1.547 NA 84055 1.317 0.862 0.919 1.248 1.012 0.933 0.922 NA 84056 0.898 1.190 1.123 0.946 1.012 1.018 0.922 NA 84057 1.277 0.902 0.919 0.973 0.938 0.961 0.922 NA 84058 1.620 0.902 0.946 0.973 0.938 0.961 0.922 NA 84059 1.466 0.902 0.919 0.973 0.938 0.961 0.922 NA 84060 1.987 0.862 0.919 1.112 1.012 0.961 1.313 NA 84061 2.134 0.825 0.946 1.189 1.049 0.961 0.922 NA 84062 2.372 0.902 0.946 1.027 1.012 0.995 1.002 NA 84063 1.310 0.825 0.982 1.112 0.908 0.890 0.801 NA 84064 1.155 0.785 0.982 0.903 0.977 0.913 1.064 NA 84065 1.768 0.902 0.887 0.946 0.876 0.890 1.064 NA 84066 1.246 0.753 0.946 1.112 0.876 0.890 0.801 NA 84067 1.018 1.265 1.060 1.054 1.198 1.208 1.064 NA\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3358 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\n**Utah Property ZC Factors** HPP, HPPO, MHPP, MHPPO, Condo **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84001 1.157 0.712 0.919 1.112 0.908 0.857 0.801 NA 84002 3.804 0.712 0.946 1.112 0.908 0.857 0.754 NA 84003 1.463 0.902 0.919 0.973 0.938 0.961 1.064 NA 84004 2.222 0.902 0.919 1.027 1.012 0.995 1.136 NA 84005 5.000 0.825 0.887 0.903 0.838 0.890 0.922 NA 84006 4.858 1.132 0.919 0.999 0.938 1.084 1.064 NA 84007 1.184 0.712 0.919 1.112 0.908 0.857 0.754 NA 84008 1.018 0.785 1.028 1.087 0.938 0.890 0.801 NA 84009 1.018 1.038 0.919 0.946 0.908 0.961 1.547 NA 84010 1.154 1.464 0.982 1.027 1.292 1.208 1.313 NA 84011 0.766 1.464 0.982 1.027 1.292 1.208 1.313 NA 84013 5.000 0.902 0.887 0.946 0.838 0.890 0.866 NA 84014 1.724 1.661 1.060 0.999 1.049 1.084 1.064 NA 84015 1.073 1.132 1.123 0.946 0.938 0.995 0.866 NA 84016 1.046 1.132 1.123 0.946 0.938 0.995 0.866 NA 84017 2.608 0.862 0.946 1.165 1.049 0.995 0.801 NA 84018 4.554 0.940 0.946 1.165 1.099 0.961 0.922 NA 84020 4.363 0.902 0.919 0.999 0.938 0.933 1.424 NA 84021 1.245 0.753 0.919 1.112 0.938 0.913 0.801 NA 84022 1.252 1.075 0.887 0.999 0.977 1.138 0.866 NA 84023 2.620 0.785 1.060 1.112 0.938 0.890 0.703 NA 84024 1.018 0.978 0.946 1.165 1.049 1.047 0.922 NA 84025 1.516 1.661 1.565 1.165 1.134 1.138 0.866 NA 84026 1.129 0.753 0.982 1.137 0.908 0.857 0.754 NA 84027 1.667 0.862 0.887 1.137 0.938 0.913 0.922 NA 84028 1.481 0.940 1.123 1.027 1.099 1.047 1.313 NA 84029 1.288 1.038 0.919 0.946 0.938 1.047 1.064 NA 84031 1.061 0.753 0.946 1.165 1.012 0.913 0.801 NA 84032 1.245 0.785 0.946 1.087 1.012 0.995 1.002 NA 84033 1.324 0.940 0.982 1.189 1.099 1.047 0.922 NA 84034 1.131 0.825 0.919 0.999 1.049 1.047 1.002 NA 84035 1.044 0.785 1.028 1.087 0.938 0.890 0.801 NA 84036 1.794 0.825 0.946 1.165 1.049 0.995 0.866 NA 84037 1.376 1.661 1.237 0.999 0.977 0.961 0.922 NA 84038 1.280 0.862 1.060 1.042 1.099 0.995 0.703 NA 84039 1.691 0.825 1.060 1.137 0.977 0.961 0.754 NA 84040 1.044 1.661 1.321 1.054 1.012 0.995 1.002 NA 84041 1.172 1.327 1.123 0.946 0.977 0.961 0.922 NA 84042 1.270 0.940 0.919 0.999 0.938 0.961 1.002 NA 84043 1.362 0.862 0.887 0.946 0.876 0.913 1.002 NA 84044 1.008 1.132 0.887 0.999 0.977 1.047 2.038 NA 84045 4.626 0.825 0.887 0.903 0.838 0.890 0.922 NA 84046 1.152 0.785 1.028 1.112 0.938 0.857 0.703 NA 84047 0.931 0.978 0.919 0.973 0.977 0.933 1.708 NA 84049 2.317 0.862 0.982 1.248 1.099 1.084 1.064 NA 84050 2.011 1.038 0.982 1.165 1.134 1.084 1.002 NA 84051 1.322 0.712 0.887 1.137 0.938 0.890 0.866 NA 84052 1.251 0.753 0.919 1.087 0.876 0.814 0.754 NA 84053 1.369 0.753 0.982 1.112 0.876 0.857 0.801 NA 84054 1.245 1.265 0.919 0.973 1.049 1.047 1.547 NA 84055 1.317 0.862 0.919 1.248 1.012 0.933 0.922 NA 84056 0.898 1.190 1.123 0.946 1.012 1.018 0.922 NA 84057 1.277 0.902 0.919 0.973 0.938 0.961 0.922 NA 84058 1.620 0.902 0.946 0.973 0.938 0.961 0.922 NA 84059 1.466 0.902 0.919 0.973 0.938 0.961 0.922 NA 84060 1.987 0.862 0.919 1.112 1.012 0.961 1.313 NA 84061 2.134 0.825 0.946 1.189 1.049 0.961 0.922 NA 84062 2.372 0.902 0.946 1.027 1.012 0.995 1.002 NA 84063 1.310 0.825 0.982 1.112 0.908 0.890 0.801 NA 84064 1.155 0.785 0.982 0.903 0.977 0.913 1.064 NA 84065 1.768 0.902 0.887 0.946 0.876 0.890 1.064 NA 84066 1.246 0.753 0.946 1.112 0.876 0.890 0.801 NA 84067 1.018 1.265 1.060 1.054 1.198 1.208 1.064 NA\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3358 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page122.pdf"]},"response":{"errors":[],"extract_id":"extract_fe7d460963085a60ae33781400b3c98f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\n**Utah Property ZC Factors** HPP, HPPO, MHPP, MHPPO, Condo **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84001 1.157 0.712 0.919 1.112 0.908 0.857 0.801 NA 84002 3.804 0.712 0.946 1.112 0.908 0.857 0.754 NA 84003 1.463 0.902 0.919 0.973 0.938 0.961 1.064 NA 84004 2.222 0.902 0.919 1.027 1.012 0.995 1.136 NA 84005 5.000 0.825 0.887 0.903 0.838 0.890 0.922 NA 84006 4.858 1.132 0.919 0.999 0.938 1.084 1.064 NA 84007 1.184 0.712 0.919 1.112 0.908 0.857 0.754 NA 84008 1.018 0.785 1.028 1.087 0.938 0.890 0.801 NA 84009 1.018 1.038 0.919 0.946 0.908 0.961 1.547 NA 84010 1.154 1.464 0.982 1.027 1.292 1.208 1.313 NA 84011 0.766 1.464 0.982 1.027 1.292 1.208 1.313 NA 84013 5.000 0.902 0.887 0.946 0.838 0.890 0.866 NA 84014 1.724 1.661 1.060 0.999 1.049 1.084 1.064 NA 84015 1.073 1.132 1.123 0.946 0.938 0.995 0.866 NA 84016 1.046 1.132 1.123 0.946 0.938 0.995 0.866 NA 84017 2.608 0.862 0.946 1.165 1.049 0.995 0.801 NA 84018 4.554 0.940 0.946 1.165 1.099 0.961 0.922 NA 84020 4.363 0.902 0.919 0.999 0.938 0.933 1.424 NA 84021 1.245 0.753 0.919 1.112 0.938 0.913 0.801 NA 84022 1.252 1.075 0.887 0.999 0.977 1.138 0.866 NA 84023 2.620 0.785 1.060 1.112 0.938 0.890 0.703 NA 84024 1.018 0.978 0.946 1.165 1.049 1.047 0.922 NA 84025 1.516 1.661 1.565 1.165 1.134 1.138 0.866 NA 84026 1.129 0.753 0.982 1.137 0.908 0.857 0.754 NA 84027 1.667 0.862 0.887 1.137 0.938 0.913 0.922 NA 84028 1.481 0.940 1.123 1.027 1.099 1.047 1.313 NA 84029 1.288 1.038 0.919 0.946 0.938 1.047 1.064 NA 84031 1.061 0.753 0.946 1.165 1.012 0.913 0.801 NA 84032 1.245 0.785 0.946 1.087 1.012 0.995 1.002 NA 84033 1.324 0.940 0.982 1.189 1.099 1.047 0.922 NA 84034 1.131 0.825 0.919 0.999 1.049 1.047 1.002 NA 84035 1.044 0.785 1.028 1.087 0.938 0.890 0.801 NA 84036 1.794 0.825 0.946 1.165 1.049 0.995 0.866 NA 84037 1.376 1.661 1.237 0.999 0.977 0.961 0.922 NA 84038 1.280 0.862 1.060 1.042 1.099 0.995 0.703 NA 84039 1.691 0.825 1.060 1.137 0.977 0.961 0.754 NA 84040 1.044 1.661 1.321 1.054 1.012 0.995 1.002 NA 84041 1.172 1.327 1.123 0.946 0.977 0.961 0.922 NA 84042 1.270 0.940 0.919 0.999 0.938 0.961 1.002 NA 84043 1.362 0.862 0.887 0.946 0.876 0.913 1.002 NA 84044 1.008 1.132 0.887 0.999 0.977 1.047 2.038 NA 84045 4.626 0.825 0.887 0.903 0.838 0.890 0.922 NA 84046 1.152 0.785 1.028 1.112 0.938 0.857 0.703 NA 84047 0.931 0.978 0.919 0.973 0.977 0.933 1.708 NA 84049 2.317 0.862 0.982 1.248 1.099 1.084 1.064 NA 84050 2.011 1.038 0.982 1.165 1.134 1.084 1.002 NA 84051 1.322 0.712 0.887 1.137 0.938 0.890 0.866 NA 84052 1.251 0.753 0.919 1.087 0.876 0.814 0.754 NA 84053 1.369 0.753 0.982 1.112 0.876 0.857 0.801 NA 84054 1.245 1.265 0.919 0.973 1.049 1.047 1.547 NA 84055 1.317 0.862 0.919 1.248 1.012 0.933 0.922 NA 84056 0.898 1.190 1.123 0.946 1.012 1.018 0.922 NA 84057 1.277 0.902 0.919 0.973 0.938 0.961 0.922 NA 84058 1.620 0.902 0.946 0.973 0.938 0.961 0.922 NA 84059 1.466 0.902 0.919 0.973 0.938 0.961 0.922 NA 84060 1.987 0.862 0.919 1.112 1.012 0.961 1.313 NA 84061 2.134 0.825 0.946 1.189 1.049 0.961 0.922 NA 84062 2.372 0.902 0.946 1.027 1.012 0.995 1.002 NA 84063 1.310 0.825 0.982 1.112 0.908 0.890 0.801 NA 84064 1.155 0.785 0.982 0.903 0.977 0.913 1.064 NA 84065 1.768 0.902 0.887 0.946 0.876 0.890 1.064 NA 84066 1.246 0.753 0.946 1.112 0.876 0.890 0.801 NA 84067 1.018 1.265 1.060 1.054 1.198 1.208 1.064 NA\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3358 Rates and Factors"],"full_content":"**Property Section Rates and Factors**\n\n**Utah Property ZC Factors** HPP, HPPO, MHPP, MHPPO, Condo **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84001 1.157 0.712 0.919 1.112 0.908 0.857 0.801 NA 84002 3.804 0.712 0.946 1.112 0.908 0.857 0.754 NA 84003 1.463 0.902 0.919 0.973 0.938 0.961 1.064 NA 84004 2.222 0.902 0.919 1.027 1.012 0.995 1.136 NA 84005 5.000 0.825 0.887 0.903 0.838 0.890 0.922 NA 84006 4.858 1.132 0.919 0.999 0.938 1.084 1.064 NA 84007 1.184 0.712 0.919 1.112 0.908 0.857 0.754 NA 84008 1.018 0.785 1.028 1.087 0.938 0.890 0.801 NA 84009 1.018 1.038 0.919 0.946 0.908 0.961 1.547 NA 84010 1.154 1.464 0.982 1.027 1.292 1.208 1.313 NA 84011 0.766 1.464 0.982 1.027 1.292 1.208 1.313 NA 84013 5.000 0.902 0.887 0.946 0.838 0.890 0.866 NA 84014 1.724 1.661 1.060 0.999 1.049 1.084 1.064 NA 84015 1.073 1.132 1.123 0.946 0.938 0.995 0.866 NA 84016 1.046 1.132 1.123 0.946 0.938 0.995 0.866 NA 84017 2.608 0.862 0.946 1.165 1.049 0.995 0.801 NA 84018 4.554 0.940 0.946 1.165 1.099 0.961 0.922 NA 84020 4.363 0.902 0.919 0.999 0.938 0.933 1.424 NA 84021 1.245 0.753 0.919 1.112 0.938 0.913 0.801 NA 84022 1.252 1.075 0.887 0.999 0.977 1.138 0.866 NA 84023 2.620 0.785 1.060 1.112 0.938 0.890 0.703 NA 84024 1.018 0.978 0.946 1.165 1.049 1.047 0.922 NA 84025 1.516 1.661 1.565 1.165 1.134 1.138 0.866 NA 84026 1.129 0.753 0.982 1.137 0.908 0.857 0.754 NA 84027 1.667 0.862 0.887 1.137 0.938 0.913 0.922 NA 84028 1.481 0.940 1.123 1.027 1.099 1.047 1.313 NA 84029 1.288 1.038 0.919 0.946 0.938 1.047 1.064 NA 84031 1.061 0.753 0.946 1.165 1.012 0.913 0.801 NA 84032 1.245 0.785 0.946 1.087 1.012 0.995 1.002 NA 84033 1.324 0.940 0.982 1.189 1.099 1.047 0.922 NA 84034 1.131 0.825 0.919 0.999 1.049 1.047 1.002 NA 84035 1.044 0.785 1.028 1.087 0.938 0.890 0.801 NA 84036 1.794 0.825 0.946 1.165 1.049 0.995 0.866 NA 84037 1.376 1.661 1.237 0.999 0.977 0.961 0.922 NA 84038 1.280 0.862 1.060 1.042 1.099 0.995 0.703 NA 84039 1.691 0.825 1.060 1.137 0.977 0.961 0.754 NA 84040 1.044 1.661 1.321 1.054 1.012 0.995 1.002 NA 84041 1.172 1.327 1.123 0.946 0.977 0.961 0.922 NA 84042 1.270 0.940 0.919 0.999 0.938 0.961 1.002 NA 84043 1.362 0.862 0.887 0.946 0.876 0.913 1.002 NA 84044 1.008 1.132 0.887 0.999 0.977 1.047 2.038 NA 84045 4.626 0.825 0.887 0.903 0.838 0.890 0.922 NA 84046 1.152 0.785 1.028 1.112 0.938 0.857 0.703 NA 84047 0.931 0.978 0.919 0.973 0.977 0.933 1.708 NA 84049 2.317 0.862 0.982 1.248 1.099 1.084 1.064 NA 84050 2.011 1.038 0.982 1.165 1.134 1.084 1.002 NA 84051 1.322 0.712 0.887 1.137 0.938 0.890 0.866 NA 84052 1.251 0.753 0.919 1.087 0.876 0.814 0.754 NA 84053 1.369 0.753 0.982 1.112 0.876 0.857 0.801 NA 84054 1.245 1.265 0.919 0.973 1.049 1.047 1.547 NA 84055 1.317 0.862 0.919 1.248 1.012 0.933 0.922 NA 84056 0.898 1.190 1.123 0.946 1.012 1.018 0.922 NA 84057 1.277 0.902 0.919 0.973 0.938 0.961 0.922 NA 84058 1.620 0.902 0.946 0.973 0.938 0.961 0.922 NA 84059 1.466 0.902 0.919 0.973 0.938 0.961 0.922 NA 84060 1.987 0.862 0.919 1.112 1.012 0.961 1.313 NA 84061 2.134 0.825 0.946 1.189 1.049 0.961 0.922 NA 84062 2.372 0.902 0.946 1.027 1.012 0.995 1.002 NA 84063 1.310 0.825 0.982 1.112 0.908 0.890 0.801 NA 84064 1.155 0.785 0.982 0.903 0.977 0.913 1.064 NA 84065 1.768 0.902 0.887 0.946 0.876 0.890 1.064 NA 84066 1.246 0.753 0.946 1.112 0.876 0.890 0.801 NA 84067 1.018 1.265 1.060 1.054 1.198 1.208 1.064 NA\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3358 Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page122.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page122.pdf"},"request":{"example_id":"table/FBLB-134215544_page122","product_type":"parse","source_file_path":"FBLB-134215544_page122.pdf"},"started_at":"2026-11-04T19:47:36.337607"} +{"completed_at":"2026-11-04T19:47:39.232759","latency_in_ms":1947,"output":{"example_id":"table/FBLB-134215544_page14","grounded_pages":[],"layout_pages":[],"markdown":"**Liability Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Primary Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 Years Y N Y N 1 Year Non-Farm 1.000 1.000 0 Years 2 Years Non-Farm 0.980 0.980 1 Year 3 Years Non-Farm 0.980 0.980 2 Years 4 Years Non-Farm 0.970 0.970 3 Years 5 Years Non-Farm 0.970 0.970 4 Years 6 Years Non-Farm 0.960 0.960 5 Years 7 Years Non-Farm 0.960 0.960 6 Years 8 Years Non-Farm 0.950 0.950 7 Years 9 Years Non-Farm 0.950 0.950 8 Years 10 Years Non-Farm 0.940 0.940 9 Years 11 Years Non-Farm 0.940 0.940 10+ Years 12 Years Non-Farm 0.940 0.940 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\n**Factors Used in Determining the Liability/Medical Multiplier - Continued**\n\n43 1.000\n\n36\n\n50\n\n90 1.560 40 0.980 91 1.560 39 0.970\n\n88 1.550 38 0.970\n\n**Ag Advantage Factors**\n\n0\\.950 11\n\n13 0.950\n\n15 0.950 0.950\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n19 0.950 0.950\n\n0\\.950 12\n\n14\n\n17 0.950 18\n\n86\n\n80 1.430 81 1.440\n\nLevel Factors **Underwriting Level Factors Underwriting Level Factors** Level Factors\n\n0\\.960 33\n\n29 0.950 30 31 32 0.950 0.950\n\n26\n\n21\n\n23\n\n0\\.950\n\n24\n\n22\n\n20\n\n0\\.950\n\n70 1.160 71 1.200 72\n\n52 1.000\n\n1\\.000\n\n37\n\n9\n\n0\\.910 5 0.900\n\n1 0.860\n\n3\n\n28\n\n0\\.960 35\n\n0\\.950\n\n27 0.950 0.950\n\n74 1.270 75 1.290\n\n89 1.560 0.970\n\n0\\.980\n\n34 0.960\n\n45 1.000\n\n94 1.600 95 1.610\n\n41\n\n82 1.450\n\n0\\.950\n\n1\\.000\n\n57 1.000 58 1.000\n\n73 1.220\n\n7 0.920 8 0.930\n\n0\\.950\n\n10\n\n0\\.950\n\n0\\.940\n\n6\n\n83 1.500 84 1.510\n\n25 0.950\n\n1\\.210\n\n68\n\n2\n\n4 0.880 0.870\n\n0\\.890\n\n60\n\n76 1.340 77 1.360 78 1.400\n\n55 1.000 56 1.000\n\n1\\.000\n\n61 1.000 62 1.000\n\n59 1.000\n\n66 1.060 67 1.090\n\n79 1.420\n\n1\\.000 54 1.000 53\n\n51 1.000\n\n1\\.000 48 1.000 47\n\n96 1.620 46 1.000 97 1.640\n\n85 1.520\n\n65 1.040 64 1.000 63\n\n98 1.660 99 1.680\n\n16\n\n100 1.700 998 1.000\n\n87 1.540\n\n1\\.110 69 1.140\n\n1\\.000 Factor Date Prior to 06/23/15\n\n**Policy Inception Date Factor**\n\n06/23/15 or Later 1.000\n\n999 1.000\n\n49 1.000\n\n92 1.570 42 0.990 93 1.580\n\n44 1.000\n\n1\\.530\n\nSmall Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000 0.990 0.990 1.000 1.000 0.980 0.980\n\n1\\.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\n1\\.000 1.000 0.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2302 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Liability Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Primary Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 Years Y N Y N 1 Year Non-Farm 1.000 1.000 0 Years 2 Years Non-Farm 0.980 0.980 1 Year 3 Years Non-Farm 0.980 0.980 2 Years 4 Years Non-Farm 0.970 0.970 3 Years 5 Years Non-Farm 0.970 0.970 4 Years 6 Years Non-Farm 0.960 0.960 5 Years 7 Years Non-Farm 0.960 0.960 6 Years 8 Years Non-Farm 0.950 0.950 7 Years 9 Years Non-Farm 0.950 0.950 8 Years 10 Years Non-Farm 0.940 0.940 9 Years 11 Years Non-Farm 0.940 0.940 10+ Years 12 Years Non-Farm 0.940 0.940 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\n**Factors Used in Determining the Liability/Medical Multiplier - Continued**\n\n43 1.000\n\n36\n\n50\n\n90 1.560 40 0.980 91 1.560 39 0.970\n\n88 1.550 38 0.970\n\n**Ag Advantage Factors**\n\n0\\.950 11\n\n13 0.950\n\n15 0.950 0.950\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n19 0.950 0.950\n\n0\\.950 12\n\n14\n\n17 0.950 18\n\n86\n\n80 1.430 81 1.440\n\nLevel Factors **Underwriting Level Factors Underwriting Level Factors** Level Factors\n\n0\\.960 33\n\n29 0.950 30 31 32 0.950 0.950\n\n26\n\n21\n\n23\n\n0\\.950\n\n24\n\n22\n\n20\n\n0\\.950\n\n70 1.160 71 1.200 72\n\n52 1.000\n\n1\\.000\n\n37\n\n9\n\n0\\.910 5 0.900\n\n1 0.860\n\n3\n\n28\n\n0\\.960 35\n\n0\\.950\n\n27 0.950 0.950\n\n74 1.270 75 1.290\n\n89 1.560 0.970\n\n0\\.980\n\n34 0.960\n\n45 1.000\n\n94 1.600 95 1.610\n\n41\n\n82 1.450\n\n0\\.950\n\n1\\.000\n\n57 1.000 58 1.000\n\n73 1.220\n\n7 0.920 8 0.930\n\n0\\.950\n\n10\n\n0\\.950\n\n0\\.940\n\n6\n\n83 1.500 84 1.510\n\n25 0.950\n\n1\\.210\n\n68\n\n2\n\n4 0.880 0.870\n\n0\\.890\n\n60\n\n76 1.340 77 1.360 78 1.400\n\n55 1.000 56 1.000\n\n1\\.000\n\n61 1.000 62 1.000\n\n59 1.000\n\n66 1.060 67 1.090\n\n79 1.420\n\n1\\.000 54 1.000 53\n\n51 1.000\n\n1\\.000 48 1.000 47\n\n96 1.620 46 1.000 97 1.640\n\n85 1.520\n\n65 1.040 64 1.000 63\n\n98 1.660 99 1.680\n\n16\n\n100 1.700 998 1.000\n\n87 1.540\n\n1\\.110 69 1.140\n\n1\\.000 Factor Date Prior to 06/23/15\n\n**Policy Inception Date Factor**\n\n06/23/15 or Later 1.000\n\n999 1.000\n\n49 1.000\n\n92 1.570 42 0.990 93 1.580\n\n44 1.000\n\n1\\.530\n\nSmall Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000 0.990 0.990 1.000 1.000 0.980 0.980\n\n1\\.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\n1\\.000 1.000 0.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2302 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Liability Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Primary Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 Years Y N Y N 1 Year Non-Farm 1.000 1.000 0 Years 2 Years Non-Farm 0.980 0.980 1 Year 3 Years Non-Farm 0.980 0.980 2 Years 4 Years Non-Farm 0.970 0.970 3 Years 5 Years Non-Farm 0.970 0.970 4 Years 6 Years Non-Farm 0.960 0.960 5 Years 7 Years Non-Farm 0.960 0.960 6 Years 8 Years Non-Farm 0.950 0.950 7 Years 9 Years Non-Farm 0.950 0.950 8 Years 10 Years Non-Farm 0.940 0.940 9 Years 11 Years Non-Farm 0.940 0.940 10+ Years 12 Years Non-Farm 0.940 0.940 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\n**Factors Used in Determining the Liability/Medical Multiplier - Continued**\n\n43 1.000\n\n36\n\n50\n\n90 1.560 40 0.980 91 1.560 39 0.970\n\n88 1.550 38 0.970\n\n**Ag Advantage Factors**\n\n0\\.950 11\n\n13 0.950\n\n15 0.950 0.950\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n19 0.950 0.950\n\n0\\.950 12\n\n14\n\n17 0.950 18\n\n86\n\n80 1.430 81 1.440\n\nLevel Factors **Underwriting Level Factors Underwriting Level Factors** Level Factors\n\n0\\.960 33\n\n29 0.950 30 31 32 0.950 0.950\n\n26\n\n21\n\n23\n\n0\\.950\n\n24\n\n22\n\n20\n\n0\\.950\n\n70 1.160 71 1.200 72\n\n52 1.000\n\n1\\.000\n\n37\n\n9\n\n0\\.910 5 0.900\n\n1 0.860\n\n3\n\n28\n\n0\\.960 35\n\n0\\.950\n\n27 0.950 0.950\n\n74 1.270 75 1.290\n\n89 1.560 0.970\n\n0\\.980\n\n34 0.960\n\n45 1.000\n\n94 1.600 95 1.610\n\n41\n\n82 1.450\n\n0\\.950\n\n1\\.000\n\n57 1.000 58 1.000\n\n73 1.220\n\n7 0.920 8 0.930\n\n0\\.950\n\n10\n\n0\\.950\n\n0\\.940\n\n6\n\n83 1.500 84 1.510\n\n25 0.950\n\n1\\.210\n\n68\n\n2\n\n4 0.880 0.870\n\n0\\.890\n\n60\n\n76 1.340 77 1.360 78 1.400\n\n55 1.000 56 1.000\n\n1\\.000\n\n61 1.000 62 1.000\n\n59 1.000\n\n66 1.060 67 1.090\n\n79 1.420\n\n1\\.000 54 1.000 53\n\n51 1.000\n\n1\\.000 48 1.000 47\n\n96 1.620 46 1.000 97 1.640\n\n85 1.520\n\n65 1.040 64 1.000 63\n\n98 1.660 99 1.680\n\n16\n\n100 1.700 998 1.000\n\n87 1.540\n\n1\\.110 69 1.140\n\n1\\.000 Factor Date Prior to 06/23/15\n\n**Policy Inception Date Factor**\n\n06/23/15 or Later 1.000\n\n999 1.000\n\n49 1.000\n\n92 1.570 42 0.990 93 1.580\n\n44 1.000\n\n1\\.530\n\nSmall Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000 0.990 0.990 1.000 1.000 0.980 0.980\n\n1\\.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\n1\\.000 1.000 0.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2302 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page14.pdf"]},"response":{"errors":[],"extract_id":"extract_b8da55147728890bf671c71bcc190ea5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Liability Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Primary Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 Years Y N Y N 1 Year Non-Farm 1.000 1.000 0 Years 2 Years Non-Farm 0.980 0.980 1 Year 3 Years Non-Farm 0.980 0.980 2 Years 4 Years Non-Farm 0.970 0.970 3 Years 5 Years Non-Farm 0.970 0.970 4 Years 6 Years Non-Farm 0.960 0.960 5 Years 7 Years Non-Farm 0.960 0.960 6 Years 8 Years Non-Farm 0.950 0.950 7 Years 9 Years Non-Farm 0.950 0.950 8 Years 10 Years Non-Farm 0.940 0.940 9 Years 11 Years Non-Farm 0.940 0.940 10+ Years 12 Years Non-Farm 0.940 0.940 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\n**Factors Used in Determining the Liability/Medical Multiplier - Continued**\n\n43 1.000\n\n36\n\n50\n\n90 1.560 40 0.980 91 1.560 39 0.970\n\n88 1.550 38 0.970\n\n**Ag Advantage Factors**\n\n0\\.950 11\n\n13 0.950\n\n15 0.950 0.950\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n19 0.950 0.950\n\n0\\.950 12\n\n14\n\n17 0.950 18\n\n86\n\n80 1.430 81 1.440\n\nLevel Factors **Underwriting Level Factors Underwriting Level Factors** Level Factors\n\n0\\.960 33\n\n29 0.950 30 31 32 0.950 0.950\n\n26\n\n21\n\n23\n\n0\\.950\n\n24\n\n22\n\n20\n\n0\\.950\n\n70 1.160 71 1.200 72\n\n52 1.000\n\n1\\.000\n\n37\n\n9\n\n0\\.910 5 0.900\n\n1 0.860\n\n3\n\n28\n\n0\\.960 35\n\n0\\.950\n\n27 0.950 0.950\n\n74 1.270 75 1.290\n\n89 1.560 0.970\n\n0\\.980\n\n34 0.960\n\n45 1.000\n\n94 1.600 95 1.610\n\n41\n\n82 1.450\n\n0\\.950\n\n1\\.000\n\n57 1.000 58 1.000\n\n73 1.220\n\n7 0.920 8 0.930\n\n0\\.950\n\n10\n\n0\\.950\n\n0\\.940\n\n6\n\n83 1.500 84 1.510\n\n25 0.950\n\n1\\.210\n\n68\n\n2\n\n4 0.880 0.870\n\n0\\.890\n\n60\n\n76 1.340 77 1.360 78 1.400\n\n55 1.000 56 1.000\n\n1\\.000\n\n61 1.000 62 1.000\n\n59 1.000\n\n66 1.060 67 1.090\n\n79 1.420\n\n1\\.000 54 1.000 53\n\n51 1.000\n\n1\\.000 48 1.000 47\n\n96 1.620 46 1.000 97 1.640\n\n85 1.520\n\n65 1.040 64 1.000 63\n\n98 1.660 99 1.680\n\n16\n\n100 1.700 998 1.000\n\n87 1.540\n\n1\\.110 69 1.140\n\n1\\.000 Factor Date Prior to 06/23/15\n\n**Policy Inception Date Factor**\n\n06/23/15 or Later 1.000\n\n999 1.000\n\n49 1.000\n\n92 1.570 42 0.990 93 1.580\n\n44 1.000\n\n1\\.530\n\nSmall Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000 0.990 0.990 1.000 1.000 0.980 0.980\n\n1\\.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\n1\\.000 1.000 0.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2302 Rates and Factors"],"full_content":"**Liability Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Primary Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 Years Y N Y N 1 Year Non-Farm 1.000 1.000 0 Years 2 Years Non-Farm 0.980 0.980 1 Year 3 Years Non-Farm 0.980 0.980 2 Years 4 Years Non-Farm 0.970 0.970 3 Years 5 Years Non-Farm 0.970 0.970 4 Years 6 Years Non-Farm 0.960 0.960 5 Years 7 Years Non-Farm 0.960 0.960 6 Years 8 Years Non-Farm 0.950 0.950 7 Years 9 Years Non-Farm 0.950 0.950 8 Years 10 Years Non-Farm 0.940 0.940 9 Years 11 Years Non-Farm 0.940 0.940 10+ Years 12 Years Non-Farm 0.940 0.940 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\n**Factors Used in Determining the Liability/Medical Multiplier - Continued**\n\n43 1.000\n\n36\n\n50\n\n90 1.560 40 0.980 91 1.560 39 0.970\n\n88 1.550 38 0.970\n\n**Ag Advantage Factors**\n\n0\\.950 11\n\n13 0.950\n\n15 0.950 0.950\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n0\\.950\n\n19 0.950 0.950\n\n0\\.950 12\n\n14\n\n17 0.950 18\n\n86\n\n80 1.430 81 1.440\n\nLevel Factors **Underwriting Level Factors Underwriting Level Factors** Level Factors\n\n0\\.960 33\n\n29 0.950 30 31 32 0.950 0.950\n\n26\n\n21\n\n23\n\n0\\.950\n\n24\n\n22\n\n20\n\n0\\.950\n\n70 1.160 71 1.200 72\n\n52 1.000\n\n1\\.000\n\n37\n\n9\n\n0\\.910 5 0.900\n\n1 0.860\n\n3\n\n28\n\n0\\.960 35\n\n0\\.950\n\n27 0.950 0.950\n\n74 1.270 75 1.290\n\n89 1.560 0.970\n\n0\\.980\n\n34 0.960\n\n45 1.000\n\n94 1.600 95 1.610\n\n41\n\n82 1.450\n\n0\\.950\n\n1\\.000\n\n57 1.000 58 1.000\n\n73 1.220\n\n7 0.920 8 0.930\n\n0\\.950\n\n10\n\n0\\.950\n\n0\\.940\n\n6\n\n83 1.500 84 1.510\n\n25 0.950\n\n1\\.210\n\n68\n\n2\n\n4 0.880 0.870\n\n0\\.890\n\n60\n\n76 1.340 77 1.360 78 1.400\n\n55 1.000 56 1.000\n\n1\\.000\n\n61 1.000 62 1.000\n\n59 1.000\n\n66 1.060 67 1.090\n\n79 1.420\n\n1\\.000 54 1.000 53\n\n51 1.000\n\n1\\.000 48 1.000 47\n\n96 1.620 46 1.000 97 1.640\n\n85 1.520\n\n65 1.040 64 1.000 63\n\n98 1.660 99 1.680\n\n16\n\n100 1.700 998 1.000\n\n87 1.540\n\n1\\.110 69 1.140\n\n1\\.000 Factor Date Prior to 06/23/15\n\n**Policy Inception Date Factor**\n\n06/23/15 or Later 1.000\n\n999 1.000\n\n49 1.000\n\n92 1.570 42 0.990 93 1.580\n\n44 1.000\n\n1\\.530\n\nSmall Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000 0.990 0.990 1.000 1.000 0.980 0.980\n\n1\\.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\n1\\.000 1.000 0.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2302 Rates and Factors","publish_date":null,"title":"Liability Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page14.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page14.pdf"},"request":{"example_id":"table/FBLB-134215544_page14","product_type":"parse","source_file_path":"FBLB-134215544_page14.pdf"},"started_at":"2026-11-04T19:47:37.284816"} +{"completed_at":"2026-11-04T19:47:40.533677","latency_in_ms":2504,"output":{"example_id":"table/FBLB-134215544_page147","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\n**Additional Factors Used in Rating**\n\n**Roofing Limitation Factor - Wood Shingles, Shakes, or Surfaces** Peril 2 Peril 3 Peril 8 Age of RPC, GRC, RPR, GRR, RPC,GRC, RPR,GRR, ACV,RPC, RPR,GRR, Occupancy Roof Peril 1 ACV FIX FIR ACV FIX FIR Peril 4 Peril 5 Peril 6 Peril 7 GRC,FIX FIR Primary/Seasonal/Unoccupied 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 1 1.000 1.000 0.996 0.996 1.000 0.987 0.987 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 2 1.000 1.000 0.993 0.993 1.000 0.974 0.974 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 3 1.000 1.000 0.989 0.989 1.000 0.961 0.961 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 4 1.000 1.000 0.986 0.986 1.000 0.948 0.948 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 5 1.000 1.000 0.982 0.982 1.000 0.935 0.935 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 6 1.000 1.000 0.978 0.978 1.000 0.922 0.922 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 7 1.000 1.000 0.975 0.975 1.000 0.909 0.909 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 8 1.000 1.000 0.971 0.971 1.000 0.896 0.896 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 9 1.000 1.000 0.967 0.967 1.000 0.883 0.883 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 10 1.000 1.000 0.964 0.964 1.000 0.870 0.870 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 11 1.000 1.000 0.960 0.960 1.000 0.857 0.857 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 12 1.000 1.000 0.957 0.957 1.000 0.844 0.844 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 13 1.000 1.000 0.953 0.953 1.000 0.831 0.831 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 14 1.000 1.000 0.949 0.949 1.000 0.818 0.818 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 15 1.000 1.000 0.946 0.946 1.000 0.805 0.805 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 16 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 17 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 18 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 19 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 20 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 21+ 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Owned Rented to Others 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 1 1.000 1.000 1.000 1.000 1.000 0.994 0.994 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 2 1.000 1.000 1.000 1.000 1.000 0.988 0.988 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 3 1.000 1.000 1.000 1.000 1.000 0.981 0.981 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 4 1.000 1.000 1.000 1.000 1.000 0.975 0.975 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 5 1.000 1.000 1.000 1.000 1.000 0.969 0.969 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 6 1.000 1.000 1.000 1.000 1.000 0.963 0.963 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 7 1.000 1.000 1.000 1.000 1.000 0.956 0.956 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 8 1.000 1.000 1.000 1.000 1.000 0.950 0.950 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 9 1.000 1.000 1.000 1.000 1.000 0.944 0.944 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 10 1.000 1.000 1.000 1.000 1.000 0.938 0.938 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 11 1.000 1.000 1.000 1.000 1.000 0.931 0.931 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 12 1.000 1.000 1.000 1.000 1.000 0.925 0.925 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 13 1.000 1.000 1.000 1.000 1.000 0.919 0.919 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 14 1.000 1.000 1.000 1.000 1.000 0.913 0.913 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 15 1.000 1.000 1.000 1.000 1.000 0.906 0.906 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 16 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 17 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 18 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 19 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 20 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 21+ 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3491 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\n**Additional Factors Used in Rating**\n\n**Roofing Limitation Factor - Wood Shingles, Shakes, or Surfaces** Peril 2 Peril 3 Peril 8 Age of RPC, GRC, RPR, GRR, RPC,GRC, RPR,GRR, ACV,RPC, RPR,GRR, Occupancy Roof Peril 1 ACV FIX FIR ACV FIX FIR Peril 4 Peril 5 Peril 6 Peril 7 GRC,FIX FIR Primary/Seasonal/Unoccupied 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 1 1.000 1.000 0.996 0.996 1.000 0.987 0.987 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 2 1.000 1.000 0.993 0.993 1.000 0.974 0.974 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 3 1.000 1.000 0.989 0.989 1.000 0.961 0.961 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 4 1.000 1.000 0.986 0.986 1.000 0.948 0.948 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 5 1.000 1.000 0.982 0.982 1.000 0.935 0.935 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 6 1.000 1.000 0.978 0.978 1.000 0.922 0.922 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 7 1.000 1.000 0.975 0.975 1.000 0.909 0.909 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 8 1.000 1.000 0.971 0.971 1.000 0.896 0.896 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 9 1.000 1.000 0.967 0.967 1.000 0.883 0.883 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 10 1.000 1.000 0.964 0.964 1.000 0.870 0.870 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 11 1.000 1.000 0.960 0.960 1.000 0.857 0.857 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 12 1.000 1.000 0.957 0.957 1.000 0.844 0.844 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 13 1.000 1.000 0.953 0.953 1.000 0.831 0.831 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 14 1.000 1.000 0.949 0.949 1.000 0.818 0.818 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 15 1.000 1.000 0.946 0.946 1.000 0.805 0.805 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 16 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 17 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 18 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 19 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 20 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 21+ 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Owned Rented to Others 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 1 1.000 1.000 1.000 1.000 1.000 0.994 0.994 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 2 1.000 1.000 1.000 1.000 1.000 0.988 0.988 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 3 1.000 1.000 1.000 1.000 1.000 0.981 0.981 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 4 1.000 1.000 1.000 1.000 1.000 0.975 0.975 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 5 1.000 1.000 1.000 1.000 1.000 0.969 0.969 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 6 1.000 1.000 1.000 1.000 1.000 0.963 0.963 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 7 1.000 1.000 1.000 1.000 1.000 0.956 0.956 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 8 1.000 1.000 1.000 1.000 1.000 0.950 0.950 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 9 1.000 1.000 1.000 1.000 1.000 0.944 0.944 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 10 1.000 1.000 1.000 1.000 1.000 0.938 0.938 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 11 1.000 1.000 1.000 1.000 1.000 0.931 0.931 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 12 1.000 1.000 1.000 1.000 1.000 0.925 0.925 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 13 1.000 1.000 1.000 1.000 1.000 0.919 0.919 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 14 1.000 1.000 1.000 1.000 1.000 0.913 0.913 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 15 1.000 1.000 1.000 1.000 1.000 0.906 0.906 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 16 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 17 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 18 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 19 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 20 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 21+ 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3491 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\n**Additional Factors Used in Rating**\n\n**Roofing Limitation Factor - Wood Shingles, Shakes, or Surfaces** Peril 2 Peril 3 Peril 8 Age of RPC, GRC, RPR, GRR, RPC,GRC, RPR,GRR, ACV,RPC, RPR,GRR, Occupancy Roof Peril 1 ACV FIX FIR ACV FIX FIR Peril 4 Peril 5 Peril 6 Peril 7 GRC,FIX FIR Primary/Seasonal/Unoccupied 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 1 1.000 1.000 0.996 0.996 1.000 0.987 0.987 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 2 1.000 1.000 0.993 0.993 1.000 0.974 0.974 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 3 1.000 1.000 0.989 0.989 1.000 0.961 0.961 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 4 1.000 1.000 0.986 0.986 1.000 0.948 0.948 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 5 1.000 1.000 0.982 0.982 1.000 0.935 0.935 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 6 1.000 1.000 0.978 0.978 1.000 0.922 0.922 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 7 1.000 1.000 0.975 0.975 1.000 0.909 0.909 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 8 1.000 1.000 0.971 0.971 1.000 0.896 0.896 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 9 1.000 1.000 0.967 0.967 1.000 0.883 0.883 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 10 1.000 1.000 0.964 0.964 1.000 0.870 0.870 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 11 1.000 1.000 0.960 0.960 1.000 0.857 0.857 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 12 1.000 1.000 0.957 0.957 1.000 0.844 0.844 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 13 1.000 1.000 0.953 0.953 1.000 0.831 0.831 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 14 1.000 1.000 0.949 0.949 1.000 0.818 0.818 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 15 1.000 1.000 0.946 0.946 1.000 0.805 0.805 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 16 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 17 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 18 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 19 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 20 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 21+ 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Owned Rented to Others 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 1 1.000 1.000 1.000 1.000 1.000 0.994 0.994 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 2 1.000 1.000 1.000 1.000 1.000 0.988 0.988 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 3 1.000 1.000 1.000 1.000 1.000 0.981 0.981 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 4 1.000 1.000 1.000 1.000 1.000 0.975 0.975 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 5 1.000 1.000 1.000 1.000 1.000 0.969 0.969 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 6 1.000 1.000 1.000 1.000 1.000 0.963 0.963 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 7 1.000 1.000 1.000 1.000 1.000 0.956 0.956 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 8 1.000 1.000 1.000 1.000 1.000 0.950 0.950 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 9 1.000 1.000 1.000 1.000 1.000 0.944 0.944 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 10 1.000 1.000 1.000 1.000 1.000 0.938 0.938 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 11 1.000 1.000 1.000 1.000 1.000 0.931 0.931 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 12 1.000 1.000 1.000 1.000 1.000 0.925 0.925 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 13 1.000 1.000 1.000 1.000 1.000 0.919 0.919 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 14 1.000 1.000 1.000 1.000 1.000 0.913 0.913 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 15 1.000 1.000 1.000 1.000 1.000 0.906 0.906 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 16 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 17 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 18 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 19 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 20 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 21+ 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3491 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page147.pdf"]},"response":{"errors":[],"extract_id":"extract_4078f925e5ffb2fe8043b41fb7891f72","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\n**Additional Factors Used in Rating**\n\n**Roofing Limitation Factor - Wood Shingles, Shakes, or Surfaces** Peril 2 Peril 3 Peril 8 Age of RPC, GRC, RPR, GRR, RPC,GRC, RPR,GRR, ACV,RPC, RPR,GRR, Occupancy Roof Peril 1 ACV FIX FIR ACV FIX FIR Peril 4 Peril 5 Peril 6 Peril 7 GRC,FIX FIR Primary/Seasonal/Unoccupied 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 1 1.000 1.000 0.996 0.996 1.000 0.987 0.987 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 2 1.000 1.000 0.993 0.993 1.000 0.974 0.974 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 3 1.000 1.000 0.989 0.989 1.000 0.961 0.961 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 4 1.000 1.000 0.986 0.986 1.000 0.948 0.948 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 5 1.000 1.000 0.982 0.982 1.000 0.935 0.935 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 6 1.000 1.000 0.978 0.978 1.000 0.922 0.922 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 7 1.000 1.000 0.975 0.975 1.000 0.909 0.909 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 8 1.000 1.000 0.971 0.971 1.000 0.896 0.896 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 9 1.000 1.000 0.967 0.967 1.000 0.883 0.883 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 10 1.000 1.000 0.964 0.964 1.000 0.870 0.870 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 11 1.000 1.000 0.960 0.960 1.000 0.857 0.857 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 12 1.000 1.000 0.957 0.957 1.000 0.844 0.844 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 13 1.000 1.000 0.953 0.953 1.000 0.831 0.831 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 14 1.000 1.000 0.949 0.949 1.000 0.818 0.818 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 15 1.000 1.000 0.946 0.946 1.000 0.805 0.805 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 16 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 17 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 18 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 19 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 20 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 21+ 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Owned Rented to Others 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 1 1.000 1.000 1.000 1.000 1.000 0.994 0.994 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 2 1.000 1.000 1.000 1.000 1.000 0.988 0.988 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 3 1.000 1.000 1.000 1.000 1.000 0.981 0.981 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 4 1.000 1.000 1.000 1.000 1.000 0.975 0.975 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 5 1.000 1.000 1.000 1.000 1.000 0.969 0.969 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 6 1.000 1.000 1.000 1.000 1.000 0.963 0.963 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 7 1.000 1.000 1.000 1.000 1.000 0.956 0.956 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 8 1.000 1.000 1.000 1.000 1.000 0.950 0.950 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 9 1.000 1.000 1.000 1.000 1.000 0.944 0.944 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 10 1.000 1.000 1.000 1.000 1.000 0.938 0.938 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 11 1.000 1.000 1.000 1.000 1.000 0.931 0.931 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 12 1.000 1.000 1.000 1.000 1.000 0.925 0.925 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 13 1.000 1.000 1.000 1.000 1.000 0.919 0.919 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 14 1.000 1.000 1.000 1.000 1.000 0.913 0.913 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 15 1.000 1.000 1.000 1.000 1.000 0.906 0.906 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 16 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 17 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 18 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 19 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 20 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 21+ 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3491 Rates and Factors"],"full_content":"**Property Section Rates and Factors**\n\n**Additional Factors Used in Rating**\n\n**Roofing Limitation Factor - Wood Shingles, Shakes, or Surfaces** Peril 2 Peril 3 Peril 8 Age of RPC, GRC, RPR, GRR, RPC,GRC, RPR,GRR, ACV,RPC, RPR,GRR, Occupancy Roof Peril 1 ACV FIX FIR ACV FIX FIR Peril 4 Peril 5 Peril 6 Peril 7 GRC,FIX FIR Primary/Seasonal/Unoccupied 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 1 1.000 1.000 0.996 0.996 1.000 0.987 0.987 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 2 1.000 1.000 0.993 0.993 1.000 0.974 0.974 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 3 1.000 1.000 0.989 0.989 1.000 0.961 0.961 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 4 1.000 1.000 0.986 0.986 1.000 0.948 0.948 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 5 1.000 1.000 0.982 0.982 1.000 0.935 0.935 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 6 1.000 1.000 0.978 0.978 1.000 0.922 0.922 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 7 1.000 1.000 0.975 0.975 1.000 0.909 0.909 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 8 1.000 1.000 0.971 0.971 1.000 0.896 0.896 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 9 1.000 1.000 0.967 0.967 1.000 0.883 0.883 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 10 1.000 1.000 0.964 0.964 1.000 0.870 0.870 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 11 1.000 1.000 0.960 0.960 1.000 0.857 0.857 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 12 1.000 1.000 0.957 0.957 1.000 0.844 0.844 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 13 1.000 1.000 0.953 0.953 1.000 0.831 0.831 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 14 1.000 1.000 0.949 0.949 1.000 0.818 0.818 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 15 1.000 1.000 0.946 0.946 1.000 0.805 0.805 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 16 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 17 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 18 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 19 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 20 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Primary/Seasonal/Unoccupied 21+ 1.000 1.000 0.942 0.942 1.000 0.792 0.792 1.000 1.000 1.000 1.000 1.000 0.970 Owned Rented to Others 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 1 1.000 1.000 1.000 1.000 1.000 0.994 0.994 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 2 1.000 1.000 1.000 1.000 1.000 0.988 0.988 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 3 1.000 1.000 1.000 1.000 1.000 0.981 0.981 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 4 1.000 1.000 1.000 1.000 1.000 0.975 0.975 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 5 1.000 1.000 1.000 1.000 1.000 0.969 0.969 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 6 1.000 1.000 1.000 1.000 1.000 0.963 0.963 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 7 1.000 1.000 1.000 1.000 1.000 0.956 0.956 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 8 1.000 1.000 1.000 1.000 1.000 0.950 0.950 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 9 1.000 1.000 1.000 1.000 1.000 0.944 0.944 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 10 1.000 1.000 1.000 1.000 1.000 0.938 0.938 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 11 1.000 1.000 1.000 1.000 1.000 0.931 0.931 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 12 1.000 1.000 1.000 1.000 1.000 0.925 0.925 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 13 1.000 1.000 1.000 1.000 1.000 0.919 0.919 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 14 1.000 1.000 1.000 1.000 1.000 0.913 0.913 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 15 1.000 1.000 1.000 1.000 1.000 0.906 0.906 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 16 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 17 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 18 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 19 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 20 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000 Owned Rented to Others 21+ 1.000 1.000 1.000 1.000 1.000 0.900 0.900 1.000 1.000 1.000 1.000 1.000 1.000\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3491 Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page147.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page147.pdf"},"request":{"example_id":"table/FBLB-134215544_page147","product_type":"parse","source_file_path":"FBLB-134215544_page147.pdf"},"started_at":"2026-11-04T19:47:38.029217"} +{"completed_at":"2026-11-04T19:47:40.408885","latency_in_ms":1103,"output":{"example_id":"table/FBLB-134215544_page15","grounded_pages":[],"layout_pages":[],"markdown":"**Liability Section Rates and Factors**\n\nFactor\n\n1\\.333 $750\n\nAcres (0 - 160)\n\nInsured is Owner\n\n1\\.00\n\n1\\.29\n\n1\\.35\n\n3\\.50 2.20\n\n**Increased Borrowed F/R PP Limit Factors**\n\n1\\.167\n\n**Increased Employer Medical Limit Factors**\n\n1\\.56\n\n$25,000\n\n1\\.000\n\n$2,000\n\n$21.75\n\nHousehold/Organizational Medical Household/Organizational Liability\n\nInsured is Tenant $32.75\n\n$21.75 Residence Medical\n\n$3.00 $4.69 Per Household/Organization\n\n$2.90 Insured is Tenant\n\nFarm/Ranch Acres Liability\n\n$12.50\n\n$42.00\n\n$5.82\n\n1 - 10 $9.50 Farm/Ranch Livestock Liability\n\n4 - 6\n\n**Liability Base Rates**\n\nInsured is Owner\n\n**Medical Base Rates**\n\nPer F/R Household/Organization $30.50 Per Household/Organization Per F/R Household/Organization\n\n$2.90 Residence Liability\n\n**Personal and Farm/Ranch (F/R) Liability and Medical Base Rate Tables**\n\n$52.00\n\nFarm/Ranch Acres Medical\n\n11 - 100\n\n**Farm/Ranch Employer Base Rates**\n\n$30.00 $64.00\n\n$3.45 Acres (0 - 160)\n\n$3.15\n\n$2.65\n\n100 +\n\nInsured is Tenant\n\n$3.36\n\n$1.05\n\nDairy\n\nExcess of 1, up to 8\n\n$75.00\n\n$27.25\n\n$170.00 Additional Locations 1 - 10 $25.25\n\nDairy\n\n$20.00\n\nF/R Additional Locations Excess of 1, up to 8 $39.75\n\nAnimal Liability\n\n$1.05\n\n100 + 11 - 100\n\nNamed Persons Medical\n\n**Optional Coverages Base Rates**\n\n1 - 3\n\nPersonal Injury Liability\n\nFarm/Ranch Livestock Medical\n\nAnimal Medical\n\nFarm/Ranch Employer Liability\n\n2\\.10\n\n2\\.80\n\n$1,000\n\n5\\.25\n\n1\\.00 1.00 $2,000 $5,000\n\n2\\.30 $1,000,000\n\n0\\.60\n\n3\\.45 $10,000 For Each Additional $1,000 Add\n\n$500\n\nLimit\n\nFarm/Ranch Employer Medical Non-Dairy\n\nNon-Dairy\n\n$65,000 0.94 $65,000\n\n$25,000\n\n0\\.90\n\n**Personal and Farm/Ranch Liability and Medical Increased Limit Factors**\n\n$300,000 1.00 1.00 $300,000 1.40\n\n**Increased Liability Limit Factors Increased Personal Injury Limit Factors**\n\n$100,000 $100,000\n\nFactor Factor Limit\n\n0\\.167\n\nLimit\n\n$10,000\n\n2\\.06\n\n$25,000\n\n$500\n\n$5,000 1.30\n\n$500,000 2.10 1.90\n\n$10,000 $5,000\n\nFactor\n\n6\\.30\n\nLimit\n\n$1,000\n\n$2,000\n\n$0.42\n\n$2.20 4 - 6 1 - 3\n\n$2.20 7 + $2.20\n\n$500,000 $750,000\n\n2\\.50\n\n**Increased Named Persons Medical Limit Factors**\n\n0\\.70 Limit Factor\n\n1\\.58\n\n$300\n\n3\\.70\n\n$750,000\n\n$0.42\n\nBorrowed F/R PP\n\n$1,000\n\nLimit 0.70\n\nInsured is Tenant\n\nLivestock/Animal Collision\n\nF/R Residence Liability Insured is Owner $32.75\n\n**Increased Medical Limit Factors**\n\n2\\.35\n\nWaterbed Liability\n\n$500\n\n$1,000,000\n\n$1,000\n\nFactor\n\nF/R Residence Medical Insured is Owner $3.36\n\n7 + $48.50\n\n$2.70\n\n$37.75\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2406 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Liability Section Rates and Factors**\n\nFactor\n\n1\\.333 $750\n\nAcres (0 - 160)\n\nInsured is Owner\n\n1\\.00\n\n1\\.29\n\n1\\.35\n\n3\\.50 2.20\n\n**Increased Borrowed F/R PP Limit Factors**\n\n1\\.167\n\n**Increased Employer Medical Limit Factors**\n\n1\\.56\n\n$25,000\n\n1\\.000\n\n$2,000\n\n$21.75\n\nHousehold/Organizational Medical Household/Organizational Liability\n\nInsured is Tenant $32.75\n\n$21.75 Residence Medical\n\n$3.00 $4.69 Per Household/Organization\n\n$2.90 Insured is Tenant\n\nFarm/Ranch Acres Liability\n\n$12.50\n\n$42.00\n\n$5.82\n\n1 - 10 $9.50 Farm/Ranch Livestock Liability\n\n4 - 6\n\n**Liability Base Rates**\n\nInsured is Owner\n\n**Medical Base Rates**\n\nPer F/R Household/Organization $30.50 Per Household/Organization Per F/R Household/Organization\n\n$2.90 Residence Liability\n\n**Personal and Farm/Ranch (F/R) Liability and Medical Base Rate Tables**\n\n$52.00\n\nFarm/Ranch Acres Medical\n\n11 - 100\n\n**Farm/Ranch Employer Base Rates**\n\n$30.00 $64.00\n\n$3.45 Acres (0 - 160)\n\n$3.15\n\n$2.65\n\n100 +\n\nInsured is Tenant\n\n$3.36\n\n$1.05\n\nDairy\n\nExcess of 1, up to 8\n\n$75.00\n\n$27.25\n\n$170.00 Additional Locations 1 - 10 $25.25\n\nDairy\n\n$20.00\n\nF/R Additional Locations Excess of 1, up to 8 $39.75\n\nAnimal Liability\n\n$1.05\n\n100 + 11 - 100\n\nNamed Persons Medical\n\n**Optional Coverages Base Rates**\n\n1 - 3\n\nPersonal Injury Liability\n\nFarm/Ranch Livestock Medical\n\nAnimal Medical\n\nFarm/Ranch Employer Liability\n\n2\\.10\n\n2\\.80\n\n$1,000\n\n5\\.25\n\n1\\.00 1.00 $2,000 $5,000\n\n2\\.30 $1,000,000\n\n0\\.60\n\n3\\.45 $10,000 For Each Additional $1,000 Add\n\n$500\n\nLimit\n\nFarm/Ranch Employer Medical Non-Dairy\n\nNon-Dairy\n\n$65,000 0.94 $65,000\n\n$25,000\n\n0\\.90\n\n**Personal and Farm/Ranch Liability and Medical Increased Limit Factors**\n\n$300,000 1.00 1.00 $300,000 1.40\n\n**Increased Liability Limit Factors Increased Personal Injury Limit Factors**\n\n$100,000 $100,000\n\nFactor Factor Limit\n\n0\\.167\n\nLimit\n\n$10,000\n\n2\\.06\n\n$25,000\n\n$500\n\n$5,000 1.30\n\n$500,000 2.10 1.90\n\n$10,000 $5,000\n\nFactor\n\n6\\.30\n\nLimit\n\n$1,000\n\n$2,000\n\n$0.42\n\n$2.20 4 - 6 1 - 3\n\n$2.20 7 + $2.20\n\n$500,000 $750,000\n\n2\\.50\n\n**Increased Named Persons Medical Limit Factors**\n\n0\\.70 Limit Factor\n\n1\\.58\n\n$300\n\n3\\.70\n\n$750,000\n\n$0.42\n\nBorrowed F/R PP\n\n$1,000\n\nLimit 0.70\n\nInsured is Tenant\n\nLivestock/Animal Collision\n\nF/R Residence Liability Insured is Owner $32.75\n\n**Increased Medical Limit Factors**\n\n2\\.35\n\nWaterbed Liability\n\n$500\n\n$1,000,000\n\n$1,000\n\nFactor\n\nF/R Residence Medical Insured is Owner $3.36\n\n7 + $48.50\n\n$2.70\n\n$37.75\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2406 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Liability Section Rates and Factors**\n\nFactor\n\n1\\.333 $750\n\nAcres (0 - 160)\n\nInsured is Owner\n\n1\\.00\n\n1\\.29\n\n1\\.35\n\n3\\.50 2.20\n\n**Increased Borrowed F/R PP Limit Factors**\n\n1\\.167\n\n**Increased Employer Medical Limit Factors**\n\n1\\.56\n\n$25,000\n\n1\\.000\n\n$2,000\n\n$21.75\n\nHousehold/Organizational Medical Household/Organizational Liability\n\nInsured is Tenant $32.75\n\n$21.75 Residence Medical\n\n$3.00 $4.69 Per Household/Organization\n\n$2.90 Insured is Tenant\n\nFarm/Ranch Acres Liability\n\n$12.50\n\n$42.00\n\n$5.82\n\n1 - 10 $9.50 Farm/Ranch Livestock Liability\n\n4 - 6\n\n**Liability Base Rates**\n\nInsured is Owner\n\n**Medical Base Rates**\n\nPer F/R Household/Organization $30.50 Per Household/Organization Per F/R Household/Organization\n\n$2.90 Residence Liability\n\n**Personal and Farm/Ranch (F/R) Liability and Medical Base Rate Tables**\n\n$52.00\n\nFarm/Ranch Acres Medical\n\n11 - 100\n\n**Farm/Ranch Employer Base Rates**\n\n$30.00 $64.00\n\n$3.45 Acres (0 - 160)\n\n$3.15\n\n$2.65\n\n100 +\n\nInsured is Tenant\n\n$3.36\n\n$1.05\n\nDairy\n\nExcess of 1, up to 8\n\n$75.00\n\n$27.25\n\n$170.00 Additional Locations 1 - 10 $25.25\n\nDairy\n\n$20.00\n\nF/R Additional Locations Excess of 1, up to 8 $39.75\n\nAnimal Liability\n\n$1.05\n\n100 + 11 - 100\n\nNamed Persons Medical\n\n**Optional Coverages Base Rates**\n\n1 - 3\n\nPersonal Injury Liability\n\nFarm/Ranch Livestock Medical\n\nAnimal Medical\n\nFarm/Ranch Employer Liability\n\n2\\.10\n\n2\\.80\n\n$1,000\n\n5\\.25\n\n1\\.00 1.00 $2,000 $5,000\n\n2\\.30 $1,000,000\n\n0\\.60\n\n3\\.45 $10,000 For Each Additional $1,000 Add\n\n$500\n\nLimit\n\nFarm/Ranch Employer Medical Non-Dairy\n\nNon-Dairy\n\n$65,000 0.94 $65,000\n\n$25,000\n\n0\\.90\n\n**Personal and Farm/Ranch Liability and Medical Increased Limit Factors**\n\n$300,000 1.00 1.00 $300,000 1.40\n\n**Increased Liability Limit Factors Increased Personal Injury Limit Factors**\n\n$100,000 $100,000\n\nFactor Factor Limit\n\n0\\.167\n\nLimit\n\n$10,000\n\n2\\.06\n\n$25,000\n\n$500\n\n$5,000 1.30\n\n$500,000 2.10 1.90\n\n$10,000 $5,000\n\nFactor\n\n6\\.30\n\nLimit\n\n$1,000\n\n$2,000\n\n$0.42\n\n$2.20 4 - 6 1 - 3\n\n$2.20 7 + $2.20\n\n$500,000 $750,000\n\n2\\.50\n\n**Increased Named Persons Medical Limit Factors**\n\n0\\.70 Limit Factor\n\n1\\.58\n\n$300\n\n3\\.70\n\n$750,000\n\n$0.42\n\nBorrowed F/R PP\n\n$1,000\n\nLimit 0.70\n\nInsured is Tenant\n\nLivestock/Animal Collision\n\nF/R Residence Liability Insured is Owner $32.75\n\n**Increased Medical Limit Factors**\n\n2\\.35\n\nWaterbed Liability\n\n$500\n\n$1,000,000\n\n$1,000\n\nFactor\n\nF/R Residence Medical Insured is Owner $3.36\n\n7 + $48.50\n\n$2.70\n\n$37.75\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2406 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page15.pdf"]},"response":{"errors":[],"extract_id":"extract_e285b12671a20db33adaeafeb472c90a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Liability Section Rates and Factors**\n\nFactor\n\n1\\.333 $750\n\nAcres (0 - 160)\n\nInsured is Owner\n\n1\\.00\n\n1\\.29\n\n1\\.35\n\n3\\.50 2.20\n\n**Increased Borrowed F/R PP Limit Factors**\n\n1\\.167\n\n**Increased Employer Medical Limit Factors**\n\n1\\.56\n\n$25,000\n\n1\\.000\n\n$2,000\n\n$21.75\n\nHousehold/Organizational Medical Household/Organizational Liability\n\nInsured is Tenant $32.75\n\n$21.75 Residence Medical\n\n$3.00 $4.69 Per Household/Organization\n\n$2.90 Insured is Tenant\n\nFarm/Ranch Acres Liability\n\n$12.50\n\n$42.00\n\n$5.82\n\n1 - 10 $9.50 Farm/Ranch Livestock Liability\n\n4 - 6\n\n**Liability Base Rates**\n\nInsured is Owner\n\n**Medical Base Rates**\n\nPer F/R Household/Organization $30.50 Per Household/Organization Per F/R Household/Organization\n\n$2.90 Residence Liability\n\n**Personal and Farm/Ranch (F/R) Liability and Medical Base Rate Tables**\n\n$52.00\n\nFarm/Ranch Acres Medical\n\n11 - 100\n\n**Farm/Ranch Employer Base Rates**\n\n$30.00 $64.00\n\n$3.45 Acres (0 - 160)\n\n$3.15\n\n$2.65\n\n100 +\n\nInsured is Tenant\n\n$3.36\n\n$1.05\n\nDairy\n\nExcess of 1, up to 8\n\n$75.00\n\n$27.25\n\n$170.00 Additional Locations 1 - 10 $25.25\n\nDairy\n\n$20.00\n\nF/R Additional Locations Excess of 1, up to 8 $39.75\n\nAnimal Liability\n\n$1.05\n\n100 + 11 - 100\n\nNamed Persons Medical\n\n**Optional Coverages Base Rates**\n\n1 - 3\n\nPersonal Injury Liability\n\nFarm/Ranch Livestock Medical\n\nAnimal Medical\n\nFarm/Ranch Employer Liability\n\n2\\.10\n\n2\\.80\n\n$1,000\n\n5\\.25\n\n1\\.00 1.00 $2,000 $5,000\n\n2\\.30 $1,000,000\n\n0\\.60\n\n3\\.45 $10,000 For Each Additional $1,000 Add\n\n$500\n\nLimit\n\nFarm/Ranch Employer Medical Non-Dairy\n\nNon-Dairy\n\n$65,000 0.94 $65,000\n\n$25,000\n\n0\\.90\n\n**Personal and Farm/Ranch Liability and Medical Increased Limit Factors**\n\n$300,000 1.00 1.00 $300,000 1.40\n\n**Increased Liability Limit Factors Increased Personal Injury Limit Factors**\n\n$100,000 $100,000\n\nFactor Factor Limit\n\n0\\.167\n\nLimit\n\n$10,000\n\n2\\.06\n\n$25,000\n\n$500\n\n$5,000 1.30\n\n$500,000 2.10 1.90\n\n$10,000 $5,000\n\nFactor\n\n6\\.30\n\nLimit\n\n$1,000\n\n$2,000\n\n$0.42\n\n$2.20 4 - 6 1 - 3\n\n$2.20 7 + $2.20\n\n$500,000 $750,000\n\n2\\.50\n\n**Increased Named Persons Medical Limit Factors**\n\n0\\.70 Limit Factor\n\n1\\.58\n\n$300\n\n3\\.70\n\n$750,000\n\n$0.42\n\nBorrowed F/R PP\n\n$1,000\n\nLimit 0.70\n\nInsured is Tenant\n\nLivestock/Animal Collision\n\nF/R Residence Liability Insured is Owner $32.75\n\n**Increased Medical Limit Factors**\n\n2\\.35\n\nWaterbed Liability\n\n$500\n\n$1,000,000\n\n$1,000\n\nFactor\n\nF/R Residence Medical Insured is Owner $3.36\n\n7 + $48.50\n\n$2.70\n\n$37.75\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2406 Rates and Factors"],"full_content":"**Liability Section Rates and Factors**\n\nFactor\n\n1\\.333 $750\n\nAcres (0 - 160)\n\nInsured is Owner\n\n1\\.00\n\n1\\.29\n\n1\\.35\n\n3\\.50 2.20\n\n**Increased Borrowed F/R PP Limit Factors**\n\n1\\.167\n\n**Increased Employer Medical Limit Factors**\n\n1\\.56\n\n$25,000\n\n1\\.000\n\n$2,000\n\n$21.75\n\nHousehold/Organizational Medical Household/Organizational Liability\n\nInsured is Tenant $32.75\n\n$21.75 Residence Medical\n\n$3.00 $4.69 Per Household/Organization\n\n$2.90 Insured is Tenant\n\nFarm/Ranch Acres Liability\n\n$12.50\n\n$42.00\n\n$5.82\n\n1 - 10 $9.50 Farm/Ranch Livestock Liability\n\n4 - 6\n\n**Liability Base Rates**\n\nInsured is Owner\n\n**Medical Base Rates**\n\nPer F/R Household/Organization $30.50 Per Household/Organization Per F/R Household/Organization\n\n$2.90 Residence Liability\n\n**Personal and Farm/Ranch (F/R) Liability and Medical Base Rate Tables**\n\n$52.00\n\nFarm/Ranch Acres Medical\n\n11 - 100\n\n**Farm/Ranch Employer Base Rates**\n\n$30.00 $64.00\n\n$3.45 Acres (0 - 160)\n\n$3.15\n\n$2.65\n\n100 +\n\nInsured is Tenant\n\n$3.36\n\n$1.05\n\nDairy\n\nExcess of 1, up to 8\n\n$75.00\n\n$27.25\n\n$170.00 Additional Locations 1 - 10 $25.25\n\nDairy\n\n$20.00\n\nF/R Additional Locations Excess of 1, up to 8 $39.75\n\nAnimal Liability\n\n$1.05\n\n100 + 11 - 100\n\nNamed Persons Medical\n\n**Optional Coverages Base Rates**\n\n1 - 3\n\nPersonal Injury Liability\n\nFarm/Ranch Livestock Medical\n\nAnimal Medical\n\nFarm/Ranch Employer Liability\n\n2\\.10\n\n2\\.80\n\n$1,000\n\n5\\.25\n\n1\\.00 1.00 $2,000 $5,000\n\n2\\.30 $1,000,000\n\n0\\.60\n\n3\\.45 $10,000 For Each Additional $1,000 Add\n\n$500\n\nLimit\n\nFarm/Ranch Employer Medical Non-Dairy\n\nNon-Dairy\n\n$65,000 0.94 $65,000\n\n$25,000\n\n0\\.90\n\n**Personal and Farm/Ranch Liability and Medical Increased Limit Factors**\n\n$300,000 1.00 1.00 $300,000 1.40\n\n**Increased Liability Limit Factors Increased Personal Injury Limit Factors**\n\n$100,000 $100,000\n\nFactor Factor Limit\n\n0\\.167\n\nLimit\n\n$10,000\n\n2\\.06\n\n$25,000\n\n$500\n\n$5,000 1.30\n\n$500,000 2.10 1.90\n\n$10,000 $5,000\n\nFactor\n\n6\\.30\n\nLimit\n\n$1,000\n\n$2,000\n\n$0.42\n\n$2.20 4 - 6 1 - 3\n\n$2.20 7 + $2.20\n\n$500,000 $750,000\n\n2\\.50\n\n**Increased Named Persons Medical Limit Factors**\n\n0\\.70 Limit Factor\n\n1\\.58\n\n$300\n\n3\\.70\n\n$750,000\n\n$0.42\n\nBorrowed F/R PP\n\n$1,000\n\nLimit 0.70\n\nInsured is Tenant\n\nLivestock/Animal Collision\n\nF/R Residence Liability Insured is Owner $32.75\n\n**Increased Medical Limit Factors**\n\n2\\.35\n\nWaterbed Liability\n\n$500\n\n$1,000,000\n\n$1,000\n\nFactor\n\nF/R Residence Medical Insured is Owner $3.36\n\n7 + $48.50\n\n$2.70\n\n$37.75\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2406 Rates and Factors","publish_date":null,"title":"Liability Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page15.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page15.pdf"},"request":{"example_id":"table/FBLB-134215544_page15","product_type":"parse","source_file_path":"FBLB-134215544_page15.pdf"},"started_at":"2026-11-04T19:47:39.305795"} +{"completed_at":"2026-11-04T19:47:42.880445","latency_in_ms":1948,"output":{"example_id":"table/FBLB-134215544_page154","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\n**Garages, Outbuildings, & Other Structures (GOOS) - Continued**\n\n**GOOS Primary Rating Factor**\n\n**Building Type Factors**\n\nBuilding Type Description Peril 1 Peril 2 Non-Farm Farm w/ Restriction Farm w/o Restriction Peril 4 Peril 5 Perils 6-8 Type 1 Detached Garages 0.750 0.650 2.000 1.800 3.300 3.036 0.458 NA Type 2 One Story Barn 1.398 0.900 0.854 0.484 1.964 0.742 0.523 NA Type 3 Two Story Barn (sidewalls >=16) 1.483 1.020 0.854 0.484 1.964 1.000 0.900 NA Type 4 Two Story Barn (sidewalls <16) 1.398 0.990 0.854 0.484 1.964 0.742 0.523 NA Type 5 Open Sided Pole Swine Finishing Bldg 0.705 1.150 0.638 0.319 1.467 2.129 1.895 NA Type 6 Frame Swine Farrowing Bldg 0.475 0.350 0.638 0.319 1.467 2.129 1.895 NA Type 7 Pole Swine Finishing Bldg (gable roof) 0.500 0.400 0.638 0.319 1.467 2.129 1.895 NA Type 8 Stud Frame Machinery Storage Bldg 0.895 0.865 0.854 0.455 1.964 1.000 0.900 NA Type 9 Pole Shed, Open Sided 1.510 2.100 1.050 0.595 2.415 1.000 1.200 NA Type 10 Pole Shed, Fully Enclosed 1.500 1.200 1.000 0.533 2.300 1.000 1.150 NA Type 11 Steel Grain Handling System 0.414 1.000 0.352 0.282 0.616 2.242 0.479 NA Type 12 Wood Frame Corn Crib 0.585 0.550 0.754 0.427 1.734 2.600 1.493 NA Type 13 Steel Glass-Lined Silos 0.289 0.272 0.201 0.201 0.221 0.666 0.127 NA Type 14 Concrete Stave Silos 1.148 1.178 0.201 0.201 0.462 0.662 0.016 NA Type 15 Frame Storage Shed – Small Animal Housing and Tool Shed 0.700 0.800 0.820 0.656 1.886 1.401 0.740 NA Type 16 Frame Grainary 0.450 0.480 0.754 0.553 1.734 2.600 1.493 NA Type 17 Quonset Grain or Machinery Storage Shed 0.577 1.050 0.424 0.226 0.975 0.573 0.400 NA Type 18 All Metal Building 1.250 0.915 0.950 0.475 2.185 1.150 1.050 NA Type 19 Concrete Building 0.571 0.900 0.865 0.692 1.990 1.100 0.899 NA Type 20 Swine Confinement Pkg, Turn-Key 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 21 Pole Swine Finishing Barn, Single-Pole Roof 0.746 1.250 0.541 0.289 1.244 2.492 1.047 NA Type 22 Pole Cage Laying House 0.746 0.499 0.541 0.397 1.244 2.492 1.047 NA Type 23 Concrete Block Dairy Parlors 0.530 0.549 0.354 0.177 0.814 2.250 1.300 NA Type 24 Metal Bulk Bins 0.414 0.915 0.352 0.176 0.616 2.242 0.479 NA Type 25 Ag Fences & Corrals 0.334 0.559 0.318 0.318 0.318 1.885 0.582 NA Type 26 Power Poles 0.334 0.873 0.318 0.318 0.318 1.885 0.593 NA Type 27 Misc. Building 1.160 2.000 1.000 0.800 2.300 2.318 1.588 NA Type 28 Swimming Pools, Patios, Driveways, Sidewalks 0.082 0.400 0.300 0.300 0.300 2.250 1.400 NA Type 29 Appurtenant Structures NA NA NA NA NA NA NA NA Type 30 Turkey Buildings 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 31 All Other Poultry Buildings 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 32 Hoop Building 1.000 2.500 0.700 0.700 0.770 1.000 1.000 NA Type 33 Greenhouse 1.000 1.900 2.500 2.500 2.750 1.000 1.250 NA Type 34 Permanently Mounted Tanks 0.150 1.000 0.650 0.650 0.715 1.500 2.000 NA Type 35 Residential Fence 0.334 0.750 0.400 0.400 0.440 0.800 0.550 NA Type 36 Buildings without a Permanent Foundation 0.800 1.500 1.100 0.807 2.530 0.500 0.500 NA Type 37 Generators & Solar Panels 0.400 0.900 0.900 0.900 0.990 0.150 0.900 NA \\*When the \"Cosmetic Damage Buyback\" endorsement is added to an outbuilding at a farm location, use the Peril 3 \"Farm w/o Restriction\" factors.\n\nPeril 3\\*\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3576 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\n**Garages, Outbuildings, & Other Structures (GOOS) - Continued**\n\n**GOOS Primary Rating Factor**\n\n**Building Type Factors**\n\nBuilding Type Description Peril 1 Peril 2 Non-Farm Farm w/ Restriction Farm w/o Restriction Peril 4 Peril 5 Perils 6-8 Type 1 Detached Garages 0.750 0.650 2.000 1.800 3.300 3.036 0.458 NA Type 2 One Story Barn 1.398 0.900 0.854 0.484 1.964 0.742 0.523 NA Type 3 Two Story Barn (sidewalls >=16) 1.483 1.020 0.854 0.484 1.964 1.000 0.900 NA Type 4 Two Story Barn (sidewalls <16) 1.398 0.990 0.854 0.484 1.964 0.742 0.523 NA Type 5 Open Sided Pole Swine Finishing Bldg 0.705 1.150 0.638 0.319 1.467 2.129 1.895 NA Type 6 Frame Swine Farrowing Bldg 0.475 0.350 0.638 0.319 1.467 2.129 1.895 NA Type 7 Pole Swine Finishing Bldg (gable roof) 0.500 0.400 0.638 0.319 1.467 2.129 1.895 NA Type 8 Stud Frame Machinery Storage Bldg 0.895 0.865 0.854 0.455 1.964 1.000 0.900 NA Type 9 Pole Shed, Open Sided 1.510 2.100 1.050 0.595 2.415 1.000 1.200 NA Type 10 Pole Shed, Fully Enclosed 1.500 1.200 1.000 0.533 2.300 1.000 1.150 NA Type 11 Steel Grain Handling System 0.414 1.000 0.352 0.282 0.616 2.242 0.479 NA Type 12 Wood Frame Corn Crib 0.585 0.550 0.754 0.427 1.734 2.600 1.493 NA Type 13 Steel Glass-Lined Silos 0.289 0.272 0.201 0.201 0.221 0.666 0.127 NA Type 14 Concrete Stave Silos 1.148 1.178 0.201 0.201 0.462 0.662 0.016 NA Type 15 Frame Storage Shed – Small Animal Housing and Tool Shed 0.700 0.800 0.820 0.656 1.886 1.401 0.740 NA Type 16 Frame Grainary 0.450 0.480 0.754 0.553 1.734 2.600 1.493 NA Type 17 Quonset Grain or Machinery Storage Shed 0.577 1.050 0.424 0.226 0.975 0.573 0.400 NA Type 18 All Metal Building 1.250 0.915 0.950 0.475 2.185 1.150 1.050 NA Type 19 Concrete Building 0.571 0.900 0.865 0.692 1.990 1.100 0.899 NA Type 20 Swine Confinement Pkg, Turn-Key 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 21 Pole Swine Finishing Barn, Single-Pole Roof 0.746 1.250 0.541 0.289 1.244 2.492 1.047 NA Type 22 Pole Cage Laying House 0.746 0.499 0.541 0.397 1.244 2.492 1.047 NA Type 23 Concrete Block Dairy Parlors 0.530 0.549 0.354 0.177 0.814 2.250 1.300 NA Type 24 Metal Bulk Bins 0.414 0.915 0.352 0.176 0.616 2.242 0.479 NA Type 25 Ag Fences & Corrals 0.334 0.559 0.318 0.318 0.318 1.885 0.582 NA Type 26 Power Poles 0.334 0.873 0.318 0.318 0.318 1.885 0.593 NA Type 27 Misc. Building 1.160 2.000 1.000 0.800 2.300 2.318 1.588 NA Type 28 Swimming Pools, Patios, Driveways, Sidewalks 0.082 0.400 0.300 0.300 0.300 2.250 1.400 NA Type 29 Appurtenant Structures NA NA NA NA NA NA NA NA Type 30 Turkey Buildings 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 31 All Other Poultry Buildings 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 32 Hoop Building 1.000 2.500 0.700 0.700 0.770 1.000 1.000 NA Type 33 Greenhouse 1.000 1.900 2.500 2.500 2.750 1.000 1.250 NA Type 34 Permanently Mounted Tanks 0.150 1.000 0.650 0.650 0.715 1.500 2.000 NA Type 35 Residential Fence 0.334 0.750 0.400 0.400 0.440 0.800 0.550 NA Type 36 Buildings without a Permanent Foundation 0.800 1.500 1.100 0.807 2.530 0.500 0.500 NA Type 37 Generators & Solar Panels 0.400 0.900 0.900 0.900 0.990 0.150 0.900 NA \\*When the \"Cosmetic Damage Buyback\" endorsement is added to an outbuilding at a farm location, use the Peril 3 \"Farm w/o Restriction\" factors.\n\nPeril 3\\*\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3576 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\n**Garages, Outbuildings, & Other Structures (GOOS) - Continued**\n\n**GOOS Primary Rating Factor**\n\n**Building Type Factors**\n\nBuilding Type Description Peril 1 Peril 2 Non-Farm Farm w/ Restriction Farm w/o Restriction Peril 4 Peril 5 Perils 6-8 Type 1 Detached Garages 0.750 0.650 2.000 1.800 3.300 3.036 0.458 NA Type 2 One Story Barn 1.398 0.900 0.854 0.484 1.964 0.742 0.523 NA Type 3 Two Story Barn (sidewalls >=16) 1.483 1.020 0.854 0.484 1.964 1.000 0.900 NA Type 4 Two Story Barn (sidewalls <16) 1.398 0.990 0.854 0.484 1.964 0.742 0.523 NA Type 5 Open Sided Pole Swine Finishing Bldg 0.705 1.150 0.638 0.319 1.467 2.129 1.895 NA Type 6 Frame Swine Farrowing Bldg 0.475 0.350 0.638 0.319 1.467 2.129 1.895 NA Type 7 Pole Swine Finishing Bldg (gable roof) 0.500 0.400 0.638 0.319 1.467 2.129 1.895 NA Type 8 Stud Frame Machinery Storage Bldg 0.895 0.865 0.854 0.455 1.964 1.000 0.900 NA Type 9 Pole Shed, Open Sided 1.510 2.100 1.050 0.595 2.415 1.000 1.200 NA Type 10 Pole Shed, Fully Enclosed 1.500 1.200 1.000 0.533 2.300 1.000 1.150 NA Type 11 Steel Grain Handling System 0.414 1.000 0.352 0.282 0.616 2.242 0.479 NA Type 12 Wood Frame Corn Crib 0.585 0.550 0.754 0.427 1.734 2.600 1.493 NA Type 13 Steel Glass-Lined Silos 0.289 0.272 0.201 0.201 0.221 0.666 0.127 NA Type 14 Concrete Stave Silos 1.148 1.178 0.201 0.201 0.462 0.662 0.016 NA Type 15 Frame Storage Shed – Small Animal Housing and Tool Shed 0.700 0.800 0.820 0.656 1.886 1.401 0.740 NA Type 16 Frame Grainary 0.450 0.480 0.754 0.553 1.734 2.600 1.493 NA Type 17 Quonset Grain or Machinery Storage Shed 0.577 1.050 0.424 0.226 0.975 0.573 0.400 NA Type 18 All Metal Building 1.250 0.915 0.950 0.475 2.185 1.150 1.050 NA Type 19 Concrete Building 0.571 0.900 0.865 0.692 1.990 1.100 0.899 NA Type 20 Swine Confinement Pkg, Turn-Key 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 21 Pole Swine Finishing Barn, Single-Pole Roof 0.746 1.250 0.541 0.289 1.244 2.492 1.047 NA Type 22 Pole Cage Laying House 0.746 0.499 0.541 0.397 1.244 2.492 1.047 NA Type 23 Concrete Block Dairy Parlors 0.530 0.549 0.354 0.177 0.814 2.250 1.300 NA Type 24 Metal Bulk Bins 0.414 0.915 0.352 0.176 0.616 2.242 0.479 NA Type 25 Ag Fences & Corrals 0.334 0.559 0.318 0.318 0.318 1.885 0.582 NA Type 26 Power Poles 0.334 0.873 0.318 0.318 0.318 1.885 0.593 NA Type 27 Misc. Building 1.160 2.000 1.000 0.800 2.300 2.318 1.588 NA Type 28 Swimming Pools, Patios, Driveways, Sidewalks 0.082 0.400 0.300 0.300 0.300 2.250 1.400 NA Type 29 Appurtenant Structures NA NA NA NA NA NA NA NA Type 30 Turkey Buildings 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 31 All Other Poultry Buildings 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 32 Hoop Building 1.000 2.500 0.700 0.700 0.770 1.000 1.000 NA Type 33 Greenhouse 1.000 1.900 2.500 2.500 2.750 1.000 1.250 NA Type 34 Permanently Mounted Tanks 0.150 1.000 0.650 0.650 0.715 1.500 2.000 NA Type 35 Residential Fence 0.334 0.750 0.400 0.400 0.440 0.800 0.550 NA Type 36 Buildings without a Permanent Foundation 0.800 1.500 1.100 0.807 2.530 0.500 0.500 NA Type 37 Generators & Solar Panels 0.400 0.900 0.900 0.900 0.990 0.150 0.900 NA \\*When the \"Cosmetic Damage Buyback\" endorsement is added to an outbuilding at a farm location, use the Peril 3 \"Farm w/o Restriction\" factors.\n\nPeril 3\\*\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3576 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page154.pdf"]},"response":{"errors":[],"extract_id":"extract_a54c2f204299b167eb03befb6f742de0","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\n**Garages, Outbuildings, & Other Structures (GOOS) - Continued**\n\n**GOOS Primary Rating Factor**\n\n**Building Type Factors**\n\nBuilding Type Description Peril 1 Peril 2 Non-Farm Farm w/ Restriction Farm w/o Restriction Peril 4 Peril 5 Perils 6-8 Type 1 Detached Garages 0.750 0.650 2.000 1.800 3.300 3.036 0.458 NA Type 2 One Story Barn 1.398 0.900 0.854 0.484 1.964 0.742 0.523 NA Type 3 Two Story Barn (sidewalls >=16) 1.483 1.020 0.854 0.484 1.964 1.000 0.900 NA Type 4 Two Story Barn (sidewalls <16) 1.398 0.990 0.854 0.484 1.964 0.742 0.523 NA Type 5 Open Sided Pole Swine Finishing Bldg 0.705 1.150 0.638 0.319 1.467 2.129 1.895 NA Type 6 Frame Swine Farrowing Bldg 0.475 0.350 0.638 0.319 1.467 2.129 1.895 NA Type 7 Pole Swine Finishing Bldg (gable roof) 0.500 0.400 0.638 0.319 1.467 2.129 1.895 NA Type 8 Stud Frame Machinery Storage Bldg 0.895 0.865 0.854 0.455 1.964 1.000 0.900 NA Type 9 Pole Shed, Open Sided 1.510 2.100 1.050 0.595 2.415 1.000 1.200 NA Type 10 Pole Shed, Fully Enclosed 1.500 1.200 1.000 0.533 2.300 1.000 1.150 NA Type 11 Steel Grain Handling System 0.414 1.000 0.352 0.282 0.616 2.242 0.479 NA Type 12 Wood Frame Corn Crib 0.585 0.550 0.754 0.427 1.734 2.600 1.493 NA Type 13 Steel Glass-Lined Silos 0.289 0.272 0.201 0.201 0.221 0.666 0.127 NA Type 14 Concrete Stave Silos 1.148 1.178 0.201 0.201 0.462 0.662 0.016 NA Type 15 Frame Storage Shed – Small Animal Housing and Tool Shed 0.700 0.800 0.820 0.656 1.886 1.401 0.740 NA Type 16 Frame Grainary 0.450 0.480 0.754 0.553 1.734 2.600 1.493 NA Type 17 Quonset Grain or Machinery Storage Shed 0.577 1.050 0.424 0.226 0.975 0.573 0.400 NA Type 18 All Metal Building 1.250 0.915 0.950 0.475 2.185 1.150 1.050 NA Type 19 Concrete Building 0.571 0.900 0.865 0.692 1.990 1.100 0.899 NA Type 20 Swine Confinement Pkg, Turn-Key 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 21 Pole Swine Finishing Barn, Single-Pole Roof 0.746 1.250 0.541 0.289 1.244 2.492 1.047 NA Type 22 Pole Cage Laying House 0.746 0.499 0.541 0.397 1.244 2.492 1.047 NA Type 23 Concrete Block Dairy Parlors 0.530 0.549 0.354 0.177 0.814 2.250 1.300 NA Type 24 Metal Bulk Bins 0.414 0.915 0.352 0.176 0.616 2.242 0.479 NA Type 25 Ag Fences & Corrals 0.334 0.559 0.318 0.318 0.318 1.885 0.582 NA Type 26 Power Poles 0.334 0.873 0.318 0.318 0.318 1.885 0.593 NA Type 27 Misc. Building 1.160 2.000 1.000 0.800 2.300 2.318 1.588 NA Type 28 Swimming Pools, Patios, Driveways, Sidewalks 0.082 0.400 0.300 0.300 0.300 2.250 1.400 NA Type 29 Appurtenant Structures NA NA NA NA NA NA NA NA Type 30 Turkey Buildings 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 31 All Other Poultry Buildings 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 32 Hoop Building 1.000 2.500 0.700 0.700 0.770 1.000 1.000 NA Type 33 Greenhouse 1.000 1.900 2.500 2.500 2.750 1.000 1.250 NA Type 34 Permanently Mounted Tanks 0.150 1.000 0.650 0.650 0.715 1.500 2.000 NA Type 35 Residential Fence 0.334 0.750 0.400 0.400 0.440 0.800 0.550 NA Type 36 Buildings without a Permanent Foundation 0.800 1.500 1.100 0.807 2.530 0.500 0.500 NA Type 37 Generators & Solar Panels 0.400 0.900 0.900 0.900 0.990 0.150 0.900 NA \\*When the \"Cosmetic Damage Buyback\" endorsement is added to an outbuilding at a farm location, use the Peril 3 \"Farm w/o Restriction\" factors.\n\nPeril 3\\*\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3576 Rates and Factors"],"full_content":"**Property Section Rates and Factors**\n\n**Garages, Outbuildings, & Other Structures (GOOS) - Continued**\n\n**GOOS Primary Rating Factor**\n\n**Building Type Factors**\n\nBuilding Type Description Peril 1 Peril 2 Non-Farm Farm w/ Restriction Farm w/o Restriction Peril 4 Peril 5 Perils 6-8 Type 1 Detached Garages 0.750 0.650 2.000 1.800 3.300 3.036 0.458 NA Type 2 One Story Barn 1.398 0.900 0.854 0.484 1.964 0.742 0.523 NA Type 3 Two Story Barn (sidewalls >=16) 1.483 1.020 0.854 0.484 1.964 1.000 0.900 NA Type 4 Two Story Barn (sidewalls <16) 1.398 0.990 0.854 0.484 1.964 0.742 0.523 NA Type 5 Open Sided Pole Swine Finishing Bldg 0.705 1.150 0.638 0.319 1.467 2.129 1.895 NA Type 6 Frame Swine Farrowing Bldg 0.475 0.350 0.638 0.319 1.467 2.129 1.895 NA Type 7 Pole Swine Finishing Bldg (gable roof) 0.500 0.400 0.638 0.319 1.467 2.129 1.895 NA Type 8 Stud Frame Machinery Storage Bldg 0.895 0.865 0.854 0.455 1.964 1.000 0.900 NA Type 9 Pole Shed, Open Sided 1.510 2.100 1.050 0.595 2.415 1.000 1.200 NA Type 10 Pole Shed, Fully Enclosed 1.500 1.200 1.000 0.533 2.300 1.000 1.150 NA Type 11 Steel Grain Handling System 0.414 1.000 0.352 0.282 0.616 2.242 0.479 NA Type 12 Wood Frame Corn Crib 0.585 0.550 0.754 0.427 1.734 2.600 1.493 NA Type 13 Steel Glass-Lined Silos 0.289 0.272 0.201 0.201 0.221 0.666 0.127 NA Type 14 Concrete Stave Silos 1.148 1.178 0.201 0.201 0.462 0.662 0.016 NA Type 15 Frame Storage Shed – Small Animal Housing and Tool Shed 0.700 0.800 0.820 0.656 1.886 1.401 0.740 NA Type 16 Frame Grainary 0.450 0.480 0.754 0.553 1.734 2.600 1.493 NA Type 17 Quonset Grain or Machinery Storage Shed 0.577 1.050 0.424 0.226 0.975 0.573 0.400 NA Type 18 All Metal Building 1.250 0.915 0.950 0.475 2.185 1.150 1.050 NA Type 19 Concrete Building 0.571 0.900 0.865 0.692 1.990 1.100 0.899 NA Type 20 Swine Confinement Pkg, Turn-Key 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 21 Pole Swine Finishing Barn, Single-Pole Roof 0.746 1.250 0.541 0.289 1.244 2.492 1.047 NA Type 22 Pole Cage Laying House 0.746 0.499 0.541 0.397 1.244 2.492 1.047 NA Type 23 Concrete Block Dairy Parlors 0.530 0.549 0.354 0.177 0.814 2.250 1.300 NA Type 24 Metal Bulk Bins 0.414 0.915 0.352 0.176 0.616 2.242 0.479 NA Type 25 Ag Fences & Corrals 0.334 0.559 0.318 0.318 0.318 1.885 0.582 NA Type 26 Power Poles 0.334 0.873 0.318 0.318 0.318 1.885 0.593 NA Type 27 Misc. Building 1.160 2.000 1.000 0.800 2.300 2.318 1.588 NA Type 28 Swimming Pools, Patios, Driveways, Sidewalks 0.082 0.400 0.300 0.300 0.300 2.250 1.400 NA Type 29 Appurtenant Structures NA NA NA NA NA NA NA NA Type 30 Turkey Buildings 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 31 All Other Poultry Buildings 0.746 0.225 0.541 0.271 1.244 2.492 1.047 NA Type 32 Hoop Building 1.000 2.500 0.700 0.700 0.770 1.000 1.000 NA Type 33 Greenhouse 1.000 1.900 2.500 2.500 2.750 1.000 1.250 NA Type 34 Permanently Mounted Tanks 0.150 1.000 0.650 0.650 0.715 1.500 2.000 NA Type 35 Residential Fence 0.334 0.750 0.400 0.400 0.440 0.800 0.550 NA Type 36 Buildings without a Permanent Foundation 0.800 1.500 1.100 0.807 2.530 0.500 0.500 NA Type 37 Generators & Solar Panels 0.400 0.900 0.900 0.900 0.990 0.150 0.900 NA \\*When the \"Cosmetic Damage Buyback\" endorsement is added to an outbuilding at a farm location, use the Peril 3 \"Farm w/o Restriction\" factors.\n\nPeril 3\\*\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3576 Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page154.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page154.pdf"},"request":{"example_id":"table/FBLB-134215544_page154","product_type":"parse","source_file_path":"FBLB-134215544_page154.pdf"},"started_at":"2026-11-04T19:47:40.931886"} +{"completed_at":"2026-11-04T19:46:54.530640","latency_in_ms":2664,"output":{"example_id":"table/FBLB-134215544_page16","grounded_pages":[],"layout_pages":[],"markdown":"### **Liability Section Rates and Factors**\n\nUtah\n\nLower $ Threshold -$100.00 -$100.00 Upper $ Threshold $100.00 $100.00\n\nNo Cap\n\n**Personal and Farm/Ranch Liability and Medical Additional Factors Used in Rating**\n\nLiability Type Non Farm/Ranch\n\nFarm/Ranch Small Farm/Ranch Indicator = N Small Farm/Ranch Indicator = Y\n\n**Maximum and Minimum Changes for Calculation of Rate Capping Factor**\n\n\\-75% 75%\n\n**Upper & Lower Thresholds**\n\n\\-75% 75% Upper % Threshold\n\nLower % Threshold\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2601- 2700 Rates and Factors","pages":[{"line_numbers":[],"markdown":"### **Liability Section Rates and Factors**\n\nUtah\n\nLower $ Threshold -$100.00 -$100.00 Upper $ Threshold $100.00 $100.00\n\nNo Cap\n\n**Personal and Farm/Ranch Liability and Medical Additional Factors Used in Rating**\n\nLiability Type Non Farm/Ranch\n\nFarm/Ranch Small Farm/Ranch Indicator = N Small Farm/Ranch Indicator = Y\n\n**Maximum and Minimum Changes for Calculation of Rate Capping Factor**\n\n\\-75% 75%\n\n**Upper & Lower Thresholds**\n\n\\-75% 75% Upper % Threshold\n\nLower % Threshold\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2601- 2700 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Liability Section Rates and Factors**\n\nUtah\n\nLower $ Threshold -$100.00 -$100.00 Upper $ Threshold $100.00 $100.00\n\nNo Cap\n\n**Personal and Farm/Ranch Liability and Medical Additional Factors Used in Rating**\n\nLiability Type Non Farm/Ranch\n\nFarm/Ranch Small Farm/Ranch Indicator = N Small Farm/Ranch Indicator = Y\n\n**Maximum and Minimum Changes for Calculation of Rate Capping Factor**\n\n\\-75% 75%\n\n**Upper & Lower Thresholds**\n\n\\-75% 75% Upper % Threshold\n\nLower % Threshold\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2601- 2700 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page16.pdf"]},"response":{"errors":[],"extract_id":"extract_8d295010669bffcadb653ec5528ca7c6","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Liability Section Rates and Factors**\n\nUtah\n\nLower $ Threshold -$100.00 -$100.00 Upper $ Threshold $100.00 $100.00\n\nNo Cap\n\n**Personal and Farm/Ranch Liability and Medical Additional Factors Used in Rating**\n\nLiability Type Non Farm/Ranch\n\nFarm/Ranch Small Farm/Ranch Indicator = N Small Farm/Ranch Indicator = Y\n\n**Maximum and Minimum Changes for Calculation of Rate Capping Factor**\n\n\\-75% 75%\n\n**Upper & Lower Thresholds**\n\n\\-75% 75% Upper % Threshold\n\nLower % Threshold\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2601- 2700 Rates and Factors"],"full_content":"### **Liability Section Rates and Factors**\n\nUtah\n\nLower $ Threshold -$100.00 -$100.00 Upper $ Threshold $100.00 $100.00\n\nNo Cap\n\n**Personal and Farm/Ranch Liability and Medical Additional Factors Used in Rating**\n\nLiability Type Non Farm/Ranch\n\nFarm/Ranch Small Farm/Ranch Indicator = N Small Farm/Ranch Indicator = Y\n\n**Maximum and Minimum Changes for Calculation of Rate Capping Factor**\n\n\\-75% 75%\n\n**Upper & Lower Thresholds**\n\n\\-75% 75% Upper % Threshold\n\nLower % Threshold\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 2601- 2700 Rates and Factors","publish_date":null,"title":"Liability Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page16.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page16.pdf"},"request":{"example_id":"table/FBLB-134215544_page16","product_type":"parse","source_file_path":"FBLB-134215544_page16.pdf"},"started_at":"2026-11-04T19:46:51.865906"} +{"completed_at":"2026-11-04T19:46:54.223866","latency_in_ms":2355,"output":{"example_id":"table/FBLB-134215544_page162","grounded_pages":[],"layout_pages":[],"markdown":"### **Liability Section Rates and Factors**\n\nAnimal Medical 1 - 3 $2.20 4 - 6 $2.20 7 + $2.20\n\nAnimal Liability 1 - 3 $27.25 4 - 6 $37.75 7 + $48.50\n\nFor Each Additional Claim Over 4 Add 5.00\n\n2 1.50 3 2.00 4 6.00\n\n**Livestock Escape Surcharge Factors** Number of Claims Factor 0 1.00 1 1.00\n\nInsured is Tenant Additional Locations\n\nInsured is Owner\n\n**Liability Base Rates Medical Base Rates**\n\nResidence Medical Per Household/Organization\n\n$2.79 $2.79 $21.25 $21.25 Insured is Tenant\n\n$25.25\n\nRate per $100 0.10\n\n$50.00 **Liability Only Charge**\n\n**Loss Assessment Rate**\n\n$12.50 $20.00\n\n$1,000,000\n\n0\\.94 1.00\n\nLimit\n\n$1,000\n\n$750,000 2.80\n\nWaterbed Liability\n\n**Optional Coverages Base Rates**\n\n2\\.10\n\n$65,000\n\n$1,000,000\n\nLimit\n\n**Account Discount Factor**\n\n2\\.35\n\n**Increased Medical Limit Factors** Factor 0.60\n\n$25,000 6.30\n\n1\\.00 $2,000 $5,000\n\n$750,000\n\n$100,000\n\n**Personal Liability and Medical Additional Factors Used in Rating**\n\n0\\.90\n\n$500\n\n$300,000 $500,000 1.40 1.58\n\n1\\.56\n\n**Increased Personal Injury Limit Factors**\n\n$100,000\n\n$10,000 3.50\n\n1\\.00 0.90\n\n1\\.90 $300,000\n\n2\\.06 2.30\n\n1\\.29 $500,000\n\nLimit $65,000\n\n**Personal Liability and Medical Increased Limit Factors**\n\nFactor **Increased Liability Limit Factors** Factor\n\n**Personal Liability and Medical Base Rate Tables**\n\nInsured is Owner\n\nPersonal Injury Liability\n\nExcess of 1, up to 8\n\nResidence Liability Per Household/Organization $29.75 Household/Organizational Medical $2.90 Household/Organizational Liability\n\n**Home Sharing Base Rate** Rate 55.00\n\n**Home Sharing Residence Count Factors Home Sharing Increased Limits Factors** Number of Residences with Limit Factor Home Sharing Coverage Factor $65,000 1.00 1 1.00 $100,000 1.15 2 1.60 $300,000 1.30 3 2.00 $500,000 1.45 4 2.30 $750,000 1.60 5+ 2.50 $1,000,000 1.75\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 529W-550W Rates and Factors","pages":[{"line_numbers":[],"markdown":"### **Liability Section Rates and Factors**\n\nAnimal Medical 1 - 3 $2.20 4 - 6 $2.20 7 + $2.20\n\nAnimal Liability 1 - 3 $27.25 4 - 6 $37.75 7 + $48.50\n\nFor Each Additional Claim Over 4 Add 5.00\n\n2 1.50 3 2.00 4 6.00\n\n**Livestock Escape Surcharge Factors** Number of Claims Factor 0 1.00 1 1.00\n\nInsured is Tenant Additional Locations\n\nInsured is Owner\n\n**Liability Base Rates Medical Base Rates**\n\nResidence Medical Per Household/Organization\n\n$2.79 $2.79 $21.25 $21.25 Insured is Tenant\n\n$25.25\n\nRate per $100 0.10\n\n$50.00 **Liability Only Charge**\n\n**Loss Assessment Rate**\n\n$12.50 $20.00\n\n$1,000,000\n\n0\\.94 1.00\n\nLimit\n\n$1,000\n\n$750,000 2.80\n\nWaterbed Liability\n\n**Optional Coverages Base Rates**\n\n2\\.10\n\n$65,000\n\n$1,000,000\n\nLimit\n\n**Account Discount Factor**\n\n2\\.35\n\n**Increased Medical Limit Factors** Factor 0.60\n\n$25,000 6.30\n\n1\\.00 $2,000 $5,000\n\n$750,000\n\n$100,000\n\n**Personal Liability and Medical Additional Factors Used in Rating**\n\n0\\.90\n\n$500\n\n$300,000 $500,000 1.40 1.58\n\n1\\.56\n\n**Increased Personal Injury Limit Factors**\n\n$100,000\n\n$10,000 3.50\n\n1\\.00 0.90\n\n1\\.90 $300,000\n\n2\\.06 2.30\n\n1\\.29 $500,000\n\nLimit $65,000\n\n**Personal Liability and Medical Increased Limit Factors**\n\nFactor **Increased Liability Limit Factors** Factor\n\n**Personal Liability and Medical Base Rate Tables**\n\nInsured is Owner\n\nPersonal Injury Liability\n\nExcess of 1, up to 8\n\nResidence Liability Per Household/Organization $29.75 Household/Organizational Medical $2.90 Household/Organizational Liability\n\n**Home Sharing Base Rate** Rate 55.00\n\n**Home Sharing Residence Count Factors Home Sharing Increased Limits Factors** Number of Residences with Limit Factor Home Sharing Coverage Factor $65,000 1.00 1 1.00 $100,000 1.15 2 1.60 $300,000 1.30 3 2.00 $500,000 1.45 4 2.30 $750,000 1.60 5+ 2.50 $1,000,000 1.75\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 529W-550W Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Liability Section Rates and Factors**\n\nAnimal Medical 1 - 3 $2.20 4 - 6 $2.20 7 + $2.20\n\nAnimal Liability 1 - 3 $27.25 4 - 6 $37.75 7 + $48.50\n\nFor Each Additional Claim Over 4 Add 5.00\n\n2 1.50 3 2.00 4 6.00\n\n**Livestock Escape Surcharge Factors** Number of Claims Factor 0 1.00 1 1.00\n\nInsured is Tenant Additional Locations\n\nInsured is Owner\n\n**Liability Base Rates Medical Base Rates**\n\nResidence Medical Per Household/Organization\n\n$2.79 $2.79 $21.25 $21.25 Insured is Tenant\n\n$25.25\n\nRate per $100 0.10\n\n$50.00 **Liability Only Charge**\n\n**Loss Assessment Rate**\n\n$12.50 $20.00\n\n$1,000,000\n\n0\\.94 1.00\n\nLimit\n\n$1,000\n\n$750,000 2.80\n\nWaterbed Liability\n\n**Optional Coverages Base Rates**\n\n2\\.10\n\n$65,000\n\n$1,000,000\n\nLimit\n\n**Account Discount Factor**\n\n2\\.35\n\n**Increased Medical Limit Factors** Factor 0.60\n\n$25,000 6.30\n\n1\\.00 $2,000 $5,000\n\n$750,000\n\n$100,000\n\n**Personal Liability and Medical Additional Factors Used in Rating**\n\n0\\.90\n\n$500\n\n$300,000 $500,000 1.40 1.58\n\n1\\.56\n\n**Increased Personal Injury Limit Factors**\n\n$100,000\n\n$10,000 3.50\n\n1\\.00 0.90\n\n1\\.90 $300,000\n\n2\\.06 2.30\n\n1\\.29 $500,000\n\nLimit $65,000\n\n**Personal Liability and Medical Increased Limit Factors**\n\nFactor **Increased Liability Limit Factors** Factor\n\n**Personal Liability and Medical Base Rate Tables**\n\nInsured is Owner\n\nPersonal Injury Liability\n\nExcess of 1, up to 8\n\nResidence Liability Per Household/Organization $29.75 Household/Organizational Medical $2.90 Household/Organizational Liability\n\n**Home Sharing Base Rate** Rate 55.00\n\n**Home Sharing Residence Count Factors Home Sharing Increased Limits Factors** Number of Residences with Limit Factor Home Sharing Coverage Factor $65,000 1.00 1 1.00 $100,000 1.15 2 1.60 $300,000 1.30 3 2.00 $500,000 1.45 4 2.30 $750,000 1.60 5+ 2.50 $1,000,000 1.75\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 529W-550W Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page162.pdf"]},"response":{"errors":[],"extract_id":"extract_3c80606dea7038bf3de7bd98fb4d48aa","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Liability Section Rates and Factors**\n\nAnimal Medical 1 - 3 $2.20 4 - 6 $2.20 7 + $2.20\n\nAnimal Liability 1 - 3 $27.25 4 - 6 $37.75 7 + $48.50\n\nFor Each Additional Claim Over 4 Add 5.00\n\n2 1.50 3 2.00 4 6.00\n\n**Livestock Escape Surcharge Factors** Number of Claims Factor 0 1.00 1 1.00\n\nInsured is Tenant Additional Locations\n\nInsured is Owner\n\n**Liability Base Rates Medical Base Rates**\n\nResidence Medical Per Household/Organization\n\n$2.79 $2.79 $21.25 $21.25 Insured is Tenant\n\n$25.25\n\nRate per $100 0.10\n\n$50.00 **Liability Only Charge**\n\n**Loss Assessment Rate**\n\n$12.50 $20.00\n\n$1,000,000\n\n0\\.94 1.00\n\nLimit\n\n$1,000\n\n$750,000 2.80\n\nWaterbed Liability\n\n**Optional Coverages Base Rates**\n\n2\\.10\n\n$65,000\n\n$1,000,000\n\nLimit\n\n**Account Discount Factor**\n\n2\\.35\n\n**Increased Medical Limit Factors** Factor 0.60\n\n$25,000 6.30\n\n1\\.00 $2,000 $5,000\n\n$750,000\n\n$100,000\n\n**Personal Liability and Medical Additional Factors Used in Rating**\n\n0\\.90\n\n$500\n\n$300,000 $500,000 1.40 1.58\n\n1\\.56\n\n**Increased Personal Injury Limit Factors**\n\n$100,000\n\n$10,000 3.50\n\n1\\.00 0.90\n\n1\\.90 $300,000\n\n2\\.06 2.30\n\n1\\.29 $500,000\n\nLimit $65,000\n\n**Personal Liability and Medical Increased Limit Factors**\n\nFactor **Increased Liability Limit Factors** Factor\n\n**Personal Liability and Medical Base Rate Tables**\n\nInsured is Owner\n\nPersonal Injury Liability\n\nExcess of 1, up to 8\n\nResidence Liability Per Household/Organization $29.75 Household/Organizational Medical $2.90 Household/Organizational Liability\n\n**Home Sharing Base Rate** Rate 55.00\n\n**Home Sharing Residence Count Factors Home Sharing Increased Limits Factors** Number of Residences with Limit Factor Home Sharing Coverage Factor $65,000 1.00 1 1.00 $100,000 1.15 2 1.60 $300,000 1.30 3 2.00 $500,000 1.45 4 2.30 $750,000 1.60 5+ 2.50 $1,000,000 1.75\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 529W-550W Rates and Factors"],"full_content":"### **Liability Section Rates and Factors**\n\nAnimal Medical 1 - 3 $2.20 4 - 6 $2.20 7 + $2.20\n\nAnimal Liability 1 - 3 $27.25 4 - 6 $37.75 7 + $48.50\n\nFor Each Additional Claim Over 4 Add 5.00\n\n2 1.50 3 2.00 4 6.00\n\n**Livestock Escape Surcharge Factors** Number of Claims Factor 0 1.00 1 1.00\n\nInsured is Tenant Additional Locations\n\nInsured is Owner\n\n**Liability Base Rates Medical Base Rates**\n\nResidence Medical Per Household/Organization\n\n$2.79 $2.79 $21.25 $21.25 Insured is Tenant\n\n$25.25\n\nRate per $100 0.10\n\n$50.00 **Liability Only Charge**\n\n**Loss Assessment Rate**\n\n$12.50 $20.00\n\n$1,000,000\n\n0\\.94 1.00\n\nLimit\n\n$1,000\n\n$750,000 2.80\n\nWaterbed Liability\n\n**Optional Coverages Base Rates**\n\n2\\.10\n\n$65,000\n\n$1,000,000\n\nLimit\n\n**Account Discount Factor**\n\n2\\.35\n\n**Increased Medical Limit Factors** Factor 0.60\n\n$25,000 6.30\n\n1\\.00 $2,000 $5,000\n\n$750,000\n\n$100,000\n\n**Personal Liability and Medical Additional Factors Used in Rating**\n\n0\\.90\n\n$500\n\n$300,000 $500,000 1.40 1.58\n\n1\\.56\n\n**Increased Personal Injury Limit Factors**\n\n$100,000\n\n$10,000 3.50\n\n1\\.00 0.90\n\n1\\.90 $300,000\n\n2\\.06 2.30\n\n1\\.29 $500,000\n\nLimit $65,000\n\n**Personal Liability and Medical Increased Limit Factors**\n\nFactor **Increased Liability Limit Factors** Factor\n\n**Personal Liability and Medical Base Rate Tables**\n\nInsured is Owner\n\nPersonal Injury Liability\n\nExcess of 1, up to 8\n\nResidence Liability Per Household/Organization $29.75 Household/Organizational Medical $2.90 Household/Organizational Liability\n\n**Home Sharing Base Rate** Rate 55.00\n\n**Home Sharing Residence Count Factors Home Sharing Increased Limits Factors** Number of Residences with Limit Factor Home Sharing Coverage Factor $65,000 1.00 1 1.00 $100,000 1.15 2 1.60 $300,000 1.30 3 2.00 $500,000 1.45 4 2.30 $750,000 1.60 5+ 2.50 $1,000,000 1.75\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 529W-550W Rates and Factors","publish_date":null,"title":"Liability Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page162.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page162.pdf"},"request":{"example_id":"table/FBLB-134215544_page162","product_type":"parse","source_file_path":"FBLB-134215544_page162.pdf"},"started_at":"2026-11-04T19:46:51.868683"} +{"completed_at":"2026-11-04T19:46:55.261439","latency_in_ms":1036,"output":{"example_id":"table/FBLB-134215544_page163","grounded_pages":[],"layout_pages":[],"markdown":"### **Liability Section Rates and Factors**\n\nUtah\n\n**Personal Liability and Medical Additional Factors Used in Rating**\n\nUpper $ Threshold\n\nLower % Threshold Upper % Threshold Lower $ Threshold\n\n**Upper & Lower Thresholds**\n\nNo Cap\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 586W - 600W Rates and Factors","pages":[{"line_numbers":[],"markdown":"### **Liability Section Rates and Factors**\n\nUtah\n\n**Personal Liability and Medical Additional Factors Used in Rating**\n\nUpper $ Threshold\n\nLower % Threshold Upper % Threshold Lower $ Threshold\n\n**Upper & Lower Thresholds**\n\nNo Cap\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 586W - 600W Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Liability Section Rates and Factors**\n\nUtah\n\n**Personal Liability and Medical Additional Factors Used in Rating**\n\nUpper $ Threshold\n\nLower % Threshold Upper % Threshold Lower $ Threshold\n\n**Upper & Lower Thresholds**\n\nNo Cap\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 586W - 600W Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page163.pdf"]},"response":{"errors":[],"extract_id":"extract_97d005f4289e87fe4c8d954318bae84d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Liability Section Rates and Factors**\n\nUtah\n\n**Personal Liability and Medical Additional Factors Used in Rating**\n\nUpper $ Threshold\n\nLower % Threshold Upper % Threshold Lower $ Threshold\n\n**Upper & Lower Thresholds**\n\nNo Cap\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 586W - 600W Rates and Factors"],"full_content":"### **Liability Section Rates and Factors**\n\nUtah\n\n**Personal Liability and Medical Additional Factors Used in Rating**\n\nUpper $ Threshold\n\nLower % Threshold Upper % Threshold Lower $ Threshold\n\n**Upper & Lower Thresholds**\n\nNo Cap\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - LIABILITY SECTION - 01/23/2025 586W - 600W Rates and Factors","publish_date":null,"title":"Liability Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page163.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page163.pdf"},"request":{"example_id":"table/FBLB-134215544_page163","product_type":"parse","source_file_path":"FBLB-134215544_page163.pdf"},"started_at":"2026-11-04T19:46:54.225200"} +{"completed_at":"2026-11-04T19:46:57.186077","latency_in_ms":1523,"output":{"example_id":"table/FBLB-134215544_page18","grounded_pages":[],"layout_pages":[],"markdown":"**PROPERTY SECTION PREMIUM DETERMINATION**\n\n**OPP2.19** _Subtotal_ **=**\n\n**Layer** **4** **‐** **Use** **only** **if** **Limit** **exceeds** **$26,000 OPP2.16 Subtract** **$26,000** **from** **the** **Limit $ # OPP2.17 Divide** **by** **100** **and** **enter** **the** **amount ÷ OPP2.18** **Layer** **4** **Property** **Assessment** **Base** **Rate X**\n\n**Layer** **1** **‐** **Use** **only** **if** **Limit** **exceeds** **$1,000**\n\n**Policy** **Inception** **Date** **Factor X X**\n\n**\\# #**\n\n**OPP2.21 Property** **Multiplier** **(Value** **of** **OPP1) X**\n\n**OPP1**\n\n**\\#**\n\n**X**\n\n**$**\n\n**OPP2.15**\n\n**OPP2.10**\n\n**OPP2.08 OPP2.07**\n\n**OPP2.04**\n\n**OPP2.20**\n\n**Layer** **1** **Property** **Assessment** **Base** **Rate**\n\n**Layer** **2** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.14 OPP2.13**\n\n**\\#**\n\n**OPP2.12 Take** **the** **lesser** **of** **Step** **OPP2.** **11** **and** **$15,000 =**\n\n**Subtract** **$6,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.06** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Subtract** **$11,000** **from** **the** **Limit**\n\n**_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.15_** **_\\+_** **_OPP2.19_** **=**\n\n**Rate** **Capping** **Factor X**\n\n**X X =**\n\n**Layer** **3** **‐** **Use** **only** **if** **Limit** **exceeds** **$11,000 $**\n\n_Subtotal_\n\n_Subtotal_\n\n**Layer** **3** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.22**\n\n**Fire** **Department** **Service** **Charge** **Coverage** **(for** **limits** **exceeding** **$1,000) OPP2** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nTotal Insured Value is equal to the sum of the Amounts of Insurance for the following: Outbuilding Types 2‐8, 10‐11, 13‐15, 17‐24, 27, 30‐34, & 36‐37, Tools/Miscellaneous insured under Blanket Farm/Ranch Personal Property, and Tools/Miscellaneous and Irrigation insured under Scheduled Farm/Ranch Personal Property. Note: Leased Irrigation Equipment amounts of insurance are included in the Total Insured Value for Farm Ranch Equipment Breakdown. Amounts of insurance for Cab Glass, Peak Season, Livestock Freezing or Smothering, Livestock Suffocation, Earthquake, Farm/Ranch Operation Records, Agricultural Earnings and Extra Expense Coverage, & Farm/Ranch Refrigerated Contents are excluded from the Total Insured Value.\n\n**OPP3.02 OPP3.01**\n\n**Farm** **Ranch** **(F/R)** **Equipment** **Breakdown**\n\n**Divide** **by** **100** **$ ÷ $ Fire** **Department** **Service** **Charge** **Amount** **of** **Insurance** **‐** **1,000**\n\n**OPP3.03 Fire** **Department** **Service** **Charge** **Rate X**\n\n**OPP3.05 OPP3**\n\n**OPP3.04 Property** **Multiplier** **(Value** **of** **OPP1) Rate** **Capping** **Factor**\n\n_Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**OPP4.04 OPP4.03 #**\n\n**OPP4.02** _Subtotal_ _1_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**F/R** **Equipment** **Breakdown** **Minimum** **Premium**\n\n**OPP4.01 Total** **Insured** **Value** **divided** **by** **1000**\n\n**F/R** **Equipment** **Breakdown** **Rate**\n\n**\\# X**\n\n**= Identity** **Services** **and** **Fraud** **Expense** **Coverage OPP4** _Subtotal_ _‐_ _(Greater_ _of_ _OPP4.03_ _&_ _OPP4.04)_ **=**\n\n**=**\n\n**F/R** **Ag** **Earnings OPP6.01 F/R** **Ag** **Earnings** **Base** **Rate**\n\n**OPP2.11**\n\n**Property** **Loss** **Assessment** **($100** **increments)**\n\n**PLA FDSC FREB OPP1.01 Claim** **Frequency** **Factor** **1**\n\n**Sum** **of** **Ag** **Factors** **‐** **1\\.00**\n\n**ID**\n\n_Subtotal_ **= =**\n\n**OPP1.09**\n\n**Step**\n\n**OPP2.06 Layer** **2** **‐** **Use** **only** **if** **Limit** **exceeds** **$6,000 OPP2.05** _Subtotal_ **=**\n\n**=**\n\n**=**\n\n**=**\n\n**÷ X #**\n\n**OPP2.09**\n\n**OPP1.10 Underwriting** **Level** **Factor X X**\n\n**OPP2.03 OPP2.02 OPP2.01 Subtract** **$1,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.01** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Divide** **by** **100** **and** **enter** **the** **amount**\n\n**$ = ÷**\n\n**OPP1.06 Ag** **\\+** **Rewards** **Factor + OPP1.07 Sum** **of** **Ag** **Factors =**\n\n**\\#**\n\n**OPP1.02 Claim** **Frequency** **Factor** **2 X X**\n\n**÷ X**\n\n**OPP1.03 Claim** **Free** **Discount** **Factor OPP1.04 Continued** **in** **Force** **Factor OPP1.05 Ag** **Advantage** **Factor**\n\n**OPP1.08**\n\n**Rating** **Algorithm AGE # X X X**\n\n**X X =**\n\n**Component**\n\n**X X X X**\n\n**X X**\n\n**=**\n\n**OPP5** _Subtotal_ **Ag** **Earnings**\n\n**\\# OPP6.02 (Ag** **Earnings** **Limit\\*** **of** **Insurance** **/** **1000)** **X OPP6.03 Ag** **Earnings** **Operation** **Type** **Factors X OPP6.04 Ag** **Earnings** **Structure** **Count** **Factors X OPP6.05 Property** **Multiplier** **(Value** **of** **OPP1) X OPP6.06 Extended** **Earnings** **Factor X OPP6.07 Individual** **Risk** **Premium** **Modification** **Factor X OPP6.08 Rate** **Capping** **Factor X OPP6** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER’S CHOICE POLICY – PROPERTY SECTION – 01/23/2025 3253 Premium Determination","pages":[{"line_numbers":[],"markdown":"**PROPERTY SECTION PREMIUM DETERMINATION**\n\n**OPP2.19** _Subtotal_ **=**\n\n**Layer** **4** **‐** **Use** **only** **if** **Limit** **exceeds** **$26,000 OPP2.16 Subtract** **$26,000** **from** **the** **Limit $ # OPP2.17 Divide** **by** **100** **and** **enter** **the** **amount ÷ OPP2.18** **Layer** **4** **Property** **Assessment** **Base** **Rate X**\n\n**Layer** **1** **‐** **Use** **only** **if** **Limit** **exceeds** **$1,000**\n\n**Policy** **Inception** **Date** **Factor X X**\n\n**\\# #**\n\n**OPP2.21 Property** **Multiplier** **(Value** **of** **OPP1) X**\n\n**OPP1**\n\n**\\#**\n\n**X**\n\n**$**\n\n**OPP2.15**\n\n**OPP2.10**\n\n**OPP2.08 OPP2.07**\n\n**OPP2.04**\n\n**OPP2.20**\n\n**Layer** **1** **Property** **Assessment** **Base** **Rate**\n\n**Layer** **2** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.14 OPP2.13**\n\n**\\#**\n\n**OPP2.12 Take** **the** **lesser** **of** **Step** **OPP2.** **11** **and** **$15,000 =**\n\n**Subtract** **$6,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.06** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Subtract** **$11,000** **from** **the** **Limit**\n\n**_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.15_** **_\\+_** **_OPP2.19_** **=**\n\n**Rate** **Capping** **Factor X**\n\n**X X =**\n\n**Layer** **3** **‐** **Use** **only** **if** **Limit** **exceeds** **$11,000 $**\n\n_Subtotal_\n\n_Subtotal_\n\n**Layer** **3** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.22**\n\n**Fire** **Department** **Service** **Charge** **Coverage** **(for** **limits** **exceeding** **$1,000) OPP2** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nTotal Insured Value is equal to the sum of the Amounts of Insurance for the following: Outbuilding Types 2‐8, 10‐11, 13‐15, 17‐24, 27, 30‐34, & 36‐37, Tools/Miscellaneous insured under Blanket Farm/Ranch Personal Property, and Tools/Miscellaneous and Irrigation insured under Scheduled Farm/Ranch Personal Property. Note: Leased Irrigation Equipment amounts of insurance are included in the Total Insured Value for Farm Ranch Equipment Breakdown. Amounts of insurance for Cab Glass, Peak Season, Livestock Freezing or Smothering, Livestock Suffocation, Earthquake, Farm/Ranch Operation Records, Agricultural Earnings and Extra Expense Coverage, & Farm/Ranch Refrigerated Contents are excluded from the Total Insured Value.\n\n**OPP3.02 OPP3.01**\n\n**Farm** **Ranch** **(F/R)** **Equipment** **Breakdown**\n\n**Divide** **by** **100** **$ ÷ $ Fire** **Department** **Service** **Charge** **Amount** **of** **Insurance** **‐** **1,000**\n\n**OPP3.03 Fire** **Department** **Service** **Charge** **Rate X**\n\n**OPP3.05 OPP3**\n\n**OPP3.04 Property** **Multiplier** **(Value** **of** **OPP1) Rate** **Capping** **Factor**\n\n_Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**OPP4.04 OPP4.03 #**\n\n**OPP4.02** _Subtotal_ _1_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**F/R** **Equipment** **Breakdown** **Minimum** **Premium**\n\n**OPP4.01 Total** **Insured** **Value** **divided** **by** **1000**\n\n**F/R** **Equipment** **Breakdown** **Rate**\n\n**\\# X**\n\n**= Identity** **Services** **and** **Fraud** **Expense** **Coverage OPP4** _Subtotal_ _‐_ _(Greater_ _of_ _OPP4.03_ _&_ _OPP4.04)_ **=**\n\n**=**\n\n**F/R** **Ag** **Earnings OPP6.01 F/R** **Ag** **Earnings** **Base** **Rate**\n\n**OPP2.11**\n\n**Property** **Loss** **Assessment** **($100** **increments)**\n\n**PLA FDSC FREB OPP1.01 Claim** **Frequency** **Factor** **1**\n\n**Sum** **of** **Ag** **Factors** **‐** **1\\.00**\n\n**ID**\n\n_Subtotal_ **= =**\n\n**OPP1.09**\n\n**Step**\n\n**OPP2.06 Layer** **2** **‐** **Use** **only** **if** **Limit** **exceeds** **$6,000 OPP2.05** _Subtotal_ **=**\n\n**=**\n\n**=**\n\n**=**\n\n**÷ X #**\n\n**OPP2.09**\n\n**OPP1.10 Underwriting** **Level** **Factor X X**\n\n**OPP2.03 OPP2.02 OPP2.01 Subtract** **$1,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.01** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Divide** **by** **100** **and** **enter** **the** **amount**\n\n**$ = ÷**\n\n**OPP1.06 Ag** **\\+** **Rewards** **Factor + OPP1.07 Sum** **of** **Ag** **Factors =**\n\n**\\#**\n\n**OPP1.02 Claim** **Frequency** **Factor** **2 X X**\n\n**÷ X**\n\n**OPP1.03 Claim** **Free** **Discount** **Factor OPP1.04 Continued** **in** **Force** **Factor OPP1.05 Ag** **Advantage** **Factor**\n\n**OPP1.08**\n\n**Rating** **Algorithm AGE # X X X**\n\n**X X =**\n\n**Component**\n\n**X X X X**\n\n**X X**\n\n**=**\n\n**OPP5** _Subtotal_ **Ag** **Earnings**\n\n**\\# OPP6.02 (Ag** **Earnings** **Limit\\*** **of** **Insurance** **/** **1000)** **X OPP6.03 Ag** **Earnings** **Operation** **Type** **Factors X OPP6.04 Ag** **Earnings** **Structure** **Count** **Factors X OPP6.05 Property** **Multiplier** **(Value** **of** **OPP1) X OPP6.06 Extended** **Earnings** **Factor X OPP6.07 Individual** **Risk** **Premium** **Modification** **Factor X OPP6.08 Rate** **Capping** **Factor X OPP6** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER’S CHOICE POLICY – PROPERTY SECTION – 01/23/2025 3253 Premium Determination","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**PROPERTY SECTION PREMIUM DETERMINATION**\n\n**OPP2.19** _Subtotal_ **=**\n\n**Layer** **4** **‐** **Use** **only** **if** **Limit** **exceeds** **$26,000 OPP2.16 Subtract** **$26,000** **from** **the** **Limit $ # OPP2.17 Divide** **by** **100** **and** **enter** **the** **amount ÷ OPP2.18** **Layer** **4** **Property** **Assessment** **Base** **Rate X**\n\n**Layer** **1** **‐** **Use** **only** **if** **Limit** **exceeds** **$1,000**\n\n**Policy** **Inception** **Date** **Factor X X**\n\n**\\# #**\n\n**OPP2.21 Property** **Multiplier** **(Value** **of** **OPP1) X**\n\n**OPP1**\n\n**\\#**\n\n**X**\n\n**$**\n\n**OPP2.15**\n\n**OPP2.10**\n\n**OPP2.08 OPP2.07**\n\n**OPP2.04**\n\n**OPP2.20**\n\n**Layer** **1** **Property** **Assessment** **Base** **Rate**\n\n**Layer** **2** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.14 OPP2.13**\n\n**\\#**\n\n**OPP2.12 Take** **the** **lesser** **of** **Step** **OPP2.** **11** **and** **$15,000 =**\n\n**Subtract** **$6,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.06** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Subtract** **$11,000** **from** **the** **Limit**\n\n**_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.15_** **_\\+_** **_OPP2.19_** **=**\n\n**Rate** **Capping** **Factor X**\n\n**X X =**\n\n**Layer** **3** **‐** **Use** **only** **if** **Limit** **exceeds** **$11,000 $**\n\n_Subtotal_\n\n_Subtotal_\n\n**Layer** **3** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.22**\n\n**Fire** **Department** **Service** **Charge** **Coverage** **(for** **limits** **exceeding** **$1,000) OPP2** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nTotal Insured Value is equal to the sum of the Amounts of Insurance for the following: Outbuilding Types 2‐8, 10‐11, 13‐15, 17‐24, 27, 30‐34, & 36‐37, Tools/Miscellaneous insured under Blanket Farm/Ranch Personal Property, and Tools/Miscellaneous and Irrigation insured under Scheduled Farm/Ranch Personal Property. Note: Leased Irrigation Equipment amounts of insurance are included in the Total Insured Value for Farm Ranch Equipment Breakdown. Amounts of insurance for Cab Glass, Peak Season, Livestock Freezing or Smothering, Livestock Suffocation, Earthquake, Farm/Ranch Operation Records, Agricultural Earnings and Extra Expense Coverage, & Farm/Ranch Refrigerated Contents are excluded from the Total Insured Value.\n\n**OPP3.02 OPP3.01**\n\n**Farm** **Ranch** **(F/R)** **Equipment** **Breakdown**\n\n**Divide** **by** **100** **$ ÷ $ Fire** **Department** **Service** **Charge** **Amount** **of** **Insurance** **‐** **1,000**\n\n**OPP3.03 Fire** **Department** **Service** **Charge** **Rate X**\n\n**OPP3.05 OPP3**\n\n**OPP3.04 Property** **Multiplier** **(Value** **of** **OPP1) Rate** **Capping** **Factor**\n\n_Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**OPP4.04 OPP4.03 #**\n\n**OPP4.02** _Subtotal_ _1_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**F/R** **Equipment** **Breakdown** **Minimum** **Premium**\n\n**OPP4.01 Total** **Insured** **Value** **divided** **by** **1000**\n\n**F/R** **Equipment** **Breakdown** **Rate**\n\n**\\# X**\n\n**= Identity** **Services** **and** **Fraud** **Expense** **Coverage OPP4** _Subtotal_ _‐_ _(Greater_ _of_ _OPP4.03_ _&_ _OPP4.04)_ **=**\n\n**=**\n\n**F/R** **Ag** **Earnings OPP6.01 F/R** **Ag** **Earnings** **Base** **Rate**\n\n**OPP2.11**\n\n**Property** **Loss** **Assessment** **($100** **increments)**\n\n**PLA FDSC FREB OPP1.01 Claim** **Frequency** **Factor** **1**\n\n**Sum** **of** **Ag** **Factors** **‐** **1\\.00**\n\n**ID**\n\n_Subtotal_ **= =**\n\n**OPP1.09**\n\n**Step**\n\n**OPP2.06 Layer** **2** **‐** **Use** **only** **if** **Limit** **exceeds** **$6,000 OPP2.05** _Subtotal_ **=**\n\n**=**\n\n**=**\n\n**=**\n\n**÷ X #**\n\n**OPP2.09**\n\n**OPP1.10 Underwriting** **Level** **Factor X X**\n\n**OPP2.03 OPP2.02 OPP2.01 Subtract** **$1,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.01** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Divide** **by** **100** **and** **enter** **the** **amount**\n\n**$ = ÷**\n\n**OPP1.06 Ag** **\\+** **Rewards** **Factor + OPP1.07 Sum** **of** **Ag** **Factors =**\n\n**\\#**\n\n**OPP1.02 Claim** **Frequency** **Factor** **2 X X**\n\n**÷ X**\n\n**OPP1.03 Claim** **Free** **Discount** **Factor OPP1.04 Continued** **in** **Force** **Factor OPP1.05 Ag** **Advantage** **Factor**\n\n**OPP1.08**\n\n**Rating** **Algorithm AGE # X X X**\n\n**X X =**\n\n**Component**\n\n**X X X X**\n\n**X X**\n\n**=**\n\n**OPP5** _Subtotal_ **Ag** **Earnings**\n\n**\\# OPP6.02 (Ag** **Earnings** **Limit\\*** **of** **Insurance** **/** **1000)** **X OPP6.03 Ag** **Earnings** **Operation** **Type** **Factors X OPP6.04 Ag** **Earnings** **Structure** **Count** **Factors X OPP6.05 Property** **Multiplier** **(Value** **of** **OPP1) X OPP6.06 Extended** **Earnings** **Factor X OPP6.07 Individual** **Risk** **Premium** **Modification** **Factor X OPP6.08 Rate** **Capping** **Factor X OPP6** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER’S CHOICE POLICY – PROPERTY SECTION – 01/23/2025 3253 Premium Determination","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page18.pdf"]},"response":{"errors":[],"extract_id":"extract_b03a8acb21bfcb095199ac77c15a483a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**PROPERTY SECTION PREMIUM DETERMINATION**\n\n**OPP2.19** _Subtotal_ **=**\n\n**Layer** **4** **‐** **Use** **only** **if** **Limit** **exceeds** **$26,000 OPP2.16 Subtract** **$26,000** **from** **the** **Limit $ # OPP2.17 Divide** **by** **100** **and** **enter** **the** **amount ÷ OPP2.18** **Layer** **4** **Property** **Assessment** **Base** **Rate X**\n\n**Layer** **1** **‐** **Use** **only** **if** **Limit** **exceeds** **$1,000**\n\n**Policy** **Inception** **Date** **Factor X X**\n\n**\\# #**\n\n**OPP2.21 Property** **Multiplier** **(Value** **of** **OPP1) X**\n\n**OPP1**\n\n**\\#**\n\n**X**\n\n**$**\n\n**OPP2.15**\n\n**OPP2.10**\n\n**OPP2.08 OPP2.07**\n\n**OPP2.04**\n\n**OPP2.20**\n\n**Layer** **1** **Property** **Assessment** **Base** **Rate**\n\n**Layer** **2** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.14 OPP2.13**\n\n**\\#**\n\n**OPP2.12 Take** **the** **lesser** **of** **Step** **OPP2.** **11** **and** **$15,000 =**\n\n**Subtract** **$6,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.06** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Subtract** **$11,000** **from** **the** **Limit**\n\n**_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.15_** **_\\+_** **_OPP2.19_** **=**\n\n**Rate** **Capping** **Factor X**\n\n**X X =**\n\n**Layer** **3** **‐** **Use** **only** **if** **Limit** **exceeds** **$11,000 $**\n\n_Subtotal_\n\n_Subtotal_\n\n**Layer** **3** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.22**\n\n**Fire** **Department** **Service** **Charge** **Coverage** **(for** **limits** **exceeding** **$1,000) OPP2** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nTotal Insured Value is equal to the sum of the Amounts of Insurance for the following: Outbuilding Types 2‐8, 10‐11, 13‐15, 17‐24, 27, 30‐34, & 36‐37, Tools/Miscellaneous insured under Blanket Farm/Ranch Personal Property, and Tools/Miscellaneous and Irrigation insured under Scheduled Farm/Ranch Personal Property. Note: Leased Irrigation Equipment amounts of insurance are included in the Total Insured Value for Farm Ranch Equipment Breakdown. Amounts of insurance for Cab Glass, Peak Season, Livestock Freezing or Smothering, Livestock Suffocation, Earthquake, Farm/Ranch Operation Records, Agricultural Earnings and Extra Expense Coverage, & Farm/Ranch Refrigerated Contents are excluded from the Total Insured Value.\n\n**OPP3.02 OPP3.01**\n\n**Farm** **Ranch** **(F/R)** **Equipment** **Breakdown**\n\n**Divide** **by** **100** **$ ÷ $ Fire** **Department** **Service** **Charge** **Amount** **of** **Insurance** **‐** **1,000**\n\n**OPP3.03 Fire** **Department** **Service** **Charge** **Rate X**\n\n**OPP3.05 OPP3**\n\n**OPP3.04 Property** **Multiplier** **(Value** **of** **OPP1) Rate** **Capping** **Factor**\n\n_Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**OPP4.04 OPP4.03 #**\n\n**OPP4.02** _Subtotal_ _1_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**F/R** **Equipment** **Breakdown** **Minimum** **Premium**\n\n**OPP4.01 Total** **Insured** **Value** **divided** **by** **1000**\n\n**F/R** **Equipment** **Breakdown** **Rate**\n\n**\\# X**\n\n**= Identity** **Services** **and** **Fraud** **Expense** **Coverage OPP4** _Subtotal_ _‐_ _(Greater_ _of_ _OPP4.03_ _&_ _OPP4.04)_ **=**\n\n**=**\n\n**F/R** **Ag** **Earnings OPP6.01 F/R** **Ag** **Earnings** **Base** **Rate**\n\n**OPP2.11**\n\n**Property** **Loss** **Assessment** **($100** **increments)**\n\n**PLA FDSC FREB OPP1.01 Claim** **Frequency** **Factor** **1**\n\n**Sum** **of** **Ag** **Factors** **‐** **1\\.00**\n\n**ID**\n\n_Subtotal_ **= =**\n\n**OPP1.09**\n\n**Step**\n\n**OPP2.06 Layer** **2** **‐** **Use** **only** **if** **Limit** **exceeds** **$6,000 OPP2.05** _Subtotal_ **=**\n\n**=**\n\n**=**\n\n**=**\n\n**÷ X #**\n\n**OPP2.09**\n\n**OPP1.10 Underwriting** **Level** **Factor X X**\n\n**OPP2.03 OPP2.02 OPP2.01 Subtract** **$1,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.01** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Divide** **by** **100** **and** **enter** **the** **amount**\n\n**$ = ÷**\n\n**OPP1.06 Ag** **\\+** **Rewards** **Factor + OPP1.07 Sum** **of** **Ag** **Factors =**\n\n**\\#**\n\n**OPP1.02 Claim** **Frequency** **Factor** **2 X X**\n\n**÷ X**\n\n**OPP1.03 Claim** **Free** **Discount** **Factor OPP1.04 Continued** **in** **Force** **Factor OPP1.05 Ag** **Advantage** **Factor**\n\n**OPP1.08**\n\n**Rating** **Algorithm AGE # X X X**\n\n**X X =**\n\n**Component**\n\n**X X X X**\n\n**X X**\n\n**=**\n\n**OPP5** _Subtotal_ **Ag** **Earnings**\n\n**\\# OPP6.02 (Ag** **Earnings** **Limit\\*** **of** **Insurance** **/** **1000)** **X OPP6.03 Ag** **Earnings** **Operation** **Type** **Factors X OPP6.04 Ag** **Earnings** **Structure** **Count** **Factors X OPP6.05 Property** **Multiplier** **(Value** **of** **OPP1) X OPP6.06 Extended** **Earnings** **Factor X OPP6.07 Individual** **Risk** **Premium** **Modification** **Factor X OPP6.08 Rate** **Capping** **Factor X OPP6** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER’S CHOICE POLICY – PROPERTY SECTION – 01/23/2025 3253 Premium Determination"],"full_content":"**PROPERTY SECTION PREMIUM DETERMINATION**\n\n**OPP2.19** _Subtotal_ **=**\n\n**Layer** **4** **‐** **Use** **only** **if** **Limit** **exceeds** **$26,000 OPP2.16 Subtract** **$26,000** **from** **the** **Limit $ # OPP2.17 Divide** **by** **100** **and** **enter** **the** **amount ÷ OPP2.18** **Layer** **4** **Property** **Assessment** **Base** **Rate X**\n\n**Layer** **1** **‐** **Use** **only** **if** **Limit** **exceeds** **$1,000**\n\n**Policy** **Inception** **Date** **Factor X X**\n\n**\\# #**\n\n**OPP2.21 Property** **Multiplier** **(Value** **of** **OPP1) X**\n\n**OPP1**\n\n**\\#**\n\n**X**\n\n**$**\n\n**OPP2.15**\n\n**OPP2.10**\n\n**OPP2.08 OPP2.07**\n\n**OPP2.04**\n\n**OPP2.20**\n\n**Layer** **1** **Property** **Assessment** **Base** **Rate**\n\n**Layer** **2** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.14 OPP2.13**\n\n**\\#**\n\n**OPP2.12 Take** **the** **lesser** **of** **Step** **OPP2.** **11** **and** **$15,000 =**\n\n**Subtract** **$6,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.06** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Subtract** **$11,000** **from** **the** **Limit**\n\n**_Sum_** **_of_** **_Steps_** **_OPP2.05_** **_\\+_** **_OPP2.10_** **_\\+_** **_OPP2.15_** **_\\+_** **_OPP2.19_** **=**\n\n**Rate** **Capping** **Factor X**\n\n**X X =**\n\n**Layer** **3** **‐** **Use** **only** **if** **Limit** **exceeds** **$11,000 $**\n\n_Subtotal_\n\n_Subtotal_\n\n**Layer** **3** **Property** **Assessment** **Base** **Rate**\n\n**OPP2.22**\n\n**Fire** **Department** **Service** **Charge** **Coverage** **(for** **limits** **exceeding** **$1,000) OPP2** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nTotal Insured Value is equal to the sum of the Amounts of Insurance for the following: Outbuilding Types 2‐8, 10‐11, 13‐15, 17‐24, 27, 30‐34, & 36‐37, Tools/Miscellaneous insured under Blanket Farm/Ranch Personal Property, and Tools/Miscellaneous and Irrigation insured under Scheduled Farm/Ranch Personal Property. Note: Leased Irrigation Equipment amounts of insurance are included in the Total Insured Value for Farm Ranch Equipment Breakdown. Amounts of insurance for Cab Glass, Peak Season, Livestock Freezing or Smothering, Livestock Suffocation, Earthquake, Farm/Ranch Operation Records, Agricultural Earnings and Extra Expense Coverage, & Farm/Ranch Refrigerated Contents are excluded from the Total Insured Value.\n\n**OPP3.02 OPP3.01**\n\n**Farm** **Ranch** **(F/R)** **Equipment** **Breakdown**\n\n**Divide** **by** **100** **$ ÷ $ Fire** **Department** **Service** **Charge** **Amount** **of** **Insurance** **‐** **1,000**\n\n**OPP3.03 Fire** **Department** **Service** **Charge** **Rate X**\n\n**OPP3.05 OPP3**\n\n**OPP3.04 Property** **Multiplier** **(Value** **of** **OPP1) Rate** **Capping** **Factor**\n\n_Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**OPP4.04 OPP4.03 #**\n\n**OPP4.02** _Subtotal_ _1_ _‐_ _Round_ _to_ _2_ _decimals_\n\n**F/R** **Equipment** **Breakdown** **Minimum** **Premium**\n\n**OPP4.01 Total** **Insured** **Value** **divided** **by** **1000**\n\n**F/R** **Equipment** **Breakdown** **Rate**\n\n**\\# X**\n\n**= Identity** **Services** **and** **Fraud** **Expense** **Coverage OPP4** _Subtotal_ _‐_ _(Greater_ _of_ _OPP4.03_ _&_ _OPP4.04)_ **=**\n\n**=**\n\n**F/R** **Ag** **Earnings OPP6.01 F/R** **Ag** **Earnings** **Base** **Rate**\n\n**OPP2.11**\n\n**Property** **Loss** **Assessment** **($100** **increments)**\n\n**PLA FDSC FREB OPP1.01 Claim** **Frequency** **Factor** **1**\n\n**Sum** **of** **Ag** **Factors** **‐** **1\\.00**\n\n**ID**\n\n_Subtotal_ **= =**\n\n**OPP1.09**\n\n**Step**\n\n**OPP2.06 Layer** **2** **‐** **Use** **only** **if** **Limit** **exceeds** **$6,000 OPP2.05** _Subtotal_ **=**\n\n**=**\n\n**=**\n\n**=**\n\n**÷ X #**\n\n**OPP2.09**\n\n**OPP1.10 Underwriting** **Level** **Factor X X**\n\n**OPP2.03 OPP2.02 OPP2.01 Subtract** **$1,000** **from** **the** **Limit Take** **the** **lesser** **of** **Step** **OPP2.01** **and** **$5,000 Divide** **by** **100** **and** **enter** **the** **amount**\n\n**Divide** **by** **100** **and** **enter** **the** **amount**\n\n**$ = ÷**\n\n**OPP1.06 Ag** **\\+** **Rewards** **Factor + OPP1.07 Sum** **of** **Ag** **Factors =**\n\n**\\#**\n\n**OPP1.02 Claim** **Frequency** **Factor** **2 X X**\n\n**÷ X**\n\n**OPP1.03 Claim** **Free** **Discount** **Factor OPP1.04 Continued** **in** **Force** **Factor OPP1.05 Ag** **Advantage** **Factor**\n\n**OPP1.08**\n\n**Rating** **Algorithm AGE # X X X**\n\n**X X =**\n\n**Component**\n\n**X X X X**\n\n**X X**\n\n**=**\n\n**OPP5** _Subtotal_ **Ag** **Earnings**\n\n**\\# OPP6.02 (Ag** **Earnings** **Limit\\*** **of** **Insurance** **/** **1000)** **X OPP6.03 Ag** **Earnings** **Operation** **Type** **Factors X OPP6.04 Ag** **Earnings** **Structure** **Count** **Factors X OPP6.05 Property** **Multiplier** **(Value** **of** **OPP1) X OPP6.06 Extended** **Earnings** **Factor X OPP6.07 Individual** **Risk** **Premium** **Modification** **Factor X OPP6.08 Rate** **Capping** **Factor X OPP6** _Subtotal_ _‐_ _Round_ _to_ _2_ _decimals_ **=**\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER’S CHOICE POLICY – PROPERTY SECTION – 01/23/2025 3253 Premium Determination","publish_date":null,"title":"PROPERTY SECTION PREMIUM DETERMINATION ÷ ÷ ÷ ÷ ÷","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page18.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page18.pdf"},"request":{"example_id":"table/FBLB-134215544_page18","product_type":"parse","source_file_path":"FBLB-134215544_page18.pdf"},"started_at":"2026-11-04T19:46:55.662963"} +{"completed_at":"2026-11-04T19:47:00.206948","latency_in_ms":2984,"output":{"example_id":"table/FBLB-134215544_page19","grounded_pages":[],"layout_pages":[],"markdown":"### **Property Section Rates and Factors**\n\n**Utah Property ZC Factors** Dwelling Structure, Mobile Home Structure **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84001 1.155 0.709 0.945 1.101 1.048 0.979 0.833 1.043 84002 3.445 0.709 0.945 1.142 1.048 0.995 0.783 1.043 84003 1.367 0.932 0.910 0.994 0.970 0.995 0.958 1.074 84004 1.879 0.932 0.945 1.069 0.996 0.995 1.023 1.123 84005 5.000 0.830 0.874 0.833 0.903 0.979 0.833 1.074 84006 5.000 1.173 0.910 1.142 0.970 1.122 1.109 0.952 84007 1.179 0.709 0.910 1.142 1.023 0.995 0.783 1.109 84008 0.958 0.766 1.052 1.272 0.996 0.953 0.890 0.978 84009 0.999 1.017 0.945 1.069 0.941 1.013 1.353 0.952 84010 1.103 1.523 0.998 1.040 1.234 1.220 1.478 1.057 84011 0.825 1.523 0.998 1.040 1.234 1.220 1.478 1.057 84013 5.000 0.932 0.874 0.891 0.903 0.979 0.833 1.029 84014 1.715 1.678 1.052 0.994 1.048 1.097 1.109 0.978 84015 0.947 1.173 0.998 0.994 0.996 1.067 0.890 0.978 84016 0.926 1.173 0.998 0.994 0.996 1.067 0.890 0.978 84017 2.480 0.932 0.998 1.142 1.132 1.067 0.833 1.043 84018 4.132 0.975 0.998 1.101 1.132 1.013 0.890 1.029 84020 3.592 0.932 0.945 1.069 0.970 0.953 1.238 1.013 84021 1.232 0.766 0.945 1.142 1.072 1.056 0.833 1.236 84022 1.389 1.173 0.874 0.994 1.048 1.145 0.833 0.952 84023 2.316 0.766 1.052 1.350 0.996 0.953 0.783 1.043 84024 1.087 1.017 0.998 1.142 1.132 1.097 0.890 0.998 84025 1.429 1.678 1.626 1.101 1.174 1.220 0.890 1.057 84026 1.162 0.766 0.998 1.176 0.996 0.953 0.783 0.998 84027 1.614 0.932 0.945 1.142 1.048 1.034 0.958 1.029 84028 1.372 0.886 1.052 0.994 0.996 0.924 1.589 1.074 84029 1.311 1.092 0.945 0.955 0.996 1.097 1.023 0.998 84031 1.102 0.766 0.998 1.142 1.132 1.056 0.783 1.043 84032 1.209 0.830 0.945 1.142 1.072 1.034 0.958 1.074 84033 1.295 0.975 1.052 1.142 1.174 1.097 0.890 1.074 84034 1.241 0.886 0.910 0.973 1.072 1.067 0.958 1.013 84035 0.981 0.766 1.052 1.272 0.996 0.953 0.890 0.978 84036 1.663 0.830 0.998 1.176 1.132 1.067 0.833 1.057 84037 1.277 1.678 1.231 1.101 1.023 1.034 1.023 1.123 84038 1.156 0.830 1.052 0.994 0.996 0.897 0.833 1.057 84039 1.569 0.830 1.052 1.218 1.023 0.979 0.783 1.057 84040 0.996 1.678 1.231 1.040 1.048 1.034 1.023 1.092 84041 1.090 1.406 1.052 0.994 1.023 1.013 0.958 1.029 84042 1.106 0.975 0.945 1.069 0.996 1.013 0.958 1.185 84043 1.253 0.886 0.910 0.955 0.903 0.953 0.890 1.043 84044 1.021 1.173 0.910 1.069 0.970 1.067 1.796 0.952 84045 4.107 0.886 0.874 0.891 0.903 0.979 0.833 1.074 84046 1.110 0.830 1.052 1.272 0.996 0.924 0.783 0.998 84047 0.958 0.975 0.945 1.101 1.023 0.995 1.589 0.998 84049 2.028 0.886 0.998 1.272 1.132 1.097 1.023 1.092 84050 1.862 1.092 1.052 1.101 1.174 1.122 1.023 1.057 84051 1.302 0.709 0.910 1.142 1.072 1.034 0.890 1.057 84052 1.241 0.766 0.945 1.142 0.996 0.924 0.783 1.029 84053 1.363 0.766 0.998 1.218 0.970 0.924 0.833 1.074 84054 1.312 1.285 0.910 0.973 1.072 1.067 1.478 1.074 84055 1.386 0.886 0.945 1.272 1.132 1.067 0.890 1.074 84056 0.926 1.285 1.052 0.973 1.048 1.034 0.958 0.998 84057 1.105 0.932 0.910 1.218 0.970 1.013 0.890 1.185 84058 1.429 0.932 0.945 1.069 0.996 1.034 0.958 1.185 84059 1.232 0.932 0.910 1.218 0.970 1.013 0.890 1.185 84060 1.728 0.886 0.945 1.142 1.072 1.013 1.238 1.057 84061 2.119 0.830 0.998 1.176 1.132 1.056 0.890 1.043 84062 2.030 0.932 0.945 1.069 1.023 1.013 0.958 1.152 84063 1.344 0.830 0.998 1.142 1.023 0.979 0.833 1.029 84064 1.215 0.766 0.874 0.935 0.970 0.897 1.023 0.978 84065 1.679 0.932 0.910 1.069 0.903 0.924 1.023 0.998 84066 1.209 0.766 0.945 1.142 0.970 0.979 0.833 1.123 84067 0.958 1.173 0.998 0.994 1.174 1.145 1.023 1.013\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3351 Rates and Factors","pages":[{"line_numbers":[],"markdown":"### **Property Section Rates and Factors**\n\n**Utah Property ZC Factors** Dwelling Structure, Mobile Home Structure **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84001 1.155 0.709 0.945 1.101 1.048 0.979 0.833 1.043 84002 3.445 0.709 0.945 1.142 1.048 0.995 0.783 1.043 84003 1.367 0.932 0.910 0.994 0.970 0.995 0.958 1.074 84004 1.879 0.932 0.945 1.069 0.996 0.995 1.023 1.123 84005 5.000 0.830 0.874 0.833 0.903 0.979 0.833 1.074 84006 5.000 1.173 0.910 1.142 0.970 1.122 1.109 0.952 84007 1.179 0.709 0.910 1.142 1.023 0.995 0.783 1.109 84008 0.958 0.766 1.052 1.272 0.996 0.953 0.890 0.978 84009 0.999 1.017 0.945 1.069 0.941 1.013 1.353 0.952 84010 1.103 1.523 0.998 1.040 1.234 1.220 1.478 1.057 84011 0.825 1.523 0.998 1.040 1.234 1.220 1.478 1.057 84013 5.000 0.932 0.874 0.891 0.903 0.979 0.833 1.029 84014 1.715 1.678 1.052 0.994 1.048 1.097 1.109 0.978 84015 0.947 1.173 0.998 0.994 0.996 1.067 0.890 0.978 84016 0.926 1.173 0.998 0.994 0.996 1.067 0.890 0.978 84017 2.480 0.932 0.998 1.142 1.132 1.067 0.833 1.043 84018 4.132 0.975 0.998 1.101 1.132 1.013 0.890 1.029 84020 3.592 0.932 0.945 1.069 0.970 0.953 1.238 1.013 84021 1.232 0.766 0.945 1.142 1.072 1.056 0.833 1.236 84022 1.389 1.173 0.874 0.994 1.048 1.145 0.833 0.952 84023 2.316 0.766 1.052 1.350 0.996 0.953 0.783 1.043 84024 1.087 1.017 0.998 1.142 1.132 1.097 0.890 0.998 84025 1.429 1.678 1.626 1.101 1.174 1.220 0.890 1.057 84026 1.162 0.766 0.998 1.176 0.996 0.953 0.783 0.998 84027 1.614 0.932 0.945 1.142 1.048 1.034 0.958 1.029 84028 1.372 0.886 1.052 0.994 0.996 0.924 1.589 1.074 84029 1.311 1.092 0.945 0.955 0.996 1.097 1.023 0.998 84031 1.102 0.766 0.998 1.142 1.132 1.056 0.783 1.043 84032 1.209 0.830 0.945 1.142 1.072 1.034 0.958 1.074 84033 1.295 0.975 1.052 1.142 1.174 1.097 0.890 1.074 84034 1.241 0.886 0.910 0.973 1.072 1.067 0.958 1.013 84035 0.981 0.766 1.052 1.272 0.996 0.953 0.890 0.978 84036 1.663 0.830 0.998 1.176 1.132 1.067 0.833 1.057 84037 1.277 1.678 1.231 1.101 1.023 1.034 1.023 1.123 84038 1.156 0.830 1.052 0.994 0.996 0.897 0.833 1.057 84039 1.569 0.830 1.052 1.218 1.023 0.979 0.783 1.057 84040 0.996 1.678 1.231 1.040 1.048 1.034 1.023 1.092 84041 1.090 1.406 1.052 0.994 1.023 1.013 0.958 1.029 84042 1.106 0.975 0.945 1.069 0.996 1.013 0.958 1.185 84043 1.253 0.886 0.910 0.955 0.903 0.953 0.890 1.043 84044 1.021 1.173 0.910 1.069 0.970 1.067 1.796 0.952 84045 4.107 0.886 0.874 0.891 0.903 0.979 0.833 1.074 84046 1.110 0.830 1.052 1.272 0.996 0.924 0.783 0.998 84047 0.958 0.975 0.945 1.101 1.023 0.995 1.589 0.998 84049 2.028 0.886 0.998 1.272 1.132 1.097 1.023 1.092 84050 1.862 1.092 1.052 1.101 1.174 1.122 1.023 1.057 84051 1.302 0.709 0.910 1.142 1.072 1.034 0.890 1.057 84052 1.241 0.766 0.945 1.142 0.996 0.924 0.783 1.029 84053 1.363 0.766 0.998 1.218 0.970 0.924 0.833 1.074 84054 1.312 1.285 0.910 0.973 1.072 1.067 1.478 1.074 84055 1.386 0.886 0.945 1.272 1.132 1.067 0.890 1.074 84056 0.926 1.285 1.052 0.973 1.048 1.034 0.958 0.998 84057 1.105 0.932 0.910 1.218 0.970 1.013 0.890 1.185 84058 1.429 0.932 0.945 1.069 0.996 1.034 0.958 1.185 84059 1.232 0.932 0.910 1.218 0.970 1.013 0.890 1.185 84060 1.728 0.886 0.945 1.142 1.072 1.013 1.238 1.057 84061 2.119 0.830 0.998 1.176 1.132 1.056 0.890 1.043 84062 2.030 0.932 0.945 1.069 1.023 1.013 0.958 1.152 84063 1.344 0.830 0.998 1.142 1.023 0.979 0.833 1.029 84064 1.215 0.766 0.874 0.935 0.970 0.897 1.023 0.978 84065 1.679 0.932 0.910 1.069 0.903 0.924 1.023 0.998 84066 1.209 0.766 0.945 1.142 0.970 0.979 0.833 1.123 84067 0.958 1.173 0.998 0.994 1.174 1.145 1.023 1.013\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3351 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Property Section Rates and Factors**\n\n**Utah Property ZC Factors** Dwelling Structure, Mobile Home Structure **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84001 1.155 0.709 0.945 1.101 1.048 0.979 0.833 1.043 84002 3.445 0.709 0.945 1.142 1.048 0.995 0.783 1.043 84003 1.367 0.932 0.910 0.994 0.970 0.995 0.958 1.074 84004 1.879 0.932 0.945 1.069 0.996 0.995 1.023 1.123 84005 5.000 0.830 0.874 0.833 0.903 0.979 0.833 1.074 84006 5.000 1.173 0.910 1.142 0.970 1.122 1.109 0.952 84007 1.179 0.709 0.910 1.142 1.023 0.995 0.783 1.109 84008 0.958 0.766 1.052 1.272 0.996 0.953 0.890 0.978 84009 0.999 1.017 0.945 1.069 0.941 1.013 1.353 0.952 84010 1.103 1.523 0.998 1.040 1.234 1.220 1.478 1.057 84011 0.825 1.523 0.998 1.040 1.234 1.220 1.478 1.057 84013 5.000 0.932 0.874 0.891 0.903 0.979 0.833 1.029 84014 1.715 1.678 1.052 0.994 1.048 1.097 1.109 0.978 84015 0.947 1.173 0.998 0.994 0.996 1.067 0.890 0.978 84016 0.926 1.173 0.998 0.994 0.996 1.067 0.890 0.978 84017 2.480 0.932 0.998 1.142 1.132 1.067 0.833 1.043 84018 4.132 0.975 0.998 1.101 1.132 1.013 0.890 1.029 84020 3.592 0.932 0.945 1.069 0.970 0.953 1.238 1.013 84021 1.232 0.766 0.945 1.142 1.072 1.056 0.833 1.236 84022 1.389 1.173 0.874 0.994 1.048 1.145 0.833 0.952 84023 2.316 0.766 1.052 1.350 0.996 0.953 0.783 1.043 84024 1.087 1.017 0.998 1.142 1.132 1.097 0.890 0.998 84025 1.429 1.678 1.626 1.101 1.174 1.220 0.890 1.057 84026 1.162 0.766 0.998 1.176 0.996 0.953 0.783 0.998 84027 1.614 0.932 0.945 1.142 1.048 1.034 0.958 1.029 84028 1.372 0.886 1.052 0.994 0.996 0.924 1.589 1.074 84029 1.311 1.092 0.945 0.955 0.996 1.097 1.023 0.998 84031 1.102 0.766 0.998 1.142 1.132 1.056 0.783 1.043 84032 1.209 0.830 0.945 1.142 1.072 1.034 0.958 1.074 84033 1.295 0.975 1.052 1.142 1.174 1.097 0.890 1.074 84034 1.241 0.886 0.910 0.973 1.072 1.067 0.958 1.013 84035 0.981 0.766 1.052 1.272 0.996 0.953 0.890 0.978 84036 1.663 0.830 0.998 1.176 1.132 1.067 0.833 1.057 84037 1.277 1.678 1.231 1.101 1.023 1.034 1.023 1.123 84038 1.156 0.830 1.052 0.994 0.996 0.897 0.833 1.057 84039 1.569 0.830 1.052 1.218 1.023 0.979 0.783 1.057 84040 0.996 1.678 1.231 1.040 1.048 1.034 1.023 1.092 84041 1.090 1.406 1.052 0.994 1.023 1.013 0.958 1.029 84042 1.106 0.975 0.945 1.069 0.996 1.013 0.958 1.185 84043 1.253 0.886 0.910 0.955 0.903 0.953 0.890 1.043 84044 1.021 1.173 0.910 1.069 0.970 1.067 1.796 0.952 84045 4.107 0.886 0.874 0.891 0.903 0.979 0.833 1.074 84046 1.110 0.830 1.052 1.272 0.996 0.924 0.783 0.998 84047 0.958 0.975 0.945 1.101 1.023 0.995 1.589 0.998 84049 2.028 0.886 0.998 1.272 1.132 1.097 1.023 1.092 84050 1.862 1.092 1.052 1.101 1.174 1.122 1.023 1.057 84051 1.302 0.709 0.910 1.142 1.072 1.034 0.890 1.057 84052 1.241 0.766 0.945 1.142 0.996 0.924 0.783 1.029 84053 1.363 0.766 0.998 1.218 0.970 0.924 0.833 1.074 84054 1.312 1.285 0.910 0.973 1.072 1.067 1.478 1.074 84055 1.386 0.886 0.945 1.272 1.132 1.067 0.890 1.074 84056 0.926 1.285 1.052 0.973 1.048 1.034 0.958 0.998 84057 1.105 0.932 0.910 1.218 0.970 1.013 0.890 1.185 84058 1.429 0.932 0.945 1.069 0.996 1.034 0.958 1.185 84059 1.232 0.932 0.910 1.218 0.970 1.013 0.890 1.185 84060 1.728 0.886 0.945 1.142 1.072 1.013 1.238 1.057 84061 2.119 0.830 0.998 1.176 1.132 1.056 0.890 1.043 84062 2.030 0.932 0.945 1.069 1.023 1.013 0.958 1.152 84063 1.344 0.830 0.998 1.142 1.023 0.979 0.833 1.029 84064 1.215 0.766 0.874 0.935 0.970 0.897 1.023 0.978 84065 1.679 0.932 0.910 1.069 0.903 0.924 1.023 0.998 84066 1.209 0.766 0.945 1.142 0.970 0.979 0.833 1.123 84067 0.958 1.173 0.998 0.994 1.174 1.145 1.023 1.013\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3351 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page19.pdf"]},"response":{"errors":[],"extract_id":"extract_282cd104f7ce5c7db13771de339a0c86","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Property Section Rates and Factors**\n\n**Utah Property ZC Factors** Dwelling Structure, Mobile Home Structure **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84001 1.155 0.709 0.945 1.101 1.048 0.979 0.833 1.043 84002 3.445 0.709 0.945 1.142 1.048 0.995 0.783 1.043 84003 1.367 0.932 0.910 0.994 0.970 0.995 0.958 1.074 84004 1.879 0.932 0.945 1.069 0.996 0.995 1.023 1.123 84005 5.000 0.830 0.874 0.833 0.903 0.979 0.833 1.074 84006 5.000 1.173 0.910 1.142 0.970 1.122 1.109 0.952 84007 1.179 0.709 0.910 1.142 1.023 0.995 0.783 1.109 84008 0.958 0.766 1.052 1.272 0.996 0.953 0.890 0.978 84009 0.999 1.017 0.945 1.069 0.941 1.013 1.353 0.952 84010 1.103 1.523 0.998 1.040 1.234 1.220 1.478 1.057 84011 0.825 1.523 0.998 1.040 1.234 1.220 1.478 1.057 84013 5.000 0.932 0.874 0.891 0.903 0.979 0.833 1.029 84014 1.715 1.678 1.052 0.994 1.048 1.097 1.109 0.978 84015 0.947 1.173 0.998 0.994 0.996 1.067 0.890 0.978 84016 0.926 1.173 0.998 0.994 0.996 1.067 0.890 0.978 84017 2.480 0.932 0.998 1.142 1.132 1.067 0.833 1.043 84018 4.132 0.975 0.998 1.101 1.132 1.013 0.890 1.029 84020 3.592 0.932 0.945 1.069 0.970 0.953 1.238 1.013 84021 1.232 0.766 0.945 1.142 1.072 1.056 0.833 1.236 84022 1.389 1.173 0.874 0.994 1.048 1.145 0.833 0.952 84023 2.316 0.766 1.052 1.350 0.996 0.953 0.783 1.043 84024 1.087 1.017 0.998 1.142 1.132 1.097 0.890 0.998 84025 1.429 1.678 1.626 1.101 1.174 1.220 0.890 1.057 84026 1.162 0.766 0.998 1.176 0.996 0.953 0.783 0.998 84027 1.614 0.932 0.945 1.142 1.048 1.034 0.958 1.029 84028 1.372 0.886 1.052 0.994 0.996 0.924 1.589 1.074 84029 1.311 1.092 0.945 0.955 0.996 1.097 1.023 0.998 84031 1.102 0.766 0.998 1.142 1.132 1.056 0.783 1.043 84032 1.209 0.830 0.945 1.142 1.072 1.034 0.958 1.074 84033 1.295 0.975 1.052 1.142 1.174 1.097 0.890 1.074 84034 1.241 0.886 0.910 0.973 1.072 1.067 0.958 1.013 84035 0.981 0.766 1.052 1.272 0.996 0.953 0.890 0.978 84036 1.663 0.830 0.998 1.176 1.132 1.067 0.833 1.057 84037 1.277 1.678 1.231 1.101 1.023 1.034 1.023 1.123 84038 1.156 0.830 1.052 0.994 0.996 0.897 0.833 1.057 84039 1.569 0.830 1.052 1.218 1.023 0.979 0.783 1.057 84040 0.996 1.678 1.231 1.040 1.048 1.034 1.023 1.092 84041 1.090 1.406 1.052 0.994 1.023 1.013 0.958 1.029 84042 1.106 0.975 0.945 1.069 0.996 1.013 0.958 1.185 84043 1.253 0.886 0.910 0.955 0.903 0.953 0.890 1.043 84044 1.021 1.173 0.910 1.069 0.970 1.067 1.796 0.952 84045 4.107 0.886 0.874 0.891 0.903 0.979 0.833 1.074 84046 1.110 0.830 1.052 1.272 0.996 0.924 0.783 0.998 84047 0.958 0.975 0.945 1.101 1.023 0.995 1.589 0.998 84049 2.028 0.886 0.998 1.272 1.132 1.097 1.023 1.092 84050 1.862 1.092 1.052 1.101 1.174 1.122 1.023 1.057 84051 1.302 0.709 0.910 1.142 1.072 1.034 0.890 1.057 84052 1.241 0.766 0.945 1.142 0.996 0.924 0.783 1.029 84053 1.363 0.766 0.998 1.218 0.970 0.924 0.833 1.074 84054 1.312 1.285 0.910 0.973 1.072 1.067 1.478 1.074 84055 1.386 0.886 0.945 1.272 1.132 1.067 0.890 1.074 84056 0.926 1.285 1.052 0.973 1.048 1.034 0.958 0.998 84057 1.105 0.932 0.910 1.218 0.970 1.013 0.890 1.185 84058 1.429 0.932 0.945 1.069 0.996 1.034 0.958 1.185 84059 1.232 0.932 0.910 1.218 0.970 1.013 0.890 1.185 84060 1.728 0.886 0.945 1.142 1.072 1.013 1.238 1.057 84061 2.119 0.830 0.998 1.176 1.132 1.056 0.890 1.043 84062 2.030 0.932 0.945 1.069 1.023 1.013 0.958 1.152 84063 1.344 0.830 0.998 1.142 1.023 0.979 0.833 1.029 84064 1.215 0.766 0.874 0.935 0.970 0.897 1.023 0.978 84065 1.679 0.932 0.910 1.069 0.903 0.924 1.023 0.998 84066 1.209 0.766 0.945 1.142 0.970 0.979 0.833 1.123 84067 0.958 1.173 0.998 0.994 1.174 1.145 1.023 1.013\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3351 Rates and Factors"],"full_content":"### **Property Section Rates and Factors**\n\n**Utah Property ZC Factors** Dwelling Structure, Mobile Home Structure **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84001 1.155 0.709 0.945 1.101 1.048 0.979 0.833 1.043 84002 3.445 0.709 0.945 1.142 1.048 0.995 0.783 1.043 84003 1.367 0.932 0.910 0.994 0.970 0.995 0.958 1.074 84004 1.879 0.932 0.945 1.069 0.996 0.995 1.023 1.123 84005 5.000 0.830 0.874 0.833 0.903 0.979 0.833 1.074 84006 5.000 1.173 0.910 1.142 0.970 1.122 1.109 0.952 84007 1.179 0.709 0.910 1.142 1.023 0.995 0.783 1.109 84008 0.958 0.766 1.052 1.272 0.996 0.953 0.890 0.978 84009 0.999 1.017 0.945 1.069 0.941 1.013 1.353 0.952 84010 1.103 1.523 0.998 1.040 1.234 1.220 1.478 1.057 84011 0.825 1.523 0.998 1.040 1.234 1.220 1.478 1.057 84013 5.000 0.932 0.874 0.891 0.903 0.979 0.833 1.029 84014 1.715 1.678 1.052 0.994 1.048 1.097 1.109 0.978 84015 0.947 1.173 0.998 0.994 0.996 1.067 0.890 0.978 84016 0.926 1.173 0.998 0.994 0.996 1.067 0.890 0.978 84017 2.480 0.932 0.998 1.142 1.132 1.067 0.833 1.043 84018 4.132 0.975 0.998 1.101 1.132 1.013 0.890 1.029 84020 3.592 0.932 0.945 1.069 0.970 0.953 1.238 1.013 84021 1.232 0.766 0.945 1.142 1.072 1.056 0.833 1.236 84022 1.389 1.173 0.874 0.994 1.048 1.145 0.833 0.952 84023 2.316 0.766 1.052 1.350 0.996 0.953 0.783 1.043 84024 1.087 1.017 0.998 1.142 1.132 1.097 0.890 0.998 84025 1.429 1.678 1.626 1.101 1.174 1.220 0.890 1.057 84026 1.162 0.766 0.998 1.176 0.996 0.953 0.783 0.998 84027 1.614 0.932 0.945 1.142 1.048 1.034 0.958 1.029 84028 1.372 0.886 1.052 0.994 0.996 0.924 1.589 1.074 84029 1.311 1.092 0.945 0.955 0.996 1.097 1.023 0.998 84031 1.102 0.766 0.998 1.142 1.132 1.056 0.783 1.043 84032 1.209 0.830 0.945 1.142 1.072 1.034 0.958 1.074 84033 1.295 0.975 1.052 1.142 1.174 1.097 0.890 1.074 84034 1.241 0.886 0.910 0.973 1.072 1.067 0.958 1.013 84035 0.981 0.766 1.052 1.272 0.996 0.953 0.890 0.978 84036 1.663 0.830 0.998 1.176 1.132 1.067 0.833 1.057 84037 1.277 1.678 1.231 1.101 1.023 1.034 1.023 1.123 84038 1.156 0.830 1.052 0.994 0.996 0.897 0.833 1.057 84039 1.569 0.830 1.052 1.218 1.023 0.979 0.783 1.057 84040 0.996 1.678 1.231 1.040 1.048 1.034 1.023 1.092 84041 1.090 1.406 1.052 0.994 1.023 1.013 0.958 1.029 84042 1.106 0.975 0.945 1.069 0.996 1.013 0.958 1.185 84043 1.253 0.886 0.910 0.955 0.903 0.953 0.890 1.043 84044 1.021 1.173 0.910 1.069 0.970 1.067 1.796 0.952 84045 4.107 0.886 0.874 0.891 0.903 0.979 0.833 1.074 84046 1.110 0.830 1.052 1.272 0.996 0.924 0.783 0.998 84047 0.958 0.975 0.945 1.101 1.023 0.995 1.589 0.998 84049 2.028 0.886 0.998 1.272 1.132 1.097 1.023 1.092 84050 1.862 1.092 1.052 1.101 1.174 1.122 1.023 1.057 84051 1.302 0.709 0.910 1.142 1.072 1.034 0.890 1.057 84052 1.241 0.766 0.945 1.142 0.996 0.924 0.783 1.029 84053 1.363 0.766 0.998 1.218 0.970 0.924 0.833 1.074 84054 1.312 1.285 0.910 0.973 1.072 1.067 1.478 1.074 84055 1.386 0.886 0.945 1.272 1.132 1.067 0.890 1.074 84056 0.926 1.285 1.052 0.973 1.048 1.034 0.958 0.998 84057 1.105 0.932 0.910 1.218 0.970 1.013 0.890 1.185 84058 1.429 0.932 0.945 1.069 0.996 1.034 0.958 1.185 84059 1.232 0.932 0.910 1.218 0.970 1.013 0.890 1.185 84060 1.728 0.886 0.945 1.142 1.072 1.013 1.238 1.057 84061 2.119 0.830 0.998 1.176 1.132 1.056 0.890 1.043 84062 2.030 0.932 0.945 1.069 1.023 1.013 0.958 1.152 84063 1.344 0.830 0.998 1.142 1.023 0.979 0.833 1.029 84064 1.215 0.766 0.874 0.935 0.970 0.897 1.023 0.978 84065 1.679 0.932 0.910 1.069 0.903 0.924 1.023 0.998 84066 1.209 0.766 0.945 1.142 0.970 0.979 0.833 1.123 84067 0.958 1.173 0.998 0.994 1.174 1.145 1.023 1.013\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3351 Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page19.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page19.pdf"},"request":{"example_id":"table/FBLB-134215544_page19","product_type":"parse","source_file_path":"FBLB-134215544_page19.pdf"},"started_at":"2026-11-04T19:46:57.222611"} +{"completed_at":"2026-11-04T19:47:00.197213","latency_in_ms":1145,"output":{"example_id":"table/FBLB-134215544_page43","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\nUtah\n\n**Coverages & Endorsements that Only Apply Once Per Policy**\n\n**Fire Department Service Charge Coverage** Rate $0.22\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\nRate Minimum Premium $0.43\n\n**Property Loss Assessment Coverage**\n\n$0.34 Layer 1 $0.32 Layer Base Rate per $100\n\n$30.00\n\nPremium\n\nDairy $30.00\n\nLayer 4 $0.45\n\n$25.00\n\n**Farm Ranch Equipment Breakdown Coverage**\n\nLayer 2\n\nType of Operation\n\nOther $0.195\n\n**Identity Services & Fraud Expense Coverage**\n\nLayer 3 $0.38\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3431 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\nUtah\n\n**Coverages & Endorsements that Only Apply Once Per Policy**\n\n**Fire Department Service Charge Coverage** Rate $0.22\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\nRate Minimum Premium $0.43\n\n**Property Loss Assessment Coverage**\n\n$0.34 Layer 1 $0.32 Layer Base Rate per $100\n\n$30.00\n\nPremium\n\nDairy $30.00\n\nLayer 4 $0.45\n\n$25.00\n\n**Farm Ranch Equipment Breakdown Coverage**\n\nLayer 2\n\nType of Operation\n\nOther $0.195\n\n**Identity Services & Fraud Expense Coverage**\n\nLayer 3 $0.38\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3431 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\nUtah\n\n**Coverages & Endorsements that Only Apply Once Per Policy**\n\n**Fire Department Service Charge Coverage** Rate $0.22\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\nRate Minimum Premium $0.43\n\n**Property Loss Assessment Coverage**\n\n$0.34 Layer 1 $0.32 Layer Base Rate per $100\n\n$30.00\n\nPremium\n\nDairy $30.00\n\nLayer 4 $0.45\n\n$25.00\n\n**Farm Ranch Equipment Breakdown Coverage**\n\nLayer 2\n\nType of Operation\n\nOther $0.195\n\n**Identity Services & Fraud Expense Coverage**\n\nLayer 3 $0.38\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3431 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page43.pdf"]},"response":{"errors":[],"extract_id":"extract_3ae9b6a5c6e0d064cc65739c7bb1a62a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\nUtah\n\n**Coverages & Endorsements that Only Apply Once Per Policy**\n\n**Fire Department Service Charge Coverage** Rate $0.22\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\nRate Minimum Premium $0.43\n\n**Property Loss Assessment Coverage**\n\n$0.34 Layer 1 $0.32 Layer Base Rate per $100\n\n$30.00\n\nPremium\n\nDairy $30.00\n\nLayer 4 $0.45\n\n$25.00\n\n**Farm Ranch Equipment Breakdown Coverage**\n\nLayer 2\n\nType of Operation\n\nOther $0.195\n\n**Identity Services & Fraud Expense Coverage**\n\nLayer 3 $0.38\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3431 Rates and Factors"],"full_content":"**Property Section Rates and Factors**\n\nUtah\n\n**Coverages & Endorsements that Only Apply Once Per Policy**\n\n**Fire Department Service Charge Coverage** Rate $0.22\n\n**Individual Risk Premium Modification** Base Factor of 1.00 IRPM Factor Minimum 0.75 Maximum 1.25\n\nRate Minimum Premium $0.43\n\n**Property Loss Assessment Coverage**\n\n$0.34 Layer 1 $0.32 Layer Base Rate per $100\n\n$30.00\n\nPremium\n\nDairy $30.00\n\nLayer 4 $0.45\n\n$25.00\n\n**Farm Ranch Equipment Breakdown Coverage**\n\nLayer 2\n\nType of Operation\n\nOther $0.195\n\n**Identity Services & Fraud Expense Coverage**\n\nLayer 3 $0.38\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3431 Rates and Factors","publish_date":null,"title":"Coverages & Endorsements that Only Apply Once Per Policy","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page43.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page43.pdf"},"request":{"example_id":"table/FBLB-134215544_page43","product_type":"parse","source_file_path":"FBLB-134215544_page43.pdf"},"started_at":"2026-11-04T19:46:59.051542"} +{"completed_at":"2026-11-04T19:47:01.397559","latency_in_ms":1189,"output":{"example_id":"table/FBLB-134215544_page44","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\n**Factors Used in Determining the Property Multipliers**\n\nNonFarm Farm SmallFarm\n\nSmall Farm Indicator Location Type\\* Y N Farm All 1.000 1.000 Non-Farm 0 Years 1.000 1.000 Non-Farm 1 Year 1.000 1.000 Non-Farm 2 Years 0.980 0.980 Non-Farm 3 Years 0.980 0.980 Non-Farm 4 Years 0.970 0.970 Non-Farm 5 Years 0.970 0.970 Non-Farm 6 Years 0.960 0.960 Non-Farm 7 Years 0.960 0.960 Non-Farm 8 Years 0.950 0.950 Non-Farm 9 Years 0.950 0.950 Non-Farm 10 Years 0.940 0.940 Non-Farm 11 Years 0.940 0.940 Non-Farm 12 Years 0.940 0.940 Non-Farm 13 Years 0.930 0.930 Non-Farm 14 Years 0.930 0.930 Non-Farm 15 Years 0.930 0.930 Non-Farm 16 Years 0.920 0.920 Non-Farm 17 Years 0.920 0.920 Non-Farm 18 Years 0.920 0.920 Non-Farm 19 Years 0.910 0.910 Non-Farm 20 Years 0.910 0.910 Non-Farm 21 Years 0.910 0.910 Non-Farm 22 Years 0.900 0.900 Non-Farm 23 Years 0.900 0.900 Non-Farm 24 Years 0.900 0.900 Non-Farm 25 Years 0.900 0.900 Non-Farm 26 Years 0.890 0.890 Non-Farm 27 Years 0.890 0.890 Non-Farm 28 Years 0.890 0.890 Non-Farm 29 Years 0.890 0.890 Non-Farm 30+ Years 0.880 0.880 \\* Farm/Ranch Personal Property uses the primary location type\n\n**Continued in Force Factors**\n\nYears\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3437 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\n**Factors Used in Determining the Property Multipliers**\n\nNonFarm Farm SmallFarm\n\nSmall Farm Indicator Location Type\\* Y N Farm All 1.000 1.000 Non-Farm 0 Years 1.000 1.000 Non-Farm 1 Year 1.000 1.000 Non-Farm 2 Years 0.980 0.980 Non-Farm 3 Years 0.980 0.980 Non-Farm 4 Years 0.970 0.970 Non-Farm 5 Years 0.970 0.970 Non-Farm 6 Years 0.960 0.960 Non-Farm 7 Years 0.960 0.960 Non-Farm 8 Years 0.950 0.950 Non-Farm 9 Years 0.950 0.950 Non-Farm 10 Years 0.940 0.940 Non-Farm 11 Years 0.940 0.940 Non-Farm 12 Years 0.940 0.940 Non-Farm 13 Years 0.930 0.930 Non-Farm 14 Years 0.930 0.930 Non-Farm 15 Years 0.930 0.930 Non-Farm 16 Years 0.920 0.920 Non-Farm 17 Years 0.920 0.920 Non-Farm 18 Years 0.920 0.920 Non-Farm 19 Years 0.910 0.910 Non-Farm 20 Years 0.910 0.910 Non-Farm 21 Years 0.910 0.910 Non-Farm 22 Years 0.900 0.900 Non-Farm 23 Years 0.900 0.900 Non-Farm 24 Years 0.900 0.900 Non-Farm 25 Years 0.900 0.900 Non-Farm 26 Years 0.890 0.890 Non-Farm 27 Years 0.890 0.890 Non-Farm 28 Years 0.890 0.890 Non-Farm 29 Years 0.890 0.890 Non-Farm 30+ Years 0.880 0.880 \\* Farm/Ranch Personal Property uses the primary location type\n\n**Continued in Force Factors**\n\nYears\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3437 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\n**Factors Used in Determining the Property Multipliers**\n\nNonFarm Farm SmallFarm\n\nSmall Farm Indicator Location Type\\* Y N Farm All 1.000 1.000 Non-Farm 0 Years 1.000 1.000 Non-Farm 1 Year 1.000 1.000 Non-Farm 2 Years 0.980 0.980 Non-Farm 3 Years 0.980 0.980 Non-Farm 4 Years 0.970 0.970 Non-Farm 5 Years 0.970 0.970 Non-Farm 6 Years 0.960 0.960 Non-Farm 7 Years 0.960 0.960 Non-Farm 8 Years 0.950 0.950 Non-Farm 9 Years 0.950 0.950 Non-Farm 10 Years 0.940 0.940 Non-Farm 11 Years 0.940 0.940 Non-Farm 12 Years 0.940 0.940 Non-Farm 13 Years 0.930 0.930 Non-Farm 14 Years 0.930 0.930 Non-Farm 15 Years 0.930 0.930 Non-Farm 16 Years 0.920 0.920 Non-Farm 17 Years 0.920 0.920 Non-Farm 18 Years 0.920 0.920 Non-Farm 19 Years 0.910 0.910 Non-Farm 20 Years 0.910 0.910 Non-Farm 21 Years 0.910 0.910 Non-Farm 22 Years 0.900 0.900 Non-Farm 23 Years 0.900 0.900 Non-Farm 24 Years 0.900 0.900 Non-Farm 25 Years 0.900 0.900 Non-Farm 26 Years 0.890 0.890 Non-Farm 27 Years 0.890 0.890 Non-Farm 28 Years 0.890 0.890 Non-Farm 29 Years 0.890 0.890 Non-Farm 30+ Years 0.880 0.880 \\* Farm/Ranch Personal Property uses the primary location type\n\n**Continued in Force Factors**\n\nYears\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3437 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page44.pdf"]},"response":{"errors":[],"extract_id":"extract_297b32097f265a6c1f07643c281cd6b7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\n**Factors Used in Determining the Property Multipliers**\n\nNonFarm Farm SmallFarm\n\nSmall Farm Indicator Location Type\\* Y N Farm All 1.000 1.000 Non-Farm 0 Years 1.000 1.000 Non-Farm 1 Year 1.000 1.000 Non-Farm 2 Years 0.980 0.980 Non-Farm 3 Years 0.980 0.980 Non-Farm 4 Years 0.970 0.970 Non-Farm 5 Years 0.970 0.970 Non-Farm 6 Years 0.960 0.960 Non-Farm 7 Years 0.960 0.960 Non-Farm 8 Years 0.950 0.950 Non-Farm 9 Years 0.950 0.950 Non-Farm 10 Years 0.940 0.940 Non-Farm 11 Years 0.940 0.940 Non-Farm 12 Years 0.940 0.940 Non-Farm 13 Years 0.930 0.930 Non-Farm 14 Years 0.930 0.930 Non-Farm 15 Years 0.930 0.930 Non-Farm 16 Years 0.920 0.920 Non-Farm 17 Years 0.920 0.920 Non-Farm 18 Years 0.920 0.920 Non-Farm 19 Years 0.910 0.910 Non-Farm 20 Years 0.910 0.910 Non-Farm 21 Years 0.910 0.910 Non-Farm 22 Years 0.900 0.900 Non-Farm 23 Years 0.900 0.900 Non-Farm 24 Years 0.900 0.900 Non-Farm 25 Years 0.900 0.900 Non-Farm 26 Years 0.890 0.890 Non-Farm 27 Years 0.890 0.890 Non-Farm 28 Years 0.890 0.890 Non-Farm 29 Years 0.890 0.890 Non-Farm 30+ Years 0.880 0.880 \\* Farm/Ranch Personal Property uses the primary location type\n\n**Continued in Force Factors**\n\nYears\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3437 Rates and Factors"],"full_content":"**Property Section Rates and Factors**\n\n**Factors Used in Determining the Property Multipliers**\n\nNonFarm Farm SmallFarm\n\nSmall Farm Indicator Location Type\\* Y N Farm All 1.000 1.000 Non-Farm 0 Years 1.000 1.000 Non-Farm 1 Year 1.000 1.000 Non-Farm 2 Years 0.980 0.980 Non-Farm 3 Years 0.980 0.980 Non-Farm 4 Years 0.970 0.970 Non-Farm 5 Years 0.970 0.970 Non-Farm 6 Years 0.960 0.960 Non-Farm 7 Years 0.960 0.960 Non-Farm 8 Years 0.950 0.950 Non-Farm 9 Years 0.950 0.950 Non-Farm 10 Years 0.940 0.940 Non-Farm 11 Years 0.940 0.940 Non-Farm 12 Years 0.940 0.940 Non-Farm 13 Years 0.930 0.930 Non-Farm 14 Years 0.930 0.930 Non-Farm 15 Years 0.930 0.930 Non-Farm 16 Years 0.920 0.920 Non-Farm 17 Years 0.920 0.920 Non-Farm 18 Years 0.920 0.920 Non-Farm 19 Years 0.910 0.910 Non-Farm 20 Years 0.910 0.910 Non-Farm 21 Years 0.910 0.910 Non-Farm 22 Years 0.900 0.900 Non-Farm 23 Years 0.900 0.900 Non-Farm 24 Years 0.900 0.900 Non-Farm 25 Years 0.900 0.900 Non-Farm 26 Years 0.890 0.890 Non-Farm 27 Years 0.890 0.890 Non-Farm 28 Years 0.890 0.890 Non-Farm 29 Years 0.890 0.890 Non-Farm 30+ Years 0.880 0.880 \\* Farm/Ranch Personal Property uses the primary location type\n\n**Continued in Force Factors**\n\nYears\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3437 Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page44.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page44.pdf"},"request":{"example_id":"table/FBLB-134215544_page44","product_type":"parse","source_file_path":"FBLB-134215544_page44.pdf"},"started_at":"2026-11-04T19:47:00.208168"} +{"completed_at":"2026-11-04T19:29:58.687547","latency_in_ms":1242,"output":{"example_id":"table/FBLB-134215544_page46","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\n**Factors Used in Determining the Primary Rating Factors**\n\n**Class Factors** Dwelling\n\nHPP, HPPO\n\nMH\n\nMHPP, MHPPO\n\nCondo\n\n**Farm Risk Factors** Dwelling and MH Small Farm/Ranch Location Type Indicator Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Farm/Ranch N 0.856 0.856 0.856 0.856 0.856 0.856 0.856 0.856 Farm/Ranch Y 0.856 0.856 0.856 0.856 0.856 0.856 0.856 0.856 Non Farm/Ranch N 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Non Farm/Ranch Y 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nHPP, HPPO, MHPP, and MHPPO Small Farm/Ranch Location Type Indicator Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Farm/Ranch N 0.845 0.845 0.845 0.845 0.845 0.845 0.845 NA Farm/Ranch Y 0.845 0.845 0.845 0.845 0.845 0.845 0.845 NA Non Farm/Ranch N 1.000 1.000 1.000 1.000 1.000 1.000 1.000 NA Non Farm/Ranch Y 1.000 1.000 1.000 1.000 1.000 1.000 1.000 NA\n\nPeril 4\n\n1\\.000\n\n1\\.000 Peril 8\n\n1\\.400\n\nPeril 5\n\n1\\.000\n\nNA\n\n1\\.283 1.050 N/A\n\n1\\.000\n\n1\\.000 1.270\n\nNA\n\n1\\.192\n\n2\n\n1\\.000 1.000\n\n1\\.000\n\n1\\.000\n\n1\\.270\n\nNA\n\n1\\.030\n\n1\\.000 NA\n\nPeril 3\n\nClass\n\n1\\.000\n\n1\\.050\n\n1\\.135 1.000\n\n1\\.319\n\n1\\.100\n\n2\n\n3\n\n1\\.000\n\nNA\n\n1\\.168 1.025\n\nNA\n\nPeril 4 1.000\n\n1\\.000 1.200\n\nNA\n\n1 Peril 2 Peril 1 Class 1.000 Peril 6 Peril 7 Peril 3\n\n1\\.144\n\n1\\.400\n\n1 Peril 2\n\n1\\.110\n\n1\\.200\n\n1\\.000\n\n2\n\nPeril 8\n\n1\\.000\n\n1\\.246 1.075\n\nPeril 2\n\nPeril 5 1.000 Peril 6\n\n1\\.126\n\n1\\.240\n\n1\\.200\n\n1\\.270\n\n1\\.000 NA 1.014\n\nPeril 5 Peril 6 1.000 1.160\n\n1\\.660\n\nPeril 1 Class\n\nNA\n\n1\\.000\n\nPeril 4 1.000\n\n1\\.050 1.050\n\nPeril 7\n\n1\\.350\n\n1\\.147\n\n1\\.197\n\n1\\.000\n\n1\\.000\n\n1\\.000\n\n1\\.478\n\nPeril 4\n\nPeril 8 Peril 1\n\n1\\.000\n\n1\\.000\n\nNA\n\nPeril 3\n\n1\\.000 1.000 1.000\n\n1\\.246\n\n1\\.000\n\n1\\.050\n\nPeril 5\n\n1\\.480\n\n1\\.000\n\n1\\.000\n\nNA\n\n1\\.000\n\n1\\.200 1.030\n\nPeril 4\n\n1\\.000 1.000\n\n1\\.147\n\n1\\.000 1.030\n\n1\\.000\n\nN/A\n\n1\\.030\n\n4 3 1.110\n\n1\\.000\n\n1\\.000 1.000\n\nPeril 7\n\n1\\.350\n\n1\\.189 2\n\nN/A 4 1.050 1.350 3\n\nPeril 5 1.000 1.000 Peril 1 1\n\n1\\.000 NA\n\nNA\n\nPeril 2\n\nPeril 7\n\n1\\.000 1.000 1.000 NA Peril 8 1 Peril 2 Peril 1 Class\n\n1\\.030\n\n3\n\nPeril 7 Peril 6\n\n1\\.270 2\n\nClass\n\n1\\.000\n\n1\\.030 1.400\n\n1\\.000\n\n1\\.030 1.050\n\nPeril 6 Peril 8 1.000\n\n1\\.400\n\n1\n\n1\\.000\n\n1\\.000\n\nPeril 3\n\n1\\.000 1.126 1.000\n\nPeril 3 1.000\n\n1\\.050\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3472 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\n**Factors Used in Determining the Primary Rating Factors**\n\n**Class Factors** Dwelling\n\nHPP, HPPO\n\nMH\n\nMHPP, MHPPO\n\nCondo\n\n**Farm Risk Factors** Dwelling and MH Small Farm/Ranch Location Type Indicator Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Farm/Ranch N 0.856 0.856 0.856 0.856 0.856 0.856 0.856 0.856 Farm/Ranch Y 0.856 0.856 0.856 0.856 0.856 0.856 0.856 0.856 Non Farm/Ranch N 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Non Farm/Ranch Y 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nHPP, HPPO, MHPP, and MHPPO Small Farm/Ranch Location Type Indicator Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Farm/Ranch N 0.845 0.845 0.845 0.845 0.845 0.845 0.845 NA Farm/Ranch Y 0.845 0.845 0.845 0.845 0.845 0.845 0.845 NA Non Farm/Ranch N 1.000 1.000 1.000 1.000 1.000 1.000 1.000 NA Non Farm/Ranch Y 1.000 1.000 1.000 1.000 1.000 1.000 1.000 NA\n\nPeril 4\n\n1\\.000\n\n1\\.000 Peril 8\n\n1\\.400\n\nPeril 5\n\n1\\.000\n\nNA\n\n1\\.283 1.050 N/A\n\n1\\.000\n\n1\\.000 1.270\n\nNA\n\n1\\.192\n\n2\n\n1\\.000 1.000\n\n1\\.000\n\n1\\.000\n\n1\\.270\n\nNA\n\n1\\.030\n\n1\\.000 NA\n\nPeril 3\n\nClass\n\n1\\.000\n\n1\\.050\n\n1\\.135 1.000\n\n1\\.319\n\n1\\.100\n\n2\n\n3\n\n1\\.000\n\nNA\n\n1\\.168 1.025\n\nNA\n\nPeril 4 1.000\n\n1\\.000 1.200\n\nNA\n\n1 Peril 2 Peril 1 Class 1.000 Peril 6 Peril 7 Peril 3\n\n1\\.144\n\n1\\.400\n\n1 Peril 2\n\n1\\.110\n\n1\\.200\n\n1\\.000\n\n2\n\nPeril 8\n\n1\\.000\n\n1\\.246 1.075\n\nPeril 2\n\nPeril 5 1.000 Peril 6\n\n1\\.126\n\n1\\.240\n\n1\\.200\n\n1\\.270\n\n1\\.000 NA 1.014\n\nPeril 5 Peril 6 1.000 1.160\n\n1\\.660\n\nPeril 1 Class\n\nNA\n\n1\\.000\n\nPeril 4 1.000\n\n1\\.050 1.050\n\nPeril 7\n\n1\\.350\n\n1\\.147\n\n1\\.197\n\n1\\.000\n\n1\\.000\n\n1\\.000\n\n1\\.478\n\nPeril 4\n\nPeril 8 Peril 1\n\n1\\.000\n\n1\\.000\n\nNA\n\nPeril 3\n\n1\\.000 1.000 1.000\n\n1\\.246\n\n1\\.000\n\n1\\.050\n\nPeril 5\n\n1\\.480\n\n1\\.000\n\n1\\.000\n\nNA\n\n1\\.000\n\n1\\.200 1.030\n\nPeril 4\n\n1\\.000 1.000\n\n1\\.147\n\n1\\.000 1.030\n\n1\\.000\n\nN/A\n\n1\\.030\n\n4 3 1.110\n\n1\\.000\n\n1\\.000 1.000\n\nPeril 7\n\n1\\.350\n\n1\\.189 2\n\nN/A 4 1.050 1.350 3\n\nPeril 5 1.000 1.000 Peril 1 1\n\n1\\.000 NA\n\nNA\n\nPeril 2\n\nPeril 7\n\n1\\.000 1.000 1.000 NA Peril 8 1 Peril 2 Peril 1 Class\n\n1\\.030\n\n3\n\nPeril 7 Peril 6\n\n1\\.270 2\n\nClass\n\n1\\.000\n\n1\\.030 1.400\n\n1\\.000\n\n1\\.030 1.050\n\nPeril 6 Peril 8 1.000\n\n1\\.400\n\n1\n\n1\\.000\n\n1\\.000\n\nPeril 3\n\n1\\.000 1.126 1.000\n\nPeril 3 1.000\n\n1\\.050\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3472 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\n**Factors Used in Determining the Primary Rating Factors**\n\n**Class Factors** Dwelling\n\nHPP, HPPO\n\nMH\n\nMHPP, MHPPO\n\nCondo\n\n**Farm Risk Factors** Dwelling and MH Small Farm/Ranch Location Type Indicator Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Farm/Ranch N 0.856 0.856 0.856 0.856 0.856 0.856 0.856 0.856 Farm/Ranch Y 0.856 0.856 0.856 0.856 0.856 0.856 0.856 0.856 Non Farm/Ranch N 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Non Farm/Ranch Y 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nHPP, HPPO, MHPP, and MHPPO Small Farm/Ranch Location Type Indicator Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Farm/Ranch N 0.845 0.845 0.845 0.845 0.845 0.845 0.845 NA Farm/Ranch Y 0.845 0.845 0.845 0.845 0.845 0.845 0.845 NA Non Farm/Ranch N 1.000 1.000 1.000 1.000 1.000 1.000 1.000 NA Non Farm/Ranch Y 1.000 1.000 1.000 1.000 1.000 1.000 1.000 NA\n\nPeril 4\n\n1\\.000\n\n1\\.000 Peril 8\n\n1\\.400\n\nPeril 5\n\n1\\.000\n\nNA\n\n1\\.283 1.050 N/A\n\n1\\.000\n\n1\\.000 1.270\n\nNA\n\n1\\.192\n\n2\n\n1\\.000 1.000\n\n1\\.000\n\n1\\.000\n\n1\\.270\n\nNA\n\n1\\.030\n\n1\\.000 NA\n\nPeril 3\n\nClass\n\n1\\.000\n\n1\\.050\n\n1\\.135 1.000\n\n1\\.319\n\n1\\.100\n\n2\n\n3\n\n1\\.000\n\nNA\n\n1\\.168 1.025\n\nNA\n\nPeril 4 1.000\n\n1\\.000 1.200\n\nNA\n\n1 Peril 2 Peril 1 Class 1.000 Peril 6 Peril 7 Peril 3\n\n1\\.144\n\n1\\.400\n\n1 Peril 2\n\n1\\.110\n\n1\\.200\n\n1\\.000\n\n2\n\nPeril 8\n\n1\\.000\n\n1\\.246 1.075\n\nPeril 2\n\nPeril 5 1.000 Peril 6\n\n1\\.126\n\n1\\.240\n\n1\\.200\n\n1\\.270\n\n1\\.000 NA 1.014\n\nPeril 5 Peril 6 1.000 1.160\n\n1\\.660\n\nPeril 1 Class\n\nNA\n\n1\\.000\n\nPeril 4 1.000\n\n1\\.050 1.050\n\nPeril 7\n\n1\\.350\n\n1\\.147\n\n1\\.197\n\n1\\.000\n\n1\\.000\n\n1\\.000\n\n1\\.478\n\nPeril 4\n\nPeril 8 Peril 1\n\n1\\.000\n\n1\\.000\n\nNA\n\nPeril 3\n\n1\\.000 1.000 1.000\n\n1\\.246\n\n1\\.000\n\n1\\.050\n\nPeril 5\n\n1\\.480\n\n1\\.000\n\n1\\.000\n\nNA\n\n1\\.000\n\n1\\.200 1.030\n\nPeril 4\n\n1\\.000 1.000\n\n1\\.147\n\n1\\.000 1.030\n\n1\\.000\n\nN/A\n\n1\\.030\n\n4 3 1.110\n\n1\\.000\n\n1\\.000 1.000\n\nPeril 7\n\n1\\.350\n\n1\\.189 2\n\nN/A 4 1.050 1.350 3\n\nPeril 5 1.000 1.000 Peril 1 1\n\n1\\.000 NA\n\nNA\n\nPeril 2\n\nPeril 7\n\n1\\.000 1.000 1.000 NA Peril 8 1 Peril 2 Peril 1 Class\n\n1\\.030\n\n3\n\nPeril 7 Peril 6\n\n1\\.270 2\n\nClass\n\n1\\.000\n\n1\\.030 1.400\n\n1\\.000\n\n1\\.030 1.050\n\nPeril 6 Peril 8 1.000\n\n1\\.400\n\n1\n\n1\\.000\n\n1\\.000\n\nPeril 3\n\n1\\.000 1.126 1.000\n\nPeril 3 1.000\n\n1\\.050\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3472 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page46.pdf"]},"response":{"errors":[],"extract_id":"extract_b103d7837e810ae2dd50df82064313dd","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\n**Factors Used in Determining the Primary Rating Factors**\n\n**Class Factors** Dwelling\n\nHPP, HPPO\n\nMH\n\nMHPP, MHPPO\n\nCondo\n\n**Farm Risk Factors** Dwelling and MH Small Farm/Ranch Location Type Indicator Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Farm/Ranch N 0.856 0.856 0.856 0.856 0.856 0.856 0.856 0.856 Farm/Ranch Y 0.856 0.856 0.856 0.856 0.856 0.856 0.856 0.856 Non Farm/Ranch N 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Non Farm/Ranch Y 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nHPP, HPPO, MHPP, and MHPPO Small Farm/Ranch Location Type Indicator Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Farm/Ranch N 0.845 0.845 0.845 0.845 0.845 0.845 0.845 NA Farm/Ranch Y 0.845 0.845 0.845 0.845 0.845 0.845 0.845 NA Non Farm/Ranch N 1.000 1.000 1.000 1.000 1.000 1.000 1.000 NA Non Farm/Ranch Y 1.000 1.000 1.000 1.000 1.000 1.000 1.000 NA\n\nPeril 4\n\n1\\.000\n\n1\\.000 Peril 8\n\n1\\.400\n\nPeril 5\n\n1\\.000\n\nNA\n\n1\\.283 1.050 N/A\n\n1\\.000\n\n1\\.000 1.270\n\nNA\n\n1\\.192\n\n2\n\n1\\.000 1.000\n\n1\\.000\n\n1\\.000\n\n1\\.270\n\nNA\n\n1\\.030\n\n1\\.000 NA\n\nPeril 3\n\nClass\n\n1\\.000\n\n1\\.050\n\n1\\.135 1.000\n\n1\\.319\n\n1\\.100\n\n2\n\n3\n\n1\\.000\n\nNA\n\n1\\.168 1.025\n\nNA\n\nPeril 4 1.000\n\n1\\.000 1.200\n\nNA\n\n1 Peril 2 Peril 1 Class 1.000 Peril 6 Peril 7 Peril 3\n\n1\\.144\n\n1\\.400\n\n1 Peril 2\n\n1\\.110\n\n1\\.200\n\n1\\.000\n\n2\n\nPeril 8\n\n1\\.000\n\n1\\.246 1.075\n\nPeril 2\n\nPeril 5 1.000 Peril 6\n\n1\\.126\n\n1\\.240\n\n1\\.200\n\n1\\.270\n\n1\\.000 NA 1.014\n\nPeril 5 Peril 6 1.000 1.160\n\n1\\.660\n\nPeril 1 Class\n\nNA\n\n1\\.000\n\nPeril 4 1.000\n\n1\\.050 1.050\n\nPeril 7\n\n1\\.350\n\n1\\.147\n\n1\\.197\n\n1\\.000\n\n1\\.000\n\n1\\.000\n\n1\\.478\n\nPeril 4\n\nPeril 8 Peril 1\n\n1\\.000\n\n1\\.000\n\nNA\n\nPeril 3\n\n1\\.000 1.000 1.000\n\n1\\.246\n\n1\\.000\n\n1\\.050\n\nPeril 5\n\n1\\.480\n\n1\\.000\n\n1\\.000\n\nNA\n\n1\\.000\n\n1\\.200 1.030\n\nPeril 4\n\n1\\.000 1.000\n\n1\\.147\n\n1\\.000 1.030\n\n1\\.000\n\nN/A\n\n1\\.030\n\n4 3 1.110\n\n1\\.000\n\n1\\.000 1.000\n\nPeril 7\n\n1\\.350\n\n1\\.189 2\n\nN/A 4 1.050 1.350 3\n\nPeril 5 1.000 1.000 Peril 1 1\n\n1\\.000 NA\n\nNA\n\nPeril 2\n\nPeril 7\n\n1\\.000 1.000 1.000 NA Peril 8 1 Peril 2 Peril 1 Class\n\n1\\.030\n\n3\n\nPeril 7 Peril 6\n\n1\\.270 2\n\nClass\n\n1\\.000\n\n1\\.030 1.400\n\n1\\.000\n\n1\\.030 1.050\n\nPeril 6 Peril 8 1.000\n\n1\\.400\n\n1\n\n1\\.000\n\n1\\.000\n\nPeril 3\n\n1\\.000 1.126 1.000\n\nPeril 3 1.000\n\n1\\.050\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3472 Rates and Factors"],"full_content":"**Property Section Rates and Factors**\n\n**Factors Used in Determining the Primary Rating Factors**\n\n**Class Factors** Dwelling\n\nHPP, HPPO\n\nMH\n\nMHPP, MHPPO\n\nCondo\n\n**Farm Risk Factors** Dwelling and MH Small Farm/Ranch Location Type Indicator Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Farm/Ranch N 0.856 0.856 0.856 0.856 0.856 0.856 0.856 0.856 Farm/Ranch Y 0.856 0.856 0.856 0.856 0.856 0.856 0.856 0.856 Non Farm/Ranch N 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Non Farm/Ranch Y 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nHPP, HPPO, MHPP, and MHPPO Small Farm/Ranch Location Type Indicator Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Farm/Ranch N 0.845 0.845 0.845 0.845 0.845 0.845 0.845 NA Farm/Ranch Y 0.845 0.845 0.845 0.845 0.845 0.845 0.845 NA Non Farm/Ranch N 1.000 1.000 1.000 1.000 1.000 1.000 1.000 NA Non Farm/Ranch Y 1.000 1.000 1.000 1.000 1.000 1.000 1.000 NA\n\nPeril 4\n\n1\\.000\n\n1\\.000 Peril 8\n\n1\\.400\n\nPeril 5\n\n1\\.000\n\nNA\n\n1\\.283 1.050 N/A\n\n1\\.000\n\n1\\.000 1.270\n\nNA\n\n1\\.192\n\n2\n\n1\\.000 1.000\n\n1\\.000\n\n1\\.000\n\n1\\.270\n\nNA\n\n1\\.030\n\n1\\.000 NA\n\nPeril 3\n\nClass\n\n1\\.000\n\n1\\.050\n\n1\\.135 1.000\n\n1\\.319\n\n1\\.100\n\n2\n\n3\n\n1\\.000\n\nNA\n\n1\\.168 1.025\n\nNA\n\nPeril 4 1.000\n\n1\\.000 1.200\n\nNA\n\n1 Peril 2 Peril 1 Class 1.000 Peril 6 Peril 7 Peril 3\n\n1\\.144\n\n1\\.400\n\n1 Peril 2\n\n1\\.110\n\n1\\.200\n\n1\\.000\n\n2\n\nPeril 8\n\n1\\.000\n\n1\\.246 1.075\n\nPeril 2\n\nPeril 5 1.000 Peril 6\n\n1\\.126\n\n1\\.240\n\n1\\.200\n\n1\\.270\n\n1\\.000 NA 1.014\n\nPeril 5 Peril 6 1.000 1.160\n\n1\\.660\n\nPeril 1 Class\n\nNA\n\n1\\.000\n\nPeril 4 1.000\n\n1\\.050 1.050\n\nPeril 7\n\n1\\.350\n\n1\\.147\n\n1\\.197\n\n1\\.000\n\n1\\.000\n\n1\\.000\n\n1\\.478\n\nPeril 4\n\nPeril 8 Peril 1\n\n1\\.000\n\n1\\.000\n\nNA\n\nPeril 3\n\n1\\.000 1.000 1.000\n\n1\\.246\n\n1\\.000\n\n1\\.050\n\nPeril 5\n\n1\\.480\n\n1\\.000\n\n1\\.000\n\nNA\n\n1\\.000\n\n1\\.200 1.030\n\nPeril 4\n\n1\\.000 1.000\n\n1\\.147\n\n1\\.000 1.030\n\n1\\.000\n\nN/A\n\n1\\.030\n\n4 3 1.110\n\n1\\.000\n\n1\\.000 1.000\n\nPeril 7\n\n1\\.350\n\n1\\.189 2\n\nN/A 4 1.050 1.350 3\n\nPeril 5 1.000 1.000 Peril 1 1\n\n1\\.000 NA\n\nNA\n\nPeril 2\n\nPeril 7\n\n1\\.000 1.000 1.000 NA Peril 8 1 Peril 2 Peril 1 Class\n\n1\\.030\n\n3\n\nPeril 7 Peril 6\n\n1\\.270 2\n\nClass\n\n1\\.000\n\n1\\.030 1.400\n\n1\\.000\n\n1\\.030 1.050\n\nPeril 6 Peril 8 1.000\n\n1\\.400\n\n1\n\n1\\.000\n\n1\\.000\n\nPeril 3\n\n1\\.000 1.126 1.000\n\nPeril 3 1.000\n\n1\\.050\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3472 Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page46.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page46.pdf"},"request":{"example_id":"table/FBLB-134215544_page46","product_type":"parse","source_file_path":"FBLB-134215544_page46.pdf"},"started_at":"2026-11-04T19:29:57.445184"} +{"completed_at":"2026-11-04T19:47:03.342792","latency_in_ms":1030,"output":{"example_id":"table/FBLB-134215544_page5","grounded_pages":[],"layout_pages":[],"markdown":"### **Correspondence Summary Dispositions**\n\n**Status Created By Created On Date Submitted**\n\nFILED FOR USE Kathy Stajduhar 11/18/2024 11/18/2024\n\n### **Amendments**\n\n**Schedule Schedule Item Name Created By Created On Date Submitted**\n\nRate UT FBPCIC Filed Pages 2025-01-23 Lisa Morrissey 11/08/2024 11/08/2024\n\nRate UT WAIC Express Filed Pages 2025-01-23 Lisa Morrissey 11/08/2024 11/08/2024\n\n### **Filing Notes**\n\n**Subject Note Type Created By Created On Date Submitted**\n\nFILING ASSIGNED Note To Filer Christine Osborne 09/24/2024 09/24/2024\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","pages":[{"line_numbers":[],"markdown":"### **Correspondence Summary Dispositions**\n\n**Status Created By Created On Date Submitted**\n\nFILED FOR USE Kathy Stajduhar 11/18/2024 11/18/2024\n\n### **Amendments**\n\n**Schedule Schedule Item Name Created By Created On Date Submitted**\n\nRate UT FBPCIC Filed Pages 2025-01-23 Lisa Morrissey 11/08/2024 11/08/2024\n\nRate UT WAIC Express Filed Pages 2025-01-23 Lisa Morrissey 11/08/2024 11/08/2024\n\n### **Filing Notes**\n\n**Subject Note Type Created By Created On Date Submitted**\n\nFILING ASSIGNED Note To Filer Christine Osborne 09/24/2024 09/24/2024\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Correspondence Summary Dispositions**\n\n**Status Created By Created On Date Submitted**\n\nFILED FOR USE Kathy Stajduhar 11/18/2024 11/18/2024\n\n### **Amendments**\n\n**Schedule Schedule Item Name Created By Created On Date Submitted**\n\nRate UT FBPCIC Filed Pages 2025-01-23 Lisa Morrissey 11/08/2024 11/08/2024\n\nRate UT WAIC Express Filed Pages 2025-01-23 Lisa Morrissey 11/08/2024 11/08/2024\n\n### **Filing Notes**\n\n**Subject Note Type Created By Created On Date Submitted**\n\nFILING ASSIGNED Note To Filer Christine Osborne 09/24/2024 09/24/2024\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page5.pdf"]},"response":{"errors":[],"extract_id":"extract_cdf81f89ae68f3511ed28ce0ed1bf86a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Correspondence Summary Dispositions**\n\n**Status Created By Created On Date Submitted**\n\nFILED FOR USE Kathy Stajduhar 11/18/2024 11/18/2024\n\n### **Amendments**\n\n**Schedule Schedule Item Name Created By Created On Date Submitted**\n\nRate UT FBPCIC Filed Pages 2025-01-23 Lisa Morrissey 11/08/2024 11/08/2024\n\nRate UT WAIC Express Filed Pages 2025-01-23 Lisa Morrissey 11/08/2024 11/08/2024\n\n### **Filing Notes**\n\n**Subject Note Type Created By Created On Date Submitted**\n\nFILING ASSIGNED Note To Filer Christine Osborne 09/24/2024 09/24/2024\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_"],"full_content":"### **Correspondence Summary Dispositions**\n\n**Status Created By Created On Date Submitted**\n\nFILED FOR USE Kathy Stajduhar 11/18/2024 11/18/2024\n\n### **Amendments**\n\n**Schedule Schedule Item Name Created By Created On Date Submitted**\n\nRate UT FBPCIC Filed Pages 2025-01-23 Lisa Morrissey 11/08/2024 11/08/2024\n\nRate UT WAIC Express Filed Pages 2025-01-23 Lisa Morrissey 11/08/2024 11/08/2024\n\n### **Filing Notes**\n\n**Subject Note Type Created By Created On Date Submitted**\n\nFILING ASSIGNED Note To Filer Christine Osborne 09/24/2024 09/24/2024\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","publish_date":null,"title":"Correspondence Summary","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page5.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page5.pdf"},"request":{"example_id":"table/FBLB-134215544_page5","product_type":"parse","source_file_path":"FBLB-134215544_page5.pdf"},"started_at":"2026-11-04T19:47:02.312379"} +{"completed_at":"2026-11-04T19:47:04.191001","latency_in_ms":847,"output":{"example_id":"table/FBLB-134215544_page6","grounded_pages":[],"layout_pages":[],"markdown":"### **Disposition**\n\nDisposition Date: 11/15/2024 Effective Date (New): Effective Date (Renewal): Status: FILED FOR USE\n\nComment: FILED FOR USE November 15, 2024 Property & Casualty Insurance Division UTAH INSURANCE DEPARTMENT\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nFarm Bureau Property & Casualty Insurance Company\n\n5\\.500% 4.400% $5,258,723 25,392 $119,944,088 245.000% -12.100%\n\nWestern Agricultural Insurance Company\n\n5\\.300% 4.000% $1,073,338 6,085 $27,091,793 164.100% -0.200%\n\n**Overall Rate Information for Multiple Company Filings Overall Percentage Rate Indicated For This Filing** 5\\.500%\n\n**Overall Percentage Rate Impact For This Filing** 4\\.300%\n\n**Effect of Rate Filing-Written Premium Change For This Program** $6,332,061\n\n**Effect of Rate Filing - Number of Policyholders Affected** 31,477\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate (revised)** UT FBPCIC Filed Pages 2025-01-23 Yes\n\n**Rate (revised)** UT WAIC Express Filed Pages 2025-01-23 Yes\n\n**Supporting Document** Letter of Authorization (P) Yes\n\n**Supporting Document** Filing Memoranda, Exhibits & Documents (P) Yes\n\n**Supporting Document** Insurer Loss Cost Multiplier and Expense Constant Supplement Filing Form (P)\n\nYes\n\n**Supporting Document** UT Actuarial Certification Yes\n\n**Supporting Document** UT Changes Tracking Documents Yes\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","pages":[{"line_numbers":[],"markdown":"### **Disposition**\n\nDisposition Date: 11/15/2024 Effective Date (New): Effective Date (Renewal): Status: FILED FOR USE\n\nComment: FILED FOR USE November 15, 2024 Property & Casualty Insurance Division UTAH INSURANCE DEPARTMENT\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nFarm Bureau Property & Casualty Insurance Company\n\n5\\.500% 4.400% $5,258,723 25,392 $119,944,088 245.000% -12.100%\n\nWestern Agricultural Insurance Company\n\n5\\.300% 4.000% $1,073,338 6,085 $27,091,793 164.100% -0.200%\n\n**Overall Rate Information for Multiple Company Filings Overall Percentage Rate Indicated For This Filing** 5\\.500%\n\n**Overall Percentage Rate Impact For This Filing** 4\\.300%\n\n**Effect of Rate Filing-Written Premium Change For This Program** $6,332,061\n\n**Effect of Rate Filing - Number of Policyholders Affected** 31,477\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate (revised)** UT FBPCIC Filed Pages 2025-01-23 Yes\n\n**Rate (revised)** UT WAIC Express Filed Pages 2025-01-23 Yes\n\n**Supporting Document** Letter of Authorization (P) Yes\n\n**Supporting Document** Filing Memoranda, Exhibits & Documents (P) Yes\n\n**Supporting Document** Insurer Loss Cost Multiplier and Expense Constant Supplement Filing Form (P)\n\nYes\n\n**Supporting Document** UT Actuarial Certification Yes\n\n**Supporting Document** UT Changes Tracking Documents Yes\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Disposition**\n\nDisposition Date: 11/15/2024 Effective Date (New): Effective Date (Renewal): Status: FILED FOR USE\n\nComment: FILED FOR USE November 15, 2024 Property & Casualty Insurance Division UTAH INSURANCE DEPARTMENT\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nFarm Bureau Property & Casualty Insurance Company\n\n5\\.500% 4.400% $5,258,723 25,392 $119,944,088 245.000% -12.100%\n\nWestern Agricultural Insurance Company\n\n5\\.300% 4.000% $1,073,338 6,085 $27,091,793 164.100% -0.200%\n\n**Overall Rate Information for Multiple Company Filings Overall Percentage Rate Indicated For This Filing** 5\\.500%\n\n**Overall Percentage Rate Impact For This Filing** 4\\.300%\n\n**Effect of Rate Filing-Written Premium Change For This Program** $6,332,061\n\n**Effect of Rate Filing - Number of Policyholders Affected** 31,477\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate (revised)** UT FBPCIC Filed Pages 2025-01-23 Yes\n\n**Rate (revised)** UT WAIC Express Filed Pages 2025-01-23 Yes\n\n**Supporting Document** Letter of Authorization (P) Yes\n\n**Supporting Document** Filing Memoranda, Exhibits & Documents (P) Yes\n\n**Supporting Document** Insurer Loss Cost Multiplier and Expense Constant Supplement Filing Form (P)\n\nYes\n\n**Supporting Document** UT Actuarial Certification Yes\n\n**Supporting Document** UT Changes Tracking Documents Yes\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_0946eef96d04a576fdf3d47e7a544070","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Disposition**\n\nDisposition Date: 11/15/2024 Effective Date (New): Effective Date (Renewal): Status: FILED FOR USE\n\nComment: FILED FOR USE November 15, 2024 Property & Casualty Insurance Division UTAH INSURANCE DEPARTMENT\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nFarm Bureau Property & Casualty Insurance Company\n\n5\\.500% 4.400% $5,258,723 25,392 $119,944,088 245.000% -12.100%\n\nWestern Agricultural Insurance Company\n\n5\\.300% 4.000% $1,073,338 6,085 $27,091,793 164.100% -0.200%\n\n**Overall Rate Information for Multiple Company Filings Overall Percentage Rate Indicated For This Filing** 5\\.500%\n\n**Overall Percentage Rate Impact For This Filing** 4\\.300%\n\n**Effect of Rate Filing-Written Premium Change For This Program** $6,332,061\n\n**Effect of Rate Filing - Number of Policyholders Affected** 31,477\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate (revised)** UT FBPCIC Filed Pages 2025-01-23 Yes\n\n**Rate (revised)** UT WAIC Express Filed Pages 2025-01-23 Yes\n\n**Supporting Document** Letter of Authorization (P) Yes\n\n**Supporting Document** Filing Memoranda, Exhibits & Documents (P) Yes\n\n**Supporting Document** Insurer Loss Cost Multiplier and Expense Constant Supplement Filing Form (P)\n\nYes\n\n**Supporting Document** UT Actuarial Certification Yes\n\n**Supporting Document** UT Changes Tracking Documents Yes\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_"],"full_content":"### **Disposition**\n\nDisposition Date: 11/15/2024 Effective Date (New): Effective Date (Renewal): Status: FILED FOR USE\n\nComment: FILED FOR USE November 15, 2024 Property & Casualty Insurance Division UTAH INSURANCE DEPARTMENT\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nFarm Bureau Property & Casualty Insurance Company\n\n5\\.500% 4.400% $5,258,723 25,392 $119,944,088 245.000% -12.100%\n\nWestern Agricultural Insurance Company\n\n5\\.300% 4.000% $1,073,338 6,085 $27,091,793 164.100% -0.200%\n\n**Overall Rate Information for Multiple Company Filings Overall Percentage Rate Indicated For This Filing** 5\\.500%\n\n**Overall Percentage Rate Impact For This Filing** 4\\.300%\n\n**Effect of Rate Filing-Written Premium Change For This Program** $6,332,061\n\n**Effect of Rate Filing - Number of Policyholders Affected** 31,477\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate (revised)** UT FBPCIC Filed Pages 2025-01-23 Yes\n\n**Rate (revised)** UT WAIC Express Filed Pages 2025-01-23 Yes\n\n**Supporting Document** Letter of Authorization (P) Yes\n\n**Supporting Document** Filing Memoranda, Exhibits & Documents (P) Yes\n\n**Supporting Document** Insurer Loss Cost Multiplier and Expense Constant Supplement Filing Form (P)\n\nYes\n\n**Supporting Document** UT Actuarial Certification Yes\n\n**Supporting Document** UT Changes Tracking Documents Yes\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","publish_date":null,"title":"Disposition","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page6.pdf"},"request":{"example_id":"table/FBLB-134215544_page6","product_type":"parse","source_file_path":"FBLB-134215544_page6.pdf"},"started_at":"2026-11-04T19:47:03.343943"} +{"completed_at":"2026-11-04T19:47:06.365553","latency_in_ms":958,"output":{"example_id":"table/FBLB-134215544_page62","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\n**Farm/Ranch Personal Property (F/R PP)**\n\n**F/R PP Base Rates**\n\nStraw\n\nIrrigation, Gun\n\nIrrigation, Pipe\n\nBlanket Layer 1 - 1st $100,000 Blanket Layer 2 - Next $150,000 Blanket Layer 3 - Next $250,000 Blanket Layer 4 - Next $500,000 Blanket Layer 5 - Excess of $1,000,000\n\n**Peak Season Coverage**\n\nPoultry, Turkeys\n\n$0.118\n\nNA\n\n$0.018 $0.349 NA\n\nNA\n\n$0.001\n\nNA\n\nNA\n\nNA\n\n$0.125 $0.131\n\nNA\n\nPeril 1\n\n$0.014 $0.001 $0.118 NA\n\n$0.152\n\nHogs, Sows\n\nNA\n\n$0.125 $0.012 NA\n\nNA\n\nNA\n\n$0.123\n\nNA $0.187\n\n$0.001\n\n$0.001 $0.004\n\n$0.004\n\nNA NA\n\nPeril 2\n\nNA NA\n\n$0.125 NA NA\n\n$0.004\n\nNA\n\nNA\n\nNA\n\nNA\n\n$0.001\n\nNA\n\nNA\n\n$0.118 $0.014 NA\n\nNA\n\n$0.001 NA\n\n$0.187\n\n$0.123\n\n$0.001\n\nNA\n\nNA\n\nPeril 8\n\nNA\n\nNA NA\n\n$0.113\n\nPeril 5\n\nNA\n\nNA\n\nNA\n\n$0.001\n\nNA\n\n$0.014\n\nNA\n\nNA\n\nNA\n\n$0.001\n\n$0.152\n\n$0.142\n\nPeril 4 $0.155\n\nPeril 8\n\n$0.014 NA\n\nPeril 7\n\nNA\n\n$0.093 NA\n\n$0.004\n\n$0.004 $0.014\n\nScheduled Farm/Ranch Personal Property\n\nNA\n\nPeril 8\n\n$0.004 $0.001\n\nNA\n\nNA\n\nPoultry, Other\n\n$0.004\n\nNA\n\n$0.001 $0.142 $0.014\n\n$0.014 NA $0.014\n\nPeril 8\n\n$0.123\n\nDairy, Cows/Heifers\n\nLivestock/Poultry\n\nNA\n\n$0.001 NA\n\nNA\n\nDairy, Bulls $0.142 $0.004\n\n$0.004\n\nNA\n\n$0.004\n\nNA\n\nNA\n\nNA\n\n$0.014\n\nHogs, Market Hogs, Feeder Pigs NA\n\nHogs, Boars\n\n$0.118 Dairy, Calves/Steers\n\n$0.014 $0.142\n\nGroup I Peril 2\n\n$0.004\n\nPeril 6 $0.014\n\n$0.142 $0.118\n\nNA $0.001 $0.118\n\nPeril 3 Peril 4 Peril 5 $0.142 $0.118 $0.014 NA\n\nin Confinement\n\nOther\n\n$0.016\n\n$0.118\n\n$0.004 $0.004 NA NA\n\nNA $0.148\n\n$0.001\n\n$0.001\n\nNA\n\n$0.157\n\nNA\n\n$0.001\n\n$0.014\n\n$0.001\n\nNA\n\nPeril 2\n\nPeril 3\n\n$0.016\n\n$0.001\n\nRate per $100\n\n$0.142 $0.004\n\nPeril 6\n\n$0.011\n\n$0.007 $0.007\n\n$0.347 $0.001\n\n$0.009\n\nBlanket Farm/Ranch Personal Property\n\n$0.001\n\n$0.001 $0.318 NA\n\n$0.012\n\n$0.007\n\n$0.010\n\nNA\n\nNA\n\nGroup IV\n\n$0.155\n\nNA\n\n$0.113 Hay in Open\n\nPeril 1 Peril 2 Peril 5 Peril 7\n\n$0.300\n\n$0.185 NA NA\n\n$0.146 $0.001\n\n$0.142 $0.004\n\nPeril 4 Peril 5\n\n$0.031\n\n$0.001 Irrigation, Center Pivot $0.001\n\n$0.012 NA\n\nGroup II\n\n$0.136\n\nPeril 3\n\nPeril 3\n\nNA\n\n$0.053 $0.269 $0.012 NA\n\nIrrigation\n\nIrrigation, Motor\n\n$0.014\n\n$0.133\n\n$0.233 $0.172\n\n$0.139\n\n$0.001\n\nNA\n\n$0.018\n\n$0.004\n\nIrrigation, Other\n\nStock, Cows/Heifers\n\n$0.128\n\n$0.014\n\n$0.001\n\n$0.001 $0.155\n\nPoultry, Chickens\n\n$0.118\n\n$0.142\n\nSilage/Fodder\n\nPeril 6\n\n$0.113\n\nStock, Bulls\n\nIrrigation, Wheel Line\n\nStock, Calves/Steers\n\nGroup II Peril 1\n\nNA\n\nPeril 6 Peril 7 Hay in Buildings\n\nNA\n\n$0.001\n\nNA\n\nNA\n\nHay/Straw/Silage/Fodder\n\n$0.473\n\nNA\n\nNA\n\nNA\n\n$0.148 $0.148\n\n$0.010\n\n$0.004 $0.001\n\n$0.014\n\n$0.009 $0.188 $0.329 NA\n\n$0.012\n\nUnknown\n\n$0.149\n\nNA NA\n\nNA\n\nNA\n\n$0.136 $0.011\n\nNA\n\n$0.125 $0.234\n\nPeril 1\n\nPeril 4\n\nNA Peril 7\n\n$0.018\n\n$0.155 $0.012 $0.001\n\nNA\n\n$0.009\n\n$0.004\n\n$0.004 NA\n\n$0.016\n\n$0.139\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3610 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\n**Farm/Ranch Personal Property (F/R PP)**\n\n**F/R PP Base Rates**\n\nStraw\n\nIrrigation, Gun\n\nIrrigation, Pipe\n\nBlanket Layer 1 - 1st $100,000 Blanket Layer 2 - Next $150,000 Blanket Layer 3 - Next $250,000 Blanket Layer 4 - Next $500,000 Blanket Layer 5 - Excess of $1,000,000\n\n**Peak Season Coverage**\n\nPoultry, Turkeys\n\n$0.118\n\nNA\n\n$0.018 $0.349 NA\n\nNA\n\n$0.001\n\nNA\n\nNA\n\nNA\n\n$0.125 $0.131\n\nNA\n\nPeril 1\n\n$0.014 $0.001 $0.118 NA\n\n$0.152\n\nHogs, Sows\n\nNA\n\n$0.125 $0.012 NA\n\nNA\n\nNA\n\n$0.123\n\nNA $0.187\n\n$0.001\n\n$0.001 $0.004\n\n$0.004\n\nNA NA\n\nPeril 2\n\nNA NA\n\n$0.125 NA NA\n\n$0.004\n\nNA\n\nNA\n\nNA\n\nNA\n\n$0.001\n\nNA\n\nNA\n\n$0.118 $0.014 NA\n\nNA\n\n$0.001 NA\n\n$0.187\n\n$0.123\n\n$0.001\n\nNA\n\nNA\n\nPeril 8\n\nNA\n\nNA NA\n\n$0.113\n\nPeril 5\n\nNA\n\nNA\n\nNA\n\n$0.001\n\nNA\n\n$0.014\n\nNA\n\nNA\n\nNA\n\n$0.001\n\n$0.152\n\n$0.142\n\nPeril 4 $0.155\n\nPeril 8\n\n$0.014 NA\n\nPeril 7\n\nNA\n\n$0.093 NA\n\n$0.004\n\n$0.004 $0.014\n\nScheduled Farm/Ranch Personal Property\n\nNA\n\nPeril 8\n\n$0.004 $0.001\n\nNA\n\nNA\n\nPoultry, Other\n\n$0.004\n\nNA\n\n$0.001 $0.142 $0.014\n\n$0.014 NA $0.014\n\nPeril 8\n\n$0.123\n\nDairy, Cows/Heifers\n\nLivestock/Poultry\n\nNA\n\n$0.001 NA\n\nNA\n\nDairy, Bulls $0.142 $0.004\n\n$0.004\n\nNA\n\n$0.004\n\nNA\n\nNA\n\nNA\n\n$0.014\n\nHogs, Market Hogs, Feeder Pigs NA\n\nHogs, Boars\n\n$0.118 Dairy, Calves/Steers\n\n$0.014 $0.142\n\nGroup I Peril 2\n\n$0.004\n\nPeril 6 $0.014\n\n$0.142 $0.118\n\nNA $0.001 $0.118\n\nPeril 3 Peril 4 Peril 5 $0.142 $0.118 $0.014 NA\n\nin Confinement\n\nOther\n\n$0.016\n\n$0.118\n\n$0.004 $0.004 NA NA\n\nNA $0.148\n\n$0.001\n\n$0.001\n\nNA\n\n$0.157\n\nNA\n\n$0.001\n\n$0.014\n\n$0.001\n\nNA\n\nPeril 2\n\nPeril 3\n\n$0.016\n\n$0.001\n\nRate per $100\n\n$0.142 $0.004\n\nPeril 6\n\n$0.011\n\n$0.007 $0.007\n\n$0.347 $0.001\n\n$0.009\n\nBlanket Farm/Ranch Personal Property\n\n$0.001\n\n$0.001 $0.318 NA\n\n$0.012\n\n$0.007\n\n$0.010\n\nNA\n\nNA\n\nGroup IV\n\n$0.155\n\nNA\n\n$0.113 Hay in Open\n\nPeril 1 Peril 2 Peril 5 Peril 7\n\n$0.300\n\n$0.185 NA NA\n\n$0.146 $0.001\n\n$0.142 $0.004\n\nPeril 4 Peril 5\n\n$0.031\n\n$0.001 Irrigation, Center Pivot $0.001\n\n$0.012 NA\n\nGroup II\n\n$0.136\n\nPeril 3\n\nPeril 3\n\nNA\n\n$0.053 $0.269 $0.012 NA\n\nIrrigation\n\nIrrigation, Motor\n\n$0.014\n\n$0.133\n\n$0.233 $0.172\n\n$0.139\n\n$0.001\n\nNA\n\n$0.018\n\n$0.004\n\nIrrigation, Other\n\nStock, Cows/Heifers\n\n$0.128\n\n$0.014\n\n$0.001\n\n$0.001 $0.155\n\nPoultry, Chickens\n\n$0.118\n\n$0.142\n\nSilage/Fodder\n\nPeril 6\n\n$0.113\n\nStock, Bulls\n\nIrrigation, Wheel Line\n\nStock, Calves/Steers\n\nGroup II Peril 1\n\nNA\n\nPeril 6 Peril 7 Hay in Buildings\n\nNA\n\n$0.001\n\nNA\n\nNA\n\nHay/Straw/Silage/Fodder\n\n$0.473\n\nNA\n\nNA\n\nNA\n\n$0.148 $0.148\n\n$0.010\n\n$0.004 $0.001\n\n$0.014\n\n$0.009 $0.188 $0.329 NA\n\n$0.012\n\nUnknown\n\n$0.149\n\nNA NA\n\nNA\n\nNA\n\n$0.136 $0.011\n\nNA\n\n$0.125 $0.234\n\nPeril 1\n\nPeril 4\n\nNA Peril 7\n\n$0.018\n\n$0.155 $0.012 $0.001\n\nNA\n\n$0.009\n\n$0.004\n\n$0.004 NA\n\n$0.016\n\n$0.139\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3610 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\n**Farm/Ranch Personal Property (F/R PP)**\n\n**F/R PP Base Rates**\n\nStraw\n\nIrrigation, Gun\n\nIrrigation, Pipe\n\nBlanket Layer 1 - 1st $100,000 Blanket Layer 2 - Next $150,000 Blanket Layer 3 - Next $250,000 Blanket Layer 4 - Next $500,000 Blanket Layer 5 - Excess of $1,000,000\n\n**Peak Season Coverage**\n\nPoultry, Turkeys\n\n$0.118\n\nNA\n\n$0.018 $0.349 NA\n\nNA\n\n$0.001\n\nNA\n\nNA\n\nNA\n\n$0.125 $0.131\n\nNA\n\nPeril 1\n\n$0.014 $0.001 $0.118 NA\n\n$0.152\n\nHogs, Sows\n\nNA\n\n$0.125 $0.012 NA\n\nNA\n\nNA\n\n$0.123\n\nNA $0.187\n\n$0.001\n\n$0.001 $0.004\n\n$0.004\n\nNA NA\n\nPeril 2\n\nNA NA\n\n$0.125 NA NA\n\n$0.004\n\nNA\n\nNA\n\nNA\n\nNA\n\n$0.001\n\nNA\n\nNA\n\n$0.118 $0.014 NA\n\nNA\n\n$0.001 NA\n\n$0.187\n\n$0.123\n\n$0.001\n\nNA\n\nNA\n\nPeril 8\n\nNA\n\nNA NA\n\n$0.113\n\nPeril 5\n\nNA\n\nNA\n\nNA\n\n$0.001\n\nNA\n\n$0.014\n\nNA\n\nNA\n\nNA\n\n$0.001\n\n$0.152\n\n$0.142\n\nPeril 4 $0.155\n\nPeril 8\n\n$0.014 NA\n\nPeril 7\n\nNA\n\n$0.093 NA\n\n$0.004\n\n$0.004 $0.014\n\nScheduled Farm/Ranch Personal Property\n\nNA\n\nPeril 8\n\n$0.004 $0.001\n\nNA\n\nNA\n\nPoultry, Other\n\n$0.004\n\nNA\n\n$0.001 $0.142 $0.014\n\n$0.014 NA $0.014\n\nPeril 8\n\n$0.123\n\nDairy, Cows/Heifers\n\nLivestock/Poultry\n\nNA\n\n$0.001 NA\n\nNA\n\nDairy, Bulls $0.142 $0.004\n\n$0.004\n\nNA\n\n$0.004\n\nNA\n\nNA\n\nNA\n\n$0.014\n\nHogs, Market Hogs, Feeder Pigs NA\n\nHogs, Boars\n\n$0.118 Dairy, Calves/Steers\n\n$0.014 $0.142\n\nGroup I Peril 2\n\n$0.004\n\nPeril 6 $0.014\n\n$0.142 $0.118\n\nNA $0.001 $0.118\n\nPeril 3 Peril 4 Peril 5 $0.142 $0.118 $0.014 NA\n\nin Confinement\n\nOther\n\n$0.016\n\n$0.118\n\n$0.004 $0.004 NA NA\n\nNA $0.148\n\n$0.001\n\n$0.001\n\nNA\n\n$0.157\n\nNA\n\n$0.001\n\n$0.014\n\n$0.001\n\nNA\n\nPeril 2\n\nPeril 3\n\n$0.016\n\n$0.001\n\nRate per $100\n\n$0.142 $0.004\n\nPeril 6\n\n$0.011\n\n$0.007 $0.007\n\n$0.347 $0.001\n\n$0.009\n\nBlanket Farm/Ranch Personal Property\n\n$0.001\n\n$0.001 $0.318 NA\n\n$0.012\n\n$0.007\n\n$0.010\n\nNA\n\nNA\n\nGroup IV\n\n$0.155\n\nNA\n\n$0.113 Hay in Open\n\nPeril 1 Peril 2 Peril 5 Peril 7\n\n$0.300\n\n$0.185 NA NA\n\n$0.146 $0.001\n\n$0.142 $0.004\n\nPeril 4 Peril 5\n\n$0.031\n\n$0.001 Irrigation, Center Pivot $0.001\n\n$0.012 NA\n\nGroup II\n\n$0.136\n\nPeril 3\n\nPeril 3\n\nNA\n\n$0.053 $0.269 $0.012 NA\n\nIrrigation\n\nIrrigation, Motor\n\n$0.014\n\n$0.133\n\n$0.233 $0.172\n\n$0.139\n\n$0.001\n\nNA\n\n$0.018\n\n$0.004\n\nIrrigation, Other\n\nStock, Cows/Heifers\n\n$0.128\n\n$0.014\n\n$0.001\n\n$0.001 $0.155\n\nPoultry, Chickens\n\n$0.118\n\n$0.142\n\nSilage/Fodder\n\nPeril 6\n\n$0.113\n\nStock, Bulls\n\nIrrigation, Wheel Line\n\nStock, Calves/Steers\n\nGroup II Peril 1\n\nNA\n\nPeril 6 Peril 7 Hay in Buildings\n\nNA\n\n$0.001\n\nNA\n\nNA\n\nHay/Straw/Silage/Fodder\n\n$0.473\n\nNA\n\nNA\n\nNA\n\n$0.148 $0.148\n\n$0.010\n\n$0.004 $0.001\n\n$0.014\n\n$0.009 $0.188 $0.329 NA\n\n$0.012\n\nUnknown\n\n$0.149\n\nNA NA\n\nNA\n\nNA\n\n$0.136 $0.011\n\nNA\n\n$0.125 $0.234\n\nPeril 1\n\nPeril 4\n\nNA Peril 7\n\n$0.018\n\n$0.155 $0.012 $0.001\n\nNA\n\n$0.009\n\n$0.004\n\n$0.004 NA\n\n$0.016\n\n$0.139\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3610 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page62.pdf"]},"response":{"errors":[],"extract_id":"extract_2e4efe99eb1be0825a9b79c5c2b6da96","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\n**Farm/Ranch Personal Property (F/R PP)**\n\n**F/R PP Base Rates**\n\nStraw\n\nIrrigation, Gun\n\nIrrigation, Pipe\n\nBlanket Layer 1 - 1st $100,000 Blanket Layer 2 - Next $150,000 Blanket Layer 3 - Next $250,000 Blanket Layer 4 - Next $500,000 Blanket Layer 5 - Excess of $1,000,000\n\n**Peak Season Coverage**\n\nPoultry, Turkeys\n\n$0.118\n\nNA\n\n$0.018 $0.349 NA\n\nNA\n\n$0.001\n\nNA\n\nNA\n\nNA\n\n$0.125 $0.131\n\nNA\n\nPeril 1\n\n$0.014 $0.001 $0.118 NA\n\n$0.152\n\nHogs, Sows\n\nNA\n\n$0.125 $0.012 NA\n\nNA\n\nNA\n\n$0.123\n\nNA $0.187\n\n$0.001\n\n$0.001 $0.004\n\n$0.004\n\nNA NA\n\nPeril 2\n\nNA NA\n\n$0.125 NA NA\n\n$0.004\n\nNA\n\nNA\n\nNA\n\nNA\n\n$0.001\n\nNA\n\nNA\n\n$0.118 $0.014 NA\n\nNA\n\n$0.001 NA\n\n$0.187\n\n$0.123\n\n$0.001\n\nNA\n\nNA\n\nPeril 8\n\nNA\n\nNA NA\n\n$0.113\n\nPeril 5\n\nNA\n\nNA\n\nNA\n\n$0.001\n\nNA\n\n$0.014\n\nNA\n\nNA\n\nNA\n\n$0.001\n\n$0.152\n\n$0.142\n\nPeril 4 $0.155\n\nPeril 8\n\n$0.014 NA\n\nPeril 7\n\nNA\n\n$0.093 NA\n\n$0.004\n\n$0.004 $0.014\n\nScheduled Farm/Ranch Personal Property\n\nNA\n\nPeril 8\n\n$0.004 $0.001\n\nNA\n\nNA\n\nPoultry, Other\n\n$0.004\n\nNA\n\n$0.001 $0.142 $0.014\n\n$0.014 NA $0.014\n\nPeril 8\n\n$0.123\n\nDairy, Cows/Heifers\n\nLivestock/Poultry\n\nNA\n\n$0.001 NA\n\nNA\n\nDairy, Bulls $0.142 $0.004\n\n$0.004\n\nNA\n\n$0.004\n\nNA\n\nNA\n\nNA\n\n$0.014\n\nHogs, Market Hogs, Feeder Pigs NA\n\nHogs, Boars\n\n$0.118 Dairy, Calves/Steers\n\n$0.014 $0.142\n\nGroup I Peril 2\n\n$0.004\n\nPeril 6 $0.014\n\n$0.142 $0.118\n\nNA $0.001 $0.118\n\nPeril 3 Peril 4 Peril 5 $0.142 $0.118 $0.014 NA\n\nin Confinement\n\nOther\n\n$0.016\n\n$0.118\n\n$0.004 $0.004 NA NA\n\nNA $0.148\n\n$0.001\n\n$0.001\n\nNA\n\n$0.157\n\nNA\n\n$0.001\n\n$0.014\n\n$0.001\n\nNA\n\nPeril 2\n\nPeril 3\n\n$0.016\n\n$0.001\n\nRate per $100\n\n$0.142 $0.004\n\nPeril 6\n\n$0.011\n\n$0.007 $0.007\n\n$0.347 $0.001\n\n$0.009\n\nBlanket Farm/Ranch Personal Property\n\n$0.001\n\n$0.001 $0.318 NA\n\n$0.012\n\n$0.007\n\n$0.010\n\nNA\n\nNA\n\nGroup IV\n\n$0.155\n\nNA\n\n$0.113 Hay in Open\n\nPeril 1 Peril 2 Peril 5 Peril 7\n\n$0.300\n\n$0.185 NA NA\n\n$0.146 $0.001\n\n$0.142 $0.004\n\nPeril 4 Peril 5\n\n$0.031\n\n$0.001 Irrigation, Center Pivot $0.001\n\n$0.012 NA\n\nGroup II\n\n$0.136\n\nPeril 3\n\nPeril 3\n\nNA\n\n$0.053 $0.269 $0.012 NA\n\nIrrigation\n\nIrrigation, Motor\n\n$0.014\n\n$0.133\n\n$0.233 $0.172\n\n$0.139\n\n$0.001\n\nNA\n\n$0.018\n\n$0.004\n\nIrrigation, Other\n\nStock, Cows/Heifers\n\n$0.128\n\n$0.014\n\n$0.001\n\n$0.001 $0.155\n\nPoultry, Chickens\n\n$0.118\n\n$0.142\n\nSilage/Fodder\n\nPeril 6\n\n$0.113\n\nStock, Bulls\n\nIrrigation, Wheel Line\n\nStock, Calves/Steers\n\nGroup II Peril 1\n\nNA\n\nPeril 6 Peril 7 Hay in Buildings\n\nNA\n\n$0.001\n\nNA\n\nNA\n\nHay/Straw/Silage/Fodder\n\n$0.473\n\nNA\n\nNA\n\nNA\n\n$0.148 $0.148\n\n$0.010\n\n$0.004 $0.001\n\n$0.014\n\n$0.009 $0.188 $0.329 NA\n\n$0.012\n\nUnknown\n\n$0.149\n\nNA NA\n\nNA\n\nNA\n\n$0.136 $0.011\n\nNA\n\n$0.125 $0.234\n\nPeril 1\n\nPeril 4\n\nNA Peril 7\n\n$0.018\n\n$0.155 $0.012 $0.001\n\nNA\n\n$0.009\n\n$0.004\n\n$0.004 NA\n\n$0.016\n\n$0.139\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3610 Rates and Factors"],"full_content":"**Property Section Rates and Factors**\n\n**Farm/Ranch Personal Property (F/R PP)**\n\n**F/R PP Base Rates**\n\nStraw\n\nIrrigation, Gun\n\nIrrigation, Pipe\n\nBlanket Layer 1 - 1st $100,000 Blanket Layer 2 - Next $150,000 Blanket Layer 3 - Next $250,000 Blanket Layer 4 - Next $500,000 Blanket Layer 5 - Excess of $1,000,000\n\n**Peak Season Coverage**\n\nPoultry, Turkeys\n\n$0.118\n\nNA\n\n$0.018 $0.349 NA\n\nNA\n\n$0.001\n\nNA\n\nNA\n\nNA\n\n$0.125 $0.131\n\nNA\n\nPeril 1\n\n$0.014 $0.001 $0.118 NA\n\n$0.152\n\nHogs, Sows\n\nNA\n\n$0.125 $0.012 NA\n\nNA\n\nNA\n\n$0.123\n\nNA $0.187\n\n$0.001\n\n$0.001 $0.004\n\n$0.004\n\nNA NA\n\nPeril 2\n\nNA NA\n\n$0.125 NA NA\n\n$0.004\n\nNA\n\nNA\n\nNA\n\nNA\n\n$0.001\n\nNA\n\nNA\n\n$0.118 $0.014 NA\n\nNA\n\n$0.001 NA\n\n$0.187\n\n$0.123\n\n$0.001\n\nNA\n\nNA\n\nPeril 8\n\nNA\n\nNA NA\n\n$0.113\n\nPeril 5\n\nNA\n\nNA\n\nNA\n\n$0.001\n\nNA\n\n$0.014\n\nNA\n\nNA\n\nNA\n\n$0.001\n\n$0.152\n\n$0.142\n\nPeril 4 $0.155\n\nPeril 8\n\n$0.014 NA\n\nPeril 7\n\nNA\n\n$0.093 NA\n\n$0.004\n\n$0.004 $0.014\n\nScheduled Farm/Ranch Personal Property\n\nNA\n\nPeril 8\n\n$0.004 $0.001\n\nNA\n\nNA\n\nPoultry, Other\n\n$0.004\n\nNA\n\n$0.001 $0.142 $0.014\n\n$0.014 NA $0.014\n\nPeril 8\n\n$0.123\n\nDairy, Cows/Heifers\n\nLivestock/Poultry\n\nNA\n\n$0.001 NA\n\nNA\n\nDairy, Bulls $0.142 $0.004\n\n$0.004\n\nNA\n\n$0.004\n\nNA\n\nNA\n\nNA\n\n$0.014\n\nHogs, Market Hogs, Feeder Pigs NA\n\nHogs, Boars\n\n$0.118 Dairy, Calves/Steers\n\n$0.014 $0.142\n\nGroup I Peril 2\n\n$0.004\n\nPeril 6 $0.014\n\n$0.142 $0.118\n\nNA $0.001 $0.118\n\nPeril 3 Peril 4 Peril 5 $0.142 $0.118 $0.014 NA\n\nin Confinement\n\nOther\n\n$0.016\n\n$0.118\n\n$0.004 $0.004 NA NA\n\nNA $0.148\n\n$0.001\n\n$0.001\n\nNA\n\n$0.157\n\nNA\n\n$0.001\n\n$0.014\n\n$0.001\n\nNA\n\nPeril 2\n\nPeril 3\n\n$0.016\n\n$0.001\n\nRate per $100\n\n$0.142 $0.004\n\nPeril 6\n\n$0.011\n\n$0.007 $0.007\n\n$0.347 $0.001\n\n$0.009\n\nBlanket Farm/Ranch Personal Property\n\n$0.001\n\n$0.001 $0.318 NA\n\n$0.012\n\n$0.007\n\n$0.010\n\nNA\n\nNA\n\nGroup IV\n\n$0.155\n\nNA\n\n$0.113 Hay in Open\n\nPeril 1 Peril 2 Peril 5 Peril 7\n\n$0.300\n\n$0.185 NA NA\n\n$0.146 $0.001\n\n$0.142 $0.004\n\nPeril 4 Peril 5\n\n$0.031\n\n$0.001 Irrigation, Center Pivot $0.001\n\n$0.012 NA\n\nGroup II\n\n$0.136\n\nPeril 3\n\nPeril 3\n\nNA\n\n$0.053 $0.269 $0.012 NA\n\nIrrigation\n\nIrrigation, Motor\n\n$0.014\n\n$0.133\n\n$0.233 $0.172\n\n$0.139\n\n$0.001\n\nNA\n\n$0.018\n\n$0.004\n\nIrrigation, Other\n\nStock, Cows/Heifers\n\n$0.128\n\n$0.014\n\n$0.001\n\n$0.001 $0.155\n\nPoultry, Chickens\n\n$0.118\n\n$0.142\n\nSilage/Fodder\n\nPeril 6\n\n$0.113\n\nStock, Bulls\n\nIrrigation, Wheel Line\n\nStock, Calves/Steers\n\nGroup II Peril 1\n\nNA\n\nPeril 6 Peril 7 Hay in Buildings\n\nNA\n\n$0.001\n\nNA\n\nNA\n\nHay/Straw/Silage/Fodder\n\n$0.473\n\nNA\n\nNA\n\nNA\n\n$0.148 $0.148\n\n$0.010\n\n$0.004 $0.001\n\n$0.014\n\n$0.009 $0.188 $0.329 NA\n\n$0.012\n\nUnknown\n\n$0.149\n\nNA NA\n\nNA\n\nNA\n\n$0.136 $0.011\n\nNA\n\n$0.125 $0.234\n\nPeril 1\n\nPeril 4\n\nNA Peril 7\n\n$0.018\n\n$0.155 $0.012 $0.001\n\nNA\n\n$0.009\n\n$0.004\n\n$0.004 NA\n\n$0.016\n\n$0.139\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3610 Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page62.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page62.pdf"},"request":{"example_id":"table/FBLB-134215544_page62","product_type":"parse","source_file_path":"FBLB-134215544_page62.pdf"},"started_at":"2026-11-04T19:47:05.406794"} +{"completed_at":"2026-11-04T19:29:58.490394","latency_in_ms":1042,"output":{"example_id":"table/FBLB-134215544_page63","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\n**Policy Inception Date Factor**\n\nDate Factor Prior to 06/23/15 1.000 06/23/15 or Later 1.000\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 1 Year Non-Farm 1.000 1.000 Years Y N Y N 2 Years Non-Farm 0.980 0.980 0 Years 3 Years Non-Farm 0.980 0.980 1 Year 4 Years Non-Farm 0.970 0.970 2 Years 5 Years Non-Farm 0.970 0.970 3 Years 6 Years Non-Farm 0.960 0.960 4 Years 7 Years Non-Farm 0.960 0.960 5 Years 8 Years Non-Farm 0.950 0.950 6 Years 9 Years Non-Farm 0.950 0.950 7 Years 10 Years Non-Farm 0.940 0.940 8 Years 11 Years Non-Farm 0.940 0.940 9 Years 12 Years Non-Farm 0.940 0.940 10+ Years 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n50 0.873 998 0.934 51 0.893 999 0.934\n\n48 0.834 99 2.744 49 0.853 100 2.817\n\n46 0.797 97 2.604 47 0.816 98 2.673\n\n44 0.762 95 2.472 45 0.779 96 2.537\n\n42 0.728 93 2.348 43 0.745 94 2.409\n\n40 0.696 91 2.232 41 0.712 92 2.289\n\n39 0.680 90 2.177 38 0.665\n\n87 2.024 88 2.073 89 2.124\n\n84 1.888 85 1.932 86 1.977\n\n81 1.762 82 1.803 83 1.845\n\n78 1.646 79 1.684 80 1.722\n\n75 1.538 76 1.573 77 1.609\n\n72 1.437 73 1.470 74 1.503\n\n69 1.342 70 1.373 71 1.405\n\n66 1.254 67 1.283 68 1.312\n\n1\\.146 63 1.172 64 1.199 65 1.226\n\n53 0.934 0.956 55 0.978 54\n\n56\n\n1\\.095\n\nLevel Factor 52 0.913\n\n57 1.023 1.000\n\n$5,000 $2,500\n\n1\\.046 59 1.070 60\n\n58\n\n61 1.120 62\n\n1\\.63\n\n0\\.396\n\n**Underwriting Level Factors Underwriting Level Factors**\n\n**Deductible Factors** Factor\n\n$500\n\n1\\.50\n\n0\\.88\n\n6\n\n0\\.75\n\n1\\.38 1.25 1.13 1.00\n\n$250 $100\n\n3 0.393 4\n\nLevel Factor\n\n$1,000\n\n**Scheduled Personal Property Base Rate and Factor Tables - Continued**\n\nDeductible NONE $50\n\n1 0.384 2 0.388\n\n5\n\n18 0.474\n\n14 0.461\n\n7 0.411 8 9\n\n15 0.464\n\n0\\.436\n\n0\\.414\n\n16 0.473 17 0.473\n\n19 0.475 20 0.475 21 0.476 22 0.476\n\n26 0.507 25 0.495 24 0.484\n\n0\\.542\n\n31 0.568 30 0.555\n\n23 0.476\n\n36 0.636 35\n\n32 0.581\n\n27 0.518 28 0.530 29\n\n11\n\n0\\.419\n\n0\\.405\n\n33 0.594\n\n37 0.650\n\n34 0.608 0.621\n\n**Ag Advantage Factors** Small Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n0\\.400\n\n13 0.456 12\n\n10 0.428\n\n0\\.448\n\n1\\.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000\n\n0\\.990 0.990 1.000 1.000 0.980 0.980 1.000 1.000\n\n0\\.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000\n\n1\\.000 1.000\n\n0\\.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000\n\n0\\.970 0.970 1.000 1.000\n\n0\\.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3663 Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\n**Policy Inception Date Factor**\n\nDate Factor Prior to 06/23/15 1.000 06/23/15 or Later 1.000\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 1 Year Non-Farm 1.000 1.000 Years Y N Y N 2 Years Non-Farm 0.980 0.980 0 Years 3 Years Non-Farm 0.980 0.980 1 Year 4 Years Non-Farm 0.970 0.970 2 Years 5 Years Non-Farm 0.970 0.970 3 Years 6 Years Non-Farm 0.960 0.960 4 Years 7 Years Non-Farm 0.960 0.960 5 Years 8 Years Non-Farm 0.950 0.950 6 Years 9 Years Non-Farm 0.950 0.950 7 Years 10 Years Non-Farm 0.940 0.940 8 Years 11 Years Non-Farm 0.940 0.940 9 Years 12 Years Non-Farm 0.940 0.940 10+ Years 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n50 0.873 998 0.934 51 0.893 999 0.934\n\n48 0.834 99 2.744 49 0.853 100 2.817\n\n46 0.797 97 2.604 47 0.816 98 2.673\n\n44 0.762 95 2.472 45 0.779 96 2.537\n\n42 0.728 93 2.348 43 0.745 94 2.409\n\n40 0.696 91 2.232 41 0.712 92 2.289\n\n39 0.680 90 2.177 38 0.665\n\n87 2.024 88 2.073 89 2.124\n\n84 1.888 85 1.932 86 1.977\n\n81 1.762 82 1.803 83 1.845\n\n78 1.646 79 1.684 80 1.722\n\n75 1.538 76 1.573 77 1.609\n\n72 1.437 73 1.470 74 1.503\n\n69 1.342 70 1.373 71 1.405\n\n66 1.254 67 1.283 68 1.312\n\n1\\.146 63 1.172 64 1.199 65 1.226\n\n53 0.934 0.956 55 0.978 54\n\n56\n\n1\\.095\n\nLevel Factor 52 0.913\n\n57 1.023 1.000\n\n$5,000 $2,500\n\n1\\.046 59 1.070 60\n\n58\n\n61 1.120 62\n\n1\\.63\n\n0\\.396\n\n**Underwriting Level Factors Underwriting Level Factors**\n\n**Deductible Factors** Factor\n\n$500\n\n1\\.50\n\n0\\.88\n\n6\n\n0\\.75\n\n1\\.38 1.25 1.13 1.00\n\n$250 $100\n\n3 0.393 4\n\nLevel Factor\n\n$1,000\n\n**Scheduled Personal Property Base Rate and Factor Tables - Continued**\n\nDeductible NONE $50\n\n1 0.384 2 0.388\n\n5\n\n18 0.474\n\n14 0.461\n\n7 0.411 8 9\n\n15 0.464\n\n0\\.436\n\n0\\.414\n\n16 0.473 17 0.473\n\n19 0.475 20 0.475 21 0.476 22 0.476\n\n26 0.507 25 0.495 24 0.484\n\n0\\.542\n\n31 0.568 30 0.555\n\n23 0.476\n\n36 0.636 35\n\n32 0.581\n\n27 0.518 28 0.530 29\n\n11\n\n0\\.419\n\n0\\.405\n\n33 0.594\n\n37 0.650\n\n34 0.608 0.621\n\n**Ag Advantage Factors** Small Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n0\\.400\n\n13 0.456 12\n\n10 0.428\n\n0\\.448\n\n1\\.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000\n\n0\\.990 0.990 1.000 1.000 0.980 0.980 1.000 1.000\n\n0\\.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000\n\n1\\.000 1.000\n\n0\\.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000\n\n0\\.970 0.970 1.000 1.000\n\n0\\.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3663 Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\n**Policy Inception Date Factor**\n\nDate Factor Prior to 06/23/15 1.000 06/23/15 or Later 1.000\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 1 Year Non-Farm 1.000 1.000 Years Y N Y N 2 Years Non-Farm 0.980 0.980 0 Years 3 Years Non-Farm 0.980 0.980 1 Year 4 Years Non-Farm 0.970 0.970 2 Years 5 Years Non-Farm 0.970 0.970 3 Years 6 Years Non-Farm 0.960 0.960 4 Years 7 Years Non-Farm 0.960 0.960 5 Years 8 Years Non-Farm 0.950 0.950 6 Years 9 Years Non-Farm 0.950 0.950 7 Years 10 Years Non-Farm 0.940 0.940 8 Years 11 Years Non-Farm 0.940 0.940 9 Years 12 Years Non-Farm 0.940 0.940 10+ Years 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n50 0.873 998 0.934 51 0.893 999 0.934\n\n48 0.834 99 2.744 49 0.853 100 2.817\n\n46 0.797 97 2.604 47 0.816 98 2.673\n\n44 0.762 95 2.472 45 0.779 96 2.537\n\n42 0.728 93 2.348 43 0.745 94 2.409\n\n40 0.696 91 2.232 41 0.712 92 2.289\n\n39 0.680 90 2.177 38 0.665\n\n87 2.024 88 2.073 89 2.124\n\n84 1.888 85 1.932 86 1.977\n\n81 1.762 82 1.803 83 1.845\n\n78 1.646 79 1.684 80 1.722\n\n75 1.538 76 1.573 77 1.609\n\n72 1.437 73 1.470 74 1.503\n\n69 1.342 70 1.373 71 1.405\n\n66 1.254 67 1.283 68 1.312\n\n1\\.146 63 1.172 64 1.199 65 1.226\n\n53 0.934 0.956 55 0.978 54\n\n56\n\n1\\.095\n\nLevel Factor 52 0.913\n\n57 1.023 1.000\n\n$5,000 $2,500\n\n1\\.046 59 1.070 60\n\n58\n\n61 1.120 62\n\n1\\.63\n\n0\\.396\n\n**Underwriting Level Factors Underwriting Level Factors**\n\n**Deductible Factors** Factor\n\n$500\n\n1\\.50\n\n0\\.88\n\n6\n\n0\\.75\n\n1\\.38 1.25 1.13 1.00\n\n$250 $100\n\n3 0.393 4\n\nLevel Factor\n\n$1,000\n\n**Scheduled Personal Property Base Rate and Factor Tables - Continued**\n\nDeductible NONE $50\n\n1 0.384 2 0.388\n\n5\n\n18 0.474\n\n14 0.461\n\n7 0.411 8 9\n\n15 0.464\n\n0\\.436\n\n0\\.414\n\n16 0.473 17 0.473\n\n19 0.475 20 0.475 21 0.476 22 0.476\n\n26 0.507 25 0.495 24 0.484\n\n0\\.542\n\n31 0.568 30 0.555\n\n23 0.476\n\n36 0.636 35\n\n32 0.581\n\n27 0.518 28 0.530 29\n\n11\n\n0\\.419\n\n0\\.405\n\n33 0.594\n\n37 0.650\n\n34 0.608 0.621\n\n**Ag Advantage Factors** Small Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n0\\.400\n\n13 0.456 12\n\n10 0.428\n\n0\\.448\n\n1\\.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000\n\n0\\.990 0.990 1.000 1.000 0.980 0.980 1.000 1.000\n\n0\\.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000\n\n1\\.000 1.000\n\n0\\.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000\n\n0\\.970 0.970 1.000 1.000\n\n0\\.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3663 Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page63.pdf"]},"response":{"errors":[],"extract_id":"extract_4195dbc5cbab57cd16acb5b95ddacb6a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\n**Policy Inception Date Factor**\n\nDate Factor Prior to 06/23/15 1.000 06/23/15 or Later 1.000\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 1 Year Non-Farm 1.000 1.000 Years Y N Y N 2 Years Non-Farm 0.980 0.980 0 Years 3 Years Non-Farm 0.980 0.980 1 Year 4 Years Non-Farm 0.970 0.970 2 Years 5 Years Non-Farm 0.970 0.970 3 Years 6 Years Non-Farm 0.960 0.960 4 Years 7 Years Non-Farm 0.960 0.960 5 Years 8 Years Non-Farm 0.950 0.950 6 Years 9 Years Non-Farm 0.950 0.950 7 Years 10 Years Non-Farm 0.940 0.940 8 Years 11 Years Non-Farm 0.940 0.940 9 Years 12 Years Non-Farm 0.940 0.940 10+ Years 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n50 0.873 998 0.934 51 0.893 999 0.934\n\n48 0.834 99 2.744 49 0.853 100 2.817\n\n46 0.797 97 2.604 47 0.816 98 2.673\n\n44 0.762 95 2.472 45 0.779 96 2.537\n\n42 0.728 93 2.348 43 0.745 94 2.409\n\n40 0.696 91 2.232 41 0.712 92 2.289\n\n39 0.680 90 2.177 38 0.665\n\n87 2.024 88 2.073 89 2.124\n\n84 1.888 85 1.932 86 1.977\n\n81 1.762 82 1.803 83 1.845\n\n78 1.646 79 1.684 80 1.722\n\n75 1.538 76 1.573 77 1.609\n\n72 1.437 73 1.470 74 1.503\n\n69 1.342 70 1.373 71 1.405\n\n66 1.254 67 1.283 68 1.312\n\n1\\.146 63 1.172 64 1.199 65 1.226\n\n53 0.934 0.956 55 0.978 54\n\n56\n\n1\\.095\n\nLevel Factor 52 0.913\n\n57 1.023 1.000\n\n$5,000 $2,500\n\n1\\.046 59 1.070 60\n\n58\n\n61 1.120 62\n\n1\\.63\n\n0\\.396\n\n**Underwriting Level Factors Underwriting Level Factors**\n\n**Deductible Factors** Factor\n\n$500\n\n1\\.50\n\n0\\.88\n\n6\n\n0\\.75\n\n1\\.38 1.25 1.13 1.00\n\n$250 $100\n\n3 0.393 4\n\nLevel Factor\n\n$1,000\n\n**Scheduled Personal Property Base Rate and Factor Tables - Continued**\n\nDeductible NONE $50\n\n1 0.384 2 0.388\n\n5\n\n18 0.474\n\n14 0.461\n\n7 0.411 8 9\n\n15 0.464\n\n0\\.436\n\n0\\.414\n\n16 0.473 17 0.473\n\n19 0.475 20 0.475 21 0.476 22 0.476\n\n26 0.507 25 0.495 24 0.484\n\n0\\.542\n\n31 0.568 30 0.555\n\n23 0.476\n\n36 0.636 35\n\n32 0.581\n\n27 0.518 28 0.530 29\n\n11\n\n0\\.419\n\n0\\.405\n\n33 0.594\n\n37 0.650\n\n34 0.608 0.621\n\n**Ag Advantage Factors** Small Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n0\\.400\n\n13 0.456 12\n\n10 0.428\n\n0\\.448\n\n1\\.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000\n\n0\\.990 0.990 1.000 1.000 0.980 0.980 1.000 1.000\n\n0\\.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000\n\n1\\.000 1.000\n\n0\\.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000\n\n0\\.970 0.970 1.000 1.000\n\n0\\.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3663 Rates and Factors"],"full_content":"**Property Section Rates and Factors**\n\nNonFarm Farm SmallFarm\n\n**Policy Inception Date Factor**\n\nDate Factor Prior to 06/23/15 1.000 06/23/15 or Later 1.000\n\nNonfarm Farm Nonfarm Farm\n\n**Continued in Force Factors** Location Type Small Farm/Ranch Indicator Non-Farm Farm Years Location Type Y N All Farm 1.000 1.000 0 Years Non-Farm 1.000 1.000 1 Year Non-Farm 1.000 1.000 Years Y N Y N 2 Years Non-Farm 0.980 0.980 0 Years 3 Years Non-Farm 0.980 0.980 1 Year 4 Years Non-Farm 0.970 0.970 2 Years 5 Years Non-Farm 0.970 0.970 3 Years 6 Years Non-Farm 0.960 0.960 4 Years 7 Years Non-Farm 0.960 0.960 5 Years 8 Years Non-Farm 0.950 0.950 6 Years 9 Years Non-Farm 0.950 0.950 7 Years 10 Years Non-Farm 0.940 0.940 8 Years 11 Years Non-Farm 0.940 0.940 9 Years 12 Years Non-Farm 0.940 0.940 10+ Years 13 Years Non-Farm 0.930 0.930 14 Years Non-Farm 0.930 0.930 15 Years Non-Farm 0.930 0.930 16 Years Non-Farm 0.920 0.920 17 Years Non-Farm 0.920 0.920 18 Years Non-Farm 0.920 0.920 19 Years Non-Farm 0.910 0.910 20 Years Non-Farm 0.910 0.910 21 Years Non-Farm 0.910 0.910 22 Years Non-Farm 0.900 0.900 23 Years Non-Farm 0.900 0.900 24 Years Non-Farm 0.900 0.900 25 Years Non-Farm 0.900 0.900 26 Years Non-Farm 0.890 0.890 27 Years Non-Farm 0.890 0.890 28 Years Non-Farm 0.890 0.890 29 Years Non-Farm 0.890 0.890 30+ Years Non-Farm 0.880 0.880\n\n50 0.873 998 0.934 51 0.893 999 0.934\n\n48 0.834 99 2.744 49 0.853 100 2.817\n\n46 0.797 97 2.604 47 0.816 98 2.673\n\n44 0.762 95 2.472 45 0.779 96 2.537\n\n42 0.728 93 2.348 43 0.745 94 2.409\n\n40 0.696 91 2.232 41 0.712 92 2.289\n\n39 0.680 90 2.177 38 0.665\n\n87 2.024 88 2.073 89 2.124\n\n84 1.888 85 1.932 86 1.977\n\n81 1.762 82 1.803 83 1.845\n\n78 1.646 79 1.684 80 1.722\n\n75 1.538 76 1.573 77 1.609\n\n72 1.437 73 1.470 74 1.503\n\n69 1.342 70 1.373 71 1.405\n\n66 1.254 67 1.283 68 1.312\n\n1\\.146 63 1.172 64 1.199 65 1.226\n\n53 0.934 0.956 55 0.978 54\n\n56\n\n1\\.095\n\nLevel Factor 52 0.913\n\n57 1.023 1.000\n\n$5,000 $2,500\n\n1\\.046 59 1.070 60\n\n58\n\n61 1.120 62\n\n1\\.63\n\n0\\.396\n\n**Underwriting Level Factors Underwriting Level Factors**\n\n**Deductible Factors** Factor\n\n$500\n\n1\\.50\n\n0\\.88\n\n6\n\n0\\.75\n\n1\\.38 1.25 1.13 1.00\n\n$250 $100\n\n3 0.393 4\n\nLevel Factor\n\n$1,000\n\n**Scheduled Personal Property Base Rate and Factor Tables - Continued**\n\nDeductible NONE $50\n\n1 0.384 2 0.388\n\n5\n\n18 0.474\n\n14 0.461\n\n7 0.411 8 9\n\n15 0.464\n\n0\\.436\n\n0\\.414\n\n16 0.473 17 0.473\n\n19 0.475 20 0.475 21 0.476 22 0.476\n\n26 0.507 25 0.495 24 0.484\n\n0\\.542\n\n31 0.568 30 0.555\n\n23 0.476\n\n36 0.636 35\n\n32 0.581\n\n27 0.518 28 0.530 29\n\n11\n\n0\\.419\n\n0\\.405\n\n33 0.594\n\n37 0.650\n\n34 0.608 0.621\n\n**Ag Advantage Factors** Small Farm/Ranch Indicator Small Farm/Ranch Indicator\n\n0\\.400\n\n13 0.456 12\n\n10 0.428\n\n0\\.448\n\n1\\.000 1.000 1.000 1.000 0.990 0.990 1.000 1.000\n\n0\\.990 0.990 1.000 1.000 0.980 0.980 1.000 1.000\n\n0\\.980 0.980 1.000 1.000 0.970 0.970 1.000 1.000\n\n1\\.000 1.000\n\n0\\.970 0.970 1.000 1.000 0.970 0.970 1.000 1.000\n\n0\\.970 0.970 1.000 1.000\n\n0\\.970 0.970 1.000 1.000 0.970 0.970\n\nFarm Bureau Property & Casualty Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 3663 Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page63.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page63.pdf"},"request":{"example_id":"table/FBLB-134215544_page63","product_type":"parse","source_file_path":"FBLB-134215544_page63.pdf"},"started_at":"2026-11-04T19:29:57.447986"} +{"completed_at":"2026-11-04T19:47:08.577234","latency_in_ms":1094,"output":{"example_id":"table/FBLB-134215544_page8","grounded_pages":[],"layout_pages":[],"markdown":"### **Amendment Letter**\n\nSubmitted Date: 11/08/2024\n\nComments: This amendment is being made to the filing for a correction to the Roofing Limitation Factors. The correction is only for peril 3, Wood UL Class 3 or 4 Impact Resistant roof type, Primary/Seasonal/Unoccupied occupancy types, and loss settlement of RPC, GRC, FIX on page 3490 for FBPCIC and page 780W for WAIC. Changed Items:\n\n_No Form Schedule Items Changed._\n\n**Rate Schedule Item Changes**\n\n**Item No. Exhibit Name Rule # or Page # Rate Action**\n\n**Previous State Filing Number**\n\n**Date Submitted**\n\n1 UT FBPCIC Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB-134101344, FBLB- 133683724, FBLB-133989630\n\n11/08/2024 By: Lisa Morrissey\n\n2 UT WAIC Express Filed Pages 2025-01- 23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB-134101344, FBLB- 133683724, FBLB-133989630\n\n11/08/2024 By: Lisa Morrissey\n\n_No Supporting Documents Changed._\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","pages":[{"line_numbers":[],"markdown":"### **Amendment Letter**\n\nSubmitted Date: 11/08/2024\n\nComments: This amendment is being made to the filing for a correction to the Roofing Limitation Factors. The correction is only for peril 3, Wood UL Class 3 or 4 Impact Resistant roof type, Primary/Seasonal/Unoccupied occupancy types, and loss settlement of RPC, GRC, FIX on page 3490 for FBPCIC and page 780W for WAIC. Changed Items:\n\n_No Form Schedule Items Changed._\n\n**Rate Schedule Item Changes**\n\n**Item No. Exhibit Name Rule # or Page # Rate Action**\n\n**Previous State Filing Number**\n\n**Date Submitted**\n\n1 UT FBPCIC Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB-134101344, FBLB- 133683724, FBLB-133989630\n\n11/08/2024 By: Lisa Morrissey\n\n2 UT WAIC Express Filed Pages 2025-01- 23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB-134101344, FBLB- 133683724, FBLB-133989630\n\n11/08/2024 By: Lisa Morrissey\n\n_No Supporting Documents Changed._\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Amendment Letter**\n\nSubmitted Date: 11/08/2024\n\nComments: This amendment is being made to the filing for a correction to the Roofing Limitation Factors. The correction is only for peril 3, Wood UL Class 3 or 4 Impact Resistant roof type, Primary/Seasonal/Unoccupied occupancy types, and loss settlement of RPC, GRC, FIX on page 3490 for FBPCIC and page 780W for WAIC. Changed Items:\n\n_No Form Schedule Items Changed._\n\n**Rate Schedule Item Changes**\n\n**Item No. Exhibit Name Rule # or Page # Rate Action**\n\n**Previous State Filing Number**\n\n**Date Submitted**\n\n1 UT FBPCIC Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB-134101344, FBLB- 133683724, FBLB-133989630\n\n11/08/2024 By: Lisa Morrissey\n\n2 UT WAIC Express Filed Pages 2025-01- 23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB-134101344, FBLB- 133683724, FBLB-133989630\n\n11/08/2024 By: Lisa Morrissey\n\n_No Supporting Documents Changed._\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page8.pdf"]},"response":{"errors":[],"extract_id":"extract_dcf72a5d34951472808a0a323bc0c253","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Amendment Letter**\n\nSubmitted Date: 11/08/2024\n\nComments: This amendment is being made to the filing for a correction to the Roofing Limitation Factors. The correction is only for peril 3, Wood UL Class 3 or 4 Impact Resistant roof type, Primary/Seasonal/Unoccupied occupancy types, and loss settlement of RPC, GRC, FIX on page 3490 for FBPCIC and page 780W for WAIC. Changed Items:\n\n_No Form Schedule Items Changed._\n\n**Rate Schedule Item Changes**\n\n**Item No. Exhibit Name Rule # or Page # Rate Action**\n\n**Previous State Filing Number**\n\n**Date Submitted**\n\n1 UT FBPCIC Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB-134101344, FBLB- 133683724, FBLB-133989630\n\n11/08/2024 By: Lisa Morrissey\n\n2 UT WAIC Express Filed Pages 2025-01- 23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB-134101344, FBLB- 133683724, FBLB-133989630\n\n11/08/2024 By: Lisa Morrissey\n\n_No Supporting Documents Changed._\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_"],"full_content":"### **Amendment Letter**\n\nSubmitted Date: 11/08/2024\n\nComments: This amendment is being made to the filing for a correction to the Roofing Limitation Factors. The correction is only for peril 3, Wood UL Class 3 or 4 Impact Resistant roof type, Primary/Seasonal/Unoccupied occupancy types, and loss settlement of RPC, GRC, FIX on page 3490 for FBPCIC and page 780W for WAIC. Changed Items:\n\n_No Form Schedule Items Changed._\n\n**Rate Schedule Item Changes**\n\n**Item No. Exhibit Name Rule # or Page # Rate Action**\n\n**Previous State Filing Number**\n\n**Date Submitted**\n\n1 UT FBPCIC Filed Pages 2025-01-23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB-134101344, FBLB- 133683724, FBLB-133989630\n\n11/08/2024 By: Lisa Morrissey\n\n2 UT WAIC Express Filed Pages 2025-01- 23\n\nVarious Replacement FBLB-130129999, FBLB-133267813, FBLB- 133805299,FBLB-134101344, FBLB- 133683724, FBLB-133989630\n\n11/08/2024 By: Lisa Morrissey\n\n_No Supporting Documents Changed._\n\n**_SERFF Tracking #:_** _FBLB-134215544_ **_State Tracking #: Company Tracking #:_** _MS-2024-07_\n\n**_State:_** _Utah_ **_First Filing Company:_** _Farm Bureau Property & Casualty Insurance Company, ..._\n\n**_TOI/Sub-TOI:_** _30\\.0 Homeowner/ Auto Combinations/30.0000 Homeowner/Auto Combinations_\n\n**_Product Name:_** _Farm Bureau Member's Choice_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number FBLB-134215544 Generated 11/26/2024 04:14 PM_","publish_date":null,"title":"Amendment Letter","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page8.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page8.pdf"},"request":{"example_id":"table/FBLB-134215544_page8","product_type":"parse","source_file_path":"FBLB-134215544_page8.pdf"},"started_at":"2026-11-04T19:47:07.483035"} +{"completed_at":"2026-11-04T19:47:11.291071","latency_in_ms":2709,"output":{"example_id":"table/FBLB-134215544_page84","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\nOutbuildings **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84634 1.144 0.875 0.654 0.847 0.672 NA NA NA 84635 1.055 1.340 0.654 0.902 0.672 NA NA NA 84636 0.982 0.919 0.715 1.072 0.714 NA NA NA 84637 0.911 0.875 0.715 1.284 0.755 NA NA NA 84638 1.021 1.001 0.786 1.072 0.755 NA NA NA 84639 1.215 0.834 0.715 0.935 0.714 NA NA NA 84640 0.943 1.001 0.786 0.998 0.755 NA NA NA 84642 1.057 0.790 0.715 0.847 0.714 NA NA NA 84643 1.088 0.875 0.715 0.799 0.672 NA NA NA 84644 0.932 0.834 0.602 1.072 0.672 NA NA NA 84645 1.748 0.919 0.715 0.847 0.714 NA NA NA 84646 1.103 0.834 0.786 0.902 0.755 NA NA NA 84647 0.989 0.790 0.786 1.149 0.786 NA NA NA 84648 1.533 0.919 0.715 0.847 0.672 NA NA NA 84649 0.982 0.962 0.715 1.072 0.755 NA NA NA 84651 1.342 0.962 0.786 0.761 0.755 NA NA NA 84652 1.049 0.962 0.654 0.847 0.672 NA NA NA 84653 1.637 0.919 0.786 0.761 0.755 NA NA NA 84654 1.087 0.834 0.602 0.935 0.672 NA NA NA 84655 2.914 1.155 0.874 0.799 0.826 NA NA NA 84656 1.041 0.875 0.786 0.998 0.826 NA NA NA 84657 1.109 0.790 0.654 0.998 0.672 NA NA NA 84660 1.000 0.919 0.786 0.761 0.755 NA NA NA 84662 1.101 0.790 0.786 0.902 0.786 NA NA NA 84663 0.999 0.875 0.786 0.847 0.755 NA NA NA 84664 1.184 0.919 0.786 0.799 0.755 NA NA NA 84665 1.155 0.875 0.715 0.847 0.672 NA NA NA 84667 1.315 0.834 0.786 0.935 0.755 NA NA NA 84701 0.946 0.711 0.602 0.964 0.672 NA NA NA 84710 1.598 0.919 0.715 0.964 0.866 NA NA NA 84711 1.000 0.790 0.715 0.998 0.714 NA NA NA 84712 1.241 0.790 0.602 0.998 0.714 NA NA NA 84713 0.981 0.919 0.602 0.998 0.714 NA NA NA 84714 1.007 0.834 0.602 0.799 0.826 NA NA NA 84715 1.133 0.711 0.715 1.284 0.755 NA NA NA 84716 0.953 0.711 0.602 0.964 0.714 NA NA NA 84718 0.943 1.039 1.015 0.998 1.046 NA NA NA 84719 0.943 0.834 0.786 0.847 0.960 NA NA NA 84720 1.129 0.834 0.602 0.799 0.866 NA NA NA 84721 1.047 0.834 0.654 0.799 0.917 NA NA NA 84722 2.053 0.790 0.654 0.847 0.917 NA NA NA 84723 1.101 0.919 0.715 1.284 0.786 NA NA NA 84724 0.961 0.834 0.715 1.072 0.714 NA NA NA 84725 2.258 0.875 1.015 0.847 1.380 NA NA NA 84726 2.815 0.711 0.715 1.072 0.826 NA NA NA 84728 1.101 1.104 0.715 0.964 0.826 NA NA NA 84729 1.455 0.919 0.654 0.964 0.866 NA NA NA 84730 0.911 0.790 0.715 1.072 0.714 NA NA NA 84731 1.547 1.039 0.602 0.998 0.672 NA NA NA 84732 1.179 0.790 0.715 0.998 0.714 NA NA NA 84733 5.000 0.834 0.715 0.847 0.786 NA NA NA 84734 1.810 0.711 0.786 0.998 0.755 NA NA NA 84735 1.194 1.001 0.786 0.935 0.917 NA NA NA 84736 0.881 1.039 1.015 0.964 1.103 NA NA NA 84737 1.266 1.001 0.654 0.847 0.755 NA NA NA 84738 1.926 0.711 0.715 0.998 0.755 NA NA NA 84739 0.881 0.834 0.602 0.998 0.672 NA NA NA 84740 0.943 0.875 0.715 1.284 0.755 NA NA NA 84741 0.952 0.919 0.715 0.935 0.866 NA NA NA 84742 1.442 0.962 0.840 0.847 0.960 NA NA NA 84743 1.101 0.711 0.715 0.998 0.786 NA NA NA 84744 1.101 0.790 0.715 1.072 0.714 NA NA NA 84745 1.366 0.919 0.602 0.799 0.755 NA NA NA\n\n**Utah Property ZC Factors Cont.**\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 669W","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\nOutbuildings **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84634 1.144 0.875 0.654 0.847 0.672 NA NA NA 84635 1.055 1.340 0.654 0.902 0.672 NA NA NA 84636 0.982 0.919 0.715 1.072 0.714 NA NA NA 84637 0.911 0.875 0.715 1.284 0.755 NA NA NA 84638 1.021 1.001 0.786 1.072 0.755 NA NA NA 84639 1.215 0.834 0.715 0.935 0.714 NA NA NA 84640 0.943 1.001 0.786 0.998 0.755 NA NA NA 84642 1.057 0.790 0.715 0.847 0.714 NA NA NA 84643 1.088 0.875 0.715 0.799 0.672 NA NA NA 84644 0.932 0.834 0.602 1.072 0.672 NA NA NA 84645 1.748 0.919 0.715 0.847 0.714 NA NA NA 84646 1.103 0.834 0.786 0.902 0.755 NA NA NA 84647 0.989 0.790 0.786 1.149 0.786 NA NA NA 84648 1.533 0.919 0.715 0.847 0.672 NA NA NA 84649 0.982 0.962 0.715 1.072 0.755 NA NA NA 84651 1.342 0.962 0.786 0.761 0.755 NA NA NA 84652 1.049 0.962 0.654 0.847 0.672 NA NA NA 84653 1.637 0.919 0.786 0.761 0.755 NA NA NA 84654 1.087 0.834 0.602 0.935 0.672 NA NA NA 84655 2.914 1.155 0.874 0.799 0.826 NA NA NA 84656 1.041 0.875 0.786 0.998 0.826 NA NA NA 84657 1.109 0.790 0.654 0.998 0.672 NA NA NA 84660 1.000 0.919 0.786 0.761 0.755 NA NA NA 84662 1.101 0.790 0.786 0.902 0.786 NA NA NA 84663 0.999 0.875 0.786 0.847 0.755 NA NA NA 84664 1.184 0.919 0.786 0.799 0.755 NA NA NA 84665 1.155 0.875 0.715 0.847 0.672 NA NA NA 84667 1.315 0.834 0.786 0.935 0.755 NA NA NA 84701 0.946 0.711 0.602 0.964 0.672 NA NA NA 84710 1.598 0.919 0.715 0.964 0.866 NA NA NA 84711 1.000 0.790 0.715 0.998 0.714 NA NA NA 84712 1.241 0.790 0.602 0.998 0.714 NA NA NA 84713 0.981 0.919 0.602 0.998 0.714 NA NA NA 84714 1.007 0.834 0.602 0.799 0.826 NA NA NA 84715 1.133 0.711 0.715 1.284 0.755 NA NA NA 84716 0.953 0.711 0.602 0.964 0.714 NA NA NA 84718 0.943 1.039 1.015 0.998 1.046 NA NA NA 84719 0.943 0.834 0.786 0.847 0.960 NA NA NA 84720 1.129 0.834 0.602 0.799 0.866 NA NA NA 84721 1.047 0.834 0.654 0.799 0.917 NA NA NA 84722 2.053 0.790 0.654 0.847 0.917 NA NA NA 84723 1.101 0.919 0.715 1.284 0.786 NA NA NA 84724 0.961 0.834 0.715 1.072 0.714 NA NA NA 84725 2.258 0.875 1.015 0.847 1.380 NA NA NA 84726 2.815 0.711 0.715 1.072 0.826 NA NA NA 84728 1.101 1.104 0.715 0.964 0.826 NA NA NA 84729 1.455 0.919 0.654 0.964 0.866 NA NA NA 84730 0.911 0.790 0.715 1.072 0.714 NA NA NA 84731 1.547 1.039 0.602 0.998 0.672 NA NA NA 84732 1.179 0.790 0.715 0.998 0.714 NA NA NA 84733 5.000 0.834 0.715 0.847 0.786 NA NA NA 84734 1.810 0.711 0.786 0.998 0.755 NA NA NA 84735 1.194 1.001 0.786 0.935 0.917 NA NA NA 84736 0.881 1.039 1.015 0.964 1.103 NA NA NA 84737 1.266 1.001 0.654 0.847 0.755 NA NA NA 84738 1.926 0.711 0.715 0.998 0.755 NA NA NA 84739 0.881 0.834 0.602 0.998 0.672 NA NA NA 84740 0.943 0.875 0.715 1.284 0.755 NA NA NA 84741 0.952 0.919 0.715 0.935 0.866 NA NA NA 84742 1.442 0.962 0.840 0.847 0.960 NA NA NA 84743 1.101 0.711 0.715 0.998 0.786 NA NA NA 84744 1.101 0.790 0.715 1.072 0.714 NA NA NA 84745 1.366 0.919 0.602 0.799 0.755 NA NA NA\n\n**Utah Property ZC Factors Cont.**\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 669W","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\nOutbuildings **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84634 1.144 0.875 0.654 0.847 0.672 NA NA NA 84635 1.055 1.340 0.654 0.902 0.672 NA NA NA 84636 0.982 0.919 0.715 1.072 0.714 NA NA NA 84637 0.911 0.875 0.715 1.284 0.755 NA NA NA 84638 1.021 1.001 0.786 1.072 0.755 NA NA NA 84639 1.215 0.834 0.715 0.935 0.714 NA NA NA 84640 0.943 1.001 0.786 0.998 0.755 NA NA NA 84642 1.057 0.790 0.715 0.847 0.714 NA NA NA 84643 1.088 0.875 0.715 0.799 0.672 NA NA NA 84644 0.932 0.834 0.602 1.072 0.672 NA NA NA 84645 1.748 0.919 0.715 0.847 0.714 NA NA NA 84646 1.103 0.834 0.786 0.902 0.755 NA NA NA 84647 0.989 0.790 0.786 1.149 0.786 NA NA NA 84648 1.533 0.919 0.715 0.847 0.672 NA NA NA 84649 0.982 0.962 0.715 1.072 0.755 NA NA NA 84651 1.342 0.962 0.786 0.761 0.755 NA NA NA 84652 1.049 0.962 0.654 0.847 0.672 NA NA NA 84653 1.637 0.919 0.786 0.761 0.755 NA NA NA 84654 1.087 0.834 0.602 0.935 0.672 NA NA NA 84655 2.914 1.155 0.874 0.799 0.826 NA NA NA 84656 1.041 0.875 0.786 0.998 0.826 NA NA NA 84657 1.109 0.790 0.654 0.998 0.672 NA NA NA 84660 1.000 0.919 0.786 0.761 0.755 NA NA NA 84662 1.101 0.790 0.786 0.902 0.786 NA NA NA 84663 0.999 0.875 0.786 0.847 0.755 NA NA NA 84664 1.184 0.919 0.786 0.799 0.755 NA NA NA 84665 1.155 0.875 0.715 0.847 0.672 NA NA NA 84667 1.315 0.834 0.786 0.935 0.755 NA NA NA 84701 0.946 0.711 0.602 0.964 0.672 NA NA NA 84710 1.598 0.919 0.715 0.964 0.866 NA NA NA 84711 1.000 0.790 0.715 0.998 0.714 NA NA NA 84712 1.241 0.790 0.602 0.998 0.714 NA NA NA 84713 0.981 0.919 0.602 0.998 0.714 NA NA NA 84714 1.007 0.834 0.602 0.799 0.826 NA NA NA 84715 1.133 0.711 0.715 1.284 0.755 NA NA NA 84716 0.953 0.711 0.602 0.964 0.714 NA NA NA 84718 0.943 1.039 1.015 0.998 1.046 NA NA NA 84719 0.943 0.834 0.786 0.847 0.960 NA NA NA 84720 1.129 0.834 0.602 0.799 0.866 NA NA NA 84721 1.047 0.834 0.654 0.799 0.917 NA NA NA 84722 2.053 0.790 0.654 0.847 0.917 NA NA NA 84723 1.101 0.919 0.715 1.284 0.786 NA NA NA 84724 0.961 0.834 0.715 1.072 0.714 NA NA NA 84725 2.258 0.875 1.015 0.847 1.380 NA NA NA 84726 2.815 0.711 0.715 1.072 0.826 NA NA NA 84728 1.101 1.104 0.715 0.964 0.826 NA NA NA 84729 1.455 0.919 0.654 0.964 0.866 NA NA NA 84730 0.911 0.790 0.715 1.072 0.714 NA NA NA 84731 1.547 1.039 0.602 0.998 0.672 NA NA NA 84732 1.179 0.790 0.715 0.998 0.714 NA NA NA 84733 5.000 0.834 0.715 0.847 0.786 NA NA NA 84734 1.810 0.711 0.786 0.998 0.755 NA NA NA 84735 1.194 1.001 0.786 0.935 0.917 NA NA NA 84736 0.881 1.039 1.015 0.964 1.103 NA NA NA 84737 1.266 1.001 0.654 0.847 0.755 NA NA NA 84738 1.926 0.711 0.715 0.998 0.755 NA NA NA 84739 0.881 0.834 0.602 0.998 0.672 NA NA NA 84740 0.943 0.875 0.715 1.284 0.755 NA NA NA 84741 0.952 0.919 0.715 0.935 0.866 NA NA NA 84742 1.442 0.962 0.840 0.847 0.960 NA NA NA 84743 1.101 0.711 0.715 0.998 0.786 NA NA NA 84744 1.101 0.790 0.715 1.072 0.714 NA NA NA 84745 1.366 0.919 0.602 0.799 0.755 NA NA NA\n\n**Utah Property ZC Factors Cont.**\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 669W","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page84.pdf"]},"response":{"errors":[],"extract_id":"extract_6523427cd3b04404ac9ae3ecf8600a8e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\nOutbuildings **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84634 1.144 0.875 0.654 0.847 0.672 NA NA NA 84635 1.055 1.340 0.654 0.902 0.672 NA NA NA 84636 0.982 0.919 0.715 1.072 0.714 NA NA NA 84637 0.911 0.875 0.715 1.284 0.755 NA NA NA 84638 1.021 1.001 0.786 1.072 0.755 NA NA NA 84639 1.215 0.834 0.715 0.935 0.714 NA NA NA 84640 0.943 1.001 0.786 0.998 0.755 NA NA NA 84642 1.057 0.790 0.715 0.847 0.714 NA NA NA 84643 1.088 0.875 0.715 0.799 0.672 NA NA NA 84644 0.932 0.834 0.602 1.072 0.672 NA NA NA 84645 1.748 0.919 0.715 0.847 0.714 NA NA NA 84646 1.103 0.834 0.786 0.902 0.755 NA NA NA 84647 0.989 0.790 0.786 1.149 0.786 NA NA NA 84648 1.533 0.919 0.715 0.847 0.672 NA NA NA 84649 0.982 0.962 0.715 1.072 0.755 NA NA NA 84651 1.342 0.962 0.786 0.761 0.755 NA NA NA 84652 1.049 0.962 0.654 0.847 0.672 NA NA NA 84653 1.637 0.919 0.786 0.761 0.755 NA NA NA 84654 1.087 0.834 0.602 0.935 0.672 NA NA NA 84655 2.914 1.155 0.874 0.799 0.826 NA NA NA 84656 1.041 0.875 0.786 0.998 0.826 NA NA NA 84657 1.109 0.790 0.654 0.998 0.672 NA NA NA 84660 1.000 0.919 0.786 0.761 0.755 NA NA NA 84662 1.101 0.790 0.786 0.902 0.786 NA NA NA 84663 0.999 0.875 0.786 0.847 0.755 NA NA NA 84664 1.184 0.919 0.786 0.799 0.755 NA NA NA 84665 1.155 0.875 0.715 0.847 0.672 NA NA NA 84667 1.315 0.834 0.786 0.935 0.755 NA NA NA 84701 0.946 0.711 0.602 0.964 0.672 NA NA NA 84710 1.598 0.919 0.715 0.964 0.866 NA NA NA 84711 1.000 0.790 0.715 0.998 0.714 NA NA NA 84712 1.241 0.790 0.602 0.998 0.714 NA NA NA 84713 0.981 0.919 0.602 0.998 0.714 NA NA NA 84714 1.007 0.834 0.602 0.799 0.826 NA NA NA 84715 1.133 0.711 0.715 1.284 0.755 NA NA NA 84716 0.953 0.711 0.602 0.964 0.714 NA NA NA 84718 0.943 1.039 1.015 0.998 1.046 NA NA NA 84719 0.943 0.834 0.786 0.847 0.960 NA NA NA 84720 1.129 0.834 0.602 0.799 0.866 NA NA NA 84721 1.047 0.834 0.654 0.799 0.917 NA NA NA 84722 2.053 0.790 0.654 0.847 0.917 NA NA NA 84723 1.101 0.919 0.715 1.284 0.786 NA NA NA 84724 0.961 0.834 0.715 1.072 0.714 NA NA NA 84725 2.258 0.875 1.015 0.847 1.380 NA NA NA 84726 2.815 0.711 0.715 1.072 0.826 NA NA NA 84728 1.101 1.104 0.715 0.964 0.826 NA NA NA 84729 1.455 0.919 0.654 0.964 0.866 NA NA NA 84730 0.911 0.790 0.715 1.072 0.714 NA NA NA 84731 1.547 1.039 0.602 0.998 0.672 NA NA NA 84732 1.179 0.790 0.715 0.998 0.714 NA NA NA 84733 5.000 0.834 0.715 0.847 0.786 NA NA NA 84734 1.810 0.711 0.786 0.998 0.755 NA NA NA 84735 1.194 1.001 0.786 0.935 0.917 NA NA NA 84736 0.881 1.039 1.015 0.964 1.103 NA NA NA 84737 1.266 1.001 0.654 0.847 0.755 NA NA NA 84738 1.926 0.711 0.715 0.998 0.755 NA NA NA 84739 0.881 0.834 0.602 0.998 0.672 NA NA NA 84740 0.943 0.875 0.715 1.284 0.755 NA NA NA 84741 0.952 0.919 0.715 0.935 0.866 NA NA NA 84742 1.442 0.962 0.840 0.847 0.960 NA NA NA 84743 1.101 0.711 0.715 0.998 0.786 NA NA NA 84744 1.101 0.790 0.715 1.072 0.714 NA NA NA 84745 1.366 0.919 0.602 0.799 0.755 NA NA NA\n\n**Utah Property ZC Factors Cont.**\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 669W"],"full_content":"**Property Section Rates and Factors**\n\nOutbuildings **Zip Code Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8** 84634 1.144 0.875 0.654 0.847 0.672 NA NA NA 84635 1.055 1.340 0.654 0.902 0.672 NA NA NA 84636 0.982 0.919 0.715 1.072 0.714 NA NA NA 84637 0.911 0.875 0.715 1.284 0.755 NA NA NA 84638 1.021 1.001 0.786 1.072 0.755 NA NA NA 84639 1.215 0.834 0.715 0.935 0.714 NA NA NA 84640 0.943 1.001 0.786 0.998 0.755 NA NA NA 84642 1.057 0.790 0.715 0.847 0.714 NA NA NA 84643 1.088 0.875 0.715 0.799 0.672 NA NA NA 84644 0.932 0.834 0.602 1.072 0.672 NA NA NA 84645 1.748 0.919 0.715 0.847 0.714 NA NA NA 84646 1.103 0.834 0.786 0.902 0.755 NA NA NA 84647 0.989 0.790 0.786 1.149 0.786 NA NA NA 84648 1.533 0.919 0.715 0.847 0.672 NA NA NA 84649 0.982 0.962 0.715 1.072 0.755 NA NA NA 84651 1.342 0.962 0.786 0.761 0.755 NA NA NA 84652 1.049 0.962 0.654 0.847 0.672 NA NA NA 84653 1.637 0.919 0.786 0.761 0.755 NA NA NA 84654 1.087 0.834 0.602 0.935 0.672 NA NA NA 84655 2.914 1.155 0.874 0.799 0.826 NA NA NA 84656 1.041 0.875 0.786 0.998 0.826 NA NA NA 84657 1.109 0.790 0.654 0.998 0.672 NA NA NA 84660 1.000 0.919 0.786 0.761 0.755 NA NA NA 84662 1.101 0.790 0.786 0.902 0.786 NA NA NA 84663 0.999 0.875 0.786 0.847 0.755 NA NA NA 84664 1.184 0.919 0.786 0.799 0.755 NA NA NA 84665 1.155 0.875 0.715 0.847 0.672 NA NA NA 84667 1.315 0.834 0.786 0.935 0.755 NA NA NA 84701 0.946 0.711 0.602 0.964 0.672 NA NA NA 84710 1.598 0.919 0.715 0.964 0.866 NA NA NA 84711 1.000 0.790 0.715 0.998 0.714 NA NA NA 84712 1.241 0.790 0.602 0.998 0.714 NA NA NA 84713 0.981 0.919 0.602 0.998 0.714 NA NA NA 84714 1.007 0.834 0.602 0.799 0.826 NA NA NA 84715 1.133 0.711 0.715 1.284 0.755 NA NA NA 84716 0.953 0.711 0.602 0.964 0.714 NA NA NA 84718 0.943 1.039 1.015 0.998 1.046 NA NA NA 84719 0.943 0.834 0.786 0.847 0.960 NA NA NA 84720 1.129 0.834 0.602 0.799 0.866 NA NA NA 84721 1.047 0.834 0.654 0.799 0.917 NA NA NA 84722 2.053 0.790 0.654 0.847 0.917 NA NA NA 84723 1.101 0.919 0.715 1.284 0.786 NA NA NA 84724 0.961 0.834 0.715 1.072 0.714 NA NA NA 84725 2.258 0.875 1.015 0.847 1.380 NA NA NA 84726 2.815 0.711 0.715 1.072 0.826 NA NA NA 84728 1.101 1.104 0.715 0.964 0.826 NA NA NA 84729 1.455 0.919 0.654 0.964 0.866 NA NA NA 84730 0.911 0.790 0.715 1.072 0.714 NA NA NA 84731 1.547 1.039 0.602 0.998 0.672 NA NA NA 84732 1.179 0.790 0.715 0.998 0.714 NA NA NA 84733 5.000 0.834 0.715 0.847 0.786 NA NA NA 84734 1.810 0.711 0.786 0.998 0.755 NA NA NA 84735 1.194 1.001 0.786 0.935 0.917 NA NA NA 84736 0.881 1.039 1.015 0.964 1.103 NA NA NA 84737 1.266 1.001 0.654 0.847 0.755 NA NA NA 84738 1.926 0.711 0.715 0.998 0.755 NA NA NA 84739 0.881 0.834 0.602 0.998 0.672 NA NA NA 84740 0.943 0.875 0.715 1.284 0.755 NA NA NA 84741 0.952 0.919 0.715 0.935 0.866 NA NA NA 84742 1.442 0.962 0.840 0.847 0.960 NA NA NA 84743 1.101 0.711 0.715 0.998 0.786 NA NA NA 84744 1.101 0.790 0.715 1.072 0.714 NA NA NA 84745 1.366 0.919 0.602 0.799 0.755 NA NA NA\n\n**Utah Property ZC Factors Cont.**\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 669W","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page84.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page84.pdf"},"request":{"example_id":"table/FBLB-134215544_page84","product_type":"parse","source_file_path":"FBLB-134215544_page84.pdf"},"started_at":"2026-11-04T19:47:08.581688"} +{"completed_at":"2026-11-04T19:47:10.566376","latency_in_ms":1192,"output":{"example_id":"table/FBLB-134215544_page88","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\n**Year of Construction Factors**\n\n**Financial Services Factor** DW, MH Financial Product Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Max Life Policy - FV $10,000 - $24,999 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Max Life Policy - FV $25,000+ 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% Max Deferred Annuity - $10,000+ 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Maximum Total Discount 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% Note: Financial Services Factor = 1 - (sum of Financial Services discounts, subject to the Maximum Total Discount)\n\nHPP, HPPO, MHPP, MHPPO, and Condo Financial Product Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Max Life Policy - FV $10,000 - $24,999 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% NA Max Life Policy - FV $25,000+ 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% NA Max Deferred Annuity - $10,000+ 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% NA Maximum Total Discount 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% NA Note: Financial Services Factor = 1 - (sum of Financial Services discounts, subject to the Maximum Total Discount)\n\n**Account Discount Factors**\n\n1\\.000 1.000 1.000 0.686 NA 0.595 1.000 0.652 1.000 1.000 1.000 0.686 NA\n\n0\\.598 0.598\n\n1\\.000 1.000 1.110 1.110\n\n1\\.220 1.000 1.000 1.220 1.000 1.000 1.220 1.220 1.190 1.000 1.000 1.190 1.000 1.000 1.190 1.190 1.190 1.000 1.000 1.190 1.000 1.000 1.190 1.190 1.000 1.110 1.110\n\nNA 0.595 1.000 0.652\n\n2011+\n\n1971-1980 1981-1990 1991-2000\n\n1\\.110\n\n1\\.000\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.100 1.000 1.000 1.100 1.000 1.000 1.100 1.100\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8\n\n1\\.000 1.000 1.110\n\n0\\.598 0.598\n\nDwelling\n\n**Factors Used in Determining the Secondary Rating Factors**\n\nCoverage\n\nHPP, HPPO MHPP, MHPPO Condo\n\n1\\.000 1.000 0.686\n\nConstruction Year 1950 & Prior 1951-1970\n\nDW, MH 0.598 0.598 0.598\n\n2001-2010 1.110 1.000 1.000 1.110 1.000\n\n0\\.598 0.595 1.000 0.652\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 766W Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\n**Year of Construction Factors**\n\n**Financial Services Factor** DW, MH Financial Product Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Max Life Policy - FV $10,000 - $24,999 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Max Life Policy - FV $25,000+ 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% Max Deferred Annuity - $10,000+ 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Maximum Total Discount 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% Note: Financial Services Factor = 1 - (sum of Financial Services discounts, subject to the Maximum Total Discount)\n\nHPP, HPPO, MHPP, MHPPO, and Condo Financial Product Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Max Life Policy - FV $10,000 - $24,999 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% NA Max Life Policy - FV $25,000+ 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% NA Max Deferred Annuity - $10,000+ 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% NA Maximum Total Discount 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% NA Note: Financial Services Factor = 1 - (sum of Financial Services discounts, subject to the Maximum Total Discount)\n\n**Account Discount Factors**\n\n1\\.000 1.000 1.000 0.686 NA 0.595 1.000 0.652 1.000 1.000 1.000 0.686 NA\n\n0\\.598 0.598\n\n1\\.000 1.000 1.110 1.110\n\n1\\.220 1.000 1.000 1.220 1.000 1.000 1.220 1.220 1.190 1.000 1.000 1.190 1.000 1.000 1.190 1.190 1.190 1.000 1.000 1.190 1.000 1.000 1.190 1.190 1.000 1.110 1.110\n\nNA 0.595 1.000 0.652\n\n2011+\n\n1971-1980 1981-1990 1991-2000\n\n1\\.110\n\n1\\.000\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.100 1.000 1.000 1.100 1.000 1.000 1.100 1.100\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8\n\n1\\.000 1.000 1.110\n\n0\\.598 0.598\n\nDwelling\n\n**Factors Used in Determining the Secondary Rating Factors**\n\nCoverage\n\nHPP, HPPO MHPP, MHPPO Condo\n\n1\\.000 1.000 0.686\n\nConstruction Year 1950 & Prior 1951-1970\n\nDW, MH 0.598 0.598 0.598\n\n2001-2010 1.110 1.000 1.000 1.110 1.000\n\n0\\.598 0.595 1.000 0.652\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 766W Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\n**Year of Construction Factors**\n\n**Financial Services Factor** DW, MH Financial Product Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Max Life Policy - FV $10,000 - $24,999 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Max Life Policy - FV $25,000+ 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% Max Deferred Annuity - $10,000+ 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Maximum Total Discount 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% Note: Financial Services Factor = 1 - (sum of Financial Services discounts, subject to the Maximum Total Discount)\n\nHPP, HPPO, MHPP, MHPPO, and Condo Financial Product Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Max Life Policy - FV $10,000 - $24,999 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% NA Max Life Policy - FV $25,000+ 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% NA Max Deferred Annuity - $10,000+ 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% NA Maximum Total Discount 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% NA Note: Financial Services Factor = 1 - (sum of Financial Services discounts, subject to the Maximum Total Discount)\n\n**Account Discount Factors**\n\n1\\.000 1.000 1.000 0.686 NA 0.595 1.000 0.652 1.000 1.000 1.000 0.686 NA\n\n0\\.598 0.598\n\n1\\.000 1.000 1.110 1.110\n\n1\\.220 1.000 1.000 1.220 1.000 1.000 1.220 1.220 1.190 1.000 1.000 1.190 1.000 1.000 1.190 1.190 1.190 1.000 1.000 1.190 1.000 1.000 1.190 1.190 1.000 1.110 1.110\n\nNA 0.595 1.000 0.652\n\n2011+\n\n1971-1980 1981-1990 1991-2000\n\n1\\.110\n\n1\\.000\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.100 1.000 1.000 1.100 1.000 1.000 1.100 1.100\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8\n\n1\\.000 1.000 1.110\n\n0\\.598 0.598\n\nDwelling\n\n**Factors Used in Determining the Secondary Rating Factors**\n\nCoverage\n\nHPP, HPPO MHPP, MHPPO Condo\n\n1\\.000 1.000 0.686\n\nConstruction Year 1950 & Prior 1951-1970\n\nDW, MH 0.598 0.598 0.598\n\n2001-2010 1.110 1.000 1.000 1.110 1.000\n\n0\\.598 0.595 1.000 0.652\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 766W Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page88.pdf"]},"response":{"errors":[],"extract_id":"extract_6c24efd9bc8570228ae85711a83faaea","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\n**Year of Construction Factors**\n\n**Financial Services Factor** DW, MH Financial Product Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Max Life Policy - FV $10,000 - $24,999 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Max Life Policy - FV $25,000+ 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% Max Deferred Annuity - $10,000+ 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Maximum Total Discount 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% Note: Financial Services Factor = 1 - (sum of Financial Services discounts, subject to the Maximum Total Discount)\n\nHPP, HPPO, MHPP, MHPPO, and Condo Financial Product Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Max Life Policy - FV $10,000 - $24,999 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% NA Max Life Policy - FV $25,000+ 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% NA Max Deferred Annuity - $10,000+ 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% NA Maximum Total Discount 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% NA Note: Financial Services Factor = 1 - (sum of Financial Services discounts, subject to the Maximum Total Discount)\n\n**Account Discount Factors**\n\n1\\.000 1.000 1.000 0.686 NA 0.595 1.000 0.652 1.000 1.000 1.000 0.686 NA\n\n0\\.598 0.598\n\n1\\.000 1.000 1.110 1.110\n\n1\\.220 1.000 1.000 1.220 1.000 1.000 1.220 1.220 1.190 1.000 1.000 1.190 1.000 1.000 1.190 1.190 1.190 1.000 1.000 1.190 1.000 1.000 1.190 1.190 1.000 1.110 1.110\n\nNA 0.595 1.000 0.652\n\n2011+\n\n1971-1980 1981-1990 1991-2000\n\n1\\.110\n\n1\\.000\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.100 1.000 1.000 1.100 1.000 1.000 1.100 1.100\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8\n\n1\\.000 1.000 1.110\n\n0\\.598 0.598\n\nDwelling\n\n**Factors Used in Determining the Secondary Rating Factors**\n\nCoverage\n\nHPP, HPPO MHPP, MHPPO Condo\n\n1\\.000 1.000 0.686\n\nConstruction Year 1950 & Prior 1951-1970\n\nDW, MH 0.598 0.598 0.598\n\n2001-2010 1.110 1.000 1.000 1.110 1.000\n\n0\\.598 0.595 1.000 0.652\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 766W Rates and Factors"],"full_content":"**Property Section Rates and Factors**\n\n**Year of Construction Factors**\n\n**Financial Services Factor** DW, MH Financial Product Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Max Life Policy - FV $10,000 - $24,999 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Max Life Policy - FV $25,000+ 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% Max Deferred Annuity - $10,000+ 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Maximum Total Discount 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% Note: Financial Services Factor = 1 - (sum of Financial Services discounts, subject to the Maximum Total Discount)\n\nHPP, HPPO, MHPP, MHPPO, and Condo Financial Product Peril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 Max Life Policy - FV $10,000 - $24,999 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% NA Max Life Policy - FV $25,000+ 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% 3.0% NA Max Deferred Annuity - $10,000+ 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% NA Maximum Total Discount 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% NA Note: Financial Services Factor = 1 - (sum of Financial Services discounts, subject to the Maximum Total Discount)\n\n**Account Discount Factors**\n\n1\\.000 1.000 1.000 0.686 NA 0.595 1.000 0.652 1.000 1.000 1.000 0.686 NA\n\n0\\.598 0.598\n\n1\\.000 1.000 1.110 1.110\n\n1\\.220 1.000 1.000 1.220 1.000 1.000 1.220 1.220 1.190 1.000 1.000 1.190 1.000 1.000 1.190 1.190 1.190 1.000 1.000 1.190 1.000 1.000 1.190 1.190 1.000 1.110 1.110\n\nNA 0.595 1.000 0.652\n\n2011+\n\n1971-1980 1981-1990 1991-2000\n\n1\\.110\n\n1\\.000\n\n1\\.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.100 1.000 1.000 1.100 1.000 1.000 1.100 1.100\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8\n\n1\\.000 1.000 1.110\n\n0\\.598 0.598\n\nDwelling\n\n**Factors Used in Determining the Secondary Rating Factors**\n\nCoverage\n\nHPP, HPPO MHPP, MHPPO Condo\n\n1\\.000 1.000 0.686\n\nConstruction Year 1950 & Prior 1951-1970\n\nDW, MH 0.598 0.598 0.598\n\n2001-2010 1.110 1.000 1.000 1.110 1.000\n\n0\\.598 0.595 1.000 0.652\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 766W Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page88.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page88.pdf"},"request":{"example_id":"table/FBLB-134215544_page88","product_type":"parse","source_file_path":"FBLB-134215544_page88.pdf"},"started_at":"2026-11-04T19:47:09.374314"} +{"completed_at":"2026-11-04T19:47:15.009571","latency_in_ms":3716,"output":{"example_id":"table/FBLB-134215544_page98","grounded_pages":[],"layout_pages":[],"markdown":"**Property Section Rates and Factors**\n\n**Garages, Outbuildings, & Other Structures (GOOS)**\n\n**GOOS Primary Rating Factor**\n\n**Building Class Factors**\n\n**Building Width Factors**\n\n\\*Building Width Exclusion factor applies to the following Building Types: 11, 13, 14, 15, 16, 24, 25, 26, 28, 34, 35 & 37\n\n**Building Type Factors**\n\nDescription Detached Garages One Story Barn Two Story Barn (sidewalls >=16) Two Story Barn (sidewalls <16) Open Sided Pole Swine Finishing Bldg Frame Swine Farrowing Bldg Pole Swine Finishing Bldg (gable roof) Stud Frame Machinery Storage Bldg Pole Shed, Open Sided Pole Shed, Fully Enclosed Steel Grain Handling System Wood Frame Corn Crib Steel Glass-Lined Silos Concrete Stave Silos Small Animal Housing Tool Sheds Frame Grainary\n\nAll Metal Building Concrete Building Swine Confinement Pkg, Turn-Key\n\nPole Cage Laying House Concrete Block Dairy Parlors Metal Bulk Bins Ag Fences & Corrals Power Poles Misc. Building Swimming Pools, Patios, Driveways, Sidewalks Appurtenant Structures Turkey Buildings\n\nHoop Building Greenhouse\n\nResidential Fence Buildings without a Permanent Foundation (excluding livestock huts)\n\n**Building Cause of Loss Factors**\n\nType 31 All Other Poultry Buildings 0.746 0.225 0.541 2.492\n\nNA NA\n\nType 35 NA\n\nType 29 NA NA\n\nNA\n\nNA NA Type 30 0.746 0.225 0.541 2.492 1.047 NA\n\nType 34\n\nType 36 0.800 1.500 1.100 0.500 0.500 NA Type 37 Generators & Solar Panels 0.400 0.900 0.900 0.150 0.900 NA\n\nType 32 1.000 2.500 0.700 1.000 1.000 NA Type 33 1.000 1.900\n\n1\\.047 NA NA NA\n\nNA\n\nNA\n\nPermanently Mounted Tanks 0.150 1.000 0.650 1.500 2.000 NA NA\n\n0\\.122 1.000 1.000 0.850 NA NA NA\n\nNA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 5 Peril 6 Peril 7 Peril 8 1.000 1.000 1.000 1.000 NA NA NA\n\n0\\.334 0.750 0.400 0.800 0.550 NA NA\n\nNA NA\n\nPeril 4 1.000 0.509 0.750 0.509\n\nNA NA NA NA\n\nNA NA 2.500 1.000 1.250 NA NA NA\n\nNA\n\n0\\.582 NA NA NA 0.334 0.873 0.318 1.885 0.593 NA NA NA 1.160 2.000 1.000 2.318 1.588 NA NA NA\n\n1\\.047 NA NA NA 0.530 0.549 0.354 2.250 1.300 NA NA NA 0.414 0.915 0.352 2.242 0.479 NA NA NA\n\n0\\.541 2.492\n\n0\\.334 0.559 0.318 1.885\n\n0\\.899 NA NA NA 0.746 0.225 0.541 2.492 1.047 NA NA NA Pole Swine Finishing Barn, Single-Pole Roof 0.746 1.250 0.541 2.492 1.047 NA NA NA\n\nQuonset Grain or Machinery Storage Shed 0.577 1.050 0.424 0.573 0.400 NA NA NA 1.250 0.915 0.950 1.150 1.050 NA NA NA 0.571 0.900 0.865 1.100\n\n0\\.016 NA NA NA 0.700 0.800 0.820 1.401 0.740 NA NA NA 0.450 0.480 0.754 2.600 1.493 NA NA NA\n\n0\\.414 1.000 0.352 2.242 0.479 NA NA NA 0.585 0.550 0.754 2.600 1.493 NA NA NA 0.289 0.272 0.201 0.666 0.127 NA NA NA 1.148 1.178 0.201 0.662\n\n0\\.900 NA NA NA 1.510 2.100 1.050 1.000 1.200 NA NA NA 1.500 1.200 1.000 1.000 1.150 NA NA NA\n\n0\\.705 1.150 0.638 2.129 1.895 NA NA NA 0.475 0.350 0.638 2.129 1.895 NA NA NA 0.500 0.400 0.638 2.129 1.895 NA NA NA 0.895 0.865 0.854 1.000\n\n0\\.900 0.854 0.742 0.523 NA NA NA 1.483 1.020 0.854 1.000 0.900 NA NA NA 1.398 0.990 0.854 0.742 0.523 NA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 0.750 0.650 2.000 3.036 0.458 NA NA NA 1.398\n\n0\\.670 0.880 NA NA NA 0.940 0.880 0.802\n\n1\\.711 1.730 1.444 NA NA NA Building Width Exclusion\\* 1.000 1.000 1.000 1.000 NA NA NA\n\n1\\.130 1.371 1.491 1.092 NA NA NA 1.226 1.582 1.596 1.213 NA NA NA 1.240 1.660 1.690 1.213 NA NA NA\n\n1\\.051 1.066 1.096 1.127 1.000\n\nBuilding\n\n>= 60 Feet, < 70 Feet 70+ Feet 1.299\n\nNA\n\nPeril 4\n\n1\\.036 1.089 1.116 1.035 NA NA NA\n\n0\\.981 0.989\n\n1\\.000 0.938 0.954 0.967\n\n1\\.073 1.190 1.230 1.092 NA NA NA 1.122 1.200 1.367 1.092 NA NA NA\n\n0\\.982 0.961 0.942 0.970 NA NA NA 1.000 1.000 1.000 1.000 NA NA NA 1.018 1.043 1.058 1.025 NA NA NA\n\n0\\.994 1.000 1.006 1.011 1.023 1.037\n\n0\\.926 0.825\n\n1\\.000 NA NA NA 1.000 1.000 1.743 NA NA NA\n\n0\\.965 0.926 0.886 0.941 NA NA NA\n\n1\\.000 1.000 1.000 1.000 NA NA NA 0.850 0.804 0.422 0.765 NA NA NA 0.890 0.814 0.549 0.810 NA NA NA\n\n1\\.000 1.000 2.000 NA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 5 Peril 6 Peril 7\n\n0\\.900 NA NA\n\nPeril 6 Peril 7 Peril 8\n\nType 19\n\nType 13\n\nPeril 8\n\nBuilding Class Peril 1 Peril 2 1 1.000 1.000 2 1.658 1.021\n\nPeril 3 Peril 4 Peril 5\n\nType 3\n\nType 27\n\nType 16\n\nType 9\n\nType 26\n\n0\\.746 0.499\n\n1\\.000 1.000\n\n3\n\nType 12 Type 11\n\nType 8\n\n>= 10 Feet, < 15 Feet\n\nNA NA\n\nType 14\n\nType 18\n\nType 20 Type 21\n\nType 17\n\nType 4\n\nType 6\n\nNA NA NA 1.000 0.200\n\nType 28\n\n1 & 2 2-10\n\nSpecial 1-10\n\n0\\.082 0.400 0.300 2.250 1.400\n\nType 24 Type 25\n\n0\\.850\n\n>= 1 Feet, < 4 Feet >= 4 Feet, < 10 Feet\n\nType 1 Type\n\n>= 40 Feet, < 45 Feet >= 45 Feet, < 50 Feet\n\n2\\.470 1.700\n\nBuilding Width\n\n>= 50 Feet, < 60 Feet\n\n>= 20 Feet, < 23 Feet\n\n0\\.200 0.750\n\nType 10\n\nBuilding Cause of Loss\n\n1\\.000 1.000 1.000\n\nType 2\n\nType 7\n\nType 5\n\nType 15\n\n>= 23 Feet, < 25 Feet >= 25 Feet, < 27 Feet >= 27 Feet, < 29 Feet >= 29 Feet, < 31 Feet >= 31 Feet, < 35 Feet >= 35 Feet, < 40 Feet\n\n>= 15 Feet, < 20 Feet\n\nType 22 Type 23\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 866W Rates and Factors","pages":[{"line_numbers":[],"markdown":"**Property Section Rates and Factors**\n\n**Garages, Outbuildings, & Other Structures (GOOS)**\n\n**GOOS Primary Rating Factor**\n\n**Building Class Factors**\n\n**Building Width Factors**\n\n\\*Building Width Exclusion factor applies to the following Building Types: 11, 13, 14, 15, 16, 24, 25, 26, 28, 34, 35 & 37\n\n**Building Type Factors**\n\nDescription Detached Garages One Story Barn Two Story Barn (sidewalls >=16) Two Story Barn (sidewalls <16) Open Sided Pole Swine Finishing Bldg Frame Swine Farrowing Bldg Pole Swine Finishing Bldg (gable roof) Stud Frame Machinery Storage Bldg Pole Shed, Open Sided Pole Shed, Fully Enclosed Steel Grain Handling System Wood Frame Corn Crib Steel Glass-Lined Silos Concrete Stave Silos Small Animal Housing Tool Sheds Frame Grainary\n\nAll Metal Building Concrete Building Swine Confinement Pkg, Turn-Key\n\nPole Cage Laying House Concrete Block Dairy Parlors Metal Bulk Bins Ag Fences & Corrals Power Poles Misc. Building Swimming Pools, Patios, Driveways, Sidewalks Appurtenant Structures Turkey Buildings\n\nHoop Building Greenhouse\n\nResidential Fence Buildings without a Permanent Foundation (excluding livestock huts)\n\n**Building Cause of Loss Factors**\n\nType 31 All Other Poultry Buildings 0.746 0.225 0.541 2.492\n\nNA NA\n\nType 35 NA\n\nType 29 NA NA\n\nNA\n\nNA NA Type 30 0.746 0.225 0.541 2.492 1.047 NA\n\nType 34\n\nType 36 0.800 1.500 1.100 0.500 0.500 NA Type 37 Generators & Solar Panels 0.400 0.900 0.900 0.150 0.900 NA\n\nType 32 1.000 2.500 0.700 1.000 1.000 NA Type 33 1.000 1.900\n\n1\\.047 NA NA NA\n\nNA\n\nNA\n\nPermanently Mounted Tanks 0.150 1.000 0.650 1.500 2.000 NA NA\n\n0\\.122 1.000 1.000 0.850 NA NA NA\n\nNA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 5 Peril 6 Peril 7 Peril 8 1.000 1.000 1.000 1.000 NA NA NA\n\n0\\.334 0.750 0.400 0.800 0.550 NA NA\n\nNA NA\n\nPeril 4 1.000 0.509 0.750 0.509\n\nNA NA NA NA\n\nNA NA 2.500 1.000 1.250 NA NA NA\n\nNA\n\n0\\.582 NA NA NA 0.334 0.873 0.318 1.885 0.593 NA NA NA 1.160 2.000 1.000 2.318 1.588 NA NA NA\n\n1\\.047 NA NA NA 0.530 0.549 0.354 2.250 1.300 NA NA NA 0.414 0.915 0.352 2.242 0.479 NA NA NA\n\n0\\.541 2.492\n\n0\\.334 0.559 0.318 1.885\n\n0\\.899 NA NA NA 0.746 0.225 0.541 2.492 1.047 NA NA NA Pole Swine Finishing Barn, Single-Pole Roof 0.746 1.250 0.541 2.492 1.047 NA NA NA\n\nQuonset Grain or Machinery Storage Shed 0.577 1.050 0.424 0.573 0.400 NA NA NA 1.250 0.915 0.950 1.150 1.050 NA NA NA 0.571 0.900 0.865 1.100\n\n0\\.016 NA NA NA 0.700 0.800 0.820 1.401 0.740 NA NA NA 0.450 0.480 0.754 2.600 1.493 NA NA NA\n\n0\\.414 1.000 0.352 2.242 0.479 NA NA NA 0.585 0.550 0.754 2.600 1.493 NA NA NA 0.289 0.272 0.201 0.666 0.127 NA NA NA 1.148 1.178 0.201 0.662\n\n0\\.900 NA NA NA 1.510 2.100 1.050 1.000 1.200 NA NA NA 1.500 1.200 1.000 1.000 1.150 NA NA NA\n\n0\\.705 1.150 0.638 2.129 1.895 NA NA NA 0.475 0.350 0.638 2.129 1.895 NA NA NA 0.500 0.400 0.638 2.129 1.895 NA NA NA 0.895 0.865 0.854 1.000\n\n0\\.900 0.854 0.742 0.523 NA NA NA 1.483 1.020 0.854 1.000 0.900 NA NA NA 1.398 0.990 0.854 0.742 0.523 NA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 0.750 0.650 2.000 3.036 0.458 NA NA NA 1.398\n\n0\\.670 0.880 NA NA NA 0.940 0.880 0.802\n\n1\\.711 1.730 1.444 NA NA NA Building Width Exclusion\\* 1.000 1.000 1.000 1.000 NA NA NA\n\n1\\.130 1.371 1.491 1.092 NA NA NA 1.226 1.582 1.596 1.213 NA NA NA 1.240 1.660 1.690 1.213 NA NA NA\n\n1\\.051 1.066 1.096 1.127 1.000\n\nBuilding\n\n>= 60 Feet, < 70 Feet 70+ Feet 1.299\n\nNA\n\nPeril 4\n\n1\\.036 1.089 1.116 1.035 NA NA NA\n\n0\\.981 0.989\n\n1\\.000 0.938 0.954 0.967\n\n1\\.073 1.190 1.230 1.092 NA NA NA 1.122 1.200 1.367 1.092 NA NA NA\n\n0\\.982 0.961 0.942 0.970 NA NA NA 1.000 1.000 1.000 1.000 NA NA NA 1.018 1.043 1.058 1.025 NA NA NA\n\n0\\.994 1.000 1.006 1.011 1.023 1.037\n\n0\\.926 0.825\n\n1\\.000 NA NA NA 1.000 1.000 1.743 NA NA NA\n\n0\\.965 0.926 0.886 0.941 NA NA NA\n\n1\\.000 1.000 1.000 1.000 NA NA NA 0.850 0.804 0.422 0.765 NA NA NA 0.890 0.814 0.549 0.810 NA NA NA\n\n1\\.000 1.000 2.000 NA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 5 Peril 6 Peril 7\n\n0\\.900 NA NA\n\nPeril 6 Peril 7 Peril 8\n\nType 19\n\nType 13\n\nPeril 8\n\nBuilding Class Peril 1 Peril 2 1 1.000 1.000 2 1.658 1.021\n\nPeril 3 Peril 4 Peril 5\n\nType 3\n\nType 27\n\nType 16\n\nType 9\n\nType 26\n\n0\\.746 0.499\n\n1\\.000 1.000\n\n3\n\nType 12 Type 11\n\nType 8\n\n>= 10 Feet, < 15 Feet\n\nNA NA\n\nType 14\n\nType 18\n\nType 20 Type 21\n\nType 17\n\nType 4\n\nType 6\n\nNA NA NA 1.000 0.200\n\nType 28\n\n1 & 2 2-10\n\nSpecial 1-10\n\n0\\.082 0.400 0.300 2.250 1.400\n\nType 24 Type 25\n\n0\\.850\n\n>= 1 Feet, < 4 Feet >= 4 Feet, < 10 Feet\n\nType 1 Type\n\n>= 40 Feet, < 45 Feet >= 45 Feet, < 50 Feet\n\n2\\.470 1.700\n\nBuilding Width\n\n>= 50 Feet, < 60 Feet\n\n>= 20 Feet, < 23 Feet\n\n0\\.200 0.750\n\nType 10\n\nBuilding Cause of Loss\n\n1\\.000 1.000 1.000\n\nType 2\n\nType 7\n\nType 5\n\nType 15\n\n>= 23 Feet, < 25 Feet >= 25 Feet, < 27 Feet >= 27 Feet, < 29 Feet >= 29 Feet, < 31 Feet >= 31 Feet, < 35 Feet >= 35 Feet, < 40 Feet\n\n>= 15 Feet, < 20 Feet\n\nType 22 Type 23\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 866W Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Property Section Rates and Factors**\n\n**Garages, Outbuildings, & Other Structures (GOOS)**\n\n**GOOS Primary Rating Factor**\n\n**Building Class Factors**\n\n**Building Width Factors**\n\n\\*Building Width Exclusion factor applies to the following Building Types: 11, 13, 14, 15, 16, 24, 25, 26, 28, 34, 35 & 37\n\n**Building Type Factors**\n\nDescription Detached Garages One Story Barn Two Story Barn (sidewalls >=16) Two Story Barn (sidewalls <16) Open Sided Pole Swine Finishing Bldg Frame Swine Farrowing Bldg Pole Swine Finishing Bldg (gable roof) Stud Frame Machinery Storage Bldg Pole Shed, Open Sided Pole Shed, Fully Enclosed Steel Grain Handling System Wood Frame Corn Crib Steel Glass-Lined Silos Concrete Stave Silos Small Animal Housing Tool Sheds Frame Grainary\n\nAll Metal Building Concrete Building Swine Confinement Pkg, Turn-Key\n\nPole Cage Laying House Concrete Block Dairy Parlors Metal Bulk Bins Ag Fences & Corrals Power Poles Misc. Building Swimming Pools, Patios, Driveways, Sidewalks Appurtenant Structures Turkey Buildings\n\nHoop Building Greenhouse\n\nResidential Fence Buildings without a Permanent Foundation (excluding livestock huts)\n\n**Building Cause of Loss Factors**\n\nType 31 All Other Poultry Buildings 0.746 0.225 0.541 2.492\n\nNA NA\n\nType 35 NA\n\nType 29 NA NA\n\nNA\n\nNA NA Type 30 0.746 0.225 0.541 2.492 1.047 NA\n\nType 34\n\nType 36 0.800 1.500 1.100 0.500 0.500 NA Type 37 Generators & Solar Panels 0.400 0.900 0.900 0.150 0.900 NA\n\nType 32 1.000 2.500 0.700 1.000 1.000 NA Type 33 1.000 1.900\n\n1\\.047 NA NA NA\n\nNA\n\nNA\n\nPermanently Mounted Tanks 0.150 1.000 0.650 1.500 2.000 NA NA\n\n0\\.122 1.000 1.000 0.850 NA NA NA\n\nNA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 5 Peril 6 Peril 7 Peril 8 1.000 1.000 1.000 1.000 NA NA NA\n\n0\\.334 0.750 0.400 0.800 0.550 NA NA\n\nNA NA\n\nPeril 4 1.000 0.509 0.750 0.509\n\nNA NA NA NA\n\nNA NA 2.500 1.000 1.250 NA NA NA\n\nNA\n\n0\\.582 NA NA NA 0.334 0.873 0.318 1.885 0.593 NA NA NA 1.160 2.000 1.000 2.318 1.588 NA NA NA\n\n1\\.047 NA NA NA 0.530 0.549 0.354 2.250 1.300 NA NA NA 0.414 0.915 0.352 2.242 0.479 NA NA NA\n\n0\\.541 2.492\n\n0\\.334 0.559 0.318 1.885\n\n0\\.899 NA NA NA 0.746 0.225 0.541 2.492 1.047 NA NA NA Pole Swine Finishing Barn, Single-Pole Roof 0.746 1.250 0.541 2.492 1.047 NA NA NA\n\nQuonset Grain or Machinery Storage Shed 0.577 1.050 0.424 0.573 0.400 NA NA NA 1.250 0.915 0.950 1.150 1.050 NA NA NA 0.571 0.900 0.865 1.100\n\n0\\.016 NA NA NA 0.700 0.800 0.820 1.401 0.740 NA NA NA 0.450 0.480 0.754 2.600 1.493 NA NA NA\n\n0\\.414 1.000 0.352 2.242 0.479 NA NA NA 0.585 0.550 0.754 2.600 1.493 NA NA NA 0.289 0.272 0.201 0.666 0.127 NA NA NA 1.148 1.178 0.201 0.662\n\n0\\.900 NA NA NA 1.510 2.100 1.050 1.000 1.200 NA NA NA 1.500 1.200 1.000 1.000 1.150 NA NA NA\n\n0\\.705 1.150 0.638 2.129 1.895 NA NA NA 0.475 0.350 0.638 2.129 1.895 NA NA NA 0.500 0.400 0.638 2.129 1.895 NA NA NA 0.895 0.865 0.854 1.000\n\n0\\.900 0.854 0.742 0.523 NA NA NA 1.483 1.020 0.854 1.000 0.900 NA NA NA 1.398 0.990 0.854 0.742 0.523 NA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 0.750 0.650 2.000 3.036 0.458 NA NA NA 1.398\n\n0\\.670 0.880 NA NA NA 0.940 0.880 0.802\n\n1\\.711 1.730 1.444 NA NA NA Building Width Exclusion\\* 1.000 1.000 1.000 1.000 NA NA NA\n\n1\\.130 1.371 1.491 1.092 NA NA NA 1.226 1.582 1.596 1.213 NA NA NA 1.240 1.660 1.690 1.213 NA NA NA\n\n1\\.051 1.066 1.096 1.127 1.000\n\nBuilding\n\n>= 60 Feet, < 70 Feet 70+ Feet 1.299\n\nNA\n\nPeril 4\n\n1\\.036 1.089 1.116 1.035 NA NA NA\n\n0\\.981 0.989\n\n1\\.000 0.938 0.954 0.967\n\n1\\.073 1.190 1.230 1.092 NA NA NA 1.122 1.200 1.367 1.092 NA NA NA\n\n0\\.982 0.961 0.942 0.970 NA NA NA 1.000 1.000 1.000 1.000 NA NA NA 1.018 1.043 1.058 1.025 NA NA NA\n\n0\\.994 1.000 1.006 1.011 1.023 1.037\n\n0\\.926 0.825\n\n1\\.000 NA NA NA 1.000 1.000 1.743 NA NA NA\n\n0\\.965 0.926 0.886 0.941 NA NA NA\n\n1\\.000 1.000 1.000 1.000 NA NA NA 0.850 0.804 0.422 0.765 NA NA NA 0.890 0.814 0.549 0.810 NA NA NA\n\n1\\.000 1.000 2.000 NA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 5 Peril 6 Peril 7\n\n0\\.900 NA NA\n\nPeril 6 Peril 7 Peril 8\n\nType 19\n\nType 13\n\nPeril 8\n\nBuilding Class Peril 1 Peril 2 1 1.000 1.000 2 1.658 1.021\n\nPeril 3 Peril 4 Peril 5\n\nType 3\n\nType 27\n\nType 16\n\nType 9\n\nType 26\n\n0\\.746 0.499\n\n1\\.000 1.000\n\n3\n\nType 12 Type 11\n\nType 8\n\n>= 10 Feet, < 15 Feet\n\nNA NA\n\nType 14\n\nType 18\n\nType 20 Type 21\n\nType 17\n\nType 4\n\nType 6\n\nNA NA NA 1.000 0.200\n\nType 28\n\n1 & 2 2-10\n\nSpecial 1-10\n\n0\\.082 0.400 0.300 2.250 1.400\n\nType 24 Type 25\n\n0\\.850\n\n>= 1 Feet, < 4 Feet >= 4 Feet, < 10 Feet\n\nType 1 Type\n\n>= 40 Feet, < 45 Feet >= 45 Feet, < 50 Feet\n\n2\\.470 1.700\n\nBuilding Width\n\n>= 50 Feet, < 60 Feet\n\n>= 20 Feet, < 23 Feet\n\n0\\.200 0.750\n\nType 10\n\nBuilding Cause of Loss\n\n1\\.000 1.000 1.000\n\nType 2\n\nType 7\n\nType 5\n\nType 15\n\n>= 23 Feet, < 25 Feet >= 25 Feet, < 27 Feet >= 27 Feet, < 29 Feet >= 29 Feet, < 31 Feet >= 31 Feet, < 35 Feet >= 35 Feet, < 40 Feet\n\n>= 15 Feet, < 20 Feet\n\nType 22 Type 23\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 866W Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page98.pdf"]},"response":{"errors":[],"extract_id":"extract_94191c5af3b572c8610b34fc198de795","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Property Section Rates and Factors**\n\n**Garages, Outbuildings, & Other Structures (GOOS)**\n\n**GOOS Primary Rating Factor**\n\n**Building Class Factors**\n\n**Building Width Factors**\n\n\\*Building Width Exclusion factor applies to the following Building Types: 11, 13, 14, 15, 16, 24, 25, 26, 28, 34, 35 & 37\n\n**Building Type Factors**\n\nDescription Detached Garages One Story Barn Two Story Barn (sidewalls >=16) Two Story Barn (sidewalls <16) Open Sided Pole Swine Finishing Bldg Frame Swine Farrowing Bldg Pole Swine Finishing Bldg (gable roof) Stud Frame Machinery Storage Bldg Pole Shed, Open Sided Pole Shed, Fully Enclosed Steel Grain Handling System Wood Frame Corn Crib Steel Glass-Lined Silos Concrete Stave Silos Small Animal Housing Tool Sheds Frame Grainary\n\nAll Metal Building Concrete Building Swine Confinement Pkg, Turn-Key\n\nPole Cage Laying House Concrete Block Dairy Parlors Metal Bulk Bins Ag Fences & Corrals Power Poles Misc. Building Swimming Pools, Patios, Driveways, Sidewalks Appurtenant Structures Turkey Buildings\n\nHoop Building Greenhouse\n\nResidential Fence Buildings without a Permanent Foundation (excluding livestock huts)\n\n**Building Cause of Loss Factors**\n\nType 31 All Other Poultry Buildings 0.746 0.225 0.541 2.492\n\nNA NA\n\nType 35 NA\n\nType 29 NA NA\n\nNA\n\nNA NA Type 30 0.746 0.225 0.541 2.492 1.047 NA\n\nType 34\n\nType 36 0.800 1.500 1.100 0.500 0.500 NA Type 37 Generators & Solar Panels 0.400 0.900 0.900 0.150 0.900 NA\n\nType 32 1.000 2.500 0.700 1.000 1.000 NA Type 33 1.000 1.900\n\n1\\.047 NA NA NA\n\nNA\n\nNA\n\nPermanently Mounted Tanks 0.150 1.000 0.650 1.500 2.000 NA NA\n\n0\\.122 1.000 1.000 0.850 NA NA NA\n\nNA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 5 Peril 6 Peril 7 Peril 8 1.000 1.000 1.000 1.000 NA NA NA\n\n0\\.334 0.750 0.400 0.800 0.550 NA NA\n\nNA NA\n\nPeril 4 1.000 0.509 0.750 0.509\n\nNA NA NA NA\n\nNA NA 2.500 1.000 1.250 NA NA NA\n\nNA\n\n0\\.582 NA NA NA 0.334 0.873 0.318 1.885 0.593 NA NA NA 1.160 2.000 1.000 2.318 1.588 NA NA NA\n\n1\\.047 NA NA NA 0.530 0.549 0.354 2.250 1.300 NA NA NA 0.414 0.915 0.352 2.242 0.479 NA NA NA\n\n0\\.541 2.492\n\n0\\.334 0.559 0.318 1.885\n\n0\\.899 NA NA NA 0.746 0.225 0.541 2.492 1.047 NA NA NA Pole Swine Finishing Barn, Single-Pole Roof 0.746 1.250 0.541 2.492 1.047 NA NA NA\n\nQuonset Grain or Machinery Storage Shed 0.577 1.050 0.424 0.573 0.400 NA NA NA 1.250 0.915 0.950 1.150 1.050 NA NA NA 0.571 0.900 0.865 1.100\n\n0\\.016 NA NA NA 0.700 0.800 0.820 1.401 0.740 NA NA NA 0.450 0.480 0.754 2.600 1.493 NA NA NA\n\n0\\.414 1.000 0.352 2.242 0.479 NA NA NA 0.585 0.550 0.754 2.600 1.493 NA NA NA 0.289 0.272 0.201 0.666 0.127 NA NA NA 1.148 1.178 0.201 0.662\n\n0\\.900 NA NA NA 1.510 2.100 1.050 1.000 1.200 NA NA NA 1.500 1.200 1.000 1.000 1.150 NA NA NA\n\n0\\.705 1.150 0.638 2.129 1.895 NA NA NA 0.475 0.350 0.638 2.129 1.895 NA NA NA 0.500 0.400 0.638 2.129 1.895 NA NA NA 0.895 0.865 0.854 1.000\n\n0\\.900 0.854 0.742 0.523 NA NA NA 1.483 1.020 0.854 1.000 0.900 NA NA NA 1.398 0.990 0.854 0.742 0.523 NA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 0.750 0.650 2.000 3.036 0.458 NA NA NA 1.398\n\n0\\.670 0.880 NA NA NA 0.940 0.880 0.802\n\n1\\.711 1.730 1.444 NA NA NA Building Width Exclusion\\* 1.000 1.000 1.000 1.000 NA NA NA\n\n1\\.130 1.371 1.491 1.092 NA NA NA 1.226 1.582 1.596 1.213 NA NA NA 1.240 1.660 1.690 1.213 NA NA NA\n\n1\\.051 1.066 1.096 1.127 1.000\n\nBuilding\n\n>= 60 Feet, < 70 Feet 70+ Feet 1.299\n\nNA\n\nPeril 4\n\n1\\.036 1.089 1.116 1.035 NA NA NA\n\n0\\.981 0.989\n\n1\\.000 0.938 0.954 0.967\n\n1\\.073 1.190 1.230 1.092 NA NA NA 1.122 1.200 1.367 1.092 NA NA NA\n\n0\\.982 0.961 0.942 0.970 NA NA NA 1.000 1.000 1.000 1.000 NA NA NA 1.018 1.043 1.058 1.025 NA NA NA\n\n0\\.994 1.000 1.006 1.011 1.023 1.037\n\n0\\.926 0.825\n\n1\\.000 NA NA NA 1.000 1.000 1.743 NA NA NA\n\n0\\.965 0.926 0.886 0.941 NA NA NA\n\n1\\.000 1.000 1.000 1.000 NA NA NA 0.850 0.804 0.422 0.765 NA NA NA 0.890 0.814 0.549 0.810 NA NA NA\n\n1\\.000 1.000 2.000 NA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 5 Peril 6 Peril 7\n\n0\\.900 NA NA\n\nPeril 6 Peril 7 Peril 8\n\nType 19\n\nType 13\n\nPeril 8\n\nBuilding Class Peril 1 Peril 2 1 1.000 1.000 2 1.658 1.021\n\nPeril 3 Peril 4 Peril 5\n\nType 3\n\nType 27\n\nType 16\n\nType 9\n\nType 26\n\n0\\.746 0.499\n\n1\\.000 1.000\n\n3\n\nType 12 Type 11\n\nType 8\n\n>= 10 Feet, < 15 Feet\n\nNA NA\n\nType 14\n\nType 18\n\nType 20 Type 21\n\nType 17\n\nType 4\n\nType 6\n\nNA NA NA 1.000 0.200\n\nType 28\n\n1 & 2 2-10\n\nSpecial 1-10\n\n0\\.082 0.400 0.300 2.250 1.400\n\nType 24 Type 25\n\n0\\.850\n\n>= 1 Feet, < 4 Feet >= 4 Feet, < 10 Feet\n\nType 1 Type\n\n>= 40 Feet, < 45 Feet >= 45 Feet, < 50 Feet\n\n2\\.470 1.700\n\nBuilding Width\n\n>= 50 Feet, < 60 Feet\n\n>= 20 Feet, < 23 Feet\n\n0\\.200 0.750\n\nType 10\n\nBuilding Cause of Loss\n\n1\\.000 1.000 1.000\n\nType 2\n\nType 7\n\nType 5\n\nType 15\n\n>= 23 Feet, < 25 Feet >= 25 Feet, < 27 Feet >= 27 Feet, < 29 Feet >= 29 Feet, < 31 Feet >= 31 Feet, < 35 Feet >= 35 Feet, < 40 Feet\n\n>= 15 Feet, < 20 Feet\n\nType 22 Type 23\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 866W Rates and Factors"],"full_content":"**Property Section Rates and Factors**\n\n**Garages, Outbuildings, & Other Structures (GOOS)**\n\n**GOOS Primary Rating Factor**\n\n**Building Class Factors**\n\n**Building Width Factors**\n\n\\*Building Width Exclusion factor applies to the following Building Types: 11, 13, 14, 15, 16, 24, 25, 26, 28, 34, 35 & 37\n\n**Building Type Factors**\n\nDescription Detached Garages One Story Barn Two Story Barn (sidewalls >=16) Two Story Barn (sidewalls <16) Open Sided Pole Swine Finishing Bldg Frame Swine Farrowing Bldg Pole Swine Finishing Bldg (gable roof) Stud Frame Machinery Storage Bldg Pole Shed, Open Sided Pole Shed, Fully Enclosed Steel Grain Handling System Wood Frame Corn Crib Steel Glass-Lined Silos Concrete Stave Silos Small Animal Housing Tool Sheds Frame Grainary\n\nAll Metal Building Concrete Building Swine Confinement Pkg, Turn-Key\n\nPole Cage Laying House Concrete Block Dairy Parlors Metal Bulk Bins Ag Fences & Corrals Power Poles Misc. Building Swimming Pools, Patios, Driveways, Sidewalks Appurtenant Structures Turkey Buildings\n\nHoop Building Greenhouse\n\nResidential Fence Buildings without a Permanent Foundation (excluding livestock huts)\n\n**Building Cause of Loss Factors**\n\nType 31 All Other Poultry Buildings 0.746 0.225 0.541 2.492\n\nNA NA\n\nType 35 NA\n\nType 29 NA NA\n\nNA\n\nNA NA Type 30 0.746 0.225 0.541 2.492 1.047 NA\n\nType 34\n\nType 36 0.800 1.500 1.100 0.500 0.500 NA Type 37 Generators & Solar Panels 0.400 0.900 0.900 0.150 0.900 NA\n\nType 32 1.000 2.500 0.700 1.000 1.000 NA Type 33 1.000 1.900\n\n1\\.047 NA NA NA\n\nNA\n\nNA\n\nPermanently Mounted Tanks 0.150 1.000 0.650 1.500 2.000 NA NA\n\n0\\.122 1.000 1.000 0.850 NA NA NA\n\nNA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 5 Peril 6 Peril 7 Peril 8 1.000 1.000 1.000 1.000 NA NA NA\n\n0\\.334 0.750 0.400 0.800 0.550 NA NA\n\nNA NA\n\nPeril 4 1.000 0.509 0.750 0.509\n\nNA NA NA NA\n\nNA NA 2.500 1.000 1.250 NA NA NA\n\nNA\n\n0\\.582 NA NA NA 0.334 0.873 0.318 1.885 0.593 NA NA NA 1.160 2.000 1.000 2.318 1.588 NA NA NA\n\n1\\.047 NA NA NA 0.530 0.549 0.354 2.250 1.300 NA NA NA 0.414 0.915 0.352 2.242 0.479 NA NA NA\n\n0\\.541 2.492\n\n0\\.334 0.559 0.318 1.885\n\n0\\.899 NA NA NA 0.746 0.225 0.541 2.492 1.047 NA NA NA Pole Swine Finishing Barn, Single-Pole Roof 0.746 1.250 0.541 2.492 1.047 NA NA NA\n\nQuonset Grain or Machinery Storage Shed 0.577 1.050 0.424 0.573 0.400 NA NA NA 1.250 0.915 0.950 1.150 1.050 NA NA NA 0.571 0.900 0.865 1.100\n\n0\\.016 NA NA NA 0.700 0.800 0.820 1.401 0.740 NA NA NA 0.450 0.480 0.754 2.600 1.493 NA NA NA\n\n0\\.414 1.000 0.352 2.242 0.479 NA NA NA 0.585 0.550 0.754 2.600 1.493 NA NA NA 0.289 0.272 0.201 0.666 0.127 NA NA NA 1.148 1.178 0.201 0.662\n\n0\\.900 NA NA NA 1.510 2.100 1.050 1.000 1.200 NA NA NA 1.500 1.200 1.000 1.000 1.150 NA NA NA\n\n0\\.705 1.150 0.638 2.129 1.895 NA NA NA 0.475 0.350 0.638 2.129 1.895 NA NA NA 0.500 0.400 0.638 2.129 1.895 NA NA NA 0.895 0.865 0.854 1.000\n\n0\\.900 0.854 0.742 0.523 NA NA NA 1.483 1.020 0.854 1.000 0.900 NA NA NA 1.398 0.990 0.854 0.742 0.523 NA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 4 Peril 5 Peril 6 Peril 7 Peril 8 0.750 0.650 2.000 3.036 0.458 NA NA NA 1.398\n\n0\\.670 0.880 NA NA NA 0.940 0.880 0.802\n\n1\\.711 1.730 1.444 NA NA NA Building Width Exclusion\\* 1.000 1.000 1.000 1.000 NA NA NA\n\n1\\.130 1.371 1.491 1.092 NA NA NA 1.226 1.582 1.596 1.213 NA NA NA 1.240 1.660 1.690 1.213 NA NA NA\n\n1\\.051 1.066 1.096 1.127 1.000\n\nBuilding\n\n>= 60 Feet, < 70 Feet 70+ Feet 1.299\n\nNA\n\nPeril 4\n\n1\\.036 1.089 1.116 1.035 NA NA NA\n\n0\\.981 0.989\n\n1\\.000 0.938 0.954 0.967\n\n1\\.073 1.190 1.230 1.092 NA NA NA 1.122 1.200 1.367 1.092 NA NA NA\n\n0\\.982 0.961 0.942 0.970 NA NA NA 1.000 1.000 1.000 1.000 NA NA NA 1.018 1.043 1.058 1.025 NA NA NA\n\n0\\.994 1.000 1.006 1.011 1.023 1.037\n\n0\\.926 0.825\n\n1\\.000 NA NA NA 1.000 1.000 1.743 NA NA NA\n\n0\\.965 0.926 0.886 0.941 NA NA NA\n\n1\\.000 1.000 1.000 1.000 NA NA NA 0.850 0.804 0.422 0.765 NA NA NA 0.890 0.814 0.549 0.810 NA NA NA\n\n1\\.000 1.000 2.000 NA NA NA\n\nPeril 1 Peril 2 Peril 3 Peril 5 Peril 6 Peril 7\n\n0\\.900 NA NA\n\nPeril 6 Peril 7 Peril 8\n\nType 19\n\nType 13\n\nPeril 8\n\nBuilding Class Peril 1 Peril 2 1 1.000 1.000 2 1.658 1.021\n\nPeril 3 Peril 4 Peril 5\n\nType 3\n\nType 27\n\nType 16\n\nType 9\n\nType 26\n\n0\\.746 0.499\n\n1\\.000 1.000\n\n3\n\nType 12 Type 11\n\nType 8\n\n>= 10 Feet, < 15 Feet\n\nNA NA\n\nType 14\n\nType 18\n\nType 20 Type 21\n\nType 17\n\nType 4\n\nType 6\n\nNA NA NA 1.000 0.200\n\nType 28\n\n1 & 2 2-10\n\nSpecial 1-10\n\n0\\.082 0.400 0.300 2.250 1.400\n\nType 24 Type 25\n\n0\\.850\n\n>= 1 Feet, < 4 Feet >= 4 Feet, < 10 Feet\n\nType 1 Type\n\n>= 40 Feet, < 45 Feet >= 45 Feet, < 50 Feet\n\n2\\.470 1.700\n\nBuilding Width\n\n>= 50 Feet, < 60 Feet\n\n>= 20 Feet, < 23 Feet\n\n0\\.200 0.750\n\nType 10\n\nBuilding Cause of Loss\n\n1\\.000 1.000 1.000\n\nType 2\n\nType 7\n\nType 5\n\nType 15\n\n>= 23 Feet, < 25 Feet >= 25 Feet, < 27 Feet >= 27 Feet, < 29 Feet >= 29 Feet, < 31 Feet >= 31 Feet, < 35 Feet >= 35 Feet, < 40 Feet\n\n>= 15 Feet, < 20 Feet\n\nType 22 Type 23\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 866W Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page98.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page98.pdf"},"request":{"example_id":"table/FBLB-134215544_page98","product_type":"parse","source_file_path":"FBLB-134215544_page98.pdf"},"started_at":"2026-11-04T19:47:11.292657"} +{"completed_at":"2026-11-04T19:47:13.859698","latency_in_ms":1822,"output":{"example_id":"table/FBLB-134215544_page99","grounded_pages":[],"layout_pages":[],"markdown":"### **Property Section Rates and Factors**\n\nUtah\n\n**Additional Factors Used in Rating**\n\nUpper $ Threshold\n\nLower % Threshold Upper % Threshold Lower $ Threshold\n\n**Upper & Lower Thresholds**\n\nNo Cap\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 951W - 1000W Rates and Factors","pages":[{"line_numbers":[],"markdown":"### **Property Section Rates and Factors**\n\nUtah\n\n**Additional Factors Used in Rating**\n\nUpper $ Threshold\n\nLower % Threshold Upper % Threshold Lower $ Threshold\n\n**Upper & Lower Thresholds**\n\nNo Cap\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 951W - 1000W Rates and Factors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Property Section Rates and Factors**\n\nUtah\n\n**Additional Factors Used in Rating**\n\nUpper $ Threshold\n\nLower % Threshold Upper % Threshold Lower $ Threshold\n\n**Upper & Lower Thresholds**\n\nNo Cap\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 951W - 1000W Rates and Factors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page99.pdf"]},"response":{"errors":[],"extract_id":"extract_be536039c1119ff52d745b75db98815e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Property Section Rates and Factors**\n\nUtah\n\n**Additional Factors Used in Rating**\n\nUpper $ Threshold\n\nLower % Threshold Upper % Threshold Lower $ Threshold\n\n**Upper & Lower Thresholds**\n\nNo Cap\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 951W - 1000W Rates and Factors"],"full_content":"### **Property Section Rates and Factors**\n\nUtah\n\n**Additional Factors Used in Rating**\n\nUpper $ Threshold\n\nLower % Threshold Upper % Threshold Lower $ Threshold\n\n**Upper & Lower Thresholds**\n\nNo Cap\n\nWestern Agricultural Insurance Company (Utah) FARM BUREAU MEMBER'S CHOICE POLICY - PROPERTY SECTION - 01/23/2025 951W - 1000W Rates and Factors","publish_date":null,"title":"Property Section Rates and Factors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page99.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/FBLB-134215544_page99.pdf"},"request":{"example_id":"table/FBLB-134215544_page99","product_type":"parse","source_file_path":"FBLB-134215544_page99.pdf"},"started_at":"2026-11-04T19:47:12.037545"} +{"completed_at":"2026-11-04T19:47:15.159317","latency_in_ms":1629,"output":{"example_id":"table/Goldman Sachs 10-k_page1","grounded_pages":[],"layout_pages":[],"markdown":"## UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n# **Form 10-K**\n\n### ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF\n\n### THE SECURITIES EXCHANGE ACT OF 1934\n\n### **For the fiscal year ended December 31, 2024 Commission File Number: 001-14965**\n\n# **The Goldman Sachs Group, Inc.**\n\n(Exact name of registrant as specified in its charter)\n\nDelaware 13-4019460\n\n(State or other jurisdiction of incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n200 West Street, New York, NY 10282\n\n(Address of principal executive offices) (Zip Code)\n\n(212) 902-1000\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading Symbol\n\nExchange on which registered\n\nCommon stock, par value $0.01 per share GS NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series A GS PRA NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series C GS PRC NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series D GS PRD NYSE\n\n5\\.793% Fixed-to-Floating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital II GS/43PE NYSE\n\nFloating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital III GS/43PF NYSE\n\nMedium-Term Notes, Series F, Callable Fixed and Floating Rate Notes due March 2031 of GS Finance Corp. GS/31B NYSE\n\nMedium-Term Notes, Series F, Callable Fixed and Floating Rate Notes due May 2031 of GS Finance Corp. GS/31X NYSE\n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ☐ Yes ☒ No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No As of June 30, 2024, the aggregate market value of the common stock of the registrant held by non-affiliates of the registrant was approximately $142.3 billion. As of February 7, 2025, there were 312,039,033 shares of the registrant’s common stock outstanding. **Documents incorporated by reference:** Portions of The Goldman Sachs Group, Inc.’s Proxy Statement for its 2025 Annual Meeting of Shareholders are incorporated by reference in the Annual Report on Form 10-K in response to Part III, Items 10, 11, 12, 13 and 14.","pages":[{"line_numbers":[],"markdown":"## UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n# **Form 10-K**\n\n### ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF\n\n### THE SECURITIES EXCHANGE ACT OF 1934\n\n### **For the fiscal year ended December 31, 2024 Commission File Number: 001-14965**\n\n# **The Goldman Sachs Group, Inc.**\n\n(Exact name of registrant as specified in its charter)\n\nDelaware 13-4019460\n\n(State or other jurisdiction of incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n200 West Street, New York, NY 10282\n\n(Address of principal executive offices) (Zip Code)\n\n(212) 902-1000\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading Symbol\n\nExchange on which registered\n\nCommon stock, par value $0.01 per share GS NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series A GS PRA NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series C GS PRC NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series D GS PRD NYSE\n\n5\\.793% Fixed-to-Floating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital II GS/43PE NYSE\n\nFloating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital III GS/43PF NYSE\n\nMedium-Term Notes, Series F, Callable Fixed and Floating Rate Notes due March 2031 of GS Finance Corp. GS/31B NYSE\n\nMedium-Term Notes, Series F, Callable Fixed and Floating Rate Notes due May 2031 of GS Finance Corp. GS/31X NYSE\n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ☐ Yes ☒ No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No As of June 30, 2024, the aggregate market value of the common stock of the registrant held by non-affiliates of the registrant was approximately $142.3 billion. As of February 7, 2025, there were 312,039,033 shares of the registrant’s common stock outstanding. **Documents incorporated by reference:** Portions of The Goldman Sachs Group, Inc.’s Proxy Statement for its 2025 Annual Meeting of Shareholders are incorporated by reference in the Annual Report on Form 10-K in response to Part III, Items 10, 11, 12, 13 and 14.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n# **Form 10-K**\n\n### ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF\n\n### THE SECURITIES EXCHANGE ACT OF 1934\n\n### **For the fiscal year ended December 31, 2024 Commission File Number: 001-14965**\n\n# **The Goldman Sachs Group, Inc.**\n\n(Exact name of registrant as specified in its charter)\n\nDelaware 13-4019460\n\n(State or other jurisdiction of incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n200 West Street, New York, NY 10282\n\n(Address of principal executive offices) (Zip Code)\n\n(212) 902-1000\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading Symbol\n\nExchange on which registered\n\nCommon stock, par value $0.01 per share GS NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series A GS PRA NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series C GS PRC NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series D GS PRD NYSE\n\n5\\.793% Fixed-to-Floating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital II GS/43PE NYSE\n\nFloating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital III GS/43PF NYSE\n\nMedium-Term Notes, Series F, Callable Fixed and Floating Rate Notes due March 2031 of GS Finance Corp. GS/31B NYSE\n\nMedium-Term Notes, Series F, Callable Fixed and Floating Rate Notes due May 2031 of GS Finance Corp. GS/31X NYSE\n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ☐ Yes ☒ No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No As of June 30, 2024, the aggregate market value of the common stock of the registrant held by non-affiliates of the registrant was approximately $142.3 billion. As of February 7, 2025, there were 312,039,033 shares of the registrant’s common stock outstanding. **Documents incorporated by reference:** Portions of The Goldman Sachs Group, Inc.’s Proxy Statement for its 2025 Annual Meeting of Shareholders are incorporated by reference in the Annual Report on Form 10-K in response to Part III, Items 10, 11, 12, 13 and 14.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_84a4f08575d2b467e0063b75cd3c5aef","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n# **Form 10-K**\n\n### ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF\n\n### THE SECURITIES EXCHANGE ACT OF 1934\n\n### **For the fiscal year ended December 31, 2024 Commission File Number: 001-14965**\n\n# **The Goldman Sachs Group, Inc.**\n\n(Exact name of registrant as specified in its charter)\n\nDelaware 13-4019460\n\n(State or other jurisdiction of incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n200 West Street, New York, NY 10282\n\n(Address of principal executive offices) (Zip Code)\n\n(212) 902-1000\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading Symbol\n\nExchange on which registered\n\nCommon stock, par value $0.01 per share GS NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series A GS PRA NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series C GS PRC NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series D GS PRD NYSE\n\n5\\.793% Fixed-to-Floating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital II GS/43PE NYSE\n\nFloating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital III GS/43PF NYSE\n\nMedium-Term Notes, Series F, Callable Fixed and Floating Rate Notes due March 2031 of GS Finance Corp. GS/31B NYSE\n\nMedium-Term Notes, Series F, Callable Fixed and Floating Rate Notes due May 2031 of GS Finance Corp. GS/31X NYSE\n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ☐ Yes ☒ No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No As of June 30, 2024, the aggregate market value of the common stock of the registrant held by non-affiliates of the registrant was approximately $142.3 billion. As of February 7, 2025, there were 312,039,033 shares of the registrant’s common stock outstanding. **Documents incorporated by reference:** Portions of The Goldman Sachs Group, Inc.’s Proxy Statement for its 2025 Annual Meeting of Shareholders are incorporated by reference in the Annual Report on Form 10-K in response to Part III, Items 10, 11, 12, 13 and 14."],"full_content":"## UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n# **Form 10-K**\n\n### ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF\n\n### THE SECURITIES EXCHANGE ACT OF 1934\n\n### **For the fiscal year ended December 31, 2024 Commission File Number: 001-14965**\n\n# **The Goldman Sachs Group, Inc.**\n\n(Exact name of registrant as specified in its charter)\n\nDelaware 13-4019460\n\n(State or other jurisdiction of incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n200 West Street, New York, NY 10282\n\n(Address of principal executive offices) (Zip Code)\n\n(212) 902-1000\n\n(Registrant’s telephone number, including area code)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading Symbol\n\nExchange on which registered\n\nCommon stock, par value $0.01 per share GS NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series A GS PRA NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series C GS PRC NYSE\n\nDepositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series D GS PRD NYSE\n\n5\\.793% Fixed-to-Floating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital II GS/43PE NYSE\n\nFloating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital III GS/43PF NYSE\n\nMedium-Term Notes, Series F, Callable Fixed and Floating Rate Notes due March 2031 of GS Finance Corp. GS/31B NYSE\n\nMedium-Term Notes, Series F, Callable Fixed and Floating Rate Notes due May 2031 of GS Finance Corp. GS/31X NYSE\n\nSecurities registered pursuant to Section 12(g) of the Act: None\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ☐ Yes ☒ No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No As of June 30, 2024, the aggregate market value of the common stock of the registrant held by non-affiliates of the registrant was approximately $142.3 billion. As of February 7, 2025, there were 312,039,033 shares of the registrant’s common stock outstanding. **Documents incorporated by reference:** Portions of The Goldman Sachs Group, Inc.’s Proxy Statement for its 2025 Annual Meeting of Shareholders are incorporated by reference in the Annual Report on Form 10-K in response to Part III, Items 10, 11, 12, 13 and 14.","publish_date":null,"title":"The Goldman Sachs Group, Inc. — Form 10-K, fiscal year ended December 31, 2024","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page1.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page1","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page1.pdf"},"started_at":"2026-11-04T19:47:13.529841"} +{"completed_at":"2026-11-04T19:29:59.169066","latency_in_ms":1718,"output":{"example_id":"table/Goldman Sachs 10-k_page106","grounded_pages":[],"layout_pages":[],"markdown":"The table below presents information about our GCLA.\n\nAverage for the\n\nThree Months Year Ended\n\nEnded December December\n\n_$ in millions_ **2024** 2023 **2024** 2023\n\n**Denomination** U.S. dollar **$ 311,839** $ 282,414 **$ 300,535** $ 282,307\n\nNon-U.S. dollar **110,252** 131,176 **128,645** 124,691\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\n**Asset Class** Overnight cash deposits **$ 143,563** $ 204,929 **$ 184,370** $ 231,066\n\nU.S. government obligations **177,721** 150,806 **163,983** 133,000\n\nU.S. agency obligations **46,979** 22,895 **32,102** 16,387\n\nNon-U.S. government obligations **53,828** 34,960 **48,725** 26,545\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\n**Entity Type** Group Inc. and Funding IHC **$ 60,609** $ 65,952 **$ 65,965** $ 66,803\n\nMajor broker-dealer subsidiaries **113,996** 117,818 **117,204** 114,824\n\nMajor bank subsidiaries **247,486** 229,820 **246,011** 225,371\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\nIn the table above:\n\n• The U.S. dollar-denominated GCLA consists of (i)\n\nunencumbered U.S. government and agency obligations (including highly liquid U.S. agency mortgage-backed obligations), all of which are eligible as collateral in Federal Reserve open market operations and (ii) certain overnight U.S. dollar cash deposits.\n\n• The non-U.S. dollar-denominated GCLA consists of non-\n\nU.S. government obligations (only unencumbered German, French, Japanese and U.K. government obligations) and certain overnight cash deposits in highly liquid currencies.\n\nWe maintain our GCLA to enable us to meet current and potential liquidity requirements of our parent company, Group Inc., and its subsidiaries. Our Modeled Liquidity Outflow and Intraday Liquidity Model incorporate a requirement for Group Inc., as well as a standalone requirement for each of our major broker-dealer and bank subsidiaries. Funding IHC is required to provide the necessary liquidity to Group Inc. during the ordinary course of business, and is also obligated to provide capital and liquidity support to major subsidiaries in the event of our material financial distress or failure. Liquidity held directly in each of our major broker-dealer and bank subsidiaries is intended for use only by that subsidiary to meet its liquidity requirements and is assumed not to be available to Group Inc. or Funding IHC unless (i) legally provided for and (ii) there are no additional regulatory, tax or other restrictions. In addition, the Modeled Liquidity Outflow and Intraday Liquidity Model also incorporate a broader assessment of standalone liquidity requirements for other subsidiaries and we hold a portion of our GCLA directly at Group Inc. or Funding IHC to support such requirements.\n\n**Other Unencumbered Assets.** In addition to our GCLA, we have a significant amount of other unencumbered cash and financial instruments, including other government obligations, high-grade money market securities, corporate obligations, marginable equities, loans and cash deposits not included in our GCLA. The fair value of our unencumbered assets averaged $295.49 billion for the three months ended December 2024, $286.51 billion for the three months ended December 2023, $292.22 billion for the year ended December 2024 and $281.95 billion for the year ended December 2023. We do not consider these assets liquid enough to be eligible for our GCLA.\n\n**Liquidity Regulatory Framework** We are subject to a minimum Liquidity Coverage Ratio (LCR) under the LCR rule approved by the U.S. federal bank regulatory agencies. The LCR rule requires organizations to maintain an adequate ratio of eligible high-quality liquid assets (HQLA) to expected net cash outflows under an acute, short-term liquidity stress scenario. Eligible HQLA excludes HQLA held by subsidiaries that is in excess of their minimum requirement and is subject to transfer restrictions. We are required to maintain a minimum LCR of 100%. We expect that fluctuations in client activity, business mix and the market environment will impact our LCR.\n\nThe table below presents information about our average daily LCR.\n\nAverage for the\n\nThree Months Ended\n\n**December** September December\n\n_$ in millions_ **2024** 2024 2023\n\nTotal HQLA **$ 407,348** $ 434,256 $ 401,721\n\nEligible HQLA **$ 352,494** $ 369,119 $ 326,181\n\nNet cash outflows **$ 279,368** $ 277,825 $ 255,106\n\n**LCR 126%** 133% 128%\n\nIn the table above, our average quarterly LCR represents the average of our daily LCRs during the quarter.\n\nWe are also subject to a minimum Net Stable Funding Ratio (NSFR) under the NSFR rule approved by the U.S. federal bank regulatory agencies. The NSFR rule requires large U.S. banking organizations to maintain available stable funding (ASF) above their required stable funding (RSF) over a one- year time horizon. Total ASF excludes ASF held by subsidiaries that is in excess of their minimum requirement and is subject to transfer restrictions. We are required to maintain a minimum NSFR of 100%. We expect that fluctuations in client activity, business mix and the market environment will impact our NSFR.\n\nThe table below presents information about our average daily NSFR.\n\nAverage for the\n\nThree Months Ended\n\n**December** September December\n\n_$ in millions_ **2024** 2024 2023\n\nTotal ASF **$ 692,474** $ 673,860 $ 628,734\n\nTotal RSF **$ 595,352** $ 577,525 $ 542,089\n\n**NSFR 116%** 117% 116%\n\nIn the table above, our average quarterly NSFR represents the average of our daily NSFRs during the quarter.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 103","pages":[{"line_numbers":[],"markdown":"The table below presents information about our GCLA.\n\nAverage for the\n\nThree Months Year Ended\n\nEnded December December\n\n_$ in millions_ **2024** 2023 **2024** 2023\n\n**Denomination** U.S. dollar **$ 311,839** $ 282,414 **$ 300,535** $ 282,307\n\nNon-U.S. dollar **110,252** 131,176 **128,645** 124,691\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\n**Asset Class** Overnight cash deposits **$ 143,563** $ 204,929 **$ 184,370** $ 231,066\n\nU.S. government obligations **177,721** 150,806 **163,983** 133,000\n\nU.S. agency obligations **46,979** 22,895 **32,102** 16,387\n\nNon-U.S. government obligations **53,828** 34,960 **48,725** 26,545\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\n**Entity Type** Group Inc. and Funding IHC **$ 60,609** $ 65,952 **$ 65,965** $ 66,803\n\nMajor broker-dealer subsidiaries **113,996** 117,818 **117,204** 114,824\n\nMajor bank subsidiaries **247,486** 229,820 **246,011** 225,371\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\nIn the table above:\n\n• The U.S. dollar-denominated GCLA consists of (i)\n\nunencumbered U.S. government and agency obligations (including highly liquid U.S. agency mortgage-backed obligations), all of which are eligible as collateral in Federal Reserve open market operations and (ii) certain overnight U.S. dollar cash deposits.\n\n• The non-U.S. dollar-denominated GCLA consists of non-\n\nU.S. government obligations (only unencumbered German, French, Japanese and U.K. government obligations) and certain overnight cash deposits in highly liquid currencies.\n\nWe maintain our GCLA to enable us to meet current and potential liquidity requirements of our parent company, Group Inc., and its subsidiaries. Our Modeled Liquidity Outflow and Intraday Liquidity Model incorporate a requirement for Group Inc., as well as a standalone requirement for each of our major broker-dealer and bank subsidiaries. Funding IHC is required to provide the necessary liquidity to Group Inc. during the ordinary course of business, and is also obligated to provide capital and liquidity support to major subsidiaries in the event of our material financial distress or failure. Liquidity held directly in each of our major broker-dealer and bank subsidiaries is intended for use only by that subsidiary to meet its liquidity requirements and is assumed not to be available to Group Inc. or Funding IHC unless (i) legally provided for and (ii) there are no additional regulatory, tax or other restrictions. In addition, the Modeled Liquidity Outflow and Intraday Liquidity Model also incorporate a broader assessment of standalone liquidity requirements for other subsidiaries and we hold a portion of our GCLA directly at Group Inc. or Funding IHC to support such requirements.\n\n**Other Unencumbered Assets.** In addition to our GCLA, we have a significant amount of other unencumbered cash and financial instruments, including other government obligations, high-grade money market securities, corporate obligations, marginable equities, loans and cash deposits not included in our GCLA. The fair value of our unencumbered assets averaged $295.49 billion for the three months ended December 2024, $286.51 billion for the three months ended December 2023, $292.22 billion for the year ended December 2024 and $281.95 billion for the year ended December 2023. We do not consider these assets liquid enough to be eligible for our GCLA.\n\n**Liquidity Regulatory Framework** We are subject to a minimum Liquidity Coverage Ratio (LCR) under the LCR rule approved by the U.S. federal bank regulatory agencies. The LCR rule requires organizations to maintain an adequate ratio of eligible high-quality liquid assets (HQLA) to expected net cash outflows under an acute, short-term liquidity stress scenario. Eligible HQLA excludes HQLA held by subsidiaries that is in excess of their minimum requirement and is subject to transfer restrictions. We are required to maintain a minimum LCR of 100%. We expect that fluctuations in client activity, business mix and the market environment will impact our LCR.\n\nThe table below presents information about our average daily LCR.\n\nAverage for the\n\nThree Months Ended\n\n**December** September December\n\n_$ in millions_ **2024** 2024 2023\n\nTotal HQLA **$ 407,348** $ 434,256 $ 401,721\n\nEligible HQLA **$ 352,494** $ 369,119 $ 326,181\n\nNet cash outflows **$ 279,368** $ 277,825 $ 255,106\n\n**LCR 126%** 133% 128%\n\nIn the table above, our average quarterly LCR represents the average of our daily LCRs during the quarter.\n\nWe are also subject to a minimum Net Stable Funding Ratio (NSFR) under the NSFR rule approved by the U.S. federal bank regulatory agencies. The NSFR rule requires large U.S. banking organizations to maintain available stable funding (ASF) above their required stable funding (RSF) over a one- year time horizon. Total ASF excludes ASF held by subsidiaries that is in excess of their minimum requirement and is subject to transfer restrictions. We are required to maintain a minimum NSFR of 100%. We expect that fluctuations in client activity, business mix and the market environment will impact our NSFR.\n\nThe table below presents information about our average daily NSFR.\n\nAverage for the\n\nThree Months Ended\n\n**December** September December\n\n_$ in millions_ **2024** 2024 2023\n\nTotal ASF **$ 692,474** $ 673,860 $ 628,734\n\nTotal RSF **$ 595,352** $ 577,525 $ 542,089\n\n**NSFR 116%** 117% 116%\n\nIn the table above, our average quarterly NSFR represents the average of our daily NSFRs during the quarter.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 103","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"The table below presents information about our GCLA.\n\nAverage for the\n\nThree Months Year Ended\n\nEnded December December\n\n_$ in millions_ **2024** 2023 **2024** 2023\n\n**Denomination** U.S. dollar **$ 311,839** $ 282,414 **$ 300,535** $ 282,307\n\nNon-U.S. dollar **110,252** 131,176 **128,645** 124,691\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\n**Asset Class** Overnight cash deposits **$ 143,563** $ 204,929 **$ 184,370** $ 231,066\n\nU.S. government obligations **177,721** 150,806 **163,983** 133,000\n\nU.S. agency obligations **46,979** 22,895 **32,102** 16,387\n\nNon-U.S. government obligations **53,828** 34,960 **48,725** 26,545\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\n**Entity Type** Group Inc. and Funding IHC **$ 60,609** $ 65,952 **$ 65,965** $ 66,803\n\nMajor broker-dealer subsidiaries **113,996** 117,818 **117,204** 114,824\n\nMajor bank subsidiaries **247,486** 229,820 **246,011** 225,371\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\nIn the table above:\n\n• The U.S. dollar-denominated GCLA consists of (i)\n\nunencumbered U.S. government and agency obligations (including highly liquid U.S. agency mortgage-backed obligations), all of which are eligible as collateral in Federal Reserve open market operations and (ii) certain overnight U.S. dollar cash deposits.\n\n• The non-U.S. dollar-denominated GCLA consists of non-\n\nU.S. government obligations (only unencumbered German, French, Japanese and U.K. government obligations) and certain overnight cash deposits in highly liquid currencies.\n\nWe maintain our GCLA to enable us to meet current and potential liquidity requirements of our parent company, Group Inc., and its subsidiaries. Our Modeled Liquidity Outflow and Intraday Liquidity Model incorporate a requirement for Group Inc., as well as a standalone requirement for each of our major broker-dealer and bank subsidiaries. Funding IHC is required to provide the necessary liquidity to Group Inc. during the ordinary course of business, and is also obligated to provide capital and liquidity support to major subsidiaries in the event of our material financial distress or failure. Liquidity held directly in each of our major broker-dealer and bank subsidiaries is intended for use only by that subsidiary to meet its liquidity requirements and is assumed not to be available to Group Inc. or Funding IHC unless (i) legally provided for and (ii) there are no additional regulatory, tax or other restrictions. In addition, the Modeled Liquidity Outflow and Intraday Liquidity Model also incorporate a broader assessment of standalone liquidity requirements for other subsidiaries and we hold a portion of our GCLA directly at Group Inc. or Funding IHC to support such requirements.\n\n**Other Unencumbered Assets.** In addition to our GCLA, we have a significant amount of other unencumbered cash and financial instruments, including other government obligations, high-grade money market securities, corporate obligations, marginable equities, loans and cash deposits not included in our GCLA. The fair value of our unencumbered assets averaged $295.49 billion for the three months ended December 2024, $286.51 billion for the three months ended December 2023, $292.22 billion for the year ended December 2024 and $281.95 billion for the year ended December 2023. We do not consider these assets liquid enough to be eligible for our GCLA.\n\n**Liquidity Regulatory Framework** We are subject to a minimum Liquidity Coverage Ratio (LCR) under the LCR rule approved by the U.S. federal bank regulatory agencies. The LCR rule requires organizations to maintain an adequate ratio of eligible high-quality liquid assets (HQLA) to expected net cash outflows under an acute, short-term liquidity stress scenario. Eligible HQLA excludes HQLA held by subsidiaries that is in excess of their minimum requirement and is subject to transfer restrictions. We are required to maintain a minimum LCR of 100%. We expect that fluctuations in client activity, business mix and the market environment will impact our LCR.\n\nThe table below presents information about our average daily LCR.\n\nAverage for the\n\nThree Months Ended\n\n**December** September December\n\n_$ in millions_ **2024** 2024 2023\n\nTotal HQLA **$ 407,348** $ 434,256 $ 401,721\n\nEligible HQLA **$ 352,494** $ 369,119 $ 326,181\n\nNet cash outflows **$ 279,368** $ 277,825 $ 255,106\n\n**LCR 126%** 133% 128%\n\nIn the table above, our average quarterly LCR represents the average of our daily LCRs during the quarter.\n\nWe are also subject to a minimum Net Stable Funding Ratio (NSFR) under the NSFR rule approved by the U.S. federal bank regulatory agencies. The NSFR rule requires large U.S. banking organizations to maintain available stable funding (ASF) above their required stable funding (RSF) over a one- year time horizon. Total ASF excludes ASF held by subsidiaries that is in excess of their minimum requirement and is subject to transfer restrictions. We are required to maintain a minimum NSFR of 100%. We expect that fluctuations in client activity, business mix and the market environment will impact our NSFR.\n\nThe table below presents information about our average daily NSFR.\n\nAverage for the\n\nThree Months Ended\n\n**December** September December\n\n_$ in millions_ **2024** 2024 2023\n\nTotal ASF **$ 692,474** $ 673,860 $ 628,734\n\nTotal RSF **$ 595,352** $ 577,525 $ 542,089\n\n**NSFR 116%** 117% 116%\n\nIn the table above, our average quarterly NSFR represents the average of our daily NSFRs during the quarter.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 103","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page106.pdf"]},"response":{"errors":[],"extract_id":"extract_97f3232f3b7ef6bb7ab9086ba3d8c92a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["The table below presents information about our GCLA.\n\nAverage for the\n\nThree Months Year Ended\n\nEnded December December\n\n_$ in millions_ **2024** 2023 **2024** 2023\n\n**Denomination** U.S. dollar **$ 311,839** $ 282,414 **$ 300,535** $ 282,307\n\nNon-U.S. dollar **110,252** 131,176 **128,645** 124,691\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\n**Asset Class** Overnight cash deposits **$ 143,563** $ 204,929 **$ 184,370** $ 231,066\n\nU.S. government obligations **177,721** 150,806 **163,983** 133,000\n\nU.S. agency obligations **46,979** 22,895 **32,102** 16,387\n\nNon-U.S. government obligations **53,828** 34,960 **48,725** 26,545\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\n**Entity Type** Group Inc. and Funding IHC **$ 60,609** $ 65,952 **$ 65,965** $ 66,803\n\nMajor broker-dealer subsidiaries **113,996** 117,818 **117,204** 114,824\n\nMajor bank subsidiaries **247,486** 229,820 **246,011** 225,371\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\nIn the table above:\n\n• The U.S. dollar-denominated GCLA consists of (i)\n\nunencumbered U.S. government and agency obligations (including highly liquid U.S. agency mortgage-backed obligations), all of which are eligible as collateral in Federal Reserve open market operations and (ii) certain overnight U.S. dollar cash deposits.\n\n• The non-U.S. dollar-denominated GCLA consists of non-\n\nU.S. government obligations (only unencumbered German, French, Japanese and U.K. government obligations) and certain overnight cash deposits in highly liquid currencies.\n\nWe maintain our GCLA to enable us to meet current and potential liquidity requirements of our parent company, Group Inc., and its subsidiaries. Our Modeled Liquidity Outflow and Intraday Liquidity Model incorporate a requirement for Group Inc., as well as a standalone requirement for each of our major broker-dealer and bank subsidiaries. Funding IHC is required to provide the necessary liquidity to Group Inc. during the ordinary course of business, and is also obligated to provide capital and liquidity support to major subsidiaries in the event of our material financial distress or failure. Liquidity held directly in each of our major broker-dealer and bank subsidiaries is intended for use only by that subsidiary to meet its liquidity requirements and is assumed not to be available to Group Inc. or Funding IHC unless (i) legally provided for and (ii) there are no additional regulatory, tax or other restrictions. In addition, the Modeled Liquidity Outflow and Intraday Liquidity Model also incorporate a broader assessment of standalone liquidity requirements for other subsidiaries and we hold a portion of our GCLA directly at Group Inc. or Funding IHC to support such requirements.\n\n**Other Unencumbered Assets.** In addition to our GCLA, we have a significant amount of other unencumbered cash and financial instruments, including other government obligations, high-grade money market securities, corporate obligations, marginable equities, loans and cash deposits not included in our GCLA. The fair value of our unencumbered assets averaged $295.49 billion for the three months ended December 2024, $286.51 billion for the three months ended December 2023, $292.22 billion for the year ended December 2024 and $281.95 billion for the year ended December 2023. We do not consider these assets liquid enough to be eligible for our GCLA.\n\n**Liquidity Regulatory Framework** We are subject to a minimum Liquidity Coverage Ratio (LCR) under the LCR rule approved by the U.S. federal bank regulatory agencies. The LCR rule requires organizations to maintain an adequate ratio of eligible high-quality liquid assets (HQLA) to expected net cash outflows under an acute, short-term liquidity stress scenario. Eligible HQLA excludes HQLA held by subsidiaries that is in excess of their minimum requirement and is subject to transfer restrictions. We are required to maintain a minimum LCR of 100%. We expect that fluctuations in client activity, business mix and the market environment will impact our LCR.\n\nThe table below presents information about our average daily LCR.\n\nAverage for the\n\nThree Months Ended\n\n**December** September December\n\n_$ in millions_ **2024** 2024 2023\n\nTotal HQLA **$ 407,348** $ 434,256 $ 401,721\n\nEligible HQLA **$ 352,494** $ 369,119 $ 326,181\n\nNet cash outflows **$ 279,368** $ 277,825 $ 255,106\n\n**LCR 126%** 133% 128%\n\nIn the table above, our average quarterly LCR represents the average of our daily LCRs during the quarter.\n\nWe are also subject to a minimum Net Stable Funding Ratio (NSFR) under the NSFR rule approved by the U.S. federal bank regulatory agencies. The NSFR rule requires large U.S. banking organizations to maintain available stable funding (ASF) above their required stable funding (RSF) over a one- year time horizon. Total ASF excludes ASF held by subsidiaries that is in excess of their minimum requirement and is subject to transfer restrictions. We are required to maintain a minimum NSFR of 100%. We expect that fluctuations in client activity, business mix and the market environment will impact our NSFR.\n\nThe table below presents information about our average daily NSFR.\n\nAverage for the\n\nThree Months Ended\n\n**December** September December\n\n_$ in millions_ **2024** 2024 2023\n\nTotal ASF **$ 692,474** $ 673,860 $ 628,734\n\nTotal RSF **$ 595,352** $ 577,525 $ 542,089\n\n**NSFR 116%** 117% 116%\n\nIn the table above, our average quarterly NSFR represents the average of our daily NSFRs during the quarter.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 103"],"full_content":"The table below presents information about our GCLA.\n\nAverage for the\n\nThree Months Year Ended\n\nEnded December December\n\n_$ in millions_ **2024** 2023 **2024** 2023\n\n**Denomination** U.S. dollar **$ 311,839** $ 282,414 **$ 300,535** $ 282,307\n\nNon-U.S. dollar **110,252** 131,176 **128,645** 124,691\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\n**Asset Class** Overnight cash deposits **$ 143,563** $ 204,929 **$ 184,370** $ 231,066\n\nU.S. government obligations **177,721** 150,806 **163,983** 133,000\n\nU.S. agency obligations **46,979** 22,895 **32,102** 16,387\n\nNon-U.S. government obligations **53,828** 34,960 **48,725** 26,545\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\n**Entity Type** Group Inc. and Funding IHC **$ 60,609** $ 65,952 **$ 65,965** $ 66,803\n\nMajor broker-dealer subsidiaries **113,996** 117,818 **117,204** 114,824\n\nMajor bank subsidiaries **247,486** 229,820 **246,011** 225,371\n\n**Total $ 422,091** $ 413,590 **$ 429,180** $ 406,998\n\nIn the table above:\n\n• The U.S. dollar-denominated GCLA consists of (i)\n\nunencumbered U.S. government and agency obligations (including highly liquid U.S. agency mortgage-backed obligations), all of which are eligible as collateral in Federal Reserve open market operations and (ii) certain overnight U.S. dollar cash deposits.\n\n• The non-U.S. dollar-denominated GCLA consists of non-\n\nU.S. government obligations (only unencumbered German, French, Japanese and U.K. government obligations) and certain overnight cash deposits in highly liquid currencies.\n\nWe maintain our GCLA to enable us to meet current and potential liquidity requirements of our parent company, Group Inc., and its subsidiaries. Our Modeled Liquidity Outflow and Intraday Liquidity Model incorporate a requirement for Group Inc., as well as a standalone requirement for each of our major broker-dealer and bank subsidiaries. Funding IHC is required to provide the necessary liquidity to Group Inc. during the ordinary course of business, and is also obligated to provide capital and liquidity support to major subsidiaries in the event of our material financial distress or failure. Liquidity held directly in each of our major broker-dealer and bank subsidiaries is intended for use only by that subsidiary to meet its liquidity requirements and is assumed not to be available to Group Inc. or Funding IHC unless (i) legally provided for and (ii) there are no additional regulatory, tax or other restrictions. In addition, the Modeled Liquidity Outflow and Intraday Liquidity Model also incorporate a broader assessment of standalone liquidity requirements for other subsidiaries and we hold a portion of our GCLA directly at Group Inc. or Funding IHC to support such requirements.\n\n**Other Unencumbered Assets.** In addition to our GCLA, we have a significant amount of other unencumbered cash and financial instruments, including other government obligations, high-grade money market securities, corporate obligations, marginable equities, loans and cash deposits not included in our GCLA. The fair value of our unencumbered assets averaged $295.49 billion for the three months ended December 2024, $286.51 billion for the three months ended December 2023, $292.22 billion for the year ended December 2024 and $281.95 billion for the year ended December 2023. We do not consider these assets liquid enough to be eligible for our GCLA.\n\n**Liquidity Regulatory Framework** We are subject to a minimum Liquidity Coverage Ratio (LCR) under the LCR rule approved by the U.S. federal bank regulatory agencies. The LCR rule requires organizations to maintain an adequate ratio of eligible high-quality liquid assets (HQLA) to expected net cash outflows under an acute, short-term liquidity stress scenario. Eligible HQLA excludes HQLA held by subsidiaries that is in excess of their minimum requirement and is subject to transfer restrictions. We are required to maintain a minimum LCR of 100%. We expect that fluctuations in client activity, business mix and the market environment will impact our LCR.\n\nThe table below presents information about our average daily LCR.\n\nAverage for the\n\nThree Months Ended\n\n**December** September December\n\n_$ in millions_ **2024** 2024 2023\n\nTotal HQLA **$ 407,348** $ 434,256 $ 401,721\n\nEligible HQLA **$ 352,494** $ 369,119 $ 326,181\n\nNet cash outflows **$ 279,368** $ 277,825 $ 255,106\n\n**LCR 126%** 133% 128%\n\nIn the table above, our average quarterly LCR represents the average of our daily LCRs during the quarter.\n\nWe are also subject to a minimum Net Stable Funding Ratio (NSFR) under the NSFR rule approved by the U.S. federal bank regulatory agencies. The NSFR rule requires large U.S. banking organizations to maintain available stable funding (ASF) above their required stable funding (RSF) over a one- year time horizon. Total ASF excludes ASF held by subsidiaries that is in excess of their minimum requirement and is subject to transfer restrictions. We are required to maintain a minimum NSFR of 100%. We expect that fluctuations in client activity, business mix and the market environment will impact our NSFR.\n\nThe table below presents information about our average daily NSFR.\n\nAverage for the\n\nThree Months Ended\n\n**December** September December\n\n_$ in millions_ **2024** 2024 2023\n\nTotal ASF **$ 692,474** $ 673,860 $ 628,734\n\nTotal RSF **$ 595,352** $ 577,525 $ 542,089\n\n**NSFR 116%** 117% 116%\n\nIn the table above, our average quarterly NSFR represents the average of our daily NSFRs during the quarter.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 103","publish_date":null,"title":"Management’s Discussion and Analysis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page106.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page106.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page106","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page106.pdf"},"started_at":"2026-11-04T19:29:57.450339"} +{"completed_at":"2026-11-04T19:47:20.889279","latency_in_ms":5348,"output":{"example_id":"table/Goldman Sachs 10-k_page107","grounded_pages":[],"layout_pages":[],"markdown":"The following provides information about our subsidiary liquidity regulatory requirements:\n\n**• GS Bank USA.** GS Bank USA is subject to a minimum\n\nLCR of 100% under the LCR rule approved by the U.S. federal bank regulatory agencies. As of December 2024, GS Bank USA’s LCR exceeded the minimum requirement. The NSFR requirement described above also applies to GS Bank USA. As of December 2024, GS Bank USA’s NSFR exceeded the minimum requirement.\n\n**• GSI and GSIB.** GSI and GSIB are subject to a minimum\n\nLCR of 100% under the LCR rule approved by the U.K. regulatory authorities. GSI’s and GSIB’s average monthly LCR for the trailing twelve-month period ended December 2024 exceeded the minimum requirement. GSI and GSIB are subject to the applicable NSFR requirement in the U.K. As of December 2024, both GSI’s and GSIB’s NSFR exceeded the minimum requirement.\n\n**• GSBE.** GSBE is subject to a minimum LCR of 100% under\n\nthe LCR rule approved by the European Parliament and Council. GSBE’s average monthly LCR for the trailing twelve-month period ended December 2024 exceeded the minimum requirement. GSBE is subject to the applicable NSFR requirement in the E.U. As of December 2024, GSBE’s NSFR exceeded the minimum requirement.\n\n**• Other Subsidiaries.** We monitor local regulatory\n\nliquidity requirements of our subsidiaries to ensure compliance. For many of our subsidiaries, these\n\nrequirements either have changed or are likely to change in the future due to the implementation of the Basel Committee’s framework for liquidity risk measurement, standards and monitoring, as well as other regulatory developments.\n\nThe implementation of these rules and any amendments adopted by the regulatory authorities could impact our liquidity and funding requirements and practices in the future.\n\n**Credit Ratings** We rely on the short- and long-term debt capital markets to fund a significant portion of our day-to-day operations, and the cost and availability of debt financing is influenced by our credit ratings. Credit ratings are also important when we are competing in certain markets, such as OTC derivatives, and when we seek to engage in longer-term transactions. See “Risk Factors” in Part I, Item 1A of this Form 10-K for information about the risks associated with a reduction in our credit ratings.\n\nThe table below presents the unsecured credit ratings and outlook of Group Inc.\n\n**As of December 2024**\n\n**DBRS Fitch Moody’s R&I S&P**\n\nShort-term debt **R-1 (middle) F1 P-1 a-1 A-2**\n\nLong-term debt **A (high) A A2 A BBB+**\n\nSubordinated debt **A BBB+ Baa2 A- BBB**\n\nTrust preferred **A BBB- Baa3 N/A BB+**\n\nPreferred stock **BBB (high) BBB- Ba1 N/A BB+**\n\nRatings outlook **Stable Stable Stable Stable Stable**\n\nIn the table above:\n\n• The ratings and outlook are by DBRS, Inc. (DBRS), Fitch,\n\nInc. (Fitch), Moody’s Investors Service (Moody’s), Rating and Investment Information, Inc. (R&I), and Standard & Poor’s Ratings Services (S&P).\n\n• The ratings for trust preferred relate to the guaranteed\n\npreferred beneficial interests issued by Goldman Sachs Capital I.\n\n• The DBRS, Fitch, Moody’s and S&P ratings for preferred\n\nstock include the APEX issued by Goldman Sachs Capital II and Goldman Sachs Capital III.\n\nThe table below presents the unsecured credit ratings and outlook of GS Bank USA, GSIB, GSBE, GS&Co. and GSI.\n\n**As of December 2024**\n\n**Fitch Moody’s S&P**\n\n**GS Bank USA** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **F1+ P-1 N/A**\n\nLong-term bank deposits **AA- A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GSIB** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **F1 P-1 N/A**\n\nLong-term bank deposits **A+ A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GSBE** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **N/A P-1 N/A**\n\nLong-term bank deposits **N/A A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GS&Co.** Short-term debt **F1 N/A A-1**\n\nLong-term debt **A+ N/A A+**\n\nRatings outlook **Stable N/A Stable**\n\n**GSI** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nRatings outlook **Stable Stable Stable**\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n104 Goldman Sachs 2024 Form 10-K","pages":[{"line_numbers":[],"markdown":"The following provides information about our subsidiary liquidity regulatory requirements:\n\n**• GS Bank USA.** GS Bank USA is subject to a minimum\n\nLCR of 100% under the LCR rule approved by the U.S. federal bank regulatory agencies. As of December 2024, GS Bank USA’s LCR exceeded the minimum requirement. The NSFR requirement described above also applies to GS Bank USA. As of December 2024, GS Bank USA’s NSFR exceeded the minimum requirement.\n\n**• GSI and GSIB.** GSI and GSIB are subject to a minimum\n\nLCR of 100% under the LCR rule approved by the U.K. regulatory authorities. GSI’s and GSIB’s average monthly LCR for the trailing twelve-month period ended December 2024 exceeded the minimum requirement. GSI and GSIB are subject to the applicable NSFR requirement in the U.K. As of December 2024, both GSI’s and GSIB’s NSFR exceeded the minimum requirement.\n\n**• GSBE.** GSBE is subject to a minimum LCR of 100% under\n\nthe LCR rule approved by the European Parliament and Council. GSBE’s average monthly LCR for the trailing twelve-month period ended December 2024 exceeded the minimum requirement. GSBE is subject to the applicable NSFR requirement in the E.U. As of December 2024, GSBE’s NSFR exceeded the minimum requirement.\n\n**• Other Subsidiaries.** We monitor local regulatory\n\nliquidity requirements of our subsidiaries to ensure compliance. For many of our subsidiaries, these\n\nrequirements either have changed or are likely to change in the future due to the implementation of the Basel Committee’s framework for liquidity risk measurement, standards and monitoring, as well as other regulatory developments.\n\nThe implementation of these rules and any amendments adopted by the regulatory authorities could impact our liquidity and funding requirements and practices in the future.\n\n**Credit Ratings** We rely on the short- and long-term debt capital markets to fund a significant portion of our day-to-day operations, and the cost and availability of debt financing is influenced by our credit ratings. Credit ratings are also important when we are competing in certain markets, such as OTC derivatives, and when we seek to engage in longer-term transactions. See “Risk Factors” in Part I, Item 1A of this Form 10-K for information about the risks associated with a reduction in our credit ratings.\n\nThe table below presents the unsecured credit ratings and outlook of Group Inc.\n\n**As of December 2024**\n\n**DBRS Fitch Moody’s R&I S&P**\n\nShort-term debt **R-1 (middle) F1 P-1 a-1 A-2**\n\nLong-term debt **A (high) A A2 A BBB+**\n\nSubordinated debt **A BBB+ Baa2 A- BBB**\n\nTrust preferred **A BBB- Baa3 N/A BB+**\n\nPreferred stock **BBB (high) BBB- Ba1 N/A BB+**\n\nRatings outlook **Stable Stable Stable Stable Stable**\n\nIn the table above:\n\n• The ratings and outlook are by DBRS, Inc. (DBRS), Fitch,\n\nInc. (Fitch), Moody’s Investors Service (Moody’s), Rating and Investment Information, Inc. (R&I), and Standard & Poor’s Ratings Services (S&P).\n\n• The ratings for trust preferred relate to the guaranteed\n\npreferred beneficial interests issued by Goldman Sachs Capital I.\n\n• The DBRS, Fitch, Moody’s and S&P ratings for preferred\n\nstock include the APEX issued by Goldman Sachs Capital II and Goldman Sachs Capital III.\n\nThe table below presents the unsecured credit ratings and outlook of GS Bank USA, GSIB, GSBE, GS&Co. and GSI.\n\n**As of December 2024**\n\n**Fitch Moody’s S&P**\n\n**GS Bank USA** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **F1+ P-1 N/A**\n\nLong-term bank deposits **AA- A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GSIB** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **F1 P-1 N/A**\n\nLong-term bank deposits **A+ A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GSBE** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **N/A P-1 N/A**\n\nLong-term bank deposits **N/A A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GS&Co.** Short-term debt **F1 N/A A-1**\n\nLong-term debt **A+ N/A A+**\n\nRatings outlook **Stable N/A Stable**\n\n**GSI** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nRatings outlook **Stable Stable Stable**\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n104 Goldman Sachs 2024 Form 10-K","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"The following provides information about our subsidiary liquidity regulatory requirements:\n\n**• GS Bank USA.** GS Bank USA is subject to a minimum\n\nLCR of 100% under the LCR rule approved by the U.S. federal bank regulatory agencies. As of December 2024, GS Bank USA’s LCR exceeded the minimum requirement. The NSFR requirement described above also applies to GS Bank USA. As of December 2024, GS Bank USA’s NSFR exceeded the minimum requirement.\n\n**• GSI and GSIB.** GSI and GSIB are subject to a minimum\n\nLCR of 100% under the LCR rule approved by the U.K. regulatory authorities. GSI’s and GSIB’s average monthly LCR for the trailing twelve-month period ended December 2024 exceeded the minimum requirement. GSI and GSIB are subject to the applicable NSFR requirement in the U.K. As of December 2024, both GSI’s and GSIB’s NSFR exceeded the minimum requirement.\n\n**• GSBE.** GSBE is subject to a minimum LCR of 100% under\n\nthe LCR rule approved by the European Parliament and Council. GSBE’s average monthly LCR for the trailing twelve-month period ended December 2024 exceeded the minimum requirement. GSBE is subject to the applicable NSFR requirement in the E.U. As of December 2024, GSBE’s NSFR exceeded the minimum requirement.\n\n**• Other Subsidiaries.** We monitor local regulatory\n\nliquidity requirements of our subsidiaries to ensure compliance. For many of our subsidiaries, these\n\nrequirements either have changed or are likely to change in the future due to the implementation of the Basel Committee’s framework for liquidity risk measurement, standards and monitoring, as well as other regulatory developments.\n\nThe implementation of these rules and any amendments adopted by the regulatory authorities could impact our liquidity and funding requirements and practices in the future.\n\n**Credit Ratings** We rely on the short- and long-term debt capital markets to fund a significant portion of our day-to-day operations, and the cost and availability of debt financing is influenced by our credit ratings. Credit ratings are also important when we are competing in certain markets, such as OTC derivatives, and when we seek to engage in longer-term transactions. See “Risk Factors” in Part I, Item 1A of this Form 10-K for information about the risks associated with a reduction in our credit ratings.\n\nThe table below presents the unsecured credit ratings and outlook of Group Inc.\n\n**As of December 2024**\n\n**DBRS Fitch Moody’s R&I S&P**\n\nShort-term debt **R-1 (middle) F1 P-1 a-1 A-2**\n\nLong-term debt **A (high) A A2 A BBB+**\n\nSubordinated debt **A BBB+ Baa2 A- BBB**\n\nTrust preferred **A BBB- Baa3 N/A BB+**\n\nPreferred stock **BBB (high) BBB- Ba1 N/A BB+**\n\nRatings outlook **Stable Stable Stable Stable Stable**\n\nIn the table above:\n\n• The ratings and outlook are by DBRS, Inc. (DBRS), Fitch,\n\nInc. (Fitch), Moody’s Investors Service (Moody’s), Rating and Investment Information, Inc. (R&I), and Standard & Poor’s Ratings Services (S&P).\n\n• The ratings for trust preferred relate to the guaranteed\n\npreferred beneficial interests issued by Goldman Sachs Capital I.\n\n• The DBRS, Fitch, Moody’s and S&P ratings for preferred\n\nstock include the APEX issued by Goldman Sachs Capital II and Goldman Sachs Capital III.\n\nThe table below presents the unsecured credit ratings and outlook of GS Bank USA, GSIB, GSBE, GS&Co. and GSI.\n\n**As of December 2024**\n\n**Fitch Moody’s S&P**\n\n**GS Bank USA** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **F1+ P-1 N/A**\n\nLong-term bank deposits **AA- A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GSIB** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **F1 P-1 N/A**\n\nLong-term bank deposits **A+ A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GSBE** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **N/A P-1 N/A**\n\nLong-term bank deposits **N/A A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GS&Co.** Short-term debt **F1 N/A A-1**\n\nLong-term debt **A+ N/A A+**\n\nRatings outlook **Stable N/A Stable**\n\n**GSI** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nRatings outlook **Stable Stable Stable**\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n104 Goldman Sachs 2024 Form 10-K","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page107.pdf"]},"response":{"errors":[],"extract_id":"extract_fcef418df52fbd867ce62447072a20ed","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["The following provides information about our subsidiary liquidity regulatory requirements:\n\n**• GS Bank USA.** GS Bank USA is subject to a minimum\n\nLCR of 100% under the LCR rule approved by the U.S. federal bank regulatory agencies. As of December 2024, GS Bank USA’s LCR exceeded the minimum requirement. The NSFR requirement described above also applies to GS Bank USA. As of December 2024, GS Bank USA’s NSFR exceeded the minimum requirement.\n\n**• GSI and GSIB.** GSI and GSIB are subject to a minimum\n\nLCR of 100% under the LCR rule approved by the U.K. regulatory authorities. GSI’s and GSIB’s average monthly LCR for the trailing twelve-month period ended December 2024 exceeded the minimum requirement. GSI and GSIB are subject to the applicable NSFR requirement in the U.K. As of December 2024, both GSI’s and GSIB’s NSFR exceeded the minimum requirement.\n\n**• GSBE.** GSBE is subject to a minimum LCR of 100% under\n\nthe LCR rule approved by the European Parliament and Council. GSBE’s average monthly LCR for the trailing twelve-month period ended December 2024 exceeded the minimum requirement. GSBE is subject to the applicable NSFR requirement in the E.U. As of December 2024, GSBE’s NSFR exceeded the minimum requirement.\n\n**• Other Subsidiaries.** We monitor local regulatory\n\nliquidity requirements of our subsidiaries to ensure compliance. For many of our subsidiaries, these\n\nrequirements either have changed or are likely to change in the future due to the implementation of the Basel Committee’s framework for liquidity risk measurement, standards and monitoring, as well as other regulatory developments.\n\nThe implementation of these rules and any amendments adopted by the regulatory authorities could impact our liquidity and funding requirements and practices in the future.\n\n**Credit Ratings** We rely on the short- and long-term debt capital markets to fund a significant portion of our day-to-day operations, and the cost and availability of debt financing is influenced by our credit ratings. Credit ratings are also important when we are competing in certain markets, such as OTC derivatives, and when we seek to engage in longer-term transactions. See “Risk Factors” in Part I, Item 1A of this Form 10-K for information about the risks associated with a reduction in our credit ratings.\n\nThe table below presents the unsecured credit ratings and outlook of Group Inc.\n\n**As of December 2024**\n\n**DBRS Fitch Moody’s R&I S&P**\n\nShort-term debt **R-1 (middle) F1 P-1 a-1 A-2**\n\nLong-term debt **A (high) A A2 A BBB+**\n\nSubordinated debt **A BBB+ Baa2 A- BBB**\n\nTrust preferred **A BBB- Baa3 N/A BB+**\n\nPreferred stock **BBB (high) BBB- Ba1 N/A BB+**\n\nRatings outlook **Stable Stable Stable Stable Stable**\n\nIn the table above:\n\n• The ratings and outlook are by DBRS, Inc. (DBRS), Fitch,\n\nInc. (Fitch), Moody’s Investors Service (Moody’s), Rating and Investment Information, Inc. (R&I), and Standard & Poor’s Ratings Services (S&P).\n\n• The ratings for trust preferred relate to the guaranteed\n\npreferred beneficial interests issued by Goldman Sachs Capital I.\n\n• The DBRS, Fitch, Moody’s and S&P ratings for preferred\n\nstock include the APEX issued by Goldman Sachs Capital II and Goldman Sachs Capital III.\n\nThe table below presents the unsecured credit ratings and outlook of GS Bank USA, GSIB, GSBE, GS&Co. and GSI.\n\n**As of December 2024**\n\n**Fitch Moody’s S&P**\n\n**GS Bank USA** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **F1+ P-1 N/A**\n\nLong-term bank deposits **AA- A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GSIB** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **F1 P-1 N/A**\n\nLong-term bank deposits **A+ A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GSBE** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **N/A P-1 N/A**\n\nLong-term bank deposits **N/A A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GS&Co.** Short-term debt **F1 N/A A-1**\n\nLong-term debt **A+ N/A A+**\n\nRatings outlook **Stable N/A Stable**\n\n**GSI** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nRatings outlook **Stable Stable Stable**\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n104 Goldman Sachs 2024 Form 10-K"],"full_content":"The following provides information about our subsidiary liquidity regulatory requirements:\n\n**• GS Bank USA.** GS Bank USA is subject to a minimum\n\nLCR of 100% under the LCR rule approved by the U.S. federal bank regulatory agencies. As of December 2024, GS Bank USA’s LCR exceeded the minimum requirement. The NSFR requirement described above also applies to GS Bank USA. As of December 2024, GS Bank USA’s NSFR exceeded the minimum requirement.\n\n**• GSI and GSIB.** GSI and GSIB are subject to a minimum\n\nLCR of 100% under the LCR rule approved by the U.K. regulatory authorities. GSI’s and GSIB’s average monthly LCR for the trailing twelve-month period ended December 2024 exceeded the minimum requirement. GSI and GSIB are subject to the applicable NSFR requirement in the U.K. As of December 2024, both GSI’s and GSIB’s NSFR exceeded the minimum requirement.\n\n**• GSBE.** GSBE is subject to a minimum LCR of 100% under\n\nthe LCR rule approved by the European Parliament and Council. GSBE’s average monthly LCR for the trailing twelve-month period ended December 2024 exceeded the minimum requirement. GSBE is subject to the applicable NSFR requirement in the E.U. As of December 2024, GSBE’s NSFR exceeded the minimum requirement.\n\n**• Other Subsidiaries.** We monitor local regulatory\n\nliquidity requirements of our subsidiaries to ensure compliance. For many of our subsidiaries, these\n\nrequirements either have changed or are likely to change in the future due to the implementation of the Basel Committee’s framework for liquidity risk measurement, standards and monitoring, as well as other regulatory developments.\n\nThe implementation of these rules and any amendments adopted by the regulatory authorities could impact our liquidity and funding requirements and practices in the future.\n\n**Credit Ratings** We rely on the short- and long-term debt capital markets to fund a significant portion of our day-to-day operations, and the cost and availability of debt financing is influenced by our credit ratings. Credit ratings are also important when we are competing in certain markets, such as OTC derivatives, and when we seek to engage in longer-term transactions. See “Risk Factors” in Part I, Item 1A of this Form 10-K for information about the risks associated with a reduction in our credit ratings.\n\nThe table below presents the unsecured credit ratings and outlook of Group Inc.\n\n**As of December 2024**\n\n**DBRS Fitch Moody’s R&I S&P**\n\nShort-term debt **R-1 (middle) F1 P-1 a-1 A-2**\n\nLong-term debt **A (high) A A2 A BBB+**\n\nSubordinated debt **A BBB+ Baa2 A- BBB**\n\nTrust preferred **A BBB- Baa3 N/A BB+**\n\nPreferred stock **BBB (high) BBB- Ba1 N/A BB+**\n\nRatings outlook **Stable Stable Stable Stable Stable**\n\nIn the table above:\n\n• The ratings and outlook are by DBRS, Inc. (DBRS), Fitch,\n\nInc. (Fitch), Moody’s Investors Service (Moody’s), Rating and Investment Information, Inc. (R&I), and Standard & Poor’s Ratings Services (S&P).\n\n• The ratings for trust preferred relate to the guaranteed\n\npreferred beneficial interests issued by Goldman Sachs Capital I.\n\n• The DBRS, Fitch, Moody’s and S&P ratings for preferred\n\nstock include the APEX issued by Goldman Sachs Capital II and Goldman Sachs Capital III.\n\nThe table below presents the unsecured credit ratings and outlook of GS Bank USA, GSIB, GSBE, GS&Co. and GSI.\n\n**As of December 2024**\n\n**Fitch Moody’s S&P**\n\n**GS Bank USA** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **F1+ P-1 N/A**\n\nLong-term bank deposits **AA- A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GSIB** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **F1 P-1 N/A**\n\nLong-term bank deposits **A+ A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GSBE** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nShort-term bank deposits **N/A P-1 N/A**\n\nLong-term bank deposits **N/A A1 N/A**\n\nRatings outlook **Stable Stable Stable**\n\n**GS&Co.** Short-term debt **F1 N/A A-1**\n\nLong-term debt **A+ N/A A+**\n\nRatings outlook **Stable N/A Stable**\n\n**GSI** Short-term debt **F1 P-1 A-1**\n\nLong-term debt **A+ A1 A+**\n\nRatings outlook **Stable Stable Stable**\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n104 Goldman Sachs 2024 Form 10-K","publish_date":null,"title":"Management’s Discussion and Analysis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page107.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page107.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page107","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page107.pdf"},"started_at":"2026-11-04T19:47:15.540584"} +{"completed_at":"2026-11-04T19:47:18.552663","latency_in_ms":1499,"output":{"example_id":"table/Goldman Sachs 10-k_page113","grounded_pages":[],"layout_pages":[],"markdown":"**Sensitivity Measures** Certain portfolios and individual positions are not included in VaR because VaR is not the most appropriate risk measure. Other sensitivity measures we use to analyze market risk are described below.\n\n**10% Sensitivity Measures.** The table below presents our market risk by asset category for positions accounted for at fair value or accounted for at the lower of cost or fair value, that are not included in VaR.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nEquity **$ 1,567** $ 1,562\n\nDebt **1,904** 2,446\n\n**Total $ 3,471** $ 4,008\n\nIn the table above:\n\n• The market risk of these positions is determined by\n\nestimating the potential reduction in net revenues of a 10% decline in the value of the underlying positions.\n\n• Equity positions relate to private and public equity\n\nsecurities, which primarily include investments in\n\ncorporate, real estate and infrastructure assets.\n\nSubstantially all such equity positions are included within Asset & Wealth Management.\n\n• Debt positions include mezzanine and senior debt, and\n\ncorporate and real estate loans, substantially all of which are included within Asset & Wealth Management. Debt positions also included approximately $1.8 billion as of December 2024 and approximately $2.0 billion as of December 2023 of GM co-branded credit card loans, and approximately $3.0 billion as of December 2023 of GreenSky loans that were classified as held for sale. These held for sale loans were included within Platform Solutions.\n\n• Funded equity and debt positions are included in our\n\nconsolidated balance sheets in investments and loans, and the related hedges are included in our consolidated balance sheets in derivatives. See Note 8 to the consolidated financial statements for further information about investments, Note 9 to the consolidated financial statements for further information about loans and Note 7 to the consolidated financial statements for further information about derivatives.\n\n• These measures do not reflect the diversification effect\n\nacross asset categories or across other market risk measures.\n\n**Credit and Funding Spread Sensitivity on Derivatives and Financial Liabilities.** VaR excludes the impact of changes in counterparty credit spreads, our own credit spreads and unsecured funding spreads on derivatives, as well as changes in our own credit spreads (debt valuation adjustment) on financial liabilities for which the fair value option was elected. The estimated sensitivity to a one basis point increase in credit spreads (counterparty and our own) and unsecured funding spreads on derivatives (including hedges) was a loss of $2 million as of both December 2024 and December 2023. In addition, the estimated sensitivity to a one basis point increase in our own credit spreads on financial liabilities for which the fair value option was elected was a gain of $43 million as of December 2024 and $42 million as of December 2023. However, the actual net impact of a change in our own credit spreads is also affected by the liquidity, duration and convexity (as the sensitivity is not linear to changes in yields) of those financial liabilities for which the fair value option was elected, as well as the relative performance of any hedges undertaken.\n\n**Earnings-at-Risk.** The table below presents the impact of a parallel shift in rates on our net revenues and preferred stock dividends over the next 12 months relative to the baseline scenario.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n\\+100 basis points parallel shift in rates **$ 140** $ 225\n\n\\-100 basis points parallel shift in rates **$ (270)** $ (232)\n\n\\+200 basis points parallel shift in rates **$ 196** $ 445\n\n\\-200 basis points parallel shift in rates **$ (525)** $ (475)\n\nIn the table above, the EaR metric utilized various assumptions, including, among other things, balance sheet size and composition, prepayment behavior and deposit repricing, all of which have inherent uncertainties. The EaR metric does not represent a forecast of our net revenues and preferred stock dividends. We expect our EaR to be more sensitive to short-term interest rates than long-term rates.\n\n**Other Market Risk Considerations** We make investments in securities that are accounted for as available-for-sale, held-to-maturity or under the equity method which are included in investments in the consolidated balance sheets. See Note 8 to the consolidated financial statements for further information.\n\nDirect investments in real estate are accounted for at cost less accumulated depreciation. See Note 12 to the consolidated financial statements for further information about other assets.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n110 Goldman Sachs 2024 Form 10-K","pages":[{"line_numbers":[],"markdown":"**Sensitivity Measures** Certain portfolios and individual positions are not included in VaR because VaR is not the most appropriate risk measure. Other sensitivity measures we use to analyze market risk are described below.\n\n**10% Sensitivity Measures.** The table below presents our market risk by asset category for positions accounted for at fair value or accounted for at the lower of cost or fair value, that are not included in VaR.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nEquity **$ 1,567** $ 1,562\n\nDebt **1,904** 2,446\n\n**Total $ 3,471** $ 4,008\n\nIn the table above:\n\n• The market risk of these positions is determined by\n\nestimating the potential reduction in net revenues of a 10% decline in the value of the underlying positions.\n\n• Equity positions relate to private and public equity\n\nsecurities, which primarily include investments in\n\ncorporate, real estate and infrastructure assets.\n\nSubstantially all such equity positions are included within Asset & Wealth Management.\n\n• Debt positions include mezzanine and senior debt, and\n\ncorporate and real estate loans, substantially all of which are included within Asset & Wealth Management. Debt positions also included approximately $1.8 billion as of December 2024 and approximately $2.0 billion as of December 2023 of GM co-branded credit card loans, and approximately $3.0 billion as of December 2023 of GreenSky loans that were classified as held for sale. These held for sale loans were included within Platform Solutions.\n\n• Funded equity and debt positions are included in our\n\nconsolidated balance sheets in investments and loans, and the related hedges are included in our consolidated balance sheets in derivatives. See Note 8 to the consolidated financial statements for further information about investments, Note 9 to the consolidated financial statements for further information about loans and Note 7 to the consolidated financial statements for further information about derivatives.\n\n• These measures do not reflect the diversification effect\n\nacross asset categories or across other market risk measures.\n\n**Credit and Funding Spread Sensitivity on Derivatives and Financial Liabilities.** VaR excludes the impact of changes in counterparty credit spreads, our own credit spreads and unsecured funding spreads on derivatives, as well as changes in our own credit spreads (debt valuation adjustment) on financial liabilities for which the fair value option was elected. The estimated sensitivity to a one basis point increase in credit spreads (counterparty and our own) and unsecured funding spreads on derivatives (including hedges) was a loss of $2 million as of both December 2024 and December 2023. In addition, the estimated sensitivity to a one basis point increase in our own credit spreads on financial liabilities for which the fair value option was elected was a gain of $43 million as of December 2024 and $42 million as of December 2023. However, the actual net impact of a change in our own credit spreads is also affected by the liquidity, duration and convexity (as the sensitivity is not linear to changes in yields) of those financial liabilities for which the fair value option was elected, as well as the relative performance of any hedges undertaken.\n\n**Earnings-at-Risk.** The table below presents the impact of a parallel shift in rates on our net revenues and preferred stock dividends over the next 12 months relative to the baseline scenario.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n\\+100 basis points parallel shift in rates **$ 140** $ 225\n\n\\-100 basis points parallel shift in rates **$ (270)** $ (232)\n\n\\+200 basis points parallel shift in rates **$ 196** $ 445\n\n\\-200 basis points parallel shift in rates **$ (525)** $ (475)\n\nIn the table above, the EaR metric utilized various assumptions, including, among other things, balance sheet size and composition, prepayment behavior and deposit repricing, all of which have inherent uncertainties. The EaR metric does not represent a forecast of our net revenues and preferred stock dividends. We expect our EaR to be more sensitive to short-term interest rates than long-term rates.\n\n**Other Market Risk Considerations** We make investments in securities that are accounted for as available-for-sale, held-to-maturity or under the equity method which are included in investments in the consolidated balance sheets. See Note 8 to the consolidated financial statements for further information.\n\nDirect investments in real estate are accounted for at cost less accumulated depreciation. See Note 12 to the consolidated financial statements for further information about other assets.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n110 Goldman Sachs 2024 Form 10-K","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Sensitivity Measures** Certain portfolios and individual positions are not included in VaR because VaR is not the most appropriate risk measure. Other sensitivity measures we use to analyze market risk are described below.\n\n**10% Sensitivity Measures.** The table below presents our market risk by asset category for positions accounted for at fair value or accounted for at the lower of cost or fair value, that are not included in VaR.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nEquity **$ 1,567** $ 1,562\n\nDebt **1,904** 2,446\n\n**Total $ 3,471** $ 4,008\n\nIn the table above:\n\n• The market risk of these positions is determined by\n\nestimating the potential reduction in net revenues of a 10% decline in the value of the underlying positions.\n\n• Equity positions relate to private and public equity\n\nsecurities, which primarily include investments in\n\ncorporate, real estate and infrastructure assets.\n\nSubstantially all such equity positions are included within Asset & Wealth Management.\n\n• Debt positions include mezzanine and senior debt, and\n\ncorporate and real estate loans, substantially all of which are included within Asset & Wealth Management. Debt positions also included approximately $1.8 billion as of December 2024 and approximately $2.0 billion as of December 2023 of GM co-branded credit card loans, and approximately $3.0 billion as of December 2023 of GreenSky loans that were classified as held for sale. These held for sale loans were included within Platform Solutions.\n\n• Funded equity and debt positions are included in our\n\nconsolidated balance sheets in investments and loans, and the related hedges are included in our consolidated balance sheets in derivatives. See Note 8 to the consolidated financial statements for further information about investments, Note 9 to the consolidated financial statements for further information about loans and Note 7 to the consolidated financial statements for further information about derivatives.\n\n• These measures do not reflect the diversification effect\n\nacross asset categories or across other market risk measures.\n\n**Credit and Funding Spread Sensitivity on Derivatives and Financial Liabilities.** VaR excludes the impact of changes in counterparty credit spreads, our own credit spreads and unsecured funding spreads on derivatives, as well as changes in our own credit spreads (debt valuation adjustment) on financial liabilities for which the fair value option was elected. The estimated sensitivity to a one basis point increase in credit spreads (counterparty and our own) and unsecured funding spreads on derivatives (including hedges) was a loss of $2 million as of both December 2024 and December 2023. In addition, the estimated sensitivity to a one basis point increase in our own credit spreads on financial liabilities for which the fair value option was elected was a gain of $43 million as of December 2024 and $42 million as of December 2023. However, the actual net impact of a change in our own credit spreads is also affected by the liquidity, duration and convexity (as the sensitivity is not linear to changes in yields) of those financial liabilities for which the fair value option was elected, as well as the relative performance of any hedges undertaken.\n\n**Earnings-at-Risk.** The table below presents the impact of a parallel shift in rates on our net revenues and preferred stock dividends over the next 12 months relative to the baseline scenario.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n\\+100 basis points parallel shift in rates **$ 140** $ 225\n\n\\-100 basis points parallel shift in rates **$ (270)** $ (232)\n\n\\+200 basis points parallel shift in rates **$ 196** $ 445\n\n\\-200 basis points parallel shift in rates **$ (525)** $ (475)\n\nIn the table above, the EaR metric utilized various assumptions, including, among other things, balance sheet size and composition, prepayment behavior and deposit repricing, all of which have inherent uncertainties. The EaR metric does not represent a forecast of our net revenues and preferred stock dividends. We expect our EaR to be more sensitive to short-term interest rates than long-term rates.\n\n**Other Market Risk Considerations** We make investments in securities that are accounted for as available-for-sale, held-to-maturity or under the equity method which are included in investments in the consolidated balance sheets. See Note 8 to the consolidated financial statements for further information.\n\nDirect investments in real estate are accounted for at cost less accumulated depreciation. See Note 12 to the consolidated financial statements for further information about other assets.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n110 Goldman Sachs 2024 Form 10-K","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page113.pdf"]},"response":{"errors":[],"extract_id":"extract_e31d5a72768ac860fc313c21ef058aaa","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Sensitivity Measures** Certain portfolios and individual positions are not included in VaR because VaR is not the most appropriate risk measure. Other sensitivity measures we use to analyze market risk are described below.\n\n**10% Sensitivity Measures.** The table below presents our market risk by asset category for positions accounted for at fair value or accounted for at the lower of cost or fair value, that are not included in VaR.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nEquity **$ 1,567** $ 1,562\n\nDebt **1,904** 2,446\n\n**Total $ 3,471** $ 4,008\n\nIn the table above:\n\n• The market risk of these positions is determined by\n\nestimating the potential reduction in net revenues of a 10% decline in the value of the underlying positions.\n\n• Equity positions relate to private and public equity\n\nsecurities, which primarily include investments in\n\ncorporate, real estate and infrastructure assets.\n\nSubstantially all such equity positions are included within Asset & Wealth Management.\n\n• Debt positions include mezzanine and senior debt, and\n\ncorporate and real estate loans, substantially all of which are included within Asset & Wealth Management. Debt positions also included approximately $1.8 billion as of December 2024 and approximately $2.0 billion as of December 2023 of GM co-branded credit card loans, and approximately $3.0 billion as of December 2023 of GreenSky loans that were classified as held for sale. These held for sale loans were included within Platform Solutions.\n\n• Funded equity and debt positions are included in our\n\nconsolidated balance sheets in investments and loans, and the related hedges are included in our consolidated balance sheets in derivatives. See Note 8 to the consolidated financial statements for further information about investments, Note 9 to the consolidated financial statements for further information about loans and Note 7 to the consolidated financial statements for further information about derivatives.\n\n• These measures do not reflect the diversification effect\n\nacross asset categories or across other market risk measures.\n\n**Credit and Funding Spread Sensitivity on Derivatives and Financial Liabilities.** VaR excludes the impact of changes in counterparty credit spreads, our own credit spreads and unsecured funding spreads on derivatives, as well as changes in our own credit spreads (debt valuation adjustment) on financial liabilities for which the fair value option was elected. The estimated sensitivity to a one basis point increase in credit spreads (counterparty and our own) and unsecured funding spreads on derivatives (including hedges) was a loss of $2 million as of both December 2024 and December 2023. In addition, the estimated sensitivity to a one basis point increase in our own credit spreads on financial liabilities for which the fair value option was elected was a gain of $43 million as of December 2024 and $42 million as of December 2023. However, the actual net impact of a change in our own credit spreads is also affected by the liquidity, duration and convexity (as the sensitivity is not linear to changes in yields) of those financial liabilities for which the fair value option was elected, as well as the relative performance of any hedges undertaken.\n\n**Earnings-at-Risk.** The table below presents the impact of a parallel shift in rates on our net revenues and preferred stock dividends over the next 12 months relative to the baseline scenario.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n\\+100 basis points parallel shift in rates **$ 140** $ 225\n\n\\-100 basis points parallel shift in rates **$ (270)** $ (232)\n\n\\+200 basis points parallel shift in rates **$ 196** $ 445\n\n\\-200 basis points parallel shift in rates **$ (525)** $ (475)\n\nIn the table above, the EaR metric utilized various assumptions, including, among other things, balance sheet size and composition, prepayment behavior and deposit repricing, all of which have inherent uncertainties. The EaR metric does not represent a forecast of our net revenues and preferred stock dividends. We expect our EaR to be more sensitive to short-term interest rates than long-term rates.\n\n**Other Market Risk Considerations** We make investments in securities that are accounted for as available-for-sale, held-to-maturity or under the equity method which are included in investments in the consolidated balance sheets. See Note 8 to the consolidated financial statements for further information.\n\nDirect investments in real estate are accounted for at cost less accumulated depreciation. See Note 12 to the consolidated financial statements for further information about other assets.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n110 Goldman Sachs 2024 Form 10-K"],"full_content":"**Sensitivity Measures** Certain portfolios and individual positions are not included in VaR because VaR is not the most appropriate risk measure. Other sensitivity measures we use to analyze market risk are described below.\n\n**10% Sensitivity Measures.** The table below presents our market risk by asset category for positions accounted for at fair value or accounted for at the lower of cost or fair value, that are not included in VaR.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nEquity **$ 1,567** $ 1,562\n\nDebt **1,904** 2,446\n\n**Total $ 3,471** $ 4,008\n\nIn the table above:\n\n• The market risk of these positions is determined by\n\nestimating the potential reduction in net revenues of a 10% decline in the value of the underlying positions.\n\n• Equity positions relate to private and public equity\n\nsecurities, which primarily include investments in\n\ncorporate, real estate and infrastructure assets.\n\nSubstantially all such equity positions are included within Asset & Wealth Management.\n\n• Debt positions include mezzanine and senior debt, and\n\ncorporate and real estate loans, substantially all of which are included within Asset & Wealth Management. Debt positions also included approximately $1.8 billion as of December 2024 and approximately $2.0 billion as of December 2023 of GM co-branded credit card loans, and approximately $3.0 billion as of December 2023 of GreenSky loans that were classified as held for sale. These held for sale loans were included within Platform Solutions.\n\n• Funded equity and debt positions are included in our\n\nconsolidated balance sheets in investments and loans, and the related hedges are included in our consolidated balance sheets in derivatives. See Note 8 to the consolidated financial statements for further information about investments, Note 9 to the consolidated financial statements for further information about loans and Note 7 to the consolidated financial statements for further information about derivatives.\n\n• These measures do not reflect the diversification effect\n\nacross asset categories or across other market risk measures.\n\n**Credit and Funding Spread Sensitivity on Derivatives and Financial Liabilities.** VaR excludes the impact of changes in counterparty credit spreads, our own credit spreads and unsecured funding spreads on derivatives, as well as changes in our own credit spreads (debt valuation adjustment) on financial liabilities for which the fair value option was elected. The estimated sensitivity to a one basis point increase in credit spreads (counterparty and our own) and unsecured funding spreads on derivatives (including hedges) was a loss of $2 million as of both December 2024 and December 2023. In addition, the estimated sensitivity to a one basis point increase in our own credit spreads on financial liabilities for which the fair value option was elected was a gain of $43 million as of December 2024 and $42 million as of December 2023. However, the actual net impact of a change in our own credit spreads is also affected by the liquidity, duration and convexity (as the sensitivity is not linear to changes in yields) of those financial liabilities for which the fair value option was elected, as well as the relative performance of any hedges undertaken.\n\n**Earnings-at-Risk.** The table below presents the impact of a parallel shift in rates on our net revenues and preferred stock dividends over the next 12 months relative to the baseline scenario.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n\\+100 basis points parallel shift in rates **$ 140** $ 225\n\n\\-100 basis points parallel shift in rates **$ (270)** $ (232)\n\n\\+200 basis points parallel shift in rates **$ 196** $ 445\n\n\\-200 basis points parallel shift in rates **$ (525)** $ (475)\n\nIn the table above, the EaR metric utilized various assumptions, including, among other things, balance sheet size and composition, prepayment behavior and deposit repricing, all of which have inherent uncertainties. The EaR metric does not represent a forecast of our net revenues and preferred stock dividends. We expect our EaR to be more sensitive to short-term interest rates than long-term rates.\n\n**Other Market Risk Considerations** We make investments in securities that are accounted for as available-for-sale, held-to-maturity or under the equity method which are included in investments in the consolidated balance sheets. See Note 8 to the consolidated financial statements for further information.\n\nDirect investments in real estate are accounted for at cost less accumulated depreciation. See Note 12 to the consolidated financial statements for further information about other assets.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n110 Goldman Sachs 2024 Form 10-K","publish_date":null,"title":"Management’s Discussion and Analysis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page113.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page113.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page113","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page113.pdf"},"started_at":"2026-11-04T19:47:17.052807"} +{"completed_at":"2026-11-04T19:47:19.281252","latency_in_ms":1072,"output":{"example_id":"table/Goldman Sachs 10-k_page118","grounded_pages":[],"layout_pages":[],"markdown":"**Corporate.** Corporate loans and lending commitments include term loans, revolving lines of credit, letter of credit facilities and bridge loans, and are principally used for operating and general corporate purposes, or in connection with acquisitions. Corporate loans are secured (typically by a senior lien on the assets of the borrower) or unsecured, depending on the loan purpose, the risk profile of the borrower and other factors.\n\nThe table below presents our credit exposure from corporate loans and lending commitments, and the concentration by industry, region, internally determined public rating agency equivalents and other credit metrics.\n\n_$ in millions_ Loans\n\nLending\n\nCommitments Total\n\n**As of December 2024 Corporate $29,972 $162,529 $192,501**\n\n**Industry** Consumer & Retail **9% 13% 12%**\n\nDiversified Industrials **16% 20% 20%**\n\nFinancial Institutions **9% 9% 9%**\n\nFunds **5% 3% 3%**\n\nHealthcare **9% 11% 11%**\n\nNatural Resources & Utilities **9% 16% 15%**\n\nReal Estate **14% 5% 6%**\n\nTechnology, Media & Telecommunications **24% 22% 22%**\n\nOther (including Special Purpose Vehicles) **5% 1% 2%**\n\n**Total 100% 100% 100%**\n\n**Region** Americas **66% 76% 75%**\n\nEMEA **26% 22% 22%**\n\nAsia **8% 2% 3%**\n\n**Total 100% 100% 100%**\n\n**Credit Quality (Credit Rating Equivalent)** AAA **– 1% 1%**\n\nAA **1% 4% 4%**\n\nA **6% 17% 16%**\n\nBBB **22% 41% 37%**\n\nBB or lower **71% 37% 42%**\n\n**Total 100% 100% 100%**\n\nAs of December 2023 Corporate $35,874 $144,463 $180,337\n\n**Industry** Consumer & Retail 11% 13% 12%\n\nDiversified Industrials 17% 20% 20%\n\nFinancial Institutions 8% 9% 9%\n\nFunds 4% 3% 3%\n\nHealthcare 9% 11% 10%\n\nNatural Resources & Utilities 8% 18% 16%\n\nReal Estate 13% 5% 7%\n\nTechnology, Media & Telecommunications 25% 20% 21%\n\nOther (including Special Purpose Vehicles) 5% 1% 2%\n\nTotal 100% 100% 100%\n\n**Region** Americas 63% 77% 74%\n\nEMEA 29% 22% 23%\n\nAsia 8% 1% 3%\n\nTotal 100% 100% 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA – 1% 1%\n\nAA 1% 5% 4%\n\nA 5% 20% 17%\n\nBBB 20% 41% 37%\n\nBB or lower 74% 33% 41%\n\nTotal 100% 100% 100%\n\n**Commercial Real Estate.** Commercial real estate includes originated loans and lending commitments that are directly or indirectly secured by hotels, retail stores, multifamily housing complexes and commercial and industrial properties. Commercial real estate also includes loans and lending commitments extended to clients who warehouse assets that are directly or indirectly backed by commercial real estate. In addition, commercial real estate includes loans purchased by us.\n\nThe table below presents our credit exposure from commercial real estate loans and lending commitments, and the concentration by region, internally determined public rating agency equivalents and other credit metrics.\n\n_$ in millions_ Loans\n\nLending\n\nCommitments Total\n\n**As of December 2024 Commercial Real Estate $29,789 $5,016 $34,805**\n\n**Region** Americas **78% 83% 78%**\n\nEMEA **18% 16% 18%**\n\nAsia **4% 1% 4%**\n\n**Total 100% 100% 100%**\n\n**Credit Quality (Credit Rating Equivalent)** Investment-grade **61% 61% 61%**\n\nNon-investment-grade **39% 38% 39%**\n\nUnrated **– 1% –**\n\n**Total 100% 100% 100%**\n\nAs of December 2023 Commercial Real Estate $26,028 $3,440 $29,468\n\n**Region** Americas 80% 74% 79%\n\nEMEA 17% 25% 18%\n\nAsia 3% 1% 3%\n\nTotal 100% 100% 100%\n\n**Credit Quality (Credit Rating Equivalent)** Investment-grade 47% 46% 47%\n\nNon-investment-grade 52% 54% 52%\n\nUnrated 1% – 1%\n\nTotal 100% 100% 100%\n\nIn the table above, the concentration of loans and lending commitments by asset class as of December 2024 was 50% for warehouse and other indirect, 11% for multifamily, 7% for industrials, 5% for hospitality, 4% for office, 3% for mixed use and 20% for other asset classes. The concentration of loans and lending commitments by asset class as of December 2023 was 42% for warehouse and other indirect, 13% for multifamily, 12% for industrials, 7% for office, 7% for hospitality, 7% for mixed use and 12% for other asset classes.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 115","pages":[{"line_numbers":[],"markdown":"**Corporate.** Corporate loans and lending commitments include term loans, revolving lines of credit, letter of credit facilities and bridge loans, and are principally used for operating and general corporate purposes, or in connection with acquisitions. Corporate loans are secured (typically by a senior lien on the assets of the borrower) or unsecured, depending on the loan purpose, the risk profile of the borrower and other factors.\n\nThe table below presents our credit exposure from corporate loans and lending commitments, and the concentration by industry, region, internally determined public rating agency equivalents and other credit metrics.\n\n_$ in millions_ Loans\n\nLending\n\nCommitments Total\n\n**As of December 2024 Corporate $29,972 $162,529 $192,501**\n\n**Industry** Consumer & Retail **9% 13% 12%**\n\nDiversified Industrials **16% 20% 20%**\n\nFinancial Institutions **9% 9% 9%**\n\nFunds **5% 3% 3%**\n\nHealthcare **9% 11% 11%**\n\nNatural Resources & Utilities **9% 16% 15%**\n\nReal Estate **14% 5% 6%**\n\nTechnology, Media & Telecommunications **24% 22% 22%**\n\nOther (including Special Purpose Vehicles) **5% 1% 2%**\n\n**Total 100% 100% 100%**\n\n**Region** Americas **66% 76% 75%**\n\nEMEA **26% 22% 22%**\n\nAsia **8% 2% 3%**\n\n**Total 100% 100% 100%**\n\n**Credit Quality (Credit Rating Equivalent)** AAA **– 1% 1%**\n\nAA **1% 4% 4%**\n\nA **6% 17% 16%**\n\nBBB **22% 41% 37%**\n\nBB or lower **71% 37% 42%**\n\n**Total 100% 100% 100%**\n\nAs of December 2023 Corporate $35,874 $144,463 $180,337\n\n**Industry** Consumer & Retail 11% 13% 12%\n\nDiversified Industrials 17% 20% 20%\n\nFinancial Institutions 8% 9% 9%\n\nFunds 4% 3% 3%\n\nHealthcare 9% 11% 10%\n\nNatural Resources & Utilities 8% 18% 16%\n\nReal Estate 13% 5% 7%\n\nTechnology, Media & Telecommunications 25% 20% 21%\n\nOther (including Special Purpose Vehicles) 5% 1% 2%\n\nTotal 100% 100% 100%\n\n**Region** Americas 63% 77% 74%\n\nEMEA 29% 22% 23%\n\nAsia 8% 1% 3%\n\nTotal 100% 100% 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA – 1% 1%\n\nAA 1% 5% 4%\n\nA 5% 20% 17%\n\nBBB 20% 41% 37%\n\nBB or lower 74% 33% 41%\n\nTotal 100% 100% 100%\n\n**Commercial Real Estate.** Commercial real estate includes originated loans and lending commitments that are directly or indirectly secured by hotels, retail stores, multifamily housing complexes and commercial and industrial properties. Commercial real estate also includes loans and lending commitments extended to clients who warehouse assets that are directly or indirectly backed by commercial real estate. In addition, commercial real estate includes loans purchased by us.\n\nThe table below presents our credit exposure from commercial real estate loans and lending commitments, and the concentration by region, internally determined public rating agency equivalents and other credit metrics.\n\n_$ in millions_ Loans\n\nLending\n\nCommitments Total\n\n**As of December 2024 Commercial Real Estate $29,789 $5,016 $34,805**\n\n**Region** Americas **78% 83% 78%**\n\nEMEA **18% 16% 18%**\n\nAsia **4% 1% 4%**\n\n**Total 100% 100% 100%**\n\n**Credit Quality (Credit Rating Equivalent)** Investment-grade **61% 61% 61%**\n\nNon-investment-grade **39% 38% 39%**\n\nUnrated **– 1% –**\n\n**Total 100% 100% 100%**\n\nAs of December 2023 Commercial Real Estate $26,028 $3,440 $29,468\n\n**Region** Americas 80% 74% 79%\n\nEMEA 17% 25% 18%\n\nAsia 3% 1% 3%\n\nTotal 100% 100% 100%\n\n**Credit Quality (Credit Rating Equivalent)** Investment-grade 47% 46% 47%\n\nNon-investment-grade 52% 54% 52%\n\nUnrated 1% – 1%\n\nTotal 100% 100% 100%\n\nIn the table above, the concentration of loans and lending commitments by asset class as of December 2024 was 50% for warehouse and other indirect, 11% for multifamily, 7% for industrials, 5% for hospitality, 4% for office, 3% for mixed use and 20% for other asset classes. The concentration of loans and lending commitments by asset class as of December 2023 was 42% for warehouse and other indirect, 13% for multifamily, 12% for industrials, 7% for office, 7% for hospitality, 7% for mixed use and 12% for other asset classes.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 115","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Corporate.** Corporate loans and lending commitments include term loans, revolving lines of credit, letter of credit facilities and bridge loans, and are principally used for operating and general corporate purposes, or in connection with acquisitions. Corporate loans are secured (typically by a senior lien on the assets of the borrower) or unsecured, depending on the loan purpose, the risk profile of the borrower and other factors.\n\nThe table below presents our credit exposure from corporate loans and lending commitments, and the concentration by industry, region, internally determined public rating agency equivalents and other credit metrics.\n\n_$ in millions_ Loans\n\nLending\n\nCommitments Total\n\n**As of December 2024 Corporate $29,972 $162,529 $192,501**\n\n**Industry** Consumer & Retail **9% 13% 12%**\n\nDiversified Industrials **16% 20% 20%**\n\nFinancial Institutions **9% 9% 9%**\n\nFunds **5% 3% 3%**\n\nHealthcare **9% 11% 11%**\n\nNatural Resources & Utilities **9% 16% 15%**\n\nReal Estate **14% 5% 6%**\n\nTechnology, Media & Telecommunications **24% 22% 22%**\n\nOther (including Special Purpose Vehicles) **5% 1% 2%**\n\n**Total 100% 100% 100%**\n\n**Region** Americas **66% 76% 75%**\n\nEMEA **26% 22% 22%**\n\nAsia **8% 2% 3%**\n\n**Total 100% 100% 100%**\n\n**Credit Quality (Credit Rating Equivalent)** AAA **– 1% 1%**\n\nAA **1% 4% 4%**\n\nA **6% 17% 16%**\n\nBBB **22% 41% 37%**\n\nBB or lower **71% 37% 42%**\n\n**Total 100% 100% 100%**\n\nAs of December 2023 Corporate $35,874 $144,463 $180,337\n\n**Industry** Consumer & Retail 11% 13% 12%\n\nDiversified Industrials 17% 20% 20%\n\nFinancial Institutions 8% 9% 9%\n\nFunds 4% 3% 3%\n\nHealthcare 9% 11% 10%\n\nNatural Resources & Utilities 8% 18% 16%\n\nReal Estate 13% 5% 7%\n\nTechnology, Media & Telecommunications 25% 20% 21%\n\nOther (including Special Purpose Vehicles) 5% 1% 2%\n\nTotal 100% 100% 100%\n\n**Region** Americas 63% 77% 74%\n\nEMEA 29% 22% 23%\n\nAsia 8% 1% 3%\n\nTotal 100% 100% 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA – 1% 1%\n\nAA 1% 5% 4%\n\nA 5% 20% 17%\n\nBBB 20% 41% 37%\n\nBB or lower 74% 33% 41%\n\nTotal 100% 100% 100%\n\n**Commercial Real Estate.** Commercial real estate includes originated loans and lending commitments that are directly or indirectly secured by hotels, retail stores, multifamily housing complexes and commercial and industrial properties. Commercial real estate also includes loans and lending commitments extended to clients who warehouse assets that are directly or indirectly backed by commercial real estate. In addition, commercial real estate includes loans purchased by us.\n\nThe table below presents our credit exposure from commercial real estate loans and lending commitments, and the concentration by region, internally determined public rating agency equivalents and other credit metrics.\n\n_$ in millions_ Loans\n\nLending\n\nCommitments Total\n\n**As of December 2024 Commercial Real Estate $29,789 $5,016 $34,805**\n\n**Region** Americas **78% 83% 78%**\n\nEMEA **18% 16% 18%**\n\nAsia **4% 1% 4%**\n\n**Total 100% 100% 100%**\n\n**Credit Quality (Credit Rating Equivalent)** Investment-grade **61% 61% 61%**\n\nNon-investment-grade **39% 38% 39%**\n\nUnrated **– 1% –**\n\n**Total 100% 100% 100%**\n\nAs of December 2023 Commercial Real Estate $26,028 $3,440 $29,468\n\n**Region** Americas 80% 74% 79%\n\nEMEA 17% 25% 18%\n\nAsia 3% 1% 3%\n\nTotal 100% 100% 100%\n\n**Credit Quality (Credit Rating Equivalent)** Investment-grade 47% 46% 47%\n\nNon-investment-grade 52% 54% 52%\n\nUnrated 1% – 1%\n\nTotal 100% 100% 100%\n\nIn the table above, the concentration of loans and lending commitments by asset class as of December 2024 was 50% for warehouse and other indirect, 11% for multifamily, 7% for industrials, 5% for hospitality, 4% for office, 3% for mixed use and 20% for other asset classes. The concentration of loans and lending commitments by asset class as of December 2023 was 42% for warehouse and other indirect, 13% for multifamily, 12% for industrials, 7% for office, 7% for hospitality, 7% for mixed use and 12% for other asset classes.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 115","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page118.pdf"]},"response":{"errors":[],"extract_id":"extract_579ee3d4b84a85ede15293e78ccf58c6","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Corporate.** Corporate loans and lending commitments include term loans, revolving lines of credit, letter of credit facilities and bridge loans, and are principally used for operating and general corporate purposes, or in connection with acquisitions. Corporate loans are secured (typically by a senior lien on the assets of the borrower) or unsecured, depending on the loan purpose, the risk profile of the borrower and other factors.\n\nThe table below presents our credit exposure from corporate loans and lending commitments, and the concentration by industry, region, internally determined public rating agency equivalents and other credit metrics.\n\n_$ in millions_ Loans\n\nLending\n\nCommitments Total\n\n**As of December 2024 Corporate $29,972 $162,529 $192,501**\n\n**Industry** Consumer & Retail **9% 13% 12%**\n\nDiversified Industrials **16% 20% 20%**\n\nFinancial Institutions **9% 9% 9%**\n\nFunds **5% 3% 3%**\n\nHealthcare **9% 11% 11%**\n\nNatural Resources & Utilities **9% 16% 15%**\n\nReal Estate **14% 5% 6%**\n\nTechnology, Media & Telecommunications **24% 22% 22%**\n\nOther (including Special Purpose Vehicles) **5% 1% 2%**\n\n**Total 100% 100% 100%**\n\n**Region** Americas **66% 76% 75%**\n\nEMEA **26% 22% 22%**\n\nAsia **8% 2% 3%**\n\n**Total 100% 100% 100%**\n\n**Credit Quality (Credit Rating Equivalent)** AAA **– 1% 1%**\n\nAA **1% 4% 4%**\n\nA **6% 17% 16%**\n\nBBB **22% 41% 37%**\n\nBB or lower **71% 37% 42%**\n\n**Total 100% 100% 100%**\n\nAs of December 2023 Corporate $35,874 $144,463 $180,337\n\n**Industry** Consumer & Retail 11% 13% 12%\n\nDiversified Industrials 17% 20% 20%\n\nFinancial Institutions 8% 9% 9%\n\nFunds 4% 3% 3%\n\nHealthcare 9% 11% 10%\n\nNatural Resources & Utilities 8% 18% 16%\n\nReal Estate 13% 5% 7%\n\nTechnology, Media & Telecommunications 25% 20% 21%\n\nOther (including Special Purpose Vehicles) 5% 1% 2%\n\nTotal 100% 100% 100%\n\n**Region** Americas 63% 77% 74%\n\nEMEA 29% 22% 23%\n\nAsia 8% 1% 3%\n\nTotal 100% 100% 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA – 1% 1%\n\nAA 1% 5% 4%\n\nA 5% 20% 17%\n\nBBB 20% 41% 37%\n\nBB or lower 74% 33% 41%\n\nTotal 100% 100% 100%\n\n**Commercial Real Estate.** Commercial real estate includes originated loans and lending commitments that are directly or indirectly secured by hotels, retail stores, multifamily housing complexes and commercial and industrial properties. Commercial real estate also includes loans and lending commitments extended to clients who warehouse assets that are directly or indirectly backed by commercial real estate. In addition, commercial real estate includes loans purchased by us.\n\nThe table below presents our credit exposure from commercial real estate loans and lending commitments, and the concentration by region, internally determined public rating agency equivalents and other credit metrics.\n\n_$ in millions_ Loans\n\nLending\n\nCommitments Total\n\n**As of December 2024 Commercial Real Estate $29,789 $5,016 $34,805**\n\n**Region** Americas **78% 83% 78%**\n\nEMEA **18% 16% 18%**\n\nAsia **4% 1% 4%**\n\n**Total 100% 100% 100%**\n\n**Credit Quality (Credit Rating Equivalent)** Investment-grade **61% 61% 61%**\n\nNon-investment-grade **39% 38% 39%**\n\nUnrated **– 1% –**\n\n**Total 100% 100% 100%**\n\nAs of December 2023 Commercial Real Estate $26,028 $3,440 $29,468\n\n**Region** Americas 80% 74% 79%\n\nEMEA 17% 25% 18%\n\nAsia 3% 1% 3%\n\nTotal 100% 100% 100%\n\n**Credit Quality (Credit Rating Equivalent)** Investment-grade 47% 46% 47%\n\nNon-investment-grade 52% 54% 52%\n\nUnrated 1% – 1%\n\nTotal 100% 100% 100%\n\nIn the table above, the concentration of loans and lending commitments by asset class as of December 2024 was 50% for warehouse and other indirect, 11% for multifamily, 7% for industrials, 5% for hospitality, 4% for office, 3% for mixed use and 20% for other asset classes. The concentration of loans and lending commitments by asset class as of December 2023 was 42% for warehouse and other indirect, 13% for multifamily, 12% for industrials, 7% for office, 7% for hospitality, 7% for mixed use and 12% for other asset classes.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 115"],"full_content":"**Corporate.** Corporate loans and lending commitments include term loans, revolving lines of credit, letter of credit facilities and bridge loans, and are principally used for operating and general corporate purposes, or in connection with acquisitions. Corporate loans are secured (typically by a senior lien on the assets of the borrower) or unsecured, depending on the loan purpose, the risk profile of the borrower and other factors.\n\nThe table below presents our credit exposure from corporate loans and lending commitments, and the concentration by industry, region, internally determined public rating agency equivalents and other credit metrics.\n\n_$ in millions_ Loans\n\nLending\n\nCommitments Total\n\n**As of December 2024 Corporate $29,972 $162,529 $192,501**\n\n**Industry** Consumer & Retail **9% 13% 12%**\n\nDiversified Industrials **16% 20% 20%**\n\nFinancial Institutions **9% 9% 9%**\n\nFunds **5% 3% 3%**\n\nHealthcare **9% 11% 11%**\n\nNatural Resources & Utilities **9% 16% 15%**\n\nReal Estate **14% 5% 6%**\n\nTechnology, Media & Telecommunications **24% 22% 22%**\n\nOther (including Special Purpose Vehicles) **5% 1% 2%**\n\n**Total 100% 100% 100%**\n\n**Region** Americas **66% 76% 75%**\n\nEMEA **26% 22% 22%**\n\nAsia **8% 2% 3%**\n\n**Total 100% 100% 100%**\n\n**Credit Quality (Credit Rating Equivalent)** AAA **– 1% 1%**\n\nAA **1% 4% 4%**\n\nA **6% 17% 16%**\n\nBBB **22% 41% 37%**\n\nBB or lower **71% 37% 42%**\n\n**Total 100% 100% 100%**\n\nAs of December 2023 Corporate $35,874 $144,463 $180,337\n\n**Industry** Consumer & Retail 11% 13% 12%\n\nDiversified Industrials 17% 20% 20%\n\nFinancial Institutions 8% 9% 9%\n\nFunds 4% 3% 3%\n\nHealthcare 9% 11% 10%\n\nNatural Resources & Utilities 8% 18% 16%\n\nReal Estate 13% 5% 7%\n\nTechnology, Media & Telecommunications 25% 20% 21%\n\nOther (including Special Purpose Vehicles) 5% 1% 2%\n\nTotal 100% 100% 100%\n\n**Region** Americas 63% 77% 74%\n\nEMEA 29% 22% 23%\n\nAsia 8% 1% 3%\n\nTotal 100% 100% 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA – 1% 1%\n\nAA 1% 5% 4%\n\nA 5% 20% 17%\n\nBBB 20% 41% 37%\n\nBB or lower 74% 33% 41%\n\nTotal 100% 100% 100%\n\n**Commercial Real Estate.** Commercial real estate includes originated loans and lending commitments that are directly or indirectly secured by hotels, retail stores, multifamily housing complexes and commercial and industrial properties. Commercial real estate also includes loans and lending commitments extended to clients who warehouse assets that are directly or indirectly backed by commercial real estate. In addition, commercial real estate includes loans purchased by us.\n\nThe table below presents our credit exposure from commercial real estate loans and lending commitments, and the concentration by region, internally determined public rating agency equivalents and other credit metrics.\n\n_$ in millions_ Loans\n\nLending\n\nCommitments Total\n\n**As of December 2024 Commercial Real Estate $29,789 $5,016 $34,805**\n\n**Region** Americas **78% 83% 78%**\n\nEMEA **18% 16% 18%**\n\nAsia **4% 1% 4%**\n\n**Total 100% 100% 100%**\n\n**Credit Quality (Credit Rating Equivalent)** Investment-grade **61% 61% 61%**\n\nNon-investment-grade **39% 38% 39%**\n\nUnrated **– 1% –**\n\n**Total 100% 100% 100%**\n\nAs of December 2023 Commercial Real Estate $26,028 $3,440 $29,468\n\n**Region** Americas 80% 74% 79%\n\nEMEA 17% 25% 18%\n\nAsia 3% 1% 3%\n\nTotal 100% 100% 100%\n\n**Credit Quality (Credit Rating Equivalent)** Investment-grade 47% 46% 47%\n\nNon-investment-grade 52% 54% 52%\n\nUnrated 1% – 1%\n\nTotal 100% 100% 100%\n\nIn the table above, the concentration of loans and lending commitments by asset class as of December 2024 was 50% for warehouse and other indirect, 11% for multifamily, 7% for industrials, 5% for hospitality, 4% for office, 3% for mixed use and 20% for other asset classes. The concentration of loans and lending commitments by asset class as of December 2023 was 42% for warehouse and other indirect, 13% for multifamily, 12% for industrials, 7% for office, 7% for hospitality, 7% for mixed use and 12% for other asset classes.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 115","publish_date":null,"title":"Management’s Discussion and Analysis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page118.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page118.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page118","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page118.pdf"},"started_at":"2026-11-04T19:47:18.208867"} +{"completed_at":"2026-11-04T19:47:20.888842","latency_in_ms":1307,"output":{"example_id":"table/Goldman Sachs 10-k_page122","grounded_pages":[],"layout_pages":[],"markdown":"**Securities Financing Transactions.** We enter into securities financing transactions in order to, among other things, facilitate client activities, invest excess cash, acquire securities to cover short positions and finance certain activities. We bear credit risk related to resale agreements and securities borrowed only to the extent that cash advanced or the value of securities pledged or delivered to the counterparty exceeds the value of the collateral received. We also have credit exposure on repurchase agreements and securities loaned to the extent that the value of securities pledged or delivered to the counterparty for these transactions exceeds the amount of cash or collateral received. Securities collateral for these transactions primarily includes U.S. and non-U.S. government and agency obligations.\n\nThe table below presents our credit exposure from securities financing transactions and the concentration by industry, region and internally determined public rating agency equivalents.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Securities Financing Transactions $39,299** $40,201\n\n**Industry** Financial Institutions **39%** 30%\n\nFunds **27%** 33%\n\nMunicipalities & Nonprofit **10%** 7%\n\nSovereign **24%** 29%\n\nOther (including Special Purpose Vehicles) **–** 1%\n\n**Total 100%** 100%\n\n**Region** Americas **55%** 45%\n\nEMEA **31%** 38%\n\nAsia **14%** 17%\n\n**Total 100%** 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA **18%** 14%\n\nAA **22%** 31%\n\nA **42%** 38%\n\nBBB **9%** 7%\n\nBB or lower **9%** 10%\n\n**Total 100%** 100%\n\nThe table above reflects both netting agreements and collateral that we consider when determining credit risk.\n\n**Other Credit Exposures.** We are exposed to credit risk from our receivables from brokers, dealers and clearing organizations and customers and counterparties. Receivables from brokers, dealers and clearing organizations primarily consist of initial margin placed with clearing organizations and receivables related to sales of securities which have traded, but not yet settled. These receivables generally have minimal credit risk due to the low probability of clearing organization default and the short-term nature of receivables related to securities settlements. Receivables from customers and counterparties generally consist of collateralized receivables related to customer securities transactions and generally have minimal credit risk due to both the value of the collateral received and the short-term nature of these receivables.\n\nThe table below presents our other credit exposures and the concentration by industry, region and internally determined public rating agency equivalents.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Other Credit Exposures $48,013** $50,820\n\n**Industry** Financial Institutions **77%** 80%\n\nFunds **13%** 13%\n\nOther (including Special Purpose Vehicles) **10%** 7%\n\n**Total 100%** 100%\n\n**Region** Americas **44%** 35%\n\nEMEA **41%** 54%\n\nAsia **15%** 11%\n\n**Total 100%** 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA **4%** 2%\n\nAA **49%** 57%\n\nA **24%** 26%\n\nBBB **8%** 6%\n\nBB or lower **14%** 8%\n\nUnrated **1%** 1%\n\n**Total 100%** 100%\n\nThe table above reflects collateral that we consider when determining credit risk.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 119","pages":[{"line_numbers":[],"markdown":"**Securities Financing Transactions.** We enter into securities financing transactions in order to, among other things, facilitate client activities, invest excess cash, acquire securities to cover short positions and finance certain activities. We bear credit risk related to resale agreements and securities borrowed only to the extent that cash advanced or the value of securities pledged or delivered to the counterparty exceeds the value of the collateral received. We also have credit exposure on repurchase agreements and securities loaned to the extent that the value of securities pledged or delivered to the counterparty for these transactions exceeds the amount of cash or collateral received. Securities collateral for these transactions primarily includes U.S. and non-U.S. government and agency obligations.\n\nThe table below presents our credit exposure from securities financing transactions and the concentration by industry, region and internally determined public rating agency equivalents.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Securities Financing Transactions $39,299** $40,201\n\n**Industry** Financial Institutions **39%** 30%\n\nFunds **27%** 33%\n\nMunicipalities & Nonprofit **10%** 7%\n\nSovereign **24%** 29%\n\nOther (including Special Purpose Vehicles) **–** 1%\n\n**Total 100%** 100%\n\n**Region** Americas **55%** 45%\n\nEMEA **31%** 38%\n\nAsia **14%** 17%\n\n**Total 100%** 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA **18%** 14%\n\nAA **22%** 31%\n\nA **42%** 38%\n\nBBB **9%** 7%\n\nBB or lower **9%** 10%\n\n**Total 100%** 100%\n\nThe table above reflects both netting agreements and collateral that we consider when determining credit risk.\n\n**Other Credit Exposures.** We are exposed to credit risk from our receivables from brokers, dealers and clearing organizations and customers and counterparties. Receivables from brokers, dealers and clearing organizations primarily consist of initial margin placed with clearing organizations and receivables related to sales of securities which have traded, but not yet settled. These receivables generally have minimal credit risk due to the low probability of clearing organization default and the short-term nature of receivables related to securities settlements. Receivables from customers and counterparties generally consist of collateralized receivables related to customer securities transactions and generally have minimal credit risk due to both the value of the collateral received and the short-term nature of these receivables.\n\nThe table below presents our other credit exposures and the concentration by industry, region and internally determined public rating agency equivalents.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Other Credit Exposures $48,013** $50,820\n\n**Industry** Financial Institutions **77%** 80%\n\nFunds **13%** 13%\n\nOther (including Special Purpose Vehicles) **10%** 7%\n\n**Total 100%** 100%\n\n**Region** Americas **44%** 35%\n\nEMEA **41%** 54%\n\nAsia **15%** 11%\n\n**Total 100%** 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA **4%** 2%\n\nAA **49%** 57%\n\nA **24%** 26%\n\nBBB **8%** 6%\n\nBB or lower **14%** 8%\n\nUnrated **1%** 1%\n\n**Total 100%** 100%\n\nThe table above reflects collateral that we consider when determining credit risk.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 119","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Securities Financing Transactions.** We enter into securities financing transactions in order to, among other things, facilitate client activities, invest excess cash, acquire securities to cover short positions and finance certain activities. We bear credit risk related to resale agreements and securities borrowed only to the extent that cash advanced or the value of securities pledged or delivered to the counterparty exceeds the value of the collateral received. We also have credit exposure on repurchase agreements and securities loaned to the extent that the value of securities pledged or delivered to the counterparty for these transactions exceeds the amount of cash or collateral received. Securities collateral for these transactions primarily includes U.S. and non-U.S. government and agency obligations.\n\nThe table below presents our credit exposure from securities financing transactions and the concentration by industry, region and internally determined public rating agency equivalents.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Securities Financing Transactions $39,299** $40,201\n\n**Industry** Financial Institutions **39%** 30%\n\nFunds **27%** 33%\n\nMunicipalities & Nonprofit **10%** 7%\n\nSovereign **24%** 29%\n\nOther (including Special Purpose Vehicles) **–** 1%\n\n**Total 100%** 100%\n\n**Region** Americas **55%** 45%\n\nEMEA **31%** 38%\n\nAsia **14%** 17%\n\n**Total 100%** 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA **18%** 14%\n\nAA **22%** 31%\n\nA **42%** 38%\n\nBBB **9%** 7%\n\nBB or lower **9%** 10%\n\n**Total 100%** 100%\n\nThe table above reflects both netting agreements and collateral that we consider when determining credit risk.\n\n**Other Credit Exposures.** We are exposed to credit risk from our receivables from brokers, dealers and clearing organizations and customers and counterparties. Receivables from brokers, dealers and clearing organizations primarily consist of initial margin placed with clearing organizations and receivables related to sales of securities which have traded, but not yet settled. These receivables generally have minimal credit risk due to the low probability of clearing organization default and the short-term nature of receivables related to securities settlements. Receivables from customers and counterparties generally consist of collateralized receivables related to customer securities transactions and generally have minimal credit risk due to both the value of the collateral received and the short-term nature of these receivables.\n\nThe table below presents our other credit exposures and the concentration by industry, region and internally determined public rating agency equivalents.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Other Credit Exposures $48,013** $50,820\n\n**Industry** Financial Institutions **77%** 80%\n\nFunds **13%** 13%\n\nOther (including Special Purpose Vehicles) **10%** 7%\n\n**Total 100%** 100%\n\n**Region** Americas **44%** 35%\n\nEMEA **41%** 54%\n\nAsia **15%** 11%\n\n**Total 100%** 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA **4%** 2%\n\nAA **49%** 57%\n\nA **24%** 26%\n\nBBB **8%** 6%\n\nBB or lower **14%** 8%\n\nUnrated **1%** 1%\n\n**Total 100%** 100%\n\nThe table above reflects collateral that we consider when determining credit risk.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 119","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page122.pdf"]},"response":{"errors":[],"extract_id":"extract_8c9d2e49b69e54210314707309065135","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Securities Financing Transactions.** We enter into securities financing transactions in order to, among other things, facilitate client activities, invest excess cash, acquire securities to cover short positions and finance certain activities. We bear credit risk related to resale agreements and securities borrowed only to the extent that cash advanced or the value of securities pledged or delivered to the counterparty exceeds the value of the collateral received. We also have credit exposure on repurchase agreements and securities loaned to the extent that the value of securities pledged or delivered to the counterparty for these transactions exceeds the amount of cash or collateral received. Securities collateral for these transactions primarily includes U.S. and non-U.S. government and agency obligations.\n\nThe table below presents our credit exposure from securities financing transactions and the concentration by industry, region and internally determined public rating agency equivalents.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Securities Financing Transactions $39,299** $40,201\n\n**Industry** Financial Institutions **39%** 30%\n\nFunds **27%** 33%\n\nMunicipalities & Nonprofit **10%** 7%\n\nSovereign **24%** 29%\n\nOther (including Special Purpose Vehicles) **–** 1%\n\n**Total 100%** 100%\n\n**Region** Americas **55%** 45%\n\nEMEA **31%** 38%\n\nAsia **14%** 17%\n\n**Total 100%** 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA **18%** 14%\n\nAA **22%** 31%\n\nA **42%** 38%\n\nBBB **9%** 7%\n\nBB or lower **9%** 10%\n\n**Total 100%** 100%\n\nThe table above reflects both netting agreements and collateral that we consider when determining credit risk.\n\n**Other Credit Exposures.** We are exposed to credit risk from our receivables from brokers, dealers and clearing organizations and customers and counterparties. Receivables from brokers, dealers and clearing organizations primarily consist of initial margin placed with clearing organizations and receivables related to sales of securities which have traded, but not yet settled. These receivables generally have minimal credit risk due to the low probability of clearing organization default and the short-term nature of receivables related to securities settlements. Receivables from customers and counterparties generally consist of collateralized receivables related to customer securities transactions and generally have minimal credit risk due to both the value of the collateral received and the short-term nature of these receivables.\n\nThe table below presents our other credit exposures and the concentration by industry, region and internally determined public rating agency equivalents.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Other Credit Exposures $48,013** $50,820\n\n**Industry** Financial Institutions **77%** 80%\n\nFunds **13%** 13%\n\nOther (including Special Purpose Vehicles) **10%** 7%\n\n**Total 100%** 100%\n\n**Region** Americas **44%** 35%\n\nEMEA **41%** 54%\n\nAsia **15%** 11%\n\n**Total 100%** 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA **4%** 2%\n\nAA **49%** 57%\n\nA **24%** 26%\n\nBBB **8%** 6%\n\nBB or lower **14%** 8%\n\nUnrated **1%** 1%\n\n**Total 100%** 100%\n\nThe table above reflects collateral that we consider when determining credit risk.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 119"],"full_content":"**Securities Financing Transactions.** We enter into securities financing transactions in order to, among other things, facilitate client activities, invest excess cash, acquire securities to cover short positions and finance certain activities. We bear credit risk related to resale agreements and securities borrowed only to the extent that cash advanced or the value of securities pledged or delivered to the counterparty exceeds the value of the collateral received. We also have credit exposure on repurchase agreements and securities loaned to the extent that the value of securities pledged or delivered to the counterparty for these transactions exceeds the amount of cash or collateral received. Securities collateral for these transactions primarily includes U.S. and non-U.S. government and agency obligations.\n\nThe table below presents our credit exposure from securities financing transactions and the concentration by industry, region and internally determined public rating agency equivalents.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Securities Financing Transactions $39,299** $40,201\n\n**Industry** Financial Institutions **39%** 30%\n\nFunds **27%** 33%\n\nMunicipalities & Nonprofit **10%** 7%\n\nSovereign **24%** 29%\n\nOther (including Special Purpose Vehicles) **–** 1%\n\n**Total 100%** 100%\n\n**Region** Americas **55%** 45%\n\nEMEA **31%** 38%\n\nAsia **14%** 17%\n\n**Total 100%** 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA **18%** 14%\n\nAA **22%** 31%\n\nA **42%** 38%\n\nBBB **9%** 7%\n\nBB or lower **9%** 10%\n\n**Total 100%** 100%\n\nThe table above reflects both netting agreements and collateral that we consider when determining credit risk.\n\n**Other Credit Exposures.** We are exposed to credit risk from our receivables from brokers, dealers and clearing organizations and customers and counterparties. Receivables from brokers, dealers and clearing organizations primarily consist of initial margin placed with clearing organizations and receivables related to sales of securities which have traded, but not yet settled. These receivables generally have minimal credit risk due to the low probability of clearing organization default and the short-term nature of receivables related to securities settlements. Receivables from customers and counterparties generally consist of collateralized receivables related to customer securities transactions and generally have minimal credit risk due to both the value of the collateral received and the short-term nature of these receivables.\n\nThe table below presents our other credit exposures and the concentration by industry, region and internally determined public rating agency equivalents.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Other Credit Exposures $48,013** $50,820\n\n**Industry** Financial Institutions **77%** 80%\n\nFunds **13%** 13%\n\nOther (including Special Purpose Vehicles) **10%** 7%\n\n**Total 100%** 100%\n\n**Region** Americas **44%** 35%\n\nEMEA **41%** 54%\n\nAsia **15%** 11%\n\n**Total 100%** 100%\n\n**Credit Quality (Credit Rating Equivalent)** AAA **4%** 2%\n\nAA **49%** 57%\n\nA **24%** 26%\n\nBBB **8%** 6%\n\nBB or lower **14%** 8%\n\nUnrated **1%** 1%\n\n**Total 100%** 100%\n\nThe table above reflects collateral that we consider when determining credit risk.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 119","publish_date":null,"title":"Management’s Discussion and Analysis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page122.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page122.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page122","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page122.pdf"},"started_at":"2026-11-04T19:47:19.580922"} +{"completed_at":"2026-11-04T19:47:23.009364","latency_in_ms":1259,"output":{"example_id":"table/Goldman Sachs 10-k_page136","grounded_pages":[],"layout_pages":[],"markdown":"Year Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Preferred stock**\n\nBeginning balance **$ 11,203** $ 10,703 $ 10,703\n\nIssued **4,250** 1,500 –\n\nRedeemed **(2,200)** (1,000) –\n\nEnding balance **13,253** 11,203 10,703\n\n**Common stock** Beginning balance **9** 9 9\n\nIssued **–** – –\n\nEnding balance **9** 9 9\n\n**Share-based awards** Beginning balance **5,121** 5,696 4,211\n\nIssuance and amortization of share-based awards **2,741** 2,098 4,110\n\nDelivery of common stock underlying share-based awards **(2,483)** (2,504) (2,468)\n\nForfeiture of share-based awards **(231)** (169) (157)\n\nEnding balance **5,148** 5,121 5,696\n\n**Additional paid-in capital** Beginning balance **60,247** 59,050 56,396\n\nDelivery of common stock underlying share-based awards **2,476** 2,549 2,516\n\nCancellation of share-based awards in satisfaction of withholding tax requirements **(1,331)** (1,345) (1,591)\n\nPreferred stock issuance costs **10** 5 –\n\nIssuance of common stock in connection with acquisition **–** – 1,730\n\nOther **(26)** (12) (1)\n\nEnding balance **61,376** 60,247 59,050\n\n**Retained earnings**\n\nBeginning balance **143,688** 139,372 131,811\n\nNet earnings **14,276** 8,516 11,261\n\nDividends and dividend equivalents declared on common stock and share-based awards **(3,801)** (3,591) (3,203)\n\nDividends declared on preferred stock **(717)** (599) (497)\n\nPreferred stock redemption premium **(34)** (10) –\n\nEnding balance **153,412** 143,688 139,372\n\n**Accumulated other comprehensive income/(loss)** Beginning balance **(2,918)** (3,010) (2,068)\n\nOther comprehensive income/(loss) **216** 92 (942)\n\nEnding balance **(2,702)** (2,918) (3,010)\n\n**Stock held in treasury, at cost** Beginning balance **(100,445)** (94,631) (91,136)\n\nRepurchased **(8,000)** (5,796) (3,500)\n\nReissued **33** 29 20\n\nOther **(88)** (47) (15)\n\nEnding balance **(108,500)** (100,445) (94,631)\n\n**Total shareholders’ equity $ 121,996** $ 116,905 $ 117,189\n\nThe accompanying notes are an integral part of these consolidated financial statements.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Consolidated Statements of Changes in Shareholders’ Equity**\n\nGoldman Sachs 2024 Form 10-K 133","pages":[{"line_numbers":[],"markdown":"Year Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Preferred stock**\n\nBeginning balance **$ 11,203** $ 10,703 $ 10,703\n\nIssued **4,250** 1,500 –\n\nRedeemed **(2,200)** (1,000) –\n\nEnding balance **13,253** 11,203 10,703\n\n**Common stock** Beginning balance **9** 9 9\n\nIssued **–** – –\n\nEnding balance **9** 9 9\n\n**Share-based awards** Beginning balance **5,121** 5,696 4,211\n\nIssuance and amortization of share-based awards **2,741** 2,098 4,110\n\nDelivery of common stock underlying share-based awards **(2,483)** (2,504) (2,468)\n\nForfeiture of share-based awards **(231)** (169) (157)\n\nEnding balance **5,148** 5,121 5,696\n\n**Additional paid-in capital** Beginning balance **60,247** 59,050 56,396\n\nDelivery of common stock underlying share-based awards **2,476** 2,549 2,516\n\nCancellation of share-based awards in satisfaction of withholding tax requirements **(1,331)** (1,345) (1,591)\n\nPreferred stock issuance costs **10** 5 –\n\nIssuance of common stock in connection with acquisition **–** – 1,730\n\nOther **(26)** (12) (1)\n\nEnding balance **61,376** 60,247 59,050\n\n**Retained earnings**\n\nBeginning balance **143,688** 139,372 131,811\n\nNet earnings **14,276** 8,516 11,261\n\nDividends and dividend equivalents declared on common stock and share-based awards **(3,801)** (3,591) (3,203)\n\nDividends declared on preferred stock **(717)** (599) (497)\n\nPreferred stock redemption premium **(34)** (10) –\n\nEnding balance **153,412** 143,688 139,372\n\n**Accumulated other comprehensive income/(loss)** Beginning balance **(2,918)** (3,010) (2,068)\n\nOther comprehensive income/(loss) **216** 92 (942)\n\nEnding balance **(2,702)** (2,918) (3,010)\n\n**Stock held in treasury, at cost** Beginning balance **(100,445)** (94,631) (91,136)\n\nRepurchased **(8,000)** (5,796) (3,500)\n\nReissued **33** 29 20\n\nOther **(88)** (47) (15)\n\nEnding balance **(108,500)** (100,445) (94,631)\n\n**Total shareholders’ equity $ 121,996** $ 116,905 $ 117,189\n\nThe accompanying notes are an integral part of these consolidated financial statements.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Consolidated Statements of Changes in Shareholders’ Equity**\n\nGoldman Sachs 2024 Form 10-K 133","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Year Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Preferred stock**\n\nBeginning balance **$ 11,203** $ 10,703 $ 10,703\n\nIssued **4,250** 1,500 –\n\nRedeemed **(2,200)** (1,000) –\n\nEnding balance **13,253** 11,203 10,703\n\n**Common stock** Beginning balance **9** 9 9\n\nIssued **–** – –\n\nEnding balance **9** 9 9\n\n**Share-based awards** Beginning balance **5,121** 5,696 4,211\n\nIssuance and amortization of share-based awards **2,741** 2,098 4,110\n\nDelivery of common stock underlying share-based awards **(2,483)** (2,504) (2,468)\n\nForfeiture of share-based awards **(231)** (169) (157)\n\nEnding balance **5,148** 5,121 5,696\n\n**Additional paid-in capital** Beginning balance **60,247** 59,050 56,396\n\nDelivery of common stock underlying share-based awards **2,476** 2,549 2,516\n\nCancellation of share-based awards in satisfaction of withholding tax requirements **(1,331)** (1,345) (1,591)\n\nPreferred stock issuance costs **10** 5 –\n\nIssuance of common stock in connection with acquisition **–** – 1,730\n\nOther **(26)** (12) (1)\n\nEnding balance **61,376** 60,247 59,050\n\n**Retained earnings**\n\nBeginning balance **143,688** 139,372 131,811\n\nNet earnings **14,276** 8,516 11,261\n\nDividends and dividend equivalents declared on common stock and share-based awards **(3,801)** (3,591) (3,203)\n\nDividends declared on preferred stock **(717)** (599) (497)\n\nPreferred stock redemption premium **(34)** (10) –\n\nEnding balance **153,412** 143,688 139,372\n\n**Accumulated other comprehensive income/(loss)** Beginning balance **(2,918)** (3,010) (2,068)\n\nOther comprehensive income/(loss) **216** 92 (942)\n\nEnding balance **(2,702)** (2,918) (3,010)\n\n**Stock held in treasury, at cost** Beginning balance **(100,445)** (94,631) (91,136)\n\nRepurchased **(8,000)** (5,796) (3,500)\n\nReissued **33** 29 20\n\nOther **(88)** (47) (15)\n\nEnding balance **(108,500)** (100,445) (94,631)\n\n**Total shareholders’ equity $ 121,996** $ 116,905 $ 117,189\n\nThe accompanying notes are an integral part of these consolidated financial statements.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Consolidated Statements of Changes in Shareholders’ Equity**\n\nGoldman Sachs 2024 Form 10-K 133","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page136.pdf"]},"response":{"errors":[],"extract_id":"extract_34ae37e3adcd5b60323748db160aba94","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Year Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Preferred stock**\n\nBeginning balance **$ 11,203** $ 10,703 $ 10,703\n\nIssued **4,250** 1,500 –\n\nRedeemed **(2,200)** (1,000) –\n\nEnding balance **13,253** 11,203 10,703\n\n**Common stock** Beginning balance **9** 9 9\n\nIssued **–** – –\n\nEnding balance **9** 9 9\n\n**Share-based awards** Beginning balance **5,121** 5,696 4,211\n\nIssuance and amortization of share-based awards **2,741** 2,098 4,110\n\nDelivery of common stock underlying share-based awards **(2,483)** (2,504) (2,468)\n\nForfeiture of share-based awards **(231)** (169) (157)\n\nEnding balance **5,148** 5,121 5,696\n\n**Additional paid-in capital** Beginning balance **60,247** 59,050 56,396\n\nDelivery of common stock underlying share-based awards **2,476** 2,549 2,516\n\nCancellation of share-based awards in satisfaction of withholding tax requirements **(1,331)** (1,345) (1,591)\n\nPreferred stock issuance costs **10** 5 –\n\nIssuance of common stock in connection with acquisition **–** – 1,730\n\nOther **(26)** (12) (1)\n\nEnding balance **61,376** 60,247 59,050\n\n**Retained earnings**\n\nBeginning balance **143,688** 139,372 131,811\n\nNet earnings **14,276** 8,516 11,261\n\nDividends and dividend equivalents declared on common stock and share-based awards **(3,801)** (3,591) (3,203)\n\nDividends declared on preferred stock **(717)** (599) (497)\n\nPreferred stock redemption premium **(34)** (10) –\n\nEnding balance **153,412** 143,688 139,372\n\n**Accumulated other comprehensive income/(loss)** Beginning balance **(2,918)** (3,010) (2,068)\n\nOther comprehensive income/(loss) **216** 92 (942)\n\nEnding balance **(2,702)** (2,918) (3,010)\n\n**Stock held in treasury, at cost** Beginning balance **(100,445)** (94,631) (91,136)\n\nRepurchased **(8,000)** (5,796) (3,500)\n\nReissued **33** 29 20\n\nOther **(88)** (47) (15)\n\nEnding balance **(108,500)** (100,445) (94,631)\n\n**Total shareholders’ equity $ 121,996** $ 116,905 $ 117,189\n\nThe accompanying notes are an integral part of these consolidated financial statements.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Consolidated Statements of Changes in Shareholders’ Equity**\n\nGoldman Sachs 2024 Form 10-K 133"],"full_content":"Year Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Preferred stock**\n\nBeginning balance **$ 11,203** $ 10,703 $ 10,703\n\nIssued **4,250** 1,500 –\n\nRedeemed **(2,200)** (1,000) –\n\nEnding balance **13,253** 11,203 10,703\n\n**Common stock** Beginning balance **9** 9 9\n\nIssued **–** – –\n\nEnding balance **9** 9 9\n\n**Share-based awards** Beginning balance **5,121** 5,696 4,211\n\nIssuance and amortization of share-based awards **2,741** 2,098 4,110\n\nDelivery of common stock underlying share-based awards **(2,483)** (2,504) (2,468)\n\nForfeiture of share-based awards **(231)** (169) (157)\n\nEnding balance **5,148** 5,121 5,696\n\n**Additional paid-in capital** Beginning balance **60,247** 59,050 56,396\n\nDelivery of common stock underlying share-based awards **2,476** 2,549 2,516\n\nCancellation of share-based awards in satisfaction of withholding tax requirements **(1,331)** (1,345) (1,591)\n\nPreferred stock issuance costs **10** 5 –\n\nIssuance of common stock in connection with acquisition **–** – 1,730\n\nOther **(26)** (12) (1)\n\nEnding balance **61,376** 60,247 59,050\n\n**Retained earnings**\n\nBeginning balance **143,688** 139,372 131,811\n\nNet earnings **14,276** 8,516 11,261\n\nDividends and dividend equivalents declared on common stock and share-based awards **(3,801)** (3,591) (3,203)\n\nDividends declared on preferred stock **(717)** (599) (497)\n\nPreferred stock redemption premium **(34)** (10) –\n\nEnding balance **153,412** 143,688 139,372\n\n**Accumulated other comprehensive income/(loss)** Beginning balance **(2,918)** (3,010) (2,068)\n\nOther comprehensive income/(loss) **216** 92 (942)\n\nEnding balance **(2,702)** (2,918) (3,010)\n\n**Stock held in treasury, at cost** Beginning balance **(100,445)** (94,631) (91,136)\n\nRepurchased **(8,000)** (5,796) (3,500)\n\nReissued **33** 29 20\n\nOther **(88)** (47) (15)\n\nEnding balance **(108,500)** (100,445) (94,631)\n\n**Total shareholders’ equity $ 121,996** $ 116,905 $ 117,189\n\nThe accompanying notes are an integral part of these consolidated financial statements.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Consolidated Statements of Changes in Shareholders’ Equity**\n\nGoldman Sachs 2024 Form 10-K 133","publish_date":null,"title":"Consolidated Statements of Changes in Shareholders’ Equity","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page136.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page136.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page136","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page136.pdf"},"started_at":"2026-11-04T19:47:21.749648"} +{"completed_at":"2026-11-04T19:47:26.405221","latency_in_ms":3698,"output":{"example_id":"table/Goldman Sachs 10-k_page137","grounded_pages":[],"layout_pages":[],"markdown":"Year Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Cash flows from operating activities**\n\nNet earnings **$ 14,276** $ 8,516 $ 11,261\n\nAdjustments to reconcile net earnings to net cash provided by/(used for) operating activities:\n\nDepreciation and amortization **2,392** 4,856 2,455\n\nDeferred income taxes **(800)** (1,360) (2,412)\n\nShare-based compensation **2,663** 2,085 4,083\n\nProvision for credit losses **1,348** 1,028 2,715\n\nChanges in operating assets and liabilities:\n\nCustomer and other receivables and payables, net **(8,367)** (28,219) 35,014\n\nCollateralized transactions (excluding other secured financings), net **68,582** 160,227 (100,996)\n\nTrading assets **(86,991)** (163,807) 45,278\n\nTrading liabilities **(212)** 5,751 8,062\n\nLoans held for sale, net **537** 1,635 3,161\n\nOther, net **(6,640)** (3,299) 87\n\nNet cash provided by/(used for) operating activities **(13,212)** (12,587) 8,708\n\n**Cash flows from investing activities**\n\nPurchase of property, leasehold improvements and equipment **(2,091)** (2,316) (3,748)\n\nProceeds from sales of property, leasehold improvements and equipment **1,613** 3,278 2,706\n\nNet cash received from/(used for) business dispositions or acquisitions **3,622** 487 (2,115)\n\nAvailable-for-sale securities:\n\nPurchases **(60,852)** (9,185) (3,753)\n\nProceeds from sales **19,005** 3,161 2\n\nProceeds from paydowns and maturities **12,809** 8,130 25\n\nHeld-to-maturity securities:\n\nPurchases **(23,018)** (26,238) (50,099)\n\nProceeds from paydowns and maturities **15,549** 8,604 3,671\n\nOther investments:\n\nPurchases **(8,226)** (4,833) (6,684)\n\nProceeds from sales, paydowns and maturities **9,010** 6,953 9,263\n\nLoans (excluding loans held for sale), net **(17,045)** (5,353) (25,228)\n\nNet cash used for investing activities **(49,624)** (17,312) (75,960)\n\n**Cash flows from financing activities**\n\nUnsecured short-term borrowings, net **934** 2,050 321\n\nOther secured financings (short-term), net **13,707** 673 (2,283)\n\nProceeds from issuance of other secured financings (long-term) **5,243** 3,047 1,800\n\nRepayment of other secured financings (long-term), including the current portion **(2,036)** (3,570) (3,407)\n\nProceeds from issuance of unsecured long-term borrowings **67,252** 47,153 84,522\n\nRepayment of unsecured long-term borrowings, including the current portion **(74,519)** (54,066) (42,806)\n\nDerivative contracts with a financing element, net **2,390** 3,280 1,797\n\nDeposits, net **5,894** 39,723 28,074\n\nPreferred stock redemption **(2,200)** (1,000) –\n\nCommon stock repurchased **(8,000)** (5,796) (3,500)\n\nSettlement of share-based awards in satisfaction of withholding tax requirements **(1,331)** (1,345) (1,595)\n\nDividends and dividend equivalents paid on common stock, preferred stock and share-based awards **(4,497)** (4,189) (3,682)\n\nProceeds from issuance of preferred stock, net of issuance costs **4,239** 1,496 –\n\nOther financing, net **247** 344 361\n\nNet cash provided by financing activities **7,323** 27,800 59,602\n\nEffect of exchange rate changes on cash and cash equivalents **(3,972)** 1,851 (11,561)\n\nNet decrease in cash and cash equivalents **(59,485)** (248) (19,211)\n\nCash and cash equivalents, beginning balance **241,577** 241,825 261,036\n\n**Cash and cash equivalents, ending balance $ 182,092** $ 241,577 $ 241,825\n\n**Supplemental disclosures:**\n\nCash payments for interest, net of capitalized interest **$ 72,623** $ 60,026 $ 19,022\n\nCash payments for income taxes, net **$ 3,673** $ 2,389 $ 4,555\n\nSee Notes 9, 12 and 16 for information about non-cash activities.\n\nThe accompanying notes are an integral part of these consolidated financial statements.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Consolidated Statements of Cash Flows**\n\n134 Goldman Sachs 2024 Form 10-K","pages":[{"line_numbers":[],"markdown":"Year Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Cash flows from operating activities**\n\nNet earnings **$ 14,276** $ 8,516 $ 11,261\n\nAdjustments to reconcile net earnings to net cash provided by/(used for) operating activities:\n\nDepreciation and amortization **2,392** 4,856 2,455\n\nDeferred income taxes **(800)** (1,360) (2,412)\n\nShare-based compensation **2,663** 2,085 4,083\n\nProvision for credit losses **1,348** 1,028 2,715\n\nChanges in operating assets and liabilities:\n\nCustomer and other receivables and payables, net **(8,367)** (28,219) 35,014\n\nCollateralized transactions (excluding other secured financings), net **68,582** 160,227 (100,996)\n\nTrading assets **(86,991)** (163,807) 45,278\n\nTrading liabilities **(212)** 5,751 8,062\n\nLoans held for sale, net **537** 1,635 3,161\n\nOther, net **(6,640)** (3,299) 87\n\nNet cash provided by/(used for) operating activities **(13,212)** (12,587) 8,708\n\n**Cash flows from investing activities**\n\nPurchase of property, leasehold improvements and equipment **(2,091)** (2,316) (3,748)\n\nProceeds from sales of property, leasehold improvements and equipment **1,613** 3,278 2,706\n\nNet cash received from/(used for) business dispositions or acquisitions **3,622** 487 (2,115)\n\nAvailable-for-sale securities:\n\nPurchases **(60,852)** (9,185) (3,753)\n\nProceeds from sales **19,005** 3,161 2\n\nProceeds from paydowns and maturities **12,809** 8,130 25\n\nHeld-to-maturity securities:\n\nPurchases **(23,018)** (26,238) (50,099)\n\nProceeds from paydowns and maturities **15,549** 8,604 3,671\n\nOther investments:\n\nPurchases **(8,226)** (4,833) (6,684)\n\nProceeds from sales, paydowns and maturities **9,010** 6,953 9,263\n\nLoans (excluding loans held for sale), net **(17,045)** (5,353) (25,228)\n\nNet cash used for investing activities **(49,624)** (17,312) (75,960)\n\n**Cash flows from financing activities**\n\nUnsecured short-term borrowings, net **934** 2,050 321\n\nOther secured financings (short-term), net **13,707** 673 (2,283)\n\nProceeds from issuance of other secured financings (long-term) **5,243** 3,047 1,800\n\nRepayment of other secured financings (long-term), including the current portion **(2,036)** (3,570) (3,407)\n\nProceeds from issuance of unsecured long-term borrowings **67,252** 47,153 84,522\n\nRepayment of unsecured long-term borrowings, including the current portion **(74,519)** (54,066) (42,806)\n\nDerivative contracts with a financing element, net **2,390** 3,280 1,797\n\nDeposits, net **5,894** 39,723 28,074\n\nPreferred stock redemption **(2,200)** (1,000) –\n\nCommon stock repurchased **(8,000)** (5,796) (3,500)\n\nSettlement of share-based awards in satisfaction of withholding tax requirements **(1,331)** (1,345) (1,595)\n\nDividends and dividend equivalents paid on common stock, preferred stock and share-based awards **(4,497)** (4,189) (3,682)\n\nProceeds from issuance of preferred stock, net of issuance costs **4,239** 1,496 –\n\nOther financing, net **247** 344 361\n\nNet cash provided by financing activities **7,323** 27,800 59,602\n\nEffect of exchange rate changes on cash and cash equivalents **(3,972)** 1,851 (11,561)\n\nNet decrease in cash and cash equivalents **(59,485)** (248) (19,211)\n\nCash and cash equivalents, beginning balance **241,577** 241,825 261,036\n\n**Cash and cash equivalents, ending balance $ 182,092** $ 241,577 $ 241,825\n\n**Supplemental disclosures:**\n\nCash payments for interest, net of capitalized interest **$ 72,623** $ 60,026 $ 19,022\n\nCash payments for income taxes, net **$ 3,673** $ 2,389 $ 4,555\n\nSee Notes 9, 12 and 16 for information about non-cash activities.\n\nThe accompanying notes are an integral part of these consolidated financial statements.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Consolidated Statements of Cash Flows**\n\n134 Goldman Sachs 2024 Form 10-K","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Year Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Cash flows from operating activities**\n\nNet earnings **$ 14,276** $ 8,516 $ 11,261\n\nAdjustments to reconcile net earnings to net cash provided by/(used for) operating activities:\n\nDepreciation and amortization **2,392** 4,856 2,455\n\nDeferred income taxes **(800)** (1,360) (2,412)\n\nShare-based compensation **2,663** 2,085 4,083\n\nProvision for credit losses **1,348** 1,028 2,715\n\nChanges in operating assets and liabilities:\n\nCustomer and other receivables and payables, net **(8,367)** (28,219) 35,014\n\nCollateralized transactions (excluding other secured financings), net **68,582** 160,227 (100,996)\n\nTrading assets **(86,991)** (163,807) 45,278\n\nTrading liabilities **(212)** 5,751 8,062\n\nLoans held for sale, net **537** 1,635 3,161\n\nOther, net **(6,640)** (3,299) 87\n\nNet cash provided by/(used for) operating activities **(13,212)** (12,587) 8,708\n\n**Cash flows from investing activities**\n\nPurchase of property, leasehold improvements and equipment **(2,091)** (2,316) (3,748)\n\nProceeds from sales of property, leasehold improvements and equipment **1,613** 3,278 2,706\n\nNet cash received from/(used for) business dispositions or acquisitions **3,622** 487 (2,115)\n\nAvailable-for-sale securities:\n\nPurchases **(60,852)** (9,185) (3,753)\n\nProceeds from sales **19,005** 3,161 2\n\nProceeds from paydowns and maturities **12,809** 8,130 25\n\nHeld-to-maturity securities:\n\nPurchases **(23,018)** (26,238) (50,099)\n\nProceeds from paydowns and maturities **15,549** 8,604 3,671\n\nOther investments:\n\nPurchases **(8,226)** (4,833) (6,684)\n\nProceeds from sales, paydowns and maturities **9,010** 6,953 9,263\n\nLoans (excluding loans held for sale), net **(17,045)** (5,353) (25,228)\n\nNet cash used for investing activities **(49,624)** (17,312) (75,960)\n\n**Cash flows from financing activities**\n\nUnsecured short-term borrowings, net **934** 2,050 321\n\nOther secured financings (short-term), net **13,707** 673 (2,283)\n\nProceeds from issuance of other secured financings (long-term) **5,243** 3,047 1,800\n\nRepayment of other secured financings (long-term), including the current portion **(2,036)** (3,570) (3,407)\n\nProceeds from issuance of unsecured long-term borrowings **67,252** 47,153 84,522\n\nRepayment of unsecured long-term borrowings, including the current portion **(74,519)** (54,066) (42,806)\n\nDerivative contracts with a financing element, net **2,390** 3,280 1,797\n\nDeposits, net **5,894** 39,723 28,074\n\nPreferred stock redemption **(2,200)** (1,000) –\n\nCommon stock repurchased **(8,000)** (5,796) (3,500)\n\nSettlement of share-based awards in satisfaction of withholding tax requirements **(1,331)** (1,345) (1,595)\n\nDividends and dividend equivalents paid on common stock, preferred stock and share-based awards **(4,497)** (4,189) (3,682)\n\nProceeds from issuance of preferred stock, net of issuance costs **4,239** 1,496 –\n\nOther financing, net **247** 344 361\n\nNet cash provided by financing activities **7,323** 27,800 59,602\n\nEffect of exchange rate changes on cash and cash equivalents **(3,972)** 1,851 (11,561)\n\nNet decrease in cash and cash equivalents **(59,485)** (248) (19,211)\n\nCash and cash equivalents, beginning balance **241,577** 241,825 261,036\n\n**Cash and cash equivalents, ending balance $ 182,092** $ 241,577 $ 241,825\n\n**Supplemental disclosures:**\n\nCash payments for interest, net of capitalized interest **$ 72,623** $ 60,026 $ 19,022\n\nCash payments for income taxes, net **$ 3,673** $ 2,389 $ 4,555\n\nSee Notes 9, 12 and 16 for information about non-cash activities.\n\nThe accompanying notes are an integral part of these consolidated financial statements.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Consolidated Statements of Cash Flows**\n\n134 Goldman Sachs 2024 Form 10-K","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page137.pdf"]},"response":{"errors":[],"extract_id":"extract_caa849d3137924c1c794662a6b886884","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Year Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Cash flows from operating activities**\n\nNet earnings **$ 14,276** $ 8,516 $ 11,261\n\nAdjustments to reconcile net earnings to net cash provided by/(used for) operating activities:\n\nDepreciation and amortization **2,392** 4,856 2,455\n\nDeferred income taxes **(800)** (1,360) (2,412)\n\nShare-based compensation **2,663** 2,085 4,083\n\nProvision for credit losses **1,348** 1,028 2,715\n\nChanges in operating assets and liabilities:\n\nCustomer and other receivables and payables, net **(8,367)** (28,219) 35,014\n\nCollateralized transactions (excluding other secured financings), net **68,582** 160,227 (100,996)\n\nTrading assets **(86,991)** (163,807) 45,278\n\nTrading liabilities **(212)** 5,751 8,062\n\nLoans held for sale, net **537** 1,635 3,161\n\nOther, net **(6,640)** (3,299) 87\n\nNet cash provided by/(used for) operating activities **(13,212)** (12,587) 8,708\n\n**Cash flows from investing activities**\n\nPurchase of property, leasehold improvements and equipment **(2,091)** (2,316) (3,748)\n\nProceeds from sales of property, leasehold improvements and equipment **1,613** 3,278 2,706\n\nNet cash received from/(used for) business dispositions or acquisitions **3,622** 487 (2,115)\n\nAvailable-for-sale securities:\n\nPurchases **(60,852)** (9,185) (3,753)\n\nProceeds from sales **19,005** 3,161 2\n\nProceeds from paydowns and maturities **12,809** 8,130 25\n\nHeld-to-maturity securities:\n\nPurchases **(23,018)** (26,238) (50,099)\n\nProceeds from paydowns and maturities **15,549** 8,604 3,671\n\nOther investments:\n\nPurchases **(8,226)** (4,833) (6,684)\n\nProceeds from sales, paydowns and maturities **9,010** 6,953 9,263\n\nLoans (excluding loans held for sale), net **(17,045)** (5,353) (25,228)\n\nNet cash used for investing activities **(49,624)** (17,312) (75,960)\n\n**Cash flows from financing activities**\n\nUnsecured short-term borrowings, net **934** 2,050 321\n\nOther secured financings (short-term), net **13,707** 673 (2,283)\n\nProceeds from issuance of other secured financings (long-term) **5,243** 3,047 1,800\n\nRepayment of other secured financings (long-term), including the current portion **(2,036)** (3,570) (3,407)\n\nProceeds from issuance of unsecured long-term borrowings **67,252** 47,153 84,522\n\nRepayment of unsecured long-term borrowings, including the current portion **(74,519)** (54,066) (42,806)\n\nDerivative contracts with a financing element, net **2,390** 3,280 1,797\n\nDeposits, net **5,894** 39,723 28,074\n\nPreferred stock redemption **(2,200)** (1,000) –\n\nCommon stock repurchased **(8,000)** (5,796) (3,500)\n\nSettlement of share-based awards in satisfaction of withholding tax requirements **(1,331)** (1,345) (1,595)\n\nDividends and dividend equivalents paid on common stock, preferred stock and share-based awards **(4,497)** (4,189) (3,682)\n\nProceeds from issuance of preferred stock, net of issuance costs **4,239** 1,496 –\n\nOther financing, net **247** 344 361\n\nNet cash provided by financing activities **7,323** 27,800 59,602\n\nEffect of exchange rate changes on cash and cash equivalents **(3,972)** 1,851 (11,561)\n\nNet decrease in cash and cash equivalents **(59,485)** (248) (19,211)\n\nCash and cash equivalents, beginning balance **241,577** 241,825 261,036\n\n**Cash and cash equivalents, ending balance $ 182,092** $ 241,577 $ 241,825\n\n**Supplemental disclosures:**\n\nCash payments for interest, net of capitalized interest **$ 72,623** $ 60,026 $ 19,022\n\nCash payments for income taxes, net **$ 3,673** $ 2,389 $ 4,555\n\nSee Notes 9, 12 and 16 for information about non-cash activities.\n\nThe accompanying notes are an integral part of these consolidated financial statements.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Consolidated Statements of Cash Flows**\n\n134 Goldman Sachs 2024 Form 10-K"],"full_content":"Year Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Cash flows from operating activities**\n\nNet earnings **$ 14,276** $ 8,516 $ 11,261\n\nAdjustments to reconcile net earnings to net cash provided by/(used for) operating activities:\n\nDepreciation and amortization **2,392** 4,856 2,455\n\nDeferred income taxes **(800)** (1,360) (2,412)\n\nShare-based compensation **2,663** 2,085 4,083\n\nProvision for credit losses **1,348** 1,028 2,715\n\nChanges in operating assets and liabilities:\n\nCustomer and other receivables and payables, net **(8,367)** (28,219) 35,014\n\nCollateralized transactions (excluding other secured financings), net **68,582** 160,227 (100,996)\n\nTrading assets **(86,991)** (163,807) 45,278\n\nTrading liabilities **(212)** 5,751 8,062\n\nLoans held for sale, net **537** 1,635 3,161\n\nOther, net **(6,640)** (3,299) 87\n\nNet cash provided by/(used for) operating activities **(13,212)** (12,587) 8,708\n\n**Cash flows from investing activities**\n\nPurchase of property, leasehold improvements and equipment **(2,091)** (2,316) (3,748)\n\nProceeds from sales of property, leasehold improvements and equipment **1,613** 3,278 2,706\n\nNet cash received from/(used for) business dispositions or acquisitions **3,622** 487 (2,115)\n\nAvailable-for-sale securities:\n\nPurchases **(60,852)** (9,185) (3,753)\n\nProceeds from sales **19,005** 3,161 2\n\nProceeds from paydowns and maturities **12,809** 8,130 25\n\nHeld-to-maturity securities:\n\nPurchases **(23,018)** (26,238) (50,099)\n\nProceeds from paydowns and maturities **15,549** 8,604 3,671\n\nOther investments:\n\nPurchases **(8,226)** (4,833) (6,684)\n\nProceeds from sales, paydowns and maturities **9,010** 6,953 9,263\n\nLoans (excluding loans held for sale), net **(17,045)** (5,353) (25,228)\n\nNet cash used for investing activities **(49,624)** (17,312) (75,960)\n\n**Cash flows from financing activities**\n\nUnsecured short-term borrowings, net **934** 2,050 321\n\nOther secured financings (short-term), net **13,707** 673 (2,283)\n\nProceeds from issuance of other secured financings (long-term) **5,243** 3,047 1,800\n\nRepayment of other secured financings (long-term), including the current portion **(2,036)** (3,570) (3,407)\n\nProceeds from issuance of unsecured long-term borrowings **67,252** 47,153 84,522\n\nRepayment of unsecured long-term borrowings, including the current portion **(74,519)** (54,066) (42,806)\n\nDerivative contracts with a financing element, net **2,390** 3,280 1,797\n\nDeposits, net **5,894** 39,723 28,074\n\nPreferred stock redemption **(2,200)** (1,000) –\n\nCommon stock repurchased **(8,000)** (5,796) (3,500)\n\nSettlement of share-based awards in satisfaction of withholding tax requirements **(1,331)** (1,345) (1,595)\n\nDividends and dividend equivalents paid on common stock, preferred stock and share-based awards **(4,497)** (4,189) (3,682)\n\nProceeds from issuance of preferred stock, net of issuance costs **4,239** 1,496 –\n\nOther financing, net **247** 344 361\n\nNet cash provided by financing activities **7,323** 27,800 59,602\n\nEffect of exchange rate changes on cash and cash equivalents **(3,972)** 1,851 (11,561)\n\nNet decrease in cash and cash equivalents **(59,485)** (248) (19,211)\n\nCash and cash equivalents, beginning balance **241,577** 241,825 261,036\n\n**Cash and cash equivalents, ending balance $ 182,092** $ 241,577 $ 241,825\n\n**Supplemental disclosures:**\n\nCash payments for interest, net of capitalized interest **$ 72,623** $ 60,026 $ 19,022\n\nCash payments for income taxes, net **$ 3,673** $ 2,389 $ 4,555\n\nSee Notes 9, 12 and 16 for information about non-cash activities.\n\nThe accompanying notes are an integral part of these consolidated financial statements.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Consolidated Statements of Cash Flows**\n\n134 Goldman Sachs 2024 Form 10-K","publish_date":null,"title":"Consolidated Statements of Cash Flows","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page137.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page137.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page137","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page137.pdf"},"started_at":"2026-11-04T19:47:22.706380"} +{"completed_at":"2026-11-04T19:47:24.856556","latency_in_ms":1502,"output":{"example_id":"table/Goldman Sachs 10-k_page411","grounded_pages":[],"layout_pages":[],"markdown":"applicable to you, the “MRT Appendix”) supplements this Paragraph 8. The MRT Appendix sets forth additional events that (i) result in forfeiture of up to all of your Short-Term RSUs and (ii) may require repayment to the Firm of up to all amounts previously delivered or paid to you under your Award in accordance with Paragraph 9. Your MRT classification, as defined in the MRT Appendix, was communicated to you separately. [If you are unsure of whether the Firm identified you as an MRT, or which classification(s) apply, you must contact HCM prior to accepting this Award.] The Firm’s records with respect to such classification(s) will be controlling as to whether and which MRT Appendix applies to your Award. The MRT classifications with their corresponding MRT Appendix are as follows:\n\n**MRT Classification MRT Appendix**\n\nEU MRT, GSAMI MRT, GSAMI Senior Management and/or UK MRT EU and UK Material Risk Taker Appendix\n\nGSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix\n\nGSBE MRT or GSBE Senior Management _and_ any combination of EU MRT, GSAMI MRT, GSAMI Senior Management or UK MRT\n\nGSBE Material Risk Taker Appendix _and_ EU and UK Material Risk Taker Appendix]\n\n(c) Actions Pending Forfeiture. In connection with any investigation as to whether any of\n\nthe events that would result in forfeiture under the Plan [or][,] this Paragraph 8 [or the MRT Appendix] have occurred, the Firm reserves the right to (i) suspend payments under Dividend Equivalent Rights or delivery of RSU Shares; (ii) deliver any RSU Shares, payments under Dividend Equivalent Rights or dividends into an escrow account in accordance with Paragraph 11(e)(iii); or (iii) apply Transfer Restrictions to any RSU Shares.\n\n**Repayment of Your Award**\n\n9\\. **When You May Be Required to Repay Your Award.** If the Committee determines\n\nthat any term of this Award was not satisfied, you will be required, immediately upon demand therefor, to repay to the Firm the following:\n\n(a) Any RSU Shares for which the terms (including the terms for delivery) of the related\n\nShort-Term RSUs were not satisfied, in accordance with Section 2.6.3 of the Plan.\n\n(b) Any payments under Dividend Equivalent Rights for which the terms were not satisfied\n\n(including any such payments made in respect of Short-Term RSUs that are forfeited or RSU Shares that are cancelled or required to be repaid), in accordance with Section 2.8.3 of the Plan.\n\n(c) Any dividends paid in respect of any RSU Shares that are cancelled or required to be\n\nrepaid.\n\n(d) Any amount applied to satisfy tax withholding or other obligations with respect to any\n\nShort-Term RSUs, RSU Shares, dividend payments and payments under Dividend Equivalent Rights that are forfeited or required to be repaid.\n\n**Exceptions to the Delivery Date**\n\n10\\. **Accelerated Delivery in the Event of [a Qualifying Termination After a Change in**\n\n**Control][,] [Conflicted Employment] [or] Death.** In the event of your [Qualifying Termination After a Change in Control][,] [Conflicted Employment] [or] death, [each] as described below, your Outstanding Short-Term RSUs will be treated as described in this Paragraph 10, and[, except as set forth in Paragraph 10(a),] all other terms of this Award Agreement, including the other forfeiture and repayment events in Paragraphs 8 and 9 [and the MRT Appendix], continue to apply.\n\n(a) [You Have a Qualifying Termination After a Change in Control. If your Employment\n\nterminates when you meet the requirements of a Qualifying Termination After a Change in Control, the\n\n\\- 3 -","pages":[{"line_numbers":[],"markdown":"applicable to you, the “MRT Appendix”) supplements this Paragraph 8. The MRT Appendix sets forth additional events that (i) result in forfeiture of up to all of your Short-Term RSUs and (ii) may require repayment to the Firm of up to all amounts previously delivered or paid to you under your Award in accordance with Paragraph 9. Your MRT classification, as defined in the MRT Appendix, was communicated to you separately. [If you are unsure of whether the Firm identified you as an MRT, or which classification(s) apply, you must contact HCM prior to accepting this Award.] The Firm’s records with respect to such classification(s) will be controlling as to whether and which MRT Appendix applies to your Award. The MRT classifications with their corresponding MRT Appendix are as follows:\n\n**MRT Classification MRT Appendix**\n\nEU MRT, GSAMI MRT, GSAMI Senior Management and/or UK MRT EU and UK Material Risk Taker Appendix\n\nGSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix\n\nGSBE MRT or GSBE Senior Management _and_ any combination of EU MRT, GSAMI MRT, GSAMI Senior Management or UK MRT\n\nGSBE Material Risk Taker Appendix _and_ EU and UK Material Risk Taker Appendix]\n\n(c) Actions Pending Forfeiture. In connection with any investigation as to whether any of\n\nthe events that would result in forfeiture under the Plan [or][,] this Paragraph 8 [or the MRT Appendix] have occurred, the Firm reserves the right to (i) suspend payments under Dividend Equivalent Rights or delivery of RSU Shares; (ii) deliver any RSU Shares, payments under Dividend Equivalent Rights or dividends into an escrow account in accordance with Paragraph 11(e)(iii); or (iii) apply Transfer Restrictions to any RSU Shares.\n\n**Repayment of Your Award**\n\n9\\. **When You May Be Required to Repay Your Award.** If the Committee determines\n\nthat any term of this Award was not satisfied, you will be required, immediately upon demand therefor, to repay to the Firm the following:\n\n(a) Any RSU Shares for which the terms (including the terms for delivery) of the related\n\nShort-Term RSUs were not satisfied, in accordance with Section 2.6.3 of the Plan.\n\n(b) Any payments under Dividend Equivalent Rights for which the terms were not satisfied\n\n(including any such payments made in respect of Short-Term RSUs that are forfeited or RSU Shares that are cancelled or required to be repaid), in accordance with Section 2.8.3 of the Plan.\n\n(c) Any dividends paid in respect of any RSU Shares that are cancelled or required to be\n\nrepaid.\n\n(d) Any amount applied to satisfy tax withholding or other obligations with respect to any\n\nShort-Term RSUs, RSU Shares, dividend payments and payments under Dividend Equivalent Rights that are forfeited or required to be repaid.\n\n**Exceptions to the Delivery Date**\n\n10\\. **Accelerated Delivery in the Event of [a Qualifying Termination After a Change in**\n\n**Control][,] [Conflicted Employment] [or] Death.** In the event of your [Qualifying Termination After a Change in Control][,] [Conflicted Employment] [or] death, [each] as described below, your Outstanding Short-Term RSUs will be treated as described in this Paragraph 10, and[, except as set forth in Paragraph 10(a),] all other terms of this Award Agreement, including the other forfeiture and repayment events in Paragraphs 8 and 9 [and the MRT Appendix], continue to apply.\n\n(a) [You Have a Qualifying Termination After a Change in Control. If your Employment\n\nterminates when you meet the requirements of a Qualifying Termination After a Change in Control, the\n\n\\- 3 -","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"applicable to you, the “MRT Appendix”) supplements this Paragraph 8. The MRT Appendix sets forth additional events that (i) result in forfeiture of up to all of your Short-Term RSUs and (ii) may require repayment to the Firm of up to all amounts previously delivered or paid to you under your Award in accordance with Paragraph 9. Your MRT classification, as defined in the MRT Appendix, was communicated to you separately. [If you are unsure of whether the Firm identified you as an MRT, or which classification(s) apply, you must contact HCM prior to accepting this Award.] The Firm’s records with respect to such classification(s) will be controlling as to whether and which MRT Appendix applies to your Award. The MRT classifications with their corresponding MRT Appendix are as follows:\n\n**MRT Classification MRT Appendix**\n\nEU MRT, GSAMI MRT, GSAMI Senior Management and/or UK MRT EU and UK Material Risk Taker Appendix\n\nGSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix\n\nGSBE MRT or GSBE Senior Management _and_ any combination of EU MRT, GSAMI MRT, GSAMI Senior Management or UK MRT\n\nGSBE Material Risk Taker Appendix _and_ EU and UK Material Risk Taker Appendix]\n\n(c) Actions Pending Forfeiture. In connection with any investigation as to whether any of\n\nthe events that would result in forfeiture under the Plan [or][,] this Paragraph 8 [or the MRT Appendix] have occurred, the Firm reserves the right to (i) suspend payments under Dividend Equivalent Rights or delivery of RSU Shares; (ii) deliver any RSU Shares, payments under Dividend Equivalent Rights or dividends into an escrow account in accordance with Paragraph 11(e)(iii); or (iii) apply Transfer Restrictions to any RSU Shares.\n\n**Repayment of Your Award**\n\n9\\. **When You May Be Required to Repay Your Award.** If the Committee determines\n\nthat any term of this Award was not satisfied, you will be required, immediately upon demand therefor, to repay to the Firm the following:\n\n(a) Any RSU Shares for which the terms (including the terms for delivery) of the related\n\nShort-Term RSUs were not satisfied, in accordance with Section 2.6.3 of the Plan.\n\n(b) Any payments under Dividend Equivalent Rights for which the terms were not satisfied\n\n(including any such payments made in respect of Short-Term RSUs that are forfeited or RSU Shares that are cancelled or required to be repaid), in accordance with Section 2.8.3 of the Plan.\n\n(c) Any dividends paid in respect of any RSU Shares that are cancelled or required to be\n\nrepaid.\n\n(d) Any amount applied to satisfy tax withholding or other obligations with respect to any\n\nShort-Term RSUs, RSU Shares, dividend payments and payments under Dividend Equivalent Rights that are forfeited or required to be repaid.\n\n**Exceptions to the Delivery Date**\n\n10\\. **Accelerated Delivery in the Event of [a Qualifying Termination After a Change in**\n\n**Control][,] [Conflicted Employment] [or] Death.** In the event of your [Qualifying Termination After a Change in Control][,] [Conflicted Employment] [or] death, [each] as described below, your Outstanding Short-Term RSUs will be treated as described in this Paragraph 10, and[, except as set forth in Paragraph 10(a),] all other terms of this Award Agreement, including the other forfeiture and repayment events in Paragraphs 8 and 9 [and the MRT Appendix], continue to apply.\n\n(a) [You Have a Qualifying Termination After a Change in Control. If your Employment\n\nterminates when you meet the requirements of a Qualifying Termination After a Change in Control, the\n\n\\- 3 -","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page411.pdf"]},"response":{"errors":[],"extract_id":"extract_362ec6da7d83ef4c6b673ebf13d37622","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["applicable to you, the “MRT Appendix”) supplements this Paragraph 8. The MRT Appendix sets forth additional events that (i) result in forfeiture of up to all of your Short-Term RSUs and (ii) may require repayment to the Firm of up to all amounts previously delivered or paid to you under your Award in accordance with Paragraph 9. Your MRT classification, as defined in the MRT Appendix, was communicated to you separately. [If you are unsure of whether the Firm identified you as an MRT, or which classification(s) apply, you must contact HCM prior to accepting this Award.] The Firm’s records with respect to such classification(s) will be controlling as to whether and which MRT Appendix applies to your Award. The MRT classifications with their corresponding MRT Appendix are as follows:\n\n**MRT Classification MRT Appendix**\n\nEU MRT, GSAMI MRT, GSAMI Senior Management and/or UK MRT EU and UK Material Risk Taker Appendix\n\nGSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix\n\nGSBE MRT or GSBE Senior Management _and_ any combination of EU MRT, GSAMI MRT, GSAMI Senior Management or UK MRT\n\nGSBE Material Risk Taker Appendix _and_ EU and UK Material Risk Taker Appendix]\n\n(c) Actions Pending Forfeiture. In connection with any investigation as to whether any of\n\nthe events that would result in forfeiture under the Plan [or][,] this Paragraph 8 [or the MRT Appendix] have occurred, the Firm reserves the right to (i) suspend payments under Dividend Equivalent Rights or delivery of RSU Shares; (ii) deliver any RSU Shares, payments under Dividend Equivalent Rights or dividends into an escrow account in accordance with Paragraph 11(e)(iii); or (iii) apply Transfer Restrictions to any RSU Shares.\n\n**Repayment of Your Award**\n\n9\\. **When You May Be Required to Repay Your Award.** If the Committee determines\n\nthat any term of this Award was not satisfied, you will be required, immediately upon demand therefor, to repay to the Firm the following:\n\n(a) Any RSU Shares for which the terms (including the terms for delivery) of the related\n\nShort-Term RSUs were not satisfied, in accordance with Section 2.6.3 of the Plan.\n\n(b) Any payments under Dividend Equivalent Rights for which the terms were not satisfied\n\n(including any such payments made in respect of Short-Term RSUs that are forfeited or RSU Shares that are cancelled or required to be repaid), in accordance with Section 2.8.3 of the Plan.\n\n(c) Any dividends paid in respect of any RSU Shares that are cancelled or required to be\n\nrepaid.\n\n(d) Any amount applied to satisfy tax withholding or other obligations with respect to any\n\nShort-Term RSUs, RSU Shares, dividend payments and payments under Dividend Equivalent Rights that are forfeited or required to be repaid.\n\n**Exceptions to the Delivery Date**\n\n10\\. **Accelerated Delivery in the Event of [a Qualifying Termination After a Change in**\n\n**Control][,] [Conflicted Employment] [or] Death.** In the event of your [Qualifying Termination After a Change in Control][,] [Conflicted Employment] [or] death, [each] as described below, your Outstanding Short-Term RSUs will be treated as described in this Paragraph 10, and[, except as set forth in Paragraph 10(a),] all other terms of this Award Agreement, including the other forfeiture and repayment events in Paragraphs 8 and 9 [and the MRT Appendix], continue to apply.\n\n(a) [You Have a Qualifying Termination After a Change in Control. If your Employment\n\nterminates when you meet the requirements of a Qualifying Termination After a Change in Control, the\n\n\\- 3 -"],"full_content":"applicable to you, the “MRT Appendix”) supplements this Paragraph 8. The MRT Appendix sets forth additional events that (i) result in forfeiture of up to all of your Short-Term RSUs and (ii) may require repayment to the Firm of up to all amounts previously delivered or paid to you under your Award in accordance with Paragraph 9. Your MRT classification, as defined in the MRT Appendix, was communicated to you separately. [If you are unsure of whether the Firm identified you as an MRT, or which classification(s) apply, you must contact HCM prior to accepting this Award.] The Firm’s records with respect to such classification(s) will be controlling as to whether and which MRT Appendix applies to your Award. The MRT classifications with their corresponding MRT Appendix are as follows:\n\n**MRT Classification MRT Appendix**\n\nEU MRT, GSAMI MRT, GSAMI Senior Management and/or UK MRT EU and UK Material Risk Taker Appendix\n\nGSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix\n\nGSBE MRT or GSBE Senior Management _and_ any combination of EU MRT, GSAMI MRT, GSAMI Senior Management or UK MRT\n\nGSBE Material Risk Taker Appendix _and_ EU and UK Material Risk Taker Appendix]\n\n(c) Actions Pending Forfeiture. In connection with any investigation as to whether any of\n\nthe events that would result in forfeiture under the Plan [or][,] this Paragraph 8 [or the MRT Appendix] have occurred, the Firm reserves the right to (i) suspend payments under Dividend Equivalent Rights or delivery of RSU Shares; (ii) deliver any RSU Shares, payments under Dividend Equivalent Rights or dividends into an escrow account in accordance with Paragraph 11(e)(iii); or (iii) apply Transfer Restrictions to any RSU Shares.\n\n**Repayment of Your Award**\n\n9\\. **When You May Be Required to Repay Your Award.** If the Committee determines\n\nthat any term of this Award was not satisfied, you will be required, immediately upon demand therefor, to repay to the Firm the following:\n\n(a) Any RSU Shares for which the terms (including the terms for delivery) of the related\n\nShort-Term RSUs were not satisfied, in accordance with Section 2.6.3 of the Plan.\n\n(b) Any payments under Dividend Equivalent Rights for which the terms were not satisfied\n\n(including any such payments made in respect of Short-Term RSUs that are forfeited or RSU Shares that are cancelled or required to be repaid), in accordance with Section 2.8.3 of the Plan.\n\n(c) Any dividends paid in respect of any RSU Shares that are cancelled or required to be\n\nrepaid.\n\n(d) Any amount applied to satisfy tax withholding or other obligations with respect to any\n\nShort-Term RSUs, RSU Shares, dividend payments and payments under Dividend Equivalent Rights that are forfeited or required to be repaid.\n\n**Exceptions to the Delivery Date**\n\n10\\. **Accelerated Delivery in the Event of [a Qualifying Termination After a Change in**\n\n**Control][,] [Conflicted Employment] [or] Death.** In the event of your [Qualifying Termination After a Change in Control][,] [Conflicted Employment] [or] death, [each] as described below, your Outstanding Short-Term RSUs will be treated as described in this Paragraph 10, and[, except as set forth in Paragraph 10(a),] all other terms of this Award Agreement, including the other forfeiture and repayment events in Paragraphs 8 and 9 [and the MRT Appendix], continue to apply.\n\n(a) [You Have a Qualifying Termination After a Change in Control. If your Employment\n\nterminates when you meet the requirements of a Qualifying Termination After a Change in Control, the\n\n\\- 3 -","publish_date":null,"title":"applicable to you, the “MRT Appendix”) supplements this Paragraph 8. The MRT Appendix sets forth additional events that (i) result","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page411.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page411.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page411","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page411.pdf"},"started_at":"2026-11-04T19:47:23.354123"} +{"completed_at":"2026-11-04T19:47:27.620800","latency_in_ms":2964,"output":{"example_id":"table/Goldman Sachs 10-k_page432","grounded_pages":[],"layout_pages":[],"markdown":"(iii) You Breach an Obligation to the Firm. The Committee determines that, before\n\nthe [applicable] Settlement Date for PSUs or the [applicable] Transferability Date for any Shares at Risk, you Breached an Obligation to the Firm.\n\n(iv) You Do Not Provide Timely Certifications or Comply with Your Certifications.\n\nYou fail to certify to GS Inc. that you have complied with all of the terms of the Plan and this Award Agreement as required by Paragraph 13(d), or the Committee determines that you have failed to comply with a term of the Plan or this Award Agreement to which you have certified compliance.\n\n(v) You Do Not Follow Dispute Resolution Procedures. You attempt to have any\n\ndispute, controversy or claim under the Plan or this Award Agreement resolved in any manner that is not provided for by Paragraph 16 or Section 3.17 of the Plan, or you attempt to arbitrate a dispute, controversy or claim without first having exhausted your internal administrative remedies in accordance with Paragraph 13(c).\n\n(vi) You Bring an Action that Results in a Determination that Any Award Agreement\n\nTerm Is Invalid. As a result of any action brought by you, it is determined that any term of this Award Agreement is invalid.\n\n(vii) You Receive Compensation in Respect of Your Award from Another Employer.\n\nYour Employment terminates for any reason or you otherwise are no longer actively Employed with the Firm and another entity grants you cash, equity or other property (whether vested or unvested) to replace, substitute for or otherwise in respect of any Outstanding PSUs or Shares at Risk; _provided_ , _however_ , that your rights will only be terminated in respect of the PSUs or Shares at Risk that are replaced, substituted for or otherwise considered by such other entity in making its grant.\n\n(viii) [Accounting Restatement Required Under Sarbanes-Oxley. GS Inc. is required\n\nto prepare an accounting restatement due to GS Inc.’s material noncompliance, as a result of misconduct, with any financial reporting requirement under the securities laws as described in Section 304(a) of Sarbanes-Oxley; _provided_ , _however_ , that your rights will only be terminated in respect of PSUs or Shares at Risk to the same extent that would be required under Section 304(a) of Sarbanes-Oxley had you been a “chief executive officer” or “chief financial officer” of GS Inc. (regardless of whether you actually hold such position at the relevant time).]\n\n(ix) Accounting Restatement Required and Dodd-Frank Clawback Policy Applies.\n\nGS Inc. is required to prepare an “Accounting Restatement” as described in GS Inc.’s Policy for Recovery of Erroneously Awarded Compensation (the “Dodd-Frank Clawback Policy”); in each case if, and to the same extent as, required under the Dodd-Frank Clawback Policy. For the avoidance of doubt, PSUs previously granted to you and Shares at Risk in respect of PSUs previously granted to you are also subject to forfeiture and clawback under this Paragraph 9(b)[(viii)/(ix)].\n\n(c) [Additional Forfeiture and Repayment Conditions for Material Risk Takers. Since the\n\nFirm identified you as a Material Risk Taker (“MRT”) in **\\_\\_\\_\\_** , the **EU and UK Material Risk Taker Appendix** and/or the **GSBE Material Risk Taker Appendix** (as applicable to you, the “MRT Appendix”) supplements this Paragraph 9. The MRT Appendix sets forth additional events that (i) result in forfeiture of up to all of your PSUs and Shares at Risk and (ii) may require repayment to the Firm of up to all amounts previously delivered or paid to you under your Award in accordance with Paragraph 10. Your MRT classification, as defined in the MRT Appendix, was communicated to you separately. If you are unsure of which classification(s) apply, you must contact HCM prior to accepting this Award. The Firm’s records with respect to such classification(s) will be controlling as to whether the MRT Appendix applies to your Award. The MRT classifications with their corresponding MRT Appendix are as follows:\n\n**MRT Classification MRT Appendix**\n\nEU MRT, GSAMI MRT, GSAMI Senior Management and/or UK MRT EU and UK Material Risk Taker Appendix\n\n\\- 4 -","pages":[{"line_numbers":[],"markdown":"(iii) You Breach an Obligation to the Firm. The Committee determines that, before\n\nthe [applicable] Settlement Date for PSUs or the [applicable] Transferability Date for any Shares at Risk, you Breached an Obligation to the Firm.\n\n(iv) You Do Not Provide Timely Certifications or Comply with Your Certifications.\n\nYou fail to certify to GS Inc. that you have complied with all of the terms of the Plan and this Award Agreement as required by Paragraph 13(d), or the Committee determines that you have failed to comply with a term of the Plan or this Award Agreement to which you have certified compliance.\n\n(v) You Do Not Follow Dispute Resolution Procedures. You attempt to have any\n\ndispute, controversy or claim under the Plan or this Award Agreement resolved in any manner that is not provided for by Paragraph 16 or Section 3.17 of the Plan, or you attempt to arbitrate a dispute, controversy or claim without first having exhausted your internal administrative remedies in accordance with Paragraph 13(c).\n\n(vi) You Bring an Action that Results in a Determination that Any Award Agreement\n\nTerm Is Invalid. As a result of any action brought by you, it is determined that any term of this Award Agreement is invalid.\n\n(vii) You Receive Compensation in Respect of Your Award from Another Employer.\n\nYour Employment terminates for any reason or you otherwise are no longer actively Employed with the Firm and another entity grants you cash, equity or other property (whether vested or unvested) to replace, substitute for or otherwise in respect of any Outstanding PSUs or Shares at Risk; _provided_ , _however_ , that your rights will only be terminated in respect of the PSUs or Shares at Risk that are replaced, substituted for or otherwise considered by such other entity in making its grant.\n\n(viii) [Accounting Restatement Required Under Sarbanes-Oxley. GS Inc. is required\n\nto prepare an accounting restatement due to GS Inc.’s material noncompliance, as a result of misconduct, with any financial reporting requirement under the securities laws as described in Section 304(a) of Sarbanes-Oxley; _provided_ , _however_ , that your rights will only be terminated in respect of PSUs or Shares at Risk to the same extent that would be required under Section 304(a) of Sarbanes-Oxley had you been a “chief executive officer” or “chief financial officer” of GS Inc. (regardless of whether you actually hold such position at the relevant time).]\n\n(ix) Accounting Restatement Required and Dodd-Frank Clawback Policy Applies.\n\nGS Inc. is required to prepare an “Accounting Restatement” as described in GS Inc.’s Policy for Recovery of Erroneously Awarded Compensation (the “Dodd-Frank Clawback Policy”); in each case if, and to the same extent as, required under the Dodd-Frank Clawback Policy. For the avoidance of doubt, PSUs previously granted to you and Shares at Risk in respect of PSUs previously granted to you are also subject to forfeiture and clawback under this Paragraph 9(b)[(viii)/(ix)].\n\n(c) [Additional Forfeiture and Repayment Conditions for Material Risk Takers. Since the\n\nFirm identified you as a Material Risk Taker (“MRT”) in **\\_\\_\\_\\_** , the **EU and UK Material Risk Taker Appendix** and/or the **GSBE Material Risk Taker Appendix** (as applicable to you, the “MRT Appendix”) supplements this Paragraph 9. The MRT Appendix sets forth additional events that (i) result in forfeiture of up to all of your PSUs and Shares at Risk and (ii) may require repayment to the Firm of up to all amounts previously delivered or paid to you under your Award in accordance with Paragraph 10. Your MRT classification, as defined in the MRT Appendix, was communicated to you separately. If you are unsure of which classification(s) apply, you must contact HCM prior to accepting this Award. The Firm’s records with respect to such classification(s) will be controlling as to whether the MRT Appendix applies to your Award. The MRT classifications with their corresponding MRT Appendix are as follows:\n\n**MRT Classification MRT Appendix**\n\nEU MRT, GSAMI MRT, GSAMI Senior Management and/or UK MRT EU and UK Material Risk Taker Appendix\n\n\\- 4 -","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"(iii) You Breach an Obligation to the Firm. The Committee determines that, before\n\nthe [applicable] Settlement Date for PSUs or the [applicable] Transferability Date for any Shares at Risk, you Breached an Obligation to the Firm.\n\n(iv) You Do Not Provide Timely Certifications or Comply with Your Certifications.\n\nYou fail to certify to GS Inc. that you have complied with all of the terms of the Plan and this Award Agreement as required by Paragraph 13(d), or the Committee determines that you have failed to comply with a term of the Plan or this Award Agreement to which you have certified compliance.\n\n(v) You Do Not Follow Dispute Resolution Procedures. You attempt to have any\n\ndispute, controversy or claim under the Plan or this Award Agreement resolved in any manner that is not provided for by Paragraph 16 or Section 3.17 of the Plan, or you attempt to arbitrate a dispute, controversy or claim without first having exhausted your internal administrative remedies in accordance with Paragraph 13(c).\n\n(vi) You Bring an Action that Results in a Determination that Any Award Agreement\n\nTerm Is Invalid. As a result of any action brought by you, it is determined that any term of this Award Agreement is invalid.\n\n(vii) You Receive Compensation in Respect of Your Award from Another Employer.\n\nYour Employment terminates for any reason or you otherwise are no longer actively Employed with the Firm and another entity grants you cash, equity or other property (whether vested or unvested) to replace, substitute for or otherwise in respect of any Outstanding PSUs or Shares at Risk; _provided_ , _however_ , that your rights will only be terminated in respect of the PSUs or Shares at Risk that are replaced, substituted for or otherwise considered by such other entity in making its grant.\n\n(viii) [Accounting Restatement Required Under Sarbanes-Oxley. GS Inc. is required\n\nto prepare an accounting restatement due to GS Inc.’s material noncompliance, as a result of misconduct, with any financial reporting requirement under the securities laws as described in Section 304(a) of Sarbanes-Oxley; _provided_ , _however_ , that your rights will only be terminated in respect of PSUs or Shares at Risk to the same extent that would be required under Section 304(a) of Sarbanes-Oxley had you been a “chief executive officer” or “chief financial officer” of GS Inc. (regardless of whether you actually hold such position at the relevant time).]\n\n(ix) Accounting Restatement Required and Dodd-Frank Clawback Policy Applies.\n\nGS Inc. is required to prepare an “Accounting Restatement” as described in GS Inc.’s Policy for Recovery of Erroneously Awarded Compensation (the “Dodd-Frank Clawback Policy”); in each case if, and to the same extent as, required under the Dodd-Frank Clawback Policy. For the avoidance of doubt, PSUs previously granted to you and Shares at Risk in respect of PSUs previously granted to you are also subject to forfeiture and clawback under this Paragraph 9(b)[(viii)/(ix)].\n\n(c) [Additional Forfeiture and Repayment Conditions for Material Risk Takers. Since the\n\nFirm identified you as a Material Risk Taker (“MRT”) in **\\_\\_\\_\\_** , the **EU and UK Material Risk Taker Appendix** and/or the **GSBE Material Risk Taker Appendix** (as applicable to you, the “MRT Appendix”) supplements this Paragraph 9. The MRT Appendix sets forth additional events that (i) result in forfeiture of up to all of your PSUs and Shares at Risk and (ii) may require repayment to the Firm of up to all amounts previously delivered or paid to you under your Award in accordance with Paragraph 10. Your MRT classification, as defined in the MRT Appendix, was communicated to you separately. If you are unsure of which classification(s) apply, you must contact HCM prior to accepting this Award. The Firm’s records with respect to such classification(s) will be controlling as to whether the MRT Appendix applies to your Award. The MRT classifications with their corresponding MRT Appendix are as follows:\n\n**MRT Classification MRT Appendix**\n\nEU MRT, GSAMI MRT, GSAMI Senior Management and/or UK MRT EU and UK Material Risk Taker Appendix\n\n\\- 4 -","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page432.pdf"]},"response":{"errors":[],"extract_id":"extract_67234cdfbb31d7c0aa387416c859f79b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["(iii) You Breach an Obligation to the Firm. The Committee determines that, before\n\nthe [applicable] Settlement Date for PSUs or the [applicable] Transferability Date for any Shares at Risk, you Breached an Obligation to the Firm.\n\n(iv) You Do Not Provide Timely Certifications or Comply with Your Certifications.\n\nYou fail to certify to GS Inc. that you have complied with all of the terms of the Plan and this Award Agreement as required by Paragraph 13(d), or the Committee determines that you have failed to comply with a term of the Plan or this Award Agreement to which you have certified compliance.\n\n(v) You Do Not Follow Dispute Resolution Procedures. You attempt to have any\n\ndispute, controversy or claim under the Plan or this Award Agreement resolved in any manner that is not provided for by Paragraph 16 or Section 3.17 of the Plan, or you attempt to arbitrate a dispute, controversy or claim without first having exhausted your internal administrative remedies in accordance with Paragraph 13(c).\n\n(vi) You Bring an Action that Results in a Determination that Any Award Agreement\n\nTerm Is Invalid. As a result of any action brought by you, it is determined that any term of this Award Agreement is invalid.\n\n(vii) You Receive Compensation in Respect of Your Award from Another Employer.\n\nYour Employment terminates for any reason or you otherwise are no longer actively Employed with the Firm and another entity grants you cash, equity or other property (whether vested or unvested) to replace, substitute for or otherwise in respect of any Outstanding PSUs or Shares at Risk; _provided_ , _however_ , that your rights will only be terminated in respect of the PSUs or Shares at Risk that are replaced, substituted for or otherwise considered by such other entity in making its grant.\n\n(viii) [Accounting Restatement Required Under Sarbanes-Oxley. GS Inc. is required\n\nto prepare an accounting restatement due to GS Inc.’s material noncompliance, as a result of misconduct, with any financial reporting requirement under the securities laws as described in Section 304(a) of Sarbanes-Oxley; _provided_ , _however_ , that your rights will only be terminated in respect of PSUs or Shares at Risk to the same extent that would be required under Section 304(a) of Sarbanes-Oxley had you been a “chief executive officer” or “chief financial officer” of GS Inc. (regardless of whether you actually hold such position at the relevant time).]\n\n(ix) Accounting Restatement Required and Dodd-Frank Clawback Policy Applies.\n\nGS Inc. is required to prepare an “Accounting Restatement” as described in GS Inc.’s Policy for Recovery of Erroneously Awarded Compensation (the “Dodd-Frank Clawback Policy”); in each case if, and to the same extent as, required under the Dodd-Frank Clawback Policy. For the avoidance of doubt, PSUs previously granted to you and Shares at Risk in respect of PSUs previously granted to you are also subject to forfeiture and clawback under this Paragraph 9(b)[(viii)/(ix)].\n\n(c) [Additional Forfeiture and Repayment Conditions for Material Risk Takers. Since the\n\nFirm identified you as a Material Risk Taker (“MRT”) in **\\_\\_\\_\\_** , the **EU and UK Material Risk Taker Appendix** and/or the **GSBE Material Risk Taker Appendix** (as applicable to you, the “MRT Appendix”) supplements this Paragraph 9. The MRT Appendix sets forth additional events that (i) result in forfeiture of up to all of your PSUs and Shares at Risk and (ii) may require repayment to the Firm of up to all amounts previously delivered or paid to you under your Award in accordance with Paragraph 10. Your MRT classification, as defined in the MRT Appendix, was communicated to you separately. If you are unsure of which classification(s) apply, you must contact HCM prior to accepting this Award. The Firm’s records with respect to such classification(s) will be controlling as to whether the MRT Appendix applies to your Award. The MRT classifications with their corresponding MRT Appendix are as follows:\n\n**MRT Classification MRT Appendix**\n\nEU MRT, GSAMI MRT, GSAMI Senior Management and/or UK MRT EU and UK Material Risk Taker Appendix\n\n\\- 4 -"],"full_content":"(iii) You Breach an Obligation to the Firm. The Committee determines that, before\n\nthe [applicable] Settlement Date for PSUs or the [applicable] Transferability Date for any Shares at Risk, you Breached an Obligation to the Firm.\n\n(iv) You Do Not Provide Timely Certifications or Comply with Your Certifications.\n\nYou fail to certify to GS Inc. that you have complied with all of the terms of the Plan and this Award Agreement as required by Paragraph 13(d), or the Committee determines that you have failed to comply with a term of the Plan or this Award Agreement to which you have certified compliance.\n\n(v) You Do Not Follow Dispute Resolution Procedures. You attempt to have any\n\ndispute, controversy or claim under the Plan or this Award Agreement resolved in any manner that is not provided for by Paragraph 16 or Section 3.17 of the Plan, or you attempt to arbitrate a dispute, controversy or claim without first having exhausted your internal administrative remedies in accordance with Paragraph 13(c).\n\n(vi) You Bring an Action that Results in a Determination that Any Award Agreement\n\nTerm Is Invalid. As a result of any action brought by you, it is determined that any term of this Award Agreement is invalid.\n\n(vii) You Receive Compensation in Respect of Your Award from Another Employer.\n\nYour Employment terminates for any reason or you otherwise are no longer actively Employed with the Firm and another entity grants you cash, equity or other property (whether vested or unvested) to replace, substitute for or otherwise in respect of any Outstanding PSUs or Shares at Risk; _provided_ , _however_ , that your rights will only be terminated in respect of the PSUs or Shares at Risk that are replaced, substituted for or otherwise considered by such other entity in making its grant.\n\n(viii) [Accounting Restatement Required Under Sarbanes-Oxley. GS Inc. is required\n\nto prepare an accounting restatement due to GS Inc.’s material noncompliance, as a result of misconduct, with any financial reporting requirement under the securities laws as described in Section 304(a) of Sarbanes-Oxley; _provided_ , _however_ , that your rights will only be terminated in respect of PSUs or Shares at Risk to the same extent that would be required under Section 304(a) of Sarbanes-Oxley had you been a “chief executive officer” or “chief financial officer” of GS Inc. (regardless of whether you actually hold such position at the relevant time).]\n\n(ix) Accounting Restatement Required and Dodd-Frank Clawback Policy Applies.\n\nGS Inc. is required to prepare an “Accounting Restatement” as described in GS Inc.’s Policy for Recovery of Erroneously Awarded Compensation (the “Dodd-Frank Clawback Policy”); in each case if, and to the same extent as, required under the Dodd-Frank Clawback Policy. For the avoidance of doubt, PSUs previously granted to you and Shares at Risk in respect of PSUs previously granted to you are also subject to forfeiture and clawback under this Paragraph 9(b)[(viii)/(ix)].\n\n(c) [Additional Forfeiture and Repayment Conditions for Material Risk Takers. Since the\n\nFirm identified you as a Material Risk Taker (“MRT”) in **\\_\\_\\_\\_** , the **EU and UK Material Risk Taker Appendix** and/or the **GSBE Material Risk Taker Appendix** (as applicable to you, the “MRT Appendix”) supplements this Paragraph 9. The MRT Appendix sets forth additional events that (i) result in forfeiture of up to all of your PSUs and Shares at Risk and (ii) may require repayment to the Firm of up to all amounts previously delivered or paid to you under your Award in accordance with Paragraph 10. Your MRT classification, as defined in the MRT Appendix, was communicated to you separately. If you are unsure of which classification(s) apply, you must contact HCM prior to accepting this Award. The Firm’s records with respect to such classification(s) will be controlling as to whether the MRT Appendix applies to your Award. The MRT classifications with their corresponding MRT Appendix are as follows:\n\n**MRT Classification MRT Appendix**\n\nEU MRT, GSAMI MRT, GSAMI Senior Management and/or UK MRT EU and UK Material Risk Taker Appendix\n\n\\- 4 -","publish_date":null,"title":"(iii) You Breach an Obligation to the Firm. The Committee determines that, before the [applicable] Settlement Date for PSUs or","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page432.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page432.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page432","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page432.pdf"},"started_at":"2026-11-04T19:47:24.656004"} +{"completed_at":"2026-11-04T19:47:28.286860","latency_in_ms":2314,"output":{"example_id":"table/Goldman Sachs 10-k_page433","grounded_pages":[],"layout_pages":[],"markdown":"GSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix\n\nGSBE MRT or GSBE Senior Management _and_ any combination of EU MRT, GSAMI MRT, GSAMI Senior Management or UK MRT\n\nGSBE Material Risk Taker Appendix _and_ EU and UK Material Risk Taker Appendix]\n\n(d) Actions Pending Forfeiture. In connection with any investigation as to whether any of\n\nthe events that would result in forfeiture under the Plan[,] [or] this Paragraph 9 [or the MRT Appendix] have occurred, the Firm reserves the right to (i) suspend [any Dividend Equivalent Payments,] delivery of the Settlement Amount or release of any Transfer Restrictions; (ii) deliver the Settlement Amount[,] [any Dividend Equivalent Payments] [or] dividends into an escrow account in accordance with Paragraph 13(e)(iii); or (iii) apply Transfer Restrictions to any Shares.\n\n**Repayment of Your Award**\n\n10\\. **When You May Be Required to Repay Your Award.**\n\n(a) Repayment Generally. If the Committee determines that any term of this Award was not\n\nsatisfied, you will be required, immediately upon demand therefor, to repay to the Firm the following:\n\n(i) Any Settlement Amount (including any Shares at Risk) for which the terms\n\n(including the terms for delivery) of the related PSUs were not satisfied, in accordance with Section 2.6.3 of the Plan.\n\n(ii) Any Shares at Risk for which the terms (including the terms for the release of\n\nTransfer Restrictions) were not satisfied, in accordance with Section 2.5.3 of the Plan.\n\n(iii) [Any Shares that were delivered (but not subject to Transfer Restrictions) at the\n\nsame time any Shares at Risk that are cancelled or required to be repaid were delivered.]\n\n(iv) [Any Dividend Equivalent Payments for which the terms were not satisfied\n\n(including any such payments made in respect of PSUs that are forfeited or any Settlement Amount that is required to be repaid), in accordance with Section 2.8.3 of the Plan.]\n\n(v) Any dividends paid in respect of any [delivered Shares (including] Shares at\n\nRisk[)] that are cancelled or required to be repaid.\n\n(vi) Any amount applied to satisfy tax withholding or other obligations with respect\n\nto any PSUs, Settlement Amount (including Shares at Risk)[,] [and] dividend payments [and Dividend Equivalent Payments] that are forfeited or required to be repaid.\n\n(b) Repayment Upon Materially Inaccurate Financial Statements. If any delivery is made\n\nunder this Award Agreement based on materially inaccurate financial statements (which includes, but is not limited to, statements of earnings, revenues or gains) or other materially inaccurate performance criteria, you will be obligated to repay to the Firm, immediately upon demand therefor, any excess amount delivered, as determined by the Committee in its sole discretion. For the avoidance of doubt, this Paragraph 10(b) includes any repayment required following an “Accounting Restatement” under the Dodd-Frank Clawback Policy.\n\n(c) [Repayment Upon Accounting Restatement Required Under Sarbanes-Oxley. If an event\n\ndescribed in Paragraph 9(b)(viii) (relating to a requirement under Sarbanes-Oxley that GS Inc. prepare an accounting restatement) occurs, any Settlement Amount (including Shares at Risk), dividend payments, [Dividend Equivalent Payments,] cash or other property delivered, paid or withheld in respect of this Award will be subject to repayment as described in Paragraph 10(a) to the same extent that would be required under Section 304(a) of Sarbanes-Oxley had you been a “chief executive officer” or “chief financial officer” of GS Inc. (regardless of whether you actually hold such position at the relevant time).]\n\n\\- 5 -","pages":[{"line_numbers":[],"markdown":"GSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix\n\nGSBE MRT or GSBE Senior Management _and_ any combination of EU MRT, GSAMI MRT, GSAMI Senior Management or UK MRT\n\nGSBE Material Risk Taker Appendix _and_ EU and UK Material Risk Taker Appendix]\n\n(d) Actions Pending Forfeiture. In connection with any investigation as to whether any of\n\nthe events that would result in forfeiture under the Plan[,] [or] this Paragraph 9 [or the MRT Appendix] have occurred, the Firm reserves the right to (i) suspend [any Dividend Equivalent Payments,] delivery of the Settlement Amount or release of any Transfer Restrictions; (ii) deliver the Settlement Amount[,] [any Dividend Equivalent Payments] [or] dividends into an escrow account in accordance with Paragraph 13(e)(iii); or (iii) apply Transfer Restrictions to any Shares.\n\n**Repayment of Your Award**\n\n10\\. **When You May Be Required to Repay Your Award.**\n\n(a) Repayment Generally. If the Committee determines that any term of this Award was not\n\nsatisfied, you will be required, immediately upon demand therefor, to repay to the Firm the following:\n\n(i) Any Settlement Amount (including any Shares at Risk) for which the terms\n\n(including the terms for delivery) of the related PSUs were not satisfied, in accordance with Section 2.6.3 of the Plan.\n\n(ii) Any Shares at Risk for which the terms (including the terms for the release of\n\nTransfer Restrictions) were not satisfied, in accordance with Section 2.5.3 of the Plan.\n\n(iii) [Any Shares that were delivered (but not subject to Transfer Restrictions) at the\n\nsame time any Shares at Risk that are cancelled or required to be repaid were delivered.]\n\n(iv) [Any Dividend Equivalent Payments for which the terms were not satisfied\n\n(including any such payments made in respect of PSUs that are forfeited or any Settlement Amount that is required to be repaid), in accordance with Section 2.8.3 of the Plan.]\n\n(v) Any dividends paid in respect of any [delivered Shares (including] Shares at\n\nRisk[)] that are cancelled or required to be repaid.\n\n(vi) Any amount applied to satisfy tax withholding or other obligations with respect\n\nto any PSUs, Settlement Amount (including Shares at Risk)[,] [and] dividend payments [and Dividend Equivalent Payments] that are forfeited or required to be repaid.\n\n(b) Repayment Upon Materially Inaccurate Financial Statements. If any delivery is made\n\nunder this Award Agreement based on materially inaccurate financial statements (which includes, but is not limited to, statements of earnings, revenues or gains) or other materially inaccurate performance criteria, you will be obligated to repay to the Firm, immediately upon demand therefor, any excess amount delivered, as determined by the Committee in its sole discretion. For the avoidance of doubt, this Paragraph 10(b) includes any repayment required following an “Accounting Restatement” under the Dodd-Frank Clawback Policy.\n\n(c) [Repayment Upon Accounting Restatement Required Under Sarbanes-Oxley. If an event\n\ndescribed in Paragraph 9(b)(viii) (relating to a requirement under Sarbanes-Oxley that GS Inc. prepare an accounting restatement) occurs, any Settlement Amount (including Shares at Risk), dividend payments, [Dividend Equivalent Payments,] cash or other property delivered, paid or withheld in respect of this Award will be subject to repayment as described in Paragraph 10(a) to the same extent that would be required under Section 304(a) of Sarbanes-Oxley had you been a “chief executive officer” or “chief financial officer” of GS Inc. (regardless of whether you actually hold such position at the relevant time).]\n\n\\- 5 -","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"GSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix\n\nGSBE MRT or GSBE Senior Management _and_ any combination of EU MRT, GSAMI MRT, GSAMI Senior Management or UK MRT\n\nGSBE Material Risk Taker Appendix _and_ EU and UK Material Risk Taker Appendix]\n\n(d) Actions Pending Forfeiture. In connection with any investigation as to whether any of\n\nthe events that would result in forfeiture under the Plan[,] [or] this Paragraph 9 [or the MRT Appendix] have occurred, the Firm reserves the right to (i) suspend [any Dividend Equivalent Payments,] delivery of the Settlement Amount or release of any Transfer Restrictions; (ii) deliver the Settlement Amount[,] [any Dividend Equivalent Payments] [or] dividends into an escrow account in accordance with Paragraph 13(e)(iii); or (iii) apply Transfer Restrictions to any Shares.\n\n**Repayment of Your Award**\n\n10\\. **When You May Be Required to Repay Your Award.**\n\n(a) Repayment Generally. If the Committee determines that any term of this Award was not\n\nsatisfied, you will be required, immediately upon demand therefor, to repay to the Firm the following:\n\n(i) Any Settlement Amount (including any Shares at Risk) for which the terms\n\n(including the terms for delivery) of the related PSUs were not satisfied, in accordance with Section 2.6.3 of the Plan.\n\n(ii) Any Shares at Risk for which the terms (including the terms for the release of\n\nTransfer Restrictions) were not satisfied, in accordance with Section 2.5.3 of the Plan.\n\n(iii) [Any Shares that were delivered (but not subject to Transfer Restrictions) at the\n\nsame time any Shares at Risk that are cancelled or required to be repaid were delivered.]\n\n(iv) [Any Dividend Equivalent Payments for which the terms were not satisfied\n\n(including any such payments made in respect of PSUs that are forfeited or any Settlement Amount that is required to be repaid), in accordance with Section 2.8.3 of the Plan.]\n\n(v) Any dividends paid in respect of any [delivered Shares (including] Shares at\n\nRisk[)] that are cancelled or required to be repaid.\n\n(vi) Any amount applied to satisfy tax withholding or other obligations with respect\n\nto any PSUs, Settlement Amount (including Shares at Risk)[,] [and] dividend payments [and Dividend Equivalent Payments] that are forfeited or required to be repaid.\n\n(b) Repayment Upon Materially Inaccurate Financial Statements. If any delivery is made\n\nunder this Award Agreement based on materially inaccurate financial statements (which includes, but is not limited to, statements of earnings, revenues or gains) or other materially inaccurate performance criteria, you will be obligated to repay to the Firm, immediately upon demand therefor, any excess amount delivered, as determined by the Committee in its sole discretion. For the avoidance of doubt, this Paragraph 10(b) includes any repayment required following an “Accounting Restatement” under the Dodd-Frank Clawback Policy.\n\n(c) [Repayment Upon Accounting Restatement Required Under Sarbanes-Oxley. If an event\n\ndescribed in Paragraph 9(b)(viii) (relating to a requirement under Sarbanes-Oxley that GS Inc. prepare an accounting restatement) occurs, any Settlement Amount (including Shares at Risk), dividend payments, [Dividend Equivalent Payments,] cash or other property delivered, paid or withheld in respect of this Award will be subject to repayment as described in Paragraph 10(a) to the same extent that would be required under Section 304(a) of Sarbanes-Oxley had you been a “chief executive officer” or “chief financial officer” of GS Inc. (regardless of whether you actually hold such position at the relevant time).]\n\n\\- 5 -","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page433.pdf"]},"response":{"errors":[],"extract_id":"extract_951878b1a243c5b2a0254c030949678d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["GSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix\n\nGSBE MRT or GSBE Senior Management _and_ any combination of EU MRT, GSAMI MRT, GSAMI Senior Management or UK MRT\n\nGSBE Material Risk Taker Appendix _and_ EU and UK Material Risk Taker Appendix]\n\n(d) Actions Pending Forfeiture. In connection with any investigation as to whether any of\n\nthe events that would result in forfeiture under the Plan[,] [or] this Paragraph 9 [or the MRT Appendix] have occurred, the Firm reserves the right to (i) suspend [any Dividend Equivalent Payments,] delivery of the Settlement Amount or release of any Transfer Restrictions; (ii) deliver the Settlement Amount[,] [any Dividend Equivalent Payments] [or] dividends into an escrow account in accordance with Paragraph 13(e)(iii); or (iii) apply Transfer Restrictions to any Shares.\n\n**Repayment of Your Award**\n\n10\\. **When You May Be Required to Repay Your Award.**\n\n(a) Repayment Generally. If the Committee determines that any term of this Award was not\n\nsatisfied, you will be required, immediately upon demand therefor, to repay to the Firm the following:\n\n(i) Any Settlement Amount (including any Shares at Risk) for which the terms\n\n(including the terms for delivery) of the related PSUs were not satisfied, in accordance with Section 2.6.3 of the Plan.\n\n(ii) Any Shares at Risk for which the terms (including the terms for the release of\n\nTransfer Restrictions) were not satisfied, in accordance with Section 2.5.3 of the Plan.\n\n(iii) [Any Shares that were delivered (but not subject to Transfer Restrictions) at the\n\nsame time any Shares at Risk that are cancelled or required to be repaid were delivered.]\n\n(iv) [Any Dividend Equivalent Payments for which the terms were not satisfied\n\n(including any such payments made in respect of PSUs that are forfeited or any Settlement Amount that is required to be repaid), in accordance with Section 2.8.3 of the Plan.]\n\n(v) Any dividends paid in respect of any [delivered Shares (including] Shares at\n\nRisk[)] that are cancelled or required to be repaid.\n\n(vi) Any amount applied to satisfy tax withholding or other obligations with respect\n\nto any PSUs, Settlement Amount (including Shares at Risk)[,] [and] dividend payments [and Dividend Equivalent Payments] that are forfeited or required to be repaid.\n\n(b) Repayment Upon Materially Inaccurate Financial Statements. If any delivery is made\n\nunder this Award Agreement based on materially inaccurate financial statements (which includes, but is not limited to, statements of earnings, revenues or gains) or other materially inaccurate performance criteria, you will be obligated to repay to the Firm, immediately upon demand therefor, any excess amount delivered, as determined by the Committee in its sole discretion. For the avoidance of doubt, this Paragraph 10(b) includes any repayment required following an “Accounting Restatement” under the Dodd-Frank Clawback Policy.\n\n(c) [Repayment Upon Accounting Restatement Required Under Sarbanes-Oxley. If an event\n\ndescribed in Paragraph 9(b)(viii) (relating to a requirement under Sarbanes-Oxley that GS Inc. prepare an accounting restatement) occurs, any Settlement Amount (including Shares at Risk), dividend payments, [Dividend Equivalent Payments,] cash or other property delivered, paid or withheld in respect of this Award will be subject to repayment as described in Paragraph 10(a) to the same extent that would be required under Section 304(a) of Sarbanes-Oxley had you been a “chief executive officer” or “chief financial officer” of GS Inc. (regardless of whether you actually hold such position at the relevant time).]\n\n\\- 5 -"],"full_content":"GSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix\n\nGSBE MRT or GSBE Senior Management _and_ any combination of EU MRT, GSAMI MRT, GSAMI Senior Management or UK MRT\n\nGSBE Material Risk Taker Appendix _and_ EU and UK Material Risk Taker Appendix]\n\n(d) Actions Pending Forfeiture. In connection with any investigation as to whether any of\n\nthe events that would result in forfeiture under the Plan[,] [or] this Paragraph 9 [or the MRT Appendix] have occurred, the Firm reserves the right to (i) suspend [any Dividend Equivalent Payments,] delivery of the Settlement Amount or release of any Transfer Restrictions; (ii) deliver the Settlement Amount[,] [any Dividend Equivalent Payments] [or] dividends into an escrow account in accordance with Paragraph 13(e)(iii); or (iii) apply Transfer Restrictions to any Shares.\n\n**Repayment of Your Award**\n\n10\\. **When You May Be Required to Repay Your Award.**\n\n(a) Repayment Generally. If the Committee determines that any term of this Award was not\n\nsatisfied, you will be required, immediately upon demand therefor, to repay to the Firm the following:\n\n(i) Any Settlement Amount (including any Shares at Risk) for which the terms\n\n(including the terms for delivery) of the related PSUs were not satisfied, in accordance with Section 2.6.3 of the Plan.\n\n(ii) Any Shares at Risk for which the terms (including the terms for the release of\n\nTransfer Restrictions) were not satisfied, in accordance with Section 2.5.3 of the Plan.\n\n(iii) [Any Shares that were delivered (but not subject to Transfer Restrictions) at the\n\nsame time any Shares at Risk that are cancelled or required to be repaid were delivered.]\n\n(iv) [Any Dividend Equivalent Payments for which the terms were not satisfied\n\n(including any such payments made in respect of PSUs that are forfeited or any Settlement Amount that is required to be repaid), in accordance with Section 2.8.3 of the Plan.]\n\n(v) Any dividends paid in respect of any [delivered Shares (including] Shares at\n\nRisk[)] that are cancelled or required to be repaid.\n\n(vi) Any amount applied to satisfy tax withholding or other obligations with respect\n\nto any PSUs, Settlement Amount (including Shares at Risk)[,] [and] dividend payments [and Dividend Equivalent Payments] that are forfeited or required to be repaid.\n\n(b) Repayment Upon Materially Inaccurate Financial Statements. If any delivery is made\n\nunder this Award Agreement based on materially inaccurate financial statements (which includes, but is not limited to, statements of earnings, revenues or gains) or other materially inaccurate performance criteria, you will be obligated to repay to the Firm, immediately upon demand therefor, any excess amount delivered, as determined by the Committee in its sole discretion. For the avoidance of doubt, this Paragraph 10(b) includes any repayment required following an “Accounting Restatement” under the Dodd-Frank Clawback Policy.\n\n(c) [Repayment Upon Accounting Restatement Required Under Sarbanes-Oxley. If an event\n\ndescribed in Paragraph 9(b)(viii) (relating to a requirement under Sarbanes-Oxley that GS Inc. prepare an accounting restatement) occurs, any Settlement Amount (including Shares at Risk), dividend payments, [Dividend Equivalent Payments,] cash or other property delivered, paid or withheld in respect of this Award will be subject to repayment as described in Paragraph 10(a) to the same extent that would be required under Section 304(a) of Sarbanes-Oxley had you been a “chief executive officer” or “chief financial officer” of GS Inc. (regardless of whether you actually hold such position at the relevant time).]\n\n\\- 5 -","publish_date":null,"title":"GSBE MRT and GSBE Senior Management GSBE Material Risk Taker Appendix GSBE MRT or GSBE Senior Management and GSBE Material","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page433.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page433.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page433","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page433.pdf"},"started_at":"2026-11-04T19:47:25.972282"} +{"completed_at":"2026-11-04T19:31:04.722682","latency_in_ms":1730,"output":{"example_id":"table/Goldman Sachs 10-k_page74","grounded_pages":[],"layout_pages":[],"markdown":"The Organisation for Economic Co-operation and\n\nDevelopment (OECD) Global Anti-Base Erosion Model Rules (Pillar II) aim to ensure that multinationals with revenues in excess of EUR 750 million pay a minimum effective corporate tax rate of 15% (minimum tax) in each jurisdiction in which they operate. The U.K. and other jurisdictions in which we operate have adopted certain portions of the OECD directive (Pillar II legislation) effective beginning in calendar year 2024. The Pillar II legislation did not have a material impact on our effective tax rate for 2024. We expect additional guidance or legislation to be issued by the OECD and various jurisdictions during 2025 which could impact any minimum tax we owe in future periods, possibly materially, and our effective tax rate could increase in 2025 and thereafter. This minimum tax, if any, will be recognized in the period in which it is incurred.\n\nOn August 26, 2024, the U.S. Tax Court issued a decision in Varian Medical Systems, Inc. v. Commissioner (Varian decision). The Varian decision reduced the U.S. tax on the deemed repatriation of unremitted foreign earnings of applicable non-U.S. subsidiaries in the transition year of the Tax Cuts and Jobs Act. We are monitoring the Varian decision and evaluating its impact, which could be a material income tax benefit, on the deemed repatriation tax we incurred for the 2018 tax year. No income tax benefit has been recognized in the provision for income taxes as a result of the Varian decision as of December 2024.\n\nWe expect our 2025 annual effective tax rate to be approximately 21%.\n\n**Segment Assets and Operating Results Segment Assets.** The table below presents assets by segment.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nGlobal Banking & Markets **$ 1,420,142** $ 1,381,247\n\nAsset & Wealth Management **193,328** 191,863\n\nPlatform Solutions **62,502** 68,484\n\n**Total $ 1,675,972** $ 1,641,594\n\nThe allocation process for segment assets is based on the activities of these segments. The allocation of assets includes allocation of GCLA (which consists of unencumbered, highly liquid securities and cash), which is included within cash and cash equivalents, collateralized agreements, trading assets and investments on our balance sheet. Due to the integrated nature of these segments, estimates and judgments are made in allocating these assets. See “Risk Management — Liquidity Risk Management” for further information about our GCLA.\n\n**Segment Operating Results.** The table below presents our segment operating results.\n\nYear Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Global Banking & Markets** Net revenues **$ 34,943** $ 29,996 $ 32,487\n\nProvision for credit losses **40** 401 468\n\nCompensation and benefits expenses **9,426** 8,571 8,661\n\nOther operating expenses **10,554** 9,469 9,190\n\nTotal operating expenses **19,980** 18,040 17,851\n\nPre-tax earnings **$ 14,923** $ 11,555 $ 14,168\n\nNet earnings to common **$ 10,998** $ 8,703 $ 11,458\n\nAverage common equity **$ 75,796** $ 71,863 $ 69,951\n\nReturn on average common equity **14\\.5%** 12\\.1% 16.4%\n\n**Asset & Wealth Management** Net revenues **$ 16,142** $ 13,880 $ 13,376\n\nProvision for credit losses **(232)** (508) 519\n\nCompensation and benefits expenses **6,595** 6,144 5,927\n\nOther operating expenses **5,230** 6,885 5,623\n\nTotal operating expenses **11,825** 13,029 11,550\n\nPre-tax earnings **$ 4,549** $ 1,359 $ 1,307\n\nNet earnings to common **$ 3,386** $ 952 $ 979\n\nAverage common equity **$ 26,405** $ 30,078 $ 31,762\n\nReturn on average common equity **12\\.8%** 3\\.2% 3.1%\n\n**Platform Solutions** Net revenues **$ 2,427** $ 2,378 $ 1,502\n\nProvision for credit losses **1,540** 1,135 1,728\n\nCompensation and benefits expenses **685** 784 560\n\nOther operating expenses **1,277** 2,634 1,203\n\nTotal operating expenses **1,962** 3,418 1,763\n\nPre-tax earnings/(loss) **$ (1,075)** $ (2,175) $ (1,989)\n\nNet earnings/(loss) to common **$ (859)** $ (1,748) $ (1,673)\n\nAverage common equity **$ 4,573** $ 3,863 $ 3,574\n\nReturn on average common equity **(18.8) %** (45.2) % (46.8) %\n\n**Total** Net revenues **$ 53,512** $ 46,254 $ 47,365\n\nProvision for credit losses **1,348** 1,028 2,715\n\nCompensation and benefits expenses **16,706** 15,499 15,148\n\nOther operating expenses **17,061** 18,988 16,016\n\nTotal operating expenses **33,767** 34,487 31,164\n\nPre-tax earnings **$ 18,397** $ 10,739 $ 13,486\n\nNet earnings to common **$ 13,525** $ 7,907 $ 10,764\n\nAverage common equity **$ 106,774** $ 105,804 $ 105,287\n\nReturn on average common equity **12\\.7%** 7\\.5% 10.2%\n\nNet revenues in our segments include allocations of interest income and expense based on the funding generated by, or the funding and liquidity requirements of, the respective segments. See Note 25 to the consolidated financial statements for further information about our business segments.\n\nThe allocation of common shareholders’ equity and preferred stock dividends to each segment is based on the estimated amount of equity required to support the activities of the segment under relevant regulatory capital requirements. Net earnings for each segment is calculated by applying the firmwide tax rate to each segment’s pre-tax earnings.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 71","pages":[{"line_numbers":[],"markdown":"The Organisation for Economic Co-operation and\n\nDevelopment (OECD) Global Anti-Base Erosion Model Rules (Pillar II) aim to ensure that multinationals with revenues in excess of EUR 750 million pay a minimum effective corporate tax rate of 15% (minimum tax) in each jurisdiction in which they operate. The U.K. and other jurisdictions in which we operate have adopted certain portions of the OECD directive (Pillar II legislation) effective beginning in calendar year 2024. The Pillar II legislation did not have a material impact on our effective tax rate for 2024. We expect additional guidance or legislation to be issued by the OECD and various jurisdictions during 2025 which could impact any minimum tax we owe in future periods, possibly materially, and our effective tax rate could increase in 2025 and thereafter. This minimum tax, if any, will be recognized in the period in which it is incurred.\n\nOn August 26, 2024, the U.S. Tax Court issued a decision in Varian Medical Systems, Inc. v. Commissioner (Varian decision). The Varian decision reduced the U.S. tax on the deemed repatriation of unremitted foreign earnings of applicable non-U.S. subsidiaries in the transition year of the Tax Cuts and Jobs Act. We are monitoring the Varian decision and evaluating its impact, which could be a material income tax benefit, on the deemed repatriation tax we incurred for the 2018 tax year. No income tax benefit has been recognized in the provision for income taxes as a result of the Varian decision as of December 2024.\n\nWe expect our 2025 annual effective tax rate to be approximately 21%.\n\n**Segment Assets and Operating Results Segment Assets.** The table below presents assets by segment.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nGlobal Banking & Markets **$ 1,420,142** $ 1,381,247\n\nAsset & Wealth Management **193,328** 191,863\n\nPlatform Solutions **62,502** 68,484\n\n**Total $ 1,675,972** $ 1,641,594\n\nThe allocation process for segment assets is based on the activities of these segments. The allocation of assets includes allocation of GCLA (which consists of unencumbered, highly liquid securities and cash), which is included within cash and cash equivalents, collateralized agreements, trading assets and investments on our balance sheet. Due to the integrated nature of these segments, estimates and judgments are made in allocating these assets. See “Risk Management — Liquidity Risk Management” for further information about our GCLA.\n\n**Segment Operating Results.** The table below presents our segment operating results.\n\nYear Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Global Banking & Markets** Net revenues **$ 34,943** $ 29,996 $ 32,487\n\nProvision for credit losses **40** 401 468\n\nCompensation and benefits expenses **9,426** 8,571 8,661\n\nOther operating expenses **10,554** 9,469 9,190\n\nTotal operating expenses **19,980** 18,040 17,851\n\nPre-tax earnings **$ 14,923** $ 11,555 $ 14,168\n\nNet earnings to common **$ 10,998** $ 8,703 $ 11,458\n\nAverage common equity **$ 75,796** $ 71,863 $ 69,951\n\nReturn on average common equity **14\\.5%** 12\\.1% 16.4%\n\n**Asset & Wealth Management** Net revenues **$ 16,142** $ 13,880 $ 13,376\n\nProvision for credit losses **(232)** (508) 519\n\nCompensation and benefits expenses **6,595** 6,144 5,927\n\nOther operating expenses **5,230** 6,885 5,623\n\nTotal operating expenses **11,825** 13,029 11,550\n\nPre-tax earnings **$ 4,549** $ 1,359 $ 1,307\n\nNet earnings to common **$ 3,386** $ 952 $ 979\n\nAverage common equity **$ 26,405** $ 30,078 $ 31,762\n\nReturn on average common equity **12\\.8%** 3\\.2% 3.1%\n\n**Platform Solutions** Net revenues **$ 2,427** $ 2,378 $ 1,502\n\nProvision for credit losses **1,540** 1,135 1,728\n\nCompensation and benefits expenses **685** 784 560\n\nOther operating expenses **1,277** 2,634 1,203\n\nTotal operating expenses **1,962** 3,418 1,763\n\nPre-tax earnings/(loss) **$ (1,075)** $ (2,175) $ (1,989)\n\nNet earnings/(loss) to common **$ (859)** $ (1,748) $ (1,673)\n\nAverage common equity **$ 4,573** $ 3,863 $ 3,574\n\nReturn on average common equity **(18.8) %** (45.2) % (46.8) %\n\n**Total** Net revenues **$ 53,512** $ 46,254 $ 47,365\n\nProvision for credit losses **1,348** 1,028 2,715\n\nCompensation and benefits expenses **16,706** 15,499 15,148\n\nOther operating expenses **17,061** 18,988 16,016\n\nTotal operating expenses **33,767** 34,487 31,164\n\nPre-tax earnings **$ 18,397** $ 10,739 $ 13,486\n\nNet earnings to common **$ 13,525** $ 7,907 $ 10,764\n\nAverage common equity **$ 106,774** $ 105,804 $ 105,287\n\nReturn on average common equity **12\\.7%** 7\\.5% 10.2%\n\nNet revenues in our segments include allocations of interest income and expense based on the funding generated by, or the funding and liquidity requirements of, the respective segments. See Note 25 to the consolidated financial statements for further information about our business segments.\n\nThe allocation of common shareholders’ equity and preferred stock dividends to each segment is based on the estimated amount of equity required to support the activities of the segment under relevant regulatory capital requirements. Net earnings for each segment is calculated by applying the firmwide tax rate to each segment’s pre-tax earnings.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 71","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"The Organisation for Economic Co-operation and\n\nDevelopment (OECD) Global Anti-Base Erosion Model Rules (Pillar II) aim to ensure that multinationals with revenues in excess of EUR 750 million pay a minimum effective corporate tax rate of 15% (minimum tax) in each jurisdiction in which they operate. The U.K. and other jurisdictions in which we operate have adopted certain portions of the OECD directive (Pillar II legislation) effective beginning in calendar year 2024. The Pillar II legislation did not have a material impact on our effective tax rate for 2024. We expect additional guidance or legislation to be issued by the OECD and various jurisdictions during 2025 which could impact any minimum tax we owe in future periods, possibly materially, and our effective tax rate could increase in 2025 and thereafter. This minimum tax, if any, will be recognized in the period in which it is incurred.\n\nOn August 26, 2024, the U.S. Tax Court issued a decision in Varian Medical Systems, Inc. v. Commissioner (Varian decision). The Varian decision reduced the U.S. tax on the deemed repatriation of unremitted foreign earnings of applicable non-U.S. subsidiaries in the transition year of the Tax Cuts and Jobs Act. We are monitoring the Varian decision and evaluating its impact, which could be a material income tax benefit, on the deemed repatriation tax we incurred for the 2018 tax year. No income tax benefit has been recognized in the provision for income taxes as a result of the Varian decision as of December 2024.\n\nWe expect our 2025 annual effective tax rate to be approximately 21%.\n\n**Segment Assets and Operating Results Segment Assets.** The table below presents assets by segment.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nGlobal Banking & Markets **$ 1,420,142** $ 1,381,247\n\nAsset & Wealth Management **193,328** 191,863\n\nPlatform Solutions **62,502** 68,484\n\n**Total $ 1,675,972** $ 1,641,594\n\nThe allocation process for segment assets is based on the activities of these segments. The allocation of assets includes allocation of GCLA (which consists of unencumbered, highly liquid securities and cash), which is included within cash and cash equivalents, collateralized agreements, trading assets and investments on our balance sheet. Due to the integrated nature of these segments, estimates and judgments are made in allocating these assets. See “Risk Management — Liquidity Risk Management” for further information about our GCLA.\n\n**Segment Operating Results.** The table below presents our segment operating results.\n\nYear Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Global Banking & Markets** Net revenues **$ 34,943** $ 29,996 $ 32,487\n\nProvision for credit losses **40** 401 468\n\nCompensation and benefits expenses **9,426** 8,571 8,661\n\nOther operating expenses **10,554** 9,469 9,190\n\nTotal operating expenses **19,980** 18,040 17,851\n\nPre-tax earnings **$ 14,923** $ 11,555 $ 14,168\n\nNet earnings to common **$ 10,998** $ 8,703 $ 11,458\n\nAverage common equity **$ 75,796** $ 71,863 $ 69,951\n\nReturn on average common equity **14\\.5%** 12\\.1% 16.4%\n\n**Asset & Wealth Management** Net revenues **$ 16,142** $ 13,880 $ 13,376\n\nProvision for credit losses **(232)** (508) 519\n\nCompensation and benefits expenses **6,595** 6,144 5,927\n\nOther operating expenses **5,230** 6,885 5,623\n\nTotal operating expenses **11,825** 13,029 11,550\n\nPre-tax earnings **$ 4,549** $ 1,359 $ 1,307\n\nNet earnings to common **$ 3,386** $ 952 $ 979\n\nAverage common equity **$ 26,405** $ 30,078 $ 31,762\n\nReturn on average common equity **12\\.8%** 3\\.2% 3.1%\n\n**Platform Solutions** Net revenues **$ 2,427** $ 2,378 $ 1,502\n\nProvision for credit losses **1,540** 1,135 1,728\n\nCompensation and benefits expenses **685** 784 560\n\nOther operating expenses **1,277** 2,634 1,203\n\nTotal operating expenses **1,962** 3,418 1,763\n\nPre-tax earnings/(loss) **$ (1,075)** $ (2,175) $ (1,989)\n\nNet earnings/(loss) to common **$ (859)** $ (1,748) $ (1,673)\n\nAverage common equity **$ 4,573** $ 3,863 $ 3,574\n\nReturn on average common equity **(18.8) %** (45.2) % (46.8) %\n\n**Total** Net revenues **$ 53,512** $ 46,254 $ 47,365\n\nProvision for credit losses **1,348** 1,028 2,715\n\nCompensation and benefits expenses **16,706** 15,499 15,148\n\nOther operating expenses **17,061** 18,988 16,016\n\nTotal operating expenses **33,767** 34,487 31,164\n\nPre-tax earnings **$ 18,397** $ 10,739 $ 13,486\n\nNet earnings to common **$ 13,525** $ 7,907 $ 10,764\n\nAverage common equity **$ 106,774** $ 105,804 $ 105,287\n\nReturn on average common equity **12\\.7%** 7\\.5% 10.2%\n\nNet revenues in our segments include allocations of interest income and expense based on the funding generated by, or the funding and liquidity requirements of, the respective segments. See Note 25 to the consolidated financial statements for further information about our business segments.\n\nThe allocation of common shareholders’ equity and preferred stock dividends to each segment is based on the estimated amount of equity required to support the activities of the segment under relevant regulatory capital requirements. Net earnings for each segment is calculated by applying the firmwide tax rate to each segment’s pre-tax earnings.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 71","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page74.pdf"]},"response":{"errors":[],"extract_id":"extract_39a3f8eadaa8426bf9deac737d22df6d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["The Organisation for Economic Co-operation and\n\nDevelopment (OECD) Global Anti-Base Erosion Model Rules (Pillar II) aim to ensure that multinationals with revenues in excess of EUR 750 million pay a minimum effective corporate tax rate of 15% (minimum tax) in each jurisdiction in which they operate. The U.K. and other jurisdictions in which we operate have adopted certain portions of the OECD directive (Pillar II legislation) effective beginning in calendar year 2024. The Pillar II legislation did not have a material impact on our effective tax rate for 2024. We expect additional guidance or legislation to be issued by the OECD and various jurisdictions during 2025 which could impact any minimum tax we owe in future periods, possibly materially, and our effective tax rate could increase in 2025 and thereafter. This minimum tax, if any, will be recognized in the period in which it is incurred.\n\nOn August 26, 2024, the U.S. Tax Court issued a decision in Varian Medical Systems, Inc. v. Commissioner (Varian decision). The Varian decision reduced the U.S. tax on the deemed repatriation of unremitted foreign earnings of applicable non-U.S. subsidiaries in the transition year of the Tax Cuts and Jobs Act. We are monitoring the Varian decision and evaluating its impact, which could be a material income tax benefit, on the deemed repatriation tax we incurred for the 2018 tax year. No income tax benefit has been recognized in the provision for income taxes as a result of the Varian decision as of December 2024.\n\nWe expect our 2025 annual effective tax rate to be approximately 21%.\n\n**Segment Assets and Operating Results Segment Assets.** The table below presents assets by segment.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nGlobal Banking & Markets **$ 1,420,142** $ 1,381,247\n\nAsset & Wealth Management **193,328** 191,863\n\nPlatform Solutions **62,502** 68,484\n\n**Total $ 1,675,972** $ 1,641,594\n\nThe allocation process for segment assets is based on the activities of these segments. The allocation of assets includes allocation of GCLA (which consists of unencumbered, highly liquid securities and cash), which is included within cash and cash equivalents, collateralized agreements, trading assets and investments on our balance sheet. Due to the integrated nature of these segments, estimates and judgments are made in allocating these assets. See “Risk Management — Liquidity Risk Management” for further information about our GCLA.\n\n**Segment Operating Results.** The table below presents our segment operating results.\n\nYear Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Global Banking & Markets** Net revenues **$ 34,943** $ 29,996 $ 32,487\n\nProvision for credit losses **40** 401 468\n\nCompensation and benefits expenses **9,426** 8,571 8,661\n\nOther operating expenses **10,554** 9,469 9,190\n\nTotal operating expenses **19,980** 18,040 17,851\n\nPre-tax earnings **$ 14,923** $ 11,555 $ 14,168\n\nNet earnings to common **$ 10,998** $ 8,703 $ 11,458\n\nAverage common equity **$ 75,796** $ 71,863 $ 69,951\n\nReturn on average common equity **14\\.5%** 12\\.1% 16.4%\n\n**Asset & Wealth Management** Net revenues **$ 16,142** $ 13,880 $ 13,376\n\nProvision for credit losses **(232)** (508) 519\n\nCompensation and benefits expenses **6,595** 6,144 5,927\n\nOther operating expenses **5,230** 6,885 5,623\n\nTotal operating expenses **11,825** 13,029 11,550\n\nPre-tax earnings **$ 4,549** $ 1,359 $ 1,307\n\nNet earnings to common **$ 3,386** $ 952 $ 979\n\nAverage common equity **$ 26,405** $ 30,078 $ 31,762\n\nReturn on average common equity **12\\.8%** 3\\.2% 3.1%\n\n**Platform Solutions** Net revenues **$ 2,427** $ 2,378 $ 1,502\n\nProvision for credit losses **1,540** 1,135 1,728\n\nCompensation and benefits expenses **685** 784 560\n\nOther operating expenses **1,277** 2,634 1,203\n\nTotal operating expenses **1,962** 3,418 1,763\n\nPre-tax earnings/(loss) **$ (1,075)** $ (2,175) $ (1,989)\n\nNet earnings/(loss) to common **$ (859)** $ (1,748) $ (1,673)\n\nAverage common equity **$ 4,573** $ 3,863 $ 3,574\n\nReturn on average common equity **(18.8) %** (45.2) % (46.8) %\n\n**Total** Net revenues **$ 53,512** $ 46,254 $ 47,365\n\nProvision for credit losses **1,348** 1,028 2,715\n\nCompensation and benefits expenses **16,706** 15,499 15,148\n\nOther operating expenses **17,061** 18,988 16,016\n\nTotal operating expenses **33,767** 34,487 31,164\n\nPre-tax earnings **$ 18,397** $ 10,739 $ 13,486\n\nNet earnings to common **$ 13,525** $ 7,907 $ 10,764\n\nAverage common equity **$ 106,774** $ 105,804 $ 105,287\n\nReturn on average common equity **12\\.7%** 7\\.5% 10.2%\n\nNet revenues in our segments include allocations of interest income and expense based on the funding generated by, or the funding and liquidity requirements of, the respective segments. See Note 25 to the consolidated financial statements for further information about our business segments.\n\nThe allocation of common shareholders’ equity and preferred stock dividends to each segment is based on the estimated amount of equity required to support the activities of the segment under relevant regulatory capital requirements. Net earnings for each segment is calculated by applying the firmwide tax rate to each segment’s pre-tax earnings.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 71"],"full_content":"The Organisation for Economic Co-operation and\n\nDevelopment (OECD) Global Anti-Base Erosion Model Rules (Pillar II) aim to ensure that multinationals with revenues in excess of EUR 750 million pay a minimum effective corporate tax rate of 15% (minimum tax) in each jurisdiction in which they operate. The U.K. and other jurisdictions in which we operate have adopted certain portions of the OECD directive (Pillar II legislation) effective beginning in calendar year 2024. The Pillar II legislation did not have a material impact on our effective tax rate for 2024. We expect additional guidance or legislation to be issued by the OECD and various jurisdictions during 2025 which could impact any minimum tax we owe in future periods, possibly materially, and our effective tax rate could increase in 2025 and thereafter. This minimum tax, if any, will be recognized in the period in which it is incurred.\n\nOn August 26, 2024, the U.S. Tax Court issued a decision in Varian Medical Systems, Inc. v. Commissioner (Varian decision). The Varian decision reduced the U.S. tax on the deemed repatriation of unremitted foreign earnings of applicable non-U.S. subsidiaries in the transition year of the Tax Cuts and Jobs Act. We are monitoring the Varian decision and evaluating its impact, which could be a material income tax benefit, on the deemed repatriation tax we incurred for the 2018 tax year. No income tax benefit has been recognized in the provision for income taxes as a result of the Varian decision as of December 2024.\n\nWe expect our 2025 annual effective tax rate to be approximately 21%.\n\n**Segment Assets and Operating Results Segment Assets.** The table below presents assets by segment.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nGlobal Banking & Markets **$ 1,420,142** $ 1,381,247\n\nAsset & Wealth Management **193,328** 191,863\n\nPlatform Solutions **62,502** 68,484\n\n**Total $ 1,675,972** $ 1,641,594\n\nThe allocation process for segment assets is based on the activities of these segments. The allocation of assets includes allocation of GCLA (which consists of unencumbered, highly liquid securities and cash), which is included within cash and cash equivalents, collateralized agreements, trading assets and investments on our balance sheet. Due to the integrated nature of these segments, estimates and judgments are made in allocating these assets. See “Risk Management — Liquidity Risk Management” for further information about our GCLA.\n\n**Segment Operating Results.** The table below presents our segment operating results.\n\nYear Ended December\n\n_$ in millions_ **2024** 2023 2022\n\n**Global Banking & Markets** Net revenues **$ 34,943** $ 29,996 $ 32,487\n\nProvision for credit losses **40** 401 468\n\nCompensation and benefits expenses **9,426** 8,571 8,661\n\nOther operating expenses **10,554** 9,469 9,190\n\nTotal operating expenses **19,980** 18,040 17,851\n\nPre-tax earnings **$ 14,923** $ 11,555 $ 14,168\n\nNet earnings to common **$ 10,998** $ 8,703 $ 11,458\n\nAverage common equity **$ 75,796** $ 71,863 $ 69,951\n\nReturn on average common equity **14\\.5%** 12\\.1% 16.4%\n\n**Asset & Wealth Management** Net revenues **$ 16,142** $ 13,880 $ 13,376\n\nProvision for credit losses **(232)** (508) 519\n\nCompensation and benefits expenses **6,595** 6,144 5,927\n\nOther operating expenses **5,230** 6,885 5,623\n\nTotal operating expenses **11,825** 13,029 11,550\n\nPre-tax earnings **$ 4,549** $ 1,359 $ 1,307\n\nNet earnings to common **$ 3,386** $ 952 $ 979\n\nAverage common equity **$ 26,405** $ 30,078 $ 31,762\n\nReturn on average common equity **12\\.8%** 3\\.2% 3.1%\n\n**Platform Solutions** Net revenues **$ 2,427** $ 2,378 $ 1,502\n\nProvision for credit losses **1,540** 1,135 1,728\n\nCompensation and benefits expenses **685** 784 560\n\nOther operating expenses **1,277** 2,634 1,203\n\nTotal operating expenses **1,962** 3,418 1,763\n\nPre-tax earnings/(loss) **$ (1,075)** $ (2,175) $ (1,989)\n\nNet earnings/(loss) to common **$ (859)** $ (1,748) $ (1,673)\n\nAverage common equity **$ 4,573** $ 3,863 $ 3,574\n\nReturn on average common equity **(18.8) %** (45.2) % (46.8) %\n\n**Total** Net revenues **$ 53,512** $ 46,254 $ 47,365\n\nProvision for credit losses **1,348** 1,028 2,715\n\nCompensation and benefits expenses **16,706** 15,499 15,148\n\nOther operating expenses **17,061** 18,988 16,016\n\nTotal operating expenses **33,767** 34,487 31,164\n\nPre-tax earnings **$ 18,397** $ 10,739 $ 13,486\n\nNet earnings to common **$ 13,525** $ 7,907 $ 10,764\n\nAverage common equity **$ 106,774** $ 105,804 $ 105,287\n\nReturn on average common equity **12\\.7%** 7\\.5% 10.2%\n\nNet revenues in our segments include allocations of interest income and expense based on the funding generated by, or the funding and liquidity requirements of, the respective segments. See Note 25 to the consolidated financial statements for further information about our business segments.\n\nThe allocation of common shareholders’ equity and preferred stock dividends to each segment is based on the estimated amount of equity required to support the activities of the segment under relevant regulatory capital requirements. Net earnings for each segment is calculated by applying the firmwide tax rate to each segment’s pre-tax earnings.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 71","publish_date":null,"title":"Management’s Discussion and Analysis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page74.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page74.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page74","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page74.pdf"},"started_at":"2026-11-04T19:31:02.992533"} +{"completed_at":"2026-11-04T19:31:04.496337","latency_in_ms":1499,"output":{"example_id":"table/Goldman Sachs 10-k_page79","grounded_pages":[],"layout_pages":[],"markdown":"We invest alongside our clients that invest in investment funds that we raise or manage. We also have investments in alternative assets across a range of asset classes. Our investing activities, which are typically longer-term, include investments in corporate equity, credit, real estate and infrastructure assets.\n\nAsset & Wealth Management generates revenues from the following:\n\n**• Management and other fees.** We receive fees related to\n\nmanaging assets for institutional and individual clients, providing investing and wealth advisory solutions, providing financial planning and counseling services, and executing brokerage transactions for wealth management clients. The vast majority of revenues in management and other fees consists of asset-based fees on client assets that we manage. For further information about assets under supervision, see “Assets Under Supervision” below. The fees that we charge vary by asset class, client channel and the types of services provided, and are affected by investment performance, as well as asset inflows and redemptions.\n\n**• Incentive fees.** In certain circumstances, we also receive\n\nincentive fees based on a percentage of a fund’s or a separately managed account’s return, or when the return exceeds a specified benchmark or other performance targets. Such fees include overrides, which consist of the increased share of the income and gains derived primarily from our private equity and credit funds when the return on a fund’s investments over the life of the fund exceeds certain threshold returns.\n\n• **Private banking and lending.** Our private banking and\n\nlending activities include issuing loans to our wealth management clients. Such loans are generally secured by commercial and residential real estate, securities or other assets. We also raise deposits from wealth management clients, including through Marcus. Private banking and lending revenues include net interest income allocated to deposits and net interest income earned on loans to individual clients.\n\n**• Equity investments.** Includes investing activities related\n\nto our asset management activities primarily related to public and private equity investments in corporate, real estate and infrastructure assets. We also make investments through CIEs, substantially all of which are engaged in real estate investment activities. In addition, we make investments in connection with our activities to satisfy requirements under the Community Reinvestment Act, primarily through our Urban Investment Group.\n\n**• Debt investments.** Includes lending activities related to\n\nour asset management activities, including investing in corporate debt, lending to middle-market clients, and providing financing for real estate and other assets. These activities include investments in mezzanine debt, senior debt and distressed debt securities.\n\nThe table below presents our Asset & Wealth Management assets.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCash and cash equivalents **$ 36,364** $ 48,677\n\nCollateralized agreements **12,126** 14,020\n\nCustomer and other receivables **19,999** 14,859\n\nTrading assets **41,724** 27,324\n\nInvestments **23,130** 24,487\n\nLoans **46,694** 45,866\n\nOther assets **13,291** 16,630\n\n**Total $ 193,328** $ 191,863\n\nThe table below presents details about our Asset & Wealth Management loans.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCorporate **$ 7,377** $ 11,715\n\nReal estate **18,053** 16,603\n\nSecurities-based **12,198** 10,863\n\nOther collateralized **8,027** 6,698\n\nOther **1,951** 1,121\n\nLoans, gross **47,606** 47,000\n\nAllowance for loan losses **(912)** (1,134)\n\n**Total loans $ 46,694** $ 45,866\n\nIn the table above, gross loans included $38 billion of loans as of December 2024 and $33 billion of loans as of December 2023 that were related to Private banking and lending.\n\nThe average Asset & Wealth Management gross loans were $45.84 billion for 2024 and $51.98 billion for 2023.\n\nThe table below presents our Asset & Wealth Management operating results.\n\nYear Ended December\n\n_$ in millions_ **2024** 2023 2022\n\nManagement and other fees **$ 10,425** $ 9,486 $ 8,781\n\nIncentive fees **393** 161 359\n\nPrivate banking and lending **2,881** 2,576 2,458\n\nEquity investments **1,359** 342 610\n\nDebt investments **1,084** 1,315 1,168\n\nTotal net revenues **16,142** 13,880 13,376\n\nProvision for credit losses **(232)** (508) 519\n\nCompensation and benefits expenses **6,595** 6,144 5,927\n\nOther operating expenses **5,230** 6,885 5,623\n\nTotal operating expenses **11,825** 13,029 11,550\n\nPre-tax earnings **4,549** 1,359 1,307\n\nProvision for taxes **1,019** 281 215\n\nNet earnings **3,530** 1,078 1,092\n\nPreferred stock dividends **144** 126 113\n\n**Net earnings to common $ 3,386** $ 952 $ 979\n\n**Average common equity $ 26,405** $ 30,078 $ 31,762\n\n**Return on average common equity 12.8%** 3\\.2% 3.1%\n\nIn the table above, Management and other fees included fees from alternatives of $2.18 billion for 2024, $2.13 billion for 2023 and $1.85 billion for 2022. In 2024, we surpassed our target to achieve annual firmwide management and other fees of more than $10 billion, including more than $2 billion from alternatives.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n76 Goldman Sachs 2024 Form 10-K","pages":[{"line_numbers":[],"markdown":"We invest alongside our clients that invest in investment funds that we raise or manage. We also have investments in alternative assets across a range of asset classes. Our investing activities, which are typically longer-term, include investments in corporate equity, credit, real estate and infrastructure assets.\n\nAsset & Wealth Management generates revenues from the following:\n\n**• Management and other fees.** We receive fees related to\n\nmanaging assets for institutional and individual clients, providing investing and wealth advisory solutions, providing financial planning and counseling services, and executing brokerage transactions for wealth management clients. The vast majority of revenues in management and other fees consists of asset-based fees on client assets that we manage. For further information about assets under supervision, see “Assets Under Supervision” below. The fees that we charge vary by asset class, client channel and the types of services provided, and are affected by investment performance, as well as asset inflows and redemptions.\n\n**• Incentive fees.** In certain circumstances, we also receive\n\nincentive fees based on a percentage of a fund’s or a separately managed account’s return, or when the return exceeds a specified benchmark or other performance targets. Such fees include overrides, which consist of the increased share of the income and gains derived primarily from our private equity and credit funds when the return on a fund’s investments over the life of the fund exceeds certain threshold returns.\n\n• **Private banking and lending.** Our private banking and\n\nlending activities include issuing loans to our wealth management clients. Such loans are generally secured by commercial and residential real estate, securities or other assets. We also raise deposits from wealth management clients, including through Marcus. Private banking and lending revenues include net interest income allocated to deposits and net interest income earned on loans to individual clients.\n\n**• Equity investments.** Includes investing activities related\n\nto our asset management activities primarily related to public and private equity investments in corporate, real estate and infrastructure assets. We also make investments through CIEs, substantially all of which are engaged in real estate investment activities. In addition, we make investments in connection with our activities to satisfy requirements under the Community Reinvestment Act, primarily through our Urban Investment Group.\n\n**• Debt investments.** Includes lending activities related to\n\nour asset management activities, including investing in corporate debt, lending to middle-market clients, and providing financing for real estate and other assets. These activities include investments in mezzanine debt, senior debt and distressed debt securities.\n\nThe table below presents our Asset & Wealth Management assets.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCash and cash equivalents **$ 36,364** $ 48,677\n\nCollateralized agreements **12,126** 14,020\n\nCustomer and other receivables **19,999** 14,859\n\nTrading assets **41,724** 27,324\n\nInvestments **23,130** 24,487\n\nLoans **46,694** 45,866\n\nOther assets **13,291** 16,630\n\n**Total $ 193,328** $ 191,863\n\nThe table below presents details about our Asset & Wealth Management loans.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCorporate **$ 7,377** $ 11,715\n\nReal estate **18,053** 16,603\n\nSecurities-based **12,198** 10,863\n\nOther collateralized **8,027** 6,698\n\nOther **1,951** 1,121\n\nLoans, gross **47,606** 47,000\n\nAllowance for loan losses **(912)** (1,134)\n\n**Total loans $ 46,694** $ 45,866\n\nIn the table above, gross loans included $38 billion of loans as of December 2024 and $33 billion of loans as of December 2023 that were related to Private banking and lending.\n\nThe average Asset & Wealth Management gross loans were $45.84 billion for 2024 and $51.98 billion for 2023.\n\nThe table below presents our Asset & Wealth Management operating results.\n\nYear Ended December\n\n_$ in millions_ **2024** 2023 2022\n\nManagement and other fees **$ 10,425** $ 9,486 $ 8,781\n\nIncentive fees **393** 161 359\n\nPrivate banking and lending **2,881** 2,576 2,458\n\nEquity investments **1,359** 342 610\n\nDebt investments **1,084** 1,315 1,168\n\nTotal net revenues **16,142** 13,880 13,376\n\nProvision for credit losses **(232)** (508) 519\n\nCompensation and benefits expenses **6,595** 6,144 5,927\n\nOther operating expenses **5,230** 6,885 5,623\n\nTotal operating expenses **11,825** 13,029 11,550\n\nPre-tax earnings **4,549** 1,359 1,307\n\nProvision for taxes **1,019** 281 215\n\nNet earnings **3,530** 1,078 1,092\n\nPreferred stock dividends **144** 126 113\n\n**Net earnings to common $ 3,386** $ 952 $ 979\n\n**Average common equity $ 26,405** $ 30,078 $ 31,762\n\n**Return on average common equity 12.8%** 3\\.2% 3.1%\n\nIn the table above, Management and other fees included fees from alternatives of $2.18 billion for 2024, $2.13 billion for 2023 and $1.85 billion for 2022. In 2024, we surpassed our target to achieve annual firmwide management and other fees of more than $10 billion, including more than $2 billion from alternatives.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n76 Goldman Sachs 2024 Form 10-K","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"We invest alongside our clients that invest in investment funds that we raise or manage. We also have investments in alternative assets across a range of asset classes. Our investing activities, which are typically longer-term, include investments in corporate equity, credit, real estate and infrastructure assets.\n\nAsset & Wealth Management generates revenues from the following:\n\n**• Management and other fees.** We receive fees related to\n\nmanaging assets for institutional and individual clients, providing investing and wealth advisory solutions, providing financial planning and counseling services, and executing brokerage transactions for wealth management clients. The vast majority of revenues in management and other fees consists of asset-based fees on client assets that we manage. For further information about assets under supervision, see “Assets Under Supervision” below. The fees that we charge vary by asset class, client channel and the types of services provided, and are affected by investment performance, as well as asset inflows and redemptions.\n\n**• Incentive fees.** In certain circumstances, we also receive\n\nincentive fees based on a percentage of a fund’s or a separately managed account’s return, or when the return exceeds a specified benchmark or other performance targets. Such fees include overrides, which consist of the increased share of the income and gains derived primarily from our private equity and credit funds when the return on a fund’s investments over the life of the fund exceeds certain threshold returns.\n\n• **Private banking and lending.** Our private banking and\n\nlending activities include issuing loans to our wealth management clients. Such loans are generally secured by commercial and residential real estate, securities or other assets. We also raise deposits from wealth management clients, including through Marcus. Private banking and lending revenues include net interest income allocated to deposits and net interest income earned on loans to individual clients.\n\n**• Equity investments.** Includes investing activities related\n\nto our asset management activities primarily related to public and private equity investments in corporate, real estate and infrastructure assets. We also make investments through CIEs, substantially all of which are engaged in real estate investment activities. In addition, we make investments in connection with our activities to satisfy requirements under the Community Reinvestment Act, primarily through our Urban Investment Group.\n\n**• Debt investments.** Includes lending activities related to\n\nour asset management activities, including investing in corporate debt, lending to middle-market clients, and providing financing for real estate and other assets. These activities include investments in mezzanine debt, senior debt and distressed debt securities.\n\nThe table below presents our Asset & Wealth Management assets.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCash and cash equivalents **$ 36,364** $ 48,677\n\nCollateralized agreements **12,126** 14,020\n\nCustomer and other receivables **19,999** 14,859\n\nTrading assets **41,724** 27,324\n\nInvestments **23,130** 24,487\n\nLoans **46,694** 45,866\n\nOther assets **13,291** 16,630\n\n**Total $ 193,328** $ 191,863\n\nThe table below presents details about our Asset & Wealth Management loans.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCorporate **$ 7,377** $ 11,715\n\nReal estate **18,053** 16,603\n\nSecurities-based **12,198** 10,863\n\nOther collateralized **8,027** 6,698\n\nOther **1,951** 1,121\n\nLoans, gross **47,606** 47,000\n\nAllowance for loan losses **(912)** (1,134)\n\n**Total loans $ 46,694** $ 45,866\n\nIn the table above, gross loans included $38 billion of loans as of December 2024 and $33 billion of loans as of December 2023 that were related to Private banking and lending.\n\nThe average Asset & Wealth Management gross loans were $45.84 billion for 2024 and $51.98 billion for 2023.\n\nThe table below presents our Asset & Wealth Management operating results.\n\nYear Ended December\n\n_$ in millions_ **2024** 2023 2022\n\nManagement and other fees **$ 10,425** $ 9,486 $ 8,781\n\nIncentive fees **393** 161 359\n\nPrivate banking and lending **2,881** 2,576 2,458\n\nEquity investments **1,359** 342 610\n\nDebt investments **1,084** 1,315 1,168\n\nTotal net revenues **16,142** 13,880 13,376\n\nProvision for credit losses **(232)** (508) 519\n\nCompensation and benefits expenses **6,595** 6,144 5,927\n\nOther operating expenses **5,230** 6,885 5,623\n\nTotal operating expenses **11,825** 13,029 11,550\n\nPre-tax earnings **4,549** 1,359 1,307\n\nProvision for taxes **1,019** 281 215\n\nNet earnings **3,530** 1,078 1,092\n\nPreferred stock dividends **144** 126 113\n\n**Net earnings to common $ 3,386** $ 952 $ 979\n\n**Average common equity $ 26,405** $ 30,078 $ 31,762\n\n**Return on average common equity 12.8%** 3\\.2% 3.1%\n\nIn the table above, Management and other fees included fees from alternatives of $2.18 billion for 2024, $2.13 billion for 2023 and $1.85 billion for 2022. In 2024, we surpassed our target to achieve annual firmwide management and other fees of more than $10 billion, including more than $2 billion from alternatives.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n76 Goldman Sachs 2024 Form 10-K","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page79.pdf"]},"response":{"errors":[],"extract_id":"extract_16254397aef33fa8b702a81157726b50","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["We invest alongside our clients that invest in investment funds that we raise or manage. We also have investments in alternative assets across a range of asset classes. Our investing activities, which are typically longer-term, include investments in corporate equity, credit, real estate and infrastructure assets.\n\nAsset & Wealth Management generates revenues from the following:\n\n**• Management and other fees.** We receive fees related to\n\nmanaging assets for institutional and individual clients, providing investing and wealth advisory solutions, providing financial planning and counseling services, and executing brokerage transactions for wealth management clients. The vast majority of revenues in management and other fees consists of asset-based fees on client assets that we manage. For further information about assets under supervision, see “Assets Under Supervision” below. The fees that we charge vary by asset class, client channel and the types of services provided, and are affected by investment performance, as well as asset inflows and redemptions.\n\n**• Incentive fees.** In certain circumstances, we also receive\n\nincentive fees based on a percentage of a fund’s or a separately managed account’s return, or when the return exceeds a specified benchmark or other performance targets. Such fees include overrides, which consist of the increased share of the income and gains derived primarily from our private equity and credit funds when the return on a fund’s investments over the life of the fund exceeds certain threshold returns.\n\n• **Private banking and lending.** Our private banking and\n\nlending activities include issuing loans to our wealth management clients. Such loans are generally secured by commercial and residential real estate, securities or other assets. We also raise deposits from wealth management clients, including through Marcus. Private banking and lending revenues include net interest income allocated to deposits and net interest income earned on loans to individual clients.\n\n**• Equity investments.** Includes investing activities related\n\nto our asset management activities primarily related to public and private equity investments in corporate, real estate and infrastructure assets. We also make investments through CIEs, substantially all of which are engaged in real estate investment activities. In addition, we make investments in connection with our activities to satisfy requirements under the Community Reinvestment Act, primarily through our Urban Investment Group.\n\n**• Debt investments.** Includes lending activities related to\n\nour asset management activities, including investing in corporate debt, lending to middle-market clients, and providing financing for real estate and other assets. These activities include investments in mezzanine debt, senior debt and distressed debt securities.\n\nThe table below presents our Asset & Wealth Management assets.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCash and cash equivalents **$ 36,364** $ 48,677\n\nCollateralized agreements **12,126** 14,020\n\nCustomer and other receivables **19,999** 14,859\n\nTrading assets **41,724** 27,324\n\nInvestments **23,130** 24,487\n\nLoans **46,694** 45,866\n\nOther assets **13,291** 16,630\n\n**Total $ 193,328** $ 191,863\n\nThe table below presents details about our Asset & Wealth Management loans.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCorporate **$ 7,377** $ 11,715\n\nReal estate **18,053** 16,603\n\nSecurities-based **12,198** 10,863\n\nOther collateralized **8,027** 6,698\n\nOther **1,951** 1,121\n\nLoans, gross **47,606** 47,000\n\nAllowance for loan losses **(912)** (1,134)\n\n**Total loans $ 46,694** $ 45,866\n\nIn the table above, gross loans included $38 billion of loans as of December 2024 and $33 billion of loans as of December 2023 that were related to Private banking and lending.\n\nThe average Asset & Wealth Management gross loans were $45.84 billion for 2024 and $51.98 billion for 2023.\n\nThe table below presents our Asset & Wealth Management operating results.\n\nYear Ended December\n\n_$ in millions_ **2024** 2023 2022\n\nManagement and other fees **$ 10,425** $ 9,486 $ 8,781\n\nIncentive fees **393** 161 359\n\nPrivate banking and lending **2,881** 2,576 2,458\n\nEquity investments **1,359** 342 610\n\nDebt investments **1,084** 1,315 1,168\n\nTotal net revenues **16,142** 13,880 13,376\n\nProvision for credit losses **(232)** (508) 519\n\nCompensation and benefits expenses **6,595** 6,144 5,927\n\nOther operating expenses **5,230** 6,885 5,623\n\nTotal operating expenses **11,825** 13,029 11,550\n\nPre-tax earnings **4,549** 1,359 1,307\n\nProvision for taxes **1,019** 281 215\n\nNet earnings **3,530** 1,078 1,092\n\nPreferred stock dividends **144** 126 113\n\n**Net earnings to common $ 3,386** $ 952 $ 979\n\n**Average common equity $ 26,405** $ 30,078 $ 31,762\n\n**Return on average common equity 12.8%** 3\\.2% 3.1%\n\nIn the table above, Management and other fees included fees from alternatives of $2.18 billion for 2024, $2.13 billion for 2023 and $1.85 billion for 2022. In 2024, we surpassed our target to achieve annual firmwide management and other fees of more than $10 billion, including more than $2 billion from alternatives.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n76 Goldman Sachs 2024 Form 10-K"],"full_content":"We invest alongside our clients that invest in investment funds that we raise or manage. We also have investments in alternative assets across a range of asset classes. Our investing activities, which are typically longer-term, include investments in corporate equity, credit, real estate and infrastructure assets.\n\nAsset & Wealth Management generates revenues from the following:\n\n**• Management and other fees.** We receive fees related to\n\nmanaging assets for institutional and individual clients, providing investing and wealth advisory solutions, providing financial planning and counseling services, and executing brokerage transactions for wealth management clients. The vast majority of revenues in management and other fees consists of asset-based fees on client assets that we manage. For further information about assets under supervision, see “Assets Under Supervision” below. The fees that we charge vary by asset class, client channel and the types of services provided, and are affected by investment performance, as well as asset inflows and redemptions.\n\n**• Incentive fees.** In certain circumstances, we also receive\n\nincentive fees based on a percentage of a fund’s or a separately managed account’s return, or when the return exceeds a specified benchmark or other performance targets. Such fees include overrides, which consist of the increased share of the income and gains derived primarily from our private equity and credit funds when the return on a fund’s investments over the life of the fund exceeds certain threshold returns.\n\n• **Private banking and lending.** Our private banking and\n\nlending activities include issuing loans to our wealth management clients. Such loans are generally secured by commercial and residential real estate, securities or other assets. We also raise deposits from wealth management clients, including through Marcus. Private banking and lending revenues include net interest income allocated to deposits and net interest income earned on loans to individual clients.\n\n**• Equity investments.** Includes investing activities related\n\nto our asset management activities primarily related to public and private equity investments in corporate, real estate and infrastructure assets. We also make investments through CIEs, substantially all of which are engaged in real estate investment activities. In addition, we make investments in connection with our activities to satisfy requirements under the Community Reinvestment Act, primarily through our Urban Investment Group.\n\n**• Debt investments.** Includes lending activities related to\n\nour asset management activities, including investing in corporate debt, lending to middle-market clients, and providing financing for real estate and other assets. These activities include investments in mezzanine debt, senior debt and distressed debt securities.\n\nThe table below presents our Asset & Wealth Management assets.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCash and cash equivalents **$ 36,364** $ 48,677\n\nCollateralized agreements **12,126** 14,020\n\nCustomer and other receivables **19,999** 14,859\n\nTrading assets **41,724** 27,324\n\nInvestments **23,130** 24,487\n\nLoans **46,694** 45,866\n\nOther assets **13,291** 16,630\n\n**Total $ 193,328** $ 191,863\n\nThe table below presents details about our Asset & Wealth Management loans.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCorporate **$ 7,377** $ 11,715\n\nReal estate **18,053** 16,603\n\nSecurities-based **12,198** 10,863\n\nOther collateralized **8,027** 6,698\n\nOther **1,951** 1,121\n\nLoans, gross **47,606** 47,000\n\nAllowance for loan losses **(912)** (1,134)\n\n**Total loans $ 46,694** $ 45,866\n\nIn the table above, gross loans included $38 billion of loans as of December 2024 and $33 billion of loans as of December 2023 that were related to Private banking and lending.\n\nThe average Asset & Wealth Management gross loans were $45.84 billion for 2024 and $51.98 billion for 2023.\n\nThe table below presents our Asset & Wealth Management operating results.\n\nYear Ended December\n\n_$ in millions_ **2024** 2023 2022\n\nManagement and other fees **$ 10,425** $ 9,486 $ 8,781\n\nIncentive fees **393** 161 359\n\nPrivate banking and lending **2,881** 2,576 2,458\n\nEquity investments **1,359** 342 610\n\nDebt investments **1,084** 1,315 1,168\n\nTotal net revenues **16,142** 13,880 13,376\n\nProvision for credit losses **(232)** (508) 519\n\nCompensation and benefits expenses **6,595** 6,144 5,927\n\nOther operating expenses **5,230** 6,885 5,623\n\nTotal operating expenses **11,825** 13,029 11,550\n\nPre-tax earnings **4,549** 1,359 1,307\n\nProvision for taxes **1,019** 281 215\n\nNet earnings **3,530** 1,078 1,092\n\nPreferred stock dividends **144** 126 113\n\n**Net earnings to common $ 3,386** $ 952 $ 979\n\n**Average common equity $ 26,405** $ 30,078 $ 31,762\n\n**Return on average common equity 12.8%** 3\\.2% 3.1%\n\nIn the table above, Management and other fees included fees from alternatives of $2.18 billion for 2024, $2.13 billion for 2023 and $1.85 billion for 2022. In 2024, we surpassed our target to achieve annual firmwide management and other fees of more than $10 billion, including more than $2 billion from alternatives.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n76 Goldman Sachs 2024 Form 10-K","publish_date":null,"title":"Management’s Discussion and Analysis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page79.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page79.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page79","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page79.pdf"},"started_at":"2026-11-04T19:31:02.997010"} +{"completed_at":"2026-11-04T19:47:30.597536","latency_in_ms":2118,"output":{"example_id":"table/Goldman Sachs 10-k_page84","grounded_pages":[],"layout_pages":[],"markdown":"The table below presents the rollforward of our alternative investments categorized as historical principal investments for 2024.\n\n**Historical principal**\n\n_$ in billions_ **investments**\n\nBeginning balance **$ 16.3**\n\nAdditions **0\\.7**\n\nDispositions **(7.9)**\n\nNet markups/(markdowns) **0\\.3**\n\n**Ending balance $ 9.4**\n\nIn the table above, dispositions included approximately $400 million of investments that were transferred out of historical principal investments into client co-invest.\n\n**Loans and Debt Securities.** The table below presents the concentration of loans and debt securities within our alternative investments by accounting classification, region and industry.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\nLoans **$ 8.5** $ 12.9\n\nDebt securities **9\\.0** 10\\.8\n\n**Total $ 17.5** $ 23.7\n\n**Accounting Classification** Debt securities at fair value **51%** 45%\n\nLoans at amortized cost **45%** 49%\n\nLoans at fair value **3%** 3%\n\nLoans held for sale **1%** 3%\n\n**Total 100%** 100%\n\n**Region** Americas **54%** 52%\n\nEMEA **35%** 37%\n\nAsia **11%** 11%\n\n**Total 100%** 100%\n\n**Industry** Consumer & Retail **11%** 11%\n\nFinancial Institutions **9%** 6%\n\nHealthcare **12%** 15%\n\nIndustrials **14%** 18%\n\nNatural Resources & Utilities **2%** 2%\n\nReal Estate **13%** 11%\n\nTechnology, Media & Telecommunications **29%** 28%\n\nOther **10%** 9%\n\n**Total 100%** 100%\n\n**Equity Securities.** The table below presents the\n\nconcentration of equity securities within our alternative investments by region and industry.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\n**Equity securities $ 13.4** $ 13.2\n\n**Region** Americas **68%** 70%\n\nEMEA **17%** 15%\n\nAsia **15%** 15%\n\n**Total 100%** 100%\n\n**Industry** Consumer & Retail **5%** 6%\n\nFinancial Institutions **15%** 11%\n\nHealthcare **6%** 6%\n\nIndustrials **7%** 10%\n\nNatural Resources & Utilities **14%** 13%\n\nReal Estate **27%** 30%\n\nTechnology, Media & Telecommunications **24%** 22%\n\nOther **2%** 2%\n\n**Total 100%** 100%\n\nIn the table above:\n\n• Equity securities included $12.6 billion as of December\n\n2024 and $12.1 billion as of December 2023 of private equity positions, and $0.8 billion as of December 2024 and $1.1 billion as of December 2023 of public equity positions that converted from private equity upon the initial public offerings of the underlying companies.\n\n• The concentrations for real estate equity securities as of\n\nDecember 2024 were 14% for multifamily (13% as of December 2023), 5% for mixed use (8% as of December 2023), 3% for industrials (3% as of December 2023), 2% for office (2% as of December 2023) and 3% for other real estate equity securities (4% as of December 2023).\n\nThe table below presents the concentration of equity securities within our alternative investments by vintage.\n\nVintage\n\n**As of December 2024** 2017 or earlier **22%**\n\n2018 - 2020 **28%**\n\n2021 - thereafter **50%**\n\n**Total 100%**\n\nAs of December 2023 2016 or earlier 25%\n\n2017 - 2019 26%\n\n2020 - thereafter 49%\n\nTotal 100%\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 81","pages":[{"line_numbers":[],"markdown":"The table below presents the rollforward of our alternative investments categorized as historical principal investments for 2024.\n\n**Historical principal**\n\n_$ in billions_ **investments**\n\nBeginning balance **$ 16.3**\n\nAdditions **0\\.7**\n\nDispositions **(7.9)**\n\nNet markups/(markdowns) **0\\.3**\n\n**Ending balance $ 9.4**\n\nIn the table above, dispositions included approximately $400 million of investments that were transferred out of historical principal investments into client co-invest.\n\n**Loans and Debt Securities.** The table below presents the concentration of loans and debt securities within our alternative investments by accounting classification, region and industry.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\nLoans **$ 8.5** $ 12.9\n\nDebt securities **9\\.0** 10\\.8\n\n**Total $ 17.5** $ 23.7\n\n**Accounting Classification** Debt securities at fair value **51%** 45%\n\nLoans at amortized cost **45%** 49%\n\nLoans at fair value **3%** 3%\n\nLoans held for sale **1%** 3%\n\n**Total 100%** 100%\n\n**Region** Americas **54%** 52%\n\nEMEA **35%** 37%\n\nAsia **11%** 11%\n\n**Total 100%** 100%\n\n**Industry** Consumer & Retail **11%** 11%\n\nFinancial Institutions **9%** 6%\n\nHealthcare **12%** 15%\n\nIndustrials **14%** 18%\n\nNatural Resources & Utilities **2%** 2%\n\nReal Estate **13%** 11%\n\nTechnology, Media & Telecommunications **29%** 28%\n\nOther **10%** 9%\n\n**Total 100%** 100%\n\n**Equity Securities.** The table below presents the\n\nconcentration of equity securities within our alternative investments by region and industry.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\n**Equity securities $ 13.4** $ 13.2\n\n**Region** Americas **68%** 70%\n\nEMEA **17%** 15%\n\nAsia **15%** 15%\n\n**Total 100%** 100%\n\n**Industry** Consumer & Retail **5%** 6%\n\nFinancial Institutions **15%** 11%\n\nHealthcare **6%** 6%\n\nIndustrials **7%** 10%\n\nNatural Resources & Utilities **14%** 13%\n\nReal Estate **27%** 30%\n\nTechnology, Media & Telecommunications **24%** 22%\n\nOther **2%** 2%\n\n**Total 100%** 100%\n\nIn the table above:\n\n• Equity securities included $12.6 billion as of December\n\n2024 and $12.1 billion as of December 2023 of private equity positions, and $0.8 billion as of December 2024 and $1.1 billion as of December 2023 of public equity positions that converted from private equity upon the initial public offerings of the underlying companies.\n\n• The concentrations for real estate equity securities as of\n\nDecember 2024 were 14% for multifamily (13% as of December 2023), 5% for mixed use (8% as of December 2023), 3% for industrials (3% as of December 2023), 2% for office (2% as of December 2023) and 3% for other real estate equity securities (4% as of December 2023).\n\nThe table below presents the concentration of equity securities within our alternative investments by vintage.\n\nVintage\n\n**As of December 2024** 2017 or earlier **22%**\n\n2018 - 2020 **28%**\n\n2021 - thereafter **50%**\n\n**Total 100%**\n\nAs of December 2023 2016 or earlier 25%\n\n2017 - 2019 26%\n\n2020 - thereafter 49%\n\nTotal 100%\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 81","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"The table below presents the rollforward of our alternative investments categorized as historical principal investments for 2024.\n\n**Historical principal**\n\n_$ in billions_ **investments**\n\nBeginning balance **$ 16.3**\n\nAdditions **0\\.7**\n\nDispositions **(7.9)**\n\nNet markups/(markdowns) **0\\.3**\n\n**Ending balance $ 9.4**\n\nIn the table above, dispositions included approximately $400 million of investments that were transferred out of historical principal investments into client co-invest.\n\n**Loans and Debt Securities.** The table below presents the concentration of loans and debt securities within our alternative investments by accounting classification, region and industry.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\nLoans **$ 8.5** $ 12.9\n\nDebt securities **9\\.0** 10\\.8\n\n**Total $ 17.5** $ 23.7\n\n**Accounting Classification** Debt securities at fair value **51%** 45%\n\nLoans at amortized cost **45%** 49%\n\nLoans at fair value **3%** 3%\n\nLoans held for sale **1%** 3%\n\n**Total 100%** 100%\n\n**Region** Americas **54%** 52%\n\nEMEA **35%** 37%\n\nAsia **11%** 11%\n\n**Total 100%** 100%\n\n**Industry** Consumer & Retail **11%** 11%\n\nFinancial Institutions **9%** 6%\n\nHealthcare **12%** 15%\n\nIndustrials **14%** 18%\n\nNatural Resources & Utilities **2%** 2%\n\nReal Estate **13%** 11%\n\nTechnology, Media & Telecommunications **29%** 28%\n\nOther **10%** 9%\n\n**Total 100%** 100%\n\n**Equity Securities.** The table below presents the\n\nconcentration of equity securities within our alternative investments by region and industry.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\n**Equity securities $ 13.4** $ 13.2\n\n**Region** Americas **68%** 70%\n\nEMEA **17%** 15%\n\nAsia **15%** 15%\n\n**Total 100%** 100%\n\n**Industry** Consumer & Retail **5%** 6%\n\nFinancial Institutions **15%** 11%\n\nHealthcare **6%** 6%\n\nIndustrials **7%** 10%\n\nNatural Resources & Utilities **14%** 13%\n\nReal Estate **27%** 30%\n\nTechnology, Media & Telecommunications **24%** 22%\n\nOther **2%** 2%\n\n**Total 100%** 100%\n\nIn the table above:\n\n• Equity securities included $12.6 billion as of December\n\n2024 and $12.1 billion as of December 2023 of private equity positions, and $0.8 billion as of December 2024 and $1.1 billion as of December 2023 of public equity positions that converted from private equity upon the initial public offerings of the underlying companies.\n\n• The concentrations for real estate equity securities as of\n\nDecember 2024 were 14% for multifamily (13% as of December 2023), 5% for mixed use (8% as of December 2023), 3% for industrials (3% as of December 2023), 2% for office (2% as of December 2023) and 3% for other real estate equity securities (4% as of December 2023).\n\nThe table below presents the concentration of equity securities within our alternative investments by vintage.\n\nVintage\n\n**As of December 2024** 2017 or earlier **22%**\n\n2018 - 2020 **28%**\n\n2021 - thereafter **50%**\n\n**Total 100%**\n\nAs of December 2023 2016 or earlier 25%\n\n2017 - 2019 26%\n\n2020 - thereafter 49%\n\nTotal 100%\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 81","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page84.pdf"]},"response":{"errors":[],"extract_id":"extract_51c53abefed0dc49af578724326ce70b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["The table below presents the rollforward of our alternative investments categorized as historical principal investments for 2024.\n\n**Historical principal**\n\n_$ in billions_ **investments**\n\nBeginning balance **$ 16.3**\n\nAdditions **0\\.7**\n\nDispositions **(7.9)**\n\nNet markups/(markdowns) **0\\.3**\n\n**Ending balance $ 9.4**\n\nIn the table above, dispositions included approximately $400 million of investments that were transferred out of historical principal investments into client co-invest.\n\n**Loans and Debt Securities.** The table below presents the concentration of loans and debt securities within our alternative investments by accounting classification, region and industry.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\nLoans **$ 8.5** $ 12.9\n\nDebt securities **9\\.0** 10\\.8\n\n**Total $ 17.5** $ 23.7\n\n**Accounting Classification** Debt securities at fair value **51%** 45%\n\nLoans at amortized cost **45%** 49%\n\nLoans at fair value **3%** 3%\n\nLoans held for sale **1%** 3%\n\n**Total 100%** 100%\n\n**Region** Americas **54%** 52%\n\nEMEA **35%** 37%\n\nAsia **11%** 11%\n\n**Total 100%** 100%\n\n**Industry** Consumer & Retail **11%** 11%\n\nFinancial Institutions **9%** 6%\n\nHealthcare **12%** 15%\n\nIndustrials **14%** 18%\n\nNatural Resources & Utilities **2%** 2%\n\nReal Estate **13%** 11%\n\nTechnology, Media & Telecommunications **29%** 28%\n\nOther **10%** 9%\n\n**Total 100%** 100%\n\n**Equity Securities.** The table below presents the\n\nconcentration of equity securities within our alternative investments by region and industry.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\n**Equity securities $ 13.4** $ 13.2\n\n**Region** Americas **68%** 70%\n\nEMEA **17%** 15%\n\nAsia **15%** 15%\n\n**Total 100%** 100%\n\n**Industry** Consumer & Retail **5%** 6%\n\nFinancial Institutions **15%** 11%\n\nHealthcare **6%** 6%\n\nIndustrials **7%** 10%\n\nNatural Resources & Utilities **14%** 13%\n\nReal Estate **27%** 30%\n\nTechnology, Media & Telecommunications **24%** 22%\n\nOther **2%** 2%\n\n**Total 100%** 100%\n\nIn the table above:\n\n• Equity securities included $12.6 billion as of December\n\n2024 and $12.1 billion as of December 2023 of private equity positions, and $0.8 billion as of December 2024 and $1.1 billion as of December 2023 of public equity positions that converted from private equity upon the initial public offerings of the underlying companies.\n\n• The concentrations for real estate equity securities as of\n\nDecember 2024 were 14% for multifamily (13% as of December 2023), 5% for mixed use (8% as of December 2023), 3% for industrials (3% as of December 2023), 2% for office (2% as of December 2023) and 3% for other real estate equity securities (4% as of December 2023).\n\nThe table below presents the concentration of equity securities within our alternative investments by vintage.\n\nVintage\n\n**As of December 2024** 2017 or earlier **22%**\n\n2018 - 2020 **28%**\n\n2021 - thereafter **50%**\n\n**Total 100%**\n\nAs of December 2023 2016 or earlier 25%\n\n2017 - 2019 26%\n\n2020 - thereafter 49%\n\nTotal 100%\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 81"],"full_content":"The table below presents the rollforward of our alternative investments categorized as historical principal investments for 2024.\n\n**Historical principal**\n\n_$ in billions_ **investments**\n\nBeginning balance **$ 16.3**\n\nAdditions **0\\.7**\n\nDispositions **(7.9)**\n\nNet markups/(markdowns) **0\\.3**\n\n**Ending balance $ 9.4**\n\nIn the table above, dispositions included approximately $400 million of investments that were transferred out of historical principal investments into client co-invest.\n\n**Loans and Debt Securities.** The table below presents the concentration of loans and debt securities within our alternative investments by accounting classification, region and industry.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\nLoans **$ 8.5** $ 12.9\n\nDebt securities **9\\.0** 10\\.8\n\n**Total $ 17.5** $ 23.7\n\n**Accounting Classification** Debt securities at fair value **51%** 45%\n\nLoans at amortized cost **45%** 49%\n\nLoans at fair value **3%** 3%\n\nLoans held for sale **1%** 3%\n\n**Total 100%** 100%\n\n**Region** Americas **54%** 52%\n\nEMEA **35%** 37%\n\nAsia **11%** 11%\n\n**Total 100%** 100%\n\n**Industry** Consumer & Retail **11%** 11%\n\nFinancial Institutions **9%** 6%\n\nHealthcare **12%** 15%\n\nIndustrials **14%** 18%\n\nNatural Resources & Utilities **2%** 2%\n\nReal Estate **13%** 11%\n\nTechnology, Media & Telecommunications **29%** 28%\n\nOther **10%** 9%\n\n**Total 100%** 100%\n\n**Equity Securities.** The table below presents the\n\nconcentration of equity securities within our alternative investments by region and industry.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\n**Equity securities $ 13.4** $ 13.2\n\n**Region** Americas **68%** 70%\n\nEMEA **17%** 15%\n\nAsia **15%** 15%\n\n**Total 100%** 100%\n\n**Industry** Consumer & Retail **5%** 6%\n\nFinancial Institutions **15%** 11%\n\nHealthcare **6%** 6%\n\nIndustrials **7%** 10%\n\nNatural Resources & Utilities **14%** 13%\n\nReal Estate **27%** 30%\n\nTechnology, Media & Telecommunications **24%** 22%\n\nOther **2%** 2%\n\n**Total 100%** 100%\n\nIn the table above:\n\n• Equity securities included $12.6 billion as of December\n\n2024 and $12.1 billion as of December 2023 of private equity positions, and $0.8 billion as of December 2024 and $1.1 billion as of December 2023 of public equity positions that converted from private equity upon the initial public offerings of the underlying companies.\n\n• The concentrations for real estate equity securities as of\n\nDecember 2024 were 14% for multifamily (13% as of December 2023), 5% for mixed use (8% as of December 2023), 3% for industrials (3% as of December 2023), 2% for office (2% as of December 2023) and 3% for other real estate equity securities (4% as of December 2023).\n\nThe table below presents the concentration of equity securities within our alternative investments by vintage.\n\nVintage\n\n**As of December 2024** 2017 or earlier **22%**\n\n2018 - 2020 **28%**\n\n2021 - thereafter **50%**\n\n**Total 100%**\n\nAs of December 2023 2016 or earlier 25%\n\n2017 - 2019 26%\n\n2020 - thereafter 49%\n\nTotal 100%\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 81","publish_date":null,"title":"Management’s Discussion and Analysis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page84.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page84.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page84","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page84.pdf"},"started_at":"2026-11-04T19:47:28.479250"} +{"completed_at":"2026-11-04T19:47:32.586256","latency_in_ms":2316,"output":{"example_id":"table/Goldman Sachs 10-k_page85","grounded_pages":[],"layout_pages":[],"markdown":"**Other.** Other investments include tax credit investments (accounted for under the proportional amortization method of accounting) of $3.2 billion as of December 2024 and $3.4 billion as of December 2023. Additionally, other investments includes CIEs, which held assets (generally accounted for at historical cost less depreciation) of $2.4 billion as of December 2024 and $5.9 billion as of December 2023, and were funded with liabilities of approximately $1.2 billion as of December 2024 and $3.5 billion as of December 2023. Substantially all such liabilities were nonrecourse, thereby reducing our equity at risk.\n\nThe table below presents the concentration of CIE assets, net of financings, within our alternative investments by region and asset class.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\n**CIE assets, net of financings $ 1.2** $ 2.4\n\n**Region** Americas **72%** 61%\n\nEMEA **15%** 25%\n\nAsia **13%** 14%\n\n**Total 100%** 100%\n\n**Asset Class** Hospitality **7%** 6%\n\nIndustrials **23%** 16%\n\nMultifamily **15%** 13%\n\nOffice **29%** 24%\n\nRetail **6%** 7%\n\nSenior Housing **4%** 15%\n\nStudent Housing **1%** 7%\n\nOther **15%** 12%\n\n**Total 100%** 100%\n\nThe table below presents the concentration of CIE assets, net of financings, within our alternative investments by vintage.\n\nVintage\n\n**As of December 2024** 2017 or earlier **29%**\n\n2018 - 2020 **37%**\n\n2021 - thereafter **34%**\n\n**Total 100%**\n\nAs of December 2023 2016 or earlier 12%\n\n2017 - 2019 57%\n\n2020 - thereafter 31%\n\nTotal 100%\n\n**Platform Solutions** Platform Solutions includes our consumer platforms and transaction banking and other.\n\nPlatform Solutions generates revenues from the following:\n\n**Consumer platforms.** Our Consumer platforms business issues credit cards, and raises deposits from Apple Card customers. Consumer platforms revenues primarily includes net interest income earned on credit card lending activities. See “Regulatory and Other Matters — Other Matters — Narrowing our Focus on Consumer-Related Activities” for further information.\n\n**Transaction banking and other.** We provide transaction banking and other services, such as deposit-taking, payment solutions and other cash management services, for corporate and institutional clients. Transaction banking revenues include net interest income attributed to transaction banking deposits. See “Regulatory and Other Matters — Other Matters — Narrowing our Focus on Consumer-Related Activities” for further information.\n\nThe table below presents our Platform Solutions assets.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCash and cash equivalents **$ 16,041** $ 24,043\n\nCollateralized agreements **5,944** 7,651\n\nCustomer and other receivables **72** 3\n\nTrading assets **20,452** 14,911\n\nInvestments **3** 2\n\nLoans **18,836** 20,028\n\nOther assets **1,154** 1,846\n\n**Total $ 62,502** $ 68,484\n\nThe table below presents details about our Platform Solutions loans.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nInstallment **$ –** $ 3,125\n\nCredit cards **21,403** 19,361\n\nOther **–** 17\n\nLoans, gross **21,403** 22,503\n\nAllowance for loan losses **(2,567)** (2,475)\n\n**Total loans $ 18,836** $ 20,028\n\nThe average Platform Solutions gross loans were $20.48 billion for 2024 and $21.48 billion for 2023.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n82 Goldman Sachs 2024 Form 10-K","pages":[{"line_numbers":[],"markdown":"**Other.** Other investments include tax credit investments (accounted for under the proportional amortization method of accounting) of $3.2 billion as of December 2024 and $3.4 billion as of December 2023. Additionally, other investments includes CIEs, which held assets (generally accounted for at historical cost less depreciation) of $2.4 billion as of December 2024 and $5.9 billion as of December 2023, and were funded with liabilities of approximately $1.2 billion as of December 2024 and $3.5 billion as of December 2023. Substantially all such liabilities were nonrecourse, thereby reducing our equity at risk.\n\nThe table below presents the concentration of CIE assets, net of financings, within our alternative investments by region and asset class.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\n**CIE assets, net of financings $ 1.2** $ 2.4\n\n**Region** Americas **72%** 61%\n\nEMEA **15%** 25%\n\nAsia **13%** 14%\n\n**Total 100%** 100%\n\n**Asset Class** Hospitality **7%** 6%\n\nIndustrials **23%** 16%\n\nMultifamily **15%** 13%\n\nOffice **29%** 24%\n\nRetail **6%** 7%\n\nSenior Housing **4%** 15%\n\nStudent Housing **1%** 7%\n\nOther **15%** 12%\n\n**Total 100%** 100%\n\nThe table below presents the concentration of CIE assets, net of financings, within our alternative investments by vintage.\n\nVintage\n\n**As of December 2024** 2017 or earlier **29%**\n\n2018 - 2020 **37%**\n\n2021 - thereafter **34%**\n\n**Total 100%**\n\nAs of December 2023 2016 or earlier 12%\n\n2017 - 2019 57%\n\n2020 - thereafter 31%\n\nTotal 100%\n\n**Platform Solutions** Platform Solutions includes our consumer platforms and transaction banking and other.\n\nPlatform Solutions generates revenues from the following:\n\n**Consumer platforms.** Our Consumer platforms business issues credit cards, and raises deposits from Apple Card customers. Consumer platforms revenues primarily includes net interest income earned on credit card lending activities. See “Regulatory and Other Matters — Other Matters — Narrowing our Focus on Consumer-Related Activities” for further information.\n\n**Transaction banking and other.** We provide transaction banking and other services, such as deposit-taking, payment solutions and other cash management services, for corporate and institutional clients. Transaction banking revenues include net interest income attributed to transaction banking deposits. See “Regulatory and Other Matters — Other Matters — Narrowing our Focus on Consumer-Related Activities” for further information.\n\nThe table below presents our Platform Solutions assets.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCash and cash equivalents **$ 16,041** $ 24,043\n\nCollateralized agreements **5,944** 7,651\n\nCustomer and other receivables **72** 3\n\nTrading assets **20,452** 14,911\n\nInvestments **3** 2\n\nLoans **18,836** 20,028\n\nOther assets **1,154** 1,846\n\n**Total $ 62,502** $ 68,484\n\nThe table below presents details about our Platform Solutions loans.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nInstallment **$ –** $ 3,125\n\nCredit cards **21,403** 19,361\n\nOther **–** 17\n\nLoans, gross **21,403** 22,503\n\nAllowance for loan losses **(2,567)** (2,475)\n\n**Total loans $ 18,836** $ 20,028\n\nThe average Platform Solutions gross loans were $20.48 billion for 2024 and $21.48 billion for 2023.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n82 Goldman Sachs 2024 Form 10-K","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Other.** Other investments include tax credit investments (accounted for under the proportional amortization method of accounting) of $3.2 billion as of December 2024 and $3.4 billion as of December 2023. Additionally, other investments includes CIEs, which held assets (generally accounted for at historical cost less depreciation) of $2.4 billion as of December 2024 and $5.9 billion as of December 2023, and were funded with liabilities of approximately $1.2 billion as of December 2024 and $3.5 billion as of December 2023. Substantially all such liabilities were nonrecourse, thereby reducing our equity at risk.\n\nThe table below presents the concentration of CIE assets, net of financings, within our alternative investments by region and asset class.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\n**CIE assets, net of financings $ 1.2** $ 2.4\n\n**Region** Americas **72%** 61%\n\nEMEA **15%** 25%\n\nAsia **13%** 14%\n\n**Total 100%** 100%\n\n**Asset Class** Hospitality **7%** 6%\n\nIndustrials **23%** 16%\n\nMultifamily **15%** 13%\n\nOffice **29%** 24%\n\nRetail **6%** 7%\n\nSenior Housing **4%** 15%\n\nStudent Housing **1%** 7%\n\nOther **15%** 12%\n\n**Total 100%** 100%\n\nThe table below presents the concentration of CIE assets, net of financings, within our alternative investments by vintage.\n\nVintage\n\n**As of December 2024** 2017 or earlier **29%**\n\n2018 - 2020 **37%**\n\n2021 - thereafter **34%**\n\n**Total 100%**\n\nAs of December 2023 2016 or earlier 12%\n\n2017 - 2019 57%\n\n2020 - thereafter 31%\n\nTotal 100%\n\n**Platform Solutions** Platform Solutions includes our consumer platforms and transaction banking and other.\n\nPlatform Solutions generates revenues from the following:\n\n**Consumer platforms.** Our Consumer platforms business issues credit cards, and raises deposits from Apple Card customers. Consumer platforms revenues primarily includes net interest income earned on credit card lending activities. See “Regulatory and Other Matters — Other Matters — Narrowing our Focus on Consumer-Related Activities” for further information.\n\n**Transaction banking and other.** We provide transaction banking and other services, such as deposit-taking, payment solutions and other cash management services, for corporate and institutional clients. Transaction banking revenues include net interest income attributed to transaction banking deposits. See “Regulatory and Other Matters — Other Matters — Narrowing our Focus on Consumer-Related Activities” for further information.\n\nThe table below presents our Platform Solutions assets.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCash and cash equivalents **$ 16,041** $ 24,043\n\nCollateralized agreements **5,944** 7,651\n\nCustomer and other receivables **72** 3\n\nTrading assets **20,452** 14,911\n\nInvestments **3** 2\n\nLoans **18,836** 20,028\n\nOther assets **1,154** 1,846\n\n**Total $ 62,502** $ 68,484\n\nThe table below presents details about our Platform Solutions loans.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nInstallment **$ –** $ 3,125\n\nCredit cards **21,403** 19,361\n\nOther **–** 17\n\nLoans, gross **21,403** 22,503\n\nAllowance for loan losses **(2,567)** (2,475)\n\n**Total loans $ 18,836** $ 20,028\n\nThe average Platform Solutions gross loans were $20.48 billion for 2024 and $21.48 billion for 2023.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n82 Goldman Sachs 2024 Form 10-K","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page85.pdf"]},"response":{"errors":[],"extract_id":"extract_b07e14dc51d474eae4747cfed2bdcb95","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Other.** Other investments include tax credit investments (accounted for under the proportional amortization method of accounting) of $3.2 billion as of December 2024 and $3.4 billion as of December 2023. Additionally, other investments includes CIEs, which held assets (generally accounted for at historical cost less depreciation) of $2.4 billion as of December 2024 and $5.9 billion as of December 2023, and were funded with liabilities of approximately $1.2 billion as of December 2024 and $3.5 billion as of December 2023. Substantially all such liabilities were nonrecourse, thereby reducing our equity at risk.\n\nThe table below presents the concentration of CIE assets, net of financings, within our alternative investments by region and asset class.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\n**CIE assets, net of financings $ 1.2** $ 2.4\n\n**Region** Americas **72%** 61%\n\nEMEA **15%** 25%\n\nAsia **13%** 14%\n\n**Total 100%** 100%\n\n**Asset Class** Hospitality **7%** 6%\n\nIndustrials **23%** 16%\n\nMultifamily **15%** 13%\n\nOffice **29%** 24%\n\nRetail **6%** 7%\n\nSenior Housing **4%** 15%\n\nStudent Housing **1%** 7%\n\nOther **15%** 12%\n\n**Total 100%** 100%\n\nThe table below presents the concentration of CIE assets, net of financings, within our alternative investments by vintage.\n\nVintage\n\n**As of December 2024** 2017 or earlier **29%**\n\n2018 - 2020 **37%**\n\n2021 - thereafter **34%**\n\n**Total 100%**\n\nAs of December 2023 2016 or earlier 12%\n\n2017 - 2019 57%\n\n2020 - thereafter 31%\n\nTotal 100%\n\n**Platform Solutions** Platform Solutions includes our consumer platforms and transaction banking and other.\n\nPlatform Solutions generates revenues from the following:\n\n**Consumer platforms.** Our Consumer platforms business issues credit cards, and raises deposits from Apple Card customers. Consumer platforms revenues primarily includes net interest income earned on credit card lending activities. See “Regulatory and Other Matters — Other Matters — Narrowing our Focus on Consumer-Related Activities” for further information.\n\n**Transaction banking and other.** We provide transaction banking and other services, such as deposit-taking, payment solutions and other cash management services, for corporate and institutional clients. Transaction banking revenues include net interest income attributed to transaction banking deposits. See “Regulatory and Other Matters — Other Matters — Narrowing our Focus on Consumer-Related Activities” for further information.\n\nThe table below presents our Platform Solutions assets.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCash and cash equivalents **$ 16,041** $ 24,043\n\nCollateralized agreements **5,944** 7,651\n\nCustomer and other receivables **72** 3\n\nTrading assets **20,452** 14,911\n\nInvestments **3** 2\n\nLoans **18,836** 20,028\n\nOther assets **1,154** 1,846\n\n**Total $ 62,502** $ 68,484\n\nThe table below presents details about our Platform Solutions loans.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nInstallment **$ –** $ 3,125\n\nCredit cards **21,403** 19,361\n\nOther **–** 17\n\nLoans, gross **21,403** 22,503\n\nAllowance for loan losses **(2,567)** (2,475)\n\n**Total loans $ 18,836** $ 20,028\n\nThe average Platform Solutions gross loans were $20.48 billion for 2024 and $21.48 billion for 2023.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n82 Goldman Sachs 2024 Form 10-K"],"full_content":"**Other.** Other investments include tax credit investments (accounted for under the proportional amortization method of accounting) of $3.2 billion as of December 2024 and $3.4 billion as of December 2023. Additionally, other investments includes CIEs, which held assets (generally accounted for at historical cost less depreciation) of $2.4 billion as of December 2024 and $5.9 billion as of December 2023, and were funded with liabilities of approximately $1.2 billion as of December 2024 and $3.5 billion as of December 2023. Substantially all such liabilities were nonrecourse, thereby reducing our equity at risk.\n\nThe table below presents the concentration of CIE assets, net of financings, within our alternative investments by region and asset class.\n\nAs of December\n\n_$ in billions_ **2024** 2023\n\n**CIE assets, net of financings $ 1.2** $ 2.4\n\n**Region** Americas **72%** 61%\n\nEMEA **15%** 25%\n\nAsia **13%** 14%\n\n**Total 100%** 100%\n\n**Asset Class** Hospitality **7%** 6%\n\nIndustrials **23%** 16%\n\nMultifamily **15%** 13%\n\nOffice **29%** 24%\n\nRetail **6%** 7%\n\nSenior Housing **4%** 15%\n\nStudent Housing **1%** 7%\n\nOther **15%** 12%\n\n**Total 100%** 100%\n\nThe table below presents the concentration of CIE assets, net of financings, within our alternative investments by vintage.\n\nVintage\n\n**As of December 2024** 2017 or earlier **29%**\n\n2018 - 2020 **37%**\n\n2021 - thereafter **34%**\n\n**Total 100%**\n\nAs of December 2023 2016 or earlier 12%\n\n2017 - 2019 57%\n\n2020 - thereafter 31%\n\nTotal 100%\n\n**Platform Solutions** Platform Solutions includes our consumer platforms and transaction banking and other.\n\nPlatform Solutions generates revenues from the following:\n\n**Consumer platforms.** Our Consumer platforms business issues credit cards, and raises deposits from Apple Card customers. Consumer platforms revenues primarily includes net interest income earned on credit card lending activities. See “Regulatory and Other Matters — Other Matters — Narrowing our Focus on Consumer-Related Activities” for further information.\n\n**Transaction banking and other.** We provide transaction banking and other services, such as deposit-taking, payment solutions and other cash management services, for corporate and institutional clients. Transaction banking revenues include net interest income attributed to transaction banking deposits. See “Regulatory and Other Matters — Other Matters — Narrowing our Focus on Consumer-Related Activities” for further information.\n\nThe table below presents our Platform Solutions assets.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nCash and cash equivalents **$ 16,041** $ 24,043\n\nCollateralized agreements **5,944** 7,651\n\nCustomer and other receivables **72** 3\n\nTrading assets **20,452** 14,911\n\nInvestments **3** 2\n\nLoans **18,836** 20,028\n\nOther assets **1,154** 1,846\n\n**Total $ 62,502** $ 68,484\n\nThe table below presents details about our Platform Solutions loans.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\nInstallment **$ –** $ 3,125\n\nCredit cards **21,403** 19,361\n\nOther **–** 17\n\nLoans, gross **21,403** 22,503\n\nAllowance for loan losses **(2,567)** (2,475)\n\n**Total loans $ 18,836** $ 20,028\n\nThe average Platform Solutions gross loans were $20.48 billion for 2024 and $21.48 billion for 2023.\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\n82 Goldman Sachs 2024 Form 10-K","publish_date":null,"title":"Management’s Discussion and Analysis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page85.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page85.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page85","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page85.pdf"},"started_at":"2026-11-04T19:47:30.269726"} +{"completed_at":"2026-11-04T19:47:33.434505","latency_in_ms":2647,"output":{"example_id":"table/Goldman Sachs 10-k_page94","grounded_pages":[],"layout_pages":[],"markdown":"• In accordance with the TLAC rules, the higher of\n\nStandardized or Advanced RWAs are used in the calculation of TLAC and external long-term debt ratios and applicable requirements. RWAs represent Standardized RWAs as of both December 2024 and December 2023.\n\n• Leverage exposure consists of average adjusted total assets\n\nand certain off-balance sheet exposures.\n\nSee “Business — Regulation” in Part I, Item 1 of this Form 10-K for further information about TLAC.\n\n**Subsidiary Capital Requirements** Many of our subsidiaries, including our bank and broker- dealer subsidiaries, are subject to separate regulation and capital requirements of the jurisdictions in which they operate.\n\n**Bank Subsidiaries.** GS Bank USA is our primary U.S. banking subsidiary and GSIB and GSBE are our primary non- U.S. banking subsidiaries. These entities are subject to regulatory capital requirements. See Note 20 to the consolidated financial statements for further information about the regulatory capital requirements for GS Bank USA.\n\n**• GSIB.** GSIB is our U.K. bank subsidiary regulated by the\n\nPrudential Regulation Authority (PRA) and the Financial Conduct Authority (FCA). GSIB is subject to the U.K. capital framework, which is largely based on the Basel Committee on Banking Supervision’s (Basel Committee) capital framework for strengthening international capital standards (Basel III). The eligible retail deposits of GSIB are covered by the U.K. Financial Services Compensation Scheme to the extent provided by law.\n\nThe table below presents GSIB’s risk-based capital requirements.\n\nAs of December\n\n**2024** 2023\n\n**Risk-based capital requirements**\n\nCET1 capital ratio **11\\.9%** 10\\.1%\n\nTier 1 capital ratio **14\\.7%** 12\\.4%\n\nTotal capital ratio **18\\.4%** 15\\.4%\n\nThe table below presents information about GSIB’s risk- based capital ratios.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Risk-based capital and risk-weighted assets**\n\nCET1 capital **$ 4,336** $ 3,936\n\nTier 1 capital **$ 4,336** $ 3,936\n\nTier 2 capital **$ 826** $ 826\n\nTotal capital **$ 5,162** $ 4,762\n\nRWAs **$ 17,767** $ 16,546\n\n**Risk-based capital ratios**\n\nCET1 capital ratio **24\\.4%** 23\\.8%\n\nTier 1 capital ratio **24\\.4%** 23\\.8%\n\nTotal capital ratio **29\\.1%** 28\\.8%\n\nIn the table above, the risk-based capital ratios as of December 2024 reflected profits that are still subject to annual audit by GSIB’s external auditors and approval by GSIB’s Board of Directors for inclusion in risk-based capital. These profits contributed 213 basis points to the CET1 capital ratio as of December 2024.\n\nThe table below presents GSIB’s leverage ratio requirement and leverage ratio.\n\nAs of December\n\n**2024** 2023\n\nLeverage ratio requirement **3\\.7%** 3\\.6%\n\nLeverage ratio **8\\.9%** 7\\.4%\n\nIn the table above, the leverage ratio as of December 2024 reflected profits that are still subject to annual audit by GSIB’s external auditors and approval by GSIB’s Board of Directors for inclusion in risk-based capital. These profits contributed 87 basis points to the leverage ratio as of December 2024.\n\nGSIB is subject to minimum reserve requirements at central banks in certain of the jurisdictions in which it operates. As of both December 2024 and December 2023, GSIB was in compliance with these requirements.\n\n**• GSBE.** GSBE is our German bank subsidiary supervised by\n\nthe European Central Bank, BaFin and Deutsche Bundesbank. GSBE is a non-U.S. banking subsidiary of GS Bank USA and is also subject to standalone regulatory capital requirements noted below. GSBE is subject to the capital requirements prescribed in the amended E.U. Capital Requirements Directive (CRD) and E.U. Capital Requirements Regulation (CRR), which are largely based on Basel III. The deposits of GSBE are covered by the German statutory deposit protection program to the extent provided by law. In addition, GSBE has elected to participate in the German voluntary deposit protection program which provides further insurance for certain eligible deposits beyond the coverage of the German statutory deposit program.\n\nThe table below presents GSBE’s risk-based capital requirements.\n\nAs of December\n\n**2024** 2023\n\n**Risk-based capital requirements**\n\nCET1 capital ratio **10\\.3%** 10\\.0%\n\nTier 1 capital ratio **12\\.3%** 12\\.1%\n\nTotal capital ratio **15\\.0%** 14\\.8%\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 91","pages":[{"line_numbers":[],"markdown":"• In accordance with the TLAC rules, the higher of\n\nStandardized or Advanced RWAs are used in the calculation of TLAC and external long-term debt ratios and applicable requirements. RWAs represent Standardized RWAs as of both December 2024 and December 2023.\n\n• Leverage exposure consists of average adjusted total assets\n\nand certain off-balance sheet exposures.\n\nSee “Business — Regulation” in Part I, Item 1 of this Form 10-K for further information about TLAC.\n\n**Subsidiary Capital Requirements** Many of our subsidiaries, including our bank and broker- dealer subsidiaries, are subject to separate regulation and capital requirements of the jurisdictions in which they operate.\n\n**Bank Subsidiaries.** GS Bank USA is our primary U.S. banking subsidiary and GSIB and GSBE are our primary non- U.S. banking subsidiaries. These entities are subject to regulatory capital requirements. See Note 20 to the consolidated financial statements for further information about the regulatory capital requirements for GS Bank USA.\n\n**• GSIB.** GSIB is our U.K. bank subsidiary regulated by the\n\nPrudential Regulation Authority (PRA) and the Financial Conduct Authority (FCA). GSIB is subject to the U.K. capital framework, which is largely based on the Basel Committee on Banking Supervision’s (Basel Committee) capital framework for strengthening international capital standards (Basel III). The eligible retail deposits of GSIB are covered by the U.K. Financial Services Compensation Scheme to the extent provided by law.\n\nThe table below presents GSIB’s risk-based capital requirements.\n\nAs of December\n\n**2024** 2023\n\n**Risk-based capital requirements**\n\nCET1 capital ratio **11\\.9%** 10\\.1%\n\nTier 1 capital ratio **14\\.7%** 12\\.4%\n\nTotal capital ratio **18\\.4%** 15\\.4%\n\nThe table below presents information about GSIB’s risk- based capital ratios.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Risk-based capital and risk-weighted assets**\n\nCET1 capital **$ 4,336** $ 3,936\n\nTier 1 capital **$ 4,336** $ 3,936\n\nTier 2 capital **$ 826** $ 826\n\nTotal capital **$ 5,162** $ 4,762\n\nRWAs **$ 17,767** $ 16,546\n\n**Risk-based capital ratios**\n\nCET1 capital ratio **24\\.4%** 23\\.8%\n\nTier 1 capital ratio **24\\.4%** 23\\.8%\n\nTotal capital ratio **29\\.1%** 28\\.8%\n\nIn the table above, the risk-based capital ratios as of December 2024 reflected profits that are still subject to annual audit by GSIB’s external auditors and approval by GSIB’s Board of Directors for inclusion in risk-based capital. These profits contributed 213 basis points to the CET1 capital ratio as of December 2024.\n\nThe table below presents GSIB’s leverage ratio requirement and leverage ratio.\n\nAs of December\n\n**2024** 2023\n\nLeverage ratio requirement **3\\.7%** 3\\.6%\n\nLeverage ratio **8\\.9%** 7\\.4%\n\nIn the table above, the leverage ratio as of December 2024 reflected profits that are still subject to annual audit by GSIB’s external auditors and approval by GSIB’s Board of Directors for inclusion in risk-based capital. These profits contributed 87 basis points to the leverage ratio as of December 2024.\n\nGSIB is subject to minimum reserve requirements at central banks in certain of the jurisdictions in which it operates. As of both December 2024 and December 2023, GSIB was in compliance with these requirements.\n\n**• GSBE.** GSBE is our German bank subsidiary supervised by\n\nthe European Central Bank, BaFin and Deutsche Bundesbank. GSBE is a non-U.S. banking subsidiary of GS Bank USA and is also subject to standalone regulatory capital requirements noted below. GSBE is subject to the capital requirements prescribed in the amended E.U. Capital Requirements Directive (CRD) and E.U. Capital Requirements Regulation (CRR), which are largely based on Basel III. The deposits of GSBE are covered by the German statutory deposit protection program to the extent provided by law. In addition, GSBE has elected to participate in the German voluntary deposit protection program which provides further insurance for certain eligible deposits beyond the coverage of the German statutory deposit program.\n\nThe table below presents GSBE’s risk-based capital requirements.\n\nAs of December\n\n**2024** 2023\n\n**Risk-based capital requirements**\n\nCET1 capital ratio **10\\.3%** 10\\.0%\n\nTier 1 capital ratio **12\\.3%** 12\\.1%\n\nTotal capital ratio **15\\.0%** 14\\.8%\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 91","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"• In accordance with the TLAC rules, the higher of\n\nStandardized or Advanced RWAs are used in the calculation of TLAC and external long-term debt ratios and applicable requirements. RWAs represent Standardized RWAs as of both December 2024 and December 2023.\n\n• Leverage exposure consists of average adjusted total assets\n\nand certain off-balance sheet exposures.\n\nSee “Business — Regulation” in Part I, Item 1 of this Form 10-K for further information about TLAC.\n\n**Subsidiary Capital Requirements** Many of our subsidiaries, including our bank and broker- dealer subsidiaries, are subject to separate regulation and capital requirements of the jurisdictions in which they operate.\n\n**Bank Subsidiaries.** GS Bank USA is our primary U.S. banking subsidiary and GSIB and GSBE are our primary non- U.S. banking subsidiaries. These entities are subject to regulatory capital requirements. See Note 20 to the consolidated financial statements for further information about the regulatory capital requirements for GS Bank USA.\n\n**• GSIB.** GSIB is our U.K. bank subsidiary regulated by the\n\nPrudential Regulation Authority (PRA) and the Financial Conduct Authority (FCA). GSIB is subject to the U.K. capital framework, which is largely based on the Basel Committee on Banking Supervision’s (Basel Committee) capital framework for strengthening international capital standards (Basel III). The eligible retail deposits of GSIB are covered by the U.K. Financial Services Compensation Scheme to the extent provided by law.\n\nThe table below presents GSIB’s risk-based capital requirements.\n\nAs of December\n\n**2024** 2023\n\n**Risk-based capital requirements**\n\nCET1 capital ratio **11\\.9%** 10\\.1%\n\nTier 1 capital ratio **14\\.7%** 12\\.4%\n\nTotal capital ratio **18\\.4%** 15\\.4%\n\nThe table below presents information about GSIB’s risk- based capital ratios.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Risk-based capital and risk-weighted assets**\n\nCET1 capital **$ 4,336** $ 3,936\n\nTier 1 capital **$ 4,336** $ 3,936\n\nTier 2 capital **$ 826** $ 826\n\nTotal capital **$ 5,162** $ 4,762\n\nRWAs **$ 17,767** $ 16,546\n\n**Risk-based capital ratios**\n\nCET1 capital ratio **24\\.4%** 23\\.8%\n\nTier 1 capital ratio **24\\.4%** 23\\.8%\n\nTotal capital ratio **29\\.1%** 28\\.8%\n\nIn the table above, the risk-based capital ratios as of December 2024 reflected profits that are still subject to annual audit by GSIB’s external auditors and approval by GSIB’s Board of Directors for inclusion in risk-based capital. These profits contributed 213 basis points to the CET1 capital ratio as of December 2024.\n\nThe table below presents GSIB’s leverage ratio requirement and leverage ratio.\n\nAs of December\n\n**2024** 2023\n\nLeverage ratio requirement **3\\.7%** 3\\.6%\n\nLeverage ratio **8\\.9%** 7\\.4%\n\nIn the table above, the leverage ratio as of December 2024 reflected profits that are still subject to annual audit by GSIB’s external auditors and approval by GSIB’s Board of Directors for inclusion in risk-based capital. These profits contributed 87 basis points to the leverage ratio as of December 2024.\n\nGSIB is subject to minimum reserve requirements at central banks in certain of the jurisdictions in which it operates. As of both December 2024 and December 2023, GSIB was in compliance with these requirements.\n\n**• GSBE.** GSBE is our German bank subsidiary supervised by\n\nthe European Central Bank, BaFin and Deutsche Bundesbank. GSBE is a non-U.S. banking subsidiary of GS Bank USA and is also subject to standalone regulatory capital requirements noted below. GSBE is subject to the capital requirements prescribed in the amended E.U. Capital Requirements Directive (CRD) and E.U. Capital Requirements Regulation (CRR), which are largely based on Basel III. The deposits of GSBE are covered by the German statutory deposit protection program to the extent provided by law. In addition, GSBE has elected to participate in the German voluntary deposit protection program which provides further insurance for certain eligible deposits beyond the coverage of the German statutory deposit program.\n\nThe table below presents GSBE’s risk-based capital requirements.\n\nAs of December\n\n**2024** 2023\n\n**Risk-based capital requirements**\n\nCET1 capital ratio **10\\.3%** 10\\.0%\n\nTier 1 capital ratio **12\\.3%** 12\\.1%\n\nTotal capital ratio **15\\.0%** 14\\.8%\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 91","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page94.pdf"]},"response":{"errors":[],"extract_id":"extract_5d19ca0f481e73f53cadcec5c99f4e0c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["• In accordance with the TLAC rules, the higher of\n\nStandardized or Advanced RWAs are used in the calculation of TLAC and external long-term debt ratios and applicable requirements. RWAs represent Standardized RWAs as of both December 2024 and December 2023.\n\n• Leverage exposure consists of average adjusted total assets\n\nand certain off-balance sheet exposures.\n\nSee “Business — Regulation” in Part I, Item 1 of this Form 10-K for further information about TLAC.\n\n**Subsidiary Capital Requirements** Many of our subsidiaries, including our bank and broker- dealer subsidiaries, are subject to separate regulation and capital requirements of the jurisdictions in which they operate.\n\n**Bank Subsidiaries.** GS Bank USA is our primary U.S. banking subsidiary and GSIB and GSBE are our primary non- U.S. banking subsidiaries. These entities are subject to regulatory capital requirements. See Note 20 to the consolidated financial statements for further information about the regulatory capital requirements for GS Bank USA.\n\n**• GSIB.** GSIB is our U.K. bank subsidiary regulated by the\n\nPrudential Regulation Authority (PRA) and the Financial Conduct Authority (FCA). GSIB is subject to the U.K. capital framework, which is largely based on the Basel Committee on Banking Supervision’s (Basel Committee) capital framework for strengthening international capital standards (Basel III). The eligible retail deposits of GSIB are covered by the U.K. Financial Services Compensation Scheme to the extent provided by law.\n\nThe table below presents GSIB’s risk-based capital requirements.\n\nAs of December\n\n**2024** 2023\n\n**Risk-based capital requirements**\n\nCET1 capital ratio **11\\.9%** 10\\.1%\n\nTier 1 capital ratio **14\\.7%** 12\\.4%\n\nTotal capital ratio **18\\.4%** 15\\.4%\n\nThe table below presents information about GSIB’s risk- based capital ratios.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Risk-based capital and risk-weighted assets**\n\nCET1 capital **$ 4,336** $ 3,936\n\nTier 1 capital **$ 4,336** $ 3,936\n\nTier 2 capital **$ 826** $ 826\n\nTotal capital **$ 5,162** $ 4,762\n\nRWAs **$ 17,767** $ 16,546\n\n**Risk-based capital ratios**\n\nCET1 capital ratio **24\\.4%** 23\\.8%\n\nTier 1 capital ratio **24\\.4%** 23\\.8%\n\nTotal capital ratio **29\\.1%** 28\\.8%\n\nIn the table above, the risk-based capital ratios as of December 2024 reflected profits that are still subject to annual audit by GSIB’s external auditors and approval by GSIB’s Board of Directors for inclusion in risk-based capital. These profits contributed 213 basis points to the CET1 capital ratio as of December 2024.\n\nThe table below presents GSIB’s leverage ratio requirement and leverage ratio.\n\nAs of December\n\n**2024** 2023\n\nLeverage ratio requirement **3\\.7%** 3\\.6%\n\nLeverage ratio **8\\.9%** 7\\.4%\n\nIn the table above, the leverage ratio as of December 2024 reflected profits that are still subject to annual audit by GSIB’s external auditors and approval by GSIB’s Board of Directors for inclusion in risk-based capital. These profits contributed 87 basis points to the leverage ratio as of December 2024.\n\nGSIB is subject to minimum reserve requirements at central banks in certain of the jurisdictions in which it operates. As of both December 2024 and December 2023, GSIB was in compliance with these requirements.\n\n**• GSBE.** GSBE is our German bank subsidiary supervised by\n\nthe European Central Bank, BaFin and Deutsche Bundesbank. GSBE is a non-U.S. banking subsidiary of GS Bank USA and is also subject to standalone regulatory capital requirements noted below. GSBE is subject to the capital requirements prescribed in the amended E.U. Capital Requirements Directive (CRD) and E.U. Capital Requirements Regulation (CRR), which are largely based on Basel III. The deposits of GSBE are covered by the German statutory deposit protection program to the extent provided by law. In addition, GSBE has elected to participate in the German voluntary deposit protection program which provides further insurance for certain eligible deposits beyond the coverage of the German statutory deposit program.\n\nThe table below presents GSBE’s risk-based capital requirements.\n\nAs of December\n\n**2024** 2023\n\n**Risk-based capital requirements**\n\nCET1 capital ratio **10\\.3%** 10\\.0%\n\nTier 1 capital ratio **12\\.3%** 12\\.1%\n\nTotal capital ratio **15\\.0%** 14\\.8%\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 91"],"full_content":"• In accordance with the TLAC rules, the higher of\n\nStandardized or Advanced RWAs are used in the calculation of TLAC and external long-term debt ratios and applicable requirements. RWAs represent Standardized RWAs as of both December 2024 and December 2023.\n\n• Leverage exposure consists of average adjusted total assets\n\nand certain off-balance sheet exposures.\n\nSee “Business — Regulation” in Part I, Item 1 of this Form 10-K for further information about TLAC.\n\n**Subsidiary Capital Requirements** Many of our subsidiaries, including our bank and broker- dealer subsidiaries, are subject to separate regulation and capital requirements of the jurisdictions in which they operate.\n\n**Bank Subsidiaries.** GS Bank USA is our primary U.S. banking subsidiary and GSIB and GSBE are our primary non- U.S. banking subsidiaries. These entities are subject to regulatory capital requirements. See Note 20 to the consolidated financial statements for further information about the regulatory capital requirements for GS Bank USA.\n\n**• GSIB.** GSIB is our U.K. bank subsidiary regulated by the\n\nPrudential Regulation Authority (PRA) and the Financial Conduct Authority (FCA). GSIB is subject to the U.K. capital framework, which is largely based on the Basel Committee on Banking Supervision’s (Basel Committee) capital framework for strengthening international capital standards (Basel III). The eligible retail deposits of GSIB are covered by the U.K. Financial Services Compensation Scheme to the extent provided by law.\n\nThe table below presents GSIB’s risk-based capital requirements.\n\nAs of December\n\n**2024** 2023\n\n**Risk-based capital requirements**\n\nCET1 capital ratio **11\\.9%** 10\\.1%\n\nTier 1 capital ratio **14\\.7%** 12\\.4%\n\nTotal capital ratio **18\\.4%** 15\\.4%\n\nThe table below presents information about GSIB’s risk- based capital ratios.\n\nAs of December\n\n_$ in millions_ **2024** 2023\n\n**Risk-based capital and risk-weighted assets**\n\nCET1 capital **$ 4,336** $ 3,936\n\nTier 1 capital **$ 4,336** $ 3,936\n\nTier 2 capital **$ 826** $ 826\n\nTotal capital **$ 5,162** $ 4,762\n\nRWAs **$ 17,767** $ 16,546\n\n**Risk-based capital ratios**\n\nCET1 capital ratio **24\\.4%** 23\\.8%\n\nTier 1 capital ratio **24\\.4%** 23\\.8%\n\nTotal capital ratio **29\\.1%** 28\\.8%\n\nIn the table above, the risk-based capital ratios as of December 2024 reflected profits that are still subject to annual audit by GSIB’s external auditors and approval by GSIB’s Board of Directors for inclusion in risk-based capital. These profits contributed 213 basis points to the CET1 capital ratio as of December 2024.\n\nThe table below presents GSIB’s leverage ratio requirement and leverage ratio.\n\nAs of December\n\n**2024** 2023\n\nLeverage ratio requirement **3\\.7%** 3\\.6%\n\nLeverage ratio **8\\.9%** 7\\.4%\n\nIn the table above, the leverage ratio as of December 2024 reflected profits that are still subject to annual audit by GSIB’s external auditors and approval by GSIB’s Board of Directors for inclusion in risk-based capital. These profits contributed 87 basis points to the leverage ratio as of December 2024.\n\nGSIB is subject to minimum reserve requirements at central banks in certain of the jurisdictions in which it operates. As of both December 2024 and December 2023, GSIB was in compliance with these requirements.\n\n**• GSBE.** GSBE is our German bank subsidiary supervised by\n\nthe European Central Bank, BaFin and Deutsche Bundesbank. GSBE is a non-U.S. banking subsidiary of GS Bank USA and is also subject to standalone regulatory capital requirements noted below. GSBE is subject to the capital requirements prescribed in the amended E.U. Capital Requirements Directive (CRD) and E.U. Capital Requirements Regulation (CRR), which are largely based on Basel III. The deposits of GSBE are covered by the German statutory deposit protection program to the extent provided by law. In addition, GSBE has elected to participate in the German voluntary deposit protection program which provides further insurance for certain eligible deposits beyond the coverage of the German statutory deposit program.\n\nThe table below presents GSBE’s risk-based capital requirements.\n\nAs of December\n\n**2024** 2023\n\n**Risk-based capital requirements**\n\nCET1 capital ratio **10\\.3%** 10\\.0%\n\nTier 1 capital ratio **12\\.3%** 12\\.1%\n\nTotal capital ratio **15\\.0%** 14\\.8%\n\nTHE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES\n\n### **Management’s Discussion and Analysis**\n\nGoldman Sachs 2024 Form 10-K 91","publish_date":null,"title":"Management’s Discussion and Analysis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page94.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Goldman%20Sachs%2010-k_page94.pdf"},"request":{"example_id":"table/Goldman Sachs 10-k_page94","product_type":"parse","source_file_path":"Goldman Sachs 10-k_page94.pdf"},"started_at":"2026-11-04T19:47:30.786508"} +{"completed_at":"2026-11-04T19:47:33.529436","latency_in_ms":1477,"output":{"example_id":"table/Home Depot 10-k unrestricted_page106","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit 21**\n\n**LIST OF SUBSIDIARIES**\n\n**NAME OF SUBSIDIARY**\n\n**STATE OR JURISDICTION OF**\n\n**INCORPORATION D/B/A**\n\nHome Depot U.S.A., Inc. Delaware\n\nThe Home Depot, blinds.com, The Company Store,\n\nContractors' Warehouse\n\nHome Depot International, Inc. Delaware (Not Applicable)\n\nHD Development Holdings, Inc. Delaware (Not Applicable)\n\nHD Development of Maryland, Inc. Maryland (Not Applicable)\n\nHome Depot Incentives, Inc. Virginia (Not Applicable)\n\nHome Depot Product Authority, LLC Georgia (Not Applicable)\n\nHome Depot of Canada Inc. Canada The Home Depot, The Home Depot Canada\n\nHome Depot Store Support, Inc. Delaware (Not Applicable)\n\nHD Supply Holdings, Inc. Delaware HD Supply\n\nHD Operations Holding Company, Inc. Delaware (Not Applicable)\n\nHome Depot México, S. de R.L. de C.V. Mexico The Home Depot, The Home Depot México\n\nSRS Distribution Inc. Delaware (Not Applicable)\n\n_Certain subsidiaries were omitted pursuant to Item 601(21)(ii) of the SEC's Regulation S-K._","pages":[{"line_numbers":[],"markdown":"**Exhibit 21**\n\n**LIST OF SUBSIDIARIES**\n\n**NAME OF SUBSIDIARY**\n\n**STATE OR JURISDICTION OF**\n\n**INCORPORATION D/B/A**\n\nHome Depot U.S.A., Inc. Delaware\n\nThe Home Depot, blinds.com, The Company Store,\n\nContractors' Warehouse\n\nHome Depot International, Inc. Delaware (Not Applicable)\n\nHD Development Holdings, Inc. Delaware (Not Applicable)\n\nHD Development of Maryland, Inc. Maryland (Not Applicable)\n\nHome Depot Incentives, Inc. Virginia (Not Applicable)\n\nHome Depot Product Authority, LLC Georgia (Not Applicable)\n\nHome Depot of Canada Inc. Canada The Home Depot, The Home Depot Canada\n\nHome Depot Store Support, Inc. Delaware (Not Applicable)\n\nHD Supply Holdings, Inc. Delaware HD Supply\n\nHD Operations Holding Company, Inc. Delaware (Not Applicable)\n\nHome Depot México, S. de R.L. de C.V. Mexico The Home Depot, The Home Depot México\n\nSRS Distribution Inc. Delaware (Not Applicable)\n\n_Certain subsidiaries were omitted pursuant to Item 601(21)(ii) of the SEC's Regulation S-K._","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit 21**\n\n**LIST OF SUBSIDIARIES**\n\n**NAME OF SUBSIDIARY**\n\n**STATE OR JURISDICTION OF**\n\n**INCORPORATION D/B/A**\n\nHome Depot U.S.A., Inc. Delaware\n\nThe Home Depot, blinds.com, The Company Store,\n\nContractors' Warehouse\n\nHome Depot International, Inc. Delaware (Not Applicable)\n\nHD Development Holdings, Inc. Delaware (Not Applicable)\n\nHD Development of Maryland, Inc. Maryland (Not Applicable)\n\nHome Depot Incentives, Inc. Virginia (Not Applicable)\n\nHome Depot Product Authority, LLC Georgia (Not Applicable)\n\nHome Depot of Canada Inc. Canada The Home Depot, The Home Depot Canada\n\nHome Depot Store Support, Inc. Delaware (Not Applicable)\n\nHD Supply Holdings, Inc. Delaware HD Supply\n\nHD Operations Holding Company, Inc. Delaware (Not Applicable)\n\nHome Depot México, S. de R.L. de C.V. Mexico The Home Depot, The Home Depot México\n\nSRS Distribution Inc. Delaware (Not Applicable)\n\n_Certain subsidiaries were omitted pursuant to Item 601(21)(ii) of the SEC's Regulation S-K._","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page106.pdf"]},"response":{"errors":[],"extract_id":"extract_ee43dfc87eaf06b40a0d353b3314a3be","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit 21**\n\n**LIST OF SUBSIDIARIES**\n\n**NAME OF SUBSIDIARY**\n\n**STATE OR JURISDICTION OF**\n\n**INCORPORATION D/B/A**\n\nHome Depot U.S.A., Inc. Delaware\n\nThe Home Depot, blinds.com, The Company Store,\n\nContractors' Warehouse\n\nHome Depot International, Inc. Delaware (Not Applicable)\n\nHD Development Holdings, Inc. Delaware (Not Applicable)\n\nHD Development of Maryland, Inc. Maryland (Not Applicable)\n\nHome Depot Incentives, Inc. Virginia (Not Applicable)\n\nHome Depot Product Authority, LLC Georgia (Not Applicable)\n\nHome Depot of Canada Inc. Canada The Home Depot, The Home Depot Canada\n\nHome Depot Store Support, Inc. Delaware (Not Applicable)\n\nHD Supply Holdings, Inc. Delaware HD Supply\n\nHD Operations Holding Company, Inc. Delaware (Not Applicable)\n\nHome Depot México, S. de R.L. de C.V. Mexico The Home Depot, The Home Depot México\n\nSRS Distribution Inc. Delaware (Not Applicable)\n\n_Certain subsidiaries were omitted pursuant to Item 601(21)(ii) of the SEC's Regulation S-K._"],"full_content":"**Exhibit 21**\n\n**LIST OF SUBSIDIARIES**\n\n**NAME OF SUBSIDIARY**\n\n**STATE OR JURISDICTION OF**\n\n**INCORPORATION D/B/A**\n\nHome Depot U.S.A., Inc. Delaware\n\nThe Home Depot, blinds.com, The Company Store,\n\nContractors' Warehouse\n\nHome Depot International, Inc. Delaware (Not Applicable)\n\nHD Development Holdings, Inc. Delaware (Not Applicable)\n\nHD Development of Maryland, Inc. Maryland (Not Applicable)\n\nHome Depot Incentives, Inc. Virginia (Not Applicable)\n\nHome Depot Product Authority, LLC Georgia (Not Applicable)\n\nHome Depot of Canada Inc. Canada The Home Depot, The Home Depot Canada\n\nHome Depot Store Support, Inc. Delaware (Not Applicable)\n\nHD Supply Holdings, Inc. Delaware HD Supply\n\nHD Operations Holding Company, Inc. Delaware (Not Applicable)\n\nHome Depot México, S. de R.L. de C.V. Mexico The Home Depot, The Home Depot México\n\nSRS Distribution Inc. Delaware (Not Applicable)\n\n_Certain subsidiaries were omitted pursuant to Item 601(21)(ii) of the SEC's Regulation S-K._","publish_date":null,"title":"Exhibit 21 LIST OF SUBSIDIARIES STATE OR JURISDICTION OF NAME OF SUBSIDIARY INCORPORATION D/B/A The Home Depot, blinds.com, The Company","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page106.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page106.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page106","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page106.pdf"},"started_at":"2026-11-04T19:47:32.051778"} +{"completed_at":"2026-11-04T19:47:34.239655","latency_in_ms":1355,"output":{"example_id":"table/Home Depot 10-k unrestricted_page3","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**COMMONLY USED OR DEFINED TERMS**\n\n**Term Definition**\n\nASU Accounting Standards Update\n\nBODFS Buy Online, Deliver From Store\n\nBOPIS Buy Online, Pickup In Store\n\nBORIS Buy Online, Return In Store\n\nBOSS Buy Online, Ship to Store\n\nComparable sales As defined in the Results of Operations section of MD&A\n\nDIFM Do-It-For-Me\n\nDIY Do-It-Yourself\n\nEH&S Environmental, Health, and Safety\n\nEPA U.S. Environmental Protection Agency\n\nESPP Employee Stock Purchase Plan\n\nExchange Act Securities Exchange Act of 1934, as amended\n\nFASB Financial Accounting Standards Board\n\nfiscal 2022 Fiscal year ended January 29, 2023 (includes 52 weeks)\n\nfiscal 2023 Fiscal year ended January 28, 2024 (includes 52 weeks)\n\nfiscal 2024 Fiscal year ended February 2, 2025 (includes 53 weeks)\n\nfiscal 2025 Fiscal year ending February 1, 2026 (includes 52 weeks)\n\nGAAP U.S. generally accepted accounting principles\n\nIRS Internal Revenue Service\n\nMD&A Management’s Discussion and Analysis of Financial Condition and Results of Operations\n\nMRO Maintenance, repair, and operations\n\nNOPAT Net operating profit after tax\n\nNYSE New York Stock Exchange\n\nPLCC Private label credit card\n\nPro Professional customer\n\nRestoration Plans Home Depot FutureBuilder Restoration Plan and HD Supply Restoration Plan\n\nROIC Return on invested capital\n\nSEC Securities and Exchange Commission\n\nSecurities Act Securities Act of 1933, as amended\n\nSG&A Selling, general, and administrative expenses\n\nSRS SRS Distribution Inc.\n\nFiscal 2024 Form 10-K ii","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**COMMONLY USED OR DEFINED TERMS**\n\n**Term Definition**\n\nASU Accounting Standards Update\n\nBODFS Buy Online, Deliver From Store\n\nBOPIS Buy Online, Pickup In Store\n\nBORIS Buy Online, Return In Store\n\nBOSS Buy Online, Ship to Store\n\nComparable sales As defined in the Results of Operations section of MD&A\n\nDIFM Do-It-For-Me\n\nDIY Do-It-Yourself\n\nEH&S Environmental, Health, and Safety\n\nEPA U.S. Environmental Protection Agency\n\nESPP Employee Stock Purchase Plan\n\nExchange Act Securities Exchange Act of 1934, as amended\n\nFASB Financial Accounting Standards Board\n\nfiscal 2022 Fiscal year ended January 29, 2023 (includes 52 weeks)\n\nfiscal 2023 Fiscal year ended January 28, 2024 (includes 52 weeks)\n\nfiscal 2024 Fiscal year ended February 2, 2025 (includes 53 weeks)\n\nfiscal 2025 Fiscal year ending February 1, 2026 (includes 52 weeks)\n\nGAAP U.S. generally accepted accounting principles\n\nIRS Internal Revenue Service\n\nMD&A Management’s Discussion and Analysis of Financial Condition and Results of Operations\n\nMRO Maintenance, repair, and operations\n\nNOPAT Net operating profit after tax\n\nNYSE New York Stock Exchange\n\nPLCC Private label credit card\n\nPro Professional customer\n\nRestoration Plans Home Depot FutureBuilder Restoration Plan and HD Supply Restoration Plan\n\nROIC Return on invested capital\n\nSEC Securities and Exchange Commission\n\nSecurities Act Securities Act of 1933, as amended\n\nSG&A Selling, general, and administrative expenses\n\nSRS SRS Distribution Inc.\n\nFiscal 2024 Form 10-K ii","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**COMMONLY USED OR DEFINED TERMS**\n\n**Term Definition**\n\nASU Accounting Standards Update\n\nBODFS Buy Online, Deliver From Store\n\nBOPIS Buy Online, Pickup In Store\n\nBORIS Buy Online, Return In Store\n\nBOSS Buy Online, Ship to Store\n\nComparable sales As defined in the Results of Operations section of MD&A\n\nDIFM Do-It-For-Me\n\nDIY Do-It-Yourself\n\nEH&S Environmental, Health, and Safety\n\nEPA U.S. Environmental Protection Agency\n\nESPP Employee Stock Purchase Plan\n\nExchange Act Securities Exchange Act of 1934, as amended\n\nFASB Financial Accounting Standards Board\n\nfiscal 2022 Fiscal year ended January 29, 2023 (includes 52 weeks)\n\nfiscal 2023 Fiscal year ended January 28, 2024 (includes 52 weeks)\n\nfiscal 2024 Fiscal year ended February 2, 2025 (includes 53 weeks)\n\nfiscal 2025 Fiscal year ending February 1, 2026 (includes 52 weeks)\n\nGAAP U.S. generally accepted accounting principles\n\nIRS Internal Revenue Service\n\nMD&A Management’s Discussion and Analysis of Financial Condition and Results of Operations\n\nMRO Maintenance, repair, and operations\n\nNOPAT Net operating profit after tax\n\nNYSE New York Stock Exchange\n\nPLCC Private label credit card\n\nPro Professional customer\n\nRestoration Plans Home Depot FutureBuilder Restoration Plan and HD Supply Restoration Plan\n\nROIC Return on invested capital\n\nSEC Securities and Exchange Commission\n\nSecurities Act Securities Act of 1933, as amended\n\nSG&A Selling, general, and administrative expenses\n\nSRS SRS Distribution Inc.\n\nFiscal 2024 Form 10-K ii","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page3.pdf"]},"response":{"errors":[],"extract_id":"extract_211d8c7d8c22b8c96c16af7d21e17315","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**COMMONLY USED OR DEFINED TERMS**\n\n**Term Definition**\n\nASU Accounting Standards Update\n\nBODFS Buy Online, Deliver From Store\n\nBOPIS Buy Online, Pickup In Store\n\nBORIS Buy Online, Return In Store\n\nBOSS Buy Online, Ship to Store\n\nComparable sales As defined in the Results of Operations section of MD&A\n\nDIFM Do-It-For-Me\n\nDIY Do-It-Yourself\n\nEH&S Environmental, Health, and Safety\n\nEPA U.S. Environmental Protection Agency\n\nESPP Employee Stock Purchase Plan\n\nExchange Act Securities Exchange Act of 1934, as amended\n\nFASB Financial Accounting Standards Board\n\nfiscal 2022 Fiscal year ended January 29, 2023 (includes 52 weeks)\n\nfiscal 2023 Fiscal year ended January 28, 2024 (includes 52 weeks)\n\nfiscal 2024 Fiscal year ended February 2, 2025 (includes 53 weeks)\n\nfiscal 2025 Fiscal year ending February 1, 2026 (includes 52 weeks)\n\nGAAP U.S. generally accepted accounting principles\n\nIRS Internal Revenue Service\n\nMD&A Management’s Discussion and Analysis of Financial Condition and Results of Operations\n\nMRO Maintenance, repair, and operations\n\nNOPAT Net operating profit after tax\n\nNYSE New York Stock Exchange\n\nPLCC Private label credit card\n\nPro Professional customer\n\nRestoration Plans Home Depot FutureBuilder Restoration Plan and HD Supply Restoration Plan\n\nROIC Return on invested capital\n\nSEC Securities and Exchange Commission\n\nSecurities Act Securities Act of 1933, as amended\n\nSG&A Selling, general, and administrative expenses\n\nSRS SRS Distribution Inc.\n\nFiscal 2024 Form 10-K ii"],"full_content":"Table of Contents\n\n**COMMONLY USED OR DEFINED TERMS**\n\n**Term Definition**\n\nASU Accounting Standards Update\n\nBODFS Buy Online, Deliver From Store\n\nBOPIS Buy Online, Pickup In Store\n\nBORIS Buy Online, Return In Store\n\nBOSS Buy Online, Ship to Store\n\nComparable sales As defined in the Results of Operations section of MD&A\n\nDIFM Do-It-For-Me\n\nDIY Do-It-Yourself\n\nEH&S Environmental, Health, and Safety\n\nEPA U.S. Environmental Protection Agency\n\nESPP Employee Stock Purchase Plan\n\nExchange Act Securities Exchange Act of 1934, as amended\n\nFASB Financial Accounting Standards Board\n\nfiscal 2022 Fiscal year ended January 29, 2023 (includes 52 weeks)\n\nfiscal 2023 Fiscal year ended January 28, 2024 (includes 52 weeks)\n\nfiscal 2024 Fiscal year ended February 2, 2025 (includes 53 weeks)\n\nfiscal 2025 Fiscal year ending February 1, 2026 (includes 52 weeks)\n\nGAAP U.S. generally accepted accounting principles\n\nIRS Internal Revenue Service\n\nMD&A Management’s Discussion and Analysis of Financial Condition and Results of Operations\n\nMRO Maintenance, repair, and operations\n\nNOPAT Net operating profit after tax\n\nNYSE New York Stock Exchange\n\nPLCC Private label credit card\n\nPro Professional customer\n\nRestoration Plans Home Depot FutureBuilder Restoration Plan and HD Supply Restoration Plan\n\nROIC Return on invested capital\n\nSEC Securities and Exchange Commission\n\nSecurities Act Securities Act of 1933, as amended\n\nSG&A Selling, general, and administrative expenses\n\nSRS SRS Distribution Inc.\n\nFiscal 2024 Form 10-K ii","publish_date":null,"title":"COMMONLY USED OR DEFINED TERMS","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page3.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page3.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page3","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page3.pdf"},"started_at":"2026-11-04T19:47:32.883873"} +{"completed_at":"2026-11-04T19:47:35.503180","latency_in_ms":1259,"output":{"example_id":"table/Home Depot 10-k unrestricted_page31","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**ISSUER PURCHASES OF EQUITY SECURITIES**\n\nThe following table presents the number and average price of shares purchased by the Company in each fiscal month of the fourth quarter of fiscal 2024:\n\n**Period**\n\n**Total Number of**\n\n**Shares Purchased**\n\n**Average Price**\n\n**Paid Per Share**\n\n**Total Number of**\n\n**Shares Purchased as Part of**\n\n**Publicly**\n\n**Announced Program**\n\n**Dollar Value of**\n\n**Shares that May Yet**\n\n**Be Purchased Under the**\n\n**Program**\n\nOctober 28, 2024 – November 24, 2024 8,166 $ 411.08 — $ 11,657,503,041\n\nNovember 25, 2024 – December 22, 2024 3,650 422.79 — 11,657,503,041\n\nDecember 23, 2024 – February 2, 2025 2,694 395.74 — 11,657,503,041\n\n14,510 411.18 —\n\n————— _(1) These amounts include deemed repurchases pursuant to our Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022, and our 1997 Omnibus Stock Incentive Plan (collectively, the “Plans”). Under the Plans, participants surrender shares as payment of applicable tax withholding on the vesting of restricted stock. Participants in the Plans may also exercise stock options by surrendering shares of common stock that the participants already own as payment of the exercise price. Shares so surrendered by participants in the Plans are repurchased pursuant to the terms of the Plans and applicable award agreement and not pursuant to publicly announced share repurchase programs._\n\n_(2) On August 14, 2023, our Board approved a $15.0 billion share repurchase authorization that replaced the previous authorization of $15.0 billion, which was approved on August 18, 2022. The August 2023 authorization does not have a prescribed expiration date. As previously disclosed, we paused share repurchases in March 2024._\n\n_(3) Excludes excise taxes incurred on share repurchases._\n\n**SALES OF UNREGISTERED SECURITIES**\n\nDuring the fourth quarter of fiscal 2024, we issued 436 deferred stock units under the Home Depot, Inc. Nonemployee Directors’ Deferred Stock Compensation Plan pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506 of the SEC’s Regulation D thereunder. The deferred stock units were credited during the fourth quarter of fiscal 2024 to the accounts of those non-employee directors who elected to receive all or a portion of board retainers in the form of deferred stock units instead of cash. The deferred stock units convert to shares of common stock on a one-for-one basis following a termination of service as described in the plan.\n\nDuring the fourth quarter of fiscal 2024, we credited 5,865 deferred stock units to participant accounts under the Restoration Plans pursuant to an exemption from the registration requirements of the Securities Act for involuntary, non-contributory plans. The deferred stock units convert to shares of common stock on a one-for-one basis following a termination of service as described in these plans.\n\n**Item 6. Reserved.**\n\n**Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.**\n\nThe following discussion provides an analysis of the Company’s financial condition and results of operations from management's perspective and should be read in conjunction with the consolidated financial statements and related notes included in this report. The discussion in this Form 10-K generally focuses on fiscal 2024 compared to fiscal 2023. A discussion of our results of operations and changes in financial condition for fiscal 2023 compared to fiscal 2022 has been omitted from this report, but can be found in Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Form 10-K for fiscal 2023.\n\n**TABLE OF CONTENTS**\n\nExecutive Summary 28\n\nResults of Operations 29\n\nLiquidity and Capital Resources 31\n\nCritical Accounting Estimates 34\n\n**(1) (1) (2) (2)(3)**\n\nFiscal 2024 Form 10-K 27","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**ISSUER PURCHASES OF EQUITY SECURITIES**\n\nThe following table presents the number and average price of shares purchased by the Company in each fiscal month of the fourth quarter of fiscal 2024:\n\n**Period**\n\n**Total Number of**\n\n**Shares Purchased**\n\n**Average Price**\n\n**Paid Per Share**\n\n**Total Number of**\n\n**Shares Purchased as Part of**\n\n**Publicly**\n\n**Announced Program**\n\n**Dollar Value of**\n\n**Shares that May Yet**\n\n**Be Purchased Under the**\n\n**Program**\n\nOctober 28, 2024 – November 24, 2024 8,166 $ 411.08 — $ 11,657,503,041\n\nNovember 25, 2024 – December 22, 2024 3,650 422.79 — 11,657,503,041\n\nDecember 23, 2024 – February 2, 2025 2,694 395.74 — 11,657,503,041\n\n14,510 411.18 —\n\n————— _(1) These amounts include deemed repurchases pursuant to our Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022, and our 1997 Omnibus Stock Incentive Plan (collectively, the “Plans”). Under the Plans, participants surrender shares as payment of applicable tax withholding on the vesting of restricted stock. Participants in the Plans may also exercise stock options by surrendering shares of common stock that the participants already own as payment of the exercise price. Shares so surrendered by participants in the Plans are repurchased pursuant to the terms of the Plans and applicable award agreement and not pursuant to publicly announced share repurchase programs._\n\n_(2) On August 14, 2023, our Board approved a $15.0 billion share repurchase authorization that replaced the previous authorization of $15.0 billion, which was approved on August 18, 2022. The August 2023 authorization does not have a prescribed expiration date. As previously disclosed, we paused share repurchases in March 2024._\n\n_(3) Excludes excise taxes incurred on share repurchases._\n\n**SALES OF UNREGISTERED SECURITIES**\n\nDuring the fourth quarter of fiscal 2024, we issued 436 deferred stock units under the Home Depot, Inc. Nonemployee Directors’ Deferred Stock Compensation Plan pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506 of the SEC’s Regulation D thereunder. The deferred stock units were credited during the fourth quarter of fiscal 2024 to the accounts of those non-employee directors who elected to receive all or a portion of board retainers in the form of deferred stock units instead of cash. The deferred stock units convert to shares of common stock on a one-for-one basis following a termination of service as described in the plan.\n\nDuring the fourth quarter of fiscal 2024, we credited 5,865 deferred stock units to participant accounts under the Restoration Plans pursuant to an exemption from the registration requirements of the Securities Act for involuntary, non-contributory plans. The deferred stock units convert to shares of common stock on a one-for-one basis following a termination of service as described in these plans.\n\n**Item 6. Reserved.**\n\n**Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.**\n\nThe following discussion provides an analysis of the Company’s financial condition and results of operations from management's perspective and should be read in conjunction with the consolidated financial statements and related notes included in this report. The discussion in this Form 10-K generally focuses on fiscal 2024 compared to fiscal 2023. A discussion of our results of operations and changes in financial condition for fiscal 2023 compared to fiscal 2022 has been omitted from this report, but can be found in Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Form 10-K for fiscal 2023.\n\n**TABLE OF CONTENTS**\n\nExecutive Summary 28\n\nResults of Operations 29\n\nLiquidity and Capital Resources 31\n\nCritical Accounting Estimates 34\n\n**(1) (1) (2) (2)(3)**\n\nFiscal 2024 Form 10-K 27","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**ISSUER PURCHASES OF EQUITY SECURITIES**\n\nThe following table presents the number and average price of shares purchased by the Company in each fiscal month of the fourth quarter of fiscal 2024:\n\n**Period**\n\n**Total Number of**\n\n**Shares Purchased**\n\n**Average Price**\n\n**Paid Per Share**\n\n**Total Number of**\n\n**Shares Purchased as Part of**\n\n**Publicly**\n\n**Announced Program**\n\n**Dollar Value of**\n\n**Shares that May Yet**\n\n**Be Purchased Under the**\n\n**Program**\n\nOctober 28, 2024 – November 24, 2024 8,166 $ 411.08 — $ 11,657,503,041\n\nNovember 25, 2024 – December 22, 2024 3,650 422.79 — 11,657,503,041\n\nDecember 23, 2024 – February 2, 2025 2,694 395.74 — 11,657,503,041\n\n14,510 411.18 —\n\n————— _(1) These amounts include deemed repurchases pursuant to our Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022, and our 1997 Omnibus Stock Incentive Plan (collectively, the “Plans”). Under the Plans, participants surrender shares as payment of applicable tax withholding on the vesting of restricted stock. Participants in the Plans may also exercise stock options by surrendering shares of common stock that the participants already own as payment of the exercise price. Shares so surrendered by participants in the Plans are repurchased pursuant to the terms of the Plans and applicable award agreement and not pursuant to publicly announced share repurchase programs._\n\n_(2) On August 14, 2023, our Board approved a $15.0 billion share repurchase authorization that replaced the previous authorization of $15.0 billion, which was approved on August 18, 2022. The August 2023 authorization does not have a prescribed expiration date. As previously disclosed, we paused share repurchases in March 2024._\n\n_(3) Excludes excise taxes incurred on share repurchases._\n\n**SALES OF UNREGISTERED SECURITIES**\n\nDuring the fourth quarter of fiscal 2024, we issued 436 deferred stock units under the Home Depot, Inc. Nonemployee Directors’ Deferred Stock Compensation Plan pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506 of the SEC’s Regulation D thereunder. The deferred stock units were credited during the fourth quarter of fiscal 2024 to the accounts of those non-employee directors who elected to receive all or a portion of board retainers in the form of deferred stock units instead of cash. The deferred stock units convert to shares of common stock on a one-for-one basis following a termination of service as described in the plan.\n\nDuring the fourth quarter of fiscal 2024, we credited 5,865 deferred stock units to participant accounts under the Restoration Plans pursuant to an exemption from the registration requirements of the Securities Act for involuntary, non-contributory plans. The deferred stock units convert to shares of common stock on a one-for-one basis following a termination of service as described in these plans.\n\n**Item 6. Reserved.**\n\n**Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.**\n\nThe following discussion provides an analysis of the Company’s financial condition and results of operations from management's perspective and should be read in conjunction with the consolidated financial statements and related notes included in this report. The discussion in this Form 10-K generally focuses on fiscal 2024 compared to fiscal 2023. A discussion of our results of operations and changes in financial condition for fiscal 2023 compared to fiscal 2022 has been omitted from this report, but can be found in Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Form 10-K for fiscal 2023.\n\n**TABLE OF CONTENTS**\n\nExecutive Summary 28\n\nResults of Operations 29\n\nLiquidity and Capital Resources 31\n\nCritical Accounting Estimates 34\n\n**(1) (1) (2) (2)(3)**\n\nFiscal 2024 Form 10-K 27","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page31.pdf"]},"response":{"errors":[],"extract_id":"extract_208d95d30dae38c23ad8a9eaac9ae1e3","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**ISSUER PURCHASES OF EQUITY SECURITIES**\n\nThe following table presents the number and average price of shares purchased by the Company in each fiscal month of the fourth quarter of fiscal 2024:\n\n**Period**\n\n**Total Number of**\n\n**Shares Purchased**\n\n**Average Price**\n\n**Paid Per Share**\n\n**Total Number of**\n\n**Shares Purchased as Part of**\n\n**Publicly**\n\n**Announced Program**\n\n**Dollar Value of**\n\n**Shares that May Yet**\n\n**Be Purchased Under the**\n\n**Program**\n\nOctober 28, 2024 – November 24, 2024 8,166 $ 411.08 — $ 11,657,503,041\n\nNovember 25, 2024 – December 22, 2024 3,650 422.79 — 11,657,503,041\n\nDecember 23, 2024 – February 2, 2025 2,694 395.74 — 11,657,503,041\n\n14,510 411.18 —\n\n————— _(1) These amounts include deemed repurchases pursuant to our Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022, and our 1997 Omnibus Stock Incentive Plan (collectively, the “Plans”). Under the Plans, participants surrender shares as payment of applicable tax withholding on the vesting of restricted stock. Participants in the Plans may also exercise stock options by surrendering shares of common stock that the participants already own as payment of the exercise price. Shares so surrendered by participants in the Plans are repurchased pursuant to the terms of the Plans and applicable award agreement and not pursuant to publicly announced share repurchase programs._\n\n_(2) On August 14, 2023, our Board approved a $15.0 billion share repurchase authorization that replaced the previous authorization of $15.0 billion, which was approved on August 18, 2022. The August 2023 authorization does not have a prescribed expiration date. As previously disclosed, we paused share repurchases in March 2024._\n\n_(3) Excludes excise taxes incurred on share repurchases._\n\n**SALES OF UNREGISTERED SECURITIES**\n\nDuring the fourth quarter of fiscal 2024, we issued 436 deferred stock units under the Home Depot, Inc. Nonemployee Directors’ Deferred Stock Compensation Plan pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506 of the SEC’s Regulation D thereunder. The deferred stock units were credited during the fourth quarter of fiscal 2024 to the accounts of those non-employee directors who elected to receive all or a portion of board retainers in the form of deferred stock units instead of cash. The deferred stock units convert to shares of common stock on a one-for-one basis following a termination of service as described in the plan.\n\nDuring the fourth quarter of fiscal 2024, we credited 5,865 deferred stock units to participant accounts under the Restoration Plans pursuant to an exemption from the registration requirements of the Securities Act for involuntary, non-contributory plans. The deferred stock units convert to shares of common stock on a one-for-one basis following a termination of service as described in these plans.\n\n**Item 6. Reserved.**\n\n**Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.**\n\nThe following discussion provides an analysis of the Company’s financial condition and results of operations from management's perspective and should be read in conjunction with the consolidated financial statements and related notes included in this report. The discussion in this Form 10-K generally focuses on fiscal 2024 compared to fiscal 2023. A discussion of our results of operations and changes in financial condition for fiscal 2023 compared to fiscal 2022 has been omitted from this report, but can be found in Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Form 10-K for fiscal 2023.\n\n**TABLE OF CONTENTS**\n\nExecutive Summary 28\n\nResults of Operations 29\n\nLiquidity and Capital Resources 31\n\nCritical Accounting Estimates 34\n\n**(1) (1) (2) (2)(3)**\n\nFiscal 2024 Form 10-K 27"],"full_content":"Table of Contents\n\n**ISSUER PURCHASES OF EQUITY SECURITIES**\n\nThe following table presents the number and average price of shares purchased by the Company in each fiscal month of the fourth quarter of fiscal 2024:\n\n**Period**\n\n**Total Number of**\n\n**Shares Purchased**\n\n**Average Price**\n\n**Paid Per Share**\n\n**Total Number of**\n\n**Shares Purchased as Part of**\n\n**Publicly**\n\n**Announced Program**\n\n**Dollar Value of**\n\n**Shares that May Yet**\n\n**Be Purchased Under the**\n\n**Program**\n\nOctober 28, 2024 – November 24, 2024 8,166 $ 411.08 — $ 11,657,503,041\n\nNovember 25, 2024 – December 22, 2024 3,650 422.79 — 11,657,503,041\n\nDecember 23, 2024 – February 2, 2025 2,694 395.74 — 11,657,503,041\n\n14,510 411.18 —\n\n————— _(1) These amounts include deemed repurchases pursuant to our Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022, and our 1997 Omnibus Stock Incentive Plan (collectively, the “Plans”). Under the Plans, participants surrender shares as payment of applicable tax withholding on the vesting of restricted stock. Participants in the Plans may also exercise stock options by surrendering shares of common stock that the participants already own as payment of the exercise price. Shares so surrendered by participants in the Plans are repurchased pursuant to the terms of the Plans and applicable award agreement and not pursuant to publicly announced share repurchase programs._\n\n_(2) On August 14, 2023, our Board approved a $15.0 billion share repurchase authorization that replaced the previous authorization of $15.0 billion, which was approved on August 18, 2022. The August 2023 authorization does not have a prescribed expiration date. As previously disclosed, we paused share repurchases in March 2024._\n\n_(3) Excludes excise taxes incurred on share repurchases._\n\n**SALES OF UNREGISTERED SECURITIES**\n\nDuring the fourth quarter of fiscal 2024, we issued 436 deferred stock units under the Home Depot, Inc. Nonemployee Directors’ Deferred Stock Compensation Plan pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506 of the SEC’s Regulation D thereunder. The deferred stock units were credited during the fourth quarter of fiscal 2024 to the accounts of those non-employee directors who elected to receive all or a portion of board retainers in the form of deferred stock units instead of cash. The deferred stock units convert to shares of common stock on a one-for-one basis following a termination of service as described in the plan.\n\nDuring the fourth quarter of fiscal 2024, we credited 5,865 deferred stock units to participant accounts under the Restoration Plans pursuant to an exemption from the registration requirements of the Securities Act for involuntary, non-contributory plans. The deferred stock units convert to shares of common stock on a one-for-one basis following a termination of service as described in these plans.\n\n**Item 6. Reserved.**\n\n**Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.**\n\nThe following discussion provides an analysis of the Company’s financial condition and results of operations from management's perspective and should be read in conjunction with the consolidated financial statements and related notes included in this report. The discussion in this Form 10-K generally focuses on fiscal 2024 compared to fiscal 2023. A discussion of our results of operations and changes in financial condition for fiscal 2023 compared to fiscal 2022 has been omitted from this report, but can be found in Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Form 10-K for fiscal 2023.\n\n**TABLE OF CONTENTS**\n\nExecutive Summary 28\n\nResults of Operations 29\n\nLiquidity and Capital Resources 31\n\nCritical Accounting Estimates 34\n\n**(1) (1) (2) (2)(3)**\n\nFiscal 2024 Form 10-K 27","publish_date":null,"title":"Item 6. Reserved. Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page31.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page31.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page31","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page31.pdf"},"started_at":"2026-11-04T19:47:34.243530"} +{"completed_at":"2026-11-04T19:47:37.283367","latency_in_ms":2260,"output":{"example_id":"table/Home Depot 10-k unrestricted_page33","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**RESULTS OF OPERATIONS**\n\nThe following table presents the percentage relationship between net sales and major categories in our consolidated statements of earnings:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**_dollars in millions_** **$ % of Net Sales $ % of Net Sales $ % of Net Sales**\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nGross profit 53,308 33.4 % 50,960 33.4 % 52,778 33.5 %\n\nOperating expenses:\n\nSelling, general and administrative 28,748 18.0 26,598 17.4 26,284 16.7\n\nDepreciation and amortization 3,034 1.9 2,673 1.8 2,455 1.6\n\nTotal operating expenses 31,782 19.9 29,271 19.2 28,739 18.3\n\nOperating income 21,526 13.5 21,689 14.2 24,039 15.3\n\nInterest and other (income) expense:\n\nInterest income and other, net (201) (0.1) (178) (0.1) (55) —\n\nInterest expense 2,321 1.5 1,943 1.3 1,617 1.0\n\nInterest and other, net 2,120 1.3 1,765 1.2 1,562 1.0\n\nEarnings before provision for income taxes 19,406 12.2 19,924 13.1 22,477 14.3\n\nProvision for income taxes 4,600 2.9 4,781 3.1 5,372 3.4\n\nNet earnings $ 14,806 9.3 % $ 15,143 9.9 % $ 17,105 10.9 %\n\n————— _Note: Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks. Certain percentages may not sum to totals due to rounding._\n\n**% Change**\n\n**Selected financial and sales data:**\n\n**Fiscal Fiscal Fiscal Fiscal Fiscal**\n\n**2024 2023 2022 2024 vs. 2023 2023 vs. 2022**\n\nComparable sales (% change) (1.8)% (3.2)% 3.1 % N/A N/A\n\nComparable customer transactions (% change) (1.0)% (2.9)% (5.4)% N/A N/A\n\nComparable average ticket (% change) (0.9)% (0.3)% 8.8 % N/A N/A\n\nCustomer transactions (in millions) 1,637.2 1,621.8 1,666.4 0.9 % (2.7)%\n\nAverage ticket $89.31 $90.07 $90.36 (0.8)% (0.3)%\n\nSales per retail square foot $599.92 $604.55 $627.17 (0.8)% (3.6)%\n\nDiluted earnings per share $14.91 $15.11 $16.69 (1.3)% (9.5)%\n\n————— _(1) Does not include results from the 53 week of fiscal 2024._\n\n_(2) Customer transactions, average ticket, and sales per retail square foot measures do not include results from HD Supply or SRS._\n\n_(3) Average ticket represents the average price paid per transaction and is used by management to monitor the performance of the Company, as it represents a primary driver in measuring sales performance._\n\n_(4) Sales per retail square foot represents sales divided by retail store square footage. Sales per retail square foot is a measure of the efficiency of sales based on the total square footage of our stores and is used by management to monitor the performance of the Company’s retail operations as an indicator of the productivity of owned and leased square footage for these retail operations._\n\n_(5) The 53rd week of fiscal 2024 increased diluted earnings per share by approximately $0.30._\n\n**FISCAL 2024 COMPARED TO FISCAL 2023**\n\n**Sales**\n\nWe assess our sales performance by evaluating both net sales and comparable sales.\n\n(1)\n\n(1) (2)\n\n(1) (2) (3)\n\n(2)\n\n(2) (3)\n\n(2) (4)\n\n(5)\n\n_rd_\n\nFiscal 2024 Form 10-K 29","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**RESULTS OF OPERATIONS**\n\nThe following table presents the percentage relationship between net sales and major categories in our consolidated statements of earnings:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**_dollars in millions_** **$ % of Net Sales $ % of Net Sales $ % of Net Sales**\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nGross profit 53,308 33.4 % 50,960 33.4 % 52,778 33.5 %\n\nOperating expenses:\n\nSelling, general and administrative 28,748 18.0 26,598 17.4 26,284 16.7\n\nDepreciation and amortization 3,034 1.9 2,673 1.8 2,455 1.6\n\nTotal operating expenses 31,782 19.9 29,271 19.2 28,739 18.3\n\nOperating income 21,526 13.5 21,689 14.2 24,039 15.3\n\nInterest and other (income) expense:\n\nInterest income and other, net (201) (0.1) (178) (0.1) (55) —\n\nInterest expense 2,321 1.5 1,943 1.3 1,617 1.0\n\nInterest and other, net 2,120 1.3 1,765 1.2 1,562 1.0\n\nEarnings before provision for income taxes 19,406 12.2 19,924 13.1 22,477 14.3\n\nProvision for income taxes 4,600 2.9 4,781 3.1 5,372 3.4\n\nNet earnings $ 14,806 9.3 % $ 15,143 9.9 % $ 17,105 10.9 %\n\n————— _Note: Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks. Certain percentages may not sum to totals due to rounding._\n\n**% Change**\n\n**Selected financial and sales data:**\n\n**Fiscal Fiscal Fiscal Fiscal Fiscal**\n\n**2024 2023 2022 2024 vs. 2023 2023 vs. 2022**\n\nComparable sales (% change) (1.8)% (3.2)% 3.1 % N/A N/A\n\nComparable customer transactions (% change) (1.0)% (2.9)% (5.4)% N/A N/A\n\nComparable average ticket (% change) (0.9)% (0.3)% 8.8 % N/A N/A\n\nCustomer transactions (in millions) 1,637.2 1,621.8 1,666.4 0.9 % (2.7)%\n\nAverage ticket $89.31 $90.07 $90.36 (0.8)% (0.3)%\n\nSales per retail square foot $599.92 $604.55 $627.17 (0.8)% (3.6)%\n\nDiluted earnings per share $14.91 $15.11 $16.69 (1.3)% (9.5)%\n\n————— _(1) Does not include results from the 53 week of fiscal 2024._\n\n_(2) Customer transactions, average ticket, and sales per retail square foot measures do not include results from HD Supply or SRS._\n\n_(3) Average ticket represents the average price paid per transaction and is used by management to monitor the performance of the Company, as it represents a primary driver in measuring sales performance._\n\n_(4) Sales per retail square foot represents sales divided by retail store square footage. Sales per retail square foot is a measure of the efficiency of sales based on the total square footage of our stores and is used by management to monitor the performance of the Company’s retail operations as an indicator of the productivity of owned and leased square footage for these retail operations._\n\n_(5) The 53rd week of fiscal 2024 increased diluted earnings per share by approximately $0.30._\n\n**FISCAL 2024 COMPARED TO FISCAL 2023**\n\n**Sales**\n\nWe assess our sales performance by evaluating both net sales and comparable sales.\n\n(1)\n\n(1) (2)\n\n(1) (2) (3)\n\n(2)\n\n(2) (3)\n\n(2) (4)\n\n(5)\n\n_rd_\n\nFiscal 2024 Form 10-K 29","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**RESULTS OF OPERATIONS**\n\nThe following table presents the percentage relationship between net sales and major categories in our consolidated statements of earnings:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**_dollars in millions_** **$ % of Net Sales $ % of Net Sales $ % of Net Sales**\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nGross profit 53,308 33.4 % 50,960 33.4 % 52,778 33.5 %\n\nOperating expenses:\n\nSelling, general and administrative 28,748 18.0 26,598 17.4 26,284 16.7\n\nDepreciation and amortization 3,034 1.9 2,673 1.8 2,455 1.6\n\nTotal operating expenses 31,782 19.9 29,271 19.2 28,739 18.3\n\nOperating income 21,526 13.5 21,689 14.2 24,039 15.3\n\nInterest and other (income) expense:\n\nInterest income and other, net (201) (0.1) (178) (0.1) (55) —\n\nInterest expense 2,321 1.5 1,943 1.3 1,617 1.0\n\nInterest and other, net 2,120 1.3 1,765 1.2 1,562 1.0\n\nEarnings before provision for income taxes 19,406 12.2 19,924 13.1 22,477 14.3\n\nProvision for income taxes 4,600 2.9 4,781 3.1 5,372 3.4\n\nNet earnings $ 14,806 9.3 % $ 15,143 9.9 % $ 17,105 10.9 %\n\n————— _Note: Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks. Certain percentages may not sum to totals due to rounding._\n\n**% Change**\n\n**Selected financial and sales data:**\n\n**Fiscal Fiscal Fiscal Fiscal Fiscal**\n\n**2024 2023 2022 2024 vs. 2023 2023 vs. 2022**\n\nComparable sales (% change) (1.8)% (3.2)% 3.1 % N/A N/A\n\nComparable customer transactions (% change) (1.0)% (2.9)% (5.4)% N/A N/A\n\nComparable average ticket (% change) (0.9)% (0.3)% 8.8 % N/A N/A\n\nCustomer transactions (in millions) 1,637.2 1,621.8 1,666.4 0.9 % (2.7)%\n\nAverage ticket $89.31 $90.07 $90.36 (0.8)% (0.3)%\n\nSales per retail square foot $599.92 $604.55 $627.17 (0.8)% (3.6)%\n\nDiluted earnings per share $14.91 $15.11 $16.69 (1.3)% (9.5)%\n\n————— _(1) Does not include results from the 53 week of fiscal 2024._\n\n_(2) Customer transactions, average ticket, and sales per retail square foot measures do not include results from HD Supply or SRS._\n\n_(3) Average ticket represents the average price paid per transaction and is used by management to monitor the performance of the Company, as it represents a primary driver in measuring sales performance._\n\n_(4) Sales per retail square foot represents sales divided by retail store square footage. Sales per retail square foot is a measure of the efficiency of sales based on the total square footage of our stores and is used by management to monitor the performance of the Company’s retail operations as an indicator of the productivity of owned and leased square footage for these retail operations._\n\n_(5) The 53rd week of fiscal 2024 increased diluted earnings per share by approximately $0.30._\n\n**FISCAL 2024 COMPARED TO FISCAL 2023**\n\n**Sales**\n\nWe assess our sales performance by evaluating both net sales and comparable sales.\n\n(1)\n\n(1) (2)\n\n(1) (2) (3)\n\n(2)\n\n(2) (3)\n\n(2) (4)\n\n(5)\n\n_rd_\n\nFiscal 2024 Form 10-K 29","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page33.pdf"]},"response":{"errors":[],"extract_id":"extract_dd5c2eb1083a327faaa4ab45355dad50","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**RESULTS OF OPERATIONS**\n\nThe following table presents the percentage relationship between net sales and major categories in our consolidated statements of earnings:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**_dollars in millions_** **$ % of Net Sales $ % of Net Sales $ % of Net Sales**\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nGross profit 53,308 33.4 % 50,960 33.4 % 52,778 33.5 %\n\nOperating expenses:\n\nSelling, general and administrative 28,748 18.0 26,598 17.4 26,284 16.7\n\nDepreciation and amortization 3,034 1.9 2,673 1.8 2,455 1.6\n\nTotal operating expenses 31,782 19.9 29,271 19.2 28,739 18.3\n\nOperating income 21,526 13.5 21,689 14.2 24,039 15.3\n\nInterest and other (income) expense:\n\nInterest income and other, net (201) (0.1) (178) (0.1) (55) —\n\nInterest expense 2,321 1.5 1,943 1.3 1,617 1.0\n\nInterest and other, net 2,120 1.3 1,765 1.2 1,562 1.0\n\nEarnings before provision for income taxes 19,406 12.2 19,924 13.1 22,477 14.3\n\nProvision for income taxes 4,600 2.9 4,781 3.1 5,372 3.4\n\nNet earnings $ 14,806 9.3 % $ 15,143 9.9 % $ 17,105 10.9 %\n\n————— _Note: Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks. Certain percentages may not sum to totals due to rounding._\n\n**% Change**\n\n**Selected financial and sales data:**\n\n**Fiscal Fiscal Fiscal Fiscal Fiscal**\n\n**2024 2023 2022 2024 vs. 2023 2023 vs. 2022**\n\nComparable sales (% change) (1.8)% (3.2)% 3.1 % N/A N/A\n\nComparable customer transactions (% change) (1.0)% (2.9)% (5.4)% N/A N/A\n\nComparable average ticket (% change) (0.9)% (0.3)% 8.8 % N/A N/A\n\nCustomer transactions (in millions) 1,637.2 1,621.8 1,666.4 0.9 % (2.7)%\n\nAverage ticket $89.31 $90.07 $90.36 (0.8)% (0.3)%\n\nSales per retail square foot $599.92 $604.55 $627.17 (0.8)% (3.6)%\n\nDiluted earnings per share $14.91 $15.11 $16.69 (1.3)% (9.5)%\n\n————— _(1) Does not include results from the 53 week of fiscal 2024._\n\n_(2) Customer transactions, average ticket, and sales per retail square foot measures do not include results from HD Supply or SRS._\n\n_(3) Average ticket represents the average price paid per transaction and is used by management to monitor the performance of the Company, as it represents a primary driver in measuring sales performance._\n\n_(4) Sales per retail square foot represents sales divided by retail store square footage. Sales per retail square foot is a measure of the efficiency of sales based on the total square footage of our stores and is used by management to monitor the performance of the Company’s retail operations as an indicator of the productivity of owned and leased square footage for these retail operations._\n\n_(5) The 53rd week of fiscal 2024 increased diluted earnings per share by approximately $0.30._\n\n**FISCAL 2024 COMPARED TO FISCAL 2023**\n\n**Sales**\n\nWe assess our sales performance by evaluating both net sales and comparable sales.\n\n(1)\n\n(1) (2)\n\n(1) (2) (3)\n\n(2)\n\n(2) (3)\n\n(2) (4)\n\n(5)\n\n_rd_\n\nFiscal 2024 Form 10-K 29"],"full_content":"Table of Contents\n\n**RESULTS OF OPERATIONS**\n\nThe following table presents the percentage relationship between net sales and major categories in our consolidated statements of earnings:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**_dollars in millions_** **$ % of Net Sales $ % of Net Sales $ % of Net Sales**\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nGross profit 53,308 33.4 % 50,960 33.4 % 52,778 33.5 %\n\nOperating expenses:\n\nSelling, general and administrative 28,748 18.0 26,598 17.4 26,284 16.7\n\nDepreciation and amortization 3,034 1.9 2,673 1.8 2,455 1.6\n\nTotal operating expenses 31,782 19.9 29,271 19.2 28,739 18.3\n\nOperating income 21,526 13.5 21,689 14.2 24,039 15.3\n\nInterest and other (income) expense:\n\nInterest income and other, net (201) (0.1) (178) (0.1) (55) —\n\nInterest expense 2,321 1.5 1,943 1.3 1,617 1.0\n\nInterest and other, net 2,120 1.3 1,765 1.2 1,562 1.0\n\nEarnings before provision for income taxes 19,406 12.2 19,924 13.1 22,477 14.3\n\nProvision for income taxes 4,600 2.9 4,781 3.1 5,372 3.4\n\nNet earnings $ 14,806 9.3 % $ 15,143 9.9 % $ 17,105 10.9 %\n\n————— _Note: Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks. Certain percentages may not sum to totals due to rounding._\n\n**% Change**\n\n**Selected financial and sales data:**\n\n**Fiscal Fiscal Fiscal Fiscal Fiscal**\n\n**2024 2023 2022 2024 vs. 2023 2023 vs. 2022**\n\nComparable sales (% change) (1.8)% (3.2)% 3.1 % N/A N/A\n\nComparable customer transactions (% change) (1.0)% (2.9)% (5.4)% N/A N/A\n\nComparable average ticket (% change) (0.9)% (0.3)% 8.8 % N/A N/A\n\nCustomer transactions (in millions) 1,637.2 1,621.8 1,666.4 0.9 % (2.7)%\n\nAverage ticket $89.31 $90.07 $90.36 (0.8)% (0.3)%\n\nSales per retail square foot $599.92 $604.55 $627.17 (0.8)% (3.6)%\n\nDiluted earnings per share $14.91 $15.11 $16.69 (1.3)% (9.5)%\n\n————— _(1) Does not include results from the 53 week of fiscal 2024._\n\n_(2) Customer transactions, average ticket, and sales per retail square foot measures do not include results from HD Supply or SRS._\n\n_(3) Average ticket represents the average price paid per transaction and is used by management to monitor the performance of the Company, as it represents a primary driver in measuring sales performance._\n\n_(4) Sales per retail square foot represents sales divided by retail store square footage. Sales per retail square foot is a measure of the efficiency of sales based on the total square footage of our stores and is used by management to monitor the performance of the Company’s retail operations as an indicator of the productivity of owned and leased square footage for these retail operations._\n\n_(5) The 53rd week of fiscal 2024 increased diluted earnings per share by approximately $0.30._\n\n**FISCAL 2024 COMPARED TO FISCAL 2023**\n\n**Sales**\n\nWe assess our sales performance by evaluating both net sales and comparable sales.\n\n(1)\n\n(1) (2)\n\n(1) (2) (3)\n\n(2)\n\n(2) (3)\n\n(2) (4)\n\n(5)\n\n_rd_\n\nFiscal 2024 Form 10-K 29","publish_date":null,"title":"RESULTS OF OPERATIONS The following table presents the percentage relationship between net sales and major categories in our consolidated statements","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page33.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page33.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page33","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page33.pdf"},"started_at":"2026-11-04T19:47:35.022845"} +{"completed_at":"2026-11-04T19:47:39.304459","latency_in_ms":2788,"output":{"example_id":"table/Home Depot 10-k unrestricted_page45","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet earnings $ 14,806 $ 15,143 $ 17,105\n\nOther comprehensive income (loss), net of tax:\n\nForeign currency translation adjustments (605) 232 (22)\n\nCash flow hedges (45) 8 9\n\nOther (2) 1 (1)\n\nTotal other comprehensive income (loss), net of tax (652) 241 (14)\n\nComprehensive income $ 14,154 $ 15,384 $ 17,091\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 41","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet earnings $ 14,806 $ 15,143 $ 17,105\n\nOther comprehensive income (loss), net of tax:\n\nForeign currency translation adjustments (605) 232 (22)\n\nCash flow hedges (45) 8 9\n\nOther (2) 1 (1)\n\nTotal other comprehensive income (loss), net of tax (652) 241 (14)\n\nComprehensive income $ 14,154 $ 15,384 $ 17,091\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 41","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet earnings $ 14,806 $ 15,143 $ 17,105\n\nOther comprehensive income (loss), net of tax:\n\nForeign currency translation adjustments (605) 232 (22)\n\nCash flow hedges (45) 8 9\n\nOther (2) 1 (1)\n\nTotal other comprehensive income (loss), net of tax (652) 241 (14)\n\nComprehensive income $ 14,154 $ 15,384 $ 17,091\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 41","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page45.pdf"]},"response":{"errors":[],"extract_id":"extract_c2c099e91af5a5bdff6d3c43cc577d0e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet earnings $ 14,806 $ 15,143 $ 17,105\n\nOther comprehensive income (loss), net of tax:\n\nForeign currency translation adjustments (605) 232 (22)\n\nCash flow hedges (45) 8 9\n\nOther (2) 1 (1)\n\nTotal other comprehensive income (loss), net of tax (652) 241 (14)\n\nComprehensive income $ 14,154 $ 15,384 $ 17,091\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 41"],"full_content":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet earnings $ 14,806 $ 15,143 $ 17,105\n\nOther comprehensive income (loss), net of tax:\n\nForeign currency translation adjustments (605) 232 (22)\n\nCash flow hedges (45) 8 9\n\nOther (2) 1 (1)\n\nTotal other comprehensive income (loss), net of tax (652) 241 (14)\n\nComprehensive income $ 14,154 $ 15,384 $ 17,091\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 41","publish_date":null,"title":"THE HOME DEPOT, INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Net earnings $ 14,806 $ 15,143 $ 17,105 Other comprehensive income","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page45.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page45.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page45","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page45.pdf"},"started_at":"2026-11-04T19:47:36.516232"} +{"completed_at":"2026-11-04T19:47:38.713188","latency_in_ms":1224,"output":{"example_id":"table/Home Depot 10-k unrestricted_page46","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY**\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**Common Stock:** Balance at beginning of year $ 90 $ 90 $ 90\n\nShares issued under employee stock plans, net — — —\n\nBalance at end of year 90 90 90\n\n**Paid-in Capital:** Balance at beginning of year 13,147 12,592 12,132\n\nShares issued under employee stock plans, net 530 175 94\n\nStock-based compensation expense 440 380 366\n\nBalance at end of year 14,117 13,147 12,592\n\n**Retained Earnings:** Balance at beginning of year 83,656 76,896 67,580\n\nNet earnings 14,806 15,143 17,105\n\nCash dividends (8,929) (8,383) (7,789)\n\nBalance at end of year 89,533 83,656 76,896\n\n**Accumulated Other Comprehensive Loss:** Balance at beginning of year (477) (718) (704)\n\nForeign currency translation adjustments, net of tax (605) 232 (22)\n\nCash flow hedges, net of tax (45) 8 9\n\nOther, net of tax (2) 1 (1)\n\nBalance at end of year (1,129) (477) (718)\n\n**Treasury Stock:** Balance at beginning of year (95,372) (87,298) (80,794)\n\nRepurchases of common stock (599) (8,074) (6,504)\n\nBalance at end of year (95,971) (95,372) (87,298)\n\nTotal stockholders’ equity $ 6,640 $ 1,044 $ 1,562\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 42","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY**\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**Common Stock:** Balance at beginning of year $ 90 $ 90 $ 90\n\nShares issued under employee stock plans, net — — —\n\nBalance at end of year 90 90 90\n\n**Paid-in Capital:** Balance at beginning of year 13,147 12,592 12,132\n\nShares issued under employee stock plans, net 530 175 94\n\nStock-based compensation expense 440 380 366\n\nBalance at end of year 14,117 13,147 12,592\n\n**Retained Earnings:** Balance at beginning of year 83,656 76,896 67,580\n\nNet earnings 14,806 15,143 17,105\n\nCash dividends (8,929) (8,383) (7,789)\n\nBalance at end of year 89,533 83,656 76,896\n\n**Accumulated Other Comprehensive Loss:** Balance at beginning of year (477) (718) (704)\n\nForeign currency translation adjustments, net of tax (605) 232 (22)\n\nCash flow hedges, net of tax (45) 8 9\n\nOther, net of tax (2) 1 (1)\n\nBalance at end of year (1,129) (477) (718)\n\n**Treasury Stock:** Balance at beginning of year (95,372) (87,298) (80,794)\n\nRepurchases of common stock (599) (8,074) (6,504)\n\nBalance at end of year (95,971) (95,372) (87,298)\n\nTotal stockholders’ equity $ 6,640 $ 1,044 $ 1,562\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 42","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY**\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**Common Stock:** Balance at beginning of year $ 90 $ 90 $ 90\n\nShares issued under employee stock plans, net — — —\n\nBalance at end of year 90 90 90\n\n**Paid-in Capital:** Balance at beginning of year 13,147 12,592 12,132\n\nShares issued under employee stock plans, net 530 175 94\n\nStock-based compensation expense 440 380 366\n\nBalance at end of year 14,117 13,147 12,592\n\n**Retained Earnings:** Balance at beginning of year 83,656 76,896 67,580\n\nNet earnings 14,806 15,143 17,105\n\nCash dividends (8,929) (8,383) (7,789)\n\nBalance at end of year 89,533 83,656 76,896\n\n**Accumulated Other Comprehensive Loss:** Balance at beginning of year (477) (718) (704)\n\nForeign currency translation adjustments, net of tax (605) 232 (22)\n\nCash flow hedges, net of tax (45) 8 9\n\nOther, net of tax (2) 1 (1)\n\nBalance at end of year (1,129) (477) (718)\n\n**Treasury Stock:** Balance at beginning of year (95,372) (87,298) (80,794)\n\nRepurchases of common stock (599) (8,074) (6,504)\n\nBalance at end of year (95,971) (95,372) (87,298)\n\nTotal stockholders’ equity $ 6,640 $ 1,044 $ 1,562\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 42","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page46.pdf"]},"response":{"errors":[],"extract_id":"extract_704d8e9ea36ee7e7b81405b348971fa0","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY**\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**Common Stock:** Balance at beginning of year $ 90 $ 90 $ 90\n\nShares issued under employee stock plans, net — — —\n\nBalance at end of year 90 90 90\n\n**Paid-in Capital:** Balance at beginning of year 13,147 12,592 12,132\n\nShares issued under employee stock plans, net 530 175 94\n\nStock-based compensation expense 440 380 366\n\nBalance at end of year 14,117 13,147 12,592\n\n**Retained Earnings:** Balance at beginning of year 83,656 76,896 67,580\n\nNet earnings 14,806 15,143 17,105\n\nCash dividends (8,929) (8,383) (7,789)\n\nBalance at end of year 89,533 83,656 76,896\n\n**Accumulated Other Comprehensive Loss:** Balance at beginning of year (477) (718) (704)\n\nForeign currency translation adjustments, net of tax (605) 232 (22)\n\nCash flow hedges, net of tax (45) 8 9\n\nOther, net of tax (2) 1 (1)\n\nBalance at end of year (1,129) (477) (718)\n\n**Treasury Stock:** Balance at beginning of year (95,372) (87,298) (80,794)\n\nRepurchases of common stock (599) (8,074) (6,504)\n\nBalance at end of year (95,971) (95,372) (87,298)\n\nTotal stockholders’ equity $ 6,640 $ 1,044 $ 1,562\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 42"],"full_content":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY**\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**Common Stock:** Balance at beginning of year $ 90 $ 90 $ 90\n\nShares issued under employee stock plans, net — — —\n\nBalance at end of year 90 90 90\n\n**Paid-in Capital:** Balance at beginning of year 13,147 12,592 12,132\n\nShares issued under employee stock plans, net 530 175 94\n\nStock-based compensation expense 440 380 366\n\nBalance at end of year 14,117 13,147 12,592\n\n**Retained Earnings:** Balance at beginning of year 83,656 76,896 67,580\n\nNet earnings 14,806 15,143 17,105\n\nCash dividends (8,929) (8,383) (7,789)\n\nBalance at end of year 89,533 83,656 76,896\n\n**Accumulated Other Comprehensive Loss:** Balance at beginning of year (477) (718) (704)\n\nForeign currency translation adjustments, net of tax (605) 232 (22)\n\nCash flow hedges, net of tax (45) 8 9\n\nOther, net of tax (2) 1 (1)\n\nBalance at end of year (1,129) (477) (718)\n\n**Treasury Stock:** Balance at beginning of year (95,372) (87,298) (80,794)\n\nRepurchases of common stock (599) (8,074) (6,504)\n\nBalance at end of year (95,971) (95,372) (87,298)\n\nTotal stockholders’ equity $ 6,640 $ 1,044 $ 1,562\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 42","publish_date":null,"title":"THE HOME DEPOT, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY Common Stock: Balance at beginning of year $ 90 $ 90","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page46.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page46.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page46","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page46.pdf"},"started_at":"2026-11-04T19:47:37.488242"} +{"completed_at":"2026-11-04T19:47:41.587088","latency_in_ms":2871,"output":{"example_id":"table/Home Depot 10-k unrestricted_page47","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF CASH FLOWS**\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\n**Cash Flows from Operating Activities:** Net earnings $ 14,806 $ 15,143 $ 17,105\n\nReconciliation of net earnings to net cash provided by operating activities:\n\nDepreciation and amortization, excluding amortization of intangible assets 3,336 3,061 2,796\n\nIntangible asset amortization 425 186 179\n\nStock-based compensation expense 442 380 366\n\nChanges in receivables, net 174 134 111\n\nChanges in merchandise inventories (743) 4,137 (2,830)\n\nChanges in other current assets 86 (184) (311)\n\nChanges in accounts payable and accrued expenses 518 (1,411) (2,577)\n\nChanges in deferred revenue (165) (318) (526)\n\nChanges in income taxes payable 809 (25) (107)\n\nChanges in deferred income taxes 15 (245) 138\n\nOther operating activities 107 314 271\n\nNet cash provided by operating activities 19,810 21,172 14,615\n\n**Cash Flows from Investing Activities:** Capital expenditures (3,485) (3,226) (3,119)\n\nPayments for businesses acquired, net (17,644) (1,514) —\n\nOther investing activities 98 11 (21)\n\nNet cash used in investing activities (21,031) (4,729) (3,140)\n\n**Cash Flows from Financing Activities:** Proceeds from (repayments of) short-term debt, net 316 — (1,035)\n\nProceeds from long-term debt, net of discounts 10,010 1,995 6,942\n\nRepayments of long-term debt (1,536) (1,271) (2,491)\n\nRepurchases of common stock (649) (7,951) (6,696)\n\nProceeds from sales of common stock 395 323 264\n\nCash dividends (8,929) (8,383) (7,789)\n\nOther financing activities (301) (156) (188)\n\nNet cash used in financing activities (694) (15,443) (10,993)\n\nChange in cash and cash equivalents (1,915) 1,000 482\n\nEffect of exchange rate changes on cash and cash equivalents (186) 3 (68)\n\nCash and cash equivalents at beginning of year 3,760 2,757 2,343\n\nCash and cash equivalents at end of year $ 1,659 $ 3,760 $ 2,757\n\n**Supplemental Disclosures:** Cash paid for income taxes $ 3,653 $ 5,023 $ 5,435\n\nCash paid for interest, net of interest capitalized 2,199 1,809 1,449\n\nNon-cash capital expenditures 250 364 351\n\nNon-cash acquisition purchase consideration (Note 13) 321 — —\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 43","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF CASH FLOWS**\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\n**Cash Flows from Operating Activities:** Net earnings $ 14,806 $ 15,143 $ 17,105\n\nReconciliation of net earnings to net cash provided by operating activities:\n\nDepreciation and amortization, excluding amortization of intangible assets 3,336 3,061 2,796\n\nIntangible asset amortization 425 186 179\n\nStock-based compensation expense 442 380 366\n\nChanges in receivables, net 174 134 111\n\nChanges in merchandise inventories (743) 4,137 (2,830)\n\nChanges in other current assets 86 (184) (311)\n\nChanges in accounts payable and accrued expenses 518 (1,411) (2,577)\n\nChanges in deferred revenue (165) (318) (526)\n\nChanges in income taxes payable 809 (25) (107)\n\nChanges in deferred income taxes 15 (245) 138\n\nOther operating activities 107 314 271\n\nNet cash provided by operating activities 19,810 21,172 14,615\n\n**Cash Flows from Investing Activities:** Capital expenditures (3,485) (3,226) (3,119)\n\nPayments for businesses acquired, net (17,644) (1,514) —\n\nOther investing activities 98 11 (21)\n\nNet cash used in investing activities (21,031) (4,729) (3,140)\n\n**Cash Flows from Financing Activities:** Proceeds from (repayments of) short-term debt, net 316 — (1,035)\n\nProceeds from long-term debt, net of discounts 10,010 1,995 6,942\n\nRepayments of long-term debt (1,536) (1,271) (2,491)\n\nRepurchases of common stock (649) (7,951) (6,696)\n\nProceeds from sales of common stock 395 323 264\n\nCash dividends (8,929) (8,383) (7,789)\n\nOther financing activities (301) (156) (188)\n\nNet cash used in financing activities (694) (15,443) (10,993)\n\nChange in cash and cash equivalents (1,915) 1,000 482\n\nEffect of exchange rate changes on cash and cash equivalents (186) 3 (68)\n\nCash and cash equivalents at beginning of year 3,760 2,757 2,343\n\nCash and cash equivalents at end of year $ 1,659 $ 3,760 $ 2,757\n\n**Supplemental Disclosures:** Cash paid for income taxes $ 3,653 $ 5,023 $ 5,435\n\nCash paid for interest, net of interest capitalized 2,199 1,809 1,449\n\nNon-cash capital expenditures 250 364 351\n\nNon-cash acquisition purchase consideration (Note 13) 321 — —\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 43","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF CASH FLOWS**\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\n**Cash Flows from Operating Activities:** Net earnings $ 14,806 $ 15,143 $ 17,105\n\nReconciliation of net earnings to net cash provided by operating activities:\n\nDepreciation and amortization, excluding amortization of intangible assets 3,336 3,061 2,796\n\nIntangible asset amortization 425 186 179\n\nStock-based compensation expense 442 380 366\n\nChanges in receivables, net 174 134 111\n\nChanges in merchandise inventories (743) 4,137 (2,830)\n\nChanges in other current assets 86 (184) (311)\n\nChanges in accounts payable and accrued expenses 518 (1,411) (2,577)\n\nChanges in deferred revenue (165) (318) (526)\n\nChanges in income taxes payable 809 (25) (107)\n\nChanges in deferred income taxes 15 (245) 138\n\nOther operating activities 107 314 271\n\nNet cash provided by operating activities 19,810 21,172 14,615\n\n**Cash Flows from Investing Activities:** Capital expenditures (3,485) (3,226) (3,119)\n\nPayments for businesses acquired, net (17,644) (1,514) —\n\nOther investing activities 98 11 (21)\n\nNet cash used in investing activities (21,031) (4,729) (3,140)\n\n**Cash Flows from Financing Activities:** Proceeds from (repayments of) short-term debt, net 316 — (1,035)\n\nProceeds from long-term debt, net of discounts 10,010 1,995 6,942\n\nRepayments of long-term debt (1,536) (1,271) (2,491)\n\nRepurchases of common stock (649) (7,951) (6,696)\n\nProceeds from sales of common stock 395 323 264\n\nCash dividends (8,929) (8,383) (7,789)\n\nOther financing activities (301) (156) (188)\n\nNet cash used in financing activities (694) (15,443) (10,993)\n\nChange in cash and cash equivalents (1,915) 1,000 482\n\nEffect of exchange rate changes on cash and cash equivalents (186) 3 (68)\n\nCash and cash equivalents at beginning of year 3,760 2,757 2,343\n\nCash and cash equivalents at end of year $ 1,659 $ 3,760 $ 2,757\n\n**Supplemental Disclosures:** Cash paid for income taxes $ 3,653 $ 5,023 $ 5,435\n\nCash paid for interest, net of interest capitalized 2,199 1,809 1,449\n\nNon-cash capital expenditures 250 364 351\n\nNon-cash acquisition purchase consideration (Note 13) 321 — —\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 43","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page47.pdf"]},"response":{"errors":[],"extract_id":"extract_09e2dbbde85c836ebbc6a9bf61ef9b3d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF CASH FLOWS**\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\n**Cash Flows from Operating Activities:** Net earnings $ 14,806 $ 15,143 $ 17,105\n\nReconciliation of net earnings to net cash provided by operating activities:\n\nDepreciation and amortization, excluding amortization of intangible assets 3,336 3,061 2,796\n\nIntangible asset amortization 425 186 179\n\nStock-based compensation expense 442 380 366\n\nChanges in receivables, net 174 134 111\n\nChanges in merchandise inventories (743) 4,137 (2,830)\n\nChanges in other current assets 86 (184) (311)\n\nChanges in accounts payable and accrued expenses 518 (1,411) (2,577)\n\nChanges in deferred revenue (165) (318) (526)\n\nChanges in income taxes payable 809 (25) (107)\n\nChanges in deferred income taxes 15 (245) 138\n\nOther operating activities 107 314 271\n\nNet cash provided by operating activities 19,810 21,172 14,615\n\n**Cash Flows from Investing Activities:** Capital expenditures (3,485) (3,226) (3,119)\n\nPayments for businesses acquired, net (17,644) (1,514) —\n\nOther investing activities 98 11 (21)\n\nNet cash used in investing activities (21,031) (4,729) (3,140)\n\n**Cash Flows from Financing Activities:** Proceeds from (repayments of) short-term debt, net 316 — (1,035)\n\nProceeds from long-term debt, net of discounts 10,010 1,995 6,942\n\nRepayments of long-term debt (1,536) (1,271) (2,491)\n\nRepurchases of common stock (649) (7,951) (6,696)\n\nProceeds from sales of common stock 395 323 264\n\nCash dividends (8,929) (8,383) (7,789)\n\nOther financing activities (301) (156) (188)\n\nNet cash used in financing activities (694) (15,443) (10,993)\n\nChange in cash and cash equivalents (1,915) 1,000 482\n\nEffect of exchange rate changes on cash and cash equivalents (186) 3 (68)\n\nCash and cash equivalents at beginning of year 3,760 2,757 2,343\n\nCash and cash equivalents at end of year $ 1,659 $ 3,760 $ 2,757\n\n**Supplemental Disclosures:** Cash paid for income taxes $ 3,653 $ 5,023 $ 5,435\n\nCash paid for interest, net of interest capitalized 2,199 1,809 1,449\n\nNon-cash capital expenditures 250 364 351\n\nNon-cash acquisition purchase consideration (Note 13) 321 — —\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 43"],"full_content":"Table of Contents\n\n**THE HOME DEPOT, INC.**\n\n**CONSOLIDATED STATEMENTS OF CASH FLOWS**\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\n**Cash Flows from Operating Activities:** Net earnings $ 14,806 $ 15,143 $ 17,105\n\nReconciliation of net earnings to net cash provided by operating activities:\n\nDepreciation and amortization, excluding amortization of intangible assets 3,336 3,061 2,796\n\nIntangible asset amortization 425 186 179\n\nStock-based compensation expense 442 380 366\n\nChanges in receivables, net 174 134 111\n\nChanges in merchandise inventories (743) 4,137 (2,830)\n\nChanges in other current assets 86 (184) (311)\n\nChanges in accounts payable and accrued expenses 518 (1,411) (2,577)\n\nChanges in deferred revenue (165) (318) (526)\n\nChanges in income taxes payable 809 (25) (107)\n\nChanges in deferred income taxes 15 (245) 138\n\nOther operating activities 107 314 271\n\nNet cash provided by operating activities 19,810 21,172 14,615\n\n**Cash Flows from Investing Activities:** Capital expenditures (3,485) (3,226) (3,119)\n\nPayments for businesses acquired, net (17,644) (1,514) —\n\nOther investing activities 98 11 (21)\n\nNet cash used in investing activities (21,031) (4,729) (3,140)\n\n**Cash Flows from Financing Activities:** Proceeds from (repayments of) short-term debt, net 316 — (1,035)\n\nProceeds from long-term debt, net of discounts 10,010 1,995 6,942\n\nRepayments of long-term debt (1,536) (1,271) (2,491)\n\nRepurchases of common stock (649) (7,951) (6,696)\n\nProceeds from sales of common stock 395 323 264\n\nCash dividends (8,929) (8,383) (7,789)\n\nOther financing activities (301) (156) (188)\n\nNet cash used in financing activities (694) (15,443) (10,993)\n\nChange in cash and cash equivalents (1,915) 1,000 482\n\nEffect of exchange rate changes on cash and cash equivalents (186) 3 (68)\n\nCash and cash equivalents at beginning of year 3,760 2,757 2,343\n\nCash and cash equivalents at end of year $ 1,659 $ 3,760 $ 2,757\n\n**Supplemental Disclosures:** Cash paid for income taxes $ 3,653 $ 5,023 $ 5,435\n\nCash paid for interest, net of interest capitalized 2,199 1,809 1,449\n\nNon-cash capital expenditures 250 364 351\n\nNon-cash acquisition purchase consideration (Note 13) 321 — —\n\n————— _Fiscal 2024 includes 53 weeks. Fiscal 2023 and fiscal 2022 include 52 weeks._\n\n_See accompanying notes to consolidated financial statements._\n\nFiscal 2024 Form 10-K 43","publish_date":null,"title":"THE HOME DEPOT, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS Cash Flows from Operating Activities: Net earnings $ 14,806 $ 15,143","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page47.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page47.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page47","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page47.pdf"},"started_at":"2026-11-04T19:47:38.715611"} +{"completed_at":"2026-11-04T19:47:42.426782","latency_in_ms":2843,"output":{"example_id":"table/Home Depot 10-k unrestricted_page57","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\nThe following table presents net sales by merchandising department (and related services) within our Primary segment, as well as Other net sales:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**_dollars in millions_**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\nAppliances $ 14,046 8.8 % $ 13,917 9.1 % $ 14,521 9.2 %\n\nBath 6,485 4.1 6,630 4.3 6,855 4.4\n\nBuilding Materials 12,423 7.8 12,118 7.9 11,410 7.2\n\nElectrical 7,877 4.9 8,038 5.3 8,824 5.6\n\nFlooring 8,596 5.4 8,762 5.7 9,198 5.8\n\nHardware 8,999 5.6 9,010 5.9 8,953 5.7\n\nIndoor Garden 10,519 6.6 10,283 6.7 10,105 6.4\n\nKitchen & Blinds 7,238 4.5 7,154 4.7 7,751 4.9\n\nLighting 4,222 2.6 4,531 3.0 5,036 3.2\n\nLumber 11,762 7.4 11,721 7.7 13,436 8.5\n\nMillwork 8,337 5.2 8,301 5.4 8,428 5.4\n\nOutdoor Garden 10,308 6.5 10,278 6.7 10,039 6.4\n\nPaint 11,203 7.0 10,951 7.2 11,081 7.0\n\nPlumbing 12,357 7.7 12,483 8.2 12,474 7.9\n\nPower 13,100 8.2 12,864 8.4 13,271 8.4\n\nStorage & Organization 5,636 3.5 5,628 3.7 6,021 3.8\n\nPrimary segment net sales 153,108 96.0 152,669 100.0 157,403 100.0\n\nOther net sales 6,406 4.0 — — — —\n\nNet sales $ 159,514 100.0 % $ 152,669 100.0 % $ 157,403 100.0 %\n\n————— _Note: Certain percentages may not sum to totals due to rounding._\n\nSee additional discussion above for information on the components of Other net sales.\n\nThe following table presents net sales, classified by geography:\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet sales – in the U.S. $ 147,007 $ 140,083 $ 144,840\n\nNet sales – outside the U.S. 12,507 12,586 12,563\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nThe following table presents net sales by products and services:\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet sales – products $ 153,674 $ 146,835 $ 151,804\n\nNet sales – services 5,840 5,834 5,599\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nNo sales to an individual customer accounted for more than 10% of revenue during any of the last three fiscal years.\n\nFiscal 2024 Form 10-K 53","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\nThe following table presents net sales by merchandising department (and related services) within our Primary segment, as well as Other net sales:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**_dollars in millions_**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\nAppliances $ 14,046 8.8 % $ 13,917 9.1 % $ 14,521 9.2 %\n\nBath 6,485 4.1 6,630 4.3 6,855 4.4\n\nBuilding Materials 12,423 7.8 12,118 7.9 11,410 7.2\n\nElectrical 7,877 4.9 8,038 5.3 8,824 5.6\n\nFlooring 8,596 5.4 8,762 5.7 9,198 5.8\n\nHardware 8,999 5.6 9,010 5.9 8,953 5.7\n\nIndoor Garden 10,519 6.6 10,283 6.7 10,105 6.4\n\nKitchen & Blinds 7,238 4.5 7,154 4.7 7,751 4.9\n\nLighting 4,222 2.6 4,531 3.0 5,036 3.2\n\nLumber 11,762 7.4 11,721 7.7 13,436 8.5\n\nMillwork 8,337 5.2 8,301 5.4 8,428 5.4\n\nOutdoor Garden 10,308 6.5 10,278 6.7 10,039 6.4\n\nPaint 11,203 7.0 10,951 7.2 11,081 7.0\n\nPlumbing 12,357 7.7 12,483 8.2 12,474 7.9\n\nPower 13,100 8.2 12,864 8.4 13,271 8.4\n\nStorage & Organization 5,636 3.5 5,628 3.7 6,021 3.8\n\nPrimary segment net sales 153,108 96.0 152,669 100.0 157,403 100.0\n\nOther net sales 6,406 4.0 — — — —\n\nNet sales $ 159,514 100.0 % $ 152,669 100.0 % $ 157,403 100.0 %\n\n————— _Note: Certain percentages may not sum to totals due to rounding._\n\nSee additional discussion above for information on the components of Other net sales.\n\nThe following table presents net sales, classified by geography:\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet sales – in the U.S. $ 147,007 $ 140,083 $ 144,840\n\nNet sales – outside the U.S. 12,507 12,586 12,563\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nThe following table presents net sales by products and services:\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet sales – products $ 153,674 $ 146,835 $ 151,804\n\nNet sales – services 5,840 5,834 5,599\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nNo sales to an individual customer accounted for more than 10% of revenue during any of the last three fiscal years.\n\nFiscal 2024 Form 10-K 53","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\nThe following table presents net sales by merchandising department (and related services) within our Primary segment, as well as Other net sales:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**_dollars in millions_**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\nAppliances $ 14,046 8.8 % $ 13,917 9.1 % $ 14,521 9.2 %\n\nBath 6,485 4.1 6,630 4.3 6,855 4.4\n\nBuilding Materials 12,423 7.8 12,118 7.9 11,410 7.2\n\nElectrical 7,877 4.9 8,038 5.3 8,824 5.6\n\nFlooring 8,596 5.4 8,762 5.7 9,198 5.8\n\nHardware 8,999 5.6 9,010 5.9 8,953 5.7\n\nIndoor Garden 10,519 6.6 10,283 6.7 10,105 6.4\n\nKitchen & Blinds 7,238 4.5 7,154 4.7 7,751 4.9\n\nLighting 4,222 2.6 4,531 3.0 5,036 3.2\n\nLumber 11,762 7.4 11,721 7.7 13,436 8.5\n\nMillwork 8,337 5.2 8,301 5.4 8,428 5.4\n\nOutdoor Garden 10,308 6.5 10,278 6.7 10,039 6.4\n\nPaint 11,203 7.0 10,951 7.2 11,081 7.0\n\nPlumbing 12,357 7.7 12,483 8.2 12,474 7.9\n\nPower 13,100 8.2 12,864 8.4 13,271 8.4\n\nStorage & Organization 5,636 3.5 5,628 3.7 6,021 3.8\n\nPrimary segment net sales 153,108 96.0 152,669 100.0 157,403 100.0\n\nOther net sales 6,406 4.0 — — — —\n\nNet sales $ 159,514 100.0 % $ 152,669 100.0 % $ 157,403 100.0 %\n\n————— _Note: Certain percentages may not sum to totals due to rounding._\n\nSee additional discussion above for information on the components of Other net sales.\n\nThe following table presents net sales, classified by geography:\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet sales – in the U.S. $ 147,007 $ 140,083 $ 144,840\n\nNet sales – outside the U.S. 12,507 12,586 12,563\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nThe following table presents net sales by products and services:\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet sales – products $ 153,674 $ 146,835 $ 151,804\n\nNet sales – services 5,840 5,834 5,599\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nNo sales to an individual customer accounted for more than 10% of revenue during any of the last three fiscal years.\n\nFiscal 2024 Form 10-K 53","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page57.pdf"]},"response":{"errors":[],"extract_id":"extract_465c9a5d2ab111daa6e661601a079fd8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\nThe following table presents net sales by merchandising department (and related services) within our Primary segment, as well as Other net sales:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**_dollars in millions_**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\nAppliances $ 14,046 8.8 % $ 13,917 9.1 % $ 14,521 9.2 %\n\nBath 6,485 4.1 6,630 4.3 6,855 4.4\n\nBuilding Materials 12,423 7.8 12,118 7.9 11,410 7.2\n\nElectrical 7,877 4.9 8,038 5.3 8,824 5.6\n\nFlooring 8,596 5.4 8,762 5.7 9,198 5.8\n\nHardware 8,999 5.6 9,010 5.9 8,953 5.7\n\nIndoor Garden 10,519 6.6 10,283 6.7 10,105 6.4\n\nKitchen & Blinds 7,238 4.5 7,154 4.7 7,751 4.9\n\nLighting 4,222 2.6 4,531 3.0 5,036 3.2\n\nLumber 11,762 7.4 11,721 7.7 13,436 8.5\n\nMillwork 8,337 5.2 8,301 5.4 8,428 5.4\n\nOutdoor Garden 10,308 6.5 10,278 6.7 10,039 6.4\n\nPaint 11,203 7.0 10,951 7.2 11,081 7.0\n\nPlumbing 12,357 7.7 12,483 8.2 12,474 7.9\n\nPower 13,100 8.2 12,864 8.4 13,271 8.4\n\nStorage & Organization 5,636 3.5 5,628 3.7 6,021 3.8\n\nPrimary segment net sales 153,108 96.0 152,669 100.0 157,403 100.0\n\nOther net sales 6,406 4.0 — — — —\n\nNet sales $ 159,514 100.0 % $ 152,669 100.0 % $ 157,403 100.0 %\n\n————— _Note: Certain percentages may not sum to totals due to rounding._\n\nSee additional discussion above for information on the components of Other net sales.\n\nThe following table presents net sales, classified by geography:\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet sales – in the U.S. $ 147,007 $ 140,083 $ 144,840\n\nNet sales – outside the U.S. 12,507 12,586 12,563\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nThe following table presents net sales by products and services:\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet sales – products $ 153,674 $ 146,835 $ 151,804\n\nNet sales – services 5,840 5,834 5,599\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nNo sales to an individual customer accounted for more than 10% of revenue during any of the last three fiscal years.\n\nFiscal 2024 Form 10-K 53"],"full_content":"Table of Contents\n\nThe following table presents net sales by merchandising department (and related services) within our Primary segment, as well as Other net sales:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\n**_dollars in millions_**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\n**Net Sales**\n\n**% of**\n\n**Net Sales**\n\nAppliances $ 14,046 8.8 % $ 13,917 9.1 % $ 14,521 9.2 %\n\nBath 6,485 4.1 6,630 4.3 6,855 4.4\n\nBuilding Materials 12,423 7.8 12,118 7.9 11,410 7.2\n\nElectrical 7,877 4.9 8,038 5.3 8,824 5.6\n\nFlooring 8,596 5.4 8,762 5.7 9,198 5.8\n\nHardware 8,999 5.6 9,010 5.9 8,953 5.7\n\nIndoor Garden 10,519 6.6 10,283 6.7 10,105 6.4\n\nKitchen & Blinds 7,238 4.5 7,154 4.7 7,751 4.9\n\nLighting 4,222 2.6 4,531 3.0 5,036 3.2\n\nLumber 11,762 7.4 11,721 7.7 13,436 8.5\n\nMillwork 8,337 5.2 8,301 5.4 8,428 5.4\n\nOutdoor Garden 10,308 6.5 10,278 6.7 10,039 6.4\n\nPaint 11,203 7.0 10,951 7.2 11,081 7.0\n\nPlumbing 12,357 7.7 12,483 8.2 12,474 7.9\n\nPower 13,100 8.2 12,864 8.4 13,271 8.4\n\nStorage & Organization 5,636 3.5 5,628 3.7 6,021 3.8\n\nPrimary segment net sales 153,108 96.0 152,669 100.0 157,403 100.0\n\nOther net sales 6,406 4.0 — — — —\n\nNet sales $ 159,514 100.0 % $ 152,669 100.0 % $ 157,403 100.0 %\n\n————— _Note: Certain percentages may not sum to totals due to rounding._\n\nSee additional discussion above for information on the components of Other net sales.\n\nThe following table presents net sales, classified by geography:\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet sales – in the U.S. $ 147,007 $ 140,083 $ 144,840\n\nNet sales – outside the U.S. 12,507 12,586 12,563\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nThe following table presents net sales by products and services:\n\n**Fiscal Fiscal Fiscal**\n\n**_in millions_** **2024 2023 2022**\n\nNet sales – products $ 153,674 $ 146,835 $ 151,804\n\nNet sales – services 5,840 5,834 5,599\n\nNet sales $ 159,514 $ 152,669 $ 157,403\n\nNo sales to an individual customer accounted for more than 10% of revenue during any of the last three fiscal years.\n\nFiscal 2024 Form 10-K 53","publish_date":null,"title":"The following table presents net sales by merchandising department (and related services) within our Primary segment, as well as Other","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page57.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page57.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page57","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page57.pdf"},"started_at":"2026-11-04T19:47:39.583509"} +{"completed_at":"2026-11-04T19:47:42.273358","latency_in_ms":1217,"output":{"example_id":"table/Home Depot 10-k unrestricted_page58","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**3\\. PROPERTY AND LEASES**\n\n**Net Property and Equipment**\n\nThe following table presents components of net property and equipment:\n\n**_in millions_**\n\n**February 2,**\n\n**2025**\n\n**January 28,**\n\n**2024**\n\nLand $ 9,060 $ 9,027\n\nBuildings and improvements 20,260 20,030\n\nFurniture, fixtures, and equipment 18,474 16,667\n\nLeasehold improvements 2,423 2,254\n\nConstruction in progress 1,521 1,192\n\nFinance leases 4,045 4,087\n\nProperty and equipment, at cost 55,783 53,257\n\nLess: accumulated depreciation and finance lease amortization 29,081 27,103\n\nNet property and equipment $ 26,702 $ 26,154\n\nThe following table presents depreciation and finance lease amortization expense, including depreciation and finance lease amortization expense included in cost of sales:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nDepreciation and finance lease amortization expense $ 3,283 $ 3,020 $ 2,756\n\n**Leases**\n\nThe following table presents the consolidated balance sheet classification related to operating and finance leases:\n\n**_in millions_** **Consolidated Balance Sheet Classification**\n\n**February 2,**\n\n**2025**\n\n**January 28,**\n\n**2024**\n\n**Assets:** Operating lease assets Operating lease right-of-use assets $ 8,592 $ 7,884\n\nFinance lease assets Net property and equipment 2,638 2,840\n\nTotal lease assets $ 11,230 $ 10,724\n\n**Liabilities:** Current: Operating lease liabilities Current operating lease liabilities $ 1,274 $ 1,050\n\nFinance lease liabilities Current installments of long-term debt 272 268\n\nLong-term: Operating lease liabilities Long-term operating lease liabilities 7,633 7,082\n\nFinance lease liabilities Long-term debt, excluding current installments 2,749 3,000\n\nTotal lease liabilities $ 11,928 $ 11,400\n\n————— _(1) Finance lease assets are recorded net of accumulated amortization of $1.4 billion as of February 2, 2025 and $1.2 billion as of January 28, 2024._\n\n(1)\n\nFiscal 2024 Form 10-K 54","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**3\\. PROPERTY AND LEASES**\n\n**Net Property and Equipment**\n\nThe following table presents components of net property and equipment:\n\n**_in millions_**\n\n**February 2,**\n\n**2025**\n\n**January 28,**\n\n**2024**\n\nLand $ 9,060 $ 9,027\n\nBuildings and improvements 20,260 20,030\n\nFurniture, fixtures, and equipment 18,474 16,667\n\nLeasehold improvements 2,423 2,254\n\nConstruction in progress 1,521 1,192\n\nFinance leases 4,045 4,087\n\nProperty and equipment, at cost 55,783 53,257\n\nLess: accumulated depreciation and finance lease amortization 29,081 27,103\n\nNet property and equipment $ 26,702 $ 26,154\n\nThe following table presents depreciation and finance lease amortization expense, including depreciation and finance lease amortization expense included in cost of sales:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nDepreciation and finance lease amortization expense $ 3,283 $ 3,020 $ 2,756\n\n**Leases**\n\nThe following table presents the consolidated balance sheet classification related to operating and finance leases:\n\n**_in millions_** **Consolidated Balance Sheet Classification**\n\n**February 2,**\n\n**2025**\n\n**January 28,**\n\n**2024**\n\n**Assets:** Operating lease assets Operating lease right-of-use assets $ 8,592 $ 7,884\n\nFinance lease assets Net property and equipment 2,638 2,840\n\nTotal lease assets $ 11,230 $ 10,724\n\n**Liabilities:** Current: Operating lease liabilities Current operating lease liabilities $ 1,274 $ 1,050\n\nFinance lease liabilities Current installments of long-term debt 272 268\n\nLong-term: Operating lease liabilities Long-term operating lease liabilities 7,633 7,082\n\nFinance lease liabilities Long-term debt, excluding current installments 2,749 3,000\n\nTotal lease liabilities $ 11,928 $ 11,400\n\n————— _(1) Finance lease assets are recorded net of accumulated amortization of $1.4 billion as of February 2, 2025 and $1.2 billion as of January 28, 2024._\n\n(1)\n\nFiscal 2024 Form 10-K 54","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**3\\. PROPERTY AND LEASES**\n\n**Net Property and Equipment**\n\nThe following table presents components of net property and equipment:\n\n**_in millions_**\n\n**February 2,**\n\n**2025**\n\n**January 28,**\n\n**2024**\n\nLand $ 9,060 $ 9,027\n\nBuildings and improvements 20,260 20,030\n\nFurniture, fixtures, and equipment 18,474 16,667\n\nLeasehold improvements 2,423 2,254\n\nConstruction in progress 1,521 1,192\n\nFinance leases 4,045 4,087\n\nProperty and equipment, at cost 55,783 53,257\n\nLess: accumulated depreciation and finance lease amortization 29,081 27,103\n\nNet property and equipment $ 26,702 $ 26,154\n\nThe following table presents depreciation and finance lease amortization expense, including depreciation and finance lease amortization expense included in cost of sales:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nDepreciation and finance lease amortization expense $ 3,283 $ 3,020 $ 2,756\n\n**Leases**\n\nThe following table presents the consolidated balance sheet classification related to operating and finance leases:\n\n**_in millions_** **Consolidated Balance Sheet Classification**\n\n**February 2,**\n\n**2025**\n\n**January 28,**\n\n**2024**\n\n**Assets:** Operating lease assets Operating lease right-of-use assets $ 8,592 $ 7,884\n\nFinance lease assets Net property and equipment 2,638 2,840\n\nTotal lease assets $ 11,230 $ 10,724\n\n**Liabilities:** Current: Operating lease liabilities Current operating lease liabilities $ 1,274 $ 1,050\n\nFinance lease liabilities Current installments of long-term debt 272 268\n\nLong-term: Operating lease liabilities Long-term operating lease liabilities 7,633 7,082\n\nFinance lease liabilities Long-term debt, excluding current installments 2,749 3,000\n\nTotal lease liabilities $ 11,928 $ 11,400\n\n————— _(1) Finance lease assets are recorded net of accumulated amortization of $1.4 billion as of February 2, 2025 and $1.2 billion as of January 28, 2024._\n\n(1)\n\nFiscal 2024 Form 10-K 54","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page58.pdf"]},"response":{"errors":[],"extract_id":"extract_99a0865183e465f2e0e35d5ff034ab8b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**3\\. PROPERTY AND LEASES**\n\n**Net Property and Equipment**\n\nThe following table presents components of net property and equipment:\n\n**_in millions_**\n\n**February 2,**\n\n**2025**\n\n**January 28,**\n\n**2024**\n\nLand $ 9,060 $ 9,027\n\nBuildings and improvements 20,260 20,030\n\nFurniture, fixtures, and equipment 18,474 16,667\n\nLeasehold improvements 2,423 2,254\n\nConstruction in progress 1,521 1,192\n\nFinance leases 4,045 4,087\n\nProperty and equipment, at cost 55,783 53,257\n\nLess: accumulated depreciation and finance lease amortization 29,081 27,103\n\nNet property and equipment $ 26,702 $ 26,154\n\nThe following table presents depreciation and finance lease amortization expense, including depreciation and finance lease amortization expense included in cost of sales:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nDepreciation and finance lease amortization expense $ 3,283 $ 3,020 $ 2,756\n\n**Leases**\n\nThe following table presents the consolidated balance sheet classification related to operating and finance leases:\n\n**_in millions_** **Consolidated Balance Sheet Classification**\n\n**February 2,**\n\n**2025**\n\n**January 28,**\n\n**2024**\n\n**Assets:** Operating lease assets Operating lease right-of-use assets $ 8,592 $ 7,884\n\nFinance lease assets Net property and equipment 2,638 2,840\n\nTotal lease assets $ 11,230 $ 10,724\n\n**Liabilities:** Current: Operating lease liabilities Current operating lease liabilities $ 1,274 $ 1,050\n\nFinance lease liabilities Current installments of long-term debt 272 268\n\nLong-term: Operating lease liabilities Long-term operating lease liabilities 7,633 7,082\n\nFinance lease liabilities Long-term debt, excluding current installments 2,749 3,000\n\nTotal lease liabilities $ 11,928 $ 11,400\n\n————— _(1) Finance lease assets are recorded net of accumulated amortization of $1.4 billion as of February 2, 2025 and $1.2 billion as of January 28, 2024._\n\n(1)\n\nFiscal 2024 Form 10-K 54"],"full_content":"Table of Contents\n\n**3\\. PROPERTY AND LEASES**\n\n**Net Property and Equipment**\n\nThe following table presents components of net property and equipment:\n\n**_in millions_**\n\n**February 2,**\n\n**2025**\n\n**January 28,**\n\n**2024**\n\nLand $ 9,060 $ 9,027\n\nBuildings and improvements 20,260 20,030\n\nFurniture, fixtures, and equipment 18,474 16,667\n\nLeasehold improvements 2,423 2,254\n\nConstruction in progress 1,521 1,192\n\nFinance leases 4,045 4,087\n\nProperty and equipment, at cost 55,783 53,257\n\nLess: accumulated depreciation and finance lease amortization 29,081 27,103\n\nNet property and equipment $ 26,702 $ 26,154\n\nThe following table presents depreciation and finance lease amortization expense, including depreciation and finance lease amortization expense included in cost of sales:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nDepreciation and finance lease amortization expense $ 3,283 $ 3,020 $ 2,756\n\n**Leases**\n\nThe following table presents the consolidated balance sheet classification related to operating and finance leases:\n\n**_in millions_** **Consolidated Balance Sheet Classification**\n\n**February 2,**\n\n**2025**\n\n**January 28,**\n\n**2024**\n\n**Assets:** Operating lease assets Operating lease right-of-use assets $ 8,592 $ 7,884\n\nFinance lease assets Net property and equipment 2,638 2,840\n\nTotal lease assets $ 11,230 $ 10,724\n\n**Liabilities:** Current: Operating lease liabilities Current operating lease liabilities $ 1,274 $ 1,050\n\nFinance lease liabilities Current installments of long-term debt 272 268\n\nLong-term: Operating lease liabilities Long-term operating lease liabilities 7,633 7,082\n\nFinance lease liabilities Long-term debt, excluding current installments 2,749 3,000\n\nTotal lease liabilities $ 11,928 $ 11,400\n\n————— _(1) Finance lease assets are recorded net of accumulated amortization of $1.4 billion as of February 2, 2025 and $1.2 billion as of January 28, 2024._\n\n(1)\n\nFiscal 2024 Form 10-K 54","publish_date":null,"title":"3. PROPERTY AND LEASES Net Property and Equipment The following table presents components of net property and equipment: Land $","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page58.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page58.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page58","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page58.pdf"},"started_at":"2026-11-04T19:47:41.055382"} +{"completed_at":"2026-11-04T19:47:43.676885","latency_in_ms":1440,"output":{"example_id":"table/Home Depot 10-k unrestricted_page71","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\nThe award types issued under the Plans are as follows:\n\n**_Stock Options._** Under the terms of the Plans, incentive stock options and nonqualified stock options must have an exercise price at or above the fair market value of our stock on the date of the grant. Typically, nonqualified stock options vest at the rate of 25% per year commencing on the second anniversary date of the grant and expire on the tenth anniversary date of the grant. Additionally, a majority of our stock options may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. There are no incentive stock options outstanding under the Plans.\n\nWe estimate the fair value of stock option awards on the date of grant using the Black-Scholes option-pricing model. Our determination of fair value of stock option awards is affected by our stock price as well as assumptions regarding a number of variables.\n\nThe following table presents the per share weighted average fair value of stock options granted and the assumptions used in determining fair value at the date of grant using the Black-Scholes option-pricing model:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nPer share weighted average fair value $ 95.50 $ 66.01 $ 70.21\n\nRisk-free interest rate 4.2 % 3.6 % 2.5 %\n\nExpected volatility 24.6 % 26.7 % 27.0 %\n\nDividend yield 2.4 % 2.8 % 2.4 %\n\nExpected term 6 years 6 years 6 years\n\nThe risk-free interest rate is based on the U.S. Treasury (constant maturity) risk-free rate in effect at the date of grant for periods corresponding with the expected term of the options. Expected volatility is based on a combination of historical and implied volatility of our stock. The expected term is based on an analysis of historical and expected future exercise patterns.\n\nThe following table presents a summary of stock option activity by number of shares and weighted average exercise price during fiscal 2024:\n\n**_shares in thousands_**\n\n**Number of**\n\n**Shares**\n\n**Weighted Average**\n\n**Exercise Price**\n\nOutstanding at beginning of year 3,085 $ 189.97\n\nGranted 175 383.15\n\nExercised (1,036) 138.64\n\nForfeited (23) 306.00\n\nOutstanding at end of year 2,201 228.23\n\nThe following table presents the total intrinsic value of stock options exercised:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nTotal intrinsic value of stock options exercised $ 254 $ 152 $ 61\n\nThe following table presents details regarding outstanding and exercisable stock options at February 2, 2025:\n\n**_shares in thousands, dollars in millions, except for per share amounts_**\n\n**Number of**\n\n**Shares**\n\n**Intrinsic**\n\n**Value**\n\n**Weighted Average**\n\n**Remaining Life**\n\n**Weighted Average**\n\n**Exercise Price**\n\nOutstanding 2,201 $ 404 5.0 years $ 228.23\n\nExercisable 1,411 320 3.6 years 185.43\n\nShares of common stock issued from stock option exercises may be issued from authorized and unissued common stock or treasury stock.\n\nFiscal 2024 Form 10-K 66","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\nThe award types issued under the Plans are as follows:\n\n**_Stock Options._** Under the terms of the Plans, incentive stock options and nonqualified stock options must have an exercise price at or above the fair market value of our stock on the date of the grant. Typically, nonqualified stock options vest at the rate of 25% per year commencing on the second anniversary date of the grant and expire on the tenth anniversary date of the grant. Additionally, a majority of our stock options may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. There are no incentive stock options outstanding under the Plans.\n\nWe estimate the fair value of stock option awards on the date of grant using the Black-Scholes option-pricing model. Our determination of fair value of stock option awards is affected by our stock price as well as assumptions regarding a number of variables.\n\nThe following table presents the per share weighted average fair value of stock options granted and the assumptions used in determining fair value at the date of grant using the Black-Scholes option-pricing model:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nPer share weighted average fair value $ 95.50 $ 66.01 $ 70.21\n\nRisk-free interest rate 4.2 % 3.6 % 2.5 %\n\nExpected volatility 24.6 % 26.7 % 27.0 %\n\nDividend yield 2.4 % 2.8 % 2.4 %\n\nExpected term 6 years 6 years 6 years\n\nThe risk-free interest rate is based on the U.S. Treasury (constant maturity) risk-free rate in effect at the date of grant for periods corresponding with the expected term of the options. Expected volatility is based on a combination of historical and implied volatility of our stock. The expected term is based on an analysis of historical and expected future exercise patterns.\n\nThe following table presents a summary of stock option activity by number of shares and weighted average exercise price during fiscal 2024:\n\n**_shares in thousands_**\n\n**Number of**\n\n**Shares**\n\n**Weighted Average**\n\n**Exercise Price**\n\nOutstanding at beginning of year 3,085 $ 189.97\n\nGranted 175 383.15\n\nExercised (1,036) 138.64\n\nForfeited (23) 306.00\n\nOutstanding at end of year 2,201 228.23\n\nThe following table presents the total intrinsic value of stock options exercised:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nTotal intrinsic value of stock options exercised $ 254 $ 152 $ 61\n\nThe following table presents details regarding outstanding and exercisable stock options at February 2, 2025:\n\n**_shares in thousands, dollars in millions, except for per share amounts_**\n\n**Number of**\n\n**Shares**\n\n**Intrinsic**\n\n**Value**\n\n**Weighted Average**\n\n**Remaining Life**\n\n**Weighted Average**\n\n**Exercise Price**\n\nOutstanding 2,201 $ 404 5.0 years $ 228.23\n\nExercisable 1,411 320 3.6 years 185.43\n\nShares of common stock issued from stock option exercises may be issued from authorized and unissued common stock or treasury stock.\n\nFiscal 2024 Form 10-K 66","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\nThe award types issued under the Plans are as follows:\n\n**_Stock Options._** Under the terms of the Plans, incentive stock options and nonqualified stock options must have an exercise price at or above the fair market value of our stock on the date of the grant. Typically, nonqualified stock options vest at the rate of 25% per year commencing on the second anniversary date of the grant and expire on the tenth anniversary date of the grant. Additionally, a majority of our stock options may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. There are no incentive stock options outstanding under the Plans.\n\nWe estimate the fair value of stock option awards on the date of grant using the Black-Scholes option-pricing model. Our determination of fair value of stock option awards is affected by our stock price as well as assumptions regarding a number of variables.\n\nThe following table presents the per share weighted average fair value of stock options granted and the assumptions used in determining fair value at the date of grant using the Black-Scholes option-pricing model:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nPer share weighted average fair value $ 95.50 $ 66.01 $ 70.21\n\nRisk-free interest rate 4.2 % 3.6 % 2.5 %\n\nExpected volatility 24.6 % 26.7 % 27.0 %\n\nDividend yield 2.4 % 2.8 % 2.4 %\n\nExpected term 6 years 6 years 6 years\n\nThe risk-free interest rate is based on the U.S. Treasury (constant maturity) risk-free rate in effect at the date of grant for periods corresponding with the expected term of the options. Expected volatility is based on a combination of historical and implied volatility of our stock. The expected term is based on an analysis of historical and expected future exercise patterns.\n\nThe following table presents a summary of stock option activity by number of shares and weighted average exercise price during fiscal 2024:\n\n**_shares in thousands_**\n\n**Number of**\n\n**Shares**\n\n**Weighted Average**\n\n**Exercise Price**\n\nOutstanding at beginning of year 3,085 $ 189.97\n\nGranted 175 383.15\n\nExercised (1,036) 138.64\n\nForfeited (23) 306.00\n\nOutstanding at end of year 2,201 228.23\n\nThe following table presents the total intrinsic value of stock options exercised:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nTotal intrinsic value of stock options exercised $ 254 $ 152 $ 61\n\nThe following table presents details regarding outstanding and exercisable stock options at February 2, 2025:\n\n**_shares in thousands, dollars in millions, except for per share amounts_**\n\n**Number of**\n\n**Shares**\n\n**Intrinsic**\n\n**Value**\n\n**Weighted Average**\n\n**Remaining Life**\n\n**Weighted Average**\n\n**Exercise Price**\n\nOutstanding 2,201 $ 404 5.0 years $ 228.23\n\nExercisable 1,411 320 3.6 years 185.43\n\nShares of common stock issued from stock option exercises may be issued from authorized and unissued common stock or treasury stock.\n\nFiscal 2024 Form 10-K 66","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page71.pdf"]},"response":{"errors":[],"extract_id":"extract_050a9e3cfc93dab694838dc0c2f22709","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\nThe award types issued under the Plans are as follows:\n\n**_Stock Options._** Under the terms of the Plans, incentive stock options and nonqualified stock options must have an exercise price at or above the fair market value of our stock on the date of the grant. Typically, nonqualified stock options vest at the rate of 25% per year commencing on the second anniversary date of the grant and expire on the tenth anniversary date of the grant. Additionally, a majority of our stock options may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. There are no incentive stock options outstanding under the Plans.\n\nWe estimate the fair value of stock option awards on the date of grant using the Black-Scholes option-pricing model. Our determination of fair value of stock option awards is affected by our stock price as well as assumptions regarding a number of variables.\n\nThe following table presents the per share weighted average fair value of stock options granted and the assumptions used in determining fair value at the date of grant using the Black-Scholes option-pricing model:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nPer share weighted average fair value $ 95.50 $ 66.01 $ 70.21\n\nRisk-free interest rate 4.2 % 3.6 % 2.5 %\n\nExpected volatility 24.6 % 26.7 % 27.0 %\n\nDividend yield 2.4 % 2.8 % 2.4 %\n\nExpected term 6 years 6 years 6 years\n\nThe risk-free interest rate is based on the U.S. Treasury (constant maturity) risk-free rate in effect at the date of grant for periods corresponding with the expected term of the options. Expected volatility is based on a combination of historical and implied volatility of our stock. The expected term is based on an analysis of historical and expected future exercise patterns.\n\nThe following table presents a summary of stock option activity by number of shares and weighted average exercise price during fiscal 2024:\n\n**_shares in thousands_**\n\n**Number of**\n\n**Shares**\n\n**Weighted Average**\n\n**Exercise Price**\n\nOutstanding at beginning of year 3,085 $ 189.97\n\nGranted 175 383.15\n\nExercised (1,036) 138.64\n\nForfeited (23) 306.00\n\nOutstanding at end of year 2,201 228.23\n\nThe following table presents the total intrinsic value of stock options exercised:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nTotal intrinsic value of stock options exercised $ 254 $ 152 $ 61\n\nThe following table presents details regarding outstanding and exercisable stock options at February 2, 2025:\n\n**_shares in thousands, dollars in millions, except for per share amounts_**\n\n**Number of**\n\n**Shares**\n\n**Intrinsic**\n\n**Value**\n\n**Weighted Average**\n\n**Remaining Life**\n\n**Weighted Average**\n\n**Exercise Price**\n\nOutstanding 2,201 $ 404 5.0 years $ 228.23\n\nExercisable 1,411 320 3.6 years 185.43\n\nShares of common stock issued from stock option exercises may be issued from authorized and unissued common stock or treasury stock.\n\nFiscal 2024 Form 10-K 66"],"full_content":"Table of Contents\n\nThe award types issued under the Plans are as follows:\n\n**_Stock Options._** Under the terms of the Plans, incentive stock options and nonqualified stock options must have an exercise price at or above the fair market value of our stock on the date of the grant. Typically, nonqualified stock options vest at the rate of 25% per year commencing on the second anniversary date of the grant and expire on the tenth anniversary date of the grant. Additionally, a majority of our stock options may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. There are no incentive stock options outstanding under the Plans.\n\nWe estimate the fair value of stock option awards on the date of grant using the Black-Scholes option-pricing model. Our determination of fair value of stock option awards is affected by our stock price as well as assumptions regarding a number of variables.\n\nThe following table presents the per share weighted average fair value of stock options granted and the assumptions used in determining fair value at the date of grant using the Black-Scholes option-pricing model:\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nPer share weighted average fair value $ 95.50 $ 66.01 $ 70.21\n\nRisk-free interest rate 4.2 % 3.6 % 2.5 %\n\nExpected volatility 24.6 % 26.7 % 27.0 %\n\nDividend yield 2.4 % 2.8 % 2.4 %\n\nExpected term 6 years 6 years 6 years\n\nThe risk-free interest rate is based on the U.S. Treasury (constant maturity) risk-free rate in effect at the date of grant for periods corresponding with the expected term of the options. Expected volatility is based on a combination of historical and implied volatility of our stock. The expected term is based on an analysis of historical and expected future exercise patterns.\n\nThe following table presents a summary of stock option activity by number of shares and weighted average exercise price during fiscal 2024:\n\n**_shares in thousands_**\n\n**Number of**\n\n**Shares**\n\n**Weighted Average**\n\n**Exercise Price**\n\nOutstanding at beginning of year 3,085 $ 189.97\n\nGranted 175 383.15\n\nExercised (1,036) 138.64\n\nForfeited (23) 306.00\n\nOutstanding at end of year 2,201 228.23\n\nThe following table presents the total intrinsic value of stock options exercised:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nTotal intrinsic value of stock options exercised $ 254 $ 152 $ 61\n\nThe following table presents details regarding outstanding and exercisable stock options at February 2, 2025:\n\n**_shares in thousands, dollars in millions, except for per share amounts_**\n\n**Number of**\n\n**Shares**\n\n**Intrinsic**\n\n**Value**\n\n**Weighted Average**\n\n**Remaining Life**\n\n**Weighted Average**\n\n**Exercise Price**\n\nOutstanding 2,201 $ 404 5.0 years $ 228.23\n\nExercisable 1,411 320 3.6 years 185.43\n\nShares of common stock issued from stock option exercises may be issued from authorized and unissued common stock or treasury stock.\n\nFiscal 2024 Form 10-K 66","publish_date":null,"title":"The award types issued under the Plans are as follows: Stock Options. Under the terms of the Plans, incentive stock","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page71.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page71.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page71","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page71.pdf"},"started_at":"2026-11-04T19:47:42.236112"} +{"completed_at":"2026-11-04T19:47:44.600043","latency_in_ms":1384,"output":{"example_id":"table/Home Depot 10-k unrestricted_page72","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**_Restricted Stock Awards._** Restrictions on the restricted stock issued under the Plans generally lapse over various periods up to five years. At the grant date of the award, recipients of restricted stock are granted voting rights and generally receive dividends on unvested shares, paid in the form of cash on each dividend payment date. Dividends paid on unvested shares were immaterial for fiscal 2024, fiscal 2023, and fiscal 2022. Additionally, the majority of our restricted stock awards may become non-forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service. The fair value of restricted stock is based on the closing stock price on the date of grant and is expensed over the period during which the restrictions lapse.\n\n**_Restricted Stock Units._** Each restricted stock unit entitles the associate to one share of common stock to be received upon vesting up to five years after the grant date. Additionally, the majority of these awards may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. Recipients of restricted stock units have no voting rights until the vesting of the award. Recipients receive dividend equivalents that accrue on unvested units and are paid out in the form of additional shares of stock on the vesting date. The fair value of restricted stock units is based on the closing stock price on the date of grant and is expensed over the period during which the units vest.\n\nThe following table presents a summary of restricted stock and restricted stock unit activity during fiscal 2024:\n\n**_shares in thousands_**\n\n**Number of**\n\n**Shares**\n\n**Weighted Average**\n\n**Grant Date Fair Value**\n\nNonvested at beginning of year 3,033 $ 277.09\n\nGranted 1,330 375.21\n\nVested (1,113) 260.05\n\nForfeited (200) 315.04\n\nNonvested at end of year 3,050 323.61\n\n————— _(1) Includes replacement restricted stock awards with service-based vesting conditions issued in connection with the SRS acquisition (see Note 13)._\n\nThe following table presents the total fair value of restricted stock and restricted stock units vested:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nTotal fair value vested $ 429 $ 312 $ 387\n\n**_Performance Share Awards._** We also grant performance share awards under the Plans. Recipients of performance share awards have no voting rights until the shares are issued following completion of the performance period. Dividend equivalents accrue on performance shares (as reinvested shares) and are paid upon the payout of the award based upon the actual number of shares earned.\n\nCertain of these performance share awards provide for the issuance of shares of our common stock at the end of a three-year performance cycle based upon our performance against target average ROIC and operating profit over that performance cycle. These awards become non- forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service and minimum performance targets are achieved. The fair value of these performance share awards is based on the closing stock price on the date of grant.\n\nSeparately, in relation to the SRS acquisition, we also granted performance share awards to various SRS employees. These awards provide for the issuance of shares of our common stock at the end of a five-year performance period. A portion of these awards are subject to the achievement of SRS EBITDA and sales targets, and a portion of these awards are subject to market conditions based on our stock price performance. The fair value of the portion of the awards subject to the achievement of EBITDA and sales targets were valued based on the closing stock price on the grant date. The portion of the awards subject to market conditions were valued using a Monte Carlo simulation on the date of grant.\n\n(1)\n\nFiscal 2024 Form 10-K 67","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**_Restricted Stock Awards._** Restrictions on the restricted stock issued under the Plans generally lapse over various periods up to five years. At the grant date of the award, recipients of restricted stock are granted voting rights and generally receive dividends on unvested shares, paid in the form of cash on each dividend payment date. Dividends paid on unvested shares were immaterial for fiscal 2024, fiscal 2023, and fiscal 2022. Additionally, the majority of our restricted stock awards may become non-forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service. The fair value of restricted stock is based on the closing stock price on the date of grant and is expensed over the period during which the restrictions lapse.\n\n**_Restricted Stock Units._** Each restricted stock unit entitles the associate to one share of common stock to be received upon vesting up to five years after the grant date. Additionally, the majority of these awards may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. Recipients of restricted stock units have no voting rights until the vesting of the award. Recipients receive dividend equivalents that accrue on unvested units and are paid out in the form of additional shares of stock on the vesting date. The fair value of restricted stock units is based on the closing stock price on the date of grant and is expensed over the period during which the units vest.\n\nThe following table presents a summary of restricted stock and restricted stock unit activity during fiscal 2024:\n\n**_shares in thousands_**\n\n**Number of**\n\n**Shares**\n\n**Weighted Average**\n\n**Grant Date Fair Value**\n\nNonvested at beginning of year 3,033 $ 277.09\n\nGranted 1,330 375.21\n\nVested (1,113) 260.05\n\nForfeited (200) 315.04\n\nNonvested at end of year 3,050 323.61\n\n————— _(1) Includes replacement restricted stock awards with service-based vesting conditions issued in connection with the SRS acquisition (see Note 13)._\n\nThe following table presents the total fair value of restricted stock and restricted stock units vested:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nTotal fair value vested $ 429 $ 312 $ 387\n\n**_Performance Share Awards._** We also grant performance share awards under the Plans. Recipients of performance share awards have no voting rights until the shares are issued following completion of the performance period. Dividend equivalents accrue on performance shares (as reinvested shares) and are paid upon the payout of the award based upon the actual number of shares earned.\n\nCertain of these performance share awards provide for the issuance of shares of our common stock at the end of a three-year performance cycle based upon our performance against target average ROIC and operating profit over that performance cycle. These awards become non- forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service and minimum performance targets are achieved. The fair value of these performance share awards is based on the closing stock price on the date of grant.\n\nSeparately, in relation to the SRS acquisition, we also granted performance share awards to various SRS employees. These awards provide for the issuance of shares of our common stock at the end of a five-year performance period. A portion of these awards are subject to the achievement of SRS EBITDA and sales targets, and a portion of these awards are subject to market conditions based on our stock price performance. The fair value of the portion of the awards subject to the achievement of EBITDA and sales targets were valued based on the closing stock price on the grant date. The portion of the awards subject to market conditions were valued using a Monte Carlo simulation on the date of grant.\n\n(1)\n\nFiscal 2024 Form 10-K 67","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**_Restricted Stock Awards._** Restrictions on the restricted stock issued under the Plans generally lapse over various periods up to five years. At the grant date of the award, recipients of restricted stock are granted voting rights and generally receive dividends on unvested shares, paid in the form of cash on each dividend payment date. Dividends paid on unvested shares were immaterial for fiscal 2024, fiscal 2023, and fiscal 2022. Additionally, the majority of our restricted stock awards may become non-forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service. The fair value of restricted stock is based on the closing stock price on the date of grant and is expensed over the period during which the restrictions lapse.\n\n**_Restricted Stock Units._** Each restricted stock unit entitles the associate to one share of common stock to be received upon vesting up to five years after the grant date. Additionally, the majority of these awards may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. Recipients of restricted stock units have no voting rights until the vesting of the award. Recipients receive dividend equivalents that accrue on unvested units and are paid out in the form of additional shares of stock on the vesting date. The fair value of restricted stock units is based on the closing stock price on the date of grant and is expensed over the period during which the units vest.\n\nThe following table presents a summary of restricted stock and restricted stock unit activity during fiscal 2024:\n\n**_shares in thousands_**\n\n**Number of**\n\n**Shares**\n\n**Weighted Average**\n\n**Grant Date Fair Value**\n\nNonvested at beginning of year 3,033 $ 277.09\n\nGranted 1,330 375.21\n\nVested (1,113) 260.05\n\nForfeited (200) 315.04\n\nNonvested at end of year 3,050 323.61\n\n————— _(1) Includes replacement restricted stock awards with service-based vesting conditions issued in connection with the SRS acquisition (see Note 13)._\n\nThe following table presents the total fair value of restricted stock and restricted stock units vested:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nTotal fair value vested $ 429 $ 312 $ 387\n\n**_Performance Share Awards._** We also grant performance share awards under the Plans. Recipients of performance share awards have no voting rights until the shares are issued following completion of the performance period. Dividend equivalents accrue on performance shares (as reinvested shares) and are paid upon the payout of the award based upon the actual number of shares earned.\n\nCertain of these performance share awards provide for the issuance of shares of our common stock at the end of a three-year performance cycle based upon our performance against target average ROIC and operating profit over that performance cycle. These awards become non- forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service and minimum performance targets are achieved. The fair value of these performance share awards is based on the closing stock price on the date of grant.\n\nSeparately, in relation to the SRS acquisition, we also granted performance share awards to various SRS employees. These awards provide for the issuance of shares of our common stock at the end of a five-year performance period. A portion of these awards are subject to the achievement of SRS EBITDA and sales targets, and a portion of these awards are subject to market conditions based on our stock price performance. The fair value of the portion of the awards subject to the achievement of EBITDA and sales targets were valued based on the closing stock price on the grant date. The portion of the awards subject to market conditions were valued using a Monte Carlo simulation on the date of grant.\n\n(1)\n\nFiscal 2024 Form 10-K 67","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page72.pdf"]},"response":{"errors":[],"extract_id":"extract_5633c5ac202dda3f2546f9cadd65342c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**_Restricted Stock Awards._** Restrictions on the restricted stock issued under the Plans generally lapse over various periods up to five years. At the grant date of the award, recipients of restricted stock are granted voting rights and generally receive dividends on unvested shares, paid in the form of cash on each dividend payment date. Dividends paid on unvested shares were immaterial for fiscal 2024, fiscal 2023, and fiscal 2022. Additionally, the majority of our restricted stock awards may become non-forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service. The fair value of restricted stock is based on the closing stock price on the date of grant and is expensed over the period during which the restrictions lapse.\n\n**_Restricted Stock Units._** Each restricted stock unit entitles the associate to one share of common stock to be received upon vesting up to five years after the grant date. Additionally, the majority of these awards may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. Recipients of restricted stock units have no voting rights until the vesting of the award. Recipients receive dividend equivalents that accrue on unvested units and are paid out in the form of additional shares of stock on the vesting date. The fair value of restricted stock units is based on the closing stock price on the date of grant and is expensed over the period during which the units vest.\n\nThe following table presents a summary of restricted stock and restricted stock unit activity during fiscal 2024:\n\n**_shares in thousands_**\n\n**Number of**\n\n**Shares**\n\n**Weighted Average**\n\n**Grant Date Fair Value**\n\nNonvested at beginning of year 3,033 $ 277.09\n\nGranted 1,330 375.21\n\nVested (1,113) 260.05\n\nForfeited (200) 315.04\n\nNonvested at end of year 3,050 323.61\n\n————— _(1) Includes replacement restricted stock awards with service-based vesting conditions issued in connection with the SRS acquisition (see Note 13)._\n\nThe following table presents the total fair value of restricted stock and restricted stock units vested:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nTotal fair value vested $ 429 $ 312 $ 387\n\n**_Performance Share Awards._** We also grant performance share awards under the Plans. Recipients of performance share awards have no voting rights until the shares are issued following completion of the performance period. Dividend equivalents accrue on performance shares (as reinvested shares) and are paid upon the payout of the award based upon the actual number of shares earned.\n\nCertain of these performance share awards provide for the issuance of shares of our common stock at the end of a three-year performance cycle based upon our performance against target average ROIC and operating profit over that performance cycle. These awards become non- forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service and minimum performance targets are achieved. The fair value of these performance share awards is based on the closing stock price on the date of grant.\n\nSeparately, in relation to the SRS acquisition, we also granted performance share awards to various SRS employees. These awards provide for the issuance of shares of our common stock at the end of a five-year performance period. A portion of these awards are subject to the achievement of SRS EBITDA and sales targets, and a portion of these awards are subject to market conditions based on our stock price performance. The fair value of the portion of the awards subject to the achievement of EBITDA and sales targets were valued based on the closing stock price on the grant date. The portion of the awards subject to market conditions were valued using a Monte Carlo simulation on the date of grant.\n\n(1)\n\nFiscal 2024 Form 10-K 67"],"full_content":"Table of Contents\n\n**_Restricted Stock Awards._** Restrictions on the restricted stock issued under the Plans generally lapse over various periods up to five years. At the grant date of the award, recipients of restricted stock are granted voting rights and generally receive dividends on unvested shares, paid in the form of cash on each dividend payment date. Dividends paid on unvested shares were immaterial for fiscal 2024, fiscal 2023, and fiscal 2022. Additionally, the majority of our restricted stock awards may become non-forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service. The fair value of restricted stock is based on the closing stock price on the date of grant and is expensed over the period during which the restrictions lapse.\n\n**_Restricted Stock Units._** Each restricted stock unit entitles the associate to one share of common stock to be received upon vesting up to five years after the grant date. Additionally, the majority of these awards may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. Recipients of restricted stock units have no voting rights until the vesting of the award. Recipients receive dividend equivalents that accrue on unvested units and are paid out in the form of additional shares of stock on the vesting date. The fair value of restricted stock units is based on the closing stock price on the date of grant and is expensed over the period during which the units vest.\n\nThe following table presents a summary of restricted stock and restricted stock unit activity during fiscal 2024:\n\n**_shares in thousands_**\n\n**Number of**\n\n**Shares**\n\n**Weighted Average**\n\n**Grant Date Fair Value**\n\nNonvested at beginning of year 3,033 $ 277.09\n\nGranted 1,330 375.21\n\nVested (1,113) 260.05\n\nForfeited (200) 315.04\n\nNonvested at end of year 3,050 323.61\n\n————— _(1) Includes replacement restricted stock awards with service-based vesting conditions issued in connection with the SRS acquisition (see Note 13)._\n\nThe following table presents the total fair value of restricted stock and restricted stock units vested:\n\n**_in millions_**\n\n**Fiscal Fiscal Fiscal**\n\n**2024 2023 2022**\n\nTotal fair value vested $ 429 $ 312 $ 387\n\n**_Performance Share Awards._** We also grant performance share awards under the Plans. Recipients of performance share awards have no voting rights until the shares are issued following completion of the performance period. Dividend equivalents accrue on performance shares (as reinvested shares) and are paid upon the payout of the award based upon the actual number of shares earned.\n\nCertain of these performance share awards provide for the issuance of shares of our common stock at the end of a three-year performance cycle based upon our performance against target average ROIC and operating profit over that performance cycle. These awards become non- forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service and minimum performance targets are achieved. The fair value of these performance share awards is based on the closing stock price on the date of grant.\n\nSeparately, in relation to the SRS acquisition, we also granted performance share awards to various SRS employees. These awards provide for the issuance of shares of our common stock at the end of a five-year performance period. A portion of these awards are subject to the achievement of SRS EBITDA and sales targets, and a portion of these awards are subject to market conditions based on our stock price performance. The fair value of the portion of the awards subject to the achievement of EBITDA and sales targets were valued based on the closing stock price on the grant date. The portion of the awards subject to market conditions were valued using a Monte Carlo simulation on the date of grant.\n\n(1)\n\nFiscal 2024 Form 10-K 67","publish_date":null,"title":"Restricted Stock Awards. Restrictions on the restricted stock issued under the Plans generally lapse over various periods up to five","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page72.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Home%20Depot%2010-k%20unrestricted_page72.pdf"},"request":{"example_id":"table/Home Depot 10-k unrestricted_page72","product_type":"parse","source_file_path":"Home Depot 10-k unrestricted_page72.pdf"},"started_at":"2026-11-04T19:47:43.215852"} +{"completed_at":"2026-11-04T19:47:46.824605","latency_in_ms":2456,"output":{"example_id":"table/IBM_Annual_Report_2018_page17","grounded_pages":[],"layout_pages":[],"markdown":"**Financial Highlights** International Business Machines Corporation and Subsidiary Companies\n\n($ in millions except per share amounts)\n\n**For the year ended December 31: 2018 2017**\n\nRevenue $ 79,591 $ 79,139\n\nNet Income $ 8,728\\* $ 5,753\\*\n\nIncome from continuing operations $ 8,723\\* $ 5,758\\*\n\nOperating (non-GAAP) earnings\\*\\* $ 12,657 $ 12,807\\*\\*\\*\n\nEarnings per share of common stock—continuing operations\n\nAssuming dilution $ 9.51\\* $ 6.14\\*\n\nBasic $ 9.56\\* $ 6.17\\*\n\nDiluted operating (non-GAAP)\\*\\* $ 13.81 $ 13.66\\*\\*\\*\n\nNet cash provided by operating activities $ 15,247 $ 16,724\n\nCapital expenditures, net $ 3,716 $ 3,312\n\nShare repurchases $ 4,443 $ 4,340\n\nCash dividends paid on common stock $ 5,666 $ 5,506\n\nPer share of common stock $ 6.21 $ 5.90\n\n**At December 31: 2018 2017**\n\nCash, cash equivalents, restricted cash and marketable securities $ 12,222 $ 12,842\\*\\*\\*\\*\n\nTotal assets $123,382 $125,356\n\nWorking capital $ 10,918 $ 12,373\n\nTotal debt $ 45,812 $ 46,824\n\nTotal equity $ 16,929 $ 17,725\n\nCommon shares outstanding (in millions) 892 922\n\nStock price per common share $ 113.67 $ 153.42\n\n\\* Includes charges of $2.0 billion in 2018 and $5.5 billion in 2017 associated with U.S. tax reform.\n\n\\*\\* See page 41 for a reconciliation of net income to operating earnings.\n\n\\*\\*\\* Recast to reflect adoption of the FASB guidance on presentation of net periodic pension and nonpension postretirement benefit costs.\n\n\\*\\*\\*\\*Recast to reflect adoption of the FASB guidance on restricted cash.\n\n16","pages":[{"line_numbers":[],"markdown":"**Financial Highlights** International Business Machines Corporation and Subsidiary Companies\n\n($ in millions except per share amounts)\n\n**For the year ended December 31: 2018 2017**\n\nRevenue $ 79,591 $ 79,139\n\nNet Income $ 8,728\\* $ 5,753\\*\n\nIncome from continuing operations $ 8,723\\* $ 5,758\\*\n\nOperating (non-GAAP) earnings\\*\\* $ 12,657 $ 12,807\\*\\*\\*\n\nEarnings per share of common stock—continuing operations\n\nAssuming dilution $ 9.51\\* $ 6.14\\*\n\nBasic $ 9.56\\* $ 6.17\\*\n\nDiluted operating (non-GAAP)\\*\\* $ 13.81 $ 13.66\\*\\*\\*\n\nNet cash provided by operating activities $ 15,247 $ 16,724\n\nCapital expenditures, net $ 3,716 $ 3,312\n\nShare repurchases $ 4,443 $ 4,340\n\nCash dividends paid on common stock $ 5,666 $ 5,506\n\nPer share of common stock $ 6.21 $ 5.90\n\n**At December 31: 2018 2017**\n\nCash, cash equivalents, restricted cash and marketable securities $ 12,222 $ 12,842\\*\\*\\*\\*\n\nTotal assets $123,382 $125,356\n\nWorking capital $ 10,918 $ 12,373\n\nTotal debt $ 45,812 $ 46,824\n\nTotal equity $ 16,929 $ 17,725\n\nCommon shares outstanding (in millions) 892 922\n\nStock price per common share $ 113.67 $ 153.42\n\n\\* Includes charges of $2.0 billion in 2018 and $5.5 billion in 2017 associated with U.S. tax reform.\n\n\\*\\* See page 41 for a reconciliation of net income to operating earnings.\n\n\\*\\*\\* Recast to reflect adoption of the FASB guidance on presentation of net periodic pension and nonpension postretirement benefit costs.\n\n\\*\\*\\*\\*Recast to reflect adoption of the FASB guidance on restricted cash.\n\n16","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Financial Highlights** International Business Machines Corporation and Subsidiary Companies\n\n($ in millions except per share amounts)\n\n**For the year ended December 31: 2018 2017**\n\nRevenue $ 79,591 $ 79,139\n\nNet Income $ 8,728\\* $ 5,753\\*\n\nIncome from continuing operations $ 8,723\\* $ 5,758\\*\n\nOperating (non-GAAP) earnings\\*\\* $ 12,657 $ 12,807\\*\\*\\*\n\nEarnings per share of common stock—continuing operations\n\nAssuming dilution $ 9.51\\* $ 6.14\\*\n\nBasic $ 9.56\\* $ 6.17\\*\n\nDiluted operating (non-GAAP)\\*\\* $ 13.81 $ 13.66\\*\\*\\*\n\nNet cash provided by operating activities $ 15,247 $ 16,724\n\nCapital expenditures, net $ 3,716 $ 3,312\n\nShare repurchases $ 4,443 $ 4,340\n\nCash dividends paid on common stock $ 5,666 $ 5,506\n\nPer share of common stock $ 6.21 $ 5.90\n\n**At December 31: 2018 2017**\n\nCash, cash equivalents, restricted cash and marketable securities $ 12,222 $ 12,842\\*\\*\\*\\*\n\nTotal assets $123,382 $125,356\n\nWorking capital $ 10,918 $ 12,373\n\nTotal debt $ 45,812 $ 46,824\n\nTotal equity $ 16,929 $ 17,725\n\nCommon shares outstanding (in millions) 892 922\n\nStock price per common share $ 113.67 $ 153.42\n\n\\* Includes charges of $2.0 billion in 2018 and $5.5 billion in 2017 associated with U.S. tax reform.\n\n\\*\\* See page 41 for a reconciliation of net income to operating earnings.\n\n\\*\\*\\* Recast to reflect adoption of the FASB guidance on presentation of net periodic pension and nonpension postretirement benefit costs.\n\n\\*\\*\\*\\*Recast to reflect adoption of the FASB guidance on restricted cash.\n\n16","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/IBM_Annual_Report_2018_page17.pdf"]},"response":{"errors":[],"extract_id":"extract_2010db34ab65429488aef703a314fa74","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Financial Highlights** International Business Machines Corporation and Subsidiary Companies\n\n($ in millions except per share amounts)\n\n**For the year ended December 31: 2018 2017**\n\nRevenue $ 79,591 $ 79,139\n\nNet Income $ 8,728\\* $ 5,753\\*\n\nIncome from continuing operations $ 8,723\\* $ 5,758\\*\n\nOperating (non-GAAP) earnings\\*\\* $ 12,657 $ 12,807\\*\\*\\*\n\nEarnings per share of common stock—continuing operations\n\nAssuming dilution $ 9.51\\* $ 6.14\\*\n\nBasic $ 9.56\\* $ 6.17\\*\n\nDiluted operating (non-GAAP)\\*\\* $ 13.81 $ 13.66\\*\\*\\*\n\nNet cash provided by operating activities $ 15,247 $ 16,724\n\nCapital expenditures, net $ 3,716 $ 3,312\n\nShare repurchases $ 4,443 $ 4,340\n\nCash dividends paid on common stock $ 5,666 $ 5,506\n\nPer share of common stock $ 6.21 $ 5.90\n\n**At December 31: 2018 2017**\n\nCash, cash equivalents, restricted cash and marketable securities $ 12,222 $ 12,842\\*\\*\\*\\*\n\nTotal assets $123,382 $125,356\n\nWorking capital $ 10,918 $ 12,373\n\nTotal debt $ 45,812 $ 46,824\n\nTotal equity $ 16,929 $ 17,725\n\nCommon shares outstanding (in millions) 892 922\n\nStock price per common share $ 113.67 $ 153.42\n\n\\* Includes charges of $2.0 billion in 2018 and $5.5 billion in 2017 associated with U.S. tax reform.\n\n\\*\\* See page 41 for a reconciliation of net income to operating earnings.\n\n\\*\\*\\* Recast to reflect adoption of the FASB guidance on presentation of net periodic pension and nonpension postretirement benefit costs.\n\n\\*\\*\\*\\*Recast to reflect adoption of the FASB guidance on restricted cash.\n\n16"],"full_content":"**Financial Highlights** International Business Machines Corporation and Subsidiary Companies\n\n($ in millions except per share amounts)\n\n**For the year ended December 31: 2018 2017**\n\nRevenue $ 79,591 $ 79,139\n\nNet Income $ 8,728\\* $ 5,753\\*\n\nIncome from continuing operations $ 8,723\\* $ 5,758\\*\n\nOperating (non-GAAP) earnings\\*\\* $ 12,657 $ 12,807\\*\\*\\*\n\nEarnings per share of common stock—continuing operations\n\nAssuming dilution $ 9.51\\* $ 6.14\\*\n\nBasic $ 9.56\\* $ 6.17\\*\n\nDiluted operating (non-GAAP)\\*\\* $ 13.81 $ 13.66\\*\\*\\*\n\nNet cash provided by operating activities $ 15,247 $ 16,724\n\nCapital expenditures, net $ 3,716 $ 3,312\n\nShare repurchases $ 4,443 $ 4,340\n\nCash dividends paid on common stock $ 5,666 $ 5,506\n\nPer share of common stock $ 6.21 $ 5.90\n\n**At December 31: 2018 2017**\n\nCash, cash equivalents, restricted cash and marketable securities $ 12,222 $ 12,842\\*\\*\\*\\*\n\nTotal assets $123,382 $125,356\n\nWorking capital $ 10,918 $ 12,373\n\nTotal debt $ 45,812 $ 46,824\n\nTotal equity $ 16,929 $ 17,725\n\nCommon shares outstanding (in millions) 892 922\n\nStock price per common share $ 113.67 $ 153.42\n\n\\* Includes charges of $2.0 billion in 2018 and $5.5 billion in 2017 associated with U.S. tax reform.\n\n\\*\\* See page 41 for a reconciliation of net income to operating earnings.\n\n\\*\\*\\* Recast to reflect adoption of the FASB guidance on presentation of net periodic pension and nonpension postretirement benefit costs.\n\n\\*\\*\\*\\*Recast to reflect adoption of the FASB guidance on restricted cash.\n\n16","publish_date":null,"title":"16 Financial Highlights International Business Machines Corporation and Subsidiary Companies Revenue $ 79,591 $ 79,139 Net Income $ 8,728* $","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/IBM_Annual_Report_2018_page17.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/IBM_Annual_Report_2018_page17.pdf"},"request":{"example_id":"table/IBM_Annual_Report_2018_page17","product_type":"parse","source_file_path":"IBM_Annual_Report_2018_page17.pdf"},"started_at":"2026-11-04T19:47:44.368531"} +{"completed_at":"2026-11-04T19:47:47.276120","latency_in_ms":2429,"output":{"example_id":"table/IBM_Annual_Report_2018_page32","grounded_pages":[],"layout_pages":[],"markdown":"31 **Management Discussion** International Business Machines Corporation and Subsidiary Companies\n\n**Services Backlog and Signings**\n\n($ in billions)\n\n**At December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Total backlog** $116.1 $121.0 (4.1)% (0.6)%\n\nThe estimated total services backlog at December 31, 2018 was $116 billion, a decrease of 4.1 percent as reported (1 percent adjusted for currency).\n\nTotal services backlog includes Infrastructure Services, Consulting, Global Process Services, Application Management and Technical Support Services (TSS). Total backlog is intended to be a statement of overall work under contract which is either noncancellable, or which historically has very low likelihood of termination, given the criticality of certain services to the company’s clients. Total backlog does not include as-a-Service arrangements that allow for termination under contractual commitment terms. Backlog estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustments for revenue not materialized and adjustments for currency.\n\nServices signings are management’s initial estimate of the value of a client’s commitment under a services contract. There are no third-party standards or requirements governing the\n\ncalculation of signings. The calculation used by management involves estimates and judgments to gauge the extent of a client’s commitment, including the type and duration of the agreement, and the presence of termination charges or wind-down costs.\n\nSignings include Infrastructure Services, Consulting, GPS and Application Management contracts. Contract extensions and increases in scope are treated as signings only to the extent of the incremental new value. TSS is generally not included in signings as the maintenance contracts tend to be more steady state, where revenues equal renewals. Certain longer-term TSS contracts that have characteristics similar to outsourcing contracts are included in signings.\n\nContract portfolios purchased in an acquisition are treated as positive backlog adjustments provided those contracts meet the company’s requirements for initial signings. A new signing will be recognized if a new services agreement is signed incidental or coincidental to an acquisition or divestiture.\n\n($ in millions)\n\n**For the year ended December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Total signings** $44,700 $42,869 4.3% 4.9%\n\n**Systems**\n\n($ in millions)\n\n**For the year ended December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Systems external revenue** $8,034 $8,194 (2.0)% (2.3)%\n\nSystems Hardware $6,363 $6,494 (2.0)% (2.3)%\n\nIBM Z (5.4) (5.6)\n\nPower Systems 8.8 8.7\n\nStorage Systems (5.5) (5.9)\n\nOperating Systems Software 1,671 1,701 (1.7) (2.4)\n\nSystems revenue of $8,034 million decreased 2.0 percent year to year as reported (2 percent adjusted for currency) driven by strong IBM Z performance in the prior year and continuing price pressures impacting Storage Systems. Both hardware platforms were down year to year for the full year, as reported and adjusted for currency. This performance was partially offset by strong growth in Power Systems (which grew as reported and adjusted\n\nfor currency in 2018). Systems Hardware revenue of $6,363 million declined 2.0 percent as reported (2 percent adjusted for currency). Operating Systems Software revenue of $1,671 million decreased 1.7 percent as reported (2 percent adjusted for currency) compared to the prior year.","pages":[{"line_numbers":[],"markdown":"31 **Management Discussion** International Business Machines Corporation and Subsidiary Companies\n\n**Services Backlog and Signings**\n\n($ in billions)\n\n**At December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Total backlog** $116.1 $121.0 (4.1)% (0.6)%\n\nThe estimated total services backlog at December 31, 2018 was $116 billion, a decrease of 4.1 percent as reported (1 percent adjusted for currency).\n\nTotal services backlog includes Infrastructure Services, Consulting, Global Process Services, Application Management and Technical Support Services (TSS). Total backlog is intended to be a statement of overall work under contract which is either noncancellable, or which historically has very low likelihood of termination, given the criticality of certain services to the company’s clients. Total backlog does not include as-a-Service arrangements that allow for termination under contractual commitment terms. Backlog estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustments for revenue not materialized and adjustments for currency.\n\nServices signings are management’s initial estimate of the value of a client’s commitment under a services contract. There are no third-party standards or requirements governing the\n\ncalculation of signings. The calculation used by management involves estimates and judgments to gauge the extent of a client’s commitment, including the type and duration of the agreement, and the presence of termination charges or wind-down costs.\n\nSignings include Infrastructure Services, Consulting, GPS and Application Management contracts. Contract extensions and increases in scope are treated as signings only to the extent of the incremental new value. TSS is generally not included in signings as the maintenance contracts tend to be more steady state, where revenues equal renewals. Certain longer-term TSS contracts that have characteristics similar to outsourcing contracts are included in signings.\n\nContract portfolios purchased in an acquisition are treated as positive backlog adjustments provided those contracts meet the company’s requirements for initial signings. A new signing will be recognized if a new services agreement is signed incidental or coincidental to an acquisition or divestiture.\n\n($ in millions)\n\n**For the year ended December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Total signings** $44,700 $42,869 4.3% 4.9%\n\n**Systems**\n\n($ in millions)\n\n**For the year ended December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Systems external revenue** $8,034 $8,194 (2.0)% (2.3)%\n\nSystems Hardware $6,363 $6,494 (2.0)% (2.3)%\n\nIBM Z (5.4) (5.6)\n\nPower Systems 8.8 8.7\n\nStorage Systems (5.5) (5.9)\n\nOperating Systems Software 1,671 1,701 (1.7) (2.4)\n\nSystems revenue of $8,034 million decreased 2.0 percent year to year as reported (2 percent adjusted for currency) driven by strong IBM Z performance in the prior year and continuing price pressures impacting Storage Systems. Both hardware platforms were down year to year for the full year, as reported and adjusted for currency. This performance was partially offset by strong growth in Power Systems (which grew as reported and adjusted\n\nfor currency in 2018). Systems Hardware revenue of $6,363 million declined 2.0 percent as reported (2 percent adjusted for currency). Operating Systems Software revenue of $1,671 million decreased 1.7 percent as reported (2 percent adjusted for currency) compared to the prior year.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"31 **Management Discussion** International Business Machines Corporation and Subsidiary Companies\n\n**Services Backlog and Signings**\n\n($ in billions)\n\n**At December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Total backlog** $116.1 $121.0 (4.1)% (0.6)%\n\nThe estimated total services backlog at December 31, 2018 was $116 billion, a decrease of 4.1 percent as reported (1 percent adjusted for currency).\n\nTotal services backlog includes Infrastructure Services, Consulting, Global Process Services, Application Management and Technical Support Services (TSS). Total backlog is intended to be a statement of overall work under contract which is either noncancellable, or which historically has very low likelihood of termination, given the criticality of certain services to the company’s clients. Total backlog does not include as-a-Service arrangements that allow for termination under contractual commitment terms. Backlog estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustments for revenue not materialized and adjustments for currency.\n\nServices signings are management’s initial estimate of the value of a client’s commitment under a services contract. There are no third-party standards or requirements governing the\n\ncalculation of signings. The calculation used by management involves estimates and judgments to gauge the extent of a client’s commitment, including the type and duration of the agreement, and the presence of termination charges or wind-down costs.\n\nSignings include Infrastructure Services, Consulting, GPS and Application Management contracts. Contract extensions and increases in scope are treated as signings only to the extent of the incremental new value. TSS is generally not included in signings as the maintenance contracts tend to be more steady state, where revenues equal renewals. Certain longer-term TSS contracts that have characteristics similar to outsourcing contracts are included in signings.\n\nContract portfolios purchased in an acquisition are treated as positive backlog adjustments provided those contracts meet the company’s requirements for initial signings. A new signing will be recognized if a new services agreement is signed incidental or coincidental to an acquisition or divestiture.\n\n($ in millions)\n\n**For the year ended December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Total signings** $44,700 $42,869 4.3% 4.9%\n\n**Systems**\n\n($ in millions)\n\n**For the year ended December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Systems external revenue** $8,034 $8,194 (2.0)% (2.3)%\n\nSystems Hardware $6,363 $6,494 (2.0)% (2.3)%\n\nIBM Z (5.4) (5.6)\n\nPower Systems 8.8 8.7\n\nStorage Systems (5.5) (5.9)\n\nOperating Systems Software 1,671 1,701 (1.7) (2.4)\n\nSystems revenue of $8,034 million decreased 2.0 percent year to year as reported (2 percent adjusted for currency) driven by strong IBM Z performance in the prior year and continuing price pressures impacting Storage Systems. Both hardware platforms were down year to year for the full year, as reported and adjusted for currency. This performance was partially offset by strong growth in Power Systems (which grew as reported and adjusted\n\nfor currency in 2018). Systems Hardware revenue of $6,363 million declined 2.0 percent as reported (2 percent adjusted for currency). Operating Systems Software revenue of $1,671 million decreased 1.7 percent as reported (2 percent adjusted for currency) compared to the prior year.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/IBM_Annual_Report_2018_page32.pdf"]},"response":{"errors":[],"extract_id":"extract_6f445bbdf18d8f2f73cfb51ddb69b0ae","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["31 **Management Discussion** International Business Machines Corporation and Subsidiary Companies\n\n**Services Backlog and Signings**\n\n($ in billions)\n\n**At December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Total backlog** $116.1 $121.0 (4.1)% (0.6)%\n\nThe estimated total services backlog at December 31, 2018 was $116 billion, a decrease of 4.1 percent as reported (1 percent adjusted for currency).\n\nTotal services backlog includes Infrastructure Services, Consulting, Global Process Services, Application Management and Technical Support Services (TSS). Total backlog is intended to be a statement of overall work under contract which is either noncancellable, or which historically has very low likelihood of termination, given the criticality of certain services to the company’s clients. Total backlog does not include as-a-Service arrangements that allow for termination under contractual commitment terms. Backlog estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustments for revenue not materialized and adjustments for currency.\n\nServices signings are management’s initial estimate of the value of a client’s commitment under a services contract. There are no third-party standards or requirements governing the\n\ncalculation of signings. The calculation used by management involves estimates and judgments to gauge the extent of a client’s commitment, including the type and duration of the agreement, and the presence of termination charges or wind-down costs.\n\nSignings include Infrastructure Services, Consulting, GPS and Application Management contracts. Contract extensions and increases in scope are treated as signings only to the extent of the incremental new value. TSS is generally not included in signings as the maintenance contracts tend to be more steady state, where revenues equal renewals. Certain longer-term TSS contracts that have characteristics similar to outsourcing contracts are included in signings.\n\nContract portfolios purchased in an acquisition are treated as positive backlog adjustments provided those contracts meet the company’s requirements for initial signings. A new signing will be recognized if a new services agreement is signed incidental or coincidental to an acquisition or divestiture.\n\n($ in millions)\n\n**For the year ended December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Total signings** $44,700 $42,869 4.3% 4.9%\n\n**Systems**\n\n($ in millions)\n\n**For the year ended December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Systems external revenue** $8,034 $8,194 (2.0)% (2.3)%\n\nSystems Hardware $6,363 $6,494 (2.0)% (2.3)%\n\nIBM Z (5.4) (5.6)\n\nPower Systems 8.8 8.7\n\nStorage Systems (5.5) (5.9)\n\nOperating Systems Software 1,671 1,701 (1.7) (2.4)\n\nSystems revenue of $8,034 million decreased 2.0 percent year to year as reported (2 percent adjusted for currency) driven by strong IBM Z performance in the prior year and continuing price pressures impacting Storage Systems. Both hardware platforms were down year to year for the full year, as reported and adjusted for currency. This performance was partially offset by strong growth in Power Systems (which grew as reported and adjusted\n\nfor currency in 2018). Systems Hardware revenue of $6,363 million declined 2.0 percent as reported (2 percent adjusted for currency). Operating Systems Software revenue of $1,671 million decreased 1.7 percent as reported (2 percent adjusted for currency) compared to the prior year."],"full_content":"31 **Management Discussion** International Business Machines Corporation and Subsidiary Companies\n\n**Services Backlog and Signings**\n\n($ in billions)\n\n**At December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Total backlog** $116.1 $121.0 (4.1)% (0.6)%\n\nThe estimated total services backlog at December 31, 2018 was $116 billion, a decrease of 4.1 percent as reported (1 percent adjusted for currency).\n\nTotal services backlog includes Infrastructure Services, Consulting, Global Process Services, Application Management and Technical Support Services (TSS). Total backlog is intended to be a statement of overall work under contract which is either noncancellable, or which historically has very low likelihood of termination, given the criticality of certain services to the company’s clients. Total backlog does not include as-a-Service arrangements that allow for termination under contractual commitment terms. Backlog estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustments for revenue not materialized and adjustments for currency.\n\nServices signings are management’s initial estimate of the value of a client’s commitment under a services contract. There are no third-party standards or requirements governing the\n\ncalculation of signings. The calculation used by management involves estimates and judgments to gauge the extent of a client’s commitment, including the type and duration of the agreement, and the presence of termination charges or wind-down costs.\n\nSignings include Infrastructure Services, Consulting, GPS and Application Management contracts. Contract extensions and increases in scope are treated as signings only to the extent of the incremental new value. TSS is generally not included in signings as the maintenance contracts tend to be more steady state, where revenues equal renewals. Certain longer-term TSS contracts that have characteristics similar to outsourcing contracts are included in signings.\n\nContract portfolios purchased in an acquisition are treated as positive backlog adjustments provided those contracts meet the company’s requirements for initial signings. A new signing will be recognized if a new services agreement is signed incidental or coincidental to an acquisition or divestiture.\n\n($ in millions)\n\n**For the year ended December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Total signings** $44,700 $42,869 4.3% 4.9%\n\n**Systems**\n\n($ in millions)\n\n**For the year ended December 31: 2018 2017**\n\n**Yr.-to-Yr. Percent Change**\n\n**Yr.-to-Yr. Percent Change Adjusted for Currency**\n\n**Systems external revenue** $8,034 $8,194 (2.0)% (2.3)%\n\nSystems Hardware $6,363 $6,494 (2.0)% (2.3)%\n\nIBM Z (5.4) (5.6)\n\nPower Systems 8.8 8.7\n\nStorage Systems (5.5) (5.9)\n\nOperating Systems Software 1,671 1,701 (1.7) (2.4)\n\nSystems revenue of $8,034 million decreased 2.0 percent year to year as reported (2 percent adjusted for currency) driven by strong IBM Z performance in the prior year and continuing price pressures impacting Storage Systems. Both hardware platforms were down year to year for the full year, as reported and adjusted for currency. This performance was partially offset by strong growth in Power Systems (which grew as reported and adjusted\n\nfor currency in 2018). Systems Hardware revenue of $6,363 million declined 2.0 percent as reported (2 percent adjusted for currency). Operating Systems Software revenue of $1,671 million decreased 1.7 percent as reported (2 percent adjusted for currency) compared to the prior year.","publish_date":null,"title":"31 Management Discussion International Business Machines Corporation and Subsidiary Companies Services Backlog and Signings $116.1 $121.0 (4.1)% (0.6)% Total backlog","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/IBM_Annual_Report_2018_page32.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/IBM_Annual_Report_2018_page32.pdf"},"request":{"example_id":"table/IBM_Annual_Report_2018_page32","product_type":"parse","source_file_path":"IBM_Annual_Report_2018_page32.pdf"},"started_at":"2026-11-04T19:47:44.846924"} +{"completed_at":"2026-11-04T19:47:47.127324","latency_in_ms":1107,"output":{"example_id":"table/IT.2009.page_74.pdf_78635_page1","grounded_pages":[],"layout_pages":[],"markdown":"over the related service period, net of estimated forfeitures (see Note 10 — Stock-Based Compensation in the Notes to the Consolidated Financial Statements).\n\nDetermining the appropriate fair value model and calculating the fair value of stock compensation awards requires the input of certain highly complex and subjective assumptions, including the expected life of the stock compensation awards and the Company’s Common Stock price volatility. In addition, determining the appropriate amount of associated periodic expense requires management to estimate the rate of employee forfeitures and the likelihood of achievement of certain performance targets. The assumptions used in calculating the fair value of stock compensation awards and the associated periodic expense represent management’s best estimates, but these estimates involve inherent uncertainties and the application of judgment. As a result, if factors change and the Company deems it necessary in the future to modify the assumptions it made or to use different assumptions, or if the quantity and nature of the Company’s stock-based compensation awards changes, then the amount of expense may need to be adjusted and future stock compensation expense could be materially different from what has been recorded in the current period.\n\n**Restructuring and other accruals** – We may record accruals for severance costs, costs associated with excess facilities that we have leased, contract terminations, asset impairments, and other costs as a result of on-going actions we undertake to streamline our organization, reposition certain businesses and reduce ongoing costs. Estimates of costs to be incurred to complete these actions, such as future lease payments, sublease income, the fair value of assets, and severance and related benefits, are based on assumptions at the time the actions are initiated. These accruals may need to be adjusted to the extent actual costs differ from such estimates. In addition, these actions may be revised due to changes in business conditions that we did not foresee at the time such plans were approved.\n\nWe also record accruals during the year for our various employee cash incentive programs. Amounts accrued at the end of each reporting period are based on our estimates and may require adjustment as the ultimate amount paid for these incentives are sometimes not known with certainty until after year end.\n\n**RESULTS OF OPERATIONS** The following table summarizes the changes in selected line items in our Consolidated Statements of Operation for the periods indicated (dollars in thousands):\n\nTwelve Months Ended December 31, 2009 (a)\n\nTwelve Months Ended December 31, 2008\n\nDollar Increase (Decrease)\n\nPercentage Increase (Decrease)\n\nTwelve Months Ended December 31, 2008\n\nTwelve Months Ended December 31, 2007\n\nDollar Increase (Decrease)\n\nPercentage Increase (Decrease)\n\n2009 vs. 2008 2008 vs. 2007\n\nTotal revenues $1,139,800 $1,279,065 $(139,265) (11)% $1,279,065 $1,168,475 $110,590 9% Costs and expenses: Cost of services and product development 498,363 572,208 73,845 13% 572,208 546,569 (25,639) (5)% Selling, general and administrative 477,003 514,994 37,991 7% 514,994 456,975 (58,019) (13)% Depreciation 25,387 25,880 493 2% 25,880 24,298 (1,582) (7)% Amortization of intangibles 1,636 1,615 (21) (1)% 1,615 2,091 476 (23)% Acquisition and integration charges 2,934 — (2,934) (100)% — — — — Other charges — — — — — 9,084 9,084 100%\n\nOperating income 134,477 164,368 (29,891) (18)% 164,368 129,458 34,910 27% Interest expense, net (16,032) (19,269) 3,237 17% (19,269) (22,154) 2,885 13% Other (expense) income, net (2,919) (358) (2,561) H(100)% (358) 3,193 (3,551) H(100)% Provision for income taxes 32,562 47,593 15,031 32% 47,593 39,831 (7,762) (19)%\n\nIncome from continuing operations 82,964 97,148 (14,184) (15)% 97,148 70,666 26,482 37% Income from discontinued operations, net of taxes — 6,723 (6,723) (100)% 6,723 2,887 3,836 H100%\n\nNet income $ 82,964 $ 103,871 $ (20,907) (20)% $ 103,871 $ 73,553 $ 30,318 41%\n\n(a) In December 2009 we acquired AMR Research and Burton Group. The operating results of these businesses are included in our consolidated results beginning on the respective dates of acquisition. The results of these businesses were not material to our 2009 results.\n\n2009 VERSUS 2008 TOTAL REVENUES for the twelve months ended December 31, 2009 decreased $139.3 million, or 11%, compared to the twelve months ended December 31, 2008. Revenues declined across all of our geographic regions and in all three of our business\n\n16","pages":[{"line_numbers":[],"markdown":"over the related service period, net of estimated forfeitures (see Note 10 — Stock-Based Compensation in the Notes to the Consolidated Financial Statements).\n\nDetermining the appropriate fair value model and calculating the fair value of stock compensation awards requires the input of certain highly complex and subjective assumptions, including the expected life of the stock compensation awards and the Company’s Common Stock price volatility. In addition, determining the appropriate amount of associated periodic expense requires management to estimate the rate of employee forfeitures and the likelihood of achievement of certain performance targets. The assumptions used in calculating the fair value of stock compensation awards and the associated periodic expense represent management’s best estimates, but these estimates involve inherent uncertainties and the application of judgment. As a result, if factors change and the Company deems it necessary in the future to modify the assumptions it made or to use different assumptions, or if the quantity and nature of the Company’s stock-based compensation awards changes, then the amount of expense may need to be adjusted and future stock compensation expense could be materially different from what has been recorded in the current period.\n\n**Restructuring and other accruals** – We may record accruals for severance costs, costs associated with excess facilities that we have leased, contract terminations, asset impairments, and other costs as a result of on-going actions we undertake to streamline our organization, reposition certain businesses and reduce ongoing costs. Estimates of costs to be incurred to complete these actions, such as future lease payments, sublease income, the fair value of assets, and severance and related benefits, are based on assumptions at the time the actions are initiated. These accruals may need to be adjusted to the extent actual costs differ from such estimates. In addition, these actions may be revised due to changes in business conditions that we did not foresee at the time such plans were approved.\n\nWe also record accruals during the year for our various employee cash incentive programs. Amounts accrued at the end of each reporting period are based on our estimates and may require adjustment as the ultimate amount paid for these incentives are sometimes not known with certainty until after year end.\n\n**RESULTS OF OPERATIONS** The following table summarizes the changes in selected line items in our Consolidated Statements of Operation for the periods indicated (dollars in thousands):\n\nTwelve Months Ended December 31, 2009 (a)\n\nTwelve Months Ended December 31, 2008\n\nDollar Increase (Decrease)\n\nPercentage Increase (Decrease)\n\nTwelve Months Ended December 31, 2008\n\nTwelve Months Ended December 31, 2007\n\nDollar Increase (Decrease)\n\nPercentage Increase (Decrease)\n\n2009 vs. 2008 2008 vs. 2007\n\nTotal revenues $1,139,800 $1,279,065 $(139,265) (11)% $1,279,065 $1,168,475 $110,590 9% Costs and expenses: Cost of services and product development 498,363 572,208 73,845 13% 572,208 546,569 (25,639) (5)% Selling, general and administrative 477,003 514,994 37,991 7% 514,994 456,975 (58,019) (13)% Depreciation 25,387 25,880 493 2% 25,880 24,298 (1,582) (7)% Amortization of intangibles 1,636 1,615 (21) (1)% 1,615 2,091 476 (23)% Acquisition and integration charges 2,934 — (2,934) (100)% — — — — Other charges — — — — — 9,084 9,084 100%\n\nOperating income 134,477 164,368 (29,891) (18)% 164,368 129,458 34,910 27% Interest expense, net (16,032) (19,269) 3,237 17% (19,269) (22,154) 2,885 13% Other (expense) income, net (2,919) (358) (2,561) H(100)% (358) 3,193 (3,551) H(100)% Provision for income taxes 32,562 47,593 15,031 32% 47,593 39,831 (7,762) (19)%\n\nIncome from continuing operations 82,964 97,148 (14,184) (15)% 97,148 70,666 26,482 37% Income from discontinued operations, net of taxes — 6,723 (6,723) (100)% 6,723 2,887 3,836 H100%\n\nNet income $ 82,964 $ 103,871 $ (20,907) (20)% $ 103,871 $ 73,553 $ 30,318 41%\n\n(a) In December 2009 we acquired AMR Research and Burton Group. The operating results of these businesses are included in our consolidated results beginning on the respective dates of acquisition. The results of these businesses were not material to our 2009 results.\n\n2009 VERSUS 2008 TOTAL REVENUES for the twelve months ended December 31, 2009 decreased $139.3 million, or 11%, compared to the twelve months ended December 31, 2008. Revenues declined across all of our geographic regions and in all three of our business\n\n16","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"over the related service period, net of estimated forfeitures (see Note 10 — Stock-Based Compensation in the Notes to the Consolidated Financial Statements).\n\nDetermining the appropriate fair value model and calculating the fair value of stock compensation awards requires the input of certain highly complex and subjective assumptions, including the expected life of the stock compensation awards and the Company’s Common Stock price volatility. In addition, determining the appropriate amount of associated periodic expense requires management to estimate the rate of employee forfeitures and the likelihood of achievement of certain performance targets. The assumptions used in calculating the fair value of stock compensation awards and the associated periodic expense represent management’s best estimates, but these estimates involve inherent uncertainties and the application of judgment. As a result, if factors change and the Company deems it necessary in the future to modify the assumptions it made or to use different assumptions, or if the quantity and nature of the Company’s stock-based compensation awards changes, then the amount of expense may need to be adjusted and future stock compensation expense could be materially different from what has been recorded in the current period.\n\n**Restructuring and other accruals** – We may record accruals for severance costs, costs associated with excess facilities that we have leased, contract terminations, asset impairments, and other costs as a result of on-going actions we undertake to streamline our organization, reposition certain businesses and reduce ongoing costs. Estimates of costs to be incurred to complete these actions, such as future lease payments, sublease income, the fair value of assets, and severance and related benefits, are based on assumptions at the time the actions are initiated. These accruals may need to be adjusted to the extent actual costs differ from such estimates. In addition, these actions may be revised due to changes in business conditions that we did not foresee at the time such plans were approved.\n\nWe also record accruals during the year for our various employee cash incentive programs. Amounts accrued at the end of each reporting period are based on our estimates and may require adjustment as the ultimate amount paid for these incentives are sometimes not known with certainty until after year end.\n\n**RESULTS OF OPERATIONS** The following table summarizes the changes in selected line items in our Consolidated Statements of Operation for the periods indicated (dollars in thousands):\n\nTwelve Months Ended December 31, 2009 (a)\n\nTwelve Months Ended December 31, 2008\n\nDollar Increase (Decrease)\n\nPercentage Increase (Decrease)\n\nTwelve Months Ended December 31, 2008\n\nTwelve Months Ended December 31, 2007\n\nDollar Increase (Decrease)\n\nPercentage Increase (Decrease)\n\n2009 vs. 2008 2008 vs. 2007\n\nTotal revenues $1,139,800 $1,279,065 $(139,265) (11)% $1,279,065 $1,168,475 $110,590 9% Costs and expenses: Cost of services and product development 498,363 572,208 73,845 13% 572,208 546,569 (25,639) (5)% Selling, general and administrative 477,003 514,994 37,991 7% 514,994 456,975 (58,019) (13)% Depreciation 25,387 25,880 493 2% 25,880 24,298 (1,582) (7)% Amortization of intangibles 1,636 1,615 (21) (1)% 1,615 2,091 476 (23)% Acquisition and integration charges 2,934 — (2,934) (100)% — — — — Other charges — — — — — 9,084 9,084 100%\n\nOperating income 134,477 164,368 (29,891) (18)% 164,368 129,458 34,910 27% Interest expense, net (16,032) (19,269) 3,237 17% (19,269) (22,154) 2,885 13% Other (expense) income, net (2,919) (358) (2,561) H(100)% (358) 3,193 (3,551) H(100)% Provision for income taxes 32,562 47,593 15,031 32% 47,593 39,831 (7,762) (19)%\n\nIncome from continuing operations 82,964 97,148 (14,184) (15)% 97,148 70,666 26,482 37% Income from discontinued operations, net of taxes — 6,723 (6,723) (100)% 6,723 2,887 3,836 H100%\n\nNet income $ 82,964 $ 103,871 $ (20,907) (20)% $ 103,871 $ 73,553 $ 30,318 41%\n\n(a) In December 2009 we acquired AMR Research and Burton Group. The operating results of these businesses are included in our consolidated results beginning on the respective dates of acquisition. The results of these businesses were not material to our 2009 results.\n\n2009 VERSUS 2008 TOTAL REVENUES for the twelve months ended December 31, 2009 decreased $139.3 million, or 11%, compared to the twelve months ended December 31, 2008. Revenues declined across all of our geographic regions and in all three of our business\n\n16","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/IT.2009.page_74.pdf_78635_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_e045c98ddf5a9e43e44ec3d7a4cc14d6","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["over the related service period, net of estimated forfeitures (see Note 10 — Stock-Based Compensation in the Notes to the Consolidated Financial Statements).\n\nDetermining the appropriate fair value model and calculating the fair value of stock compensation awards requires the input of certain highly complex and subjective assumptions, including the expected life of the stock compensation awards and the Company’s Common Stock price volatility. In addition, determining the appropriate amount of associated periodic expense requires management to estimate the rate of employee forfeitures and the likelihood of achievement of certain performance targets. The assumptions used in calculating the fair value of stock compensation awards and the associated periodic expense represent management’s best estimates, but these estimates involve inherent uncertainties and the application of judgment. As a result, if factors change and the Company deems it necessary in the future to modify the assumptions it made or to use different assumptions, or if the quantity and nature of the Company’s stock-based compensation awards changes, then the amount of expense may need to be adjusted and future stock compensation expense could be materially different from what has been recorded in the current period.\n\n**Restructuring and other accruals** – We may record accruals for severance costs, costs associated with excess facilities that we have leased, contract terminations, asset impairments, and other costs as a result of on-going actions we undertake to streamline our organization, reposition certain businesses and reduce ongoing costs. Estimates of costs to be incurred to complete these actions, such as future lease payments, sublease income, the fair value of assets, and severance and related benefits, are based on assumptions at the time the actions are initiated. These accruals may need to be adjusted to the extent actual costs differ from such estimates. In addition, these actions may be revised due to changes in business conditions that we did not foresee at the time such plans were approved.\n\nWe also record accruals during the year for our various employee cash incentive programs. Amounts accrued at the end of each reporting period are based on our estimates and may require adjustment as the ultimate amount paid for these incentives are sometimes not known with certainty until after year end.\n\n**RESULTS OF OPERATIONS** The following table summarizes the changes in selected line items in our Consolidated Statements of Operation for the periods indicated (dollars in thousands):\n\nTwelve Months Ended December 31, 2009 (a)\n\nTwelve Months Ended December 31, 2008\n\nDollar Increase (Decrease)\n\nPercentage Increase (Decrease)\n\nTwelve Months Ended December 31, 2008\n\nTwelve Months Ended December 31, 2007\n\nDollar Increase (Decrease)\n\nPercentage Increase (Decrease)\n\n2009 vs. 2008 2008 vs. 2007\n\nTotal revenues $1,139,800 $1,279,065 $(139,265) (11)% $1,279,065 $1,168,475 $110,590 9% Costs and expenses: Cost of services and product development 498,363 572,208 73,845 13% 572,208 546,569 (25,639) (5)% Selling, general and administrative 477,003 514,994 37,991 7% 514,994 456,975 (58,019) (13)% Depreciation 25,387 25,880 493 2% 25,880 24,298 (1,582) (7)% Amortization of intangibles 1,636 1,615 (21) (1)% 1,615 2,091 476 (23)% Acquisition and integration charges 2,934 — (2,934) (100)% — — — — Other charges — — — — — 9,084 9,084 100%\n\nOperating income 134,477 164,368 (29,891) (18)% 164,368 129,458 34,910 27% Interest expense, net (16,032) (19,269) 3,237 17% (19,269) (22,154) 2,885 13% Other (expense) income, net (2,919) (358) (2,561) H(100)% (358) 3,193 (3,551) H(100)% Provision for income taxes 32,562 47,593 15,031 32% 47,593 39,831 (7,762) (19)%\n\nIncome from continuing operations 82,964 97,148 (14,184) (15)% 97,148 70,666 26,482 37% Income from discontinued operations, net of taxes — 6,723 (6,723) (100)% 6,723 2,887 3,836 H100%\n\nNet income $ 82,964 $ 103,871 $ (20,907) (20)% $ 103,871 $ 73,553 $ 30,318 41%\n\n(a) In December 2009 we acquired AMR Research and Burton Group. The operating results of these businesses are included in our consolidated results beginning on the respective dates of acquisition. The results of these businesses were not material to our 2009 results.\n\n2009 VERSUS 2008 TOTAL REVENUES for the twelve months ended December 31, 2009 decreased $139.3 million, or 11%, compared to the twelve months ended December 31, 2008. Revenues declined across all of our geographic regions and in all three of our business\n\n16"],"full_content":"over the related service period, net of estimated forfeitures (see Note 10 — Stock-Based Compensation in the Notes to the Consolidated Financial Statements).\n\nDetermining the appropriate fair value model and calculating the fair value of stock compensation awards requires the input of certain highly complex and subjective assumptions, including the expected life of the stock compensation awards and the Company’s Common Stock price volatility. In addition, determining the appropriate amount of associated periodic expense requires management to estimate the rate of employee forfeitures and the likelihood of achievement of certain performance targets. The assumptions used in calculating the fair value of stock compensation awards and the associated periodic expense represent management’s best estimates, but these estimates involve inherent uncertainties and the application of judgment. As a result, if factors change and the Company deems it necessary in the future to modify the assumptions it made or to use different assumptions, or if the quantity and nature of the Company’s stock-based compensation awards changes, then the amount of expense may need to be adjusted and future stock compensation expense could be materially different from what has been recorded in the current period.\n\n**Restructuring and other accruals** – We may record accruals for severance costs, costs associated with excess facilities that we have leased, contract terminations, asset impairments, and other costs as a result of on-going actions we undertake to streamline our organization, reposition certain businesses and reduce ongoing costs. Estimates of costs to be incurred to complete these actions, such as future lease payments, sublease income, the fair value of assets, and severance and related benefits, are based on assumptions at the time the actions are initiated. These accruals may need to be adjusted to the extent actual costs differ from such estimates. In addition, these actions may be revised due to changes in business conditions that we did not foresee at the time such plans were approved.\n\nWe also record accruals during the year for our various employee cash incentive programs. Amounts accrued at the end of each reporting period are based on our estimates and may require adjustment as the ultimate amount paid for these incentives are sometimes not known with certainty until after year end.\n\n**RESULTS OF OPERATIONS** The following table summarizes the changes in selected line items in our Consolidated Statements of Operation for the periods indicated (dollars in thousands):\n\nTwelve Months Ended December 31, 2009 (a)\n\nTwelve Months Ended December 31, 2008\n\nDollar Increase (Decrease)\n\nPercentage Increase (Decrease)\n\nTwelve Months Ended December 31, 2008\n\nTwelve Months Ended December 31, 2007\n\nDollar Increase (Decrease)\n\nPercentage Increase (Decrease)\n\n2009 vs. 2008 2008 vs. 2007\n\nTotal revenues $1,139,800 $1,279,065 $(139,265) (11)% $1,279,065 $1,168,475 $110,590 9% Costs and expenses: Cost of services and product development 498,363 572,208 73,845 13% 572,208 546,569 (25,639) (5)% Selling, general and administrative 477,003 514,994 37,991 7% 514,994 456,975 (58,019) (13)% Depreciation 25,387 25,880 493 2% 25,880 24,298 (1,582) (7)% Amortization of intangibles 1,636 1,615 (21) (1)% 1,615 2,091 476 (23)% Acquisition and integration charges 2,934 — (2,934) (100)% — — — — Other charges — — — — — 9,084 9,084 100%\n\nOperating income 134,477 164,368 (29,891) (18)% 164,368 129,458 34,910 27% Interest expense, net (16,032) (19,269) 3,237 17% (19,269) (22,154) 2,885 13% Other (expense) income, net (2,919) (358) (2,561) H(100)% (358) 3,193 (3,551) H(100)% Provision for income taxes 32,562 47,593 15,031 32% 47,593 39,831 (7,762) (19)%\n\nIncome from continuing operations 82,964 97,148 (14,184) (15)% 97,148 70,666 26,482 37% Income from discontinued operations, net of taxes — 6,723 (6,723) (100)% 6,723 2,887 3,836 H100%\n\nNet income $ 82,964 $ 103,871 $ (20,907) (20)% $ 103,871 $ 73,553 $ 30,318 41%\n\n(a) In December 2009 we acquired AMR Research and Burton Group. The operating results of these businesses are included in our consolidated results beginning on the respective dates of acquisition. The results of these businesses were not material to our 2009 results.\n\n2009 VERSUS 2008 TOTAL REVENUES for the twelve months ended December 31, 2009 decreased $139.3 million, or 11%, compared to the twelve months ended December 31, 2008. Revenues declined across all of our geographic regions and in all three of our business\n\n16","publish_date":null,"title":"2009VERSUS2008","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/IT.2009.page_74.pdf_78635_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/IT.2009.page_74.pdf_78635_page1.pdf"},"request":{"example_id":"table/IT.2009.page_74.pdf_78635_page1","product_type":"parse","source_file_path":"IT.2009.page_74.pdf_78635_page1.pdf"},"started_at":"2026-11-04T19:47:46.020240"} +{"completed_at":"2026-11-04T19:47:48.773859","latency_in_ms":1736,"output":{"example_id":"table/JNPR.2008.page_50.pdf_110961_page1","grounded_pages":[],"layout_pages":[],"markdown":"Financial information for each segment used by management to make financial decisions and allocate resources is as follows (in millions, except percentages):\n\n**2008 2007(1) $ Change % Change 2007(1) 2006(1) $ Change % Change Years Ended December 31, Years Ended December 31,**\n\nNet revenues:\n\nInfrastructure:\n\nProduct . . . . . . . . . . . . . . . . . $2,301.9 $1,753.2 $548.7 31% $1,753.2 $ 1,413.4 $ 339.8 24% Service. . . . . . . . . . . . . . . . . . 424.0 320.1 103.9 32% 320.1 266.7 53.4 20%\n\nTotal Infrastructure revenues . . 2,725.9 2,073.3 652.6 31% 2,073.3 1,680.1 393.2 23%\n\nService Layer Technologies: Product . . . . . . . . . . . . . . . . . 609.1 573.8 35.3 6% 573.8 479.9 93.9 20%\n\nService. . . . . . . . . . . . . . . . . . 237.4 189.0 48.4 26% 189.0 143.6 45.4 32%\n\nTotal Service Layer Technologies revenues . . . . 846.5 762.8 83.7 11% 762.8 623.5 139.3 22%\n\nTotal net revenues . . . . . . . 3,572.4 2,836.1 736.3 26% 2,836.1 2,303.6 532.5 23%\n\nOperating income: Infrastructure . . . . . . . . . . . . . . . 806.0 597.8 208.2 35% 597.8 505.9 91.9 18%\n\nService Layer Technologies . . . . . . 65.8 5.8 60.0 N/M 5.8 5.2 0.6 12%\n\nTotal segment operating income . . . . . . . . . . . . . . . . 871.8 603.6 268.2 44% 603.6 511.1 92.5 18%\n\nOther corporate(2) . . . . . . . . . . . . (7.9) — (7.9) N/M — — — N/M\n\nTotal management operating income . . . . . . . . . . . . . . . . 863.9 603.6 260.3 43% 603.6 511.1 92.5 18% Amortization of purchased intangible assets . . . . . . . . . . . . (44.0) (91.4) 47.4 (52)% (91.4) (97.3) 5.9 (6)%\n\nStock-based compensation expense . . . . . . . . . . . . . . . . . (108.1) (88.0) (20.1) 23% (88.0) (87.6) (0.4) N/M\n\nStock-based payroll tax expense . . . (2.8) (7.7) 4.9 (64)% (7.7) (2.7) (5.0) 185%\n\nImpairment of goodwill and intangible assets . . . . . . . . . . . . (5.0) — 5.0 100% — (1,283.4) 1,283.4 (100)% Other charges, net(3) . . . . . . . . . . (9.0) (9.4) 0.4 N/M (9.4) (37.9) 28.5 (75)%\n\nTotal operating income (loss) . . . 695.0 407.1 287.9 71% 407.1 (997.8) 1,404.9 141%\n\nOther income and expense, net . . . . . 33.9 103.5 (69.6) (67)% 103.5 100.7 2.8 3%\n\nIncome (loss) before income taxes . . . . . . . . . . . . . . . . . . . $ 728.9 $ 510.6 $218.3 43% $ 510.6 $ (897.1) $1,407.7 157%\n\nN/M Not meaningful.\n\n(1) Prior year amounts have been reclassified to reflect the 2008 segment structure, which now includes service revenues and operating results in Infrastructure and SLT segments.\n\n(2) Other corporate charges include workforce-rebalancing charges primarily for severance and related costs. Workforce-rebalancing activities are considered part of our normal operations as we continue to optimize our cost structure. Workforce-rebalancing costs are not included in our business segment results, and we may incur additional workforce-rebalancing costs in the future. (3) Other charges, net, for 2008 includes loss on litigation settlement. Other charges, net, for 2007 includes charges such as restructuring, acquisition-related charges, stock option investigation costs, as well as stock amendment and tax-related charges. Other charges, net, for 2006 includes charges such as restructuring, acquisition-related charges, stock option investigation costs and tax-related charges, as well as certain restructuring charges in cost of product revenues.\n\n49","pages":[{"line_numbers":[],"markdown":"Financial information for each segment used by management to make financial decisions and allocate resources is as follows (in millions, except percentages):\n\n**2008 2007(1) $ Change % Change 2007(1) 2006(1) $ Change % Change Years Ended December 31, Years Ended December 31,**\n\nNet revenues:\n\nInfrastructure:\n\nProduct . . . . . . . . . . . . . . . . . $2,301.9 $1,753.2 $548.7 31% $1,753.2 $ 1,413.4 $ 339.8 24% Service. . . . . . . . . . . . . . . . . . 424.0 320.1 103.9 32% 320.1 266.7 53.4 20%\n\nTotal Infrastructure revenues . . 2,725.9 2,073.3 652.6 31% 2,073.3 1,680.1 393.2 23%\n\nService Layer Technologies: Product . . . . . . . . . . . . . . . . . 609.1 573.8 35.3 6% 573.8 479.9 93.9 20%\n\nService. . . . . . . . . . . . . . . . . . 237.4 189.0 48.4 26% 189.0 143.6 45.4 32%\n\nTotal Service Layer Technologies revenues . . . . 846.5 762.8 83.7 11% 762.8 623.5 139.3 22%\n\nTotal net revenues . . . . . . . 3,572.4 2,836.1 736.3 26% 2,836.1 2,303.6 532.5 23%\n\nOperating income: Infrastructure . . . . . . . . . . . . . . . 806.0 597.8 208.2 35% 597.8 505.9 91.9 18%\n\nService Layer Technologies . . . . . . 65.8 5.8 60.0 N/M 5.8 5.2 0.6 12%\n\nTotal segment operating income . . . . . . . . . . . . . . . . 871.8 603.6 268.2 44% 603.6 511.1 92.5 18%\n\nOther corporate(2) . . . . . . . . . . . . (7.9) — (7.9) N/M — — — N/M\n\nTotal management operating income . . . . . . . . . . . . . . . . 863.9 603.6 260.3 43% 603.6 511.1 92.5 18% Amortization of purchased intangible assets . . . . . . . . . . . . (44.0) (91.4) 47.4 (52)% (91.4) (97.3) 5.9 (6)%\n\nStock-based compensation expense . . . . . . . . . . . . . . . . . (108.1) (88.0) (20.1) 23% (88.0) (87.6) (0.4) N/M\n\nStock-based payroll tax expense . . . (2.8) (7.7) 4.9 (64)% (7.7) (2.7) (5.0) 185%\n\nImpairment of goodwill and intangible assets . . . . . . . . . . . . (5.0) — 5.0 100% — (1,283.4) 1,283.4 (100)% Other charges, net(3) . . . . . . . . . . (9.0) (9.4) 0.4 N/M (9.4) (37.9) 28.5 (75)%\n\nTotal operating income (loss) . . . 695.0 407.1 287.9 71% 407.1 (997.8) 1,404.9 141%\n\nOther income and expense, net . . . . . 33.9 103.5 (69.6) (67)% 103.5 100.7 2.8 3%\n\nIncome (loss) before income taxes . . . . . . . . . . . . . . . . . . . $ 728.9 $ 510.6 $218.3 43% $ 510.6 $ (897.1) $1,407.7 157%\n\nN/M Not meaningful.\n\n(1) Prior year amounts have been reclassified to reflect the 2008 segment structure, which now includes service revenues and operating results in Infrastructure and SLT segments.\n\n(2) Other corporate charges include workforce-rebalancing charges primarily for severance and related costs. Workforce-rebalancing activities are considered part of our normal operations as we continue to optimize our cost structure. Workforce-rebalancing costs are not included in our business segment results, and we may incur additional workforce-rebalancing costs in the future. (3) Other charges, net, for 2008 includes loss on litigation settlement. Other charges, net, for 2007 includes charges such as restructuring, acquisition-related charges, stock option investigation costs, as well as stock amendment and tax-related charges. Other charges, net, for 2006 includes charges such as restructuring, acquisition-related charges, stock option investigation costs and tax-related charges, as well as certain restructuring charges in cost of product revenues.\n\n49","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Financial information for each segment used by management to make financial decisions and allocate resources is as follows (in millions, except percentages):\n\n**2008 2007(1) $ Change % Change 2007(1) 2006(1) $ Change % Change Years Ended December 31, Years Ended December 31,**\n\nNet revenues:\n\nInfrastructure:\n\nProduct . . . . . . . . . . . . . . . . . $2,301.9 $1,753.2 $548.7 31% $1,753.2 $ 1,413.4 $ 339.8 24% Service. . . . . . . . . . . . . . . . . . 424.0 320.1 103.9 32% 320.1 266.7 53.4 20%\n\nTotal Infrastructure revenues . . 2,725.9 2,073.3 652.6 31% 2,073.3 1,680.1 393.2 23%\n\nService Layer Technologies: Product . . . . . . . . . . . . . . . . . 609.1 573.8 35.3 6% 573.8 479.9 93.9 20%\n\nService. . . . . . . . . . . . . . . . . . 237.4 189.0 48.4 26% 189.0 143.6 45.4 32%\n\nTotal Service Layer Technologies revenues . . . . 846.5 762.8 83.7 11% 762.8 623.5 139.3 22%\n\nTotal net revenues . . . . . . . 3,572.4 2,836.1 736.3 26% 2,836.1 2,303.6 532.5 23%\n\nOperating income: Infrastructure . . . . . . . . . . . . . . . 806.0 597.8 208.2 35% 597.8 505.9 91.9 18%\n\nService Layer Technologies . . . . . . 65.8 5.8 60.0 N/M 5.8 5.2 0.6 12%\n\nTotal segment operating income . . . . . . . . . . . . . . . . 871.8 603.6 268.2 44% 603.6 511.1 92.5 18%\n\nOther corporate(2) . . . . . . . . . . . . (7.9) — (7.9) N/M — — — N/M\n\nTotal management operating income . . . . . . . . . . . . . . . . 863.9 603.6 260.3 43% 603.6 511.1 92.5 18% Amortization of purchased intangible assets . . . . . . . . . . . . (44.0) (91.4) 47.4 (52)% (91.4) (97.3) 5.9 (6)%\n\nStock-based compensation expense . . . . . . . . . . . . . . . . . (108.1) (88.0) (20.1) 23% (88.0) (87.6) (0.4) N/M\n\nStock-based payroll tax expense . . . (2.8) (7.7) 4.9 (64)% (7.7) (2.7) (5.0) 185%\n\nImpairment of goodwill and intangible assets . . . . . . . . . . . . (5.0) — 5.0 100% — (1,283.4) 1,283.4 (100)% Other charges, net(3) . . . . . . . . . . (9.0) (9.4) 0.4 N/M (9.4) (37.9) 28.5 (75)%\n\nTotal operating income (loss) . . . 695.0 407.1 287.9 71% 407.1 (997.8) 1,404.9 141%\n\nOther income and expense, net . . . . . 33.9 103.5 (69.6) (67)% 103.5 100.7 2.8 3%\n\nIncome (loss) before income taxes . . . . . . . . . . . . . . . . . . . $ 728.9 $ 510.6 $218.3 43% $ 510.6 $ (897.1) $1,407.7 157%\n\nN/M Not meaningful.\n\n(1) Prior year amounts have been reclassified to reflect the 2008 segment structure, which now includes service revenues and operating results in Infrastructure and SLT segments.\n\n(2) Other corporate charges include workforce-rebalancing charges primarily for severance and related costs. Workforce-rebalancing activities are considered part of our normal operations as we continue to optimize our cost structure. Workforce-rebalancing costs are not included in our business segment results, and we may incur additional workforce-rebalancing costs in the future. (3) Other charges, net, for 2008 includes loss on litigation settlement. Other charges, net, for 2007 includes charges such as restructuring, acquisition-related charges, stock option investigation costs, as well as stock amendment and tax-related charges. Other charges, net, for 2006 includes charges such as restructuring, acquisition-related charges, stock option investigation costs and tax-related charges, as well as certain restructuring charges in cost of product revenues.\n\n49","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2008.page_50.pdf_110961_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_c33e9758b5cf8aea1e5e499aab8b280c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Financial information for each segment used by management to make financial decisions and allocate resources is as follows (in millions, except percentages):\n\n**2008 2007(1) $ Change % Change 2007(1) 2006(1) $ Change % Change Years Ended December 31, Years Ended December 31,**\n\nNet revenues:\n\nInfrastructure:\n\nProduct . . . . . . . . . . . . . . . . . $2,301.9 $1,753.2 $548.7 31% $1,753.2 $ 1,413.4 $ 339.8 24% Service. . . . . . . . . . . . . . . . . . 424.0 320.1 103.9 32% 320.1 266.7 53.4 20%\n\nTotal Infrastructure revenues . . 2,725.9 2,073.3 652.6 31% 2,073.3 1,680.1 393.2 23%\n\nService Layer Technologies: Product . . . . . . . . . . . . . . . . . 609.1 573.8 35.3 6% 573.8 479.9 93.9 20%\n\nService. . . . . . . . . . . . . . . . . . 237.4 189.0 48.4 26% 189.0 143.6 45.4 32%\n\nTotal Service Layer Technologies revenues . . . . 846.5 762.8 83.7 11% 762.8 623.5 139.3 22%\n\nTotal net revenues . . . . . . . 3,572.4 2,836.1 736.3 26% 2,836.1 2,303.6 532.5 23%\n\nOperating income: Infrastructure . . . . . . . . . . . . . . . 806.0 597.8 208.2 35% 597.8 505.9 91.9 18%\n\nService Layer Technologies . . . . . . 65.8 5.8 60.0 N/M 5.8 5.2 0.6 12%\n\nTotal segment operating income . . . . . . . . . . . . . . . . 871.8 603.6 268.2 44% 603.6 511.1 92.5 18%\n\nOther corporate(2) . . . . . . . . . . . . (7.9) — (7.9) N/M — — — N/M\n\nTotal management operating income . . . . . . . . . . . . . . . . 863.9 603.6 260.3 43% 603.6 511.1 92.5 18% Amortization of purchased intangible assets . . . . . . . . . . . . (44.0) (91.4) 47.4 (52)% (91.4) (97.3) 5.9 (6)%\n\nStock-based compensation expense . . . . . . . . . . . . . . . . . (108.1) (88.0) (20.1) 23% (88.0) (87.6) (0.4) N/M\n\nStock-based payroll tax expense . . . (2.8) (7.7) 4.9 (64)% (7.7) (2.7) (5.0) 185%\n\nImpairment of goodwill and intangible assets . . . . . . . . . . . . (5.0) — 5.0 100% — (1,283.4) 1,283.4 (100)% Other charges, net(3) . . . . . . . . . . (9.0) (9.4) 0.4 N/M (9.4) (37.9) 28.5 (75)%\n\nTotal operating income (loss) . . . 695.0 407.1 287.9 71% 407.1 (997.8) 1,404.9 141%\n\nOther income and expense, net . . . . . 33.9 103.5 (69.6) (67)% 103.5 100.7 2.8 3%\n\nIncome (loss) before income taxes . . . . . . . . . . . . . . . . . . . $ 728.9 $ 510.6 $218.3 43% $ 510.6 $ (897.1) $1,407.7 157%\n\nN/M Not meaningful.\n\n(1) Prior year amounts have been reclassified to reflect the 2008 segment structure, which now includes service revenues and operating results in Infrastructure and SLT segments.\n\n(2) Other corporate charges include workforce-rebalancing charges primarily for severance and related costs. Workforce-rebalancing activities are considered part of our normal operations as we continue to optimize our cost structure. Workforce-rebalancing costs are not included in our business segment results, and we may incur additional workforce-rebalancing costs in the future. (3) Other charges, net, for 2008 includes loss on litigation settlement. Other charges, net, for 2007 includes charges such as restructuring, acquisition-related charges, stock option investigation costs, as well as stock amendment and tax-related charges. Other charges, net, for 2006 includes charges such as restructuring, acquisition-related charges, stock option investigation costs and tax-related charges, as well as certain restructuring charges in cost of product revenues.\n\n49"],"full_content":"Financial information for each segment used by management to make financial decisions and allocate resources is as follows (in millions, except percentages):\n\n**2008 2007(1) $ Change % Change 2007(1) 2006(1) $ Change % Change Years Ended December 31, Years Ended December 31,**\n\nNet revenues:\n\nInfrastructure:\n\nProduct . . . . . . . . . . . . . . . . . $2,301.9 $1,753.2 $548.7 31% $1,753.2 $ 1,413.4 $ 339.8 24% Service. . . . . . . . . . . . . . . . . . 424.0 320.1 103.9 32% 320.1 266.7 53.4 20%\n\nTotal Infrastructure revenues . . 2,725.9 2,073.3 652.6 31% 2,073.3 1,680.1 393.2 23%\n\nService Layer Technologies: Product . . . . . . . . . . . . . . . . . 609.1 573.8 35.3 6% 573.8 479.9 93.9 20%\n\nService. . . . . . . . . . . . . . . . . . 237.4 189.0 48.4 26% 189.0 143.6 45.4 32%\n\nTotal Service Layer Technologies revenues . . . . 846.5 762.8 83.7 11% 762.8 623.5 139.3 22%\n\nTotal net revenues . . . . . . . 3,572.4 2,836.1 736.3 26% 2,836.1 2,303.6 532.5 23%\n\nOperating income: Infrastructure . . . . . . . . . . . . . . . 806.0 597.8 208.2 35% 597.8 505.9 91.9 18%\n\nService Layer Technologies . . . . . . 65.8 5.8 60.0 N/M 5.8 5.2 0.6 12%\n\nTotal segment operating income . . . . . . . . . . . . . . . . 871.8 603.6 268.2 44% 603.6 511.1 92.5 18%\n\nOther corporate(2) . . . . . . . . . . . . (7.9) — (7.9) N/M — — — N/M\n\nTotal management operating income . . . . . . . . . . . . . . . . 863.9 603.6 260.3 43% 603.6 511.1 92.5 18% Amortization of purchased intangible assets . . . . . . . . . . . . (44.0) (91.4) 47.4 (52)% (91.4) (97.3) 5.9 (6)%\n\nStock-based compensation expense . . . . . . . . . . . . . . . . . (108.1) (88.0) (20.1) 23% (88.0) (87.6) (0.4) N/M\n\nStock-based payroll tax expense . . . (2.8) (7.7) 4.9 (64)% (7.7) (2.7) (5.0) 185%\n\nImpairment of goodwill and intangible assets . . . . . . . . . . . . (5.0) — 5.0 100% — (1,283.4) 1,283.4 (100)% Other charges, net(3) . . . . . . . . . . (9.0) (9.4) 0.4 N/M (9.4) (37.9) 28.5 (75)%\n\nTotal operating income (loss) . . . 695.0 407.1 287.9 71% 407.1 (997.8) 1,404.9 141%\n\nOther income and expense, net . . . . . 33.9 103.5 (69.6) (67)% 103.5 100.7 2.8 3%\n\nIncome (loss) before income taxes . . . . . . . . . . . . . . . . . . . $ 728.9 $ 510.6 $218.3 43% $ 510.6 $ (897.1) $1,407.7 157%\n\nN/M Not meaningful.\n\n(1) Prior year amounts have been reclassified to reflect the 2008 segment structure, which now includes service revenues and operating results in Infrastructure and SLT segments.\n\n(2) Other corporate charges include workforce-rebalancing charges primarily for severance and related costs. Workforce-rebalancing activities are considered part of our normal operations as we continue to optimize our cost structure. Workforce-rebalancing costs are not included in our business segment results, and we may incur additional workforce-rebalancing costs in the future. (3) Other charges, net, for 2008 includes loss on litigation settlement. Other charges, net, for 2007 includes charges such as restructuring, acquisition-related charges, stock option investigation costs, as well as stock amendment and tax-related charges. Other charges, net, for 2006 includes charges such as restructuring, acquisition-related charges, stock option investigation costs and tax-related charges, as well as certain restructuring charges in cost of product revenues.\n\n49","publish_date":null,"title":"Financial information for each segment used by management to make financial decisions and allocate resources is as follows (in millions,","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2008.page_50.pdf_110961_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2008.page_50.pdf_110961_page1.pdf"},"request":{"example_id":"table/JNPR.2008.page_50.pdf_110961_page1","product_type":"parse","source_file_path":"JNPR.2008.page_50.pdf_110961_page1.pdf"},"started_at":"2026-11-04T19:47:47.037268"} +{"completed_at":"2026-11-04T19:47:49.664665","latency_in_ms":1409,"output":{"example_id":"table/JNPR.2010.page_167.pdf_111113_page1","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents Exhibit Index\n\n**Incorporated by Reference**\n\n**Exhibit No.** **Exhibit** **Filing** **Exhibit No.** **File No.** **File Date**\n\n3\\.1 Juniper Networks, Inc. Amended and Restated Certificate of Incorporation 10-K 3.1 000-26339 3/27/2001\n\n3\\.2 Amended and Restated Bylaws of Juniper Networks, Inc. 8-K 3.1 000-34501 9/3/2010\n\n10\\.1 Form of Indemnification Agreement entered into by the Registrant with each of its directors, officers and certain employees 10-Q 10.1 000-26339 11/14/2003\n\n10\\.2 Amended and Restated 1996 Stock Plan++ 8-K 10.1 000-26339 11/9/2005\n\n10\\.3 Form of Stock Option Agreement for the Juniper Networks, Inc. Amended and Restated 1996 Stock Plan++ 10-Q 10.16 000-26339 11/2/2004\n\n10\\.4 Form of Notice of Grant and Restricted Stock Unit Agreement for the Juniper Networks, Inc. Amended and Restated 1996 Stock Plan++ 8-K 10.2 000-26339 11/9/2005\n\n10\\.5 Juniper Networks 2000 Nonstatutory Stock Option Plan++ S-8 10.1 333-92086 7/9/2002\n\n10\\.6 Form of Option Agreement for the Juniper Networks 2000 Nonstatutory Stock Option Plan++ 10-K 10.6 000-26339 3/4/2005\n\n10\\.7 Juniper Networks, Inc. 2006 Equity Incentive Plan, as amended++ 10-Q 10.1 000-34501 11/5/2010\n\n10\\.8 Form of Stock Option Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 8-K 10.2 000-26339 5/24/2006\n\n10\\.9 Form of Non-Employee Director Stock Option Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 8-K 10.3 000-26339 5/24/2006\n\n10\\.10 Form of Notice of Grant and Restricted Stock Unit Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 10-K 10.20 000-26339 2/29/2008\n\n10\\.11 Form of Notice of Grant and Performance Share Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 10-K 10.21 000-26339 2/29/2008\n\n10\\.12 Form of India Stock Option Agreement under the Juniper Networks, Inc. 2006 Equity Incentive Plan 10-Q 10.2 000-26339 5/9/2008\n\n10\\.13 Form of India Restricted Stock Unit Agreement under the Juniper Networks, Inc. 2006 Equity Incentive Plan 10-Q 10.3 000-26339 5/9/2008\n\n10\\.14 Unisphere Networks, Inc. Second Amended and Restated 1999 Stock Incentive Plan++ S-8 10.1 333-92090 7/9/2002\n\n10\\.15 NetScreen Technologies, Inc. 1997 Equity Incentive Plan++ S-1+ 10.2 333-71048 10/5/2001\n\n10\\.16 NetScreen Technologies, Inc. 2001 Equity Incentive Plan++ S-1+ 10.3 333-71048 12/10/2001\n\n10\\.17 NetScreen Technologies, Inc. 2002 Stock Option Plan++ S-8 4.7 333-114688 4/21/2004\n\n10\\.18 Neoteris 2001 Stock Plan++ S-8+ 4.1 333-110709 11/24/2003\n\n10\\.19 Kagoor Networks, Inc. 2003 General Stock Option Plan++ S-8 4.1 333-124572 5/3/2005\n\n10\\.20 Kagoor Networks, Inc. 2003 Israel Stock Option Plan++ S-8 4.2 333-124572 5/3/2005\n\n10\\.21 Redline Networks 2000 Stock Plan++ S-8 4.1 333-124610 5/4/2005\n\n10\\.22 Peribit Networks 2000 Stock Plan++ S-8 99.1 333-126404 7/6/2005\n\n10\\.23 Amended and Restated Juniper Networks 1999 Employee Stock Purchase Plan++ 10-Q 10.2 000-26339 8/9/2007\n\n108","pages":[{"line_numbers":[],"markdown":"Table of Contents Exhibit Index\n\n**Incorporated by Reference**\n\n**Exhibit No.** **Exhibit** **Filing** **Exhibit No.** **File No.** **File Date**\n\n3\\.1 Juniper Networks, Inc. Amended and Restated Certificate of Incorporation 10-K 3.1 000-26339 3/27/2001\n\n3\\.2 Amended and Restated Bylaws of Juniper Networks, Inc. 8-K 3.1 000-34501 9/3/2010\n\n10\\.1 Form of Indemnification Agreement entered into by the Registrant with each of its directors, officers and certain employees 10-Q 10.1 000-26339 11/14/2003\n\n10\\.2 Amended and Restated 1996 Stock Plan++ 8-K 10.1 000-26339 11/9/2005\n\n10\\.3 Form of Stock Option Agreement for the Juniper Networks, Inc. Amended and Restated 1996 Stock Plan++ 10-Q 10.16 000-26339 11/2/2004\n\n10\\.4 Form of Notice of Grant and Restricted Stock Unit Agreement for the Juniper Networks, Inc. Amended and Restated 1996 Stock Plan++ 8-K 10.2 000-26339 11/9/2005\n\n10\\.5 Juniper Networks 2000 Nonstatutory Stock Option Plan++ S-8 10.1 333-92086 7/9/2002\n\n10\\.6 Form of Option Agreement for the Juniper Networks 2000 Nonstatutory Stock Option Plan++ 10-K 10.6 000-26339 3/4/2005\n\n10\\.7 Juniper Networks, Inc. 2006 Equity Incentive Plan, as amended++ 10-Q 10.1 000-34501 11/5/2010\n\n10\\.8 Form of Stock Option Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 8-K 10.2 000-26339 5/24/2006\n\n10\\.9 Form of Non-Employee Director Stock Option Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 8-K 10.3 000-26339 5/24/2006\n\n10\\.10 Form of Notice of Grant and Restricted Stock Unit Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 10-K 10.20 000-26339 2/29/2008\n\n10\\.11 Form of Notice of Grant and Performance Share Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 10-K 10.21 000-26339 2/29/2008\n\n10\\.12 Form of India Stock Option Agreement under the Juniper Networks, Inc. 2006 Equity Incentive Plan 10-Q 10.2 000-26339 5/9/2008\n\n10\\.13 Form of India Restricted Stock Unit Agreement under the Juniper Networks, Inc. 2006 Equity Incentive Plan 10-Q 10.3 000-26339 5/9/2008\n\n10\\.14 Unisphere Networks, Inc. Second Amended and Restated 1999 Stock Incentive Plan++ S-8 10.1 333-92090 7/9/2002\n\n10\\.15 NetScreen Technologies, Inc. 1997 Equity Incentive Plan++ S-1+ 10.2 333-71048 10/5/2001\n\n10\\.16 NetScreen Technologies, Inc. 2001 Equity Incentive Plan++ S-1+ 10.3 333-71048 12/10/2001\n\n10\\.17 NetScreen Technologies, Inc. 2002 Stock Option Plan++ S-8 4.7 333-114688 4/21/2004\n\n10\\.18 Neoteris 2001 Stock Plan++ S-8+ 4.1 333-110709 11/24/2003\n\n10\\.19 Kagoor Networks, Inc. 2003 General Stock Option Plan++ S-8 4.1 333-124572 5/3/2005\n\n10\\.20 Kagoor Networks, Inc. 2003 Israel Stock Option Plan++ S-8 4.2 333-124572 5/3/2005\n\n10\\.21 Redline Networks 2000 Stock Plan++ S-8 4.1 333-124610 5/4/2005\n\n10\\.22 Peribit Networks 2000 Stock Plan++ S-8 99.1 333-126404 7/6/2005\n\n10\\.23 Amended and Restated Juniper Networks 1999 Employee Stock Purchase Plan++ 10-Q 10.2 000-26339 8/9/2007\n\n108","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents Exhibit Index\n\n**Incorporated by Reference**\n\n**Exhibit No.** **Exhibit** **Filing** **Exhibit No.** **File No.** **File Date**\n\n3\\.1 Juniper Networks, Inc. Amended and Restated Certificate of Incorporation 10-K 3.1 000-26339 3/27/2001\n\n3\\.2 Amended and Restated Bylaws of Juniper Networks, Inc. 8-K 3.1 000-34501 9/3/2010\n\n10\\.1 Form of Indemnification Agreement entered into by the Registrant with each of its directors, officers and certain employees 10-Q 10.1 000-26339 11/14/2003\n\n10\\.2 Amended and Restated 1996 Stock Plan++ 8-K 10.1 000-26339 11/9/2005\n\n10\\.3 Form of Stock Option Agreement for the Juniper Networks, Inc. Amended and Restated 1996 Stock Plan++ 10-Q 10.16 000-26339 11/2/2004\n\n10\\.4 Form of Notice of Grant and Restricted Stock Unit Agreement for the Juniper Networks, Inc. Amended and Restated 1996 Stock Plan++ 8-K 10.2 000-26339 11/9/2005\n\n10\\.5 Juniper Networks 2000 Nonstatutory Stock Option Plan++ S-8 10.1 333-92086 7/9/2002\n\n10\\.6 Form of Option Agreement for the Juniper Networks 2000 Nonstatutory Stock Option Plan++ 10-K 10.6 000-26339 3/4/2005\n\n10\\.7 Juniper Networks, Inc. 2006 Equity Incentive Plan, as amended++ 10-Q 10.1 000-34501 11/5/2010\n\n10\\.8 Form of Stock Option Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 8-K 10.2 000-26339 5/24/2006\n\n10\\.9 Form of Non-Employee Director Stock Option Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 8-K 10.3 000-26339 5/24/2006\n\n10\\.10 Form of Notice of Grant and Restricted Stock Unit Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 10-K 10.20 000-26339 2/29/2008\n\n10\\.11 Form of Notice of Grant and Performance Share Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 10-K 10.21 000-26339 2/29/2008\n\n10\\.12 Form of India Stock Option Agreement under the Juniper Networks, Inc. 2006 Equity Incentive Plan 10-Q 10.2 000-26339 5/9/2008\n\n10\\.13 Form of India Restricted Stock Unit Agreement under the Juniper Networks, Inc. 2006 Equity Incentive Plan 10-Q 10.3 000-26339 5/9/2008\n\n10\\.14 Unisphere Networks, Inc. Second Amended and Restated 1999 Stock Incentive Plan++ S-8 10.1 333-92090 7/9/2002\n\n10\\.15 NetScreen Technologies, Inc. 1997 Equity Incentive Plan++ S-1+ 10.2 333-71048 10/5/2001\n\n10\\.16 NetScreen Technologies, Inc. 2001 Equity Incentive Plan++ S-1+ 10.3 333-71048 12/10/2001\n\n10\\.17 NetScreen Technologies, Inc. 2002 Stock Option Plan++ S-8 4.7 333-114688 4/21/2004\n\n10\\.18 Neoteris 2001 Stock Plan++ S-8+ 4.1 333-110709 11/24/2003\n\n10\\.19 Kagoor Networks, Inc. 2003 General Stock Option Plan++ S-8 4.1 333-124572 5/3/2005\n\n10\\.20 Kagoor Networks, Inc. 2003 Israel Stock Option Plan++ S-8 4.2 333-124572 5/3/2005\n\n10\\.21 Redline Networks 2000 Stock Plan++ S-8 4.1 333-124610 5/4/2005\n\n10\\.22 Peribit Networks 2000 Stock Plan++ S-8 99.1 333-126404 7/6/2005\n\n10\\.23 Amended and Restated Juniper Networks 1999 Employee Stock Purchase Plan++ 10-Q 10.2 000-26339 8/9/2007\n\n108","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2010.page_167.pdf_111113_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_af7c068fe69260d3d00d733ec82e6503","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents Exhibit Index\n\n**Incorporated by Reference**\n\n**Exhibit No.** **Exhibit** **Filing** **Exhibit No.** **File No.** **File Date**\n\n3\\.1 Juniper Networks, Inc. Amended and Restated Certificate of Incorporation 10-K 3.1 000-26339 3/27/2001\n\n3\\.2 Amended and Restated Bylaws of Juniper Networks, Inc. 8-K 3.1 000-34501 9/3/2010\n\n10\\.1 Form of Indemnification Agreement entered into by the Registrant with each of its directors, officers and certain employees 10-Q 10.1 000-26339 11/14/2003\n\n10\\.2 Amended and Restated 1996 Stock Plan++ 8-K 10.1 000-26339 11/9/2005\n\n10\\.3 Form of Stock Option Agreement for the Juniper Networks, Inc. Amended and Restated 1996 Stock Plan++ 10-Q 10.16 000-26339 11/2/2004\n\n10\\.4 Form of Notice of Grant and Restricted Stock Unit Agreement for the Juniper Networks, Inc. Amended and Restated 1996 Stock Plan++ 8-K 10.2 000-26339 11/9/2005\n\n10\\.5 Juniper Networks 2000 Nonstatutory Stock Option Plan++ S-8 10.1 333-92086 7/9/2002\n\n10\\.6 Form of Option Agreement for the Juniper Networks 2000 Nonstatutory Stock Option Plan++ 10-K 10.6 000-26339 3/4/2005\n\n10\\.7 Juniper Networks, Inc. 2006 Equity Incentive Plan, as amended++ 10-Q 10.1 000-34501 11/5/2010\n\n10\\.8 Form of Stock Option Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 8-K 10.2 000-26339 5/24/2006\n\n10\\.9 Form of Non-Employee Director Stock Option Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 8-K 10.3 000-26339 5/24/2006\n\n10\\.10 Form of Notice of Grant and Restricted Stock Unit Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 10-K 10.20 000-26339 2/29/2008\n\n10\\.11 Form of Notice of Grant and Performance Share Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 10-K 10.21 000-26339 2/29/2008\n\n10\\.12 Form of India Stock Option Agreement under the Juniper Networks, Inc. 2006 Equity Incentive Plan 10-Q 10.2 000-26339 5/9/2008\n\n10\\.13 Form of India Restricted Stock Unit Agreement under the Juniper Networks, Inc. 2006 Equity Incentive Plan 10-Q 10.3 000-26339 5/9/2008\n\n10\\.14 Unisphere Networks, Inc. Second Amended and Restated 1999 Stock Incentive Plan++ S-8 10.1 333-92090 7/9/2002\n\n10\\.15 NetScreen Technologies, Inc. 1997 Equity Incentive Plan++ S-1+ 10.2 333-71048 10/5/2001\n\n10\\.16 NetScreen Technologies, Inc. 2001 Equity Incentive Plan++ S-1+ 10.3 333-71048 12/10/2001\n\n10\\.17 NetScreen Technologies, Inc. 2002 Stock Option Plan++ S-8 4.7 333-114688 4/21/2004\n\n10\\.18 Neoteris 2001 Stock Plan++ S-8+ 4.1 333-110709 11/24/2003\n\n10\\.19 Kagoor Networks, Inc. 2003 General Stock Option Plan++ S-8 4.1 333-124572 5/3/2005\n\n10\\.20 Kagoor Networks, Inc. 2003 Israel Stock Option Plan++ S-8 4.2 333-124572 5/3/2005\n\n10\\.21 Redline Networks 2000 Stock Plan++ S-8 4.1 333-124610 5/4/2005\n\n10\\.22 Peribit Networks 2000 Stock Plan++ S-8 99.1 333-126404 7/6/2005\n\n10\\.23 Amended and Restated Juniper Networks 1999 Employee Stock Purchase Plan++ 10-Q 10.2 000-26339 8/9/2007\n\n108"],"full_content":"Table of Contents Exhibit Index\n\n**Incorporated by Reference**\n\n**Exhibit No.** **Exhibit** **Filing** **Exhibit No.** **File No.** **File Date**\n\n3\\.1 Juniper Networks, Inc. Amended and Restated Certificate of Incorporation 10-K 3.1 000-26339 3/27/2001\n\n3\\.2 Amended and Restated Bylaws of Juniper Networks, Inc. 8-K 3.1 000-34501 9/3/2010\n\n10\\.1 Form of Indemnification Agreement entered into by the Registrant with each of its directors, officers and certain employees 10-Q 10.1 000-26339 11/14/2003\n\n10\\.2 Amended and Restated 1996 Stock Plan++ 8-K 10.1 000-26339 11/9/2005\n\n10\\.3 Form of Stock Option Agreement for the Juniper Networks, Inc. Amended and Restated 1996 Stock Plan++ 10-Q 10.16 000-26339 11/2/2004\n\n10\\.4 Form of Notice of Grant and Restricted Stock Unit Agreement for the Juniper Networks, Inc. Amended and Restated 1996 Stock Plan++ 8-K 10.2 000-26339 11/9/2005\n\n10\\.5 Juniper Networks 2000 Nonstatutory Stock Option Plan++ S-8 10.1 333-92086 7/9/2002\n\n10\\.6 Form of Option Agreement for the Juniper Networks 2000 Nonstatutory Stock Option Plan++ 10-K 10.6 000-26339 3/4/2005\n\n10\\.7 Juniper Networks, Inc. 2006 Equity Incentive Plan, as amended++ 10-Q 10.1 000-34501 11/5/2010\n\n10\\.8 Form of Stock Option Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 8-K 10.2 000-26339 5/24/2006\n\n10\\.9 Form of Non-Employee Director Stock Option Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 8-K 10.3 000-26339 5/24/2006\n\n10\\.10 Form of Notice of Grant and Restricted Stock Unit Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 10-K 10.20 000-26339 2/29/2008\n\n10\\.11 Form of Notice of Grant and Performance Share Agreement for the Juniper Networks, Inc. 2006 Equity Incentive Plan++ 10-K 10.21 000-26339 2/29/2008\n\n10\\.12 Form of India Stock Option Agreement under the Juniper Networks, Inc. 2006 Equity Incentive Plan 10-Q 10.2 000-26339 5/9/2008\n\n10\\.13 Form of India Restricted Stock Unit Agreement under the Juniper Networks, Inc. 2006 Equity Incentive Plan 10-Q 10.3 000-26339 5/9/2008\n\n10\\.14 Unisphere Networks, Inc. Second Amended and Restated 1999 Stock Incentive Plan++ S-8 10.1 333-92090 7/9/2002\n\n10\\.15 NetScreen Technologies, Inc. 1997 Equity Incentive Plan++ S-1+ 10.2 333-71048 10/5/2001\n\n10\\.16 NetScreen Technologies, Inc. 2001 Equity Incentive Plan++ S-1+ 10.3 333-71048 12/10/2001\n\n10\\.17 NetScreen Technologies, Inc. 2002 Stock Option Plan++ S-8 4.7 333-114688 4/21/2004\n\n10\\.18 Neoteris 2001 Stock Plan++ S-8+ 4.1 333-110709 11/24/2003\n\n10\\.19 Kagoor Networks, Inc. 2003 General Stock Option Plan++ S-8 4.1 333-124572 5/3/2005\n\n10\\.20 Kagoor Networks, Inc. 2003 Israel Stock Option Plan++ S-8 4.2 333-124572 5/3/2005\n\n10\\.21 Redline Networks 2000 Stock Plan++ S-8 4.1 333-124610 5/4/2005\n\n10\\.22 Peribit Networks 2000 Stock Plan++ S-8 99.1 333-126404 7/6/2005\n\n10\\.23 Amended and Restated Juniper Networks 1999 Employee Stock Purchase Plan++ 10-Q 10.2 000-26339 8/9/2007\n\n108","publish_date":null,"title":"Table of Contents Exhibit Index 108","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2010.page_167.pdf_111113_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2010.page_167.pdf_111113_page1.pdf"},"request":{"example_id":"table/JNPR.2010.page_167.pdf_111113_page1","product_type":"parse","source_file_path":"JNPR.2010.page_167.pdf_111113_page1.pdf"},"started_at":"2026-11-04T19:47:48.254802"} +{"completed_at":"2026-11-04T19:47:50.412369","latency_in_ms":1351,"output":{"example_id":"table/JNPR.2011.page_114.pdf_110685_page1","grounded_pages":[],"layout_pages":[],"markdown":"**Table of Contents**\n\n**Incorporated by Reference**\n\n**Exhibit No.** **Exhibit** **Filing** **Exhibit No.** **File No.** **File Date**\n\n10\\.47 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated January 24, 2002\n\n10-K 10.47 000-34501 2/26/2010\n\n10\\.48 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated February 28, 2000\n\n10-K 10.48 000-34501 2/26/2010\n\n10\\.49 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.49 000-34501 2/26/2010\n\n10\\.50 Second Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.50 000-34501 2/26/2010\n\n10\\.51 Amendment No. 2 to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.51 000-34501 2/26/2010\n\n10\\.52 Ankeena Networks, Inc. 2008 Stock Plan++ S-8 4.3 333-166248 4/23/2010\n\n10\\.53 Altor Networks, Inc. 2007 Stock Plan and 2009 Israeli Equity Incentive Sub Plan++ S-8 10.1 333-171299 12/12/2010\n\n10\\.54 Australian Addendum to the Juniper Networks, Inc. 2006 Equity Incentive Plan, as amended+ +\n\n10-Q 10.2 000-34501 11/5/2010\n\n10\\.55 Australian Addendum to the Juniper Networks, Inc. 2008 Employee Stock Purchase Plan, as amended++\n\n10-Q 10.3 000-34501 11/5/2010\n\n10\\.56 Employee Agreement between Juniper Networks, Inc. and Robert Muglia++ 10-Q 10.3 001-34501 11/4/2011\n\n10\\.57 Form of Severance Agreement for Certain Officers adopted on February 14, 2012\\*++\n\n10\\.58 Form of Change of Control Agreement for Certain Officers adopted on February 14, 2012\\*++\n\n12\\.1 Computation of Ratio of Earnings to Fixed Charges\\*\n\n21\\.1 Subsidiaries of the Company\\*\n\n23\\.1 Consent of Independent Registered Public Accounting Firm\\*\n\n24\\.1 Power of Attorney (see page 105)\n\n31\\.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934\\*\n\n31\\.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934\\*\n\n32\\.1 Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\\*\\*\n\n32\\.2 Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\\*\\*\n\n101 The following materials from Juniper Networks Inc.'s Annual Report on Form 10-K for the year ended December 31, 2011, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Balance Sheets, and (iii) the Consolidated Statements of Cash Flows, and (iv) Notes to Consolidated Financial Statements, tagged as blocks of text\n\n101\\.INS XBRL Instance Document\n\n101\\.SCH XBRL Taxonomy Extension Schema Document\n\n101\\.CAL XBRL Taxonomy Extension Calculation Linkbase Document\n\n101\\.DEF XBRL Taxonomy Extension Definition Linkbase Document\n\n101\\.LAB XBRL Taxonomy Extension Label Linkbase Document\n\n101\\.PRE XBRL Taxonomy Extension Presentation Linkbase Document\n\n\\* Filed herewith\n\n\\*\\* Furnished herewith\n\n\\+ Filed by NetScreen Technologies, Inc.\n\n\\++ Indicates management contract or compensatory plan, contract or arrangement.\n\n109","pages":[{"line_numbers":[],"markdown":"**Table of Contents**\n\n**Incorporated by Reference**\n\n**Exhibit No.** **Exhibit** **Filing** **Exhibit No.** **File No.** **File Date**\n\n10\\.47 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated January 24, 2002\n\n10-K 10.47 000-34501 2/26/2010\n\n10\\.48 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated February 28, 2000\n\n10-K 10.48 000-34501 2/26/2010\n\n10\\.49 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.49 000-34501 2/26/2010\n\n10\\.50 Second Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.50 000-34501 2/26/2010\n\n10\\.51 Amendment No. 2 to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.51 000-34501 2/26/2010\n\n10\\.52 Ankeena Networks, Inc. 2008 Stock Plan++ S-8 4.3 333-166248 4/23/2010\n\n10\\.53 Altor Networks, Inc. 2007 Stock Plan and 2009 Israeli Equity Incentive Sub Plan++ S-8 10.1 333-171299 12/12/2010\n\n10\\.54 Australian Addendum to the Juniper Networks, Inc. 2006 Equity Incentive Plan, as amended+ +\n\n10-Q 10.2 000-34501 11/5/2010\n\n10\\.55 Australian Addendum to the Juniper Networks, Inc. 2008 Employee Stock Purchase Plan, as amended++\n\n10-Q 10.3 000-34501 11/5/2010\n\n10\\.56 Employee Agreement between Juniper Networks, Inc. and Robert Muglia++ 10-Q 10.3 001-34501 11/4/2011\n\n10\\.57 Form of Severance Agreement for Certain Officers adopted on February 14, 2012\\*++\n\n10\\.58 Form of Change of Control Agreement for Certain Officers adopted on February 14, 2012\\*++\n\n12\\.1 Computation of Ratio of Earnings to Fixed Charges\\*\n\n21\\.1 Subsidiaries of the Company\\*\n\n23\\.1 Consent of Independent Registered Public Accounting Firm\\*\n\n24\\.1 Power of Attorney (see page 105)\n\n31\\.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934\\*\n\n31\\.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934\\*\n\n32\\.1 Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\\*\\*\n\n32\\.2 Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\\*\\*\n\n101 The following materials from Juniper Networks Inc.'s Annual Report on Form 10-K for the year ended December 31, 2011, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Balance Sheets, and (iii) the Consolidated Statements of Cash Flows, and (iv) Notes to Consolidated Financial Statements, tagged as blocks of text\n\n101\\.INS XBRL Instance Document\n\n101\\.SCH XBRL Taxonomy Extension Schema Document\n\n101\\.CAL XBRL Taxonomy Extension Calculation Linkbase Document\n\n101\\.DEF XBRL Taxonomy Extension Definition Linkbase Document\n\n101\\.LAB XBRL Taxonomy Extension Label Linkbase Document\n\n101\\.PRE XBRL Taxonomy Extension Presentation Linkbase Document\n\n\\* Filed herewith\n\n\\*\\* Furnished herewith\n\n\\+ Filed by NetScreen Technologies, Inc.\n\n\\++ Indicates management contract or compensatory plan, contract or arrangement.\n\n109","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Table of Contents**\n\n**Incorporated by Reference**\n\n**Exhibit No.** **Exhibit** **Filing** **Exhibit No.** **File No.** **File Date**\n\n10\\.47 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated January 24, 2002\n\n10-K 10.47 000-34501 2/26/2010\n\n10\\.48 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated February 28, 2000\n\n10-K 10.48 000-34501 2/26/2010\n\n10\\.49 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.49 000-34501 2/26/2010\n\n10\\.50 Second Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.50 000-34501 2/26/2010\n\n10\\.51 Amendment No. 2 to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.51 000-34501 2/26/2010\n\n10\\.52 Ankeena Networks, Inc. 2008 Stock Plan++ S-8 4.3 333-166248 4/23/2010\n\n10\\.53 Altor Networks, Inc. 2007 Stock Plan and 2009 Israeli Equity Incentive Sub Plan++ S-8 10.1 333-171299 12/12/2010\n\n10\\.54 Australian Addendum to the Juniper Networks, Inc. 2006 Equity Incentive Plan, as amended+ +\n\n10-Q 10.2 000-34501 11/5/2010\n\n10\\.55 Australian Addendum to the Juniper Networks, Inc. 2008 Employee Stock Purchase Plan, as amended++\n\n10-Q 10.3 000-34501 11/5/2010\n\n10\\.56 Employee Agreement between Juniper Networks, Inc. and Robert Muglia++ 10-Q 10.3 001-34501 11/4/2011\n\n10\\.57 Form of Severance Agreement for Certain Officers adopted on February 14, 2012\\*++\n\n10\\.58 Form of Change of Control Agreement for Certain Officers adopted on February 14, 2012\\*++\n\n12\\.1 Computation of Ratio of Earnings to Fixed Charges\\*\n\n21\\.1 Subsidiaries of the Company\\*\n\n23\\.1 Consent of Independent Registered Public Accounting Firm\\*\n\n24\\.1 Power of Attorney (see page 105)\n\n31\\.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934\\*\n\n31\\.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934\\*\n\n32\\.1 Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\\*\\*\n\n32\\.2 Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\\*\\*\n\n101 The following materials from Juniper Networks Inc.'s Annual Report on Form 10-K for the year ended December 31, 2011, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Balance Sheets, and (iii) the Consolidated Statements of Cash Flows, and (iv) Notes to Consolidated Financial Statements, tagged as blocks of text\n\n101\\.INS XBRL Instance Document\n\n101\\.SCH XBRL Taxonomy Extension Schema Document\n\n101\\.CAL XBRL Taxonomy Extension Calculation Linkbase Document\n\n101\\.DEF XBRL Taxonomy Extension Definition Linkbase Document\n\n101\\.LAB XBRL Taxonomy Extension Label Linkbase Document\n\n101\\.PRE XBRL Taxonomy Extension Presentation Linkbase Document\n\n\\* Filed herewith\n\n\\*\\* Furnished herewith\n\n\\+ Filed by NetScreen Technologies, Inc.\n\n\\++ Indicates management contract or compensatory plan, contract or arrangement.\n\n109","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2011.page_114.pdf_110685_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_8b7c0e55c7ec30ea6ef85285bd37b17d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Table of Contents**\n\n**Incorporated by Reference**\n\n**Exhibit No.** **Exhibit** **Filing** **Exhibit No.** **File No.** **File Date**\n\n10\\.47 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated January 24, 2002\n\n10-K 10.47 000-34501 2/26/2010\n\n10\\.48 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated February 28, 2000\n\n10-K 10.48 000-34501 2/26/2010\n\n10\\.49 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.49 000-34501 2/26/2010\n\n10\\.50 Second Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.50 000-34501 2/26/2010\n\n10\\.51 Amendment No. 2 to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.51 000-34501 2/26/2010\n\n10\\.52 Ankeena Networks, Inc. 2008 Stock Plan++ S-8 4.3 333-166248 4/23/2010\n\n10\\.53 Altor Networks, Inc. 2007 Stock Plan and 2009 Israeli Equity Incentive Sub Plan++ S-8 10.1 333-171299 12/12/2010\n\n10\\.54 Australian Addendum to the Juniper Networks, Inc. 2006 Equity Incentive Plan, as amended+ +\n\n10-Q 10.2 000-34501 11/5/2010\n\n10\\.55 Australian Addendum to the Juniper Networks, Inc. 2008 Employee Stock Purchase Plan, as amended++\n\n10-Q 10.3 000-34501 11/5/2010\n\n10\\.56 Employee Agreement between Juniper Networks, Inc. and Robert Muglia++ 10-Q 10.3 001-34501 11/4/2011\n\n10\\.57 Form of Severance Agreement for Certain Officers adopted on February 14, 2012\\*++\n\n10\\.58 Form of Change of Control Agreement for Certain Officers adopted on February 14, 2012\\*++\n\n12\\.1 Computation of Ratio of Earnings to Fixed Charges\\*\n\n21\\.1 Subsidiaries of the Company\\*\n\n23\\.1 Consent of Independent Registered Public Accounting Firm\\*\n\n24\\.1 Power of Attorney (see page 105)\n\n31\\.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934\\*\n\n31\\.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934\\*\n\n32\\.1 Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\\*\\*\n\n32\\.2 Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\\*\\*\n\n101 The following materials from Juniper Networks Inc.'s Annual Report on Form 10-K for the year ended December 31, 2011, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Balance Sheets, and (iii) the Consolidated Statements of Cash Flows, and (iv) Notes to Consolidated Financial Statements, tagged as blocks of text\n\n101\\.INS XBRL Instance Document\n\n101\\.SCH XBRL Taxonomy Extension Schema Document\n\n101\\.CAL XBRL Taxonomy Extension Calculation Linkbase Document\n\n101\\.DEF XBRL Taxonomy Extension Definition Linkbase Document\n\n101\\.LAB XBRL Taxonomy Extension Label Linkbase Document\n\n101\\.PRE XBRL Taxonomy Extension Presentation Linkbase Document\n\n\\* Filed herewith\n\n\\*\\* Furnished herewith\n\n\\+ Filed by NetScreen Technologies, Inc.\n\n\\++ Indicates management contract or compensatory plan, contract or arrangement.\n\n109"],"full_content":"**Table of Contents**\n\n**Incorporated by Reference**\n\n**Exhibit No.** **Exhibit** **Filing** **Exhibit No.** **File No.** **File Date**\n\n10\\.47 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated January 24, 2002\n\n10-K 10.47 000-34501 2/26/2010\n\n10\\.48 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated February 28, 2000\n\n10-K 10.48 000-34501 2/26/2010\n\n10\\.49 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.49 000-34501 2/26/2010\n\n10\\.50 Second Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.50 000-34501 2/26/2010\n\n10\\.51 Amendment No. 2 to Lease between Sunnyvale Office Park, L.P. and the Registrant dated October 14, 2009\n\n10-K 10.51 000-34501 2/26/2010\n\n10\\.52 Ankeena Networks, Inc. 2008 Stock Plan++ S-8 4.3 333-166248 4/23/2010\n\n10\\.53 Altor Networks, Inc. 2007 Stock Plan and 2009 Israeli Equity Incentive Sub Plan++ S-8 10.1 333-171299 12/12/2010\n\n10\\.54 Australian Addendum to the Juniper Networks, Inc. 2006 Equity Incentive Plan, as amended+ +\n\n10-Q 10.2 000-34501 11/5/2010\n\n10\\.55 Australian Addendum to the Juniper Networks, Inc. 2008 Employee Stock Purchase Plan, as amended++\n\n10-Q 10.3 000-34501 11/5/2010\n\n10\\.56 Employee Agreement between Juniper Networks, Inc. and Robert Muglia++ 10-Q 10.3 001-34501 11/4/2011\n\n10\\.57 Form of Severance Agreement for Certain Officers adopted on February 14, 2012\\*++\n\n10\\.58 Form of Change of Control Agreement for Certain Officers adopted on February 14, 2012\\*++\n\n12\\.1 Computation of Ratio of Earnings to Fixed Charges\\*\n\n21\\.1 Subsidiaries of the Company\\*\n\n23\\.1 Consent of Independent Registered Public Accounting Firm\\*\n\n24\\.1 Power of Attorney (see page 105)\n\n31\\.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934\\*\n\n31\\.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934\\*\n\n32\\.1 Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\\*\\*\n\n32\\.2 Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\\*\\*\n\n101 The following materials from Juniper Networks Inc.'s Annual Report on Form 10-K for the year ended December 31, 2011, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Balance Sheets, and (iii) the Consolidated Statements of Cash Flows, and (iv) Notes to Consolidated Financial Statements, tagged as blocks of text\n\n101\\.INS XBRL Instance Document\n\n101\\.SCH XBRL Taxonomy Extension Schema Document\n\n101\\.CAL XBRL Taxonomy Extension Calculation Linkbase Document\n\n101\\.DEF XBRL Taxonomy Extension Definition Linkbase Document\n\n101\\.LAB XBRL Taxonomy Extension Label Linkbase Document\n\n101\\.PRE XBRL Taxonomy Extension Presentation Linkbase Document\n\n\\* Filed herewith\n\n\\*\\* Furnished herewith\n\n\\+ Filed by NetScreen Technologies, Inc.\n\n\\++ Indicates management contract or compensatory plan, contract or arrangement.\n\n109","publish_date":null,"title":"Table of Contents 10.47 First Amendment to Lease between Sunnyvale Office Park, L.P. and the Registrant dated 10-K 10.47 000-34501","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2011.page_114.pdf_110685_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2011.page_114.pdf_110685_page1.pdf"},"request":{"example_id":"table/JNPR.2011.page_114.pdf_110685_page1","product_type":"parse","source_file_path":"JNPR.2011.page_114.pdf_110685_page1.pdf"},"started_at":"2026-11-04T19:47:49.060592"} +{"completed_at":"2026-11-04T19:47:52.382939","latency_in_ms":2356,"output":{"example_id":"table/JNPR.2011.page_82.pdf_110673_page1","grounded_pages":[],"layout_pages":[],"markdown":"**Table of Contents**\n\n**Juniper Networks, Inc. Notes to Consolidated Financial Statements (Continued)**\n\n**2010 Acquisitions**\n\n**Ankeena** **SMobile** **Altor** **Trapeze**\n\n**Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Total Amount**\n\nExisting technology 4.0 $ 9.0 5.0 $ 24.3 6.0 $ 13.9 5.0 $ 45.0 $ 92.2\n\nIn-process research and development\n\n— — — — — 2.8 — — 2.8\n\nCore technology 4.0 3.2 — — 6.0 4.6 — — 7.8\n\nCustomer contracts and related relationships\n\n— — 6.0 2.1 — — 7.0 8.6 10.7\n\nSupport agreements and related relationships\n\n— — 6.0 0.1 — — 7.0 2.6 2.7\n\nNon-compete agreements\n\n— — 2.0 0.1 — — — — 0.1\n\nOEM customer contracts\n\n— — — — — — 2.0 0.2 0.2\n\nTotal $ 12.2 $ 26.6 $ 21.3 $ 56.4 $ 116.5\n\nAcquired in-process research and development (“IPR&D”) consists of existing research and development projects at the time of the acquisition. Projects that qualify as IPR&D assets represent those that have not yet reached technological feasibility and have no alternative future use. After initial recognition, acquired IPR&D assets are accounted for as indefinite-lived intangible assets. Development costs incurred after acquisition on acquired development projects are expensed as incurred. Upon completion of development, acquired IPR&D assets are considered amortizable intangible assets. If the IPR&D project is abandoned, the Company writes off the related purchased intangible asset in the period it is abandoned.\n\n**Note 8. Goodwill and Purchased Intangible Assets**\n\n**_Goodwill_**\n\nThe following table summarizes the Company's goodwill activities by segment (in millions):\n\n**Infrastructure** **SLT** **Total**\n\n**December 31, 2009** $ 1,500.5 $ 2,158.1 $ 3,658.6\n\nAdjustment to goodwill — 0.2 0.2\n\nAdditions due to business combinations 142.9 126.1 269.0\n\n**December 31, 2010** 1,643.4 2,284.4 3,927.8\n\nAdjustments to goodwill 1.7 (1.8) (0.1)\n\nAdditions due to business combinations 0.4 — 0.4\n\n**December 31, 2011** $ 1,645.5 $ 2,282.6 $ 3,928.1\n\nThe adjustments to goodwill during the year ended December 31, 2011, were related to adjustments in net tangible assets assumed from certain businesses acquired in 2010 and 2011. There were no impairments to goodwill during the years ended December 31, 2011, 2010 and 2009. As of December 31, 2011, accumulated impairment losses were $1,280.0 million, all of which were associated with the SLT segment. **_Purchased Intangible Assets_**\n\nChanges to the Company’s purchased intangible assets were as follows (in millions):\n\n78","pages":[{"line_numbers":[],"markdown":"**Table of Contents**\n\n**Juniper Networks, Inc. Notes to Consolidated Financial Statements (Continued)**\n\n**2010 Acquisitions**\n\n**Ankeena** **SMobile** **Altor** **Trapeze**\n\n**Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Total Amount**\n\nExisting technology 4.0 $ 9.0 5.0 $ 24.3 6.0 $ 13.9 5.0 $ 45.0 $ 92.2\n\nIn-process research and development\n\n— — — — — 2.8 — — 2.8\n\nCore technology 4.0 3.2 — — 6.0 4.6 — — 7.8\n\nCustomer contracts and related relationships\n\n— — 6.0 2.1 — — 7.0 8.6 10.7\n\nSupport agreements and related relationships\n\n— — 6.0 0.1 — — 7.0 2.6 2.7\n\nNon-compete agreements\n\n— — 2.0 0.1 — — — — 0.1\n\nOEM customer contracts\n\n— — — — — — 2.0 0.2 0.2\n\nTotal $ 12.2 $ 26.6 $ 21.3 $ 56.4 $ 116.5\n\nAcquired in-process research and development (“IPR&D”) consists of existing research and development projects at the time of the acquisition. Projects that qualify as IPR&D assets represent those that have not yet reached technological feasibility and have no alternative future use. After initial recognition, acquired IPR&D assets are accounted for as indefinite-lived intangible assets. Development costs incurred after acquisition on acquired development projects are expensed as incurred. Upon completion of development, acquired IPR&D assets are considered amortizable intangible assets. If the IPR&D project is abandoned, the Company writes off the related purchased intangible asset in the period it is abandoned.\n\n**Note 8. Goodwill and Purchased Intangible Assets**\n\n**_Goodwill_**\n\nThe following table summarizes the Company's goodwill activities by segment (in millions):\n\n**Infrastructure** **SLT** **Total**\n\n**December 31, 2009** $ 1,500.5 $ 2,158.1 $ 3,658.6\n\nAdjustment to goodwill — 0.2 0.2\n\nAdditions due to business combinations 142.9 126.1 269.0\n\n**December 31, 2010** 1,643.4 2,284.4 3,927.8\n\nAdjustments to goodwill 1.7 (1.8) (0.1)\n\nAdditions due to business combinations 0.4 — 0.4\n\n**December 31, 2011** $ 1,645.5 $ 2,282.6 $ 3,928.1\n\nThe adjustments to goodwill during the year ended December 31, 2011, were related to adjustments in net tangible assets assumed from certain businesses acquired in 2010 and 2011. There were no impairments to goodwill during the years ended December 31, 2011, 2010 and 2009. As of December 31, 2011, accumulated impairment losses were $1,280.0 million, all of which were associated with the SLT segment. **_Purchased Intangible Assets_**\n\nChanges to the Company’s purchased intangible assets were as follows (in millions):\n\n78","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Table of Contents**\n\n**Juniper Networks, Inc. Notes to Consolidated Financial Statements (Continued)**\n\n**2010 Acquisitions**\n\n**Ankeena** **SMobile** **Altor** **Trapeze**\n\n**Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Total Amount**\n\nExisting technology 4.0 $ 9.0 5.0 $ 24.3 6.0 $ 13.9 5.0 $ 45.0 $ 92.2\n\nIn-process research and development\n\n— — — — — 2.8 — — 2.8\n\nCore technology 4.0 3.2 — — 6.0 4.6 — — 7.8\n\nCustomer contracts and related relationships\n\n— — 6.0 2.1 — — 7.0 8.6 10.7\n\nSupport agreements and related relationships\n\n— — 6.0 0.1 — — 7.0 2.6 2.7\n\nNon-compete agreements\n\n— — 2.0 0.1 — — — — 0.1\n\nOEM customer contracts\n\n— — — — — — 2.0 0.2 0.2\n\nTotal $ 12.2 $ 26.6 $ 21.3 $ 56.4 $ 116.5\n\nAcquired in-process research and development (“IPR&D”) consists of existing research and development projects at the time of the acquisition. Projects that qualify as IPR&D assets represent those that have not yet reached technological feasibility and have no alternative future use. After initial recognition, acquired IPR&D assets are accounted for as indefinite-lived intangible assets. Development costs incurred after acquisition on acquired development projects are expensed as incurred. Upon completion of development, acquired IPR&D assets are considered amortizable intangible assets. If the IPR&D project is abandoned, the Company writes off the related purchased intangible asset in the period it is abandoned.\n\n**Note 8. Goodwill and Purchased Intangible Assets**\n\n**_Goodwill_**\n\nThe following table summarizes the Company's goodwill activities by segment (in millions):\n\n**Infrastructure** **SLT** **Total**\n\n**December 31, 2009** $ 1,500.5 $ 2,158.1 $ 3,658.6\n\nAdjustment to goodwill — 0.2 0.2\n\nAdditions due to business combinations 142.9 126.1 269.0\n\n**December 31, 2010** 1,643.4 2,284.4 3,927.8\n\nAdjustments to goodwill 1.7 (1.8) (0.1)\n\nAdditions due to business combinations 0.4 — 0.4\n\n**December 31, 2011** $ 1,645.5 $ 2,282.6 $ 3,928.1\n\nThe adjustments to goodwill during the year ended December 31, 2011, were related to adjustments in net tangible assets assumed from certain businesses acquired in 2010 and 2011. There were no impairments to goodwill during the years ended December 31, 2011, 2010 and 2009. As of December 31, 2011, accumulated impairment losses were $1,280.0 million, all of which were associated with the SLT segment. **_Purchased Intangible Assets_**\n\nChanges to the Company’s purchased intangible assets were as follows (in millions):\n\n78","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2011.page_82.pdf_110673_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_bc2121529375ffb14144a98af39d34c5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Table of Contents**\n\n**Juniper Networks, Inc. Notes to Consolidated Financial Statements (Continued)**\n\n**2010 Acquisitions**\n\n**Ankeena** **SMobile** **Altor** **Trapeze**\n\n**Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Total Amount**\n\nExisting technology 4.0 $ 9.0 5.0 $ 24.3 6.0 $ 13.9 5.0 $ 45.0 $ 92.2\n\nIn-process research and development\n\n— — — — — 2.8 — — 2.8\n\nCore technology 4.0 3.2 — — 6.0 4.6 — — 7.8\n\nCustomer contracts and related relationships\n\n— — 6.0 2.1 — — 7.0 8.6 10.7\n\nSupport agreements and related relationships\n\n— — 6.0 0.1 — — 7.0 2.6 2.7\n\nNon-compete agreements\n\n— — 2.0 0.1 — — — — 0.1\n\nOEM customer contracts\n\n— — — — — — 2.0 0.2 0.2\n\nTotal $ 12.2 $ 26.6 $ 21.3 $ 56.4 $ 116.5\n\nAcquired in-process research and development (“IPR&D”) consists of existing research and development projects at the time of the acquisition. Projects that qualify as IPR&D assets represent those that have not yet reached technological feasibility and have no alternative future use. After initial recognition, acquired IPR&D assets are accounted for as indefinite-lived intangible assets. Development costs incurred after acquisition on acquired development projects are expensed as incurred. Upon completion of development, acquired IPR&D assets are considered amortizable intangible assets. If the IPR&D project is abandoned, the Company writes off the related purchased intangible asset in the period it is abandoned.\n\n**Note 8. Goodwill and Purchased Intangible Assets**\n\n**_Goodwill_**\n\nThe following table summarizes the Company's goodwill activities by segment (in millions):\n\n**Infrastructure** **SLT** **Total**\n\n**December 31, 2009** $ 1,500.5 $ 2,158.1 $ 3,658.6\n\nAdjustment to goodwill — 0.2 0.2\n\nAdditions due to business combinations 142.9 126.1 269.0\n\n**December 31, 2010** 1,643.4 2,284.4 3,927.8\n\nAdjustments to goodwill 1.7 (1.8) (0.1)\n\nAdditions due to business combinations 0.4 — 0.4\n\n**December 31, 2011** $ 1,645.5 $ 2,282.6 $ 3,928.1\n\nThe adjustments to goodwill during the year ended December 31, 2011, were related to adjustments in net tangible assets assumed from certain businesses acquired in 2010 and 2011. There were no impairments to goodwill during the years ended December 31, 2011, 2010 and 2009. As of December 31, 2011, accumulated impairment losses were $1,280.0 million, all of which were associated with the SLT segment. **_Purchased Intangible Assets_**\n\nChanges to the Company’s purchased intangible assets were as follows (in millions):\n\n78"],"full_content":"**Table of Contents**\n\n**Juniper Networks, Inc. Notes to Consolidated Financial Statements (Continued)**\n\n**2010 Acquisitions**\n\n**Ankeena** **SMobile** **Altor** **Trapeze**\n\n**Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Estimated Useful Life (In Years)**\n\n**Amount** **Total Amount**\n\nExisting technology 4.0 $ 9.0 5.0 $ 24.3 6.0 $ 13.9 5.0 $ 45.0 $ 92.2\n\nIn-process research and development\n\n— — — — — 2.8 — — 2.8\n\nCore technology 4.0 3.2 — — 6.0 4.6 — — 7.8\n\nCustomer contracts and related relationships\n\n— — 6.0 2.1 — — 7.0 8.6 10.7\n\nSupport agreements and related relationships\n\n— — 6.0 0.1 — — 7.0 2.6 2.7\n\nNon-compete agreements\n\n— — 2.0 0.1 — — — — 0.1\n\nOEM customer contracts\n\n— — — — — — 2.0 0.2 0.2\n\nTotal $ 12.2 $ 26.6 $ 21.3 $ 56.4 $ 116.5\n\nAcquired in-process research and development (“IPR&D”) consists of existing research and development projects at the time of the acquisition. Projects that qualify as IPR&D assets represent those that have not yet reached technological feasibility and have no alternative future use. After initial recognition, acquired IPR&D assets are accounted for as indefinite-lived intangible assets. Development costs incurred after acquisition on acquired development projects are expensed as incurred. Upon completion of development, acquired IPR&D assets are considered amortizable intangible assets. If the IPR&D project is abandoned, the Company writes off the related purchased intangible asset in the period it is abandoned.\n\n**Note 8. Goodwill and Purchased Intangible Assets**\n\n**_Goodwill_**\n\nThe following table summarizes the Company's goodwill activities by segment (in millions):\n\n**Infrastructure** **SLT** **Total**\n\n**December 31, 2009** $ 1,500.5 $ 2,158.1 $ 3,658.6\n\nAdjustment to goodwill — 0.2 0.2\n\nAdditions due to business combinations 142.9 126.1 269.0\n\n**December 31, 2010** 1,643.4 2,284.4 3,927.8\n\nAdjustments to goodwill 1.7 (1.8) (0.1)\n\nAdditions due to business combinations 0.4 — 0.4\n\n**December 31, 2011** $ 1,645.5 $ 2,282.6 $ 3,928.1\n\nThe adjustments to goodwill during the year ended December 31, 2011, were related to adjustments in net tangible assets assumed from certain businesses acquired in 2010 and 2011. There were no impairments to goodwill during the years ended December 31, 2011, 2010 and 2009. As of December 31, 2011, accumulated impairment losses were $1,280.0 million, all of which were associated with the SLT segment. **_Purchased Intangible Assets_**\n\nChanges to the Company’s purchased intangible assets were as follows (in millions):\n\n78","publish_date":null,"title":"Table of Contents Juniper Networks, Inc. Notes to Consolidated Financial Statements (Continued) Existing technology 4.0 $ 9.0 5.0 $ 24.3","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2011.page_82.pdf_110673_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2011.page_82.pdf_110673_page1.pdf"},"request":{"example_id":"table/JNPR.2011.page_82.pdf_110673_page1","product_type":"parse","source_file_path":"JNPR.2011.page_82.pdf_110673_page1.pdf"},"started_at":"2026-11-04T19:47:50.026607"} +{"completed_at":"2026-11-04T19:47:52.852066","latency_in_ms":1737,"output":{"example_id":"table/JNPR.2017.page_127.pdf_110920_page1","grounded_pages":[],"layout_pages":[],"markdown":"43\n\n**_Financial Results and Key Performance Metrics Overview_**\n\nThe following table provides an overview of our financial results and key financial metrics (in millions, except per share amounts, percentages and days sales outstanding, or DSO):\n\n**As of and for the Years Ended December 31,**\n\n**2017 2016 2015 2017 vs. 2016 2016 vs. 2015**\n\n**$ Change % Change $ Change % Change**\n\nNet revenues $ 5,027.2 $ 4,990.1 $ 4,857.8 $ 37.1 1 % $ 132.3 3 %\n\nGross margin $ 3,072.1 $ 3,104.5 $ 3,078.6 $ (32.4) (1)% $ 25.9 1 %\n\n_Percentage of net revenues 61.1% 62.2% 63.4%_\n\nOperating income $ 848.1 $ 889.7 $ 912.0 $ (41.6) (5)% $ (22.3) (2)%\n\n_Percentage of net revenues 16.9% 17.8% 18.8%_\n\nNet income $ 306.2 $ 592.7 $ 633.7 $ (286.5) (48)% $ (41.0) (6)%\n\n_Percentage of net revenues 6.1% 11.9% 13.0%_\n\nNet income per share\n\nBasic $ 0.81 $ 1.55 $ 1.62 $ (0.74) (48)% $ (0.07) (4)%\n\nDiluted $ 0.80 $ 1.53 $ 1.59 $ (0.73) (48)% $ (0.06) (4)%\n\nCash dividends declared per\n\ncommon stock $ 0.40 $ 0.40 $ 0.40 $ — — % $ — — %\n\nOperating cash flows $ 1,260.1 $ 1,107.2 $ 899.5 $ 152.9 14 % $ 207.7 23 %\n\nStock repurchase plan activity 719.7 312.9 1,142.5 406.8 130 % (829.6) (73)%\n\nDSO (\\*) 62 68 53 (6) (9)% 15 28 %\n\nDeferred revenue $ 1,539.3 $ 1,481.1 $ 1,168.1 $ 58.2 4 % $ 313 27 %\n\nProduct deferred revenue $ 334.2 $ 322.9 $ 240.3 $ 11.3 3 % $ 82.6 34 %\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(\\*) DSO is for the fourth quarter ended December 31, 2017, 2016, and 2015.\n\n_• Net Revenues:_ During 2017, net revenues increased compared to 2016, due to growth from our services business driven\n\nby strong attach rates and renewals of support contracts, partially offset by a decline in product revenues. The decline in product revenues was primarily driven by lower revenues from our routing products as a result of the continued architectural shifts in the Cloud vertical to more automated, cost efficient, and scalable networks and a decrease in our high-end SRX series in our security business. This was partially offset by an increase in net revenues from our switching products driven by continued growth from our data center switching portfolio, particularly from our QFX product family which grew 25% year-over-year.\n\nOf our top ten customers for 2017, four were Cloud, five were Telecom/Cable, and one was a Strategic Enterprise. Of these customers, two were located outside of the U.S.\n\n• _Gross Margin:_ Our gross margin as a percentage of net revenues decreased during 2017, compared to 2016, primarily\n\ndue to lower product net revenues, customer mix, and product mix resulting from the year-over-year decline in routing revenues, including as a result of architectural shifts described above, partially offset by higher service gross margin.\n\n• _Operating Margin:_ During 2017, compared to 2016, operating income as a percentage of net revenues decreased\n\nprimarily due to lower gross margin as discussed above and higher operating expenses primarily from restructuring charges, partially offset by higher net revenues driven by the strength from our services and switching businesses.\n\n• _Capital Return:_ In 2017, we repurchased 26.1 million shares of our common stock for an aggregate amount of $719.7\n\nmillion and paid cash dividends of $0.10 per share each quarter for an aggregate annual amount of $150.4 million.\n\n• _Operating Cash Flows:_ Cash flow from operations increased in 2017, compared to 2016, primarily due to an increase\n\nin cash collections from customers in the first half of 2017 due to higher invoicing activity during the fourth quarter","pages":[{"line_numbers":[],"markdown":"43\n\n**_Financial Results and Key Performance Metrics Overview_**\n\nThe following table provides an overview of our financial results and key financial metrics (in millions, except per share amounts, percentages and days sales outstanding, or DSO):\n\n**As of and for the Years Ended December 31,**\n\n**2017 2016 2015 2017 vs. 2016 2016 vs. 2015**\n\n**$ Change % Change $ Change % Change**\n\nNet revenues $ 5,027.2 $ 4,990.1 $ 4,857.8 $ 37.1 1 % $ 132.3 3 %\n\nGross margin $ 3,072.1 $ 3,104.5 $ 3,078.6 $ (32.4) (1)% $ 25.9 1 %\n\n_Percentage of net revenues 61.1% 62.2% 63.4%_\n\nOperating income $ 848.1 $ 889.7 $ 912.0 $ (41.6) (5)% $ (22.3) (2)%\n\n_Percentage of net revenues 16.9% 17.8% 18.8%_\n\nNet income $ 306.2 $ 592.7 $ 633.7 $ (286.5) (48)% $ (41.0) (6)%\n\n_Percentage of net revenues 6.1% 11.9% 13.0%_\n\nNet income per share\n\nBasic $ 0.81 $ 1.55 $ 1.62 $ (0.74) (48)% $ (0.07) (4)%\n\nDiluted $ 0.80 $ 1.53 $ 1.59 $ (0.73) (48)% $ (0.06) (4)%\n\nCash dividends declared per\n\ncommon stock $ 0.40 $ 0.40 $ 0.40 $ — — % $ — — %\n\nOperating cash flows $ 1,260.1 $ 1,107.2 $ 899.5 $ 152.9 14 % $ 207.7 23 %\n\nStock repurchase plan activity 719.7 312.9 1,142.5 406.8 130 % (829.6) (73)%\n\nDSO (\\*) 62 68 53 (6) (9)% 15 28 %\n\nDeferred revenue $ 1,539.3 $ 1,481.1 $ 1,168.1 $ 58.2 4 % $ 313 27 %\n\nProduct deferred revenue $ 334.2 $ 322.9 $ 240.3 $ 11.3 3 % $ 82.6 34 %\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(\\*) DSO is for the fourth quarter ended December 31, 2017, 2016, and 2015.\n\n_• Net Revenues:_ During 2017, net revenues increased compared to 2016, due to growth from our services business driven\n\nby strong attach rates and renewals of support contracts, partially offset by a decline in product revenues. The decline in product revenues was primarily driven by lower revenues from our routing products as a result of the continued architectural shifts in the Cloud vertical to more automated, cost efficient, and scalable networks and a decrease in our high-end SRX series in our security business. This was partially offset by an increase in net revenues from our switching products driven by continued growth from our data center switching portfolio, particularly from our QFX product family which grew 25% year-over-year.\n\nOf our top ten customers for 2017, four were Cloud, five were Telecom/Cable, and one was a Strategic Enterprise. Of these customers, two were located outside of the U.S.\n\n• _Gross Margin:_ Our gross margin as a percentage of net revenues decreased during 2017, compared to 2016, primarily\n\ndue to lower product net revenues, customer mix, and product mix resulting from the year-over-year decline in routing revenues, including as a result of architectural shifts described above, partially offset by higher service gross margin.\n\n• _Operating Margin:_ During 2017, compared to 2016, operating income as a percentage of net revenues decreased\n\nprimarily due to lower gross margin as discussed above and higher operating expenses primarily from restructuring charges, partially offset by higher net revenues driven by the strength from our services and switching businesses.\n\n• _Capital Return:_ In 2017, we repurchased 26.1 million shares of our common stock for an aggregate amount of $719.7\n\nmillion and paid cash dividends of $0.10 per share each quarter for an aggregate annual amount of $150.4 million.\n\n• _Operating Cash Flows:_ Cash flow from operations increased in 2017, compared to 2016, primarily due to an increase\n\nin cash collections from customers in the first half of 2017 due to higher invoicing activity during the fourth quarter","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"43\n\n**_Financial Results and Key Performance Metrics Overview_**\n\nThe following table provides an overview of our financial results and key financial metrics (in millions, except per share amounts, percentages and days sales outstanding, or DSO):\n\n**As of and for the Years Ended December 31,**\n\n**2017 2016 2015 2017 vs. 2016 2016 vs. 2015**\n\n**$ Change % Change $ Change % Change**\n\nNet revenues $ 5,027.2 $ 4,990.1 $ 4,857.8 $ 37.1 1 % $ 132.3 3 %\n\nGross margin $ 3,072.1 $ 3,104.5 $ 3,078.6 $ (32.4) (1)% $ 25.9 1 %\n\n_Percentage of net revenues 61.1% 62.2% 63.4%_\n\nOperating income $ 848.1 $ 889.7 $ 912.0 $ (41.6) (5)% $ (22.3) (2)%\n\n_Percentage of net revenues 16.9% 17.8% 18.8%_\n\nNet income $ 306.2 $ 592.7 $ 633.7 $ (286.5) (48)% $ (41.0) (6)%\n\n_Percentage of net revenues 6.1% 11.9% 13.0%_\n\nNet income per share\n\nBasic $ 0.81 $ 1.55 $ 1.62 $ (0.74) (48)% $ (0.07) (4)%\n\nDiluted $ 0.80 $ 1.53 $ 1.59 $ (0.73) (48)% $ (0.06) (4)%\n\nCash dividends declared per\n\ncommon stock $ 0.40 $ 0.40 $ 0.40 $ — — % $ — — %\n\nOperating cash flows $ 1,260.1 $ 1,107.2 $ 899.5 $ 152.9 14 % $ 207.7 23 %\n\nStock repurchase plan activity 719.7 312.9 1,142.5 406.8 130 % (829.6) (73)%\n\nDSO (\\*) 62 68 53 (6) (9)% 15 28 %\n\nDeferred revenue $ 1,539.3 $ 1,481.1 $ 1,168.1 $ 58.2 4 % $ 313 27 %\n\nProduct deferred revenue $ 334.2 $ 322.9 $ 240.3 $ 11.3 3 % $ 82.6 34 %\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(\\*) DSO is for the fourth quarter ended December 31, 2017, 2016, and 2015.\n\n_• Net Revenues:_ During 2017, net revenues increased compared to 2016, due to growth from our services business driven\n\nby strong attach rates and renewals of support contracts, partially offset by a decline in product revenues. The decline in product revenues was primarily driven by lower revenues from our routing products as a result of the continued architectural shifts in the Cloud vertical to more automated, cost efficient, and scalable networks and a decrease in our high-end SRX series in our security business. This was partially offset by an increase in net revenues from our switching products driven by continued growth from our data center switching portfolio, particularly from our QFX product family which grew 25% year-over-year.\n\nOf our top ten customers for 2017, four were Cloud, five were Telecom/Cable, and one was a Strategic Enterprise. Of these customers, two were located outside of the U.S.\n\n• _Gross Margin:_ Our gross margin as a percentage of net revenues decreased during 2017, compared to 2016, primarily\n\ndue to lower product net revenues, customer mix, and product mix resulting from the year-over-year decline in routing revenues, including as a result of architectural shifts described above, partially offset by higher service gross margin.\n\n• _Operating Margin:_ During 2017, compared to 2016, operating income as a percentage of net revenues decreased\n\nprimarily due to lower gross margin as discussed above and higher operating expenses primarily from restructuring charges, partially offset by higher net revenues driven by the strength from our services and switching businesses.\n\n• _Capital Return:_ In 2017, we repurchased 26.1 million shares of our common stock for an aggregate amount of $719.7\n\nmillion and paid cash dividends of $0.10 per share each quarter for an aggregate annual amount of $150.4 million.\n\n• _Operating Cash Flows:_ Cash flow from operations increased in 2017, compared to 2016, primarily due to an increase\n\nin cash collections from customers in the first half of 2017 due to higher invoicing activity during the fourth quarter","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2017.page_127.pdf_110920_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_0cb8b7f6b5a7bca520c359853ac995a9","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["43\n\n**_Financial Results and Key Performance Metrics Overview_**\n\nThe following table provides an overview of our financial results and key financial metrics (in millions, except per share amounts, percentages and days sales outstanding, or DSO):\n\n**As of and for the Years Ended December 31,**\n\n**2017 2016 2015 2017 vs. 2016 2016 vs. 2015**\n\n**$ Change % Change $ Change % Change**\n\nNet revenues $ 5,027.2 $ 4,990.1 $ 4,857.8 $ 37.1 1 % $ 132.3 3 %\n\nGross margin $ 3,072.1 $ 3,104.5 $ 3,078.6 $ (32.4) (1)% $ 25.9 1 %\n\n_Percentage of net revenues 61.1% 62.2% 63.4%_\n\nOperating income $ 848.1 $ 889.7 $ 912.0 $ (41.6) (5)% $ (22.3) (2)%\n\n_Percentage of net revenues 16.9% 17.8% 18.8%_\n\nNet income $ 306.2 $ 592.7 $ 633.7 $ (286.5) (48)% $ (41.0) (6)%\n\n_Percentage of net revenues 6.1% 11.9% 13.0%_\n\nNet income per share\n\nBasic $ 0.81 $ 1.55 $ 1.62 $ (0.74) (48)% $ (0.07) (4)%\n\nDiluted $ 0.80 $ 1.53 $ 1.59 $ (0.73) (48)% $ (0.06) (4)%\n\nCash dividends declared per\n\ncommon stock $ 0.40 $ 0.40 $ 0.40 $ — — % $ — — %\n\nOperating cash flows $ 1,260.1 $ 1,107.2 $ 899.5 $ 152.9 14 % $ 207.7 23 %\n\nStock repurchase plan activity 719.7 312.9 1,142.5 406.8 130 % (829.6) (73)%\n\nDSO (\\*) 62 68 53 (6) (9)% 15 28 %\n\nDeferred revenue $ 1,539.3 $ 1,481.1 $ 1,168.1 $ 58.2 4 % $ 313 27 %\n\nProduct deferred revenue $ 334.2 $ 322.9 $ 240.3 $ 11.3 3 % $ 82.6 34 %\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(\\*) DSO is for the fourth quarter ended December 31, 2017, 2016, and 2015.\n\n_• Net Revenues:_ During 2017, net revenues increased compared to 2016, due to growth from our services business driven\n\nby strong attach rates and renewals of support contracts, partially offset by a decline in product revenues. The decline in product revenues was primarily driven by lower revenues from our routing products as a result of the continued architectural shifts in the Cloud vertical to more automated, cost efficient, and scalable networks and a decrease in our high-end SRX series in our security business. This was partially offset by an increase in net revenues from our switching products driven by continued growth from our data center switching portfolio, particularly from our QFX product family which grew 25% year-over-year.\n\nOf our top ten customers for 2017, four were Cloud, five were Telecom/Cable, and one was a Strategic Enterprise. Of these customers, two were located outside of the U.S.\n\n• _Gross Margin:_ Our gross margin as a percentage of net revenues decreased during 2017, compared to 2016, primarily\n\ndue to lower product net revenues, customer mix, and product mix resulting from the year-over-year decline in routing revenues, including as a result of architectural shifts described above, partially offset by higher service gross margin.\n\n• _Operating Margin:_ During 2017, compared to 2016, operating income as a percentage of net revenues decreased\n\nprimarily due to lower gross margin as discussed above and higher operating expenses primarily from restructuring charges, partially offset by higher net revenues driven by the strength from our services and switching businesses.\n\n• _Capital Return:_ In 2017, we repurchased 26.1 million shares of our common stock for an aggregate amount of $719.7\n\nmillion and paid cash dividends of $0.10 per share each quarter for an aggregate annual amount of $150.4 million.\n\n• _Operating Cash Flows:_ Cash flow from operations increased in 2017, compared to 2016, primarily due to an increase\n\nin cash collections from customers in the first half of 2017 due to higher invoicing activity during the fourth quarter"],"full_content":"43\n\n**_Financial Results and Key Performance Metrics Overview_**\n\nThe following table provides an overview of our financial results and key financial metrics (in millions, except per share amounts, percentages and days sales outstanding, or DSO):\n\n**As of and for the Years Ended December 31,**\n\n**2017 2016 2015 2017 vs. 2016 2016 vs. 2015**\n\n**$ Change % Change $ Change % Change**\n\nNet revenues $ 5,027.2 $ 4,990.1 $ 4,857.8 $ 37.1 1 % $ 132.3 3 %\n\nGross margin $ 3,072.1 $ 3,104.5 $ 3,078.6 $ (32.4) (1)% $ 25.9 1 %\n\n_Percentage of net revenues 61.1% 62.2% 63.4%_\n\nOperating income $ 848.1 $ 889.7 $ 912.0 $ (41.6) (5)% $ (22.3) (2)%\n\n_Percentage of net revenues 16.9% 17.8% 18.8%_\n\nNet income $ 306.2 $ 592.7 $ 633.7 $ (286.5) (48)% $ (41.0) (6)%\n\n_Percentage of net revenues 6.1% 11.9% 13.0%_\n\nNet income per share\n\nBasic $ 0.81 $ 1.55 $ 1.62 $ (0.74) (48)% $ (0.07) (4)%\n\nDiluted $ 0.80 $ 1.53 $ 1.59 $ (0.73) (48)% $ (0.06) (4)%\n\nCash dividends declared per\n\ncommon stock $ 0.40 $ 0.40 $ 0.40 $ — — % $ — — %\n\nOperating cash flows $ 1,260.1 $ 1,107.2 $ 899.5 $ 152.9 14 % $ 207.7 23 %\n\nStock repurchase plan activity 719.7 312.9 1,142.5 406.8 130 % (829.6) (73)%\n\nDSO (\\*) 62 68 53 (6) (9)% 15 28 %\n\nDeferred revenue $ 1,539.3 $ 1,481.1 $ 1,168.1 $ 58.2 4 % $ 313 27 %\n\nProduct deferred revenue $ 334.2 $ 322.9 $ 240.3 $ 11.3 3 % $ 82.6 34 %\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(\\*) DSO is for the fourth quarter ended December 31, 2017, 2016, and 2015.\n\n_• Net Revenues:_ During 2017, net revenues increased compared to 2016, due to growth from our services business driven\n\nby strong attach rates and renewals of support contracts, partially offset by a decline in product revenues. The decline in product revenues was primarily driven by lower revenues from our routing products as a result of the continued architectural shifts in the Cloud vertical to more automated, cost efficient, and scalable networks and a decrease in our high-end SRX series in our security business. This was partially offset by an increase in net revenues from our switching products driven by continued growth from our data center switching portfolio, particularly from our QFX product family which grew 25% year-over-year.\n\nOf our top ten customers for 2017, four were Cloud, five were Telecom/Cable, and one was a Strategic Enterprise. Of these customers, two were located outside of the U.S.\n\n• _Gross Margin:_ Our gross margin as a percentage of net revenues decreased during 2017, compared to 2016, primarily\n\ndue to lower product net revenues, customer mix, and product mix resulting from the year-over-year decline in routing revenues, including as a result of architectural shifts described above, partially offset by higher service gross margin.\n\n• _Operating Margin:_ During 2017, compared to 2016, operating income as a percentage of net revenues decreased\n\nprimarily due to lower gross margin as discussed above and higher operating expenses primarily from restructuring charges, partially offset by higher net revenues driven by the strength from our services and switching businesses.\n\n• _Capital Return:_ In 2017, we repurchased 26.1 million shares of our common stock for an aggregate amount of $719.7\n\nmillion and paid cash dividends of $0.10 per share each quarter for an aggregate annual amount of $150.4 million.\n\n• _Operating Cash Flows:_ Cash flow from operations increased in 2017, compared to 2016, primarily due to an increase\n\nin cash collections from customers in the first half of 2017 due to higher invoicing activity during the fourth quarter","publish_date":null,"title":"Financial Results and Key Performance Metrics Overview The following table provides an overview of our financial results and key financial","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2017.page_127.pdf_110920_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2017.page_127.pdf_110920_page1.pdf"},"request":{"example_id":"table/JNPR.2017.page_127.pdf_110920_page1","product_type":"parse","source_file_path":"JNPR.2017.page_127.pdf_110920_page1.pdf"},"started_at":"2026-11-04T19:47:51.114257"} +{"completed_at":"2026-11-04T19:47:53.407728","latency_in_ms":1022,"output":{"example_id":"table/JNPR.2018.page_212.pdf_110717_page1","grounded_pages":[],"layout_pages":[],"markdown":"116\n\n**Incorporated by Reference**\n\n**Exhibit**\n\n**No.** **Exhibit** **Filing** **Exhibit**\n\n**No.** **File No.** **File Date**\n\n10\\.14 Amended and Restated Juniper Networks, Inc. 2015 Equity Incentive Plan+\n\n8-K 10.1 001-34501 5/30/2017\n\n10\\.15 HTBase Corporation 2018 Equity Incentive Plan and Forms of Award Agreement Thereunder\\*+\n\n10\\.16 Amended and Restated Juniper Networks, Inc. 2008 Employee Stock Purchase Plan+\n\n10-K 10.19 001-34501 2/23/2018\n\n10\\.17 Form of Restricted Stock Unit Agreement effective as of May 19, 2015+\n\n8-K 10.2 001-34501 5/20/2015\n\n10\\.18 Form of Performance Share Agreement effective as of May 19, 2015+\n\n8-K 10.3 001-34501 5/20/2015\n\n10\\.19 Form of Stock Option Agreement effective as of May 19, 2015+ 8-K 10.4 001-34501 5/20/2015\n\n10\\.20 Form of Severance Agreement for Certain Officers, approved for use on September 19, 2016+\n\n8-K 10.1 001-34501 9/20/2016\n\n10\\.21 Form of Severance Agreement for Certain Officers, approved for use on August 29, 2017+\n\n8-K 10.2 001-34501 8/31/2017\n\n10\\.22 Severance Agreement, dated September 5, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.6 001-34501 11/7/2017\n\n10\\.23 Form of Change of Control Agreement for Certain Officers, approved for use on September 19, 2016+\n\n8-K 10.2 001-34501 9/20/2016\n\n10\\.24 Form of Change of Control Agreement for Certain Officers, approved for use on August 29, 2017+\n\n8-K 10.1 001-34501 8/31/2017\n\n10\\.25 Change of Control Agreement, dated September 5, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.5 001-34501 11/7/2017\n\n10\\.26 Settlement, Release and Cross-License Agreement, dated May 27, 2014, by and between Juniper Networks, Inc. and Palo Alto Networks, Inc.\n\n8-K 10.1 001-34501 5/29/2014\n\n10\\.27 Credit Agreement, dated as of June 27, 2014, by and among Juniper Networks, Inc., the lenders from time to time party thereto and Citibank, N.A., as administrative agent\n\n8-K 10.1 001-34501 6/27/2014\n\n10\\.28 Letter Amendment to Credit Agreement, dated as of November 21, 2017, by and among Juniper Networks, Inc., the lenders from time to time party thereto and Citibank, N.A., as administrative agent\n\n10-K 10.31 001-34501 2/23/2018\n\n10\\.29 Master Services Agreement, dated December 31, 2018, between Juniper Networks, Inc. and International Business Machines Corporation, as amended on January 4, 2019\\*†\n\n10\\.30 Employment Offer Letter, dated November 18, 2014, between Juniper Networks, Inc. and Rami Rahim+\n\n8-K 10.1 001-34501 11/24/2014\n\n10\\.31 Employment Offer Letter between Juniper Networks, Inc. and Brian Martin+\n\n10-Q 10.2 001-34501 11/5/2015\n\n10\\.32 Compensation Letter, dated August 9, 2017, between Juniper Networks, Inc. and Anand Athreya+\n\n10-Q 10.3 001-34501 11/7/2017\n\n10\\.33 Employment Offer Letter, dated August 9, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.4 001-34501 11/7/2017\n\n10\\.34 Employment Offer Letter, dated March 5, 2018, between Juniper Networks, Inc. and Manoj Leelanivas+\n\n10-Q 10.3 001-34501 5/8/2018\n\n10\\.35 Letter Agreement, dated May 4, 2018, between Juniper Networks, Inc. and Vincent Molinaro+\n\n10-Q 10.4 001-34501 5/8/2018\n\n10\\.36 Letter Agreement, dated May 24, 2018, between Juniper Networks, Inc. and Terrance F. Spidell+\n\n8-K 10.1 001-34501 5/29/2018\n\n10\\.37 Amendment to Letter Agreement, dated November 5, 2018, between Juniper Networks, Inc. and Terrance F. Spidell+\n\n10-Q 10.3 001-34501 11/7/2018\n\n10\\.38 Letter Agreement, dated June 19, 2018, between Juniper Networks, Inc. and Pierre-Paul Allard+\n\n10-Q 10.1 001-34501 11/7/2018\n\n10\\.39 Form of Executive Compensation Recovery Agreement for Certain Officers, approved for use in November 2015+\n\n10-K 10.60 001-34501 2/29/2016\n\n10\\.40 Form of Indemnification Agreement entered into by Juniper Networks, Inc. with each of its directors, officers and certain employees, approved for use on August 9, 2018+\n\n8-K 10.1 001-34501 8/10/2018","pages":[{"line_numbers":[],"markdown":"116\n\n**Incorporated by Reference**\n\n**Exhibit**\n\n**No.** **Exhibit** **Filing** **Exhibit**\n\n**No.** **File No.** **File Date**\n\n10\\.14 Amended and Restated Juniper Networks, Inc. 2015 Equity Incentive Plan+\n\n8-K 10.1 001-34501 5/30/2017\n\n10\\.15 HTBase Corporation 2018 Equity Incentive Plan and Forms of Award Agreement Thereunder\\*+\n\n10\\.16 Amended and Restated Juniper Networks, Inc. 2008 Employee Stock Purchase Plan+\n\n10-K 10.19 001-34501 2/23/2018\n\n10\\.17 Form of Restricted Stock Unit Agreement effective as of May 19, 2015+\n\n8-K 10.2 001-34501 5/20/2015\n\n10\\.18 Form of Performance Share Agreement effective as of May 19, 2015+\n\n8-K 10.3 001-34501 5/20/2015\n\n10\\.19 Form of Stock Option Agreement effective as of May 19, 2015+ 8-K 10.4 001-34501 5/20/2015\n\n10\\.20 Form of Severance Agreement for Certain Officers, approved for use on September 19, 2016+\n\n8-K 10.1 001-34501 9/20/2016\n\n10\\.21 Form of Severance Agreement for Certain Officers, approved for use on August 29, 2017+\n\n8-K 10.2 001-34501 8/31/2017\n\n10\\.22 Severance Agreement, dated September 5, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.6 001-34501 11/7/2017\n\n10\\.23 Form of Change of Control Agreement for Certain Officers, approved for use on September 19, 2016+\n\n8-K 10.2 001-34501 9/20/2016\n\n10\\.24 Form of Change of Control Agreement for Certain Officers, approved for use on August 29, 2017+\n\n8-K 10.1 001-34501 8/31/2017\n\n10\\.25 Change of Control Agreement, dated September 5, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.5 001-34501 11/7/2017\n\n10\\.26 Settlement, Release and Cross-License Agreement, dated May 27, 2014, by and between Juniper Networks, Inc. and Palo Alto Networks, Inc.\n\n8-K 10.1 001-34501 5/29/2014\n\n10\\.27 Credit Agreement, dated as of June 27, 2014, by and among Juniper Networks, Inc., the lenders from time to time party thereto and Citibank, N.A., as administrative agent\n\n8-K 10.1 001-34501 6/27/2014\n\n10\\.28 Letter Amendment to Credit Agreement, dated as of November 21, 2017, by and among Juniper Networks, Inc., the lenders from time to time party thereto and Citibank, N.A., as administrative agent\n\n10-K 10.31 001-34501 2/23/2018\n\n10\\.29 Master Services Agreement, dated December 31, 2018, between Juniper Networks, Inc. and International Business Machines Corporation, as amended on January 4, 2019\\*†\n\n10\\.30 Employment Offer Letter, dated November 18, 2014, between Juniper Networks, Inc. and Rami Rahim+\n\n8-K 10.1 001-34501 11/24/2014\n\n10\\.31 Employment Offer Letter between Juniper Networks, Inc. and Brian Martin+\n\n10-Q 10.2 001-34501 11/5/2015\n\n10\\.32 Compensation Letter, dated August 9, 2017, between Juniper Networks, Inc. and Anand Athreya+\n\n10-Q 10.3 001-34501 11/7/2017\n\n10\\.33 Employment Offer Letter, dated August 9, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.4 001-34501 11/7/2017\n\n10\\.34 Employment Offer Letter, dated March 5, 2018, between Juniper Networks, Inc. and Manoj Leelanivas+\n\n10-Q 10.3 001-34501 5/8/2018\n\n10\\.35 Letter Agreement, dated May 4, 2018, between Juniper Networks, Inc. and Vincent Molinaro+\n\n10-Q 10.4 001-34501 5/8/2018\n\n10\\.36 Letter Agreement, dated May 24, 2018, between Juniper Networks, Inc. and Terrance F. Spidell+\n\n8-K 10.1 001-34501 5/29/2018\n\n10\\.37 Amendment to Letter Agreement, dated November 5, 2018, between Juniper Networks, Inc. and Terrance F. Spidell+\n\n10-Q 10.3 001-34501 11/7/2018\n\n10\\.38 Letter Agreement, dated June 19, 2018, between Juniper Networks, Inc. and Pierre-Paul Allard+\n\n10-Q 10.1 001-34501 11/7/2018\n\n10\\.39 Form of Executive Compensation Recovery Agreement for Certain Officers, approved for use in November 2015+\n\n10-K 10.60 001-34501 2/29/2016\n\n10\\.40 Form of Indemnification Agreement entered into by Juniper Networks, Inc. with each of its directors, officers and certain employees, approved for use on August 9, 2018+\n\n8-K 10.1 001-34501 8/10/2018","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"116\n\n**Incorporated by Reference**\n\n**Exhibit**\n\n**No.** **Exhibit** **Filing** **Exhibit**\n\n**No.** **File No.** **File Date**\n\n10\\.14 Amended and Restated Juniper Networks, Inc. 2015 Equity Incentive Plan+\n\n8-K 10.1 001-34501 5/30/2017\n\n10\\.15 HTBase Corporation 2018 Equity Incentive Plan and Forms of Award Agreement Thereunder\\*+\n\n10\\.16 Amended and Restated Juniper Networks, Inc. 2008 Employee Stock Purchase Plan+\n\n10-K 10.19 001-34501 2/23/2018\n\n10\\.17 Form of Restricted Stock Unit Agreement effective as of May 19, 2015+\n\n8-K 10.2 001-34501 5/20/2015\n\n10\\.18 Form of Performance Share Agreement effective as of May 19, 2015+\n\n8-K 10.3 001-34501 5/20/2015\n\n10\\.19 Form of Stock Option Agreement effective as of May 19, 2015+ 8-K 10.4 001-34501 5/20/2015\n\n10\\.20 Form of Severance Agreement for Certain Officers, approved for use on September 19, 2016+\n\n8-K 10.1 001-34501 9/20/2016\n\n10\\.21 Form of Severance Agreement for Certain Officers, approved for use on August 29, 2017+\n\n8-K 10.2 001-34501 8/31/2017\n\n10\\.22 Severance Agreement, dated September 5, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.6 001-34501 11/7/2017\n\n10\\.23 Form of Change of Control Agreement for Certain Officers, approved for use on September 19, 2016+\n\n8-K 10.2 001-34501 9/20/2016\n\n10\\.24 Form of Change of Control Agreement for Certain Officers, approved for use on August 29, 2017+\n\n8-K 10.1 001-34501 8/31/2017\n\n10\\.25 Change of Control Agreement, dated September 5, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.5 001-34501 11/7/2017\n\n10\\.26 Settlement, Release and Cross-License Agreement, dated May 27, 2014, by and between Juniper Networks, Inc. and Palo Alto Networks, Inc.\n\n8-K 10.1 001-34501 5/29/2014\n\n10\\.27 Credit Agreement, dated as of June 27, 2014, by and among Juniper Networks, Inc., the lenders from time to time party thereto and Citibank, N.A., as administrative agent\n\n8-K 10.1 001-34501 6/27/2014\n\n10\\.28 Letter Amendment to Credit Agreement, dated as of November 21, 2017, by and among Juniper Networks, Inc., the lenders from time to time party thereto and Citibank, N.A., as administrative agent\n\n10-K 10.31 001-34501 2/23/2018\n\n10\\.29 Master Services Agreement, dated December 31, 2018, between Juniper Networks, Inc. and International Business Machines Corporation, as amended on January 4, 2019\\*†\n\n10\\.30 Employment Offer Letter, dated November 18, 2014, between Juniper Networks, Inc. and Rami Rahim+\n\n8-K 10.1 001-34501 11/24/2014\n\n10\\.31 Employment Offer Letter between Juniper Networks, Inc. and Brian Martin+\n\n10-Q 10.2 001-34501 11/5/2015\n\n10\\.32 Compensation Letter, dated August 9, 2017, between Juniper Networks, Inc. and Anand Athreya+\n\n10-Q 10.3 001-34501 11/7/2017\n\n10\\.33 Employment Offer Letter, dated August 9, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.4 001-34501 11/7/2017\n\n10\\.34 Employment Offer Letter, dated March 5, 2018, between Juniper Networks, Inc. and Manoj Leelanivas+\n\n10-Q 10.3 001-34501 5/8/2018\n\n10\\.35 Letter Agreement, dated May 4, 2018, between Juniper Networks, Inc. and Vincent Molinaro+\n\n10-Q 10.4 001-34501 5/8/2018\n\n10\\.36 Letter Agreement, dated May 24, 2018, between Juniper Networks, Inc. and Terrance F. Spidell+\n\n8-K 10.1 001-34501 5/29/2018\n\n10\\.37 Amendment to Letter Agreement, dated November 5, 2018, between Juniper Networks, Inc. and Terrance F. Spidell+\n\n10-Q 10.3 001-34501 11/7/2018\n\n10\\.38 Letter Agreement, dated June 19, 2018, between Juniper Networks, Inc. and Pierre-Paul Allard+\n\n10-Q 10.1 001-34501 11/7/2018\n\n10\\.39 Form of Executive Compensation Recovery Agreement for Certain Officers, approved for use in November 2015+\n\n10-K 10.60 001-34501 2/29/2016\n\n10\\.40 Form of Indemnification Agreement entered into by Juniper Networks, Inc. with each of its directors, officers and certain employees, approved for use on August 9, 2018+\n\n8-K 10.1 001-34501 8/10/2018","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2018.page_212.pdf_110717_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_97d8aaa14bf3ec555fd02abb1e0c21cc","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["116\n\n**Incorporated by Reference**\n\n**Exhibit**\n\n**No.** **Exhibit** **Filing** **Exhibit**\n\n**No.** **File No.** **File Date**\n\n10\\.14 Amended and Restated Juniper Networks, Inc. 2015 Equity Incentive Plan+\n\n8-K 10.1 001-34501 5/30/2017\n\n10\\.15 HTBase Corporation 2018 Equity Incentive Plan and Forms of Award Agreement Thereunder\\*+\n\n10\\.16 Amended and Restated Juniper Networks, Inc. 2008 Employee Stock Purchase Plan+\n\n10-K 10.19 001-34501 2/23/2018\n\n10\\.17 Form of Restricted Stock Unit Agreement effective as of May 19, 2015+\n\n8-K 10.2 001-34501 5/20/2015\n\n10\\.18 Form of Performance Share Agreement effective as of May 19, 2015+\n\n8-K 10.3 001-34501 5/20/2015\n\n10\\.19 Form of Stock Option Agreement effective as of May 19, 2015+ 8-K 10.4 001-34501 5/20/2015\n\n10\\.20 Form of Severance Agreement for Certain Officers, approved for use on September 19, 2016+\n\n8-K 10.1 001-34501 9/20/2016\n\n10\\.21 Form of Severance Agreement for Certain Officers, approved for use on August 29, 2017+\n\n8-K 10.2 001-34501 8/31/2017\n\n10\\.22 Severance Agreement, dated September 5, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.6 001-34501 11/7/2017\n\n10\\.23 Form of Change of Control Agreement for Certain Officers, approved for use on September 19, 2016+\n\n8-K 10.2 001-34501 9/20/2016\n\n10\\.24 Form of Change of Control Agreement for Certain Officers, approved for use on August 29, 2017+\n\n8-K 10.1 001-34501 8/31/2017\n\n10\\.25 Change of Control Agreement, dated September 5, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.5 001-34501 11/7/2017\n\n10\\.26 Settlement, Release and Cross-License Agreement, dated May 27, 2014, by and between Juniper Networks, Inc. and Palo Alto Networks, Inc.\n\n8-K 10.1 001-34501 5/29/2014\n\n10\\.27 Credit Agreement, dated as of June 27, 2014, by and among Juniper Networks, Inc., the lenders from time to time party thereto and Citibank, N.A., as administrative agent\n\n8-K 10.1 001-34501 6/27/2014\n\n10\\.28 Letter Amendment to Credit Agreement, dated as of November 21, 2017, by and among Juniper Networks, Inc., the lenders from time to time party thereto and Citibank, N.A., as administrative agent\n\n10-K 10.31 001-34501 2/23/2018\n\n10\\.29 Master Services Agreement, dated December 31, 2018, between Juniper Networks, Inc. and International Business Machines Corporation, as amended on January 4, 2019\\*†\n\n10\\.30 Employment Offer Letter, dated November 18, 2014, between Juniper Networks, Inc. and Rami Rahim+\n\n8-K 10.1 001-34501 11/24/2014\n\n10\\.31 Employment Offer Letter between Juniper Networks, Inc. and Brian Martin+\n\n10-Q 10.2 001-34501 11/5/2015\n\n10\\.32 Compensation Letter, dated August 9, 2017, between Juniper Networks, Inc. and Anand Athreya+\n\n10-Q 10.3 001-34501 11/7/2017\n\n10\\.33 Employment Offer Letter, dated August 9, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.4 001-34501 11/7/2017\n\n10\\.34 Employment Offer Letter, dated March 5, 2018, between Juniper Networks, Inc. and Manoj Leelanivas+\n\n10-Q 10.3 001-34501 5/8/2018\n\n10\\.35 Letter Agreement, dated May 4, 2018, between Juniper Networks, Inc. and Vincent Molinaro+\n\n10-Q 10.4 001-34501 5/8/2018\n\n10\\.36 Letter Agreement, dated May 24, 2018, between Juniper Networks, Inc. and Terrance F. Spidell+\n\n8-K 10.1 001-34501 5/29/2018\n\n10\\.37 Amendment to Letter Agreement, dated November 5, 2018, between Juniper Networks, Inc. and Terrance F. Spidell+\n\n10-Q 10.3 001-34501 11/7/2018\n\n10\\.38 Letter Agreement, dated June 19, 2018, between Juniper Networks, Inc. and Pierre-Paul Allard+\n\n10-Q 10.1 001-34501 11/7/2018\n\n10\\.39 Form of Executive Compensation Recovery Agreement for Certain Officers, approved for use in November 2015+\n\n10-K 10.60 001-34501 2/29/2016\n\n10\\.40 Form of Indemnification Agreement entered into by Juniper Networks, Inc. with each of its directors, officers and certain employees, approved for use on August 9, 2018+\n\n8-K 10.1 001-34501 8/10/2018"],"full_content":"116\n\n**Incorporated by Reference**\n\n**Exhibit**\n\n**No.** **Exhibit** **Filing** **Exhibit**\n\n**No.** **File No.** **File Date**\n\n10\\.14 Amended and Restated Juniper Networks, Inc. 2015 Equity Incentive Plan+\n\n8-K 10.1 001-34501 5/30/2017\n\n10\\.15 HTBase Corporation 2018 Equity Incentive Plan and Forms of Award Agreement Thereunder\\*+\n\n10\\.16 Amended and Restated Juniper Networks, Inc. 2008 Employee Stock Purchase Plan+\n\n10-K 10.19 001-34501 2/23/2018\n\n10\\.17 Form of Restricted Stock Unit Agreement effective as of May 19, 2015+\n\n8-K 10.2 001-34501 5/20/2015\n\n10\\.18 Form of Performance Share Agreement effective as of May 19, 2015+\n\n8-K 10.3 001-34501 5/20/2015\n\n10\\.19 Form of Stock Option Agreement effective as of May 19, 2015+ 8-K 10.4 001-34501 5/20/2015\n\n10\\.20 Form of Severance Agreement for Certain Officers, approved for use on September 19, 2016+\n\n8-K 10.1 001-34501 9/20/2016\n\n10\\.21 Form of Severance Agreement for Certain Officers, approved for use on August 29, 2017+\n\n8-K 10.2 001-34501 8/31/2017\n\n10\\.22 Severance Agreement, dated September 5, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.6 001-34501 11/7/2017\n\n10\\.23 Form of Change of Control Agreement for Certain Officers, approved for use on September 19, 2016+\n\n8-K 10.2 001-34501 9/20/2016\n\n10\\.24 Form of Change of Control Agreement for Certain Officers, approved for use on August 29, 2017+\n\n8-K 10.1 001-34501 8/31/2017\n\n10\\.25 Change of Control Agreement, dated September 5, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.5 001-34501 11/7/2017\n\n10\\.26 Settlement, Release and Cross-License Agreement, dated May 27, 2014, by and between Juniper Networks, Inc. and Palo Alto Networks, Inc.\n\n8-K 10.1 001-34501 5/29/2014\n\n10\\.27 Credit Agreement, dated as of June 27, 2014, by and among Juniper Networks, Inc., the lenders from time to time party thereto and Citibank, N.A., as administrative agent\n\n8-K 10.1 001-34501 6/27/2014\n\n10\\.28 Letter Amendment to Credit Agreement, dated as of November 21, 2017, by and among Juniper Networks, Inc., the lenders from time to time party thereto and Citibank, N.A., as administrative agent\n\n10-K 10.31 001-34501 2/23/2018\n\n10\\.29 Master Services Agreement, dated December 31, 2018, between Juniper Networks, Inc. and International Business Machines Corporation, as amended on January 4, 2019\\*†\n\n10\\.30 Employment Offer Letter, dated November 18, 2014, between Juniper Networks, Inc. and Rami Rahim+\n\n8-K 10.1 001-34501 11/24/2014\n\n10\\.31 Employment Offer Letter between Juniper Networks, Inc. and Brian Martin+\n\n10-Q 10.2 001-34501 11/5/2015\n\n10\\.32 Compensation Letter, dated August 9, 2017, between Juniper Networks, Inc. and Anand Athreya+\n\n10-Q 10.3 001-34501 11/7/2017\n\n10\\.33 Employment Offer Letter, dated August 9, 2017, between Juniper Networks, Inc. and Bikash Koley+\n\n10-Q 10.4 001-34501 11/7/2017\n\n10\\.34 Employment Offer Letter, dated March 5, 2018, between Juniper Networks, Inc. and Manoj Leelanivas+\n\n10-Q 10.3 001-34501 5/8/2018\n\n10\\.35 Letter Agreement, dated May 4, 2018, between Juniper Networks, Inc. and Vincent Molinaro+\n\n10-Q 10.4 001-34501 5/8/2018\n\n10\\.36 Letter Agreement, dated May 24, 2018, between Juniper Networks, Inc. and Terrance F. Spidell+\n\n8-K 10.1 001-34501 5/29/2018\n\n10\\.37 Amendment to Letter Agreement, dated November 5, 2018, between Juniper Networks, Inc. and Terrance F. Spidell+\n\n10-Q 10.3 001-34501 11/7/2018\n\n10\\.38 Letter Agreement, dated June 19, 2018, between Juniper Networks, Inc. and Pierre-Paul Allard+\n\n10-Q 10.1 001-34501 11/7/2018\n\n10\\.39 Form of Executive Compensation Recovery Agreement for Certain Officers, approved for use in November 2015+\n\n10-K 10.60 001-34501 2/29/2016\n\n10\\.40 Form of Indemnification Agreement entered into by Juniper Networks, Inc. with each of its directors, officers and certain employees, approved for use on August 9, 2018+\n\n8-K 10.1 001-34501 8/10/2018","publish_date":null,"title":"116","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2018.page_212.pdf_110717_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/JNPR.2018.page_212.pdf_110717_page1.pdf"},"request":{"example_id":"table/JNPR.2018.page_212.pdf_110717_page1","product_type":"parse","source_file_path":"JNPR.2018.page_212.pdf_110717_page1.pdf"},"started_at":"2026-11-04T19:47:52.385013"} +{"completed_at":"2026-11-04T19:47:56.017320","latency_in_ms":2632,"output":{"example_id":"table/KEY.2014.page_103.pdf_98246_page1","grounded_pages":[],"layout_pages":[],"markdown":"**Figure 39. Summary of Loan and Lease Loss Experience from Continuing Operations**\n\n**Year ended December 31,** _dollars in millions_ **2014 2013 2012 2011 2010** Average loans outstanding **$55,679** $53,054 $50,362 $48,606 $53,971\n\nAllowance for loan and lease losses at beginning of period **$ 848** $ 888 $ 1,004 $ 1,604 $ 2,534 Loans charged off: Commercial, financial and agricultural (a) **45** 62 80 169 565\n\nReal estate — commercial mortgage **6** 20 102 113 360 Real estate — construction **5** 3 24 83 380\n\nTotal commercial real estate loans (b) **11** 23 126 196 740 Commercial lease financing **10** 27 27 42 88\n\nTotal commercial loans **66** 112 233 407 1,393 Real estate — residential mortgage **10** 20 27 29 36 Home equity: Key Community Bank **37** 62 99 100 123 Other **9** 20 35 45 62\n\nTotal home equity loans **46** 82 134 145 185 Consumer other — Key Community Bank **30** 31 38 45 64 Credit cards **34** 30 11 — — Consumer other: Marine **23** 29 59 80 129 Other **2** 4 6 9 15\n\nTotal consumer other **25** 33 65 89 144\n\nTotal consumer loans **145** 196 275 308 429\n\nTotal loans charged off **211** 308 508 715 1,822 Recoveries: Commercial, financial and agricultural (a) **33** 39 63 50 87\n\nReal estate — commercial mortgage **4** 27 23 10 30 Real estate — construction **17** 14 5 27 44\n\nTotal commercial real estate loans (b) **21** 41 28 37 74 Commercial lease financing **10** 15 22 25 25\n\nTotal commercial loans **64** 95 113 112 186 Real estate — residential mortgage **2** 2 3 3 2 Home equity: Key Community Bank **9** 10 11 11 7 Other **5** 6 5 4 3\n\nTotal home equity loans **14** 16 16 15 10 Consumer other — Key Community Bank **6** 7 6 8 7 Credit cards **1** 3 — — — Consumer other: Marine **9** 15 22 32 43 Other **2** 2 3 4 4\n\nTotal consumer other **11** 17 25 36 47\n\nTotal consumer loans **34** 45 50 62 66\n\nTotal recoveries **98** 140 163 174 252\n\nNet loans charged off **(113)** (168) (345) (541) (1,570) Provision (credit) for loan and lease losses **59** 130 229 (60) 638 Foreign currency translation adjustment **—** (2) — 1 2\n\nAllowance for loan and lease losses at end of year **$ 794** $ 848 $ 888 $ 1,004 $ 1,604\n\nLiability for credit losses on lending-related commitments at beginning of the year **$ 37** $ 29 $ 45 $ 73 $ 121 Provision (credit) for losses on lending-related commitments **(1)** 8 (16) (28) (48)\n\nLiability for credit losses on lending-related commitments at end of the year (c) **$ 36** $ 37 $ 29 $ 45 $ 73\n\nTotal allowance for credit losses at end of the year **$ 830** $ 885 $ 917 $ 1,049 $ 1,677\n\nNet loan charge-offs to average loans **.20 %** .32 % .69 % 1.11 % 2.91 % Allowance for loan and lease losses to period-end loans **1\\.38** 1\\.56 1.68 2.03 3.20 Allowance for credit losses to period-end loans **1\\.45** 1\\.63 1.74 2.12 3.35 Allowance for loan and lease losses to nonperforming loans **190\\.0** 166\\.9 131.8 138.1 150.2 Allowance for credit losses to nonperforming loans **198\\.6** 174\\.2 136.1 144.3 157.0\n\nDiscontinued operations — education lending business: Loans charged off **$ 45** $ 55 $ 75 $ 138 $ 129 Recoveries **14** 18 17 15 8\n\nNet loan charge-offs **$ (31)** $ (37) $ (58) $ (123) $ (121)\n\n90","pages":[{"line_numbers":[],"markdown":"**Figure 39. Summary of Loan and Lease Loss Experience from Continuing Operations**\n\n**Year ended December 31,** _dollars in millions_ **2014 2013 2012 2011 2010** Average loans outstanding **$55,679** $53,054 $50,362 $48,606 $53,971\n\nAllowance for loan and lease losses at beginning of period **$ 848** $ 888 $ 1,004 $ 1,604 $ 2,534 Loans charged off: Commercial, financial and agricultural (a) **45** 62 80 169 565\n\nReal estate — commercial mortgage **6** 20 102 113 360 Real estate — construction **5** 3 24 83 380\n\nTotal commercial real estate loans (b) **11** 23 126 196 740 Commercial lease financing **10** 27 27 42 88\n\nTotal commercial loans **66** 112 233 407 1,393 Real estate — residential mortgage **10** 20 27 29 36 Home equity: Key Community Bank **37** 62 99 100 123 Other **9** 20 35 45 62\n\nTotal home equity loans **46** 82 134 145 185 Consumer other — Key Community Bank **30** 31 38 45 64 Credit cards **34** 30 11 — — Consumer other: Marine **23** 29 59 80 129 Other **2** 4 6 9 15\n\nTotal consumer other **25** 33 65 89 144\n\nTotal consumer loans **145** 196 275 308 429\n\nTotal loans charged off **211** 308 508 715 1,822 Recoveries: Commercial, financial and agricultural (a) **33** 39 63 50 87\n\nReal estate — commercial mortgage **4** 27 23 10 30 Real estate — construction **17** 14 5 27 44\n\nTotal commercial real estate loans (b) **21** 41 28 37 74 Commercial lease financing **10** 15 22 25 25\n\nTotal commercial loans **64** 95 113 112 186 Real estate — residential mortgage **2** 2 3 3 2 Home equity: Key Community Bank **9** 10 11 11 7 Other **5** 6 5 4 3\n\nTotal home equity loans **14** 16 16 15 10 Consumer other — Key Community Bank **6** 7 6 8 7 Credit cards **1** 3 — — — Consumer other: Marine **9** 15 22 32 43 Other **2** 2 3 4 4\n\nTotal consumer other **11** 17 25 36 47\n\nTotal consumer loans **34** 45 50 62 66\n\nTotal recoveries **98** 140 163 174 252\n\nNet loans charged off **(113)** (168) (345) (541) (1,570) Provision (credit) for loan and lease losses **59** 130 229 (60) 638 Foreign currency translation adjustment **—** (2) — 1 2\n\nAllowance for loan and lease losses at end of year **$ 794** $ 848 $ 888 $ 1,004 $ 1,604\n\nLiability for credit losses on lending-related commitments at beginning of the year **$ 37** $ 29 $ 45 $ 73 $ 121 Provision (credit) for losses on lending-related commitments **(1)** 8 (16) (28) (48)\n\nLiability for credit losses on lending-related commitments at end of the year (c) **$ 36** $ 37 $ 29 $ 45 $ 73\n\nTotal allowance for credit losses at end of the year **$ 830** $ 885 $ 917 $ 1,049 $ 1,677\n\nNet loan charge-offs to average loans **.20 %** .32 % .69 % 1.11 % 2.91 % Allowance for loan and lease losses to period-end loans **1\\.38** 1\\.56 1.68 2.03 3.20 Allowance for credit losses to period-end loans **1\\.45** 1\\.63 1.74 2.12 3.35 Allowance for loan and lease losses to nonperforming loans **190\\.0** 166\\.9 131.8 138.1 150.2 Allowance for credit losses to nonperforming loans **198\\.6** 174\\.2 136.1 144.3 157.0\n\nDiscontinued operations — education lending business: Loans charged off **$ 45** $ 55 $ 75 $ 138 $ 129 Recoveries **14** 18 17 15 8\n\nNet loan charge-offs **$ (31)** $ (37) $ (58) $ (123) $ (121)\n\n90","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Figure 39. Summary of Loan and Lease Loss Experience from Continuing Operations**\n\n**Year ended December 31,** _dollars in millions_ **2014 2013 2012 2011 2010** Average loans outstanding **$55,679** $53,054 $50,362 $48,606 $53,971\n\nAllowance for loan and lease losses at beginning of period **$ 848** $ 888 $ 1,004 $ 1,604 $ 2,534 Loans charged off: Commercial, financial and agricultural (a) **45** 62 80 169 565\n\nReal estate — commercial mortgage **6** 20 102 113 360 Real estate — construction **5** 3 24 83 380\n\nTotal commercial real estate loans (b) **11** 23 126 196 740 Commercial lease financing **10** 27 27 42 88\n\nTotal commercial loans **66** 112 233 407 1,393 Real estate — residential mortgage **10** 20 27 29 36 Home equity: Key Community Bank **37** 62 99 100 123 Other **9** 20 35 45 62\n\nTotal home equity loans **46** 82 134 145 185 Consumer other — Key Community Bank **30** 31 38 45 64 Credit cards **34** 30 11 — — Consumer other: Marine **23** 29 59 80 129 Other **2** 4 6 9 15\n\nTotal consumer other **25** 33 65 89 144\n\nTotal consumer loans **145** 196 275 308 429\n\nTotal loans charged off **211** 308 508 715 1,822 Recoveries: Commercial, financial and agricultural (a) **33** 39 63 50 87\n\nReal estate — commercial mortgage **4** 27 23 10 30 Real estate — construction **17** 14 5 27 44\n\nTotal commercial real estate loans (b) **21** 41 28 37 74 Commercial lease financing **10** 15 22 25 25\n\nTotal commercial loans **64** 95 113 112 186 Real estate — residential mortgage **2** 2 3 3 2 Home equity: Key Community Bank **9** 10 11 11 7 Other **5** 6 5 4 3\n\nTotal home equity loans **14** 16 16 15 10 Consumer other — Key Community Bank **6** 7 6 8 7 Credit cards **1** 3 — — — Consumer other: Marine **9** 15 22 32 43 Other **2** 2 3 4 4\n\nTotal consumer other **11** 17 25 36 47\n\nTotal consumer loans **34** 45 50 62 66\n\nTotal recoveries **98** 140 163 174 252\n\nNet loans charged off **(113)** (168) (345) (541) (1,570) Provision (credit) for loan and lease losses **59** 130 229 (60) 638 Foreign currency translation adjustment **—** (2) — 1 2\n\nAllowance for loan and lease losses at end of year **$ 794** $ 848 $ 888 $ 1,004 $ 1,604\n\nLiability for credit losses on lending-related commitments at beginning of the year **$ 37** $ 29 $ 45 $ 73 $ 121 Provision (credit) for losses on lending-related commitments **(1)** 8 (16) (28) (48)\n\nLiability for credit losses on lending-related commitments at end of the year (c) **$ 36** $ 37 $ 29 $ 45 $ 73\n\nTotal allowance for credit losses at end of the year **$ 830** $ 885 $ 917 $ 1,049 $ 1,677\n\nNet loan charge-offs to average loans **.20 %** .32 % .69 % 1.11 % 2.91 % Allowance for loan and lease losses to period-end loans **1\\.38** 1\\.56 1.68 2.03 3.20 Allowance for credit losses to period-end loans **1\\.45** 1\\.63 1.74 2.12 3.35 Allowance for loan and lease losses to nonperforming loans **190\\.0** 166\\.9 131.8 138.1 150.2 Allowance for credit losses to nonperforming loans **198\\.6** 174\\.2 136.1 144.3 157.0\n\nDiscontinued operations — education lending business: Loans charged off **$ 45** $ 55 $ 75 $ 138 $ 129 Recoveries **14** 18 17 15 8\n\nNet loan charge-offs **$ (31)** $ (37) $ (58) $ (123) $ (121)\n\n90","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/KEY.2014.page_103.pdf_98246_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_a4130c810a345d4f63ab54511a65bc48","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Figure 39. Summary of Loan and Lease Loss Experience from Continuing Operations**\n\n**Year ended December 31,** _dollars in millions_ **2014 2013 2012 2011 2010** Average loans outstanding **$55,679** $53,054 $50,362 $48,606 $53,971\n\nAllowance for loan and lease losses at beginning of period **$ 848** $ 888 $ 1,004 $ 1,604 $ 2,534 Loans charged off: Commercial, financial and agricultural (a) **45** 62 80 169 565\n\nReal estate — commercial mortgage **6** 20 102 113 360 Real estate — construction **5** 3 24 83 380\n\nTotal commercial real estate loans (b) **11** 23 126 196 740 Commercial lease financing **10** 27 27 42 88\n\nTotal commercial loans **66** 112 233 407 1,393 Real estate — residential mortgage **10** 20 27 29 36 Home equity: Key Community Bank **37** 62 99 100 123 Other **9** 20 35 45 62\n\nTotal home equity loans **46** 82 134 145 185 Consumer other — Key Community Bank **30** 31 38 45 64 Credit cards **34** 30 11 — — Consumer other: Marine **23** 29 59 80 129 Other **2** 4 6 9 15\n\nTotal consumer other **25** 33 65 89 144\n\nTotal consumer loans **145** 196 275 308 429\n\nTotal loans charged off **211** 308 508 715 1,822 Recoveries: Commercial, financial and agricultural (a) **33** 39 63 50 87\n\nReal estate — commercial mortgage **4** 27 23 10 30 Real estate — construction **17** 14 5 27 44\n\nTotal commercial real estate loans (b) **21** 41 28 37 74 Commercial lease financing **10** 15 22 25 25\n\nTotal commercial loans **64** 95 113 112 186 Real estate — residential mortgage **2** 2 3 3 2 Home equity: Key Community Bank **9** 10 11 11 7 Other **5** 6 5 4 3\n\nTotal home equity loans **14** 16 16 15 10 Consumer other — Key Community Bank **6** 7 6 8 7 Credit cards **1** 3 — — — Consumer other: Marine **9** 15 22 32 43 Other **2** 2 3 4 4\n\nTotal consumer other **11** 17 25 36 47\n\nTotal consumer loans **34** 45 50 62 66\n\nTotal recoveries **98** 140 163 174 252\n\nNet loans charged off **(113)** (168) (345) (541) (1,570) Provision (credit) for loan and lease losses **59** 130 229 (60) 638 Foreign currency translation adjustment **—** (2) — 1 2\n\nAllowance for loan and lease losses at end of year **$ 794** $ 848 $ 888 $ 1,004 $ 1,604\n\nLiability for credit losses on lending-related commitments at beginning of the year **$ 37** $ 29 $ 45 $ 73 $ 121 Provision (credit) for losses on lending-related commitments **(1)** 8 (16) (28) (48)\n\nLiability for credit losses on lending-related commitments at end of the year (c) **$ 36** $ 37 $ 29 $ 45 $ 73\n\nTotal allowance for credit losses at end of the year **$ 830** $ 885 $ 917 $ 1,049 $ 1,677\n\nNet loan charge-offs to average loans **.20 %** .32 % .69 % 1.11 % 2.91 % Allowance for loan and lease losses to period-end loans **1\\.38** 1\\.56 1.68 2.03 3.20 Allowance for credit losses to period-end loans **1\\.45** 1\\.63 1.74 2.12 3.35 Allowance for loan and lease losses to nonperforming loans **190\\.0** 166\\.9 131.8 138.1 150.2 Allowance for credit losses to nonperforming loans **198\\.6** 174\\.2 136.1 144.3 157.0\n\nDiscontinued operations — education lending business: Loans charged off **$ 45** $ 55 $ 75 $ 138 $ 129 Recoveries **14** 18 17 15 8\n\nNet loan charge-offs **$ (31)** $ (37) $ (58) $ (123) $ (121)\n\n90"],"full_content":"**Figure 39. Summary of Loan and Lease Loss Experience from Continuing Operations**\n\n**Year ended December 31,** _dollars in millions_ **2014 2013 2012 2011 2010** Average loans outstanding **$55,679** $53,054 $50,362 $48,606 $53,971\n\nAllowance for loan and lease losses at beginning of period **$ 848** $ 888 $ 1,004 $ 1,604 $ 2,534 Loans charged off: Commercial, financial and agricultural (a) **45** 62 80 169 565\n\nReal estate — commercial mortgage **6** 20 102 113 360 Real estate — construction **5** 3 24 83 380\n\nTotal commercial real estate loans (b) **11** 23 126 196 740 Commercial lease financing **10** 27 27 42 88\n\nTotal commercial loans **66** 112 233 407 1,393 Real estate — residential mortgage **10** 20 27 29 36 Home equity: Key Community Bank **37** 62 99 100 123 Other **9** 20 35 45 62\n\nTotal home equity loans **46** 82 134 145 185 Consumer other — Key Community Bank **30** 31 38 45 64 Credit cards **34** 30 11 — — Consumer other: Marine **23** 29 59 80 129 Other **2** 4 6 9 15\n\nTotal consumer other **25** 33 65 89 144\n\nTotal consumer loans **145** 196 275 308 429\n\nTotal loans charged off **211** 308 508 715 1,822 Recoveries: Commercial, financial and agricultural (a) **33** 39 63 50 87\n\nReal estate — commercial mortgage **4** 27 23 10 30 Real estate — construction **17** 14 5 27 44\n\nTotal commercial real estate loans (b) **21** 41 28 37 74 Commercial lease financing **10** 15 22 25 25\n\nTotal commercial loans **64** 95 113 112 186 Real estate — residential mortgage **2** 2 3 3 2 Home equity: Key Community Bank **9** 10 11 11 7 Other **5** 6 5 4 3\n\nTotal home equity loans **14** 16 16 15 10 Consumer other — Key Community Bank **6** 7 6 8 7 Credit cards **1** 3 — — — Consumer other: Marine **9** 15 22 32 43 Other **2** 2 3 4 4\n\nTotal consumer other **11** 17 25 36 47\n\nTotal consumer loans **34** 45 50 62 66\n\nTotal recoveries **98** 140 163 174 252\n\nNet loans charged off **(113)** (168) (345) (541) (1,570) Provision (credit) for loan and lease losses **59** 130 229 (60) 638 Foreign currency translation adjustment **—** (2) — 1 2\n\nAllowance for loan and lease losses at end of year **$ 794** $ 848 $ 888 $ 1,004 $ 1,604\n\nLiability for credit losses on lending-related commitments at beginning of the year **$ 37** $ 29 $ 45 $ 73 $ 121 Provision (credit) for losses on lending-related commitments **(1)** 8 (16) (28) (48)\n\nLiability for credit losses on lending-related commitments at end of the year (c) **$ 36** $ 37 $ 29 $ 45 $ 73\n\nTotal allowance for credit losses at end of the year **$ 830** $ 885 $ 917 $ 1,049 $ 1,677\n\nNet loan charge-offs to average loans **.20 %** .32 % .69 % 1.11 % 2.91 % Allowance for loan and lease losses to period-end loans **1\\.38** 1\\.56 1.68 2.03 3.20 Allowance for credit losses to period-end loans **1\\.45** 1\\.63 1.74 2.12 3.35 Allowance for loan and lease losses to nonperforming loans **190\\.0** 166\\.9 131.8 138.1 150.2 Allowance for credit losses to nonperforming loans **198\\.6** 174\\.2 136.1 144.3 157.0\n\nDiscontinued operations — education lending business: Loans charged off **$ 45** $ 55 $ 75 $ 138 $ 129 Recoveries **14** 18 17 15 8\n\nNet loan charge-offs **$ (31)** $ (37) $ (58) $ (123) $ (121)\n\n90","publish_date":null,"title":"Figure39.SummaryofLoanandLeaseLossExperiencefromContinuingOperations 90","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/KEY.2014.page_103.pdf_98246_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/KEY.2014.page_103.pdf_98246_page1.pdf"},"request":{"example_id":"table/KEY.2014.page_103.pdf_98246_page1","product_type":"parse","source_file_path":"KEY.2014.page_103.pdf_98246_page1.pdf"},"started_at":"2026-11-04T19:47:53.384783"} +{"completed_at":"2026-11-04T19:47:57.735538","latency_in_ms":3348,"output":{"example_id":"table/Kimco-Realty-2023-Annual-Report-Web_page11","grounded_pages":[],"layout_pages":[],"markdown":"**UNITED STATES** **SECURITIES AND EXCHANGE COMMISSION** **Washington, D.C. 20549** **FORM 10-K**\n\n☑ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** **For the fiscal year ended December 31, 2023** **OR**\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** **For the transition period from to**\n\n**Commission file number 1-10899** ‐‐‐‐ **(Kimco Realty Corporation)** **Commission file number 333-269102-01 (Kimco Realty OP, LLC)**\n\n**KIMCO REALTY CORPORATION**\n\n**KIMCO REALTY OP, LLC**\n\n(Exact name of registrant as specified in its charter)\n\n**Maryland (Kimco Realty Corporation)** **Delaware (Kimco Realty OP, LLC)** **13-2744380** **92-1489725**\n\n(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)\n\n**500 North Broadway, Suite 201, Jericho, NY 11753** (Address of principal executive offices) (Zip Code) **(516) 869-9000**\n\n(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: **Kimco Realty Corporation** Title of each class Trading Symbol(s) Name of each exchange on which registered\n\nCommon Stock, par value $.01 per share. KIM New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 5.125% Class L Cumulative Redeemable Preferred Stock, $1.00 par value per share. KIMprL New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 5.250% Class M Cumulative Redeemable Preferred Stock, $1.00 par value per share. KIMprM New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 7.250% Class N Cumulative Convertible Preferred Stock, $1.00 par value per share. KIMprN New York Stock Exchange\n\n**Kimco Realty OP, LLC**\n\nTitle of each class Trading Symbol(s) Name of each exchange on which registered\n\nNone N/A N/A\n\nSecurities registered pursuant to section 12(g) of the Act: None\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐\n\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. **Kimco Realty Corporation** Yes ☐ No ☑ **Kimco Realty OP, LLC** Yes ☐ No ☑ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. **Kimco Realty Corporation:** Large accelerated filer ☑ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐\n\n**Kimco Realty OP, LLC:** Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☑ Smaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. **Kimco Realty Corporation** ☑ **Kimco Realty OP, LLC** ☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). **Kimco Realty Corporation** Yes ☐ No ☑ **Kimco Realty OP, LLC** Yes ☐ No ☑ The aggregate market value of the voting and non-voting common equity held by non-affiliates of Kimco Realty Corporation was approximately $12.0 billion based upon the closing price on the New York Stock Exchange for such equity on June 30, 2023. (APPLICABLE ONLY TO CORPORATE REGISTRANTS) Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date. As of February 9, 2024, Kimco Realty Corporation had 672,904,480 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates certain information by reference to the Kimco Realty Corporation's definitive proxy statement to be filed with respect to the Annual Meeting of Stockholders expected to be held on May 7, 2024.\n\nIndex to Exhibits begins on page 53.","pages":[{"line_numbers":[],"markdown":"**UNITED STATES** **SECURITIES AND EXCHANGE COMMISSION** **Washington, D.C. 20549** **FORM 10-K**\n\n☑ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** **For the fiscal year ended December 31, 2023** **OR**\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** **For the transition period from to**\n\n**Commission file number 1-10899** ‐‐‐‐ **(Kimco Realty Corporation)** **Commission file number 333-269102-01 (Kimco Realty OP, LLC)**\n\n**KIMCO REALTY CORPORATION**\n\n**KIMCO REALTY OP, LLC**\n\n(Exact name of registrant as specified in its charter)\n\n**Maryland (Kimco Realty Corporation)** **Delaware (Kimco Realty OP, LLC)** **13-2744380** **92-1489725**\n\n(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)\n\n**500 North Broadway, Suite 201, Jericho, NY 11753** (Address of principal executive offices) (Zip Code) **(516) 869-9000**\n\n(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: **Kimco Realty Corporation** Title of each class Trading Symbol(s) Name of each exchange on which registered\n\nCommon Stock, par value $.01 per share. KIM New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 5.125% Class L Cumulative Redeemable Preferred Stock, $1.00 par value per share. KIMprL New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 5.250% Class M Cumulative Redeemable Preferred Stock, $1.00 par value per share. KIMprM New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 7.250% Class N Cumulative Convertible Preferred Stock, $1.00 par value per share. KIMprN New York Stock Exchange\n\n**Kimco Realty OP, LLC**\n\nTitle of each class Trading Symbol(s) Name of each exchange on which registered\n\nNone N/A N/A\n\nSecurities registered pursuant to section 12(g) of the Act: None\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐\n\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. **Kimco Realty Corporation** Yes ☐ No ☑ **Kimco Realty OP, LLC** Yes ☐ No ☑ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. **Kimco Realty Corporation:** Large accelerated filer ☑ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐\n\n**Kimco Realty OP, LLC:** Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☑ Smaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. **Kimco Realty Corporation** ☑ **Kimco Realty OP, LLC** ☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). **Kimco Realty Corporation** Yes ☐ No ☑ **Kimco Realty OP, LLC** Yes ☐ No ☑ The aggregate market value of the voting and non-voting common equity held by non-affiliates of Kimco Realty Corporation was approximately $12.0 billion based upon the closing price on the New York Stock Exchange for such equity on June 30, 2023. (APPLICABLE ONLY TO CORPORATE REGISTRANTS) Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date. As of February 9, 2024, Kimco Realty Corporation had 672,904,480 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates certain information by reference to the Kimco Realty Corporation's definitive proxy statement to be filed with respect to the Annual Meeting of Stockholders expected to be held on May 7, 2024.\n\nIndex to Exhibits begins on page 53.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**UNITED STATES** **SECURITIES AND EXCHANGE COMMISSION** **Washington, D.C. 20549** **FORM 10-K**\n\n☑ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** **For the fiscal year ended December 31, 2023** **OR**\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** **For the transition period from to**\n\n**Commission file number 1-10899** ‐‐‐‐ **(Kimco Realty Corporation)** **Commission file number 333-269102-01 (Kimco Realty OP, LLC)**\n\n**KIMCO REALTY CORPORATION**\n\n**KIMCO REALTY OP, LLC**\n\n(Exact name of registrant as specified in its charter)\n\n**Maryland (Kimco Realty Corporation)** **Delaware (Kimco Realty OP, LLC)** **13-2744380** **92-1489725**\n\n(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)\n\n**500 North Broadway, Suite 201, Jericho, NY 11753** (Address of principal executive offices) (Zip Code) **(516) 869-9000**\n\n(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: **Kimco Realty Corporation** Title of each class Trading Symbol(s) Name of each exchange on which registered\n\nCommon Stock, par value $.01 per share. KIM New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 5.125% Class L Cumulative Redeemable Preferred Stock, $1.00 par value per share. KIMprL New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 5.250% Class M Cumulative Redeemable Preferred Stock, $1.00 par value per share. KIMprM New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 7.250% Class N Cumulative Convertible Preferred Stock, $1.00 par value per share. KIMprN New York Stock Exchange\n\n**Kimco Realty OP, LLC**\n\nTitle of each class Trading Symbol(s) Name of each exchange on which registered\n\nNone N/A N/A\n\nSecurities registered pursuant to section 12(g) of the Act: None\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐\n\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. **Kimco Realty Corporation** Yes ☐ No ☑ **Kimco Realty OP, LLC** Yes ☐ No ☑ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. **Kimco Realty Corporation:** Large accelerated filer ☑ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐\n\n**Kimco Realty OP, LLC:** Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☑ Smaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. **Kimco Realty Corporation** ☑ **Kimco Realty OP, LLC** ☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). **Kimco Realty Corporation** Yes ☐ No ☑ **Kimco Realty OP, LLC** Yes ☐ No ☑ The aggregate market value of the voting and non-voting common equity held by non-affiliates of Kimco Realty Corporation was approximately $12.0 billion based upon the closing price on the New York Stock Exchange for such equity on June 30, 2023. (APPLICABLE ONLY TO CORPORATE REGISTRANTS) Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date. As of February 9, 2024, Kimco Realty Corporation had 672,904,480 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates certain information by reference to the Kimco Realty Corporation's definitive proxy statement to be filed with respect to the Annual Meeting of Stockholders expected to be held on May 7, 2024.\n\nIndex to Exhibits begins on page 53.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Kimco-Realty-2023-Annual-Report-Web_page11.pdf"]},"response":{"errors":[],"extract_id":"extract_f9b7ac7a8cda1393bb972bd7b28e5a69","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**UNITED STATES** **SECURITIES AND EXCHANGE COMMISSION** **Washington, D.C. 20549** **FORM 10-K**\n\n☑ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** **For the fiscal year ended December 31, 2023** **OR**\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** **For the transition period from to**\n\n**Commission file number 1-10899** ‐‐‐‐ **(Kimco Realty Corporation)** **Commission file number 333-269102-01 (Kimco Realty OP, LLC)**\n\n**KIMCO REALTY CORPORATION**\n\n**KIMCO REALTY OP, LLC**\n\n(Exact name of registrant as specified in its charter)\n\n**Maryland (Kimco Realty Corporation)** **Delaware (Kimco Realty OP, LLC)** **13-2744380** **92-1489725**\n\n(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)\n\n**500 North Broadway, Suite 201, Jericho, NY 11753** (Address of principal executive offices) (Zip Code) **(516) 869-9000**\n\n(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: **Kimco Realty Corporation** Title of each class Trading Symbol(s) Name of each exchange on which registered\n\nCommon Stock, par value $.01 per share. KIM New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 5.125% Class L Cumulative Redeemable Preferred Stock, $1.00 par value per share. KIMprL New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 5.250% Class M Cumulative Redeemable Preferred Stock, $1.00 par value per share. KIMprM New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 7.250% Class N Cumulative Convertible Preferred Stock, $1.00 par value per share. KIMprN New York Stock Exchange\n\n**Kimco Realty OP, LLC**\n\nTitle of each class Trading Symbol(s) Name of each exchange on which registered\n\nNone N/A N/A\n\nSecurities registered pursuant to section 12(g) of the Act: None\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐\n\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. **Kimco Realty Corporation** Yes ☐ No ☑ **Kimco Realty OP, LLC** Yes ☐ No ☑ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. **Kimco Realty Corporation:** Large accelerated filer ☑ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐\n\n**Kimco Realty OP, LLC:** Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☑ Smaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. **Kimco Realty Corporation** ☑ **Kimco Realty OP, LLC** ☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). **Kimco Realty Corporation** Yes ☐ No ☑ **Kimco Realty OP, LLC** Yes ☐ No ☑ The aggregate market value of the voting and non-voting common equity held by non-affiliates of Kimco Realty Corporation was approximately $12.0 billion based upon the closing price on the New York Stock Exchange for such equity on June 30, 2023. (APPLICABLE ONLY TO CORPORATE REGISTRANTS) Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date. As of February 9, 2024, Kimco Realty Corporation had 672,904,480 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates certain information by reference to the Kimco Realty Corporation's definitive proxy statement to be filed with respect to the Annual Meeting of Stockholders expected to be held on May 7, 2024.\n\nIndex to Exhibits begins on page 53."],"full_content":"**UNITED STATES** **SECURITIES AND EXCHANGE COMMISSION** **Washington, D.C. 20549** **FORM 10-K**\n\n☑ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** **For the fiscal year ended December 31, 2023** **OR**\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** **For the transition period from to**\n\n**Commission file number 1-10899** ‐‐‐‐ **(Kimco Realty Corporation)** **Commission file number 333-269102-01 (Kimco Realty OP, LLC)**\n\n**KIMCO REALTY CORPORATION**\n\n**KIMCO REALTY OP, LLC**\n\n(Exact name of registrant as specified in its charter)\n\n**Maryland (Kimco Realty Corporation)** **Delaware (Kimco Realty OP, LLC)** **13-2744380** **92-1489725**\n\n(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)\n\n**500 North Broadway, Suite 201, Jericho, NY 11753** (Address of principal executive offices) (Zip Code) **(516) 869-9000**\n\n(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: **Kimco Realty Corporation** Title of each class Trading Symbol(s) Name of each exchange on which registered\n\nCommon Stock, par value $.01 per share. KIM New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 5.125% Class L Cumulative Redeemable Preferred Stock, $1.00 par value per share. KIMprL New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 5.250% Class M Cumulative Redeemable Preferred Stock, $1.00 par value per share. KIMprM New York Stock Exchange\n\nDepositary Shares, each representing one-thousandth of a share of 7.250% Class N Cumulative Convertible Preferred Stock, $1.00 par value per share. KIMprN New York Stock Exchange\n\n**Kimco Realty OP, LLC**\n\nTitle of each class Trading Symbol(s) Name of each exchange on which registered\n\nNone N/A N/A\n\nSecurities registered pursuant to section 12(g) of the Act: None\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐\n\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. **Kimco Realty Corporation** Yes ☐ No ☑ **Kimco Realty OP, LLC** Yes ☐ No ☑ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). **Kimco Realty Corporation** Yes ☑ No ☐ **Kimco Realty OP, LLC** Yes ☑ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. **Kimco Realty Corporation:** Large accelerated filer ☑ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐\n\n**Kimco Realty OP, LLC:** Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☑ Smaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. **Kimco Realty Corporation** ☑ **Kimco Realty OP, LLC** ☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). **Kimco Realty Corporation** ☐ **Kimco Realty OP, LLC** ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). **Kimco Realty Corporation** Yes ☐ No ☑ **Kimco Realty OP, LLC** Yes ☐ No ☑ The aggregate market value of the voting and non-voting common equity held by non-affiliates of Kimco Realty Corporation was approximately $12.0 billion based upon the closing price on the New York Stock Exchange for such equity on June 30, 2023. (APPLICABLE ONLY TO CORPORATE REGISTRANTS) Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date. As of February 9, 2024, Kimco Realty Corporation had 672,904,480 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates certain information by reference to the Kimco Realty Corporation's definitive proxy statement to be filed with respect to the Annual Meeting of Stockholders expected to be held on May 7, 2024.\n\nIndex to Exhibits begins on page 53.","publish_date":null,"title":"KIMCO REALTY OP, LLC — FORM 10-K, fiscal year ended December 31, 2023","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Kimco-Realty-2023-Annual-Report-Web_page11.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Kimco-Realty-2023-Annual-Report-Web_page11.pdf"},"request":{"example_id":"table/Kimco-Realty-2023-Annual-Report-Web_page11","product_type":"parse","source_file_path":"Kimco-Realty-2023-Annual-Report-Web_page11.pdf"},"started_at":"2026-11-04T19:47:54.386772"} +{"completed_at":"2026-11-04T19:47:56.515516","latency_in_ms":1287,"output":{"example_id":"table/Kimco-Realty-2023-Annual-Report-Web_page41","grounded_pages":[],"layout_pages":[],"markdown":"27\n\nThe Company has a total of 8,413 leases in the consolidated operating portfolio. The following table sets forth the aggregate lease expirations for each of the next ten years, assuming no renewal options are exercised. For purposes of the table, the Total Annual Base Rent Expiring represents annualized rental revenue, excluding the impact of straight-line rent, for each lease that expires during the respective year. Amounts in thousands, except for number of leases data: **Year Ending** **December 31,** **Number of Leases** **Expiring** **Square Feet** **Expiring** **Total Annual Base** **Rent Expiring** **% of Gross** **Annual Rent**\n\n(1) 115 381 $ 9,741 0.7 %\n\n2024 814 3,965 $ 85,798 6.6 %\n\n2025 1,167 7,756 $ 150,601 11.6 %\n\n2026 1,150 9,600 $ 164,580 12.7 %\n\n2027 1,178 9,559 $ 177,095 13.6 %\n\n2028 1,218 10,467 $ 200,255 15.4 %\n\n2029 796 7,299 $ 130,729 10.1 %\n\n2030 368 2,903 $ 65,229 5.0 %\n\n2031 355 2,350 $ 54,949 4.2 %\n\n2032 381 2,717 $ 54,113 4.2 %\n\n2033 411 3,209 $ 61,773 4.8 %\n\n(1) Leases currently under a month-to-month lease or in process of renewal.\n\nDuring 2023, the Company executed 1,620 leases totaling 11.1 million square feet in the Company’s consolidated operating portfolio comprised of 500 new leases and 1,120 renewals and options. The leasing costs associated with these new leases are estimated to aggregate $119.5 million or $39.74 per square foot. These costs include $93.9 million of tenant improvements and $25.6 million of external leasing commissions. The average rent per square foot for (i) new leases was $21.41 and (ii) renewals and options was $19.20. The Company will seek to obtain rents that are higher than amounts within its expiring leases, however, there are many variables and uncertainties which can significantly affect the leasing market at any time; as such, the Company cannot guarantee that future leases will continue to be signed for rents that are equal to or higher than current amounts. _Ground-Leased Properties_ . The Company has interests in 38 consolidated shopping center properties that are subject to long-term ground leases where a third party owns and has leased the underlying land to the Company to construct and/or operate a shopping center. The Company pays rent for the use of the land and generally is responsible for all costs and expenses associated with the building and improvements. At the end of these long-term leases, unless extended, the land together with all improvements reverts to the landowner. More specific information with respect to each of the Company's property interests is set forth in Exhibit 99.1, which is incorporated herein by reference. Item 3. Legal Proceedings The Company is not presently involved in any litigation nor, to its knowledge, is any litigation threatened against the Company or its subsidiaries that, in management's opinion, would result in any material effect on the Company's ownership, management or operation of its properties taken as a whole, or which is not covered by the Company's insurance. Item 4. Mine Safety Disclosures Not applicable.","pages":[{"line_numbers":[],"markdown":"27\n\nThe Company has a total of 8,413 leases in the consolidated operating portfolio. The following table sets forth the aggregate lease expirations for each of the next ten years, assuming no renewal options are exercised. For purposes of the table, the Total Annual Base Rent Expiring represents annualized rental revenue, excluding the impact of straight-line rent, for each lease that expires during the respective year. Amounts in thousands, except for number of leases data: **Year Ending** **December 31,** **Number of Leases** **Expiring** **Square Feet** **Expiring** **Total Annual Base** **Rent Expiring** **% of Gross** **Annual Rent**\n\n(1) 115 381 $ 9,741 0.7 %\n\n2024 814 3,965 $ 85,798 6.6 %\n\n2025 1,167 7,756 $ 150,601 11.6 %\n\n2026 1,150 9,600 $ 164,580 12.7 %\n\n2027 1,178 9,559 $ 177,095 13.6 %\n\n2028 1,218 10,467 $ 200,255 15.4 %\n\n2029 796 7,299 $ 130,729 10.1 %\n\n2030 368 2,903 $ 65,229 5.0 %\n\n2031 355 2,350 $ 54,949 4.2 %\n\n2032 381 2,717 $ 54,113 4.2 %\n\n2033 411 3,209 $ 61,773 4.8 %\n\n(1) Leases currently under a month-to-month lease or in process of renewal.\n\nDuring 2023, the Company executed 1,620 leases totaling 11.1 million square feet in the Company’s consolidated operating portfolio comprised of 500 new leases and 1,120 renewals and options. The leasing costs associated with these new leases are estimated to aggregate $119.5 million or $39.74 per square foot. These costs include $93.9 million of tenant improvements and $25.6 million of external leasing commissions. The average rent per square foot for (i) new leases was $21.41 and (ii) renewals and options was $19.20. The Company will seek to obtain rents that are higher than amounts within its expiring leases, however, there are many variables and uncertainties which can significantly affect the leasing market at any time; as such, the Company cannot guarantee that future leases will continue to be signed for rents that are equal to or higher than current amounts. _Ground-Leased Properties_ . The Company has interests in 38 consolidated shopping center properties that are subject to long-term ground leases where a third party owns and has leased the underlying land to the Company to construct and/or operate a shopping center. The Company pays rent for the use of the land and generally is responsible for all costs and expenses associated with the building and improvements. At the end of these long-term leases, unless extended, the land together with all improvements reverts to the landowner. More specific information with respect to each of the Company's property interests is set forth in Exhibit 99.1, which is incorporated herein by reference. Item 3. Legal Proceedings The Company is not presently involved in any litigation nor, to its knowledge, is any litigation threatened against the Company or its subsidiaries that, in management's opinion, would result in any material effect on the Company's ownership, management or operation of its properties taken as a whole, or which is not covered by the Company's insurance. Item 4. Mine Safety Disclosures Not applicable.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"27\n\nThe Company has a total of 8,413 leases in the consolidated operating portfolio. The following table sets forth the aggregate lease expirations for each of the next ten years, assuming no renewal options are exercised. For purposes of the table, the Total Annual Base Rent Expiring represents annualized rental revenue, excluding the impact of straight-line rent, for each lease that expires during the respective year. Amounts in thousands, except for number of leases data: **Year Ending** **December 31,** **Number of Leases** **Expiring** **Square Feet** **Expiring** **Total Annual Base** **Rent Expiring** **% of Gross** **Annual Rent**\n\n(1) 115 381 $ 9,741 0.7 %\n\n2024 814 3,965 $ 85,798 6.6 %\n\n2025 1,167 7,756 $ 150,601 11.6 %\n\n2026 1,150 9,600 $ 164,580 12.7 %\n\n2027 1,178 9,559 $ 177,095 13.6 %\n\n2028 1,218 10,467 $ 200,255 15.4 %\n\n2029 796 7,299 $ 130,729 10.1 %\n\n2030 368 2,903 $ 65,229 5.0 %\n\n2031 355 2,350 $ 54,949 4.2 %\n\n2032 381 2,717 $ 54,113 4.2 %\n\n2033 411 3,209 $ 61,773 4.8 %\n\n(1) Leases currently under a month-to-month lease or in process of renewal.\n\nDuring 2023, the Company executed 1,620 leases totaling 11.1 million square feet in the Company’s consolidated operating portfolio comprised of 500 new leases and 1,120 renewals and options. The leasing costs associated with these new leases are estimated to aggregate $119.5 million or $39.74 per square foot. These costs include $93.9 million of tenant improvements and $25.6 million of external leasing commissions. The average rent per square foot for (i) new leases was $21.41 and (ii) renewals and options was $19.20. The Company will seek to obtain rents that are higher than amounts within its expiring leases, however, there are many variables and uncertainties which can significantly affect the leasing market at any time; as such, the Company cannot guarantee that future leases will continue to be signed for rents that are equal to or higher than current amounts. _Ground-Leased Properties_ . The Company has interests in 38 consolidated shopping center properties that are subject to long-term ground leases where a third party owns and has leased the underlying land to the Company to construct and/or operate a shopping center. The Company pays rent for the use of the land and generally is responsible for all costs and expenses associated with the building and improvements. At the end of these long-term leases, unless extended, the land together with all improvements reverts to the landowner. More specific information with respect to each of the Company's property interests is set forth in Exhibit 99.1, which is incorporated herein by reference. Item 3. Legal Proceedings The Company is not presently involved in any litigation nor, to its knowledge, is any litigation threatened against the Company or its subsidiaries that, in management's opinion, would result in any material effect on the Company's ownership, management or operation of its properties taken as a whole, or which is not covered by the Company's insurance. Item 4. Mine Safety Disclosures Not applicable.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Kimco-Realty-2023-Annual-Report-Web_page41.pdf"]},"response":{"errors":[],"extract_id":"extract_00c520e7351b9ce059cab1d6efbfef88","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["27\n\nThe Company has a total of 8,413 leases in the consolidated operating portfolio. The following table sets forth the aggregate lease expirations for each of the next ten years, assuming no renewal options are exercised. For purposes of the table, the Total Annual Base Rent Expiring represents annualized rental revenue, excluding the impact of straight-line rent, for each lease that expires during the respective year. Amounts in thousands, except for number of leases data: **Year Ending** **December 31,** **Number of Leases** **Expiring** **Square Feet** **Expiring** **Total Annual Base** **Rent Expiring** **% of Gross** **Annual Rent**\n\n(1) 115 381 $ 9,741 0.7 %\n\n2024 814 3,965 $ 85,798 6.6 %\n\n2025 1,167 7,756 $ 150,601 11.6 %\n\n2026 1,150 9,600 $ 164,580 12.7 %\n\n2027 1,178 9,559 $ 177,095 13.6 %\n\n2028 1,218 10,467 $ 200,255 15.4 %\n\n2029 796 7,299 $ 130,729 10.1 %\n\n2030 368 2,903 $ 65,229 5.0 %\n\n2031 355 2,350 $ 54,949 4.2 %\n\n2032 381 2,717 $ 54,113 4.2 %\n\n2033 411 3,209 $ 61,773 4.8 %\n\n(1) Leases currently under a month-to-month lease or in process of renewal.\n\nDuring 2023, the Company executed 1,620 leases totaling 11.1 million square feet in the Company’s consolidated operating portfolio comprised of 500 new leases and 1,120 renewals and options. The leasing costs associated with these new leases are estimated to aggregate $119.5 million or $39.74 per square foot. These costs include $93.9 million of tenant improvements and $25.6 million of external leasing commissions. The average rent per square foot for (i) new leases was $21.41 and (ii) renewals and options was $19.20. The Company will seek to obtain rents that are higher than amounts within its expiring leases, however, there are many variables and uncertainties which can significantly affect the leasing market at any time; as such, the Company cannot guarantee that future leases will continue to be signed for rents that are equal to or higher than current amounts. _Ground-Leased Properties_ . The Company has interests in 38 consolidated shopping center properties that are subject to long-term ground leases where a third party owns and has leased the underlying land to the Company to construct and/or operate a shopping center. The Company pays rent for the use of the land and generally is responsible for all costs and expenses associated with the building and improvements. At the end of these long-term leases, unless extended, the land together with all improvements reverts to the landowner. More specific information with respect to each of the Company's property interests is set forth in Exhibit 99.1, which is incorporated herein by reference. Item 3. Legal Proceedings The Company is not presently involved in any litigation nor, to its knowledge, is any litigation threatened against the Company or its subsidiaries that, in management's opinion, would result in any material effect on the Company's ownership, management or operation of its properties taken as a whole, or which is not covered by the Company's insurance. Item 4. Mine Safety Disclosures Not applicable."],"full_content":"27\n\nThe Company has a total of 8,413 leases in the consolidated operating portfolio. The following table sets forth the aggregate lease expirations for each of the next ten years, assuming no renewal options are exercised. For purposes of the table, the Total Annual Base Rent Expiring represents annualized rental revenue, excluding the impact of straight-line rent, for each lease that expires during the respective year. Amounts in thousands, except for number of leases data: **Year Ending** **December 31,** **Number of Leases** **Expiring** **Square Feet** **Expiring** **Total Annual Base** **Rent Expiring** **% of Gross** **Annual Rent**\n\n(1) 115 381 $ 9,741 0.7 %\n\n2024 814 3,965 $ 85,798 6.6 %\n\n2025 1,167 7,756 $ 150,601 11.6 %\n\n2026 1,150 9,600 $ 164,580 12.7 %\n\n2027 1,178 9,559 $ 177,095 13.6 %\n\n2028 1,218 10,467 $ 200,255 15.4 %\n\n2029 796 7,299 $ 130,729 10.1 %\n\n2030 368 2,903 $ 65,229 5.0 %\n\n2031 355 2,350 $ 54,949 4.2 %\n\n2032 381 2,717 $ 54,113 4.2 %\n\n2033 411 3,209 $ 61,773 4.8 %\n\n(1) Leases currently under a month-to-month lease or in process of renewal.\n\nDuring 2023, the Company executed 1,620 leases totaling 11.1 million square feet in the Company’s consolidated operating portfolio comprised of 500 new leases and 1,120 renewals and options. The leasing costs associated with these new leases are estimated to aggregate $119.5 million or $39.74 per square foot. These costs include $93.9 million of tenant improvements and $25.6 million of external leasing commissions. The average rent per square foot for (i) new leases was $21.41 and (ii) renewals and options was $19.20. The Company will seek to obtain rents that are higher than amounts within its expiring leases, however, there are many variables and uncertainties which can significantly affect the leasing market at any time; as such, the Company cannot guarantee that future leases will continue to be signed for rents that are equal to or higher than current amounts. _Ground-Leased Properties_ . The Company has interests in 38 consolidated shopping center properties that are subject to long-term ground leases where a third party owns and has leased the underlying land to the Company to construct and/or operate a shopping center. The Company pays rent for the use of the land and generally is responsible for all costs and expenses associated with the building and improvements. At the end of these long-term leases, unless extended, the land together with all improvements reverts to the landowner. More specific information with respect to each of the Company's property interests is set forth in Exhibit 99.1, which is incorporated herein by reference. Item 3. Legal Proceedings The Company is not presently involved in any litigation nor, to its knowledge, is any litigation threatened against the Company or its subsidiaries that, in management's opinion, would result in any material effect on the Company's ownership, management or operation of its properties taken as a whole, or which is not covered by the Company's insurance. Item 4. Mine Safety Disclosures Not applicable.","publish_date":null,"title":"The Company has a total of 8,413 leases in the consolidated operating portfolio. The following table sets forth the aggregate","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Kimco-Realty-2023-Annual-Report-Web_page41.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Kimco-Realty-2023-Annual-Report-Web_page41.pdf"},"request":{"example_id":"table/Kimco-Realty-2023-Annual-Report-Web_page41","product_type":"parse","source_file_path":"Kimco-Realty-2023-Annual-Report-Web_page41.pdf"},"started_at":"2026-11-04T19:47:55.227816"} +{"completed_at":"2026-11-04T19:47:57.675627","latency_in_ms":1653,"output":{"example_id":"table/Kimco-Realty-2023-Annual-Report-Web_page43","grounded_pages":[],"layout_pages":[],"markdown":"29\n\nIssuer Purchases of Equity Securities: The Company’s Board of Directors had authorized the repurchase of up to 894,000 depositary shares of Class L preferred stock and 1,048,000 depositary shares of Class M preferred stock through December 31, 2023, which represented up to an aggregate of 1,942 shares of the Company’s preferred stock, par value $1.00 per share. During the year ended December 31, 2023, the Company repurchased 43,777 depositary shares of Class L preferred stock and 23,791 depositary shares of Class M preferred stock for a purchase price of $1.0 million and $0.5 million, respectively. In addition, during January 2024, the Company’s Board of Directors authorized the repurchase of up to 891,000 depositary shares of Class L Preferred Stock, 1,047,000 depositary shares of Class M Preferred Stock, and 185,000 depositary shares of Class N Preferred Stock through February 28, 2026. The Company’s Board of Directors also extended its previously authorized common share repurchase program, which is now scheduled to expire February 28, 2026. Under this program, the Company may repurchase shares of its common stock, par value $0.01 per share, with an aggregate gross purchase price of up to $300.0 million. The Company did not repurchase any shares under the share repurchase program during the year ended December 31, 2023. As of December 31, 2023, the Company had $224.9 million available under this common share repurchase program. During the year ended December 31, 2023, the Company repurchased 761,149 shares of the Company’s common stock for an aggregate purchase price of $16.3 million (weighted average price of $21.41 per share) in connection with common shares surrendered or deemed surrendered to the Company to satisfy statutory minimum tax withholding obligations in connection with equity-based compensation plans. The following table presents information regarding the shares of common stock repurchased by the Company during the three months ended December 31, 2023.\n\n**Period**\n\n**Total** **Number of** **Shares** **Purchased**\n\n**Average** **Price** **Paid per Share**\n\n**Total Number of** **Shares Purchased** **as Part of Publicly Announced Plans or Programs**\n\n**Approximate Dollar** **Value of Shares that May Yet Be Purchased Under** **the Plans or Programs** **(in millions)**\n\nOctober 1, 2023 – October 31, 2023 213 $ 17.28 - $ 224.9\n\nNovember 1, 2023 – November 30, 2023 - - - $ 224.9\n\nDecember 1, 2023 – December 31, 2023 2,250 22.33 - $ 224.9\n\n**Total** **2,463** **$** **21\\.89** \\-","pages":[{"line_numbers":[],"markdown":"29\n\nIssuer Purchases of Equity Securities: The Company’s Board of Directors had authorized the repurchase of up to 894,000 depositary shares of Class L preferred stock and 1,048,000 depositary shares of Class M preferred stock through December 31, 2023, which represented up to an aggregate of 1,942 shares of the Company’s preferred stock, par value $1.00 per share. During the year ended December 31, 2023, the Company repurchased 43,777 depositary shares of Class L preferred stock and 23,791 depositary shares of Class M preferred stock for a purchase price of $1.0 million and $0.5 million, respectively. In addition, during January 2024, the Company’s Board of Directors authorized the repurchase of up to 891,000 depositary shares of Class L Preferred Stock, 1,047,000 depositary shares of Class M Preferred Stock, and 185,000 depositary shares of Class N Preferred Stock through February 28, 2026. The Company’s Board of Directors also extended its previously authorized common share repurchase program, which is now scheduled to expire February 28, 2026. Under this program, the Company may repurchase shares of its common stock, par value $0.01 per share, with an aggregate gross purchase price of up to $300.0 million. The Company did not repurchase any shares under the share repurchase program during the year ended December 31, 2023. As of December 31, 2023, the Company had $224.9 million available under this common share repurchase program. During the year ended December 31, 2023, the Company repurchased 761,149 shares of the Company’s common stock for an aggregate purchase price of $16.3 million (weighted average price of $21.41 per share) in connection with common shares surrendered or deemed surrendered to the Company to satisfy statutory minimum tax withholding obligations in connection with equity-based compensation plans. The following table presents information regarding the shares of common stock repurchased by the Company during the three months ended December 31, 2023.\n\n**Period**\n\n**Total** **Number of** **Shares** **Purchased**\n\n**Average** **Price** **Paid per Share**\n\n**Total Number of** **Shares Purchased** **as Part of Publicly Announced Plans or Programs**\n\n**Approximate Dollar** **Value of Shares that May Yet Be Purchased Under** **the Plans or Programs** **(in millions)**\n\nOctober 1, 2023 – October 31, 2023 213 $ 17.28 - $ 224.9\n\nNovember 1, 2023 – November 30, 2023 - - - $ 224.9\n\nDecember 1, 2023 – December 31, 2023 2,250 22.33 - $ 224.9\n\n**Total** **2,463** **$** **21\\.89** \\-","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"29\n\nIssuer Purchases of Equity Securities: The Company’s Board of Directors had authorized the repurchase of up to 894,000 depositary shares of Class L preferred stock and 1,048,000 depositary shares of Class M preferred stock through December 31, 2023, which represented up to an aggregate of 1,942 shares of the Company’s preferred stock, par value $1.00 per share. During the year ended December 31, 2023, the Company repurchased 43,777 depositary shares of Class L preferred stock and 23,791 depositary shares of Class M preferred stock for a purchase price of $1.0 million and $0.5 million, respectively. In addition, during January 2024, the Company’s Board of Directors authorized the repurchase of up to 891,000 depositary shares of Class L Preferred Stock, 1,047,000 depositary shares of Class M Preferred Stock, and 185,000 depositary shares of Class N Preferred Stock through February 28, 2026. The Company’s Board of Directors also extended its previously authorized common share repurchase program, which is now scheduled to expire February 28, 2026. Under this program, the Company may repurchase shares of its common stock, par value $0.01 per share, with an aggregate gross purchase price of up to $300.0 million. The Company did not repurchase any shares under the share repurchase program during the year ended December 31, 2023. As of December 31, 2023, the Company had $224.9 million available under this common share repurchase program. During the year ended December 31, 2023, the Company repurchased 761,149 shares of the Company’s common stock for an aggregate purchase price of $16.3 million (weighted average price of $21.41 per share) in connection with common shares surrendered or deemed surrendered to the Company to satisfy statutory minimum tax withholding obligations in connection with equity-based compensation plans. The following table presents information regarding the shares of common stock repurchased by the Company during the three months ended December 31, 2023.\n\n**Period**\n\n**Total** **Number of** **Shares** **Purchased**\n\n**Average** **Price** **Paid per Share**\n\n**Total Number of** **Shares Purchased** **as Part of Publicly Announced Plans or Programs**\n\n**Approximate Dollar** **Value of Shares that May Yet Be Purchased Under** **the Plans or Programs** **(in millions)**\n\nOctober 1, 2023 – October 31, 2023 213 $ 17.28 - $ 224.9\n\nNovember 1, 2023 – November 30, 2023 - - - $ 224.9\n\nDecember 1, 2023 – December 31, 2023 2,250 22.33 - $ 224.9\n\n**Total** **2,463** **$** **21\\.89** \\-","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Kimco-Realty-2023-Annual-Report-Web_page43.pdf"]},"response":{"errors":[],"extract_id":"extract_5d4012114a278c936aba172ba457782f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["29\n\nIssuer Purchases of Equity Securities: The Company’s Board of Directors had authorized the repurchase of up to 894,000 depositary shares of Class L preferred stock and 1,048,000 depositary shares of Class M preferred stock through December 31, 2023, which represented up to an aggregate of 1,942 shares of the Company’s preferred stock, par value $1.00 per share. During the year ended December 31, 2023, the Company repurchased 43,777 depositary shares of Class L preferred stock and 23,791 depositary shares of Class M preferred stock for a purchase price of $1.0 million and $0.5 million, respectively. In addition, during January 2024, the Company’s Board of Directors authorized the repurchase of up to 891,000 depositary shares of Class L Preferred Stock, 1,047,000 depositary shares of Class M Preferred Stock, and 185,000 depositary shares of Class N Preferred Stock through February 28, 2026. The Company’s Board of Directors also extended its previously authorized common share repurchase program, which is now scheduled to expire February 28, 2026. Under this program, the Company may repurchase shares of its common stock, par value $0.01 per share, with an aggregate gross purchase price of up to $300.0 million. The Company did not repurchase any shares under the share repurchase program during the year ended December 31, 2023. As of December 31, 2023, the Company had $224.9 million available under this common share repurchase program. During the year ended December 31, 2023, the Company repurchased 761,149 shares of the Company’s common stock for an aggregate purchase price of $16.3 million (weighted average price of $21.41 per share) in connection with common shares surrendered or deemed surrendered to the Company to satisfy statutory minimum tax withholding obligations in connection with equity-based compensation plans. The following table presents information regarding the shares of common stock repurchased by the Company during the three months ended December 31, 2023.\n\n**Period**\n\n**Total** **Number of** **Shares** **Purchased**\n\n**Average** **Price** **Paid per Share**\n\n**Total Number of** **Shares Purchased** **as Part of Publicly Announced Plans or Programs**\n\n**Approximate Dollar** **Value of Shares that May Yet Be Purchased Under** **the Plans or Programs** **(in millions)**\n\nOctober 1, 2023 – October 31, 2023 213 $ 17.28 - $ 224.9\n\nNovember 1, 2023 – November 30, 2023 - - - $ 224.9\n\nDecember 1, 2023 – December 31, 2023 2,250 22.33 - $ 224.9\n\n**Total** **2,463** **$** **21\\.89** \\-"],"full_content":"29\n\nIssuer Purchases of Equity Securities: The Company’s Board of Directors had authorized the repurchase of up to 894,000 depositary shares of Class L preferred stock and 1,048,000 depositary shares of Class M preferred stock through December 31, 2023, which represented up to an aggregate of 1,942 shares of the Company’s preferred stock, par value $1.00 per share. During the year ended December 31, 2023, the Company repurchased 43,777 depositary shares of Class L preferred stock and 23,791 depositary shares of Class M preferred stock for a purchase price of $1.0 million and $0.5 million, respectively. In addition, during January 2024, the Company’s Board of Directors authorized the repurchase of up to 891,000 depositary shares of Class L Preferred Stock, 1,047,000 depositary shares of Class M Preferred Stock, and 185,000 depositary shares of Class N Preferred Stock through February 28, 2026. The Company’s Board of Directors also extended its previously authorized common share repurchase program, which is now scheduled to expire February 28, 2026. Under this program, the Company may repurchase shares of its common stock, par value $0.01 per share, with an aggregate gross purchase price of up to $300.0 million. The Company did not repurchase any shares under the share repurchase program during the year ended December 31, 2023. As of December 31, 2023, the Company had $224.9 million available under this common share repurchase program. During the year ended December 31, 2023, the Company repurchased 761,149 shares of the Company’s common stock for an aggregate purchase price of $16.3 million (weighted average price of $21.41 per share) in connection with common shares surrendered or deemed surrendered to the Company to satisfy statutory minimum tax withholding obligations in connection with equity-based compensation plans. The following table presents information regarding the shares of common stock repurchased by the Company during the three months ended December 31, 2023.\n\n**Period**\n\n**Total** **Number of** **Shares** **Purchased**\n\n**Average** **Price** **Paid per Share**\n\n**Total Number of** **Shares Purchased** **as Part of Publicly Announced Plans or Programs**\n\n**Approximate Dollar** **Value of Shares that May Yet Be Purchased Under** **the Plans or Programs** **(in millions)**\n\nOctober 1, 2023 – October 31, 2023 213 $ 17.28 - $ 224.9\n\nNovember 1, 2023 – November 30, 2023 - - - $ 224.9\n\nDecember 1, 2023 – December 31, 2023 2,250 22.33 - $ 224.9\n\n**Total** **2,463** **$** **21\\.89** \\-","publish_date":null,"title":"Issuer Purchases of Equity Securities: The Company’s Board of Directors had authorized the repurchase of up to 894,000 depositary shares","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Kimco-Realty-2023-Annual-Report-Web_page43.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Kimco-Realty-2023-Annual-Report-Web_page43.pdf"},"request":{"example_id":"table/Kimco-Realty-2023-Annual-Report-Web_page43","product_type":"parse","source_file_path":"Kimco-Realty-2023-Annual-Report-Web_page43.pdf"},"started_at":"2026-11-04T19:47:56.021973"} +{"completed_at":"2026-11-04T19:48:00.307206","latency_in_ms":2776,"output":{"example_id":"table/LTCprodkitLincolnStateAvailabilty0216_page1","grounded_pages":[],"layout_pages":[],"markdown":"**For agent or broker use only. Not for use with the public.** ADM1101-0010 Page 1 of 2\n\nState Availability as of 2/8/2016 **PRODUCT AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MP MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY**\n\n**Lincoln** **_MoneyGuard_** **® II \\* X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Lincoln** **_MoneyGuard_** **® Reserve Plus**            **O**          **O**             **O**                    \n\n**Lincoln** **_MoneyGuard_** **® Reserve**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**RIDERS AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MP MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY**\n\n**Value Protection Rider (VPR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Enhanced Surrender Value Endorsement (ESVE)**            **O**          **O**             **O**                    \n\n**Long-Term Care Acceleration of Benefits Rider (LABR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Convalescent Care Benefits Rider (CCBR)**            **O**          **O**             **O**                    \n\n**Long-Term Care Extension of Benefits Rider (LEBR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Extension of Benefits Rider (EOBR)**            **O**          **O**             **O**                    \n\n**Nonforfeiture Benefit Rider**            **O**          **O**             **O**                    \n\n**Return of Premium Rider**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**\\#Convalescent Care Benefits Rider (CCBR)**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**\\#Extension of Benefits Rider (EOBR)**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**PRODUCTS Riders for Lincoln** **_MoneyGuard_** **®** **II - LN880 Riders for Lincoln** **_MoneyGuard_** **®** **Reserve Plus - LN870 Riders for Lincoln** **_MoneyGuard_** **®** **Reserve - LN850 (8/05)**\n\n**LN880 - Lincoln** **_MoneyGuard_** **® II Value Protection Rider (VPR) - LR880 or LR880 Rev Enhanced Surrender Value Endorsement (ESVE) - B10504F Return of Premium Rider** **_\\-_** **LR850 (10/07)**\n\n**LN870 - Lincoln** **_MoneyGuard_** **® Reserve Plus Long-Term Care Acceleration of Benefits Rider (LABR) - LR881 Convalescent Care Benefits Rider (CCBR) - LR870 #Convalescent Care Benefits Rider (CCBR) - LR851 (8/05)**\n\n**LN850 (8/05) - Lincoln** **_MoneyGuard_** **® Reserve Long-Term Care Extension of Benefits Rider (LEBR) - LR882 Extension of Benefits Rider (EOBR) - LR871 #Extension of Benefits Rider (EOBR) - LR852 (8/05)**\n\n**Nonforfeiture Benefit Rider - LR872 LR853 (8/05) - Terminal Illness Accelerated Benefit Rider** **_(NY ONLY)_**\n\n**LR855 (8/05) - Nonforfeiture Benefit Rider** **_(NY ONLY)_**\n\n**LR856 (8/05) - Right to Purchase a Long-Term Care Policy Endorsement** **_(NY ONLY)_**\n\n**X = Available**\n\n**O = Will not be made available**  **= Product and riders withdrawn - see attached page for withdrawal information**\n\n**\\* States approved via the Interstate Compact: AL, AK, AR, CO, GA, ID, IL, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NE, NV, NH, NM, NC, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VT, VA, WA, WV, WI and WY.**\n\n**Note: Form numbers and rider names may vary by state.**\n\n**The Lincoln National Life Insurance Company** **_MoneyGuard_** **®** **Life Portfolio**\n\n**Insurance products are issued by The Lincoln National Life Insurance Company, Fort Wayne, IN. The Lincoln National Life Insurance Company is not authorized nor does it solicit business in the state of New York. Policies sold in New York are issued by Lincoln Life & Annuity Company of New York, Syracuse, NY. Affiliates are separately responsible for their own financial and contractual obligations.**\n\n**REMINDER TO PRODUCERS: APPLICATIONS WILL NOT BE ACCEPTED UNTIL STATE AVAILABILITY IS COMMUNICATED. PLEASE DO NOT SOLICIT APPLICATIONS UNTIL SUCH TIME.**","pages":[{"line_numbers":[],"markdown":"**For agent or broker use only. Not for use with the public.** ADM1101-0010 Page 1 of 2\n\nState Availability as of 2/8/2016 **PRODUCT AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MP MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY**\n\n**Lincoln** **_MoneyGuard_** **® II \\* X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Lincoln** **_MoneyGuard_** **® Reserve Plus**            **O**          **O**             **O**                    \n\n**Lincoln** **_MoneyGuard_** **® Reserve**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**RIDERS AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MP MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY**\n\n**Value Protection Rider (VPR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Enhanced Surrender Value Endorsement (ESVE)**            **O**          **O**             **O**                    \n\n**Long-Term Care Acceleration of Benefits Rider (LABR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Convalescent Care Benefits Rider (CCBR)**            **O**          **O**             **O**                    \n\n**Long-Term Care Extension of Benefits Rider (LEBR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Extension of Benefits Rider (EOBR)**            **O**          **O**             **O**                    \n\n**Nonforfeiture Benefit Rider**            **O**          **O**             **O**                    \n\n**Return of Premium Rider**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**\\#Convalescent Care Benefits Rider (CCBR)**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**\\#Extension of Benefits Rider (EOBR)**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**PRODUCTS Riders for Lincoln** **_MoneyGuard_** **®** **II - LN880 Riders for Lincoln** **_MoneyGuard_** **®** **Reserve Plus - LN870 Riders for Lincoln** **_MoneyGuard_** **®** **Reserve - LN850 (8/05)**\n\n**LN880 - Lincoln** **_MoneyGuard_** **® II Value Protection Rider (VPR) - LR880 or LR880 Rev Enhanced Surrender Value Endorsement (ESVE) - B10504F Return of Premium Rider** **_\\-_** **LR850 (10/07)**\n\n**LN870 - Lincoln** **_MoneyGuard_** **® Reserve Plus Long-Term Care Acceleration of Benefits Rider (LABR) - LR881 Convalescent Care Benefits Rider (CCBR) - LR870 #Convalescent Care Benefits Rider (CCBR) - LR851 (8/05)**\n\n**LN850 (8/05) - Lincoln** **_MoneyGuard_** **® Reserve Long-Term Care Extension of Benefits Rider (LEBR) - LR882 Extension of Benefits Rider (EOBR) - LR871 #Extension of Benefits Rider (EOBR) - LR852 (8/05)**\n\n**Nonforfeiture Benefit Rider - LR872 LR853 (8/05) - Terminal Illness Accelerated Benefit Rider** **_(NY ONLY)_**\n\n**LR855 (8/05) - Nonforfeiture Benefit Rider** **_(NY ONLY)_**\n\n**LR856 (8/05) - Right to Purchase a Long-Term Care Policy Endorsement** **_(NY ONLY)_**\n\n**X = Available**\n\n**O = Will not be made available**  **= Product and riders withdrawn - see attached page for withdrawal information**\n\n**\\* States approved via the Interstate Compact: AL, AK, AR, CO, GA, ID, IL, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NE, NV, NH, NM, NC, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VT, VA, WA, WV, WI and WY.**\n\n**Note: Form numbers and rider names may vary by state.**\n\n**The Lincoln National Life Insurance Company** **_MoneyGuard_** **®** **Life Portfolio**\n\n**Insurance products are issued by The Lincoln National Life Insurance Company, Fort Wayne, IN. The Lincoln National Life Insurance Company is not authorized nor does it solicit business in the state of New York. Policies sold in New York are issued by Lincoln Life & Annuity Company of New York, Syracuse, NY. Affiliates are separately responsible for their own financial and contractual obligations.**\n\n**REMINDER TO PRODUCERS: APPLICATIONS WILL NOT BE ACCEPTED UNTIL STATE AVAILABILITY IS COMMUNICATED. PLEASE DO NOT SOLICIT APPLICATIONS UNTIL SUCH TIME.**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**For agent or broker use only. Not for use with the public.** ADM1101-0010 Page 1 of 2\n\nState Availability as of 2/8/2016 **PRODUCT AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MP MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY**\n\n**Lincoln** **_MoneyGuard_** **® II \\* X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Lincoln** **_MoneyGuard_** **® Reserve Plus**            **O**          **O**             **O**                    \n\n**Lincoln** **_MoneyGuard_** **® Reserve**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**RIDERS AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MP MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY**\n\n**Value Protection Rider (VPR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Enhanced Surrender Value Endorsement (ESVE)**            **O**          **O**             **O**                    \n\n**Long-Term Care Acceleration of Benefits Rider (LABR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Convalescent Care Benefits Rider (CCBR)**            **O**          **O**             **O**                    \n\n**Long-Term Care Extension of Benefits Rider (LEBR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Extension of Benefits Rider (EOBR)**            **O**          **O**             **O**                    \n\n**Nonforfeiture Benefit Rider**            **O**          **O**             **O**                    \n\n**Return of Premium Rider**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**\\#Convalescent Care Benefits Rider (CCBR)**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**\\#Extension of Benefits Rider (EOBR)**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**PRODUCTS Riders for Lincoln** **_MoneyGuard_** **®** **II - LN880 Riders for Lincoln** **_MoneyGuard_** **®** **Reserve Plus - LN870 Riders for Lincoln** **_MoneyGuard_** **®** **Reserve - LN850 (8/05)**\n\n**LN880 - Lincoln** **_MoneyGuard_** **® II Value Protection Rider (VPR) - LR880 or LR880 Rev Enhanced Surrender Value Endorsement (ESVE) - B10504F Return of Premium Rider** **_\\-_** **LR850 (10/07)**\n\n**LN870 - Lincoln** **_MoneyGuard_** **® Reserve Plus Long-Term Care Acceleration of Benefits Rider (LABR) - LR881 Convalescent Care Benefits Rider (CCBR) - LR870 #Convalescent Care Benefits Rider (CCBR) - LR851 (8/05)**\n\n**LN850 (8/05) - Lincoln** **_MoneyGuard_** **® Reserve Long-Term Care Extension of Benefits Rider (LEBR) - LR882 Extension of Benefits Rider (EOBR) - LR871 #Extension of Benefits Rider (EOBR) - LR852 (8/05)**\n\n**Nonforfeiture Benefit Rider - LR872 LR853 (8/05) - Terminal Illness Accelerated Benefit Rider** **_(NY ONLY)_**\n\n**LR855 (8/05) - Nonforfeiture Benefit Rider** **_(NY ONLY)_**\n\n**LR856 (8/05) - Right to Purchase a Long-Term Care Policy Endorsement** **_(NY ONLY)_**\n\n**X = Available**\n\n**O = Will not be made available**  **= Product and riders withdrawn - see attached page for withdrawal information**\n\n**\\* States approved via the Interstate Compact: AL, AK, AR, CO, GA, ID, IL, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NE, NV, NH, NM, NC, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VT, VA, WA, WV, WI and WY.**\n\n**Note: Form numbers and rider names may vary by state.**\n\n**The Lincoln National Life Insurance Company** **_MoneyGuard_** **®** **Life Portfolio**\n\n**Insurance products are issued by The Lincoln National Life Insurance Company, Fort Wayne, IN. The Lincoln National Life Insurance Company is not authorized nor does it solicit business in the state of New York. Policies sold in New York are issued by Lincoln Life & Annuity Company of New York, Syracuse, NY. Affiliates are separately responsible for their own financial and contractual obligations.**\n\n**REMINDER TO PRODUCERS: APPLICATIONS WILL NOT BE ACCEPTED UNTIL STATE AVAILABILITY IS COMMUNICATED. PLEASE DO NOT SOLICIT APPLICATIONS UNTIL SUCH TIME.**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/LTCprodkitLincolnStateAvailabilty0216_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_b666188605afce5e2ef0aa9fc40d7ec7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**For agent or broker use only. Not for use with the public.** ADM1101-0010 Page 1 of 2\n\nState Availability as of 2/8/2016 **PRODUCT AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MP MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY**\n\n**Lincoln** **_MoneyGuard_** **® II \\* X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Lincoln** **_MoneyGuard_** **® Reserve Plus**            **O**          **O**             **O**                    \n\n**Lincoln** **_MoneyGuard_** **® Reserve**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**RIDERS AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MP MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY**\n\n**Value Protection Rider (VPR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Enhanced Surrender Value Endorsement (ESVE)**            **O**          **O**             **O**                    \n\n**Long-Term Care Acceleration of Benefits Rider (LABR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Convalescent Care Benefits Rider (CCBR)**            **O**          **O**             **O**                    \n\n**Long-Term Care Extension of Benefits Rider (LEBR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Extension of Benefits Rider (EOBR)**            **O**          **O**             **O**                    \n\n**Nonforfeiture Benefit Rider**            **O**          **O**             **O**                    \n\n**Return of Premium Rider**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**\\#Convalescent Care Benefits Rider (CCBR)**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**\\#Extension of Benefits Rider (EOBR)**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**PRODUCTS Riders for Lincoln** **_MoneyGuard_** **®** **II - LN880 Riders for Lincoln** **_MoneyGuard_** **®** **Reserve Plus - LN870 Riders for Lincoln** **_MoneyGuard_** **®** **Reserve - LN850 (8/05)**\n\n**LN880 - Lincoln** **_MoneyGuard_** **® II Value Protection Rider (VPR) - LR880 or LR880 Rev Enhanced Surrender Value Endorsement (ESVE) - B10504F Return of Premium Rider** **_\\-_** **LR850 (10/07)**\n\n**LN870 - Lincoln** **_MoneyGuard_** **® Reserve Plus Long-Term Care Acceleration of Benefits Rider (LABR) - LR881 Convalescent Care Benefits Rider (CCBR) - LR870 #Convalescent Care Benefits Rider (CCBR) - LR851 (8/05)**\n\n**LN850 (8/05) - Lincoln** **_MoneyGuard_** **® Reserve Long-Term Care Extension of Benefits Rider (LEBR) - LR882 Extension of Benefits Rider (EOBR) - LR871 #Extension of Benefits Rider (EOBR) - LR852 (8/05)**\n\n**Nonforfeiture Benefit Rider - LR872 LR853 (8/05) - Terminal Illness Accelerated Benefit Rider** **_(NY ONLY)_**\n\n**LR855 (8/05) - Nonforfeiture Benefit Rider** **_(NY ONLY)_**\n\n**LR856 (8/05) - Right to Purchase a Long-Term Care Policy Endorsement** **_(NY ONLY)_**\n\n**X = Available**\n\n**O = Will not be made available**  **= Product and riders withdrawn - see attached page for withdrawal information**\n\n**\\* States approved via the Interstate Compact: AL, AK, AR, CO, GA, ID, IL, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NE, NV, NH, NM, NC, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VT, VA, WA, WV, WI and WY.**\n\n**Note: Form numbers and rider names may vary by state.**\n\n**The Lincoln National Life Insurance Company** **_MoneyGuard_** **®** **Life Portfolio**\n\n**Insurance products are issued by The Lincoln National Life Insurance Company, Fort Wayne, IN. The Lincoln National Life Insurance Company is not authorized nor does it solicit business in the state of New York. Policies sold in New York are issued by Lincoln Life & Annuity Company of New York, Syracuse, NY. Affiliates are separately responsible for their own financial and contractual obligations.**\n\n**REMINDER TO PRODUCERS: APPLICATIONS WILL NOT BE ACCEPTED UNTIL STATE AVAILABILITY IS COMMUNICATED. PLEASE DO NOT SOLICIT APPLICATIONS UNTIL SUCH TIME.**"],"full_content":"**For agent or broker use only. Not for use with the public.** ADM1101-0010 Page 1 of 2\n\nState Availability as of 2/8/2016 **PRODUCT AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MP MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY**\n\n**Lincoln** **_MoneyGuard_** **® II \\* X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Lincoln** **_MoneyGuard_** **® Reserve Plus**            **O**          **O**             **O**                    \n\n**Lincoln** **_MoneyGuard_** **® Reserve**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**RIDERS AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MP MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY**\n\n**Value Protection Rider (VPR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Enhanced Surrender Value Endorsement (ESVE)**            **O**          **O**             **O**                    \n\n**Long-Term Care Acceleration of Benefits Rider (LABR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Convalescent Care Benefits Rider (CCBR)**            **O**          **O**             **O**                    \n\n**Long-Term Care Extension of Benefits Rider (LEBR) X X X X X X X X X X X O X X X X X X X X X O X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X**\n\n**Extension of Benefits Rider (EOBR)**            **O**          **O**             **O**                    \n\n**Nonforfeiture Benefit Rider**            **O**          **O**             **O**                    \n\n**Return of Premium Rider**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**\\#Convalescent Care Benefits Rider (CCBR)**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**\\#Extension of Benefits Rider (EOBR)**            **O**          **O**             **X**       **O**      **O**  **O**  **O**   \n\n**PRODUCTS Riders for Lincoln** **_MoneyGuard_** **®** **II - LN880 Riders for Lincoln** **_MoneyGuard_** **®** **Reserve Plus - LN870 Riders for Lincoln** **_MoneyGuard_** **®** **Reserve - LN850 (8/05)**\n\n**LN880 - Lincoln** **_MoneyGuard_** **® II Value Protection Rider (VPR) - LR880 or LR880 Rev Enhanced Surrender Value Endorsement (ESVE) - B10504F Return of Premium Rider** **_\\-_** **LR850 (10/07)**\n\n**LN870 - Lincoln** **_MoneyGuard_** **® Reserve Plus Long-Term Care Acceleration of Benefits Rider (LABR) - LR881 Convalescent Care Benefits Rider (CCBR) - LR870 #Convalescent Care Benefits Rider (CCBR) - LR851 (8/05)**\n\n**LN850 (8/05) - Lincoln** **_MoneyGuard_** **® Reserve Long-Term Care Extension of Benefits Rider (LEBR) - LR882 Extension of Benefits Rider (EOBR) - LR871 #Extension of Benefits Rider (EOBR) - LR852 (8/05)**\n\n**Nonforfeiture Benefit Rider - LR872 LR853 (8/05) - Terminal Illness Accelerated Benefit Rider** **_(NY ONLY)_**\n\n**LR855 (8/05) - Nonforfeiture Benefit Rider** **_(NY ONLY)_**\n\n**LR856 (8/05) - Right to Purchase a Long-Term Care Policy Endorsement** **_(NY ONLY)_**\n\n**X = Available**\n\n**O = Will not be made available**  **= Product and riders withdrawn - see attached page for withdrawal information**\n\n**\\* States approved via the Interstate Compact: AL, AK, AR, CO, GA, ID, IL, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NE, NV, NH, NM, NC, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VT, VA, WA, WV, WI and WY.**\n\n**Note: Form numbers and rider names may vary by state.**\n\n**The Lincoln National Life Insurance Company** **_MoneyGuard_** **®** **Life Portfolio**\n\n**Insurance products are issued by The Lincoln National Life Insurance Company, Fort Wayne, IN. The Lincoln National Life Insurance Company is not authorized nor does it solicit business in the state of New York. Policies sold in New York are issued by Lincoln Life & Annuity Company of New York, Syracuse, NY. Affiliates are separately responsible for their own financial and contractual obligations.**\n\n**REMINDER TO PRODUCERS: APPLICATIONS WILL NOT BE ACCEPTED UNTIL STATE AVAILABILITY IS COMMUNICATED. PLEASE DO NOT SOLICIT APPLICATIONS UNTIL SUCH TIME.**","publish_date":null,"title":"The Lincoln National Life Insurance Company MoneyGuard Life Portfolio","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/LTCprodkitLincolnStateAvailabilty0216_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/LTCprodkitLincolnStateAvailabilty0216_page1.pdf"},"request":{"example_id":"table/LTCprodkitLincolnStateAvailabilty0216_page1","product_type":"parse","source_file_path":"LTCprodkitLincolnStateAvailabilty0216_page1.pdf"},"started_at":"2026-11-04T19:47:57.531011"} +{"completed_at":"2026-11-04T19:48:00.042446","latency_in_ms":1090,"output":{"example_id":"table/LTCprodkitLincolnStateAvailabilty0216_page2","grounded_pages":[],"layout_pages":[],"markdown":"**For agent or broker use only. Not for use with the public.** ADM1101-0010 Page 2 of 2\n\n**PUBLISHED AVAILABILITY DATE PUBLISHED WITHDRAWAL DATE PUBLISHED AVAILABILITY DATE PUBLISHED WITHDRAWAL DATE**\n\n**STATE FOR Lincoln** **_MoneyGuard_** **®** **II FOR Lincoln** **_MoneyGuard_** **®** **Reserve Plus STATE FOR Lincoln** **_MoneyGuard_** **®** **II FOR Lincoln** **_MoneyGuard_** **®** **Reserve Plus**\n\n**AL** 2/10/2014 3/14/2014 **MO** 2/10/2014 3/14/2014\n\n**AK** 2/10/2014 3/14/2014 **MT** 2/10/2014 3/14/2014\n\n**AZ** 6/16/2014 7/16/2014 **NE** 2/10/2014 3/14/2014\n\n**AR** 2/10/2014 3/14/2014 **NV** 2/10/2014 3/14/2014\n\n**CA** 8/31/2015 9/30/2015 **NH** 2/10/2014 3/14/2014\n\n**CO** 2/10/2014 3/14/2014 **NJ** 8/11/2014 9/10/2014\n\n**CT** 6/30/2014 7/30/2014 **NM** 2/10/2014 3/14/2014\n\n**DE** 3/10/2014 4/11/2014 **NC** 2/10/2014 3/14/2014\n\n**DC** 2/10/2014 3/14/2014 **ND** 2/10/2014 3/14/2014\n\n**FL** 2/9/2015 3/11/2015 **NY** N/A\n\n**GA** 2/10/2014 3/14/2014 **OH** 2/10/2014 3/14/2014\n\n**GU** N/A N/A **OK** 2/10/2014 3/14/2014\n\n**HI** 1/12/2015 2/11/2015 **OR** 2/10/2014 3/14/2014\n\n**ID** 2/10/2014 3/14/2014 **PA** 2/10/2014 3/14/2014\n\n**IL** 2/10/2014 3/14/2014 **PR** 2/10/2014 3/14/2014\n\n**IN** 3/10/2014 4/11/2014 **RI** 2/10/2014 3/14/2014\n\n**IA** 2/10/2014 3/14/2014 **SC** 2/10/2014 3/14/2014\n\n**KS** 2/10/2014 3/14/2014 **SD** 2/10/2014 3/14/2014\n\n**KY** 2/10/2014 3/14/2014 **TN** 2/10/2014 3/14/2014\n\n**LA** 2/10/2014 3/14/2014 **TX** 2/10/2014 3/14/2014\n\n**ME** 2/10/2014 3/14/2014 **UT** 2/10/2014 3/14/2014\n\n**MP** N/A N/A **VT** 2/10/2014 3/14/2014\n\n**MD** 2/10/2014 3/14/2014 **VA** 2/10/2014 3/14/2014\n\n**MA** 2/10/2014 3/14/2014 **VI** 5/12/2014 6/13/2014\n\n**MI** 2/10/2014 3/14/2014 **WA** 2/10/2014 3/14/2014\n\n**MN** 2/10/2014 3/14/2014 **WV** 2/10/2014 3/14/2014\n\n**MS** 2/10/2014 3/14/2014 **WI** 2/10/2014 3/14/2014\n\n**WY** 2/10/2014 3/14/2014","pages":[{"line_numbers":[],"markdown":"**For agent or broker use only. Not for use with the public.** ADM1101-0010 Page 2 of 2\n\n**PUBLISHED AVAILABILITY DATE PUBLISHED WITHDRAWAL DATE PUBLISHED AVAILABILITY DATE PUBLISHED WITHDRAWAL DATE**\n\n**STATE FOR Lincoln** **_MoneyGuard_** **®** **II FOR Lincoln** **_MoneyGuard_** **®** **Reserve Plus STATE FOR Lincoln** **_MoneyGuard_** **®** **II FOR Lincoln** **_MoneyGuard_** **®** **Reserve Plus**\n\n**AL** 2/10/2014 3/14/2014 **MO** 2/10/2014 3/14/2014\n\n**AK** 2/10/2014 3/14/2014 **MT** 2/10/2014 3/14/2014\n\n**AZ** 6/16/2014 7/16/2014 **NE** 2/10/2014 3/14/2014\n\n**AR** 2/10/2014 3/14/2014 **NV** 2/10/2014 3/14/2014\n\n**CA** 8/31/2015 9/30/2015 **NH** 2/10/2014 3/14/2014\n\n**CO** 2/10/2014 3/14/2014 **NJ** 8/11/2014 9/10/2014\n\n**CT** 6/30/2014 7/30/2014 **NM** 2/10/2014 3/14/2014\n\n**DE** 3/10/2014 4/11/2014 **NC** 2/10/2014 3/14/2014\n\n**DC** 2/10/2014 3/14/2014 **ND** 2/10/2014 3/14/2014\n\n**FL** 2/9/2015 3/11/2015 **NY** N/A\n\n**GA** 2/10/2014 3/14/2014 **OH** 2/10/2014 3/14/2014\n\n**GU** N/A N/A **OK** 2/10/2014 3/14/2014\n\n**HI** 1/12/2015 2/11/2015 **OR** 2/10/2014 3/14/2014\n\n**ID** 2/10/2014 3/14/2014 **PA** 2/10/2014 3/14/2014\n\n**IL** 2/10/2014 3/14/2014 **PR** 2/10/2014 3/14/2014\n\n**IN** 3/10/2014 4/11/2014 **RI** 2/10/2014 3/14/2014\n\n**IA** 2/10/2014 3/14/2014 **SC** 2/10/2014 3/14/2014\n\n**KS** 2/10/2014 3/14/2014 **SD** 2/10/2014 3/14/2014\n\n**KY** 2/10/2014 3/14/2014 **TN** 2/10/2014 3/14/2014\n\n**LA** 2/10/2014 3/14/2014 **TX** 2/10/2014 3/14/2014\n\n**ME** 2/10/2014 3/14/2014 **UT** 2/10/2014 3/14/2014\n\n**MP** N/A N/A **VT** 2/10/2014 3/14/2014\n\n**MD** 2/10/2014 3/14/2014 **VA** 2/10/2014 3/14/2014\n\n**MA** 2/10/2014 3/14/2014 **VI** 5/12/2014 6/13/2014\n\n**MI** 2/10/2014 3/14/2014 **WA** 2/10/2014 3/14/2014\n\n**MN** 2/10/2014 3/14/2014 **WV** 2/10/2014 3/14/2014\n\n**MS** 2/10/2014 3/14/2014 **WI** 2/10/2014 3/14/2014\n\n**WY** 2/10/2014 3/14/2014","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**For agent or broker use only. Not for use with the public.** ADM1101-0010 Page 2 of 2\n\n**PUBLISHED AVAILABILITY DATE PUBLISHED WITHDRAWAL DATE PUBLISHED AVAILABILITY DATE PUBLISHED WITHDRAWAL DATE**\n\n**STATE FOR Lincoln** **_MoneyGuard_** **®** **II FOR Lincoln** **_MoneyGuard_** **®** **Reserve Plus STATE FOR Lincoln** **_MoneyGuard_** **®** **II FOR Lincoln** **_MoneyGuard_** **®** **Reserve Plus**\n\n**AL** 2/10/2014 3/14/2014 **MO** 2/10/2014 3/14/2014\n\n**AK** 2/10/2014 3/14/2014 **MT** 2/10/2014 3/14/2014\n\n**AZ** 6/16/2014 7/16/2014 **NE** 2/10/2014 3/14/2014\n\n**AR** 2/10/2014 3/14/2014 **NV** 2/10/2014 3/14/2014\n\n**CA** 8/31/2015 9/30/2015 **NH** 2/10/2014 3/14/2014\n\n**CO** 2/10/2014 3/14/2014 **NJ** 8/11/2014 9/10/2014\n\n**CT** 6/30/2014 7/30/2014 **NM** 2/10/2014 3/14/2014\n\n**DE** 3/10/2014 4/11/2014 **NC** 2/10/2014 3/14/2014\n\n**DC** 2/10/2014 3/14/2014 **ND** 2/10/2014 3/14/2014\n\n**FL** 2/9/2015 3/11/2015 **NY** N/A\n\n**GA** 2/10/2014 3/14/2014 **OH** 2/10/2014 3/14/2014\n\n**GU** N/A N/A **OK** 2/10/2014 3/14/2014\n\n**HI** 1/12/2015 2/11/2015 **OR** 2/10/2014 3/14/2014\n\n**ID** 2/10/2014 3/14/2014 **PA** 2/10/2014 3/14/2014\n\n**IL** 2/10/2014 3/14/2014 **PR** 2/10/2014 3/14/2014\n\n**IN** 3/10/2014 4/11/2014 **RI** 2/10/2014 3/14/2014\n\n**IA** 2/10/2014 3/14/2014 **SC** 2/10/2014 3/14/2014\n\n**KS** 2/10/2014 3/14/2014 **SD** 2/10/2014 3/14/2014\n\n**KY** 2/10/2014 3/14/2014 **TN** 2/10/2014 3/14/2014\n\n**LA** 2/10/2014 3/14/2014 **TX** 2/10/2014 3/14/2014\n\n**ME** 2/10/2014 3/14/2014 **UT** 2/10/2014 3/14/2014\n\n**MP** N/A N/A **VT** 2/10/2014 3/14/2014\n\n**MD** 2/10/2014 3/14/2014 **VA** 2/10/2014 3/14/2014\n\n**MA** 2/10/2014 3/14/2014 **VI** 5/12/2014 6/13/2014\n\n**MI** 2/10/2014 3/14/2014 **WA** 2/10/2014 3/14/2014\n\n**MN** 2/10/2014 3/14/2014 **WV** 2/10/2014 3/14/2014\n\n**MS** 2/10/2014 3/14/2014 **WI** 2/10/2014 3/14/2014\n\n**WY** 2/10/2014 3/14/2014","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/LTCprodkitLincolnStateAvailabilty0216_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_d68c6ec99af52eca7bfed15c9f259751","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**For agent or broker use only. Not for use with the public.** ADM1101-0010 Page 2 of 2\n\n**PUBLISHED AVAILABILITY DATE PUBLISHED WITHDRAWAL DATE PUBLISHED AVAILABILITY DATE PUBLISHED WITHDRAWAL DATE**\n\n**STATE FOR Lincoln** **_MoneyGuard_** **®** **II FOR Lincoln** **_MoneyGuard_** **®** **Reserve Plus STATE FOR Lincoln** **_MoneyGuard_** **®** **II FOR Lincoln** **_MoneyGuard_** **®** **Reserve Plus**\n\n**AL** 2/10/2014 3/14/2014 **MO** 2/10/2014 3/14/2014\n\n**AK** 2/10/2014 3/14/2014 **MT** 2/10/2014 3/14/2014\n\n**AZ** 6/16/2014 7/16/2014 **NE** 2/10/2014 3/14/2014\n\n**AR** 2/10/2014 3/14/2014 **NV** 2/10/2014 3/14/2014\n\n**CA** 8/31/2015 9/30/2015 **NH** 2/10/2014 3/14/2014\n\n**CO** 2/10/2014 3/14/2014 **NJ** 8/11/2014 9/10/2014\n\n**CT** 6/30/2014 7/30/2014 **NM** 2/10/2014 3/14/2014\n\n**DE** 3/10/2014 4/11/2014 **NC** 2/10/2014 3/14/2014\n\n**DC** 2/10/2014 3/14/2014 **ND** 2/10/2014 3/14/2014\n\n**FL** 2/9/2015 3/11/2015 **NY** N/A\n\n**GA** 2/10/2014 3/14/2014 **OH** 2/10/2014 3/14/2014\n\n**GU** N/A N/A **OK** 2/10/2014 3/14/2014\n\n**HI** 1/12/2015 2/11/2015 **OR** 2/10/2014 3/14/2014\n\n**ID** 2/10/2014 3/14/2014 **PA** 2/10/2014 3/14/2014\n\n**IL** 2/10/2014 3/14/2014 **PR** 2/10/2014 3/14/2014\n\n**IN** 3/10/2014 4/11/2014 **RI** 2/10/2014 3/14/2014\n\n**IA** 2/10/2014 3/14/2014 **SC** 2/10/2014 3/14/2014\n\n**KS** 2/10/2014 3/14/2014 **SD** 2/10/2014 3/14/2014\n\n**KY** 2/10/2014 3/14/2014 **TN** 2/10/2014 3/14/2014\n\n**LA** 2/10/2014 3/14/2014 **TX** 2/10/2014 3/14/2014\n\n**ME** 2/10/2014 3/14/2014 **UT** 2/10/2014 3/14/2014\n\n**MP** N/A N/A **VT** 2/10/2014 3/14/2014\n\n**MD** 2/10/2014 3/14/2014 **VA** 2/10/2014 3/14/2014\n\n**MA** 2/10/2014 3/14/2014 **VI** 5/12/2014 6/13/2014\n\n**MI** 2/10/2014 3/14/2014 **WA** 2/10/2014 3/14/2014\n\n**MN** 2/10/2014 3/14/2014 **WV** 2/10/2014 3/14/2014\n\n**MS** 2/10/2014 3/14/2014 **WI** 2/10/2014 3/14/2014\n\n**WY** 2/10/2014 3/14/2014"],"full_content":"**For agent or broker use only. Not for use with the public.** ADM1101-0010 Page 2 of 2\n\n**PUBLISHED AVAILABILITY DATE PUBLISHED WITHDRAWAL DATE PUBLISHED AVAILABILITY DATE PUBLISHED WITHDRAWAL DATE**\n\n**STATE FOR Lincoln** **_MoneyGuard_** **®** **II FOR Lincoln** **_MoneyGuard_** **®** **Reserve Plus STATE FOR Lincoln** **_MoneyGuard_** **®** **II FOR Lincoln** **_MoneyGuard_** **®** **Reserve Plus**\n\n**AL** 2/10/2014 3/14/2014 **MO** 2/10/2014 3/14/2014\n\n**AK** 2/10/2014 3/14/2014 **MT** 2/10/2014 3/14/2014\n\n**AZ** 6/16/2014 7/16/2014 **NE** 2/10/2014 3/14/2014\n\n**AR** 2/10/2014 3/14/2014 **NV** 2/10/2014 3/14/2014\n\n**CA** 8/31/2015 9/30/2015 **NH** 2/10/2014 3/14/2014\n\n**CO** 2/10/2014 3/14/2014 **NJ** 8/11/2014 9/10/2014\n\n**CT** 6/30/2014 7/30/2014 **NM** 2/10/2014 3/14/2014\n\n**DE** 3/10/2014 4/11/2014 **NC** 2/10/2014 3/14/2014\n\n**DC** 2/10/2014 3/14/2014 **ND** 2/10/2014 3/14/2014\n\n**FL** 2/9/2015 3/11/2015 **NY** N/A\n\n**GA** 2/10/2014 3/14/2014 **OH** 2/10/2014 3/14/2014\n\n**GU** N/A N/A **OK** 2/10/2014 3/14/2014\n\n**HI** 1/12/2015 2/11/2015 **OR** 2/10/2014 3/14/2014\n\n**ID** 2/10/2014 3/14/2014 **PA** 2/10/2014 3/14/2014\n\n**IL** 2/10/2014 3/14/2014 **PR** 2/10/2014 3/14/2014\n\n**IN** 3/10/2014 4/11/2014 **RI** 2/10/2014 3/14/2014\n\n**IA** 2/10/2014 3/14/2014 **SC** 2/10/2014 3/14/2014\n\n**KS** 2/10/2014 3/14/2014 **SD** 2/10/2014 3/14/2014\n\n**KY** 2/10/2014 3/14/2014 **TN** 2/10/2014 3/14/2014\n\n**LA** 2/10/2014 3/14/2014 **TX** 2/10/2014 3/14/2014\n\n**ME** 2/10/2014 3/14/2014 **UT** 2/10/2014 3/14/2014\n\n**MP** N/A N/A **VT** 2/10/2014 3/14/2014\n\n**MD** 2/10/2014 3/14/2014 **VA** 2/10/2014 3/14/2014\n\n**MA** 2/10/2014 3/14/2014 **VI** 5/12/2014 6/13/2014\n\n**MI** 2/10/2014 3/14/2014 **WA** 2/10/2014 3/14/2014\n\n**MN** 2/10/2014 3/14/2014 **WV** 2/10/2014 3/14/2014\n\n**MS** 2/10/2014 3/14/2014 **WI** 2/10/2014 3/14/2014\n\n**WY** 2/10/2014 3/14/2014","publish_date":null,"title":"2/10/2014 3/14/2014 2/10/2014 3/14/2014 AL MO 2/10/2014 3/14/2014 2/10/2014 3/14/2014 AK MT 6/16/2014 7/16/2014 2/10/2014 3/14/2014 AZ NE 2/10/2014 3/14/2014","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/LTCprodkitLincolnStateAvailabilty0216_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/LTCprodkitLincolnStateAvailabilty0216_page2.pdf"},"request":{"example_id":"table/LTCprodkitLincolnStateAvailabilty0216_page2","product_type":"parse","source_file_path":"LTCprodkitLincolnStateAvailabilty0216_page2.pdf"},"started_at":"2026-11-04T19:47:58.951495"} +{"completed_at":"2026-11-04T19:48:01.372431","latency_in_ms":1295,"output":{"example_id":"table/Layout with Boxes and text_page1","grounded_pages":[],"layout_pages":[],"markdown":"Text 1 Continue Text1\n\nText 2 Text3 Text3 Continue","pages":[{"line_numbers":[],"markdown":"Text 1 Continue Text1\n\nText 2 Text3 Text3 Continue","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Text 1 Continue Text1\n\nText 2 Text3 Text3 Continue","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Layout%20with%20Boxes%20and%20text_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_9ea3230e46ae40124da766c3d1908cb7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Text 1 Continue Text1\n\nText 2 Text3 Text3 Continue"],"full_content":"Text 1 Continue Text1\n\nText 2 Text3 Text3 Continue","publish_date":null,"title":"Text 1 Text 2 Text3 Continue Text1 Text3 Continue","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Layout%20with%20Boxes%20and%20text_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Layout%20with%20Boxes%20and%20text_page1.pdf"},"request":{"example_id":"table/Layout with Boxes and text_page1","product_type":"parse","source_file_path":"Layout with Boxes and text_page1.pdf"},"started_at":"2026-11-04T19:48:00.077396"} +{"completed_at":"2026-11-04T19:48:03.852031","latency_in_ms":2475,"output":{"example_id":"table/Low-Back-Guideline (1)_page2","grounded_pages":[],"layout_pages":[],"markdown":"### with potentially work-related low back symptoms. Findings of the medical history and physical examination may alert the examiner to other pathology (e.g., not of low back origin) that can present as low back disorders. In this assessment, certain findings, referred to as red flags, raise suspicion of serious underlying medical conditions (see Table 1). The absence of red flags and conditions rules out the need for special studies, referral, or inpatient care during the first 4 to 6 weeks. During this time, spontaneous recovery is expected, provided any associated workplace factors are mitigated.(29)\n\n### There also are psychological red flags that should be evaluated, such as PTSD, suicidality, hallucinations or intoxication, which have been called primary risk factors,(49) and have been reviewed elsewhere.(50) Suicidality though is a potentially fatal complication, which makes it a more severe complication than cauda equina.\n\n### **_Red Flags_** Potentially serious disorders are referred to as “red flags.” These include acute fractures, acute dislocations infection, tumor, progressive neurologic deficit, or cauda equina syndrome.\n\n**Table 1. Red Flags for Potentially Serious Low Back Conditions**\n\n**Disorder Medical History Physical Examination/Diagnostic Testing**\n\n**SPINAL DISORDERS**\n\n**Fracture** Major trauma, such as vehicular accident or fall from height\n\nMinor trauma or supra-maximal lifting in older or potentially osteoporotic patients\n\nPercussion tenderness over specific spinous processes\n\nCareful neurological examination for signs of neurological compromise\n\n**Tumor and Neoplasia** Severe localized pain over specific spinal processes\n\nHistory of cancer\n\nAge >50 years\n\nConstitutional symptoms, such as recent unexplained weight loss or fatigue\n\nPain that worsens when patient is supine\n\nPain at night or at rest\n\nPallor, reduced blood pressure, diffuse weakness\n\nTenderness over spinous process and percussion tenderness\n\nDecreased range of motion due to protective muscle spasm\n\nHistory of sciatica for detection of cancer †  Sciatica sensitivity = 58 to 93%  Sciatica specificity = 78%\n\nHistory of paresthesia for detection of cancer †  Paresthesia sensitivity = 58%\n\nPlain radiography for detection of cancer ‡  Radiography sensitivity = 60%  Radiography specificity = 90 to 99.5%\n\nMagnetic resonance imaging (MRI) for detection of cancer ‡\n\n MRI sensitivity = 83 to 93%\n\n MRI specificity = 90 to 97%\n\nRadionuclide scanning for detection of cancer ‡  Planer imaging sensitivity = 74 to 98%  Planer imaging specificity = 64 to 81%","pages":[{"line_numbers":[],"markdown":"### with potentially work-related low back symptoms. Findings of the medical history and physical examination may alert the examiner to other pathology (e.g., not of low back origin) that can present as low back disorders. In this assessment, certain findings, referred to as red flags, raise suspicion of serious underlying medical conditions (see Table 1). The absence of red flags and conditions rules out the need for special studies, referral, or inpatient care during the first 4 to 6 weeks. During this time, spontaneous recovery is expected, provided any associated workplace factors are mitigated.(29)\n\n### There also are psychological red flags that should be evaluated, such as PTSD, suicidality, hallucinations or intoxication, which have been called primary risk factors,(49) and have been reviewed elsewhere.(50) Suicidality though is a potentially fatal complication, which makes it a more severe complication than cauda equina.\n\n### **_Red Flags_** Potentially serious disorders are referred to as “red flags.” These include acute fractures, acute dislocations infection, tumor, progressive neurologic deficit, or cauda equina syndrome.\n\n**Table 1. Red Flags for Potentially Serious Low Back Conditions**\n\n**Disorder Medical History Physical Examination/Diagnostic Testing**\n\n**SPINAL DISORDERS**\n\n**Fracture** Major trauma, such as vehicular accident or fall from height\n\nMinor trauma or supra-maximal lifting in older or potentially osteoporotic patients\n\nPercussion tenderness over specific spinous processes\n\nCareful neurological examination for signs of neurological compromise\n\n**Tumor and Neoplasia** Severe localized pain over specific spinal processes\n\nHistory of cancer\n\nAge >50 years\n\nConstitutional symptoms, such as recent unexplained weight loss or fatigue\n\nPain that worsens when patient is supine\n\nPain at night or at rest\n\nPallor, reduced blood pressure, diffuse weakness\n\nTenderness over spinous process and percussion tenderness\n\nDecreased range of motion due to protective muscle spasm\n\nHistory of sciatica for detection of cancer †  Sciatica sensitivity = 58 to 93%  Sciatica specificity = 78%\n\nHistory of paresthesia for detection of cancer †  Paresthesia sensitivity = 58%\n\nPlain radiography for detection of cancer ‡  Radiography sensitivity = 60%  Radiography specificity = 90 to 99.5%\n\nMagnetic resonance imaging (MRI) for detection of cancer ‡\n\n MRI sensitivity = 83 to 93%\n\n MRI specificity = 90 to 97%\n\nRadionuclide scanning for detection of cancer ‡  Planer imaging sensitivity = 74 to 98%  Planer imaging specificity = 64 to 81%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### with potentially work-related low back symptoms. Findings of the medical history and physical examination may alert the examiner to other pathology (e.g., not of low back origin) that can present as low back disorders. In this assessment, certain findings, referred to as red flags, raise suspicion of serious underlying medical conditions (see Table 1). The absence of red flags and conditions rules out the need for special studies, referral, or inpatient care during the first 4 to 6 weeks. During this time, spontaneous recovery is expected, provided any associated workplace factors are mitigated.(29)\n\n### There also are psychological red flags that should be evaluated, such as PTSD, suicidality, hallucinations or intoxication, which have been called primary risk factors,(49) and have been reviewed elsewhere.(50) Suicidality though is a potentially fatal complication, which makes it a more severe complication than cauda equina.\n\n### **_Red Flags_** Potentially serious disorders are referred to as “red flags.” These include acute fractures, acute dislocations infection, tumor, progressive neurologic deficit, or cauda equina syndrome.\n\n**Table 1. Red Flags for Potentially Serious Low Back Conditions**\n\n**Disorder Medical History Physical Examination/Diagnostic Testing**\n\n**SPINAL DISORDERS**\n\n**Fracture** Major trauma, such as vehicular accident or fall from height\n\nMinor trauma or supra-maximal lifting in older or potentially osteoporotic patients\n\nPercussion tenderness over specific spinous processes\n\nCareful neurological examination for signs of neurological compromise\n\n**Tumor and Neoplasia** Severe localized pain over specific spinal processes\n\nHistory of cancer\n\nAge >50 years\n\nConstitutional symptoms, such as recent unexplained weight loss or fatigue\n\nPain that worsens when patient is supine\n\nPain at night or at rest\n\nPallor, reduced blood pressure, diffuse weakness\n\nTenderness over spinous process and percussion tenderness\n\nDecreased range of motion due to protective muscle spasm\n\nHistory of sciatica for detection of cancer †  Sciatica sensitivity = 58 to 93%  Sciatica specificity = 78%\n\nHistory of paresthesia for detection of cancer †  Paresthesia sensitivity = 58%\n\nPlain radiography for detection of cancer ‡  Radiography sensitivity = 60%  Radiography specificity = 90 to 99.5%\n\nMagnetic resonance imaging (MRI) for detection of cancer ‡\n\n MRI sensitivity = 83 to 93%\n\n MRI specificity = 90 to 97%\n\nRadionuclide scanning for detection of cancer ‡  Planer imaging sensitivity = 74 to 98%  Planer imaging specificity = 64 to 81%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Low-Back-Guideline%20%281%29_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_ccfa992624af731ecc93a8ba493c9379","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### with potentially work-related low back symptoms. Findings of the medical history and physical examination may alert the examiner to other pathology (e.g., not of low back origin) that can present as low back disorders. In this assessment, certain findings, referred to as red flags, raise suspicion of serious underlying medical conditions (see Table 1). The absence of red flags and conditions rules out the need for special studies, referral, or inpatient care during the first 4 to 6 weeks. During this time, spontaneous recovery is expected, provided any associated workplace factors are mitigated.(29)\n\n### There also are psychological red flags that should be evaluated, such as PTSD, suicidality, hallucinations or intoxication, which have been called primary risk factors,(49) and have been reviewed elsewhere.(50) Suicidality though is a potentially fatal complication, which makes it a more severe complication than cauda equina.\n\n### **_Red Flags_** Potentially serious disorders are referred to as “red flags.” These include acute fractures, acute dislocations infection, tumor, progressive neurologic deficit, or cauda equina syndrome.\n\n**Table 1. Red Flags for Potentially Serious Low Back Conditions**\n\n**Disorder Medical History Physical Examination/Diagnostic Testing**\n\n**SPINAL DISORDERS**\n\n**Fracture** Major trauma, such as vehicular accident or fall from height\n\nMinor trauma or supra-maximal lifting in older or potentially osteoporotic patients\n\nPercussion tenderness over specific spinous processes\n\nCareful neurological examination for signs of neurological compromise\n\n**Tumor and Neoplasia** Severe localized pain over specific spinal processes\n\nHistory of cancer\n\nAge >50 years\n\nConstitutional symptoms, such as recent unexplained weight loss or fatigue\n\nPain that worsens when patient is supine\n\nPain at night or at rest\n\nPallor, reduced blood pressure, diffuse weakness\n\nTenderness over spinous process and percussion tenderness\n\nDecreased range of motion due to protective muscle spasm\n\nHistory of sciatica for detection of cancer †  Sciatica sensitivity = 58 to 93%  Sciatica specificity = 78%\n\nHistory of paresthesia for detection of cancer †  Paresthesia sensitivity = 58%\n\nPlain radiography for detection of cancer ‡  Radiography sensitivity = 60%  Radiography specificity = 90 to 99.5%\n\nMagnetic resonance imaging (MRI) for detection of cancer ‡\n\n MRI sensitivity = 83 to 93%\n\n MRI specificity = 90 to 97%\n\nRadionuclide scanning for detection of cancer ‡  Planer imaging sensitivity = 74 to 98%  Planer imaging specificity = 64 to 81%"],"full_content":"### with potentially work-related low back symptoms. Findings of the medical history and physical examination may alert the examiner to other pathology (e.g., not of low back origin) that can present as low back disorders. In this assessment, certain findings, referred to as red flags, raise suspicion of serious underlying medical conditions (see Table 1). The absence of red flags and conditions rules out the need for special studies, referral, or inpatient care during the first 4 to 6 weeks. During this time, spontaneous recovery is expected, provided any associated workplace factors are mitigated.(29)\n\n### There also are psychological red flags that should be evaluated, such as PTSD, suicidality, hallucinations or intoxication, which have been called primary risk factors,(49) and have been reviewed elsewhere.(50) Suicidality though is a potentially fatal complication, which makes it a more severe complication than cauda equina.\n\n### **_Red Flags_** Potentially serious disorders are referred to as “red flags.” These include acute fractures, acute dislocations infection, tumor, progressive neurologic deficit, or cauda equina syndrome.\n\n**Table 1. Red Flags for Potentially Serious Low Back Conditions**\n\n**Disorder Medical History Physical Examination/Diagnostic Testing**\n\n**SPINAL DISORDERS**\n\n**Fracture** Major trauma, such as vehicular accident or fall from height\n\nMinor trauma or supra-maximal lifting in older or potentially osteoporotic patients\n\nPercussion tenderness over specific spinous processes\n\nCareful neurological examination for signs of neurological compromise\n\n**Tumor and Neoplasia** Severe localized pain over specific spinal processes\n\nHistory of cancer\n\nAge >50 years\n\nConstitutional symptoms, such as recent unexplained weight loss or fatigue\n\nPain that worsens when patient is supine\n\nPain at night or at rest\n\nPallor, reduced blood pressure, diffuse weakness\n\nTenderness over spinous process and percussion tenderness\n\nDecreased range of motion due to protective muscle spasm\n\nHistory of sciatica for detection of cancer †  Sciatica sensitivity = 58 to 93%  Sciatica specificity = 78%\n\nHistory of paresthesia for detection of cancer †  Paresthesia sensitivity = 58%\n\nPlain radiography for detection of cancer ‡  Radiography sensitivity = 60%  Radiography specificity = 90 to 99.5%\n\nMagnetic resonance imaging (MRI) for detection of cancer ‡\n\n MRI sensitivity = 83 to 93%\n\n MRI specificity = 90 to 97%\n\nRadionuclide scanning for detection of cancer ‡  Planer imaging sensitivity = 74 to 98%  Planer imaging specificity = 64 to 81%","publish_date":null,"title":"Red Flags","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Low-Back-Guideline%20%281%29_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Low-Back-Guideline%20%281%29_page2.pdf"},"request":{"example_id":"table/Low-Back-Guideline (1)_page2","product_type":"parse","source_file_path":"Low-Back-Guideline (1)_page2.pdf"},"started_at":"2026-11-04T19:48:01.376665"} +{"completed_at":"2026-11-04T19:48:05.011371","latency_in_ms":1603,"output":{"example_id":"table/MAP-CategoryI-LON_page1","grounded_pages":[],"layout_pages":[],"markdown":"1 of 14\n\n**MAP Category I List of Neutrals** As of October 1, 2025. Rates and other information are subject to change.\n\n\\* - Practice areas in addition to those specifically listed ++ - Fluent in other language(s)\n\n**Name and Contact Information** **Rate** **Self-Identified Practice Areas**\n\nAdler, James F. \\* $350 Class Actions, Contracts, Employment,\n\nAdler & Manson, LC Employment/Employee, Employment/Employer,\n\n9233 Ward Parkway, Suite 240 Employment/Labor, Employment/Management,\n\nKansas City, MO 64114 Fraud, Insurance/Carrier, Insurance/Coverage,\n\nTel: (816) 333-0400 Insurance/Policyholder, §1983 Cases\n\nFax: (816) 333-1547\n\nE-mail: jim@adlerandmanson.com\n\nBiographica l Information\n\nAppelquist, John F. \\* $300 Contracts, Fraud, Insurance, Insurance/Carrier,\n\nJohn F. Appelquist, Attorney at Law Insurance/Coverage, Insurance/Policyholder,\n\n313 S. Glenstone Ave. §1983 Cases\n\nSpringfield, MO 65802\n\nTel: (417) 869-6001\n\nFax: (417) 869-2099\n\nE-mail: jappelquist@usa.net\n\nAsberry, Brian K. \\* $300 Fraud, Insurance/Coverage, Class Actions,\n\nNeale & Newman, L.L.P. Contracts, Employment, FCRA, FLSA\n\n2144 East Republic Road, Suite F-302\n\nSpringfield, MO 65804\n\nTel: (417) 882-9090\n\nFax: (417) 882-2529\n\nE-mail: basberry@nnlaw.com\n\nAtwell, Charles E. \\* $475 - $545 Class Actions, Contracts, Copyright, patent and/or\n\nJay Daugherty Mediation & Arbitration trademark, Employment, FCRA, FLSA, Fraud,\n\n4717 Grand Avenue, Suite 830 Insurance, Trade Secrets, §1983 Cases\n\nKansas City, MO 64112\n\nTel: (816) 931-6300\n\nFax: (816) 531-2795\n\nE-mail: charles@jaydaughertymediation.com\n\nBiographica l Information\n\nBangert, Jack T. \\* $395 - $550 Class Actions, Contracts, Copyright, patent and/or\n\nKutak Rock LLP trademark, Insurance/Carrier, Insurance/Coverage,\n\n2405 Grand Boulevard, Suite 600 Insurance/Policyholder\n\nKansas City, MO 64108\n\nTel: (816) 960-0090\n\nFax: (816) 960-0041\n\nE-mail: jack.bangert@kutakrock.com\n\nBiographica l Information\n\nBarnes, Ellen K. \\* Out of Court Mediation Services LLC 5623 N Ames Ave Kansas City, MO 64151 Tel: (816) 226-8817 Fax: n/a E-mail: outofcourtmediation@yahoo.com Biographica l Information\n\n$175\n\nBartalos, Molly B. \\* McCausland Barrett & Bartalos P.C. 9233 Ward Parkway, Suite 720 Kansas City, MO 64114 Tel: (816) 523-3000 Fax: (816) 523-1588 E-mail: mbartalos@mbblawfirmkc.com Biographica l Information\n\n$300 Contracts, Employment, Insurance/Coverage\n\nBeaver, Chad C. \\* $350 Contracts, Employment/Employee,\n\nBeaver Law Firm, LLC Employment/Management\n\n1600 Genessee Street, Suite 920\n\nKansas City, MO 64102\n\nTel: (816) 579-1800\n\nFax: n/a\n\nE-mail: cbeaver@beaver-law.com\n\nBiographica l Information","pages":[{"line_numbers":[],"markdown":"1 of 14\n\n**MAP Category I List of Neutrals** As of October 1, 2025. Rates and other information are subject to change.\n\n\\* - Practice areas in addition to those specifically listed ++ - Fluent in other language(s)\n\n**Name and Contact Information** **Rate** **Self-Identified Practice Areas**\n\nAdler, James F. \\* $350 Class Actions, Contracts, Employment,\n\nAdler & Manson, LC Employment/Employee, Employment/Employer,\n\n9233 Ward Parkway, Suite 240 Employment/Labor, Employment/Management,\n\nKansas City, MO 64114 Fraud, Insurance/Carrier, Insurance/Coverage,\n\nTel: (816) 333-0400 Insurance/Policyholder, §1983 Cases\n\nFax: (816) 333-1547\n\nE-mail: jim@adlerandmanson.com\n\nBiographica l Information\n\nAppelquist, John F. \\* $300 Contracts, Fraud, Insurance, Insurance/Carrier,\n\nJohn F. Appelquist, Attorney at Law Insurance/Coverage, Insurance/Policyholder,\n\n313 S. Glenstone Ave. §1983 Cases\n\nSpringfield, MO 65802\n\nTel: (417) 869-6001\n\nFax: (417) 869-2099\n\nE-mail: jappelquist@usa.net\n\nAsberry, Brian K. \\* $300 Fraud, Insurance/Coverage, Class Actions,\n\nNeale & Newman, L.L.P. Contracts, Employment, FCRA, FLSA\n\n2144 East Republic Road, Suite F-302\n\nSpringfield, MO 65804\n\nTel: (417) 882-9090\n\nFax: (417) 882-2529\n\nE-mail: basberry@nnlaw.com\n\nAtwell, Charles E. \\* $475 - $545 Class Actions, Contracts, Copyright, patent and/or\n\nJay Daugherty Mediation & Arbitration trademark, Employment, FCRA, FLSA, Fraud,\n\n4717 Grand Avenue, Suite 830 Insurance, Trade Secrets, §1983 Cases\n\nKansas City, MO 64112\n\nTel: (816) 931-6300\n\nFax: (816) 531-2795\n\nE-mail: charles@jaydaughertymediation.com\n\nBiographica l Information\n\nBangert, Jack T. \\* $395 - $550 Class Actions, Contracts, Copyright, patent and/or\n\nKutak Rock LLP trademark, Insurance/Carrier, Insurance/Coverage,\n\n2405 Grand Boulevard, Suite 600 Insurance/Policyholder\n\nKansas City, MO 64108\n\nTel: (816) 960-0090\n\nFax: (816) 960-0041\n\nE-mail: jack.bangert@kutakrock.com\n\nBiographica l Information\n\nBarnes, Ellen K. \\* Out of Court Mediation Services LLC 5623 N Ames Ave Kansas City, MO 64151 Tel: (816) 226-8817 Fax: n/a E-mail: outofcourtmediation@yahoo.com Biographica l Information\n\n$175\n\nBartalos, Molly B. \\* McCausland Barrett & Bartalos P.C. 9233 Ward Parkway, Suite 720 Kansas City, MO 64114 Tel: (816) 523-3000 Fax: (816) 523-1588 E-mail: mbartalos@mbblawfirmkc.com Biographica l Information\n\n$300 Contracts, Employment, Insurance/Coverage\n\nBeaver, Chad C. \\* $350 Contracts, Employment/Employee,\n\nBeaver Law Firm, LLC Employment/Management\n\n1600 Genessee Street, Suite 920\n\nKansas City, MO 64102\n\nTel: (816) 579-1800\n\nFax: n/a\n\nE-mail: cbeaver@beaver-law.com\n\nBiographica l Information","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"1 of 14\n\n**MAP Category I List of Neutrals** As of October 1, 2025. Rates and other information are subject to change.\n\n\\* - Practice areas in addition to those specifically listed ++ - Fluent in other language(s)\n\n**Name and Contact Information** **Rate** **Self-Identified Practice Areas**\n\nAdler, James F. \\* $350 Class Actions, Contracts, Employment,\n\nAdler & Manson, LC Employment/Employee, Employment/Employer,\n\n9233 Ward Parkway, Suite 240 Employment/Labor, Employment/Management,\n\nKansas City, MO 64114 Fraud, Insurance/Carrier, Insurance/Coverage,\n\nTel: (816) 333-0400 Insurance/Policyholder, §1983 Cases\n\nFax: (816) 333-1547\n\nE-mail: jim@adlerandmanson.com\n\nBiographica l Information\n\nAppelquist, John F. \\* $300 Contracts, Fraud, Insurance, Insurance/Carrier,\n\nJohn F. Appelquist, Attorney at Law Insurance/Coverage, Insurance/Policyholder,\n\n313 S. Glenstone Ave. §1983 Cases\n\nSpringfield, MO 65802\n\nTel: (417) 869-6001\n\nFax: (417) 869-2099\n\nE-mail: jappelquist@usa.net\n\nAsberry, Brian K. \\* $300 Fraud, Insurance/Coverage, Class Actions,\n\nNeale & Newman, L.L.P. Contracts, Employment, FCRA, FLSA\n\n2144 East Republic Road, Suite F-302\n\nSpringfield, MO 65804\n\nTel: (417) 882-9090\n\nFax: (417) 882-2529\n\nE-mail: basberry@nnlaw.com\n\nAtwell, Charles E. \\* $475 - $545 Class Actions, Contracts, Copyright, patent and/or\n\nJay Daugherty Mediation & Arbitration trademark, Employment, FCRA, FLSA, Fraud,\n\n4717 Grand Avenue, Suite 830 Insurance, Trade Secrets, §1983 Cases\n\nKansas City, MO 64112\n\nTel: (816) 931-6300\n\nFax: (816) 531-2795\n\nE-mail: charles@jaydaughertymediation.com\n\nBiographica l Information\n\nBangert, Jack T. \\* $395 - $550 Class Actions, Contracts, Copyright, patent and/or\n\nKutak Rock LLP trademark, Insurance/Carrier, Insurance/Coverage,\n\n2405 Grand Boulevard, Suite 600 Insurance/Policyholder\n\nKansas City, MO 64108\n\nTel: (816) 960-0090\n\nFax: (816) 960-0041\n\nE-mail: jack.bangert@kutakrock.com\n\nBiographica l Information\n\nBarnes, Ellen K. \\* Out of Court Mediation Services LLC 5623 N Ames Ave Kansas City, MO 64151 Tel: (816) 226-8817 Fax: n/a E-mail: outofcourtmediation@yahoo.com Biographica l Information\n\n$175\n\nBartalos, Molly B. \\* McCausland Barrett & Bartalos P.C. 9233 Ward Parkway, Suite 720 Kansas City, MO 64114 Tel: (816) 523-3000 Fax: (816) 523-1588 E-mail: mbartalos@mbblawfirmkc.com Biographica l Information\n\n$300 Contracts, Employment, Insurance/Coverage\n\nBeaver, Chad C. \\* $350 Contracts, Employment/Employee,\n\nBeaver Law Firm, LLC Employment/Management\n\n1600 Genessee Street, Suite 920\n\nKansas City, MO 64102\n\nTel: (816) 579-1800\n\nFax: n/a\n\nE-mail: cbeaver@beaver-law.com\n\nBiographica l Information","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/MAP-CategoryI-LON_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_cfd264a2a964f3551cc2114c812bc08a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["1 of 14\n\n**MAP Category I List of Neutrals** As of October 1, 2025. Rates and other information are subject to change.\n\n\\* - Practice areas in addition to those specifically listed ++ - Fluent in other language(s)\n\n**Name and Contact Information** **Rate** **Self-Identified Practice Areas**\n\nAdler, James F. \\* $350 Class Actions, Contracts, Employment,\n\nAdler & Manson, LC Employment/Employee, Employment/Employer,\n\n9233 Ward Parkway, Suite 240 Employment/Labor, Employment/Management,\n\nKansas City, MO 64114 Fraud, Insurance/Carrier, Insurance/Coverage,\n\nTel: (816) 333-0400 Insurance/Policyholder, §1983 Cases\n\nFax: (816) 333-1547\n\nE-mail: jim@adlerandmanson.com\n\nBiographica l Information\n\nAppelquist, John F. \\* $300 Contracts, Fraud, Insurance, Insurance/Carrier,\n\nJohn F. Appelquist, Attorney at Law Insurance/Coverage, Insurance/Policyholder,\n\n313 S. Glenstone Ave. §1983 Cases\n\nSpringfield, MO 65802\n\nTel: (417) 869-6001\n\nFax: (417) 869-2099\n\nE-mail: jappelquist@usa.net\n\nAsberry, Brian K. \\* $300 Fraud, Insurance/Coverage, Class Actions,\n\nNeale & Newman, L.L.P. Contracts, Employment, FCRA, FLSA\n\n2144 East Republic Road, Suite F-302\n\nSpringfield, MO 65804\n\nTel: (417) 882-9090\n\nFax: (417) 882-2529\n\nE-mail: basberry@nnlaw.com\n\nAtwell, Charles E. \\* $475 - $545 Class Actions, Contracts, Copyright, patent and/or\n\nJay Daugherty Mediation & Arbitration trademark, Employment, FCRA, FLSA, Fraud,\n\n4717 Grand Avenue, Suite 830 Insurance, Trade Secrets, §1983 Cases\n\nKansas City, MO 64112\n\nTel: (816) 931-6300\n\nFax: (816) 531-2795\n\nE-mail: charles@jaydaughertymediation.com\n\nBiographica l Information\n\nBangert, Jack T. \\* $395 - $550 Class Actions, Contracts, Copyright, patent and/or\n\nKutak Rock LLP trademark, Insurance/Carrier, Insurance/Coverage,\n\n2405 Grand Boulevard, Suite 600 Insurance/Policyholder\n\nKansas City, MO 64108\n\nTel: (816) 960-0090\n\nFax: (816) 960-0041\n\nE-mail: jack.bangert@kutakrock.com\n\nBiographica l Information\n\nBarnes, Ellen K. \\* Out of Court Mediation Services LLC 5623 N Ames Ave Kansas City, MO 64151 Tel: (816) 226-8817 Fax: n/a E-mail: outofcourtmediation@yahoo.com Biographica l Information\n\n$175\n\nBartalos, Molly B. \\* McCausland Barrett & Bartalos P.C. 9233 Ward Parkway, Suite 720 Kansas City, MO 64114 Tel: (816) 523-3000 Fax: (816) 523-1588 E-mail: mbartalos@mbblawfirmkc.com Biographica l Information\n\n$300 Contracts, Employment, Insurance/Coverage\n\nBeaver, Chad C. \\* $350 Contracts, Employment/Employee,\n\nBeaver Law Firm, LLC Employment/Management\n\n1600 Genessee Street, Suite 920\n\nKansas City, MO 64102\n\nTel: (816) 579-1800\n\nFax: n/a\n\nE-mail: cbeaver@beaver-law.com\n\nBiographica l Information"],"full_content":"1 of 14\n\n**MAP Category I List of Neutrals** As of October 1, 2025. Rates and other information are subject to change.\n\n\\* - Practice areas in addition to those specifically listed ++ - Fluent in other language(s)\n\n**Name and Contact Information** **Rate** **Self-Identified Practice Areas**\n\nAdler, James F. \\* $350 Class Actions, Contracts, Employment,\n\nAdler & Manson, LC Employment/Employee, Employment/Employer,\n\n9233 Ward Parkway, Suite 240 Employment/Labor, Employment/Management,\n\nKansas City, MO 64114 Fraud, Insurance/Carrier, Insurance/Coverage,\n\nTel: (816) 333-0400 Insurance/Policyholder, §1983 Cases\n\nFax: (816) 333-1547\n\nE-mail: jim@adlerandmanson.com\n\nBiographica l Information\n\nAppelquist, John F. \\* $300 Contracts, Fraud, Insurance, Insurance/Carrier,\n\nJohn F. Appelquist, Attorney at Law Insurance/Coverage, Insurance/Policyholder,\n\n313 S. Glenstone Ave. §1983 Cases\n\nSpringfield, MO 65802\n\nTel: (417) 869-6001\n\nFax: (417) 869-2099\n\nE-mail: jappelquist@usa.net\n\nAsberry, Brian K. \\* $300 Fraud, Insurance/Coverage, Class Actions,\n\nNeale & Newman, L.L.P. Contracts, Employment, FCRA, FLSA\n\n2144 East Republic Road, Suite F-302\n\nSpringfield, MO 65804\n\nTel: (417) 882-9090\n\nFax: (417) 882-2529\n\nE-mail: basberry@nnlaw.com\n\nAtwell, Charles E. \\* $475 - $545 Class Actions, Contracts, Copyright, patent and/or\n\nJay Daugherty Mediation & Arbitration trademark, Employment, FCRA, FLSA, Fraud,\n\n4717 Grand Avenue, Suite 830 Insurance, Trade Secrets, §1983 Cases\n\nKansas City, MO 64112\n\nTel: (816) 931-6300\n\nFax: (816) 531-2795\n\nE-mail: charles@jaydaughertymediation.com\n\nBiographica l Information\n\nBangert, Jack T. \\* $395 - $550 Class Actions, Contracts, Copyright, patent and/or\n\nKutak Rock LLP trademark, Insurance/Carrier, Insurance/Coverage,\n\n2405 Grand Boulevard, Suite 600 Insurance/Policyholder\n\nKansas City, MO 64108\n\nTel: (816) 960-0090\n\nFax: (816) 960-0041\n\nE-mail: jack.bangert@kutakrock.com\n\nBiographica l Information\n\nBarnes, Ellen K. \\* Out of Court Mediation Services LLC 5623 N Ames Ave Kansas City, MO 64151 Tel: (816) 226-8817 Fax: n/a E-mail: outofcourtmediation@yahoo.com Biographica l Information\n\n$175\n\nBartalos, Molly B. \\* McCausland Barrett & Bartalos P.C. 9233 Ward Parkway, Suite 720 Kansas City, MO 64114 Tel: (816) 523-3000 Fax: (816) 523-1588 E-mail: mbartalos@mbblawfirmkc.com Biographica l Information\n\n$300 Contracts, Employment, Insurance/Coverage\n\nBeaver, Chad C. \\* $350 Contracts, Employment/Employee,\n\nBeaver Law Firm, LLC Employment/Management\n\n1600 Genessee Street, Suite 920\n\nKansas City, MO 64102\n\nTel: (816) 579-1800\n\nFax: n/a\n\nE-mail: cbeaver@beaver-law.com\n\nBiographica l Information","publish_date":null,"title":"MAP Category I List of Neutrals","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/MAP-CategoryI-LON_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/MAP-CategoryI-LON_page1.pdf"},"request":{"example_id":"table/MAP-CategoryI-LON_page1","product_type":"parse","source_file_path":"MAP-CategoryI-LON_page1.pdf"},"started_at":"2026-11-04T19:48:03.407421"} +{"completed_at":"2026-11-04T19:48:07.445459","latency_in_ms":2881,"output":{"example_id":"table/MAP-CategoryI-LON_page2","grounded_pages":[],"layout_pages":[],"markdown":"2 of 14\n\n**Name and Contact Information** **Rate** **Self-Identified Practice Areas**\n\nBender, Thomas V. Horn Aylward & Bandy, LLC 2600 Grand Blvd, Suite 1100 Kansas City, MO 64108 Tel: (816) 595-7759 Fax: n/a E-mail: tbender@hab-law.com Biographica l Information\n\n$450 Class Actions, Contracts, Copyright, patent and/or trademark, Employment, Trade Secrets, §1983 Cases\n\nBledsoe, Stephen M. Berkowitz Oliver 2600 Grand Blvd., Suite 1200 Kansas City, MO 64108 Tel: (816) 627-0240 Fax: (816) 561-1888 E-mail: sbledsoe@berkowitzoliver.com Biographica l Information\n\n$350 Contracts, Employment, §1983 Cases\n\nBodamer, A. Bradley \\* $400 Class Actions, Contracts, Employment, Fraud,\n\nGraves Garrett Greim LLC §1983 Cases\n\n1100 Main Street, Suite 2700\n\nKansas City, MO 64105\n\nTel: (816) 256-3181\n\nFax: (816) 817-0021\n\nE-mail: bbodamer@gravesgarrett.com\n\nBiographica l Information\n\nBonney, Stephen (Doug) D. Bonney Arbitration & Mediation 5542 Crestwood Drive Kansas City, MO 64110 Tel: (816) 363-3675 Fax: n/a E-mail: sdbonney@outlook.com\n\n$350 Employment/Employee, Employment/Employer, Employment/Labor, Employment/Management, FLSA, §1983 Cases\n\nBower, Lisa C. \\* ++ $400 Insurance/Carrier, Insurance/Coverage,\n\nBower Mediation Solutions, LLC Insurance/Policyholder\n\n7007 College Boulevard\n\nOverland Park, KS 66211\n\nTel: (913) 283-7003\n\nFax: n/a\n\nE-mail: BowerMediation@outlook.com\n\nBiographica l Information\n\nBrandt, W. Perry $500 Class Actions, Contracts, Employment, Fraud, Trade\n\nSandberg Phoenix & von Gontard P.C. Secrets, §1983 Cases\n\n4600 Madison Avenue, Suite 1000\n\nKansas City, MO 64112\n\nTel: (816) 305-7377\n\nFax: (816) 627-5532\n\nE-mail: pbrandt@sandbergphoenix.com\n\nBiographica l Information\n\nBrown, Jane Pansing \\* ++ $320 Contracts, Employment/Employee,\n\nJane Pansing Brown Law Firm LLC Employment/Employer, Employment/Labor,\n\nPO Box 9169 Employment/Management, Fraud,\n\nKansas City, MO 64168 Insurance/Carrier, Insurance/Coverage,\n\nTel: (816) 255-8194 Insurance/Policyholder, §1983 Cases\n\nFax: n/a\n\nE-mail: contactjanebrown@gmail.com\n\nBiographica l Information\n\nBrown, Jason R. \\* Jay Daugherty Mediation & Arbitration 1901 S. Ventura Ave, Ste. A1 Springfield, MO 65804 Tel: (417) 714-0440 Fax: n/a E-mail: jason@jaydaughertymediation.com Biographica l Information\n\n$350 - $420 Contracts, Copyright, patent and/or trademark, Employment/Employee, Employment/Employer, Fraud, Insurance/Carrier, Insurance/Coverage, Insurance/Policyholder, Trade Secrets, §1983 Cases","pages":[{"line_numbers":[],"markdown":"2 of 14\n\n**Name and Contact Information** **Rate** **Self-Identified Practice Areas**\n\nBender, Thomas V. Horn Aylward & Bandy, LLC 2600 Grand Blvd, Suite 1100 Kansas City, MO 64108 Tel: (816) 595-7759 Fax: n/a E-mail: tbender@hab-law.com Biographica l Information\n\n$450 Class Actions, Contracts, Copyright, patent and/or trademark, Employment, Trade Secrets, §1983 Cases\n\nBledsoe, Stephen M. Berkowitz Oliver 2600 Grand Blvd., Suite 1200 Kansas City, MO 64108 Tel: (816) 627-0240 Fax: (816) 561-1888 E-mail: sbledsoe@berkowitzoliver.com Biographica l Information\n\n$350 Contracts, Employment, §1983 Cases\n\nBodamer, A. Bradley \\* $400 Class Actions, Contracts, Employment, Fraud,\n\nGraves Garrett Greim LLC §1983 Cases\n\n1100 Main Street, Suite 2700\n\nKansas City, MO 64105\n\nTel: (816) 256-3181\n\nFax: (816) 817-0021\n\nE-mail: bbodamer@gravesgarrett.com\n\nBiographica l Information\n\nBonney, Stephen (Doug) D. Bonney Arbitration & Mediation 5542 Crestwood Drive Kansas City, MO 64110 Tel: (816) 363-3675 Fax: n/a E-mail: sdbonney@outlook.com\n\n$350 Employment/Employee, Employment/Employer, Employment/Labor, Employment/Management, FLSA, §1983 Cases\n\nBower, Lisa C. \\* ++ $400 Insurance/Carrier, Insurance/Coverage,\n\nBower Mediation Solutions, LLC Insurance/Policyholder\n\n7007 College Boulevard\n\nOverland Park, KS 66211\n\nTel: (913) 283-7003\n\nFax: n/a\n\nE-mail: BowerMediation@outlook.com\n\nBiographica l Information\n\nBrandt, W. Perry $500 Class Actions, Contracts, Employment, Fraud, Trade\n\nSandberg Phoenix & von Gontard P.C. Secrets, §1983 Cases\n\n4600 Madison Avenue, Suite 1000\n\nKansas City, MO 64112\n\nTel: (816) 305-7377\n\nFax: (816) 627-5532\n\nE-mail: pbrandt@sandbergphoenix.com\n\nBiographica l Information\n\nBrown, Jane Pansing \\* ++ $320 Contracts, Employment/Employee,\n\nJane Pansing Brown Law Firm LLC Employment/Employer, Employment/Labor,\n\nPO Box 9169 Employment/Management, Fraud,\n\nKansas City, MO 64168 Insurance/Carrier, Insurance/Coverage,\n\nTel: (816) 255-8194 Insurance/Policyholder, §1983 Cases\n\nFax: n/a\n\nE-mail: contactjanebrown@gmail.com\n\nBiographica l Information\n\nBrown, Jason R. \\* Jay Daugherty Mediation & Arbitration 1901 S. Ventura Ave, Ste. A1 Springfield, MO 65804 Tel: (417) 714-0440 Fax: n/a E-mail: jason@jaydaughertymediation.com Biographica l Information\n\n$350 - $420 Contracts, Copyright, patent and/or trademark, Employment/Employee, Employment/Employer, Fraud, Insurance/Carrier, Insurance/Coverage, Insurance/Policyholder, Trade Secrets, §1983 Cases","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"2 of 14\n\n**Name and Contact Information** **Rate** **Self-Identified Practice Areas**\n\nBender, Thomas V. Horn Aylward & Bandy, LLC 2600 Grand Blvd, Suite 1100 Kansas City, MO 64108 Tel: (816) 595-7759 Fax: n/a E-mail: tbender@hab-law.com Biographica l Information\n\n$450 Class Actions, Contracts, Copyright, patent and/or trademark, Employment, Trade Secrets, §1983 Cases\n\nBledsoe, Stephen M. Berkowitz Oliver 2600 Grand Blvd., Suite 1200 Kansas City, MO 64108 Tel: (816) 627-0240 Fax: (816) 561-1888 E-mail: sbledsoe@berkowitzoliver.com Biographica l Information\n\n$350 Contracts, Employment, §1983 Cases\n\nBodamer, A. Bradley \\* $400 Class Actions, Contracts, Employment, Fraud,\n\nGraves Garrett Greim LLC §1983 Cases\n\n1100 Main Street, Suite 2700\n\nKansas City, MO 64105\n\nTel: (816) 256-3181\n\nFax: (816) 817-0021\n\nE-mail: bbodamer@gravesgarrett.com\n\nBiographica l Information\n\nBonney, Stephen (Doug) D. Bonney Arbitration & Mediation 5542 Crestwood Drive Kansas City, MO 64110 Tel: (816) 363-3675 Fax: n/a E-mail: sdbonney@outlook.com\n\n$350 Employment/Employee, Employment/Employer, Employment/Labor, Employment/Management, FLSA, §1983 Cases\n\nBower, Lisa C. \\* ++ $400 Insurance/Carrier, Insurance/Coverage,\n\nBower Mediation Solutions, LLC Insurance/Policyholder\n\n7007 College Boulevard\n\nOverland Park, KS 66211\n\nTel: (913) 283-7003\n\nFax: n/a\n\nE-mail: BowerMediation@outlook.com\n\nBiographica l Information\n\nBrandt, W. Perry $500 Class Actions, Contracts, Employment, Fraud, Trade\n\nSandberg Phoenix & von Gontard P.C. Secrets, §1983 Cases\n\n4600 Madison Avenue, Suite 1000\n\nKansas City, MO 64112\n\nTel: (816) 305-7377\n\nFax: (816) 627-5532\n\nE-mail: pbrandt@sandbergphoenix.com\n\nBiographica l Information\n\nBrown, Jane Pansing \\* ++ $320 Contracts, Employment/Employee,\n\nJane Pansing Brown Law Firm LLC Employment/Employer, Employment/Labor,\n\nPO Box 9169 Employment/Management, Fraud,\n\nKansas City, MO 64168 Insurance/Carrier, Insurance/Coverage,\n\nTel: (816) 255-8194 Insurance/Policyholder, §1983 Cases\n\nFax: n/a\n\nE-mail: contactjanebrown@gmail.com\n\nBiographica l Information\n\nBrown, Jason R. \\* Jay Daugherty Mediation & Arbitration 1901 S. Ventura Ave, Ste. A1 Springfield, MO 65804 Tel: (417) 714-0440 Fax: n/a E-mail: jason@jaydaughertymediation.com Biographica l Information\n\n$350 - $420 Contracts, Copyright, patent and/or trademark, Employment/Employee, Employment/Employer, Fraud, Insurance/Carrier, Insurance/Coverage, Insurance/Policyholder, Trade Secrets, §1983 Cases","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/MAP-CategoryI-LON_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_56571dc06632668c6b3d90185e988584","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["2 of 14\n\n**Name and Contact Information** **Rate** **Self-Identified Practice Areas**\n\nBender, Thomas V. Horn Aylward & Bandy, LLC 2600 Grand Blvd, Suite 1100 Kansas City, MO 64108 Tel: (816) 595-7759 Fax: n/a E-mail: tbender@hab-law.com Biographica l Information\n\n$450 Class Actions, Contracts, Copyright, patent and/or trademark, Employment, Trade Secrets, §1983 Cases\n\nBledsoe, Stephen M. Berkowitz Oliver 2600 Grand Blvd., Suite 1200 Kansas City, MO 64108 Tel: (816) 627-0240 Fax: (816) 561-1888 E-mail: sbledsoe@berkowitzoliver.com Biographica l Information\n\n$350 Contracts, Employment, §1983 Cases\n\nBodamer, A. Bradley \\* $400 Class Actions, Contracts, Employment, Fraud,\n\nGraves Garrett Greim LLC §1983 Cases\n\n1100 Main Street, Suite 2700\n\nKansas City, MO 64105\n\nTel: (816) 256-3181\n\nFax: (816) 817-0021\n\nE-mail: bbodamer@gravesgarrett.com\n\nBiographica l Information\n\nBonney, Stephen (Doug) D. Bonney Arbitration & Mediation 5542 Crestwood Drive Kansas City, MO 64110 Tel: (816) 363-3675 Fax: n/a E-mail: sdbonney@outlook.com\n\n$350 Employment/Employee, Employment/Employer, Employment/Labor, Employment/Management, FLSA, §1983 Cases\n\nBower, Lisa C. \\* ++ $400 Insurance/Carrier, Insurance/Coverage,\n\nBower Mediation Solutions, LLC Insurance/Policyholder\n\n7007 College Boulevard\n\nOverland Park, KS 66211\n\nTel: (913) 283-7003\n\nFax: n/a\n\nE-mail: BowerMediation@outlook.com\n\nBiographica l Information\n\nBrandt, W. Perry $500 Class Actions, Contracts, Employment, Fraud, Trade\n\nSandberg Phoenix & von Gontard P.C. Secrets, §1983 Cases\n\n4600 Madison Avenue, Suite 1000\n\nKansas City, MO 64112\n\nTel: (816) 305-7377\n\nFax: (816) 627-5532\n\nE-mail: pbrandt@sandbergphoenix.com\n\nBiographica l Information\n\nBrown, Jane Pansing \\* ++ $320 Contracts, Employment/Employee,\n\nJane Pansing Brown Law Firm LLC Employment/Employer, Employment/Labor,\n\nPO Box 9169 Employment/Management, Fraud,\n\nKansas City, MO 64168 Insurance/Carrier, Insurance/Coverage,\n\nTel: (816) 255-8194 Insurance/Policyholder, §1983 Cases\n\nFax: n/a\n\nE-mail: contactjanebrown@gmail.com\n\nBiographica l Information\n\nBrown, Jason R. \\* Jay Daugherty Mediation & Arbitration 1901 S. Ventura Ave, Ste. A1 Springfield, MO 65804 Tel: (417) 714-0440 Fax: n/a E-mail: jason@jaydaughertymediation.com Biographica l Information\n\n$350 - $420 Contracts, Copyright, patent and/or trademark, Employment/Employee, Employment/Employer, Fraud, Insurance/Carrier, Insurance/Coverage, Insurance/Policyholder, Trade Secrets, §1983 Cases"],"full_content":"2 of 14\n\n**Name and Contact Information** **Rate** **Self-Identified Practice Areas**\n\nBender, Thomas V. Horn Aylward & Bandy, LLC 2600 Grand Blvd, Suite 1100 Kansas City, MO 64108 Tel: (816) 595-7759 Fax: n/a E-mail: tbender@hab-law.com Biographica l Information\n\n$450 Class Actions, Contracts, Copyright, patent and/or trademark, Employment, Trade Secrets, §1983 Cases\n\nBledsoe, Stephen M. Berkowitz Oliver 2600 Grand Blvd., Suite 1200 Kansas City, MO 64108 Tel: (816) 627-0240 Fax: (816) 561-1888 E-mail: sbledsoe@berkowitzoliver.com Biographica l Information\n\n$350 Contracts, Employment, §1983 Cases\n\nBodamer, A. Bradley \\* $400 Class Actions, Contracts, Employment, Fraud,\n\nGraves Garrett Greim LLC §1983 Cases\n\n1100 Main Street, Suite 2700\n\nKansas City, MO 64105\n\nTel: (816) 256-3181\n\nFax: (816) 817-0021\n\nE-mail: bbodamer@gravesgarrett.com\n\nBiographica l Information\n\nBonney, Stephen (Doug) D. Bonney Arbitration & Mediation 5542 Crestwood Drive Kansas City, MO 64110 Tel: (816) 363-3675 Fax: n/a E-mail: sdbonney@outlook.com\n\n$350 Employment/Employee, Employment/Employer, Employment/Labor, Employment/Management, FLSA, §1983 Cases\n\nBower, Lisa C. \\* ++ $400 Insurance/Carrier, Insurance/Coverage,\n\nBower Mediation Solutions, LLC Insurance/Policyholder\n\n7007 College Boulevard\n\nOverland Park, KS 66211\n\nTel: (913) 283-7003\n\nFax: n/a\n\nE-mail: BowerMediation@outlook.com\n\nBiographica l Information\n\nBrandt, W. Perry $500 Class Actions, Contracts, Employment, Fraud, Trade\n\nSandberg Phoenix & von Gontard P.C. Secrets, §1983 Cases\n\n4600 Madison Avenue, Suite 1000\n\nKansas City, MO 64112\n\nTel: (816) 305-7377\n\nFax: (816) 627-5532\n\nE-mail: pbrandt@sandbergphoenix.com\n\nBiographica l Information\n\nBrown, Jane Pansing \\* ++ $320 Contracts, Employment/Employee,\n\nJane Pansing Brown Law Firm LLC Employment/Employer, Employment/Labor,\n\nPO Box 9169 Employment/Management, Fraud,\n\nKansas City, MO 64168 Insurance/Carrier, Insurance/Coverage,\n\nTel: (816) 255-8194 Insurance/Policyholder, §1983 Cases\n\nFax: n/a\n\nE-mail: contactjanebrown@gmail.com\n\nBiographica l Information\n\nBrown, Jason R. \\* Jay Daugherty Mediation & Arbitration 1901 S. Ventura Ave, Ste. A1 Springfield, MO 65804 Tel: (417) 714-0440 Fax: n/a E-mail: jason@jaydaughertymediation.com Biographica l Information\n\n$350 - $420 Contracts, Copyright, patent and/or trademark, Employment/Employee, Employment/Employer, Fraud, Insurance/Carrier, Insurance/Coverage, Insurance/Policyholder, Trade Secrets, §1983 Cases","publish_date":null,"title":"2 of 14","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/MAP-CategoryI-LON_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/MAP-CategoryI-LON_page2.pdf"},"request":{"example_id":"table/MAP-CategoryI-LON_page2","product_type":"parse","source_file_path":"MAP-CategoryI-LON_page2.pdf"},"started_at":"2026-11-04T19:48:04.563538"} +{"completed_at":"2026-11-04T19:48:07.515012","latency_in_ms":1650,"output":{"example_id":"table/METLIFE-10Q-20240205 unrestricted_page16","grounded_pages":[],"layout_pages":[],"markdown":"**Table of Contents**\n\n**MetLife, Inc.**\n\n**Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)**\n\n**2\\. Segment Information (continued)**\n\n**Three Months Ended March 31, 2024**\n\n**Group Benefits RIS Asia**\n\n**Latin**\n\n**America EMEA**\n\n**MetLife Holdings**\n\n**Corporate & Other Total Adjustments**\n\n**Total**\n\n**Consolidated**\n\n**(In millions)**\n\n**Revenues** Premiums $ 5,711 $ 675 $ 1,297 $ 1,115 $ 536 $ 713 $ 6 $ 10,053 $ — $ 10,053\n\nUniversal life and investment-type product policy fees 222 75 426 370 77 78 — 1,248 — 1,248\n\nNet investment income 315 2,089 1,108 386 54 1,010 106 5,068 368 5,436\n\nOther revenues 397 63 21 11 7 50 98 647 27 674\n\nNet investment gains (losses) — — — — — — — — (375) (375)\n\nNet derivative gains (losses) — — — — — — — — (979) (979)\n\nTotal revenues 6,645 2,902 2,852 1,882 674 1,851 210 17,016 (959) 16,057\n\n**Expenses** Policyholder benefits and claims and policyholder dividends 5,236 1,471 1,067 983 258 1,251 8 10,274 (53) 10,221\n\nPolicyholder liability remeasurement (gains) losses (3) 1 (32) (8) — 20 — (22) — (22)\n\nMarket risk benefit remeasurement (gains) losses — — — — — — — — (694) (694)\n\nInterest credited to policyholder account balances 48 796 647 114 19 103 — 1,727 563 2,290\n\nCapitalization of deferred policy acquisition costs (4) (61) (361) (178) (128) (5) (3) (740) — (740)\n\nAmortization of deferred policy acquisition costs and\n\nvalue of business acquired 6 15 210 125 91 59 2 508 — 508\n\nAmortization of negative value of business acquired — — (5) — (1) — — (6) — (6)\n\nInterest expense on debt — 4 — 3 — 4 253 264 — 264\n\nOther expenses 1,003 172 744 512 332 223 194 3,180 11 3,191\n\nTotal expenses 6,286 2,398 2,270 1,551 571 1,655 454 15,185 (173) 15,012\n\nProvision for income tax expense (benefit) 75 105 159 98 26 37 (70) 430 (260) 170\n\nAdjusted earnings $ 284 $ 399 $ 423 $ 233 $ 77 $ 159 $ (174) 1,401\n\nAdjustments to: Total revenues (959)\n\nTotal expenses 173\n\nProvision for income tax (expense) benefit 260\n\nNet income (loss) $ 875 $ 875\n\n14","pages":[{"line_numbers":[],"markdown":"**Table of Contents**\n\n**MetLife, Inc.**\n\n**Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)**\n\n**2\\. Segment Information (continued)**\n\n**Three Months Ended March 31, 2024**\n\n**Group Benefits RIS Asia**\n\n**Latin**\n\n**America EMEA**\n\n**MetLife Holdings**\n\n**Corporate & Other Total Adjustments**\n\n**Total**\n\n**Consolidated**\n\n**(In millions)**\n\n**Revenues** Premiums $ 5,711 $ 675 $ 1,297 $ 1,115 $ 536 $ 713 $ 6 $ 10,053 $ — $ 10,053\n\nUniversal life and investment-type product policy fees 222 75 426 370 77 78 — 1,248 — 1,248\n\nNet investment income 315 2,089 1,108 386 54 1,010 106 5,068 368 5,436\n\nOther revenues 397 63 21 11 7 50 98 647 27 674\n\nNet investment gains (losses) — — — — — — — — (375) (375)\n\nNet derivative gains (losses) — — — — — — — — (979) (979)\n\nTotal revenues 6,645 2,902 2,852 1,882 674 1,851 210 17,016 (959) 16,057\n\n**Expenses** Policyholder benefits and claims and policyholder dividends 5,236 1,471 1,067 983 258 1,251 8 10,274 (53) 10,221\n\nPolicyholder liability remeasurement (gains) losses (3) 1 (32) (8) — 20 — (22) — (22)\n\nMarket risk benefit remeasurement (gains) losses — — — — — — — — (694) (694)\n\nInterest credited to policyholder account balances 48 796 647 114 19 103 — 1,727 563 2,290\n\nCapitalization of deferred policy acquisition costs (4) (61) (361) (178) (128) (5) (3) (740) — (740)\n\nAmortization of deferred policy acquisition costs and\n\nvalue of business acquired 6 15 210 125 91 59 2 508 — 508\n\nAmortization of negative value of business acquired — — (5) — (1) — — (6) — (6)\n\nInterest expense on debt — 4 — 3 — 4 253 264 — 264\n\nOther expenses 1,003 172 744 512 332 223 194 3,180 11 3,191\n\nTotal expenses 6,286 2,398 2,270 1,551 571 1,655 454 15,185 (173) 15,012\n\nProvision for income tax expense (benefit) 75 105 159 98 26 37 (70) 430 (260) 170\n\nAdjusted earnings $ 284 $ 399 $ 423 $ 233 $ 77 $ 159 $ (174) 1,401\n\nAdjustments to: Total revenues (959)\n\nTotal expenses 173\n\nProvision for income tax (expense) benefit 260\n\nNet income (loss) $ 875 $ 875\n\n14","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Table of Contents**\n\n**MetLife, Inc.**\n\n**Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)**\n\n**2\\. Segment Information (continued)**\n\n**Three Months Ended March 31, 2024**\n\n**Group Benefits RIS Asia**\n\n**Latin**\n\n**America EMEA**\n\n**MetLife Holdings**\n\n**Corporate & Other Total Adjustments**\n\n**Total**\n\n**Consolidated**\n\n**(In millions)**\n\n**Revenues** Premiums $ 5,711 $ 675 $ 1,297 $ 1,115 $ 536 $ 713 $ 6 $ 10,053 $ — $ 10,053\n\nUniversal life and investment-type product policy fees 222 75 426 370 77 78 — 1,248 — 1,248\n\nNet investment income 315 2,089 1,108 386 54 1,010 106 5,068 368 5,436\n\nOther revenues 397 63 21 11 7 50 98 647 27 674\n\nNet investment gains (losses) — — — — — — — — (375) (375)\n\nNet derivative gains (losses) — — — — — — — — (979) (979)\n\nTotal revenues 6,645 2,902 2,852 1,882 674 1,851 210 17,016 (959) 16,057\n\n**Expenses** Policyholder benefits and claims and policyholder dividends 5,236 1,471 1,067 983 258 1,251 8 10,274 (53) 10,221\n\nPolicyholder liability remeasurement (gains) losses (3) 1 (32) (8) — 20 — (22) — (22)\n\nMarket risk benefit remeasurement (gains) losses — — — — — — — — (694) (694)\n\nInterest credited to policyholder account balances 48 796 647 114 19 103 — 1,727 563 2,290\n\nCapitalization of deferred policy acquisition costs (4) (61) (361) (178) (128) (5) (3) (740) — (740)\n\nAmortization of deferred policy acquisition costs and\n\nvalue of business acquired 6 15 210 125 91 59 2 508 — 508\n\nAmortization of negative value of business acquired — — (5) — (1) — — (6) — (6)\n\nInterest expense on debt — 4 — 3 — 4 253 264 — 264\n\nOther expenses 1,003 172 744 512 332 223 194 3,180 11 3,191\n\nTotal expenses 6,286 2,398 2,270 1,551 571 1,655 454 15,185 (173) 15,012\n\nProvision for income tax expense (benefit) 75 105 159 98 26 37 (70) 430 (260) 170\n\nAdjusted earnings $ 284 $ 399 $ 423 $ 233 $ 77 $ 159 $ (174) 1,401\n\nAdjustments to: Total revenues (959)\n\nTotal expenses 173\n\nProvision for income tax (expense) benefit 260\n\nNet income (loss) $ 875 $ 875\n\n14","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/METLIFE-10Q-20240205%20unrestricted_page16.pdf"]},"response":{"errors":[],"extract_id":"extract_22ab06169aa2ace308334e289164b07c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Table of Contents**\n\n**MetLife, Inc.**\n\n**Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)**\n\n**2\\. Segment Information (continued)**\n\n**Three Months Ended March 31, 2024**\n\n**Group Benefits RIS Asia**\n\n**Latin**\n\n**America EMEA**\n\n**MetLife Holdings**\n\n**Corporate & Other Total Adjustments**\n\n**Total**\n\n**Consolidated**\n\n**(In millions)**\n\n**Revenues** Premiums $ 5,711 $ 675 $ 1,297 $ 1,115 $ 536 $ 713 $ 6 $ 10,053 $ — $ 10,053\n\nUniversal life and investment-type product policy fees 222 75 426 370 77 78 — 1,248 — 1,248\n\nNet investment income 315 2,089 1,108 386 54 1,010 106 5,068 368 5,436\n\nOther revenues 397 63 21 11 7 50 98 647 27 674\n\nNet investment gains (losses) — — — — — — — — (375) (375)\n\nNet derivative gains (losses) — — — — — — — — (979) (979)\n\nTotal revenues 6,645 2,902 2,852 1,882 674 1,851 210 17,016 (959) 16,057\n\n**Expenses** Policyholder benefits and claims and policyholder dividends 5,236 1,471 1,067 983 258 1,251 8 10,274 (53) 10,221\n\nPolicyholder liability remeasurement (gains) losses (3) 1 (32) (8) — 20 — (22) — (22)\n\nMarket risk benefit remeasurement (gains) losses — — — — — — — — (694) (694)\n\nInterest credited to policyholder account balances 48 796 647 114 19 103 — 1,727 563 2,290\n\nCapitalization of deferred policy acquisition costs (4) (61) (361) (178) (128) (5) (3) (740) — (740)\n\nAmortization of deferred policy acquisition costs and\n\nvalue of business acquired 6 15 210 125 91 59 2 508 — 508\n\nAmortization of negative value of business acquired — — (5) — (1) — — (6) — (6)\n\nInterest expense on debt — 4 — 3 — 4 253 264 — 264\n\nOther expenses 1,003 172 744 512 332 223 194 3,180 11 3,191\n\nTotal expenses 6,286 2,398 2,270 1,551 571 1,655 454 15,185 (173) 15,012\n\nProvision for income tax expense (benefit) 75 105 159 98 26 37 (70) 430 (260) 170\n\nAdjusted earnings $ 284 $ 399 $ 423 $ 233 $ 77 $ 159 $ (174) 1,401\n\nAdjustments to: Total revenues (959)\n\nTotal expenses 173\n\nProvision for income tax (expense) benefit 260\n\nNet income (loss) $ 875 $ 875\n\n14"],"full_content":"**Table of Contents**\n\n**MetLife, Inc.**\n\n**Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)**\n\n**2\\. Segment Information (continued)**\n\n**Three Months Ended March 31, 2024**\n\n**Group Benefits RIS Asia**\n\n**Latin**\n\n**America EMEA**\n\n**MetLife Holdings**\n\n**Corporate & Other Total Adjustments**\n\n**Total**\n\n**Consolidated**\n\n**(In millions)**\n\n**Revenues** Premiums $ 5,711 $ 675 $ 1,297 $ 1,115 $ 536 $ 713 $ 6 $ 10,053 $ — $ 10,053\n\nUniversal life and investment-type product policy fees 222 75 426 370 77 78 — 1,248 — 1,248\n\nNet investment income 315 2,089 1,108 386 54 1,010 106 5,068 368 5,436\n\nOther revenues 397 63 21 11 7 50 98 647 27 674\n\nNet investment gains (losses) — — — — — — — — (375) (375)\n\nNet derivative gains (losses) — — — — — — — — (979) (979)\n\nTotal revenues 6,645 2,902 2,852 1,882 674 1,851 210 17,016 (959) 16,057\n\n**Expenses** Policyholder benefits and claims and policyholder dividends 5,236 1,471 1,067 983 258 1,251 8 10,274 (53) 10,221\n\nPolicyholder liability remeasurement (gains) losses (3) 1 (32) (8) — 20 — (22) — (22)\n\nMarket risk benefit remeasurement (gains) losses — — — — — — — — (694) (694)\n\nInterest credited to policyholder account balances 48 796 647 114 19 103 — 1,727 563 2,290\n\nCapitalization of deferred policy acquisition costs (4) (61) (361) (178) (128) (5) (3) (740) — (740)\n\nAmortization of deferred policy acquisition costs and\n\nvalue of business acquired 6 15 210 125 91 59 2 508 — 508\n\nAmortization of negative value of business acquired — — (5) — (1) — — (6) — (6)\n\nInterest expense on debt — 4 — 3 — 4 253 264 — 264\n\nOther expenses 1,003 172 744 512 332 223 194 3,180 11 3,191\n\nTotal expenses 6,286 2,398 2,270 1,551 571 1,655 454 15,185 (173) 15,012\n\nProvision for income tax expense (benefit) 75 105 159 98 26 37 (70) 430 (260) 170\n\nAdjusted earnings $ 284 $ 399 $ 423 $ 233 $ 77 $ 159 $ (174) 1,401\n\nAdjustments to: Total revenues (959)\n\nTotal expenses 173\n\nProvision for income tax (expense) benefit 260\n\nNet income (loss) $ 875 $ 875\n\n14","publish_date":null,"title":"Table of Contents MetLife, Inc. Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued) 2. Segment Information (continued)","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/METLIFE-10Q-20240205%20unrestricted_page16.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/METLIFE-10Q-20240205%20unrestricted_page16.pdf"},"request":{"example_id":"table/METLIFE-10Q-20240205 unrestricted_page16","product_type":"parse","source_file_path":"METLIFE-10Q-20240205 unrestricted_page16.pdf"},"started_at":"2026-11-04T19:48:05.864836"} +{"completed_at":"2026-11-04T19:48:11.035149","latency_in_ms":3737,"output":{"example_id":"table/METLIFE-10Q-20240205 unrestricted_page8","grounded_pages":[],"layout_pages":[],"markdown":"**Table of Contents**\n\n**MetLife, Inc.**\n\n**Interim Condensed Consolidated Statements of Equity**\n\n**Three Months Ended March 31, 2024 and 2023 (Unaudited)**\n\n**(In millions)**\n\n**Preferred**\n\n**Stock**\n\n**Common**\n\n**Stock**\n\n**Additional**\n\n**Paid-in Capital**\n\n**Retained Earnings**\n\n**Treasury**\n\n**Stock at Cost**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive Income (Loss)**\n\n**Total**\n\n**MetLife, Inc.’s Stockholders’**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interests**\n\n**Total Equity**\n\nBalance at December 31, 2023 $ — $ 12 $ 33,690 $ 40,146 $ (24,591) $ (19,242) $ 30,015 $ 238 $ 30,253\n\nCumulative effects of changes in accounting principles, net of\n\nincome tax (219) (219) (219)\n\nTreasury stock acquired in connection with share repurchases\n\n(includes $11 million of excise tax) (1,183) (1,183) (1,183)\n\nStock-based compensation 28 28 28\n\nDividends on preferred stock (67) (67) (67)\n\nDividends on common stock (declared per share of $0.520) (377) (377) (377)\n\nChange in equity of noncontrolling interests — 14 14\n\nNet income (loss) 867 867 8 875\n\nOther comprehensive income (loss), net of income tax (529) (529) 1 (528)\n\nBalance at March 31, 2024 $ — $ 12 $ 33,718 $ 40,350 $ (25,774) $ (19,771) $ 28,535 $ 261 $ 28,796\n\n**Preferred**\n\n**Stock**\n\n**Common**\n\n**Stock**\n\n**Additional**\n\n**Paid-in Capital**\n\n**Retained Earnings**\n\n**Treasury**\n\n**Stock at Cost**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive Income (Loss)**\n\n**Total**\n\n**MetLife, Inc.’s Stockholders’**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interests**\n\n**Total Equity**\n\nBalance at December 31, 2022 $ — $ 12 $ 33,616 $ 40,332 $ (21,458) $ (22,621) $ 29,881 $ 244 $ 30,125\n\nTreasury stock acquired in connection with share repurchases\n\n(includes $7 million of excise tax) (787) (787) (787)\n\nStock-based compensation 1 1 1\n\nDividends on preferred stock (66) (66) (66)\n\nDividends on common stock (declared per share of $0.500) (389) (389) (389)\n\nChange in equity of noncontrolling interests — (2) (2)\n\nNet income (loss) 80 80 5 85\n\nOther comprehensive income (loss), net of income tax 3,474 3,474 (18) 3,456\n\nBalance at March 31, 2023 $ — $ 12 $ 33,617 $ 39,957 $ (22,245) $ (19,147) $ 32,194 $ 229 $ 32,423\n\n**See accompanying notes to the interim condensed consolidated financial statements.**\n\n6","pages":[{"line_numbers":[],"markdown":"**Table of Contents**\n\n**MetLife, Inc.**\n\n**Interim Condensed Consolidated Statements of Equity**\n\n**Three Months Ended March 31, 2024 and 2023 (Unaudited)**\n\n**(In millions)**\n\n**Preferred**\n\n**Stock**\n\n**Common**\n\n**Stock**\n\n**Additional**\n\n**Paid-in Capital**\n\n**Retained Earnings**\n\n**Treasury**\n\n**Stock at Cost**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive Income (Loss)**\n\n**Total**\n\n**MetLife, Inc.’s Stockholders’**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interests**\n\n**Total Equity**\n\nBalance at December 31, 2023 $ — $ 12 $ 33,690 $ 40,146 $ (24,591) $ (19,242) $ 30,015 $ 238 $ 30,253\n\nCumulative effects of changes in accounting principles, net of\n\nincome tax (219) (219) (219)\n\nTreasury stock acquired in connection with share repurchases\n\n(includes $11 million of excise tax) (1,183) (1,183) (1,183)\n\nStock-based compensation 28 28 28\n\nDividends on preferred stock (67) (67) (67)\n\nDividends on common stock (declared per share of $0.520) (377) (377) (377)\n\nChange in equity of noncontrolling interests — 14 14\n\nNet income (loss) 867 867 8 875\n\nOther comprehensive income (loss), net of income tax (529) (529) 1 (528)\n\nBalance at March 31, 2024 $ — $ 12 $ 33,718 $ 40,350 $ (25,774) $ (19,771) $ 28,535 $ 261 $ 28,796\n\n**Preferred**\n\n**Stock**\n\n**Common**\n\n**Stock**\n\n**Additional**\n\n**Paid-in Capital**\n\n**Retained Earnings**\n\n**Treasury**\n\n**Stock at Cost**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive Income (Loss)**\n\n**Total**\n\n**MetLife, Inc.’s Stockholders’**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interests**\n\n**Total Equity**\n\nBalance at December 31, 2022 $ — $ 12 $ 33,616 $ 40,332 $ (21,458) $ (22,621) $ 29,881 $ 244 $ 30,125\n\nTreasury stock acquired in connection with share repurchases\n\n(includes $7 million of excise tax) (787) (787) (787)\n\nStock-based compensation 1 1 1\n\nDividends on preferred stock (66) (66) (66)\n\nDividends on common stock (declared per share of $0.500) (389) (389) (389)\n\nChange in equity of noncontrolling interests — (2) (2)\n\nNet income (loss) 80 80 5 85\n\nOther comprehensive income (loss), net of income tax 3,474 3,474 (18) 3,456\n\nBalance at March 31, 2023 $ — $ 12 $ 33,617 $ 39,957 $ (22,245) $ (19,147) $ 32,194 $ 229 $ 32,423\n\n**See accompanying notes to the interim condensed consolidated financial statements.**\n\n6","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Table of Contents**\n\n**MetLife, Inc.**\n\n**Interim Condensed Consolidated Statements of Equity**\n\n**Three Months Ended March 31, 2024 and 2023 (Unaudited)**\n\n**(In millions)**\n\n**Preferred**\n\n**Stock**\n\n**Common**\n\n**Stock**\n\n**Additional**\n\n**Paid-in Capital**\n\n**Retained Earnings**\n\n**Treasury**\n\n**Stock at Cost**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive Income (Loss)**\n\n**Total**\n\n**MetLife, Inc.’s Stockholders’**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interests**\n\n**Total Equity**\n\nBalance at December 31, 2023 $ — $ 12 $ 33,690 $ 40,146 $ (24,591) $ (19,242) $ 30,015 $ 238 $ 30,253\n\nCumulative effects of changes in accounting principles, net of\n\nincome tax (219) (219) (219)\n\nTreasury stock acquired in connection with share repurchases\n\n(includes $11 million of excise tax) (1,183) (1,183) (1,183)\n\nStock-based compensation 28 28 28\n\nDividends on preferred stock (67) (67) (67)\n\nDividends on common stock (declared per share of $0.520) (377) (377) (377)\n\nChange in equity of noncontrolling interests — 14 14\n\nNet income (loss) 867 867 8 875\n\nOther comprehensive income (loss), net of income tax (529) (529) 1 (528)\n\nBalance at March 31, 2024 $ — $ 12 $ 33,718 $ 40,350 $ (25,774) $ (19,771) $ 28,535 $ 261 $ 28,796\n\n**Preferred**\n\n**Stock**\n\n**Common**\n\n**Stock**\n\n**Additional**\n\n**Paid-in Capital**\n\n**Retained Earnings**\n\n**Treasury**\n\n**Stock at Cost**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive Income (Loss)**\n\n**Total**\n\n**MetLife, Inc.’s Stockholders’**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interests**\n\n**Total Equity**\n\nBalance at December 31, 2022 $ — $ 12 $ 33,616 $ 40,332 $ (21,458) $ (22,621) $ 29,881 $ 244 $ 30,125\n\nTreasury stock acquired in connection with share repurchases\n\n(includes $7 million of excise tax) (787) (787) (787)\n\nStock-based compensation 1 1 1\n\nDividends on preferred stock (66) (66) (66)\n\nDividends on common stock (declared per share of $0.500) (389) (389) (389)\n\nChange in equity of noncontrolling interests — (2) (2)\n\nNet income (loss) 80 80 5 85\n\nOther comprehensive income (loss), net of income tax 3,474 3,474 (18) 3,456\n\nBalance at March 31, 2023 $ — $ 12 $ 33,617 $ 39,957 $ (22,245) $ (19,147) $ 32,194 $ 229 $ 32,423\n\n**See accompanying notes to the interim condensed consolidated financial statements.**\n\n6","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/METLIFE-10Q-20240205%20unrestricted_page8.pdf"]},"response":{"errors":[],"extract_id":"extract_cd641011f70ae1978227becc4a611b45","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Table of Contents**\n\n**MetLife, Inc.**\n\n**Interim Condensed Consolidated Statements of Equity**\n\n**Three Months Ended March 31, 2024 and 2023 (Unaudited)**\n\n**(In millions)**\n\n**Preferred**\n\n**Stock**\n\n**Common**\n\n**Stock**\n\n**Additional**\n\n**Paid-in Capital**\n\n**Retained Earnings**\n\n**Treasury**\n\n**Stock at Cost**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive Income (Loss)**\n\n**Total**\n\n**MetLife, Inc.’s Stockholders’**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interests**\n\n**Total Equity**\n\nBalance at December 31, 2023 $ — $ 12 $ 33,690 $ 40,146 $ (24,591) $ (19,242) $ 30,015 $ 238 $ 30,253\n\nCumulative effects of changes in accounting principles, net of\n\nincome tax (219) (219) (219)\n\nTreasury stock acquired in connection with share repurchases\n\n(includes $11 million of excise tax) (1,183) (1,183) (1,183)\n\nStock-based compensation 28 28 28\n\nDividends on preferred stock (67) (67) (67)\n\nDividends on common stock (declared per share of $0.520) (377) (377) (377)\n\nChange in equity of noncontrolling interests — 14 14\n\nNet income (loss) 867 867 8 875\n\nOther comprehensive income (loss), net of income tax (529) (529) 1 (528)\n\nBalance at March 31, 2024 $ — $ 12 $ 33,718 $ 40,350 $ (25,774) $ (19,771) $ 28,535 $ 261 $ 28,796\n\n**Preferred**\n\n**Stock**\n\n**Common**\n\n**Stock**\n\n**Additional**\n\n**Paid-in Capital**\n\n**Retained Earnings**\n\n**Treasury**\n\n**Stock at Cost**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive Income (Loss)**\n\n**Total**\n\n**MetLife, Inc.’s Stockholders’**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interests**\n\n**Total Equity**\n\nBalance at December 31, 2022 $ — $ 12 $ 33,616 $ 40,332 $ (21,458) $ (22,621) $ 29,881 $ 244 $ 30,125\n\nTreasury stock acquired in connection with share repurchases\n\n(includes $7 million of excise tax) (787) (787) (787)\n\nStock-based compensation 1 1 1\n\nDividends on preferred stock (66) (66) (66)\n\nDividends on common stock (declared per share of $0.500) (389) (389) (389)\n\nChange in equity of noncontrolling interests — (2) (2)\n\nNet income (loss) 80 80 5 85\n\nOther comprehensive income (loss), net of income tax 3,474 3,474 (18) 3,456\n\nBalance at March 31, 2023 $ — $ 12 $ 33,617 $ 39,957 $ (22,245) $ (19,147) $ 32,194 $ 229 $ 32,423\n\n**See accompanying notes to the interim condensed consolidated financial statements.**\n\n6"],"full_content":"**Table of Contents**\n\n**MetLife, Inc.**\n\n**Interim Condensed Consolidated Statements of Equity**\n\n**Three Months Ended March 31, 2024 and 2023 (Unaudited)**\n\n**(In millions)**\n\n**Preferred**\n\n**Stock**\n\n**Common**\n\n**Stock**\n\n**Additional**\n\n**Paid-in Capital**\n\n**Retained Earnings**\n\n**Treasury**\n\n**Stock at Cost**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive Income (Loss)**\n\n**Total**\n\n**MetLife, Inc.’s Stockholders’**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interests**\n\n**Total Equity**\n\nBalance at December 31, 2023 $ — $ 12 $ 33,690 $ 40,146 $ (24,591) $ (19,242) $ 30,015 $ 238 $ 30,253\n\nCumulative effects of changes in accounting principles, net of\n\nincome tax (219) (219) (219)\n\nTreasury stock acquired in connection with share repurchases\n\n(includes $11 million of excise tax) (1,183) (1,183) (1,183)\n\nStock-based compensation 28 28 28\n\nDividends on preferred stock (67) (67) (67)\n\nDividends on common stock (declared per share of $0.520) (377) (377) (377)\n\nChange in equity of noncontrolling interests — 14 14\n\nNet income (loss) 867 867 8 875\n\nOther comprehensive income (loss), net of income tax (529) (529) 1 (528)\n\nBalance at March 31, 2024 $ — $ 12 $ 33,718 $ 40,350 $ (25,774) $ (19,771) $ 28,535 $ 261 $ 28,796\n\n**Preferred**\n\n**Stock**\n\n**Common**\n\n**Stock**\n\n**Additional**\n\n**Paid-in Capital**\n\n**Retained Earnings**\n\n**Treasury**\n\n**Stock at Cost**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive Income (Loss)**\n\n**Total**\n\n**MetLife, Inc.’s Stockholders’**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interests**\n\n**Total Equity**\n\nBalance at December 31, 2022 $ — $ 12 $ 33,616 $ 40,332 $ (21,458) $ (22,621) $ 29,881 $ 244 $ 30,125\n\nTreasury stock acquired in connection with share repurchases\n\n(includes $7 million of excise tax) (787) (787) (787)\n\nStock-based compensation 1 1 1\n\nDividends on preferred stock (66) (66) (66)\n\nDividends on common stock (declared per share of $0.500) (389) (389) (389)\n\nChange in equity of noncontrolling interests — (2) (2)\n\nNet income (loss) 80 80 5 85\n\nOther comprehensive income (loss), net of income tax 3,474 3,474 (18) 3,456\n\nBalance at March 31, 2023 $ — $ 12 $ 33,617 $ 39,957 $ (22,245) $ (19,147) $ 32,194 $ 229 $ 32,423\n\n**See accompanying notes to the interim condensed consolidated financial statements.**\n\n6","publish_date":null,"title":"MetLife, Inc. Interim Condensed Consolidated Statements of Equity Three Months Ended March 31, 2024 and 2023 (Unaudited) (In millions)","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/METLIFE-10Q-20240205%20unrestricted_page8.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/METLIFE-10Q-20240205%20unrestricted_page8.pdf"},"request":{"example_id":"table/METLIFE-10Q-20240205 unrestricted_page8","product_type":"parse","source_file_path":"METLIFE-10Q-20240205 unrestricted_page8.pdf"},"started_at":"2026-11-04T19:48:07.297587"} +{"completed_at":"2026-11-04T19:48:10.761689","latency_in_ms":2653,"output":{"example_id":"table/NEE.2011.page_47.pdf_133659_page1","grounded_pages":[],"layout_pages":[],"markdown":"41\n\n**Item 6. Selected Financial Data**\n\nSELECTED DATA OF NEE (millions, except per share amounts):\n\nOperating revenues\n\nNet income (a)\n\nEarnings per share of common stock - basic\n\nEarnings per share of common stock - assuming dilution\n\nDividends paid per share of common stock\n\nTotal assets\n\nLong-term debt, excluding current maturities\n\nSELECTED DATA OF FPL (millions):\n\nOperating revenues\n\nNet income\n\nTotal assets\n\nLong-term debt, excluding current maturities\n\nEnergy sales (kwh)\n\nEnergy sales:\n\nResidential\n\nCommercial\n\nIndustrial\n\nInterchange power sales\n\nOther (b)\n\nTotal\n\nApproximate 60-minute peak load (mw): (c)\n\nSummer season\n\nWinter season\n\nAverage number of customer accounts (thousands):\n\nResidential\n\nCommercial\n\nIndustrial\n\nOther\n\nTotal\n\nAverage price billed to customers (cents per kwh)\n\nYears Ended December 31,\n\n2011\n\n$ 15,341\n\n$ 1,923\n\n$ 4.62\n\n$ 4.59\n\n$ 2.20\n\n$ 57,188\n\n$ 20,810\n\n$ 10,613\n\n$ 1,068\n\n$ 31,816\n\n$ 7,483\n\n106,662\n\n51\\.2%\n\n42\\.2\n\n2\\.9\n\n0\\.9\n\n2\\.8\n\n100\\.0%\n\n21,619\n\n17,934\n\n4,027\n\n508\n\n9\n\n3\n\n4,547\n\n9\\.83\n\n2010\n\n$ 15,317\n\n$ 1,957\n\n$ 4.77\n\n$ 4.74\n\n$ 2.00\n\n$ 52,994\n\n$ 18,013\n\n$ 10,485\n\n$ 945\n\n$ 28,698\n\n$ 6,682\n\n107,978\n\n52\\.2%\n\n41\\.3\n\n2\\.9\n\n0\\.8\n\n2\\.8\n\n100\\.0%\n\n22,256\n\n21,153\n\n4,004\n\n504\n\n9\n\n3\n\n4,520\n\n9\\.34\n\n2009\n\n$ 15,643\n\n$ 1,615\n\n$ 3.99\n\n$ 3.97\n\n$ 1.89\n\n$ 48,458\n\n$ 16,300\n\n$ 11,491\n\n$ 831\n\n$ 26,812\n\n$ 5,794\n\n105,414\n\n51\\.2%\n\n42\\.7\n\n3\\.1\n\n1\\.4\n\n1\\.6\n\n100\\.0%\n\n22,351\n\n24,346\n\n3,984\n\n501\n\n10\n\n4\n\n4,499\n\n11\\.19\n\n2008\n\n$ 16,410\n\n$ 1,639\n\n$ 4.10\n\n$ 4.07\n\n$ 1.78\n\n$ 44,821\n\n$ 13,833\n\n$ 11,649\n\n$ 789\n\n$ 26,175\n\n$ 5,311\n\n105,406\n\n50\\.5%\n\n43\\.2\n\n3\\.4\n\n1\\.6\n\n1\\.3\n\n100\\.0%\n\n21,060\n\n20,031\n\n3,992\n\n501\n\n13\n\n4\n\n4,510\n\n10\\.96\n\n2007\n\n$ 15,263\n\n$ 1,312\n\n$ 3.30\n\n$ 3.27\n\n$ 1.64\n\n$ 40,123\n\n$ 11,280\n\n$ 11,622\n\n$ 836\n\n$ 24,044\n\n$ 4,976\n\n108,636\n\n50\\.8%\n\n42\\.3\n\n3\\.5\n\n1\\.8\n\n1\\.6\n\n100\\.0%\n\n21,962\n\n18,055\n\n3,981\n\n493\n\n19\n\n4\n\n4,497\n\n10\\.63\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Includes net unrealized mark-to-market after-tax (gains) losses associated with non-qualifying hedges of $(190) million, $(175) million, $20 million, $(170) million and $86 million and OTTI after-tax losses, net of OTTI reversals of $6 million, $(4) million, $13 million, $76 million and $6 million for the years ended December 31, 2011, 2010, 2009, 2008 and 2007, respectively. Also, 2011 includes a loss on the sale of natural gas-fired generating assets of approximately $98 million. See Note 4 - Nonrecurring Fair Value Measurements. (b) Includes the net change in unbilled sales. (c) Winter season includes November and December of the current year and January to March of the following year (for 2011, through February 27, 2012).\n\n**Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations**\n\n**OVERVIEW**\n\nNEE’s operating performance is driven primarily by the operations of its two principal subsidiaries, FPL, which serves approximately 4.6 million customer accounts in Florida and is one of the largest rate-regulated electric utilities in the U.S., and NEER, which together with its affiliated entities is the largest generator in the U.S. of renewable energy from the wind and sun. The table below presents NEE’s net income and earnings per share by reportable segment - FPL, NEER and Corporate and Other, which is primarily comprised of interest expense, the operating results of FPL FiberNet, Lone Star and other business activities, as well as other income and expense items, including income taxes and eliminating entries (see Note 15 for additional segment information). The","pages":[{"line_numbers":[],"markdown":"41\n\n**Item 6. Selected Financial Data**\n\nSELECTED DATA OF NEE (millions, except per share amounts):\n\nOperating revenues\n\nNet income (a)\n\nEarnings per share of common stock - basic\n\nEarnings per share of common stock - assuming dilution\n\nDividends paid per share of common stock\n\nTotal assets\n\nLong-term debt, excluding current maturities\n\nSELECTED DATA OF FPL (millions):\n\nOperating revenues\n\nNet income\n\nTotal assets\n\nLong-term debt, excluding current maturities\n\nEnergy sales (kwh)\n\nEnergy sales:\n\nResidential\n\nCommercial\n\nIndustrial\n\nInterchange power sales\n\nOther (b)\n\nTotal\n\nApproximate 60-minute peak load (mw): (c)\n\nSummer season\n\nWinter season\n\nAverage number of customer accounts (thousands):\n\nResidential\n\nCommercial\n\nIndustrial\n\nOther\n\nTotal\n\nAverage price billed to customers (cents per kwh)\n\nYears Ended December 31,\n\n2011\n\n$ 15,341\n\n$ 1,923\n\n$ 4.62\n\n$ 4.59\n\n$ 2.20\n\n$ 57,188\n\n$ 20,810\n\n$ 10,613\n\n$ 1,068\n\n$ 31,816\n\n$ 7,483\n\n106,662\n\n51\\.2%\n\n42\\.2\n\n2\\.9\n\n0\\.9\n\n2\\.8\n\n100\\.0%\n\n21,619\n\n17,934\n\n4,027\n\n508\n\n9\n\n3\n\n4,547\n\n9\\.83\n\n2010\n\n$ 15,317\n\n$ 1,957\n\n$ 4.77\n\n$ 4.74\n\n$ 2.00\n\n$ 52,994\n\n$ 18,013\n\n$ 10,485\n\n$ 945\n\n$ 28,698\n\n$ 6,682\n\n107,978\n\n52\\.2%\n\n41\\.3\n\n2\\.9\n\n0\\.8\n\n2\\.8\n\n100\\.0%\n\n22,256\n\n21,153\n\n4,004\n\n504\n\n9\n\n3\n\n4,520\n\n9\\.34\n\n2009\n\n$ 15,643\n\n$ 1,615\n\n$ 3.99\n\n$ 3.97\n\n$ 1.89\n\n$ 48,458\n\n$ 16,300\n\n$ 11,491\n\n$ 831\n\n$ 26,812\n\n$ 5,794\n\n105,414\n\n51\\.2%\n\n42\\.7\n\n3\\.1\n\n1\\.4\n\n1\\.6\n\n100\\.0%\n\n22,351\n\n24,346\n\n3,984\n\n501\n\n10\n\n4\n\n4,499\n\n11\\.19\n\n2008\n\n$ 16,410\n\n$ 1,639\n\n$ 4.10\n\n$ 4.07\n\n$ 1.78\n\n$ 44,821\n\n$ 13,833\n\n$ 11,649\n\n$ 789\n\n$ 26,175\n\n$ 5,311\n\n105,406\n\n50\\.5%\n\n43\\.2\n\n3\\.4\n\n1\\.6\n\n1\\.3\n\n100\\.0%\n\n21,060\n\n20,031\n\n3,992\n\n501\n\n13\n\n4\n\n4,510\n\n10\\.96\n\n2007\n\n$ 15,263\n\n$ 1,312\n\n$ 3.30\n\n$ 3.27\n\n$ 1.64\n\n$ 40,123\n\n$ 11,280\n\n$ 11,622\n\n$ 836\n\n$ 24,044\n\n$ 4,976\n\n108,636\n\n50\\.8%\n\n42\\.3\n\n3\\.5\n\n1\\.8\n\n1\\.6\n\n100\\.0%\n\n21,962\n\n18,055\n\n3,981\n\n493\n\n19\n\n4\n\n4,497\n\n10\\.63\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Includes net unrealized mark-to-market after-tax (gains) losses associated with non-qualifying hedges of $(190) million, $(175) million, $20 million, $(170) million and $86 million and OTTI after-tax losses, net of OTTI reversals of $6 million, $(4) million, $13 million, $76 million and $6 million for the years ended December 31, 2011, 2010, 2009, 2008 and 2007, respectively. Also, 2011 includes a loss on the sale of natural gas-fired generating assets of approximately $98 million. See Note 4 - Nonrecurring Fair Value Measurements. (b) Includes the net change in unbilled sales. (c) Winter season includes November and December of the current year and January to March of the following year (for 2011, through February 27, 2012).\n\n**Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations**\n\n**OVERVIEW**\n\nNEE’s operating performance is driven primarily by the operations of its two principal subsidiaries, FPL, which serves approximately 4.6 million customer accounts in Florida and is one of the largest rate-regulated electric utilities in the U.S., and NEER, which together with its affiliated entities is the largest generator in the U.S. of renewable energy from the wind and sun. The table below presents NEE’s net income and earnings per share by reportable segment - FPL, NEER and Corporate and Other, which is primarily comprised of interest expense, the operating results of FPL FiberNet, Lone Star and other business activities, as well as other income and expense items, including income taxes and eliminating entries (see Note 15 for additional segment information). The","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"41\n\n**Item 6. Selected Financial Data**\n\nSELECTED DATA OF NEE (millions, except per share amounts):\n\nOperating revenues\n\nNet income (a)\n\nEarnings per share of common stock - basic\n\nEarnings per share of common stock - assuming dilution\n\nDividends paid per share of common stock\n\nTotal assets\n\nLong-term debt, excluding current maturities\n\nSELECTED DATA OF FPL (millions):\n\nOperating revenues\n\nNet income\n\nTotal assets\n\nLong-term debt, excluding current maturities\n\nEnergy sales (kwh)\n\nEnergy sales:\n\nResidential\n\nCommercial\n\nIndustrial\n\nInterchange power sales\n\nOther (b)\n\nTotal\n\nApproximate 60-minute peak load (mw): (c)\n\nSummer season\n\nWinter season\n\nAverage number of customer accounts (thousands):\n\nResidential\n\nCommercial\n\nIndustrial\n\nOther\n\nTotal\n\nAverage price billed to customers (cents per kwh)\n\nYears Ended December 31,\n\n2011\n\n$ 15,341\n\n$ 1,923\n\n$ 4.62\n\n$ 4.59\n\n$ 2.20\n\n$ 57,188\n\n$ 20,810\n\n$ 10,613\n\n$ 1,068\n\n$ 31,816\n\n$ 7,483\n\n106,662\n\n51\\.2%\n\n42\\.2\n\n2\\.9\n\n0\\.9\n\n2\\.8\n\n100\\.0%\n\n21,619\n\n17,934\n\n4,027\n\n508\n\n9\n\n3\n\n4,547\n\n9\\.83\n\n2010\n\n$ 15,317\n\n$ 1,957\n\n$ 4.77\n\n$ 4.74\n\n$ 2.00\n\n$ 52,994\n\n$ 18,013\n\n$ 10,485\n\n$ 945\n\n$ 28,698\n\n$ 6,682\n\n107,978\n\n52\\.2%\n\n41\\.3\n\n2\\.9\n\n0\\.8\n\n2\\.8\n\n100\\.0%\n\n22,256\n\n21,153\n\n4,004\n\n504\n\n9\n\n3\n\n4,520\n\n9\\.34\n\n2009\n\n$ 15,643\n\n$ 1,615\n\n$ 3.99\n\n$ 3.97\n\n$ 1.89\n\n$ 48,458\n\n$ 16,300\n\n$ 11,491\n\n$ 831\n\n$ 26,812\n\n$ 5,794\n\n105,414\n\n51\\.2%\n\n42\\.7\n\n3\\.1\n\n1\\.4\n\n1\\.6\n\n100\\.0%\n\n22,351\n\n24,346\n\n3,984\n\n501\n\n10\n\n4\n\n4,499\n\n11\\.19\n\n2008\n\n$ 16,410\n\n$ 1,639\n\n$ 4.10\n\n$ 4.07\n\n$ 1.78\n\n$ 44,821\n\n$ 13,833\n\n$ 11,649\n\n$ 789\n\n$ 26,175\n\n$ 5,311\n\n105,406\n\n50\\.5%\n\n43\\.2\n\n3\\.4\n\n1\\.6\n\n1\\.3\n\n100\\.0%\n\n21,060\n\n20,031\n\n3,992\n\n501\n\n13\n\n4\n\n4,510\n\n10\\.96\n\n2007\n\n$ 15,263\n\n$ 1,312\n\n$ 3.30\n\n$ 3.27\n\n$ 1.64\n\n$ 40,123\n\n$ 11,280\n\n$ 11,622\n\n$ 836\n\n$ 24,044\n\n$ 4,976\n\n108,636\n\n50\\.8%\n\n42\\.3\n\n3\\.5\n\n1\\.8\n\n1\\.6\n\n100\\.0%\n\n21,962\n\n18,055\n\n3,981\n\n493\n\n19\n\n4\n\n4,497\n\n10\\.63\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Includes net unrealized mark-to-market after-tax (gains) losses associated with non-qualifying hedges of $(190) million, $(175) million, $20 million, $(170) million and $86 million and OTTI after-tax losses, net of OTTI reversals of $6 million, $(4) million, $13 million, $76 million and $6 million for the years ended December 31, 2011, 2010, 2009, 2008 and 2007, respectively. Also, 2011 includes a loss on the sale of natural gas-fired generating assets of approximately $98 million. See Note 4 - Nonrecurring Fair Value Measurements. (b) Includes the net change in unbilled sales. (c) Winter season includes November and December of the current year and January to March of the following year (for 2011, through February 27, 2012).\n\n**Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations**\n\n**OVERVIEW**\n\nNEE’s operating performance is driven primarily by the operations of its two principal subsidiaries, FPL, which serves approximately 4.6 million customer accounts in Florida and is one of the largest rate-regulated electric utilities in the U.S., and NEER, which together with its affiliated entities is the largest generator in the U.S. of renewable energy from the wind and sun. The table below presents NEE’s net income and earnings per share by reportable segment - FPL, NEER and Corporate and Other, which is primarily comprised of interest expense, the operating results of FPL FiberNet, Lone Star and other business activities, as well as other income and expense items, including income taxes and eliminating entries (see Note 15 for additional segment information). The","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/NEE.2011.page_47.pdf_133659_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_476e71461a76547cf5fcf21792a07518","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["41\n\n**Item 6. Selected Financial Data**\n\nSELECTED DATA OF NEE (millions, except per share amounts):\n\nOperating revenues\n\nNet income (a)\n\nEarnings per share of common stock - basic\n\nEarnings per share of common stock - assuming dilution\n\nDividends paid per share of common stock\n\nTotal assets\n\nLong-term debt, excluding current maturities\n\nSELECTED DATA OF FPL (millions):\n\nOperating revenues\n\nNet income\n\nTotal assets\n\nLong-term debt, excluding current maturities\n\nEnergy sales (kwh)\n\nEnergy sales:\n\nResidential\n\nCommercial\n\nIndustrial\n\nInterchange power sales\n\nOther (b)\n\nTotal\n\nApproximate 60-minute peak load (mw): (c)\n\nSummer season\n\nWinter season\n\nAverage number of customer accounts (thousands):\n\nResidential\n\nCommercial\n\nIndustrial\n\nOther\n\nTotal\n\nAverage price billed to customers (cents per kwh)\n\nYears Ended December 31,\n\n2011\n\n$ 15,341\n\n$ 1,923\n\n$ 4.62\n\n$ 4.59\n\n$ 2.20\n\n$ 57,188\n\n$ 20,810\n\n$ 10,613\n\n$ 1,068\n\n$ 31,816\n\n$ 7,483\n\n106,662\n\n51\\.2%\n\n42\\.2\n\n2\\.9\n\n0\\.9\n\n2\\.8\n\n100\\.0%\n\n21,619\n\n17,934\n\n4,027\n\n508\n\n9\n\n3\n\n4,547\n\n9\\.83\n\n2010\n\n$ 15,317\n\n$ 1,957\n\n$ 4.77\n\n$ 4.74\n\n$ 2.00\n\n$ 52,994\n\n$ 18,013\n\n$ 10,485\n\n$ 945\n\n$ 28,698\n\n$ 6,682\n\n107,978\n\n52\\.2%\n\n41\\.3\n\n2\\.9\n\n0\\.8\n\n2\\.8\n\n100\\.0%\n\n22,256\n\n21,153\n\n4,004\n\n504\n\n9\n\n3\n\n4,520\n\n9\\.34\n\n2009\n\n$ 15,643\n\n$ 1,615\n\n$ 3.99\n\n$ 3.97\n\n$ 1.89\n\n$ 48,458\n\n$ 16,300\n\n$ 11,491\n\n$ 831\n\n$ 26,812\n\n$ 5,794\n\n105,414\n\n51\\.2%\n\n42\\.7\n\n3\\.1\n\n1\\.4\n\n1\\.6\n\n100\\.0%\n\n22,351\n\n24,346\n\n3,984\n\n501\n\n10\n\n4\n\n4,499\n\n11\\.19\n\n2008\n\n$ 16,410\n\n$ 1,639\n\n$ 4.10\n\n$ 4.07\n\n$ 1.78\n\n$ 44,821\n\n$ 13,833\n\n$ 11,649\n\n$ 789\n\n$ 26,175\n\n$ 5,311\n\n105,406\n\n50\\.5%\n\n43\\.2\n\n3\\.4\n\n1\\.6\n\n1\\.3\n\n100\\.0%\n\n21,060\n\n20,031\n\n3,992\n\n501\n\n13\n\n4\n\n4,510\n\n10\\.96\n\n2007\n\n$ 15,263\n\n$ 1,312\n\n$ 3.30\n\n$ 3.27\n\n$ 1.64\n\n$ 40,123\n\n$ 11,280\n\n$ 11,622\n\n$ 836\n\n$ 24,044\n\n$ 4,976\n\n108,636\n\n50\\.8%\n\n42\\.3\n\n3\\.5\n\n1\\.8\n\n1\\.6\n\n100\\.0%\n\n21,962\n\n18,055\n\n3,981\n\n493\n\n19\n\n4\n\n4,497\n\n10\\.63\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Includes net unrealized mark-to-market after-tax (gains) losses associated with non-qualifying hedges of $(190) million, $(175) million, $20 million, $(170) million and $86 million and OTTI after-tax losses, net of OTTI reversals of $6 million, $(4) million, $13 million, $76 million and $6 million for the years ended December 31, 2011, 2010, 2009, 2008 and 2007, respectively. Also, 2011 includes a loss on the sale of natural gas-fired generating assets of approximately $98 million. See Note 4 - Nonrecurring Fair Value Measurements. (b) Includes the net change in unbilled sales. (c) Winter season includes November and December of the current year and January to March of the following year (for 2011, through February 27, 2012).\n\n**Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations**\n\n**OVERVIEW**\n\nNEE’s operating performance is driven primarily by the operations of its two principal subsidiaries, FPL, which serves approximately 4.6 million customer accounts in Florida and is one of the largest rate-regulated electric utilities in the U.S., and NEER, which together with its affiliated entities is the largest generator in the U.S. of renewable energy from the wind and sun. The table below presents NEE’s net income and earnings per share by reportable segment - FPL, NEER and Corporate and Other, which is primarily comprised of interest expense, the operating results of FPL FiberNet, Lone Star and other business activities, as well as other income and expense items, including income taxes and eliminating entries (see Note 15 for additional segment information). The"],"full_content":"41\n\n**Item 6. Selected Financial Data**\n\nSELECTED DATA OF NEE (millions, except per share amounts):\n\nOperating revenues\n\nNet income (a)\n\nEarnings per share of common stock - basic\n\nEarnings per share of common stock - assuming dilution\n\nDividends paid per share of common stock\n\nTotal assets\n\nLong-term debt, excluding current maturities\n\nSELECTED DATA OF FPL (millions):\n\nOperating revenues\n\nNet income\n\nTotal assets\n\nLong-term debt, excluding current maturities\n\nEnergy sales (kwh)\n\nEnergy sales:\n\nResidential\n\nCommercial\n\nIndustrial\n\nInterchange power sales\n\nOther (b)\n\nTotal\n\nApproximate 60-minute peak load (mw): (c)\n\nSummer season\n\nWinter season\n\nAverage number of customer accounts (thousands):\n\nResidential\n\nCommercial\n\nIndustrial\n\nOther\n\nTotal\n\nAverage price billed to customers (cents per kwh)\n\nYears Ended December 31,\n\n2011\n\n$ 15,341\n\n$ 1,923\n\n$ 4.62\n\n$ 4.59\n\n$ 2.20\n\n$ 57,188\n\n$ 20,810\n\n$ 10,613\n\n$ 1,068\n\n$ 31,816\n\n$ 7,483\n\n106,662\n\n51\\.2%\n\n42\\.2\n\n2\\.9\n\n0\\.9\n\n2\\.8\n\n100\\.0%\n\n21,619\n\n17,934\n\n4,027\n\n508\n\n9\n\n3\n\n4,547\n\n9\\.83\n\n2010\n\n$ 15,317\n\n$ 1,957\n\n$ 4.77\n\n$ 4.74\n\n$ 2.00\n\n$ 52,994\n\n$ 18,013\n\n$ 10,485\n\n$ 945\n\n$ 28,698\n\n$ 6,682\n\n107,978\n\n52\\.2%\n\n41\\.3\n\n2\\.9\n\n0\\.8\n\n2\\.8\n\n100\\.0%\n\n22,256\n\n21,153\n\n4,004\n\n504\n\n9\n\n3\n\n4,520\n\n9\\.34\n\n2009\n\n$ 15,643\n\n$ 1,615\n\n$ 3.99\n\n$ 3.97\n\n$ 1.89\n\n$ 48,458\n\n$ 16,300\n\n$ 11,491\n\n$ 831\n\n$ 26,812\n\n$ 5,794\n\n105,414\n\n51\\.2%\n\n42\\.7\n\n3\\.1\n\n1\\.4\n\n1\\.6\n\n100\\.0%\n\n22,351\n\n24,346\n\n3,984\n\n501\n\n10\n\n4\n\n4,499\n\n11\\.19\n\n2008\n\n$ 16,410\n\n$ 1,639\n\n$ 4.10\n\n$ 4.07\n\n$ 1.78\n\n$ 44,821\n\n$ 13,833\n\n$ 11,649\n\n$ 789\n\n$ 26,175\n\n$ 5,311\n\n105,406\n\n50\\.5%\n\n43\\.2\n\n3\\.4\n\n1\\.6\n\n1\\.3\n\n100\\.0%\n\n21,060\n\n20,031\n\n3,992\n\n501\n\n13\n\n4\n\n4,510\n\n10\\.96\n\n2007\n\n$ 15,263\n\n$ 1,312\n\n$ 3.30\n\n$ 3.27\n\n$ 1.64\n\n$ 40,123\n\n$ 11,280\n\n$ 11,622\n\n$ 836\n\n$ 24,044\n\n$ 4,976\n\n108,636\n\n50\\.8%\n\n42\\.3\n\n3\\.5\n\n1\\.8\n\n1\\.6\n\n100\\.0%\n\n21,962\n\n18,055\n\n3,981\n\n493\n\n19\n\n4\n\n4,497\n\n10\\.63\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Includes net unrealized mark-to-market after-tax (gains) losses associated with non-qualifying hedges of $(190) million, $(175) million, $20 million, $(170) million and $86 million and OTTI after-tax losses, net of OTTI reversals of $6 million, $(4) million, $13 million, $76 million and $6 million for the years ended December 31, 2011, 2010, 2009, 2008 and 2007, respectively. Also, 2011 includes a loss on the sale of natural gas-fired generating assets of approximately $98 million. See Note 4 - Nonrecurring Fair Value Measurements. (b) Includes the net change in unbilled sales. (c) Winter season includes November and December of the current year and January to March of the following year (for 2011, through February 27, 2012).\n\n**Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations**\n\n**OVERVIEW**\n\nNEE’s operating performance is driven primarily by the operations of its two principal subsidiaries, FPL, which serves approximately 4.6 million customer accounts in Florida and is one of the largest rate-regulated electric utilities in the U.S., and NEER, which together with its affiliated entities is the largest generator in the U.S. of renewable energy from the wind and sun. The table below presents NEE’s net income and earnings per share by reportable segment - FPL, NEER and Corporate and Other, which is primarily comprised of interest expense, the operating results of FPL FiberNet, Lone Star and other business activities, as well as other income and expense items, including income taxes and eliminating entries (see Note 15 for additional segment information). The","publish_date":null,"title":"Item 6. Selected Financial Data Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations OVERVIEW","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/NEE.2011.page_47.pdf_133659_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/NEE.2011.page_47.pdf_133659_page1.pdf"},"request":{"example_id":"table/NEE.2011.page_47.pdf_133659_page1","product_type":"parse","source_file_path":"NEE.2011.page_47.pdf_133659_page1.pdf"},"started_at":"2026-11-04T19:48:08.108140"} +{"completed_at":"2026-11-04T19:48:13.060760","latency_in_ms":3492,"output":{"example_id":"table/NFLX.2005.page_70.pdf_72335_page1","grounded_pages":[],"layout_pages":[],"markdown":"**NETFLIX, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) (in thousands, except share and per share data and percentages)**\n\nprofit and Operating expenses in the Consolidated Statements of Income for 2003 and 2004 have been reclassified to conform to the 2005 presentation.\n\nThe reclassifications did not impact operating income or net income, working capital or net cash provided by operating activities as previously reported. The following amounts were reclassified for 2003 and 2004:\n\n**Year ended December 31, 2003 Year ended December 31, 2004**\n\n**Consolidated Statements of Income**\n\n**As previously reported Reclassifications**\n\n**As Reclassified**\n\n**As previously reported Reclassifications**\n\n**As Reclassified**\n\nRevenues: Subscription . . . . . . . . . . . . . . . . $270,410 $ — $270,410 $500,611 $ — $500,611 Sales . . . . . . . . . . . . . . . . . . . . . . 1,833 (1,833) — 5,617 (5,617) —\n\nTotal revenues . . . . . . . . . . 272,243 (1,833) 270,410 506,228 (5,617) 500,611 Cost of revenues: — Subscription . . . . . . . . . . . . . . . . 147,736 — 147,736 273,401 — 273,401 Sales . . . . . . . . . . . . . . . . . . . . . . 624 (624) — 3,057 (3,057) — Fulfillment expenses . . . . . . . . . — 31,274 31,274 — 56,609 56,609\n\nTotal cost of revenues . . . . 148,360 30,650 179,010 276,458 53,552 330,010\n\nGross profit . . . . . . . . . . . . . . . . . . . . . 123,883 (32,483) 91,400 229,770 (59,169) 170,601 Operating expenses: Fulfillment . . . . . . . . . . . . . . . . . 31,274 (31,274) — 56,609 (56,609) — Technology and development . . 17,884 — 17,884 22,906 — 22,906 Marketing . . . . . . . . . . . . . . . . . . 49,949 — 49,949 98,027 — 98,027 General and administrative . . . . 9,585 — 9,585 16,287 — 16,287 Stock-based compensation . . . . . 10,719 — 10,719 16,587 — 16,587 Gain on disposal of DVDs . . . . . — (1,209) (1,209) — (2,560) (2,560)\n\nTotal operating expenses . . 119,411 (32,483) 86,928 210,416 (59,169) 151,247\n\nOperating income . . . . . . . . . . . . . . . . 4,472 — 4,472 19,354 — 19,354 Other income (expense): Interest and other income . . . . . . 2,457 — 2,457 2,592 — 2,592 Interest and other expense. . . . . . (417) — (417) (170) — (170)\n\nIncome before income taxes . . . . . . . 6,512 — 6,512 21,776 — 21,776 Provision for (benefit from) income taxes . . . . . . . . . . . . . . . . . . . . . . . . — — — 181 — 181\n\nNet income . . . . . . . . . . . . . . . . . . . . . $ 6,512 $ — $ 6,512 $ 21,595 $ — $ 21,595\n\n**_Stock Split_**\n\nOn January 16, 2004, the Company’s Board of Directors approved a two-for-one stock split in the form of a stock dividend on all outstanding shares of the Company’s common stock. As a result of the stock split, the Company’s stockholders received one additional share for each share of common stock held on the record date of February 2, 2004. The additional shares of common stock were distributed on February 11, 2004. All common share and per-share amounts in the accompanying consolidated financial statements and related notes have been retroactively adjusted to reflect the stock split for all years presented.\n\n**_Fair Value of Financial Instruments_**\n\nThe fair value of the Company’s cash, short-term investments, accounts payable, accrued expenses and capital lease obligations approximates their carrying value due to their short maturity.\n\nF-10","pages":[{"line_numbers":[],"markdown":"**NETFLIX, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) (in thousands, except share and per share data and percentages)**\n\nprofit and Operating expenses in the Consolidated Statements of Income for 2003 and 2004 have been reclassified to conform to the 2005 presentation.\n\nThe reclassifications did not impact operating income or net income, working capital or net cash provided by operating activities as previously reported. The following amounts were reclassified for 2003 and 2004:\n\n**Year ended December 31, 2003 Year ended December 31, 2004**\n\n**Consolidated Statements of Income**\n\n**As previously reported Reclassifications**\n\n**As Reclassified**\n\n**As previously reported Reclassifications**\n\n**As Reclassified**\n\nRevenues: Subscription . . . . . . . . . . . . . . . . $270,410 $ — $270,410 $500,611 $ — $500,611 Sales . . . . . . . . . . . . . . . . . . . . . . 1,833 (1,833) — 5,617 (5,617) —\n\nTotal revenues . . . . . . . . . . 272,243 (1,833) 270,410 506,228 (5,617) 500,611 Cost of revenues: — Subscription . . . . . . . . . . . . . . . . 147,736 — 147,736 273,401 — 273,401 Sales . . . . . . . . . . . . . . . . . . . . . . 624 (624) — 3,057 (3,057) — Fulfillment expenses . . . . . . . . . — 31,274 31,274 — 56,609 56,609\n\nTotal cost of revenues . . . . 148,360 30,650 179,010 276,458 53,552 330,010\n\nGross profit . . . . . . . . . . . . . . . . . . . . . 123,883 (32,483) 91,400 229,770 (59,169) 170,601 Operating expenses: Fulfillment . . . . . . . . . . . . . . . . . 31,274 (31,274) — 56,609 (56,609) — Technology and development . . 17,884 — 17,884 22,906 — 22,906 Marketing . . . . . . . . . . . . . . . . . . 49,949 — 49,949 98,027 — 98,027 General and administrative . . . . 9,585 — 9,585 16,287 — 16,287 Stock-based compensation . . . . . 10,719 — 10,719 16,587 — 16,587 Gain on disposal of DVDs . . . . . — (1,209) (1,209) — (2,560) (2,560)\n\nTotal operating expenses . . 119,411 (32,483) 86,928 210,416 (59,169) 151,247\n\nOperating income . . . . . . . . . . . . . . . . 4,472 — 4,472 19,354 — 19,354 Other income (expense): Interest and other income . . . . . . 2,457 — 2,457 2,592 — 2,592 Interest and other expense. . . . . . (417) — (417) (170) — (170)\n\nIncome before income taxes . . . . . . . 6,512 — 6,512 21,776 — 21,776 Provision for (benefit from) income taxes . . . . . . . . . . . . . . . . . . . . . . . . — — — 181 — 181\n\nNet income . . . . . . . . . . . . . . . . . . . . . $ 6,512 $ — $ 6,512 $ 21,595 $ — $ 21,595\n\n**_Stock Split_**\n\nOn January 16, 2004, the Company’s Board of Directors approved a two-for-one stock split in the form of a stock dividend on all outstanding shares of the Company’s common stock. As a result of the stock split, the Company’s stockholders received one additional share for each share of common stock held on the record date of February 2, 2004. The additional shares of common stock were distributed on February 11, 2004. All common share and per-share amounts in the accompanying consolidated financial statements and related notes have been retroactively adjusted to reflect the stock split for all years presented.\n\n**_Fair Value of Financial Instruments_**\n\nThe fair value of the Company’s cash, short-term investments, accounts payable, accrued expenses and capital lease obligations approximates their carrying value due to their short maturity.\n\nF-10","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**NETFLIX, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) (in thousands, except share and per share data and percentages)**\n\nprofit and Operating expenses in the Consolidated Statements of Income for 2003 and 2004 have been reclassified to conform to the 2005 presentation.\n\nThe reclassifications did not impact operating income or net income, working capital or net cash provided by operating activities as previously reported. The following amounts were reclassified for 2003 and 2004:\n\n**Year ended December 31, 2003 Year ended December 31, 2004**\n\n**Consolidated Statements of Income**\n\n**As previously reported Reclassifications**\n\n**As Reclassified**\n\n**As previously reported Reclassifications**\n\n**As Reclassified**\n\nRevenues: Subscription . . . . . . . . . . . . . . . . $270,410 $ — $270,410 $500,611 $ — $500,611 Sales . . . . . . . . . . . . . . . . . . . . . . 1,833 (1,833) — 5,617 (5,617) —\n\nTotal revenues . . . . . . . . . . 272,243 (1,833) 270,410 506,228 (5,617) 500,611 Cost of revenues: — Subscription . . . . . . . . . . . . . . . . 147,736 — 147,736 273,401 — 273,401 Sales . . . . . . . . . . . . . . . . . . . . . . 624 (624) — 3,057 (3,057) — Fulfillment expenses . . . . . . . . . — 31,274 31,274 — 56,609 56,609\n\nTotal cost of revenues . . . . 148,360 30,650 179,010 276,458 53,552 330,010\n\nGross profit . . . . . . . . . . . . . . . . . . . . . 123,883 (32,483) 91,400 229,770 (59,169) 170,601 Operating expenses: Fulfillment . . . . . . . . . . . . . . . . . 31,274 (31,274) — 56,609 (56,609) — Technology and development . . 17,884 — 17,884 22,906 — 22,906 Marketing . . . . . . . . . . . . . . . . . . 49,949 — 49,949 98,027 — 98,027 General and administrative . . . . 9,585 — 9,585 16,287 — 16,287 Stock-based compensation . . . . . 10,719 — 10,719 16,587 — 16,587 Gain on disposal of DVDs . . . . . — (1,209) (1,209) — (2,560) (2,560)\n\nTotal operating expenses . . 119,411 (32,483) 86,928 210,416 (59,169) 151,247\n\nOperating income . . . . . . . . . . . . . . . . 4,472 — 4,472 19,354 — 19,354 Other income (expense): Interest and other income . . . . . . 2,457 — 2,457 2,592 — 2,592 Interest and other expense. . . . . . (417) — (417) (170) — (170)\n\nIncome before income taxes . . . . . . . 6,512 — 6,512 21,776 — 21,776 Provision for (benefit from) income taxes . . . . . . . . . . . . . . . . . . . . . . . . — — — 181 — 181\n\nNet income . . . . . . . . . . . . . . . . . . . . . $ 6,512 $ — $ 6,512 $ 21,595 $ — $ 21,595\n\n**_Stock Split_**\n\nOn January 16, 2004, the Company’s Board of Directors approved a two-for-one stock split in the form of a stock dividend on all outstanding shares of the Company’s common stock. As a result of the stock split, the Company’s stockholders received one additional share for each share of common stock held on the record date of February 2, 2004. The additional shares of common stock were distributed on February 11, 2004. All common share and per-share amounts in the accompanying consolidated financial statements and related notes have been retroactively adjusted to reflect the stock split for all years presented.\n\n**_Fair Value of Financial Instruments_**\n\nThe fair value of the Company’s cash, short-term investments, accounts payable, accrued expenses and capital lease obligations approximates their carrying value due to their short maturity.\n\nF-10","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/NFLX.2005.page_70.pdf_72335_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_7e002c7aa593b3fe14f4ba231c9a83d3","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**NETFLIX, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) (in thousands, except share and per share data and percentages)**\n\nprofit and Operating expenses in the Consolidated Statements of Income for 2003 and 2004 have been reclassified to conform to the 2005 presentation.\n\nThe reclassifications did not impact operating income or net income, working capital or net cash provided by operating activities as previously reported. The following amounts were reclassified for 2003 and 2004:\n\n**Year ended December 31, 2003 Year ended December 31, 2004**\n\n**Consolidated Statements of Income**\n\n**As previously reported Reclassifications**\n\n**As Reclassified**\n\n**As previously reported Reclassifications**\n\n**As Reclassified**\n\nRevenues: Subscription . . . . . . . . . . . . . . . . $270,410 $ — $270,410 $500,611 $ — $500,611 Sales . . . . . . . . . . . . . . . . . . . . . . 1,833 (1,833) — 5,617 (5,617) —\n\nTotal revenues . . . . . . . . . . 272,243 (1,833) 270,410 506,228 (5,617) 500,611 Cost of revenues: — Subscription . . . . . . . . . . . . . . . . 147,736 — 147,736 273,401 — 273,401 Sales . . . . . . . . . . . . . . . . . . . . . . 624 (624) — 3,057 (3,057) — Fulfillment expenses . . . . . . . . . — 31,274 31,274 — 56,609 56,609\n\nTotal cost of revenues . . . . 148,360 30,650 179,010 276,458 53,552 330,010\n\nGross profit . . . . . . . . . . . . . . . . . . . . . 123,883 (32,483) 91,400 229,770 (59,169) 170,601 Operating expenses: Fulfillment . . . . . . . . . . . . . . . . . 31,274 (31,274) — 56,609 (56,609) — Technology and development . . 17,884 — 17,884 22,906 — 22,906 Marketing . . . . . . . . . . . . . . . . . . 49,949 — 49,949 98,027 — 98,027 General and administrative . . . . 9,585 — 9,585 16,287 — 16,287 Stock-based compensation . . . . . 10,719 — 10,719 16,587 — 16,587 Gain on disposal of DVDs . . . . . — (1,209) (1,209) — (2,560) (2,560)\n\nTotal operating expenses . . 119,411 (32,483) 86,928 210,416 (59,169) 151,247\n\nOperating income . . . . . . . . . . . . . . . . 4,472 — 4,472 19,354 — 19,354 Other income (expense): Interest and other income . . . . . . 2,457 — 2,457 2,592 — 2,592 Interest and other expense. . . . . . (417) — (417) (170) — (170)\n\nIncome before income taxes . . . . . . . 6,512 — 6,512 21,776 — 21,776 Provision for (benefit from) income taxes . . . . . . . . . . . . . . . . . . . . . . . . — — — 181 — 181\n\nNet income . . . . . . . . . . . . . . . . . . . . . $ 6,512 $ — $ 6,512 $ 21,595 $ — $ 21,595\n\n**_Stock Split_**\n\nOn January 16, 2004, the Company’s Board of Directors approved a two-for-one stock split in the form of a stock dividend on all outstanding shares of the Company’s common stock. As a result of the stock split, the Company’s stockholders received one additional share for each share of common stock held on the record date of February 2, 2004. The additional shares of common stock were distributed on February 11, 2004. All common share and per-share amounts in the accompanying consolidated financial statements and related notes have been retroactively adjusted to reflect the stock split for all years presented.\n\n**_Fair Value of Financial Instruments_**\n\nThe fair value of the Company’s cash, short-term investments, accounts payable, accrued expenses and capital lease obligations approximates their carrying value due to their short maturity.\n\nF-10"],"full_content":"**NETFLIX, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued) (in thousands, except share and per share data and percentages)**\n\nprofit and Operating expenses in the Consolidated Statements of Income for 2003 and 2004 have been reclassified to conform to the 2005 presentation.\n\nThe reclassifications did not impact operating income or net income, working capital or net cash provided by operating activities as previously reported. The following amounts were reclassified for 2003 and 2004:\n\n**Year ended December 31, 2003 Year ended December 31, 2004**\n\n**Consolidated Statements of Income**\n\n**As previously reported Reclassifications**\n\n**As Reclassified**\n\n**As previously reported Reclassifications**\n\n**As Reclassified**\n\nRevenues: Subscription . . . . . . . . . . . . . . . . $270,410 $ — $270,410 $500,611 $ — $500,611 Sales . . . . . . . . . . . . . . . . . . . . . . 1,833 (1,833) — 5,617 (5,617) —\n\nTotal revenues . . . . . . . . . . 272,243 (1,833) 270,410 506,228 (5,617) 500,611 Cost of revenues: — Subscription . . . . . . . . . . . . . . . . 147,736 — 147,736 273,401 — 273,401 Sales . . . . . . . . . . . . . . . . . . . . . . 624 (624) — 3,057 (3,057) — Fulfillment expenses . . . . . . . . . — 31,274 31,274 — 56,609 56,609\n\nTotal cost of revenues . . . . 148,360 30,650 179,010 276,458 53,552 330,010\n\nGross profit . . . . . . . . . . . . . . . . . . . . . 123,883 (32,483) 91,400 229,770 (59,169) 170,601 Operating expenses: Fulfillment . . . . . . . . . . . . . . . . . 31,274 (31,274) — 56,609 (56,609) — Technology and development . . 17,884 — 17,884 22,906 — 22,906 Marketing . . . . . . . . . . . . . . . . . . 49,949 — 49,949 98,027 — 98,027 General and administrative . . . . 9,585 — 9,585 16,287 — 16,287 Stock-based compensation . . . . . 10,719 — 10,719 16,587 — 16,587 Gain on disposal of DVDs . . . . . — (1,209) (1,209) — (2,560) (2,560)\n\nTotal operating expenses . . 119,411 (32,483) 86,928 210,416 (59,169) 151,247\n\nOperating income . . . . . . . . . . . . . . . . 4,472 — 4,472 19,354 — 19,354 Other income (expense): Interest and other income . . . . . . 2,457 — 2,457 2,592 — 2,592 Interest and other expense. . . . . . (417) — (417) (170) — (170)\n\nIncome before income taxes . . . . . . . 6,512 — 6,512 21,776 — 21,776 Provision for (benefit from) income taxes . . . . . . . . . . . . . . . . . . . . . . . . — — — 181 — 181\n\nNet income . . . . . . . . . . . . . . . . . . . . . $ 6,512 $ — $ 6,512 $ 21,595 $ — $ 21,595\n\n**_Stock Split_**\n\nOn January 16, 2004, the Company’s Board of Directors approved a two-for-one stock split in the form of a stock dividend on all outstanding shares of the Company’s common stock. As a result of the stock split, the Company’s stockholders received one additional share for each share of common stock held on the record date of February 2, 2004. The additional shares of common stock were distributed on February 11, 2004. All common share and per-share amounts in the accompanying consolidated financial statements and related notes have been retroactively adjusted to reflect the stock split for all years presented.\n\n**_Fair Value of Financial Instruments_**\n\nThe fair value of the Company’s cash, short-term investments, accounts payable, accrued expenses and capital lease obligations approximates their carrying value due to their short maturity.\n\nF-10","publish_date":null,"title":"NETFLIX,INC. NOTESTOCONSOLIDATEDFINANCIALSTATEMENTS—(Continued) (inthousands,exceptshareandpersharedataandpercentages) profit and Operating expenses in the Consolidated Statements of Income for 2003 and 2004 have been reclassifiedtoconformtothe2005presentation.","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/NFLX.2005.page_70.pdf_72335_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/NFLX.2005.page_70.pdf_72335_page1.pdf"},"request":{"example_id":"table/NFLX.2005.page_70.pdf_72335_page1","product_type":"parse","source_file_path":"NFLX.2005.page_70.pdf_72335_page1.pdf"},"started_at":"2026-11-04T19:48:09.568729"} +{"completed_at":"2026-11-04T19:48:13.156153","latency_in_ms":2392,"output":{"example_id":"table/PrintableRulesSection_page17","grounded_pages":[],"layout_pages":[],"markdown":"MASSACHUSETTS PRIVATE PASSENGER RESIDUAL MARKET AUTOMOBILE INSURANCE MANUAL\n\n12 Commonwealth Automobile Reinsurers –May 1, 2024\n\n**(Rule 18) SHORT RATE CANCELLATION OF SHORT TERM POLICIES** **Percentages of Policy Premiums to be Retained by Insurance Company** **Policy Effective Date No. of Days** **August September October November December**\n\n**in force** **Jan. Feb. Mar. Apr. May June July 1-15 16- 31 1-15 16- 30 1-15 16- 31 1-15 16- 30 1-15 16- 31** 1-10 9 9 10 11 13 15 16 17 18 19 20 22 25 29 37 54 73\n\n11-15 11 12 13 15 16 17 18 19 20 21 23 26 29 35 45 65 100 16-20 15 16 16 17 18 19 21 22 24 26 28 31 37 44 59 83 21-25 17 17 18 19 20 22 24 26 28 30 34 37 44 53 70 100 26-30 18 19 20 21 22 24 27 29 32 35 39 43 51 62 81 100 31-35 19 20 21 23 24 27 30 33 36 39 44 49 59 70 91 36-40 21 22 23 25 27 29 33 36 40 43 49 55 65 77 100 41-45 22 24 25 27 29 32 35 40 43 48 54 61 71 85 100 46-50 24 25 27 29 31 34 38 43 47 52 59 66 76 92 51-55 25 27 28 30 33 37 41 47 51 57 63 71 82 100 56-60 27 28 30 32 35 39 44 50 55 61 67 76 88 100 61-65 28 30 32 34 37 42 47 53 59 64 71 80 94 66-70 30 31 33 36 40 44 50 57 62 68 76 85 100 71-75 31 33 35 38 42 47 53 60 65 71 80 90 100 76-80 32 35 37 40 44 49 56 63 68 75 84 94 81-85 34 36 39 42 46 52 59 66 71 78 88 99 86-90 35 38 40 44 48 54 62 69 75 82 92 100 91-105 38 41 44 48 53 59 66 74 81 89 100 106-120 42 45 49 54 59 65 74 82 90 100 121-135 47 50 54 59 65 71 81 91 100 136-150 51 55 59 64 70 78 88 100 151-165 55 60 63 69 75 84 95 166-180 59 63 68 72 80 90 100 181-195 63 67 72 78 85 96 196-210 67 71 76 83 91 100 211-225 70 75 80 87 94 226-240 73 78 84 92 100 241-255 77 82 88 94 256-270 80 86 92 100 271-285 84 90 96 TABLE 1 286-300 87 93 100 (Motorcycles with Registration 301-315 90 97 Expiration of December 31) 316-330 94 100 331-360 99 361-365 100 **No. of Days** **July August September October November**\n\n**in force** **Dec. Jan. Feb. Mar. Apr. May June 1-15 16- 31 1-15 16- 31 1-15 16- 30 1-15 16- 31 1-15 16- 30** 1-10 9 9 10 11 13 15 16 17 18 19 20 22 25 29 37 54 73\n\n11-15 11 12 13 15 16 17 18 19 20 21 23 26 29 35 45 65 100 16-20 15 16 16 17 18 19 21 22 24 26 28 31 37 44 59 83 21-25 17 17 18 19 20 22 24 26 28 30 34 37 44 53 70 100 26-30 18 19 20 21 22 24 27 29 32 35 39 43 51 62 81 100 31-35 19 20 21 23 24 27 30 33 36 39 44 49 59 70 91 36-40 21 22 23 25 27 29 33 36 40 43 49 55 65 77 100 41-45 22 24 25 27 29 32 35 40 43 48 54 61 71 85 100 46-50 24 25 27 29 31 34 38 43 47 52 59 66 76 92 51-55 25 27 28 30 33 37 41 47 51 57 63 71 82 100 56-60 27 28 30 32 35 39 44 50 55 61 67 76 88 100 61-65 28 30 32 34 37 42 47 53 59 64 71 80 94 66-70 30 31 33 36 40 44 50 57 62 68 76 85 100 71-75 31 33 35 38 42 47 53 60 65 71 80 90 100 76-80 32 35 37 40 44 49 56 63 68 75 84 94 81-85 34 36 39 42 46 52 59 66 71 78 88 99 86-90 35 38 40 44 48 54 62 69 75 82 92 100 91-105 38 41 44 48 53 59 66 74 81 89 100 106-120 42 45 49 54 59 65 74 82 90 100 121-135 47 50 54 59 65 71 81 91 100 136-150 51 55 59 64 70 78 88 100 151-165 55 60 63 69 75 84 95 166-180 59 63 68 72 80 90 100 181-195 63 67 72 78 85 96 196-210 67 71 76 83 91 100 211-225 70 75 80 87 94 226-240 73 78 84 92 100 241-255 77 82 88 94 256-270 80 86 92 100 271-285 84 90 96 TABLE 2 286-300 87 93 100 (All Vehicles with Registration 301-315 90 97 Expiration of November 30) 316-330 94 100 331-360 99 361-365 100","pages":[{"line_numbers":[],"markdown":"MASSACHUSETTS PRIVATE PASSENGER RESIDUAL MARKET AUTOMOBILE INSURANCE MANUAL\n\n12 Commonwealth Automobile Reinsurers –May 1, 2024\n\n**(Rule 18) SHORT RATE CANCELLATION OF SHORT TERM POLICIES** **Percentages of Policy Premiums to be Retained by Insurance Company** **Policy Effective Date No. of Days** **August September October November December**\n\n**in force** **Jan. Feb. Mar. Apr. May June July 1-15 16- 31 1-15 16- 30 1-15 16- 31 1-15 16- 30 1-15 16- 31** 1-10 9 9 10 11 13 15 16 17 18 19 20 22 25 29 37 54 73\n\n11-15 11 12 13 15 16 17 18 19 20 21 23 26 29 35 45 65 100 16-20 15 16 16 17 18 19 21 22 24 26 28 31 37 44 59 83 21-25 17 17 18 19 20 22 24 26 28 30 34 37 44 53 70 100 26-30 18 19 20 21 22 24 27 29 32 35 39 43 51 62 81 100 31-35 19 20 21 23 24 27 30 33 36 39 44 49 59 70 91 36-40 21 22 23 25 27 29 33 36 40 43 49 55 65 77 100 41-45 22 24 25 27 29 32 35 40 43 48 54 61 71 85 100 46-50 24 25 27 29 31 34 38 43 47 52 59 66 76 92 51-55 25 27 28 30 33 37 41 47 51 57 63 71 82 100 56-60 27 28 30 32 35 39 44 50 55 61 67 76 88 100 61-65 28 30 32 34 37 42 47 53 59 64 71 80 94 66-70 30 31 33 36 40 44 50 57 62 68 76 85 100 71-75 31 33 35 38 42 47 53 60 65 71 80 90 100 76-80 32 35 37 40 44 49 56 63 68 75 84 94 81-85 34 36 39 42 46 52 59 66 71 78 88 99 86-90 35 38 40 44 48 54 62 69 75 82 92 100 91-105 38 41 44 48 53 59 66 74 81 89 100 106-120 42 45 49 54 59 65 74 82 90 100 121-135 47 50 54 59 65 71 81 91 100 136-150 51 55 59 64 70 78 88 100 151-165 55 60 63 69 75 84 95 166-180 59 63 68 72 80 90 100 181-195 63 67 72 78 85 96 196-210 67 71 76 83 91 100 211-225 70 75 80 87 94 226-240 73 78 84 92 100 241-255 77 82 88 94 256-270 80 86 92 100 271-285 84 90 96 TABLE 1 286-300 87 93 100 (Motorcycles with Registration 301-315 90 97 Expiration of December 31) 316-330 94 100 331-360 99 361-365 100 **No. of Days** **July August September October November**\n\n**in force** **Dec. Jan. Feb. Mar. Apr. May June 1-15 16- 31 1-15 16- 31 1-15 16- 30 1-15 16- 31 1-15 16- 30** 1-10 9 9 10 11 13 15 16 17 18 19 20 22 25 29 37 54 73\n\n11-15 11 12 13 15 16 17 18 19 20 21 23 26 29 35 45 65 100 16-20 15 16 16 17 18 19 21 22 24 26 28 31 37 44 59 83 21-25 17 17 18 19 20 22 24 26 28 30 34 37 44 53 70 100 26-30 18 19 20 21 22 24 27 29 32 35 39 43 51 62 81 100 31-35 19 20 21 23 24 27 30 33 36 39 44 49 59 70 91 36-40 21 22 23 25 27 29 33 36 40 43 49 55 65 77 100 41-45 22 24 25 27 29 32 35 40 43 48 54 61 71 85 100 46-50 24 25 27 29 31 34 38 43 47 52 59 66 76 92 51-55 25 27 28 30 33 37 41 47 51 57 63 71 82 100 56-60 27 28 30 32 35 39 44 50 55 61 67 76 88 100 61-65 28 30 32 34 37 42 47 53 59 64 71 80 94 66-70 30 31 33 36 40 44 50 57 62 68 76 85 100 71-75 31 33 35 38 42 47 53 60 65 71 80 90 100 76-80 32 35 37 40 44 49 56 63 68 75 84 94 81-85 34 36 39 42 46 52 59 66 71 78 88 99 86-90 35 38 40 44 48 54 62 69 75 82 92 100 91-105 38 41 44 48 53 59 66 74 81 89 100 106-120 42 45 49 54 59 65 74 82 90 100 121-135 47 50 54 59 65 71 81 91 100 136-150 51 55 59 64 70 78 88 100 151-165 55 60 63 69 75 84 95 166-180 59 63 68 72 80 90 100 181-195 63 67 72 78 85 96 196-210 67 71 76 83 91 100 211-225 70 75 80 87 94 226-240 73 78 84 92 100 241-255 77 82 88 94 256-270 80 86 92 100 271-285 84 90 96 TABLE 2 286-300 87 93 100 (All Vehicles with Registration 301-315 90 97 Expiration of November 30) 316-330 94 100 331-360 99 361-365 100","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"MASSACHUSETTS PRIVATE PASSENGER RESIDUAL MARKET AUTOMOBILE INSURANCE MANUAL\n\n12 Commonwealth Automobile Reinsurers –May 1, 2024\n\n**(Rule 18) SHORT RATE CANCELLATION OF SHORT TERM POLICIES** **Percentages of Policy Premiums to be Retained by Insurance Company** **Policy Effective Date No. of Days** **August September October November December**\n\n**in force** **Jan. Feb. Mar. Apr. May June July 1-15 16- 31 1-15 16- 30 1-15 16- 31 1-15 16- 30 1-15 16- 31** 1-10 9 9 10 11 13 15 16 17 18 19 20 22 25 29 37 54 73\n\n11-15 11 12 13 15 16 17 18 19 20 21 23 26 29 35 45 65 100 16-20 15 16 16 17 18 19 21 22 24 26 28 31 37 44 59 83 21-25 17 17 18 19 20 22 24 26 28 30 34 37 44 53 70 100 26-30 18 19 20 21 22 24 27 29 32 35 39 43 51 62 81 100 31-35 19 20 21 23 24 27 30 33 36 39 44 49 59 70 91 36-40 21 22 23 25 27 29 33 36 40 43 49 55 65 77 100 41-45 22 24 25 27 29 32 35 40 43 48 54 61 71 85 100 46-50 24 25 27 29 31 34 38 43 47 52 59 66 76 92 51-55 25 27 28 30 33 37 41 47 51 57 63 71 82 100 56-60 27 28 30 32 35 39 44 50 55 61 67 76 88 100 61-65 28 30 32 34 37 42 47 53 59 64 71 80 94 66-70 30 31 33 36 40 44 50 57 62 68 76 85 100 71-75 31 33 35 38 42 47 53 60 65 71 80 90 100 76-80 32 35 37 40 44 49 56 63 68 75 84 94 81-85 34 36 39 42 46 52 59 66 71 78 88 99 86-90 35 38 40 44 48 54 62 69 75 82 92 100 91-105 38 41 44 48 53 59 66 74 81 89 100 106-120 42 45 49 54 59 65 74 82 90 100 121-135 47 50 54 59 65 71 81 91 100 136-150 51 55 59 64 70 78 88 100 151-165 55 60 63 69 75 84 95 166-180 59 63 68 72 80 90 100 181-195 63 67 72 78 85 96 196-210 67 71 76 83 91 100 211-225 70 75 80 87 94 226-240 73 78 84 92 100 241-255 77 82 88 94 256-270 80 86 92 100 271-285 84 90 96 TABLE 1 286-300 87 93 100 (Motorcycles with Registration 301-315 90 97 Expiration of December 31) 316-330 94 100 331-360 99 361-365 100 **No. of Days** **July August September October November**\n\n**in force** **Dec. Jan. Feb. Mar. Apr. May June 1-15 16- 31 1-15 16- 31 1-15 16- 30 1-15 16- 31 1-15 16- 30** 1-10 9 9 10 11 13 15 16 17 18 19 20 22 25 29 37 54 73\n\n11-15 11 12 13 15 16 17 18 19 20 21 23 26 29 35 45 65 100 16-20 15 16 16 17 18 19 21 22 24 26 28 31 37 44 59 83 21-25 17 17 18 19 20 22 24 26 28 30 34 37 44 53 70 100 26-30 18 19 20 21 22 24 27 29 32 35 39 43 51 62 81 100 31-35 19 20 21 23 24 27 30 33 36 39 44 49 59 70 91 36-40 21 22 23 25 27 29 33 36 40 43 49 55 65 77 100 41-45 22 24 25 27 29 32 35 40 43 48 54 61 71 85 100 46-50 24 25 27 29 31 34 38 43 47 52 59 66 76 92 51-55 25 27 28 30 33 37 41 47 51 57 63 71 82 100 56-60 27 28 30 32 35 39 44 50 55 61 67 76 88 100 61-65 28 30 32 34 37 42 47 53 59 64 71 80 94 66-70 30 31 33 36 40 44 50 57 62 68 76 85 100 71-75 31 33 35 38 42 47 53 60 65 71 80 90 100 76-80 32 35 37 40 44 49 56 63 68 75 84 94 81-85 34 36 39 42 46 52 59 66 71 78 88 99 86-90 35 38 40 44 48 54 62 69 75 82 92 100 91-105 38 41 44 48 53 59 66 74 81 89 100 106-120 42 45 49 54 59 65 74 82 90 100 121-135 47 50 54 59 65 71 81 91 100 136-150 51 55 59 64 70 78 88 100 151-165 55 60 63 69 75 84 95 166-180 59 63 68 72 80 90 100 181-195 63 67 72 78 85 96 196-210 67 71 76 83 91 100 211-225 70 75 80 87 94 226-240 73 78 84 92 100 241-255 77 82 88 94 256-270 80 86 92 100 271-285 84 90 96 TABLE 2 286-300 87 93 100 (All Vehicles with Registration 301-315 90 97 Expiration of November 30) 316-330 94 100 331-360 99 361-365 100","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/PrintableRulesSection_page17.pdf"]},"response":{"errors":[],"extract_id":"extract_15c8bf6aa6ad82f5c8f7a890a0012ad0","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["MASSACHUSETTS PRIVATE PASSENGER RESIDUAL MARKET AUTOMOBILE INSURANCE MANUAL\n\n12 Commonwealth Automobile Reinsurers –May 1, 2024\n\n**(Rule 18) SHORT RATE CANCELLATION OF SHORT TERM POLICIES** **Percentages of Policy Premiums to be Retained by Insurance Company** **Policy Effective Date No. of Days** **August September October November December**\n\n**in force** **Jan. Feb. Mar. Apr. May June July 1-15 16- 31 1-15 16- 30 1-15 16- 31 1-15 16- 30 1-15 16- 31** 1-10 9 9 10 11 13 15 16 17 18 19 20 22 25 29 37 54 73\n\n11-15 11 12 13 15 16 17 18 19 20 21 23 26 29 35 45 65 100 16-20 15 16 16 17 18 19 21 22 24 26 28 31 37 44 59 83 21-25 17 17 18 19 20 22 24 26 28 30 34 37 44 53 70 100 26-30 18 19 20 21 22 24 27 29 32 35 39 43 51 62 81 100 31-35 19 20 21 23 24 27 30 33 36 39 44 49 59 70 91 36-40 21 22 23 25 27 29 33 36 40 43 49 55 65 77 100 41-45 22 24 25 27 29 32 35 40 43 48 54 61 71 85 100 46-50 24 25 27 29 31 34 38 43 47 52 59 66 76 92 51-55 25 27 28 30 33 37 41 47 51 57 63 71 82 100 56-60 27 28 30 32 35 39 44 50 55 61 67 76 88 100 61-65 28 30 32 34 37 42 47 53 59 64 71 80 94 66-70 30 31 33 36 40 44 50 57 62 68 76 85 100 71-75 31 33 35 38 42 47 53 60 65 71 80 90 100 76-80 32 35 37 40 44 49 56 63 68 75 84 94 81-85 34 36 39 42 46 52 59 66 71 78 88 99 86-90 35 38 40 44 48 54 62 69 75 82 92 100 91-105 38 41 44 48 53 59 66 74 81 89 100 106-120 42 45 49 54 59 65 74 82 90 100 121-135 47 50 54 59 65 71 81 91 100 136-150 51 55 59 64 70 78 88 100 151-165 55 60 63 69 75 84 95 166-180 59 63 68 72 80 90 100 181-195 63 67 72 78 85 96 196-210 67 71 76 83 91 100 211-225 70 75 80 87 94 226-240 73 78 84 92 100 241-255 77 82 88 94 256-270 80 86 92 100 271-285 84 90 96 TABLE 1 286-300 87 93 100 (Motorcycles with Registration 301-315 90 97 Expiration of December 31) 316-330 94 100 331-360 99 361-365 100 **No. of Days** **July August September October November**\n\n**in force** **Dec. Jan. Feb. Mar. Apr. May June 1-15 16- 31 1-15 16- 31 1-15 16- 30 1-15 16- 31 1-15 16- 30** 1-10 9 9 10 11 13 15 16 17 18 19 20 22 25 29 37 54 73\n\n11-15 11 12 13 15 16 17 18 19 20 21 23 26 29 35 45 65 100 16-20 15 16 16 17 18 19 21 22 24 26 28 31 37 44 59 83 21-25 17 17 18 19 20 22 24 26 28 30 34 37 44 53 70 100 26-30 18 19 20 21 22 24 27 29 32 35 39 43 51 62 81 100 31-35 19 20 21 23 24 27 30 33 36 39 44 49 59 70 91 36-40 21 22 23 25 27 29 33 36 40 43 49 55 65 77 100 41-45 22 24 25 27 29 32 35 40 43 48 54 61 71 85 100 46-50 24 25 27 29 31 34 38 43 47 52 59 66 76 92 51-55 25 27 28 30 33 37 41 47 51 57 63 71 82 100 56-60 27 28 30 32 35 39 44 50 55 61 67 76 88 100 61-65 28 30 32 34 37 42 47 53 59 64 71 80 94 66-70 30 31 33 36 40 44 50 57 62 68 76 85 100 71-75 31 33 35 38 42 47 53 60 65 71 80 90 100 76-80 32 35 37 40 44 49 56 63 68 75 84 94 81-85 34 36 39 42 46 52 59 66 71 78 88 99 86-90 35 38 40 44 48 54 62 69 75 82 92 100 91-105 38 41 44 48 53 59 66 74 81 89 100 106-120 42 45 49 54 59 65 74 82 90 100 121-135 47 50 54 59 65 71 81 91 100 136-150 51 55 59 64 70 78 88 100 151-165 55 60 63 69 75 84 95 166-180 59 63 68 72 80 90 100 181-195 63 67 72 78 85 96 196-210 67 71 76 83 91 100 211-225 70 75 80 87 94 226-240 73 78 84 92 100 241-255 77 82 88 94 256-270 80 86 92 100 271-285 84 90 96 TABLE 2 286-300 87 93 100 (All Vehicles with Registration 301-315 90 97 Expiration of November 30) 316-330 94 100 331-360 99 361-365 100"],"full_content":"MASSACHUSETTS PRIVATE PASSENGER RESIDUAL MARKET AUTOMOBILE INSURANCE MANUAL\n\n12 Commonwealth Automobile Reinsurers –May 1, 2024\n\n**(Rule 18) SHORT RATE CANCELLATION OF SHORT TERM POLICIES** **Percentages of Policy Premiums to be Retained by Insurance Company** **Policy Effective Date No. of Days** **August September October November December**\n\n**in force** **Jan. Feb. Mar. Apr. May June July 1-15 16- 31 1-15 16- 30 1-15 16- 31 1-15 16- 30 1-15 16- 31** 1-10 9 9 10 11 13 15 16 17 18 19 20 22 25 29 37 54 73\n\n11-15 11 12 13 15 16 17 18 19 20 21 23 26 29 35 45 65 100 16-20 15 16 16 17 18 19 21 22 24 26 28 31 37 44 59 83 21-25 17 17 18 19 20 22 24 26 28 30 34 37 44 53 70 100 26-30 18 19 20 21 22 24 27 29 32 35 39 43 51 62 81 100 31-35 19 20 21 23 24 27 30 33 36 39 44 49 59 70 91 36-40 21 22 23 25 27 29 33 36 40 43 49 55 65 77 100 41-45 22 24 25 27 29 32 35 40 43 48 54 61 71 85 100 46-50 24 25 27 29 31 34 38 43 47 52 59 66 76 92 51-55 25 27 28 30 33 37 41 47 51 57 63 71 82 100 56-60 27 28 30 32 35 39 44 50 55 61 67 76 88 100 61-65 28 30 32 34 37 42 47 53 59 64 71 80 94 66-70 30 31 33 36 40 44 50 57 62 68 76 85 100 71-75 31 33 35 38 42 47 53 60 65 71 80 90 100 76-80 32 35 37 40 44 49 56 63 68 75 84 94 81-85 34 36 39 42 46 52 59 66 71 78 88 99 86-90 35 38 40 44 48 54 62 69 75 82 92 100 91-105 38 41 44 48 53 59 66 74 81 89 100 106-120 42 45 49 54 59 65 74 82 90 100 121-135 47 50 54 59 65 71 81 91 100 136-150 51 55 59 64 70 78 88 100 151-165 55 60 63 69 75 84 95 166-180 59 63 68 72 80 90 100 181-195 63 67 72 78 85 96 196-210 67 71 76 83 91 100 211-225 70 75 80 87 94 226-240 73 78 84 92 100 241-255 77 82 88 94 256-270 80 86 92 100 271-285 84 90 96 TABLE 1 286-300 87 93 100 (Motorcycles with Registration 301-315 90 97 Expiration of December 31) 316-330 94 100 331-360 99 361-365 100 **No. of Days** **July August September October November**\n\n**in force** **Dec. Jan. Feb. Mar. Apr. May June 1-15 16- 31 1-15 16- 31 1-15 16- 30 1-15 16- 31 1-15 16- 30** 1-10 9 9 10 11 13 15 16 17 18 19 20 22 25 29 37 54 73\n\n11-15 11 12 13 15 16 17 18 19 20 21 23 26 29 35 45 65 100 16-20 15 16 16 17 18 19 21 22 24 26 28 31 37 44 59 83 21-25 17 17 18 19 20 22 24 26 28 30 34 37 44 53 70 100 26-30 18 19 20 21 22 24 27 29 32 35 39 43 51 62 81 100 31-35 19 20 21 23 24 27 30 33 36 39 44 49 59 70 91 36-40 21 22 23 25 27 29 33 36 40 43 49 55 65 77 100 41-45 22 24 25 27 29 32 35 40 43 48 54 61 71 85 100 46-50 24 25 27 29 31 34 38 43 47 52 59 66 76 92 51-55 25 27 28 30 33 37 41 47 51 57 63 71 82 100 56-60 27 28 30 32 35 39 44 50 55 61 67 76 88 100 61-65 28 30 32 34 37 42 47 53 59 64 71 80 94 66-70 30 31 33 36 40 44 50 57 62 68 76 85 100 71-75 31 33 35 38 42 47 53 60 65 71 80 90 100 76-80 32 35 37 40 44 49 56 63 68 75 84 94 81-85 34 36 39 42 46 52 59 66 71 78 88 99 86-90 35 38 40 44 48 54 62 69 75 82 92 100 91-105 38 41 44 48 53 59 66 74 81 89 100 106-120 42 45 49 54 59 65 74 82 90 100 121-135 47 50 54 59 65 71 81 91 100 136-150 51 55 59 64 70 78 88 100 151-165 55 60 63 69 75 84 95 166-180 59 63 68 72 80 90 100 181-195 63 67 72 78 85 96 196-210 67 71 76 83 91 100 211-225 70 75 80 87 94 226-240 73 78 84 92 100 241-255 77 82 88 94 256-270 80 86 92 100 271-285 84 90 96 TABLE 2 286-300 87 93 100 (All Vehicles with Registration 301-315 90 97 Expiration of November 30) 316-330 94 100 331-360 99 361-365 100","publish_date":null,"title":"MASSACHUSETTS PRIVATE PASSENGER RESIDUAL MARKET AUTOMOBILE INSURANCE MANUAL","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/PrintableRulesSection_page17.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/PrintableRulesSection_page17.pdf"},"request":{"example_id":"table/PrintableRulesSection_page17","product_type":"parse","source_file_path":"PrintableRulesSection_page17.pdf"},"started_at":"2026-11-04T19:48:10.763477"} +{"completed_at":"2026-11-04T19:48:14.115503","latency_in_ms":2217,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1020","grounded_pages":[],"layout_pages":[],"markdown":"S. EXPERIENCE CREDIT RULE 1. Eligibility a. When the premium at the inception date is $1,500 or more excluding Equipment Breakdown and Employment Practices Liability, prior to the application of a Scheduled Premium Modification Factor, an Experience Credit for a favorable loss ratio shall apply to that premium. Losses used to calculate the loss ratio are to include loss and loss adjusting expense reserves on open claims, and allocated loss adjusting expenses, but not Equipment Breakdown - Boiler and Machinery Coverage losses. b. This credit shall not be applied as a new credit during the policy term. c. When the credit applies at the inception, any changes occurring during the policy period will reflect this credit. 2. New Business Documented experience must be obtained from the prior carrier for this credit to apply. This experience must include not less than the thirty (30) consecutive month period that begins thirty six (36) months prior to the proposed inception date. Loss Ratio Credit Up to 25% 10%\n\n25\\.01% to 35% 5% 3. Renewal Business a. The loss ratio shall be calculated based upon the latest available Florists' Mutual premium and losses at the time the policy is renewed. All premiums and losses up to three (3) years prior to the renewal date must be included. The experience of a prior carrier shall not be used. b. For the appropriate renewal year, the policyholder will earn the larger of the experience credits they qualify for based on the table shown below:\n\nRenewal Year\n\nCombined Yrs Loss Ratio Is 25% Or Less (Max. - 3 Latest Yrs)\n\nCombined Yrs Loss Ratio Is More Than 25% And Less Than 35% (Max. - 3 Latest Yrs)\n\nCombined Yrs Loss Ratio Is More Than 35% And Less Than 40% (Max. - 3 Latest Yrs)\n\nLoss Ratio Is Less Than 25% In 2 Out Of The Last 3 Years\n\nLoss Ratio Is Less Than 40% In 2 Out Of The Last 3 Years\n\n1st 10% 5% 0% N/A N/A\n\n2nd 15% 7.50% 5% N/A N/A\n\n3rd and Later 20% 10% 5% 10% 5%\n\n4\\. Exposure Codes: Property = 797 Liability = 798","pages":[{"line_numbers":[],"markdown":"S. EXPERIENCE CREDIT RULE 1. Eligibility a. When the premium at the inception date is $1,500 or more excluding Equipment Breakdown and Employment Practices Liability, prior to the application of a Scheduled Premium Modification Factor, an Experience Credit for a favorable loss ratio shall apply to that premium. Losses used to calculate the loss ratio are to include loss and loss adjusting expense reserves on open claims, and allocated loss adjusting expenses, but not Equipment Breakdown - Boiler and Machinery Coverage losses. b. This credit shall not be applied as a new credit during the policy term. c. When the credit applies at the inception, any changes occurring during the policy period will reflect this credit. 2. New Business Documented experience must be obtained from the prior carrier for this credit to apply. This experience must include not less than the thirty (30) consecutive month period that begins thirty six (36) months prior to the proposed inception date. Loss Ratio Credit Up to 25% 10%\n\n25\\.01% to 35% 5% 3. Renewal Business a. The loss ratio shall be calculated based upon the latest available Florists' Mutual premium and losses at the time the policy is renewed. All premiums and losses up to three (3) years prior to the renewal date must be included. The experience of a prior carrier shall not be used. b. For the appropriate renewal year, the policyholder will earn the larger of the experience credits they qualify for based on the table shown below:\n\nRenewal Year\n\nCombined Yrs Loss Ratio Is 25% Or Less (Max. - 3 Latest Yrs)\n\nCombined Yrs Loss Ratio Is More Than 25% And Less Than 35% (Max. - 3 Latest Yrs)\n\nCombined Yrs Loss Ratio Is More Than 35% And Less Than 40% (Max. - 3 Latest Yrs)\n\nLoss Ratio Is Less Than 25% In 2 Out Of The Last 3 Years\n\nLoss Ratio Is Less Than 40% In 2 Out Of The Last 3 Years\n\n1st 10% 5% 0% N/A N/A\n\n2nd 15% 7.50% 5% N/A N/A\n\n3rd and Later 20% 10% 5% 10% 5%\n\n4\\. Exposure Codes: Property = 797 Liability = 798","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"S. EXPERIENCE CREDIT RULE 1. Eligibility a. When the premium at the inception date is $1,500 or more excluding Equipment Breakdown and Employment Practices Liability, prior to the application of a Scheduled Premium Modification Factor, an Experience Credit for a favorable loss ratio shall apply to that premium. Losses used to calculate the loss ratio are to include loss and loss adjusting expense reserves on open claims, and allocated loss adjusting expenses, but not Equipment Breakdown - Boiler and Machinery Coverage losses. b. This credit shall not be applied as a new credit during the policy term. c. When the credit applies at the inception, any changes occurring during the policy period will reflect this credit. 2. New Business Documented experience must be obtained from the prior carrier for this credit to apply. This experience must include not less than the thirty (30) consecutive month period that begins thirty six (36) months prior to the proposed inception date. Loss Ratio Credit Up to 25% 10%\n\n25\\.01% to 35% 5% 3. Renewal Business a. The loss ratio shall be calculated based upon the latest available Florists' Mutual premium and losses at the time the policy is renewed. All premiums and losses up to three (3) years prior to the renewal date must be included. The experience of a prior carrier shall not be used. b. For the appropriate renewal year, the policyholder will earn the larger of the experience credits they qualify for based on the table shown below:\n\nRenewal Year\n\nCombined Yrs Loss Ratio Is 25% Or Less (Max. - 3 Latest Yrs)\n\nCombined Yrs Loss Ratio Is More Than 25% And Less Than 35% (Max. - 3 Latest Yrs)\n\nCombined Yrs Loss Ratio Is More Than 35% And Less Than 40% (Max. - 3 Latest Yrs)\n\nLoss Ratio Is Less Than 25% In 2 Out Of The Last 3 Years\n\nLoss Ratio Is Less Than 40% In 2 Out Of The Last 3 Years\n\n1st 10% 5% 0% N/A N/A\n\n2nd 15% 7.50% 5% N/A N/A\n\n3rd and Later 20% 10% 5% 10% 5%\n\n4\\. Exposure Codes: Property = 797 Liability = 798","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1020.pdf"]},"response":{"errors":[],"extract_id":"extract_ae45a82c233a7e2750164b5cf4a707f4","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["S. EXPERIENCE CREDIT RULE 1. Eligibility a. When the premium at the inception date is $1,500 or more excluding Equipment Breakdown and Employment Practices Liability, prior to the application of a Scheduled Premium Modification Factor, an Experience Credit for a favorable loss ratio shall apply to that premium. Losses used to calculate the loss ratio are to include loss and loss adjusting expense reserves on open claims, and allocated loss adjusting expenses, but not Equipment Breakdown - Boiler and Machinery Coverage losses. b. This credit shall not be applied as a new credit during the policy term. c. When the credit applies at the inception, any changes occurring during the policy period will reflect this credit. 2. New Business Documented experience must be obtained from the prior carrier for this credit to apply. This experience must include not less than the thirty (30) consecutive month period that begins thirty six (36) months prior to the proposed inception date. Loss Ratio Credit Up to 25% 10%\n\n25\\.01% to 35% 5% 3. Renewal Business a. The loss ratio shall be calculated based upon the latest available Florists' Mutual premium and losses at the time the policy is renewed. All premiums and losses up to three (3) years prior to the renewal date must be included. The experience of a prior carrier shall not be used. b. For the appropriate renewal year, the policyholder will earn the larger of the experience credits they qualify for based on the table shown below:\n\nRenewal Year\n\nCombined Yrs Loss Ratio Is 25% Or Less (Max. - 3 Latest Yrs)\n\nCombined Yrs Loss Ratio Is More Than 25% And Less Than 35% (Max. - 3 Latest Yrs)\n\nCombined Yrs Loss Ratio Is More Than 35% And Less Than 40% (Max. - 3 Latest Yrs)\n\nLoss Ratio Is Less Than 25% In 2 Out Of The Last 3 Years\n\nLoss Ratio Is Less Than 40% In 2 Out Of The Last 3 Years\n\n1st 10% 5% 0% N/A N/A\n\n2nd 15% 7.50% 5% N/A N/A\n\n3rd and Later 20% 10% 5% 10% 5%\n\n4\\. Exposure Codes: Property = 797 Liability = 798"],"full_content":"S. EXPERIENCE CREDIT RULE 1. Eligibility a. When the premium at the inception date is $1,500 or more excluding Equipment Breakdown and Employment Practices Liability, prior to the application of a Scheduled Premium Modification Factor, an Experience Credit for a favorable loss ratio shall apply to that premium. Losses used to calculate the loss ratio are to include loss and loss adjusting expense reserves on open claims, and allocated loss adjusting expenses, but not Equipment Breakdown - Boiler and Machinery Coverage losses. b. This credit shall not be applied as a new credit during the policy term. c. When the credit applies at the inception, any changes occurring during the policy period will reflect this credit. 2. New Business Documented experience must be obtained from the prior carrier for this credit to apply. This experience must include not less than the thirty (30) consecutive month period that begins thirty six (36) months prior to the proposed inception date. Loss Ratio Credit Up to 25% 10%\n\n25\\.01% to 35% 5% 3. Renewal Business a. The loss ratio shall be calculated based upon the latest available Florists' Mutual premium and losses at the time the policy is renewed. All premiums and losses up to three (3) years prior to the renewal date must be included. The experience of a prior carrier shall not be used. b. For the appropriate renewal year, the policyholder will earn the larger of the experience credits they qualify for based on the table shown below:\n\nRenewal Year\n\nCombined Yrs Loss Ratio Is 25% Or Less (Max. - 3 Latest Yrs)\n\nCombined Yrs Loss Ratio Is More Than 25% And Less Than 35% (Max. - 3 Latest Yrs)\n\nCombined Yrs Loss Ratio Is More Than 35% And Less Than 40% (Max. - 3 Latest Yrs)\n\nLoss Ratio Is Less Than 25% In 2 Out Of The Last 3 Years\n\nLoss Ratio Is Less Than 40% In 2 Out Of The Last 3 Years\n\n1st 10% 5% 0% N/A N/A\n\n2nd 15% 7.50% 5% N/A N/A\n\n3rd and Later 20% 10% 5% 10% 5%\n\n4\\. Exposure Codes: Property = 797 Liability = 798","publish_date":null,"title":"S. EXPERIENCE CREDIT RULE 1. Eligibility a. When the premium at the inception date is $1,500 or more excluding Equipment","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1020.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1020.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1020","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1020.pdf"},"started_at":"2026-11-04T19:48:11.897591"} +{"completed_at":"2026-11-04T19:48:16.242283","latency_in_ms":3028,"output":{"example_id":"table/SERFF_CA_random_pages 1_page106","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit 2 - 2017 Second Quarter Rate Tables**\n\n**Aetna Individual Dental PPO Rate Filing**\n\n**California**\n\n**Effective June 1, 2017**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n0 $20.76 $23.99 $26.67 0 $20.13 $23.26 $25.86 0 $16.23 $18.75 $20.84\n\n1 $20.76 $23.99 $26.67 1 $20.13 $23.26 $25.86 1 $16.23 $18.75 $20.84\n\n2 $20.76 $23.99 $26.67 2 $20.13 $23.26 $25.86 2 $16.23 $18.75 $20.84\n\n3 $20.76 $23.99 $26.67 3 $20.13 $23.26 $25.86 3 $16.23 $18.75 $20.84\n\n4 $20.76 $23.99 $26.67 4 $20.13 $23.26 $25.86 4 $16.23 $18.75 $20.84\n\n5 $45.75 $56.81 $65.10 5 $44.36 $55.09 $63.12 5 $35.76 $44.40 $50.87\n\n6 $45.75 $56.81 $65.10 6 $44.36 $55.09 $63.12 6 $35.76 $44.40 $50.87\n\n7 $45.75 $56.81 $65.10 7 $44.36 $55.09 $63.12 7 $35.76 $44.40 $50.87\n\n8 $45.75 $56.81 $65.10 8 $44.36 $55.09 $63.12 8 $35.76 $44.40 $50.87\n\n9 $45.75 $56.81 $65.10 9 $44.36 $55.09 $63.12 9 $35.76 $44.40 $50.87\n\n10 $42.57 $51.72 $58.52 10 $41.27 $50.15 $56.74 10 $33.27 $40.42 $45.73\n\n11 $42.57 $51.72 $58.52 11 $41.27 $50.15 $56.74 11 $33.27 $40.42 $45.73\n\n12 $42.57 $51.72 $58.52 12 $41.27 $50.15 $56.74 12 $33.27 $40.42 $45.73\n\n13 $42.57 $51.72 $58.52 13 $41.27 $50.15 $56.74 13 $33.27 $40.42 $45.73\n\n14 $42.57 $51.72 $58.52 14 $41.27 $50.15 $56.74 14 $33.27 $40.42 $45.73\n\n15 $33.79 $52.87 $61.66 15 $32.77 $51.27 $59.79 15 $26.41 $41.32 $48.18\n\n16 $33.79 $52.87 $61.66 16 $32.77 $51.27 $59.79 16 $26.41 $41.32 $48.18\n\n17 $33.79 $52.87 $61.66 17 $32.77 $51.27 $59.79 17 $26.41 $41.32 $48.18\n\n18 $33.79 $52.87 $61.66 18 $32.77 $51.27 $59.79 18 $26.41 $41.32 $48.18\n\n19 $33.79 $52.87 $61.66 19 $32.77 $51.27 $59.79 19 $26.41 $41.32 $48.18\n\n20 $27.28 $45.98 $54.00 20 $26.45 $44.59 $52.36 20 $21.32 $35.94 $42.20\n\n21 $27.28 $45.98 $54.00 21 $26.45 $44.59 $52.36 21 $21.32 $35.94 $42.20\n\n22 $27.28 $45.98 $54.00 22 $26.45 $44.59 $52.36 22 $21.32 $35.94 $42.20\n\n23 $27.28 $45.98 $54.00 23 $26.45 $44.59 $52.36 23 $21.32 $35.94 $42.20\n\n24 $27.28 $45.98 $54.00 24 $26.45 $44.59 $52.36 24 $21.32 $35.94 $42.20\n\n25 $28.06 $48.51 $57.26 25 $27.21 $47.04 $55.52 25 $21.93 $37.91 $44.75\n\n26 $28.06 $48.51 $57.26 26 $27.21 $47.04 $55.52 26 $21.93 $37.91 $44.75\n\n27 $28.06 $48.51 $57.26 27 $27.21 $47.04 $55.52 27 $21.93 $37.91 $44.75\n\n28 $28.06 $48.51 $57.26 28 $27.21 $47.04 $55.52 28 $21.93 $37.91 $44.75\n\n29 $28.06 $48.51 $57.26 29 $27.21 $47.04 $55.52 29 $21.93 $37.91 $44.75\n\n30 $30.15 $55.84 $65.78 30 $29.24 $54.15 $63.78 30 $23.57 $43.64 $51.40\n\n31 $30.15 $55.84 $65.78 31 $29.24 $54.15 $63.78 31 $23.57 $43.64 $51.40\n\n32 $30.15 $55.84 $65.78 32 $29.24 $54.15 $63.78 32 $23.57 $43.64 $51.40\n\n33 $30.15 $55.84 $65.78 33 $29.24 $54.15 $63.78 33 $23.57 $43.64 $51.40\n\n34 $30.15 $55.84 $65.78 34 $29.24 $54.15 $63.78 34 $23.57 $43.64 $51.40\n\n35 $30.57 $56.35 $65.96 35 $29.65 $54.64 $63.95 35 $23.89 $44.03 $51.54\n\n36 $30.57 $56.35 $65.96 36 $29.65 $54.64 $63.95 36 $23.89 $44.03 $51.54\n\n37 $30.57 $56.35 $65.96 37 $29.65 $54.64 $63.95 37 $23.89 $44.03 $51.54\n\n38 $30.57 $56.35 $65.96 38 $29.65 $54.64 $63.95 38 $23.89 $44.03 $51.54\n\n39 $30.57 $56.35 $65.96 39 $29.65 $54.64 $63.95 39 $23.89 $44.03 $51.54\n\n40 $31.25 $56.14 $65.19 40 $30.30 $54.43 $63.21 40 $24.42 $43.87 $50.95\n\n41 $31.25 $56.14 $65.19 41 $30.30 $54.43 $63.21 41 $24.42 $43.87 $50.95\n\n42 $31.25 $56.14 $65.19 42 $30.30 $54.43 $63.21 42 $24.42 $43.87 $50.95\n\n43 $31.25 $56.14 $65.19 43 $30.30 $54.43 $63.21 43 $24.42 $43.87 $50.95\n\n44 $31.25 $56.14 $65.19 44 $30.30 $54.43 $63.21 44 $24.42 $43.87 $50.95\n\n45 $32.27 $60.29 $69.83 45 $31.29 $58.46 $67.71 45 $25.22 $47.12 $54.57\n\n46 $32.27 $60.29 $69.83 46 $31.29 $58.46 $67.71 46 $25.22 $47.12 $54.57\n\n47 $32.27 $60.29 $69.83 47 $31.29 $58.46 $67.71 47 $25.22 $47.12 $54.57\n\n48 $32.27 $60.29 $69.83 48 $31.29 $58.46 $67.71 48 $25.22 $47.12 $54.57\n\n49 $32.27 $60.29 $69.83 49 $31.29 $58.46 $67.71 49 $25.22 $47.12 $54.57\n\n**Table 10 - CA 926 - 927, 929 (Orange County**\n\n**excluding Anaheim) Table 11 - CA 928 (Anaheim)**\n\n**Table 12 - CA 930 (Ventura County excluding**\n\n**Thousand Oaks)**","pages":[{"line_numbers":[],"markdown":"**Exhibit 2 - 2017 Second Quarter Rate Tables**\n\n**Aetna Individual Dental PPO Rate Filing**\n\n**California**\n\n**Effective June 1, 2017**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n0 $20.76 $23.99 $26.67 0 $20.13 $23.26 $25.86 0 $16.23 $18.75 $20.84\n\n1 $20.76 $23.99 $26.67 1 $20.13 $23.26 $25.86 1 $16.23 $18.75 $20.84\n\n2 $20.76 $23.99 $26.67 2 $20.13 $23.26 $25.86 2 $16.23 $18.75 $20.84\n\n3 $20.76 $23.99 $26.67 3 $20.13 $23.26 $25.86 3 $16.23 $18.75 $20.84\n\n4 $20.76 $23.99 $26.67 4 $20.13 $23.26 $25.86 4 $16.23 $18.75 $20.84\n\n5 $45.75 $56.81 $65.10 5 $44.36 $55.09 $63.12 5 $35.76 $44.40 $50.87\n\n6 $45.75 $56.81 $65.10 6 $44.36 $55.09 $63.12 6 $35.76 $44.40 $50.87\n\n7 $45.75 $56.81 $65.10 7 $44.36 $55.09 $63.12 7 $35.76 $44.40 $50.87\n\n8 $45.75 $56.81 $65.10 8 $44.36 $55.09 $63.12 8 $35.76 $44.40 $50.87\n\n9 $45.75 $56.81 $65.10 9 $44.36 $55.09 $63.12 9 $35.76 $44.40 $50.87\n\n10 $42.57 $51.72 $58.52 10 $41.27 $50.15 $56.74 10 $33.27 $40.42 $45.73\n\n11 $42.57 $51.72 $58.52 11 $41.27 $50.15 $56.74 11 $33.27 $40.42 $45.73\n\n12 $42.57 $51.72 $58.52 12 $41.27 $50.15 $56.74 12 $33.27 $40.42 $45.73\n\n13 $42.57 $51.72 $58.52 13 $41.27 $50.15 $56.74 13 $33.27 $40.42 $45.73\n\n14 $42.57 $51.72 $58.52 14 $41.27 $50.15 $56.74 14 $33.27 $40.42 $45.73\n\n15 $33.79 $52.87 $61.66 15 $32.77 $51.27 $59.79 15 $26.41 $41.32 $48.18\n\n16 $33.79 $52.87 $61.66 16 $32.77 $51.27 $59.79 16 $26.41 $41.32 $48.18\n\n17 $33.79 $52.87 $61.66 17 $32.77 $51.27 $59.79 17 $26.41 $41.32 $48.18\n\n18 $33.79 $52.87 $61.66 18 $32.77 $51.27 $59.79 18 $26.41 $41.32 $48.18\n\n19 $33.79 $52.87 $61.66 19 $32.77 $51.27 $59.79 19 $26.41 $41.32 $48.18\n\n20 $27.28 $45.98 $54.00 20 $26.45 $44.59 $52.36 20 $21.32 $35.94 $42.20\n\n21 $27.28 $45.98 $54.00 21 $26.45 $44.59 $52.36 21 $21.32 $35.94 $42.20\n\n22 $27.28 $45.98 $54.00 22 $26.45 $44.59 $52.36 22 $21.32 $35.94 $42.20\n\n23 $27.28 $45.98 $54.00 23 $26.45 $44.59 $52.36 23 $21.32 $35.94 $42.20\n\n24 $27.28 $45.98 $54.00 24 $26.45 $44.59 $52.36 24 $21.32 $35.94 $42.20\n\n25 $28.06 $48.51 $57.26 25 $27.21 $47.04 $55.52 25 $21.93 $37.91 $44.75\n\n26 $28.06 $48.51 $57.26 26 $27.21 $47.04 $55.52 26 $21.93 $37.91 $44.75\n\n27 $28.06 $48.51 $57.26 27 $27.21 $47.04 $55.52 27 $21.93 $37.91 $44.75\n\n28 $28.06 $48.51 $57.26 28 $27.21 $47.04 $55.52 28 $21.93 $37.91 $44.75\n\n29 $28.06 $48.51 $57.26 29 $27.21 $47.04 $55.52 29 $21.93 $37.91 $44.75\n\n30 $30.15 $55.84 $65.78 30 $29.24 $54.15 $63.78 30 $23.57 $43.64 $51.40\n\n31 $30.15 $55.84 $65.78 31 $29.24 $54.15 $63.78 31 $23.57 $43.64 $51.40\n\n32 $30.15 $55.84 $65.78 32 $29.24 $54.15 $63.78 32 $23.57 $43.64 $51.40\n\n33 $30.15 $55.84 $65.78 33 $29.24 $54.15 $63.78 33 $23.57 $43.64 $51.40\n\n34 $30.15 $55.84 $65.78 34 $29.24 $54.15 $63.78 34 $23.57 $43.64 $51.40\n\n35 $30.57 $56.35 $65.96 35 $29.65 $54.64 $63.95 35 $23.89 $44.03 $51.54\n\n36 $30.57 $56.35 $65.96 36 $29.65 $54.64 $63.95 36 $23.89 $44.03 $51.54\n\n37 $30.57 $56.35 $65.96 37 $29.65 $54.64 $63.95 37 $23.89 $44.03 $51.54\n\n38 $30.57 $56.35 $65.96 38 $29.65 $54.64 $63.95 38 $23.89 $44.03 $51.54\n\n39 $30.57 $56.35 $65.96 39 $29.65 $54.64 $63.95 39 $23.89 $44.03 $51.54\n\n40 $31.25 $56.14 $65.19 40 $30.30 $54.43 $63.21 40 $24.42 $43.87 $50.95\n\n41 $31.25 $56.14 $65.19 41 $30.30 $54.43 $63.21 41 $24.42 $43.87 $50.95\n\n42 $31.25 $56.14 $65.19 42 $30.30 $54.43 $63.21 42 $24.42 $43.87 $50.95\n\n43 $31.25 $56.14 $65.19 43 $30.30 $54.43 $63.21 43 $24.42 $43.87 $50.95\n\n44 $31.25 $56.14 $65.19 44 $30.30 $54.43 $63.21 44 $24.42 $43.87 $50.95\n\n45 $32.27 $60.29 $69.83 45 $31.29 $58.46 $67.71 45 $25.22 $47.12 $54.57\n\n46 $32.27 $60.29 $69.83 46 $31.29 $58.46 $67.71 46 $25.22 $47.12 $54.57\n\n47 $32.27 $60.29 $69.83 47 $31.29 $58.46 $67.71 47 $25.22 $47.12 $54.57\n\n48 $32.27 $60.29 $69.83 48 $31.29 $58.46 $67.71 48 $25.22 $47.12 $54.57\n\n49 $32.27 $60.29 $69.83 49 $31.29 $58.46 $67.71 49 $25.22 $47.12 $54.57\n\n**Table 10 - CA 926 - 927, 929 (Orange County**\n\n**excluding Anaheim) Table 11 - CA 928 (Anaheim)**\n\n**Table 12 - CA 930 (Ventura County excluding**\n\n**Thousand Oaks)**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit 2 - 2017 Second Quarter Rate Tables**\n\n**Aetna Individual Dental PPO Rate Filing**\n\n**California**\n\n**Effective June 1, 2017**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n0 $20.76 $23.99 $26.67 0 $20.13 $23.26 $25.86 0 $16.23 $18.75 $20.84\n\n1 $20.76 $23.99 $26.67 1 $20.13 $23.26 $25.86 1 $16.23 $18.75 $20.84\n\n2 $20.76 $23.99 $26.67 2 $20.13 $23.26 $25.86 2 $16.23 $18.75 $20.84\n\n3 $20.76 $23.99 $26.67 3 $20.13 $23.26 $25.86 3 $16.23 $18.75 $20.84\n\n4 $20.76 $23.99 $26.67 4 $20.13 $23.26 $25.86 4 $16.23 $18.75 $20.84\n\n5 $45.75 $56.81 $65.10 5 $44.36 $55.09 $63.12 5 $35.76 $44.40 $50.87\n\n6 $45.75 $56.81 $65.10 6 $44.36 $55.09 $63.12 6 $35.76 $44.40 $50.87\n\n7 $45.75 $56.81 $65.10 7 $44.36 $55.09 $63.12 7 $35.76 $44.40 $50.87\n\n8 $45.75 $56.81 $65.10 8 $44.36 $55.09 $63.12 8 $35.76 $44.40 $50.87\n\n9 $45.75 $56.81 $65.10 9 $44.36 $55.09 $63.12 9 $35.76 $44.40 $50.87\n\n10 $42.57 $51.72 $58.52 10 $41.27 $50.15 $56.74 10 $33.27 $40.42 $45.73\n\n11 $42.57 $51.72 $58.52 11 $41.27 $50.15 $56.74 11 $33.27 $40.42 $45.73\n\n12 $42.57 $51.72 $58.52 12 $41.27 $50.15 $56.74 12 $33.27 $40.42 $45.73\n\n13 $42.57 $51.72 $58.52 13 $41.27 $50.15 $56.74 13 $33.27 $40.42 $45.73\n\n14 $42.57 $51.72 $58.52 14 $41.27 $50.15 $56.74 14 $33.27 $40.42 $45.73\n\n15 $33.79 $52.87 $61.66 15 $32.77 $51.27 $59.79 15 $26.41 $41.32 $48.18\n\n16 $33.79 $52.87 $61.66 16 $32.77 $51.27 $59.79 16 $26.41 $41.32 $48.18\n\n17 $33.79 $52.87 $61.66 17 $32.77 $51.27 $59.79 17 $26.41 $41.32 $48.18\n\n18 $33.79 $52.87 $61.66 18 $32.77 $51.27 $59.79 18 $26.41 $41.32 $48.18\n\n19 $33.79 $52.87 $61.66 19 $32.77 $51.27 $59.79 19 $26.41 $41.32 $48.18\n\n20 $27.28 $45.98 $54.00 20 $26.45 $44.59 $52.36 20 $21.32 $35.94 $42.20\n\n21 $27.28 $45.98 $54.00 21 $26.45 $44.59 $52.36 21 $21.32 $35.94 $42.20\n\n22 $27.28 $45.98 $54.00 22 $26.45 $44.59 $52.36 22 $21.32 $35.94 $42.20\n\n23 $27.28 $45.98 $54.00 23 $26.45 $44.59 $52.36 23 $21.32 $35.94 $42.20\n\n24 $27.28 $45.98 $54.00 24 $26.45 $44.59 $52.36 24 $21.32 $35.94 $42.20\n\n25 $28.06 $48.51 $57.26 25 $27.21 $47.04 $55.52 25 $21.93 $37.91 $44.75\n\n26 $28.06 $48.51 $57.26 26 $27.21 $47.04 $55.52 26 $21.93 $37.91 $44.75\n\n27 $28.06 $48.51 $57.26 27 $27.21 $47.04 $55.52 27 $21.93 $37.91 $44.75\n\n28 $28.06 $48.51 $57.26 28 $27.21 $47.04 $55.52 28 $21.93 $37.91 $44.75\n\n29 $28.06 $48.51 $57.26 29 $27.21 $47.04 $55.52 29 $21.93 $37.91 $44.75\n\n30 $30.15 $55.84 $65.78 30 $29.24 $54.15 $63.78 30 $23.57 $43.64 $51.40\n\n31 $30.15 $55.84 $65.78 31 $29.24 $54.15 $63.78 31 $23.57 $43.64 $51.40\n\n32 $30.15 $55.84 $65.78 32 $29.24 $54.15 $63.78 32 $23.57 $43.64 $51.40\n\n33 $30.15 $55.84 $65.78 33 $29.24 $54.15 $63.78 33 $23.57 $43.64 $51.40\n\n34 $30.15 $55.84 $65.78 34 $29.24 $54.15 $63.78 34 $23.57 $43.64 $51.40\n\n35 $30.57 $56.35 $65.96 35 $29.65 $54.64 $63.95 35 $23.89 $44.03 $51.54\n\n36 $30.57 $56.35 $65.96 36 $29.65 $54.64 $63.95 36 $23.89 $44.03 $51.54\n\n37 $30.57 $56.35 $65.96 37 $29.65 $54.64 $63.95 37 $23.89 $44.03 $51.54\n\n38 $30.57 $56.35 $65.96 38 $29.65 $54.64 $63.95 38 $23.89 $44.03 $51.54\n\n39 $30.57 $56.35 $65.96 39 $29.65 $54.64 $63.95 39 $23.89 $44.03 $51.54\n\n40 $31.25 $56.14 $65.19 40 $30.30 $54.43 $63.21 40 $24.42 $43.87 $50.95\n\n41 $31.25 $56.14 $65.19 41 $30.30 $54.43 $63.21 41 $24.42 $43.87 $50.95\n\n42 $31.25 $56.14 $65.19 42 $30.30 $54.43 $63.21 42 $24.42 $43.87 $50.95\n\n43 $31.25 $56.14 $65.19 43 $30.30 $54.43 $63.21 43 $24.42 $43.87 $50.95\n\n44 $31.25 $56.14 $65.19 44 $30.30 $54.43 $63.21 44 $24.42 $43.87 $50.95\n\n45 $32.27 $60.29 $69.83 45 $31.29 $58.46 $67.71 45 $25.22 $47.12 $54.57\n\n46 $32.27 $60.29 $69.83 46 $31.29 $58.46 $67.71 46 $25.22 $47.12 $54.57\n\n47 $32.27 $60.29 $69.83 47 $31.29 $58.46 $67.71 47 $25.22 $47.12 $54.57\n\n48 $32.27 $60.29 $69.83 48 $31.29 $58.46 $67.71 48 $25.22 $47.12 $54.57\n\n49 $32.27 $60.29 $69.83 49 $31.29 $58.46 $67.71 49 $25.22 $47.12 $54.57\n\n**Table 10 - CA 926 - 927, 929 (Orange County**\n\n**excluding Anaheim) Table 11 - CA 928 (Anaheim)**\n\n**Table 12 - CA 930 (Ventura County excluding**\n\n**Thousand Oaks)**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page106.pdf"]},"response":{"errors":[],"extract_id":"extract_ef30baddf2c9c264d3a5d97e4d5d309a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit 2 - 2017 Second Quarter Rate Tables**\n\n**Aetna Individual Dental PPO Rate Filing**\n\n**California**\n\n**Effective June 1, 2017**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n0 $20.76 $23.99 $26.67 0 $20.13 $23.26 $25.86 0 $16.23 $18.75 $20.84\n\n1 $20.76 $23.99 $26.67 1 $20.13 $23.26 $25.86 1 $16.23 $18.75 $20.84\n\n2 $20.76 $23.99 $26.67 2 $20.13 $23.26 $25.86 2 $16.23 $18.75 $20.84\n\n3 $20.76 $23.99 $26.67 3 $20.13 $23.26 $25.86 3 $16.23 $18.75 $20.84\n\n4 $20.76 $23.99 $26.67 4 $20.13 $23.26 $25.86 4 $16.23 $18.75 $20.84\n\n5 $45.75 $56.81 $65.10 5 $44.36 $55.09 $63.12 5 $35.76 $44.40 $50.87\n\n6 $45.75 $56.81 $65.10 6 $44.36 $55.09 $63.12 6 $35.76 $44.40 $50.87\n\n7 $45.75 $56.81 $65.10 7 $44.36 $55.09 $63.12 7 $35.76 $44.40 $50.87\n\n8 $45.75 $56.81 $65.10 8 $44.36 $55.09 $63.12 8 $35.76 $44.40 $50.87\n\n9 $45.75 $56.81 $65.10 9 $44.36 $55.09 $63.12 9 $35.76 $44.40 $50.87\n\n10 $42.57 $51.72 $58.52 10 $41.27 $50.15 $56.74 10 $33.27 $40.42 $45.73\n\n11 $42.57 $51.72 $58.52 11 $41.27 $50.15 $56.74 11 $33.27 $40.42 $45.73\n\n12 $42.57 $51.72 $58.52 12 $41.27 $50.15 $56.74 12 $33.27 $40.42 $45.73\n\n13 $42.57 $51.72 $58.52 13 $41.27 $50.15 $56.74 13 $33.27 $40.42 $45.73\n\n14 $42.57 $51.72 $58.52 14 $41.27 $50.15 $56.74 14 $33.27 $40.42 $45.73\n\n15 $33.79 $52.87 $61.66 15 $32.77 $51.27 $59.79 15 $26.41 $41.32 $48.18\n\n16 $33.79 $52.87 $61.66 16 $32.77 $51.27 $59.79 16 $26.41 $41.32 $48.18\n\n17 $33.79 $52.87 $61.66 17 $32.77 $51.27 $59.79 17 $26.41 $41.32 $48.18\n\n18 $33.79 $52.87 $61.66 18 $32.77 $51.27 $59.79 18 $26.41 $41.32 $48.18\n\n19 $33.79 $52.87 $61.66 19 $32.77 $51.27 $59.79 19 $26.41 $41.32 $48.18\n\n20 $27.28 $45.98 $54.00 20 $26.45 $44.59 $52.36 20 $21.32 $35.94 $42.20\n\n21 $27.28 $45.98 $54.00 21 $26.45 $44.59 $52.36 21 $21.32 $35.94 $42.20\n\n22 $27.28 $45.98 $54.00 22 $26.45 $44.59 $52.36 22 $21.32 $35.94 $42.20\n\n23 $27.28 $45.98 $54.00 23 $26.45 $44.59 $52.36 23 $21.32 $35.94 $42.20\n\n24 $27.28 $45.98 $54.00 24 $26.45 $44.59 $52.36 24 $21.32 $35.94 $42.20\n\n25 $28.06 $48.51 $57.26 25 $27.21 $47.04 $55.52 25 $21.93 $37.91 $44.75\n\n26 $28.06 $48.51 $57.26 26 $27.21 $47.04 $55.52 26 $21.93 $37.91 $44.75\n\n27 $28.06 $48.51 $57.26 27 $27.21 $47.04 $55.52 27 $21.93 $37.91 $44.75\n\n28 $28.06 $48.51 $57.26 28 $27.21 $47.04 $55.52 28 $21.93 $37.91 $44.75\n\n29 $28.06 $48.51 $57.26 29 $27.21 $47.04 $55.52 29 $21.93 $37.91 $44.75\n\n30 $30.15 $55.84 $65.78 30 $29.24 $54.15 $63.78 30 $23.57 $43.64 $51.40\n\n31 $30.15 $55.84 $65.78 31 $29.24 $54.15 $63.78 31 $23.57 $43.64 $51.40\n\n32 $30.15 $55.84 $65.78 32 $29.24 $54.15 $63.78 32 $23.57 $43.64 $51.40\n\n33 $30.15 $55.84 $65.78 33 $29.24 $54.15 $63.78 33 $23.57 $43.64 $51.40\n\n34 $30.15 $55.84 $65.78 34 $29.24 $54.15 $63.78 34 $23.57 $43.64 $51.40\n\n35 $30.57 $56.35 $65.96 35 $29.65 $54.64 $63.95 35 $23.89 $44.03 $51.54\n\n36 $30.57 $56.35 $65.96 36 $29.65 $54.64 $63.95 36 $23.89 $44.03 $51.54\n\n37 $30.57 $56.35 $65.96 37 $29.65 $54.64 $63.95 37 $23.89 $44.03 $51.54\n\n38 $30.57 $56.35 $65.96 38 $29.65 $54.64 $63.95 38 $23.89 $44.03 $51.54\n\n39 $30.57 $56.35 $65.96 39 $29.65 $54.64 $63.95 39 $23.89 $44.03 $51.54\n\n40 $31.25 $56.14 $65.19 40 $30.30 $54.43 $63.21 40 $24.42 $43.87 $50.95\n\n41 $31.25 $56.14 $65.19 41 $30.30 $54.43 $63.21 41 $24.42 $43.87 $50.95\n\n42 $31.25 $56.14 $65.19 42 $30.30 $54.43 $63.21 42 $24.42 $43.87 $50.95\n\n43 $31.25 $56.14 $65.19 43 $30.30 $54.43 $63.21 43 $24.42 $43.87 $50.95\n\n44 $31.25 $56.14 $65.19 44 $30.30 $54.43 $63.21 44 $24.42 $43.87 $50.95\n\n45 $32.27 $60.29 $69.83 45 $31.29 $58.46 $67.71 45 $25.22 $47.12 $54.57\n\n46 $32.27 $60.29 $69.83 46 $31.29 $58.46 $67.71 46 $25.22 $47.12 $54.57\n\n47 $32.27 $60.29 $69.83 47 $31.29 $58.46 $67.71 47 $25.22 $47.12 $54.57\n\n48 $32.27 $60.29 $69.83 48 $31.29 $58.46 $67.71 48 $25.22 $47.12 $54.57\n\n49 $32.27 $60.29 $69.83 49 $31.29 $58.46 $67.71 49 $25.22 $47.12 $54.57\n\n**Table 10 - CA 926 - 927, 929 (Orange County**\n\n**excluding Anaheim) Table 11 - CA 928 (Anaheim)**\n\n**Table 12 - CA 930 (Ventura County excluding**\n\n**Thousand Oaks)**"],"full_content":"**Exhibit 2 - 2017 Second Quarter Rate Tables**\n\n**Aetna Individual Dental PPO Rate Filing**\n\n**California**\n\n**Effective June 1, 2017**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n**Age Aetna Leap Dental PPO**\n\n**Aetna Leap Dental PPO**\n\n**Select**\n\n**Aetna Leap Dental PPO**\n\n**Plus**\n\n0 $20.76 $23.99 $26.67 0 $20.13 $23.26 $25.86 0 $16.23 $18.75 $20.84\n\n1 $20.76 $23.99 $26.67 1 $20.13 $23.26 $25.86 1 $16.23 $18.75 $20.84\n\n2 $20.76 $23.99 $26.67 2 $20.13 $23.26 $25.86 2 $16.23 $18.75 $20.84\n\n3 $20.76 $23.99 $26.67 3 $20.13 $23.26 $25.86 3 $16.23 $18.75 $20.84\n\n4 $20.76 $23.99 $26.67 4 $20.13 $23.26 $25.86 4 $16.23 $18.75 $20.84\n\n5 $45.75 $56.81 $65.10 5 $44.36 $55.09 $63.12 5 $35.76 $44.40 $50.87\n\n6 $45.75 $56.81 $65.10 6 $44.36 $55.09 $63.12 6 $35.76 $44.40 $50.87\n\n7 $45.75 $56.81 $65.10 7 $44.36 $55.09 $63.12 7 $35.76 $44.40 $50.87\n\n8 $45.75 $56.81 $65.10 8 $44.36 $55.09 $63.12 8 $35.76 $44.40 $50.87\n\n9 $45.75 $56.81 $65.10 9 $44.36 $55.09 $63.12 9 $35.76 $44.40 $50.87\n\n10 $42.57 $51.72 $58.52 10 $41.27 $50.15 $56.74 10 $33.27 $40.42 $45.73\n\n11 $42.57 $51.72 $58.52 11 $41.27 $50.15 $56.74 11 $33.27 $40.42 $45.73\n\n12 $42.57 $51.72 $58.52 12 $41.27 $50.15 $56.74 12 $33.27 $40.42 $45.73\n\n13 $42.57 $51.72 $58.52 13 $41.27 $50.15 $56.74 13 $33.27 $40.42 $45.73\n\n14 $42.57 $51.72 $58.52 14 $41.27 $50.15 $56.74 14 $33.27 $40.42 $45.73\n\n15 $33.79 $52.87 $61.66 15 $32.77 $51.27 $59.79 15 $26.41 $41.32 $48.18\n\n16 $33.79 $52.87 $61.66 16 $32.77 $51.27 $59.79 16 $26.41 $41.32 $48.18\n\n17 $33.79 $52.87 $61.66 17 $32.77 $51.27 $59.79 17 $26.41 $41.32 $48.18\n\n18 $33.79 $52.87 $61.66 18 $32.77 $51.27 $59.79 18 $26.41 $41.32 $48.18\n\n19 $33.79 $52.87 $61.66 19 $32.77 $51.27 $59.79 19 $26.41 $41.32 $48.18\n\n20 $27.28 $45.98 $54.00 20 $26.45 $44.59 $52.36 20 $21.32 $35.94 $42.20\n\n21 $27.28 $45.98 $54.00 21 $26.45 $44.59 $52.36 21 $21.32 $35.94 $42.20\n\n22 $27.28 $45.98 $54.00 22 $26.45 $44.59 $52.36 22 $21.32 $35.94 $42.20\n\n23 $27.28 $45.98 $54.00 23 $26.45 $44.59 $52.36 23 $21.32 $35.94 $42.20\n\n24 $27.28 $45.98 $54.00 24 $26.45 $44.59 $52.36 24 $21.32 $35.94 $42.20\n\n25 $28.06 $48.51 $57.26 25 $27.21 $47.04 $55.52 25 $21.93 $37.91 $44.75\n\n26 $28.06 $48.51 $57.26 26 $27.21 $47.04 $55.52 26 $21.93 $37.91 $44.75\n\n27 $28.06 $48.51 $57.26 27 $27.21 $47.04 $55.52 27 $21.93 $37.91 $44.75\n\n28 $28.06 $48.51 $57.26 28 $27.21 $47.04 $55.52 28 $21.93 $37.91 $44.75\n\n29 $28.06 $48.51 $57.26 29 $27.21 $47.04 $55.52 29 $21.93 $37.91 $44.75\n\n30 $30.15 $55.84 $65.78 30 $29.24 $54.15 $63.78 30 $23.57 $43.64 $51.40\n\n31 $30.15 $55.84 $65.78 31 $29.24 $54.15 $63.78 31 $23.57 $43.64 $51.40\n\n32 $30.15 $55.84 $65.78 32 $29.24 $54.15 $63.78 32 $23.57 $43.64 $51.40\n\n33 $30.15 $55.84 $65.78 33 $29.24 $54.15 $63.78 33 $23.57 $43.64 $51.40\n\n34 $30.15 $55.84 $65.78 34 $29.24 $54.15 $63.78 34 $23.57 $43.64 $51.40\n\n35 $30.57 $56.35 $65.96 35 $29.65 $54.64 $63.95 35 $23.89 $44.03 $51.54\n\n36 $30.57 $56.35 $65.96 36 $29.65 $54.64 $63.95 36 $23.89 $44.03 $51.54\n\n37 $30.57 $56.35 $65.96 37 $29.65 $54.64 $63.95 37 $23.89 $44.03 $51.54\n\n38 $30.57 $56.35 $65.96 38 $29.65 $54.64 $63.95 38 $23.89 $44.03 $51.54\n\n39 $30.57 $56.35 $65.96 39 $29.65 $54.64 $63.95 39 $23.89 $44.03 $51.54\n\n40 $31.25 $56.14 $65.19 40 $30.30 $54.43 $63.21 40 $24.42 $43.87 $50.95\n\n41 $31.25 $56.14 $65.19 41 $30.30 $54.43 $63.21 41 $24.42 $43.87 $50.95\n\n42 $31.25 $56.14 $65.19 42 $30.30 $54.43 $63.21 42 $24.42 $43.87 $50.95\n\n43 $31.25 $56.14 $65.19 43 $30.30 $54.43 $63.21 43 $24.42 $43.87 $50.95\n\n44 $31.25 $56.14 $65.19 44 $30.30 $54.43 $63.21 44 $24.42 $43.87 $50.95\n\n45 $32.27 $60.29 $69.83 45 $31.29 $58.46 $67.71 45 $25.22 $47.12 $54.57\n\n46 $32.27 $60.29 $69.83 46 $31.29 $58.46 $67.71 46 $25.22 $47.12 $54.57\n\n47 $32.27 $60.29 $69.83 47 $31.29 $58.46 $67.71 47 $25.22 $47.12 $54.57\n\n48 $32.27 $60.29 $69.83 48 $31.29 $58.46 $67.71 48 $25.22 $47.12 $54.57\n\n49 $32.27 $60.29 $69.83 49 $31.29 $58.46 $67.71 49 $25.22 $47.12 $54.57\n\n**Table 10 - CA 926 - 927, 929 (Orange County**\n\n**excluding Anaheim) Table 11 - CA 928 (Anaheim)**\n\n**Table 12 - CA 930 (Ventura County excluding**\n\n**Thousand Oaks)**","publish_date":null,"title":"Exhibit 2 - 2017 Second Quarter Rate Tables Aetna Individual Dental PPO Rate Filing California Effective June 1, 2017","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page106.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page106.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page106","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page106.pdf"},"started_at":"2026-11-04T19:48:13.213325"} +{"completed_at":"2026-11-04T19:31:06.454417","latency_in_ms":3455,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1116","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 5 Sheet 2 **_(revised 2/19/09)_**\n\nProposed Effective Date: **1/1/2009** Avg Date of Loss: **10/1/2009**\n\nTrend Period (number of years from the midpoint of the accident year to the average date of loss)\n\n9/30/2005 4.50 9/30/2006 3.50 9/30/2007 2.50\n\nBI PD Coll Comp UM MP UMPD\n\nSelected Historical -4.9% -1.8% 2.0% 5.2% -3.0% -10.4% 0.0% Trend Prospective -4.9% -1.8% 2.0% 5.2% -3.0% -10.4% 0.0% (12 point)\n\nPremium Trend Factor 9/30/2005 0.796 0.922 1.092 1.254 0.871 0.609 1.000 9/30/2006 0.837 0.939 1.071 1.193 0.898 0.679 1.000 9/30/2007 0.881 0.956 1.050 1.134 0.926 0.759 1.000\n\nNote: UMPD uses 0% trend\n\n12 point exponential fit (see sheet 1)\n\n**Affinity Program**\n\n**Calculation of Premium Trend Factors for Rate Application Page 7, Line 4**\n\n**GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA PREMIUM TREND FACTORS**","pages":[{"line_numbers":[],"markdown":"Exhibit 5 Sheet 2 **_(revised 2/19/09)_**\n\nProposed Effective Date: **1/1/2009** Avg Date of Loss: **10/1/2009**\n\nTrend Period (number of years from the midpoint of the accident year to the average date of loss)\n\n9/30/2005 4.50 9/30/2006 3.50 9/30/2007 2.50\n\nBI PD Coll Comp UM MP UMPD\n\nSelected Historical -4.9% -1.8% 2.0% 5.2% -3.0% -10.4% 0.0% Trend Prospective -4.9% -1.8% 2.0% 5.2% -3.0% -10.4% 0.0% (12 point)\n\nPremium Trend Factor 9/30/2005 0.796 0.922 1.092 1.254 0.871 0.609 1.000 9/30/2006 0.837 0.939 1.071 1.193 0.898 0.679 1.000 9/30/2007 0.881 0.956 1.050 1.134 0.926 0.759 1.000\n\nNote: UMPD uses 0% trend\n\n12 point exponential fit (see sheet 1)\n\n**Affinity Program**\n\n**Calculation of Premium Trend Factors for Rate Application Page 7, Line 4**\n\n**GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA PREMIUM TREND FACTORS**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 5 Sheet 2 **_(revised 2/19/09)_**\n\nProposed Effective Date: **1/1/2009** Avg Date of Loss: **10/1/2009**\n\nTrend Period (number of years from the midpoint of the accident year to the average date of loss)\n\n9/30/2005 4.50 9/30/2006 3.50 9/30/2007 2.50\n\nBI PD Coll Comp UM MP UMPD\n\nSelected Historical -4.9% -1.8% 2.0% 5.2% -3.0% -10.4% 0.0% Trend Prospective -4.9% -1.8% 2.0% 5.2% -3.0% -10.4% 0.0% (12 point)\n\nPremium Trend Factor 9/30/2005 0.796 0.922 1.092 1.254 0.871 0.609 1.000 9/30/2006 0.837 0.939 1.071 1.193 0.898 0.679 1.000 9/30/2007 0.881 0.956 1.050 1.134 0.926 0.759 1.000\n\nNote: UMPD uses 0% trend\n\n12 point exponential fit (see sheet 1)\n\n**Affinity Program**\n\n**Calculation of Premium Trend Factors for Rate Application Page 7, Line 4**\n\n**GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA PREMIUM TREND FACTORS**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1116.pdf"]},"response":{"errors":[],"extract_id":"extract_1d9db95a0ef8f42cb708533a9432838a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 5 Sheet 2 **_(revised 2/19/09)_**\n\nProposed Effective Date: **1/1/2009** Avg Date of Loss: **10/1/2009**\n\nTrend Period (number of years from the midpoint of the accident year to the average date of loss)\n\n9/30/2005 4.50 9/30/2006 3.50 9/30/2007 2.50\n\nBI PD Coll Comp UM MP UMPD\n\nSelected Historical -4.9% -1.8% 2.0% 5.2% -3.0% -10.4% 0.0% Trend Prospective -4.9% -1.8% 2.0% 5.2% -3.0% -10.4% 0.0% (12 point)\n\nPremium Trend Factor 9/30/2005 0.796 0.922 1.092 1.254 0.871 0.609 1.000 9/30/2006 0.837 0.939 1.071 1.193 0.898 0.679 1.000 9/30/2007 0.881 0.956 1.050 1.134 0.926 0.759 1.000\n\nNote: UMPD uses 0% trend\n\n12 point exponential fit (see sheet 1)\n\n**Affinity Program**\n\n**Calculation of Premium Trend Factors for Rate Application Page 7, Line 4**\n\n**GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA PREMIUM TREND FACTORS**"],"full_content":"Exhibit 5 Sheet 2 **_(revised 2/19/09)_**\n\nProposed Effective Date: **1/1/2009** Avg Date of Loss: **10/1/2009**\n\nTrend Period (number of years from the midpoint of the accident year to the average date of loss)\n\n9/30/2005 4.50 9/30/2006 3.50 9/30/2007 2.50\n\nBI PD Coll Comp UM MP UMPD\n\nSelected Historical -4.9% -1.8% 2.0% 5.2% -3.0% -10.4% 0.0% Trend Prospective -4.9% -1.8% 2.0% 5.2% -3.0% -10.4% 0.0% (12 point)\n\nPremium Trend Factor 9/30/2005 0.796 0.922 1.092 1.254 0.871 0.609 1.000 9/30/2006 0.837 0.939 1.071 1.193 0.898 0.679 1.000 9/30/2007 0.881 0.956 1.050 1.134 0.926 0.759 1.000\n\nNote: UMPD uses 0% trend\n\n12 point exponential fit (see sheet 1)\n\n**Affinity Program**\n\n**Calculation of Premium Trend Factors for Rate Application Page 7, Line 4**\n\n**GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA PREMIUM TREND FACTORS**","publish_date":null,"title":"GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA PREMIUM TREND FACTORS Affinity Program Calculation of Premium Trend Factors for Rate Application","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1116.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1116.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1116","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1116.pdf"},"started_at":"2026-11-04T19:31:02.999257"} +{"completed_at":"2026-11-04T19:48:17.450058","latency_in_ms":1205,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1131","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 8 Sheet 6 (footnote added 5-13-09)\n\nAll Programs Combined Data\n\n**Quarterly**\n\n**12 month Rolling**\n\n**Frequency**\n\n**12 month Rolling**\n\n**Severity**\n\n**Date**\n\n**Claim Counts**\n\n**GEICO**\n\n**Casualty\\***\n\n**Fast Track**\n\n**GEICO**\n\n**Casualty\\*\\***\n\n**Fast Track** Mar-02 18 3.10 2.01 3181 8849 Jun-02 16 2.85 2.00 3795 8864 Sep-02 13 3.16 1.99 3507 8911 Dec-02 20 3.35 1.97 3622 9059 Mar-03 27 3.87 1.95 3579 9213 Jun-03 25 4.00 1.93 3338 9434 Sep-03 26 4.20 1.93 3702 9616 Dec-03 42 4.21 1.92 3829 9581 Mar-04 31 3.84 1.90 4027 9513 Jun-04 36 3.68 1.89 4298 9416 Sep-04 40 3.31 1.85 4360 9402 Dec-04 18 2.99 1.80 4613 9471 Mar-05 33 3.23 1.77 4405 9490 Jun-05 32 3.34 1.73 4258 9555 Sep-05 32 3.56 1.69 3747 9522 Dec-05 35 3.74 1.65 3706 9540 Mar-06 35 3.37 1.61 3599 9751 Jun-06 36 3.32 1.56 3421 9812 Sep-06 32 3.22 1.53 3489 9947 Dec-06 27 3.14 1.51 3299 10080 Mar-07 26 3.13 1.48 3410 10277 Jun-07 19 2.98 1.47 3491 10461 Sep-07 21 2.72 1.46 3851 10675 Dec-07 39 2.68 1.45 3625 10942\n\nCredibility Credibility Weighted Credibility Weighted 24 Point 33.6% -3.0% -6.3% -5.2% -0.2% 2.9% 1.9% 20 Point 31.9% -7.2% -7.0% -7.1% -2.2% 2.8% 1.2% 16 Point 28.6% -6.2% -7.7% -7.3% -6.5% 3.8% 0.9% 12 Point 24.7% -8.5% -7.3% -7.6% -5.7% 5.3% 2.6% 8 Point 19.8% -12.7% -5.6% -7.0% 3.3% 6.9% 6.2%\n\nSelected Loss and DCCE Trend -7.6% 2.6% (12 Point) Frequency Severity\n\nCredibility: 6000 claims for full credibility, square root formula for partial credibility\n\n\\* Frequency as calculated by reported claims divided by exposures \\*\\* Severity as calculated by total paid losses, including partial payments in previous calendar years, on closed claims divided by closed claims\n\nAnnual % Change Annual % Change\n\n**GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA LOSS AND DCCE TREND**\n\n**Medical Payments**","pages":[{"line_numbers":[],"markdown":"Exhibit 8 Sheet 6 (footnote added 5-13-09)\n\nAll Programs Combined Data\n\n**Quarterly**\n\n**12 month Rolling**\n\n**Frequency**\n\n**12 month Rolling**\n\n**Severity**\n\n**Date**\n\n**Claim Counts**\n\n**GEICO**\n\n**Casualty\\***\n\n**Fast Track**\n\n**GEICO**\n\n**Casualty\\*\\***\n\n**Fast Track** Mar-02 18 3.10 2.01 3181 8849 Jun-02 16 2.85 2.00 3795 8864 Sep-02 13 3.16 1.99 3507 8911 Dec-02 20 3.35 1.97 3622 9059 Mar-03 27 3.87 1.95 3579 9213 Jun-03 25 4.00 1.93 3338 9434 Sep-03 26 4.20 1.93 3702 9616 Dec-03 42 4.21 1.92 3829 9581 Mar-04 31 3.84 1.90 4027 9513 Jun-04 36 3.68 1.89 4298 9416 Sep-04 40 3.31 1.85 4360 9402 Dec-04 18 2.99 1.80 4613 9471 Mar-05 33 3.23 1.77 4405 9490 Jun-05 32 3.34 1.73 4258 9555 Sep-05 32 3.56 1.69 3747 9522 Dec-05 35 3.74 1.65 3706 9540 Mar-06 35 3.37 1.61 3599 9751 Jun-06 36 3.32 1.56 3421 9812 Sep-06 32 3.22 1.53 3489 9947 Dec-06 27 3.14 1.51 3299 10080 Mar-07 26 3.13 1.48 3410 10277 Jun-07 19 2.98 1.47 3491 10461 Sep-07 21 2.72 1.46 3851 10675 Dec-07 39 2.68 1.45 3625 10942\n\nCredibility Credibility Weighted Credibility Weighted 24 Point 33.6% -3.0% -6.3% -5.2% -0.2% 2.9% 1.9% 20 Point 31.9% -7.2% -7.0% -7.1% -2.2% 2.8% 1.2% 16 Point 28.6% -6.2% -7.7% -7.3% -6.5% 3.8% 0.9% 12 Point 24.7% -8.5% -7.3% -7.6% -5.7% 5.3% 2.6% 8 Point 19.8% -12.7% -5.6% -7.0% 3.3% 6.9% 6.2%\n\nSelected Loss and DCCE Trend -7.6% 2.6% (12 Point) Frequency Severity\n\nCredibility: 6000 claims for full credibility, square root formula for partial credibility\n\n\\* Frequency as calculated by reported claims divided by exposures \\*\\* Severity as calculated by total paid losses, including partial payments in previous calendar years, on closed claims divided by closed claims\n\nAnnual % Change Annual % Change\n\n**GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA LOSS AND DCCE TREND**\n\n**Medical Payments**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 8 Sheet 6 (footnote added 5-13-09)\n\nAll Programs Combined Data\n\n**Quarterly**\n\n**12 month Rolling**\n\n**Frequency**\n\n**12 month Rolling**\n\n**Severity**\n\n**Date**\n\n**Claim Counts**\n\n**GEICO**\n\n**Casualty\\***\n\n**Fast Track**\n\n**GEICO**\n\n**Casualty\\*\\***\n\n**Fast Track** Mar-02 18 3.10 2.01 3181 8849 Jun-02 16 2.85 2.00 3795 8864 Sep-02 13 3.16 1.99 3507 8911 Dec-02 20 3.35 1.97 3622 9059 Mar-03 27 3.87 1.95 3579 9213 Jun-03 25 4.00 1.93 3338 9434 Sep-03 26 4.20 1.93 3702 9616 Dec-03 42 4.21 1.92 3829 9581 Mar-04 31 3.84 1.90 4027 9513 Jun-04 36 3.68 1.89 4298 9416 Sep-04 40 3.31 1.85 4360 9402 Dec-04 18 2.99 1.80 4613 9471 Mar-05 33 3.23 1.77 4405 9490 Jun-05 32 3.34 1.73 4258 9555 Sep-05 32 3.56 1.69 3747 9522 Dec-05 35 3.74 1.65 3706 9540 Mar-06 35 3.37 1.61 3599 9751 Jun-06 36 3.32 1.56 3421 9812 Sep-06 32 3.22 1.53 3489 9947 Dec-06 27 3.14 1.51 3299 10080 Mar-07 26 3.13 1.48 3410 10277 Jun-07 19 2.98 1.47 3491 10461 Sep-07 21 2.72 1.46 3851 10675 Dec-07 39 2.68 1.45 3625 10942\n\nCredibility Credibility Weighted Credibility Weighted 24 Point 33.6% -3.0% -6.3% -5.2% -0.2% 2.9% 1.9% 20 Point 31.9% -7.2% -7.0% -7.1% -2.2% 2.8% 1.2% 16 Point 28.6% -6.2% -7.7% -7.3% -6.5% 3.8% 0.9% 12 Point 24.7% -8.5% -7.3% -7.6% -5.7% 5.3% 2.6% 8 Point 19.8% -12.7% -5.6% -7.0% 3.3% 6.9% 6.2%\n\nSelected Loss and DCCE Trend -7.6% 2.6% (12 Point) Frequency Severity\n\nCredibility: 6000 claims for full credibility, square root formula for partial credibility\n\n\\* Frequency as calculated by reported claims divided by exposures \\*\\* Severity as calculated by total paid losses, including partial payments in previous calendar years, on closed claims divided by closed claims\n\nAnnual % Change Annual % Change\n\n**GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA LOSS AND DCCE TREND**\n\n**Medical Payments**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1131.pdf"]},"response":{"errors":[],"extract_id":"extract_eb62e5ccb4cffa418c6d5802896b75c9","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 8 Sheet 6 (footnote added 5-13-09)\n\nAll Programs Combined Data\n\n**Quarterly**\n\n**12 month Rolling**\n\n**Frequency**\n\n**12 month Rolling**\n\n**Severity**\n\n**Date**\n\n**Claim Counts**\n\n**GEICO**\n\n**Casualty\\***\n\n**Fast Track**\n\n**GEICO**\n\n**Casualty\\*\\***\n\n**Fast Track** Mar-02 18 3.10 2.01 3181 8849 Jun-02 16 2.85 2.00 3795 8864 Sep-02 13 3.16 1.99 3507 8911 Dec-02 20 3.35 1.97 3622 9059 Mar-03 27 3.87 1.95 3579 9213 Jun-03 25 4.00 1.93 3338 9434 Sep-03 26 4.20 1.93 3702 9616 Dec-03 42 4.21 1.92 3829 9581 Mar-04 31 3.84 1.90 4027 9513 Jun-04 36 3.68 1.89 4298 9416 Sep-04 40 3.31 1.85 4360 9402 Dec-04 18 2.99 1.80 4613 9471 Mar-05 33 3.23 1.77 4405 9490 Jun-05 32 3.34 1.73 4258 9555 Sep-05 32 3.56 1.69 3747 9522 Dec-05 35 3.74 1.65 3706 9540 Mar-06 35 3.37 1.61 3599 9751 Jun-06 36 3.32 1.56 3421 9812 Sep-06 32 3.22 1.53 3489 9947 Dec-06 27 3.14 1.51 3299 10080 Mar-07 26 3.13 1.48 3410 10277 Jun-07 19 2.98 1.47 3491 10461 Sep-07 21 2.72 1.46 3851 10675 Dec-07 39 2.68 1.45 3625 10942\n\nCredibility Credibility Weighted Credibility Weighted 24 Point 33.6% -3.0% -6.3% -5.2% -0.2% 2.9% 1.9% 20 Point 31.9% -7.2% -7.0% -7.1% -2.2% 2.8% 1.2% 16 Point 28.6% -6.2% -7.7% -7.3% -6.5% 3.8% 0.9% 12 Point 24.7% -8.5% -7.3% -7.6% -5.7% 5.3% 2.6% 8 Point 19.8% -12.7% -5.6% -7.0% 3.3% 6.9% 6.2%\n\nSelected Loss and DCCE Trend -7.6% 2.6% (12 Point) Frequency Severity\n\nCredibility: 6000 claims for full credibility, square root formula for partial credibility\n\n\\* Frequency as calculated by reported claims divided by exposures \\*\\* Severity as calculated by total paid losses, including partial payments in previous calendar years, on closed claims divided by closed claims\n\nAnnual % Change Annual % Change\n\n**GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA LOSS AND DCCE TREND**\n\n**Medical Payments**"],"full_content":"Exhibit 8 Sheet 6 (footnote added 5-13-09)\n\nAll Programs Combined Data\n\n**Quarterly**\n\n**12 month Rolling**\n\n**Frequency**\n\n**12 month Rolling**\n\n**Severity**\n\n**Date**\n\n**Claim Counts**\n\n**GEICO**\n\n**Casualty\\***\n\n**Fast Track**\n\n**GEICO**\n\n**Casualty\\*\\***\n\n**Fast Track** Mar-02 18 3.10 2.01 3181 8849 Jun-02 16 2.85 2.00 3795 8864 Sep-02 13 3.16 1.99 3507 8911 Dec-02 20 3.35 1.97 3622 9059 Mar-03 27 3.87 1.95 3579 9213 Jun-03 25 4.00 1.93 3338 9434 Sep-03 26 4.20 1.93 3702 9616 Dec-03 42 4.21 1.92 3829 9581 Mar-04 31 3.84 1.90 4027 9513 Jun-04 36 3.68 1.89 4298 9416 Sep-04 40 3.31 1.85 4360 9402 Dec-04 18 2.99 1.80 4613 9471 Mar-05 33 3.23 1.77 4405 9490 Jun-05 32 3.34 1.73 4258 9555 Sep-05 32 3.56 1.69 3747 9522 Dec-05 35 3.74 1.65 3706 9540 Mar-06 35 3.37 1.61 3599 9751 Jun-06 36 3.32 1.56 3421 9812 Sep-06 32 3.22 1.53 3489 9947 Dec-06 27 3.14 1.51 3299 10080 Mar-07 26 3.13 1.48 3410 10277 Jun-07 19 2.98 1.47 3491 10461 Sep-07 21 2.72 1.46 3851 10675 Dec-07 39 2.68 1.45 3625 10942\n\nCredibility Credibility Weighted Credibility Weighted 24 Point 33.6% -3.0% -6.3% -5.2% -0.2% 2.9% 1.9% 20 Point 31.9% -7.2% -7.0% -7.1% -2.2% 2.8% 1.2% 16 Point 28.6% -6.2% -7.7% -7.3% -6.5% 3.8% 0.9% 12 Point 24.7% -8.5% -7.3% -7.6% -5.7% 5.3% 2.6% 8 Point 19.8% -12.7% -5.6% -7.0% 3.3% 6.9% 6.2%\n\nSelected Loss and DCCE Trend -7.6% 2.6% (12 Point) Frequency Severity\n\nCredibility: 6000 claims for full credibility, square root formula for partial credibility\n\n\\* Frequency as calculated by reported claims divided by exposures \\*\\* Severity as calculated by total paid losses, including partial payments in previous calendar years, on closed claims divided by closed claims\n\nAnnual % Change Annual % Change\n\n**GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA LOSS AND DCCE TREND**\n\n**Medical Payments**","publish_date":null,"title":"GEICO CASUALTY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA LOSS AND DCCE TREND Medical Payments","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1131.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1131.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1131","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1131.pdf"},"started_at":"2026-11-04T19:48:16.244724"} +{"completed_at":"2026-11-04T19:48:20.464017","latency_in_ms":3016,"output":{"example_id":"table/SERFF_CA_random_pages 1_page115","grounded_pages":[],"layout_pages":[],"markdown":"QBE Insurance Corporation\n\nSingle Female 0 2.69 2.86 2.52 2.86 2.60 2.60 2.24 2.49 1 2.65 2.80 2.48 2.80 2.55 2.55 2.18 2.46 2 2.58 2.62 2.42 2.64 2.49 2.49 2.13 2.28 3 2.54 2.58 2.37 2.60 2.44 2.44 2.11 2.26 4 1.73 1.85 1.62 1.87 1.69 1.67 2.08 1.76 5 1.68 1.81 1.58 1.81 1.62 1.62 2.06 1.74 6 1.53 1.61 1.43 1.63 1.51 1.47 1.96 1.54 7 1.48 1.56 1.39 1.56 1.43 1.43 1.85 1.51 8 1.41 1.32 1.32 1.32 1.38 1.36 1.74 1.36 9 1.39 1.28 1.29 1.28 1.34 1.34 1.62 1.33 10 1.12 1.15 1.05 1.10 1.08 1.08 1.31 1.16 11 1.12 1.12 1.05 1.10 1.08 1.08 1.30 1.16 12 1.12 1.10 1.05 1.10 1.08 1.08 1.29 1.16 13 1.12 1.10 1.05 1.10 1.08 1.08 1.28 1.16 14 1.12 1.10 1.05 1.10 1.08 1.08 1.27 1.16 15 1.08 1.10 1.01 1.10 1.04 1.04 1.20 1.08 16 1.08 1.10 1.01 1.10 1.04 1.04 1.20 1.08 17 1.08 1.10 1.01 1.10 1.04 1.04 1.18 1.08 18 1.07 1.10 1.01 1.10 1.04 1.04 1.18 1.08 19 1.07 1.10 1.01 1.10 1.04 1.04 1.18 1.08 20 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.06 21 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.06 22 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.04 23 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.04 24 1.05 1.07 1.01 1.10 1.05 1.05 1.12 1.04 25 1.05 1.07 1.01 1.10 1.05 1.05 1.12 1.13 26-39 1.08 1.10 1.03 1.10 1.08 1.08 1.12 1.13 40-59 1.18 1.19 1.10 1.19 1.19 1.14 1.10 1.18 60+ 1.40 1.38 1.31 1.38 1.38 1.35 1.10 1.23 Single Male 0 2.64 2.65 2.55 2.65 2.50 2.50 2.35 2.61 1 2.60 2.59 2.50 2.59 2.45 2.45 2.29 2.59 2 2.53 2.43 2.44 2.45 2.39 2.39 2.23 2.40 3 2.49 2.39 2.40 2.41 2.35 2.35 2.21 2.37 4 1.69 1.71 1.63 1.73 1.62 1.60 2.19 1.85 5 1.65 1.67 1.59 1.67 1.56 1.56 2.16 1.83 6 1.50 1.49 1.44 1.51 1.46 1.41 2.06 1.61 7 1.45 1.45 1.40 1.45 1.37 1.37 1.94 1.59 8 1.39 1.22 1.34 1.22 1.33 1.31 1.82 1.42 9 1.36 1.18 1.30 1.18 1.29 1.29 1.71 1.40 10 1.10 1.06 1.06 1.02 1.04 1.04 1.38 1.22 11 1.10 1.04 1.06 1.02 1.04 1.04 1.36 1.22 12 1.10 1.02 1.06 1.02 1.04 1.04 1.35 1.22 13 1.10 1.02 1.06 1.02 1.04 1.04 1.34 1.22 14 1.10 1.02 1.06 1.02 1.04 1.04 1.33 1.22 15 1.06 1.02 1.02 1.02 1.00 1.00 1.26 1.14 16 1.06 1.02 1.02 1.02 1.00 1.00 1.26 1.14 17 1.06 1.02 1.02 1.02 1.00 1.00 1.23 1.14 18 1.05 1.02 1.02 1.02 1.00 1.00 1.23 1.14 19 1.05 1.02 1.02 1.02 1.00 1.00 1.23 1.14 20 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.12 21 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.12 22 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.09 23 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.09 24 1.03 0.99 1.02 1.02 1.01 1.01 1.18 1.09 25 1.03 0.99 1.02 1.02 1.01 1.01 1.18 1.19 26-39 1.06 1.02 1.04 1.02 1.04 1.04 1.18 1.19 40-59 1.16 1.10 1.11 1.10 1.14 1.09 1.15 1.23 60+ 1.38 1.28 1.33 1.28 1.33 1.30 1.15 1.29 No Driver 0.91 0.97 0.92 1.00 0.92 0.92 0.98 0.92\n\nEffective xx/xx/2012 Rates-PROPOSED","pages":[{"line_numbers":[],"markdown":"QBE Insurance Corporation\n\nSingle Female 0 2.69 2.86 2.52 2.86 2.60 2.60 2.24 2.49 1 2.65 2.80 2.48 2.80 2.55 2.55 2.18 2.46 2 2.58 2.62 2.42 2.64 2.49 2.49 2.13 2.28 3 2.54 2.58 2.37 2.60 2.44 2.44 2.11 2.26 4 1.73 1.85 1.62 1.87 1.69 1.67 2.08 1.76 5 1.68 1.81 1.58 1.81 1.62 1.62 2.06 1.74 6 1.53 1.61 1.43 1.63 1.51 1.47 1.96 1.54 7 1.48 1.56 1.39 1.56 1.43 1.43 1.85 1.51 8 1.41 1.32 1.32 1.32 1.38 1.36 1.74 1.36 9 1.39 1.28 1.29 1.28 1.34 1.34 1.62 1.33 10 1.12 1.15 1.05 1.10 1.08 1.08 1.31 1.16 11 1.12 1.12 1.05 1.10 1.08 1.08 1.30 1.16 12 1.12 1.10 1.05 1.10 1.08 1.08 1.29 1.16 13 1.12 1.10 1.05 1.10 1.08 1.08 1.28 1.16 14 1.12 1.10 1.05 1.10 1.08 1.08 1.27 1.16 15 1.08 1.10 1.01 1.10 1.04 1.04 1.20 1.08 16 1.08 1.10 1.01 1.10 1.04 1.04 1.20 1.08 17 1.08 1.10 1.01 1.10 1.04 1.04 1.18 1.08 18 1.07 1.10 1.01 1.10 1.04 1.04 1.18 1.08 19 1.07 1.10 1.01 1.10 1.04 1.04 1.18 1.08 20 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.06 21 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.06 22 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.04 23 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.04 24 1.05 1.07 1.01 1.10 1.05 1.05 1.12 1.04 25 1.05 1.07 1.01 1.10 1.05 1.05 1.12 1.13 26-39 1.08 1.10 1.03 1.10 1.08 1.08 1.12 1.13 40-59 1.18 1.19 1.10 1.19 1.19 1.14 1.10 1.18 60+ 1.40 1.38 1.31 1.38 1.38 1.35 1.10 1.23 Single Male 0 2.64 2.65 2.55 2.65 2.50 2.50 2.35 2.61 1 2.60 2.59 2.50 2.59 2.45 2.45 2.29 2.59 2 2.53 2.43 2.44 2.45 2.39 2.39 2.23 2.40 3 2.49 2.39 2.40 2.41 2.35 2.35 2.21 2.37 4 1.69 1.71 1.63 1.73 1.62 1.60 2.19 1.85 5 1.65 1.67 1.59 1.67 1.56 1.56 2.16 1.83 6 1.50 1.49 1.44 1.51 1.46 1.41 2.06 1.61 7 1.45 1.45 1.40 1.45 1.37 1.37 1.94 1.59 8 1.39 1.22 1.34 1.22 1.33 1.31 1.82 1.42 9 1.36 1.18 1.30 1.18 1.29 1.29 1.71 1.40 10 1.10 1.06 1.06 1.02 1.04 1.04 1.38 1.22 11 1.10 1.04 1.06 1.02 1.04 1.04 1.36 1.22 12 1.10 1.02 1.06 1.02 1.04 1.04 1.35 1.22 13 1.10 1.02 1.06 1.02 1.04 1.04 1.34 1.22 14 1.10 1.02 1.06 1.02 1.04 1.04 1.33 1.22 15 1.06 1.02 1.02 1.02 1.00 1.00 1.26 1.14 16 1.06 1.02 1.02 1.02 1.00 1.00 1.26 1.14 17 1.06 1.02 1.02 1.02 1.00 1.00 1.23 1.14 18 1.05 1.02 1.02 1.02 1.00 1.00 1.23 1.14 19 1.05 1.02 1.02 1.02 1.00 1.00 1.23 1.14 20 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.12 21 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.12 22 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.09 23 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.09 24 1.03 0.99 1.02 1.02 1.01 1.01 1.18 1.09 25 1.03 0.99 1.02 1.02 1.01 1.01 1.18 1.19 26-39 1.06 1.02 1.04 1.02 1.04 1.04 1.18 1.19 40-59 1.16 1.10 1.11 1.10 1.14 1.09 1.15 1.23 60+ 1.38 1.28 1.33 1.28 1.33 1.30 1.15 1.29 No Driver 0.91 0.97 0.92 1.00 0.92 0.92 0.98 0.92\n\nEffective xx/xx/2012 Rates-PROPOSED","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"QBE Insurance Corporation\n\nSingle Female 0 2.69 2.86 2.52 2.86 2.60 2.60 2.24 2.49 1 2.65 2.80 2.48 2.80 2.55 2.55 2.18 2.46 2 2.58 2.62 2.42 2.64 2.49 2.49 2.13 2.28 3 2.54 2.58 2.37 2.60 2.44 2.44 2.11 2.26 4 1.73 1.85 1.62 1.87 1.69 1.67 2.08 1.76 5 1.68 1.81 1.58 1.81 1.62 1.62 2.06 1.74 6 1.53 1.61 1.43 1.63 1.51 1.47 1.96 1.54 7 1.48 1.56 1.39 1.56 1.43 1.43 1.85 1.51 8 1.41 1.32 1.32 1.32 1.38 1.36 1.74 1.36 9 1.39 1.28 1.29 1.28 1.34 1.34 1.62 1.33 10 1.12 1.15 1.05 1.10 1.08 1.08 1.31 1.16 11 1.12 1.12 1.05 1.10 1.08 1.08 1.30 1.16 12 1.12 1.10 1.05 1.10 1.08 1.08 1.29 1.16 13 1.12 1.10 1.05 1.10 1.08 1.08 1.28 1.16 14 1.12 1.10 1.05 1.10 1.08 1.08 1.27 1.16 15 1.08 1.10 1.01 1.10 1.04 1.04 1.20 1.08 16 1.08 1.10 1.01 1.10 1.04 1.04 1.20 1.08 17 1.08 1.10 1.01 1.10 1.04 1.04 1.18 1.08 18 1.07 1.10 1.01 1.10 1.04 1.04 1.18 1.08 19 1.07 1.10 1.01 1.10 1.04 1.04 1.18 1.08 20 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.06 21 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.06 22 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.04 23 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.04 24 1.05 1.07 1.01 1.10 1.05 1.05 1.12 1.04 25 1.05 1.07 1.01 1.10 1.05 1.05 1.12 1.13 26-39 1.08 1.10 1.03 1.10 1.08 1.08 1.12 1.13 40-59 1.18 1.19 1.10 1.19 1.19 1.14 1.10 1.18 60+ 1.40 1.38 1.31 1.38 1.38 1.35 1.10 1.23 Single Male 0 2.64 2.65 2.55 2.65 2.50 2.50 2.35 2.61 1 2.60 2.59 2.50 2.59 2.45 2.45 2.29 2.59 2 2.53 2.43 2.44 2.45 2.39 2.39 2.23 2.40 3 2.49 2.39 2.40 2.41 2.35 2.35 2.21 2.37 4 1.69 1.71 1.63 1.73 1.62 1.60 2.19 1.85 5 1.65 1.67 1.59 1.67 1.56 1.56 2.16 1.83 6 1.50 1.49 1.44 1.51 1.46 1.41 2.06 1.61 7 1.45 1.45 1.40 1.45 1.37 1.37 1.94 1.59 8 1.39 1.22 1.34 1.22 1.33 1.31 1.82 1.42 9 1.36 1.18 1.30 1.18 1.29 1.29 1.71 1.40 10 1.10 1.06 1.06 1.02 1.04 1.04 1.38 1.22 11 1.10 1.04 1.06 1.02 1.04 1.04 1.36 1.22 12 1.10 1.02 1.06 1.02 1.04 1.04 1.35 1.22 13 1.10 1.02 1.06 1.02 1.04 1.04 1.34 1.22 14 1.10 1.02 1.06 1.02 1.04 1.04 1.33 1.22 15 1.06 1.02 1.02 1.02 1.00 1.00 1.26 1.14 16 1.06 1.02 1.02 1.02 1.00 1.00 1.26 1.14 17 1.06 1.02 1.02 1.02 1.00 1.00 1.23 1.14 18 1.05 1.02 1.02 1.02 1.00 1.00 1.23 1.14 19 1.05 1.02 1.02 1.02 1.00 1.00 1.23 1.14 20 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.12 21 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.12 22 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.09 23 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.09 24 1.03 0.99 1.02 1.02 1.01 1.01 1.18 1.09 25 1.03 0.99 1.02 1.02 1.01 1.01 1.18 1.19 26-39 1.06 1.02 1.04 1.02 1.04 1.04 1.18 1.19 40-59 1.16 1.10 1.11 1.10 1.14 1.09 1.15 1.23 60+ 1.38 1.28 1.33 1.28 1.33 1.30 1.15 1.29 No Driver 0.91 0.97 0.92 1.00 0.92 0.92 0.98 0.92\n\nEffective xx/xx/2012 Rates-PROPOSED","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page115.pdf"]},"response":{"errors":[],"extract_id":"extract_c69d3d83563279cdbeca1b6d6812a077","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["QBE Insurance Corporation\n\nSingle Female 0 2.69 2.86 2.52 2.86 2.60 2.60 2.24 2.49 1 2.65 2.80 2.48 2.80 2.55 2.55 2.18 2.46 2 2.58 2.62 2.42 2.64 2.49 2.49 2.13 2.28 3 2.54 2.58 2.37 2.60 2.44 2.44 2.11 2.26 4 1.73 1.85 1.62 1.87 1.69 1.67 2.08 1.76 5 1.68 1.81 1.58 1.81 1.62 1.62 2.06 1.74 6 1.53 1.61 1.43 1.63 1.51 1.47 1.96 1.54 7 1.48 1.56 1.39 1.56 1.43 1.43 1.85 1.51 8 1.41 1.32 1.32 1.32 1.38 1.36 1.74 1.36 9 1.39 1.28 1.29 1.28 1.34 1.34 1.62 1.33 10 1.12 1.15 1.05 1.10 1.08 1.08 1.31 1.16 11 1.12 1.12 1.05 1.10 1.08 1.08 1.30 1.16 12 1.12 1.10 1.05 1.10 1.08 1.08 1.29 1.16 13 1.12 1.10 1.05 1.10 1.08 1.08 1.28 1.16 14 1.12 1.10 1.05 1.10 1.08 1.08 1.27 1.16 15 1.08 1.10 1.01 1.10 1.04 1.04 1.20 1.08 16 1.08 1.10 1.01 1.10 1.04 1.04 1.20 1.08 17 1.08 1.10 1.01 1.10 1.04 1.04 1.18 1.08 18 1.07 1.10 1.01 1.10 1.04 1.04 1.18 1.08 19 1.07 1.10 1.01 1.10 1.04 1.04 1.18 1.08 20 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.06 21 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.06 22 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.04 23 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.04 24 1.05 1.07 1.01 1.10 1.05 1.05 1.12 1.04 25 1.05 1.07 1.01 1.10 1.05 1.05 1.12 1.13 26-39 1.08 1.10 1.03 1.10 1.08 1.08 1.12 1.13 40-59 1.18 1.19 1.10 1.19 1.19 1.14 1.10 1.18 60+ 1.40 1.38 1.31 1.38 1.38 1.35 1.10 1.23 Single Male 0 2.64 2.65 2.55 2.65 2.50 2.50 2.35 2.61 1 2.60 2.59 2.50 2.59 2.45 2.45 2.29 2.59 2 2.53 2.43 2.44 2.45 2.39 2.39 2.23 2.40 3 2.49 2.39 2.40 2.41 2.35 2.35 2.21 2.37 4 1.69 1.71 1.63 1.73 1.62 1.60 2.19 1.85 5 1.65 1.67 1.59 1.67 1.56 1.56 2.16 1.83 6 1.50 1.49 1.44 1.51 1.46 1.41 2.06 1.61 7 1.45 1.45 1.40 1.45 1.37 1.37 1.94 1.59 8 1.39 1.22 1.34 1.22 1.33 1.31 1.82 1.42 9 1.36 1.18 1.30 1.18 1.29 1.29 1.71 1.40 10 1.10 1.06 1.06 1.02 1.04 1.04 1.38 1.22 11 1.10 1.04 1.06 1.02 1.04 1.04 1.36 1.22 12 1.10 1.02 1.06 1.02 1.04 1.04 1.35 1.22 13 1.10 1.02 1.06 1.02 1.04 1.04 1.34 1.22 14 1.10 1.02 1.06 1.02 1.04 1.04 1.33 1.22 15 1.06 1.02 1.02 1.02 1.00 1.00 1.26 1.14 16 1.06 1.02 1.02 1.02 1.00 1.00 1.26 1.14 17 1.06 1.02 1.02 1.02 1.00 1.00 1.23 1.14 18 1.05 1.02 1.02 1.02 1.00 1.00 1.23 1.14 19 1.05 1.02 1.02 1.02 1.00 1.00 1.23 1.14 20 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.12 21 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.12 22 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.09 23 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.09 24 1.03 0.99 1.02 1.02 1.01 1.01 1.18 1.09 25 1.03 0.99 1.02 1.02 1.01 1.01 1.18 1.19 26-39 1.06 1.02 1.04 1.02 1.04 1.04 1.18 1.19 40-59 1.16 1.10 1.11 1.10 1.14 1.09 1.15 1.23 60+ 1.38 1.28 1.33 1.28 1.33 1.30 1.15 1.29 No Driver 0.91 0.97 0.92 1.00 0.92 0.92 0.98 0.92\n\nEffective xx/xx/2012 Rates-PROPOSED"],"full_content":"QBE Insurance Corporation\n\nSingle Female 0 2.69 2.86 2.52 2.86 2.60 2.60 2.24 2.49 1 2.65 2.80 2.48 2.80 2.55 2.55 2.18 2.46 2 2.58 2.62 2.42 2.64 2.49 2.49 2.13 2.28 3 2.54 2.58 2.37 2.60 2.44 2.44 2.11 2.26 4 1.73 1.85 1.62 1.87 1.69 1.67 2.08 1.76 5 1.68 1.81 1.58 1.81 1.62 1.62 2.06 1.74 6 1.53 1.61 1.43 1.63 1.51 1.47 1.96 1.54 7 1.48 1.56 1.39 1.56 1.43 1.43 1.85 1.51 8 1.41 1.32 1.32 1.32 1.38 1.36 1.74 1.36 9 1.39 1.28 1.29 1.28 1.34 1.34 1.62 1.33 10 1.12 1.15 1.05 1.10 1.08 1.08 1.31 1.16 11 1.12 1.12 1.05 1.10 1.08 1.08 1.30 1.16 12 1.12 1.10 1.05 1.10 1.08 1.08 1.29 1.16 13 1.12 1.10 1.05 1.10 1.08 1.08 1.28 1.16 14 1.12 1.10 1.05 1.10 1.08 1.08 1.27 1.16 15 1.08 1.10 1.01 1.10 1.04 1.04 1.20 1.08 16 1.08 1.10 1.01 1.10 1.04 1.04 1.20 1.08 17 1.08 1.10 1.01 1.10 1.04 1.04 1.18 1.08 18 1.07 1.10 1.01 1.10 1.04 1.04 1.18 1.08 19 1.07 1.10 1.01 1.10 1.04 1.04 1.18 1.08 20 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.06 21 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.06 22 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.04 23 1.02 1.07 0.97 1.10 1.00 1.00 1.12 1.04 24 1.05 1.07 1.01 1.10 1.05 1.05 1.12 1.04 25 1.05 1.07 1.01 1.10 1.05 1.05 1.12 1.13 26-39 1.08 1.10 1.03 1.10 1.08 1.08 1.12 1.13 40-59 1.18 1.19 1.10 1.19 1.19 1.14 1.10 1.18 60+ 1.40 1.38 1.31 1.38 1.38 1.35 1.10 1.23 Single Male 0 2.64 2.65 2.55 2.65 2.50 2.50 2.35 2.61 1 2.60 2.59 2.50 2.59 2.45 2.45 2.29 2.59 2 2.53 2.43 2.44 2.45 2.39 2.39 2.23 2.40 3 2.49 2.39 2.40 2.41 2.35 2.35 2.21 2.37 4 1.69 1.71 1.63 1.73 1.62 1.60 2.19 1.85 5 1.65 1.67 1.59 1.67 1.56 1.56 2.16 1.83 6 1.50 1.49 1.44 1.51 1.46 1.41 2.06 1.61 7 1.45 1.45 1.40 1.45 1.37 1.37 1.94 1.59 8 1.39 1.22 1.34 1.22 1.33 1.31 1.82 1.42 9 1.36 1.18 1.30 1.18 1.29 1.29 1.71 1.40 10 1.10 1.06 1.06 1.02 1.04 1.04 1.38 1.22 11 1.10 1.04 1.06 1.02 1.04 1.04 1.36 1.22 12 1.10 1.02 1.06 1.02 1.04 1.04 1.35 1.22 13 1.10 1.02 1.06 1.02 1.04 1.04 1.34 1.22 14 1.10 1.02 1.06 1.02 1.04 1.04 1.33 1.22 15 1.06 1.02 1.02 1.02 1.00 1.00 1.26 1.14 16 1.06 1.02 1.02 1.02 1.00 1.00 1.26 1.14 17 1.06 1.02 1.02 1.02 1.00 1.00 1.23 1.14 18 1.05 1.02 1.02 1.02 1.00 1.00 1.23 1.14 19 1.05 1.02 1.02 1.02 1.00 1.00 1.23 1.14 20 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.12 21 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.12 22 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.09 23 1.00 0.99 0.98 1.02 0.96 0.96 1.18 1.09 24 1.03 0.99 1.02 1.02 1.01 1.01 1.18 1.09 25 1.03 0.99 1.02 1.02 1.01 1.01 1.18 1.19 26-39 1.06 1.02 1.04 1.02 1.04 1.04 1.18 1.19 40-59 1.16 1.10 1.11 1.10 1.14 1.09 1.15 1.23 60+ 1.38 1.28 1.33 1.28 1.33 1.30 1.15 1.29 No Driver 0.91 0.97 0.92 1.00 0.92 0.92 0.98 0.92\n\nEffective xx/xx/2012 Rates-PROPOSED","publish_date":null,"title":"QBE Insurance Corporation Single Female 0 2.69 2.86 2.52 2.86 2.60 2.60 2.24 2.49 1 2.65 2.80 2.48 2.80 2.55","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page115.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page115.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page115","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page115.pdf"},"started_at":"2026-11-04T19:48:17.447078"} +{"completed_at":"2026-11-04T19:48:21.441921","latency_in_ms":2450,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1187","grounded_pages":[],"layout_pages":[],"markdown":"### **GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n### **SKILLED ARTISANS AND TECHNICIANS GROUP INSURANCE PLAN –**\n\n### **CALIFORNIA**\n\n### **1**\n\n### **EFFECTIVE 07/16/2018**\n\n\\*Rating Rules\n\nFor those risks meeting the group eligibility outlined below, premiums will be reduced by the following percentages:\n\nBodily Injury 6%\n\nProperty Damage 6%\n\nCollision 11%\n\nComprehensive 22%\n\nUninsured Motorists – BI 12%\n\nUninsured Motorists – PD 12%\n\nMedical Payments 12%\n\nRental Reimbursement 2%\n\nEmergency Road Service 2%\n\nMBI 7%\n\nThis reduction will not apply if the named insured/applicant or spouse or registered domestic partner of the named insured is already receiving a lower rate under another Group Insurance Plan. This reduction will not apply to motor homes or travel trailers covered under Miscellaneous Rule 6.\n\nGroup Eligibility\n\nThe named insured/applicant or spouse or registered domestic partner of the named insured must be an operator and a graduate student, employed in one of the following occupations, or retired from one of the following occupations and no longer employed.","pages":[{"line_numbers":[],"markdown":"### **GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n### **SKILLED ARTISANS AND TECHNICIANS GROUP INSURANCE PLAN –**\n\n### **CALIFORNIA**\n\n### **1**\n\n### **EFFECTIVE 07/16/2018**\n\n\\*Rating Rules\n\nFor those risks meeting the group eligibility outlined below, premiums will be reduced by the following percentages:\n\nBodily Injury 6%\n\nProperty Damage 6%\n\nCollision 11%\n\nComprehensive 22%\n\nUninsured Motorists – BI 12%\n\nUninsured Motorists – PD 12%\n\nMedical Payments 12%\n\nRental Reimbursement 2%\n\nEmergency Road Service 2%\n\nMBI 7%\n\nThis reduction will not apply if the named insured/applicant or spouse or registered domestic partner of the named insured is already receiving a lower rate under another Group Insurance Plan. This reduction will not apply to motor homes or travel trailers covered under Miscellaneous Rule 6.\n\nGroup Eligibility\n\nThe named insured/applicant or spouse or registered domestic partner of the named insured must be an operator and a graduate student, employed in one of the following occupations, or retired from one of the following occupations and no longer employed.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n### **SKILLED ARTISANS AND TECHNICIANS GROUP INSURANCE PLAN –**\n\n### **CALIFORNIA**\n\n### **1**\n\n### **EFFECTIVE 07/16/2018**\n\n\\*Rating Rules\n\nFor those risks meeting the group eligibility outlined below, premiums will be reduced by the following percentages:\n\nBodily Injury 6%\n\nProperty Damage 6%\n\nCollision 11%\n\nComprehensive 22%\n\nUninsured Motorists – BI 12%\n\nUninsured Motorists – PD 12%\n\nMedical Payments 12%\n\nRental Reimbursement 2%\n\nEmergency Road Service 2%\n\nMBI 7%\n\nThis reduction will not apply if the named insured/applicant or spouse or registered domestic partner of the named insured is already receiving a lower rate under another Group Insurance Plan. This reduction will not apply to motor homes or travel trailers covered under Miscellaneous Rule 6.\n\nGroup Eligibility\n\nThe named insured/applicant or spouse or registered domestic partner of the named insured must be an operator and a graduate student, employed in one of the following occupations, or retired from one of the following occupations and no longer employed.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1187.pdf"]},"response":{"errors":[],"extract_id":"extract_6e5133a9601d6f0f0e33e21bbb6720b0","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n### **SKILLED ARTISANS AND TECHNICIANS GROUP INSURANCE PLAN –**\n\n### **CALIFORNIA**\n\n### **1**\n\n### **EFFECTIVE 07/16/2018**\n\n\\*Rating Rules\n\nFor those risks meeting the group eligibility outlined below, premiums will be reduced by the following percentages:\n\nBodily Injury 6%\n\nProperty Damage 6%\n\nCollision 11%\n\nComprehensive 22%\n\nUninsured Motorists – BI 12%\n\nUninsured Motorists – PD 12%\n\nMedical Payments 12%\n\nRental Reimbursement 2%\n\nEmergency Road Service 2%\n\nMBI 7%\n\nThis reduction will not apply if the named insured/applicant or spouse or registered domestic partner of the named insured is already receiving a lower rate under another Group Insurance Plan. This reduction will not apply to motor homes or travel trailers covered under Miscellaneous Rule 6.\n\nGroup Eligibility\n\nThe named insured/applicant or spouse or registered domestic partner of the named insured must be an operator and a graduate student, employed in one of the following occupations, or retired from one of the following occupations and no longer employed."],"full_content":"### **GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n### **SKILLED ARTISANS AND TECHNICIANS GROUP INSURANCE PLAN –**\n\n### **CALIFORNIA**\n\n### **1**\n\n### **EFFECTIVE 07/16/2018**\n\n\\*Rating Rules\n\nFor those risks meeting the group eligibility outlined below, premiums will be reduced by the following percentages:\n\nBodily Injury 6%\n\nProperty Damage 6%\n\nCollision 11%\n\nComprehensive 22%\n\nUninsured Motorists – BI 12%\n\nUninsured Motorists – PD 12%\n\nMedical Payments 12%\n\nRental Reimbursement 2%\n\nEmergency Road Service 2%\n\nMBI 7%\n\nThis reduction will not apply if the named insured/applicant or spouse or registered domestic partner of the named insured is already receiving a lower rate under another Group Insurance Plan. This reduction will not apply to motor homes or travel trailers covered under Miscellaneous Rule 6.\n\nGroup Eligibility\n\nThe named insured/applicant or spouse or registered domestic partner of the named insured must be an operator and a graduate student, employed in one of the following occupations, or retired from one of the following occupations and no longer employed.","publish_date":null,"title":"GOVERNMENT EMPLOYEES INSURANCE COMPANY SKILLED ARTISANS AND TECHNICIANS GROUP INSURANCE PLAN – CALIFORNIA 1 EFFECTIVE 07/16/2018","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1187.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1187.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1187","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1187.pdf"},"started_at":"2026-11-04T19:48:18.991072"} +{"completed_at":"2026-11-04T19:48:21.611320","latency_in_ms":1143,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1201","grounded_pages":[],"layout_pages":[],"markdown":"### **GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n### **PRIVATE PASSENGER RULES SECTION**\n\n### **CALIFORNIA**\n\n### **5**\n\n### **EFFECTIVE 04/03/2017**\n\n**\\*RULE 3.PREMIUM DETERMINATION (Cont'd) E. EMERGENCY ROAD SERVICE**\n\n**1\\.** The Emergency Road Service premium is found below and is determined in accordance with the\n\nfollowing:\n\n**a.** Identify the age of the vehicle.\n\n**b** . Determine if the vehicle is rated for liability only or full coverage as defined below:\n\nFull Coverage – any vehicle carrying either Comprehensive and/or Collision coverage.\n\n**c.** Apply discounts in accordance with private passenger rules.\n\n**d.** Multiply by term percent.\n\n**2\\.** The definition of “age” is as follows:\n\n**Age Definition**\n\n1 All vehicles of the current model year.\n\n2 All vehicles of the first preceding model year.\n\n3 through 8 The appropriate age applies for the 2 nd through 7 th preceding model years, respectively.\n\n9 All other preceding model years.\n\nNOTE: For the purpose of this definition, the current model year shall change effective October 1, of each calendar year regardless of actual introductory dates of the several makes and models.\n\nVehicle\n\nAge Full Coverage Liability Only\n\nAge\n\nFactor\n\nFull\n\nCoverage\n\nFactor\n\nPremium Age\n\nFactor\n\nLiability Only\n\nFactor Premium\n\n1 0.49 1.000 15.40 0.49 1.6501 25.50\n\n2 0.54 1.000 17.00 0.54 1.6501 28.10\n\n3 0.60 1.000 18.90 0.60 1.6501 31.20\n\n4 0.66 1.000 20.80 0.66 1.6501 34.40\n\n5 0.72 1.000 22.70 0.72 1.6501 37.50\n\n6 0.80 1.000 25.20 0.80 1.6501 41.60\n\n7 0.89 1.000 28.00 0.89 1.6501 46.30\n\n8 1.00 1.000 31.40 1.00 1.6501 51.90\n\n9+ 1.12 1.000 35.20 1.12 1.6501 58.10\n\n**F. RENTAL REIMBURSEMENT**\n\n1\\. Available on private passenger vehicles, at limits shown below:\n\nDaily Limit Aggregate Limit\n\n$35 $1,050\n\n$45 $1,350\n\n$50 $1,500","pages":[{"line_numbers":[],"markdown":"### **GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n### **PRIVATE PASSENGER RULES SECTION**\n\n### **CALIFORNIA**\n\n### **5**\n\n### **EFFECTIVE 04/03/2017**\n\n**\\*RULE 3.PREMIUM DETERMINATION (Cont'd) E. EMERGENCY ROAD SERVICE**\n\n**1\\.** The Emergency Road Service premium is found below and is determined in accordance with the\n\nfollowing:\n\n**a.** Identify the age of the vehicle.\n\n**b** . Determine if the vehicle is rated for liability only or full coverage as defined below:\n\nFull Coverage – any vehicle carrying either Comprehensive and/or Collision coverage.\n\n**c.** Apply discounts in accordance with private passenger rules.\n\n**d.** Multiply by term percent.\n\n**2\\.** The definition of “age” is as follows:\n\n**Age Definition**\n\n1 All vehicles of the current model year.\n\n2 All vehicles of the first preceding model year.\n\n3 through 8 The appropriate age applies for the 2 nd through 7 th preceding model years, respectively.\n\n9 All other preceding model years.\n\nNOTE: For the purpose of this definition, the current model year shall change effective October 1, of each calendar year regardless of actual introductory dates of the several makes and models.\n\nVehicle\n\nAge Full Coverage Liability Only\n\nAge\n\nFactor\n\nFull\n\nCoverage\n\nFactor\n\nPremium Age\n\nFactor\n\nLiability Only\n\nFactor Premium\n\n1 0.49 1.000 15.40 0.49 1.6501 25.50\n\n2 0.54 1.000 17.00 0.54 1.6501 28.10\n\n3 0.60 1.000 18.90 0.60 1.6501 31.20\n\n4 0.66 1.000 20.80 0.66 1.6501 34.40\n\n5 0.72 1.000 22.70 0.72 1.6501 37.50\n\n6 0.80 1.000 25.20 0.80 1.6501 41.60\n\n7 0.89 1.000 28.00 0.89 1.6501 46.30\n\n8 1.00 1.000 31.40 1.00 1.6501 51.90\n\n9+ 1.12 1.000 35.20 1.12 1.6501 58.10\n\n**F. RENTAL REIMBURSEMENT**\n\n1\\. Available on private passenger vehicles, at limits shown below:\n\nDaily Limit Aggregate Limit\n\n$35 $1,050\n\n$45 $1,350\n\n$50 $1,500","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n### **PRIVATE PASSENGER RULES SECTION**\n\n### **CALIFORNIA**\n\n### **5**\n\n### **EFFECTIVE 04/03/2017**\n\n**\\*RULE 3.PREMIUM DETERMINATION (Cont'd) E. EMERGENCY ROAD SERVICE**\n\n**1\\.** The Emergency Road Service premium is found below and is determined in accordance with the\n\nfollowing:\n\n**a.** Identify the age of the vehicle.\n\n**b** . Determine if the vehicle is rated for liability only or full coverage as defined below:\n\nFull Coverage – any vehicle carrying either Comprehensive and/or Collision coverage.\n\n**c.** Apply discounts in accordance with private passenger rules.\n\n**d.** Multiply by term percent.\n\n**2\\.** The definition of “age” is as follows:\n\n**Age Definition**\n\n1 All vehicles of the current model year.\n\n2 All vehicles of the first preceding model year.\n\n3 through 8 The appropriate age applies for the 2 nd through 7 th preceding model years, respectively.\n\n9 All other preceding model years.\n\nNOTE: For the purpose of this definition, the current model year shall change effective October 1, of each calendar year regardless of actual introductory dates of the several makes and models.\n\nVehicle\n\nAge Full Coverage Liability Only\n\nAge\n\nFactor\n\nFull\n\nCoverage\n\nFactor\n\nPremium Age\n\nFactor\n\nLiability Only\n\nFactor Premium\n\n1 0.49 1.000 15.40 0.49 1.6501 25.50\n\n2 0.54 1.000 17.00 0.54 1.6501 28.10\n\n3 0.60 1.000 18.90 0.60 1.6501 31.20\n\n4 0.66 1.000 20.80 0.66 1.6501 34.40\n\n5 0.72 1.000 22.70 0.72 1.6501 37.50\n\n6 0.80 1.000 25.20 0.80 1.6501 41.60\n\n7 0.89 1.000 28.00 0.89 1.6501 46.30\n\n8 1.00 1.000 31.40 1.00 1.6501 51.90\n\n9+ 1.12 1.000 35.20 1.12 1.6501 58.10\n\n**F. RENTAL REIMBURSEMENT**\n\n1\\. Available on private passenger vehicles, at limits shown below:\n\nDaily Limit Aggregate Limit\n\n$35 $1,050\n\n$45 $1,350\n\n$50 $1,500","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1201.pdf"]},"response":{"errors":[],"extract_id":"extract_a112c506230d0deffbd6879bb1b80bea","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n### **PRIVATE PASSENGER RULES SECTION**\n\n### **CALIFORNIA**\n\n### **5**\n\n### **EFFECTIVE 04/03/2017**\n\n**\\*RULE 3.PREMIUM DETERMINATION (Cont'd) E. EMERGENCY ROAD SERVICE**\n\n**1\\.** The Emergency Road Service premium is found below and is determined in accordance with the\n\nfollowing:\n\n**a.** Identify the age of the vehicle.\n\n**b** . Determine if the vehicle is rated for liability only or full coverage as defined below:\n\nFull Coverage – any vehicle carrying either Comprehensive and/or Collision coverage.\n\n**c.** Apply discounts in accordance with private passenger rules.\n\n**d.** Multiply by term percent.\n\n**2\\.** The definition of “age” is as follows:\n\n**Age Definition**\n\n1 All vehicles of the current model year.\n\n2 All vehicles of the first preceding model year.\n\n3 through 8 The appropriate age applies for the 2 nd through 7 th preceding model years, respectively.\n\n9 All other preceding model years.\n\nNOTE: For the purpose of this definition, the current model year shall change effective October 1, of each calendar year regardless of actual introductory dates of the several makes and models.\n\nVehicle\n\nAge Full Coverage Liability Only\n\nAge\n\nFactor\n\nFull\n\nCoverage\n\nFactor\n\nPremium Age\n\nFactor\n\nLiability Only\n\nFactor Premium\n\n1 0.49 1.000 15.40 0.49 1.6501 25.50\n\n2 0.54 1.000 17.00 0.54 1.6501 28.10\n\n3 0.60 1.000 18.90 0.60 1.6501 31.20\n\n4 0.66 1.000 20.80 0.66 1.6501 34.40\n\n5 0.72 1.000 22.70 0.72 1.6501 37.50\n\n6 0.80 1.000 25.20 0.80 1.6501 41.60\n\n7 0.89 1.000 28.00 0.89 1.6501 46.30\n\n8 1.00 1.000 31.40 1.00 1.6501 51.90\n\n9+ 1.12 1.000 35.20 1.12 1.6501 58.10\n\n**F. RENTAL REIMBURSEMENT**\n\n1\\. Available on private passenger vehicles, at limits shown below:\n\nDaily Limit Aggregate Limit\n\n$35 $1,050\n\n$45 $1,350\n\n$50 $1,500"],"full_content":"### **GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n### **PRIVATE PASSENGER RULES SECTION**\n\n### **CALIFORNIA**\n\n### **5**\n\n### **EFFECTIVE 04/03/2017**\n\n**\\*RULE 3.PREMIUM DETERMINATION (Cont'd) E. EMERGENCY ROAD SERVICE**\n\n**1\\.** The Emergency Road Service premium is found below and is determined in accordance with the\n\nfollowing:\n\n**a.** Identify the age of the vehicle.\n\n**b** . Determine if the vehicle is rated for liability only or full coverage as defined below:\n\nFull Coverage – any vehicle carrying either Comprehensive and/or Collision coverage.\n\n**c.** Apply discounts in accordance with private passenger rules.\n\n**d.** Multiply by term percent.\n\n**2\\.** The definition of “age” is as follows:\n\n**Age Definition**\n\n1 All vehicles of the current model year.\n\n2 All vehicles of the first preceding model year.\n\n3 through 8 The appropriate age applies for the 2 nd through 7 th preceding model years, respectively.\n\n9 All other preceding model years.\n\nNOTE: For the purpose of this definition, the current model year shall change effective October 1, of each calendar year regardless of actual introductory dates of the several makes and models.\n\nVehicle\n\nAge Full Coverage Liability Only\n\nAge\n\nFactor\n\nFull\n\nCoverage\n\nFactor\n\nPremium Age\n\nFactor\n\nLiability Only\n\nFactor Premium\n\n1 0.49 1.000 15.40 0.49 1.6501 25.50\n\n2 0.54 1.000 17.00 0.54 1.6501 28.10\n\n3 0.60 1.000 18.90 0.60 1.6501 31.20\n\n4 0.66 1.000 20.80 0.66 1.6501 34.40\n\n5 0.72 1.000 22.70 0.72 1.6501 37.50\n\n6 0.80 1.000 25.20 0.80 1.6501 41.60\n\n7 0.89 1.000 28.00 0.89 1.6501 46.30\n\n8 1.00 1.000 31.40 1.00 1.6501 51.90\n\n9+ 1.12 1.000 35.20 1.12 1.6501 58.10\n\n**F. RENTAL REIMBURSEMENT**\n\n1\\. Available on private passenger vehicles, at limits shown below:\n\nDaily Limit Aggregate Limit\n\n$35 $1,050\n\n$45 $1,350\n\n$50 $1,500","publish_date":null,"title":"GOVERNMENT EMPLOYEES INSURANCE COMPANY PRIVATE PASSENGER RULES SECTION CALIFORNIA 5 EFFECTIVE 04/03/2017","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1201.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1201.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1201","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1201.pdf"},"started_at":"2026-11-04T19:48:20.468177"} +{"completed_at":"2026-11-04T19:48:22.849967","latency_in_ms":1404,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1213","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 13\n\nSheet 5\n\nCalendar Qtr Earned Exposures\n\nTotal Paid Losses & DCCE including\n\nPartial Payments on Prior\n\nCalendar Years, on Closed Claims Pure Premium\n\n20103 292,142 25,372,233\n\n20104 296,355 34,314,444\n\n20111 293,765 28,880,097\n\n20112 301,521 24,357,382 95\n\n20113 307,550 27,659,624 96\n\n20114 314,720 24,901,070 87\n\n20121 321,320 31,520,458 87\n\n20122 331,852 30,958,213 90\n\n20123 344,913 31,386,367 90\n\n20124 354,469 37,964,072 97\n\n20131 357,304 34,567,565 97\n\n20132 373,469 43,240,837 103\n\n20133 388,362 44,120,022 109\n\n20134 398,988 41,902,968 108\n\n20141 400,392 41,234,849 109\n\n20142 416,088 47,383,183 109\n\n20143 431,045 41,619,692 105\n\n20144 442,321 43,832,740 103\n\n20151 444,591 47,782,503 104\n\n20152 462,545 51,941,003 104\n\n20153 477,218 51,254,103 107\n\n20154 486,042 56,183,152 111\n\n20161 491,854 53,836,018 111\n\n20162 507,374 65,124,822 115\n\n20163 529,914 62,984,146 118\n\n20164 546,896 66,476,429 120\n\n20171 554,210 68,996,078 123\n\nPP\n\nTrend\n\n8 pt 10.0%\n\n12 pt 6.2%\n\n16 pt 3.6%\n\n20 pt 5.0%\n\n24 pt 5.0%\n\nTrend Period (Years) for Most Recent Year in Experience Period: 2.500\n\nTrend Factors:\n\n6 th Prior Year **1\\.568**\n\n5 th Prior Year **1\\.477**\n\n4 th Prior Year **1\\.391**\n\n3 rd Prior Year **1\\.310**\n\n2 nd Prior Year **1\\.234**\n\nMost Recent Year **1\\.162**\n\n## **GEICO/GEICO General/GEICO Indemnity**\n\n## **Private Passenger Auto Liability**\n\n## **Non-Catastrophe Loss and DCCE Trend**\n\n**_Bodily Injury_**\n\n**California Company-Specific Loss and DCCE Trend Data Rolling 4-**\n\n**Quarter Data Quarterly Data**","pages":[{"line_numbers":[],"markdown":"Exhibit 13\n\nSheet 5\n\nCalendar Qtr Earned Exposures\n\nTotal Paid Losses & DCCE including\n\nPartial Payments on Prior\n\nCalendar Years, on Closed Claims Pure Premium\n\n20103 292,142 25,372,233\n\n20104 296,355 34,314,444\n\n20111 293,765 28,880,097\n\n20112 301,521 24,357,382 95\n\n20113 307,550 27,659,624 96\n\n20114 314,720 24,901,070 87\n\n20121 321,320 31,520,458 87\n\n20122 331,852 30,958,213 90\n\n20123 344,913 31,386,367 90\n\n20124 354,469 37,964,072 97\n\n20131 357,304 34,567,565 97\n\n20132 373,469 43,240,837 103\n\n20133 388,362 44,120,022 109\n\n20134 398,988 41,902,968 108\n\n20141 400,392 41,234,849 109\n\n20142 416,088 47,383,183 109\n\n20143 431,045 41,619,692 105\n\n20144 442,321 43,832,740 103\n\n20151 444,591 47,782,503 104\n\n20152 462,545 51,941,003 104\n\n20153 477,218 51,254,103 107\n\n20154 486,042 56,183,152 111\n\n20161 491,854 53,836,018 111\n\n20162 507,374 65,124,822 115\n\n20163 529,914 62,984,146 118\n\n20164 546,896 66,476,429 120\n\n20171 554,210 68,996,078 123\n\nPP\n\nTrend\n\n8 pt 10.0%\n\n12 pt 6.2%\n\n16 pt 3.6%\n\n20 pt 5.0%\n\n24 pt 5.0%\n\nTrend Period (Years) for Most Recent Year in Experience Period: 2.500\n\nTrend Factors:\n\n6 th Prior Year **1\\.568**\n\n5 th Prior Year **1\\.477**\n\n4 th Prior Year **1\\.391**\n\n3 rd Prior Year **1\\.310**\n\n2 nd Prior Year **1\\.234**\n\nMost Recent Year **1\\.162**\n\n## **GEICO/GEICO General/GEICO Indemnity**\n\n## **Private Passenger Auto Liability**\n\n## **Non-Catastrophe Loss and DCCE Trend**\n\n**_Bodily Injury_**\n\n**California Company-Specific Loss and DCCE Trend Data Rolling 4-**\n\n**Quarter Data Quarterly Data**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 13\n\nSheet 5\n\nCalendar Qtr Earned Exposures\n\nTotal Paid Losses & DCCE including\n\nPartial Payments on Prior\n\nCalendar Years, on Closed Claims Pure Premium\n\n20103 292,142 25,372,233\n\n20104 296,355 34,314,444\n\n20111 293,765 28,880,097\n\n20112 301,521 24,357,382 95\n\n20113 307,550 27,659,624 96\n\n20114 314,720 24,901,070 87\n\n20121 321,320 31,520,458 87\n\n20122 331,852 30,958,213 90\n\n20123 344,913 31,386,367 90\n\n20124 354,469 37,964,072 97\n\n20131 357,304 34,567,565 97\n\n20132 373,469 43,240,837 103\n\n20133 388,362 44,120,022 109\n\n20134 398,988 41,902,968 108\n\n20141 400,392 41,234,849 109\n\n20142 416,088 47,383,183 109\n\n20143 431,045 41,619,692 105\n\n20144 442,321 43,832,740 103\n\n20151 444,591 47,782,503 104\n\n20152 462,545 51,941,003 104\n\n20153 477,218 51,254,103 107\n\n20154 486,042 56,183,152 111\n\n20161 491,854 53,836,018 111\n\n20162 507,374 65,124,822 115\n\n20163 529,914 62,984,146 118\n\n20164 546,896 66,476,429 120\n\n20171 554,210 68,996,078 123\n\nPP\n\nTrend\n\n8 pt 10.0%\n\n12 pt 6.2%\n\n16 pt 3.6%\n\n20 pt 5.0%\n\n24 pt 5.0%\n\nTrend Period (Years) for Most Recent Year in Experience Period: 2.500\n\nTrend Factors:\n\n6 th Prior Year **1\\.568**\n\n5 th Prior Year **1\\.477**\n\n4 th Prior Year **1\\.391**\n\n3 rd Prior Year **1\\.310**\n\n2 nd Prior Year **1\\.234**\n\nMost Recent Year **1\\.162**\n\n## **GEICO/GEICO General/GEICO Indemnity**\n\n## **Private Passenger Auto Liability**\n\n## **Non-Catastrophe Loss and DCCE Trend**\n\n**_Bodily Injury_**\n\n**California Company-Specific Loss and DCCE Trend Data Rolling 4-**\n\n**Quarter Data Quarterly Data**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1213.pdf"]},"response":{"errors":[],"extract_id":"extract_53aa6eeed5defe816b673387da24e93e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 13\n\nSheet 5\n\nCalendar Qtr Earned Exposures\n\nTotal Paid Losses & DCCE including\n\nPartial Payments on Prior\n\nCalendar Years, on Closed Claims Pure Premium\n\n20103 292,142 25,372,233\n\n20104 296,355 34,314,444\n\n20111 293,765 28,880,097\n\n20112 301,521 24,357,382 95\n\n20113 307,550 27,659,624 96\n\n20114 314,720 24,901,070 87\n\n20121 321,320 31,520,458 87\n\n20122 331,852 30,958,213 90\n\n20123 344,913 31,386,367 90\n\n20124 354,469 37,964,072 97\n\n20131 357,304 34,567,565 97\n\n20132 373,469 43,240,837 103\n\n20133 388,362 44,120,022 109\n\n20134 398,988 41,902,968 108\n\n20141 400,392 41,234,849 109\n\n20142 416,088 47,383,183 109\n\n20143 431,045 41,619,692 105\n\n20144 442,321 43,832,740 103\n\n20151 444,591 47,782,503 104\n\n20152 462,545 51,941,003 104\n\n20153 477,218 51,254,103 107\n\n20154 486,042 56,183,152 111\n\n20161 491,854 53,836,018 111\n\n20162 507,374 65,124,822 115\n\n20163 529,914 62,984,146 118\n\n20164 546,896 66,476,429 120\n\n20171 554,210 68,996,078 123\n\nPP\n\nTrend\n\n8 pt 10.0%\n\n12 pt 6.2%\n\n16 pt 3.6%\n\n20 pt 5.0%\n\n24 pt 5.0%\n\nTrend Period (Years) for Most Recent Year in Experience Period: 2.500\n\nTrend Factors:\n\n6 th Prior Year **1\\.568**\n\n5 th Prior Year **1\\.477**\n\n4 th Prior Year **1\\.391**\n\n3 rd Prior Year **1\\.310**\n\n2 nd Prior Year **1\\.234**\n\nMost Recent Year **1\\.162**\n\n## **GEICO/GEICO General/GEICO Indemnity**\n\n## **Private Passenger Auto Liability**\n\n## **Non-Catastrophe Loss and DCCE Trend**\n\n**_Bodily Injury_**\n\n**California Company-Specific Loss and DCCE Trend Data Rolling 4-**\n\n**Quarter Data Quarterly Data**"],"full_content":"Exhibit 13\n\nSheet 5\n\nCalendar Qtr Earned Exposures\n\nTotal Paid Losses & DCCE including\n\nPartial Payments on Prior\n\nCalendar Years, on Closed Claims Pure Premium\n\n20103 292,142 25,372,233\n\n20104 296,355 34,314,444\n\n20111 293,765 28,880,097\n\n20112 301,521 24,357,382 95\n\n20113 307,550 27,659,624 96\n\n20114 314,720 24,901,070 87\n\n20121 321,320 31,520,458 87\n\n20122 331,852 30,958,213 90\n\n20123 344,913 31,386,367 90\n\n20124 354,469 37,964,072 97\n\n20131 357,304 34,567,565 97\n\n20132 373,469 43,240,837 103\n\n20133 388,362 44,120,022 109\n\n20134 398,988 41,902,968 108\n\n20141 400,392 41,234,849 109\n\n20142 416,088 47,383,183 109\n\n20143 431,045 41,619,692 105\n\n20144 442,321 43,832,740 103\n\n20151 444,591 47,782,503 104\n\n20152 462,545 51,941,003 104\n\n20153 477,218 51,254,103 107\n\n20154 486,042 56,183,152 111\n\n20161 491,854 53,836,018 111\n\n20162 507,374 65,124,822 115\n\n20163 529,914 62,984,146 118\n\n20164 546,896 66,476,429 120\n\n20171 554,210 68,996,078 123\n\nPP\n\nTrend\n\n8 pt 10.0%\n\n12 pt 6.2%\n\n16 pt 3.6%\n\n20 pt 5.0%\n\n24 pt 5.0%\n\nTrend Period (Years) for Most Recent Year in Experience Period: 2.500\n\nTrend Factors:\n\n6 th Prior Year **1\\.568**\n\n5 th Prior Year **1\\.477**\n\n4 th Prior Year **1\\.391**\n\n3 rd Prior Year **1\\.310**\n\n2 nd Prior Year **1\\.234**\n\nMost Recent Year **1\\.162**\n\n## **GEICO/GEICO General/GEICO Indemnity**\n\n## **Private Passenger Auto Liability**\n\n## **Non-Catastrophe Loss and DCCE Trend**\n\n**_Bodily Injury_**\n\n**California Company-Specific Loss and DCCE Trend Data Rolling 4-**\n\n**Quarter Data Quarterly Data**","publish_date":null,"title":"GEICO/GEICO General/GEICO Indemnity Private Passenger Auto Liability Non-Catastrophe Loss and DCCE Trend","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1213.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1213.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1213","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1213.pdf"},"started_at":"2026-11-04T19:48:21.445089"} +{"completed_at":"2026-11-04T19:48:24.736464","latency_in_ms":2224,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1220","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 2\n\n**Standard Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -13.0 0.0 -22.0 -9.0 -15.0 0.0 -25.0 0.0 21.0 -11.1\n\n10/01/13 -0.8 10.1 -5.2 -2.8 8.2 9.2 6.3 0.0 0.0 1.5\n\n04/03/17 21.7 9.5 4.2 -21.9 27.2 -11.8 -6.4 -1.7 0.1 7.3\n\n**Affinity Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -11.2 2.1 -15.9 -1.9 -13.2 2.1 -23.4 0.0 21.0 -8.1\n\n10/01/13 -1.8 9.0 -12.1 -24.9 -1.8 -1.0 -3.6 0.0 0.0 -5.1\n\n04/03/17 17.9 6.1 3.1 -21.9 25.7 -12.8 -7.5 -2.8 -1.1 4.6\n\n**Professional Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -9.7 3.7 -18.8 -5.3 -11.8 3.7 -22.2 0.0 21.0 -8.7\n\n10/01/13 2.8 14.1 -0.2 -15.6 -3.5 -2.6 -5.2 0.0 0.0 1.9\n\n04/03/17 24.5 12.0 0.3 -27.8 22.0 -15.4 -10.2 1.0 2.8 5.7\n\n**Sponsored Marketing Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -13.0 0.0 -17.7 -3.9 -15.0 0.0 -25.0 0.0 21.0 -9.9\n\n10/01/13 1.3 12.4 -7.2 -23.3 0.2 1.1 -1.6 0.0 0.0 -1.8\n\n04/03/17 22.9 10.6 4.2 -19.8 30.1 -9.8 -4.3 -0.6 1.2 8.2\n\n**Skilled Artisans & Technicians Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -18.4 -6.2 -27.9 -15.8 -15.0 0.0 -25.0 0.0 21.0 -16.7\n\n10/01/13 -0.8 10.1 -3.1 -15.2 -1.8 -1.0 -3.6 0.0 0.0 -0.1\n\n04/03/17 24.3 11.9 5.4 -20.8 27.2 -11.8 -6.4 1.5 3.3 8.9\n\n**All Groups Combined**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -12.3 0.7 -20.8 -7.7 -13.4 2.1 -24.1 0.0 21.0 -10.7\n\n10/01/13 1.0 12.0 -2.5 -13.2 0.0 0.0 0.0 0.0 0.0 1.1\n\n04/03/17 23.4 11.0 2.6 -24.2 25.0 -13.6 -7.4 0.0 1.9 6.9\n\n**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**PRIVATE PASSENGER AUTOMOBILE**\n\n**CALIFORNIA**\n\n**RATE LEVEL HISTORY**","pages":[{"line_numbers":[],"markdown":"Exhibit 2\n\n**Standard Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -13.0 0.0 -22.0 -9.0 -15.0 0.0 -25.0 0.0 21.0 -11.1\n\n10/01/13 -0.8 10.1 -5.2 -2.8 8.2 9.2 6.3 0.0 0.0 1.5\n\n04/03/17 21.7 9.5 4.2 -21.9 27.2 -11.8 -6.4 -1.7 0.1 7.3\n\n**Affinity Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -11.2 2.1 -15.9 -1.9 -13.2 2.1 -23.4 0.0 21.0 -8.1\n\n10/01/13 -1.8 9.0 -12.1 -24.9 -1.8 -1.0 -3.6 0.0 0.0 -5.1\n\n04/03/17 17.9 6.1 3.1 -21.9 25.7 -12.8 -7.5 -2.8 -1.1 4.6\n\n**Professional Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -9.7 3.7 -18.8 -5.3 -11.8 3.7 -22.2 0.0 21.0 -8.7\n\n10/01/13 2.8 14.1 -0.2 -15.6 -3.5 -2.6 -5.2 0.0 0.0 1.9\n\n04/03/17 24.5 12.0 0.3 -27.8 22.0 -15.4 -10.2 1.0 2.8 5.7\n\n**Sponsored Marketing Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -13.0 0.0 -17.7 -3.9 -15.0 0.0 -25.0 0.0 21.0 -9.9\n\n10/01/13 1.3 12.4 -7.2 -23.3 0.2 1.1 -1.6 0.0 0.0 -1.8\n\n04/03/17 22.9 10.6 4.2 -19.8 30.1 -9.8 -4.3 -0.6 1.2 8.2\n\n**Skilled Artisans & Technicians Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -18.4 -6.2 -27.9 -15.8 -15.0 0.0 -25.0 0.0 21.0 -16.7\n\n10/01/13 -0.8 10.1 -3.1 -15.2 -1.8 -1.0 -3.6 0.0 0.0 -0.1\n\n04/03/17 24.3 11.9 5.4 -20.8 27.2 -11.8 -6.4 1.5 3.3 8.9\n\n**All Groups Combined**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -12.3 0.7 -20.8 -7.7 -13.4 2.1 -24.1 0.0 21.0 -10.7\n\n10/01/13 1.0 12.0 -2.5 -13.2 0.0 0.0 0.0 0.0 0.0 1.1\n\n04/03/17 23.4 11.0 2.6 -24.2 25.0 -13.6 -7.4 0.0 1.9 6.9\n\n**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**PRIVATE PASSENGER AUTOMOBILE**\n\n**CALIFORNIA**\n\n**RATE LEVEL HISTORY**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 2\n\n**Standard Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -13.0 0.0 -22.0 -9.0 -15.0 0.0 -25.0 0.0 21.0 -11.1\n\n10/01/13 -0.8 10.1 -5.2 -2.8 8.2 9.2 6.3 0.0 0.0 1.5\n\n04/03/17 21.7 9.5 4.2 -21.9 27.2 -11.8 -6.4 -1.7 0.1 7.3\n\n**Affinity Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -11.2 2.1 -15.9 -1.9 -13.2 2.1 -23.4 0.0 21.0 -8.1\n\n10/01/13 -1.8 9.0 -12.1 -24.9 -1.8 -1.0 -3.6 0.0 0.0 -5.1\n\n04/03/17 17.9 6.1 3.1 -21.9 25.7 -12.8 -7.5 -2.8 -1.1 4.6\n\n**Professional Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -9.7 3.7 -18.8 -5.3 -11.8 3.7 -22.2 0.0 21.0 -8.7\n\n10/01/13 2.8 14.1 -0.2 -15.6 -3.5 -2.6 -5.2 0.0 0.0 1.9\n\n04/03/17 24.5 12.0 0.3 -27.8 22.0 -15.4 -10.2 1.0 2.8 5.7\n\n**Sponsored Marketing Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -13.0 0.0 -17.7 -3.9 -15.0 0.0 -25.0 0.0 21.0 -9.9\n\n10/01/13 1.3 12.4 -7.2 -23.3 0.2 1.1 -1.6 0.0 0.0 -1.8\n\n04/03/17 22.9 10.6 4.2 -19.8 30.1 -9.8 -4.3 -0.6 1.2 8.2\n\n**Skilled Artisans & Technicians Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -18.4 -6.2 -27.9 -15.8 -15.0 0.0 -25.0 0.0 21.0 -16.7\n\n10/01/13 -0.8 10.1 -3.1 -15.2 -1.8 -1.0 -3.6 0.0 0.0 -0.1\n\n04/03/17 24.3 11.9 5.4 -20.8 27.2 -11.8 -6.4 1.5 3.3 8.9\n\n**All Groups Combined**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -12.3 0.7 -20.8 -7.7 -13.4 2.1 -24.1 0.0 21.0 -10.7\n\n10/01/13 1.0 12.0 -2.5 -13.2 0.0 0.0 0.0 0.0 0.0 1.1\n\n04/03/17 23.4 11.0 2.6 -24.2 25.0 -13.6 -7.4 0.0 1.9 6.9\n\n**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**PRIVATE PASSENGER AUTOMOBILE**\n\n**CALIFORNIA**\n\n**RATE LEVEL HISTORY**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1220.pdf"]},"response":{"errors":[],"extract_id":"extract_e8ee1fd30f6a5266328297c9f9dbd651","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 2\n\n**Standard Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -13.0 0.0 -22.0 -9.0 -15.0 0.0 -25.0 0.0 21.0 -11.1\n\n10/01/13 -0.8 10.1 -5.2 -2.8 8.2 9.2 6.3 0.0 0.0 1.5\n\n04/03/17 21.7 9.5 4.2 -21.9 27.2 -11.8 -6.4 -1.7 0.1 7.3\n\n**Affinity Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -11.2 2.1 -15.9 -1.9 -13.2 2.1 -23.4 0.0 21.0 -8.1\n\n10/01/13 -1.8 9.0 -12.1 -24.9 -1.8 -1.0 -3.6 0.0 0.0 -5.1\n\n04/03/17 17.9 6.1 3.1 -21.9 25.7 -12.8 -7.5 -2.8 -1.1 4.6\n\n**Professional Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -9.7 3.7 -18.8 -5.3 -11.8 3.7 -22.2 0.0 21.0 -8.7\n\n10/01/13 2.8 14.1 -0.2 -15.6 -3.5 -2.6 -5.2 0.0 0.0 1.9\n\n04/03/17 24.5 12.0 0.3 -27.8 22.0 -15.4 -10.2 1.0 2.8 5.7\n\n**Sponsored Marketing Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -13.0 0.0 -17.7 -3.9 -15.0 0.0 -25.0 0.0 21.0 -9.9\n\n10/01/13 1.3 12.4 -7.2 -23.3 0.2 1.1 -1.6 0.0 0.0 -1.8\n\n04/03/17 22.9 10.6 4.2 -19.8 30.1 -9.8 -4.3 -0.6 1.2 8.2\n\n**Skilled Artisans & Technicians Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -18.4 -6.2 -27.9 -15.8 -15.0 0.0 -25.0 0.0 21.0 -16.7\n\n10/01/13 -0.8 10.1 -3.1 -15.2 -1.8 -1.0 -3.6 0.0 0.0 -0.1\n\n04/03/17 24.3 11.9 5.4 -20.8 27.2 -11.8 -6.4 1.5 3.3 8.9\n\n**All Groups Combined**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -12.3 0.7 -20.8 -7.7 -13.4 2.1 -24.1 0.0 21.0 -10.7\n\n10/01/13 1.0 12.0 -2.5 -13.2 0.0 0.0 0.0 0.0 0.0 1.1\n\n04/03/17 23.4 11.0 2.6 -24.2 25.0 -13.6 -7.4 0.0 1.9 6.9\n\n**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**PRIVATE PASSENGER AUTOMOBILE**\n\n**CALIFORNIA**\n\n**RATE LEVEL HISTORY**"],"full_content":"Exhibit 2\n\n**Standard Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -13.0 0.0 -22.0 -9.0 -15.0 0.0 -25.0 0.0 21.0 -11.1\n\n10/01/13 -0.8 10.1 -5.2 -2.8 8.2 9.2 6.3 0.0 0.0 1.5\n\n04/03/17 21.7 9.5 4.2 -21.9 27.2 -11.8 -6.4 -1.7 0.1 7.3\n\n**Affinity Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -11.2 2.1 -15.9 -1.9 -13.2 2.1 -23.4 0.0 21.0 -8.1\n\n10/01/13 -1.8 9.0 -12.1 -24.9 -1.8 -1.0 -3.6 0.0 0.0 -5.1\n\n04/03/17 17.9 6.1 3.1 -21.9 25.7 -12.8 -7.5 -2.8 -1.1 4.6\n\n**Professional Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -9.7 3.7 -18.8 -5.3 -11.8 3.7 -22.2 0.0 21.0 -8.7\n\n10/01/13 2.8 14.1 -0.2 -15.6 -3.5 -2.6 -5.2 0.0 0.0 1.9\n\n04/03/17 24.5 12.0 0.3 -27.8 22.0 -15.4 -10.2 1.0 2.8 5.7\n\n**Sponsored Marketing Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -13.0 0.0 -17.7 -3.9 -15.0 0.0 -25.0 0.0 21.0 -9.9\n\n10/01/13 1.3 12.4 -7.2 -23.3 0.2 1.1 -1.6 0.0 0.0 -1.8\n\n04/03/17 22.9 10.6 4.2 -19.8 30.1 -9.8 -4.3 -0.6 1.2 8.2\n\n**Skilled Artisans & Technicians Group**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -18.4 -6.2 -27.9 -15.8 -15.0 0.0 -25.0 0.0 21.0 -16.7\n\n10/01/13 -0.8 10.1 -3.1 -15.2 -1.8 -1.0 -3.6 0.0 0.0 -0.1\n\n04/03/17 24.3 11.9 5.4 -20.8 27.2 -11.8 -6.4 1.5 3.3 8.9\n\n**All Groups Combined**\n\nEffective Date BI PD COLL COMP UM MP UMPD ERS RR Combined\n\n08/15/11 -12.3 0.7 -20.8 -7.7 -13.4 2.1 -24.1 0.0 21.0 -10.7\n\n10/01/13 1.0 12.0 -2.5 -13.2 0.0 0.0 0.0 0.0 0.0 1.1\n\n04/03/17 23.4 11.0 2.6 -24.2 25.0 -13.6 -7.4 0.0 1.9 6.9\n\n**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**PRIVATE PASSENGER AUTOMOBILE**\n\n**CALIFORNIA**\n\n**RATE LEVEL HISTORY**","publish_date":null,"title":"GOVERNMENT EMPLOYEES INSURANCE COMPANY GEICO GENERAL INSURANCE COMPANY GEICO INDEMNITY COMPANY PRIVATE PASSENGER AUTOMOBILE CALIFORNIA RATE LEVEL HISTORY Standard Group","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1220.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1220.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1220","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1220.pdf"},"started_at":"2026-11-04T19:48:22.511706"} +{"completed_at":"2026-11-04T19:48:25.311317","latency_in_ms":1664,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1221","grounded_pages":[],"layout_pages":[],"markdown":"**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**Market Dislocation**\n\n**California**\n\n**Percentage Changes per Policy (5% intervals)**\n\n**Voluntary Private Passenger Automobile Insurance**\n\n\\-5 to 0 - 0 to 5 5 to 10 10 to 15 15 to 20 20 to 25\n\n% of PIF 0.1% 0.0% 6.9% 86.0% 6.8% 0.2% 0.0%\n\nCumulative PIF 0.1% 0.1% 7.1% 93.0% 99.8% 100.0% 100.0%\n\nPIF as of 3/31/2017 1,461 0 95,491 1,182,448 92,821 2,246 539\n\n0\n\n200,000\n\n400,000\n\n600,000\n\n800,000\n\n1,000,000\n\n1,200,000\n\n0\\.0%\n\n10\\.0%\n\n20\\.0%\n\n30\\.0%\n\n40\\.0%\n\n50\\.0%\n\n60\\.0%\n\n70\\.0%\n\n80\\.0%\n\n90\\.0%\n\nExhibit 20","pages":[{"line_numbers":[],"markdown":"**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**Market Dislocation**\n\n**California**\n\n**Percentage Changes per Policy (5% intervals)**\n\n**Voluntary Private Passenger Automobile Insurance**\n\n\\-5 to 0 - 0 to 5 5 to 10 10 to 15 15 to 20 20 to 25\n\n% of PIF 0.1% 0.0% 6.9% 86.0% 6.8% 0.2% 0.0%\n\nCumulative PIF 0.1% 0.1% 7.1% 93.0% 99.8% 100.0% 100.0%\n\nPIF as of 3/31/2017 1,461 0 95,491 1,182,448 92,821 2,246 539\n\n0\n\n200,000\n\n400,000\n\n600,000\n\n800,000\n\n1,000,000\n\n1,200,000\n\n0\\.0%\n\n10\\.0%\n\n20\\.0%\n\n30\\.0%\n\n40\\.0%\n\n50\\.0%\n\n60\\.0%\n\n70\\.0%\n\n80\\.0%\n\n90\\.0%\n\nExhibit 20","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**Market Dislocation**\n\n**California**\n\n**Percentage Changes per Policy (5% intervals)**\n\n**Voluntary Private Passenger Automobile Insurance**\n\n\\-5 to 0 - 0 to 5 5 to 10 10 to 15 15 to 20 20 to 25\n\n% of PIF 0.1% 0.0% 6.9% 86.0% 6.8% 0.2% 0.0%\n\nCumulative PIF 0.1% 0.1% 7.1% 93.0% 99.8% 100.0% 100.0%\n\nPIF as of 3/31/2017 1,461 0 95,491 1,182,448 92,821 2,246 539\n\n0\n\n200,000\n\n400,000\n\n600,000\n\n800,000\n\n1,000,000\n\n1,200,000\n\n0\\.0%\n\n10\\.0%\n\n20\\.0%\n\n30\\.0%\n\n40\\.0%\n\n50\\.0%\n\n60\\.0%\n\n70\\.0%\n\n80\\.0%\n\n90\\.0%\n\nExhibit 20","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1221.pdf"]},"response":{"errors":[],"extract_id":"extract_14001ab2fe837f7447292042f20d5f07","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**Market Dislocation**\n\n**California**\n\n**Percentage Changes per Policy (5% intervals)**\n\n**Voluntary Private Passenger Automobile Insurance**\n\n\\-5 to 0 - 0 to 5 5 to 10 10 to 15 15 to 20 20 to 25\n\n% of PIF 0.1% 0.0% 6.9% 86.0% 6.8% 0.2% 0.0%\n\nCumulative PIF 0.1% 0.1% 7.1% 93.0% 99.8% 100.0% 100.0%\n\nPIF as of 3/31/2017 1,461 0 95,491 1,182,448 92,821 2,246 539\n\n0\n\n200,000\n\n400,000\n\n600,000\n\n800,000\n\n1,000,000\n\n1,200,000\n\n0\\.0%\n\n10\\.0%\n\n20\\.0%\n\n30\\.0%\n\n40\\.0%\n\n50\\.0%\n\n60\\.0%\n\n70\\.0%\n\n80\\.0%\n\n90\\.0%\n\nExhibit 20"],"full_content":"**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**Market Dislocation**\n\n**California**\n\n**Percentage Changes per Policy (5% intervals)**\n\n**Voluntary Private Passenger Automobile Insurance**\n\n\\-5 to 0 - 0 to 5 5 to 10 10 to 15 15 to 20 20 to 25\n\n% of PIF 0.1% 0.0% 6.9% 86.0% 6.8% 0.2% 0.0%\n\nCumulative PIF 0.1% 0.1% 7.1% 93.0% 99.8% 100.0% 100.0%\n\nPIF as of 3/31/2017 1,461 0 95,491 1,182,448 92,821 2,246 539\n\n0\n\n200,000\n\n400,000\n\n600,000\n\n800,000\n\n1,000,000\n\n1,200,000\n\n0\\.0%\n\n10\\.0%\n\n20\\.0%\n\n30\\.0%\n\n40\\.0%\n\n50\\.0%\n\n60\\.0%\n\n70\\.0%\n\n80\\.0%\n\n90\\.0%\n\nExhibit 20","publish_date":null,"title":"GOVERNMENT EMPLOYEES INSURANCE COMPANY GEICO GENERAL INSURANCE COMPANY GEICO INDEMNITY COMPANY Market Dislocation Voluntary Private Passenger Automobile Insurance California Percentage","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1221.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1221.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1221","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1221.pdf"},"started_at":"2026-11-04T19:48:23.646538"} +{"completed_at":"2026-11-04T19:48:26.274151","latency_in_ms":1137,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1226","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 6\n\nInstallment Fees (service charge for pay plans) Reinstatement Fees SR-22 Fees Allocated to Coverage by Earned Premium\n\n(1) (2) (3)\n\nAcc Yr Acc Yr Acc Yr\n\n12/31/2014 12/31/2015 12/31/2016\n\nBodily Injury 6,366,867 7,277,711 8,142,391\n\nProperty Damage 7,252,500 8,317,010 9,295,679\n\nCollision 9,069,368 11,242,377 13,795,076\n\nComprehensive 2,474,318 3,015,952 3,652,791\n\nUninsured Motorists 1,587,590 1,834,026 2,102,229\n\nEmergency Road Service 379,888 442,220 523,324\n\nMedical Payments 471,352 504,560 527,375\n\nUninsured Motorists Property Damage 71,625 80,405 98,366\n\nRental Reimbursement 703,781 854,395 1,061,919\n\n**All Groups Combined**\n\n**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**PRIVATE PASSENGER AUTOMOBILE**\n\n**CALIFORNIA**\n\n**MISCELLANEOUS FEES AND OTHER CHARGES**","pages":[{"line_numbers":[],"markdown":"Exhibit 6\n\nInstallment Fees (service charge for pay plans) Reinstatement Fees SR-22 Fees Allocated to Coverage by Earned Premium\n\n(1) (2) (3)\n\nAcc Yr Acc Yr Acc Yr\n\n12/31/2014 12/31/2015 12/31/2016\n\nBodily Injury 6,366,867 7,277,711 8,142,391\n\nProperty Damage 7,252,500 8,317,010 9,295,679\n\nCollision 9,069,368 11,242,377 13,795,076\n\nComprehensive 2,474,318 3,015,952 3,652,791\n\nUninsured Motorists 1,587,590 1,834,026 2,102,229\n\nEmergency Road Service 379,888 442,220 523,324\n\nMedical Payments 471,352 504,560 527,375\n\nUninsured Motorists Property Damage 71,625 80,405 98,366\n\nRental Reimbursement 703,781 854,395 1,061,919\n\n**All Groups Combined**\n\n**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**PRIVATE PASSENGER AUTOMOBILE**\n\n**CALIFORNIA**\n\n**MISCELLANEOUS FEES AND OTHER CHARGES**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 6\n\nInstallment Fees (service charge for pay plans) Reinstatement Fees SR-22 Fees Allocated to Coverage by Earned Premium\n\n(1) (2) (3)\n\nAcc Yr Acc Yr Acc Yr\n\n12/31/2014 12/31/2015 12/31/2016\n\nBodily Injury 6,366,867 7,277,711 8,142,391\n\nProperty Damage 7,252,500 8,317,010 9,295,679\n\nCollision 9,069,368 11,242,377 13,795,076\n\nComprehensive 2,474,318 3,015,952 3,652,791\n\nUninsured Motorists 1,587,590 1,834,026 2,102,229\n\nEmergency Road Service 379,888 442,220 523,324\n\nMedical Payments 471,352 504,560 527,375\n\nUninsured Motorists Property Damage 71,625 80,405 98,366\n\nRental Reimbursement 703,781 854,395 1,061,919\n\n**All Groups Combined**\n\n**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**PRIVATE PASSENGER AUTOMOBILE**\n\n**CALIFORNIA**\n\n**MISCELLANEOUS FEES AND OTHER CHARGES**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1226.pdf"]},"response":{"errors":[],"extract_id":"extract_4e4796905254bae29a8e93211e99342f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 6\n\nInstallment Fees (service charge for pay plans) Reinstatement Fees SR-22 Fees Allocated to Coverage by Earned Premium\n\n(1) (2) (3)\n\nAcc Yr Acc Yr Acc Yr\n\n12/31/2014 12/31/2015 12/31/2016\n\nBodily Injury 6,366,867 7,277,711 8,142,391\n\nProperty Damage 7,252,500 8,317,010 9,295,679\n\nCollision 9,069,368 11,242,377 13,795,076\n\nComprehensive 2,474,318 3,015,952 3,652,791\n\nUninsured Motorists 1,587,590 1,834,026 2,102,229\n\nEmergency Road Service 379,888 442,220 523,324\n\nMedical Payments 471,352 504,560 527,375\n\nUninsured Motorists Property Damage 71,625 80,405 98,366\n\nRental Reimbursement 703,781 854,395 1,061,919\n\n**All Groups Combined**\n\n**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**PRIVATE PASSENGER AUTOMOBILE**\n\n**CALIFORNIA**\n\n**MISCELLANEOUS FEES AND OTHER CHARGES**"],"full_content":"Exhibit 6\n\nInstallment Fees (service charge for pay plans) Reinstatement Fees SR-22 Fees Allocated to Coverage by Earned Premium\n\n(1) (2) (3)\n\nAcc Yr Acc Yr Acc Yr\n\n12/31/2014 12/31/2015 12/31/2016\n\nBodily Injury 6,366,867 7,277,711 8,142,391\n\nProperty Damage 7,252,500 8,317,010 9,295,679\n\nCollision 9,069,368 11,242,377 13,795,076\n\nComprehensive 2,474,318 3,015,952 3,652,791\n\nUninsured Motorists 1,587,590 1,834,026 2,102,229\n\nEmergency Road Service 379,888 442,220 523,324\n\nMedical Payments 471,352 504,560 527,375\n\nUninsured Motorists Property Damage 71,625 80,405 98,366\n\nRental Reimbursement 703,781 854,395 1,061,919\n\n**All Groups Combined**\n\n**GOVERNMENT EMPLOYEES INSURANCE COMPANY**\n\n**GEICO GENERAL INSURANCE COMPANY**\n\n**GEICO INDEMNITY COMPANY**\n\n**PRIVATE PASSENGER AUTOMOBILE**\n\n**CALIFORNIA**\n\n**MISCELLANEOUS FEES AND OTHER CHARGES**","publish_date":null,"title":"GOVERNMENTEMPLOYEESINSURANCECOMPANY GEICOGENERALINSURANCECOMPANY GEICOINDEMNITYCOMPANY PRIVATEPASSENGERAUTOMOBILE CALIFORNIA MISCELLANEOUSFEESANDOTHERCHARGES AllGroupsCombined","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1226.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1226.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1226","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1226.pdf"},"started_at":"2026-11-04T19:48:25.137129"} +{"completed_at":"2026-11-04T19:48:27.965348","latency_in_ms":1673,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1261","grounded_pages":[],"layout_pages":[],"markdown":"**State of California Company: GEICO/GEICO General/GEICO Indemnity**\n\n**Department of Insurance (CDI) Line: Auto Liability and Physical Damage**\n\n**CDI File # (Department Use Only):**\n\n### **RATEMAKING DATA**\n\n**Completed by:** Tim Stump **Variance #(s): 2C**\n\n**Date Completed:** 5/3/2017\n\n**Detailed Line Description:** Private Passenger Auto Physical Damage\n\n**Coverage:** Emergency Road Service\n\n**Line Description Source 2nd Prior Year**\n\n**Ending**\n\n**1st Prior Year**\n\n**Ending**\n\n**Most Recent Year**\n\n**Ending Projected** **1** **New Program** **2**\n\n(0) **Year 20144 20154 20164**\n\n(1) California Direct Written Premium 22,835,818\n\n(2) California Direct Earned Premium 22,091,398\n\n(3) Premium Adjustment Factor Exh 4 1.051\n\n(4) Premium Trend Factor ¹ Exh 5 0.981 -0.8%\n\n(5) Miscellaneous Fees and Flat Charges not included in Line (2) Exh 6 523,324\n\n(6) Earned Exposure Units 1,256,602\n\n(7) Historic Losses 14,755,140\n\n(8) Historic Defense and Cost Containment Expense (DCCE) 0\n\n(9) Loss Development Factor Exh 7 1.002\n\n(10) DCCE Development Factor Exh 7 1.000\n\n(11) Loss Trend Factor ¹ Exh 8 1.356 12.9%\n\n(12) DCCE Trend Factor ¹ Exh 8 1.000 0.0%\n\n(13) Catastrophe Adjustment Factor Exh 9 1.000\n\n(14) Credibility for Losses & DCCE Exh 10 100.0%\n\n(15) Ancillary Income Exh 11 6,084\n\n_Lines 16-18 link directly to pages 3 and 4 of the rate template._\n\n(16) Excluded Expense Ratio Pg 4.2 0.6%\n\n(17) Projected Federal Income Tax Rate\n\non Investment Income Pg 3.2 29.1%\n\n(18) Projected Yield Pg 3.2 7.3%\n\n_Complete Lines 19 and 20 if a Request for Variance (1A, 1B, 2A, 2B, 2C or 4) accompanies this filing (see instructions)._\n\n(19) Change to Efficiency Standard ³ Exh 13 0.6%\n\n(20) Most Recent Year Total Expense\n\nRatio (excluding DCCE) ⁴ Exh 13 27.7%\n\n1 The Projected column should reflect the annual trend expressed as a percentage for premium, loss and DCCE trends, and credibility.\n\n2 Refer to Section III.C. of the Prior Approval Rate Filing Instructions for New Program requirements.\n\n3 Applicable if any of Variance 1A, 1B, 2A, 2B, 2C or 4 (or any combination thereof) is being requested. Subject to CDI approval.\n\n4 Refer to CCR §2644.27 (h).\n\nPrior Approval Rate Template Page 6.8 03/01/2017 Edition","pages":[{"line_numbers":[],"markdown":"**State of California Company: GEICO/GEICO General/GEICO Indemnity**\n\n**Department of Insurance (CDI) Line: Auto Liability and Physical Damage**\n\n**CDI File # (Department Use Only):**\n\n### **RATEMAKING DATA**\n\n**Completed by:** Tim Stump **Variance #(s): 2C**\n\n**Date Completed:** 5/3/2017\n\n**Detailed Line Description:** Private Passenger Auto Physical Damage\n\n**Coverage:** Emergency Road Service\n\n**Line Description Source 2nd Prior Year**\n\n**Ending**\n\n**1st Prior Year**\n\n**Ending**\n\n**Most Recent Year**\n\n**Ending Projected** **1** **New Program** **2**\n\n(0) **Year 20144 20154 20164**\n\n(1) California Direct Written Premium 22,835,818\n\n(2) California Direct Earned Premium 22,091,398\n\n(3) Premium Adjustment Factor Exh 4 1.051\n\n(4) Premium Trend Factor ¹ Exh 5 0.981 -0.8%\n\n(5) Miscellaneous Fees and Flat Charges not included in Line (2) Exh 6 523,324\n\n(6) Earned Exposure Units 1,256,602\n\n(7) Historic Losses 14,755,140\n\n(8) Historic Defense and Cost Containment Expense (DCCE) 0\n\n(9) Loss Development Factor Exh 7 1.002\n\n(10) DCCE Development Factor Exh 7 1.000\n\n(11) Loss Trend Factor ¹ Exh 8 1.356 12.9%\n\n(12) DCCE Trend Factor ¹ Exh 8 1.000 0.0%\n\n(13) Catastrophe Adjustment Factor Exh 9 1.000\n\n(14) Credibility for Losses & DCCE Exh 10 100.0%\n\n(15) Ancillary Income Exh 11 6,084\n\n_Lines 16-18 link directly to pages 3 and 4 of the rate template._\n\n(16) Excluded Expense Ratio Pg 4.2 0.6%\n\n(17) Projected Federal Income Tax Rate\n\non Investment Income Pg 3.2 29.1%\n\n(18) Projected Yield Pg 3.2 7.3%\n\n_Complete Lines 19 and 20 if a Request for Variance (1A, 1B, 2A, 2B, 2C or 4) accompanies this filing (see instructions)._\n\n(19) Change to Efficiency Standard ³ Exh 13 0.6%\n\n(20) Most Recent Year Total Expense\n\nRatio (excluding DCCE) ⁴ Exh 13 27.7%\n\n1 The Projected column should reflect the annual trend expressed as a percentage for premium, loss and DCCE trends, and credibility.\n\n2 Refer to Section III.C. of the Prior Approval Rate Filing Instructions for New Program requirements.\n\n3 Applicable if any of Variance 1A, 1B, 2A, 2B, 2C or 4 (or any combination thereof) is being requested. Subject to CDI approval.\n\n4 Refer to CCR §2644.27 (h).\n\nPrior Approval Rate Template Page 6.8 03/01/2017 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**State of California Company: GEICO/GEICO General/GEICO Indemnity**\n\n**Department of Insurance (CDI) Line: Auto Liability and Physical Damage**\n\n**CDI File # (Department Use Only):**\n\n### **RATEMAKING DATA**\n\n**Completed by:** Tim Stump **Variance #(s): 2C**\n\n**Date Completed:** 5/3/2017\n\n**Detailed Line Description:** Private Passenger Auto Physical Damage\n\n**Coverage:** Emergency Road Service\n\n**Line Description Source 2nd Prior Year**\n\n**Ending**\n\n**1st Prior Year**\n\n**Ending**\n\n**Most Recent Year**\n\n**Ending Projected** **1** **New Program** **2**\n\n(0) **Year 20144 20154 20164**\n\n(1) California Direct Written Premium 22,835,818\n\n(2) California Direct Earned Premium 22,091,398\n\n(3) Premium Adjustment Factor Exh 4 1.051\n\n(4) Premium Trend Factor ¹ Exh 5 0.981 -0.8%\n\n(5) Miscellaneous Fees and Flat Charges not included in Line (2) Exh 6 523,324\n\n(6) Earned Exposure Units 1,256,602\n\n(7) Historic Losses 14,755,140\n\n(8) Historic Defense and Cost Containment Expense (DCCE) 0\n\n(9) Loss Development Factor Exh 7 1.002\n\n(10) DCCE Development Factor Exh 7 1.000\n\n(11) Loss Trend Factor ¹ Exh 8 1.356 12.9%\n\n(12) DCCE Trend Factor ¹ Exh 8 1.000 0.0%\n\n(13) Catastrophe Adjustment Factor Exh 9 1.000\n\n(14) Credibility for Losses & DCCE Exh 10 100.0%\n\n(15) Ancillary Income Exh 11 6,084\n\n_Lines 16-18 link directly to pages 3 and 4 of the rate template._\n\n(16) Excluded Expense Ratio Pg 4.2 0.6%\n\n(17) Projected Federal Income Tax Rate\n\non Investment Income Pg 3.2 29.1%\n\n(18) Projected Yield Pg 3.2 7.3%\n\n_Complete Lines 19 and 20 if a Request for Variance (1A, 1B, 2A, 2B, 2C or 4) accompanies this filing (see instructions)._\n\n(19) Change to Efficiency Standard ³ Exh 13 0.6%\n\n(20) Most Recent Year Total Expense\n\nRatio (excluding DCCE) ⁴ Exh 13 27.7%\n\n1 The Projected column should reflect the annual trend expressed as a percentage for premium, loss and DCCE trends, and credibility.\n\n2 Refer to Section III.C. of the Prior Approval Rate Filing Instructions for New Program requirements.\n\n3 Applicable if any of Variance 1A, 1B, 2A, 2B, 2C or 4 (or any combination thereof) is being requested. Subject to CDI approval.\n\n4 Refer to CCR §2644.27 (h).\n\nPrior Approval Rate Template Page 6.8 03/01/2017 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1261.pdf"]},"response":{"errors":[],"extract_id":"extract_7b78966931b8cfe14146c3d84f6f690c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**State of California Company: GEICO/GEICO General/GEICO Indemnity**\n\n**Department of Insurance (CDI) Line: Auto Liability and Physical Damage**\n\n**CDI File # (Department Use Only):**\n\n### **RATEMAKING DATA**\n\n**Completed by:** Tim Stump **Variance #(s): 2C**\n\n**Date Completed:** 5/3/2017\n\n**Detailed Line Description:** Private Passenger Auto Physical Damage\n\n**Coverage:** Emergency Road Service\n\n**Line Description Source 2nd Prior Year**\n\n**Ending**\n\n**1st Prior Year**\n\n**Ending**\n\n**Most Recent Year**\n\n**Ending Projected** **1** **New Program** **2**\n\n(0) **Year 20144 20154 20164**\n\n(1) California Direct Written Premium 22,835,818\n\n(2) California Direct Earned Premium 22,091,398\n\n(3) Premium Adjustment Factor Exh 4 1.051\n\n(4) Premium Trend Factor ¹ Exh 5 0.981 -0.8%\n\n(5) Miscellaneous Fees and Flat Charges not included in Line (2) Exh 6 523,324\n\n(6) Earned Exposure Units 1,256,602\n\n(7) Historic Losses 14,755,140\n\n(8) Historic Defense and Cost Containment Expense (DCCE) 0\n\n(9) Loss Development Factor Exh 7 1.002\n\n(10) DCCE Development Factor Exh 7 1.000\n\n(11) Loss Trend Factor ¹ Exh 8 1.356 12.9%\n\n(12) DCCE Trend Factor ¹ Exh 8 1.000 0.0%\n\n(13) Catastrophe Adjustment Factor Exh 9 1.000\n\n(14) Credibility for Losses & DCCE Exh 10 100.0%\n\n(15) Ancillary Income Exh 11 6,084\n\n_Lines 16-18 link directly to pages 3 and 4 of the rate template._\n\n(16) Excluded Expense Ratio Pg 4.2 0.6%\n\n(17) Projected Federal Income Tax Rate\n\non Investment Income Pg 3.2 29.1%\n\n(18) Projected Yield Pg 3.2 7.3%\n\n_Complete Lines 19 and 20 if a Request for Variance (1A, 1B, 2A, 2B, 2C or 4) accompanies this filing (see instructions)._\n\n(19) Change to Efficiency Standard ³ Exh 13 0.6%\n\n(20) Most Recent Year Total Expense\n\nRatio (excluding DCCE) ⁴ Exh 13 27.7%\n\n1 The Projected column should reflect the annual trend expressed as a percentage for premium, loss and DCCE trends, and credibility.\n\n2 Refer to Section III.C. of the Prior Approval Rate Filing Instructions for New Program requirements.\n\n3 Applicable if any of Variance 1A, 1B, 2A, 2B, 2C or 4 (or any combination thereof) is being requested. Subject to CDI approval.\n\n4 Refer to CCR §2644.27 (h).\n\nPrior Approval Rate Template Page 6.8 03/01/2017 Edition"],"full_content":"**State of California Company: GEICO/GEICO General/GEICO Indemnity**\n\n**Department of Insurance (CDI) Line: Auto Liability and Physical Damage**\n\n**CDI File # (Department Use Only):**\n\n### **RATEMAKING DATA**\n\n**Completed by:** Tim Stump **Variance #(s): 2C**\n\n**Date Completed:** 5/3/2017\n\n**Detailed Line Description:** Private Passenger Auto Physical Damage\n\n**Coverage:** Emergency Road Service\n\n**Line Description Source 2nd Prior Year**\n\n**Ending**\n\n**1st Prior Year**\n\n**Ending**\n\n**Most Recent Year**\n\n**Ending Projected** **1** **New Program** **2**\n\n(0) **Year 20144 20154 20164**\n\n(1) California Direct Written Premium 22,835,818\n\n(2) California Direct Earned Premium 22,091,398\n\n(3) Premium Adjustment Factor Exh 4 1.051\n\n(4) Premium Trend Factor ¹ Exh 5 0.981 -0.8%\n\n(5) Miscellaneous Fees and Flat Charges not included in Line (2) Exh 6 523,324\n\n(6) Earned Exposure Units 1,256,602\n\n(7) Historic Losses 14,755,140\n\n(8) Historic Defense and Cost Containment Expense (DCCE) 0\n\n(9) Loss Development Factor Exh 7 1.002\n\n(10) DCCE Development Factor Exh 7 1.000\n\n(11) Loss Trend Factor ¹ Exh 8 1.356 12.9%\n\n(12) DCCE Trend Factor ¹ Exh 8 1.000 0.0%\n\n(13) Catastrophe Adjustment Factor Exh 9 1.000\n\n(14) Credibility for Losses & DCCE Exh 10 100.0%\n\n(15) Ancillary Income Exh 11 6,084\n\n_Lines 16-18 link directly to pages 3 and 4 of the rate template._\n\n(16) Excluded Expense Ratio Pg 4.2 0.6%\n\n(17) Projected Federal Income Tax Rate\n\non Investment Income Pg 3.2 29.1%\n\n(18) Projected Yield Pg 3.2 7.3%\n\n_Complete Lines 19 and 20 if a Request for Variance (1A, 1B, 2A, 2B, 2C or 4) accompanies this filing (see instructions)._\n\n(19) Change to Efficiency Standard ³ Exh 13 0.6%\n\n(20) Most Recent Year Total Expense\n\nRatio (excluding DCCE) ⁴ Exh 13 27.7%\n\n1 The Projected column should reflect the annual trend expressed as a percentage for premium, loss and DCCE trends, and credibility.\n\n2 Refer to Section III.C. of the Prior Approval Rate Filing Instructions for New Program requirements.\n\n3 Applicable if any of Variance 1A, 1B, 2A, 2B, 2C or 4 (or any combination thereof) is being requested. Subject to CDI approval.\n\n4 Refer to CCR §2644.27 (h).\n\nPrior Approval Rate Template Page 6.8 03/01/2017 Edition","publish_date":null,"title":"RATEMAKING DATA","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1261.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1261.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1261","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1261.pdf"},"started_at":"2026-11-04T19:48:26.291857"} +{"completed_at":"2026-11-04T19:48:29.368537","latency_in_ms":2347,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1262","grounded_pages":[],"layout_pages":[],"markdown":"**State of California Company:** GEICO/GEICO General/GEICO Indemnity\n\n**Department of Insurance (CDI) Line:** Auto Liability and Physical Damage\n\n**CDI File # (Department Use Only):**\n\n### **PRIOR APPROVAL RATE TEMPLATE FOR PROPERTY & LIABILITY LINES**\n\n### **SUMMARY**\n\n**Coverage/Form/Program Latest Year Adjusted Annual Premium ($)**\n\n**Minimum Permitted Earned Premium ($)**\n\n**Maximum Permitted Earned Premium ($)**\n\n**Change at Minimum**\n\n**%**\n\n**Change at Maximum**\n\n**% Proposed %**\n\nBodily Injury 429,733,962 397,501,729 528,544,283 -7.5% 23.0% 8.0%\n\nProperty Damage 458,511,889 393,579,084 523,328,478 -14.2% 14.1% 5.0%\n\nUninsured Motorists 131,178,696 126,091,688 167,659,751 -3.9% 27.8% 20.0%\n\nMedical Payments 18,047,148 15,506,495 20,618,449 -14.1% 14.2% 9.0%\n\nUninsured Motorists Property Damage 4,125,464 3,588,293 4,771,229 -13.0% 15.7% 10.0%\n\nCollision 725,929,129 675,359,520 809,840,601 -7.0% 11.6% 5.9%\n\nComprehensive 128,582,886 110,374,938 132,353,366 -14.2% 2.9% 0.0%\n\nEmergency Road Service 23,301,611 22,265,174 26,698,731 -4.4% 14.6% 10.0%\n\nRental Reimbursement 55,485,009 54,668,669 65,554,577 -1.5% 18.1% 10.0%\n\n**Combined 1,974,895,795 1,798,935,590 2,279,369,465 -8.9% 15.4% 6.9%**\n\n**Combined Total Earned Exposures for Latest Year: 2,076,177**\n\n**Average Earned Premium $ per Exposure**\n\n**Latest Year Adjusted Minimum Permitted Maximum Permitted Proposed**\n\nBodily Injury 206.98 191.46 254.58 223.54 2,076,177\n\nProperty Damage 220.84 189.57 252.06 231.89 2,076,177\n\nUninsured Motorists 67.08 64.61 85.91 80.50 1,955,444\n\nMedical Payments 39.98 34.35 45.68 43.58 451,370\n\nUninsured Motorists Property Damage 10.82 9.39 12.49 11.90 381,290\n\nCollision 470.72 437.93 525.13 498.49 1,542,178\n\nComprehensive 76.83 65.95 79.09 76.83 1,673,519\n\nEmergency Road Service 18.54 17.72 21.25 20.40 1,256,602\n\nRental Reimbursement 50.80 50.05 60.02 55.88 1,092,228\n\n**Combined 951.22 866.47 1,097.87 1,016.86 2,076,177**\n\n**Coverage/Form/Program Latest Year Adjusted Annual Premium ($)**\n\n**Latest Year Projected Ultimate Loss & DCCE**\n\n**($)**\n\n**Latest Year Projected Ultimate Loss & DCCE**\n\n**Ratio**\n\nBodily Injury 429,733,962 425,236,906 99.0%\n\nProperty Damage 458,511,889 421,056,192 91.8%\n\nUninsured Motorists 131,178,696 130,375,292 99.4%\n\nMedical Payments 18,047,148 16,591,098 91.9%\n\nUninsured Motorists Property Damage 4,125,464 4,065,443 98.5%\n\nCollision 725,929,129 607,973,081 83.8%\n\nComprehensive 128,582,886 99,378,226 77.3%\n\nEmergency Road Service 23,301,611 20,044,387 86.0%\n\nRental Reimbursement 55,485,009 49,213,265 88.7%\n\n**Combined 1,974,895,795 1,773,933,889 89.8%**\n\n**Coverage/Form/Program Latest Year Earned**\n\n**Exposures**\n\nPrior Approval Rate Template Page 2 03/01/2017 Edition","pages":[{"line_numbers":[],"markdown":"**State of California Company:** GEICO/GEICO General/GEICO Indemnity\n\n**Department of Insurance (CDI) Line:** Auto Liability and Physical Damage\n\n**CDI File # (Department Use Only):**\n\n### **PRIOR APPROVAL RATE TEMPLATE FOR PROPERTY & LIABILITY LINES**\n\n### **SUMMARY**\n\n**Coverage/Form/Program Latest Year Adjusted Annual Premium ($)**\n\n**Minimum Permitted Earned Premium ($)**\n\n**Maximum Permitted Earned Premium ($)**\n\n**Change at Minimum**\n\n**%**\n\n**Change at Maximum**\n\n**% Proposed %**\n\nBodily Injury 429,733,962 397,501,729 528,544,283 -7.5% 23.0% 8.0%\n\nProperty Damage 458,511,889 393,579,084 523,328,478 -14.2% 14.1% 5.0%\n\nUninsured Motorists 131,178,696 126,091,688 167,659,751 -3.9% 27.8% 20.0%\n\nMedical Payments 18,047,148 15,506,495 20,618,449 -14.1% 14.2% 9.0%\n\nUninsured Motorists Property Damage 4,125,464 3,588,293 4,771,229 -13.0% 15.7% 10.0%\n\nCollision 725,929,129 675,359,520 809,840,601 -7.0% 11.6% 5.9%\n\nComprehensive 128,582,886 110,374,938 132,353,366 -14.2% 2.9% 0.0%\n\nEmergency Road Service 23,301,611 22,265,174 26,698,731 -4.4% 14.6% 10.0%\n\nRental Reimbursement 55,485,009 54,668,669 65,554,577 -1.5% 18.1% 10.0%\n\n**Combined 1,974,895,795 1,798,935,590 2,279,369,465 -8.9% 15.4% 6.9%**\n\n**Combined Total Earned Exposures for Latest Year: 2,076,177**\n\n**Average Earned Premium $ per Exposure**\n\n**Latest Year Adjusted Minimum Permitted Maximum Permitted Proposed**\n\nBodily Injury 206.98 191.46 254.58 223.54 2,076,177\n\nProperty Damage 220.84 189.57 252.06 231.89 2,076,177\n\nUninsured Motorists 67.08 64.61 85.91 80.50 1,955,444\n\nMedical Payments 39.98 34.35 45.68 43.58 451,370\n\nUninsured Motorists Property Damage 10.82 9.39 12.49 11.90 381,290\n\nCollision 470.72 437.93 525.13 498.49 1,542,178\n\nComprehensive 76.83 65.95 79.09 76.83 1,673,519\n\nEmergency Road Service 18.54 17.72 21.25 20.40 1,256,602\n\nRental Reimbursement 50.80 50.05 60.02 55.88 1,092,228\n\n**Combined 951.22 866.47 1,097.87 1,016.86 2,076,177**\n\n**Coverage/Form/Program Latest Year Adjusted Annual Premium ($)**\n\n**Latest Year Projected Ultimate Loss & DCCE**\n\n**($)**\n\n**Latest Year Projected Ultimate Loss & DCCE**\n\n**Ratio**\n\nBodily Injury 429,733,962 425,236,906 99.0%\n\nProperty Damage 458,511,889 421,056,192 91.8%\n\nUninsured Motorists 131,178,696 130,375,292 99.4%\n\nMedical Payments 18,047,148 16,591,098 91.9%\n\nUninsured Motorists Property Damage 4,125,464 4,065,443 98.5%\n\nCollision 725,929,129 607,973,081 83.8%\n\nComprehensive 128,582,886 99,378,226 77.3%\n\nEmergency Road Service 23,301,611 20,044,387 86.0%\n\nRental Reimbursement 55,485,009 49,213,265 88.7%\n\n**Combined 1,974,895,795 1,773,933,889 89.8%**\n\n**Coverage/Form/Program Latest Year Earned**\n\n**Exposures**\n\nPrior Approval Rate Template Page 2 03/01/2017 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**State of California Company:** GEICO/GEICO General/GEICO Indemnity\n\n**Department of Insurance (CDI) Line:** Auto Liability and Physical Damage\n\n**CDI File # (Department Use Only):**\n\n### **PRIOR APPROVAL RATE TEMPLATE FOR PROPERTY & LIABILITY LINES**\n\n### **SUMMARY**\n\n**Coverage/Form/Program Latest Year Adjusted Annual Premium ($)**\n\n**Minimum Permitted Earned Premium ($)**\n\n**Maximum Permitted Earned Premium ($)**\n\n**Change at Minimum**\n\n**%**\n\n**Change at Maximum**\n\n**% Proposed %**\n\nBodily Injury 429,733,962 397,501,729 528,544,283 -7.5% 23.0% 8.0%\n\nProperty Damage 458,511,889 393,579,084 523,328,478 -14.2% 14.1% 5.0%\n\nUninsured Motorists 131,178,696 126,091,688 167,659,751 -3.9% 27.8% 20.0%\n\nMedical Payments 18,047,148 15,506,495 20,618,449 -14.1% 14.2% 9.0%\n\nUninsured Motorists Property Damage 4,125,464 3,588,293 4,771,229 -13.0% 15.7% 10.0%\n\nCollision 725,929,129 675,359,520 809,840,601 -7.0% 11.6% 5.9%\n\nComprehensive 128,582,886 110,374,938 132,353,366 -14.2% 2.9% 0.0%\n\nEmergency Road Service 23,301,611 22,265,174 26,698,731 -4.4% 14.6% 10.0%\n\nRental Reimbursement 55,485,009 54,668,669 65,554,577 -1.5% 18.1% 10.0%\n\n**Combined 1,974,895,795 1,798,935,590 2,279,369,465 -8.9% 15.4% 6.9%**\n\n**Combined Total Earned Exposures for Latest Year: 2,076,177**\n\n**Average Earned Premium $ per Exposure**\n\n**Latest Year Adjusted Minimum Permitted Maximum Permitted Proposed**\n\nBodily Injury 206.98 191.46 254.58 223.54 2,076,177\n\nProperty Damage 220.84 189.57 252.06 231.89 2,076,177\n\nUninsured Motorists 67.08 64.61 85.91 80.50 1,955,444\n\nMedical Payments 39.98 34.35 45.68 43.58 451,370\n\nUninsured Motorists Property Damage 10.82 9.39 12.49 11.90 381,290\n\nCollision 470.72 437.93 525.13 498.49 1,542,178\n\nComprehensive 76.83 65.95 79.09 76.83 1,673,519\n\nEmergency Road Service 18.54 17.72 21.25 20.40 1,256,602\n\nRental Reimbursement 50.80 50.05 60.02 55.88 1,092,228\n\n**Combined 951.22 866.47 1,097.87 1,016.86 2,076,177**\n\n**Coverage/Form/Program Latest Year Adjusted Annual Premium ($)**\n\n**Latest Year Projected Ultimate Loss & DCCE**\n\n**($)**\n\n**Latest Year Projected Ultimate Loss & DCCE**\n\n**Ratio**\n\nBodily Injury 429,733,962 425,236,906 99.0%\n\nProperty Damage 458,511,889 421,056,192 91.8%\n\nUninsured Motorists 131,178,696 130,375,292 99.4%\n\nMedical Payments 18,047,148 16,591,098 91.9%\n\nUninsured Motorists Property Damage 4,125,464 4,065,443 98.5%\n\nCollision 725,929,129 607,973,081 83.8%\n\nComprehensive 128,582,886 99,378,226 77.3%\n\nEmergency Road Service 23,301,611 20,044,387 86.0%\n\nRental Reimbursement 55,485,009 49,213,265 88.7%\n\n**Combined 1,974,895,795 1,773,933,889 89.8%**\n\n**Coverage/Form/Program Latest Year Earned**\n\n**Exposures**\n\nPrior Approval Rate Template Page 2 03/01/2017 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1262.pdf"]},"response":{"errors":[],"extract_id":"extract_d9dc876e9edf15b9ba4ddc040b925705","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**State of California Company:** GEICO/GEICO General/GEICO Indemnity\n\n**Department of Insurance (CDI) Line:** Auto Liability and Physical Damage\n\n**CDI File # (Department Use Only):**\n\n### **PRIOR APPROVAL RATE TEMPLATE FOR PROPERTY & LIABILITY LINES**\n\n### **SUMMARY**\n\n**Coverage/Form/Program Latest Year Adjusted Annual Premium ($)**\n\n**Minimum Permitted Earned Premium ($)**\n\n**Maximum Permitted Earned Premium ($)**\n\n**Change at Minimum**\n\n**%**\n\n**Change at Maximum**\n\n**% Proposed %**\n\nBodily Injury 429,733,962 397,501,729 528,544,283 -7.5% 23.0% 8.0%\n\nProperty Damage 458,511,889 393,579,084 523,328,478 -14.2% 14.1% 5.0%\n\nUninsured Motorists 131,178,696 126,091,688 167,659,751 -3.9% 27.8% 20.0%\n\nMedical Payments 18,047,148 15,506,495 20,618,449 -14.1% 14.2% 9.0%\n\nUninsured Motorists Property Damage 4,125,464 3,588,293 4,771,229 -13.0% 15.7% 10.0%\n\nCollision 725,929,129 675,359,520 809,840,601 -7.0% 11.6% 5.9%\n\nComprehensive 128,582,886 110,374,938 132,353,366 -14.2% 2.9% 0.0%\n\nEmergency Road Service 23,301,611 22,265,174 26,698,731 -4.4% 14.6% 10.0%\n\nRental Reimbursement 55,485,009 54,668,669 65,554,577 -1.5% 18.1% 10.0%\n\n**Combined 1,974,895,795 1,798,935,590 2,279,369,465 -8.9% 15.4% 6.9%**\n\n**Combined Total Earned Exposures for Latest Year: 2,076,177**\n\n**Average Earned Premium $ per Exposure**\n\n**Latest Year Adjusted Minimum Permitted Maximum Permitted Proposed**\n\nBodily Injury 206.98 191.46 254.58 223.54 2,076,177\n\nProperty Damage 220.84 189.57 252.06 231.89 2,076,177\n\nUninsured Motorists 67.08 64.61 85.91 80.50 1,955,444\n\nMedical Payments 39.98 34.35 45.68 43.58 451,370\n\nUninsured Motorists Property Damage 10.82 9.39 12.49 11.90 381,290\n\nCollision 470.72 437.93 525.13 498.49 1,542,178\n\nComprehensive 76.83 65.95 79.09 76.83 1,673,519\n\nEmergency Road Service 18.54 17.72 21.25 20.40 1,256,602\n\nRental Reimbursement 50.80 50.05 60.02 55.88 1,092,228\n\n**Combined 951.22 866.47 1,097.87 1,016.86 2,076,177**\n\n**Coverage/Form/Program Latest Year Adjusted Annual Premium ($)**\n\n**Latest Year Projected Ultimate Loss & DCCE**\n\n**($)**\n\n**Latest Year Projected Ultimate Loss & DCCE**\n\n**Ratio**\n\nBodily Injury 429,733,962 425,236,906 99.0%\n\nProperty Damage 458,511,889 421,056,192 91.8%\n\nUninsured Motorists 131,178,696 130,375,292 99.4%\n\nMedical Payments 18,047,148 16,591,098 91.9%\n\nUninsured Motorists Property Damage 4,125,464 4,065,443 98.5%\n\nCollision 725,929,129 607,973,081 83.8%\n\nComprehensive 128,582,886 99,378,226 77.3%\n\nEmergency Road Service 23,301,611 20,044,387 86.0%\n\nRental Reimbursement 55,485,009 49,213,265 88.7%\n\n**Combined 1,974,895,795 1,773,933,889 89.8%**\n\n**Coverage/Form/Program Latest Year Earned**\n\n**Exposures**\n\nPrior Approval Rate Template Page 2 03/01/2017 Edition"],"full_content":"**State of California Company:** GEICO/GEICO General/GEICO Indemnity\n\n**Department of Insurance (CDI) Line:** Auto Liability and Physical Damage\n\n**CDI File # (Department Use Only):**\n\n### **PRIOR APPROVAL RATE TEMPLATE FOR PROPERTY & LIABILITY LINES**\n\n### **SUMMARY**\n\n**Coverage/Form/Program Latest Year Adjusted Annual Premium ($)**\n\n**Minimum Permitted Earned Premium ($)**\n\n**Maximum Permitted Earned Premium ($)**\n\n**Change at Minimum**\n\n**%**\n\n**Change at Maximum**\n\n**% Proposed %**\n\nBodily Injury 429,733,962 397,501,729 528,544,283 -7.5% 23.0% 8.0%\n\nProperty Damage 458,511,889 393,579,084 523,328,478 -14.2% 14.1% 5.0%\n\nUninsured Motorists 131,178,696 126,091,688 167,659,751 -3.9% 27.8% 20.0%\n\nMedical Payments 18,047,148 15,506,495 20,618,449 -14.1% 14.2% 9.0%\n\nUninsured Motorists Property Damage 4,125,464 3,588,293 4,771,229 -13.0% 15.7% 10.0%\n\nCollision 725,929,129 675,359,520 809,840,601 -7.0% 11.6% 5.9%\n\nComprehensive 128,582,886 110,374,938 132,353,366 -14.2% 2.9% 0.0%\n\nEmergency Road Service 23,301,611 22,265,174 26,698,731 -4.4% 14.6% 10.0%\n\nRental Reimbursement 55,485,009 54,668,669 65,554,577 -1.5% 18.1% 10.0%\n\n**Combined 1,974,895,795 1,798,935,590 2,279,369,465 -8.9% 15.4% 6.9%**\n\n**Combined Total Earned Exposures for Latest Year: 2,076,177**\n\n**Average Earned Premium $ per Exposure**\n\n**Latest Year Adjusted Minimum Permitted Maximum Permitted Proposed**\n\nBodily Injury 206.98 191.46 254.58 223.54 2,076,177\n\nProperty Damage 220.84 189.57 252.06 231.89 2,076,177\n\nUninsured Motorists 67.08 64.61 85.91 80.50 1,955,444\n\nMedical Payments 39.98 34.35 45.68 43.58 451,370\n\nUninsured Motorists Property Damage 10.82 9.39 12.49 11.90 381,290\n\nCollision 470.72 437.93 525.13 498.49 1,542,178\n\nComprehensive 76.83 65.95 79.09 76.83 1,673,519\n\nEmergency Road Service 18.54 17.72 21.25 20.40 1,256,602\n\nRental Reimbursement 50.80 50.05 60.02 55.88 1,092,228\n\n**Combined 951.22 866.47 1,097.87 1,016.86 2,076,177**\n\n**Coverage/Form/Program Latest Year Adjusted Annual Premium ($)**\n\n**Latest Year Projected Ultimate Loss & DCCE**\n\n**($)**\n\n**Latest Year Projected Ultimate Loss & DCCE**\n\n**Ratio**\n\nBodily Injury 429,733,962 425,236,906 99.0%\n\nProperty Damage 458,511,889 421,056,192 91.8%\n\nUninsured Motorists 131,178,696 130,375,292 99.4%\n\nMedical Payments 18,047,148 16,591,098 91.9%\n\nUninsured Motorists Property Damage 4,125,464 4,065,443 98.5%\n\nCollision 725,929,129 607,973,081 83.8%\n\nComprehensive 128,582,886 99,378,226 77.3%\n\nEmergency Road Service 23,301,611 20,044,387 86.0%\n\nRental Reimbursement 55,485,009 49,213,265 88.7%\n\n**Combined 1,974,895,795 1,773,933,889 89.8%**\n\n**Coverage/Form/Program Latest Year Earned**\n\n**Exposures**\n\nPrior Approval Rate Template Page 2 03/01/2017 Edition","publish_date":null,"title":"PRIOR APPROVAL RATE TEMPLATE FOR PROPERTY & LIABILITY LINES SUMMARY","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1262.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1262.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1262","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1262.pdf"},"started_at":"2026-11-04T19:48:27.021219"} +{"completed_at":"2026-11-04T19:48:29.832838","latency_in_ms":1501,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1377","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit 7**\n\n**Fiscal Accident Quarter Ending**\n\n**20121 20122 20123 20124 20131 20132 20133 20134 20141 20142 20143 20144 20151 20152 20153 20154 20161 20162 20163 20164 20171 20172 20173 20174 20181 20182 20183 20184 20191 20192 20193 20194 20201 20202 20203 20204 20211 20212 20213 20214**\n\n**GEICO Indemnity Company Private Passenger Auto Physical Damage**\n\n**Non-Catastrophe Closed With Payment Claim Count Development - Quarterly Triangles** **_Comprehensive_**\n\n**Months of Development**\n\n**3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60**\n\n1 94 110 111 112 111 111 112 112 112 112 112 112 112 112 112 112 112 112 112\n\n1 109 124 128 132 133 133 134 133 134 134 134 134 134 134 134 134 134 134 134\n\n6 160 166 168 168 169 168 170 170 170 170 170 170 170 170 170 170 170 170 170\n\n2 115 123 124 125 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126\n\n2 126 136 145 147 149 150 150 150 150 151 151 151 151 151 151 151 151 151 151\n\n3 174 192 193 194 194 197 197 197 197 197 197 196 197 197 197 197 197 197 197\n\n1 181 192 196 194 196 194 194 195 196 196 196 196 196 196 196 197 197 197 198\n\n0 178 194 194 196 194 195 196 196 195 195 195 195 196 196 196 195 196 195 195\n\n0 178 187 193 195 195 195 195 195 195 195 195 195 194 194 195 195 195 195 196\n\n1 197 206 212 213 213 214 212 214 213 213 214 214 214 214 215 215 215 215 215\n\n2 255 273 274 275 276 280 281 281 281 281 280 280 280 279 280 280 280 280 280\n\n3 181 206 209 211 212 212 213 212 213 213 214 215 215 215 215 215 215 215 215\n\n0 186 207 212 214 213 214 214 214 213 215 215 215 215 215 215 215 215 215 215\n\n0 247 278 286 290 290 290 290 291 291 291 291 292 293 294 294 294 294 294 294\n\n2 286 324 329 332 333 333 334 333 333 335 336 336 336 336 336 336 336 336 336\n\n3 197 231 232 237 240 240 241 241 241 240 240 241 241 241 241 240 240 241 241\n\n1 230 254 263 264 264 267 266 266 266 266 266 266 266 265 266 266 266 266 266\n\n3 283 309 313 319 319 322 324 321 324 325 325 325 325 325 324 324 325 325 325\n\n1 288 324 335 342 345 344 345 346 346 346 348 348 348 348 348 349 348 348 349\n\n3 257 275 296 298 298 301 300 300 302 302 302 303 303 303 303 303 303 303 303\n\n1 231 260 273 277 279 282 283 283 282 282 282 283 281 282 282 282 282 282 282\n\n3 291 330 341 351 353 356 358 358 357 359 361 361 361 361 361 361 361 361\n\n4 350 379 399 421 421 422 421 421 423 423 423 424 424 424 424 424 425\n\n5 286 324 351 355 354 357 354 357 358 356 356 358 358 358 358 358\n\n0 209 253 260 270 269 270 270 270 270 271 271 271 270 271 270\n\n5 304 343 361 366 359 370 374 374 374 375 373 374 373 375\n\n6 343 374 389 391 395 397 398 398 398 398 399 399 400\n\n4 311 362 370 385 390 390 393 394 393 393 393 391\n\n0 278 309 310 319 318 322 327 326 328 327 327\n\n3 372 413 430 435 438 438 439 440 439 440\n\n4 371 419 422 429 432 433 438 439 439\n\n4 335 377 371 385 385 388 387 387\n\n2 301 326 335 342 341 343 344\n\n1 427 487 499 504 507 510\n\n2 466 518 540 548 550\n\n2 470 521 536 542\n\n1 411 452 466\n\n2 431 498\n\n4 483\n\n13\n\nSupplemental Quarterly Development Template Page 2.129 06/01/2021 Edition","pages":[{"line_numbers":[],"markdown":"**Exhibit 7**\n\n**Fiscal Accident Quarter Ending**\n\n**20121 20122 20123 20124 20131 20132 20133 20134 20141 20142 20143 20144 20151 20152 20153 20154 20161 20162 20163 20164 20171 20172 20173 20174 20181 20182 20183 20184 20191 20192 20193 20194 20201 20202 20203 20204 20211 20212 20213 20214**\n\n**GEICO Indemnity Company Private Passenger Auto Physical Damage**\n\n**Non-Catastrophe Closed With Payment Claim Count Development - Quarterly Triangles** **_Comprehensive_**\n\n**Months of Development**\n\n**3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60**\n\n1 94 110 111 112 111 111 112 112 112 112 112 112 112 112 112 112 112 112 112\n\n1 109 124 128 132 133 133 134 133 134 134 134 134 134 134 134 134 134 134 134\n\n6 160 166 168 168 169 168 170 170 170 170 170 170 170 170 170 170 170 170 170\n\n2 115 123 124 125 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126\n\n2 126 136 145 147 149 150 150 150 150 151 151 151 151 151 151 151 151 151 151\n\n3 174 192 193 194 194 197 197 197 197 197 197 196 197 197 197 197 197 197 197\n\n1 181 192 196 194 196 194 194 195 196 196 196 196 196 196 196 197 197 197 198\n\n0 178 194 194 196 194 195 196 196 195 195 195 195 196 196 196 195 196 195 195\n\n0 178 187 193 195 195 195 195 195 195 195 195 195 194 194 195 195 195 195 196\n\n1 197 206 212 213 213 214 212 214 213 213 214 214 214 214 215 215 215 215 215\n\n2 255 273 274 275 276 280 281 281 281 281 280 280 280 279 280 280 280 280 280\n\n3 181 206 209 211 212 212 213 212 213 213 214 215 215 215 215 215 215 215 215\n\n0 186 207 212 214 213 214 214 214 213 215 215 215 215 215 215 215 215 215 215\n\n0 247 278 286 290 290 290 290 291 291 291 291 292 293 294 294 294 294 294 294\n\n2 286 324 329 332 333 333 334 333 333 335 336 336 336 336 336 336 336 336 336\n\n3 197 231 232 237 240 240 241 241 241 240 240 241 241 241 241 240 240 241 241\n\n1 230 254 263 264 264 267 266 266 266 266 266 266 266 265 266 266 266 266 266\n\n3 283 309 313 319 319 322 324 321 324 325 325 325 325 325 324 324 325 325 325\n\n1 288 324 335 342 345 344 345 346 346 346 348 348 348 348 348 349 348 348 349\n\n3 257 275 296 298 298 301 300 300 302 302 302 303 303 303 303 303 303 303 303\n\n1 231 260 273 277 279 282 283 283 282 282 282 283 281 282 282 282 282 282 282\n\n3 291 330 341 351 353 356 358 358 357 359 361 361 361 361 361 361 361 361\n\n4 350 379 399 421 421 422 421 421 423 423 423 424 424 424 424 424 425\n\n5 286 324 351 355 354 357 354 357 358 356 356 358 358 358 358 358\n\n0 209 253 260 270 269 270 270 270 270 271 271 271 270 271 270\n\n5 304 343 361 366 359 370 374 374 374 375 373 374 373 375\n\n6 343 374 389 391 395 397 398 398 398 398 399 399 400\n\n4 311 362 370 385 390 390 393 394 393 393 393 391\n\n0 278 309 310 319 318 322 327 326 328 327 327\n\n3 372 413 430 435 438 438 439 440 439 440\n\n4 371 419 422 429 432 433 438 439 439\n\n4 335 377 371 385 385 388 387 387\n\n2 301 326 335 342 341 343 344\n\n1 427 487 499 504 507 510\n\n2 466 518 540 548 550\n\n2 470 521 536 542\n\n1 411 452 466\n\n2 431 498\n\n4 483\n\n13\n\nSupplemental Quarterly Development Template Page 2.129 06/01/2021 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit 7**\n\n**Fiscal Accident Quarter Ending**\n\n**20121 20122 20123 20124 20131 20132 20133 20134 20141 20142 20143 20144 20151 20152 20153 20154 20161 20162 20163 20164 20171 20172 20173 20174 20181 20182 20183 20184 20191 20192 20193 20194 20201 20202 20203 20204 20211 20212 20213 20214**\n\n**GEICO Indemnity Company Private Passenger Auto Physical Damage**\n\n**Non-Catastrophe Closed With Payment Claim Count Development - Quarterly Triangles** **_Comprehensive_**\n\n**Months of Development**\n\n**3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60**\n\n1 94 110 111 112 111 111 112 112 112 112 112 112 112 112 112 112 112 112 112\n\n1 109 124 128 132 133 133 134 133 134 134 134 134 134 134 134 134 134 134 134\n\n6 160 166 168 168 169 168 170 170 170 170 170 170 170 170 170 170 170 170 170\n\n2 115 123 124 125 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126\n\n2 126 136 145 147 149 150 150 150 150 151 151 151 151 151 151 151 151 151 151\n\n3 174 192 193 194 194 197 197 197 197 197 197 196 197 197 197 197 197 197 197\n\n1 181 192 196 194 196 194 194 195 196 196 196 196 196 196 196 197 197 197 198\n\n0 178 194 194 196 194 195 196 196 195 195 195 195 196 196 196 195 196 195 195\n\n0 178 187 193 195 195 195 195 195 195 195 195 195 194 194 195 195 195 195 196\n\n1 197 206 212 213 213 214 212 214 213 213 214 214 214 214 215 215 215 215 215\n\n2 255 273 274 275 276 280 281 281 281 281 280 280 280 279 280 280 280 280 280\n\n3 181 206 209 211 212 212 213 212 213 213 214 215 215 215 215 215 215 215 215\n\n0 186 207 212 214 213 214 214 214 213 215 215 215 215 215 215 215 215 215 215\n\n0 247 278 286 290 290 290 290 291 291 291 291 292 293 294 294 294 294 294 294\n\n2 286 324 329 332 333 333 334 333 333 335 336 336 336 336 336 336 336 336 336\n\n3 197 231 232 237 240 240 241 241 241 240 240 241 241 241 241 240 240 241 241\n\n1 230 254 263 264 264 267 266 266 266 266 266 266 266 265 266 266 266 266 266\n\n3 283 309 313 319 319 322 324 321 324 325 325 325 325 325 324 324 325 325 325\n\n1 288 324 335 342 345 344 345 346 346 346 348 348 348 348 348 349 348 348 349\n\n3 257 275 296 298 298 301 300 300 302 302 302 303 303 303 303 303 303 303 303\n\n1 231 260 273 277 279 282 283 283 282 282 282 283 281 282 282 282 282 282 282\n\n3 291 330 341 351 353 356 358 358 357 359 361 361 361 361 361 361 361 361\n\n4 350 379 399 421 421 422 421 421 423 423 423 424 424 424 424 424 425\n\n5 286 324 351 355 354 357 354 357 358 356 356 358 358 358 358 358\n\n0 209 253 260 270 269 270 270 270 270 271 271 271 270 271 270\n\n5 304 343 361 366 359 370 374 374 374 375 373 374 373 375\n\n6 343 374 389 391 395 397 398 398 398 398 399 399 400\n\n4 311 362 370 385 390 390 393 394 393 393 393 391\n\n0 278 309 310 319 318 322 327 326 328 327 327\n\n3 372 413 430 435 438 438 439 440 439 440\n\n4 371 419 422 429 432 433 438 439 439\n\n4 335 377 371 385 385 388 387 387\n\n2 301 326 335 342 341 343 344\n\n1 427 487 499 504 507 510\n\n2 466 518 540 548 550\n\n2 470 521 536 542\n\n1 411 452 466\n\n2 431 498\n\n4 483\n\n13\n\nSupplemental Quarterly Development Template Page 2.129 06/01/2021 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1377.pdf"]},"response":{"errors":[],"extract_id":"extract_6dd321f2dfd7ed22b7caeb3495d1c1c5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit 7**\n\n**Fiscal Accident Quarter Ending**\n\n**20121 20122 20123 20124 20131 20132 20133 20134 20141 20142 20143 20144 20151 20152 20153 20154 20161 20162 20163 20164 20171 20172 20173 20174 20181 20182 20183 20184 20191 20192 20193 20194 20201 20202 20203 20204 20211 20212 20213 20214**\n\n**GEICO Indemnity Company Private Passenger Auto Physical Damage**\n\n**Non-Catastrophe Closed With Payment Claim Count Development - Quarterly Triangles** **_Comprehensive_**\n\n**Months of Development**\n\n**3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60**\n\n1 94 110 111 112 111 111 112 112 112 112 112 112 112 112 112 112 112 112 112\n\n1 109 124 128 132 133 133 134 133 134 134 134 134 134 134 134 134 134 134 134\n\n6 160 166 168 168 169 168 170 170 170 170 170 170 170 170 170 170 170 170 170\n\n2 115 123 124 125 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126\n\n2 126 136 145 147 149 150 150 150 150 151 151 151 151 151 151 151 151 151 151\n\n3 174 192 193 194 194 197 197 197 197 197 197 196 197 197 197 197 197 197 197\n\n1 181 192 196 194 196 194 194 195 196 196 196 196 196 196 196 197 197 197 198\n\n0 178 194 194 196 194 195 196 196 195 195 195 195 196 196 196 195 196 195 195\n\n0 178 187 193 195 195 195 195 195 195 195 195 195 194 194 195 195 195 195 196\n\n1 197 206 212 213 213 214 212 214 213 213 214 214 214 214 215 215 215 215 215\n\n2 255 273 274 275 276 280 281 281 281 281 280 280 280 279 280 280 280 280 280\n\n3 181 206 209 211 212 212 213 212 213 213 214 215 215 215 215 215 215 215 215\n\n0 186 207 212 214 213 214 214 214 213 215 215 215 215 215 215 215 215 215 215\n\n0 247 278 286 290 290 290 290 291 291 291 291 292 293 294 294 294 294 294 294\n\n2 286 324 329 332 333 333 334 333 333 335 336 336 336 336 336 336 336 336 336\n\n3 197 231 232 237 240 240 241 241 241 240 240 241 241 241 241 240 240 241 241\n\n1 230 254 263 264 264 267 266 266 266 266 266 266 266 265 266 266 266 266 266\n\n3 283 309 313 319 319 322 324 321 324 325 325 325 325 325 324 324 325 325 325\n\n1 288 324 335 342 345 344 345 346 346 346 348 348 348 348 348 349 348 348 349\n\n3 257 275 296 298 298 301 300 300 302 302 302 303 303 303 303 303 303 303 303\n\n1 231 260 273 277 279 282 283 283 282 282 282 283 281 282 282 282 282 282 282\n\n3 291 330 341 351 353 356 358 358 357 359 361 361 361 361 361 361 361 361\n\n4 350 379 399 421 421 422 421 421 423 423 423 424 424 424 424 424 425\n\n5 286 324 351 355 354 357 354 357 358 356 356 358 358 358 358 358\n\n0 209 253 260 270 269 270 270 270 270 271 271 271 270 271 270\n\n5 304 343 361 366 359 370 374 374 374 375 373 374 373 375\n\n6 343 374 389 391 395 397 398 398 398 398 399 399 400\n\n4 311 362 370 385 390 390 393 394 393 393 393 391\n\n0 278 309 310 319 318 322 327 326 328 327 327\n\n3 372 413 430 435 438 438 439 440 439 440\n\n4 371 419 422 429 432 433 438 439 439\n\n4 335 377 371 385 385 388 387 387\n\n2 301 326 335 342 341 343 344\n\n1 427 487 499 504 507 510\n\n2 466 518 540 548 550\n\n2 470 521 536 542\n\n1 411 452 466\n\n2 431 498\n\n4 483\n\n13\n\nSupplemental Quarterly Development Template Page 2.129 06/01/2021 Edition"],"full_content":"**Exhibit 7**\n\n**Fiscal Accident Quarter Ending**\n\n**20121 20122 20123 20124 20131 20132 20133 20134 20141 20142 20143 20144 20151 20152 20153 20154 20161 20162 20163 20164 20171 20172 20173 20174 20181 20182 20183 20184 20191 20192 20193 20194 20201 20202 20203 20204 20211 20212 20213 20214**\n\n**GEICO Indemnity Company Private Passenger Auto Physical Damage**\n\n**Non-Catastrophe Closed With Payment Claim Count Development - Quarterly Triangles** **_Comprehensive_**\n\n**Months of Development**\n\n**3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60**\n\n1 94 110 111 112 111 111 112 112 112 112 112 112 112 112 112 112 112 112 112\n\n1 109 124 128 132 133 133 134 133 134 134 134 134 134 134 134 134 134 134 134\n\n6 160 166 168 168 169 168 170 170 170 170 170 170 170 170 170 170 170 170 170\n\n2 115 123 124 125 126 126 126 126 126 126 126 126 126 126 126 126 126 126 126\n\n2 126 136 145 147 149 150 150 150 150 151 151 151 151 151 151 151 151 151 151\n\n3 174 192 193 194 194 197 197 197 197 197 197 196 197 197 197 197 197 197 197\n\n1 181 192 196 194 196 194 194 195 196 196 196 196 196 196 196 197 197 197 198\n\n0 178 194 194 196 194 195 196 196 195 195 195 195 196 196 196 195 196 195 195\n\n0 178 187 193 195 195 195 195 195 195 195 195 195 194 194 195 195 195 195 196\n\n1 197 206 212 213 213 214 212 214 213 213 214 214 214 214 215 215 215 215 215\n\n2 255 273 274 275 276 280 281 281 281 281 280 280 280 279 280 280 280 280 280\n\n3 181 206 209 211 212 212 213 212 213 213 214 215 215 215 215 215 215 215 215\n\n0 186 207 212 214 213 214 214 214 213 215 215 215 215 215 215 215 215 215 215\n\n0 247 278 286 290 290 290 290 291 291 291 291 292 293 294 294 294 294 294 294\n\n2 286 324 329 332 333 333 334 333 333 335 336 336 336 336 336 336 336 336 336\n\n3 197 231 232 237 240 240 241 241 241 240 240 241 241 241 241 240 240 241 241\n\n1 230 254 263 264 264 267 266 266 266 266 266 266 266 265 266 266 266 266 266\n\n3 283 309 313 319 319 322 324 321 324 325 325 325 325 325 324 324 325 325 325\n\n1 288 324 335 342 345 344 345 346 346 346 348 348 348 348 348 349 348 348 349\n\n3 257 275 296 298 298 301 300 300 302 302 302 303 303 303 303 303 303 303 303\n\n1 231 260 273 277 279 282 283 283 282 282 282 283 281 282 282 282 282 282 282\n\n3 291 330 341 351 353 356 358 358 357 359 361 361 361 361 361 361 361 361\n\n4 350 379 399 421 421 422 421 421 423 423 423 424 424 424 424 424 425\n\n5 286 324 351 355 354 357 354 357 358 356 356 358 358 358 358 358\n\n0 209 253 260 270 269 270 270 270 270 271 271 271 270 271 270\n\n5 304 343 361 366 359 370 374 374 374 375 373 374 373 375\n\n6 343 374 389 391 395 397 398 398 398 398 399 399 400\n\n4 311 362 370 385 390 390 393 394 393 393 393 391\n\n0 278 309 310 319 318 322 327 326 328 327 327\n\n3 372 413 430 435 438 438 439 440 439 440\n\n4 371 419 422 429 432 433 438 439 439\n\n4 335 377 371 385 385 388 387 387\n\n2 301 326 335 342 341 343 344\n\n1 427 487 499 504 507 510\n\n2 466 518 540 548 550\n\n2 470 521 536 542\n\n1 411 452 466\n\n2 431 498\n\n4 483\n\n13\n\nSupplemental Quarterly Development Template Page 2.129 06/01/2021 Edition","publish_date":null,"title":"GEICO Indemnity Company Private Passenger Auto Physical Damage Non-Catastrophe Closed With Payment Claim Count Development - Quarterly Triangles","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1377.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1377.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1377","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1377.pdf"},"started_at":"2026-11-04T19:48:28.330874"} +{"completed_at":"2026-11-04T19:48:31.945012","latency_in_ms":2046,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1387","grounded_pages":[],"layout_pages":[],"markdown":"**PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME**\n\nCurrently Federal\n\nInvested Available Return On Income Federal Income\n\nAssets Yield \\* Invested Assets Tax Rate Taxes\n\n[1] [2] [3]=[1]\\*[2] [4] [5]=[3]\\*[4]\n\n(1) US government bonds (A) Short 13,587,380 0.03% 4,529 35.00% 1,585\n\n(B) Intermediate 114,542,903 2.77% 3,169,020 35.00% 1,109,157\n\n(C) Long 216,726,521 3.70% 8,018,881 35.00% 2,806,608\n\n(2) Other taxable bonds (A) Short 19,800,957 0.18% 36,302 35.00% 12,706\n\n(B) Intermediate 302,835,697 3.85% 11,674,216 35.00% 4,085,976\n\n(C) Long 122,162,710 5.13% 6,262,969 35.00% 2,192,039\n\n(3) Tax exempt bonds (A) Short 0 0.12% 0 5.25% 0\n\n(B) Intermediate 0 2.90% 0 5.25% 0\n\n(C) Long 29,726,257 5.03% 1,495,165 5.25% 78,496\n\n(4) Common Stock 0\n\n(A) Dividends 1.65% 0 14.18% 0\n\n(B) Capital gains 8.05% 0 34.10% 0\n\n(5) Preferred stock 0 5.63%\n\ndividends 0.00% 0 14.18% 0\n\n(6) Mortgage loans 0 5.13% 0 35.00% 0\n\n(7) Real estate 3.70% 0 35.00% 0\n\n(8) Cash\\*\\* -27,190,494 0.03% -9,063 35.00% -3,172\n\n(9) Other\\*\\*\\* 224,322\n\n(A) Dividends 1.65% 3,701 14.18% 525\n\n(B) Capital gains 8.05% 18,063 34.10% 6,159\n\n(10) Total Sum of line (1) thru (9) 792,416,253 30,673,784 10,290,079\n\nData in column [1], line 4 through (9), are from the insurer group's most recent consolidated statutory annual statement page 2 - Assets.\n\n\\* Currently available yields are defined in CCR §2644.20. Latest values are posted at http://www.insurance.ca.gov/0250-insurers/0800-rate-filings/0200-prior-approval-factors/\n\n\\*\\* Annual statement page 2, line 5, cash only. Cash equivalents and short-term investments are included in Schedule D.\n\n\\*\\*\\* Annual statement page 2, line 6 through 9.\n\nPage 14b\n\nPrior Approval Rate Application\n\n(Yield Tax Worksheet)","pages":[{"line_numbers":[],"markdown":"**PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME**\n\nCurrently Federal\n\nInvested Available Return On Income Federal Income\n\nAssets Yield \\* Invested Assets Tax Rate Taxes\n\n[1] [2] [3]=[1]\\*[2] [4] [5]=[3]\\*[4]\n\n(1) US government bonds (A) Short 13,587,380 0.03% 4,529 35.00% 1,585\n\n(B) Intermediate 114,542,903 2.77% 3,169,020 35.00% 1,109,157\n\n(C) Long 216,726,521 3.70% 8,018,881 35.00% 2,806,608\n\n(2) Other taxable bonds (A) Short 19,800,957 0.18% 36,302 35.00% 12,706\n\n(B) Intermediate 302,835,697 3.85% 11,674,216 35.00% 4,085,976\n\n(C) Long 122,162,710 5.13% 6,262,969 35.00% 2,192,039\n\n(3) Tax exempt bonds (A) Short 0 0.12% 0 5.25% 0\n\n(B) Intermediate 0 2.90% 0 5.25% 0\n\n(C) Long 29,726,257 5.03% 1,495,165 5.25% 78,496\n\n(4) Common Stock 0\n\n(A) Dividends 1.65% 0 14.18% 0\n\n(B) Capital gains 8.05% 0 34.10% 0\n\n(5) Preferred stock 0 5.63%\n\ndividends 0.00% 0 14.18% 0\n\n(6) Mortgage loans 0 5.13% 0 35.00% 0\n\n(7) Real estate 3.70% 0 35.00% 0\n\n(8) Cash\\*\\* -27,190,494 0.03% -9,063 35.00% -3,172\n\n(9) Other\\*\\*\\* 224,322\n\n(A) Dividends 1.65% 3,701 14.18% 525\n\n(B) Capital gains 8.05% 18,063 34.10% 6,159\n\n(10) Total Sum of line (1) thru (9) 792,416,253 30,673,784 10,290,079\n\nData in column [1], line 4 through (9), are from the insurer group's most recent consolidated statutory annual statement page 2 - Assets.\n\n\\* Currently available yields are defined in CCR §2644.20. Latest values are posted at http://www.insurance.ca.gov/0250-insurers/0800-rate-filings/0200-prior-approval-factors/\n\n\\*\\* Annual statement page 2, line 5, cash only. Cash equivalents and short-term investments are included in Schedule D.\n\n\\*\\*\\* Annual statement page 2, line 6 through 9.\n\nPage 14b\n\nPrior Approval Rate Application\n\n(Yield Tax Worksheet)","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME**\n\nCurrently Federal\n\nInvested Available Return On Income Federal Income\n\nAssets Yield \\* Invested Assets Tax Rate Taxes\n\n[1] [2] [3]=[1]\\*[2] [4] [5]=[3]\\*[4]\n\n(1) US government bonds (A) Short 13,587,380 0.03% 4,529 35.00% 1,585\n\n(B) Intermediate 114,542,903 2.77% 3,169,020 35.00% 1,109,157\n\n(C) Long 216,726,521 3.70% 8,018,881 35.00% 2,806,608\n\n(2) Other taxable bonds (A) Short 19,800,957 0.18% 36,302 35.00% 12,706\n\n(B) Intermediate 302,835,697 3.85% 11,674,216 35.00% 4,085,976\n\n(C) Long 122,162,710 5.13% 6,262,969 35.00% 2,192,039\n\n(3) Tax exempt bonds (A) Short 0 0.12% 0 5.25% 0\n\n(B) Intermediate 0 2.90% 0 5.25% 0\n\n(C) Long 29,726,257 5.03% 1,495,165 5.25% 78,496\n\n(4) Common Stock 0\n\n(A) Dividends 1.65% 0 14.18% 0\n\n(B) Capital gains 8.05% 0 34.10% 0\n\n(5) Preferred stock 0 5.63%\n\ndividends 0.00% 0 14.18% 0\n\n(6) Mortgage loans 0 5.13% 0 35.00% 0\n\n(7) Real estate 3.70% 0 35.00% 0\n\n(8) Cash\\*\\* -27,190,494 0.03% -9,063 35.00% -3,172\n\n(9) Other\\*\\*\\* 224,322\n\n(A) Dividends 1.65% 3,701 14.18% 525\n\n(B) Capital gains 8.05% 18,063 34.10% 6,159\n\n(10) Total Sum of line (1) thru (9) 792,416,253 30,673,784 10,290,079\n\nData in column [1], line 4 through (9), are from the insurer group's most recent consolidated statutory annual statement page 2 - Assets.\n\n\\* Currently available yields are defined in CCR §2644.20. Latest values are posted at http://www.insurance.ca.gov/0250-insurers/0800-rate-filings/0200-prior-approval-factors/\n\n\\*\\* Annual statement page 2, line 5, cash only. Cash equivalents and short-term investments are included in Schedule D.\n\n\\*\\*\\* Annual statement page 2, line 6 through 9.\n\nPage 14b\n\nPrior Approval Rate Application\n\n(Yield Tax Worksheet)","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1387.pdf"]},"response":{"errors":[],"extract_id":"extract_27ca31cd2c47610ed0ea4b76d4591a95","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME**\n\nCurrently Federal\n\nInvested Available Return On Income Federal Income\n\nAssets Yield \\* Invested Assets Tax Rate Taxes\n\n[1] [2] [3]=[1]\\*[2] [4] [5]=[3]\\*[4]\n\n(1) US government bonds (A) Short 13,587,380 0.03% 4,529 35.00% 1,585\n\n(B) Intermediate 114,542,903 2.77% 3,169,020 35.00% 1,109,157\n\n(C) Long 216,726,521 3.70% 8,018,881 35.00% 2,806,608\n\n(2) Other taxable bonds (A) Short 19,800,957 0.18% 36,302 35.00% 12,706\n\n(B) Intermediate 302,835,697 3.85% 11,674,216 35.00% 4,085,976\n\n(C) Long 122,162,710 5.13% 6,262,969 35.00% 2,192,039\n\n(3) Tax exempt bonds (A) Short 0 0.12% 0 5.25% 0\n\n(B) Intermediate 0 2.90% 0 5.25% 0\n\n(C) Long 29,726,257 5.03% 1,495,165 5.25% 78,496\n\n(4) Common Stock 0\n\n(A) Dividends 1.65% 0 14.18% 0\n\n(B) Capital gains 8.05% 0 34.10% 0\n\n(5) Preferred stock 0 5.63%\n\ndividends 0.00% 0 14.18% 0\n\n(6) Mortgage loans 0 5.13% 0 35.00% 0\n\n(7) Real estate 3.70% 0 35.00% 0\n\n(8) Cash\\*\\* -27,190,494 0.03% -9,063 35.00% -3,172\n\n(9) Other\\*\\*\\* 224,322\n\n(A) Dividends 1.65% 3,701 14.18% 525\n\n(B) Capital gains 8.05% 18,063 34.10% 6,159\n\n(10) Total Sum of line (1) thru (9) 792,416,253 30,673,784 10,290,079\n\nData in column [1], line 4 through (9), are from the insurer group's most recent consolidated statutory annual statement page 2 - Assets.\n\n\\* Currently available yields are defined in CCR §2644.20. Latest values are posted at http://www.insurance.ca.gov/0250-insurers/0800-rate-filings/0200-prior-approval-factors/\n\n\\*\\* Annual statement page 2, line 5, cash only. Cash equivalents and short-term investments are included in Schedule D.\n\n\\*\\*\\* Annual statement page 2, line 6 through 9.\n\nPage 14b\n\nPrior Approval Rate Application\n\n(Yield Tax Worksheet)"],"full_content":"**PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME**\n\nCurrently Federal\n\nInvested Available Return On Income Federal Income\n\nAssets Yield \\* Invested Assets Tax Rate Taxes\n\n[1] [2] [3]=[1]\\*[2] [4] [5]=[3]\\*[4]\n\n(1) US government bonds (A) Short 13,587,380 0.03% 4,529 35.00% 1,585\n\n(B) Intermediate 114,542,903 2.77% 3,169,020 35.00% 1,109,157\n\n(C) Long 216,726,521 3.70% 8,018,881 35.00% 2,806,608\n\n(2) Other taxable bonds (A) Short 19,800,957 0.18% 36,302 35.00% 12,706\n\n(B) Intermediate 302,835,697 3.85% 11,674,216 35.00% 4,085,976\n\n(C) Long 122,162,710 5.13% 6,262,969 35.00% 2,192,039\n\n(3) Tax exempt bonds (A) Short 0 0.12% 0 5.25% 0\n\n(B) Intermediate 0 2.90% 0 5.25% 0\n\n(C) Long 29,726,257 5.03% 1,495,165 5.25% 78,496\n\n(4) Common Stock 0\n\n(A) Dividends 1.65% 0 14.18% 0\n\n(B) Capital gains 8.05% 0 34.10% 0\n\n(5) Preferred stock 0 5.63%\n\ndividends 0.00% 0 14.18% 0\n\n(6) Mortgage loans 0 5.13% 0 35.00% 0\n\n(7) Real estate 3.70% 0 35.00% 0\n\n(8) Cash\\*\\* -27,190,494 0.03% -9,063 35.00% -3,172\n\n(9) Other\\*\\*\\* 224,322\n\n(A) Dividends 1.65% 3,701 14.18% 525\n\n(B) Capital gains 8.05% 18,063 34.10% 6,159\n\n(10) Total Sum of line (1) thru (9) 792,416,253 30,673,784 10,290,079\n\nData in column [1], line 4 through (9), are from the insurer group's most recent consolidated statutory annual statement page 2 - Assets.\n\n\\* Currently available yields are defined in CCR §2644.20. Latest values are posted at http://www.insurance.ca.gov/0250-insurers/0800-rate-filings/0200-prior-approval-factors/\n\n\\*\\* Annual statement page 2, line 5, cash only. Cash equivalents and short-term investments are included in Schedule D.\n\n\\*\\*\\* Annual statement page 2, line 6 through 9.\n\nPage 14b\n\nPrior Approval Rate Application\n\n(Yield Tax Worksheet)","publish_date":null,"title":"PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME Currently Federal Invested Available Return On Income Federal Income Assets","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1387.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1387.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1387","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1387.pdf"},"started_at":"2026-11-04T19:48:29.898969"} +{"completed_at":"2026-11-04T19:48:32.244920","latency_in_ms":1843,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1414","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 1 - Section A\n\n**Hired / Nonowned Algorithm Steps Round to X Places Coverage** X A 0 places\n\n**Algorithm Steps Round to X Places**\n\n**Roadside Assistance** A BASE RATE 3 places\n\nB A x TERM FACTOR 0 places\n\nC B x VEHICLE RATING - SYMBOLS FACTOR 3 places\n\nD C x INCREASED LIMITS FACTOR 3 places\n\nE SUBTRACT DISCOUNTS & ADD SURCHARG 3 places\n\n**Algorithm Steps Round to X Places**\n\n**Rental** A BASE RATE 3 places\n\nB A x TERM FACTOR 0 places\n\nC B x VEHICLE RATING - SYMBOLS FACTOR 3 places\n\nD C x INCREASED LIMITS FACTOR 3 places\n\nE SUBTRACT DISCOUNTS & ADD SURCHARG 3 places\n\n2% of Fully Developed BI/PD premium for each coverage at a policy level\n\nIntegon Preferred Insurance Company 2","pages":[{"line_numbers":[],"markdown":"Exhibit 1 - Section A\n\n**Hired / Nonowned Algorithm Steps Round to X Places Coverage** X A 0 places\n\n**Algorithm Steps Round to X Places**\n\n**Roadside Assistance** A BASE RATE 3 places\n\nB A x TERM FACTOR 0 places\n\nC B x VEHICLE RATING - SYMBOLS FACTOR 3 places\n\nD C x INCREASED LIMITS FACTOR 3 places\n\nE SUBTRACT DISCOUNTS & ADD SURCHARG 3 places\n\n**Algorithm Steps Round to X Places**\n\n**Rental** A BASE RATE 3 places\n\nB A x TERM FACTOR 0 places\n\nC B x VEHICLE RATING - SYMBOLS FACTOR 3 places\n\nD C x INCREASED LIMITS FACTOR 3 places\n\nE SUBTRACT DISCOUNTS & ADD SURCHARG 3 places\n\n2% of Fully Developed BI/PD premium for each coverage at a policy level\n\nIntegon Preferred Insurance Company 2","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 1 - Section A\n\n**Hired / Nonowned Algorithm Steps Round to X Places Coverage** X A 0 places\n\n**Algorithm Steps Round to X Places**\n\n**Roadside Assistance** A BASE RATE 3 places\n\nB A x TERM FACTOR 0 places\n\nC B x VEHICLE RATING - SYMBOLS FACTOR 3 places\n\nD C x INCREASED LIMITS FACTOR 3 places\n\nE SUBTRACT DISCOUNTS & ADD SURCHARG 3 places\n\n**Algorithm Steps Round to X Places**\n\n**Rental** A BASE RATE 3 places\n\nB A x TERM FACTOR 0 places\n\nC B x VEHICLE RATING - SYMBOLS FACTOR 3 places\n\nD C x INCREASED LIMITS FACTOR 3 places\n\nE SUBTRACT DISCOUNTS & ADD SURCHARG 3 places\n\n2% of Fully Developed BI/PD premium for each coverage at a policy level\n\nIntegon Preferred Insurance Company 2","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1414.pdf"]},"response":{"errors":[],"extract_id":"extract_720249d58eeaa867ce7ca691eea31ae9","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 1 - Section A\n\n**Hired / Nonowned Algorithm Steps Round to X Places Coverage** X A 0 places\n\n**Algorithm Steps Round to X Places**\n\n**Roadside Assistance** A BASE RATE 3 places\n\nB A x TERM FACTOR 0 places\n\nC B x VEHICLE RATING - SYMBOLS FACTOR 3 places\n\nD C x INCREASED LIMITS FACTOR 3 places\n\nE SUBTRACT DISCOUNTS & ADD SURCHARG 3 places\n\n**Algorithm Steps Round to X Places**\n\n**Rental** A BASE RATE 3 places\n\nB A x TERM FACTOR 0 places\n\nC B x VEHICLE RATING - SYMBOLS FACTOR 3 places\n\nD C x INCREASED LIMITS FACTOR 3 places\n\nE SUBTRACT DISCOUNTS & ADD SURCHARG 3 places\n\n2% of Fully Developed BI/PD premium for each coverage at a policy level\n\nIntegon Preferred Insurance Company 2"],"full_content":"Exhibit 1 - Section A\n\n**Hired / Nonowned Algorithm Steps Round to X Places Coverage** X A 0 places\n\n**Algorithm Steps Round to X Places**\n\n**Roadside Assistance** A BASE RATE 3 places\n\nB A x TERM FACTOR 0 places\n\nC B x VEHICLE RATING - SYMBOLS FACTOR 3 places\n\nD C x INCREASED LIMITS FACTOR 3 places\n\nE SUBTRACT DISCOUNTS & ADD SURCHARG 3 places\n\n**Algorithm Steps Round to X Places**\n\n**Rental** A BASE RATE 3 places\n\nB A x TERM FACTOR 0 places\n\nC B x VEHICLE RATING - SYMBOLS FACTOR 3 places\n\nD C x INCREASED LIMITS FACTOR 3 places\n\nE SUBTRACT DISCOUNTS & ADD SURCHARG 3 places\n\n2% of Fully Developed BI/PD premium for each coverage at a policy level\n\nIntegon Preferred Insurance Company 2","publish_date":null,"title":"Exhibit 1 - Section A Hired / Nonowned Algorithm Steps Coverage X A 2% of Fully Developed BI/PD premium for","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1414.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1414.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1414","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1414.pdf"},"started_at":"2026-11-04T19:48:30.401191"} +{"completed_at":"2026-11-04T19:47:43.443833","latency_in_ms":1168,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1423","grounded_pages":[],"layout_pages":[],"markdown":"State of California Department of Insurance Exhibit 7‐ BI Integon Preferred Insurance Company ‐ Commercial Vehicle\n\n**Loss** **and** **Defense** **&** **Cost** **Containment** **Expense** (DCCE Development Factors)\n\n**Bodily** **Injury** _Accident Period Development as of 2012m06_ Latest Cum. _Start Month End Month_ 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72 75 78 81 Diagonal LDFs\n\n2005m07 2005m09 109,344 187,820 203,326 183,426 188,626 188,626 214,646 235,996 242,896 240,896 230,896 243,996 249,296 249,296 234,546 234,546 237,946 409,375 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 1.0000 2005m10 2005m12 152,036 145,882 160,782 164,924 171,874 177,924 158,099 232,649 298,149 309,499 309,499 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 1.0000 2006m01 2006m03 119,381 169,646 175,562 244,512 270,062 378,612 396,612 474,342 639,842 714,591 714,591 714,591 720,541 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 1.0000 2006m04 2006m06 125,941 158,841 170,091 205,991 213,322 248,722 245,172 245,522 252,854 252,854 252,854 252,854 277,554 277,554 277,554 277,554 274,104 272,204 272,204 272,204 302,154 302,154 302,154 302,154 302,154 302,154 1.0000 2006m07 2006m09 165,450 180,077 202,409 198,334 295,434 517,134 530,334 574,384 574,834 591,384 591,384 591,384 591,384 609,434 609,434 609,434 617,784 593,384 593,384 593,384 593,384 593,384 593,384 593,384 593,384 1.0000 2006m10 2006m12 56,150 64,325 78,875 85,225 85,175 78,525 81,575 74,225 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 1.0000 2007m01 2007m03 69,850 93,068 222,604 225,154 224,254 224,954 226,254 221,304 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 1.0000 2007m04 2007m06 116,063 269,251 298,787 308,187 318,849 315,049 353,649 358,199 357,399 357,399 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 1.0000 2007m07 2007m09 213,500 348,400 442,420 477,081 515,467 531,517 544,067 553,517 631,367 631,367 646,417 664,167 670,267 670,267 670,267 658,867 693,117 693,117 693,117 693,117 693,117 1.0131 2007m10 2007m12 309,850 318,158 347,608 376,558 369,204 443,704 434,404 450,104 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 1.0131 2008m01 2008m03 159,150 172,470 171,670 163,927 193,627 186,277 170,627 170,377 183,377 203,777 203,777 189,478 189,478 189,478 189,478 189,478 189,478 189,478 189,478 1.0131 2008m04 2008m06 155,605 141,816 137,851 231,751 236,501 330,605 249,280 283,780 293,380 284,930 310,830 310,830 311,380 311,380 315,830 315,830 315,830 315,830 1.0131 2008m07 2008m09 383,869 467,263 441,163 547,454 550,004 570,904 668,854 664,562 685,779 718,424 724,874 724,874 724,874 724,874 724,874 724,874 724,874 1.0228 2008m10 2008m12 142,695 236,777 401,986 482,714 573,847 560,897 556,020 495,783 497,283 505,833 512,483 511,433 514,633 514,633 526,483 526,483 1.0204 2009m01 2009m03 134,916 182,706 201,157 322,527 368,227 380,999 384,349 390,749 399,999 365,099 391,849 391,849 391,849 391,849 391,849 1.0237 2009m04 2009m06 266,373 257,137 342,635 358,185 350,811 338,786 341,036 368,836 361,736 361,736 373,636 373,636 379,736 379,736 1.0275 2009m07 2009m09 248,776 327,405 328,205 368,410 477,510 511,956 516,565 509,158 509,858 509,858 509,858 470,971 470,971 1.0309 2009m10 2009m12 182,183 372,091 432,236 519,436 506,486 531,270 595,070 582,970 546,120 559,120 559,120 559,120 1.0230 2010m01 2010m03 94,700 264,601 285,154 241,761 319,981 317,216 333,155 333,455 330,805 330,805 330,805 1.0484 2010m04 2010m06 314,770 386,635 408,235 387,027 399,177 379,477 435,977 446,777 483,366 483,366 1.0547 1.038 2010m07 2010m09 273,505 320,098 420,512 594,334 605,734 592,934 584,648 683,743 683,743 1.0772 2010m10 2010m12 238,056 237,356 221,085 225,785 245,362 271,863 305,863 305,863 1.0997 2011m01 2011m03 105,324 127,504 208,026 270,426 278,836 266,286 266,286 1.1369 2011m04 2011m06 208,079 220,411 235,761 350,566 359,566 359,566 1.1695 1.112 2011m07 2011m09 187,476 193,147 226,322 433,749 433,749 1.2614 2011m10 2011m12 329,310 383,971 407,338 407,338 1.5481 2012m01 2012m03 208,194 221,090 221,090 1.7579 2012m04 2012m06 292,558 292,558 2.1911 1.627\n\n_Accident Period Loss Development Factors Start Month End Month_ 3 ‐ 6 6 ‐ 9 9 ‐ 12 12 ‐ 15 15 ‐ 18 18 ‐ 21 21 ‐ 24 24 ‐ 27 27 ‐ 30 30 ‐ 33 33 ‐ 36 36 ‐ 39 39 ‐ 42 42 ‐ 45 45 ‐ 48 48 ‐ 51 51 ‐ 54 54 ‐ 57 57 ‐ 60 60 ‐ 63 63 ‐ 66 66 ‐ 69 69 ‐ 72 72 ‐ 75 75 ‐ 78 78 ‐ 81 81 ‐\n\n2005m07 2005m09 1.7177 1.0826 0.9021 1.0283 1.0000 1.1379 1.0995 1.0292 0.9918 0.9585 1.0567 1.0217 1.0000 0.9408 1.0000 1.0145 1.7205 0.9646 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2005m10 2005m12 0.9595 1.1021 1.0258 1.0421 1.0352 0.8886 1.4715 1.2815 1.0381 1.0000 1.0141 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m01 2006m03 1.4210 1.0349 1.3927 1.1045 1.4019 1.0475 1.1960 1.3489 1.1168 1.0000 1.0000 1.0083 1.0170 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m04 2006m06 1.2612 1.0708 1.2111 1.0356 1.1659 0.9857 1.0014 1.0299 1.0000 1.0000 1.0000 1.0977 1.0000 1.0000 1.0000 0.9876 0.9931 1.0000 1.0000 1.1100 1.0000 1.0000 1.0000 1.0000 2006m07 2006m09 1.0884 1.1240 0.9799 1.4896 1.7504 1.0255 1.0831 1.0008 1.0288 1.0000 1.0000 1.0000 1.0305 1.0000 1.0000 1.0137 0.9605 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m10 2006m12 1.1456 1.2262 1.0805 0.9994 0.9219 1.0388 0.9099 0.9737 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m01 2007m03 1.3324 2.3918 1.0115 0.9960 1.0031 1.0058 0.9781 0.9903 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m04 2007m06 2.3199 1.1097 1.0315 1.0346 0.9881 1.1225 1.0129 0.9978 1.0000 1.0985 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m07 2007m09 1.6319 1.2699 1.0783 1.0805 1.0311 1.0236 1.0174 1.1406 1.0000 1.0238 1.0275 1.0092 1.0000 1.0000 0.9830 1.0520 1.0000 1.0000 1.0000 2007m10 2007m12 1.0268 1.0926 1.0833 0.9805 1.2018 0.9790 1.0361 0.9751 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2008m01 2008m03 1.0837 0.9954 0.9549 1.1812 0.9620 0.9160 0.9985 1.0763 1.1112 1.0000 0.9298 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2008m04 2008m06 0.9114 0.9720 1.6812 1.0205 1.3979 0.7540 1.1384 1.0338 0.9712 1.0909 1.0000 1.0018 1.0000 1.0143 1.0000 1.0000 2008m07 2008m09 1.2172 0.9441 1.2409 1.0047 1.0380 1.1716 0.9936 1.0319 1.0476 1.0090 1.0000 1.0000 1.0000 1.0000 1.0000 2008m10 2008m12 1.6593 1.6977 1.2008 1.1888 0.9774 0.9913 0.8917 1.0030 1.0172 1.0131 0.9980 1.0063 1.0000 1.0230 2009m01 2009m03 1.3542 1.1010 1.6034 1.1417 1.0347 1.0088 1.0167 1.0237 0.9127 1.0733 1.0000 1.0000 1.0000 2009m04 2009m06 0.9653 1.3325 1.0454 0.9794 0.9657 1.0066 1.0815 0.9808 1.0000 1.0329 1.0000 1.0163 2009m07 2009m09 1.3161 1.0024 1.1225 1.2961 1.0721 1.0090 0.9857 1.0014 1.0000 1.0000 0.9237 2009m10 2009m12 2.0424 1.1616 1.2017 0.9751 1.0489 1.1201 0.9797 0.9368 1.0238 1.0000 2010m01 2010m03 2.7941 1.0777 0.8478 1.3235 0.9914 1.0502 1.0009 0.9921 1.0000 2010m04 2010m06 1.2283 1.0559 0.9480 1.0314 0.9506 1.1489 1.0248 1.0819 2010m07 2010m09 1.1704 1.3137 1.4134 1.0192 0.9789 0.9860 1.1695 2010m10 2010m12 0.9971 0.9314 1.0213 1.0867 1.1080 1.1251 2011m01 2011m03 1.2106 1.6315 1.3000 1.0311 0.9550 2011m04 2011m06 1.0593 1.0696 1.4870 1.0257 2011m07 2011m09 1.0302 1.1718 1.9165 2011m10 2011m12 1.1660 1.0609 2012m01 2012m03 1.0619 2012m04 2012m06\n\n**All Period** 1\\.3397 1.1932 1.1913 1.0873 1.0861 1.0247 1.0517 1.0465 1.0136 1.0167 0.9970 1.0101 1.0032 0.9984 0.9987 1.0056 1.0613 0.9965 1.0000 1.0138 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **All Period Wtd** 1\\.2716 1.1518 1.1778 1.0776 1.0755 1.0307 1.0411 1.0460 1.0175 1.0161 0.9972 1.0081 1.0050 1.0003 0.9978 1.0096 1.0347 0.9965 1.0000 1.0100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Maximum** 2\\.7941 2.3918 1.9165 1.4896 1.7504 1.1716 1.4715 1.3489 1.1168 1.0985 1.0567 1.0977 1.0305 1.0230 1.0000 1.0520 1.7205 1.0000 1.0000 1.1100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Minimum** 0\\.9114 0.9314 0.8478 0.9751 0.9219 0.7540 0.8917 0.9368 0.9127 0.9585 0.9237 1.0000 1.0000 0.9408 0.9830 0.9876 0.9605 0.9646 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Median** 1\\.2106 1.0968 1.0833 1.0330 1.0311 1.0163 1.0167 1.0133 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **M12L14 Wtd** 1\\.2471 1.1238 1.2328 1.0781 1.0276 1.0307 1.0170 1.0145 1.0093 1.0189 0.9966 1.0042 1.0025 1.0009 **Last 12** 1\\.3368 1.1592 1.2590 1.0919 1.0432 1.0240 1.0264 1.0231 1.0070 1.0285 0.9899 1.0028 1.0025 1.0031 0.9986 1.0056 **Last 12 Wtd** 1\\.2464 1.1355 1.2273 1.0786 1.0286 1.0338 1.0209 1.0213 1.0060 1.0248 0.9924 1.0033 1.0038 1.0032 0.9977 1.0096 **M6L8 Wtd** 1\\.1176 1.1212 1.2190 1.0772 1.0075 1.0527 1.0099 1.0083 1.0052 1.0194 0.9941 1.0035 1.0000 1.0020 1.0000 1.0043 0.9991 1.0000 1.0000 1.0000 **Last 6** 1\\.0875 1.1965 1.3477 1.0863 1.0055 1.0732 1.0403 1.0028 0.9923 1.0214 0.9869 1.0041 1.0000 1.0062 0.9972 1.0087 1.0000 1.0000 1.0000 1.0183 1.0000 1.0000 **Last 6 Wtd** 1\\.0839 1.1596 1.3151 1.0670 1.0015 1.0639 1.0422 1.0000 0.9950 1.0171 0.9859 1.0039 1.0000 1.0057 0.9958 1.0155 1.0000 1.0000 1.0000 1.0131 1.0000 1.0000 **M3L5 Wtd** 1\\.1072 1.0901 1.4061 1.0293 0.9767 1.1015 1.0029 0.9925 1.0000 1.0135 0.9994 1.0024 1.0000 1.0047 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Last 3 Wtd** 1\\.1010 1.0901 1.5740 1.0437 1.0010 1.0661 1.0814 0.9979 1.0094 1.0083 0.9695 1.0073 1.0000 1.0105 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nSelected LDF 1.2464 1.1355 1.2273 1.0786 1.0286 1.0338 1.0209 1.0213 1.0060 1.0248 0.9924 1.0033 1.0038 1.0032 0.9977 1.0096 1.0000 1.0000 1.0000 1.0131 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 Cumulative LDF 2.1911 1.7579 1.5481 1.2614 1.1695 1.1369 1.0997 1.0772 1.0547 1.0484 1.0230 1.0309 1.0275 1.0237 1.0204 1.0228 1.0131 1.0131 1.0131 1.0131 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000","pages":[{"line_numbers":[],"markdown":"State of California Department of Insurance Exhibit 7‐ BI Integon Preferred Insurance Company ‐ Commercial Vehicle\n\n**Loss** **and** **Defense** **&** **Cost** **Containment** **Expense** (DCCE Development Factors)\n\n**Bodily** **Injury** _Accident Period Development as of 2012m06_ Latest Cum. _Start Month End Month_ 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72 75 78 81 Diagonal LDFs\n\n2005m07 2005m09 109,344 187,820 203,326 183,426 188,626 188,626 214,646 235,996 242,896 240,896 230,896 243,996 249,296 249,296 234,546 234,546 237,946 409,375 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 1.0000 2005m10 2005m12 152,036 145,882 160,782 164,924 171,874 177,924 158,099 232,649 298,149 309,499 309,499 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 1.0000 2006m01 2006m03 119,381 169,646 175,562 244,512 270,062 378,612 396,612 474,342 639,842 714,591 714,591 714,591 720,541 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 1.0000 2006m04 2006m06 125,941 158,841 170,091 205,991 213,322 248,722 245,172 245,522 252,854 252,854 252,854 252,854 277,554 277,554 277,554 277,554 274,104 272,204 272,204 272,204 302,154 302,154 302,154 302,154 302,154 302,154 1.0000 2006m07 2006m09 165,450 180,077 202,409 198,334 295,434 517,134 530,334 574,384 574,834 591,384 591,384 591,384 591,384 609,434 609,434 609,434 617,784 593,384 593,384 593,384 593,384 593,384 593,384 593,384 593,384 1.0000 2006m10 2006m12 56,150 64,325 78,875 85,225 85,175 78,525 81,575 74,225 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 1.0000 2007m01 2007m03 69,850 93,068 222,604 225,154 224,254 224,954 226,254 221,304 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 1.0000 2007m04 2007m06 116,063 269,251 298,787 308,187 318,849 315,049 353,649 358,199 357,399 357,399 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 1.0000 2007m07 2007m09 213,500 348,400 442,420 477,081 515,467 531,517 544,067 553,517 631,367 631,367 646,417 664,167 670,267 670,267 670,267 658,867 693,117 693,117 693,117 693,117 693,117 1.0131 2007m10 2007m12 309,850 318,158 347,608 376,558 369,204 443,704 434,404 450,104 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 1.0131 2008m01 2008m03 159,150 172,470 171,670 163,927 193,627 186,277 170,627 170,377 183,377 203,777 203,777 189,478 189,478 189,478 189,478 189,478 189,478 189,478 189,478 1.0131 2008m04 2008m06 155,605 141,816 137,851 231,751 236,501 330,605 249,280 283,780 293,380 284,930 310,830 310,830 311,380 311,380 315,830 315,830 315,830 315,830 1.0131 2008m07 2008m09 383,869 467,263 441,163 547,454 550,004 570,904 668,854 664,562 685,779 718,424 724,874 724,874 724,874 724,874 724,874 724,874 724,874 1.0228 2008m10 2008m12 142,695 236,777 401,986 482,714 573,847 560,897 556,020 495,783 497,283 505,833 512,483 511,433 514,633 514,633 526,483 526,483 1.0204 2009m01 2009m03 134,916 182,706 201,157 322,527 368,227 380,999 384,349 390,749 399,999 365,099 391,849 391,849 391,849 391,849 391,849 1.0237 2009m04 2009m06 266,373 257,137 342,635 358,185 350,811 338,786 341,036 368,836 361,736 361,736 373,636 373,636 379,736 379,736 1.0275 2009m07 2009m09 248,776 327,405 328,205 368,410 477,510 511,956 516,565 509,158 509,858 509,858 509,858 470,971 470,971 1.0309 2009m10 2009m12 182,183 372,091 432,236 519,436 506,486 531,270 595,070 582,970 546,120 559,120 559,120 559,120 1.0230 2010m01 2010m03 94,700 264,601 285,154 241,761 319,981 317,216 333,155 333,455 330,805 330,805 330,805 1.0484 2010m04 2010m06 314,770 386,635 408,235 387,027 399,177 379,477 435,977 446,777 483,366 483,366 1.0547 1.038 2010m07 2010m09 273,505 320,098 420,512 594,334 605,734 592,934 584,648 683,743 683,743 1.0772 2010m10 2010m12 238,056 237,356 221,085 225,785 245,362 271,863 305,863 305,863 1.0997 2011m01 2011m03 105,324 127,504 208,026 270,426 278,836 266,286 266,286 1.1369 2011m04 2011m06 208,079 220,411 235,761 350,566 359,566 359,566 1.1695 1.112 2011m07 2011m09 187,476 193,147 226,322 433,749 433,749 1.2614 2011m10 2011m12 329,310 383,971 407,338 407,338 1.5481 2012m01 2012m03 208,194 221,090 221,090 1.7579 2012m04 2012m06 292,558 292,558 2.1911 1.627\n\n_Accident Period Loss Development Factors Start Month End Month_ 3 ‐ 6 6 ‐ 9 9 ‐ 12 12 ‐ 15 15 ‐ 18 18 ‐ 21 21 ‐ 24 24 ‐ 27 27 ‐ 30 30 ‐ 33 33 ‐ 36 36 ‐ 39 39 ‐ 42 42 ‐ 45 45 ‐ 48 48 ‐ 51 51 ‐ 54 54 ‐ 57 57 ‐ 60 60 ‐ 63 63 ‐ 66 66 ‐ 69 69 ‐ 72 72 ‐ 75 75 ‐ 78 78 ‐ 81 81 ‐\n\n2005m07 2005m09 1.7177 1.0826 0.9021 1.0283 1.0000 1.1379 1.0995 1.0292 0.9918 0.9585 1.0567 1.0217 1.0000 0.9408 1.0000 1.0145 1.7205 0.9646 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2005m10 2005m12 0.9595 1.1021 1.0258 1.0421 1.0352 0.8886 1.4715 1.2815 1.0381 1.0000 1.0141 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m01 2006m03 1.4210 1.0349 1.3927 1.1045 1.4019 1.0475 1.1960 1.3489 1.1168 1.0000 1.0000 1.0083 1.0170 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m04 2006m06 1.2612 1.0708 1.2111 1.0356 1.1659 0.9857 1.0014 1.0299 1.0000 1.0000 1.0000 1.0977 1.0000 1.0000 1.0000 0.9876 0.9931 1.0000 1.0000 1.1100 1.0000 1.0000 1.0000 1.0000 2006m07 2006m09 1.0884 1.1240 0.9799 1.4896 1.7504 1.0255 1.0831 1.0008 1.0288 1.0000 1.0000 1.0000 1.0305 1.0000 1.0000 1.0137 0.9605 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m10 2006m12 1.1456 1.2262 1.0805 0.9994 0.9219 1.0388 0.9099 0.9737 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m01 2007m03 1.3324 2.3918 1.0115 0.9960 1.0031 1.0058 0.9781 0.9903 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m04 2007m06 2.3199 1.1097 1.0315 1.0346 0.9881 1.1225 1.0129 0.9978 1.0000 1.0985 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m07 2007m09 1.6319 1.2699 1.0783 1.0805 1.0311 1.0236 1.0174 1.1406 1.0000 1.0238 1.0275 1.0092 1.0000 1.0000 0.9830 1.0520 1.0000 1.0000 1.0000 2007m10 2007m12 1.0268 1.0926 1.0833 0.9805 1.2018 0.9790 1.0361 0.9751 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2008m01 2008m03 1.0837 0.9954 0.9549 1.1812 0.9620 0.9160 0.9985 1.0763 1.1112 1.0000 0.9298 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2008m04 2008m06 0.9114 0.9720 1.6812 1.0205 1.3979 0.7540 1.1384 1.0338 0.9712 1.0909 1.0000 1.0018 1.0000 1.0143 1.0000 1.0000 2008m07 2008m09 1.2172 0.9441 1.2409 1.0047 1.0380 1.1716 0.9936 1.0319 1.0476 1.0090 1.0000 1.0000 1.0000 1.0000 1.0000 2008m10 2008m12 1.6593 1.6977 1.2008 1.1888 0.9774 0.9913 0.8917 1.0030 1.0172 1.0131 0.9980 1.0063 1.0000 1.0230 2009m01 2009m03 1.3542 1.1010 1.6034 1.1417 1.0347 1.0088 1.0167 1.0237 0.9127 1.0733 1.0000 1.0000 1.0000 2009m04 2009m06 0.9653 1.3325 1.0454 0.9794 0.9657 1.0066 1.0815 0.9808 1.0000 1.0329 1.0000 1.0163 2009m07 2009m09 1.3161 1.0024 1.1225 1.2961 1.0721 1.0090 0.9857 1.0014 1.0000 1.0000 0.9237 2009m10 2009m12 2.0424 1.1616 1.2017 0.9751 1.0489 1.1201 0.9797 0.9368 1.0238 1.0000 2010m01 2010m03 2.7941 1.0777 0.8478 1.3235 0.9914 1.0502 1.0009 0.9921 1.0000 2010m04 2010m06 1.2283 1.0559 0.9480 1.0314 0.9506 1.1489 1.0248 1.0819 2010m07 2010m09 1.1704 1.3137 1.4134 1.0192 0.9789 0.9860 1.1695 2010m10 2010m12 0.9971 0.9314 1.0213 1.0867 1.1080 1.1251 2011m01 2011m03 1.2106 1.6315 1.3000 1.0311 0.9550 2011m04 2011m06 1.0593 1.0696 1.4870 1.0257 2011m07 2011m09 1.0302 1.1718 1.9165 2011m10 2011m12 1.1660 1.0609 2012m01 2012m03 1.0619 2012m04 2012m06\n\n**All Period** 1\\.3397 1.1932 1.1913 1.0873 1.0861 1.0247 1.0517 1.0465 1.0136 1.0167 0.9970 1.0101 1.0032 0.9984 0.9987 1.0056 1.0613 0.9965 1.0000 1.0138 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **All Period Wtd** 1\\.2716 1.1518 1.1778 1.0776 1.0755 1.0307 1.0411 1.0460 1.0175 1.0161 0.9972 1.0081 1.0050 1.0003 0.9978 1.0096 1.0347 0.9965 1.0000 1.0100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Maximum** 2\\.7941 2.3918 1.9165 1.4896 1.7504 1.1716 1.4715 1.3489 1.1168 1.0985 1.0567 1.0977 1.0305 1.0230 1.0000 1.0520 1.7205 1.0000 1.0000 1.1100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Minimum** 0\\.9114 0.9314 0.8478 0.9751 0.9219 0.7540 0.8917 0.9368 0.9127 0.9585 0.9237 1.0000 1.0000 0.9408 0.9830 0.9876 0.9605 0.9646 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Median** 1\\.2106 1.0968 1.0833 1.0330 1.0311 1.0163 1.0167 1.0133 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **M12L14 Wtd** 1\\.2471 1.1238 1.2328 1.0781 1.0276 1.0307 1.0170 1.0145 1.0093 1.0189 0.9966 1.0042 1.0025 1.0009 **Last 12** 1\\.3368 1.1592 1.2590 1.0919 1.0432 1.0240 1.0264 1.0231 1.0070 1.0285 0.9899 1.0028 1.0025 1.0031 0.9986 1.0056 **Last 12 Wtd** 1\\.2464 1.1355 1.2273 1.0786 1.0286 1.0338 1.0209 1.0213 1.0060 1.0248 0.9924 1.0033 1.0038 1.0032 0.9977 1.0096 **M6L8 Wtd** 1\\.1176 1.1212 1.2190 1.0772 1.0075 1.0527 1.0099 1.0083 1.0052 1.0194 0.9941 1.0035 1.0000 1.0020 1.0000 1.0043 0.9991 1.0000 1.0000 1.0000 **Last 6** 1\\.0875 1.1965 1.3477 1.0863 1.0055 1.0732 1.0403 1.0028 0.9923 1.0214 0.9869 1.0041 1.0000 1.0062 0.9972 1.0087 1.0000 1.0000 1.0000 1.0183 1.0000 1.0000 **Last 6 Wtd** 1\\.0839 1.1596 1.3151 1.0670 1.0015 1.0639 1.0422 1.0000 0.9950 1.0171 0.9859 1.0039 1.0000 1.0057 0.9958 1.0155 1.0000 1.0000 1.0000 1.0131 1.0000 1.0000 **M3L5 Wtd** 1\\.1072 1.0901 1.4061 1.0293 0.9767 1.1015 1.0029 0.9925 1.0000 1.0135 0.9994 1.0024 1.0000 1.0047 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Last 3 Wtd** 1\\.1010 1.0901 1.5740 1.0437 1.0010 1.0661 1.0814 0.9979 1.0094 1.0083 0.9695 1.0073 1.0000 1.0105 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nSelected LDF 1.2464 1.1355 1.2273 1.0786 1.0286 1.0338 1.0209 1.0213 1.0060 1.0248 0.9924 1.0033 1.0038 1.0032 0.9977 1.0096 1.0000 1.0000 1.0000 1.0131 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 Cumulative LDF 2.1911 1.7579 1.5481 1.2614 1.1695 1.1369 1.0997 1.0772 1.0547 1.0484 1.0230 1.0309 1.0275 1.0237 1.0204 1.0228 1.0131 1.0131 1.0131 1.0131 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"State of California Department of Insurance Exhibit 7‐ BI Integon Preferred Insurance Company ‐ Commercial Vehicle\n\n**Loss** **and** **Defense** **&** **Cost** **Containment** **Expense** (DCCE Development Factors)\n\n**Bodily** **Injury** _Accident Period Development as of 2012m06_ Latest Cum. _Start Month End Month_ 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72 75 78 81 Diagonal LDFs\n\n2005m07 2005m09 109,344 187,820 203,326 183,426 188,626 188,626 214,646 235,996 242,896 240,896 230,896 243,996 249,296 249,296 234,546 234,546 237,946 409,375 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 1.0000 2005m10 2005m12 152,036 145,882 160,782 164,924 171,874 177,924 158,099 232,649 298,149 309,499 309,499 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 1.0000 2006m01 2006m03 119,381 169,646 175,562 244,512 270,062 378,612 396,612 474,342 639,842 714,591 714,591 714,591 720,541 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 1.0000 2006m04 2006m06 125,941 158,841 170,091 205,991 213,322 248,722 245,172 245,522 252,854 252,854 252,854 252,854 277,554 277,554 277,554 277,554 274,104 272,204 272,204 272,204 302,154 302,154 302,154 302,154 302,154 302,154 1.0000 2006m07 2006m09 165,450 180,077 202,409 198,334 295,434 517,134 530,334 574,384 574,834 591,384 591,384 591,384 591,384 609,434 609,434 609,434 617,784 593,384 593,384 593,384 593,384 593,384 593,384 593,384 593,384 1.0000 2006m10 2006m12 56,150 64,325 78,875 85,225 85,175 78,525 81,575 74,225 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 1.0000 2007m01 2007m03 69,850 93,068 222,604 225,154 224,254 224,954 226,254 221,304 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 1.0000 2007m04 2007m06 116,063 269,251 298,787 308,187 318,849 315,049 353,649 358,199 357,399 357,399 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 1.0000 2007m07 2007m09 213,500 348,400 442,420 477,081 515,467 531,517 544,067 553,517 631,367 631,367 646,417 664,167 670,267 670,267 670,267 658,867 693,117 693,117 693,117 693,117 693,117 1.0131 2007m10 2007m12 309,850 318,158 347,608 376,558 369,204 443,704 434,404 450,104 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 1.0131 2008m01 2008m03 159,150 172,470 171,670 163,927 193,627 186,277 170,627 170,377 183,377 203,777 203,777 189,478 189,478 189,478 189,478 189,478 189,478 189,478 189,478 1.0131 2008m04 2008m06 155,605 141,816 137,851 231,751 236,501 330,605 249,280 283,780 293,380 284,930 310,830 310,830 311,380 311,380 315,830 315,830 315,830 315,830 1.0131 2008m07 2008m09 383,869 467,263 441,163 547,454 550,004 570,904 668,854 664,562 685,779 718,424 724,874 724,874 724,874 724,874 724,874 724,874 724,874 1.0228 2008m10 2008m12 142,695 236,777 401,986 482,714 573,847 560,897 556,020 495,783 497,283 505,833 512,483 511,433 514,633 514,633 526,483 526,483 1.0204 2009m01 2009m03 134,916 182,706 201,157 322,527 368,227 380,999 384,349 390,749 399,999 365,099 391,849 391,849 391,849 391,849 391,849 1.0237 2009m04 2009m06 266,373 257,137 342,635 358,185 350,811 338,786 341,036 368,836 361,736 361,736 373,636 373,636 379,736 379,736 1.0275 2009m07 2009m09 248,776 327,405 328,205 368,410 477,510 511,956 516,565 509,158 509,858 509,858 509,858 470,971 470,971 1.0309 2009m10 2009m12 182,183 372,091 432,236 519,436 506,486 531,270 595,070 582,970 546,120 559,120 559,120 559,120 1.0230 2010m01 2010m03 94,700 264,601 285,154 241,761 319,981 317,216 333,155 333,455 330,805 330,805 330,805 1.0484 2010m04 2010m06 314,770 386,635 408,235 387,027 399,177 379,477 435,977 446,777 483,366 483,366 1.0547 1.038 2010m07 2010m09 273,505 320,098 420,512 594,334 605,734 592,934 584,648 683,743 683,743 1.0772 2010m10 2010m12 238,056 237,356 221,085 225,785 245,362 271,863 305,863 305,863 1.0997 2011m01 2011m03 105,324 127,504 208,026 270,426 278,836 266,286 266,286 1.1369 2011m04 2011m06 208,079 220,411 235,761 350,566 359,566 359,566 1.1695 1.112 2011m07 2011m09 187,476 193,147 226,322 433,749 433,749 1.2614 2011m10 2011m12 329,310 383,971 407,338 407,338 1.5481 2012m01 2012m03 208,194 221,090 221,090 1.7579 2012m04 2012m06 292,558 292,558 2.1911 1.627\n\n_Accident Period Loss Development Factors Start Month End Month_ 3 ‐ 6 6 ‐ 9 9 ‐ 12 12 ‐ 15 15 ‐ 18 18 ‐ 21 21 ‐ 24 24 ‐ 27 27 ‐ 30 30 ‐ 33 33 ‐ 36 36 ‐ 39 39 ‐ 42 42 ‐ 45 45 ‐ 48 48 ‐ 51 51 ‐ 54 54 ‐ 57 57 ‐ 60 60 ‐ 63 63 ‐ 66 66 ‐ 69 69 ‐ 72 72 ‐ 75 75 ‐ 78 78 ‐ 81 81 ‐\n\n2005m07 2005m09 1.7177 1.0826 0.9021 1.0283 1.0000 1.1379 1.0995 1.0292 0.9918 0.9585 1.0567 1.0217 1.0000 0.9408 1.0000 1.0145 1.7205 0.9646 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2005m10 2005m12 0.9595 1.1021 1.0258 1.0421 1.0352 0.8886 1.4715 1.2815 1.0381 1.0000 1.0141 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m01 2006m03 1.4210 1.0349 1.3927 1.1045 1.4019 1.0475 1.1960 1.3489 1.1168 1.0000 1.0000 1.0083 1.0170 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m04 2006m06 1.2612 1.0708 1.2111 1.0356 1.1659 0.9857 1.0014 1.0299 1.0000 1.0000 1.0000 1.0977 1.0000 1.0000 1.0000 0.9876 0.9931 1.0000 1.0000 1.1100 1.0000 1.0000 1.0000 1.0000 2006m07 2006m09 1.0884 1.1240 0.9799 1.4896 1.7504 1.0255 1.0831 1.0008 1.0288 1.0000 1.0000 1.0000 1.0305 1.0000 1.0000 1.0137 0.9605 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m10 2006m12 1.1456 1.2262 1.0805 0.9994 0.9219 1.0388 0.9099 0.9737 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m01 2007m03 1.3324 2.3918 1.0115 0.9960 1.0031 1.0058 0.9781 0.9903 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m04 2007m06 2.3199 1.1097 1.0315 1.0346 0.9881 1.1225 1.0129 0.9978 1.0000 1.0985 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m07 2007m09 1.6319 1.2699 1.0783 1.0805 1.0311 1.0236 1.0174 1.1406 1.0000 1.0238 1.0275 1.0092 1.0000 1.0000 0.9830 1.0520 1.0000 1.0000 1.0000 2007m10 2007m12 1.0268 1.0926 1.0833 0.9805 1.2018 0.9790 1.0361 0.9751 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2008m01 2008m03 1.0837 0.9954 0.9549 1.1812 0.9620 0.9160 0.9985 1.0763 1.1112 1.0000 0.9298 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2008m04 2008m06 0.9114 0.9720 1.6812 1.0205 1.3979 0.7540 1.1384 1.0338 0.9712 1.0909 1.0000 1.0018 1.0000 1.0143 1.0000 1.0000 2008m07 2008m09 1.2172 0.9441 1.2409 1.0047 1.0380 1.1716 0.9936 1.0319 1.0476 1.0090 1.0000 1.0000 1.0000 1.0000 1.0000 2008m10 2008m12 1.6593 1.6977 1.2008 1.1888 0.9774 0.9913 0.8917 1.0030 1.0172 1.0131 0.9980 1.0063 1.0000 1.0230 2009m01 2009m03 1.3542 1.1010 1.6034 1.1417 1.0347 1.0088 1.0167 1.0237 0.9127 1.0733 1.0000 1.0000 1.0000 2009m04 2009m06 0.9653 1.3325 1.0454 0.9794 0.9657 1.0066 1.0815 0.9808 1.0000 1.0329 1.0000 1.0163 2009m07 2009m09 1.3161 1.0024 1.1225 1.2961 1.0721 1.0090 0.9857 1.0014 1.0000 1.0000 0.9237 2009m10 2009m12 2.0424 1.1616 1.2017 0.9751 1.0489 1.1201 0.9797 0.9368 1.0238 1.0000 2010m01 2010m03 2.7941 1.0777 0.8478 1.3235 0.9914 1.0502 1.0009 0.9921 1.0000 2010m04 2010m06 1.2283 1.0559 0.9480 1.0314 0.9506 1.1489 1.0248 1.0819 2010m07 2010m09 1.1704 1.3137 1.4134 1.0192 0.9789 0.9860 1.1695 2010m10 2010m12 0.9971 0.9314 1.0213 1.0867 1.1080 1.1251 2011m01 2011m03 1.2106 1.6315 1.3000 1.0311 0.9550 2011m04 2011m06 1.0593 1.0696 1.4870 1.0257 2011m07 2011m09 1.0302 1.1718 1.9165 2011m10 2011m12 1.1660 1.0609 2012m01 2012m03 1.0619 2012m04 2012m06\n\n**All Period** 1\\.3397 1.1932 1.1913 1.0873 1.0861 1.0247 1.0517 1.0465 1.0136 1.0167 0.9970 1.0101 1.0032 0.9984 0.9987 1.0056 1.0613 0.9965 1.0000 1.0138 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **All Period Wtd** 1\\.2716 1.1518 1.1778 1.0776 1.0755 1.0307 1.0411 1.0460 1.0175 1.0161 0.9972 1.0081 1.0050 1.0003 0.9978 1.0096 1.0347 0.9965 1.0000 1.0100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Maximum** 2\\.7941 2.3918 1.9165 1.4896 1.7504 1.1716 1.4715 1.3489 1.1168 1.0985 1.0567 1.0977 1.0305 1.0230 1.0000 1.0520 1.7205 1.0000 1.0000 1.1100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Minimum** 0\\.9114 0.9314 0.8478 0.9751 0.9219 0.7540 0.8917 0.9368 0.9127 0.9585 0.9237 1.0000 1.0000 0.9408 0.9830 0.9876 0.9605 0.9646 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Median** 1\\.2106 1.0968 1.0833 1.0330 1.0311 1.0163 1.0167 1.0133 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **M12L14 Wtd** 1\\.2471 1.1238 1.2328 1.0781 1.0276 1.0307 1.0170 1.0145 1.0093 1.0189 0.9966 1.0042 1.0025 1.0009 **Last 12** 1\\.3368 1.1592 1.2590 1.0919 1.0432 1.0240 1.0264 1.0231 1.0070 1.0285 0.9899 1.0028 1.0025 1.0031 0.9986 1.0056 **Last 12 Wtd** 1\\.2464 1.1355 1.2273 1.0786 1.0286 1.0338 1.0209 1.0213 1.0060 1.0248 0.9924 1.0033 1.0038 1.0032 0.9977 1.0096 **M6L8 Wtd** 1\\.1176 1.1212 1.2190 1.0772 1.0075 1.0527 1.0099 1.0083 1.0052 1.0194 0.9941 1.0035 1.0000 1.0020 1.0000 1.0043 0.9991 1.0000 1.0000 1.0000 **Last 6** 1\\.0875 1.1965 1.3477 1.0863 1.0055 1.0732 1.0403 1.0028 0.9923 1.0214 0.9869 1.0041 1.0000 1.0062 0.9972 1.0087 1.0000 1.0000 1.0000 1.0183 1.0000 1.0000 **Last 6 Wtd** 1\\.0839 1.1596 1.3151 1.0670 1.0015 1.0639 1.0422 1.0000 0.9950 1.0171 0.9859 1.0039 1.0000 1.0057 0.9958 1.0155 1.0000 1.0000 1.0000 1.0131 1.0000 1.0000 **M3L5 Wtd** 1\\.1072 1.0901 1.4061 1.0293 0.9767 1.1015 1.0029 0.9925 1.0000 1.0135 0.9994 1.0024 1.0000 1.0047 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Last 3 Wtd** 1\\.1010 1.0901 1.5740 1.0437 1.0010 1.0661 1.0814 0.9979 1.0094 1.0083 0.9695 1.0073 1.0000 1.0105 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nSelected LDF 1.2464 1.1355 1.2273 1.0786 1.0286 1.0338 1.0209 1.0213 1.0060 1.0248 0.9924 1.0033 1.0038 1.0032 0.9977 1.0096 1.0000 1.0000 1.0000 1.0131 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 Cumulative LDF 2.1911 1.7579 1.5481 1.2614 1.1695 1.1369 1.0997 1.0772 1.0547 1.0484 1.0230 1.0309 1.0275 1.0237 1.0204 1.0228 1.0131 1.0131 1.0131 1.0131 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1423.pdf"]},"response":{"errors":[],"extract_id":"extract_e4afa8099c950a36a645bbb8e1c76809","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["State of California Department of Insurance Exhibit 7‐ BI Integon Preferred Insurance Company ‐ Commercial Vehicle\n\n**Loss** **and** **Defense** **&** **Cost** **Containment** **Expense** (DCCE Development Factors)\n\n**Bodily** **Injury** _Accident Period Development as of 2012m06_ Latest Cum. _Start Month End Month_ 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72 75 78 81 Diagonal LDFs\n\n2005m07 2005m09 109,344 187,820 203,326 183,426 188,626 188,626 214,646 235,996 242,896 240,896 230,896 243,996 249,296 249,296 234,546 234,546 237,946 409,375 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 1.0000 2005m10 2005m12 152,036 145,882 160,782 164,924 171,874 177,924 158,099 232,649 298,149 309,499 309,499 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 1.0000 2006m01 2006m03 119,381 169,646 175,562 244,512 270,062 378,612 396,612 474,342 639,842 714,591 714,591 714,591 720,541 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 1.0000 2006m04 2006m06 125,941 158,841 170,091 205,991 213,322 248,722 245,172 245,522 252,854 252,854 252,854 252,854 277,554 277,554 277,554 277,554 274,104 272,204 272,204 272,204 302,154 302,154 302,154 302,154 302,154 302,154 1.0000 2006m07 2006m09 165,450 180,077 202,409 198,334 295,434 517,134 530,334 574,384 574,834 591,384 591,384 591,384 591,384 609,434 609,434 609,434 617,784 593,384 593,384 593,384 593,384 593,384 593,384 593,384 593,384 1.0000 2006m10 2006m12 56,150 64,325 78,875 85,225 85,175 78,525 81,575 74,225 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 1.0000 2007m01 2007m03 69,850 93,068 222,604 225,154 224,254 224,954 226,254 221,304 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 1.0000 2007m04 2007m06 116,063 269,251 298,787 308,187 318,849 315,049 353,649 358,199 357,399 357,399 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 1.0000 2007m07 2007m09 213,500 348,400 442,420 477,081 515,467 531,517 544,067 553,517 631,367 631,367 646,417 664,167 670,267 670,267 670,267 658,867 693,117 693,117 693,117 693,117 693,117 1.0131 2007m10 2007m12 309,850 318,158 347,608 376,558 369,204 443,704 434,404 450,104 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 1.0131 2008m01 2008m03 159,150 172,470 171,670 163,927 193,627 186,277 170,627 170,377 183,377 203,777 203,777 189,478 189,478 189,478 189,478 189,478 189,478 189,478 189,478 1.0131 2008m04 2008m06 155,605 141,816 137,851 231,751 236,501 330,605 249,280 283,780 293,380 284,930 310,830 310,830 311,380 311,380 315,830 315,830 315,830 315,830 1.0131 2008m07 2008m09 383,869 467,263 441,163 547,454 550,004 570,904 668,854 664,562 685,779 718,424 724,874 724,874 724,874 724,874 724,874 724,874 724,874 1.0228 2008m10 2008m12 142,695 236,777 401,986 482,714 573,847 560,897 556,020 495,783 497,283 505,833 512,483 511,433 514,633 514,633 526,483 526,483 1.0204 2009m01 2009m03 134,916 182,706 201,157 322,527 368,227 380,999 384,349 390,749 399,999 365,099 391,849 391,849 391,849 391,849 391,849 1.0237 2009m04 2009m06 266,373 257,137 342,635 358,185 350,811 338,786 341,036 368,836 361,736 361,736 373,636 373,636 379,736 379,736 1.0275 2009m07 2009m09 248,776 327,405 328,205 368,410 477,510 511,956 516,565 509,158 509,858 509,858 509,858 470,971 470,971 1.0309 2009m10 2009m12 182,183 372,091 432,236 519,436 506,486 531,270 595,070 582,970 546,120 559,120 559,120 559,120 1.0230 2010m01 2010m03 94,700 264,601 285,154 241,761 319,981 317,216 333,155 333,455 330,805 330,805 330,805 1.0484 2010m04 2010m06 314,770 386,635 408,235 387,027 399,177 379,477 435,977 446,777 483,366 483,366 1.0547 1.038 2010m07 2010m09 273,505 320,098 420,512 594,334 605,734 592,934 584,648 683,743 683,743 1.0772 2010m10 2010m12 238,056 237,356 221,085 225,785 245,362 271,863 305,863 305,863 1.0997 2011m01 2011m03 105,324 127,504 208,026 270,426 278,836 266,286 266,286 1.1369 2011m04 2011m06 208,079 220,411 235,761 350,566 359,566 359,566 1.1695 1.112 2011m07 2011m09 187,476 193,147 226,322 433,749 433,749 1.2614 2011m10 2011m12 329,310 383,971 407,338 407,338 1.5481 2012m01 2012m03 208,194 221,090 221,090 1.7579 2012m04 2012m06 292,558 292,558 2.1911 1.627\n\n_Accident Period Loss Development Factors Start Month End Month_ 3 ‐ 6 6 ‐ 9 9 ‐ 12 12 ‐ 15 15 ‐ 18 18 ‐ 21 21 ‐ 24 24 ‐ 27 27 ‐ 30 30 ‐ 33 33 ‐ 36 36 ‐ 39 39 ‐ 42 42 ‐ 45 45 ‐ 48 48 ‐ 51 51 ‐ 54 54 ‐ 57 57 ‐ 60 60 ‐ 63 63 ‐ 66 66 ‐ 69 69 ‐ 72 72 ‐ 75 75 ‐ 78 78 ‐ 81 81 ‐\n\n2005m07 2005m09 1.7177 1.0826 0.9021 1.0283 1.0000 1.1379 1.0995 1.0292 0.9918 0.9585 1.0567 1.0217 1.0000 0.9408 1.0000 1.0145 1.7205 0.9646 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2005m10 2005m12 0.9595 1.1021 1.0258 1.0421 1.0352 0.8886 1.4715 1.2815 1.0381 1.0000 1.0141 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m01 2006m03 1.4210 1.0349 1.3927 1.1045 1.4019 1.0475 1.1960 1.3489 1.1168 1.0000 1.0000 1.0083 1.0170 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m04 2006m06 1.2612 1.0708 1.2111 1.0356 1.1659 0.9857 1.0014 1.0299 1.0000 1.0000 1.0000 1.0977 1.0000 1.0000 1.0000 0.9876 0.9931 1.0000 1.0000 1.1100 1.0000 1.0000 1.0000 1.0000 2006m07 2006m09 1.0884 1.1240 0.9799 1.4896 1.7504 1.0255 1.0831 1.0008 1.0288 1.0000 1.0000 1.0000 1.0305 1.0000 1.0000 1.0137 0.9605 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m10 2006m12 1.1456 1.2262 1.0805 0.9994 0.9219 1.0388 0.9099 0.9737 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m01 2007m03 1.3324 2.3918 1.0115 0.9960 1.0031 1.0058 0.9781 0.9903 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m04 2007m06 2.3199 1.1097 1.0315 1.0346 0.9881 1.1225 1.0129 0.9978 1.0000 1.0985 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m07 2007m09 1.6319 1.2699 1.0783 1.0805 1.0311 1.0236 1.0174 1.1406 1.0000 1.0238 1.0275 1.0092 1.0000 1.0000 0.9830 1.0520 1.0000 1.0000 1.0000 2007m10 2007m12 1.0268 1.0926 1.0833 0.9805 1.2018 0.9790 1.0361 0.9751 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2008m01 2008m03 1.0837 0.9954 0.9549 1.1812 0.9620 0.9160 0.9985 1.0763 1.1112 1.0000 0.9298 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2008m04 2008m06 0.9114 0.9720 1.6812 1.0205 1.3979 0.7540 1.1384 1.0338 0.9712 1.0909 1.0000 1.0018 1.0000 1.0143 1.0000 1.0000 2008m07 2008m09 1.2172 0.9441 1.2409 1.0047 1.0380 1.1716 0.9936 1.0319 1.0476 1.0090 1.0000 1.0000 1.0000 1.0000 1.0000 2008m10 2008m12 1.6593 1.6977 1.2008 1.1888 0.9774 0.9913 0.8917 1.0030 1.0172 1.0131 0.9980 1.0063 1.0000 1.0230 2009m01 2009m03 1.3542 1.1010 1.6034 1.1417 1.0347 1.0088 1.0167 1.0237 0.9127 1.0733 1.0000 1.0000 1.0000 2009m04 2009m06 0.9653 1.3325 1.0454 0.9794 0.9657 1.0066 1.0815 0.9808 1.0000 1.0329 1.0000 1.0163 2009m07 2009m09 1.3161 1.0024 1.1225 1.2961 1.0721 1.0090 0.9857 1.0014 1.0000 1.0000 0.9237 2009m10 2009m12 2.0424 1.1616 1.2017 0.9751 1.0489 1.1201 0.9797 0.9368 1.0238 1.0000 2010m01 2010m03 2.7941 1.0777 0.8478 1.3235 0.9914 1.0502 1.0009 0.9921 1.0000 2010m04 2010m06 1.2283 1.0559 0.9480 1.0314 0.9506 1.1489 1.0248 1.0819 2010m07 2010m09 1.1704 1.3137 1.4134 1.0192 0.9789 0.9860 1.1695 2010m10 2010m12 0.9971 0.9314 1.0213 1.0867 1.1080 1.1251 2011m01 2011m03 1.2106 1.6315 1.3000 1.0311 0.9550 2011m04 2011m06 1.0593 1.0696 1.4870 1.0257 2011m07 2011m09 1.0302 1.1718 1.9165 2011m10 2011m12 1.1660 1.0609 2012m01 2012m03 1.0619 2012m04 2012m06\n\n**All Period** 1\\.3397 1.1932 1.1913 1.0873 1.0861 1.0247 1.0517 1.0465 1.0136 1.0167 0.9970 1.0101 1.0032 0.9984 0.9987 1.0056 1.0613 0.9965 1.0000 1.0138 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **All Period Wtd** 1\\.2716 1.1518 1.1778 1.0776 1.0755 1.0307 1.0411 1.0460 1.0175 1.0161 0.9972 1.0081 1.0050 1.0003 0.9978 1.0096 1.0347 0.9965 1.0000 1.0100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Maximum** 2\\.7941 2.3918 1.9165 1.4896 1.7504 1.1716 1.4715 1.3489 1.1168 1.0985 1.0567 1.0977 1.0305 1.0230 1.0000 1.0520 1.7205 1.0000 1.0000 1.1100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Minimum** 0\\.9114 0.9314 0.8478 0.9751 0.9219 0.7540 0.8917 0.9368 0.9127 0.9585 0.9237 1.0000 1.0000 0.9408 0.9830 0.9876 0.9605 0.9646 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Median** 1\\.2106 1.0968 1.0833 1.0330 1.0311 1.0163 1.0167 1.0133 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **M12L14 Wtd** 1\\.2471 1.1238 1.2328 1.0781 1.0276 1.0307 1.0170 1.0145 1.0093 1.0189 0.9966 1.0042 1.0025 1.0009 **Last 12** 1\\.3368 1.1592 1.2590 1.0919 1.0432 1.0240 1.0264 1.0231 1.0070 1.0285 0.9899 1.0028 1.0025 1.0031 0.9986 1.0056 **Last 12 Wtd** 1\\.2464 1.1355 1.2273 1.0786 1.0286 1.0338 1.0209 1.0213 1.0060 1.0248 0.9924 1.0033 1.0038 1.0032 0.9977 1.0096 **M6L8 Wtd** 1\\.1176 1.1212 1.2190 1.0772 1.0075 1.0527 1.0099 1.0083 1.0052 1.0194 0.9941 1.0035 1.0000 1.0020 1.0000 1.0043 0.9991 1.0000 1.0000 1.0000 **Last 6** 1\\.0875 1.1965 1.3477 1.0863 1.0055 1.0732 1.0403 1.0028 0.9923 1.0214 0.9869 1.0041 1.0000 1.0062 0.9972 1.0087 1.0000 1.0000 1.0000 1.0183 1.0000 1.0000 **Last 6 Wtd** 1\\.0839 1.1596 1.3151 1.0670 1.0015 1.0639 1.0422 1.0000 0.9950 1.0171 0.9859 1.0039 1.0000 1.0057 0.9958 1.0155 1.0000 1.0000 1.0000 1.0131 1.0000 1.0000 **M3L5 Wtd** 1\\.1072 1.0901 1.4061 1.0293 0.9767 1.1015 1.0029 0.9925 1.0000 1.0135 0.9994 1.0024 1.0000 1.0047 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Last 3 Wtd** 1\\.1010 1.0901 1.5740 1.0437 1.0010 1.0661 1.0814 0.9979 1.0094 1.0083 0.9695 1.0073 1.0000 1.0105 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nSelected LDF 1.2464 1.1355 1.2273 1.0786 1.0286 1.0338 1.0209 1.0213 1.0060 1.0248 0.9924 1.0033 1.0038 1.0032 0.9977 1.0096 1.0000 1.0000 1.0000 1.0131 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 Cumulative LDF 2.1911 1.7579 1.5481 1.2614 1.1695 1.1369 1.0997 1.0772 1.0547 1.0484 1.0230 1.0309 1.0275 1.0237 1.0204 1.0228 1.0131 1.0131 1.0131 1.0131 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000"],"full_content":"State of California Department of Insurance Exhibit 7‐ BI Integon Preferred Insurance Company ‐ Commercial Vehicle\n\n**Loss** **and** **Defense** **&** **Cost** **Containment** **Expense** (DCCE Development Factors)\n\n**Bodily** **Injury** _Accident Period Development as of 2012m06_ Latest Cum. _Start Month End Month_ 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72 75 78 81 Diagonal LDFs\n\n2005m07 2005m09 109,344 187,820 203,326 183,426 188,626 188,626 214,646 235,996 242,896 240,896 230,896 243,996 249,296 249,296 234,546 234,546 237,946 409,375 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 394,875 1.0000 2005m10 2005m12 152,036 145,882 160,782 164,924 171,874 177,924 158,099 232,649 298,149 309,499 309,499 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 313,849 1.0000 2006m01 2006m03 119,381 169,646 175,562 244,512 270,062 378,612 396,612 474,342 639,842 714,591 714,591 714,591 720,541 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 732,791 1.0000 2006m04 2006m06 125,941 158,841 170,091 205,991 213,322 248,722 245,172 245,522 252,854 252,854 252,854 252,854 277,554 277,554 277,554 277,554 274,104 272,204 272,204 272,204 302,154 302,154 302,154 302,154 302,154 302,154 1.0000 2006m07 2006m09 165,450 180,077 202,409 198,334 295,434 517,134 530,334 574,384 574,834 591,384 591,384 591,384 591,384 609,434 609,434 609,434 617,784 593,384 593,384 593,384 593,384 593,384 593,384 593,384 593,384 1.0000 2006m10 2006m12 56,150 64,325 78,875 85,225 85,175 78,525 81,575 74,225 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 72,275 1.0000 2007m01 2007m03 69,850 93,068 222,604 225,154 224,254 224,954 226,254 221,304 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 219,154 1.0000 2007m04 2007m06 116,063 269,251 298,787 308,187 318,849 315,049 353,649 358,199 357,399 357,399 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 392,599 1.0000 2007m07 2007m09 213,500 348,400 442,420 477,081 515,467 531,517 544,067 553,517 631,367 631,367 646,417 664,167 670,267 670,267 670,267 658,867 693,117 693,117 693,117 693,117 693,117 1.0131 2007m10 2007m12 309,850 318,158 347,608 376,558 369,204 443,704 434,404 450,104 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 438,904 1.0131 2008m01 2008m03 159,150 172,470 171,670 163,927 193,627 186,277 170,627 170,377 183,377 203,777 203,777 189,478 189,478 189,478 189,478 189,478 189,478 189,478 189,478 1.0131 2008m04 2008m06 155,605 141,816 137,851 231,751 236,501 330,605 249,280 283,780 293,380 284,930 310,830 310,830 311,380 311,380 315,830 315,830 315,830 315,830 1.0131 2008m07 2008m09 383,869 467,263 441,163 547,454 550,004 570,904 668,854 664,562 685,779 718,424 724,874 724,874 724,874 724,874 724,874 724,874 724,874 1.0228 2008m10 2008m12 142,695 236,777 401,986 482,714 573,847 560,897 556,020 495,783 497,283 505,833 512,483 511,433 514,633 514,633 526,483 526,483 1.0204 2009m01 2009m03 134,916 182,706 201,157 322,527 368,227 380,999 384,349 390,749 399,999 365,099 391,849 391,849 391,849 391,849 391,849 1.0237 2009m04 2009m06 266,373 257,137 342,635 358,185 350,811 338,786 341,036 368,836 361,736 361,736 373,636 373,636 379,736 379,736 1.0275 2009m07 2009m09 248,776 327,405 328,205 368,410 477,510 511,956 516,565 509,158 509,858 509,858 509,858 470,971 470,971 1.0309 2009m10 2009m12 182,183 372,091 432,236 519,436 506,486 531,270 595,070 582,970 546,120 559,120 559,120 559,120 1.0230 2010m01 2010m03 94,700 264,601 285,154 241,761 319,981 317,216 333,155 333,455 330,805 330,805 330,805 1.0484 2010m04 2010m06 314,770 386,635 408,235 387,027 399,177 379,477 435,977 446,777 483,366 483,366 1.0547 1.038 2010m07 2010m09 273,505 320,098 420,512 594,334 605,734 592,934 584,648 683,743 683,743 1.0772 2010m10 2010m12 238,056 237,356 221,085 225,785 245,362 271,863 305,863 305,863 1.0997 2011m01 2011m03 105,324 127,504 208,026 270,426 278,836 266,286 266,286 1.1369 2011m04 2011m06 208,079 220,411 235,761 350,566 359,566 359,566 1.1695 1.112 2011m07 2011m09 187,476 193,147 226,322 433,749 433,749 1.2614 2011m10 2011m12 329,310 383,971 407,338 407,338 1.5481 2012m01 2012m03 208,194 221,090 221,090 1.7579 2012m04 2012m06 292,558 292,558 2.1911 1.627\n\n_Accident Period Loss Development Factors Start Month End Month_ 3 ‐ 6 6 ‐ 9 9 ‐ 12 12 ‐ 15 15 ‐ 18 18 ‐ 21 21 ‐ 24 24 ‐ 27 27 ‐ 30 30 ‐ 33 33 ‐ 36 36 ‐ 39 39 ‐ 42 42 ‐ 45 45 ‐ 48 48 ‐ 51 51 ‐ 54 54 ‐ 57 57 ‐ 60 60 ‐ 63 63 ‐ 66 66 ‐ 69 69 ‐ 72 72 ‐ 75 75 ‐ 78 78 ‐ 81 81 ‐\n\n2005m07 2005m09 1.7177 1.0826 0.9021 1.0283 1.0000 1.1379 1.0995 1.0292 0.9918 0.9585 1.0567 1.0217 1.0000 0.9408 1.0000 1.0145 1.7205 0.9646 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2005m10 2005m12 0.9595 1.1021 1.0258 1.0421 1.0352 0.8886 1.4715 1.2815 1.0381 1.0000 1.0141 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m01 2006m03 1.4210 1.0349 1.3927 1.1045 1.4019 1.0475 1.1960 1.3489 1.1168 1.0000 1.0000 1.0083 1.0170 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m04 2006m06 1.2612 1.0708 1.2111 1.0356 1.1659 0.9857 1.0014 1.0299 1.0000 1.0000 1.0000 1.0977 1.0000 1.0000 1.0000 0.9876 0.9931 1.0000 1.0000 1.1100 1.0000 1.0000 1.0000 1.0000 2006m07 2006m09 1.0884 1.1240 0.9799 1.4896 1.7504 1.0255 1.0831 1.0008 1.0288 1.0000 1.0000 1.0000 1.0305 1.0000 1.0000 1.0137 0.9605 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2006m10 2006m12 1.1456 1.2262 1.0805 0.9994 0.9219 1.0388 0.9099 0.9737 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m01 2007m03 1.3324 2.3918 1.0115 0.9960 1.0031 1.0058 0.9781 0.9903 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m04 2007m06 2.3199 1.1097 1.0315 1.0346 0.9881 1.1225 1.0129 0.9978 1.0000 1.0985 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2007m07 2007m09 1.6319 1.2699 1.0783 1.0805 1.0311 1.0236 1.0174 1.1406 1.0000 1.0238 1.0275 1.0092 1.0000 1.0000 0.9830 1.0520 1.0000 1.0000 1.0000 2007m10 2007m12 1.0268 1.0926 1.0833 0.9805 1.2018 0.9790 1.0361 0.9751 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2008m01 2008m03 1.0837 0.9954 0.9549 1.1812 0.9620 0.9160 0.9985 1.0763 1.1112 1.0000 0.9298 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 2008m04 2008m06 0.9114 0.9720 1.6812 1.0205 1.3979 0.7540 1.1384 1.0338 0.9712 1.0909 1.0000 1.0018 1.0000 1.0143 1.0000 1.0000 2008m07 2008m09 1.2172 0.9441 1.2409 1.0047 1.0380 1.1716 0.9936 1.0319 1.0476 1.0090 1.0000 1.0000 1.0000 1.0000 1.0000 2008m10 2008m12 1.6593 1.6977 1.2008 1.1888 0.9774 0.9913 0.8917 1.0030 1.0172 1.0131 0.9980 1.0063 1.0000 1.0230 2009m01 2009m03 1.3542 1.1010 1.6034 1.1417 1.0347 1.0088 1.0167 1.0237 0.9127 1.0733 1.0000 1.0000 1.0000 2009m04 2009m06 0.9653 1.3325 1.0454 0.9794 0.9657 1.0066 1.0815 0.9808 1.0000 1.0329 1.0000 1.0163 2009m07 2009m09 1.3161 1.0024 1.1225 1.2961 1.0721 1.0090 0.9857 1.0014 1.0000 1.0000 0.9237 2009m10 2009m12 2.0424 1.1616 1.2017 0.9751 1.0489 1.1201 0.9797 0.9368 1.0238 1.0000 2010m01 2010m03 2.7941 1.0777 0.8478 1.3235 0.9914 1.0502 1.0009 0.9921 1.0000 2010m04 2010m06 1.2283 1.0559 0.9480 1.0314 0.9506 1.1489 1.0248 1.0819 2010m07 2010m09 1.1704 1.3137 1.4134 1.0192 0.9789 0.9860 1.1695 2010m10 2010m12 0.9971 0.9314 1.0213 1.0867 1.1080 1.1251 2011m01 2011m03 1.2106 1.6315 1.3000 1.0311 0.9550 2011m04 2011m06 1.0593 1.0696 1.4870 1.0257 2011m07 2011m09 1.0302 1.1718 1.9165 2011m10 2011m12 1.1660 1.0609 2012m01 2012m03 1.0619 2012m04 2012m06\n\n**All Period** 1\\.3397 1.1932 1.1913 1.0873 1.0861 1.0247 1.0517 1.0465 1.0136 1.0167 0.9970 1.0101 1.0032 0.9984 0.9987 1.0056 1.0613 0.9965 1.0000 1.0138 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **All Period Wtd** 1\\.2716 1.1518 1.1778 1.0776 1.0755 1.0307 1.0411 1.0460 1.0175 1.0161 0.9972 1.0081 1.0050 1.0003 0.9978 1.0096 1.0347 0.9965 1.0000 1.0100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Maximum** 2\\.7941 2.3918 1.9165 1.4896 1.7504 1.1716 1.4715 1.3489 1.1168 1.0985 1.0567 1.0977 1.0305 1.0230 1.0000 1.0520 1.7205 1.0000 1.0000 1.1100 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Minimum** 0\\.9114 0.9314 0.8478 0.9751 0.9219 0.7540 0.8917 0.9368 0.9127 0.9585 0.9237 1.0000 1.0000 0.9408 0.9830 0.9876 0.9605 0.9646 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Median** 1\\.2106 1.0968 1.0833 1.0330 1.0311 1.0163 1.0167 1.0133 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **M12L14 Wtd** 1\\.2471 1.1238 1.2328 1.0781 1.0276 1.0307 1.0170 1.0145 1.0093 1.0189 0.9966 1.0042 1.0025 1.0009 **Last 12** 1\\.3368 1.1592 1.2590 1.0919 1.0432 1.0240 1.0264 1.0231 1.0070 1.0285 0.9899 1.0028 1.0025 1.0031 0.9986 1.0056 **Last 12 Wtd** 1\\.2464 1.1355 1.2273 1.0786 1.0286 1.0338 1.0209 1.0213 1.0060 1.0248 0.9924 1.0033 1.0038 1.0032 0.9977 1.0096 **M6L8 Wtd** 1\\.1176 1.1212 1.2190 1.0772 1.0075 1.0527 1.0099 1.0083 1.0052 1.0194 0.9941 1.0035 1.0000 1.0020 1.0000 1.0043 0.9991 1.0000 1.0000 1.0000 **Last 6** 1\\.0875 1.1965 1.3477 1.0863 1.0055 1.0732 1.0403 1.0028 0.9923 1.0214 0.9869 1.0041 1.0000 1.0062 0.9972 1.0087 1.0000 1.0000 1.0000 1.0183 1.0000 1.0000 **Last 6 Wtd** 1\\.0839 1.1596 1.3151 1.0670 1.0015 1.0639 1.0422 1.0000 0.9950 1.0171 0.9859 1.0039 1.0000 1.0057 0.9958 1.0155 1.0000 1.0000 1.0000 1.0131 1.0000 1.0000 **M3L5 Wtd** 1\\.1072 1.0901 1.4061 1.0293 0.9767 1.1015 1.0029 0.9925 1.0000 1.0135 0.9994 1.0024 1.0000 1.0047 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 **Last 3 Wtd** 1\\.1010 1.0901 1.5740 1.0437 1.0010 1.0661 1.0814 0.9979 1.0094 1.0083 0.9695 1.0073 1.0000 1.0105 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\n\nSelected LDF 1.2464 1.1355 1.2273 1.0786 1.0286 1.0338 1.0209 1.0213 1.0060 1.0248 0.9924 1.0033 1.0038 1.0032 0.9977 1.0096 1.0000 1.0000 1.0000 1.0131 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 Cumulative LDF 2.1911 1.7579 1.5481 1.2614 1.1695 1.1369 1.0997 1.0772 1.0547 1.0484 1.0230 1.0309 1.0275 1.0237 1.0204 1.0228 1.0131 1.0131 1.0131 1.0131 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000","publish_date":null,"title":"State of California Department of Insurance Exhibit 7‐ BI Integon Preferred Insurance Company ‐ Commercial Vehicle Loss and Defense &","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1423.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1423.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1423","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1423.pdf"},"started_at":"2026-11-04T19:47:42.274948"} +{"completed_at":"2026-11-04T19:47:45.546113","latency_in_ms":2179,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1433","grounded_pages":[],"layout_pages":[],"markdown":"### **RATEMAKING DATA**\n\n**_Edition Date: 8/16/2012_**\n\n_(Click + to expand for more than 3 years; - to contract)_\n\n**Completed by** Guy McClain\n\n**Date Completed** 6/18/2013\n\n**Company/Group Line Description**\n\n**_Coverage_**\n\n_%Captive %Direct %Independent (Must add up to 100%)_\n\n**Marketing System:** 100\\.00%\n\n**Prior Effective Date (current rates)**\n\n**Proposed Effective Date (new rates)**\n\n**CDI File Number (** _Department use only_ **)**\n\n**Does the data provided below reflect a Request for Variance?** Variance #:\n\n**Data below is:**\n\n**2nd Prior Year 1st Prior Year**\n\n**Most Recent**\n\n**Year**\n\n**Projected\\*/ New**\n\n**Program\\*\\***\n\n201006 201106 201206\n\n1 **California Direct Written Premium** 679,729 651,244 724,092\n\n2 **California Direct Earned Premium** 762,285 637,850 624,218\n\n3 **Premium Adjustment Factor (Developed in Exhibit 4)** 1\\.000 1.000 1.000\n\n4 **Premium Trend Factor \\* (Developed in Exhibit 5)** 0\\.892 0.920 0.948 -3.00%\n\n5 **Miscellaneous Fees and Flat Charges (Not included in Line 2;**\n\n**Developed in Exhibit 6)**\n\n25,441 24,916 41,769\n\n6 **Earned Exposure Units** 1,724 1,532 1,647\n\n7 **Historic Losses** 236,997 391,197 158,133\n\n8 **Historic Defense and Cost Containment Expense (DCCE)** 71,317 64,823 63,648\n\n9 **Loss Development Factor (Developed in Exhibit 7)** 1\\.038 1.112 1.627\n\n10 **DCCE Development Factor (Developed in Exhibit 7)** 1\\.038 1.112 1.627\n\n11 **Loss Trend Factor\\* (Developed in Exhibit 8)** 1\\.195 1.139 1.087 4.90%\n\n12 **DCCE Trend Factor\\* (Developed in Exhibit 8)** 1\\.195 1.139 1.087 4.90%\n\n13 **Catastrophe Adjustment Factor (Developed in Exh 9)** 1\\.000 1.000 1.000\n\n14 **Credibility Factor for Losses & DCCE (Developed in Exhibit 10)** 17\\.00%\n\n15 **Excluded Expense Factor (From Page 13 of Rate Application)** 0\\.23%\n\n16 **Ancillary Income (Developed in Exhibit 11)** 3,399 3,256 3,620\n\n17 **Projected Federal Income Tax Rate on Investment Income (From**\n\n**Page 14 of Rate Application)**\n\n33\\.46%\n\n18 **Projected Yield (From Page 14 of Rate Application)** 3\\.43%\n\n**_Complete 19, 20 & 21 For Earthquake and certain Medical Malpractice with Reinsurance Only (see instructions)_**\n\n19 **Direct Commissions** 20 **Reinsurance Premium (Developed in Exhibit 14)** 21 **Reinsurance Recoverables (Developed in Exhibit 14)**\n\n**Variance Change to Leverage on the basis that the insurer either writes at least 90% of its direct earned premium in one line or writes at least 90% of its direct earned premium in California. (Must be accompanied by Variance Request, subject to CDI approval) Variance Change to Efficiency Standard (Must be accompanied by Variance Request, subject to approval by CDI)**\n\n### \\*\n\n**For all trend factors, the Projected Column should reflect the annual trend expressed as a percentage.**\n\n\\*\\* **For New Programs, please see Rate Filing Instructions, Page 4.**\n\nCOMMERCIAL MULTIPLE PERIL (COMBINED)\n\nBodily Injury\n\nIntegon Preferred Insurance Company\n\nAccident Year Data\n\nCOMMERCIAL MULTIPLE PERIL (COMBINED)\n\nNo\n\nNo","pages":[{"line_numbers":[],"markdown":"### **RATEMAKING DATA**\n\n**_Edition Date: 8/16/2012_**\n\n_(Click + to expand for more than 3 years; - to contract)_\n\n**Completed by** Guy McClain\n\n**Date Completed** 6/18/2013\n\n**Company/Group Line Description**\n\n**_Coverage_**\n\n_%Captive %Direct %Independent (Must add up to 100%)_\n\n**Marketing System:** 100\\.00%\n\n**Prior Effective Date (current rates)**\n\n**Proposed Effective Date (new rates)**\n\n**CDI File Number (** _Department use only_ **)**\n\n**Does the data provided below reflect a Request for Variance?** Variance #:\n\n**Data below is:**\n\n**2nd Prior Year 1st Prior Year**\n\n**Most Recent**\n\n**Year**\n\n**Projected\\*/ New**\n\n**Program\\*\\***\n\n201006 201106 201206\n\n1 **California Direct Written Premium** 679,729 651,244 724,092\n\n2 **California Direct Earned Premium** 762,285 637,850 624,218\n\n3 **Premium Adjustment Factor (Developed in Exhibit 4)** 1\\.000 1.000 1.000\n\n4 **Premium Trend Factor \\* (Developed in Exhibit 5)** 0\\.892 0.920 0.948 -3.00%\n\n5 **Miscellaneous Fees and Flat Charges (Not included in Line 2;**\n\n**Developed in Exhibit 6)**\n\n25,441 24,916 41,769\n\n6 **Earned Exposure Units** 1,724 1,532 1,647\n\n7 **Historic Losses** 236,997 391,197 158,133\n\n8 **Historic Defense and Cost Containment Expense (DCCE)** 71,317 64,823 63,648\n\n9 **Loss Development Factor (Developed in Exhibit 7)** 1\\.038 1.112 1.627\n\n10 **DCCE Development Factor (Developed in Exhibit 7)** 1\\.038 1.112 1.627\n\n11 **Loss Trend Factor\\* (Developed in Exhibit 8)** 1\\.195 1.139 1.087 4.90%\n\n12 **DCCE Trend Factor\\* (Developed in Exhibit 8)** 1\\.195 1.139 1.087 4.90%\n\n13 **Catastrophe Adjustment Factor (Developed in Exh 9)** 1\\.000 1.000 1.000\n\n14 **Credibility Factor for Losses & DCCE (Developed in Exhibit 10)** 17\\.00%\n\n15 **Excluded Expense Factor (From Page 13 of Rate Application)** 0\\.23%\n\n16 **Ancillary Income (Developed in Exhibit 11)** 3,399 3,256 3,620\n\n17 **Projected Federal Income Tax Rate on Investment Income (From**\n\n**Page 14 of Rate Application)**\n\n33\\.46%\n\n18 **Projected Yield (From Page 14 of Rate Application)** 3\\.43%\n\n**_Complete 19, 20 & 21 For Earthquake and certain Medical Malpractice with Reinsurance Only (see instructions)_**\n\n19 **Direct Commissions** 20 **Reinsurance Premium (Developed in Exhibit 14)** 21 **Reinsurance Recoverables (Developed in Exhibit 14)**\n\n**Variance Change to Leverage on the basis that the insurer either writes at least 90% of its direct earned premium in one line or writes at least 90% of its direct earned premium in California. (Must be accompanied by Variance Request, subject to CDI approval) Variance Change to Efficiency Standard (Must be accompanied by Variance Request, subject to approval by CDI)**\n\n### \\*\n\n**For all trend factors, the Projected Column should reflect the annual trend expressed as a percentage.**\n\n\\*\\* **For New Programs, please see Rate Filing Instructions, Page 4.**\n\nCOMMERCIAL MULTIPLE PERIL (COMBINED)\n\nBodily Injury\n\nIntegon Preferred Insurance Company\n\nAccident Year Data\n\nCOMMERCIAL MULTIPLE PERIL (COMBINED)\n\nNo\n\nNo","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **RATEMAKING DATA**\n\n**_Edition Date: 8/16/2012_**\n\n_(Click + to expand for more than 3 years; - to contract)_\n\n**Completed by** Guy McClain\n\n**Date Completed** 6/18/2013\n\n**Company/Group Line Description**\n\n**_Coverage_**\n\n_%Captive %Direct %Independent (Must add up to 100%)_\n\n**Marketing System:** 100\\.00%\n\n**Prior Effective Date (current rates)**\n\n**Proposed Effective Date (new rates)**\n\n**CDI File Number (** _Department use only_ **)**\n\n**Does the data provided below reflect a Request for Variance?** Variance #:\n\n**Data below is:**\n\n**2nd Prior Year 1st Prior Year**\n\n**Most Recent**\n\n**Year**\n\n**Projected\\*/ New**\n\n**Program\\*\\***\n\n201006 201106 201206\n\n1 **California Direct Written Premium** 679,729 651,244 724,092\n\n2 **California Direct Earned Premium** 762,285 637,850 624,218\n\n3 **Premium Adjustment Factor (Developed in Exhibit 4)** 1\\.000 1.000 1.000\n\n4 **Premium Trend Factor \\* (Developed in Exhibit 5)** 0\\.892 0.920 0.948 -3.00%\n\n5 **Miscellaneous Fees and Flat Charges (Not included in Line 2;**\n\n**Developed in Exhibit 6)**\n\n25,441 24,916 41,769\n\n6 **Earned Exposure Units** 1,724 1,532 1,647\n\n7 **Historic Losses** 236,997 391,197 158,133\n\n8 **Historic Defense and Cost Containment Expense (DCCE)** 71,317 64,823 63,648\n\n9 **Loss Development Factor (Developed in Exhibit 7)** 1\\.038 1.112 1.627\n\n10 **DCCE Development Factor (Developed in Exhibit 7)** 1\\.038 1.112 1.627\n\n11 **Loss Trend Factor\\* (Developed in Exhibit 8)** 1\\.195 1.139 1.087 4.90%\n\n12 **DCCE Trend Factor\\* (Developed in Exhibit 8)** 1\\.195 1.139 1.087 4.90%\n\n13 **Catastrophe Adjustment Factor (Developed in Exh 9)** 1\\.000 1.000 1.000\n\n14 **Credibility Factor for Losses & DCCE (Developed in Exhibit 10)** 17\\.00%\n\n15 **Excluded Expense Factor (From Page 13 of Rate Application)** 0\\.23%\n\n16 **Ancillary Income (Developed in Exhibit 11)** 3,399 3,256 3,620\n\n17 **Projected Federal Income Tax Rate on Investment Income (From**\n\n**Page 14 of Rate Application)**\n\n33\\.46%\n\n18 **Projected Yield (From Page 14 of Rate Application)** 3\\.43%\n\n**_Complete 19, 20 & 21 For Earthquake and certain Medical Malpractice with Reinsurance Only (see instructions)_**\n\n19 **Direct Commissions** 20 **Reinsurance Premium (Developed in Exhibit 14)** 21 **Reinsurance Recoverables (Developed in Exhibit 14)**\n\n**Variance Change to Leverage on the basis that the insurer either writes at least 90% of its direct earned premium in one line or writes at least 90% of its direct earned premium in California. (Must be accompanied by Variance Request, subject to CDI approval) Variance Change to Efficiency Standard (Must be accompanied by Variance Request, subject to approval by CDI)**\n\n### \\*\n\n**For all trend factors, the Projected Column should reflect the annual trend expressed as a percentage.**\n\n\\*\\* **For New Programs, please see Rate Filing Instructions, Page 4.**\n\nCOMMERCIAL MULTIPLE PERIL (COMBINED)\n\nBodily Injury\n\nIntegon Preferred Insurance Company\n\nAccident Year Data\n\nCOMMERCIAL MULTIPLE PERIL (COMBINED)\n\nNo\n\nNo","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1433.pdf"]},"response":{"errors":[],"extract_id":"extract_fbba40f6b3c6bf1e47bb0d04be8c8c61","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **RATEMAKING DATA**\n\n**_Edition Date: 8/16/2012_**\n\n_(Click + to expand for more than 3 years; - to contract)_\n\n**Completed by** Guy McClain\n\n**Date Completed** 6/18/2013\n\n**Company/Group Line Description**\n\n**_Coverage_**\n\n_%Captive %Direct %Independent (Must add up to 100%)_\n\n**Marketing System:** 100\\.00%\n\n**Prior Effective Date (current rates)**\n\n**Proposed Effective Date (new rates)**\n\n**CDI File Number (** _Department use only_ **)**\n\n**Does the data provided below reflect a Request for Variance?** Variance #:\n\n**Data below is:**\n\n**2nd Prior Year 1st Prior Year**\n\n**Most Recent**\n\n**Year**\n\n**Projected\\*/ New**\n\n**Program\\*\\***\n\n201006 201106 201206\n\n1 **California Direct Written Premium** 679,729 651,244 724,092\n\n2 **California Direct Earned Premium** 762,285 637,850 624,218\n\n3 **Premium Adjustment Factor (Developed in Exhibit 4)** 1\\.000 1.000 1.000\n\n4 **Premium Trend Factor \\* (Developed in Exhibit 5)** 0\\.892 0.920 0.948 -3.00%\n\n5 **Miscellaneous Fees and Flat Charges (Not included in Line 2;**\n\n**Developed in Exhibit 6)**\n\n25,441 24,916 41,769\n\n6 **Earned Exposure Units** 1,724 1,532 1,647\n\n7 **Historic Losses** 236,997 391,197 158,133\n\n8 **Historic Defense and Cost Containment Expense (DCCE)** 71,317 64,823 63,648\n\n9 **Loss Development Factor (Developed in Exhibit 7)** 1\\.038 1.112 1.627\n\n10 **DCCE Development Factor (Developed in Exhibit 7)** 1\\.038 1.112 1.627\n\n11 **Loss Trend Factor\\* (Developed in Exhibit 8)** 1\\.195 1.139 1.087 4.90%\n\n12 **DCCE Trend Factor\\* (Developed in Exhibit 8)** 1\\.195 1.139 1.087 4.90%\n\n13 **Catastrophe Adjustment Factor (Developed in Exh 9)** 1\\.000 1.000 1.000\n\n14 **Credibility Factor for Losses & DCCE (Developed in Exhibit 10)** 17\\.00%\n\n15 **Excluded Expense Factor (From Page 13 of Rate Application)** 0\\.23%\n\n16 **Ancillary Income (Developed in Exhibit 11)** 3,399 3,256 3,620\n\n17 **Projected Federal Income Tax Rate on Investment Income (From**\n\n**Page 14 of Rate Application)**\n\n33\\.46%\n\n18 **Projected Yield (From Page 14 of Rate Application)** 3\\.43%\n\n**_Complete 19, 20 & 21 For Earthquake and certain Medical Malpractice with Reinsurance Only (see instructions)_**\n\n19 **Direct Commissions** 20 **Reinsurance Premium (Developed in Exhibit 14)** 21 **Reinsurance Recoverables (Developed in Exhibit 14)**\n\n**Variance Change to Leverage on the basis that the insurer either writes at least 90% of its direct earned premium in one line or writes at least 90% of its direct earned premium in California. (Must be accompanied by Variance Request, subject to CDI approval) Variance Change to Efficiency Standard (Must be accompanied by Variance Request, subject to approval by CDI)**\n\n### \\*\n\n**For all trend factors, the Projected Column should reflect the annual trend expressed as a percentage.**\n\n\\*\\* **For New Programs, please see Rate Filing Instructions, Page 4.**\n\nCOMMERCIAL MULTIPLE PERIL (COMBINED)\n\nBodily Injury\n\nIntegon Preferred Insurance Company\n\nAccident Year Data\n\nCOMMERCIAL MULTIPLE PERIL (COMBINED)\n\nNo\n\nNo"],"full_content":"### **RATEMAKING DATA**\n\n**_Edition Date: 8/16/2012_**\n\n_(Click + to expand for more than 3 years; - to contract)_\n\n**Completed by** Guy McClain\n\n**Date Completed** 6/18/2013\n\n**Company/Group Line Description**\n\n**_Coverage_**\n\n_%Captive %Direct %Independent (Must add up to 100%)_\n\n**Marketing System:** 100\\.00%\n\n**Prior Effective Date (current rates)**\n\n**Proposed Effective Date (new rates)**\n\n**CDI File Number (** _Department use only_ **)**\n\n**Does the data provided below reflect a Request for Variance?** Variance #:\n\n**Data below is:**\n\n**2nd Prior Year 1st Prior Year**\n\n**Most Recent**\n\n**Year**\n\n**Projected\\*/ New**\n\n**Program\\*\\***\n\n201006 201106 201206\n\n1 **California Direct Written Premium** 679,729 651,244 724,092\n\n2 **California Direct Earned Premium** 762,285 637,850 624,218\n\n3 **Premium Adjustment Factor (Developed in Exhibit 4)** 1\\.000 1.000 1.000\n\n4 **Premium Trend Factor \\* (Developed in Exhibit 5)** 0\\.892 0.920 0.948 -3.00%\n\n5 **Miscellaneous Fees and Flat Charges (Not included in Line 2;**\n\n**Developed in Exhibit 6)**\n\n25,441 24,916 41,769\n\n6 **Earned Exposure Units** 1,724 1,532 1,647\n\n7 **Historic Losses** 236,997 391,197 158,133\n\n8 **Historic Defense and Cost Containment Expense (DCCE)** 71,317 64,823 63,648\n\n9 **Loss Development Factor (Developed in Exhibit 7)** 1\\.038 1.112 1.627\n\n10 **DCCE Development Factor (Developed in Exhibit 7)** 1\\.038 1.112 1.627\n\n11 **Loss Trend Factor\\* (Developed in Exhibit 8)** 1\\.195 1.139 1.087 4.90%\n\n12 **DCCE Trend Factor\\* (Developed in Exhibit 8)** 1\\.195 1.139 1.087 4.90%\n\n13 **Catastrophe Adjustment Factor (Developed in Exh 9)** 1\\.000 1.000 1.000\n\n14 **Credibility Factor for Losses & DCCE (Developed in Exhibit 10)** 17\\.00%\n\n15 **Excluded Expense Factor (From Page 13 of Rate Application)** 0\\.23%\n\n16 **Ancillary Income (Developed in Exhibit 11)** 3,399 3,256 3,620\n\n17 **Projected Federal Income Tax Rate on Investment Income (From**\n\n**Page 14 of Rate Application)**\n\n33\\.46%\n\n18 **Projected Yield (From Page 14 of Rate Application)** 3\\.43%\n\n**_Complete 19, 20 & 21 For Earthquake and certain Medical Malpractice with Reinsurance Only (see instructions)_**\n\n19 **Direct Commissions** 20 **Reinsurance Premium (Developed in Exhibit 14)** 21 **Reinsurance Recoverables (Developed in Exhibit 14)**\n\n**Variance Change to Leverage on the basis that the insurer either writes at least 90% of its direct earned premium in one line or writes at least 90% of its direct earned premium in California. (Must be accompanied by Variance Request, subject to CDI approval) Variance Change to Efficiency Standard (Must be accompanied by Variance Request, subject to approval by CDI)**\n\n### \\*\n\n**For all trend factors, the Projected Column should reflect the annual trend expressed as a percentage.**\n\n\\*\\* **For New Programs, please see Rate Filing Instructions, Page 4.**\n\nCOMMERCIAL MULTIPLE PERIL (COMBINED)\n\nBodily Injury\n\nIntegon Preferred Insurance Company\n\nAccident Year Data\n\nCOMMERCIAL MULTIPLE PERIL (COMBINED)\n\nNo\n\nNo","publish_date":null,"title":"RATEMAKING DATA * **","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1433.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1433.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1433","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1433.pdf"},"started_at":"2026-11-04T19:47:43.366656"} +{"completed_at":"2026-11-04T19:47:46.661849","latency_in_ms":2060,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1434","grounded_pages":[],"layout_pages":[],"markdown":"FIXED\\_INV\\_INC\\_FACTOR 8\\.39%\n\nVAR\\_INV\\_INC\\_FACTOR 5\\.38%\n\nANNUAL\\_NET\\_TREND \\-6.70%\n\nCOMP\\_TREND \\-24.23%\n\nMAX\\_PROFIT 14\\.16%\n\nMIN\\_PROFIT \\-11.86%\n\nUW\\_PROFIT 3\\.43%\n\nMAX\\_DENOM 0\\.535\n\nMIN\\_DENOM 0\\.795\n\nMAX\\_PREMIUM $387.55\n\nMIN\\_PREMIUM $260.79\n\nCHANGE\\_AT\\_MIN \\-15.77%\n\n### **CHANGE\\_AT\\_MAX** **25\\.16%**\n\n**_Alternate Calculation with Reinsurance_** COMMISSION\\_RATE 0\\.00%\n\nRE\\_PREM - \\- - 0\n\nRE\\_RECOV - \\- - 0\n\nRE\\_PREM\\_PER\\_EXP 0\\.00 0.00 0.00 0.00\n\nRE\\_RECOV\\_PER\\_EXP 0\\.00 0.00 0.00 0.00\n\nCOMP\\_LOSS\\_RE 1\\.44 1.54 1.70 138.78\n\nRMAX\\_PREMIUM NA\n\nRCHANGE\\_AT\\_MAX **_NA_**","pages":[{"line_numbers":[],"markdown":"FIXED\\_INV\\_INC\\_FACTOR 8\\.39%\n\nVAR\\_INV\\_INC\\_FACTOR 5\\.38%\n\nANNUAL\\_NET\\_TREND \\-6.70%\n\nCOMP\\_TREND \\-24.23%\n\nMAX\\_PROFIT 14\\.16%\n\nMIN\\_PROFIT \\-11.86%\n\nUW\\_PROFIT 3\\.43%\n\nMAX\\_DENOM 0\\.535\n\nMIN\\_DENOM 0\\.795\n\nMAX\\_PREMIUM $387.55\n\nMIN\\_PREMIUM $260.79\n\nCHANGE\\_AT\\_MIN \\-15.77%\n\n### **CHANGE\\_AT\\_MAX** **25\\.16%**\n\n**_Alternate Calculation with Reinsurance_** COMMISSION\\_RATE 0\\.00%\n\nRE\\_PREM - \\- - 0\n\nRE\\_RECOV - \\- - 0\n\nRE\\_PREM\\_PER\\_EXP 0\\.00 0.00 0.00 0.00\n\nRE\\_RECOV\\_PER\\_EXP 0\\.00 0.00 0.00 0.00\n\nCOMP\\_LOSS\\_RE 1\\.44 1.54 1.70 138.78\n\nRMAX\\_PREMIUM NA\n\nRCHANGE\\_AT\\_MAX **_NA_**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"FIXED\\_INV\\_INC\\_FACTOR 8\\.39%\n\nVAR\\_INV\\_INC\\_FACTOR 5\\.38%\n\nANNUAL\\_NET\\_TREND \\-6.70%\n\nCOMP\\_TREND \\-24.23%\n\nMAX\\_PROFIT 14\\.16%\n\nMIN\\_PROFIT \\-11.86%\n\nUW\\_PROFIT 3\\.43%\n\nMAX\\_DENOM 0\\.535\n\nMIN\\_DENOM 0\\.795\n\nMAX\\_PREMIUM $387.55\n\nMIN\\_PREMIUM $260.79\n\nCHANGE\\_AT\\_MIN \\-15.77%\n\n### **CHANGE\\_AT\\_MAX** **25\\.16%**\n\n**_Alternate Calculation with Reinsurance_** COMMISSION\\_RATE 0\\.00%\n\nRE\\_PREM - \\- - 0\n\nRE\\_RECOV - \\- - 0\n\nRE\\_PREM\\_PER\\_EXP 0\\.00 0.00 0.00 0.00\n\nRE\\_RECOV\\_PER\\_EXP 0\\.00 0.00 0.00 0.00\n\nCOMP\\_LOSS\\_RE 1\\.44 1.54 1.70 138.78\n\nRMAX\\_PREMIUM NA\n\nRCHANGE\\_AT\\_MAX **_NA_**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1434.pdf"]},"response":{"errors":[],"extract_id":"extract_fb6bd90be90f01cb7a22b7633df54de5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["FIXED\\_INV\\_INC\\_FACTOR 8\\.39%\n\nVAR\\_INV\\_INC\\_FACTOR 5\\.38%\n\nANNUAL\\_NET\\_TREND \\-6.70%\n\nCOMP\\_TREND \\-24.23%\n\nMAX\\_PROFIT 14\\.16%\n\nMIN\\_PROFIT \\-11.86%\n\nUW\\_PROFIT 3\\.43%\n\nMAX\\_DENOM 0\\.535\n\nMIN\\_DENOM 0\\.795\n\nMAX\\_PREMIUM $387.55\n\nMIN\\_PREMIUM $260.79\n\nCHANGE\\_AT\\_MIN \\-15.77%\n\n### **CHANGE\\_AT\\_MAX** **25\\.16%**\n\n**_Alternate Calculation with Reinsurance_** COMMISSION\\_RATE 0\\.00%\n\nRE\\_PREM - \\- - 0\n\nRE\\_RECOV - \\- - 0\n\nRE\\_PREM\\_PER\\_EXP 0\\.00 0.00 0.00 0.00\n\nRE\\_RECOV\\_PER\\_EXP 0\\.00 0.00 0.00 0.00\n\nCOMP\\_LOSS\\_RE 1\\.44 1.54 1.70 138.78\n\nRMAX\\_PREMIUM NA\n\nRCHANGE\\_AT\\_MAX **_NA_**"],"full_content":"FIXED\\_INV\\_INC\\_FACTOR 8\\.39%\n\nVAR\\_INV\\_INC\\_FACTOR 5\\.38%\n\nANNUAL\\_NET\\_TREND \\-6.70%\n\nCOMP\\_TREND \\-24.23%\n\nMAX\\_PROFIT 14\\.16%\n\nMIN\\_PROFIT \\-11.86%\n\nUW\\_PROFIT 3\\.43%\n\nMAX\\_DENOM 0\\.535\n\nMIN\\_DENOM 0\\.795\n\nMAX\\_PREMIUM $387.55\n\nMIN\\_PREMIUM $260.79\n\nCHANGE\\_AT\\_MIN \\-15.77%\n\n### **CHANGE\\_AT\\_MAX** **25\\.16%**\n\n**_Alternate Calculation with Reinsurance_** COMMISSION\\_RATE 0\\.00%\n\nRE\\_PREM - \\- - 0\n\nRE\\_RECOV - \\- - 0\n\nRE\\_PREM\\_PER\\_EXP 0\\.00 0.00 0.00 0.00\n\nRE\\_RECOV\\_PER\\_EXP 0\\.00 0.00 0.00 0.00\n\nCOMP\\_LOSS\\_RE 1\\.44 1.54 1.70 138.78\n\nRMAX\\_PREMIUM NA\n\nRCHANGE\\_AT\\_MAX **_NA_**","publish_date":null,"title":"25.16% CHANGE_AT_MAX","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1434.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1434.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1434","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1434.pdf"},"started_at":"2026-11-04T19:47:44.601579"} +{"completed_at":"2026-11-04T19:47:46.825441","latency_in_ms":1738,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1492","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit 8**\n\n**Century-National Insurance Company**\n\n**Private Passenger Auto Physical Damage**\n\n**Complement Loss and DCCE Trend**\n\n**_Complement Coverage6/Form6/Program6_**\n\n**Complement Loss and DCCE Trend Data Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned Exposures Closed Claims Reported Claims Paid Losses & DCCE**\n\n**Total Paid Losses & DCCE including Partial Payments on Prior Calendar Years, on Closed Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses & DCCE**\n\n**Total Paid Losses & DCCE including Partial Payments on Prior Calendar Years, on Closed Claims**\n\n**Closed Frequency per 100 Exposures**\n\n**Reported Frequency per 100 Exposures**\n\n**Paid Loss & DCCE Severity**\n\n**Total Paid Loss & DCCE Severity including Partial Payments on Prior Calendar Years, on Closed Claims 20094** 2,761,379 167,445 0 571,788,503 571,788,503\n\n**20101** 2,753,351 170,124 0 585,146,952 585,146,952\n\n**20102** 2,752,040 165,592 0 541,562,332 541,562,332\n\n**20103** 2,757,555 170,205 0 543,019,482 543,019,482 11,024,325 673,366 0 2,241,517,269 2,241,517,269 6.11 0.00 3,329 3,329\n\n**20104** 2,759,137 170,925 0 589,634,239 589,634,239 11,022,083 676,846 0 2,259,363,005 2,259,363,005 6.14 0.00 3,338 3,338\n\n**20111** 2,093,286 106,338 0 120,493,446 120,493,446 10,362,018 613,060 0 1,794,709,499 1,794,709,499 5.92 0.00 2,927 2,927\n\n**20112** 2,177,262 117,556 0 116,338,830 116,338,830 9,787,240 565,024 0 1,369,485,997 1,369,485,997 5.77 0.00 2,424 2,424\n\n**20113** 2,217,458 135,826 0 126,923,247 126,923,247 9,247,143 530,645 0 953,389,762 953,389,762 5.74 0.00 1,797 1,797\n\n**20114** 2,217,797 117,406 0 129,556,202 129,556,202 8,705,803 477,126 0 493,311,725 493,311,725 5.48 0.00 1,034 1,034\n\n**20121** 2,216,759 109,629 0 124,596,875 124,596,875 8,829,276 480,417 0 497,415,154 497,415,154 5.44 0.00 1,035 1,035\n\n**20122** 2,229,715 123,746 0 120,292,013 120,292,013 8,881,729 486,607 0 501,368,337 501,368,337 5.48 0.00 1,030 1,030\n\n**20123** 2,251,981 125,161 0 130,448,734 130,448,734 8,916,252 475,942 0 504,893,824 504,893,824 5.34 0.00 1,061 1,061\n\n**20124** 2,268,799 106,555 0 131,635,448 131,635,448 8,967,254 465,091 0 506,973,070 506,973,070 5.19 0.00 1,090 1,090\n\n**20131** 2,265,463 110,090 0 123,775,435 123,775,435 9,015,958 465,552 0 506,151,630 506,151,630 5.16 0.00 1,087 1,087\n\n**20132** 2,281,885 118,015 0 129,617,714 129,617,714 9,068,128 459,821 0 515,477,331 515,477,331 5.07 0.00 1,121 1,121\n\n**20133** 2,297,513 112,606 0 128,711,069 128,711,069 9,113,660 447,266 0 513,739,666 513,739,666 4.91 0.00 1,149 1,149\n\n**20134** 2,311,255 104,334 0 130,149,301 130,149,301 9,156,116 445,045 0 512,253,519 512,253,519 4.86 0.00 1,151 1,151\n\n**20141** 2,310,112 94,469 0 120,973,967 120,973,967 9,200,765 429,424 0 509,452,051 509,452,051 4.67 0.00 1,186 1,186\n\n**20142** 2,337,998 108,725 0 126,485,068 126,485,068 9,256,878 420,134 0 506,319,405 506,319,405 4.54 0.00 1,205 1,205\n\n**20143** 2,361,478 110,783 0 137,678,890 137,678,890 9,320,843 418,311 0 515,287,226 515,287,226 4.49 0.00 1,232 1,232\n\n**20144** 2,379,934 99,563 0 141,113,580 141,113,580 9,389,522 413,540 0 526,251,505 526,251,505 4.40 0.00 1,273 1,273\n\n**20151** 2,406,400 105,259 0 139,919,113 139,919,113 9,485,810 424,330 0 545,196,651 545,196,651 4.47 0.00 1,285 1,285\n\n**20152** 2,440,019 108,089 0 132,567,383 132,567,383 9,587,831 423,694 0 551,278,966 551,278,966 4.42 0.00 1,301 1,301\n\n**20153** 2,476,603 111,588 0 150,815,083 150,815,083 9,702,956 424,499 0 564,415,159 564,415,159 4.37 0.00 1,330 1,330\n\n**20154** 2,509,398 108,589 0 153,539,334 153,539,334 9,832,420 433,525 0 576,840,913 576,840,913 4.41 0.00 1,331 1,331\n\n**20161** 2,527,076 114,676 0 161,311,798 161,311,798 9,953,096 442,942 0 598,233,598 598,233,598 4.45 0.00 1,351 1,351\n\n**20162** 2,565,238 120,310 0 151,478,461 151,478,461 10,078,315 455,163 0 617,144,676 617,144,676 4.52 0.00 1,356 1,356\n\nRolling 4-Quarter Annual Trends\n\nSelected: **12 pt Complement Trend** Closed Frequency Reported Frequency Paid Severity Total Paid\n\n(w/Partials) Severity\n\nFrequency: **Closed -3.2%** 8 pt 0.2% #NUM! 5.4% 5.4%\n\nSeverity: **Paid 6.8%** 12 pt -3.2% #NUM! 6.8% 6.8%\n\nPure Premium: **3\\.4%** 16 pt -5.1% #NUM! 7.2% 7.2%\n\n20 pt -5.7% #NUM! 3.6% 3.6%\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt -6.2% #NUM! -10.1% -10.1%\n\nStandard Exhibits Template Page 4.12 10/24/2016 Edition","pages":[{"line_numbers":[],"markdown":"**Exhibit 8**\n\n**Century-National Insurance Company**\n\n**Private Passenger Auto Physical Damage**\n\n**Complement Loss and DCCE Trend**\n\n**_Complement Coverage6/Form6/Program6_**\n\n**Complement Loss and DCCE Trend Data Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned Exposures Closed Claims Reported Claims Paid Losses & DCCE**\n\n**Total Paid Losses & DCCE including Partial Payments on Prior Calendar Years, on Closed Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses & DCCE**\n\n**Total Paid Losses & DCCE including Partial Payments on Prior Calendar Years, on Closed Claims**\n\n**Closed Frequency per 100 Exposures**\n\n**Reported Frequency per 100 Exposures**\n\n**Paid Loss & DCCE Severity**\n\n**Total Paid Loss & DCCE Severity including Partial Payments on Prior Calendar Years, on Closed Claims 20094** 2,761,379 167,445 0 571,788,503 571,788,503\n\n**20101** 2,753,351 170,124 0 585,146,952 585,146,952\n\n**20102** 2,752,040 165,592 0 541,562,332 541,562,332\n\n**20103** 2,757,555 170,205 0 543,019,482 543,019,482 11,024,325 673,366 0 2,241,517,269 2,241,517,269 6.11 0.00 3,329 3,329\n\n**20104** 2,759,137 170,925 0 589,634,239 589,634,239 11,022,083 676,846 0 2,259,363,005 2,259,363,005 6.14 0.00 3,338 3,338\n\n**20111** 2,093,286 106,338 0 120,493,446 120,493,446 10,362,018 613,060 0 1,794,709,499 1,794,709,499 5.92 0.00 2,927 2,927\n\n**20112** 2,177,262 117,556 0 116,338,830 116,338,830 9,787,240 565,024 0 1,369,485,997 1,369,485,997 5.77 0.00 2,424 2,424\n\n**20113** 2,217,458 135,826 0 126,923,247 126,923,247 9,247,143 530,645 0 953,389,762 953,389,762 5.74 0.00 1,797 1,797\n\n**20114** 2,217,797 117,406 0 129,556,202 129,556,202 8,705,803 477,126 0 493,311,725 493,311,725 5.48 0.00 1,034 1,034\n\n**20121** 2,216,759 109,629 0 124,596,875 124,596,875 8,829,276 480,417 0 497,415,154 497,415,154 5.44 0.00 1,035 1,035\n\n**20122** 2,229,715 123,746 0 120,292,013 120,292,013 8,881,729 486,607 0 501,368,337 501,368,337 5.48 0.00 1,030 1,030\n\n**20123** 2,251,981 125,161 0 130,448,734 130,448,734 8,916,252 475,942 0 504,893,824 504,893,824 5.34 0.00 1,061 1,061\n\n**20124** 2,268,799 106,555 0 131,635,448 131,635,448 8,967,254 465,091 0 506,973,070 506,973,070 5.19 0.00 1,090 1,090\n\n**20131** 2,265,463 110,090 0 123,775,435 123,775,435 9,015,958 465,552 0 506,151,630 506,151,630 5.16 0.00 1,087 1,087\n\n**20132** 2,281,885 118,015 0 129,617,714 129,617,714 9,068,128 459,821 0 515,477,331 515,477,331 5.07 0.00 1,121 1,121\n\n**20133** 2,297,513 112,606 0 128,711,069 128,711,069 9,113,660 447,266 0 513,739,666 513,739,666 4.91 0.00 1,149 1,149\n\n**20134** 2,311,255 104,334 0 130,149,301 130,149,301 9,156,116 445,045 0 512,253,519 512,253,519 4.86 0.00 1,151 1,151\n\n**20141** 2,310,112 94,469 0 120,973,967 120,973,967 9,200,765 429,424 0 509,452,051 509,452,051 4.67 0.00 1,186 1,186\n\n**20142** 2,337,998 108,725 0 126,485,068 126,485,068 9,256,878 420,134 0 506,319,405 506,319,405 4.54 0.00 1,205 1,205\n\n**20143** 2,361,478 110,783 0 137,678,890 137,678,890 9,320,843 418,311 0 515,287,226 515,287,226 4.49 0.00 1,232 1,232\n\n**20144** 2,379,934 99,563 0 141,113,580 141,113,580 9,389,522 413,540 0 526,251,505 526,251,505 4.40 0.00 1,273 1,273\n\n**20151** 2,406,400 105,259 0 139,919,113 139,919,113 9,485,810 424,330 0 545,196,651 545,196,651 4.47 0.00 1,285 1,285\n\n**20152** 2,440,019 108,089 0 132,567,383 132,567,383 9,587,831 423,694 0 551,278,966 551,278,966 4.42 0.00 1,301 1,301\n\n**20153** 2,476,603 111,588 0 150,815,083 150,815,083 9,702,956 424,499 0 564,415,159 564,415,159 4.37 0.00 1,330 1,330\n\n**20154** 2,509,398 108,589 0 153,539,334 153,539,334 9,832,420 433,525 0 576,840,913 576,840,913 4.41 0.00 1,331 1,331\n\n**20161** 2,527,076 114,676 0 161,311,798 161,311,798 9,953,096 442,942 0 598,233,598 598,233,598 4.45 0.00 1,351 1,351\n\n**20162** 2,565,238 120,310 0 151,478,461 151,478,461 10,078,315 455,163 0 617,144,676 617,144,676 4.52 0.00 1,356 1,356\n\nRolling 4-Quarter Annual Trends\n\nSelected: **12 pt Complement Trend** Closed Frequency Reported Frequency Paid Severity Total Paid\n\n(w/Partials) Severity\n\nFrequency: **Closed -3.2%** 8 pt 0.2% #NUM! 5.4% 5.4%\n\nSeverity: **Paid 6.8%** 12 pt -3.2% #NUM! 6.8% 6.8%\n\nPure Premium: **3\\.4%** 16 pt -5.1% #NUM! 7.2% 7.2%\n\n20 pt -5.7% #NUM! 3.6% 3.6%\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt -6.2% #NUM! -10.1% -10.1%\n\nStandard Exhibits Template Page 4.12 10/24/2016 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit 8**\n\n**Century-National Insurance Company**\n\n**Private Passenger Auto Physical Damage**\n\n**Complement Loss and DCCE Trend**\n\n**_Complement Coverage6/Form6/Program6_**\n\n**Complement Loss and DCCE Trend Data Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned Exposures Closed Claims Reported Claims Paid Losses & DCCE**\n\n**Total Paid Losses & DCCE including Partial Payments on Prior Calendar Years, on Closed Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses & DCCE**\n\n**Total Paid Losses & DCCE including Partial Payments on Prior Calendar Years, on Closed Claims**\n\n**Closed Frequency per 100 Exposures**\n\n**Reported Frequency per 100 Exposures**\n\n**Paid Loss & DCCE Severity**\n\n**Total Paid Loss & DCCE Severity including Partial Payments on Prior Calendar Years, on Closed Claims 20094** 2,761,379 167,445 0 571,788,503 571,788,503\n\n**20101** 2,753,351 170,124 0 585,146,952 585,146,952\n\n**20102** 2,752,040 165,592 0 541,562,332 541,562,332\n\n**20103** 2,757,555 170,205 0 543,019,482 543,019,482 11,024,325 673,366 0 2,241,517,269 2,241,517,269 6.11 0.00 3,329 3,329\n\n**20104** 2,759,137 170,925 0 589,634,239 589,634,239 11,022,083 676,846 0 2,259,363,005 2,259,363,005 6.14 0.00 3,338 3,338\n\n**20111** 2,093,286 106,338 0 120,493,446 120,493,446 10,362,018 613,060 0 1,794,709,499 1,794,709,499 5.92 0.00 2,927 2,927\n\n**20112** 2,177,262 117,556 0 116,338,830 116,338,830 9,787,240 565,024 0 1,369,485,997 1,369,485,997 5.77 0.00 2,424 2,424\n\n**20113** 2,217,458 135,826 0 126,923,247 126,923,247 9,247,143 530,645 0 953,389,762 953,389,762 5.74 0.00 1,797 1,797\n\n**20114** 2,217,797 117,406 0 129,556,202 129,556,202 8,705,803 477,126 0 493,311,725 493,311,725 5.48 0.00 1,034 1,034\n\n**20121** 2,216,759 109,629 0 124,596,875 124,596,875 8,829,276 480,417 0 497,415,154 497,415,154 5.44 0.00 1,035 1,035\n\n**20122** 2,229,715 123,746 0 120,292,013 120,292,013 8,881,729 486,607 0 501,368,337 501,368,337 5.48 0.00 1,030 1,030\n\n**20123** 2,251,981 125,161 0 130,448,734 130,448,734 8,916,252 475,942 0 504,893,824 504,893,824 5.34 0.00 1,061 1,061\n\n**20124** 2,268,799 106,555 0 131,635,448 131,635,448 8,967,254 465,091 0 506,973,070 506,973,070 5.19 0.00 1,090 1,090\n\n**20131** 2,265,463 110,090 0 123,775,435 123,775,435 9,015,958 465,552 0 506,151,630 506,151,630 5.16 0.00 1,087 1,087\n\n**20132** 2,281,885 118,015 0 129,617,714 129,617,714 9,068,128 459,821 0 515,477,331 515,477,331 5.07 0.00 1,121 1,121\n\n**20133** 2,297,513 112,606 0 128,711,069 128,711,069 9,113,660 447,266 0 513,739,666 513,739,666 4.91 0.00 1,149 1,149\n\n**20134** 2,311,255 104,334 0 130,149,301 130,149,301 9,156,116 445,045 0 512,253,519 512,253,519 4.86 0.00 1,151 1,151\n\n**20141** 2,310,112 94,469 0 120,973,967 120,973,967 9,200,765 429,424 0 509,452,051 509,452,051 4.67 0.00 1,186 1,186\n\n**20142** 2,337,998 108,725 0 126,485,068 126,485,068 9,256,878 420,134 0 506,319,405 506,319,405 4.54 0.00 1,205 1,205\n\n**20143** 2,361,478 110,783 0 137,678,890 137,678,890 9,320,843 418,311 0 515,287,226 515,287,226 4.49 0.00 1,232 1,232\n\n**20144** 2,379,934 99,563 0 141,113,580 141,113,580 9,389,522 413,540 0 526,251,505 526,251,505 4.40 0.00 1,273 1,273\n\n**20151** 2,406,400 105,259 0 139,919,113 139,919,113 9,485,810 424,330 0 545,196,651 545,196,651 4.47 0.00 1,285 1,285\n\n**20152** 2,440,019 108,089 0 132,567,383 132,567,383 9,587,831 423,694 0 551,278,966 551,278,966 4.42 0.00 1,301 1,301\n\n**20153** 2,476,603 111,588 0 150,815,083 150,815,083 9,702,956 424,499 0 564,415,159 564,415,159 4.37 0.00 1,330 1,330\n\n**20154** 2,509,398 108,589 0 153,539,334 153,539,334 9,832,420 433,525 0 576,840,913 576,840,913 4.41 0.00 1,331 1,331\n\n**20161** 2,527,076 114,676 0 161,311,798 161,311,798 9,953,096 442,942 0 598,233,598 598,233,598 4.45 0.00 1,351 1,351\n\n**20162** 2,565,238 120,310 0 151,478,461 151,478,461 10,078,315 455,163 0 617,144,676 617,144,676 4.52 0.00 1,356 1,356\n\nRolling 4-Quarter Annual Trends\n\nSelected: **12 pt Complement Trend** Closed Frequency Reported Frequency Paid Severity Total Paid\n\n(w/Partials) Severity\n\nFrequency: **Closed -3.2%** 8 pt 0.2% #NUM! 5.4% 5.4%\n\nSeverity: **Paid 6.8%** 12 pt -3.2% #NUM! 6.8% 6.8%\n\nPure Premium: **3\\.4%** 16 pt -5.1% #NUM! 7.2% 7.2%\n\n20 pt -5.7% #NUM! 3.6% 3.6%\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt -6.2% #NUM! -10.1% -10.1%\n\nStandard Exhibits Template Page 4.12 10/24/2016 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1492.pdf"]},"response":{"errors":[],"extract_id":"extract_74a918e1576de1a3c173aacff4af2a0a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit 8**\n\n**Century-National Insurance Company**\n\n**Private Passenger Auto Physical Damage**\n\n**Complement Loss and DCCE Trend**\n\n**_Complement Coverage6/Form6/Program6_**\n\n**Complement Loss and DCCE Trend Data Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned Exposures Closed Claims Reported Claims Paid Losses & DCCE**\n\n**Total Paid Losses & DCCE including Partial Payments on Prior Calendar Years, on Closed Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses & DCCE**\n\n**Total Paid Losses & DCCE including Partial Payments on Prior Calendar Years, on Closed Claims**\n\n**Closed Frequency per 100 Exposures**\n\n**Reported Frequency per 100 Exposures**\n\n**Paid Loss & DCCE Severity**\n\n**Total Paid Loss & DCCE Severity including Partial Payments on Prior Calendar Years, on Closed Claims 20094** 2,761,379 167,445 0 571,788,503 571,788,503\n\n**20101** 2,753,351 170,124 0 585,146,952 585,146,952\n\n**20102** 2,752,040 165,592 0 541,562,332 541,562,332\n\n**20103** 2,757,555 170,205 0 543,019,482 543,019,482 11,024,325 673,366 0 2,241,517,269 2,241,517,269 6.11 0.00 3,329 3,329\n\n**20104** 2,759,137 170,925 0 589,634,239 589,634,239 11,022,083 676,846 0 2,259,363,005 2,259,363,005 6.14 0.00 3,338 3,338\n\n**20111** 2,093,286 106,338 0 120,493,446 120,493,446 10,362,018 613,060 0 1,794,709,499 1,794,709,499 5.92 0.00 2,927 2,927\n\n**20112** 2,177,262 117,556 0 116,338,830 116,338,830 9,787,240 565,024 0 1,369,485,997 1,369,485,997 5.77 0.00 2,424 2,424\n\n**20113** 2,217,458 135,826 0 126,923,247 126,923,247 9,247,143 530,645 0 953,389,762 953,389,762 5.74 0.00 1,797 1,797\n\n**20114** 2,217,797 117,406 0 129,556,202 129,556,202 8,705,803 477,126 0 493,311,725 493,311,725 5.48 0.00 1,034 1,034\n\n**20121** 2,216,759 109,629 0 124,596,875 124,596,875 8,829,276 480,417 0 497,415,154 497,415,154 5.44 0.00 1,035 1,035\n\n**20122** 2,229,715 123,746 0 120,292,013 120,292,013 8,881,729 486,607 0 501,368,337 501,368,337 5.48 0.00 1,030 1,030\n\n**20123** 2,251,981 125,161 0 130,448,734 130,448,734 8,916,252 475,942 0 504,893,824 504,893,824 5.34 0.00 1,061 1,061\n\n**20124** 2,268,799 106,555 0 131,635,448 131,635,448 8,967,254 465,091 0 506,973,070 506,973,070 5.19 0.00 1,090 1,090\n\n**20131** 2,265,463 110,090 0 123,775,435 123,775,435 9,015,958 465,552 0 506,151,630 506,151,630 5.16 0.00 1,087 1,087\n\n**20132** 2,281,885 118,015 0 129,617,714 129,617,714 9,068,128 459,821 0 515,477,331 515,477,331 5.07 0.00 1,121 1,121\n\n**20133** 2,297,513 112,606 0 128,711,069 128,711,069 9,113,660 447,266 0 513,739,666 513,739,666 4.91 0.00 1,149 1,149\n\n**20134** 2,311,255 104,334 0 130,149,301 130,149,301 9,156,116 445,045 0 512,253,519 512,253,519 4.86 0.00 1,151 1,151\n\n**20141** 2,310,112 94,469 0 120,973,967 120,973,967 9,200,765 429,424 0 509,452,051 509,452,051 4.67 0.00 1,186 1,186\n\n**20142** 2,337,998 108,725 0 126,485,068 126,485,068 9,256,878 420,134 0 506,319,405 506,319,405 4.54 0.00 1,205 1,205\n\n**20143** 2,361,478 110,783 0 137,678,890 137,678,890 9,320,843 418,311 0 515,287,226 515,287,226 4.49 0.00 1,232 1,232\n\n**20144** 2,379,934 99,563 0 141,113,580 141,113,580 9,389,522 413,540 0 526,251,505 526,251,505 4.40 0.00 1,273 1,273\n\n**20151** 2,406,400 105,259 0 139,919,113 139,919,113 9,485,810 424,330 0 545,196,651 545,196,651 4.47 0.00 1,285 1,285\n\n**20152** 2,440,019 108,089 0 132,567,383 132,567,383 9,587,831 423,694 0 551,278,966 551,278,966 4.42 0.00 1,301 1,301\n\n**20153** 2,476,603 111,588 0 150,815,083 150,815,083 9,702,956 424,499 0 564,415,159 564,415,159 4.37 0.00 1,330 1,330\n\n**20154** 2,509,398 108,589 0 153,539,334 153,539,334 9,832,420 433,525 0 576,840,913 576,840,913 4.41 0.00 1,331 1,331\n\n**20161** 2,527,076 114,676 0 161,311,798 161,311,798 9,953,096 442,942 0 598,233,598 598,233,598 4.45 0.00 1,351 1,351\n\n**20162** 2,565,238 120,310 0 151,478,461 151,478,461 10,078,315 455,163 0 617,144,676 617,144,676 4.52 0.00 1,356 1,356\n\nRolling 4-Quarter Annual Trends\n\nSelected: **12 pt Complement Trend** Closed Frequency Reported Frequency Paid Severity Total Paid\n\n(w/Partials) Severity\n\nFrequency: **Closed -3.2%** 8 pt 0.2% #NUM! 5.4% 5.4%\n\nSeverity: **Paid 6.8%** 12 pt -3.2% #NUM! 6.8% 6.8%\n\nPure Premium: **3\\.4%** 16 pt -5.1% #NUM! 7.2% 7.2%\n\n20 pt -5.7% #NUM! 3.6% 3.6%\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt -6.2% #NUM! -10.1% -10.1%\n\nStandard Exhibits Template Page 4.12 10/24/2016 Edition"],"full_content":"**Exhibit 8**\n\n**Century-National Insurance Company**\n\n**Private Passenger Auto Physical Damage**\n\n**Complement Loss and DCCE Trend**\n\n**_Complement Coverage6/Form6/Program6_**\n\n**Complement Loss and DCCE Trend Data Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned Exposures Closed Claims Reported Claims Paid Losses & DCCE**\n\n**Total Paid Losses & DCCE including Partial Payments on Prior Calendar Years, on Closed Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses & DCCE**\n\n**Total Paid Losses & DCCE including Partial Payments on Prior Calendar Years, on Closed Claims**\n\n**Closed Frequency per 100 Exposures**\n\n**Reported Frequency per 100 Exposures**\n\n**Paid Loss & DCCE Severity**\n\n**Total Paid Loss & DCCE Severity including Partial Payments on Prior Calendar Years, on Closed Claims 20094** 2,761,379 167,445 0 571,788,503 571,788,503\n\n**20101** 2,753,351 170,124 0 585,146,952 585,146,952\n\n**20102** 2,752,040 165,592 0 541,562,332 541,562,332\n\n**20103** 2,757,555 170,205 0 543,019,482 543,019,482 11,024,325 673,366 0 2,241,517,269 2,241,517,269 6.11 0.00 3,329 3,329\n\n**20104** 2,759,137 170,925 0 589,634,239 589,634,239 11,022,083 676,846 0 2,259,363,005 2,259,363,005 6.14 0.00 3,338 3,338\n\n**20111** 2,093,286 106,338 0 120,493,446 120,493,446 10,362,018 613,060 0 1,794,709,499 1,794,709,499 5.92 0.00 2,927 2,927\n\n**20112** 2,177,262 117,556 0 116,338,830 116,338,830 9,787,240 565,024 0 1,369,485,997 1,369,485,997 5.77 0.00 2,424 2,424\n\n**20113** 2,217,458 135,826 0 126,923,247 126,923,247 9,247,143 530,645 0 953,389,762 953,389,762 5.74 0.00 1,797 1,797\n\n**20114** 2,217,797 117,406 0 129,556,202 129,556,202 8,705,803 477,126 0 493,311,725 493,311,725 5.48 0.00 1,034 1,034\n\n**20121** 2,216,759 109,629 0 124,596,875 124,596,875 8,829,276 480,417 0 497,415,154 497,415,154 5.44 0.00 1,035 1,035\n\n**20122** 2,229,715 123,746 0 120,292,013 120,292,013 8,881,729 486,607 0 501,368,337 501,368,337 5.48 0.00 1,030 1,030\n\n**20123** 2,251,981 125,161 0 130,448,734 130,448,734 8,916,252 475,942 0 504,893,824 504,893,824 5.34 0.00 1,061 1,061\n\n**20124** 2,268,799 106,555 0 131,635,448 131,635,448 8,967,254 465,091 0 506,973,070 506,973,070 5.19 0.00 1,090 1,090\n\n**20131** 2,265,463 110,090 0 123,775,435 123,775,435 9,015,958 465,552 0 506,151,630 506,151,630 5.16 0.00 1,087 1,087\n\n**20132** 2,281,885 118,015 0 129,617,714 129,617,714 9,068,128 459,821 0 515,477,331 515,477,331 5.07 0.00 1,121 1,121\n\n**20133** 2,297,513 112,606 0 128,711,069 128,711,069 9,113,660 447,266 0 513,739,666 513,739,666 4.91 0.00 1,149 1,149\n\n**20134** 2,311,255 104,334 0 130,149,301 130,149,301 9,156,116 445,045 0 512,253,519 512,253,519 4.86 0.00 1,151 1,151\n\n**20141** 2,310,112 94,469 0 120,973,967 120,973,967 9,200,765 429,424 0 509,452,051 509,452,051 4.67 0.00 1,186 1,186\n\n**20142** 2,337,998 108,725 0 126,485,068 126,485,068 9,256,878 420,134 0 506,319,405 506,319,405 4.54 0.00 1,205 1,205\n\n**20143** 2,361,478 110,783 0 137,678,890 137,678,890 9,320,843 418,311 0 515,287,226 515,287,226 4.49 0.00 1,232 1,232\n\n**20144** 2,379,934 99,563 0 141,113,580 141,113,580 9,389,522 413,540 0 526,251,505 526,251,505 4.40 0.00 1,273 1,273\n\n**20151** 2,406,400 105,259 0 139,919,113 139,919,113 9,485,810 424,330 0 545,196,651 545,196,651 4.47 0.00 1,285 1,285\n\n**20152** 2,440,019 108,089 0 132,567,383 132,567,383 9,587,831 423,694 0 551,278,966 551,278,966 4.42 0.00 1,301 1,301\n\n**20153** 2,476,603 111,588 0 150,815,083 150,815,083 9,702,956 424,499 0 564,415,159 564,415,159 4.37 0.00 1,330 1,330\n\n**20154** 2,509,398 108,589 0 153,539,334 153,539,334 9,832,420 433,525 0 576,840,913 576,840,913 4.41 0.00 1,331 1,331\n\n**20161** 2,527,076 114,676 0 161,311,798 161,311,798 9,953,096 442,942 0 598,233,598 598,233,598 4.45 0.00 1,351 1,351\n\n**20162** 2,565,238 120,310 0 151,478,461 151,478,461 10,078,315 455,163 0 617,144,676 617,144,676 4.52 0.00 1,356 1,356\n\nRolling 4-Quarter Annual Trends\n\nSelected: **12 pt Complement Trend** Closed Frequency Reported Frequency Paid Severity Total Paid\n\n(w/Partials) Severity\n\nFrequency: **Closed -3.2%** 8 pt 0.2% #NUM! 5.4% 5.4%\n\nSeverity: **Paid 6.8%** 12 pt -3.2% #NUM! 6.8% 6.8%\n\nPure Premium: **3\\.4%** 16 pt -5.1% #NUM! 7.2% 7.2%\n\n20 pt -5.7% #NUM! 3.6% 3.6%\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt -6.2% #NUM! -10.1% -10.1%\n\nStandard Exhibits Template Page 4.12 10/24/2016 Edition","publish_date":null,"title":"Century-National Insurance Company Private Passenger Auto Physical Damage Complement Loss and DCCE Trend","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1492.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1492.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1492","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1492.pdf"},"started_at":"2026-11-04T19:47:45.086747"} +{"completed_at":"2026-11-04T19:47:48.410667","latency_in_ms":2186,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1498","grounded_pages":[],"layout_pages":[],"markdown":"California 101 18 Page 3 of 7\n\nAll Other Covered Causes V&MM Vacant Property Factor\n\n$500 $1,000 $1,000 .800\n\n$1,000 $1,000 $1,000 .700\n\n$2,000 $2,000 $2,000 .663\n\n$2,500 $2,500 $2,500 .644\n\n$5,000 $5,000 $5,000 .515\n\n$7,500 $7,500 $7,500 .400\n\n$10,000 $10,000 $10,000 .330\n\n**II. Commercial Occupancies**\n\nAll Covered Causes Factor\n\n500 1.100\n\n$1,000 1.000\n\n$2,000 0.950\n\n$2,500 0.910\n\n$5,000 0.780\n\n$7,500 0.662\n\n$10,000 0.510\n\n$25,000 0.380\n\n**III. Residential Flood**\n\nA $1,000 deductible applies to any property damaged by the peril of flood, which is located in a “V” zone with the elevation of the lowest floor below the Base Flood Elevation (BFE) defined in the Federal National Flood Insurance Program. A $750 deductible applies in all other zones.\n\n**IV. Commercial Flood**\n\nA $1,000 deductible applies to any property damaged by the peril of flood, which is located in a “V” zone with the elevation of the lowest floor below the Base Flood Elevation (BFE) defined in the Federal National Flood Insurance Program. A $750 deductible applies in all other zones.\n\n**V. OPTIONAL FLOOD DEDUCTIBLES**\n\n**VI. CBRA and Nonparticipating Community Flood Coverages** \\- Residential or Commercial\n\nA $2,500 deductible applies to any property damaged by the peril of flood in any CBRA or Nonparticipating Community. An optional deductible of $5,000 is available at 0.90 factor.\n\n**V Zones All Other Zones FACTOR**\n\n$1,000 $750 1.00\n\n$1,000 $1,000 0.970\n\n$2,500 $1,000 0.950\n\n$2,500 $2,500 0.870\n\n$5,000 $2,500 0.850\n\n$5,000 $5,000 0.710","pages":[{"line_numbers":[],"markdown":"California 101 18 Page 3 of 7\n\nAll Other Covered Causes V&MM Vacant Property Factor\n\n$500 $1,000 $1,000 .800\n\n$1,000 $1,000 $1,000 .700\n\n$2,000 $2,000 $2,000 .663\n\n$2,500 $2,500 $2,500 .644\n\n$5,000 $5,000 $5,000 .515\n\n$7,500 $7,500 $7,500 .400\n\n$10,000 $10,000 $10,000 .330\n\n**II. Commercial Occupancies**\n\nAll Covered Causes Factor\n\n500 1.100\n\n$1,000 1.000\n\n$2,000 0.950\n\n$2,500 0.910\n\n$5,000 0.780\n\n$7,500 0.662\n\n$10,000 0.510\n\n$25,000 0.380\n\n**III. Residential Flood**\n\nA $1,000 deductible applies to any property damaged by the peril of flood, which is located in a “V” zone with the elevation of the lowest floor below the Base Flood Elevation (BFE) defined in the Federal National Flood Insurance Program. A $750 deductible applies in all other zones.\n\n**IV. Commercial Flood**\n\nA $1,000 deductible applies to any property damaged by the peril of flood, which is located in a “V” zone with the elevation of the lowest floor below the Base Flood Elevation (BFE) defined in the Federal National Flood Insurance Program. A $750 deductible applies in all other zones.\n\n**V. OPTIONAL FLOOD DEDUCTIBLES**\n\n**VI. CBRA and Nonparticipating Community Flood Coverages** \\- Residential or Commercial\n\nA $2,500 deductible applies to any property damaged by the peril of flood in any CBRA or Nonparticipating Community. An optional deductible of $5,000 is available at 0.90 factor.\n\n**V Zones All Other Zones FACTOR**\n\n$1,000 $750 1.00\n\n$1,000 $1,000 0.970\n\n$2,500 $1,000 0.950\n\n$2,500 $2,500 0.870\n\n$5,000 $2,500 0.850\n\n$5,000 $5,000 0.710","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"California 101 18 Page 3 of 7\n\nAll Other Covered Causes V&MM Vacant Property Factor\n\n$500 $1,000 $1,000 .800\n\n$1,000 $1,000 $1,000 .700\n\n$2,000 $2,000 $2,000 .663\n\n$2,500 $2,500 $2,500 .644\n\n$5,000 $5,000 $5,000 .515\n\n$7,500 $7,500 $7,500 .400\n\n$10,000 $10,000 $10,000 .330\n\n**II. Commercial Occupancies**\n\nAll Covered Causes Factor\n\n500 1.100\n\n$1,000 1.000\n\n$2,000 0.950\n\n$2,500 0.910\n\n$5,000 0.780\n\n$7,500 0.662\n\n$10,000 0.510\n\n$25,000 0.380\n\n**III. Residential Flood**\n\nA $1,000 deductible applies to any property damaged by the peril of flood, which is located in a “V” zone with the elevation of the lowest floor below the Base Flood Elevation (BFE) defined in the Federal National Flood Insurance Program. A $750 deductible applies in all other zones.\n\n**IV. Commercial Flood**\n\nA $1,000 deductible applies to any property damaged by the peril of flood, which is located in a “V” zone with the elevation of the lowest floor below the Base Flood Elevation (BFE) defined in the Federal National Flood Insurance Program. A $750 deductible applies in all other zones.\n\n**V. OPTIONAL FLOOD DEDUCTIBLES**\n\n**VI. CBRA and Nonparticipating Community Flood Coverages** \\- Residential or Commercial\n\nA $2,500 deductible applies to any property damaged by the peril of flood in any CBRA or Nonparticipating Community. An optional deductible of $5,000 is available at 0.90 factor.\n\n**V Zones All Other Zones FACTOR**\n\n$1,000 $750 1.00\n\n$1,000 $1,000 0.970\n\n$2,500 $1,000 0.950\n\n$2,500 $2,500 0.870\n\n$5,000 $2,500 0.850\n\n$5,000 $5,000 0.710","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1498.pdf"]},"response":{"errors":[],"extract_id":"extract_36774eb3db72718a5a0298534ae445e8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["California 101 18 Page 3 of 7\n\nAll Other Covered Causes V&MM Vacant Property Factor\n\n$500 $1,000 $1,000 .800\n\n$1,000 $1,000 $1,000 .700\n\n$2,000 $2,000 $2,000 .663\n\n$2,500 $2,500 $2,500 .644\n\n$5,000 $5,000 $5,000 .515\n\n$7,500 $7,500 $7,500 .400\n\n$10,000 $10,000 $10,000 .330\n\n**II. Commercial Occupancies**\n\nAll Covered Causes Factor\n\n500 1.100\n\n$1,000 1.000\n\n$2,000 0.950\n\n$2,500 0.910\n\n$5,000 0.780\n\n$7,500 0.662\n\n$10,000 0.510\n\n$25,000 0.380\n\n**III. Residential Flood**\n\nA $1,000 deductible applies to any property damaged by the peril of flood, which is located in a “V” zone with the elevation of the lowest floor below the Base Flood Elevation (BFE) defined in the Federal National Flood Insurance Program. A $750 deductible applies in all other zones.\n\n**IV. Commercial Flood**\n\nA $1,000 deductible applies to any property damaged by the peril of flood, which is located in a “V” zone with the elevation of the lowest floor below the Base Flood Elevation (BFE) defined in the Federal National Flood Insurance Program. A $750 deductible applies in all other zones.\n\n**V. OPTIONAL FLOOD DEDUCTIBLES**\n\n**VI. CBRA and Nonparticipating Community Flood Coverages** \\- Residential or Commercial\n\nA $2,500 deductible applies to any property damaged by the peril of flood in any CBRA or Nonparticipating Community. An optional deductible of $5,000 is available at 0.90 factor.\n\n**V Zones All Other Zones FACTOR**\n\n$1,000 $750 1.00\n\n$1,000 $1,000 0.970\n\n$2,500 $1,000 0.950\n\n$2,500 $2,500 0.870\n\n$5,000 $2,500 0.850\n\n$5,000 $5,000 0.710"],"full_content":"California 101 18 Page 3 of 7\n\nAll Other Covered Causes V&MM Vacant Property Factor\n\n$500 $1,000 $1,000 .800\n\n$1,000 $1,000 $1,000 .700\n\n$2,000 $2,000 $2,000 .663\n\n$2,500 $2,500 $2,500 .644\n\n$5,000 $5,000 $5,000 .515\n\n$7,500 $7,500 $7,500 .400\n\n$10,000 $10,000 $10,000 .330\n\n**II. Commercial Occupancies**\n\nAll Covered Causes Factor\n\n500 1.100\n\n$1,000 1.000\n\n$2,000 0.950\n\n$2,500 0.910\n\n$5,000 0.780\n\n$7,500 0.662\n\n$10,000 0.510\n\n$25,000 0.380\n\n**III. Residential Flood**\n\nA $1,000 deductible applies to any property damaged by the peril of flood, which is located in a “V” zone with the elevation of the lowest floor below the Base Flood Elevation (BFE) defined in the Federal National Flood Insurance Program. A $750 deductible applies in all other zones.\n\n**IV. Commercial Flood**\n\nA $1,000 deductible applies to any property damaged by the peril of flood, which is located in a “V” zone with the elevation of the lowest floor below the Base Flood Elevation (BFE) defined in the Federal National Flood Insurance Program. A $750 deductible applies in all other zones.\n\n**V. OPTIONAL FLOOD DEDUCTIBLES**\n\n**VI. CBRA and Nonparticipating Community Flood Coverages** \\- Residential or Commercial\n\nA $2,500 deductible applies to any property damaged by the peril of flood in any CBRA or Nonparticipating Community. An optional deductible of $5,000 is available at 0.90 factor.\n\n**V Zones All Other Zones FACTOR**\n\n$1,000 $750 1.00\n\n$1,000 $1,000 0.970\n\n$2,500 $1,000 0.950\n\n$2,500 $2,500 0.870\n\n$5,000 $2,500 0.850\n\n$5,000 $5,000 0.710","publish_date":null,"title":"$500 $1,000 $1,000 .800 $1,000 $1,000 $1,000 .700 $2,000 $2,000 $2,000 .663 $2,500 $2,500 $2,500 .644 $5,000 $5,000 $5,000 .515","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1498.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1498.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1498","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1498.pdf"},"started_at":"2026-11-04T19:47:46.224333"} +{"completed_at":"2026-11-04T19:47:48.308247","latency_in_ms":1178,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1551","grounded_pages":[],"layout_pages":[],"markdown":"Replacement Cost Factor Countrywide Multivariate Discount Factor 4 MULT\n\nLegacy Family Discount Factor Policy & Vehicle Level Discount Factor 4 MULT\n\nPolicy & Vehicle Level Surcharge Factor 4 MULT\n\nAcquisition Cost Full Coverage Policy Level Paid in Full Discount (1- % discount) 4 MULT x x x x x x x x x x x x x x\n\nAutopay Discount Factor (1- %discount) 4 MULT x x x x x x x x x x x x x x\n\nPayment Adjustment\n\nRV Basic Economy 4 MULT x x x x x x x x x x x x x x\n\nRV Depreciation Free Claims 4 MULT x x\n\nRV Broadened Comp 4 MULT x\n\nRV Custom Equip 4 MULT x x x x x x x x x Rate Stability Factor Accident Forgiveness 4 MULT x x x x x x x x x x x x x x x x x\n\n**Coverage Premium**\n\nSee Countrywide Multivariate Discount section of Discount & Surcharge sheet\n\nSee Policy & Vehicle Level Discount section of Discount and Surcharge sheet. - (1-Discount #1) X (1-Discount #2) X . . . for each coverage.\n\nSee Policy & Vehicle Level Surcharge section of Discount and Surcharge sheet. - (1+ Surcharge #1) X (1 + Surcharge #2) X . . . for each coverage.\n\n0\n\nRates - Section 1A Page 2 of 3","pages":[{"line_numbers":[],"markdown":"Replacement Cost Factor Countrywide Multivariate Discount Factor 4 MULT\n\nLegacy Family Discount Factor Policy & Vehicle Level Discount Factor 4 MULT\n\nPolicy & Vehicle Level Surcharge Factor 4 MULT\n\nAcquisition Cost Full Coverage Policy Level Paid in Full Discount (1- % discount) 4 MULT x x x x x x x x x x x x x x\n\nAutopay Discount Factor (1- %discount) 4 MULT x x x x x x x x x x x x x x\n\nPayment Adjustment\n\nRV Basic Economy 4 MULT x x x x x x x x x x x x x x\n\nRV Depreciation Free Claims 4 MULT x x\n\nRV Broadened Comp 4 MULT x\n\nRV Custom Equip 4 MULT x x x x x x x x x Rate Stability Factor Accident Forgiveness 4 MULT x x x x x x x x x x x x x x x x x\n\n**Coverage Premium**\n\nSee Countrywide Multivariate Discount section of Discount & Surcharge sheet\n\nSee Policy & Vehicle Level Discount section of Discount and Surcharge sheet. - (1-Discount #1) X (1-Discount #2) X . . . for each coverage.\n\nSee Policy & Vehicle Level Surcharge section of Discount and Surcharge sheet. - (1+ Surcharge #1) X (1 + Surcharge #2) X . . . for each coverage.\n\n0\n\nRates - Section 1A Page 2 of 3","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Replacement Cost Factor Countrywide Multivariate Discount Factor 4 MULT\n\nLegacy Family Discount Factor Policy & Vehicle Level Discount Factor 4 MULT\n\nPolicy & Vehicle Level Surcharge Factor 4 MULT\n\nAcquisition Cost Full Coverage Policy Level Paid in Full Discount (1- % discount) 4 MULT x x x x x x x x x x x x x x\n\nAutopay Discount Factor (1- %discount) 4 MULT x x x x x x x x x x x x x x\n\nPayment Adjustment\n\nRV Basic Economy 4 MULT x x x x x x x x x x x x x x\n\nRV Depreciation Free Claims 4 MULT x x\n\nRV Broadened Comp 4 MULT x\n\nRV Custom Equip 4 MULT x x x x x x x x x Rate Stability Factor Accident Forgiveness 4 MULT x x x x x x x x x x x x x x x x x\n\n**Coverage Premium**\n\nSee Countrywide Multivariate Discount section of Discount & Surcharge sheet\n\nSee Policy & Vehicle Level Discount section of Discount and Surcharge sheet. - (1-Discount #1) X (1-Discount #2) X . . . for each coverage.\n\nSee Policy & Vehicle Level Surcharge section of Discount and Surcharge sheet. - (1+ Surcharge #1) X (1 + Surcharge #2) X . . . for each coverage.\n\n0\n\nRates - Section 1A Page 2 of 3","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1551.pdf"]},"response":{"errors":[],"extract_id":"extract_d8137f35205a7887684ec72e3319d11d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Replacement Cost Factor Countrywide Multivariate Discount Factor 4 MULT\n\nLegacy Family Discount Factor Policy & Vehicle Level Discount Factor 4 MULT\n\nPolicy & Vehicle Level Surcharge Factor 4 MULT\n\nAcquisition Cost Full Coverage Policy Level Paid in Full Discount (1- % discount) 4 MULT x x x x x x x x x x x x x x\n\nAutopay Discount Factor (1- %discount) 4 MULT x x x x x x x x x x x x x x\n\nPayment Adjustment\n\nRV Basic Economy 4 MULT x x x x x x x x x x x x x x\n\nRV Depreciation Free Claims 4 MULT x x\n\nRV Broadened Comp 4 MULT x\n\nRV Custom Equip 4 MULT x x x x x x x x x Rate Stability Factor Accident Forgiveness 4 MULT x x x x x x x x x x x x x x x x x\n\n**Coverage Premium**\n\nSee Countrywide Multivariate Discount section of Discount & Surcharge sheet\n\nSee Policy & Vehicle Level Discount section of Discount and Surcharge sheet. - (1-Discount #1) X (1-Discount #2) X . . . for each coverage.\n\nSee Policy & Vehicle Level Surcharge section of Discount and Surcharge sheet. - (1+ Surcharge #1) X (1 + Surcharge #2) X . . . for each coverage.\n\n0\n\nRates - Section 1A Page 2 of 3"],"full_content":"Replacement Cost Factor Countrywide Multivariate Discount Factor 4 MULT\n\nLegacy Family Discount Factor Policy & Vehicle Level Discount Factor 4 MULT\n\nPolicy & Vehicle Level Surcharge Factor 4 MULT\n\nAcquisition Cost Full Coverage Policy Level Paid in Full Discount (1- % discount) 4 MULT x x x x x x x x x x x x x x\n\nAutopay Discount Factor (1- %discount) 4 MULT x x x x x x x x x x x x x x\n\nPayment Adjustment\n\nRV Basic Economy 4 MULT x x x x x x x x x x x x x x\n\nRV Depreciation Free Claims 4 MULT x x\n\nRV Broadened Comp 4 MULT x\n\nRV Custom Equip 4 MULT x x x x x x x x x Rate Stability Factor Accident Forgiveness 4 MULT x x x x x x x x x x x x x x x x x\n\n**Coverage Premium**\n\nSee Countrywide Multivariate Discount section of Discount & Surcharge sheet\n\nSee Policy & Vehicle Level Discount section of Discount and Surcharge sheet. - (1-Discount #1) X (1-Discount #2) X . . . for each coverage.\n\nSee Policy & Vehicle Level Surcharge section of Discount and Surcharge sheet. - (1+ Surcharge #1) X (1 + Surcharge #2) X . . . for each coverage.\n\n0\n\nRates - Section 1A Page 2 of 3","publish_date":null,"title":"Replacement Cost Factor Countrywide See Countrywide Multivariate Discount section of Discount & Surcharge sheet Multivariate 4 MULT Discount Factor Legacy","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1551.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1551.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1551","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1551.pdf"},"started_at":"2026-11-04T19:47:47.129547"} +{"completed_at":"2026-11-04T19:47:49.350204","latency_in_ms":1040,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1634","grounded_pages":[],"layout_pages":[],"markdown":"### will be in the trends but not in the triangle. Below is a table balancing the CY between the two. As you can see, exhibit 7 is always greater than exhibit 8.\n\nExhibit 8 Exhibit 7 Diff\n\n2014\n\n3,103,723\n\n3,109,545\n\n5,822\n\n2015\n\n3,125,758\n\n3,139,441\n\n13,683\n\n2016\n\n3,856,833\n\n3,899,579\n\n42,746\n\n2017\n\n3,705,044\n\n3,716,028\n\n10,984\n\n2018\n\n3,985,383\n\n3,997,190\n\n11,806\n\n2019\n\n5,658,138\n\n5,663,972\n\n5,834\n\n### **Exhibit 8: Loss and Defense and Cost Containment (DCCE) Trend** The standard exhibit has been completed for all perils combined. For HO-3 and HO-5, we felt it was the most appropriate to select the 12-point trend because it uses more of our data and fits the data well. In addition, changing the trending period would impact the premium trend. Evaluating all the combinations of frequency, severity, and premium trend to get a loss ratio trend for HO-3 and HO-5 (where frequency is closed, severity is paid), we get this table of trends: 8-point 1.33\n\n### 12-point 1.09\n\n### 16-point 1.05\n\n### 20-point 1.05\n\n### 24-point 1.11\n\n### Thus, the 12-point trend selection also results in the median loss ratio trend that could be selected. Previously, we also selected the 12-point trend, however we had instead selected the frequency reported. If we instead selected the reported, our loss trend would have been 5.8% instead of the 5.1% that was selected. For MH-7, we thought stability of the book was reasonable and a 20 point trend is consistent with past experience. **Exhibit 9: Catastrophe Adjustment** 25 years of internal Homeowners loss experience in California was used to determine a catastrophe load by splitting incurred losses into catastrophic and non-catastrophic components.","pages":[{"line_numbers":[],"markdown":"### will be in the trends but not in the triangle. Below is a table balancing the CY between the two. As you can see, exhibit 7 is always greater than exhibit 8.\n\nExhibit 8 Exhibit 7 Diff\n\n2014\n\n3,103,723\n\n3,109,545\n\n5,822\n\n2015\n\n3,125,758\n\n3,139,441\n\n13,683\n\n2016\n\n3,856,833\n\n3,899,579\n\n42,746\n\n2017\n\n3,705,044\n\n3,716,028\n\n10,984\n\n2018\n\n3,985,383\n\n3,997,190\n\n11,806\n\n2019\n\n5,658,138\n\n5,663,972\n\n5,834\n\n### **Exhibit 8: Loss and Defense and Cost Containment (DCCE) Trend** The standard exhibit has been completed for all perils combined. For HO-3 and HO-5, we felt it was the most appropriate to select the 12-point trend because it uses more of our data and fits the data well. In addition, changing the trending period would impact the premium trend. Evaluating all the combinations of frequency, severity, and premium trend to get a loss ratio trend for HO-3 and HO-5 (where frequency is closed, severity is paid), we get this table of trends: 8-point 1.33\n\n### 12-point 1.09\n\n### 16-point 1.05\n\n### 20-point 1.05\n\n### 24-point 1.11\n\n### Thus, the 12-point trend selection also results in the median loss ratio trend that could be selected. Previously, we also selected the 12-point trend, however we had instead selected the frequency reported. If we instead selected the reported, our loss trend would have been 5.8% instead of the 5.1% that was selected. For MH-7, we thought stability of the book was reasonable and a 20 point trend is consistent with past experience. **Exhibit 9: Catastrophe Adjustment** 25 years of internal Homeowners loss experience in California was used to determine a catastrophe load by splitting incurred losses into catastrophic and non-catastrophic components.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### will be in the trends but not in the triangle. Below is a table balancing the CY between the two. As you can see, exhibit 7 is always greater than exhibit 8.\n\nExhibit 8 Exhibit 7 Diff\n\n2014\n\n3,103,723\n\n3,109,545\n\n5,822\n\n2015\n\n3,125,758\n\n3,139,441\n\n13,683\n\n2016\n\n3,856,833\n\n3,899,579\n\n42,746\n\n2017\n\n3,705,044\n\n3,716,028\n\n10,984\n\n2018\n\n3,985,383\n\n3,997,190\n\n11,806\n\n2019\n\n5,658,138\n\n5,663,972\n\n5,834\n\n### **Exhibit 8: Loss and Defense and Cost Containment (DCCE) Trend** The standard exhibit has been completed for all perils combined. For HO-3 and HO-5, we felt it was the most appropriate to select the 12-point trend because it uses more of our data and fits the data well. In addition, changing the trending period would impact the premium trend. Evaluating all the combinations of frequency, severity, and premium trend to get a loss ratio trend for HO-3 and HO-5 (where frequency is closed, severity is paid), we get this table of trends: 8-point 1.33\n\n### 12-point 1.09\n\n### 16-point 1.05\n\n### 20-point 1.05\n\n### 24-point 1.11\n\n### Thus, the 12-point trend selection also results in the median loss ratio trend that could be selected. Previously, we also selected the 12-point trend, however we had instead selected the frequency reported. If we instead selected the reported, our loss trend would have been 5.8% instead of the 5.1% that was selected. For MH-7, we thought stability of the book was reasonable and a 20 point trend is consistent with past experience. **Exhibit 9: Catastrophe Adjustment** 25 years of internal Homeowners loss experience in California was used to determine a catastrophe load by splitting incurred losses into catastrophic and non-catastrophic components.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1634.pdf"]},"response":{"errors":[],"extract_id":"extract_43c410967944fcb451c5d3338826c462","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### will be in the trends but not in the triangle. Below is a table balancing the CY between the two. As you can see, exhibit 7 is always greater than exhibit 8.\n\nExhibit 8 Exhibit 7 Diff\n\n2014\n\n3,103,723\n\n3,109,545\n\n5,822\n\n2015\n\n3,125,758\n\n3,139,441\n\n13,683\n\n2016\n\n3,856,833\n\n3,899,579\n\n42,746\n\n2017\n\n3,705,044\n\n3,716,028\n\n10,984\n\n2018\n\n3,985,383\n\n3,997,190\n\n11,806\n\n2019\n\n5,658,138\n\n5,663,972\n\n5,834\n\n### **Exhibit 8: Loss and Defense and Cost Containment (DCCE) Trend** The standard exhibit has been completed for all perils combined. For HO-3 and HO-5, we felt it was the most appropriate to select the 12-point trend because it uses more of our data and fits the data well. In addition, changing the trending period would impact the premium trend. Evaluating all the combinations of frequency, severity, and premium trend to get a loss ratio trend for HO-3 and HO-5 (where frequency is closed, severity is paid), we get this table of trends: 8-point 1.33\n\n### 12-point 1.09\n\n### 16-point 1.05\n\n### 20-point 1.05\n\n### 24-point 1.11\n\n### Thus, the 12-point trend selection also results in the median loss ratio trend that could be selected. Previously, we also selected the 12-point trend, however we had instead selected the frequency reported. If we instead selected the reported, our loss trend would have been 5.8% instead of the 5.1% that was selected. For MH-7, we thought stability of the book was reasonable and a 20 point trend is consistent with past experience. **Exhibit 9: Catastrophe Adjustment** 25 years of internal Homeowners loss experience in California was used to determine a catastrophe load by splitting incurred losses into catastrophic and non-catastrophic components."],"full_content":"### will be in the trends but not in the triangle. Below is a table balancing the CY between the two. As you can see, exhibit 7 is always greater than exhibit 8.\n\nExhibit 8 Exhibit 7 Diff\n\n2014\n\n3,103,723\n\n3,109,545\n\n5,822\n\n2015\n\n3,125,758\n\n3,139,441\n\n13,683\n\n2016\n\n3,856,833\n\n3,899,579\n\n42,746\n\n2017\n\n3,705,044\n\n3,716,028\n\n10,984\n\n2018\n\n3,985,383\n\n3,997,190\n\n11,806\n\n2019\n\n5,658,138\n\n5,663,972\n\n5,834\n\n### **Exhibit 8: Loss and Defense and Cost Containment (DCCE) Trend** The standard exhibit has been completed for all perils combined. For HO-3 and HO-5, we felt it was the most appropriate to select the 12-point trend because it uses more of our data and fits the data well. In addition, changing the trending period would impact the premium trend. Evaluating all the combinations of frequency, severity, and premium trend to get a loss ratio trend for HO-3 and HO-5 (where frequency is closed, severity is paid), we get this table of trends: 8-point 1.33\n\n### 12-point 1.09\n\n### 16-point 1.05\n\n### 20-point 1.05\n\n### 24-point 1.11\n\n### Thus, the 12-point trend selection also results in the median loss ratio trend that could be selected. Previously, we also selected the 12-point trend, however we had instead selected the frequency reported. If we instead selected the reported, our loss trend would have been 5.8% instead of the 5.1% that was selected. For MH-7, we thought stability of the book was reasonable and a 20 point trend is consistent with past experience. **Exhibit 9: Catastrophe Adjustment** 25 years of internal Homeowners loss experience in California was used to determine a catastrophe load by splitting incurred losses into catastrophic and non-catastrophic components.","publish_date":null,"title":"will be in the trends but not in the triangle. Below is a table balancing the CY between the two.","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1634.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1634.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1634","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1634.pdf"},"started_at":"2026-11-04T19:47:48.309890"} +{"completed_at":"2026-11-04T19:47:51.549614","latency_in_ms":2276,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1637","grounded_pages":[],"layout_pages":[],"markdown":"**Zipcode Policy Current Premium Proposed Premium Average**\n\n**Count Change**\n\n**EXHIBIT 20**\n\n### **Customer Dislocation by Zipcode**\n\n**California Homeowners**\n\n95437 62 53,429 49,746 -6.89%\n\n95441 2 1,930 1,982 2.71%\n\n95442 2 2,125 3,448 62.28%\n\n95444 1 1,526 1,573 3.11%\n\n95445 9 7,946 7,504 -5.56%\n\n95446 5 4,167 4,320 3.68%\n\n95448 16 27,406 28,573 4.26%\n\n95449 14 15,648 18,871 20.60%\n\n95450 1 908 859 -5.38%\n\n95451 32 35,201 47,033 33.61%\n\n95452 1 1,484 1,581 6.56%\n\n95453 2 2,017 2,838 40.70%\n\n95453 83 118,159 163,024 37.97%\n\n95457 2 2,683 4,374 63.02%\n\n95458 1 664 739 11.28%\n\n95458 14 14,191 15,852 11.70%\n\n95459 3 2,078 1,929 -7.18%\n\n95460 5 6,751 6,321 -6.37%\n\n95461 4 5,787 9,534 64.75%\n\n95462 1 892 845 -5.24%\n\n95463 1 1,489 1,408 -5.43%\n\n95464 6 5,930 6,364 7.33%\n\n95465 1 1,862 1,917 2.95%\n\n95466 11 17,589 19,252 9.45%\n\n95467 8 11,541 19,090 65.41%\n\n95468 6 5,087 4,727 -7.09%\n\n95469 9 10,945 11,594 5.93%\n\n95470 1 863 890 3.08%\n\n95470 89 94,423 113,756 20.47%\n\n95472 15 26,917 30,487 13.26%\n\n95476 5 7,939 9,032 13.77%\n\n95482 1 682 702 2.95%\n\n95482 270 247,873 257,846 4.02%\n\n95485 2 1,182 1,523 28.85%\n\n95485 21 29,181 36,153 23.89%\n\n95488 1 2,373 2,243 -5.50%\n\n95490 1 727 689 -5.28%\n\n95490 41 41,479 42,411 2.25%\n\n95492 4 5,016 4,989 -0.54%\n\n95493 4 7,449 11,403 53.08%\n\n95497 4 7,387 6,988 -5.40%\n\n95501 143 87,158 81,139 -6.91%\n\n95503 293 191,024 177,974 -6.83%\n\n95519 139 90,406 86,341 -4.50%\n\n95521 89 57,823 54,434 -5.86%\n\n95524 26 21,819 20,580 -5.68%\n\n95525 17 13,221 13,055 -1.25%\n\n95528 20 14,779 13,833 -6.40%\n\n95531 284 225,229 208,768 -7.31%\n\n95536 18 13,802 12,904 -6.51%\n\n95537 3 1,290 1,200 -7.00%\n\n95540 154 101,940 95,102 -6.71%\n\n95542 1 1,493 1,539 3.09%\n\n95543 1 792 989 24.82%\n\n95546 3 2,584 3,522 36.30%\n\n95547 15 11,448 10,634 -7.11%\n\n95548 7 5,068 4,592 -9.39%\n\n95549 7 9,876 9,389 -4.93%","pages":[{"line_numbers":[],"markdown":"**Zipcode Policy Current Premium Proposed Premium Average**\n\n**Count Change**\n\n**EXHIBIT 20**\n\n### **Customer Dislocation by Zipcode**\n\n**California Homeowners**\n\n95437 62 53,429 49,746 -6.89%\n\n95441 2 1,930 1,982 2.71%\n\n95442 2 2,125 3,448 62.28%\n\n95444 1 1,526 1,573 3.11%\n\n95445 9 7,946 7,504 -5.56%\n\n95446 5 4,167 4,320 3.68%\n\n95448 16 27,406 28,573 4.26%\n\n95449 14 15,648 18,871 20.60%\n\n95450 1 908 859 -5.38%\n\n95451 32 35,201 47,033 33.61%\n\n95452 1 1,484 1,581 6.56%\n\n95453 2 2,017 2,838 40.70%\n\n95453 83 118,159 163,024 37.97%\n\n95457 2 2,683 4,374 63.02%\n\n95458 1 664 739 11.28%\n\n95458 14 14,191 15,852 11.70%\n\n95459 3 2,078 1,929 -7.18%\n\n95460 5 6,751 6,321 -6.37%\n\n95461 4 5,787 9,534 64.75%\n\n95462 1 892 845 -5.24%\n\n95463 1 1,489 1,408 -5.43%\n\n95464 6 5,930 6,364 7.33%\n\n95465 1 1,862 1,917 2.95%\n\n95466 11 17,589 19,252 9.45%\n\n95467 8 11,541 19,090 65.41%\n\n95468 6 5,087 4,727 -7.09%\n\n95469 9 10,945 11,594 5.93%\n\n95470 1 863 890 3.08%\n\n95470 89 94,423 113,756 20.47%\n\n95472 15 26,917 30,487 13.26%\n\n95476 5 7,939 9,032 13.77%\n\n95482 1 682 702 2.95%\n\n95482 270 247,873 257,846 4.02%\n\n95485 2 1,182 1,523 28.85%\n\n95485 21 29,181 36,153 23.89%\n\n95488 1 2,373 2,243 -5.50%\n\n95490 1 727 689 -5.28%\n\n95490 41 41,479 42,411 2.25%\n\n95492 4 5,016 4,989 -0.54%\n\n95493 4 7,449 11,403 53.08%\n\n95497 4 7,387 6,988 -5.40%\n\n95501 143 87,158 81,139 -6.91%\n\n95503 293 191,024 177,974 -6.83%\n\n95519 139 90,406 86,341 -4.50%\n\n95521 89 57,823 54,434 -5.86%\n\n95524 26 21,819 20,580 -5.68%\n\n95525 17 13,221 13,055 -1.25%\n\n95528 20 14,779 13,833 -6.40%\n\n95531 284 225,229 208,768 -7.31%\n\n95536 18 13,802 12,904 -6.51%\n\n95537 3 1,290 1,200 -7.00%\n\n95540 154 101,940 95,102 -6.71%\n\n95542 1 1,493 1,539 3.09%\n\n95543 1 792 989 24.82%\n\n95546 3 2,584 3,522 36.30%\n\n95547 15 11,448 10,634 -7.11%\n\n95548 7 5,068 4,592 -9.39%\n\n95549 7 9,876 9,389 -4.93%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Zipcode Policy Current Premium Proposed Premium Average**\n\n**Count Change**\n\n**EXHIBIT 20**\n\n### **Customer Dislocation by Zipcode**\n\n**California Homeowners**\n\n95437 62 53,429 49,746 -6.89%\n\n95441 2 1,930 1,982 2.71%\n\n95442 2 2,125 3,448 62.28%\n\n95444 1 1,526 1,573 3.11%\n\n95445 9 7,946 7,504 -5.56%\n\n95446 5 4,167 4,320 3.68%\n\n95448 16 27,406 28,573 4.26%\n\n95449 14 15,648 18,871 20.60%\n\n95450 1 908 859 -5.38%\n\n95451 32 35,201 47,033 33.61%\n\n95452 1 1,484 1,581 6.56%\n\n95453 2 2,017 2,838 40.70%\n\n95453 83 118,159 163,024 37.97%\n\n95457 2 2,683 4,374 63.02%\n\n95458 1 664 739 11.28%\n\n95458 14 14,191 15,852 11.70%\n\n95459 3 2,078 1,929 -7.18%\n\n95460 5 6,751 6,321 -6.37%\n\n95461 4 5,787 9,534 64.75%\n\n95462 1 892 845 -5.24%\n\n95463 1 1,489 1,408 -5.43%\n\n95464 6 5,930 6,364 7.33%\n\n95465 1 1,862 1,917 2.95%\n\n95466 11 17,589 19,252 9.45%\n\n95467 8 11,541 19,090 65.41%\n\n95468 6 5,087 4,727 -7.09%\n\n95469 9 10,945 11,594 5.93%\n\n95470 1 863 890 3.08%\n\n95470 89 94,423 113,756 20.47%\n\n95472 15 26,917 30,487 13.26%\n\n95476 5 7,939 9,032 13.77%\n\n95482 1 682 702 2.95%\n\n95482 270 247,873 257,846 4.02%\n\n95485 2 1,182 1,523 28.85%\n\n95485 21 29,181 36,153 23.89%\n\n95488 1 2,373 2,243 -5.50%\n\n95490 1 727 689 -5.28%\n\n95490 41 41,479 42,411 2.25%\n\n95492 4 5,016 4,989 -0.54%\n\n95493 4 7,449 11,403 53.08%\n\n95497 4 7,387 6,988 -5.40%\n\n95501 143 87,158 81,139 -6.91%\n\n95503 293 191,024 177,974 -6.83%\n\n95519 139 90,406 86,341 -4.50%\n\n95521 89 57,823 54,434 -5.86%\n\n95524 26 21,819 20,580 -5.68%\n\n95525 17 13,221 13,055 -1.25%\n\n95528 20 14,779 13,833 -6.40%\n\n95531 284 225,229 208,768 -7.31%\n\n95536 18 13,802 12,904 -6.51%\n\n95537 3 1,290 1,200 -7.00%\n\n95540 154 101,940 95,102 -6.71%\n\n95542 1 1,493 1,539 3.09%\n\n95543 1 792 989 24.82%\n\n95546 3 2,584 3,522 36.30%\n\n95547 15 11,448 10,634 -7.11%\n\n95548 7 5,068 4,592 -9.39%\n\n95549 7 9,876 9,389 -4.93%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1637.pdf"]},"response":{"errors":[],"extract_id":"extract_61989e4f3016d45df26b9514193e23bc","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Zipcode Policy Current Premium Proposed Premium Average**\n\n**Count Change**\n\n**EXHIBIT 20**\n\n### **Customer Dislocation by Zipcode**\n\n**California Homeowners**\n\n95437 62 53,429 49,746 -6.89%\n\n95441 2 1,930 1,982 2.71%\n\n95442 2 2,125 3,448 62.28%\n\n95444 1 1,526 1,573 3.11%\n\n95445 9 7,946 7,504 -5.56%\n\n95446 5 4,167 4,320 3.68%\n\n95448 16 27,406 28,573 4.26%\n\n95449 14 15,648 18,871 20.60%\n\n95450 1 908 859 -5.38%\n\n95451 32 35,201 47,033 33.61%\n\n95452 1 1,484 1,581 6.56%\n\n95453 2 2,017 2,838 40.70%\n\n95453 83 118,159 163,024 37.97%\n\n95457 2 2,683 4,374 63.02%\n\n95458 1 664 739 11.28%\n\n95458 14 14,191 15,852 11.70%\n\n95459 3 2,078 1,929 -7.18%\n\n95460 5 6,751 6,321 -6.37%\n\n95461 4 5,787 9,534 64.75%\n\n95462 1 892 845 -5.24%\n\n95463 1 1,489 1,408 -5.43%\n\n95464 6 5,930 6,364 7.33%\n\n95465 1 1,862 1,917 2.95%\n\n95466 11 17,589 19,252 9.45%\n\n95467 8 11,541 19,090 65.41%\n\n95468 6 5,087 4,727 -7.09%\n\n95469 9 10,945 11,594 5.93%\n\n95470 1 863 890 3.08%\n\n95470 89 94,423 113,756 20.47%\n\n95472 15 26,917 30,487 13.26%\n\n95476 5 7,939 9,032 13.77%\n\n95482 1 682 702 2.95%\n\n95482 270 247,873 257,846 4.02%\n\n95485 2 1,182 1,523 28.85%\n\n95485 21 29,181 36,153 23.89%\n\n95488 1 2,373 2,243 -5.50%\n\n95490 1 727 689 -5.28%\n\n95490 41 41,479 42,411 2.25%\n\n95492 4 5,016 4,989 -0.54%\n\n95493 4 7,449 11,403 53.08%\n\n95497 4 7,387 6,988 -5.40%\n\n95501 143 87,158 81,139 -6.91%\n\n95503 293 191,024 177,974 -6.83%\n\n95519 139 90,406 86,341 -4.50%\n\n95521 89 57,823 54,434 -5.86%\n\n95524 26 21,819 20,580 -5.68%\n\n95525 17 13,221 13,055 -1.25%\n\n95528 20 14,779 13,833 -6.40%\n\n95531 284 225,229 208,768 -7.31%\n\n95536 18 13,802 12,904 -6.51%\n\n95537 3 1,290 1,200 -7.00%\n\n95540 154 101,940 95,102 -6.71%\n\n95542 1 1,493 1,539 3.09%\n\n95543 1 792 989 24.82%\n\n95546 3 2,584 3,522 36.30%\n\n95547 15 11,448 10,634 -7.11%\n\n95548 7 5,068 4,592 -9.39%\n\n95549 7 9,876 9,389 -4.93%"],"full_content":"**Zipcode Policy Current Premium Proposed Premium Average**\n\n**Count Change**\n\n**EXHIBIT 20**\n\n### **Customer Dislocation by Zipcode**\n\n**California Homeowners**\n\n95437 62 53,429 49,746 -6.89%\n\n95441 2 1,930 1,982 2.71%\n\n95442 2 2,125 3,448 62.28%\n\n95444 1 1,526 1,573 3.11%\n\n95445 9 7,946 7,504 -5.56%\n\n95446 5 4,167 4,320 3.68%\n\n95448 16 27,406 28,573 4.26%\n\n95449 14 15,648 18,871 20.60%\n\n95450 1 908 859 -5.38%\n\n95451 32 35,201 47,033 33.61%\n\n95452 1 1,484 1,581 6.56%\n\n95453 2 2,017 2,838 40.70%\n\n95453 83 118,159 163,024 37.97%\n\n95457 2 2,683 4,374 63.02%\n\n95458 1 664 739 11.28%\n\n95458 14 14,191 15,852 11.70%\n\n95459 3 2,078 1,929 -7.18%\n\n95460 5 6,751 6,321 -6.37%\n\n95461 4 5,787 9,534 64.75%\n\n95462 1 892 845 -5.24%\n\n95463 1 1,489 1,408 -5.43%\n\n95464 6 5,930 6,364 7.33%\n\n95465 1 1,862 1,917 2.95%\n\n95466 11 17,589 19,252 9.45%\n\n95467 8 11,541 19,090 65.41%\n\n95468 6 5,087 4,727 -7.09%\n\n95469 9 10,945 11,594 5.93%\n\n95470 1 863 890 3.08%\n\n95470 89 94,423 113,756 20.47%\n\n95472 15 26,917 30,487 13.26%\n\n95476 5 7,939 9,032 13.77%\n\n95482 1 682 702 2.95%\n\n95482 270 247,873 257,846 4.02%\n\n95485 2 1,182 1,523 28.85%\n\n95485 21 29,181 36,153 23.89%\n\n95488 1 2,373 2,243 -5.50%\n\n95490 1 727 689 -5.28%\n\n95490 41 41,479 42,411 2.25%\n\n95492 4 5,016 4,989 -0.54%\n\n95493 4 7,449 11,403 53.08%\n\n95497 4 7,387 6,988 -5.40%\n\n95501 143 87,158 81,139 -6.91%\n\n95503 293 191,024 177,974 -6.83%\n\n95519 139 90,406 86,341 -4.50%\n\n95521 89 57,823 54,434 -5.86%\n\n95524 26 21,819 20,580 -5.68%\n\n95525 17 13,221 13,055 -1.25%\n\n95528 20 14,779 13,833 -6.40%\n\n95531 284 225,229 208,768 -7.31%\n\n95536 18 13,802 12,904 -6.51%\n\n95537 3 1,290 1,200 -7.00%\n\n95540 154 101,940 95,102 -6.71%\n\n95542 1 1,493 1,539 3.09%\n\n95543 1 792 989 24.82%\n\n95546 3 2,584 3,522 36.30%\n\n95547 15 11,448 10,634 -7.11%\n\n95548 7 5,068 4,592 -9.39%\n\n95549 7 9,876 9,389 -4.93%","publish_date":null,"title":"Customer Dislocation by Zipcode","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1637.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1637.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1637","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1637.pdf"},"started_at":"2026-11-04T19:47:49.272693"} +{"completed_at":"2026-11-04T19:47:52.451662","latency_in_ms":2292,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1661","grounded_pages":[],"layout_pages":[],"markdown":"### **Exhibit 7**\n\n## **Grange Insurance Association Homeowners Multiple Peril**\n\n## **Loss & DCCE Development**\n\n**_HO3/HO5_**\n\n**Selected Ultimate Loss & DCCE:** Incurred\n\n**Selected Ultimate DCCE (if applicable):** NA\n\n**Fiscal Accident Year Ending**\n\n**Ultimate $ 20104 20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Paid Loss Method** 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,181,560 2,731,529 4,374,040 4,931,360 5,518,315\n\n**Incurred Loss Method** 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,308,938 2,549,865 4,473,656 4,736,208 4,819,487\n\n**Selected 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,308,938 2,549,865 4,473,656 4,736,208 4,819,487**\n\n**Dollar DCCE Method Ratio DCCE Ratio Method**\n\n**Selected**\n\n**Fiscal Accident Year Ending**\n\n**Selected LDFs 20104 20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Loss 1.000 1.000 1.000 1.000 1.001 1.001 0.996 1.034 1.034 1.122**\n\n**DCCE 1.000 1.000 1.000 1.000 1.001 1.001 0.996 1.034 1.034 1.122**\n\nStandard Exhibits Template Page 3.1 7/29/2019 Edition","pages":[{"line_numbers":[],"markdown":"### **Exhibit 7**\n\n## **Grange Insurance Association Homeowners Multiple Peril**\n\n## **Loss & DCCE Development**\n\n**_HO3/HO5_**\n\n**Selected Ultimate Loss & DCCE:** Incurred\n\n**Selected Ultimate DCCE (if applicable):** NA\n\n**Fiscal Accident Year Ending**\n\n**Ultimate $ 20104 20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Paid Loss Method** 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,181,560 2,731,529 4,374,040 4,931,360 5,518,315\n\n**Incurred Loss Method** 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,308,938 2,549,865 4,473,656 4,736,208 4,819,487\n\n**Selected 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,308,938 2,549,865 4,473,656 4,736,208 4,819,487**\n\n**Dollar DCCE Method Ratio DCCE Ratio Method**\n\n**Selected**\n\n**Fiscal Accident Year Ending**\n\n**Selected LDFs 20104 20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Loss 1.000 1.000 1.000 1.000 1.001 1.001 0.996 1.034 1.034 1.122**\n\n**DCCE 1.000 1.000 1.000 1.000 1.001 1.001 0.996 1.034 1.034 1.122**\n\nStandard Exhibits Template Page 3.1 7/29/2019 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Exhibit 7**\n\n## **Grange Insurance Association Homeowners Multiple Peril**\n\n## **Loss & DCCE Development**\n\n**_HO3/HO5_**\n\n**Selected Ultimate Loss & DCCE:** Incurred\n\n**Selected Ultimate DCCE (if applicable):** NA\n\n**Fiscal Accident Year Ending**\n\n**Ultimate $ 20104 20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Paid Loss Method** 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,181,560 2,731,529 4,374,040 4,931,360 5,518,315\n\n**Incurred Loss Method** 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,308,938 2,549,865 4,473,656 4,736,208 4,819,487\n\n**Selected 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,308,938 2,549,865 4,473,656 4,736,208 4,819,487**\n\n**Dollar DCCE Method Ratio DCCE Ratio Method**\n\n**Selected**\n\n**Fiscal Accident Year Ending**\n\n**Selected LDFs 20104 20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Loss 1.000 1.000 1.000 1.000 1.001 1.001 0.996 1.034 1.034 1.122**\n\n**DCCE 1.000 1.000 1.000 1.000 1.001 1.001 0.996 1.034 1.034 1.122**\n\nStandard Exhibits Template Page 3.1 7/29/2019 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1661.pdf"]},"response":{"errors":[],"extract_id":"extract_d9f71b007062cb47d9f9cc1c75f0fc74","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Exhibit 7**\n\n## **Grange Insurance Association Homeowners Multiple Peril**\n\n## **Loss & DCCE Development**\n\n**_HO3/HO5_**\n\n**Selected Ultimate Loss & DCCE:** Incurred\n\n**Selected Ultimate DCCE (if applicable):** NA\n\n**Fiscal Accident Year Ending**\n\n**Ultimate $ 20104 20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Paid Loss Method** 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,181,560 2,731,529 4,374,040 4,931,360 5,518,315\n\n**Incurred Loss Method** 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,308,938 2,549,865 4,473,656 4,736,208 4,819,487\n\n**Selected 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,308,938 2,549,865 4,473,656 4,736,208 4,819,487**\n\n**Dollar DCCE Method Ratio DCCE Ratio Method**\n\n**Selected**\n\n**Fiscal Accident Year Ending**\n\n**Selected LDFs 20104 20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Loss 1.000 1.000 1.000 1.000 1.001 1.001 0.996 1.034 1.034 1.122**\n\n**DCCE 1.000 1.000 1.000 1.000 1.001 1.001 0.996 1.034 1.034 1.122**\n\nStandard Exhibits Template Page 3.1 7/29/2019 Edition"],"full_content":"### **Exhibit 7**\n\n## **Grange Insurance Association Homeowners Multiple Peril**\n\n## **Loss & DCCE Development**\n\n**_HO3/HO5_**\n\n**Selected Ultimate Loss & DCCE:** Incurred\n\n**Selected Ultimate DCCE (if applicable):** NA\n\n**Fiscal Accident Year Ending**\n\n**Ultimate $ 20104 20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Paid Loss Method** 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,181,560 2,731,529 4,374,040 4,931,360 5,518,315\n\n**Incurred Loss Method** 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,308,938 2,549,865 4,473,656 4,736,208 4,819,487\n\n**Selected 1,747,701 3,787,832 3,337,861 1,605,158 4,286,419 4,308,938 2,549,865 4,473,656 4,736,208 4,819,487**\n\n**Dollar DCCE Method Ratio DCCE Ratio Method**\n\n**Selected**\n\n**Fiscal Accident Year Ending**\n\n**Selected LDFs 20104 20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Loss 1.000 1.000 1.000 1.000 1.001 1.001 0.996 1.034 1.034 1.122**\n\n**DCCE 1.000 1.000 1.000 1.000 1.001 1.001 0.996 1.034 1.034 1.122**\n\nStandard Exhibits Template Page 3.1 7/29/2019 Edition","publish_date":null,"title":"Grange Insurance Association Homeowners Multiple Peril Loss & DCCE Development","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1661.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1661.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1661","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1661.pdf"},"started_at":"2026-11-04T19:47:50.159542"} +{"completed_at":"2026-11-04T19:47:53.416611","latency_in_ms":2024,"output":{"example_id":"table/SERFF_CA_random_pages 1_page168","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit VII\n\n2008 2009 2010 Selected\n\nCommission 9.2% 8.7% 9.1% 10.0%\n\nTaxes, Licenses, and Fees 3.1% 2.6% 2.7% 2.7% \\*\n\nOther Acquisition Expenses 7.5% 8.6% 9.8% 9.0%\n\nGeneral Expense 6.1% 6.8% 7.3% 7.0%\n\n\\* Alaska premium tax rate -- charged due to California's retaliatory tax rules\n\n**(As a Percent of Direct Earned Premium)**\n\n## **Alaska National Insurance Company**\n\n## **California Workers' Compensation Filing**\n\n**Effective January 1, 2012**\n\n### **Historical Expenses**","pages":[{"line_numbers":[],"markdown":"Exhibit VII\n\n2008 2009 2010 Selected\n\nCommission 9.2% 8.7% 9.1% 10.0%\n\nTaxes, Licenses, and Fees 3.1% 2.6% 2.7% 2.7% \\*\n\nOther Acquisition Expenses 7.5% 8.6% 9.8% 9.0%\n\nGeneral Expense 6.1% 6.8% 7.3% 7.0%\n\n\\* Alaska premium tax rate -- charged due to California's retaliatory tax rules\n\n**(As a Percent of Direct Earned Premium)**\n\n## **Alaska National Insurance Company**\n\n## **California Workers' Compensation Filing**\n\n**Effective January 1, 2012**\n\n### **Historical Expenses**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit VII\n\n2008 2009 2010 Selected\n\nCommission 9.2% 8.7% 9.1% 10.0%\n\nTaxes, Licenses, and Fees 3.1% 2.6% 2.7% 2.7% \\*\n\nOther Acquisition Expenses 7.5% 8.6% 9.8% 9.0%\n\nGeneral Expense 6.1% 6.8% 7.3% 7.0%\n\n\\* Alaska premium tax rate -- charged due to California's retaliatory tax rules\n\n**(As a Percent of Direct Earned Premium)**\n\n## **Alaska National Insurance Company**\n\n## **California Workers' Compensation Filing**\n\n**Effective January 1, 2012**\n\n### **Historical Expenses**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page168.pdf"]},"response":{"errors":[],"extract_id":"extract_5e3454d1a1e3efe0f685f183c4981f89","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit VII\n\n2008 2009 2010 Selected\n\nCommission 9.2% 8.7% 9.1% 10.0%\n\nTaxes, Licenses, and Fees 3.1% 2.6% 2.7% 2.7% \\*\n\nOther Acquisition Expenses 7.5% 8.6% 9.8% 9.0%\n\nGeneral Expense 6.1% 6.8% 7.3% 7.0%\n\n\\* Alaska premium tax rate -- charged due to California's retaliatory tax rules\n\n**(As a Percent of Direct Earned Premium)**\n\n## **Alaska National Insurance Company**\n\n## **California Workers' Compensation Filing**\n\n**Effective January 1, 2012**\n\n### **Historical Expenses**"],"full_content":"Exhibit VII\n\n2008 2009 2010 Selected\n\nCommission 9.2% 8.7% 9.1% 10.0%\n\nTaxes, Licenses, and Fees 3.1% 2.6% 2.7% 2.7% \\*\n\nOther Acquisition Expenses 7.5% 8.6% 9.8% 9.0%\n\nGeneral Expense 6.1% 6.8% 7.3% 7.0%\n\n\\* Alaska premium tax rate -- charged due to California's retaliatory tax rules\n\n**(As a Percent of Direct Earned Premium)**\n\n## **Alaska National Insurance Company**\n\n## **California Workers' Compensation Filing**\n\n**Effective January 1, 2012**\n\n### **Historical Expenses**","publish_date":null,"title":"Alaska National Insurance Company California Workers' Compensation Filing","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page168.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page168.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page168","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page168.pdf"},"started_at":"2026-11-04T19:47:51.391889"} +{"completed_at":"2026-11-04T19:47:54.707497","latency_in_ms":2254,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1682","grounded_pages":[],"layout_pages":[],"markdown":"(1) (2) (3) (4) (5) (6) (7)\n\nAcc Year Claim Count Incd Loss + DCC Vehicle Count\n\nClaims per\n\nMonth\n\nClaim Frequency (per 100 Vehicles)\n\nClaim Severity\n\nClaim Pure Premium\n\n2015 - - 260 - - - -\n\n2016 3 8,372 558 0.25 0.54 2,791 15\n\n2017 1 998 854 0.08 0.12 998 1\n\n2018 - - 1,036 - - - -\n\n2019 3 13,554 1,125 0.25 0.27 4,518 12\n\n2020 2 8,639 1,114 0.17 0.18 4,320 8\n\n2021 1 5,766 1,092 0.08 0.09 5,766 5\n\n2022 15 83,954 1,039 1.25 1.44 5,597 81\n\n2023 44 400,070 1,056 3.67 4.17 9,092 379\n\nMay-24 9 38,786 962 1.80 2.25 4,310 97\n\nAverage Annual Pure Premium 2015-2021: 6\n\n2024 January - May Pure Premium: 97\n\n1\\. Accident Year Comprehensive claims for theft or vandalism as related to theft/attempted theft 2. Incurred Loss including DCC expense as of 5/31/24 for claims in (1) 3. Inforce Vehicle Count at the end of the Accident Period 4. (1) / # Months in Accident Period 5. (1) / (3) \\* 100 --- Annualized for 2024 6. (2) / (1) 7. (5) \\* (6) / 100\n\nThe following data is provided to support the need for underwriting restrictions on certain model/year KIA and Hyundai vehicle susceptible to an extreme shift in theft and vandalism as related to theft/attempted theft. The claim and exposure information is specific to the model/years affected by this underwriting restriction. Prior to this issue being highlighted on social media, the pure premium for this comprehensive coverage exposure was around $6. This pure premium peaked in 2023, but the data for 2024 through May shows it is still at significantly higher levels (over 15x greater) due to the continuing substantial risk of loss. KIA and Hyundai may have made statements around their expectations of theft trends, but that has yet to shown in the data. We are revising this restriction to allow liability only polices until our data indicates the substantial risk of theft loss has subsided.\n\nEXHIBIT UW1\n\n### KIA/Hyundai UW Restrictions\n\nCalifornia Personal Auto\n\n\\-\n\n0\\.50\n\n1\\.00\n\n1\\.50\n\n2\\.00\n\n2\\.50\n\n3\\.00\n\n3\\.50\n\n4\\.00\n\n4\\.50\n\n\\-\n\n1,000\n\n2,000\n\n3,000\n\n4,000\n\n5,000\n\n6,000\n\n7,000\n\n8,000\n\n9,000\n\n10,000\n\n2015 2016 2017 2018 2019 2020 2021 2022 2023 May-24\n\nClaim Frequency\n\nClaim Severity\n\nClaim Severity Claim Frequency (per 100 Vehicles)","pages":[{"line_numbers":[],"markdown":"(1) (2) (3) (4) (5) (6) (7)\n\nAcc Year Claim Count Incd Loss + DCC Vehicle Count\n\nClaims per\n\nMonth\n\nClaim Frequency (per 100 Vehicles)\n\nClaim Severity\n\nClaim Pure Premium\n\n2015 - - 260 - - - -\n\n2016 3 8,372 558 0.25 0.54 2,791 15\n\n2017 1 998 854 0.08 0.12 998 1\n\n2018 - - 1,036 - - - -\n\n2019 3 13,554 1,125 0.25 0.27 4,518 12\n\n2020 2 8,639 1,114 0.17 0.18 4,320 8\n\n2021 1 5,766 1,092 0.08 0.09 5,766 5\n\n2022 15 83,954 1,039 1.25 1.44 5,597 81\n\n2023 44 400,070 1,056 3.67 4.17 9,092 379\n\nMay-24 9 38,786 962 1.80 2.25 4,310 97\n\nAverage Annual Pure Premium 2015-2021: 6\n\n2024 January - May Pure Premium: 97\n\n1\\. Accident Year Comprehensive claims for theft or vandalism as related to theft/attempted theft 2. Incurred Loss including DCC expense as of 5/31/24 for claims in (1) 3. Inforce Vehicle Count at the end of the Accident Period 4. (1) / # Months in Accident Period 5. (1) / (3) \\* 100 --- Annualized for 2024 6. (2) / (1) 7. (5) \\* (6) / 100\n\nThe following data is provided to support the need for underwriting restrictions on certain model/year KIA and Hyundai vehicle susceptible to an extreme shift in theft and vandalism as related to theft/attempted theft. The claim and exposure information is specific to the model/years affected by this underwriting restriction. Prior to this issue being highlighted on social media, the pure premium for this comprehensive coverage exposure was around $6. This pure premium peaked in 2023, but the data for 2024 through May shows it is still at significantly higher levels (over 15x greater) due to the continuing substantial risk of loss. KIA and Hyundai may have made statements around their expectations of theft trends, but that has yet to shown in the data. We are revising this restriction to allow liability only polices until our data indicates the substantial risk of theft loss has subsided.\n\nEXHIBIT UW1\n\n### KIA/Hyundai UW Restrictions\n\nCalifornia Personal Auto\n\n\\-\n\n0\\.50\n\n1\\.00\n\n1\\.50\n\n2\\.00\n\n2\\.50\n\n3\\.00\n\n3\\.50\n\n4\\.00\n\n4\\.50\n\n\\-\n\n1,000\n\n2,000\n\n3,000\n\n4,000\n\n5,000\n\n6,000\n\n7,000\n\n8,000\n\n9,000\n\n10,000\n\n2015 2016 2017 2018 2019 2020 2021 2022 2023 May-24\n\nClaim Frequency\n\nClaim Severity\n\nClaim Severity Claim Frequency (per 100 Vehicles)","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"(1) (2) (3) (4) (5) (6) (7)\n\nAcc Year Claim Count Incd Loss + DCC Vehicle Count\n\nClaims per\n\nMonth\n\nClaim Frequency (per 100 Vehicles)\n\nClaim Severity\n\nClaim Pure Premium\n\n2015 - - 260 - - - -\n\n2016 3 8,372 558 0.25 0.54 2,791 15\n\n2017 1 998 854 0.08 0.12 998 1\n\n2018 - - 1,036 - - - -\n\n2019 3 13,554 1,125 0.25 0.27 4,518 12\n\n2020 2 8,639 1,114 0.17 0.18 4,320 8\n\n2021 1 5,766 1,092 0.08 0.09 5,766 5\n\n2022 15 83,954 1,039 1.25 1.44 5,597 81\n\n2023 44 400,070 1,056 3.67 4.17 9,092 379\n\nMay-24 9 38,786 962 1.80 2.25 4,310 97\n\nAverage Annual Pure Premium 2015-2021: 6\n\n2024 January - May Pure Premium: 97\n\n1\\. Accident Year Comprehensive claims for theft or vandalism as related to theft/attempted theft 2. Incurred Loss including DCC expense as of 5/31/24 for claims in (1) 3. Inforce Vehicle Count at the end of the Accident Period 4. (1) / # Months in Accident Period 5. (1) / (3) \\* 100 --- Annualized for 2024 6. (2) / (1) 7. (5) \\* (6) / 100\n\nThe following data is provided to support the need for underwriting restrictions on certain model/year KIA and Hyundai vehicle susceptible to an extreme shift in theft and vandalism as related to theft/attempted theft. The claim and exposure information is specific to the model/years affected by this underwriting restriction. Prior to this issue being highlighted on social media, the pure premium for this comprehensive coverage exposure was around $6. This pure premium peaked in 2023, but the data for 2024 through May shows it is still at significantly higher levels (over 15x greater) due to the continuing substantial risk of loss. KIA and Hyundai may have made statements around their expectations of theft trends, but that has yet to shown in the data. We are revising this restriction to allow liability only polices until our data indicates the substantial risk of theft loss has subsided.\n\nEXHIBIT UW1\n\n### KIA/Hyundai UW Restrictions\n\nCalifornia Personal Auto\n\n\\-\n\n0\\.50\n\n1\\.00\n\n1\\.50\n\n2\\.00\n\n2\\.50\n\n3\\.00\n\n3\\.50\n\n4\\.00\n\n4\\.50\n\n\\-\n\n1,000\n\n2,000\n\n3,000\n\n4,000\n\n5,000\n\n6,000\n\n7,000\n\n8,000\n\n9,000\n\n10,000\n\n2015 2016 2017 2018 2019 2020 2021 2022 2023 May-24\n\nClaim Frequency\n\nClaim Severity\n\nClaim Severity Claim Frequency (per 100 Vehicles)","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1682.pdf"]},"response":{"errors":[],"extract_id":"extract_5a5b69ee4e9b99973b241625358617f7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["(1) (2) (3) (4) (5) (6) (7)\n\nAcc Year Claim Count Incd Loss + DCC Vehicle Count\n\nClaims per\n\nMonth\n\nClaim Frequency (per 100 Vehicles)\n\nClaim Severity\n\nClaim Pure Premium\n\n2015 - - 260 - - - -\n\n2016 3 8,372 558 0.25 0.54 2,791 15\n\n2017 1 998 854 0.08 0.12 998 1\n\n2018 - - 1,036 - - - -\n\n2019 3 13,554 1,125 0.25 0.27 4,518 12\n\n2020 2 8,639 1,114 0.17 0.18 4,320 8\n\n2021 1 5,766 1,092 0.08 0.09 5,766 5\n\n2022 15 83,954 1,039 1.25 1.44 5,597 81\n\n2023 44 400,070 1,056 3.67 4.17 9,092 379\n\nMay-24 9 38,786 962 1.80 2.25 4,310 97\n\nAverage Annual Pure Premium 2015-2021: 6\n\n2024 January - May Pure Premium: 97\n\n1\\. Accident Year Comprehensive claims for theft or vandalism as related to theft/attempted theft 2. Incurred Loss including DCC expense as of 5/31/24 for claims in (1) 3. Inforce Vehicle Count at the end of the Accident Period 4. (1) / # Months in Accident Period 5. (1) / (3) \\* 100 --- Annualized for 2024 6. (2) / (1) 7. (5) \\* (6) / 100\n\nThe following data is provided to support the need for underwriting restrictions on certain model/year KIA and Hyundai vehicle susceptible to an extreme shift in theft and vandalism as related to theft/attempted theft. The claim and exposure information is specific to the model/years affected by this underwriting restriction. Prior to this issue being highlighted on social media, the pure premium for this comprehensive coverage exposure was around $6. This pure premium peaked in 2023, but the data for 2024 through May shows it is still at significantly higher levels (over 15x greater) due to the continuing substantial risk of loss. KIA and Hyundai may have made statements around their expectations of theft trends, but that has yet to shown in the data. We are revising this restriction to allow liability only polices until our data indicates the substantial risk of theft loss has subsided.\n\nEXHIBIT UW1\n\n### KIA/Hyundai UW Restrictions\n\nCalifornia Personal Auto\n\n\\-\n\n0\\.50\n\n1\\.00\n\n1\\.50\n\n2\\.00\n\n2\\.50\n\n3\\.00\n\n3\\.50\n\n4\\.00\n\n4\\.50\n\n\\-\n\n1,000\n\n2,000\n\n3,000\n\n4,000\n\n5,000\n\n6,000\n\n7,000\n\n8,000\n\n9,000\n\n10,000\n\n2015 2016 2017 2018 2019 2020 2021 2022 2023 May-24\n\nClaim Frequency\n\nClaim Severity\n\nClaim Severity Claim Frequency (per 100 Vehicles)"],"full_content":"(1) (2) (3) (4) (5) (6) (7)\n\nAcc Year Claim Count Incd Loss + DCC Vehicle Count\n\nClaims per\n\nMonth\n\nClaim Frequency (per 100 Vehicles)\n\nClaim Severity\n\nClaim Pure Premium\n\n2015 - - 260 - - - -\n\n2016 3 8,372 558 0.25 0.54 2,791 15\n\n2017 1 998 854 0.08 0.12 998 1\n\n2018 - - 1,036 - - - -\n\n2019 3 13,554 1,125 0.25 0.27 4,518 12\n\n2020 2 8,639 1,114 0.17 0.18 4,320 8\n\n2021 1 5,766 1,092 0.08 0.09 5,766 5\n\n2022 15 83,954 1,039 1.25 1.44 5,597 81\n\n2023 44 400,070 1,056 3.67 4.17 9,092 379\n\nMay-24 9 38,786 962 1.80 2.25 4,310 97\n\nAverage Annual Pure Premium 2015-2021: 6\n\n2024 January - May Pure Premium: 97\n\n1\\. Accident Year Comprehensive claims for theft or vandalism as related to theft/attempted theft 2. Incurred Loss including DCC expense as of 5/31/24 for claims in (1) 3. Inforce Vehicle Count at the end of the Accident Period 4. (1) / # Months in Accident Period 5. (1) / (3) \\* 100 --- Annualized for 2024 6. (2) / (1) 7. (5) \\* (6) / 100\n\nThe following data is provided to support the need for underwriting restrictions on certain model/year KIA and Hyundai vehicle susceptible to an extreme shift in theft and vandalism as related to theft/attempted theft. The claim and exposure information is specific to the model/years affected by this underwriting restriction. Prior to this issue being highlighted on social media, the pure premium for this comprehensive coverage exposure was around $6. This pure premium peaked in 2023, but the data for 2024 through May shows it is still at significantly higher levels (over 15x greater) due to the continuing substantial risk of loss. KIA and Hyundai may have made statements around their expectations of theft trends, but that has yet to shown in the data. We are revising this restriction to allow liability only polices until our data indicates the substantial risk of theft loss has subsided.\n\nEXHIBIT UW1\n\n### KIA/Hyundai UW Restrictions\n\nCalifornia Personal Auto\n\n\\-\n\n0\\.50\n\n1\\.00\n\n1\\.50\n\n2\\.00\n\n2\\.50\n\n3\\.00\n\n3\\.50\n\n4\\.00\n\n4\\.50\n\n\\-\n\n1,000\n\n2,000\n\n3,000\n\n4,000\n\n5,000\n\n6,000\n\n7,000\n\n8,000\n\n9,000\n\n10,000\n\n2015 2016 2017 2018 2019 2020 2021 2022 2023 May-24\n\nClaim Frequency\n\nClaim Severity\n\nClaim Severity Claim Frequency (per 100 Vehicles)","publish_date":null,"title":"KIA/Hyundai UW Restrictions","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1682.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1682.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1682","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1682.pdf"},"started_at":"2026-11-04T19:47:52.452992"} +{"completed_at":"2026-11-04T19:47:54.802473","latency_in_ms":1392,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1724","grounded_pages":[],"layout_pages":[],"markdown":"GRANGE INSURANCE ASSOCIATION PERSONAL AUTO MANUAL BAND DEFINITIONS\n\n**CALIFORNIA (04)**\n\nEdition: 03/15/25 **BD-31** **GIA**\n\nContains copyrighted material from ISO, Inc., used with permission\n\n**CLAIM FREQUENCY/SEVERITY BAND DEFINITIONS**\n\n**FREQUENCY BANDS SEVERITY BANDS**\n\nZIP BI PD Med Pay UMBI UMPD Comp Coll ZIP BI PD Med Pay UMBI UMPD Comp Coll\n\n93950 18 13 14 17 16 11 13 93950 11 17 8 4 14 15 20\n\n93953 19 17 19 20 18 11 17 93953 1 10 5 3 14 14 17\n\n93954 20 20 18 17 16 9 20 93954 6 15 17 10 12 13 8\n\n93955 14 13 10 14 13 8 13 93955 13 14 11 18 14 12 18\n\n93960 19 18 12 15 14 8 19 93960 7 17 9 10 15 7 13\n\n93962 19 16 13 14 15 7 17 93962 16 12 16 14 7 16 9\n\n94002 17 10 14 18 14 10 10 94002 13 9 9 10 12 12 16\n\n94005 15 11 10 11 11 10 11 94005 17 10 14 15 14 11 15\n\n94010 16 10 15 18 14 11 10 94010 10 5 8 9 10 10 9\n\n94011 16 9 15 18 14 11 9 94011 10 5 8 9 10 10 9\n\n94014 10 5 4 9 7 9 5 94014 11 11 7 20 16 6 19\n\n94015 8 4 6 12 11 11 5 94015 11 11 6 19 15 7 20\n\n94016 9 4 3 9 4 8 3 94016 12 9 4 19 10 6 18\n\n94017 10 5 4 9 7 9 5 94017 11 11 7 20 16 6 19\n\n94018 17 15 14 20 16 11 15 94018 14 5 14 7 13 12 14\n\n94019 18 13 16 20 17 11 14 94019 5 2 12 9 7 10 10\n\n94020 18 16 16 19 18 9 16 94020 3 6 12 1 8 9 3\n\n94021 17 17 16 19 18 10 17 94021 13 18 4 13 11 9 9\n\n94022 18 11 20 20 16 13 11 94022 9 9 10 8 14 14 10\n\n94023 18 11 20 20 16 13 11 94023 9 9 10 8 14 14 10\n\n94024 19 12 20 20 18 8 12 94024 14 12 10 15 3 15 13\n\n94025 17 6 18 19 14 9 9 94025 12 12 8 6 17 12 15\n\n94026 17 8 18 19 14 10 8 94026 12 11 8 6 17 12 15\n\n94027 17 8 20 20 17 11 12 94027 2 2 2 6 12 10 4\n\n94028 19 13 20 20 18 11 9 94028 6 7 7 12 6 13 7\n\n94030 16 11 8 14 14 10 11 94030 9 9 8 9 13 11 14\n\n94031 17 8 18 19 16 11 7 94031 1 8 9 9 12 13 13\n\n94035 15 8 13 17 14 10 8 94035 15 13 9 12 14 13 17\n\n94037 14 14 18 19 16 10 14 94037 11 5 9 11 14 14 13\n\n94038 13 10 14 19 17 10 10 94038 13 6 3 13 17 11 17\n\n94039 17 10 15 16 15 11 10 94039 12 17 14 12 11 15 18\n\n94040 16 7 14 18 14 11 7 94040 12 13 10 13 14 14 17\n\n94041 17 10 15 16 15 11 10 94041 12 17 14 12 11 15 18\n\n94042 17 10 15 16 15 11 10 94042 12 17 14 12 11 15 18\n\n94043 15 8 13 17 14 10 8 94043 15 13 9 12 15 13 17\n\n94044 15 12 11 16 14 10 12 94044 15 8 12 9 13 12 15\n\n94045 15 8 13 17 14 10 8 94045 15 13 9 12 14 13 17\n\n94060 18 16 13 18 18 7 16 94060 17 1 17 3 2 7 5\n\n94061 16 9 12 14 12 11 9 94061 14 8 14 16 10 10 19\n\n94062 19 14 20 18 18 9 13 94062 8 10 5 5 12 10 9\n\n94063 13 7 8 11 8 8 6 94063 14 6 6 20 12 6 18\n\n94064 13 6 8 11 8 7 5 94064 14 6 6 20 12 6 18\n\n94065 16 10 12 16 17 9 10 94065 11 15 4 10 5 14 18\n\n94066 14 7 8 12 12 9 8 94066 11 2 8 12 13 9 19\n\n94070 18 9 17 19 16 10 10 94070 6 9 9 6 16 14 12\n\n94074 11 12 18 19 18 11 15 94074 15 7 5 13 11 10 2\n\n94080 10 6 8 14 11 9 11 94080 4 9 17 11 15 8 17\n\n94083 12 10 8 14 11 10 10 94083 12 10 17 11 15 7 17\n\n94085 14 6 9 14 13 10 5 94085 16 11 9 17 8 11 15\n\n94086 14 6 10 14 11 11 5 94086 16 13 11 15 8 12 16","pages":[{"line_numbers":[],"markdown":"GRANGE INSURANCE ASSOCIATION PERSONAL AUTO MANUAL BAND DEFINITIONS\n\n**CALIFORNIA (04)**\n\nEdition: 03/15/25 **BD-31** **GIA**\n\nContains copyrighted material from ISO, Inc., used with permission\n\n**CLAIM FREQUENCY/SEVERITY BAND DEFINITIONS**\n\n**FREQUENCY BANDS SEVERITY BANDS**\n\nZIP BI PD Med Pay UMBI UMPD Comp Coll ZIP BI PD Med Pay UMBI UMPD Comp Coll\n\n93950 18 13 14 17 16 11 13 93950 11 17 8 4 14 15 20\n\n93953 19 17 19 20 18 11 17 93953 1 10 5 3 14 14 17\n\n93954 20 20 18 17 16 9 20 93954 6 15 17 10 12 13 8\n\n93955 14 13 10 14 13 8 13 93955 13 14 11 18 14 12 18\n\n93960 19 18 12 15 14 8 19 93960 7 17 9 10 15 7 13\n\n93962 19 16 13 14 15 7 17 93962 16 12 16 14 7 16 9\n\n94002 17 10 14 18 14 10 10 94002 13 9 9 10 12 12 16\n\n94005 15 11 10 11 11 10 11 94005 17 10 14 15 14 11 15\n\n94010 16 10 15 18 14 11 10 94010 10 5 8 9 10 10 9\n\n94011 16 9 15 18 14 11 9 94011 10 5 8 9 10 10 9\n\n94014 10 5 4 9 7 9 5 94014 11 11 7 20 16 6 19\n\n94015 8 4 6 12 11 11 5 94015 11 11 6 19 15 7 20\n\n94016 9 4 3 9 4 8 3 94016 12 9 4 19 10 6 18\n\n94017 10 5 4 9 7 9 5 94017 11 11 7 20 16 6 19\n\n94018 17 15 14 20 16 11 15 94018 14 5 14 7 13 12 14\n\n94019 18 13 16 20 17 11 14 94019 5 2 12 9 7 10 10\n\n94020 18 16 16 19 18 9 16 94020 3 6 12 1 8 9 3\n\n94021 17 17 16 19 18 10 17 94021 13 18 4 13 11 9 9\n\n94022 18 11 20 20 16 13 11 94022 9 9 10 8 14 14 10\n\n94023 18 11 20 20 16 13 11 94023 9 9 10 8 14 14 10\n\n94024 19 12 20 20 18 8 12 94024 14 12 10 15 3 15 13\n\n94025 17 6 18 19 14 9 9 94025 12 12 8 6 17 12 15\n\n94026 17 8 18 19 14 10 8 94026 12 11 8 6 17 12 15\n\n94027 17 8 20 20 17 11 12 94027 2 2 2 6 12 10 4\n\n94028 19 13 20 20 18 11 9 94028 6 7 7 12 6 13 7\n\n94030 16 11 8 14 14 10 11 94030 9 9 8 9 13 11 14\n\n94031 17 8 18 19 16 11 7 94031 1 8 9 9 12 13 13\n\n94035 15 8 13 17 14 10 8 94035 15 13 9 12 14 13 17\n\n94037 14 14 18 19 16 10 14 94037 11 5 9 11 14 14 13\n\n94038 13 10 14 19 17 10 10 94038 13 6 3 13 17 11 17\n\n94039 17 10 15 16 15 11 10 94039 12 17 14 12 11 15 18\n\n94040 16 7 14 18 14 11 7 94040 12 13 10 13 14 14 17\n\n94041 17 10 15 16 15 11 10 94041 12 17 14 12 11 15 18\n\n94042 17 10 15 16 15 11 10 94042 12 17 14 12 11 15 18\n\n94043 15 8 13 17 14 10 8 94043 15 13 9 12 15 13 17\n\n94044 15 12 11 16 14 10 12 94044 15 8 12 9 13 12 15\n\n94045 15 8 13 17 14 10 8 94045 15 13 9 12 14 13 17\n\n94060 18 16 13 18 18 7 16 94060 17 1 17 3 2 7 5\n\n94061 16 9 12 14 12 11 9 94061 14 8 14 16 10 10 19\n\n94062 19 14 20 18 18 9 13 94062 8 10 5 5 12 10 9\n\n94063 13 7 8 11 8 8 6 94063 14 6 6 20 12 6 18\n\n94064 13 6 8 11 8 7 5 94064 14 6 6 20 12 6 18\n\n94065 16 10 12 16 17 9 10 94065 11 15 4 10 5 14 18\n\n94066 14 7 8 12 12 9 8 94066 11 2 8 12 13 9 19\n\n94070 18 9 17 19 16 10 10 94070 6 9 9 6 16 14 12\n\n94074 11 12 18 19 18 11 15 94074 15 7 5 13 11 10 2\n\n94080 10 6 8 14 11 9 11 94080 4 9 17 11 15 8 17\n\n94083 12 10 8 14 11 10 10 94083 12 10 17 11 15 7 17\n\n94085 14 6 9 14 13 10 5 94085 16 11 9 17 8 11 15\n\n94086 14 6 10 14 11 11 5 94086 16 13 11 15 8 12 16","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"GRANGE INSURANCE ASSOCIATION PERSONAL AUTO MANUAL BAND DEFINITIONS\n\n**CALIFORNIA (04)**\n\nEdition: 03/15/25 **BD-31** **GIA**\n\nContains copyrighted material from ISO, Inc., used with permission\n\n**CLAIM FREQUENCY/SEVERITY BAND DEFINITIONS**\n\n**FREQUENCY BANDS SEVERITY BANDS**\n\nZIP BI PD Med Pay UMBI UMPD Comp Coll ZIP BI PD Med Pay UMBI UMPD Comp Coll\n\n93950 18 13 14 17 16 11 13 93950 11 17 8 4 14 15 20\n\n93953 19 17 19 20 18 11 17 93953 1 10 5 3 14 14 17\n\n93954 20 20 18 17 16 9 20 93954 6 15 17 10 12 13 8\n\n93955 14 13 10 14 13 8 13 93955 13 14 11 18 14 12 18\n\n93960 19 18 12 15 14 8 19 93960 7 17 9 10 15 7 13\n\n93962 19 16 13 14 15 7 17 93962 16 12 16 14 7 16 9\n\n94002 17 10 14 18 14 10 10 94002 13 9 9 10 12 12 16\n\n94005 15 11 10 11 11 10 11 94005 17 10 14 15 14 11 15\n\n94010 16 10 15 18 14 11 10 94010 10 5 8 9 10 10 9\n\n94011 16 9 15 18 14 11 9 94011 10 5 8 9 10 10 9\n\n94014 10 5 4 9 7 9 5 94014 11 11 7 20 16 6 19\n\n94015 8 4 6 12 11 11 5 94015 11 11 6 19 15 7 20\n\n94016 9 4 3 9 4 8 3 94016 12 9 4 19 10 6 18\n\n94017 10 5 4 9 7 9 5 94017 11 11 7 20 16 6 19\n\n94018 17 15 14 20 16 11 15 94018 14 5 14 7 13 12 14\n\n94019 18 13 16 20 17 11 14 94019 5 2 12 9 7 10 10\n\n94020 18 16 16 19 18 9 16 94020 3 6 12 1 8 9 3\n\n94021 17 17 16 19 18 10 17 94021 13 18 4 13 11 9 9\n\n94022 18 11 20 20 16 13 11 94022 9 9 10 8 14 14 10\n\n94023 18 11 20 20 16 13 11 94023 9 9 10 8 14 14 10\n\n94024 19 12 20 20 18 8 12 94024 14 12 10 15 3 15 13\n\n94025 17 6 18 19 14 9 9 94025 12 12 8 6 17 12 15\n\n94026 17 8 18 19 14 10 8 94026 12 11 8 6 17 12 15\n\n94027 17 8 20 20 17 11 12 94027 2 2 2 6 12 10 4\n\n94028 19 13 20 20 18 11 9 94028 6 7 7 12 6 13 7\n\n94030 16 11 8 14 14 10 11 94030 9 9 8 9 13 11 14\n\n94031 17 8 18 19 16 11 7 94031 1 8 9 9 12 13 13\n\n94035 15 8 13 17 14 10 8 94035 15 13 9 12 14 13 17\n\n94037 14 14 18 19 16 10 14 94037 11 5 9 11 14 14 13\n\n94038 13 10 14 19 17 10 10 94038 13 6 3 13 17 11 17\n\n94039 17 10 15 16 15 11 10 94039 12 17 14 12 11 15 18\n\n94040 16 7 14 18 14 11 7 94040 12 13 10 13 14 14 17\n\n94041 17 10 15 16 15 11 10 94041 12 17 14 12 11 15 18\n\n94042 17 10 15 16 15 11 10 94042 12 17 14 12 11 15 18\n\n94043 15 8 13 17 14 10 8 94043 15 13 9 12 15 13 17\n\n94044 15 12 11 16 14 10 12 94044 15 8 12 9 13 12 15\n\n94045 15 8 13 17 14 10 8 94045 15 13 9 12 14 13 17\n\n94060 18 16 13 18 18 7 16 94060 17 1 17 3 2 7 5\n\n94061 16 9 12 14 12 11 9 94061 14 8 14 16 10 10 19\n\n94062 19 14 20 18 18 9 13 94062 8 10 5 5 12 10 9\n\n94063 13 7 8 11 8 8 6 94063 14 6 6 20 12 6 18\n\n94064 13 6 8 11 8 7 5 94064 14 6 6 20 12 6 18\n\n94065 16 10 12 16 17 9 10 94065 11 15 4 10 5 14 18\n\n94066 14 7 8 12 12 9 8 94066 11 2 8 12 13 9 19\n\n94070 18 9 17 19 16 10 10 94070 6 9 9 6 16 14 12\n\n94074 11 12 18 19 18 11 15 94074 15 7 5 13 11 10 2\n\n94080 10 6 8 14 11 9 11 94080 4 9 17 11 15 8 17\n\n94083 12 10 8 14 11 10 10 94083 12 10 17 11 15 7 17\n\n94085 14 6 9 14 13 10 5 94085 16 11 9 17 8 11 15\n\n94086 14 6 10 14 11 11 5 94086 16 13 11 15 8 12 16","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1724.pdf"]},"response":{"errors":[],"extract_id":"extract_73a20f9ad9e0d402dbd87ef671891696","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["GRANGE INSURANCE ASSOCIATION PERSONAL AUTO MANUAL BAND DEFINITIONS\n\n**CALIFORNIA (04)**\n\nEdition: 03/15/25 **BD-31** **GIA**\n\nContains copyrighted material from ISO, Inc., used with permission\n\n**CLAIM FREQUENCY/SEVERITY BAND DEFINITIONS**\n\n**FREQUENCY BANDS SEVERITY BANDS**\n\nZIP BI PD Med Pay UMBI UMPD Comp Coll ZIP BI PD Med Pay UMBI UMPD Comp Coll\n\n93950 18 13 14 17 16 11 13 93950 11 17 8 4 14 15 20\n\n93953 19 17 19 20 18 11 17 93953 1 10 5 3 14 14 17\n\n93954 20 20 18 17 16 9 20 93954 6 15 17 10 12 13 8\n\n93955 14 13 10 14 13 8 13 93955 13 14 11 18 14 12 18\n\n93960 19 18 12 15 14 8 19 93960 7 17 9 10 15 7 13\n\n93962 19 16 13 14 15 7 17 93962 16 12 16 14 7 16 9\n\n94002 17 10 14 18 14 10 10 94002 13 9 9 10 12 12 16\n\n94005 15 11 10 11 11 10 11 94005 17 10 14 15 14 11 15\n\n94010 16 10 15 18 14 11 10 94010 10 5 8 9 10 10 9\n\n94011 16 9 15 18 14 11 9 94011 10 5 8 9 10 10 9\n\n94014 10 5 4 9 7 9 5 94014 11 11 7 20 16 6 19\n\n94015 8 4 6 12 11 11 5 94015 11 11 6 19 15 7 20\n\n94016 9 4 3 9 4 8 3 94016 12 9 4 19 10 6 18\n\n94017 10 5 4 9 7 9 5 94017 11 11 7 20 16 6 19\n\n94018 17 15 14 20 16 11 15 94018 14 5 14 7 13 12 14\n\n94019 18 13 16 20 17 11 14 94019 5 2 12 9 7 10 10\n\n94020 18 16 16 19 18 9 16 94020 3 6 12 1 8 9 3\n\n94021 17 17 16 19 18 10 17 94021 13 18 4 13 11 9 9\n\n94022 18 11 20 20 16 13 11 94022 9 9 10 8 14 14 10\n\n94023 18 11 20 20 16 13 11 94023 9 9 10 8 14 14 10\n\n94024 19 12 20 20 18 8 12 94024 14 12 10 15 3 15 13\n\n94025 17 6 18 19 14 9 9 94025 12 12 8 6 17 12 15\n\n94026 17 8 18 19 14 10 8 94026 12 11 8 6 17 12 15\n\n94027 17 8 20 20 17 11 12 94027 2 2 2 6 12 10 4\n\n94028 19 13 20 20 18 11 9 94028 6 7 7 12 6 13 7\n\n94030 16 11 8 14 14 10 11 94030 9 9 8 9 13 11 14\n\n94031 17 8 18 19 16 11 7 94031 1 8 9 9 12 13 13\n\n94035 15 8 13 17 14 10 8 94035 15 13 9 12 14 13 17\n\n94037 14 14 18 19 16 10 14 94037 11 5 9 11 14 14 13\n\n94038 13 10 14 19 17 10 10 94038 13 6 3 13 17 11 17\n\n94039 17 10 15 16 15 11 10 94039 12 17 14 12 11 15 18\n\n94040 16 7 14 18 14 11 7 94040 12 13 10 13 14 14 17\n\n94041 17 10 15 16 15 11 10 94041 12 17 14 12 11 15 18\n\n94042 17 10 15 16 15 11 10 94042 12 17 14 12 11 15 18\n\n94043 15 8 13 17 14 10 8 94043 15 13 9 12 15 13 17\n\n94044 15 12 11 16 14 10 12 94044 15 8 12 9 13 12 15\n\n94045 15 8 13 17 14 10 8 94045 15 13 9 12 14 13 17\n\n94060 18 16 13 18 18 7 16 94060 17 1 17 3 2 7 5\n\n94061 16 9 12 14 12 11 9 94061 14 8 14 16 10 10 19\n\n94062 19 14 20 18 18 9 13 94062 8 10 5 5 12 10 9\n\n94063 13 7 8 11 8 8 6 94063 14 6 6 20 12 6 18\n\n94064 13 6 8 11 8 7 5 94064 14 6 6 20 12 6 18\n\n94065 16 10 12 16 17 9 10 94065 11 15 4 10 5 14 18\n\n94066 14 7 8 12 12 9 8 94066 11 2 8 12 13 9 19\n\n94070 18 9 17 19 16 10 10 94070 6 9 9 6 16 14 12\n\n94074 11 12 18 19 18 11 15 94074 15 7 5 13 11 10 2\n\n94080 10 6 8 14 11 9 11 94080 4 9 17 11 15 8 17\n\n94083 12 10 8 14 11 10 10 94083 12 10 17 11 15 7 17\n\n94085 14 6 9 14 13 10 5 94085 16 11 9 17 8 11 15\n\n94086 14 6 10 14 11 11 5 94086 16 13 11 15 8 12 16"],"full_content":"GRANGE INSURANCE ASSOCIATION PERSONAL AUTO MANUAL BAND DEFINITIONS\n\n**CALIFORNIA (04)**\n\nEdition: 03/15/25 **BD-31** **GIA**\n\nContains copyrighted material from ISO, Inc., used with permission\n\n**CLAIM FREQUENCY/SEVERITY BAND DEFINITIONS**\n\n**FREQUENCY BANDS SEVERITY BANDS**\n\nZIP BI PD Med Pay UMBI UMPD Comp Coll ZIP BI PD Med Pay UMBI UMPD Comp Coll\n\n93950 18 13 14 17 16 11 13 93950 11 17 8 4 14 15 20\n\n93953 19 17 19 20 18 11 17 93953 1 10 5 3 14 14 17\n\n93954 20 20 18 17 16 9 20 93954 6 15 17 10 12 13 8\n\n93955 14 13 10 14 13 8 13 93955 13 14 11 18 14 12 18\n\n93960 19 18 12 15 14 8 19 93960 7 17 9 10 15 7 13\n\n93962 19 16 13 14 15 7 17 93962 16 12 16 14 7 16 9\n\n94002 17 10 14 18 14 10 10 94002 13 9 9 10 12 12 16\n\n94005 15 11 10 11 11 10 11 94005 17 10 14 15 14 11 15\n\n94010 16 10 15 18 14 11 10 94010 10 5 8 9 10 10 9\n\n94011 16 9 15 18 14 11 9 94011 10 5 8 9 10 10 9\n\n94014 10 5 4 9 7 9 5 94014 11 11 7 20 16 6 19\n\n94015 8 4 6 12 11 11 5 94015 11 11 6 19 15 7 20\n\n94016 9 4 3 9 4 8 3 94016 12 9 4 19 10 6 18\n\n94017 10 5 4 9 7 9 5 94017 11 11 7 20 16 6 19\n\n94018 17 15 14 20 16 11 15 94018 14 5 14 7 13 12 14\n\n94019 18 13 16 20 17 11 14 94019 5 2 12 9 7 10 10\n\n94020 18 16 16 19 18 9 16 94020 3 6 12 1 8 9 3\n\n94021 17 17 16 19 18 10 17 94021 13 18 4 13 11 9 9\n\n94022 18 11 20 20 16 13 11 94022 9 9 10 8 14 14 10\n\n94023 18 11 20 20 16 13 11 94023 9 9 10 8 14 14 10\n\n94024 19 12 20 20 18 8 12 94024 14 12 10 15 3 15 13\n\n94025 17 6 18 19 14 9 9 94025 12 12 8 6 17 12 15\n\n94026 17 8 18 19 14 10 8 94026 12 11 8 6 17 12 15\n\n94027 17 8 20 20 17 11 12 94027 2 2 2 6 12 10 4\n\n94028 19 13 20 20 18 11 9 94028 6 7 7 12 6 13 7\n\n94030 16 11 8 14 14 10 11 94030 9 9 8 9 13 11 14\n\n94031 17 8 18 19 16 11 7 94031 1 8 9 9 12 13 13\n\n94035 15 8 13 17 14 10 8 94035 15 13 9 12 14 13 17\n\n94037 14 14 18 19 16 10 14 94037 11 5 9 11 14 14 13\n\n94038 13 10 14 19 17 10 10 94038 13 6 3 13 17 11 17\n\n94039 17 10 15 16 15 11 10 94039 12 17 14 12 11 15 18\n\n94040 16 7 14 18 14 11 7 94040 12 13 10 13 14 14 17\n\n94041 17 10 15 16 15 11 10 94041 12 17 14 12 11 15 18\n\n94042 17 10 15 16 15 11 10 94042 12 17 14 12 11 15 18\n\n94043 15 8 13 17 14 10 8 94043 15 13 9 12 15 13 17\n\n94044 15 12 11 16 14 10 12 94044 15 8 12 9 13 12 15\n\n94045 15 8 13 17 14 10 8 94045 15 13 9 12 14 13 17\n\n94060 18 16 13 18 18 7 16 94060 17 1 17 3 2 7 5\n\n94061 16 9 12 14 12 11 9 94061 14 8 14 16 10 10 19\n\n94062 19 14 20 18 18 9 13 94062 8 10 5 5 12 10 9\n\n94063 13 7 8 11 8 8 6 94063 14 6 6 20 12 6 18\n\n94064 13 6 8 11 8 7 5 94064 14 6 6 20 12 6 18\n\n94065 16 10 12 16 17 9 10 94065 11 15 4 10 5 14 18\n\n94066 14 7 8 12 12 9 8 94066 11 2 8 12 13 9 19\n\n94070 18 9 17 19 16 10 10 94070 6 9 9 6 16 14 12\n\n94074 11 12 18 19 18 11 15 94074 15 7 5 13 11 10 2\n\n94080 10 6 8 14 11 9 11 94080 4 9 17 11 15 8 17\n\n94083 12 10 8 14 11 10 10 94083 12 10 17 11 15 7 17\n\n94085 14 6 9 14 13 10 5 94085 16 11 9 17 8 11 15\n\n94086 14 6 10 14 11 11 5 94086 16 13 11 15 8 12 16","publish_date":null,"title":"GRANGE INSURANCE ASSOCIATION PERSONAL AUTO MANUAL CALIFORNIA (04) BAND DEFINITIONS CLAIM FREQUENCY/SEVERITY BAND DEFINITIONS FREQUENCY BANDS SEVERITY BANDS GIA","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1724.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1724.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1724","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1724.pdf"},"started_at":"2026-11-04T19:47:53.409537"} +{"completed_at":"2026-11-04T19:47:57.527423","latency_in_ms":2818,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1751","grounded_pages":[],"layout_pages":[],"markdown":"95205 13,258 15,157 5 14.3%\n\n95206 34,858 38,845 12 11.4%\n\n95207 33,184 36,836 11 11.0%\n\n95209 40,632 45,336 14 11.6%\n\n95210 11,366 12,928 8 13.7%\n\n95212 30,112 33,814 9 12.3%\n\n95215 19,127 21,693 6 13.4%\n\n95219 26,829 29,897 13 11.4%\n\n95220 25,084 28,105 10 12.0%\n\n95222 30,194 33,960 17 12.5%\n\n95223 11,552 13,146 8 13.8%\n\n95224 888 985 1 10.9%\n\n95225 12,692 14,328 5 12.9%\n\n95227 3,546 3,982 2 12.3%\n\n95228 30,910 34,423 12 11.4%\n\n95230 10,386 11,652 4 12.2%\n\n95231 1,886 2,147 1 13.8%\n\n95232 15,830 17,739 4 12.1%\n\n95233 1,258 1,427 1 13.4%\n\n95236 17,142 19,403 5 13.2%\n\n95237 13,692 15,481 6 13.1%\n\n95240 55,974 62,776 28 12.2%\n\n95242 48,868 55,015 22 12.6%\n\n95245 28,912 32,265 14 11.6%\n\n95246 21,116 23,502 8 11.3%\n\n95247 42,456 47,553 16 12.0%\n\n95248 2,566 2,952 1 15.0%\n\n95249 38,456 43,619 14 13.4%\n\n95251 15,870 17,645 5 11.2%\n\n95252 194,143 220,324 70 13.5%\n\n95254 3,894 4,264 1 9.5%\n\n95255 19,162 21,882 11 14.2%\n\n95257 13,488 15,085 4 11.8%\n\n95301 357,805 400,300 142 11.9%\n\n95303 11,310 12,478 2 10.3%\n\n95304 23,818 26,733 7 12.2%\n\n95306 52,052 58,236 16 11.9%\n\n95307 83,062 95,084 40 14.5%\n\n95310 48,398 54,606 27 12.8%\n\n95311 57,606 64,590 32 12.1%\n\n95312 2,647 2,982 1 12.7%\n\n95313 7,362 8,346 4 13.4%\n\n95315 44,404 49,789 17 12.1%\n\n95316 65,898 73,772 30 11.9%\n\n95317 8,574 9,414 3 9.8%\n\n95318 836 952 1 13.9%\n\n95319 1,306 1,439 1 10.2%\n\n95320 73,430 81,883 24 11.5%\n\n95321 25,196 28,136 18 11.7%\n\n95322 216,518 241,351 108 11.5%\n\n95323 18,580 20,354 6 9.5%\n\n95324 122,790 136,823 46 11.4%\n\n95325 21,746 24,190 8 11.2%\n\n95326 79,028 88,804 34 12.4%\n\n95327 120,604 135,109 58 12.0%\n\n95328 13,096 14,456 3 10.4%\n\n95329 39,246 43,232 14 10.2%\n\n95330 8,034 9,008 3 12.1%\n\n95333 57,854 63,952 27 10.5%\n\n95334 80,158 89,907 28 12.2%\n\n95335 12,498 14,194 6 13.6%\n\n95336 41,994 46,749 15 11.3%\n\n95337 41,190 46,016 14 11.7%\n\n95338 223,425 250,038 116 11.9%\n\n95340 254,038 283,423 114 11.6%\n\n95341 282,106 315,623 103 11.9%","pages":[{"line_numbers":[],"markdown":"95205 13,258 15,157 5 14.3%\n\n95206 34,858 38,845 12 11.4%\n\n95207 33,184 36,836 11 11.0%\n\n95209 40,632 45,336 14 11.6%\n\n95210 11,366 12,928 8 13.7%\n\n95212 30,112 33,814 9 12.3%\n\n95215 19,127 21,693 6 13.4%\n\n95219 26,829 29,897 13 11.4%\n\n95220 25,084 28,105 10 12.0%\n\n95222 30,194 33,960 17 12.5%\n\n95223 11,552 13,146 8 13.8%\n\n95224 888 985 1 10.9%\n\n95225 12,692 14,328 5 12.9%\n\n95227 3,546 3,982 2 12.3%\n\n95228 30,910 34,423 12 11.4%\n\n95230 10,386 11,652 4 12.2%\n\n95231 1,886 2,147 1 13.8%\n\n95232 15,830 17,739 4 12.1%\n\n95233 1,258 1,427 1 13.4%\n\n95236 17,142 19,403 5 13.2%\n\n95237 13,692 15,481 6 13.1%\n\n95240 55,974 62,776 28 12.2%\n\n95242 48,868 55,015 22 12.6%\n\n95245 28,912 32,265 14 11.6%\n\n95246 21,116 23,502 8 11.3%\n\n95247 42,456 47,553 16 12.0%\n\n95248 2,566 2,952 1 15.0%\n\n95249 38,456 43,619 14 13.4%\n\n95251 15,870 17,645 5 11.2%\n\n95252 194,143 220,324 70 13.5%\n\n95254 3,894 4,264 1 9.5%\n\n95255 19,162 21,882 11 14.2%\n\n95257 13,488 15,085 4 11.8%\n\n95301 357,805 400,300 142 11.9%\n\n95303 11,310 12,478 2 10.3%\n\n95304 23,818 26,733 7 12.2%\n\n95306 52,052 58,236 16 11.9%\n\n95307 83,062 95,084 40 14.5%\n\n95310 48,398 54,606 27 12.8%\n\n95311 57,606 64,590 32 12.1%\n\n95312 2,647 2,982 1 12.7%\n\n95313 7,362 8,346 4 13.4%\n\n95315 44,404 49,789 17 12.1%\n\n95316 65,898 73,772 30 11.9%\n\n95317 8,574 9,414 3 9.8%\n\n95318 836 952 1 13.9%\n\n95319 1,306 1,439 1 10.2%\n\n95320 73,430 81,883 24 11.5%\n\n95321 25,196 28,136 18 11.7%\n\n95322 216,518 241,351 108 11.5%\n\n95323 18,580 20,354 6 9.5%\n\n95324 122,790 136,823 46 11.4%\n\n95325 21,746 24,190 8 11.2%\n\n95326 79,028 88,804 34 12.4%\n\n95327 120,604 135,109 58 12.0%\n\n95328 13,096 14,456 3 10.4%\n\n95329 39,246 43,232 14 10.2%\n\n95330 8,034 9,008 3 12.1%\n\n95333 57,854 63,952 27 10.5%\n\n95334 80,158 89,907 28 12.2%\n\n95335 12,498 14,194 6 13.6%\n\n95336 41,994 46,749 15 11.3%\n\n95337 41,190 46,016 14 11.7%\n\n95338 223,425 250,038 116 11.9%\n\n95340 254,038 283,423 114 11.6%\n\n95341 282,106 315,623 103 11.9%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"95205 13,258 15,157 5 14.3%\n\n95206 34,858 38,845 12 11.4%\n\n95207 33,184 36,836 11 11.0%\n\n95209 40,632 45,336 14 11.6%\n\n95210 11,366 12,928 8 13.7%\n\n95212 30,112 33,814 9 12.3%\n\n95215 19,127 21,693 6 13.4%\n\n95219 26,829 29,897 13 11.4%\n\n95220 25,084 28,105 10 12.0%\n\n95222 30,194 33,960 17 12.5%\n\n95223 11,552 13,146 8 13.8%\n\n95224 888 985 1 10.9%\n\n95225 12,692 14,328 5 12.9%\n\n95227 3,546 3,982 2 12.3%\n\n95228 30,910 34,423 12 11.4%\n\n95230 10,386 11,652 4 12.2%\n\n95231 1,886 2,147 1 13.8%\n\n95232 15,830 17,739 4 12.1%\n\n95233 1,258 1,427 1 13.4%\n\n95236 17,142 19,403 5 13.2%\n\n95237 13,692 15,481 6 13.1%\n\n95240 55,974 62,776 28 12.2%\n\n95242 48,868 55,015 22 12.6%\n\n95245 28,912 32,265 14 11.6%\n\n95246 21,116 23,502 8 11.3%\n\n95247 42,456 47,553 16 12.0%\n\n95248 2,566 2,952 1 15.0%\n\n95249 38,456 43,619 14 13.4%\n\n95251 15,870 17,645 5 11.2%\n\n95252 194,143 220,324 70 13.5%\n\n95254 3,894 4,264 1 9.5%\n\n95255 19,162 21,882 11 14.2%\n\n95257 13,488 15,085 4 11.8%\n\n95301 357,805 400,300 142 11.9%\n\n95303 11,310 12,478 2 10.3%\n\n95304 23,818 26,733 7 12.2%\n\n95306 52,052 58,236 16 11.9%\n\n95307 83,062 95,084 40 14.5%\n\n95310 48,398 54,606 27 12.8%\n\n95311 57,606 64,590 32 12.1%\n\n95312 2,647 2,982 1 12.7%\n\n95313 7,362 8,346 4 13.4%\n\n95315 44,404 49,789 17 12.1%\n\n95316 65,898 73,772 30 11.9%\n\n95317 8,574 9,414 3 9.8%\n\n95318 836 952 1 13.9%\n\n95319 1,306 1,439 1 10.2%\n\n95320 73,430 81,883 24 11.5%\n\n95321 25,196 28,136 18 11.7%\n\n95322 216,518 241,351 108 11.5%\n\n95323 18,580 20,354 6 9.5%\n\n95324 122,790 136,823 46 11.4%\n\n95325 21,746 24,190 8 11.2%\n\n95326 79,028 88,804 34 12.4%\n\n95327 120,604 135,109 58 12.0%\n\n95328 13,096 14,456 3 10.4%\n\n95329 39,246 43,232 14 10.2%\n\n95330 8,034 9,008 3 12.1%\n\n95333 57,854 63,952 27 10.5%\n\n95334 80,158 89,907 28 12.2%\n\n95335 12,498 14,194 6 13.6%\n\n95336 41,994 46,749 15 11.3%\n\n95337 41,190 46,016 14 11.7%\n\n95338 223,425 250,038 116 11.9%\n\n95340 254,038 283,423 114 11.6%\n\n95341 282,106 315,623 103 11.9%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1751.pdf"]},"response":{"errors":[],"extract_id":"extract_980ad4e2d315558eed65b80a8bc5c073","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["95205 13,258 15,157 5 14.3%\n\n95206 34,858 38,845 12 11.4%\n\n95207 33,184 36,836 11 11.0%\n\n95209 40,632 45,336 14 11.6%\n\n95210 11,366 12,928 8 13.7%\n\n95212 30,112 33,814 9 12.3%\n\n95215 19,127 21,693 6 13.4%\n\n95219 26,829 29,897 13 11.4%\n\n95220 25,084 28,105 10 12.0%\n\n95222 30,194 33,960 17 12.5%\n\n95223 11,552 13,146 8 13.8%\n\n95224 888 985 1 10.9%\n\n95225 12,692 14,328 5 12.9%\n\n95227 3,546 3,982 2 12.3%\n\n95228 30,910 34,423 12 11.4%\n\n95230 10,386 11,652 4 12.2%\n\n95231 1,886 2,147 1 13.8%\n\n95232 15,830 17,739 4 12.1%\n\n95233 1,258 1,427 1 13.4%\n\n95236 17,142 19,403 5 13.2%\n\n95237 13,692 15,481 6 13.1%\n\n95240 55,974 62,776 28 12.2%\n\n95242 48,868 55,015 22 12.6%\n\n95245 28,912 32,265 14 11.6%\n\n95246 21,116 23,502 8 11.3%\n\n95247 42,456 47,553 16 12.0%\n\n95248 2,566 2,952 1 15.0%\n\n95249 38,456 43,619 14 13.4%\n\n95251 15,870 17,645 5 11.2%\n\n95252 194,143 220,324 70 13.5%\n\n95254 3,894 4,264 1 9.5%\n\n95255 19,162 21,882 11 14.2%\n\n95257 13,488 15,085 4 11.8%\n\n95301 357,805 400,300 142 11.9%\n\n95303 11,310 12,478 2 10.3%\n\n95304 23,818 26,733 7 12.2%\n\n95306 52,052 58,236 16 11.9%\n\n95307 83,062 95,084 40 14.5%\n\n95310 48,398 54,606 27 12.8%\n\n95311 57,606 64,590 32 12.1%\n\n95312 2,647 2,982 1 12.7%\n\n95313 7,362 8,346 4 13.4%\n\n95315 44,404 49,789 17 12.1%\n\n95316 65,898 73,772 30 11.9%\n\n95317 8,574 9,414 3 9.8%\n\n95318 836 952 1 13.9%\n\n95319 1,306 1,439 1 10.2%\n\n95320 73,430 81,883 24 11.5%\n\n95321 25,196 28,136 18 11.7%\n\n95322 216,518 241,351 108 11.5%\n\n95323 18,580 20,354 6 9.5%\n\n95324 122,790 136,823 46 11.4%\n\n95325 21,746 24,190 8 11.2%\n\n95326 79,028 88,804 34 12.4%\n\n95327 120,604 135,109 58 12.0%\n\n95328 13,096 14,456 3 10.4%\n\n95329 39,246 43,232 14 10.2%\n\n95330 8,034 9,008 3 12.1%\n\n95333 57,854 63,952 27 10.5%\n\n95334 80,158 89,907 28 12.2%\n\n95335 12,498 14,194 6 13.6%\n\n95336 41,994 46,749 15 11.3%\n\n95337 41,190 46,016 14 11.7%\n\n95338 223,425 250,038 116 11.9%\n\n95340 254,038 283,423 114 11.6%\n\n95341 282,106 315,623 103 11.9%"],"full_content":"95205 13,258 15,157 5 14.3%\n\n95206 34,858 38,845 12 11.4%\n\n95207 33,184 36,836 11 11.0%\n\n95209 40,632 45,336 14 11.6%\n\n95210 11,366 12,928 8 13.7%\n\n95212 30,112 33,814 9 12.3%\n\n95215 19,127 21,693 6 13.4%\n\n95219 26,829 29,897 13 11.4%\n\n95220 25,084 28,105 10 12.0%\n\n95222 30,194 33,960 17 12.5%\n\n95223 11,552 13,146 8 13.8%\n\n95224 888 985 1 10.9%\n\n95225 12,692 14,328 5 12.9%\n\n95227 3,546 3,982 2 12.3%\n\n95228 30,910 34,423 12 11.4%\n\n95230 10,386 11,652 4 12.2%\n\n95231 1,886 2,147 1 13.8%\n\n95232 15,830 17,739 4 12.1%\n\n95233 1,258 1,427 1 13.4%\n\n95236 17,142 19,403 5 13.2%\n\n95237 13,692 15,481 6 13.1%\n\n95240 55,974 62,776 28 12.2%\n\n95242 48,868 55,015 22 12.6%\n\n95245 28,912 32,265 14 11.6%\n\n95246 21,116 23,502 8 11.3%\n\n95247 42,456 47,553 16 12.0%\n\n95248 2,566 2,952 1 15.0%\n\n95249 38,456 43,619 14 13.4%\n\n95251 15,870 17,645 5 11.2%\n\n95252 194,143 220,324 70 13.5%\n\n95254 3,894 4,264 1 9.5%\n\n95255 19,162 21,882 11 14.2%\n\n95257 13,488 15,085 4 11.8%\n\n95301 357,805 400,300 142 11.9%\n\n95303 11,310 12,478 2 10.3%\n\n95304 23,818 26,733 7 12.2%\n\n95306 52,052 58,236 16 11.9%\n\n95307 83,062 95,084 40 14.5%\n\n95310 48,398 54,606 27 12.8%\n\n95311 57,606 64,590 32 12.1%\n\n95312 2,647 2,982 1 12.7%\n\n95313 7,362 8,346 4 13.4%\n\n95315 44,404 49,789 17 12.1%\n\n95316 65,898 73,772 30 11.9%\n\n95317 8,574 9,414 3 9.8%\n\n95318 836 952 1 13.9%\n\n95319 1,306 1,439 1 10.2%\n\n95320 73,430 81,883 24 11.5%\n\n95321 25,196 28,136 18 11.7%\n\n95322 216,518 241,351 108 11.5%\n\n95323 18,580 20,354 6 9.5%\n\n95324 122,790 136,823 46 11.4%\n\n95325 21,746 24,190 8 11.2%\n\n95326 79,028 88,804 34 12.4%\n\n95327 120,604 135,109 58 12.0%\n\n95328 13,096 14,456 3 10.4%\n\n95329 39,246 43,232 14 10.2%\n\n95330 8,034 9,008 3 12.1%\n\n95333 57,854 63,952 27 10.5%\n\n95334 80,158 89,907 28 12.2%\n\n95335 12,498 14,194 6 13.6%\n\n95336 41,994 46,749 15 11.3%\n\n95337 41,190 46,016 14 11.7%\n\n95338 223,425 250,038 116 11.9%\n\n95340 254,038 283,423 114 11.6%\n\n95341 282,106 315,623 103 11.9%","publish_date":null,"title":"95205 13,258 15,157 5 14.3% 95206 34,858 38,845 12 11.4% 95207 33,184 36,836 11 11.0% 95209 40,632 45,336 14 11.6%","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1751.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1751.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1751","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1751.pdf"},"started_at":"2026-11-04T19:47:54.709358"} +{"completed_at":"2026-11-04T19:47:57.117117","latency_in_ms":1573,"output":{"example_id":"table/SERFF_CA_random_pages 1_page179","grounded_pages":[],"layout_pages":[],"markdown":"### Page **1** of **5**\n\n### **Allstate Insurance Company**\n\n### **Allstate Commercial Fire**\n\n### **California**\n\n### **Explanatory Memorandum**\n\n### This filing package includes two new and one revised coverage forms to enhance the Commercial Fire policy for Allstate Insurance Company in the state of California. CyberOne are optional coverages which consist of a series of coverage components for first and third-party exposures related to attacks on computer systems, data and subsequent recovery expenses. Also with this filing, Allstate is adopting the outstanding ISO filings containing policy and endorsements. **Proprietary Forms to be Filed:** Form Number Edition Date Title Broaden/Restrict/Clarify\n\n### HP CW 30 01 15\n\n**CYBERONE COVERAGE**\n\n### BROADEN\n\n### HP CW 12 01 15\n\n**DATA COMPROMISE**\n\n**COVERAGE** – Replaces the 11 09 edition\n\n### BROADEN\n\n### HP CW 15 01 15\n\n**DATA COMPROMISE**\n\n**COVERAGE** **–**\n\n**RESPONSE EXPENSES AND DEFENSE AND**\n\n**LIABILITY**\n\n### BROADEN\n\n### **ISO Filing Adoption** Provided below is a list of the most recent circulars that are being adopted in this filing:\n\n### **ISO Designation**\n\n### **Number CDI File Number Form #**\n\n### PROPOSED CF-2011-OFR11 12-1384 CP 00 10 10 12\n\n### CURRENT CF-2007-OFR07 07-5796 CP 00 10 06 07\n\n### PROPOSED CF-2011-OFR11 12-1385 CP 00 17 10 12\n\n### CURRENT CF-2007-OFR07 07-5797 CP 00 17 06 07\n\n### PROPOSED CF-2011-OFR11 12-1386 CP 00 18 10 12\n\n### CURRENT CF-2007-OFR07 07-5798 CP 00 18 06 07\n\n### PROPOSED CF-2011-OFR11 12-1387 CP 00 20 10 12\n\n### CURRENT CF-2007-OFR07 07-5799 CP 00 20 06 07\n\n### PROPOSED CF-2011-OFR11 12-1388 CP 00 30 10 12\n\n### CURRENT CF-2007-OFR07 07-5800 CP 00 30 06 07\n\n### PROPOSED CF-2011-OFR11 12-1389 CP 00 32 10 12\n\n### CURRENT CF-2007-OFR07 07-5801 CP 00 32 06 07\n\n### PROPOSED CF-2011-OFR11 12-1390 CP 00 40 10 12\n\n### CURRENT CF-2007-OFR07 07-5802 CP 00 40 06 07\n\n### PROPOSED CF-2011-OFR11 12-1391 CP 00 50 10 12","pages":[{"line_numbers":[],"markdown":"### Page **1** of **5**\n\n### **Allstate Insurance Company**\n\n### **Allstate Commercial Fire**\n\n### **California**\n\n### **Explanatory Memorandum**\n\n### This filing package includes two new and one revised coverage forms to enhance the Commercial Fire policy for Allstate Insurance Company in the state of California. CyberOne are optional coverages which consist of a series of coverage components for first and third-party exposures related to attacks on computer systems, data and subsequent recovery expenses. Also with this filing, Allstate is adopting the outstanding ISO filings containing policy and endorsements. **Proprietary Forms to be Filed:** Form Number Edition Date Title Broaden/Restrict/Clarify\n\n### HP CW 30 01 15\n\n**CYBERONE COVERAGE**\n\n### BROADEN\n\n### HP CW 12 01 15\n\n**DATA COMPROMISE**\n\n**COVERAGE** – Replaces the 11 09 edition\n\n### BROADEN\n\n### HP CW 15 01 15\n\n**DATA COMPROMISE**\n\n**COVERAGE** **–**\n\n**RESPONSE EXPENSES AND DEFENSE AND**\n\n**LIABILITY**\n\n### BROADEN\n\n### **ISO Filing Adoption** Provided below is a list of the most recent circulars that are being adopted in this filing:\n\n### **ISO Designation**\n\n### **Number CDI File Number Form #**\n\n### PROPOSED CF-2011-OFR11 12-1384 CP 00 10 10 12\n\n### CURRENT CF-2007-OFR07 07-5796 CP 00 10 06 07\n\n### PROPOSED CF-2011-OFR11 12-1385 CP 00 17 10 12\n\n### CURRENT CF-2007-OFR07 07-5797 CP 00 17 06 07\n\n### PROPOSED CF-2011-OFR11 12-1386 CP 00 18 10 12\n\n### CURRENT CF-2007-OFR07 07-5798 CP 00 18 06 07\n\n### PROPOSED CF-2011-OFR11 12-1387 CP 00 20 10 12\n\n### CURRENT CF-2007-OFR07 07-5799 CP 00 20 06 07\n\n### PROPOSED CF-2011-OFR11 12-1388 CP 00 30 10 12\n\n### CURRENT CF-2007-OFR07 07-5800 CP 00 30 06 07\n\n### PROPOSED CF-2011-OFR11 12-1389 CP 00 32 10 12\n\n### CURRENT CF-2007-OFR07 07-5801 CP 00 32 06 07\n\n### PROPOSED CF-2011-OFR11 12-1390 CP 00 40 10 12\n\n### CURRENT CF-2007-OFR07 07-5802 CP 00 40 06 07\n\n### PROPOSED CF-2011-OFR11 12-1391 CP 00 50 10 12","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### Page **1** of **5**\n\n### **Allstate Insurance Company**\n\n### **Allstate Commercial Fire**\n\n### **California**\n\n### **Explanatory Memorandum**\n\n### This filing package includes two new and one revised coverage forms to enhance the Commercial Fire policy for Allstate Insurance Company in the state of California. CyberOne are optional coverages which consist of a series of coverage components for first and third-party exposures related to attacks on computer systems, data and subsequent recovery expenses. Also with this filing, Allstate is adopting the outstanding ISO filings containing policy and endorsements. **Proprietary Forms to be Filed:** Form Number Edition Date Title Broaden/Restrict/Clarify\n\n### HP CW 30 01 15\n\n**CYBERONE COVERAGE**\n\n### BROADEN\n\n### HP CW 12 01 15\n\n**DATA COMPROMISE**\n\n**COVERAGE** – Replaces the 11 09 edition\n\n### BROADEN\n\n### HP CW 15 01 15\n\n**DATA COMPROMISE**\n\n**COVERAGE** **–**\n\n**RESPONSE EXPENSES AND DEFENSE AND**\n\n**LIABILITY**\n\n### BROADEN\n\n### **ISO Filing Adoption** Provided below is a list of the most recent circulars that are being adopted in this filing:\n\n### **ISO Designation**\n\n### **Number CDI File Number Form #**\n\n### PROPOSED CF-2011-OFR11 12-1384 CP 00 10 10 12\n\n### CURRENT CF-2007-OFR07 07-5796 CP 00 10 06 07\n\n### PROPOSED CF-2011-OFR11 12-1385 CP 00 17 10 12\n\n### CURRENT CF-2007-OFR07 07-5797 CP 00 17 06 07\n\n### PROPOSED CF-2011-OFR11 12-1386 CP 00 18 10 12\n\n### CURRENT CF-2007-OFR07 07-5798 CP 00 18 06 07\n\n### PROPOSED CF-2011-OFR11 12-1387 CP 00 20 10 12\n\n### CURRENT CF-2007-OFR07 07-5799 CP 00 20 06 07\n\n### PROPOSED CF-2011-OFR11 12-1388 CP 00 30 10 12\n\n### CURRENT CF-2007-OFR07 07-5800 CP 00 30 06 07\n\n### PROPOSED CF-2011-OFR11 12-1389 CP 00 32 10 12\n\n### CURRENT CF-2007-OFR07 07-5801 CP 00 32 06 07\n\n### PROPOSED CF-2011-OFR11 12-1390 CP 00 40 10 12\n\n### CURRENT CF-2007-OFR07 07-5802 CP 00 40 06 07\n\n### PROPOSED CF-2011-OFR11 12-1391 CP 00 50 10 12","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page179.pdf"]},"response":{"errors":[],"extract_id":"extract_74bb28ed4fe877fdb198ee85f0325ed6","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### Page **1** of **5**\n\n### **Allstate Insurance Company**\n\n### **Allstate Commercial Fire**\n\n### **California**\n\n### **Explanatory Memorandum**\n\n### This filing package includes two new and one revised coverage forms to enhance the Commercial Fire policy for Allstate Insurance Company in the state of California. CyberOne are optional coverages which consist of a series of coverage components for first and third-party exposures related to attacks on computer systems, data and subsequent recovery expenses. Also with this filing, Allstate is adopting the outstanding ISO filings containing policy and endorsements. **Proprietary Forms to be Filed:** Form Number Edition Date Title Broaden/Restrict/Clarify\n\n### HP CW 30 01 15\n\n**CYBERONE COVERAGE**\n\n### BROADEN\n\n### HP CW 12 01 15\n\n**DATA COMPROMISE**\n\n**COVERAGE** – Replaces the 11 09 edition\n\n### BROADEN\n\n### HP CW 15 01 15\n\n**DATA COMPROMISE**\n\n**COVERAGE** **–**\n\n**RESPONSE EXPENSES AND DEFENSE AND**\n\n**LIABILITY**\n\n### BROADEN\n\n### **ISO Filing Adoption** Provided below is a list of the most recent circulars that are being adopted in this filing:\n\n### **ISO Designation**\n\n### **Number CDI File Number Form #**\n\n### PROPOSED CF-2011-OFR11 12-1384 CP 00 10 10 12\n\n### CURRENT CF-2007-OFR07 07-5796 CP 00 10 06 07\n\n### PROPOSED CF-2011-OFR11 12-1385 CP 00 17 10 12\n\n### CURRENT CF-2007-OFR07 07-5797 CP 00 17 06 07\n\n### PROPOSED CF-2011-OFR11 12-1386 CP 00 18 10 12\n\n### CURRENT CF-2007-OFR07 07-5798 CP 00 18 06 07\n\n### PROPOSED CF-2011-OFR11 12-1387 CP 00 20 10 12\n\n### CURRENT CF-2007-OFR07 07-5799 CP 00 20 06 07\n\n### PROPOSED CF-2011-OFR11 12-1388 CP 00 30 10 12\n\n### CURRENT CF-2007-OFR07 07-5800 CP 00 30 06 07\n\n### PROPOSED CF-2011-OFR11 12-1389 CP 00 32 10 12\n\n### CURRENT CF-2007-OFR07 07-5801 CP 00 32 06 07\n\n### PROPOSED CF-2011-OFR11 12-1390 CP 00 40 10 12\n\n### CURRENT CF-2007-OFR07 07-5802 CP 00 40 06 07\n\n### PROPOSED CF-2011-OFR11 12-1391 CP 00 50 10 12"],"full_content":"### Page **1** of **5**\n\n### **Allstate Insurance Company**\n\n### **Allstate Commercial Fire**\n\n### **California**\n\n### **Explanatory Memorandum**\n\n### This filing package includes two new and one revised coverage forms to enhance the Commercial Fire policy for Allstate Insurance Company in the state of California. CyberOne are optional coverages which consist of a series of coverage components for first and third-party exposures related to attacks on computer systems, data and subsequent recovery expenses. Also with this filing, Allstate is adopting the outstanding ISO filings containing policy and endorsements. **Proprietary Forms to be Filed:** Form Number Edition Date Title Broaden/Restrict/Clarify\n\n### HP CW 30 01 15\n\n**CYBERONE COVERAGE**\n\n### BROADEN\n\n### HP CW 12 01 15\n\n**DATA COMPROMISE**\n\n**COVERAGE** – Replaces the 11 09 edition\n\n### BROADEN\n\n### HP CW 15 01 15\n\n**DATA COMPROMISE**\n\n**COVERAGE** **–**\n\n**RESPONSE EXPENSES AND DEFENSE AND**\n\n**LIABILITY**\n\n### BROADEN\n\n### **ISO Filing Adoption** Provided below is a list of the most recent circulars that are being adopted in this filing:\n\n### **ISO Designation**\n\n### **Number CDI File Number Form #**\n\n### PROPOSED CF-2011-OFR11 12-1384 CP 00 10 10 12\n\n### CURRENT CF-2007-OFR07 07-5796 CP 00 10 06 07\n\n### PROPOSED CF-2011-OFR11 12-1385 CP 00 17 10 12\n\n### CURRENT CF-2007-OFR07 07-5797 CP 00 17 06 07\n\n### PROPOSED CF-2011-OFR11 12-1386 CP 00 18 10 12\n\n### CURRENT CF-2007-OFR07 07-5798 CP 00 18 06 07\n\n### PROPOSED CF-2011-OFR11 12-1387 CP 00 20 10 12\n\n### CURRENT CF-2007-OFR07 07-5799 CP 00 20 06 07\n\n### PROPOSED CF-2011-OFR11 12-1388 CP 00 30 10 12\n\n### CURRENT CF-2007-OFR07 07-5800 CP 00 30 06 07\n\n### PROPOSED CF-2011-OFR11 12-1389 CP 00 32 10 12\n\n### CURRENT CF-2007-OFR07 07-5801 CP 00 32 06 07\n\n### PROPOSED CF-2011-OFR11 12-1390 CP 00 40 10 12\n\n### CURRENT CF-2007-OFR07 07-5802 CP 00 40 06 07\n\n### PROPOSED CF-2011-OFR11 12-1391 CP 00 50 10 12","publish_date":null,"title":"Allstate Insurance Company Allstate Commercial Fire California Explanatory Memorandum This filing package includes two new and one revised coverage forms","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page179.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page179.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page179","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page179.pdf"},"started_at":"2026-11-04T19:47:55.543308"} +{"completed_at":"2026-11-04T19:47:57.525830","latency_in_ms":1008,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1800","grounded_pages":[],"layout_pages":[],"markdown":"**Great American Assurance Company Exhibit 6 California Mortgage Protection Insurance Miscellaneous Fees and Other Charges**\n\n**Calendar Year Ending Installment Fees**\n\n12/31/2008 None\n\n12/31/2009 None\n\n12/31/2010 None\n\n12/31/2011 None","pages":[{"line_numbers":[],"markdown":"**Great American Assurance Company Exhibit 6 California Mortgage Protection Insurance Miscellaneous Fees and Other Charges**\n\n**Calendar Year Ending Installment Fees**\n\n12/31/2008 None\n\n12/31/2009 None\n\n12/31/2010 None\n\n12/31/2011 None","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Great American Assurance Company Exhibit 6 California Mortgage Protection Insurance Miscellaneous Fees and Other Charges**\n\n**Calendar Year Ending Installment Fees**\n\n12/31/2008 None\n\n12/31/2009 None\n\n12/31/2010 None\n\n12/31/2011 None","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1800.pdf"]},"response":{"errors":[],"extract_id":"extract_ae88b13a84e0ca849b5b5ace6e104911","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Great American Assurance Company Exhibit 6 California Mortgage Protection Insurance Miscellaneous Fees and Other Charges**\n\n**Calendar Year Ending Installment Fees**\n\n12/31/2008 None\n\n12/31/2009 None\n\n12/31/2010 None\n\n12/31/2011 None"],"full_content":"**Great American Assurance Company Exhibit 6 California Mortgage Protection Insurance Miscellaneous Fees and Other Charges**\n\n**Calendar Year Ending Installment Fees**\n\n12/31/2008 None\n\n12/31/2009 None\n\n12/31/2010 None\n\n12/31/2011 None","publish_date":null,"title":"Great American Assurance Company Exhibit 6 California Mortgage Protection Insurance Miscellaneous Fees and Other Charges Calendar Installment Year Ending Fees","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1800.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1800.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1800","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1800.pdf"},"started_at":"2026-11-04T19:47:56.517449"} +{"completed_at":"2026-11-04T19:47:58.739771","latency_in_ms":1062,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1801","grounded_pages":[],"layout_pages":[],"markdown":"FIS Mortgage Protection Insurance Exhibit II All Lines PLLS Loss Development Report Dec-2011 Page 1 FIS MPI\n\nIncurred Losses (000's)\n\nAccident Age in Period Months: Ending 12 24 36 48 60 72 84 96 108 @ 12/11 12 / 1999 435 435 435 435 12 / 2000 1,210 1,194 1,194 1,194 1,194 12 / 2001 1,462 1,443 1,415 1,415 1,415 1,415 12 / 2002 5,066 5,897 5,733 5,614 5,551 5,551 5,547 5,547 5,547 5,546 12 / 2003 6,978 8,051 7,812 7,665 7,696 7,670 7,670 7,670 7,670 12 / 2004 12,127 14,314 14,361 14,423 14,403 14,423 14,426 14,426 12 / 2005 13,488 17,226 17,449 17,375 17,569 17,569 17,560 12 / 2006 11,435 13,619 13,506 13,321 13,307 13,314 12 / 2007 12,139 14,582 15,000 15,244 14,979 12 / 2008 26,147 30,037 29,974 29,847 12 / 2009 18,707 20,328 20,258 12 / 2010 21,769 25,335 12 / 2011 38,700\n\nIncurred Development Factors\n\nAccident Period Ending 12 / 24 24 / 36 36 / 48 48 / 60 60 / 72 72 / 84 84 / 96 96 / 108 108 / Now 12 / 1999 1.000 1.000 1.000 12 / 2000 0.987 1.000 1.000 1.000 12 / 2001 0.987 0.981 1.000 1.000 1.000 12 / 2002 1.164 0.972 0.979 0.989 1.000 0.999 1.000 1.000 1.000 12 / 2003 1.154 0.970 0.981 1.004 0.997 1.000 1.000 1.000 12 / 2004 1.180 1.003 1.004 0.999 1.001 1.000 1.000 12 / 2005 1.277 1.013 0.996 1.011 1.000 1.000 12 / 2006 1.191 0.992 0.986 0.999 1.001 12 / 2007 1.201 1.029 1.016 0.983 12 / 2008 1.149 0.998 0.996 12 / 2009 1.087 0.997 12 / 2010 1.164 12 / 2011 Mod. Avg. 1.172 0.996 0.993 0.998 0.999 0.996 1.000 1.000 1.000 Average 1.174 0.997 0.994 0.997 0.998 0.994 1.000 1.000 1.000 Loss Wtd 1.168 1.000 0.997 0.998 1.000 0.999 1.000 1.000 1.000 3 Yr. Wtd. Avg. 1.136 1.004 0.999 0.998 1.001 1.000 1.000 1.000 1.000 Selected 1.136 1.004 0.999 0.998 1.001 1.000 1.000 1.000 1.000 1.000\n\nTo Ult 1.138 1.002 0.997 0.999 1.000 1.000 1.000 1.000 1.000 1.000","pages":[{"line_numbers":[],"markdown":"FIS Mortgage Protection Insurance Exhibit II All Lines PLLS Loss Development Report Dec-2011 Page 1 FIS MPI\n\nIncurred Losses (000's)\n\nAccident Age in Period Months: Ending 12 24 36 48 60 72 84 96 108 @ 12/11 12 / 1999 435 435 435 435 12 / 2000 1,210 1,194 1,194 1,194 1,194 12 / 2001 1,462 1,443 1,415 1,415 1,415 1,415 12 / 2002 5,066 5,897 5,733 5,614 5,551 5,551 5,547 5,547 5,547 5,546 12 / 2003 6,978 8,051 7,812 7,665 7,696 7,670 7,670 7,670 7,670 12 / 2004 12,127 14,314 14,361 14,423 14,403 14,423 14,426 14,426 12 / 2005 13,488 17,226 17,449 17,375 17,569 17,569 17,560 12 / 2006 11,435 13,619 13,506 13,321 13,307 13,314 12 / 2007 12,139 14,582 15,000 15,244 14,979 12 / 2008 26,147 30,037 29,974 29,847 12 / 2009 18,707 20,328 20,258 12 / 2010 21,769 25,335 12 / 2011 38,700\n\nIncurred Development Factors\n\nAccident Period Ending 12 / 24 24 / 36 36 / 48 48 / 60 60 / 72 72 / 84 84 / 96 96 / 108 108 / Now 12 / 1999 1.000 1.000 1.000 12 / 2000 0.987 1.000 1.000 1.000 12 / 2001 0.987 0.981 1.000 1.000 1.000 12 / 2002 1.164 0.972 0.979 0.989 1.000 0.999 1.000 1.000 1.000 12 / 2003 1.154 0.970 0.981 1.004 0.997 1.000 1.000 1.000 12 / 2004 1.180 1.003 1.004 0.999 1.001 1.000 1.000 12 / 2005 1.277 1.013 0.996 1.011 1.000 1.000 12 / 2006 1.191 0.992 0.986 0.999 1.001 12 / 2007 1.201 1.029 1.016 0.983 12 / 2008 1.149 0.998 0.996 12 / 2009 1.087 0.997 12 / 2010 1.164 12 / 2011 Mod. Avg. 1.172 0.996 0.993 0.998 0.999 0.996 1.000 1.000 1.000 Average 1.174 0.997 0.994 0.997 0.998 0.994 1.000 1.000 1.000 Loss Wtd 1.168 1.000 0.997 0.998 1.000 0.999 1.000 1.000 1.000 3 Yr. Wtd. Avg. 1.136 1.004 0.999 0.998 1.001 1.000 1.000 1.000 1.000 Selected 1.136 1.004 0.999 0.998 1.001 1.000 1.000 1.000 1.000 1.000\n\nTo Ult 1.138 1.002 0.997 0.999 1.000 1.000 1.000 1.000 1.000 1.000","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"FIS Mortgage Protection Insurance Exhibit II All Lines PLLS Loss Development Report Dec-2011 Page 1 FIS MPI\n\nIncurred Losses (000's)\n\nAccident Age in Period Months: Ending 12 24 36 48 60 72 84 96 108 @ 12/11 12 / 1999 435 435 435 435 12 / 2000 1,210 1,194 1,194 1,194 1,194 12 / 2001 1,462 1,443 1,415 1,415 1,415 1,415 12 / 2002 5,066 5,897 5,733 5,614 5,551 5,551 5,547 5,547 5,547 5,546 12 / 2003 6,978 8,051 7,812 7,665 7,696 7,670 7,670 7,670 7,670 12 / 2004 12,127 14,314 14,361 14,423 14,403 14,423 14,426 14,426 12 / 2005 13,488 17,226 17,449 17,375 17,569 17,569 17,560 12 / 2006 11,435 13,619 13,506 13,321 13,307 13,314 12 / 2007 12,139 14,582 15,000 15,244 14,979 12 / 2008 26,147 30,037 29,974 29,847 12 / 2009 18,707 20,328 20,258 12 / 2010 21,769 25,335 12 / 2011 38,700\n\nIncurred Development Factors\n\nAccident Period Ending 12 / 24 24 / 36 36 / 48 48 / 60 60 / 72 72 / 84 84 / 96 96 / 108 108 / Now 12 / 1999 1.000 1.000 1.000 12 / 2000 0.987 1.000 1.000 1.000 12 / 2001 0.987 0.981 1.000 1.000 1.000 12 / 2002 1.164 0.972 0.979 0.989 1.000 0.999 1.000 1.000 1.000 12 / 2003 1.154 0.970 0.981 1.004 0.997 1.000 1.000 1.000 12 / 2004 1.180 1.003 1.004 0.999 1.001 1.000 1.000 12 / 2005 1.277 1.013 0.996 1.011 1.000 1.000 12 / 2006 1.191 0.992 0.986 0.999 1.001 12 / 2007 1.201 1.029 1.016 0.983 12 / 2008 1.149 0.998 0.996 12 / 2009 1.087 0.997 12 / 2010 1.164 12 / 2011 Mod. Avg. 1.172 0.996 0.993 0.998 0.999 0.996 1.000 1.000 1.000 Average 1.174 0.997 0.994 0.997 0.998 0.994 1.000 1.000 1.000 Loss Wtd 1.168 1.000 0.997 0.998 1.000 0.999 1.000 1.000 1.000 3 Yr. Wtd. Avg. 1.136 1.004 0.999 0.998 1.001 1.000 1.000 1.000 1.000 Selected 1.136 1.004 0.999 0.998 1.001 1.000 1.000 1.000 1.000 1.000\n\nTo Ult 1.138 1.002 0.997 0.999 1.000 1.000 1.000 1.000 1.000 1.000","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1801.pdf"]},"response":{"errors":[],"extract_id":"extract_e25965cc4634f886a3df18e3f98f6549","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["FIS Mortgage Protection Insurance Exhibit II All Lines PLLS Loss Development Report Dec-2011 Page 1 FIS MPI\n\nIncurred Losses (000's)\n\nAccident Age in Period Months: Ending 12 24 36 48 60 72 84 96 108 @ 12/11 12 / 1999 435 435 435 435 12 / 2000 1,210 1,194 1,194 1,194 1,194 12 / 2001 1,462 1,443 1,415 1,415 1,415 1,415 12 / 2002 5,066 5,897 5,733 5,614 5,551 5,551 5,547 5,547 5,547 5,546 12 / 2003 6,978 8,051 7,812 7,665 7,696 7,670 7,670 7,670 7,670 12 / 2004 12,127 14,314 14,361 14,423 14,403 14,423 14,426 14,426 12 / 2005 13,488 17,226 17,449 17,375 17,569 17,569 17,560 12 / 2006 11,435 13,619 13,506 13,321 13,307 13,314 12 / 2007 12,139 14,582 15,000 15,244 14,979 12 / 2008 26,147 30,037 29,974 29,847 12 / 2009 18,707 20,328 20,258 12 / 2010 21,769 25,335 12 / 2011 38,700\n\nIncurred Development Factors\n\nAccident Period Ending 12 / 24 24 / 36 36 / 48 48 / 60 60 / 72 72 / 84 84 / 96 96 / 108 108 / Now 12 / 1999 1.000 1.000 1.000 12 / 2000 0.987 1.000 1.000 1.000 12 / 2001 0.987 0.981 1.000 1.000 1.000 12 / 2002 1.164 0.972 0.979 0.989 1.000 0.999 1.000 1.000 1.000 12 / 2003 1.154 0.970 0.981 1.004 0.997 1.000 1.000 1.000 12 / 2004 1.180 1.003 1.004 0.999 1.001 1.000 1.000 12 / 2005 1.277 1.013 0.996 1.011 1.000 1.000 12 / 2006 1.191 0.992 0.986 0.999 1.001 12 / 2007 1.201 1.029 1.016 0.983 12 / 2008 1.149 0.998 0.996 12 / 2009 1.087 0.997 12 / 2010 1.164 12 / 2011 Mod. Avg. 1.172 0.996 0.993 0.998 0.999 0.996 1.000 1.000 1.000 Average 1.174 0.997 0.994 0.997 0.998 0.994 1.000 1.000 1.000 Loss Wtd 1.168 1.000 0.997 0.998 1.000 0.999 1.000 1.000 1.000 3 Yr. Wtd. Avg. 1.136 1.004 0.999 0.998 1.001 1.000 1.000 1.000 1.000 Selected 1.136 1.004 0.999 0.998 1.001 1.000 1.000 1.000 1.000 1.000\n\nTo Ult 1.138 1.002 0.997 0.999 1.000 1.000 1.000 1.000 1.000 1.000"],"full_content":"FIS Mortgage Protection Insurance Exhibit II All Lines PLLS Loss Development Report Dec-2011 Page 1 FIS MPI\n\nIncurred Losses (000's)\n\nAccident Age in Period Months: Ending 12 24 36 48 60 72 84 96 108 @ 12/11 12 / 1999 435 435 435 435 12 / 2000 1,210 1,194 1,194 1,194 1,194 12 / 2001 1,462 1,443 1,415 1,415 1,415 1,415 12 / 2002 5,066 5,897 5,733 5,614 5,551 5,551 5,547 5,547 5,547 5,546 12 / 2003 6,978 8,051 7,812 7,665 7,696 7,670 7,670 7,670 7,670 12 / 2004 12,127 14,314 14,361 14,423 14,403 14,423 14,426 14,426 12 / 2005 13,488 17,226 17,449 17,375 17,569 17,569 17,560 12 / 2006 11,435 13,619 13,506 13,321 13,307 13,314 12 / 2007 12,139 14,582 15,000 15,244 14,979 12 / 2008 26,147 30,037 29,974 29,847 12 / 2009 18,707 20,328 20,258 12 / 2010 21,769 25,335 12 / 2011 38,700\n\nIncurred Development Factors\n\nAccident Period Ending 12 / 24 24 / 36 36 / 48 48 / 60 60 / 72 72 / 84 84 / 96 96 / 108 108 / Now 12 / 1999 1.000 1.000 1.000 12 / 2000 0.987 1.000 1.000 1.000 12 / 2001 0.987 0.981 1.000 1.000 1.000 12 / 2002 1.164 0.972 0.979 0.989 1.000 0.999 1.000 1.000 1.000 12 / 2003 1.154 0.970 0.981 1.004 0.997 1.000 1.000 1.000 12 / 2004 1.180 1.003 1.004 0.999 1.001 1.000 1.000 12 / 2005 1.277 1.013 0.996 1.011 1.000 1.000 12 / 2006 1.191 0.992 0.986 0.999 1.001 12 / 2007 1.201 1.029 1.016 0.983 12 / 2008 1.149 0.998 0.996 12 / 2009 1.087 0.997 12 / 2010 1.164 12 / 2011 Mod. Avg. 1.172 0.996 0.993 0.998 0.999 0.996 1.000 1.000 1.000 Average 1.174 0.997 0.994 0.997 0.998 0.994 1.000 1.000 1.000 Loss Wtd 1.168 1.000 0.997 0.998 1.000 0.999 1.000 1.000 1.000 3 Yr. Wtd. Avg. 1.136 1.004 0.999 0.998 1.001 1.000 1.000 1.000 1.000 Selected 1.136 1.004 0.999 0.998 1.001 1.000 1.000 1.000 1.000 1.000\n\nTo Ult 1.138 1.002 0.997 0.999 1.000 1.000 1.000 1.000 1.000 1.000","publish_date":null,"title":"FIS Mortgage Protection Insurance Exhibit II All Lines PLLS Loss Development Report Page 1 FIS MPI Accident Age in Period","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1801.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1801.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1801","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1801.pdf"},"started_at":"2026-11-04T19:47:57.677371"} +{"completed_at":"2026-11-04T19:48:01.052485","latency_in_ms":1782,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1869","grounded_pages":[],"layout_pages":[],"markdown":"**GROWING SPECTRUM**\n\n**CALIFORNIA**\n\n**BI WAITING PERIOD**\n\nMarket Group 24 Hours 48 Hours 72 Hours\n\nAN 0.960 0.930 0.910\n\nAO 0.960 0.930 0.910\n\nAS 0.960 0.930 0.910\n\nBU 0.960 0.930 0.910\n\nCM 0.960 0.930 0.910\n\nCT 0.960 0.930 0.910\n\nCU 0.960 0.930 0.910\n\nED 0.960 0.930 0.910\n\nEN 0.960 0.930 0.910\n\nFP 0.960 0.930 0.910\n\nFS 0.960 0.930 0.910\n\nFW 0.960 0.930 0.910\n\nHB 0.960 0.930 0.910\n\nHS 0.960 0.930 0.910\n\nJS 0.960 0.930 0.910\n\nMF 0.960 0.930 0.910\n\nMM 0.960 0.930 0.910\n\nMO 0.960 0.930 0.910\n\nPF 0.960 0.930 0.910\n\nPM 0.960 0.930 0.910\n\nPR 0.960 0.930 0.910\n\nPS 0.960 0.930 0.910\n\nRE 0.960 0.930 0.910\n\nRO 0.960 0.930 0.910\n\nRS 0.960 0.930 0.910\n\nRT 0.960 0.930 0.910\n\nTE 0.960 0.930 0.910\n\nTM 0.960 0.930 0.910\n\nWH 0.960 0.930 0.910\n\n**RF-11**","pages":[{"line_numbers":[],"markdown":"**GROWING SPECTRUM**\n\n**CALIFORNIA**\n\n**BI WAITING PERIOD**\n\nMarket Group 24 Hours 48 Hours 72 Hours\n\nAN 0.960 0.930 0.910\n\nAO 0.960 0.930 0.910\n\nAS 0.960 0.930 0.910\n\nBU 0.960 0.930 0.910\n\nCM 0.960 0.930 0.910\n\nCT 0.960 0.930 0.910\n\nCU 0.960 0.930 0.910\n\nED 0.960 0.930 0.910\n\nEN 0.960 0.930 0.910\n\nFP 0.960 0.930 0.910\n\nFS 0.960 0.930 0.910\n\nFW 0.960 0.930 0.910\n\nHB 0.960 0.930 0.910\n\nHS 0.960 0.930 0.910\n\nJS 0.960 0.930 0.910\n\nMF 0.960 0.930 0.910\n\nMM 0.960 0.930 0.910\n\nMO 0.960 0.930 0.910\n\nPF 0.960 0.930 0.910\n\nPM 0.960 0.930 0.910\n\nPR 0.960 0.930 0.910\n\nPS 0.960 0.930 0.910\n\nRE 0.960 0.930 0.910\n\nRO 0.960 0.930 0.910\n\nRS 0.960 0.930 0.910\n\nRT 0.960 0.930 0.910\n\nTE 0.960 0.930 0.910\n\nTM 0.960 0.930 0.910\n\nWH 0.960 0.930 0.910\n\n**RF-11**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**GROWING SPECTRUM**\n\n**CALIFORNIA**\n\n**BI WAITING PERIOD**\n\nMarket Group 24 Hours 48 Hours 72 Hours\n\nAN 0.960 0.930 0.910\n\nAO 0.960 0.930 0.910\n\nAS 0.960 0.930 0.910\n\nBU 0.960 0.930 0.910\n\nCM 0.960 0.930 0.910\n\nCT 0.960 0.930 0.910\n\nCU 0.960 0.930 0.910\n\nED 0.960 0.930 0.910\n\nEN 0.960 0.930 0.910\n\nFP 0.960 0.930 0.910\n\nFS 0.960 0.930 0.910\n\nFW 0.960 0.930 0.910\n\nHB 0.960 0.930 0.910\n\nHS 0.960 0.930 0.910\n\nJS 0.960 0.930 0.910\n\nMF 0.960 0.930 0.910\n\nMM 0.960 0.930 0.910\n\nMO 0.960 0.930 0.910\n\nPF 0.960 0.930 0.910\n\nPM 0.960 0.930 0.910\n\nPR 0.960 0.930 0.910\n\nPS 0.960 0.930 0.910\n\nRE 0.960 0.930 0.910\n\nRO 0.960 0.930 0.910\n\nRS 0.960 0.930 0.910\n\nRT 0.960 0.930 0.910\n\nTE 0.960 0.930 0.910\n\nTM 0.960 0.930 0.910\n\nWH 0.960 0.930 0.910\n\n**RF-11**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1869.pdf"]},"response":{"errors":[],"extract_id":"extract_00525b8a8cbc7d5d315e3fdf85d4040e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**GROWING SPECTRUM**\n\n**CALIFORNIA**\n\n**BI WAITING PERIOD**\n\nMarket Group 24 Hours 48 Hours 72 Hours\n\nAN 0.960 0.930 0.910\n\nAO 0.960 0.930 0.910\n\nAS 0.960 0.930 0.910\n\nBU 0.960 0.930 0.910\n\nCM 0.960 0.930 0.910\n\nCT 0.960 0.930 0.910\n\nCU 0.960 0.930 0.910\n\nED 0.960 0.930 0.910\n\nEN 0.960 0.930 0.910\n\nFP 0.960 0.930 0.910\n\nFS 0.960 0.930 0.910\n\nFW 0.960 0.930 0.910\n\nHB 0.960 0.930 0.910\n\nHS 0.960 0.930 0.910\n\nJS 0.960 0.930 0.910\n\nMF 0.960 0.930 0.910\n\nMM 0.960 0.930 0.910\n\nMO 0.960 0.930 0.910\n\nPF 0.960 0.930 0.910\n\nPM 0.960 0.930 0.910\n\nPR 0.960 0.930 0.910\n\nPS 0.960 0.930 0.910\n\nRE 0.960 0.930 0.910\n\nRO 0.960 0.930 0.910\n\nRS 0.960 0.930 0.910\n\nRT 0.960 0.930 0.910\n\nTE 0.960 0.930 0.910\n\nTM 0.960 0.930 0.910\n\nWH 0.960 0.930 0.910\n\n**RF-11**"],"full_content":"**GROWING SPECTRUM**\n\n**CALIFORNIA**\n\n**BI WAITING PERIOD**\n\nMarket Group 24 Hours 48 Hours 72 Hours\n\nAN 0.960 0.930 0.910\n\nAO 0.960 0.930 0.910\n\nAS 0.960 0.930 0.910\n\nBU 0.960 0.930 0.910\n\nCM 0.960 0.930 0.910\n\nCT 0.960 0.930 0.910\n\nCU 0.960 0.930 0.910\n\nED 0.960 0.930 0.910\n\nEN 0.960 0.930 0.910\n\nFP 0.960 0.930 0.910\n\nFS 0.960 0.930 0.910\n\nFW 0.960 0.930 0.910\n\nHB 0.960 0.930 0.910\n\nHS 0.960 0.930 0.910\n\nJS 0.960 0.930 0.910\n\nMF 0.960 0.930 0.910\n\nMM 0.960 0.930 0.910\n\nMO 0.960 0.930 0.910\n\nPF 0.960 0.930 0.910\n\nPM 0.960 0.930 0.910\n\nPR 0.960 0.930 0.910\n\nPS 0.960 0.930 0.910\n\nRE 0.960 0.930 0.910\n\nRO 0.960 0.930 0.910\n\nRS 0.960 0.930 0.910\n\nRT 0.960 0.930 0.910\n\nTE 0.960 0.930 0.910\n\nTM 0.960 0.930 0.910\n\nWH 0.960 0.930 0.910\n\n**RF-11**","publish_date":null,"title":"GROWINGSPECTRUM CALIFORNIA BIWAITINGPERIOD MarketGroup 24Hours 48Hours 72Hours AN 0.960 0.930 0.910 AO 0.960 0.930 0.910 AS 0.960 0.930 0.910 BU","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1869.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1869.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1869","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1869.pdf"},"started_at":"2026-11-04T19:47:59.270069"} +{"completed_at":"2026-11-04T19:48:03.405299","latency_in_ms":3209,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1870","grounded_pages":[],"layout_pages":[],"markdown":"**GROWING SPECTRUM**\n\n**CALIFORNIA**\n\n**CLASS FACTORS**\n\nEquip Equip\n\nClass Building Contents BI Prem/Ops Products Breakdown Class Building Contents BI Prem/Ops Products Breakdown\n\n62111 1.097 0.869 0.998 0.620 N/A 0.771 73481 2.686 3.496 0.918 2.473 5.518 1.324\n\n62211 1.192 0.985 1.337 0.666 N/A 0.771 73951 1.164 1.135 1.318 1.315 0.541 0.934\n\n63321 1.072 0.888 1.051 0.619 N/A 0.771 73981 1.404 1.423 1.969 1.711 0.563 0.934\n\n65111 1.729 0.895 0.870 0.158 N/A 0.567 73991 1.297 1.355 0.966 0.302 0.088 1.337\n\n65141 2.086 0.793 1.011 0.459 N/A 0.922 75361 2.399 2.614 6.372 1.249 11.496 2.011\n\n65151 1.356 1.096 1.226 0.282 0.028 0.617 75481 2.399 2.614 6.372 1.249 11.496 2.011\n\n65161 1.187 1.130 1.303 0.981 N/A 1.459 75491 2.399 2.614 6.372 1.249 11.496 2.011\n\n65181 1.080 0.913 0.935 0.957 N/A 0.617 76221 1.433 1.283 1.865 1.729 0.679 0.716\n\n65198 1.989 0.780 1.105 0.325 N/A 0.340 76271 3.292 3.715 2.789 1.807 2.036 0.314\n\n65221 5.310 2.447 7.257 0.574 N/A 0.521 76281 1.421 1.264 1.820 1.715 0.554 0.716\n\n65271 1.556 1.294 1.701 0.346 N/A 0.467 76291 1.701 1.584 2.591 2.525 9.055 0.716\n\n65272 1.556 1.294 1.701 0.346 N/A 0.467 76311 1.402 1.514 1.817 1.631 0.412 0.716\n\n65273 1.556 1.294 1.701 0.346 N/A 0.467 76321 1.415 1.282 1.866 1.645 0.421 0.716\n\n65491 N/A N/A N/A N/A N/A N/A 76911 1.433 1.282 1.866 1.729 0.679 0.716\n\n65511 5.468 2.570 7.930 0.587 N/A 0.521 76961 1.348 1.137 1.468 1.686 6.474 0.716\n\n65611 5.477 2.570 7.930 0.587 N/A 0.521 76991 1.761 1.675 2.799 2.660 1.625 0.716\n\n65641 1.823 0.708 0.337 0.657 N/A 1.182 80721 1.355 1.163 1.597 1.731 0.389 0.712\n\n65661 1.402 0.599 0.697 0.141 N/A 0.333 82001 2.145 0.726 1.063 0.501 N/A 0.659\n\n65671 1.869 1.084 1.690 0.368 N/A 0.475 82031 2.656 1.192 1.556 2.121 N/A 0.691\n\n65681 1.883 0.985 1.221 0.481 N/A 0.426 82051 2.656 1.192 1.556 2.121 N/A 0.691\n\n65691 2.090 1.283 1.700 0.542 N/A 0.426 82071 2.656 1.192 1.556 2.121 N/A 0.691\n\n65701 2.003 1.057 1.537 0.512 N/A 0.426 82081 2.656 1.192 1.556 2.121 N/A 0.691\n\n65711 1.947 1.226 1.376 0.497 N/A 0.426 82141 1.988 1.192 1.556 0.760 N/A 0.691\n\n65721 1.852 0.966 1.149 0.473 N/A 0.426 82151 1.988 1.192 1.556 0.760 N/A 0.691\n\n65741 1.824 0.764 1.006 0.120 N/A 0.411 82161 2.070 1.335 1.806 0.686 N/A 0.695\n\n65751 1.072 0.893 0.610 0.097 0.017 0.618 82171 2.070 1.335 1.806 0.686 N/A 0.695\n\n65761 1.017 0.840 0.610 0.093 0.017 0.618 82191 1.980 1.192 1.556 0.747 N/A 0.691\n\n65771 1.446 0.625 0.824 0.145 N/A 0.333 82201 1.980 1.192 1.556 0.747 N/A 0.691\n\n65781 0.907 0.803 0.515 0.604 0.200 0.360 82221 1.980 1.192 1.556 0.747 N/A 0.691\n\n65791 0.847 0.836 0.518 0.900 0.606 0.934 82231 2.656 1.192 1.556 2.121 N/A 0.691\n\n65801 0.877 0.775 0.723 0.793 0.575 0.563 82241 2.656 1.192 1.556 2.121 N/A 0.691\n\n65811 1.167 1.057 1.153 1.071 N/A 0.955 82251 2.656 1.192 1.556 2.121 N/A 0.691\n\n65821 0.809 0.786 0.498 0.743 0.315 0.934 82261 2.656 1.192 1.556 2.121 N/A 0.691\n\n65831 1.242 1.231 1.457 1.217 N/A 0.934 82271 2.656 1.192 1.556 2.121 N/A 0.691\n\n65841 1.316 1.330 1.683 1.299 N/A 0.934 82281 2.656 1.192 1.556 2.121 N/A 0.691\n\n65851 1.962 1.034 1.424 0.501 N/A 0.426 82291 2.656 1.192 1.556 2.121 N/A 0.691\n\n65861 0.971 1.000 0.954 0.889 N/A 0.934 82301 2.656 1.192 1.556 2.121 N/A 0.691\n\n65871 0.797 0.948 0.663 0.990 0.385 0.666 82321 1.988 1.192 1.556 0.760 N/A 0.691\n\n65881 0.889 0.784 0.498 0.582 0.170 0.360 82351 2.656 1.192 1.556 2.121 N/A 0.691\n\n65891 1.592 1.374 1.004 0.467 0.068 1.266 82361 1.949 1.192 1.556 0.703 N/A 0.691\n\n65901 0.937 0.763 0.579 0.829 0.210 0.617 82371 1.988 1.192 1.556 0.760 N/A 0.691\n\n65911 1.143 1.000 1.021 1.000 N/A 0.367 82381 1.988 1.192 1.556 0.760 N/A 0.691\n\n65921 1.039 1.022 1.044 0.977 N/A 0.934 82401 2.656 1.192 1.556 2.121 N/A 0.691\n\n65931 2.060 1.060 1.659 0.553 N/A 0.711 82411 2.656 1.192 1.556 2.121 N/A 0.691\n\n65941 1.225 1.202 1.205 1.002 N/A 0.612 82421 2.656 1.192 1.556 2.121 N/A 0.691\n\n69951 2.312 0.880 1.106 0.515 N/A 0.922 82431 2.656 1.192 1.556 2.121 N/A 0.691\n\n69961 2.790 0.926 2.463 0.292 0.565 0.656 82441 2.656 1.192 1.556 2.121 N/A 0.691\n\n69971 2.790 0.771 2.463 0.292 0.553 0.656 82451 1.988 1.192 1.556 0.760 N/A 0.691\n\n69981 2.250 0.859 1.063 0.494 N/A 0.922 82461 2.656 1.192 1.556 2.121 N/A 0.691\n\n69991 2.193 0.834 1.016 0.482 N/A 0.922 82471 2.656 1.192 1.556 2.121 N/A 0.691\n\n70001 2.124 0.827 1.155 0.494 N/A 0.659 82481 2.656 1.312 1.556 2.121 N/A 0.691\n\n72121 1.331 1.343 1.817 1.496 0.409 1.459 40451 1.043 0.823 0.790 0.922 N/A 0.475\n\n72131 1.262 1.223 1.601 1.239 0.274 1.459 40471 1.056 0.837 0.800 0.933 N/A 0.475\n\n72151 1.718 1.832 3.117 2.437 1.138 3.405\n\n72161 1.457 1.421 2.082 1.599 0.372 3.405\n\n72171 1.314 1.302 1.817 1.289 0.251 3.405\n\n72181 1.296 1.249 1.669 1.324 0.384 3.405\n\n72191 1.291 1.252 1.780 1.385 0.379 0.746\n\n72211 1.399 1.386 2.010 1.418 0.548 1.861\n\n72311 1.473 1.379 2.023 1.786 0.544 0.481\n\n72351 1.497 1.436 2.102 2.002 0.571 0.481\n\n72511 1.373 1.640 2.001 1.401 0.441 1.459\n\n72611 1.393 1.336 1.890 1.682 5.940 1.459\n\n72621 1.321 1.266 1.716 1.396 5.556 1.459\n\n72991 1.318 1.282 1.761 1.346 0.400 1.459\n\n73311 1.148 1.332 1.258 1.299 0.437 0.934\n\n73371 1.683 1.424 1.004 0.589 0.079 1.266\n\n73391 1.148 1.109 1.252 1.298 0.437 0.934\n\n73451 2.561 3.316 0.838 2.285 4.649 1.324\n\n73461 2.356 3.040 0.787 1.992 3.417 1.324\n\n**CF-6**\n\nSentinel Insurance Company","pages":[{"line_numbers":[],"markdown":"**GROWING SPECTRUM**\n\n**CALIFORNIA**\n\n**CLASS FACTORS**\n\nEquip Equip\n\nClass Building Contents BI Prem/Ops Products Breakdown Class Building Contents BI Prem/Ops Products Breakdown\n\n62111 1.097 0.869 0.998 0.620 N/A 0.771 73481 2.686 3.496 0.918 2.473 5.518 1.324\n\n62211 1.192 0.985 1.337 0.666 N/A 0.771 73951 1.164 1.135 1.318 1.315 0.541 0.934\n\n63321 1.072 0.888 1.051 0.619 N/A 0.771 73981 1.404 1.423 1.969 1.711 0.563 0.934\n\n65111 1.729 0.895 0.870 0.158 N/A 0.567 73991 1.297 1.355 0.966 0.302 0.088 1.337\n\n65141 2.086 0.793 1.011 0.459 N/A 0.922 75361 2.399 2.614 6.372 1.249 11.496 2.011\n\n65151 1.356 1.096 1.226 0.282 0.028 0.617 75481 2.399 2.614 6.372 1.249 11.496 2.011\n\n65161 1.187 1.130 1.303 0.981 N/A 1.459 75491 2.399 2.614 6.372 1.249 11.496 2.011\n\n65181 1.080 0.913 0.935 0.957 N/A 0.617 76221 1.433 1.283 1.865 1.729 0.679 0.716\n\n65198 1.989 0.780 1.105 0.325 N/A 0.340 76271 3.292 3.715 2.789 1.807 2.036 0.314\n\n65221 5.310 2.447 7.257 0.574 N/A 0.521 76281 1.421 1.264 1.820 1.715 0.554 0.716\n\n65271 1.556 1.294 1.701 0.346 N/A 0.467 76291 1.701 1.584 2.591 2.525 9.055 0.716\n\n65272 1.556 1.294 1.701 0.346 N/A 0.467 76311 1.402 1.514 1.817 1.631 0.412 0.716\n\n65273 1.556 1.294 1.701 0.346 N/A 0.467 76321 1.415 1.282 1.866 1.645 0.421 0.716\n\n65491 N/A N/A N/A N/A N/A N/A 76911 1.433 1.282 1.866 1.729 0.679 0.716\n\n65511 5.468 2.570 7.930 0.587 N/A 0.521 76961 1.348 1.137 1.468 1.686 6.474 0.716\n\n65611 5.477 2.570 7.930 0.587 N/A 0.521 76991 1.761 1.675 2.799 2.660 1.625 0.716\n\n65641 1.823 0.708 0.337 0.657 N/A 1.182 80721 1.355 1.163 1.597 1.731 0.389 0.712\n\n65661 1.402 0.599 0.697 0.141 N/A 0.333 82001 2.145 0.726 1.063 0.501 N/A 0.659\n\n65671 1.869 1.084 1.690 0.368 N/A 0.475 82031 2.656 1.192 1.556 2.121 N/A 0.691\n\n65681 1.883 0.985 1.221 0.481 N/A 0.426 82051 2.656 1.192 1.556 2.121 N/A 0.691\n\n65691 2.090 1.283 1.700 0.542 N/A 0.426 82071 2.656 1.192 1.556 2.121 N/A 0.691\n\n65701 2.003 1.057 1.537 0.512 N/A 0.426 82081 2.656 1.192 1.556 2.121 N/A 0.691\n\n65711 1.947 1.226 1.376 0.497 N/A 0.426 82141 1.988 1.192 1.556 0.760 N/A 0.691\n\n65721 1.852 0.966 1.149 0.473 N/A 0.426 82151 1.988 1.192 1.556 0.760 N/A 0.691\n\n65741 1.824 0.764 1.006 0.120 N/A 0.411 82161 2.070 1.335 1.806 0.686 N/A 0.695\n\n65751 1.072 0.893 0.610 0.097 0.017 0.618 82171 2.070 1.335 1.806 0.686 N/A 0.695\n\n65761 1.017 0.840 0.610 0.093 0.017 0.618 82191 1.980 1.192 1.556 0.747 N/A 0.691\n\n65771 1.446 0.625 0.824 0.145 N/A 0.333 82201 1.980 1.192 1.556 0.747 N/A 0.691\n\n65781 0.907 0.803 0.515 0.604 0.200 0.360 82221 1.980 1.192 1.556 0.747 N/A 0.691\n\n65791 0.847 0.836 0.518 0.900 0.606 0.934 82231 2.656 1.192 1.556 2.121 N/A 0.691\n\n65801 0.877 0.775 0.723 0.793 0.575 0.563 82241 2.656 1.192 1.556 2.121 N/A 0.691\n\n65811 1.167 1.057 1.153 1.071 N/A 0.955 82251 2.656 1.192 1.556 2.121 N/A 0.691\n\n65821 0.809 0.786 0.498 0.743 0.315 0.934 82261 2.656 1.192 1.556 2.121 N/A 0.691\n\n65831 1.242 1.231 1.457 1.217 N/A 0.934 82271 2.656 1.192 1.556 2.121 N/A 0.691\n\n65841 1.316 1.330 1.683 1.299 N/A 0.934 82281 2.656 1.192 1.556 2.121 N/A 0.691\n\n65851 1.962 1.034 1.424 0.501 N/A 0.426 82291 2.656 1.192 1.556 2.121 N/A 0.691\n\n65861 0.971 1.000 0.954 0.889 N/A 0.934 82301 2.656 1.192 1.556 2.121 N/A 0.691\n\n65871 0.797 0.948 0.663 0.990 0.385 0.666 82321 1.988 1.192 1.556 0.760 N/A 0.691\n\n65881 0.889 0.784 0.498 0.582 0.170 0.360 82351 2.656 1.192 1.556 2.121 N/A 0.691\n\n65891 1.592 1.374 1.004 0.467 0.068 1.266 82361 1.949 1.192 1.556 0.703 N/A 0.691\n\n65901 0.937 0.763 0.579 0.829 0.210 0.617 82371 1.988 1.192 1.556 0.760 N/A 0.691\n\n65911 1.143 1.000 1.021 1.000 N/A 0.367 82381 1.988 1.192 1.556 0.760 N/A 0.691\n\n65921 1.039 1.022 1.044 0.977 N/A 0.934 82401 2.656 1.192 1.556 2.121 N/A 0.691\n\n65931 2.060 1.060 1.659 0.553 N/A 0.711 82411 2.656 1.192 1.556 2.121 N/A 0.691\n\n65941 1.225 1.202 1.205 1.002 N/A 0.612 82421 2.656 1.192 1.556 2.121 N/A 0.691\n\n69951 2.312 0.880 1.106 0.515 N/A 0.922 82431 2.656 1.192 1.556 2.121 N/A 0.691\n\n69961 2.790 0.926 2.463 0.292 0.565 0.656 82441 2.656 1.192 1.556 2.121 N/A 0.691\n\n69971 2.790 0.771 2.463 0.292 0.553 0.656 82451 1.988 1.192 1.556 0.760 N/A 0.691\n\n69981 2.250 0.859 1.063 0.494 N/A 0.922 82461 2.656 1.192 1.556 2.121 N/A 0.691\n\n69991 2.193 0.834 1.016 0.482 N/A 0.922 82471 2.656 1.192 1.556 2.121 N/A 0.691\n\n70001 2.124 0.827 1.155 0.494 N/A 0.659 82481 2.656 1.312 1.556 2.121 N/A 0.691\n\n72121 1.331 1.343 1.817 1.496 0.409 1.459 40451 1.043 0.823 0.790 0.922 N/A 0.475\n\n72131 1.262 1.223 1.601 1.239 0.274 1.459 40471 1.056 0.837 0.800 0.933 N/A 0.475\n\n72151 1.718 1.832 3.117 2.437 1.138 3.405\n\n72161 1.457 1.421 2.082 1.599 0.372 3.405\n\n72171 1.314 1.302 1.817 1.289 0.251 3.405\n\n72181 1.296 1.249 1.669 1.324 0.384 3.405\n\n72191 1.291 1.252 1.780 1.385 0.379 0.746\n\n72211 1.399 1.386 2.010 1.418 0.548 1.861\n\n72311 1.473 1.379 2.023 1.786 0.544 0.481\n\n72351 1.497 1.436 2.102 2.002 0.571 0.481\n\n72511 1.373 1.640 2.001 1.401 0.441 1.459\n\n72611 1.393 1.336 1.890 1.682 5.940 1.459\n\n72621 1.321 1.266 1.716 1.396 5.556 1.459\n\n72991 1.318 1.282 1.761 1.346 0.400 1.459\n\n73311 1.148 1.332 1.258 1.299 0.437 0.934\n\n73371 1.683 1.424 1.004 0.589 0.079 1.266\n\n73391 1.148 1.109 1.252 1.298 0.437 0.934\n\n73451 2.561 3.316 0.838 2.285 4.649 1.324\n\n73461 2.356 3.040 0.787 1.992 3.417 1.324\n\n**CF-6**\n\nSentinel Insurance Company","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**GROWING SPECTRUM**\n\n**CALIFORNIA**\n\n**CLASS FACTORS**\n\nEquip Equip\n\nClass Building Contents BI Prem/Ops Products Breakdown Class Building Contents BI Prem/Ops Products Breakdown\n\n62111 1.097 0.869 0.998 0.620 N/A 0.771 73481 2.686 3.496 0.918 2.473 5.518 1.324\n\n62211 1.192 0.985 1.337 0.666 N/A 0.771 73951 1.164 1.135 1.318 1.315 0.541 0.934\n\n63321 1.072 0.888 1.051 0.619 N/A 0.771 73981 1.404 1.423 1.969 1.711 0.563 0.934\n\n65111 1.729 0.895 0.870 0.158 N/A 0.567 73991 1.297 1.355 0.966 0.302 0.088 1.337\n\n65141 2.086 0.793 1.011 0.459 N/A 0.922 75361 2.399 2.614 6.372 1.249 11.496 2.011\n\n65151 1.356 1.096 1.226 0.282 0.028 0.617 75481 2.399 2.614 6.372 1.249 11.496 2.011\n\n65161 1.187 1.130 1.303 0.981 N/A 1.459 75491 2.399 2.614 6.372 1.249 11.496 2.011\n\n65181 1.080 0.913 0.935 0.957 N/A 0.617 76221 1.433 1.283 1.865 1.729 0.679 0.716\n\n65198 1.989 0.780 1.105 0.325 N/A 0.340 76271 3.292 3.715 2.789 1.807 2.036 0.314\n\n65221 5.310 2.447 7.257 0.574 N/A 0.521 76281 1.421 1.264 1.820 1.715 0.554 0.716\n\n65271 1.556 1.294 1.701 0.346 N/A 0.467 76291 1.701 1.584 2.591 2.525 9.055 0.716\n\n65272 1.556 1.294 1.701 0.346 N/A 0.467 76311 1.402 1.514 1.817 1.631 0.412 0.716\n\n65273 1.556 1.294 1.701 0.346 N/A 0.467 76321 1.415 1.282 1.866 1.645 0.421 0.716\n\n65491 N/A N/A N/A N/A N/A N/A 76911 1.433 1.282 1.866 1.729 0.679 0.716\n\n65511 5.468 2.570 7.930 0.587 N/A 0.521 76961 1.348 1.137 1.468 1.686 6.474 0.716\n\n65611 5.477 2.570 7.930 0.587 N/A 0.521 76991 1.761 1.675 2.799 2.660 1.625 0.716\n\n65641 1.823 0.708 0.337 0.657 N/A 1.182 80721 1.355 1.163 1.597 1.731 0.389 0.712\n\n65661 1.402 0.599 0.697 0.141 N/A 0.333 82001 2.145 0.726 1.063 0.501 N/A 0.659\n\n65671 1.869 1.084 1.690 0.368 N/A 0.475 82031 2.656 1.192 1.556 2.121 N/A 0.691\n\n65681 1.883 0.985 1.221 0.481 N/A 0.426 82051 2.656 1.192 1.556 2.121 N/A 0.691\n\n65691 2.090 1.283 1.700 0.542 N/A 0.426 82071 2.656 1.192 1.556 2.121 N/A 0.691\n\n65701 2.003 1.057 1.537 0.512 N/A 0.426 82081 2.656 1.192 1.556 2.121 N/A 0.691\n\n65711 1.947 1.226 1.376 0.497 N/A 0.426 82141 1.988 1.192 1.556 0.760 N/A 0.691\n\n65721 1.852 0.966 1.149 0.473 N/A 0.426 82151 1.988 1.192 1.556 0.760 N/A 0.691\n\n65741 1.824 0.764 1.006 0.120 N/A 0.411 82161 2.070 1.335 1.806 0.686 N/A 0.695\n\n65751 1.072 0.893 0.610 0.097 0.017 0.618 82171 2.070 1.335 1.806 0.686 N/A 0.695\n\n65761 1.017 0.840 0.610 0.093 0.017 0.618 82191 1.980 1.192 1.556 0.747 N/A 0.691\n\n65771 1.446 0.625 0.824 0.145 N/A 0.333 82201 1.980 1.192 1.556 0.747 N/A 0.691\n\n65781 0.907 0.803 0.515 0.604 0.200 0.360 82221 1.980 1.192 1.556 0.747 N/A 0.691\n\n65791 0.847 0.836 0.518 0.900 0.606 0.934 82231 2.656 1.192 1.556 2.121 N/A 0.691\n\n65801 0.877 0.775 0.723 0.793 0.575 0.563 82241 2.656 1.192 1.556 2.121 N/A 0.691\n\n65811 1.167 1.057 1.153 1.071 N/A 0.955 82251 2.656 1.192 1.556 2.121 N/A 0.691\n\n65821 0.809 0.786 0.498 0.743 0.315 0.934 82261 2.656 1.192 1.556 2.121 N/A 0.691\n\n65831 1.242 1.231 1.457 1.217 N/A 0.934 82271 2.656 1.192 1.556 2.121 N/A 0.691\n\n65841 1.316 1.330 1.683 1.299 N/A 0.934 82281 2.656 1.192 1.556 2.121 N/A 0.691\n\n65851 1.962 1.034 1.424 0.501 N/A 0.426 82291 2.656 1.192 1.556 2.121 N/A 0.691\n\n65861 0.971 1.000 0.954 0.889 N/A 0.934 82301 2.656 1.192 1.556 2.121 N/A 0.691\n\n65871 0.797 0.948 0.663 0.990 0.385 0.666 82321 1.988 1.192 1.556 0.760 N/A 0.691\n\n65881 0.889 0.784 0.498 0.582 0.170 0.360 82351 2.656 1.192 1.556 2.121 N/A 0.691\n\n65891 1.592 1.374 1.004 0.467 0.068 1.266 82361 1.949 1.192 1.556 0.703 N/A 0.691\n\n65901 0.937 0.763 0.579 0.829 0.210 0.617 82371 1.988 1.192 1.556 0.760 N/A 0.691\n\n65911 1.143 1.000 1.021 1.000 N/A 0.367 82381 1.988 1.192 1.556 0.760 N/A 0.691\n\n65921 1.039 1.022 1.044 0.977 N/A 0.934 82401 2.656 1.192 1.556 2.121 N/A 0.691\n\n65931 2.060 1.060 1.659 0.553 N/A 0.711 82411 2.656 1.192 1.556 2.121 N/A 0.691\n\n65941 1.225 1.202 1.205 1.002 N/A 0.612 82421 2.656 1.192 1.556 2.121 N/A 0.691\n\n69951 2.312 0.880 1.106 0.515 N/A 0.922 82431 2.656 1.192 1.556 2.121 N/A 0.691\n\n69961 2.790 0.926 2.463 0.292 0.565 0.656 82441 2.656 1.192 1.556 2.121 N/A 0.691\n\n69971 2.790 0.771 2.463 0.292 0.553 0.656 82451 1.988 1.192 1.556 0.760 N/A 0.691\n\n69981 2.250 0.859 1.063 0.494 N/A 0.922 82461 2.656 1.192 1.556 2.121 N/A 0.691\n\n69991 2.193 0.834 1.016 0.482 N/A 0.922 82471 2.656 1.192 1.556 2.121 N/A 0.691\n\n70001 2.124 0.827 1.155 0.494 N/A 0.659 82481 2.656 1.312 1.556 2.121 N/A 0.691\n\n72121 1.331 1.343 1.817 1.496 0.409 1.459 40451 1.043 0.823 0.790 0.922 N/A 0.475\n\n72131 1.262 1.223 1.601 1.239 0.274 1.459 40471 1.056 0.837 0.800 0.933 N/A 0.475\n\n72151 1.718 1.832 3.117 2.437 1.138 3.405\n\n72161 1.457 1.421 2.082 1.599 0.372 3.405\n\n72171 1.314 1.302 1.817 1.289 0.251 3.405\n\n72181 1.296 1.249 1.669 1.324 0.384 3.405\n\n72191 1.291 1.252 1.780 1.385 0.379 0.746\n\n72211 1.399 1.386 2.010 1.418 0.548 1.861\n\n72311 1.473 1.379 2.023 1.786 0.544 0.481\n\n72351 1.497 1.436 2.102 2.002 0.571 0.481\n\n72511 1.373 1.640 2.001 1.401 0.441 1.459\n\n72611 1.393 1.336 1.890 1.682 5.940 1.459\n\n72621 1.321 1.266 1.716 1.396 5.556 1.459\n\n72991 1.318 1.282 1.761 1.346 0.400 1.459\n\n73311 1.148 1.332 1.258 1.299 0.437 0.934\n\n73371 1.683 1.424 1.004 0.589 0.079 1.266\n\n73391 1.148 1.109 1.252 1.298 0.437 0.934\n\n73451 2.561 3.316 0.838 2.285 4.649 1.324\n\n73461 2.356 3.040 0.787 1.992 3.417 1.324\n\n**CF-6**\n\nSentinel Insurance Company","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1870.pdf"]},"response":{"errors":[],"extract_id":"extract_0cd702ec617b9678737b58e25a2f81ea","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**GROWING SPECTRUM**\n\n**CALIFORNIA**\n\n**CLASS FACTORS**\n\nEquip Equip\n\nClass Building Contents BI Prem/Ops Products Breakdown Class Building Contents BI Prem/Ops Products Breakdown\n\n62111 1.097 0.869 0.998 0.620 N/A 0.771 73481 2.686 3.496 0.918 2.473 5.518 1.324\n\n62211 1.192 0.985 1.337 0.666 N/A 0.771 73951 1.164 1.135 1.318 1.315 0.541 0.934\n\n63321 1.072 0.888 1.051 0.619 N/A 0.771 73981 1.404 1.423 1.969 1.711 0.563 0.934\n\n65111 1.729 0.895 0.870 0.158 N/A 0.567 73991 1.297 1.355 0.966 0.302 0.088 1.337\n\n65141 2.086 0.793 1.011 0.459 N/A 0.922 75361 2.399 2.614 6.372 1.249 11.496 2.011\n\n65151 1.356 1.096 1.226 0.282 0.028 0.617 75481 2.399 2.614 6.372 1.249 11.496 2.011\n\n65161 1.187 1.130 1.303 0.981 N/A 1.459 75491 2.399 2.614 6.372 1.249 11.496 2.011\n\n65181 1.080 0.913 0.935 0.957 N/A 0.617 76221 1.433 1.283 1.865 1.729 0.679 0.716\n\n65198 1.989 0.780 1.105 0.325 N/A 0.340 76271 3.292 3.715 2.789 1.807 2.036 0.314\n\n65221 5.310 2.447 7.257 0.574 N/A 0.521 76281 1.421 1.264 1.820 1.715 0.554 0.716\n\n65271 1.556 1.294 1.701 0.346 N/A 0.467 76291 1.701 1.584 2.591 2.525 9.055 0.716\n\n65272 1.556 1.294 1.701 0.346 N/A 0.467 76311 1.402 1.514 1.817 1.631 0.412 0.716\n\n65273 1.556 1.294 1.701 0.346 N/A 0.467 76321 1.415 1.282 1.866 1.645 0.421 0.716\n\n65491 N/A N/A N/A N/A N/A N/A 76911 1.433 1.282 1.866 1.729 0.679 0.716\n\n65511 5.468 2.570 7.930 0.587 N/A 0.521 76961 1.348 1.137 1.468 1.686 6.474 0.716\n\n65611 5.477 2.570 7.930 0.587 N/A 0.521 76991 1.761 1.675 2.799 2.660 1.625 0.716\n\n65641 1.823 0.708 0.337 0.657 N/A 1.182 80721 1.355 1.163 1.597 1.731 0.389 0.712\n\n65661 1.402 0.599 0.697 0.141 N/A 0.333 82001 2.145 0.726 1.063 0.501 N/A 0.659\n\n65671 1.869 1.084 1.690 0.368 N/A 0.475 82031 2.656 1.192 1.556 2.121 N/A 0.691\n\n65681 1.883 0.985 1.221 0.481 N/A 0.426 82051 2.656 1.192 1.556 2.121 N/A 0.691\n\n65691 2.090 1.283 1.700 0.542 N/A 0.426 82071 2.656 1.192 1.556 2.121 N/A 0.691\n\n65701 2.003 1.057 1.537 0.512 N/A 0.426 82081 2.656 1.192 1.556 2.121 N/A 0.691\n\n65711 1.947 1.226 1.376 0.497 N/A 0.426 82141 1.988 1.192 1.556 0.760 N/A 0.691\n\n65721 1.852 0.966 1.149 0.473 N/A 0.426 82151 1.988 1.192 1.556 0.760 N/A 0.691\n\n65741 1.824 0.764 1.006 0.120 N/A 0.411 82161 2.070 1.335 1.806 0.686 N/A 0.695\n\n65751 1.072 0.893 0.610 0.097 0.017 0.618 82171 2.070 1.335 1.806 0.686 N/A 0.695\n\n65761 1.017 0.840 0.610 0.093 0.017 0.618 82191 1.980 1.192 1.556 0.747 N/A 0.691\n\n65771 1.446 0.625 0.824 0.145 N/A 0.333 82201 1.980 1.192 1.556 0.747 N/A 0.691\n\n65781 0.907 0.803 0.515 0.604 0.200 0.360 82221 1.980 1.192 1.556 0.747 N/A 0.691\n\n65791 0.847 0.836 0.518 0.900 0.606 0.934 82231 2.656 1.192 1.556 2.121 N/A 0.691\n\n65801 0.877 0.775 0.723 0.793 0.575 0.563 82241 2.656 1.192 1.556 2.121 N/A 0.691\n\n65811 1.167 1.057 1.153 1.071 N/A 0.955 82251 2.656 1.192 1.556 2.121 N/A 0.691\n\n65821 0.809 0.786 0.498 0.743 0.315 0.934 82261 2.656 1.192 1.556 2.121 N/A 0.691\n\n65831 1.242 1.231 1.457 1.217 N/A 0.934 82271 2.656 1.192 1.556 2.121 N/A 0.691\n\n65841 1.316 1.330 1.683 1.299 N/A 0.934 82281 2.656 1.192 1.556 2.121 N/A 0.691\n\n65851 1.962 1.034 1.424 0.501 N/A 0.426 82291 2.656 1.192 1.556 2.121 N/A 0.691\n\n65861 0.971 1.000 0.954 0.889 N/A 0.934 82301 2.656 1.192 1.556 2.121 N/A 0.691\n\n65871 0.797 0.948 0.663 0.990 0.385 0.666 82321 1.988 1.192 1.556 0.760 N/A 0.691\n\n65881 0.889 0.784 0.498 0.582 0.170 0.360 82351 2.656 1.192 1.556 2.121 N/A 0.691\n\n65891 1.592 1.374 1.004 0.467 0.068 1.266 82361 1.949 1.192 1.556 0.703 N/A 0.691\n\n65901 0.937 0.763 0.579 0.829 0.210 0.617 82371 1.988 1.192 1.556 0.760 N/A 0.691\n\n65911 1.143 1.000 1.021 1.000 N/A 0.367 82381 1.988 1.192 1.556 0.760 N/A 0.691\n\n65921 1.039 1.022 1.044 0.977 N/A 0.934 82401 2.656 1.192 1.556 2.121 N/A 0.691\n\n65931 2.060 1.060 1.659 0.553 N/A 0.711 82411 2.656 1.192 1.556 2.121 N/A 0.691\n\n65941 1.225 1.202 1.205 1.002 N/A 0.612 82421 2.656 1.192 1.556 2.121 N/A 0.691\n\n69951 2.312 0.880 1.106 0.515 N/A 0.922 82431 2.656 1.192 1.556 2.121 N/A 0.691\n\n69961 2.790 0.926 2.463 0.292 0.565 0.656 82441 2.656 1.192 1.556 2.121 N/A 0.691\n\n69971 2.790 0.771 2.463 0.292 0.553 0.656 82451 1.988 1.192 1.556 0.760 N/A 0.691\n\n69981 2.250 0.859 1.063 0.494 N/A 0.922 82461 2.656 1.192 1.556 2.121 N/A 0.691\n\n69991 2.193 0.834 1.016 0.482 N/A 0.922 82471 2.656 1.192 1.556 2.121 N/A 0.691\n\n70001 2.124 0.827 1.155 0.494 N/A 0.659 82481 2.656 1.312 1.556 2.121 N/A 0.691\n\n72121 1.331 1.343 1.817 1.496 0.409 1.459 40451 1.043 0.823 0.790 0.922 N/A 0.475\n\n72131 1.262 1.223 1.601 1.239 0.274 1.459 40471 1.056 0.837 0.800 0.933 N/A 0.475\n\n72151 1.718 1.832 3.117 2.437 1.138 3.405\n\n72161 1.457 1.421 2.082 1.599 0.372 3.405\n\n72171 1.314 1.302 1.817 1.289 0.251 3.405\n\n72181 1.296 1.249 1.669 1.324 0.384 3.405\n\n72191 1.291 1.252 1.780 1.385 0.379 0.746\n\n72211 1.399 1.386 2.010 1.418 0.548 1.861\n\n72311 1.473 1.379 2.023 1.786 0.544 0.481\n\n72351 1.497 1.436 2.102 2.002 0.571 0.481\n\n72511 1.373 1.640 2.001 1.401 0.441 1.459\n\n72611 1.393 1.336 1.890 1.682 5.940 1.459\n\n72621 1.321 1.266 1.716 1.396 5.556 1.459\n\n72991 1.318 1.282 1.761 1.346 0.400 1.459\n\n73311 1.148 1.332 1.258 1.299 0.437 0.934\n\n73371 1.683 1.424 1.004 0.589 0.079 1.266\n\n73391 1.148 1.109 1.252 1.298 0.437 0.934\n\n73451 2.561 3.316 0.838 2.285 4.649 1.324\n\n73461 2.356 3.040 0.787 1.992 3.417 1.324\n\n**CF-6**\n\nSentinel Insurance Company"],"full_content":"**GROWING SPECTRUM**\n\n**CALIFORNIA**\n\n**CLASS FACTORS**\n\nEquip Equip\n\nClass Building Contents BI Prem/Ops Products Breakdown Class Building Contents BI Prem/Ops Products Breakdown\n\n62111 1.097 0.869 0.998 0.620 N/A 0.771 73481 2.686 3.496 0.918 2.473 5.518 1.324\n\n62211 1.192 0.985 1.337 0.666 N/A 0.771 73951 1.164 1.135 1.318 1.315 0.541 0.934\n\n63321 1.072 0.888 1.051 0.619 N/A 0.771 73981 1.404 1.423 1.969 1.711 0.563 0.934\n\n65111 1.729 0.895 0.870 0.158 N/A 0.567 73991 1.297 1.355 0.966 0.302 0.088 1.337\n\n65141 2.086 0.793 1.011 0.459 N/A 0.922 75361 2.399 2.614 6.372 1.249 11.496 2.011\n\n65151 1.356 1.096 1.226 0.282 0.028 0.617 75481 2.399 2.614 6.372 1.249 11.496 2.011\n\n65161 1.187 1.130 1.303 0.981 N/A 1.459 75491 2.399 2.614 6.372 1.249 11.496 2.011\n\n65181 1.080 0.913 0.935 0.957 N/A 0.617 76221 1.433 1.283 1.865 1.729 0.679 0.716\n\n65198 1.989 0.780 1.105 0.325 N/A 0.340 76271 3.292 3.715 2.789 1.807 2.036 0.314\n\n65221 5.310 2.447 7.257 0.574 N/A 0.521 76281 1.421 1.264 1.820 1.715 0.554 0.716\n\n65271 1.556 1.294 1.701 0.346 N/A 0.467 76291 1.701 1.584 2.591 2.525 9.055 0.716\n\n65272 1.556 1.294 1.701 0.346 N/A 0.467 76311 1.402 1.514 1.817 1.631 0.412 0.716\n\n65273 1.556 1.294 1.701 0.346 N/A 0.467 76321 1.415 1.282 1.866 1.645 0.421 0.716\n\n65491 N/A N/A N/A N/A N/A N/A 76911 1.433 1.282 1.866 1.729 0.679 0.716\n\n65511 5.468 2.570 7.930 0.587 N/A 0.521 76961 1.348 1.137 1.468 1.686 6.474 0.716\n\n65611 5.477 2.570 7.930 0.587 N/A 0.521 76991 1.761 1.675 2.799 2.660 1.625 0.716\n\n65641 1.823 0.708 0.337 0.657 N/A 1.182 80721 1.355 1.163 1.597 1.731 0.389 0.712\n\n65661 1.402 0.599 0.697 0.141 N/A 0.333 82001 2.145 0.726 1.063 0.501 N/A 0.659\n\n65671 1.869 1.084 1.690 0.368 N/A 0.475 82031 2.656 1.192 1.556 2.121 N/A 0.691\n\n65681 1.883 0.985 1.221 0.481 N/A 0.426 82051 2.656 1.192 1.556 2.121 N/A 0.691\n\n65691 2.090 1.283 1.700 0.542 N/A 0.426 82071 2.656 1.192 1.556 2.121 N/A 0.691\n\n65701 2.003 1.057 1.537 0.512 N/A 0.426 82081 2.656 1.192 1.556 2.121 N/A 0.691\n\n65711 1.947 1.226 1.376 0.497 N/A 0.426 82141 1.988 1.192 1.556 0.760 N/A 0.691\n\n65721 1.852 0.966 1.149 0.473 N/A 0.426 82151 1.988 1.192 1.556 0.760 N/A 0.691\n\n65741 1.824 0.764 1.006 0.120 N/A 0.411 82161 2.070 1.335 1.806 0.686 N/A 0.695\n\n65751 1.072 0.893 0.610 0.097 0.017 0.618 82171 2.070 1.335 1.806 0.686 N/A 0.695\n\n65761 1.017 0.840 0.610 0.093 0.017 0.618 82191 1.980 1.192 1.556 0.747 N/A 0.691\n\n65771 1.446 0.625 0.824 0.145 N/A 0.333 82201 1.980 1.192 1.556 0.747 N/A 0.691\n\n65781 0.907 0.803 0.515 0.604 0.200 0.360 82221 1.980 1.192 1.556 0.747 N/A 0.691\n\n65791 0.847 0.836 0.518 0.900 0.606 0.934 82231 2.656 1.192 1.556 2.121 N/A 0.691\n\n65801 0.877 0.775 0.723 0.793 0.575 0.563 82241 2.656 1.192 1.556 2.121 N/A 0.691\n\n65811 1.167 1.057 1.153 1.071 N/A 0.955 82251 2.656 1.192 1.556 2.121 N/A 0.691\n\n65821 0.809 0.786 0.498 0.743 0.315 0.934 82261 2.656 1.192 1.556 2.121 N/A 0.691\n\n65831 1.242 1.231 1.457 1.217 N/A 0.934 82271 2.656 1.192 1.556 2.121 N/A 0.691\n\n65841 1.316 1.330 1.683 1.299 N/A 0.934 82281 2.656 1.192 1.556 2.121 N/A 0.691\n\n65851 1.962 1.034 1.424 0.501 N/A 0.426 82291 2.656 1.192 1.556 2.121 N/A 0.691\n\n65861 0.971 1.000 0.954 0.889 N/A 0.934 82301 2.656 1.192 1.556 2.121 N/A 0.691\n\n65871 0.797 0.948 0.663 0.990 0.385 0.666 82321 1.988 1.192 1.556 0.760 N/A 0.691\n\n65881 0.889 0.784 0.498 0.582 0.170 0.360 82351 2.656 1.192 1.556 2.121 N/A 0.691\n\n65891 1.592 1.374 1.004 0.467 0.068 1.266 82361 1.949 1.192 1.556 0.703 N/A 0.691\n\n65901 0.937 0.763 0.579 0.829 0.210 0.617 82371 1.988 1.192 1.556 0.760 N/A 0.691\n\n65911 1.143 1.000 1.021 1.000 N/A 0.367 82381 1.988 1.192 1.556 0.760 N/A 0.691\n\n65921 1.039 1.022 1.044 0.977 N/A 0.934 82401 2.656 1.192 1.556 2.121 N/A 0.691\n\n65931 2.060 1.060 1.659 0.553 N/A 0.711 82411 2.656 1.192 1.556 2.121 N/A 0.691\n\n65941 1.225 1.202 1.205 1.002 N/A 0.612 82421 2.656 1.192 1.556 2.121 N/A 0.691\n\n69951 2.312 0.880 1.106 0.515 N/A 0.922 82431 2.656 1.192 1.556 2.121 N/A 0.691\n\n69961 2.790 0.926 2.463 0.292 0.565 0.656 82441 2.656 1.192 1.556 2.121 N/A 0.691\n\n69971 2.790 0.771 2.463 0.292 0.553 0.656 82451 1.988 1.192 1.556 0.760 N/A 0.691\n\n69981 2.250 0.859 1.063 0.494 N/A 0.922 82461 2.656 1.192 1.556 2.121 N/A 0.691\n\n69991 2.193 0.834 1.016 0.482 N/A 0.922 82471 2.656 1.192 1.556 2.121 N/A 0.691\n\n70001 2.124 0.827 1.155 0.494 N/A 0.659 82481 2.656 1.312 1.556 2.121 N/A 0.691\n\n72121 1.331 1.343 1.817 1.496 0.409 1.459 40451 1.043 0.823 0.790 0.922 N/A 0.475\n\n72131 1.262 1.223 1.601 1.239 0.274 1.459 40471 1.056 0.837 0.800 0.933 N/A 0.475\n\n72151 1.718 1.832 3.117 2.437 1.138 3.405\n\n72161 1.457 1.421 2.082 1.599 0.372 3.405\n\n72171 1.314 1.302 1.817 1.289 0.251 3.405\n\n72181 1.296 1.249 1.669 1.324 0.384 3.405\n\n72191 1.291 1.252 1.780 1.385 0.379 0.746\n\n72211 1.399 1.386 2.010 1.418 0.548 1.861\n\n72311 1.473 1.379 2.023 1.786 0.544 0.481\n\n72351 1.497 1.436 2.102 2.002 0.571 0.481\n\n72511 1.373 1.640 2.001 1.401 0.441 1.459\n\n72611 1.393 1.336 1.890 1.682 5.940 1.459\n\n72621 1.321 1.266 1.716 1.396 5.556 1.459\n\n72991 1.318 1.282 1.761 1.346 0.400 1.459\n\n73311 1.148 1.332 1.258 1.299 0.437 0.934\n\n73371 1.683 1.424 1.004 0.589 0.079 1.266\n\n73391 1.148 1.109 1.252 1.298 0.437 0.934\n\n73451 2.561 3.316 0.838 2.285 4.649 1.324\n\n73461 2.356 3.040 0.787 1.992 3.417 1.324\n\n**CF-6**\n\nSentinel Insurance Company","publish_date":null,"title":"GROWINGSPECTRUM CALIFORNIA CLASSFACTORS Equip Equip Class Building Contents BI Prem/OpsProductsBreakdown Class Building Contents BI Prem/OpsProductsBreakdown 62111 1.097 0.869 0.998 0.620","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1870.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1870.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1870","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1870.pdf"},"started_at":"2026-11-04T19:48:00.196130"} +{"completed_at":"2026-11-04T19:48:02.916461","latency_in_ms":1330,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1878","grounded_pages":[],"layout_pages":[],"markdown":"**State of California Company: Sentinel Insurance Co, LTD**\n\n**Department of Insurance (CDI) Line: Multiple Peril**\n\n**CDI File # (Department Use Only):**\n\n### **RATEMAKING DATA**\n\n**Completed by:** Cathy Marshall **Variance #(s): 7B,8A,8B**\n\n**Date Completed:** 2/26/2016\n\n**Detailed Line Description:** Commercial Multiple Peril (Non-Liability)\n\n**Coverage:** Growing Spectrum Property\n\n**Line Description Source 2nd Prior Year**\n\n**Ending**\n\n**1st Prior Year**\n\n**Ending**\n\n**Most Recent Year**\n\n**Ending Projected** **1** **New Program** **2**\n\n(0) **Year 20132 20142 20152**\n\n(1) California Direct Written Premium 48,487,235 63,756,622 77,973,298\n\n(2) California Direct Earned Premium 37,788,884 55,806,703 70,589,347\n\n(3) Premium Adjustment Factor Exh 4 0.911 0.912 0.917\n\n(4) Premium Trend Factor ¹ Exh 5 0.879 0.904 0.929 -2.7%\n\n(5) Miscellaneous Fees and Flat Charges not included in Line (2) Exh 6 0 0 0\n\n(6) Earned Exposure Units 41,777 58,900 73,935\n\n(7) Historic Losses 22,450,387 28,674,750 31,737,707\n\n(8) Historic Defense and Cost Containment Expense (DCCE) 716,240 835,249 893,693\n\n(9) Loss Development Factor Exh 7 1.037 1.061 1.239\n\n(10) DCCE Development Factor Exh 7 1.037 1.061 1.239\n\n(11) Loss Trend Factor ¹ Exh 8 1.093 1.072 1.052 1.9%\n\n(12) DCCE Trend Factor ¹ Exh 8 1.093 1.072 1.052 1.9%\n\n(13) Catastrophe Adjustment Factor Exh 9 1.021 1.021 1.021\n\n(14) Credibility for Losses & DCCE Exh 10 76.3%\n\n(15) Ancillary Income Exh 11 0 0 0\n\n_Lines 16-18 link directly to pages 3 and 4 of the application._\n\n(16) Excluded Expense Ratio Pg 4.2 0.9%\n\n(17) Projected Federal Income Tax Rate\n\non Investment Income Pg 3.2 28.7%\n\n(18) Projected Yield Pg 3.2 2.4%\n\n1 The Projected column should reflect the annual trend expressed as a percentage for premium, loss and DCCE trends, and credibility.\n\n2 Refer to Section III.C. of the Prior Approval Rate Filing Instructions for New Program requirements.\n\nPrior Approval Rate Template Page 6.1 9/1/2015 Edition","pages":[{"line_numbers":[],"markdown":"**State of California Company: Sentinel Insurance Co, LTD**\n\n**Department of Insurance (CDI) Line: Multiple Peril**\n\n**CDI File # (Department Use Only):**\n\n### **RATEMAKING DATA**\n\n**Completed by:** Cathy Marshall **Variance #(s): 7B,8A,8B**\n\n**Date Completed:** 2/26/2016\n\n**Detailed Line Description:** Commercial Multiple Peril (Non-Liability)\n\n**Coverage:** Growing Spectrum Property\n\n**Line Description Source 2nd Prior Year**\n\n**Ending**\n\n**1st Prior Year**\n\n**Ending**\n\n**Most Recent Year**\n\n**Ending Projected** **1** **New Program** **2**\n\n(0) **Year 20132 20142 20152**\n\n(1) California Direct Written Premium 48,487,235 63,756,622 77,973,298\n\n(2) California Direct Earned Premium 37,788,884 55,806,703 70,589,347\n\n(3) Premium Adjustment Factor Exh 4 0.911 0.912 0.917\n\n(4) Premium Trend Factor ¹ Exh 5 0.879 0.904 0.929 -2.7%\n\n(5) Miscellaneous Fees and Flat Charges not included in Line (2) Exh 6 0 0 0\n\n(6) Earned Exposure Units 41,777 58,900 73,935\n\n(7) Historic Losses 22,450,387 28,674,750 31,737,707\n\n(8) Historic Defense and Cost Containment Expense (DCCE) 716,240 835,249 893,693\n\n(9) Loss Development Factor Exh 7 1.037 1.061 1.239\n\n(10) DCCE Development Factor Exh 7 1.037 1.061 1.239\n\n(11) Loss Trend Factor ¹ Exh 8 1.093 1.072 1.052 1.9%\n\n(12) DCCE Trend Factor ¹ Exh 8 1.093 1.072 1.052 1.9%\n\n(13) Catastrophe Adjustment Factor Exh 9 1.021 1.021 1.021\n\n(14) Credibility for Losses & DCCE Exh 10 76.3%\n\n(15) Ancillary Income Exh 11 0 0 0\n\n_Lines 16-18 link directly to pages 3 and 4 of the application._\n\n(16) Excluded Expense Ratio Pg 4.2 0.9%\n\n(17) Projected Federal Income Tax Rate\n\non Investment Income Pg 3.2 28.7%\n\n(18) Projected Yield Pg 3.2 2.4%\n\n1 The Projected column should reflect the annual trend expressed as a percentage for premium, loss and DCCE trends, and credibility.\n\n2 Refer to Section III.C. of the Prior Approval Rate Filing Instructions for New Program requirements.\n\nPrior Approval Rate Template Page 6.1 9/1/2015 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**State of California Company: Sentinel Insurance Co, LTD**\n\n**Department of Insurance (CDI) Line: Multiple Peril**\n\n**CDI File # (Department Use Only):**\n\n### **RATEMAKING DATA**\n\n**Completed by:** Cathy Marshall **Variance #(s): 7B,8A,8B**\n\n**Date Completed:** 2/26/2016\n\n**Detailed Line Description:** Commercial Multiple Peril (Non-Liability)\n\n**Coverage:** Growing Spectrum Property\n\n**Line Description Source 2nd Prior Year**\n\n**Ending**\n\n**1st Prior Year**\n\n**Ending**\n\n**Most Recent Year**\n\n**Ending Projected** **1** **New Program** **2**\n\n(0) **Year 20132 20142 20152**\n\n(1) California Direct Written Premium 48,487,235 63,756,622 77,973,298\n\n(2) California Direct Earned Premium 37,788,884 55,806,703 70,589,347\n\n(3) Premium Adjustment Factor Exh 4 0.911 0.912 0.917\n\n(4) Premium Trend Factor ¹ Exh 5 0.879 0.904 0.929 -2.7%\n\n(5) Miscellaneous Fees and Flat Charges not included in Line (2) Exh 6 0 0 0\n\n(6) Earned Exposure Units 41,777 58,900 73,935\n\n(7) Historic Losses 22,450,387 28,674,750 31,737,707\n\n(8) Historic Defense and Cost Containment Expense (DCCE) 716,240 835,249 893,693\n\n(9) Loss Development Factor Exh 7 1.037 1.061 1.239\n\n(10) DCCE Development Factor Exh 7 1.037 1.061 1.239\n\n(11) Loss Trend Factor ¹ Exh 8 1.093 1.072 1.052 1.9%\n\n(12) DCCE Trend Factor ¹ Exh 8 1.093 1.072 1.052 1.9%\n\n(13) Catastrophe Adjustment Factor Exh 9 1.021 1.021 1.021\n\n(14) Credibility for Losses & DCCE Exh 10 76.3%\n\n(15) Ancillary Income Exh 11 0 0 0\n\n_Lines 16-18 link directly to pages 3 and 4 of the application._\n\n(16) Excluded Expense Ratio Pg 4.2 0.9%\n\n(17) Projected Federal Income Tax Rate\n\non Investment Income Pg 3.2 28.7%\n\n(18) Projected Yield Pg 3.2 2.4%\n\n1 The Projected column should reflect the annual trend expressed as a percentage for premium, loss and DCCE trends, and credibility.\n\n2 Refer to Section III.C. of the Prior Approval Rate Filing Instructions for New Program requirements.\n\nPrior Approval Rate Template Page 6.1 9/1/2015 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1878.pdf"]},"response":{"errors":[],"extract_id":"extract_1dfaa7cf1b5fd4619183368154643f1c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**State of California Company: Sentinel Insurance Co, LTD**\n\n**Department of Insurance (CDI) Line: Multiple Peril**\n\n**CDI File # (Department Use Only):**\n\n### **RATEMAKING DATA**\n\n**Completed by:** Cathy Marshall **Variance #(s): 7B,8A,8B**\n\n**Date Completed:** 2/26/2016\n\n**Detailed Line Description:** Commercial Multiple Peril (Non-Liability)\n\n**Coverage:** Growing Spectrum Property\n\n**Line Description Source 2nd Prior Year**\n\n**Ending**\n\n**1st Prior Year**\n\n**Ending**\n\n**Most Recent Year**\n\n**Ending Projected** **1** **New Program** **2**\n\n(0) **Year 20132 20142 20152**\n\n(1) California Direct Written Premium 48,487,235 63,756,622 77,973,298\n\n(2) California Direct Earned Premium 37,788,884 55,806,703 70,589,347\n\n(3) Premium Adjustment Factor Exh 4 0.911 0.912 0.917\n\n(4) Premium Trend Factor ¹ Exh 5 0.879 0.904 0.929 -2.7%\n\n(5) Miscellaneous Fees and Flat Charges not included in Line (2) Exh 6 0 0 0\n\n(6) Earned Exposure Units 41,777 58,900 73,935\n\n(7) Historic Losses 22,450,387 28,674,750 31,737,707\n\n(8) Historic Defense and Cost Containment Expense (DCCE) 716,240 835,249 893,693\n\n(9) Loss Development Factor Exh 7 1.037 1.061 1.239\n\n(10) DCCE Development Factor Exh 7 1.037 1.061 1.239\n\n(11) Loss Trend Factor ¹ Exh 8 1.093 1.072 1.052 1.9%\n\n(12) DCCE Trend Factor ¹ Exh 8 1.093 1.072 1.052 1.9%\n\n(13) Catastrophe Adjustment Factor Exh 9 1.021 1.021 1.021\n\n(14) Credibility for Losses & DCCE Exh 10 76.3%\n\n(15) Ancillary Income Exh 11 0 0 0\n\n_Lines 16-18 link directly to pages 3 and 4 of the application._\n\n(16) Excluded Expense Ratio Pg 4.2 0.9%\n\n(17) Projected Federal Income Tax Rate\n\non Investment Income Pg 3.2 28.7%\n\n(18) Projected Yield Pg 3.2 2.4%\n\n1 The Projected column should reflect the annual trend expressed as a percentage for premium, loss and DCCE trends, and credibility.\n\n2 Refer to Section III.C. of the Prior Approval Rate Filing Instructions for New Program requirements.\n\nPrior Approval Rate Template Page 6.1 9/1/2015 Edition"],"full_content":"**State of California Company: Sentinel Insurance Co, LTD**\n\n**Department of Insurance (CDI) Line: Multiple Peril**\n\n**CDI File # (Department Use Only):**\n\n### **RATEMAKING DATA**\n\n**Completed by:** Cathy Marshall **Variance #(s): 7B,8A,8B**\n\n**Date Completed:** 2/26/2016\n\n**Detailed Line Description:** Commercial Multiple Peril (Non-Liability)\n\n**Coverage:** Growing Spectrum Property\n\n**Line Description Source 2nd Prior Year**\n\n**Ending**\n\n**1st Prior Year**\n\n**Ending**\n\n**Most Recent Year**\n\n**Ending Projected** **1** **New Program** **2**\n\n(0) **Year 20132 20142 20152**\n\n(1) California Direct Written Premium 48,487,235 63,756,622 77,973,298\n\n(2) California Direct Earned Premium 37,788,884 55,806,703 70,589,347\n\n(3) Premium Adjustment Factor Exh 4 0.911 0.912 0.917\n\n(4) Premium Trend Factor ¹ Exh 5 0.879 0.904 0.929 -2.7%\n\n(5) Miscellaneous Fees and Flat Charges not included in Line (2) Exh 6 0 0 0\n\n(6) Earned Exposure Units 41,777 58,900 73,935\n\n(7) Historic Losses 22,450,387 28,674,750 31,737,707\n\n(8) Historic Defense and Cost Containment Expense (DCCE) 716,240 835,249 893,693\n\n(9) Loss Development Factor Exh 7 1.037 1.061 1.239\n\n(10) DCCE Development Factor Exh 7 1.037 1.061 1.239\n\n(11) Loss Trend Factor ¹ Exh 8 1.093 1.072 1.052 1.9%\n\n(12) DCCE Trend Factor ¹ Exh 8 1.093 1.072 1.052 1.9%\n\n(13) Catastrophe Adjustment Factor Exh 9 1.021 1.021 1.021\n\n(14) Credibility for Losses & DCCE Exh 10 76.3%\n\n(15) Ancillary Income Exh 11 0 0 0\n\n_Lines 16-18 link directly to pages 3 and 4 of the application._\n\n(16) Excluded Expense Ratio Pg 4.2 0.9%\n\n(17) Projected Federal Income Tax Rate\n\non Investment Income Pg 3.2 28.7%\n\n(18) Projected Yield Pg 3.2 2.4%\n\n1 The Projected column should reflect the annual trend expressed as a percentage for premium, loss and DCCE trends, and credibility.\n\n2 Refer to Section III.C. of the Prior Approval Rate Filing Instructions for New Program requirements.\n\nPrior Approval Rate Template Page 6.1 9/1/2015 Edition","publish_date":null,"title":"RATEMAKING DATA","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1878.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1878.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1878","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1878.pdf"},"started_at":"2026-11-04T19:48:01.585732"} +{"completed_at":"2026-11-04T19:48:05.480609","latency_in_ms":1625,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1915","grounded_pages":[],"layout_pages":[],"markdown":"# HARLEYSVILLE INSURANCE\n\nH A R L E Y S V I L L E I N S U R A N C E C O M P A N Y\n\nCALIFORNIA\n\nCOMMERCIAL MULTI-PERIL\n\n**ACTUARIAL EXPLANATORY MEMORANDUM**\n\nHarleysville Insurance proposes to revise our Commercial Multi-Peril program in the state of California as described below and in the attached exhibits. We propose a November 1, 2016 effective date for these revisions. The total commercial multi-peril rate effect for this filing is **\\-4.0%** . Specifically, we propose to make the following revisions:\n\n1\\. Adopt the following previously deferred ISO commercial multi-peril related reference filings:\n\nISO Reference Filing Description ISO Reference Filing Number\n\nLoss Costs GL-2013-BGL1\n\nLoss Costs CF-2013-RLA1\n\nLoss Costs CF-2012-RLA1\n\nLoss Costs CF-2011-RLA1\n\nLoss Costs CF-2010-RLA1\n\nLoss Costs CR-2007-RLA1\n\nEQ Loss Costs/Rules CF-2013-RZPEQ\n\nEQ Loss Costs/Rules CF-2011-RZPEQ\n\nILFs GL-2014-IALL1\n\nELPs GL-2010-OELP1\n\nRules GL-2014-RDD14\n\nRules GL-2010-OCT10\n\nRules CF-2009-RRU09\\*\n\nRules CF-2009-RRU09(S3)\\*\n\nRules CF-2009-RLC09\n\nRules CF-2009-RLC09(A)\n\nRules CF-2011-ORU1\n\n_\\* Note: ISO Rule “A#: Transition Rule – Limit of Insurance Relativities and Related Change” does not apply. Please refer to #3 below for additional information regarding Harleysville’s proposed transition rule._\n\n2\\. Make no changes to our currently filed and approved loss cost multipliers and package modification factors.\n\nNote that we have not written one full year’s worth of premium. As a result, the attached Prior Approval Rate Application form displays no premium in the most recent year.","pages":[{"line_numbers":[],"markdown":"# HARLEYSVILLE INSURANCE\n\nH A R L E Y S V I L L E I N S U R A N C E C O M P A N Y\n\nCALIFORNIA\n\nCOMMERCIAL MULTI-PERIL\n\n**ACTUARIAL EXPLANATORY MEMORANDUM**\n\nHarleysville Insurance proposes to revise our Commercial Multi-Peril program in the state of California as described below and in the attached exhibits. We propose a November 1, 2016 effective date for these revisions. The total commercial multi-peril rate effect for this filing is **\\-4.0%** . Specifically, we propose to make the following revisions:\n\n1\\. Adopt the following previously deferred ISO commercial multi-peril related reference filings:\n\nISO Reference Filing Description ISO Reference Filing Number\n\nLoss Costs GL-2013-BGL1\n\nLoss Costs CF-2013-RLA1\n\nLoss Costs CF-2012-RLA1\n\nLoss Costs CF-2011-RLA1\n\nLoss Costs CF-2010-RLA1\n\nLoss Costs CR-2007-RLA1\n\nEQ Loss Costs/Rules CF-2013-RZPEQ\n\nEQ Loss Costs/Rules CF-2011-RZPEQ\n\nILFs GL-2014-IALL1\n\nELPs GL-2010-OELP1\n\nRules GL-2014-RDD14\n\nRules GL-2010-OCT10\n\nRules CF-2009-RRU09\\*\n\nRules CF-2009-RRU09(S3)\\*\n\nRules CF-2009-RLC09\n\nRules CF-2009-RLC09(A)\n\nRules CF-2011-ORU1\n\n_\\* Note: ISO Rule “A#: Transition Rule – Limit of Insurance Relativities and Related Change” does not apply. Please refer to #3 below for additional information regarding Harleysville’s proposed transition rule._\n\n2\\. Make no changes to our currently filed and approved loss cost multipliers and package modification factors.\n\nNote that we have not written one full year’s worth of premium. As a result, the attached Prior Approval Rate Application form displays no premium in the most recent year.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"# HARLEYSVILLE INSURANCE\n\nH A R L E Y S V I L L E I N S U R A N C E C O M P A N Y\n\nCALIFORNIA\n\nCOMMERCIAL MULTI-PERIL\n\n**ACTUARIAL EXPLANATORY MEMORANDUM**\n\nHarleysville Insurance proposes to revise our Commercial Multi-Peril program in the state of California as described below and in the attached exhibits. We propose a November 1, 2016 effective date for these revisions. The total commercial multi-peril rate effect for this filing is **\\-4.0%** . Specifically, we propose to make the following revisions:\n\n1\\. Adopt the following previously deferred ISO commercial multi-peril related reference filings:\n\nISO Reference Filing Description ISO Reference Filing Number\n\nLoss Costs GL-2013-BGL1\n\nLoss Costs CF-2013-RLA1\n\nLoss Costs CF-2012-RLA1\n\nLoss Costs CF-2011-RLA1\n\nLoss Costs CF-2010-RLA1\n\nLoss Costs CR-2007-RLA1\n\nEQ Loss Costs/Rules CF-2013-RZPEQ\n\nEQ Loss Costs/Rules CF-2011-RZPEQ\n\nILFs GL-2014-IALL1\n\nELPs GL-2010-OELP1\n\nRules GL-2014-RDD14\n\nRules GL-2010-OCT10\n\nRules CF-2009-RRU09\\*\n\nRules CF-2009-RRU09(S3)\\*\n\nRules CF-2009-RLC09\n\nRules CF-2009-RLC09(A)\n\nRules CF-2011-ORU1\n\n_\\* Note: ISO Rule “A#: Transition Rule – Limit of Insurance Relativities and Related Change” does not apply. Please refer to #3 below for additional information regarding Harleysville’s proposed transition rule._\n\n2\\. Make no changes to our currently filed and approved loss cost multipliers and package modification factors.\n\nNote that we have not written one full year’s worth of premium. As a result, the attached Prior Approval Rate Application form displays no premium in the most recent year.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1915.pdf"]},"response":{"errors":[],"extract_id":"extract_727c96fd5e68c9a0a519abf60520554c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["# HARLEYSVILLE INSURANCE\n\nH A R L E Y S V I L L E I N S U R A N C E C O M P A N Y\n\nCALIFORNIA\n\nCOMMERCIAL MULTI-PERIL\n\n**ACTUARIAL EXPLANATORY MEMORANDUM**\n\nHarleysville Insurance proposes to revise our Commercial Multi-Peril program in the state of California as described below and in the attached exhibits. We propose a November 1, 2016 effective date for these revisions. The total commercial multi-peril rate effect for this filing is **\\-4.0%** . Specifically, we propose to make the following revisions:\n\n1\\. Adopt the following previously deferred ISO commercial multi-peril related reference filings:\n\nISO Reference Filing Description ISO Reference Filing Number\n\nLoss Costs GL-2013-BGL1\n\nLoss Costs CF-2013-RLA1\n\nLoss Costs CF-2012-RLA1\n\nLoss Costs CF-2011-RLA1\n\nLoss Costs CF-2010-RLA1\n\nLoss Costs CR-2007-RLA1\n\nEQ Loss Costs/Rules CF-2013-RZPEQ\n\nEQ Loss Costs/Rules CF-2011-RZPEQ\n\nILFs GL-2014-IALL1\n\nELPs GL-2010-OELP1\n\nRules GL-2014-RDD14\n\nRules GL-2010-OCT10\n\nRules CF-2009-RRU09\\*\n\nRules CF-2009-RRU09(S3)\\*\n\nRules CF-2009-RLC09\n\nRules CF-2009-RLC09(A)\n\nRules CF-2011-ORU1\n\n_\\* Note: ISO Rule “A#: Transition Rule – Limit of Insurance Relativities and Related Change” does not apply. Please refer to #3 below for additional information regarding Harleysville’s proposed transition rule._\n\n2\\. Make no changes to our currently filed and approved loss cost multipliers and package modification factors.\n\nNote that we have not written one full year’s worth of premium. As a result, the attached Prior Approval Rate Application form displays no premium in the most recent year."],"full_content":"# HARLEYSVILLE INSURANCE\n\nH A R L E Y S V I L L E I N S U R A N C E C O M P A N Y\n\nCALIFORNIA\n\nCOMMERCIAL MULTI-PERIL\n\n**ACTUARIAL EXPLANATORY MEMORANDUM**\n\nHarleysville Insurance proposes to revise our Commercial Multi-Peril program in the state of California as described below and in the attached exhibits. We propose a November 1, 2016 effective date for these revisions. The total commercial multi-peril rate effect for this filing is **\\-4.0%** . Specifically, we propose to make the following revisions:\n\n1\\. Adopt the following previously deferred ISO commercial multi-peril related reference filings:\n\nISO Reference Filing Description ISO Reference Filing Number\n\nLoss Costs GL-2013-BGL1\n\nLoss Costs CF-2013-RLA1\n\nLoss Costs CF-2012-RLA1\n\nLoss Costs CF-2011-RLA1\n\nLoss Costs CF-2010-RLA1\n\nLoss Costs CR-2007-RLA1\n\nEQ Loss Costs/Rules CF-2013-RZPEQ\n\nEQ Loss Costs/Rules CF-2011-RZPEQ\n\nILFs GL-2014-IALL1\n\nELPs GL-2010-OELP1\n\nRules GL-2014-RDD14\n\nRules GL-2010-OCT10\n\nRules CF-2009-RRU09\\*\n\nRules CF-2009-RRU09(S3)\\*\n\nRules CF-2009-RLC09\n\nRules CF-2009-RLC09(A)\n\nRules CF-2011-ORU1\n\n_\\* Note: ISO Rule “A#: Transition Rule – Limit of Insurance Relativities and Related Change” does not apply. Please refer to #3 below for additional information regarding Harleysville’s proposed transition rule._\n\n2\\. Make no changes to our currently filed and approved loss cost multipliers and package modification factors.\n\nNote that we have not written one full year’s worth of premium. As a result, the attached Prior Approval Rate Application form displays no premium in the most recent year.","publish_date":null,"title":"HA RL E YS V I L L E I N S U RA NC E","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1915.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1915.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1915","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1915.pdf"},"started_at":"2026-11-04T19:48:03.855583"} +{"completed_at":"2026-11-04T19:48:05.980231","latency_in_ms":1415,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1961","grounded_pages":[],"layout_pages":[],"markdown":"**State of California Company: Incline National Insurance Company**\n\n**Department of Insurance (CDI) Line: Auto Liability and Physical Damage**\n\n**CDI File # (Department Use Only):**\n\n**VARIANCE 8B**\n\n### **RATE CHANGE CALCULATION**\n\nCompleted by: Mitchell Paden\n\nDate Completed: 12/12/2022\n\nPrior Effective Date: 2/8/2023\n\nProposed Effective Date: 4/1/2023\n\nDetailed Line Description: Private Passenger Auto Liability\n\nCoverage: Medical Payments\n\n**Data Provided by Filer 20203 20213 20223 Projected**\n\nPrem\\_Written 3,065 3,065\n\nPrem\\_Earned 2,585 2,585\n\nPrem\\_Adj 1.000\n\nPrem\\_Trend 1.000 0.0%\n\nMisc\\_Fees 295 295\n\nExposures\\_Earned 172 172\n\nLosses 2,000 2,000\n\nDCCE 0 0\n\nLoss\\_Devt 1.544\n\nDCCE\\_Devt 1.544\n\nLoss\\_Trend 1.175 9.1%\n\nDCCE\\_Trend 1.175 9.1%\n\nCAT\\_Adj 1.000\n\nAnc\\_Income 2 2\n\nCredibility 2.6%\n\nExpRatio\\_Excluded 1.7%\n\nFIT\\_Inv 20.9%\n\nYield 3.8%\n\n**CDI Parameters** FIT\\_UW 21.0%\n\nEffStd\\_Final **_Data as of: 2020_** 33\\.9%\n\nLevFact\\_Final **_Data as of: 2020_** 0\\.80\n\nPremTaxRate 2.4%\n\nSurplusRatio 1.25\n\nResRatio\\_UPR **_Data as of: 2020_** 0\\.33\n\nResRatio\\_Loss **_Data as of: 2020_** 1\\.23\n\nROR\\_RiskFree **_Data as of: November 2022_** 3\\.8%\n\nROR\\_Min -6.0%\n\nROR\\_Max 9.8%\n\n**Calculations 20203 20213 20223**\n\nPrem\\_Adjusted 2,880 2,880\n\nLosses\\_Adjusted 3,629 3,629\n\nDCCE\\_Adjusted 0 0\n\nLossDCCERatio\\_Adjusted 126.0% 126.0%\n\nTCRLP\\_perExp 16.78 16.78\n\nLossDCCE\\_perExp 21.14 21.14\n\nCompLossDCCE\\_perExp 10.10 10.10\n\nCredLoss\\_perExp 10.38 10.38\n\nAnc\\_Inc\\_perExp 0.01 0.01\n\nInvInc\\_Fixed 4.7%\n\nInvInc\\_Variable 6.0%\n\nNet\\_AnnualTrend 9.1%\n\nComp\\_Trend 1.2%\n\nMax\\_Profit 15.5%\n\nMin\\_Profit -9.5%\n\nUW\\_Profit 6.6%\n\nMin\\_Denom 0.82\n\nMax\\_Denom 0.57\n\nMin\\_Premium $12.11\n\nMax\\_Premium $17.47\n\n**CHANGE\\_AT\\_MIN -27.9%**\n\n**CHANGE\\_AT\\_MAX 4.1%**\n\nPrior Approval Rate Template Page 7.3 06/27/2022 Edition","pages":[{"line_numbers":[],"markdown":"**State of California Company: Incline National Insurance Company**\n\n**Department of Insurance (CDI) Line: Auto Liability and Physical Damage**\n\n**CDI File # (Department Use Only):**\n\n**VARIANCE 8B**\n\n### **RATE CHANGE CALCULATION**\n\nCompleted by: Mitchell Paden\n\nDate Completed: 12/12/2022\n\nPrior Effective Date: 2/8/2023\n\nProposed Effective Date: 4/1/2023\n\nDetailed Line Description: Private Passenger Auto Liability\n\nCoverage: Medical Payments\n\n**Data Provided by Filer 20203 20213 20223 Projected**\n\nPrem\\_Written 3,065 3,065\n\nPrem\\_Earned 2,585 2,585\n\nPrem\\_Adj 1.000\n\nPrem\\_Trend 1.000 0.0%\n\nMisc\\_Fees 295 295\n\nExposures\\_Earned 172 172\n\nLosses 2,000 2,000\n\nDCCE 0 0\n\nLoss\\_Devt 1.544\n\nDCCE\\_Devt 1.544\n\nLoss\\_Trend 1.175 9.1%\n\nDCCE\\_Trend 1.175 9.1%\n\nCAT\\_Adj 1.000\n\nAnc\\_Income 2 2\n\nCredibility 2.6%\n\nExpRatio\\_Excluded 1.7%\n\nFIT\\_Inv 20.9%\n\nYield 3.8%\n\n**CDI Parameters** FIT\\_UW 21.0%\n\nEffStd\\_Final **_Data as of: 2020_** 33\\.9%\n\nLevFact\\_Final **_Data as of: 2020_** 0\\.80\n\nPremTaxRate 2.4%\n\nSurplusRatio 1.25\n\nResRatio\\_UPR **_Data as of: 2020_** 0\\.33\n\nResRatio\\_Loss **_Data as of: 2020_** 1\\.23\n\nROR\\_RiskFree **_Data as of: November 2022_** 3\\.8%\n\nROR\\_Min -6.0%\n\nROR\\_Max 9.8%\n\n**Calculations 20203 20213 20223**\n\nPrem\\_Adjusted 2,880 2,880\n\nLosses\\_Adjusted 3,629 3,629\n\nDCCE\\_Adjusted 0 0\n\nLossDCCERatio\\_Adjusted 126.0% 126.0%\n\nTCRLP\\_perExp 16.78 16.78\n\nLossDCCE\\_perExp 21.14 21.14\n\nCompLossDCCE\\_perExp 10.10 10.10\n\nCredLoss\\_perExp 10.38 10.38\n\nAnc\\_Inc\\_perExp 0.01 0.01\n\nInvInc\\_Fixed 4.7%\n\nInvInc\\_Variable 6.0%\n\nNet\\_AnnualTrend 9.1%\n\nComp\\_Trend 1.2%\n\nMax\\_Profit 15.5%\n\nMin\\_Profit -9.5%\n\nUW\\_Profit 6.6%\n\nMin\\_Denom 0.82\n\nMax\\_Denom 0.57\n\nMin\\_Premium $12.11\n\nMax\\_Premium $17.47\n\n**CHANGE\\_AT\\_MIN -27.9%**\n\n**CHANGE\\_AT\\_MAX 4.1%**\n\nPrior Approval Rate Template Page 7.3 06/27/2022 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**State of California Company: Incline National Insurance Company**\n\n**Department of Insurance (CDI) Line: Auto Liability and Physical Damage**\n\n**CDI File # (Department Use Only):**\n\n**VARIANCE 8B**\n\n### **RATE CHANGE CALCULATION**\n\nCompleted by: Mitchell Paden\n\nDate Completed: 12/12/2022\n\nPrior Effective Date: 2/8/2023\n\nProposed Effective Date: 4/1/2023\n\nDetailed Line Description: Private Passenger Auto Liability\n\nCoverage: Medical Payments\n\n**Data Provided by Filer 20203 20213 20223 Projected**\n\nPrem\\_Written 3,065 3,065\n\nPrem\\_Earned 2,585 2,585\n\nPrem\\_Adj 1.000\n\nPrem\\_Trend 1.000 0.0%\n\nMisc\\_Fees 295 295\n\nExposures\\_Earned 172 172\n\nLosses 2,000 2,000\n\nDCCE 0 0\n\nLoss\\_Devt 1.544\n\nDCCE\\_Devt 1.544\n\nLoss\\_Trend 1.175 9.1%\n\nDCCE\\_Trend 1.175 9.1%\n\nCAT\\_Adj 1.000\n\nAnc\\_Income 2 2\n\nCredibility 2.6%\n\nExpRatio\\_Excluded 1.7%\n\nFIT\\_Inv 20.9%\n\nYield 3.8%\n\n**CDI Parameters** FIT\\_UW 21.0%\n\nEffStd\\_Final **_Data as of: 2020_** 33\\.9%\n\nLevFact\\_Final **_Data as of: 2020_** 0\\.80\n\nPremTaxRate 2.4%\n\nSurplusRatio 1.25\n\nResRatio\\_UPR **_Data as of: 2020_** 0\\.33\n\nResRatio\\_Loss **_Data as of: 2020_** 1\\.23\n\nROR\\_RiskFree **_Data as of: November 2022_** 3\\.8%\n\nROR\\_Min -6.0%\n\nROR\\_Max 9.8%\n\n**Calculations 20203 20213 20223**\n\nPrem\\_Adjusted 2,880 2,880\n\nLosses\\_Adjusted 3,629 3,629\n\nDCCE\\_Adjusted 0 0\n\nLossDCCERatio\\_Adjusted 126.0% 126.0%\n\nTCRLP\\_perExp 16.78 16.78\n\nLossDCCE\\_perExp 21.14 21.14\n\nCompLossDCCE\\_perExp 10.10 10.10\n\nCredLoss\\_perExp 10.38 10.38\n\nAnc\\_Inc\\_perExp 0.01 0.01\n\nInvInc\\_Fixed 4.7%\n\nInvInc\\_Variable 6.0%\n\nNet\\_AnnualTrend 9.1%\n\nComp\\_Trend 1.2%\n\nMax\\_Profit 15.5%\n\nMin\\_Profit -9.5%\n\nUW\\_Profit 6.6%\n\nMin\\_Denom 0.82\n\nMax\\_Denom 0.57\n\nMin\\_Premium $12.11\n\nMax\\_Premium $17.47\n\n**CHANGE\\_AT\\_MIN -27.9%**\n\n**CHANGE\\_AT\\_MAX 4.1%**\n\nPrior Approval Rate Template Page 7.3 06/27/2022 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1961.pdf"]},"response":{"errors":[],"extract_id":"extract_fdc9e22d040b7a4e9fc41ffa53c08e64","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**State of California Company: Incline National Insurance Company**\n\n**Department of Insurance (CDI) Line: Auto Liability and Physical Damage**\n\n**CDI File # (Department Use Only):**\n\n**VARIANCE 8B**\n\n### **RATE CHANGE CALCULATION**\n\nCompleted by: Mitchell Paden\n\nDate Completed: 12/12/2022\n\nPrior Effective Date: 2/8/2023\n\nProposed Effective Date: 4/1/2023\n\nDetailed Line Description: Private Passenger Auto Liability\n\nCoverage: Medical Payments\n\n**Data Provided by Filer 20203 20213 20223 Projected**\n\nPrem\\_Written 3,065 3,065\n\nPrem\\_Earned 2,585 2,585\n\nPrem\\_Adj 1.000\n\nPrem\\_Trend 1.000 0.0%\n\nMisc\\_Fees 295 295\n\nExposures\\_Earned 172 172\n\nLosses 2,000 2,000\n\nDCCE 0 0\n\nLoss\\_Devt 1.544\n\nDCCE\\_Devt 1.544\n\nLoss\\_Trend 1.175 9.1%\n\nDCCE\\_Trend 1.175 9.1%\n\nCAT\\_Adj 1.000\n\nAnc\\_Income 2 2\n\nCredibility 2.6%\n\nExpRatio\\_Excluded 1.7%\n\nFIT\\_Inv 20.9%\n\nYield 3.8%\n\n**CDI Parameters** FIT\\_UW 21.0%\n\nEffStd\\_Final **_Data as of: 2020_** 33\\.9%\n\nLevFact\\_Final **_Data as of: 2020_** 0\\.80\n\nPremTaxRate 2.4%\n\nSurplusRatio 1.25\n\nResRatio\\_UPR **_Data as of: 2020_** 0\\.33\n\nResRatio\\_Loss **_Data as of: 2020_** 1\\.23\n\nROR\\_RiskFree **_Data as of: November 2022_** 3\\.8%\n\nROR\\_Min -6.0%\n\nROR\\_Max 9.8%\n\n**Calculations 20203 20213 20223**\n\nPrem\\_Adjusted 2,880 2,880\n\nLosses\\_Adjusted 3,629 3,629\n\nDCCE\\_Adjusted 0 0\n\nLossDCCERatio\\_Adjusted 126.0% 126.0%\n\nTCRLP\\_perExp 16.78 16.78\n\nLossDCCE\\_perExp 21.14 21.14\n\nCompLossDCCE\\_perExp 10.10 10.10\n\nCredLoss\\_perExp 10.38 10.38\n\nAnc\\_Inc\\_perExp 0.01 0.01\n\nInvInc\\_Fixed 4.7%\n\nInvInc\\_Variable 6.0%\n\nNet\\_AnnualTrend 9.1%\n\nComp\\_Trend 1.2%\n\nMax\\_Profit 15.5%\n\nMin\\_Profit -9.5%\n\nUW\\_Profit 6.6%\n\nMin\\_Denom 0.82\n\nMax\\_Denom 0.57\n\nMin\\_Premium $12.11\n\nMax\\_Premium $17.47\n\n**CHANGE\\_AT\\_MIN -27.9%**\n\n**CHANGE\\_AT\\_MAX 4.1%**\n\nPrior Approval Rate Template Page 7.3 06/27/2022 Edition"],"full_content":"**State of California Company: Incline National Insurance Company**\n\n**Department of Insurance (CDI) Line: Auto Liability and Physical Damage**\n\n**CDI File # (Department Use Only):**\n\n**VARIANCE 8B**\n\n### **RATE CHANGE CALCULATION**\n\nCompleted by: Mitchell Paden\n\nDate Completed: 12/12/2022\n\nPrior Effective Date: 2/8/2023\n\nProposed Effective Date: 4/1/2023\n\nDetailed Line Description: Private Passenger Auto Liability\n\nCoverage: Medical Payments\n\n**Data Provided by Filer 20203 20213 20223 Projected**\n\nPrem\\_Written 3,065 3,065\n\nPrem\\_Earned 2,585 2,585\n\nPrem\\_Adj 1.000\n\nPrem\\_Trend 1.000 0.0%\n\nMisc\\_Fees 295 295\n\nExposures\\_Earned 172 172\n\nLosses 2,000 2,000\n\nDCCE 0 0\n\nLoss\\_Devt 1.544\n\nDCCE\\_Devt 1.544\n\nLoss\\_Trend 1.175 9.1%\n\nDCCE\\_Trend 1.175 9.1%\n\nCAT\\_Adj 1.000\n\nAnc\\_Income 2 2\n\nCredibility 2.6%\n\nExpRatio\\_Excluded 1.7%\n\nFIT\\_Inv 20.9%\n\nYield 3.8%\n\n**CDI Parameters** FIT\\_UW 21.0%\n\nEffStd\\_Final **_Data as of: 2020_** 33\\.9%\n\nLevFact\\_Final **_Data as of: 2020_** 0\\.80\n\nPremTaxRate 2.4%\n\nSurplusRatio 1.25\n\nResRatio\\_UPR **_Data as of: 2020_** 0\\.33\n\nResRatio\\_Loss **_Data as of: 2020_** 1\\.23\n\nROR\\_RiskFree **_Data as of: November 2022_** 3\\.8%\n\nROR\\_Min -6.0%\n\nROR\\_Max 9.8%\n\n**Calculations 20203 20213 20223**\n\nPrem\\_Adjusted 2,880 2,880\n\nLosses\\_Adjusted 3,629 3,629\n\nDCCE\\_Adjusted 0 0\n\nLossDCCERatio\\_Adjusted 126.0% 126.0%\n\nTCRLP\\_perExp 16.78 16.78\n\nLossDCCE\\_perExp 21.14 21.14\n\nCompLossDCCE\\_perExp 10.10 10.10\n\nCredLoss\\_perExp 10.38 10.38\n\nAnc\\_Inc\\_perExp 0.01 0.01\n\nInvInc\\_Fixed 4.7%\n\nInvInc\\_Variable 6.0%\n\nNet\\_AnnualTrend 9.1%\n\nComp\\_Trend 1.2%\n\nMax\\_Profit 15.5%\n\nMin\\_Profit -9.5%\n\nUW\\_Profit 6.6%\n\nMin\\_Denom 0.82\n\nMax\\_Denom 0.57\n\nMin\\_Premium $12.11\n\nMax\\_Premium $17.47\n\n**CHANGE\\_AT\\_MIN -27.9%**\n\n**CHANGE\\_AT\\_MAX 4.1%**\n\nPrior Approval Rate Template Page 7.3 06/27/2022 Edition","publish_date":null,"title":"RATE CHANGE CALCULATION","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1961.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1961.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1961","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1961.pdf"},"started_at":"2026-11-04T19:48:04.564476"} +{"completed_at":"2026-11-04T19:48:07.868861","latency_in_ms":1996,"output":{"example_id":"table/SERFF_CA_random_pages 1_page1999","grounded_pages":[],"layout_pages":[],"markdown":"# **STAR**\n\nI N S U R A N C E C 0 M P A N Y **REAL ESTATE APPRAISER PROGRAM - BASE RATES** **CALIFORNIA RESIDENTIAL APPRAISERS**\n\nStar-CA-REAP-RES-1 Ed. 0211\n\n### **TABLE 1 -APPRAISER ONLY**\n\n**NUMBER OF APPRAISERS**\n\n**MINIMUM DEDUCTIBLE**\n\n**LIMITS OF $500,000/ $500,000**\n\n**LIMITS OF $1,000,000/ $1,000,000**\n\n**LIMITS OF $300,000/ $300,000**\n\n1 $1,000 $ 750 $ 850 $ 550\n\n2 $1,000 1,500 1,700 1,100\n\n3 $1,000 2,250 2,550 1,650\n\n4 $1,000 3,000 3,400 2,200\n\n5 $2,500 3,750 4,250 2,750\n\nEACH ADDITIONAL $2,500 $750 $850 $550\n\n### **TABLE 2 – APPRAISER/REALTOR**\n\n**NUMBER OF APPRAISERS**\n\n**MINIMUM DEDUCTIBLE**\n\n**LIMITS OF $500,000/ $500,000**\n\n**LIMITS OF $1,000,000/ $1,000,000**\n\n**LIMITS OF $300,000/ $300,000**\n\n1 $1,000 $ 1,053 $ 1,188 N/A\n\n2 $1,000 2,104 2,376 N/A\n\n3 $1,000 3,156 3,564 N/A\n\n4 $1,000 4,208 4,752 N/A\n\n5 $2,500 4,612 5,940 N/A\n\nEACH ADDITIONAL $2,500 $1053 $1,188 N/A","pages":[{"line_numbers":[],"markdown":"# **STAR**\n\nI N S U R A N C E C 0 M P A N Y **REAL ESTATE APPRAISER PROGRAM - BASE RATES** **CALIFORNIA RESIDENTIAL APPRAISERS**\n\nStar-CA-REAP-RES-1 Ed. 0211\n\n### **TABLE 1 -APPRAISER ONLY**\n\n**NUMBER OF APPRAISERS**\n\n**MINIMUM DEDUCTIBLE**\n\n**LIMITS OF $500,000/ $500,000**\n\n**LIMITS OF $1,000,000/ $1,000,000**\n\n**LIMITS OF $300,000/ $300,000**\n\n1 $1,000 $ 750 $ 850 $ 550\n\n2 $1,000 1,500 1,700 1,100\n\n3 $1,000 2,250 2,550 1,650\n\n4 $1,000 3,000 3,400 2,200\n\n5 $2,500 3,750 4,250 2,750\n\nEACH ADDITIONAL $2,500 $750 $850 $550\n\n### **TABLE 2 – APPRAISER/REALTOR**\n\n**NUMBER OF APPRAISERS**\n\n**MINIMUM DEDUCTIBLE**\n\n**LIMITS OF $500,000/ $500,000**\n\n**LIMITS OF $1,000,000/ $1,000,000**\n\n**LIMITS OF $300,000/ $300,000**\n\n1 $1,000 $ 1,053 $ 1,188 N/A\n\n2 $1,000 2,104 2,376 N/A\n\n3 $1,000 3,156 3,564 N/A\n\n4 $1,000 4,208 4,752 N/A\n\n5 $2,500 4,612 5,940 N/A\n\nEACH ADDITIONAL $2,500 $1053 $1,188 N/A","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"# **STAR**\n\nI N S U R A N C E C 0 M P A N Y **REAL ESTATE APPRAISER PROGRAM - BASE RATES** **CALIFORNIA RESIDENTIAL APPRAISERS**\n\nStar-CA-REAP-RES-1 Ed. 0211\n\n### **TABLE 1 -APPRAISER ONLY**\n\n**NUMBER OF APPRAISERS**\n\n**MINIMUM DEDUCTIBLE**\n\n**LIMITS OF $500,000/ $500,000**\n\n**LIMITS OF $1,000,000/ $1,000,000**\n\n**LIMITS OF $300,000/ $300,000**\n\n1 $1,000 $ 750 $ 850 $ 550\n\n2 $1,000 1,500 1,700 1,100\n\n3 $1,000 2,250 2,550 1,650\n\n4 $1,000 3,000 3,400 2,200\n\n5 $2,500 3,750 4,250 2,750\n\nEACH ADDITIONAL $2,500 $750 $850 $550\n\n### **TABLE 2 – APPRAISER/REALTOR**\n\n**NUMBER OF APPRAISERS**\n\n**MINIMUM DEDUCTIBLE**\n\n**LIMITS OF $500,000/ $500,000**\n\n**LIMITS OF $1,000,000/ $1,000,000**\n\n**LIMITS OF $300,000/ $300,000**\n\n1 $1,000 $ 1,053 $ 1,188 N/A\n\n2 $1,000 2,104 2,376 N/A\n\n3 $1,000 3,156 3,564 N/A\n\n4 $1,000 4,208 4,752 N/A\n\n5 $2,500 4,612 5,940 N/A\n\nEACH ADDITIONAL $2,500 $1053 $1,188 N/A","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1999.pdf"]},"response":{"errors":[],"extract_id":"extract_da6b41cdff1bbf3c3fab6311924343c1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["# **STAR**\n\nI N S U R A N C E C 0 M P A N Y **REAL ESTATE APPRAISER PROGRAM - BASE RATES** **CALIFORNIA RESIDENTIAL APPRAISERS**\n\nStar-CA-REAP-RES-1 Ed. 0211\n\n### **TABLE 1 -APPRAISER ONLY**\n\n**NUMBER OF APPRAISERS**\n\n**MINIMUM DEDUCTIBLE**\n\n**LIMITS OF $500,000/ $500,000**\n\n**LIMITS OF $1,000,000/ $1,000,000**\n\n**LIMITS OF $300,000/ $300,000**\n\n1 $1,000 $ 750 $ 850 $ 550\n\n2 $1,000 1,500 1,700 1,100\n\n3 $1,000 2,250 2,550 1,650\n\n4 $1,000 3,000 3,400 2,200\n\n5 $2,500 3,750 4,250 2,750\n\nEACH ADDITIONAL $2,500 $750 $850 $550\n\n### **TABLE 2 – APPRAISER/REALTOR**\n\n**NUMBER OF APPRAISERS**\n\n**MINIMUM DEDUCTIBLE**\n\n**LIMITS OF $500,000/ $500,000**\n\n**LIMITS OF $1,000,000/ $1,000,000**\n\n**LIMITS OF $300,000/ $300,000**\n\n1 $1,000 $ 1,053 $ 1,188 N/A\n\n2 $1,000 2,104 2,376 N/A\n\n3 $1,000 3,156 3,564 N/A\n\n4 $1,000 4,208 4,752 N/A\n\n5 $2,500 4,612 5,940 N/A\n\nEACH ADDITIONAL $2,500 $1053 $1,188 N/A"],"full_content":"# **STAR**\n\nI N S U R A N C E C 0 M P A N Y **REAL ESTATE APPRAISER PROGRAM - BASE RATES** **CALIFORNIA RESIDENTIAL APPRAISERS**\n\nStar-CA-REAP-RES-1 Ed. 0211\n\n### **TABLE 1 -APPRAISER ONLY**\n\n**NUMBER OF APPRAISERS**\n\n**MINIMUM DEDUCTIBLE**\n\n**LIMITS OF $500,000/ $500,000**\n\n**LIMITS OF $1,000,000/ $1,000,000**\n\n**LIMITS OF $300,000/ $300,000**\n\n1 $1,000 $ 750 $ 850 $ 550\n\n2 $1,000 1,500 1,700 1,100\n\n3 $1,000 2,250 2,550 1,650\n\n4 $1,000 3,000 3,400 2,200\n\n5 $2,500 3,750 4,250 2,750\n\nEACH ADDITIONAL $2,500 $750 $850 $550\n\n### **TABLE 2 – APPRAISER/REALTOR**\n\n**NUMBER OF APPRAISERS**\n\n**MINIMUM DEDUCTIBLE**\n\n**LIMITS OF $500,000/ $500,000**\n\n**LIMITS OF $1,000,000/ $1,000,000**\n\n**LIMITS OF $300,000/ $300,000**\n\n1 $1,000 $ 1,053 $ 1,188 N/A\n\n2 $1,000 2,104 2,376 N/A\n\n3 $1,000 3,156 3,564 N/A\n\n4 $1,000 4,208 4,752 N/A\n\n5 $2,500 4,612 5,940 N/A\n\nEACH ADDITIONAL $2,500 $1053 $1,188 N/A","publish_date":null,"title":"STAR","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1999.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page1999.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page1999","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page1999.pdf"},"started_at":"2026-11-04T19:48:05.872405"} +{"completed_at":"2026-11-04T19:48:08.661510","latency_in_ms":1214,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2005","grounded_pages":[],"layout_pages":[],"markdown":"Lawyer’s E&O Rating Guidelines Page 2 of 10\n\n**Table B:** **AREA OF PRACTICE FACTORS**\n\n**Area of Practice Rate Group Factor**\n\nArbitration/Mediation A 0.70\n\nBodily Injury/Property Damage- Defense (Average Case <$.5M) A 0.70\n\nBodily Injury/Property Damage- _Defense (Average Case >$.5M)_ A 0.70\n\nCivil Rights/Employment Law- _Defense_ A 0.70\n\nCommercial/Civil Litigation- _Defense_ A 0.70\n\nGovernmental- _Administrative/Local_ A 0.70\n\nGovernmental- _Federal/State_ A 0.70\n\nGovernmental- _Lobbying_ A 0.70\n\nInsurance Coverage- _Defense_ A 0.70\n\nLabor- _Management_ A 0.70\n\nLabor- _Union_ A 0.70\n\nWorkers Compensation- _Defense_ A 0.70\n\n**Area of Practice Rate Group Factor**\n\nAdmiralty/Maritime B 0.90\n\nClass Action/Mass Tort- _Defense_ B 0.90\n\nCorporate Transactions- _General Corporate/Business Transactions_ B 0.90\n\nCriminal- _Defense_ B 0.90\n\nFamily Law- _Adoption, Domestic_ B 0.90\n\nFamily Law- _Adoption, Foreign_ B 0.90\n\nFamily Law- _Guardianships, Juvenile & Elder_ B 0.90\n\nFamily Law- _Pre-Nuptial/Divorce (Assets <$1M)_ B 0.90\n\nFamily Law- _Immigration/Naturalization_ B 0.90\n\nInsurance Coverage- _Opinions_ B 0.90\n\nNatural Resources & Energy B 0.90\n\nReal Estate- _Landlord/Tenant_ B 0.90\n\nTaxation- _Preparation/Business_ B 0.90\n\nTaxation- _Preparation/Individual_ B 0.90\n\nWorkers Compensation- _Plaintiff_ B 0.90\n\n**Area of Practice Rate Group Factor**\n\nAntitrust- _Non-class action, mass tort_ C 1.15\n\nBankruptcy- Commercial C 1.15\n\nBankruptcy- _Individual_ C 1.15\n\nBodily Injury/Property Damage- _Plaintiff, Avg. Case <$.5M_ C 1.15\n\nCivil Rights/Employment Law- _Plaintiff_ C 1.15\n\nCommercial/Civil Litigation- _Appellate/Plaintiff_ C 1.15\n\nCommercial Collection (Greater than 5yrs experience) C 1.15\n\nCorporate Transactions- _Formation/Alteration_ C 1.15\n\nConstruction Law C 1.15\n\nFamily Law- Pre- _Nuptial/Divorce (Assets >$1-5M)_ C 1.15\n\nInsurance Coverage- _Plaintiff_ C 1.15\n\nLabor- _ERISA/Employee Benefits_ C 1.15\n\nReal Estate- _Development/Land Use_ C 1.15\n\nReal Estate- _General/Transactional_ C 1.15\n\nReal Estate- _Title - Commercial_ C 1.15","pages":[{"line_numbers":[],"markdown":"Lawyer’s E&O Rating Guidelines Page 2 of 10\n\n**Table B:** **AREA OF PRACTICE FACTORS**\n\n**Area of Practice Rate Group Factor**\n\nArbitration/Mediation A 0.70\n\nBodily Injury/Property Damage- Defense (Average Case <$.5M) A 0.70\n\nBodily Injury/Property Damage- _Defense (Average Case >$.5M)_ A 0.70\n\nCivil Rights/Employment Law- _Defense_ A 0.70\n\nCommercial/Civil Litigation- _Defense_ A 0.70\n\nGovernmental- _Administrative/Local_ A 0.70\n\nGovernmental- _Federal/State_ A 0.70\n\nGovernmental- _Lobbying_ A 0.70\n\nInsurance Coverage- _Defense_ A 0.70\n\nLabor- _Management_ A 0.70\n\nLabor- _Union_ A 0.70\n\nWorkers Compensation- _Defense_ A 0.70\n\n**Area of Practice Rate Group Factor**\n\nAdmiralty/Maritime B 0.90\n\nClass Action/Mass Tort- _Defense_ B 0.90\n\nCorporate Transactions- _General Corporate/Business Transactions_ B 0.90\n\nCriminal- _Defense_ B 0.90\n\nFamily Law- _Adoption, Domestic_ B 0.90\n\nFamily Law- _Adoption, Foreign_ B 0.90\n\nFamily Law- _Guardianships, Juvenile & Elder_ B 0.90\n\nFamily Law- _Pre-Nuptial/Divorce (Assets <$1M)_ B 0.90\n\nFamily Law- _Immigration/Naturalization_ B 0.90\n\nInsurance Coverage- _Opinions_ B 0.90\n\nNatural Resources & Energy B 0.90\n\nReal Estate- _Landlord/Tenant_ B 0.90\n\nTaxation- _Preparation/Business_ B 0.90\n\nTaxation- _Preparation/Individual_ B 0.90\n\nWorkers Compensation- _Plaintiff_ B 0.90\n\n**Area of Practice Rate Group Factor**\n\nAntitrust- _Non-class action, mass tort_ C 1.15\n\nBankruptcy- Commercial C 1.15\n\nBankruptcy- _Individual_ C 1.15\n\nBodily Injury/Property Damage- _Plaintiff, Avg. Case <$.5M_ C 1.15\n\nCivil Rights/Employment Law- _Plaintiff_ C 1.15\n\nCommercial/Civil Litigation- _Appellate/Plaintiff_ C 1.15\n\nCommercial Collection (Greater than 5yrs experience) C 1.15\n\nCorporate Transactions- _Formation/Alteration_ C 1.15\n\nConstruction Law C 1.15\n\nFamily Law- Pre- _Nuptial/Divorce (Assets >$1-5M)_ C 1.15\n\nInsurance Coverage- _Plaintiff_ C 1.15\n\nLabor- _ERISA/Employee Benefits_ C 1.15\n\nReal Estate- _Development/Land Use_ C 1.15\n\nReal Estate- _General/Transactional_ C 1.15\n\nReal Estate- _Title - Commercial_ C 1.15","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Lawyer’s E&O Rating Guidelines Page 2 of 10\n\n**Table B:** **AREA OF PRACTICE FACTORS**\n\n**Area of Practice Rate Group Factor**\n\nArbitration/Mediation A 0.70\n\nBodily Injury/Property Damage- Defense (Average Case <$.5M) A 0.70\n\nBodily Injury/Property Damage- _Defense (Average Case >$.5M)_ A 0.70\n\nCivil Rights/Employment Law- _Defense_ A 0.70\n\nCommercial/Civil Litigation- _Defense_ A 0.70\n\nGovernmental- _Administrative/Local_ A 0.70\n\nGovernmental- _Federal/State_ A 0.70\n\nGovernmental- _Lobbying_ A 0.70\n\nInsurance Coverage- _Defense_ A 0.70\n\nLabor- _Management_ A 0.70\n\nLabor- _Union_ A 0.70\n\nWorkers Compensation- _Defense_ A 0.70\n\n**Area of Practice Rate Group Factor**\n\nAdmiralty/Maritime B 0.90\n\nClass Action/Mass Tort- _Defense_ B 0.90\n\nCorporate Transactions- _General Corporate/Business Transactions_ B 0.90\n\nCriminal- _Defense_ B 0.90\n\nFamily Law- _Adoption, Domestic_ B 0.90\n\nFamily Law- _Adoption, Foreign_ B 0.90\n\nFamily Law- _Guardianships, Juvenile & Elder_ B 0.90\n\nFamily Law- _Pre-Nuptial/Divorce (Assets <$1M)_ B 0.90\n\nFamily Law- _Immigration/Naturalization_ B 0.90\n\nInsurance Coverage- _Opinions_ B 0.90\n\nNatural Resources & Energy B 0.90\n\nReal Estate- _Landlord/Tenant_ B 0.90\n\nTaxation- _Preparation/Business_ B 0.90\n\nTaxation- _Preparation/Individual_ B 0.90\n\nWorkers Compensation- _Plaintiff_ B 0.90\n\n**Area of Practice Rate Group Factor**\n\nAntitrust- _Non-class action, mass tort_ C 1.15\n\nBankruptcy- Commercial C 1.15\n\nBankruptcy- _Individual_ C 1.15\n\nBodily Injury/Property Damage- _Plaintiff, Avg. Case <$.5M_ C 1.15\n\nCivil Rights/Employment Law- _Plaintiff_ C 1.15\n\nCommercial/Civil Litigation- _Appellate/Plaintiff_ C 1.15\n\nCommercial Collection (Greater than 5yrs experience) C 1.15\n\nCorporate Transactions- _Formation/Alteration_ C 1.15\n\nConstruction Law C 1.15\n\nFamily Law- Pre- _Nuptial/Divorce (Assets >$1-5M)_ C 1.15\n\nInsurance Coverage- _Plaintiff_ C 1.15\n\nLabor- _ERISA/Employee Benefits_ C 1.15\n\nReal Estate- _Development/Land Use_ C 1.15\n\nReal Estate- _General/Transactional_ C 1.15\n\nReal Estate- _Title - Commercial_ C 1.15","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2005.pdf"]},"response":{"errors":[],"extract_id":"extract_f954c6bec6667fd3de1f13c8adb9cdf1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Lawyer’s E&O Rating Guidelines Page 2 of 10\n\n**Table B:** **AREA OF PRACTICE FACTORS**\n\n**Area of Practice Rate Group Factor**\n\nArbitration/Mediation A 0.70\n\nBodily Injury/Property Damage- Defense (Average Case <$.5M) A 0.70\n\nBodily Injury/Property Damage- _Defense (Average Case >$.5M)_ A 0.70\n\nCivil Rights/Employment Law- _Defense_ A 0.70\n\nCommercial/Civil Litigation- _Defense_ A 0.70\n\nGovernmental- _Administrative/Local_ A 0.70\n\nGovernmental- _Federal/State_ A 0.70\n\nGovernmental- _Lobbying_ A 0.70\n\nInsurance Coverage- _Defense_ A 0.70\n\nLabor- _Management_ A 0.70\n\nLabor- _Union_ A 0.70\n\nWorkers Compensation- _Defense_ A 0.70\n\n**Area of Practice Rate Group Factor**\n\nAdmiralty/Maritime B 0.90\n\nClass Action/Mass Tort- _Defense_ B 0.90\n\nCorporate Transactions- _General Corporate/Business Transactions_ B 0.90\n\nCriminal- _Defense_ B 0.90\n\nFamily Law- _Adoption, Domestic_ B 0.90\n\nFamily Law- _Adoption, Foreign_ B 0.90\n\nFamily Law- _Guardianships, Juvenile & Elder_ B 0.90\n\nFamily Law- _Pre-Nuptial/Divorce (Assets <$1M)_ B 0.90\n\nFamily Law- _Immigration/Naturalization_ B 0.90\n\nInsurance Coverage- _Opinions_ B 0.90\n\nNatural Resources & Energy B 0.90\n\nReal Estate- _Landlord/Tenant_ B 0.90\n\nTaxation- _Preparation/Business_ B 0.90\n\nTaxation- _Preparation/Individual_ B 0.90\n\nWorkers Compensation- _Plaintiff_ B 0.90\n\n**Area of Practice Rate Group Factor**\n\nAntitrust- _Non-class action, mass tort_ C 1.15\n\nBankruptcy- Commercial C 1.15\n\nBankruptcy- _Individual_ C 1.15\n\nBodily Injury/Property Damage- _Plaintiff, Avg. Case <$.5M_ C 1.15\n\nCivil Rights/Employment Law- _Plaintiff_ C 1.15\n\nCommercial/Civil Litigation- _Appellate/Plaintiff_ C 1.15\n\nCommercial Collection (Greater than 5yrs experience) C 1.15\n\nCorporate Transactions- _Formation/Alteration_ C 1.15\n\nConstruction Law C 1.15\n\nFamily Law- Pre- _Nuptial/Divorce (Assets >$1-5M)_ C 1.15\n\nInsurance Coverage- _Plaintiff_ C 1.15\n\nLabor- _ERISA/Employee Benefits_ C 1.15\n\nReal Estate- _Development/Land Use_ C 1.15\n\nReal Estate- _General/Transactional_ C 1.15\n\nReal Estate- _Title - Commercial_ C 1.15"],"full_content":"Lawyer’s E&O Rating Guidelines Page 2 of 10\n\n**Table B:** **AREA OF PRACTICE FACTORS**\n\n**Area of Practice Rate Group Factor**\n\nArbitration/Mediation A 0.70\n\nBodily Injury/Property Damage- Defense (Average Case <$.5M) A 0.70\n\nBodily Injury/Property Damage- _Defense (Average Case >$.5M)_ A 0.70\n\nCivil Rights/Employment Law- _Defense_ A 0.70\n\nCommercial/Civil Litigation- _Defense_ A 0.70\n\nGovernmental- _Administrative/Local_ A 0.70\n\nGovernmental- _Federal/State_ A 0.70\n\nGovernmental- _Lobbying_ A 0.70\n\nInsurance Coverage- _Defense_ A 0.70\n\nLabor- _Management_ A 0.70\n\nLabor- _Union_ A 0.70\n\nWorkers Compensation- _Defense_ A 0.70\n\n**Area of Practice Rate Group Factor**\n\nAdmiralty/Maritime B 0.90\n\nClass Action/Mass Tort- _Defense_ B 0.90\n\nCorporate Transactions- _General Corporate/Business Transactions_ B 0.90\n\nCriminal- _Defense_ B 0.90\n\nFamily Law- _Adoption, Domestic_ B 0.90\n\nFamily Law- _Adoption, Foreign_ B 0.90\n\nFamily Law- _Guardianships, Juvenile & Elder_ B 0.90\n\nFamily Law- _Pre-Nuptial/Divorce (Assets <$1M)_ B 0.90\n\nFamily Law- _Immigration/Naturalization_ B 0.90\n\nInsurance Coverage- _Opinions_ B 0.90\n\nNatural Resources & Energy B 0.90\n\nReal Estate- _Landlord/Tenant_ B 0.90\n\nTaxation- _Preparation/Business_ B 0.90\n\nTaxation- _Preparation/Individual_ B 0.90\n\nWorkers Compensation- _Plaintiff_ B 0.90\n\n**Area of Practice Rate Group Factor**\n\nAntitrust- _Non-class action, mass tort_ C 1.15\n\nBankruptcy- Commercial C 1.15\n\nBankruptcy- _Individual_ C 1.15\n\nBodily Injury/Property Damage- _Plaintiff, Avg. Case <$.5M_ C 1.15\n\nCivil Rights/Employment Law- _Plaintiff_ C 1.15\n\nCommercial/Civil Litigation- _Appellate/Plaintiff_ C 1.15\n\nCommercial Collection (Greater than 5yrs experience) C 1.15\n\nCorporate Transactions- _Formation/Alteration_ C 1.15\n\nConstruction Law C 1.15\n\nFamily Law- Pre- _Nuptial/Divorce (Assets >$1-5M)_ C 1.15\n\nInsurance Coverage- _Plaintiff_ C 1.15\n\nLabor- _ERISA/Employee Benefits_ C 1.15\n\nReal Estate- _Development/Land Use_ C 1.15\n\nReal Estate- _General/Transactional_ C 1.15\n\nReal Estate- _Title - Commercial_ C 1.15","publish_date":null,"title":"Table B: AREA OF PRACTICE FACTORS Area of Practice Rate Group Factor Arbitration/Mediation A 0.70 0.70 Bodily Injury/Property Damage- Defense","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2005.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2005.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2005","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2005.pdf"},"started_at":"2026-11-04T19:48:07.447461"} +{"completed_at":"2026-11-04T19:48:09.561736","latency_in_ms":1140,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2024","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 20-1\n\nForm Dislocation % Policy Count\n\nHO3 0% to 5% 27.6%\n\nHO3 5% to 10% 61.8%\n\nHO3 10% to 15% 7.9%\n\nHO3 15% to 20% 1.3%\n\nHO3 20% to 25% 0.7%\n\nHO3 25% to 30% 0.4%\n\nHO3 30% to 35% 0.2%\n\nHO3 35% to 40% 0.1%\n\nHO3 40% to 45% 0.0%\n\nHO3 45% to 50% 0.0%\n\nHO3 50%+ 0.0%\n\nHO4 0% to 5% 9.6%\n\nHO4 5% to 10% 90.0%\n\nHO4 10% to 15% 0.4%\n\nHO4 15% to 20% 0.0%\n\nHO4 20% to 25% 0.0%\n\nHO4 25% to 30% 0.0%\n\nHO4 30% to 35% 0.0%\n\nHO4 35% to 40% 0.0%\n\nHO4 40% to 45% 0.0%\n\nHO4 45% to 50% 0.0%\n\nHO4 50%+ 0.0%\n\nHO6 0% to 5% 1.3%\n\nHO6 5% to 10% 98.7%\n\nHO6 10% to 15% 0.0%\n\nHO6 15% to 20% 0.0%\n\nHO6 20% to 25% 0.0%\n\nHO6 25% to 30% 0.0%\n\nHO6 30% to 35% 0.0%\n\nHO6 35% to 40% 0.0%\n\nHO6 40% to 45% 0.0%\n\nHO6 45% to 50% 0.0%\n\nHO6 50%+ 0.0%\n\n**CALIFORNIA AUTOMOBILE INSURANCE COMPANY**\n\n**HOMEOWNERS MULTIPLE PERIL**\n\n**CALIFORNIA**\n\n**Exhibit 20-1 Dislocation**","pages":[{"line_numbers":[],"markdown":"Exhibit 20-1\n\nForm Dislocation % Policy Count\n\nHO3 0% to 5% 27.6%\n\nHO3 5% to 10% 61.8%\n\nHO3 10% to 15% 7.9%\n\nHO3 15% to 20% 1.3%\n\nHO3 20% to 25% 0.7%\n\nHO3 25% to 30% 0.4%\n\nHO3 30% to 35% 0.2%\n\nHO3 35% to 40% 0.1%\n\nHO3 40% to 45% 0.0%\n\nHO3 45% to 50% 0.0%\n\nHO3 50%+ 0.0%\n\nHO4 0% to 5% 9.6%\n\nHO4 5% to 10% 90.0%\n\nHO4 10% to 15% 0.4%\n\nHO4 15% to 20% 0.0%\n\nHO4 20% to 25% 0.0%\n\nHO4 25% to 30% 0.0%\n\nHO4 30% to 35% 0.0%\n\nHO4 35% to 40% 0.0%\n\nHO4 40% to 45% 0.0%\n\nHO4 45% to 50% 0.0%\n\nHO4 50%+ 0.0%\n\nHO6 0% to 5% 1.3%\n\nHO6 5% to 10% 98.7%\n\nHO6 10% to 15% 0.0%\n\nHO6 15% to 20% 0.0%\n\nHO6 20% to 25% 0.0%\n\nHO6 25% to 30% 0.0%\n\nHO6 30% to 35% 0.0%\n\nHO6 35% to 40% 0.0%\n\nHO6 40% to 45% 0.0%\n\nHO6 45% to 50% 0.0%\n\nHO6 50%+ 0.0%\n\n**CALIFORNIA AUTOMOBILE INSURANCE COMPANY**\n\n**HOMEOWNERS MULTIPLE PERIL**\n\n**CALIFORNIA**\n\n**Exhibit 20-1 Dislocation**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 20-1\n\nForm Dislocation % Policy Count\n\nHO3 0% to 5% 27.6%\n\nHO3 5% to 10% 61.8%\n\nHO3 10% to 15% 7.9%\n\nHO3 15% to 20% 1.3%\n\nHO3 20% to 25% 0.7%\n\nHO3 25% to 30% 0.4%\n\nHO3 30% to 35% 0.2%\n\nHO3 35% to 40% 0.1%\n\nHO3 40% to 45% 0.0%\n\nHO3 45% to 50% 0.0%\n\nHO3 50%+ 0.0%\n\nHO4 0% to 5% 9.6%\n\nHO4 5% to 10% 90.0%\n\nHO4 10% to 15% 0.4%\n\nHO4 15% to 20% 0.0%\n\nHO4 20% to 25% 0.0%\n\nHO4 25% to 30% 0.0%\n\nHO4 30% to 35% 0.0%\n\nHO4 35% to 40% 0.0%\n\nHO4 40% to 45% 0.0%\n\nHO4 45% to 50% 0.0%\n\nHO4 50%+ 0.0%\n\nHO6 0% to 5% 1.3%\n\nHO6 5% to 10% 98.7%\n\nHO6 10% to 15% 0.0%\n\nHO6 15% to 20% 0.0%\n\nHO6 20% to 25% 0.0%\n\nHO6 25% to 30% 0.0%\n\nHO6 30% to 35% 0.0%\n\nHO6 35% to 40% 0.0%\n\nHO6 40% to 45% 0.0%\n\nHO6 45% to 50% 0.0%\n\nHO6 50%+ 0.0%\n\n**CALIFORNIA AUTOMOBILE INSURANCE COMPANY**\n\n**HOMEOWNERS MULTIPLE PERIL**\n\n**CALIFORNIA**\n\n**Exhibit 20-1 Dislocation**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2024.pdf"]},"response":{"errors":[],"extract_id":"extract_eec24b34881c4e88b056016b062440f5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 20-1\n\nForm Dislocation % Policy Count\n\nHO3 0% to 5% 27.6%\n\nHO3 5% to 10% 61.8%\n\nHO3 10% to 15% 7.9%\n\nHO3 15% to 20% 1.3%\n\nHO3 20% to 25% 0.7%\n\nHO3 25% to 30% 0.4%\n\nHO3 30% to 35% 0.2%\n\nHO3 35% to 40% 0.1%\n\nHO3 40% to 45% 0.0%\n\nHO3 45% to 50% 0.0%\n\nHO3 50%+ 0.0%\n\nHO4 0% to 5% 9.6%\n\nHO4 5% to 10% 90.0%\n\nHO4 10% to 15% 0.4%\n\nHO4 15% to 20% 0.0%\n\nHO4 20% to 25% 0.0%\n\nHO4 25% to 30% 0.0%\n\nHO4 30% to 35% 0.0%\n\nHO4 35% to 40% 0.0%\n\nHO4 40% to 45% 0.0%\n\nHO4 45% to 50% 0.0%\n\nHO4 50%+ 0.0%\n\nHO6 0% to 5% 1.3%\n\nHO6 5% to 10% 98.7%\n\nHO6 10% to 15% 0.0%\n\nHO6 15% to 20% 0.0%\n\nHO6 20% to 25% 0.0%\n\nHO6 25% to 30% 0.0%\n\nHO6 30% to 35% 0.0%\n\nHO6 35% to 40% 0.0%\n\nHO6 40% to 45% 0.0%\n\nHO6 45% to 50% 0.0%\n\nHO6 50%+ 0.0%\n\n**CALIFORNIA AUTOMOBILE INSURANCE COMPANY**\n\n**HOMEOWNERS MULTIPLE PERIL**\n\n**CALIFORNIA**\n\n**Exhibit 20-1 Dislocation**"],"full_content":"Exhibit 20-1\n\nForm Dislocation % Policy Count\n\nHO3 0% to 5% 27.6%\n\nHO3 5% to 10% 61.8%\n\nHO3 10% to 15% 7.9%\n\nHO3 15% to 20% 1.3%\n\nHO3 20% to 25% 0.7%\n\nHO3 25% to 30% 0.4%\n\nHO3 30% to 35% 0.2%\n\nHO3 35% to 40% 0.1%\n\nHO3 40% to 45% 0.0%\n\nHO3 45% to 50% 0.0%\n\nHO3 50%+ 0.0%\n\nHO4 0% to 5% 9.6%\n\nHO4 5% to 10% 90.0%\n\nHO4 10% to 15% 0.4%\n\nHO4 15% to 20% 0.0%\n\nHO4 20% to 25% 0.0%\n\nHO4 25% to 30% 0.0%\n\nHO4 30% to 35% 0.0%\n\nHO4 35% to 40% 0.0%\n\nHO4 40% to 45% 0.0%\n\nHO4 45% to 50% 0.0%\n\nHO4 50%+ 0.0%\n\nHO6 0% to 5% 1.3%\n\nHO6 5% to 10% 98.7%\n\nHO6 10% to 15% 0.0%\n\nHO6 15% to 20% 0.0%\n\nHO6 20% to 25% 0.0%\n\nHO6 25% to 30% 0.0%\n\nHO6 30% to 35% 0.0%\n\nHO6 35% to 40% 0.0%\n\nHO6 40% to 45% 0.0%\n\nHO6 45% to 50% 0.0%\n\nHO6 50%+ 0.0%\n\n**CALIFORNIA AUTOMOBILE INSURANCE COMPANY**\n\n**HOMEOWNERS MULTIPLE PERIL**\n\n**CALIFORNIA**\n\n**Exhibit 20-1 Dislocation**","publish_date":null,"title":"Exhibit 20-1 CALIFORNIA AUTOMOBILE INSURANCE COMPANY HOMEOWNERS MULTIPLE PERIL CALIFORNIA Exhibit 20-1 Dislocation Form Dislocation % Policy Count HO3 0%","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2024.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2024.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2024","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2024.pdf"},"started_at":"2026-11-04T19:48:08.421673"} +{"completed_at":"2026-11-04T19:48:12.577318","latency_in_ms":2555,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2029","grounded_pages":[],"layout_pages":[],"markdown":"**State of California Company: California Automobile Insurance Company**\n\n**Department of Insurance (CDI) Line: Homeowners Multiple Peril**\n\n**CDI File # (Department Use Only):**\n\n**VARIANCE - NONE**\n\n### **RATE CHANGE CALCULATION**\n\nCompleted by: Bryan Wright\n\nDate Completed: 6/20/2019\n\nPrior Effective Date: 8/13/2019\n\nProposed Effective Date: 1/1/2020\n\nDetailed Line Description: Homeowners Multiple Peril\n\nCoverage: HO4\n\n**Data Provided by Filer 20171 20181 20191 Projected**\n\nPrem\\_Written 10,779,981 11,673,914 12,876,465 35,330,360\n\nPrem\\_Earned 9,814,481 11,176,518 12,258,723 33,249,722\n\nPrem\\_Adj 0.943 0.956 0.996\n\nPrem\\_Trend 1.013 1.010 1.007 0.3%\n\nMisc\\_Fees 74,231 80,151 86,848 241,230\n\nExposures\\_Earned 58,440 67,635 76,561 202,636\n\nLosses 5,149,744 5,782,198 5,494,423 16,426,365\n\nDCCE 199,307 75,476 44,922 319,705\n\nLoss\\_Devt 1.024 1.108 1.274\n\nDCCE\\_Devt 1.242 3.347 8.436\n\nLoss\\_Trend 1.164 1.123 1.084 3.6%\n\nDCCE\\_Trend 1.164 1.123 1.084 3.6%\n\nCAT\\_Adj 1.052 1.052 1.052\n\nAnc\\_Income 23,860 27,171 29,802 80,833\n\nCredibility 100.0%\n\nExpRatio\\_Excluded 0.2%\n\nFIT\\_Inv 16.0%\n\nYield 2.5%\n\n**CDI Parameters** FIT\\_UW 21.0%\n\nEffStd\\_Final **_Data as of: 2017_** 41\\.0%\n\nLevFact\\_Final **_Data as of: 2017_** 1\\.03\n\nPremTaxRate 2.4%\n\nSurplusRatio 0.97\n\nResRatio\\_UPR **_Data as of: 2017_** 0\\.51\n\nResRatio\\_Loss **_Data as of: 2017_** 0\\.54\n\nROR\\_RiskFree **_Data as of: May 2019_** 2\\.5%\n\nROR\\_Min -6.0%\n\nROR\\_Max 8.5%\n\n**Calculations 20171 20181 20191**\n\nPrem\\_Adjusted 9,449,602 10,871,750 12,382,004 32,703,356\n\nLosses\\_Adjusted 6,457,350 7,568,821 7,982,456 22,008,627\n\nDCCE\\_Adjusted 303,119 298,442 432,156 1,033,717\n\nLossDCCERatio\\_Adjusted 71.5% 72.4% 68.0% 70.5%\n\nTCRLP\\_perExp 161.70 160.74 161.73 161.39\n\nLossDCCE\\_perExp 115.68 116.32 109.91 113.71\n\nCompLossDCCE\\_perExp 87.55 87.04 87.57 87.39\n\nCredLoss\\_perExp 115.68 116.32 109.91 113.71\n\nAnc\\_Inc\\_perExp 0.41 0.40 0.39 0.40\n\nInvInc\\_Fixed 1.4%\n\nInvInc\\_Variable 3.9%\n\nNet\\_AnnualTrend 3.3%\n\nComp\\_Trend 1.3%\n\nMax\\_Profit 10.4%\n\nMin\\_Profit -7.4%\n\nUW\\_Profit 5.6%\n\nMin\\_Denom 0.70\n\nMax\\_Denom 0.52\n\nMin\\_Premium $158.92\n\nMax\\_Premium $212.88\n\n**CHANGE\\_AT\\_MIN -1.5%**\n\n**CHANGE\\_AT\\_MAX 31.9%**\n\nPrior Approval Rate Template Page 7.2 04/30/2019 Edition","pages":[{"line_numbers":[],"markdown":"**State of California Company: California Automobile Insurance Company**\n\n**Department of Insurance (CDI) Line: Homeowners Multiple Peril**\n\n**CDI File # (Department Use Only):**\n\n**VARIANCE - NONE**\n\n### **RATE CHANGE CALCULATION**\n\nCompleted by: Bryan Wright\n\nDate Completed: 6/20/2019\n\nPrior Effective Date: 8/13/2019\n\nProposed Effective Date: 1/1/2020\n\nDetailed Line Description: Homeowners Multiple Peril\n\nCoverage: HO4\n\n**Data Provided by Filer 20171 20181 20191 Projected**\n\nPrem\\_Written 10,779,981 11,673,914 12,876,465 35,330,360\n\nPrem\\_Earned 9,814,481 11,176,518 12,258,723 33,249,722\n\nPrem\\_Adj 0.943 0.956 0.996\n\nPrem\\_Trend 1.013 1.010 1.007 0.3%\n\nMisc\\_Fees 74,231 80,151 86,848 241,230\n\nExposures\\_Earned 58,440 67,635 76,561 202,636\n\nLosses 5,149,744 5,782,198 5,494,423 16,426,365\n\nDCCE 199,307 75,476 44,922 319,705\n\nLoss\\_Devt 1.024 1.108 1.274\n\nDCCE\\_Devt 1.242 3.347 8.436\n\nLoss\\_Trend 1.164 1.123 1.084 3.6%\n\nDCCE\\_Trend 1.164 1.123 1.084 3.6%\n\nCAT\\_Adj 1.052 1.052 1.052\n\nAnc\\_Income 23,860 27,171 29,802 80,833\n\nCredibility 100.0%\n\nExpRatio\\_Excluded 0.2%\n\nFIT\\_Inv 16.0%\n\nYield 2.5%\n\n**CDI Parameters** FIT\\_UW 21.0%\n\nEffStd\\_Final **_Data as of: 2017_** 41\\.0%\n\nLevFact\\_Final **_Data as of: 2017_** 1\\.03\n\nPremTaxRate 2.4%\n\nSurplusRatio 0.97\n\nResRatio\\_UPR **_Data as of: 2017_** 0\\.51\n\nResRatio\\_Loss **_Data as of: 2017_** 0\\.54\n\nROR\\_RiskFree **_Data as of: May 2019_** 2\\.5%\n\nROR\\_Min -6.0%\n\nROR\\_Max 8.5%\n\n**Calculations 20171 20181 20191**\n\nPrem\\_Adjusted 9,449,602 10,871,750 12,382,004 32,703,356\n\nLosses\\_Adjusted 6,457,350 7,568,821 7,982,456 22,008,627\n\nDCCE\\_Adjusted 303,119 298,442 432,156 1,033,717\n\nLossDCCERatio\\_Adjusted 71.5% 72.4% 68.0% 70.5%\n\nTCRLP\\_perExp 161.70 160.74 161.73 161.39\n\nLossDCCE\\_perExp 115.68 116.32 109.91 113.71\n\nCompLossDCCE\\_perExp 87.55 87.04 87.57 87.39\n\nCredLoss\\_perExp 115.68 116.32 109.91 113.71\n\nAnc\\_Inc\\_perExp 0.41 0.40 0.39 0.40\n\nInvInc\\_Fixed 1.4%\n\nInvInc\\_Variable 3.9%\n\nNet\\_AnnualTrend 3.3%\n\nComp\\_Trend 1.3%\n\nMax\\_Profit 10.4%\n\nMin\\_Profit -7.4%\n\nUW\\_Profit 5.6%\n\nMin\\_Denom 0.70\n\nMax\\_Denom 0.52\n\nMin\\_Premium $158.92\n\nMax\\_Premium $212.88\n\n**CHANGE\\_AT\\_MIN -1.5%**\n\n**CHANGE\\_AT\\_MAX 31.9%**\n\nPrior Approval Rate Template Page 7.2 04/30/2019 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**State of California Company: California Automobile Insurance Company**\n\n**Department of Insurance (CDI) Line: Homeowners Multiple Peril**\n\n**CDI File # (Department Use Only):**\n\n**VARIANCE - NONE**\n\n### **RATE CHANGE CALCULATION**\n\nCompleted by: Bryan Wright\n\nDate Completed: 6/20/2019\n\nPrior Effective Date: 8/13/2019\n\nProposed Effective Date: 1/1/2020\n\nDetailed Line Description: Homeowners Multiple Peril\n\nCoverage: HO4\n\n**Data Provided by Filer 20171 20181 20191 Projected**\n\nPrem\\_Written 10,779,981 11,673,914 12,876,465 35,330,360\n\nPrem\\_Earned 9,814,481 11,176,518 12,258,723 33,249,722\n\nPrem\\_Adj 0.943 0.956 0.996\n\nPrem\\_Trend 1.013 1.010 1.007 0.3%\n\nMisc\\_Fees 74,231 80,151 86,848 241,230\n\nExposures\\_Earned 58,440 67,635 76,561 202,636\n\nLosses 5,149,744 5,782,198 5,494,423 16,426,365\n\nDCCE 199,307 75,476 44,922 319,705\n\nLoss\\_Devt 1.024 1.108 1.274\n\nDCCE\\_Devt 1.242 3.347 8.436\n\nLoss\\_Trend 1.164 1.123 1.084 3.6%\n\nDCCE\\_Trend 1.164 1.123 1.084 3.6%\n\nCAT\\_Adj 1.052 1.052 1.052\n\nAnc\\_Income 23,860 27,171 29,802 80,833\n\nCredibility 100.0%\n\nExpRatio\\_Excluded 0.2%\n\nFIT\\_Inv 16.0%\n\nYield 2.5%\n\n**CDI Parameters** FIT\\_UW 21.0%\n\nEffStd\\_Final **_Data as of: 2017_** 41\\.0%\n\nLevFact\\_Final **_Data as of: 2017_** 1\\.03\n\nPremTaxRate 2.4%\n\nSurplusRatio 0.97\n\nResRatio\\_UPR **_Data as of: 2017_** 0\\.51\n\nResRatio\\_Loss **_Data as of: 2017_** 0\\.54\n\nROR\\_RiskFree **_Data as of: May 2019_** 2\\.5%\n\nROR\\_Min -6.0%\n\nROR\\_Max 8.5%\n\n**Calculations 20171 20181 20191**\n\nPrem\\_Adjusted 9,449,602 10,871,750 12,382,004 32,703,356\n\nLosses\\_Adjusted 6,457,350 7,568,821 7,982,456 22,008,627\n\nDCCE\\_Adjusted 303,119 298,442 432,156 1,033,717\n\nLossDCCERatio\\_Adjusted 71.5% 72.4% 68.0% 70.5%\n\nTCRLP\\_perExp 161.70 160.74 161.73 161.39\n\nLossDCCE\\_perExp 115.68 116.32 109.91 113.71\n\nCompLossDCCE\\_perExp 87.55 87.04 87.57 87.39\n\nCredLoss\\_perExp 115.68 116.32 109.91 113.71\n\nAnc\\_Inc\\_perExp 0.41 0.40 0.39 0.40\n\nInvInc\\_Fixed 1.4%\n\nInvInc\\_Variable 3.9%\n\nNet\\_AnnualTrend 3.3%\n\nComp\\_Trend 1.3%\n\nMax\\_Profit 10.4%\n\nMin\\_Profit -7.4%\n\nUW\\_Profit 5.6%\n\nMin\\_Denom 0.70\n\nMax\\_Denom 0.52\n\nMin\\_Premium $158.92\n\nMax\\_Premium $212.88\n\n**CHANGE\\_AT\\_MIN -1.5%**\n\n**CHANGE\\_AT\\_MAX 31.9%**\n\nPrior Approval Rate Template Page 7.2 04/30/2019 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2029.pdf"]},"response":{"errors":[],"extract_id":"extract_513a36e15f9e6436f892285f23b10822","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**State of California Company: California Automobile Insurance Company**\n\n**Department of Insurance (CDI) Line: Homeowners Multiple Peril**\n\n**CDI File # (Department Use Only):**\n\n**VARIANCE - NONE**\n\n### **RATE CHANGE CALCULATION**\n\nCompleted by: Bryan Wright\n\nDate Completed: 6/20/2019\n\nPrior Effective Date: 8/13/2019\n\nProposed Effective Date: 1/1/2020\n\nDetailed Line Description: Homeowners Multiple Peril\n\nCoverage: HO4\n\n**Data Provided by Filer 20171 20181 20191 Projected**\n\nPrem\\_Written 10,779,981 11,673,914 12,876,465 35,330,360\n\nPrem\\_Earned 9,814,481 11,176,518 12,258,723 33,249,722\n\nPrem\\_Adj 0.943 0.956 0.996\n\nPrem\\_Trend 1.013 1.010 1.007 0.3%\n\nMisc\\_Fees 74,231 80,151 86,848 241,230\n\nExposures\\_Earned 58,440 67,635 76,561 202,636\n\nLosses 5,149,744 5,782,198 5,494,423 16,426,365\n\nDCCE 199,307 75,476 44,922 319,705\n\nLoss\\_Devt 1.024 1.108 1.274\n\nDCCE\\_Devt 1.242 3.347 8.436\n\nLoss\\_Trend 1.164 1.123 1.084 3.6%\n\nDCCE\\_Trend 1.164 1.123 1.084 3.6%\n\nCAT\\_Adj 1.052 1.052 1.052\n\nAnc\\_Income 23,860 27,171 29,802 80,833\n\nCredibility 100.0%\n\nExpRatio\\_Excluded 0.2%\n\nFIT\\_Inv 16.0%\n\nYield 2.5%\n\n**CDI Parameters** FIT\\_UW 21.0%\n\nEffStd\\_Final **_Data as of: 2017_** 41\\.0%\n\nLevFact\\_Final **_Data as of: 2017_** 1\\.03\n\nPremTaxRate 2.4%\n\nSurplusRatio 0.97\n\nResRatio\\_UPR **_Data as of: 2017_** 0\\.51\n\nResRatio\\_Loss **_Data as of: 2017_** 0\\.54\n\nROR\\_RiskFree **_Data as of: May 2019_** 2\\.5%\n\nROR\\_Min -6.0%\n\nROR\\_Max 8.5%\n\n**Calculations 20171 20181 20191**\n\nPrem\\_Adjusted 9,449,602 10,871,750 12,382,004 32,703,356\n\nLosses\\_Adjusted 6,457,350 7,568,821 7,982,456 22,008,627\n\nDCCE\\_Adjusted 303,119 298,442 432,156 1,033,717\n\nLossDCCERatio\\_Adjusted 71.5% 72.4% 68.0% 70.5%\n\nTCRLP\\_perExp 161.70 160.74 161.73 161.39\n\nLossDCCE\\_perExp 115.68 116.32 109.91 113.71\n\nCompLossDCCE\\_perExp 87.55 87.04 87.57 87.39\n\nCredLoss\\_perExp 115.68 116.32 109.91 113.71\n\nAnc\\_Inc\\_perExp 0.41 0.40 0.39 0.40\n\nInvInc\\_Fixed 1.4%\n\nInvInc\\_Variable 3.9%\n\nNet\\_AnnualTrend 3.3%\n\nComp\\_Trend 1.3%\n\nMax\\_Profit 10.4%\n\nMin\\_Profit -7.4%\n\nUW\\_Profit 5.6%\n\nMin\\_Denom 0.70\n\nMax\\_Denom 0.52\n\nMin\\_Premium $158.92\n\nMax\\_Premium $212.88\n\n**CHANGE\\_AT\\_MIN -1.5%**\n\n**CHANGE\\_AT\\_MAX 31.9%**\n\nPrior Approval Rate Template Page 7.2 04/30/2019 Edition"],"full_content":"**State of California Company: California Automobile Insurance Company**\n\n**Department of Insurance (CDI) Line: Homeowners Multiple Peril**\n\n**CDI File # (Department Use Only):**\n\n**VARIANCE - NONE**\n\n### **RATE CHANGE CALCULATION**\n\nCompleted by: Bryan Wright\n\nDate Completed: 6/20/2019\n\nPrior Effective Date: 8/13/2019\n\nProposed Effective Date: 1/1/2020\n\nDetailed Line Description: Homeowners Multiple Peril\n\nCoverage: HO4\n\n**Data Provided by Filer 20171 20181 20191 Projected**\n\nPrem\\_Written 10,779,981 11,673,914 12,876,465 35,330,360\n\nPrem\\_Earned 9,814,481 11,176,518 12,258,723 33,249,722\n\nPrem\\_Adj 0.943 0.956 0.996\n\nPrem\\_Trend 1.013 1.010 1.007 0.3%\n\nMisc\\_Fees 74,231 80,151 86,848 241,230\n\nExposures\\_Earned 58,440 67,635 76,561 202,636\n\nLosses 5,149,744 5,782,198 5,494,423 16,426,365\n\nDCCE 199,307 75,476 44,922 319,705\n\nLoss\\_Devt 1.024 1.108 1.274\n\nDCCE\\_Devt 1.242 3.347 8.436\n\nLoss\\_Trend 1.164 1.123 1.084 3.6%\n\nDCCE\\_Trend 1.164 1.123 1.084 3.6%\n\nCAT\\_Adj 1.052 1.052 1.052\n\nAnc\\_Income 23,860 27,171 29,802 80,833\n\nCredibility 100.0%\n\nExpRatio\\_Excluded 0.2%\n\nFIT\\_Inv 16.0%\n\nYield 2.5%\n\n**CDI Parameters** FIT\\_UW 21.0%\n\nEffStd\\_Final **_Data as of: 2017_** 41\\.0%\n\nLevFact\\_Final **_Data as of: 2017_** 1\\.03\n\nPremTaxRate 2.4%\n\nSurplusRatio 0.97\n\nResRatio\\_UPR **_Data as of: 2017_** 0\\.51\n\nResRatio\\_Loss **_Data as of: 2017_** 0\\.54\n\nROR\\_RiskFree **_Data as of: May 2019_** 2\\.5%\n\nROR\\_Min -6.0%\n\nROR\\_Max 8.5%\n\n**Calculations 20171 20181 20191**\n\nPrem\\_Adjusted 9,449,602 10,871,750 12,382,004 32,703,356\n\nLosses\\_Adjusted 6,457,350 7,568,821 7,982,456 22,008,627\n\nDCCE\\_Adjusted 303,119 298,442 432,156 1,033,717\n\nLossDCCERatio\\_Adjusted 71.5% 72.4% 68.0% 70.5%\n\nTCRLP\\_perExp 161.70 160.74 161.73 161.39\n\nLossDCCE\\_perExp 115.68 116.32 109.91 113.71\n\nCompLossDCCE\\_perExp 87.55 87.04 87.57 87.39\n\nCredLoss\\_perExp 115.68 116.32 109.91 113.71\n\nAnc\\_Inc\\_perExp 0.41 0.40 0.39 0.40\n\nInvInc\\_Fixed 1.4%\n\nInvInc\\_Variable 3.9%\n\nNet\\_AnnualTrend 3.3%\n\nComp\\_Trend 1.3%\n\nMax\\_Profit 10.4%\n\nMin\\_Profit -7.4%\n\nUW\\_Profit 5.6%\n\nMin\\_Denom 0.70\n\nMax\\_Denom 0.52\n\nMin\\_Premium $158.92\n\nMax\\_Premium $212.88\n\n**CHANGE\\_AT\\_MIN -1.5%**\n\n**CHANGE\\_AT\\_MAX 31.9%**\n\nPrior Approval Rate Template Page 7.2 04/30/2019 Edition","publish_date":null,"title":"RATE CHANGE CALCULATION","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2029.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2029.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2029","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2029.pdf"},"started_at":"2026-11-04T19:48:10.022133"} +{"completed_at":"2026-11-04T19:31:06.712074","latency_in_ms":1987,"output":{"example_id":"table/SERFF_CA_random_pages 1_page204","grounded_pages":[],"layout_pages":[],"markdown":"COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE AND ALLIED LINES LOSS COST MULTIPLIER All Loss Costs shall be adjusted by the applicable Loss Cost Multiplier. The Loss Cost Multiplier shall apply before all applicable manual factors such as the coinsurance credit, the deductible, and the package credit factor. This multiplier shall apply only to Loss Costs, not to rates, premiums, or minimum premium charges. The Loss Costs applicable to this division shall be multiplied by the following Loss Cost Multiplier:\n\nCoverage Loss Cost Multiplier\n\nAll applicable coverage 2.198\n\nNOTE: Before applying multiplier, make sure the coverage being rated is based on Loss Costs and not rates or premiums. Do not apply multiplier to any coverage that shows rates or premiums (i.e. Equipment Breakdown, Water Damage, etc.). The loss costs, premiums and additional charges applicable to this division shall apply. ALLSTATE INSURANCE COMPANY CA-CP-LOSS-1 04/01/22","pages":[{"line_numbers":[],"markdown":"COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE AND ALLIED LINES LOSS COST MULTIPLIER All Loss Costs shall be adjusted by the applicable Loss Cost Multiplier. The Loss Cost Multiplier shall apply before all applicable manual factors such as the coinsurance credit, the deductible, and the package credit factor. This multiplier shall apply only to Loss Costs, not to rates, premiums, or minimum premium charges. The Loss Costs applicable to this division shall be multiplied by the following Loss Cost Multiplier:\n\nCoverage Loss Cost Multiplier\n\nAll applicable coverage 2.198\n\nNOTE: Before applying multiplier, make sure the coverage being rated is based on Loss Costs and not rates or premiums. Do not apply multiplier to any coverage that shows rates or premiums (i.e. Equipment Breakdown, Water Damage, etc.). The loss costs, premiums and additional charges applicable to this division shall apply. ALLSTATE INSURANCE COMPANY CA-CP-LOSS-1 04/01/22","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE AND ALLIED LINES LOSS COST MULTIPLIER All Loss Costs shall be adjusted by the applicable Loss Cost Multiplier. The Loss Cost Multiplier shall apply before all applicable manual factors such as the coinsurance credit, the deductible, and the package credit factor. This multiplier shall apply only to Loss Costs, not to rates, premiums, or minimum premium charges. The Loss Costs applicable to this division shall be multiplied by the following Loss Cost Multiplier:\n\nCoverage Loss Cost Multiplier\n\nAll applicable coverage 2.198\n\nNOTE: Before applying multiplier, make sure the coverage being rated is based on Loss Costs and not rates or premiums. Do not apply multiplier to any coverage that shows rates or premiums (i.e. Equipment Breakdown, Water Damage, etc.). The loss costs, premiums and additional charges applicable to this division shall apply. ALLSTATE INSURANCE COMPANY CA-CP-LOSS-1 04/01/22","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page204.pdf"]},"response":{"errors":[],"extract_id":"extract_3a78cf37abfd43520046056b04161afe","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE AND ALLIED LINES LOSS COST MULTIPLIER All Loss Costs shall be adjusted by the applicable Loss Cost Multiplier. The Loss Cost Multiplier shall apply before all applicable manual factors such as the coinsurance credit, the deductible, and the package credit factor. This multiplier shall apply only to Loss Costs, not to rates, premiums, or minimum premium charges. The Loss Costs applicable to this division shall be multiplied by the following Loss Cost Multiplier:\n\nCoverage Loss Cost Multiplier\n\nAll applicable coverage 2.198\n\nNOTE: Before applying multiplier, make sure the coverage being rated is based on Loss Costs and not rates or premiums. Do not apply multiplier to any coverage that shows rates or premiums (i.e. Equipment Breakdown, Water Damage, etc.). The loss costs, premiums and additional charges applicable to this division shall apply. ALLSTATE INSURANCE COMPANY CA-CP-LOSS-1 04/01/22"],"full_content":"COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE AND ALLIED LINES LOSS COST MULTIPLIER All Loss Costs shall be adjusted by the applicable Loss Cost Multiplier. The Loss Cost Multiplier shall apply before all applicable manual factors such as the coinsurance credit, the deductible, and the package credit factor. This multiplier shall apply only to Loss Costs, not to rates, premiums, or minimum premium charges. The Loss Costs applicable to this division shall be multiplied by the following Loss Cost Multiplier:\n\nCoverage Loss Cost Multiplier\n\nAll applicable coverage 2.198\n\nNOTE: Before applying multiplier, make sure the coverage being rated is based on Loss Costs and not rates or premiums. Do not apply multiplier to any coverage that shows rates or premiums (i.e. Equipment Breakdown, Water Damage, etc.). The loss costs, premiums and additional charges applicable to this division shall apply. ALLSTATE INSURANCE COMPANY CA-CP-LOSS-1 04/01/22","publish_date":null,"title":"COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page204.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page204.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page204","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page204.pdf"},"started_at":"2026-11-04T19:31:04.724615"} +{"completed_at":"2026-11-04T19:48:14.884082","latency_in_ms":2302,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2069","grounded_pages":[],"layout_pages":[],"markdown":"**_California Automobile Insurance Company Exhibit 12 - Rate Manual (Proposed) California Automobile Insurance Company Exhibit 12 - Rate Manual (Current)_**\n\n**Symbols Symbols**\n\nModel Year Symbol Code BI PD UMBI MP COMP COLL Model Year Symbol Code BI PD UMBI MP COMP COLL\n\n1998 BUPAXX 0.924 0.863 0.921 0.985 0.728 0.961 1998 BUPAXX 0.924 0.863 0.921 0.985 0.728 0.961\n\n1999 BUPAXX 0.930 0.888 0.927 0.988 0.783 0.952 1999 BUPAXX 0.930 0.888 0.927 0.988 0.783 0.952\n\n2000 BUPAXX 0.937 0.906 0.934 1.001 0.833 0.908 2000 BUPAXX 0.937 0.906 0.934 1.001 0.833 0.908\n\n2001 BUPAXX 0.944 0.929 0.941 1.007 0.883 0.908 2001 BUPAXX 0.944 0.929 0.941 1.007 0.883 0.908\n\n2002 BUPAXX 0.953 0.900 0.950 1.019 0.856 0.901 2002 BUPAXX 0.953 0.900 0.950 1.019 0.856 0.901\n\n2003 BUPAXX 0.958 0.905 0.955 1.036 0.886 0.984 2003 BUPAXX 0.958 0.905 0.955 1.036 0.886 0.984\n\n2004 BUPAXX 0.962 0.910 0.959 1.047 0.905 1.067 2004 BUPAXX 0.962 0.910 0.959 1.047 0.905 1.067\n\n2005 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2005 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2006 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2006 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2007 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2007 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2008 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2008 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2009 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2009 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2010 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2010 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2011 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2011 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2012-2025 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2012-2025 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2004 BURA56 0.987 0.985 0.834 0.897 0.678 0.891 2004 BURA56 0.987 0.985 0.834 0.897 0.678 0.891\n\n2005 BURA56 0.999 0.986 0.834 0.899 0.675 0.898 2005 BURA56 0.999 0.986 0.834 0.899 0.675 0.898\n\n2006 BURA56 1.000 0.994 0.832 0.899 0.677 0.910 2006 BURA56 1.000 0.994 0.832 0.899 0.677 0.910\n\n2007 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2007 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2008 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2008 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2009 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2009 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2010 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2010 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2011 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2011 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2012-2025 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2012-2025 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2004 BURA58 1.047 0.979 0.899 0.824 0.741 0.951 2004 BURA58 1.047 0.979 0.899 0.824 0.741 0.951\n\n2005 BURA58 1.051 0.981 0.896 0.824 0.736 0.962 2005 BURA58 1.051 0.981 0.896 0.824 0.736 0.962\n\n2006 BURA58 1.052 0.977 0.896 0.824 0.737 0.967 2006 BURA58 1.052 0.977 0.896 0.824 0.737 0.967\n\n2007 BURA58 1.058 0.975 0.899 0.822 0.732 0.985 2007 BURA58 1.058 0.975 0.899 0.822 0.732 0.985\n\n2008 BURA58 1.058 0.975 0.899 0.822 0.732 0.985 2008 BURA58 1.058 0.975 0.899 0.822 0.732 0.985\n\n2009 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2009 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2010 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2010 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2011 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2011 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2012-2025 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2012-2025 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2004 BURA5K 0.920 1.020 0.791 0.874 0.828 0.897 2004 BURA5K 0.920 1.020 0.791 0.874 0.828 0.897\n\n2005 BURA5K 0.926 1.020 0.791 0.875 0.828 0.902 2005 BURA5K 0.926 1.020 0.791 0.875 0.828 0.902\n\n2006 BURA5K 0.930 1.022 0.780 0.876 0.842 0.941 2006 BURA5K 0.930 1.022 0.780 0.876 0.842 0.941\n\n2007 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2007 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2008 BURA5K 0.930 1.022 0.769 0.878 0.854 0.971 2008 BURA5K 0.930 1.022 0.769 0.878 0.854 0.971\n\n2009 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2009 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2010 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2010 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2011 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2011 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2012-2025 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2012-2025 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2004 BURA5L 0.975 0.996 0.851 0.804 0.745 0.959 2004 BURA5L 0.975 0.996 0.851 0.804 0.745 0.959\n\n2005 BURA5L 0.980 0.996 0.847 0.805 0.752 0.973 2005 BURA5L 0.980 0.996 0.847 0.805 0.752 0.973\n\n2006 BURA5L 0.983 0.996 0.845 0.806 0.752 0.984 2006 BURA5L 0.983 0.996 0.845 0.806 0.752 0.984\n\n2007 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2007 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2008 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2008 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2009 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2009 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2010 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2010 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2011 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2011 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020","pages":[{"line_numbers":[],"markdown":"**_California Automobile Insurance Company Exhibit 12 - Rate Manual (Proposed) California Automobile Insurance Company Exhibit 12 - Rate Manual (Current)_**\n\n**Symbols Symbols**\n\nModel Year Symbol Code BI PD UMBI MP COMP COLL Model Year Symbol Code BI PD UMBI MP COMP COLL\n\n1998 BUPAXX 0.924 0.863 0.921 0.985 0.728 0.961 1998 BUPAXX 0.924 0.863 0.921 0.985 0.728 0.961\n\n1999 BUPAXX 0.930 0.888 0.927 0.988 0.783 0.952 1999 BUPAXX 0.930 0.888 0.927 0.988 0.783 0.952\n\n2000 BUPAXX 0.937 0.906 0.934 1.001 0.833 0.908 2000 BUPAXX 0.937 0.906 0.934 1.001 0.833 0.908\n\n2001 BUPAXX 0.944 0.929 0.941 1.007 0.883 0.908 2001 BUPAXX 0.944 0.929 0.941 1.007 0.883 0.908\n\n2002 BUPAXX 0.953 0.900 0.950 1.019 0.856 0.901 2002 BUPAXX 0.953 0.900 0.950 1.019 0.856 0.901\n\n2003 BUPAXX 0.958 0.905 0.955 1.036 0.886 0.984 2003 BUPAXX 0.958 0.905 0.955 1.036 0.886 0.984\n\n2004 BUPAXX 0.962 0.910 0.959 1.047 0.905 1.067 2004 BUPAXX 0.962 0.910 0.959 1.047 0.905 1.067\n\n2005 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2005 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2006 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2006 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2007 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2007 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2008 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2008 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2009 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2009 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2010 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2010 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2011 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2011 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2012-2025 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2012-2025 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2004 BURA56 0.987 0.985 0.834 0.897 0.678 0.891 2004 BURA56 0.987 0.985 0.834 0.897 0.678 0.891\n\n2005 BURA56 0.999 0.986 0.834 0.899 0.675 0.898 2005 BURA56 0.999 0.986 0.834 0.899 0.675 0.898\n\n2006 BURA56 1.000 0.994 0.832 0.899 0.677 0.910 2006 BURA56 1.000 0.994 0.832 0.899 0.677 0.910\n\n2007 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2007 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2008 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2008 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2009 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2009 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2010 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2010 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2011 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2011 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2012-2025 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2012-2025 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2004 BURA58 1.047 0.979 0.899 0.824 0.741 0.951 2004 BURA58 1.047 0.979 0.899 0.824 0.741 0.951\n\n2005 BURA58 1.051 0.981 0.896 0.824 0.736 0.962 2005 BURA58 1.051 0.981 0.896 0.824 0.736 0.962\n\n2006 BURA58 1.052 0.977 0.896 0.824 0.737 0.967 2006 BURA58 1.052 0.977 0.896 0.824 0.737 0.967\n\n2007 BURA58 1.058 0.975 0.899 0.822 0.732 0.985 2007 BURA58 1.058 0.975 0.899 0.822 0.732 0.985\n\n2008 BURA58 1.058 0.975 0.899 0.822 0.732 0.985 2008 BURA58 1.058 0.975 0.899 0.822 0.732 0.985\n\n2009 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2009 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2010 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2010 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2011 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2011 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2012-2025 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2012-2025 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2004 BURA5K 0.920 1.020 0.791 0.874 0.828 0.897 2004 BURA5K 0.920 1.020 0.791 0.874 0.828 0.897\n\n2005 BURA5K 0.926 1.020 0.791 0.875 0.828 0.902 2005 BURA5K 0.926 1.020 0.791 0.875 0.828 0.902\n\n2006 BURA5K 0.930 1.022 0.780 0.876 0.842 0.941 2006 BURA5K 0.930 1.022 0.780 0.876 0.842 0.941\n\n2007 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2007 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2008 BURA5K 0.930 1.022 0.769 0.878 0.854 0.971 2008 BURA5K 0.930 1.022 0.769 0.878 0.854 0.971\n\n2009 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2009 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2010 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2010 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2011 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2011 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2012-2025 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2012-2025 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2004 BURA5L 0.975 0.996 0.851 0.804 0.745 0.959 2004 BURA5L 0.975 0.996 0.851 0.804 0.745 0.959\n\n2005 BURA5L 0.980 0.996 0.847 0.805 0.752 0.973 2005 BURA5L 0.980 0.996 0.847 0.805 0.752 0.973\n\n2006 BURA5L 0.983 0.996 0.845 0.806 0.752 0.984 2006 BURA5L 0.983 0.996 0.845 0.806 0.752 0.984\n\n2007 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2007 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2008 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2008 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2009 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2009 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2010 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2010 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2011 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2011 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**_California Automobile Insurance Company Exhibit 12 - Rate Manual (Proposed) California Automobile Insurance Company Exhibit 12 - Rate Manual (Current)_**\n\n**Symbols Symbols**\n\nModel Year Symbol Code BI PD UMBI MP COMP COLL Model Year Symbol Code BI PD UMBI MP COMP COLL\n\n1998 BUPAXX 0.924 0.863 0.921 0.985 0.728 0.961 1998 BUPAXX 0.924 0.863 0.921 0.985 0.728 0.961\n\n1999 BUPAXX 0.930 0.888 0.927 0.988 0.783 0.952 1999 BUPAXX 0.930 0.888 0.927 0.988 0.783 0.952\n\n2000 BUPAXX 0.937 0.906 0.934 1.001 0.833 0.908 2000 BUPAXX 0.937 0.906 0.934 1.001 0.833 0.908\n\n2001 BUPAXX 0.944 0.929 0.941 1.007 0.883 0.908 2001 BUPAXX 0.944 0.929 0.941 1.007 0.883 0.908\n\n2002 BUPAXX 0.953 0.900 0.950 1.019 0.856 0.901 2002 BUPAXX 0.953 0.900 0.950 1.019 0.856 0.901\n\n2003 BUPAXX 0.958 0.905 0.955 1.036 0.886 0.984 2003 BUPAXX 0.958 0.905 0.955 1.036 0.886 0.984\n\n2004 BUPAXX 0.962 0.910 0.959 1.047 0.905 1.067 2004 BUPAXX 0.962 0.910 0.959 1.047 0.905 1.067\n\n2005 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2005 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2006 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2006 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2007 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2007 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2008 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2008 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2009 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2009 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2010 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2010 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2011 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2011 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2012-2025 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2012-2025 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2004 BURA56 0.987 0.985 0.834 0.897 0.678 0.891 2004 BURA56 0.987 0.985 0.834 0.897 0.678 0.891\n\n2005 BURA56 0.999 0.986 0.834 0.899 0.675 0.898 2005 BURA56 0.999 0.986 0.834 0.899 0.675 0.898\n\n2006 BURA56 1.000 0.994 0.832 0.899 0.677 0.910 2006 BURA56 1.000 0.994 0.832 0.899 0.677 0.910\n\n2007 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2007 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2008 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2008 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2009 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2009 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2010 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2010 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2011 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2011 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2012-2025 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2012-2025 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2004 BURA58 1.047 0.979 0.899 0.824 0.741 0.951 2004 BURA58 1.047 0.979 0.899 0.824 0.741 0.951\n\n2005 BURA58 1.051 0.981 0.896 0.824 0.736 0.962 2005 BURA58 1.051 0.981 0.896 0.824 0.736 0.962\n\n2006 BURA58 1.052 0.977 0.896 0.824 0.737 0.967 2006 BURA58 1.052 0.977 0.896 0.824 0.737 0.967\n\n2007 BURA58 1.058 0.975 0.899 0.822 0.732 0.985 2007 BURA58 1.058 0.975 0.899 0.822 0.732 0.985\n\n2008 BURA58 1.058 0.975 0.899 0.822 0.732 0.985 2008 BURA58 1.058 0.975 0.899 0.822 0.732 0.985\n\n2009 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2009 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2010 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2010 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2011 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2011 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2012-2025 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2012-2025 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2004 BURA5K 0.920 1.020 0.791 0.874 0.828 0.897 2004 BURA5K 0.920 1.020 0.791 0.874 0.828 0.897\n\n2005 BURA5K 0.926 1.020 0.791 0.875 0.828 0.902 2005 BURA5K 0.926 1.020 0.791 0.875 0.828 0.902\n\n2006 BURA5K 0.930 1.022 0.780 0.876 0.842 0.941 2006 BURA5K 0.930 1.022 0.780 0.876 0.842 0.941\n\n2007 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2007 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2008 BURA5K 0.930 1.022 0.769 0.878 0.854 0.971 2008 BURA5K 0.930 1.022 0.769 0.878 0.854 0.971\n\n2009 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2009 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2010 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2010 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2011 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2011 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2012-2025 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2012-2025 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2004 BURA5L 0.975 0.996 0.851 0.804 0.745 0.959 2004 BURA5L 0.975 0.996 0.851 0.804 0.745 0.959\n\n2005 BURA5L 0.980 0.996 0.847 0.805 0.752 0.973 2005 BURA5L 0.980 0.996 0.847 0.805 0.752 0.973\n\n2006 BURA5L 0.983 0.996 0.845 0.806 0.752 0.984 2006 BURA5L 0.983 0.996 0.845 0.806 0.752 0.984\n\n2007 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2007 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2008 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2008 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2009 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2009 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2010 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2010 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2011 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2011 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2069.pdf"]},"response":{"errors":[],"extract_id":"extract_268c46a4acd77a8adc219d258655727f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**_California Automobile Insurance Company Exhibit 12 - Rate Manual (Proposed) California Automobile Insurance Company Exhibit 12 - Rate Manual (Current)_**\n\n**Symbols Symbols**\n\nModel Year Symbol Code BI PD UMBI MP COMP COLL Model Year Symbol Code BI PD UMBI MP COMP COLL\n\n1998 BUPAXX 0.924 0.863 0.921 0.985 0.728 0.961 1998 BUPAXX 0.924 0.863 0.921 0.985 0.728 0.961\n\n1999 BUPAXX 0.930 0.888 0.927 0.988 0.783 0.952 1999 BUPAXX 0.930 0.888 0.927 0.988 0.783 0.952\n\n2000 BUPAXX 0.937 0.906 0.934 1.001 0.833 0.908 2000 BUPAXX 0.937 0.906 0.934 1.001 0.833 0.908\n\n2001 BUPAXX 0.944 0.929 0.941 1.007 0.883 0.908 2001 BUPAXX 0.944 0.929 0.941 1.007 0.883 0.908\n\n2002 BUPAXX 0.953 0.900 0.950 1.019 0.856 0.901 2002 BUPAXX 0.953 0.900 0.950 1.019 0.856 0.901\n\n2003 BUPAXX 0.958 0.905 0.955 1.036 0.886 0.984 2003 BUPAXX 0.958 0.905 0.955 1.036 0.886 0.984\n\n2004 BUPAXX 0.962 0.910 0.959 1.047 0.905 1.067 2004 BUPAXX 0.962 0.910 0.959 1.047 0.905 1.067\n\n2005 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2005 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2006 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2006 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2007 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2007 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2008 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2008 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2009 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2009 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2010 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2010 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2011 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2011 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2012-2025 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2012-2025 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2004 BURA56 0.987 0.985 0.834 0.897 0.678 0.891 2004 BURA56 0.987 0.985 0.834 0.897 0.678 0.891\n\n2005 BURA56 0.999 0.986 0.834 0.899 0.675 0.898 2005 BURA56 0.999 0.986 0.834 0.899 0.675 0.898\n\n2006 BURA56 1.000 0.994 0.832 0.899 0.677 0.910 2006 BURA56 1.000 0.994 0.832 0.899 0.677 0.910\n\n2007 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2007 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2008 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2008 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2009 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2009 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2010 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2010 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2011 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2011 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2012-2025 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2012-2025 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2004 BURA58 1.047 0.979 0.899 0.824 0.741 0.951 2004 BURA58 1.047 0.979 0.899 0.824 0.741 0.951\n\n2005 BURA58 1.051 0.981 0.896 0.824 0.736 0.962 2005 BURA58 1.051 0.981 0.896 0.824 0.736 0.962\n\n2006 BURA58 1.052 0.977 0.896 0.824 0.737 0.967 2006 BURA58 1.052 0.977 0.896 0.824 0.737 0.967\n\n2007 BURA58 1.058 0.975 0.899 0.822 0.732 0.985 2007 BURA58 1.058 0.975 0.899 0.822 0.732 0.985\n\n2008 BURA58 1.058 0.975 0.899 0.822 0.732 0.985 2008 BURA58 1.058 0.975 0.899 0.822 0.732 0.985\n\n2009 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2009 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2010 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2010 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2011 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2011 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2012-2025 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2012-2025 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2004 BURA5K 0.920 1.020 0.791 0.874 0.828 0.897 2004 BURA5K 0.920 1.020 0.791 0.874 0.828 0.897\n\n2005 BURA5K 0.926 1.020 0.791 0.875 0.828 0.902 2005 BURA5K 0.926 1.020 0.791 0.875 0.828 0.902\n\n2006 BURA5K 0.930 1.022 0.780 0.876 0.842 0.941 2006 BURA5K 0.930 1.022 0.780 0.876 0.842 0.941\n\n2007 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2007 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2008 BURA5K 0.930 1.022 0.769 0.878 0.854 0.971 2008 BURA5K 0.930 1.022 0.769 0.878 0.854 0.971\n\n2009 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2009 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2010 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2010 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2011 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2011 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2012-2025 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2012-2025 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2004 BURA5L 0.975 0.996 0.851 0.804 0.745 0.959 2004 BURA5L 0.975 0.996 0.851 0.804 0.745 0.959\n\n2005 BURA5L 0.980 0.996 0.847 0.805 0.752 0.973 2005 BURA5L 0.980 0.996 0.847 0.805 0.752 0.973\n\n2006 BURA5L 0.983 0.996 0.845 0.806 0.752 0.984 2006 BURA5L 0.983 0.996 0.845 0.806 0.752 0.984\n\n2007 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2007 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2008 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2008 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2009 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2009 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2010 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2010 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2011 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2011 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020"],"full_content":"**_California Automobile Insurance Company Exhibit 12 - Rate Manual (Proposed) California Automobile Insurance Company Exhibit 12 - Rate Manual (Current)_**\n\n**Symbols Symbols**\n\nModel Year Symbol Code BI PD UMBI MP COMP COLL Model Year Symbol Code BI PD UMBI MP COMP COLL\n\n1998 BUPAXX 0.924 0.863 0.921 0.985 0.728 0.961 1998 BUPAXX 0.924 0.863 0.921 0.985 0.728 0.961\n\n1999 BUPAXX 0.930 0.888 0.927 0.988 0.783 0.952 1999 BUPAXX 0.930 0.888 0.927 0.988 0.783 0.952\n\n2000 BUPAXX 0.937 0.906 0.934 1.001 0.833 0.908 2000 BUPAXX 0.937 0.906 0.934 1.001 0.833 0.908\n\n2001 BUPAXX 0.944 0.929 0.941 1.007 0.883 0.908 2001 BUPAXX 0.944 0.929 0.941 1.007 0.883 0.908\n\n2002 BUPAXX 0.953 0.900 0.950 1.019 0.856 0.901 2002 BUPAXX 0.953 0.900 0.950 1.019 0.856 0.901\n\n2003 BUPAXX 0.958 0.905 0.955 1.036 0.886 0.984 2003 BUPAXX 0.958 0.905 0.955 1.036 0.886 0.984\n\n2004 BUPAXX 0.962 0.910 0.959 1.047 0.905 1.067 2004 BUPAXX 0.962 0.910 0.959 1.047 0.905 1.067\n\n2005 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2005 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2006 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2006 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2007 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2007 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2008 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2008 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2009 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2009 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2010 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2010 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2011 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2011 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2012-2025 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134 2012-2025 BUPAXX 0.962 0.910 0.959 1.057 0.932 1.134\n\n2004 BURA56 0.987 0.985 0.834 0.897 0.678 0.891 2004 BURA56 0.987 0.985 0.834 0.897 0.678 0.891\n\n2005 BURA56 0.999 0.986 0.834 0.899 0.675 0.898 2005 BURA56 0.999 0.986 0.834 0.899 0.675 0.898\n\n2006 BURA56 1.000 0.994 0.832 0.899 0.677 0.910 2006 BURA56 1.000 0.994 0.832 0.899 0.677 0.910\n\n2007 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2007 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2008 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2008 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2009 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2009 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2010 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2010 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2011 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2011 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2012-2025 BURA56 1.001 1.002 0.829 0.901 0.678 0.931 2012-2025 BURA56 1.001 1.002 0.829 0.901 0.678 0.931\n\n2004 BURA58 1.047 0.979 0.899 0.824 0.741 0.951 2004 BURA58 1.047 0.979 0.899 0.824 0.741 0.951\n\n2005 BURA58 1.051 0.981 0.896 0.824 0.736 0.962 2005 BURA58 1.051 0.981 0.896 0.824 0.736 0.962\n\n2006 BURA58 1.052 0.977 0.896 0.824 0.737 0.967 2006 BURA58 1.052 0.977 0.896 0.824 0.737 0.967\n\n2007 BURA58 1.058 0.975 0.899 0.822 0.732 0.985 2007 BURA58 1.058 0.975 0.899 0.822 0.732 0.985\n\n2008 BURA58 1.058 0.975 0.899 0.822 0.732 0.985 2008 BURA58 1.058 0.975 0.899 0.822 0.732 0.985\n\n2009 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2009 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2010 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2010 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2011 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2011 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2012-2025 BURA58 1.047 0.975 0.899 0.822 0.732 0.985 2012-2025 BURA58 1.047 0.975 0.899 0.822 0.732 0.985\n\n2004 BURA5K 0.920 1.020 0.791 0.874 0.828 0.897 2004 BURA5K 0.920 1.020 0.791 0.874 0.828 0.897\n\n2005 BURA5K 0.926 1.020 0.791 0.875 0.828 0.902 2005 BURA5K 0.926 1.020 0.791 0.875 0.828 0.902\n\n2006 BURA5K 0.930 1.022 0.780 0.876 0.842 0.941 2006 BURA5K 0.930 1.022 0.780 0.876 0.842 0.941\n\n2007 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2007 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2008 BURA5K 0.930 1.022 0.769 0.878 0.854 0.971 2008 BURA5K 0.930 1.022 0.769 0.878 0.854 0.971\n\n2009 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2009 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2010 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2010 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2011 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2011 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2012-2025 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971 2012-2025 BURA5K 0.930 1.021 0.769 0.878 0.854 0.971\n\n2004 BURA5L 0.975 0.996 0.851 0.804 0.745 0.959 2004 BURA5L 0.975 0.996 0.851 0.804 0.745 0.959\n\n2005 BURA5L 0.980 0.996 0.847 0.805 0.752 0.973 2005 BURA5L 0.980 0.996 0.847 0.805 0.752 0.973\n\n2006 BURA5L 0.983 0.996 0.845 0.806 0.752 0.984 2006 BURA5L 0.983 0.996 0.845 0.806 0.752 0.984\n\n2007 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2007 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2008 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2008 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2009 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2009 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2010 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2010 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020\n\n2011 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020 2011 BURA5L 0.985 0.987 0.834 0.809 0.764 1.020","publish_date":null,"title":"California Automobile Insurance Company Exhibit 12 - Rate Manual (Proposed) California Automobile Insurance Company Exhibit 12 - Rate Manual (Current)","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2069.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2069.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2069","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2069.pdf"},"started_at":"2026-11-04T19:48:12.581447"} +{"completed_at":"2026-11-04T19:48:14.884756","latency_in_ms":1486,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2104","grounded_pages":[],"layout_pages":[],"markdown":"### **Appendix B2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **LTC-TQ CA 12/00**\n\n**_Premiums to be used only with those_**\n\n**_that have previously elected an inflation decrease option_**\n\n### **Standard Rates per $10 of Nursing Home Daily Benefit - 90 Day Elimination Period**\n\n**Home Health Monthly Benefit at 80% of 30x the Nursing Home Daily Benefit; Residential Care Facility Daily Benefit at 100% of the Nursing Home Daily Benefit**\n\n**4\\.1% Simple Inflation 4.1% Compound Inflation**\n\n**Age** Benefit Period Benefit Period\n\n1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life\n\n18-29 29.79 42.55 52.90 62.10 66.70 70.15 75.90 79.35 38.64 55.20 71.30 85.10 94.30 100.05 106.95 111.55\n\n30 29.79 42.55 52.90 62.10 66.70 70.15 75.90 79.35 38.64 55.20 71.30 85.10 94.30 100.05 106.95 111.55\n\n31 30.59 43.70 54.05 62.10 67.85 71.30 78.20 80.50 39.45 56.35 72.45 86.25 95.45 101.20 108.10 112.70\n\n32 30.59 43.70 55.20 63.25 69.00 72.45 79.35 82.80 39.45 56.35 73.60 87.40 96.60 102.35 110.40 115.00\n\n33 30.59 43.70 56.35 64.40 70.15 73.60 80.50 83.95 40.25 57.50 74.75 87.40 98.90 103.50 111.55 116.15\n\n34 31.40 44.85 56.35 65.55 72.45 74.75 82.80 86.25 41.06 58.65 74.75 88.55 100.05 105.80 112.70 117.30\n\n35 32.20 46.00 57.50 66.70 73.60 75.90 83.95 87.40 41.06 58.65 75.90 89.70 101.20 106.95 113.85 119.60\n\n36 33.01 47.15 58.65 67.85 74.75 78.20 83.95 89.70 41.86 59.80 77.05 90.85 102.35 108.10 116.15 119.60\n\n37 33.01 47.15 59.80 69.00 75.90 79.35 86.25 90.85 42.67 60.95 78.20 92.00 103.50 109.25 117.30 120.75\n\n38 33.81 48.30 60.95 71.30 78.20 80.50 87.40 93.15 43.47 62.10 79.35 93.15 103.50 110.40 118.45 123.05\n\n39 34.62 49.45 60.95 72.45 78.20 82.80 89.70 94.30 43.47 62.10 80.50 94.30 104.65 112.70 120.75 124.20\n\n40 35.42 50.60 62.10 73.60 79.35 83.95 90.85 96.60 44.28 63.25 81.65 95.45 106.95 113.85 121.90 126.50\n\n41 36.23 51.75 63.25 74.75 81.65 86.25 93.15 97.75 45.08 64.40 82.80 97.75 108.10 116.15 123.05 128.80\n\n42 37.03 52.90 64.40 77.05 82.80 87.40 95.45 98.90 45.89 65.55 83.95 98.90 110.40 118.45 125.35 131.10\n\n43 37.84 54.05 66.70 78.20 85.10 89.70 97.75 101.20 46.69 66.70 85.10 101.20 112.70 119.60 127.65 133.40\n\n44 38.64 55.20 67.85 80.50 86.25 90.85 98.90 103.50 47.50 67.85 86.25 102.35 113.85 120.75 129.95 135.70\n\n45 39.45 56.35 69.00 81.65 88.55 93.15 101.20 105.80 48.30 69.00 88.55 104.65 116.15 123.05 132.25 138.00\n\n46 40.25 57.50 70.15 83.95 89.70 94.30 102.35 108.10 49.11 70.15 89.70 106.95 118.45 125.35 135.70 141.45\n\n47 41.06 58.65 72.45 85.10 92.00 95.45 104.65 110.40 50.72 72.45 92.00 109.25 121.90 128.80 138.00 142.60\n\n48 42.67 60.95 73.60 87.40 94.30 97.75 106.95 112.70 51.52 73.60 93.15 111.55 124.20 131.10 141.45 146.05\n\n49 43.47 62.10 75.90 87.40 96.60 100.05 109.25 115.00 53.13 75.90 94.30 112.70 126.50 134.55 143.75 149.50\n\n50 44.28 63.25 77.05 89.70 97.75 102.35 111.55 117.30 53.94 77.05 96.60 115.00 127.65 136.85 146.05 152.95\n\n51 45.89 65.55 79.35 93.15 101.20 105.80 116.15 121.90 55.55 79.35 100.05 118.45 132.25 141.45 150.65 157.55\n\n52 46.69 66.70 82.80 96.60 104.65 110.40 120.75 126.50 57.16 81.65 104.65 121.90 135.70 144.90 155.25 162.15\n\n53 48.30 69.00 86.25 100.05 108.10 113.85 123.05 131.10 59.57 85.10 108.10 125.35 140.30 149.50 161.00 166.75\n\n54 49.91 71.30 87.40 103.50 112.70 117.30 127.65 134.55 61.18 87.40 111.55 129.95 144.90 154.10 165.60 171.35\n\n55 51.52 73.60 90.85 106.95 116.15 121.90 133.40 139.15 63.60 90.85 116.15 133.40 149.50 158.70 170.20 177.10\n\n56 53.13 75.90 96.60 112.70 123.05 129.95 141.45 149.50 66.82 95.45 120.75 140.30 156.40 165.60 180.55 187.45\n\n57 56.35 80.50 102.35 119.60 131.10 138.00 151.80 159.85 70.04 100.05 127.65 148.35 164.45 174.80 189.75 200.10\n\n58 59.57 85.10 108.10 126.50 139.15 147.20 161.00 170.20 74.06 105.80 134.55 157.55 173.65 184.00 201.25 212.75\n\n59 62.79 89.70 113.85 134.55 147.20 156.40 172.50 182.85 77.28 110.40 141.45 165.60 181.70 192.05 212.75 226.55\n\n60 66.01 94.30 120.75 141.45 157.55 166.75 184.00 195.50 80.50 115.00 147.20 174.80 192.05 202.40 226.55 240.35\n\n61 70.84 101.20 129.95 151.80 167.90 178.25 196.65 208.15 86.14 123.05 157.55 186.30 204.70 216.20 241.50 256.45\n\n62 74.87 106.95 138.00 162.15 180.55 192.05 210.45 221.95 91.77 131.10 167.90 196.65 218.50 231.15 257.60 272.55\n\n63 80.50 115.00 148.35 173.65 193.20 204.70 224.25 236.90 98.21 140.30 178.25 209.30 232.30 247.25 274.85 292.10\n\n64 86.14 123.05 158.70 185.15 207.00 219.65 239.20 253.00 103.85 148.35 190.90 221.95 247.25 263.35 293.25 311.65\n\n65 92.58 132.25 169.05 197.80 220.80 235.75 255.30 269.10 111.09 158.70 202.40 235.75 264.50 281.75 313.95 332.35\n\n66 100.63 143.75 184.00 215.05 241.50 257.60 279.45 293.25 119.95 171.35 219.65 254.15 286.35 303.60 339.25 359.95\n\n67 109.48 156.40 200.10 234.60 263.35 280.60 305.90 320.85 129.61 185.15 236.90 274.85 309.35 328.90 365.70 388.70\n\n68 119.14 170.20 216.20 255.30 287.50 307.05 333.50 349.60 140.07 200.10 255.30 297.85 333.50 354.20 395.60 420.90\n\n69 129.61 185.15 234.60 278.30 313.95 335.80 363.40 381.80 150.54 215.05 276.00 322.00 358.80 382.95 427.80 454.25\n\n70 140.88 201.25 256.45 302.45 342.70 366.85 397.90 416.30 163.42 233.45 297.85 348.45 388.70 412.85 462.30 491.05\n\n71 155.37 221.95 282.90 333.50 377.20 404.80 438.15 461.15 178.71 255.30 326.60 381.80 425.50 451.95 504.85 537.05\n\n72 171.47 244.95 311.65 366.85 415.15 445.05 484.15 508.30 195.62 279.45 357.65 417.45 463.45 492.20 552.00 587.65\n\n73 189.18 270.25 343.85 405.95 456.55 488.75 533.60 562.35 213.33 304.75 393.30 457.70 507.15 537.05 602.60 642.85\n\n74 208.50 297.85 379.50 446.20 502.55 538.20 588.80 622.15 233.45 333.50 432.40 500.25 553.15 585.35 657.80 702.65\n\n75 230.23 328.90 418.60 492.20 554.30 591.10 650.90 686.55 255.99 365.70 473.80 547.40 604.90 639.40 718.75 768.20\n\n76 252.77 361.10 458.85 539.35 604.90 645.15 709.55 748.65 279.34 399.05 515.20 596.85 656.65 693.45 780.85 834.90\n\n77 276.92 395.60 503.70 589.95 660.10 702.65 775.10 818.80 305.10 435.85 560.05 649.75 711.85 750.95 848.70 906.20\n\n78 302.68 432.40 552.00 646.30 721.05 764.75 845.25 892.40 332.47 474.95 608.35 708.40 773.95 813.05 920.00 985.55\n\n79 332.47 474.95 603.75 708.40 786.60 833.75 922.30 975.20 363.06 518.65 661.25 771.65 839.50 880.90 999.35 1070.65\n\n80 368.69 526.70 671.60 0.00 0.00 0.00 0.00 0.00 402.50 575.00 733.70 0.00 0.00 0.00 0.00 0.00\n\n81 409.75 585.35 745.20 0.00 0.00 0.00 0.00 0.00 446.78 638.25 814.20 0.00 0.00 0.00 0.00 0.00\n\n82 454.83 649.75 825.70 0.00 0.00 0.00 0.00 0.00 496.69 709.55 905.05 0.00 0.00 0.00 0.00 0.00\n\n83 503.93 719.90 917.70 0.00 0.00 0.00 0.00 0.00 550.62 786.60 1003.95 0.00 0.00 0.00 0.00 0.00\n\n84 560.28 800.40 1018.90 0.00 0.00 0.00 0.00 0.00 611.00 872.85 1114.35 0.00 0.00 0.00 0.00 0.00\n\n85+ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\n\nA 6-month benefit period is also available as a step-down in coverage after issue; the rate for this is 70% of the 1-Yearbenefit period rate","pages":[{"line_numbers":[],"markdown":"### **Appendix B2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **LTC-TQ CA 12/00**\n\n**_Premiums to be used only with those_**\n\n**_that have previously elected an inflation decrease option_**\n\n### **Standard Rates per $10 of Nursing Home Daily Benefit - 90 Day Elimination Period**\n\n**Home Health Monthly Benefit at 80% of 30x the Nursing Home Daily Benefit; Residential Care Facility Daily Benefit at 100% of the Nursing Home Daily Benefit**\n\n**4\\.1% Simple Inflation 4.1% Compound Inflation**\n\n**Age** Benefit Period Benefit Period\n\n1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life\n\n18-29 29.79 42.55 52.90 62.10 66.70 70.15 75.90 79.35 38.64 55.20 71.30 85.10 94.30 100.05 106.95 111.55\n\n30 29.79 42.55 52.90 62.10 66.70 70.15 75.90 79.35 38.64 55.20 71.30 85.10 94.30 100.05 106.95 111.55\n\n31 30.59 43.70 54.05 62.10 67.85 71.30 78.20 80.50 39.45 56.35 72.45 86.25 95.45 101.20 108.10 112.70\n\n32 30.59 43.70 55.20 63.25 69.00 72.45 79.35 82.80 39.45 56.35 73.60 87.40 96.60 102.35 110.40 115.00\n\n33 30.59 43.70 56.35 64.40 70.15 73.60 80.50 83.95 40.25 57.50 74.75 87.40 98.90 103.50 111.55 116.15\n\n34 31.40 44.85 56.35 65.55 72.45 74.75 82.80 86.25 41.06 58.65 74.75 88.55 100.05 105.80 112.70 117.30\n\n35 32.20 46.00 57.50 66.70 73.60 75.90 83.95 87.40 41.06 58.65 75.90 89.70 101.20 106.95 113.85 119.60\n\n36 33.01 47.15 58.65 67.85 74.75 78.20 83.95 89.70 41.86 59.80 77.05 90.85 102.35 108.10 116.15 119.60\n\n37 33.01 47.15 59.80 69.00 75.90 79.35 86.25 90.85 42.67 60.95 78.20 92.00 103.50 109.25 117.30 120.75\n\n38 33.81 48.30 60.95 71.30 78.20 80.50 87.40 93.15 43.47 62.10 79.35 93.15 103.50 110.40 118.45 123.05\n\n39 34.62 49.45 60.95 72.45 78.20 82.80 89.70 94.30 43.47 62.10 80.50 94.30 104.65 112.70 120.75 124.20\n\n40 35.42 50.60 62.10 73.60 79.35 83.95 90.85 96.60 44.28 63.25 81.65 95.45 106.95 113.85 121.90 126.50\n\n41 36.23 51.75 63.25 74.75 81.65 86.25 93.15 97.75 45.08 64.40 82.80 97.75 108.10 116.15 123.05 128.80\n\n42 37.03 52.90 64.40 77.05 82.80 87.40 95.45 98.90 45.89 65.55 83.95 98.90 110.40 118.45 125.35 131.10\n\n43 37.84 54.05 66.70 78.20 85.10 89.70 97.75 101.20 46.69 66.70 85.10 101.20 112.70 119.60 127.65 133.40\n\n44 38.64 55.20 67.85 80.50 86.25 90.85 98.90 103.50 47.50 67.85 86.25 102.35 113.85 120.75 129.95 135.70\n\n45 39.45 56.35 69.00 81.65 88.55 93.15 101.20 105.80 48.30 69.00 88.55 104.65 116.15 123.05 132.25 138.00\n\n46 40.25 57.50 70.15 83.95 89.70 94.30 102.35 108.10 49.11 70.15 89.70 106.95 118.45 125.35 135.70 141.45\n\n47 41.06 58.65 72.45 85.10 92.00 95.45 104.65 110.40 50.72 72.45 92.00 109.25 121.90 128.80 138.00 142.60\n\n48 42.67 60.95 73.60 87.40 94.30 97.75 106.95 112.70 51.52 73.60 93.15 111.55 124.20 131.10 141.45 146.05\n\n49 43.47 62.10 75.90 87.40 96.60 100.05 109.25 115.00 53.13 75.90 94.30 112.70 126.50 134.55 143.75 149.50\n\n50 44.28 63.25 77.05 89.70 97.75 102.35 111.55 117.30 53.94 77.05 96.60 115.00 127.65 136.85 146.05 152.95\n\n51 45.89 65.55 79.35 93.15 101.20 105.80 116.15 121.90 55.55 79.35 100.05 118.45 132.25 141.45 150.65 157.55\n\n52 46.69 66.70 82.80 96.60 104.65 110.40 120.75 126.50 57.16 81.65 104.65 121.90 135.70 144.90 155.25 162.15\n\n53 48.30 69.00 86.25 100.05 108.10 113.85 123.05 131.10 59.57 85.10 108.10 125.35 140.30 149.50 161.00 166.75\n\n54 49.91 71.30 87.40 103.50 112.70 117.30 127.65 134.55 61.18 87.40 111.55 129.95 144.90 154.10 165.60 171.35\n\n55 51.52 73.60 90.85 106.95 116.15 121.90 133.40 139.15 63.60 90.85 116.15 133.40 149.50 158.70 170.20 177.10\n\n56 53.13 75.90 96.60 112.70 123.05 129.95 141.45 149.50 66.82 95.45 120.75 140.30 156.40 165.60 180.55 187.45\n\n57 56.35 80.50 102.35 119.60 131.10 138.00 151.80 159.85 70.04 100.05 127.65 148.35 164.45 174.80 189.75 200.10\n\n58 59.57 85.10 108.10 126.50 139.15 147.20 161.00 170.20 74.06 105.80 134.55 157.55 173.65 184.00 201.25 212.75\n\n59 62.79 89.70 113.85 134.55 147.20 156.40 172.50 182.85 77.28 110.40 141.45 165.60 181.70 192.05 212.75 226.55\n\n60 66.01 94.30 120.75 141.45 157.55 166.75 184.00 195.50 80.50 115.00 147.20 174.80 192.05 202.40 226.55 240.35\n\n61 70.84 101.20 129.95 151.80 167.90 178.25 196.65 208.15 86.14 123.05 157.55 186.30 204.70 216.20 241.50 256.45\n\n62 74.87 106.95 138.00 162.15 180.55 192.05 210.45 221.95 91.77 131.10 167.90 196.65 218.50 231.15 257.60 272.55\n\n63 80.50 115.00 148.35 173.65 193.20 204.70 224.25 236.90 98.21 140.30 178.25 209.30 232.30 247.25 274.85 292.10\n\n64 86.14 123.05 158.70 185.15 207.00 219.65 239.20 253.00 103.85 148.35 190.90 221.95 247.25 263.35 293.25 311.65\n\n65 92.58 132.25 169.05 197.80 220.80 235.75 255.30 269.10 111.09 158.70 202.40 235.75 264.50 281.75 313.95 332.35\n\n66 100.63 143.75 184.00 215.05 241.50 257.60 279.45 293.25 119.95 171.35 219.65 254.15 286.35 303.60 339.25 359.95\n\n67 109.48 156.40 200.10 234.60 263.35 280.60 305.90 320.85 129.61 185.15 236.90 274.85 309.35 328.90 365.70 388.70\n\n68 119.14 170.20 216.20 255.30 287.50 307.05 333.50 349.60 140.07 200.10 255.30 297.85 333.50 354.20 395.60 420.90\n\n69 129.61 185.15 234.60 278.30 313.95 335.80 363.40 381.80 150.54 215.05 276.00 322.00 358.80 382.95 427.80 454.25\n\n70 140.88 201.25 256.45 302.45 342.70 366.85 397.90 416.30 163.42 233.45 297.85 348.45 388.70 412.85 462.30 491.05\n\n71 155.37 221.95 282.90 333.50 377.20 404.80 438.15 461.15 178.71 255.30 326.60 381.80 425.50 451.95 504.85 537.05\n\n72 171.47 244.95 311.65 366.85 415.15 445.05 484.15 508.30 195.62 279.45 357.65 417.45 463.45 492.20 552.00 587.65\n\n73 189.18 270.25 343.85 405.95 456.55 488.75 533.60 562.35 213.33 304.75 393.30 457.70 507.15 537.05 602.60 642.85\n\n74 208.50 297.85 379.50 446.20 502.55 538.20 588.80 622.15 233.45 333.50 432.40 500.25 553.15 585.35 657.80 702.65\n\n75 230.23 328.90 418.60 492.20 554.30 591.10 650.90 686.55 255.99 365.70 473.80 547.40 604.90 639.40 718.75 768.20\n\n76 252.77 361.10 458.85 539.35 604.90 645.15 709.55 748.65 279.34 399.05 515.20 596.85 656.65 693.45 780.85 834.90\n\n77 276.92 395.60 503.70 589.95 660.10 702.65 775.10 818.80 305.10 435.85 560.05 649.75 711.85 750.95 848.70 906.20\n\n78 302.68 432.40 552.00 646.30 721.05 764.75 845.25 892.40 332.47 474.95 608.35 708.40 773.95 813.05 920.00 985.55\n\n79 332.47 474.95 603.75 708.40 786.60 833.75 922.30 975.20 363.06 518.65 661.25 771.65 839.50 880.90 999.35 1070.65\n\n80 368.69 526.70 671.60 0.00 0.00 0.00 0.00 0.00 402.50 575.00 733.70 0.00 0.00 0.00 0.00 0.00\n\n81 409.75 585.35 745.20 0.00 0.00 0.00 0.00 0.00 446.78 638.25 814.20 0.00 0.00 0.00 0.00 0.00\n\n82 454.83 649.75 825.70 0.00 0.00 0.00 0.00 0.00 496.69 709.55 905.05 0.00 0.00 0.00 0.00 0.00\n\n83 503.93 719.90 917.70 0.00 0.00 0.00 0.00 0.00 550.62 786.60 1003.95 0.00 0.00 0.00 0.00 0.00\n\n84 560.28 800.40 1018.90 0.00 0.00 0.00 0.00 0.00 611.00 872.85 1114.35 0.00 0.00 0.00 0.00 0.00\n\n85+ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\n\nA 6-month benefit period is also available as a step-down in coverage after issue; the rate for this is 70% of the 1-Yearbenefit period rate","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Appendix B2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **LTC-TQ CA 12/00**\n\n**_Premiums to be used only with those_**\n\n**_that have previously elected an inflation decrease option_**\n\n### **Standard Rates per $10 of Nursing Home Daily Benefit - 90 Day Elimination Period**\n\n**Home Health Monthly Benefit at 80% of 30x the Nursing Home Daily Benefit; Residential Care Facility Daily Benefit at 100% of the Nursing Home Daily Benefit**\n\n**4\\.1% Simple Inflation 4.1% Compound Inflation**\n\n**Age** Benefit Period Benefit Period\n\n1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life\n\n18-29 29.79 42.55 52.90 62.10 66.70 70.15 75.90 79.35 38.64 55.20 71.30 85.10 94.30 100.05 106.95 111.55\n\n30 29.79 42.55 52.90 62.10 66.70 70.15 75.90 79.35 38.64 55.20 71.30 85.10 94.30 100.05 106.95 111.55\n\n31 30.59 43.70 54.05 62.10 67.85 71.30 78.20 80.50 39.45 56.35 72.45 86.25 95.45 101.20 108.10 112.70\n\n32 30.59 43.70 55.20 63.25 69.00 72.45 79.35 82.80 39.45 56.35 73.60 87.40 96.60 102.35 110.40 115.00\n\n33 30.59 43.70 56.35 64.40 70.15 73.60 80.50 83.95 40.25 57.50 74.75 87.40 98.90 103.50 111.55 116.15\n\n34 31.40 44.85 56.35 65.55 72.45 74.75 82.80 86.25 41.06 58.65 74.75 88.55 100.05 105.80 112.70 117.30\n\n35 32.20 46.00 57.50 66.70 73.60 75.90 83.95 87.40 41.06 58.65 75.90 89.70 101.20 106.95 113.85 119.60\n\n36 33.01 47.15 58.65 67.85 74.75 78.20 83.95 89.70 41.86 59.80 77.05 90.85 102.35 108.10 116.15 119.60\n\n37 33.01 47.15 59.80 69.00 75.90 79.35 86.25 90.85 42.67 60.95 78.20 92.00 103.50 109.25 117.30 120.75\n\n38 33.81 48.30 60.95 71.30 78.20 80.50 87.40 93.15 43.47 62.10 79.35 93.15 103.50 110.40 118.45 123.05\n\n39 34.62 49.45 60.95 72.45 78.20 82.80 89.70 94.30 43.47 62.10 80.50 94.30 104.65 112.70 120.75 124.20\n\n40 35.42 50.60 62.10 73.60 79.35 83.95 90.85 96.60 44.28 63.25 81.65 95.45 106.95 113.85 121.90 126.50\n\n41 36.23 51.75 63.25 74.75 81.65 86.25 93.15 97.75 45.08 64.40 82.80 97.75 108.10 116.15 123.05 128.80\n\n42 37.03 52.90 64.40 77.05 82.80 87.40 95.45 98.90 45.89 65.55 83.95 98.90 110.40 118.45 125.35 131.10\n\n43 37.84 54.05 66.70 78.20 85.10 89.70 97.75 101.20 46.69 66.70 85.10 101.20 112.70 119.60 127.65 133.40\n\n44 38.64 55.20 67.85 80.50 86.25 90.85 98.90 103.50 47.50 67.85 86.25 102.35 113.85 120.75 129.95 135.70\n\n45 39.45 56.35 69.00 81.65 88.55 93.15 101.20 105.80 48.30 69.00 88.55 104.65 116.15 123.05 132.25 138.00\n\n46 40.25 57.50 70.15 83.95 89.70 94.30 102.35 108.10 49.11 70.15 89.70 106.95 118.45 125.35 135.70 141.45\n\n47 41.06 58.65 72.45 85.10 92.00 95.45 104.65 110.40 50.72 72.45 92.00 109.25 121.90 128.80 138.00 142.60\n\n48 42.67 60.95 73.60 87.40 94.30 97.75 106.95 112.70 51.52 73.60 93.15 111.55 124.20 131.10 141.45 146.05\n\n49 43.47 62.10 75.90 87.40 96.60 100.05 109.25 115.00 53.13 75.90 94.30 112.70 126.50 134.55 143.75 149.50\n\n50 44.28 63.25 77.05 89.70 97.75 102.35 111.55 117.30 53.94 77.05 96.60 115.00 127.65 136.85 146.05 152.95\n\n51 45.89 65.55 79.35 93.15 101.20 105.80 116.15 121.90 55.55 79.35 100.05 118.45 132.25 141.45 150.65 157.55\n\n52 46.69 66.70 82.80 96.60 104.65 110.40 120.75 126.50 57.16 81.65 104.65 121.90 135.70 144.90 155.25 162.15\n\n53 48.30 69.00 86.25 100.05 108.10 113.85 123.05 131.10 59.57 85.10 108.10 125.35 140.30 149.50 161.00 166.75\n\n54 49.91 71.30 87.40 103.50 112.70 117.30 127.65 134.55 61.18 87.40 111.55 129.95 144.90 154.10 165.60 171.35\n\n55 51.52 73.60 90.85 106.95 116.15 121.90 133.40 139.15 63.60 90.85 116.15 133.40 149.50 158.70 170.20 177.10\n\n56 53.13 75.90 96.60 112.70 123.05 129.95 141.45 149.50 66.82 95.45 120.75 140.30 156.40 165.60 180.55 187.45\n\n57 56.35 80.50 102.35 119.60 131.10 138.00 151.80 159.85 70.04 100.05 127.65 148.35 164.45 174.80 189.75 200.10\n\n58 59.57 85.10 108.10 126.50 139.15 147.20 161.00 170.20 74.06 105.80 134.55 157.55 173.65 184.00 201.25 212.75\n\n59 62.79 89.70 113.85 134.55 147.20 156.40 172.50 182.85 77.28 110.40 141.45 165.60 181.70 192.05 212.75 226.55\n\n60 66.01 94.30 120.75 141.45 157.55 166.75 184.00 195.50 80.50 115.00 147.20 174.80 192.05 202.40 226.55 240.35\n\n61 70.84 101.20 129.95 151.80 167.90 178.25 196.65 208.15 86.14 123.05 157.55 186.30 204.70 216.20 241.50 256.45\n\n62 74.87 106.95 138.00 162.15 180.55 192.05 210.45 221.95 91.77 131.10 167.90 196.65 218.50 231.15 257.60 272.55\n\n63 80.50 115.00 148.35 173.65 193.20 204.70 224.25 236.90 98.21 140.30 178.25 209.30 232.30 247.25 274.85 292.10\n\n64 86.14 123.05 158.70 185.15 207.00 219.65 239.20 253.00 103.85 148.35 190.90 221.95 247.25 263.35 293.25 311.65\n\n65 92.58 132.25 169.05 197.80 220.80 235.75 255.30 269.10 111.09 158.70 202.40 235.75 264.50 281.75 313.95 332.35\n\n66 100.63 143.75 184.00 215.05 241.50 257.60 279.45 293.25 119.95 171.35 219.65 254.15 286.35 303.60 339.25 359.95\n\n67 109.48 156.40 200.10 234.60 263.35 280.60 305.90 320.85 129.61 185.15 236.90 274.85 309.35 328.90 365.70 388.70\n\n68 119.14 170.20 216.20 255.30 287.50 307.05 333.50 349.60 140.07 200.10 255.30 297.85 333.50 354.20 395.60 420.90\n\n69 129.61 185.15 234.60 278.30 313.95 335.80 363.40 381.80 150.54 215.05 276.00 322.00 358.80 382.95 427.80 454.25\n\n70 140.88 201.25 256.45 302.45 342.70 366.85 397.90 416.30 163.42 233.45 297.85 348.45 388.70 412.85 462.30 491.05\n\n71 155.37 221.95 282.90 333.50 377.20 404.80 438.15 461.15 178.71 255.30 326.60 381.80 425.50 451.95 504.85 537.05\n\n72 171.47 244.95 311.65 366.85 415.15 445.05 484.15 508.30 195.62 279.45 357.65 417.45 463.45 492.20 552.00 587.65\n\n73 189.18 270.25 343.85 405.95 456.55 488.75 533.60 562.35 213.33 304.75 393.30 457.70 507.15 537.05 602.60 642.85\n\n74 208.50 297.85 379.50 446.20 502.55 538.20 588.80 622.15 233.45 333.50 432.40 500.25 553.15 585.35 657.80 702.65\n\n75 230.23 328.90 418.60 492.20 554.30 591.10 650.90 686.55 255.99 365.70 473.80 547.40 604.90 639.40 718.75 768.20\n\n76 252.77 361.10 458.85 539.35 604.90 645.15 709.55 748.65 279.34 399.05 515.20 596.85 656.65 693.45 780.85 834.90\n\n77 276.92 395.60 503.70 589.95 660.10 702.65 775.10 818.80 305.10 435.85 560.05 649.75 711.85 750.95 848.70 906.20\n\n78 302.68 432.40 552.00 646.30 721.05 764.75 845.25 892.40 332.47 474.95 608.35 708.40 773.95 813.05 920.00 985.55\n\n79 332.47 474.95 603.75 708.40 786.60 833.75 922.30 975.20 363.06 518.65 661.25 771.65 839.50 880.90 999.35 1070.65\n\n80 368.69 526.70 671.60 0.00 0.00 0.00 0.00 0.00 402.50 575.00 733.70 0.00 0.00 0.00 0.00 0.00\n\n81 409.75 585.35 745.20 0.00 0.00 0.00 0.00 0.00 446.78 638.25 814.20 0.00 0.00 0.00 0.00 0.00\n\n82 454.83 649.75 825.70 0.00 0.00 0.00 0.00 0.00 496.69 709.55 905.05 0.00 0.00 0.00 0.00 0.00\n\n83 503.93 719.90 917.70 0.00 0.00 0.00 0.00 0.00 550.62 786.60 1003.95 0.00 0.00 0.00 0.00 0.00\n\n84 560.28 800.40 1018.90 0.00 0.00 0.00 0.00 0.00 611.00 872.85 1114.35 0.00 0.00 0.00 0.00 0.00\n\n85+ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\n\nA 6-month benefit period is also available as a step-down in coverage after issue; the rate for this is 70% of the 1-Yearbenefit period rate","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2104.pdf"]},"response":{"errors":[],"extract_id":"extract_36cbb841431ecc9ac1282c154b9b2d8b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Appendix B2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **LTC-TQ CA 12/00**\n\n**_Premiums to be used only with those_**\n\n**_that have previously elected an inflation decrease option_**\n\n### **Standard Rates per $10 of Nursing Home Daily Benefit - 90 Day Elimination Period**\n\n**Home Health Monthly Benefit at 80% of 30x the Nursing Home Daily Benefit; Residential Care Facility Daily Benefit at 100% of the Nursing Home Daily Benefit**\n\n**4\\.1% Simple Inflation 4.1% Compound Inflation**\n\n**Age** Benefit Period Benefit Period\n\n1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life\n\n18-29 29.79 42.55 52.90 62.10 66.70 70.15 75.90 79.35 38.64 55.20 71.30 85.10 94.30 100.05 106.95 111.55\n\n30 29.79 42.55 52.90 62.10 66.70 70.15 75.90 79.35 38.64 55.20 71.30 85.10 94.30 100.05 106.95 111.55\n\n31 30.59 43.70 54.05 62.10 67.85 71.30 78.20 80.50 39.45 56.35 72.45 86.25 95.45 101.20 108.10 112.70\n\n32 30.59 43.70 55.20 63.25 69.00 72.45 79.35 82.80 39.45 56.35 73.60 87.40 96.60 102.35 110.40 115.00\n\n33 30.59 43.70 56.35 64.40 70.15 73.60 80.50 83.95 40.25 57.50 74.75 87.40 98.90 103.50 111.55 116.15\n\n34 31.40 44.85 56.35 65.55 72.45 74.75 82.80 86.25 41.06 58.65 74.75 88.55 100.05 105.80 112.70 117.30\n\n35 32.20 46.00 57.50 66.70 73.60 75.90 83.95 87.40 41.06 58.65 75.90 89.70 101.20 106.95 113.85 119.60\n\n36 33.01 47.15 58.65 67.85 74.75 78.20 83.95 89.70 41.86 59.80 77.05 90.85 102.35 108.10 116.15 119.60\n\n37 33.01 47.15 59.80 69.00 75.90 79.35 86.25 90.85 42.67 60.95 78.20 92.00 103.50 109.25 117.30 120.75\n\n38 33.81 48.30 60.95 71.30 78.20 80.50 87.40 93.15 43.47 62.10 79.35 93.15 103.50 110.40 118.45 123.05\n\n39 34.62 49.45 60.95 72.45 78.20 82.80 89.70 94.30 43.47 62.10 80.50 94.30 104.65 112.70 120.75 124.20\n\n40 35.42 50.60 62.10 73.60 79.35 83.95 90.85 96.60 44.28 63.25 81.65 95.45 106.95 113.85 121.90 126.50\n\n41 36.23 51.75 63.25 74.75 81.65 86.25 93.15 97.75 45.08 64.40 82.80 97.75 108.10 116.15 123.05 128.80\n\n42 37.03 52.90 64.40 77.05 82.80 87.40 95.45 98.90 45.89 65.55 83.95 98.90 110.40 118.45 125.35 131.10\n\n43 37.84 54.05 66.70 78.20 85.10 89.70 97.75 101.20 46.69 66.70 85.10 101.20 112.70 119.60 127.65 133.40\n\n44 38.64 55.20 67.85 80.50 86.25 90.85 98.90 103.50 47.50 67.85 86.25 102.35 113.85 120.75 129.95 135.70\n\n45 39.45 56.35 69.00 81.65 88.55 93.15 101.20 105.80 48.30 69.00 88.55 104.65 116.15 123.05 132.25 138.00\n\n46 40.25 57.50 70.15 83.95 89.70 94.30 102.35 108.10 49.11 70.15 89.70 106.95 118.45 125.35 135.70 141.45\n\n47 41.06 58.65 72.45 85.10 92.00 95.45 104.65 110.40 50.72 72.45 92.00 109.25 121.90 128.80 138.00 142.60\n\n48 42.67 60.95 73.60 87.40 94.30 97.75 106.95 112.70 51.52 73.60 93.15 111.55 124.20 131.10 141.45 146.05\n\n49 43.47 62.10 75.90 87.40 96.60 100.05 109.25 115.00 53.13 75.90 94.30 112.70 126.50 134.55 143.75 149.50\n\n50 44.28 63.25 77.05 89.70 97.75 102.35 111.55 117.30 53.94 77.05 96.60 115.00 127.65 136.85 146.05 152.95\n\n51 45.89 65.55 79.35 93.15 101.20 105.80 116.15 121.90 55.55 79.35 100.05 118.45 132.25 141.45 150.65 157.55\n\n52 46.69 66.70 82.80 96.60 104.65 110.40 120.75 126.50 57.16 81.65 104.65 121.90 135.70 144.90 155.25 162.15\n\n53 48.30 69.00 86.25 100.05 108.10 113.85 123.05 131.10 59.57 85.10 108.10 125.35 140.30 149.50 161.00 166.75\n\n54 49.91 71.30 87.40 103.50 112.70 117.30 127.65 134.55 61.18 87.40 111.55 129.95 144.90 154.10 165.60 171.35\n\n55 51.52 73.60 90.85 106.95 116.15 121.90 133.40 139.15 63.60 90.85 116.15 133.40 149.50 158.70 170.20 177.10\n\n56 53.13 75.90 96.60 112.70 123.05 129.95 141.45 149.50 66.82 95.45 120.75 140.30 156.40 165.60 180.55 187.45\n\n57 56.35 80.50 102.35 119.60 131.10 138.00 151.80 159.85 70.04 100.05 127.65 148.35 164.45 174.80 189.75 200.10\n\n58 59.57 85.10 108.10 126.50 139.15 147.20 161.00 170.20 74.06 105.80 134.55 157.55 173.65 184.00 201.25 212.75\n\n59 62.79 89.70 113.85 134.55 147.20 156.40 172.50 182.85 77.28 110.40 141.45 165.60 181.70 192.05 212.75 226.55\n\n60 66.01 94.30 120.75 141.45 157.55 166.75 184.00 195.50 80.50 115.00 147.20 174.80 192.05 202.40 226.55 240.35\n\n61 70.84 101.20 129.95 151.80 167.90 178.25 196.65 208.15 86.14 123.05 157.55 186.30 204.70 216.20 241.50 256.45\n\n62 74.87 106.95 138.00 162.15 180.55 192.05 210.45 221.95 91.77 131.10 167.90 196.65 218.50 231.15 257.60 272.55\n\n63 80.50 115.00 148.35 173.65 193.20 204.70 224.25 236.90 98.21 140.30 178.25 209.30 232.30 247.25 274.85 292.10\n\n64 86.14 123.05 158.70 185.15 207.00 219.65 239.20 253.00 103.85 148.35 190.90 221.95 247.25 263.35 293.25 311.65\n\n65 92.58 132.25 169.05 197.80 220.80 235.75 255.30 269.10 111.09 158.70 202.40 235.75 264.50 281.75 313.95 332.35\n\n66 100.63 143.75 184.00 215.05 241.50 257.60 279.45 293.25 119.95 171.35 219.65 254.15 286.35 303.60 339.25 359.95\n\n67 109.48 156.40 200.10 234.60 263.35 280.60 305.90 320.85 129.61 185.15 236.90 274.85 309.35 328.90 365.70 388.70\n\n68 119.14 170.20 216.20 255.30 287.50 307.05 333.50 349.60 140.07 200.10 255.30 297.85 333.50 354.20 395.60 420.90\n\n69 129.61 185.15 234.60 278.30 313.95 335.80 363.40 381.80 150.54 215.05 276.00 322.00 358.80 382.95 427.80 454.25\n\n70 140.88 201.25 256.45 302.45 342.70 366.85 397.90 416.30 163.42 233.45 297.85 348.45 388.70 412.85 462.30 491.05\n\n71 155.37 221.95 282.90 333.50 377.20 404.80 438.15 461.15 178.71 255.30 326.60 381.80 425.50 451.95 504.85 537.05\n\n72 171.47 244.95 311.65 366.85 415.15 445.05 484.15 508.30 195.62 279.45 357.65 417.45 463.45 492.20 552.00 587.65\n\n73 189.18 270.25 343.85 405.95 456.55 488.75 533.60 562.35 213.33 304.75 393.30 457.70 507.15 537.05 602.60 642.85\n\n74 208.50 297.85 379.50 446.20 502.55 538.20 588.80 622.15 233.45 333.50 432.40 500.25 553.15 585.35 657.80 702.65\n\n75 230.23 328.90 418.60 492.20 554.30 591.10 650.90 686.55 255.99 365.70 473.80 547.40 604.90 639.40 718.75 768.20\n\n76 252.77 361.10 458.85 539.35 604.90 645.15 709.55 748.65 279.34 399.05 515.20 596.85 656.65 693.45 780.85 834.90\n\n77 276.92 395.60 503.70 589.95 660.10 702.65 775.10 818.80 305.10 435.85 560.05 649.75 711.85 750.95 848.70 906.20\n\n78 302.68 432.40 552.00 646.30 721.05 764.75 845.25 892.40 332.47 474.95 608.35 708.40 773.95 813.05 920.00 985.55\n\n79 332.47 474.95 603.75 708.40 786.60 833.75 922.30 975.20 363.06 518.65 661.25 771.65 839.50 880.90 999.35 1070.65\n\n80 368.69 526.70 671.60 0.00 0.00 0.00 0.00 0.00 402.50 575.00 733.70 0.00 0.00 0.00 0.00 0.00\n\n81 409.75 585.35 745.20 0.00 0.00 0.00 0.00 0.00 446.78 638.25 814.20 0.00 0.00 0.00 0.00 0.00\n\n82 454.83 649.75 825.70 0.00 0.00 0.00 0.00 0.00 496.69 709.55 905.05 0.00 0.00 0.00 0.00 0.00\n\n83 503.93 719.90 917.70 0.00 0.00 0.00 0.00 0.00 550.62 786.60 1003.95 0.00 0.00 0.00 0.00 0.00\n\n84 560.28 800.40 1018.90 0.00 0.00 0.00 0.00 0.00 611.00 872.85 1114.35 0.00 0.00 0.00 0.00 0.00\n\n85+ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\n\nA 6-month benefit period is also available as a step-down in coverage after issue; the rate for this is 70% of the 1-Yearbenefit period rate"],"full_content":"### **Appendix B2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **LTC-TQ CA 12/00**\n\n**_Premiums to be used only with those_**\n\n**_that have previously elected an inflation decrease option_**\n\n### **Standard Rates per $10 of Nursing Home Daily Benefit - 90 Day Elimination Period**\n\n**Home Health Monthly Benefit at 80% of 30x the Nursing Home Daily Benefit; Residential Care Facility Daily Benefit at 100% of the Nursing Home Daily Benefit**\n\n**4\\.1% Simple Inflation 4.1% Compound Inflation**\n\n**Age** Benefit Period Benefit Period\n\n1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life\n\n18-29 29.79 42.55 52.90 62.10 66.70 70.15 75.90 79.35 38.64 55.20 71.30 85.10 94.30 100.05 106.95 111.55\n\n30 29.79 42.55 52.90 62.10 66.70 70.15 75.90 79.35 38.64 55.20 71.30 85.10 94.30 100.05 106.95 111.55\n\n31 30.59 43.70 54.05 62.10 67.85 71.30 78.20 80.50 39.45 56.35 72.45 86.25 95.45 101.20 108.10 112.70\n\n32 30.59 43.70 55.20 63.25 69.00 72.45 79.35 82.80 39.45 56.35 73.60 87.40 96.60 102.35 110.40 115.00\n\n33 30.59 43.70 56.35 64.40 70.15 73.60 80.50 83.95 40.25 57.50 74.75 87.40 98.90 103.50 111.55 116.15\n\n34 31.40 44.85 56.35 65.55 72.45 74.75 82.80 86.25 41.06 58.65 74.75 88.55 100.05 105.80 112.70 117.30\n\n35 32.20 46.00 57.50 66.70 73.60 75.90 83.95 87.40 41.06 58.65 75.90 89.70 101.20 106.95 113.85 119.60\n\n36 33.01 47.15 58.65 67.85 74.75 78.20 83.95 89.70 41.86 59.80 77.05 90.85 102.35 108.10 116.15 119.60\n\n37 33.01 47.15 59.80 69.00 75.90 79.35 86.25 90.85 42.67 60.95 78.20 92.00 103.50 109.25 117.30 120.75\n\n38 33.81 48.30 60.95 71.30 78.20 80.50 87.40 93.15 43.47 62.10 79.35 93.15 103.50 110.40 118.45 123.05\n\n39 34.62 49.45 60.95 72.45 78.20 82.80 89.70 94.30 43.47 62.10 80.50 94.30 104.65 112.70 120.75 124.20\n\n40 35.42 50.60 62.10 73.60 79.35 83.95 90.85 96.60 44.28 63.25 81.65 95.45 106.95 113.85 121.90 126.50\n\n41 36.23 51.75 63.25 74.75 81.65 86.25 93.15 97.75 45.08 64.40 82.80 97.75 108.10 116.15 123.05 128.80\n\n42 37.03 52.90 64.40 77.05 82.80 87.40 95.45 98.90 45.89 65.55 83.95 98.90 110.40 118.45 125.35 131.10\n\n43 37.84 54.05 66.70 78.20 85.10 89.70 97.75 101.20 46.69 66.70 85.10 101.20 112.70 119.60 127.65 133.40\n\n44 38.64 55.20 67.85 80.50 86.25 90.85 98.90 103.50 47.50 67.85 86.25 102.35 113.85 120.75 129.95 135.70\n\n45 39.45 56.35 69.00 81.65 88.55 93.15 101.20 105.80 48.30 69.00 88.55 104.65 116.15 123.05 132.25 138.00\n\n46 40.25 57.50 70.15 83.95 89.70 94.30 102.35 108.10 49.11 70.15 89.70 106.95 118.45 125.35 135.70 141.45\n\n47 41.06 58.65 72.45 85.10 92.00 95.45 104.65 110.40 50.72 72.45 92.00 109.25 121.90 128.80 138.00 142.60\n\n48 42.67 60.95 73.60 87.40 94.30 97.75 106.95 112.70 51.52 73.60 93.15 111.55 124.20 131.10 141.45 146.05\n\n49 43.47 62.10 75.90 87.40 96.60 100.05 109.25 115.00 53.13 75.90 94.30 112.70 126.50 134.55 143.75 149.50\n\n50 44.28 63.25 77.05 89.70 97.75 102.35 111.55 117.30 53.94 77.05 96.60 115.00 127.65 136.85 146.05 152.95\n\n51 45.89 65.55 79.35 93.15 101.20 105.80 116.15 121.90 55.55 79.35 100.05 118.45 132.25 141.45 150.65 157.55\n\n52 46.69 66.70 82.80 96.60 104.65 110.40 120.75 126.50 57.16 81.65 104.65 121.90 135.70 144.90 155.25 162.15\n\n53 48.30 69.00 86.25 100.05 108.10 113.85 123.05 131.10 59.57 85.10 108.10 125.35 140.30 149.50 161.00 166.75\n\n54 49.91 71.30 87.40 103.50 112.70 117.30 127.65 134.55 61.18 87.40 111.55 129.95 144.90 154.10 165.60 171.35\n\n55 51.52 73.60 90.85 106.95 116.15 121.90 133.40 139.15 63.60 90.85 116.15 133.40 149.50 158.70 170.20 177.10\n\n56 53.13 75.90 96.60 112.70 123.05 129.95 141.45 149.50 66.82 95.45 120.75 140.30 156.40 165.60 180.55 187.45\n\n57 56.35 80.50 102.35 119.60 131.10 138.00 151.80 159.85 70.04 100.05 127.65 148.35 164.45 174.80 189.75 200.10\n\n58 59.57 85.10 108.10 126.50 139.15 147.20 161.00 170.20 74.06 105.80 134.55 157.55 173.65 184.00 201.25 212.75\n\n59 62.79 89.70 113.85 134.55 147.20 156.40 172.50 182.85 77.28 110.40 141.45 165.60 181.70 192.05 212.75 226.55\n\n60 66.01 94.30 120.75 141.45 157.55 166.75 184.00 195.50 80.50 115.00 147.20 174.80 192.05 202.40 226.55 240.35\n\n61 70.84 101.20 129.95 151.80 167.90 178.25 196.65 208.15 86.14 123.05 157.55 186.30 204.70 216.20 241.50 256.45\n\n62 74.87 106.95 138.00 162.15 180.55 192.05 210.45 221.95 91.77 131.10 167.90 196.65 218.50 231.15 257.60 272.55\n\n63 80.50 115.00 148.35 173.65 193.20 204.70 224.25 236.90 98.21 140.30 178.25 209.30 232.30 247.25 274.85 292.10\n\n64 86.14 123.05 158.70 185.15 207.00 219.65 239.20 253.00 103.85 148.35 190.90 221.95 247.25 263.35 293.25 311.65\n\n65 92.58 132.25 169.05 197.80 220.80 235.75 255.30 269.10 111.09 158.70 202.40 235.75 264.50 281.75 313.95 332.35\n\n66 100.63 143.75 184.00 215.05 241.50 257.60 279.45 293.25 119.95 171.35 219.65 254.15 286.35 303.60 339.25 359.95\n\n67 109.48 156.40 200.10 234.60 263.35 280.60 305.90 320.85 129.61 185.15 236.90 274.85 309.35 328.90 365.70 388.70\n\n68 119.14 170.20 216.20 255.30 287.50 307.05 333.50 349.60 140.07 200.10 255.30 297.85 333.50 354.20 395.60 420.90\n\n69 129.61 185.15 234.60 278.30 313.95 335.80 363.40 381.80 150.54 215.05 276.00 322.00 358.80 382.95 427.80 454.25\n\n70 140.88 201.25 256.45 302.45 342.70 366.85 397.90 416.30 163.42 233.45 297.85 348.45 388.70 412.85 462.30 491.05\n\n71 155.37 221.95 282.90 333.50 377.20 404.80 438.15 461.15 178.71 255.30 326.60 381.80 425.50 451.95 504.85 537.05\n\n72 171.47 244.95 311.65 366.85 415.15 445.05 484.15 508.30 195.62 279.45 357.65 417.45 463.45 492.20 552.00 587.65\n\n73 189.18 270.25 343.85 405.95 456.55 488.75 533.60 562.35 213.33 304.75 393.30 457.70 507.15 537.05 602.60 642.85\n\n74 208.50 297.85 379.50 446.20 502.55 538.20 588.80 622.15 233.45 333.50 432.40 500.25 553.15 585.35 657.80 702.65\n\n75 230.23 328.90 418.60 492.20 554.30 591.10 650.90 686.55 255.99 365.70 473.80 547.40 604.90 639.40 718.75 768.20\n\n76 252.77 361.10 458.85 539.35 604.90 645.15 709.55 748.65 279.34 399.05 515.20 596.85 656.65 693.45 780.85 834.90\n\n77 276.92 395.60 503.70 589.95 660.10 702.65 775.10 818.80 305.10 435.85 560.05 649.75 711.85 750.95 848.70 906.20\n\n78 302.68 432.40 552.00 646.30 721.05 764.75 845.25 892.40 332.47 474.95 608.35 708.40 773.95 813.05 920.00 985.55\n\n79 332.47 474.95 603.75 708.40 786.60 833.75 922.30 975.20 363.06 518.65 661.25 771.65 839.50 880.90 999.35 1070.65\n\n80 368.69 526.70 671.60 0.00 0.00 0.00 0.00 0.00 402.50 575.00 733.70 0.00 0.00 0.00 0.00 0.00\n\n81 409.75 585.35 745.20 0.00 0.00 0.00 0.00 0.00 446.78 638.25 814.20 0.00 0.00 0.00 0.00 0.00\n\n82 454.83 649.75 825.70 0.00 0.00 0.00 0.00 0.00 496.69 709.55 905.05 0.00 0.00 0.00 0.00 0.00\n\n83 503.93 719.90 917.70 0.00 0.00 0.00 0.00 0.00 550.62 786.60 1003.95 0.00 0.00 0.00 0.00 0.00\n\n84 560.28 800.40 1018.90 0.00 0.00 0.00 0.00 0.00 611.00 872.85 1114.35 0.00 0.00 0.00 0.00 0.00\n\n85+ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\n\nA 6-month benefit period is also available as a step-down in coverage after issue; the rate for this is 70% of the 1-Yearbenefit period rate","publish_date":null,"title":"Appendix B2","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2104.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2104.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2104","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2104.pdf"},"started_at":"2026-11-04T19:48:13.398255"} +{"completed_at":"2026-11-04T19:48:17.040152","latency_in_ms":2152,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2139","grounded_pages":[],"layout_pages":[],"markdown":"**State** **of** **California Company: Allied** **World** **Insurance** **Company Department** **of** **Insurance** **(CDI) Line: Other** **Liability CDI** **File** **\\#** **(Department** **Use** **Only):**\n\n### **PROJECTED** **YIELD** **AND** **FEDERAL** **INCOME** **TAX** **RATE** **ON** **INVESTMENT** **INCOME**\n\n**(continued)**\n\nInvested Assets ¹ Currently Available Yield ² Return on Invested Assets Federal Income Tax Rate Federal Income Taxes\n\n[1] [2] [3] = [1] \\* [2] [4] [5) = [3] \\* [4]\n\n(1) U.S. Government Bonds\n\n(i) Short‐Term 118,677,580 _0\\.3%_ 316,474 35.00% 110,766\n\n(ii) Intermediate‐Term 208,004,882 _2\\.0%_ 4,236,366 35.00% 1,482,728\n\n(iii) Long‐Term 3,854,148 _2\\.4%_ 93,784 35.00% 32,824\n\n(2) Other Taxable Bonds\n\n(i) Short‐Term 89,373,591 _0\\.6%_ 491,555 35.00% 172,044\n\n(ii) Intermediate‐Term 681,995,940 _3\\.0%_ 20,649,700 35.00% 7,227,395\n\n(iii) Long‐Term 18,952,987 _4\\.2%_ 795,220 35.00% 278,327\n\n(3) Tax‐Exempt Bonds\n\n(i) Short‐Term 12,342,525 _0\\.4%_ 44,125 5.25% 2,317\n\n(ii) Intermediate‐Term 129,992,992 _2\\.0%_ 2,642,754 5.25% 138,745\n\n(iii) Long‐Term 10,156,336 _2\\.9%_ 293,983 5.25% 15,434\n\n(4) Common Stock 356,487,300\n\n(i) Dividends _2\\.1%_ 7,628,828 14.18% 1,081,386\n\n(ii) Capital Gains _7\\.2%_ 25,801,759 34.10% 8,798,400\n\n(5) Preferred Stock Dividends _4\\.9%_ 0 14.18% 0\n\n(6) Mortgage Loans _4\\.2%_ 0 35.00% 0\n\n(7) Real Estate _3\\.4%_ 0 35.00% 0\n\n(8) Cash 179,279,237 _0\\.3%_ 478,078 35.00% 167,327\n\n(9) Other 70,613,686\n\n(i) Dividends _2\\.1%_ 1,511,133 14.18% 214,203\n\n(ii) Capital Gains _7\\.2%_ 5,110,862 34.10% 1,742,804\n\n(10) Total Gross Invested Assets 1,879,731,201 70,094,621 34.10% 21,464,700\n\n(11) Investment Expense ³ 4,978,122 35.00% 1,742,343 (12) Total Net Invested Assets 1,879,731,201 65,116,499 19,722,358\n\n(13) Federal Income Tax: Line (12); column [5]/column [3] **30\\.3%**\n\n(14) Projected Yield on Invested Assets: Line (12), column [3]/column [1] 3.5%\n\nMost Recent Calendar Year (15) Loss Reserves ⁴ 556,929,939\n\n(16) Loss Adjustment Expense Reserves ⁴ 207,276,047\n\n(17) Unearned Premium Reserves ⁴ 242,498,358\n\n(18) Surplus as Regards to Policyholders ⁴ 1,118,479,718\n\n(19) Total Reserves and Surplus 2,125,184,062\n\n(20) Projected Yield adjusted to Reserve and Surplus Base: Line (14), column [2]\\*Line (12), column [1]/Line (10), column [1] **3\\.1%**\n\n1 Source for Column [1], Lines (4) through (9): Page 2 (Assets) of the insurer **group's** most recent consolidated (combined) statutory Annual Statement. ‐ Line (8) Cash: Page 2 (Assets) Line 5, cash only; cash equivalents and short‐term investments are included in Schedule D. ‐ Line (9) Other: Page 2 (Assets) Sum of Lines 6, 8, 9 and 11.\n\n2 Currently available yields are defined in CCR §2644.20. Latest values are posted at:\n\nhttp://www.insurance.ca.gov/0250‐insurers/0800‐rate‐filings/0200‐prior‐approval‐factors/ Month/Year (Yield): **_February_** **_2016_**\n\n3 Source: Page 11, Line 25 of the insurer group's most recent consolidated statutory Annual Statement. Entered as a positive expense.\n\n4 Source for Column [1], Lines (15) through (18): Page 3 (Liabilities, Surplus and Other Funds) of the insurer group's most recent consolidated statutory Annual Statement, Lines 1, 3, 9 and 37, respectively.\n\nPrior Approval Rate Template Page 3.2 1/12/2016 Edition","pages":[{"line_numbers":[],"markdown":"**State** **of** **California Company: Allied** **World** **Insurance** **Company Department** **of** **Insurance** **(CDI) Line: Other** **Liability CDI** **File** **\\#** **(Department** **Use** **Only):**\n\n### **PROJECTED** **YIELD** **AND** **FEDERAL** **INCOME** **TAX** **RATE** **ON** **INVESTMENT** **INCOME**\n\n**(continued)**\n\nInvested Assets ¹ Currently Available Yield ² Return on Invested Assets Federal Income Tax Rate Federal Income Taxes\n\n[1] [2] [3] = [1] \\* [2] [4] [5) = [3] \\* [4]\n\n(1) U.S. Government Bonds\n\n(i) Short‐Term 118,677,580 _0\\.3%_ 316,474 35.00% 110,766\n\n(ii) Intermediate‐Term 208,004,882 _2\\.0%_ 4,236,366 35.00% 1,482,728\n\n(iii) Long‐Term 3,854,148 _2\\.4%_ 93,784 35.00% 32,824\n\n(2) Other Taxable Bonds\n\n(i) Short‐Term 89,373,591 _0\\.6%_ 491,555 35.00% 172,044\n\n(ii) Intermediate‐Term 681,995,940 _3\\.0%_ 20,649,700 35.00% 7,227,395\n\n(iii) Long‐Term 18,952,987 _4\\.2%_ 795,220 35.00% 278,327\n\n(3) Tax‐Exempt Bonds\n\n(i) Short‐Term 12,342,525 _0\\.4%_ 44,125 5.25% 2,317\n\n(ii) Intermediate‐Term 129,992,992 _2\\.0%_ 2,642,754 5.25% 138,745\n\n(iii) Long‐Term 10,156,336 _2\\.9%_ 293,983 5.25% 15,434\n\n(4) Common Stock 356,487,300\n\n(i) Dividends _2\\.1%_ 7,628,828 14.18% 1,081,386\n\n(ii) Capital Gains _7\\.2%_ 25,801,759 34.10% 8,798,400\n\n(5) Preferred Stock Dividends _4\\.9%_ 0 14.18% 0\n\n(6) Mortgage Loans _4\\.2%_ 0 35.00% 0\n\n(7) Real Estate _3\\.4%_ 0 35.00% 0\n\n(8) Cash 179,279,237 _0\\.3%_ 478,078 35.00% 167,327\n\n(9) Other 70,613,686\n\n(i) Dividends _2\\.1%_ 1,511,133 14.18% 214,203\n\n(ii) Capital Gains _7\\.2%_ 5,110,862 34.10% 1,742,804\n\n(10) Total Gross Invested Assets 1,879,731,201 70,094,621 34.10% 21,464,700\n\n(11) Investment Expense ³ 4,978,122 35.00% 1,742,343 (12) Total Net Invested Assets 1,879,731,201 65,116,499 19,722,358\n\n(13) Federal Income Tax: Line (12); column [5]/column [3] **30\\.3%**\n\n(14) Projected Yield on Invested Assets: Line (12), column [3]/column [1] 3.5%\n\nMost Recent Calendar Year (15) Loss Reserves ⁴ 556,929,939\n\n(16) Loss Adjustment Expense Reserves ⁴ 207,276,047\n\n(17) Unearned Premium Reserves ⁴ 242,498,358\n\n(18) Surplus as Regards to Policyholders ⁴ 1,118,479,718\n\n(19) Total Reserves and Surplus 2,125,184,062\n\n(20) Projected Yield adjusted to Reserve and Surplus Base: Line (14), column [2]\\*Line (12), column [1]/Line (10), column [1] **3\\.1%**\n\n1 Source for Column [1], Lines (4) through (9): Page 2 (Assets) of the insurer **group's** most recent consolidated (combined) statutory Annual Statement. ‐ Line (8) Cash: Page 2 (Assets) Line 5, cash only; cash equivalents and short‐term investments are included in Schedule D. ‐ Line (9) Other: Page 2 (Assets) Sum of Lines 6, 8, 9 and 11.\n\n2 Currently available yields are defined in CCR §2644.20. Latest values are posted at:\n\nhttp://www.insurance.ca.gov/0250‐insurers/0800‐rate‐filings/0200‐prior‐approval‐factors/ Month/Year (Yield): **_February_** **_2016_**\n\n3 Source: Page 11, Line 25 of the insurer group's most recent consolidated statutory Annual Statement. Entered as a positive expense.\n\n4 Source for Column [1], Lines (15) through (18): Page 3 (Liabilities, Surplus and Other Funds) of the insurer group's most recent consolidated statutory Annual Statement, Lines 1, 3, 9 and 37, respectively.\n\nPrior Approval Rate Template Page 3.2 1/12/2016 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**State** **of** **California Company: Allied** **World** **Insurance** **Company Department** **of** **Insurance** **(CDI) Line: Other** **Liability CDI** **File** **\\#** **(Department** **Use** **Only):**\n\n### **PROJECTED** **YIELD** **AND** **FEDERAL** **INCOME** **TAX** **RATE** **ON** **INVESTMENT** **INCOME**\n\n**(continued)**\n\nInvested Assets ¹ Currently Available Yield ² Return on Invested Assets Federal Income Tax Rate Federal Income Taxes\n\n[1] [2] [3] = [1] \\* [2] [4] [5) = [3] \\* [4]\n\n(1) U.S. Government Bonds\n\n(i) Short‐Term 118,677,580 _0\\.3%_ 316,474 35.00% 110,766\n\n(ii) Intermediate‐Term 208,004,882 _2\\.0%_ 4,236,366 35.00% 1,482,728\n\n(iii) Long‐Term 3,854,148 _2\\.4%_ 93,784 35.00% 32,824\n\n(2) Other Taxable Bonds\n\n(i) Short‐Term 89,373,591 _0\\.6%_ 491,555 35.00% 172,044\n\n(ii) Intermediate‐Term 681,995,940 _3\\.0%_ 20,649,700 35.00% 7,227,395\n\n(iii) Long‐Term 18,952,987 _4\\.2%_ 795,220 35.00% 278,327\n\n(3) Tax‐Exempt Bonds\n\n(i) Short‐Term 12,342,525 _0\\.4%_ 44,125 5.25% 2,317\n\n(ii) Intermediate‐Term 129,992,992 _2\\.0%_ 2,642,754 5.25% 138,745\n\n(iii) Long‐Term 10,156,336 _2\\.9%_ 293,983 5.25% 15,434\n\n(4) Common Stock 356,487,300\n\n(i) Dividends _2\\.1%_ 7,628,828 14.18% 1,081,386\n\n(ii) Capital Gains _7\\.2%_ 25,801,759 34.10% 8,798,400\n\n(5) Preferred Stock Dividends _4\\.9%_ 0 14.18% 0\n\n(6) Mortgage Loans _4\\.2%_ 0 35.00% 0\n\n(7) Real Estate _3\\.4%_ 0 35.00% 0\n\n(8) Cash 179,279,237 _0\\.3%_ 478,078 35.00% 167,327\n\n(9) Other 70,613,686\n\n(i) Dividends _2\\.1%_ 1,511,133 14.18% 214,203\n\n(ii) Capital Gains _7\\.2%_ 5,110,862 34.10% 1,742,804\n\n(10) Total Gross Invested Assets 1,879,731,201 70,094,621 34.10% 21,464,700\n\n(11) Investment Expense ³ 4,978,122 35.00% 1,742,343 (12) Total Net Invested Assets 1,879,731,201 65,116,499 19,722,358\n\n(13) Federal Income Tax: Line (12); column [5]/column [3] **30\\.3%**\n\n(14) Projected Yield on Invested Assets: Line (12), column [3]/column [1] 3.5%\n\nMost Recent Calendar Year (15) Loss Reserves ⁴ 556,929,939\n\n(16) Loss Adjustment Expense Reserves ⁴ 207,276,047\n\n(17) Unearned Premium Reserves ⁴ 242,498,358\n\n(18) Surplus as Regards to Policyholders ⁴ 1,118,479,718\n\n(19) Total Reserves and Surplus 2,125,184,062\n\n(20) Projected Yield adjusted to Reserve and Surplus Base: Line (14), column [2]\\*Line (12), column [1]/Line (10), column [1] **3\\.1%**\n\n1 Source for Column [1], Lines (4) through (9): Page 2 (Assets) of the insurer **group's** most recent consolidated (combined) statutory Annual Statement. ‐ Line (8) Cash: Page 2 (Assets) Line 5, cash only; cash equivalents and short‐term investments are included in Schedule D. ‐ Line (9) Other: Page 2 (Assets) Sum of Lines 6, 8, 9 and 11.\n\n2 Currently available yields are defined in CCR §2644.20. Latest values are posted at:\n\nhttp://www.insurance.ca.gov/0250‐insurers/0800‐rate‐filings/0200‐prior‐approval‐factors/ Month/Year (Yield): **_February_** **_2016_**\n\n3 Source: Page 11, Line 25 of the insurer group's most recent consolidated statutory Annual Statement. Entered as a positive expense.\n\n4 Source for Column [1], Lines (15) through (18): Page 3 (Liabilities, Surplus and Other Funds) of the insurer group's most recent consolidated statutory Annual Statement, Lines 1, 3, 9 and 37, respectively.\n\nPrior Approval Rate Template Page 3.2 1/12/2016 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2139.pdf"]},"response":{"errors":[],"extract_id":"extract_32c0b48807000338a9be7cb57b8e4821","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**State** **of** **California Company: Allied** **World** **Insurance** **Company Department** **of** **Insurance** **(CDI) Line: Other** **Liability CDI** **File** **\\#** **(Department** **Use** **Only):**\n\n### **PROJECTED** **YIELD** **AND** **FEDERAL** **INCOME** **TAX** **RATE** **ON** **INVESTMENT** **INCOME**\n\n**(continued)**\n\nInvested Assets ¹ Currently Available Yield ² Return on Invested Assets Federal Income Tax Rate Federal Income Taxes\n\n[1] [2] [3] = [1] \\* [2] [4] [5) = [3] \\* [4]\n\n(1) U.S. Government Bonds\n\n(i) Short‐Term 118,677,580 _0\\.3%_ 316,474 35.00% 110,766\n\n(ii) Intermediate‐Term 208,004,882 _2\\.0%_ 4,236,366 35.00% 1,482,728\n\n(iii) Long‐Term 3,854,148 _2\\.4%_ 93,784 35.00% 32,824\n\n(2) Other Taxable Bonds\n\n(i) Short‐Term 89,373,591 _0\\.6%_ 491,555 35.00% 172,044\n\n(ii) Intermediate‐Term 681,995,940 _3\\.0%_ 20,649,700 35.00% 7,227,395\n\n(iii) Long‐Term 18,952,987 _4\\.2%_ 795,220 35.00% 278,327\n\n(3) Tax‐Exempt Bonds\n\n(i) Short‐Term 12,342,525 _0\\.4%_ 44,125 5.25% 2,317\n\n(ii) Intermediate‐Term 129,992,992 _2\\.0%_ 2,642,754 5.25% 138,745\n\n(iii) Long‐Term 10,156,336 _2\\.9%_ 293,983 5.25% 15,434\n\n(4) Common Stock 356,487,300\n\n(i) Dividends _2\\.1%_ 7,628,828 14.18% 1,081,386\n\n(ii) Capital Gains _7\\.2%_ 25,801,759 34.10% 8,798,400\n\n(5) Preferred Stock Dividends _4\\.9%_ 0 14.18% 0\n\n(6) Mortgage Loans _4\\.2%_ 0 35.00% 0\n\n(7) Real Estate _3\\.4%_ 0 35.00% 0\n\n(8) Cash 179,279,237 _0\\.3%_ 478,078 35.00% 167,327\n\n(9) Other 70,613,686\n\n(i) Dividends _2\\.1%_ 1,511,133 14.18% 214,203\n\n(ii) Capital Gains _7\\.2%_ 5,110,862 34.10% 1,742,804\n\n(10) Total Gross Invested Assets 1,879,731,201 70,094,621 34.10% 21,464,700\n\n(11) Investment Expense ³ 4,978,122 35.00% 1,742,343 (12) Total Net Invested Assets 1,879,731,201 65,116,499 19,722,358\n\n(13) Federal Income Tax: Line (12); column [5]/column [3] **30\\.3%**\n\n(14) Projected Yield on Invested Assets: Line (12), column [3]/column [1] 3.5%\n\nMost Recent Calendar Year (15) Loss Reserves ⁴ 556,929,939\n\n(16) Loss Adjustment Expense Reserves ⁴ 207,276,047\n\n(17) Unearned Premium Reserves ⁴ 242,498,358\n\n(18) Surplus as Regards to Policyholders ⁴ 1,118,479,718\n\n(19) Total Reserves and Surplus 2,125,184,062\n\n(20) Projected Yield adjusted to Reserve and Surplus Base: Line (14), column [2]\\*Line (12), column [1]/Line (10), column [1] **3\\.1%**\n\n1 Source for Column [1], Lines (4) through (9): Page 2 (Assets) of the insurer **group's** most recent consolidated (combined) statutory Annual Statement. ‐ Line (8) Cash: Page 2 (Assets) Line 5, cash only; cash equivalents and short‐term investments are included in Schedule D. ‐ Line (9) Other: Page 2 (Assets) Sum of Lines 6, 8, 9 and 11.\n\n2 Currently available yields are defined in CCR §2644.20. Latest values are posted at:\n\nhttp://www.insurance.ca.gov/0250‐insurers/0800‐rate‐filings/0200‐prior‐approval‐factors/ Month/Year (Yield): **_February_** **_2016_**\n\n3 Source: Page 11, Line 25 of the insurer group's most recent consolidated statutory Annual Statement. Entered as a positive expense.\n\n4 Source for Column [1], Lines (15) through (18): Page 3 (Liabilities, Surplus and Other Funds) of the insurer group's most recent consolidated statutory Annual Statement, Lines 1, 3, 9 and 37, respectively.\n\nPrior Approval Rate Template Page 3.2 1/12/2016 Edition"],"full_content":"**State** **of** **California Company: Allied** **World** **Insurance** **Company Department** **of** **Insurance** **(CDI) Line: Other** **Liability CDI** **File** **\\#** **(Department** **Use** **Only):**\n\n### **PROJECTED** **YIELD** **AND** **FEDERAL** **INCOME** **TAX** **RATE** **ON** **INVESTMENT** **INCOME**\n\n**(continued)**\n\nInvested Assets ¹ Currently Available Yield ² Return on Invested Assets Federal Income Tax Rate Federal Income Taxes\n\n[1] [2] [3] = [1] \\* [2] [4] [5) = [3] \\* [4]\n\n(1) U.S. Government Bonds\n\n(i) Short‐Term 118,677,580 _0\\.3%_ 316,474 35.00% 110,766\n\n(ii) Intermediate‐Term 208,004,882 _2\\.0%_ 4,236,366 35.00% 1,482,728\n\n(iii) Long‐Term 3,854,148 _2\\.4%_ 93,784 35.00% 32,824\n\n(2) Other Taxable Bonds\n\n(i) Short‐Term 89,373,591 _0\\.6%_ 491,555 35.00% 172,044\n\n(ii) Intermediate‐Term 681,995,940 _3\\.0%_ 20,649,700 35.00% 7,227,395\n\n(iii) Long‐Term 18,952,987 _4\\.2%_ 795,220 35.00% 278,327\n\n(3) Tax‐Exempt Bonds\n\n(i) Short‐Term 12,342,525 _0\\.4%_ 44,125 5.25% 2,317\n\n(ii) Intermediate‐Term 129,992,992 _2\\.0%_ 2,642,754 5.25% 138,745\n\n(iii) Long‐Term 10,156,336 _2\\.9%_ 293,983 5.25% 15,434\n\n(4) Common Stock 356,487,300\n\n(i) Dividends _2\\.1%_ 7,628,828 14.18% 1,081,386\n\n(ii) Capital Gains _7\\.2%_ 25,801,759 34.10% 8,798,400\n\n(5) Preferred Stock Dividends _4\\.9%_ 0 14.18% 0\n\n(6) Mortgage Loans _4\\.2%_ 0 35.00% 0\n\n(7) Real Estate _3\\.4%_ 0 35.00% 0\n\n(8) Cash 179,279,237 _0\\.3%_ 478,078 35.00% 167,327\n\n(9) Other 70,613,686\n\n(i) Dividends _2\\.1%_ 1,511,133 14.18% 214,203\n\n(ii) Capital Gains _7\\.2%_ 5,110,862 34.10% 1,742,804\n\n(10) Total Gross Invested Assets 1,879,731,201 70,094,621 34.10% 21,464,700\n\n(11) Investment Expense ³ 4,978,122 35.00% 1,742,343 (12) Total Net Invested Assets 1,879,731,201 65,116,499 19,722,358\n\n(13) Federal Income Tax: Line (12); column [5]/column [3] **30\\.3%**\n\n(14) Projected Yield on Invested Assets: Line (12), column [3]/column [1] 3.5%\n\nMost Recent Calendar Year (15) Loss Reserves ⁴ 556,929,939\n\n(16) Loss Adjustment Expense Reserves ⁴ 207,276,047\n\n(17) Unearned Premium Reserves ⁴ 242,498,358\n\n(18) Surplus as Regards to Policyholders ⁴ 1,118,479,718\n\n(19) Total Reserves and Surplus 2,125,184,062\n\n(20) Projected Yield adjusted to Reserve and Surplus Base: Line (14), column [2]\\*Line (12), column [1]/Line (10), column [1] **3\\.1%**\n\n1 Source for Column [1], Lines (4) through (9): Page 2 (Assets) of the insurer **group's** most recent consolidated (combined) statutory Annual Statement. ‐ Line (8) Cash: Page 2 (Assets) Line 5, cash only; cash equivalents and short‐term investments are included in Schedule D. ‐ Line (9) Other: Page 2 (Assets) Sum of Lines 6, 8, 9 and 11.\n\n2 Currently available yields are defined in CCR §2644.20. Latest values are posted at:\n\nhttp://www.insurance.ca.gov/0250‐insurers/0800‐rate‐filings/0200‐prior‐approval‐factors/ Month/Year (Yield): **_February_** **_2016_**\n\n3 Source: Page 11, Line 25 of the insurer group's most recent consolidated statutory Annual Statement. Entered as a positive expense.\n\n4 Source for Column [1], Lines (15) through (18): Page 3 (Liabilities, Surplus and Other Funds) of the insurer group's most recent consolidated statutory Annual Statement, Lines 1, 3, 9 and 37, respectively.\n\nPrior Approval Rate Template Page 3.2 1/12/2016 Edition","publish_date":null,"title":"PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2139.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2139.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2139","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2139.pdf"},"started_at":"2026-11-04T19:48:14.887268"} +{"completed_at":"2026-11-04T19:48:19.358923","latency_in_ms":2880,"output":{"example_id":"table/SERFF_CA_random_pages 1_page22","grounded_pages":[],"layout_pages":[],"markdown":"ACA Edition 16 (12/11) 1\n\n**Company: Access General Insurance Company State: California Program: Private Passenger Auto Section: Base Rates & Factors Effective: New Business May 28, 2012**\n\n(B) – Conviction Factors: # Conv. Factor\n\n0 -0.125\n\n1 0.070\n\n2 0.200\n\n3 0.395\n\n4 0.577\n\n5 0.772\n\n6 1.045\n\n7 1.240\n\n8 1.435\n\n9 1.630\n\n10 1.825\n\n11 2.020\n\n12 2.215\n\n13 2.410\n\n14 2.605\n\n15+ 2.800\n\n(C) – Accident Factors:\n\n\\# Acc. Factor\n\n0 -0.001\n\n1 0.259\n\n2 0.649\n\n3 0.974\n\n4 1.299\n\n5 1.624\n\n6 1.949\n\n7 2.274\n\n8 2.599\n\n9 2.924\n\n10+ 3.249\n\n(D) – Term Factors:\n\nTerm Factor\n\n1 month 3 months 6 months\n\n0\\.083 0.250 0.500\n\n12 months 1.000\n\n(A) – Base Rates:\n\nBI [290] 319\n\nPD [242] 290\n\nMP [52] 39\n\nUM/UIM BI [104] 86\n\nUM/UIM PD [18] 20\n\nCP [172] 151\n\nCL [580] 603\n\nTW 21\n\n(E) – Mileage Factors:\n\nBand Factor\n\n0 - 2,499 -0.136\n\n2,499-4,499 -0.127\n\n4,500-5,700 -0.065\n\n5,701-6,999 -0.064\n\n7,000-8,500 -0.001\n\n8,501-10,000 0.006\n\n10,001-11,500 0.037\n\n11,501-13,000 0.049\n\n13,001-14,250 0.075\n\n14,251-15,500 0.091\n\n15,501-16,750 0.113\n\n16,751-18,000 0.134\n\n18,001-21,500 0.145\n\n21,501-24,999 0.170\n\n25,000-29,999 0.189\n\n30,000-49,999 0.204\n\n50,000+ 0.219\n\n(F) – MedPay Limits Factor\n\n500 1.00\n\n1,000 1.20\n\n(G) – BI/PD UM/UIM BI/PD Limits\n\nFactor\n\n15/30/5 0.97\n\n15/30/10 1.00\n\n100/300/50 1.47\n\n(H) – Deductible Factors\n\nDeductible Max Ded Max Ded\n\nAmount Comp Credit Coll Credit\n\n$250 1.000 1.000\n\n$500 0.850 $13 0.850 $27\n\n$1,000 0.600 $40 0.600 $80\n\n$1,500 0.500 $50 0.500 $100\n\n$2,000 0.400 $60 0.400 $125\n\n(I) – Collision Deductible Waiver\n\nDeductible Premium\n\n$250 $20\n\n$500 $28\n\n$1,000 $40\n\n$1,500 $50\n\n$2,000 $60","pages":[{"line_numbers":[],"markdown":"ACA Edition 16 (12/11) 1\n\n**Company: Access General Insurance Company State: California Program: Private Passenger Auto Section: Base Rates & Factors Effective: New Business May 28, 2012**\n\n(B) – Conviction Factors: # Conv. Factor\n\n0 -0.125\n\n1 0.070\n\n2 0.200\n\n3 0.395\n\n4 0.577\n\n5 0.772\n\n6 1.045\n\n7 1.240\n\n8 1.435\n\n9 1.630\n\n10 1.825\n\n11 2.020\n\n12 2.215\n\n13 2.410\n\n14 2.605\n\n15+ 2.800\n\n(C) – Accident Factors:\n\n\\# Acc. Factor\n\n0 -0.001\n\n1 0.259\n\n2 0.649\n\n3 0.974\n\n4 1.299\n\n5 1.624\n\n6 1.949\n\n7 2.274\n\n8 2.599\n\n9 2.924\n\n10+ 3.249\n\n(D) – Term Factors:\n\nTerm Factor\n\n1 month 3 months 6 months\n\n0\\.083 0.250 0.500\n\n12 months 1.000\n\n(A) – Base Rates:\n\nBI [290] 319\n\nPD [242] 290\n\nMP [52] 39\n\nUM/UIM BI [104] 86\n\nUM/UIM PD [18] 20\n\nCP [172] 151\n\nCL [580] 603\n\nTW 21\n\n(E) – Mileage Factors:\n\nBand Factor\n\n0 - 2,499 -0.136\n\n2,499-4,499 -0.127\n\n4,500-5,700 -0.065\n\n5,701-6,999 -0.064\n\n7,000-8,500 -0.001\n\n8,501-10,000 0.006\n\n10,001-11,500 0.037\n\n11,501-13,000 0.049\n\n13,001-14,250 0.075\n\n14,251-15,500 0.091\n\n15,501-16,750 0.113\n\n16,751-18,000 0.134\n\n18,001-21,500 0.145\n\n21,501-24,999 0.170\n\n25,000-29,999 0.189\n\n30,000-49,999 0.204\n\n50,000+ 0.219\n\n(F) – MedPay Limits Factor\n\n500 1.00\n\n1,000 1.20\n\n(G) – BI/PD UM/UIM BI/PD Limits\n\nFactor\n\n15/30/5 0.97\n\n15/30/10 1.00\n\n100/300/50 1.47\n\n(H) – Deductible Factors\n\nDeductible Max Ded Max Ded\n\nAmount Comp Credit Coll Credit\n\n$250 1.000 1.000\n\n$500 0.850 $13 0.850 $27\n\n$1,000 0.600 $40 0.600 $80\n\n$1,500 0.500 $50 0.500 $100\n\n$2,000 0.400 $60 0.400 $125\n\n(I) – Collision Deductible Waiver\n\nDeductible Premium\n\n$250 $20\n\n$500 $28\n\n$1,000 $40\n\n$1,500 $50\n\n$2,000 $60","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"ACA Edition 16 (12/11) 1\n\n**Company: Access General Insurance Company State: California Program: Private Passenger Auto Section: Base Rates & Factors Effective: New Business May 28, 2012**\n\n(B) – Conviction Factors: # Conv. Factor\n\n0 -0.125\n\n1 0.070\n\n2 0.200\n\n3 0.395\n\n4 0.577\n\n5 0.772\n\n6 1.045\n\n7 1.240\n\n8 1.435\n\n9 1.630\n\n10 1.825\n\n11 2.020\n\n12 2.215\n\n13 2.410\n\n14 2.605\n\n15+ 2.800\n\n(C) – Accident Factors:\n\n\\# Acc. Factor\n\n0 -0.001\n\n1 0.259\n\n2 0.649\n\n3 0.974\n\n4 1.299\n\n5 1.624\n\n6 1.949\n\n7 2.274\n\n8 2.599\n\n9 2.924\n\n10+ 3.249\n\n(D) – Term Factors:\n\nTerm Factor\n\n1 month 3 months 6 months\n\n0\\.083 0.250 0.500\n\n12 months 1.000\n\n(A) – Base Rates:\n\nBI [290] 319\n\nPD [242] 290\n\nMP [52] 39\n\nUM/UIM BI [104] 86\n\nUM/UIM PD [18] 20\n\nCP [172] 151\n\nCL [580] 603\n\nTW 21\n\n(E) – Mileage Factors:\n\nBand Factor\n\n0 - 2,499 -0.136\n\n2,499-4,499 -0.127\n\n4,500-5,700 -0.065\n\n5,701-6,999 -0.064\n\n7,000-8,500 -0.001\n\n8,501-10,000 0.006\n\n10,001-11,500 0.037\n\n11,501-13,000 0.049\n\n13,001-14,250 0.075\n\n14,251-15,500 0.091\n\n15,501-16,750 0.113\n\n16,751-18,000 0.134\n\n18,001-21,500 0.145\n\n21,501-24,999 0.170\n\n25,000-29,999 0.189\n\n30,000-49,999 0.204\n\n50,000+ 0.219\n\n(F) – MedPay Limits Factor\n\n500 1.00\n\n1,000 1.20\n\n(G) – BI/PD UM/UIM BI/PD Limits\n\nFactor\n\n15/30/5 0.97\n\n15/30/10 1.00\n\n100/300/50 1.47\n\n(H) – Deductible Factors\n\nDeductible Max Ded Max Ded\n\nAmount Comp Credit Coll Credit\n\n$250 1.000 1.000\n\n$500 0.850 $13 0.850 $27\n\n$1,000 0.600 $40 0.600 $80\n\n$1,500 0.500 $50 0.500 $100\n\n$2,000 0.400 $60 0.400 $125\n\n(I) – Collision Deductible Waiver\n\nDeductible Premium\n\n$250 $20\n\n$500 $28\n\n$1,000 $40\n\n$1,500 $50\n\n$2,000 $60","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page22.pdf"]},"response":{"errors":[],"extract_id":"extract_b74234b488d06a86952e75b4778be09d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["ACA Edition 16 (12/11) 1\n\n**Company: Access General Insurance Company State: California Program: Private Passenger Auto Section: Base Rates & Factors Effective: New Business May 28, 2012**\n\n(B) – Conviction Factors: # Conv. Factor\n\n0 -0.125\n\n1 0.070\n\n2 0.200\n\n3 0.395\n\n4 0.577\n\n5 0.772\n\n6 1.045\n\n7 1.240\n\n8 1.435\n\n9 1.630\n\n10 1.825\n\n11 2.020\n\n12 2.215\n\n13 2.410\n\n14 2.605\n\n15+ 2.800\n\n(C) – Accident Factors:\n\n\\# Acc. Factor\n\n0 -0.001\n\n1 0.259\n\n2 0.649\n\n3 0.974\n\n4 1.299\n\n5 1.624\n\n6 1.949\n\n7 2.274\n\n8 2.599\n\n9 2.924\n\n10+ 3.249\n\n(D) – Term Factors:\n\nTerm Factor\n\n1 month 3 months 6 months\n\n0\\.083 0.250 0.500\n\n12 months 1.000\n\n(A) – Base Rates:\n\nBI [290] 319\n\nPD [242] 290\n\nMP [52] 39\n\nUM/UIM BI [104] 86\n\nUM/UIM PD [18] 20\n\nCP [172] 151\n\nCL [580] 603\n\nTW 21\n\n(E) – Mileage Factors:\n\nBand Factor\n\n0 - 2,499 -0.136\n\n2,499-4,499 -0.127\n\n4,500-5,700 -0.065\n\n5,701-6,999 -0.064\n\n7,000-8,500 -0.001\n\n8,501-10,000 0.006\n\n10,001-11,500 0.037\n\n11,501-13,000 0.049\n\n13,001-14,250 0.075\n\n14,251-15,500 0.091\n\n15,501-16,750 0.113\n\n16,751-18,000 0.134\n\n18,001-21,500 0.145\n\n21,501-24,999 0.170\n\n25,000-29,999 0.189\n\n30,000-49,999 0.204\n\n50,000+ 0.219\n\n(F) – MedPay Limits Factor\n\n500 1.00\n\n1,000 1.20\n\n(G) – BI/PD UM/UIM BI/PD Limits\n\nFactor\n\n15/30/5 0.97\n\n15/30/10 1.00\n\n100/300/50 1.47\n\n(H) – Deductible Factors\n\nDeductible Max Ded Max Ded\n\nAmount Comp Credit Coll Credit\n\n$250 1.000 1.000\n\n$500 0.850 $13 0.850 $27\n\n$1,000 0.600 $40 0.600 $80\n\n$1,500 0.500 $50 0.500 $100\n\n$2,000 0.400 $60 0.400 $125\n\n(I) – Collision Deductible Waiver\n\nDeductible Premium\n\n$250 $20\n\n$500 $28\n\n$1,000 $40\n\n$1,500 $50\n\n$2,000 $60"],"full_content":"ACA Edition 16 (12/11) 1\n\n**Company: Access General Insurance Company State: California Program: Private Passenger Auto Section: Base Rates & Factors Effective: New Business May 28, 2012**\n\n(B) – Conviction Factors: # Conv. Factor\n\n0 -0.125\n\n1 0.070\n\n2 0.200\n\n3 0.395\n\n4 0.577\n\n5 0.772\n\n6 1.045\n\n7 1.240\n\n8 1.435\n\n9 1.630\n\n10 1.825\n\n11 2.020\n\n12 2.215\n\n13 2.410\n\n14 2.605\n\n15+ 2.800\n\n(C) – Accident Factors:\n\n\\# Acc. Factor\n\n0 -0.001\n\n1 0.259\n\n2 0.649\n\n3 0.974\n\n4 1.299\n\n5 1.624\n\n6 1.949\n\n7 2.274\n\n8 2.599\n\n9 2.924\n\n10+ 3.249\n\n(D) – Term Factors:\n\nTerm Factor\n\n1 month 3 months 6 months\n\n0\\.083 0.250 0.500\n\n12 months 1.000\n\n(A) – Base Rates:\n\nBI [290] 319\n\nPD [242] 290\n\nMP [52] 39\n\nUM/UIM BI [104] 86\n\nUM/UIM PD [18] 20\n\nCP [172] 151\n\nCL [580] 603\n\nTW 21\n\n(E) – Mileage Factors:\n\nBand Factor\n\n0 - 2,499 -0.136\n\n2,499-4,499 -0.127\n\n4,500-5,700 -0.065\n\n5,701-6,999 -0.064\n\n7,000-8,500 -0.001\n\n8,501-10,000 0.006\n\n10,001-11,500 0.037\n\n11,501-13,000 0.049\n\n13,001-14,250 0.075\n\n14,251-15,500 0.091\n\n15,501-16,750 0.113\n\n16,751-18,000 0.134\n\n18,001-21,500 0.145\n\n21,501-24,999 0.170\n\n25,000-29,999 0.189\n\n30,000-49,999 0.204\n\n50,000+ 0.219\n\n(F) – MedPay Limits Factor\n\n500 1.00\n\n1,000 1.20\n\n(G) – BI/PD UM/UIM BI/PD Limits\n\nFactor\n\n15/30/5 0.97\n\n15/30/10 1.00\n\n100/300/50 1.47\n\n(H) – Deductible Factors\n\nDeductible Max Ded Max Ded\n\nAmount Comp Credit Coll Credit\n\n$250 1.000 1.000\n\n$500 0.850 $13 0.850 $27\n\n$1,000 0.600 $40 0.600 $80\n\n$1,500 0.500 $50 0.500 $100\n\n$2,000 0.400 $60 0.400 $125\n\n(I) – Collision Deductible Waiver\n\nDeductible Premium\n\n$250 $20\n\n$500 $28\n\n$1,000 $40\n\n$1,500 $50\n\n$2,000 $60","publish_date":null,"title":"Company: Access General Insurance Company State: California Program: Private Passenger Auto Section: Base Rates & Factors Effective: (A) – Base","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page22.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page22.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page22","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page22.pdf"},"started_at":"2026-11-04T19:48:16.478353"} +{"completed_at":"2026-11-04T19:48:19.727738","latency_in_ms":2276,"output":{"example_id":"table/SERFF_CA_random_pages 1_page223","grounded_pages":[],"layout_pages":[],"markdown":"COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE AND ALLIED LINES MISCELLANEOUS RULES **EQUIPMENT BREAKDOWN COVERAGE (Cont’d)** To determine the rate for intermediate values, apply the following calculation: =C/(V/1000)^e Where V is the insurable value.\n\nExample: Rating ID A1 V: $400,000 $0.0919 = 8.339/(400000/1000)^0.752\n\nC: 8.339 $368 = $400,000/100 x 0.0919\n\ne: 0.752\n\n**(b) Actual Cash Value** If the valuation of loss is on an Actual Cash Value basis, multiply the base premium from (2)(a) by a factor of 0.870.\n\n**(3) Reserved for Future Use**\n\n**(4) Equipment Modification**\n\nThe Base Premium includes loss content for all general types of equipment used in building operating systems. The premium may be modified to reflect absence of certain types of equipment or additional equipment not contemplated in the rates.\n\n**(a)** Select the Equipment Modification (EM) factor(s) for all applicable items.\n\n**EM Factors Equipment / Conditions**\n\n0\\.150 Risk has diagnostic equipment\n\n(0.240) Risk does not have any steam or hot water boilers\n\n0\\.200 Risk uses steam for processing\n\n0\\.500 Risk has printers with more than 3 color capability\n\n0\\.100 Risk has products in refrigerated storage\n\n(0.150) Risk does not have any A/C > 50 hp\n\n(0.350) Risk does not have any A/C equipment\n\n(0.050) Risk does not have any owned transformers\n\n0\\.200 Presses greater than 250 but no larger than 500 tons\n\n0\\.400 Presses greater than 500 tons\n\n**(b)** Add all EM Factors together and add to 1.000 to create a factor to modify the premium. Multiply the premium from Step (2) by this factor.\n\n**(5) Optional PD Deductibles**\n\nThe base rates contemplate a deductible of $500. **(a)** If a deductible other than $500 is desired, select the applicable Deductible Factor from Table B.\n\nALLSTATE INSURANCE COMPANY CA-CP-EB-4 06/03/11","pages":[{"line_numbers":[],"markdown":"COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE AND ALLIED LINES MISCELLANEOUS RULES **EQUIPMENT BREAKDOWN COVERAGE (Cont’d)** To determine the rate for intermediate values, apply the following calculation: =C/(V/1000)^e Where V is the insurable value.\n\nExample: Rating ID A1 V: $400,000 $0.0919 = 8.339/(400000/1000)^0.752\n\nC: 8.339 $368 = $400,000/100 x 0.0919\n\ne: 0.752\n\n**(b) Actual Cash Value** If the valuation of loss is on an Actual Cash Value basis, multiply the base premium from (2)(a) by a factor of 0.870.\n\n**(3) Reserved for Future Use**\n\n**(4) Equipment Modification**\n\nThe Base Premium includes loss content for all general types of equipment used in building operating systems. The premium may be modified to reflect absence of certain types of equipment or additional equipment not contemplated in the rates.\n\n**(a)** Select the Equipment Modification (EM) factor(s) for all applicable items.\n\n**EM Factors Equipment / Conditions**\n\n0\\.150 Risk has diagnostic equipment\n\n(0.240) Risk does not have any steam or hot water boilers\n\n0\\.200 Risk uses steam for processing\n\n0\\.500 Risk has printers with more than 3 color capability\n\n0\\.100 Risk has products in refrigerated storage\n\n(0.150) Risk does not have any A/C > 50 hp\n\n(0.350) Risk does not have any A/C equipment\n\n(0.050) Risk does not have any owned transformers\n\n0\\.200 Presses greater than 250 but no larger than 500 tons\n\n0\\.400 Presses greater than 500 tons\n\n**(b)** Add all EM Factors together and add to 1.000 to create a factor to modify the premium. Multiply the premium from Step (2) by this factor.\n\n**(5) Optional PD Deductibles**\n\nThe base rates contemplate a deductible of $500. **(a)** If a deductible other than $500 is desired, select the applicable Deductible Factor from Table B.\n\nALLSTATE INSURANCE COMPANY CA-CP-EB-4 06/03/11","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE AND ALLIED LINES MISCELLANEOUS RULES **EQUIPMENT BREAKDOWN COVERAGE (Cont’d)** To determine the rate for intermediate values, apply the following calculation: =C/(V/1000)^e Where V is the insurable value.\n\nExample: Rating ID A1 V: $400,000 $0.0919 = 8.339/(400000/1000)^0.752\n\nC: 8.339 $368 = $400,000/100 x 0.0919\n\ne: 0.752\n\n**(b) Actual Cash Value** If the valuation of loss is on an Actual Cash Value basis, multiply the base premium from (2)(a) by a factor of 0.870.\n\n**(3) Reserved for Future Use**\n\n**(4) Equipment Modification**\n\nThe Base Premium includes loss content for all general types of equipment used in building operating systems. The premium may be modified to reflect absence of certain types of equipment or additional equipment not contemplated in the rates.\n\n**(a)** Select the Equipment Modification (EM) factor(s) for all applicable items.\n\n**EM Factors Equipment / Conditions**\n\n0\\.150 Risk has diagnostic equipment\n\n(0.240) Risk does not have any steam or hot water boilers\n\n0\\.200 Risk uses steam for processing\n\n0\\.500 Risk has printers with more than 3 color capability\n\n0\\.100 Risk has products in refrigerated storage\n\n(0.150) Risk does not have any A/C > 50 hp\n\n(0.350) Risk does not have any A/C equipment\n\n(0.050) Risk does not have any owned transformers\n\n0\\.200 Presses greater than 250 but no larger than 500 tons\n\n0\\.400 Presses greater than 500 tons\n\n**(b)** Add all EM Factors together and add to 1.000 to create a factor to modify the premium. Multiply the premium from Step (2) by this factor.\n\n**(5) Optional PD Deductibles**\n\nThe base rates contemplate a deductible of $500. **(a)** If a deductible other than $500 is desired, select the applicable Deductible Factor from Table B.\n\nALLSTATE INSURANCE COMPANY CA-CP-EB-4 06/03/11","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page223.pdf"]},"response":{"errors":[],"extract_id":"extract_bfac348a88711f63997e9c58fdaa8103","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE AND ALLIED LINES MISCELLANEOUS RULES **EQUIPMENT BREAKDOWN COVERAGE (Cont’d)** To determine the rate for intermediate values, apply the following calculation: =C/(V/1000)^e Where V is the insurable value.\n\nExample: Rating ID A1 V: $400,000 $0.0919 = 8.339/(400000/1000)^0.752\n\nC: 8.339 $368 = $400,000/100 x 0.0919\n\ne: 0.752\n\n**(b) Actual Cash Value** If the valuation of loss is on an Actual Cash Value basis, multiply the base premium from (2)(a) by a factor of 0.870.\n\n**(3) Reserved for Future Use**\n\n**(4) Equipment Modification**\n\nThe Base Premium includes loss content for all general types of equipment used in building operating systems. The premium may be modified to reflect absence of certain types of equipment or additional equipment not contemplated in the rates.\n\n**(a)** Select the Equipment Modification (EM) factor(s) for all applicable items.\n\n**EM Factors Equipment / Conditions**\n\n0\\.150 Risk has diagnostic equipment\n\n(0.240) Risk does not have any steam or hot water boilers\n\n0\\.200 Risk uses steam for processing\n\n0\\.500 Risk has printers with more than 3 color capability\n\n0\\.100 Risk has products in refrigerated storage\n\n(0.150) Risk does not have any A/C > 50 hp\n\n(0.350) Risk does not have any A/C equipment\n\n(0.050) Risk does not have any owned transformers\n\n0\\.200 Presses greater than 250 but no larger than 500 tons\n\n0\\.400 Presses greater than 500 tons\n\n**(b)** Add all EM Factors together and add to 1.000 to create a factor to modify the premium. Multiply the premium from Step (2) by this factor.\n\n**(5) Optional PD Deductibles**\n\nThe base rates contemplate a deductible of $500. **(a)** If a deductible other than $500 is desired, select the applicable Deductible Factor from Table B.\n\nALLSTATE INSURANCE COMPANY CA-CP-EB-4 06/03/11"],"full_content":"COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE AND ALLIED LINES MISCELLANEOUS RULES **EQUIPMENT BREAKDOWN COVERAGE (Cont’d)** To determine the rate for intermediate values, apply the following calculation: =C/(V/1000)^e Where V is the insurable value.\n\nExample: Rating ID A1 V: $400,000 $0.0919 = 8.339/(400000/1000)^0.752\n\nC: 8.339 $368 = $400,000/100 x 0.0919\n\ne: 0.752\n\n**(b) Actual Cash Value** If the valuation of loss is on an Actual Cash Value basis, multiply the base premium from (2)(a) by a factor of 0.870.\n\n**(3) Reserved for Future Use**\n\n**(4) Equipment Modification**\n\nThe Base Premium includes loss content for all general types of equipment used in building operating systems. The premium may be modified to reflect absence of certain types of equipment or additional equipment not contemplated in the rates.\n\n**(a)** Select the Equipment Modification (EM) factor(s) for all applicable items.\n\n**EM Factors Equipment / Conditions**\n\n0\\.150 Risk has diagnostic equipment\n\n(0.240) Risk does not have any steam or hot water boilers\n\n0\\.200 Risk uses steam for processing\n\n0\\.500 Risk has printers with more than 3 color capability\n\n0\\.100 Risk has products in refrigerated storage\n\n(0.150) Risk does not have any A/C > 50 hp\n\n(0.350) Risk does not have any A/C equipment\n\n(0.050) Risk does not have any owned transformers\n\n0\\.200 Presses greater than 250 but no larger than 500 tons\n\n0\\.400 Presses greater than 500 tons\n\n**(b)** Add all EM Factors together and add to 1.000 to create a factor to modify the premium. Multiply the premium from Step (2) by this factor.\n\n**(5) Optional PD Deductibles**\n\nThe base rates contemplate a deductible of $500. **(a)** If a deductible other than $500 is desired, select the applicable Deductible Factor from Table B.\n\nALLSTATE INSURANCE COMPANY CA-CP-EB-4 06/03/11","publish_date":null,"title":"COMMERCIAL LINES MANUAL EXCEPTION CALIFORNIA THE INSURANCE SERVICES OFFICE COMMERCIAL LINES MANUAL APPLIES EXCEPT AS MODIFIED BELOW: DIVISION FIVE FIRE","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page223.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page223.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page223","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page223.pdf"},"started_at":"2026-11-04T19:48:17.451433"} +{"completed_at":"2026-11-04T19:48:20.884107","latency_in_ms":1540,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2248","grounded_pages":[],"layout_pages":[],"markdown":"Aegis Security Primary Residence Insurance Program\n\n39 HO-Man-CA (Ed. 10.0)\n\n**Zip Code HO-3 HO-4 HO-6 Zip Code HO-3 HO-4 HO-6**\n\n90001 0.96024 0.95904 0.73186 90059 1.06951 1.07196 0.73186 90002 0.97829 0.95904 0.73186 90061 0.97268 0.95904 0.74066 90003 1.01481 0.96831 0.77355 90062 1.15541 0.97349 1.00675 90004 1.14816 1.13735 1.05255 90063 0.89141 0.84625 0.57652 90005 1.19093 1.10216 0.96771 90064 1.10683 1.13333 1.10086 90006 0.97858 0.97349 0.97278 90065 0.91797 0.84391 0.93246 90007 1.00556 0.97349 0.69658 90066 0.92624 0.97116 0.99542 90008 1.33262 0.96947 1.00675 90067 1.22652 1.15873 1.34176 90010 1.09893 0.97349 0.96246 90068 1.34276 1.18008 1.35088 90011 0.91653 0.97349 0.69658 90069 1.43809 1.15176 1.14812 90012 0.95357 0.97116 0.76927 90071 1.22704 0.97116 0.97278 90013 1.03131 0.97116 0.76927 90077 1.26308 1.15873 1.35333 90014 1.03836 0.97116 0.97278 90079 1.16646 0.97116 0.76927 90015 1.06024 0.97116 0.97278 90094 0.99738 0.85698 0.70959 90016 1.22876 1.10216 1.00439 90201 0.98269 0.95904 0.73186 90017 1.00162 0.98790 0.97278 90210 1.49027 1.17314 1.32108 90018 1.08094 1.08775 1.00675 90211 1.43863 1.13735 1.12540 90019 1.05794 1.08775 0.98770 90212 1.38984 1.15176 1.12540 90020 1.00123 0.97349 0.96246 90213 1.75055 1.18008 1.38016 90021 0.98867 0.97116 0.97278 90220 0.96049 1.07196 0.73186 90022 0.80863 0.85469 0.57652 90221 0.94190 1.07196 0.73186 90023 1.03891 0.84257 0.76927 90222 1.10356 1.07196 0.73186 90024 1.18479 1.13333 1.06683 90230 0.97212 0.97116 1.06683 90025 1.10478 1.01907 1.11163 90232 0.99338 0.97349 1.00574 90026 0.94929 0.97116 0.97208 90240 0.91734 0.95770 0.75965 90027 0.96017 0.97349 0.96246 90241 0.81633 0.95770 0.73186 90028 1.07737 1.13735 1.05255 90242 0.87963 1.08637 0.75248 90029 1.09929 0.97349 1.05255 90245 0.94621 0.85603 0.80325 90031 0.90460 0.85698 0.70959 90247 1.02756 0.96598 0.74066 90032 0.91152 0.95770 0.60582 90248 0.85878 0.96598 0.74066 90033 0.93444 0.97116 0.76927 90249 0.97781 0.98043 0.77909 90034 1.12867 1.01907 1.04611 90250 0.88234 1.07330 0.74800 90035 1.30310 1.10216 1.01770 90254 0.98956 0.97349 0.73347 90036 1.29086 1.08775 0.94033 90255 0.80327 0.85085 0.73186 90037 1.03191 0.97349 0.69658 90260 0.86776 0.97116 0.97208 90038 1.13266 1.13735 1.05255 90261 1.04546 0.97116 0.97208 90039 0.99969 0.97116 0.93246 90262 0.95330 0.95770 0.73186 90040 0.86981 0.85469 0.64731 90263 1.18466 0.96947 1.02034 90041 0.98550 0.95904 0.76927 90265 1.21890 0.96947 1.02034 90042 0.86653 0.95904 0.65717 90266 1.04443 0.85836 0.94380 90043 1.09557 0.96137 0.80325 90270 0.84215 0.85085 0.73186 90044 1.05465 0.95904 0.77355 90272 1.08953 1.13333 1.08746 90045 1.02903 0.97116 0.96176 90274 1.05098 0.98790 0.69428 90046 1.32439 1.13735 1.03015 90275 0.94161 0.97349 0.84044 90047 1.09426 0.98154 0.77355 90277 1.00267 0.97349 0.73781 90048 1.25669 1.15176 1.11558 90278 1.00635 0.97810 0.73990 90049 1.17684 1.15873 1.33792 90280 0.91455 0.95904 0.73186 90056 1.18541 0.97349 1.00675 90290 0.93894 1.14774 1.35333 90057 0.94528 0.97116 0.97208 90291 1.09282 1.09469 1.02945 90058 0.92691 0.85085 0.73186 90292 1.09135 1.01673 1.11011\n\n**Territory Factors - California Primary Residence Insurance Program**","pages":[{"line_numbers":[],"markdown":"Aegis Security Primary Residence Insurance Program\n\n39 HO-Man-CA (Ed. 10.0)\n\n**Zip Code HO-3 HO-4 HO-6 Zip Code HO-3 HO-4 HO-6**\n\n90001 0.96024 0.95904 0.73186 90059 1.06951 1.07196 0.73186 90002 0.97829 0.95904 0.73186 90061 0.97268 0.95904 0.74066 90003 1.01481 0.96831 0.77355 90062 1.15541 0.97349 1.00675 90004 1.14816 1.13735 1.05255 90063 0.89141 0.84625 0.57652 90005 1.19093 1.10216 0.96771 90064 1.10683 1.13333 1.10086 90006 0.97858 0.97349 0.97278 90065 0.91797 0.84391 0.93246 90007 1.00556 0.97349 0.69658 90066 0.92624 0.97116 0.99542 90008 1.33262 0.96947 1.00675 90067 1.22652 1.15873 1.34176 90010 1.09893 0.97349 0.96246 90068 1.34276 1.18008 1.35088 90011 0.91653 0.97349 0.69658 90069 1.43809 1.15176 1.14812 90012 0.95357 0.97116 0.76927 90071 1.22704 0.97116 0.97278 90013 1.03131 0.97116 0.76927 90077 1.26308 1.15873 1.35333 90014 1.03836 0.97116 0.97278 90079 1.16646 0.97116 0.76927 90015 1.06024 0.97116 0.97278 90094 0.99738 0.85698 0.70959 90016 1.22876 1.10216 1.00439 90201 0.98269 0.95904 0.73186 90017 1.00162 0.98790 0.97278 90210 1.49027 1.17314 1.32108 90018 1.08094 1.08775 1.00675 90211 1.43863 1.13735 1.12540 90019 1.05794 1.08775 0.98770 90212 1.38984 1.15176 1.12540 90020 1.00123 0.97349 0.96246 90213 1.75055 1.18008 1.38016 90021 0.98867 0.97116 0.97278 90220 0.96049 1.07196 0.73186 90022 0.80863 0.85469 0.57652 90221 0.94190 1.07196 0.73186 90023 1.03891 0.84257 0.76927 90222 1.10356 1.07196 0.73186 90024 1.18479 1.13333 1.06683 90230 0.97212 0.97116 1.06683 90025 1.10478 1.01907 1.11163 90232 0.99338 0.97349 1.00574 90026 0.94929 0.97116 0.97208 90240 0.91734 0.95770 0.75965 90027 0.96017 0.97349 0.96246 90241 0.81633 0.95770 0.73186 90028 1.07737 1.13735 1.05255 90242 0.87963 1.08637 0.75248 90029 1.09929 0.97349 1.05255 90245 0.94621 0.85603 0.80325 90031 0.90460 0.85698 0.70959 90247 1.02756 0.96598 0.74066 90032 0.91152 0.95770 0.60582 90248 0.85878 0.96598 0.74066 90033 0.93444 0.97116 0.76927 90249 0.97781 0.98043 0.77909 90034 1.12867 1.01907 1.04611 90250 0.88234 1.07330 0.74800 90035 1.30310 1.10216 1.01770 90254 0.98956 0.97349 0.73347 90036 1.29086 1.08775 0.94033 90255 0.80327 0.85085 0.73186 90037 1.03191 0.97349 0.69658 90260 0.86776 0.97116 0.97208 90038 1.13266 1.13735 1.05255 90261 1.04546 0.97116 0.97208 90039 0.99969 0.97116 0.93246 90262 0.95330 0.95770 0.73186 90040 0.86981 0.85469 0.64731 90263 1.18466 0.96947 1.02034 90041 0.98550 0.95904 0.76927 90265 1.21890 0.96947 1.02034 90042 0.86653 0.95904 0.65717 90266 1.04443 0.85836 0.94380 90043 1.09557 0.96137 0.80325 90270 0.84215 0.85085 0.73186 90044 1.05465 0.95904 0.77355 90272 1.08953 1.13333 1.08746 90045 1.02903 0.97116 0.96176 90274 1.05098 0.98790 0.69428 90046 1.32439 1.13735 1.03015 90275 0.94161 0.97349 0.84044 90047 1.09426 0.98154 0.77355 90277 1.00267 0.97349 0.73781 90048 1.25669 1.15176 1.11558 90278 1.00635 0.97810 0.73990 90049 1.17684 1.15873 1.33792 90280 0.91455 0.95904 0.73186 90056 1.18541 0.97349 1.00675 90290 0.93894 1.14774 1.35333 90057 0.94528 0.97116 0.97208 90291 1.09282 1.09469 1.02945 90058 0.92691 0.85085 0.73186 90292 1.09135 1.01673 1.11011\n\n**Territory Factors - California Primary Residence Insurance Program**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Aegis Security Primary Residence Insurance Program\n\n39 HO-Man-CA (Ed. 10.0)\n\n**Zip Code HO-3 HO-4 HO-6 Zip Code HO-3 HO-4 HO-6**\n\n90001 0.96024 0.95904 0.73186 90059 1.06951 1.07196 0.73186 90002 0.97829 0.95904 0.73186 90061 0.97268 0.95904 0.74066 90003 1.01481 0.96831 0.77355 90062 1.15541 0.97349 1.00675 90004 1.14816 1.13735 1.05255 90063 0.89141 0.84625 0.57652 90005 1.19093 1.10216 0.96771 90064 1.10683 1.13333 1.10086 90006 0.97858 0.97349 0.97278 90065 0.91797 0.84391 0.93246 90007 1.00556 0.97349 0.69658 90066 0.92624 0.97116 0.99542 90008 1.33262 0.96947 1.00675 90067 1.22652 1.15873 1.34176 90010 1.09893 0.97349 0.96246 90068 1.34276 1.18008 1.35088 90011 0.91653 0.97349 0.69658 90069 1.43809 1.15176 1.14812 90012 0.95357 0.97116 0.76927 90071 1.22704 0.97116 0.97278 90013 1.03131 0.97116 0.76927 90077 1.26308 1.15873 1.35333 90014 1.03836 0.97116 0.97278 90079 1.16646 0.97116 0.76927 90015 1.06024 0.97116 0.97278 90094 0.99738 0.85698 0.70959 90016 1.22876 1.10216 1.00439 90201 0.98269 0.95904 0.73186 90017 1.00162 0.98790 0.97278 90210 1.49027 1.17314 1.32108 90018 1.08094 1.08775 1.00675 90211 1.43863 1.13735 1.12540 90019 1.05794 1.08775 0.98770 90212 1.38984 1.15176 1.12540 90020 1.00123 0.97349 0.96246 90213 1.75055 1.18008 1.38016 90021 0.98867 0.97116 0.97278 90220 0.96049 1.07196 0.73186 90022 0.80863 0.85469 0.57652 90221 0.94190 1.07196 0.73186 90023 1.03891 0.84257 0.76927 90222 1.10356 1.07196 0.73186 90024 1.18479 1.13333 1.06683 90230 0.97212 0.97116 1.06683 90025 1.10478 1.01907 1.11163 90232 0.99338 0.97349 1.00574 90026 0.94929 0.97116 0.97208 90240 0.91734 0.95770 0.75965 90027 0.96017 0.97349 0.96246 90241 0.81633 0.95770 0.73186 90028 1.07737 1.13735 1.05255 90242 0.87963 1.08637 0.75248 90029 1.09929 0.97349 1.05255 90245 0.94621 0.85603 0.80325 90031 0.90460 0.85698 0.70959 90247 1.02756 0.96598 0.74066 90032 0.91152 0.95770 0.60582 90248 0.85878 0.96598 0.74066 90033 0.93444 0.97116 0.76927 90249 0.97781 0.98043 0.77909 90034 1.12867 1.01907 1.04611 90250 0.88234 1.07330 0.74800 90035 1.30310 1.10216 1.01770 90254 0.98956 0.97349 0.73347 90036 1.29086 1.08775 0.94033 90255 0.80327 0.85085 0.73186 90037 1.03191 0.97349 0.69658 90260 0.86776 0.97116 0.97208 90038 1.13266 1.13735 1.05255 90261 1.04546 0.97116 0.97208 90039 0.99969 0.97116 0.93246 90262 0.95330 0.95770 0.73186 90040 0.86981 0.85469 0.64731 90263 1.18466 0.96947 1.02034 90041 0.98550 0.95904 0.76927 90265 1.21890 0.96947 1.02034 90042 0.86653 0.95904 0.65717 90266 1.04443 0.85836 0.94380 90043 1.09557 0.96137 0.80325 90270 0.84215 0.85085 0.73186 90044 1.05465 0.95904 0.77355 90272 1.08953 1.13333 1.08746 90045 1.02903 0.97116 0.96176 90274 1.05098 0.98790 0.69428 90046 1.32439 1.13735 1.03015 90275 0.94161 0.97349 0.84044 90047 1.09426 0.98154 0.77355 90277 1.00267 0.97349 0.73781 90048 1.25669 1.15176 1.11558 90278 1.00635 0.97810 0.73990 90049 1.17684 1.15873 1.33792 90280 0.91455 0.95904 0.73186 90056 1.18541 0.97349 1.00675 90290 0.93894 1.14774 1.35333 90057 0.94528 0.97116 0.97208 90291 1.09282 1.09469 1.02945 90058 0.92691 0.85085 0.73186 90292 1.09135 1.01673 1.11011\n\n**Territory Factors - California Primary Residence Insurance Program**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2248.pdf"]},"response":{"errors":[],"extract_id":"extract_85845b6b7bed96860475fb2155cb9889","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Aegis Security Primary Residence Insurance Program\n\n39 HO-Man-CA (Ed. 10.0)\n\n**Zip Code HO-3 HO-4 HO-6 Zip Code HO-3 HO-4 HO-6**\n\n90001 0.96024 0.95904 0.73186 90059 1.06951 1.07196 0.73186 90002 0.97829 0.95904 0.73186 90061 0.97268 0.95904 0.74066 90003 1.01481 0.96831 0.77355 90062 1.15541 0.97349 1.00675 90004 1.14816 1.13735 1.05255 90063 0.89141 0.84625 0.57652 90005 1.19093 1.10216 0.96771 90064 1.10683 1.13333 1.10086 90006 0.97858 0.97349 0.97278 90065 0.91797 0.84391 0.93246 90007 1.00556 0.97349 0.69658 90066 0.92624 0.97116 0.99542 90008 1.33262 0.96947 1.00675 90067 1.22652 1.15873 1.34176 90010 1.09893 0.97349 0.96246 90068 1.34276 1.18008 1.35088 90011 0.91653 0.97349 0.69658 90069 1.43809 1.15176 1.14812 90012 0.95357 0.97116 0.76927 90071 1.22704 0.97116 0.97278 90013 1.03131 0.97116 0.76927 90077 1.26308 1.15873 1.35333 90014 1.03836 0.97116 0.97278 90079 1.16646 0.97116 0.76927 90015 1.06024 0.97116 0.97278 90094 0.99738 0.85698 0.70959 90016 1.22876 1.10216 1.00439 90201 0.98269 0.95904 0.73186 90017 1.00162 0.98790 0.97278 90210 1.49027 1.17314 1.32108 90018 1.08094 1.08775 1.00675 90211 1.43863 1.13735 1.12540 90019 1.05794 1.08775 0.98770 90212 1.38984 1.15176 1.12540 90020 1.00123 0.97349 0.96246 90213 1.75055 1.18008 1.38016 90021 0.98867 0.97116 0.97278 90220 0.96049 1.07196 0.73186 90022 0.80863 0.85469 0.57652 90221 0.94190 1.07196 0.73186 90023 1.03891 0.84257 0.76927 90222 1.10356 1.07196 0.73186 90024 1.18479 1.13333 1.06683 90230 0.97212 0.97116 1.06683 90025 1.10478 1.01907 1.11163 90232 0.99338 0.97349 1.00574 90026 0.94929 0.97116 0.97208 90240 0.91734 0.95770 0.75965 90027 0.96017 0.97349 0.96246 90241 0.81633 0.95770 0.73186 90028 1.07737 1.13735 1.05255 90242 0.87963 1.08637 0.75248 90029 1.09929 0.97349 1.05255 90245 0.94621 0.85603 0.80325 90031 0.90460 0.85698 0.70959 90247 1.02756 0.96598 0.74066 90032 0.91152 0.95770 0.60582 90248 0.85878 0.96598 0.74066 90033 0.93444 0.97116 0.76927 90249 0.97781 0.98043 0.77909 90034 1.12867 1.01907 1.04611 90250 0.88234 1.07330 0.74800 90035 1.30310 1.10216 1.01770 90254 0.98956 0.97349 0.73347 90036 1.29086 1.08775 0.94033 90255 0.80327 0.85085 0.73186 90037 1.03191 0.97349 0.69658 90260 0.86776 0.97116 0.97208 90038 1.13266 1.13735 1.05255 90261 1.04546 0.97116 0.97208 90039 0.99969 0.97116 0.93246 90262 0.95330 0.95770 0.73186 90040 0.86981 0.85469 0.64731 90263 1.18466 0.96947 1.02034 90041 0.98550 0.95904 0.76927 90265 1.21890 0.96947 1.02034 90042 0.86653 0.95904 0.65717 90266 1.04443 0.85836 0.94380 90043 1.09557 0.96137 0.80325 90270 0.84215 0.85085 0.73186 90044 1.05465 0.95904 0.77355 90272 1.08953 1.13333 1.08746 90045 1.02903 0.97116 0.96176 90274 1.05098 0.98790 0.69428 90046 1.32439 1.13735 1.03015 90275 0.94161 0.97349 0.84044 90047 1.09426 0.98154 0.77355 90277 1.00267 0.97349 0.73781 90048 1.25669 1.15176 1.11558 90278 1.00635 0.97810 0.73990 90049 1.17684 1.15873 1.33792 90280 0.91455 0.95904 0.73186 90056 1.18541 0.97349 1.00675 90290 0.93894 1.14774 1.35333 90057 0.94528 0.97116 0.97208 90291 1.09282 1.09469 1.02945 90058 0.92691 0.85085 0.73186 90292 1.09135 1.01673 1.11011\n\n**Territory Factors - California Primary Residence Insurance Program**"],"full_content":"Aegis Security Primary Residence Insurance Program\n\n39 HO-Man-CA (Ed. 10.0)\n\n**Zip Code HO-3 HO-4 HO-6 Zip Code HO-3 HO-4 HO-6**\n\n90001 0.96024 0.95904 0.73186 90059 1.06951 1.07196 0.73186 90002 0.97829 0.95904 0.73186 90061 0.97268 0.95904 0.74066 90003 1.01481 0.96831 0.77355 90062 1.15541 0.97349 1.00675 90004 1.14816 1.13735 1.05255 90063 0.89141 0.84625 0.57652 90005 1.19093 1.10216 0.96771 90064 1.10683 1.13333 1.10086 90006 0.97858 0.97349 0.97278 90065 0.91797 0.84391 0.93246 90007 1.00556 0.97349 0.69658 90066 0.92624 0.97116 0.99542 90008 1.33262 0.96947 1.00675 90067 1.22652 1.15873 1.34176 90010 1.09893 0.97349 0.96246 90068 1.34276 1.18008 1.35088 90011 0.91653 0.97349 0.69658 90069 1.43809 1.15176 1.14812 90012 0.95357 0.97116 0.76927 90071 1.22704 0.97116 0.97278 90013 1.03131 0.97116 0.76927 90077 1.26308 1.15873 1.35333 90014 1.03836 0.97116 0.97278 90079 1.16646 0.97116 0.76927 90015 1.06024 0.97116 0.97278 90094 0.99738 0.85698 0.70959 90016 1.22876 1.10216 1.00439 90201 0.98269 0.95904 0.73186 90017 1.00162 0.98790 0.97278 90210 1.49027 1.17314 1.32108 90018 1.08094 1.08775 1.00675 90211 1.43863 1.13735 1.12540 90019 1.05794 1.08775 0.98770 90212 1.38984 1.15176 1.12540 90020 1.00123 0.97349 0.96246 90213 1.75055 1.18008 1.38016 90021 0.98867 0.97116 0.97278 90220 0.96049 1.07196 0.73186 90022 0.80863 0.85469 0.57652 90221 0.94190 1.07196 0.73186 90023 1.03891 0.84257 0.76927 90222 1.10356 1.07196 0.73186 90024 1.18479 1.13333 1.06683 90230 0.97212 0.97116 1.06683 90025 1.10478 1.01907 1.11163 90232 0.99338 0.97349 1.00574 90026 0.94929 0.97116 0.97208 90240 0.91734 0.95770 0.75965 90027 0.96017 0.97349 0.96246 90241 0.81633 0.95770 0.73186 90028 1.07737 1.13735 1.05255 90242 0.87963 1.08637 0.75248 90029 1.09929 0.97349 1.05255 90245 0.94621 0.85603 0.80325 90031 0.90460 0.85698 0.70959 90247 1.02756 0.96598 0.74066 90032 0.91152 0.95770 0.60582 90248 0.85878 0.96598 0.74066 90033 0.93444 0.97116 0.76927 90249 0.97781 0.98043 0.77909 90034 1.12867 1.01907 1.04611 90250 0.88234 1.07330 0.74800 90035 1.30310 1.10216 1.01770 90254 0.98956 0.97349 0.73347 90036 1.29086 1.08775 0.94033 90255 0.80327 0.85085 0.73186 90037 1.03191 0.97349 0.69658 90260 0.86776 0.97116 0.97208 90038 1.13266 1.13735 1.05255 90261 1.04546 0.97116 0.97208 90039 0.99969 0.97116 0.93246 90262 0.95330 0.95770 0.73186 90040 0.86981 0.85469 0.64731 90263 1.18466 0.96947 1.02034 90041 0.98550 0.95904 0.76927 90265 1.21890 0.96947 1.02034 90042 0.86653 0.95904 0.65717 90266 1.04443 0.85836 0.94380 90043 1.09557 0.96137 0.80325 90270 0.84215 0.85085 0.73186 90044 1.05465 0.95904 0.77355 90272 1.08953 1.13333 1.08746 90045 1.02903 0.97116 0.96176 90274 1.05098 0.98790 0.69428 90046 1.32439 1.13735 1.03015 90275 0.94161 0.97349 0.84044 90047 1.09426 0.98154 0.77355 90277 1.00267 0.97349 0.73781 90048 1.25669 1.15176 1.11558 90278 1.00635 0.97810 0.73990 90049 1.17684 1.15873 1.33792 90280 0.91455 0.95904 0.73186 90056 1.18541 0.97349 1.00675 90290 0.93894 1.14774 1.35333 90057 0.94528 0.97116 0.97208 90291 1.09282 1.09469 1.02945 90058 0.92691 0.85085 0.73186 90292 1.09135 1.01673 1.11011\n\n**Territory Factors - California Primary Residence Insurance Program**","publish_date":null,"title":"Aegis Security Primary Residence Insurance Program 39 HO-Man-CA (Ed. 10.0)","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2248.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2248.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2248","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2248.pdf"},"started_at":"2026-11-04T19:48:19.343817"} +{"completed_at":"2026-11-04T19:48:21.287995","latency_in_ms":819,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2321","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit EXP-4\n\nCredibility and Complement of Credibility\n\nCredibility\n\n(1) Total Claims in Historical Period 1,214\n\n(2) Number of Claims for Full Credibility 1,082\n\n(3) Credibility 100%\n\nCalculation\n\n(3) = Min( [(1) / (2) ] ^ (1/2) , 1.0)\n\nComplement of Credibility\n\nSelected Complement None\n\nDue to our data being 100% credible, there was no complement selected.\n\n## **CyberSuite**","pages":[{"line_numbers":[],"markdown":"Exhibit EXP-4\n\nCredibility and Complement of Credibility\n\nCredibility\n\n(1) Total Claims in Historical Period 1,214\n\n(2) Number of Claims for Full Credibility 1,082\n\n(3) Credibility 100%\n\nCalculation\n\n(3) = Min( [(1) / (2) ] ^ (1/2) , 1.0)\n\nComplement of Credibility\n\nSelected Complement None\n\nDue to our data being 100% credible, there was no complement selected.\n\n## **CyberSuite**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit EXP-4\n\nCredibility and Complement of Credibility\n\nCredibility\n\n(1) Total Claims in Historical Period 1,214\n\n(2) Number of Claims for Full Credibility 1,082\n\n(3) Credibility 100%\n\nCalculation\n\n(3) = Min( [(1) / (2) ] ^ (1/2) , 1.0)\n\nComplement of Credibility\n\nSelected Complement None\n\nDue to our data being 100% credible, there was no complement selected.\n\n## **CyberSuite**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2321.pdf"]},"response":{"errors":[],"extract_id":"extract_d7fb07f82d4a532c62fe6211e9fe5bbf","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit EXP-4\n\nCredibility and Complement of Credibility\n\nCredibility\n\n(1) Total Claims in Historical Period 1,214\n\n(2) Number of Claims for Full Credibility 1,082\n\n(3) Credibility 100%\n\nCalculation\n\n(3) = Min( [(1) / (2) ] ^ (1/2) , 1.0)\n\nComplement of Credibility\n\nSelected Complement None\n\nDue to our data being 100% credible, there was no complement selected.\n\n## **CyberSuite**"],"full_content":"Exhibit EXP-4\n\nCredibility and Complement of Credibility\n\nCredibility\n\n(1) Total Claims in Historical Period 1,214\n\n(2) Number of Claims for Full Credibility 1,082\n\n(3) Credibility 100%\n\nCalculation\n\n(3) = Min( [(1) / (2) ] ^ (1/2) , 1.0)\n\nComplement of Credibility\n\nSelected Complement None\n\nDue to our data being 100% credible, there was no complement selected.\n\n## **CyberSuite**","publish_date":null,"title":"CyberSuite","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2321.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2321.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2321","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2321.pdf"},"started_at":"2026-11-04T19:48:20.468740"} +{"completed_at":"2026-11-04T19:48:24.038289","latency_in_ms":2460,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2323","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 10\n\n**CALIFORNIA** **Cyber Liability**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\n_Credibility Adjustment_\n\nCredibility is determined by the square root formula, i.e., the credibility equals the square root of the quotient of the claim count divided by the full credibilty standard Shown below are the credibilty calculations\n\n**Liability**\n\n**Liability** Selected Loss Trend Period 12pt\n\nLoss Trend Full Credibility Standard 1,082 Selected Experience Period 3 Year\n\nExperience Full Credibility Standard 1,082\n\nClaims for YYYYQ\n\nLoss Trend Period 79\n\nExperience Period 53\n\nFormula Credibility: SQRT(Claims÷Credibility Standard)\n\nLoss Trend 27.0%\n\nExperience 22.1%\n\n**Liability**\n\nFor AY ending\n\n20181 6 6 Year\n\n20191 9 5 Year\n\n20201 14 4 Year\n\n20211 20 3 Year\n\n20221 16 2 Year\n\n20231 17 1 Year\n\nFor AY ending\n\n20181 8\n\n20191 13\n\n20201 18\n\n20211 19\n\n20221 20\n\n20231 18\n\nFor AY ending\n\n20181 3\n\n20191 2\n\n20201 5\n\n20211 4\n\n20221 3\n\n20231 2\n\nPeriod used\n\n6 Year 27.5%\n\n5 Year 26.5%\n\n4 Year 24.9%\n\n3 Year 22.1%\n\n2 Year 17.5%\n\n1 Year 12.5%\n\n**Liability**\n\n20163 20163 - 20172 2 24pt\n\n20173 20173 - 20182 9 20pt\n\n20183 20183 - 20192 9 16pt\n\n20193 20193 - 20202 19 12pt\n\n20203 20203 - 20212 22 8pt\n\n20213 20213 - 20222 20\n\n20223 20223 - 20231 18\n\n30\\.2% 29.9% 28.5% 27.0% 23.5%\n\n20pt 16pt 12pt 8pt\n\nExperience Calculated Credibility\n\nCY Qtrs Exhibit 8 Reported Claims\n\nPeriod used Loss Trend Calculated Credibility\n\n24pt\n\nExhibit 7 Incurred Claims\n\nExhibit 7 Reported Claims\n\nExhibit 7 Claims Closed w/o payment","pages":[{"line_numbers":[],"markdown":"Exhibit 10\n\n**CALIFORNIA** **Cyber Liability**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\n_Credibility Adjustment_\n\nCredibility is determined by the square root formula, i.e., the credibility equals the square root of the quotient of the claim count divided by the full credibilty standard Shown below are the credibilty calculations\n\n**Liability**\n\n**Liability** Selected Loss Trend Period 12pt\n\nLoss Trend Full Credibility Standard 1,082 Selected Experience Period 3 Year\n\nExperience Full Credibility Standard 1,082\n\nClaims for YYYYQ\n\nLoss Trend Period 79\n\nExperience Period 53\n\nFormula Credibility: SQRT(Claims÷Credibility Standard)\n\nLoss Trend 27.0%\n\nExperience 22.1%\n\n**Liability**\n\nFor AY ending\n\n20181 6 6 Year\n\n20191 9 5 Year\n\n20201 14 4 Year\n\n20211 20 3 Year\n\n20221 16 2 Year\n\n20231 17 1 Year\n\nFor AY ending\n\n20181 8\n\n20191 13\n\n20201 18\n\n20211 19\n\n20221 20\n\n20231 18\n\nFor AY ending\n\n20181 3\n\n20191 2\n\n20201 5\n\n20211 4\n\n20221 3\n\n20231 2\n\nPeriod used\n\n6 Year 27.5%\n\n5 Year 26.5%\n\n4 Year 24.9%\n\n3 Year 22.1%\n\n2 Year 17.5%\n\n1 Year 12.5%\n\n**Liability**\n\n20163 20163 - 20172 2 24pt\n\n20173 20173 - 20182 9 20pt\n\n20183 20183 - 20192 9 16pt\n\n20193 20193 - 20202 19 12pt\n\n20203 20203 - 20212 22 8pt\n\n20213 20213 - 20222 20\n\n20223 20223 - 20231 18\n\n30\\.2% 29.9% 28.5% 27.0% 23.5%\n\n20pt 16pt 12pt 8pt\n\nExperience Calculated Credibility\n\nCY Qtrs Exhibit 8 Reported Claims\n\nPeriod used Loss Trend Calculated Credibility\n\n24pt\n\nExhibit 7 Incurred Claims\n\nExhibit 7 Reported Claims\n\nExhibit 7 Claims Closed w/o payment","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 10\n\n**CALIFORNIA** **Cyber Liability**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\n_Credibility Adjustment_\n\nCredibility is determined by the square root formula, i.e., the credibility equals the square root of the quotient of the claim count divided by the full credibilty standard Shown below are the credibilty calculations\n\n**Liability**\n\n**Liability** Selected Loss Trend Period 12pt\n\nLoss Trend Full Credibility Standard 1,082 Selected Experience Period 3 Year\n\nExperience Full Credibility Standard 1,082\n\nClaims for YYYYQ\n\nLoss Trend Period 79\n\nExperience Period 53\n\nFormula Credibility: SQRT(Claims÷Credibility Standard)\n\nLoss Trend 27.0%\n\nExperience 22.1%\n\n**Liability**\n\nFor AY ending\n\n20181 6 6 Year\n\n20191 9 5 Year\n\n20201 14 4 Year\n\n20211 20 3 Year\n\n20221 16 2 Year\n\n20231 17 1 Year\n\nFor AY ending\n\n20181 8\n\n20191 13\n\n20201 18\n\n20211 19\n\n20221 20\n\n20231 18\n\nFor AY ending\n\n20181 3\n\n20191 2\n\n20201 5\n\n20211 4\n\n20221 3\n\n20231 2\n\nPeriod used\n\n6 Year 27.5%\n\n5 Year 26.5%\n\n4 Year 24.9%\n\n3 Year 22.1%\n\n2 Year 17.5%\n\n1 Year 12.5%\n\n**Liability**\n\n20163 20163 - 20172 2 24pt\n\n20173 20173 - 20182 9 20pt\n\n20183 20183 - 20192 9 16pt\n\n20193 20193 - 20202 19 12pt\n\n20203 20203 - 20212 22 8pt\n\n20213 20213 - 20222 20\n\n20223 20223 - 20231 18\n\n30\\.2% 29.9% 28.5% 27.0% 23.5%\n\n20pt 16pt 12pt 8pt\n\nExperience Calculated Credibility\n\nCY Qtrs Exhibit 8 Reported Claims\n\nPeriod used Loss Trend Calculated Credibility\n\n24pt\n\nExhibit 7 Incurred Claims\n\nExhibit 7 Reported Claims\n\nExhibit 7 Claims Closed w/o payment","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2323.pdf"]},"response":{"errors":[],"extract_id":"extract_4870262d1af4f801773bce128e6d47c0","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 10\n\n**CALIFORNIA** **Cyber Liability**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\n_Credibility Adjustment_\n\nCredibility is determined by the square root formula, i.e., the credibility equals the square root of the quotient of the claim count divided by the full credibilty standard Shown below are the credibilty calculations\n\n**Liability**\n\n**Liability** Selected Loss Trend Period 12pt\n\nLoss Trend Full Credibility Standard 1,082 Selected Experience Period 3 Year\n\nExperience Full Credibility Standard 1,082\n\nClaims for YYYYQ\n\nLoss Trend Period 79\n\nExperience Period 53\n\nFormula Credibility: SQRT(Claims÷Credibility Standard)\n\nLoss Trend 27.0%\n\nExperience 22.1%\n\n**Liability**\n\nFor AY ending\n\n20181 6 6 Year\n\n20191 9 5 Year\n\n20201 14 4 Year\n\n20211 20 3 Year\n\n20221 16 2 Year\n\n20231 17 1 Year\n\nFor AY ending\n\n20181 8\n\n20191 13\n\n20201 18\n\n20211 19\n\n20221 20\n\n20231 18\n\nFor AY ending\n\n20181 3\n\n20191 2\n\n20201 5\n\n20211 4\n\n20221 3\n\n20231 2\n\nPeriod used\n\n6 Year 27.5%\n\n5 Year 26.5%\n\n4 Year 24.9%\n\n3 Year 22.1%\n\n2 Year 17.5%\n\n1 Year 12.5%\n\n**Liability**\n\n20163 20163 - 20172 2 24pt\n\n20173 20173 - 20182 9 20pt\n\n20183 20183 - 20192 9 16pt\n\n20193 20193 - 20202 19 12pt\n\n20203 20203 - 20212 22 8pt\n\n20213 20213 - 20222 20\n\n20223 20223 - 20231 18\n\n30\\.2% 29.9% 28.5% 27.0% 23.5%\n\n20pt 16pt 12pt 8pt\n\nExperience Calculated Credibility\n\nCY Qtrs Exhibit 8 Reported Claims\n\nPeriod used Loss Trend Calculated Credibility\n\n24pt\n\nExhibit 7 Incurred Claims\n\nExhibit 7 Reported Claims\n\nExhibit 7 Claims Closed w/o payment"],"full_content":"Exhibit 10\n\n**CALIFORNIA** **Cyber Liability**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\n_Credibility Adjustment_\n\nCredibility is determined by the square root formula, i.e., the credibility equals the square root of the quotient of the claim count divided by the full credibilty standard Shown below are the credibilty calculations\n\n**Liability**\n\n**Liability** Selected Loss Trend Period 12pt\n\nLoss Trend Full Credibility Standard 1,082 Selected Experience Period 3 Year\n\nExperience Full Credibility Standard 1,082\n\nClaims for YYYYQ\n\nLoss Trend Period 79\n\nExperience Period 53\n\nFormula Credibility: SQRT(Claims÷Credibility Standard)\n\nLoss Trend 27.0%\n\nExperience 22.1%\n\n**Liability**\n\nFor AY ending\n\n20181 6 6 Year\n\n20191 9 5 Year\n\n20201 14 4 Year\n\n20211 20 3 Year\n\n20221 16 2 Year\n\n20231 17 1 Year\n\nFor AY ending\n\n20181 8\n\n20191 13\n\n20201 18\n\n20211 19\n\n20221 20\n\n20231 18\n\nFor AY ending\n\n20181 3\n\n20191 2\n\n20201 5\n\n20211 4\n\n20221 3\n\n20231 2\n\nPeriod used\n\n6 Year 27.5%\n\n5 Year 26.5%\n\n4 Year 24.9%\n\n3 Year 22.1%\n\n2 Year 17.5%\n\n1 Year 12.5%\n\n**Liability**\n\n20163 20163 - 20172 2 24pt\n\n20173 20173 - 20182 9 20pt\n\n20183 20183 - 20192 9 16pt\n\n20193 20193 - 20202 19 12pt\n\n20203 20203 - 20212 22 8pt\n\n20213 20213 - 20222 20\n\n20223 20223 - 20231 18\n\n30\\.2% 29.9% 28.5% 27.0% 23.5%\n\n20pt 16pt 12pt 8pt\n\nExperience Calculated Credibility\n\nCY Qtrs Exhibit 8 Reported Claims\n\nPeriod used Loss Trend Calculated Credibility\n\n24pt\n\nExhibit 7 Incurred Claims\n\nExhibit 7 Reported Claims\n\nExhibit 7 Claims Closed w/o payment","publish_date":null,"title":"CALIFORNIA","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2323.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2323.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2323","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2323.pdf"},"started_at":"2026-11-04T19:48:21.578175"} +{"completed_at":"2026-11-04T19:48:24.037585","latency_in_ms":1320,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2324","grounded_pages":[],"layout_pages":[],"markdown":"1) Incurred Loss & DCCE 2) Claim Counts 3) Mean Claim Severity 4) Standard Deviation of Claim Severity 5) Coefficient of Variation (4)/(3) 6) Credibility Adjustment 1 + (5)^2 7) Credibility Standard (See Above) **8) Credibility Adjusted Standard (6) x (7)**\n\n**Credibility**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\nCyber Liability\n\nExhibit 10: Experience Credibility\n\n833,855\n\n25,436\n\n88\n\n9,476\n\n2\\.684 8.206 1,082 **8,880**\n\n**34\\.9%**","pages":[{"line_numbers":[],"markdown":"1) Incurred Loss & DCCE 2) Claim Counts 3) Mean Claim Severity 4) Standard Deviation of Claim Severity 5) Coefficient of Variation (4)/(3) 6) Credibility Adjustment 1 + (5)^2 7) Credibility Standard (See Above) **8) Credibility Adjusted Standard (6) x (7)**\n\n**Credibility**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\nCyber Liability\n\nExhibit 10: Experience Credibility\n\n833,855\n\n25,436\n\n88\n\n9,476\n\n2\\.684 8.206 1,082 **8,880**\n\n**34\\.9%**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"1) Incurred Loss & DCCE 2) Claim Counts 3) Mean Claim Severity 4) Standard Deviation of Claim Severity 5) Coefficient of Variation (4)/(3) 6) Credibility Adjustment 1 + (5)^2 7) Credibility Standard (See Above) **8) Credibility Adjusted Standard (6) x (7)**\n\n**Credibility**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\nCyber Liability\n\nExhibit 10: Experience Credibility\n\n833,855\n\n25,436\n\n88\n\n9,476\n\n2\\.684 8.206 1,082 **8,880**\n\n**34\\.9%**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2324.pdf"]},"response":{"errors":[],"extract_id":"extract_4f49857bb5cc97d34add7a53567f1086","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["1) Incurred Loss & DCCE 2) Claim Counts 3) Mean Claim Severity 4) Standard Deviation of Claim Severity 5) Coefficient of Variation (4)/(3) 6) Credibility Adjustment 1 + (5)^2 7) Credibility Standard (See Above) **8) Credibility Adjusted Standard (6) x (7)**\n\n**Credibility**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\nCyber Liability\n\nExhibit 10: Experience Credibility\n\n833,855\n\n25,436\n\n88\n\n9,476\n\n2\\.684 8.206 1,082 **8,880**\n\n**34\\.9%**"],"full_content":"1) Incurred Loss & DCCE 2) Claim Counts 3) Mean Claim Severity 4) Standard Deviation of Claim Severity 5) Coefficient of Variation (4)/(3) 6) Credibility Adjustment 1 + (5)^2 7) Credibility Standard (See Above) **8) Credibility Adjusted Standard (6) x (7)**\n\n**Credibility**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\nCyber Liability\n\nExhibit 10: Experience Credibility\n\n833,855\n\n25,436\n\n88\n\n9,476\n\n2\\.684 8.206 1,082 **8,880**\n\n**34\\.9%**","publish_date":null,"title":"1) Incurred Loss & DCCE 833,855 2) Claim Counts 88 3) Mean Claim Severity 9,476 4) Standard Deviation of Claim","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2324.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2324.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2324","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2324.pdf"},"started_at":"2026-11-04T19:48:22.717090"} +{"completed_at":"2026-11-04T19:48:25.312149","latency_in_ms":1271,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2326","grounded_pages":[],"layout_pages":[],"markdown":"**CALIFORNIA** **Cyber Liability**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\n_Credibility Adjustment_\n\n**Liability**\n\n**Liability** Selected Loss Trend Period 12pt\n\nLoss Trend Full Credibility Standard 4,761 Selected Experience Period 3 Year\n\nExperience Full Credibility Standard 4,761\n\nClaims for YYYYQ\n\nLoss Trend Period 84\n\nExperience Period 55\n\nFormula Credibility: SQRT(Claims÷Credibility Standard) Selected Loss Trend Credibility **13\\.3%**\n\nSelected Experience Credibility **10\\.7%**\n\n**Liability**\n\nFor AY ending\n\n20194 7 6 Year\n\n20204 8 5 Year\n\n20214 17 4 Year\n\n20224 18 3 Year\n\n20234 16 2 Year\n\n20244 21 1 Year\n\nFor AY ending\n\n20194 9\n\n20204 19\n\n20214 19\n\n20224 18\n\n20234 18\n\n20244 32\n\nFor AY ending\n\n20194 2\n\n20204 5\n\n20214 4\n\n20224 3\n\n20234 3\n\n20244 6\n\nPeriod used\n\n6 Year 13.5%\n\n5 Year 13.0%\n\n4 Year 12.3%\n\n3 Year 10.7%\n\n2 Year 8.8%\n\n1 Year 6.6%\n\n**Liability**\n\n20182 20182 - 20191 10 24pt\n\n20192 20192 - 20201 7 20pt\n\n20202 20202 - 20211 27 16pt\n\n20212 20212 - 20221 20 12pt\n\n20222 20222 - 20231 17 8pt\n\n20232 20232 - 20241 23\n\n20242 20242 - 20244 24\n\n16\\.4% 15.7% 15.3% 13.3% 11.6%\n\nExhibit 7 Claims Closed w/o payment\n\nExhibit 10B\n\nExhibit 7 Incurred Claims\n\nExhibit 7 Reported Claims\n\n20pt 16pt 12pt 8pt\n\nExperience Calculated Credibility\n\nCY Qtrs Exhibit 8 Reported Claims\n\nPeriod used Loss Trend Calculated Credibility\n\n24pt","pages":[{"line_numbers":[],"markdown":"**CALIFORNIA** **Cyber Liability**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\n_Credibility Adjustment_\n\n**Liability**\n\n**Liability** Selected Loss Trend Period 12pt\n\nLoss Trend Full Credibility Standard 4,761 Selected Experience Period 3 Year\n\nExperience Full Credibility Standard 4,761\n\nClaims for YYYYQ\n\nLoss Trend Period 84\n\nExperience Period 55\n\nFormula Credibility: SQRT(Claims÷Credibility Standard) Selected Loss Trend Credibility **13\\.3%**\n\nSelected Experience Credibility **10\\.7%**\n\n**Liability**\n\nFor AY ending\n\n20194 7 6 Year\n\n20204 8 5 Year\n\n20214 17 4 Year\n\n20224 18 3 Year\n\n20234 16 2 Year\n\n20244 21 1 Year\n\nFor AY ending\n\n20194 9\n\n20204 19\n\n20214 19\n\n20224 18\n\n20234 18\n\n20244 32\n\nFor AY ending\n\n20194 2\n\n20204 5\n\n20214 4\n\n20224 3\n\n20234 3\n\n20244 6\n\nPeriod used\n\n6 Year 13.5%\n\n5 Year 13.0%\n\n4 Year 12.3%\n\n3 Year 10.7%\n\n2 Year 8.8%\n\n1 Year 6.6%\n\n**Liability**\n\n20182 20182 - 20191 10 24pt\n\n20192 20192 - 20201 7 20pt\n\n20202 20202 - 20211 27 16pt\n\n20212 20212 - 20221 20 12pt\n\n20222 20222 - 20231 17 8pt\n\n20232 20232 - 20241 23\n\n20242 20242 - 20244 24\n\n16\\.4% 15.7% 15.3% 13.3% 11.6%\n\nExhibit 7 Claims Closed w/o payment\n\nExhibit 10B\n\nExhibit 7 Incurred Claims\n\nExhibit 7 Reported Claims\n\n20pt 16pt 12pt 8pt\n\nExperience Calculated Credibility\n\nCY Qtrs Exhibit 8 Reported Claims\n\nPeriod used Loss Trend Calculated Credibility\n\n24pt","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**CALIFORNIA** **Cyber Liability**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\n_Credibility Adjustment_\n\n**Liability**\n\n**Liability** Selected Loss Trend Period 12pt\n\nLoss Trend Full Credibility Standard 4,761 Selected Experience Period 3 Year\n\nExperience Full Credibility Standard 4,761\n\nClaims for YYYYQ\n\nLoss Trend Period 84\n\nExperience Period 55\n\nFormula Credibility: SQRT(Claims÷Credibility Standard) Selected Loss Trend Credibility **13\\.3%**\n\nSelected Experience Credibility **10\\.7%**\n\n**Liability**\n\nFor AY ending\n\n20194 7 6 Year\n\n20204 8 5 Year\n\n20214 17 4 Year\n\n20224 18 3 Year\n\n20234 16 2 Year\n\n20244 21 1 Year\n\nFor AY ending\n\n20194 9\n\n20204 19\n\n20214 19\n\n20224 18\n\n20234 18\n\n20244 32\n\nFor AY ending\n\n20194 2\n\n20204 5\n\n20214 4\n\n20224 3\n\n20234 3\n\n20244 6\n\nPeriod used\n\n6 Year 13.5%\n\n5 Year 13.0%\n\n4 Year 12.3%\n\n3 Year 10.7%\n\n2 Year 8.8%\n\n1 Year 6.6%\n\n**Liability**\n\n20182 20182 - 20191 10 24pt\n\n20192 20192 - 20201 7 20pt\n\n20202 20202 - 20211 27 16pt\n\n20212 20212 - 20221 20 12pt\n\n20222 20222 - 20231 17 8pt\n\n20232 20232 - 20241 23\n\n20242 20242 - 20244 24\n\n16\\.4% 15.7% 15.3% 13.3% 11.6%\n\nExhibit 7 Claims Closed w/o payment\n\nExhibit 10B\n\nExhibit 7 Incurred Claims\n\nExhibit 7 Reported Claims\n\n20pt 16pt 12pt 8pt\n\nExperience Calculated Credibility\n\nCY Qtrs Exhibit 8 Reported Claims\n\nPeriod used Loss Trend Calculated Credibility\n\n24pt","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2326.pdf"]},"response":{"errors":[],"extract_id":"extract_c76b88e1bc25e91bbefa34e8e7eae75d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**CALIFORNIA** **Cyber Liability**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\n_Credibility Adjustment_\n\n**Liability**\n\n**Liability** Selected Loss Trend Period 12pt\n\nLoss Trend Full Credibility Standard 4,761 Selected Experience Period 3 Year\n\nExperience Full Credibility Standard 4,761\n\nClaims for YYYYQ\n\nLoss Trend Period 84\n\nExperience Period 55\n\nFormula Credibility: SQRT(Claims÷Credibility Standard) Selected Loss Trend Credibility **13\\.3%**\n\nSelected Experience Credibility **10\\.7%**\n\n**Liability**\n\nFor AY ending\n\n20194 7 6 Year\n\n20204 8 5 Year\n\n20214 17 4 Year\n\n20224 18 3 Year\n\n20234 16 2 Year\n\n20244 21 1 Year\n\nFor AY ending\n\n20194 9\n\n20204 19\n\n20214 19\n\n20224 18\n\n20234 18\n\n20244 32\n\nFor AY ending\n\n20194 2\n\n20204 5\n\n20214 4\n\n20224 3\n\n20234 3\n\n20244 6\n\nPeriod used\n\n6 Year 13.5%\n\n5 Year 13.0%\n\n4 Year 12.3%\n\n3 Year 10.7%\n\n2 Year 8.8%\n\n1 Year 6.6%\n\n**Liability**\n\n20182 20182 - 20191 10 24pt\n\n20192 20192 - 20201 7 20pt\n\n20202 20202 - 20211 27 16pt\n\n20212 20212 - 20221 20 12pt\n\n20222 20222 - 20231 17 8pt\n\n20232 20232 - 20241 23\n\n20242 20242 - 20244 24\n\n16\\.4% 15.7% 15.3% 13.3% 11.6%\n\nExhibit 7 Claims Closed w/o payment\n\nExhibit 10B\n\nExhibit 7 Incurred Claims\n\nExhibit 7 Reported Claims\n\n20pt 16pt 12pt 8pt\n\nExperience Calculated Credibility\n\nCY Qtrs Exhibit 8 Reported Claims\n\nPeriod used Loss Trend Calculated Credibility\n\n24pt"],"full_content":"**CALIFORNIA** **Cyber Liability**\n\n**Pennsylvania Lumbermens Mutual Insurance Company**\n\n_Credibility Adjustment_\n\n**Liability**\n\n**Liability** Selected Loss Trend Period 12pt\n\nLoss Trend Full Credibility Standard 4,761 Selected Experience Period 3 Year\n\nExperience Full Credibility Standard 4,761\n\nClaims for YYYYQ\n\nLoss Trend Period 84\n\nExperience Period 55\n\nFormula Credibility: SQRT(Claims÷Credibility Standard) Selected Loss Trend Credibility **13\\.3%**\n\nSelected Experience Credibility **10\\.7%**\n\n**Liability**\n\nFor AY ending\n\n20194 7 6 Year\n\n20204 8 5 Year\n\n20214 17 4 Year\n\n20224 18 3 Year\n\n20234 16 2 Year\n\n20244 21 1 Year\n\nFor AY ending\n\n20194 9\n\n20204 19\n\n20214 19\n\n20224 18\n\n20234 18\n\n20244 32\n\nFor AY ending\n\n20194 2\n\n20204 5\n\n20214 4\n\n20224 3\n\n20234 3\n\n20244 6\n\nPeriod used\n\n6 Year 13.5%\n\n5 Year 13.0%\n\n4 Year 12.3%\n\n3 Year 10.7%\n\n2 Year 8.8%\n\n1 Year 6.6%\n\n**Liability**\n\n20182 20182 - 20191 10 24pt\n\n20192 20192 - 20201 7 20pt\n\n20202 20202 - 20211 27 16pt\n\n20212 20212 - 20221 20 12pt\n\n20222 20222 - 20231 17 8pt\n\n20232 20232 - 20241 23\n\n20242 20242 - 20244 24\n\n16\\.4% 15.7% 15.3% 13.3% 11.6%\n\nExhibit 7 Claims Closed w/o payment\n\nExhibit 10B\n\nExhibit 7 Incurred Claims\n\nExhibit 7 Reported Claims\n\n20pt 16pt 12pt 8pt\n\nExperience Calculated Credibility\n\nCY Qtrs Exhibit 8 Reported Claims\n\nPeriod used Loss Trend Calculated Credibility\n\n24pt","publish_date":null,"title":"CALIFORNIA","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2326.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2326.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2326","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2326.pdf"},"started_at":"2026-11-04T19:48:24.040502"} +{"completed_at":"2026-11-04T19:48:26.290125","latency_in_ms":1151,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2329","grounded_pages":[],"layout_pages":[],"markdown":"**California**\n\n**_Cyber Liability_**\n\n**Customer Dislocation**\n\n**Total Book of Business By Coverage/Program**\n\nPercent Range\\* Policy Count Policy Distribution Total Rate Change Current Total Premium Proposed Total Premium Current Average Premium Proposed Average Premium Average Premium Increase/Decrease\n\nChange\n\nHighest Premium Increase A\n\nPolicyholder Will Receive\n\nAverage _Cyber Liability_ Premium\n\nChange\n\n\\+95% to +100%\n\n\\+90% to +95%\n\n\\+85% to +90%\n\n\\+80% to +85%\n\n\\+75% to +80%\n\n\\+70% to +75%\n\n\\+65% to +70%\n\n\\+60% to +65% 2 100.0% 62.7% $466 $758 $233 $379 $146 $146 62.7%\n\n\\+55% to +60%\n\n\\+50% to +55%\n\n\\+45% to +50%\n\n\\+40% to +45%\n\n\\+35% to +40%\n\n\\+30% to +35% 410 100.0% 33.1% $77,900 $103,684 $190 $253 $63 $63 33.1%\n\n\\+25% to +30%\n\n\\+20% to +25%\n\n\\+15% to +20%\n\n\\+10% to +15%\n\n\\+5% to +10% 14 100.0% 8.9% $8,428 $9,178 $602 $656 $54 $54 8.9%\n\n\\+0.01% to +5%\n\n0%\n\n\\-0.01% to -5%\n\n\\-5% to -10%\n\n\\-10% to -15%\n\n\\-15% to -20% 2 100.0% -19.1% $2,624 $2,122 $1,312 $1,061 -$251 -$251 -19.1%\n\n\\-20% to -25% 2 100.0% -21.4% $3,844 $3,021 $1,992 $1,566 -$426 -$426 -21.4%\n\n\\-25% to -30%\n\n\\-30% to -35%\n\n\\-35% to -40%\n\n\\-40% to -45%\n\n\\-45% to -50%\n\n\\-50% to -55%\n\n\\-55% to -60%\n\n\\-60% to -65%\n\n\\-65% to -70%\n\n\\-70% to -75%\n\n\\-75% to -80%\n\n\\-80% to -85%\n\n\\-85% to -90%\n\n\\-90% to -95%\n\n\\-95% to -100%\n\n**Total 430 100.0% 27.3% 93,262 $ 118,763 $ 4,329 $ 27.3%**","pages":[{"line_numbers":[],"markdown":"**California**\n\n**_Cyber Liability_**\n\n**Customer Dislocation**\n\n**Total Book of Business By Coverage/Program**\n\nPercent Range\\* Policy Count Policy Distribution Total Rate Change Current Total Premium Proposed Total Premium Current Average Premium Proposed Average Premium Average Premium Increase/Decrease\n\nChange\n\nHighest Premium Increase A\n\nPolicyholder Will Receive\n\nAverage _Cyber Liability_ Premium\n\nChange\n\n\\+95% to +100%\n\n\\+90% to +95%\n\n\\+85% to +90%\n\n\\+80% to +85%\n\n\\+75% to +80%\n\n\\+70% to +75%\n\n\\+65% to +70%\n\n\\+60% to +65% 2 100.0% 62.7% $466 $758 $233 $379 $146 $146 62.7%\n\n\\+55% to +60%\n\n\\+50% to +55%\n\n\\+45% to +50%\n\n\\+40% to +45%\n\n\\+35% to +40%\n\n\\+30% to +35% 410 100.0% 33.1% $77,900 $103,684 $190 $253 $63 $63 33.1%\n\n\\+25% to +30%\n\n\\+20% to +25%\n\n\\+15% to +20%\n\n\\+10% to +15%\n\n\\+5% to +10% 14 100.0% 8.9% $8,428 $9,178 $602 $656 $54 $54 8.9%\n\n\\+0.01% to +5%\n\n0%\n\n\\-0.01% to -5%\n\n\\-5% to -10%\n\n\\-10% to -15%\n\n\\-15% to -20% 2 100.0% -19.1% $2,624 $2,122 $1,312 $1,061 -$251 -$251 -19.1%\n\n\\-20% to -25% 2 100.0% -21.4% $3,844 $3,021 $1,992 $1,566 -$426 -$426 -21.4%\n\n\\-25% to -30%\n\n\\-30% to -35%\n\n\\-35% to -40%\n\n\\-40% to -45%\n\n\\-45% to -50%\n\n\\-50% to -55%\n\n\\-55% to -60%\n\n\\-60% to -65%\n\n\\-65% to -70%\n\n\\-70% to -75%\n\n\\-75% to -80%\n\n\\-80% to -85%\n\n\\-85% to -90%\n\n\\-90% to -95%\n\n\\-95% to -100%\n\n**Total 430 100.0% 27.3% 93,262 $ 118,763 $ 4,329 $ 27.3%**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**California**\n\n**_Cyber Liability_**\n\n**Customer Dislocation**\n\n**Total Book of Business By Coverage/Program**\n\nPercent Range\\* Policy Count Policy Distribution Total Rate Change Current Total Premium Proposed Total Premium Current Average Premium Proposed Average Premium Average Premium Increase/Decrease\n\nChange\n\nHighest Premium Increase A\n\nPolicyholder Will Receive\n\nAverage _Cyber Liability_ Premium\n\nChange\n\n\\+95% to +100%\n\n\\+90% to +95%\n\n\\+85% to +90%\n\n\\+80% to +85%\n\n\\+75% to +80%\n\n\\+70% to +75%\n\n\\+65% to +70%\n\n\\+60% to +65% 2 100.0% 62.7% $466 $758 $233 $379 $146 $146 62.7%\n\n\\+55% to +60%\n\n\\+50% to +55%\n\n\\+45% to +50%\n\n\\+40% to +45%\n\n\\+35% to +40%\n\n\\+30% to +35% 410 100.0% 33.1% $77,900 $103,684 $190 $253 $63 $63 33.1%\n\n\\+25% to +30%\n\n\\+20% to +25%\n\n\\+15% to +20%\n\n\\+10% to +15%\n\n\\+5% to +10% 14 100.0% 8.9% $8,428 $9,178 $602 $656 $54 $54 8.9%\n\n\\+0.01% to +5%\n\n0%\n\n\\-0.01% to -5%\n\n\\-5% to -10%\n\n\\-10% to -15%\n\n\\-15% to -20% 2 100.0% -19.1% $2,624 $2,122 $1,312 $1,061 -$251 -$251 -19.1%\n\n\\-20% to -25% 2 100.0% -21.4% $3,844 $3,021 $1,992 $1,566 -$426 -$426 -21.4%\n\n\\-25% to -30%\n\n\\-30% to -35%\n\n\\-35% to -40%\n\n\\-40% to -45%\n\n\\-45% to -50%\n\n\\-50% to -55%\n\n\\-55% to -60%\n\n\\-60% to -65%\n\n\\-65% to -70%\n\n\\-70% to -75%\n\n\\-75% to -80%\n\n\\-80% to -85%\n\n\\-85% to -90%\n\n\\-90% to -95%\n\n\\-95% to -100%\n\n**Total 430 100.0% 27.3% 93,262 $ 118,763 $ 4,329 $ 27.3%**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2329.pdf"]},"response":{"errors":[],"extract_id":"extract_5a42f6cf779a0dc4580ea869f0ee32bf","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**California**\n\n**_Cyber Liability_**\n\n**Customer Dislocation**\n\n**Total Book of Business By Coverage/Program**\n\nPercent Range\\* Policy Count Policy Distribution Total Rate Change Current Total Premium Proposed Total Premium Current Average Premium Proposed Average Premium Average Premium Increase/Decrease\n\nChange\n\nHighest Premium Increase A\n\nPolicyholder Will Receive\n\nAverage _Cyber Liability_ Premium\n\nChange\n\n\\+95% to +100%\n\n\\+90% to +95%\n\n\\+85% to +90%\n\n\\+80% to +85%\n\n\\+75% to +80%\n\n\\+70% to +75%\n\n\\+65% to +70%\n\n\\+60% to +65% 2 100.0% 62.7% $466 $758 $233 $379 $146 $146 62.7%\n\n\\+55% to +60%\n\n\\+50% to +55%\n\n\\+45% to +50%\n\n\\+40% to +45%\n\n\\+35% to +40%\n\n\\+30% to +35% 410 100.0% 33.1% $77,900 $103,684 $190 $253 $63 $63 33.1%\n\n\\+25% to +30%\n\n\\+20% to +25%\n\n\\+15% to +20%\n\n\\+10% to +15%\n\n\\+5% to +10% 14 100.0% 8.9% $8,428 $9,178 $602 $656 $54 $54 8.9%\n\n\\+0.01% to +5%\n\n0%\n\n\\-0.01% to -5%\n\n\\-5% to -10%\n\n\\-10% to -15%\n\n\\-15% to -20% 2 100.0% -19.1% $2,624 $2,122 $1,312 $1,061 -$251 -$251 -19.1%\n\n\\-20% to -25% 2 100.0% -21.4% $3,844 $3,021 $1,992 $1,566 -$426 -$426 -21.4%\n\n\\-25% to -30%\n\n\\-30% to -35%\n\n\\-35% to -40%\n\n\\-40% to -45%\n\n\\-45% to -50%\n\n\\-50% to -55%\n\n\\-55% to -60%\n\n\\-60% to -65%\n\n\\-65% to -70%\n\n\\-70% to -75%\n\n\\-75% to -80%\n\n\\-80% to -85%\n\n\\-85% to -90%\n\n\\-90% to -95%\n\n\\-95% to -100%\n\n**Total 430 100.0% 27.3% 93,262 $ 118,763 $ 4,329 $ 27.3%**"],"full_content":"**California**\n\n**_Cyber Liability_**\n\n**Customer Dislocation**\n\n**Total Book of Business By Coverage/Program**\n\nPercent Range\\* Policy Count Policy Distribution Total Rate Change Current Total Premium Proposed Total Premium Current Average Premium Proposed Average Premium Average Premium Increase/Decrease\n\nChange\n\nHighest Premium Increase A\n\nPolicyholder Will Receive\n\nAverage _Cyber Liability_ Premium\n\nChange\n\n\\+95% to +100%\n\n\\+90% to +95%\n\n\\+85% to +90%\n\n\\+80% to +85%\n\n\\+75% to +80%\n\n\\+70% to +75%\n\n\\+65% to +70%\n\n\\+60% to +65% 2 100.0% 62.7% $466 $758 $233 $379 $146 $146 62.7%\n\n\\+55% to +60%\n\n\\+50% to +55%\n\n\\+45% to +50%\n\n\\+40% to +45%\n\n\\+35% to +40%\n\n\\+30% to +35% 410 100.0% 33.1% $77,900 $103,684 $190 $253 $63 $63 33.1%\n\n\\+25% to +30%\n\n\\+20% to +25%\n\n\\+15% to +20%\n\n\\+10% to +15%\n\n\\+5% to +10% 14 100.0% 8.9% $8,428 $9,178 $602 $656 $54 $54 8.9%\n\n\\+0.01% to +5%\n\n0%\n\n\\-0.01% to -5%\n\n\\-5% to -10%\n\n\\-10% to -15%\n\n\\-15% to -20% 2 100.0% -19.1% $2,624 $2,122 $1,312 $1,061 -$251 -$251 -19.1%\n\n\\-20% to -25% 2 100.0% -21.4% $3,844 $3,021 $1,992 $1,566 -$426 -$426 -21.4%\n\n\\-25% to -30%\n\n\\-30% to -35%\n\n\\-35% to -40%\n\n\\-40% to -45%\n\n\\-45% to -50%\n\n\\-50% to -55%\n\n\\-55% to -60%\n\n\\-60% to -65%\n\n\\-65% to -70%\n\n\\-70% to -75%\n\n\\-75% to -80%\n\n\\-80% to -85%\n\n\\-85% to -90%\n\n\\-90% to -95%\n\n\\-95% to -100%\n\n**Total 430 100.0% 27.3% 93,262 $ 118,763 $ 4,329 $ 27.3%**","publish_date":null,"title":"California Cyber Liability Customer Dislocation Total Book of Business By Coverage/Program Average Premium Increase/Decrease Highest Premium Increase A Average Cyber","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2329.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2329.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2329","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2329.pdf"},"started_at":"2026-11-04T19:48:25.138911"} +{"completed_at":"2026-11-04T19:48:28.328410","latency_in_ms":1592,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2373","grounded_pages":[],"layout_pages":[],"markdown":"**Commercial Inland Marine Objection Response to Letter of December 21, 2017:** This letter is in response to the objection to filing SERFF Tr Num: QBEC-131306101 which requests the following information: _Submit the template with variance. Indicate the variance number on the space provided on the Ratemaking Data page. Page 6.B of our filing instructions reads: \"Filings requesting a variance must include one Rate Template excluding the variance and one Rate Template including the variance. A filing with multiple variances must include one Rate Template for each individual variance as well as the combined impact of all variances.\"_ The following is a chart that lists the annual premium trend, loss development factors, annual loss trend, and indicated rate change range for the Commercial Inland Marine filing referenced above.\n\nInland Marine Premium Trend LDF Loss Trend Range\n\n**1\\. As Filed (Variance)**\n\n**3\\.0%** **1\\.227, 1.042, 1.000, 1.000, 1.000, 1.000**\n\n**0\\.3%** **\\-32.4% to -12.4%**\n\n2\\. No Variance -10.0% 1.000, 1.000, 1.000,1.000, 1.000, 1.000\n\nError Not Possible\n\n3\\. 8B Loss Trend\n\nOnly\n\n\\-10.0% 1.000, 1.000, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% 12.7% to 46.1%\n\n4\\. 8B Loss\n\nTrend/7A LDF\n\nVariance\n\n\\-10.0% 1.227, 1.042, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% 13.0% to 46.4%\n\n5\\. 8B Loss and Premium Trend\n\n3\\.0% 1.000, 1.000, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% -32.6% to -12.6%\n\nThe first line of the chart is a summary of what was originally filed with the California Department of Insurance. The objection requested one rate template for each variance as well as the combined impact of all variances. Since the loss trend produced an error on the standard exhibit, it is not possible to complete the rate template with no variance (see line 2 of the chart). Line 3 is a summary of variance 8B, Loss Trend Only. Since the standard exhibits produced an error for the loss trend as noted above, variance 7A (loss development factors) and variance 8B (premium trend) were combined with variance 8B (loss trend), to calculate the indicated rate change ranges shown in lines 4 and 5, respectively. The attached files contain the rate templates for scenarios 3-5 above. Scenario 1 was submitted with the original filing and scenario 2 cannot be calculated. The file names are numbered according to the corresponding scenario. Please let me know if any further information is needed for your continued review of our filing.","pages":[{"line_numbers":[],"markdown":"**Commercial Inland Marine Objection Response to Letter of December 21, 2017:** This letter is in response to the objection to filing SERFF Tr Num: QBEC-131306101 which requests the following information: _Submit the template with variance. Indicate the variance number on the space provided on the Ratemaking Data page. Page 6.B of our filing instructions reads: \"Filings requesting a variance must include one Rate Template excluding the variance and one Rate Template including the variance. A filing with multiple variances must include one Rate Template for each individual variance as well as the combined impact of all variances.\"_ The following is a chart that lists the annual premium trend, loss development factors, annual loss trend, and indicated rate change range for the Commercial Inland Marine filing referenced above.\n\nInland Marine Premium Trend LDF Loss Trend Range\n\n**1\\. As Filed (Variance)**\n\n**3\\.0%** **1\\.227, 1.042, 1.000, 1.000, 1.000, 1.000**\n\n**0\\.3%** **\\-32.4% to -12.4%**\n\n2\\. No Variance -10.0% 1.000, 1.000, 1.000,1.000, 1.000, 1.000\n\nError Not Possible\n\n3\\. 8B Loss Trend\n\nOnly\n\n\\-10.0% 1.000, 1.000, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% 12.7% to 46.1%\n\n4\\. 8B Loss\n\nTrend/7A LDF\n\nVariance\n\n\\-10.0% 1.227, 1.042, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% 13.0% to 46.4%\n\n5\\. 8B Loss and Premium Trend\n\n3\\.0% 1.000, 1.000, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% -32.6% to -12.6%\n\nThe first line of the chart is a summary of what was originally filed with the California Department of Insurance. The objection requested one rate template for each variance as well as the combined impact of all variances. Since the loss trend produced an error on the standard exhibit, it is not possible to complete the rate template with no variance (see line 2 of the chart). Line 3 is a summary of variance 8B, Loss Trend Only. Since the standard exhibits produced an error for the loss trend as noted above, variance 7A (loss development factors) and variance 8B (premium trend) were combined with variance 8B (loss trend), to calculate the indicated rate change ranges shown in lines 4 and 5, respectively. The attached files contain the rate templates for scenarios 3-5 above. Scenario 1 was submitted with the original filing and scenario 2 cannot be calculated. The file names are numbered according to the corresponding scenario. Please let me know if any further information is needed for your continued review of our filing.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Commercial Inland Marine Objection Response to Letter of December 21, 2017:** This letter is in response to the objection to filing SERFF Tr Num: QBEC-131306101 which requests the following information: _Submit the template with variance. Indicate the variance number on the space provided on the Ratemaking Data page. Page 6.B of our filing instructions reads: \"Filings requesting a variance must include one Rate Template excluding the variance and one Rate Template including the variance. A filing with multiple variances must include one Rate Template for each individual variance as well as the combined impact of all variances.\"_ The following is a chart that lists the annual premium trend, loss development factors, annual loss trend, and indicated rate change range for the Commercial Inland Marine filing referenced above.\n\nInland Marine Premium Trend LDF Loss Trend Range\n\n**1\\. As Filed (Variance)**\n\n**3\\.0%** **1\\.227, 1.042, 1.000, 1.000, 1.000, 1.000**\n\n**0\\.3%** **\\-32.4% to -12.4%**\n\n2\\. No Variance -10.0% 1.000, 1.000, 1.000,1.000, 1.000, 1.000\n\nError Not Possible\n\n3\\. 8B Loss Trend\n\nOnly\n\n\\-10.0% 1.000, 1.000, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% 12.7% to 46.1%\n\n4\\. 8B Loss\n\nTrend/7A LDF\n\nVariance\n\n\\-10.0% 1.227, 1.042, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% 13.0% to 46.4%\n\n5\\. 8B Loss and Premium Trend\n\n3\\.0% 1.000, 1.000, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% -32.6% to -12.6%\n\nThe first line of the chart is a summary of what was originally filed with the California Department of Insurance. The objection requested one rate template for each variance as well as the combined impact of all variances. Since the loss trend produced an error on the standard exhibit, it is not possible to complete the rate template with no variance (see line 2 of the chart). Line 3 is a summary of variance 8B, Loss Trend Only. Since the standard exhibits produced an error for the loss trend as noted above, variance 7A (loss development factors) and variance 8B (premium trend) were combined with variance 8B (loss trend), to calculate the indicated rate change ranges shown in lines 4 and 5, respectively. The attached files contain the rate templates for scenarios 3-5 above. Scenario 1 was submitted with the original filing and scenario 2 cannot be calculated. The file names are numbered according to the corresponding scenario. Please let me know if any further information is needed for your continued review of our filing.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2373.pdf"]},"response":{"errors":[],"extract_id":"extract_6a2c47a9a6928c8b100cad13479c1e7e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Commercial Inland Marine Objection Response to Letter of December 21, 2017:** This letter is in response to the objection to filing SERFF Tr Num: QBEC-131306101 which requests the following information: _Submit the template with variance. Indicate the variance number on the space provided on the Ratemaking Data page. Page 6.B of our filing instructions reads: \"Filings requesting a variance must include one Rate Template excluding the variance and one Rate Template including the variance. A filing with multiple variances must include one Rate Template for each individual variance as well as the combined impact of all variances.\"_ The following is a chart that lists the annual premium trend, loss development factors, annual loss trend, and indicated rate change range for the Commercial Inland Marine filing referenced above.\n\nInland Marine Premium Trend LDF Loss Trend Range\n\n**1\\. As Filed (Variance)**\n\n**3\\.0%** **1\\.227, 1.042, 1.000, 1.000, 1.000, 1.000**\n\n**0\\.3%** **\\-32.4% to -12.4%**\n\n2\\. No Variance -10.0% 1.000, 1.000, 1.000,1.000, 1.000, 1.000\n\nError Not Possible\n\n3\\. 8B Loss Trend\n\nOnly\n\n\\-10.0% 1.000, 1.000, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% 12.7% to 46.1%\n\n4\\. 8B Loss\n\nTrend/7A LDF\n\nVariance\n\n\\-10.0% 1.227, 1.042, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% 13.0% to 46.4%\n\n5\\. 8B Loss and Premium Trend\n\n3\\.0% 1.000, 1.000, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% -32.6% to -12.6%\n\nThe first line of the chart is a summary of what was originally filed with the California Department of Insurance. The objection requested one rate template for each variance as well as the combined impact of all variances. Since the loss trend produced an error on the standard exhibit, it is not possible to complete the rate template with no variance (see line 2 of the chart). Line 3 is a summary of variance 8B, Loss Trend Only. Since the standard exhibits produced an error for the loss trend as noted above, variance 7A (loss development factors) and variance 8B (premium trend) were combined with variance 8B (loss trend), to calculate the indicated rate change ranges shown in lines 4 and 5, respectively. The attached files contain the rate templates for scenarios 3-5 above. Scenario 1 was submitted with the original filing and scenario 2 cannot be calculated. The file names are numbered according to the corresponding scenario. Please let me know if any further information is needed for your continued review of our filing."],"full_content":"**Commercial Inland Marine Objection Response to Letter of December 21, 2017:** This letter is in response to the objection to filing SERFF Tr Num: QBEC-131306101 which requests the following information: _Submit the template with variance. Indicate the variance number on the space provided on the Ratemaking Data page. Page 6.B of our filing instructions reads: \"Filings requesting a variance must include one Rate Template excluding the variance and one Rate Template including the variance. A filing with multiple variances must include one Rate Template for each individual variance as well as the combined impact of all variances.\"_ The following is a chart that lists the annual premium trend, loss development factors, annual loss trend, and indicated rate change range for the Commercial Inland Marine filing referenced above.\n\nInland Marine Premium Trend LDF Loss Trend Range\n\n**1\\. As Filed (Variance)**\n\n**3\\.0%** **1\\.227, 1.042, 1.000, 1.000, 1.000, 1.000**\n\n**0\\.3%** **\\-32.4% to -12.4%**\n\n2\\. No Variance -10.0% 1.000, 1.000, 1.000,1.000, 1.000, 1.000\n\nError Not Possible\n\n3\\. 8B Loss Trend\n\nOnly\n\n\\-10.0% 1.000, 1.000, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% 12.7% to 46.1%\n\n4\\. 8B Loss\n\nTrend/7A LDF\n\nVariance\n\n\\-10.0% 1.227, 1.042, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% 13.0% to 46.4%\n\n5\\. 8B Loss and Premium Trend\n\n3\\.0% 1.000, 1.000, 1.000, 1.000, 1.000, 1.000\n\n0\\.3% -32.6% to -12.6%\n\nThe first line of the chart is a summary of what was originally filed with the California Department of Insurance. The objection requested one rate template for each variance as well as the combined impact of all variances. Since the loss trend produced an error on the standard exhibit, it is not possible to complete the rate template with no variance (see line 2 of the chart). Line 3 is a summary of variance 8B, Loss Trend Only. Since the standard exhibits produced an error for the loss trend as noted above, variance 7A (loss development factors) and variance 8B (premium trend) were combined with variance 8B (loss trend), to calculate the indicated rate change ranges shown in lines 4 and 5, respectively. The attached files contain the rate templates for scenarios 3-5 above. Scenario 1 was submitted with the original filing and scenario 2 cannot be calculated. The file names are numbered according to the corresponding scenario. Please let me know if any further information is needed for your continued review of our filing.","publish_date":null,"title":"Commercial Inland Marine Objection Response to Letter of December 21, 2017: This letter is in response to the objection to","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2373.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2373.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2373","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2373.pdf"},"started_at":"2026-11-04T19:48:26.735519"} +{"completed_at":"2026-11-04T19:48:30.150139","latency_in_ms":2908,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2402","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit 8**\n\n**General Casualty Company of Wisconsin**\n\n**Complement Loss and DCCE Trend**\n\n**_Complement Coverage4/Form4/Program4_**\n\n**Complement Loss Trend Data**\n\n**Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**Total Paid Losses including Partial**\n\n**Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**Total Paid Losses including Partial**\n\n**Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Closed Frequency per 100 Exposures**\n\n**Reported**\n\n**Frequency per 100 Exposures**\n\n**Paid Loss Severity**\n\n**Total Paid Loss**\n\n**Severity including Partial Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**20074 20081 20082 20083** 0 0 0 0 0 0.00 0.00 0 0\n\n**20084** 0 0 0 0 0 0.00 0.00 0 0\n\n**20091** 0 0 0 0 0 0.00 0.00 0 0\n\n**20092** 0 0 0 0 0 0.00 0.00 0 0\n\n**20093** 0 0 0 0 0 0.00 0.00 0 0\n\n**20094** 0 0 0 0 0 0.00 0.00 0 0\n\n**20101** 0 0 0 0 0 0.00 0.00 0 0\n\n**20102** 0 0 0 0 0 0.00 0.00 0 0\n\n**20103** 0 0 0 0 0 0.00 0.00 0 0\n\n**20104** 0 0 0 0 0 0.00 0.00 0 0\n\n**20111** 0 0 0 0 0 0.00 0.00 0 0\n\n**20112** 0 0 0 0 0 0.00 0.00 0 0\n\n**20113** 0 0 0 0 0 0.00 0.00 0 0\n\n**20114** 0 0 0 0 0 0.00 0.00 0 0\n\n**20121** 0 0 0 0 0 0.00 0.00 0 0\n\n**20122** 0 0 0 0 0 0.00 0.00 0 0\n\n**20123** 0 0 0 0 0 0.00 0.00 0 0\n\n**20124** 0 0 0 0 0 0.00 0.00 0 0\n\n**20131** 0 0 0 0 0 0.00 0.00 0 0\n\n**20132** 0 0 0 0 0 0.00 0.00 0 0\n\n**20133** 0 0 0 0 0 0.00 0.00 0 0\n\n**20134** 0 0 0 0 0 0.00 0.00 0 0\n\n**20141** 0 0 0 0 0 0.00 0.00 0 0\n\n**20142** 0 0 0 0 0 0.00 0.00 0 0\n\nRolling 4-Quarter Annual Trends\n\nSelected: **Complement**\n\n**Trend** Closed Frequency Reported Frequency Paid Severity Total Paid\n\n(w/Partials) Severity\n\nFrequency: **\\#N/A** 8 pt #NUM! #NUM! #NUM! #NUM!\n\nSeverity: **\\#N/A** 12 pt #NUM! #NUM! #NUM! #NUM!\n\nPure Premium: **\\#N/A** 16 pt #NUM! #NUM! #NUM! #NUM!\n\n20 pt #NUM! #NUM! #NUM! #NUM!\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt #NUM! #NUM! #NUM! #NUM!\n\nStandard Exhibits Template Page 4.8 10/24/2016 Edition","pages":[{"line_numbers":[],"markdown":"**Exhibit 8**\n\n**General Casualty Company of Wisconsin**\n\n**Complement Loss and DCCE Trend**\n\n**_Complement Coverage4/Form4/Program4_**\n\n**Complement Loss Trend Data**\n\n**Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**Total Paid Losses including Partial**\n\n**Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**Total Paid Losses including Partial**\n\n**Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Closed Frequency per 100 Exposures**\n\n**Reported**\n\n**Frequency per 100 Exposures**\n\n**Paid Loss Severity**\n\n**Total Paid Loss**\n\n**Severity including Partial Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**20074 20081 20082 20083** 0 0 0 0 0 0.00 0.00 0 0\n\n**20084** 0 0 0 0 0 0.00 0.00 0 0\n\n**20091** 0 0 0 0 0 0.00 0.00 0 0\n\n**20092** 0 0 0 0 0 0.00 0.00 0 0\n\n**20093** 0 0 0 0 0 0.00 0.00 0 0\n\n**20094** 0 0 0 0 0 0.00 0.00 0 0\n\n**20101** 0 0 0 0 0 0.00 0.00 0 0\n\n**20102** 0 0 0 0 0 0.00 0.00 0 0\n\n**20103** 0 0 0 0 0 0.00 0.00 0 0\n\n**20104** 0 0 0 0 0 0.00 0.00 0 0\n\n**20111** 0 0 0 0 0 0.00 0.00 0 0\n\n**20112** 0 0 0 0 0 0.00 0.00 0 0\n\n**20113** 0 0 0 0 0 0.00 0.00 0 0\n\n**20114** 0 0 0 0 0 0.00 0.00 0 0\n\n**20121** 0 0 0 0 0 0.00 0.00 0 0\n\n**20122** 0 0 0 0 0 0.00 0.00 0 0\n\n**20123** 0 0 0 0 0 0.00 0.00 0 0\n\n**20124** 0 0 0 0 0 0.00 0.00 0 0\n\n**20131** 0 0 0 0 0 0.00 0.00 0 0\n\n**20132** 0 0 0 0 0 0.00 0.00 0 0\n\n**20133** 0 0 0 0 0 0.00 0.00 0 0\n\n**20134** 0 0 0 0 0 0.00 0.00 0 0\n\n**20141** 0 0 0 0 0 0.00 0.00 0 0\n\n**20142** 0 0 0 0 0 0.00 0.00 0 0\n\nRolling 4-Quarter Annual Trends\n\nSelected: **Complement**\n\n**Trend** Closed Frequency Reported Frequency Paid Severity Total Paid\n\n(w/Partials) Severity\n\nFrequency: **\\#N/A** 8 pt #NUM! #NUM! #NUM! #NUM!\n\nSeverity: **\\#N/A** 12 pt #NUM! #NUM! #NUM! #NUM!\n\nPure Premium: **\\#N/A** 16 pt #NUM! #NUM! #NUM! #NUM!\n\n20 pt #NUM! #NUM! #NUM! #NUM!\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt #NUM! #NUM! #NUM! #NUM!\n\nStandard Exhibits Template Page 4.8 10/24/2016 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit 8**\n\n**General Casualty Company of Wisconsin**\n\n**Complement Loss and DCCE Trend**\n\n**_Complement Coverage4/Form4/Program4_**\n\n**Complement Loss Trend Data**\n\n**Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**Total Paid Losses including Partial**\n\n**Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**Total Paid Losses including Partial**\n\n**Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Closed Frequency per 100 Exposures**\n\n**Reported**\n\n**Frequency per 100 Exposures**\n\n**Paid Loss Severity**\n\n**Total Paid Loss**\n\n**Severity including Partial Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**20074 20081 20082 20083** 0 0 0 0 0 0.00 0.00 0 0\n\n**20084** 0 0 0 0 0 0.00 0.00 0 0\n\n**20091** 0 0 0 0 0 0.00 0.00 0 0\n\n**20092** 0 0 0 0 0 0.00 0.00 0 0\n\n**20093** 0 0 0 0 0 0.00 0.00 0 0\n\n**20094** 0 0 0 0 0 0.00 0.00 0 0\n\n**20101** 0 0 0 0 0 0.00 0.00 0 0\n\n**20102** 0 0 0 0 0 0.00 0.00 0 0\n\n**20103** 0 0 0 0 0 0.00 0.00 0 0\n\n**20104** 0 0 0 0 0 0.00 0.00 0 0\n\n**20111** 0 0 0 0 0 0.00 0.00 0 0\n\n**20112** 0 0 0 0 0 0.00 0.00 0 0\n\n**20113** 0 0 0 0 0 0.00 0.00 0 0\n\n**20114** 0 0 0 0 0 0.00 0.00 0 0\n\n**20121** 0 0 0 0 0 0.00 0.00 0 0\n\n**20122** 0 0 0 0 0 0.00 0.00 0 0\n\n**20123** 0 0 0 0 0 0.00 0.00 0 0\n\n**20124** 0 0 0 0 0 0.00 0.00 0 0\n\n**20131** 0 0 0 0 0 0.00 0.00 0 0\n\n**20132** 0 0 0 0 0 0.00 0.00 0 0\n\n**20133** 0 0 0 0 0 0.00 0.00 0 0\n\n**20134** 0 0 0 0 0 0.00 0.00 0 0\n\n**20141** 0 0 0 0 0 0.00 0.00 0 0\n\n**20142** 0 0 0 0 0 0.00 0.00 0 0\n\nRolling 4-Quarter Annual Trends\n\nSelected: **Complement**\n\n**Trend** Closed Frequency Reported Frequency Paid Severity Total Paid\n\n(w/Partials) Severity\n\nFrequency: **\\#N/A** 8 pt #NUM! #NUM! #NUM! #NUM!\n\nSeverity: **\\#N/A** 12 pt #NUM! #NUM! #NUM! #NUM!\n\nPure Premium: **\\#N/A** 16 pt #NUM! #NUM! #NUM! #NUM!\n\n20 pt #NUM! #NUM! #NUM! #NUM!\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt #NUM! #NUM! #NUM! #NUM!\n\nStandard Exhibits Template Page 4.8 10/24/2016 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2402.pdf"]},"response":{"errors":[],"extract_id":"extract_2e17f2f7d44ba5031171e11bc87e089a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit 8**\n\n**General Casualty Company of Wisconsin**\n\n**Complement Loss and DCCE Trend**\n\n**_Complement Coverage4/Form4/Program4_**\n\n**Complement Loss Trend Data**\n\n**Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**Total Paid Losses including Partial**\n\n**Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**Total Paid Losses including Partial**\n\n**Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Closed Frequency per 100 Exposures**\n\n**Reported**\n\n**Frequency per 100 Exposures**\n\n**Paid Loss Severity**\n\n**Total Paid Loss**\n\n**Severity including Partial Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**20074 20081 20082 20083** 0 0 0 0 0 0.00 0.00 0 0\n\n**20084** 0 0 0 0 0 0.00 0.00 0 0\n\n**20091** 0 0 0 0 0 0.00 0.00 0 0\n\n**20092** 0 0 0 0 0 0.00 0.00 0 0\n\n**20093** 0 0 0 0 0 0.00 0.00 0 0\n\n**20094** 0 0 0 0 0 0.00 0.00 0 0\n\n**20101** 0 0 0 0 0 0.00 0.00 0 0\n\n**20102** 0 0 0 0 0 0.00 0.00 0 0\n\n**20103** 0 0 0 0 0 0.00 0.00 0 0\n\n**20104** 0 0 0 0 0 0.00 0.00 0 0\n\n**20111** 0 0 0 0 0 0.00 0.00 0 0\n\n**20112** 0 0 0 0 0 0.00 0.00 0 0\n\n**20113** 0 0 0 0 0 0.00 0.00 0 0\n\n**20114** 0 0 0 0 0 0.00 0.00 0 0\n\n**20121** 0 0 0 0 0 0.00 0.00 0 0\n\n**20122** 0 0 0 0 0 0.00 0.00 0 0\n\n**20123** 0 0 0 0 0 0.00 0.00 0 0\n\n**20124** 0 0 0 0 0 0.00 0.00 0 0\n\n**20131** 0 0 0 0 0 0.00 0.00 0 0\n\n**20132** 0 0 0 0 0 0.00 0.00 0 0\n\n**20133** 0 0 0 0 0 0.00 0.00 0 0\n\n**20134** 0 0 0 0 0 0.00 0.00 0 0\n\n**20141** 0 0 0 0 0 0.00 0.00 0 0\n\n**20142** 0 0 0 0 0 0.00 0.00 0 0\n\nRolling 4-Quarter Annual Trends\n\nSelected: **Complement**\n\n**Trend** Closed Frequency Reported Frequency Paid Severity Total Paid\n\n(w/Partials) Severity\n\nFrequency: **\\#N/A** 8 pt #NUM! #NUM! #NUM! #NUM!\n\nSeverity: **\\#N/A** 12 pt #NUM! #NUM! #NUM! #NUM!\n\nPure Premium: **\\#N/A** 16 pt #NUM! #NUM! #NUM! #NUM!\n\n20 pt #NUM! #NUM! #NUM! #NUM!\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt #NUM! #NUM! #NUM! #NUM!\n\nStandard Exhibits Template Page 4.8 10/24/2016 Edition"],"full_content":"**Exhibit 8**\n\n**General Casualty Company of Wisconsin**\n\n**Complement Loss and DCCE Trend**\n\n**_Complement Coverage4/Form4/Program4_**\n\n**Complement Loss Trend Data**\n\n**Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**Total Paid Losses including Partial**\n\n**Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**Total Paid Losses including Partial**\n\n**Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Closed Frequency per 100 Exposures**\n\n**Reported**\n\n**Frequency per 100 Exposures**\n\n**Paid Loss Severity**\n\n**Total Paid Loss**\n\n**Severity including Partial Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**20074 20081 20082 20083** 0 0 0 0 0 0.00 0.00 0 0\n\n**20084** 0 0 0 0 0 0.00 0.00 0 0\n\n**20091** 0 0 0 0 0 0.00 0.00 0 0\n\n**20092** 0 0 0 0 0 0.00 0.00 0 0\n\n**20093** 0 0 0 0 0 0.00 0.00 0 0\n\n**20094** 0 0 0 0 0 0.00 0.00 0 0\n\n**20101** 0 0 0 0 0 0.00 0.00 0 0\n\n**20102** 0 0 0 0 0 0.00 0.00 0 0\n\n**20103** 0 0 0 0 0 0.00 0.00 0 0\n\n**20104** 0 0 0 0 0 0.00 0.00 0 0\n\n**20111** 0 0 0 0 0 0.00 0.00 0 0\n\n**20112** 0 0 0 0 0 0.00 0.00 0 0\n\n**20113** 0 0 0 0 0 0.00 0.00 0 0\n\n**20114** 0 0 0 0 0 0.00 0.00 0 0\n\n**20121** 0 0 0 0 0 0.00 0.00 0 0\n\n**20122** 0 0 0 0 0 0.00 0.00 0 0\n\n**20123** 0 0 0 0 0 0.00 0.00 0 0\n\n**20124** 0 0 0 0 0 0.00 0.00 0 0\n\n**20131** 0 0 0 0 0 0.00 0.00 0 0\n\n**20132** 0 0 0 0 0 0.00 0.00 0 0\n\n**20133** 0 0 0 0 0 0.00 0.00 0 0\n\n**20134** 0 0 0 0 0 0.00 0.00 0 0\n\n**20141** 0 0 0 0 0 0.00 0.00 0 0\n\n**20142** 0 0 0 0 0 0.00 0.00 0 0\n\nRolling 4-Quarter Annual Trends\n\nSelected: **Complement**\n\n**Trend** Closed Frequency Reported Frequency Paid Severity Total Paid\n\n(w/Partials) Severity\n\nFrequency: **\\#N/A** 8 pt #NUM! #NUM! #NUM! #NUM!\n\nSeverity: **\\#N/A** 12 pt #NUM! #NUM! #NUM! #NUM!\n\nPure Premium: **\\#N/A** 16 pt #NUM! #NUM! #NUM! #NUM!\n\n20 pt #NUM! #NUM! #NUM! #NUM!\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt #NUM! #NUM! #NUM! #NUM!\n\nStandard Exhibits Template Page 4.8 10/24/2016 Edition","publish_date":null,"title":"General Casualty Company of Wisconsin General Casualty Company of Wisconsin Complement Loss and DCCE Trend Complement Loss and DCCE Trend","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2402.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2402.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2402","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2402.pdf"},"started_at":"2026-11-04T19:48:27.241961"} +{"completed_at":"2026-11-04T19:48:29.896340","latency_in_ms":1482,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2443","grounded_pages":[],"layout_pages":[],"markdown":"**EXHIBIT 10** Page 2\n\nThe Credibility formula used is [ (N) / (Z) ] ^ 1/2 where Z is based on the full Credibility Claims Standard for Property from ISO reference CF-2013-RLA1 (CDI #13-7547).\n\n**Loss Trend**\n\nYear Reported Claims\n\n20142-20144 404\n\n2015 541\n\n2016 504\n\n2017 474\n\n2018 458\n\n2019 444\n\n2020 368\n\nN = 3193\n\nZ = 20000\n\nCW Credibility 40.0%\n\n**Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned**\n\n**Exposures Closed Claims Reported Claims Paid Losses &**\n\n**DCCE**\n\n**Total Paid Losses &**\n\n**DCCE including Partial Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**& DCCE**\n\n**Total Paid Losses &**\n\n**DCCE including**\n\n**Partial Payments on Prior Calendar Years,**\n\n**on Closed Claims**\n\n**Closed Frequency per**\n\n**100 Exposures**\n\n**Reported Frequency per 100 Exposures**\n\n**Paid Loss &**\n\n**DCCE Severity**\n\n**Total Paid Loss & DCCE**\n\n**Severity including**\n\n**Partial**\n\n**Payments on Prior Calendar**\n\n**Years, on**\n\n**Closed Claims**\n\n**20142** 473,452,233 81 132 4,091,025 1,245,450\n\n**20143** 326,408,973 98 139 2,472,237 1,856,809\n\n**20144** 312,764,107 105 133 1,293,250 7,856,950\n\n**20151** 888,146,499 79 99 2,368,794 5,312,073 2,000,771,812 363 503 10,225,306 16,271,281 0.00 0.00 28,169 44,824\n\n**20152** 688,998,576 91 116 854,196 1,215,476 2,216,318,154 373 487 6,988,477 16,241,307 0.00 0.00 18,736 43,542\n\n**20153** 1,214,232,244 106 168 2,261,539 1,461,435 3,104,141,425 381 516 6,777,780 15,845,934 0.00 0.00 17,789 41,590\n\n**20154** 1,728,096,918 124 158 2,281,730 1,685,491 4,519,474,237 400 541 7,766,260 9,674,475 0.00 0.00 19,416 24,186\n\n**20161** 2,840,406,751 74 96 1,371,550 1,498,092 6,471,734,488 395 538 6,769,016 5,860,494 0.00 0.00 17,137 14,837\n\n**20162** 560,538,525 70 101 1,564,640 1,067,248 6,343,274,437 374 523 7,479,460 5,712,267 0.00 0.00 19,999 15,273\n\n**20163** 392,329,558 127 158 4,118,001 1,851,163 5,521,371,751 395 513 9,335,922 6,101,995 0.00 0.00 23,635 15,448\n\n**20164** 561,062,726 110 149 2,154,865 2,103,281 4,354,337,559 381 504 9,209,056 6,519,785 0.00 0.00 24,171 17,112\n\n**20171** 884,001,265 84 113 1,471,544 1,267,638 2,397,932,074 391 521 9,309,050 6,289,330 0.00 0.00 23,808 16,085\n\n**20172** 669,092,293 83 111 1,365,961 1,355,059 2,506,485,842 404 531 9,110,371 6,577,141 0.00 0.00 22,550 16,280\n\n**20173** 430,215,424 100 136 2,818,641 2,764,375 2,544,371,707 377 509 7,811,011 7,490,353 0.00 0.00 20,719 19,868\n\n**20174** 870,014,972 81 114 2,634,684 1,641,641 2,853,323,953 348 474 8,290,830 7,028,713 0.00 0.00 23,824 20,197\n\n**20181** 1,269,748,479 74 81 3,720,794 2,603,438 3,239,071,167 338 442 10,540,080 8,364,514 0.00 0.00 31,184 24,747\n\n**20182** 938,163,369 85 122 2,274,471 1,699,085 3,508,142,243 340 453 11,448,589 8,708,540 0.00 0.00 33,672 25,613\n\n**20183** 481,993,570 79 123 2,161,979 1,431,635 3,559,920,390 319 440 10,791,927 7,375,800 0.00 0.00 33,830 23,122\n\n**20184** 613,618,012 82 132 2,664,673 1,650,426 3,303,523,430 320 458 10,821,917 7,384,584 0.00 0.00 33,818 23,077\n\n**20191** 1,034,476,647 89 99 1,677,938 1,945,164 3,068,251,598 335 476 8,779,061 6,726,310 0.00 0.00 26,206 20,079\n\n**20192** 883,257,298 74 101 2,795,511 1,338,073 3,013,345,527 324 455 9,300,101 6,365,297 0.00 0.00 28,704 19,646\n\n**20193** 443,432,218 73 127 2,108,810 1,398,198 2,974,784,175 318 459 9,246,932 6,331,860 0.00 0.00 29,078 19,912\n\n**20194** 561,723,703 81 117 2,354,049 3,489,662 2,922,889,865 317 444 8,936,308 8,171,096 0.00 0.00 28,190 25,776\n\n**20201** 905,820,948 90 89 3,547,192 1,646,087 2,794,234,167 318 434 10,805,562 7,872,020 0.00 0.00 33,980 24,755\n\n**20202** 745,538,548 76 96 739,137 1,359,039 2,656,515,417 320 429 8,749,188 7,892,987 0.00 0.00 27,341 24,666\n\n**20203** 417,866,147 60 96 2,422,974 979,211 2,630,949,346 307 398 9,063,353 7,474,000 0.00 0.00 29,522 24,345\n\n**20204** 597,845,335 76 87 71,522 2,603,567 2,667,070,978 302 368 6,780,826 6,587,905 0.00 0.00 22,453 21,814\n\nRolling 4-Quarter Annual Trends\n\nSelected: **24 pt Complement**\n\n**Trend** Closed Frequency Reported Frequency Paid Severity\n\nTotal Paid (w/Partials) Severity\n\nFrequency: **Reported 0.0%** 8 pt 5.2% -3.1% -4.4% 11.3%\n\nSeverity: **Paid 7.8%** 12 pt 7.9% 5.7% -8.1% -0.4%\n\nPure Premium: **7\\.9%** 16 pt -6.3% -6.7% 4.0% 7.6%\n\n20 pt 7.3% 7.2% 8.0% 10.6%\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt 0.0% 0.0% 7.8% -3.0%\n\n**CREDIBILITY ADJUSTMENT**\n\n**SENTRY SELECT INSURANCE COMPANY**\n\n**Dealer Operations**\n\n**INLAND MARINE**\n\n**CALIFORNIA**\n\nA credibility adjustment is necessary if the data in the three-year recorded period is less than fully credible. In the event the data is fully credible with fewer than three years of experience, only as many years as needed to be fully credible shall be used as the recorded period. If the data in the three-year recorded period has less than 25% credibility, up to three additional years shall be added to the recorded period until the data is at least 25% credible. Refer to CCR §2642.6. If after six years, the data remains less than 25% credible, alternative complementary loss and DCCE may be used, provided that the alternative is the most actuarially sound method. Refer to CCR §2644.23(i).\n\nPursuant to CCR §2644.23, if the data is not 100% credible, indicate how the loss and DCCE credibility factor on Page 6, line 14 of the Rate Template was determined. Provide the credibility formula or table that was used to derive the factor.\n\nIf alternative loss and DCCE are used as pertaining to CCR §2644.23(i), then the credibility-weighted projected ultimate loss and DCCE should be entered on Page 6, lines 7 and 8 of the Rate Template. Enter a factor of 1.00 for all loss and DCCE development, trend and catastrophe adjustment on lines 9 through 13, and enter 100% for credibility in line 14. Detailed data and calculations supporting the development of the credibility-weighted projected ultimate loss and DCCE should be provided within the corresponding exhibits.\n\nThe full credibility standard is 3,000 claims for each homeowners form and for each coverage for private passenger auto. The calculation for partial credibility is the square root of the ratio of the actual number of incurred claims in the recorded period divided by the full credibility standard. For other lines of insurance, the standard for full and partial credibility shall be calculated using the most actuarially sound method.","pages":[{"line_numbers":[],"markdown":"**EXHIBIT 10** Page 2\n\nThe Credibility formula used is [ (N) / (Z) ] ^ 1/2 where Z is based on the full Credibility Claims Standard for Property from ISO reference CF-2013-RLA1 (CDI #13-7547).\n\n**Loss Trend**\n\nYear Reported Claims\n\n20142-20144 404\n\n2015 541\n\n2016 504\n\n2017 474\n\n2018 458\n\n2019 444\n\n2020 368\n\nN = 3193\n\nZ = 20000\n\nCW Credibility 40.0%\n\n**Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned**\n\n**Exposures Closed Claims Reported Claims Paid Losses &**\n\n**DCCE**\n\n**Total Paid Losses &**\n\n**DCCE including Partial Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**& DCCE**\n\n**Total Paid Losses &**\n\n**DCCE including**\n\n**Partial Payments on Prior Calendar Years,**\n\n**on Closed Claims**\n\n**Closed Frequency per**\n\n**100 Exposures**\n\n**Reported Frequency per 100 Exposures**\n\n**Paid Loss &**\n\n**DCCE Severity**\n\n**Total Paid Loss & DCCE**\n\n**Severity including**\n\n**Partial**\n\n**Payments on Prior Calendar**\n\n**Years, on**\n\n**Closed Claims**\n\n**20142** 473,452,233 81 132 4,091,025 1,245,450\n\n**20143** 326,408,973 98 139 2,472,237 1,856,809\n\n**20144** 312,764,107 105 133 1,293,250 7,856,950\n\n**20151** 888,146,499 79 99 2,368,794 5,312,073 2,000,771,812 363 503 10,225,306 16,271,281 0.00 0.00 28,169 44,824\n\n**20152** 688,998,576 91 116 854,196 1,215,476 2,216,318,154 373 487 6,988,477 16,241,307 0.00 0.00 18,736 43,542\n\n**20153** 1,214,232,244 106 168 2,261,539 1,461,435 3,104,141,425 381 516 6,777,780 15,845,934 0.00 0.00 17,789 41,590\n\n**20154** 1,728,096,918 124 158 2,281,730 1,685,491 4,519,474,237 400 541 7,766,260 9,674,475 0.00 0.00 19,416 24,186\n\n**20161** 2,840,406,751 74 96 1,371,550 1,498,092 6,471,734,488 395 538 6,769,016 5,860,494 0.00 0.00 17,137 14,837\n\n**20162** 560,538,525 70 101 1,564,640 1,067,248 6,343,274,437 374 523 7,479,460 5,712,267 0.00 0.00 19,999 15,273\n\n**20163** 392,329,558 127 158 4,118,001 1,851,163 5,521,371,751 395 513 9,335,922 6,101,995 0.00 0.00 23,635 15,448\n\n**20164** 561,062,726 110 149 2,154,865 2,103,281 4,354,337,559 381 504 9,209,056 6,519,785 0.00 0.00 24,171 17,112\n\n**20171** 884,001,265 84 113 1,471,544 1,267,638 2,397,932,074 391 521 9,309,050 6,289,330 0.00 0.00 23,808 16,085\n\n**20172** 669,092,293 83 111 1,365,961 1,355,059 2,506,485,842 404 531 9,110,371 6,577,141 0.00 0.00 22,550 16,280\n\n**20173** 430,215,424 100 136 2,818,641 2,764,375 2,544,371,707 377 509 7,811,011 7,490,353 0.00 0.00 20,719 19,868\n\n**20174** 870,014,972 81 114 2,634,684 1,641,641 2,853,323,953 348 474 8,290,830 7,028,713 0.00 0.00 23,824 20,197\n\n**20181** 1,269,748,479 74 81 3,720,794 2,603,438 3,239,071,167 338 442 10,540,080 8,364,514 0.00 0.00 31,184 24,747\n\n**20182** 938,163,369 85 122 2,274,471 1,699,085 3,508,142,243 340 453 11,448,589 8,708,540 0.00 0.00 33,672 25,613\n\n**20183** 481,993,570 79 123 2,161,979 1,431,635 3,559,920,390 319 440 10,791,927 7,375,800 0.00 0.00 33,830 23,122\n\n**20184** 613,618,012 82 132 2,664,673 1,650,426 3,303,523,430 320 458 10,821,917 7,384,584 0.00 0.00 33,818 23,077\n\n**20191** 1,034,476,647 89 99 1,677,938 1,945,164 3,068,251,598 335 476 8,779,061 6,726,310 0.00 0.00 26,206 20,079\n\n**20192** 883,257,298 74 101 2,795,511 1,338,073 3,013,345,527 324 455 9,300,101 6,365,297 0.00 0.00 28,704 19,646\n\n**20193** 443,432,218 73 127 2,108,810 1,398,198 2,974,784,175 318 459 9,246,932 6,331,860 0.00 0.00 29,078 19,912\n\n**20194** 561,723,703 81 117 2,354,049 3,489,662 2,922,889,865 317 444 8,936,308 8,171,096 0.00 0.00 28,190 25,776\n\n**20201** 905,820,948 90 89 3,547,192 1,646,087 2,794,234,167 318 434 10,805,562 7,872,020 0.00 0.00 33,980 24,755\n\n**20202** 745,538,548 76 96 739,137 1,359,039 2,656,515,417 320 429 8,749,188 7,892,987 0.00 0.00 27,341 24,666\n\n**20203** 417,866,147 60 96 2,422,974 979,211 2,630,949,346 307 398 9,063,353 7,474,000 0.00 0.00 29,522 24,345\n\n**20204** 597,845,335 76 87 71,522 2,603,567 2,667,070,978 302 368 6,780,826 6,587,905 0.00 0.00 22,453 21,814\n\nRolling 4-Quarter Annual Trends\n\nSelected: **24 pt Complement**\n\n**Trend** Closed Frequency Reported Frequency Paid Severity\n\nTotal Paid (w/Partials) Severity\n\nFrequency: **Reported 0.0%** 8 pt 5.2% -3.1% -4.4% 11.3%\n\nSeverity: **Paid 7.8%** 12 pt 7.9% 5.7% -8.1% -0.4%\n\nPure Premium: **7\\.9%** 16 pt -6.3% -6.7% 4.0% 7.6%\n\n20 pt 7.3% 7.2% 8.0% 10.6%\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt 0.0% 0.0% 7.8% -3.0%\n\n**CREDIBILITY ADJUSTMENT**\n\n**SENTRY SELECT INSURANCE COMPANY**\n\n**Dealer Operations**\n\n**INLAND MARINE**\n\n**CALIFORNIA**\n\nA credibility adjustment is necessary if the data in the three-year recorded period is less than fully credible. In the event the data is fully credible with fewer than three years of experience, only as many years as needed to be fully credible shall be used as the recorded period. If the data in the three-year recorded period has less than 25% credibility, up to three additional years shall be added to the recorded period until the data is at least 25% credible. Refer to CCR §2642.6. If after six years, the data remains less than 25% credible, alternative complementary loss and DCCE may be used, provided that the alternative is the most actuarially sound method. Refer to CCR §2644.23(i).\n\nPursuant to CCR §2644.23, if the data is not 100% credible, indicate how the loss and DCCE credibility factor on Page 6, line 14 of the Rate Template was determined. Provide the credibility formula or table that was used to derive the factor.\n\nIf alternative loss and DCCE are used as pertaining to CCR §2644.23(i), then the credibility-weighted projected ultimate loss and DCCE should be entered on Page 6, lines 7 and 8 of the Rate Template. Enter a factor of 1.00 for all loss and DCCE development, trend and catastrophe adjustment on lines 9 through 13, and enter 100% for credibility in line 14. Detailed data and calculations supporting the development of the credibility-weighted projected ultimate loss and DCCE should be provided within the corresponding exhibits.\n\nThe full credibility standard is 3,000 claims for each homeowners form and for each coverage for private passenger auto. The calculation for partial credibility is the square root of the ratio of the actual number of incurred claims in the recorded period divided by the full credibility standard. For other lines of insurance, the standard for full and partial credibility shall be calculated using the most actuarially sound method.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**EXHIBIT 10** Page 2\n\nThe Credibility formula used is [ (N) / (Z) ] ^ 1/2 where Z is based on the full Credibility Claims Standard for Property from ISO reference CF-2013-RLA1 (CDI #13-7547).\n\n**Loss Trend**\n\nYear Reported Claims\n\n20142-20144 404\n\n2015 541\n\n2016 504\n\n2017 474\n\n2018 458\n\n2019 444\n\n2020 368\n\nN = 3193\n\nZ = 20000\n\nCW Credibility 40.0%\n\n**Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned**\n\n**Exposures Closed Claims Reported Claims Paid Losses &**\n\n**DCCE**\n\n**Total Paid Losses &**\n\n**DCCE including Partial Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**& DCCE**\n\n**Total Paid Losses &**\n\n**DCCE including**\n\n**Partial Payments on Prior Calendar Years,**\n\n**on Closed Claims**\n\n**Closed Frequency per**\n\n**100 Exposures**\n\n**Reported Frequency per 100 Exposures**\n\n**Paid Loss &**\n\n**DCCE Severity**\n\n**Total Paid Loss & DCCE**\n\n**Severity including**\n\n**Partial**\n\n**Payments on Prior Calendar**\n\n**Years, on**\n\n**Closed Claims**\n\n**20142** 473,452,233 81 132 4,091,025 1,245,450\n\n**20143** 326,408,973 98 139 2,472,237 1,856,809\n\n**20144** 312,764,107 105 133 1,293,250 7,856,950\n\n**20151** 888,146,499 79 99 2,368,794 5,312,073 2,000,771,812 363 503 10,225,306 16,271,281 0.00 0.00 28,169 44,824\n\n**20152** 688,998,576 91 116 854,196 1,215,476 2,216,318,154 373 487 6,988,477 16,241,307 0.00 0.00 18,736 43,542\n\n**20153** 1,214,232,244 106 168 2,261,539 1,461,435 3,104,141,425 381 516 6,777,780 15,845,934 0.00 0.00 17,789 41,590\n\n**20154** 1,728,096,918 124 158 2,281,730 1,685,491 4,519,474,237 400 541 7,766,260 9,674,475 0.00 0.00 19,416 24,186\n\n**20161** 2,840,406,751 74 96 1,371,550 1,498,092 6,471,734,488 395 538 6,769,016 5,860,494 0.00 0.00 17,137 14,837\n\n**20162** 560,538,525 70 101 1,564,640 1,067,248 6,343,274,437 374 523 7,479,460 5,712,267 0.00 0.00 19,999 15,273\n\n**20163** 392,329,558 127 158 4,118,001 1,851,163 5,521,371,751 395 513 9,335,922 6,101,995 0.00 0.00 23,635 15,448\n\n**20164** 561,062,726 110 149 2,154,865 2,103,281 4,354,337,559 381 504 9,209,056 6,519,785 0.00 0.00 24,171 17,112\n\n**20171** 884,001,265 84 113 1,471,544 1,267,638 2,397,932,074 391 521 9,309,050 6,289,330 0.00 0.00 23,808 16,085\n\n**20172** 669,092,293 83 111 1,365,961 1,355,059 2,506,485,842 404 531 9,110,371 6,577,141 0.00 0.00 22,550 16,280\n\n**20173** 430,215,424 100 136 2,818,641 2,764,375 2,544,371,707 377 509 7,811,011 7,490,353 0.00 0.00 20,719 19,868\n\n**20174** 870,014,972 81 114 2,634,684 1,641,641 2,853,323,953 348 474 8,290,830 7,028,713 0.00 0.00 23,824 20,197\n\n**20181** 1,269,748,479 74 81 3,720,794 2,603,438 3,239,071,167 338 442 10,540,080 8,364,514 0.00 0.00 31,184 24,747\n\n**20182** 938,163,369 85 122 2,274,471 1,699,085 3,508,142,243 340 453 11,448,589 8,708,540 0.00 0.00 33,672 25,613\n\n**20183** 481,993,570 79 123 2,161,979 1,431,635 3,559,920,390 319 440 10,791,927 7,375,800 0.00 0.00 33,830 23,122\n\n**20184** 613,618,012 82 132 2,664,673 1,650,426 3,303,523,430 320 458 10,821,917 7,384,584 0.00 0.00 33,818 23,077\n\n**20191** 1,034,476,647 89 99 1,677,938 1,945,164 3,068,251,598 335 476 8,779,061 6,726,310 0.00 0.00 26,206 20,079\n\n**20192** 883,257,298 74 101 2,795,511 1,338,073 3,013,345,527 324 455 9,300,101 6,365,297 0.00 0.00 28,704 19,646\n\n**20193** 443,432,218 73 127 2,108,810 1,398,198 2,974,784,175 318 459 9,246,932 6,331,860 0.00 0.00 29,078 19,912\n\n**20194** 561,723,703 81 117 2,354,049 3,489,662 2,922,889,865 317 444 8,936,308 8,171,096 0.00 0.00 28,190 25,776\n\n**20201** 905,820,948 90 89 3,547,192 1,646,087 2,794,234,167 318 434 10,805,562 7,872,020 0.00 0.00 33,980 24,755\n\n**20202** 745,538,548 76 96 739,137 1,359,039 2,656,515,417 320 429 8,749,188 7,892,987 0.00 0.00 27,341 24,666\n\n**20203** 417,866,147 60 96 2,422,974 979,211 2,630,949,346 307 398 9,063,353 7,474,000 0.00 0.00 29,522 24,345\n\n**20204** 597,845,335 76 87 71,522 2,603,567 2,667,070,978 302 368 6,780,826 6,587,905 0.00 0.00 22,453 21,814\n\nRolling 4-Quarter Annual Trends\n\nSelected: **24 pt Complement**\n\n**Trend** Closed Frequency Reported Frequency Paid Severity\n\nTotal Paid (w/Partials) Severity\n\nFrequency: **Reported 0.0%** 8 pt 5.2% -3.1% -4.4% 11.3%\n\nSeverity: **Paid 7.8%** 12 pt 7.9% 5.7% -8.1% -0.4%\n\nPure Premium: **7\\.9%** 16 pt -6.3% -6.7% 4.0% 7.6%\n\n20 pt 7.3% 7.2% 8.0% 10.6%\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt 0.0% 0.0% 7.8% -3.0%\n\n**CREDIBILITY ADJUSTMENT**\n\n**SENTRY SELECT INSURANCE COMPANY**\n\n**Dealer Operations**\n\n**INLAND MARINE**\n\n**CALIFORNIA**\n\nA credibility adjustment is necessary if the data in the three-year recorded period is less than fully credible. In the event the data is fully credible with fewer than three years of experience, only as many years as needed to be fully credible shall be used as the recorded period. If the data in the three-year recorded period has less than 25% credibility, up to three additional years shall be added to the recorded period until the data is at least 25% credible. Refer to CCR §2642.6. If after six years, the data remains less than 25% credible, alternative complementary loss and DCCE may be used, provided that the alternative is the most actuarially sound method. Refer to CCR §2644.23(i).\n\nPursuant to CCR §2644.23, if the data is not 100% credible, indicate how the loss and DCCE credibility factor on Page 6, line 14 of the Rate Template was determined. Provide the credibility formula or table that was used to derive the factor.\n\nIf alternative loss and DCCE are used as pertaining to CCR §2644.23(i), then the credibility-weighted projected ultimate loss and DCCE should be entered on Page 6, lines 7 and 8 of the Rate Template. Enter a factor of 1.00 for all loss and DCCE development, trend and catastrophe adjustment on lines 9 through 13, and enter 100% for credibility in line 14. Detailed data and calculations supporting the development of the credibility-weighted projected ultimate loss and DCCE should be provided within the corresponding exhibits.\n\nThe full credibility standard is 3,000 claims for each homeowners form and for each coverage for private passenger auto. The calculation for partial credibility is the square root of the ratio of the actual number of incurred claims in the recorded period divided by the full credibility standard. For other lines of insurance, the standard for full and partial credibility shall be calculated using the most actuarially sound method.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2443.pdf"]},"response":{"errors":[],"extract_id":"extract_67460d7dd7b2f0fd86f44b368555ea8f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**EXHIBIT 10** Page 2\n\nThe Credibility formula used is [ (N) / (Z) ] ^ 1/2 where Z is based on the full Credibility Claims Standard for Property from ISO reference CF-2013-RLA1 (CDI #13-7547).\n\n**Loss Trend**\n\nYear Reported Claims\n\n20142-20144 404\n\n2015 541\n\n2016 504\n\n2017 474\n\n2018 458\n\n2019 444\n\n2020 368\n\nN = 3193\n\nZ = 20000\n\nCW Credibility 40.0%\n\n**Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned**\n\n**Exposures Closed Claims Reported Claims Paid Losses &**\n\n**DCCE**\n\n**Total Paid Losses &**\n\n**DCCE including Partial Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**& DCCE**\n\n**Total Paid Losses &**\n\n**DCCE including**\n\n**Partial Payments on Prior Calendar Years,**\n\n**on Closed Claims**\n\n**Closed Frequency per**\n\n**100 Exposures**\n\n**Reported Frequency per 100 Exposures**\n\n**Paid Loss &**\n\n**DCCE Severity**\n\n**Total Paid Loss & DCCE**\n\n**Severity including**\n\n**Partial**\n\n**Payments on Prior Calendar**\n\n**Years, on**\n\n**Closed Claims**\n\n**20142** 473,452,233 81 132 4,091,025 1,245,450\n\n**20143** 326,408,973 98 139 2,472,237 1,856,809\n\n**20144** 312,764,107 105 133 1,293,250 7,856,950\n\n**20151** 888,146,499 79 99 2,368,794 5,312,073 2,000,771,812 363 503 10,225,306 16,271,281 0.00 0.00 28,169 44,824\n\n**20152** 688,998,576 91 116 854,196 1,215,476 2,216,318,154 373 487 6,988,477 16,241,307 0.00 0.00 18,736 43,542\n\n**20153** 1,214,232,244 106 168 2,261,539 1,461,435 3,104,141,425 381 516 6,777,780 15,845,934 0.00 0.00 17,789 41,590\n\n**20154** 1,728,096,918 124 158 2,281,730 1,685,491 4,519,474,237 400 541 7,766,260 9,674,475 0.00 0.00 19,416 24,186\n\n**20161** 2,840,406,751 74 96 1,371,550 1,498,092 6,471,734,488 395 538 6,769,016 5,860,494 0.00 0.00 17,137 14,837\n\n**20162** 560,538,525 70 101 1,564,640 1,067,248 6,343,274,437 374 523 7,479,460 5,712,267 0.00 0.00 19,999 15,273\n\n**20163** 392,329,558 127 158 4,118,001 1,851,163 5,521,371,751 395 513 9,335,922 6,101,995 0.00 0.00 23,635 15,448\n\n**20164** 561,062,726 110 149 2,154,865 2,103,281 4,354,337,559 381 504 9,209,056 6,519,785 0.00 0.00 24,171 17,112\n\n**20171** 884,001,265 84 113 1,471,544 1,267,638 2,397,932,074 391 521 9,309,050 6,289,330 0.00 0.00 23,808 16,085\n\n**20172** 669,092,293 83 111 1,365,961 1,355,059 2,506,485,842 404 531 9,110,371 6,577,141 0.00 0.00 22,550 16,280\n\n**20173** 430,215,424 100 136 2,818,641 2,764,375 2,544,371,707 377 509 7,811,011 7,490,353 0.00 0.00 20,719 19,868\n\n**20174** 870,014,972 81 114 2,634,684 1,641,641 2,853,323,953 348 474 8,290,830 7,028,713 0.00 0.00 23,824 20,197\n\n**20181** 1,269,748,479 74 81 3,720,794 2,603,438 3,239,071,167 338 442 10,540,080 8,364,514 0.00 0.00 31,184 24,747\n\n**20182** 938,163,369 85 122 2,274,471 1,699,085 3,508,142,243 340 453 11,448,589 8,708,540 0.00 0.00 33,672 25,613\n\n**20183** 481,993,570 79 123 2,161,979 1,431,635 3,559,920,390 319 440 10,791,927 7,375,800 0.00 0.00 33,830 23,122\n\n**20184** 613,618,012 82 132 2,664,673 1,650,426 3,303,523,430 320 458 10,821,917 7,384,584 0.00 0.00 33,818 23,077\n\n**20191** 1,034,476,647 89 99 1,677,938 1,945,164 3,068,251,598 335 476 8,779,061 6,726,310 0.00 0.00 26,206 20,079\n\n**20192** 883,257,298 74 101 2,795,511 1,338,073 3,013,345,527 324 455 9,300,101 6,365,297 0.00 0.00 28,704 19,646\n\n**20193** 443,432,218 73 127 2,108,810 1,398,198 2,974,784,175 318 459 9,246,932 6,331,860 0.00 0.00 29,078 19,912\n\n**20194** 561,723,703 81 117 2,354,049 3,489,662 2,922,889,865 317 444 8,936,308 8,171,096 0.00 0.00 28,190 25,776\n\n**20201** 905,820,948 90 89 3,547,192 1,646,087 2,794,234,167 318 434 10,805,562 7,872,020 0.00 0.00 33,980 24,755\n\n**20202** 745,538,548 76 96 739,137 1,359,039 2,656,515,417 320 429 8,749,188 7,892,987 0.00 0.00 27,341 24,666\n\n**20203** 417,866,147 60 96 2,422,974 979,211 2,630,949,346 307 398 9,063,353 7,474,000 0.00 0.00 29,522 24,345\n\n**20204** 597,845,335 76 87 71,522 2,603,567 2,667,070,978 302 368 6,780,826 6,587,905 0.00 0.00 22,453 21,814\n\nRolling 4-Quarter Annual Trends\n\nSelected: **24 pt Complement**\n\n**Trend** Closed Frequency Reported Frequency Paid Severity\n\nTotal Paid (w/Partials) Severity\n\nFrequency: **Reported 0.0%** 8 pt 5.2% -3.1% -4.4% 11.3%\n\nSeverity: **Paid 7.8%** 12 pt 7.9% 5.7% -8.1% -0.4%\n\nPure Premium: **7\\.9%** 16 pt -6.3% -6.7% 4.0% 7.6%\n\n20 pt 7.3% 7.2% 8.0% 10.6%\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt 0.0% 0.0% 7.8% -3.0%\n\n**CREDIBILITY ADJUSTMENT**\n\n**SENTRY SELECT INSURANCE COMPANY**\n\n**Dealer Operations**\n\n**INLAND MARINE**\n\n**CALIFORNIA**\n\nA credibility adjustment is necessary if the data in the three-year recorded period is less than fully credible. In the event the data is fully credible with fewer than three years of experience, only as many years as needed to be fully credible shall be used as the recorded period. If the data in the three-year recorded period has less than 25% credibility, up to three additional years shall be added to the recorded period until the data is at least 25% credible. Refer to CCR §2642.6. If after six years, the data remains less than 25% credible, alternative complementary loss and DCCE may be used, provided that the alternative is the most actuarially sound method. Refer to CCR §2644.23(i).\n\nPursuant to CCR §2644.23, if the data is not 100% credible, indicate how the loss and DCCE credibility factor on Page 6, line 14 of the Rate Template was determined. Provide the credibility formula or table that was used to derive the factor.\n\nIf alternative loss and DCCE are used as pertaining to CCR §2644.23(i), then the credibility-weighted projected ultimate loss and DCCE should be entered on Page 6, lines 7 and 8 of the Rate Template. Enter a factor of 1.00 for all loss and DCCE development, trend and catastrophe adjustment on lines 9 through 13, and enter 100% for credibility in line 14. Detailed data and calculations supporting the development of the credibility-weighted projected ultimate loss and DCCE should be provided within the corresponding exhibits.\n\nThe full credibility standard is 3,000 claims for each homeowners form and for each coverage for private passenger auto. The calculation for partial credibility is the square root of the ratio of the actual number of incurred claims in the recorded period divided by the full credibility standard. For other lines of insurance, the standard for full and partial credibility shall be calculated using the most actuarially sound method."],"full_content":"**EXHIBIT 10** Page 2\n\nThe Credibility formula used is [ (N) / (Z) ] ^ 1/2 where Z is based on the full Credibility Claims Standard for Property from ISO reference CF-2013-RLA1 (CDI #13-7547).\n\n**Loss Trend**\n\nYear Reported Claims\n\n20142-20144 404\n\n2015 541\n\n2016 504\n\n2017 474\n\n2018 458\n\n2019 444\n\n2020 368\n\nN = 3193\n\nZ = 20000\n\nCW Credibility 40.0%\n\n**Quarterly Data Rolling 4-Quarter Data Rolling 4-Quarter Data**\n\n**Calendar YYYYQ Earned**\n\n**Exposures Closed Claims Reported Claims Paid Losses &**\n\n**DCCE**\n\n**Total Paid Losses &**\n\n**DCCE including Partial Payments on Prior Calendar Years, on Closed**\n\n**Claims**\n\n**Earned Exposures Closed Claims Reported Claims Paid Losses**\n\n**& DCCE**\n\n**Total Paid Losses &**\n\n**DCCE including**\n\n**Partial Payments on Prior Calendar Years,**\n\n**on Closed Claims**\n\n**Closed Frequency per**\n\n**100 Exposures**\n\n**Reported Frequency per 100 Exposures**\n\n**Paid Loss &**\n\n**DCCE Severity**\n\n**Total Paid Loss & DCCE**\n\n**Severity including**\n\n**Partial**\n\n**Payments on Prior Calendar**\n\n**Years, on**\n\n**Closed Claims**\n\n**20142** 473,452,233 81 132 4,091,025 1,245,450\n\n**20143** 326,408,973 98 139 2,472,237 1,856,809\n\n**20144** 312,764,107 105 133 1,293,250 7,856,950\n\n**20151** 888,146,499 79 99 2,368,794 5,312,073 2,000,771,812 363 503 10,225,306 16,271,281 0.00 0.00 28,169 44,824\n\n**20152** 688,998,576 91 116 854,196 1,215,476 2,216,318,154 373 487 6,988,477 16,241,307 0.00 0.00 18,736 43,542\n\n**20153** 1,214,232,244 106 168 2,261,539 1,461,435 3,104,141,425 381 516 6,777,780 15,845,934 0.00 0.00 17,789 41,590\n\n**20154** 1,728,096,918 124 158 2,281,730 1,685,491 4,519,474,237 400 541 7,766,260 9,674,475 0.00 0.00 19,416 24,186\n\n**20161** 2,840,406,751 74 96 1,371,550 1,498,092 6,471,734,488 395 538 6,769,016 5,860,494 0.00 0.00 17,137 14,837\n\n**20162** 560,538,525 70 101 1,564,640 1,067,248 6,343,274,437 374 523 7,479,460 5,712,267 0.00 0.00 19,999 15,273\n\n**20163** 392,329,558 127 158 4,118,001 1,851,163 5,521,371,751 395 513 9,335,922 6,101,995 0.00 0.00 23,635 15,448\n\n**20164** 561,062,726 110 149 2,154,865 2,103,281 4,354,337,559 381 504 9,209,056 6,519,785 0.00 0.00 24,171 17,112\n\n**20171** 884,001,265 84 113 1,471,544 1,267,638 2,397,932,074 391 521 9,309,050 6,289,330 0.00 0.00 23,808 16,085\n\n**20172** 669,092,293 83 111 1,365,961 1,355,059 2,506,485,842 404 531 9,110,371 6,577,141 0.00 0.00 22,550 16,280\n\n**20173** 430,215,424 100 136 2,818,641 2,764,375 2,544,371,707 377 509 7,811,011 7,490,353 0.00 0.00 20,719 19,868\n\n**20174** 870,014,972 81 114 2,634,684 1,641,641 2,853,323,953 348 474 8,290,830 7,028,713 0.00 0.00 23,824 20,197\n\n**20181** 1,269,748,479 74 81 3,720,794 2,603,438 3,239,071,167 338 442 10,540,080 8,364,514 0.00 0.00 31,184 24,747\n\n**20182** 938,163,369 85 122 2,274,471 1,699,085 3,508,142,243 340 453 11,448,589 8,708,540 0.00 0.00 33,672 25,613\n\n**20183** 481,993,570 79 123 2,161,979 1,431,635 3,559,920,390 319 440 10,791,927 7,375,800 0.00 0.00 33,830 23,122\n\n**20184** 613,618,012 82 132 2,664,673 1,650,426 3,303,523,430 320 458 10,821,917 7,384,584 0.00 0.00 33,818 23,077\n\n**20191** 1,034,476,647 89 99 1,677,938 1,945,164 3,068,251,598 335 476 8,779,061 6,726,310 0.00 0.00 26,206 20,079\n\n**20192** 883,257,298 74 101 2,795,511 1,338,073 3,013,345,527 324 455 9,300,101 6,365,297 0.00 0.00 28,704 19,646\n\n**20193** 443,432,218 73 127 2,108,810 1,398,198 2,974,784,175 318 459 9,246,932 6,331,860 0.00 0.00 29,078 19,912\n\n**20194** 561,723,703 81 117 2,354,049 3,489,662 2,922,889,865 317 444 8,936,308 8,171,096 0.00 0.00 28,190 25,776\n\n**20201** 905,820,948 90 89 3,547,192 1,646,087 2,794,234,167 318 434 10,805,562 7,872,020 0.00 0.00 33,980 24,755\n\n**20202** 745,538,548 76 96 739,137 1,359,039 2,656,515,417 320 429 8,749,188 7,892,987 0.00 0.00 27,341 24,666\n\n**20203** 417,866,147 60 96 2,422,974 979,211 2,630,949,346 307 398 9,063,353 7,474,000 0.00 0.00 29,522 24,345\n\n**20204** 597,845,335 76 87 71,522 2,603,567 2,667,070,978 302 368 6,780,826 6,587,905 0.00 0.00 22,453 21,814\n\nRolling 4-Quarter Annual Trends\n\nSelected: **24 pt Complement**\n\n**Trend** Closed Frequency Reported Frequency Paid Severity\n\nTotal Paid (w/Partials) Severity\n\nFrequency: **Reported 0.0%** 8 pt 5.2% -3.1% -4.4% 11.3%\n\nSeverity: **Paid 7.8%** 12 pt 7.9% 5.7% -8.1% -0.4%\n\nPure Premium: **7\\.9%** 16 pt -6.3% -6.7% 4.0% 7.6%\n\n20 pt 7.3% 7.2% 8.0% 10.6%\n\nAlternate Pure Premium : (Justify in Filing Memorandum) 24 pt 0.0% 0.0% 7.8% -3.0%\n\n**CREDIBILITY ADJUSTMENT**\n\n**SENTRY SELECT INSURANCE COMPANY**\n\n**Dealer Operations**\n\n**INLAND MARINE**\n\n**CALIFORNIA**\n\nA credibility adjustment is necessary if the data in the three-year recorded period is less than fully credible. In the event the data is fully credible with fewer than three years of experience, only as many years as needed to be fully credible shall be used as the recorded period. If the data in the three-year recorded period has less than 25% credibility, up to three additional years shall be added to the recorded period until the data is at least 25% credible. Refer to CCR §2642.6. If after six years, the data remains less than 25% credible, alternative complementary loss and DCCE may be used, provided that the alternative is the most actuarially sound method. Refer to CCR §2644.23(i).\n\nPursuant to CCR §2644.23, if the data is not 100% credible, indicate how the loss and DCCE credibility factor on Page 6, line 14 of the Rate Template was determined. Provide the credibility formula or table that was used to derive the factor.\n\nIf alternative loss and DCCE are used as pertaining to CCR §2644.23(i), then the credibility-weighted projected ultimate loss and DCCE should be entered on Page 6, lines 7 and 8 of the Rate Template. Enter a factor of 1.00 for all loss and DCCE development, trend and catastrophe adjustment on lines 9 through 13, and enter 100% for credibility in line 14. Detailed data and calculations supporting the development of the credibility-weighted projected ultimate loss and DCCE should be provided within the corresponding exhibits.\n\nThe full credibility standard is 3,000 claims for each homeowners form and for each coverage for private passenger auto. The calculation for partial credibility is the square root of the ratio of the actual number of incurred claims in the recorded period divided by the full credibility standard. For other lines of insurance, the standard for full and partial credibility shall be calculated using the most actuarially sound method.","publish_date":null,"title":"SENTRY SELECT INSURANCE COMPANY Dealer Operations Loss Trend","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2443.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2443.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2443","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2443.pdf"},"started_at":"2026-11-04T19:48:28.413917"} +{"completed_at":"2026-11-04T19:48:31.391009","latency_in_ms":1353,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2467","grounded_pages":[],"layout_pages":[],"markdown":"**State of California Company: Sentry Select Insurance Company**\n\n**Department of Insurance (CDI) Line: Inland Marine**\n\n**CDI File #:**\n\n## **FINAL ADJUSTED CDI PARAMETERS**\n\n### **Efficiency Standard**\n\n**Marketing System Distribution**\n\n**0\\.0% 100.0% 0.0%**\n\n**Detailed Line Description Line Code Coverage/Form Captive Direct Independent Weighted Average**\n\n**Variance**\n\n**Adjustment**\n\n**Excluded**\n\n**Expense Ratio**\n\n**Final Adjusted**\n\n**Efficiency Standard**\n\nInland Marine 9 Inland Marine 28.6% 28.9% 28.6% 28.9% 0.0% 0.3% 28.7%\n\n### **Leverage Factor**\n\n**_(Variance 3 not applied)_**\n\n**Detailed Line Description Line Code Coverage/Form**\n\n**Unearned Premium Reserves**\n\n**Loss Reserves Raw Factor Variance**\n\n**Adjustment**\n\n**Final Adjusted**\n\n**Leverage**\n\n**Factor**\n\n**Yield 4.4%**\n\nInland Marine 9 Inland Marine 0.2606 0.3528 1.1509 1.0000 1.1509\n\n### **Reserves Ratio**\n\n**_1\\.7%_**\n\n**FIT 18.9%**\n\n**Premium Tax**\n\n**Rate 2.4%**\n\n**Risk Free Rate**\n\n**of Return**\n\n### **Yields, Rate of Return & Premium Tax Values**\n\n### **as of April 2022**\n\nPrior Approval Rate Template Page 5 06/01/2021 Edition","pages":[{"line_numbers":[],"markdown":"**State of California Company: Sentry Select Insurance Company**\n\n**Department of Insurance (CDI) Line: Inland Marine**\n\n**CDI File #:**\n\n## **FINAL ADJUSTED CDI PARAMETERS**\n\n### **Efficiency Standard**\n\n**Marketing System Distribution**\n\n**0\\.0% 100.0% 0.0%**\n\n**Detailed Line Description Line Code Coverage/Form Captive Direct Independent Weighted Average**\n\n**Variance**\n\n**Adjustment**\n\n**Excluded**\n\n**Expense Ratio**\n\n**Final Adjusted**\n\n**Efficiency Standard**\n\nInland Marine 9 Inland Marine 28.6% 28.9% 28.6% 28.9% 0.0% 0.3% 28.7%\n\n### **Leverage Factor**\n\n**_(Variance 3 not applied)_**\n\n**Detailed Line Description Line Code Coverage/Form**\n\n**Unearned Premium Reserves**\n\n**Loss Reserves Raw Factor Variance**\n\n**Adjustment**\n\n**Final Adjusted**\n\n**Leverage**\n\n**Factor**\n\n**Yield 4.4%**\n\nInland Marine 9 Inland Marine 0.2606 0.3528 1.1509 1.0000 1.1509\n\n### **Reserves Ratio**\n\n**_1\\.7%_**\n\n**FIT 18.9%**\n\n**Premium Tax**\n\n**Rate 2.4%**\n\n**Risk Free Rate**\n\n**of Return**\n\n### **Yields, Rate of Return & Premium Tax Values**\n\n### **as of April 2022**\n\nPrior Approval Rate Template Page 5 06/01/2021 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**State of California Company: Sentry Select Insurance Company**\n\n**Department of Insurance (CDI) Line: Inland Marine**\n\n**CDI File #:**\n\n## **FINAL ADJUSTED CDI PARAMETERS**\n\n### **Efficiency Standard**\n\n**Marketing System Distribution**\n\n**0\\.0% 100.0% 0.0%**\n\n**Detailed Line Description Line Code Coverage/Form Captive Direct Independent Weighted Average**\n\n**Variance**\n\n**Adjustment**\n\n**Excluded**\n\n**Expense Ratio**\n\n**Final Adjusted**\n\n**Efficiency Standard**\n\nInland Marine 9 Inland Marine 28.6% 28.9% 28.6% 28.9% 0.0% 0.3% 28.7%\n\n### **Leverage Factor**\n\n**_(Variance 3 not applied)_**\n\n**Detailed Line Description Line Code Coverage/Form**\n\n**Unearned Premium Reserves**\n\n**Loss Reserves Raw Factor Variance**\n\n**Adjustment**\n\n**Final Adjusted**\n\n**Leverage**\n\n**Factor**\n\n**Yield 4.4%**\n\nInland Marine 9 Inland Marine 0.2606 0.3528 1.1509 1.0000 1.1509\n\n### **Reserves Ratio**\n\n**_1\\.7%_**\n\n**FIT 18.9%**\n\n**Premium Tax**\n\n**Rate 2.4%**\n\n**Risk Free Rate**\n\n**of Return**\n\n### **Yields, Rate of Return & Premium Tax Values**\n\n### **as of April 2022**\n\nPrior Approval Rate Template Page 5 06/01/2021 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2467.pdf"]},"response":{"errors":[],"extract_id":"extract_91ded3ee86cb7d945f29ec16b37d2824","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**State of California Company: Sentry Select Insurance Company**\n\n**Department of Insurance (CDI) Line: Inland Marine**\n\n**CDI File #:**\n\n## **FINAL ADJUSTED CDI PARAMETERS**\n\n### **Efficiency Standard**\n\n**Marketing System Distribution**\n\n**0\\.0% 100.0% 0.0%**\n\n**Detailed Line Description Line Code Coverage/Form Captive Direct Independent Weighted Average**\n\n**Variance**\n\n**Adjustment**\n\n**Excluded**\n\n**Expense Ratio**\n\n**Final Adjusted**\n\n**Efficiency Standard**\n\nInland Marine 9 Inland Marine 28.6% 28.9% 28.6% 28.9% 0.0% 0.3% 28.7%\n\n### **Leverage Factor**\n\n**_(Variance 3 not applied)_**\n\n**Detailed Line Description Line Code Coverage/Form**\n\n**Unearned Premium Reserves**\n\n**Loss Reserves Raw Factor Variance**\n\n**Adjustment**\n\n**Final Adjusted**\n\n**Leverage**\n\n**Factor**\n\n**Yield 4.4%**\n\nInland Marine 9 Inland Marine 0.2606 0.3528 1.1509 1.0000 1.1509\n\n### **Reserves Ratio**\n\n**_1\\.7%_**\n\n**FIT 18.9%**\n\n**Premium Tax**\n\n**Rate 2.4%**\n\n**Risk Free Rate**\n\n**of Return**\n\n### **Yields, Rate of Return & Premium Tax Values**\n\n### **as of April 2022**\n\nPrior Approval Rate Template Page 5 06/01/2021 Edition"],"full_content":"**State of California Company: Sentry Select Insurance Company**\n\n**Department of Insurance (CDI) Line: Inland Marine**\n\n**CDI File #:**\n\n## **FINAL ADJUSTED CDI PARAMETERS**\n\n### **Efficiency Standard**\n\n**Marketing System Distribution**\n\n**0\\.0% 100.0% 0.0%**\n\n**Detailed Line Description Line Code Coverage/Form Captive Direct Independent Weighted Average**\n\n**Variance**\n\n**Adjustment**\n\n**Excluded**\n\n**Expense Ratio**\n\n**Final Adjusted**\n\n**Efficiency Standard**\n\nInland Marine 9 Inland Marine 28.6% 28.9% 28.6% 28.9% 0.0% 0.3% 28.7%\n\n### **Leverage Factor**\n\n**_(Variance 3 not applied)_**\n\n**Detailed Line Description Line Code Coverage/Form**\n\n**Unearned Premium Reserves**\n\n**Loss Reserves Raw Factor Variance**\n\n**Adjustment**\n\n**Final Adjusted**\n\n**Leverage**\n\n**Factor**\n\n**Yield 4.4%**\n\nInland Marine 9 Inland Marine 0.2606 0.3528 1.1509 1.0000 1.1509\n\n### **Reserves Ratio**\n\n**_1\\.7%_**\n\n**FIT 18.9%**\n\n**Premium Tax**\n\n**Rate 2.4%**\n\n**Risk Free Rate**\n\n**of Return**\n\n### **Yields, Rate of Return & Premium Tax Values**\n\n### **as of April 2022**\n\nPrior Approval Rate Template Page 5 06/01/2021 Edition","publish_date":null,"title":"FINAL ADJUSTED CDI PARAMETERS","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2467.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2467.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2467","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2467.pdf"},"started_at":"2026-11-04T19:48:30.037177"} +{"completed_at":"2026-11-04T19:48:32.584546","latency_in_ms":2095,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2475","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit 7**\n\n### **Sentry Select Insurance Company**\n\n### **Inland Marine**\n\n### **Non-Catastrophe Incurred DCCE to Incurred Loss Ratio Development - Annual Triangles**\n\n**_Inland Marine_**\n\n**Months of Development**\n\n**Fiscal Accident Year Ending 12 24 36 48 60 72 84 96 108 120**\n\n**20114** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20124** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20134** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20144** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20154** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20164** 0\\.00% 0.00% 0.00% 0.00% 0.00%\n\n**20174** 0\\.00% 0.00% 0.00% 0.00%\n\n**20184** 0\\.00% 0.00% 0.00%\n\n**20194** 0\\.00% 0.00%\n\n**20204** 0\\.00%\n\n**Age to Age Factors**\n\n**Fiscal Accident Year Ending 12-24 24-36 36-48 48-60 60-72 72-84 84-96 96-108 108-120 120-Ult**\n\n**20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Tail**\n\n**3 Yr Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Age-Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Ultimate DCCE Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%**\n\n**Selected Ult Loss N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\n**Ultimate DCCE N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\n**DCCE Age-Ult N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\nStandard Exhibits Template Page 3.9 06/01/2021 Edition","pages":[{"line_numbers":[],"markdown":"**Exhibit 7**\n\n### **Sentry Select Insurance Company**\n\n### **Inland Marine**\n\n### **Non-Catastrophe Incurred DCCE to Incurred Loss Ratio Development - Annual Triangles**\n\n**_Inland Marine_**\n\n**Months of Development**\n\n**Fiscal Accident Year Ending 12 24 36 48 60 72 84 96 108 120**\n\n**20114** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20124** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20134** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20144** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20154** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20164** 0\\.00% 0.00% 0.00% 0.00% 0.00%\n\n**20174** 0\\.00% 0.00% 0.00% 0.00%\n\n**20184** 0\\.00% 0.00% 0.00%\n\n**20194** 0\\.00% 0.00%\n\n**20204** 0\\.00%\n\n**Age to Age Factors**\n\n**Fiscal Accident Year Ending 12-24 24-36 36-48 48-60 60-72 72-84 84-96 96-108 108-120 120-Ult**\n\n**20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Tail**\n\n**3 Yr Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Age-Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Ultimate DCCE Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%**\n\n**Selected Ult Loss N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\n**Ultimate DCCE N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\n**DCCE Age-Ult N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\nStandard Exhibits Template Page 3.9 06/01/2021 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit 7**\n\n### **Sentry Select Insurance Company**\n\n### **Inland Marine**\n\n### **Non-Catastrophe Incurred DCCE to Incurred Loss Ratio Development - Annual Triangles**\n\n**_Inland Marine_**\n\n**Months of Development**\n\n**Fiscal Accident Year Ending 12 24 36 48 60 72 84 96 108 120**\n\n**20114** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20124** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20134** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20144** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20154** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20164** 0\\.00% 0.00% 0.00% 0.00% 0.00%\n\n**20174** 0\\.00% 0.00% 0.00% 0.00%\n\n**20184** 0\\.00% 0.00% 0.00%\n\n**20194** 0\\.00% 0.00%\n\n**20204** 0\\.00%\n\n**Age to Age Factors**\n\n**Fiscal Accident Year Ending 12-24 24-36 36-48 48-60 60-72 72-84 84-96 96-108 108-120 120-Ult**\n\n**20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Tail**\n\n**3 Yr Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Age-Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Ultimate DCCE Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%**\n\n**Selected Ult Loss N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\n**Ultimate DCCE N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\n**DCCE Age-Ult N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\nStandard Exhibits Template Page 3.9 06/01/2021 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2475.pdf"]},"response":{"errors":[],"extract_id":"extract_9a7e4a6976a67bdd6d5d2cabf263cc50","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit 7**\n\n### **Sentry Select Insurance Company**\n\n### **Inland Marine**\n\n### **Non-Catastrophe Incurred DCCE to Incurred Loss Ratio Development - Annual Triangles**\n\n**_Inland Marine_**\n\n**Months of Development**\n\n**Fiscal Accident Year Ending 12 24 36 48 60 72 84 96 108 120**\n\n**20114** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20124** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20134** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20144** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20154** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20164** 0\\.00% 0.00% 0.00% 0.00% 0.00%\n\n**20174** 0\\.00% 0.00% 0.00% 0.00%\n\n**20184** 0\\.00% 0.00% 0.00%\n\n**20194** 0\\.00% 0.00%\n\n**20204** 0\\.00%\n\n**Age to Age Factors**\n\n**Fiscal Accident Year Ending 12-24 24-36 36-48 48-60 60-72 72-84 84-96 96-108 108-120 120-Ult**\n\n**20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Tail**\n\n**3 Yr Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Age-Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Ultimate DCCE Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%**\n\n**Selected Ult Loss N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\n**Ultimate DCCE N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\n**DCCE Age-Ult N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\nStandard Exhibits Template Page 3.9 06/01/2021 Edition"],"full_content":"**Exhibit 7**\n\n### **Sentry Select Insurance Company**\n\n### **Inland Marine**\n\n### **Non-Catastrophe Incurred DCCE to Incurred Loss Ratio Development - Annual Triangles**\n\n**_Inland Marine_**\n\n**Months of Development**\n\n**Fiscal Accident Year Ending 12 24 36 48 60 72 84 96 108 120**\n\n**20114** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20124** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20134** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20144** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20154** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00%\n\n**20164** 0\\.00% 0.00% 0.00% 0.00% 0.00%\n\n**20174** 0\\.00% 0.00% 0.00% 0.00%\n\n**20184** 0\\.00% 0.00% 0.00%\n\n**20194** 0\\.00% 0.00%\n\n**20204** 0\\.00%\n\n**Age to Age Factors**\n\n**Fiscal Accident Year Ending 12-24 24-36 36-48 48-60 60-72 72-84 84-96 96-108 108-120 120-Ult**\n\n**20114 20124 20134 20144 20154 20164 20174 20184 20194**\n\n**Tail**\n\n**3 Yr Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Age-Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Ultimate DCCE Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%**\n\n**Selected Ult Loss N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\n**Ultimate DCCE N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\n**DCCE Age-Ult N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A**\n\nStandard Exhibits Template Page 3.9 06/01/2021 Edition","publish_date":null,"title":"Sentry Select Insurance Company Inland Marine Non-Catastrophe Incurred DCCE to Incurred Loss Ratio Development - Annual Triangles","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2475.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2475.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2475","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2475.pdf"},"started_at":"2026-11-04T19:48:30.488881"} +{"completed_at":"2026-11-04T19:46:53.240257","latency_in_ms":1374,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2526","grounded_pages":[],"layout_pages":[],"markdown":"# Y\n\n### Non-Profit Directors & Officers\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2008-11-0006**\n\n**EXPERIENCE MODIFICATION PLAN** Experience modification does not apply if insured does not have one full experience year. Experience modification factors relate to directors' and officers' claims or litigation that have been brought against the insured. A modification factor is applied based on claim experience and is applied as follows:\n\n**Modification Factors**\n\n1\\.00 - 1.00 1.00 - 1.20 1.20 - 1.40 1.40 - 1.60\n\nDefinitions for above criteria: No claims reported, or claims reported have had either no payout or a low likelihood of ultimate payout. Little to no impact on overall earnings or financial condition; Little to no loss paid by carrier Impact on overall earnings or financial condition; the carrier has paid in excess of retention Significant impact on overall earnings or financial condition; the carrier has paid significantly in excess of retention\n\nMajor\n\n**Description**\n\nNone - Immaterial Minimal Material\n\nNone - Immaterial\n\nMinimal\n\nMaterial\n\nMajor\n\n55867 CA Ed. 11a-2008 Printed in USA 2010 The Travelers Companies, Inc. All Rights Reserved Rate Page 12","pages":[{"line_numbers":[],"markdown":"# Y\n\n### Non-Profit Directors & Officers\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2008-11-0006**\n\n**EXPERIENCE MODIFICATION PLAN** Experience modification does not apply if insured does not have one full experience year. Experience modification factors relate to directors' and officers' claims or litigation that have been brought against the insured. A modification factor is applied based on claim experience and is applied as follows:\n\n**Modification Factors**\n\n1\\.00 - 1.00 1.00 - 1.20 1.20 - 1.40 1.40 - 1.60\n\nDefinitions for above criteria: No claims reported, or claims reported have had either no payout or a low likelihood of ultimate payout. Little to no impact on overall earnings or financial condition; Little to no loss paid by carrier Impact on overall earnings or financial condition; the carrier has paid in excess of retention Significant impact on overall earnings or financial condition; the carrier has paid significantly in excess of retention\n\nMajor\n\n**Description**\n\nNone - Immaterial Minimal Material\n\nNone - Immaterial\n\nMinimal\n\nMaterial\n\nMajor\n\n55867 CA Ed. 11a-2008 Printed in USA 2010 The Travelers Companies, Inc. All Rights Reserved Rate Page 12","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"# Y\n\n### Non-Profit Directors & Officers\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2008-11-0006**\n\n**EXPERIENCE MODIFICATION PLAN** Experience modification does not apply if insured does not have one full experience year. Experience modification factors relate to directors' and officers' claims or litigation that have been brought against the insured. A modification factor is applied based on claim experience and is applied as follows:\n\n**Modification Factors**\n\n1\\.00 - 1.00 1.00 - 1.20 1.20 - 1.40 1.40 - 1.60\n\nDefinitions for above criteria: No claims reported, or claims reported have had either no payout or a low likelihood of ultimate payout. Little to no impact on overall earnings or financial condition; Little to no loss paid by carrier Impact on overall earnings or financial condition; the carrier has paid in excess of retention Significant impact on overall earnings or financial condition; the carrier has paid significantly in excess of retention\n\nMajor\n\n**Description**\n\nNone - Immaterial Minimal Material\n\nNone - Immaterial\n\nMinimal\n\nMaterial\n\nMajor\n\n55867 CA Ed. 11a-2008 Printed in USA 2010 The Travelers Companies, Inc. All Rights Reserved Rate Page 12","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2526.pdf"]},"response":{"errors":[],"extract_id":"extract_8afd2ec571c50e9d16b192233951ce79","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["# Y\n\n### Non-Profit Directors & Officers\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2008-11-0006**\n\n**EXPERIENCE MODIFICATION PLAN** Experience modification does not apply if insured does not have one full experience year. Experience modification factors relate to directors' and officers' claims or litigation that have been brought against the insured. A modification factor is applied based on claim experience and is applied as follows:\n\n**Modification Factors**\n\n1\\.00 - 1.00 1.00 - 1.20 1.20 - 1.40 1.40 - 1.60\n\nDefinitions for above criteria: No claims reported, or claims reported have had either no payout or a low likelihood of ultimate payout. Little to no impact on overall earnings or financial condition; Little to no loss paid by carrier Impact on overall earnings or financial condition; the carrier has paid in excess of retention Significant impact on overall earnings or financial condition; the carrier has paid significantly in excess of retention\n\nMajor\n\n**Description**\n\nNone - Immaterial Minimal Material\n\nNone - Immaterial\n\nMinimal\n\nMaterial\n\nMajor\n\n55867 CA Ed. 11a-2008 Printed in USA 2010 The Travelers Companies, Inc. All Rights Reserved Rate Page 12"],"full_content":"# Y\n\n### Non-Profit Directors & Officers\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2008-11-0006**\n\n**EXPERIENCE MODIFICATION PLAN** Experience modification does not apply if insured does not have one full experience year. Experience modification factors relate to directors' and officers' claims or litigation that have been brought against the insured. A modification factor is applied based on claim experience and is applied as follows:\n\n**Modification Factors**\n\n1\\.00 - 1.00 1.00 - 1.20 1.20 - 1.40 1.40 - 1.60\n\nDefinitions for above criteria: No claims reported, or claims reported have had either no payout or a low likelihood of ultimate payout. Little to no impact on overall earnings or financial condition; Little to no loss paid by carrier Impact on overall earnings or financial condition; the carrier has paid in excess of retention Significant impact on overall earnings or financial condition; the carrier has paid significantly in excess of retention\n\nMajor\n\n**Description**\n\nNone - Immaterial Minimal Material\n\nNone - Immaterial\n\nMinimal\n\nMaterial\n\nMajor\n\n55867 CA Ed. 11a-2008 Printed in USA 2010 The Travelers Companies, Inc. All Rights Reserved Rate Page 12","publish_date":null,"title":"Manual Rates","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2526.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2526.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2526","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2526.pdf"},"started_at":"2026-11-04T19:46:51.866083"} +{"completed_at":"2026-11-04T19:46:54.093287","latency_in_ms":2224,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2538","grounded_pages":[],"layout_pages":[],"markdown":"### _Non-Profit Directors & Officers_\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2022-05-0073**\n\n**ASSET SIZE FACTOR** Apply the applicable factor to the basic premium. Interpolation applies.\n\n**Total Assets Modification Factor**\n\nup to $100,000 0.900\n\n$250,000 0.934\n\n$500,000 0.965\n\n$1,000,000 1.000\n\n$2,500,000 1.214\n\n$5,000,000 1.406\n\n$10,000,000 1.629\n\n$25,000,000 1.977\n\n$50,000,000 2.290\n\n$100,000,000 2.652\n\n$150,000,000 2.890\n\n$250,000,000 3.220\n\n$500,000,000 3.729\n\n$1,000,000,000 4.319\n\n$2,500,000,000 5.244\n\n$5,000,000,000 6.074\n\n$7,500,000,000 6.618\n\nover $10,000,000,000 7.034","pages":[{"line_numbers":[],"markdown":"### _Non-Profit Directors & Officers_\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2022-05-0073**\n\n**ASSET SIZE FACTOR** Apply the applicable factor to the basic premium. Interpolation applies.\n\n**Total Assets Modification Factor**\n\nup to $100,000 0.900\n\n$250,000 0.934\n\n$500,000 0.965\n\n$1,000,000 1.000\n\n$2,500,000 1.214\n\n$5,000,000 1.406\n\n$10,000,000 1.629\n\n$25,000,000 1.977\n\n$50,000,000 2.290\n\n$100,000,000 2.652\n\n$150,000,000 2.890\n\n$250,000,000 3.220\n\n$500,000,000 3.729\n\n$1,000,000,000 4.319\n\n$2,500,000,000 5.244\n\n$5,000,000,000 6.074\n\n$7,500,000,000 6.618\n\nover $10,000,000,000 7.034","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### _Non-Profit Directors & Officers_\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2022-05-0073**\n\n**ASSET SIZE FACTOR** Apply the applicable factor to the basic premium. Interpolation applies.\n\n**Total Assets Modification Factor**\n\nup to $100,000 0.900\n\n$250,000 0.934\n\n$500,000 0.965\n\n$1,000,000 1.000\n\n$2,500,000 1.214\n\n$5,000,000 1.406\n\n$10,000,000 1.629\n\n$25,000,000 1.977\n\n$50,000,000 2.290\n\n$100,000,000 2.652\n\n$150,000,000 2.890\n\n$250,000,000 3.220\n\n$500,000,000 3.729\n\n$1,000,000,000 4.319\n\n$2,500,000,000 5.244\n\n$5,000,000,000 6.074\n\n$7,500,000,000 6.618\n\nover $10,000,000,000 7.034","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2538.pdf"]},"response":{"errors":[],"extract_id":"extract_da5beb375d3970de5339b99b479e2d59","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### _Non-Profit Directors & Officers_\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2022-05-0073**\n\n**ASSET SIZE FACTOR** Apply the applicable factor to the basic premium. Interpolation applies.\n\n**Total Assets Modification Factor**\n\nup to $100,000 0.900\n\n$250,000 0.934\n\n$500,000 0.965\n\n$1,000,000 1.000\n\n$2,500,000 1.214\n\n$5,000,000 1.406\n\n$10,000,000 1.629\n\n$25,000,000 1.977\n\n$50,000,000 2.290\n\n$100,000,000 2.652\n\n$150,000,000 2.890\n\n$250,000,000 3.220\n\n$500,000,000 3.729\n\n$1,000,000,000 4.319\n\n$2,500,000,000 5.244\n\n$5,000,000,000 6.074\n\n$7,500,000,000 6.618\n\nover $10,000,000,000 7.034"],"full_content":"### _Non-Profit Directors & Officers_\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2022-05-0073**\n\n**ASSET SIZE FACTOR** Apply the applicable factor to the basic premium. Interpolation applies.\n\n**Total Assets Modification Factor**\n\nup to $100,000 0.900\n\n$250,000 0.934\n\n$500,000 0.965\n\n$1,000,000 1.000\n\n$2,500,000 1.214\n\n$5,000,000 1.406\n\n$10,000,000 1.629\n\n$25,000,000 1.977\n\n$50,000,000 2.290\n\n$100,000,000 2.652\n\n$150,000,000 2.890\n\n$250,000,000 3.220\n\n$500,000,000 3.729\n\n$1,000,000,000 4.319\n\n$2,500,000,000 5.244\n\n$5,000,000,000 6.074\n\n$7,500,000,000 6.618\n\nover $10,000,000,000 7.034","publish_date":null,"title":"Non-Profit Directors & Officers Manual Rates California","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2538.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2538.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2538","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2538.pdf"},"started_at":"2026-11-04T19:46:51.868962"} +{"completed_at":"2026-11-04T19:46:57.861014","latency_in_ms":3329,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2561","grounded_pages":[],"layout_pages":[],"markdown":"**State of California Company:** Travelers Casualty and\n\n**Department of Insurance (CDI) Line:** Other Liability\n\n**FORMS**\n\n**Legend of Response Codes Type Code Source Code Category Code**\n\n(1) Application (1) Insurance Services Office (ISO) (1) New, mandatory (4) Replacement, mandatory (7) Withdrawn, mandatory\n\n(2) Endorsement (2) Other Advisory Organization (2) New, optional (required) (5) Replacement, optional (required) (8) Withdrawn, optional (required)\n\n(3) Policy (3) Company (3) New, optional (elective) (6) Replacement, optional (elective) (9) Withdrawn, optional (elective)\n\n1 (4) Other (Describe in box below) (4) Other (Describe in box below) (10) Other (Describe in box below)\n\nMandatory - refers to forms that the insurer attaches to all policies. Optional (required) - refers to forms that the insurer requires be attached to some policies. Optional (elective) - refers to forms that the insured requests be added to their policy.\n\n**Applicable Form Source of Form Coverage Change Reflects Coverage Change Includes**\n\n**\\# Title Type Source CDI File #** **1** **Category** **3** **Restriction?** **2** **Broadening? Rate Impact? % Impact**\n\n**(1) Proposed Current**\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\nPrior Approval Rate Application Page 9.1 6/5/2023 Edition","pages":[{"line_numbers":[],"markdown":"**State of California Company:** Travelers Casualty and\n\n**Department of Insurance (CDI) Line:** Other Liability\n\n**FORMS**\n\n**Legend of Response Codes Type Code Source Code Category Code**\n\n(1) Application (1) Insurance Services Office (ISO) (1) New, mandatory (4) Replacement, mandatory (7) Withdrawn, mandatory\n\n(2) Endorsement (2) Other Advisory Organization (2) New, optional (required) (5) Replacement, optional (required) (8) Withdrawn, optional (required)\n\n(3) Policy (3) Company (3) New, optional (elective) (6) Replacement, optional (elective) (9) Withdrawn, optional (elective)\n\n1 (4) Other (Describe in box below) (4) Other (Describe in box below) (10) Other (Describe in box below)\n\nMandatory - refers to forms that the insurer attaches to all policies. Optional (required) - refers to forms that the insurer requires be attached to some policies. Optional (elective) - refers to forms that the insured requests be added to their policy.\n\n**Applicable Form Source of Form Coverage Change Reflects Coverage Change Includes**\n\n**\\# Title Type Source CDI File #** **1** **Category** **3** **Restriction?** **2** **Broadening? Rate Impact? % Impact**\n\n**(1) Proposed Current**\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\nPrior Approval Rate Application Page 9.1 6/5/2023 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**State of California Company:** Travelers Casualty and\n\n**Department of Insurance (CDI) Line:** Other Liability\n\n**FORMS**\n\n**Legend of Response Codes Type Code Source Code Category Code**\n\n(1) Application (1) Insurance Services Office (ISO) (1) New, mandatory (4) Replacement, mandatory (7) Withdrawn, mandatory\n\n(2) Endorsement (2) Other Advisory Organization (2) New, optional (required) (5) Replacement, optional (required) (8) Withdrawn, optional (required)\n\n(3) Policy (3) Company (3) New, optional (elective) (6) Replacement, optional (elective) (9) Withdrawn, optional (elective)\n\n1 (4) Other (Describe in box below) (4) Other (Describe in box below) (10) Other (Describe in box below)\n\nMandatory - refers to forms that the insurer attaches to all policies. Optional (required) - refers to forms that the insurer requires be attached to some policies. Optional (elective) - refers to forms that the insured requests be added to their policy.\n\n**Applicable Form Source of Form Coverage Change Reflects Coverage Change Includes**\n\n**\\# Title Type Source CDI File #** **1** **Category** **3** **Restriction?** **2** **Broadening? Rate Impact? % Impact**\n\n**(1) Proposed Current**\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\nPrior Approval Rate Application Page 9.1 6/5/2023 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2561.pdf"]},"response":{"errors":[],"extract_id":"extract_e4f887524e7bf10bea1f18741ea5f5e4","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**State of California Company:** Travelers Casualty and\n\n**Department of Insurance (CDI) Line:** Other Liability\n\n**FORMS**\n\n**Legend of Response Codes Type Code Source Code Category Code**\n\n(1) Application (1) Insurance Services Office (ISO) (1) New, mandatory (4) Replacement, mandatory (7) Withdrawn, mandatory\n\n(2) Endorsement (2) Other Advisory Organization (2) New, optional (required) (5) Replacement, optional (required) (8) Withdrawn, optional (required)\n\n(3) Policy (3) Company (3) New, optional (elective) (6) Replacement, optional (elective) (9) Withdrawn, optional (elective)\n\n1 (4) Other (Describe in box below) (4) Other (Describe in box below) (10) Other (Describe in box below)\n\nMandatory - refers to forms that the insurer attaches to all policies. Optional (required) - refers to forms that the insurer requires be attached to some policies. Optional (elective) - refers to forms that the insured requests be added to their policy.\n\n**Applicable Form Source of Form Coverage Change Reflects Coverage Change Includes**\n\n**\\# Title Type Source CDI File #** **1** **Category** **3** **Restriction?** **2** **Broadening? Rate Impact? % Impact**\n\n**(1) Proposed Current**\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\nPrior Approval Rate Application Page 9.1 6/5/2023 Edition"],"full_content":"**State of California Company:** Travelers Casualty and\n\n**Department of Insurance (CDI) Line:** Other Liability\n\n**FORMS**\n\n**Legend of Response Codes Type Code Source Code Category Code**\n\n(1) Application (1) Insurance Services Office (ISO) (1) New, mandatory (4) Replacement, mandatory (7) Withdrawn, mandatory\n\n(2) Endorsement (2) Other Advisory Organization (2) New, optional (required) (5) Replacement, optional (required) (8) Withdrawn, optional (required)\n\n(3) Policy (3) Company (3) New, optional (elective) (6) Replacement, optional (elective) (9) Withdrawn, optional (elective)\n\n1 (4) Other (Describe in box below) (4) Other (Describe in box below) (10) Other (Describe in box below)\n\nMandatory - refers to forms that the insurer attaches to all policies. Optional (required) - refers to forms that the insurer requires be attached to some policies. Optional (elective) - refers to forms that the insured requests be added to their policy.\n\n**Applicable Form Source of Form Coverage Change Reflects Coverage Change Includes**\n\n**\\# Title Type Source CDI File #** **1** **Category** **3** **Restriction?** **2** **Broadening? Rate Impact? % Impact**\n\n**(1) Proposed Current**\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\nPrior Approval Rate Application Page 9.1 6/5/2023 Edition","publish_date":null,"title":"FORMS","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2561.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2561.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2561","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2561.pdf"},"started_at":"2026-11-04T19:46:54.531859"} +{"completed_at":"2026-11-04T19:47:09.564806","latency_in_ms":13548,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2600","grounded_pages":[],"layout_pages":[],"markdown":"Modification\n\nPeer Review Factor\nYes - Pass 0.90 - 1.00\nYes - Not Passed 1.00 - 1.10\nNo 1.00 - 1.10\nNo Answer 1.00\nModification\nSue for Fees Range |\nDoes Sue for Fees 1.00 - 1.10\nDoes Not Sue for Fees 0.90 - 1.00\nNo Answer 1.00\nEngagement Modification\nLetters Ra\nAll Engagements 0.90 - 1.00\nSome Engagements 0.90 - 1.00\nNot Used in Engagements 1.00 - 1.10\nNo Answer 1.00","pages":[{"line_numbers":[],"markdown":"Modification\n\nPeer Review Factor\nYes - Pass 0.90 - 1.00\nYes - Not Passed 1.00 - 1.10\nNo 1.00 - 1.10\nNo Answer 1.00\nModification\nSue for Fees Range |\nDoes Sue for Fees 1.00 - 1.10\nDoes Not Sue for Fees 0.90 - 1.00\nNo Answer 1.00\nEngagement Modification\nLetters Ra\nAll Engagements 0.90 - 1.00\nSome Engagements 0.90 - 1.00\nNot Used in Engagements 1.00 - 1.10\nNo Answer 1.00","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Modification\n\nPeer Review Factor\nYes - Pass 0.90 - 1.00\nYes - Not Passed 1.00 - 1.10\nNo 1.00 - 1.10\nNo Answer 1.00\nModification\nSue for Fees Range |\nDoes Sue for Fees 1.00 - 1.10\nDoes Not Sue for Fees 0.90 - 1.00\nNo Answer 1.00\nEngagement Modification\nLetters Ra\nAll Engagements 0.90 - 1.00\nSome Engagements 0.90 - 1.00\nNot Used in Engagements 1.00 - 1.10\nNo Answer 1.00","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2600.pdf"]},"response":{"errors":[],"extract_id":"extract_458d8f35c3631bd5a40ffbe1eb902f3e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Modification\n\nPeer Review Factor\nYes - Pass 0.90 - 1.00\nYes - Not Passed 1.00 - 1.10\nNo 1.00 - 1.10\nNo Answer 1.00\nModification\nSue for Fees Range |\nDoes Sue for Fees 1.00 - 1.10\nDoes Not Sue for Fees 0.90 - 1.00\nNo Answer 1.00\nEngagement Modification\nLetters Ra\nAll Engagements 0.90 - 1.00\nSome Engagements 0.90 - 1.00\nNot Used in Engagements 1.00 - 1.10\nNo Answer 1.00"],"full_content":"Modification\n\nPeer Review Factor\nYes - Pass 0.90 - 1.00\nYes - Not Passed 1.00 - 1.10\nNo 1.00 - 1.10\nNo Answer 1.00\nModification\nSue for Fees Range |\nDoes Sue for Fees 1.00 - 1.10\nDoes Not Sue for Fees 0.90 - 1.00\nNo Answer 1.00\nEngagement Modification\nLetters Ra\nAll Engagements 0.90 - 1.00\nSome Engagements 0.90 - 1.00\nNot Used in Engagements 1.00 - 1.10\nNo Answer 1.00","publish_date":null,"title":"Serff Ca Random Pages 1 Page2600","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2600.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2600.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2600","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2600.pdf"},"started_at":"2026-11-04T19:46:56.016656"} +{"completed_at":"2026-11-04T19:46:59.164958","latency_in_ms":1764,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2706","grounded_pages":[],"layout_pages":[],"markdown":"CC-F-019 Ed. 08-24 Reduced Limits Endorsement Known Wrongful Acts Provides that increased limits do not apply to claims for\n\nwrongful acts that any insured knew might result in claim prior to the effective date of increase.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring increased limit exposure during the policy period to an acceptable risk level.\n\nCC-F-020 Ed. 08-24 Additional Limits Endorsement Specific Client, Contract, Project, or Service\n\nAdds a separate limit for work for a specific client, contract, project, or service.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nBroadens Yes This endorsement will be attached at the request of the insured and at the agreement of Travelers to add a separate limit for work performed for a specific client, contract, project, or services.\n\nCC-F-021 Ed. 08-24 Defense Outside Limits Endorsement Changes policy to Defense Outside Limits. AP-C-001, Accountants Professional Liability Coverage\n\nBroadens Yes This endorsement will be attached at the request of the insured and at the agreement of Travelers when defense limits should not erode limit of liability.\n\nCC-F-022 Ed. 08-24 Sublimit For Specific Entities Or Persons Endorsement Defense Outside Limits\n\nAdds sublimit for professional services for a specific entity or person.\n\nAP-C-001, Accountants Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring certain professional services exposures for a specific entity or person to an acceptable risk level for defense outside limit policies.\n\nCC-F-023 Ed. 08-24 Sublimit For Specific Entities Or Persons Endorsement Defense Within Limits\n\nAdds sublimit for professional services for a specific entity or person.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring professional services exposures for a specific entity or person to an acceptable risk level.\n\nCC-F-024 Ed. 08-24 Sublimit For Specific Professional Services Endorsement Defense Outside Limits\n\nAdds sublimit for specific professional services. AP-C-001, Accountants Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring specific professional services exposures to an acceptable risk level for defense outside limit policies on accounts that may offer several services.\n\nCC-F-025 Ed. 08-24 Sublimit For Specific Professional Services Endorsement Defense Within Limits\n\nAdds sublimit for specific professional services. • AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring specific professional services exposures to an acceptable risk level on accounts that may offer several services.","pages":[{"line_numbers":[],"markdown":"CC-F-019 Ed. 08-24 Reduced Limits Endorsement Known Wrongful Acts Provides that increased limits do not apply to claims for\n\nwrongful acts that any insured knew might result in claim prior to the effective date of increase.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring increased limit exposure during the policy period to an acceptable risk level.\n\nCC-F-020 Ed. 08-24 Additional Limits Endorsement Specific Client, Contract, Project, or Service\n\nAdds a separate limit for work for a specific client, contract, project, or service.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nBroadens Yes This endorsement will be attached at the request of the insured and at the agreement of Travelers to add a separate limit for work performed for a specific client, contract, project, or services.\n\nCC-F-021 Ed. 08-24 Defense Outside Limits Endorsement Changes policy to Defense Outside Limits. AP-C-001, Accountants Professional Liability Coverage\n\nBroadens Yes This endorsement will be attached at the request of the insured and at the agreement of Travelers when defense limits should not erode limit of liability.\n\nCC-F-022 Ed. 08-24 Sublimit For Specific Entities Or Persons Endorsement Defense Outside Limits\n\nAdds sublimit for professional services for a specific entity or person.\n\nAP-C-001, Accountants Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring certain professional services exposures for a specific entity or person to an acceptable risk level for defense outside limit policies.\n\nCC-F-023 Ed. 08-24 Sublimit For Specific Entities Or Persons Endorsement Defense Within Limits\n\nAdds sublimit for professional services for a specific entity or person.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring professional services exposures for a specific entity or person to an acceptable risk level.\n\nCC-F-024 Ed. 08-24 Sublimit For Specific Professional Services Endorsement Defense Outside Limits\n\nAdds sublimit for specific professional services. AP-C-001, Accountants Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring specific professional services exposures to an acceptable risk level for defense outside limit policies on accounts that may offer several services.\n\nCC-F-025 Ed. 08-24 Sublimit For Specific Professional Services Endorsement Defense Within Limits\n\nAdds sublimit for specific professional services. • AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring specific professional services exposures to an acceptable risk level on accounts that may offer several services.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"CC-F-019 Ed. 08-24 Reduced Limits Endorsement Known Wrongful Acts Provides that increased limits do not apply to claims for\n\nwrongful acts that any insured knew might result in claim prior to the effective date of increase.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring increased limit exposure during the policy period to an acceptable risk level.\n\nCC-F-020 Ed. 08-24 Additional Limits Endorsement Specific Client, Contract, Project, or Service\n\nAdds a separate limit for work for a specific client, contract, project, or service.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nBroadens Yes This endorsement will be attached at the request of the insured and at the agreement of Travelers to add a separate limit for work performed for a specific client, contract, project, or services.\n\nCC-F-021 Ed. 08-24 Defense Outside Limits Endorsement Changes policy to Defense Outside Limits. AP-C-001, Accountants Professional Liability Coverage\n\nBroadens Yes This endorsement will be attached at the request of the insured and at the agreement of Travelers when defense limits should not erode limit of liability.\n\nCC-F-022 Ed. 08-24 Sublimit For Specific Entities Or Persons Endorsement Defense Outside Limits\n\nAdds sublimit for professional services for a specific entity or person.\n\nAP-C-001, Accountants Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring certain professional services exposures for a specific entity or person to an acceptable risk level for defense outside limit policies.\n\nCC-F-023 Ed. 08-24 Sublimit For Specific Entities Or Persons Endorsement Defense Within Limits\n\nAdds sublimit for professional services for a specific entity or person.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring professional services exposures for a specific entity or person to an acceptable risk level.\n\nCC-F-024 Ed. 08-24 Sublimit For Specific Professional Services Endorsement Defense Outside Limits\n\nAdds sublimit for specific professional services. AP-C-001, Accountants Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring specific professional services exposures to an acceptable risk level for defense outside limit policies on accounts that may offer several services.\n\nCC-F-025 Ed. 08-24 Sublimit For Specific Professional Services Endorsement Defense Within Limits\n\nAdds sublimit for specific professional services. • AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring specific professional services exposures to an acceptable risk level on accounts that may offer several services.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2706.pdf"]},"response":{"errors":[],"extract_id":"extract_3e4f0b6e48a8c308752f7242e9083cd0","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["CC-F-019 Ed. 08-24 Reduced Limits Endorsement Known Wrongful Acts Provides that increased limits do not apply to claims for\n\nwrongful acts that any insured knew might result in claim prior to the effective date of increase.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring increased limit exposure during the policy period to an acceptable risk level.\n\nCC-F-020 Ed. 08-24 Additional Limits Endorsement Specific Client, Contract, Project, or Service\n\nAdds a separate limit for work for a specific client, contract, project, or service.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nBroadens Yes This endorsement will be attached at the request of the insured and at the agreement of Travelers to add a separate limit for work performed for a specific client, contract, project, or services.\n\nCC-F-021 Ed. 08-24 Defense Outside Limits Endorsement Changes policy to Defense Outside Limits. AP-C-001, Accountants Professional Liability Coverage\n\nBroadens Yes This endorsement will be attached at the request of the insured and at the agreement of Travelers when defense limits should not erode limit of liability.\n\nCC-F-022 Ed. 08-24 Sublimit For Specific Entities Or Persons Endorsement Defense Outside Limits\n\nAdds sublimit for professional services for a specific entity or person.\n\nAP-C-001, Accountants Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring certain professional services exposures for a specific entity or person to an acceptable risk level for defense outside limit policies.\n\nCC-F-023 Ed. 08-24 Sublimit For Specific Entities Or Persons Endorsement Defense Within Limits\n\nAdds sublimit for professional services for a specific entity or person.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring professional services exposures for a specific entity or person to an acceptable risk level.\n\nCC-F-024 Ed. 08-24 Sublimit For Specific Professional Services Endorsement Defense Outside Limits\n\nAdds sublimit for specific professional services. AP-C-001, Accountants Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring specific professional services exposures to an acceptable risk level for defense outside limit policies on accounts that may offer several services.\n\nCC-F-025 Ed. 08-24 Sublimit For Specific Professional Services Endorsement Defense Within Limits\n\nAdds sublimit for specific professional services. • AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring specific professional services exposures to an acceptable risk level on accounts that may offer several services."],"full_content":"CC-F-019 Ed. 08-24 Reduced Limits Endorsement Known Wrongful Acts Provides that increased limits do not apply to claims for\n\nwrongful acts that any insured knew might result in claim prior to the effective date of increase.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring increased limit exposure during the policy period to an acceptable risk level.\n\nCC-F-020 Ed. 08-24 Additional Limits Endorsement Specific Client, Contract, Project, or Service\n\nAdds a separate limit for work for a specific client, contract, project, or service.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nBroadens Yes This endorsement will be attached at the request of the insured and at the agreement of Travelers to add a separate limit for work performed for a specific client, contract, project, or services.\n\nCC-F-021 Ed. 08-24 Defense Outside Limits Endorsement Changes policy to Defense Outside Limits. AP-C-001, Accountants Professional Liability Coverage\n\nBroadens Yes This endorsement will be attached at the request of the insured and at the agreement of Travelers when defense limits should not erode limit of liability.\n\nCC-F-022 Ed. 08-24 Sublimit For Specific Entities Or Persons Endorsement Defense Outside Limits\n\nAdds sublimit for professional services for a specific entity or person.\n\nAP-C-001, Accountants Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring certain professional services exposures for a specific entity or person to an acceptable risk level for defense outside limit policies.\n\nCC-F-023 Ed. 08-24 Sublimit For Specific Entities Or Persons Endorsement Defense Within Limits\n\nAdds sublimit for professional services for a specific entity or person.\n\n• AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring professional services exposures for a specific entity or person to an acceptable risk level.\n\nCC-F-024 Ed. 08-24 Sublimit For Specific Professional Services Endorsement Defense Outside Limits\n\nAdds sublimit for specific professional services. AP-C-001, Accountants Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring specific professional services exposures to an acceptable risk level for defense outside limit policies on accounts that may offer several services.\n\nCC-F-025 Ed. 08-24 Sublimit For Specific Professional Services Endorsement Defense Within Limits\n\nAdds sublimit for specific professional services. • AP-C-001 Accountants Professional Liability Coverage • DP-C-001, Design Professional Liability Coverage\n\nRestricts No The use of this endorsement will be mutually agreed upon by Travelers and the insured in order to bring specific professional services exposures to an acceptable risk level on accounts that may offer several services.","publish_date":null,"title":"CC-F-019 Ed. 08-24 Reduced Limits Endorsement Known Wrongful Acts Provides that increased limits do not apply to claims for •","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2706.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2706.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2706","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2706.pdf"},"started_at":"2026-11-04T19:46:57.400239"} +{"completed_at":"2026-11-04T19:47:01.607980","latency_in_ms":2547,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2747","grounded_pages":[],"layout_pages":[],"markdown":"### _Insurance Company Professional Liability_\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2017-02-0003**\n\n**TWO YEAR REPORTING OF NON-SIGNIFICANT CLAIMS ENDORSEMENT** For this coverage, begin with the base premium with all factors applied. Multiply this premium by the charge shown below.\n\nCharge\n\n0% to 15%\n\n55899 CA Rev. 05-2017 Printed in USA 2017 The Travelers Indemnity Company. All Rights Reserved Rate Page 13","pages":[{"line_numbers":[],"markdown":"### _Insurance Company Professional Liability_\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2017-02-0003**\n\n**TWO YEAR REPORTING OF NON-SIGNIFICANT CLAIMS ENDORSEMENT** For this coverage, begin with the base premium with all factors applied. Multiply this premium by the charge shown below.\n\nCharge\n\n0% to 15%\n\n55899 CA Rev. 05-2017 Printed in USA 2017 The Travelers Indemnity Company. All Rights Reserved Rate Page 13","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### _Insurance Company Professional Liability_\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2017-02-0003**\n\n**TWO YEAR REPORTING OF NON-SIGNIFICANT CLAIMS ENDORSEMENT** For this coverage, begin with the base premium with all factors applied. Multiply this premium by the charge shown below.\n\nCharge\n\n0% to 15%\n\n55899 CA Rev. 05-2017 Printed in USA 2017 The Travelers Indemnity Company. All Rights Reserved Rate Page 13","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2747.pdf"]},"response":{"errors":[],"extract_id":"extract_ddb1c8bbeb28ee60035518d29657047d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### _Insurance Company Professional Liability_\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2017-02-0003**\n\n**TWO YEAR REPORTING OF NON-SIGNIFICANT CLAIMS ENDORSEMENT** For this coverage, begin with the base premium with all factors applied. Multiply this premium by the charge shown below.\n\nCharge\n\n0% to 15%\n\n55899 CA Rev. 05-2017 Printed in USA 2017 The Travelers Indemnity Company. All Rights Reserved Rate Page 13"],"full_content":"### _Insurance Company Professional Liability_\n\n### **Manual Rates**\n\nTravelers Casualty and Surety Company of America\n\n### **California**\n\n**Filing Number: 2017-02-0003**\n\n**TWO YEAR REPORTING OF NON-SIGNIFICANT CLAIMS ENDORSEMENT** For this coverage, begin with the base premium with all factors applied. Multiply this premium by the charge shown below.\n\nCharge\n\n0% to 15%\n\n55899 CA Rev. 05-2017 Printed in USA 2017 The Travelers Indemnity Company. All Rights Reserved Rate Page 13","publish_date":null,"title":"Insurance Company Professional Liability Manual Rates California","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2747.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2747.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2747","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2747.pdf"},"started_at":"2026-11-04T19:46:59.060039"} +{"completed_at":"2026-11-04T19:47:04.572964","latency_in_ms":4359,"output":{"example_id":"table/SERFF_CA_random_pages 1_page275","grounded_pages":[],"layout_pages":[],"markdown":"WORKERS' COMPENSATION AND EMPLOYERS' LIABILITY California\nARGONAUT INSURANCE COMPANIES Page 4\nEFFECTIVE: February 1, 2009\n\nCode Rate Incl. Min. Code \\_\\_ Rate Incl. Min. Code Rate Incl. Min.\nNo. Disease Prem. No. Disease Prem. No. Disease Prem.\n8742 0.64 381 9043 2.12 685 9620 2.64 791\n8743 0.19 289 9048 6.11. 1000\n8745 8.74 1000 9050 5.96 1000\n8748 1.14 484 9053 2.31 724\n8749 0.44 339 9059 3.54 975\n8755 0.95 445 9060 4.43 1000\n8800 3.82 1000 9061 3.81 1000\n8801 1.14 484 9066 4.13 1000\n8803 0.35 322 9067 2.72 808\n8804 3.39 944 9069 4.73 1000\n8806 5.30 1000 9070 7.22 1000\n8807 0.99 454 9079 3.50 967\n8808 0.83 420 9085 5.10 1000\n8810 0.53 359 9092 3.52 972\n8813 0.87 428 9096 13.98 — 1000\n8818 0.99 454 9097 4.69 1000\n8820 0.52 356 9101 5.94 500\n8821 2.34 730 9151 1.16 487\n8822 1.03 462 9154 3.82 1000\n8823 5.48 1000 9155 1.93 646\n8827 4.80 1000 9156 5.52 1000\n8829 4.68 1000 9180 4.47 1000\n8830 2.12 685 9181 14.76 1000\n8831 2.92 849 9182 3.01 866\n8834 1.54 565 9184 9.17 1000\n8838 1.58 573 9185 23.87 1000\n8839 1.16 487 9220 7.74 1000\n8840 0.87 428 9402 5.78 1000\n8846 0.97 448 9403 8.89 1000\n8847 10.66 1000 9410 2.09 679\n8850 2.88 841 9420 6.39 1000\n8851 5.88 1000 9422 5.92 1000\n8852 3.79 1000 9424 8.72 1000\n8859 0.18 286 9426 10.54 1000\n8868 1.13 481 9501 4.15 1000\n8875 1.80 618 9507 3.82 1000\n9007 4.30 1000 9516 3.55 978\n9008 9.07 1000 9519 7.70 1000\n9009 4.73 1000 9521 4.83 1000\n9010 6.16 1000 9522 5.13 1000\n9011 4.58 1000 9529 9.14 1000\n9015 5.68 1000 9549 9.32 1000\n9016 5.56 1000 9552 13.57 1000\n9031 5.32 1000 9586 2.67 796\n9033 6.41. 1000 9610 2.30 721\n\nCOPYRIGHT, ARGONAUT INSURANCE COMPANIES EDITION OF February 1, 2009","pages":[{"line_numbers":[],"markdown":"WORKERS' COMPENSATION AND EMPLOYERS' LIABILITY California\nARGONAUT INSURANCE COMPANIES Page 4\nEFFECTIVE: February 1, 2009\n\nCode Rate Incl. Min. Code \\_\\_ Rate Incl. Min. Code Rate Incl. Min.\nNo. Disease Prem. No. Disease Prem. No. Disease Prem.\n8742 0.64 381 9043 2.12 685 9620 2.64 791\n8743 0.19 289 9048 6.11. 1000\n8745 8.74 1000 9050 5.96 1000\n8748 1.14 484 9053 2.31 724\n8749 0.44 339 9059 3.54 975\n8755 0.95 445 9060 4.43 1000\n8800 3.82 1000 9061 3.81 1000\n8801 1.14 484 9066 4.13 1000\n8803 0.35 322 9067 2.72 808\n8804 3.39 944 9069 4.73 1000\n8806 5.30 1000 9070 7.22 1000\n8807 0.99 454 9079 3.50 967\n8808 0.83 420 9085 5.10 1000\n8810 0.53 359 9092 3.52 972\n8813 0.87 428 9096 13.98 — 1000\n8818 0.99 454 9097 4.69 1000\n8820 0.52 356 9101 5.94 500\n8821 2.34 730 9151 1.16 487\n8822 1.03 462 9154 3.82 1000\n8823 5.48 1000 9155 1.93 646\n8827 4.80 1000 9156 5.52 1000\n8829 4.68 1000 9180 4.47 1000\n8830 2.12 685 9181 14.76 1000\n8831 2.92 849 9182 3.01 866\n8834 1.54 565 9184 9.17 1000\n8838 1.58 573 9185 23.87 1000\n8839 1.16 487 9220 7.74 1000\n8840 0.87 428 9402 5.78 1000\n8846 0.97 448 9403 8.89 1000\n8847 10.66 1000 9410 2.09 679\n8850 2.88 841 9420 6.39 1000\n8851 5.88 1000 9422 5.92 1000\n8852 3.79 1000 9424 8.72 1000\n8859 0.18 286 9426 10.54 1000\n8868 1.13 481 9501 4.15 1000\n8875 1.80 618 9507 3.82 1000\n9007 4.30 1000 9516 3.55 978\n9008 9.07 1000 9519 7.70 1000\n9009 4.73 1000 9521 4.83 1000\n9010 6.16 1000 9522 5.13 1000\n9011 4.58 1000 9529 9.14 1000\n9015 5.68 1000 9549 9.32 1000\n9016 5.56 1000 9552 13.57 1000\n9031 5.32 1000 9586 2.67 796\n9033 6.41. 1000 9610 2.30 721\n\nCOPYRIGHT, ARGONAUT INSURANCE COMPANIES EDITION OF February 1, 2009","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"WORKERS' COMPENSATION AND EMPLOYERS' LIABILITY California\nARGONAUT INSURANCE COMPANIES Page 4\nEFFECTIVE: February 1, 2009\n\nCode Rate Incl. Min. Code \\_\\_ Rate Incl. Min. Code Rate Incl. Min.\nNo. Disease Prem. No. Disease Prem. No. Disease Prem.\n8742 0.64 381 9043 2.12 685 9620 2.64 791\n8743 0.19 289 9048 6.11. 1000\n8745 8.74 1000 9050 5.96 1000\n8748 1.14 484 9053 2.31 724\n8749 0.44 339 9059 3.54 975\n8755 0.95 445 9060 4.43 1000\n8800 3.82 1000 9061 3.81 1000\n8801 1.14 484 9066 4.13 1000\n8803 0.35 322 9067 2.72 808\n8804 3.39 944 9069 4.73 1000\n8806 5.30 1000 9070 7.22 1000\n8807 0.99 454 9079 3.50 967\n8808 0.83 420 9085 5.10 1000\n8810 0.53 359 9092 3.52 972\n8813 0.87 428 9096 13.98 — 1000\n8818 0.99 454 9097 4.69 1000\n8820 0.52 356 9101 5.94 500\n8821 2.34 730 9151 1.16 487\n8822 1.03 462 9154 3.82 1000\n8823 5.48 1000 9155 1.93 646\n8827 4.80 1000 9156 5.52 1000\n8829 4.68 1000 9180 4.47 1000\n8830 2.12 685 9181 14.76 1000\n8831 2.92 849 9182 3.01 866\n8834 1.54 565 9184 9.17 1000\n8838 1.58 573 9185 23.87 1000\n8839 1.16 487 9220 7.74 1000\n8840 0.87 428 9402 5.78 1000\n8846 0.97 448 9403 8.89 1000\n8847 10.66 1000 9410 2.09 679\n8850 2.88 841 9420 6.39 1000\n8851 5.88 1000 9422 5.92 1000\n8852 3.79 1000 9424 8.72 1000\n8859 0.18 286 9426 10.54 1000\n8868 1.13 481 9501 4.15 1000\n8875 1.80 618 9507 3.82 1000\n9007 4.30 1000 9516 3.55 978\n9008 9.07 1000 9519 7.70 1000\n9009 4.73 1000 9521 4.83 1000\n9010 6.16 1000 9522 5.13 1000\n9011 4.58 1000 9529 9.14 1000\n9015 5.68 1000 9549 9.32 1000\n9016 5.56 1000 9552 13.57 1000\n9031 5.32 1000 9586 2.67 796\n9033 6.41. 1000 9610 2.30 721\n\nCOPYRIGHT, ARGONAUT INSURANCE COMPANIES EDITION OF February 1, 2009","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page275.pdf"]},"response":{"errors":[],"extract_id":"extract_ea2094f2991ed15cb06568fdea15d054","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["WORKERS' COMPENSATION AND EMPLOYERS' LIABILITY California\nARGONAUT INSURANCE COMPANIES Page 4\nEFFECTIVE: February 1, 2009\n\nCode Rate Incl. Min. Code \\_\\_ Rate Incl. Min. Code Rate Incl. Min.\nNo. Disease Prem. No. Disease Prem. No. Disease Prem.\n8742 0.64 381 9043 2.12 685 9620 2.64 791\n8743 0.19 289 9048 6.11. 1000\n8745 8.74 1000 9050 5.96 1000\n8748 1.14 484 9053 2.31 724\n8749 0.44 339 9059 3.54 975\n8755 0.95 445 9060 4.43 1000\n8800 3.82 1000 9061 3.81 1000\n8801 1.14 484 9066 4.13 1000\n8803 0.35 322 9067 2.72 808\n8804 3.39 944 9069 4.73 1000\n8806 5.30 1000 9070 7.22 1000\n8807 0.99 454 9079 3.50 967\n8808 0.83 420 9085 5.10 1000\n8810 0.53 359 9092 3.52 972\n8813 0.87 428 9096 13.98 — 1000\n8818 0.99 454 9097 4.69 1000\n8820 0.52 356 9101 5.94 500\n8821 2.34 730 9151 1.16 487\n8822 1.03 462 9154 3.82 1000\n8823 5.48 1000 9155 1.93 646\n8827 4.80 1000 9156 5.52 1000\n8829 4.68 1000 9180 4.47 1000\n8830 2.12 685 9181 14.76 1000\n8831 2.92 849 9182 3.01 866\n8834 1.54 565 9184 9.17 1000\n8838 1.58 573 9185 23.87 1000\n8839 1.16 487 9220 7.74 1000\n8840 0.87 428 9402 5.78 1000\n8846 0.97 448 9403 8.89 1000\n8847 10.66 1000 9410 2.09 679\n8850 2.88 841 9420 6.39 1000\n8851 5.88 1000 9422 5.92 1000\n8852 3.79 1000 9424 8.72 1000\n8859 0.18 286 9426 10.54 1000\n8868 1.13 481 9501 4.15 1000\n8875 1.80 618 9507 3.82 1000\n9007 4.30 1000 9516 3.55 978\n9008 9.07 1000 9519 7.70 1000\n9009 4.73 1000 9521 4.83 1000\n9010 6.16 1000 9522 5.13 1000\n9011 4.58 1000 9529 9.14 1000\n9015 5.68 1000 9549 9.32 1000\n9016 5.56 1000 9552 13.57 1000\n9031 5.32 1000 9586 2.67 796\n9033 6.41. 1000 9610 2.30 721\n\nCOPYRIGHT, ARGONAUT INSURANCE COMPANIES EDITION OF February 1, 2009"],"full_content":"WORKERS' COMPENSATION AND EMPLOYERS' LIABILITY California\nARGONAUT INSURANCE COMPANIES Page 4\nEFFECTIVE: February 1, 2009\n\nCode Rate Incl. Min. Code \\_\\_ Rate Incl. Min. Code Rate Incl. Min.\nNo. Disease Prem. No. Disease Prem. No. Disease Prem.\n8742 0.64 381 9043 2.12 685 9620 2.64 791\n8743 0.19 289 9048 6.11. 1000\n8745 8.74 1000 9050 5.96 1000\n8748 1.14 484 9053 2.31 724\n8749 0.44 339 9059 3.54 975\n8755 0.95 445 9060 4.43 1000\n8800 3.82 1000 9061 3.81 1000\n8801 1.14 484 9066 4.13 1000\n8803 0.35 322 9067 2.72 808\n8804 3.39 944 9069 4.73 1000\n8806 5.30 1000 9070 7.22 1000\n8807 0.99 454 9079 3.50 967\n8808 0.83 420 9085 5.10 1000\n8810 0.53 359 9092 3.52 972\n8813 0.87 428 9096 13.98 — 1000\n8818 0.99 454 9097 4.69 1000\n8820 0.52 356 9101 5.94 500\n8821 2.34 730 9151 1.16 487\n8822 1.03 462 9154 3.82 1000\n8823 5.48 1000 9155 1.93 646\n8827 4.80 1000 9156 5.52 1000\n8829 4.68 1000 9180 4.47 1000\n8830 2.12 685 9181 14.76 1000\n8831 2.92 849 9182 3.01 866\n8834 1.54 565 9184 9.17 1000\n8838 1.58 573 9185 23.87 1000\n8839 1.16 487 9220 7.74 1000\n8840 0.87 428 9402 5.78 1000\n8846 0.97 448 9403 8.89 1000\n8847 10.66 1000 9410 2.09 679\n8850 2.88 841 9420 6.39 1000\n8851 5.88 1000 9422 5.92 1000\n8852 3.79 1000 9424 8.72 1000\n8859 0.18 286 9426 10.54 1000\n8868 1.13 481 9501 4.15 1000\n8875 1.80 618 9507 3.82 1000\n9007 4.30 1000 9516 3.55 978\n9008 9.07 1000 9519 7.70 1000\n9009 4.73 1000 9521 4.83 1000\n9010 6.16 1000 9522 5.13 1000\n9011 4.58 1000 9529 9.14 1000\n9015 5.68 1000 9549 9.32 1000\n9016 5.56 1000 9552 13.57 1000\n9031 5.32 1000 9586 2.67 796\n9033 6.41. 1000 9610 2.30 721\n\nCOPYRIGHT, ARGONAUT INSURANCE COMPANIES EDITION OF February 1, 2009","publish_date":null,"title":"Serff Ca Random Pages 1 Page275","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page275.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page275.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page275","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page275.pdf"},"started_at":"2026-11-04T19:47:00.213321"} +{"completed_at":"2026-11-04T19:47:03.327130","latency_in_ms":1717,"output":{"example_id":"table/SERFF_CA_random_pages 1_page283","grounded_pages":[],"layout_pages":[],"markdown":"**CALIFORNIA WORKERS COMPENSATION AND EMPLOYERS LIABILITY INSURANCE MANUAL** 14th Reprint _Effective February 1, 2009_ Page R-37 \\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nf. Short rate portion of loss constant = Not applicable. g. Short rate portion of expense constant = $140 x $.80 = $112. h. Total premium for canceled policy = $412. i. Minimum premium = $178. Not applicable to this policy. **A. SHORT RATE CANCELLATION TABLE FOR TERM OF ONE YEAR** **Percent Days of Policy One Year In Force Premium**\n\n**Percent Days of Policy One Year In Force Premium**\n\n**Percent Days of Policy One Year In Force Premium** 1\\.... .............. ............. ...... 5% 2.... .............. ............. ......... 6 3 - 4... .............. ............. ......... 7 5 - 6... .............. ............. ......... 8 7 - 8... .............. ............. ......... 9 9 -10.. .............. ............. ........ 10 11 -12. .............. ............. ........ 11 13 -14. .............. ............. ........ 12 15 -16. .............. ............. ........ 13 17 -18. .............. ............. ........ 14 19 -20. .............. ............. ........ 15 21 -22. .............. ............. ........ 16 23 -25. .............. ............. ........ 17 26 -29. .............. ............. ........ 18 30- 32 (1 mo.)... ............. ........ 19 33- 36. .............. ............. ........ 20 37- 40. .............. ............. ........ 21 41- 43. .............. ............. ........ 22 44- 47. .............. ............. ........ 23 48- 51. .............. ............. ........ 24 52- 54. .............. ............. ........ 25 55- 58. .............. ............. ........ 26 59- 62 (2 mos.) . ............. ........ 27 63- 65. .............. ............. ........ 28 66- 69. .............. ............. ........ 29 70- 73. .............. ............. ........ 30 74- 76. .............. ............. ........ 31 77- 80. .............. ............. ........ 32 81- 83. .............. ............. ........ 33 84- 87. .............. ............. ........ 34 88- 91 (3 mos.) . ............. ........ 35 92- 94. .............. ............. ........ 36 95- 98. .............. ............. ........ 37 99-102 .............. ............. ........ 38 103-105.............. ............. ........ 39\n\n106-109............. .............. ........ 40 110-113............. .............. ........ 41 114-116............. .............. ........ 42 117-120............. .............. ........ 43 121-124 (4 mos.).............. ........ 44 125-127............. .............. ........ 45 128-131............. .............. ........ 46 132-135............. .............. ........ 47 136-138............. .............. ........ 48 139-142............. .............. ........ 49 143-146............. .............. ........ 50 147-149............. .............. ........ 51 150-153 (5 mos.).............. ........ 52 154-156............. .............. ........ 53 157-160............. .............. ........ 54 161-164............. .............. ........ 55 165-167............. .............. ........ 56 168-171............. .............. ........ 57 172-175............. .............. ........ 58 176-178............. .............. ........ 59 179-182 (6 mos.).............. ........ 60 183-187............. .............. ........ 61 188-191............. .............. ........ 62 192-196............. .............. ........ 63 197-200............. .............. ........ 64 201-205............. .............. ........ 65 206-209............. .............. ........ 66 210-214 (7 mos.).............. ........ 67 215-218............. .............. ........ 68 219-223............. .............. ........ 69 224-228............. .............. ........ 70 229-232............. .............. ........ 71 233-237............. .............. ........ 72 238-241............. .............. ........ 73 242-246 (8 mos.).............. ........ 74\n\n247-250 ............. ............. ......... 75 251-255 ............. ............. ......... 76 256-260 ............. ............. ......... 77 261-264 ............. ............. ......... 78 265-269 ............. ............. ......... 79 270-273 (9 mos.)............. ......... 80 274-278 ............. ............. ......... 81 279-282 ............. ............. ......... 82 283-287 ............. ............. ......... 83 288-291 ............. ............. ......... 84 292-296 ............. ............. ......... 85 297-301 ............. ............. ......... 86 302-305 (10 mos.)........... ......... 87 306-310 ............. ............. ......... 88 311-314 ............. ............. ......... 89 315-319 ............. ............. ......... 90 320-323 ............. ............. ......... 91 324-328 ............. ............. ......... 92 329-332 ............. ............. ......... 93 333-337 (11 mos.)........... ......... 94 338-342 ............. ............. ......... 95 343-346 ............. ............. ......... 96 347-351 ............. ............. ......... 97 352-355 ............. ............. ......... 98 356-360 ............. ............. ......... 99 361-365 (12 mos.)........... ........100","pages":[{"line_numbers":[],"markdown":"**CALIFORNIA WORKERS COMPENSATION AND EMPLOYERS LIABILITY INSURANCE MANUAL** 14th Reprint _Effective February 1, 2009_ Page R-37 \\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nf. Short rate portion of loss constant = Not applicable. g. Short rate portion of expense constant = $140 x $.80 = $112. h. Total premium for canceled policy = $412. i. Minimum premium = $178. Not applicable to this policy. **A. SHORT RATE CANCELLATION TABLE FOR TERM OF ONE YEAR** **Percent Days of Policy One Year In Force Premium**\n\n**Percent Days of Policy One Year In Force Premium**\n\n**Percent Days of Policy One Year In Force Premium** 1\\.... .............. ............. ...... 5% 2.... .............. ............. ......... 6 3 - 4... .............. ............. ......... 7 5 - 6... .............. ............. ......... 8 7 - 8... .............. ............. ......... 9 9 -10.. .............. ............. ........ 10 11 -12. .............. ............. ........ 11 13 -14. .............. ............. ........ 12 15 -16. .............. ............. ........ 13 17 -18. .............. ............. ........ 14 19 -20. .............. ............. ........ 15 21 -22. .............. ............. ........ 16 23 -25. .............. ............. ........ 17 26 -29. .............. ............. ........ 18 30- 32 (1 mo.)... ............. ........ 19 33- 36. .............. ............. ........ 20 37- 40. .............. ............. ........ 21 41- 43. .............. ............. ........ 22 44- 47. .............. ............. ........ 23 48- 51. .............. ............. ........ 24 52- 54. .............. ............. ........ 25 55- 58. .............. ............. ........ 26 59- 62 (2 mos.) . ............. ........ 27 63- 65. .............. ............. ........ 28 66- 69. .............. ............. ........ 29 70- 73. .............. ............. ........ 30 74- 76. .............. ............. ........ 31 77- 80. .............. ............. ........ 32 81- 83. .............. ............. ........ 33 84- 87. .............. ............. ........ 34 88- 91 (3 mos.) . ............. ........ 35 92- 94. .............. ............. ........ 36 95- 98. .............. ............. ........ 37 99-102 .............. ............. ........ 38 103-105.............. ............. ........ 39\n\n106-109............. .............. ........ 40 110-113............. .............. ........ 41 114-116............. .............. ........ 42 117-120............. .............. ........ 43 121-124 (4 mos.).............. ........ 44 125-127............. .............. ........ 45 128-131............. .............. ........ 46 132-135............. .............. ........ 47 136-138............. .............. ........ 48 139-142............. .............. ........ 49 143-146............. .............. ........ 50 147-149............. .............. ........ 51 150-153 (5 mos.).............. ........ 52 154-156............. .............. ........ 53 157-160............. .............. ........ 54 161-164............. .............. ........ 55 165-167............. .............. ........ 56 168-171............. .............. ........ 57 172-175............. .............. ........ 58 176-178............. .............. ........ 59 179-182 (6 mos.).............. ........ 60 183-187............. .............. ........ 61 188-191............. .............. ........ 62 192-196............. .............. ........ 63 197-200............. .............. ........ 64 201-205............. .............. ........ 65 206-209............. .............. ........ 66 210-214 (7 mos.).............. ........ 67 215-218............. .............. ........ 68 219-223............. .............. ........ 69 224-228............. .............. ........ 70 229-232............. .............. ........ 71 233-237............. .............. ........ 72 238-241............. .............. ........ 73 242-246 (8 mos.).............. ........ 74\n\n247-250 ............. ............. ......... 75 251-255 ............. ............. ......... 76 256-260 ............. ............. ......... 77 261-264 ............. ............. ......... 78 265-269 ............. ............. ......... 79 270-273 (9 mos.)............. ......... 80 274-278 ............. ............. ......... 81 279-282 ............. ............. ......... 82 283-287 ............. ............. ......... 83 288-291 ............. ............. ......... 84 292-296 ............. ............. ......... 85 297-301 ............. ............. ......... 86 302-305 (10 mos.)........... ......... 87 306-310 ............. ............. ......... 88 311-314 ............. ............. ......... 89 315-319 ............. ............. ......... 90 320-323 ............. ............. ......... 91 324-328 ............. ............. ......... 92 329-332 ............. ............. ......... 93 333-337 (11 mos.)........... ......... 94 338-342 ............. ............. ......... 95 343-346 ............. ............. ......... 96 347-351 ............. ............. ......... 97 352-355 ............. ............. ......... 98 356-360 ............. ............. ......... 99 361-365 (12 mos.)........... ........100","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**CALIFORNIA WORKERS COMPENSATION AND EMPLOYERS LIABILITY INSURANCE MANUAL** 14th Reprint _Effective February 1, 2009_ Page R-37 \\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nf. Short rate portion of loss constant = Not applicable. g. Short rate portion of expense constant = $140 x $.80 = $112. h. Total premium for canceled policy = $412. i. Minimum premium = $178. Not applicable to this policy. **A. SHORT RATE CANCELLATION TABLE FOR TERM OF ONE YEAR** **Percent Days of Policy One Year In Force Premium**\n\n**Percent Days of Policy One Year In Force Premium**\n\n**Percent Days of Policy One Year In Force Premium** 1\\.... .............. ............. ...... 5% 2.... .............. ............. ......... 6 3 - 4... .............. ............. ......... 7 5 - 6... .............. ............. ......... 8 7 - 8... .............. ............. ......... 9 9 -10.. .............. ............. ........ 10 11 -12. .............. ............. ........ 11 13 -14. .............. ............. ........ 12 15 -16. .............. ............. ........ 13 17 -18. .............. ............. ........ 14 19 -20. .............. ............. ........ 15 21 -22. .............. ............. ........ 16 23 -25. .............. ............. ........ 17 26 -29. .............. ............. ........ 18 30- 32 (1 mo.)... ............. ........ 19 33- 36. .............. ............. ........ 20 37- 40. .............. ............. ........ 21 41- 43. .............. ............. ........ 22 44- 47. .............. ............. ........ 23 48- 51. .............. ............. ........ 24 52- 54. .............. ............. ........ 25 55- 58. .............. ............. ........ 26 59- 62 (2 mos.) . ............. ........ 27 63- 65. .............. ............. ........ 28 66- 69. .............. ............. ........ 29 70- 73. .............. ............. ........ 30 74- 76. .............. ............. ........ 31 77- 80. .............. ............. ........ 32 81- 83. .............. ............. ........ 33 84- 87. .............. ............. ........ 34 88- 91 (3 mos.) . ............. ........ 35 92- 94. .............. ............. ........ 36 95- 98. .............. ............. ........ 37 99-102 .............. ............. ........ 38 103-105.............. ............. ........ 39\n\n106-109............. .............. ........ 40 110-113............. .............. ........ 41 114-116............. .............. ........ 42 117-120............. .............. ........ 43 121-124 (4 mos.).............. ........ 44 125-127............. .............. ........ 45 128-131............. .............. ........ 46 132-135............. .............. ........ 47 136-138............. .............. ........ 48 139-142............. .............. ........ 49 143-146............. .............. ........ 50 147-149............. .............. ........ 51 150-153 (5 mos.).............. ........ 52 154-156............. .............. ........ 53 157-160............. .............. ........ 54 161-164............. .............. ........ 55 165-167............. .............. ........ 56 168-171............. .............. ........ 57 172-175............. .............. ........ 58 176-178............. .............. ........ 59 179-182 (6 mos.).............. ........ 60 183-187............. .............. ........ 61 188-191............. .............. ........ 62 192-196............. .............. ........ 63 197-200............. .............. ........ 64 201-205............. .............. ........ 65 206-209............. .............. ........ 66 210-214 (7 mos.).............. ........ 67 215-218............. .............. ........ 68 219-223............. .............. ........ 69 224-228............. .............. ........ 70 229-232............. .............. ........ 71 233-237............. .............. ........ 72 238-241............. .............. ........ 73 242-246 (8 mos.).............. ........ 74\n\n247-250 ............. ............. ......... 75 251-255 ............. ............. ......... 76 256-260 ............. ............. ......... 77 261-264 ............. ............. ......... 78 265-269 ............. ............. ......... 79 270-273 (9 mos.)............. ......... 80 274-278 ............. ............. ......... 81 279-282 ............. ............. ......... 82 283-287 ............. ............. ......... 83 288-291 ............. ............. ......... 84 292-296 ............. ............. ......... 85 297-301 ............. ............. ......... 86 302-305 (10 mos.)........... ......... 87 306-310 ............. ............. ......... 88 311-314 ............. ............. ......... 89 315-319 ............. ............. ......... 90 320-323 ............. ............. ......... 91 324-328 ............. ............. ......... 92 329-332 ............. ............. ......... 93 333-337 (11 mos.)........... ......... 94 338-342 ............. ............. ......... 95 343-346 ............. ............. ......... 96 347-351 ............. ............. ......... 97 352-355 ............. ............. ......... 98 356-360 ............. ............. ......... 99 361-365 (12 mos.)........... ........100","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page283.pdf"]},"response":{"errors":[],"extract_id":"extract_82239a3c9d2a9f3b54aa9bfe575820cf","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**CALIFORNIA WORKERS COMPENSATION AND EMPLOYERS LIABILITY INSURANCE MANUAL** 14th Reprint _Effective February 1, 2009_ Page R-37 \\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nf. Short rate portion of loss constant = Not applicable. g. Short rate portion of expense constant = $140 x $.80 = $112. h. Total premium for canceled policy = $412. i. Minimum premium = $178. Not applicable to this policy. **A. SHORT RATE CANCELLATION TABLE FOR TERM OF ONE YEAR** **Percent Days of Policy One Year In Force Premium**\n\n**Percent Days of Policy One Year In Force Premium**\n\n**Percent Days of Policy One Year In Force Premium** 1\\.... .............. ............. ...... 5% 2.... .............. ............. ......... 6 3 - 4... .............. ............. ......... 7 5 - 6... .............. ............. ......... 8 7 - 8... .............. ............. ......... 9 9 -10.. .............. ............. ........ 10 11 -12. .............. ............. ........ 11 13 -14. .............. ............. ........ 12 15 -16. .............. ............. ........ 13 17 -18. .............. ............. ........ 14 19 -20. .............. ............. ........ 15 21 -22. .............. ............. ........ 16 23 -25. .............. ............. ........ 17 26 -29. .............. ............. ........ 18 30- 32 (1 mo.)... ............. ........ 19 33- 36. .............. ............. ........ 20 37- 40. .............. ............. ........ 21 41- 43. .............. ............. ........ 22 44- 47. .............. ............. ........ 23 48- 51. .............. ............. ........ 24 52- 54. .............. ............. ........ 25 55- 58. .............. ............. ........ 26 59- 62 (2 mos.) . ............. ........ 27 63- 65. .............. ............. ........ 28 66- 69. .............. ............. ........ 29 70- 73. .............. ............. ........ 30 74- 76. .............. ............. ........ 31 77- 80. .............. ............. ........ 32 81- 83. .............. ............. ........ 33 84- 87. .............. ............. ........ 34 88- 91 (3 mos.) . ............. ........ 35 92- 94. .............. ............. ........ 36 95- 98. .............. ............. ........ 37 99-102 .............. ............. ........ 38 103-105.............. ............. ........ 39\n\n106-109............. .............. ........ 40 110-113............. .............. ........ 41 114-116............. .............. ........ 42 117-120............. .............. ........ 43 121-124 (4 mos.).............. ........ 44 125-127............. .............. ........ 45 128-131............. .............. ........ 46 132-135............. .............. ........ 47 136-138............. .............. ........ 48 139-142............. .............. ........ 49 143-146............. .............. ........ 50 147-149............. .............. ........ 51 150-153 (5 mos.).............. ........ 52 154-156............. .............. ........ 53 157-160............. .............. ........ 54 161-164............. .............. ........ 55 165-167............. .............. ........ 56 168-171............. .............. ........ 57 172-175............. .............. ........ 58 176-178............. .............. ........ 59 179-182 (6 mos.).............. ........ 60 183-187............. .............. ........ 61 188-191............. .............. ........ 62 192-196............. .............. ........ 63 197-200............. .............. ........ 64 201-205............. .............. ........ 65 206-209............. .............. ........ 66 210-214 (7 mos.).............. ........ 67 215-218............. .............. ........ 68 219-223............. .............. ........ 69 224-228............. .............. ........ 70 229-232............. .............. ........ 71 233-237............. .............. ........ 72 238-241............. .............. ........ 73 242-246 (8 mos.).............. ........ 74\n\n247-250 ............. ............. ......... 75 251-255 ............. ............. ......... 76 256-260 ............. ............. ......... 77 261-264 ............. ............. ......... 78 265-269 ............. ............. ......... 79 270-273 (9 mos.)............. ......... 80 274-278 ............. ............. ......... 81 279-282 ............. ............. ......... 82 283-287 ............. ............. ......... 83 288-291 ............. ............. ......... 84 292-296 ............. ............. ......... 85 297-301 ............. ............. ......... 86 302-305 (10 mos.)........... ......... 87 306-310 ............. ............. ......... 88 311-314 ............. ............. ......... 89 315-319 ............. ............. ......... 90 320-323 ............. ............. ......... 91 324-328 ............. ............. ......... 92 329-332 ............. ............. ......... 93 333-337 (11 mos.)........... ......... 94 338-342 ............. ............. ......... 95 343-346 ............. ............. ......... 96 347-351 ............. ............. ......... 97 352-355 ............. ............. ......... 98 356-360 ............. ............. ......... 99 361-365 (12 mos.)........... ........100"],"full_content":"**CALIFORNIA WORKERS COMPENSATION AND EMPLOYERS LIABILITY INSURANCE MANUAL** 14th Reprint _Effective February 1, 2009_ Page R-37 \\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nf. Short rate portion of loss constant = Not applicable. g. Short rate portion of expense constant = $140 x $.80 = $112. h. Total premium for canceled policy = $412. i. Minimum premium = $178. Not applicable to this policy. **A. SHORT RATE CANCELLATION TABLE FOR TERM OF ONE YEAR** **Percent Days of Policy One Year In Force Premium**\n\n**Percent Days of Policy One Year In Force Premium**\n\n**Percent Days of Policy One Year In Force Premium** 1\\.... .............. ............. ...... 5% 2.... .............. ............. ......... 6 3 - 4... .............. ............. ......... 7 5 - 6... .............. ............. ......... 8 7 - 8... .............. ............. ......... 9 9 -10.. .............. ............. ........ 10 11 -12. .............. ............. ........ 11 13 -14. .............. ............. ........ 12 15 -16. .............. ............. ........ 13 17 -18. .............. ............. ........ 14 19 -20. .............. ............. ........ 15 21 -22. .............. ............. ........ 16 23 -25. .............. ............. ........ 17 26 -29. .............. ............. ........ 18 30- 32 (1 mo.)... ............. ........ 19 33- 36. .............. ............. ........ 20 37- 40. .............. ............. ........ 21 41- 43. .............. ............. ........ 22 44- 47. .............. ............. ........ 23 48- 51. .............. ............. ........ 24 52- 54. .............. ............. ........ 25 55- 58. .............. ............. ........ 26 59- 62 (2 mos.) . ............. ........ 27 63- 65. .............. ............. ........ 28 66- 69. .............. ............. ........ 29 70- 73. .............. ............. ........ 30 74- 76. .............. ............. ........ 31 77- 80. .............. ............. ........ 32 81- 83. .............. ............. ........ 33 84- 87. .............. ............. ........ 34 88- 91 (3 mos.) . ............. ........ 35 92- 94. .............. ............. ........ 36 95- 98. .............. ............. ........ 37 99-102 .............. ............. ........ 38 103-105.............. ............. ........ 39\n\n106-109............. .............. ........ 40 110-113............. .............. ........ 41 114-116............. .............. ........ 42 117-120............. .............. ........ 43 121-124 (4 mos.).............. ........ 44 125-127............. .............. ........ 45 128-131............. .............. ........ 46 132-135............. .............. ........ 47 136-138............. .............. ........ 48 139-142............. .............. ........ 49 143-146............. .............. ........ 50 147-149............. .............. ........ 51 150-153 (5 mos.).............. ........ 52 154-156............. .............. ........ 53 157-160............. .............. ........ 54 161-164............. .............. ........ 55 165-167............. .............. ........ 56 168-171............. .............. ........ 57 172-175............. .............. ........ 58 176-178............. .............. ........ 59 179-182 (6 mos.).............. ........ 60 183-187............. .............. ........ 61 188-191............. .............. ........ 62 192-196............. .............. ........ 63 197-200............. .............. ........ 64 201-205............. .............. ........ 65 206-209............. .............. ........ 66 210-214 (7 mos.).............. ........ 67 215-218............. .............. ........ 68 219-223............. .............. ........ 69 224-228............. .............. ........ 70 229-232............. .............. ........ 71 233-237............. .............. ........ 72 238-241............. .............. ........ 73 242-246 (8 mos.).............. ........ 74\n\n247-250 ............. ............. ......... 75 251-255 ............. ............. ......... 76 256-260 ............. ............. ......... 77 261-264 ............. ............. ......... 78 265-269 ............. ............. ......... 79 270-273 (9 mos.)............. ......... 80 274-278 ............. ............. ......... 81 279-282 ............. ............. ......... 82 283-287 ............. ............. ......... 83 288-291 ............. ............. ......... 84 292-296 ............. ............. ......... 85 297-301 ............. ............. ......... 86 302-305 (10 mos.)........... ......... 87 306-310 ............. ............. ......... 88 311-314 ............. ............. ......... 89 315-319 ............. ............. ......... 90 320-323 ............. ............. ......... 91 324-328 ............. ............. ......... 92 329-332 ............. ............. ......... 93 333-337 (11 mos.)........... ......... 94 338-342 ............. ............. ......... 95 343-346 ............. ............. ......... 96 347-351 ............. ............. ......... 97 352-355 ............. ............. ......... 98 356-360 ............. ............. ......... 99 361-365 (12 mos.)........... ........100","publish_date":null,"title":"CALIFORNIA WORKERS COMPENSATION AND EMPLOYERS LIABILITY INSURANCE MANUAL 14th Reprint Effective February 1, 2009 Page R-37 _____________________________________________________________________________________________ f. Short rate","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page283.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page283.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page283","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page283.pdf"},"started_at":"2026-11-04T19:47:01.609374"} +{"completed_at":"2026-11-04T19:47:05.404213","latency_in_ms":2785,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2861","grounded_pages":[],"layout_pages":[],"markdown":"**Greenwich Insurance Company Real Estate Professionals Risk Purchasing Association**\n\n**Real Estate Errors and Omissions California**\n\n**_Value Rating Plan_**\n\n**Base Rate** $668\n\n**Required Rating Factors**\n\n_Limit/Deductible Factor_\n\n$2,500 $5,000 $10,000 $15,000 $25,000 $50,000\n\n1\\.000 0.824 0.717 0.667 0.603 0.506\n\n1\\.046 0.882 0.767 0.714 0.645 0.541\n\n1\\.127 0.949 0.826 0.768 0.695 0.583\n\n1\\.203 1.014 0.882 0.820 0.742 0.622\n\n1\\.267 1.067 0.929 0.864 0.781 0.655\n\n1\\.362 1.148 0.999 0.929 0.840 0.705\n\n1\\.410 1.188 1.034 0.962 0.869 0.730\n\n1\\.565 1.318 1.147 1.067 n/a n/a\n\n_Claims Modification Factor Average Revenue per Agent Factor_\n\n1-10 11-15 Factor\n\n$0 0.95 0.90 0.830\n\n$1 -- $5,000 1.00 0.95 $50,001 -- $60,000 0.890\n\n$5,001 -- $10,000 1.05 1.00 $60,001 -- $70,000 0.940\n\n$10,001 -- $20,000 1.10 1.05 $70,001 -- $85,000 1.000\n\n$20,001 -- $30,000 1.15 1.10 $85,001 -- $100,000 1.060\n\n$30,001 -- $45,000 1.20 1.15 $100,001 -- $125,000 1.110\n\n$45,001 -- $60,000 1.25 1.20 $125,001 -- $150,000 1.180\n\n$60,001 -- $75,000 1.30 1.25 $150,001 -- $175,000 1.240\n\n$75,001 -- $100,000 1.30 1.30 $175,001 -- $200,000 1.290\n\n$100,001 -- $125,000 1.30 1.30 $200,001 -- $250,000 1.350\n\n$125,001 -- $150,000 1.30 1.30 $250,001 -- $400,000 1.450\n\n1\\.30 1.30 $400,001 -- $600,000 1.580\n\n$600,001 -- $800,000 1.650 1.740\n\n_Non-residential Exposure Factor_\n\nFactor _Size of Firm Factor_\n\n0% -- 5% 1.000\n\n6% -- 10% 1.100 Factor\n\n11% -- 15% 1.150 1 -- 3 1.000\n\n16% -- 20% 1.200 4 -- 5 0.950\n\n21% -- 25% 1.250 6 -- 10 0.900\n\n26% -- 30% 1.300 11 -- 15 0.850\n\n31% -- 35% 1.350\n\n36% -- 40% 1.400\n\nDeductible\n\nBelow $50,000\n\n$500,000 / $500,000\n\n$2,000,000 / $2,000,000 $1,000,000 / $3,000,000\n\nSize of Firm Average Revenue\n\nper Agent\n\nTotal Incurred Claims\n\nLast Five Years\n\n$500,000 / $1,000,000 $1,000,000 / $1,000,000 $1,000,000 / $2,000,000\n\nNon-Residential Exposure\n\nTotal Sales Staff\n\nOver $150,000\n\nOver $800,000\n\nLimit/Aggregate\n\n$250,000 / $250,000 $250,000 / $500,000\n\nMay not be copied without permission. 1 of 6","pages":[{"line_numbers":[],"markdown":"**Greenwich Insurance Company Real Estate Professionals Risk Purchasing Association**\n\n**Real Estate Errors and Omissions California**\n\n**_Value Rating Plan_**\n\n**Base Rate** $668\n\n**Required Rating Factors**\n\n_Limit/Deductible Factor_\n\n$2,500 $5,000 $10,000 $15,000 $25,000 $50,000\n\n1\\.000 0.824 0.717 0.667 0.603 0.506\n\n1\\.046 0.882 0.767 0.714 0.645 0.541\n\n1\\.127 0.949 0.826 0.768 0.695 0.583\n\n1\\.203 1.014 0.882 0.820 0.742 0.622\n\n1\\.267 1.067 0.929 0.864 0.781 0.655\n\n1\\.362 1.148 0.999 0.929 0.840 0.705\n\n1\\.410 1.188 1.034 0.962 0.869 0.730\n\n1\\.565 1.318 1.147 1.067 n/a n/a\n\n_Claims Modification Factor Average Revenue per Agent Factor_\n\n1-10 11-15 Factor\n\n$0 0.95 0.90 0.830\n\n$1 -- $5,000 1.00 0.95 $50,001 -- $60,000 0.890\n\n$5,001 -- $10,000 1.05 1.00 $60,001 -- $70,000 0.940\n\n$10,001 -- $20,000 1.10 1.05 $70,001 -- $85,000 1.000\n\n$20,001 -- $30,000 1.15 1.10 $85,001 -- $100,000 1.060\n\n$30,001 -- $45,000 1.20 1.15 $100,001 -- $125,000 1.110\n\n$45,001 -- $60,000 1.25 1.20 $125,001 -- $150,000 1.180\n\n$60,001 -- $75,000 1.30 1.25 $150,001 -- $175,000 1.240\n\n$75,001 -- $100,000 1.30 1.30 $175,001 -- $200,000 1.290\n\n$100,001 -- $125,000 1.30 1.30 $200,001 -- $250,000 1.350\n\n$125,001 -- $150,000 1.30 1.30 $250,001 -- $400,000 1.450\n\n1\\.30 1.30 $400,001 -- $600,000 1.580\n\n$600,001 -- $800,000 1.650 1.740\n\n_Non-residential Exposure Factor_\n\nFactor _Size of Firm Factor_\n\n0% -- 5% 1.000\n\n6% -- 10% 1.100 Factor\n\n11% -- 15% 1.150 1 -- 3 1.000\n\n16% -- 20% 1.200 4 -- 5 0.950\n\n21% -- 25% 1.250 6 -- 10 0.900\n\n26% -- 30% 1.300 11 -- 15 0.850\n\n31% -- 35% 1.350\n\n36% -- 40% 1.400\n\nDeductible\n\nBelow $50,000\n\n$500,000 / $500,000\n\n$2,000,000 / $2,000,000 $1,000,000 / $3,000,000\n\nSize of Firm Average Revenue\n\nper Agent\n\nTotal Incurred Claims\n\nLast Five Years\n\n$500,000 / $1,000,000 $1,000,000 / $1,000,000 $1,000,000 / $2,000,000\n\nNon-Residential Exposure\n\nTotal Sales Staff\n\nOver $150,000\n\nOver $800,000\n\nLimit/Aggregate\n\n$250,000 / $250,000 $250,000 / $500,000\n\nMay not be copied without permission. 1 of 6","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Greenwich Insurance Company Real Estate Professionals Risk Purchasing Association**\n\n**Real Estate Errors and Omissions California**\n\n**_Value Rating Plan_**\n\n**Base Rate** $668\n\n**Required Rating Factors**\n\n_Limit/Deductible Factor_\n\n$2,500 $5,000 $10,000 $15,000 $25,000 $50,000\n\n1\\.000 0.824 0.717 0.667 0.603 0.506\n\n1\\.046 0.882 0.767 0.714 0.645 0.541\n\n1\\.127 0.949 0.826 0.768 0.695 0.583\n\n1\\.203 1.014 0.882 0.820 0.742 0.622\n\n1\\.267 1.067 0.929 0.864 0.781 0.655\n\n1\\.362 1.148 0.999 0.929 0.840 0.705\n\n1\\.410 1.188 1.034 0.962 0.869 0.730\n\n1\\.565 1.318 1.147 1.067 n/a n/a\n\n_Claims Modification Factor Average Revenue per Agent Factor_\n\n1-10 11-15 Factor\n\n$0 0.95 0.90 0.830\n\n$1 -- $5,000 1.00 0.95 $50,001 -- $60,000 0.890\n\n$5,001 -- $10,000 1.05 1.00 $60,001 -- $70,000 0.940\n\n$10,001 -- $20,000 1.10 1.05 $70,001 -- $85,000 1.000\n\n$20,001 -- $30,000 1.15 1.10 $85,001 -- $100,000 1.060\n\n$30,001 -- $45,000 1.20 1.15 $100,001 -- $125,000 1.110\n\n$45,001 -- $60,000 1.25 1.20 $125,001 -- $150,000 1.180\n\n$60,001 -- $75,000 1.30 1.25 $150,001 -- $175,000 1.240\n\n$75,001 -- $100,000 1.30 1.30 $175,001 -- $200,000 1.290\n\n$100,001 -- $125,000 1.30 1.30 $200,001 -- $250,000 1.350\n\n$125,001 -- $150,000 1.30 1.30 $250,001 -- $400,000 1.450\n\n1\\.30 1.30 $400,001 -- $600,000 1.580\n\n$600,001 -- $800,000 1.650 1.740\n\n_Non-residential Exposure Factor_\n\nFactor _Size of Firm Factor_\n\n0% -- 5% 1.000\n\n6% -- 10% 1.100 Factor\n\n11% -- 15% 1.150 1 -- 3 1.000\n\n16% -- 20% 1.200 4 -- 5 0.950\n\n21% -- 25% 1.250 6 -- 10 0.900\n\n26% -- 30% 1.300 11 -- 15 0.850\n\n31% -- 35% 1.350\n\n36% -- 40% 1.400\n\nDeductible\n\nBelow $50,000\n\n$500,000 / $500,000\n\n$2,000,000 / $2,000,000 $1,000,000 / $3,000,000\n\nSize of Firm Average Revenue\n\nper Agent\n\nTotal Incurred Claims\n\nLast Five Years\n\n$500,000 / $1,000,000 $1,000,000 / $1,000,000 $1,000,000 / $2,000,000\n\nNon-Residential Exposure\n\nTotal Sales Staff\n\nOver $150,000\n\nOver $800,000\n\nLimit/Aggregate\n\n$250,000 / $250,000 $250,000 / $500,000\n\nMay not be copied without permission. 1 of 6","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2861.pdf"]},"response":{"errors":[],"extract_id":"extract_fbea8a5e0ed378f5c07b2390afe8932a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Greenwich Insurance Company Real Estate Professionals Risk Purchasing Association**\n\n**Real Estate Errors and Omissions California**\n\n**_Value Rating Plan_**\n\n**Base Rate** $668\n\n**Required Rating Factors**\n\n_Limit/Deductible Factor_\n\n$2,500 $5,000 $10,000 $15,000 $25,000 $50,000\n\n1\\.000 0.824 0.717 0.667 0.603 0.506\n\n1\\.046 0.882 0.767 0.714 0.645 0.541\n\n1\\.127 0.949 0.826 0.768 0.695 0.583\n\n1\\.203 1.014 0.882 0.820 0.742 0.622\n\n1\\.267 1.067 0.929 0.864 0.781 0.655\n\n1\\.362 1.148 0.999 0.929 0.840 0.705\n\n1\\.410 1.188 1.034 0.962 0.869 0.730\n\n1\\.565 1.318 1.147 1.067 n/a n/a\n\n_Claims Modification Factor Average Revenue per Agent Factor_\n\n1-10 11-15 Factor\n\n$0 0.95 0.90 0.830\n\n$1 -- $5,000 1.00 0.95 $50,001 -- $60,000 0.890\n\n$5,001 -- $10,000 1.05 1.00 $60,001 -- $70,000 0.940\n\n$10,001 -- $20,000 1.10 1.05 $70,001 -- $85,000 1.000\n\n$20,001 -- $30,000 1.15 1.10 $85,001 -- $100,000 1.060\n\n$30,001 -- $45,000 1.20 1.15 $100,001 -- $125,000 1.110\n\n$45,001 -- $60,000 1.25 1.20 $125,001 -- $150,000 1.180\n\n$60,001 -- $75,000 1.30 1.25 $150,001 -- $175,000 1.240\n\n$75,001 -- $100,000 1.30 1.30 $175,001 -- $200,000 1.290\n\n$100,001 -- $125,000 1.30 1.30 $200,001 -- $250,000 1.350\n\n$125,001 -- $150,000 1.30 1.30 $250,001 -- $400,000 1.450\n\n1\\.30 1.30 $400,001 -- $600,000 1.580\n\n$600,001 -- $800,000 1.650 1.740\n\n_Non-residential Exposure Factor_\n\nFactor _Size of Firm Factor_\n\n0% -- 5% 1.000\n\n6% -- 10% 1.100 Factor\n\n11% -- 15% 1.150 1 -- 3 1.000\n\n16% -- 20% 1.200 4 -- 5 0.950\n\n21% -- 25% 1.250 6 -- 10 0.900\n\n26% -- 30% 1.300 11 -- 15 0.850\n\n31% -- 35% 1.350\n\n36% -- 40% 1.400\n\nDeductible\n\nBelow $50,000\n\n$500,000 / $500,000\n\n$2,000,000 / $2,000,000 $1,000,000 / $3,000,000\n\nSize of Firm Average Revenue\n\nper Agent\n\nTotal Incurred Claims\n\nLast Five Years\n\n$500,000 / $1,000,000 $1,000,000 / $1,000,000 $1,000,000 / $2,000,000\n\nNon-Residential Exposure\n\nTotal Sales Staff\n\nOver $150,000\n\nOver $800,000\n\nLimit/Aggregate\n\n$250,000 / $250,000 $250,000 / $500,000\n\nMay not be copied without permission. 1 of 6"],"full_content":"**Greenwich Insurance Company Real Estate Professionals Risk Purchasing Association**\n\n**Real Estate Errors and Omissions California**\n\n**_Value Rating Plan_**\n\n**Base Rate** $668\n\n**Required Rating Factors**\n\n_Limit/Deductible Factor_\n\n$2,500 $5,000 $10,000 $15,000 $25,000 $50,000\n\n1\\.000 0.824 0.717 0.667 0.603 0.506\n\n1\\.046 0.882 0.767 0.714 0.645 0.541\n\n1\\.127 0.949 0.826 0.768 0.695 0.583\n\n1\\.203 1.014 0.882 0.820 0.742 0.622\n\n1\\.267 1.067 0.929 0.864 0.781 0.655\n\n1\\.362 1.148 0.999 0.929 0.840 0.705\n\n1\\.410 1.188 1.034 0.962 0.869 0.730\n\n1\\.565 1.318 1.147 1.067 n/a n/a\n\n_Claims Modification Factor Average Revenue per Agent Factor_\n\n1-10 11-15 Factor\n\n$0 0.95 0.90 0.830\n\n$1 -- $5,000 1.00 0.95 $50,001 -- $60,000 0.890\n\n$5,001 -- $10,000 1.05 1.00 $60,001 -- $70,000 0.940\n\n$10,001 -- $20,000 1.10 1.05 $70,001 -- $85,000 1.000\n\n$20,001 -- $30,000 1.15 1.10 $85,001 -- $100,000 1.060\n\n$30,001 -- $45,000 1.20 1.15 $100,001 -- $125,000 1.110\n\n$45,001 -- $60,000 1.25 1.20 $125,001 -- $150,000 1.180\n\n$60,001 -- $75,000 1.30 1.25 $150,001 -- $175,000 1.240\n\n$75,001 -- $100,000 1.30 1.30 $175,001 -- $200,000 1.290\n\n$100,001 -- $125,000 1.30 1.30 $200,001 -- $250,000 1.350\n\n$125,001 -- $150,000 1.30 1.30 $250,001 -- $400,000 1.450\n\n1\\.30 1.30 $400,001 -- $600,000 1.580\n\n$600,001 -- $800,000 1.650 1.740\n\n_Non-residential Exposure Factor_\n\nFactor _Size of Firm Factor_\n\n0% -- 5% 1.000\n\n6% -- 10% 1.100 Factor\n\n11% -- 15% 1.150 1 -- 3 1.000\n\n16% -- 20% 1.200 4 -- 5 0.950\n\n21% -- 25% 1.250 6 -- 10 0.900\n\n26% -- 30% 1.300 11 -- 15 0.850\n\n31% -- 35% 1.350\n\n36% -- 40% 1.400\n\nDeductible\n\nBelow $50,000\n\n$500,000 / $500,000\n\n$2,000,000 / $2,000,000 $1,000,000 / $3,000,000\n\nSize of Firm Average Revenue\n\nper Agent\n\nTotal Incurred Claims\n\nLast Five Years\n\n$500,000 / $1,000,000 $1,000,000 / $1,000,000 $1,000,000 / $2,000,000\n\nNon-Residential Exposure\n\nTotal Sales Staff\n\nOver $150,000\n\nOver $800,000\n\nLimit/Aggregate\n\n$250,000 / $250,000 $250,000 / $500,000\n\nMay not be copied without permission. 1 of 6","publish_date":null,"title":"Greenwich Insurance Company Real Estate Professionals Risk Purchasing Association Real Estate Errors and Omissions California","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2861.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2861.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2861","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2861.pdf"},"started_at":"2026-11-04T19:47:02.619128"} +{"completed_at":"2026-11-04T19:47:05.639759","latency_in_ms":1447,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2867","grounded_pages":[],"layout_pages":[],"markdown":"**State of California Company: Greenwich Insurance Company**\n\n**Department of Insurance (CDI) Line: Other Liability**\n\n## **ADDITIONAL CALENDAR YEAR DATA REQUIRED BY STATUTE**\n\n_Refer to CIC §1857.7, CIC §1857.9 and CIC §1864 for more information._\n\n**Line Type of Data Most Recent Calendar**\n\n**Year**\n\n(0) **Calendar Year 2015**\n\n(1) Number of claims outstanding at beginning of year 5\n\n(2) Number of claims during the year 8\n\n(3) Number of claims closed during the year 6\n\n(4) Number of claims outstanding at year's end [ (1) + (2) - (3) ] 7\n\n(5) Unearned Premiums $215,444\n\n(6) Dollar amount of claims paid $375,926\n\n(7) Net loss reserves for outstanding claims excluding claims incurred but not reported (case reserves) $212,609\n\n(8) Net loss reserves for claims incurred but not reported (IBNR) $71,597.01\n\n(9) Losses incurred as a percentage of premiums earned, including IBNR 248.8%\n\n(10) Net investment gain or loss and other income or gain or loss allocated to the line $10,614\n\n(11) Net income before federal and foreign income taxes [ (10) + (15) ] ($312,560)\n\n(12) Total number of policies in force on the last day of the reporting period 248\n\n(13) Total number of policies canceled 9\n\n(14) Total number of policies non-renewed 44\n\n(15) Net underwriting gain or loss ( = CY earned premiums less CY incurred loss less CY incurred expense ) ($323,174.84)\n\n(16) Separate allocations of expenses for:\n\n(17) (a) commissions and brokerage expense $76,761\n\n(18) (b) other acquisition costs $0\n\n(19) (c) general office expenses $19,776\n\n(20) (d) taxes, licenses and fees $7,447\n\n(21) (e) loss adjustment expense (DCCE & AOE) included in 7-9\n\n(22) (f) other expenses\n\nPrior Approval Rate Application Page 7 4/29/2016 Edition","pages":[{"line_numbers":[],"markdown":"**State of California Company: Greenwich Insurance Company**\n\n**Department of Insurance (CDI) Line: Other Liability**\n\n## **ADDITIONAL CALENDAR YEAR DATA REQUIRED BY STATUTE**\n\n_Refer to CIC §1857.7, CIC §1857.9 and CIC §1864 for more information._\n\n**Line Type of Data Most Recent Calendar**\n\n**Year**\n\n(0) **Calendar Year 2015**\n\n(1) Number of claims outstanding at beginning of year 5\n\n(2) Number of claims during the year 8\n\n(3) Number of claims closed during the year 6\n\n(4) Number of claims outstanding at year's end [ (1) + (2) - (3) ] 7\n\n(5) Unearned Premiums $215,444\n\n(6) Dollar amount of claims paid $375,926\n\n(7) Net loss reserves for outstanding claims excluding claims incurred but not reported (case reserves) $212,609\n\n(8) Net loss reserves for claims incurred but not reported (IBNR) $71,597.01\n\n(9) Losses incurred as a percentage of premiums earned, including IBNR 248.8%\n\n(10) Net investment gain or loss and other income or gain or loss allocated to the line $10,614\n\n(11) Net income before federal and foreign income taxes [ (10) + (15) ] ($312,560)\n\n(12) Total number of policies in force on the last day of the reporting period 248\n\n(13) Total number of policies canceled 9\n\n(14) Total number of policies non-renewed 44\n\n(15) Net underwriting gain or loss ( = CY earned premiums less CY incurred loss less CY incurred expense ) ($323,174.84)\n\n(16) Separate allocations of expenses for:\n\n(17) (a) commissions and brokerage expense $76,761\n\n(18) (b) other acquisition costs $0\n\n(19) (c) general office expenses $19,776\n\n(20) (d) taxes, licenses and fees $7,447\n\n(21) (e) loss adjustment expense (DCCE & AOE) included in 7-9\n\n(22) (f) other expenses\n\nPrior Approval Rate Application Page 7 4/29/2016 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**State of California Company: Greenwich Insurance Company**\n\n**Department of Insurance (CDI) Line: Other Liability**\n\n## **ADDITIONAL CALENDAR YEAR DATA REQUIRED BY STATUTE**\n\n_Refer to CIC §1857.7, CIC §1857.9 and CIC §1864 for more information._\n\n**Line Type of Data Most Recent Calendar**\n\n**Year**\n\n(0) **Calendar Year 2015**\n\n(1) Number of claims outstanding at beginning of year 5\n\n(2) Number of claims during the year 8\n\n(3) Number of claims closed during the year 6\n\n(4) Number of claims outstanding at year's end [ (1) + (2) - (3) ] 7\n\n(5) Unearned Premiums $215,444\n\n(6) Dollar amount of claims paid $375,926\n\n(7) Net loss reserves for outstanding claims excluding claims incurred but not reported (case reserves) $212,609\n\n(8) Net loss reserves for claims incurred but not reported (IBNR) $71,597.01\n\n(9) Losses incurred as a percentage of premiums earned, including IBNR 248.8%\n\n(10) Net investment gain or loss and other income or gain or loss allocated to the line $10,614\n\n(11) Net income before federal and foreign income taxes [ (10) + (15) ] ($312,560)\n\n(12) Total number of policies in force on the last day of the reporting period 248\n\n(13) Total number of policies canceled 9\n\n(14) Total number of policies non-renewed 44\n\n(15) Net underwriting gain or loss ( = CY earned premiums less CY incurred loss less CY incurred expense ) ($323,174.84)\n\n(16) Separate allocations of expenses for:\n\n(17) (a) commissions and brokerage expense $76,761\n\n(18) (b) other acquisition costs $0\n\n(19) (c) general office expenses $19,776\n\n(20) (d) taxes, licenses and fees $7,447\n\n(21) (e) loss adjustment expense (DCCE & AOE) included in 7-9\n\n(22) (f) other expenses\n\nPrior Approval Rate Application Page 7 4/29/2016 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2867.pdf"]},"response":{"errors":[],"extract_id":"extract_dfaff4dbbfd80499affebfcadd3bbe59","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**State of California Company: Greenwich Insurance Company**\n\n**Department of Insurance (CDI) Line: Other Liability**\n\n## **ADDITIONAL CALENDAR YEAR DATA REQUIRED BY STATUTE**\n\n_Refer to CIC §1857.7, CIC §1857.9 and CIC §1864 for more information._\n\n**Line Type of Data Most Recent Calendar**\n\n**Year**\n\n(0) **Calendar Year 2015**\n\n(1) Number of claims outstanding at beginning of year 5\n\n(2) Number of claims during the year 8\n\n(3) Number of claims closed during the year 6\n\n(4) Number of claims outstanding at year's end [ (1) + (2) - (3) ] 7\n\n(5) Unearned Premiums $215,444\n\n(6) Dollar amount of claims paid $375,926\n\n(7) Net loss reserves for outstanding claims excluding claims incurred but not reported (case reserves) $212,609\n\n(8) Net loss reserves for claims incurred but not reported (IBNR) $71,597.01\n\n(9) Losses incurred as a percentage of premiums earned, including IBNR 248.8%\n\n(10) Net investment gain or loss and other income or gain or loss allocated to the line $10,614\n\n(11) Net income before federal and foreign income taxes [ (10) + (15) ] ($312,560)\n\n(12) Total number of policies in force on the last day of the reporting period 248\n\n(13) Total number of policies canceled 9\n\n(14) Total number of policies non-renewed 44\n\n(15) Net underwriting gain or loss ( = CY earned premiums less CY incurred loss less CY incurred expense ) ($323,174.84)\n\n(16) Separate allocations of expenses for:\n\n(17) (a) commissions and brokerage expense $76,761\n\n(18) (b) other acquisition costs $0\n\n(19) (c) general office expenses $19,776\n\n(20) (d) taxes, licenses and fees $7,447\n\n(21) (e) loss adjustment expense (DCCE & AOE) included in 7-9\n\n(22) (f) other expenses\n\nPrior Approval Rate Application Page 7 4/29/2016 Edition"],"full_content":"**State of California Company: Greenwich Insurance Company**\n\n**Department of Insurance (CDI) Line: Other Liability**\n\n## **ADDITIONAL CALENDAR YEAR DATA REQUIRED BY STATUTE**\n\n_Refer to CIC §1857.7, CIC §1857.9 and CIC §1864 for more information._\n\n**Line Type of Data Most Recent Calendar**\n\n**Year**\n\n(0) **Calendar Year 2015**\n\n(1) Number of claims outstanding at beginning of year 5\n\n(2) Number of claims during the year 8\n\n(3) Number of claims closed during the year 6\n\n(4) Number of claims outstanding at year's end [ (1) + (2) - (3) ] 7\n\n(5) Unearned Premiums $215,444\n\n(6) Dollar amount of claims paid $375,926\n\n(7) Net loss reserves for outstanding claims excluding claims incurred but not reported (case reserves) $212,609\n\n(8) Net loss reserves for claims incurred but not reported (IBNR) $71,597.01\n\n(9) Losses incurred as a percentage of premiums earned, including IBNR 248.8%\n\n(10) Net investment gain or loss and other income or gain or loss allocated to the line $10,614\n\n(11) Net income before federal and foreign income taxes [ (10) + (15) ] ($312,560)\n\n(12) Total number of policies in force on the last day of the reporting period 248\n\n(13) Total number of policies canceled 9\n\n(14) Total number of policies non-renewed 44\n\n(15) Net underwriting gain or loss ( = CY earned premiums less CY incurred loss less CY incurred expense ) ($323,174.84)\n\n(16) Separate allocations of expenses for:\n\n(17) (a) commissions and brokerage expense $76,761\n\n(18) (b) other acquisition costs $0\n\n(19) (c) general office expenses $19,776\n\n(20) (d) taxes, licenses and fees $7,447\n\n(21) (e) loss adjustment expense (DCCE & AOE) included in 7-9\n\n(22) (f) other expenses\n\nPrior Approval Rate Application Page 7 4/29/2016 Edition","publish_date":null,"title":"ADDITIONAL CALENDAR YEAR DATA REQUIRED BY STATUTE","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2867.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2867.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2867","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2867.pdf"},"started_at":"2026-11-04T19:47:04.192622"} +{"completed_at":"2026-11-04T19:47:07.864501","latency_in_ms":2438,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2884","grounded_pages":[],"layout_pages":[],"markdown":"**Group Name: NAIC Group Code: 212**\n\n**Company Name (s): NAIC Company Code: 19356**\n\nas it appears in the **19305**\n\nfiling application **19372**\n\n**40142**\n\n**Countrywide Direct Earned Premium for Prop 103 Lines of Business for the Group**\n\n**Group Cash & Salary Bonus Total Cash & Salary Total Cash & Salary**\n\n**1st Highest Paid** 1,249,072 $ $ 600,000 1,849,072 $ 1,283,755 $ 3,570,580 $ 1,021,712 $\n\n**2nd Highest Paid** $ 881,260 $ 108,945 $ 990,205 $ 448,720 1,312,459 $ 782,716 $\n\n**3rd Highest Paid** $ 479,085 $ 372,300 $ 851,385 $ 427,600 1,080,216 $ 1,019,148 $\n\n**4th Highest Paid** $ 544,357 $ 179,339 $ 723,696 $ 571,819 1,034,090 $ 846,472 $\n\n**5th Highest Paid** $ 555,521 74,085 $ $ 629,606 $ 506,305 $ 972,595 494,725 $\n\n**(Section 2644.10 and 2646.3 of the California Code of Regulations)**\n\n# **State of California**\n\n## **Department of Insurance**\n\n## **EXECUTIVE COMPENSATION EXHIBIT**\n\n(Total Cash Paid, including Salary & Bonus)\n\n**2005**\n\n**9,764,427,245 $ $ 9,294,483,975 9,323,190,850 $**\n\n**Bonus**\n\n**Zurich North America**\n\n**Maryland Casualty Company**\n\n**2003 2004**\n\n**Assurance Company of America**\n\n**Northern Insurance Company of New York**\n\n**American Zurich Insurance Company**\n\n466,290 $\n\n652,616 $\n\n462,271 $\n\n$ 2,767,172\n\n$ 1,944,370\n\n$ 1,821,472\n\n$ 1,620,270 $ 1,125,545\n\n2,286,825 $\n\n863,739 $\n\n**Bonus Total**\n\n$ 2,944,670\n\n**Stock Co. Mutual Co. Reciprocal Co.**\n\n$ 1,922,958\n\n$ 1,984,456\n\n$ 925,222\n\n$ 975,000\n\nCDI - RATE REGULATION BRANCH - MARCH 2004 EXECUTIVE COMPENSATION EXHIBIT","pages":[{"line_numbers":[],"markdown":"**Group Name: NAIC Group Code: 212**\n\n**Company Name (s): NAIC Company Code: 19356**\n\nas it appears in the **19305**\n\nfiling application **19372**\n\n**40142**\n\n**Countrywide Direct Earned Premium for Prop 103 Lines of Business for the Group**\n\n**Group Cash & Salary Bonus Total Cash & Salary Total Cash & Salary**\n\n**1st Highest Paid** 1,249,072 $ $ 600,000 1,849,072 $ 1,283,755 $ 3,570,580 $ 1,021,712 $\n\n**2nd Highest Paid** $ 881,260 $ 108,945 $ 990,205 $ 448,720 1,312,459 $ 782,716 $\n\n**3rd Highest Paid** $ 479,085 $ 372,300 $ 851,385 $ 427,600 1,080,216 $ 1,019,148 $\n\n**4th Highest Paid** $ 544,357 $ 179,339 $ 723,696 $ 571,819 1,034,090 $ 846,472 $\n\n**5th Highest Paid** $ 555,521 74,085 $ $ 629,606 $ 506,305 $ 972,595 494,725 $\n\n**(Section 2644.10 and 2646.3 of the California Code of Regulations)**\n\n# **State of California**\n\n## **Department of Insurance**\n\n## **EXECUTIVE COMPENSATION EXHIBIT**\n\n(Total Cash Paid, including Salary & Bonus)\n\n**2005**\n\n**9,764,427,245 $ $ 9,294,483,975 9,323,190,850 $**\n\n**Bonus**\n\n**Zurich North America**\n\n**Maryland Casualty Company**\n\n**2003 2004**\n\n**Assurance Company of America**\n\n**Northern Insurance Company of New York**\n\n**American Zurich Insurance Company**\n\n466,290 $\n\n652,616 $\n\n462,271 $\n\n$ 2,767,172\n\n$ 1,944,370\n\n$ 1,821,472\n\n$ 1,620,270 $ 1,125,545\n\n2,286,825 $\n\n863,739 $\n\n**Bonus Total**\n\n$ 2,944,670\n\n**Stock Co. Mutual Co. Reciprocal Co.**\n\n$ 1,922,958\n\n$ 1,984,456\n\n$ 925,222\n\n$ 975,000\n\nCDI - RATE REGULATION BRANCH - MARCH 2004 EXECUTIVE COMPENSATION EXHIBIT","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Group Name: NAIC Group Code: 212**\n\n**Company Name (s): NAIC Company Code: 19356**\n\nas it appears in the **19305**\n\nfiling application **19372**\n\n**40142**\n\n**Countrywide Direct Earned Premium for Prop 103 Lines of Business for the Group**\n\n**Group Cash & Salary Bonus Total Cash & Salary Total Cash & Salary**\n\n**1st Highest Paid** 1,249,072 $ $ 600,000 1,849,072 $ 1,283,755 $ 3,570,580 $ 1,021,712 $\n\n**2nd Highest Paid** $ 881,260 $ 108,945 $ 990,205 $ 448,720 1,312,459 $ 782,716 $\n\n**3rd Highest Paid** $ 479,085 $ 372,300 $ 851,385 $ 427,600 1,080,216 $ 1,019,148 $\n\n**4th Highest Paid** $ 544,357 $ 179,339 $ 723,696 $ 571,819 1,034,090 $ 846,472 $\n\n**5th Highest Paid** $ 555,521 74,085 $ $ 629,606 $ 506,305 $ 972,595 494,725 $\n\n**(Section 2644.10 and 2646.3 of the California Code of Regulations)**\n\n# **State of California**\n\n## **Department of Insurance**\n\n## **EXECUTIVE COMPENSATION EXHIBIT**\n\n(Total Cash Paid, including Salary & Bonus)\n\n**2005**\n\n**9,764,427,245 $ $ 9,294,483,975 9,323,190,850 $**\n\n**Bonus**\n\n**Zurich North America**\n\n**Maryland Casualty Company**\n\n**2003 2004**\n\n**Assurance Company of America**\n\n**Northern Insurance Company of New York**\n\n**American Zurich Insurance Company**\n\n466,290 $\n\n652,616 $\n\n462,271 $\n\n$ 2,767,172\n\n$ 1,944,370\n\n$ 1,821,472\n\n$ 1,620,270 $ 1,125,545\n\n2,286,825 $\n\n863,739 $\n\n**Bonus Total**\n\n$ 2,944,670\n\n**Stock Co. Mutual Co. Reciprocal Co.**\n\n$ 1,922,958\n\n$ 1,984,456\n\n$ 925,222\n\n$ 975,000\n\nCDI - RATE REGULATION BRANCH - MARCH 2004 EXECUTIVE COMPENSATION EXHIBIT","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2884.pdf"]},"response":{"errors":[],"extract_id":"extract_ba435b947c7c247fbc0887039b89858c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Group Name: NAIC Group Code: 212**\n\n**Company Name (s): NAIC Company Code: 19356**\n\nas it appears in the **19305**\n\nfiling application **19372**\n\n**40142**\n\n**Countrywide Direct Earned Premium for Prop 103 Lines of Business for the Group**\n\n**Group Cash & Salary Bonus Total Cash & Salary Total Cash & Salary**\n\n**1st Highest Paid** 1,249,072 $ $ 600,000 1,849,072 $ 1,283,755 $ 3,570,580 $ 1,021,712 $\n\n**2nd Highest Paid** $ 881,260 $ 108,945 $ 990,205 $ 448,720 1,312,459 $ 782,716 $\n\n**3rd Highest Paid** $ 479,085 $ 372,300 $ 851,385 $ 427,600 1,080,216 $ 1,019,148 $\n\n**4th Highest Paid** $ 544,357 $ 179,339 $ 723,696 $ 571,819 1,034,090 $ 846,472 $\n\n**5th Highest Paid** $ 555,521 74,085 $ $ 629,606 $ 506,305 $ 972,595 494,725 $\n\n**(Section 2644.10 and 2646.3 of the California Code of Regulations)**\n\n# **State of California**\n\n## **Department of Insurance**\n\n## **EXECUTIVE COMPENSATION EXHIBIT**\n\n(Total Cash Paid, including Salary & Bonus)\n\n**2005**\n\n**9,764,427,245 $ $ 9,294,483,975 9,323,190,850 $**\n\n**Bonus**\n\n**Zurich North America**\n\n**Maryland Casualty Company**\n\n**2003 2004**\n\n**Assurance Company of America**\n\n**Northern Insurance Company of New York**\n\n**American Zurich Insurance Company**\n\n466,290 $\n\n652,616 $\n\n462,271 $\n\n$ 2,767,172\n\n$ 1,944,370\n\n$ 1,821,472\n\n$ 1,620,270 $ 1,125,545\n\n2,286,825 $\n\n863,739 $\n\n**Bonus Total**\n\n$ 2,944,670\n\n**Stock Co. Mutual Co. Reciprocal Co.**\n\n$ 1,922,958\n\n$ 1,984,456\n\n$ 925,222\n\n$ 975,000\n\nCDI - RATE REGULATION BRANCH - MARCH 2004 EXECUTIVE COMPENSATION EXHIBIT"],"full_content":"**Group Name: NAIC Group Code: 212**\n\n**Company Name (s): NAIC Company Code: 19356**\n\nas it appears in the **19305**\n\nfiling application **19372**\n\n**40142**\n\n**Countrywide Direct Earned Premium for Prop 103 Lines of Business for the Group**\n\n**Group Cash & Salary Bonus Total Cash & Salary Total Cash & Salary**\n\n**1st Highest Paid** 1,249,072 $ $ 600,000 1,849,072 $ 1,283,755 $ 3,570,580 $ 1,021,712 $\n\n**2nd Highest Paid** $ 881,260 $ 108,945 $ 990,205 $ 448,720 1,312,459 $ 782,716 $\n\n**3rd Highest Paid** $ 479,085 $ 372,300 $ 851,385 $ 427,600 1,080,216 $ 1,019,148 $\n\n**4th Highest Paid** $ 544,357 $ 179,339 $ 723,696 $ 571,819 1,034,090 $ 846,472 $\n\n**5th Highest Paid** $ 555,521 74,085 $ $ 629,606 $ 506,305 $ 972,595 494,725 $\n\n**(Section 2644.10 and 2646.3 of the California Code of Regulations)**\n\n# **State of California**\n\n## **Department of Insurance**\n\n## **EXECUTIVE COMPENSATION EXHIBIT**\n\n(Total Cash Paid, including Salary & Bonus)\n\n**2005**\n\n**9,764,427,245 $ $ 9,294,483,975 9,323,190,850 $**\n\n**Bonus**\n\n**Zurich North America**\n\n**Maryland Casualty Company**\n\n**2003 2004**\n\n**Assurance Company of America**\n\n**Northern Insurance Company of New York**\n\n**American Zurich Insurance Company**\n\n466,290 $\n\n652,616 $\n\n462,271 $\n\n$ 2,767,172\n\n$ 1,944,370\n\n$ 1,821,472\n\n$ 1,620,270 $ 1,125,545\n\n2,286,825 $\n\n863,739 $\n\n**Bonus Total**\n\n$ 2,944,670\n\n**Stock Co. Mutual Co. Reciprocal Co.**\n\n$ 1,922,958\n\n$ 1,984,456\n\n$ 925,222\n\n$ 975,000\n\nCDI - RATE REGULATION BRANCH - MARCH 2004 EXECUTIVE COMPENSATION EXHIBIT","publish_date":null,"title":"State of California","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2884.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2884.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2884","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2884.pdf"},"started_at":"2026-11-04T19:47:05.425536"} +{"completed_at":"2026-11-04T19:47:07.481748","latency_in_ms":837,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2893","grounded_pages":[],"layout_pages":[],"markdown":"Page 1 of 1\n\nENTERTAINMENT PROGRAM COMMERCIAL AUTOMOBILE **SHORT TERM PRODUCTIONS** **RATES AND RULE MANUAL**\n\n**B. Short Term Production I Policy – Hired/Non-Owned Auto Rating Structure**\n\n**1\\. Hired/Non-Owned Auto Liability Coverage**\n\nLimit $1,000,000 Combined Single Limit.\n\n**Rating Base by Number of Days Liability Premium**\n\n1-10 319\n\n11-20 372\n\n21-30 426\n\n31-45 532\n\n46-60 691\n\n**2\\. Deductibles**\n\nNone\n\n**3\\. Increased Limits**\n\nFor increased limits, apply the following factors to the premium developed for the $1,000,000 limit.\n\n**Increased Limits of Liability Factor**\n\n$1,000,000 CSL 1.00\n\n$2,000,000 CSL 1.11\n\n$3,000,000 CSL 1.18\n\n$4,000,000 CSL 1.23\n\n$5,000,000 CSL 1.27","pages":[{"line_numbers":[],"markdown":"Page 1 of 1\n\nENTERTAINMENT PROGRAM COMMERCIAL AUTOMOBILE **SHORT TERM PRODUCTIONS** **RATES AND RULE MANUAL**\n\n**B. Short Term Production I Policy – Hired/Non-Owned Auto Rating Structure**\n\n**1\\. Hired/Non-Owned Auto Liability Coverage**\n\nLimit $1,000,000 Combined Single Limit.\n\n**Rating Base by Number of Days Liability Premium**\n\n1-10 319\n\n11-20 372\n\n21-30 426\n\n31-45 532\n\n46-60 691\n\n**2\\. Deductibles**\n\nNone\n\n**3\\. Increased Limits**\n\nFor increased limits, apply the following factors to the premium developed for the $1,000,000 limit.\n\n**Increased Limits of Liability Factor**\n\n$1,000,000 CSL 1.00\n\n$2,000,000 CSL 1.11\n\n$3,000,000 CSL 1.18\n\n$4,000,000 CSL 1.23\n\n$5,000,000 CSL 1.27","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Page 1 of 1\n\nENTERTAINMENT PROGRAM COMMERCIAL AUTOMOBILE **SHORT TERM PRODUCTIONS** **RATES AND RULE MANUAL**\n\n**B. Short Term Production I Policy – Hired/Non-Owned Auto Rating Structure**\n\n**1\\. Hired/Non-Owned Auto Liability Coverage**\n\nLimit $1,000,000 Combined Single Limit.\n\n**Rating Base by Number of Days Liability Premium**\n\n1-10 319\n\n11-20 372\n\n21-30 426\n\n31-45 532\n\n46-60 691\n\n**2\\. Deductibles**\n\nNone\n\n**3\\. Increased Limits**\n\nFor increased limits, apply the following factors to the premium developed for the $1,000,000 limit.\n\n**Increased Limits of Liability Factor**\n\n$1,000,000 CSL 1.00\n\n$2,000,000 CSL 1.11\n\n$3,000,000 CSL 1.18\n\n$4,000,000 CSL 1.23\n\n$5,000,000 CSL 1.27","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2893.pdf"]},"response":{"errors":[],"extract_id":"extract_85414a896e1156fe9623200e7f7cc253","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Page 1 of 1\n\nENTERTAINMENT PROGRAM COMMERCIAL AUTOMOBILE **SHORT TERM PRODUCTIONS** **RATES AND RULE MANUAL**\n\n**B. Short Term Production I Policy – Hired/Non-Owned Auto Rating Structure**\n\n**1\\. Hired/Non-Owned Auto Liability Coverage**\n\nLimit $1,000,000 Combined Single Limit.\n\n**Rating Base by Number of Days Liability Premium**\n\n1-10 319\n\n11-20 372\n\n21-30 426\n\n31-45 532\n\n46-60 691\n\n**2\\. Deductibles**\n\nNone\n\n**3\\. Increased Limits**\n\nFor increased limits, apply the following factors to the premium developed for the $1,000,000 limit.\n\n**Increased Limits of Liability Factor**\n\n$1,000,000 CSL 1.00\n\n$2,000,000 CSL 1.11\n\n$3,000,000 CSL 1.18\n\n$4,000,000 CSL 1.23\n\n$5,000,000 CSL 1.27"],"full_content":"Page 1 of 1\n\nENTERTAINMENT PROGRAM COMMERCIAL AUTOMOBILE **SHORT TERM PRODUCTIONS** **RATES AND RULE MANUAL**\n\n**B. Short Term Production I Policy – Hired/Non-Owned Auto Rating Structure**\n\n**1\\. Hired/Non-Owned Auto Liability Coverage**\n\nLimit $1,000,000 Combined Single Limit.\n\n**Rating Base by Number of Days Liability Premium**\n\n1-10 319\n\n11-20 372\n\n21-30 426\n\n31-45 532\n\n46-60 691\n\n**2\\. Deductibles**\n\nNone\n\n**3\\. Increased Limits**\n\nFor increased limits, apply the following factors to the premium developed for the $1,000,000 limit.\n\n**Increased Limits of Liability Factor**\n\n$1,000,000 CSL 1.00\n\n$2,000,000 CSL 1.11\n\n$3,000,000 CSL 1.18\n\n$4,000,000 CSL 1.23\n\n$5,000,000 CSL 1.27","publish_date":null,"title":"ENTERTAINMENT PROGRAM COMMERCIAL AUTOMOBILE SHORT TERM PRODUCTIONS RATES AND RULE MANUAL B. Short Term Production I Policy – Hired/Non-Owned Auto","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2893.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2893.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2893","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2893.pdf"},"started_at":"2026-11-04T19:47:06.644148"} +{"completed_at":"2026-11-04T19:47:08.522819","latency_in_ms":1032,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2905","grounded_pages":[],"layout_pages":[],"markdown":"11\n\n### UNIVERSAL UNDERWRITERS INSURANCE COMPANY VEHICLE SERVICE CONTRACT REIMBURSEMENT PROGRAM NEW VEHICLE PREMIUM\n\nCOVERAGE LEVEL: A ELIGIBLE VEHICLES: CHRYSLER, DODGE, JEEP vehicles, 2010 model year and newer DEDUCTIBLE: $100\n\n**Preferred Symbol 24/60 24/75 24/100 36/60 36/75 36/100 48/60 48/75 48/100 60/60 60/70 60/75 60/100** 24,001 - 36,000 1 22 42 69 30 47 79 45 62 112 59 66 86 143 miles J 25 47 78 33 53 87 50 70 124 66 73 97 160 2 29 54 88 39 60 100 57 78 141 76 83 109 182 3 36 66 109 47 74 124 70 97 175 93 103 135 225 4 42 79 128 57 88 147 84 115 208 111 124 161 267 5 52 97 159 69 109 180 102 143 255 136 151 198 328 6 61 115 188 82 128 214 122 168 303 162 178 234 390 7 70 132 215 94 147 245 140 193 347 185 206 269 446 8 80 150 245 108 167 278 159 220 394 211 233 306 506 9 91 168 275 121 189 314 179 248 445 238 263 344 571 B 105 195 319 139 218 362 206 287 514 274 303 398 660 C 119 221 360 157 246 409 233 323 580 310 343 450 746 D 131 245 400 175 273 454 259 359 644 344 381 499 827 E 148 278 454 198 310 516 293 407 731 389 432 566 939 F 174 326 531 232 363 603 344 476 855 457 506 662 1099 G 200 373 608 266 416 693 393 546 981 523 579 759 1260 H 224 420 685 300 468 779 443 614 1103 589 652 854 1417 U 249 466 760 333 520 865 492 682 1225 654 723 949 1574 V 280 524 854 373 585 972 553 768 1378 735 814 1068 1770 W 311 582 950 415 648 1080 615 852 1530 816 905 1185 1966 X 351 655 1069 467 730 1215 692 959 1722 919 1017 1334 2213\n\nY 389 729 1189 520 813 1353 770 1068 1917 1022 1133 1484 2463 Z 445 833 1358 594 928 1545 879 1219 2188 1167 1294 1695 2812 A 784 1467 2393 1047 1636 2721 1549 2148 3855 2058 2279 2986 4954\n\n**Preferred Symbol 24/75 24/100 36/75 36/100 48/75 48/100** 36,001 - 50,000 1 57 94 75 134 104 172 miles J 64 106 84 150 116 193 2 72 120 94 171 132 219 3 89 148 117 210 163 270 4 106 177 140 251 194 322 5 130 217 171 307 238 395 6 154 257 203 364 282 468 7 177 295 232 418 323 537 8 202 334 265 474 368 609 9 227 378 298 535 414 687 B 262 436 344 618 478 794 C 296 493 389 699 541 898 D 329 547 432 775 601 996 E 372 620 489 878 680 1128 F 437 726 574 1029 797 1322 G 501 832 657 1179 914 1516 H 563 936 739 1326 1028 1704 U 625 1040 821 1473 1142 1893 V 703 1170 923 1657 1283 2129 W 781 1300 1026 1841 1426 2366 X 878 1463 1153 2072 1604 2662\n\nY 978 1627 1284 2305 1785 2963 Z 1117 1859 1467 2633 2040 3383 A 1968 3273 2584 4637 3593 5959\n\nUUIC VSC 2010 CA (07/2010)","pages":[{"line_numbers":[],"markdown":"11\n\n### UNIVERSAL UNDERWRITERS INSURANCE COMPANY VEHICLE SERVICE CONTRACT REIMBURSEMENT PROGRAM NEW VEHICLE PREMIUM\n\nCOVERAGE LEVEL: A ELIGIBLE VEHICLES: CHRYSLER, DODGE, JEEP vehicles, 2010 model year and newer DEDUCTIBLE: $100\n\n**Preferred Symbol 24/60 24/75 24/100 36/60 36/75 36/100 48/60 48/75 48/100 60/60 60/70 60/75 60/100** 24,001 - 36,000 1 22 42 69 30 47 79 45 62 112 59 66 86 143 miles J 25 47 78 33 53 87 50 70 124 66 73 97 160 2 29 54 88 39 60 100 57 78 141 76 83 109 182 3 36 66 109 47 74 124 70 97 175 93 103 135 225 4 42 79 128 57 88 147 84 115 208 111 124 161 267 5 52 97 159 69 109 180 102 143 255 136 151 198 328 6 61 115 188 82 128 214 122 168 303 162 178 234 390 7 70 132 215 94 147 245 140 193 347 185 206 269 446 8 80 150 245 108 167 278 159 220 394 211 233 306 506 9 91 168 275 121 189 314 179 248 445 238 263 344 571 B 105 195 319 139 218 362 206 287 514 274 303 398 660 C 119 221 360 157 246 409 233 323 580 310 343 450 746 D 131 245 400 175 273 454 259 359 644 344 381 499 827 E 148 278 454 198 310 516 293 407 731 389 432 566 939 F 174 326 531 232 363 603 344 476 855 457 506 662 1099 G 200 373 608 266 416 693 393 546 981 523 579 759 1260 H 224 420 685 300 468 779 443 614 1103 589 652 854 1417 U 249 466 760 333 520 865 492 682 1225 654 723 949 1574 V 280 524 854 373 585 972 553 768 1378 735 814 1068 1770 W 311 582 950 415 648 1080 615 852 1530 816 905 1185 1966 X 351 655 1069 467 730 1215 692 959 1722 919 1017 1334 2213\n\nY 389 729 1189 520 813 1353 770 1068 1917 1022 1133 1484 2463 Z 445 833 1358 594 928 1545 879 1219 2188 1167 1294 1695 2812 A 784 1467 2393 1047 1636 2721 1549 2148 3855 2058 2279 2986 4954\n\n**Preferred Symbol 24/75 24/100 36/75 36/100 48/75 48/100** 36,001 - 50,000 1 57 94 75 134 104 172 miles J 64 106 84 150 116 193 2 72 120 94 171 132 219 3 89 148 117 210 163 270 4 106 177 140 251 194 322 5 130 217 171 307 238 395 6 154 257 203 364 282 468 7 177 295 232 418 323 537 8 202 334 265 474 368 609 9 227 378 298 535 414 687 B 262 436 344 618 478 794 C 296 493 389 699 541 898 D 329 547 432 775 601 996 E 372 620 489 878 680 1128 F 437 726 574 1029 797 1322 G 501 832 657 1179 914 1516 H 563 936 739 1326 1028 1704 U 625 1040 821 1473 1142 1893 V 703 1170 923 1657 1283 2129 W 781 1300 1026 1841 1426 2366 X 878 1463 1153 2072 1604 2662\n\nY 978 1627 1284 2305 1785 2963 Z 1117 1859 1467 2633 2040 3383 A 1968 3273 2584 4637 3593 5959\n\nUUIC VSC 2010 CA (07/2010)","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"11\n\n### UNIVERSAL UNDERWRITERS INSURANCE COMPANY VEHICLE SERVICE CONTRACT REIMBURSEMENT PROGRAM NEW VEHICLE PREMIUM\n\nCOVERAGE LEVEL: A ELIGIBLE VEHICLES: CHRYSLER, DODGE, JEEP vehicles, 2010 model year and newer DEDUCTIBLE: $100\n\n**Preferred Symbol 24/60 24/75 24/100 36/60 36/75 36/100 48/60 48/75 48/100 60/60 60/70 60/75 60/100** 24,001 - 36,000 1 22 42 69 30 47 79 45 62 112 59 66 86 143 miles J 25 47 78 33 53 87 50 70 124 66 73 97 160 2 29 54 88 39 60 100 57 78 141 76 83 109 182 3 36 66 109 47 74 124 70 97 175 93 103 135 225 4 42 79 128 57 88 147 84 115 208 111 124 161 267 5 52 97 159 69 109 180 102 143 255 136 151 198 328 6 61 115 188 82 128 214 122 168 303 162 178 234 390 7 70 132 215 94 147 245 140 193 347 185 206 269 446 8 80 150 245 108 167 278 159 220 394 211 233 306 506 9 91 168 275 121 189 314 179 248 445 238 263 344 571 B 105 195 319 139 218 362 206 287 514 274 303 398 660 C 119 221 360 157 246 409 233 323 580 310 343 450 746 D 131 245 400 175 273 454 259 359 644 344 381 499 827 E 148 278 454 198 310 516 293 407 731 389 432 566 939 F 174 326 531 232 363 603 344 476 855 457 506 662 1099 G 200 373 608 266 416 693 393 546 981 523 579 759 1260 H 224 420 685 300 468 779 443 614 1103 589 652 854 1417 U 249 466 760 333 520 865 492 682 1225 654 723 949 1574 V 280 524 854 373 585 972 553 768 1378 735 814 1068 1770 W 311 582 950 415 648 1080 615 852 1530 816 905 1185 1966 X 351 655 1069 467 730 1215 692 959 1722 919 1017 1334 2213\n\nY 389 729 1189 520 813 1353 770 1068 1917 1022 1133 1484 2463 Z 445 833 1358 594 928 1545 879 1219 2188 1167 1294 1695 2812 A 784 1467 2393 1047 1636 2721 1549 2148 3855 2058 2279 2986 4954\n\n**Preferred Symbol 24/75 24/100 36/75 36/100 48/75 48/100** 36,001 - 50,000 1 57 94 75 134 104 172 miles J 64 106 84 150 116 193 2 72 120 94 171 132 219 3 89 148 117 210 163 270 4 106 177 140 251 194 322 5 130 217 171 307 238 395 6 154 257 203 364 282 468 7 177 295 232 418 323 537 8 202 334 265 474 368 609 9 227 378 298 535 414 687 B 262 436 344 618 478 794 C 296 493 389 699 541 898 D 329 547 432 775 601 996 E 372 620 489 878 680 1128 F 437 726 574 1029 797 1322 G 501 832 657 1179 914 1516 H 563 936 739 1326 1028 1704 U 625 1040 821 1473 1142 1893 V 703 1170 923 1657 1283 2129 W 781 1300 1026 1841 1426 2366 X 878 1463 1153 2072 1604 2662\n\nY 978 1627 1284 2305 1785 2963 Z 1117 1859 1467 2633 2040 3383 A 1968 3273 2584 4637 3593 5959\n\nUUIC VSC 2010 CA (07/2010)","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2905.pdf"]},"response":{"errors":[],"extract_id":"extract_e5a2c5b9c696e1b4c5a494cdb190ac5a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["11\n\n### UNIVERSAL UNDERWRITERS INSURANCE COMPANY VEHICLE SERVICE CONTRACT REIMBURSEMENT PROGRAM NEW VEHICLE PREMIUM\n\nCOVERAGE LEVEL: A ELIGIBLE VEHICLES: CHRYSLER, DODGE, JEEP vehicles, 2010 model year and newer DEDUCTIBLE: $100\n\n**Preferred Symbol 24/60 24/75 24/100 36/60 36/75 36/100 48/60 48/75 48/100 60/60 60/70 60/75 60/100** 24,001 - 36,000 1 22 42 69 30 47 79 45 62 112 59 66 86 143 miles J 25 47 78 33 53 87 50 70 124 66 73 97 160 2 29 54 88 39 60 100 57 78 141 76 83 109 182 3 36 66 109 47 74 124 70 97 175 93 103 135 225 4 42 79 128 57 88 147 84 115 208 111 124 161 267 5 52 97 159 69 109 180 102 143 255 136 151 198 328 6 61 115 188 82 128 214 122 168 303 162 178 234 390 7 70 132 215 94 147 245 140 193 347 185 206 269 446 8 80 150 245 108 167 278 159 220 394 211 233 306 506 9 91 168 275 121 189 314 179 248 445 238 263 344 571 B 105 195 319 139 218 362 206 287 514 274 303 398 660 C 119 221 360 157 246 409 233 323 580 310 343 450 746 D 131 245 400 175 273 454 259 359 644 344 381 499 827 E 148 278 454 198 310 516 293 407 731 389 432 566 939 F 174 326 531 232 363 603 344 476 855 457 506 662 1099 G 200 373 608 266 416 693 393 546 981 523 579 759 1260 H 224 420 685 300 468 779 443 614 1103 589 652 854 1417 U 249 466 760 333 520 865 492 682 1225 654 723 949 1574 V 280 524 854 373 585 972 553 768 1378 735 814 1068 1770 W 311 582 950 415 648 1080 615 852 1530 816 905 1185 1966 X 351 655 1069 467 730 1215 692 959 1722 919 1017 1334 2213\n\nY 389 729 1189 520 813 1353 770 1068 1917 1022 1133 1484 2463 Z 445 833 1358 594 928 1545 879 1219 2188 1167 1294 1695 2812 A 784 1467 2393 1047 1636 2721 1549 2148 3855 2058 2279 2986 4954\n\n**Preferred Symbol 24/75 24/100 36/75 36/100 48/75 48/100** 36,001 - 50,000 1 57 94 75 134 104 172 miles J 64 106 84 150 116 193 2 72 120 94 171 132 219 3 89 148 117 210 163 270 4 106 177 140 251 194 322 5 130 217 171 307 238 395 6 154 257 203 364 282 468 7 177 295 232 418 323 537 8 202 334 265 474 368 609 9 227 378 298 535 414 687 B 262 436 344 618 478 794 C 296 493 389 699 541 898 D 329 547 432 775 601 996 E 372 620 489 878 680 1128 F 437 726 574 1029 797 1322 G 501 832 657 1179 914 1516 H 563 936 739 1326 1028 1704 U 625 1040 821 1473 1142 1893 V 703 1170 923 1657 1283 2129 W 781 1300 1026 1841 1426 2366 X 878 1463 1153 2072 1604 2662\n\nY 978 1627 1284 2305 1785 2963 Z 1117 1859 1467 2633 2040 3383 A 1968 3273 2584 4637 3593 5959\n\nUUIC VSC 2010 CA (07/2010)"],"full_content":"11\n\n### UNIVERSAL UNDERWRITERS INSURANCE COMPANY VEHICLE SERVICE CONTRACT REIMBURSEMENT PROGRAM NEW VEHICLE PREMIUM\n\nCOVERAGE LEVEL: A ELIGIBLE VEHICLES: CHRYSLER, DODGE, JEEP vehicles, 2010 model year and newer DEDUCTIBLE: $100\n\n**Preferred Symbol 24/60 24/75 24/100 36/60 36/75 36/100 48/60 48/75 48/100 60/60 60/70 60/75 60/100** 24,001 - 36,000 1 22 42 69 30 47 79 45 62 112 59 66 86 143 miles J 25 47 78 33 53 87 50 70 124 66 73 97 160 2 29 54 88 39 60 100 57 78 141 76 83 109 182 3 36 66 109 47 74 124 70 97 175 93 103 135 225 4 42 79 128 57 88 147 84 115 208 111 124 161 267 5 52 97 159 69 109 180 102 143 255 136 151 198 328 6 61 115 188 82 128 214 122 168 303 162 178 234 390 7 70 132 215 94 147 245 140 193 347 185 206 269 446 8 80 150 245 108 167 278 159 220 394 211 233 306 506 9 91 168 275 121 189 314 179 248 445 238 263 344 571 B 105 195 319 139 218 362 206 287 514 274 303 398 660 C 119 221 360 157 246 409 233 323 580 310 343 450 746 D 131 245 400 175 273 454 259 359 644 344 381 499 827 E 148 278 454 198 310 516 293 407 731 389 432 566 939 F 174 326 531 232 363 603 344 476 855 457 506 662 1099 G 200 373 608 266 416 693 393 546 981 523 579 759 1260 H 224 420 685 300 468 779 443 614 1103 589 652 854 1417 U 249 466 760 333 520 865 492 682 1225 654 723 949 1574 V 280 524 854 373 585 972 553 768 1378 735 814 1068 1770 W 311 582 950 415 648 1080 615 852 1530 816 905 1185 1966 X 351 655 1069 467 730 1215 692 959 1722 919 1017 1334 2213\n\nY 389 729 1189 520 813 1353 770 1068 1917 1022 1133 1484 2463 Z 445 833 1358 594 928 1545 879 1219 2188 1167 1294 1695 2812 A 784 1467 2393 1047 1636 2721 1549 2148 3855 2058 2279 2986 4954\n\n**Preferred Symbol 24/75 24/100 36/75 36/100 48/75 48/100** 36,001 - 50,000 1 57 94 75 134 104 172 miles J 64 106 84 150 116 193 2 72 120 94 171 132 219 3 89 148 117 210 163 270 4 106 177 140 251 194 322 5 130 217 171 307 238 395 6 154 257 203 364 282 468 7 177 295 232 418 323 537 8 202 334 265 474 368 609 9 227 378 298 535 414 687 B 262 436 344 618 478 794 C 296 493 389 699 541 898 D 329 547 432 775 601 996 E 372 620 489 878 680 1128 F 437 726 574 1029 797 1322 G 501 832 657 1179 914 1516 H 563 936 739 1326 1028 1704 U 625 1040 821 1473 1142 1893 V 703 1170 923 1657 1283 2129 W 781 1300 1026 1841 1426 2366 X 878 1463 1153 2072 1604 2662\n\nY 978 1627 1284 2305 1785 2963 Z 1117 1859 1467 2633 2040 3383 A 1968 3273 2584 4637 3593 5959\n\nUUIC VSC 2010 CA (07/2010)","publish_date":null,"title":"UNIVERSAL UNDERWRITERS INSURANCE COMPANY VEHICLE SERVICE CONTRACT REIMBURSEMENT PROGRAM NEW VEHICLE PREMIUM","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2905.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2905.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2905","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2905.pdf"},"started_at":"2026-11-04T19:47:07.489952"} +{"completed_at":"2026-11-04T19:47:10.567064","latency_in_ms":1984,"output":{"example_id":"table/SERFF_CA_random_pages 1_page2930","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 3\n\nSelected Ratio Selected Ratio to Net Prem to Std Prem \\* Commission 16.00% 11.52% Other Acquisition 6.70% 4.82% General 0.20% 0.14% Tax, Licenses, and Fees 2.35% 1.69% Profit Load 8.67% 6.24% Total Expense and Profit Load 33.92% 24.42%\n\nPermissible Loss and LAE Ratio 66.08%\n\nAdjusting And Other Expense 8.40%\n\nPermissible Loss and ALAE Ratio 57.68%\n\nExpected Loss Ratio 49.85%\n\n\\* Ratio Net to Standard Premium 0.72\n\nNOTES: 1. Expenses are based on three years of historical expense data for the group of three companies combined. See Exhibit 4.\n\n2\\. Tax, license and fees are as follows for California:\n\nPremium Tax 2.3500%\n\nTotal 2.3500%\n\n3\\. DCCE to Loss Ratio 0.1570\n\nAssurance Company of America\n\nCalifornia\n\nWorkers' Compensation\n\nPermissible Loss and ALAE Ratio\n\nMaryland Casualty Company Northern Insurance Company of New York","pages":[{"line_numbers":[],"markdown":"Exhibit 3\n\nSelected Ratio Selected Ratio to Net Prem to Std Prem \\* Commission 16.00% 11.52% Other Acquisition 6.70% 4.82% General 0.20% 0.14% Tax, Licenses, and Fees 2.35% 1.69% Profit Load 8.67% 6.24% Total Expense and Profit Load 33.92% 24.42%\n\nPermissible Loss and LAE Ratio 66.08%\n\nAdjusting And Other Expense 8.40%\n\nPermissible Loss and ALAE Ratio 57.68%\n\nExpected Loss Ratio 49.85%\n\n\\* Ratio Net to Standard Premium 0.72\n\nNOTES: 1. Expenses are based on three years of historical expense data for the group of three companies combined. See Exhibit 4.\n\n2\\. Tax, license and fees are as follows for California:\n\nPremium Tax 2.3500%\n\nTotal 2.3500%\n\n3\\. DCCE to Loss Ratio 0.1570\n\nAssurance Company of America\n\nCalifornia\n\nWorkers' Compensation\n\nPermissible Loss and ALAE Ratio\n\nMaryland Casualty Company Northern Insurance Company of New York","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 3\n\nSelected Ratio Selected Ratio to Net Prem to Std Prem \\* Commission 16.00% 11.52% Other Acquisition 6.70% 4.82% General 0.20% 0.14% Tax, Licenses, and Fees 2.35% 1.69% Profit Load 8.67% 6.24% Total Expense and Profit Load 33.92% 24.42%\n\nPermissible Loss and LAE Ratio 66.08%\n\nAdjusting And Other Expense 8.40%\n\nPermissible Loss and ALAE Ratio 57.68%\n\nExpected Loss Ratio 49.85%\n\n\\* Ratio Net to Standard Premium 0.72\n\nNOTES: 1. Expenses are based on three years of historical expense data for the group of three companies combined. See Exhibit 4.\n\n2\\. Tax, license and fees are as follows for California:\n\nPremium Tax 2.3500%\n\nTotal 2.3500%\n\n3\\. DCCE to Loss Ratio 0.1570\n\nAssurance Company of America\n\nCalifornia\n\nWorkers' Compensation\n\nPermissible Loss and ALAE Ratio\n\nMaryland Casualty Company Northern Insurance Company of New York","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2930.pdf"]},"response":{"errors":[],"extract_id":"extract_5b242bfd18eadd2d22da0a00d8650e68","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 3\n\nSelected Ratio Selected Ratio to Net Prem to Std Prem \\* Commission 16.00% 11.52% Other Acquisition 6.70% 4.82% General 0.20% 0.14% Tax, Licenses, and Fees 2.35% 1.69% Profit Load 8.67% 6.24% Total Expense and Profit Load 33.92% 24.42%\n\nPermissible Loss and LAE Ratio 66.08%\n\nAdjusting And Other Expense 8.40%\n\nPermissible Loss and ALAE Ratio 57.68%\n\nExpected Loss Ratio 49.85%\n\n\\* Ratio Net to Standard Premium 0.72\n\nNOTES: 1. Expenses are based on three years of historical expense data for the group of three companies combined. See Exhibit 4.\n\n2\\. Tax, license and fees are as follows for California:\n\nPremium Tax 2.3500%\n\nTotal 2.3500%\n\n3\\. DCCE to Loss Ratio 0.1570\n\nAssurance Company of America\n\nCalifornia\n\nWorkers' Compensation\n\nPermissible Loss and ALAE Ratio\n\nMaryland Casualty Company Northern Insurance Company of New York"],"full_content":"Exhibit 3\n\nSelected Ratio Selected Ratio to Net Prem to Std Prem \\* Commission 16.00% 11.52% Other Acquisition 6.70% 4.82% General 0.20% 0.14% Tax, Licenses, and Fees 2.35% 1.69% Profit Load 8.67% 6.24% Total Expense and Profit Load 33.92% 24.42%\n\nPermissible Loss and LAE Ratio 66.08%\n\nAdjusting And Other Expense 8.40%\n\nPermissible Loss and ALAE Ratio 57.68%\n\nExpected Loss Ratio 49.85%\n\n\\* Ratio Net to Standard Premium 0.72\n\nNOTES: 1. Expenses are based on three years of historical expense data for the group of three companies combined. See Exhibit 4.\n\n2\\. Tax, license and fees are as follows for California:\n\nPremium Tax 2.3500%\n\nTotal 2.3500%\n\n3\\. DCCE to Loss Ratio 0.1570\n\nAssurance Company of America\n\nCalifornia\n\nWorkers' Compensation\n\nPermissible Loss and ALAE Ratio\n\nMaryland Casualty Company Northern Insurance Company of New York","publish_date":null,"title":"Exhibit 3 Assurance Company of America Maryland Casualty Company Northern Insurance Company of New York California Workers' Compensation Permissible Loss","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2930.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page2930.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page2930","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page2930.pdf"},"started_at":"2026-11-04T19:47:08.582372"} +{"completed_at":"2026-11-04T19:47:11.551982","latency_in_ms":1985,"output":{"example_id":"table/SERFF_CA_random_pages 1_page310","grounded_pages":[],"layout_pages":[],"markdown":"Comparison of proposed Atlas National Title rate changes to major competitors","pages":[{"line_numbers":[],"markdown":"Comparison of proposed Atlas National Title rate changes to major competitors","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Comparison of proposed Atlas National Title rate changes to major competitors","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page310.pdf"]},"response":{"errors":[],"extract_id":"extract_d373677c404f12ca782f02caa55ca0ca","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Comparison of proposed Atlas National Title rate changes to major competitors"],"full_content":"Comparison of proposed Atlas National Title rate changes to major competitors","publish_date":null,"title":"Comparison of proposed Atlas National Title rate changes to major competitors","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page310.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page310.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page310","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page310.pdf"},"started_at":"2026-11-04T19:47:09.566248"} +{"completed_at":"2026-11-04T19:47:13.527733","latency_in_ms":2123,"output":{"example_id":"table/SERFF_CA_random_pages 1_page316","grounded_pages":[],"layout_pages":[],"markdown":"**WORKERS COMPENSATION AND EMPLOYERS LIABILITY**\n\n**OBI NATIONAL INSURANCE COMPANY**\n\n**STANDARD**\n\n**STATE: CALIFORNIA EFFECTIVE DATE: DECEMBER 15, 2013**\n\n**CLASS MIN. HAZ CLASS MIN. HAZ CLASS MIN. HAZ CODE RATE PREM. L/C CODE CODE RATE PREM. L/C CODE CODE RATE PREM. L/C CODE**\n\n**3400** 9\\.97 1000 2 **4112** 1\\.30 1000 3 **4635** 4\\.57 1000 3\n\n**3401** 10\\.50 1000 3 **4114** 16\\.72 1000 2 **4665** 13\\.41 1000 1\n\n**3501** 9\\.44 1000 3 **4130** 15\\.12 1000 3 **4683** 8\\.79 1000 3\n\n**3507** 10\\.98 1000 3 **4150** 6\\.18 1000 1 **4691** 3\\.54 1000 3\n\n**3560** 8\\.24 1000 3 **4239** 8\\.74 1000 1 **4692** 3\\.46 1000 3\n\n**3568** 3\\.91 1000 3 **4240** 27\\.27 1000 3 **4717** 13\\.42 1000 1\n\n**3569** 5\\.82 1000 3 **4243** 10\\.42 1000 3 **4720** 6\\.96 1000 3\n\n**3570** 6\\.31 1000 3 **4244** 12\\.38 1000 2 **4740** 2\\.79 1000 2\n\n**3572** 2\\.38 1000 3 **4250** 7\\.89 1000 3 **4771** 4\\.60 1000 2\n\n**3573** 3\\.49 1000 3 **4251** 9\\.56 1000 2 **4828** 6\\.33 1000 2\n\n**3574** 6\\.93 1000 3 **4279** 9\\.85 1000 1 **4829** 4\\.42 1000 2\n\n**3577** 3\\.16 1000 3 **4283** 6\\.75 1000 1 **4831** 9\\.97 1000 3\n\n**3612** 7\\.58 1000 3 **4286** 12\\.28 1000 1 **4922** 4\\.52 1000 1\n\n**3620** 10\\.73 1000 2 **4295** 8\\.94 1000 1 **4983** 8\\.42 1000 2\n\n**3632** 7\\.96 1000 3 **4297** 0\\.83 1000 2 **5020** 8\\.64 1000 4\n\n**3634** 9\\.43 1000 3 **4299** 8\\.99 1000 1 **5027** 17\\.48 1000 2\n\n**3643** 5\\.56 1000 3 **4304** 16\\.78 1000 3 **5028** 10\\.62 1000 4\n\n**3647** 12\\.38 1000 2 **4312** 9\\.31 1000 2 **5040** 22\\.30 1000 4\n\n**3651** 5\\.09 1000 3 **4351** 4\\.26 1000 3 **5057** 14\\.06 1000 4\n\n**3681** 2\\.28 1000 3 **4354** 3\\.83 1000 3 **5059** 33\\.11 1000 4\n\n**3682** 2\\.97 1000 4 **4361** 4\\.30 1000 3 **5102** 11\\.25 1000 2\n\n**3683** 8\\.25 1000 4 **4362** 3\\.69 1000 2 **5107** 11\\.03 1000 2\n\n**3719** 4\\.26 1000 4 **4410** 12\\.67 1000 3 **5108** 19\\.60 1000 2\n\n**3724** 8\\.11 1000 2 **4420** 21\\.12 1000 2 **5128** 2\\.53 1000 1\n\n**3726** 7\\.05 1000 3 **4432** 10\\.06 1000 1 **5140** 5\\.04 1000 2\n\n**3805** 2\\.41 1000 2 **4470** 6\\.98 1000 2 **5146** 11\\.56 1000 2\n\n**3808** 8\\.61 1000 3 **4478** 11\\.22 1000 1 **5160** 4\\.03 1000 4\n\n**3815** 11\\.12 1000 2 **4492** 7\\.57 1000 3 **5183** 11\\.27 1000 2\n\n**3821** 19\\.75 1000 3 **4494** 10\\.37 1000 3 **5184** 7\\.37 1000 4\n\n**3828** 9\\.12 1000 3 **4495** 12\\.84 1000 1 **5185** 11\\.78 1000 1\n\n**3830** 3\\.64 1000 2 **4496** 10\\.14 1000 3 **5186** 4\\.32 1000 1\n\n**3831** 5\\.68 1000 3 **4497** 8\\.16 1000 3 **5187** 8\\.17 1000 2\n\n**3840** 10\\.18 1000 3 **4498** 10\\.32 1000 3 **5190** 8\\.95 1000 2\n\n**4000** 8\\.94 1000 2 **4499** 9\\.43 1000 3 **5191** 3\\.72 1000 2\n\n**4034** 13\\.99 1000 3 **4511** 2\\.01 1000 3 **5192** 12\\.27 1000 2\n\n**4036** 4\\.80 1000 2 **4512** 0\\.78 1000 3 **5195** 12\\.53 1000 4\n\n**4038** 14\\.14 1000 2 **4557** 5\\.77 1000 2 **5201** 12\\.54 1000 2\n\n**4041** 11\\.12 1000 1 **4558** 6\\.44 1000 3 **5205** 8\\.68 1000 4\n\n**4049** 8\\.81 1000 3 **4611** 4\\.47 1000 3 **5207** 10\\.73 1000 1\n\n**4111** 4\\.11 1000 3 **4623** 14\\.11 1000 3 **5212** 16\\.83 1000 4\n\n2 of 6","pages":[{"line_numbers":[],"markdown":"**WORKERS COMPENSATION AND EMPLOYERS LIABILITY**\n\n**OBI NATIONAL INSURANCE COMPANY**\n\n**STANDARD**\n\n**STATE: CALIFORNIA EFFECTIVE DATE: DECEMBER 15, 2013**\n\n**CLASS MIN. HAZ CLASS MIN. HAZ CLASS MIN. HAZ CODE RATE PREM. L/C CODE CODE RATE PREM. L/C CODE CODE RATE PREM. L/C CODE**\n\n**3400** 9\\.97 1000 2 **4112** 1\\.30 1000 3 **4635** 4\\.57 1000 3\n\n**3401** 10\\.50 1000 3 **4114** 16\\.72 1000 2 **4665** 13\\.41 1000 1\n\n**3501** 9\\.44 1000 3 **4130** 15\\.12 1000 3 **4683** 8\\.79 1000 3\n\n**3507** 10\\.98 1000 3 **4150** 6\\.18 1000 1 **4691** 3\\.54 1000 3\n\n**3560** 8\\.24 1000 3 **4239** 8\\.74 1000 1 **4692** 3\\.46 1000 3\n\n**3568** 3\\.91 1000 3 **4240** 27\\.27 1000 3 **4717** 13\\.42 1000 1\n\n**3569** 5\\.82 1000 3 **4243** 10\\.42 1000 3 **4720** 6\\.96 1000 3\n\n**3570** 6\\.31 1000 3 **4244** 12\\.38 1000 2 **4740** 2\\.79 1000 2\n\n**3572** 2\\.38 1000 3 **4250** 7\\.89 1000 3 **4771** 4\\.60 1000 2\n\n**3573** 3\\.49 1000 3 **4251** 9\\.56 1000 2 **4828** 6\\.33 1000 2\n\n**3574** 6\\.93 1000 3 **4279** 9\\.85 1000 1 **4829** 4\\.42 1000 2\n\n**3577** 3\\.16 1000 3 **4283** 6\\.75 1000 1 **4831** 9\\.97 1000 3\n\n**3612** 7\\.58 1000 3 **4286** 12\\.28 1000 1 **4922** 4\\.52 1000 1\n\n**3620** 10\\.73 1000 2 **4295** 8\\.94 1000 1 **4983** 8\\.42 1000 2\n\n**3632** 7\\.96 1000 3 **4297** 0\\.83 1000 2 **5020** 8\\.64 1000 4\n\n**3634** 9\\.43 1000 3 **4299** 8\\.99 1000 1 **5027** 17\\.48 1000 2\n\n**3643** 5\\.56 1000 3 **4304** 16\\.78 1000 3 **5028** 10\\.62 1000 4\n\n**3647** 12\\.38 1000 2 **4312** 9\\.31 1000 2 **5040** 22\\.30 1000 4\n\n**3651** 5\\.09 1000 3 **4351** 4\\.26 1000 3 **5057** 14\\.06 1000 4\n\n**3681** 2\\.28 1000 3 **4354** 3\\.83 1000 3 **5059** 33\\.11 1000 4\n\n**3682** 2\\.97 1000 4 **4361** 4\\.30 1000 3 **5102** 11\\.25 1000 2\n\n**3683** 8\\.25 1000 4 **4362** 3\\.69 1000 2 **5107** 11\\.03 1000 2\n\n**3719** 4\\.26 1000 4 **4410** 12\\.67 1000 3 **5108** 19\\.60 1000 2\n\n**3724** 8\\.11 1000 2 **4420** 21\\.12 1000 2 **5128** 2\\.53 1000 1\n\n**3726** 7\\.05 1000 3 **4432** 10\\.06 1000 1 **5140** 5\\.04 1000 2\n\n**3805** 2\\.41 1000 2 **4470** 6\\.98 1000 2 **5146** 11\\.56 1000 2\n\n**3808** 8\\.61 1000 3 **4478** 11\\.22 1000 1 **5160** 4\\.03 1000 4\n\n**3815** 11\\.12 1000 2 **4492** 7\\.57 1000 3 **5183** 11\\.27 1000 2\n\n**3821** 19\\.75 1000 3 **4494** 10\\.37 1000 3 **5184** 7\\.37 1000 4\n\n**3828** 9\\.12 1000 3 **4495** 12\\.84 1000 1 **5185** 11\\.78 1000 1\n\n**3830** 3\\.64 1000 2 **4496** 10\\.14 1000 3 **5186** 4\\.32 1000 1\n\n**3831** 5\\.68 1000 3 **4497** 8\\.16 1000 3 **5187** 8\\.17 1000 2\n\n**3840** 10\\.18 1000 3 **4498** 10\\.32 1000 3 **5190** 8\\.95 1000 2\n\n**4000** 8\\.94 1000 2 **4499** 9\\.43 1000 3 **5191** 3\\.72 1000 2\n\n**4034** 13\\.99 1000 3 **4511** 2\\.01 1000 3 **5192** 12\\.27 1000 2\n\n**4036** 4\\.80 1000 2 **4512** 0\\.78 1000 3 **5195** 12\\.53 1000 4\n\n**4038** 14\\.14 1000 2 **4557** 5\\.77 1000 2 **5201** 12\\.54 1000 2\n\n**4041** 11\\.12 1000 1 **4558** 6\\.44 1000 3 **5205** 8\\.68 1000 4\n\n**4049** 8\\.81 1000 3 **4611** 4\\.47 1000 3 **5207** 10\\.73 1000 1\n\n**4111** 4\\.11 1000 3 **4623** 14\\.11 1000 3 **5212** 16\\.83 1000 4\n\n2 of 6","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**WORKERS COMPENSATION AND EMPLOYERS LIABILITY**\n\n**OBI NATIONAL INSURANCE COMPANY**\n\n**STANDARD**\n\n**STATE: CALIFORNIA EFFECTIVE DATE: DECEMBER 15, 2013**\n\n**CLASS MIN. HAZ CLASS MIN. HAZ CLASS MIN. HAZ CODE RATE PREM. L/C CODE CODE RATE PREM. L/C CODE CODE RATE PREM. L/C CODE**\n\n**3400** 9\\.97 1000 2 **4112** 1\\.30 1000 3 **4635** 4\\.57 1000 3\n\n**3401** 10\\.50 1000 3 **4114** 16\\.72 1000 2 **4665** 13\\.41 1000 1\n\n**3501** 9\\.44 1000 3 **4130** 15\\.12 1000 3 **4683** 8\\.79 1000 3\n\n**3507** 10\\.98 1000 3 **4150** 6\\.18 1000 1 **4691** 3\\.54 1000 3\n\n**3560** 8\\.24 1000 3 **4239** 8\\.74 1000 1 **4692** 3\\.46 1000 3\n\n**3568** 3\\.91 1000 3 **4240** 27\\.27 1000 3 **4717** 13\\.42 1000 1\n\n**3569** 5\\.82 1000 3 **4243** 10\\.42 1000 3 **4720** 6\\.96 1000 3\n\n**3570** 6\\.31 1000 3 **4244** 12\\.38 1000 2 **4740** 2\\.79 1000 2\n\n**3572** 2\\.38 1000 3 **4250** 7\\.89 1000 3 **4771** 4\\.60 1000 2\n\n**3573** 3\\.49 1000 3 **4251** 9\\.56 1000 2 **4828** 6\\.33 1000 2\n\n**3574** 6\\.93 1000 3 **4279** 9\\.85 1000 1 **4829** 4\\.42 1000 2\n\n**3577** 3\\.16 1000 3 **4283** 6\\.75 1000 1 **4831** 9\\.97 1000 3\n\n**3612** 7\\.58 1000 3 **4286** 12\\.28 1000 1 **4922** 4\\.52 1000 1\n\n**3620** 10\\.73 1000 2 **4295** 8\\.94 1000 1 **4983** 8\\.42 1000 2\n\n**3632** 7\\.96 1000 3 **4297** 0\\.83 1000 2 **5020** 8\\.64 1000 4\n\n**3634** 9\\.43 1000 3 **4299** 8\\.99 1000 1 **5027** 17\\.48 1000 2\n\n**3643** 5\\.56 1000 3 **4304** 16\\.78 1000 3 **5028** 10\\.62 1000 4\n\n**3647** 12\\.38 1000 2 **4312** 9\\.31 1000 2 **5040** 22\\.30 1000 4\n\n**3651** 5\\.09 1000 3 **4351** 4\\.26 1000 3 **5057** 14\\.06 1000 4\n\n**3681** 2\\.28 1000 3 **4354** 3\\.83 1000 3 **5059** 33\\.11 1000 4\n\n**3682** 2\\.97 1000 4 **4361** 4\\.30 1000 3 **5102** 11\\.25 1000 2\n\n**3683** 8\\.25 1000 4 **4362** 3\\.69 1000 2 **5107** 11\\.03 1000 2\n\n**3719** 4\\.26 1000 4 **4410** 12\\.67 1000 3 **5108** 19\\.60 1000 2\n\n**3724** 8\\.11 1000 2 **4420** 21\\.12 1000 2 **5128** 2\\.53 1000 1\n\n**3726** 7\\.05 1000 3 **4432** 10\\.06 1000 1 **5140** 5\\.04 1000 2\n\n**3805** 2\\.41 1000 2 **4470** 6\\.98 1000 2 **5146** 11\\.56 1000 2\n\n**3808** 8\\.61 1000 3 **4478** 11\\.22 1000 1 **5160** 4\\.03 1000 4\n\n**3815** 11\\.12 1000 2 **4492** 7\\.57 1000 3 **5183** 11\\.27 1000 2\n\n**3821** 19\\.75 1000 3 **4494** 10\\.37 1000 3 **5184** 7\\.37 1000 4\n\n**3828** 9\\.12 1000 3 **4495** 12\\.84 1000 1 **5185** 11\\.78 1000 1\n\n**3830** 3\\.64 1000 2 **4496** 10\\.14 1000 3 **5186** 4\\.32 1000 1\n\n**3831** 5\\.68 1000 3 **4497** 8\\.16 1000 3 **5187** 8\\.17 1000 2\n\n**3840** 10\\.18 1000 3 **4498** 10\\.32 1000 3 **5190** 8\\.95 1000 2\n\n**4000** 8\\.94 1000 2 **4499** 9\\.43 1000 3 **5191** 3\\.72 1000 2\n\n**4034** 13\\.99 1000 3 **4511** 2\\.01 1000 3 **5192** 12\\.27 1000 2\n\n**4036** 4\\.80 1000 2 **4512** 0\\.78 1000 3 **5195** 12\\.53 1000 4\n\n**4038** 14\\.14 1000 2 **4557** 5\\.77 1000 2 **5201** 12\\.54 1000 2\n\n**4041** 11\\.12 1000 1 **4558** 6\\.44 1000 3 **5205** 8\\.68 1000 4\n\n**4049** 8\\.81 1000 3 **4611** 4\\.47 1000 3 **5207** 10\\.73 1000 1\n\n**4111** 4\\.11 1000 3 **4623** 14\\.11 1000 3 **5212** 16\\.83 1000 4\n\n2 of 6","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page316.pdf"]},"response":{"errors":[],"extract_id":"extract_c66c98f8cfb78affe750852fc53de5e5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**WORKERS COMPENSATION AND EMPLOYERS LIABILITY**\n\n**OBI NATIONAL INSURANCE COMPANY**\n\n**STANDARD**\n\n**STATE: CALIFORNIA EFFECTIVE DATE: DECEMBER 15, 2013**\n\n**CLASS MIN. HAZ CLASS MIN. HAZ CLASS MIN. HAZ CODE RATE PREM. L/C CODE CODE RATE PREM. L/C CODE CODE RATE PREM. L/C CODE**\n\n**3400** 9\\.97 1000 2 **4112** 1\\.30 1000 3 **4635** 4\\.57 1000 3\n\n**3401** 10\\.50 1000 3 **4114** 16\\.72 1000 2 **4665** 13\\.41 1000 1\n\n**3501** 9\\.44 1000 3 **4130** 15\\.12 1000 3 **4683** 8\\.79 1000 3\n\n**3507** 10\\.98 1000 3 **4150** 6\\.18 1000 1 **4691** 3\\.54 1000 3\n\n**3560** 8\\.24 1000 3 **4239** 8\\.74 1000 1 **4692** 3\\.46 1000 3\n\n**3568** 3\\.91 1000 3 **4240** 27\\.27 1000 3 **4717** 13\\.42 1000 1\n\n**3569** 5\\.82 1000 3 **4243** 10\\.42 1000 3 **4720** 6\\.96 1000 3\n\n**3570** 6\\.31 1000 3 **4244** 12\\.38 1000 2 **4740** 2\\.79 1000 2\n\n**3572** 2\\.38 1000 3 **4250** 7\\.89 1000 3 **4771** 4\\.60 1000 2\n\n**3573** 3\\.49 1000 3 **4251** 9\\.56 1000 2 **4828** 6\\.33 1000 2\n\n**3574** 6\\.93 1000 3 **4279** 9\\.85 1000 1 **4829** 4\\.42 1000 2\n\n**3577** 3\\.16 1000 3 **4283** 6\\.75 1000 1 **4831** 9\\.97 1000 3\n\n**3612** 7\\.58 1000 3 **4286** 12\\.28 1000 1 **4922** 4\\.52 1000 1\n\n**3620** 10\\.73 1000 2 **4295** 8\\.94 1000 1 **4983** 8\\.42 1000 2\n\n**3632** 7\\.96 1000 3 **4297** 0\\.83 1000 2 **5020** 8\\.64 1000 4\n\n**3634** 9\\.43 1000 3 **4299** 8\\.99 1000 1 **5027** 17\\.48 1000 2\n\n**3643** 5\\.56 1000 3 **4304** 16\\.78 1000 3 **5028** 10\\.62 1000 4\n\n**3647** 12\\.38 1000 2 **4312** 9\\.31 1000 2 **5040** 22\\.30 1000 4\n\n**3651** 5\\.09 1000 3 **4351** 4\\.26 1000 3 **5057** 14\\.06 1000 4\n\n**3681** 2\\.28 1000 3 **4354** 3\\.83 1000 3 **5059** 33\\.11 1000 4\n\n**3682** 2\\.97 1000 4 **4361** 4\\.30 1000 3 **5102** 11\\.25 1000 2\n\n**3683** 8\\.25 1000 4 **4362** 3\\.69 1000 2 **5107** 11\\.03 1000 2\n\n**3719** 4\\.26 1000 4 **4410** 12\\.67 1000 3 **5108** 19\\.60 1000 2\n\n**3724** 8\\.11 1000 2 **4420** 21\\.12 1000 2 **5128** 2\\.53 1000 1\n\n**3726** 7\\.05 1000 3 **4432** 10\\.06 1000 1 **5140** 5\\.04 1000 2\n\n**3805** 2\\.41 1000 2 **4470** 6\\.98 1000 2 **5146** 11\\.56 1000 2\n\n**3808** 8\\.61 1000 3 **4478** 11\\.22 1000 1 **5160** 4\\.03 1000 4\n\n**3815** 11\\.12 1000 2 **4492** 7\\.57 1000 3 **5183** 11\\.27 1000 2\n\n**3821** 19\\.75 1000 3 **4494** 10\\.37 1000 3 **5184** 7\\.37 1000 4\n\n**3828** 9\\.12 1000 3 **4495** 12\\.84 1000 1 **5185** 11\\.78 1000 1\n\n**3830** 3\\.64 1000 2 **4496** 10\\.14 1000 3 **5186** 4\\.32 1000 1\n\n**3831** 5\\.68 1000 3 **4497** 8\\.16 1000 3 **5187** 8\\.17 1000 2\n\n**3840** 10\\.18 1000 3 **4498** 10\\.32 1000 3 **5190** 8\\.95 1000 2\n\n**4000** 8\\.94 1000 2 **4499** 9\\.43 1000 3 **5191** 3\\.72 1000 2\n\n**4034** 13\\.99 1000 3 **4511** 2\\.01 1000 3 **5192** 12\\.27 1000 2\n\n**4036** 4\\.80 1000 2 **4512** 0\\.78 1000 3 **5195** 12\\.53 1000 4\n\n**4038** 14\\.14 1000 2 **4557** 5\\.77 1000 2 **5201** 12\\.54 1000 2\n\n**4041** 11\\.12 1000 1 **4558** 6\\.44 1000 3 **5205** 8\\.68 1000 4\n\n**4049** 8\\.81 1000 3 **4611** 4\\.47 1000 3 **5207** 10\\.73 1000 1\n\n**4111** 4\\.11 1000 3 **4623** 14\\.11 1000 3 **5212** 16\\.83 1000 4\n\n2 of 6"],"full_content":"**WORKERS COMPENSATION AND EMPLOYERS LIABILITY**\n\n**OBI NATIONAL INSURANCE COMPANY**\n\n**STANDARD**\n\n**STATE: CALIFORNIA EFFECTIVE DATE: DECEMBER 15, 2013**\n\n**CLASS MIN. HAZ CLASS MIN. HAZ CLASS MIN. HAZ CODE RATE PREM. L/C CODE CODE RATE PREM. L/C CODE CODE RATE PREM. L/C CODE**\n\n**3400** 9\\.97 1000 2 **4112** 1\\.30 1000 3 **4635** 4\\.57 1000 3\n\n**3401** 10\\.50 1000 3 **4114** 16\\.72 1000 2 **4665** 13\\.41 1000 1\n\n**3501** 9\\.44 1000 3 **4130** 15\\.12 1000 3 **4683** 8\\.79 1000 3\n\n**3507** 10\\.98 1000 3 **4150** 6\\.18 1000 1 **4691** 3\\.54 1000 3\n\n**3560** 8\\.24 1000 3 **4239** 8\\.74 1000 1 **4692** 3\\.46 1000 3\n\n**3568** 3\\.91 1000 3 **4240** 27\\.27 1000 3 **4717** 13\\.42 1000 1\n\n**3569** 5\\.82 1000 3 **4243** 10\\.42 1000 3 **4720** 6\\.96 1000 3\n\n**3570** 6\\.31 1000 3 **4244** 12\\.38 1000 2 **4740** 2\\.79 1000 2\n\n**3572** 2\\.38 1000 3 **4250** 7\\.89 1000 3 **4771** 4\\.60 1000 2\n\n**3573** 3\\.49 1000 3 **4251** 9\\.56 1000 2 **4828** 6\\.33 1000 2\n\n**3574** 6\\.93 1000 3 **4279** 9\\.85 1000 1 **4829** 4\\.42 1000 2\n\n**3577** 3\\.16 1000 3 **4283** 6\\.75 1000 1 **4831** 9\\.97 1000 3\n\n**3612** 7\\.58 1000 3 **4286** 12\\.28 1000 1 **4922** 4\\.52 1000 1\n\n**3620** 10\\.73 1000 2 **4295** 8\\.94 1000 1 **4983** 8\\.42 1000 2\n\n**3632** 7\\.96 1000 3 **4297** 0\\.83 1000 2 **5020** 8\\.64 1000 4\n\n**3634** 9\\.43 1000 3 **4299** 8\\.99 1000 1 **5027** 17\\.48 1000 2\n\n**3643** 5\\.56 1000 3 **4304** 16\\.78 1000 3 **5028** 10\\.62 1000 4\n\n**3647** 12\\.38 1000 2 **4312** 9\\.31 1000 2 **5040** 22\\.30 1000 4\n\n**3651** 5\\.09 1000 3 **4351** 4\\.26 1000 3 **5057** 14\\.06 1000 4\n\n**3681** 2\\.28 1000 3 **4354** 3\\.83 1000 3 **5059** 33\\.11 1000 4\n\n**3682** 2\\.97 1000 4 **4361** 4\\.30 1000 3 **5102** 11\\.25 1000 2\n\n**3683** 8\\.25 1000 4 **4362** 3\\.69 1000 2 **5107** 11\\.03 1000 2\n\n**3719** 4\\.26 1000 4 **4410** 12\\.67 1000 3 **5108** 19\\.60 1000 2\n\n**3724** 8\\.11 1000 2 **4420** 21\\.12 1000 2 **5128** 2\\.53 1000 1\n\n**3726** 7\\.05 1000 3 **4432** 10\\.06 1000 1 **5140** 5\\.04 1000 2\n\n**3805** 2\\.41 1000 2 **4470** 6\\.98 1000 2 **5146** 11\\.56 1000 2\n\n**3808** 8\\.61 1000 3 **4478** 11\\.22 1000 1 **5160** 4\\.03 1000 4\n\n**3815** 11\\.12 1000 2 **4492** 7\\.57 1000 3 **5183** 11\\.27 1000 2\n\n**3821** 19\\.75 1000 3 **4494** 10\\.37 1000 3 **5184** 7\\.37 1000 4\n\n**3828** 9\\.12 1000 3 **4495** 12\\.84 1000 1 **5185** 11\\.78 1000 1\n\n**3830** 3\\.64 1000 2 **4496** 10\\.14 1000 3 **5186** 4\\.32 1000 1\n\n**3831** 5\\.68 1000 3 **4497** 8\\.16 1000 3 **5187** 8\\.17 1000 2\n\n**3840** 10\\.18 1000 3 **4498** 10\\.32 1000 3 **5190** 8\\.95 1000 2\n\n**4000** 8\\.94 1000 2 **4499** 9\\.43 1000 3 **5191** 3\\.72 1000 2\n\n**4034** 13\\.99 1000 3 **4511** 2\\.01 1000 3 **5192** 12\\.27 1000 2\n\n**4036** 4\\.80 1000 2 **4512** 0\\.78 1000 3 **5195** 12\\.53 1000 4\n\n**4038** 14\\.14 1000 2 **4557** 5\\.77 1000 2 **5201** 12\\.54 1000 2\n\n**4041** 11\\.12 1000 1 **4558** 6\\.44 1000 3 **5205** 8\\.68 1000 4\n\n**4049** 8\\.81 1000 3 **4611** 4\\.47 1000 3 **5207** 10\\.73 1000 1\n\n**4111** 4\\.11 1000 3 **4623** 14\\.11 1000 3 **5212** 16\\.83 1000 4\n\n2 of 6","publish_date":null,"title":"WORKERS COMPENSATION AND EMPLOYERS LIABILITY OBI NATIONAL INSURANCE COMPANY STANDARD STATE: CALIFORNIA EFFECTIVE DATE: DECEMBER 15, 2013","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page316.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page316.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page316","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page316.pdf"},"started_at":"2026-11-04T19:47:11.404280"} +{"completed_at":"2026-11-04T19:47:14.545040","latency_in_ms":2330,"output":{"example_id":"table/SERFF_CA_random_pages 1_page330","grounded_pages":[],"layout_pages":[],"markdown":"Current Proposed\n\nAsset or revenue size Base Base\n\nin Millions Rate Rate\n\nUp to 50 2,000 2,150\n\n50-60 2,200 2,365\n\n60-70 2,400 2,580\n\n70-80 2,600 2,795\n\n80-90 2,800 3,010\n\n90-100 3,000 3,225\n\n100-110 3,200 3,440\n\n110-120 3,400 3,655\n\n120-130 3,600 3,870\n\n130-140 3,800 4,085\n\n140-150 4,000 4,300\n\n150-160 4,200 4,515\n\n160-170 4,400 4,730\n\n170-180 4,600 4,945\n\n180-190 4,800 5,160\n\n190-200 5,000 5,375\n\n200-225 5,250 5,644\n\n225-250 5,500 5,913\n\n250-275 5,750 6,181\n\n275-300 6,000 6,450\n\n300-325 6,250 6,719\n\n325-350 6,500 6,988\n\n350-375 6,750 7,256\n\n375-400 7,000 7,525\n\n400-425 7,250 7,794\n\n425-450 7,500 8,063\n\n450-475 7,750 8,331\n\n475-500 8,000 8,600\n\n500-600 8,400 9,030\n\n600-700 8,800 9,460\n\n700-800 9,200 9,890\n\n800-900 9,600 10,320\n\n900-1,000 10,000 10,750\n\n1,000-1,500 10,500 11,288\n\n1,500-2,000 11,500 12,363\n\n2,000-2,500 12,500 13,438\n\n2,500-3,000 13,500 14,513\n\n3,000-4,000 14,000 15,050\n\n4,000-5,000 14,500 15,588\n\n5,000-6,000 15,000 16,125\n\n6,000-7,000 15,500 16,663\n\n7,000-8,000 16,000 17,200\n\n8,000-9,000 16,500 17,738\n\n9,000-10,000 17,000 18,275\n\n>10,000 an additional 250 for each billion in assets","pages":[{"line_numbers":[],"markdown":"Current Proposed\n\nAsset or revenue size Base Base\n\nin Millions Rate Rate\n\nUp to 50 2,000 2,150\n\n50-60 2,200 2,365\n\n60-70 2,400 2,580\n\n70-80 2,600 2,795\n\n80-90 2,800 3,010\n\n90-100 3,000 3,225\n\n100-110 3,200 3,440\n\n110-120 3,400 3,655\n\n120-130 3,600 3,870\n\n130-140 3,800 4,085\n\n140-150 4,000 4,300\n\n150-160 4,200 4,515\n\n160-170 4,400 4,730\n\n170-180 4,600 4,945\n\n180-190 4,800 5,160\n\n190-200 5,000 5,375\n\n200-225 5,250 5,644\n\n225-250 5,500 5,913\n\n250-275 5,750 6,181\n\n275-300 6,000 6,450\n\n300-325 6,250 6,719\n\n325-350 6,500 6,988\n\n350-375 6,750 7,256\n\n375-400 7,000 7,525\n\n400-425 7,250 7,794\n\n425-450 7,500 8,063\n\n450-475 7,750 8,331\n\n475-500 8,000 8,600\n\n500-600 8,400 9,030\n\n600-700 8,800 9,460\n\n700-800 9,200 9,890\n\n800-900 9,600 10,320\n\n900-1,000 10,000 10,750\n\n1,000-1,500 10,500 11,288\n\n1,500-2,000 11,500 12,363\n\n2,000-2,500 12,500 13,438\n\n2,500-3,000 13,500 14,513\n\n3,000-4,000 14,000 15,050\n\n4,000-5,000 14,500 15,588\n\n5,000-6,000 15,000 16,125\n\n6,000-7,000 15,500 16,663\n\n7,000-8,000 16,000 17,200\n\n8,000-9,000 16,500 17,738\n\n9,000-10,000 17,000 18,275\n\n>10,000 an additional 250 for each billion in assets","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Current Proposed\n\nAsset or revenue size Base Base\n\nin Millions Rate Rate\n\nUp to 50 2,000 2,150\n\n50-60 2,200 2,365\n\n60-70 2,400 2,580\n\n70-80 2,600 2,795\n\n80-90 2,800 3,010\n\n90-100 3,000 3,225\n\n100-110 3,200 3,440\n\n110-120 3,400 3,655\n\n120-130 3,600 3,870\n\n130-140 3,800 4,085\n\n140-150 4,000 4,300\n\n150-160 4,200 4,515\n\n160-170 4,400 4,730\n\n170-180 4,600 4,945\n\n180-190 4,800 5,160\n\n190-200 5,000 5,375\n\n200-225 5,250 5,644\n\n225-250 5,500 5,913\n\n250-275 5,750 6,181\n\n275-300 6,000 6,450\n\n300-325 6,250 6,719\n\n325-350 6,500 6,988\n\n350-375 6,750 7,256\n\n375-400 7,000 7,525\n\n400-425 7,250 7,794\n\n425-450 7,500 8,063\n\n450-475 7,750 8,331\n\n475-500 8,000 8,600\n\n500-600 8,400 9,030\n\n600-700 8,800 9,460\n\n700-800 9,200 9,890\n\n800-900 9,600 10,320\n\n900-1,000 10,000 10,750\n\n1,000-1,500 10,500 11,288\n\n1,500-2,000 11,500 12,363\n\n2,000-2,500 12,500 13,438\n\n2,500-3,000 13,500 14,513\n\n3,000-4,000 14,000 15,050\n\n4,000-5,000 14,500 15,588\n\n5,000-6,000 15,000 16,125\n\n6,000-7,000 15,500 16,663\n\n7,000-8,000 16,000 17,200\n\n8,000-9,000 16,500 17,738\n\n9,000-10,000 17,000 18,275\n\n>10,000 an additional 250 for each billion in assets","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page330.pdf"]},"response":{"errors":[],"extract_id":"extract_0413e80d359b42504626e4fde34dba07","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Current Proposed\n\nAsset or revenue size Base Base\n\nin Millions Rate Rate\n\nUp to 50 2,000 2,150\n\n50-60 2,200 2,365\n\n60-70 2,400 2,580\n\n70-80 2,600 2,795\n\n80-90 2,800 3,010\n\n90-100 3,000 3,225\n\n100-110 3,200 3,440\n\n110-120 3,400 3,655\n\n120-130 3,600 3,870\n\n130-140 3,800 4,085\n\n140-150 4,000 4,300\n\n150-160 4,200 4,515\n\n160-170 4,400 4,730\n\n170-180 4,600 4,945\n\n180-190 4,800 5,160\n\n190-200 5,000 5,375\n\n200-225 5,250 5,644\n\n225-250 5,500 5,913\n\n250-275 5,750 6,181\n\n275-300 6,000 6,450\n\n300-325 6,250 6,719\n\n325-350 6,500 6,988\n\n350-375 6,750 7,256\n\n375-400 7,000 7,525\n\n400-425 7,250 7,794\n\n425-450 7,500 8,063\n\n450-475 7,750 8,331\n\n475-500 8,000 8,600\n\n500-600 8,400 9,030\n\n600-700 8,800 9,460\n\n700-800 9,200 9,890\n\n800-900 9,600 10,320\n\n900-1,000 10,000 10,750\n\n1,000-1,500 10,500 11,288\n\n1,500-2,000 11,500 12,363\n\n2,000-2,500 12,500 13,438\n\n2,500-3,000 13,500 14,513\n\n3,000-4,000 14,000 15,050\n\n4,000-5,000 14,500 15,588\n\n5,000-6,000 15,000 16,125\n\n6,000-7,000 15,500 16,663\n\n7,000-8,000 16,000 17,200\n\n8,000-9,000 16,500 17,738\n\n9,000-10,000 17,000 18,275\n\n>10,000 an additional 250 for each billion in assets"],"full_content":"Current Proposed\n\nAsset or revenue size Base Base\n\nin Millions Rate Rate\n\nUp to 50 2,000 2,150\n\n50-60 2,200 2,365\n\n60-70 2,400 2,580\n\n70-80 2,600 2,795\n\n80-90 2,800 3,010\n\n90-100 3,000 3,225\n\n100-110 3,200 3,440\n\n110-120 3,400 3,655\n\n120-130 3,600 3,870\n\n130-140 3,800 4,085\n\n140-150 4,000 4,300\n\n150-160 4,200 4,515\n\n160-170 4,400 4,730\n\n170-180 4,600 4,945\n\n180-190 4,800 5,160\n\n190-200 5,000 5,375\n\n200-225 5,250 5,644\n\n225-250 5,500 5,913\n\n250-275 5,750 6,181\n\n275-300 6,000 6,450\n\n300-325 6,250 6,719\n\n325-350 6,500 6,988\n\n350-375 6,750 7,256\n\n375-400 7,000 7,525\n\n400-425 7,250 7,794\n\n425-450 7,500 8,063\n\n450-475 7,750 8,331\n\n475-500 8,000 8,600\n\n500-600 8,400 9,030\n\n600-700 8,800 9,460\n\n700-800 9,200 9,890\n\n800-900 9,600 10,320\n\n900-1,000 10,000 10,750\n\n1,000-1,500 10,500 11,288\n\n1,500-2,000 11,500 12,363\n\n2,000-2,500 12,500 13,438\n\n2,500-3,000 13,500 14,513\n\n3,000-4,000 14,000 15,050\n\n4,000-5,000 14,500 15,588\n\n5,000-6,000 15,000 16,125\n\n6,000-7,000 15,500 16,663\n\n7,000-8,000 16,000 17,200\n\n8,000-9,000 16,500 17,738\n\n9,000-10,000 17,000 18,275\n\n>10,000 an additional 250 for each billion in assets","publish_date":null,"title":"Current Proposed Asset or revenue size Base Base in Millions Rate Rate Up to 50 2,000 2,150 50-60 2,200 2,365","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page330.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page330.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page330","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page330.pdf"},"started_at":"2026-11-04T19:47:12.214321"} +{"completed_at":"2026-11-04T19:47:15.569822","latency_in_ms":1708,"output":{"example_id":"table/SERFF_CA_random_pages 1_page36","grounded_pages":[],"layout_pages":[],"markdown":"Access General Insurance Company Exhibit 10 **Credibility Adjustment** Support Data Exhibit Used to determine the number of years input into the data sheet of the CDI Rate Template Excel file.\n\nAccess is using 3,000 claim features and the square root rule as the credibility adjustment. The complement of credibility used is the net trend. **(8) \\* Minimal Years Combined (1) (2) (3) (4) (5) (6) (7) For full Credibility (9) (10) = Min(1, ((9)/3000)^(1/2)) Claims Reported the Past 6 Years by AY Evaluated through December 31, 2011 ---> or 25% Credibility in \\* Claims Counted (All >= 0.25) Coverages 2006 2007 2008 2009 2010 2011 the latest years from Years Combined Credibility** BI 1,458 6,908 10,468 15,998 18,241 23,637 2011 23,637 1.00 CL 539 4,252 5,799 8,022 6,268 11,076 2011 11,076 1.00 CP 81 798 1,311 1,789 1,527 2,638 2010, 2011 4,165 1.00 MP 33 208 212 347 397 472 2009, 2010 and 2011 1,216 0.64 PD 2,851 13,319 23,453 37,018 44,962 62,561 2011 62,561 1.00 UB 73 255 263 412 462 531 2009, 2010 and 2011 1,405 0.68 UP 72 259 262 385 472 673 2009, 2010 and 2011 1,530 0.71","pages":[{"line_numbers":[],"markdown":"Access General Insurance Company Exhibit 10 **Credibility Adjustment** Support Data Exhibit Used to determine the number of years input into the data sheet of the CDI Rate Template Excel file.\n\nAccess is using 3,000 claim features and the square root rule as the credibility adjustment. The complement of credibility used is the net trend. **(8) \\* Minimal Years Combined (1) (2) (3) (4) (5) (6) (7) For full Credibility (9) (10) = Min(1, ((9)/3000)^(1/2)) Claims Reported the Past 6 Years by AY Evaluated through December 31, 2011 ---> or 25% Credibility in \\* Claims Counted (All >= 0.25) Coverages 2006 2007 2008 2009 2010 2011 the latest years from Years Combined Credibility** BI 1,458 6,908 10,468 15,998 18,241 23,637 2011 23,637 1.00 CL 539 4,252 5,799 8,022 6,268 11,076 2011 11,076 1.00 CP 81 798 1,311 1,789 1,527 2,638 2010, 2011 4,165 1.00 MP 33 208 212 347 397 472 2009, 2010 and 2011 1,216 0.64 PD 2,851 13,319 23,453 37,018 44,962 62,561 2011 62,561 1.00 UB 73 255 263 412 462 531 2009, 2010 and 2011 1,405 0.68 UP 72 259 262 385 472 673 2009, 2010 and 2011 1,530 0.71","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Access General Insurance Company Exhibit 10 **Credibility Adjustment** Support Data Exhibit Used to determine the number of years input into the data sheet of the CDI Rate Template Excel file.\n\nAccess is using 3,000 claim features and the square root rule as the credibility adjustment. The complement of credibility used is the net trend. **(8) \\* Minimal Years Combined (1) (2) (3) (4) (5) (6) (7) For full Credibility (9) (10) = Min(1, ((9)/3000)^(1/2)) Claims Reported the Past 6 Years by AY Evaluated through December 31, 2011 ---> or 25% Credibility in \\* Claims Counted (All >= 0.25) Coverages 2006 2007 2008 2009 2010 2011 the latest years from Years Combined Credibility** BI 1,458 6,908 10,468 15,998 18,241 23,637 2011 23,637 1.00 CL 539 4,252 5,799 8,022 6,268 11,076 2011 11,076 1.00 CP 81 798 1,311 1,789 1,527 2,638 2010, 2011 4,165 1.00 MP 33 208 212 347 397 472 2009, 2010 and 2011 1,216 0.64 PD 2,851 13,319 23,453 37,018 44,962 62,561 2011 62,561 1.00 UB 73 255 263 412 462 531 2009, 2010 and 2011 1,405 0.68 UP 72 259 262 385 472 673 2009, 2010 and 2011 1,530 0.71","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page36.pdf"]},"response":{"errors":[],"extract_id":"extract_721575b1e03967aa5a39b2aa67c6daa3","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Access General Insurance Company Exhibit 10 **Credibility Adjustment** Support Data Exhibit Used to determine the number of years input into the data sheet of the CDI Rate Template Excel file.\n\nAccess is using 3,000 claim features and the square root rule as the credibility adjustment. The complement of credibility used is the net trend. **(8) \\* Minimal Years Combined (1) (2) (3) (4) (5) (6) (7) For full Credibility (9) (10) = Min(1, ((9)/3000)^(1/2)) Claims Reported the Past 6 Years by AY Evaluated through December 31, 2011 ---> or 25% Credibility in \\* Claims Counted (All >= 0.25) Coverages 2006 2007 2008 2009 2010 2011 the latest years from Years Combined Credibility** BI 1,458 6,908 10,468 15,998 18,241 23,637 2011 23,637 1.00 CL 539 4,252 5,799 8,022 6,268 11,076 2011 11,076 1.00 CP 81 798 1,311 1,789 1,527 2,638 2010, 2011 4,165 1.00 MP 33 208 212 347 397 472 2009, 2010 and 2011 1,216 0.64 PD 2,851 13,319 23,453 37,018 44,962 62,561 2011 62,561 1.00 UB 73 255 263 412 462 531 2009, 2010 and 2011 1,405 0.68 UP 72 259 262 385 472 673 2009, 2010 and 2011 1,530 0.71"],"full_content":"Access General Insurance Company Exhibit 10 **Credibility Adjustment** Support Data Exhibit Used to determine the number of years input into the data sheet of the CDI Rate Template Excel file.\n\nAccess is using 3,000 claim features and the square root rule as the credibility adjustment. The complement of credibility used is the net trend. **(8) \\* Minimal Years Combined (1) (2) (3) (4) (5) (6) (7) For full Credibility (9) (10) = Min(1, ((9)/3000)^(1/2)) Claims Reported the Past 6 Years by AY Evaluated through December 31, 2011 ---> or 25% Credibility in \\* Claims Counted (All >= 0.25) Coverages 2006 2007 2008 2009 2010 2011 the latest years from Years Combined Credibility** BI 1,458 6,908 10,468 15,998 18,241 23,637 2011 23,637 1.00 CL 539 4,252 5,799 8,022 6,268 11,076 2011 11,076 1.00 CP 81 798 1,311 1,789 1,527 2,638 2010, 2011 4,165 1.00 MP 33 208 212 347 397 472 2009, 2010 and 2011 1,216 0.64 PD 2,851 13,319 23,453 37,018 44,962 62,561 2011 62,561 1.00 UB 73 255 263 412 462 531 2009, 2010 and 2011 1,405 0.68 UP 72 259 262 385 472 673 2009, 2010 and 2011 1,530 0.71","publish_date":null,"title":"Access General Insurance Company Exhibit 10 Credibility Adjustment Support Data Exhibit Used to determine the number of years input into","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page36.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page36.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page36","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page36.pdf"},"started_at":"2026-11-04T19:47:13.861818"} +{"completed_at":"2026-11-04T19:31:07.703413","latency_in_ms":1760,"output":{"example_id":"table/SERFF_CA_random_pages 1_page37","grounded_pages":[],"layout_pages":[],"markdown":"**Access General Insurance Company** Exhibit 14 **CALIFORNIA PRIVATE PASSENGER AUTO** Support Data Exhibit Page 6 of 10\n\n**RATEMAKING CALCULATION - LOSS RATIO METHOD CL 2008 2009 2010 2011 Evaluated at Evaluated at Evaluated at Evaluated at 20111231 20111231 20111231 20111231 Total Source** (1) Calendar Period Earned Premium at Collected Rate Level 17,413,919 23,344,250 19,526,648 26,600,360 86,885,178 Exhibit 7\n\n(2) Current Rate Level Factor 1.000 1.000 1.000 1.000 1.000 Exhibit 4\n\n(3) Calendar Period Earned Premium Projected to Current Rate Level 17,413,919 23,344,250 19,526,648 26,600,360 86,885,178 (1) \\* (2)\n\n(3A) Fees and Other Charges 1,558,238 1,981,447 1,709,680 1,979,715 7,229,079 Exhibit 6\n\n(3B) Total Premium Projected to Current Rate Level 18,972,157 25,325,697 21,236,328 28,580,075 94,114,257 (3)+(3A)\n\n(4) Accident Period Incurred Loss & DCCE at 20111231 9,443,580 12,130,159 10,815,930 17,348,320 49,737,988 Exhibit 7\n\n(5) Incurred Loss & DCCE Selected Ultimate Development Factor 1.000 1.000 1.000 1.006 1.002 Exhibit 7\n\n(6) Developed Ultimate Incurred Loss & DCCE 9,443,580 12,130,159 10,815,930 17,452,410 49,842,078 (4) \\* (5)\n\n(7) Selected Average Annual Loss Trend 0.053 0.053 0.053 0.053 0.053 Exhibit 8, Page 8 of 8\n\n(8) Loss Trend Term in Years 4.96 3.95 2.95 1.95 X Exhibit 8, Page 8 of 8\n\n(9) Loss Trend Factor 1.292 1.226 1.164 1.106 1.183 [1 + (7)] ^ (8)\n\n(10) Trended Developed Ultimate Incurred Loss 12,201,899 14,873,260 12,594,779 19,300,522 58,970,459 (6) \\* (9)\n\n(11) Selected Average Annual Premium Trend 0.000 0.000 0.000 0.000 0.000 Exhibit 5, Page 2 of 2\n\n(12) Premium Trend Term in Years 4.96 3.95 2.95 1.95 X Exhibit 5, Page 2 of 2\n\n(13) Premium Trend Factor 0.999 0.999 1.000 1.000 0.999 [1 + (11)] ^ (12)\n\n(14) Trended Premium at Current Rate Level 18,957,533 25,310,099 21,226,583 28,571,298 94,065,513 [(3B)-(3A)] \\* (13) + (3A)\n\n(15) Trended, Projected, Developed Ultimate Incurred Loss & DCCE Ratio 64.4% 58.8% 59.3% 67.6% 62.7% (10) / (14)\n\n(16A) Fixed Expense Ratio 15.7% 15.7% 15.7% 15.7% 15.7% Exhibit 14, Page 8 of 10, Row (14)\n\n(16B) Variable Expense Ratio 24.5% 24.5% 24.5% 24.5% 24.5% Exhibit 14, Page 8 of 10, Row (15)\n\n(17) Experience Indicated Rate Level Change 5.9% -1.5% -0.7% 10.1% 3.7% [(15)+(16A)]/[(1-(16B)]-1\n\n(18) Closed Claim Features 5,799 8,022 6,268 10,938 31,027 Exhibit 7\n\n(19) Credibility (3000 features is fully credible) 1.000 1.000 1.000 1.000 1.000 MIN(( (18) / 3000 ) ^ 0.5, 1)\n\n(20) Net Trend (Complement of Credibility) 0.29 0.23 0.17 0.11 0.18 (9) / (13) - 1\n\n(21) Final Indicated Rate Level Change 3.7% (17) \\* (19) + (20) \\* (1-(19))\n\n(22) CA DOI Min Allowed Rate Change -4.7%\n\n(23) CA DOI Max Allowed Rate Change 13.9%\n\n(24) Proposed Rate Change 4.0%","pages":[{"line_numbers":[],"markdown":"**Access General Insurance Company** Exhibit 14 **CALIFORNIA PRIVATE PASSENGER AUTO** Support Data Exhibit Page 6 of 10\n\n**RATEMAKING CALCULATION - LOSS RATIO METHOD CL 2008 2009 2010 2011 Evaluated at Evaluated at Evaluated at Evaluated at 20111231 20111231 20111231 20111231 Total Source** (1) Calendar Period Earned Premium at Collected Rate Level 17,413,919 23,344,250 19,526,648 26,600,360 86,885,178 Exhibit 7\n\n(2) Current Rate Level Factor 1.000 1.000 1.000 1.000 1.000 Exhibit 4\n\n(3) Calendar Period Earned Premium Projected to Current Rate Level 17,413,919 23,344,250 19,526,648 26,600,360 86,885,178 (1) \\* (2)\n\n(3A) Fees and Other Charges 1,558,238 1,981,447 1,709,680 1,979,715 7,229,079 Exhibit 6\n\n(3B) Total Premium Projected to Current Rate Level 18,972,157 25,325,697 21,236,328 28,580,075 94,114,257 (3)+(3A)\n\n(4) Accident Period Incurred Loss & DCCE at 20111231 9,443,580 12,130,159 10,815,930 17,348,320 49,737,988 Exhibit 7\n\n(5) Incurred Loss & DCCE Selected Ultimate Development Factor 1.000 1.000 1.000 1.006 1.002 Exhibit 7\n\n(6) Developed Ultimate Incurred Loss & DCCE 9,443,580 12,130,159 10,815,930 17,452,410 49,842,078 (4) \\* (5)\n\n(7) Selected Average Annual Loss Trend 0.053 0.053 0.053 0.053 0.053 Exhibit 8, Page 8 of 8\n\n(8) Loss Trend Term in Years 4.96 3.95 2.95 1.95 X Exhibit 8, Page 8 of 8\n\n(9) Loss Trend Factor 1.292 1.226 1.164 1.106 1.183 [1 + (7)] ^ (8)\n\n(10) Trended Developed Ultimate Incurred Loss 12,201,899 14,873,260 12,594,779 19,300,522 58,970,459 (6) \\* (9)\n\n(11) Selected Average Annual Premium Trend 0.000 0.000 0.000 0.000 0.000 Exhibit 5, Page 2 of 2\n\n(12) Premium Trend Term in Years 4.96 3.95 2.95 1.95 X Exhibit 5, Page 2 of 2\n\n(13) Premium Trend Factor 0.999 0.999 1.000 1.000 0.999 [1 + (11)] ^ (12)\n\n(14) Trended Premium at Current Rate Level 18,957,533 25,310,099 21,226,583 28,571,298 94,065,513 [(3B)-(3A)] \\* (13) + (3A)\n\n(15) Trended, Projected, Developed Ultimate Incurred Loss & DCCE Ratio 64.4% 58.8% 59.3% 67.6% 62.7% (10) / (14)\n\n(16A) Fixed Expense Ratio 15.7% 15.7% 15.7% 15.7% 15.7% Exhibit 14, Page 8 of 10, Row (14)\n\n(16B) Variable Expense Ratio 24.5% 24.5% 24.5% 24.5% 24.5% Exhibit 14, Page 8 of 10, Row (15)\n\n(17) Experience Indicated Rate Level Change 5.9% -1.5% -0.7% 10.1% 3.7% [(15)+(16A)]/[(1-(16B)]-1\n\n(18) Closed Claim Features 5,799 8,022 6,268 10,938 31,027 Exhibit 7\n\n(19) Credibility (3000 features is fully credible) 1.000 1.000 1.000 1.000 1.000 MIN(( (18) / 3000 ) ^ 0.5, 1)\n\n(20) Net Trend (Complement of Credibility) 0.29 0.23 0.17 0.11 0.18 (9) / (13) - 1\n\n(21) Final Indicated Rate Level Change 3.7% (17) \\* (19) + (20) \\* (1-(19))\n\n(22) CA DOI Min Allowed Rate Change -4.7%\n\n(23) CA DOI Max Allowed Rate Change 13.9%\n\n(24) Proposed Rate Change 4.0%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Access General Insurance Company** Exhibit 14 **CALIFORNIA PRIVATE PASSENGER AUTO** Support Data Exhibit Page 6 of 10\n\n**RATEMAKING CALCULATION - LOSS RATIO METHOD CL 2008 2009 2010 2011 Evaluated at Evaluated at Evaluated at Evaluated at 20111231 20111231 20111231 20111231 Total Source** (1) Calendar Period Earned Premium at Collected Rate Level 17,413,919 23,344,250 19,526,648 26,600,360 86,885,178 Exhibit 7\n\n(2) Current Rate Level Factor 1.000 1.000 1.000 1.000 1.000 Exhibit 4\n\n(3) Calendar Period Earned Premium Projected to Current Rate Level 17,413,919 23,344,250 19,526,648 26,600,360 86,885,178 (1) \\* (2)\n\n(3A) Fees and Other Charges 1,558,238 1,981,447 1,709,680 1,979,715 7,229,079 Exhibit 6\n\n(3B) Total Premium Projected to Current Rate Level 18,972,157 25,325,697 21,236,328 28,580,075 94,114,257 (3)+(3A)\n\n(4) Accident Period Incurred Loss & DCCE at 20111231 9,443,580 12,130,159 10,815,930 17,348,320 49,737,988 Exhibit 7\n\n(5) Incurred Loss & DCCE Selected Ultimate Development Factor 1.000 1.000 1.000 1.006 1.002 Exhibit 7\n\n(6) Developed Ultimate Incurred Loss & DCCE 9,443,580 12,130,159 10,815,930 17,452,410 49,842,078 (4) \\* (5)\n\n(7) Selected Average Annual Loss Trend 0.053 0.053 0.053 0.053 0.053 Exhibit 8, Page 8 of 8\n\n(8) Loss Trend Term in Years 4.96 3.95 2.95 1.95 X Exhibit 8, Page 8 of 8\n\n(9) Loss Trend Factor 1.292 1.226 1.164 1.106 1.183 [1 + (7)] ^ (8)\n\n(10) Trended Developed Ultimate Incurred Loss 12,201,899 14,873,260 12,594,779 19,300,522 58,970,459 (6) \\* (9)\n\n(11) Selected Average Annual Premium Trend 0.000 0.000 0.000 0.000 0.000 Exhibit 5, Page 2 of 2\n\n(12) Premium Trend Term in Years 4.96 3.95 2.95 1.95 X Exhibit 5, Page 2 of 2\n\n(13) Premium Trend Factor 0.999 0.999 1.000 1.000 0.999 [1 + (11)] ^ (12)\n\n(14) Trended Premium at Current Rate Level 18,957,533 25,310,099 21,226,583 28,571,298 94,065,513 [(3B)-(3A)] \\* (13) + (3A)\n\n(15) Trended, Projected, Developed Ultimate Incurred Loss & DCCE Ratio 64.4% 58.8% 59.3% 67.6% 62.7% (10) / (14)\n\n(16A) Fixed Expense Ratio 15.7% 15.7% 15.7% 15.7% 15.7% Exhibit 14, Page 8 of 10, Row (14)\n\n(16B) Variable Expense Ratio 24.5% 24.5% 24.5% 24.5% 24.5% Exhibit 14, Page 8 of 10, Row (15)\n\n(17) Experience Indicated Rate Level Change 5.9% -1.5% -0.7% 10.1% 3.7% [(15)+(16A)]/[(1-(16B)]-1\n\n(18) Closed Claim Features 5,799 8,022 6,268 10,938 31,027 Exhibit 7\n\n(19) Credibility (3000 features is fully credible) 1.000 1.000 1.000 1.000 1.000 MIN(( (18) / 3000 ) ^ 0.5, 1)\n\n(20) Net Trend (Complement of Credibility) 0.29 0.23 0.17 0.11 0.18 (9) / (13) - 1\n\n(21) Final Indicated Rate Level Change 3.7% (17) \\* (19) + (20) \\* (1-(19))\n\n(22) CA DOI Min Allowed Rate Change -4.7%\n\n(23) CA DOI Max Allowed Rate Change 13.9%\n\n(24) Proposed Rate Change 4.0%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page37.pdf"]},"response":{"errors":[],"extract_id":"extract_86fd1e6c363a563735a4b5339bf00d47","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Access General Insurance Company** Exhibit 14 **CALIFORNIA PRIVATE PASSENGER AUTO** Support Data Exhibit Page 6 of 10\n\n**RATEMAKING CALCULATION - LOSS RATIO METHOD CL 2008 2009 2010 2011 Evaluated at Evaluated at Evaluated at Evaluated at 20111231 20111231 20111231 20111231 Total Source** (1) Calendar Period Earned Premium at Collected Rate Level 17,413,919 23,344,250 19,526,648 26,600,360 86,885,178 Exhibit 7\n\n(2) Current Rate Level Factor 1.000 1.000 1.000 1.000 1.000 Exhibit 4\n\n(3) Calendar Period Earned Premium Projected to Current Rate Level 17,413,919 23,344,250 19,526,648 26,600,360 86,885,178 (1) \\* (2)\n\n(3A) Fees and Other Charges 1,558,238 1,981,447 1,709,680 1,979,715 7,229,079 Exhibit 6\n\n(3B) Total Premium Projected to Current Rate Level 18,972,157 25,325,697 21,236,328 28,580,075 94,114,257 (3)+(3A)\n\n(4) Accident Period Incurred Loss & DCCE at 20111231 9,443,580 12,130,159 10,815,930 17,348,320 49,737,988 Exhibit 7\n\n(5) Incurred Loss & DCCE Selected Ultimate Development Factor 1.000 1.000 1.000 1.006 1.002 Exhibit 7\n\n(6) Developed Ultimate Incurred Loss & DCCE 9,443,580 12,130,159 10,815,930 17,452,410 49,842,078 (4) \\* (5)\n\n(7) Selected Average Annual Loss Trend 0.053 0.053 0.053 0.053 0.053 Exhibit 8, Page 8 of 8\n\n(8) Loss Trend Term in Years 4.96 3.95 2.95 1.95 X Exhibit 8, Page 8 of 8\n\n(9) Loss Trend Factor 1.292 1.226 1.164 1.106 1.183 [1 + (7)] ^ (8)\n\n(10) Trended Developed Ultimate Incurred Loss 12,201,899 14,873,260 12,594,779 19,300,522 58,970,459 (6) \\* (9)\n\n(11) Selected Average Annual Premium Trend 0.000 0.000 0.000 0.000 0.000 Exhibit 5, Page 2 of 2\n\n(12) Premium Trend Term in Years 4.96 3.95 2.95 1.95 X Exhibit 5, Page 2 of 2\n\n(13) Premium Trend Factor 0.999 0.999 1.000 1.000 0.999 [1 + (11)] ^ (12)\n\n(14) Trended Premium at Current Rate Level 18,957,533 25,310,099 21,226,583 28,571,298 94,065,513 [(3B)-(3A)] \\* (13) + (3A)\n\n(15) Trended, Projected, Developed Ultimate Incurred Loss & DCCE Ratio 64.4% 58.8% 59.3% 67.6% 62.7% (10) / (14)\n\n(16A) Fixed Expense Ratio 15.7% 15.7% 15.7% 15.7% 15.7% Exhibit 14, Page 8 of 10, Row (14)\n\n(16B) Variable Expense Ratio 24.5% 24.5% 24.5% 24.5% 24.5% Exhibit 14, Page 8 of 10, Row (15)\n\n(17) Experience Indicated Rate Level Change 5.9% -1.5% -0.7% 10.1% 3.7% [(15)+(16A)]/[(1-(16B)]-1\n\n(18) Closed Claim Features 5,799 8,022 6,268 10,938 31,027 Exhibit 7\n\n(19) Credibility (3000 features is fully credible) 1.000 1.000 1.000 1.000 1.000 MIN(( (18) / 3000 ) ^ 0.5, 1)\n\n(20) Net Trend (Complement of Credibility) 0.29 0.23 0.17 0.11 0.18 (9) / (13) - 1\n\n(21) Final Indicated Rate Level Change 3.7% (17) \\* (19) + (20) \\* (1-(19))\n\n(22) CA DOI Min Allowed Rate Change -4.7%\n\n(23) CA DOI Max Allowed Rate Change 13.9%\n\n(24) Proposed Rate Change 4.0%"],"full_content":"**Access General Insurance Company** Exhibit 14 **CALIFORNIA PRIVATE PASSENGER AUTO** Support Data Exhibit Page 6 of 10\n\n**RATEMAKING CALCULATION - LOSS RATIO METHOD CL 2008 2009 2010 2011 Evaluated at Evaluated at Evaluated at Evaluated at 20111231 20111231 20111231 20111231 Total Source** (1) Calendar Period Earned Premium at Collected Rate Level 17,413,919 23,344,250 19,526,648 26,600,360 86,885,178 Exhibit 7\n\n(2) Current Rate Level Factor 1.000 1.000 1.000 1.000 1.000 Exhibit 4\n\n(3) Calendar Period Earned Premium Projected to Current Rate Level 17,413,919 23,344,250 19,526,648 26,600,360 86,885,178 (1) \\* (2)\n\n(3A) Fees and Other Charges 1,558,238 1,981,447 1,709,680 1,979,715 7,229,079 Exhibit 6\n\n(3B) Total Premium Projected to Current Rate Level 18,972,157 25,325,697 21,236,328 28,580,075 94,114,257 (3)+(3A)\n\n(4) Accident Period Incurred Loss & DCCE at 20111231 9,443,580 12,130,159 10,815,930 17,348,320 49,737,988 Exhibit 7\n\n(5) Incurred Loss & DCCE Selected Ultimate Development Factor 1.000 1.000 1.000 1.006 1.002 Exhibit 7\n\n(6) Developed Ultimate Incurred Loss & DCCE 9,443,580 12,130,159 10,815,930 17,452,410 49,842,078 (4) \\* (5)\n\n(7) Selected Average Annual Loss Trend 0.053 0.053 0.053 0.053 0.053 Exhibit 8, Page 8 of 8\n\n(8) Loss Trend Term in Years 4.96 3.95 2.95 1.95 X Exhibit 8, Page 8 of 8\n\n(9) Loss Trend Factor 1.292 1.226 1.164 1.106 1.183 [1 + (7)] ^ (8)\n\n(10) Trended Developed Ultimate Incurred Loss 12,201,899 14,873,260 12,594,779 19,300,522 58,970,459 (6) \\* (9)\n\n(11) Selected Average Annual Premium Trend 0.000 0.000 0.000 0.000 0.000 Exhibit 5, Page 2 of 2\n\n(12) Premium Trend Term in Years 4.96 3.95 2.95 1.95 X Exhibit 5, Page 2 of 2\n\n(13) Premium Trend Factor 0.999 0.999 1.000 1.000 0.999 [1 + (11)] ^ (12)\n\n(14) Trended Premium at Current Rate Level 18,957,533 25,310,099 21,226,583 28,571,298 94,065,513 [(3B)-(3A)] \\* (13) + (3A)\n\n(15) Trended, Projected, Developed Ultimate Incurred Loss & DCCE Ratio 64.4% 58.8% 59.3% 67.6% 62.7% (10) / (14)\n\n(16A) Fixed Expense Ratio 15.7% 15.7% 15.7% 15.7% 15.7% Exhibit 14, Page 8 of 10, Row (14)\n\n(16B) Variable Expense Ratio 24.5% 24.5% 24.5% 24.5% 24.5% Exhibit 14, Page 8 of 10, Row (15)\n\n(17) Experience Indicated Rate Level Change 5.9% -1.5% -0.7% 10.1% 3.7% [(15)+(16A)]/[(1-(16B)]-1\n\n(18) Closed Claim Features 5,799 8,022 6,268 10,938 31,027 Exhibit 7\n\n(19) Credibility (3000 features is fully credible) 1.000 1.000 1.000 1.000 1.000 MIN(( (18) / 3000 ) ^ 0.5, 1)\n\n(20) Net Trend (Complement of Credibility) 0.29 0.23 0.17 0.11 0.18 (9) / (13) - 1\n\n(21) Final Indicated Rate Level Change 3.7% (17) \\* (19) + (20) \\* (1-(19))\n\n(22) CA DOI Min Allowed Rate Change -4.7%\n\n(23) CA DOI Max Allowed Rate Change 13.9%\n\n(24) Proposed Rate Change 4.0%","publish_date":null,"title":"Access General Insurance Company Exhibit 14 CALIFORNIA PRIVATE PASSENGER AUTO Support Data Exhibit Page 6 of 10 RATEMAKING CALCULATION -","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page37.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page37.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page37","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page37.pdf"},"started_at":"2026-11-04T19:31:05.943018"} +{"completed_at":"2026-11-04T19:47:17.720913","latency_in_ms":2149,"output":{"example_id":"table/SERFF_CA_random_pages 1_page408","grounded_pages":[],"layout_pages":[],"markdown":"**(2) Proposed** 1975 CA OEM Parts Replacement Endorsement 2 3 3 N N N 0%\n\n**Current**\n\n**(3) Proposed**\n\n**Current**\n\nPlease see the newly filed Rule V08.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nThis new endorsement gives customers the option to purchase OEM coverage. We have listed the endorsement here as not broadening coverage, because the endorsement is optional and is offset by the additional premium charge on the Collision and Comprehensive coverages. Please refer to exhibit 21 of our filed rate manual for details on those charges.\n\nWe propose using a 10% surcharge on Collision and Comprehensive premium, patterned after the factors currently in use for this endorsement by CSAA in California. The factors are filed with age-based splits, as we expect to be able to support such distinctions over time.\n\nAdditional premium is offset by the additional coverage provided.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nPrior Approval Rate Application Page 9.2 2/21/2025 Edition","pages":[{"line_numbers":[],"markdown":"**(2) Proposed** 1975 CA OEM Parts Replacement Endorsement 2 3 3 N N N 0%\n\n**Current**\n\n**(3) Proposed**\n\n**Current**\n\nPlease see the newly filed Rule V08.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nThis new endorsement gives customers the option to purchase OEM coverage. We have listed the endorsement here as not broadening coverage, because the endorsement is optional and is offset by the additional premium charge on the Collision and Comprehensive coverages. Please refer to exhibit 21 of our filed rate manual for details on those charges.\n\nWe propose using a 10% surcharge on Collision and Comprehensive premium, patterned after the factors currently in use for this endorsement by CSAA in California. The factors are filed with age-based splits, as we expect to be able to support such distinctions over time.\n\nAdditional premium is offset by the additional coverage provided.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nPrior Approval Rate Application Page 9.2 2/21/2025 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**(2) Proposed** 1975 CA OEM Parts Replacement Endorsement 2 3 3 N N N 0%\n\n**Current**\n\n**(3) Proposed**\n\n**Current**\n\nPlease see the newly filed Rule V08.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nThis new endorsement gives customers the option to purchase OEM coverage. We have listed the endorsement here as not broadening coverage, because the endorsement is optional and is offset by the additional premium charge on the Collision and Comprehensive coverages. Please refer to exhibit 21 of our filed rate manual for details on those charges.\n\nWe propose using a 10% surcharge on Collision and Comprehensive premium, patterned after the factors currently in use for this endorsement by CSAA in California. The factors are filed with age-based splits, as we expect to be able to support such distinctions over time.\n\nAdditional premium is offset by the additional coverage provided.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nPrior Approval Rate Application Page 9.2 2/21/2025 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page408.pdf"]},"response":{"errors":[],"extract_id":"extract_92b9c14266f17c7a798bb1e7016daf13","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**(2) Proposed** 1975 CA OEM Parts Replacement Endorsement 2 3 3 N N N 0%\n\n**Current**\n\n**(3) Proposed**\n\n**Current**\n\nPlease see the newly filed Rule V08.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nThis new endorsement gives customers the option to purchase OEM coverage. We have listed the endorsement here as not broadening coverage, because the endorsement is optional and is offset by the additional premium charge on the Collision and Comprehensive coverages. Please refer to exhibit 21 of our filed rate manual for details on those charges.\n\nWe propose using a 10% surcharge on Collision and Comprehensive premium, patterned after the factors currently in use for this endorsement by CSAA in California. The factors are filed with age-based splits, as we expect to be able to support such distinctions over time.\n\nAdditional premium is offset by the additional coverage provided.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nPrior Approval Rate Application Page 9.2 2/21/2025 Edition"],"full_content":"**(2) Proposed** 1975 CA OEM Parts Replacement Endorsement 2 3 3 N N N 0%\n\n**Current**\n\n**(3) Proposed**\n\n**Current**\n\nPlease see the newly filed Rule V08.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nThis new endorsement gives customers the option to purchase OEM coverage. We have listed the endorsement here as not broadening coverage, because the endorsement is optional and is offset by the additional premium charge on the Collision and Comprehensive coverages. Please refer to exhibit 21 of our filed rate manual for details on those charges.\n\nWe propose using a 10% surcharge on Collision and Comprehensive premium, patterned after the factors currently in use for this endorsement by CSAA in California. The factors are filed with age-based splits, as we expect to be able to support such distinctions over time.\n\nAdditional premium is offset by the additional coverage provided.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nPrior Approval Rate Application Page 9.2 2/21/2025 Edition","publish_date":null,"title":"(2) Proposed 1975 CA 2 3 3 N N N 0% OEM Parts Replacement Endorsement Current This new endorsement gives","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page408.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page408.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page408","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page408.pdf"},"started_at":"2026-11-04T19:47:15.571284"} +{"completed_at":"2026-11-04T19:47:19.451991","latency_in_ms":1928,"output":{"example_id":"table/SERFF_CA_random_pages 1_page41","grounded_pages":[],"layout_pages":[],"markdown":"Access General Insurance Company Exhibit 7 PPA Loss & DCC Development Factors Support Data Exhibit Accident Quarter Cumulative Statistics Page 11 of 18 **MP**\n\n**CUMU DOLLARS - LOSS & DCC REPORTED -------> To-Date Quarterly Annual Loss + DCC Ultimate Ultimate Accident Ultimate Coverage ACC QTR Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16 Q17 Q18 Q19 Q20 Q21 Q22 Q23 Q24 Q25 Reported LDF Loss + DCC Year Incur LDF** MP 20054 0 2,010 2,000 2,000 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1.00 1,330 2005 1.000 MP 20061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.00 0 MP 20062 2,400 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 1.00 3,000 MP 20063 5,300 4,600 4,600 8,372 10,252 10,252 10,252 10,252 10,252 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 1.00 5,049 MP 20064 8,000 5,000 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 1.00 6,500 2006 1.000 MP 20071 25,583 16,173 19,173 20,173 18,173 23,173 23,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 1.00 22,173 MP 20072 6,960 12,094 18,124 22,372 22,372 23,372 26,372 26,372 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 1.00 25,872 MP 20073 8,200 14,679 16,379 22,079 22,079 21,579 21,579 21,579 21,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 1.00 22,579 MP 20074 11,672 18,164 23,814 23,955 26,455 27,655 29,655 30,655 30,655 29,988 29,988 29,988 29,688 29,688 29,688 29,688 29,688 29,688 1.00 29,688 2007 1.000 MP 20081 3,700 11,000 14,000 15,000 19,600 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 1.00 19,100 MP 20082 19,156 27,732 38,978 37,711 38,711 38,711 38,711 37,651 39,651 39,651 39,651 39,651 39,651 39,651 39,651 39,651 1.00 39,651 MP 20083 12,605 16,075 29,303 29,303 29,703 29,703 32,703 33,036 33,036 33,036 34,036 34,036 34,036 34,036 34,036 1.00 34,036 MP 20084 2,700 20,662 28,242 26,608 30,858 31,466 33,132 34,132 33,541 34,541 34,541 34,091 34,091 34,091 1.00 34,091 2008 1.000 MP 20091 18,440 27,877 35,330 41,550 43,550 43,550 42,850 42,850 42,850 42,850 42,850 42,850 42,850 1.00 42,850 MP 20092 11,160 22,995 28,262 31,937 31,885 31,885 32,885 31,819 32,087 32,087 32,087 32,087 1.00 31,957 MP 20093 25,681 37,139 54,160 54,660 57,260 57,260 58,610 58,610 59,495 58,795 58,795 1.00 58,557 MP 20094 15,712 16,772 23,330 36,070 36,570 36,504 33,670 31,670 31,670 31,670 0.99 31,378 2009 0.996 MP 20101 9,385 24,975 36,886 40,072 40,805 42,405 42,405 42,405 42,405 1.00 42,411 MP 20102 20,106 40,626 54,076 55,476 52,662 52,247 52,247 52,247 0.99 51,477 MP 20103 18,799 22,384 33,492 39,825 39,158 38,504 38,504 0.96 37,118 MP 20104 23,111 30,298 49,673 55,952 56,586 56,586 0.97 54,766 2010 0.979 MP 20111 16,548 42,154 61,958 67,292 67,292 0.95 63,903 MP 20112 21,009 29,293 60,935 60,935 1.07 65,022 MP 20113 15,825 30,815 30,815 1.81 55,769 MP 20114 14,531 14,531 3.47 50,378 2011 1.354\n\nMP All 771,785 828,656\n\n**AGE-TO-AGE - LOSS & DCC REPORTED ------->**\n\n**Coverage ACC QTR Q2/Q1 Q3/Q2 Q4/Q3 Q5/Q4 Q6/Q5 Q7/Q6 Q8/Q7 Q9/Q8 Q10/Q9 Q11/Q10 Q12/Q11 Q13/Q12 Q14/Q13 Q15/Q14 Q16/Q15 Q17/Q16 Q18/Q17 Q19/Q18 Q20/Q19 Q21/Q20 Q22/Q21 Q23/Q22 Q24/Q23 Q25/Q24 TAIL / Q25** MP 20054 1.00 1.00 0.67 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00** MP 20061 #DIV/0! MP 20062 1.25 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20063 0.87 1.00 1.82 1.22 1.00 1.00 1.00 1.00 0.49 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20064 0.63 1.30 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20071 0.63 1.19 1.05 0.90 1.28 1.00 0.96 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20072 1.74 1.50 1.23 1.00 1.04 1.13 1.00 0.98 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20073 1.79 1.12 1.35 1.00 0.98 1.00 1.00 1.00 1.05 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20074 1.56 1.31 1.01 1.10 1.05 1.07 1.03 1.00 0.98 1.00 1.00 0.99 1.00 1.00 1.00 1.00 MP 20081 2.97 1.27 1.07 1.31 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20082 1.45 1.41 0.97 1.03 1.00 1.00 0.97 1.05 1.00 1.00 1.00 1.00 1.00 1.00 MP 20083 1.28 1.82 1.00 1.01 1.00 1.10 1.01 1.00 1.00 1.03 1.00 1.00 1.00 MP 20084 7.65 1.37 0.94 1.16 1.02 1.05 1.03 0.98 1.03 1.00 0.99 1.00 MP 20091 1.51 1.27 1.18 1.05 1.00 0.98 1.00 1.00 1.00 1.00 1.00 MP 20092 2.06 1.23 1.13 1.00 1.00 1.03 0.97 1.01 1.00 1.00 MP 20093 1.45 1.46 1.01 1.05 1.00 1.02 1.00 1.02 0.99 MP 20094 1.07 1.39 1.55 1.01 1.00 0.92 0.94 1.00 MP 20101 2.66 1.48 1.09 1.02 1.04 1.00 1.00 MP 20102 2.02 1.33 1.03 0.95 0.99 1.00 MP 20103 1.19 1.50 1.19 0.98 0.98 MP 20104 1.31 1.64 1.13 1.01 MP 20111 2.55 1.47 1.09 MP 20112 1.39 2.08 MP 20113 1.95\n\nCoefficient of Variation 0.77 0.19 0.19 0.12 0.06 0.05 0.02 0.02 0.14 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 #DIV/0! 0.00 0.00 Weighted Average Age-to-Age Factor 1.58 1.44 1.10 1.03 1.01 1.02 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00** Flat Average Age-to-Age Factor 1.86 1.37 1.13 1.02 1.02 1.02 0.99 1.00 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 #DIV/0! 1.00 **1\\.00** Weighted Average Last 3 Quarters 1.92 1.70 1.12 0.98 1.00 0.98 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00**\n\nSelected Age-to-Age Factor 1.92 1.70 1.12 0.98 1.00 0.98 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Age-to-Ultimate 3.47 1.81 1.07 0.95 0.97 0.96 0.99 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00","pages":[{"line_numbers":[],"markdown":"Access General Insurance Company Exhibit 7 PPA Loss & DCC Development Factors Support Data Exhibit Accident Quarter Cumulative Statistics Page 11 of 18 **MP**\n\n**CUMU DOLLARS - LOSS & DCC REPORTED -------> To-Date Quarterly Annual Loss + DCC Ultimate Ultimate Accident Ultimate Coverage ACC QTR Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16 Q17 Q18 Q19 Q20 Q21 Q22 Q23 Q24 Q25 Reported LDF Loss + DCC Year Incur LDF** MP 20054 0 2,010 2,000 2,000 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1.00 1,330 2005 1.000 MP 20061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.00 0 MP 20062 2,400 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 1.00 3,000 MP 20063 5,300 4,600 4,600 8,372 10,252 10,252 10,252 10,252 10,252 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 1.00 5,049 MP 20064 8,000 5,000 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 1.00 6,500 2006 1.000 MP 20071 25,583 16,173 19,173 20,173 18,173 23,173 23,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 1.00 22,173 MP 20072 6,960 12,094 18,124 22,372 22,372 23,372 26,372 26,372 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 1.00 25,872 MP 20073 8,200 14,679 16,379 22,079 22,079 21,579 21,579 21,579 21,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 1.00 22,579 MP 20074 11,672 18,164 23,814 23,955 26,455 27,655 29,655 30,655 30,655 29,988 29,988 29,988 29,688 29,688 29,688 29,688 29,688 29,688 1.00 29,688 2007 1.000 MP 20081 3,700 11,000 14,000 15,000 19,600 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 1.00 19,100 MP 20082 19,156 27,732 38,978 37,711 38,711 38,711 38,711 37,651 39,651 39,651 39,651 39,651 39,651 39,651 39,651 39,651 1.00 39,651 MP 20083 12,605 16,075 29,303 29,303 29,703 29,703 32,703 33,036 33,036 33,036 34,036 34,036 34,036 34,036 34,036 1.00 34,036 MP 20084 2,700 20,662 28,242 26,608 30,858 31,466 33,132 34,132 33,541 34,541 34,541 34,091 34,091 34,091 1.00 34,091 2008 1.000 MP 20091 18,440 27,877 35,330 41,550 43,550 43,550 42,850 42,850 42,850 42,850 42,850 42,850 42,850 1.00 42,850 MP 20092 11,160 22,995 28,262 31,937 31,885 31,885 32,885 31,819 32,087 32,087 32,087 32,087 1.00 31,957 MP 20093 25,681 37,139 54,160 54,660 57,260 57,260 58,610 58,610 59,495 58,795 58,795 1.00 58,557 MP 20094 15,712 16,772 23,330 36,070 36,570 36,504 33,670 31,670 31,670 31,670 0.99 31,378 2009 0.996 MP 20101 9,385 24,975 36,886 40,072 40,805 42,405 42,405 42,405 42,405 1.00 42,411 MP 20102 20,106 40,626 54,076 55,476 52,662 52,247 52,247 52,247 0.99 51,477 MP 20103 18,799 22,384 33,492 39,825 39,158 38,504 38,504 0.96 37,118 MP 20104 23,111 30,298 49,673 55,952 56,586 56,586 0.97 54,766 2010 0.979 MP 20111 16,548 42,154 61,958 67,292 67,292 0.95 63,903 MP 20112 21,009 29,293 60,935 60,935 1.07 65,022 MP 20113 15,825 30,815 30,815 1.81 55,769 MP 20114 14,531 14,531 3.47 50,378 2011 1.354\n\nMP All 771,785 828,656\n\n**AGE-TO-AGE - LOSS & DCC REPORTED ------->**\n\n**Coverage ACC QTR Q2/Q1 Q3/Q2 Q4/Q3 Q5/Q4 Q6/Q5 Q7/Q6 Q8/Q7 Q9/Q8 Q10/Q9 Q11/Q10 Q12/Q11 Q13/Q12 Q14/Q13 Q15/Q14 Q16/Q15 Q17/Q16 Q18/Q17 Q19/Q18 Q20/Q19 Q21/Q20 Q22/Q21 Q23/Q22 Q24/Q23 Q25/Q24 TAIL / Q25** MP 20054 1.00 1.00 0.67 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00** MP 20061 #DIV/0! MP 20062 1.25 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20063 0.87 1.00 1.82 1.22 1.00 1.00 1.00 1.00 0.49 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20064 0.63 1.30 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20071 0.63 1.19 1.05 0.90 1.28 1.00 0.96 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20072 1.74 1.50 1.23 1.00 1.04 1.13 1.00 0.98 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20073 1.79 1.12 1.35 1.00 0.98 1.00 1.00 1.00 1.05 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20074 1.56 1.31 1.01 1.10 1.05 1.07 1.03 1.00 0.98 1.00 1.00 0.99 1.00 1.00 1.00 1.00 MP 20081 2.97 1.27 1.07 1.31 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20082 1.45 1.41 0.97 1.03 1.00 1.00 0.97 1.05 1.00 1.00 1.00 1.00 1.00 1.00 MP 20083 1.28 1.82 1.00 1.01 1.00 1.10 1.01 1.00 1.00 1.03 1.00 1.00 1.00 MP 20084 7.65 1.37 0.94 1.16 1.02 1.05 1.03 0.98 1.03 1.00 0.99 1.00 MP 20091 1.51 1.27 1.18 1.05 1.00 0.98 1.00 1.00 1.00 1.00 1.00 MP 20092 2.06 1.23 1.13 1.00 1.00 1.03 0.97 1.01 1.00 1.00 MP 20093 1.45 1.46 1.01 1.05 1.00 1.02 1.00 1.02 0.99 MP 20094 1.07 1.39 1.55 1.01 1.00 0.92 0.94 1.00 MP 20101 2.66 1.48 1.09 1.02 1.04 1.00 1.00 MP 20102 2.02 1.33 1.03 0.95 0.99 1.00 MP 20103 1.19 1.50 1.19 0.98 0.98 MP 20104 1.31 1.64 1.13 1.01 MP 20111 2.55 1.47 1.09 MP 20112 1.39 2.08 MP 20113 1.95\n\nCoefficient of Variation 0.77 0.19 0.19 0.12 0.06 0.05 0.02 0.02 0.14 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 #DIV/0! 0.00 0.00 Weighted Average Age-to-Age Factor 1.58 1.44 1.10 1.03 1.01 1.02 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00** Flat Average Age-to-Age Factor 1.86 1.37 1.13 1.02 1.02 1.02 0.99 1.00 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 #DIV/0! 1.00 **1\\.00** Weighted Average Last 3 Quarters 1.92 1.70 1.12 0.98 1.00 0.98 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00**\n\nSelected Age-to-Age Factor 1.92 1.70 1.12 0.98 1.00 0.98 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Age-to-Ultimate 3.47 1.81 1.07 0.95 0.97 0.96 0.99 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Access General Insurance Company Exhibit 7 PPA Loss & DCC Development Factors Support Data Exhibit Accident Quarter Cumulative Statistics Page 11 of 18 **MP**\n\n**CUMU DOLLARS - LOSS & DCC REPORTED -------> To-Date Quarterly Annual Loss + DCC Ultimate Ultimate Accident Ultimate Coverage ACC QTR Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16 Q17 Q18 Q19 Q20 Q21 Q22 Q23 Q24 Q25 Reported LDF Loss + DCC Year Incur LDF** MP 20054 0 2,010 2,000 2,000 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1.00 1,330 2005 1.000 MP 20061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.00 0 MP 20062 2,400 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 1.00 3,000 MP 20063 5,300 4,600 4,600 8,372 10,252 10,252 10,252 10,252 10,252 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 1.00 5,049 MP 20064 8,000 5,000 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 1.00 6,500 2006 1.000 MP 20071 25,583 16,173 19,173 20,173 18,173 23,173 23,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 1.00 22,173 MP 20072 6,960 12,094 18,124 22,372 22,372 23,372 26,372 26,372 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 1.00 25,872 MP 20073 8,200 14,679 16,379 22,079 22,079 21,579 21,579 21,579 21,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 1.00 22,579 MP 20074 11,672 18,164 23,814 23,955 26,455 27,655 29,655 30,655 30,655 29,988 29,988 29,988 29,688 29,688 29,688 29,688 29,688 29,688 1.00 29,688 2007 1.000 MP 20081 3,700 11,000 14,000 15,000 19,600 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 1.00 19,100 MP 20082 19,156 27,732 38,978 37,711 38,711 38,711 38,711 37,651 39,651 39,651 39,651 39,651 39,651 39,651 39,651 39,651 1.00 39,651 MP 20083 12,605 16,075 29,303 29,303 29,703 29,703 32,703 33,036 33,036 33,036 34,036 34,036 34,036 34,036 34,036 1.00 34,036 MP 20084 2,700 20,662 28,242 26,608 30,858 31,466 33,132 34,132 33,541 34,541 34,541 34,091 34,091 34,091 1.00 34,091 2008 1.000 MP 20091 18,440 27,877 35,330 41,550 43,550 43,550 42,850 42,850 42,850 42,850 42,850 42,850 42,850 1.00 42,850 MP 20092 11,160 22,995 28,262 31,937 31,885 31,885 32,885 31,819 32,087 32,087 32,087 32,087 1.00 31,957 MP 20093 25,681 37,139 54,160 54,660 57,260 57,260 58,610 58,610 59,495 58,795 58,795 1.00 58,557 MP 20094 15,712 16,772 23,330 36,070 36,570 36,504 33,670 31,670 31,670 31,670 0.99 31,378 2009 0.996 MP 20101 9,385 24,975 36,886 40,072 40,805 42,405 42,405 42,405 42,405 1.00 42,411 MP 20102 20,106 40,626 54,076 55,476 52,662 52,247 52,247 52,247 0.99 51,477 MP 20103 18,799 22,384 33,492 39,825 39,158 38,504 38,504 0.96 37,118 MP 20104 23,111 30,298 49,673 55,952 56,586 56,586 0.97 54,766 2010 0.979 MP 20111 16,548 42,154 61,958 67,292 67,292 0.95 63,903 MP 20112 21,009 29,293 60,935 60,935 1.07 65,022 MP 20113 15,825 30,815 30,815 1.81 55,769 MP 20114 14,531 14,531 3.47 50,378 2011 1.354\n\nMP All 771,785 828,656\n\n**AGE-TO-AGE - LOSS & DCC REPORTED ------->**\n\n**Coverage ACC QTR Q2/Q1 Q3/Q2 Q4/Q3 Q5/Q4 Q6/Q5 Q7/Q6 Q8/Q7 Q9/Q8 Q10/Q9 Q11/Q10 Q12/Q11 Q13/Q12 Q14/Q13 Q15/Q14 Q16/Q15 Q17/Q16 Q18/Q17 Q19/Q18 Q20/Q19 Q21/Q20 Q22/Q21 Q23/Q22 Q24/Q23 Q25/Q24 TAIL / Q25** MP 20054 1.00 1.00 0.67 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00** MP 20061 #DIV/0! MP 20062 1.25 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20063 0.87 1.00 1.82 1.22 1.00 1.00 1.00 1.00 0.49 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20064 0.63 1.30 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20071 0.63 1.19 1.05 0.90 1.28 1.00 0.96 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20072 1.74 1.50 1.23 1.00 1.04 1.13 1.00 0.98 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20073 1.79 1.12 1.35 1.00 0.98 1.00 1.00 1.00 1.05 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20074 1.56 1.31 1.01 1.10 1.05 1.07 1.03 1.00 0.98 1.00 1.00 0.99 1.00 1.00 1.00 1.00 MP 20081 2.97 1.27 1.07 1.31 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20082 1.45 1.41 0.97 1.03 1.00 1.00 0.97 1.05 1.00 1.00 1.00 1.00 1.00 1.00 MP 20083 1.28 1.82 1.00 1.01 1.00 1.10 1.01 1.00 1.00 1.03 1.00 1.00 1.00 MP 20084 7.65 1.37 0.94 1.16 1.02 1.05 1.03 0.98 1.03 1.00 0.99 1.00 MP 20091 1.51 1.27 1.18 1.05 1.00 0.98 1.00 1.00 1.00 1.00 1.00 MP 20092 2.06 1.23 1.13 1.00 1.00 1.03 0.97 1.01 1.00 1.00 MP 20093 1.45 1.46 1.01 1.05 1.00 1.02 1.00 1.02 0.99 MP 20094 1.07 1.39 1.55 1.01 1.00 0.92 0.94 1.00 MP 20101 2.66 1.48 1.09 1.02 1.04 1.00 1.00 MP 20102 2.02 1.33 1.03 0.95 0.99 1.00 MP 20103 1.19 1.50 1.19 0.98 0.98 MP 20104 1.31 1.64 1.13 1.01 MP 20111 2.55 1.47 1.09 MP 20112 1.39 2.08 MP 20113 1.95\n\nCoefficient of Variation 0.77 0.19 0.19 0.12 0.06 0.05 0.02 0.02 0.14 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 #DIV/0! 0.00 0.00 Weighted Average Age-to-Age Factor 1.58 1.44 1.10 1.03 1.01 1.02 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00** Flat Average Age-to-Age Factor 1.86 1.37 1.13 1.02 1.02 1.02 0.99 1.00 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 #DIV/0! 1.00 **1\\.00** Weighted Average Last 3 Quarters 1.92 1.70 1.12 0.98 1.00 0.98 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00**\n\nSelected Age-to-Age Factor 1.92 1.70 1.12 0.98 1.00 0.98 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Age-to-Ultimate 3.47 1.81 1.07 0.95 0.97 0.96 0.99 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page41.pdf"]},"response":{"errors":[],"extract_id":"extract_45ac1d759efaf2bfcf45a3f66c13d595","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Access General Insurance Company Exhibit 7 PPA Loss & DCC Development Factors Support Data Exhibit Accident Quarter Cumulative Statistics Page 11 of 18 **MP**\n\n**CUMU DOLLARS - LOSS & DCC REPORTED -------> To-Date Quarterly Annual Loss + DCC Ultimate Ultimate Accident Ultimate Coverage ACC QTR Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16 Q17 Q18 Q19 Q20 Q21 Q22 Q23 Q24 Q25 Reported LDF Loss + DCC Year Incur LDF** MP 20054 0 2,010 2,000 2,000 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1.00 1,330 2005 1.000 MP 20061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.00 0 MP 20062 2,400 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 1.00 3,000 MP 20063 5,300 4,600 4,600 8,372 10,252 10,252 10,252 10,252 10,252 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 1.00 5,049 MP 20064 8,000 5,000 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 1.00 6,500 2006 1.000 MP 20071 25,583 16,173 19,173 20,173 18,173 23,173 23,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 1.00 22,173 MP 20072 6,960 12,094 18,124 22,372 22,372 23,372 26,372 26,372 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 1.00 25,872 MP 20073 8,200 14,679 16,379 22,079 22,079 21,579 21,579 21,579 21,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 1.00 22,579 MP 20074 11,672 18,164 23,814 23,955 26,455 27,655 29,655 30,655 30,655 29,988 29,988 29,988 29,688 29,688 29,688 29,688 29,688 29,688 1.00 29,688 2007 1.000 MP 20081 3,700 11,000 14,000 15,000 19,600 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 1.00 19,100 MP 20082 19,156 27,732 38,978 37,711 38,711 38,711 38,711 37,651 39,651 39,651 39,651 39,651 39,651 39,651 39,651 39,651 1.00 39,651 MP 20083 12,605 16,075 29,303 29,303 29,703 29,703 32,703 33,036 33,036 33,036 34,036 34,036 34,036 34,036 34,036 1.00 34,036 MP 20084 2,700 20,662 28,242 26,608 30,858 31,466 33,132 34,132 33,541 34,541 34,541 34,091 34,091 34,091 1.00 34,091 2008 1.000 MP 20091 18,440 27,877 35,330 41,550 43,550 43,550 42,850 42,850 42,850 42,850 42,850 42,850 42,850 1.00 42,850 MP 20092 11,160 22,995 28,262 31,937 31,885 31,885 32,885 31,819 32,087 32,087 32,087 32,087 1.00 31,957 MP 20093 25,681 37,139 54,160 54,660 57,260 57,260 58,610 58,610 59,495 58,795 58,795 1.00 58,557 MP 20094 15,712 16,772 23,330 36,070 36,570 36,504 33,670 31,670 31,670 31,670 0.99 31,378 2009 0.996 MP 20101 9,385 24,975 36,886 40,072 40,805 42,405 42,405 42,405 42,405 1.00 42,411 MP 20102 20,106 40,626 54,076 55,476 52,662 52,247 52,247 52,247 0.99 51,477 MP 20103 18,799 22,384 33,492 39,825 39,158 38,504 38,504 0.96 37,118 MP 20104 23,111 30,298 49,673 55,952 56,586 56,586 0.97 54,766 2010 0.979 MP 20111 16,548 42,154 61,958 67,292 67,292 0.95 63,903 MP 20112 21,009 29,293 60,935 60,935 1.07 65,022 MP 20113 15,825 30,815 30,815 1.81 55,769 MP 20114 14,531 14,531 3.47 50,378 2011 1.354\n\nMP All 771,785 828,656\n\n**AGE-TO-AGE - LOSS & DCC REPORTED ------->**\n\n**Coverage ACC QTR Q2/Q1 Q3/Q2 Q4/Q3 Q5/Q4 Q6/Q5 Q7/Q6 Q8/Q7 Q9/Q8 Q10/Q9 Q11/Q10 Q12/Q11 Q13/Q12 Q14/Q13 Q15/Q14 Q16/Q15 Q17/Q16 Q18/Q17 Q19/Q18 Q20/Q19 Q21/Q20 Q22/Q21 Q23/Q22 Q24/Q23 Q25/Q24 TAIL / Q25** MP 20054 1.00 1.00 0.67 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00** MP 20061 #DIV/0! MP 20062 1.25 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20063 0.87 1.00 1.82 1.22 1.00 1.00 1.00 1.00 0.49 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20064 0.63 1.30 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20071 0.63 1.19 1.05 0.90 1.28 1.00 0.96 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20072 1.74 1.50 1.23 1.00 1.04 1.13 1.00 0.98 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20073 1.79 1.12 1.35 1.00 0.98 1.00 1.00 1.00 1.05 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20074 1.56 1.31 1.01 1.10 1.05 1.07 1.03 1.00 0.98 1.00 1.00 0.99 1.00 1.00 1.00 1.00 MP 20081 2.97 1.27 1.07 1.31 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20082 1.45 1.41 0.97 1.03 1.00 1.00 0.97 1.05 1.00 1.00 1.00 1.00 1.00 1.00 MP 20083 1.28 1.82 1.00 1.01 1.00 1.10 1.01 1.00 1.00 1.03 1.00 1.00 1.00 MP 20084 7.65 1.37 0.94 1.16 1.02 1.05 1.03 0.98 1.03 1.00 0.99 1.00 MP 20091 1.51 1.27 1.18 1.05 1.00 0.98 1.00 1.00 1.00 1.00 1.00 MP 20092 2.06 1.23 1.13 1.00 1.00 1.03 0.97 1.01 1.00 1.00 MP 20093 1.45 1.46 1.01 1.05 1.00 1.02 1.00 1.02 0.99 MP 20094 1.07 1.39 1.55 1.01 1.00 0.92 0.94 1.00 MP 20101 2.66 1.48 1.09 1.02 1.04 1.00 1.00 MP 20102 2.02 1.33 1.03 0.95 0.99 1.00 MP 20103 1.19 1.50 1.19 0.98 0.98 MP 20104 1.31 1.64 1.13 1.01 MP 20111 2.55 1.47 1.09 MP 20112 1.39 2.08 MP 20113 1.95\n\nCoefficient of Variation 0.77 0.19 0.19 0.12 0.06 0.05 0.02 0.02 0.14 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 #DIV/0! 0.00 0.00 Weighted Average Age-to-Age Factor 1.58 1.44 1.10 1.03 1.01 1.02 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00** Flat Average Age-to-Age Factor 1.86 1.37 1.13 1.02 1.02 1.02 0.99 1.00 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 #DIV/0! 1.00 **1\\.00** Weighted Average Last 3 Quarters 1.92 1.70 1.12 0.98 1.00 0.98 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00**\n\nSelected Age-to-Age Factor 1.92 1.70 1.12 0.98 1.00 0.98 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Age-to-Ultimate 3.47 1.81 1.07 0.95 0.97 0.96 0.99 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00"],"full_content":"Access General Insurance Company Exhibit 7 PPA Loss & DCC Development Factors Support Data Exhibit Accident Quarter Cumulative Statistics Page 11 of 18 **MP**\n\n**CUMU DOLLARS - LOSS & DCC REPORTED -------> To-Date Quarterly Annual Loss + DCC Ultimate Ultimate Accident Ultimate Coverage ACC QTR Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16 Q17 Q18 Q19 Q20 Q21 Q22 Q23 Q24 Q25 Reported LDF Loss + DCC Year Incur LDF** MP 20054 0 2,010 2,000 2,000 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1,330 1.00 1,330 2005 1.000 MP 20061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.00 0 MP 20062 2,400 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 1.00 3,000 MP 20063 5,300 4,600 4,600 8,372 10,252 10,252 10,252 10,252 10,252 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 5,049 1.00 5,049 MP 20064 8,000 5,000 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 6,500 1.00 6,500 2006 1.000 MP 20071 25,583 16,173 19,173 20,173 18,173 23,173 23,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 22,173 1.00 22,173 MP 20072 6,960 12,094 18,124 22,372 22,372 23,372 26,372 26,372 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 25,872 1.00 25,872 MP 20073 8,200 14,679 16,379 22,079 22,079 21,579 21,579 21,579 21,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 22,579 1.00 22,579 MP 20074 11,672 18,164 23,814 23,955 26,455 27,655 29,655 30,655 30,655 29,988 29,988 29,988 29,688 29,688 29,688 29,688 29,688 29,688 1.00 29,688 2007 1.000 MP 20081 3,700 11,000 14,000 15,000 19,600 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 19,100 1.00 19,100 MP 20082 19,156 27,732 38,978 37,711 38,711 38,711 38,711 37,651 39,651 39,651 39,651 39,651 39,651 39,651 39,651 39,651 1.00 39,651 MP 20083 12,605 16,075 29,303 29,303 29,703 29,703 32,703 33,036 33,036 33,036 34,036 34,036 34,036 34,036 34,036 1.00 34,036 MP 20084 2,700 20,662 28,242 26,608 30,858 31,466 33,132 34,132 33,541 34,541 34,541 34,091 34,091 34,091 1.00 34,091 2008 1.000 MP 20091 18,440 27,877 35,330 41,550 43,550 43,550 42,850 42,850 42,850 42,850 42,850 42,850 42,850 1.00 42,850 MP 20092 11,160 22,995 28,262 31,937 31,885 31,885 32,885 31,819 32,087 32,087 32,087 32,087 1.00 31,957 MP 20093 25,681 37,139 54,160 54,660 57,260 57,260 58,610 58,610 59,495 58,795 58,795 1.00 58,557 MP 20094 15,712 16,772 23,330 36,070 36,570 36,504 33,670 31,670 31,670 31,670 0.99 31,378 2009 0.996 MP 20101 9,385 24,975 36,886 40,072 40,805 42,405 42,405 42,405 42,405 1.00 42,411 MP 20102 20,106 40,626 54,076 55,476 52,662 52,247 52,247 52,247 0.99 51,477 MP 20103 18,799 22,384 33,492 39,825 39,158 38,504 38,504 0.96 37,118 MP 20104 23,111 30,298 49,673 55,952 56,586 56,586 0.97 54,766 2010 0.979 MP 20111 16,548 42,154 61,958 67,292 67,292 0.95 63,903 MP 20112 21,009 29,293 60,935 60,935 1.07 65,022 MP 20113 15,825 30,815 30,815 1.81 55,769 MP 20114 14,531 14,531 3.47 50,378 2011 1.354\n\nMP All 771,785 828,656\n\n**AGE-TO-AGE - LOSS & DCC REPORTED ------->**\n\n**Coverage ACC QTR Q2/Q1 Q3/Q2 Q4/Q3 Q5/Q4 Q6/Q5 Q7/Q6 Q8/Q7 Q9/Q8 Q10/Q9 Q11/Q10 Q12/Q11 Q13/Q12 Q14/Q13 Q15/Q14 Q16/Q15 Q17/Q16 Q18/Q17 Q19/Q18 Q20/Q19 Q21/Q20 Q22/Q21 Q23/Q22 Q24/Q23 Q25/Q24 TAIL / Q25** MP 20054 1.00 1.00 0.67 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00** MP 20061 #DIV/0! MP 20062 1.25 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20063 0.87 1.00 1.82 1.22 1.00 1.00 1.00 1.00 0.49 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20064 0.63 1.30 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20071 0.63 1.19 1.05 0.90 1.28 1.00 0.96 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20072 1.74 1.50 1.23 1.00 1.04 1.13 1.00 0.98 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20073 1.79 1.12 1.35 1.00 0.98 1.00 1.00 1.00 1.05 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20074 1.56 1.31 1.01 1.10 1.05 1.07 1.03 1.00 0.98 1.00 1.00 0.99 1.00 1.00 1.00 1.00 MP 20081 2.97 1.27 1.07 1.31 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 MP 20082 1.45 1.41 0.97 1.03 1.00 1.00 0.97 1.05 1.00 1.00 1.00 1.00 1.00 1.00 MP 20083 1.28 1.82 1.00 1.01 1.00 1.10 1.01 1.00 1.00 1.03 1.00 1.00 1.00 MP 20084 7.65 1.37 0.94 1.16 1.02 1.05 1.03 0.98 1.03 1.00 0.99 1.00 MP 20091 1.51 1.27 1.18 1.05 1.00 0.98 1.00 1.00 1.00 1.00 1.00 MP 20092 2.06 1.23 1.13 1.00 1.00 1.03 0.97 1.01 1.00 1.00 MP 20093 1.45 1.46 1.01 1.05 1.00 1.02 1.00 1.02 0.99 MP 20094 1.07 1.39 1.55 1.01 1.00 0.92 0.94 1.00 MP 20101 2.66 1.48 1.09 1.02 1.04 1.00 1.00 MP 20102 2.02 1.33 1.03 0.95 0.99 1.00 MP 20103 1.19 1.50 1.19 0.98 0.98 MP 20104 1.31 1.64 1.13 1.01 MP 20111 2.55 1.47 1.09 MP 20112 1.39 2.08 MP 20113 1.95\n\nCoefficient of Variation 0.77 0.19 0.19 0.12 0.06 0.05 0.02 0.02 0.14 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 #DIV/0! 0.00 0.00 Weighted Average Age-to-Age Factor 1.58 1.44 1.10 1.03 1.01 1.02 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00** Flat Average Age-to-Age Factor 1.86 1.37 1.13 1.02 1.02 1.02 0.99 1.00 0.97 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 #DIV/0! 1.00 **1\\.00** Weighted Average Last 3 Quarters 1.92 1.70 1.12 0.98 1.00 0.98 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 **1\\.00**\n\nSelected Age-to-Age Factor 1.92 1.70 1.12 0.98 1.00 0.98 0.99 1.01 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Age-to-Ultimate 3.47 1.81 1.07 0.95 0.97 0.96 0.99 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00","publish_date":null,"title":"Access General Insurance Company Exhibit 7 PPA Loss & DCC Development Factors Support Data Exhibit Accident Quarter Cumulative Statistics Page","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page41.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page41.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page41","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page41.pdf"},"started_at":"2026-11-04T19:47:17.523435"} +{"completed_at":"2026-11-04T19:47:20.896749","latency_in_ms":2243,"output":{"example_id":"table/SERFF_CA_random_pages 1_page449","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit** **7**\n\n### **Commerce** **West** **Insurance** **Company Private** **Passenger** **Auto** **Liability**\n\n### **Non** **‐** **Catastrophe** **Paid** **DCCE** **to** **Paid** **Loss** **Ratio** **Development** **‐** **Annual** **Triangles**\n\n**_Medical_** **_Payments_**\n\n**Months** **of** **Development**\n\n**Fiscal** **Accident** **Year** **Ending 3** **15 27** **39** **51** **63** **75** **87** **99** **111** **123**\n\n**20071** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20081** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20091** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20101** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20111** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20121** 0\\.00% 0.00% 0.00% 0.00% 0.00% **20131** 0\\.00% 0.00% 0.00% 0.00% **20141** 0\\.00% 0.00% 0.00% **20151** 0\\.00% 0.00% **20161** 0\\.00%\n\n**Age** **to** **Age** **Factors**\n\n**Fiscal** **Accident** **Year** **Ending 15** **‐** **27 27** **‐** **39 39** **‐** **51 51** **‐** **63 63** **‐** **75 75** **‐** **87 87** **‐** **99 99** **‐** **111 111** **‐** **123 123** **‐** **Ult**\n\n**20071 20081 20091 20101 20111 20121 20131 20141 20151 Tail**\n\n**3** **Yr** **Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Age** **‐** **Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Ultimate** **DCCE** **Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Selected** **Ult** **Loss 466,960 491,934 466,803 556,039 678,543 563,632 422,057 340,006 389,080 337,196 Ultimate** **DCCE 0 0 0 0 0 0 0 0 0 0 DCCE** **Age** **‐** **Ult #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!**\n\nStandard Exhibits Template Page 3.19 4/29/2016 Edition","pages":[{"line_numbers":[],"markdown":"**Exhibit** **7**\n\n### **Commerce** **West** **Insurance** **Company Private** **Passenger** **Auto** **Liability**\n\n### **Non** **‐** **Catastrophe** **Paid** **DCCE** **to** **Paid** **Loss** **Ratio** **Development** **‐** **Annual** **Triangles**\n\n**_Medical_** **_Payments_**\n\n**Months** **of** **Development**\n\n**Fiscal** **Accident** **Year** **Ending 3** **15 27** **39** **51** **63** **75** **87** **99** **111** **123**\n\n**20071** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20081** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20091** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20101** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20111** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20121** 0\\.00% 0.00% 0.00% 0.00% 0.00% **20131** 0\\.00% 0.00% 0.00% 0.00% **20141** 0\\.00% 0.00% 0.00% **20151** 0\\.00% 0.00% **20161** 0\\.00%\n\n**Age** **to** **Age** **Factors**\n\n**Fiscal** **Accident** **Year** **Ending 15** **‐** **27 27** **‐** **39 39** **‐** **51 51** **‐** **63 63** **‐** **75 75** **‐** **87 87** **‐** **99 99** **‐** **111 111** **‐** **123 123** **‐** **Ult**\n\n**20071 20081 20091 20101 20111 20121 20131 20141 20151 Tail**\n\n**3** **Yr** **Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Age** **‐** **Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Ultimate** **DCCE** **Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Selected** **Ult** **Loss 466,960 491,934 466,803 556,039 678,543 563,632 422,057 340,006 389,080 337,196 Ultimate** **DCCE 0 0 0 0 0 0 0 0 0 0 DCCE** **Age** **‐** **Ult #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!**\n\nStandard Exhibits Template Page 3.19 4/29/2016 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit** **7**\n\n### **Commerce** **West** **Insurance** **Company Private** **Passenger** **Auto** **Liability**\n\n### **Non** **‐** **Catastrophe** **Paid** **DCCE** **to** **Paid** **Loss** **Ratio** **Development** **‐** **Annual** **Triangles**\n\n**_Medical_** **_Payments_**\n\n**Months** **of** **Development**\n\n**Fiscal** **Accident** **Year** **Ending 3** **15 27** **39** **51** **63** **75** **87** **99** **111** **123**\n\n**20071** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20081** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20091** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20101** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20111** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20121** 0\\.00% 0.00% 0.00% 0.00% 0.00% **20131** 0\\.00% 0.00% 0.00% 0.00% **20141** 0\\.00% 0.00% 0.00% **20151** 0\\.00% 0.00% **20161** 0\\.00%\n\n**Age** **to** **Age** **Factors**\n\n**Fiscal** **Accident** **Year** **Ending 15** **‐** **27 27** **‐** **39 39** **‐** **51 51** **‐** **63 63** **‐** **75 75** **‐** **87 87** **‐** **99 99** **‐** **111 111** **‐** **123 123** **‐** **Ult**\n\n**20071 20081 20091 20101 20111 20121 20131 20141 20151 Tail**\n\n**3** **Yr** **Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Age** **‐** **Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Ultimate** **DCCE** **Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Selected** **Ult** **Loss 466,960 491,934 466,803 556,039 678,543 563,632 422,057 340,006 389,080 337,196 Ultimate** **DCCE 0 0 0 0 0 0 0 0 0 0 DCCE** **Age** **‐** **Ult #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!**\n\nStandard Exhibits Template Page 3.19 4/29/2016 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page449.pdf"]},"response":{"errors":[],"extract_id":"extract_b567cc5d42167ad1defac51bd42d5b39","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit** **7**\n\n### **Commerce** **West** **Insurance** **Company Private** **Passenger** **Auto** **Liability**\n\n### **Non** **‐** **Catastrophe** **Paid** **DCCE** **to** **Paid** **Loss** **Ratio** **Development** **‐** **Annual** **Triangles**\n\n**_Medical_** **_Payments_**\n\n**Months** **of** **Development**\n\n**Fiscal** **Accident** **Year** **Ending 3** **15 27** **39** **51** **63** **75** **87** **99** **111** **123**\n\n**20071** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20081** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20091** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20101** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20111** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20121** 0\\.00% 0.00% 0.00% 0.00% 0.00% **20131** 0\\.00% 0.00% 0.00% 0.00% **20141** 0\\.00% 0.00% 0.00% **20151** 0\\.00% 0.00% **20161** 0\\.00%\n\n**Age** **to** **Age** **Factors**\n\n**Fiscal** **Accident** **Year** **Ending 15** **‐** **27 27** **‐** **39 39** **‐** **51 51** **‐** **63 63** **‐** **75 75** **‐** **87 87** **‐** **99 99** **‐** **111 111** **‐** **123 123** **‐** **Ult**\n\n**20071 20081 20091 20101 20111 20121 20131 20141 20151 Tail**\n\n**3** **Yr** **Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Age** **‐** **Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Ultimate** **DCCE** **Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Selected** **Ult** **Loss 466,960 491,934 466,803 556,039 678,543 563,632 422,057 340,006 389,080 337,196 Ultimate** **DCCE 0 0 0 0 0 0 0 0 0 0 DCCE** **Age** **‐** **Ult #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!**\n\nStandard Exhibits Template Page 3.19 4/29/2016 Edition"],"full_content":"**Exhibit** **7**\n\n### **Commerce** **West** **Insurance** **Company Private** **Passenger** **Auto** **Liability**\n\n### **Non** **‐** **Catastrophe** **Paid** **DCCE** **to** **Paid** **Loss** **Ratio** **Development** **‐** **Annual** **Triangles**\n\n**_Medical_** **_Payments_**\n\n**Months** **of** **Development**\n\n**Fiscal** **Accident** **Year** **Ending 3** **15 27** **39** **51** **63** **75** **87** **99** **111** **123**\n\n**20071** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20081** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20091** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20101** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20111** 0\\.00% 0.00% 0.00% 0.00% 0.00% 0.00% **20121** 0\\.00% 0.00% 0.00% 0.00% 0.00% **20131** 0\\.00% 0.00% 0.00% 0.00% **20141** 0\\.00% 0.00% 0.00% **20151** 0\\.00% 0.00% **20161** 0\\.00%\n\n**Age** **to** **Age** **Factors**\n\n**Fiscal** **Accident** **Year** **Ending 15** **‐** **27 27** **‐** **39 39** **‐** **51 51** **‐** **63 63** **‐** **75 75** **‐** **87 87** **‐** **99 99** **‐** **111 111** **‐** **123 123** **‐** **Ult**\n\n**20071 20081 20091 20101 20111 20121 20131 20141 20151 Tail**\n\n**3** **Yr** **Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000**\n\n**Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Age** **‐** **Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Ultimate** **DCCE** **Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Selected** **Ult** **Loss 466,960 491,934 466,803 556,039 678,543 563,632 422,057 340,006 389,080 337,196 Ultimate** **DCCE 0 0 0 0 0 0 0 0 0 0 DCCE** **Age** **‐** **Ult #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!**\n\nStandard Exhibits Template Page 3.19 4/29/2016 Edition","publish_date":null,"title":"Commerce West Insurance Company Private Passenger Auto Liability Non‐Catastrophe Paid DCCE to Paid Loss Ratio Development ‐ Annual Triangles","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page449.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page449.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page449","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page449.pdf"},"started_at":"2026-11-04T19:47:18.653192"} +{"completed_at":"2026-11-04T19:47:23.296491","latency_in_ms":2832,"output":{"example_id":"table/SERFF_CA_random_pages 1_page46","grounded_pages":[],"layout_pages":[],"markdown":"**WCF National Insurance Company**\n\n**California Class Deviations**\n\n**Effective August 1, 2022 on New and Renewal Policies**\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\n0005 0.950 2108 1.000 3039 1.000 3651 1.000 4420 1.000 5160 1.000 6003 1.000\n\n0016 1.000 2109 1.000 3040 1.000 3681 1.000 4432 1.000 5183 1.000 6011 1.000\n\n0034 1.000 2111 1.000 3060 1.000 3682 1.000 4470 1.000 5184 1.000 6204 1.000\n\n0035 0.950 2113 1.000 3066 1.000 3683 1.000 4478 1.000 5185 1.000 6206 1.000\n\n0036 1.000 2116 1.000 3070 1.000 3719 1.000 4492 1.000 5186 1.000 6213 1.000\n\n0038 1.000 2117 1.000 3076 1.000 3724 1.000 4494 1.000 5187 1.000 6216 1.000\n\n0040 0.800 2121 1.000 3081 1.000 3726 1.000 4495 1.000 5190 1.000 6218 1.000\n\n0041 1.000 2123 1.000 3082 1.000 3805 1.000 4496 1.000 5191 1.000 6220 1.000\n\n0042 1.000 2142 0.800 3085 1.000 3808 1.000 4497 1.000 5192 1.000 6233 1.000\n\n0044 1.000 2163 1.000 3099 1.000 3815 1.000 4498 1.000 5193 1.000 6235 1.000\n\n0045 0.950 2222 1.000 3110 1.000 3821 1.000 4499 1.000 5195 1.000 6237 1.000\n\n0050 0.950 2362 1.000 3131 1.000 3828 1.000 4511 1.000 5201 1.000 6251 1.000\n\n0079 1.000 2402 1.000 3146 1.000 3830 1.000 4512 1.000 5205 1.000 6258 1.000\n\n0096 0.950 2413 1.000 3152 1.000 3831 1.000 4557 1.000 5212 1.000 6307 1.000\n\n0106 1.000 2501 1.000 3165 1.000 3840 1.000 4558 1.000 5213 1.000 6308 1.000\n\n0171 1.000 2570 1.000 3169 1.000 4000 1.000 4611 1.000 5214 1.000 6315 1.000\n\n0172 1.000 2571 1.000 3175 1.000 4034 1.000 4623 1.000 5222 1.000 6316 1.000\n\n0251 1.000 2576 1.000 3178 1.000 4036 1.000 4635 1.000 5225 1.000 6325 1.000\n\n0400 1.000 2584 1.000 3179 1.000 4038 1.000 4665 1.000 5348 1.000 6361 1.000\n\n0401 1.000 2585 1.000 3180 1.000 4041 1.000 4683 1.000 5403 1.000 6364 1.000\n\n1122 1.000 2589 1.000 3220 1.000 4049 1.000 4691 1.000 5432 1.000 6400 1.000\n\n1123 1.000 2660 1.000 3241 1.000 4111 1.000 4692 1.000 5436 1.000 6504 0.900\n\n1124 1.000 2683 1.000 3257 1.000 4112 1.000 4717 1.000 5443 1.000 6834 1.000\n\n1320 1.000 2688 1.000 3339 1.000 4114 1.000 4720 1.000 5446 1.000 7133 1.000\n\n1322 1.000 2702 1.000 3365 1.000 4130 1.000 4740 1.000 5447 1.000 7198 1.000\n\n1330 1.000 2710 1.000 3372 1.000 4150 1.000 4771 1.000 5467 1.000 7207 1.000\n\n1438 1.000 2727 1.000 3383 1.000 4239 1.000 4828 1.000 5470 1.000 7219 1.000\n\n1452 1.000 2731 1.000 3400 0.950 4240 1.000 4829 1.000 5473 1.000 7227 1.000\n\n1463 1.000 2757 1.000 3401 1.000 4243 1.000 4831 1.000 5474 1.000 7232 1.000\n\n1624 1.000 2759 1.000 3501 1.000 4244 1.000 4983 1.000 5479 1.000 7248 1.000\n\n1699 1.000 2790 1.000 3507 1.000 4250 1.000 5020 1.000 5482 1.000 7272 1.000\n\n1701 1.000 2797 1.000 3560 1.000 4251 1.000 5027 1.000 5484 1.000 7332 1.000\n\n1710 1.000 2806 1.000 3568 1.000 4279 1.000 5028 1.000 5485 1.000 7360 1.000\n\n1741 1.000 2812 1.000 3569 1.000 4283 1.000 5029 1.000 5506 1.000 7365 1.000\n\n1803 1.000 2819 1.000 3570 1.000 4286 1.000 5040 1.000 5507 1.000 7382 1.000\n\n1925 1.000 2840 1.000 3572 1.000 4295 1.000 5057 1.000 5538 1.000 7392 1.000\n\n2002 1.000 2842 1.000 3573 1.000 4297 1.000 5059 1.000 5542 1.000 7403 1.000\n\n2003 0.950 2852 1.000 3574 1.000 4299 1.000 5102 1.000 5552 1.000 7405 1.000\n\n2014 1.000 2881 1.000 3577 1.000 4304 1.000 5107 1.000 5553 1.000 7409 1.000\n\n2030 1.000 2883 0.950 3612 1.000 4312 1.000 5108 1.000 5606 1.000 7410 1.000\n\n2063 0.950 2915 1.000 3620 1.000 4351 1.000 5128 1.000 5610 1.000 7421 1.000\n\n2081 0.950 2923 1.000 3632 1.000 4354 1.000 5129 1.000 5632 1.000 7424 1.000\n\n2095 1.000 3018 1.000 3634 1.000 4361 1.000 5130 1.000 5633 1.000 7428 1.000\n\n2102 1.000 3022 1.000 3643 1.000 4362 1.000 5140 1.000 5650 1.000 7429 1.000\n\n2107 0.950 3030 1.000 3647 1.000 4410 1.000 5146 1.000 5951 1.000 7500 1.000\n\nActuarial CA NAT Rates and Analysis 2022 08 01.xlsx 4/24/2022 3:30 PM","pages":[{"line_numbers":[],"markdown":"**WCF National Insurance Company**\n\n**California Class Deviations**\n\n**Effective August 1, 2022 on New and Renewal Policies**\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\n0005 0.950 2108 1.000 3039 1.000 3651 1.000 4420 1.000 5160 1.000 6003 1.000\n\n0016 1.000 2109 1.000 3040 1.000 3681 1.000 4432 1.000 5183 1.000 6011 1.000\n\n0034 1.000 2111 1.000 3060 1.000 3682 1.000 4470 1.000 5184 1.000 6204 1.000\n\n0035 0.950 2113 1.000 3066 1.000 3683 1.000 4478 1.000 5185 1.000 6206 1.000\n\n0036 1.000 2116 1.000 3070 1.000 3719 1.000 4492 1.000 5186 1.000 6213 1.000\n\n0038 1.000 2117 1.000 3076 1.000 3724 1.000 4494 1.000 5187 1.000 6216 1.000\n\n0040 0.800 2121 1.000 3081 1.000 3726 1.000 4495 1.000 5190 1.000 6218 1.000\n\n0041 1.000 2123 1.000 3082 1.000 3805 1.000 4496 1.000 5191 1.000 6220 1.000\n\n0042 1.000 2142 0.800 3085 1.000 3808 1.000 4497 1.000 5192 1.000 6233 1.000\n\n0044 1.000 2163 1.000 3099 1.000 3815 1.000 4498 1.000 5193 1.000 6235 1.000\n\n0045 0.950 2222 1.000 3110 1.000 3821 1.000 4499 1.000 5195 1.000 6237 1.000\n\n0050 0.950 2362 1.000 3131 1.000 3828 1.000 4511 1.000 5201 1.000 6251 1.000\n\n0079 1.000 2402 1.000 3146 1.000 3830 1.000 4512 1.000 5205 1.000 6258 1.000\n\n0096 0.950 2413 1.000 3152 1.000 3831 1.000 4557 1.000 5212 1.000 6307 1.000\n\n0106 1.000 2501 1.000 3165 1.000 3840 1.000 4558 1.000 5213 1.000 6308 1.000\n\n0171 1.000 2570 1.000 3169 1.000 4000 1.000 4611 1.000 5214 1.000 6315 1.000\n\n0172 1.000 2571 1.000 3175 1.000 4034 1.000 4623 1.000 5222 1.000 6316 1.000\n\n0251 1.000 2576 1.000 3178 1.000 4036 1.000 4635 1.000 5225 1.000 6325 1.000\n\n0400 1.000 2584 1.000 3179 1.000 4038 1.000 4665 1.000 5348 1.000 6361 1.000\n\n0401 1.000 2585 1.000 3180 1.000 4041 1.000 4683 1.000 5403 1.000 6364 1.000\n\n1122 1.000 2589 1.000 3220 1.000 4049 1.000 4691 1.000 5432 1.000 6400 1.000\n\n1123 1.000 2660 1.000 3241 1.000 4111 1.000 4692 1.000 5436 1.000 6504 0.900\n\n1124 1.000 2683 1.000 3257 1.000 4112 1.000 4717 1.000 5443 1.000 6834 1.000\n\n1320 1.000 2688 1.000 3339 1.000 4114 1.000 4720 1.000 5446 1.000 7133 1.000\n\n1322 1.000 2702 1.000 3365 1.000 4130 1.000 4740 1.000 5447 1.000 7198 1.000\n\n1330 1.000 2710 1.000 3372 1.000 4150 1.000 4771 1.000 5467 1.000 7207 1.000\n\n1438 1.000 2727 1.000 3383 1.000 4239 1.000 4828 1.000 5470 1.000 7219 1.000\n\n1452 1.000 2731 1.000 3400 0.950 4240 1.000 4829 1.000 5473 1.000 7227 1.000\n\n1463 1.000 2757 1.000 3401 1.000 4243 1.000 4831 1.000 5474 1.000 7232 1.000\n\n1624 1.000 2759 1.000 3501 1.000 4244 1.000 4983 1.000 5479 1.000 7248 1.000\n\n1699 1.000 2790 1.000 3507 1.000 4250 1.000 5020 1.000 5482 1.000 7272 1.000\n\n1701 1.000 2797 1.000 3560 1.000 4251 1.000 5027 1.000 5484 1.000 7332 1.000\n\n1710 1.000 2806 1.000 3568 1.000 4279 1.000 5028 1.000 5485 1.000 7360 1.000\n\n1741 1.000 2812 1.000 3569 1.000 4283 1.000 5029 1.000 5506 1.000 7365 1.000\n\n1803 1.000 2819 1.000 3570 1.000 4286 1.000 5040 1.000 5507 1.000 7382 1.000\n\n1925 1.000 2840 1.000 3572 1.000 4295 1.000 5057 1.000 5538 1.000 7392 1.000\n\n2002 1.000 2842 1.000 3573 1.000 4297 1.000 5059 1.000 5542 1.000 7403 1.000\n\n2003 0.950 2852 1.000 3574 1.000 4299 1.000 5102 1.000 5552 1.000 7405 1.000\n\n2014 1.000 2881 1.000 3577 1.000 4304 1.000 5107 1.000 5553 1.000 7409 1.000\n\n2030 1.000 2883 0.950 3612 1.000 4312 1.000 5108 1.000 5606 1.000 7410 1.000\n\n2063 0.950 2915 1.000 3620 1.000 4351 1.000 5128 1.000 5610 1.000 7421 1.000\n\n2081 0.950 2923 1.000 3632 1.000 4354 1.000 5129 1.000 5632 1.000 7424 1.000\n\n2095 1.000 3018 1.000 3634 1.000 4361 1.000 5130 1.000 5633 1.000 7428 1.000\n\n2102 1.000 3022 1.000 3643 1.000 4362 1.000 5140 1.000 5650 1.000 7429 1.000\n\n2107 0.950 3030 1.000 3647 1.000 4410 1.000 5146 1.000 5951 1.000 7500 1.000\n\nActuarial CA NAT Rates and Analysis 2022 08 01.xlsx 4/24/2022 3:30 PM","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**WCF National Insurance Company**\n\n**California Class Deviations**\n\n**Effective August 1, 2022 on New and Renewal Policies**\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\n0005 0.950 2108 1.000 3039 1.000 3651 1.000 4420 1.000 5160 1.000 6003 1.000\n\n0016 1.000 2109 1.000 3040 1.000 3681 1.000 4432 1.000 5183 1.000 6011 1.000\n\n0034 1.000 2111 1.000 3060 1.000 3682 1.000 4470 1.000 5184 1.000 6204 1.000\n\n0035 0.950 2113 1.000 3066 1.000 3683 1.000 4478 1.000 5185 1.000 6206 1.000\n\n0036 1.000 2116 1.000 3070 1.000 3719 1.000 4492 1.000 5186 1.000 6213 1.000\n\n0038 1.000 2117 1.000 3076 1.000 3724 1.000 4494 1.000 5187 1.000 6216 1.000\n\n0040 0.800 2121 1.000 3081 1.000 3726 1.000 4495 1.000 5190 1.000 6218 1.000\n\n0041 1.000 2123 1.000 3082 1.000 3805 1.000 4496 1.000 5191 1.000 6220 1.000\n\n0042 1.000 2142 0.800 3085 1.000 3808 1.000 4497 1.000 5192 1.000 6233 1.000\n\n0044 1.000 2163 1.000 3099 1.000 3815 1.000 4498 1.000 5193 1.000 6235 1.000\n\n0045 0.950 2222 1.000 3110 1.000 3821 1.000 4499 1.000 5195 1.000 6237 1.000\n\n0050 0.950 2362 1.000 3131 1.000 3828 1.000 4511 1.000 5201 1.000 6251 1.000\n\n0079 1.000 2402 1.000 3146 1.000 3830 1.000 4512 1.000 5205 1.000 6258 1.000\n\n0096 0.950 2413 1.000 3152 1.000 3831 1.000 4557 1.000 5212 1.000 6307 1.000\n\n0106 1.000 2501 1.000 3165 1.000 3840 1.000 4558 1.000 5213 1.000 6308 1.000\n\n0171 1.000 2570 1.000 3169 1.000 4000 1.000 4611 1.000 5214 1.000 6315 1.000\n\n0172 1.000 2571 1.000 3175 1.000 4034 1.000 4623 1.000 5222 1.000 6316 1.000\n\n0251 1.000 2576 1.000 3178 1.000 4036 1.000 4635 1.000 5225 1.000 6325 1.000\n\n0400 1.000 2584 1.000 3179 1.000 4038 1.000 4665 1.000 5348 1.000 6361 1.000\n\n0401 1.000 2585 1.000 3180 1.000 4041 1.000 4683 1.000 5403 1.000 6364 1.000\n\n1122 1.000 2589 1.000 3220 1.000 4049 1.000 4691 1.000 5432 1.000 6400 1.000\n\n1123 1.000 2660 1.000 3241 1.000 4111 1.000 4692 1.000 5436 1.000 6504 0.900\n\n1124 1.000 2683 1.000 3257 1.000 4112 1.000 4717 1.000 5443 1.000 6834 1.000\n\n1320 1.000 2688 1.000 3339 1.000 4114 1.000 4720 1.000 5446 1.000 7133 1.000\n\n1322 1.000 2702 1.000 3365 1.000 4130 1.000 4740 1.000 5447 1.000 7198 1.000\n\n1330 1.000 2710 1.000 3372 1.000 4150 1.000 4771 1.000 5467 1.000 7207 1.000\n\n1438 1.000 2727 1.000 3383 1.000 4239 1.000 4828 1.000 5470 1.000 7219 1.000\n\n1452 1.000 2731 1.000 3400 0.950 4240 1.000 4829 1.000 5473 1.000 7227 1.000\n\n1463 1.000 2757 1.000 3401 1.000 4243 1.000 4831 1.000 5474 1.000 7232 1.000\n\n1624 1.000 2759 1.000 3501 1.000 4244 1.000 4983 1.000 5479 1.000 7248 1.000\n\n1699 1.000 2790 1.000 3507 1.000 4250 1.000 5020 1.000 5482 1.000 7272 1.000\n\n1701 1.000 2797 1.000 3560 1.000 4251 1.000 5027 1.000 5484 1.000 7332 1.000\n\n1710 1.000 2806 1.000 3568 1.000 4279 1.000 5028 1.000 5485 1.000 7360 1.000\n\n1741 1.000 2812 1.000 3569 1.000 4283 1.000 5029 1.000 5506 1.000 7365 1.000\n\n1803 1.000 2819 1.000 3570 1.000 4286 1.000 5040 1.000 5507 1.000 7382 1.000\n\n1925 1.000 2840 1.000 3572 1.000 4295 1.000 5057 1.000 5538 1.000 7392 1.000\n\n2002 1.000 2842 1.000 3573 1.000 4297 1.000 5059 1.000 5542 1.000 7403 1.000\n\n2003 0.950 2852 1.000 3574 1.000 4299 1.000 5102 1.000 5552 1.000 7405 1.000\n\n2014 1.000 2881 1.000 3577 1.000 4304 1.000 5107 1.000 5553 1.000 7409 1.000\n\n2030 1.000 2883 0.950 3612 1.000 4312 1.000 5108 1.000 5606 1.000 7410 1.000\n\n2063 0.950 2915 1.000 3620 1.000 4351 1.000 5128 1.000 5610 1.000 7421 1.000\n\n2081 0.950 2923 1.000 3632 1.000 4354 1.000 5129 1.000 5632 1.000 7424 1.000\n\n2095 1.000 3018 1.000 3634 1.000 4361 1.000 5130 1.000 5633 1.000 7428 1.000\n\n2102 1.000 3022 1.000 3643 1.000 4362 1.000 5140 1.000 5650 1.000 7429 1.000\n\n2107 0.950 3030 1.000 3647 1.000 4410 1.000 5146 1.000 5951 1.000 7500 1.000\n\nActuarial CA NAT Rates and Analysis 2022 08 01.xlsx 4/24/2022 3:30 PM","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page46.pdf"]},"response":{"errors":[],"extract_id":"extract_2e6711bc5415bd3ded25e22f3afa1d03","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**WCF National Insurance Company**\n\n**California Class Deviations**\n\n**Effective August 1, 2022 on New and Renewal Policies**\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\n0005 0.950 2108 1.000 3039 1.000 3651 1.000 4420 1.000 5160 1.000 6003 1.000\n\n0016 1.000 2109 1.000 3040 1.000 3681 1.000 4432 1.000 5183 1.000 6011 1.000\n\n0034 1.000 2111 1.000 3060 1.000 3682 1.000 4470 1.000 5184 1.000 6204 1.000\n\n0035 0.950 2113 1.000 3066 1.000 3683 1.000 4478 1.000 5185 1.000 6206 1.000\n\n0036 1.000 2116 1.000 3070 1.000 3719 1.000 4492 1.000 5186 1.000 6213 1.000\n\n0038 1.000 2117 1.000 3076 1.000 3724 1.000 4494 1.000 5187 1.000 6216 1.000\n\n0040 0.800 2121 1.000 3081 1.000 3726 1.000 4495 1.000 5190 1.000 6218 1.000\n\n0041 1.000 2123 1.000 3082 1.000 3805 1.000 4496 1.000 5191 1.000 6220 1.000\n\n0042 1.000 2142 0.800 3085 1.000 3808 1.000 4497 1.000 5192 1.000 6233 1.000\n\n0044 1.000 2163 1.000 3099 1.000 3815 1.000 4498 1.000 5193 1.000 6235 1.000\n\n0045 0.950 2222 1.000 3110 1.000 3821 1.000 4499 1.000 5195 1.000 6237 1.000\n\n0050 0.950 2362 1.000 3131 1.000 3828 1.000 4511 1.000 5201 1.000 6251 1.000\n\n0079 1.000 2402 1.000 3146 1.000 3830 1.000 4512 1.000 5205 1.000 6258 1.000\n\n0096 0.950 2413 1.000 3152 1.000 3831 1.000 4557 1.000 5212 1.000 6307 1.000\n\n0106 1.000 2501 1.000 3165 1.000 3840 1.000 4558 1.000 5213 1.000 6308 1.000\n\n0171 1.000 2570 1.000 3169 1.000 4000 1.000 4611 1.000 5214 1.000 6315 1.000\n\n0172 1.000 2571 1.000 3175 1.000 4034 1.000 4623 1.000 5222 1.000 6316 1.000\n\n0251 1.000 2576 1.000 3178 1.000 4036 1.000 4635 1.000 5225 1.000 6325 1.000\n\n0400 1.000 2584 1.000 3179 1.000 4038 1.000 4665 1.000 5348 1.000 6361 1.000\n\n0401 1.000 2585 1.000 3180 1.000 4041 1.000 4683 1.000 5403 1.000 6364 1.000\n\n1122 1.000 2589 1.000 3220 1.000 4049 1.000 4691 1.000 5432 1.000 6400 1.000\n\n1123 1.000 2660 1.000 3241 1.000 4111 1.000 4692 1.000 5436 1.000 6504 0.900\n\n1124 1.000 2683 1.000 3257 1.000 4112 1.000 4717 1.000 5443 1.000 6834 1.000\n\n1320 1.000 2688 1.000 3339 1.000 4114 1.000 4720 1.000 5446 1.000 7133 1.000\n\n1322 1.000 2702 1.000 3365 1.000 4130 1.000 4740 1.000 5447 1.000 7198 1.000\n\n1330 1.000 2710 1.000 3372 1.000 4150 1.000 4771 1.000 5467 1.000 7207 1.000\n\n1438 1.000 2727 1.000 3383 1.000 4239 1.000 4828 1.000 5470 1.000 7219 1.000\n\n1452 1.000 2731 1.000 3400 0.950 4240 1.000 4829 1.000 5473 1.000 7227 1.000\n\n1463 1.000 2757 1.000 3401 1.000 4243 1.000 4831 1.000 5474 1.000 7232 1.000\n\n1624 1.000 2759 1.000 3501 1.000 4244 1.000 4983 1.000 5479 1.000 7248 1.000\n\n1699 1.000 2790 1.000 3507 1.000 4250 1.000 5020 1.000 5482 1.000 7272 1.000\n\n1701 1.000 2797 1.000 3560 1.000 4251 1.000 5027 1.000 5484 1.000 7332 1.000\n\n1710 1.000 2806 1.000 3568 1.000 4279 1.000 5028 1.000 5485 1.000 7360 1.000\n\n1741 1.000 2812 1.000 3569 1.000 4283 1.000 5029 1.000 5506 1.000 7365 1.000\n\n1803 1.000 2819 1.000 3570 1.000 4286 1.000 5040 1.000 5507 1.000 7382 1.000\n\n1925 1.000 2840 1.000 3572 1.000 4295 1.000 5057 1.000 5538 1.000 7392 1.000\n\n2002 1.000 2842 1.000 3573 1.000 4297 1.000 5059 1.000 5542 1.000 7403 1.000\n\n2003 0.950 2852 1.000 3574 1.000 4299 1.000 5102 1.000 5552 1.000 7405 1.000\n\n2014 1.000 2881 1.000 3577 1.000 4304 1.000 5107 1.000 5553 1.000 7409 1.000\n\n2030 1.000 2883 0.950 3612 1.000 4312 1.000 5108 1.000 5606 1.000 7410 1.000\n\n2063 0.950 2915 1.000 3620 1.000 4351 1.000 5128 1.000 5610 1.000 7421 1.000\n\n2081 0.950 2923 1.000 3632 1.000 4354 1.000 5129 1.000 5632 1.000 7424 1.000\n\n2095 1.000 3018 1.000 3634 1.000 4361 1.000 5130 1.000 5633 1.000 7428 1.000\n\n2102 1.000 3022 1.000 3643 1.000 4362 1.000 5140 1.000 5650 1.000 7429 1.000\n\n2107 0.950 3030 1.000 3647 1.000 4410 1.000 5146 1.000 5951 1.000 7500 1.000\n\nActuarial CA NAT Rates and Analysis 2022 08 01.xlsx 4/24/2022 3:30 PM"],"full_content":"**WCF National Insurance Company**\n\n**California Class Deviations**\n\n**Effective August 1, 2022 on New and Renewal Policies**\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\nClass Code\n\nDeviation Factor\n\n0005 0.950 2108 1.000 3039 1.000 3651 1.000 4420 1.000 5160 1.000 6003 1.000\n\n0016 1.000 2109 1.000 3040 1.000 3681 1.000 4432 1.000 5183 1.000 6011 1.000\n\n0034 1.000 2111 1.000 3060 1.000 3682 1.000 4470 1.000 5184 1.000 6204 1.000\n\n0035 0.950 2113 1.000 3066 1.000 3683 1.000 4478 1.000 5185 1.000 6206 1.000\n\n0036 1.000 2116 1.000 3070 1.000 3719 1.000 4492 1.000 5186 1.000 6213 1.000\n\n0038 1.000 2117 1.000 3076 1.000 3724 1.000 4494 1.000 5187 1.000 6216 1.000\n\n0040 0.800 2121 1.000 3081 1.000 3726 1.000 4495 1.000 5190 1.000 6218 1.000\n\n0041 1.000 2123 1.000 3082 1.000 3805 1.000 4496 1.000 5191 1.000 6220 1.000\n\n0042 1.000 2142 0.800 3085 1.000 3808 1.000 4497 1.000 5192 1.000 6233 1.000\n\n0044 1.000 2163 1.000 3099 1.000 3815 1.000 4498 1.000 5193 1.000 6235 1.000\n\n0045 0.950 2222 1.000 3110 1.000 3821 1.000 4499 1.000 5195 1.000 6237 1.000\n\n0050 0.950 2362 1.000 3131 1.000 3828 1.000 4511 1.000 5201 1.000 6251 1.000\n\n0079 1.000 2402 1.000 3146 1.000 3830 1.000 4512 1.000 5205 1.000 6258 1.000\n\n0096 0.950 2413 1.000 3152 1.000 3831 1.000 4557 1.000 5212 1.000 6307 1.000\n\n0106 1.000 2501 1.000 3165 1.000 3840 1.000 4558 1.000 5213 1.000 6308 1.000\n\n0171 1.000 2570 1.000 3169 1.000 4000 1.000 4611 1.000 5214 1.000 6315 1.000\n\n0172 1.000 2571 1.000 3175 1.000 4034 1.000 4623 1.000 5222 1.000 6316 1.000\n\n0251 1.000 2576 1.000 3178 1.000 4036 1.000 4635 1.000 5225 1.000 6325 1.000\n\n0400 1.000 2584 1.000 3179 1.000 4038 1.000 4665 1.000 5348 1.000 6361 1.000\n\n0401 1.000 2585 1.000 3180 1.000 4041 1.000 4683 1.000 5403 1.000 6364 1.000\n\n1122 1.000 2589 1.000 3220 1.000 4049 1.000 4691 1.000 5432 1.000 6400 1.000\n\n1123 1.000 2660 1.000 3241 1.000 4111 1.000 4692 1.000 5436 1.000 6504 0.900\n\n1124 1.000 2683 1.000 3257 1.000 4112 1.000 4717 1.000 5443 1.000 6834 1.000\n\n1320 1.000 2688 1.000 3339 1.000 4114 1.000 4720 1.000 5446 1.000 7133 1.000\n\n1322 1.000 2702 1.000 3365 1.000 4130 1.000 4740 1.000 5447 1.000 7198 1.000\n\n1330 1.000 2710 1.000 3372 1.000 4150 1.000 4771 1.000 5467 1.000 7207 1.000\n\n1438 1.000 2727 1.000 3383 1.000 4239 1.000 4828 1.000 5470 1.000 7219 1.000\n\n1452 1.000 2731 1.000 3400 0.950 4240 1.000 4829 1.000 5473 1.000 7227 1.000\n\n1463 1.000 2757 1.000 3401 1.000 4243 1.000 4831 1.000 5474 1.000 7232 1.000\n\n1624 1.000 2759 1.000 3501 1.000 4244 1.000 4983 1.000 5479 1.000 7248 1.000\n\n1699 1.000 2790 1.000 3507 1.000 4250 1.000 5020 1.000 5482 1.000 7272 1.000\n\n1701 1.000 2797 1.000 3560 1.000 4251 1.000 5027 1.000 5484 1.000 7332 1.000\n\n1710 1.000 2806 1.000 3568 1.000 4279 1.000 5028 1.000 5485 1.000 7360 1.000\n\n1741 1.000 2812 1.000 3569 1.000 4283 1.000 5029 1.000 5506 1.000 7365 1.000\n\n1803 1.000 2819 1.000 3570 1.000 4286 1.000 5040 1.000 5507 1.000 7382 1.000\n\n1925 1.000 2840 1.000 3572 1.000 4295 1.000 5057 1.000 5538 1.000 7392 1.000\n\n2002 1.000 2842 1.000 3573 1.000 4297 1.000 5059 1.000 5542 1.000 7403 1.000\n\n2003 0.950 2852 1.000 3574 1.000 4299 1.000 5102 1.000 5552 1.000 7405 1.000\n\n2014 1.000 2881 1.000 3577 1.000 4304 1.000 5107 1.000 5553 1.000 7409 1.000\n\n2030 1.000 2883 0.950 3612 1.000 4312 1.000 5108 1.000 5606 1.000 7410 1.000\n\n2063 0.950 2915 1.000 3620 1.000 4351 1.000 5128 1.000 5610 1.000 7421 1.000\n\n2081 0.950 2923 1.000 3632 1.000 4354 1.000 5129 1.000 5632 1.000 7424 1.000\n\n2095 1.000 3018 1.000 3634 1.000 4361 1.000 5130 1.000 5633 1.000 7428 1.000\n\n2102 1.000 3022 1.000 3643 1.000 4362 1.000 5140 1.000 5650 1.000 7429 1.000\n\n2107 0.950 3030 1.000 3647 1.000 4410 1.000 5146 1.000 5951 1.000 7500 1.000\n\nActuarial CA NAT Rates and Analysis 2022 08 01.xlsx 4/24/2022 3:30 PM","publish_date":null,"title":"Actuarial CA NAT Rates and Analysis 2022 08 01.xlsx 4/24/2022 3:30 PM","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page46.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page46.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page46","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page46.pdf"},"started_at":"2026-11-04T19:47:20.464328"} +{"completed_at":"2026-11-04T19:47:23.132595","latency_in_ms":1181,"output":{"example_id":"table/SERFF_CA_random_pages 1_page513","grounded_pages":[],"layout_pages":[],"markdown":"### **Epack3**\n\n### **Product Manual**\n\n### **Other Liability**\n\n**_California (04) State Pages_**\n\nCA Epack3 - 2\n\n6-20225\n\n**Employment Practices Liability**\n\nTable EPL.1 is deleted and replaced by the following:\n\nTable EPL.20 is introduced below. This table contains additional factors used only for California accounts, depending on the insured location within the state of California. This table is used in an additional step which falls between steps (e) and (f) of the rating algorithm. Multiply the result of step (e) by this factor, before proceeding to step (f).\n\n**Headcount Base Premium**\n\n1 505\n\n5 609\n\n10 952\n\n25 1,944\n\n50 3,052\n\n100 5,624\n\n250 11,142\n\n350 14,169\n\n500 18,921\n\n750 21,919\n\n1,000 36,794\n\n2,000 41,580\n\n3,000 102,634\n\n5,000 125,850\n\n10,000 155,176\n\n15,000 172,408\n\n25,000 222,649\n\n50,000 284,801\n\n100,000 464,015\n\n150,000 779,763\n\n200,000 913,108\n\n250,000 945,642\n\n500,000 983,046\n\n**Domicile Location Factor**\n\nImperial County, CA Kern County, CA Los Angeles County, CA Orange County, CA Riverside County, CA San Bernardino County, CA San Diego County, CA San Luis Obispo, CA Santa Barbara County, CA Ventura County, CA All Other 1.000\n\n1\\.152","pages":[{"line_numbers":[],"markdown":"### **Epack3**\n\n### **Product Manual**\n\n### **Other Liability**\n\n**_California (04) State Pages_**\n\nCA Epack3 - 2\n\n6-20225\n\n**Employment Practices Liability**\n\nTable EPL.1 is deleted and replaced by the following:\n\nTable EPL.20 is introduced below. This table contains additional factors used only for California accounts, depending on the insured location within the state of California. This table is used in an additional step which falls between steps (e) and (f) of the rating algorithm. Multiply the result of step (e) by this factor, before proceeding to step (f).\n\n**Headcount Base Premium**\n\n1 505\n\n5 609\n\n10 952\n\n25 1,944\n\n50 3,052\n\n100 5,624\n\n250 11,142\n\n350 14,169\n\n500 18,921\n\n750 21,919\n\n1,000 36,794\n\n2,000 41,580\n\n3,000 102,634\n\n5,000 125,850\n\n10,000 155,176\n\n15,000 172,408\n\n25,000 222,649\n\n50,000 284,801\n\n100,000 464,015\n\n150,000 779,763\n\n200,000 913,108\n\n250,000 945,642\n\n500,000 983,046\n\n**Domicile Location Factor**\n\nImperial County, CA Kern County, CA Los Angeles County, CA Orange County, CA Riverside County, CA San Bernardino County, CA San Diego County, CA San Luis Obispo, CA Santa Barbara County, CA Ventura County, CA All Other 1.000\n\n1\\.152","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Epack3**\n\n### **Product Manual**\n\n### **Other Liability**\n\n**_California (04) State Pages_**\n\nCA Epack3 - 2\n\n6-20225\n\n**Employment Practices Liability**\n\nTable EPL.1 is deleted and replaced by the following:\n\nTable EPL.20 is introduced below. This table contains additional factors used only for California accounts, depending on the insured location within the state of California. This table is used in an additional step which falls between steps (e) and (f) of the rating algorithm. Multiply the result of step (e) by this factor, before proceeding to step (f).\n\n**Headcount Base Premium**\n\n1 505\n\n5 609\n\n10 952\n\n25 1,944\n\n50 3,052\n\n100 5,624\n\n250 11,142\n\n350 14,169\n\n500 18,921\n\n750 21,919\n\n1,000 36,794\n\n2,000 41,580\n\n3,000 102,634\n\n5,000 125,850\n\n10,000 155,176\n\n15,000 172,408\n\n25,000 222,649\n\n50,000 284,801\n\n100,000 464,015\n\n150,000 779,763\n\n200,000 913,108\n\n250,000 945,642\n\n500,000 983,046\n\n**Domicile Location Factor**\n\nImperial County, CA Kern County, CA Los Angeles County, CA Orange County, CA Riverside County, CA San Bernardino County, CA San Diego County, CA San Luis Obispo, CA Santa Barbara County, CA Ventura County, CA All Other 1.000\n\n1\\.152","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page513.pdf"]},"response":{"errors":[],"extract_id":"extract_67e0e9fecfb8780cb8b05ed84862631d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Epack3**\n\n### **Product Manual**\n\n### **Other Liability**\n\n**_California (04) State Pages_**\n\nCA Epack3 - 2\n\n6-20225\n\n**Employment Practices Liability**\n\nTable EPL.1 is deleted and replaced by the following:\n\nTable EPL.20 is introduced below. This table contains additional factors used only for California accounts, depending on the insured location within the state of California. This table is used in an additional step which falls between steps (e) and (f) of the rating algorithm. Multiply the result of step (e) by this factor, before proceeding to step (f).\n\n**Headcount Base Premium**\n\n1 505\n\n5 609\n\n10 952\n\n25 1,944\n\n50 3,052\n\n100 5,624\n\n250 11,142\n\n350 14,169\n\n500 18,921\n\n750 21,919\n\n1,000 36,794\n\n2,000 41,580\n\n3,000 102,634\n\n5,000 125,850\n\n10,000 155,176\n\n15,000 172,408\n\n25,000 222,649\n\n50,000 284,801\n\n100,000 464,015\n\n150,000 779,763\n\n200,000 913,108\n\n250,000 945,642\n\n500,000 983,046\n\n**Domicile Location Factor**\n\nImperial County, CA Kern County, CA Los Angeles County, CA Orange County, CA Riverside County, CA San Bernardino County, CA San Diego County, CA San Luis Obispo, CA Santa Barbara County, CA Ventura County, CA All Other 1.000\n\n1\\.152"],"full_content":"### **Epack3**\n\n### **Product Manual**\n\n### **Other Liability**\n\n**_California (04) State Pages_**\n\nCA Epack3 - 2\n\n6-20225\n\n**Employment Practices Liability**\n\nTable EPL.1 is deleted and replaced by the following:\n\nTable EPL.20 is introduced below. This table contains additional factors used only for California accounts, depending on the insured location within the state of California. This table is used in an additional step which falls between steps (e) and (f) of the rating algorithm. Multiply the result of step (e) by this factor, before proceeding to step (f).\n\n**Headcount Base Premium**\n\n1 505\n\n5 609\n\n10 952\n\n25 1,944\n\n50 3,052\n\n100 5,624\n\n250 11,142\n\n350 14,169\n\n500 18,921\n\n750 21,919\n\n1,000 36,794\n\n2,000 41,580\n\n3,000 102,634\n\n5,000 125,850\n\n10,000 155,176\n\n15,000 172,408\n\n25,000 222,649\n\n50,000 284,801\n\n100,000 464,015\n\n150,000 779,763\n\n200,000 913,108\n\n250,000 945,642\n\n500,000 983,046\n\n**Domicile Location Factor**\n\nImperial County, CA Kern County, CA Los Angeles County, CA Orange County, CA Riverside County, CA San Bernardino County, CA San Diego County, CA San Luis Obispo, CA Santa Barbara County, CA Ventura County, CA All Other 1.000\n\n1\\.152","publish_date":null,"title":"Epack3 Product Manual Other Liability","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page513.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page513.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page513","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page513.pdf"},"started_at":"2026-11-04T19:47:21.951541"} +{"completed_at":"2026-11-04T19:47:24.593191","latency_in_ms":1581,"output":{"example_id":"table/SERFF_CA_random_pages 1_page523","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit 20 - Customer Dislocation**\n\n**Rate Change Range**\n\n**In-Force Premium Proposed Premium Total Policy Count Pollicy Count Distribution**\n\n\\-5 to 0% 31,007 30,789 7 1%\n\n0 to 5% 1,433,728 1,466,716 379 36%\n\n5 to 10% 1,661,906 1,814,812 256 25%\n\n10 to 15% 4,402,235 4,885,793 268 26%\n\n15 to 20% 1,474,127 1,720,032 122 12%\n\n20 to 25% 22,355 26,857 7 1%\n\n25 to 30% - - - 0%\n\n30 to 35% 562,890 741,160 3 0%\n\nTotal 9,588,248 10,686,160 1,042 100%\n\nEvaluated using In-Force policies as of 4/30/2025","pages":[{"line_numbers":[],"markdown":"**Exhibit 20 - Customer Dislocation**\n\n**Rate Change Range**\n\n**In-Force Premium Proposed Premium Total Policy Count Pollicy Count Distribution**\n\n\\-5 to 0% 31,007 30,789 7 1%\n\n0 to 5% 1,433,728 1,466,716 379 36%\n\n5 to 10% 1,661,906 1,814,812 256 25%\n\n10 to 15% 4,402,235 4,885,793 268 26%\n\n15 to 20% 1,474,127 1,720,032 122 12%\n\n20 to 25% 22,355 26,857 7 1%\n\n25 to 30% - - - 0%\n\n30 to 35% 562,890 741,160 3 0%\n\nTotal 9,588,248 10,686,160 1,042 100%\n\nEvaluated using In-Force policies as of 4/30/2025","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit 20 - Customer Dislocation**\n\n**Rate Change Range**\n\n**In-Force Premium Proposed Premium Total Policy Count Pollicy Count Distribution**\n\n\\-5 to 0% 31,007 30,789 7 1%\n\n0 to 5% 1,433,728 1,466,716 379 36%\n\n5 to 10% 1,661,906 1,814,812 256 25%\n\n10 to 15% 4,402,235 4,885,793 268 26%\n\n15 to 20% 1,474,127 1,720,032 122 12%\n\n20 to 25% 22,355 26,857 7 1%\n\n25 to 30% - - - 0%\n\n30 to 35% 562,890 741,160 3 0%\n\nTotal 9,588,248 10,686,160 1,042 100%\n\nEvaluated using In-Force policies as of 4/30/2025","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page523.pdf"]},"response":{"errors":[],"extract_id":"extract_86cf4fb02dfb2f85dd69b9d66eac13c2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit 20 - Customer Dislocation**\n\n**Rate Change Range**\n\n**In-Force Premium Proposed Premium Total Policy Count Pollicy Count Distribution**\n\n\\-5 to 0% 31,007 30,789 7 1%\n\n0 to 5% 1,433,728 1,466,716 379 36%\n\n5 to 10% 1,661,906 1,814,812 256 25%\n\n10 to 15% 4,402,235 4,885,793 268 26%\n\n15 to 20% 1,474,127 1,720,032 122 12%\n\n20 to 25% 22,355 26,857 7 1%\n\n25 to 30% - - - 0%\n\n30 to 35% 562,890 741,160 3 0%\n\nTotal 9,588,248 10,686,160 1,042 100%\n\nEvaluated using In-Force policies as of 4/30/2025"],"full_content":"**Exhibit 20 - Customer Dislocation**\n\n**Rate Change Range**\n\n**In-Force Premium Proposed Premium Total Policy Count Pollicy Count Distribution**\n\n\\-5 to 0% 31,007 30,789 7 1%\n\n0 to 5% 1,433,728 1,466,716 379 36%\n\n5 to 10% 1,661,906 1,814,812 256 25%\n\n10 to 15% 4,402,235 4,885,793 268 26%\n\n15 to 20% 1,474,127 1,720,032 122 12%\n\n20 to 25% 22,355 26,857 7 1%\n\n25 to 30% - - - 0%\n\n30 to 35% 562,890 741,160 3 0%\n\nTotal 9,588,248 10,686,160 1,042 100%\n\nEvaluated using In-Force policies as of 4/30/2025","publish_date":null,"title":"Exhibit 20 - Customer Dislocation","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page523.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page523.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page523","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page523.pdf"},"started_at":"2026-11-04T19:47:23.012119"} +{"completed_at":"2026-11-04T19:47:25.587738","latency_in_ms":1843,"output":{"example_id":"table/SERFF_CA_random_pages 1_page536","grounded_pages":[],"layout_pages":[],"markdown":"**Canal Insurance Company – California** Commercial Auto Liability and Physical Damage Rates and Rules\n\nPPF-29\n\n### **B - Physical Damage Territory Factor**\n\n**Territory Radius Collision Comprehensive Specified Causes of Loss**\n\n101 Local 1.2524 1.0141 1.0141\n\n102 Local 0\\.8952 1.0000 1.0000\n\n103 Local 1\\.0286 1.0000 1.0000\n\n104 Local 1\\.0571 1.0000 1.0000\n\n105 Local 1\\.0000 1.0000 1.0000\n\n106 Local 0\\.9143 1.0141 1.0141\n\n107 Local 1\\.2381 1.0423 1.0423\n\n108 Local 0\\.9810 1.2535 1.2535\n\n109 Local 0\\.9857 1.0000 1.0000\n\n110 Local 1\\.3143 1.3521 1.3521\n\n111 Local 0\\.9810 1.2394 1.2394\n\n112 Local 0\\.8143 1.0704 1.0704\n\n113 Local 0\\.9143 1.0000 1.0000\n\n114 Local 0\\.8429 1.1972 1.1972\n\n115 Local 0\\.9810 1.0704 1.0704\n\n116 Local 1\\.0667 1.2394 1.2394\n\n117 Local 0\\.9143 1.0423 1.0423\n\n120 Local 1\\.0381 1.1690 1.1690\n\n121 Local 1\\.2429 1.0141 1.0141\n\n122 Local 1\\.1095 1.3521 1.3521\n\n123 Local 1\\.0952 0.9437 0.9437\n\n124 Local 1\\.2857 1.3521 1.3521\n\n125 Local 1\\.0857 0.8873 0.8873\n\n126 Local 1\\.2524 0.8169 0.8169\n\n127 Local 1\\.1095 0.8592 0.8592\n\n128 Local 0\\.9095 0.9014 0.9014\n\n129 Local 1\\.1238 0.9155 0.9155\n\n130 Local 1\\.0857 0.7465 0.7465\n\n131 Local 0\\.9095 1.3662 1.3662\n\n132 Local 0\\.9429 1.0563 1.0563\n\n133 Local 1\\.1143 1.0563 1.0563\n\n134 Local 1\\.2286 1.4507 1.4507\n\n135 Local 1\\.1000 1.0704 1.0704\n\n136 Local 1\\.1143 0.9437 0.9437\n\n137 Local 1\\.2714 1.0423 1.0423\n\n138 Local 1\\.0571 1.2113 1.2113\n\n139 Local 1\\.0429 0.8169 0.8169\n\n140 Local 1\\.1714 0.8169 0.8169\n\n141 Local 0\\.7381 1.0141 1.0141\n\n142 Local 0\\.9857 0.9014 0.9014\n\n151 Local 1\\.2810 0.9014 0.9014\n\n153 Local 0\\.9524 0.7042 0.7042\n\n155 Local 0\\.8714 0.8592 0.8592","pages":[{"line_numbers":[],"markdown":"**Canal Insurance Company – California** Commercial Auto Liability and Physical Damage Rates and Rules\n\nPPF-29\n\n### **B - Physical Damage Territory Factor**\n\n**Territory Radius Collision Comprehensive Specified Causes of Loss**\n\n101 Local 1.2524 1.0141 1.0141\n\n102 Local 0\\.8952 1.0000 1.0000\n\n103 Local 1\\.0286 1.0000 1.0000\n\n104 Local 1\\.0571 1.0000 1.0000\n\n105 Local 1\\.0000 1.0000 1.0000\n\n106 Local 0\\.9143 1.0141 1.0141\n\n107 Local 1\\.2381 1.0423 1.0423\n\n108 Local 0\\.9810 1.2535 1.2535\n\n109 Local 0\\.9857 1.0000 1.0000\n\n110 Local 1\\.3143 1.3521 1.3521\n\n111 Local 0\\.9810 1.2394 1.2394\n\n112 Local 0\\.8143 1.0704 1.0704\n\n113 Local 0\\.9143 1.0000 1.0000\n\n114 Local 0\\.8429 1.1972 1.1972\n\n115 Local 0\\.9810 1.0704 1.0704\n\n116 Local 1\\.0667 1.2394 1.2394\n\n117 Local 0\\.9143 1.0423 1.0423\n\n120 Local 1\\.0381 1.1690 1.1690\n\n121 Local 1\\.2429 1.0141 1.0141\n\n122 Local 1\\.1095 1.3521 1.3521\n\n123 Local 1\\.0952 0.9437 0.9437\n\n124 Local 1\\.2857 1.3521 1.3521\n\n125 Local 1\\.0857 0.8873 0.8873\n\n126 Local 1\\.2524 0.8169 0.8169\n\n127 Local 1\\.1095 0.8592 0.8592\n\n128 Local 0\\.9095 0.9014 0.9014\n\n129 Local 1\\.1238 0.9155 0.9155\n\n130 Local 1\\.0857 0.7465 0.7465\n\n131 Local 0\\.9095 1.3662 1.3662\n\n132 Local 0\\.9429 1.0563 1.0563\n\n133 Local 1\\.1143 1.0563 1.0563\n\n134 Local 1\\.2286 1.4507 1.4507\n\n135 Local 1\\.1000 1.0704 1.0704\n\n136 Local 1\\.1143 0.9437 0.9437\n\n137 Local 1\\.2714 1.0423 1.0423\n\n138 Local 1\\.0571 1.2113 1.2113\n\n139 Local 1\\.0429 0.8169 0.8169\n\n140 Local 1\\.1714 0.8169 0.8169\n\n141 Local 0\\.7381 1.0141 1.0141\n\n142 Local 0\\.9857 0.9014 0.9014\n\n151 Local 1\\.2810 0.9014 0.9014\n\n153 Local 0\\.9524 0.7042 0.7042\n\n155 Local 0\\.8714 0.8592 0.8592","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Canal Insurance Company – California** Commercial Auto Liability and Physical Damage Rates and Rules\n\nPPF-29\n\n### **B - Physical Damage Territory Factor**\n\n**Territory Radius Collision Comprehensive Specified Causes of Loss**\n\n101 Local 1.2524 1.0141 1.0141\n\n102 Local 0\\.8952 1.0000 1.0000\n\n103 Local 1\\.0286 1.0000 1.0000\n\n104 Local 1\\.0571 1.0000 1.0000\n\n105 Local 1\\.0000 1.0000 1.0000\n\n106 Local 0\\.9143 1.0141 1.0141\n\n107 Local 1\\.2381 1.0423 1.0423\n\n108 Local 0\\.9810 1.2535 1.2535\n\n109 Local 0\\.9857 1.0000 1.0000\n\n110 Local 1\\.3143 1.3521 1.3521\n\n111 Local 0\\.9810 1.2394 1.2394\n\n112 Local 0\\.8143 1.0704 1.0704\n\n113 Local 0\\.9143 1.0000 1.0000\n\n114 Local 0\\.8429 1.1972 1.1972\n\n115 Local 0\\.9810 1.0704 1.0704\n\n116 Local 1\\.0667 1.2394 1.2394\n\n117 Local 0\\.9143 1.0423 1.0423\n\n120 Local 1\\.0381 1.1690 1.1690\n\n121 Local 1\\.2429 1.0141 1.0141\n\n122 Local 1\\.1095 1.3521 1.3521\n\n123 Local 1\\.0952 0.9437 0.9437\n\n124 Local 1\\.2857 1.3521 1.3521\n\n125 Local 1\\.0857 0.8873 0.8873\n\n126 Local 1\\.2524 0.8169 0.8169\n\n127 Local 1\\.1095 0.8592 0.8592\n\n128 Local 0\\.9095 0.9014 0.9014\n\n129 Local 1\\.1238 0.9155 0.9155\n\n130 Local 1\\.0857 0.7465 0.7465\n\n131 Local 0\\.9095 1.3662 1.3662\n\n132 Local 0\\.9429 1.0563 1.0563\n\n133 Local 1\\.1143 1.0563 1.0563\n\n134 Local 1\\.2286 1.4507 1.4507\n\n135 Local 1\\.1000 1.0704 1.0704\n\n136 Local 1\\.1143 0.9437 0.9437\n\n137 Local 1\\.2714 1.0423 1.0423\n\n138 Local 1\\.0571 1.2113 1.2113\n\n139 Local 1\\.0429 0.8169 0.8169\n\n140 Local 1\\.1714 0.8169 0.8169\n\n141 Local 0\\.7381 1.0141 1.0141\n\n142 Local 0\\.9857 0.9014 0.9014\n\n151 Local 1\\.2810 0.9014 0.9014\n\n153 Local 0\\.9524 0.7042 0.7042\n\n155 Local 0\\.8714 0.8592 0.8592","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page536.pdf"]},"response":{"errors":[],"extract_id":"extract_58ac865f10944cd3e4a707f86f16ad22","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Canal Insurance Company – California** Commercial Auto Liability and Physical Damage Rates and Rules\n\nPPF-29\n\n### **B - Physical Damage Territory Factor**\n\n**Territory Radius Collision Comprehensive Specified Causes of Loss**\n\n101 Local 1.2524 1.0141 1.0141\n\n102 Local 0\\.8952 1.0000 1.0000\n\n103 Local 1\\.0286 1.0000 1.0000\n\n104 Local 1\\.0571 1.0000 1.0000\n\n105 Local 1\\.0000 1.0000 1.0000\n\n106 Local 0\\.9143 1.0141 1.0141\n\n107 Local 1\\.2381 1.0423 1.0423\n\n108 Local 0\\.9810 1.2535 1.2535\n\n109 Local 0\\.9857 1.0000 1.0000\n\n110 Local 1\\.3143 1.3521 1.3521\n\n111 Local 0\\.9810 1.2394 1.2394\n\n112 Local 0\\.8143 1.0704 1.0704\n\n113 Local 0\\.9143 1.0000 1.0000\n\n114 Local 0\\.8429 1.1972 1.1972\n\n115 Local 0\\.9810 1.0704 1.0704\n\n116 Local 1\\.0667 1.2394 1.2394\n\n117 Local 0\\.9143 1.0423 1.0423\n\n120 Local 1\\.0381 1.1690 1.1690\n\n121 Local 1\\.2429 1.0141 1.0141\n\n122 Local 1\\.1095 1.3521 1.3521\n\n123 Local 1\\.0952 0.9437 0.9437\n\n124 Local 1\\.2857 1.3521 1.3521\n\n125 Local 1\\.0857 0.8873 0.8873\n\n126 Local 1\\.2524 0.8169 0.8169\n\n127 Local 1\\.1095 0.8592 0.8592\n\n128 Local 0\\.9095 0.9014 0.9014\n\n129 Local 1\\.1238 0.9155 0.9155\n\n130 Local 1\\.0857 0.7465 0.7465\n\n131 Local 0\\.9095 1.3662 1.3662\n\n132 Local 0\\.9429 1.0563 1.0563\n\n133 Local 1\\.1143 1.0563 1.0563\n\n134 Local 1\\.2286 1.4507 1.4507\n\n135 Local 1\\.1000 1.0704 1.0704\n\n136 Local 1\\.1143 0.9437 0.9437\n\n137 Local 1\\.2714 1.0423 1.0423\n\n138 Local 1\\.0571 1.2113 1.2113\n\n139 Local 1\\.0429 0.8169 0.8169\n\n140 Local 1\\.1714 0.8169 0.8169\n\n141 Local 0\\.7381 1.0141 1.0141\n\n142 Local 0\\.9857 0.9014 0.9014\n\n151 Local 1\\.2810 0.9014 0.9014\n\n153 Local 0\\.9524 0.7042 0.7042\n\n155 Local 0\\.8714 0.8592 0.8592"],"full_content":"**Canal Insurance Company – California** Commercial Auto Liability and Physical Damage Rates and Rules\n\nPPF-29\n\n### **B - Physical Damage Territory Factor**\n\n**Territory Radius Collision Comprehensive Specified Causes of Loss**\n\n101 Local 1.2524 1.0141 1.0141\n\n102 Local 0\\.8952 1.0000 1.0000\n\n103 Local 1\\.0286 1.0000 1.0000\n\n104 Local 1\\.0571 1.0000 1.0000\n\n105 Local 1\\.0000 1.0000 1.0000\n\n106 Local 0\\.9143 1.0141 1.0141\n\n107 Local 1\\.2381 1.0423 1.0423\n\n108 Local 0\\.9810 1.2535 1.2535\n\n109 Local 0\\.9857 1.0000 1.0000\n\n110 Local 1\\.3143 1.3521 1.3521\n\n111 Local 0\\.9810 1.2394 1.2394\n\n112 Local 0\\.8143 1.0704 1.0704\n\n113 Local 0\\.9143 1.0000 1.0000\n\n114 Local 0\\.8429 1.1972 1.1972\n\n115 Local 0\\.9810 1.0704 1.0704\n\n116 Local 1\\.0667 1.2394 1.2394\n\n117 Local 0\\.9143 1.0423 1.0423\n\n120 Local 1\\.0381 1.1690 1.1690\n\n121 Local 1\\.2429 1.0141 1.0141\n\n122 Local 1\\.1095 1.3521 1.3521\n\n123 Local 1\\.0952 0.9437 0.9437\n\n124 Local 1\\.2857 1.3521 1.3521\n\n125 Local 1\\.0857 0.8873 0.8873\n\n126 Local 1\\.2524 0.8169 0.8169\n\n127 Local 1\\.1095 0.8592 0.8592\n\n128 Local 0\\.9095 0.9014 0.9014\n\n129 Local 1\\.1238 0.9155 0.9155\n\n130 Local 1\\.0857 0.7465 0.7465\n\n131 Local 0\\.9095 1.3662 1.3662\n\n132 Local 0\\.9429 1.0563 1.0563\n\n133 Local 1\\.1143 1.0563 1.0563\n\n134 Local 1\\.2286 1.4507 1.4507\n\n135 Local 1\\.1000 1.0704 1.0704\n\n136 Local 1\\.1143 0.9437 0.9437\n\n137 Local 1\\.2714 1.0423 1.0423\n\n138 Local 1\\.0571 1.2113 1.2113\n\n139 Local 1\\.0429 0.8169 0.8169\n\n140 Local 1\\.1714 0.8169 0.8169\n\n141 Local 0\\.7381 1.0141 1.0141\n\n142 Local 0\\.9857 0.9014 0.9014\n\n151 Local 1\\.2810 0.9014 0.9014\n\n153 Local 0\\.9524 0.7042 0.7042\n\n155 Local 0\\.8714 0.8592 0.8592","publish_date":null,"title":"B - Physical Damage Territory Factor","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page536.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page536.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page536","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page536.pdf"},"started_at":"2026-11-04T19:47:23.744367"} +{"completed_at":"2026-11-04T19:47:26.189864","latency_in_ms":1331,"output":{"example_id":"table/SERFF_CA_random_pages 1_page56","grounded_pages":[],"layout_pages":[],"markdown":"**WCF Select Insurance Company WCF National Insurance Company California Schedule Rating Plan Effective: October 1, 2022**\n\n**Range of Modifications**\n\n**Risk Characteristics Credit to Debit**\n\n**_Classification Peculiarities_** Exposure variation due to technology, employee distribution, fit in class, grade in class, assignment by analogy.\n\n20% 20%\n\n**_Employees_** Selection and hiring, training, experience, controls, supervision, benefits, wage levels.\n\n20% 20%\n\n**_Medical Controls_** First aid, emergency and disaster plans, prompt injury reporting, MPN participation, litigation management, return-to-work programs.\n\n10% 10%\n\n**_Premises / Work Environment_** Physical condition, hazards controlled, housekeeping, documented inspection and preventive maintenance (including records of corrective action), industrial hygiene, ergonomics, workplace design, workflow, resource distribution, and administrative controls.\n\n15% 15%\n\n**_Safety Devices and Equipment_** Type and condition, guarding, lockout/tagout, personal protective equipment, inspection and maintenance, MSDS available, required training with documentation.\n\n10% 10%\n\n**_Management Safety Organization_** Demonstrated management commitment to providing a safe work place, safety programs, compliance with company safety recommendations, communications, safety culture.\n\n5% 5%\n\n**_Safety Organization_** Demonstrated commitment to safety through activities such as accident investigation and analysis with corrective action, record-keeping, safety committee organization and effectiveness, employee involvement.\n\n10% 10%\n\nMaximum +/- 50%\n\n1\\. The minimum premium which qualifies for scheduled rating is $500 estimated annual modified manual premium (modified manual premium = manual premium after the application of experience modification).\n\n2\\. The schedule rating factor is applied in a multiplicative manner after the application of the experience rating modification (if the risk is experience rated) and before the application of the premium discount.\n\n3\\. The credit or debit must be within the range for a specific risk characteristic as provided in this plan.\n\n4\\. The effective date of the schedule rating factor must be on or after the date of the carrier’s receipt of the documentation supporting the basis for the schedule rating factor.\n\n5\\. At the time that the schedule rating factor is applied, the carrier must have documentation on file detailing the basis for the credit or debit.","pages":[{"line_numbers":[],"markdown":"**WCF Select Insurance Company WCF National Insurance Company California Schedule Rating Plan Effective: October 1, 2022**\n\n**Range of Modifications**\n\n**Risk Characteristics Credit to Debit**\n\n**_Classification Peculiarities_** Exposure variation due to technology, employee distribution, fit in class, grade in class, assignment by analogy.\n\n20% 20%\n\n**_Employees_** Selection and hiring, training, experience, controls, supervision, benefits, wage levels.\n\n20% 20%\n\n**_Medical Controls_** First aid, emergency and disaster plans, prompt injury reporting, MPN participation, litigation management, return-to-work programs.\n\n10% 10%\n\n**_Premises / Work Environment_** Physical condition, hazards controlled, housekeeping, documented inspection and preventive maintenance (including records of corrective action), industrial hygiene, ergonomics, workplace design, workflow, resource distribution, and administrative controls.\n\n15% 15%\n\n**_Safety Devices and Equipment_** Type and condition, guarding, lockout/tagout, personal protective equipment, inspection and maintenance, MSDS available, required training with documentation.\n\n10% 10%\n\n**_Management Safety Organization_** Demonstrated management commitment to providing a safe work place, safety programs, compliance with company safety recommendations, communications, safety culture.\n\n5% 5%\n\n**_Safety Organization_** Demonstrated commitment to safety through activities such as accident investigation and analysis with corrective action, record-keeping, safety committee organization and effectiveness, employee involvement.\n\n10% 10%\n\nMaximum +/- 50%\n\n1\\. The minimum premium which qualifies for scheduled rating is $500 estimated annual modified manual premium (modified manual premium = manual premium after the application of experience modification).\n\n2\\. The schedule rating factor is applied in a multiplicative manner after the application of the experience rating modification (if the risk is experience rated) and before the application of the premium discount.\n\n3\\. The credit or debit must be within the range for a specific risk characteristic as provided in this plan.\n\n4\\. The effective date of the schedule rating factor must be on or after the date of the carrier’s receipt of the documentation supporting the basis for the schedule rating factor.\n\n5\\. At the time that the schedule rating factor is applied, the carrier must have documentation on file detailing the basis for the credit or debit.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**WCF Select Insurance Company WCF National Insurance Company California Schedule Rating Plan Effective: October 1, 2022**\n\n**Range of Modifications**\n\n**Risk Characteristics Credit to Debit**\n\n**_Classification Peculiarities_** Exposure variation due to technology, employee distribution, fit in class, grade in class, assignment by analogy.\n\n20% 20%\n\n**_Employees_** Selection and hiring, training, experience, controls, supervision, benefits, wage levels.\n\n20% 20%\n\n**_Medical Controls_** First aid, emergency and disaster plans, prompt injury reporting, MPN participation, litigation management, return-to-work programs.\n\n10% 10%\n\n**_Premises / Work Environment_** Physical condition, hazards controlled, housekeeping, documented inspection and preventive maintenance (including records of corrective action), industrial hygiene, ergonomics, workplace design, workflow, resource distribution, and administrative controls.\n\n15% 15%\n\n**_Safety Devices and Equipment_** Type and condition, guarding, lockout/tagout, personal protective equipment, inspection and maintenance, MSDS available, required training with documentation.\n\n10% 10%\n\n**_Management Safety Organization_** Demonstrated management commitment to providing a safe work place, safety programs, compliance with company safety recommendations, communications, safety culture.\n\n5% 5%\n\n**_Safety Organization_** Demonstrated commitment to safety through activities such as accident investigation and analysis with corrective action, record-keeping, safety committee organization and effectiveness, employee involvement.\n\n10% 10%\n\nMaximum +/- 50%\n\n1\\. The minimum premium which qualifies for scheduled rating is $500 estimated annual modified manual premium (modified manual premium = manual premium after the application of experience modification).\n\n2\\. The schedule rating factor is applied in a multiplicative manner after the application of the experience rating modification (if the risk is experience rated) and before the application of the premium discount.\n\n3\\. The credit or debit must be within the range for a specific risk characteristic as provided in this plan.\n\n4\\. The effective date of the schedule rating factor must be on or after the date of the carrier’s receipt of the documentation supporting the basis for the schedule rating factor.\n\n5\\. At the time that the schedule rating factor is applied, the carrier must have documentation on file detailing the basis for the credit or debit.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page56.pdf"]},"response":{"errors":[],"extract_id":"extract_9c14862c1bfbf273cd51719124558db5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**WCF Select Insurance Company WCF National Insurance Company California Schedule Rating Plan Effective: October 1, 2022**\n\n**Range of Modifications**\n\n**Risk Characteristics Credit to Debit**\n\n**_Classification Peculiarities_** Exposure variation due to technology, employee distribution, fit in class, grade in class, assignment by analogy.\n\n20% 20%\n\n**_Employees_** Selection and hiring, training, experience, controls, supervision, benefits, wage levels.\n\n20% 20%\n\n**_Medical Controls_** First aid, emergency and disaster plans, prompt injury reporting, MPN participation, litigation management, return-to-work programs.\n\n10% 10%\n\n**_Premises / Work Environment_** Physical condition, hazards controlled, housekeeping, documented inspection and preventive maintenance (including records of corrective action), industrial hygiene, ergonomics, workplace design, workflow, resource distribution, and administrative controls.\n\n15% 15%\n\n**_Safety Devices and Equipment_** Type and condition, guarding, lockout/tagout, personal protective equipment, inspection and maintenance, MSDS available, required training with documentation.\n\n10% 10%\n\n**_Management Safety Organization_** Demonstrated management commitment to providing a safe work place, safety programs, compliance with company safety recommendations, communications, safety culture.\n\n5% 5%\n\n**_Safety Organization_** Demonstrated commitment to safety through activities such as accident investigation and analysis with corrective action, record-keeping, safety committee organization and effectiveness, employee involvement.\n\n10% 10%\n\nMaximum +/- 50%\n\n1\\. The minimum premium which qualifies for scheduled rating is $500 estimated annual modified manual premium (modified manual premium = manual premium after the application of experience modification).\n\n2\\. The schedule rating factor is applied in a multiplicative manner after the application of the experience rating modification (if the risk is experience rated) and before the application of the premium discount.\n\n3\\. The credit or debit must be within the range for a specific risk characteristic as provided in this plan.\n\n4\\. The effective date of the schedule rating factor must be on or after the date of the carrier’s receipt of the documentation supporting the basis for the schedule rating factor.\n\n5\\. At the time that the schedule rating factor is applied, the carrier must have documentation on file detailing the basis for the credit or debit."],"full_content":"**WCF Select Insurance Company WCF National Insurance Company California Schedule Rating Plan Effective: October 1, 2022**\n\n**Range of Modifications**\n\n**Risk Characteristics Credit to Debit**\n\n**_Classification Peculiarities_** Exposure variation due to technology, employee distribution, fit in class, grade in class, assignment by analogy.\n\n20% 20%\n\n**_Employees_** Selection and hiring, training, experience, controls, supervision, benefits, wage levels.\n\n20% 20%\n\n**_Medical Controls_** First aid, emergency and disaster plans, prompt injury reporting, MPN participation, litigation management, return-to-work programs.\n\n10% 10%\n\n**_Premises / Work Environment_** Physical condition, hazards controlled, housekeeping, documented inspection and preventive maintenance (including records of corrective action), industrial hygiene, ergonomics, workplace design, workflow, resource distribution, and administrative controls.\n\n15% 15%\n\n**_Safety Devices and Equipment_** Type and condition, guarding, lockout/tagout, personal protective equipment, inspection and maintenance, MSDS available, required training with documentation.\n\n10% 10%\n\n**_Management Safety Organization_** Demonstrated management commitment to providing a safe work place, safety programs, compliance with company safety recommendations, communications, safety culture.\n\n5% 5%\n\n**_Safety Organization_** Demonstrated commitment to safety through activities such as accident investigation and analysis with corrective action, record-keeping, safety committee organization and effectiveness, employee involvement.\n\n10% 10%\n\nMaximum +/- 50%\n\n1\\. The minimum premium which qualifies for scheduled rating is $500 estimated annual modified manual premium (modified manual premium = manual premium after the application of experience modification).\n\n2\\. The schedule rating factor is applied in a multiplicative manner after the application of the experience rating modification (if the risk is experience rated) and before the application of the premium discount.\n\n3\\. The credit or debit must be within the range for a specific risk characteristic as provided in this plan.\n\n4\\. The effective date of the schedule rating factor must be on or after the date of the carrier’s receipt of the documentation supporting the basis for the schedule rating factor.\n\n5\\. At the time that the schedule rating factor is applied, the carrier must have documentation on file detailing the basis for the credit or debit.","publish_date":null,"title":"WCF Select Insurance Company WCF National Insurance Company California Schedule Rating Plan Effective: October 1, 2022 Range of Modifications Risk","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page56.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page56.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page56","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page56.pdf"},"started_at":"2026-11-04T19:47:24.858376"} +{"completed_at":"2026-11-04T19:47:27.310771","latency_in_ms":1142,"output":{"example_id":"table/SERFF_CA_random_pages 1_page569","grounded_pages":[],"layout_pages":[],"markdown":"**Cincinnati Insurance Company ‐ Homeowners Program California Base Rates ‐ Executive and Executive Capstone Forms Exhibit BR**\n\n**Territory All Other Perils Wildfire All Other Perils Wildfire All Other Perils Wildfire All Other Perils Wildfire Impact**\n\n**Proposed Current Executive Forms Executive Capstone Forms Current Proposed**\n\n**45** 3,510 184 3,187 207 3,510 184 3,187 207 ‐2.3% **46** 2,569 453 2,592 510 2,569 453 2,592 510 2.9% **47** 1,443 361 1,456 407 1,443 361 1,456 407 4.6% **48** 2,576 454 2,339 512 2,576 454 2,339 512 2.1% **49** 1,754 439 1,858 495 1,754 439 1,858 495 13.1% **51** 2,355 262 2,138 295 2,355 262 2,138 295 1.2% **52** 2,908 513 2,934 578 2,908 513 2,934 578 9.5% **53** 2,908 513 2,934 578 2,908 513 2,934 578 18.9% **54** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **55** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **56** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **58** 1,942 343 1,959 386 1,942 343 1,959 386 9.9% **59** 2,355 262 2,376 295 2,355 262 2,376 295 0.0% **60** 2,345 414 2,366 466 2,345 414 2,366 466 0.0% **61** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **62** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **63** 2,397 423 2,418 477 2,397 423 2,418 477 0.0% **64** 2,355 262 2,376 295 2,355 262 2,376 295 0.0% **65** 1,443 361 1,674 407 1,443 361 1,674 407 19.3% **66** 2,312 453 2,333 510 2,312 453 2,333 510 0.0% **67** 2,345 414 2,366 466 2,345 414 2,366 466 0.0% **68** 2,345 414 2,011 466 2,345 414 2,011 466 ‐5.2% **69** 2,343 261 2,080 294 2,343 261 2,080 294 0.3% **70** 2,935 517 2,961 583 2,935 517 2,961 583 0.0% **71** 2,351 415 2,372 468 2,351 415 2,372 468 2.2% **72** 2,935 517 2,961 583 2,935 517 2,961 583 0.0% **73** 2,525 330 2,293 372 2,525 330 2,293 372 1.8% **76** 1,942 343 1,959 386 1,942 343 1,959 386 4.2% **77** 3,130 783 3,271 882 3,130 783 3,271 882 8.7% **78** 3,565 629 3,777 709 3,565 629 3,777 709 10.8% **79** 3,128 783 3,156 882 3,128 783 3,156 882 7.3% **80** 1,883 470 1,995 530 1,883 470 1,995 530 9.7% **81** 2,327 410 2,465 462 2,327 410 2,465 462 8.7% **82** 2,048 414 1,922 466 2,048 414 1,922 466 2.8% **83** 2,488 439 2,510 495 2,488 439 2,510 495 5.0% **84** 3,455 610 3,486 687 3,455 610 3,486 687 8.5% **85** 3,011 531 3,038 598 3,011 531 3,038 598 5.3% **86** 1,789 475 1,715 535 1,789 475 1,715 535 3.0% **87** 2,984 184 2,559 207 2,984 184 2,559 207 ‐9.5% **88** 1,947 403 1,964 454 1,947 403 1,964 454 10.8%","pages":[{"line_numbers":[],"markdown":"**Cincinnati Insurance Company ‐ Homeowners Program California Base Rates ‐ Executive and Executive Capstone Forms Exhibit BR**\n\n**Territory All Other Perils Wildfire All Other Perils Wildfire All Other Perils Wildfire All Other Perils Wildfire Impact**\n\n**Proposed Current Executive Forms Executive Capstone Forms Current Proposed**\n\n**45** 3,510 184 3,187 207 3,510 184 3,187 207 ‐2.3% **46** 2,569 453 2,592 510 2,569 453 2,592 510 2.9% **47** 1,443 361 1,456 407 1,443 361 1,456 407 4.6% **48** 2,576 454 2,339 512 2,576 454 2,339 512 2.1% **49** 1,754 439 1,858 495 1,754 439 1,858 495 13.1% **51** 2,355 262 2,138 295 2,355 262 2,138 295 1.2% **52** 2,908 513 2,934 578 2,908 513 2,934 578 9.5% **53** 2,908 513 2,934 578 2,908 513 2,934 578 18.9% **54** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **55** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **56** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **58** 1,942 343 1,959 386 1,942 343 1,959 386 9.9% **59** 2,355 262 2,376 295 2,355 262 2,376 295 0.0% **60** 2,345 414 2,366 466 2,345 414 2,366 466 0.0% **61** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **62** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **63** 2,397 423 2,418 477 2,397 423 2,418 477 0.0% **64** 2,355 262 2,376 295 2,355 262 2,376 295 0.0% **65** 1,443 361 1,674 407 1,443 361 1,674 407 19.3% **66** 2,312 453 2,333 510 2,312 453 2,333 510 0.0% **67** 2,345 414 2,366 466 2,345 414 2,366 466 0.0% **68** 2,345 414 2,011 466 2,345 414 2,011 466 ‐5.2% **69** 2,343 261 2,080 294 2,343 261 2,080 294 0.3% **70** 2,935 517 2,961 583 2,935 517 2,961 583 0.0% **71** 2,351 415 2,372 468 2,351 415 2,372 468 2.2% **72** 2,935 517 2,961 583 2,935 517 2,961 583 0.0% **73** 2,525 330 2,293 372 2,525 330 2,293 372 1.8% **76** 1,942 343 1,959 386 1,942 343 1,959 386 4.2% **77** 3,130 783 3,271 882 3,130 783 3,271 882 8.7% **78** 3,565 629 3,777 709 3,565 629 3,777 709 10.8% **79** 3,128 783 3,156 882 3,128 783 3,156 882 7.3% **80** 1,883 470 1,995 530 1,883 470 1,995 530 9.7% **81** 2,327 410 2,465 462 2,327 410 2,465 462 8.7% **82** 2,048 414 1,922 466 2,048 414 1,922 466 2.8% **83** 2,488 439 2,510 495 2,488 439 2,510 495 5.0% **84** 3,455 610 3,486 687 3,455 610 3,486 687 8.5% **85** 3,011 531 3,038 598 3,011 531 3,038 598 5.3% **86** 1,789 475 1,715 535 1,789 475 1,715 535 3.0% **87** 2,984 184 2,559 207 2,984 184 2,559 207 ‐9.5% **88** 1,947 403 1,964 454 1,947 403 1,964 454 10.8%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Cincinnati Insurance Company ‐ Homeowners Program California Base Rates ‐ Executive and Executive Capstone Forms Exhibit BR**\n\n**Territory All Other Perils Wildfire All Other Perils Wildfire All Other Perils Wildfire All Other Perils Wildfire Impact**\n\n**Proposed Current Executive Forms Executive Capstone Forms Current Proposed**\n\n**45** 3,510 184 3,187 207 3,510 184 3,187 207 ‐2.3% **46** 2,569 453 2,592 510 2,569 453 2,592 510 2.9% **47** 1,443 361 1,456 407 1,443 361 1,456 407 4.6% **48** 2,576 454 2,339 512 2,576 454 2,339 512 2.1% **49** 1,754 439 1,858 495 1,754 439 1,858 495 13.1% **51** 2,355 262 2,138 295 2,355 262 2,138 295 1.2% **52** 2,908 513 2,934 578 2,908 513 2,934 578 9.5% **53** 2,908 513 2,934 578 2,908 513 2,934 578 18.9% **54** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **55** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **56** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **58** 1,942 343 1,959 386 1,942 343 1,959 386 9.9% **59** 2,355 262 2,376 295 2,355 262 2,376 295 0.0% **60** 2,345 414 2,366 466 2,345 414 2,366 466 0.0% **61** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **62** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **63** 2,397 423 2,418 477 2,397 423 2,418 477 0.0% **64** 2,355 262 2,376 295 2,355 262 2,376 295 0.0% **65** 1,443 361 1,674 407 1,443 361 1,674 407 19.3% **66** 2,312 453 2,333 510 2,312 453 2,333 510 0.0% **67** 2,345 414 2,366 466 2,345 414 2,366 466 0.0% **68** 2,345 414 2,011 466 2,345 414 2,011 466 ‐5.2% **69** 2,343 261 2,080 294 2,343 261 2,080 294 0.3% **70** 2,935 517 2,961 583 2,935 517 2,961 583 0.0% **71** 2,351 415 2,372 468 2,351 415 2,372 468 2.2% **72** 2,935 517 2,961 583 2,935 517 2,961 583 0.0% **73** 2,525 330 2,293 372 2,525 330 2,293 372 1.8% **76** 1,942 343 1,959 386 1,942 343 1,959 386 4.2% **77** 3,130 783 3,271 882 3,130 783 3,271 882 8.7% **78** 3,565 629 3,777 709 3,565 629 3,777 709 10.8% **79** 3,128 783 3,156 882 3,128 783 3,156 882 7.3% **80** 1,883 470 1,995 530 1,883 470 1,995 530 9.7% **81** 2,327 410 2,465 462 2,327 410 2,465 462 8.7% **82** 2,048 414 1,922 466 2,048 414 1,922 466 2.8% **83** 2,488 439 2,510 495 2,488 439 2,510 495 5.0% **84** 3,455 610 3,486 687 3,455 610 3,486 687 8.5% **85** 3,011 531 3,038 598 3,011 531 3,038 598 5.3% **86** 1,789 475 1,715 535 1,789 475 1,715 535 3.0% **87** 2,984 184 2,559 207 2,984 184 2,559 207 ‐9.5% **88** 1,947 403 1,964 454 1,947 403 1,964 454 10.8%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page569.pdf"]},"response":{"errors":[],"extract_id":"extract_fe22e35048e8e0cd39ef60560d029551","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Cincinnati Insurance Company ‐ Homeowners Program California Base Rates ‐ Executive and Executive Capstone Forms Exhibit BR**\n\n**Territory All Other Perils Wildfire All Other Perils Wildfire All Other Perils Wildfire All Other Perils Wildfire Impact**\n\n**Proposed Current Executive Forms Executive Capstone Forms Current Proposed**\n\n**45** 3,510 184 3,187 207 3,510 184 3,187 207 ‐2.3% **46** 2,569 453 2,592 510 2,569 453 2,592 510 2.9% **47** 1,443 361 1,456 407 1,443 361 1,456 407 4.6% **48** 2,576 454 2,339 512 2,576 454 2,339 512 2.1% **49** 1,754 439 1,858 495 1,754 439 1,858 495 13.1% **51** 2,355 262 2,138 295 2,355 262 2,138 295 1.2% **52** 2,908 513 2,934 578 2,908 513 2,934 578 9.5% **53** 2,908 513 2,934 578 2,908 513 2,934 578 18.9% **54** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **55** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **56** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **58** 1,942 343 1,959 386 1,942 343 1,959 386 9.9% **59** 2,355 262 2,376 295 2,355 262 2,376 295 0.0% **60** 2,345 414 2,366 466 2,345 414 2,366 466 0.0% **61** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **62** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **63** 2,397 423 2,418 477 2,397 423 2,418 477 0.0% **64** 2,355 262 2,376 295 2,355 262 2,376 295 0.0% **65** 1,443 361 1,674 407 1,443 361 1,674 407 19.3% **66** 2,312 453 2,333 510 2,312 453 2,333 510 0.0% **67** 2,345 414 2,366 466 2,345 414 2,366 466 0.0% **68** 2,345 414 2,011 466 2,345 414 2,011 466 ‐5.2% **69** 2,343 261 2,080 294 2,343 261 2,080 294 0.3% **70** 2,935 517 2,961 583 2,935 517 2,961 583 0.0% **71** 2,351 415 2,372 468 2,351 415 2,372 468 2.2% **72** 2,935 517 2,961 583 2,935 517 2,961 583 0.0% **73** 2,525 330 2,293 372 2,525 330 2,293 372 1.8% **76** 1,942 343 1,959 386 1,942 343 1,959 386 4.2% **77** 3,130 783 3,271 882 3,130 783 3,271 882 8.7% **78** 3,565 629 3,777 709 3,565 629 3,777 709 10.8% **79** 3,128 783 3,156 882 3,128 783 3,156 882 7.3% **80** 1,883 470 1,995 530 1,883 470 1,995 530 9.7% **81** 2,327 410 2,465 462 2,327 410 2,465 462 8.7% **82** 2,048 414 1,922 466 2,048 414 1,922 466 2.8% **83** 2,488 439 2,510 495 2,488 439 2,510 495 5.0% **84** 3,455 610 3,486 687 3,455 610 3,486 687 8.5% **85** 3,011 531 3,038 598 3,011 531 3,038 598 5.3% **86** 1,789 475 1,715 535 1,789 475 1,715 535 3.0% **87** 2,984 184 2,559 207 2,984 184 2,559 207 ‐9.5% **88** 1,947 403 1,964 454 1,947 403 1,964 454 10.8%"],"full_content":"**Cincinnati Insurance Company ‐ Homeowners Program California Base Rates ‐ Executive and Executive Capstone Forms Exhibit BR**\n\n**Territory All Other Perils Wildfire All Other Perils Wildfire All Other Perils Wildfire All Other Perils Wildfire Impact**\n\n**Proposed Current Executive Forms Executive Capstone Forms Current Proposed**\n\n**45** 3,510 184 3,187 207 3,510 184 3,187 207 ‐2.3% **46** 2,569 453 2,592 510 2,569 453 2,592 510 2.9% **47** 1,443 361 1,456 407 1,443 361 1,456 407 4.6% **48** 2,576 454 2,339 512 2,576 454 2,339 512 2.1% **49** 1,754 439 1,858 495 1,754 439 1,858 495 13.1% **51** 2,355 262 2,138 295 2,355 262 2,138 295 1.2% **52** 2,908 513 2,934 578 2,908 513 2,934 578 9.5% **53** 2,908 513 2,934 578 2,908 513 2,934 578 18.9% **54** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **55** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **56** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **58** 1,942 343 1,959 386 1,942 343 1,959 386 9.9% **59** 2,355 262 2,376 295 2,355 262 2,376 295 0.0% **60** 2,345 414 2,366 466 2,345 414 2,366 466 0.0% **61** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **62** 3,336 588 3,366 663 3,336 588 3,366 663 0.0% **63** 2,397 423 2,418 477 2,397 423 2,418 477 0.0% **64** 2,355 262 2,376 295 2,355 262 2,376 295 0.0% **65** 1,443 361 1,674 407 1,443 361 1,674 407 19.3% **66** 2,312 453 2,333 510 2,312 453 2,333 510 0.0% **67** 2,345 414 2,366 466 2,345 414 2,366 466 0.0% **68** 2,345 414 2,011 466 2,345 414 2,011 466 ‐5.2% **69** 2,343 261 2,080 294 2,343 261 2,080 294 0.3% **70** 2,935 517 2,961 583 2,935 517 2,961 583 0.0% **71** 2,351 415 2,372 468 2,351 415 2,372 468 2.2% **72** 2,935 517 2,961 583 2,935 517 2,961 583 0.0% **73** 2,525 330 2,293 372 2,525 330 2,293 372 1.8% **76** 1,942 343 1,959 386 1,942 343 1,959 386 4.2% **77** 3,130 783 3,271 882 3,130 783 3,271 882 8.7% **78** 3,565 629 3,777 709 3,565 629 3,777 709 10.8% **79** 3,128 783 3,156 882 3,128 783 3,156 882 7.3% **80** 1,883 470 1,995 530 1,883 470 1,995 530 9.7% **81** 2,327 410 2,465 462 2,327 410 2,465 462 8.7% **82** 2,048 414 1,922 466 2,048 414 1,922 466 2.8% **83** 2,488 439 2,510 495 2,488 439 2,510 495 5.0% **84** 3,455 610 3,486 687 3,455 610 3,486 687 8.5% **85** 3,011 531 3,038 598 3,011 531 3,038 598 5.3% **86** 1,789 475 1,715 535 1,789 475 1,715 535 3.0% **87** 2,984 184 2,559 207 2,984 184 2,559 207 ‐9.5% **88** 1,947 403 1,964 454 1,947 403 1,964 454 10.8%","publish_date":null,"title":"Cincinnati Insurance Company ‐ Homeowners Program California Base Rates ‐ Executive and Executive Capstone Forms Exhibit BR Executive Forms Executive","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page569.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page569.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page569","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page569.pdf"},"started_at":"2026-11-04T19:47:26.168737"} +{"completed_at":"2026-11-04T19:47:29.322713","latency_in_ms":2693,"output":{"example_id":"table/SERFF_CA_random_pages 1_page622","grounded_pages":[],"layout_pages":[],"markdown":"Optional Personal Property\n\n**Form ProtectionClass Rate per thousand**\n\nFL1-Basic Protected 3.00\n\nFL1-Basic Partial 4.70\n\nFL1-Basic Unprotected 10.00\n\nFL1-Vacant Protected NA\n\nFL1-Vacant Partial NA\n\nFL1-Vacant Unprotected NA\n\nFL2-Broad Protected 3.00\n\nFL2-Broad Partial 4.70\n\nFL2-Broad Unprotected 10.00\n\nFL3-Special Protected 3.00\n\nFL3-Special Partial 4.70\n\nFL3-Special Unprotected 10.00","pages":[{"line_numbers":[],"markdown":"Optional Personal Property\n\n**Form ProtectionClass Rate per thousand**\n\nFL1-Basic Protected 3.00\n\nFL1-Basic Partial 4.70\n\nFL1-Basic Unprotected 10.00\n\nFL1-Vacant Protected NA\n\nFL1-Vacant Partial NA\n\nFL1-Vacant Unprotected NA\n\nFL2-Broad Protected 3.00\n\nFL2-Broad Partial 4.70\n\nFL2-Broad Unprotected 10.00\n\nFL3-Special Protected 3.00\n\nFL3-Special Partial 4.70\n\nFL3-Special Unprotected 10.00","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Optional Personal Property\n\n**Form ProtectionClass Rate per thousand**\n\nFL1-Basic Protected 3.00\n\nFL1-Basic Partial 4.70\n\nFL1-Basic Unprotected 10.00\n\nFL1-Vacant Protected NA\n\nFL1-Vacant Partial NA\n\nFL1-Vacant Unprotected NA\n\nFL2-Broad Protected 3.00\n\nFL2-Broad Partial 4.70\n\nFL2-Broad Unprotected 10.00\n\nFL3-Special Protected 3.00\n\nFL3-Special Partial 4.70\n\nFL3-Special Unprotected 10.00","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page622.pdf"]},"response":{"errors":[],"extract_id":"extract_f73e808ad1afdf2621521d9413f58c97","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Optional Personal Property\n\n**Form ProtectionClass Rate per thousand**\n\nFL1-Basic Protected 3.00\n\nFL1-Basic Partial 4.70\n\nFL1-Basic Unprotected 10.00\n\nFL1-Vacant Protected NA\n\nFL1-Vacant Partial NA\n\nFL1-Vacant Unprotected NA\n\nFL2-Broad Protected 3.00\n\nFL2-Broad Partial 4.70\n\nFL2-Broad Unprotected 10.00\n\nFL3-Special Protected 3.00\n\nFL3-Special Partial 4.70\n\nFL3-Special Unprotected 10.00"],"full_content":"Optional Personal Property\n\n**Form ProtectionClass Rate per thousand**\n\nFL1-Basic Protected 3.00\n\nFL1-Basic Partial 4.70\n\nFL1-Basic Unprotected 10.00\n\nFL1-Vacant Protected NA\n\nFL1-Vacant Partial NA\n\nFL1-Vacant Unprotected NA\n\nFL2-Broad Protected 3.00\n\nFL2-Broad Partial 4.70\n\nFL2-Broad Unprotected 10.00\n\nFL3-Special Protected 3.00\n\nFL3-Special Partial 4.70\n\nFL3-Special Unprotected 10.00","publish_date":null,"title":"Optional Personal Property FL1-Basic Protected 3.00 FL1-Basic Partial 4.70 FL1-Basic Unprotected 10.00 FL1-Vacant Protected NA FL1-Vacant Partial NA FL1-Vacant Unprotected","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page622.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page622.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page622","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page622.pdf"},"started_at":"2026-11-04T19:47:26.629126"} +{"completed_at":"2026-11-04T19:47:29.808365","latency_in_ms":2186,"output":{"example_id":"table/SERFF_CA_random_pages 1_page647","grounded_pages":[],"layout_pages":[],"markdown":"**State of California Company: CSE Safeguard Insurance Company**\n\n**Department of Insurance (CDI) Line: Fire & Allied Lines**\n\n**CDI File # (Department Use Only): 0**\n\n### **PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME**\n\nShort-Term Assets Intermediate-Term Assets Long-Term Assets No Maturity\n\nLine Description 1 Year or Less Over 1 Year thru 5\n\nYears\n\nOver 5 Years thru\n\n10 Years\n\nOver 10 Years thru\n\n20 Years Over 20 Years Date\n\n1\\.7 U.S. Governments 6,898,625 50,327,203 15,908,846 2,463,044 216,539\n\n2\\.7 All Other Governments 0 1,191,044 0 0 0\n\n3\\.7 States, Territories and Possessions 0 477,683 0 0 0\n\n4\\.7 Political Subdivisions 1,096,339 1,047,641 1,250,000 0 0\n\n5\\.7 Special Revenue and Assessment Obligations 5,900,506 23,898,124 9,658,713 7,238,250 385,181\n\n6\\.7 Industrial and Miscellaneous 7,114,749 53,810,198 47,814,373 2,215,060 0\n\n7\\.7 Hybrid Securities 0 0 0 0 0\n\n8\\.7 Parent, Subsidiaries and Affiliates 0 0 0 0 0\n\n9\\.7 SVO Identified Funds\n\nSource: Schedule D, Part 1A, Section 1 of the insurer **group's** most recent consolidated (combined) statutory Annual Statement.\n\nShort-Term Assets Intermediate-Term Assets Long-Term Assets\n\n1 Year or Less Over 1 Year thru 10 Years Over 10 Years\n\n(1) Government Bonds (Sum of Lines 1.7 & 2.7) 6,898,625\n\n(2)\n\nOther Taxable Bonds (Sum of Lines 6.7, 7.7, 8.7 and one-half of Line 5.7) ¹\n\n10,065,002\n\n(3)\n\nTax-Exempt Bonds (Sum of Lines 3.7, 4.7 and one-half of Line 5.7)\n\n4,046,592\n\n_(Note: CCR §2644.20 refers to bond asset classes of \"Credit Tenant Loans\" and \"Public Utilities\" that are no longer recorded in the NAIC Annual Statement Schedule D, Part 1A, Section 1. Assets included in \"Other Taxable Bonds\" conform to the current NAIC Annual Statement Blank.)_\n\n1 SVO Identified Funds are treated as Other Taxable Long-Term Bonds.\n\n67,427,093 2,679,583\n\n118,402,990 6,026,776\n\n19,553,743 3,811,716\n\nPrior Approval Rate Template Page 3.1 07/22/2020 Edition","pages":[{"line_numbers":[],"markdown":"**State of California Company: CSE Safeguard Insurance Company**\n\n**Department of Insurance (CDI) Line: Fire & Allied Lines**\n\n**CDI File # (Department Use Only): 0**\n\n### **PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME**\n\nShort-Term Assets Intermediate-Term Assets Long-Term Assets No Maturity\n\nLine Description 1 Year or Less Over 1 Year thru 5\n\nYears\n\nOver 5 Years thru\n\n10 Years\n\nOver 10 Years thru\n\n20 Years Over 20 Years Date\n\n1\\.7 U.S. Governments 6,898,625 50,327,203 15,908,846 2,463,044 216,539\n\n2\\.7 All Other Governments 0 1,191,044 0 0 0\n\n3\\.7 States, Territories and Possessions 0 477,683 0 0 0\n\n4\\.7 Political Subdivisions 1,096,339 1,047,641 1,250,000 0 0\n\n5\\.7 Special Revenue and Assessment Obligations 5,900,506 23,898,124 9,658,713 7,238,250 385,181\n\n6\\.7 Industrial and Miscellaneous 7,114,749 53,810,198 47,814,373 2,215,060 0\n\n7\\.7 Hybrid Securities 0 0 0 0 0\n\n8\\.7 Parent, Subsidiaries and Affiliates 0 0 0 0 0\n\n9\\.7 SVO Identified Funds\n\nSource: Schedule D, Part 1A, Section 1 of the insurer **group's** most recent consolidated (combined) statutory Annual Statement.\n\nShort-Term Assets Intermediate-Term Assets Long-Term Assets\n\n1 Year or Less Over 1 Year thru 10 Years Over 10 Years\n\n(1) Government Bonds (Sum of Lines 1.7 & 2.7) 6,898,625\n\n(2)\n\nOther Taxable Bonds (Sum of Lines 6.7, 7.7, 8.7 and one-half of Line 5.7) ¹\n\n10,065,002\n\n(3)\n\nTax-Exempt Bonds (Sum of Lines 3.7, 4.7 and one-half of Line 5.7)\n\n4,046,592\n\n_(Note: CCR §2644.20 refers to bond asset classes of \"Credit Tenant Loans\" and \"Public Utilities\" that are no longer recorded in the NAIC Annual Statement Schedule D, Part 1A, Section 1. Assets included in \"Other Taxable Bonds\" conform to the current NAIC Annual Statement Blank.)_\n\n1 SVO Identified Funds are treated as Other Taxable Long-Term Bonds.\n\n67,427,093 2,679,583\n\n118,402,990 6,026,776\n\n19,553,743 3,811,716\n\nPrior Approval Rate Template Page 3.1 07/22/2020 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**State of California Company: CSE Safeguard Insurance Company**\n\n**Department of Insurance (CDI) Line: Fire & Allied Lines**\n\n**CDI File # (Department Use Only): 0**\n\n### **PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME**\n\nShort-Term Assets Intermediate-Term Assets Long-Term Assets No Maturity\n\nLine Description 1 Year or Less Over 1 Year thru 5\n\nYears\n\nOver 5 Years thru\n\n10 Years\n\nOver 10 Years thru\n\n20 Years Over 20 Years Date\n\n1\\.7 U.S. Governments 6,898,625 50,327,203 15,908,846 2,463,044 216,539\n\n2\\.7 All Other Governments 0 1,191,044 0 0 0\n\n3\\.7 States, Territories and Possessions 0 477,683 0 0 0\n\n4\\.7 Political Subdivisions 1,096,339 1,047,641 1,250,000 0 0\n\n5\\.7 Special Revenue and Assessment Obligations 5,900,506 23,898,124 9,658,713 7,238,250 385,181\n\n6\\.7 Industrial and Miscellaneous 7,114,749 53,810,198 47,814,373 2,215,060 0\n\n7\\.7 Hybrid Securities 0 0 0 0 0\n\n8\\.7 Parent, Subsidiaries and Affiliates 0 0 0 0 0\n\n9\\.7 SVO Identified Funds\n\nSource: Schedule D, Part 1A, Section 1 of the insurer **group's** most recent consolidated (combined) statutory Annual Statement.\n\nShort-Term Assets Intermediate-Term Assets Long-Term Assets\n\n1 Year or Less Over 1 Year thru 10 Years Over 10 Years\n\n(1) Government Bonds (Sum of Lines 1.7 & 2.7) 6,898,625\n\n(2)\n\nOther Taxable Bonds (Sum of Lines 6.7, 7.7, 8.7 and one-half of Line 5.7) ¹\n\n10,065,002\n\n(3)\n\nTax-Exempt Bonds (Sum of Lines 3.7, 4.7 and one-half of Line 5.7)\n\n4,046,592\n\n_(Note: CCR §2644.20 refers to bond asset classes of \"Credit Tenant Loans\" and \"Public Utilities\" that are no longer recorded in the NAIC Annual Statement Schedule D, Part 1A, Section 1. Assets included in \"Other Taxable Bonds\" conform to the current NAIC Annual Statement Blank.)_\n\n1 SVO Identified Funds are treated as Other Taxable Long-Term Bonds.\n\n67,427,093 2,679,583\n\n118,402,990 6,026,776\n\n19,553,743 3,811,716\n\nPrior Approval Rate Template Page 3.1 07/22/2020 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page647.pdf"]},"response":{"errors":[],"extract_id":"extract_d19fff75eae65dd579d52e90818bd84b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**State of California Company: CSE Safeguard Insurance Company**\n\n**Department of Insurance (CDI) Line: Fire & Allied Lines**\n\n**CDI File # (Department Use Only): 0**\n\n### **PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME**\n\nShort-Term Assets Intermediate-Term Assets Long-Term Assets No Maturity\n\nLine Description 1 Year or Less Over 1 Year thru 5\n\nYears\n\nOver 5 Years thru\n\n10 Years\n\nOver 10 Years thru\n\n20 Years Over 20 Years Date\n\n1\\.7 U.S. Governments 6,898,625 50,327,203 15,908,846 2,463,044 216,539\n\n2\\.7 All Other Governments 0 1,191,044 0 0 0\n\n3\\.7 States, Territories and Possessions 0 477,683 0 0 0\n\n4\\.7 Political Subdivisions 1,096,339 1,047,641 1,250,000 0 0\n\n5\\.7 Special Revenue and Assessment Obligations 5,900,506 23,898,124 9,658,713 7,238,250 385,181\n\n6\\.7 Industrial and Miscellaneous 7,114,749 53,810,198 47,814,373 2,215,060 0\n\n7\\.7 Hybrid Securities 0 0 0 0 0\n\n8\\.7 Parent, Subsidiaries and Affiliates 0 0 0 0 0\n\n9\\.7 SVO Identified Funds\n\nSource: Schedule D, Part 1A, Section 1 of the insurer **group's** most recent consolidated (combined) statutory Annual Statement.\n\nShort-Term Assets Intermediate-Term Assets Long-Term Assets\n\n1 Year or Less Over 1 Year thru 10 Years Over 10 Years\n\n(1) Government Bonds (Sum of Lines 1.7 & 2.7) 6,898,625\n\n(2)\n\nOther Taxable Bonds (Sum of Lines 6.7, 7.7, 8.7 and one-half of Line 5.7) ¹\n\n10,065,002\n\n(3)\n\nTax-Exempt Bonds (Sum of Lines 3.7, 4.7 and one-half of Line 5.7)\n\n4,046,592\n\n_(Note: CCR §2644.20 refers to bond asset classes of \"Credit Tenant Loans\" and \"Public Utilities\" that are no longer recorded in the NAIC Annual Statement Schedule D, Part 1A, Section 1. Assets included in \"Other Taxable Bonds\" conform to the current NAIC Annual Statement Blank.)_\n\n1 SVO Identified Funds are treated as Other Taxable Long-Term Bonds.\n\n67,427,093 2,679,583\n\n118,402,990 6,026,776\n\n19,553,743 3,811,716\n\nPrior Approval Rate Template Page 3.1 07/22/2020 Edition"],"full_content":"**State of California Company: CSE Safeguard Insurance Company**\n\n**Department of Insurance (CDI) Line: Fire & Allied Lines**\n\n**CDI File # (Department Use Only): 0**\n\n### **PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME**\n\nShort-Term Assets Intermediate-Term Assets Long-Term Assets No Maturity\n\nLine Description 1 Year or Less Over 1 Year thru 5\n\nYears\n\nOver 5 Years thru\n\n10 Years\n\nOver 10 Years thru\n\n20 Years Over 20 Years Date\n\n1\\.7 U.S. Governments 6,898,625 50,327,203 15,908,846 2,463,044 216,539\n\n2\\.7 All Other Governments 0 1,191,044 0 0 0\n\n3\\.7 States, Territories and Possessions 0 477,683 0 0 0\n\n4\\.7 Political Subdivisions 1,096,339 1,047,641 1,250,000 0 0\n\n5\\.7 Special Revenue and Assessment Obligations 5,900,506 23,898,124 9,658,713 7,238,250 385,181\n\n6\\.7 Industrial and Miscellaneous 7,114,749 53,810,198 47,814,373 2,215,060 0\n\n7\\.7 Hybrid Securities 0 0 0 0 0\n\n8\\.7 Parent, Subsidiaries and Affiliates 0 0 0 0 0\n\n9\\.7 SVO Identified Funds\n\nSource: Schedule D, Part 1A, Section 1 of the insurer **group's** most recent consolidated (combined) statutory Annual Statement.\n\nShort-Term Assets Intermediate-Term Assets Long-Term Assets\n\n1 Year or Less Over 1 Year thru 10 Years Over 10 Years\n\n(1) Government Bonds (Sum of Lines 1.7 & 2.7) 6,898,625\n\n(2)\n\nOther Taxable Bonds (Sum of Lines 6.7, 7.7, 8.7 and one-half of Line 5.7) ¹\n\n10,065,002\n\n(3)\n\nTax-Exempt Bonds (Sum of Lines 3.7, 4.7 and one-half of Line 5.7)\n\n4,046,592\n\n_(Note: CCR §2644.20 refers to bond asset classes of \"Credit Tenant Loans\" and \"Public Utilities\" that are no longer recorded in the NAIC Annual Statement Schedule D, Part 1A, Section 1. Assets included in \"Other Taxable Bonds\" conform to the current NAIC Annual Statement Blank.)_\n\n1 SVO Identified Funds are treated as Other Taxable Long-Term Bonds.\n\n67,427,093 2,679,583\n\n118,402,990 6,026,776\n\n19,553,743 3,811,716\n\nPrior Approval Rate Template Page 3.1 07/22/2020 Edition","publish_date":null,"title":"PROJECTED YIELD AND FEDERAL INCOME TAX RATE ON INVESTMENT INCOME","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page647.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page647.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page647","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page647.pdf"},"started_at":"2026-11-04T19:47:27.622365"} +{"completed_at":"2026-11-04T19:47:31.133281","latency_in_ms":2128,"output":{"example_id":"table/SERFF_CA_random_pages 1_page65","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 5 Sheet 4\n\n**WCF National Insurance Company Workers' Compensation - California**\n\n**FILING EFFECTIVE 10/1/2022**\n\nData Evaluated as of December 31, 2020\n\n**A. Determination of Loss Adjustment Expense**\n\nAccident\n\nYear\n\nCountrywide\n\nUltimate Incurred\n\nLosses\n\n(in thousands)\n\nCountrywide\n\nUltimate Incurred\n\nDCC\n\n(in thousands)\n\nCountrywide\n\nUltimate Incurred\n\nAOE\n\n(in thousands) DCC Ratio AOE Ratio\n\n(1) (2) (3) (4) = (2) / (1) (5) = (3) / (1)\n\n1/1/1904 0.0% 0.0% 0.0% 0.0% -\n\n2016 33,848 4,208 4,309 12.4% 12.7%\n\n2017 40,675 4,950 4,661 12.2% 11.5%\n\n2018 38,660 5,160 5,475 13.3% 14.2%\n\n2019 46,472 6,232 6,734 13.4% 14.5%\n\n2020 57,699 7,246 7,432 12.6% 12.9%\n\nTotal 217,354 27,796 28,611 12.8% 13.2%\n\n4-yr Wtd Avg: 12.9% 13.2%\n\n3-yr Wtd Avg: 13.0% 13.8%\n\n2-yr Wtd Avg: 12.9% 13.6%\n\nAvg Ex Hi/Lo: 12.8% 13.2%\n\nNCCI - Countrywide: N/A 9.4%\n\nWCIRB - California: 19.8% 13.7%\n\n(6) Countrywide Selected: N/A 9.4%\n\n(7) California Selected: 19.8% 13.7%\n\n**B. Selected LAE & LBA Provision**\n\n(1) Selected LAE Provision 33.5%\n\n(2) Selected LBA Provision 0.0%\n\n(3) Selected LAE & LBA Provision = (1) + (2) 33.5%\n\nNotes: Columns (1) through (3) from Annual Statement, Schedule P - Part 1D The selected Countrywide and California DCC & AOE ratios are from the NCCI and the WCIRB, respectively.\n\nActuarial Filing Exhibits\\_CA\\_NAT 2022-10-01.xlsx 7/6/2022 10:50 AM","pages":[{"line_numbers":[],"markdown":"Exhibit 5 Sheet 4\n\n**WCF National Insurance Company Workers' Compensation - California**\n\n**FILING EFFECTIVE 10/1/2022**\n\nData Evaluated as of December 31, 2020\n\n**A. Determination of Loss Adjustment Expense**\n\nAccident\n\nYear\n\nCountrywide\n\nUltimate Incurred\n\nLosses\n\n(in thousands)\n\nCountrywide\n\nUltimate Incurred\n\nDCC\n\n(in thousands)\n\nCountrywide\n\nUltimate Incurred\n\nAOE\n\n(in thousands) DCC Ratio AOE Ratio\n\n(1) (2) (3) (4) = (2) / (1) (5) = (3) / (1)\n\n1/1/1904 0.0% 0.0% 0.0% 0.0% -\n\n2016 33,848 4,208 4,309 12.4% 12.7%\n\n2017 40,675 4,950 4,661 12.2% 11.5%\n\n2018 38,660 5,160 5,475 13.3% 14.2%\n\n2019 46,472 6,232 6,734 13.4% 14.5%\n\n2020 57,699 7,246 7,432 12.6% 12.9%\n\nTotal 217,354 27,796 28,611 12.8% 13.2%\n\n4-yr Wtd Avg: 12.9% 13.2%\n\n3-yr Wtd Avg: 13.0% 13.8%\n\n2-yr Wtd Avg: 12.9% 13.6%\n\nAvg Ex Hi/Lo: 12.8% 13.2%\n\nNCCI - Countrywide: N/A 9.4%\n\nWCIRB - California: 19.8% 13.7%\n\n(6) Countrywide Selected: N/A 9.4%\n\n(7) California Selected: 19.8% 13.7%\n\n**B. Selected LAE & LBA Provision**\n\n(1) Selected LAE Provision 33.5%\n\n(2) Selected LBA Provision 0.0%\n\n(3) Selected LAE & LBA Provision = (1) + (2) 33.5%\n\nNotes: Columns (1) through (3) from Annual Statement, Schedule P - Part 1D The selected Countrywide and California DCC & AOE ratios are from the NCCI and the WCIRB, respectively.\n\nActuarial Filing Exhibits\\_CA\\_NAT 2022-10-01.xlsx 7/6/2022 10:50 AM","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 5 Sheet 4\n\n**WCF National Insurance Company Workers' Compensation - California**\n\n**FILING EFFECTIVE 10/1/2022**\n\nData Evaluated as of December 31, 2020\n\n**A. Determination of Loss Adjustment Expense**\n\nAccident\n\nYear\n\nCountrywide\n\nUltimate Incurred\n\nLosses\n\n(in thousands)\n\nCountrywide\n\nUltimate Incurred\n\nDCC\n\n(in thousands)\n\nCountrywide\n\nUltimate Incurred\n\nAOE\n\n(in thousands) DCC Ratio AOE Ratio\n\n(1) (2) (3) (4) = (2) / (1) (5) = (3) / (1)\n\n1/1/1904 0.0% 0.0% 0.0% 0.0% -\n\n2016 33,848 4,208 4,309 12.4% 12.7%\n\n2017 40,675 4,950 4,661 12.2% 11.5%\n\n2018 38,660 5,160 5,475 13.3% 14.2%\n\n2019 46,472 6,232 6,734 13.4% 14.5%\n\n2020 57,699 7,246 7,432 12.6% 12.9%\n\nTotal 217,354 27,796 28,611 12.8% 13.2%\n\n4-yr Wtd Avg: 12.9% 13.2%\n\n3-yr Wtd Avg: 13.0% 13.8%\n\n2-yr Wtd Avg: 12.9% 13.6%\n\nAvg Ex Hi/Lo: 12.8% 13.2%\n\nNCCI - Countrywide: N/A 9.4%\n\nWCIRB - California: 19.8% 13.7%\n\n(6) Countrywide Selected: N/A 9.4%\n\n(7) California Selected: 19.8% 13.7%\n\n**B. Selected LAE & LBA Provision**\n\n(1) Selected LAE Provision 33.5%\n\n(2) Selected LBA Provision 0.0%\n\n(3) Selected LAE & LBA Provision = (1) + (2) 33.5%\n\nNotes: Columns (1) through (3) from Annual Statement, Schedule P - Part 1D The selected Countrywide and California DCC & AOE ratios are from the NCCI and the WCIRB, respectively.\n\nActuarial Filing Exhibits\\_CA\\_NAT 2022-10-01.xlsx 7/6/2022 10:50 AM","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page65.pdf"]},"response":{"errors":[],"extract_id":"extract_870ce8271d770069abd6da04b8763cd1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 5 Sheet 4\n\n**WCF National Insurance Company Workers' Compensation - California**\n\n**FILING EFFECTIVE 10/1/2022**\n\nData Evaluated as of December 31, 2020\n\n**A. Determination of Loss Adjustment Expense**\n\nAccident\n\nYear\n\nCountrywide\n\nUltimate Incurred\n\nLosses\n\n(in thousands)\n\nCountrywide\n\nUltimate Incurred\n\nDCC\n\n(in thousands)\n\nCountrywide\n\nUltimate Incurred\n\nAOE\n\n(in thousands) DCC Ratio AOE Ratio\n\n(1) (2) (3) (4) = (2) / (1) (5) = (3) / (1)\n\n1/1/1904 0.0% 0.0% 0.0% 0.0% -\n\n2016 33,848 4,208 4,309 12.4% 12.7%\n\n2017 40,675 4,950 4,661 12.2% 11.5%\n\n2018 38,660 5,160 5,475 13.3% 14.2%\n\n2019 46,472 6,232 6,734 13.4% 14.5%\n\n2020 57,699 7,246 7,432 12.6% 12.9%\n\nTotal 217,354 27,796 28,611 12.8% 13.2%\n\n4-yr Wtd Avg: 12.9% 13.2%\n\n3-yr Wtd Avg: 13.0% 13.8%\n\n2-yr Wtd Avg: 12.9% 13.6%\n\nAvg Ex Hi/Lo: 12.8% 13.2%\n\nNCCI - Countrywide: N/A 9.4%\n\nWCIRB - California: 19.8% 13.7%\n\n(6) Countrywide Selected: N/A 9.4%\n\n(7) California Selected: 19.8% 13.7%\n\n**B. Selected LAE & LBA Provision**\n\n(1) Selected LAE Provision 33.5%\n\n(2) Selected LBA Provision 0.0%\n\n(3) Selected LAE & LBA Provision = (1) + (2) 33.5%\n\nNotes: Columns (1) through (3) from Annual Statement, Schedule P - Part 1D The selected Countrywide and California DCC & AOE ratios are from the NCCI and the WCIRB, respectively.\n\nActuarial Filing Exhibits\\_CA\\_NAT 2022-10-01.xlsx 7/6/2022 10:50 AM"],"full_content":"Exhibit 5 Sheet 4\n\n**WCF National Insurance Company Workers' Compensation - California**\n\n**FILING EFFECTIVE 10/1/2022**\n\nData Evaluated as of December 31, 2020\n\n**A. Determination of Loss Adjustment Expense**\n\nAccident\n\nYear\n\nCountrywide\n\nUltimate Incurred\n\nLosses\n\n(in thousands)\n\nCountrywide\n\nUltimate Incurred\n\nDCC\n\n(in thousands)\n\nCountrywide\n\nUltimate Incurred\n\nAOE\n\n(in thousands) DCC Ratio AOE Ratio\n\n(1) (2) (3) (4) = (2) / (1) (5) = (3) / (1)\n\n1/1/1904 0.0% 0.0% 0.0% 0.0% -\n\n2016 33,848 4,208 4,309 12.4% 12.7%\n\n2017 40,675 4,950 4,661 12.2% 11.5%\n\n2018 38,660 5,160 5,475 13.3% 14.2%\n\n2019 46,472 6,232 6,734 13.4% 14.5%\n\n2020 57,699 7,246 7,432 12.6% 12.9%\n\nTotal 217,354 27,796 28,611 12.8% 13.2%\n\n4-yr Wtd Avg: 12.9% 13.2%\n\n3-yr Wtd Avg: 13.0% 13.8%\n\n2-yr Wtd Avg: 12.9% 13.6%\n\nAvg Ex Hi/Lo: 12.8% 13.2%\n\nNCCI - Countrywide: N/A 9.4%\n\nWCIRB - California: 19.8% 13.7%\n\n(6) Countrywide Selected: N/A 9.4%\n\n(7) California Selected: 19.8% 13.7%\n\n**B. Selected LAE & LBA Provision**\n\n(1) Selected LAE Provision 33.5%\n\n(2) Selected LBA Provision 0.0%\n\n(3) Selected LAE & LBA Provision = (1) + (2) 33.5%\n\nNotes: Columns (1) through (3) from Annual Statement, Schedule P - Part 1D The selected Countrywide and California DCC & AOE ratios are from the NCCI and the WCIRB, respectively.\n\nActuarial Filing Exhibits\\_CA\\_NAT 2022-10-01.xlsx 7/6/2022 10:50 AM","publish_date":null,"title":"Exhibit 5 Sheet 4","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page65.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page65.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page65","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page65.pdf"},"started_at":"2026-11-04T19:47:29.004460"} +{"completed_at":"2026-11-04T19:47:31.688534","latency_in_ms":1088,"output":{"example_id":"table/SERFF_CA_random_pages 1_page687","grounded_pages":[],"layout_pages":[],"markdown":"**(2) Proposed** BOP2530-0126AS Period of Restoration Endorsement 2 3 3 Y N Y -5%\n\n**Current**\n\n**(3) Proposed** BOP1010-0126AS Application for Coverage Commercial Property Business Owners Policy 1 3 4 N N N 0%\n\n**Current** BOP1010-0324AS Application for Coverage Commercial Property Business Owners Policy 1 3 23-3674 7\n\nPage 2 of the rule manual.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nThis is a new optional endorsement reduces the Loss of Income coverage from 24 months to 12 months for a reduced premium.\n\nPlease see supplemental attachment describing premium determination\n\nThere is a premium reduction if this endorsement is selected.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nUpdated application to allow for a 12 or 24-month Loss of Income option.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nPrior Approval Rate Application Page 9.2 6/5/2023 Edition","pages":[{"line_numbers":[],"markdown":"**(2) Proposed** BOP2530-0126AS Period of Restoration Endorsement 2 3 3 Y N Y -5%\n\n**Current**\n\n**(3) Proposed** BOP1010-0126AS Application for Coverage Commercial Property Business Owners Policy 1 3 4 N N N 0%\n\n**Current** BOP1010-0324AS Application for Coverage Commercial Property Business Owners Policy 1 3 23-3674 7\n\nPage 2 of the rule manual.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nThis is a new optional endorsement reduces the Loss of Income coverage from 24 months to 12 months for a reduced premium.\n\nPlease see supplemental attachment describing premium determination\n\nThere is a premium reduction if this endorsement is selected.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nUpdated application to allow for a 12 or 24-month Loss of Income option.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nPrior Approval Rate Application Page 9.2 6/5/2023 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**(2) Proposed** BOP2530-0126AS Period of Restoration Endorsement 2 3 3 Y N Y -5%\n\n**Current**\n\n**(3) Proposed** BOP1010-0126AS Application for Coverage Commercial Property Business Owners Policy 1 3 4 N N N 0%\n\n**Current** BOP1010-0324AS Application for Coverage Commercial Property Business Owners Policy 1 3 23-3674 7\n\nPage 2 of the rule manual.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nThis is a new optional endorsement reduces the Loss of Income coverage from 24 months to 12 months for a reduced premium.\n\nPlease see supplemental attachment describing premium determination\n\nThere is a premium reduction if this endorsement is selected.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nUpdated application to allow for a 12 or 24-month Loss of Income option.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nPrior Approval Rate Application Page 9.2 6/5/2023 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page687.pdf"]},"response":{"errors":[],"extract_id":"extract_e2b7cb14aa433442e1d68ec4aa64f575","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**(2) Proposed** BOP2530-0126AS Period of Restoration Endorsement 2 3 3 Y N Y -5%\n\n**Current**\n\n**(3) Proposed** BOP1010-0126AS Application for Coverage Commercial Property Business Owners Policy 1 3 4 N N N 0%\n\n**Current** BOP1010-0324AS Application for Coverage Commercial Property Business Owners Policy 1 3 23-3674 7\n\nPage 2 of the rule manual.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nThis is a new optional endorsement reduces the Loss of Income coverage from 24 months to 12 months for a reduced premium.\n\nPlease see supplemental attachment describing premium determination\n\nThere is a premium reduction if this endorsement is selected.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nUpdated application to allow for a 12 or 24-month Loss of Income option.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nPrior Approval Rate Application Page 9.2 6/5/2023 Edition"],"full_content":"**(2) Proposed** BOP2530-0126AS Period of Restoration Endorsement 2 3 3 Y N Y -5%\n\n**Current**\n\n**(3) Proposed** BOP1010-0126AS Application for Coverage Commercial Property Business Owners Policy 1 3 4 N N N 0%\n\n**Current** BOP1010-0324AS Application for Coverage Commercial Property Business Owners Policy 1 3 23-3674 7\n\nPage 2 of the rule manual.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nThis is a new optional endorsement reduces the Loss of Income coverage from 24 months to 12 months for a reduced premium.\n\nPlease see supplemental attachment describing premium determination\n\nThere is a premium reduction if this endorsement is selected.\n\n**Explain Revision/New Form** Provide a summary - when does it attach, how does it broaden or restrict coverage, and why are you seeking to revise or adopt it.\n\n**Premium Determination** (Factor or Charge - $, %, or description) - **Any changes or introduction of rates/premium charge must be justified and supported** . If additional space is needed submit a supplemental exhibit.\n\n**Rate Impact** Explain why there is or isn't a rate impact.\n\n**Rule** If applicable, specify the applicable rule(s) and manual page number(s).\n\nUpdated application to allow for a 12 or 24-month Loss of Income option.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nNA - Used to determine eligibility and pricing for new applicants.\n\nPrior Approval Rate Application Page 9.2 6/5/2023 Edition","publish_date":null,"title":"(2) Proposed BOP2530-0126AS Period of Restoration Endorsement 2 3 3 Y N Y -5% Current This is a new optional","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page687.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page687.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page687","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page687.pdf"},"started_at":"2026-11-04T19:47:30.600316"} +{"completed_at":"2026-11-04T19:47:31.886988","latency_in_ms":974,"output":{"example_id":"table/SERFF_CA_random_pages 1_page696","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit 7**\n\n### **The Dentists Insurance Company**\n\n### **Non-Catastrophe Paid DCCE Development - Annual Triangles**\n\n**_0_**\n\n**Months of Development Fiscal Accident Year Data Ending 12 24 36 48 60 72 84 96 108 120**\n\n**20154 20164 20174 20184 20194 20204 20214 20224 20234 20244**\n\n**Age to Age Factors Fiscal Accident Year Data Ending 12-24 24-36 36-48 48-60 60-72 72-84 84-96 96-108 108-120 120-Ult**\n\n**20154 20164 20174 20184 20194 20204 20214 20224 20234 Tail 3 Yr Wtd Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Age-Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Ultimate $ 0 0 0 0 0 0 0 0 0 0**\n\n**Back to Top**\n\nStandard Exhibits Template Page 3.69 2/21/2025 Edition","pages":[{"line_numbers":[],"markdown":"**Exhibit 7**\n\n### **The Dentists Insurance Company**\n\n### **Non-Catastrophe Paid DCCE Development - Annual Triangles**\n\n**_0_**\n\n**Months of Development Fiscal Accident Year Data Ending 12 24 36 48 60 72 84 96 108 120**\n\n**20154 20164 20174 20184 20194 20204 20214 20224 20234 20244**\n\n**Age to Age Factors Fiscal Accident Year Data Ending 12-24 24-36 36-48 48-60 60-72 72-84 84-96 96-108 108-120 120-Ult**\n\n**20154 20164 20174 20184 20194 20204 20214 20224 20234 Tail 3 Yr Wtd Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Age-Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Ultimate $ 0 0 0 0 0 0 0 0 0 0**\n\n**Back to Top**\n\nStandard Exhibits Template Page 3.69 2/21/2025 Edition","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit 7**\n\n### **The Dentists Insurance Company**\n\n### **Non-Catastrophe Paid DCCE Development - Annual Triangles**\n\n**_0_**\n\n**Months of Development Fiscal Accident Year Data Ending 12 24 36 48 60 72 84 96 108 120**\n\n**20154 20164 20174 20184 20194 20204 20214 20224 20234 20244**\n\n**Age to Age Factors Fiscal Accident Year Data Ending 12-24 24-36 36-48 48-60 60-72 72-84 84-96 96-108 108-120 120-Ult**\n\n**20154 20164 20174 20184 20194 20204 20214 20224 20234 Tail 3 Yr Wtd Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Age-Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Ultimate $ 0 0 0 0 0 0 0 0 0 0**\n\n**Back to Top**\n\nStandard Exhibits Template Page 3.69 2/21/2025 Edition","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page696.pdf"]},"response":{"errors":[],"extract_id":"extract_9dcb1a136ad99272a359686dd0607dd2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit 7**\n\n### **The Dentists Insurance Company**\n\n### **Non-Catastrophe Paid DCCE Development - Annual Triangles**\n\n**_0_**\n\n**Months of Development Fiscal Accident Year Data Ending 12 24 36 48 60 72 84 96 108 120**\n\n**20154 20164 20174 20184 20194 20204 20214 20224 20234 20244**\n\n**Age to Age Factors Fiscal Accident Year Data Ending 12-24 24-36 36-48 48-60 60-72 72-84 84-96 96-108 108-120 120-Ult**\n\n**20154 20164 20174 20184 20194 20204 20214 20224 20234 Tail 3 Yr Wtd Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Age-Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Ultimate $ 0 0 0 0 0 0 0 0 0 0**\n\n**Back to Top**\n\nStandard Exhibits Template Page 3.69 2/21/2025 Edition"],"full_content":"**Exhibit 7**\n\n### **The Dentists Insurance Company**\n\n### **Non-Catastrophe Paid DCCE Development - Annual Triangles**\n\n**_0_**\n\n**Months of Development Fiscal Accident Year Data Ending 12 24 36 48 60 72 84 96 108 120**\n\n**20154 20164 20174 20184 20194 20204 20214 20224 20234 20244**\n\n**Age to Age Factors Fiscal Accident Year Data Ending 12-24 24-36 36-48 48-60 60-72 72-84 84-96 96-108 108-120 120-Ult**\n\n**20154 20164 20174 20184 20194 20204 20214 20224 20234 Tail 3 Yr Wtd Avg 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Selected 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Age-Ult 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Ultimate $ 0 0 0 0 0 0 0 0 0 0**\n\n**Back to Top**\n\nStandard Exhibits Template Page 3.69 2/21/2025 Edition","publish_date":null,"title":"The Dentists Insurance Company Non-Catastrophe Paid DCCE Development - Annual Triangles","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page696.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page696.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page696","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page696.pdf"},"started_at":"2026-11-04T19:47:30.912038"} +{"completed_at":"2026-11-04T19:47:34.651789","latency_in_ms":2460,"output":{"example_id":"table/SERFF_CA_random_pages 1_page728","grounded_pages":[],"layout_pages":[],"markdown":"**Loss of Income Analysis The Dentists Insurance Company Exhibit 2 Loss of Income Analysis- CA BOP Sheet 1**\n\n**Loss of Income and Other CMP Ultimate Loss & ALAE Ratios**\n\n(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13)\n\n**_Loss of Income Other_** Estimated Estimated Estimated Ultimate Estimated Ultimate Ultimate Loss & ALAE Ultimate Loss & ALAE Accident Period Paid Case Estimated Loss & ALAE Earned Loss Ratio Paid Case Estimated Loss & ALAE Earned Ratio\n\nEnding 12/31/XX Loss & ALAE Reserves IBNR (2) + (3) + (4) Premium (5) / (6) Loss & ALAE Reserves IBNR (8) + (9) + (10) Premium (11) / (12) 2014 2,083,196 0 0 2,083,196 3,410,064 61.1% 5,258,505 0 0 5,258,505 7,956,815 66.1% 2015 3,048,123 0 0 3,048,123 3,451,870 88.3% 8,771,723 0 0 8,771,723 8,054,364 108.9% 2016 2,454,456 0 0 2,454,456 3,612,583 67.9% 4,486,127 0 0 4,486,127 8,429,359 53.2% 2017 2,883,141 0 0 2,883,141 3,735,634 77.2% 4,913,513 0 0 4,913,513 8,716,478 56.4% 2018 6,745,249 0 0 6,745,249 3,879,082 173.9% 4,670,992 0 0 4,670,992 9,051,190 51.6% 2019 3,744,808 0 0 3,744,808 4,059,080 92.3% 7,191,781 15,000 7,500 7,214,281 9,471,187 76.2% 2020 2,928,744 0 0 2,928,744 4,289,782 68.3% 6,964,480 53,462 78,431 7,096,373 10,086,233 70.4% 2021 4,025,575 0 0 4,025,575 4,345,331 92.6% 9,089,348 0 0 9,089,348 10,351,635 87.8% 2022 4,898,833 228,128 0 5,126,961 4,430,100 115.7% 6,949,651 263,474 67,553 7,280,677 10,622,725 68.5% 2023 3,819,355 438,135 69,244 4,326,733 5,069,394 85.4% 7,749,723 242,088 38,260 8,030,072 11,622,189 69.1% 2024 3,720,073 2,226,171 1,009,302 6,955,546 5,534,682 125.7% 9,686,553 1,602,173 726,394 12,015,120 12,728,446 94.4%\n\nTotal 40,351,551 2,892,434 1,078,546 44,322,530 45,817,600 75,732,395 2,176,197 918,138 78,826,730 107,090,622\n\nWeighted Average All Years 96.7% Weighted Average All Years 73.6% Weighted Average Latest 6 Years 97.8% Weighted Average Latest 6 Years 78.2% Weighted Average Latest 4 Years 105.4% Weighted Average Latest 4 Years 80.3%\n\nNotes: _Data is actual historical values- losses and premium are untrended and not on-leveled_ (2)-(3),(8)-(9): Provided by The Dentists Insurance Company (4),(10): Exhibit 2, Sheet 3 (6),(12): Exhibit 2, Sheet 2\n\n**Milliman**","pages":[{"line_numbers":[],"markdown":"**Loss of Income Analysis The Dentists Insurance Company Exhibit 2 Loss of Income Analysis- CA BOP Sheet 1**\n\n**Loss of Income and Other CMP Ultimate Loss & ALAE Ratios**\n\n(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13)\n\n**_Loss of Income Other_** Estimated Estimated Estimated Ultimate Estimated Ultimate Ultimate Loss & ALAE Ultimate Loss & ALAE Accident Period Paid Case Estimated Loss & ALAE Earned Loss Ratio Paid Case Estimated Loss & ALAE Earned Ratio\n\nEnding 12/31/XX Loss & ALAE Reserves IBNR (2) + (3) + (4) Premium (5) / (6) Loss & ALAE Reserves IBNR (8) + (9) + (10) Premium (11) / (12) 2014 2,083,196 0 0 2,083,196 3,410,064 61.1% 5,258,505 0 0 5,258,505 7,956,815 66.1% 2015 3,048,123 0 0 3,048,123 3,451,870 88.3% 8,771,723 0 0 8,771,723 8,054,364 108.9% 2016 2,454,456 0 0 2,454,456 3,612,583 67.9% 4,486,127 0 0 4,486,127 8,429,359 53.2% 2017 2,883,141 0 0 2,883,141 3,735,634 77.2% 4,913,513 0 0 4,913,513 8,716,478 56.4% 2018 6,745,249 0 0 6,745,249 3,879,082 173.9% 4,670,992 0 0 4,670,992 9,051,190 51.6% 2019 3,744,808 0 0 3,744,808 4,059,080 92.3% 7,191,781 15,000 7,500 7,214,281 9,471,187 76.2% 2020 2,928,744 0 0 2,928,744 4,289,782 68.3% 6,964,480 53,462 78,431 7,096,373 10,086,233 70.4% 2021 4,025,575 0 0 4,025,575 4,345,331 92.6% 9,089,348 0 0 9,089,348 10,351,635 87.8% 2022 4,898,833 228,128 0 5,126,961 4,430,100 115.7% 6,949,651 263,474 67,553 7,280,677 10,622,725 68.5% 2023 3,819,355 438,135 69,244 4,326,733 5,069,394 85.4% 7,749,723 242,088 38,260 8,030,072 11,622,189 69.1% 2024 3,720,073 2,226,171 1,009,302 6,955,546 5,534,682 125.7% 9,686,553 1,602,173 726,394 12,015,120 12,728,446 94.4%\n\nTotal 40,351,551 2,892,434 1,078,546 44,322,530 45,817,600 75,732,395 2,176,197 918,138 78,826,730 107,090,622\n\nWeighted Average All Years 96.7% Weighted Average All Years 73.6% Weighted Average Latest 6 Years 97.8% Weighted Average Latest 6 Years 78.2% Weighted Average Latest 4 Years 105.4% Weighted Average Latest 4 Years 80.3%\n\nNotes: _Data is actual historical values- losses and premium are untrended and not on-leveled_ (2)-(3),(8)-(9): Provided by The Dentists Insurance Company (4),(10): Exhibit 2, Sheet 3 (6),(12): Exhibit 2, Sheet 2\n\n**Milliman**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Loss of Income Analysis The Dentists Insurance Company Exhibit 2 Loss of Income Analysis- CA BOP Sheet 1**\n\n**Loss of Income and Other CMP Ultimate Loss & ALAE Ratios**\n\n(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13)\n\n**_Loss of Income Other_** Estimated Estimated Estimated Ultimate Estimated Ultimate Ultimate Loss & ALAE Ultimate Loss & ALAE Accident Period Paid Case Estimated Loss & ALAE Earned Loss Ratio Paid Case Estimated Loss & ALAE Earned Ratio\n\nEnding 12/31/XX Loss & ALAE Reserves IBNR (2) + (3) + (4) Premium (5) / (6) Loss & ALAE Reserves IBNR (8) + (9) + (10) Premium (11) / (12) 2014 2,083,196 0 0 2,083,196 3,410,064 61.1% 5,258,505 0 0 5,258,505 7,956,815 66.1% 2015 3,048,123 0 0 3,048,123 3,451,870 88.3% 8,771,723 0 0 8,771,723 8,054,364 108.9% 2016 2,454,456 0 0 2,454,456 3,612,583 67.9% 4,486,127 0 0 4,486,127 8,429,359 53.2% 2017 2,883,141 0 0 2,883,141 3,735,634 77.2% 4,913,513 0 0 4,913,513 8,716,478 56.4% 2018 6,745,249 0 0 6,745,249 3,879,082 173.9% 4,670,992 0 0 4,670,992 9,051,190 51.6% 2019 3,744,808 0 0 3,744,808 4,059,080 92.3% 7,191,781 15,000 7,500 7,214,281 9,471,187 76.2% 2020 2,928,744 0 0 2,928,744 4,289,782 68.3% 6,964,480 53,462 78,431 7,096,373 10,086,233 70.4% 2021 4,025,575 0 0 4,025,575 4,345,331 92.6% 9,089,348 0 0 9,089,348 10,351,635 87.8% 2022 4,898,833 228,128 0 5,126,961 4,430,100 115.7% 6,949,651 263,474 67,553 7,280,677 10,622,725 68.5% 2023 3,819,355 438,135 69,244 4,326,733 5,069,394 85.4% 7,749,723 242,088 38,260 8,030,072 11,622,189 69.1% 2024 3,720,073 2,226,171 1,009,302 6,955,546 5,534,682 125.7% 9,686,553 1,602,173 726,394 12,015,120 12,728,446 94.4%\n\nTotal 40,351,551 2,892,434 1,078,546 44,322,530 45,817,600 75,732,395 2,176,197 918,138 78,826,730 107,090,622\n\nWeighted Average All Years 96.7% Weighted Average All Years 73.6% Weighted Average Latest 6 Years 97.8% Weighted Average Latest 6 Years 78.2% Weighted Average Latest 4 Years 105.4% Weighted Average Latest 4 Years 80.3%\n\nNotes: _Data is actual historical values- losses and premium are untrended and not on-leveled_ (2)-(3),(8)-(9): Provided by The Dentists Insurance Company (4),(10): Exhibit 2, Sheet 3 (6),(12): Exhibit 2, Sheet 2\n\n**Milliman**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page728.pdf"]},"response":{"errors":[],"extract_id":"extract_f75b6330bfcee81d6a350baa8185f3e9","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Loss of Income Analysis The Dentists Insurance Company Exhibit 2 Loss of Income Analysis- CA BOP Sheet 1**\n\n**Loss of Income and Other CMP Ultimate Loss & ALAE Ratios**\n\n(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13)\n\n**_Loss of Income Other_** Estimated Estimated Estimated Ultimate Estimated Ultimate Ultimate Loss & ALAE Ultimate Loss & ALAE Accident Period Paid Case Estimated Loss & ALAE Earned Loss Ratio Paid Case Estimated Loss & ALAE Earned Ratio\n\nEnding 12/31/XX Loss & ALAE Reserves IBNR (2) + (3) + (4) Premium (5) / (6) Loss & ALAE Reserves IBNR (8) + (9) + (10) Premium (11) / (12) 2014 2,083,196 0 0 2,083,196 3,410,064 61.1% 5,258,505 0 0 5,258,505 7,956,815 66.1% 2015 3,048,123 0 0 3,048,123 3,451,870 88.3% 8,771,723 0 0 8,771,723 8,054,364 108.9% 2016 2,454,456 0 0 2,454,456 3,612,583 67.9% 4,486,127 0 0 4,486,127 8,429,359 53.2% 2017 2,883,141 0 0 2,883,141 3,735,634 77.2% 4,913,513 0 0 4,913,513 8,716,478 56.4% 2018 6,745,249 0 0 6,745,249 3,879,082 173.9% 4,670,992 0 0 4,670,992 9,051,190 51.6% 2019 3,744,808 0 0 3,744,808 4,059,080 92.3% 7,191,781 15,000 7,500 7,214,281 9,471,187 76.2% 2020 2,928,744 0 0 2,928,744 4,289,782 68.3% 6,964,480 53,462 78,431 7,096,373 10,086,233 70.4% 2021 4,025,575 0 0 4,025,575 4,345,331 92.6% 9,089,348 0 0 9,089,348 10,351,635 87.8% 2022 4,898,833 228,128 0 5,126,961 4,430,100 115.7% 6,949,651 263,474 67,553 7,280,677 10,622,725 68.5% 2023 3,819,355 438,135 69,244 4,326,733 5,069,394 85.4% 7,749,723 242,088 38,260 8,030,072 11,622,189 69.1% 2024 3,720,073 2,226,171 1,009,302 6,955,546 5,534,682 125.7% 9,686,553 1,602,173 726,394 12,015,120 12,728,446 94.4%\n\nTotal 40,351,551 2,892,434 1,078,546 44,322,530 45,817,600 75,732,395 2,176,197 918,138 78,826,730 107,090,622\n\nWeighted Average All Years 96.7% Weighted Average All Years 73.6% Weighted Average Latest 6 Years 97.8% Weighted Average Latest 6 Years 78.2% Weighted Average Latest 4 Years 105.4% Weighted Average Latest 4 Years 80.3%\n\nNotes: _Data is actual historical values- losses and premium are untrended and not on-leveled_ (2)-(3),(8)-(9): Provided by The Dentists Insurance Company (4),(10): Exhibit 2, Sheet 3 (6),(12): Exhibit 2, Sheet 2\n\n**Milliman**"],"full_content":"**Loss of Income Analysis The Dentists Insurance Company Exhibit 2 Loss of Income Analysis- CA BOP Sheet 1**\n\n**Loss of Income and Other CMP Ultimate Loss & ALAE Ratios**\n\n(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13)\n\n**_Loss of Income Other_** Estimated Estimated Estimated Ultimate Estimated Ultimate Ultimate Loss & ALAE Ultimate Loss & ALAE Accident Period Paid Case Estimated Loss & ALAE Earned Loss Ratio Paid Case Estimated Loss & ALAE Earned Ratio\n\nEnding 12/31/XX Loss & ALAE Reserves IBNR (2) + (3) + (4) Premium (5) / (6) Loss & ALAE Reserves IBNR (8) + (9) + (10) Premium (11) / (12) 2014 2,083,196 0 0 2,083,196 3,410,064 61.1% 5,258,505 0 0 5,258,505 7,956,815 66.1% 2015 3,048,123 0 0 3,048,123 3,451,870 88.3% 8,771,723 0 0 8,771,723 8,054,364 108.9% 2016 2,454,456 0 0 2,454,456 3,612,583 67.9% 4,486,127 0 0 4,486,127 8,429,359 53.2% 2017 2,883,141 0 0 2,883,141 3,735,634 77.2% 4,913,513 0 0 4,913,513 8,716,478 56.4% 2018 6,745,249 0 0 6,745,249 3,879,082 173.9% 4,670,992 0 0 4,670,992 9,051,190 51.6% 2019 3,744,808 0 0 3,744,808 4,059,080 92.3% 7,191,781 15,000 7,500 7,214,281 9,471,187 76.2% 2020 2,928,744 0 0 2,928,744 4,289,782 68.3% 6,964,480 53,462 78,431 7,096,373 10,086,233 70.4% 2021 4,025,575 0 0 4,025,575 4,345,331 92.6% 9,089,348 0 0 9,089,348 10,351,635 87.8% 2022 4,898,833 228,128 0 5,126,961 4,430,100 115.7% 6,949,651 263,474 67,553 7,280,677 10,622,725 68.5% 2023 3,819,355 438,135 69,244 4,326,733 5,069,394 85.4% 7,749,723 242,088 38,260 8,030,072 11,622,189 69.1% 2024 3,720,073 2,226,171 1,009,302 6,955,546 5,534,682 125.7% 9,686,553 1,602,173 726,394 12,015,120 12,728,446 94.4%\n\nTotal 40,351,551 2,892,434 1,078,546 44,322,530 45,817,600 75,732,395 2,176,197 918,138 78,826,730 107,090,622\n\nWeighted Average All Years 96.7% Weighted Average All Years 73.6% Weighted Average Latest 6 Years 97.8% Weighted Average Latest 6 Years 78.2% Weighted Average Latest 4 Years 105.4% Weighted Average Latest 4 Years 80.3%\n\nNotes: _Data is actual historical values- losses and premium are untrended and not on-leveled_ (2)-(3),(8)-(9): Provided by The Dentists Insurance Company (4),(10): Exhibit 2, Sheet 3 (6),(12): Exhibit 2, Sheet 2\n\n**Milliman**","publish_date":null,"title":"Milliman","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page728.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page728.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page728","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page728.pdf"},"started_at":"2026-11-04T19:47:32.191674"} +{"completed_at":"2026-11-04T19:47:36.183881","latency_in_ms":2747,"output":{"example_id":"table/SERFF_CA_random_pages 1_page748","grounded_pages":[],"layout_pages":[],"markdown":"### California\n\nWORKERS COMPENSATION\n\n### EMC INSURANCE COMPANIES\n\nACCIDENT YEAR PAID LOSS RATE LEVEL INDICATIONS\n\nYear 2008 2009 2010 2011 2012\n\nTotal\n\n### (1) (2) (3) (4) (5) (6) (7) (8) O) (lO)\n\nCurrent Accident Current Current Ultimate Projected Calendar Level Year Paid Level Level Losses & Loss & LAE Experience Year Adjusted Paid Loÿes Losses Losses LAE Ratio at Permissible Based Standard Standard Losses at Current Adjusted and LAE Trended to Future Loss & Rate Level Earned Earned as of Benefit for Developed Future Date Date of Loss LAE Indication Premium Premium 9/30/13 Level LAE to Ultimate of Loss (7)/(2) Ratio 1(8)/(9)1-1 557,951 1,022,724 645,075 632,173 766,826 893,825 1,151,79I 1.126 0.717 57.1% 599,412 1,114,307 62,896 60,820 73,775 88,931 111,292 0.I00 0.717 -86.1% 534,002 955,330 236,605 228,560 277,243 350,852 423,529 0.443 0.717 -38.2% 581,284 1,032,360 174,922 168,975 204,967 312,663 353,781 0.343 0.717 -52.2% 652,037 1,045,867 125,530 I21,137 146,939 276,799 305,401 0.292 0.717 -59.3%\n\n2,924,686 5,170,588 !.245,028 1,211,665 1,469,750 1,923,070 Z345,794 0.454 0.717 -36.7%\n\n(11)\n\nCredibility Weighted Rate Level Indication\n\n# [\n\nColumn (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11)\n\nDescription Calendar Year Standard Earned Premium including expense constant Premium adjusted to Current Rate Level excluding expense constant Accident Year Paid Losses as of 9/30/2013. Accident Year Paid Losses at Current Benefit Level Loss Adjustment Expense Loading: 21.3% Losses and LAE Developed to Ultimate Settlement Value Losses and LAE trended to average date of future loss (2/1/2015) using the following ratio trends: Indemnity 2.5%; Medical 5.0% Column (7) / Column (2) Expenses include a profit loading of 2.7% and assumes 12.5% return on equity [Column (8)/Column (9)] -1 Califomia experience based indication credibility weighted with Countrywide Experience\n\nActÿna] Depot tmÿt Iÿ15113 16:41 F AL)ÿn .VÿWC ÿop o ÿ i a/C al fro rnloL2014 kFÿ,7ÿWC Indleaforÿs\\_CA","pages":[{"line_numbers":[],"markdown":"### California\n\nWORKERS COMPENSATION\n\n### EMC INSURANCE COMPANIES\n\nACCIDENT YEAR PAID LOSS RATE LEVEL INDICATIONS\n\nYear 2008 2009 2010 2011 2012\n\nTotal\n\n### (1) (2) (3) (4) (5) (6) (7) (8) O) (lO)\n\nCurrent Accident Current Current Ultimate Projected Calendar Level Year Paid Level Level Losses & Loss & LAE Experience Year Adjusted Paid Loÿes Losses Losses LAE Ratio at Permissible Based Standard Standard Losses at Current Adjusted and LAE Trended to Future Loss & Rate Level Earned Earned as of Benefit for Developed Future Date Date of Loss LAE Indication Premium Premium 9/30/13 Level LAE to Ultimate of Loss (7)/(2) Ratio 1(8)/(9)1-1 557,951 1,022,724 645,075 632,173 766,826 893,825 1,151,79I 1.126 0.717 57.1% 599,412 1,114,307 62,896 60,820 73,775 88,931 111,292 0.I00 0.717 -86.1% 534,002 955,330 236,605 228,560 277,243 350,852 423,529 0.443 0.717 -38.2% 581,284 1,032,360 174,922 168,975 204,967 312,663 353,781 0.343 0.717 -52.2% 652,037 1,045,867 125,530 I21,137 146,939 276,799 305,401 0.292 0.717 -59.3%\n\n2,924,686 5,170,588 !.245,028 1,211,665 1,469,750 1,923,070 Z345,794 0.454 0.717 -36.7%\n\n(11)\n\nCredibility Weighted Rate Level Indication\n\n# [\n\nColumn (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11)\n\nDescription Calendar Year Standard Earned Premium including expense constant Premium adjusted to Current Rate Level excluding expense constant Accident Year Paid Losses as of 9/30/2013. Accident Year Paid Losses at Current Benefit Level Loss Adjustment Expense Loading: 21.3% Losses and LAE Developed to Ultimate Settlement Value Losses and LAE trended to average date of future loss (2/1/2015) using the following ratio trends: Indemnity 2.5%; Medical 5.0% Column (7) / Column (2) Expenses include a profit loading of 2.7% and assumes 12.5% return on equity [Column (8)/Column (9)] -1 Califomia experience based indication credibility weighted with Countrywide Experience\n\nActÿna] Depot tmÿt Iÿ15113 16:41 F AL)ÿn .VÿWC ÿop o ÿ i a/C al fro rnloL2014 kFÿ,7ÿWC Indleaforÿs\\_CA","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### California\n\nWORKERS COMPENSATION\n\n### EMC INSURANCE COMPANIES\n\nACCIDENT YEAR PAID LOSS RATE LEVEL INDICATIONS\n\nYear 2008 2009 2010 2011 2012\n\nTotal\n\n### (1) (2) (3) (4) (5) (6) (7) (8) O) (lO)\n\nCurrent Accident Current Current Ultimate Projected Calendar Level Year Paid Level Level Losses & Loss & LAE Experience Year Adjusted Paid Loÿes Losses Losses LAE Ratio at Permissible Based Standard Standard Losses at Current Adjusted and LAE Trended to Future Loss & Rate Level Earned Earned as of Benefit for Developed Future Date Date of Loss LAE Indication Premium Premium 9/30/13 Level LAE to Ultimate of Loss (7)/(2) Ratio 1(8)/(9)1-1 557,951 1,022,724 645,075 632,173 766,826 893,825 1,151,79I 1.126 0.717 57.1% 599,412 1,114,307 62,896 60,820 73,775 88,931 111,292 0.I00 0.717 -86.1% 534,002 955,330 236,605 228,560 277,243 350,852 423,529 0.443 0.717 -38.2% 581,284 1,032,360 174,922 168,975 204,967 312,663 353,781 0.343 0.717 -52.2% 652,037 1,045,867 125,530 I21,137 146,939 276,799 305,401 0.292 0.717 -59.3%\n\n2,924,686 5,170,588 !.245,028 1,211,665 1,469,750 1,923,070 Z345,794 0.454 0.717 -36.7%\n\n(11)\n\nCredibility Weighted Rate Level Indication\n\n# [\n\nColumn (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11)\n\nDescription Calendar Year Standard Earned Premium including expense constant Premium adjusted to Current Rate Level excluding expense constant Accident Year Paid Losses as of 9/30/2013. Accident Year Paid Losses at Current Benefit Level Loss Adjustment Expense Loading: 21.3% Losses and LAE Developed to Ultimate Settlement Value Losses and LAE trended to average date of future loss (2/1/2015) using the following ratio trends: Indemnity 2.5%; Medical 5.0% Column (7) / Column (2) Expenses include a profit loading of 2.7% and assumes 12.5% return on equity [Column (8)/Column (9)] -1 Califomia experience based indication credibility weighted with Countrywide Experience\n\nActÿna] Depot tmÿt Iÿ15113 16:41 F AL)ÿn .VÿWC ÿop o ÿ i a/C al fro rnloL2014 kFÿ,7ÿWC Indleaforÿs\\_CA","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page748.pdf"]},"response":{"errors":[],"extract_id":"extract_eab50ff1c9fce455367205dd0be0329c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### California\n\nWORKERS COMPENSATION\n\n### EMC INSURANCE COMPANIES\n\nACCIDENT YEAR PAID LOSS RATE LEVEL INDICATIONS\n\nYear 2008 2009 2010 2011 2012\n\nTotal\n\n### (1) (2) (3) (4) (5) (6) (7) (8) O) (lO)\n\nCurrent Accident Current Current Ultimate Projected Calendar Level Year Paid Level Level Losses & Loss & LAE Experience Year Adjusted Paid Loÿes Losses Losses LAE Ratio at Permissible Based Standard Standard Losses at Current Adjusted and LAE Trended to Future Loss & Rate Level Earned Earned as of Benefit for Developed Future Date Date of Loss LAE Indication Premium Premium 9/30/13 Level LAE to Ultimate of Loss (7)/(2) Ratio 1(8)/(9)1-1 557,951 1,022,724 645,075 632,173 766,826 893,825 1,151,79I 1.126 0.717 57.1% 599,412 1,114,307 62,896 60,820 73,775 88,931 111,292 0.I00 0.717 -86.1% 534,002 955,330 236,605 228,560 277,243 350,852 423,529 0.443 0.717 -38.2% 581,284 1,032,360 174,922 168,975 204,967 312,663 353,781 0.343 0.717 -52.2% 652,037 1,045,867 125,530 I21,137 146,939 276,799 305,401 0.292 0.717 -59.3%\n\n2,924,686 5,170,588 !.245,028 1,211,665 1,469,750 1,923,070 Z345,794 0.454 0.717 -36.7%\n\n(11)\n\nCredibility Weighted Rate Level Indication\n\n# [\n\nColumn (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11)\n\nDescription Calendar Year Standard Earned Premium including expense constant Premium adjusted to Current Rate Level excluding expense constant Accident Year Paid Losses as of 9/30/2013. Accident Year Paid Losses at Current Benefit Level Loss Adjustment Expense Loading: 21.3% Losses and LAE Developed to Ultimate Settlement Value Losses and LAE trended to average date of future loss (2/1/2015) using the following ratio trends: Indemnity 2.5%; Medical 5.0% Column (7) / Column (2) Expenses include a profit loading of 2.7% and assumes 12.5% return on equity [Column (8)/Column (9)] -1 Califomia experience based indication credibility weighted with Countrywide Experience\n\nActÿna] Depot tmÿt Iÿ15113 16:41 F AL)ÿn .VÿWC ÿop o ÿ i a/C al fro rnloL2014 kFÿ,7ÿWC Indleaforÿs\\_CA"],"full_content":"### California\n\nWORKERS COMPENSATION\n\n### EMC INSURANCE COMPANIES\n\nACCIDENT YEAR PAID LOSS RATE LEVEL INDICATIONS\n\nYear 2008 2009 2010 2011 2012\n\nTotal\n\n### (1) (2) (3) (4) (5) (6) (7) (8) O) (lO)\n\nCurrent Accident Current Current Ultimate Projected Calendar Level Year Paid Level Level Losses & Loss & LAE Experience Year Adjusted Paid Loÿes Losses Losses LAE Ratio at Permissible Based Standard Standard Losses at Current Adjusted and LAE Trended to Future Loss & Rate Level Earned Earned as of Benefit for Developed Future Date Date of Loss LAE Indication Premium Premium 9/30/13 Level LAE to Ultimate of Loss (7)/(2) Ratio 1(8)/(9)1-1 557,951 1,022,724 645,075 632,173 766,826 893,825 1,151,79I 1.126 0.717 57.1% 599,412 1,114,307 62,896 60,820 73,775 88,931 111,292 0.I00 0.717 -86.1% 534,002 955,330 236,605 228,560 277,243 350,852 423,529 0.443 0.717 -38.2% 581,284 1,032,360 174,922 168,975 204,967 312,663 353,781 0.343 0.717 -52.2% 652,037 1,045,867 125,530 I21,137 146,939 276,799 305,401 0.292 0.717 -59.3%\n\n2,924,686 5,170,588 !.245,028 1,211,665 1,469,750 1,923,070 Z345,794 0.454 0.717 -36.7%\n\n(11)\n\nCredibility Weighted Rate Level Indication\n\n# [\n\nColumn (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11)\n\nDescription Calendar Year Standard Earned Premium including expense constant Premium adjusted to Current Rate Level excluding expense constant Accident Year Paid Losses as of 9/30/2013. Accident Year Paid Losses at Current Benefit Level Loss Adjustment Expense Loading: 21.3% Losses and LAE Developed to Ultimate Settlement Value Losses and LAE trended to average date of future loss (2/1/2015) using the following ratio trends: Indemnity 2.5%; Medical 5.0% Column (7) / Column (2) Expenses include a profit loading of 2.7% and assumes 12.5% return on equity [Column (8)/Column (9)] -1 Califomia experience based indication credibility weighted with Countrywide Experience\n\nActÿna] Depot tmÿt Iÿ15113 16:41 F AL)ÿn .VÿWC ÿop o ÿ i a/C al fro rnloL2014 kFÿ,7ÿWC Indleaforÿs\\_CA","publish_date":null,"title":"[","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page748.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page748.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page748","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page748.pdf"},"started_at":"2026-11-04T19:47:33.436665"} +{"completed_at":"2026-11-04T19:47:36.556685","latency_in_ms":2079,"output":{"example_id":"table/SERFF_CA_random_pages 1_page756","grounded_pages":[],"layout_pages":[],"markdown":"**RATE TEMPLATE** **_Edition Date: 1/28/2013_**\n\n**CDI FILE NUMBER:** 0 **COMPANY/GROUP:** EVEREST NATIONAL INSURANCE **LINE OF INSURANCE:** COMMERCIAL AUTO LIABILITY **COVERAGE:** 0 **PRIOR\\_EFF\\_DATE:** 10/1/2013 **_Completed by: MARC FOURNIER_**\n\n**PROPOSED\\_EFF\\_DATE:** 3/1/2014 **_Date: 1/0/1900_**\n\n**_DATA PROVIDED BY FILER_**\n\n_Year:_ 2010 2011 2012\n\nPRIOR2 PRIOR1 RECENT\n\nPROJECTED/ SUMMARY WRT\\_PREM 0 0 696,081 696,081 ERN\\_PREM 0 0 525,990 525,990 PREM\\_ADJ 1\\.000 1.000 1.000 PREM\\_TREND 1\\.000 1.000 1.000 0.000 MISCELLANEOUS\\_FEES (& other flat charges) 0 0 0 0 EARNED\\_EXP 0 0 26 26 LOSSES 0 0 22,489 22,489 DCCE 0 0 2,905 2,905 LOSS\\_DEV 1\\.000 1.000 1.000 DCCE\\_DEV 1\\.000 1.000 1.000 LOSS\\_TREND 1\\.000 1.000 1.000 0.000 DCCE\\_TREND 1\\.000 1.000 1.000 0.000 CAT\\_ADJ 1\\.000 1.000 1.000 CREDIBILITY 5\\.20% EXPENSE EXCLUSION FACTOR 0\\.00% ANC\\_INC 0 0 0 0 FIT\\_INV 31\\.04% YIELD 2\\.64%\n\n**_CDI PARAMETERS:_** FIT\\_UW 35\\.00% EFF\\_STANDARD 34\\.33% LEVERAGE 0\\.72 PREMIUM\\_TAX\\_RATE 2\\.35% SURPLUS\\_RATIO 1\\.38 UEP\\_RES\\_RATIO 0\\.45 LOSS\\_RES\\_RATIO 2\\.41 RISK FREE RATE OF RETURN 1\\.21% **_March 2013_**\n\nMAXIMUM RATE OF RETURN 7\\.21% MINIMUM RATE OF RETURN \\-6.00%\n\n**_CDI CALCULATIONS:_** ADJ\\_PREM 0 0 525,990 525,990 ADJUSTED\\_LOSSES 0 0 22,489 22,489 ADJUSTED\\_DCCE 0 0 2,905 2,905 **_ADJUSTED\\_LOSS+DCCE\\_RATIO_** **_0\\.00% 0.00% 4.83% 4.83%_** TRENDED\\_CURRENT\\_RATE\\_LEVEL\\_PREMIUM \\#DIV/0! #DIV/0! 20230.38 20230.38 LOSS+DCCE\\_PER\\_EXP \\#DIV/0! #DIV/0! 976.69 976.69 COMP\\_LOSS+DCCE\\_PER\\_EXP \\#DIV/0! #DIV/0! 12031.47 12031.47 CRED\\_LOSS\\_PER\\_EXP \\#DIV/0! #DIV/0! 11456.62 11456.62 ANC\\_INC\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 FIXED\\_INV\\_INC\\_FACTOR 6\\.76% VAR\\_INV\\_INC\\_FACTOR 5\\.15% ANNUAL\\_NET\\_TREND 0\\.00% COMP\\_TREND 0\\.00% MAX\\_PROFIT 15\\.37% MIN\\_PROFIT \\-12.78% UW\\_PROFIT 6\\.20% MAX\\_DENOM 0\\.555 MIN\\_DENOM 0\\.836 MAX\\_PREMIUM $19,263.80 MIN\\_PREMIUM $12,777.43 CHANGE\\_AT\\_MIN \\-36.84% **CHANGE\\_AT\\_MAX** **\\-4.78%**\n\n**_Alternate Calculation with Reinsurance_** COMMISSION\\_RATE 0\\.00% RE\\_PREM - \\- - 0 RE\\_RECOV - \\- - 0 RE\\_PREM\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 RE\\_RECOV\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 COMP\\_LOSS\\_RE \\#DIV/0! #DIV/0! 12031.47 12031.47 RMAX\\_PREMIUM NA RCHANGE\\_AT\\_MAX **_NA_**","pages":[{"line_numbers":[],"markdown":"**RATE TEMPLATE** **_Edition Date: 1/28/2013_**\n\n**CDI FILE NUMBER:** 0 **COMPANY/GROUP:** EVEREST NATIONAL INSURANCE **LINE OF INSURANCE:** COMMERCIAL AUTO LIABILITY **COVERAGE:** 0 **PRIOR\\_EFF\\_DATE:** 10/1/2013 **_Completed by: MARC FOURNIER_**\n\n**PROPOSED\\_EFF\\_DATE:** 3/1/2014 **_Date: 1/0/1900_**\n\n**_DATA PROVIDED BY FILER_**\n\n_Year:_ 2010 2011 2012\n\nPRIOR2 PRIOR1 RECENT\n\nPROJECTED/ SUMMARY WRT\\_PREM 0 0 696,081 696,081 ERN\\_PREM 0 0 525,990 525,990 PREM\\_ADJ 1\\.000 1.000 1.000 PREM\\_TREND 1\\.000 1.000 1.000 0.000 MISCELLANEOUS\\_FEES (& other flat charges) 0 0 0 0 EARNED\\_EXP 0 0 26 26 LOSSES 0 0 22,489 22,489 DCCE 0 0 2,905 2,905 LOSS\\_DEV 1\\.000 1.000 1.000 DCCE\\_DEV 1\\.000 1.000 1.000 LOSS\\_TREND 1\\.000 1.000 1.000 0.000 DCCE\\_TREND 1\\.000 1.000 1.000 0.000 CAT\\_ADJ 1\\.000 1.000 1.000 CREDIBILITY 5\\.20% EXPENSE EXCLUSION FACTOR 0\\.00% ANC\\_INC 0 0 0 0 FIT\\_INV 31\\.04% YIELD 2\\.64%\n\n**_CDI PARAMETERS:_** FIT\\_UW 35\\.00% EFF\\_STANDARD 34\\.33% LEVERAGE 0\\.72 PREMIUM\\_TAX\\_RATE 2\\.35% SURPLUS\\_RATIO 1\\.38 UEP\\_RES\\_RATIO 0\\.45 LOSS\\_RES\\_RATIO 2\\.41 RISK FREE RATE OF RETURN 1\\.21% **_March 2013_**\n\nMAXIMUM RATE OF RETURN 7\\.21% MINIMUM RATE OF RETURN \\-6.00%\n\n**_CDI CALCULATIONS:_** ADJ\\_PREM 0 0 525,990 525,990 ADJUSTED\\_LOSSES 0 0 22,489 22,489 ADJUSTED\\_DCCE 0 0 2,905 2,905 **_ADJUSTED\\_LOSS+DCCE\\_RATIO_** **_0\\.00% 0.00% 4.83% 4.83%_** TRENDED\\_CURRENT\\_RATE\\_LEVEL\\_PREMIUM \\#DIV/0! #DIV/0! 20230.38 20230.38 LOSS+DCCE\\_PER\\_EXP \\#DIV/0! #DIV/0! 976.69 976.69 COMP\\_LOSS+DCCE\\_PER\\_EXP \\#DIV/0! #DIV/0! 12031.47 12031.47 CRED\\_LOSS\\_PER\\_EXP \\#DIV/0! #DIV/0! 11456.62 11456.62 ANC\\_INC\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 FIXED\\_INV\\_INC\\_FACTOR 6\\.76% VAR\\_INV\\_INC\\_FACTOR 5\\.15% ANNUAL\\_NET\\_TREND 0\\.00% COMP\\_TREND 0\\.00% MAX\\_PROFIT 15\\.37% MIN\\_PROFIT \\-12.78% UW\\_PROFIT 6\\.20% MAX\\_DENOM 0\\.555 MIN\\_DENOM 0\\.836 MAX\\_PREMIUM $19,263.80 MIN\\_PREMIUM $12,777.43 CHANGE\\_AT\\_MIN \\-36.84% **CHANGE\\_AT\\_MAX** **\\-4.78%**\n\n**_Alternate Calculation with Reinsurance_** COMMISSION\\_RATE 0\\.00% RE\\_PREM - \\- - 0 RE\\_RECOV - \\- - 0 RE\\_PREM\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 RE\\_RECOV\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 COMP\\_LOSS\\_RE \\#DIV/0! #DIV/0! 12031.47 12031.47 RMAX\\_PREMIUM NA RCHANGE\\_AT\\_MAX **_NA_**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**RATE TEMPLATE** **_Edition Date: 1/28/2013_**\n\n**CDI FILE NUMBER:** 0 **COMPANY/GROUP:** EVEREST NATIONAL INSURANCE **LINE OF INSURANCE:** COMMERCIAL AUTO LIABILITY **COVERAGE:** 0 **PRIOR\\_EFF\\_DATE:** 10/1/2013 **_Completed by: MARC FOURNIER_**\n\n**PROPOSED\\_EFF\\_DATE:** 3/1/2014 **_Date: 1/0/1900_**\n\n**_DATA PROVIDED BY FILER_**\n\n_Year:_ 2010 2011 2012\n\nPRIOR2 PRIOR1 RECENT\n\nPROJECTED/ SUMMARY WRT\\_PREM 0 0 696,081 696,081 ERN\\_PREM 0 0 525,990 525,990 PREM\\_ADJ 1\\.000 1.000 1.000 PREM\\_TREND 1\\.000 1.000 1.000 0.000 MISCELLANEOUS\\_FEES (& other flat charges) 0 0 0 0 EARNED\\_EXP 0 0 26 26 LOSSES 0 0 22,489 22,489 DCCE 0 0 2,905 2,905 LOSS\\_DEV 1\\.000 1.000 1.000 DCCE\\_DEV 1\\.000 1.000 1.000 LOSS\\_TREND 1\\.000 1.000 1.000 0.000 DCCE\\_TREND 1\\.000 1.000 1.000 0.000 CAT\\_ADJ 1\\.000 1.000 1.000 CREDIBILITY 5\\.20% EXPENSE EXCLUSION FACTOR 0\\.00% ANC\\_INC 0 0 0 0 FIT\\_INV 31\\.04% YIELD 2\\.64%\n\n**_CDI PARAMETERS:_** FIT\\_UW 35\\.00% EFF\\_STANDARD 34\\.33% LEVERAGE 0\\.72 PREMIUM\\_TAX\\_RATE 2\\.35% SURPLUS\\_RATIO 1\\.38 UEP\\_RES\\_RATIO 0\\.45 LOSS\\_RES\\_RATIO 2\\.41 RISK FREE RATE OF RETURN 1\\.21% **_March 2013_**\n\nMAXIMUM RATE OF RETURN 7\\.21% MINIMUM RATE OF RETURN \\-6.00%\n\n**_CDI CALCULATIONS:_** ADJ\\_PREM 0 0 525,990 525,990 ADJUSTED\\_LOSSES 0 0 22,489 22,489 ADJUSTED\\_DCCE 0 0 2,905 2,905 **_ADJUSTED\\_LOSS+DCCE\\_RATIO_** **_0\\.00% 0.00% 4.83% 4.83%_** TRENDED\\_CURRENT\\_RATE\\_LEVEL\\_PREMIUM \\#DIV/0! #DIV/0! 20230.38 20230.38 LOSS+DCCE\\_PER\\_EXP \\#DIV/0! #DIV/0! 976.69 976.69 COMP\\_LOSS+DCCE\\_PER\\_EXP \\#DIV/0! #DIV/0! 12031.47 12031.47 CRED\\_LOSS\\_PER\\_EXP \\#DIV/0! #DIV/0! 11456.62 11456.62 ANC\\_INC\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 FIXED\\_INV\\_INC\\_FACTOR 6\\.76% VAR\\_INV\\_INC\\_FACTOR 5\\.15% ANNUAL\\_NET\\_TREND 0\\.00% COMP\\_TREND 0\\.00% MAX\\_PROFIT 15\\.37% MIN\\_PROFIT \\-12.78% UW\\_PROFIT 6\\.20% MAX\\_DENOM 0\\.555 MIN\\_DENOM 0\\.836 MAX\\_PREMIUM $19,263.80 MIN\\_PREMIUM $12,777.43 CHANGE\\_AT\\_MIN \\-36.84% **CHANGE\\_AT\\_MAX** **\\-4.78%**\n\n**_Alternate Calculation with Reinsurance_** COMMISSION\\_RATE 0\\.00% RE\\_PREM - \\- - 0 RE\\_RECOV - \\- - 0 RE\\_PREM\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 RE\\_RECOV\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 COMP\\_LOSS\\_RE \\#DIV/0! #DIV/0! 12031.47 12031.47 RMAX\\_PREMIUM NA RCHANGE\\_AT\\_MAX **_NA_**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page756.pdf"]},"response":{"errors":[],"extract_id":"extract_8386e2068ef50544aed588265bf440b7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**RATE TEMPLATE** **_Edition Date: 1/28/2013_**\n\n**CDI FILE NUMBER:** 0 **COMPANY/GROUP:** EVEREST NATIONAL INSURANCE **LINE OF INSURANCE:** COMMERCIAL AUTO LIABILITY **COVERAGE:** 0 **PRIOR\\_EFF\\_DATE:** 10/1/2013 **_Completed by: MARC FOURNIER_**\n\n**PROPOSED\\_EFF\\_DATE:** 3/1/2014 **_Date: 1/0/1900_**\n\n**_DATA PROVIDED BY FILER_**\n\n_Year:_ 2010 2011 2012\n\nPRIOR2 PRIOR1 RECENT\n\nPROJECTED/ SUMMARY WRT\\_PREM 0 0 696,081 696,081 ERN\\_PREM 0 0 525,990 525,990 PREM\\_ADJ 1\\.000 1.000 1.000 PREM\\_TREND 1\\.000 1.000 1.000 0.000 MISCELLANEOUS\\_FEES (& other flat charges) 0 0 0 0 EARNED\\_EXP 0 0 26 26 LOSSES 0 0 22,489 22,489 DCCE 0 0 2,905 2,905 LOSS\\_DEV 1\\.000 1.000 1.000 DCCE\\_DEV 1\\.000 1.000 1.000 LOSS\\_TREND 1\\.000 1.000 1.000 0.000 DCCE\\_TREND 1\\.000 1.000 1.000 0.000 CAT\\_ADJ 1\\.000 1.000 1.000 CREDIBILITY 5\\.20% EXPENSE EXCLUSION FACTOR 0\\.00% ANC\\_INC 0 0 0 0 FIT\\_INV 31\\.04% YIELD 2\\.64%\n\n**_CDI PARAMETERS:_** FIT\\_UW 35\\.00% EFF\\_STANDARD 34\\.33% LEVERAGE 0\\.72 PREMIUM\\_TAX\\_RATE 2\\.35% SURPLUS\\_RATIO 1\\.38 UEP\\_RES\\_RATIO 0\\.45 LOSS\\_RES\\_RATIO 2\\.41 RISK FREE RATE OF RETURN 1\\.21% **_March 2013_**\n\nMAXIMUM RATE OF RETURN 7\\.21% MINIMUM RATE OF RETURN \\-6.00%\n\n**_CDI CALCULATIONS:_** ADJ\\_PREM 0 0 525,990 525,990 ADJUSTED\\_LOSSES 0 0 22,489 22,489 ADJUSTED\\_DCCE 0 0 2,905 2,905 **_ADJUSTED\\_LOSS+DCCE\\_RATIO_** **_0\\.00% 0.00% 4.83% 4.83%_** TRENDED\\_CURRENT\\_RATE\\_LEVEL\\_PREMIUM \\#DIV/0! #DIV/0! 20230.38 20230.38 LOSS+DCCE\\_PER\\_EXP \\#DIV/0! #DIV/0! 976.69 976.69 COMP\\_LOSS+DCCE\\_PER\\_EXP \\#DIV/0! #DIV/0! 12031.47 12031.47 CRED\\_LOSS\\_PER\\_EXP \\#DIV/0! #DIV/0! 11456.62 11456.62 ANC\\_INC\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 FIXED\\_INV\\_INC\\_FACTOR 6\\.76% VAR\\_INV\\_INC\\_FACTOR 5\\.15% ANNUAL\\_NET\\_TREND 0\\.00% COMP\\_TREND 0\\.00% MAX\\_PROFIT 15\\.37% MIN\\_PROFIT \\-12.78% UW\\_PROFIT 6\\.20% MAX\\_DENOM 0\\.555 MIN\\_DENOM 0\\.836 MAX\\_PREMIUM $19,263.80 MIN\\_PREMIUM $12,777.43 CHANGE\\_AT\\_MIN \\-36.84% **CHANGE\\_AT\\_MAX** **\\-4.78%**\n\n**_Alternate Calculation with Reinsurance_** COMMISSION\\_RATE 0\\.00% RE\\_PREM - \\- - 0 RE\\_RECOV - \\- - 0 RE\\_PREM\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 RE\\_RECOV\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 COMP\\_LOSS\\_RE \\#DIV/0! #DIV/0! 12031.47 12031.47 RMAX\\_PREMIUM NA RCHANGE\\_AT\\_MAX **_NA_**"],"full_content":"**RATE TEMPLATE** **_Edition Date: 1/28/2013_**\n\n**CDI FILE NUMBER:** 0 **COMPANY/GROUP:** EVEREST NATIONAL INSURANCE **LINE OF INSURANCE:** COMMERCIAL AUTO LIABILITY **COVERAGE:** 0 **PRIOR\\_EFF\\_DATE:** 10/1/2013 **_Completed by: MARC FOURNIER_**\n\n**PROPOSED\\_EFF\\_DATE:** 3/1/2014 **_Date: 1/0/1900_**\n\n**_DATA PROVIDED BY FILER_**\n\n_Year:_ 2010 2011 2012\n\nPRIOR2 PRIOR1 RECENT\n\nPROJECTED/ SUMMARY WRT\\_PREM 0 0 696,081 696,081 ERN\\_PREM 0 0 525,990 525,990 PREM\\_ADJ 1\\.000 1.000 1.000 PREM\\_TREND 1\\.000 1.000 1.000 0.000 MISCELLANEOUS\\_FEES (& other flat charges) 0 0 0 0 EARNED\\_EXP 0 0 26 26 LOSSES 0 0 22,489 22,489 DCCE 0 0 2,905 2,905 LOSS\\_DEV 1\\.000 1.000 1.000 DCCE\\_DEV 1\\.000 1.000 1.000 LOSS\\_TREND 1\\.000 1.000 1.000 0.000 DCCE\\_TREND 1\\.000 1.000 1.000 0.000 CAT\\_ADJ 1\\.000 1.000 1.000 CREDIBILITY 5\\.20% EXPENSE EXCLUSION FACTOR 0\\.00% ANC\\_INC 0 0 0 0 FIT\\_INV 31\\.04% YIELD 2\\.64%\n\n**_CDI PARAMETERS:_** FIT\\_UW 35\\.00% EFF\\_STANDARD 34\\.33% LEVERAGE 0\\.72 PREMIUM\\_TAX\\_RATE 2\\.35% SURPLUS\\_RATIO 1\\.38 UEP\\_RES\\_RATIO 0\\.45 LOSS\\_RES\\_RATIO 2\\.41 RISK FREE RATE OF RETURN 1\\.21% **_March 2013_**\n\nMAXIMUM RATE OF RETURN 7\\.21% MINIMUM RATE OF RETURN \\-6.00%\n\n**_CDI CALCULATIONS:_** ADJ\\_PREM 0 0 525,990 525,990 ADJUSTED\\_LOSSES 0 0 22,489 22,489 ADJUSTED\\_DCCE 0 0 2,905 2,905 **_ADJUSTED\\_LOSS+DCCE\\_RATIO_** **_0\\.00% 0.00% 4.83% 4.83%_** TRENDED\\_CURRENT\\_RATE\\_LEVEL\\_PREMIUM \\#DIV/0! #DIV/0! 20230.38 20230.38 LOSS+DCCE\\_PER\\_EXP \\#DIV/0! #DIV/0! 976.69 976.69 COMP\\_LOSS+DCCE\\_PER\\_EXP \\#DIV/0! #DIV/0! 12031.47 12031.47 CRED\\_LOSS\\_PER\\_EXP \\#DIV/0! #DIV/0! 11456.62 11456.62 ANC\\_INC\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 FIXED\\_INV\\_INC\\_FACTOR 6\\.76% VAR\\_INV\\_INC\\_FACTOR 5\\.15% ANNUAL\\_NET\\_TREND 0\\.00% COMP\\_TREND 0\\.00% MAX\\_PROFIT 15\\.37% MIN\\_PROFIT \\-12.78% UW\\_PROFIT 6\\.20% MAX\\_DENOM 0\\.555 MIN\\_DENOM 0\\.836 MAX\\_PREMIUM $19,263.80 MIN\\_PREMIUM $12,777.43 CHANGE\\_AT\\_MIN \\-36.84% **CHANGE\\_AT\\_MAX** **\\-4.78%**\n\n**_Alternate Calculation with Reinsurance_** COMMISSION\\_RATE 0\\.00% RE\\_PREM - \\- - 0 RE\\_RECOV - \\- - 0 RE\\_PREM\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 RE\\_RECOV\\_PER\\_EXP \\#DIV/0! #DIV/0! 0.00 0.00 COMP\\_LOSS\\_RE \\#DIV/0! #DIV/0! 12031.47 12031.47 RMAX\\_PREMIUM NA RCHANGE\\_AT\\_MAX **_NA_**","publish_date":null,"title":"RATE TEMPLATE","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page756.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page756.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page756","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page756.pdf"},"started_at":"2026-11-04T19:47:34.477144"} +{"completed_at":"2026-11-04T19:47:37.486532","latency_in_ms":1981,"output":{"example_id":"table/SERFF_CA_random_pages 1_page822","grounded_pages":[],"layout_pages":[],"markdown":"CHICAGO TITLE INSURANCE COMPANY\n\n115 State of California Effective: November 7, 2007\n\n**CLTA NO.** **DESCRIPTION**\n\n**POLICY FORM**\n\n**CHARGE**\n\n(Percentage of\n\napplicable Base Rate unless otherwise\n\nindicated)\n\n104A Assignment of beneficial interest Lender: Standard See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.1 Assignment of beneficial interest Lender: All Policies See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.4 Collateral assignment of beneficial interest Lender: All Policies See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.6 Assignment of lessor's interest in lease - no defect in execution, no prior assignment\n\nLender: Extended $50. On tracts where three or more are issued concurrently, $25 per issue\n\n104\\.7 No prior assignment of rents Lender: All Policies $50. On tracts where three or more are issued concurrently, $25 per issue.\n\n104\\.8 Assignment of beneficial interest Lender: Extended Same as 104\n\n104\\.9 Assignment of beneficial interest Lender: Standard Same as 104A\n\n104\\.12 (ALTA 10)\n\nAssignment of beneficial Interest Effective Date: 8-23-02 Lender: Extended Same as 104.1\n\n104\\.13 (ALTA 10.1)\n\nAssignment of beneficial Interest Effective Date: 8-23-02 Lender: Extended Same as 104\n\n104\\.10 Assignment of beneficial interest Lender: All Policies Same as 104.1\n\n104\\.11 Collateral assignment of beneficial interest Lender: All Policies Same as 104.1\n\n105 Insuring two or more Deeds of Trust Lender: ALTA $25\n\n105\\.1 Insuring two or more Deeds of Trust Lender: CLTA $25\n\n**Deleted:** May 29, 2006","pages":[{"line_numbers":[],"markdown":"CHICAGO TITLE INSURANCE COMPANY\n\n115 State of California Effective: November 7, 2007\n\n**CLTA NO.** **DESCRIPTION**\n\n**POLICY FORM**\n\n**CHARGE**\n\n(Percentage of\n\napplicable Base Rate unless otherwise\n\nindicated)\n\n104A Assignment of beneficial interest Lender: Standard See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.1 Assignment of beneficial interest Lender: All Policies See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.4 Collateral assignment of beneficial interest Lender: All Policies See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.6 Assignment of lessor's interest in lease - no defect in execution, no prior assignment\n\nLender: Extended $50. On tracts where three or more are issued concurrently, $25 per issue\n\n104\\.7 No prior assignment of rents Lender: All Policies $50. On tracts where three or more are issued concurrently, $25 per issue.\n\n104\\.8 Assignment of beneficial interest Lender: Extended Same as 104\n\n104\\.9 Assignment of beneficial interest Lender: Standard Same as 104A\n\n104\\.12 (ALTA 10)\n\nAssignment of beneficial Interest Effective Date: 8-23-02 Lender: Extended Same as 104.1\n\n104\\.13 (ALTA 10.1)\n\nAssignment of beneficial Interest Effective Date: 8-23-02 Lender: Extended Same as 104\n\n104\\.10 Assignment of beneficial interest Lender: All Policies Same as 104.1\n\n104\\.11 Collateral assignment of beneficial interest Lender: All Policies Same as 104.1\n\n105 Insuring two or more Deeds of Trust Lender: ALTA $25\n\n105\\.1 Insuring two or more Deeds of Trust Lender: CLTA $25\n\n**Deleted:** May 29, 2006","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"CHICAGO TITLE INSURANCE COMPANY\n\n115 State of California Effective: November 7, 2007\n\n**CLTA NO.** **DESCRIPTION**\n\n**POLICY FORM**\n\n**CHARGE**\n\n(Percentage of\n\napplicable Base Rate unless otherwise\n\nindicated)\n\n104A Assignment of beneficial interest Lender: Standard See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.1 Assignment of beneficial interest Lender: All Policies See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.4 Collateral assignment of beneficial interest Lender: All Policies See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.6 Assignment of lessor's interest in lease - no defect in execution, no prior assignment\n\nLender: Extended $50. On tracts where three or more are issued concurrently, $25 per issue\n\n104\\.7 No prior assignment of rents Lender: All Policies $50. On tracts where three or more are issued concurrently, $25 per issue.\n\n104\\.8 Assignment of beneficial interest Lender: Extended Same as 104\n\n104\\.9 Assignment of beneficial interest Lender: Standard Same as 104A\n\n104\\.12 (ALTA 10)\n\nAssignment of beneficial Interest Effective Date: 8-23-02 Lender: Extended Same as 104.1\n\n104\\.13 (ALTA 10.1)\n\nAssignment of beneficial Interest Effective Date: 8-23-02 Lender: Extended Same as 104\n\n104\\.10 Assignment of beneficial interest Lender: All Policies Same as 104.1\n\n104\\.11 Collateral assignment of beneficial interest Lender: All Policies Same as 104.1\n\n105 Insuring two or more Deeds of Trust Lender: ALTA $25\n\n105\\.1 Insuring two or more Deeds of Trust Lender: CLTA $25\n\n**Deleted:** May 29, 2006","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page822.pdf"]},"response":{"errors":[],"extract_id":"extract_ff48412bb177aedbe5fd3bf49138f74d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["CHICAGO TITLE INSURANCE COMPANY\n\n115 State of California Effective: November 7, 2007\n\n**CLTA NO.** **DESCRIPTION**\n\n**POLICY FORM**\n\n**CHARGE**\n\n(Percentage of\n\napplicable Base Rate unless otherwise\n\nindicated)\n\n104A Assignment of beneficial interest Lender: Standard See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.1 Assignment of beneficial interest Lender: All Policies See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.4 Collateral assignment of beneficial interest Lender: All Policies See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.6 Assignment of lessor's interest in lease - no defect in execution, no prior assignment\n\nLender: Extended $50. On tracts where three or more are issued concurrently, $25 per issue\n\n104\\.7 No prior assignment of rents Lender: All Policies $50. On tracts where three or more are issued concurrently, $25 per issue.\n\n104\\.8 Assignment of beneficial interest Lender: Extended Same as 104\n\n104\\.9 Assignment of beneficial interest Lender: Standard Same as 104A\n\n104\\.12 (ALTA 10)\n\nAssignment of beneficial Interest Effective Date: 8-23-02 Lender: Extended Same as 104.1\n\n104\\.13 (ALTA 10.1)\n\nAssignment of beneficial Interest Effective Date: 8-23-02 Lender: Extended Same as 104\n\n104\\.10 Assignment of beneficial interest Lender: All Policies Same as 104.1\n\n104\\.11 Collateral assignment of beneficial interest Lender: All Policies Same as 104.1\n\n105 Insuring two or more Deeds of Trust Lender: ALTA $25\n\n105\\.1 Insuring two or more Deeds of Trust Lender: CLTA $25\n\n**Deleted:** May 29, 2006"],"full_content":"CHICAGO TITLE INSURANCE COMPANY\n\n115 State of California Effective: November 7, 2007\n\n**CLTA NO.** **DESCRIPTION**\n\n**POLICY FORM**\n\n**CHARGE**\n\n(Percentage of\n\napplicable Base Rate unless otherwise\n\nindicated)\n\n104A Assignment of beneficial interest Lender: Standard See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.1 Assignment of beneficial interest Lender: All Policies See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.4 Collateral assignment of beneficial interest Lender: All Policies See applicable Part and Section Residential, C&I Project/Contract\n\n104\\.6 Assignment of lessor's interest in lease - no defect in execution, no prior assignment\n\nLender: Extended $50. On tracts where three or more are issued concurrently, $25 per issue\n\n104\\.7 No prior assignment of rents Lender: All Policies $50. On tracts where three or more are issued concurrently, $25 per issue.\n\n104\\.8 Assignment of beneficial interest Lender: Extended Same as 104\n\n104\\.9 Assignment of beneficial interest Lender: Standard Same as 104A\n\n104\\.12 (ALTA 10)\n\nAssignment of beneficial Interest Effective Date: 8-23-02 Lender: Extended Same as 104.1\n\n104\\.13 (ALTA 10.1)\n\nAssignment of beneficial Interest Effective Date: 8-23-02 Lender: Extended Same as 104\n\n104\\.10 Assignment of beneficial interest Lender: All Policies Same as 104.1\n\n104\\.11 Collateral assignment of beneficial interest Lender: All Policies Same as 104.1\n\n105 Insuring two or more Deeds of Trust Lender: ALTA $25\n\n105\\.1 Insuring two or more Deeds of Trust Lender: CLTA $25\n\n**Deleted:** May 29, 2006","publish_date":null,"title":"CHICAGO TITLE INSURANCE COMPANY CHARGE (Percentage of applicable Base Rate CLTA POLICY unless otherwise NO. DESCRIPTION FORM indicated) 104A Assignment","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page822.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page822.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page822","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page822.pdf"},"started_at":"2026-11-04T19:47:35.504594"} +{"completed_at":"2026-11-04T19:47:38.027267","latency_in_ms":1477,"output":{"example_id":"table/SERFF_CA_random_pages 1_page844","grounded_pages":[],"layout_pages":[],"markdown":"CHICAGO TITLE INSURANCE COMPANY\n\n29 State of California – Escrow Fees and Charges Effective: August 30, 2010\n\n**Chapter 8 Escrow Fees and Charges Applicable to Zone 7**\n\n(Imperial County)\n\n8\\.0 Residential Sale Escrow Services\n\nFor transactions involving the sale of Residential Property the following rates shall apply:\n\n**Sale Price Up To Escrow Rate**\n\n$0-$1,000,000 $300 base plus $3.00 per thousand\n\nOver $1,000,000 Minimum $3,300. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.\n\n8\\.1 Residential Loan Escrow Services (including refinance)\n\n**Transaction Amount** **Escrow Rate**\n\n$0-$250,000 $400.00\n\n$250,001-$500,000 $450.00\n\n$500,001-$750,000 $500.00\n\n$750,001-$1,500,000 $550.00\n\n$1,500,001-$3,000,000 $650.00\n\n$3,000,001-$5,000,000 $750.00\n\nOver $5,000,000 Minimum $750.00. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.\n\n8\\.2 Relocation Escrow Rate\n\nIn connection with escrows on the sale of relocation 1-to-4 family residential properties a charge of $900.00 may be applied.\n\n**Deleted:** 400\n\n**Deleted:** 4\\.00\n\n**Deleted:** 4,400","pages":[{"line_numbers":[],"markdown":"CHICAGO TITLE INSURANCE COMPANY\n\n29 State of California – Escrow Fees and Charges Effective: August 30, 2010\n\n**Chapter 8 Escrow Fees and Charges Applicable to Zone 7**\n\n(Imperial County)\n\n8\\.0 Residential Sale Escrow Services\n\nFor transactions involving the sale of Residential Property the following rates shall apply:\n\n**Sale Price Up To Escrow Rate**\n\n$0-$1,000,000 $300 base plus $3.00 per thousand\n\nOver $1,000,000 Minimum $3,300. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.\n\n8\\.1 Residential Loan Escrow Services (including refinance)\n\n**Transaction Amount** **Escrow Rate**\n\n$0-$250,000 $400.00\n\n$250,001-$500,000 $450.00\n\n$500,001-$750,000 $500.00\n\n$750,001-$1,500,000 $550.00\n\n$1,500,001-$3,000,000 $650.00\n\n$3,000,001-$5,000,000 $750.00\n\nOver $5,000,000 Minimum $750.00. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.\n\n8\\.2 Relocation Escrow Rate\n\nIn connection with escrows on the sale of relocation 1-to-4 family residential properties a charge of $900.00 may be applied.\n\n**Deleted:** 400\n\n**Deleted:** 4\\.00\n\n**Deleted:** 4,400","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"CHICAGO TITLE INSURANCE COMPANY\n\n29 State of California – Escrow Fees and Charges Effective: August 30, 2010\n\n**Chapter 8 Escrow Fees and Charges Applicable to Zone 7**\n\n(Imperial County)\n\n8\\.0 Residential Sale Escrow Services\n\nFor transactions involving the sale of Residential Property the following rates shall apply:\n\n**Sale Price Up To Escrow Rate**\n\n$0-$1,000,000 $300 base plus $3.00 per thousand\n\nOver $1,000,000 Minimum $3,300. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.\n\n8\\.1 Residential Loan Escrow Services (including refinance)\n\n**Transaction Amount** **Escrow Rate**\n\n$0-$250,000 $400.00\n\n$250,001-$500,000 $450.00\n\n$500,001-$750,000 $500.00\n\n$750,001-$1,500,000 $550.00\n\n$1,500,001-$3,000,000 $650.00\n\n$3,000,001-$5,000,000 $750.00\n\nOver $5,000,000 Minimum $750.00. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.\n\n8\\.2 Relocation Escrow Rate\n\nIn connection with escrows on the sale of relocation 1-to-4 family residential properties a charge of $900.00 may be applied.\n\n**Deleted:** 400\n\n**Deleted:** 4\\.00\n\n**Deleted:** 4,400","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page844.pdf"]},"response":{"errors":[],"extract_id":"extract_c8b38a16039bda0e5f59e6cc50267d2b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["CHICAGO TITLE INSURANCE COMPANY\n\n29 State of California – Escrow Fees and Charges Effective: August 30, 2010\n\n**Chapter 8 Escrow Fees and Charges Applicable to Zone 7**\n\n(Imperial County)\n\n8\\.0 Residential Sale Escrow Services\n\nFor transactions involving the sale of Residential Property the following rates shall apply:\n\n**Sale Price Up To Escrow Rate**\n\n$0-$1,000,000 $300 base plus $3.00 per thousand\n\nOver $1,000,000 Minimum $3,300. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.\n\n8\\.1 Residential Loan Escrow Services (including refinance)\n\n**Transaction Amount** **Escrow Rate**\n\n$0-$250,000 $400.00\n\n$250,001-$500,000 $450.00\n\n$500,001-$750,000 $500.00\n\n$750,001-$1,500,000 $550.00\n\n$1,500,001-$3,000,000 $650.00\n\n$3,000,001-$5,000,000 $750.00\n\nOver $5,000,000 Minimum $750.00. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.\n\n8\\.2 Relocation Escrow Rate\n\nIn connection with escrows on the sale of relocation 1-to-4 family residential properties a charge of $900.00 may be applied.\n\n**Deleted:** 400\n\n**Deleted:** 4\\.00\n\n**Deleted:** 4,400"],"full_content":"CHICAGO TITLE INSURANCE COMPANY\n\n29 State of California – Escrow Fees and Charges Effective: August 30, 2010\n\n**Chapter 8 Escrow Fees and Charges Applicable to Zone 7**\n\n(Imperial County)\n\n8\\.0 Residential Sale Escrow Services\n\nFor transactions involving the sale of Residential Property the following rates shall apply:\n\n**Sale Price Up To Escrow Rate**\n\n$0-$1,000,000 $300 base plus $3.00 per thousand\n\nOver $1,000,000 Minimum $3,300. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.\n\n8\\.1 Residential Loan Escrow Services (including refinance)\n\n**Transaction Amount** **Escrow Rate**\n\n$0-$250,000 $400.00\n\n$250,001-$500,000 $450.00\n\n$500,001-$750,000 $500.00\n\n$750,001-$1,500,000 $550.00\n\n$1,500,001-$3,000,000 $650.00\n\n$3,000,001-$5,000,000 $750.00\n\nOver $5,000,000 Minimum $750.00. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.\n\n8\\.2 Relocation Escrow Rate\n\nIn connection with escrows on the sale of relocation 1-to-4 family residential properties a charge of $900.00 may be applied.\n\n**Deleted:** 400\n\n**Deleted:** 4\\.00\n\n**Deleted:** 4,400","publish_date":null,"title":"CHICAGO TITLE INSURANCE COMPANY Chapter 8 Escrow Fees and Charges Applicable to Zone 7 (Imperial County) 8.0 Residential Sale Escrow","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page844.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page844.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page844","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page844.pdf"},"started_at":"2026-11-04T19:47:36.549989"} +{"completed_at":"2026-11-04T19:47:40.389698","latency_in_ms":2533,"output":{"example_id":"table/SERFF_CA_random_pages 1_page883","grounded_pages":[],"layout_pages":[],"markdown":"### CHICAGO TITLE INSURANCE COMPANY\n\n92 State of California Effective: May 18, 2016\n\n### **CLTA NO. DESCRIPTION POLICY FORM**\n\n### **CHARGE** (Percentage of applicable Base Rate unless otherwise indicated)\n\n### 116\\.4-06 (ALTA 19.1-06) Contiguity – Single Parcel (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### 20% 20% 10% 20%\n\n### 116\\.4.1-06 (ALTA 19-06) Contiguity – Multiple Parcels (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### N/C 20% N/C 10%\n\n### 116\\.5-06 (ALTA 7-06) Manufactured Housing Unit (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### $50 $50 $50 $50\n\n### 116\\.5A (not CLTA End) (SE-18)\n\n### Unconverted Mobile home Lender: Extended N/C\n\n### 116\\.5.1-06 (ALTA 7.1-06) Manufactured Housing, Conversion, Loan (Lender) Lender: Extended Standard\n\n### $50 $50\n\n### 116\\.5.2-06 (ALTA 7.2-06) Manufactured Housing, Conversion, Owner (Owner) Owner: Extended Standard\n\n### $50 $50\n\n### 116\\.6-06 Manufactured Housing Unit Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### $50 $50 $50 $50","pages":[{"line_numbers":[],"markdown":"### CHICAGO TITLE INSURANCE COMPANY\n\n92 State of California Effective: May 18, 2016\n\n### **CLTA NO. DESCRIPTION POLICY FORM**\n\n### **CHARGE** (Percentage of applicable Base Rate unless otherwise indicated)\n\n### 116\\.4-06 (ALTA 19.1-06) Contiguity – Single Parcel (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### 20% 20% 10% 20%\n\n### 116\\.4.1-06 (ALTA 19-06) Contiguity – Multiple Parcels (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### N/C 20% N/C 10%\n\n### 116\\.5-06 (ALTA 7-06) Manufactured Housing Unit (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### $50 $50 $50 $50\n\n### 116\\.5A (not CLTA End) (SE-18)\n\n### Unconverted Mobile home Lender: Extended N/C\n\n### 116\\.5.1-06 (ALTA 7.1-06) Manufactured Housing, Conversion, Loan (Lender) Lender: Extended Standard\n\n### $50 $50\n\n### 116\\.5.2-06 (ALTA 7.2-06) Manufactured Housing, Conversion, Owner (Owner) Owner: Extended Standard\n\n### $50 $50\n\n### 116\\.6-06 Manufactured Housing Unit Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### $50 $50 $50 $50","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### CHICAGO TITLE INSURANCE COMPANY\n\n92 State of California Effective: May 18, 2016\n\n### **CLTA NO. DESCRIPTION POLICY FORM**\n\n### **CHARGE** (Percentage of applicable Base Rate unless otherwise indicated)\n\n### 116\\.4-06 (ALTA 19.1-06) Contiguity – Single Parcel (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### 20% 20% 10% 20%\n\n### 116\\.4.1-06 (ALTA 19-06) Contiguity – Multiple Parcels (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### N/C 20% N/C 10%\n\n### 116\\.5-06 (ALTA 7-06) Manufactured Housing Unit (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### $50 $50 $50 $50\n\n### 116\\.5A (not CLTA End) (SE-18)\n\n### Unconverted Mobile home Lender: Extended N/C\n\n### 116\\.5.1-06 (ALTA 7.1-06) Manufactured Housing, Conversion, Loan (Lender) Lender: Extended Standard\n\n### $50 $50\n\n### 116\\.5.2-06 (ALTA 7.2-06) Manufactured Housing, Conversion, Owner (Owner) Owner: Extended Standard\n\n### $50 $50\n\n### 116\\.6-06 Manufactured Housing Unit Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### $50 $50 $50 $50","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page883.pdf"]},"response":{"errors":[],"extract_id":"extract_4e723fc2da39d4111311389dfeaa50c9","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### CHICAGO TITLE INSURANCE COMPANY\n\n92 State of California Effective: May 18, 2016\n\n### **CLTA NO. DESCRIPTION POLICY FORM**\n\n### **CHARGE** (Percentage of applicable Base Rate unless otherwise indicated)\n\n### 116\\.4-06 (ALTA 19.1-06) Contiguity – Single Parcel (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### 20% 20% 10% 20%\n\n### 116\\.4.1-06 (ALTA 19-06) Contiguity – Multiple Parcels (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### N/C 20% N/C 10%\n\n### 116\\.5-06 (ALTA 7-06) Manufactured Housing Unit (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### $50 $50 $50 $50\n\n### 116\\.5A (not CLTA End) (SE-18)\n\n### Unconverted Mobile home Lender: Extended N/C\n\n### 116\\.5.1-06 (ALTA 7.1-06) Manufactured Housing, Conversion, Loan (Lender) Lender: Extended Standard\n\n### $50 $50\n\n### 116\\.5.2-06 (ALTA 7.2-06) Manufactured Housing, Conversion, Owner (Owner) Owner: Extended Standard\n\n### $50 $50\n\n### 116\\.6-06 Manufactured Housing Unit Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### $50 $50 $50 $50"],"full_content":"### CHICAGO TITLE INSURANCE COMPANY\n\n92 State of California Effective: May 18, 2016\n\n### **CLTA NO. DESCRIPTION POLICY FORM**\n\n### **CHARGE** (Percentage of applicable Base Rate unless otherwise indicated)\n\n### 116\\.4-06 (ALTA 19.1-06) Contiguity – Single Parcel (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### 20% 20% 10% 20%\n\n### 116\\.4.1-06 (ALTA 19-06) Contiguity – Multiple Parcels (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### N/C 20% N/C 10%\n\n### 116\\.5-06 (ALTA 7-06) Manufactured Housing Unit (Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### $50 $50 $50 $50\n\n### 116\\.5A (not CLTA End) (SE-18)\n\n### Unconverted Mobile home Lender: Extended N/C\n\n### 116\\.5.1-06 (ALTA 7.1-06) Manufactured Housing, Conversion, Loan (Lender) Lender: Extended Standard\n\n### $50 $50\n\n### 116\\.5.2-06 (ALTA 7.2-06) Manufactured Housing, Conversion, Owner (Owner) Owner: Extended Standard\n\n### $50 $50\n\n### 116\\.6-06 Manufactured Housing Unit Owner or Lender) Owner: Extended Standard Lender: Extended Standard\n\n### $50 $50 $50 $50","publish_date":null,"title":"CHICAGO TITLE INSURANCE COMPANY CHARGE (Percentage of applicable Base POLICY Rate unless otherwise indicated) CLTA NO. DESCRIPTION FORM 20% 116.4-06","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page883.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page883.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page883","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page883.pdf"},"started_at":"2026-11-04T19:47:37.856277"} +{"completed_at":"2026-11-04T19:47:43.364893","latency_in_ms":4633,"output":{"example_id":"table/SERFF_CA_random_pages 1_page887","grounded_pages":[],"layout_pages":[],"markdown":"CTIC, CLTIC FNTIC CA Commercial Rate Comparisons Current vs. Proposed\n\nAmount of Insurance\n\nProposed Chicago, Commonwealth and Fidelity Commercial Rate Prior to Sept 30, 2015 (wo‐ST)\n\nCurrent Commercial Rate Chicago, Commonwealth and Fidelity Underwriters % Difference\n\n$1,590,000 $3,524 $2,819 20% $1,595,000 $3,531 $2,825 20% $1,600,000 $3,538 $2,830 20% $1,605,000 $3,545 $2,836 20% $1,610,000 $3,553 $2,842 20% $1,615,000 $3,560 $2,848 20% $1,620,000 $3,567 $2,854 20% $1,625,000 $3,574 $2,859 20% $1,630,000 $3,582 $2,865 20% $1,635,000 $3,589 $2,871 20% $1,640,000 $3,596 $2,877 20% $1,645,000 $3,603 $2,883 20% $1,650,000 $3,611 $2,888 20% $1,655,000 $3,618 $2,894 20% $1,660,000 $3,625 $2,900 20% $1,665,000 $3,632 $2,906 20% $1,670,000 $3,640 $2,912 20% $1,675,000 $3,647 $2,917 20% $1,680,000 $3,654 $2,923 20% $1,685,000 $3,661 $2,929 20% $1,690,000 $3,669 $2,935 20% $1,695,000 $3,676 $2,941 20% $1,700,000 $3,683 $2,946 20% $1,705,000 $3,690 $2,952 20% $1,710,000 $3,698 $2,958 20% $1,715,000 $3,705 $2,964 20% $1,720,000 $3,712 $2,970 20% $1,725,000 $3,719 $2,975 20% $1,730,000 $3,727 $2,981 20% $1,735,000 $3,734 $2,987 20% $1,740,000 $3,741 $2,993 20% $1,745,000 $3,748 $2,999 20% $1,750,000 $3,756 $3,004 20% $1,755,000 $3,763 $3,010 20% $1,760,000 $3,770 $3,016 20% $1,765,000 $3,777 $3,022 20% $1,770,000 $3,785 $3,028 20% $1,775,000 $3,792 $3,033 20% $1,780,000 $3,799 $3,039 20%\n\nApril 4, 2016 9 of 16 JKRyan","pages":[{"line_numbers":[],"markdown":"CTIC, CLTIC FNTIC CA Commercial Rate Comparisons Current vs. Proposed\n\nAmount of Insurance\n\nProposed Chicago, Commonwealth and Fidelity Commercial Rate Prior to Sept 30, 2015 (wo‐ST)\n\nCurrent Commercial Rate Chicago, Commonwealth and Fidelity Underwriters % Difference\n\n$1,590,000 $3,524 $2,819 20% $1,595,000 $3,531 $2,825 20% $1,600,000 $3,538 $2,830 20% $1,605,000 $3,545 $2,836 20% $1,610,000 $3,553 $2,842 20% $1,615,000 $3,560 $2,848 20% $1,620,000 $3,567 $2,854 20% $1,625,000 $3,574 $2,859 20% $1,630,000 $3,582 $2,865 20% $1,635,000 $3,589 $2,871 20% $1,640,000 $3,596 $2,877 20% $1,645,000 $3,603 $2,883 20% $1,650,000 $3,611 $2,888 20% $1,655,000 $3,618 $2,894 20% $1,660,000 $3,625 $2,900 20% $1,665,000 $3,632 $2,906 20% $1,670,000 $3,640 $2,912 20% $1,675,000 $3,647 $2,917 20% $1,680,000 $3,654 $2,923 20% $1,685,000 $3,661 $2,929 20% $1,690,000 $3,669 $2,935 20% $1,695,000 $3,676 $2,941 20% $1,700,000 $3,683 $2,946 20% $1,705,000 $3,690 $2,952 20% $1,710,000 $3,698 $2,958 20% $1,715,000 $3,705 $2,964 20% $1,720,000 $3,712 $2,970 20% $1,725,000 $3,719 $2,975 20% $1,730,000 $3,727 $2,981 20% $1,735,000 $3,734 $2,987 20% $1,740,000 $3,741 $2,993 20% $1,745,000 $3,748 $2,999 20% $1,750,000 $3,756 $3,004 20% $1,755,000 $3,763 $3,010 20% $1,760,000 $3,770 $3,016 20% $1,765,000 $3,777 $3,022 20% $1,770,000 $3,785 $3,028 20% $1,775,000 $3,792 $3,033 20% $1,780,000 $3,799 $3,039 20%\n\nApril 4, 2016 9 of 16 JKRyan","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"CTIC, CLTIC FNTIC CA Commercial Rate Comparisons Current vs. Proposed\n\nAmount of Insurance\n\nProposed Chicago, Commonwealth and Fidelity Commercial Rate Prior to Sept 30, 2015 (wo‐ST)\n\nCurrent Commercial Rate Chicago, Commonwealth and Fidelity Underwriters % Difference\n\n$1,590,000 $3,524 $2,819 20% $1,595,000 $3,531 $2,825 20% $1,600,000 $3,538 $2,830 20% $1,605,000 $3,545 $2,836 20% $1,610,000 $3,553 $2,842 20% $1,615,000 $3,560 $2,848 20% $1,620,000 $3,567 $2,854 20% $1,625,000 $3,574 $2,859 20% $1,630,000 $3,582 $2,865 20% $1,635,000 $3,589 $2,871 20% $1,640,000 $3,596 $2,877 20% $1,645,000 $3,603 $2,883 20% $1,650,000 $3,611 $2,888 20% $1,655,000 $3,618 $2,894 20% $1,660,000 $3,625 $2,900 20% $1,665,000 $3,632 $2,906 20% $1,670,000 $3,640 $2,912 20% $1,675,000 $3,647 $2,917 20% $1,680,000 $3,654 $2,923 20% $1,685,000 $3,661 $2,929 20% $1,690,000 $3,669 $2,935 20% $1,695,000 $3,676 $2,941 20% $1,700,000 $3,683 $2,946 20% $1,705,000 $3,690 $2,952 20% $1,710,000 $3,698 $2,958 20% $1,715,000 $3,705 $2,964 20% $1,720,000 $3,712 $2,970 20% $1,725,000 $3,719 $2,975 20% $1,730,000 $3,727 $2,981 20% $1,735,000 $3,734 $2,987 20% $1,740,000 $3,741 $2,993 20% $1,745,000 $3,748 $2,999 20% $1,750,000 $3,756 $3,004 20% $1,755,000 $3,763 $3,010 20% $1,760,000 $3,770 $3,016 20% $1,765,000 $3,777 $3,022 20% $1,770,000 $3,785 $3,028 20% $1,775,000 $3,792 $3,033 20% $1,780,000 $3,799 $3,039 20%\n\nApril 4, 2016 9 of 16 JKRyan","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page887.pdf"]},"response":{"errors":[],"extract_id":"extract_0556cdeeb3ce4993c46bd34868f3a409","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["CTIC, CLTIC FNTIC CA Commercial Rate Comparisons Current vs. Proposed\n\nAmount of Insurance\n\nProposed Chicago, Commonwealth and Fidelity Commercial Rate Prior to Sept 30, 2015 (wo‐ST)\n\nCurrent Commercial Rate Chicago, Commonwealth and Fidelity Underwriters % Difference\n\n$1,590,000 $3,524 $2,819 20% $1,595,000 $3,531 $2,825 20% $1,600,000 $3,538 $2,830 20% $1,605,000 $3,545 $2,836 20% $1,610,000 $3,553 $2,842 20% $1,615,000 $3,560 $2,848 20% $1,620,000 $3,567 $2,854 20% $1,625,000 $3,574 $2,859 20% $1,630,000 $3,582 $2,865 20% $1,635,000 $3,589 $2,871 20% $1,640,000 $3,596 $2,877 20% $1,645,000 $3,603 $2,883 20% $1,650,000 $3,611 $2,888 20% $1,655,000 $3,618 $2,894 20% $1,660,000 $3,625 $2,900 20% $1,665,000 $3,632 $2,906 20% $1,670,000 $3,640 $2,912 20% $1,675,000 $3,647 $2,917 20% $1,680,000 $3,654 $2,923 20% $1,685,000 $3,661 $2,929 20% $1,690,000 $3,669 $2,935 20% $1,695,000 $3,676 $2,941 20% $1,700,000 $3,683 $2,946 20% $1,705,000 $3,690 $2,952 20% $1,710,000 $3,698 $2,958 20% $1,715,000 $3,705 $2,964 20% $1,720,000 $3,712 $2,970 20% $1,725,000 $3,719 $2,975 20% $1,730,000 $3,727 $2,981 20% $1,735,000 $3,734 $2,987 20% $1,740,000 $3,741 $2,993 20% $1,745,000 $3,748 $2,999 20% $1,750,000 $3,756 $3,004 20% $1,755,000 $3,763 $3,010 20% $1,760,000 $3,770 $3,016 20% $1,765,000 $3,777 $3,022 20% $1,770,000 $3,785 $3,028 20% $1,775,000 $3,792 $3,033 20% $1,780,000 $3,799 $3,039 20%\n\nApril 4, 2016 9 of 16 JKRyan"],"full_content":"CTIC, CLTIC FNTIC CA Commercial Rate Comparisons Current vs. Proposed\n\nAmount of Insurance\n\nProposed Chicago, Commonwealth and Fidelity Commercial Rate Prior to Sept 30, 2015 (wo‐ST)\n\nCurrent Commercial Rate Chicago, Commonwealth and Fidelity Underwriters % Difference\n\n$1,590,000 $3,524 $2,819 20% $1,595,000 $3,531 $2,825 20% $1,600,000 $3,538 $2,830 20% $1,605,000 $3,545 $2,836 20% $1,610,000 $3,553 $2,842 20% $1,615,000 $3,560 $2,848 20% $1,620,000 $3,567 $2,854 20% $1,625,000 $3,574 $2,859 20% $1,630,000 $3,582 $2,865 20% $1,635,000 $3,589 $2,871 20% $1,640,000 $3,596 $2,877 20% $1,645,000 $3,603 $2,883 20% $1,650,000 $3,611 $2,888 20% $1,655,000 $3,618 $2,894 20% $1,660,000 $3,625 $2,900 20% $1,665,000 $3,632 $2,906 20% $1,670,000 $3,640 $2,912 20% $1,675,000 $3,647 $2,917 20% $1,680,000 $3,654 $2,923 20% $1,685,000 $3,661 $2,929 20% $1,690,000 $3,669 $2,935 20% $1,695,000 $3,676 $2,941 20% $1,700,000 $3,683 $2,946 20% $1,705,000 $3,690 $2,952 20% $1,710,000 $3,698 $2,958 20% $1,715,000 $3,705 $2,964 20% $1,720,000 $3,712 $2,970 20% $1,725,000 $3,719 $2,975 20% $1,730,000 $3,727 $2,981 20% $1,735,000 $3,734 $2,987 20% $1,740,000 $3,741 $2,993 20% $1,745,000 $3,748 $2,999 20% $1,750,000 $3,756 $3,004 20% $1,755,000 $3,763 $3,010 20% $1,760,000 $3,770 $3,016 20% $1,765,000 $3,777 $3,022 20% $1,770,000 $3,785 $3,028 20% $1,775,000 $3,792 $3,033 20% $1,780,000 $3,799 $3,039 20%\n\nApril 4, 2016 9 of 16 JKRyan","publish_date":null,"title":"CTIC, CLTIC FNTIC CA Commercial Rate Comparisons Current vs. Proposed Proposed Current Chicago, Commercial Commonwealth Rate Chicago, and Fidelity Commonwealth","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page887.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page887.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page887","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page887.pdf"},"started_at":"2026-11-04T19:47:38.731783"} +{"completed_at":"2026-11-04T19:47:41.053982","latency_in_ms":861,"output":{"example_id":"table/SERFF_CA_random_pages 1_page890","grounded_pages":[],"layout_pages":[],"markdown":"### COMMONWEALTH LAND TITLE INSURANCE COMPANY\n\n100 State of California Effective: May 18, 2016\n\n### **CLTA NO. DESCRIPTION POLICY FORM**\n\n### **CHARGE** (Percentage of applicable Base Rate unless otherwise indicated)\n\n### 137\\.2-06 (ALTA 32.2-06) Construction Loan, Loss of Priority, Insured’s Direct Payment (Lender)\n\n### Lender: Extended Pricing is commensurate with the loss of priority risk and the issuance of these forms must be authorized in writing by State or Regional Underwriting Counsel or higher per Company’s underwriting requirements prior to closing. (Note: This endorsement requires a general ML exception and a special Schedule B Exception regarding Definition of Mechanics’ Lien Limit in the Preliminary report, title commitment and policy.)","pages":[{"line_numbers":[],"markdown":"### COMMONWEALTH LAND TITLE INSURANCE COMPANY\n\n100 State of California Effective: May 18, 2016\n\n### **CLTA NO. DESCRIPTION POLICY FORM**\n\n### **CHARGE** (Percentage of applicable Base Rate unless otherwise indicated)\n\n### 137\\.2-06 (ALTA 32.2-06) Construction Loan, Loss of Priority, Insured’s Direct Payment (Lender)\n\n### Lender: Extended Pricing is commensurate with the loss of priority risk and the issuance of these forms must be authorized in writing by State or Regional Underwriting Counsel or higher per Company’s underwriting requirements prior to closing. (Note: This endorsement requires a general ML exception and a special Schedule B Exception regarding Definition of Mechanics’ Lien Limit in the Preliminary report, title commitment and policy.)","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### COMMONWEALTH LAND TITLE INSURANCE COMPANY\n\n100 State of California Effective: May 18, 2016\n\n### **CLTA NO. DESCRIPTION POLICY FORM**\n\n### **CHARGE** (Percentage of applicable Base Rate unless otherwise indicated)\n\n### 137\\.2-06 (ALTA 32.2-06) Construction Loan, Loss of Priority, Insured’s Direct Payment (Lender)\n\n### Lender: Extended Pricing is commensurate with the loss of priority risk and the issuance of these forms must be authorized in writing by State or Regional Underwriting Counsel or higher per Company’s underwriting requirements prior to closing. (Note: This endorsement requires a general ML exception and a special Schedule B Exception regarding Definition of Mechanics’ Lien Limit in the Preliminary report, title commitment and policy.)","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page890.pdf"]},"response":{"errors":[],"extract_id":"extract_d9abd7333766ce122f2888e386261275","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### COMMONWEALTH LAND TITLE INSURANCE COMPANY\n\n100 State of California Effective: May 18, 2016\n\n### **CLTA NO. DESCRIPTION POLICY FORM**\n\n### **CHARGE** (Percentage of applicable Base Rate unless otherwise indicated)\n\n### 137\\.2-06 (ALTA 32.2-06) Construction Loan, Loss of Priority, Insured’s Direct Payment (Lender)\n\n### Lender: Extended Pricing is commensurate with the loss of priority risk and the issuance of these forms must be authorized in writing by State or Regional Underwriting Counsel or higher per Company’s underwriting requirements prior to closing. (Note: This endorsement requires a general ML exception and a special Schedule B Exception regarding Definition of Mechanics’ Lien Limit in the Preliminary report, title commitment and policy.)"],"full_content":"### COMMONWEALTH LAND TITLE INSURANCE COMPANY\n\n100 State of California Effective: May 18, 2016\n\n### **CLTA NO. DESCRIPTION POLICY FORM**\n\n### **CHARGE** (Percentage of applicable Base Rate unless otherwise indicated)\n\n### 137\\.2-06 (ALTA 32.2-06) Construction Loan, Loss of Priority, Insured’s Direct Payment (Lender)\n\n### Lender: Extended Pricing is commensurate with the loss of priority risk and the issuance of these forms must be authorized in writing by State or Regional Underwriting Counsel or higher per Company’s underwriting requirements prior to closing. (Note: This endorsement requires a general ML exception and a special Schedule B Exception regarding Definition of Mechanics’ Lien Limit in the Preliminary report, title commitment and policy.)","publish_date":null,"title":"COMMONWEALTH LAND TITLE INSURANCE COMPANY CHARGE (Percentage of applicable Base Rate unless otherwise POLICY indicated) CLTA NO. DESCRIPTION FORM Lender:","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page890.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page890.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page890","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page890.pdf"},"started_at":"2026-11-04T19:47:40.192918"} +{"completed_at":"2026-11-04T19:47:42.708182","latency_in_ms":1114,"output":{"example_id":"table/SERFF_CA_random_pages 1_page900","grounded_pages":[],"layout_pages":[],"markdown":"COMMONWEALTH LAND TITLE COMPANY\n\n30 State of California Effective: July 27, 2016\n\n**Chapter 7 Commercial Escrow Fees and Charges for any Property other than a Single Family 1-4 Residence not otherwise addressed in other parts of this Manual**\n\n7\\.0 Commercial Sale Escrow Services\n\nApplicable to the following Zones: a. Zone 1, Orange, Riverside and San Bernardino Counties b. Zone 2, Los Angeles County c. Zone 10, San Diego County Transaction Amount Fee Charged\n\nUp to $ 60,000 $630\n\n$ 60,001 to $100,000 $725\n\n$100,001 to $150,000 $775\n\n$150,001 to $200,000 $825\n\n$200,001 to $250,000 $875\n\n$250,001 to $300,000 $925\n\n$300,001 to $350,000 $975\n\n$350,001 to $400,000 $1,025\n\n$400,001 to $450,000 $1,075\n\n$450,001 to $500,000 $1,125\n\n$500,001 to $550,000 $1,240\n\n$550,001 to $600,000 $1,355\n\n$600,001 to $650,000 $1,470\n\n$650,001 to $700,000 $1,585\n\n$700,001 to $750,000 $1,700\n\n$750,001 to $800,000 $1,815\n\n$800,001 to $850,000 $1,930\n\n$850,001 to $900,000 $2,045\n\n$900,001 to $950,000 $2,160\n\n$950,001 to $1,000,000 $2,275\n\n$1,000,001 to $2,000,000 $2,675\n\n$2,000,001 to $3,000,000 $3,175\n\n$3,000,001 and up\n\nMinimum $3,175. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.","pages":[{"line_numbers":[],"markdown":"COMMONWEALTH LAND TITLE COMPANY\n\n30 State of California Effective: July 27, 2016\n\n**Chapter 7 Commercial Escrow Fees and Charges for any Property other than a Single Family 1-4 Residence not otherwise addressed in other parts of this Manual**\n\n7\\.0 Commercial Sale Escrow Services\n\nApplicable to the following Zones: a. Zone 1, Orange, Riverside and San Bernardino Counties b. Zone 2, Los Angeles County c. Zone 10, San Diego County Transaction Amount Fee Charged\n\nUp to $ 60,000 $630\n\n$ 60,001 to $100,000 $725\n\n$100,001 to $150,000 $775\n\n$150,001 to $200,000 $825\n\n$200,001 to $250,000 $875\n\n$250,001 to $300,000 $925\n\n$300,001 to $350,000 $975\n\n$350,001 to $400,000 $1,025\n\n$400,001 to $450,000 $1,075\n\n$450,001 to $500,000 $1,125\n\n$500,001 to $550,000 $1,240\n\n$550,001 to $600,000 $1,355\n\n$600,001 to $650,000 $1,470\n\n$650,001 to $700,000 $1,585\n\n$700,001 to $750,000 $1,700\n\n$750,001 to $800,000 $1,815\n\n$800,001 to $850,000 $1,930\n\n$850,001 to $900,000 $2,045\n\n$900,001 to $950,000 $2,160\n\n$950,001 to $1,000,000 $2,275\n\n$1,000,001 to $2,000,000 $2,675\n\n$2,000,001 to $3,000,000 $3,175\n\n$3,000,001 and up\n\nMinimum $3,175. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"COMMONWEALTH LAND TITLE COMPANY\n\n30 State of California Effective: July 27, 2016\n\n**Chapter 7 Commercial Escrow Fees and Charges for any Property other than a Single Family 1-4 Residence not otherwise addressed in other parts of this Manual**\n\n7\\.0 Commercial Sale Escrow Services\n\nApplicable to the following Zones: a. Zone 1, Orange, Riverside and San Bernardino Counties b. Zone 2, Los Angeles County c. Zone 10, San Diego County Transaction Amount Fee Charged\n\nUp to $ 60,000 $630\n\n$ 60,001 to $100,000 $725\n\n$100,001 to $150,000 $775\n\n$150,001 to $200,000 $825\n\n$200,001 to $250,000 $875\n\n$250,001 to $300,000 $925\n\n$300,001 to $350,000 $975\n\n$350,001 to $400,000 $1,025\n\n$400,001 to $450,000 $1,075\n\n$450,001 to $500,000 $1,125\n\n$500,001 to $550,000 $1,240\n\n$550,001 to $600,000 $1,355\n\n$600,001 to $650,000 $1,470\n\n$650,001 to $700,000 $1,585\n\n$700,001 to $750,000 $1,700\n\n$750,001 to $800,000 $1,815\n\n$800,001 to $850,000 $1,930\n\n$850,001 to $900,000 $2,045\n\n$900,001 to $950,000 $2,160\n\n$950,001 to $1,000,000 $2,275\n\n$1,000,001 to $2,000,000 $2,675\n\n$2,000,001 to $3,000,000 $3,175\n\n$3,000,001 and up\n\nMinimum $3,175. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page900.pdf"]},"response":{"errors":[],"extract_id":"extract_c9455eddcc20409b5fe8c12e489b821f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["COMMONWEALTH LAND TITLE COMPANY\n\n30 State of California Effective: July 27, 2016\n\n**Chapter 7 Commercial Escrow Fees and Charges for any Property other than a Single Family 1-4 Residence not otherwise addressed in other parts of this Manual**\n\n7\\.0 Commercial Sale Escrow Services\n\nApplicable to the following Zones: a. Zone 1, Orange, Riverside and San Bernardino Counties b. Zone 2, Los Angeles County c. Zone 10, San Diego County Transaction Amount Fee Charged\n\nUp to $ 60,000 $630\n\n$ 60,001 to $100,000 $725\n\n$100,001 to $150,000 $775\n\n$150,001 to $200,000 $825\n\n$200,001 to $250,000 $875\n\n$250,001 to $300,000 $925\n\n$300,001 to $350,000 $975\n\n$350,001 to $400,000 $1,025\n\n$400,001 to $450,000 $1,075\n\n$450,001 to $500,000 $1,125\n\n$500,001 to $550,000 $1,240\n\n$550,001 to $600,000 $1,355\n\n$600,001 to $650,000 $1,470\n\n$650,001 to $700,000 $1,585\n\n$700,001 to $750,000 $1,700\n\n$750,001 to $800,000 $1,815\n\n$800,001 to $850,000 $1,930\n\n$850,001 to $900,000 $2,045\n\n$900,001 to $950,000 $2,160\n\n$950,001 to $1,000,000 $2,275\n\n$1,000,001 to $2,000,000 $2,675\n\n$2,000,001 to $3,000,000 $3,175\n\n$3,000,001 and up\n\nMinimum $3,175. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement."],"full_content":"COMMONWEALTH LAND TITLE COMPANY\n\n30 State of California Effective: July 27, 2016\n\n**Chapter 7 Commercial Escrow Fees and Charges for any Property other than a Single Family 1-4 Residence not otherwise addressed in other parts of this Manual**\n\n7\\.0 Commercial Sale Escrow Services\n\nApplicable to the following Zones: a. Zone 1, Orange, Riverside and San Bernardino Counties b. Zone 2, Los Angeles County c. Zone 10, San Diego County Transaction Amount Fee Charged\n\nUp to $ 60,000 $630\n\n$ 60,001 to $100,000 $725\n\n$100,001 to $150,000 $775\n\n$150,001 to $200,000 $825\n\n$200,001 to $250,000 $875\n\n$250,001 to $300,000 $925\n\n$300,001 to $350,000 $975\n\n$350,001 to $400,000 $1,025\n\n$400,001 to $450,000 $1,075\n\n$450,001 to $500,000 $1,125\n\n$500,001 to $550,000 $1,240\n\n$550,001 to $600,000 $1,355\n\n$600,001 to $650,000 $1,470\n\n$650,001 to $700,000 $1,585\n\n$700,001 to $750,000 $1,700\n\n$750,001 to $800,000 $1,815\n\n$800,001 to $850,000 $1,930\n\n$850,001 to $900,000 $2,045\n\n$900,001 to $950,000 $2,160\n\n$950,001 to $1,000,000 $2,275\n\n$1,000,001 to $2,000,000 $2,675\n\n$2,000,001 to $3,000,000 $3,175\n\n$3,000,001 and up\n\nMinimum $3,175. If additional charges are to be made, they will be based on the costs incurred and additional responsibilities assumed by the Company, and must be agreed to by the customer in writing. In writing includes customer’s approval of settlement statement.","publish_date":null,"title":"COMMONWEALTH LAND TITLE COMPANY Chapter 7 Commercial Escrow Fees and Charges for any Property other than a Single Family 1-4","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page900.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page900.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page900","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page900.pdf"},"started_at":"2026-11-04T19:47:41.593276"} +{"completed_at":"2026-11-04T19:47:44.307122","latency_in_ms":1878,"output":{"example_id":"table/SERFF_CA_random_pages 1_page917","grounded_pages":[],"layout_pages":[],"markdown":"FNTG CA Counties Sale Escrow Rate Compairsons Current vs. Proposed Zone 2\n\n**Liability Current Rate Proposed Rate % Diff** **Sysnopsis of All Zones Rate Change**\n\n$1,512,000 $4,600 $4,700 2%\n\n$1,513,000 $4,600 $4,700 2%\n\n$1,514,000 $4,600 $4,700 2%\n\n$1,515,000 $4,600 $4,700 2%\n\n$1,516,000 $4,600 $4,700 2%\n\n$1,517,000 $4,600 $4,700 2%\n\n$1,518,000 $4,600 $4,700 2%\n\n$1,519,000 $4,600 $4,700 2%\n\n$1,520,000 $4,600 $4,700 2%\n\n$1,521,000 $4,600 $4,700 2%\n\n$1,522,000 $4,600 $4,700 2%\n\n$1,523,000 $4,600 $4,700 2%\n\n$1,524,000 $4,600 $4,700 2%\n\n$1,525,000 $4,600 $4,700 2%\n\n$1,526,000 $4,600 $4,700 2%\n\n$1,527,000 $4,600 $4,700 2%\n\n$1,528,000 $4,600 $4,700 2%\n\n$1,529,000 $4,600 $4,700 2%\n\n$1,530,000 $4,600 $4,700 2%\n\n$1,531,000 $4,600 $4,700 2%\n\n$1,532,000 $4,600 $4,700 2%\n\n$1,533,000 $4,600 $4,700 2%\n\n$1,534,000 $4,600 $4,700 2%\n\n$1,535,000 $4,600 $4,700 2%\n\n$1,536,000 $4,600 $4,700 2%\n\n$1,537,000 $4,600 $4,700 2%\n\n$1,538,000 $4,600 $4,700 2%\n\n$1,539,000 $4,600 $4,700 2%\n\n$1,540,000 $4,600 $4,700 2%\n\n$1,541,000 $4,600 $4,700 2%\n\n$1,542,000 $4,600 $4,700 2%\n\n$1,543,000 $4,600 $4,700 2%\n\n$1,544,000 $4,600 $4,700 2%\n\n$1,545,000 $4,600 $4,700 2%\n\n$1,546,000 $4,600 $4,700 2%\n\n$1,547,000 $4,600 $4,700 2%\n\n$1,548,000 $4,600 $4,700 2%\n\n$1,549,000 $4,600 $4,700 2%\n\n$1,550,000 $4,600 $4,700 2%\n\n$1,551,000 $4,600 $4,700 2%\n\n$1,552,000 $4,600 $4,700 2%\n\n$1,553,000 $4,600 $4,700 2%\n\n$1,554,000 $4,600 $4,700 2%\n\n$1,555,000 $4,600 $4,700 2%\n\n$1,556,000 $4,600 $4,700 2%\n\n$1,557,000 $4,600 $4,700 2%\n\n$1,558,000 $4,600 $4,700 2%\n\n$1,559,000 $4,600 $4,700 2%\n\n$1,560,000 $4,600 $4,700 2%\n\n$1,561,000 $4,600 $4,700 2%\n\n$1,562,000 $4,600 $4,700 2%\n\n$1,563,000 $4,600 $4,700 2%\n\n$1,564,000 $4,600 $4,700 2%\n\n$1,565,000 $4,600 $4,700 2%\n\n$1,566,000 $4,600 $4,700 2%\n\n$1,567,000 $4,600 $4,700 2%\n\n$1,568,000 $4,600 $4,700 2%\n\n$1,569,000 $4,600 $4,700 2%\n\n$1,570,000 $4,600 $4,700 2%\n\n$1,571,000 $4,600 $4,700 2%\n\n$1,572,000 $4,600 $4,700 2%\n\n$1,573,000 $4,600 $4,700 2%\n\n$1,574,000 $4,600 $4,700 2%\n\nUpdaated: 8‐6‐19 August 1, 2019 32 of 32 JKRyan","pages":[{"line_numbers":[],"markdown":"FNTG CA Counties Sale Escrow Rate Compairsons Current vs. Proposed Zone 2\n\n**Liability Current Rate Proposed Rate % Diff** **Sysnopsis of All Zones Rate Change**\n\n$1,512,000 $4,600 $4,700 2%\n\n$1,513,000 $4,600 $4,700 2%\n\n$1,514,000 $4,600 $4,700 2%\n\n$1,515,000 $4,600 $4,700 2%\n\n$1,516,000 $4,600 $4,700 2%\n\n$1,517,000 $4,600 $4,700 2%\n\n$1,518,000 $4,600 $4,700 2%\n\n$1,519,000 $4,600 $4,700 2%\n\n$1,520,000 $4,600 $4,700 2%\n\n$1,521,000 $4,600 $4,700 2%\n\n$1,522,000 $4,600 $4,700 2%\n\n$1,523,000 $4,600 $4,700 2%\n\n$1,524,000 $4,600 $4,700 2%\n\n$1,525,000 $4,600 $4,700 2%\n\n$1,526,000 $4,600 $4,700 2%\n\n$1,527,000 $4,600 $4,700 2%\n\n$1,528,000 $4,600 $4,700 2%\n\n$1,529,000 $4,600 $4,700 2%\n\n$1,530,000 $4,600 $4,700 2%\n\n$1,531,000 $4,600 $4,700 2%\n\n$1,532,000 $4,600 $4,700 2%\n\n$1,533,000 $4,600 $4,700 2%\n\n$1,534,000 $4,600 $4,700 2%\n\n$1,535,000 $4,600 $4,700 2%\n\n$1,536,000 $4,600 $4,700 2%\n\n$1,537,000 $4,600 $4,700 2%\n\n$1,538,000 $4,600 $4,700 2%\n\n$1,539,000 $4,600 $4,700 2%\n\n$1,540,000 $4,600 $4,700 2%\n\n$1,541,000 $4,600 $4,700 2%\n\n$1,542,000 $4,600 $4,700 2%\n\n$1,543,000 $4,600 $4,700 2%\n\n$1,544,000 $4,600 $4,700 2%\n\n$1,545,000 $4,600 $4,700 2%\n\n$1,546,000 $4,600 $4,700 2%\n\n$1,547,000 $4,600 $4,700 2%\n\n$1,548,000 $4,600 $4,700 2%\n\n$1,549,000 $4,600 $4,700 2%\n\n$1,550,000 $4,600 $4,700 2%\n\n$1,551,000 $4,600 $4,700 2%\n\n$1,552,000 $4,600 $4,700 2%\n\n$1,553,000 $4,600 $4,700 2%\n\n$1,554,000 $4,600 $4,700 2%\n\n$1,555,000 $4,600 $4,700 2%\n\n$1,556,000 $4,600 $4,700 2%\n\n$1,557,000 $4,600 $4,700 2%\n\n$1,558,000 $4,600 $4,700 2%\n\n$1,559,000 $4,600 $4,700 2%\n\n$1,560,000 $4,600 $4,700 2%\n\n$1,561,000 $4,600 $4,700 2%\n\n$1,562,000 $4,600 $4,700 2%\n\n$1,563,000 $4,600 $4,700 2%\n\n$1,564,000 $4,600 $4,700 2%\n\n$1,565,000 $4,600 $4,700 2%\n\n$1,566,000 $4,600 $4,700 2%\n\n$1,567,000 $4,600 $4,700 2%\n\n$1,568,000 $4,600 $4,700 2%\n\n$1,569,000 $4,600 $4,700 2%\n\n$1,570,000 $4,600 $4,700 2%\n\n$1,571,000 $4,600 $4,700 2%\n\n$1,572,000 $4,600 $4,700 2%\n\n$1,573,000 $4,600 $4,700 2%\n\n$1,574,000 $4,600 $4,700 2%\n\nUpdaated: 8‐6‐19 August 1, 2019 32 of 32 JKRyan","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"FNTG CA Counties Sale Escrow Rate Compairsons Current vs. Proposed Zone 2\n\n**Liability Current Rate Proposed Rate % Diff** **Sysnopsis of All Zones Rate Change**\n\n$1,512,000 $4,600 $4,700 2%\n\n$1,513,000 $4,600 $4,700 2%\n\n$1,514,000 $4,600 $4,700 2%\n\n$1,515,000 $4,600 $4,700 2%\n\n$1,516,000 $4,600 $4,700 2%\n\n$1,517,000 $4,600 $4,700 2%\n\n$1,518,000 $4,600 $4,700 2%\n\n$1,519,000 $4,600 $4,700 2%\n\n$1,520,000 $4,600 $4,700 2%\n\n$1,521,000 $4,600 $4,700 2%\n\n$1,522,000 $4,600 $4,700 2%\n\n$1,523,000 $4,600 $4,700 2%\n\n$1,524,000 $4,600 $4,700 2%\n\n$1,525,000 $4,600 $4,700 2%\n\n$1,526,000 $4,600 $4,700 2%\n\n$1,527,000 $4,600 $4,700 2%\n\n$1,528,000 $4,600 $4,700 2%\n\n$1,529,000 $4,600 $4,700 2%\n\n$1,530,000 $4,600 $4,700 2%\n\n$1,531,000 $4,600 $4,700 2%\n\n$1,532,000 $4,600 $4,700 2%\n\n$1,533,000 $4,600 $4,700 2%\n\n$1,534,000 $4,600 $4,700 2%\n\n$1,535,000 $4,600 $4,700 2%\n\n$1,536,000 $4,600 $4,700 2%\n\n$1,537,000 $4,600 $4,700 2%\n\n$1,538,000 $4,600 $4,700 2%\n\n$1,539,000 $4,600 $4,700 2%\n\n$1,540,000 $4,600 $4,700 2%\n\n$1,541,000 $4,600 $4,700 2%\n\n$1,542,000 $4,600 $4,700 2%\n\n$1,543,000 $4,600 $4,700 2%\n\n$1,544,000 $4,600 $4,700 2%\n\n$1,545,000 $4,600 $4,700 2%\n\n$1,546,000 $4,600 $4,700 2%\n\n$1,547,000 $4,600 $4,700 2%\n\n$1,548,000 $4,600 $4,700 2%\n\n$1,549,000 $4,600 $4,700 2%\n\n$1,550,000 $4,600 $4,700 2%\n\n$1,551,000 $4,600 $4,700 2%\n\n$1,552,000 $4,600 $4,700 2%\n\n$1,553,000 $4,600 $4,700 2%\n\n$1,554,000 $4,600 $4,700 2%\n\n$1,555,000 $4,600 $4,700 2%\n\n$1,556,000 $4,600 $4,700 2%\n\n$1,557,000 $4,600 $4,700 2%\n\n$1,558,000 $4,600 $4,700 2%\n\n$1,559,000 $4,600 $4,700 2%\n\n$1,560,000 $4,600 $4,700 2%\n\n$1,561,000 $4,600 $4,700 2%\n\n$1,562,000 $4,600 $4,700 2%\n\n$1,563,000 $4,600 $4,700 2%\n\n$1,564,000 $4,600 $4,700 2%\n\n$1,565,000 $4,600 $4,700 2%\n\n$1,566,000 $4,600 $4,700 2%\n\n$1,567,000 $4,600 $4,700 2%\n\n$1,568,000 $4,600 $4,700 2%\n\n$1,569,000 $4,600 $4,700 2%\n\n$1,570,000 $4,600 $4,700 2%\n\n$1,571,000 $4,600 $4,700 2%\n\n$1,572,000 $4,600 $4,700 2%\n\n$1,573,000 $4,600 $4,700 2%\n\n$1,574,000 $4,600 $4,700 2%\n\nUpdaated: 8‐6‐19 August 1, 2019 32 of 32 JKRyan","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page917.pdf"]},"response":{"errors":[],"extract_id":"extract_ce6768a5ccc35fd57a6cc0db1795c1fa","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["FNTG CA Counties Sale Escrow Rate Compairsons Current vs. Proposed Zone 2\n\n**Liability Current Rate Proposed Rate % Diff** **Sysnopsis of All Zones Rate Change**\n\n$1,512,000 $4,600 $4,700 2%\n\n$1,513,000 $4,600 $4,700 2%\n\n$1,514,000 $4,600 $4,700 2%\n\n$1,515,000 $4,600 $4,700 2%\n\n$1,516,000 $4,600 $4,700 2%\n\n$1,517,000 $4,600 $4,700 2%\n\n$1,518,000 $4,600 $4,700 2%\n\n$1,519,000 $4,600 $4,700 2%\n\n$1,520,000 $4,600 $4,700 2%\n\n$1,521,000 $4,600 $4,700 2%\n\n$1,522,000 $4,600 $4,700 2%\n\n$1,523,000 $4,600 $4,700 2%\n\n$1,524,000 $4,600 $4,700 2%\n\n$1,525,000 $4,600 $4,700 2%\n\n$1,526,000 $4,600 $4,700 2%\n\n$1,527,000 $4,600 $4,700 2%\n\n$1,528,000 $4,600 $4,700 2%\n\n$1,529,000 $4,600 $4,700 2%\n\n$1,530,000 $4,600 $4,700 2%\n\n$1,531,000 $4,600 $4,700 2%\n\n$1,532,000 $4,600 $4,700 2%\n\n$1,533,000 $4,600 $4,700 2%\n\n$1,534,000 $4,600 $4,700 2%\n\n$1,535,000 $4,600 $4,700 2%\n\n$1,536,000 $4,600 $4,700 2%\n\n$1,537,000 $4,600 $4,700 2%\n\n$1,538,000 $4,600 $4,700 2%\n\n$1,539,000 $4,600 $4,700 2%\n\n$1,540,000 $4,600 $4,700 2%\n\n$1,541,000 $4,600 $4,700 2%\n\n$1,542,000 $4,600 $4,700 2%\n\n$1,543,000 $4,600 $4,700 2%\n\n$1,544,000 $4,600 $4,700 2%\n\n$1,545,000 $4,600 $4,700 2%\n\n$1,546,000 $4,600 $4,700 2%\n\n$1,547,000 $4,600 $4,700 2%\n\n$1,548,000 $4,600 $4,700 2%\n\n$1,549,000 $4,600 $4,700 2%\n\n$1,550,000 $4,600 $4,700 2%\n\n$1,551,000 $4,600 $4,700 2%\n\n$1,552,000 $4,600 $4,700 2%\n\n$1,553,000 $4,600 $4,700 2%\n\n$1,554,000 $4,600 $4,700 2%\n\n$1,555,000 $4,600 $4,700 2%\n\n$1,556,000 $4,600 $4,700 2%\n\n$1,557,000 $4,600 $4,700 2%\n\n$1,558,000 $4,600 $4,700 2%\n\n$1,559,000 $4,600 $4,700 2%\n\n$1,560,000 $4,600 $4,700 2%\n\n$1,561,000 $4,600 $4,700 2%\n\n$1,562,000 $4,600 $4,700 2%\n\n$1,563,000 $4,600 $4,700 2%\n\n$1,564,000 $4,600 $4,700 2%\n\n$1,565,000 $4,600 $4,700 2%\n\n$1,566,000 $4,600 $4,700 2%\n\n$1,567,000 $4,600 $4,700 2%\n\n$1,568,000 $4,600 $4,700 2%\n\n$1,569,000 $4,600 $4,700 2%\n\n$1,570,000 $4,600 $4,700 2%\n\n$1,571,000 $4,600 $4,700 2%\n\n$1,572,000 $4,600 $4,700 2%\n\n$1,573,000 $4,600 $4,700 2%\n\n$1,574,000 $4,600 $4,700 2%\n\nUpdaated: 8‐6‐19 August 1, 2019 32 of 32 JKRyan"],"full_content":"FNTG CA Counties Sale Escrow Rate Compairsons Current vs. Proposed Zone 2\n\n**Liability Current Rate Proposed Rate % Diff** **Sysnopsis of All Zones Rate Change**\n\n$1,512,000 $4,600 $4,700 2%\n\n$1,513,000 $4,600 $4,700 2%\n\n$1,514,000 $4,600 $4,700 2%\n\n$1,515,000 $4,600 $4,700 2%\n\n$1,516,000 $4,600 $4,700 2%\n\n$1,517,000 $4,600 $4,700 2%\n\n$1,518,000 $4,600 $4,700 2%\n\n$1,519,000 $4,600 $4,700 2%\n\n$1,520,000 $4,600 $4,700 2%\n\n$1,521,000 $4,600 $4,700 2%\n\n$1,522,000 $4,600 $4,700 2%\n\n$1,523,000 $4,600 $4,700 2%\n\n$1,524,000 $4,600 $4,700 2%\n\n$1,525,000 $4,600 $4,700 2%\n\n$1,526,000 $4,600 $4,700 2%\n\n$1,527,000 $4,600 $4,700 2%\n\n$1,528,000 $4,600 $4,700 2%\n\n$1,529,000 $4,600 $4,700 2%\n\n$1,530,000 $4,600 $4,700 2%\n\n$1,531,000 $4,600 $4,700 2%\n\n$1,532,000 $4,600 $4,700 2%\n\n$1,533,000 $4,600 $4,700 2%\n\n$1,534,000 $4,600 $4,700 2%\n\n$1,535,000 $4,600 $4,700 2%\n\n$1,536,000 $4,600 $4,700 2%\n\n$1,537,000 $4,600 $4,700 2%\n\n$1,538,000 $4,600 $4,700 2%\n\n$1,539,000 $4,600 $4,700 2%\n\n$1,540,000 $4,600 $4,700 2%\n\n$1,541,000 $4,600 $4,700 2%\n\n$1,542,000 $4,600 $4,700 2%\n\n$1,543,000 $4,600 $4,700 2%\n\n$1,544,000 $4,600 $4,700 2%\n\n$1,545,000 $4,600 $4,700 2%\n\n$1,546,000 $4,600 $4,700 2%\n\n$1,547,000 $4,600 $4,700 2%\n\n$1,548,000 $4,600 $4,700 2%\n\n$1,549,000 $4,600 $4,700 2%\n\n$1,550,000 $4,600 $4,700 2%\n\n$1,551,000 $4,600 $4,700 2%\n\n$1,552,000 $4,600 $4,700 2%\n\n$1,553,000 $4,600 $4,700 2%\n\n$1,554,000 $4,600 $4,700 2%\n\n$1,555,000 $4,600 $4,700 2%\n\n$1,556,000 $4,600 $4,700 2%\n\n$1,557,000 $4,600 $4,700 2%\n\n$1,558,000 $4,600 $4,700 2%\n\n$1,559,000 $4,600 $4,700 2%\n\n$1,560,000 $4,600 $4,700 2%\n\n$1,561,000 $4,600 $4,700 2%\n\n$1,562,000 $4,600 $4,700 2%\n\n$1,563,000 $4,600 $4,700 2%\n\n$1,564,000 $4,600 $4,700 2%\n\n$1,565,000 $4,600 $4,700 2%\n\n$1,566,000 $4,600 $4,700 2%\n\n$1,567,000 $4,600 $4,700 2%\n\n$1,568,000 $4,600 $4,700 2%\n\n$1,569,000 $4,600 $4,700 2%\n\n$1,570,000 $4,600 $4,700 2%\n\n$1,571,000 $4,600 $4,700 2%\n\n$1,572,000 $4,600 $4,700 2%\n\n$1,573,000 $4,600 $4,700 2%\n\n$1,574,000 $4,600 $4,700 2%\n\nUpdaated: 8‐6‐19 August 1, 2019 32 of 32 JKRyan","publish_date":null,"title":"FNTG CA Counties Sale Escrow Rate Compairsons Current vs. Proposed Zone 2 Liability Current Rate Proposed Rate % Diff Sysnopsis","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page917.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page917.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page917","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page917.pdf"},"started_at":"2026-11-04T19:47:42.428695"} +{"completed_at":"2026-11-04T19:47:44.367325","latency_in_ms":921,"output":{"example_id":"table/SERFF_CA_random_pages 1_page96","grounded_pages":[],"layout_pages":[],"markdown":"**Aetna Life Insurance Company Filing #CA-2015-01-AARP-GF Exhibit D Essential Premier Health Plan Base Rates**\n\nExhibit D-1\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 254.96 207.94 135.31 173.76 138.15 138.15 96.85\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 284.28 231.85 150.87 193.74 154.04 154.04 107.99\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 11.50% 11.50% 11.50% 11.50% 11.50% 11.50% 11.50%\n\nCurrent Base Rate\n\nProposed Base Rate\n\nRate Changes","pages":[{"line_numbers":[],"markdown":"**Aetna Life Insurance Company Filing #CA-2015-01-AARP-GF Exhibit D Essential Premier Health Plan Base Rates**\n\nExhibit D-1\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 254.96 207.94 135.31 173.76 138.15 138.15 96.85\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 284.28 231.85 150.87 193.74 154.04 154.04 107.99\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 11.50% 11.50% 11.50% 11.50% 11.50% 11.50% 11.50%\n\nCurrent Base Rate\n\nProposed Base Rate\n\nRate Changes","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Aetna Life Insurance Company Filing #CA-2015-01-AARP-GF Exhibit D Essential Premier Health Plan Base Rates**\n\nExhibit D-1\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 254.96 207.94 135.31 173.76 138.15 138.15 96.85\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 284.28 231.85 150.87 193.74 154.04 154.04 107.99\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 11.50% 11.50% 11.50% 11.50% 11.50% 11.50% 11.50%\n\nCurrent Base Rate\n\nProposed Base Rate\n\nRate Changes","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page96.pdf"]},"response":{"errors":[],"extract_id":"extract_bb4bf17c49901d2db425d3bd7e5cc821","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Aetna Life Insurance Company Filing #CA-2015-01-AARP-GF Exhibit D Essential Premier Health Plan Base Rates**\n\nExhibit D-1\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 254.96 207.94 135.31 173.76 138.15 138.15 96.85\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 284.28 231.85 150.87 193.74 154.04 154.04 107.99\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 11.50% 11.50% 11.50% 11.50% 11.50% 11.50% 11.50%\n\nCurrent Base Rate\n\nProposed Base Rate\n\nRate Changes"],"full_content":"**Aetna Life Insurance Company Filing #CA-2015-01-AARP-GF Exhibit D Essential Premier Health Plan Base Rates**\n\nExhibit D-1\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 254.96 207.94 135.31 173.76 138.15 138.15 96.85\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 284.28 231.85 150.87 193.74 154.04 154.04 107.99\n\n**CA** **PPO 1500 PPO 2500 PPO 5000 HDHP 3000 HDHP 5000 PHC 1250 PHC 3000**\n\nBlock A - Grandfathered (Issued before 3/23/10) 11.50% 11.50% 11.50% 11.50% 11.50% 11.50% 11.50%\n\nCurrent Base Rate\n\nProposed Base Rate\n\nRate Changes","publish_date":null,"title":"Aetna Life Insurance Company Filing #CA-2015-01-AARP-GF Exhibit D Essential Premier Health Plan Base Rates","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page96.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page96.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page96","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page96.pdf"},"started_at":"2026-11-04T19:47:43.445501"} +{"completed_at":"2026-11-04T19:47:45.775717","latency_in_ms":1161,"output":{"example_id":"table/SERFF_CA_random_pages 1_page965","grounded_pages":[],"layout_pages":[],"markdown":"CTIC, CLTIC, FNTIC CA Subdivision Title Rate Table S‐1 Current vs. Proposed\n\n$ 1,460,001.00 $ 1,465,000.00 $ 1,414.00 1,549.00 $ 10% $ 1,465,001.00 $ 1,470,000.00 $ 1,417.00 1,552.00 $ 10% $ 1,470,001.00 $ 1,475,000.00 $ 1,420.00 1,555.00 $ 10% $ 1,475,001.00 $ 1,480,000.00 $ 1,423.00 1,558.00 $ 9% $ 1,480,001.00 $ 1,485,000.00 $ 1,426.00 1,561.00 $ 9% $ 1,485,001.00 $ 1,490,000.00 $ 1,429.00 1,564.00 $ 9% $ 1,490,001.00 $ 1,495,000.00 $ 1,432.00 1,567.00 $ 9% $ 1,495,001.00 $ 1,500,000.00 $ 1,435.00 1,570.00 $ 9% $ 1,500,001.00 $ 1,505,000.00 $ 1,438.00 1,573.00 $ 9% $ 1,505,001.00 $ 1,510,000.00 $ 1,441.00 1,576.00 $ 9% $ 1,510,001.00 $ 1,515,000.00 $ 1,444.00 1,579.00 $ 9% $ 1,515,001.00 $ 1,520,000.00 $ 1,447.00 1,582.00 $ 9% $ 1,520,001.00 $ 1,525,000.00 $ 1,450.00 1,585.00 $ 9% $ 1,525,001.00 $ 1,530,000.00 $ 1,453.00 1,588.00 $ 9% $ 1,530,001.00 $ 1,535,000.00 $ 1,456.00 1,591.00 $ 9% $ 1,535,001.00 $ 1,540,000.00 $ 1,459.00 1,594.00 $ 9% $ 1,540,001.00 $ 1,545,000.00 $ 1,462.00 1,597.00 $ 9% $ 1,545,001.00 $ 1,550,000.00 $ 1,465.00 1,600.00 $ 9% $ 1,550,001.00 $ 1,555,000.00 $ 1,468.00 1,603.00 $ 9% $ 1,555,001.00 $ 1,560,000.00 $ 1,471.00 1,606.00 $ 9% $ 1,560,001.00 $ 1,565,000.00 $ 1,474.00 1,609.00 $ 9% $ 1,565,001.00 $ 1,570,000.00 $ 1,477.00 1,612.00 $ 9% $ 1,570,001.00 $ 1,575,000.00 $ 1,480.00 1,615.00 $ 9% $ 1,575,001.00 $ 1,580,000.00 $ 1,483.00 1,618.00 $ 9% $ 1,580,001.00 $ 1,585,000.00 $ 1,486.00 1,621.00 $ 9% $ 1,585,001.00 $ 1,590,000.00 $ 1,489.00 1,624.00 $ 9% $ 1,590,001.00 $ 1,595,000.00 $ 1,492.00 1,627.00 $ 9% $ 1,595,001.00 $ 1,600,000.00 $ 1,495.00 1,630.00 $ 9% $ 1,600,001.00 $ 1,605,000.00 $ 1,498.00 1,633.00 $ 9% $ 1,605,001.00 $ 1,610,000.00 $ 1,501.00 1,636.00 $ 9% $ 1,610,001.00 $ 1,615,000.00 $ 1,504.00 1,639.00 $ 9% $ 1,615,001.00 $ 1,620,000.00 $ 1,507.00 1,642.00 $ 9% $ 1,620,001.00 $ 1,625,000.00 $ 1,510.00 1,645.00 $ 9% $ 1,625,001.00 $ 1,630,000.00 $ 1,513.00 1,648.00 $ 9% $ 1,630,001.00 $ 1,635,000.00 $ 1,516.00 1,651.00 $ 9% $ 1,635,001.00 $ 1,640,000.00 $ 1,519.00 1,654.00 $ 9% $ 1,640,001.00 $ 1,645,000.00 $ 1,522.00 1,657.00 $ 9% $ 1,645,001.00 $ 1,650,000.00 $ 1,525.00 1,660.00 $ 9% $ 1,650,001.00 $ 1,655,000.00 $ 1,528.00 1,663.00 $ 9% $ 1,655,001.00 $ 1,660,000.00 $ 1,531.00 1,666.00 $ 9% $ 1,660,001.00 $ 1,665,000.00 $ 1,534.00 1,669.00 $ 9% $ 1,665,001.00 $ 1,670,000.00 $ 1,537.00 1,672.00 $ 9% $ 1,670,001.00 $ 1,675,000.00 $ 1,540.00 1,675.00 $ 9% $ 1,675,001.00 $ 1,680,000.00 $ 1,543.00 1,678.00 $ 9% $ 1,680,001.00 $ 1,685,000.00 $ 1,546.00 1,681.00 $ 9% $ 1,685,001.00 $ 1,690,000.00 $ 1,549.00 1,684.00 $ 9% $ 1,690,001.00 $ 1,695,000.00 $ 1,552.00 1,687.00 $ 9%\n\nCreated January 7, 2023 6 of 16 JKRyan","pages":[{"line_numbers":[],"markdown":"CTIC, CLTIC, FNTIC CA Subdivision Title Rate Table S‐1 Current vs. Proposed\n\n$ 1,460,001.00 $ 1,465,000.00 $ 1,414.00 1,549.00 $ 10% $ 1,465,001.00 $ 1,470,000.00 $ 1,417.00 1,552.00 $ 10% $ 1,470,001.00 $ 1,475,000.00 $ 1,420.00 1,555.00 $ 10% $ 1,475,001.00 $ 1,480,000.00 $ 1,423.00 1,558.00 $ 9% $ 1,480,001.00 $ 1,485,000.00 $ 1,426.00 1,561.00 $ 9% $ 1,485,001.00 $ 1,490,000.00 $ 1,429.00 1,564.00 $ 9% $ 1,490,001.00 $ 1,495,000.00 $ 1,432.00 1,567.00 $ 9% $ 1,495,001.00 $ 1,500,000.00 $ 1,435.00 1,570.00 $ 9% $ 1,500,001.00 $ 1,505,000.00 $ 1,438.00 1,573.00 $ 9% $ 1,505,001.00 $ 1,510,000.00 $ 1,441.00 1,576.00 $ 9% $ 1,510,001.00 $ 1,515,000.00 $ 1,444.00 1,579.00 $ 9% $ 1,515,001.00 $ 1,520,000.00 $ 1,447.00 1,582.00 $ 9% $ 1,520,001.00 $ 1,525,000.00 $ 1,450.00 1,585.00 $ 9% $ 1,525,001.00 $ 1,530,000.00 $ 1,453.00 1,588.00 $ 9% $ 1,530,001.00 $ 1,535,000.00 $ 1,456.00 1,591.00 $ 9% $ 1,535,001.00 $ 1,540,000.00 $ 1,459.00 1,594.00 $ 9% $ 1,540,001.00 $ 1,545,000.00 $ 1,462.00 1,597.00 $ 9% $ 1,545,001.00 $ 1,550,000.00 $ 1,465.00 1,600.00 $ 9% $ 1,550,001.00 $ 1,555,000.00 $ 1,468.00 1,603.00 $ 9% $ 1,555,001.00 $ 1,560,000.00 $ 1,471.00 1,606.00 $ 9% $ 1,560,001.00 $ 1,565,000.00 $ 1,474.00 1,609.00 $ 9% $ 1,565,001.00 $ 1,570,000.00 $ 1,477.00 1,612.00 $ 9% $ 1,570,001.00 $ 1,575,000.00 $ 1,480.00 1,615.00 $ 9% $ 1,575,001.00 $ 1,580,000.00 $ 1,483.00 1,618.00 $ 9% $ 1,580,001.00 $ 1,585,000.00 $ 1,486.00 1,621.00 $ 9% $ 1,585,001.00 $ 1,590,000.00 $ 1,489.00 1,624.00 $ 9% $ 1,590,001.00 $ 1,595,000.00 $ 1,492.00 1,627.00 $ 9% $ 1,595,001.00 $ 1,600,000.00 $ 1,495.00 1,630.00 $ 9% $ 1,600,001.00 $ 1,605,000.00 $ 1,498.00 1,633.00 $ 9% $ 1,605,001.00 $ 1,610,000.00 $ 1,501.00 1,636.00 $ 9% $ 1,610,001.00 $ 1,615,000.00 $ 1,504.00 1,639.00 $ 9% $ 1,615,001.00 $ 1,620,000.00 $ 1,507.00 1,642.00 $ 9% $ 1,620,001.00 $ 1,625,000.00 $ 1,510.00 1,645.00 $ 9% $ 1,625,001.00 $ 1,630,000.00 $ 1,513.00 1,648.00 $ 9% $ 1,630,001.00 $ 1,635,000.00 $ 1,516.00 1,651.00 $ 9% $ 1,635,001.00 $ 1,640,000.00 $ 1,519.00 1,654.00 $ 9% $ 1,640,001.00 $ 1,645,000.00 $ 1,522.00 1,657.00 $ 9% $ 1,645,001.00 $ 1,650,000.00 $ 1,525.00 1,660.00 $ 9% $ 1,650,001.00 $ 1,655,000.00 $ 1,528.00 1,663.00 $ 9% $ 1,655,001.00 $ 1,660,000.00 $ 1,531.00 1,666.00 $ 9% $ 1,660,001.00 $ 1,665,000.00 $ 1,534.00 1,669.00 $ 9% $ 1,665,001.00 $ 1,670,000.00 $ 1,537.00 1,672.00 $ 9% $ 1,670,001.00 $ 1,675,000.00 $ 1,540.00 1,675.00 $ 9% $ 1,675,001.00 $ 1,680,000.00 $ 1,543.00 1,678.00 $ 9% $ 1,680,001.00 $ 1,685,000.00 $ 1,546.00 1,681.00 $ 9% $ 1,685,001.00 $ 1,690,000.00 $ 1,549.00 1,684.00 $ 9% $ 1,690,001.00 $ 1,695,000.00 $ 1,552.00 1,687.00 $ 9%\n\nCreated January 7, 2023 6 of 16 JKRyan","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"CTIC, CLTIC, FNTIC CA Subdivision Title Rate Table S‐1 Current vs. Proposed\n\n$ 1,460,001.00 $ 1,465,000.00 $ 1,414.00 1,549.00 $ 10% $ 1,465,001.00 $ 1,470,000.00 $ 1,417.00 1,552.00 $ 10% $ 1,470,001.00 $ 1,475,000.00 $ 1,420.00 1,555.00 $ 10% $ 1,475,001.00 $ 1,480,000.00 $ 1,423.00 1,558.00 $ 9% $ 1,480,001.00 $ 1,485,000.00 $ 1,426.00 1,561.00 $ 9% $ 1,485,001.00 $ 1,490,000.00 $ 1,429.00 1,564.00 $ 9% $ 1,490,001.00 $ 1,495,000.00 $ 1,432.00 1,567.00 $ 9% $ 1,495,001.00 $ 1,500,000.00 $ 1,435.00 1,570.00 $ 9% $ 1,500,001.00 $ 1,505,000.00 $ 1,438.00 1,573.00 $ 9% $ 1,505,001.00 $ 1,510,000.00 $ 1,441.00 1,576.00 $ 9% $ 1,510,001.00 $ 1,515,000.00 $ 1,444.00 1,579.00 $ 9% $ 1,515,001.00 $ 1,520,000.00 $ 1,447.00 1,582.00 $ 9% $ 1,520,001.00 $ 1,525,000.00 $ 1,450.00 1,585.00 $ 9% $ 1,525,001.00 $ 1,530,000.00 $ 1,453.00 1,588.00 $ 9% $ 1,530,001.00 $ 1,535,000.00 $ 1,456.00 1,591.00 $ 9% $ 1,535,001.00 $ 1,540,000.00 $ 1,459.00 1,594.00 $ 9% $ 1,540,001.00 $ 1,545,000.00 $ 1,462.00 1,597.00 $ 9% $ 1,545,001.00 $ 1,550,000.00 $ 1,465.00 1,600.00 $ 9% $ 1,550,001.00 $ 1,555,000.00 $ 1,468.00 1,603.00 $ 9% $ 1,555,001.00 $ 1,560,000.00 $ 1,471.00 1,606.00 $ 9% $ 1,560,001.00 $ 1,565,000.00 $ 1,474.00 1,609.00 $ 9% $ 1,565,001.00 $ 1,570,000.00 $ 1,477.00 1,612.00 $ 9% $ 1,570,001.00 $ 1,575,000.00 $ 1,480.00 1,615.00 $ 9% $ 1,575,001.00 $ 1,580,000.00 $ 1,483.00 1,618.00 $ 9% $ 1,580,001.00 $ 1,585,000.00 $ 1,486.00 1,621.00 $ 9% $ 1,585,001.00 $ 1,590,000.00 $ 1,489.00 1,624.00 $ 9% $ 1,590,001.00 $ 1,595,000.00 $ 1,492.00 1,627.00 $ 9% $ 1,595,001.00 $ 1,600,000.00 $ 1,495.00 1,630.00 $ 9% $ 1,600,001.00 $ 1,605,000.00 $ 1,498.00 1,633.00 $ 9% $ 1,605,001.00 $ 1,610,000.00 $ 1,501.00 1,636.00 $ 9% $ 1,610,001.00 $ 1,615,000.00 $ 1,504.00 1,639.00 $ 9% $ 1,615,001.00 $ 1,620,000.00 $ 1,507.00 1,642.00 $ 9% $ 1,620,001.00 $ 1,625,000.00 $ 1,510.00 1,645.00 $ 9% $ 1,625,001.00 $ 1,630,000.00 $ 1,513.00 1,648.00 $ 9% $ 1,630,001.00 $ 1,635,000.00 $ 1,516.00 1,651.00 $ 9% $ 1,635,001.00 $ 1,640,000.00 $ 1,519.00 1,654.00 $ 9% $ 1,640,001.00 $ 1,645,000.00 $ 1,522.00 1,657.00 $ 9% $ 1,645,001.00 $ 1,650,000.00 $ 1,525.00 1,660.00 $ 9% $ 1,650,001.00 $ 1,655,000.00 $ 1,528.00 1,663.00 $ 9% $ 1,655,001.00 $ 1,660,000.00 $ 1,531.00 1,666.00 $ 9% $ 1,660,001.00 $ 1,665,000.00 $ 1,534.00 1,669.00 $ 9% $ 1,665,001.00 $ 1,670,000.00 $ 1,537.00 1,672.00 $ 9% $ 1,670,001.00 $ 1,675,000.00 $ 1,540.00 1,675.00 $ 9% $ 1,675,001.00 $ 1,680,000.00 $ 1,543.00 1,678.00 $ 9% $ 1,680,001.00 $ 1,685,000.00 $ 1,546.00 1,681.00 $ 9% $ 1,685,001.00 $ 1,690,000.00 $ 1,549.00 1,684.00 $ 9% $ 1,690,001.00 $ 1,695,000.00 $ 1,552.00 1,687.00 $ 9%\n\nCreated January 7, 2023 6 of 16 JKRyan","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page965.pdf"]},"response":{"errors":[],"extract_id":"extract_b531aada1974d15b8f0d3dd2c1899953","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["CTIC, CLTIC, FNTIC CA Subdivision Title Rate Table S‐1 Current vs. Proposed\n\n$ 1,460,001.00 $ 1,465,000.00 $ 1,414.00 1,549.00 $ 10% $ 1,465,001.00 $ 1,470,000.00 $ 1,417.00 1,552.00 $ 10% $ 1,470,001.00 $ 1,475,000.00 $ 1,420.00 1,555.00 $ 10% $ 1,475,001.00 $ 1,480,000.00 $ 1,423.00 1,558.00 $ 9% $ 1,480,001.00 $ 1,485,000.00 $ 1,426.00 1,561.00 $ 9% $ 1,485,001.00 $ 1,490,000.00 $ 1,429.00 1,564.00 $ 9% $ 1,490,001.00 $ 1,495,000.00 $ 1,432.00 1,567.00 $ 9% $ 1,495,001.00 $ 1,500,000.00 $ 1,435.00 1,570.00 $ 9% $ 1,500,001.00 $ 1,505,000.00 $ 1,438.00 1,573.00 $ 9% $ 1,505,001.00 $ 1,510,000.00 $ 1,441.00 1,576.00 $ 9% $ 1,510,001.00 $ 1,515,000.00 $ 1,444.00 1,579.00 $ 9% $ 1,515,001.00 $ 1,520,000.00 $ 1,447.00 1,582.00 $ 9% $ 1,520,001.00 $ 1,525,000.00 $ 1,450.00 1,585.00 $ 9% $ 1,525,001.00 $ 1,530,000.00 $ 1,453.00 1,588.00 $ 9% $ 1,530,001.00 $ 1,535,000.00 $ 1,456.00 1,591.00 $ 9% $ 1,535,001.00 $ 1,540,000.00 $ 1,459.00 1,594.00 $ 9% $ 1,540,001.00 $ 1,545,000.00 $ 1,462.00 1,597.00 $ 9% $ 1,545,001.00 $ 1,550,000.00 $ 1,465.00 1,600.00 $ 9% $ 1,550,001.00 $ 1,555,000.00 $ 1,468.00 1,603.00 $ 9% $ 1,555,001.00 $ 1,560,000.00 $ 1,471.00 1,606.00 $ 9% $ 1,560,001.00 $ 1,565,000.00 $ 1,474.00 1,609.00 $ 9% $ 1,565,001.00 $ 1,570,000.00 $ 1,477.00 1,612.00 $ 9% $ 1,570,001.00 $ 1,575,000.00 $ 1,480.00 1,615.00 $ 9% $ 1,575,001.00 $ 1,580,000.00 $ 1,483.00 1,618.00 $ 9% $ 1,580,001.00 $ 1,585,000.00 $ 1,486.00 1,621.00 $ 9% $ 1,585,001.00 $ 1,590,000.00 $ 1,489.00 1,624.00 $ 9% $ 1,590,001.00 $ 1,595,000.00 $ 1,492.00 1,627.00 $ 9% $ 1,595,001.00 $ 1,600,000.00 $ 1,495.00 1,630.00 $ 9% $ 1,600,001.00 $ 1,605,000.00 $ 1,498.00 1,633.00 $ 9% $ 1,605,001.00 $ 1,610,000.00 $ 1,501.00 1,636.00 $ 9% $ 1,610,001.00 $ 1,615,000.00 $ 1,504.00 1,639.00 $ 9% $ 1,615,001.00 $ 1,620,000.00 $ 1,507.00 1,642.00 $ 9% $ 1,620,001.00 $ 1,625,000.00 $ 1,510.00 1,645.00 $ 9% $ 1,625,001.00 $ 1,630,000.00 $ 1,513.00 1,648.00 $ 9% $ 1,630,001.00 $ 1,635,000.00 $ 1,516.00 1,651.00 $ 9% $ 1,635,001.00 $ 1,640,000.00 $ 1,519.00 1,654.00 $ 9% $ 1,640,001.00 $ 1,645,000.00 $ 1,522.00 1,657.00 $ 9% $ 1,645,001.00 $ 1,650,000.00 $ 1,525.00 1,660.00 $ 9% $ 1,650,001.00 $ 1,655,000.00 $ 1,528.00 1,663.00 $ 9% $ 1,655,001.00 $ 1,660,000.00 $ 1,531.00 1,666.00 $ 9% $ 1,660,001.00 $ 1,665,000.00 $ 1,534.00 1,669.00 $ 9% $ 1,665,001.00 $ 1,670,000.00 $ 1,537.00 1,672.00 $ 9% $ 1,670,001.00 $ 1,675,000.00 $ 1,540.00 1,675.00 $ 9% $ 1,675,001.00 $ 1,680,000.00 $ 1,543.00 1,678.00 $ 9% $ 1,680,001.00 $ 1,685,000.00 $ 1,546.00 1,681.00 $ 9% $ 1,685,001.00 $ 1,690,000.00 $ 1,549.00 1,684.00 $ 9% $ 1,690,001.00 $ 1,695,000.00 $ 1,552.00 1,687.00 $ 9%\n\nCreated January 7, 2023 6 of 16 JKRyan"],"full_content":"CTIC, CLTIC, FNTIC CA Subdivision Title Rate Table S‐1 Current vs. Proposed\n\n$ 1,460,001.00 $ 1,465,000.00 $ 1,414.00 1,549.00 $ 10% $ 1,465,001.00 $ 1,470,000.00 $ 1,417.00 1,552.00 $ 10% $ 1,470,001.00 $ 1,475,000.00 $ 1,420.00 1,555.00 $ 10% $ 1,475,001.00 $ 1,480,000.00 $ 1,423.00 1,558.00 $ 9% $ 1,480,001.00 $ 1,485,000.00 $ 1,426.00 1,561.00 $ 9% $ 1,485,001.00 $ 1,490,000.00 $ 1,429.00 1,564.00 $ 9% $ 1,490,001.00 $ 1,495,000.00 $ 1,432.00 1,567.00 $ 9% $ 1,495,001.00 $ 1,500,000.00 $ 1,435.00 1,570.00 $ 9% $ 1,500,001.00 $ 1,505,000.00 $ 1,438.00 1,573.00 $ 9% $ 1,505,001.00 $ 1,510,000.00 $ 1,441.00 1,576.00 $ 9% $ 1,510,001.00 $ 1,515,000.00 $ 1,444.00 1,579.00 $ 9% $ 1,515,001.00 $ 1,520,000.00 $ 1,447.00 1,582.00 $ 9% $ 1,520,001.00 $ 1,525,000.00 $ 1,450.00 1,585.00 $ 9% $ 1,525,001.00 $ 1,530,000.00 $ 1,453.00 1,588.00 $ 9% $ 1,530,001.00 $ 1,535,000.00 $ 1,456.00 1,591.00 $ 9% $ 1,535,001.00 $ 1,540,000.00 $ 1,459.00 1,594.00 $ 9% $ 1,540,001.00 $ 1,545,000.00 $ 1,462.00 1,597.00 $ 9% $ 1,545,001.00 $ 1,550,000.00 $ 1,465.00 1,600.00 $ 9% $ 1,550,001.00 $ 1,555,000.00 $ 1,468.00 1,603.00 $ 9% $ 1,555,001.00 $ 1,560,000.00 $ 1,471.00 1,606.00 $ 9% $ 1,560,001.00 $ 1,565,000.00 $ 1,474.00 1,609.00 $ 9% $ 1,565,001.00 $ 1,570,000.00 $ 1,477.00 1,612.00 $ 9% $ 1,570,001.00 $ 1,575,000.00 $ 1,480.00 1,615.00 $ 9% $ 1,575,001.00 $ 1,580,000.00 $ 1,483.00 1,618.00 $ 9% $ 1,580,001.00 $ 1,585,000.00 $ 1,486.00 1,621.00 $ 9% $ 1,585,001.00 $ 1,590,000.00 $ 1,489.00 1,624.00 $ 9% $ 1,590,001.00 $ 1,595,000.00 $ 1,492.00 1,627.00 $ 9% $ 1,595,001.00 $ 1,600,000.00 $ 1,495.00 1,630.00 $ 9% $ 1,600,001.00 $ 1,605,000.00 $ 1,498.00 1,633.00 $ 9% $ 1,605,001.00 $ 1,610,000.00 $ 1,501.00 1,636.00 $ 9% $ 1,610,001.00 $ 1,615,000.00 $ 1,504.00 1,639.00 $ 9% $ 1,615,001.00 $ 1,620,000.00 $ 1,507.00 1,642.00 $ 9% $ 1,620,001.00 $ 1,625,000.00 $ 1,510.00 1,645.00 $ 9% $ 1,625,001.00 $ 1,630,000.00 $ 1,513.00 1,648.00 $ 9% $ 1,630,001.00 $ 1,635,000.00 $ 1,516.00 1,651.00 $ 9% $ 1,635,001.00 $ 1,640,000.00 $ 1,519.00 1,654.00 $ 9% $ 1,640,001.00 $ 1,645,000.00 $ 1,522.00 1,657.00 $ 9% $ 1,645,001.00 $ 1,650,000.00 $ 1,525.00 1,660.00 $ 9% $ 1,650,001.00 $ 1,655,000.00 $ 1,528.00 1,663.00 $ 9% $ 1,655,001.00 $ 1,660,000.00 $ 1,531.00 1,666.00 $ 9% $ 1,660,001.00 $ 1,665,000.00 $ 1,534.00 1,669.00 $ 9% $ 1,665,001.00 $ 1,670,000.00 $ 1,537.00 1,672.00 $ 9% $ 1,670,001.00 $ 1,675,000.00 $ 1,540.00 1,675.00 $ 9% $ 1,675,001.00 $ 1,680,000.00 $ 1,543.00 1,678.00 $ 9% $ 1,680,001.00 $ 1,685,000.00 $ 1,546.00 1,681.00 $ 9% $ 1,685,001.00 $ 1,690,000.00 $ 1,549.00 1,684.00 $ 9% $ 1,690,001.00 $ 1,695,000.00 $ 1,552.00 1,687.00 $ 9%\n\nCreated January 7, 2023 6 of 16 JKRyan","publish_date":null,"title":"CTIC, CLTIC, FNTIC CA Subdivision Title Rate Table S‐1 Current vs. Proposed 1,549.00 $ 10% $ 1,460,001.00 $ 1,465,000.00 $","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page965.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page965.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page965","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page965.pdf"},"started_at":"2026-11-04T19:47:44.614702"} +{"completed_at":"2026-11-04T19:47:48.252719","latency_in_ms":2705,"output":{"example_id":"table/SERFF_CA_random_pages 1_page995","grounded_pages":[],"layout_pages":[],"markdown":"### **Explanatory Memorandum**\n\n### **Allianz Global Risks US Insurance Company**\n\n### **Allianz America Preferred Property Program Endorsement Filing**\n\n1\n\nAllianz Global Risks US Insurance Company is submitting for your department’s review and approval, a form filing of the new endorsement detailed below. The Cosmetic Damage Exclusion will, at the insured’s option, exclude coverage for Cosmetic Damage to roof surfacing, car ports, HVAC units, antennas, dust filtration and/or collection units including piping and supply line components, electrical equipment, conduits and wiring, ladders, stairs railings, roof top service doors and man cages, roof ventilation components, satellite dishes, sky lights, solar panels, or water tanks, caused by the perils of Windstorm or Hail. This exclusion applies only to the locations indicated in the Location Schedule shown in the endorsement.\n\nSince this is being filed for large multi-million dollar commercial property policies, rated based on multiple properties across multiple locations, natural modeled and unmodeled perils, reinsurance costs and other variables, use of this form does not result in any direct impact to the overall premium for the policy so there are no rates associated with this form filing.\n\nThis endorsement is for use with our Corporate Property Program (Allianz America Preferred Property Form. We propose an effective date of January 1, 2023.\n\n**Form Title Form Number**\n\n**Edition Date**\n\n**Conditional/Optional/ Mandatory Form Description**\n\nAllianz America Preferred Property Program AGR-CP 5128 10-22 Optional\n\nCosmetic Damage Exclusion","pages":[{"line_numbers":[],"markdown":"### **Explanatory Memorandum**\n\n### **Allianz Global Risks US Insurance Company**\n\n### **Allianz America Preferred Property Program Endorsement Filing**\n\n1\n\nAllianz Global Risks US Insurance Company is submitting for your department’s review and approval, a form filing of the new endorsement detailed below. The Cosmetic Damage Exclusion will, at the insured’s option, exclude coverage for Cosmetic Damage to roof surfacing, car ports, HVAC units, antennas, dust filtration and/or collection units including piping and supply line components, electrical equipment, conduits and wiring, ladders, stairs railings, roof top service doors and man cages, roof ventilation components, satellite dishes, sky lights, solar panels, or water tanks, caused by the perils of Windstorm or Hail. This exclusion applies only to the locations indicated in the Location Schedule shown in the endorsement.\n\nSince this is being filed for large multi-million dollar commercial property policies, rated based on multiple properties across multiple locations, natural modeled and unmodeled perils, reinsurance costs and other variables, use of this form does not result in any direct impact to the overall premium for the policy so there are no rates associated with this form filing.\n\nThis endorsement is for use with our Corporate Property Program (Allianz America Preferred Property Form. We propose an effective date of January 1, 2023.\n\n**Form Title Form Number**\n\n**Edition Date**\n\n**Conditional/Optional/ Mandatory Form Description**\n\nAllianz America Preferred Property Program AGR-CP 5128 10-22 Optional\n\nCosmetic Damage Exclusion","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Explanatory Memorandum**\n\n### **Allianz Global Risks US Insurance Company**\n\n### **Allianz America Preferred Property Program Endorsement Filing**\n\n1\n\nAllianz Global Risks US Insurance Company is submitting for your department’s review and approval, a form filing of the new endorsement detailed below. The Cosmetic Damage Exclusion will, at the insured’s option, exclude coverage for Cosmetic Damage to roof surfacing, car ports, HVAC units, antennas, dust filtration and/or collection units including piping and supply line components, electrical equipment, conduits and wiring, ladders, stairs railings, roof top service doors and man cages, roof ventilation components, satellite dishes, sky lights, solar panels, or water tanks, caused by the perils of Windstorm or Hail. This exclusion applies only to the locations indicated in the Location Schedule shown in the endorsement.\n\nSince this is being filed for large multi-million dollar commercial property policies, rated based on multiple properties across multiple locations, natural modeled and unmodeled perils, reinsurance costs and other variables, use of this form does not result in any direct impact to the overall premium for the policy so there are no rates associated with this form filing.\n\nThis endorsement is for use with our Corporate Property Program (Allianz America Preferred Property Form. We propose an effective date of January 1, 2023.\n\n**Form Title Form Number**\n\n**Edition Date**\n\n**Conditional/Optional/ Mandatory Form Description**\n\nAllianz America Preferred Property Program AGR-CP 5128 10-22 Optional\n\nCosmetic Damage Exclusion","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page995.pdf"]},"response":{"errors":[],"extract_id":"extract_14e67761f6ec746a5b41a9e4da5b06fd","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Explanatory Memorandum**\n\n### **Allianz Global Risks US Insurance Company**\n\n### **Allianz America Preferred Property Program Endorsement Filing**\n\n1\n\nAllianz Global Risks US Insurance Company is submitting for your department’s review and approval, a form filing of the new endorsement detailed below. The Cosmetic Damage Exclusion will, at the insured’s option, exclude coverage for Cosmetic Damage to roof surfacing, car ports, HVAC units, antennas, dust filtration and/or collection units including piping and supply line components, electrical equipment, conduits and wiring, ladders, stairs railings, roof top service doors and man cages, roof ventilation components, satellite dishes, sky lights, solar panels, or water tanks, caused by the perils of Windstorm or Hail. This exclusion applies only to the locations indicated in the Location Schedule shown in the endorsement.\n\nSince this is being filed for large multi-million dollar commercial property policies, rated based on multiple properties across multiple locations, natural modeled and unmodeled perils, reinsurance costs and other variables, use of this form does not result in any direct impact to the overall premium for the policy so there are no rates associated with this form filing.\n\nThis endorsement is for use with our Corporate Property Program (Allianz America Preferred Property Form. We propose an effective date of January 1, 2023.\n\n**Form Title Form Number**\n\n**Edition Date**\n\n**Conditional/Optional/ Mandatory Form Description**\n\nAllianz America Preferred Property Program AGR-CP 5128 10-22 Optional\n\nCosmetic Damage Exclusion"],"full_content":"### **Explanatory Memorandum**\n\n### **Allianz Global Risks US Insurance Company**\n\n### **Allianz America Preferred Property Program Endorsement Filing**\n\n1\n\nAllianz Global Risks US Insurance Company is submitting for your department’s review and approval, a form filing of the new endorsement detailed below. The Cosmetic Damage Exclusion will, at the insured’s option, exclude coverage for Cosmetic Damage to roof surfacing, car ports, HVAC units, antennas, dust filtration and/or collection units including piping and supply line components, electrical equipment, conduits and wiring, ladders, stairs railings, roof top service doors and man cages, roof ventilation components, satellite dishes, sky lights, solar panels, or water tanks, caused by the perils of Windstorm or Hail. This exclusion applies only to the locations indicated in the Location Schedule shown in the endorsement.\n\nSince this is being filed for large multi-million dollar commercial property policies, rated based on multiple properties across multiple locations, natural modeled and unmodeled perils, reinsurance costs and other variables, use of this form does not result in any direct impact to the overall premium for the policy so there are no rates associated with this form filing.\n\nThis endorsement is for use with our Corporate Property Program (Allianz America Preferred Property Form. We propose an effective date of January 1, 2023.\n\n**Form Title Form Number**\n\n**Edition Date**\n\n**Conditional/Optional/ Mandatory Form Description**\n\nAllianz America Preferred Property Program AGR-CP 5128 10-22 Optional\n\nCosmetic Damage Exclusion","publish_date":null,"title":"Explanatory Memorandum Allianz Global Risks US Insurance Company Allianz America Preferred Property Program Endorsement Filing","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page995.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_CA_random_pages%201_page995.pdf"},"request":{"example_id":"table/SERFF_CA_random_pages 1_page995","product_type":"parse","source_file_path":"SERFF_CA_random_pages 1_page995.pdf"},"started_at":"2026-11-04T19:47:45.547547"} +{"completed_at":"2026-11-04T19:47:47.876284","latency_in_ms":1213,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page157","grounded_pages":[],"layout_pages":[],"markdown":"4\n\nPage 3 – End of Table\n\nTemporary Monthly Flat Extra Amount [0.00] [all] contract years\n\nThis item identifies the amount of extra premium the owner must pay for the finite period of time because of some risk impairment presented by the insured that will decrease or disappear over the time period.\n\nPage 3, 1 st paragraph\n\nAnnual Premium Required\n\nThis is the amount the policy owner must pay annually to guarantee maturity of the policy of the policy contract on the Final Policy Date.\n\nPage 3 – 4 th\n\nparagraph\n\n[Missouri], [800-726-7390]\n\nEach policy will reference the Issue state and the toll free number for the state’s regulatory agency.\n\nPage 3 -Form number\n\n[Missouri]\n\n[Missouri] bracketed in the form number indicates that the state in the form number will change to match the state in the 4 th paragraph.\n\nPage 4\n\nTable A – Monthly Loads\n\nThese items represent the maximum amounts the company may deduct from premium payments to cover items such as operational, acquisition and tax expenses. Loads last anywhere from 2 years to 7 years and are dependent upon issue age.\n\nPage 14 -Section 7.17- Governing Law & Form number\n\n[Missouri]\n\nThis the issue state of the policy. [Missouri] bracketed in the form number indicates that the state in the form number will change to match the state in Section 7.17.\n\n**ENDORSEMENT VARIABILTY**\n\nTitle and Schedule for Contract Number\n\nContract Number\n\nThe contract number is policyholder specific and varies with each policyholder.\n\nSection 5.2 and Schedule, page 3 (Guaranteed Minimum Annual Interest Rate)\n\nInterest rate credited on cash value\n\nIndicated as variable to allow for anticipated changes with passage of Section 7702 of the Consolidated Appropriations Act.\n\nSection 7.7\n\nInterest rate used to calculate minimum cash values\n\nIndicated as variable to allow for anticipated change with passage of the HEROES act. This would only be changed upon prior approval after demonstrating compliance with any new regulations.\n\nBottom of page\n\nOfficers’ signatures\n\nThese are the signatures of the company officers. They will change if or when officers are replaced.\n\n**Updated Policy SOV based on these endorsement changes**\n\nPage 4\n\nTable A – Monthly Loads\n\nThese items represent the maximum amounts the company may deduct from premium payments to cover items such as operational, acquisition and tax expenses. Loads last anywhere from 2 years to 6 years and are dependent upon issue age and smoker status.","pages":[{"line_numbers":[],"markdown":"4\n\nPage 3 – End of Table\n\nTemporary Monthly Flat Extra Amount [0.00] [all] contract years\n\nThis item identifies the amount of extra premium the owner must pay for the finite period of time because of some risk impairment presented by the insured that will decrease or disappear over the time period.\n\nPage 3, 1 st paragraph\n\nAnnual Premium Required\n\nThis is the amount the policy owner must pay annually to guarantee maturity of the policy of the policy contract on the Final Policy Date.\n\nPage 3 – 4 th\n\nparagraph\n\n[Missouri], [800-726-7390]\n\nEach policy will reference the Issue state and the toll free number for the state’s regulatory agency.\n\nPage 3 -Form number\n\n[Missouri]\n\n[Missouri] bracketed in the form number indicates that the state in the form number will change to match the state in the 4 th paragraph.\n\nPage 4\n\nTable A – Monthly Loads\n\nThese items represent the maximum amounts the company may deduct from premium payments to cover items such as operational, acquisition and tax expenses. Loads last anywhere from 2 years to 7 years and are dependent upon issue age.\n\nPage 14 -Section 7.17- Governing Law & Form number\n\n[Missouri]\n\nThis the issue state of the policy. [Missouri] bracketed in the form number indicates that the state in the form number will change to match the state in Section 7.17.\n\n**ENDORSEMENT VARIABILTY**\n\nTitle and Schedule for Contract Number\n\nContract Number\n\nThe contract number is policyholder specific and varies with each policyholder.\n\nSection 5.2 and Schedule, page 3 (Guaranteed Minimum Annual Interest Rate)\n\nInterest rate credited on cash value\n\nIndicated as variable to allow for anticipated changes with passage of Section 7702 of the Consolidated Appropriations Act.\n\nSection 7.7\n\nInterest rate used to calculate minimum cash values\n\nIndicated as variable to allow for anticipated change with passage of the HEROES act. This would only be changed upon prior approval after demonstrating compliance with any new regulations.\n\nBottom of page\n\nOfficers’ signatures\n\nThese are the signatures of the company officers. They will change if or when officers are replaced.\n\n**Updated Policy SOV based on these endorsement changes**\n\nPage 4\n\nTable A – Monthly Loads\n\nThese items represent the maximum amounts the company may deduct from premium payments to cover items such as operational, acquisition and tax expenses. Loads last anywhere from 2 years to 6 years and are dependent upon issue age and smoker status.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"4\n\nPage 3 – End of Table\n\nTemporary Monthly Flat Extra Amount [0.00] [all] contract years\n\nThis item identifies the amount of extra premium the owner must pay for the finite period of time because of some risk impairment presented by the insured that will decrease or disappear over the time period.\n\nPage 3, 1 st paragraph\n\nAnnual Premium Required\n\nThis is the amount the policy owner must pay annually to guarantee maturity of the policy of the policy contract on the Final Policy Date.\n\nPage 3 – 4 th\n\nparagraph\n\n[Missouri], [800-726-7390]\n\nEach policy will reference the Issue state and the toll free number for the state’s regulatory agency.\n\nPage 3 -Form number\n\n[Missouri]\n\n[Missouri] bracketed in the form number indicates that the state in the form number will change to match the state in the 4 th paragraph.\n\nPage 4\n\nTable A – Monthly Loads\n\nThese items represent the maximum amounts the company may deduct from premium payments to cover items such as operational, acquisition and tax expenses. Loads last anywhere from 2 years to 7 years and are dependent upon issue age.\n\nPage 14 -Section 7.17- Governing Law & Form number\n\n[Missouri]\n\nThis the issue state of the policy. [Missouri] bracketed in the form number indicates that the state in the form number will change to match the state in Section 7.17.\n\n**ENDORSEMENT VARIABILTY**\n\nTitle and Schedule for Contract Number\n\nContract Number\n\nThe contract number is policyholder specific and varies with each policyholder.\n\nSection 5.2 and Schedule, page 3 (Guaranteed Minimum Annual Interest Rate)\n\nInterest rate credited on cash value\n\nIndicated as variable to allow for anticipated changes with passage of Section 7702 of the Consolidated Appropriations Act.\n\nSection 7.7\n\nInterest rate used to calculate minimum cash values\n\nIndicated as variable to allow for anticipated change with passage of the HEROES act. This would only be changed upon prior approval after demonstrating compliance with any new regulations.\n\nBottom of page\n\nOfficers’ signatures\n\nThese are the signatures of the company officers. They will change if or when officers are replaced.\n\n**Updated Policy SOV based on these endorsement changes**\n\nPage 4\n\nTable A – Monthly Loads\n\nThese items represent the maximum amounts the company may deduct from premium payments to cover items such as operational, acquisition and tax expenses. Loads last anywhere from 2 years to 6 years and are dependent upon issue age and smoker status.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page157.pdf"]},"response":{"errors":[],"extract_id":"extract_83aa60dcbcd6f1c7c5d3ed2c12ac70bb","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["4\n\nPage 3 – End of Table\n\nTemporary Monthly Flat Extra Amount [0.00] [all] contract years\n\nThis item identifies the amount of extra premium the owner must pay for the finite period of time because of some risk impairment presented by the insured that will decrease or disappear over the time period.\n\nPage 3, 1 st paragraph\n\nAnnual Premium Required\n\nThis is the amount the policy owner must pay annually to guarantee maturity of the policy of the policy contract on the Final Policy Date.\n\nPage 3 – 4 th\n\nparagraph\n\n[Missouri], [800-726-7390]\n\nEach policy will reference the Issue state and the toll free number for the state’s regulatory agency.\n\nPage 3 -Form number\n\n[Missouri]\n\n[Missouri] bracketed in the form number indicates that the state in the form number will change to match the state in the 4 th paragraph.\n\nPage 4\n\nTable A – Monthly Loads\n\nThese items represent the maximum amounts the company may deduct from premium payments to cover items such as operational, acquisition and tax expenses. Loads last anywhere from 2 years to 7 years and are dependent upon issue age.\n\nPage 14 -Section 7.17- Governing Law & Form number\n\n[Missouri]\n\nThis the issue state of the policy. [Missouri] bracketed in the form number indicates that the state in the form number will change to match the state in Section 7.17.\n\n**ENDORSEMENT VARIABILTY**\n\nTitle and Schedule for Contract Number\n\nContract Number\n\nThe contract number is policyholder specific and varies with each policyholder.\n\nSection 5.2 and Schedule, page 3 (Guaranteed Minimum Annual Interest Rate)\n\nInterest rate credited on cash value\n\nIndicated as variable to allow for anticipated changes with passage of Section 7702 of the Consolidated Appropriations Act.\n\nSection 7.7\n\nInterest rate used to calculate minimum cash values\n\nIndicated as variable to allow for anticipated change with passage of the HEROES act. This would only be changed upon prior approval after demonstrating compliance with any new regulations.\n\nBottom of page\n\nOfficers’ signatures\n\nThese are the signatures of the company officers. They will change if or when officers are replaced.\n\n**Updated Policy SOV based on these endorsement changes**\n\nPage 4\n\nTable A – Monthly Loads\n\nThese items represent the maximum amounts the company may deduct from premium payments to cover items such as operational, acquisition and tax expenses. Loads last anywhere from 2 years to 6 years and are dependent upon issue age and smoker status."],"full_content":"4\n\nPage 3 – End of Table\n\nTemporary Monthly Flat Extra Amount [0.00] [all] contract years\n\nThis item identifies the amount of extra premium the owner must pay for the finite period of time because of some risk impairment presented by the insured that will decrease or disappear over the time period.\n\nPage 3, 1 st paragraph\n\nAnnual Premium Required\n\nThis is the amount the policy owner must pay annually to guarantee maturity of the policy of the policy contract on the Final Policy Date.\n\nPage 3 – 4 th\n\nparagraph\n\n[Missouri], [800-726-7390]\n\nEach policy will reference the Issue state and the toll free number for the state’s regulatory agency.\n\nPage 3 -Form number\n\n[Missouri]\n\n[Missouri] bracketed in the form number indicates that the state in the form number will change to match the state in the 4 th paragraph.\n\nPage 4\n\nTable A – Monthly Loads\n\nThese items represent the maximum amounts the company may deduct from premium payments to cover items such as operational, acquisition and tax expenses. Loads last anywhere from 2 years to 7 years and are dependent upon issue age.\n\nPage 14 -Section 7.17- Governing Law & Form number\n\n[Missouri]\n\nThis the issue state of the policy. [Missouri] bracketed in the form number indicates that the state in the form number will change to match the state in Section 7.17.\n\n**ENDORSEMENT VARIABILTY**\n\nTitle and Schedule for Contract Number\n\nContract Number\n\nThe contract number is policyholder specific and varies with each policyholder.\n\nSection 5.2 and Schedule, page 3 (Guaranteed Minimum Annual Interest Rate)\n\nInterest rate credited on cash value\n\nIndicated as variable to allow for anticipated changes with passage of Section 7702 of the Consolidated Appropriations Act.\n\nSection 7.7\n\nInterest rate used to calculate minimum cash values\n\nIndicated as variable to allow for anticipated change with passage of the HEROES act. This would only be changed upon prior approval after demonstrating compliance with any new regulations.\n\nBottom of page\n\nOfficers’ signatures\n\nThese are the signatures of the company officers. They will change if or when officers are replaced.\n\n**Updated Policy SOV based on these endorsement changes**\n\nPage 4\n\nTable A – Monthly Loads\n\nThese items represent the maximum amounts the company may deduct from premium payments to cover items such as operational, acquisition and tax expenses. Loads last anywhere from 2 years to 6 years and are dependent upon issue age and smoker status.","publish_date":null,"title":"ENDORSEMENT VARIABILTY Title and Schedule for Contract Number Section 5.2 and Interest rate credited on Indicated as variable to allow","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page157.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page157.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page157","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page157.pdf"},"started_at":"2026-11-04T19:47:46.663193"} +{"completed_at":"2026-11-04T19:47:48.982631","latency_in_ms":1704,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page174","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit** **5**\n\nRating Class: Male & Unisex Preferred Specified Amount: $1,000\n\n**Table** **of** **Per** **$1,000** **Maximum** **First** **Year** **Excess** **Expense** **Allowances**\n\nSNFL Max Actual Unamortized Excess 1st Excess Excess 1st Issue Yr Expense Gross 1st Year Yr Expense Unamortized Excess First Year Expense Allowance End of Year \\* Age Allowance Premium \\*\\* Expenses Allowance 1 2 3 4 5 6 7 8 9 10\n\n20 15.77 393.81 ‐ 15.77 15.60 15.42 15.24 15.06 14.87 14.69 14.50 14.30 14.11 13.91 21 15.98 407.20 ‐ 15.98 15.79 15.61 15.42 15.23 15.04 14.85 14.65 14.45 14.24 14.04 22 16.18 414.71 ‐ 16.18 16.00 15.80 15.61 15.41 15.21 15.01 14.81 14.60 14.39 14.17 23 16.41 422.32 ‐ 16.41 16.21 16.01 15.81 15.60 15.40 15.18 14.97 14.75 14.54 14.32 24 16.64 430.02 ‐ 16.64 16.44 16.23 16.02 15.80 15.59 15.37 15.14 14.92 14.70 14.47 25 16.88 437.85 ‐ 16.88 16.67 16.45 16.23 16.01 15.79 15.56 15.33 15.10 14.87 14.63 26 17.14 445.79 ‐ 17.14 16.92 16.69 16.46 16.23 15.99 15.76 15.52 15.28 15.04 14.80 27 17.41 453.86 ‐ 17.41 17.18 16.94 16.71 16.47 16.22 15.98 15.73 15.49 15.24 14.99 28 17.70 462.06 ‐ 17.70 17.46 17.21 16.97 16.72 16.46 16.21 15.96 15.70 15.45 15.19 29 18.01 470.39 ‐ 18.01 17.76 17.50 17.24 16.98 16.72 16.46 16.20 15.94 15.67 15.41 30 18.34 478.86 ‐ 18.34 18.07 17.81 17.54 17.27 17.00 16.73 16.46 16.18 15.91 15.63 31 18.68 487.47 ‐ 18.68 18.41 18.13 17.85 17.57 17.29 17.01 16.73 16.45 16.16 15.87 32 19.04 496.23 ‐ 19.04 18.76 18.47 18.18 17.89 17.60 17.31 17.02 16.72 16.42 16.12 33 19.43 505.18 ‐ 19.43 19.13 18.83 18.53 18.23 17.93 17.62 17.32 17.01 16.70 16.38 34 19.82 514.24 ‐ 19.82 19.51 19.20 18.89 18.58 18.26 17.95 17.63 17.30 16.98 16.65 35 20.24 523.51 ‐ 20.24 19.91 19.59 19.27 18.94 18.61 18.28 17.95 17.61 17.27 16.93 36 20.67 532.91 ‐ 20.67 20.33 19.99 19.66 19.31 18.97 18.62 18.27 17.92 17.57 17.21 37 21.11 542.45 ‐ 21.11 20.76 20.41 20.05 19.70 19.34 18.98 18.61 18.24 17.87 17.50 38 21.57 552.09 ‐ 21.57 21.21 20.84 20.47 20.09 19.72 19.34 18.96 18.57 18.18 17.79 39 22.05 561.83 ‐ 22.05 21.67 21.28 20.89 20.50 20.11 19.71 19.31 18.91 18.50 18.09 40 22.55 571.69 ‐ 22.55 22.15 21.75 21.34 20.93 20.52 20.10 19.68 19.25 18.83 18.39 41 23.08 581.70 ‐ 23.08 22.66 22.24 21.81 21.38 20.94 20.50 20.06 19.62 19.17 18.71 42 23.64 591.79 ‐ 23.64 23.19 22.75 22.30 21.84 21.39 20.93 20.46 19.99 19.52 19.05 43 24.22 602.05 ‐ 24.22 23.75 23.28 22.81 22.33 21.85 21.36 20.87 20.38 19.89 19.39 44 24.83 612.48 ‐ 24.83 24.34 23.84 23.34 22.84 22.33 21.82 21.31 20.79 20.27 19.75 45 25.47 623.01 ‐ 25.47 24.95 24.43 23.90 23.37 22.84 22.30 21.76 21.22 20.67 20.13 46 26.15 633.71 ‐ 26.15 25.60 25.05 24.49 23.93 23.37 22.80 22.23 21.66 21.09 20.52 47 26.87 644.50 ‐ 26.87 26.29 25.70 25.11 24.52 23.93 23.33 22.74 22.14 21.53 20.93 48 27.63 655.31 ‐ 27.63 27.01 26.39 25.77 25.15 24.52 23.89 23.26 22.63 21.99 21.35 49 28.43 666.22 ‐ 28.43 27.78 27.13 26.47 25.81 25.15 24.49 23.82 23.15 22.48 21.80 50 29.29 677.19 ‐ 29.29 28.60 27.90 27.21 26.51 25.81 25.11 24.40 23.69 22.98 22.26 51 30.19 688.14 ‐ 30.19 29.46 28.73 27.99 27.26 26.51 25.77 25.02 24.26 23.51 22.75 52 31.16 699.20 ‐ 31.16 30.38 29.60 28.82 28.04 27.25 26.45 25.66 24.86 24.05 23.26 53 32.17 710.28 ‐ 32.17 31.35 30.52 29.69 28.85 28.01 27.17 26.32 25.47 24.63 23.78 54 33.25 721.40 ‐ 33.25 32.37 31.49 30.60 29.71 28.81 27.92 27.02 26.12 25.22 24.33 55 34.38 732.55 ‐ 34.38 33.45 32.50 31.56 30.61 29.65 28.70 27.74 26.79 25.84 24.90","pages":[{"line_numbers":[],"markdown":"**Exhibit** **5**\n\nRating Class: Male & Unisex Preferred Specified Amount: $1,000\n\n**Table** **of** **Per** **$1,000** **Maximum** **First** **Year** **Excess** **Expense** **Allowances**\n\nSNFL Max Actual Unamortized Excess 1st Excess Excess 1st Issue Yr Expense Gross 1st Year Yr Expense Unamortized Excess First Year Expense Allowance End of Year \\* Age Allowance Premium \\*\\* Expenses Allowance 1 2 3 4 5 6 7 8 9 10\n\n20 15.77 393.81 ‐ 15.77 15.60 15.42 15.24 15.06 14.87 14.69 14.50 14.30 14.11 13.91 21 15.98 407.20 ‐ 15.98 15.79 15.61 15.42 15.23 15.04 14.85 14.65 14.45 14.24 14.04 22 16.18 414.71 ‐ 16.18 16.00 15.80 15.61 15.41 15.21 15.01 14.81 14.60 14.39 14.17 23 16.41 422.32 ‐ 16.41 16.21 16.01 15.81 15.60 15.40 15.18 14.97 14.75 14.54 14.32 24 16.64 430.02 ‐ 16.64 16.44 16.23 16.02 15.80 15.59 15.37 15.14 14.92 14.70 14.47 25 16.88 437.85 ‐ 16.88 16.67 16.45 16.23 16.01 15.79 15.56 15.33 15.10 14.87 14.63 26 17.14 445.79 ‐ 17.14 16.92 16.69 16.46 16.23 15.99 15.76 15.52 15.28 15.04 14.80 27 17.41 453.86 ‐ 17.41 17.18 16.94 16.71 16.47 16.22 15.98 15.73 15.49 15.24 14.99 28 17.70 462.06 ‐ 17.70 17.46 17.21 16.97 16.72 16.46 16.21 15.96 15.70 15.45 15.19 29 18.01 470.39 ‐ 18.01 17.76 17.50 17.24 16.98 16.72 16.46 16.20 15.94 15.67 15.41 30 18.34 478.86 ‐ 18.34 18.07 17.81 17.54 17.27 17.00 16.73 16.46 16.18 15.91 15.63 31 18.68 487.47 ‐ 18.68 18.41 18.13 17.85 17.57 17.29 17.01 16.73 16.45 16.16 15.87 32 19.04 496.23 ‐ 19.04 18.76 18.47 18.18 17.89 17.60 17.31 17.02 16.72 16.42 16.12 33 19.43 505.18 ‐ 19.43 19.13 18.83 18.53 18.23 17.93 17.62 17.32 17.01 16.70 16.38 34 19.82 514.24 ‐ 19.82 19.51 19.20 18.89 18.58 18.26 17.95 17.63 17.30 16.98 16.65 35 20.24 523.51 ‐ 20.24 19.91 19.59 19.27 18.94 18.61 18.28 17.95 17.61 17.27 16.93 36 20.67 532.91 ‐ 20.67 20.33 19.99 19.66 19.31 18.97 18.62 18.27 17.92 17.57 17.21 37 21.11 542.45 ‐ 21.11 20.76 20.41 20.05 19.70 19.34 18.98 18.61 18.24 17.87 17.50 38 21.57 552.09 ‐ 21.57 21.21 20.84 20.47 20.09 19.72 19.34 18.96 18.57 18.18 17.79 39 22.05 561.83 ‐ 22.05 21.67 21.28 20.89 20.50 20.11 19.71 19.31 18.91 18.50 18.09 40 22.55 571.69 ‐ 22.55 22.15 21.75 21.34 20.93 20.52 20.10 19.68 19.25 18.83 18.39 41 23.08 581.70 ‐ 23.08 22.66 22.24 21.81 21.38 20.94 20.50 20.06 19.62 19.17 18.71 42 23.64 591.79 ‐ 23.64 23.19 22.75 22.30 21.84 21.39 20.93 20.46 19.99 19.52 19.05 43 24.22 602.05 ‐ 24.22 23.75 23.28 22.81 22.33 21.85 21.36 20.87 20.38 19.89 19.39 44 24.83 612.48 ‐ 24.83 24.34 23.84 23.34 22.84 22.33 21.82 21.31 20.79 20.27 19.75 45 25.47 623.01 ‐ 25.47 24.95 24.43 23.90 23.37 22.84 22.30 21.76 21.22 20.67 20.13 46 26.15 633.71 ‐ 26.15 25.60 25.05 24.49 23.93 23.37 22.80 22.23 21.66 21.09 20.52 47 26.87 644.50 ‐ 26.87 26.29 25.70 25.11 24.52 23.93 23.33 22.74 22.14 21.53 20.93 48 27.63 655.31 ‐ 27.63 27.01 26.39 25.77 25.15 24.52 23.89 23.26 22.63 21.99 21.35 49 28.43 666.22 ‐ 28.43 27.78 27.13 26.47 25.81 25.15 24.49 23.82 23.15 22.48 21.80 50 29.29 677.19 ‐ 29.29 28.60 27.90 27.21 26.51 25.81 25.11 24.40 23.69 22.98 22.26 51 30.19 688.14 ‐ 30.19 29.46 28.73 27.99 27.26 26.51 25.77 25.02 24.26 23.51 22.75 52 31.16 699.20 ‐ 31.16 30.38 29.60 28.82 28.04 27.25 26.45 25.66 24.86 24.05 23.26 53 32.17 710.28 ‐ 32.17 31.35 30.52 29.69 28.85 28.01 27.17 26.32 25.47 24.63 23.78 54 33.25 721.40 ‐ 33.25 32.37 31.49 30.60 29.71 28.81 27.92 27.02 26.12 25.22 24.33 55 34.38 732.55 ‐ 34.38 33.45 32.50 31.56 30.61 29.65 28.70 27.74 26.79 25.84 24.90","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit** **5**\n\nRating Class: Male & Unisex Preferred Specified Amount: $1,000\n\n**Table** **of** **Per** **$1,000** **Maximum** **First** **Year** **Excess** **Expense** **Allowances**\n\nSNFL Max Actual Unamortized Excess 1st Excess Excess 1st Issue Yr Expense Gross 1st Year Yr Expense Unamortized Excess First Year Expense Allowance End of Year \\* Age Allowance Premium \\*\\* Expenses Allowance 1 2 3 4 5 6 7 8 9 10\n\n20 15.77 393.81 ‐ 15.77 15.60 15.42 15.24 15.06 14.87 14.69 14.50 14.30 14.11 13.91 21 15.98 407.20 ‐ 15.98 15.79 15.61 15.42 15.23 15.04 14.85 14.65 14.45 14.24 14.04 22 16.18 414.71 ‐ 16.18 16.00 15.80 15.61 15.41 15.21 15.01 14.81 14.60 14.39 14.17 23 16.41 422.32 ‐ 16.41 16.21 16.01 15.81 15.60 15.40 15.18 14.97 14.75 14.54 14.32 24 16.64 430.02 ‐ 16.64 16.44 16.23 16.02 15.80 15.59 15.37 15.14 14.92 14.70 14.47 25 16.88 437.85 ‐ 16.88 16.67 16.45 16.23 16.01 15.79 15.56 15.33 15.10 14.87 14.63 26 17.14 445.79 ‐ 17.14 16.92 16.69 16.46 16.23 15.99 15.76 15.52 15.28 15.04 14.80 27 17.41 453.86 ‐ 17.41 17.18 16.94 16.71 16.47 16.22 15.98 15.73 15.49 15.24 14.99 28 17.70 462.06 ‐ 17.70 17.46 17.21 16.97 16.72 16.46 16.21 15.96 15.70 15.45 15.19 29 18.01 470.39 ‐ 18.01 17.76 17.50 17.24 16.98 16.72 16.46 16.20 15.94 15.67 15.41 30 18.34 478.86 ‐ 18.34 18.07 17.81 17.54 17.27 17.00 16.73 16.46 16.18 15.91 15.63 31 18.68 487.47 ‐ 18.68 18.41 18.13 17.85 17.57 17.29 17.01 16.73 16.45 16.16 15.87 32 19.04 496.23 ‐ 19.04 18.76 18.47 18.18 17.89 17.60 17.31 17.02 16.72 16.42 16.12 33 19.43 505.18 ‐ 19.43 19.13 18.83 18.53 18.23 17.93 17.62 17.32 17.01 16.70 16.38 34 19.82 514.24 ‐ 19.82 19.51 19.20 18.89 18.58 18.26 17.95 17.63 17.30 16.98 16.65 35 20.24 523.51 ‐ 20.24 19.91 19.59 19.27 18.94 18.61 18.28 17.95 17.61 17.27 16.93 36 20.67 532.91 �� 20.67 20.33 19.99 19.66 19.31 18.97 18.62 18.27 17.92 17.57 17.21 37 21.11 542.45 ‐ 21.11 20.76 20.41 20.05 19.70 19.34 18.98 18.61 18.24 17.87 17.50 38 21.57 552.09 ‐ 21.57 21.21 20.84 20.47 20.09 19.72 19.34 18.96 18.57 18.18 17.79 39 22.05 561.83 ‐ 22.05 21.67 21.28 20.89 20.50 20.11 19.71 19.31 18.91 18.50 18.09 40 22.55 571.69 ‐ 22.55 22.15 21.75 21.34 20.93 20.52 20.10 19.68 19.25 18.83 18.39 41 23.08 581.70 ‐ 23.08 22.66 22.24 21.81 21.38 20.94 20.50 20.06 19.62 19.17 18.71 42 23.64 591.79 ‐ 23.64 23.19 22.75 22.30 21.84 21.39 20.93 20.46 19.99 19.52 19.05 43 24.22 602.05 ‐ 24.22 23.75 23.28 22.81 22.33 21.85 21.36 20.87 20.38 19.89 19.39 44 24.83 612.48 ‐ 24.83 24.34 23.84 23.34 22.84 22.33 21.82 21.31 20.79 20.27 19.75 45 25.47 623.01 ‐ 25.47 24.95 24.43 23.90 23.37 22.84 22.30 21.76 21.22 20.67 20.13 46 26.15 633.71 ‐ 26.15 25.60 25.05 24.49 23.93 23.37 22.80 22.23 21.66 21.09 20.52 47 26.87 644.50 ‐ 26.87 26.29 25.70 25.11 24.52 23.93 23.33 22.74 22.14 21.53 20.93 48 27.63 655.31 ‐ 27.63 27.01 26.39 25.77 25.15 24.52 23.89 23.26 22.63 21.99 21.35 49 28.43 666.22 ‐ 28.43 27.78 27.13 26.47 25.81 25.15 24.49 23.82 23.15 22.48 21.80 50 29.29 677.19 ‐ 29.29 28.60 27.90 27.21 26.51 25.81 25.11 24.40 23.69 22.98 22.26 51 30.19 688.14 ‐ 30.19 29.46 28.73 27.99 27.26 26.51 25.77 25.02 24.26 23.51 22.75 52 31.16 699.20 ‐ 31.16 30.38 29.60 28.82 28.04 27.25 26.45 25.66 24.86 24.05 23.26 53 32.17 710.28 ‐ 32.17 31.35 30.52 29.69 28.85 28.01 27.17 26.32 25.47 24.63 23.78 54 33.25 721.40 ‐ 33.25 32.37 31.49 30.60 29.71 28.81 27.92 27.02 26.12 25.22 24.33 55 34.38 732.55 ‐ 34.38 33.45 32.50 31.56 30.61 29.65 28.70 27.74 26.79 25.84 24.90","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page174.pdf"]},"response":{"errors":[],"extract_id":"extract_b08a716dc26eb8095c00d7e5e8eb2eab","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit** **5**\n\nRating Class: Male & Unisex Preferred Specified Amount: $1,000\n\n**Table** **of** **Per** **$1,000** **Maximum** **First** **Year** **Excess** **Expense** **Allowances**\n\nSNFL Max Actual Unamortized Excess 1st Excess Excess 1st Issue Yr Expense Gross 1st Year Yr Expense Unamortized Excess First Year Expense Allowance End of Year \\* Age Allowance Premium \\*\\* Expenses Allowance 1 2 3 4 5 6 7 8 9 10\n\n20 15.77 393.81 ‐ 15.77 15.60 15.42 15.24 15.06 14.87 14.69 14.50 14.30 14.11 13.91 21 15.98 407.20 ‐ 15.98 15.79 15.61 15.42 15.23 15.04 14.85 14.65 14.45 14.24 14.04 22 16.18 414.71 ‐ 16.18 16.00 15.80 15.61 15.41 15.21 15.01 14.81 14.60 14.39 14.17 23 16.41 422.32 ‐ 16.41 16.21 16.01 15.81 15.60 15.40 15.18 14.97 14.75 14.54 14.32 24 16.64 430.02 ‐ 16.64 16.44 16.23 16.02 15.80 15.59 15.37 15.14 14.92 14.70 14.47 25 16.88 437.85 ‐ 16.88 16.67 16.45 16.23 16.01 15.79 15.56 15.33 15.10 14.87 14.63 26 17.14 445.79 ‐ 17.14 16.92 16.69 16.46 16.23 15.99 15.76 15.52 15.28 15.04 14.80 27 17.41 453.86 ‐ 17.41 17.18 16.94 16.71 16.47 16.22 15.98 15.73 15.49 15.24 14.99 28 17.70 462.06 ‐ 17.70 17.46 17.21 16.97 16.72 16.46 16.21 15.96 15.70 15.45 15.19 29 18.01 470.39 ‐ 18.01 17.76 17.50 17.24 16.98 16.72 16.46 16.20 15.94 15.67 15.41 30 18.34 478.86 ‐ 18.34 18.07 17.81 17.54 17.27 17.00 16.73 16.46 16.18 15.91 15.63 31 18.68 487.47 ‐ 18.68 18.41 18.13 17.85 17.57 17.29 17.01 16.73 16.45 16.16 15.87 32 19.04 496.23 ‐ 19.04 18.76 18.47 18.18 17.89 17.60 17.31 17.02 16.72 16.42 16.12 33 19.43 505.18 ‐ 19.43 19.13 18.83 18.53 18.23 17.93 17.62 17.32 17.01 16.70 16.38 34 19.82 514.24 ‐ 19.82 19.51 19.20 18.89 18.58 18.26 17.95 17.63 17.30 16.98 16.65 35 20.24 523.51 ‐ 20.24 19.91 19.59 19.27 18.94 18.61 18.28 17.95 17.61 17.27 16.93 36 20.67 532.91 ‐ 20.67 20.33 19.99 19.66 19.31 18.97 18.62 18.27 17.92 17.57 17.21 37 21.11 542.45 ‐ 21.11 20.76 20.41 20.05 19.70 19.34 18.98 18.61 18.24 17.87 17.50 38 21.57 552.09 ‐ 21.57 21.21 20.84 20.47 20.09 19.72 19.34 18.96 18.57 18.18 17.79 39 22.05 561.83 ‐ 22.05 21.67 21.28 20.89 20.50 20.11 19.71 19.31 18.91 18.50 18.09 40 22.55 571.69 ‐ 22.55 22.15 21.75 21.34 20.93 20.52 20.10 19.68 19.25 18.83 18.39 41 23.08 581.70 ‐ 23.08 22.66 22.24 21.81 21.38 20.94 20.50 20.06 19.62 19.17 18.71 42 23.64 591.79 ‐ 23.64 23.19 22.75 22.30 21.84 21.39 20.93 20.46 19.99 19.52 19.05 43 24.22 602.05 ‐ 24.22 23.75 23.28 22.81 22.33 21.85 21.36 20.87 20.38 19.89 19.39 44 24.83 612.48 ‐ 24.83 24.34 23.84 23.34 22.84 22.33 21.82 21.31 20.79 20.27 19.75 45 25.47 623.01 ‐ 25.47 24.95 24.43 23.90 23.37 22.84 22.30 21.76 21.22 20.67 20.13 46 26.15 633.71 ‐ 26.15 25.60 25.05 24.49 23.93 23.37 22.80 22.23 21.66 21.09 20.52 47 26.87 644.50 ‐ 26.87 26.29 25.70 25.11 24.52 23.93 23.33 22.74 22.14 21.53 20.93 48 27.63 655.31 ‐ 27.63 27.01 26.39 25.77 25.15 24.52 23.89 23.26 22.63 21.99 21.35 49 28.43 666.22 ‐ 28.43 27.78 27.13 26.47 25.81 25.15 24.49 23.82 23.15 22.48 21.80 50 29.29 677.19 ‐ 29.29 28.60 27.90 27.21 26.51 25.81 25.11 24.40 23.69 22.98 22.26 51 30.19 688.14 ‐ 30.19 29.46 28.73 27.99 27.26 26.51 25.77 25.02 24.26 23.51 22.75 52 31.16 699.20 ‐ 31.16 30.38 29.60 28.82 28.04 27.25 26.45 25.66 24.86 24.05 23.26 53 32.17 710.28 ‐ 32.17 31.35 30.52 29.69 28.85 28.01 27.17 26.32 25.47 24.63 23.78 54 33.25 721.40 ‐ 33.25 32.37 31.49 30.60 29.71 28.81 27.92 27.02 26.12 25.22 24.33 55 34.38 732.55 ‐ 34.38 33.45 32.50 31.56 30.61 29.65 28.70 27.74 26.79 25.84 24.90"],"full_content":"**Exhibit** **5**\n\nRating Class: Male & Unisex Preferred Specified Amount: $1,000\n\n**Table** **of** **Per** **$1,000** **Maximum** **First** **Year** **Excess** **Expense** **Allowances**\n\nSNFL Max Actual Unamortized Excess 1st Excess Excess 1st Issue Yr Expense Gross 1st Year Yr Expense Unamortized Excess First Year Expense Allowance End of Year \\* Age Allowance Premium \\*\\* Expenses Allowance 1 2 3 4 5 6 7 8 9 10\n\n20 15.77 393.81 ‐ 15.77 15.60 15.42 15.24 15.06 14.87 14.69 14.50 14.30 14.11 13.91 21 15.98 407.20 ‐ 15.98 15.79 15.61 15.42 15.23 15.04 14.85 14.65 14.45 14.24 14.04 22 16.18 414.71 ‐ 16.18 16.00 15.80 15.61 15.41 15.21 15.01 14.81 14.60 14.39 14.17 23 16.41 422.32 ‐ 16.41 16.21 16.01 15.81 15.60 15.40 15.18 14.97 14.75 14.54 14.32 24 16.64 430.02 ‐ 16.64 16.44 16.23 16.02 15.80 15.59 15.37 15.14 14.92 14.70 14.47 25 16.88 437.85 ‐ 16.88 16.67 16.45 16.23 16.01 15.79 15.56 15.33 15.10 14.87 14.63 26 17.14 445.79 ‐ 17.14 16.92 16.69 16.46 16.23 15.99 15.76 15.52 15.28 15.04 14.80 27 17.41 453.86 ‐ 17.41 17.18 16.94 16.71 16.47 16.22 15.98 15.73 15.49 15.24 14.99 28 17.70 462.06 ‐ 17.70 17.46 17.21 16.97 16.72 16.46 16.21 15.96 15.70 15.45 15.19 29 18.01 470.39 ‐ 18.01 17.76 17.50 17.24 16.98 16.72 16.46 16.20 15.94 15.67 15.41 30 18.34 478.86 ‐ 18.34 18.07 17.81 17.54 17.27 17.00 16.73 16.46 16.18 15.91 15.63 31 18.68 487.47 ‐ 18.68 18.41 18.13 17.85 17.57 17.29 17.01 16.73 16.45 16.16 15.87 32 19.04 496.23 ‐ 19.04 18.76 18.47 18.18 17.89 17.60 17.31 17.02 16.72 16.42 16.12 33 19.43 505.18 ‐ 19.43 19.13 18.83 18.53 18.23 17.93 17.62 17.32 17.01 16.70 16.38 34 19.82 514.24 ‐ 19.82 19.51 19.20 18.89 18.58 18.26 17.95 17.63 17.30 16.98 16.65 35 20.24 523.51 ‐ 20.24 19.91 19.59 19.27 18.94 18.61 18.28 17.95 17.61 17.27 16.93 36 20.67 532.91 ‐ 20.67 20.33 19.99 19.66 19.31 18.97 18.62 18.27 17.92 17.57 17.21 37 21.11 542.45 ‐ 21.11 20.76 20.41 20.05 19.70 19.34 18.98 18.61 18.24 17.87 17.50 38 21.57 552.09 ‐ 21.57 21.21 20.84 20.47 20.09 19.72 19.34 18.96 18.57 18.18 17.79 39 22.05 561.83 ‐ 22.05 21.67 21.28 20.89 20.50 20.11 19.71 19.31 18.91 18.50 18.09 40 22.55 571.69 ‐ 22.55 22.15 21.75 21.34 20.93 20.52 20.10 19.68 19.25 18.83 18.39 41 23.08 581.70 ‐ 23.08 22.66 22.24 21.81 21.38 20.94 20.50 20.06 19.62 19.17 18.71 42 23.64 591.79 ‐ 23.64 23.19 22.75 22.30 21.84 21.39 20.93 20.46 19.99 19.52 19.05 43 24.22 602.05 ‐ 24.22 23.75 23.28 22.81 22.33 21.85 21.36 20.87 20.38 19.89 19.39 44 24.83 612.48 ‐ 24.83 24.34 23.84 23.34 22.84 22.33 21.82 21.31 20.79 20.27 19.75 45 25.47 623.01 ‐ 25.47 24.95 24.43 23.90 23.37 22.84 22.30 21.76 21.22 20.67 20.13 46 26.15 633.71 ‐ 26.15 25.60 25.05 24.49 23.93 23.37 22.80 22.23 21.66 21.09 20.52 47 26.87 644.50 ‐ 26.87 26.29 25.70 25.11 24.52 23.93 23.33 22.74 22.14 21.53 20.93 48 27.63 655.31 ‐ 27.63 27.01 26.39 25.77 25.15 24.52 23.89 23.26 22.63 21.99 21.35 49 28.43 666.22 ‐ 28.43 27.78 27.13 26.47 25.81 25.15 24.49 23.82 23.15 22.48 21.80 50 29.29 677.19 ‐ 29.29 28.60 27.90 27.21 26.51 25.81 25.11 24.40 23.69 22.98 22.26 51 30.19 688.14 ‐ 30.19 29.46 28.73 27.99 27.26 26.51 25.77 25.02 24.26 23.51 22.75 52 31.16 699.20 ‐ 31.16 30.38 29.60 28.82 28.04 27.25 26.45 25.66 24.86 24.05 23.26 53 32.17 710.28 ‐ 32.17 31.35 30.52 29.69 28.85 28.01 27.17 26.32 25.47 24.63 23.78 54 33.25 721.40 ‐ 33.25 32.37 31.49 30.60 29.71 28.81 27.92 27.02 26.12 25.22 24.33 55 34.38 732.55 ‐ 34.38 33.45 32.50 31.56 30.61 29.65 28.70 27.74 26.79 25.84 24.90","publish_date":null,"title":"Exhibit 5 Rating Class: Male & Unisex Preferred Specified Amount: $1,000 Table of Per $1,000 Maximum First Year Excess Expense","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page174.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page174.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page174","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page174.pdf"},"started_at":"2026-11-04T19:47:47.278063"} +{"completed_at":"2026-11-04T19:47:49.977752","latency_in_ms":1565,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page178","grounded_pages":[],"layout_pages":[],"markdown":"### **NATIONWIDE LIFE INSURANCE COMPANY STATEMENT OF VARIABILITY**\n\n**ICC14-COLI-4049, Potential Rate Increase Disclosure Form** Variability in the above referenced form is listed as follows: Company Logo This is bracketed as it could possibly change over time.\n\nBusiness Group Name and location, Home Office address and telephone number\n\nThese items are bracketed in the form as they could possibly change over time.\n\nBracketed number in Rate Adjustments section This number can vary depending upon state required durations.","pages":[{"line_numbers":[],"markdown":"### **NATIONWIDE LIFE INSURANCE COMPANY STATEMENT OF VARIABILITY**\n\n**ICC14-COLI-4049, Potential Rate Increase Disclosure Form** Variability in the above referenced form is listed as follows: Company Logo This is bracketed as it could possibly change over time.\n\nBusiness Group Name and location, Home Office address and telephone number\n\nThese items are bracketed in the form as they could possibly change over time.\n\nBracketed number in Rate Adjustments section This number can vary depending upon state required durations.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **NATIONWIDE LIFE INSURANCE COMPANY STATEMENT OF VARIABILITY**\n\n**ICC14-COLI-4049, Potential Rate Increase Disclosure Form** Variability in the above referenced form is listed as follows: Company Logo This is bracketed as it could possibly change over time.\n\nBusiness Group Name and location, Home Office address and telephone number\n\nThese items are bracketed in the form as they could possibly change over time.\n\nBracketed number in Rate Adjustments section This number can vary depending upon state required durations.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page178.pdf"]},"response":{"errors":[],"extract_id":"extract_1814a41bbd190b2d47f75c02347bc45d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **NATIONWIDE LIFE INSURANCE COMPANY STATEMENT OF VARIABILITY**\n\n**ICC14-COLI-4049, Potential Rate Increase Disclosure Form** Variability in the above referenced form is listed as follows: Company Logo This is bracketed as it could possibly change over time.\n\nBusiness Group Name and location, Home Office address and telephone number\n\nThese items are bracketed in the form as they could possibly change over time.\n\nBracketed number in Rate Adjustments section This number can vary depending upon state required durations."],"full_content":"### **NATIONWIDE LIFE INSURANCE COMPANY STATEMENT OF VARIABILITY**\n\n**ICC14-COLI-4049, Potential Rate Increase Disclosure Form** Variability in the above referenced form is listed as follows: Company Logo This is bracketed as it could possibly change over time.\n\nBusiness Group Name and location, Home Office address and telephone number\n\nThese items are bracketed in the form as they could possibly change over time.\n\nBracketed number in Rate Adjustments section This number can vary depending upon state required durations.","publish_date":null,"title":"NATIONWIDE LIFE INSURANCE COMPANY STATEMENT OF VARIABILITY","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page178.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page178.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page178","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page178.pdf"},"started_at":"2026-11-04T19:47:48.412293"} +{"completed_at":"2026-11-04T19:47:51.732165","latency_in_ms":2380,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page205","grounded_pages":[],"layout_pages":[],"markdown":"**ICC21221-100DP-CSWL** **\\#27** **[3.5]**\n\n**\\#34**\n\n### **WP Rider Premium Schedule**\n\n**Policy Number:** **\\#2** **[00 000 000]**\n\n**Named Insured(s):** **\\#34A** [John Doe] **\\#34A** [Jane Doe]\n\n**Policy Year**\n\n**WP Rider Premium**\n\n**for Base Policy**\n\n**WP Rider Premium**\n\n**for LFD Rider**\n\n**WP Rider Premium for**\n\n**SLTR Rider**\n\n**WP Rider**\n\n**Premium for DOT**\n\n**Rider**\n\n**\\#34B** [2 **\\#34B** [$76.70 **\\#34B** [$52.61 **\\#34B** [$3.70 **\\#34B** [$53.60\n\n3 $76.70 $52.61 $3.70 $53.60\n\n4 $72.02 $52.61 $2.00 $28.90\n\n5 $72.02 $52.61 $2.00 $28.90\n\n6 $67.34 $69.65 $0.30 $4.45\n\n7 $67.34 $82.00 $0.30 $4.69\n\n8 $67.34 $87.69 $0.30 $4.94\n\n9 $67.34 $97.81 $0.30 $5.19\n\n10 $67.34 $108.43 $0.30] $5.68\n\n11 $67.34 $120.78 **\\#34C** [SLTR RIDER ENDS] $5.93\n\n12 $67.34 $142.03 $6.18\n\n13 $67.34 $165.49 $6.92\n\n14 $67.34 $187.97 $8.15\n\n15 $67.34 $209.21 $9.14\n\n16 $67.34 $243.54 $11.12\n\n17 $67.34 $271.45 $13.34\n\n18 $67.34 $310.97 $13.34\n\n19 $67.34 $348.52 $16.80\n\n20 $67.34 $394.21 $21.49\n\n21 $67.34 $435.71 $26.68\n\n22 $67.34 $482.14 $33.35\n\n23 $67.34 $538.71 $41.50\n\n24 $67.34 $597.00 $51.38\n\n25 $67.34 $666.41 $63.73\n\n26 $67.34 $741.49 $78.55\n\n27 $67.34 $802.75 $93.86\n\n28 $67.34 $861.54 $110.90\n\n29 $67.34 $927.49 $130.66\n\n30 $67.34] $1,007.76] $154.38]\n\n31]\n\n**\\#34C** [WP RIDER\n\nENDS]\n\n**\\#34C** [WP RIDER ENDS] **\\#34C** [WP RIDER\n\nENDS]\n\n**\\#34D** [The premium amounts shown assume there are no Dividend Accumulations or any Paid-Up Additional Insurance provided by this Base Policy or any attached riders.] **\\#34E** [The WP Rider Premiums for the Base Policy will end on the Scheduled Paid-Up Date. However, the rider will remain in effect until its expiry date as specified in the rider.] **\\#34F** [The premiums shown for the LFD Rider are based on the Scheduled LFD Rider Premiums shown on the LFD Rider Specifications Pages.] **\\#34G** [The premiums shown for the SLTR Rider are based on the Scheduled SLTR Rider Premiums shown on the SLTR Rider Specifications Pages.] **\\#34H** [The premiums shown for the DOT Rider are based on the Initial DOT Premium for Policy years 2-5 and the Current Term Rates for Policy years 6 and later shown on the DOT Rider Specifications Pages, assuming a constant DOT Target Face Amount of **\\#31A** [$100,000.00].]","pages":[{"line_numbers":[],"markdown":"**ICC21221-100DP-CSWL** **\\#27** **[3.5]**\n\n**\\#34**\n\n### **WP Rider Premium Schedule**\n\n**Policy Number:** **\\#2** **[00 000 000]**\n\n**Named Insured(s):** **\\#34A** [John Doe] **\\#34A** [Jane Doe]\n\n**Policy Year**\n\n**WP Rider Premium**\n\n**for Base Policy**\n\n**WP Rider Premium**\n\n**for LFD Rider**\n\n**WP Rider Premium for**\n\n**SLTR Rider**\n\n**WP Rider**\n\n**Premium for DOT**\n\n**Rider**\n\n**\\#34B** [2 **\\#34B** [$76.70 **\\#34B** [$52.61 **\\#34B** [$3.70 **\\#34B** [$53.60\n\n3 $76.70 $52.61 $3.70 $53.60\n\n4 $72.02 $52.61 $2.00 $28.90\n\n5 $72.02 $52.61 $2.00 $28.90\n\n6 $67.34 $69.65 $0.30 $4.45\n\n7 $67.34 $82.00 $0.30 $4.69\n\n8 $67.34 $87.69 $0.30 $4.94\n\n9 $67.34 $97.81 $0.30 $5.19\n\n10 $67.34 $108.43 $0.30] $5.68\n\n11 $67.34 $120.78 **\\#34C** [SLTR RIDER ENDS] $5.93\n\n12 $67.34 $142.03 $6.18\n\n13 $67.34 $165.49 $6.92\n\n14 $67.34 $187.97 $8.15\n\n15 $67.34 $209.21 $9.14\n\n16 $67.34 $243.54 $11.12\n\n17 $67.34 $271.45 $13.34\n\n18 $67.34 $310.97 $13.34\n\n19 $67.34 $348.52 $16.80\n\n20 $67.34 $394.21 $21.49\n\n21 $67.34 $435.71 $26.68\n\n22 $67.34 $482.14 $33.35\n\n23 $67.34 $538.71 $41.50\n\n24 $67.34 $597.00 $51.38\n\n25 $67.34 $666.41 $63.73\n\n26 $67.34 $741.49 $78.55\n\n27 $67.34 $802.75 $93.86\n\n28 $67.34 $861.54 $110.90\n\n29 $67.34 $927.49 $130.66\n\n30 $67.34] $1,007.76] $154.38]\n\n31]\n\n**\\#34C** [WP RIDER\n\nENDS]\n\n**\\#34C** [WP RIDER ENDS] **\\#34C** [WP RIDER\n\nENDS]\n\n**\\#34D** [The premium amounts shown assume there are no Dividend Accumulations or any Paid-Up Additional Insurance provided by this Base Policy or any attached riders.] **\\#34E** [The WP Rider Premiums for the Base Policy will end on the Scheduled Paid-Up Date. However, the rider will remain in effect until its expiry date as specified in the rider.] **\\#34F** [The premiums shown for the LFD Rider are based on the Scheduled LFD Rider Premiums shown on the LFD Rider Specifications Pages.] **\\#34G** [The premiums shown for the SLTR Rider are based on the Scheduled SLTR Rider Premiums shown on the SLTR Rider Specifications Pages.] **\\#34H** [The premiums shown for the DOT Rider are based on the Initial DOT Premium for Policy years 2-5 and the Current Term Rates for Policy years 6 and later shown on the DOT Rider Specifications Pages, assuming a constant DOT Target Face Amount of **\\#31A** [$100,000.00].]","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**ICC21221-100DP-CSWL** **\\#27** **[3.5]**\n\n**\\#34**\n\n### **WP Rider Premium Schedule**\n\n**Policy Number:** **\\#2** **[00 000 000]**\n\n**Named Insured(s):** **\\#34A** [John Doe] **\\#34A** [Jane Doe]\n\n**Policy Year**\n\n**WP Rider Premium**\n\n**for Base Policy**\n\n**WP Rider Premium**\n\n**for LFD Rider**\n\n**WP Rider Premium for**\n\n**SLTR Rider**\n\n**WP Rider**\n\n**Premium for DOT**\n\n**Rider**\n\n**\\#34B** [2 **\\#34B** [$76.70 **\\#34B** [$52.61 **\\#34B** [$3.70 **\\#34B** [$53.60\n\n3 $76.70 $52.61 $3.70 $53.60\n\n4 $72.02 $52.61 $2.00 $28.90\n\n5 $72.02 $52.61 $2.00 $28.90\n\n6 $67.34 $69.65 $0.30 $4.45\n\n7 $67.34 $82.00 $0.30 $4.69\n\n8 $67.34 $87.69 $0.30 $4.94\n\n9 $67.34 $97.81 $0.30 $5.19\n\n10 $67.34 $108.43 $0.30] $5.68\n\n11 $67.34 $120.78 **\\#34C** [SLTR RIDER ENDS] $5.93\n\n12 $67.34 $142.03 $6.18\n\n13 $67.34 $165.49 $6.92\n\n14 $67.34 $187.97 $8.15\n\n15 $67.34 $209.21 $9.14\n\n16 $67.34 $243.54 $11.12\n\n17 $67.34 $271.45 $13.34\n\n18 $67.34 $310.97 $13.34\n\n19 $67.34 $348.52 $16.80\n\n20 $67.34 $394.21 $21.49\n\n21 $67.34 $435.71 $26.68\n\n22 $67.34 $482.14 $33.35\n\n23 $67.34 $538.71 $41.50\n\n24 $67.34 $597.00 $51.38\n\n25 $67.34 $666.41 $63.73\n\n26 $67.34 $741.49 $78.55\n\n27 $67.34 $802.75 $93.86\n\n28 $67.34 $861.54 $110.90\n\n29 $67.34 $927.49 $130.66\n\n30 $67.34] $1,007.76] $154.38]\n\n31]\n\n**\\#34C** [WP RIDER\n\nENDS]\n\n**\\#34C** [WP RIDER ENDS] **\\#34C** [WP RIDER\n\nENDS]\n\n**\\#34D** [The premium amounts shown assume there are no Dividend Accumulations or any Paid-Up Additional Insurance provided by this Base Policy or any attached riders.] **\\#34E** [The WP Rider Premiums for the Base Policy will end on the Scheduled Paid-Up Date. However, the rider will remain in effect until its expiry date as specified in the rider.] **\\#34F** [The premiums shown for the LFD Rider are based on the Scheduled LFD Rider Premiums shown on the LFD Rider Specifications Pages.] **\\#34G** [The premiums shown for the SLTR Rider are based on the Scheduled SLTR Rider Premiums shown on the SLTR Rider Specifications Pages.] **\\#34H** [The premiums shown for the DOT Rider are based on the Initial DOT Premium for Policy years 2-5 and the Current Term Rates for Policy years 6 and later shown on the DOT Rider Specifications Pages, assuming a constant DOT Target Face Amount of **\\#31A** [$100,000.00].]","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page205.pdf"]},"response":{"errors":[],"extract_id":"extract_a31742140c451da3f07d1de4209cdc16","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**ICC21221-100DP-CSWL** **\\#27** **[3.5]**\n\n**\\#34**\n\n### **WP Rider Premium Schedule**\n\n**Policy Number:** **\\#2** **[00 000 000]**\n\n**Named Insured(s):** **\\#34A** [John Doe] **\\#34A** [Jane Doe]\n\n**Policy Year**\n\n**WP Rider Premium**\n\n**for Base Policy**\n\n**WP Rider Premium**\n\n**for LFD Rider**\n\n**WP Rider Premium for**\n\n**SLTR Rider**\n\n**WP Rider**\n\n**Premium for DOT**\n\n**Rider**\n\n**\\#34B** [2 **\\#34B** [$76.70 **\\#34B** [$52.61 **\\#34B** [$3.70 **\\#34B** [$53.60\n\n3 $76.70 $52.61 $3.70 $53.60\n\n4 $72.02 $52.61 $2.00 $28.90\n\n5 $72.02 $52.61 $2.00 $28.90\n\n6 $67.34 $69.65 $0.30 $4.45\n\n7 $67.34 $82.00 $0.30 $4.69\n\n8 $67.34 $87.69 $0.30 $4.94\n\n9 $67.34 $97.81 $0.30 $5.19\n\n10 $67.34 $108.43 $0.30] $5.68\n\n11 $67.34 $120.78 **\\#34C** [SLTR RIDER ENDS] $5.93\n\n12 $67.34 $142.03 $6.18\n\n13 $67.34 $165.49 $6.92\n\n14 $67.34 $187.97 $8.15\n\n15 $67.34 $209.21 $9.14\n\n16 $67.34 $243.54 $11.12\n\n17 $67.34 $271.45 $13.34\n\n18 $67.34 $310.97 $13.34\n\n19 $67.34 $348.52 $16.80\n\n20 $67.34 $394.21 $21.49\n\n21 $67.34 $435.71 $26.68\n\n22 $67.34 $482.14 $33.35\n\n23 $67.34 $538.71 $41.50\n\n24 $67.34 $597.00 $51.38\n\n25 $67.34 $666.41 $63.73\n\n26 $67.34 $741.49 $78.55\n\n27 $67.34 $802.75 $93.86\n\n28 $67.34 $861.54 $110.90\n\n29 $67.34 $927.49 $130.66\n\n30 $67.34] $1,007.76] $154.38]\n\n31]\n\n**\\#34C** [WP RIDER\n\nENDS]\n\n**\\#34C** [WP RIDER ENDS] **\\#34C** [WP RIDER\n\nENDS]\n\n**\\#34D** [The premium amounts shown assume there are no Dividend Accumulations or any Paid-Up Additional Insurance provided by this Base Policy or any attached riders.] **\\#34E** [The WP Rider Premiums for the Base Policy will end on the Scheduled Paid-Up Date. However, the rider will remain in effect until its expiry date as specified in the rider.] **\\#34F** [The premiums shown for the LFD Rider are based on the Scheduled LFD Rider Premiums shown on the LFD Rider Specifications Pages.] **\\#34G** [The premiums shown for the SLTR Rider are based on the Scheduled SLTR Rider Premiums shown on the SLTR Rider Specifications Pages.] **\\#34H** [The premiums shown for the DOT Rider are based on the Initial DOT Premium for Policy years 2-5 and the Current Term Rates for Policy years 6 and later shown on the DOT Rider Specifications Pages, assuming a constant DOT Target Face Amount of **\\#31A** [$100,000.00].]"],"full_content":"**ICC21221-100DP-CSWL** **\\#27** **[3.5]**\n\n**\\#34**\n\n### **WP Rider Premium Schedule**\n\n**Policy Number:** **\\#2** **[00 000 000]**\n\n**Named Insured(s):** **\\#34A** [John Doe] **\\#34A** [Jane Doe]\n\n**Policy Year**\n\n**WP Rider Premium**\n\n**for Base Policy**\n\n**WP Rider Premium**\n\n**for LFD Rider**\n\n**WP Rider Premium for**\n\n**SLTR Rider**\n\n**WP Rider**\n\n**Premium for DOT**\n\n**Rider**\n\n**\\#34B** [2 **\\#34B** [$76.70 **\\#34B** [$52.61 **\\#34B** [$3.70 **\\#34B** [$53.60\n\n3 $76.70 $52.61 $3.70 $53.60\n\n4 $72.02 $52.61 $2.00 $28.90\n\n5 $72.02 $52.61 $2.00 $28.90\n\n6 $67.34 $69.65 $0.30 $4.45\n\n7 $67.34 $82.00 $0.30 $4.69\n\n8 $67.34 $87.69 $0.30 $4.94\n\n9 $67.34 $97.81 $0.30 $5.19\n\n10 $67.34 $108.43 $0.30] $5.68\n\n11 $67.34 $120.78 **\\#34C** [SLTR RIDER ENDS] $5.93\n\n12 $67.34 $142.03 $6.18\n\n13 $67.34 $165.49 $6.92\n\n14 $67.34 $187.97 $8.15\n\n15 $67.34 $209.21 $9.14\n\n16 $67.34 $243.54 $11.12\n\n17 $67.34 $271.45 $13.34\n\n18 $67.34 $310.97 $13.34\n\n19 $67.34 $348.52 $16.80\n\n20 $67.34 $394.21 $21.49\n\n21 $67.34 $435.71 $26.68\n\n22 $67.34 $482.14 $33.35\n\n23 $67.34 $538.71 $41.50\n\n24 $67.34 $597.00 $51.38\n\n25 $67.34 $666.41 $63.73\n\n26 $67.34 $741.49 $78.55\n\n27 $67.34 $802.75 $93.86\n\n28 $67.34 $861.54 $110.90\n\n29 $67.34 $927.49 $130.66\n\n30 $67.34] $1,007.76] $154.38]\n\n31]\n\n**\\#34C** [WP RIDER\n\nENDS]\n\n**\\#34C** [WP RIDER ENDS] **\\#34C** [WP RIDER\n\nENDS]\n\n**\\#34D** [The premium amounts shown assume there are no Dividend Accumulations or any Paid-Up Additional Insurance provided by this Base Policy or any attached riders.] **\\#34E** [The WP Rider Premiums for the Base Policy will end on the Scheduled Paid-Up Date. However, the rider will remain in effect until its expiry date as specified in the rider.] **\\#34F** [The premiums shown for the LFD Rider are based on the Scheduled LFD Rider Premiums shown on the LFD Rider Specifications Pages.] **\\#34G** [The premiums shown for the SLTR Rider are based on the Scheduled SLTR Rider Premiums shown on the SLTR Rider Specifications Pages.] **\\#34H** [The premiums shown for the DOT Rider are based on the Initial DOT Premium for Policy years 2-5 and the Current Term Rates for Policy years 6 and later shown on the DOT Rider Specifications Pages, assuming a constant DOT Target Face Amount of **\\#31A** [$100,000.00].]","publish_date":null,"title":"WP Rider Premium Schedule","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page205.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page205.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page205","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page205.pdf"},"started_at":"2026-11-04T19:47:49.351804"} +{"completed_at":"2026-11-04T19:47:52.870091","latency_in_ms":2532,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page222","grounded_pages":[],"layout_pages":[],"markdown":"PACIFIC GUARDIAN LIFE INSURANCE COMPANY, LIMITED\n\nACCUMULATOR ONE (FORM ICC19 AC1901)\n\nUpdated Filing to Show Compliance at Nonforfeiture Rate of 3.00%\n\nActuarial Memorandum\n\n**Appendix A - DEATH BENEFIT CORRIDOR PERCENTAGES TABLE**\n\nMALE FEMALE\n\nAttained Age\n\nPremier\n\nPreferred Non-\n\nTobacco\n\nPreferred Non-\n\nTobacco\n\nStandard Non-\n\nTobacco\n\nStandard Tobacco\n\nPremier\n\nPreferred Non-\n\nTobacco\n\nPreferred Non-\n\nTobacco\n\nStandard Non-\n\nTobacco\n\nStandard Tobacco\n\n59 208% 208% 208% 179% 224% 224% 224% 188%\n\n60 203% 203% 203% 175% 219% 219% 219% 184%\n\n61 198% 198% 198% 171% 213% 213% 213% 180%\n\n62 193% 193% 193% 168% 208% 208% 208% 176%\n\n63 189% 189% 189% 164% 203% 203% 203% 173%\n\n64 184% 184% 184% 161% 198% 198% 198% 169%\n\n65 180% 180% 180% 158% 193% 193% 193% 166%\n\n66 176% 176% 176% 155% 188% 188% 188% 162%\n\n67 172% 172% 172% 152% 183% 183% 183% 159%\n\n68 168% 168% 168% 150% 179% 179% 179% 156%\n\n69 164% 164% 164% 147% 175% 175% 175% 153%\n\n70 160% 160% 160% 145% 171% 171% 171% 151%\n\n71 157% 157% 157% 142% 167% 167% 167% 148%\n\n72 154% 154% 154% 140% 163% 163% 163% 146%\n\n73 150% 150% 150% 138% 159% 159% 159% 143%\n\n74 147% 147% 147% 136% 156% 156% 156% 141%\n\n75 144% 144% 144% 134% 152% 152% 152% 138%\n\n76 142% 142% 142% 133% 149% 149% 149% 136%\n\n77 139% 139% 139% 131% 146% 146% 146% 134%\n\n78 136% 136% 136% 129% 143% 143% 143% 132%\n\n79 134% 134% 134% 128% 140% 140% 140% 130%\n\n80 132% 132% 132% 126% 137% 137% 137% 128%\n\n81 129% 129% 129% 125% 135% 135% 135% 126%\n\n82 127% 127% 127% 123% 132% 132% 132% 125%\n\n83 125% 125% 125% 122% 130% 130% 130% 123%\n\n84 123% 123% 123% 120% 128% 128% 128% 121%\n\n85 122% 122% 122% 119% 126% 126% 126% 120%\n\n86 120% 120% 120% 118% 124% 124% 124% 119%\n\n87 118% 118% 118% 117% 122% 122% 122% 118%\n\n88 117% 117% 117% 115% 120% 120% 120% 116%\n\n89 116% 116% 116% 114% 119% 119% 119% 115%\n\n90 115% 115% 115% 114% 117% 117% 117% 114%\n\n91 113% 113% 113% 113% 116% 116% 116% 113%\n\n92 112% 112% 112% 112% 114% 114% 114% 113%\n\n93 112% 112% 112% 111% 113% 113% 113% 112%\n\n94 111% 111% 111% 110% 112% 112% 112% 111%\n\n95 110% 110% 110% 109% 110% 110% 110% 110%\n\n96 109% 109% 109% 108% 109% 109% 109% 109%\n\n97 107% 107% 107% 107% 108% 108% 108% 107%\n\n98 106% 106% 106% 106% 106% 106% 106% 106%\n\n99 104% 104% 104% 104% 104% 104% 104% 104%\n\n100+ 100% 100% 100% 100% 100% 100% 100% 100%\n\n6","pages":[{"line_numbers":[],"markdown":"PACIFIC GUARDIAN LIFE INSURANCE COMPANY, LIMITED\n\nACCUMULATOR ONE (FORM ICC19 AC1901)\n\nUpdated Filing to Show Compliance at Nonforfeiture Rate of 3.00%\n\nActuarial Memorandum\n\n**Appendix A - DEATH BENEFIT CORRIDOR PERCENTAGES TABLE**\n\nMALE FEMALE\n\nAttained Age\n\nPremier\n\nPreferred Non-\n\nTobacco\n\nPreferred Non-\n\nTobacco\n\nStandard Non-\n\nTobacco\n\nStandard Tobacco\n\nPremier\n\nPreferred Non-\n\nTobacco\n\nPreferred Non-\n\nTobacco\n\nStandard Non-\n\nTobacco\n\nStandard Tobacco\n\n59 208% 208% 208% 179% 224% 224% 224% 188%\n\n60 203% 203% 203% 175% 219% 219% 219% 184%\n\n61 198% 198% 198% 171% 213% 213% 213% 180%\n\n62 193% 193% 193% 168% 208% 208% 208% 176%\n\n63 189% 189% 189% 164% 203% 203% 203% 173%\n\n64 184% 184% 184% 161% 198% 198% 198% 169%\n\n65 180% 180% 180% 158% 193% 193% 193% 166%\n\n66 176% 176% 176% 155% 188% 188% 188% 162%\n\n67 172% 172% 172% 152% 183% 183% 183% 159%\n\n68 168% 168% 168% 150% 179% 179% 179% 156%\n\n69 164% 164% 164% 147% 175% 175% 175% 153%\n\n70 160% 160% 160% 145% 171% 171% 171% 151%\n\n71 157% 157% 157% 142% 167% 167% 167% 148%\n\n72 154% 154% 154% 140% 163% 163% 163% 146%\n\n73 150% 150% 150% 138% 159% 159% 159% 143%\n\n74 147% 147% 147% 136% 156% 156% 156% 141%\n\n75 144% 144% 144% 134% 152% 152% 152% 138%\n\n76 142% 142% 142% 133% 149% 149% 149% 136%\n\n77 139% 139% 139% 131% 146% 146% 146% 134%\n\n78 136% 136% 136% 129% 143% 143% 143% 132%\n\n79 134% 134% 134% 128% 140% 140% 140% 130%\n\n80 132% 132% 132% 126% 137% 137% 137% 128%\n\n81 129% 129% 129% 125% 135% 135% 135% 126%\n\n82 127% 127% 127% 123% 132% 132% 132% 125%\n\n83 125% 125% 125% 122% 130% 130% 130% 123%\n\n84 123% 123% 123% 120% 128% 128% 128% 121%\n\n85 122% 122% 122% 119% 126% 126% 126% 120%\n\n86 120% 120% 120% 118% 124% 124% 124% 119%\n\n87 118% 118% 118% 117% 122% 122% 122% 118%\n\n88 117% 117% 117% 115% 120% 120% 120% 116%\n\n89 116% 116% 116% 114% 119% 119% 119% 115%\n\n90 115% 115% 115% 114% 117% 117% 117% 114%\n\n91 113% 113% 113% 113% 116% 116% 116% 113%\n\n92 112% 112% 112% 112% 114% 114% 114% 113%\n\n93 112% 112% 112% 111% 113% 113% 113% 112%\n\n94 111% 111% 111% 110% 112% 112% 112% 111%\n\n95 110% 110% 110% 109% 110% 110% 110% 110%\n\n96 109% 109% 109% 108% 109% 109% 109% 109%\n\n97 107% 107% 107% 107% 108% 108% 108% 107%\n\n98 106% 106% 106% 106% 106% 106% 106% 106%\n\n99 104% 104% 104% 104% 104% 104% 104% 104%\n\n100+ 100% 100% 100% 100% 100% 100% 100% 100%\n\n6","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"PACIFIC GUARDIAN LIFE INSURANCE COMPANY, LIMITED\n\nACCUMULATOR ONE (FORM ICC19 AC1901)\n\nUpdated Filing to Show Compliance at Nonforfeiture Rate of 3.00%\n\nActuarial Memorandum\n\n**Appendix A - DEATH BENEFIT CORRIDOR PERCENTAGES TABLE**\n\nMALE FEMALE\n\nAttained Age\n\nPremier\n\nPreferred Non-\n\nTobacco\n\nPreferred Non-\n\nTobacco\n\nStandard Non-\n\nTobacco\n\nStandard Tobacco\n\nPremier\n\nPreferred Non-\n\nTobacco\n\nPreferred Non-\n\nTobacco\n\nStandard Non-\n\nTobacco\n\nStandard Tobacco\n\n59 208% 208% 208% 179% 224% 224% 224% 188%\n\n60 203% 203% 203% 175% 219% 219% 219% 184%\n\n61 198% 198% 198% 171% 213% 213% 213% 180%\n\n62 193% 193% 193% 168% 208% 208% 208% 176%\n\n63 189% 189% 189% 164% 203% 203% 203% 173%\n\n64 184% 184% 184% 161% 198% 198% 198% 169%\n\n65 180% 180% 180% 158% 193% 193% 193% 166%\n\n66 176% 176% 176% 155% 188% 188% 188% 162%\n\n67 172% 172% 172% 152% 183% 183% 183% 159%\n\n68 168% 168% 168% 150% 179% 179% 179% 156%\n\n69 164% 164% 164% 147% 175% 175% 175% 153%\n\n70 160% 160% 160% 145% 171% 171% 171% 151%\n\n71 157% 157% 157% 142% 167% 167% 167% 148%\n\n72 154% 154% 154% 140% 163% 163% 163% 146%\n\n73 150% 150% 150% 138% 159% 159% 159% 143%\n\n74 147% 147% 147% 136% 156% 156% 156% 141%\n\n75 144% 144% 144% 134% 152% 152% 152% 138%\n\n76 142% 142% 142% 133% 149% 149% 149% 136%\n\n77 139% 139% 139% 131% 146% 146% 146% 134%\n\n78 136% 136% 136% 129% 143% 143% 143% 132%\n\n79 134% 134% 134% 128% 140% 140% 140% 130%\n\n80 132% 132% 132% 126% 137% 137% 137% 128%\n\n81 129% 129% 129% 125% 135% 135% 135% 126%\n\n82 127% 127% 127% 123% 132% 132% 132% 125%\n\n83 125% 125% 125% 122% 130% 130% 130% 123%\n\n84 123% 123% 123% 120% 128% 128% 128% 121%\n\n85 122% 122% 122% 119% 126% 126% 126% 120%\n\n86 120% 120% 120% 118% 124% 124% 124% 119%\n\n87 118% 118% 118% 117% 122% 122% 122% 118%\n\n88 117% 117% 117% 115% 120% 120% 120% 116%\n\n89 116% 116% 116% 114% 119% 119% 119% 115%\n\n90 115% 115% 115% 114% 117% 117% 117% 114%\n\n91 113% 113% 113% 113% 116% 116% 116% 113%\n\n92 112% 112% 112% 112% 114% 114% 114% 113%\n\n93 112% 112% 112% 111% 113% 113% 113% 112%\n\n94 111% 111% 111% 110% 112% 112% 112% 111%\n\n95 110% 110% 110% 109% 110% 110% 110% 110%\n\n96 109% 109% 109% 108% 109% 109% 109% 109%\n\n97 107% 107% 107% 107% 108% 108% 108% 107%\n\n98 106% 106% 106% 106% 106% 106% 106% 106%\n\n99 104% 104% 104% 104% 104% 104% 104% 104%\n\n100+ 100% 100% 100% 100% 100% 100% 100% 100%\n\n6","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page222.pdf"]},"response":{"errors":[],"extract_id":"extract_ab8365f8f6611aca9ae1456f90d11f02","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["PACIFIC GUARDIAN LIFE INSURANCE COMPANY, LIMITED\n\nACCUMULATOR ONE (FORM ICC19 AC1901)\n\nUpdated Filing to Show Compliance at Nonforfeiture Rate of 3.00%\n\nActuarial Memorandum\n\n**Appendix A - DEATH BENEFIT CORRIDOR PERCENTAGES TABLE**\n\nMALE FEMALE\n\nAttained Age\n\nPremier\n\nPreferred Non-\n\nTobacco\n\nPreferred Non-\n\nTobacco\n\nStandard Non-\n\nTobacco\n\nStandard Tobacco\n\nPremier\n\nPreferred Non-\n\nTobacco\n\nPreferred Non-\n\nTobacco\n\nStandard Non-\n\nTobacco\n\nStandard Tobacco\n\n59 208% 208% 208% 179% 224% 224% 224% 188%\n\n60 203% 203% 203% 175% 219% 219% 219% 184%\n\n61 198% 198% 198% 171% 213% 213% 213% 180%\n\n62 193% 193% 193% 168% 208% 208% 208% 176%\n\n63 189% 189% 189% 164% 203% 203% 203% 173%\n\n64 184% 184% 184% 161% 198% 198% 198% 169%\n\n65 180% 180% 180% 158% 193% 193% 193% 166%\n\n66 176% 176% 176% 155% 188% 188% 188% 162%\n\n67 172% 172% 172% 152% 183% 183% 183% 159%\n\n68 168% 168% 168% 150% 179% 179% 179% 156%\n\n69 164% 164% 164% 147% 175% 175% 175% 153%\n\n70 160% 160% 160% 145% 171% 171% 171% 151%\n\n71 157% 157% 157% 142% 167% 167% 167% 148%\n\n72 154% 154% 154% 140% 163% 163% 163% 146%\n\n73 150% 150% 150% 138% 159% 159% 159% 143%\n\n74 147% 147% 147% 136% 156% 156% 156% 141%\n\n75 144% 144% 144% 134% 152% 152% 152% 138%\n\n76 142% 142% 142% 133% 149% 149% 149% 136%\n\n77 139% 139% 139% 131% 146% 146% 146% 134%\n\n78 136% 136% 136% 129% 143% 143% 143% 132%\n\n79 134% 134% 134% 128% 140% 140% 140% 130%\n\n80 132% 132% 132% 126% 137% 137% 137% 128%\n\n81 129% 129% 129% 125% 135% 135% 135% 126%\n\n82 127% 127% 127% 123% 132% 132% 132% 125%\n\n83 125% 125% 125% 122% 130% 130% 130% 123%\n\n84 123% 123% 123% 120% 128% 128% 128% 121%\n\n85 122% 122% 122% 119% 126% 126% 126% 120%\n\n86 120% 120% 120% 118% 124% 124% 124% 119%\n\n87 118% 118% 118% 117% 122% 122% 122% 118%\n\n88 117% 117% 117% 115% 120% 120% 120% 116%\n\n89 116% 116% 116% 114% 119% 119% 119% 115%\n\n90 115% 115% 115% 114% 117% 117% 117% 114%\n\n91 113% 113% 113% 113% 116% 116% 116% 113%\n\n92 112% 112% 112% 112% 114% 114% 114% 113%\n\n93 112% 112% 112% 111% 113% 113% 113% 112%\n\n94 111% 111% 111% 110% 112% 112% 112% 111%\n\n95 110% 110% 110% 109% 110% 110% 110% 110%\n\n96 109% 109% 109% 108% 109% 109% 109% 109%\n\n97 107% 107% 107% 107% 108% 108% 108% 107%\n\n98 106% 106% 106% 106% 106% 106% 106% 106%\n\n99 104% 104% 104% 104% 104% 104% 104% 104%\n\n100+ 100% 100% 100% 100% 100% 100% 100% 100%\n\n6"],"full_content":"PACIFIC GUARDIAN LIFE INSURANCE COMPANY, LIMITED\n\nACCUMULATOR ONE (FORM ICC19 AC1901)\n\nUpdated Filing to Show Compliance at Nonforfeiture Rate of 3.00%\n\nActuarial Memorandum\n\n**Appendix A - DEATH BENEFIT CORRIDOR PERCENTAGES TABLE**\n\nMALE FEMALE\n\nAttained Age\n\nPremier\n\nPreferred Non-\n\nTobacco\n\nPreferred Non-\n\nTobacco\n\nStandard Non-\n\nTobacco\n\nStandard Tobacco\n\nPremier\n\nPreferred Non-\n\nTobacco\n\nPreferred Non-\n\nTobacco\n\nStandard Non-\n\nTobacco\n\nStandard Tobacco\n\n59 208% 208% 208% 179% 224% 224% 224% 188%\n\n60 203% 203% 203% 175% 219% 219% 219% 184%\n\n61 198% 198% 198% 171% 213% 213% 213% 180%\n\n62 193% 193% 193% 168% 208% 208% 208% 176%\n\n63 189% 189% 189% 164% 203% 203% 203% 173%\n\n64 184% 184% 184% 161% 198% 198% 198% 169%\n\n65 180% 180% 180% 158% 193% 193% 193% 166%\n\n66 176% 176% 176% 155% 188% 188% 188% 162%\n\n67 172% 172% 172% 152% 183% 183% 183% 159%\n\n68 168% 168% 168% 150% 179% 179% 179% 156%\n\n69 164% 164% 164% 147% 175% 175% 175% 153%\n\n70 160% 160% 160% 145% 171% 171% 171% 151%\n\n71 157% 157% 157% 142% 167% 167% 167% 148%\n\n72 154% 154% 154% 140% 163% 163% 163% 146%\n\n73 150% 150% 150% 138% 159% 159% 159% 143%\n\n74 147% 147% 147% 136% 156% 156% 156% 141%\n\n75 144% 144% 144% 134% 152% 152% 152% 138%\n\n76 142% 142% 142% 133% 149% 149% 149% 136%\n\n77 139% 139% 139% 131% 146% 146% 146% 134%\n\n78 136% 136% 136% 129% 143% 143% 143% 132%\n\n79 134% 134% 134% 128% 140% 140% 140% 130%\n\n80 132% 132% 132% 126% 137% 137% 137% 128%\n\n81 129% 129% 129% 125% 135% 135% 135% 126%\n\n82 127% 127% 127% 123% 132% 132% 132% 125%\n\n83 125% 125% 125% 122% 130% 130% 130% 123%\n\n84 123% 123% 123% 120% 128% 128% 128% 121%\n\n85 122% 122% 122% 119% 126% 126% 126% 120%\n\n86 120% 120% 120% 118% 124% 124% 124% 119%\n\n87 118% 118% 118% 117% 122% 122% 122% 118%\n\n88 117% 117% 117% 115% 120% 120% 120% 116%\n\n89 116% 116% 116% 114% 119% 119% 119% 115%\n\n90 115% 115% 115% 114% 117% 117% 117% 114%\n\n91 113% 113% 113% 113% 116% 116% 116% 113%\n\n92 112% 112% 112% 112% 114% 114% 114% 113%\n\n93 112% 112% 112% 111% 113% 113% 113% 112%\n\n94 111% 111% 111% 110% 112% 112% 112% 111%\n\n95 110% 110% 110% 109% 110% 110% 110% 110%\n\n96 109% 109% 109% 108% 109% 109% 109% 109%\n\n97 107% 107% 107% 107% 108% 108% 108% 107%\n\n98 106% 106% 106% 106% 106% 106% 106% 106%\n\n99 104% 104% 104% 104% 104% 104% 104% 104%\n\n100+ 100% 100% 100% 100% 100% 100% 100% 100%\n\n6","publish_date":null,"title":"PACIFIC GUARDIAN LIFE INSURANCE COMPANY, LIMITED ACCUMULATOR ONE (FORM ICC19 AC1901) Updated Filing to Show Compliance at Nonforfeiture Rate of","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page222.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page222.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page222","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page222.pdf"},"started_at":"2026-11-04T19:47:50.337565"} +{"completed_at":"2026-11-04T19:47:54.299571","latency_in_ms":2748,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page224","grounded_pages":[],"layout_pages":[],"markdown":"ICC19 AC1901 3.4\n\n**_POLICY INFORMATION_** \\- POLICY NUMBER [0123456789]\n\n**TABLE OF PERCENTAGES**\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\n[35 [389.00%[583.0\n\n0% 57 219.00%278.\n\n00% 79 134.00%146.0\n\n0%\n\n36 378.00%563.00\n\n% 58 214.00%269.\n\n00% 80 132.00%143.0\n\n0%\n\n37 368.00%544.00\n\n% 59 208.00%260.\n\n00% 81 129.00%140.0\n\n0%\n\n38 359.00%526.00\n\n% 60 203.00%252.\n\n00% 82 127.00%137.0\n\n0%\n\n39 349.00%508.00\n\n% 61 198.00%244.\n\n00% 83 125.00%134.0\n\n0%\n\n40 340.00%491.00\n\n% 62 193.00%236.\n\n00% 84 123.00%131.0\n\n0%\n\n41 331.00%475.00\n\n% 63 189.00%229.\n\n00% 85 122.00%129.0\n\n0%\n\n42 323.00%459.00\n\n% 64 184.00%222.\n\n00% 86 120.00%127.0\n\n0%\n\n43 315.00%444.00\n\n% 65 180.00%215.\n\n00% 87 118.00%125.0\n\n0%\n\n44 306.00%429.00\n\n% 66 176.00%208.\n\n00% 88 117.00%123.0\n\n0%\n\n45 299.00%415.00\n\n% 67 172.00%202.\n\n00% 89 116.00%121.0\n\n0%\n\n46 291.00%401.00\n\n% 68 168.00%196.\n\n00% 90 115.00%119.0\n\n0%\n\n47 283.00%388.00\n\n% 69 164.00%191.\n\n00% 91 113.00%118.0\n\n0%\n\n48 276.00%375.00\n\n% 70 160.00%185.\n\n00% 92 112.00%117.0\n\n0%\n\n49 269.00%363.00\n\n% 71 157.00%180.\n\n00% 93 112.00%115.0\n\n0%\n\n50 262.00%351.00\n\n% 72 154.00%175.\n\n00% 94 111.00%114.0\n\n0%\n\n51 255.00%339.00\n\n% 73 150.00%170.\n\n00% 95 110.00%113.0\n\n0%\n\n52 249.00%328.00\n\n% 74 147.00%166.\n\n00% 96 109.00%111.0\n\n0%\n\n53 243.00%317.00\n\n% 75 144.00%161.\n\n00% 97 107.00%110.0\n\n0%\n\n54 236.00%306.00\n\n% 76 142.00%157.\n\n00% 98 106.00%107.0\n\n0%\n\n55 230.00%297.00\n\n% 77 139.00%153.\n\n00% 99 104.00%104.0\n\n0%\n\n56 225.00%287.00\n\n% 78 136.00%150.\n\n00% 100] 100.00]%100.0\n\n0]%","pages":[{"line_numbers":[],"markdown":"ICC19 AC1901 3.4\n\n**_POLICY INFORMATION_** \\- POLICY NUMBER [0123456789]\n\n**TABLE OF PERCENTAGES**\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\n[35 [389.00%[583.0\n\n0% 57 219.00%278.\n\n00% 79 134.00%146.0\n\n0%\n\n36 378.00%563.00\n\n% 58 214.00%269.\n\n00% 80 132.00%143.0\n\n0%\n\n37 368.00%544.00\n\n% 59 208.00%260.\n\n00% 81 129.00%140.0\n\n0%\n\n38 359.00%526.00\n\n% 60 203.00%252.\n\n00% 82 127.00%137.0\n\n0%\n\n39 349.00%508.00\n\n% 61 198.00%244.\n\n00% 83 125.00%134.0\n\n0%\n\n40 340.00%491.00\n\n% 62 193.00%236.\n\n00% 84 123.00%131.0\n\n0%\n\n41 331.00%475.00\n\n% 63 189.00%229.\n\n00% 85 122.00%129.0\n\n0%\n\n42 323.00%459.00\n\n% 64 184.00%222.\n\n00% 86 120.00%127.0\n\n0%\n\n43 315.00%444.00\n\n% 65 180.00%215.\n\n00% 87 118.00%125.0\n\n0%\n\n44 306.00%429.00\n\n% 66 176.00%208.\n\n00% 88 117.00%123.0\n\n0%\n\n45 299.00%415.00\n\n% 67 172.00%202.\n\n00% 89 116.00%121.0\n\n0%\n\n46 291.00%401.00\n\n% 68 168.00%196.\n\n00% 90 115.00%119.0\n\n0%\n\n47 283.00%388.00\n\n% 69 164.00%191.\n\n00% 91 113.00%118.0\n\n0%\n\n48 276.00%375.00\n\n% 70 160.00%185.\n\n00% 92 112.00%117.0\n\n0%\n\n49 269.00%363.00\n\n% 71 157.00%180.\n\n00% 93 112.00%115.0\n\n0%\n\n50 262.00%351.00\n\n% 72 154.00%175.\n\n00% 94 111.00%114.0\n\n0%\n\n51 255.00%339.00\n\n% 73 150.00%170.\n\n00% 95 110.00%113.0\n\n0%\n\n52 249.00%328.00\n\n% 74 147.00%166.\n\n00% 96 109.00%111.0\n\n0%\n\n53 243.00%317.00\n\n% 75 144.00%161.\n\n00% 97 107.00%110.0\n\n0%\n\n54 236.00%306.00\n\n% 76 142.00%157.\n\n00% 98 106.00%107.0\n\n0%\n\n55 230.00%297.00\n\n% 77 139.00%153.\n\n00% 99 104.00%104.0\n\n0%\n\n56 225.00%287.00\n\n% 78 136.00%150.\n\n00% 100] 100.00]%100.0\n\n0]%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"ICC19 AC1901 3.4\n\n**_POLICY INFORMATION_** \\- POLICY NUMBER [0123456789]\n\n**TABLE OF PERCENTAGES**\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\n[35 [389.00%[583.0\n\n0% 57 219.00%278.\n\n00% 79 134.00%146.0\n\n0%\n\n36 378.00%563.00\n\n% 58 214.00%269.\n\n00% 80 132.00%143.0\n\n0%\n\n37 368.00%544.00\n\n% 59 208.00%260.\n\n00% 81 129.00%140.0\n\n0%\n\n38 359.00%526.00\n\n% 60 203.00%252.\n\n00% 82 127.00%137.0\n\n0%\n\n39 349.00%508.00\n\n% 61 198.00%244.\n\n00% 83 125.00%134.0\n\n0%\n\n40 340.00%491.00\n\n% 62 193.00%236.\n\n00% 84 123.00%131.0\n\n0%\n\n41 331.00%475.00\n\n% 63 189.00%229.\n\n00% 85 122.00%129.0\n\n0%\n\n42 323.00%459.00\n\n% 64 184.00%222.\n\n00% 86 120.00%127.0\n\n0%\n\n43 315.00%444.00\n\n% 65 180.00%215.\n\n00% 87 118.00%125.0\n\n0%\n\n44 306.00%429.00\n\n% 66 176.00%208.\n\n00% 88 117.00%123.0\n\n0%\n\n45 299.00%415.00\n\n% 67 172.00%202.\n\n00% 89 116.00%121.0\n\n0%\n\n46 291.00%401.00\n\n% 68 168.00%196.\n\n00% 90 115.00%119.0\n\n0%\n\n47 283.00%388.00\n\n% 69 164.00%191.\n\n00% 91 113.00%118.0\n\n0%\n\n48 276.00%375.00\n\n% 70 160.00%185.\n\n00% 92 112.00%117.0\n\n0%\n\n49 269.00%363.00\n\n% 71 157.00%180.\n\n00% 93 112.00%115.0\n\n0%\n\n50 262.00%351.00\n\n% 72 154.00%175.\n\n00% 94 111.00%114.0\n\n0%\n\n51 255.00%339.00\n\n% 73 150.00%170.\n\n00% 95 110.00%113.0\n\n0%\n\n52 249.00%328.00\n\n% 74 147.00%166.\n\n00% 96 109.00%111.0\n\n0%\n\n53 243.00%317.00\n\n% 75 144.00%161.\n\n00% 97 107.00%110.0\n\n0%\n\n54 236.00%306.00\n\n% 76 142.00%157.\n\n00% 98 106.00%107.0\n\n0%\n\n55 230.00%297.00\n\n% 77 139.00%153.\n\n00% 99 104.00%104.0\n\n0%\n\n56 225.00%287.00\n\n% 78 136.00%150.\n\n00% 100] 100.00]%100.0\n\n0]%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page224.pdf"]},"response":{"errors":[],"extract_id":"extract_577db8b8ab2c2f2d70c781176cac190e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["ICC19 AC1901 3.4\n\n**_POLICY INFORMATION_** \\- POLICY NUMBER [0123456789]\n\n**TABLE OF PERCENTAGES**\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\n[35 [389.00%[583.0\n\n0% 57 219.00%278.\n\n00% 79 134.00%146.0\n\n0%\n\n36 378.00%563.00\n\n% 58 214.00%269.\n\n00% 80 132.00%143.0\n\n0%\n\n37 368.00%544.00\n\n% 59 208.00%260.\n\n00% 81 129.00%140.0\n\n0%\n\n38 359.00%526.00\n\n% 60 203.00%252.\n\n00% 82 127.00%137.0\n\n0%\n\n39 349.00%508.00\n\n% 61 198.00%244.\n\n00% 83 125.00%134.0\n\n0%\n\n40 340.00%491.00\n\n% 62 193.00%236.\n\n00% 84 123.00%131.0\n\n0%\n\n41 331.00%475.00\n\n% 63 189.00%229.\n\n00% 85 122.00%129.0\n\n0%\n\n42 323.00%459.00\n\n% 64 184.00%222.\n\n00% 86 120.00%127.0\n\n0%\n\n43 315.00%444.00\n\n% 65 180.00%215.\n\n00% 87 118.00%125.0\n\n0%\n\n44 306.00%429.00\n\n% 66 176.00%208.\n\n00% 88 117.00%123.0\n\n0%\n\n45 299.00%415.00\n\n% 67 172.00%202.\n\n00% 89 116.00%121.0\n\n0%\n\n46 291.00%401.00\n\n% 68 168.00%196.\n\n00% 90 115.00%119.0\n\n0%\n\n47 283.00%388.00\n\n% 69 164.00%191.\n\n00% 91 113.00%118.0\n\n0%\n\n48 276.00%375.00\n\n% 70 160.00%185.\n\n00% 92 112.00%117.0\n\n0%\n\n49 269.00%363.00\n\n% 71 157.00%180.\n\n00% 93 112.00%115.0\n\n0%\n\n50 262.00%351.00\n\n% 72 154.00%175.\n\n00% 94 111.00%114.0\n\n0%\n\n51 255.00%339.00\n\n% 73 150.00%170.\n\n00% 95 110.00%113.0\n\n0%\n\n52 249.00%328.00\n\n% 74 147.00%166.\n\n00% 96 109.00%111.0\n\n0%\n\n53 243.00%317.00\n\n% 75 144.00%161.\n\n00% 97 107.00%110.0\n\n0%\n\n54 236.00%306.00\n\n% 76 142.00%157.\n\n00% 98 106.00%107.0\n\n0%\n\n55 230.00%297.00\n\n% 77 139.00%153.\n\n00% 99 104.00%104.0\n\n0%\n\n56 225.00%287.00\n\n% 78 136.00%150.\n\n00% 100] 100.00]%100.0\n\n0]%"],"full_content":"ICC19 AC1901 3.4\n\n**_POLICY INFORMATION_** \\- POLICY NUMBER [0123456789]\n\n**TABLE OF PERCENTAGES**\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\nINSURED PERSON’S ATTAINED\n\nAGE\n\nPERCENTAGE\n\n[35 [389.00%[583.0\n\n0% 57 219.00%278.\n\n00% 79 134.00%146.0\n\n0%\n\n36 378.00%563.00\n\n% 58 214.00%269.\n\n00% 80 132.00%143.0\n\n0%\n\n37 368.00%544.00\n\n% 59 208.00%260.\n\n00% 81 129.00%140.0\n\n0%\n\n38 359.00%526.00\n\n% 60 203.00%252.\n\n00% 82 127.00%137.0\n\n0%\n\n39 349.00%508.00\n\n% 61 198.00%244.\n\n00% 83 125.00%134.0\n\n0%\n\n40 340.00%491.00\n\n% 62 193.00%236.\n\n00% 84 123.00%131.0\n\n0%\n\n41 331.00%475.00\n\n% 63 189.00%229.\n\n00% 85 122.00%129.0\n\n0%\n\n42 323.00%459.00\n\n% 64 184.00%222.\n\n00% 86 120.00%127.0\n\n0%\n\n43 315.00%444.00\n\n% 65 180.00%215.\n\n00% 87 118.00%125.0\n\n0%\n\n44 306.00%429.00\n\n% 66 176.00%208.\n\n00% 88 117.00%123.0\n\n0%\n\n45 299.00%415.00\n\n% 67 172.00%202.\n\n00% 89 116.00%121.0\n\n0%\n\n46 291.00%401.00\n\n% 68 168.00%196.\n\n00% 90 115.00%119.0\n\n0%\n\n47 283.00%388.00\n\n% 69 164.00%191.\n\n00% 91 113.00%118.0\n\n0%\n\n48 276.00%375.00\n\n% 70 160.00%185.\n\n00% 92 112.00%117.0\n\n0%\n\n49 269.00%363.00\n\n% 71 157.00%180.\n\n00% 93 112.00%115.0\n\n0%\n\n50 262.00%351.00\n\n% 72 154.00%175.\n\n00% 94 111.00%114.0\n\n0%\n\n51 255.00%339.00\n\n% 73 150.00%170.\n\n00% 95 110.00%113.0\n\n0%\n\n52 249.00%328.00\n\n% 74 147.00%166.\n\n00% 96 109.00%111.0\n\n0%\n\n53 243.00%317.00\n\n% 75 144.00%161.\n\n00% 97 107.00%110.0\n\n0%\n\n54 236.00%306.00\n\n% 76 142.00%157.\n\n00% 98 106.00%107.0\n\n0%\n\n55 230.00%297.00\n\n% 77 139.00%153.\n\n00% 99 104.00%104.0\n\n0%\n\n56 225.00%287.00\n\n% 78 136.00%150.\n\n00% 100] 100.00]%100.0\n\n0]%","publish_date":null,"title":"POLICY INFORMATION","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page224.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page224.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page224","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page224.pdf"},"started_at":"2026-11-04T19:47:51.551294"} +{"completed_at":"2026-11-04T19:47:54.751936","latency_in_ms":2199,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page230","grounded_pages":[],"layout_pages":[],"markdown":"### Page 12 5/17/2021\n\n**Issue Attained Cash Reduced Extended Extended**\n\n**Class Age Duration Age Value Paid-Up Term Yrs Term Days**\n\nMN 35 1 36 - - 0 0\n\nMN 35 2 37 - - 0 0\n\nMN 35 3 38 108.75 525 3 136\n\nMN 35 4 39 328.00 1,500 9 116\n\nMN 35 5 40 554.00 2,450 14 174\n\nMN 35 6 41 787.00 3,375 18 134\n\nMN 35 7 42 1,027.00 4,275 21 128\n\nMN 35 8 43 1,273.75 5,125 23 160\n\nMN 35 9 44 1,528.25 5,950 24 364\n\nMN 35 10 45 1,791.00 6,750 26 52\n\nMN 35 11 46 2,063.00 7,525 26 351\n\nMN 35 12 47 2,344.00 8,300 27 186\n\nMN 35 13 48 2,634.50 9,025 27 319\n\nMN 35 14 49 2,934.50 9,750 28 33\n\nMN 35 15 50 3,244.25 10,425 28 71\n\nMN 35 16 51 3,563.50 11,100 28 76\n\nMN 35 17 52 3,891.50 11,725 28 51\n\nMN 35 18 53 4,227.75 12,350 28 2\n\nMN 35 19 54 4,572.50 12,950 27 294\n\nMN 35 20 55 4,925.75 13,525 27 203\n\nMN 35 21 56 5,288.75 14,075 27 96\n\nMN 35 22 57 5,662.25 14,600 26 339\n\nMN 35 23 58 6,046.50 15,125 26 203\n\nMN 35 24 59 6,442.00 15,625 26 56\n\nMN 35 25 60 6,848.25 16,100 25 263\n\nMN 35 26 61 7,264.50 16,575 25 97\n\nMN 35 27 62 7,689.25 17,025 24 286\n\nMN 35 28 63 8,122.00 17,450 24 104\n\nMN 35 29 64 8,562.25 17,850 23 280\n\nMN 35 30 65 9,010.00 18,250 23 86\n\nMN 35 31 66 9,465.00 18,625 22 252\n\nMN 35 32 67 9,928.00 19,000 22 48\n\nMN 35 33 68 10,398.75 19,350 21 208\n\nMN 35 34 69 10,876.75 19,675 20 361\n\nMN 35 35 70 11,361.25 20,000 20 153\n\nMN 35 36 71 11,850.75 20,300 19 303\n\nMN 35 37 72 12,343.75 20,600 19 91\n\nMN 35 38 73 12,837.75 20,875 18 243\n\nMN 35 39 74 13,331.75 21,150 18 25\n\nMN 35 40 75 13,824.00 21,400 17 182\n\n**Exhibit B (page 1 of 3)**\n\n**Nonforfeiture Values for a Sample Policy**\n\n**Volume = 25,000**","pages":[{"line_numbers":[],"markdown":"### Page 12 5/17/2021\n\n**Issue Attained Cash Reduced Extended Extended**\n\n**Class Age Duration Age Value Paid-Up Term Yrs Term Days**\n\nMN 35 1 36 - - 0 0\n\nMN 35 2 37 - - 0 0\n\nMN 35 3 38 108.75 525 3 136\n\nMN 35 4 39 328.00 1,500 9 116\n\nMN 35 5 40 554.00 2,450 14 174\n\nMN 35 6 41 787.00 3,375 18 134\n\nMN 35 7 42 1,027.00 4,275 21 128\n\nMN 35 8 43 1,273.75 5,125 23 160\n\nMN 35 9 44 1,528.25 5,950 24 364\n\nMN 35 10 45 1,791.00 6,750 26 52\n\nMN 35 11 46 2,063.00 7,525 26 351\n\nMN 35 12 47 2,344.00 8,300 27 186\n\nMN 35 13 48 2,634.50 9,025 27 319\n\nMN 35 14 49 2,934.50 9,750 28 33\n\nMN 35 15 50 3,244.25 10,425 28 71\n\nMN 35 16 51 3,563.50 11,100 28 76\n\nMN 35 17 52 3,891.50 11,725 28 51\n\nMN 35 18 53 4,227.75 12,350 28 2\n\nMN 35 19 54 4,572.50 12,950 27 294\n\nMN 35 20 55 4,925.75 13,525 27 203\n\nMN 35 21 56 5,288.75 14,075 27 96\n\nMN 35 22 57 5,662.25 14,600 26 339\n\nMN 35 23 58 6,046.50 15,125 26 203\n\nMN 35 24 59 6,442.00 15,625 26 56\n\nMN 35 25 60 6,848.25 16,100 25 263\n\nMN 35 26 61 7,264.50 16,575 25 97\n\nMN 35 27 62 7,689.25 17,025 24 286\n\nMN 35 28 63 8,122.00 17,450 24 104\n\nMN 35 29 64 8,562.25 17,850 23 280\n\nMN 35 30 65 9,010.00 18,250 23 86\n\nMN 35 31 66 9,465.00 18,625 22 252\n\nMN 35 32 67 9,928.00 19,000 22 48\n\nMN 35 33 68 10,398.75 19,350 21 208\n\nMN 35 34 69 10,876.75 19,675 20 361\n\nMN 35 35 70 11,361.25 20,000 20 153\n\nMN 35 36 71 11,850.75 20,300 19 303\n\nMN 35 37 72 12,343.75 20,600 19 91\n\nMN 35 38 73 12,837.75 20,875 18 243\n\nMN 35 39 74 13,331.75 21,150 18 25\n\nMN 35 40 75 13,824.00 21,400 17 182\n\n**Exhibit B (page 1 of 3)**\n\n**Nonforfeiture Values for a Sample Policy**\n\n**Volume = 25,000**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### Page 12 5/17/2021\n\n**Issue Attained Cash Reduced Extended Extended**\n\n**Class Age Duration Age Value Paid-Up Term Yrs Term Days**\n\nMN 35 1 36 - - 0 0\n\nMN 35 2 37 - - 0 0\n\nMN 35 3 38 108.75 525 3 136\n\nMN 35 4 39 328.00 1,500 9 116\n\nMN 35 5 40 554.00 2,450 14 174\n\nMN 35 6 41 787.00 3,375 18 134\n\nMN 35 7 42 1,027.00 4,275 21 128\n\nMN 35 8 43 1,273.75 5,125 23 160\n\nMN 35 9 44 1,528.25 5,950 24 364\n\nMN 35 10 45 1,791.00 6,750 26 52\n\nMN 35 11 46 2,063.00 7,525 26 351\n\nMN 35 12 47 2,344.00 8,300 27 186\n\nMN 35 13 48 2,634.50 9,025 27 319\n\nMN 35 14 49 2,934.50 9,750 28 33\n\nMN 35 15 50 3,244.25 10,425 28 71\n\nMN 35 16 51 3,563.50 11,100 28 76\n\nMN 35 17 52 3,891.50 11,725 28 51\n\nMN 35 18 53 4,227.75 12,350 28 2\n\nMN 35 19 54 4,572.50 12,950 27 294\n\nMN 35 20 55 4,925.75 13,525 27 203\n\nMN 35 21 56 5,288.75 14,075 27 96\n\nMN 35 22 57 5,662.25 14,600 26 339\n\nMN 35 23 58 6,046.50 15,125 26 203\n\nMN 35 24 59 6,442.00 15,625 26 56\n\nMN 35 25 60 6,848.25 16,100 25 263\n\nMN 35 26 61 7,264.50 16,575 25 97\n\nMN 35 27 62 7,689.25 17,025 24 286\n\nMN 35 28 63 8,122.00 17,450 24 104\n\nMN 35 29 64 8,562.25 17,850 23 280\n\nMN 35 30 65 9,010.00 18,250 23 86\n\nMN 35 31 66 9,465.00 18,625 22 252\n\nMN 35 32 67 9,928.00 19,000 22 48\n\nMN 35 33 68 10,398.75 19,350 21 208\n\nMN 35 34 69 10,876.75 19,675 20 361\n\nMN 35 35 70 11,361.25 20,000 20 153\n\nMN 35 36 71 11,850.75 20,300 19 303\n\nMN 35 37 72 12,343.75 20,600 19 91\n\nMN 35 38 73 12,837.75 20,875 18 243\n\nMN 35 39 74 13,331.75 21,150 18 25\n\nMN 35 40 75 13,824.00 21,400 17 182\n\n**Exhibit B (page 1 of 3)**\n\n**Nonforfeiture Values for a Sample Policy**\n\n**Volume = 25,000**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page230.pdf"]},"response":{"errors":[],"extract_id":"extract_068485c5c0f0055970b7c149977e90f1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### Page 12 5/17/2021\n\n**Issue Attained Cash Reduced Extended Extended**\n\n**Class Age Duration Age Value Paid-Up Term Yrs Term Days**\n\nMN 35 1 36 - - 0 0\n\nMN 35 2 37 - - 0 0\n\nMN 35 3 38 108.75 525 3 136\n\nMN 35 4 39 328.00 1,500 9 116\n\nMN 35 5 40 554.00 2,450 14 174\n\nMN 35 6 41 787.00 3,375 18 134\n\nMN 35 7 42 1,027.00 4,275 21 128\n\nMN 35 8 43 1,273.75 5,125 23 160\n\nMN 35 9 44 1,528.25 5,950 24 364\n\nMN 35 10 45 1,791.00 6,750 26 52\n\nMN 35 11 46 2,063.00 7,525 26 351\n\nMN 35 12 47 2,344.00 8,300 27 186\n\nMN 35 13 48 2,634.50 9,025 27 319\n\nMN 35 14 49 2,934.50 9,750 28 33\n\nMN 35 15 50 3,244.25 10,425 28 71\n\nMN 35 16 51 3,563.50 11,100 28 76\n\nMN 35 17 52 3,891.50 11,725 28 51\n\nMN 35 18 53 4,227.75 12,350 28 2\n\nMN 35 19 54 4,572.50 12,950 27 294\n\nMN 35 20 55 4,925.75 13,525 27 203\n\nMN 35 21 56 5,288.75 14,075 27 96\n\nMN 35 22 57 5,662.25 14,600 26 339\n\nMN 35 23 58 6,046.50 15,125 26 203\n\nMN 35 24 59 6,442.00 15,625 26 56\n\nMN 35 25 60 6,848.25 16,100 25 263\n\nMN 35 26 61 7,264.50 16,575 25 97\n\nMN 35 27 62 7,689.25 17,025 24 286\n\nMN 35 28 63 8,122.00 17,450 24 104\n\nMN 35 29 64 8,562.25 17,850 23 280\n\nMN 35 30 65 9,010.00 18,250 23 86\n\nMN 35 31 66 9,465.00 18,625 22 252\n\nMN 35 32 67 9,928.00 19,000 22 48\n\nMN 35 33 68 10,398.75 19,350 21 208\n\nMN 35 34 69 10,876.75 19,675 20 361\n\nMN 35 35 70 11,361.25 20,000 20 153\n\nMN 35 36 71 11,850.75 20,300 19 303\n\nMN 35 37 72 12,343.75 20,600 19 91\n\nMN 35 38 73 12,837.75 20,875 18 243\n\nMN 35 39 74 13,331.75 21,150 18 25\n\nMN 35 40 75 13,824.00 21,400 17 182\n\n**Exhibit B (page 1 of 3)**\n\n**Nonforfeiture Values for a Sample Policy**\n\n**Volume = 25,000**"],"full_content":"### Page 12 5/17/2021\n\n**Issue Attained Cash Reduced Extended Extended**\n\n**Class Age Duration Age Value Paid-Up Term Yrs Term Days**\n\nMN 35 1 36 - - 0 0\n\nMN 35 2 37 - - 0 0\n\nMN 35 3 38 108.75 525 3 136\n\nMN 35 4 39 328.00 1,500 9 116\n\nMN 35 5 40 554.00 2,450 14 174\n\nMN 35 6 41 787.00 3,375 18 134\n\nMN 35 7 42 1,027.00 4,275 21 128\n\nMN 35 8 43 1,273.75 5,125 23 160\n\nMN 35 9 44 1,528.25 5,950 24 364\n\nMN 35 10 45 1,791.00 6,750 26 52\n\nMN 35 11 46 2,063.00 7,525 26 351\n\nMN 35 12 47 2,344.00 8,300 27 186\n\nMN 35 13 48 2,634.50 9,025 27 319\n\nMN 35 14 49 2,934.50 9,750 28 33\n\nMN 35 15 50 3,244.25 10,425 28 71\n\nMN 35 16 51 3,563.50 11,100 28 76\n\nMN 35 17 52 3,891.50 11,725 28 51\n\nMN 35 18 53 4,227.75 12,350 28 2\n\nMN 35 19 54 4,572.50 12,950 27 294\n\nMN 35 20 55 4,925.75 13,525 27 203\n\nMN 35 21 56 5,288.75 14,075 27 96\n\nMN 35 22 57 5,662.25 14,600 26 339\n\nMN 35 23 58 6,046.50 15,125 26 203\n\nMN 35 24 59 6,442.00 15,625 26 56\n\nMN 35 25 60 6,848.25 16,100 25 263\n\nMN 35 26 61 7,264.50 16,575 25 97\n\nMN 35 27 62 7,689.25 17,025 24 286\n\nMN 35 28 63 8,122.00 17,450 24 104\n\nMN 35 29 64 8,562.25 17,850 23 280\n\nMN 35 30 65 9,010.00 18,250 23 86\n\nMN 35 31 66 9,465.00 18,625 22 252\n\nMN 35 32 67 9,928.00 19,000 22 48\n\nMN 35 33 68 10,398.75 19,350 21 208\n\nMN 35 34 69 10,876.75 19,675 20 361\n\nMN 35 35 70 11,361.25 20,000 20 153\n\nMN 35 36 71 11,850.75 20,300 19 303\n\nMN 35 37 72 12,343.75 20,600 19 91\n\nMN 35 38 73 12,837.75 20,875 18 243\n\nMN 35 39 74 13,331.75 21,150 18 25\n\nMN 35 40 75 13,824.00 21,400 17 182\n\n**Exhibit B (page 1 of 3)**\n\n**Nonforfeiture Values for a Sample Policy**\n\n**Volume = 25,000**","publish_date":null,"title":"Page 12 5/17/2021","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page230.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page230.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page230","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page230.pdf"},"started_at":"2026-11-04T19:47:52.552162"} +{"completed_at":"2026-11-04T19:47:54.385054","latency_in_ms":966,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page255","grounded_pages":[],"layout_pages":[],"markdown":"2\n\nInsurance\n\n6\n\nCash Value Mortality, Interest and Functions The cash value basis is bracketed to allow for changes for new issues in the future; currently the interest rate is 3.75%; any changes to mortality or interest will comply with applicable nonforfeiture law requirements and can only be made with prior approval.","pages":[{"line_numbers":[],"markdown":"2\n\nInsurance\n\n6\n\nCash Value Mortality, Interest and Functions The cash value basis is bracketed to allow for changes for new issues in the future; currently the interest rate is 3.75%; any changes to mortality or interest will comply with applicable nonforfeiture law requirements and can only be made with prior approval.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"2\n\nInsurance\n\n6\n\nCash Value Mortality, Interest and Functions The cash value basis is bracketed to allow for changes for new issues in the future; currently the interest rate is 3.75%; any changes to mortality or interest will comply with applicable nonforfeiture law requirements and can only be made with prior approval.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page255.pdf"]},"response":{"errors":[],"extract_id":"extract_8180e241be81bbaba9960379f2269c44","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["2\n\nInsurance\n\n6\n\nCash Value Mortality, Interest and Functions The cash value basis is bracketed to allow for changes for new issues in the future; currently the interest rate is 3.75%; any changes to mortality or interest will comply with applicable nonforfeiture law requirements and can only be made with prior approval."],"full_content":"2\n\nInsurance\n\n6\n\nCash Value Mortality, Interest and Functions The cash value basis is bracketed to allow for changes for new issues in the future; currently the interest rate is 3.75%; any changes to mortality or interest will comply with applicable nonforfeiture law requirements and can only be made with prior approval.","publish_date":null,"title":"Insurance 6 Cash Value Mortality, Interest The cash value basis is bracketed to allow for changes for new issues in","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page255.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page255.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page255","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page255.pdf"},"started_at":"2026-11-04T19:47:53.418126"} +{"completed_at":"2026-11-04T19:47:55.668623","latency_in_ms":915,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page274","grounded_pages":[],"layout_pages":[],"markdown":"ICC22 EE.48 2208 SOV\n\n**Western-Southern Life Assurance Company**\n\n**Statement of Variability**\n\n**Date:** **August 17** **, 20** **22**\n\nThis Statement of Variability applies to the following form:\n\nICC22 EE.48 2208, Account Value Band Interest Rate Endorsement\n\nWe certify that we will administer any change to a variable item in accordance with the requirements in this Statement of Variability, including any requirements for prior approval of a change.\n\nThe variable information is identified by brackets and may change as indicated below.\n\n**Description** **Variable Explanation**\n\n**1 Officer Signatures and Titles**\n\nWe reserve the right to change if the relevant individuals or titles should change in the future.","pages":[{"line_numbers":[],"markdown":"ICC22 EE.48 2208 SOV\n\n**Western-Southern Life Assurance Company**\n\n**Statement of Variability**\n\n**Date:** **August 17** **, 20** **22**\n\nThis Statement of Variability applies to the following form:\n\nICC22 EE.48 2208, Account Value Band Interest Rate Endorsement\n\nWe certify that we will administer any change to a variable item in accordance with the requirements in this Statement of Variability, including any requirements for prior approval of a change.\n\nThe variable information is identified by brackets and may change as indicated below.\n\n**Description** **Variable Explanation**\n\n**1 Officer Signatures and Titles**\n\nWe reserve the right to change if the relevant individuals or titles should change in the future.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"ICC22 EE.48 2208 SOV\n\n**Western-Southern Life Assurance Company**\n\n**Statement of Variability**\n\n**Date:** **August 17** **, 20** **22**\n\nThis Statement of Variability applies to the following form:\n\nICC22 EE.48 2208, Account Value Band Interest Rate Endorsement\n\nWe certify that we will administer any change to a variable item in accordance with the requirements in this Statement of Variability, including any requirements for prior approval of a change.\n\nThe variable information is identified by brackets and may change as indicated below.\n\n**Description** **Variable Explanation**\n\n**1 Officer Signatures and Titles**\n\nWe reserve the right to change if the relevant individuals or titles should change in the future.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page274.pdf"]},"response":{"errors":[],"extract_id":"extract_ddaca6153c1da957103f5aa058490bbe","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["ICC22 EE.48 2208 SOV\n\n**Western-Southern Life Assurance Company**\n\n**Statement of Variability**\n\n**Date:** **August 17** **, 20** **22**\n\nThis Statement of Variability applies to the following form:\n\nICC22 EE.48 2208, Account Value Band Interest Rate Endorsement\n\nWe certify that we will administer any change to a variable item in accordance with the requirements in this Statement of Variability, including any requirements for prior approval of a change.\n\nThe variable information is identified by brackets and may change as indicated below.\n\n**Description** **Variable Explanation**\n\n**1 Officer Signatures and Titles**\n\nWe reserve the right to change if the relevant individuals or titles should change in the future."],"full_content":"ICC22 EE.48 2208 SOV\n\n**Western-Southern Life Assurance Company**\n\n**Statement of Variability**\n\n**Date:** **August 17** **, 20** **22**\n\nThis Statement of Variability applies to the following form:\n\nICC22 EE.48 2208, Account Value Band Interest Rate Endorsement\n\nWe certify that we will administer any change to a variable item in accordance with the requirements in this Statement of Variability, including any requirements for prior approval of a change.\n\nThe variable information is identified by brackets and may change as indicated below.\n\n**Description** **Variable Explanation**\n\n**1 Officer Signatures and Titles**\n\nWe reserve the right to change if the relevant individuals or titles should change in the future.","publish_date":null,"title":"Western-Southern Life Assurance Company Statement of Variability Date: August 17, 2022 This Statement of Variability applies to the following form:","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page274.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page274.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page274","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page274.pdf"},"started_at":"2026-11-04T19:47:54.753320"} +{"completed_at":"2026-11-04T19:47:58.483185","latency_in_ms":2841,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page276","grounded_pages":[],"layout_pages":[],"markdown":"## **ACTUARIAL MEMORANDUM**\n\n**Supporting Policy Form:**\n\n**ICC18 ENT-06 1805 Single Premium Deferred Annuity Contract with Market Value Adjustment Feature**\n\n**ICC18 ENT-06 1805 DP Data Page**\n\n**ICC18 ENT-06 1805 DP-A Data Page**\n\n**ICC18 ENT-06 1805 DP-B Data Page**\n\n**ICC18 ENT-06 1805 DP-C Data Page**\n\n**ICC18 ENT-06 1805 DP-D Data Page**\n\n**ICC18 ENT-06 1805 DP-E Data Page**\n\n**ICC22 EE.48 2208 Account Value Band Interest Rate Endorsement**\n\nPatrick F. McCormack, FSA, MAAA Assistant Vice President Annuity Products September 7, 2022 I am a member of the American Academy of Actuaries, and I meet the Qualifications Standards of the American Academy of Actuaries to render the actuarial opinion contained herein.","pages":[{"line_numbers":[],"markdown":"## **ACTUARIAL MEMORANDUM**\n\n**Supporting Policy Form:**\n\n**ICC18 ENT-06 1805 Single Premium Deferred Annuity Contract with Market Value Adjustment Feature**\n\n**ICC18 ENT-06 1805 DP Data Page**\n\n**ICC18 ENT-06 1805 DP-A Data Page**\n\n**ICC18 ENT-06 1805 DP-B Data Page**\n\n**ICC18 ENT-06 1805 DP-C Data Page**\n\n**ICC18 ENT-06 1805 DP-D Data Page**\n\n**ICC18 ENT-06 1805 DP-E Data Page**\n\n**ICC22 EE.48 2208 Account Value Band Interest Rate Endorsement**\n\nPatrick F. McCormack, FSA, MAAA Assistant Vice President Annuity Products September 7, 2022 I am a member of the American Academy of Actuaries, and I meet the Qualifications Standards of the American Academy of Actuaries to render the actuarial opinion contained herein.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## **ACTUARIAL MEMORANDUM**\n\n**Supporting Policy Form:**\n\n**ICC18 ENT-06 1805 Single Premium Deferred Annuity Contract with Market Value Adjustment Feature**\n\n**ICC18 ENT-06 1805 DP Data Page**\n\n**ICC18 ENT-06 1805 DP-A Data Page**\n\n**ICC18 ENT-06 1805 DP-B Data Page**\n\n**ICC18 ENT-06 1805 DP-C Data Page**\n\n**ICC18 ENT-06 1805 DP-D Data Page**\n\n**ICC18 ENT-06 1805 DP-E Data Page**\n\n**ICC22 EE.48 2208 Account Value Band Interest Rate Endorsement**\n\nPatrick F. McCormack, FSA, MAAA Assistant Vice President Annuity Products September 7, 2022 I am a member of the American Academy of Actuaries, and I meet the Qualifications Standards of the American Academy of Actuaries to render the actuarial opinion contained herein.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page276.pdf"]},"response":{"errors":[],"extract_id":"extract_4549a8d2cbf8d28bad59f79bdc408454","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## **ACTUARIAL MEMORANDUM**\n\n**Supporting Policy Form:**\n\n**ICC18 ENT-06 1805 Single Premium Deferred Annuity Contract with Market Value Adjustment Feature**\n\n**ICC18 ENT-06 1805 DP Data Page**\n\n**ICC18 ENT-06 1805 DP-A Data Page**\n\n**ICC18 ENT-06 1805 DP-B Data Page**\n\n**ICC18 ENT-06 1805 DP-C Data Page**\n\n**ICC18 ENT-06 1805 DP-D Data Page**\n\n**ICC18 ENT-06 1805 DP-E Data Page**\n\n**ICC22 EE.48 2208 Account Value Band Interest Rate Endorsement**\n\nPatrick F. McCormack, FSA, MAAA Assistant Vice President Annuity Products September 7, 2022 I am a member of the American Academy of Actuaries, and I meet the Qualifications Standards of the American Academy of Actuaries to render the actuarial opinion contained herein."],"full_content":"## **ACTUARIAL MEMORANDUM**\n\n**Supporting Policy Form:**\n\n**ICC18 ENT-06 1805 Single Premium Deferred Annuity Contract with Market Value Adjustment Feature**\n\n**ICC18 ENT-06 1805 DP Data Page**\n\n**ICC18 ENT-06 1805 DP-A Data Page**\n\n**ICC18 ENT-06 1805 DP-B Data Page**\n\n**ICC18 ENT-06 1805 DP-C Data Page**\n\n**ICC18 ENT-06 1805 DP-D Data Page**\n\n**ICC18 ENT-06 1805 DP-E Data Page**\n\n**ICC22 EE.48 2208 Account Value Band Interest Rate Endorsement**\n\nPatrick F. McCormack, FSA, MAAA Assistant Vice President Annuity Products September 7, 2022 I am a member of the American Academy of Actuaries, and I meet the Qualifications Standards of the American Academy of Actuaries to render the actuarial opinion contained herein.","publish_date":null,"title":"ACTUARIAL MEMORANDUM","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page276.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page276.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page276","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page276.pdf"},"started_at":"2026-11-04T19:47:55.641323"} +{"completed_at":"2026-11-04T19:47:59.267429","latency_in_ms":2310,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page277","grounded_pages":[],"layout_pages":[],"markdown":"**Western-Southern Life Assurance Company**\n\n**C E R T I F I C A T I O N**\n\nI, Bruce W. Maisel, an officer of The Western and Southern Life Insurance Company and Western-Southern Life Assurance Company hereby certify that the following form has the following readability score as calculated by the Flesch Reading Ease Test and that this form meet the reading ease requirements of your statutes and regulations. If this Certification is accompanied by identified language or terminology excepted from testing, I further certify that the language or terminology excepted is entitled to exception under applicable by law or regulation.\n\nAll flesched with ICC18 ENT-06 1805, Single Premium Deferred Annuity Policy.\n\nBruce W. Maisel Vice President & Chief Compliance Officer\n\nDate: 8/17/2022\n\nForm Numbers Form Description Readability Score\n\n1\\.\n\nICC22 EE.48 2208 Account Value Band Interest Rate Endorsement 50.3","pages":[{"line_numbers":[],"markdown":"**Western-Southern Life Assurance Company**\n\n**C E R T I F I C A T I O N**\n\nI, Bruce W. Maisel, an officer of The Western and Southern Life Insurance Company and Western-Southern Life Assurance Company hereby certify that the following form has the following readability score as calculated by the Flesch Reading Ease Test and that this form meet the reading ease requirements of your statutes and regulations. If this Certification is accompanied by identified language or terminology excepted from testing, I further certify that the language or terminology excepted is entitled to exception under applicable by law or regulation.\n\nAll flesched with ICC18 ENT-06 1805, Single Premium Deferred Annuity Policy.\n\nBruce W. Maisel Vice President & Chief Compliance Officer\n\nDate: 8/17/2022\n\nForm Numbers Form Description Readability Score\n\n1\\.\n\nICC22 EE.48 2208 Account Value Band Interest Rate Endorsement 50.3","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Western-Southern Life Assurance Company**\n\n**C E R T I F I C A T I O N**\n\nI, Bruce W. Maisel, an officer of The Western and Southern Life Insurance Company and Western-Southern Life Assurance Company hereby certify that the following form has the following readability score as calculated by the Flesch Reading Ease Test and that this form meet the reading ease requirements of your statutes and regulations. If this Certification is accompanied by identified language or terminology excepted from testing, I further certify that the language or terminology excepted is entitled to exception under applicable by law or regulation.\n\nAll flesched with ICC18 ENT-06 1805, Single Premium Deferred Annuity Policy.\n\nBruce W. Maisel Vice President & Chief Compliance Officer\n\nDate: 8/17/2022\n\nForm Numbers Form Description Readability Score\n\n1\\.\n\nICC22 EE.48 2208 Account Value Band Interest Rate Endorsement 50.3","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page277.pdf"]},"response":{"errors":[],"extract_id":"extract_41e514c554ed94c87b83a97d7600ec0c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Western-Southern Life Assurance Company**\n\n**C E R T I F I C A T I O N**\n\nI, Bruce W. Maisel, an officer of The Western and Southern Life Insurance Company and Western-Southern Life Assurance Company hereby certify that the following form has the following readability score as calculated by the Flesch Reading Ease Test and that this form meet the reading ease requirements of your statutes and regulations. If this Certification is accompanied by identified language or terminology excepted from testing, I further certify that the language or terminology excepted is entitled to exception under applicable by law or regulation.\n\nAll flesched with ICC18 ENT-06 1805, Single Premium Deferred Annuity Policy.\n\nBruce W. Maisel Vice President & Chief Compliance Officer\n\nDate: 8/17/2022\n\nForm Numbers Form Description Readability Score\n\n1\\.\n\nICC22 EE.48 2208 Account Value Band Interest Rate Endorsement 50.3"],"full_content":"**Western-Southern Life Assurance Company**\n\n**C E R T I F I C A T I O N**\n\nI, Bruce W. Maisel, an officer of The Western and Southern Life Insurance Company and Western-Southern Life Assurance Company hereby certify that the following form has the following readability score as calculated by the Flesch Reading Ease Test and that this form meet the reading ease requirements of your statutes and regulations. If this Certification is accompanied by identified language or terminology excepted from testing, I further certify that the language or terminology excepted is entitled to exception under applicable by law or regulation.\n\nAll flesched with ICC18 ENT-06 1805, Single Premium Deferred Annuity Policy.\n\nBruce W. Maisel Vice President & Chief Compliance Officer\n\nDate: 8/17/2022\n\nForm Numbers Form Description Readability Score\n\n1\\.\n\nICC22 EE.48 2208 Account Value Band Interest Rate Endorsement 50.3","publish_date":null,"title":"Western-Southern Life Assurance Company C E R T I F I C A T I O N I, Bruce W.","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page277.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page277.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page277","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page277.pdf"},"started_at":"2026-11-04T19:47:56.956767"} +{"completed_at":"2026-11-04T19:47:58.948390","latency_in_ms":1211,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page42","grounded_pages":[],"layout_pages":[],"markdown":"### **LIFE UNIFORM STANDARDS AND FORMS**\n\n### **TO WHICH THE STANDARDS APPLY**\n\n**STANDARD FORM(S) FORM(S) NUMBER**\n\n**Life Insurance Policy Uniform Standards**\n\nCompact A64000 Series Whole Life SOV Compact A68000 Series Whole Life SOV ICC18B60C10 SOV ICC18B60100 SOV ICC18B60100GBA SOV ICC18B60100GBNA SOV ICC18B60100NA SOV ICC18B61JWO SOV\n\nN/A\n\n**Uniform Standards for Filing Revisions to Life Insurance Rate Filings**\n\n30YT (ICC0964500) Revised Actuarial Memo 10YT (ICC0964200) Revised Actuarial Memo 20YT (ICC0964300) Revised Actuarial Memo Whole Life (ICC0964100) Revised Actuarial Memo 10YT Spouse Rider (ICC1368050) Revised Actuarial Memo 10YT (ICC18B60200) Revised Actuarial Memo 20YT (ICC18Q60300C) Revised Actuarial Memo Spouse 30YT (ICC18Q60052) Revised Actuarial Memo Spouse 20YT (ICC18Q60051) Revised Actuarial Memo 20YT Spouse Rider (ICC0964051) Revised Actuarial Memo Whole Life (ICC1368C10) Revised Actuarial Memo 30YT (ICC18B60400) Revised Actuarial Memo 30YT Spouse Rider (ICC0964052) Revised Actuarial Memo 10YT (ICC1368200) Revised Actuarial Memo 20YT (ICC1368300) Revised Actuarial Memo 20YT Spouse Rider (ICC1368051) Revised Actuarial Memo 30YT (ICC18B60400A) Revised Actuarial Memo 10YT Spouse Rider (ICC0964050) Revised Actuarial Memo Child Rider (ICC0964053) Revised Actuarial Memo 30YT Spouse Rider (ICC1368052) Revised Actuarial Memo Juvenile Whole Life (ICC18B61JWO) Revised Actuarial Memo 30YT (ICC1368400) Revised Actuarial Memo Child Rider (ICC1368400) Revised Actuarial Memo Juvenile Term Life (ICC18B61JTO) Revised Actuarial Memo Whole Life (ICC1368100) Revised Actuarial Memo Spouse 10YT (ICC18Q60050) Revised Actuarial Memo 10YT (ICC18B60200A) Revised Actuarial Memo 20YT (ICC18B60300) Revised Actuarial Memo 10YT (ICC18Q60200C) Revised Actuarial Memo 20YT (ICC18B60300A) Revised Actuarial Memo 30YT (ICC18Q60400C) Revised Actuarial Memo Child Rider (ICC18B60053) Revised Actuarial Memo Whole Life (ICC18B60100GB) Revised Actuarial Memo Whole Life (ICC18B60C10) Revised Actuarial Memo Whole Life (ICC18B60100) Revised Actuarial Memo\n\nN/A","pages":[{"line_numbers":[],"markdown":"### **LIFE UNIFORM STANDARDS AND FORMS**\n\n### **TO WHICH THE STANDARDS APPLY**\n\n**STANDARD FORM(S) FORM(S) NUMBER**\n\n**Life Insurance Policy Uniform Standards**\n\nCompact A64000 Series Whole Life SOV Compact A68000 Series Whole Life SOV ICC18B60C10 SOV ICC18B60100 SOV ICC18B60100GBA SOV ICC18B60100GBNA SOV ICC18B60100NA SOV ICC18B61JWO SOV\n\nN/A\n\n**Uniform Standards for Filing Revisions to Life Insurance Rate Filings**\n\n30YT (ICC0964500) Revised Actuarial Memo 10YT (ICC0964200) Revised Actuarial Memo 20YT (ICC0964300) Revised Actuarial Memo Whole Life (ICC0964100) Revised Actuarial Memo 10YT Spouse Rider (ICC1368050) Revised Actuarial Memo 10YT (ICC18B60200) Revised Actuarial Memo 20YT (ICC18Q60300C) Revised Actuarial Memo Spouse 30YT (ICC18Q60052) Revised Actuarial Memo Spouse 20YT (ICC18Q60051) Revised Actuarial Memo 20YT Spouse Rider (ICC0964051) Revised Actuarial Memo Whole Life (ICC1368C10) Revised Actuarial Memo 30YT (ICC18B60400) Revised Actuarial Memo 30YT Spouse Rider (ICC0964052) Revised Actuarial Memo 10YT (ICC1368200) Revised Actuarial Memo 20YT (ICC1368300) Revised Actuarial Memo 20YT Spouse Rider (ICC1368051) Revised Actuarial Memo 30YT (ICC18B60400A) Revised Actuarial Memo 10YT Spouse Rider (ICC0964050) Revised Actuarial Memo Child Rider (ICC0964053) Revised Actuarial Memo 30YT Spouse Rider (ICC1368052) Revised Actuarial Memo Juvenile Whole Life (ICC18B61JWO) Revised Actuarial Memo 30YT (ICC1368400) Revised Actuarial Memo Child Rider (ICC1368400) Revised Actuarial Memo Juvenile Term Life (ICC18B61JTO) Revised Actuarial Memo Whole Life (ICC1368100) Revised Actuarial Memo Spouse 10YT (ICC18Q60050) Revised Actuarial Memo 10YT (ICC18B60200A) Revised Actuarial Memo 20YT (ICC18B60300) Revised Actuarial Memo 10YT (ICC18Q60200C) Revised Actuarial Memo 20YT (ICC18B60300A) Revised Actuarial Memo 30YT (ICC18Q60400C) Revised Actuarial Memo Child Rider (ICC18B60053) Revised Actuarial Memo Whole Life (ICC18B60100GB) Revised Actuarial Memo Whole Life (ICC18B60C10) Revised Actuarial Memo Whole Life (ICC18B60100) Revised Actuarial Memo\n\nN/A","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **LIFE UNIFORM STANDARDS AND FORMS**\n\n### **TO WHICH THE STANDARDS APPLY**\n\n**STANDARD FORM(S) FORM(S) NUMBER**\n\n**Life Insurance Policy Uniform Standards**\n\nCompact A64000 Series Whole Life SOV Compact A68000 Series Whole Life SOV ICC18B60C10 SOV ICC18B60100 SOV ICC18B60100GBA SOV ICC18B60100GBNA SOV ICC18B60100NA SOV ICC18B61JWO SOV\n\nN/A\n\n**Uniform Standards for Filing Revisions to Life Insurance Rate Filings**\n\n30YT (ICC0964500) Revised Actuarial Memo 10YT (ICC0964200) Revised Actuarial Memo 20YT (ICC0964300) Revised Actuarial Memo Whole Life (ICC0964100) Revised Actuarial Memo 10YT Spouse Rider (ICC1368050) Revised Actuarial Memo 10YT (ICC18B60200) Revised Actuarial Memo 20YT (ICC18Q60300C) Revised Actuarial Memo Spouse 30YT (ICC18Q60052) Revised Actuarial Memo Spouse 20YT (ICC18Q60051) Revised Actuarial Memo 20YT Spouse Rider (ICC0964051) Revised Actuarial Memo Whole Life (ICC1368C10) Revised Actuarial Memo 30YT (ICC18B60400) Revised Actuarial Memo 30YT Spouse Rider (ICC0964052) Revised Actuarial Memo 10YT (ICC1368200) Revised Actuarial Memo 20YT (ICC1368300) Revised Actuarial Memo 20YT Spouse Rider (ICC1368051) Revised Actuarial Memo 30YT (ICC18B60400A) Revised Actuarial Memo 10YT Spouse Rider (ICC0964050) Revised Actuarial Memo Child Rider (ICC0964053) Revised Actuarial Memo 30YT Spouse Rider (ICC1368052) Revised Actuarial Memo Juvenile Whole Life (ICC18B61JWO) Revised Actuarial Memo 30YT (ICC1368400) Revised Actuarial Memo Child Rider (ICC1368400) Revised Actuarial Memo Juvenile Term Life (ICC18B61JTO) Revised Actuarial Memo Whole Life (ICC1368100) Revised Actuarial Memo Spouse 10YT (ICC18Q60050) Revised Actuarial Memo 10YT (ICC18B60200A) Revised Actuarial Memo 20YT (ICC18B60300) Revised Actuarial Memo 10YT (ICC18Q60200C) Revised Actuarial Memo 20YT (ICC18B60300A) Revised Actuarial Memo 30YT (ICC18Q60400C) Revised Actuarial Memo Child Rider (ICC18B60053) Revised Actuarial Memo Whole Life (ICC18B60100GB) Revised Actuarial Memo Whole Life (ICC18B60C10) Revised Actuarial Memo Whole Life (ICC18B60100) Revised Actuarial Memo\n\nN/A","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page42.pdf"]},"response":{"errors":[],"extract_id":"extract_dfd0221529758ecb2b1dbd58069ea19d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **LIFE UNIFORM STANDARDS AND FORMS**\n\n### **TO WHICH THE STANDARDS APPLY**\n\n**STANDARD FORM(S) FORM(S) NUMBER**\n\n**Life Insurance Policy Uniform Standards**\n\nCompact A64000 Series Whole Life SOV Compact A68000 Series Whole Life SOV ICC18B60C10 SOV ICC18B60100 SOV ICC18B60100GBA SOV ICC18B60100GBNA SOV ICC18B60100NA SOV ICC18B61JWO SOV\n\nN/A\n\n**Uniform Standards for Filing Revisions to Life Insurance Rate Filings**\n\n30YT (ICC0964500) Revised Actuarial Memo 10YT (ICC0964200) Revised Actuarial Memo 20YT (ICC0964300) Revised Actuarial Memo Whole Life (ICC0964100) Revised Actuarial Memo 10YT Spouse Rider (ICC1368050) Revised Actuarial Memo 10YT (ICC18B60200) Revised Actuarial Memo 20YT (ICC18Q60300C) Revised Actuarial Memo Spouse 30YT (ICC18Q60052) Revised Actuarial Memo Spouse 20YT (ICC18Q60051) Revised Actuarial Memo 20YT Spouse Rider (ICC0964051) Revised Actuarial Memo Whole Life (ICC1368C10) Revised Actuarial Memo 30YT (ICC18B60400) Revised Actuarial Memo 30YT Spouse Rider (ICC0964052) Revised Actuarial Memo 10YT (ICC1368200) Revised Actuarial Memo 20YT (ICC1368300) Revised Actuarial Memo 20YT Spouse Rider (ICC1368051) Revised Actuarial Memo 30YT (ICC18B60400A) Revised Actuarial Memo 10YT Spouse Rider (ICC0964050) Revised Actuarial Memo Child Rider (ICC0964053) Revised Actuarial Memo 30YT Spouse Rider (ICC1368052) Revised Actuarial Memo Juvenile Whole Life (ICC18B61JWO) Revised Actuarial Memo 30YT (ICC1368400) Revised Actuarial Memo Child Rider (ICC1368400) Revised Actuarial Memo Juvenile Term Life (ICC18B61JTO) Revised Actuarial Memo Whole Life (ICC1368100) Revised Actuarial Memo Spouse 10YT (ICC18Q60050) Revised Actuarial Memo 10YT (ICC18B60200A) Revised Actuarial Memo 20YT (ICC18B60300) Revised Actuarial Memo 10YT (ICC18Q60200C) Revised Actuarial Memo 20YT (ICC18B60300A) Revised Actuarial Memo 30YT (ICC18Q60400C) Revised Actuarial Memo Child Rider (ICC18B60053) Revised Actuarial Memo Whole Life (ICC18B60100GB) Revised Actuarial Memo Whole Life (ICC18B60C10) Revised Actuarial Memo Whole Life (ICC18B60100) Revised Actuarial Memo\n\nN/A"],"full_content":"### **LIFE UNIFORM STANDARDS AND FORMS**\n\n### **TO WHICH THE STANDARDS APPLY**\n\n**STANDARD FORM(S) FORM(S) NUMBER**\n\n**Life Insurance Policy Uniform Standards**\n\nCompact A64000 Series Whole Life SOV Compact A68000 Series Whole Life SOV ICC18B60C10 SOV ICC18B60100 SOV ICC18B60100GBA SOV ICC18B60100GBNA SOV ICC18B60100NA SOV ICC18B61JWO SOV\n\nN/A\n\n**Uniform Standards for Filing Revisions to Life Insurance Rate Filings**\n\n30YT (ICC0964500) Revised Actuarial Memo 10YT (ICC0964200) Revised Actuarial Memo 20YT (ICC0964300) Revised Actuarial Memo Whole Life (ICC0964100) Revised Actuarial Memo 10YT Spouse Rider (ICC1368050) Revised Actuarial Memo 10YT (ICC18B60200) Revised Actuarial Memo 20YT (ICC18Q60300C) Revised Actuarial Memo Spouse 30YT (ICC18Q60052) Revised Actuarial Memo Spouse 20YT (ICC18Q60051) Revised Actuarial Memo 20YT Spouse Rider (ICC0964051) Revised Actuarial Memo Whole Life (ICC1368C10) Revised Actuarial Memo 30YT (ICC18B60400) Revised Actuarial Memo 30YT Spouse Rider (ICC0964052) Revised Actuarial Memo 10YT (ICC1368200) Revised Actuarial Memo 20YT (ICC1368300) Revised Actuarial Memo 20YT Spouse Rider (ICC1368051) Revised Actuarial Memo 30YT (ICC18B60400A) Revised Actuarial Memo 10YT Spouse Rider (ICC0964050) Revised Actuarial Memo Child Rider (ICC0964053) Revised Actuarial Memo 30YT Spouse Rider (ICC1368052) Revised Actuarial Memo Juvenile Whole Life (ICC18B61JWO) Revised Actuarial Memo 30YT (ICC1368400) Revised Actuarial Memo Child Rider (ICC1368400) Revised Actuarial Memo Juvenile Term Life (ICC18B61JTO) Revised Actuarial Memo Whole Life (ICC1368100) Revised Actuarial Memo Spouse 10YT (ICC18Q60050) Revised Actuarial Memo 10YT (ICC18B60200A) Revised Actuarial Memo 20YT (ICC18B60300) Revised Actuarial Memo 10YT (ICC18Q60200C) Revised Actuarial Memo 20YT (ICC18B60300A) Revised Actuarial Memo 30YT (ICC18Q60400C) Revised Actuarial Memo Child Rider (ICC18B60053) Revised Actuarial Memo Whole Life (ICC18B60100GB) Revised Actuarial Memo Whole Life (ICC18B60C10) Revised Actuarial Memo Whole Life (ICC18B60100) Revised Actuarial Memo\n\nN/A","publish_date":null,"title":"LIFE UNIFORM STANDARDS AND FORMS TO WHICH THE STANDARDS APPLY","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page42.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page42.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page42","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page42.pdf"},"started_at":"2026-11-04T19:47:57.737306"} +{"completed_at":"2026-11-04T19:48:02.261621","latency_in_ms":2747,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page50","grounded_pages":[],"layout_pages":[],"markdown":"**Term Life Appendix IV**\n\nPV of PV of Policy Mortality Death Death PV of Annual PV of NLP Net Net Minimum Year Age Rate v Benefit Benefit Benefits Premium Premiums äx Premium Premium Cash Value 31 66 0.00926 0.31942 100,000 0.4062 40,623.87 2,778.00 123,380.19 13.1049 1,245.97 55,337.85 0.00 32 67 0.01022 0.30788 100,000 0.4161 41,606.54 3,066.00 126,294.26 12.6763 1,375.15 56,644.86 0.00 33 68 0.01129 0.29675 100,000 0.4258 42,579.95 3,387.00 129,169.43 12.2392 1,519.12 57,934.41 0.00 34 69 0.01253 0.28603 100,000 0.4354 43,539.26 3,759.00 131,989.43 11.7938 1,685.97 59,199.23 0.00 35 70 0.01400 0.27569 100,000 0.4448 44,476.27 4,200.00 134,727.20 11.3407 1,883.76 60,427.16 0.00 36 71 0.01574 0.26572 100,000 0.4538 45,379.44 4,722.00 137,344.80 10.8808 2,117.89 61,601.19 0.00 37 72 0.01779 0.25612 100,000 0.4623 46,234.91 5,337.00 139,796.55 10.4153 2,393.72 62,700.84 0.00 38 73 0.02015 0.24686 100,000 0.4703 47,026.31 6,045.00 142,028.47 9.9453 2,711.27 63,701.89 0.00 39 74 0.02282 0.23794 100,000 0.4774 47,736.69 6,846.00 143,984.13 9.4716 3,070.53 64,579.03 0.00 40 75 0.02576 0.22934 100,000 0.4835 48,348.12 7,728.00 145,603.49 8.9945 3,466.12 65,305.33 0.00 41 76 0.02899 0.22105 100,000 0.4884 48,843.38 8,697.00 146,828.11 8.5136 3,900.73 65,854.59 0.00 42 77 0.03256 0.21306 100,000 0.4920 49,202.39 9,768.00 147,589.65 8.0281 4,381.09 66,196.16 0.00 43 78 0.03657 0.20536 100,000 0.4940 49,399.94 10,971.00 147,802.41 7.5370 4,920.66 66,291.58 0.00 44 79 0.04117 0.19794 100,000 0.4940 49,402.07 12,351.00 147,351.22 7.0396 5,539.61 66,089.22 0.00 45 80 0.04651 0.19078 100,000 0.4916 49,161.63 13,953.00 146,076.71 6.5352 6,258.13 65,517.58 0.00 46 81 0.05261 0.18389 100,000 0.4862 48,615.29 15,783.00 143,764.85 6.0229 7,078.91 64,480.68 0.00 47 82 0.05959 0.17724 100,000 0.4769 47,686.13 17,877.00 140,154.71 5.5006 8,018.10 62,861.47 0.00 48 83 0.06768 0.17083 100,000 0.4627 46,272.76 20,304.00 134,901.93 4.9653 9,106.65 60,505.52 0.00 49 84 0.07708 0.16466 100,000 0.4423 44,233.72 23,124.00 127,526.33 4.4126 10,371.46 57,197.46 0.00 50 85 0.08797 0.15871 100,000 0.4137 41,373.56 26,391.00 117,363.82 3.8363 11,836.76 52,639.42 0.00 51 86 0.10052 0.15297 100,000 0.3742 37,419.90 28,648.00 103,488.15 3.2265 12,849.05 46,415.98 0.00 52 87 0.11482 0.14744 100,000 0.3199 31,986.42 31,158.00 86,323.94 2.5681 13,974.83 38,717.57 0.00 53 88 0.13065 0.14211 100,000 0.2452 24,519.21 33,875.00 64,658.79 1.8379 15,193.44 29,000.43 0.00 54 89 0.14767 0.13698 100,000 0.1423 14,233.25 36,738.00 36,738.00 1.0000 16,477.54 16,477.54 0.00 55 90 0.16549 0.13202 0 0.0000 0.00 0.00 0.00 0.0000 0.00 0.00 0.00","pages":[{"line_numbers":[],"markdown":"**Term Life Appendix IV**\n\nPV of PV of Policy Mortality Death Death PV of Annual PV of NLP Net Net Minimum Year Age Rate v Benefit Benefit Benefits Premium Premiums äx Premium Premium Cash Value 31 66 0.00926 0.31942 100,000 0.4062 40,623.87 2,778.00 123,380.19 13.1049 1,245.97 55,337.85 0.00 32 67 0.01022 0.30788 100,000 0.4161 41,606.54 3,066.00 126,294.26 12.6763 1,375.15 56,644.86 0.00 33 68 0.01129 0.29675 100,000 0.4258 42,579.95 3,387.00 129,169.43 12.2392 1,519.12 57,934.41 0.00 34 69 0.01253 0.28603 100,000 0.4354 43,539.26 3,759.00 131,989.43 11.7938 1,685.97 59,199.23 0.00 35 70 0.01400 0.27569 100,000 0.4448 44,476.27 4,200.00 134,727.20 11.3407 1,883.76 60,427.16 0.00 36 71 0.01574 0.26572 100,000 0.4538 45,379.44 4,722.00 137,344.80 10.8808 2,117.89 61,601.19 0.00 37 72 0.01779 0.25612 100,000 0.4623 46,234.91 5,337.00 139,796.55 10.4153 2,393.72 62,700.84 0.00 38 73 0.02015 0.24686 100,000 0.4703 47,026.31 6,045.00 142,028.47 9.9453 2,711.27 63,701.89 0.00 39 74 0.02282 0.23794 100,000 0.4774 47,736.69 6,846.00 143,984.13 9.4716 3,070.53 64,579.03 0.00 40 75 0.02576 0.22934 100,000 0.4835 48,348.12 7,728.00 145,603.49 8.9945 3,466.12 65,305.33 0.00 41 76 0.02899 0.22105 100,000 0.4884 48,843.38 8,697.00 146,828.11 8.5136 3,900.73 65,854.59 0.00 42 77 0.03256 0.21306 100,000 0.4920 49,202.39 9,768.00 147,589.65 8.0281 4,381.09 66,196.16 0.00 43 78 0.03657 0.20536 100,000 0.4940 49,399.94 10,971.00 147,802.41 7.5370 4,920.66 66,291.58 0.00 44 79 0.04117 0.19794 100,000 0.4940 49,402.07 12,351.00 147,351.22 7.0396 5,539.61 66,089.22 0.00 45 80 0.04651 0.19078 100,000 0.4916 49,161.63 13,953.00 146,076.71 6.5352 6,258.13 65,517.58 0.00 46 81 0.05261 0.18389 100,000 0.4862 48,615.29 15,783.00 143,764.85 6.0229 7,078.91 64,480.68 0.00 47 82 0.05959 0.17724 100,000 0.4769 47,686.13 17,877.00 140,154.71 5.5006 8,018.10 62,861.47 0.00 48 83 0.06768 0.17083 100,000 0.4627 46,272.76 20,304.00 134,901.93 4.9653 9,106.65 60,505.52 0.00 49 84 0.07708 0.16466 100,000 0.4423 44,233.72 23,124.00 127,526.33 4.4126 10,371.46 57,197.46 0.00 50 85 0.08797 0.15871 100,000 0.4137 41,373.56 26,391.00 117,363.82 3.8363 11,836.76 52,639.42 0.00 51 86 0.10052 0.15297 100,000 0.3742 37,419.90 28,648.00 103,488.15 3.2265 12,849.05 46,415.98 0.00 52 87 0.11482 0.14744 100,000 0.3199 31,986.42 31,158.00 86,323.94 2.5681 13,974.83 38,717.57 0.00 53 88 0.13065 0.14211 100,000 0.2452 24,519.21 33,875.00 64,658.79 1.8379 15,193.44 29,000.43 0.00 54 89 0.14767 0.13698 100,000 0.1423 14,233.25 36,738.00 36,738.00 1.0000 16,477.54 16,477.54 0.00 55 90 0.16549 0.13202 0 0.0000 0.00 0.00 0.00 0.0000 0.00 0.00 0.00","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Term Life Appendix IV**\n\nPV of PV of Policy Mortality Death Death PV of Annual PV of NLP Net Net Minimum Year Age Rate v Benefit Benefit Benefits Premium Premiums äx Premium Premium Cash Value 31 66 0.00926 0.31942 100,000 0.4062 40,623.87 2,778.00 123,380.19 13.1049 1,245.97 55,337.85 0.00 32 67 0.01022 0.30788 100,000 0.4161 41,606.54 3,066.00 126,294.26 12.6763 1,375.15 56,644.86 0.00 33 68 0.01129 0.29675 100,000 0.4258 42,579.95 3,387.00 129,169.43 12.2392 1,519.12 57,934.41 0.00 34 69 0.01253 0.28603 100,000 0.4354 43,539.26 3,759.00 131,989.43 11.7938 1,685.97 59,199.23 0.00 35 70 0.01400 0.27569 100,000 0.4448 44,476.27 4,200.00 134,727.20 11.3407 1,883.76 60,427.16 0.00 36 71 0.01574 0.26572 100,000 0.4538 45,379.44 4,722.00 137,344.80 10.8808 2,117.89 61,601.19 0.00 37 72 0.01779 0.25612 100,000 0.4623 46,234.91 5,337.00 139,796.55 10.4153 2,393.72 62,700.84 0.00 38 73 0.02015 0.24686 100,000 0.4703 47,026.31 6,045.00 142,028.47 9.9453 2,711.27 63,701.89 0.00 39 74 0.02282 0.23794 100,000 0.4774 47,736.69 6,846.00 143,984.13 9.4716 3,070.53 64,579.03 0.00 40 75 0.02576 0.22934 100,000 0.4835 48,348.12 7,728.00 145,603.49 8.9945 3,466.12 65,305.33 0.00 41 76 0.02899 0.22105 100,000 0.4884 48,843.38 8,697.00 146,828.11 8.5136 3,900.73 65,854.59 0.00 42 77 0.03256 0.21306 100,000 0.4920 49,202.39 9,768.00 147,589.65 8.0281 4,381.09 66,196.16 0.00 43 78 0.03657 0.20536 100,000 0.4940 49,399.94 10,971.00 147,802.41 7.5370 4,920.66 66,291.58 0.00 44 79 0.04117 0.19794 100,000 0.4940 49,402.07 12,351.00 147,351.22 7.0396 5,539.61 66,089.22 0.00 45 80 0.04651 0.19078 100,000 0.4916 49,161.63 13,953.00 146,076.71 6.5352 6,258.13 65,517.58 0.00 46 81 0.05261 0.18389 100,000 0.4862 48,615.29 15,783.00 143,764.85 6.0229 7,078.91 64,480.68 0.00 47 82 0.05959 0.17724 100,000 0.4769 47,686.13 17,877.00 140,154.71 5.5006 8,018.10 62,861.47 0.00 48 83 0.06768 0.17083 100,000 0.4627 46,272.76 20,304.00 134,901.93 4.9653 9,106.65 60,505.52 0.00 49 84 0.07708 0.16466 100,000 0.4423 44,233.72 23,124.00 127,526.33 4.4126 10,371.46 57,197.46 0.00 50 85 0.08797 0.15871 100,000 0.4137 41,373.56 26,391.00 117,363.82 3.8363 11,836.76 52,639.42 0.00 51 86 0.10052 0.15297 100,000 0.3742 37,419.90 28,648.00 103,488.15 3.2265 12,849.05 46,415.98 0.00 52 87 0.11482 0.14744 100,000 0.3199 31,986.42 31,158.00 86,323.94 2.5681 13,974.83 38,717.57 0.00 53 88 0.13065 0.14211 100,000 0.2452 24,519.21 33,875.00 64,658.79 1.8379 15,193.44 29,000.43 0.00 54 89 0.14767 0.13698 100,000 0.1423 14,233.25 36,738.00 36,738.00 1.0000 16,477.54 16,477.54 0.00 55 90 0.16549 0.13202 0 0.0000 0.00 0.00 0.00 0.0000 0.00 0.00 0.00","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page50.pdf"]},"response":{"errors":[],"extract_id":"extract_49906175887a87d6c68afea9778f79ed","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Term Life Appendix IV**\n\nPV of PV of Policy Mortality Death Death PV of Annual PV of NLP Net Net Minimum Year Age Rate v Benefit Benefit Benefits Premium Premiums äx Premium Premium Cash Value 31 66 0.00926 0.31942 100,000 0.4062 40,623.87 2,778.00 123,380.19 13.1049 1,245.97 55,337.85 0.00 32 67 0.01022 0.30788 100,000 0.4161 41,606.54 3,066.00 126,294.26 12.6763 1,375.15 56,644.86 0.00 33 68 0.01129 0.29675 100,000 0.4258 42,579.95 3,387.00 129,169.43 12.2392 1,519.12 57,934.41 0.00 34 69 0.01253 0.28603 100,000 0.4354 43,539.26 3,759.00 131,989.43 11.7938 1,685.97 59,199.23 0.00 35 70 0.01400 0.27569 100,000 0.4448 44,476.27 4,200.00 134,727.20 11.3407 1,883.76 60,427.16 0.00 36 71 0.01574 0.26572 100,000 0.4538 45,379.44 4,722.00 137,344.80 10.8808 2,117.89 61,601.19 0.00 37 72 0.01779 0.25612 100,000 0.4623 46,234.91 5,337.00 139,796.55 10.4153 2,393.72 62,700.84 0.00 38 73 0.02015 0.24686 100,000 0.4703 47,026.31 6,045.00 142,028.47 9.9453 2,711.27 63,701.89 0.00 39 74 0.02282 0.23794 100,000 0.4774 47,736.69 6,846.00 143,984.13 9.4716 3,070.53 64,579.03 0.00 40 75 0.02576 0.22934 100,000 0.4835 48,348.12 7,728.00 145,603.49 8.9945 3,466.12 65,305.33 0.00 41 76 0.02899 0.22105 100,000 0.4884 48,843.38 8,697.00 146,828.11 8.5136 3,900.73 65,854.59 0.00 42 77 0.03256 0.21306 100,000 0.4920 49,202.39 9,768.00 147,589.65 8.0281 4,381.09 66,196.16 0.00 43 78 0.03657 0.20536 100,000 0.4940 49,399.94 10,971.00 147,802.41 7.5370 4,920.66 66,291.58 0.00 44 79 0.04117 0.19794 100,000 0.4940 49,402.07 12,351.00 147,351.22 7.0396 5,539.61 66,089.22 0.00 45 80 0.04651 0.19078 100,000 0.4916 49,161.63 13,953.00 146,076.71 6.5352 6,258.13 65,517.58 0.00 46 81 0.05261 0.18389 100,000 0.4862 48,615.29 15,783.00 143,764.85 6.0229 7,078.91 64,480.68 0.00 47 82 0.05959 0.17724 100,000 0.4769 47,686.13 17,877.00 140,154.71 5.5006 8,018.10 62,861.47 0.00 48 83 0.06768 0.17083 100,000 0.4627 46,272.76 20,304.00 134,901.93 4.9653 9,106.65 60,505.52 0.00 49 84 0.07708 0.16466 100,000 0.4423 44,233.72 23,124.00 127,526.33 4.4126 10,371.46 57,197.46 0.00 50 85 0.08797 0.15871 100,000 0.4137 41,373.56 26,391.00 117,363.82 3.8363 11,836.76 52,639.42 0.00 51 86 0.10052 0.15297 100,000 0.3742 37,419.90 28,648.00 103,488.15 3.2265 12,849.05 46,415.98 0.00 52 87 0.11482 0.14744 100,000 0.3199 31,986.42 31,158.00 86,323.94 2.5681 13,974.83 38,717.57 0.00 53 88 0.13065 0.14211 100,000 0.2452 24,519.21 33,875.00 64,658.79 1.8379 15,193.44 29,000.43 0.00 54 89 0.14767 0.13698 100,000 0.1423 14,233.25 36,738.00 36,738.00 1.0000 16,477.54 16,477.54 0.00 55 90 0.16549 0.13202 0 0.0000 0.00 0.00 0.00 0.0000 0.00 0.00 0.00"],"full_content":"**Term Life Appendix IV**\n\nPV of PV of Policy Mortality Death Death PV of Annual PV of NLP Net Net Minimum Year Age Rate v Benefit Benefit Benefits Premium Premiums äx Premium Premium Cash Value 31 66 0.00926 0.31942 100,000 0.4062 40,623.87 2,778.00 123,380.19 13.1049 1,245.97 55,337.85 0.00 32 67 0.01022 0.30788 100,000 0.4161 41,606.54 3,066.00 126,294.26 12.6763 1,375.15 56,644.86 0.00 33 68 0.01129 0.29675 100,000 0.4258 42,579.95 3,387.00 129,169.43 12.2392 1,519.12 57,934.41 0.00 34 69 0.01253 0.28603 100,000 0.4354 43,539.26 3,759.00 131,989.43 11.7938 1,685.97 59,199.23 0.00 35 70 0.01400 0.27569 100,000 0.4448 44,476.27 4,200.00 134,727.20 11.3407 1,883.76 60,427.16 0.00 36 71 0.01574 0.26572 100,000 0.4538 45,379.44 4,722.00 137,344.80 10.8808 2,117.89 61,601.19 0.00 37 72 0.01779 0.25612 100,000 0.4623 46,234.91 5,337.00 139,796.55 10.4153 2,393.72 62,700.84 0.00 38 73 0.02015 0.24686 100,000 0.4703 47,026.31 6,045.00 142,028.47 9.9453 2,711.27 63,701.89 0.00 39 74 0.02282 0.23794 100,000 0.4774 47,736.69 6,846.00 143,984.13 9.4716 3,070.53 64,579.03 0.00 40 75 0.02576 0.22934 100,000 0.4835 48,348.12 7,728.00 145,603.49 8.9945 3,466.12 65,305.33 0.00 41 76 0.02899 0.22105 100,000 0.4884 48,843.38 8,697.00 146,828.11 8.5136 3,900.73 65,854.59 0.00 42 77 0.03256 0.21306 100,000 0.4920 49,202.39 9,768.00 147,589.65 8.0281 4,381.09 66,196.16 0.00 43 78 0.03657 0.20536 100,000 0.4940 49,399.94 10,971.00 147,802.41 7.5370 4,920.66 66,291.58 0.00 44 79 0.04117 0.19794 100,000 0.4940 49,402.07 12,351.00 147,351.22 7.0396 5,539.61 66,089.22 0.00 45 80 0.04651 0.19078 100,000 0.4916 49,161.63 13,953.00 146,076.71 6.5352 6,258.13 65,517.58 0.00 46 81 0.05261 0.18389 100,000 0.4862 48,615.29 15,783.00 143,764.85 6.0229 7,078.91 64,480.68 0.00 47 82 0.05959 0.17724 100,000 0.4769 47,686.13 17,877.00 140,154.71 5.5006 8,018.10 62,861.47 0.00 48 83 0.06768 0.17083 100,000 0.4627 46,272.76 20,304.00 134,901.93 4.9653 9,106.65 60,505.52 0.00 49 84 0.07708 0.16466 100,000 0.4423 44,233.72 23,124.00 127,526.33 4.4126 10,371.46 57,197.46 0.00 50 85 0.08797 0.15871 100,000 0.4137 41,373.56 26,391.00 117,363.82 3.8363 11,836.76 52,639.42 0.00 51 86 0.10052 0.15297 100,000 0.3742 37,419.90 28,648.00 103,488.15 3.2265 12,849.05 46,415.98 0.00 52 87 0.11482 0.14744 100,000 0.3199 31,986.42 31,158.00 86,323.94 2.5681 13,974.83 38,717.57 0.00 53 88 0.13065 0.14211 100,000 0.2452 24,519.21 33,875.00 64,658.79 1.8379 15,193.44 29,000.43 0.00 54 89 0.14767 0.13698 100,000 0.1423 14,233.25 36,738.00 36,738.00 1.0000 16,477.54 16,477.54 0.00 55 90 0.16549 0.13202 0 0.0000 0.00 0.00 0.00 0.0000 0.00 0.00 0.00","publish_date":null,"title":"Term Life Appendix IV PV of PV of Policy Mortality Death Death PV of Annual PV of NLP Net Net","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page50.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page50.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page50","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page50.pdf"},"started_at":"2026-11-04T19:47:59.513719"} +{"completed_at":"2026-11-04T19:48:03.852839","latency_in_ms":3541,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page80","grounded_pages":[],"layout_pages":[],"markdown":"**_Plan_** 20Pay **NF Interest Rate** 3\\.75%\n\n**_Sex_** M **\\# of Prem Payments (n)** 20\n\n**_Class_** SN\n\n**_Issue Age_** 35 **PVFB** 212\\.2229\n\n**_Face Amount_** 100,000 **NLP** 14\\.7039\n\n**Pa** 16\\.9809\n\n**Beginning of Reduced**\n\n**Beginning Year Paid-up**\n\n**Of SNFL**\n\n**Year Age 1000\\*qx tpx Lx Cx Dx Mx Mbarx Nx 1000\\*Ax+t 1000\\*ABarx+t PVFBx+t PVFP** **a**\n\n**x+t t** **CV** **x t** **RPU** **x**\n\n1 35 1.41 1.0000000 1,000.0000 1.3590 1,000.0000 208.3405 212.2229 21,902.5797 208.3405 212.2229 14.1690 212.2229 240.6028 - -\n\n2 36 1.54 0.9985900 998.5900 1.4287 962.4964 206.9815 210.8385 20,902.5797 215.0465 219.0539 13.6822 219.0539 232.3353 - -\n\n3 37 1.69 0.9970522 997.0522 1.5088 926.2787 205.5528 209.3833 19,940.0833 221.9125 226.0478 13.1780 226.0478 223.7749 228.00 1,008.64\n\n4 38 1.83 0.9953672 995.3672 1.5721 891.2899 204.0440 207.8463 19,013.8046 228.9311 233.1972 12.6561 233.1972 214.9120 1,829.00 7,843.15\n\n5 39 1.98 0.9935456 993.5456 1.6365 857.5025 202.4719 206.2449 18,122.5147 236.1181 240.5181 12.1154 240.5181 205.7300 3,479.00 14,464.61\n\n6 40 2.13 0.9915784 991.5784 1.6935 824.8720 200.8354 204.5779 17,265.0122 243.4746 248.0117 11.5551 248.0117 196.2157 5,180.00 20,886.11\n\n7 41 2.27 0.9894663 989.4663 1.7358 793.3638 199.1419 202.8529 16,440.1402 251.0095 255.6871 10.9743 255.6871 186.3530 6,934.00 27,119.08\n\n8 42 2.39 0.9872203 987.2203 1.7575 762.9522 197.4061 201.0847 15,646.7764 258.7397 263.5613 10.3719 263.5613 176.1234 8,744.00 33,176.34\n\n9 43 2.44 0.9848608 984.8608 1.7253 733.6181 195.6485 199.2944 14,883.8242 266.6899 271.6596 9.7466 271.6596 165.5059 10,616.00 39,078.31\n\n10 44 2.51 0.9824577 982.4577 1.7065 705.3764 193.9232 197.5369 14,150.2062 274.9215 280.0447 9.0968 280.0447 154.4717 12,558.00 44,842.84\n\n11 45 2.57 0.9799918 979.9918 1.6799 678.1744 192.2167 195.7986 13,444.8297 283.4325 288.7143 8.4216 288.7143 143.0056 14,571.00 50,468.58\n\n12 46 2.64 0.9774732 977.4732 1.6590 651.9821 190.5368 194.0874 12,766.6554 292.2423 297.6882 7.7197 297.6882 131.0876 16,661.00 55,967.95\n\n13 47 2.71 0.9748927 974.8927 1.6371 626.7575 188.8777 192.3975 12,114.6732 301.3570 306.9727 6.9902 306.9727 118.6990 18,828.00 61,334.43\n\n14 48 2.77 0.9722507 972.2507 1.6085 602.4665 187.2406 190.7298 11,487.9157 310.7901 316.5817 6.2317 316.5817 105.8194 21,077.00 66,576.82\n\n15 49 2.87 0.9695576 969.5576 1.6019 579.0821 185.6321 189.0914 10,885.4492 320.5627 326.5364 5.4429 326.5364 92.4259 23,412.00 71,697.99\n\n16 50 3.01 0.9667749 966.7749 1.6147 556.5495 184.0302 187.4596 10,306.3672 330.6628 336.8247 4.6228 336.8247 78.4995 25,833.00 76,695.69\n\n17 51 3.19 0.9638650 963.8650 1.6444 534.8186 182.4156 185.8149 9,749.8176 341.0793 347.4353 3.7700 347.4353 64.0183 28,342.00 81,574.90\n\n18 52 3.39 0.9607902 960.7902 1.6790 513.8434 180.7711 184.1398 9,214.9990 351.8020 358.3578 2.8831 358.3578 48.9575 30,941.00 86,341.07\n\n19 53 3.63 0.9575331 957.5331 1.7270 493.5918 179.0922 182.4296 8,701.1556 362.8346 369.5960 1.9604 369.5960 33.2886 33,631.00 90,993.95\n\n20 54 3.90 0.9540573 954.0573 1.7819 474.0241 177.3652 180.6704 8,207.5639 374.1691 381.1418 1.0000 381.1418 16.9809 36,417.00 95,547.13\n\n21 55 4.22 0.9503365 950.3365 1.8511 455.1089 175.5833 178.8553 7,733.5397 385.8051 392.9946 - 392.9946 - 39,300.00 100,000.00\n\n22 56 4.58 0.9463261 946.3261 1.9283 436.8080 173.7322 176.9697 7,278.4309 397.7312 405.1429 - 405.1429 - 40,515.00 100,000.00\n\n23 57 5.00 0.9419919 941.9919 2.0197 419.0915 171.8039 175.0055 6,841.6229 409.9437 417.5830 - 417.5830 - 41,759.00 100,000.00\n\n24 58 5.48 0.9372819 937.2819 2.1229 401.9239 169.7842 172.9481 6,422.5314 422.4287 430.3007 - 430.3007 - 43,031.00 100,000.00\n\n25 59 6.04 0.9321456 932.1456 2.2429 385.2736 167.6613 170.7856 6,020.6075 435.1746 443.2840 - 443.2840 - 44,329.00 100,000.00\n\n26 60 6.67 0.9265155 926.5155 2.3729 369.1051 165.4183 168.5009 5,635.3339 448.1605 456.5120 - 456.5120 - 45,652.00 100,000.00\n\n27 61 7.40 0.9203356 920.3356 2.5206 353.3910 163.0454 166.0837 5,266.2288 461.3739 469.9716 - 469.9716 - 46,998.00 100,000.00\n\n28 62 8.22 0.9135251 913.5251 2.6787 338.0973 160.5248 163.5162 4,912.8378 474.7888 483.6365 - 483.6365 - 48,364.00 100,000.00\n\n29 63 9.14 0.9060159 906.0159 2.8473 323.1982 157.8461 160.7876 4,574.7406 488.3880 497.4891 - 497.4891 - 49,749.00 100,000.00\n\n30 64 10.13 0.8977350 897.7350 3.0138 308.6690 154.9988 157.8872 4,251.5424 502.1522 511.5098 - 511.5098 - 51,151.00 100,000.00\n\n31 65 11.18 0.8886409 888.6409 3.1735 294.4985 151.9850 154.8173 3,942.8734 516.0808 525.6979 - 525.6979 - 52,570.00 100,000.00\n\n**Country Life Insurance Company**\n\n**_Policy Form ICC18(WL)_**\n\n𝒂̈ 𝒙 𝒕:𝒏|","pages":[{"line_numbers":[],"markdown":"**_Plan_** 20Pay **NF Interest Rate** 3\\.75%\n\n**_Sex_** M **\\# of Prem Payments (n)** 20\n\n**_Class_** SN\n\n**_Issue Age_** 35 **PVFB** 212\\.2229\n\n**_Face Amount_** 100,000 **NLP** 14\\.7039\n\n**Pa** 16\\.9809\n\n**Beginning of Reduced**\n\n**Beginning Year Paid-up**\n\n**Of SNFL**\n\n**Year Age 1000\\*qx tpx Lx Cx Dx Mx Mbarx Nx 1000\\*Ax+t 1000\\*ABarx+t PVFBx+t PVFP** **a**\n\n**x+t t** **CV** **x t** **RPU** **x**\n\n1 35 1.41 1.0000000 1,000.0000 1.3590 1,000.0000 208.3405 212.2229 21,902.5797 208.3405 212.2229 14.1690 212.2229 240.6028 - -\n\n2 36 1.54 0.9985900 998.5900 1.4287 962.4964 206.9815 210.8385 20,902.5797 215.0465 219.0539 13.6822 219.0539 232.3353 - -\n\n3 37 1.69 0.9970522 997.0522 1.5088 926.2787 205.5528 209.3833 19,940.0833 221.9125 226.0478 13.1780 226.0478 223.7749 228.00 1,008.64\n\n4 38 1.83 0.9953672 995.3672 1.5721 891.2899 204.0440 207.8463 19,013.8046 228.9311 233.1972 12.6561 233.1972 214.9120 1,829.00 7,843.15\n\n5 39 1.98 0.9935456 993.5456 1.6365 857.5025 202.4719 206.2449 18,122.5147 236.1181 240.5181 12.1154 240.5181 205.7300 3,479.00 14,464.61\n\n6 40 2.13 0.9915784 991.5784 1.6935 824.8720 200.8354 204.5779 17,265.0122 243.4746 248.0117 11.5551 248.0117 196.2157 5,180.00 20,886.11\n\n7 41 2.27 0.9894663 989.4663 1.7358 793.3638 199.1419 202.8529 16,440.1402 251.0095 255.6871 10.9743 255.6871 186.3530 6,934.00 27,119.08\n\n8 42 2.39 0.9872203 987.2203 1.7575 762.9522 197.4061 201.0847 15,646.7764 258.7397 263.5613 10.3719 263.5613 176.1234 8,744.00 33,176.34\n\n9 43 2.44 0.9848608 984.8608 1.7253 733.6181 195.6485 199.2944 14,883.8242 266.6899 271.6596 9.7466 271.6596 165.5059 10,616.00 39,078.31\n\n10 44 2.51 0.9824577 982.4577 1.7065 705.3764 193.9232 197.5369 14,150.2062 274.9215 280.0447 9.0968 280.0447 154.4717 12,558.00 44,842.84\n\n11 45 2.57 0.9799918 979.9918 1.6799 678.1744 192.2167 195.7986 13,444.8297 283.4325 288.7143 8.4216 288.7143 143.0056 14,571.00 50,468.58\n\n12 46 2.64 0.9774732 977.4732 1.6590 651.9821 190.5368 194.0874 12,766.6554 292.2423 297.6882 7.7197 297.6882 131.0876 16,661.00 55,967.95\n\n13 47 2.71 0.9748927 974.8927 1.6371 626.7575 188.8777 192.3975 12,114.6732 301.3570 306.9727 6.9902 306.9727 118.6990 18,828.00 61,334.43\n\n14 48 2.77 0.9722507 972.2507 1.6085 602.4665 187.2406 190.7298 11,487.9157 310.7901 316.5817 6.2317 316.5817 105.8194 21,077.00 66,576.82\n\n15 49 2.87 0.9695576 969.5576 1.6019 579.0821 185.6321 189.0914 10,885.4492 320.5627 326.5364 5.4429 326.5364 92.4259 23,412.00 71,697.99\n\n16 50 3.01 0.9667749 966.7749 1.6147 556.5495 184.0302 187.4596 10,306.3672 330.6628 336.8247 4.6228 336.8247 78.4995 25,833.00 76,695.69\n\n17 51 3.19 0.9638650 963.8650 1.6444 534.8186 182.4156 185.8149 9,749.8176 341.0793 347.4353 3.7700 347.4353 64.0183 28,342.00 81,574.90\n\n18 52 3.39 0.9607902 960.7902 1.6790 513.8434 180.7711 184.1398 9,214.9990 351.8020 358.3578 2.8831 358.3578 48.9575 30,941.00 86,341.07\n\n19 53 3.63 0.9575331 957.5331 1.7270 493.5918 179.0922 182.4296 8,701.1556 362.8346 369.5960 1.9604 369.5960 33.2886 33,631.00 90,993.95\n\n20 54 3.90 0.9540573 954.0573 1.7819 474.0241 177.3652 180.6704 8,207.5639 374.1691 381.1418 1.0000 381.1418 16.9809 36,417.00 95,547.13\n\n21 55 4.22 0.9503365 950.3365 1.8511 455.1089 175.5833 178.8553 7,733.5397 385.8051 392.9946 - 392.9946 - 39,300.00 100,000.00\n\n22 56 4.58 0.9463261 946.3261 1.9283 436.8080 173.7322 176.9697 7,278.4309 397.7312 405.1429 - 405.1429 - 40,515.00 100,000.00\n\n23 57 5.00 0.9419919 941.9919 2.0197 419.0915 171.8039 175.0055 6,841.6229 409.9437 417.5830 - 417.5830 - 41,759.00 100,000.00\n\n24 58 5.48 0.9372819 937.2819 2.1229 401.9239 169.7842 172.9481 6,422.5314 422.4287 430.3007 - 430.3007 - 43,031.00 100,000.00\n\n25 59 6.04 0.9321456 932.1456 2.2429 385.2736 167.6613 170.7856 6,020.6075 435.1746 443.2840 - 443.2840 - 44,329.00 100,000.00\n\n26 60 6.67 0.9265155 926.5155 2.3729 369.1051 165.4183 168.5009 5,635.3339 448.1605 456.5120 - 456.5120 - 45,652.00 100,000.00\n\n27 61 7.40 0.9203356 920.3356 2.5206 353.3910 163.0454 166.0837 5,266.2288 461.3739 469.9716 - 469.9716 - 46,998.00 100,000.00\n\n28 62 8.22 0.9135251 913.5251 2.6787 338.0973 160.5248 163.5162 4,912.8378 474.7888 483.6365 - 483.6365 - 48,364.00 100,000.00\n\n29 63 9.14 0.9060159 906.0159 2.8473 323.1982 157.8461 160.7876 4,574.7406 488.3880 497.4891 - 497.4891 - 49,749.00 100,000.00\n\n30 64 10.13 0.8977350 897.7350 3.0138 308.6690 154.9988 157.8872 4,251.5424 502.1522 511.5098 - 511.5098 - 51,151.00 100,000.00\n\n31 65 11.18 0.8886409 888.6409 3.1735 294.4985 151.9850 154.8173 3,942.8734 516.0808 525.6979 - 525.6979 - 52,570.00 100,000.00\n\n**Country Life Insurance Company**\n\n**_Policy Form ICC18(WL)_**\n\n𝒂̈ 𝒙 𝒕:𝒏|","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**_Plan_** 20Pay **NF Interest Rate** 3\\.75%\n\n**_Sex_** M **\\# of Prem Payments (n)** 20\n\n**_Class_** SN\n\n**_Issue Age_** 35 **PVFB** 212\\.2229\n\n**_Face Amount_** 100,000 **NLP** 14\\.7039\n\n**Pa** 16\\.9809\n\n**Beginning of Reduced**\n\n**Beginning Year Paid-up**\n\n**Of SNFL**\n\n**Year Age 1000\\*qx tpx Lx Cx Dx Mx Mbarx Nx 1000\\*Ax+t 1000\\*ABarx+t PVFBx+t PVFP** **a**\n\n**x+t t** **CV** **x t** **RPU** **x**\n\n1 35 1.41 1.0000000 1,000.0000 1.3590 1,000.0000 208.3405 212.2229 21,902.5797 208.3405 212.2229 14.1690 212.2229 240.6028 - -\n\n2 36 1.54 0.9985900 998.5900 1.4287 962.4964 206.9815 210.8385 20,902.5797 215.0465 219.0539 13.6822 219.0539 232.3353 - -\n\n3 37 1.69 0.9970522 997.0522 1.5088 926.2787 205.5528 209.3833 19,940.0833 221.9125 226.0478 13.1780 226.0478 223.7749 228.00 1,008.64\n\n4 38 1.83 0.9953672 995.3672 1.5721 891.2899 204.0440 207.8463 19,013.8046 228.9311 233.1972 12.6561 233.1972 214.9120 1,829.00 7,843.15\n\n5 39 1.98 0.9935456 993.5456 1.6365 857.5025 202.4719 206.2449 18,122.5147 236.1181 240.5181 12.1154 240.5181 205.7300 3,479.00 14,464.61\n\n6 40 2.13 0.9915784 991.5784 1.6935 824.8720 200.8354 204.5779 17,265.0122 243.4746 248.0117 11.5551 248.0117 196.2157 5,180.00 20,886.11\n\n7 41 2.27 0.9894663 989.4663 1.7358 793.3638 199.1419 202.8529 16,440.1402 251.0095 255.6871 10.9743 255.6871 186.3530 6,934.00 27,119.08\n\n8 42 2.39 0.9872203 987.2203 1.7575 762.9522 197.4061 201.0847 15,646.7764 258.7397 263.5613 10.3719 263.5613 176.1234 8,744.00 33,176.34\n\n9 43 2.44 0.9848608 984.8608 1.7253 733.6181 195.6485 199.2944 14,883.8242 266.6899 271.6596 9.7466 271.6596 165.5059 10,616.00 39,078.31\n\n10 44 2.51 0.9824577 982.4577 1.7065 705.3764 193.9232 197.5369 14,150.2062 274.9215 280.0447 9.0968 280.0447 154.4717 12,558.00 44,842.84\n\n11 45 2.57 0.9799918 979.9918 1.6799 678.1744 192.2167 195.7986 13,444.8297 283.4325 288.7143 8.4216 288.7143 143.0056 14,571.00 50,468.58\n\n12 46 2.64 0.9774732 977.4732 1.6590 651.9821 190.5368 194.0874 12,766.6554 292.2423 297.6882 7.7197 297.6882 131.0876 16,661.00 55,967.95\n\n13 47 2.71 0.9748927 974.8927 1.6371 626.7575 188.8777 192.3975 12,114.6732 301.3570 306.9727 6.9902 306.9727 118.6990 18,828.00 61,334.43\n\n14 48 2.77 0.9722507 972.2507 1.6085 602.4665 187.2406 190.7298 11,487.9157 310.7901 316.5817 6.2317 316.5817 105.8194 21,077.00 66,576.82\n\n15 49 2.87 0.9695576 969.5576 1.6019 579.0821 185.6321 189.0914 10,885.4492 320.5627 326.5364 5.4429 326.5364 92.4259 23,412.00 71,697.99\n\n16 50 3.01 0.9667749 966.7749 1.6147 556.5495 184.0302 187.4596 10,306.3672 330.6628 336.8247 4.6228 336.8247 78.4995 25,833.00 76,695.69\n\n17 51 3.19 0.9638650 963.8650 1.6444 534.8186 182.4156 185.8149 9,749.8176 341.0793 347.4353 3.7700 347.4353 64.0183 28,342.00 81,574.90\n\n18 52 3.39 0.9607902 960.7902 1.6790 513.8434 180.7711 184.1398 9,214.9990 351.8020 358.3578 2.8831 358.3578 48.9575 30,941.00 86,341.07\n\n19 53 3.63 0.9575331 957.5331 1.7270 493.5918 179.0922 182.4296 8,701.1556 362.8346 369.5960 1.9604 369.5960 33.2886 33,631.00 90,993.95\n\n20 54 3.90 0.9540573 954.0573 1.7819 474.0241 177.3652 180.6704 8,207.5639 374.1691 381.1418 1.0000 381.1418 16.9809 36,417.00 95,547.13\n\n21 55 4.22 0.9503365 950.3365 1.8511 455.1089 175.5833 178.8553 7,733.5397 385.8051 392.9946 - 392.9946 - 39,300.00 100,000.00\n\n22 56 4.58 0.9463261 946.3261 1.9283 436.8080 173.7322 176.9697 7,278.4309 397.7312 405.1429 - 405.1429 - 40,515.00 100,000.00\n\n23 57 5.00 0.9419919 941.9919 2.0197 419.0915 171.8039 175.0055 6,841.6229 409.9437 417.5830 - 417.5830 - 41,759.00 100,000.00\n\n24 58 5.48 0.9372819 937.2819 2.1229 401.9239 169.7842 172.9481 6,422.5314 422.4287 430.3007 - 430.3007 - 43,031.00 100,000.00\n\n25 59 6.04 0.9321456 932.1456 2.2429 385.2736 167.6613 170.7856 6,020.6075 435.1746 443.2840 - 443.2840 - 44,329.00 100,000.00\n\n26 60 6.67 0.9265155 926.5155 2.3729 369.1051 165.4183 168.5009 5,635.3339 448.1605 456.5120 - 456.5120 - 45,652.00 100,000.00\n\n27 61 7.40 0.9203356 920.3356 2.5206 353.3910 163.0454 166.0837 5,266.2288 461.3739 469.9716 - 469.9716 - 46,998.00 100,000.00\n\n28 62 8.22 0.9135251 913.5251 2.6787 338.0973 160.5248 163.5162 4,912.8378 474.7888 483.6365 - 483.6365 - 48,364.00 100,000.00\n\n29 63 9.14 0.9060159 906.0159 2.8473 323.1982 157.8461 160.7876 4,574.7406 488.3880 497.4891 - 497.4891 - 49,749.00 100,000.00\n\n30 64 10.13 0.8977350 897.7350 3.0138 308.6690 154.9988 157.8872 4,251.5424 502.1522 511.5098 - 511.5098 - 51,151.00 100,000.00\n\n31 65 11.18 0.8886409 888.6409 3.1735 294.4985 151.9850 154.8173 3,942.8734 516.0808 525.6979 - 525.6979 - 52,570.00 100,000.00\n\n**Country Life Insurance Company**\n\n**_Policy Form ICC18(WL)_**\n\n𝒂̈ 𝒙 𝒕:𝒏|","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page80.pdf"]},"response":{"errors":[],"extract_id":"extract_7c8b71ba4d4f38225774eb28a44b0e2e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**_Plan_** 20Pay **NF Interest Rate** 3\\.75%\n\n**_Sex_** M **\\# of Prem Payments (n)** 20\n\n**_Class_** SN\n\n**_Issue Age_** 35 **PVFB** 212\\.2229\n\n**_Face Amount_** 100,000 **NLP** 14\\.7039\n\n**Pa** 16\\.9809\n\n**Beginning of Reduced**\n\n**Beginning Year Paid-up**\n\n**Of SNFL**\n\n**Year Age 1000\\*qx tpx Lx Cx Dx Mx Mbarx Nx 1000\\*Ax+t 1000\\*ABarx+t PVFBx+t PVFP** **a**\n\n**x+t t** **CV** **x t** **RPU** **x**\n\n1 35 1.41 1.0000000 1,000.0000 1.3590 1,000.0000 208.3405 212.2229 21,902.5797 208.3405 212.2229 14.1690 212.2229 240.6028 - -\n\n2 36 1.54 0.9985900 998.5900 1.4287 962.4964 206.9815 210.8385 20,902.5797 215.0465 219.0539 13.6822 219.0539 232.3353 - -\n\n3 37 1.69 0.9970522 997.0522 1.5088 926.2787 205.5528 209.3833 19,940.0833 221.9125 226.0478 13.1780 226.0478 223.7749 228.00 1,008.64\n\n4 38 1.83 0.9953672 995.3672 1.5721 891.2899 204.0440 207.8463 19,013.8046 228.9311 233.1972 12.6561 233.1972 214.9120 1,829.00 7,843.15\n\n5 39 1.98 0.9935456 993.5456 1.6365 857.5025 202.4719 206.2449 18,122.5147 236.1181 240.5181 12.1154 240.5181 205.7300 3,479.00 14,464.61\n\n6 40 2.13 0.9915784 991.5784 1.6935 824.8720 200.8354 204.5779 17,265.0122 243.4746 248.0117 11.5551 248.0117 196.2157 5,180.00 20,886.11\n\n7 41 2.27 0.9894663 989.4663 1.7358 793.3638 199.1419 202.8529 16,440.1402 251.0095 255.6871 10.9743 255.6871 186.3530 6,934.00 27,119.08\n\n8 42 2.39 0.9872203 987.2203 1.7575 762.9522 197.4061 201.0847 15,646.7764 258.7397 263.5613 10.3719 263.5613 176.1234 8,744.00 33,176.34\n\n9 43 2.44 0.9848608 984.8608 1.7253 733.6181 195.6485 199.2944 14,883.8242 266.6899 271.6596 9.7466 271.6596 165.5059 10,616.00 39,078.31\n\n10 44 2.51 0.9824577 982.4577 1.7065 705.3764 193.9232 197.5369 14,150.2062 274.9215 280.0447 9.0968 280.0447 154.4717 12,558.00 44,842.84\n\n11 45 2.57 0.9799918 979.9918 1.6799 678.1744 192.2167 195.7986 13,444.8297 283.4325 288.7143 8.4216 288.7143 143.0056 14,571.00 50,468.58\n\n12 46 2.64 0.9774732 977.4732 1.6590 651.9821 190.5368 194.0874 12,766.6554 292.2423 297.6882 7.7197 297.6882 131.0876 16,661.00 55,967.95\n\n13 47 2.71 0.9748927 974.8927 1.6371 626.7575 188.8777 192.3975 12,114.6732 301.3570 306.9727 6.9902 306.9727 118.6990 18,828.00 61,334.43\n\n14 48 2.77 0.9722507 972.2507 1.6085 602.4665 187.2406 190.7298 11,487.9157 310.7901 316.5817 6.2317 316.5817 105.8194 21,077.00 66,576.82\n\n15 49 2.87 0.9695576 969.5576 1.6019 579.0821 185.6321 189.0914 10,885.4492 320.5627 326.5364 5.4429 326.5364 92.4259 23,412.00 71,697.99\n\n16 50 3.01 0.9667749 966.7749 1.6147 556.5495 184.0302 187.4596 10,306.3672 330.6628 336.8247 4.6228 336.8247 78.4995 25,833.00 76,695.69\n\n17 51 3.19 0.9638650 963.8650 1.6444 534.8186 182.4156 185.8149 9,749.8176 341.0793 347.4353 3.7700 347.4353 64.0183 28,342.00 81,574.90\n\n18 52 3.39 0.9607902 960.7902 1.6790 513.8434 180.7711 184.1398 9,214.9990 351.8020 358.3578 2.8831 358.3578 48.9575 30,941.00 86,341.07\n\n19 53 3.63 0.9575331 957.5331 1.7270 493.5918 179.0922 182.4296 8,701.1556 362.8346 369.5960 1.9604 369.5960 33.2886 33,631.00 90,993.95\n\n20 54 3.90 0.9540573 954.0573 1.7819 474.0241 177.3652 180.6704 8,207.5639 374.1691 381.1418 1.0000 381.1418 16.9809 36,417.00 95,547.13\n\n21 55 4.22 0.9503365 950.3365 1.8511 455.1089 175.5833 178.8553 7,733.5397 385.8051 392.9946 - 392.9946 - 39,300.00 100,000.00\n\n22 56 4.58 0.9463261 946.3261 1.9283 436.8080 173.7322 176.9697 7,278.4309 397.7312 405.1429 - 405.1429 - 40,515.00 100,000.00\n\n23 57 5.00 0.9419919 941.9919 2.0197 419.0915 171.8039 175.0055 6,841.6229 409.9437 417.5830 - 417.5830 - 41,759.00 100,000.00\n\n24 58 5.48 0.9372819 937.2819 2.1229 401.9239 169.7842 172.9481 6,422.5314 422.4287 430.3007 - 430.3007 - 43,031.00 100,000.00\n\n25 59 6.04 0.9321456 932.1456 2.2429 385.2736 167.6613 170.7856 6,020.6075 435.1746 443.2840 - 443.2840 - 44,329.00 100,000.00\n\n26 60 6.67 0.9265155 926.5155 2.3729 369.1051 165.4183 168.5009 5,635.3339 448.1605 456.5120 - 456.5120 - 45,652.00 100,000.00\n\n27 61 7.40 0.9203356 920.3356 2.5206 353.3910 163.0454 166.0837 5,266.2288 461.3739 469.9716 - 469.9716 - 46,998.00 100,000.00\n\n28 62 8.22 0.9135251 913.5251 2.6787 338.0973 160.5248 163.5162 4,912.8378 474.7888 483.6365 - 483.6365 - 48,364.00 100,000.00\n\n29 63 9.14 0.9060159 906.0159 2.8473 323.1982 157.8461 160.7876 4,574.7406 488.3880 497.4891 - 497.4891 - 49,749.00 100,000.00\n\n30 64 10.13 0.8977350 897.7350 3.0138 308.6690 154.9988 157.8872 4,251.5424 502.1522 511.5098 - 511.5098 - 51,151.00 100,000.00\n\n31 65 11.18 0.8886409 888.6409 3.1735 294.4985 151.9850 154.8173 3,942.8734 516.0808 525.6979 - 525.6979 - 52,570.00 100,000.00\n\n**Country Life Insurance Company**\n\n**_Policy Form ICC18(WL)_**\n\n𝒂̈ 𝒙 𝒕:𝒏|"],"full_content":"**_Plan_** 20Pay **NF Interest Rate** 3\\.75%\n\n**_Sex_** M **\\# of Prem Payments (n)** 20\n\n**_Class_** SN\n\n**_Issue Age_** 35 **PVFB** 212\\.2229\n\n**_Face Amount_** 100,000 **NLP** 14\\.7039\n\n**Pa** 16\\.9809\n\n**Beginning of Reduced**\n\n**Beginning Year Paid-up**\n\n**Of SNFL**\n\n**Year Age 1000\\*qx tpx Lx Cx Dx Mx Mbarx Nx 1000\\*Ax+t 1000\\*ABarx+t PVFBx+t PVFP** **a**\n\n**x+t t** **CV** **x t** **RPU** **x**\n\n1 35 1.41 1.0000000 1,000.0000 1.3590 1,000.0000 208.3405 212.2229 21,902.5797 208.3405 212.2229 14.1690 212.2229 240.6028 - -\n\n2 36 1.54 0.9985900 998.5900 1.4287 962.4964 206.9815 210.8385 20,902.5797 215.0465 219.0539 13.6822 219.0539 232.3353 - -\n\n3 37 1.69 0.9970522 997.0522 1.5088 926.2787 205.5528 209.3833 19,940.0833 221.9125 226.0478 13.1780 226.0478 223.7749 228.00 1,008.64\n\n4 38 1.83 0.9953672 995.3672 1.5721 891.2899 204.0440 207.8463 19,013.8046 228.9311 233.1972 12.6561 233.1972 214.9120 1,829.00 7,843.15\n\n5 39 1.98 0.9935456 993.5456 1.6365 857.5025 202.4719 206.2449 18,122.5147 236.1181 240.5181 12.1154 240.5181 205.7300 3,479.00 14,464.61\n\n6 40 2.13 0.9915784 991.5784 1.6935 824.8720 200.8354 204.5779 17,265.0122 243.4746 248.0117 11.5551 248.0117 196.2157 5,180.00 20,886.11\n\n7 41 2.27 0.9894663 989.4663 1.7358 793.3638 199.1419 202.8529 16,440.1402 251.0095 255.6871 10.9743 255.6871 186.3530 6,934.00 27,119.08\n\n8 42 2.39 0.9872203 987.2203 1.7575 762.9522 197.4061 201.0847 15,646.7764 258.7397 263.5613 10.3719 263.5613 176.1234 8,744.00 33,176.34\n\n9 43 2.44 0.9848608 984.8608 1.7253 733.6181 195.6485 199.2944 14,883.8242 266.6899 271.6596 9.7466 271.6596 165.5059 10,616.00 39,078.31\n\n10 44 2.51 0.9824577 982.4577 1.7065 705.3764 193.9232 197.5369 14,150.2062 274.9215 280.0447 9.0968 280.0447 154.4717 12,558.00 44,842.84\n\n11 45 2.57 0.9799918 979.9918 1.6799 678.1744 192.2167 195.7986 13,444.8297 283.4325 288.7143 8.4216 288.7143 143.0056 14,571.00 50,468.58\n\n12 46 2.64 0.9774732 977.4732 1.6590 651.9821 190.5368 194.0874 12,766.6554 292.2423 297.6882 7.7197 297.6882 131.0876 16,661.00 55,967.95\n\n13 47 2.71 0.9748927 974.8927 1.6371 626.7575 188.8777 192.3975 12,114.6732 301.3570 306.9727 6.9902 306.9727 118.6990 18,828.00 61,334.43\n\n14 48 2.77 0.9722507 972.2507 1.6085 602.4665 187.2406 190.7298 11,487.9157 310.7901 316.5817 6.2317 316.5817 105.8194 21,077.00 66,576.82\n\n15 49 2.87 0.9695576 969.5576 1.6019 579.0821 185.6321 189.0914 10,885.4492 320.5627 326.5364 5.4429 326.5364 92.4259 23,412.00 71,697.99\n\n16 50 3.01 0.9667749 966.7749 1.6147 556.5495 184.0302 187.4596 10,306.3672 330.6628 336.8247 4.6228 336.8247 78.4995 25,833.00 76,695.69\n\n17 51 3.19 0.9638650 963.8650 1.6444 534.8186 182.4156 185.8149 9,749.8176 341.0793 347.4353 3.7700 347.4353 64.0183 28,342.00 81,574.90\n\n18 52 3.39 0.9607902 960.7902 1.6790 513.8434 180.7711 184.1398 9,214.9990 351.8020 358.3578 2.8831 358.3578 48.9575 30,941.00 86,341.07\n\n19 53 3.63 0.9575331 957.5331 1.7270 493.5918 179.0922 182.4296 8,701.1556 362.8346 369.5960 1.9604 369.5960 33.2886 33,631.00 90,993.95\n\n20 54 3.90 0.9540573 954.0573 1.7819 474.0241 177.3652 180.6704 8,207.5639 374.1691 381.1418 1.0000 381.1418 16.9809 36,417.00 95,547.13\n\n21 55 4.22 0.9503365 950.3365 1.8511 455.1089 175.5833 178.8553 7,733.5397 385.8051 392.9946 - 392.9946 - 39,300.00 100,000.00\n\n22 56 4.58 0.9463261 946.3261 1.9283 436.8080 173.7322 176.9697 7,278.4309 397.7312 405.1429 - 405.1429 - 40,515.00 100,000.00\n\n23 57 5.00 0.9419919 941.9919 2.0197 419.0915 171.8039 175.0055 6,841.6229 409.9437 417.5830 - 417.5830 - 41,759.00 100,000.00\n\n24 58 5.48 0.9372819 937.2819 2.1229 401.9239 169.7842 172.9481 6,422.5314 422.4287 430.3007 - 430.3007 - 43,031.00 100,000.00\n\n25 59 6.04 0.9321456 932.1456 2.2429 385.2736 167.6613 170.7856 6,020.6075 435.1746 443.2840 - 443.2840 - 44,329.00 100,000.00\n\n26 60 6.67 0.9265155 926.5155 2.3729 369.1051 165.4183 168.5009 5,635.3339 448.1605 456.5120 - 456.5120 - 45,652.00 100,000.00\n\n27 61 7.40 0.9203356 920.3356 2.5206 353.3910 163.0454 166.0837 5,266.2288 461.3739 469.9716 - 469.9716 - 46,998.00 100,000.00\n\n28 62 8.22 0.9135251 913.5251 2.6787 338.0973 160.5248 163.5162 4,912.8378 474.7888 483.6365 - 483.6365 - 48,364.00 100,000.00\n\n29 63 9.14 0.9060159 906.0159 2.8473 323.1982 157.8461 160.7876 4,574.7406 488.3880 497.4891 - 497.4891 - 49,749.00 100,000.00\n\n30 64 10.13 0.8977350 897.7350 3.0138 308.6690 154.9988 157.8872 4,251.5424 502.1522 511.5098 - 511.5098 - 51,151.00 100,000.00\n\n31 65 11.18 0.8886409 888.6409 3.1735 294.4985 151.9850 154.8173 3,942.8734 516.0808 525.6979 - 525.6979 - 52,570.00 100,000.00\n\n**Country Life Insurance Company**\n\n**_Policy Form ICC18(WL)_**\n\n𝒂̈ 𝒙 𝒕:𝒏|","publish_date":null,"title":"Country Life Insurance Company ̈ 𝒂","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page80.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page80.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page80","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page80.pdf"},"started_at":"2026-11-04T19:48:00.311121"} +{"completed_at":"2026-11-04T19:48:04.083287","latency_in_ms":1875,"output":{"example_id":"table/SERFF_Interstate_random_pages 1_page9","grounded_pages":[],"layout_pages":[],"markdown":"### 6\n\n### **VII.** **NUMERICAL DEMONSTRATION FOR NONFORFEITURE VALUES** x = Issue age 35, male, nonsmoker, level death benefit\n\n### t = 5\n\n0PVB35 N\n\n### =\n\n1,000 ∙ (M35 N – M45 N ) / D35 N = 11.4828\n\nNFLP35\n\n### =\n\n0PVB35 N / ä35:10 N\n\n### = 11.4828 / 8.4771 = 1.3546\n\n### AAI = 1,000\n\nP adj\n\n35\n\n### =\n\n[0PVB35 N \\+ 0.01 ∙ (AAI) +1.25 ∙ Min(NFLP35, 0.04∙AAI)] / ä35:10 N\n\n### = (11.4828 + 10 + 1.6932) / 8.4771 = 2.7339\n\n5NCV35\n\n### =\n\n5PVB35 N – P35 adj ∙ ä40:5 N\n\n### = 7.4539 – (2.7339  4.6375) = -5.22\n\n5CV35\n\n### = Max[0, -5.22] = 0.00\n\n### A table of cash values at all durations for this sample age:\n\n10-Year Term, Age 35, Male, Nonsmoker\n\nx+t t Gx+t tNCVx tCVx\n\n35 0 1.34 -11.69 0.00\n\n36 1 1.34 \\-10.24 0.00\n\n37 2 1.34 \\-8.88 0.00\n\n38 3 1.34 \\-7.61 0.00\n\n39 4 1.34 \\-6.40 0.00\n\n40 5 1.34 \\-5.22 0.00\n\n41 6 1.34 \\-4.08 0.00\n\n42 7 1.34 \\-2.98 0.00\n\n43 8 1.34 \\-1.94 0.00\n\n44 9 1.34 \\-0.96 0.00\n\n45 10 0.000 0\\.00 0.00","pages":[{"line_numbers":[],"markdown":"### 6\n\n### **VII.** **NUMERICAL DEMONSTRATION FOR NONFORFEITURE VALUES** x = Issue age 35, male, nonsmoker, level death benefit\n\n### t = 5\n\n0PVB35 N\n\n### =\n\n1,000 ∙ (M35 N – M45 N ) / D35 N = 11.4828\n\nNFLP35\n\n### =\n\n0PVB35 N / ä35:10 N\n\n### = 11.4828 / 8.4771 = 1.3546\n\n### AAI = 1,000\n\nP adj\n\n35\n\n### =\n\n[0PVB35 N \\+ 0.01 ∙ (AAI) +1.25 ∙ Min(NFLP35, 0.04∙AAI)] / ä35:10 N\n\n### = (11.4828 + 10 + 1.6932) / 8.4771 = 2.7339\n\n5NCV35\n\n### =\n\n5PVB35 N – P35 adj ∙ ä40:5 N\n\n### = 7.4539 – (2.7339  4.6375) = -5.22\n\n5CV35\n\n### = Max[0, -5.22] = 0.00\n\n### A table of cash values at all durations for this sample age:\n\n10-Year Term, Age 35, Male, Nonsmoker\n\nx+t t Gx+t tNCVx tCVx\n\n35 0 1.34 -11.69 0.00\n\n36 1 1.34 \\-10.24 0.00\n\n37 2 1.34 \\-8.88 0.00\n\n38 3 1.34 \\-7.61 0.00\n\n39 4 1.34 \\-6.40 0.00\n\n40 5 1.34 \\-5.22 0.00\n\n41 6 1.34 \\-4.08 0.00\n\n42 7 1.34 \\-2.98 0.00\n\n43 8 1.34 \\-1.94 0.00\n\n44 9 1.34 \\-0.96 0.00\n\n45 10 0.000 0\\.00 0.00","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### 6\n\n### **VII.** **NUMERICAL DEMONSTRATION FOR NONFORFEITURE VALUES** x = Issue age 35, male, nonsmoker, level death benefit\n\n### t = 5\n\n0PVB35 N\n\n### =\n\n1,000 ∙ (M35 N – M45 N ) / D35 N = 11.4828\n\nNFLP35\n\n### =\n\n0PVB35 N / ä35:10 N\n\n### = 11.4828 / 8.4771 = 1.3546\n\n### AAI = 1,000\n\nP adj\n\n35\n\n### =\n\n[0PVB35 N \\+ 0.01 ∙ (AAI) +1.25 ∙ Min(NFLP35, 0.04∙AAI)] / ä35:10 N\n\n### = (11.4828 + 10 + 1.6932) / 8.4771 = 2.7339\n\n5NCV35\n\n### =\n\n5PVB35 N – P35 adj ∙ ä40:5 N\n\n### = 7.4539 – (2.7339  4.6375) = -5.22\n\n5CV35\n\n### = Max[0, -5.22] = 0.00\n\n### A table of cash values at all durations for this sample age:\n\n10-Year Term, Age 35, Male, Nonsmoker\n\nx+t t Gx+t tNCVx tCVx\n\n35 0 1.34 -11.69 0.00\n\n36 1 1.34 \\-10.24 0.00\n\n37 2 1.34 \\-8.88 0.00\n\n38 3 1.34 \\-7.61 0.00\n\n39 4 1.34 \\-6.40 0.00\n\n40 5 1.34 \\-5.22 0.00\n\n41 6 1.34 \\-4.08 0.00\n\n42 7 1.34 \\-2.98 0.00\n\n43 8 1.34 \\-1.94 0.00\n\n44 9 1.34 \\-0.96 0.00\n\n45 10 0.000 0\\.00 0.00","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page9.pdf"]},"response":{"errors":[],"extract_id":"extract_4286acc0c9bb79e738cd51e0edd84df7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### 6\n\n### **VII.** **NUMERICAL DEMONSTRATION FOR NONFORFEITURE VALUES** x = Issue age 35, male, nonsmoker, level death benefit\n\n### t = 5\n\n0PVB35 N\n\n### =\n\n1,000 ∙ (M35 N – M45 N ) / D35 N = 11.4828\n\nNFLP35\n\n### =\n\n0PVB35 N / ä35:10 N\n\n### = 11.4828 / 8.4771 = 1.3546\n\n### AAI = 1,000\n\nP adj\n\n35\n\n### =\n\n[0PVB35 N \\+ 0.01 ∙ (AAI) +1.25 ∙ Min(NFLP35, 0.04∙AAI)] / ä35:10 N\n\n### = (11.4828 + 10 + 1.6932) / 8.4771 = 2.7339\n\n5NCV35\n\n### =\n\n5PVB35 N – P35 adj ∙ ä40:5 N\n\n### = 7.4539 – (2.7339  4.6375) = -5.22\n\n5CV35\n\n### = Max[0, -5.22] = 0.00\n\n### A table of cash values at all durations for this sample age:\n\n10-Year Term, Age 35, Male, Nonsmoker\n\nx+t t Gx+t tNCVx tCVx\n\n35 0 1.34 -11.69 0.00\n\n36 1 1.34 \\-10.24 0.00\n\n37 2 1.34 \\-8.88 0.00\n\n38 3 1.34 \\-7.61 0.00\n\n39 4 1.34 \\-6.40 0.00\n\n40 5 1.34 \\-5.22 0.00\n\n41 6 1.34 \\-4.08 0.00\n\n42 7 1.34 \\-2.98 0.00\n\n43 8 1.34 \\-1.94 0.00\n\n44 9 1.34 \\-0.96 0.00\n\n45 10 0.000 0\\.00 0.00"],"full_content":"### 6\n\n### **VII.** **NUMERICAL DEMONSTRATION FOR NONFORFEITURE VALUES** x = Issue age 35, male, nonsmoker, level death benefit\n\n### t = 5\n\n0PVB35 N\n\n### =\n\n1,000 ∙ (M35 N – M45 N ) / D35 N = 11.4828\n\nNFLP35\n\n### =\n\n0PVB35 N / ä35:10 N\n\n### = 11.4828 / 8.4771 = 1.3546\n\n### AAI = 1,000\n\nP adj\n\n35\n\n### =\n\n[0PVB35 N \\+ 0.01 ∙ (AAI) +1.25 ∙ Min(NFLP35, 0.04∙AAI)] / ä35:10 N\n\n### = (11.4828 + 10 + 1.6932) / 8.4771 = 2.7339\n\n5NCV35\n\n### =\n\n5PVB35 N – P35 adj ∙ ä40:5 N\n\n### = 7.4539 – (2.7339  4.6375) = -5.22\n\n5CV35\n\n### = Max[0, -5.22] = 0.00\n\n### A table of cash values at all durations for this sample age:\n\n10-Year Term, Age 35, Male, Nonsmoker\n\nx+t t Gx+t tNCVx tCVx\n\n35 0 1.34 -11.69 0.00\n\n36 1 1.34 \\-10.24 0.00\n\n37 2 1.34 \\-8.88 0.00\n\n38 3 1.34 \\-7.61 0.00\n\n39 4 1.34 \\-6.40 0.00\n\n40 5 1.34 \\-5.22 0.00\n\n41 6 1.34 \\-4.08 0.00\n\n42 7 1.34 \\-2.98 0.00\n\n43 8 1.34 \\-1.94 0.00\n\n44 9 1.34 \\-0.96 0.00\n\n45 10 0.000 0\\.00 0.00","publish_date":null,"title":"ä ä ä","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page9.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_Interstate_random_pages%201_page9.pdf"},"request":{"example_id":"table/SERFF_Interstate_random_pages 1_page9","product_type":"parse","source_file_path":"SERFF_Interstate_random_pages 1_page9.pdf"},"started_at":"2026-11-04T19:48:02.207769"} +{"completed_at":"2026-11-04T19:48:05.213888","latency_in_ms":1357,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1","grounded_pages":[],"layout_pages":[],"markdown":"**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Supporting Document** Annual Report AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Transmittal Checklist for Life/Health Form Filings AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Authorization AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Under 65 experience - PLAN A AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Actuarial Certification AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**_SERFF Tracking #:_** _ABAI-130604077_ **_State Tracking #:_** _ABAI-130604077_ **_Company Tracking #:_**\n\n**_State:_** _Texas_ **_Filing Company:_** _Gerber Life Insurance Company_\n\n**_TOI/Sub-TOI:_** _MS08I Individual Medicare Supplement - Standard Plans 2010/MS08I.005 Plan F (Basic) 2010_\n\n**_Product Name:_** _Gerber 2016 Rate Increase_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number ABAI-130604077 Generated 02/23/2026 07:12 PM_","pages":[{"line_numbers":[],"markdown":"**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Supporting Document** Annual Report AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Transmittal Checklist for Life/Health Form Filings AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Authorization AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Under 65 experience - PLAN A AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Actuarial Certification AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**_SERFF Tracking #:_** _ABAI-130604077_ **_State Tracking #:_** _ABAI-130604077_ **_Company Tracking #:_**\n\n**_State:_** _Texas_ **_Filing Company:_** _Gerber Life Insurance Company_\n\n**_TOI/Sub-TOI:_** _MS08I Individual Medicare Supplement - Standard Plans 2010/MS08I.005 Plan F (Basic) 2010_\n\n**_Product Name:_** _Gerber 2016 Rate Increase_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number ABAI-130604077 Generated 02/23/2026 07:12 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Supporting Document** Annual Report AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Transmittal Checklist for Life/Health Form Filings AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Authorization AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Under 65 experience - PLAN A AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Actuarial Certification AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**_SERFF Tracking #:_** _ABAI-130604077_ **_State Tracking #:_** _ABAI-130604077_ **_Company Tracking #:_**\n\n**_State:_** _Texas_ **_Filing Company:_** _Gerber Life Insurance Company_\n\n**_TOI/Sub-TOI:_** _MS08I Individual Medicare Supplement - Standard Plans 2010/MS08I.005 Plan F (Basic) 2010_\n\n**_Product Name:_** _Gerber 2016 Rate Increase_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number ABAI-130604077 Generated 02/23/2026 07:12 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_838f109e4b39edfd35ce7b72af015bc8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Supporting Document** Annual Report AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Transmittal Checklist for Life/Health Form Filings AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Authorization AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Under 65 experience - PLAN A AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Actuarial Certification AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**_SERFF Tracking #:_** _ABAI-130604077_ **_State Tracking #:_** _ABAI-130604077_ **_Company Tracking #:_**\n\n**_State:_** _Texas_ **_Filing Company:_** _Gerber Life Insurance Company_\n\n**_TOI/Sub-TOI:_** _MS08I Individual Medicare Supplement - Standard Plans 2010/MS08I.005 Plan F (Basic) 2010_\n\n**_Product Name:_** _Gerber 2016 Rate Increase_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number ABAI-130604077 Generated 02/23/2026 07:12 PM_"],"full_content":"**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Supporting Document** Annual Report AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Transmittal Checklist for Life/Health Form Filings AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Authorization AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Under 65 experience - PLAN A AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**Supporting Document** Actuarial Certification AP-APPROVAL OF THE FILED POLICY\n\nYes\n\n**_SERFF Tracking #:_** _ABAI-130604077_ **_State Tracking #:_** _ABAI-130604077_ **_Company Tracking #:_**\n\n**_State:_** _Texas_ **_Filing Company:_** _Gerber Life Insurance Company_\n\n**_TOI/Sub-TOI:_** _MS08I Individual Medicare Supplement - Standard Plans 2010/MS08I.005 Plan F (Basic) 2010_\n\n**_Product Name:_** _Gerber 2016 Rate Increase_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number ABAI-130604077 Generated 02/23/2026 07:12 PM_","publish_date":null,"title":"Schedule Schedule Item Schedule Item Status Public Access Annual Report AP-APPROVAL OF THE FILED Yes Supporting Document POLICY Transmittal Checklist","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1.pdf"},"started_at":"2026-11-04T19:48:03.856068"} +{"completed_at":"2026-11-04T19:48:06.164872","latency_in_ms":1151,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1028","grounded_pages":[],"layout_pages":[],"markdown":"### **Monitor Life Insurance Company of New York**\n\n**Exhibit 4: Texas Rate Increase History**\n\n**Year Approval Date Effective Date Plan A Plan F Plan G Plan HDG Plan N**\n\n2023 11/1/2023 4/1/2024 4.0% 4.0% 4.0% 4.0% 4.0%","pages":[{"line_numbers":[],"markdown":"### **Monitor Life Insurance Company of New York**\n\n**Exhibit 4: Texas Rate Increase History**\n\n**Year Approval Date Effective Date Plan A Plan F Plan G Plan HDG Plan N**\n\n2023 11/1/2023 4/1/2024 4.0% 4.0% 4.0% 4.0% 4.0%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Monitor Life Insurance Company of New York**\n\n**Exhibit 4: Texas Rate Increase History**\n\n**Year Approval Date Effective Date Plan A Plan F Plan G Plan HDG Plan N**\n\n2023 11/1/2023 4/1/2024 4.0% 4.0% 4.0% 4.0% 4.0%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1028.pdf"]},"response":{"errors":[],"extract_id":"extract_dbd5081be86cd50a88b41986797bfafe","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Monitor Life Insurance Company of New York**\n\n**Exhibit 4: Texas Rate Increase History**\n\n**Year Approval Date Effective Date Plan A Plan F Plan G Plan HDG Plan N**\n\n2023 11/1/2023 4/1/2024 4.0% 4.0% 4.0% 4.0% 4.0%"],"full_content":"### **Monitor Life Insurance Company of New York**\n\n**Exhibit 4: Texas Rate Increase History**\n\n**Year Approval Date Effective Date Plan A Plan F Plan G Plan HDG Plan N**\n\n2023 11/1/2023 4/1/2024 4.0% 4.0% 4.0% 4.0% 4.0%","publish_date":null,"title":"Monitor Life Insurance Company of New York","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1028.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1028.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1028","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1028.pdf"},"started_at":"2026-11-04T19:48:05.013657"} +{"completed_at":"2026-11-04T19:48:07.294222","latency_in_ms":1126,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1029","grounded_pages":[],"layout_pages":[],"markdown":"Sta te Sta tu s A F G HDG N A F G HDG N A F G HDG N\n\nAK To b e file d - 12/ 2024 0 0 0 0 2,468 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAL To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAR To b e file d - 12/ 2024 0 0 5,963 0 2,769 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAZ To b e file d - 12/ 2024 0 9,588 18,138 0 5,966 9.0% 9.0% 9.0% 9.0% 9.0%\n\nCO To b e file d - 12/ 2024 0 1,966 6,620 911 6,090 9.0% 9.0% 9.0% 9.0% 9.0%\n\nDC To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nDE To b e file d - 12/ 2024 0 7,962 5,189 748 4,937 9.0% 9.0% 9.0% 9.0% 9.0%\n\nFL To b e file d - 12/ 2024 0 0 12,210 3,850 3,103 9.0% 9.0% 9.0% 9.0% 9.0%\n\nGA Ap p rove d 0 14,188 16,348 960 19,265 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIA Pe nd ing 0 16,471 17,114 520 9,020 9.0% 9.0% 9.0% 9.0% 9.0%\n\nID To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIL Pe nd ing 0 27,936 19,521 0 19,461 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIN To b e file d - 12/ 2024 0 12,670 12,544 628 4,264 9.0% 9.0% 9.0% 9.0% 9.0%\n\nKS To b e file d - 12/ 2024 0 16,791 1,601 1,290 4,871 9.0% 9.0% 9.0% 9.0% 9.0%\n\nKY To b e file d - 12/ 2024 0 12,392 15,082 0 9,154 9.0% 9.0% 9.0% 9.0% 9.0%\n\nLA To b e file d - 12/ 2024 0 14,640 7,244 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMD To b e file d - 12/ 2024 0 0 0 0 2,097 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMI To b e file d - 12/ 2024 0 7,335 0 0 2,593 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMO To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMS Pe nd ing 0 2,221 9,200 0 5,342 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMT To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAp p rove d Ra te Inc re a se Prop ose d Ra te Inc re a se In Forc e Annua lize d Pre m ium\n\nMon itor Life In s u ra n c e Com p a n y of Ne w York\n\nExh ib it 5 - Filin g Sta tu s","pages":[{"line_numbers":[],"markdown":"Sta te Sta tu s A F G HDG N A F G HDG N A F G HDG N\n\nAK To b e file d - 12/ 2024 0 0 0 0 2,468 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAL To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAR To b e file d - 12/ 2024 0 0 5,963 0 2,769 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAZ To b e file d - 12/ 2024 0 9,588 18,138 0 5,966 9.0% 9.0% 9.0% 9.0% 9.0%\n\nCO To b e file d - 12/ 2024 0 1,966 6,620 911 6,090 9.0% 9.0% 9.0% 9.0% 9.0%\n\nDC To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nDE To b e file d - 12/ 2024 0 7,962 5,189 748 4,937 9.0% 9.0% 9.0% 9.0% 9.0%\n\nFL To b e file d - 12/ 2024 0 0 12,210 3,850 3,103 9.0% 9.0% 9.0% 9.0% 9.0%\n\nGA Ap p rove d 0 14,188 16,348 960 19,265 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIA Pe nd ing 0 16,471 17,114 520 9,020 9.0% 9.0% 9.0% 9.0% 9.0%\n\nID To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIL Pe nd ing 0 27,936 19,521 0 19,461 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIN To b e file d - 12/ 2024 0 12,670 12,544 628 4,264 9.0% 9.0% 9.0% 9.0% 9.0%\n\nKS To b e file d - 12/ 2024 0 16,791 1,601 1,290 4,871 9.0% 9.0% 9.0% 9.0% 9.0%\n\nKY To b e file d - 12/ 2024 0 12,392 15,082 0 9,154 9.0% 9.0% 9.0% 9.0% 9.0%\n\nLA To b e file d - 12/ 2024 0 14,640 7,244 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMD To b e file d - 12/ 2024 0 0 0 0 2,097 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMI To b e file d - 12/ 2024 0 7,335 0 0 2,593 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMO To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMS Pe nd ing 0 2,221 9,200 0 5,342 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMT To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAp p rove d Ra te Inc re a se Prop ose d Ra te Inc re a se In Forc e Annua lize d Pre m ium\n\nMon itor Life In s u ra n c e Com p a n y of Ne w York\n\nExh ib it 5 - Filin g Sta tu s","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Sta te Sta tu s A F G HDG N A F G HDG N A F G HDG N\n\nAK To b e file d - 12/ 2024 0 0 0 0 2,468 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAL To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAR To b e file d - 12/ 2024 0 0 5,963 0 2,769 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAZ To b e file d - 12/ 2024 0 9,588 18,138 0 5,966 9.0% 9.0% 9.0% 9.0% 9.0%\n\nCO To b e file d - 12/ 2024 0 1,966 6,620 911 6,090 9.0% 9.0% 9.0% 9.0% 9.0%\n\nDC To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nDE To b e file d - 12/ 2024 0 7,962 5,189 748 4,937 9.0% 9.0% 9.0% 9.0% 9.0%\n\nFL To b e file d - 12/ 2024 0 0 12,210 3,850 3,103 9.0% 9.0% 9.0% 9.0% 9.0%\n\nGA Ap p rove d 0 14,188 16,348 960 19,265 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIA Pe nd ing 0 16,471 17,114 520 9,020 9.0% 9.0% 9.0% 9.0% 9.0%\n\nID To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIL Pe nd ing 0 27,936 19,521 0 19,461 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIN To b e file d - 12/ 2024 0 12,670 12,544 628 4,264 9.0% 9.0% 9.0% 9.0% 9.0%\n\nKS To b e file d - 12/ 2024 0 16,791 1,601 1,290 4,871 9.0% 9.0% 9.0% 9.0% 9.0%\n\nKY To b e file d - 12/ 2024 0 12,392 15,082 0 9,154 9.0% 9.0% 9.0% 9.0% 9.0%\n\nLA To b e file d - 12/ 2024 0 14,640 7,244 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMD To b e file d - 12/ 2024 0 0 0 0 2,097 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMI To b e file d - 12/ 2024 0 7,335 0 0 2,593 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMO To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMS Pe nd ing 0 2,221 9,200 0 5,342 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMT To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAp p rove d Ra te Inc re a se Prop ose d Ra te Inc re a se In Forc e Annua lize d Pre m ium\n\nMon itor Life In s u ra n c e Com p a n y of Ne w York\n\nExh ib it 5 - Filin g Sta tu s","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1029.pdf"]},"response":{"errors":[],"extract_id":"extract_bf11235fe8f7bdff82bb1249a1bc644e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Sta te Sta tu s A F G HDG N A F G HDG N A F G HDG N\n\nAK To b e file d - 12/ 2024 0 0 0 0 2,468 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAL To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAR To b e file d - 12/ 2024 0 0 5,963 0 2,769 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAZ To b e file d - 12/ 2024 0 9,588 18,138 0 5,966 9.0% 9.0% 9.0% 9.0% 9.0%\n\nCO To b e file d - 12/ 2024 0 1,966 6,620 911 6,090 9.0% 9.0% 9.0% 9.0% 9.0%\n\nDC To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nDE To b e file d - 12/ 2024 0 7,962 5,189 748 4,937 9.0% 9.0% 9.0% 9.0% 9.0%\n\nFL To b e file d - 12/ 2024 0 0 12,210 3,850 3,103 9.0% 9.0% 9.0% 9.0% 9.0%\n\nGA Ap p rove d 0 14,188 16,348 960 19,265 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIA Pe nd ing 0 16,471 17,114 520 9,020 9.0% 9.0% 9.0% 9.0% 9.0%\n\nID To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIL Pe nd ing 0 27,936 19,521 0 19,461 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIN To b e file d - 12/ 2024 0 12,670 12,544 628 4,264 9.0% 9.0% 9.0% 9.0% 9.0%\n\nKS To b e file d - 12/ 2024 0 16,791 1,601 1,290 4,871 9.0% 9.0% 9.0% 9.0% 9.0%\n\nKY To b e file d - 12/ 2024 0 12,392 15,082 0 9,154 9.0% 9.0% 9.0% 9.0% 9.0%\n\nLA To b e file d - 12/ 2024 0 14,640 7,244 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMD To b e file d - 12/ 2024 0 0 0 0 2,097 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMI To b e file d - 12/ 2024 0 7,335 0 0 2,593 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMO To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMS Pe nd ing 0 2,221 9,200 0 5,342 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMT To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAp p rove d Ra te Inc re a se Prop ose d Ra te Inc re a se In Forc e Annua lize d Pre m ium\n\nMon itor Life In s u ra n c e Com p a n y of Ne w York\n\nExh ib it 5 - Filin g Sta tu s"],"full_content":"Sta te Sta tu s A F G HDG N A F G HDG N A F G HDG N\n\nAK To b e file d - 12/ 2024 0 0 0 0 2,468 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAL To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAR To b e file d - 12/ 2024 0 0 5,963 0 2,769 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAZ To b e file d - 12/ 2024 0 9,588 18,138 0 5,966 9.0% 9.0% 9.0% 9.0% 9.0%\n\nCO To b e file d - 12/ 2024 0 1,966 6,620 911 6,090 9.0% 9.0% 9.0% 9.0% 9.0%\n\nDC To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nDE To b e file d - 12/ 2024 0 7,962 5,189 748 4,937 9.0% 9.0% 9.0% 9.0% 9.0%\n\nFL To b e file d - 12/ 2024 0 0 12,210 3,850 3,103 9.0% 9.0% 9.0% 9.0% 9.0%\n\nGA Ap p rove d 0 14,188 16,348 960 19,265 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIA Pe nd ing 0 16,471 17,114 520 9,020 9.0% 9.0% 9.0% 9.0% 9.0%\n\nID To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIL Pe nd ing 0 27,936 19,521 0 19,461 9.0% 9.0% 9.0% 9.0% 9.0%\n\nIN To b e file d - 12/ 2024 0 12,670 12,544 628 4,264 9.0% 9.0% 9.0% 9.0% 9.0%\n\nKS To b e file d - 12/ 2024 0 16,791 1,601 1,290 4,871 9.0% 9.0% 9.0% 9.0% 9.0%\n\nKY To b e file d - 12/ 2024 0 12,392 15,082 0 9,154 9.0% 9.0% 9.0% 9.0% 9.0%\n\nLA To b e file d - 12/ 2024 0 14,640 7,244 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMD To b e file d - 12/ 2024 0 0 0 0 2,097 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMI To b e file d - 12/ 2024 0 7,335 0 0 2,593 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMO To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMS Pe nd ing 0 2,221 9,200 0 5,342 9.0% 9.0% 9.0% 9.0% 9.0%\n\nMT To b e file d - 12/ 2024 0 0 0 0 0 9.0% 9.0% 9.0% 9.0% 9.0%\n\nAp p rove d Ra te Inc re a se Prop ose d Ra te Inc re a se In Forc e Annua lize d Pre m ium\n\nMon itor Life In s u ra n c e Com p a n y of Ne w York\n\nExh ib it 5 - Filin g Sta tu s","publish_date":null,"title":"Monitor Life Insurance Company of New York Exhibit 5 - Filing Status","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1029.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1029.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1029","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1029.pdf"},"started_at":"2026-11-04T19:48:06.167422"} +{"completed_at":"2026-11-04T19:48:11.894071","latency_in_ms":4376,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1036","grounded_pages":[],"layout_pages":[],"markdown":"Female Male Female Male Female Male Female Male\n\nUnder 65 NA NA NA NA NA NA NA NA\n\n65 2,542.38 2,846.55 2,856.47 3,200.25 2,704.19 3,028.69 2,171.42 2,428.87\n\n66 2,542.38 2,846.55 2,856.47 3,200.25 2,704.19 3,028.69 2,171.42 2,428.87\n\n67 2,607.39 2,916.19 2,926.35 3,278.51 2,773.02 3,103.42 2,225.30 2,490.74\n\n68 2,672.41 2,990.49 3,001.82 3,362.35 2,841.86 3,182.09 2,281.18 2,552.60\n\n69 2,737.41 3,064.79 3,074.48 3,446.22 2,912.66 3,260.76 2,337.06 2,616.47\n\n70 2,807.07 3,183.20 3,152.74 3,580.36 2,985.42 3,388.60 2,394.94 2,718.25\n\n71 2,886.01 3,290.00 3,242.17 3,697.76 3,070.00 3,502.67 2,462.80 2,808.06\n\n72 2,964.96 3,399.13 3,328.82 3,817.94 3,152.60 3,616.73 2,528.66 2,897.88\n\n73 3,048.54 3,508.26 3,423.85 3,940.92 3,245.03 3,732.76 2,600.50 2,993.67\n\n74 3,134.44 3,615.06 3,521.67 4,063.90 3,335.49 3,848.80 2,674.35 3,085.47\n\n75 3,222.68 3,719.54 3,619.50 4,181.28 3,427.93 3,958.93 2,748.19 3,175.29\n\n76 3,313.22 3,819.38 3,722.91 4,295.88 3,526.26 4,067.10 2,828.02 3,261.10\n\n77 3,422.35 3,928.50 3,843.09 4,416.07 3,640.33 4,181.17 2,919.82 3,352.91\n\n78 3,538.44 4,035.31 3,980.06 4,536.25 3,768.16 4,293.27 3,021.61 3,444.71\n\n79 3,670.78 4,142.11 4,125.39 4,653.64 3,903.87 4,407.34 3,131.38 3,534.53\n\n80 3,837.95 4,281.42 4,312.66 4,810.16 4,082.83 4,556.80 3,273.08 3,654.28\n\n81 4,007.45 4,418.41 4,505.51 4,966.68 4,263.76 4,702.34 3,418.77 3,772.03\n\n82 4,202.47 4,583.25 4,723.52 5,151.15 4,470.27 4,875.41 3,584.42 3,911.73\n\n83 4,402.16 4,755.07 4,949.91 5,341.20 4,684.64 5,060.28 3,758.05 4,059.42\n\n84 4,590.22 4,922.24 5,162.34 5,531.26 4,887.21 5,237.28 3,919.72 4,203.11\n\n85+ 4,773.64 5,098.70 5,369.17 5,729.70 5,081.91 5,426.08 4,075.39 4,352.80\n\nZip Codes Factor\n\n750-754, 760-762, 779-781 1.15\n\n763, 769, 791, 798, 799, 885 0.95\n\n765-767 0.85\n\n770, 772-777, 783-784 1.25\n\nRest of State 1.05\n\nG\n\n**American National Life Insurance Company of Texas**\n\n**CURRENT RATES**\n\n**Tobacco Rates**\n\nArea Factors\n\nD E F\n\n**Exhibit A - Gross Annual Premiums**\n\n**TEXAS RATES**\n\n10/16/2025","pages":[{"line_numbers":[],"markdown":"Female Male Female Male Female Male Female Male\n\nUnder 65 NA NA NA NA NA NA NA NA\n\n65 2,542.38 2,846.55 2,856.47 3,200.25 2,704.19 3,028.69 2,171.42 2,428.87\n\n66 2,542.38 2,846.55 2,856.47 3,200.25 2,704.19 3,028.69 2,171.42 2,428.87\n\n67 2,607.39 2,916.19 2,926.35 3,278.51 2,773.02 3,103.42 2,225.30 2,490.74\n\n68 2,672.41 2,990.49 3,001.82 3,362.35 2,841.86 3,182.09 2,281.18 2,552.60\n\n69 2,737.41 3,064.79 3,074.48 3,446.22 2,912.66 3,260.76 2,337.06 2,616.47\n\n70 2,807.07 3,183.20 3,152.74 3,580.36 2,985.42 3,388.60 2,394.94 2,718.25\n\n71 2,886.01 3,290.00 3,242.17 3,697.76 3,070.00 3,502.67 2,462.80 2,808.06\n\n72 2,964.96 3,399.13 3,328.82 3,817.94 3,152.60 3,616.73 2,528.66 2,897.88\n\n73 3,048.54 3,508.26 3,423.85 3,940.92 3,245.03 3,732.76 2,600.50 2,993.67\n\n74 3,134.44 3,615.06 3,521.67 4,063.90 3,335.49 3,848.80 2,674.35 3,085.47\n\n75 3,222.68 3,719.54 3,619.50 4,181.28 3,427.93 3,958.93 2,748.19 3,175.29\n\n76 3,313.22 3,819.38 3,722.91 4,295.88 3,526.26 4,067.10 2,828.02 3,261.10\n\n77 3,422.35 3,928.50 3,843.09 4,416.07 3,640.33 4,181.17 2,919.82 3,352.91\n\n78 3,538.44 4,035.31 3,980.06 4,536.25 3,768.16 4,293.27 3,021.61 3,444.71\n\n79 3,670.78 4,142.11 4,125.39 4,653.64 3,903.87 4,407.34 3,131.38 3,534.53\n\n80 3,837.95 4,281.42 4,312.66 4,810.16 4,082.83 4,556.80 3,273.08 3,654.28\n\n81 4,007.45 4,418.41 4,505.51 4,966.68 4,263.76 4,702.34 3,418.77 3,772.03\n\n82 4,202.47 4,583.25 4,723.52 5,151.15 4,470.27 4,875.41 3,584.42 3,911.73\n\n83 4,402.16 4,755.07 4,949.91 5,341.20 4,684.64 5,060.28 3,758.05 4,059.42\n\n84 4,590.22 4,922.24 5,162.34 5,531.26 4,887.21 5,237.28 3,919.72 4,203.11\n\n85+ 4,773.64 5,098.70 5,369.17 5,729.70 5,081.91 5,426.08 4,075.39 4,352.80\n\nZip Codes Factor\n\n750-754, 760-762, 779-781 1.15\n\n763, 769, 791, 798, 799, 885 0.95\n\n765-767 0.85\n\n770, 772-777, 783-784 1.25\n\nRest of State 1.05\n\nG\n\n**American National Life Insurance Company of Texas**\n\n**CURRENT RATES**\n\n**Tobacco Rates**\n\nArea Factors\n\nD E F\n\n**Exhibit A - Gross Annual Premiums**\n\n**TEXAS RATES**\n\n10/16/2025","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Female Male Female Male Female Male Female Male\n\nUnder 65 NA NA NA NA NA NA NA NA\n\n65 2,542.38 2,846.55 2,856.47 3,200.25 2,704.19 3,028.69 2,171.42 2,428.87\n\n66 2,542.38 2,846.55 2,856.47 3,200.25 2,704.19 3,028.69 2,171.42 2,428.87\n\n67 2,607.39 2,916.19 2,926.35 3,278.51 2,773.02 3,103.42 2,225.30 2,490.74\n\n68 2,672.41 2,990.49 3,001.82 3,362.35 2,841.86 3,182.09 2,281.18 2,552.60\n\n69 2,737.41 3,064.79 3,074.48 3,446.22 2,912.66 3,260.76 2,337.06 2,616.47\n\n70 2,807.07 3,183.20 3,152.74 3,580.36 2,985.42 3,388.60 2,394.94 2,718.25\n\n71 2,886.01 3,290.00 3,242.17 3,697.76 3,070.00 3,502.67 2,462.80 2,808.06\n\n72 2,964.96 3,399.13 3,328.82 3,817.94 3,152.60 3,616.73 2,528.66 2,897.88\n\n73 3,048.54 3,508.26 3,423.85 3,940.92 3,245.03 3,732.76 2,600.50 2,993.67\n\n74 3,134.44 3,615.06 3,521.67 4,063.90 3,335.49 3,848.80 2,674.35 3,085.47\n\n75 3,222.68 3,719.54 3,619.50 4,181.28 3,427.93 3,958.93 2,748.19 3,175.29\n\n76 3,313.22 3,819.38 3,722.91 4,295.88 3,526.26 4,067.10 2,828.02 3,261.10\n\n77 3,422.35 3,928.50 3,843.09 4,416.07 3,640.33 4,181.17 2,919.82 3,352.91\n\n78 3,538.44 4,035.31 3,980.06 4,536.25 3,768.16 4,293.27 3,021.61 3,444.71\n\n79 3,670.78 4,142.11 4,125.39 4,653.64 3,903.87 4,407.34 3,131.38 3,534.53\n\n80 3,837.95 4,281.42 4,312.66 4,810.16 4,082.83 4,556.80 3,273.08 3,654.28\n\n81 4,007.45 4,418.41 4,505.51 4,966.68 4,263.76 4,702.34 3,418.77 3,772.03\n\n82 4,202.47 4,583.25 4,723.52 5,151.15 4,470.27 4,875.41 3,584.42 3,911.73\n\n83 4,402.16 4,755.07 4,949.91 5,341.20 4,684.64 5,060.28 3,758.05 4,059.42\n\n84 4,590.22 4,922.24 5,162.34 5,531.26 4,887.21 5,237.28 3,919.72 4,203.11\n\n85+ 4,773.64 5,098.70 5,369.17 5,729.70 5,081.91 5,426.08 4,075.39 4,352.80\n\nZip Codes Factor\n\n750-754, 760-762, 779-781 1.15\n\n763, 769, 791, 798, 799, 885 0.95\n\n765-767 0.85\n\n770, 772-777, 783-784 1.25\n\nRest of State 1.05\n\nG\n\n**American National Life Insurance Company of Texas**\n\n**CURRENT RATES**\n\n**Tobacco Rates**\n\nArea Factors\n\nD E F\n\n**Exhibit A - Gross Annual Premiums**\n\n**TEXAS RATES**\n\n10/16/2025","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1036.pdf"]},"response":{"errors":[],"extract_id":"extract_f1cb87e0db34811b665c24a1c0615d8f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Female Male Female Male Female Male Female Male\n\nUnder 65 NA NA NA NA NA NA NA NA\n\n65 2,542.38 2,846.55 2,856.47 3,200.25 2,704.19 3,028.69 2,171.42 2,428.87\n\n66 2,542.38 2,846.55 2,856.47 3,200.25 2,704.19 3,028.69 2,171.42 2,428.87\n\n67 2,607.39 2,916.19 2,926.35 3,278.51 2,773.02 3,103.42 2,225.30 2,490.74\n\n68 2,672.41 2,990.49 3,001.82 3,362.35 2,841.86 3,182.09 2,281.18 2,552.60\n\n69 2,737.41 3,064.79 3,074.48 3,446.22 2,912.66 3,260.76 2,337.06 2,616.47\n\n70 2,807.07 3,183.20 3,152.74 3,580.36 2,985.42 3,388.60 2,394.94 2,718.25\n\n71 2,886.01 3,290.00 3,242.17 3,697.76 3,070.00 3,502.67 2,462.80 2,808.06\n\n72 2,964.96 3,399.13 3,328.82 3,817.94 3,152.60 3,616.73 2,528.66 2,897.88\n\n73 3,048.54 3,508.26 3,423.85 3,940.92 3,245.03 3,732.76 2,600.50 2,993.67\n\n74 3,134.44 3,615.06 3,521.67 4,063.90 3,335.49 3,848.80 2,674.35 3,085.47\n\n75 3,222.68 3,719.54 3,619.50 4,181.28 3,427.93 3,958.93 2,748.19 3,175.29\n\n76 3,313.22 3,819.38 3,722.91 4,295.88 3,526.26 4,067.10 2,828.02 3,261.10\n\n77 3,422.35 3,928.50 3,843.09 4,416.07 3,640.33 4,181.17 2,919.82 3,352.91\n\n78 3,538.44 4,035.31 3,980.06 4,536.25 3,768.16 4,293.27 3,021.61 3,444.71\n\n79 3,670.78 4,142.11 4,125.39 4,653.64 3,903.87 4,407.34 3,131.38 3,534.53\n\n80 3,837.95 4,281.42 4,312.66 4,810.16 4,082.83 4,556.80 3,273.08 3,654.28\n\n81 4,007.45 4,418.41 4,505.51 4,966.68 4,263.76 4,702.34 3,418.77 3,772.03\n\n82 4,202.47 4,583.25 4,723.52 5,151.15 4,470.27 4,875.41 3,584.42 3,911.73\n\n83 4,402.16 4,755.07 4,949.91 5,341.20 4,684.64 5,060.28 3,758.05 4,059.42\n\n84 4,590.22 4,922.24 5,162.34 5,531.26 4,887.21 5,237.28 3,919.72 4,203.11\n\n85+ 4,773.64 5,098.70 5,369.17 5,729.70 5,081.91 5,426.08 4,075.39 4,352.80\n\nZip Codes Factor\n\n750-754, 760-762, 779-781 1.15\n\n763, 769, 791, 798, 799, 885 0.95\n\n765-767 0.85\n\n770, 772-777, 783-784 1.25\n\nRest of State 1.05\n\nG\n\n**American National Life Insurance Company of Texas**\n\n**CURRENT RATES**\n\n**Tobacco Rates**\n\nArea Factors\n\nD E F\n\n**Exhibit A - Gross Annual Premiums**\n\n**TEXAS RATES**\n\n10/16/2025"],"full_content":"Female Male Female Male Female Male Female Male\n\nUnder 65 NA NA NA NA NA NA NA NA\n\n65 2,542.38 2,846.55 2,856.47 3,200.25 2,704.19 3,028.69 2,171.42 2,428.87\n\n66 2,542.38 2,846.55 2,856.47 3,200.25 2,704.19 3,028.69 2,171.42 2,428.87\n\n67 2,607.39 2,916.19 2,926.35 3,278.51 2,773.02 3,103.42 2,225.30 2,490.74\n\n68 2,672.41 2,990.49 3,001.82 3,362.35 2,841.86 3,182.09 2,281.18 2,552.60\n\n69 2,737.41 3,064.79 3,074.48 3,446.22 2,912.66 3,260.76 2,337.06 2,616.47\n\n70 2,807.07 3,183.20 3,152.74 3,580.36 2,985.42 3,388.60 2,394.94 2,718.25\n\n71 2,886.01 3,290.00 3,242.17 3,697.76 3,070.00 3,502.67 2,462.80 2,808.06\n\n72 2,964.96 3,399.13 3,328.82 3,817.94 3,152.60 3,616.73 2,528.66 2,897.88\n\n73 3,048.54 3,508.26 3,423.85 3,940.92 3,245.03 3,732.76 2,600.50 2,993.67\n\n74 3,134.44 3,615.06 3,521.67 4,063.90 3,335.49 3,848.80 2,674.35 3,085.47\n\n75 3,222.68 3,719.54 3,619.50 4,181.28 3,427.93 3,958.93 2,748.19 3,175.29\n\n76 3,313.22 3,819.38 3,722.91 4,295.88 3,526.26 4,067.10 2,828.02 3,261.10\n\n77 3,422.35 3,928.50 3,843.09 4,416.07 3,640.33 4,181.17 2,919.82 3,352.91\n\n78 3,538.44 4,035.31 3,980.06 4,536.25 3,768.16 4,293.27 3,021.61 3,444.71\n\n79 3,670.78 4,142.11 4,125.39 4,653.64 3,903.87 4,407.34 3,131.38 3,534.53\n\n80 3,837.95 4,281.42 4,312.66 4,810.16 4,082.83 4,556.80 3,273.08 3,654.28\n\n81 4,007.45 4,418.41 4,505.51 4,966.68 4,263.76 4,702.34 3,418.77 3,772.03\n\n82 4,202.47 4,583.25 4,723.52 5,151.15 4,470.27 4,875.41 3,584.42 3,911.73\n\n83 4,402.16 4,755.07 4,949.91 5,341.20 4,684.64 5,060.28 3,758.05 4,059.42\n\n84 4,590.22 4,922.24 5,162.34 5,531.26 4,887.21 5,237.28 3,919.72 4,203.11\n\n85+ 4,773.64 5,098.70 5,369.17 5,729.70 5,081.91 5,426.08 4,075.39 4,352.80\n\nZip Codes Factor\n\n750-754, 760-762, 779-781 1.15\n\n763, 769, 791, 798, 799, 885 0.95\n\n765-767 0.85\n\n770, 772-777, 783-784 1.25\n\nRest of State 1.05\n\nG\n\n**American National Life Insurance Company of Texas**\n\n**CURRENT RATES**\n\n**Tobacco Rates**\n\nArea Factors\n\nD E F\n\n**Exhibit A - Gross Annual Premiums**\n\n**TEXAS RATES**\n\n10/16/2025","publish_date":null,"title":"American National Life Insurance Company of Texas TEXAS RATES","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1036.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1036.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1036","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1036.pdf"},"started_at":"2026-11-04T19:48:07.517189"} +{"completed_at":"2026-11-04T19:48:09.564781","latency_in_ms":1067,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1045","grounded_pages":[],"layout_pages":[],"markdown":"### **Rate/Rule Schedule**\n\n**Item No.**\n\n**Schedule Item Status**\n\n**Document Name**\n\n**Affected Form Numbers (Separated with commas) Rate Action Rate Action Information Attachments**\n\n1 Rates Cover Letter MHCHP\\_LG\\_AGR (1/21) New Watkins01 - Large Group 2021 Memo - HMO.pdf,\n\n**_SERFF Tracking #:_** _MEMH-132548319_ **_State Tracking #:_** _MEMH-132548319_ **_Company Tracking #:_**\n\n**_State:_** _Texas_ **_Filing Company:_** _Memorial Hermann Commercial Health Plan, Inc._\n\n**_TOI/Sub-TOI:_** _HOrg02G Group Health Organizations - Health Maintenance (HMO)/HOrg02G.003C Large Group Only - HMO_\n\n**_Product Name:_** _2021 MHCHP Large Group HMO Rates_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number MEMH-132548319 Generated 02/23/2026 06:58 PM_","pages":[{"line_numbers":[],"markdown":"### **Rate/Rule Schedule**\n\n**Item No.**\n\n**Schedule Item Status**\n\n**Document Name**\n\n**Affected Form Numbers (Separated with commas) Rate Action Rate Action Information Attachments**\n\n1 Rates Cover Letter MHCHP\\_LG\\_AGR (1/21) New Watkins01 - Large Group 2021 Memo - HMO.pdf,\n\n**_SERFF Tracking #:_** _MEMH-132548319_ **_State Tracking #:_** _MEMH-132548319_ **_Company Tracking #:_**\n\n**_State:_** _Texas_ **_Filing Company:_** _Memorial Hermann Commercial Health Plan, Inc._\n\n**_TOI/Sub-TOI:_** _HOrg02G Group Health Organizations - Health Maintenance (HMO)/HOrg02G.003C Large Group Only - HMO_\n\n**_Product Name:_** _2021 MHCHP Large Group HMO Rates_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number MEMH-132548319 Generated 02/23/2026 06:58 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Rate/Rule Schedule**\n\n**Item No.**\n\n**Schedule Item Status**\n\n**Document Name**\n\n**Affected Form Numbers (Separated with commas) Rate Action Rate Action Information Attachments**\n\n1 Rates Cover Letter MHCHP\\_LG\\_AGR (1/21) New Watkins01 - Large Group 2021 Memo - HMO.pdf,\n\n**_SERFF Tracking #:_** _MEMH-132548319_ **_State Tracking #:_** _MEMH-132548319_ **_Company Tracking #:_**\n\n**_State:_** _Texas_ **_Filing Company:_** _Memorial Hermann Commercial Health Plan, Inc._\n\n**_TOI/Sub-TOI:_** _HOrg02G Group Health Organizations - Health Maintenance (HMO)/HOrg02G.003C Large Group Only - HMO_\n\n**_Product Name:_** _2021 MHCHP Large Group HMO Rates_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number MEMH-132548319 Generated 02/23/2026 06:58 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1045.pdf"]},"response":{"errors":[],"extract_id":"extract_857da8ca79b55616b071647852567b6e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Rate/Rule Schedule**\n\n**Item No.**\n\n**Schedule Item Status**\n\n**Document Name**\n\n**Affected Form Numbers (Separated with commas) Rate Action Rate Action Information Attachments**\n\n1 Rates Cover Letter MHCHP\\_LG\\_AGR (1/21) New Watkins01 - Large Group 2021 Memo - HMO.pdf,\n\n**_SERFF Tracking #:_** _MEMH-132548319_ **_State Tracking #:_** _MEMH-132548319_ **_Company Tracking #:_**\n\n**_State:_** _Texas_ **_Filing Company:_** _Memorial Hermann Commercial Health Plan, Inc._\n\n**_TOI/Sub-TOI:_** _HOrg02G Group Health Organizations - Health Maintenance (HMO)/HOrg02G.003C Large Group Only - HMO_\n\n**_Product Name:_** _2021 MHCHP Large Group HMO Rates_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number MEMH-132548319 Generated 02/23/2026 06:58 PM_"],"full_content":"### **Rate/Rule Schedule**\n\n**Item No.**\n\n**Schedule Item Status**\n\n**Document Name**\n\n**Affected Form Numbers (Separated with commas) Rate Action Rate Action Information Attachments**\n\n1 Rates Cover Letter MHCHP\\_LG\\_AGR (1/21) New Watkins01 - Large Group 2021 Memo - HMO.pdf,\n\n**_SERFF Tracking #:_** _MEMH-132548319_ **_State Tracking #:_** _MEMH-132548319_ **_Company Tracking #:_**\n\n**_State:_** _Texas_ **_Filing Company:_** _Memorial Hermann Commercial Health Plan, Inc._\n\n**_TOI/Sub-TOI:_** _HOrg02G Group Health Organizations - Health Maintenance (HMO)/HOrg02G.003C Large Group Only - HMO_\n\n**_Product Name:_** _2021 MHCHP Large Group HMO Rates_\n\n**_Project Name/Number:_** _/_\n\n_PDF Pipeline for SERFF Tracking Number MEMH-132548319 Generated 02/23/2026 06:58 PM_","publish_date":null,"title":"Rate/Rule Schedule","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1045.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1045.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1045","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1045.pdf"},"started_at":"2026-11-04T19:48:08.497207"} +{"completed_at":"2026-11-04T19:48:11.492305","latency_in_ms":1469,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1051","grounded_pages":[],"layout_pages":[],"markdown":"**Mercury Casualty Company Texas Homeowners**\n\n**Water Leak Detection Discount Factor**\n\n**Form Device Type P1 P2 P3 P4 P5 P6 P7 P8 P9 P10**\n\nHO-3 No 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Central Monitor 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Valve Closure 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Valve Closure with Central Monitor 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\n\\* This discount not applicable for HO4 and HO6.","pages":[{"line_numbers":[],"markdown":"**Mercury Casualty Company Texas Homeowners**\n\n**Water Leak Detection Discount Factor**\n\n**Form Device Type P1 P2 P3 P4 P5 P6 P7 P8 P9 P10**\n\nHO-3 No 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Central Monitor 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Valve Closure 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Valve Closure with Central Monitor 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\n\\* This discount not applicable for HO4 and HO6.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Mercury Casualty Company Texas Homeowners**\n\n**Water Leak Detection Discount Factor**\n\n**Form Device Type P1 P2 P3 P4 P5 P6 P7 P8 P9 P10**\n\nHO-3 No 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Central Monitor 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Valve Closure 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Valve Closure with Central Monitor 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\n\\* This discount not applicable for HO4 and HO6.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1051.pdf"]},"response":{"errors":[],"extract_id":"extract_2470707cb0f86bc7fdd012a2ce14cd5e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Mercury Casualty Company Texas Homeowners**\n\n**Water Leak Detection Discount Factor**\n\n**Form Device Type P1 P2 P3 P4 P5 P6 P7 P8 P9 P10**\n\nHO-3 No 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Central Monitor 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Valve Closure 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Valve Closure with Central Monitor 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\n\\* This discount not applicable for HO4 and HO6."],"full_content":"**Mercury Casualty Company Texas Homeowners**\n\n**Water Leak Detection Discount Factor**\n\n**Form Device Type P1 P2 P3 P4 P5 P6 P7 P8 P9 P10**\n\nHO-3 No 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Central Monitor 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Valve Closure 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\nHO-3 Valve Closure with Central Monitor 1.000 1.000 1.000 1.000 0.950 1.000 1.000 1.000 1.000 1.000\n\n\\* This discount not applicable for HO4 and HO6.","publish_date":null,"title":"Mercury Casualty Company Texas Homeowners Water Leak Detection Discount Factor Form Device Type P1 P2 P3 P4 P5 P6 P7","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1051.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1051.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1051","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1051.pdf"},"started_at":"2026-11-04T19:48:10.023014"} +{"completed_at":"2026-11-04T19:48:13.395159","latency_in_ms":2356,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1056","grounded_pages":[],"layout_pages":[],"markdown":"**Accident**\n\n**Qtr** 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72+\n\n2009-3 141 145 134 160 163 166 166 166 169 169 169 169 169 169 169 169 169 169 169 169 169 169 169 169\n\n2009-4 594 725 733 709 695 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702\n\n2010-1 1,379 1,601 1,634 1,665 1,635 1,667 1,698 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727\n\n2010-2 675 1,124 1,158 1,185 1,204 1,205 1,207 1,208 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210\n\n2010-3 261 306 315 329 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328\n\n2010-4 790 920 876 978 984 983 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015\n\n2011-1 1,494 2,108 2,210 2,212 2,185 2,192 2,194 2,146 2,143 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146\n\n2011-2 2,056 2,521 2,499 2,513 2,513 2,524 2,534 2,541 2,537 2,537 2,537 2,562 2,562 2,562 2,562 2,562 2,560 2,560 2,560 2,560 2,560\n\n2011-3 716 887 938 977 997 1,001 1,001 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,032 1,032 1,032 1,032 1,032\n\n2011-4 3,177 3,842 4,498 4,635 4,804 4,916 4,859 4,934 4,915 4,915 4,877 4,877 4,877 4,876 4,876 4,876 4,876 4,876 4,876\n\n2012-1 1,002 1,312 1,430 1,460 1,496 1,500 1,501 1,501 1,503 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509\n\n2012-2 935 970 1,058 1,114 1,116 1,130 1,131 1,141 1,131 1,143 1,123 1,130 1,130 1,130 1,130 1,130 1,130\n\n2012-3 860 943 998 1,045 1,046 1,046 1,060 1,073 1,073 1,082 1,082 1,082 1,082 1,082 1,082 1,082\n\n2012-4 517 1,121 1,324 1,395 1,496 1,505 1,521 1,525 1,525 1,529 1,529 1,529 1,569 1,569 1,569\n\n2013-1 716 1,024 1,092 1,138 1,171 1,180 1,180 1,180 1,180 1,180 1,180 1,187 1,194 1,195\n\n2013-2 2,165 2,616 2,743 2,790 2,889 2,914 2,930 2,944 2,947 2,947 2,947 2,947 2,947\n\n2013-3 1,008 1,117 1,235 1,259 1,277 1,286 1,286 1,292 1,300 1,300 1,300 1,345\n\n2013-4 629 685 712 764 847 844 888 892 899 899 899\n\n2014-1 788 976 1,047 1,100 1,122 1,167 1,168 1,169 1,163 1,163\n\n2014-2 891 1,346 1,513 1,631 1,676 1,659 1,665 1,665 1,641\n\n2014-3 935 1,073 1,163 1,261 1,269 1,293 1,294 1,294\n\n2014-4 699 1,090 1,260 1,322 1,369 1,407 1,408\n\n2015-1 973 1,248 1,298 1,332 1,360 1,381\n\n2015-2 928 1,130 1,226 1,285 1,246\n\n2015-3 1,387 1,524 1,652 1,706\n\n2015-4 1,099 1,300 1,406\n\n2016-1 1,409 1,889\n\n2016-2 1,030\n\n**Accident**\n\n**Qtr** 3 - 6 6 - 9 9 - 12 12 - 15 15 - 18 18 - 21 21 - 24 24 - 27 27 - 30 30 - 33 33 - 36 36 - 39 39 - 42 42 - 45 45 - 48 48 - 51 51 - 54 54 - 57 57 - 60 60 - 63 63 - 66 66 - 69 69 - 72+\n\n2009-3 1.031 0.920 1.196 1.023 1.013 1.000 1.000 1.020 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2009-4 1.219 1.012 0.967 0.980 1.011 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-1 1.162 1.021 1.018 0.982 1.020 1.019 1.017 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-2 1.665 1.030 1.024 1.016 1.001 1.002 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-3 1.174 1.029 1.044 0.997 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-4 1.164 0.953 1.116 1.007 0.999 1.033 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2011-1 1.411 1.048 1.001 0.988 1.003 1.001 0.978 0.999 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2011-2 1.226 0.991 1.005 1.000 1.004 1.004 1.003 0.998 1.000 1.000 1.010 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000\n\n2011-3 1.239 1.058 1.041 1.021 1.004 1.000 1.019 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.012 1.000 1.000 1.000 1.000\n\n2011-4 1.210 1.171 1.031 1.036 1.023 0.988 1.015 0.996 1.000 0.992 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-1 1.309 1.089 1.021 1.025 1.003 1.000 1.000 1.002 1.004 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-2 1.038 1.090 1.054 1.002 1.012 1.001 1.009 0.991 1.010 0.983 1.006 1.000 1.000 1.000 1.000 1.000\n\n2012-3 1.096 1.059 1.047 1.001 1.000 1.013 1.013 1.000 1.008 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-4 2.169 1.181 1.054 1.073 1.006 1.011 1.002 1.000 1.003 1.000 1.000 1.026 1.000 1.000\n\n2013-1 1.431 1.066 1.042 1.029 1.008 1.000 1.000 1.000 1.000 1.000 1.007 1.006 1.001\n\n2013-2 1.208 1.049 1.017 1.035 1.008 1.006 1.005 1.001 1.000 1.000 1.000 1.000\n\n2013-3 1.108 1.106 1.019 1.014 1.007 1.000 1.005 1.006 1.000 1.000 1.035\n\n2013-4 1.089 1.040 1.072 1.109 0.996 1.053 1.005 1.007 1.000 1.000\n\n2014-1 1.239 1.073 1.050 1.021 1.040 1.001 1.001 0.995 1.000\n\n2014-2 1.510 1.124 1.078 1.028 0.990 1.003 1.000 0.986\n\n2014-3 1.148 1.084 1.084 1.006 1.019 1.001 1.000\n\n2014-4 1.560 1.155 1.049 1.035 1.028 1.001\n\n2015-1 1.282 1.040 1.027 1.021 1.015\n\n2015-2 1.218 1.085 1.048 0.970\n\n2015-3 1.099 1.084 1.032\n\n2015-4 1.183 1.082\n\n2016-1 1.341\n\n**Age-to-Age** Method 3 - 6 6 - 9 9 - 12 12 - 15 15 - 18 18 - 21 21 - 24 24 - 27 27 - 30 30 - 33 33 - 36 36 - 39 39 - 42 42 - 45 45 - 48 48 - 51 51 - 54 54 - 57 57 - 60 60 - 63 63 - 66 66 - 69 69 - 72+ 72-Ult\n\n(1) Latest Quarter 1.341 1.082 1.032 0.970 1.015 1.001 1.000 0.986 1.000 1.000 1.035 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(2) Last 5 Quarter Avg 1.225 1.089 1.048 1.012 1.018 1.012 1.002 0.999 1.000 1.000 1.008 1.006 1.000 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(3) Last 6 Qtr Wt Avg 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(4) Avg 5Qtrs Ex Min&Max 1.228 1.084 1.043 1.018 1.021 1.002 1.002 1.001 1.000 1.000 1.002 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(5) All Quarters Avg 1.279 1.063 1.045 1.017 1.009 1.006 1.003 1.000 1.001 0.999 1.003 1.002 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(6) High 2.169 1.181 1.196 1.109 1.040 1.053 1.019 1.020 1.010 1.000 1.035 1.026 1.001 1.000 1.012 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(7) Low 1.031 0.920 0.967 0.970 0.990 0.988 0.978 0.986 1.000 0.983 1.000 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(8) Sel. Data for Power Curve 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(9) Inv Power 1.210 1.074 1.035 1.020 1.012 1.008 1.006 1.004 1.003 1.003 1.002 1.002 1.001 1.001 1.001 1.001 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.002\n\n(10) Double Exponential 1.070 1.049 1.035 1.025 1.018 1.013 1.009 1.006 1.005 1.003 1.002 1.002 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000\n\nSelected 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nMethod 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3\n\n**Age-to-Ultimate** Method 3-Ult 6-Ult 9-Ult 12-Ult 15-Ult 18-Ult 21-Ult 24-Ult 27-Ult 30-Ult 33-Ult 36-Ult 39-Ult 42-Ult 45-Ult 48-Ult 51-Ult 54-Ult 57-Ult 60-Ult 63-Ult 66-Ult 69-Ult 72-Ult\n\n(1) Latest Quarter 1.506 1.124 1.039 1.006 1.037 1.022 1.020 1.020 1.035 1.035 1.035 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(2) Last 5 Quarter Avg 1.485 1.212 1.113 1.062 1.049 1.031 1.019 1.016 1.017 1.017 1.017 1.009 1.002 1.002 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(3) Last 6 Qtr Wt Avg 1.513 1.201 1.106 1.051 1.036 1.021 1.014 1.012 1.013 1.012 1.012 1.006 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(4) Avg 5Qtrs Ex Min&Max 1.455 1.185 1.093 1.048 1.030 1.009 1.007 1.005 1.004 1.004 1.004 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(5) All Quarters Avg 1.483 1.159 1.091 1.043 1.025 1.016 1.010 1.006 1.006 1.005 1.006 1.003 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(6) High 4.197 1.935 1.638 1.370 1.235 1.188 1.129 1.108 1.086 1.075 1.075 1.039 1.012 1.012 1.012 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(7) Low 0.825 0.800 0.870 0.899 0.927 0.936 0.947 0.968 0.982 0.982 0.999 0.999 0.999 0.999 0.999 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nSelected 1.513 1.201 1.106 1.051 1.036 1.021 1.014 1.012 1.013 1.012 1.012 1.006 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n**Reported and Ultimate Losses**\n\n**Accident**\n\n**Years**\n\n**Inc to Date**\n\n**Selected Ult. Loss**\n\n**Latest Quarter**\n\n**Last 5**\n\n**Quarter**\n\n**Avg**\n\n**Last 6 Qtr**\n\n**Wt Avg**\n\n**Avg 5Qtrs**\n\n**Ex**\n\n**Min&Max**\n\n**All Year Average High Low**\n\n**2009-3** 169 169 169 169 169 169 169 169 169\n\n**2009-4** 702 702 702 702 702 702 702 702 702\n\n**2010-1** 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727\n\n**2010-2** 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210\n\n**2010-3** 328 328 328 328 328 328 328 328 328\n\n**2010-4** 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015\n\n**2011-1** 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146\n\n**2011-2** 2,560 2,560 2,560 2,560 2,560 2,560 2,560 2,560 2,560\n\n**2011-3** 1,032 1,032 1,032 1,032 1,032 1,032 1,032 1,032 1,032\n\n**2011-4** 4,876 4,876 4,876 4,876 4,876 4,876 4,876 4,876 4,876\n\n**2012-1** 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509\n\n**2012-2** 1,130 1,130 1,130 1,130 1,130 1,130 1,130 1,130 1,130\n\n**2012-3** 1,082 1,082 1,082 1,081 1,082 1,082 1,082 1,082 1,081\n\n**2012-4** 1,569 1,571 1,569 1,573 1,571 1,569 1,571 1,588 1,568\n\n**2013-1** 1,195 1,196 1,195 1,198 1,196 1,195 1,196 1,209 1,194\n\n**2013-2** 2,947 2,950 2,949 2,955 2,950 2,947 2,950 2,984 2,945\n\n**2013-3** 1,345 1,353 1,346 1,357 1,353 1,348 1,349 1,398 1,344\n\n**2013-4** 899 910 930 914 910 902 904 966 898\n\n**2014-1** 1,163 1,178 1,204 1,183 1,178 1,168 1,169 1,250 1,142\n\n**2014-2** 1,641 1,662 1,699 1,669 1,662 1,648 1,651 1,782 1,611\n\n**2014-3** 1,294 1,309 1,320 1,315 1,309 1,301 1,302 1,434 1,253\n\n**2014-4** 1,408 1,429 1,437 1,434 1,429 1,418 1,422 1,590 1,334\n\n**2015-1** 1,381 1,411 1,411 1,424 1,411 1,393 1,404 1,641 1,293\n\n**2015-2** 1,246 1,291 1,293 1,308 1,291 1,283 1,278 1,539 1,155\n\n**2015-3** 1,706 1,792 1,716 1,811 1,792 1,788 1,779 2,336 1,533\n\n**2015-4** 1,406 1,554 1,460 1,565 1,554 1,537 1,533 2,303 1,222\n\n**2016-1** 1,889 2,269 2,122 2,290 2,269 2,238 2,190 3,655 1,511\n\n**2016-2** 1,030 1,559 1,552 1,530 1,559 1,499 1,528 4,324 850\n\n**ALL COMPANIES COMBINED - COUNTRYWIDE**\n\n**LOSS DEVELOPMENT FACTOR**\n\n**Form - All (Wind & Hail)**\n\n**INCURRED LOSSES NET OF SAL & SUB (000's)**\n\n**Age in Months**\n\n**Age-to-Age Development**","pages":[{"line_numbers":[],"markdown":"**Accident**\n\n**Qtr** 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72+\n\n2009-3 141 145 134 160 163 166 166 166 169 169 169 169 169 169 169 169 169 169 169 169 169 169 169 169\n\n2009-4 594 725 733 709 695 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702\n\n2010-1 1,379 1,601 1,634 1,665 1,635 1,667 1,698 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727\n\n2010-2 675 1,124 1,158 1,185 1,204 1,205 1,207 1,208 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210\n\n2010-3 261 306 315 329 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328\n\n2010-4 790 920 876 978 984 983 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015\n\n2011-1 1,494 2,108 2,210 2,212 2,185 2,192 2,194 2,146 2,143 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146\n\n2011-2 2,056 2,521 2,499 2,513 2,513 2,524 2,534 2,541 2,537 2,537 2,537 2,562 2,562 2,562 2,562 2,562 2,560 2,560 2,560 2,560 2,560\n\n2011-3 716 887 938 977 997 1,001 1,001 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,032 1,032 1,032 1,032 1,032\n\n2011-4 3,177 3,842 4,498 4,635 4,804 4,916 4,859 4,934 4,915 4,915 4,877 4,877 4,877 4,876 4,876 4,876 4,876 4,876 4,876\n\n2012-1 1,002 1,312 1,430 1,460 1,496 1,500 1,501 1,501 1,503 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509\n\n2012-2 935 970 1,058 1,114 1,116 1,130 1,131 1,141 1,131 1,143 1,123 1,130 1,130 1,130 1,130 1,130 1,130\n\n2012-3 860 943 998 1,045 1,046 1,046 1,060 1,073 1,073 1,082 1,082 1,082 1,082 1,082 1,082 1,082\n\n2012-4 517 1,121 1,324 1,395 1,496 1,505 1,521 1,525 1,525 1,529 1,529 1,529 1,569 1,569 1,569\n\n2013-1 716 1,024 1,092 1,138 1,171 1,180 1,180 1,180 1,180 1,180 1,180 1,187 1,194 1,195\n\n2013-2 2,165 2,616 2,743 2,790 2,889 2,914 2,930 2,944 2,947 2,947 2,947 2,947 2,947\n\n2013-3 1,008 1,117 1,235 1,259 1,277 1,286 1,286 1,292 1,300 1,300 1,300 1,345\n\n2013-4 629 685 712 764 847 844 888 892 899 899 899\n\n2014-1 788 976 1,047 1,100 1,122 1,167 1,168 1,169 1,163 1,163\n\n2014-2 891 1,346 1,513 1,631 1,676 1,659 1,665 1,665 1,641\n\n2014-3 935 1,073 1,163 1,261 1,269 1,293 1,294 1,294\n\n2014-4 699 1,090 1,260 1,322 1,369 1,407 1,408\n\n2015-1 973 1,248 1,298 1,332 1,360 1,381\n\n2015-2 928 1,130 1,226 1,285 1,246\n\n2015-3 1,387 1,524 1,652 1,706\n\n2015-4 1,099 1,300 1,406\n\n2016-1 1,409 1,889\n\n2016-2 1,030\n\n**Accident**\n\n**Qtr** 3 - 6 6 - 9 9 - 12 12 - 15 15 - 18 18 - 21 21 - 24 24 - 27 27 - 30 30 - 33 33 - 36 36 - 39 39 - 42 42 - 45 45 - 48 48 - 51 51 - 54 54 - 57 57 - 60 60 - 63 63 - 66 66 - 69 69 - 72+\n\n2009-3 1.031 0.920 1.196 1.023 1.013 1.000 1.000 1.020 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2009-4 1.219 1.012 0.967 0.980 1.011 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-1 1.162 1.021 1.018 0.982 1.020 1.019 1.017 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-2 1.665 1.030 1.024 1.016 1.001 1.002 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-3 1.174 1.029 1.044 0.997 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-4 1.164 0.953 1.116 1.007 0.999 1.033 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2011-1 1.411 1.048 1.001 0.988 1.003 1.001 0.978 0.999 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2011-2 1.226 0.991 1.005 1.000 1.004 1.004 1.003 0.998 1.000 1.000 1.010 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000\n\n2011-3 1.239 1.058 1.041 1.021 1.004 1.000 1.019 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.012 1.000 1.000 1.000 1.000\n\n2011-4 1.210 1.171 1.031 1.036 1.023 0.988 1.015 0.996 1.000 0.992 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-1 1.309 1.089 1.021 1.025 1.003 1.000 1.000 1.002 1.004 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-2 1.038 1.090 1.054 1.002 1.012 1.001 1.009 0.991 1.010 0.983 1.006 1.000 1.000 1.000 1.000 1.000\n\n2012-3 1.096 1.059 1.047 1.001 1.000 1.013 1.013 1.000 1.008 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-4 2.169 1.181 1.054 1.073 1.006 1.011 1.002 1.000 1.003 1.000 1.000 1.026 1.000 1.000\n\n2013-1 1.431 1.066 1.042 1.029 1.008 1.000 1.000 1.000 1.000 1.000 1.007 1.006 1.001\n\n2013-2 1.208 1.049 1.017 1.035 1.008 1.006 1.005 1.001 1.000 1.000 1.000 1.000\n\n2013-3 1.108 1.106 1.019 1.014 1.007 1.000 1.005 1.006 1.000 1.000 1.035\n\n2013-4 1.089 1.040 1.072 1.109 0.996 1.053 1.005 1.007 1.000 1.000\n\n2014-1 1.239 1.073 1.050 1.021 1.040 1.001 1.001 0.995 1.000\n\n2014-2 1.510 1.124 1.078 1.028 0.990 1.003 1.000 0.986\n\n2014-3 1.148 1.084 1.084 1.006 1.019 1.001 1.000\n\n2014-4 1.560 1.155 1.049 1.035 1.028 1.001\n\n2015-1 1.282 1.040 1.027 1.021 1.015\n\n2015-2 1.218 1.085 1.048 0.970\n\n2015-3 1.099 1.084 1.032\n\n2015-4 1.183 1.082\n\n2016-1 1.341\n\n**Age-to-Age** Method 3 - 6 6 - 9 9 - 12 12 - 15 15 - 18 18 - 21 21 - 24 24 - 27 27 - 30 30 - 33 33 - 36 36 - 39 39 - 42 42 - 45 45 - 48 48 - 51 51 - 54 54 - 57 57 - 60 60 - 63 63 - 66 66 - 69 69 - 72+ 72-Ult\n\n(1) Latest Quarter 1.341 1.082 1.032 0.970 1.015 1.001 1.000 0.986 1.000 1.000 1.035 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(2) Last 5 Quarter Avg 1.225 1.089 1.048 1.012 1.018 1.012 1.002 0.999 1.000 1.000 1.008 1.006 1.000 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(3) Last 6 Qtr Wt Avg 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(4) Avg 5Qtrs Ex Min&Max 1.228 1.084 1.043 1.018 1.021 1.002 1.002 1.001 1.000 1.000 1.002 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(5) All Quarters Avg 1.279 1.063 1.045 1.017 1.009 1.006 1.003 1.000 1.001 0.999 1.003 1.002 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(6) High 2.169 1.181 1.196 1.109 1.040 1.053 1.019 1.020 1.010 1.000 1.035 1.026 1.001 1.000 1.012 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(7) Low 1.031 0.920 0.967 0.970 0.990 0.988 0.978 0.986 1.000 0.983 1.000 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(8) Sel. Data for Power Curve 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(9) Inv Power 1.210 1.074 1.035 1.020 1.012 1.008 1.006 1.004 1.003 1.003 1.002 1.002 1.001 1.001 1.001 1.001 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.002\n\n(10) Double Exponential 1.070 1.049 1.035 1.025 1.018 1.013 1.009 1.006 1.005 1.003 1.002 1.002 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000\n\nSelected 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nMethod 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3\n\n**Age-to-Ultimate** Method 3-Ult 6-Ult 9-Ult 12-Ult 15-Ult 18-Ult 21-Ult 24-Ult 27-Ult 30-Ult 33-Ult 36-Ult 39-Ult 42-Ult 45-Ult 48-Ult 51-Ult 54-Ult 57-Ult 60-Ult 63-Ult 66-Ult 69-Ult 72-Ult\n\n(1) Latest Quarter 1.506 1.124 1.039 1.006 1.037 1.022 1.020 1.020 1.035 1.035 1.035 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(2) Last 5 Quarter Avg 1.485 1.212 1.113 1.062 1.049 1.031 1.019 1.016 1.017 1.017 1.017 1.009 1.002 1.002 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(3) Last 6 Qtr Wt Avg 1.513 1.201 1.106 1.051 1.036 1.021 1.014 1.012 1.013 1.012 1.012 1.006 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(4) Avg 5Qtrs Ex Min&Max 1.455 1.185 1.093 1.048 1.030 1.009 1.007 1.005 1.004 1.004 1.004 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(5) All Quarters Avg 1.483 1.159 1.091 1.043 1.025 1.016 1.010 1.006 1.006 1.005 1.006 1.003 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(6) High 4.197 1.935 1.638 1.370 1.235 1.188 1.129 1.108 1.086 1.075 1.075 1.039 1.012 1.012 1.012 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(7) Low 0.825 0.800 0.870 0.899 0.927 0.936 0.947 0.968 0.982 0.982 0.999 0.999 0.999 0.999 0.999 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nSelected 1.513 1.201 1.106 1.051 1.036 1.021 1.014 1.012 1.013 1.012 1.012 1.006 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n**Reported and Ultimate Losses**\n\n**Accident**\n\n**Years**\n\n**Inc to Date**\n\n**Selected Ult. Loss**\n\n**Latest Quarter**\n\n**Last 5**\n\n**Quarter**\n\n**Avg**\n\n**Last 6 Qtr**\n\n**Wt Avg**\n\n**Avg 5Qtrs**\n\n**Ex**\n\n**Min&Max**\n\n**All Year Average High Low**\n\n**2009-3** 169 169 169 169 169 169 169 169 169\n\n**2009-4** 702 702 702 702 702 702 702 702 702\n\n**2010-1** 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727\n\n**2010-2** 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210\n\n**2010-3** 328 328 328 328 328 328 328 328 328\n\n**2010-4** 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015\n\n**2011-1** 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146\n\n**2011-2** 2,560 2,560 2,560 2,560 2,560 2,560 2,560 2,560 2,560\n\n**2011-3** 1,032 1,032 1,032 1,032 1,032 1,032 1,032 1,032 1,032\n\n**2011-4** 4,876 4,876 4,876 4,876 4,876 4,876 4,876 4,876 4,876\n\n**2012-1** 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509\n\n**2012-2** 1,130 1,130 1,130 1,130 1,130 1,130 1,130 1,130 1,130\n\n**2012-3** 1,082 1,082 1,082 1,081 1,082 1,082 1,082 1,082 1,081\n\n**2012-4** 1,569 1,571 1,569 1,573 1,571 1,569 1,571 1,588 1,568\n\n**2013-1** 1,195 1,196 1,195 1,198 1,196 1,195 1,196 1,209 1,194\n\n**2013-2** 2,947 2,950 2,949 2,955 2,950 2,947 2,950 2,984 2,945\n\n**2013-3** 1,345 1,353 1,346 1,357 1,353 1,348 1,349 1,398 1,344\n\n**2013-4** 899 910 930 914 910 902 904 966 898\n\n**2014-1** 1,163 1,178 1,204 1,183 1,178 1,168 1,169 1,250 1,142\n\n**2014-2** 1,641 1,662 1,699 1,669 1,662 1,648 1,651 1,782 1,611\n\n**2014-3** 1,294 1,309 1,320 1,315 1,309 1,301 1,302 1,434 1,253\n\n**2014-4** 1,408 1,429 1,437 1,434 1,429 1,418 1,422 1,590 1,334\n\n**2015-1** 1,381 1,411 1,411 1,424 1,411 1,393 1,404 1,641 1,293\n\n**2015-2** 1,246 1,291 1,293 1,308 1,291 1,283 1,278 1,539 1,155\n\n**2015-3** 1,706 1,792 1,716 1,811 1,792 1,788 1,779 2,336 1,533\n\n**2015-4** 1,406 1,554 1,460 1,565 1,554 1,537 1,533 2,303 1,222\n\n**2016-1** 1,889 2,269 2,122 2,290 2,269 2,238 2,190 3,655 1,511\n\n**2016-2** 1,030 1,559 1,552 1,530 1,559 1,499 1,528 4,324 850\n\n**ALL COMPANIES COMBINED - COUNTRYWIDE**\n\n**LOSS DEVELOPMENT FACTOR**\n\n**Form - All (Wind & Hail)**\n\n**INCURRED LOSSES NET OF SAL & SUB (000's)**\n\n**Age in Months**\n\n**Age-to-Age Development**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Accident**\n\n**Qtr** 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72+\n\n2009-3 141 145 134 160 163 166 166 166 169 169 169 169 169 169 169 169 169 169 169 169 169 169 169 169\n\n2009-4 594 725 733 709 695 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702\n\n2010-1 1,379 1,601 1,634 1,665 1,635 1,667 1,698 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727\n\n2010-2 675 1,124 1,158 1,185 1,204 1,205 1,207 1,208 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210\n\n2010-3 261 306 315 329 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328\n\n2010-4 790 920 876 978 984 983 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015\n\n2011-1 1,494 2,108 2,210 2,212 2,185 2,192 2,194 2,146 2,143 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146\n\n2011-2 2,056 2,521 2,499 2,513 2,513 2,524 2,534 2,541 2,537 2,537 2,537 2,562 2,562 2,562 2,562 2,562 2,560 2,560 2,560 2,560 2,560\n\n2011-3 716 887 938 977 997 1,001 1,001 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,032 1,032 1,032 1,032 1,032\n\n2011-4 3,177 3,842 4,498 4,635 4,804 4,916 4,859 4,934 4,915 4,915 4,877 4,877 4,877 4,876 4,876 4,876 4,876 4,876 4,876\n\n2012-1 1,002 1,312 1,430 1,460 1,496 1,500 1,501 1,501 1,503 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509\n\n2012-2 935 970 1,058 1,114 1,116 1,130 1,131 1,141 1,131 1,143 1,123 1,130 1,130 1,130 1,130 1,130 1,130\n\n2012-3 860 943 998 1,045 1,046 1,046 1,060 1,073 1,073 1,082 1,082 1,082 1,082 1,082 1,082 1,082\n\n2012-4 517 1,121 1,324 1,395 1,496 1,505 1,521 1,525 1,525 1,529 1,529 1,529 1,569 1,569 1,569\n\n2013-1 716 1,024 1,092 1,138 1,171 1,180 1,180 1,180 1,180 1,180 1,180 1,187 1,194 1,195\n\n2013-2 2,165 2,616 2,743 2,790 2,889 2,914 2,930 2,944 2,947 2,947 2,947 2,947 2,947\n\n2013-3 1,008 1,117 1,235 1,259 1,277 1,286 1,286 1,292 1,300 1,300 1,300 1,345\n\n2013-4 629 685 712 764 847 844 888 892 899 899 899\n\n2014-1 788 976 1,047 1,100 1,122 1,167 1,168 1,169 1,163 1,163\n\n2014-2 891 1,346 1,513 1,631 1,676 1,659 1,665 1,665 1,641\n\n2014-3 935 1,073 1,163 1,261 1,269 1,293 1,294 1,294\n\n2014-4 699 1,090 1,260 1,322 1,369 1,407 1,408\n\n2015-1 973 1,248 1,298 1,332 1,360 1,381\n\n2015-2 928 1,130 1,226 1,285 1,246\n\n2015-3 1,387 1,524 1,652 1,706\n\n2015-4 1,099 1,300 1,406\n\n2016-1 1,409 1,889\n\n2016-2 1,030\n\n**Accident**\n\n**Qtr** 3 - 6 6 - 9 9 - 12 12 - 15 15 - 18 18 - 21 21 - 24 24 - 27 27 - 30 30 - 33 33 - 36 36 - 39 39 - 42 42 - 45 45 - 48 48 - 51 51 - 54 54 - 57 57 - 60 60 - 63 63 - 66 66 - 69 69 - 72+\n\n2009-3 1.031 0.920 1.196 1.023 1.013 1.000 1.000 1.020 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2009-4 1.219 1.012 0.967 0.980 1.011 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-1 1.162 1.021 1.018 0.982 1.020 1.019 1.017 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-2 1.665 1.030 1.024 1.016 1.001 1.002 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-3 1.174 1.029 1.044 0.997 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-4 1.164 0.953 1.116 1.007 0.999 1.033 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2011-1 1.411 1.048 1.001 0.988 1.003 1.001 0.978 0.999 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2011-2 1.226 0.991 1.005 1.000 1.004 1.004 1.003 0.998 1.000 1.000 1.010 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000\n\n2011-3 1.239 1.058 1.041 1.021 1.004 1.000 1.019 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.012 1.000 1.000 1.000 1.000\n\n2011-4 1.210 1.171 1.031 1.036 1.023 0.988 1.015 0.996 1.000 0.992 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-1 1.309 1.089 1.021 1.025 1.003 1.000 1.000 1.002 1.004 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-2 1.038 1.090 1.054 1.002 1.012 1.001 1.009 0.991 1.010 0.983 1.006 1.000 1.000 1.000 1.000 1.000\n\n2012-3 1.096 1.059 1.047 1.001 1.000 1.013 1.013 1.000 1.008 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-4 2.169 1.181 1.054 1.073 1.006 1.011 1.002 1.000 1.003 1.000 1.000 1.026 1.000 1.000\n\n2013-1 1.431 1.066 1.042 1.029 1.008 1.000 1.000 1.000 1.000 1.000 1.007 1.006 1.001\n\n2013-2 1.208 1.049 1.017 1.035 1.008 1.006 1.005 1.001 1.000 1.000 1.000 1.000\n\n2013-3 1.108 1.106 1.019 1.014 1.007 1.000 1.005 1.006 1.000 1.000 1.035\n\n2013-4 1.089 1.040 1.072 1.109 0.996 1.053 1.005 1.007 1.000 1.000\n\n2014-1 1.239 1.073 1.050 1.021 1.040 1.001 1.001 0.995 1.000\n\n2014-2 1.510 1.124 1.078 1.028 0.990 1.003 1.000 0.986\n\n2014-3 1.148 1.084 1.084 1.006 1.019 1.001 1.000\n\n2014-4 1.560 1.155 1.049 1.035 1.028 1.001\n\n2015-1 1.282 1.040 1.027 1.021 1.015\n\n2015-2 1.218 1.085 1.048 0.970\n\n2015-3 1.099 1.084 1.032\n\n2015-4 1.183 1.082\n\n2016-1 1.341\n\n**Age-to-Age** Method 3 - 6 6 - 9 9 - 12 12 - 15 15 - 18 18 - 21 21 - 24 24 - 27 27 - 30 30 - 33 33 - 36 36 - 39 39 - 42 42 - 45 45 - 48 48 - 51 51 - 54 54 - 57 57 - 60 60 - 63 63 - 66 66 - 69 69 - 72+ 72-Ult\n\n(1) Latest Quarter 1.341 1.082 1.032 0.970 1.015 1.001 1.000 0.986 1.000 1.000 1.035 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(2) Last 5 Quarter Avg 1.225 1.089 1.048 1.012 1.018 1.012 1.002 0.999 1.000 1.000 1.008 1.006 1.000 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(3) Last 6 Qtr Wt Avg 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(4) Avg 5Qtrs Ex Min&Max 1.228 1.084 1.043 1.018 1.021 1.002 1.002 1.001 1.000 1.000 1.002 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(5) All Quarters Avg 1.279 1.063 1.045 1.017 1.009 1.006 1.003 1.000 1.001 0.999 1.003 1.002 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(6) High 2.169 1.181 1.196 1.109 1.040 1.053 1.019 1.020 1.010 1.000 1.035 1.026 1.001 1.000 1.012 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(7) Low 1.031 0.920 0.967 0.970 0.990 0.988 0.978 0.986 1.000 0.983 1.000 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(8) Sel. Data for Power Curve 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(9) Inv Power 1.210 1.074 1.035 1.020 1.012 1.008 1.006 1.004 1.003 1.003 1.002 1.002 1.001 1.001 1.001 1.001 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.002\n\n(10) Double Exponential 1.070 1.049 1.035 1.025 1.018 1.013 1.009 1.006 1.005 1.003 1.002 1.002 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000\n\nSelected 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nMethod 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3\n\n**Age-to-Ultimate** Method 3-Ult 6-Ult 9-Ult 12-Ult 15-Ult 18-Ult 21-Ult 24-Ult 27-Ult 30-Ult 33-Ult 36-Ult 39-Ult 42-Ult 45-Ult 48-Ult 51-Ult 54-Ult 57-Ult 60-Ult 63-Ult 66-Ult 69-Ult 72-Ult\n\n(1) Latest Quarter 1.506 1.124 1.039 1.006 1.037 1.022 1.020 1.020 1.035 1.035 1.035 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(2) Last 5 Quarter Avg 1.485 1.212 1.113 1.062 1.049 1.031 1.019 1.016 1.017 1.017 1.017 1.009 1.002 1.002 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(3) Last 6 Qtr Wt Avg 1.513 1.201 1.106 1.051 1.036 1.021 1.014 1.012 1.013 1.012 1.012 1.006 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(4) Avg 5Qtrs Ex Min&Max 1.455 1.185 1.093 1.048 1.030 1.009 1.007 1.005 1.004 1.004 1.004 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(5) All Quarters Avg 1.483 1.159 1.091 1.043 1.025 1.016 1.010 1.006 1.006 1.005 1.006 1.003 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(6) High 4.197 1.935 1.638 1.370 1.235 1.188 1.129 1.108 1.086 1.075 1.075 1.039 1.012 1.012 1.012 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(7) Low 0.825 0.800 0.870 0.899 0.927 0.936 0.947 0.968 0.982 0.982 0.999 0.999 0.999 0.999 0.999 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nSelected 1.513 1.201 1.106 1.051 1.036 1.021 1.014 1.012 1.013 1.012 1.012 1.006 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n**Reported and Ultimate Losses**\n\n**Accident**\n\n**Years**\n\n**Inc to Date**\n\n**Selected Ult. Loss**\n\n**Latest Quarter**\n\n**Last 5**\n\n**Quarter**\n\n**Avg**\n\n**Last 6 Qtr**\n\n**Wt Avg**\n\n**Avg 5Qtrs**\n\n**Ex**\n\n**Min&Max**\n\n**All Year Average High Low**\n\n**2009-3** 169 169 169 169 169 169 169 169 169\n\n**2009-4** 702 702 702 702 702 702 702 702 702\n\n**2010-1** 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727\n\n**2010-2** 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210\n\n**2010-3** 328 328 328 328 328 328 328 328 328\n\n**2010-4** 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015\n\n**2011-1** 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146\n\n**2011-2** 2,560 2,560 2,560 2,560 2,560 2,560 2,560 2,560 2,560\n\n**2011-3** 1,032 1,032 1,032 1,032 1,032 1,032 1,032 1,032 1,032\n\n**2011-4** 4,876 4,876 4,876 4,876 4,876 4,876 4,876 4,876 4,876\n\n**2012-1** 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509\n\n**2012-2** 1,130 1,130 1,130 1,130 1,130 1,130 1,130 1,130 1,130\n\n**2012-3** 1,082 1,082 1,082 1,081 1,082 1,082 1,082 1,082 1,081\n\n**2012-4** 1,569 1,571 1,569 1,573 1,571 1,569 1,571 1,588 1,568\n\n**2013-1** 1,195 1,196 1,195 1,198 1,196 1,195 1,196 1,209 1,194\n\n**2013-2** 2,947 2,950 2,949 2,955 2,950 2,947 2,950 2,984 2,945\n\n**2013-3** 1,345 1,353 1,346 1,357 1,353 1,348 1,349 1,398 1,344\n\n**2013-4** 899 910 930 914 910 902 904 966 898\n\n**2014-1** 1,163 1,178 1,204 1,183 1,178 1,168 1,169 1,250 1,142\n\n**2014-2** 1,641 1,662 1,699 1,669 1,662 1,648 1,651 1,782 1,611\n\n**2014-3** 1,294 1,309 1,320 1,315 1,309 1,301 1,302 1,434 1,253\n\n**2014-4** 1,408 1,429 1,437 1,434 1,429 1,418 1,422 1,590 1,334\n\n**2015-1** 1,381 1,411 1,411 1,424 1,411 1,393 1,404 1,641 1,293\n\n**2015-2** 1,246 1,291 1,293 1,308 1,291 1,283 1,278 1,539 1,155\n\n**2015-3** 1,706 1,792 1,716 1,811 1,792 1,788 1,779 2,336 1,533\n\n**2015-4** 1,406 1,554 1,460 1,565 1,554 1,537 1,533 2,303 1,222\n\n**2016-1** 1,889 2,269 2,122 2,290 2,269 2,238 2,190 3,655 1,511\n\n**2016-2** 1,030 1,559 1,552 1,530 1,559 1,499 1,528 4,324 850\n\n**ALL COMPANIES COMBINED - COUNTRYWIDE**\n\n**LOSS DEVELOPMENT FACTOR**\n\n**Form - All (Wind & Hail)**\n\n**INCURRED LOSSES NET OF SAL & SUB (000's)**\n\n**Age in Months**\n\n**Age-to-Age Development**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1056.pdf"]},"response":{"errors":[],"extract_id":"extract_6621077ded880658a4c7b3034b30b03a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Accident**\n\n**Qtr** 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72+\n\n2009-3 141 145 134 160 163 166 166 166 169 169 169 169 169 169 169 169 169 169 169 169 169 169 169 169\n\n2009-4 594 725 733 709 695 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702\n\n2010-1 1,379 1,601 1,634 1,665 1,635 1,667 1,698 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727\n\n2010-2 675 1,124 1,158 1,185 1,204 1,205 1,207 1,208 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210\n\n2010-3 261 306 315 329 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328\n\n2010-4 790 920 876 978 984 983 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015\n\n2011-1 1,494 2,108 2,210 2,212 2,185 2,192 2,194 2,146 2,143 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146\n\n2011-2 2,056 2,521 2,499 2,513 2,513 2,524 2,534 2,541 2,537 2,537 2,537 2,562 2,562 2,562 2,562 2,562 2,560 2,560 2,560 2,560 2,560\n\n2011-3 716 887 938 977 997 1,001 1,001 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,032 1,032 1,032 1,032 1,032\n\n2011-4 3,177 3,842 4,498 4,635 4,804 4,916 4,859 4,934 4,915 4,915 4,877 4,877 4,877 4,876 4,876 4,876 4,876 4,876 4,876\n\n2012-1 1,002 1,312 1,430 1,460 1,496 1,500 1,501 1,501 1,503 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509\n\n2012-2 935 970 1,058 1,114 1,116 1,130 1,131 1,141 1,131 1,143 1,123 1,130 1,130 1,130 1,130 1,130 1,130\n\n2012-3 860 943 998 1,045 1,046 1,046 1,060 1,073 1,073 1,082 1,082 1,082 1,082 1,082 1,082 1,082\n\n2012-4 517 1,121 1,324 1,395 1,496 1,505 1,521 1,525 1,525 1,529 1,529 1,529 1,569 1,569 1,569\n\n2013-1 716 1,024 1,092 1,138 1,171 1,180 1,180 1,180 1,180 1,180 1,180 1,187 1,194 1,195\n\n2013-2 2,165 2,616 2,743 2,790 2,889 2,914 2,930 2,944 2,947 2,947 2,947 2,947 2,947\n\n2013-3 1,008 1,117 1,235 1,259 1,277 1,286 1,286 1,292 1,300 1,300 1,300 1,345\n\n2013-4 629 685 712 764 847 844 888 892 899 899 899\n\n2014-1 788 976 1,047 1,100 1,122 1,167 1,168 1,169 1,163 1,163\n\n2014-2 891 1,346 1,513 1,631 1,676 1,659 1,665 1,665 1,641\n\n2014-3 935 1,073 1,163 1,261 1,269 1,293 1,294 1,294\n\n2014-4 699 1,090 1,260 1,322 1,369 1,407 1,408\n\n2015-1 973 1,248 1,298 1,332 1,360 1,381\n\n2015-2 928 1,130 1,226 1,285 1,246\n\n2015-3 1,387 1,524 1,652 1,706\n\n2015-4 1,099 1,300 1,406\n\n2016-1 1,409 1,889\n\n2016-2 1,030\n\n**Accident**\n\n**Qtr** 3 - 6 6 - 9 9 - 12 12 - 15 15 - 18 18 - 21 21 - 24 24 - 27 27 - 30 30 - 33 33 - 36 36 - 39 39 - 42 42 - 45 45 - 48 48 - 51 51 - 54 54 - 57 57 - 60 60 - 63 63 - 66 66 - 69 69 - 72+\n\n2009-3 1.031 0.920 1.196 1.023 1.013 1.000 1.000 1.020 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2009-4 1.219 1.012 0.967 0.980 1.011 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-1 1.162 1.021 1.018 0.982 1.020 1.019 1.017 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-2 1.665 1.030 1.024 1.016 1.001 1.002 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-3 1.174 1.029 1.044 0.997 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-4 1.164 0.953 1.116 1.007 0.999 1.033 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2011-1 1.411 1.048 1.001 0.988 1.003 1.001 0.978 0.999 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2011-2 1.226 0.991 1.005 1.000 1.004 1.004 1.003 0.998 1.000 1.000 1.010 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000\n\n2011-3 1.239 1.058 1.041 1.021 1.004 1.000 1.019 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.012 1.000 1.000 1.000 1.000\n\n2011-4 1.210 1.171 1.031 1.036 1.023 0.988 1.015 0.996 1.000 0.992 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-1 1.309 1.089 1.021 1.025 1.003 1.000 1.000 1.002 1.004 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-2 1.038 1.090 1.054 1.002 1.012 1.001 1.009 0.991 1.010 0.983 1.006 1.000 1.000 1.000 1.000 1.000\n\n2012-3 1.096 1.059 1.047 1.001 1.000 1.013 1.013 1.000 1.008 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-4 2.169 1.181 1.054 1.073 1.006 1.011 1.002 1.000 1.003 1.000 1.000 1.026 1.000 1.000\n\n2013-1 1.431 1.066 1.042 1.029 1.008 1.000 1.000 1.000 1.000 1.000 1.007 1.006 1.001\n\n2013-2 1.208 1.049 1.017 1.035 1.008 1.006 1.005 1.001 1.000 1.000 1.000 1.000\n\n2013-3 1.108 1.106 1.019 1.014 1.007 1.000 1.005 1.006 1.000 1.000 1.035\n\n2013-4 1.089 1.040 1.072 1.109 0.996 1.053 1.005 1.007 1.000 1.000\n\n2014-1 1.239 1.073 1.050 1.021 1.040 1.001 1.001 0.995 1.000\n\n2014-2 1.510 1.124 1.078 1.028 0.990 1.003 1.000 0.986\n\n2014-3 1.148 1.084 1.084 1.006 1.019 1.001 1.000\n\n2014-4 1.560 1.155 1.049 1.035 1.028 1.001\n\n2015-1 1.282 1.040 1.027 1.021 1.015\n\n2015-2 1.218 1.085 1.048 0.970\n\n2015-3 1.099 1.084 1.032\n\n2015-4 1.183 1.082\n\n2016-1 1.341\n\n**Age-to-Age** Method 3 - 6 6 - 9 9 - 12 12 - 15 15 - 18 18 - 21 21 - 24 24 - 27 27 - 30 30 - 33 33 - 36 36 - 39 39 - 42 42 - 45 45 - 48 48 - 51 51 - 54 54 - 57 57 - 60 60 - 63 63 - 66 66 - 69 69 - 72+ 72-Ult\n\n(1) Latest Quarter 1.341 1.082 1.032 0.970 1.015 1.001 1.000 0.986 1.000 1.000 1.035 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(2) Last 5 Quarter Avg 1.225 1.089 1.048 1.012 1.018 1.012 1.002 0.999 1.000 1.000 1.008 1.006 1.000 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(3) Last 6 Qtr Wt Avg 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(4) Avg 5Qtrs Ex Min&Max 1.228 1.084 1.043 1.018 1.021 1.002 1.002 1.001 1.000 1.000 1.002 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(5) All Quarters Avg 1.279 1.063 1.045 1.017 1.009 1.006 1.003 1.000 1.001 0.999 1.003 1.002 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(6) High 2.169 1.181 1.196 1.109 1.040 1.053 1.019 1.020 1.010 1.000 1.035 1.026 1.001 1.000 1.012 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(7) Low 1.031 0.920 0.967 0.970 0.990 0.988 0.978 0.986 1.000 0.983 1.000 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(8) Sel. Data for Power Curve 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(9) Inv Power 1.210 1.074 1.035 1.020 1.012 1.008 1.006 1.004 1.003 1.003 1.002 1.002 1.001 1.001 1.001 1.001 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.002\n\n(10) Double Exponential 1.070 1.049 1.035 1.025 1.018 1.013 1.009 1.006 1.005 1.003 1.002 1.002 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000\n\nSelected 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nMethod 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3\n\n**Age-to-Ultimate** Method 3-Ult 6-Ult 9-Ult 12-Ult 15-Ult 18-Ult 21-Ult 24-Ult 27-Ult 30-Ult 33-Ult 36-Ult 39-Ult 42-Ult 45-Ult 48-Ult 51-Ult 54-Ult 57-Ult 60-Ult 63-Ult 66-Ult 69-Ult 72-Ult\n\n(1) Latest Quarter 1.506 1.124 1.039 1.006 1.037 1.022 1.020 1.020 1.035 1.035 1.035 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(2) Last 5 Quarter Avg 1.485 1.212 1.113 1.062 1.049 1.031 1.019 1.016 1.017 1.017 1.017 1.009 1.002 1.002 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(3) Last 6 Qtr Wt Avg 1.513 1.201 1.106 1.051 1.036 1.021 1.014 1.012 1.013 1.012 1.012 1.006 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(4) Avg 5Qtrs Ex Min&Max 1.455 1.185 1.093 1.048 1.030 1.009 1.007 1.005 1.004 1.004 1.004 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(5) All Quarters Avg 1.483 1.159 1.091 1.043 1.025 1.016 1.010 1.006 1.006 1.005 1.006 1.003 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(6) High 4.197 1.935 1.638 1.370 1.235 1.188 1.129 1.108 1.086 1.075 1.075 1.039 1.012 1.012 1.012 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(7) Low 0.825 0.800 0.870 0.899 0.927 0.936 0.947 0.968 0.982 0.982 0.999 0.999 0.999 0.999 0.999 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nSelected 1.513 1.201 1.106 1.051 1.036 1.021 1.014 1.012 1.013 1.012 1.012 1.006 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n**Reported and Ultimate Losses**\n\n**Accident**\n\n**Years**\n\n**Inc to Date**\n\n**Selected Ult. Loss**\n\n**Latest Quarter**\n\n**Last 5**\n\n**Quarter**\n\n**Avg**\n\n**Last 6 Qtr**\n\n**Wt Avg**\n\n**Avg 5Qtrs**\n\n**Ex**\n\n**Min&Max**\n\n**All Year Average High Low**\n\n**2009-3** 169 169 169 169 169 169 169 169 169\n\n**2009-4** 702 702 702 702 702 702 702 702 702\n\n**2010-1** 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727\n\n**2010-2** 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210\n\n**2010-3** 328 328 328 328 328 328 328 328 328\n\n**2010-4** 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015\n\n**2011-1** 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146\n\n**2011-2** 2,560 2,560 2,560 2,560 2,560 2,560 2,560 2,560 2,560\n\n**2011-3** 1,032 1,032 1,032 1,032 1,032 1,032 1,032 1,032 1,032\n\n**2011-4** 4,876 4,876 4,876 4,876 4,876 4,876 4,876 4,876 4,876\n\n**2012-1** 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509\n\n**2012-2** 1,130 1,130 1,130 1,130 1,130 1,130 1,130 1,130 1,130\n\n**2012-3** 1,082 1,082 1,082 1,081 1,082 1,082 1,082 1,082 1,081\n\n**2012-4** 1,569 1,571 1,569 1,573 1,571 1,569 1,571 1,588 1,568\n\n**2013-1** 1,195 1,196 1,195 1,198 1,196 1,195 1,196 1,209 1,194\n\n**2013-2** 2,947 2,950 2,949 2,955 2,950 2,947 2,950 2,984 2,945\n\n**2013-3** 1,345 1,353 1,346 1,357 1,353 1,348 1,349 1,398 1,344\n\n**2013-4** 899 910 930 914 910 902 904 966 898\n\n**2014-1** 1,163 1,178 1,204 1,183 1,178 1,168 1,169 1,250 1,142\n\n**2014-2** 1,641 1,662 1,699 1,669 1,662 1,648 1,651 1,782 1,611\n\n**2014-3** 1,294 1,309 1,320 1,315 1,309 1,301 1,302 1,434 1,253\n\n**2014-4** 1,408 1,429 1,437 1,434 1,429 1,418 1,422 1,590 1,334\n\n**2015-1** 1,381 1,411 1,411 1,424 1,411 1,393 1,404 1,641 1,293\n\n**2015-2** 1,246 1,291 1,293 1,308 1,291 1,283 1,278 1,539 1,155\n\n**2015-3** 1,706 1,792 1,716 1,811 1,792 1,788 1,779 2,336 1,533\n\n**2015-4** 1,406 1,554 1,460 1,565 1,554 1,537 1,533 2,303 1,222\n\n**2016-1** 1,889 2,269 2,122 2,290 2,269 2,238 2,190 3,655 1,511\n\n**2016-2** 1,030 1,559 1,552 1,530 1,559 1,499 1,528 4,324 850\n\n**ALL COMPANIES COMBINED - COUNTRYWIDE**\n\n**LOSS DEVELOPMENT FACTOR**\n\n**Form - All (Wind & Hail)**\n\n**INCURRED LOSSES NET OF SAL & SUB (000's)**\n\n**Age in Months**\n\n**Age-to-Age Development**"],"full_content":"**Accident**\n\n**Qtr** 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72+\n\n2009-3 141 145 134 160 163 166 166 166 169 169 169 169 169 169 169 169 169 169 169 169 169 169 169 169\n\n2009-4 594 725 733 709 695 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702 702\n\n2010-1 1,379 1,601 1,634 1,665 1,635 1,667 1,698 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727\n\n2010-2 675 1,124 1,158 1,185 1,204 1,205 1,207 1,208 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210\n\n2010-3 261 306 315 329 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328 328\n\n2010-4 790 920 876 978 984 983 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015\n\n2011-1 1,494 2,108 2,210 2,212 2,185 2,192 2,194 2,146 2,143 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146\n\n2011-2 2,056 2,521 2,499 2,513 2,513 2,524 2,534 2,541 2,537 2,537 2,537 2,562 2,562 2,562 2,562 2,562 2,560 2,560 2,560 2,560 2,560\n\n2011-3 716 887 938 977 997 1,001 1,001 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,032 1,032 1,032 1,032 1,032\n\n2011-4 3,177 3,842 4,498 4,635 4,804 4,916 4,859 4,934 4,915 4,915 4,877 4,877 4,877 4,876 4,876 4,876 4,876 4,876 4,876\n\n2012-1 1,002 1,312 1,430 1,460 1,496 1,500 1,501 1,501 1,503 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509\n\n2012-2 935 970 1,058 1,114 1,116 1,130 1,131 1,141 1,131 1,143 1,123 1,130 1,130 1,130 1,130 1,130 1,130\n\n2012-3 860 943 998 1,045 1,046 1,046 1,060 1,073 1,073 1,082 1,082 1,082 1,082 1,082 1,082 1,082\n\n2012-4 517 1,121 1,324 1,395 1,496 1,505 1,521 1,525 1,525 1,529 1,529 1,529 1,569 1,569 1,569\n\n2013-1 716 1,024 1,092 1,138 1,171 1,180 1,180 1,180 1,180 1,180 1,180 1,187 1,194 1,195\n\n2013-2 2,165 2,616 2,743 2,790 2,889 2,914 2,930 2,944 2,947 2,947 2,947 2,947 2,947\n\n2013-3 1,008 1,117 1,235 1,259 1,277 1,286 1,286 1,292 1,300 1,300 1,300 1,345\n\n2013-4 629 685 712 764 847 844 888 892 899 899 899\n\n2014-1 788 976 1,047 1,100 1,122 1,167 1,168 1,169 1,163 1,163\n\n2014-2 891 1,346 1,513 1,631 1,676 1,659 1,665 1,665 1,641\n\n2014-3 935 1,073 1,163 1,261 1,269 1,293 1,294 1,294\n\n2014-4 699 1,090 1,260 1,322 1,369 1,407 1,408\n\n2015-1 973 1,248 1,298 1,332 1,360 1,381\n\n2015-2 928 1,130 1,226 1,285 1,246\n\n2015-3 1,387 1,524 1,652 1,706\n\n2015-4 1,099 1,300 1,406\n\n2016-1 1,409 1,889\n\n2016-2 1,030\n\n**Accident**\n\n**Qtr** 3 - 6 6 - 9 9 - 12 12 - 15 15 - 18 18 - 21 21 - 24 24 - 27 27 - 30 30 - 33 33 - 36 36 - 39 39 - 42 42 - 45 45 - 48 48 - 51 51 - 54 54 - 57 57 - 60 60 - 63 63 - 66 66 - 69 69 - 72+\n\n2009-3 1.031 0.920 1.196 1.023 1.013 1.000 1.000 1.020 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2009-4 1.219 1.012 0.967 0.980 1.011 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-1 1.162 1.021 1.018 0.982 1.020 1.019 1.017 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-2 1.665 1.030 1.024 1.016 1.001 1.002 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-3 1.174 1.029 1.044 0.997 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2010-4 1.164 0.953 1.116 1.007 0.999 1.033 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2011-1 1.411 1.048 1.001 0.988 1.003 1.001 0.978 0.999 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2011-2 1.226 0.991 1.005 1.000 1.004 1.004 1.003 0.998 1.000 1.000 1.010 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000\n\n2011-3 1.239 1.058 1.041 1.021 1.004 1.000 1.019 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.012 1.000 1.000 1.000 1.000\n\n2011-4 1.210 1.171 1.031 1.036 1.023 0.988 1.015 0.996 1.000 0.992 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-1 1.309 1.089 1.021 1.025 1.003 1.000 1.000 1.002 1.004 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-2 1.038 1.090 1.054 1.002 1.012 1.001 1.009 0.991 1.010 0.983 1.006 1.000 1.000 1.000 1.000 1.000\n\n2012-3 1.096 1.059 1.047 1.001 1.000 1.013 1.013 1.000 1.008 1.000 1.000 1.000 1.000 1.000 1.000\n\n2012-4 2.169 1.181 1.054 1.073 1.006 1.011 1.002 1.000 1.003 1.000 1.000 1.026 1.000 1.000\n\n2013-1 1.431 1.066 1.042 1.029 1.008 1.000 1.000 1.000 1.000 1.000 1.007 1.006 1.001\n\n2013-2 1.208 1.049 1.017 1.035 1.008 1.006 1.005 1.001 1.000 1.000 1.000 1.000\n\n2013-3 1.108 1.106 1.019 1.014 1.007 1.000 1.005 1.006 1.000 1.000 1.035\n\n2013-4 1.089 1.040 1.072 1.109 0.996 1.053 1.005 1.007 1.000 1.000\n\n2014-1 1.239 1.073 1.050 1.021 1.040 1.001 1.001 0.995 1.000\n\n2014-2 1.510 1.124 1.078 1.028 0.990 1.003 1.000 0.986\n\n2014-3 1.148 1.084 1.084 1.006 1.019 1.001 1.000\n\n2014-4 1.560 1.155 1.049 1.035 1.028 1.001\n\n2015-1 1.282 1.040 1.027 1.021 1.015\n\n2015-2 1.218 1.085 1.048 0.970\n\n2015-3 1.099 1.084 1.032\n\n2015-4 1.183 1.082\n\n2016-1 1.341\n\n**Age-to-Age** Method 3 - 6 6 - 9 9 - 12 12 - 15 15 - 18 18 - 21 21 - 24 24 - 27 27 - 30 30 - 33 33 - 36 36 - 39 39 - 42 42 - 45 45 - 48 48 - 51 51 - 54 54 - 57 57 - 60 60 - 63 63 - 66 66 - 69 69 - 72+ 72-Ult\n\n(1) Latest Quarter 1.341 1.082 1.032 0.970 1.015 1.001 1.000 0.986 1.000 1.000 1.035 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(2) Last 5 Quarter Avg 1.225 1.089 1.048 1.012 1.018 1.012 1.002 0.999 1.000 1.000 1.008 1.006 1.000 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(3) Last 6 Qtr Wt Avg 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(4) Avg 5Qtrs Ex Min&Max 1.228 1.084 1.043 1.018 1.021 1.002 1.002 1.001 1.000 1.000 1.002 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(5) All Quarters Avg 1.279 1.063 1.045 1.017 1.009 1.006 1.003 1.000 1.001 0.999 1.003 1.002 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(6) High 2.169 1.181 1.196 1.109 1.040 1.053 1.019 1.020 1.010 1.000 1.035 1.026 1.001 1.000 1.012 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(7) Low 1.031 0.920 0.967 0.970 0.990 0.988 0.978 0.986 1.000 0.983 1.000 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(8) Sel. Data for Power Curve 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(9) Inv Power 1.210 1.074 1.035 1.020 1.012 1.008 1.006 1.004 1.003 1.003 1.002 1.002 1.001 1.001 1.001 1.001 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.002\n\n(10) Double Exponential 1.070 1.049 1.035 1.025 1.018 1.013 1.009 1.006 1.005 1.003 1.002 1.002 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000\n\nSelected 1.260 1.087 1.052 1.014 1.014 1.007 1.003 0.999 1.001 1.000 1.006 1.005 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nMethod 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3\n\n**Age-to-Ultimate** Method 3-Ult 6-Ult 9-Ult 12-Ult 15-Ult 18-Ult 21-Ult 24-Ult 27-Ult 30-Ult 33-Ult 36-Ult 39-Ult 42-Ult 45-Ult 48-Ult 51-Ult 54-Ult 57-Ult 60-Ult 63-Ult 66-Ult 69-Ult 72-Ult\n\n(1) Latest Quarter 1.506 1.124 1.039 1.006 1.037 1.022 1.020 1.020 1.035 1.035 1.035 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(2) Last 5 Quarter Avg 1.485 1.212 1.113 1.062 1.049 1.031 1.019 1.016 1.017 1.017 1.017 1.009 1.002 1.002 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(3) Last 6 Qtr Wt Avg 1.513 1.201 1.106 1.051 1.036 1.021 1.014 1.012 1.013 1.012 1.012 1.006 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(4) Avg 5Qtrs Ex Min&Max 1.455 1.185 1.093 1.048 1.030 1.009 1.007 1.005 1.004 1.004 1.004 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(5) All Quarters Avg 1.483 1.159 1.091 1.043 1.025 1.016 1.010 1.006 1.006 1.005 1.006 1.003 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(6) High 4.197 1.935 1.638 1.370 1.235 1.188 1.129 1.108 1.086 1.075 1.075 1.039 1.012 1.012 1.012 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n(7) Low 0.825 0.800 0.870 0.899 0.927 0.936 0.947 0.968 0.982 0.982 0.999 0.999 0.999 0.999 0.999 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nSelected 1.513 1.201 1.106 1.051 1.036 1.021 1.014 1.012 1.013 1.012 1.012 1.006 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n**Reported and Ultimate Losses**\n\n**Accident**\n\n**Years**\n\n**Inc to Date**\n\n**Selected Ult. Loss**\n\n**Latest Quarter**\n\n**Last 5**\n\n**Quarter**\n\n**Avg**\n\n**Last 6 Qtr**\n\n**Wt Avg**\n\n**Avg 5Qtrs**\n\n**Ex**\n\n**Min&Max**\n\n**All Year Average High Low**\n\n**2009-3** 169 169 169 169 169 169 169 169 169\n\n**2009-4** 702 702 702 702 702 702 702 702 702\n\n**2010-1** 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727 1,727\n\n**2010-2** 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210 1,210\n\n**2010-3** 328 328 328 328 328 328 328 328 328\n\n**2010-4** 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015 1,015\n\n**2011-1** 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146 2,146\n\n**2011-2** 2,560 2,560 2,560 2,560 2,560 2,560 2,560 2,560 2,560\n\n**2011-3** 1,032 1,032 1,032 1,032 1,032 1,032 1,032 1,032 1,032\n\n**2011-4** 4,876 4,876 4,876 4,876 4,876 4,876 4,876 4,876 4,876\n\n**2012-1** 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509 1,509\n\n**2012-2** 1,130 1,130 1,130 1,130 1,130 1,130 1,130 1,130 1,130\n\n**2012-3** 1,082 1,082 1,082 1,081 1,082 1,082 1,082 1,082 1,081\n\n**2012-4** 1,569 1,571 1,569 1,573 1,571 1,569 1,571 1,588 1,568\n\n**2013-1** 1,195 1,196 1,195 1,198 1,196 1,195 1,196 1,209 1,194\n\n**2013-2** 2,947 2,950 2,949 2,955 2,950 2,947 2,950 2,984 2,945\n\n**2013-3** 1,345 1,353 1,346 1,357 1,353 1,348 1,349 1,398 1,344\n\n**2013-4** 899 910 930 914 910 902 904 966 898\n\n**2014-1** 1,163 1,178 1,204 1,183 1,178 1,168 1,169 1,250 1,142\n\n**2014-2** 1,641 1,662 1,699 1,669 1,662 1,648 1,651 1,782 1,611\n\n**2014-3** 1,294 1,309 1,320 1,315 1,309 1,301 1,302 1,434 1,253\n\n**2014-4** 1,408 1,429 1,437 1,434 1,429 1,418 1,422 1,590 1,334\n\n**2015-1** 1,381 1,411 1,411 1,424 1,411 1,393 1,404 1,641 1,293\n\n**2015-2** 1,246 1,291 1,293 1,308 1,291 1,283 1,278 1,539 1,155\n\n**2015-3** 1,706 1,792 1,716 1,811 1,792 1,788 1,779 2,336 1,533\n\n**2015-4** 1,406 1,554 1,460 1,565 1,554 1,537 1,533 2,303 1,222\n\n**2016-1** 1,889 2,269 2,122 2,290 2,269 2,238 2,190 3,655 1,511\n\n**2016-2** 1,030 1,559 1,552 1,530 1,559 1,499 1,528 4,324 850\n\n**ALL COMPANIES COMBINED - COUNTRYWIDE**\n\n**LOSS DEVELOPMENT FACTOR**\n\n**Form - All (Wind & Hail)**\n\n**INCURRED LOSSES NET OF SAL & SUB (000's)**\n\n**Age in Months**\n\n**Age-to-Age Development**","publish_date":null,"title":"ALL COMPANIES COMBINED - COUNTRYWIDE LOSS DEVELOPMENT FACTOR Form - All (Wind & Hail) INCURRED LOSSES NET OF SAL &","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1056.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1056.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1056","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1056.pdf"},"started_at":"2026-11-04T19:48:11.038247"} +{"completed_at":"2026-11-04T19:48:14.631647","latency_in_ms":1565,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1057","grounded_pages":[],"layout_pages":[],"markdown":"**American Mercury Lloyds Insurance Company American Mercury Lloyds Insurance Company**\n\n**Texas Homeowners Texas Homeowners**\n\n**RL07 - CURRENT RL09 - PROPOSED**\n\n**Base Rate Base Rate**\n\n**Form Region P1 P2 P3 P4 P5 P6 P7 Form Region P1 P2 P3 P4 P5 P6 P7**\n\nHO-3 D 396.700 51.860 101.180 277.460 306.700 24.910 790.830 HO-3 D 409.380 53.520 104.410 286.330 316.500 25.710 816.110\n\nHO-3 E 426.560 55.760 108.800 298.349 329.790 26.780 850.360 HO-3 E 440.190 57.540 112.280 307.890 340.330 27.640 877.540\n\nHO-3 H 439.000 57.390 111.980 307.050 339.410 27.560 875.150 HO-3 H 453.030 59.220 115.560 316.860 350.260 28.440 903.120\n\nHO-3 W 426.560 55.760 108.800 298.349 329.790 26.780 850.360 HO-3 W 440.190 57.540 112.280 307.890 340.330 27.640 877.540\n\nHO-4 D 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 D 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 E 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 E 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 H 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 H 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 W 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 W 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-6 D 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 D 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 E 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 E 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 H 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 H 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 W 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 W 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\n**Hurricane Base Rates Hurricane Base Rates**\n\n**Form Construction Region P9 Form Construction Region P9**\n\nHO-3 Concrete D 178.490 HO-3 Concrete D 184.200\n\nHO-3 Frame D 178.490 HO-3 Frame D 184.200\n\nHO-3 Masonry D 178.490 HO-3 Masonry D 184.200\n\nHO-3 Steel D 178.490 HO-3 Steel D 184.200\n\nHO-3 Concrete E 191.930 HO-3 Concrete E 198.060\n\nHO-3 Frame E 191.930 HO-3 Frame E 198.060\n\nHO-3 Masonry E 191.930 HO-3 Masonry E 198.060\n\nHO-3 Steel E 191.930 HO-3 Steel E 198.060\n\nHO-3 Concrete H 197.520 HO-3 Concrete H 203.830\n\nHO-3 Frame H 197.520 HO-3 Frame H 203.830\n\nHO-3 Masonry H 197.520 HO-3 Masonry H 203.830\n\nHO-3 Steel H 197.520 HO-3 Steel H 203.830\n\nHO-3 Concrete W 191.930 HO-3 Concrete W 198.060\n\nHO-3 Frame W 191.930 HO-3 Frame W 198.060\n\nHO-3 Masonry W 191.930 HO-3 Masonry W 198.060\n\nHO-3 Steel W 191.930 HO-3 Steel W 198.060\n\nHO-4 Concrete D 11.390 HO-4 Concrete D 11.850\n\nHO-4 Frame D 11.390 HO-4 Frame D 11.850\n\nHO-4 Masonry D 11.390 HO-4 Masonry D 11.850\n\nHO-4 Steel D 11.390 HO-4 Steel D 11.850\n\nHO-4 Concrete E 11.390 HO-4 Concrete E 11.850\n\nHO-4 Frame E 11.390 HO-4 Frame E 11.850\n\nHO-4 Masonry E 11.390 HO-4 Masonry E 11.850\n\nHO-4 Steel E 11.390 HO-4 Steel E 11.850\n\nHO-4 Concrete H 11.390 HO-4 Concrete H 11.850\n\nHO-4 Frame H 11.390 HO-4 Frame H 11.850\n\nHO-4 Masonry H 11.390 HO-4 Masonry H 11.850\n\nHO-4 Steel H 11.390 HO-4 Steel H 11.850\n\nHO-4 Concrete W 11.390 HO-4 Concrete W 11.850\n\nHO-4 Frame W 11.390 HO-4 Frame W 11.850\n\nHO-4 Masonry W 11.390 HO-4 Masonry W 11.850\n\nHO-4 Steel W 11.390 HO-4 Steel W 11.850\n\nHO-6 Concrete D 16.780 HO-6 Concrete D 17.330\n\nHO-6 Frame D 16.780 HO-6 Frame D 17.330\n\nHO-6 Masonry D 16.780 HO-6 Masonry D 17.330\n\nHO-6 Steel D 16.780 HO-6 Steel D 17.330\n\nHO-6 Concrete E 16.780 HO-6 Concrete E 17.330\n\nHO-6 Frame E 16.780 HO-6 Frame E 17.330\n\nHO-6 Masonry E 16.780 HO-6 Masonry E 17.330\n\nHO-6 Steel E 16.780 HO-6 Steel E 17.330\n\nHO-6 Concrete H 16.780 HO-6 Concrete H 17.330\n\nHO-6 Frame H 16.780 HO-6 Frame H 17.330\n\nHO-6 Masonry H 16.780 HO-6 Masonry H 17.330\n\nHO-6 Steel H 16.780 HO-6 Steel H 17.330\n\nHO-6 Concrete W 16.780 HO-6 Concrete W 17.330\n\nHO-6 Frame W 16.780 HO-6 Frame W 17.330\n\nHO-6 Masonry W 16.780 HO-6 Masonry W 17.330\n\nHO-6 Steel W 16.780 HO-6 Steel W 17.330","pages":[{"line_numbers":[],"markdown":"**American Mercury Lloyds Insurance Company American Mercury Lloyds Insurance Company**\n\n**Texas Homeowners Texas Homeowners**\n\n**RL07 - CURRENT RL09 - PROPOSED**\n\n**Base Rate Base Rate**\n\n**Form Region P1 P2 P3 P4 P5 P6 P7 Form Region P1 P2 P3 P4 P5 P6 P7**\n\nHO-3 D 396.700 51.860 101.180 277.460 306.700 24.910 790.830 HO-3 D 409.380 53.520 104.410 286.330 316.500 25.710 816.110\n\nHO-3 E 426.560 55.760 108.800 298.349 329.790 26.780 850.360 HO-3 E 440.190 57.540 112.280 307.890 340.330 27.640 877.540\n\nHO-3 H 439.000 57.390 111.980 307.050 339.410 27.560 875.150 HO-3 H 453.030 59.220 115.560 316.860 350.260 28.440 903.120\n\nHO-3 W 426.560 55.760 108.800 298.349 329.790 26.780 850.360 HO-3 W 440.190 57.540 112.280 307.890 340.330 27.640 877.540\n\nHO-4 D 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 D 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 E 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 E 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 H 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 H 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 W 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 W 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-6 D 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 D 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 E 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 E 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 H 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 H 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 W 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 W 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\n**Hurricane Base Rates Hurricane Base Rates**\n\n**Form Construction Region P9 Form Construction Region P9**\n\nHO-3 Concrete D 178.490 HO-3 Concrete D 184.200\n\nHO-3 Frame D 178.490 HO-3 Frame D 184.200\n\nHO-3 Masonry D 178.490 HO-3 Masonry D 184.200\n\nHO-3 Steel D 178.490 HO-3 Steel D 184.200\n\nHO-3 Concrete E 191.930 HO-3 Concrete E 198.060\n\nHO-3 Frame E 191.930 HO-3 Frame E 198.060\n\nHO-3 Masonry E 191.930 HO-3 Masonry E 198.060\n\nHO-3 Steel E 191.930 HO-3 Steel E 198.060\n\nHO-3 Concrete H 197.520 HO-3 Concrete H 203.830\n\nHO-3 Frame H 197.520 HO-3 Frame H 203.830\n\nHO-3 Masonry H 197.520 HO-3 Masonry H 203.830\n\nHO-3 Steel H 197.520 HO-3 Steel H 203.830\n\nHO-3 Concrete W 191.930 HO-3 Concrete W 198.060\n\nHO-3 Frame W 191.930 HO-3 Frame W 198.060\n\nHO-3 Masonry W 191.930 HO-3 Masonry W 198.060\n\nHO-3 Steel W 191.930 HO-3 Steel W 198.060\n\nHO-4 Concrete D 11.390 HO-4 Concrete D 11.850\n\nHO-4 Frame D 11.390 HO-4 Frame D 11.850\n\nHO-4 Masonry D 11.390 HO-4 Masonry D 11.850\n\nHO-4 Steel D 11.390 HO-4 Steel D 11.850\n\nHO-4 Concrete E 11.390 HO-4 Concrete E 11.850\n\nHO-4 Frame E 11.390 HO-4 Frame E 11.850\n\nHO-4 Masonry E 11.390 HO-4 Masonry E 11.850\n\nHO-4 Steel E 11.390 HO-4 Steel E 11.850\n\nHO-4 Concrete H 11.390 HO-4 Concrete H 11.850\n\nHO-4 Frame H 11.390 HO-4 Frame H 11.850\n\nHO-4 Masonry H 11.390 HO-4 Masonry H 11.850\n\nHO-4 Steel H 11.390 HO-4 Steel H 11.850\n\nHO-4 Concrete W 11.390 HO-4 Concrete W 11.850\n\nHO-4 Frame W 11.390 HO-4 Frame W 11.850\n\nHO-4 Masonry W 11.390 HO-4 Masonry W 11.850\n\nHO-4 Steel W 11.390 HO-4 Steel W 11.850\n\nHO-6 Concrete D 16.780 HO-6 Concrete D 17.330\n\nHO-6 Frame D 16.780 HO-6 Frame D 17.330\n\nHO-6 Masonry D 16.780 HO-6 Masonry D 17.330\n\nHO-6 Steel D 16.780 HO-6 Steel D 17.330\n\nHO-6 Concrete E 16.780 HO-6 Concrete E 17.330\n\nHO-6 Frame E 16.780 HO-6 Frame E 17.330\n\nHO-6 Masonry E 16.780 HO-6 Masonry E 17.330\n\nHO-6 Steel E 16.780 HO-6 Steel E 17.330\n\nHO-6 Concrete H 16.780 HO-6 Concrete H 17.330\n\nHO-6 Frame H 16.780 HO-6 Frame H 17.330\n\nHO-6 Masonry H 16.780 HO-6 Masonry H 17.330\n\nHO-6 Steel H 16.780 HO-6 Steel H 17.330\n\nHO-6 Concrete W 16.780 HO-6 Concrete W 17.330\n\nHO-6 Frame W 16.780 HO-6 Frame W 17.330\n\nHO-6 Masonry W 16.780 HO-6 Masonry W 17.330\n\nHO-6 Steel W 16.780 HO-6 Steel W 17.330","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**American Mercury Lloyds Insurance Company American Mercury Lloyds Insurance Company**\n\n**Texas Homeowners Texas Homeowners**\n\n**RL07 - CURRENT RL09 - PROPOSED**\n\n**Base Rate Base Rate**\n\n**Form Region P1 P2 P3 P4 P5 P6 P7 Form Region P1 P2 P3 P4 P5 P6 P7**\n\nHO-3 D 396.700 51.860 101.180 277.460 306.700 24.910 790.830 HO-3 D 409.380 53.520 104.410 286.330 316.500 25.710 816.110\n\nHO-3 E 426.560 55.760 108.800 298.349 329.790 26.780 850.360 HO-3 E 440.190 57.540 112.280 307.890 340.330 27.640 877.540\n\nHO-3 H 439.000 57.390 111.980 307.050 339.410 27.560 875.150 HO-3 H 453.030 59.220 115.560 316.860 350.260 28.440 903.120\n\nHO-3 W 426.560 55.760 108.800 298.349 329.790 26.780 850.360 HO-3 W 440.190 57.540 112.280 307.890 340.330 27.640 877.540\n\nHO-4 D 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 D 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 E 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 E 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 H 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 H 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 W 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 W 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-6 D 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 D 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 E 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 E 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 H 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 H 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 W 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 W 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\n**Hurricane Base Rates Hurricane Base Rates**\n\n**Form Construction Region P9 Form Construction Region P9**\n\nHO-3 Concrete D 178.490 HO-3 Concrete D 184.200\n\nHO-3 Frame D 178.490 HO-3 Frame D 184.200\n\nHO-3 Masonry D 178.490 HO-3 Masonry D 184.200\n\nHO-3 Steel D 178.490 HO-3 Steel D 184.200\n\nHO-3 Concrete E 191.930 HO-3 Concrete E 198.060\n\nHO-3 Frame E 191.930 HO-3 Frame E 198.060\n\nHO-3 Masonry E 191.930 HO-3 Masonry E 198.060\n\nHO-3 Steel E 191.930 HO-3 Steel E 198.060\n\nHO-3 Concrete H 197.520 HO-3 Concrete H 203.830\n\nHO-3 Frame H 197.520 HO-3 Frame H 203.830\n\nHO-3 Masonry H 197.520 HO-3 Masonry H 203.830\n\nHO-3 Steel H 197.520 HO-3 Steel H 203.830\n\nHO-3 Concrete W 191.930 HO-3 Concrete W 198.060\n\nHO-3 Frame W 191.930 HO-3 Frame W 198.060\n\nHO-3 Masonry W 191.930 HO-3 Masonry W 198.060\n\nHO-3 Steel W 191.930 HO-3 Steel W 198.060\n\nHO-4 Concrete D 11.390 HO-4 Concrete D 11.850\n\nHO-4 Frame D 11.390 HO-4 Frame D 11.850\n\nHO-4 Masonry D 11.390 HO-4 Masonry D 11.850\n\nHO-4 Steel D 11.390 HO-4 Steel D 11.850\n\nHO-4 Concrete E 11.390 HO-4 Concrete E 11.850\n\nHO-4 Frame E 11.390 HO-4 Frame E 11.850\n\nHO-4 Masonry E 11.390 HO-4 Masonry E 11.850\n\nHO-4 Steel E 11.390 HO-4 Steel E 11.850\n\nHO-4 Concrete H 11.390 HO-4 Concrete H 11.850\n\nHO-4 Frame H 11.390 HO-4 Frame H 11.850\n\nHO-4 Masonry H 11.390 HO-4 Masonry H 11.850\n\nHO-4 Steel H 11.390 HO-4 Steel H 11.850\n\nHO-4 Concrete W 11.390 HO-4 Concrete W 11.850\n\nHO-4 Frame W 11.390 HO-4 Frame W 11.850\n\nHO-4 Masonry W 11.390 HO-4 Masonry W 11.850\n\nHO-4 Steel W 11.390 HO-4 Steel W 11.850\n\nHO-6 Concrete D 16.780 HO-6 Concrete D 17.330\n\nHO-6 Frame D 16.780 HO-6 Frame D 17.330\n\nHO-6 Masonry D 16.780 HO-6 Masonry D 17.330\n\nHO-6 Steel D 16.780 HO-6 Steel D 17.330\n\nHO-6 Concrete E 16.780 HO-6 Concrete E 17.330\n\nHO-6 Frame E 16.780 HO-6 Frame E 17.330\n\nHO-6 Masonry E 16.780 HO-6 Masonry E 17.330\n\nHO-6 Steel E 16.780 HO-6 Steel E 17.330\n\nHO-6 Concrete H 16.780 HO-6 Concrete H 17.330\n\nHO-6 Frame H 16.780 HO-6 Frame H 17.330\n\nHO-6 Masonry H 16.780 HO-6 Masonry H 17.330\n\nHO-6 Steel H 16.780 HO-6 Steel H 17.330\n\nHO-6 Concrete W 16.780 HO-6 Concrete W 17.330\n\nHO-6 Frame W 16.780 HO-6 Frame W 17.330\n\nHO-6 Masonry W 16.780 HO-6 Masonry W 17.330\n\nHO-6 Steel W 16.780 HO-6 Steel W 17.330","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1057.pdf"]},"response":{"errors":[],"extract_id":"extract_3f1dd0252f0ddc9a4d544c288cdd3870","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**American Mercury Lloyds Insurance Company American Mercury Lloyds Insurance Company**\n\n**Texas Homeowners Texas Homeowners**\n\n**RL07 - CURRENT RL09 - PROPOSED**\n\n**Base Rate Base Rate**\n\n**Form Region P1 P2 P3 P4 P5 P6 P7 Form Region P1 P2 P3 P4 P5 P6 P7**\n\nHO-3 D 396.700 51.860 101.180 277.460 306.700 24.910 790.830 HO-3 D 409.380 53.520 104.410 286.330 316.500 25.710 816.110\n\nHO-3 E 426.560 55.760 108.800 298.349 329.790 26.780 850.360 HO-3 E 440.190 57.540 112.280 307.890 340.330 27.640 877.540\n\nHO-3 H 439.000 57.390 111.980 307.050 339.410 27.560 875.150 HO-3 H 453.030 59.220 115.560 316.860 350.260 28.440 903.120\n\nHO-3 W 426.560 55.760 108.800 298.349 329.790 26.780 850.360 HO-3 W 440.190 57.540 112.280 307.890 340.330 27.640 877.540\n\nHO-4 D 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 D 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 E 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 E 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 H 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 H 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 W 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 W 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-6 D 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 D 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 E 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 E 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 H 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 H 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 W 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 W 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\n**Hurricane Base Rates Hurricane Base Rates**\n\n**Form Construction Region P9 Form Construction Region P9**\n\nHO-3 Concrete D 178.490 HO-3 Concrete D 184.200\n\nHO-3 Frame D 178.490 HO-3 Frame D 184.200\n\nHO-3 Masonry D 178.490 HO-3 Masonry D 184.200\n\nHO-3 Steel D 178.490 HO-3 Steel D 184.200\n\nHO-3 Concrete E 191.930 HO-3 Concrete E 198.060\n\nHO-3 Frame E 191.930 HO-3 Frame E 198.060\n\nHO-3 Masonry E 191.930 HO-3 Masonry E 198.060\n\nHO-3 Steel E 191.930 HO-3 Steel E 198.060\n\nHO-3 Concrete H 197.520 HO-3 Concrete H 203.830\n\nHO-3 Frame H 197.520 HO-3 Frame H 203.830\n\nHO-3 Masonry H 197.520 HO-3 Masonry H 203.830\n\nHO-3 Steel H 197.520 HO-3 Steel H 203.830\n\nHO-3 Concrete W 191.930 HO-3 Concrete W 198.060\n\nHO-3 Frame W 191.930 HO-3 Frame W 198.060\n\nHO-3 Masonry W 191.930 HO-3 Masonry W 198.060\n\nHO-3 Steel W 191.930 HO-3 Steel W 198.060\n\nHO-4 Concrete D 11.390 HO-4 Concrete D 11.850\n\nHO-4 Frame D 11.390 HO-4 Frame D 11.850\n\nHO-4 Masonry D 11.390 HO-4 Masonry D 11.850\n\nHO-4 Steel D 11.390 HO-4 Steel D 11.850\n\nHO-4 Concrete E 11.390 HO-4 Concrete E 11.850\n\nHO-4 Frame E 11.390 HO-4 Frame E 11.850\n\nHO-4 Masonry E 11.390 HO-4 Masonry E 11.850\n\nHO-4 Steel E 11.390 HO-4 Steel E 11.850\n\nHO-4 Concrete H 11.390 HO-4 Concrete H 11.850\n\nHO-4 Frame H 11.390 HO-4 Frame H 11.850\n\nHO-4 Masonry H 11.390 HO-4 Masonry H 11.850\n\nHO-4 Steel H 11.390 HO-4 Steel H 11.850\n\nHO-4 Concrete W 11.390 HO-4 Concrete W 11.850\n\nHO-4 Frame W 11.390 HO-4 Frame W 11.850\n\nHO-4 Masonry W 11.390 HO-4 Masonry W 11.850\n\nHO-4 Steel W 11.390 HO-4 Steel W 11.850\n\nHO-6 Concrete D 16.780 HO-6 Concrete D 17.330\n\nHO-6 Frame D 16.780 HO-6 Frame D 17.330\n\nHO-6 Masonry D 16.780 HO-6 Masonry D 17.330\n\nHO-6 Steel D 16.780 HO-6 Steel D 17.330\n\nHO-6 Concrete E 16.780 HO-6 Concrete E 17.330\n\nHO-6 Frame E 16.780 HO-6 Frame E 17.330\n\nHO-6 Masonry E 16.780 HO-6 Masonry E 17.330\n\nHO-6 Steel E 16.780 HO-6 Steel E 17.330\n\nHO-6 Concrete H 16.780 HO-6 Concrete H 17.330\n\nHO-6 Frame H 16.780 HO-6 Frame H 17.330\n\nHO-6 Masonry H 16.780 HO-6 Masonry H 17.330\n\nHO-6 Steel H 16.780 HO-6 Steel H 17.330\n\nHO-6 Concrete W 16.780 HO-6 Concrete W 17.330\n\nHO-6 Frame W 16.780 HO-6 Frame W 17.330\n\nHO-6 Masonry W 16.780 HO-6 Masonry W 17.330\n\nHO-6 Steel W 16.780 HO-6 Steel W 17.330"],"full_content":"**American Mercury Lloyds Insurance Company American Mercury Lloyds Insurance Company**\n\n**Texas Homeowners Texas Homeowners**\n\n**RL07 - CURRENT RL09 - PROPOSED**\n\n**Base Rate Base Rate**\n\n**Form Region P1 P2 P3 P4 P5 P6 P7 Form Region P1 P2 P3 P4 P5 P6 P7**\n\nHO-3 D 396.700 51.860 101.180 277.460 306.700 24.910 790.830 HO-3 D 409.380 53.520 104.410 286.330 316.500 25.710 816.110\n\nHO-3 E 426.560 55.760 108.800 298.349 329.790 26.780 850.360 HO-3 E 440.190 57.540 112.280 307.890 340.330 27.640 877.540\n\nHO-3 H 439.000 57.390 111.980 307.050 339.410 27.560 875.150 HO-3 H 453.030 59.220 115.560 316.860 350.260 28.440 903.120\n\nHO-3 W 426.560 55.760 108.800 298.349 329.790 26.780 850.360 HO-3 W 440.190 57.540 112.280 307.890 340.330 27.640 877.540\n\nHO-4 D 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 D 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 E 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 E 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 H 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 H 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-4 W 75.410 60.740 80.910 2.080 13.520 3.810 6.950 HO-4 W 78.440 63.180 84.160 2.160 14.060 3.960 7.230\n\nHO-6 D 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 D 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 E 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 E 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 H 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 H 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\nHO-6 W 66.350 94.100 58.450 9.790 334.100 6.300 12.620 HO-6 W 68.520 97.180 60.360 10.110 345.030 6.510 13.030\n\n**Hurricane Base Rates Hurricane Base Rates**\n\n**Form Construction Region P9 Form Construction Region P9**\n\nHO-3 Concrete D 178.490 HO-3 Concrete D 184.200\n\nHO-3 Frame D 178.490 HO-3 Frame D 184.200\n\nHO-3 Masonry D 178.490 HO-3 Masonry D 184.200\n\nHO-3 Steel D 178.490 HO-3 Steel D 184.200\n\nHO-3 Concrete E 191.930 HO-3 Concrete E 198.060\n\nHO-3 Frame E 191.930 HO-3 Frame E 198.060\n\nHO-3 Masonry E 191.930 HO-3 Masonry E 198.060\n\nHO-3 Steel E 191.930 HO-3 Steel E 198.060\n\nHO-3 Concrete H 197.520 HO-3 Concrete H 203.830\n\nHO-3 Frame H 197.520 HO-3 Frame H 203.830\n\nHO-3 Masonry H 197.520 HO-3 Masonry H 203.830\n\nHO-3 Steel H 197.520 HO-3 Steel H 203.830\n\nHO-3 Concrete W 191.930 HO-3 Concrete W 198.060\n\nHO-3 Frame W 191.930 HO-3 Frame W 198.060\n\nHO-3 Masonry W 191.930 HO-3 Masonry W 198.060\n\nHO-3 Steel W 191.930 HO-3 Steel W 198.060\n\nHO-4 Concrete D 11.390 HO-4 Concrete D 11.850\n\nHO-4 Frame D 11.390 HO-4 Frame D 11.850\n\nHO-4 Masonry D 11.390 HO-4 Masonry D 11.850\n\nHO-4 Steel D 11.390 HO-4 Steel D 11.850\n\nHO-4 Concrete E 11.390 HO-4 Concrete E 11.850\n\nHO-4 Frame E 11.390 HO-4 Frame E 11.850\n\nHO-4 Masonry E 11.390 HO-4 Masonry E 11.850\n\nHO-4 Steel E 11.390 HO-4 Steel E 11.850\n\nHO-4 Concrete H 11.390 HO-4 Concrete H 11.850\n\nHO-4 Frame H 11.390 HO-4 Frame H 11.850\n\nHO-4 Masonry H 11.390 HO-4 Masonry H 11.850\n\nHO-4 Steel H 11.390 HO-4 Steel H 11.850\n\nHO-4 Concrete W 11.390 HO-4 Concrete W 11.850\n\nHO-4 Frame W 11.390 HO-4 Frame W 11.850\n\nHO-4 Masonry W 11.390 HO-4 Masonry W 11.850\n\nHO-4 Steel W 11.390 HO-4 Steel W 11.850\n\nHO-6 Concrete D 16.780 HO-6 Concrete D 17.330\n\nHO-6 Frame D 16.780 HO-6 Frame D 17.330\n\nHO-6 Masonry D 16.780 HO-6 Masonry D 17.330\n\nHO-6 Steel D 16.780 HO-6 Steel D 17.330\n\nHO-6 Concrete E 16.780 HO-6 Concrete E 17.330\n\nHO-6 Frame E 16.780 HO-6 Frame E 17.330\n\nHO-6 Masonry E 16.780 HO-6 Masonry E 17.330\n\nHO-6 Steel E 16.780 HO-6 Steel E 17.330\n\nHO-6 Concrete H 16.780 HO-6 Concrete H 17.330\n\nHO-6 Frame H 16.780 HO-6 Frame H 17.330\n\nHO-6 Masonry H 16.780 HO-6 Masonry H 17.330\n\nHO-6 Steel H 16.780 HO-6 Steel H 17.330\n\nHO-6 Concrete W 16.780 HO-6 Concrete W 17.330\n\nHO-6 Frame W 16.780 HO-6 Frame W 17.330\n\nHO-6 Masonry W 16.780 HO-6 Masonry W 17.330\n\nHO-6 Steel W 16.780 HO-6 Steel W 17.330","publish_date":null,"title":"American Mercury Lloyds Insurance Company American Mercury Lloyds Insurance Company Texas Homeowners Texas Homeowners RL07 - CURRENT RL09 - PROPOSED","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1057.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1057.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1057","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1057.pdf"},"started_at":"2026-11-04T19:48:13.066576"} +{"completed_at":"2026-11-04T19:48:16.475403","latency_in_ms":2357,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1065","grounded_pages":[],"layout_pages":[],"markdown":"**John Hancock Life Insurance Company (U.S.A.)**\n\nJohn Hancock Place Post Office Box 111 C-7-30 Boston, Massachusetts 02117 1-888-877-6075 Email: cfolsom@jhancock.com\n\n**Carol A. Folsom Senior Contract Consultant US Insurance Legacy – LTC** May 10, 2018 KENT SULLIVAN Commissioner Texas Department of Insurance 333 Guadalupe Street Austin, Texas 78701\n\nRe: **John Hancock Life Insurance Company (U.S.A.)** **Company NAIC # 65838; FEIN #: 01-0233346** **Individual Long-Term Care Insurance Rate Revision Submission Revised Actuarial Memo LTC-06 TX** Dear Commissioner Sullivan: We are submitting the above captioned filing for your consideration. This submission was based upon information generated by our comprehensive 2016 claims study which examined the usage trend for our insured population. In general, we are seeing longer-lasting and more expensive claims and increased claim incidence at the older attained ages.\n\nAs a result of the factors listed above, we are requesting a premium rate increase on the policy series listed below and are enclosing the actuarial memo and rates for your review and acceptance. Policy Series Approval Date Years Sold Increase Percentage\n\nLTC-06 TX 11/2/2006 2007 – 2014 26.9%\n\nThe proposed premium rates will be effective on the next policy anniversary date, following a 90-day policyholder notification period, which will be made as soon as practicable following state acceptance. As we will describe later in this letter, we will also offer affected insureds various benefit reduction options to help mitigate the impact of the rate increase.\n\n**Policyholder Options**\n\nWe are fully aware that a premium increase may be difficult for our policyholders. Therefore, we will provide all policyholders with an array of options which will help them mitigate the impact of any increase. Most important, for those policyholders who originally purchased lifetime 5% compound inflation we will provide them with the ability to retain their existing premium by decreasing their future inflation coverage to a lower percentage. These policyholders will be able to keep all accrued inflation increase amounts to date and the lower inflation index will apply on a prospective basis only. The endorsements and other applicable forms needed to implement the benefit reduction option will be filed under a separate forms submission. In addition, policyholders will be able to reduce their benefit period, adjust their daily/monthly benefit amount, drop optional benefit riders or extend their elimination period. Where the NAIC contingent nonforfeiture benefit or the nonforfeiture benefit (if purchased) is triggered, customers will be offered paid-up coverage in accordance with the applicable provision. We are allowing contingent nonforfeiture if the rate increase trigger is met for all affected policyholders, even if it was not otherwise required in your State. _(Please note, that we will be voluntarily administering the enhanced contingent nonforfeiture benefit as described in the NAIC LTCi Model Regulation # 641 (2017) and the NAIC Model Bulletin \"Announcement of Alternative Filing Requirements for Long-Term Care Premium Rate Increases\" (as adopted by the Senior Issues Task Force on 8/9/2013.)_","pages":[{"line_numbers":[],"markdown":"**John Hancock Life Insurance Company (U.S.A.)**\n\nJohn Hancock Place Post Office Box 111 C-7-30 Boston, Massachusetts 02117 1-888-877-6075 Email: cfolsom@jhancock.com\n\n**Carol A. Folsom Senior Contract Consultant US Insurance Legacy – LTC** May 10, 2018 KENT SULLIVAN Commissioner Texas Department of Insurance 333 Guadalupe Street Austin, Texas 78701\n\nRe: **John Hancock Life Insurance Company (U.S.A.)** **Company NAIC # 65838; FEIN #: 01-0233346** **Individual Long-Term Care Insurance Rate Revision Submission Revised Actuarial Memo LTC-06 TX** Dear Commissioner Sullivan: We are submitting the above captioned filing for your consideration. This submission was based upon information generated by our comprehensive 2016 claims study which examined the usage trend for our insured population. In general, we are seeing longer-lasting and more expensive claims and increased claim incidence at the older attained ages.\n\nAs a result of the factors listed above, we are requesting a premium rate increase on the policy series listed below and are enclosing the actuarial memo and rates for your review and acceptance. Policy Series Approval Date Years Sold Increase Percentage\n\nLTC-06 TX 11/2/2006 2007 – 2014 26.9%\n\nThe proposed premium rates will be effective on the next policy anniversary date, following a 90-day policyholder notification period, which will be made as soon as practicable following state acceptance. As we will describe later in this letter, we will also offer affected insureds various benefit reduction options to help mitigate the impact of the rate increase.\n\n**Policyholder Options**\n\nWe are fully aware that a premium increase may be difficult for our policyholders. Therefore, we will provide all policyholders with an array of options which will help them mitigate the impact of any increase. Most important, for those policyholders who originally purchased lifetime 5% compound inflation we will provide them with the ability to retain their existing premium by decreasing their future inflation coverage to a lower percentage. These policyholders will be able to keep all accrued inflation increase amounts to date and the lower inflation index will apply on a prospective basis only. The endorsements and other applicable forms needed to implement the benefit reduction option will be filed under a separate forms submission. In addition, policyholders will be able to reduce their benefit period, adjust their daily/monthly benefit amount, drop optional benefit riders or extend their elimination period. Where the NAIC contingent nonforfeiture benefit or the nonforfeiture benefit (if purchased) is triggered, customers will be offered paid-up coverage in accordance with the applicable provision. We are allowing contingent nonforfeiture if the rate increase trigger is met for all affected policyholders, even if it was not otherwise required in your State. _(Please note, that we will be voluntarily administering the enhanced contingent nonforfeiture benefit as described in the NAIC LTCi Model Regulation # 641 (2017) and the NAIC Model Bulletin \"Announcement of Alternative Filing Requirements for Long-Term Care Premium Rate Increases\" (as adopted by the Senior Issues Task Force on 8/9/2013.)_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**John Hancock Life Insurance Company (U.S.A.)**\n\nJohn Hancock Place Post Office Box 111 C-7-30 Boston, Massachusetts 02117 1-888-877-6075 Email: cfolsom@jhancock.com\n\n**Carol A. Folsom Senior Contract Consultant US Insurance Legacy – LTC** May 10, 2018 KENT SULLIVAN Commissioner Texas Department of Insurance 333 Guadalupe Street Austin, Texas 78701\n\nRe: **John Hancock Life Insurance Company (U.S.A.)** **Company NAIC # 65838; FEIN #: 01-0233346** **Individual Long-Term Care Insurance Rate Revision Submission Revised Actuarial Memo LTC-06 TX** Dear Commissioner Sullivan: We are submitting the above captioned filing for your consideration. This submission was based upon information generated by our comprehensive 2016 claims study which examined the usage trend for our insured population. In general, we are seeing longer-lasting and more expensive claims and increased claim incidence at the older attained ages.\n\nAs a result of the factors listed above, we are requesting a premium rate increase on the policy series listed below and are enclosing the actuarial memo and rates for your review and acceptance. Policy Series Approval Date Years Sold Increase Percentage\n\nLTC-06 TX 11/2/2006 2007 – 2014 26.9%\n\nThe proposed premium rates will be effective on the next policy anniversary date, following a 90-day policyholder notification period, which will be made as soon as practicable following state acceptance. As we will describe later in this letter, we will also offer affected insureds various benefit reduction options to help mitigate the impact of the rate increase.\n\n**Policyholder Options**\n\nWe are fully aware that a premium increase may be difficult for our policyholders. Therefore, we will provide all policyholders with an array of options which will help them mitigate the impact of any increase. Most important, for those policyholders who originally purchased lifetime 5% compound inflation we will provide them with the ability to retain their existing premium by decreasing their future inflation coverage to a lower percentage. These policyholders will be able to keep all accrued inflation increase amounts to date and the lower inflation index will apply on a prospective basis only. The endorsements and other applicable forms needed to implement the benefit reduction option will be filed under a separate forms submission. In addition, policyholders will be able to reduce their benefit period, adjust their daily/monthly benefit amount, drop optional benefit riders or extend their elimination period. Where the NAIC contingent nonforfeiture benefit or the nonforfeiture benefit (if purchased) is triggered, customers will be offered paid-up coverage in accordance with the applicable provision. We are allowing contingent nonforfeiture if the rate increase trigger is met for all affected policyholders, even if it was not otherwise required in your State. _(Please note, that we will be voluntarily administering the enhanced contingent nonforfeiture benefit as described in the NAIC LTCi Model Regulation # 641 (2017) and the NAIC Model Bulletin \"Announcement of Alternative Filing Requirements for Long-Term Care Premium Rate Increases\" (as adopted by the Senior Issues Task Force on 8/9/2013.)_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1065.pdf"]},"response":{"errors":[],"extract_id":"extract_58708f66ba3fe91fc90e64c0c5565e1d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**John Hancock Life Insurance Company (U.S.A.)**\n\nJohn Hancock Place Post Office Box 111 C-7-30 Boston, Massachusetts 02117 1-888-877-6075 Email: cfolsom@jhancock.com\n\n**Carol A. Folsom Senior Contract Consultant US Insurance Legacy – LTC** May 10, 2018 KENT SULLIVAN Commissioner Texas Department of Insurance 333 Guadalupe Street Austin, Texas 78701\n\nRe: **John Hancock Life Insurance Company (U.S.A.)** **Company NAIC # 65838; FEIN #: 01-0233346** **Individual Long-Term Care Insurance Rate Revision Submission Revised Actuarial Memo LTC-06 TX** Dear Commissioner Sullivan: We are submitting the above captioned filing for your consideration. This submission was based upon information generated by our comprehensive 2016 claims study which examined the usage trend for our insured population. In general, we are seeing longer-lasting and more expensive claims and increased claim incidence at the older attained ages.\n\nAs a result of the factors listed above, we are requesting a premium rate increase on the policy series listed below and are enclosing the actuarial memo and rates for your review and acceptance. Policy Series Approval Date Years Sold Increase Percentage\n\nLTC-06 TX 11/2/2006 2007 – 2014 26.9%\n\nThe proposed premium rates will be effective on the next policy anniversary date, following a 90-day policyholder notification period, which will be made as soon as practicable following state acceptance. As we will describe later in this letter, we will also offer affected insureds various benefit reduction options to help mitigate the impact of the rate increase.\n\n**Policyholder Options**\n\nWe are fully aware that a premium increase may be difficult for our policyholders. Therefore, we will provide all policyholders with an array of options which will help them mitigate the impact of any increase. Most important, for those policyholders who originally purchased lifetime 5% compound inflation we will provide them with the ability to retain their existing premium by decreasing their future inflation coverage to a lower percentage. These policyholders will be able to keep all accrued inflation increase amounts to date and the lower inflation index will apply on a prospective basis only. The endorsements and other applicable forms needed to implement the benefit reduction option will be filed under a separate forms submission. In addition, policyholders will be able to reduce their benefit period, adjust their daily/monthly benefit amount, drop optional benefit riders or extend their elimination period. Where the NAIC contingent nonforfeiture benefit or the nonforfeiture benefit (if purchased) is triggered, customers will be offered paid-up coverage in accordance with the applicable provision. We are allowing contingent nonforfeiture if the rate increase trigger is met for all affected policyholders, even if it was not otherwise required in your State. _(Please note, that we will be voluntarily administering the enhanced contingent nonforfeiture benefit as described in the NAIC LTCi Model Regulation # 641 (2017) and the NAIC Model Bulletin \"Announcement of Alternative Filing Requirements for Long-Term Care Premium Rate Increases\" (as adopted by the Senior Issues Task Force on 8/9/2013.)_"],"full_content":"**John Hancock Life Insurance Company (U.S.A.)**\n\nJohn Hancock Place Post Office Box 111 C-7-30 Boston, Massachusetts 02117 1-888-877-6075 Email: cfolsom@jhancock.com\n\n**Carol A. Folsom Senior Contract Consultant US Insurance Legacy – LTC** May 10, 2018 KENT SULLIVAN Commissioner Texas Department of Insurance 333 Guadalupe Street Austin, Texas 78701\n\nRe: **John Hancock Life Insurance Company (U.S.A.)** **Company NAIC # 65838; FEIN #: 01-0233346** **Individual Long-Term Care Insurance Rate Revision Submission Revised Actuarial Memo LTC-06 TX** Dear Commissioner Sullivan: We are submitting the above captioned filing for your consideration. This submission was based upon information generated by our comprehensive 2016 claims study which examined the usage trend for our insured population. In general, we are seeing longer-lasting and more expensive claims and increased claim incidence at the older attained ages.\n\nAs a result of the factors listed above, we are requesting a premium rate increase on the policy series listed below and are enclosing the actuarial memo and rates for your review and acceptance. Policy Series Approval Date Years Sold Increase Percentage\n\nLTC-06 TX 11/2/2006 2007 – 2014 26.9%\n\nThe proposed premium rates will be effective on the next policy anniversary date, following a 90-day policyholder notification period, which will be made as soon as practicable following state acceptance. As we will describe later in this letter, we will also offer affected insureds various benefit reduction options to help mitigate the impact of the rate increase.\n\n**Policyholder Options**\n\nWe are fully aware that a premium increase may be difficult for our policyholders. Therefore, we will provide all policyholders with an array of options which will help them mitigate the impact of any increase. Most important, for those policyholders who originally purchased lifetime 5% compound inflation we will provide them with the ability to retain their existing premium by decreasing their future inflation coverage to a lower percentage. These policyholders will be able to keep all accrued inflation increase amounts to date and the lower inflation index will apply on a prospective basis only. The endorsements and other applicable forms needed to implement the benefit reduction option will be filed under a separate forms submission. In addition, policyholders will be able to reduce their benefit period, adjust their daily/monthly benefit amount, drop optional benefit riders or extend their elimination period. Where the NAIC contingent nonforfeiture benefit or the nonforfeiture benefit (if purchased) is triggered, customers will be offered paid-up coverage in accordance with the applicable provision. We are allowing contingent nonforfeiture if the rate increase trigger is met for all affected policyholders, even if it was not otherwise required in your State. _(Please note, that we will be voluntarily administering the enhanced contingent nonforfeiture benefit as described in the NAIC LTCi Model Regulation # 641 (2017) and the NAIC Model Bulletin \"Announcement of Alternative Filing Requirements for Long-Term Care Premium Rate Increases\" (as adopted by the Senior Issues Task Force on 8/9/2013.)_","publish_date":null,"title":"John Hancock Life Insurance Company (U.S.A.) Carol A. Folsom Senior Contract Consultant US Insurance Legacy – LTC May 10, 2018","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1065.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1065.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1065","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1065.pdf"},"started_at":"2026-11-04T19:48:14.117933"} +{"completed_at":"2026-11-04T19:48:17.539979","latency_in_ms":2209,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1072","grounded_pages":[],"layout_pages":[],"markdown":"### **Appendix B2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **BSC-02 TX**\n\n**_Premiums to be used only with those that have_**\n\n**_previously elected an inflation decrease option during the 2010 Rate Filing_**\n\n### **Standard rates per $10 of Daily Benefit**\n\n### **100% Home Health Care**\n\nTRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE\n\n**2\\.7% Simple Inflation 2.7% Compound Inflation**\n\n**Age** Benefit Period Benefit Period\n\n2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life\n\n18-29 43.65 56.16 64.75 72.36 79.97 92.14 97.84 61.51 79.60 94.08 103.12 112.17 126.64 130.26\n\n30 46.86 59.39 67.97 75.60 84.84 97.06 101.61 65.13 83.22 94.08 106.74 117.60 130.26 139.31\n\n31 47.34 59.88 68.46 76.08 85.34 97.58 107.11 65.13 83.22 97.70 112.17 121.21 135.69 139.31\n\n32 47.34 59.88 68.95 76.57 85.83 101.31 107.65 65.13 88.65 97.70 112.17 121.21 135.69 144.73\n\n33 47.18 64.76 73.84 81.46 89.06 101.82 108.73 70.56 88.65 97.70 112.17 121.21 139.31 144.73\n\n34 52.24 65.26 74.34 81.95 89.55 102.84 114.24 70.56 88.65 103.12 117.60 126.64 139.31 150.16\n\n35 52.73 65.76 74.34 82.44 90.04 108.30 114.79 70.56 88.65 103.12 117.60 126.64 139.31 150.16\n\n36 53.22 66.25 74.83 87.33 95.42 108.81 118.53 70.56 94.08 103.12 121.21 130.26 144.73 153.78\n\n37 53.71 66.75 78.52 87.83 95.91 114.27 119.62 74.18 94.08 106.74 121.21 130.26 144.73 153.78\n\n38 53.71 69.95 79.01 88.32 96.41 115.31 120.70 74.18 94.08 106.74 126.64 135.69 150.16 159.21\n\n39 54.21 70.44 79.50 92.01 100.10 116.35 126.64 74.18 97.70 106.74 126.64 135.69 150.16 159.21\n\n40 59.12 70.93 79.98 92.51 100.59 120.03 126.64 74.18 97.70 112.17 126.64 135.69 153.78 162.83\n\n41 59.67 71.47 84.96 93.06 101.15 121.18 126.64 79.60 103.12 112.17 130.26 139.31 159.21 162.83\n\n42 59.71 76.44 85.52 98.54 106.62 121.21 130.26 79.60 103.12 117.60 135.69 144.73 159.21 168.25\n\n43 60.27 77.00 86.58 99.11 107.20 126.64 130.26 83.22 106.74 121.21 135.69 144.73 162.83 171.87\n\n44 60.83 77.56 91.58 99.68 107.78 126.64 130.26 83.22 106.74 121.21 139.31 150.16 168.25 171.87\n\n45 64.04 80.79 92.16 103.44 113.28 126.64 135.69 88.65 112.17 126.64 144.73 153.78 168.25 177.30\n\n46 64.09 81.85 93.25 104.02 113.88 130.26 135.69 88.65 112.17 130.26 144.73 153.78 171.87 182.73\n\n47 64.65 82.42 96.48 105.11 114.99 130.26 135.69 94.08 117.60 135.69 150.16 159.21 177.30 186.35\n\n48 65.13 83.00 97.58 106.21 116.11 130.26 139.31 94.08 121.21 135.69 153.78 162.83 177.30 186.35\n\n49 65.13 88.54 97.70 111.25 119.37 135.69 139.31 97.70 121.21 139.31 159.21 168.25 182.73 191.77\n\n50 70.56 88.65 103.12 112.17 120.50 135.69 139.31 97.70 126.64 144.73 159.21 168.25 186.35 195.39\n\n51 70.56 94.08 106.74 117.60 126.08 139.31 150.16 103.12 130.26 150.16 162.83 171.87 191.77 206.25\n\n52 74.18 97.70 112.17 126.20 134.32 150.16 159.21 106.74 135.69 153.78 171.87 182.73 200.82 209.86\n\n53 79.60 103.12 117.60 130.00 138.13 159.21 162.83 112.17 139.31 159.21 177.30 186.35 206.25 218.91\n\n54 83.22 106.74 121.21 138.25 148.71 162.83 171.87 117.60 150.16 168.25 182.73 191.77 215.29 224.34\n\n55 83.22 112.17 126.64 143.87 156.98 171.87 182.73 121.21 153.78 171.87 191.77 200.82 224.34 233.38\n\n56 94.08 117.60 135.69 152.66 165.77 186.35 195.39 126.64 159.21 182.73 200.82 209.86 233.38 247.86\n\n57 97.70 126.21 144.63 161.46 174.58 200.82 209.86 130.26 168.25 186.35 209.86 224.34 247.86 260.52\n\n58 103.12 134.46 152.90 174.72 187.84 215.29 224.34 135.69 171.87 195.39 218.91 238.81 265.95 280.42\n\n59 111.66 143.26 161.71 183.54 201.11 227.96 242.43 139.31 182.73 206.25 233.38 251.48 280.42 294.90\n\n60 119.91 151.53 174.98 196.82 212.62 247.86 260.52 144.73 191.77 215.29 247.86 264.94 294.90 312.99\n\n61 126.02 160.84 184.30 210.58 226.92 260.52 274.99 153.78 200.82 227.96 260.52 278.73 316.61 336.51\n\n62 134.78 174.59 198.60 223.12 240.69 274.99 289.47 168.25 215.29 242.43 274.94 295.72 340.12 360.03\n\n63 143.94 188.36 212.38 237.44 253.79 293.27 305.86 176.32 226.70 255.49 293.19 317.16 361.64 381.43\n\n64 157.31 202.12 229.90 254.43 272.55 304.17 323.85 184.29 239.75 271.96 309.53 334.17 388.26 406.15\n\n65 165.47 214.67 243.76 269.31 287.44 322.04 339.83 197.49 252.65 284.68 330.94 355.64 409.22 432.35\n\n66 178.70 233.54 265.39 296.16 317.50 352.08 369.78 210.54 274.24 309.62 355.62 385.70 442.32 465.32\n\n67 195.28 253.34 290.28 321.79 344.21 385.29 404.64 226.95 295.56 330.75 381.77 416.30 471.49 499.64\n\n68 211.67 274.64 316.63 351.62 379.60 425.09 446.08 243.16 316.63 360.36 411.09 446.08 510.80 537.04\n\n69 229.60 300.91 340.92 386.14 412.23 462.67 488.76 264.38 340.92 389.62 448.76 485.28 547.90 573.99\n\n70 249.04 325.13 370.09 420.25 451.38 508.45 536.12 281.89 366.64 420.25 482.51 522.28 584.54 615.67\n\n71 269.96 354.21 404.07 457.38 491.77 555.39 586.34 306.06 398.91 457.38 519.28 563.98 634.48 665.43\n\n72 295.75 382.93 441.05 499.18 538.50 608.59 639.36 331.65 432.51 494.05 564.14 608.59 687.22 723.12\n\n73 319.52 421.49 477.58 548.96 591.45 662.83 696.82 360.31 469.08 538.76 613.54 662.83 741.01 780.10\n\n74 348.06 457.89 523.78 596.44 645.44 728.23 763.71 391.99 510.27 584.61 662.33 714.71 802.57 846.50\n\n75 381.29 498.87 567.74 650.04 702.11 792.81 836.49 424.96 554.30 636.60 718.91 776.02 871.76 913.75\n\n76 414.10 539.33 616.14 702.97 763.08 856.59 905.01 452.50 599.44 684.60 774.77 836.55 935.07 986.83\n\n77 449.81 585.92 667.25 761.86 826.60 929.51 975.98 487.99 642.35 736.97 834.90 899.63 1005.86 1062.29\n\n78 485.07 633.56 727.61 826.60 894.25 1004.79 1055.94 523.02 694.61 795.26 902.50 970.15 1085.64 1140.09\n\n79 524.80 690.43 790.47 897.07 969.23 1087.31 1143.07 562.52 744.55 859.35 969.23 1044.67 1167.67 1226.71\n\n80 572.16 753.09 0.00 0.00 0.00 0.00 0.00 614.54 816.67 0.00 0.00 0.00 0.00 0.00\n\n81 630.84 828.08 0.00 0.00 0.00 0.00 0.00 676.48 896.54 0.00 0.00 0.00 0.00 0.00\n\n82 694.41 912.84 0.00 0.00 0.00 0.00 0.00 744.94 984.56 0.00 0.00 0.00 0.00 0.00\n\n83 766.13 1005.75 0.00 0.00 0.00 0.00 0.00 816.67 1085.63 0.00 0.00 0.00 0.00 0.00\n\n84 841.12 1101.93 0.00 0.00 0.00 0.00 0.00 899.80 1194.84 0.00 0.00 0.00 0.00 0.00\n\n85 1017.16 0.00 0.00 0.00 0.00 0.00 0.00 1088.89 0.00 0.00 0.00 0.00 0.00 0.00\n\n86 1118.23 0.00 0.00 0.00 0.00 0.00 0.00 1198.10 0.00 0.00 0.00 0.00 0.00 0.00\n\n87 1232.33 0.00 0.00 0.00 0.00 0.00 0.00 1317.10 0.00 0.00 0.00 0.00 0.00 0.00\n\n88 1421.42 0.00 0.00 0.00 0.00 0.00 0.00 1522.49 0.00 0.00 0.00 0.00 0.00 0.00\n\n89 1564.87 0.00 0.00 0.00 0.00 0.00 0.00 1674.08 0.00 0.00 0.00 0.00 0.00 0.00\n\n90 1719.73 0.00 0.00 0.00 0.00 0.00 0.00 1841.98 0.00 0.00 0.00 0.00 0.00 0.00\n\n91+ 1892.51 0.00 0.00 0.00 0.00 0.00 0.00 2022.92 0.00 0.00 0.00 0.00 0.00 0.00\n\nGPO rates shown below the line apply only to attained age GPO Inflation Adjustment offers made to current inforce policies at these ages","pages":[{"line_numbers":[],"markdown":"### **Appendix B2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **BSC-02 TX**\n\n**_Premiums to be used only with those that have_**\n\n**_previously elected an inflation decrease option during the 2010 Rate Filing_**\n\n### **Standard rates per $10 of Daily Benefit**\n\n### **100% Home Health Care**\n\nTRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE\n\n**2\\.7% Simple Inflation 2.7% Compound Inflation**\n\n**Age** Benefit Period Benefit Period\n\n2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life\n\n18-29 43.65 56.16 64.75 72.36 79.97 92.14 97.84 61.51 79.60 94.08 103.12 112.17 126.64 130.26\n\n30 46.86 59.39 67.97 75.60 84.84 97.06 101.61 65.13 83.22 94.08 106.74 117.60 130.26 139.31\n\n31 47.34 59.88 68.46 76.08 85.34 97.58 107.11 65.13 83.22 97.70 112.17 121.21 135.69 139.31\n\n32 47.34 59.88 68.95 76.57 85.83 101.31 107.65 65.13 88.65 97.70 112.17 121.21 135.69 144.73\n\n33 47.18 64.76 73.84 81.46 89.06 101.82 108.73 70.56 88.65 97.70 112.17 121.21 139.31 144.73\n\n34 52.24 65.26 74.34 81.95 89.55 102.84 114.24 70.56 88.65 103.12 117.60 126.64 139.31 150.16\n\n35 52.73 65.76 74.34 82.44 90.04 108.30 114.79 70.56 88.65 103.12 117.60 126.64 139.31 150.16\n\n36 53.22 66.25 74.83 87.33 95.42 108.81 118.53 70.56 94.08 103.12 121.21 130.26 144.73 153.78\n\n37 53.71 66.75 78.52 87.83 95.91 114.27 119.62 74.18 94.08 106.74 121.21 130.26 144.73 153.78\n\n38 53.71 69.95 79.01 88.32 96.41 115.31 120.70 74.18 94.08 106.74 126.64 135.69 150.16 159.21\n\n39 54.21 70.44 79.50 92.01 100.10 116.35 126.64 74.18 97.70 106.74 126.64 135.69 150.16 159.21\n\n40 59.12 70.93 79.98 92.51 100.59 120.03 126.64 74.18 97.70 112.17 126.64 135.69 153.78 162.83\n\n41 59.67 71.47 84.96 93.06 101.15 121.18 126.64 79.60 103.12 112.17 130.26 139.31 159.21 162.83\n\n42 59.71 76.44 85.52 98.54 106.62 121.21 130.26 79.60 103.12 117.60 135.69 144.73 159.21 168.25\n\n43 60.27 77.00 86.58 99.11 107.20 126.64 130.26 83.22 106.74 121.21 135.69 144.73 162.83 171.87\n\n44 60.83 77.56 91.58 99.68 107.78 126.64 130.26 83.22 106.74 121.21 139.31 150.16 168.25 171.87\n\n45 64.04 80.79 92.16 103.44 113.28 126.64 135.69 88.65 112.17 126.64 144.73 153.78 168.25 177.30\n\n46 64.09 81.85 93.25 104.02 113.88 130.26 135.69 88.65 112.17 130.26 144.73 153.78 171.87 182.73\n\n47 64.65 82.42 96.48 105.11 114.99 130.26 135.69 94.08 117.60 135.69 150.16 159.21 177.30 186.35\n\n48 65.13 83.00 97.58 106.21 116.11 130.26 139.31 94.08 121.21 135.69 153.78 162.83 177.30 186.35\n\n49 65.13 88.54 97.70 111.25 119.37 135.69 139.31 97.70 121.21 139.31 159.21 168.25 182.73 191.77\n\n50 70.56 88.65 103.12 112.17 120.50 135.69 139.31 97.70 126.64 144.73 159.21 168.25 186.35 195.39\n\n51 70.56 94.08 106.74 117.60 126.08 139.31 150.16 103.12 130.26 150.16 162.83 171.87 191.77 206.25\n\n52 74.18 97.70 112.17 126.20 134.32 150.16 159.21 106.74 135.69 153.78 171.87 182.73 200.82 209.86\n\n53 79.60 103.12 117.60 130.00 138.13 159.21 162.83 112.17 139.31 159.21 177.30 186.35 206.25 218.91\n\n54 83.22 106.74 121.21 138.25 148.71 162.83 171.87 117.60 150.16 168.25 182.73 191.77 215.29 224.34\n\n55 83.22 112.17 126.64 143.87 156.98 171.87 182.73 121.21 153.78 171.87 191.77 200.82 224.34 233.38\n\n56 94.08 117.60 135.69 152.66 165.77 186.35 195.39 126.64 159.21 182.73 200.82 209.86 233.38 247.86\n\n57 97.70 126.21 144.63 161.46 174.58 200.82 209.86 130.26 168.25 186.35 209.86 224.34 247.86 260.52\n\n58 103.12 134.46 152.90 174.72 187.84 215.29 224.34 135.69 171.87 195.39 218.91 238.81 265.95 280.42\n\n59 111.66 143.26 161.71 183.54 201.11 227.96 242.43 139.31 182.73 206.25 233.38 251.48 280.42 294.90\n\n60 119.91 151.53 174.98 196.82 212.62 247.86 260.52 144.73 191.77 215.29 247.86 264.94 294.90 312.99\n\n61 126.02 160.84 184.30 210.58 226.92 260.52 274.99 153.78 200.82 227.96 260.52 278.73 316.61 336.51\n\n62 134.78 174.59 198.60 223.12 240.69 274.99 289.47 168.25 215.29 242.43 274.94 295.72 340.12 360.03\n\n63 143.94 188.36 212.38 237.44 253.79 293.27 305.86 176.32 226.70 255.49 293.19 317.16 361.64 381.43\n\n64 157.31 202.12 229.90 254.43 272.55 304.17 323.85 184.29 239.75 271.96 309.53 334.17 388.26 406.15\n\n65 165.47 214.67 243.76 269.31 287.44 322.04 339.83 197.49 252.65 284.68 330.94 355.64 409.22 432.35\n\n66 178.70 233.54 265.39 296.16 317.50 352.08 369.78 210.54 274.24 309.62 355.62 385.70 442.32 465.32\n\n67 195.28 253.34 290.28 321.79 344.21 385.29 404.64 226.95 295.56 330.75 381.77 416.30 471.49 499.64\n\n68 211.67 274.64 316.63 351.62 379.60 425.09 446.08 243.16 316.63 360.36 411.09 446.08 510.80 537.04\n\n69 229.60 300.91 340.92 386.14 412.23 462.67 488.76 264.38 340.92 389.62 448.76 485.28 547.90 573.99\n\n70 249.04 325.13 370.09 420.25 451.38 508.45 536.12 281.89 366.64 420.25 482.51 522.28 584.54 615.67\n\n71 269.96 354.21 404.07 457.38 491.77 555.39 586.34 306.06 398.91 457.38 519.28 563.98 634.48 665.43\n\n72 295.75 382.93 441.05 499.18 538.50 608.59 639.36 331.65 432.51 494.05 564.14 608.59 687.22 723.12\n\n73 319.52 421.49 477.58 548.96 591.45 662.83 696.82 360.31 469.08 538.76 613.54 662.83 741.01 780.10\n\n74 348.06 457.89 523.78 596.44 645.44 728.23 763.71 391.99 510.27 584.61 662.33 714.71 802.57 846.50\n\n75 381.29 498.87 567.74 650.04 702.11 792.81 836.49 424.96 554.30 636.60 718.91 776.02 871.76 913.75\n\n76 414.10 539.33 616.14 702.97 763.08 856.59 905.01 452.50 599.44 684.60 774.77 836.55 935.07 986.83\n\n77 449.81 585.92 667.25 761.86 826.60 929.51 975.98 487.99 642.35 736.97 834.90 899.63 1005.86 1062.29\n\n78 485.07 633.56 727.61 826.60 894.25 1004.79 1055.94 523.02 694.61 795.26 902.50 970.15 1085.64 1140.09\n\n79 524.80 690.43 790.47 897.07 969.23 1087.31 1143.07 562.52 744.55 859.35 969.23 1044.67 1167.67 1226.71\n\n80 572.16 753.09 0.00 0.00 0.00 0.00 0.00 614.54 816.67 0.00 0.00 0.00 0.00 0.00\n\n81 630.84 828.08 0.00 0.00 0.00 0.00 0.00 676.48 896.54 0.00 0.00 0.00 0.00 0.00\n\n82 694.41 912.84 0.00 0.00 0.00 0.00 0.00 744.94 984.56 0.00 0.00 0.00 0.00 0.00\n\n83 766.13 1005.75 0.00 0.00 0.00 0.00 0.00 816.67 1085.63 0.00 0.00 0.00 0.00 0.00\n\n84 841.12 1101.93 0.00 0.00 0.00 0.00 0.00 899.80 1194.84 0.00 0.00 0.00 0.00 0.00\n\n85 1017.16 0.00 0.00 0.00 0.00 0.00 0.00 1088.89 0.00 0.00 0.00 0.00 0.00 0.00\n\n86 1118.23 0.00 0.00 0.00 0.00 0.00 0.00 1198.10 0.00 0.00 0.00 0.00 0.00 0.00\n\n87 1232.33 0.00 0.00 0.00 0.00 0.00 0.00 1317.10 0.00 0.00 0.00 0.00 0.00 0.00\n\n88 1421.42 0.00 0.00 0.00 0.00 0.00 0.00 1522.49 0.00 0.00 0.00 0.00 0.00 0.00\n\n89 1564.87 0.00 0.00 0.00 0.00 0.00 0.00 1674.08 0.00 0.00 0.00 0.00 0.00 0.00\n\n90 1719.73 0.00 0.00 0.00 0.00 0.00 0.00 1841.98 0.00 0.00 0.00 0.00 0.00 0.00\n\n91+ 1892.51 0.00 0.00 0.00 0.00 0.00 0.00 2022.92 0.00 0.00 0.00 0.00 0.00 0.00\n\nGPO rates shown below the line apply only to attained age GPO Inflation Adjustment offers made to current inforce policies at these ages","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Appendix B2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **BSC-02 TX**\n\n**_Premiums to be used only with those that have_**\n\n**_previously elected an inflation decrease option during the 2010 Rate Filing_**\n\n### **Standard rates per $10 of Daily Benefit**\n\n### **100% Home Health Care**\n\nTRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE\n\n**2\\.7% Simple Inflation 2.7% Compound Inflation**\n\n**Age** Benefit Period Benefit Period\n\n2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life\n\n18-29 43.65 56.16 64.75 72.36 79.97 92.14 97.84 61.51 79.60 94.08 103.12 112.17 126.64 130.26\n\n30 46.86 59.39 67.97 75.60 84.84 97.06 101.61 65.13 83.22 94.08 106.74 117.60 130.26 139.31\n\n31 47.34 59.88 68.46 76.08 85.34 97.58 107.11 65.13 83.22 97.70 112.17 121.21 135.69 139.31\n\n32 47.34 59.88 68.95 76.57 85.83 101.31 107.65 65.13 88.65 97.70 112.17 121.21 135.69 144.73\n\n33 47.18 64.76 73.84 81.46 89.06 101.82 108.73 70.56 88.65 97.70 112.17 121.21 139.31 144.73\n\n34 52.24 65.26 74.34 81.95 89.55 102.84 114.24 70.56 88.65 103.12 117.60 126.64 139.31 150.16\n\n35 52.73 65.76 74.34 82.44 90.04 108.30 114.79 70.56 88.65 103.12 117.60 126.64 139.31 150.16\n\n36 53.22 66.25 74.83 87.33 95.42 108.81 118.53 70.56 94.08 103.12 121.21 130.26 144.73 153.78\n\n37 53.71 66.75 78.52 87.83 95.91 114.27 119.62 74.18 94.08 106.74 121.21 130.26 144.73 153.78\n\n38 53.71 69.95 79.01 88.32 96.41 115.31 120.70 74.18 94.08 106.74 126.64 135.69 150.16 159.21\n\n39 54.21 70.44 79.50 92.01 100.10 116.35 126.64 74.18 97.70 106.74 126.64 135.69 150.16 159.21\n\n40 59.12 70.93 79.98 92.51 100.59 120.03 126.64 74.18 97.70 112.17 126.64 135.69 153.78 162.83\n\n41 59.67 71.47 84.96 93.06 101.15 121.18 126.64 79.60 103.12 112.17 130.26 139.31 159.21 162.83\n\n42 59.71 76.44 85.52 98.54 106.62 121.21 130.26 79.60 103.12 117.60 135.69 144.73 159.21 168.25\n\n43 60.27 77.00 86.58 99.11 107.20 126.64 130.26 83.22 106.74 121.21 135.69 144.73 162.83 171.87\n\n44 60.83 77.56 91.58 99.68 107.78 126.64 130.26 83.22 106.74 121.21 139.31 150.16 168.25 171.87\n\n45 64.04 80.79 92.16 103.44 113.28 126.64 135.69 88.65 112.17 126.64 144.73 153.78 168.25 177.30\n\n46 64.09 81.85 93.25 104.02 113.88 130.26 135.69 88.65 112.17 130.26 144.73 153.78 171.87 182.73\n\n47 64.65 82.42 96.48 105.11 114.99 130.26 135.69 94.08 117.60 135.69 150.16 159.21 177.30 186.35\n\n48 65.13 83.00 97.58 106.21 116.11 130.26 139.31 94.08 121.21 135.69 153.78 162.83 177.30 186.35\n\n49 65.13 88.54 97.70 111.25 119.37 135.69 139.31 97.70 121.21 139.31 159.21 168.25 182.73 191.77\n\n50 70.56 88.65 103.12 112.17 120.50 135.69 139.31 97.70 126.64 144.73 159.21 168.25 186.35 195.39\n\n51 70.56 94.08 106.74 117.60 126.08 139.31 150.16 103.12 130.26 150.16 162.83 171.87 191.77 206.25\n\n52 74.18 97.70 112.17 126.20 134.32 150.16 159.21 106.74 135.69 153.78 171.87 182.73 200.82 209.86\n\n53 79.60 103.12 117.60 130.00 138.13 159.21 162.83 112.17 139.31 159.21 177.30 186.35 206.25 218.91\n\n54 83.22 106.74 121.21 138.25 148.71 162.83 171.87 117.60 150.16 168.25 182.73 191.77 215.29 224.34\n\n55 83.22 112.17 126.64 143.87 156.98 171.87 182.73 121.21 153.78 171.87 191.77 200.82 224.34 233.38\n\n56 94.08 117.60 135.69 152.66 165.77 186.35 195.39 126.64 159.21 182.73 200.82 209.86 233.38 247.86\n\n57 97.70 126.21 144.63 161.46 174.58 200.82 209.86 130.26 168.25 186.35 209.86 224.34 247.86 260.52\n\n58 103.12 134.46 152.90 174.72 187.84 215.29 224.34 135.69 171.87 195.39 218.91 238.81 265.95 280.42\n\n59 111.66 143.26 161.71 183.54 201.11 227.96 242.43 139.31 182.73 206.25 233.38 251.48 280.42 294.90\n\n60 119.91 151.53 174.98 196.82 212.62 247.86 260.52 144.73 191.77 215.29 247.86 264.94 294.90 312.99\n\n61 126.02 160.84 184.30 210.58 226.92 260.52 274.99 153.78 200.82 227.96 260.52 278.73 316.61 336.51\n\n62 134.78 174.59 198.60 223.12 240.69 274.99 289.47 168.25 215.29 242.43 274.94 295.72 340.12 360.03\n\n63 143.94 188.36 212.38 237.44 253.79 293.27 305.86 176.32 226.70 255.49 293.19 317.16 361.64 381.43\n\n64 157.31 202.12 229.90 254.43 272.55 304.17 323.85 184.29 239.75 271.96 309.53 334.17 388.26 406.15\n\n65 165.47 214.67 243.76 269.31 287.44 322.04 339.83 197.49 252.65 284.68 330.94 355.64 409.22 432.35\n\n66 178.70 233.54 265.39 296.16 317.50 352.08 369.78 210.54 274.24 309.62 355.62 385.70 442.32 465.32\n\n67 195.28 253.34 290.28 321.79 344.21 385.29 404.64 226.95 295.56 330.75 381.77 416.30 471.49 499.64\n\n68 211.67 274.64 316.63 351.62 379.60 425.09 446.08 243.16 316.63 360.36 411.09 446.08 510.80 537.04\n\n69 229.60 300.91 340.92 386.14 412.23 462.67 488.76 264.38 340.92 389.62 448.76 485.28 547.90 573.99\n\n70 249.04 325.13 370.09 420.25 451.38 508.45 536.12 281.89 366.64 420.25 482.51 522.28 584.54 615.67\n\n71 269.96 354.21 404.07 457.38 491.77 555.39 586.34 306.06 398.91 457.38 519.28 563.98 634.48 665.43\n\n72 295.75 382.93 441.05 499.18 538.50 608.59 639.36 331.65 432.51 494.05 564.14 608.59 687.22 723.12\n\n73 319.52 421.49 477.58 548.96 591.45 662.83 696.82 360.31 469.08 538.76 613.54 662.83 741.01 780.10\n\n74 348.06 457.89 523.78 596.44 645.44 728.23 763.71 391.99 510.27 584.61 662.33 714.71 802.57 846.50\n\n75 381.29 498.87 567.74 650.04 702.11 792.81 836.49 424.96 554.30 636.60 718.91 776.02 871.76 913.75\n\n76 414.10 539.33 616.14 702.97 763.08 856.59 905.01 452.50 599.44 684.60 774.77 836.55 935.07 986.83\n\n77 449.81 585.92 667.25 761.86 826.60 929.51 975.98 487.99 642.35 736.97 834.90 899.63 1005.86 1062.29\n\n78 485.07 633.56 727.61 826.60 894.25 1004.79 1055.94 523.02 694.61 795.26 902.50 970.15 1085.64 1140.09\n\n79 524.80 690.43 790.47 897.07 969.23 1087.31 1143.07 562.52 744.55 859.35 969.23 1044.67 1167.67 1226.71\n\n80 572.16 753.09 0.00 0.00 0.00 0.00 0.00 614.54 816.67 0.00 0.00 0.00 0.00 0.00\n\n81 630.84 828.08 0.00 0.00 0.00 0.00 0.00 676.48 896.54 0.00 0.00 0.00 0.00 0.00\n\n82 694.41 912.84 0.00 0.00 0.00 0.00 0.00 744.94 984.56 0.00 0.00 0.00 0.00 0.00\n\n83 766.13 1005.75 0.00 0.00 0.00 0.00 0.00 816.67 1085.63 0.00 0.00 0.00 0.00 0.00\n\n84 841.12 1101.93 0.00 0.00 0.00 0.00 0.00 899.80 1194.84 0.00 0.00 0.00 0.00 0.00\n\n85 1017.16 0.00 0.00 0.00 0.00 0.00 0.00 1088.89 0.00 0.00 0.00 0.00 0.00 0.00\n\n86 1118.23 0.00 0.00 0.00 0.00 0.00 0.00 1198.10 0.00 0.00 0.00 0.00 0.00 0.00\n\n87 1232.33 0.00 0.00 0.00 0.00 0.00 0.00 1317.10 0.00 0.00 0.00 0.00 0.00 0.00\n\n88 1421.42 0.00 0.00 0.00 0.00 0.00 0.00 1522.49 0.00 0.00 0.00 0.00 0.00 0.00\n\n89 1564.87 0.00 0.00 0.00 0.00 0.00 0.00 1674.08 0.00 0.00 0.00 0.00 0.00 0.00\n\n90 1719.73 0.00 0.00 0.00 0.00 0.00 0.00 1841.98 0.00 0.00 0.00 0.00 0.00 0.00\n\n91+ 1892.51 0.00 0.00 0.00 0.00 0.00 0.00 2022.92 0.00 0.00 0.00 0.00 0.00 0.00\n\nGPO rates shown below the line apply only to attained age GPO Inflation Adjustment offers made to current inforce policies at these ages","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1072.pdf"]},"response":{"errors":[],"extract_id":"extract_07ef516e1e23deeef19f692d3e8f365f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Appendix B2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **BSC-02 TX**\n\n**_Premiums to be used only with those that have_**\n\n**_previously elected an inflation decrease option during the 2010 Rate Filing_**\n\n### **Standard rates per $10 of Daily Benefit**\n\n### **100% Home Health Care**\n\nTRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE\n\n**2\\.7% Simple Inflation 2.7% Compound Inflation**\n\n**Age** Benefit Period Benefit Period\n\n2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life\n\n18-29 43.65 56.16 64.75 72.36 79.97 92.14 97.84 61.51 79.60 94.08 103.12 112.17 126.64 130.26\n\n30 46.86 59.39 67.97 75.60 84.84 97.06 101.61 65.13 83.22 94.08 106.74 117.60 130.26 139.31\n\n31 47.34 59.88 68.46 76.08 85.34 97.58 107.11 65.13 83.22 97.70 112.17 121.21 135.69 139.31\n\n32 47.34 59.88 68.95 76.57 85.83 101.31 107.65 65.13 88.65 97.70 112.17 121.21 135.69 144.73\n\n33 47.18 64.76 73.84 81.46 89.06 101.82 108.73 70.56 88.65 97.70 112.17 121.21 139.31 144.73\n\n34 52.24 65.26 74.34 81.95 89.55 102.84 114.24 70.56 88.65 103.12 117.60 126.64 139.31 150.16\n\n35 52.73 65.76 74.34 82.44 90.04 108.30 114.79 70.56 88.65 103.12 117.60 126.64 139.31 150.16\n\n36 53.22 66.25 74.83 87.33 95.42 108.81 118.53 70.56 94.08 103.12 121.21 130.26 144.73 153.78\n\n37 53.71 66.75 78.52 87.83 95.91 114.27 119.62 74.18 94.08 106.74 121.21 130.26 144.73 153.78\n\n38 53.71 69.95 79.01 88.32 96.41 115.31 120.70 74.18 94.08 106.74 126.64 135.69 150.16 159.21\n\n39 54.21 70.44 79.50 92.01 100.10 116.35 126.64 74.18 97.70 106.74 126.64 135.69 150.16 159.21\n\n40 59.12 70.93 79.98 92.51 100.59 120.03 126.64 74.18 97.70 112.17 126.64 135.69 153.78 162.83\n\n41 59.67 71.47 84.96 93.06 101.15 121.18 126.64 79.60 103.12 112.17 130.26 139.31 159.21 162.83\n\n42 59.71 76.44 85.52 98.54 106.62 121.21 130.26 79.60 103.12 117.60 135.69 144.73 159.21 168.25\n\n43 60.27 77.00 86.58 99.11 107.20 126.64 130.26 83.22 106.74 121.21 135.69 144.73 162.83 171.87\n\n44 60.83 77.56 91.58 99.68 107.78 126.64 130.26 83.22 106.74 121.21 139.31 150.16 168.25 171.87\n\n45 64.04 80.79 92.16 103.44 113.28 126.64 135.69 88.65 112.17 126.64 144.73 153.78 168.25 177.30\n\n46 64.09 81.85 93.25 104.02 113.88 130.26 135.69 88.65 112.17 130.26 144.73 153.78 171.87 182.73\n\n47 64.65 82.42 96.48 105.11 114.99 130.26 135.69 94.08 117.60 135.69 150.16 159.21 177.30 186.35\n\n48 65.13 83.00 97.58 106.21 116.11 130.26 139.31 94.08 121.21 135.69 153.78 162.83 177.30 186.35\n\n49 65.13 88.54 97.70 111.25 119.37 135.69 139.31 97.70 121.21 139.31 159.21 168.25 182.73 191.77\n\n50 70.56 88.65 103.12 112.17 120.50 135.69 139.31 97.70 126.64 144.73 159.21 168.25 186.35 195.39\n\n51 70.56 94.08 106.74 117.60 126.08 139.31 150.16 103.12 130.26 150.16 162.83 171.87 191.77 206.25\n\n52 74.18 97.70 112.17 126.20 134.32 150.16 159.21 106.74 135.69 153.78 171.87 182.73 200.82 209.86\n\n53 79.60 103.12 117.60 130.00 138.13 159.21 162.83 112.17 139.31 159.21 177.30 186.35 206.25 218.91\n\n54 83.22 106.74 121.21 138.25 148.71 162.83 171.87 117.60 150.16 168.25 182.73 191.77 215.29 224.34\n\n55 83.22 112.17 126.64 143.87 156.98 171.87 182.73 121.21 153.78 171.87 191.77 200.82 224.34 233.38\n\n56 94.08 117.60 135.69 152.66 165.77 186.35 195.39 126.64 159.21 182.73 200.82 209.86 233.38 247.86\n\n57 97.70 126.21 144.63 161.46 174.58 200.82 209.86 130.26 168.25 186.35 209.86 224.34 247.86 260.52\n\n58 103.12 134.46 152.90 174.72 187.84 215.29 224.34 135.69 171.87 195.39 218.91 238.81 265.95 280.42\n\n59 111.66 143.26 161.71 183.54 201.11 227.96 242.43 139.31 182.73 206.25 233.38 251.48 280.42 294.90\n\n60 119.91 151.53 174.98 196.82 212.62 247.86 260.52 144.73 191.77 215.29 247.86 264.94 294.90 312.99\n\n61 126.02 160.84 184.30 210.58 226.92 260.52 274.99 153.78 200.82 227.96 260.52 278.73 316.61 336.51\n\n62 134.78 174.59 198.60 223.12 240.69 274.99 289.47 168.25 215.29 242.43 274.94 295.72 340.12 360.03\n\n63 143.94 188.36 212.38 237.44 253.79 293.27 305.86 176.32 226.70 255.49 293.19 317.16 361.64 381.43\n\n64 157.31 202.12 229.90 254.43 272.55 304.17 323.85 184.29 239.75 271.96 309.53 334.17 388.26 406.15\n\n65 165.47 214.67 243.76 269.31 287.44 322.04 339.83 197.49 252.65 284.68 330.94 355.64 409.22 432.35\n\n66 178.70 233.54 265.39 296.16 317.50 352.08 369.78 210.54 274.24 309.62 355.62 385.70 442.32 465.32\n\n67 195.28 253.34 290.28 321.79 344.21 385.29 404.64 226.95 295.56 330.75 381.77 416.30 471.49 499.64\n\n68 211.67 274.64 316.63 351.62 379.60 425.09 446.08 243.16 316.63 360.36 411.09 446.08 510.80 537.04\n\n69 229.60 300.91 340.92 386.14 412.23 462.67 488.76 264.38 340.92 389.62 448.76 485.28 547.90 573.99\n\n70 249.04 325.13 370.09 420.25 451.38 508.45 536.12 281.89 366.64 420.25 482.51 522.28 584.54 615.67\n\n71 269.96 354.21 404.07 457.38 491.77 555.39 586.34 306.06 398.91 457.38 519.28 563.98 634.48 665.43\n\n72 295.75 382.93 441.05 499.18 538.50 608.59 639.36 331.65 432.51 494.05 564.14 608.59 687.22 723.12\n\n73 319.52 421.49 477.58 548.96 591.45 662.83 696.82 360.31 469.08 538.76 613.54 662.83 741.01 780.10\n\n74 348.06 457.89 523.78 596.44 645.44 728.23 763.71 391.99 510.27 584.61 662.33 714.71 802.57 846.50\n\n75 381.29 498.87 567.74 650.04 702.11 792.81 836.49 424.96 554.30 636.60 718.91 776.02 871.76 913.75\n\n76 414.10 539.33 616.14 702.97 763.08 856.59 905.01 452.50 599.44 684.60 774.77 836.55 935.07 986.83\n\n77 449.81 585.92 667.25 761.86 826.60 929.51 975.98 487.99 642.35 736.97 834.90 899.63 1005.86 1062.29\n\n78 485.07 633.56 727.61 826.60 894.25 1004.79 1055.94 523.02 694.61 795.26 902.50 970.15 1085.64 1140.09\n\n79 524.80 690.43 790.47 897.07 969.23 1087.31 1143.07 562.52 744.55 859.35 969.23 1044.67 1167.67 1226.71\n\n80 572.16 753.09 0.00 0.00 0.00 0.00 0.00 614.54 816.67 0.00 0.00 0.00 0.00 0.00\n\n81 630.84 828.08 0.00 0.00 0.00 0.00 0.00 676.48 896.54 0.00 0.00 0.00 0.00 0.00\n\n82 694.41 912.84 0.00 0.00 0.00 0.00 0.00 744.94 984.56 0.00 0.00 0.00 0.00 0.00\n\n83 766.13 1005.75 0.00 0.00 0.00 0.00 0.00 816.67 1085.63 0.00 0.00 0.00 0.00 0.00\n\n84 841.12 1101.93 0.00 0.00 0.00 0.00 0.00 899.80 1194.84 0.00 0.00 0.00 0.00 0.00\n\n85 1017.16 0.00 0.00 0.00 0.00 0.00 0.00 1088.89 0.00 0.00 0.00 0.00 0.00 0.00\n\n86 1118.23 0.00 0.00 0.00 0.00 0.00 0.00 1198.10 0.00 0.00 0.00 0.00 0.00 0.00\n\n87 1232.33 0.00 0.00 0.00 0.00 0.00 0.00 1317.10 0.00 0.00 0.00 0.00 0.00 0.00\n\n88 1421.42 0.00 0.00 0.00 0.00 0.00 0.00 1522.49 0.00 0.00 0.00 0.00 0.00 0.00\n\n89 1564.87 0.00 0.00 0.00 0.00 0.00 0.00 1674.08 0.00 0.00 0.00 0.00 0.00 0.00\n\n90 1719.73 0.00 0.00 0.00 0.00 0.00 0.00 1841.98 0.00 0.00 0.00 0.00 0.00 0.00\n\n91+ 1892.51 0.00 0.00 0.00 0.00 0.00 0.00 2022.92 0.00 0.00 0.00 0.00 0.00 0.00\n\nGPO rates shown below the line apply only to attained age GPO Inflation Adjustment offers made to current inforce policies at these ages"],"full_content":"### **Appendix B2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **BSC-02 TX**\n\n**_Premiums to be used only with those that have_**\n\n**_previously elected an inflation decrease option during the 2010 Rate Filing_**\n\n### **Standard rates per $10 of Daily Benefit**\n\n### **100% Home Health Care**\n\nTRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE\n\n**2\\.7% Simple Inflation 2.7% Compound Inflation**\n\n**Age** Benefit Period Benefit Period\n\n2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life\n\n18-29 43.65 56.16 64.75 72.36 79.97 92.14 97.84 61.51 79.60 94.08 103.12 112.17 126.64 130.26\n\n30 46.86 59.39 67.97 75.60 84.84 97.06 101.61 65.13 83.22 94.08 106.74 117.60 130.26 139.31\n\n31 47.34 59.88 68.46 76.08 85.34 97.58 107.11 65.13 83.22 97.70 112.17 121.21 135.69 139.31\n\n32 47.34 59.88 68.95 76.57 85.83 101.31 107.65 65.13 88.65 97.70 112.17 121.21 135.69 144.73\n\n33 47.18 64.76 73.84 81.46 89.06 101.82 108.73 70.56 88.65 97.70 112.17 121.21 139.31 144.73\n\n34 52.24 65.26 74.34 81.95 89.55 102.84 114.24 70.56 88.65 103.12 117.60 126.64 139.31 150.16\n\n35 52.73 65.76 74.34 82.44 90.04 108.30 114.79 70.56 88.65 103.12 117.60 126.64 139.31 150.16\n\n36 53.22 66.25 74.83 87.33 95.42 108.81 118.53 70.56 94.08 103.12 121.21 130.26 144.73 153.78\n\n37 53.71 66.75 78.52 87.83 95.91 114.27 119.62 74.18 94.08 106.74 121.21 130.26 144.73 153.78\n\n38 53.71 69.95 79.01 88.32 96.41 115.31 120.70 74.18 94.08 106.74 126.64 135.69 150.16 159.21\n\n39 54.21 70.44 79.50 92.01 100.10 116.35 126.64 74.18 97.70 106.74 126.64 135.69 150.16 159.21\n\n40 59.12 70.93 79.98 92.51 100.59 120.03 126.64 74.18 97.70 112.17 126.64 135.69 153.78 162.83\n\n41 59.67 71.47 84.96 93.06 101.15 121.18 126.64 79.60 103.12 112.17 130.26 139.31 159.21 162.83\n\n42 59.71 76.44 85.52 98.54 106.62 121.21 130.26 79.60 103.12 117.60 135.69 144.73 159.21 168.25\n\n43 60.27 77.00 86.58 99.11 107.20 126.64 130.26 83.22 106.74 121.21 135.69 144.73 162.83 171.87\n\n44 60.83 77.56 91.58 99.68 107.78 126.64 130.26 83.22 106.74 121.21 139.31 150.16 168.25 171.87\n\n45 64.04 80.79 92.16 103.44 113.28 126.64 135.69 88.65 112.17 126.64 144.73 153.78 168.25 177.30\n\n46 64.09 81.85 93.25 104.02 113.88 130.26 135.69 88.65 112.17 130.26 144.73 153.78 171.87 182.73\n\n47 64.65 82.42 96.48 105.11 114.99 130.26 135.69 94.08 117.60 135.69 150.16 159.21 177.30 186.35\n\n48 65.13 83.00 97.58 106.21 116.11 130.26 139.31 94.08 121.21 135.69 153.78 162.83 177.30 186.35\n\n49 65.13 88.54 97.70 111.25 119.37 135.69 139.31 97.70 121.21 139.31 159.21 168.25 182.73 191.77\n\n50 70.56 88.65 103.12 112.17 120.50 135.69 139.31 97.70 126.64 144.73 159.21 168.25 186.35 195.39\n\n51 70.56 94.08 106.74 117.60 126.08 139.31 150.16 103.12 130.26 150.16 162.83 171.87 191.77 206.25\n\n52 74.18 97.70 112.17 126.20 134.32 150.16 159.21 106.74 135.69 153.78 171.87 182.73 200.82 209.86\n\n53 79.60 103.12 117.60 130.00 138.13 159.21 162.83 112.17 139.31 159.21 177.30 186.35 206.25 218.91\n\n54 83.22 106.74 121.21 138.25 148.71 162.83 171.87 117.60 150.16 168.25 182.73 191.77 215.29 224.34\n\n55 83.22 112.17 126.64 143.87 156.98 171.87 182.73 121.21 153.78 171.87 191.77 200.82 224.34 233.38\n\n56 94.08 117.60 135.69 152.66 165.77 186.35 195.39 126.64 159.21 182.73 200.82 209.86 233.38 247.86\n\n57 97.70 126.21 144.63 161.46 174.58 200.82 209.86 130.26 168.25 186.35 209.86 224.34 247.86 260.52\n\n58 103.12 134.46 152.90 174.72 187.84 215.29 224.34 135.69 171.87 195.39 218.91 238.81 265.95 280.42\n\n59 111.66 143.26 161.71 183.54 201.11 227.96 242.43 139.31 182.73 206.25 233.38 251.48 280.42 294.90\n\n60 119.91 151.53 174.98 196.82 212.62 247.86 260.52 144.73 191.77 215.29 247.86 264.94 294.90 312.99\n\n61 126.02 160.84 184.30 210.58 226.92 260.52 274.99 153.78 200.82 227.96 260.52 278.73 316.61 336.51\n\n62 134.78 174.59 198.60 223.12 240.69 274.99 289.47 168.25 215.29 242.43 274.94 295.72 340.12 360.03\n\n63 143.94 188.36 212.38 237.44 253.79 293.27 305.86 176.32 226.70 255.49 293.19 317.16 361.64 381.43\n\n64 157.31 202.12 229.90 254.43 272.55 304.17 323.85 184.29 239.75 271.96 309.53 334.17 388.26 406.15\n\n65 165.47 214.67 243.76 269.31 287.44 322.04 339.83 197.49 252.65 284.68 330.94 355.64 409.22 432.35\n\n66 178.70 233.54 265.39 296.16 317.50 352.08 369.78 210.54 274.24 309.62 355.62 385.70 442.32 465.32\n\n67 195.28 253.34 290.28 321.79 344.21 385.29 404.64 226.95 295.56 330.75 381.77 416.30 471.49 499.64\n\n68 211.67 274.64 316.63 351.62 379.60 425.09 446.08 243.16 316.63 360.36 411.09 446.08 510.80 537.04\n\n69 229.60 300.91 340.92 386.14 412.23 462.67 488.76 264.38 340.92 389.62 448.76 485.28 547.90 573.99\n\n70 249.04 325.13 370.09 420.25 451.38 508.45 536.12 281.89 366.64 420.25 482.51 522.28 584.54 615.67\n\n71 269.96 354.21 404.07 457.38 491.77 555.39 586.34 306.06 398.91 457.38 519.28 563.98 634.48 665.43\n\n72 295.75 382.93 441.05 499.18 538.50 608.59 639.36 331.65 432.51 494.05 564.14 608.59 687.22 723.12\n\n73 319.52 421.49 477.58 548.96 591.45 662.83 696.82 360.31 469.08 538.76 613.54 662.83 741.01 780.10\n\n74 348.06 457.89 523.78 596.44 645.44 728.23 763.71 391.99 510.27 584.61 662.33 714.71 802.57 846.50\n\n75 381.29 498.87 567.74 650.04 702.11 792.81 836.49 424.96 554.30 636.60 718.91 776.02 871.76 913.75\n\n76 414.10 539.33 616.14 702.97 763.08 856.59 905.01 452.50 599.44 684.60 774.77 836.55 935.07 986.83\n\n77 449.81 585.92 667.25 761.86 826.60 929.51 975.98 487.99 642.35 736.97 834.90 899.63 1005.86 1062.29\n\n78 485.07 633.56 727.61 826.60 894.25 1004.79 1055.94 523.02 694.61 795.26 902.50 970.15 1085.64 1140.09\n\n79 524.80 690.43 790.47 897.07 969.23 1087.31 1143.07 562.52 744.55 859.35 969.23 1044.67 1167.67 1226.71\n\n80 572.16 753.09 0.00 0.00 0.00 0.00 0.00 614.54 816.67 0.00 0.00 0.00 0.00 0.00\n\n81 630.84 828.08 0.00 0.00 0.00 0.00 0.00 676.48 896.54 0.00 0.00 0.00 0.00 0.00\n\n82 694.41 912.84 0.00 0.00 0.00 0.00 0.00 744.94 984.56 0.00 0.00 0.00 0.00 0.00\n\n83 766.13 1005.75 0.00 0.00 0.00 0.00 0.00 816.67 1085.63 0.00 0.00 0.00 0.00 0.00\n\n84 841.12 1101.93 0.00 0.00 0.00 0.00 0.00 899.80 1194.84 0.00 0.00 0.00 0.00 0.00\n\n85 1017.16 0.00 0.00 0.00 0.00 0.00 0.00 1088.89 0.00 0.00 0.00 0.00 0.00 0.00\n\n86 1118.23 0.00 0.00 0.00 0.00 0.00 0.00 1198.10 0.00 0.00 0.00 0.00 0.00 0.00\n\n87 1232.33 0.00 0.00 0.00 0.00 0.00 0.00 1317.10 0.00 0.00 0.00 0.00 0.00 0.00\n\n88 1421.42 0.00 0.00 0.00 0.00 0.00 0.00 1522.49 0.00 0.00 0.00 0.00 0.00 0.00\n\n89 1564.87 0.00 0.00 0.00 0.00 0.00 0.00 1674.08 0.00 0.00 0.00 0.00 0.00 0.00\n\n90 1719.73 0.00 0.00 0.00 0.00 0.00 0.00 1841.98 0.00 0.00 0.00 0.00 0.00 0.00\n\n91+ 1892.51 0.00 0.00 0.00 0.00 0.00 0.00 2022.92 0.00 0.00 0.00 0.00 0.00 0.00\n\nGPO rates shown below the line apply only to attained age GPO Inflation Adjustment offers made to current inforce policies at these ages","publish_date":null,"title":"Appendix B2","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1072.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1072.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1072","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1072.pdf"},"started_at":"2026-11-04T19:48:15.330758"} +{"completed_at":"2026-11-04T19:48:17.918519","latency_in_ms":1433,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1075","grounded_pages":[],"layout_pages":[],"markdown":"### **Appendix C2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **LTC-03 TX**\n\n**_Premiums to be used only with those that have previously elected an inflation decrease option_**\n\n### **Standard rates per $100 of Monthly Benefit**\n\n### **90 Day Elimination Period**\n\nTRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE ## TRUE TRUE\n\n**2\\.2% Simple Inflation or**\n\n**3\\.9% Simple Inflation with Shared Cost**\n\n**2\\.2%/3% Compound Inflation or**\n\n**3\\.9%/3% Compound Inflation with Shared Cost** Multiplier for 5%/5%\n\n**Age** Benefit Period Benefit Period Compound Inflation\n\n2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2-10yr BP LifeBP\n\n18-29 13.00 17.00 19.00 21.00 22.00 27.00 28.00 14.00 20.00 23.00 26.00 29.00 36.00 57.00 1.44 1.00\n\n30 14.00 18.00 20.00 22.00 23.00 28.00 29.00 15.00 21.00 24.00 28.00 31.00 38.00 60.00 1.40 1.00\n\n31 14.00 18.00 20.00 22.00 23.00 28.00 29.00 15.00 21.00 24.00 28.00 31.00 39.00 61.00 1.40 1.00\n\n32 14.00 19.00 21.00 23.00 24.00 29.00 30.00 16.00 22.00 24.00 29.00 32.00 39.00 62.00 1.40 1.00\n\n33 15.00 19.00 21.00 23.00 24.00 29.00 30.00 16.00 22.00 25.00 29.00 32.00 40.00 63.00 1.40 1.00\n\n34 15.00 19.00 21.00 23.00 24.00 30.00 31.00 16.00 22.00 26.00 30.00 33.00 40.00 64.00 1.40 1.00\n\n35 15.00 19.00 21.00 23.00 24.00 30.00 31.00 16.00 22.00 27.00 31.00 33.00 41.00 65.00 1.40 1.00\n\n36 16.00 20.00 22.00 24.00 25.00 31.00 32.00 17.00 23.00 27.00 31.00 34.00 41.00 66.00 1.40 1.00\n\n37 16.00 20.00 22.00 24.00 25.00 31.00 32.00 17.00 23.00 27.00 32.00 34.00 42.00 67.00 1.40 1.00\n\n38 16.00 20.00 22.00 24.00 25.00 31.00 33.00 17.00 23.00 28.00 32.00 34.00 42.00 68.00 1.40 1.00\n\n39 16.00 21.00 23.00 25.00 26.00 32.00 33.00 18.00 23.00 28.00 32.00 34.00 42.00 69.00 1.40 1.00\n\n40 16.00 21.00 23.00 25.00 26.00 32.00 34.00 19.00 24.00 30.00 34.00 36.00 44.00 70.00 1.35 1.00\n\n41 16.00 21.00 24.00 26.00 27.00 33.00 35.00 19.00 24.00 30.00 34.00 36.00 45.00 71.00 1.35 1.00\n\n42 17.00 22.00 24.00 26.00 28.00 34.00 37.00 20.00 25.00 30.00 35.00 37.00 45.00 72.00 1.35 1.00\n\n43 17.00 22.00 25.00 27.00 28.00 35.00 38.00 20.00 25.00 31.00 35.00 37.00 46.00 73.00 1.35 1.00\n\n44 17.00 23.00 26.00 28.00 29.00 37.00 39.00 20.00 25.00 31.00 35.00 38.00 47.00 74.00 1.35 1.00\n\n45 18.00 23.00 26.00 29.00 30.00 38.00 41.00 21.00 26.00 32.00 36.00 39.00 48.00 75.00 1.33 1.00\n\n46 18.00 24.00 27.00 30.00 31.00 39.00 42.00 21.00 27.00 32.00 37.00 40.00 48.00 76.00 1.33 1.00\n\n47 19.00 24.00 28.00 30.00 32.00 41.00 44.00 21.00 27.00 33.00 37.00 40.00 49.00 78.00 1.33 1.00\n\n48 19.00 25.00 28.00 31.00 33.00 42.00 46.00 21.00 28.00 33.00 38.00 40.00 49.00 79.00 1.33 1.00\n\n49 20.00 25.00 29.00 32.00 34.00 43.00 47.00 21.00 28.00 33.00 38.00 40.00 49.00 80.00 1.33 1.00\n\n50 20.00 26.00 30.00 33.00 35.00 45.00 49.00 22.00 29.00 34.00 39.00 41.00 51.00 81.00 1.30 1.00\n\n51 20.00 27.00 31.00 34.00 36.00 46.00 51.00 22.00 30.00 35.00 40.00 42.00 52.00 83.00 1.30 1.00\n\n52 21.00 28.00 32.00 36.00 38.00 48.00 53.00 23.00 31.00 36.00 41.00 43.00 53.00 86.00 1.29 1.00\n\n53 21.00 29.00 33.00 37.00 40.00 49.00 56.00 23.00 31.00 37.00 41.00 45.00 53.00 88.00 1.29 1.00\n\n54 22.00 31.00 34.00 39.00 42.00 51.00 58.00 24.00 32.00 38.00 42.00 46.00 54.00 90.00 1.28 1.00\n\n55 22.00 32.00 35.00 40.00 43.00 52.00 61.00 25.00 33.00 39.00 43.00 47.00 55.00 93.00 1.28 1.00\n\n56 24.00 34.00 37.00 42.00 46.00 55.00 64.00 26.00 35.00 40.00 45.00 49.00 58.00 96.00 1.26 1.00\n\n57 25.00 35.00 39.00 45.00 49.00 58.00 68.00 27.00 37.00 42.00 48.00 51.00 62.00 100.00 1.25 1.00\n\n58 27.00 37.00 42.00 47.00 52.00 62.00 71.00 28.00 39.00 44.00 51.00 54.00 65.00 103.00 1.23 1.00\n\n59 29.00 39.00 44.00 50.00 55.00 65.00 75.00 29.00 41.00 46.00 53.00 57.00 69.00 107.00 1.22 1.00\n\n60 31.00 41.00 47.00 53.00 59.00 69.00 79.00 30.00 43.00 48.00 56.00 60.00 73.00 111.00 1.20 1.00\n\n61 33.00 43.00 50.00 56.00 62.00 73.00 84.00 32.00 45.00 51.00 59.00 64.00 78.00 116.00 1.19 1.00\n\n62 35.00 46.00 52.00 59.00 65.00 77.00 89.00 35.00 48.00 55.00 62.00 67.00 82.00 120.00 1.18 1.00\n\n63 37.00 49.00 55.00 63.00 68.00 81.00 94.00 38.00 51.00 59.00 66.00 71.00 88.00 125.00 1.16 1.00\n\n64 40.00 52.00 58.00 66.00 71.00 86.00 100.00 41.00 54.00 63.00 70.00 76.00 93.00 131.00 1.15 1.00\n\n65 42.00 55.00 61.00 70.00 74.00 91.00 106.00 44.00 57.00 67.00 74.00 80.00 99.00 136.00 1.14 1.00\n\n66 46.00 60.00 67.00 77.00 81.00 99.00 115.00 48.00 62.00 73.00 81.00 87.00 107.00 144.00 1.13 1.00\n\n67 50.00 66.00 74.00 84.00 89.00 109.00 124.00 52.00 68.00 79.00 88.00 95.00 116.00 153.00 1.13 1.00\n\n68 55.00 72.00 81.00 92.00 98.00 119.00 135.00 57.00 73.00 85.00 96.00 104.00 126.00 163.00 1.12 1.00\n\n69 60.00 79.00 89.00 101.00 108.00 130.00 146.00 62.00 80.00 92.00 105.00 114.00 137.00 172.00 1.12 1.00\n\n70 66.00 86.00 98.00 111.00 119.00 142.00 158.00 67.00 87.00 100.00 114.00 124.00 148.00 183.00 1.11 1.00\n\n71 73.00 95.00 109.00 123.00 133.00 157.00 173.00 73.00 95.00 111.00 125.00 135.00 161.00 197.00 1.11 1.00\n\n72 81.00 106.00 120.00 137.00 148.00 173.00 190.00 80.00 104.00 123.00 138.00 148.00 174.00 212.00 1.11 1.00\n\n73 90.00 117.00 133.00 152.00 164.00 190.00 208.00 88.00 114.00 136.00 151.00 161.00 189.00 229.00 1.10 1.00\n\n74 99.00 130.00 148.00 168.00 183.00 210.00 227.00 97.00 125.00 151.00 166.00 176.00 205.00 246.00 1.10 1.00\n\n75 110.00 144.00 164.00 187.00 204.00 231.00 249.00 106.00 137.00 167.00 183.00 192.00 223.00 265.00 1.10 1.00\n\n76 121.00 158.00 180.00 205.00 224.00 254.00 274.00 116.00 151.00 183.00 201.00 211.00 245.00 291.00 1.10 1.00\n\n77 133.00 174.00 198.00 226.00 246.00 279.00 301.00 128.00 165.00 202.00 221.00 232.00 269.00 320.00 1.09 1.00\n\n78 146.00 191.00 217.00 248.00 270.00 306.00 330.00 141.00 182.00 221.00 243.00 255.00 296.00 351.00 1.09 1.00\n\n79 160.00 210.00 239.00 272.00 297.00 336.00 363.00 154.00 200.00 243.00 267.00 280.00 325.00 386.00 1.08 1.00\n\n80 176.00 230.00 262.00 299.00 326.00 370.00 0.00 170.00 219.00 267.00 293.00 307.00 357.00 424.00 1.08 1.00\n\n81 193.00 253.00 288.00 329.00 359.00 406.00 0.00 186.00 241.00 294.00 322.00 337.00 392.00 466.00 1.08 1.00\n\n82 212.00 278.00 317.00 361.00 394.00 446.00 0.00 205.00 265.00 322.00 353.00 371.00 431.00 512.00 1.08 1.00\n\n83 233.00 305.00 348.00 397.00 433.00 490.00 0.00 225.00 291.00 354.00 388.00 407.00 473.00 562.00 1.08 1.00\n\n84 256.00 336.00 382.00 436.00 475.00 538.00 0.00 247.00 319.00 389.00 426.00 447.00 520.00 618.00 1.08 1.00\n\n85 282.00 0.00 420.00 479.00 522.00 591.00 0.00 271.00 351.00 428.00 468.00 492.00 571.00 678.00 1.08 1.00\n\n86 309.00 0.00 461.00 526.00 574.00 650.00 0.00 298.00 385.00 470.00 515.00 540.00 627.00 745.00 1.08 1.00\n\n87 340.00 0.00 507.00 578.00 630.00 714.00 0.00 327.00 423.00 516.00 565.00 593.00 689.00 819.00 1.08 1.00\n\n88 373.00 0.00 557.00 635.00 692.00 784.00 0.00 360.00 465.00 567.00 621.00 652.00 757.00 899.00 1.08 1.00\n\n89 410.00 0.00 611.00 697.00 761.00 861.00 0.00 395.00 511.00 623.00 682.00 716.00 831.00 988.00 1.08 1.00\n\n90 451.00 0.00 0.00 0.00 0.00 0.00 0.00 434.00 561.00 684.00 750.00 786.00 913.00 1085.00 1.08 1.00\n\n91+ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.08 1.00\n\nRates shown below the line apply only to attained age GPO Inflation Adjustment offers, Shared Care 2-year purchases on exhaustion of benefits, and/or Family Care purchases See Appendix D for details on premium calculations for policyholders who elected the Shared Cost options Compound rates reflect rates with a 5% annual increase in monthly/daily benefits and a 3% increase in policy limit; rates reflecting a 5% annual increase in both benefit and policy limit are calculated by multiplying the rates in the table by the factors listed to the right","pages":[{"line_numbers":[],"markdown":"### **Appendix C2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **LTC-03 TX**\n\n**_Premiums to be used only with those that have previously elected an inflation decrease option_**\n\n### **Standard rates per $100 of Monthly Benefit**\n\n### **90 Day Elimination Period**\n\nTRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE ## TRUE TRUE\n\n**2\\.2% Simple Inflation or**\n\n**3\\.9% Simple Inflation with Shared Cost**\n\n**2\\.2%/3% Compound Inflation or**\n\n**3\\.9%/3% Compound Inflation with Shared Cost** Multiplier for 5%/5%\n\n**Age** Benefit Period Benefit Period Compound Inflation\n\n2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2-10yr BP LifeBP\n\n18-29 13.00 17.00 19.00 21.00 22.00 27.00 28.00 14.00 20.00 23.00 26.00 29.00 36.00 57.00 1.44 1.00\n\n30 14.00 18.00 20.00 22.00 23.00 28.00 29.00 15.00 21.00 24.00 28.00 31.00 38.00 60.00 1.40 1.00\n\n31 14.00 18.00 20.00 22.00 23.00 28.00 29.00 15.00 21.00 24.00 28.00 31.00 39.00 61.00 1.40 1.00\n\n32 14.00 19.00 21.00 23.00 24.00 29.00 30.00 16.00 22.00 24.00 29.00 32.00 39.00 62.00 1.40 1.00\n\n33 15.00 19.00 21.00 23.00 24.00 29.00 30.00 16.00 22.00 25.00 29.00 32.00 40.00 63.00 1.40 1.00\n\n34 15.00 19.00 21.00 23.00 24.00 30.00 31.00 16.00 22.00 26.00 30.00 33.00 40.00 64.00 1.40 1.00\n\n35 15.00 19.00 21.00 23.00 24.00 30.00 31.00 16.00 22.00 27.00 31.00 33.00 41.00 65.00 1.40 1.00\n\n36 16.00 20.00 22.00 24.00 25.00 31.00 32.00 17.00 23.00 27.00 31.00 34.00 41.00 66.00 1.40 1.00\n\n37 16.00 20.00 22.00 24.00 25.00 31.00 32.00 17.00 23.00 27.00 32.00 34.00 42.00 67.00 1.40 1.00\n\n38 16.00 20.00 22.00 24.00 25.00 31.00 33.00 17.00 23.00 28.00 32.00 34.00 42.00 68.00 1.40 1.00\n\n39 16.00 21.00 23.00 25.00 26.00 32.00 33.00 18.00 23.00 28.00 32.00 34.00 42.00 69.00 1.40 1.00\n\n40 16.00 21.00 23.00 25.00 26.00 32.00 34.00 19.00 24.00 30.00 34.00 36.00 44.00 70.00 1.35 1.00\n\n41 16.00 21.00 24.00 26.00 27.00 33.00 35.00 19.00 24.00 30.00 34.00 36.00 45.00 71.00 1.35 1.00\n\n42 17.00 22.00 24.00 26.00 28.00 34.00 37.00 20.00 25.00 30.00 35.00 37.00 45.00 72.00 1.35 1.00\n\n43 17.00 22.00 25.00 27.00 28.00 35.00 38.00 20.00 25.00 31.00 35.00 37.00 46.00 73.00 1.35 1.00\n\n44 17.00 23.00 26.00 28.00 29.00 37.00 39.00 20.00 25.00 31.00 35.00 38.00 47.00 74.00 1.35 1.00\n\n45 18.00 23.00 26.00 29.00 30.00 38.00 41.00 21.00 26.00 32.00 36.00 39.00 48.00 75.00 1.33 1.00\n\n46 18.00 24.00 27.00 30.00 31.00 39.00 42.00 21.00 27.00 32.00 37.00 40.00 48.00 76.00 1.33 1.00\n\n47 19.00 24.00 28.00 30.00 32.00 41.00 44.00 21.00 27.00 33.00 37.00 40.00 49.00 78.00 1.33 1.00\n\n48 19.00 25.00 28.00 31.00 33.00 42.00 46.00 21.00 28.00 33.00 38.00 40.00 49.00 79.00 1.33 1.00\n\n49 20.00 25.00 29.00 32.00 34.00 43.00 47.00 21.00 28.00 33.00 38.00 40.00 49.00 80.00 1.33 1.00\n\n50 20.00 26.00 30.00 33.00 35.00 45.00 49.00 22.00 29.00 34.00 39.00 41.00 51.00 81.00 1.30 1.00\n\n51 20.00 27.00 31.00 34.00 36.00 46.00 51.00 22.00 30.00 35.00 40.00 42.00 52.00 83.00 1.30 1.00\n\n52 21.00 28.00 32.00 36.00 38.00 48.00 53.00 23.00 31.00 36.00 41.00 43.00 53.00 86.00 1.29 1.00\n\n53 21.00 29.00 33.00 37.00 40.00 49.00 56.00 23.00 31.00 37.00 41.00 45.00 53.00 88.00 1.29 1.00\n\n54 22.00 31.00 34.00 39.00 42.00 51.00 58.00 24.00 32.00 38.00 42.00 46.00 54.00 90.00 1.28 1.00\n\n55 22.00 32.00 35.00 40.00 43.00 52.00 61.00 25.00 33.00 39.00 43.00 47.00 55.00 93.00 1.28 1.00\n\n56 24.00 34.00 37.00 42.00 46.00 55.00 64.00 26.00 35.00 40.00 45.00 49.00 58.00 96.00 1.26 1.00\n\n57 25.00 35.00 39.00 45.00 49.00 58.00 68.00 27.00 37.00 42.00 48.00 51.00 62.00 100.00 1.25 1.00\n\n58 27.00 37.00 42.00 47.00 52.00 62.00 71.00 28.00 39.00 44.00 51.00 54.00 65.00 103.00 1.23 1.00\n\n59 29.00 39.00 44.00 50.00 55.00 65.00 75.00 29.00 41.00 46.00 53.00 57.00 69.00 107.00 1.22 1.00\n\n60 31.00 41.00 47.00 53.00 59.00 69.00 79.00 30.00 43.00 48.00 56.00 60.00 73.00 111.00 1.20 1.00\n\n61 33.00 43.00 50.00 56.00 62.00 73.00 84.00 32.00 45.00 51.00 59.00 64.00 78.00 116.00 1.19 1.00\n\n62 35.00 46.00 52.00 59.00 65.00 77.00 89.00 35.00 48.00 55.00 62.00 67.00 82.00 120.00 1.18 1.00\n\n63 37.00 49.00 55.00 63.00 68.00 81.00 94.00 38.00 51.00 59.00 66.00 71.00 88.00 125.00 1.16 1.00\n\n64 40.00 52.00 58.00 66.00 71.00 86.00 100.00 41.00 54.00 63.00 70.00 76.00 93.00 131.00 1.15 1.00\n\n65 42.00 55.00 61.00 70.00 74.00 91.00 106.00 44.00 57.00 67.00 74.00 80.00 99.00 136.00 1.14 1.00\n\n66 46.00 60.00 67.00 77.00 81.00 99.00 115.00 48.00 62.00 73.00 81.00 87.00 107.00 144.00 1.13 1.00\n\n67 50.00 66.00 74.00 84.00 89.00 109.00 124.00 52.00 68.00 79.00 88.00 95.00 116.00 153.00 1.13 1.00\n\n68 55.00 72.00 81.00 92.00 98.00 119.00 135.00 57.00 73.00 85.00 96.00 104.00 126.00 163.00 1.12 1.00\n\n69 60.00 79.00 89.00 101.00 108.00 130.00 146.00 62.00 80.00 92.00 105.00 114.00 137.00 172.00 1.12 1.00\n\n70 66.00 86.00 98.00 111.00 119.00 142.00 158.00 67.00 87.00 100.00 114.00 124.00 148.00 183.00 1.11 1.00\n\n71 73.00 95.00 109.00 123.00 133.00 157.00 173.00 73.00 95.00 111.00 125.00 135.00 161.00 197.00 1.11 1.00\n\n72 81.00 106.00 120.00 137.00 148.00 173.00 190.00 80.00 104.00 123.00 138.00 148.00 174.00 212.00 1.11 1.00\n\n73 90.00 117.00 133.00 152.00 164.00 190.00 208.00 88.00 114.00 136.00 151.00 161.00 189.00 229.00 1.10 1.00\n\n74 99.00 130.00 148.00 168.00 183.00 210.00 227.00 97.00 125.00 151.00 166.00 176.00 205.00 246.00 1.10 1.00\n\n75 110.00 144.00 164.00 187.00 204.00 231.00 249.00 106.00 137.00 167.00 183.00 192.00 223.00 265.00 1.10 1.00\n\n76 121.00 158.00 180.00 205.00 224.00 254.00 274.00 116.00 151.00 183.00 201.00 211.00 245.00 291.00 1.10 1.00\n\n77 133.00 174.00 198.00 226.00 246.00 279.00 301.00 128.00 165.00 202.00 221.00 232.00 269.00 320.00 1.09 1.00\n\n78 146.00 191.00 217.00 248.00 270.00 306.00 330.00 141.00 182.00 221.00 243.00 255.00 296.00 351.00 1.09 1.00\n\n79 160.00 210.00 239.00 272.00 297.00 336.00 363.00 154.00 200.00 243.00 267.00 280.00 325.00 386.00 1.08 1.00\n\n80 176.00 230.00 262.00 299.00 326.00 370.00 0.00 170.00 219.00 267.00 293.00 307.00 357.00 424.00 1.08 1.00\n\n81 193.00 253.00 288.00 329.00 359.00 406.00 0.00 186.00 241.00 294.00 322.00 337.00 392.00 466.00 1.08 1.00\n\n82 212.00 278.00 317.00 361.00 394.00 446.00 0.00 205.00 265.00 322.00 353.00 371.00 431.00 512.00 1.08 1.00\n\n83 233.00 305.00 348.00 397.00 433.00 490.00 0.00 225.00 291.00 354.00 388.00 407.00 473.00 562.00 1.08 1.00\n\n84 256.00 336.00 382.00 436.00 475.00 538.00 0.00 247.00 319.00 389.00 426.00 447.00 520.00 618.00 1.08 1.00\n\n85 282.00 0.00 420.00 479.00 522.00 591.00 0.00 271.00 351.00 428.00 468.00 492.00 571.00 678.00 1.08 1.00\n\n86 309.00 0.00 461.00 526.00 574.00 650.00 0.00 298.00 385.00 470.00 515.00 540.00 627.00 745.00 1.08 1.00\n\n87 340.00 0.00 507.00 578.00 630.00 714.00 0.00 327.00 423.00 516.00 565.00 593.00 689.00 819.00 1.08 1.00\n\n88 373.00 0.00 557.00 635.00 692.00 784.00 0.00 360.00 465.00 567.00 621.00 652.00 757.00 899.00 1.08 1.00\n\n89 410.00 0.00 611.00 697.00 761.00 861.00 0.00 395.00 511.00 623.00 682.00 716.00 831.00 988.00 1.08 1.00\n\n90 451.00 0.00 0.00 0.00 0.00 0.00 0.00 434.00 561.00 684.00 750.00 786.00 913.00 1085.00 1.08 1.00\n\n91+ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.08 1.00\n\nRates shown below the line apply only to attained age GPO Inflation Adjustment offers, Shared Care 2-year purchases on exhaustion of benefits, and/or Family Care purchases See Appendix D for details on premium calculations for policyholders who elected the Shared Cost options Compound rates reflect rates with a 5% annual increase in monthly/daily benefits and a 3% increase in policy limit; rates reflecting a 5% annual increase in both benefit and policy limit are calculated by multiplying the rates in the table by the factors listed to the right","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Appendix C2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **LTC-03 TX**\n\n**_Premiums to be used only with those that have previously elected an inflation decrease option_**\n\n### **Standard rates per $100 of Monthly Benefit**\n\n### **90 Day Elimination Period**\n\nTRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE ## TRUE TRUE\n\n**2\\.2% Simple Inflation or**\n\n**3\\.9% Simple Inflation with Shared Cost**\n\n**2\\.2%/3% Compound Inflation or**\n\n**3\\.9%/3% Compound Inflation with Shared Cost** Multiplier for 5%/5%\n\n**Age** Benefit Period Benefit Period Compound Inflation\n\n2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2-10yr BP LifeBP\n\n18-29 13.00 17.00 19.00 21.00 22.00 27.00 28.00 14.00 20.00 23.00 26.00 29.00 36.00 57.00 1.44 1.00\n\n30 14.00 18.00 20.00 22.00 23.00 28.00 29.00 15.00 21.00 24.00 28.00 31.00 38.00 60.00 1.40 1.00\n\n31 14.00 18.00 20.00 22.00 23.00 28.00 29.00 15.00 21.00 24.00 28.00 31.00 39.00 61.00 1.40 1.00\n\n32 14.00 19.00 21.00 23.00 24.00 29.00 30.00 16.00 22.00 24.00 29.00 32.00 39.00 62.00 1.40 1.00\n\n33 15.00 19.00 21.00 23.00 24.00 29.00 30.00 16.00 22.00 25.00 29.00 32.00 40.00 63.00 1.40 1.00\n\n34 15.00 19.00 21.00 23.00 24.00 30.00 31.00 16.00 22.00 26.00 30.00 33.00 40.00 64.00 1.40 1.00\n\n35 15.00 19.00 21.00 23.00 24.00 30.00 31.00 16.00 22.00 27.00 31.00 33.00 41.00 65.00 1.40 1.00\n\n36 16.00 20.00 22.00 24.00 25.00 31.00 32.00 17.00 23.00 27.00 31.00 34.00 41.00 66.00 1.40 1.00\n\n37 16.00 20.00 22.00 24.00 25.00 31.00 32.00 17.00 23.00 27.00 32.00 34.00 42.00 67.00 1.40 1.00\n\n38 16.00 20.00 22.00 24.00 25.00 31.00 33.00 17.00 23.00 28.00 32.00 34.00 42.00 68.00 1.40 1.00\n\n39 16.00 21.00 23.00 25.00 26.00 32.00 33.00 18.00 23.00 28.00 32.00 34.00 42.00 69.00 1.40 1.00\n\n40 16.00 21.00 23.00 25.00 26.00 32.00 34.00 19.00 24.00 30.00 34.00 36.00 44.00 70.00 1.35 1.00\n\n41 16.00 21.00 24.00 26.00 27.00 33.00 35.00 19.00 24.00 30.00 34.00 36.00 45.00 71.00 1.35 1.00\n\n42 17.00 22.00 24.00 26.00 28.00 34.00 37.00 20.00 25.00 30.00 35.00 37.00 45.00 72.00 1.35 1.00\n\n43 17.00 22.00 25.00 27.00 28.00 35.00 38.00 20.00 25.00 31.00 35.00 37.00 46.00 73.00 1.35 1.00\n\n44 17.00 23.00 26.00 28.00 29.00 37.00 39.00 20.00 25.00 31.00 35.00 38.00 47.00 74.00 1.35 1.00\n\n45 18.00 23.00 26.00 29.00 30.00 38.00 41.00 21.00 26.00 32.00 36.00 39.00 48.00 75.00 1.33 1.00\n\n46 18.00 24.00 27.00 30.00 31.00 39.00 42.00 21.00 27.00 32.00 37.00 40.00 48.00 76.00 1.33 1.00\n\n47 19.00 24.00 28.00 30.00 32.00 41.00 44.00 21.00 27.00 33.00 37.00 40.00 49.00 78.00 1.33 1.00\n\n48 19.00 25.00 28.00 31.00 33.00 42.00 46.00 21.00 28.00 33.00 38.00 40.00 49.00 79.00 1.33 1.00\n\n49 20.00 25.00 29.00 32.00 34.00 43.00 47.00 21.00 28.00 33.00 38.00 40.00 49.00 80.00 1.33 1.00\n\n50 20.00 26.00 30.00 33.00 35.00 45.00 49.00 22.00 29.00 34.00 39.00 41.00 51.00 81.00 1.30 1.00\n\n51 20.00 27.00 31.00 34.00 36.00 46.00 51.00 22.00 30.00 35.00 40.00 42.00 52.00 83.00 1.30 1.00\n\n52 21.00 28.00 32.00 36.00 38.00 48.00 53.00 23.00 31.00 36.00 41.00 43.00 53.00 86.00 1.29 1.00\n\n53 21.00 29.00 33.00 37.00 40.00 49.00 56.00 23.00 31.00 37.00 41.00 45.00 53.00 88.00 1.29 1.00\n\n54 22.00 31.00 34.00 39.00 42.00 51.00 58.00 24.00 32.00 38.00 42.00 46.00 54.00 90.00 1.28 1.00\n\n55 22.00 32.00 35.00 40.00 43.00 52.00 61.00 25.00 33.00 39.00 43.00 47.00 55.00 93.00 1.28 1.00\n\n56 24.00 34.00 37.00 42.00 46.00 55.00 64.00 26.00 35.00 40.00 45.00 49.00 58.00 96.00 1.26 1.00\n\n57 25.00 35.00 39.00 45.00 49.00 58.00 68.00 27.00 37.00 42.00 48.00 51.00 62.00 100.00 1.25 1.00\n\n58 27.00 37.00 42.00 47.00 52.00 62.00 71.00 28.00 39.00 44.00 51.00 54.00 65.00 103.00 1.23 1.00\n\n59 29.00 39.00 44.00 50.00 55.00 65.00 75.00 29.00 41.00 46.00 53.00 57.00 69.00 107.00 1.22 1.00\n\n60 31.00 41.00 47.00 53.00 59.00 69.00 79.00 30.00 43.00 48.00 56.00 60.00 73.00 111.00 1.20 1.00\n\n61 33.00 43.00 50.00 56.00 62.00 73.00 84.00 32.00 45.00 51.00 59.00 64.00 78.00 116.00 1.19 1.00\n\n62 35.00 46.00 52.00 59.00 65.00 77.00 89.00 35.00 48.00 55.00 62.00 67.00 82.00 120.00 1.18 1.00\n\n63 37.00 49.00 55.00 63.00 68.00 81.00 94.00 38.00 51.00 59.00 66.00 71.00 88.00 125.00 1.16 1.00\n\n64 40.00 52.00 58.00 66.00 71.00 86.00 100.00 41.00 54.00 63.00 70.00 76.00 93.00 131.00 1.15 1.00\n\n65 42.00 55.00 61.00 70.00 74.00 91.00 106.00 44.00 57.00 67.00 74.00 80.00 99.00 136.00 1.14 1.00\n\n66 46.00 60.00 67.00 77.00 81.00 99.00 115.00 48.00 62.00 73.00 81.00 87.00 107.00 144.00 1.13 1.00\n\n67 50.00 66.00 74.00 84.00 89.00 109.00 124.00 52.00 68.00 79.00 88.00 95.00 116.00 153.00 1.13 1.00\n\n68 55.00 72.00 81.00 92.00 98.00 119.00 135.00 57.00 73.00 85.00 96.00 104.00 126.00 163.00 1.12 1.00\n\n69 60.00 79.00 89.00 101.00 108.00 130.00 146.00 62.00 80.00 92.00 105.00 114.00 137.00 172.00 1.12 1.00\n\n70 66.00 86.00 98.00 111.00 119.00 142.00 158.00 67.00 87.00 100.00 114.00 124.00 148.00 183.00 1.11 1.00\n\n71 73.00 95.00 109.00 123.00 133.00 157.00 173.00 73.00 95.00 111.00 125.00 135.00 161.00 197.00 1.11 1.00\n\n72 81.00 106.00 120.00 137.00 148.00 173.00 190.00 80.00 104.00 123.00 138.00 148.00 174.00 212.00 1.11 1.00\n\n73 90.00 117.00 133.00 152.00 164.00 190.00 208.00 88.00 114.00 136.00 151.00 161.00 189.00 229.00 1.10 1.00\n\n74 99.00 130.00 148.00 168.00 183.00 210.00 227.00 97.00 125.00 151.00 166.00 176.00 205.00 246.00 1.10 1.00\n\n75 110.00 144.00 164.00 187.00 204.00 231.00 249.00 106.00 137.00 167.00 183.00 192.00 223.00 265.00 1.10 1.00\n\n76 121.00 158.00 180.00 205.00 224.00 254.00 274.00 116.00 151.00 183.00 201.00 211.00 245.00 291.00 1.10 1.00\n\n77 133.00 174.00 198.00 226.00 246.00 279.00 301.00 128.00 165.00 202.00 221.00 232.00 269.00 320.00 1.09 1.00\n\n78 146.00 191.00 217.00 248.00 270.00 306.00 330.00 141.00 182.00 221.00 243.00 255.00 296.00 351.00 1.09 1.00\n\n79 160.00 210.00 239.00 272.00 297.00 336.00 363.00 154.00 200.00 243.00 267.00 280.00 325.00 386.00 1.08 1.00\n\n80 176.00 230.00 262.00 299.00 326.00 370.00 0.00 170.00 219.00 267.00 293.00 307.00 357.00 424.00 1.08 1.00\n\n81 193.00 253.00 288.00 329.00 359.00 406.00 0.00 186.00 241.00 294.00 322.00 337.00 392.00 466.00 1.08 1.00\n\n82 212.00 278.00 317.00 361.00 394.00 446.00 0.00 205.00 265.00 322.00 353.00 371.00 431.00 512.00 1.08 1.00\n\n83 233.00 305.00 348.00 397.00 433.00 490.00 0.00 225.00 291.00 354.00 388.00 407.00 473.00 562.00 1.08 1.00\n\n84 256.00 336.00 382.00 436.00 475.00 538.00 0.00 247.00 319.00 389.00 426.00 447.00 520.00 618.00 1.08 1.00\n\n85 282.00 0.00 420.00 479.00 522.00 591.00 0.00 271.00 351.00 428.00 468.00 492.00 571.00 678.00 1.08 1.00\n\n86 309.00 0.00 461.00 526.00 574.00 650.00 0.00 298.00 385.00 470.00 515.00 540.00 627.00 745.00 1.08 1.00\n\n87 340.00 0.00 507.00 578.00 630.00 714.00 0.00 327.00 423.00 516.00 565.00 593.00 689.00 819.00 1.08 1.00\n\n88 373.00 0.00 557.00 635.00 692.00 784.00 0.00 360.00 465.00 567.00 621.00 652.00 757.00 899.00 1.08 1.00\n\n89 410.00 0.00 611.00 697.00 761.00 861.00 0.00 395.00 511.00 623.00 682.00 716.00 831.00 988.00 1.08 1.00\n\n90 451.00 0.00 0.00 0.00 0.00 0.00 0.00 434.00 561.00 684.00 750.00 786.00 913.00 1085.00 1.08 1.00\n\n91+ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.08 1.00\n\nRates shown below the line apply only to attained age GPO Inflation Adjustment offers, Shared Care 2-year purchases on exhaustion of benefits, and/or Family Care purchases See Appendix D for details on premium calculations for policyholders who elected the Shared Cost options Compound rates reflect rates with a 5% annual increase in monthly/daily benefits and a 3% increase in policy limit; rates reflecting a 5% annual increase in both benefit and policy limit are calculated by multiplying the rates in the table by the factors listed to the right","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1075.pdf"]},"response":{"errors":[],"extract_id":"extract_03b4575981405176ee1be2c77256a6c4","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Appendix C2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **LTC-03 TX**\n\n**_Premiums to be used only with those that have previously elected an inflation decrease option_**\n\n### **Standard rates per $100 of Monthly Benefit**\n\n### **90 Day Elimination Period**\n\nTRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE ## TRUE TRUE\n\n**2\\.2% Simple Inflation or**\n\n**3\\.9% Simple Inflation with Shared Cost**\n\n**2\\.2%/3% Compound Inflation or**\n\n**3\\.9%/3% Compound Inflation with Shared Cost** Multiplier for 5%/5%\n\n**Age** Benefit Period Benefit Period Compound Inflation\n\n2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2-10yr BP LifeBP\n\n18-29 13.00 17.00 19.00 21.00 22.00 27.00 28.00 14.00 20.00 23.00 26.00 29.00 36.00 57.00 1.44 1.00\n\n30 14.00 18.00 20.00 22.00 23.00 28.00 29.00 15.00 21.00 24.00 28.00 31.00 38.00 60.00 1.40 1.00\n\n31 14.00 18.00 20.00 22.00 23.00 28.00 29.00 15.00 21.00 24.00 28.00 31.00 39.00 61.00 1.40 1.00\n\n32 14.00 19.00 21.00 23.00 24.00 29.00 30.00 16.00 22.00 24.00 29.00 32.00 39.00 62.00 1.40 1.00\n\n33 15.00 19.00 21.00 23.00 24.00 29.00 30.00 16.00 22.00 25.00 29.00 32.00 40.00 63.00 1.40 1.00\n\n34 15.00 19.00 21.00 23.00 24.00 30.00 31.00 16.00 22.00 26.00 30.00 33.00 40.00 64.00 1.40 1.00\n\n35 15.00 19.00 21.00 23.00 24.00 30.00 31.00 16.00 22.00 27.00 31.00 33.00 41.00 65.00 1.40 1.00\n\n36 16.00 20.00 22.00 24.00 25.00 31.00 32.00 17.00 23.00 27.00 31.00 34.00 41.00 66.00 1.40 1.00\n\n37 16.00 20.00 22.00 24.00 25.00 31.00 32.00 17.00 23.00 27.00 32.00 34.00 42.00 67.00 1.40 1.00\n\n38 16.00 20.00 22.00 24.00 25.00 31.00 33.00 17.00 23.00 28.00 32.00 34.00 42.00 68.00 1.40 1.00\n\n39 16.00 21.00 23.00 25.00 26.00 32.00 33.00 18.00 23.00 28.00 32.00 34.00 42.00 69.00 1.40 1.00\n\n40 16.00 21.00 23.00 25.00 26.00 32.00 34.00 19.00 24.00 30.00 34.00 36.00 44.00 70.00 1.35 1.00\n\n41 16.00 21.00 24.00 26.00 27.00 33.00 35.00 19.00 24.00 30.00 34.00 36.00 45.00 71.00 1.35 1.00\n\n42 17.00 22.00 24.00 26.00 28.00 34.00 37.00 20.00 25.00 30.00 35.00 37.00 45.00 72.00 1.35 1.00\n\n43 17.00 22.00 25.00 27.00 28.00 35.00 38.00 20.00 25.00 31.00 35.00 37.00 46.00 73.00 1.35 1.00\n\n44 17.00 23.00 26.00 28.00 29.00 37.00 39.00 20.00 25.00 31.00 35.00 38.00 47.00 74.00 1.35 1.00\n\n45 18.00 23.00 26.00 29.00 30.00 38.00 41.00 21.00 26.00 32.00 36.00 39.00 48.00 75.00 1.33 1.00\n\n46 18.00 24.00 27.00 30.00 31.00 39.00 42.00 21.00 27.00 32.00 37.00 40.00 48.00 76.00 1.33 1.00\n\n47 19.00 24.00 28.00 30.00 32.00 41.00 44.00 21.00 27.00 33.00 37.00 40.00 49.00 78.00 1.33 1.00\n\n48 19.00 25.00 28.00 31.00 33.00 42.00 46.00 21.00 28.00 33.00 38.00 40.00 49.00 79.00 1.33 1.00\n\n49 20.00 25.00 29.00 32.00 34.00 43.00 47.00 21.00 28.00 33.00 38.00 40.00 49.00 80.00 1.33 1.00\n\n50 20.00 26.00 30.00 33.00 35.00 45.00 49.00 22.00 29.00 34.00 39.00 41.00 51.00 81.00 1.30 1.00\n\n51 20.00 27.00 31.00 34.00 36.00 46.00 51.00 22.00 30.00 35.00 40.00 42.00 52.00 83.00 1.30 1.00\n\n52 21.00 28.00 32.00 36.00 38.00 48.00 53.00 23.00 31.00 36.00 41.00 43.00 53.00 86.00 1.29 1.00\n\n53 21.00 29.00 33.00 37.00 40.00 49.00 56.00 23.00 31.00 37.00 41.00 45.00 53.00 88.00 1.29 1.00\n\n54 22.00 31.00 34.00 39.00 42.00 51.00 58.00 24.00 32.00 38.00 42.00 46.00 54.00 90.00 1.28 1.00\n\n55 22.00 32.00 35.00 40.00 43.00 52.00 61.00 25.00 33.00 39.00 43.00 47.00 55.00 93.00 1.28 1.00\n\n56 24.00 34.00 37.00 42.00 46.00 55.00 64.00 26.00 35.00 40.00 45.00 49.00 58.00 96.00 1.26 1.00\n\n57 25.00 35.00 39.00 45.00 49.00 58.00 68.00 27.00 37.00 42.00 48.00 51.00 62.00 100.00 1.25 1.00\n\n58 27.00 37.00 42.00 47.00 52.00 62.00 71.00 28.00 39.00 44.00 51.00 54.00 65.00 103.00 1.23 1.00\n\n59 29.00 39.00 44.00 50.00 55.00 65.00 75.00 29.00 41.00 46.00 53.00 57.00 69.00 107.00 1.22 1.00\n\n60 31.00 41.00 47.00 53.00 59.00 69.00 79.00 30.00 43.00 48.00 56.00 60.00 73.00 111.00 1.20 1.00\n\n61 33.00 43.00 50.00 56.00 62.00 73.00 84.00 32.00 45.00 51.00 59.00 64.00 78.00 116.00 1.19 1.00\n\n62 35.00 46.00 52.00 59.00 65.00 77.00 89.00 35.00 48.00 55.00 62.00 67.00 82.00 120.00 1.18 1.00\n\n63 37.00 49.00 55.00 63.00 68.00 81.00 94.00 38.00 51.00 59.00 66.00 71.00 88.00 125.00 1.16 1.00\n\n64 40.00 52.00 58.00 66.00 71.00 86.00 100.00 41.00 54.00 63.00 70.00 76.00 93.00 131.00 1.15 1.00\n\n65 42.00 55.00 61.00 70.00 74.00 91.00 106.00 44.00 57.00 67.00 74.00 80.00 99.00 136.00 1.14 1.00\n\n66 46.00 60.00 67.00 77.00 81.00 99.00 115.00 48.00 62.00 73.00 81.00 87.00 107.00 144.00 1.13 1.00\n\n67 50.00 66.00 74.00 84.00 89.00 109.00 124.00 52.00 68.00 79.00 88.00 95.00 116.00 153.00 1.13 1.00\n\n68 55.00 72.00 81.00 92.00 98.00 119.00 135.00 57.00 73.00 85.00 96.00 104.00 126.00 163.00 1.12 1.00\n\n69 60.00 79.00 89.00 101.00 108.00 130.00 146.00 62.00 80.00 92.00 105.00 114.00 137.00 172.00 1.12 1.00\n\n70 66.00 86.00 98.00 111.00 119.00 142.00 158.00 67.00 87.00 100.00 114.00 124.00 148.00 183.00 1.11 1.00\n\n71 73.00 95.00 109.00 123.00 133.00 157.00 173.00 73.00 95.00 111.00 125.00 135.00 161.00 197.00 1.11 1.00\n\n72 81.00 106.00 120.00 137.00 148.00 173.00 190.00 80.00 104.00 123.00 138.00 148.00 174.00 212.00 1.11 1.00\n\n73 90.00 117.00 133.00 152.00 164.00 190.00 208.00 88.00 114.00 136.00 151.00 161.00 189.00 229.00 1.10 1.00\n\n74 99.00 130.00 148.00 168.00 183.00 210.00 227.00 97.00 125.00 151.00 166.00 176.00 205.00 246.00 1.10 1.00\n\n75 110.00 144.00 164.00 187.00 204.00 231.00 249.00 106.00 137.00 167.00 183.00 192.00 223.00 265.00 1.10 1.00\n\n76 121.00 158.00 180.00 205.00 224.00 254.00 274.00 116.00 151.00 183.00 201.00 211.00 245.00 291.00 1.10 1.00\n\n77 133.00 174.00 198.00 226.00 246.00 279.00 301.00 128.00 165.00 202.00 221.00 232.00 269.00 320.00 1.09 1.00\n\n78 146.00 191.00 217.00 248.00 270.00 306.00 330.00 141.00 182.00 221.00 243.00 255.00 296.00 351.00 1.09 1.00\n\n79 160.00 210.00 239.00 272.00 297.00 336.00 363.00 154.00 200.00 243.00 267.00 280.00 325.00 386.00 1.08 1.00\n\n80 176.00 230.00 262.00 299.00 326.00 370.00 0.00 170.00 219.00 267.00 293.00 307.00 357.00 424.00 1.08 1.00\n\n81 193.00 253.00 288.00 329.00 359.00 406.00 0.00 186.00 241.00 294.00 322.00 337.00 392.00 466.00 1.08 1.00\n\n82 212.00 278.00 317.00 361.00 394.00 446.00 0.00 205.00 265.00 322.00 353.00 371.00 431.00 512.00 1.08 1.00\n\n83 233.00 305.00 348.00 397.00 433.00 490.00 0.00 225.00 291.00 354.00 388.00 407.00 473.00 562.00 1.08 1.00\n\n84 256.00 336.00 382.00 436.00 475.00 538.00 0.00 247.00 319.00 389.00 426.00 447.00 520.00 618.00 1.08 1.00\n\n85 282.00 0.00 420.00 479.00 522.00 591.00 0.00 271.00 351.00 428.00 468.00 492.00 571.00 678.00 1.08 1.00\n\n86 309.00 0.00 461.00 526.00 574.00 650.00 0.00 298.00 385.00 470.00 515.00 540.00 627.00 745.00 1.08 1.00\n\n87 340.00 0.00 507.00 578.00 630.00 714.00 0.00 327.00 423.00 516.00 565.00 593.00 689.00 819.00 1.08 1.00\n\n88 373.00 0.00 557.00 635.00 692.00 784.00 0.00 360.00 465.00 567.00 621.00 652.00 757.00 899.00 1.08 1.00\n\n89 410.00 0.00 611.00 697.00 761.00 861.00 0.00 395.00 511.00 623.00 682.00 716.00 831.00 988.00 1.08 1.00\n\n90 451.00 0.00 0.00 0.00 0.00 0.00 0.00 434.00 561.00 684.00 750.00 786.00 913.00 1085.00 1.08 1.00\n\n91+ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.08 1.00\n\nRates shown below the line apply only to attained age GPO Inflation Adjustment offers, Shared Care 2-year purchases on exhaustion of benefits, and/or Family Care purchases See Appendix D for details on premium calculations for policyholders who elected the Shared Cost options Compound rates reflect rates with a 5% annual increase in monthly/daily benefits and a 3% increase in policy limit; rates reflecting a 5% annual increase in both benefit and policy limit are calculated by multiplying the rates in the table by the factors listed to the right"],"full_content":"### **Appendix C2**\n\n### **John Hancock Life Insurance Company (U.S.A.)**\n\n### **LTC-03 TX**\n\n**_Premiums to be used only with those that have previously elected an inflation decrease option_**\n\n### **Standard rates per $100 of Monthly Benefit**\n\n### **90 Day Elimination Period**\n\nTRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE TRUE ## TRUE TRUE\n\n**2\\.2% Simple Inflation or**\n\n**3\\.9% Simple Inflation with Shared Cost**\n\n**2\\.2%/3% Compound Inflation or**\n\n**3\\.9%/3% Compound Inflation with Shared Cost** Multiplier for 5%/5%\n\n**Age** Benefit Period Benefit Period Compound Inflation\n\n2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2 Years 3 Years 4 Years 5 Years 6 Years 10 Years Life 2-10yr BP LifeBP\n\n18-29 13.00 17.00 19.00 21.00 22.00 27.00 28.00 14.00 20.00 23.00 26.00 29.00 36.00 57.00 1.44 1.00\n\n30 14.00 18.00 20.00 22.00 23.00 28.00 29.00 15.00 21.00 24.00 28.00 31.00 38.00 60.00 1.40 1.00\n\n31 14.00 18.00 20.00 22.00 23.00 28.00 29.00 15.00 21.00 24.00 28.00 31.00 39.00 61.00 1.40 1.00\n\n32 14.00 19.00 21.00 23.00 24.00 29.00 30.00 16.00 22.00 24.00 29.00 32.00 39.00 62.00 1.40 1.00\n\n33 15.00 19.00 21.00 23.00 24.00 29.00 30.00 16.00 22.00 25.00 29.00 32.00 40.00 63.00 1.40 1.00\n\n34 15.00 19.00 21.00 23.00 24.00 30.00 31.00 16.00 22.00 26.00 30.00 33.00 40.00 64.00 1.40 1.00\n\n35 15.00 19.00 21.00 23.00 24.00 30.00 31.00 16.00 22.00 27.00 31.00 33.00 41.00 65.00 1.40 1.00\n\n36 16.00 20.00 22.00 24.00 25.00 31.00 32.00 17.00 23.00 27.00 31.00 34.00 41.00 66.00 1.40 1.00\n\n37 16.00 20.00 22.00 24.00 25.00 31.00 32.00 17.00 23.00 27.00 32.00 34.00 42.00 67.00 1.40 1.00\n\n38 16.00 20.00 22.00 24.00 25.00 31.00 33.00 17.00 23.00 28.00 32.00 34.00 42.00 68.00 1.40 1.00\n\n39 16.00 21.00 23.00 25.00 26.00 32.00 33.00 18.00 23.00 28.00 32.00 34.00 42.00 69.00 1.40 1.00\n\n40 16.00 21.00 23.00 25.00 26.00 32.00 34.00 19.00 24.00 30.00 34.00 36.00 44.00 70.00 1.35 1.00\n\n41 16.00 21.00 24.00 26.00 27.00 33.00 35.00 19.00 24.00 30.00 34.00 36.00 45.00 71.00 1.35 1.00\n\n42 17.00 22.00 24.00 26.00 28.00 34.00 37.00 20.00 25.00 30.00 35.00 37.00 45.00 72.00 1.35 1.00\n\n43 17.00 22.00 25.00 27.00 28.00 35.00 38.00 20.00 25.00 31.00 35.00 37.00 46.00 73.00 1.35 1.00\n\n44 17.00 23.00 26.00 28.00 29.00 37.00 39.00 20.00 25.00 31.00 35.00 38.00 47.00 74.00 1.35 1.00\n\n45 18.00 23.00 26.00 29.00 30.00 38.00 41.00 21.00 26.00 32.00 36.00 39.00 48.00 75.00 1.33 1.00\n\n46 18.00 24.00 27.00 30.00 31.00 39.00 42.00 21.00 27.00 32.00 37.00 40.00 48.00 76.00 1.33 1.00\n\n47 19.00 24.00 28.00 30.00 32.00 41.00 44.00 21.00 27.00 33.00 37.00 40.00 49.00 78.00 1.33 1.00\n\n48 19.00 25.00 28.00 31.00 33.00 42.00 46.00 21.00 28.00 33.00 38.00 40.00 49.00 79.00 1.33 1.00\n\n49 20.00 25.00 29.00 32.00 34.00 43.00 47.00 21.00 28.00 33.00 38.00 40.00 49.00 80.00 1.33 1.00\n\n50 20.00 26.00 30.00 33.00 35.00 45.00 49.00 22.00 29.00 34.00 39.00 41.00 51.00 81.00 1.30 1.00\n\n51 20.00 27.00 31.00 34.00 36.00 46.00 51.00 22.00 30.00 35.00 40.00 42.00 52.00 83.00 1.30 1.00\n\n52 21.00 28.00 32.00 36.00 38.00 48.00 53.00 23.00 31.00 36.00 41.00 43.00 53.00 86.00 1.29 1.00\n\n53 21.00 29.00 33.00 37.00 40.00 49.00 56.00 23.00 31.00 37.00 41.00 45.00 53.00 88.00 1.29 1.00\n\n54 22.00 31.00 34.00 39.00 42.00 51.00 58.00 24.00 32.00 38.00 42.00 46.00 54.00 90.00 1.28 1.00\n\n55 22.00 32.00 35.00 40.00 43.00 52.00 61.00 25.00 33.00 39.00 43.00 47.00 55.00 93.00 1.28 1.00\n\n56 24.00 34.00 37.00 42.00 46.00 55.00 64.00 26.00 35.00 40.00 45.00 49.00 58.00 96.00 1.26 1.00\n\n57 25.00 35.00 39.00 45.00 49.00 58.00 68.00 27.00 37.00 42.00 48.00 51.00 62.00 100.00 1.25 1.00\n\n58 27.00 37.00 42.00 47.00 52.00 62.00 71.00 28.00 39.00 44.00 51.00 54.00 65.00 103.00 1.23 1.00\n\n59 29.00 39.00 44.00 50.00 55.00 65.00 75.00 29.00 41.00 46.00 53.00 57.00 69.00 107.00 1.22 1.00\n\n60 31.00 41.00 47.00 53.00 59.00 69.00 79.00 30.00 43.00 48.00 56.00 60.00 73.00 111.00 1.20 1.00\n\n61 33.00 43.00 50.00 56.00 62.00 73.00 84.00 32.00 45.00 51.00 59.00 64.00 78.00 116.00 1.19 1.00\n\n62 35.00 46.00 52.00 59.00 65.00 77.00 89.00 35.00 48.00 55.00 62.00 67.00 82.00 120.00 1.18 1.00\n\n63 37.00 49.00 55.00 63.00 68.00 81.00 94.00 38.00 51.00 59.00 66.00 71.00 88.00 125.00 1.16 1.00\n\n64 40.00 52.00 58.00 66.00 71.00 86.00 100.00 41.00 54.00 63.00 70.00 76.00 93.00 131.00 1.15 1.00\n\n65 42.00 55.00 61.00 70.00 74.00 91.00 106.00 44.00 57.00 67.00 74.00 80.00 99.00 136.00 1.14 1.00\n\n66 46.00 60.00 67.00 77.00 81.00 99.00 115.00 48.00 62.00 73.00 81.00 87.00 107.00 144.00 1.13 1.00\n\n67 50.00 66.00 74.00 84.00 89.00 109.00 124.00 52.00 68.00 79.00 88.00 95.00 116.00 153.00 1.13 1.00\n\n68 55.00 72.00 81.00 92.00 98.00 119.00 135.00 57.00 73.00 85.00 96.00 104.00 126.00 163.00 1.12 1.00\n\n69 60.00 79.00 89.00 101.00 108.00 130.00 146.00 62.00 80.00 92.00 105.00 114.00 137.00 172.00 1.12 1.00\n\n70 66.00 86.00 98.00 111.00 119.00 142.00 158.00 67.00 87.00 100.00 114.00 124.00 148.00 183.00 1.11 1.00\n\n71 73.00 95.00 109.00 123.00 133.00 157.00 173.00 73.00 95.00 111.00 125.00 135.00 161.00 197.00 1.11 1.00\n\n72 81.00 106.00 120.00 137.00 148.00 173.00 190.00 80.00 104.00 123.00 138.00 148.00 174.00 212.00 1.11 1.00\n\n73 90.00 117.00 133.00 152.00 164.00 190.00 208.00 88.00 114.00 136.00 151.00 161.00 189.00 229.00 1.10 1.00\n\n74 99.00 130.00 148.00 168.00 183.00 210.00 227.00 97.00 125.00 151.00 166.00 176.00 205.00 246.00 1.10 1.00\n\n75 110.00 144.00 164.00 187.00 204.00 231.00 249.00 106.00 137.00 167.00 183.00 192.00 223.00 265.00 1.10 1.00\n\n76 121.00 158.00 180.00 205.00 224.00 254.00 274.00 116.00 151.00 183.00 201.00 211.00 245.00 291.00 1.10 1.00\n\n77 133.00 174.00 198.00 226.00 246.00 279.00 301.00 128.00 165.00 202.00 221.00 232.00 269.00 320.00 1.09 1.00\n\n78 146.00 191.00 217.00 248.00 270.00 306.00 330.00 141.00 182.00 221.00 243.00 255.00 296.00 351.00 1.09 1.00\n\n79 160.00 210.00 239.00 272.00 297.00 336.00 363.00 154.00 200.00 243.00 267.00 280.00 325.00 386.00 1.08 1.00\n\n80 176.00 230.00 262.00 299.00 326.00 370.00 0.00 170.00 219.00 267.00 293.00 307.00 357.00 424.00 1.08 1.00\n\n81 193.00 253.00 288.00 329.00 359.00 406.00 0.00 186.00 241.00 294.00 322.00 337.00 392.00 466.00 1.08 1.00\n\n82 212.00 278.00 317.00 361.00 394.00 446.00 0.00 205.00 265.00 322.00 353.00 371.00 431.00 512.00 1.08 1.00\n\n83 233.00 305.00 348.00 397.00 433.00 490.00 0.00 225.00 291.00 354.00 388.00 407.00 473.00 562.00 1.08 1.00\n\n84 256.00 336.00 382.00 436.00 475.00 538.00 0.00 247.00 319.00 389.00 426.00 447.00 520.00 618.00 1.08 1.00\n\n85 282.00 0.00 420.00 479.00 522.00 591.00 0.00 271.00 351.00 428.00 468.00 492.00 571.00 678.00 1.08 1.00\n\n86 309.00 0.00 461.00 526.00 574.00 650.00 0.00 298.00 385.00 470.00 515.00 540.00 627.00 745.00 1.08 1.00\n\n87 340.00 0.00 507.00 578.00 630.00 714.00 0.00 327.00 423.00 516.00 565.00 593.00 689.00 819.00 1.08 1.00\n\n88 373.00 0.00 557.00 635.00 692.00 784.00 0.00 360.00 465.00 567.00 621.00 652.00 757.00 899.00 1.08 1.00\n\n89 410.00 0.00 611.00 697.00 761.00 861.00 0.00 395.00 511.00 623.00 682.00 716.00 831.00 988.00 1.08 1.00\n\n90 451.00 0.00 0.00 0.00 0.00 0.00 0.00 434.00 561.00 684.00 750.00 786.00 913.00 1085.00 1.08 1.00\n\n91+ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.08 1.00\n\nRates shown below the line apply only to attained age GPO Inflation Adjustment offers, Shared Care 2-year purchases on exhaustion of benefits, and/or Family Care purchases See Appendix D for details on premium calculations for policyholders who elected the Shared Cost options Compound rates reflect rates with a 5% annual increase in monthly/daily benefits and a 3% increase in policy limit; rates reflecting a 5% annual increase in both benefit and policy limit are calculated by multiplying the rates in the table by the factors listed to the right","publish_date":null,"title":"Appendix C2","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1075.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1075.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1075","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1075.pdf"},"started_at":"2026-11-04T19:48:16.485203"} +{"completed_at":"2026-11-04T19:48:20.466516","latency_in_ms":2925,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1124","grounded_pages":[],"layout_pages":[],"markdown":"PHYSICIANS MUTUAL INSURANCE COMPANY Table of Rates Medicare Supplement Policy\n\nPlan C Texas 2012\n\nAutomatic Bank Withdrawal Base Premiums\n\nISSUES PRIOR\n\nTO\n\nJul 31, 2000\n\nAge Attained\n\nAge\n\n65 $195.70\n\n66 $201.40\n\n67 $210.05\n\n68 $217.40\n\n69 $222.70\n\n70 $228.20\n\n71 $233.20\n\n72 $237.90\n\n73 $241.75\n\n74 $245.65\n\n75 $249.55\n\n76 $253.40\n\n77 $257.25\n\n78 $261.35\n\n79 $265.55\n\n80 $269.60\n\n81 $275.95\n\n82 $280.45\n\n83 $284.75\n\n84 $289.20\n\n85 $293.75\n\n86 $298.40\n\n87 $303.05\n\n88 $308.00\n\n89 $312.90\n\n90 $315.10\n\n91 $320.20\n\n92 $325.40\n\n93 $330.60\n\n94 $335.70\n\n95 $341.25\n\n96 $346.45\n\n97 $352.20\n\n98 $357.70\n\n99 $363.60\n\nPlease refer to CORE-TX- 011398 for areas and factors.\n\nISSUES ON OR\n\nAFTER\n\nAug 1, 2000\n\nAge Attained\n\nAge\n\n65 $175.25\n\n66 $182.10\n\n67 $190.05\n\n68 $195.65\n\n69 $200.90\n\n70 $206.15\n\n71 $211.00\n\n72 $215.65\n\n73 $219.85\n\n74 $223.70\n\n75 $227.75\n\n76 $231.65\n\n77 $235.85\n\n78 $239.85\n\n79 $244.20\n\n80 $248.60\n\n81 $254.85\n\n82 $259.50\n\n83 $263.90\n\n84 $268.60\n\n85 $273.40\n\n86 $278.40\n\n87 $283.40\n\n88 $288.55\n\n89 $293.75\n\n90 $296.30\n\n91 $301.60\n\n92 $307.15\n\n93 $312.65\n\n94 $318.20\n\n95 $324.15\n\n96 $329.80\n\n97 $335.80\n\n98 $341.70\n\n99 $347.95\n\nPlease refer to AREA -STD- 071205 for areas and factors.\n\nPlease refer to TOBACCO-STD- 010903 for areas and factors.\n\nTo obtain Monthly rates, add $5 to the above quoted Automatic Bank Withdrawal rates. To obtain Quarterly, Semi-Annual, and Annual rates, multiply the above quoted Automatic Bank Withdrawal by 3, 6 and 12 respectively.\n\nPage 1 of 1","pages":[{"line_numbers":[],"markdown":"PHYSICIANS MUTUAL INSURANCE COMPANY Table of Rates Medicare Supplement Policy\n\nPlan C Texas 2012\n\nAutomatic Bank Withdrawal Base Premiums\n\nISSUES PRIOR\n\nTO\n\nJul 31, 2000\n\nAge Attained\n\nAge\n\n65 $195.70\n\n66 $201.40\n\n67 $210.05\n\n68 $217.40\n\n69 $222.70\n\n70 $228.20\n\n71 $233.20\n\n72 $237.90\n\n73 $241.75\n\n74 $245.65\n\n75 $249.55\n\n76 $253.40\n\n77 $257.25\n\n78 $261.35\n\n79 $265.55\n\n80 $269.60\n\n81 $275.95\n\n82 $280.45\n\n83 $284.75\n\n84 $289.20\n\n85 $293.75\n\n86 $298.40\n\n87 $303.05\n\n88 $308.00\n\n89 $312.90\n\n90 $315.10\n\n91 $320.20\n\n92 $325.40\n\n93 $330.60\n\n94 $335.70\n\n95 $341.25\n\n96 $346.45\n\n97 $352.20\n\n98 $357.70\n\n99 $363.60\n\nPlease refer to CORE-TX- 011398 for areas and factors.\n\nISSUES ON OR\n\nAFTER\n\nAug 1, 2000\n\nAge Attained\n\nAge\n\n65 $175.25\n\n66 $182.10\n\n67 $190.05\n\n68 $195.65\n\n69 $200.90\n\n70 $206.15\n\n71 $211.00\n\n72 $215.65\n\n73 $219.85\n\n74 $223.70\n\n75 $227.75\n\n76 $231.65\n\n77 $235.85\n\n78 $239.85\n\n79 $244.20\n\n80 $248.60\n\n81 $254.85\n\n82 $259.50\n\n83 $263.90\n\n84 $268.60\n\n85 $273.40\n\n86 $278.40\n\n87 $283.40\n\n88 $288.55\n\n89 $293.75\n\n90 $296.30\n\n91 $301.60\n\n92 $307.15\n\n93 $312.65\n\n94 $318.20\n\n95 $324.15\n\n96 $329.80\n\n97 $335.80\n\n98 $341.70\n\n99 $347.95\n\nPlease refer to AREA -STD- 071205 for areas and factors.\n\nPlease refer to TOBACCO-STD- 010903 for areas and factors.\n\nTo obtain Monthly rates, add $5 to the above quoted Automatic Bank Withdrawal rates. To obtain Quarterly, Semi-Annual, and Annual rates, multiply the above quoted Automatic Bank Withdrawal by 3, 6 and 12 respectively.\n\nPage 1 of 1","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"PHYSICIANS MUTUAL INSURANCE COMPANY Table of Rates Medicare Supplement Policy\n\nPlan C Texas 2012\n\nAutomatic Bank Withdrawal Base Premiums\n\nISSUES PRIOR\n\nTO\n\nJul 31, 2000\n\nAge Attained\n\nAge\n\n65 $195.70\n\n66 $201.40\n\n67 $210.05\n\n68 $217.40\n\n69 $222.70\n\n70 $228.20\n\n71 $233.20\n\n72 $237.90\n\n73 $241.75\n\n74 $245.65\n\n75 $249.55\n\n76 $253.40\n\n77 $257.25\n\n78 $261.35\n\n79 $265.55\n\n80 $269.60\n\n81 $275.95\n\n82 $280.45\n\n83 $284.75\n\n84 $289.20\n\n85 $293.75\n\n86 $298.40\n\n87 $303.05\n\n88 $308.00\n\n89 $312.90\n\n90 $315.10\n\n91 $320.20\n\n92 $325.40\n\n93 $330.60\n\n94 $335.70\n\n95 $341.25\n\n96 $346.45\n\n97 $352.20\n\n98 $357.70\n\n99 $363.60\n\nPlease refer to CORE-TX- 011398 for areas and factors.\n\nISSUES ON OR\n\nAFTER\n\nAug 1, 2000\n\nAge Attained\n\nAge\n\n65 $175.25\n\n66 $182.10\n\n67 $190.05\n\n68 $195.65\n\n69 $200.90\n\n70 $206.15\n\n71 $211.00\n\n72 $215.65\n\n73 $219.85\n\n74 $223.70\n\n75 $227.75\n\n76 $231.65\n\n77 $235.85\n\n78 $239.85\n\n79 $244.20\n\n80 $248.60\n\n81 $254.85\n\n82 $259.50\n\n83 $263.90\n\n84 $268.60\n\n85 $273.40\n\n86 $278.40\n\n87 $283.40\n\n88 $288.55\n\n89 $293.75\n\n90 $296.30\n\n91 $301.60\n\n92 $307.15\n\n93 $312.65\n\n94 $318.20\n\n95 $324.15\n\n96 $329.80\n\n97 $335.80\n\n98 $341.70\n\n99 $347.95\n\nPlease refer to AREA -STD- 071205 for areas and factors.\n\nPlease refer to TOBACCO-STD- 010903 for areas and factors.\n\nTo obtain Monthly rates, add $5 to the above quoted Automatic Bank Withdrawal rates. To obtain Quarterly, Semi-Annual, and Annual rates, multiply the above quoted Automatic Bank Withdrawal by 3, 6 and 12 respectively.\n\nPage 1 of 1","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1124.pdf"]},"response":{"errors":[],"extract_id":"extract_656406c24394069ffcbb7e084aed09c9","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["PHYSICIANS MUTUAL INSURANCE COMPANY Table of Rates Medicare Supplement Policy\n\nPlan C Texas 2012\n\nAutomatic Bank Withdrawal Base Premiums\n\nISSUES PRIOR\n\nTO\n\nJul 31, 2000\n\nAge Attained\n\nAge\n\n65 $195.70\n\n66 $201.40\n\n67 $210.05\n\n68 $217.40\n\n69 $222.70\n\n70 $228.20\n\n71 $233.20\n\n72 $237.90\n\n73 $241.75\n\n74 $245.65\n\n75 $249.55\n\n76 $253.40\n\n77 $257.25\n\n78 $261.35\n\n79 $265.55\n\n80 $269.60\n\n81 $275.95\n\n82 $280.45\n\n83 $284.75\n\n84 $289.20\n\n85 $293.75\n\n86 $298.40\n\n87 $303.05\n\n88 $308.00\n\n89 $312.90\n\n90 $315.10\n\n91 $320.20\n\n92 $325.40\n\n93 $330.60\n\n94 $335.70\n\n95 $341.25\n\n96 $346.45\n\n97 $352.20\n\n98 $357.70\n\n99 $363.60\n\nPlease refer to CORE-TX- 011398 for areas and factors.\n\nISSUES ON OR\n\nAFTER\n\nAug 1, 2000\n\nAge Attained\n\nAge\n\n65 $175.25\n\n66 $182.10\n\n67 $190.05\n\n68 $195.65\n\n69 $200.90\n\n70 $206.15\n\n71 $211.00\n\n72 $215.65\n\n73 $219.85\n\n74 $223.70\n\n75 $227.75\n\n76 $231.65\n\n77 $235.85\n\n78 $239.85\n\n79 $244.20\n\n80 $248.60\n\n81 $254.85\n\n82 $259.50\n\n83 $263.90\n\n84 $268.60\n\n85 $273.40\n\n86 $278.40\n\n87 $283.40\n\n88 $288.55\n\n89 $293.75\n\n90 $296.30\n\n91 $301.60\n\n92 $307.15\n\n93 $312.65\n\n94 $318.20\n\n95 $324.15\n\n96 $329.80\n\n97 $335.80\n\n98 $341.70\n\n99 $347.95\n\nPlease refer to AREA -STD- 071205 for areas and factors.\n\nPlease refer to TOBACCO-STD- 010903 for areas and factors.\n\nTo obtain Monthly rates, add $5 to the above quoted Automatic Bank Withdrawal rates. To obtain Quarterly, Semi-Annual, and Annual rates, multiply the above quoted Automatic Bank Withdrawal by 3, 6 and 12 respectively.\n\nPage 1 of 1"],"full_content":"PHYSICIANS MUTUAL INSURANCE COMPANY Table of Rates Medicare Supplement Policy\n\nPlan C Texas 2012\n\nAutomatic Bank Withdrawal Base Premiums\n\nISSUES PRIOR\n\nTO\n\nJul 31, 2000\n\nAge Attained\n\nAge\n\n65 $195.70\n\n66 $201.40\n\n67 $210.05\n\n68 $217.40\n\n69 $222.70\n\n70 $228.20\n\n71 $233.20\n\n72 $237.90\n\n73 $241.75\n\n74 $245.65\n\n75 $249.55\n\n76 $253.40\n\n77 $257.25\n\n78 $261.35\n\n79 $265.55\n\n80 $269.60\n\n81 $275.95\n\n82 $280.45\n\n83 $284.75\n\n84 $289.20\n\n85 $293.75\n\n86 $298.40\n\n87 $303.05\n\n88 $308.00\n\n89 $312.90\n\n90 $315.10\n\n91 $320.20\n\n92 $325.40\n\n93 $330.60\n\n94 $335.70\n\n95 $341.25\n\n96 $346.45\n\n97 $352.20\n\n98 $357.70\n\n99 $363.60\n\nPlease refer to CORE-TX- 011398 for areas and factors.\n\nISSUES ON OR\n\nAFTER\n\nAug 1, 2000\n\nAge Attained\n\nAge\n\n65 $175.25\n\n66 $182.10\n\n67 $190.05\n\n68 $195.65\n\n69 $200.90\n\n70 $206.15\n\n71 $211.00\n\n72 $215.65\n\n73 $219.85\n\n74 $223.70\n\n75 $227.75\n\n76 $231.65\n\n77 $235.85\n\n78 $239.85\n\n79 $244.20\n\n80 $248.60\n\n81 $254.85\n\n82 $259.50\n\n83 $263.90\n\n84 $268.60\n\n85 $273.40\n\n86 $278.40\n\n87 $283.40\n\n88 $288.55\n\n89 $293.75\n\n90 $296.30\n\n91 $301.60\n\n92 $307.15\n\n93 $312.65\n\n94 $318.20\n\n95 $324.15\n\n96 $329.80\n\n97 $335.80\n\n98 $341.70\n\n99 $347.95\n\nPlease refer to AREA -STD- 071205 for areas and factors.\n\nPlease refer to TOBACCO-STD- 010903 for areas and factors.\n\nTo obtain Monthly rates, add $5 to the above quoted Automatic Bank Withdrawal rates. To obtain Quarterly, Semi-Annual, and Annual rates, multiply the above quoted Automatic Bank Withdrawal by 3, 6 and 12 respectively.\n\nPage 1 of 1","publish_date":null,"title":"PHYSICIANS MUTUAL INSURANCE COMPANY Table of Rates Medicare Supplement Policy Plan C Texas 2012 Automatic Bank Withdrawal Base Premiums ISSUES","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1124.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1124.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1124","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1124.pdf"},"started_at":"2026-11-04T19:48:17.541424"} +{"completed_at":"2026-11-04T19:48:21.289429","latency_in_ms":1928,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1139","grounded_pages":[],"layout_pages":[],"markdown":"Issue Age Discount Year One\n\n65 42.0%\n\n66 39.2%\n\n67 36.4%\n\n68 33.6%\n\n69 30.8%\n\n70 28.0%\n\n71 25.2%\n\n72 22.4%\n\n73 19.6%\n\n74 16.8%\n\n75 14.0%\n\n76 11.2%\n\n77 8.4%\n\n78 5.6%\n\n79 2.8%\n\n80+ 0.0%\n\nDiscounts in subsequent years will be reduced by 2.8% for each year until the discount reaches 0% at age 80. (For example, the discount for a 66 year old who was issued at age 65 will be 39.2%).\n\nEARLYENROLLMENT-SPECIAL-04222016\n\n**EARLY ENROLLMENT DISCOUNT**\n\n**AGENT SOLICITED BUSINESS**\n\n**PHYSICIANS MUTUAL INSURANCE COMPANY**\n\n2600 DODGE STREET\n\nOMAHA, NEBRASKA 68131\n\n**MEDICARE SUPPLEMENT**","pages":[{"line_numbers":[],"markdown":"Issue Age Discount Year One\n\n65 42.0%\n\n66 39.2%\n\n67 36.4%\n\n68 33.6%\n\n69 30.8%\n\n70 28.0%\n\n71 25.2%\n\n72 22.4%\n\n73 19.6%\n\n74 16.8%\n\n75 14.0%\n\n76 11.2%\n\n77 8.4%\n\n78 5.6%\n\n79 2.8%\n\n80+ 0.0%\n\nDiscounts in subsequent years will be reduced by 2.8% for each year until the discount reaches 0% at age 80. (For example, the discount for a 66 year old who was issued at age 65 will be 39.2%).\n\nEARLYENROLLMENT-SPECIAL-04222016\n\n**EARLY ENROLLMENT DISCOUNT**\n\n**AGENT SOLICITED BUSINESS**\n\n**PHYSICIANS MUTUAL INSURANCE COMPANY**\n\n2600 DODGE STREET\n\nOMAHA, NEBRASKA 68131\n\n**MEDICARE SUPPLEMENT**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Issue Age Discount Year One\n\n65 42.0%\n\n66 39.2%\n\n67 36.4%\n\n68 33.6%\n\n69 30.8%\n\n70 28.0%\n\n71 25.2%\n\n72 22.4%\n\n73 19.6%\n\n74 16.8%\n\n75 14.0%\n\n76 11.2%\n\n77 8.4%\n\n78 5.6%\n\n79 2.8%\n\n80+ 0.0%\n\nDiscounts in subsequent years will be reduced by 2.8% for each year until the discount reaches 0% at age 80. (For example, the discount for a 66 year old who was issued at age 65 will be 39.2%).\n\nEARLYENROLLMENT-SPECIAL-04222016\n\n**EARLY ENROLLMENT DISCOUNT**\n\n**AGENT SOLICITED BUSINESS**\n\n**PHYSICIANS MUTUAL INSURANCE COMPANY**\n\n2600 DODGE STREET\n\nOMAHA, NEBRASKA 68131\n\n**MEDICARE SUPPLEMENT**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1139.pdf"]},"response":{"errors":[],"extract_id":"extract_f81e117c62f6d6fe0ec36389c08a5ea9","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Issue Age Discount Year One\n\n65 42.0%\n\n66 39.2%\n\n67 36.4%\n\n68 33.6%\n\n69 30.8%\n\n70 28.0%\n\n71 25.2%\n\n72 22.4%\n\n73 19.6%\n\n74 16.8%\n\n75 14.0%\n\n76 11.2%\n\n77 8.4%\n\n78 5.6%\n\n79 2.8%\n\n80+ 0.0%\n\nDiscounts in subsequent years will be reduced by 2.8% for each year until the discount reaches 0% at age 80. (For example, the discount for a 66 year old who was issued at age 65 will be 39.2%).\n\nEARLYENROLLMENT-SPECIAL-04222016\n\n**EARLY ENROLLMENT DISCOUNT**\n\n**AGENT SOLICITED BUSINESS**\n\n**PHYSICIANS MUTUAL INSURANCE COMPANY**\n\n2600 DODGE STREET\n\nOMAHA, NEBRASKA 68131\n\n**MEDICARE SUPPLEMENT**"],"full_content":"Issue Age Discount Year One\n\n65 42.0%\n\n66 39.2%\n\n67 36.4%\n\n68 33.6%\n\n69 30.8%\n\n70 28.0%\n\n71 25.2%\n\n72 22.4%\n\n73 19.6%\n\n74 16.8%\n\n75 14.0%\n\n76 11.2%\n\n77 8.4%\n\n78 5.6%\n\n79 2.8%\n\n80+ 0.0%\n\nDiscounts in subsequent years will be reduced by 2.8% for each year until the discount reaches 0% at age 80. (For example, the discount for a 66 year old who was issued at age 65 will be 39.2%).\n\nEARLYENROLLMENT-SPECIAL-04222016\n\n**EARLY ENROLLMENT DISCOUNT**\n\n**AGENT SOLICITED BUSINESS**\n\n**PHYSICIANS MUTUAL INSURANCE COMPANY**\n\n2600 DODGE STREET\n\nOMAHA, NEBRASKA 68131\n\n**MEDICARE SUPPLEMENT**","publish_date":null,"title":"PHYSICIANS MUTUAL INSURANCE COMPANY 2600 DODGE STREET OMAHA, NEBRASKA 68131 MEDICARE SUPPLEMENT EARLY ENROLLMENT DISCOUNT AGENT SOLICITED BUSINESS Issue Age","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1139.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1139.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1139","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1139.pdf"},"started_at":"2026-11-04T19:48:19.360880"} +{"completed_at":"2026-11-04T19:48:22.073322","latency_in_ms":1603,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1168","grounded_pages":[],"layout_pages":[],"markdown":"### **PHYSICIANS MUTUAL INSURANCE COMPANY**\n\n2600 DODGE STREET OMAHA, NEBRASKA 68131\n\n**MEDICARE SUPPLEMENT TOBACCO RATE FACTORS AGENT-SOLD AND DIRECT RESPONSE BUSINESS**\n\nFactors\n\nNon-Tobacco 1.00\n\nTobacco 1.12\n\nTOBACCO-STD-010903","pages":[{"line_numbers":[],"markdown":"### **PHYSICIANS MUTUAL INSURANCE COMPANY**\n\n2600 DODGE STREET OMAHA, NEBRASKA 68131\n\n**MEDICARE SUPPLEMENT TOBACCO RATE FACTORS AGENT-SOLD AND DIRECT RESPONSE BUSINESS**\n\nFactors\n\nNon-Tobacco 1.00\n\nTobacco 1.12\n\nTOBACCO-STD-010903","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **PHYSICIANS MUTUAL INSURANCE COMPANY**\n\n2600 DODGE STREET OMAHA, NEBRASKA 68131\n\n**MEDICARE SUPPLEMENT TOBACCO RATE FACTORS AGENT-SOLD AND DIRECT RESPONSE BUSINESS**\n\nFactors\n\nNon-Tobacco 1.00\n\nTobacco 1.12\n\nTOBACCO-STD-010903","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1168.pdf"]},"response":{"errors":[],"extract_id":"extract_fb4f06d77676691ef0878b31c8426153","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **PHYSICIANS MUTUAL INSURANCE COMPANY**\n\n2600 DODGE STREET OMAHA, NEBRASKA 68131\n\n**MEDICARE SUPPLEMENT TOBACCO RATE FACTORS AGENT-SOLD AND DIRECT RESPONSE BUSINESS**\n\nFactors\n\nNon-Tobacco 1.00\n\nTobacco 1.12\n\nTOBACCO-STD-010903"],"full_content":"### **PHYSICIANS MUTUAL INSURANCE COMPANY**\n\n2600 DODGE STREET OMAHA, NEBRASKA 68131\n\n**MEDICARE SUPPLEMENT TOBACCO RATE FACTORS AGENT-SOLD AND DIRECT RESPONSE BUSINESS**\n\nFactors\n\nNon-Tobacco 1.00\n\nTobacco 1.12\n\nTOBACCO-STD-010903","publish_date":null,"title":"PHYSICIANS MUTUAL INSURANCE COMPANY","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1168.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1168.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1168","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1168.pdf"},"started_at":"2026-11-04T19:48:20.470096"} +{"completed_at":"2026-11-04T19:48:22.713785","latency_in_ms":1105,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1193","grounded_pages":[],"layout_pages":[],"markdown":"**TEXAS COMMERCIAL LINES MANUAL DIVISION SIX – GENERAL LIABILITY STATE EXCEPTION PAGES ENERGI PROGRAM**\n\n**GAIC-GL-TX (Edition 08-15) Page 2 of 6 HDI-GERLING AMERICA INSURANCE COMPANY**\n\n**RATING PLANS** **EXPECTED LOSS RATIO** The Expected Loss Ratio (ELR) below is applicable to the following ISO plans:  Experience and Schedule Rating Plan  Retrospective Rating Plan  Composite Rating Plan\n\n**Coverage ELR\\***\n\nGeneral Liability 0.712\n\n\\* ELR - Includes ALAE and excludes ULAE","pages":[{"line_numbers":[],"markdown":"**TEXAS COMMERCIAL LINES MANUAL DIVISION SIX – GENERAL LIABILITY STATE EXCEPTION PAGES ENERGI PROGRAM**\n\n**GAIC-GL-TX (Edition 08-15) Page 2 of 6 HDI-GERLING AMERICA INSURANCE COMPANY**\n\n**RATING PLANS** **EXPECTED LOSS RATIO** The Expected Loss Ratio (ELR) below is applicable to the following ISO plans:  Experience and Schedule Rating Plan  Retrospective Rating Plan  Composite Rating Plan\n\n**Coverage ELR\\***\n\nGeneral Liability 0.712\n\n\\* ELR - Includes ALAE and excludes ULAE","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**TEXAS COMMERCIAL LINES MANUAL DIVISION SIX – GENERAL LIABILITY STATE EXCEPTION PAGES ENERGI PROGRAM**\n\n**GAIC-GL-TX (Edition 08-15) Page 2 of 6 HDI-GERLING AMERICA INSURANCE COMPANY**\n\n**RATING PLANS** **EXPECTED LOSS RATIO** The Expected Loss Ratio (ELR) below is applicable to the following ISO plans:  Experience and Schedule Rating Plan  Retrospective Rating Plan  Composite Rating Plan\n\n**Coverage ELR\\***\n\nGeneral Liability 0.712\n\n\\* ELR - Includes ALAE and excludes ULAE","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1193.pdf"]},"response":{"errors":[],"extract_id":"extract_edbd6a4dd828997ec62b3d0e859b97f6","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**TEXAS COMMERCIAL LINES MANUAL DIVISION SIX – GENERAL LIABILITY STATE EXCEPTION PAGES ENERGI PROGRAM**\n\n**GAIC-GL-TX (Edition 08-15) Page 2 of 6 HDI-GERLING AMERICA INSURANCE COMPANY**\n\n**RATING PLANS** **EXPECTED LOSS RATIO** The Expected Loss Ratio (ELR) below is applicable to the following ISO plans:  Experience and Schedule Rating Plan  Retrospective Rating Plan  Composite Rating Plan\n\n**Coverage ELR\\***\n\nGeneral Liability 0.712\n\n\\* ELR - Includes ALAE and excludes ULAE"],"full_content":"**TEXAS COMMERCIAL LINES MANUAL DIVISION SIX – GENERAL LIABILITY STATE EXCEPTION PAGES ENERGI PROGRAM**\n\n**GAIC-GL-TX (Edition 08-15) Page 2 of 6 HDI-GERLING AMERICA INSURANCE COMPANY**\n\n**RATING PLANS** **EXPECTED LOSS RATIO** The Expected Loss Ratio (ELR) below is applicable to the following ISO plans:  Experience and Schedule Rating Plan  Retrospective Rating Plan  Composite Rating Plan\n\n**Coverage ELR\\***\n\nGeneral Liability 0.712\n\n\\* ELR - Includes ALAE and excludes ULAE","publish_date":null,"title":"TEXAS COMMERCIAL LINES MANUAL DIVISION SIX – GENERAL LIABILITY STATE EXCEPTION PAGES ENERGI PROGRAM RATING PLANS EXPECTED LOSS RATIO The","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1193.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1193.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1193","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1193.pdf"},"started_at":"2026-11-04T19:48:21.608717"} +{"completed_at":"2026-11-04T19:48:24.261776","latency_in_ms":1406,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1197","grounded_pages":[],"layout_pages":[],"markdown":"ISO GL RT GL 2002‐BGLI\n\nCommercial General Liability Revision of Basic Limit Loss Costs For Premises & Operations (Subline Code 334) and Products & Completed Operations (Subline Code 336) 9212430090 64685 Pitaktong 2/17/2003\n\nISO GL RT RP 2002‐RGLRP\n\nIntroduction of the Latest Version of the ISO Retrospective Rating Plan for the Division Six ‐ General Liability Line of Business Only in Texas 9212428398 63785 Pitaktong 6/20/2002\n\nISO GL RT GL 2001‐OTA01 Relocation of Increased Limits Table Assignments 9212423035 61348 Pitaktong 4/5/2002\n\nISO GL RT GL 2001‐BGL1 Revision of Basic Limit Loss Costs For Prem/Ops and Prod/Cops 9212416753 58337 Pitaktong 11/20/2001\n\nISO GL RT GL 2000‐BGL1 Revision of Basic Limit Loss Costs for Prem/Ops & Prod/Cops 9212407949 53912 Pitaktong 12/5/2000\n\nISO GL RT RP 99‐R98CR Composite Rating Plan for General Liability 9212403515 51536 Pitaktong 10/24/2000\n\nISO GL RT RP 99‐RCGL1 Commercial GL Experience and Schedule Rating Plan for 01/01/2000 Tort Reform. 9212403791 51717 Presley 12/3/1999\n\nISO GL RT GL 99‐RTREL Estimated Loss Potentials for Tort Reform Effective 01/01/2000 9212403433 51490 Wu 11/17/1999 ISO GL RT GL 99‐RTR99 Loss Costs for Tort Reform 01/01/2000 9212403432 51489 Wu 11/17/1999 TDI‐92‐400 GL PLC (General Liability) TDI 94‐400 GLBAS (General Liability) Basic Limits Loss Costs TDI 94‐400 GLILF (General Liability) Increased Limits TDI 94‐400 GLGOV (General Liability) Gov't Subdivisions TDI‐95‐400‐GL PLC Anticipated Savings from Tort Reform\n\nRevision of Basic Limit Loss Costs‐Division Six of CLM TDI‐95‐400‐GL PELP Anticipated Savings from Tort Reform Revision of Basic Limit Advisory Prospective Estimated Loss Potentials TDI 95 400 GL BLLC\n\nISO RT GL 95‐RTREL Presley 10/16/1995\n\nISO RT GL 95‐RTR95 Presley 10/16/1995\n\nISO RT GL 93‐BGOV1 Gleba 10/26/1994\n\nISO RT GL 94‐TALL1 Gleba 10/26/1994\n\nISO RT GL 94‐TALL1 Gleba 10/26/1994\n\nISO RT ISO GL 92‐TALL 2 Actuary 1992\n\nTDI‐95‐400‐GL BLLC Anticipated Savings from Tort Reform\n\nRevision of Basic Limit Loss Costs‐Division Six of CLM TDI‐95‐457‐ISO RP Revision of the Commercial General Liability Experience and Schedule Rating Plan Anticipated Savings from Tort Reform TDI‐97‐400‐GL‐ISO‐BLLC Revision of Basic Limit Loss Costs for Prem/Ops & Products Completed Ops Reflecting Revised Tort Reform Factors TDI‐97‐400‐GL‐ISO‐ELP Revision of Basic Limit Advisory Prospective Estimated Loss Potentials (ELPs) Reflecting Revised Tort Reform Factors TDI‐97‐457‐GL‐RP Revision to the CGL Experience and Schedule Rating Plan 17‐100 to Reflect 1998 Tort Reform Reduction Percentages TDI‐98‐400‐ISO‐PLC Revision of Basic Limit Loss Costs for Prem/Ops and Products/Completed Ops Division Six General Liability of CLM TDI‐98‐457‐ISO‐RP Experience and Schedule Rating Plan TDI‐98‐400‐ELP Addition of Estimated Loss Potentials (ELPs) TDI‐98‐400‐ISO‐IL Increased Limit Factors and Deductible Discount Factors TDI‐98‐400‐GLLC‐CT Loss Cost Filing Reflecting Revised Classification Tables\n\nISO RT GL 96‐ILDD1 Attoh‐Okine 3/12/1998\n\nISO RT GL 96‐REP1 Attoh‐Okine 3/12/1998\n\nISO RP RP 97‐R97GL Attoh‐Okine 3/12/1998\n\nISO RT GL 96‐BGL1 Attoh‐Okine 3/6/1998\n\nISO RP RP 97‐RCGL1 Ryder 12/10/1997\n\nISO RT GL 97‐RTREL Ryder 12/8/1997\n\nISO RT GL 97‐ RTR97 Ryder 12/8/1997\n\nISO RP RP 95‐RGL1 Yorty 11/21/1995\n\nISO RT GL 95‐RTR92 Presley 10/16/1995","pages":[{"line_numbers":[],"markdown":"ISO GL RT GL 2002‐BGLI\n\nCommercial General Liability Revision of Basic Limit Loss Costs For Premises & Operations (Subline Code 334) and Products & Completed Operations (Subline Code 336) 9212430090 64685 Pitaktong 2/17/2003\n\nISO GL RT RP 2002‐RGLRP\n\nIntroduction of the Latest Version of the ISO Retrospective Rating Plan for the Division Six ‐ General Liability Line of Business Only in Texas 9212428398 63785 Pitaktong 6/20/2002\n\nISO GL RT GL 2001‐OTA01 Relocation of Increased Limits Table Assignments 9212423035 61348 Pitaktong 4/5/2002\n\nISO GL RT GL 2001‐BGL1 Revision of Basic Limit Loss Costs For Prem/Ops and Prod/Cops 9212416753 58337 Pitaktong 11/20/2001\n\nISO GL RT GL 2000‐BGL1 Revision of Basic Limit Loss Costs for Prem/Ops & Prod/Cops 9212407949 53912 Pitaktong 12/5/2000\n\nISO GL RT RP 99‐R98CR Composite Rating Plan for General Liability 9212403515 51536 Pitaktong 10/24/2000\n\nISO GL RT RP 99‐RCGL1 Commercial GL Experience and Schedule Rating Plan for 01/01/2000 Tort Reform. 9212403791 51717 Presley 12/3/1999\n\nISO GL RT GL 99‐RTREL Estimated Loss Potentials for Tort Reform Effective 01/01/2000 9212403433 51490 Wu 11/17/1999 ISO GL RT GL 99‐RTR99 Loss Costs for Tort Reform 01/01/2000 9212403432 51489 Wu 11/17/1999 TDI‐92‐400 GL PLC (General Liability) TDI 94‐400 GLBAS (General Liability) Basic Limits Loss Costs TDI 94‐400 GLILF (General Liability) Increased Limits TDI 94‐400 GLGOV (General Liability) Gov't Subdivisions TDI‐95‐400‐GL PLC Anticipated Savings from Tort Reform\n\nRevision of Basic Limit Loss Costs‐Division Six of CLM TDI‐95‐400‐GL PELP Anticipated Savings from Tort Reform Revision of Basic Limit Advisory Prospective Estimated Loss Potentials TDI 95 400 GL BLLC\n\nISO RT GL 95‐RTREL Presley 10/16/1995\n\nISO RT GL 95‐RTR95 Presley 10/16/1995\n\nISO RT GL 93‐BGOV1 Gleba 10/26/1994\n\nISO RT GL 94‐TALL1 Gleba 10/26/1994\n\nISO RT GL 94‐TALL1 Gleba 10/26/1994\n\nISO RT ISO GL 92‐TALL 2 Actuary 1992\n\nTDI‐95‐400‐GL BLLC Anticipated Savings from Tort Reform\n\nRevision of Basic Limit Loss Costs‐Division Six of CLM TDI‐95‐457‐ISO RP Revision of the Commercial General Liability Experience and Schedule Rating Plan Anticipated Savings from Tort Reform TDI‐97‐400‐GL‐ISO‐BLLC Revision of Basic Limit Loss Costs for Prem/Ops & Products Completed Ops Reflecting Revised Tort Reform Factors TDI‐97‐400‐GL‐ISO‐ELP Revision of Basic Limit Advisory Prospective Estimated Loss Potentials (ELPs) Reflecting Revised Tort Reform Factors TDI‐97‐457‐GL‐RP Revision to the CGL Experience and Schedule Rating Plan 17‐100 to Reflect 1998 Tort Reform Reduction Percentages TDI‐98‐400‐ISO‐PLC Revision of Basic Limit Loss Costs for Prem/Ops and Products/Completed Ops Division Six General Liability of CLM TDI‐98‐457‐ISO‐RP Experience and Schedule Rating Plan TDI‐98‐400‐ELP Addition of Estimated Loss Potentials (ELPs) TDI‐98‐400‐ISO‐IL Increased Limit Factors and Deductible Discount Factors TDI‐98‐400‐GLLC‐CT Loss Cost Filing Reflecting Revised Classification Tables\n\nISO RT GL 96‐ILDD1 Attoh‐Okine 3/12/1998\n\nISO RT GL 96‐REP1 Attoh‐Okine 3/12/1998\n\nISO RP RP 97‐R97GL Attoh‐Okine 3/12/1998\n\nISO RT GL 96‐BGL1 Attoh‐Okine 3/6/1998\n\nISO RP RP 97‐RCGL1 Ryder 12/10/1997\n\nISO RT GL 97‐RTREL Ryder 12/8/1997\n\nISO RT GL 97‐ RTR97 Ryder 12/8/1997\n\nISO RP RP 95‐RGL1 Yorty 11/21/1995\n\nISO RT GL 95‐RTR92 Presley 10/16/1995","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"ISO GL RT GL 2002‐BGLI\n\nCommercial General Liability Revision of Basic Limit Loss Costs For Premises & Operations (Subline Code 334) and Products & Completed Operations (Subline Code 336) 9212430090 64685 Pitaktong 2/17/2003\n\nISO GL RT RP 2002‐RGLRP\n\nIntroduction of the Latest Version of the ISO Retrospective Rating Plan for the Division Six ‐ General Liability Line of Business Only in Texas 9212428398 63785 Pitaktong 6/20/2002\n\nISO GL RT GL 2001‐OTA01 Relocation of Increased Limits Table Assignments 9212423035 61348 Pitaktong 4/5/2002\n\nISO GL RT GL 2001‐BGL1 Revision of Basic Limit Loss Costs For Prem/Ops and Prod/Cops 9212416753 58337 Pitaktong 11/20/2001\n\nISO GL RT GL 2000‐BGL1 Revision of Basic Limit Loss Costs for Prem/Ops & Prod/Cops 9212407949 53912 Pitaktong 12/5/2000\n\nISO GL RT RP 99‐R98CR Composite Rating Plan for General Liability 9212403515 51536 Pitaktong 10/24/2000\n\nISO GL RT RP 99‐RCGL1 Commercial GL Experience and Schedule Rating Plan for 01/01/2000 Tort Reform. 9212403791 51717 Presley 12/3/1999\n\nISO GL RT GL 99‐RTREL Estimated Loss Potentials for Tort Reform Effective 01/01/2000 9212403433 51490 Wu 11/17/1999 ISO GL RT GL 99‐RTR99 Loss Costs for Tort Reform 01/01/2000 9212403432 51489 Wu 11/17/1999 TDI‐92‐400 GL PLC (General Liability) TDI 94‐400 GLBAS (General Liability) Basic Limits Loss Costs TDI 94‐400 GLILF (General Liability) Increased Limits TDI 94‐400 GLGOV (General Liability) Gov't Subdivisions TDI‐95‐400‐GL PLC Anticipated Savings from Tort Reform\n\nRevision of Basic Limit Loss Costs‐Division Six of CLM TDI‐95‐400‐GL PELP Anticipated Savings from Tort Reform Revision of Basic Limit Advisory Prospective Estimated Loss Potentials TDI 95 400 GL BLLC\n\nISO RT GL 95‐RTREL Presley 10/16/1995\n\nISO RT GL 95‐RTR95 Presley 10/16/1995\n\nISO RT GL 93‐BGOV1 Gleba 10/26/1994\n\nISO RT GL 94‐TALL1 Gleba 10/26/1994\n\nISO RT GL 94‐TALL1 Gleba 10/26/1994\n\nISO RT ISO GL 92‐TALL 2 Actuary 1992\n\nTDI‐95‐400‐GL BLLC Anticipated Savings from Tort Reform\n\nRevision of Basic Limit Loss Costs‐Division Six of CLM TDI‐95‐457‐ISO RP Revision of the Commercial General Liability Experience and Schedule Rating Plan Anticipated Savings from Tort Reform TDI‐97‐400‐GL‐ISO‐BLLC Revision of Basic Limit Loss Costs for Prem/Ops & Products Completed Ops Reflecting Revised Tort Reform Factors TDI‐97‐400‐GL‐ISO‐ELP Revision of Basic Limit Advisory Prospective Estimated Loss Potentials (ELPs) Reflecting Revised Tort Reform Factors TDI‐97‐457‐GL‐RP Revision to the CGL Experience and Schedule Rating Plan 17‐100 to Reflect 1998 Tort Reform Reduction Percentages TDI‐98‐400‐ISO‐PLC Revision of Basic Limit Loss Costs for Prem/Ops and Products/Completed Ops Division Six General Liability of CLM TDI‐98‐457‐ISO‐RP Experience and Schedule Rating Plan TDI‐98‐400‐ELP Addition of Estimated Loss Potentials (ELPs) TDI‐98‐400‐ISO‐IL Increased Limit Factors and Deductible Discount Factors TDI‐98‐400‐GLLC‐CT Loss Cost Filing Reflecting Revised Classification Tables\n\nISO RT GL 96‐ILDD1 Attoh‐Okine 3/12/1998\n\nISO RT GL 96‐REP1 Attoh‐Okine 3/12/1998\n\nISO RP RP 97‐R97GL Attoh‐Okine 3/12/1998\n\nISO RT GL 96‐BGL1 Attoh‐Okine 3/6/1998\n\nISO RP RP 97‐RCGL1 Ryder 12/10/1997\n\nISO RT GL 97‐RTREL Ryder 12/8/1997\n\nISO RT GL 97‐ RTR97 Ryder 12/8/1997\n\nISO RP RP 95‐RGL1 Yorty 11/21/1995\n\nISO RT GL 95‐RTR92 Presley 10/16/1995","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1197.pdf"]},"response":{"errors":[],"extract_id":"extract_9adb0603ddbd84b2d473694d836056c1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["ISO GL RT GL 2002‐BGLI\n\nCommercial General Liability Revision of Basic Limit Loss Costs For Premises & Operations (Subline Code 334) and Products & Completed Operations (Subline Code 336) 9212430090 64685 Pitaktong 2/17/2003\n\nISO GL RT RP 2002‐RGLRP\n\nIntroduction of the Latest Version of the ISO Retrospective Rating Plan for the Division Six ‐ General Liability Line of Business Only in Texas 9212428398 63785 Pitaktong 6/20/2002\n\nISO GL RT GL 2001‐OTA01 Relocation of Increased Limits Table Assignments 9212423035 61348 Pitaktong 4/5/2002\n\nISO GL RT GL 2001‐BGL1 Revision of Basic Limit Loss Costs For Prem/Ops and Prod/Cops 9212416753 58337 Pitaktong 11/20/2001\n\nISO GL RT GL 2000‐BGL1 Revision of Basic Limit Loss Costs for Prem/Ops & Prod/Cops 9212407949 53912 Pitaktong 12/5/2000\n\nISO GL RT RP 99‐R98CR Composite Rating Plan for General Liability 9212403515 51536 Pitaktong 10/24/2000\n\nISO GL RT RP 99‐RCGL1 Commercial GL Experience and Schedule Rating Plan for 01/01/2000 Tort Reform. 9212403791 51717 Presley 12/3/1999\n\nISO GL RT GL 99‐RTREL Estimated Loss Potentials for Tort Reform Effective 01/01/2000 9212403433 51490 Wu 11/17/1999 ISO GL RT GL 99‐RTR99 Loss Costs for Tort Reform 01/01/2000 9212403432 51489 Wu 11/17/1999 TDI‐92‐400 GL PLC (General Liability) TDI 94‐400 GLBAS (General Liability) Basic Limits Loss Costs TDI 94‐400 GLILF (General Liability) Increased Limits TDI 94‐400 GLGOV (General Liability) Gov't Subdivisions TDI‐95‐400‐GL PLC Anticipated Savings from Tort Reform\n\nRevision of Basic Limit Loss Costs‐Division Six of CLM TDI‐95‐400‐GL PELP Anticipated Savings from Tort Reform Revision of Basic Limit Advisory Prospective Estimated Loss Potentials TDI 95 400 GL BLLC\n\nISO RT GL 95‐RTREL Presley 10/16/1995\n\nISO RT GL 95‐RTR95 Presley 10/16/1995\n\nISO RT GL 93‐BGOV1 Gleba 10/26/1994\n\nISO RT GL 94‐TALL1 Gleba 10/26/1994\n\nISO RT GL 94‐TALL1 Gleba 10/26/1994\n\nISO RT ISO GL 92‐TALL 2 Actuary 1992\n\nTDI‐95‐400‐GL BLLC Anticipated Savings from Tort Reform\n\nRevision of Basic Limit Loss Costs‐Division Six of CLM TDI‐95‐457‐ISO RP Revision of the Commercial General Liability Experience and Schedule Rating Plan Anticipated Savings from Tort Reform TDI‐97‐400‐GL‐ISO‐BLLC Revision of Basic Limit Loss Costs for Prem/Ops & Products Completed Ops Reflecting Revised Tort Reform Factors TDI‐97‐400‐GL‐ISO‐ELP Revision of Basic Limit Advisory Prospective Estimated Loss Potentials (ELPs) Reflecting Revised Tort Reform Factors TDI‐97‐457‐GL‐RP Revision to the CGL Experience and Schedule Rating Plan 17‐100 to Reflect 1998 Tort Reform Reduction Percentages TDI‐98‐400‐ISO‐PLC Revision of Basic Limit Loss Costs for Prem/Ops and Products/Completed Ops Division Six General Liability of CLM TDI‐98‐457‐ISO‐RP Experience and Schedule Rating Plan TDI‐98‐400‐ELP Addition of Estimated Loss Potentials (ELPs) TDI‐98‐400‐ISO‐IL Increased Limit Factors and Deductible Discount Factors TDI‐98‐400‐GLLC‐CT Loss Cost Filing Reflecting Revised Classification Tables\n\nISO RT GL 96‐ILDD1 Attoh‐Okine 3/12/1998\n\nISO RT GL 96‐REP1 Attoh‐Okine 3/12/1998\n\nISO RP RP 97‐R97GL Attoh‐Okine 3/12/1998\n\nISO RT GL 96‐BGL1 Attoh‐Okine 3/6/1998\n\nISO RP RP 97‐RCGL1 Ryder 12/10/1997\n\nISO RT GL 97‐RTREL Ryder 12/8/1997\n\nISO RT GL 97‐ RTR97 Ryder 12/8/1997\n\nISO RP RP 95‐RGL1 Yorty 11/21/1995\n\nISO RT GL 95‐RTR92 Presley 10/16/1995"],"full_content":"ISO GL RT GL 2002‐BGLI\n\nCommercial General Liability Revision of Basic Limit Loss Costs For Premises & Operations (Subline Code 334) and Products & Completed Operations (Subline Code 336) 9212430090 64685 Pitaktong 2/17/2003\n\nISO GL RT RP 2002‐RGLRP\n\nIntroduction of the Latest Version of the ISO Retrospective Rating Plan for the Division Six ‐ General Liability Line of Business Only in Texas 9212428398 63785 Pitaktong 6/20/2002\n\nISO GL RT GL 2001‐OTA01 Relocation of Increased Limits Table Assignments 9212423035 61348 Pitaktong 4/5/2002\n\nISO GL RT GL 2001‐BGL1 Revision of Basic Limit Loss Costs For Prem/Ops and Prod/Cops 9212416753 58337 Pitaktong 11/20/2001\n\nISO GL RT GL 2000‐BGL1 Revision of Basic Limit Loss Costs for Prem/Ops & Prod/Cops 9212407949 53912 Pitaktong 12/5/2000\n\nISO GL RT RP 99‐R98CR Composite Rating Plan for General Liability 9212403515 51536 Pitaktong 10/24/2000\n\nISO GL RT RP 99‐RCGL1 Commercial GL Experience and Schedule Rating Plan for 01/01/2000 Tort Reform. 9212403791 51717 Presley 12/3/1999\n\nISO GL RT GL 99‐RTREL Estimated Loss Potentials for Tort Reform Effective 01/01/2000 9212403433 51490 Wu 11/17/1999 ISO GL RT GL 99‐RTR99 Loss Costs for Tort Reform 01/01/2000 9212403432 51489 Wu 11/17/1999 TDI‐92‐400 GL PLC (General Liability) TDI 94‐400 GLBAS (General Liability) Basic Limits Loss Costs TDI 94‐400 GLILF (General Liability) Increased Limits TDI 94‐400 GLGOV (General Liability) Gov't Subdivisions TDI‐95‐400‐GL PLC Anticipated Savings from Tort Reform\n\nRevision of Basic Limit Loss Costs‐Division Six of CLM TDI‐95‐400‐GL PELP Anticipated Savings from Tort Reform Revision of Basic Limit Advisory Prospective Estimated Loss Potentials TDI 95 400 GL BLLC\n\nISO RT GL 95‐RTREL Presley 10/16/1995\n\nISO RT GL 95‐RTR95 Presley 10/16/1995\n\nISO RT GL 93‐BGOV1 Gleba 10/26/1994\n\nISO RT GL 94‐TALL1 Gleba 10/26/1994\n\nISO RT GL 94‐TALL1 Gleba 10/26/1994\n\nISO RT ISO GL 92‐TALL 2 Actuary 1992\n\nTDI‐95‐400‐GL BLLC Anticipated Savings from Tort Reform\n\nRevision of Basic Limit Loss Costs‐Division Six of CLM TDI‐95‐457‐ISO RP Revision of the Commercial General Liability Experience and Schedule Rating Plan Anticipated Savings from Tort Reform TDI‐97‐400‐GL‐ISO‐BLLC Revision of Basic Limit Loss Costs for Prem/Ops & Products Completed Ops Reflecting Revised Tort Reform Factors TDI‐97‐400‐GL‐ISO‐ELP Revision of Basic Limit Advisory Prospective Estimated Loss Potentials (ELPs) Reflecting Revised Tort Reform Factors TDI‐97‐457‐GL‐RP Revision to the CGL Experience and Schedule Rating Plan 17‐100 to Reflect 1998 Tort Reform Reduction Percentages TDI‐98‐400‐ISO‐PLC Revision of Basic Limit Loss Costs for Prem/Ops and Products/Completed Ops Division Six General Liability of CLM TDI‐98‐457‐ISO‐RP Experience and Schedule Rating Plan TDI‐98‐400‐ELP Addition of Estimated Loss Potentials (ELPs) TDI‐98‐400‐ISO‐IL Increased Limit Factors and Deductible Discount Factors TDI‐98‐400‐GLLC‐CT Loss Cost Filing Reflecting Revised Classification Tables\n\nISO RT GL 96‐ILDD1 Attoh‐Okine 3/12/1998\n\nISO RT GL 96‐REP1 Attoh‐Okine 3/12/1998\n\nISO RP RP 97‐R97GL Attoh‐Okine 3/12/1998\n\nISO RT GL 96‐BGL1 Attoh‐Okine 3/6/1998\n\nISO RP RP 97‐RCGL1 Ryder 12/10/1997\n\nISO RT GL 97‐RTREL Ryder 12/8/1997\n\nISO RT GL 97‐ RTR97 Ryder 12/8/1997\n\nISO RP RP 95‐RGL1 Yorty 11/21/1995\n\nISO RT GL 95‐RTR92 Presley 10/16/1995","publish_date":null,"title":"Commercial General Liability Revision of Basic Limit Loss Costs For Premises & Operations (Subline Code 334) and Products & Completed","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1197.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1197.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1197","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1197.pdf"},"started_at":"2026-11-04T19:48:22.855306"} +{"completed_at":"2026-11-04T19:48:26.733655","latency_in_ms":2692,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1209","grounded_pages":[],"layout_pages":[],"markdown":"**Aegis TST Trucking Program** TX\n\n**Historical Experience Review** Liability\n\n**Results as-of 12/31/17** Loss & ALAE Limitation 500,000\n\n**Auto Liability**\n\n**Texas**\n\n(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12)\n\nOn-Level Average Ultimate Ultimate Ultimate\n\nAccident Written Earned On-Level Earned Policy Premium Exposure Claim Claim Claim Claim Claim\n\nYear Premium Premium Factor Premium Counts Per Policy Counts Counts LDF Counts Frequency Severity\n\n2013 2,277,113 1,269,037 1.244 1,578,259 23 99,005 689 59 1.000 59 0.1 15,708\n\n2014 3,160,677 2,712,097 1.244 3,373,119 29 108,989 995 111 1.001 111 0.1 33,315\n\n2015 5,260,800 4,159,483 1.239 5,153,698 45 116,907 1,674 174 1.003 175 0.1 17,255\n\n2016 6,986,792 6,147,786 1.196 7,350,808 57 122,575 2,082 270 1.008 272 0.1 22,377\n\n2017 6,493,866 6,586,311 1.101 7,252,117 56 115,962 1,708 269 1.058 285 0.2 18,211\n\n24,179,249 20,874,715 24,708,001 210 115,139 7,148 883 902 0.1 20,981\n\n(13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24)\n\n3\\.5% Trended Ultimate L&ALAE Indications Selected\n\nOn-Level Reported Reported Loss Paid Paid Incurred Incurred Ultimate Ultimate\n\nAccident Earned Paid Incurred Trend Paid Incurred Chain- Bornhuetter- Chain- Bornhuetter- Trended L&ALAE\n\nYear Premium L&ALAE L&ALAE Factor LDF LDF Ladder Ferguson Ladder Ferguson L&ALAE Ratio\n\n2013 1,578,259 765,165 765,165 1.188 1.025 1.015 931,496 936,492 922,408 925,570 926,767 58.7%\n\n2014 3,373,119 2,823,859 3,255,624 1.148 1.076 1.040 3,487,527 3,412,508 3,886,740 3,830,154 3,701,656 109.7%\n\n2015 5,153,698 2,022,044 2,400,040 1.109 1.238 1.144 2,774,742 2,954,478 3,045,244 3,129,213 3,011,366 58.4%\n\n2016 7,350,808 2,711,368 4,466,194 1.071 1.857 1.459 5,392,267 5,346,276 6,980,895 6,449,653 6,090,288 82.9%\n\n2017 7,252,117 1,387,335 2,307,343 1.035 3.435 2.189 4,931,690 5,137,137 5,226,808 5,223,938 5,184,878 71.5%\n\n24,708,001 9,709,771 13,194,366 17,517,722 17,786,891 20,062,095 19,558,528 18,914,955 76.6%\n\nSelected: 77.0% (25)\n\n(1) Provided by company (19) = (14) x (17) Large Loss Load: 1.080 (26)\n\n(2) Provided by company (20) = [ (13) x (25) from Countrywide Total by LOB x [ 1 - 1 / (17) ] ] + [ (14) x (16) ] ULAE Load: 1.074 (27)\n\n(3) Based on historical average rate level reported (21) = (15) x (18) Projected Loss and LAE Ratio: 89.3% (28)\n\n(4) = (2) x (3) (22) = [ (13) x (25) from Countrywide Total by LOB x [ 1 - 1 / (18) ] ] + [ (15) x (16) ]\n\n(5) Provided by company (23) Selected judgmentally based on indications in (19) - (22) Credibility (Z): 90.3% (29)\n\n(6) = (1) x (5) (24) = (23) / (13) Z-Weighted Indication: 88.8% (30)\n\n(7) Provided by company (25) Selected judgmentally based on (24) for 2013-17\n\n(8) Provided by company (26) Ratio of losses incurred to losses limited by selected threshold, by LOB. Targeted Loss and LAE Ratio: 65.0% (31)\n\n(9) Developed from company triangles, by LOB (27) Developed from company IEE (2015-17), by LOB Indicated Rate Need: 36.5% (32)\n\n(10) = (8) x (9) (28) = (25) x (26) x (27)\n\n(11) = (10) / (7) (29) Selected judgmentally based on indications in (25) - (28)\n\n(12) = (23) / (10) (29) Square root of S(8) / 1,082, by LOB.\n\n(13) = (4) (30) = [ (28) x (29) ] + [ (32) from Countrywide Total by LOB x [ 1 - (29) ] ]\n\n(14) Provided by company (31) Based on company UW target\n\n(15) Provided by company (32) = [ (30) / (31) ] - 1\n\n(16) Based on industry data in ISO filing CA-2016-BRLA-1\n\n(17) Developed from company triangles, by LOB\n\n(18) Developed from company triangles, by LOB\n\n8/20/2018 Prepared by Brian M. Fernandes, ACAS, MAAA","pages":[{"line_numbers":[],"markdown":"**Aegis TST Trucking Program** TX\n\n**Historical Experience Review** Liability\n\n**Results as-of 12/31/17** Loss & ALAE Limitation 500,000\n\n**Auto Liability**\n\n**Texas**\n\n(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12)\n\nOn-Level Average Ultimate Ultimate Ultimate\n\nAccident Written Earned On-Level Earned Policy Premium Exposure Claim Claim Claim Claim Claim\n\nYear Premium Premium Factor Premium Counts Per Policy Counts Counts LDF Counts Frequency Severity\n\n2013 2,277,113 1,269,037 1.244 1,578,259 23 99,005 689 59 1.000 59 0.1 15,708\n\n2014 3,160,677 2,712,097 1.244 3,373,119 29 108,989 995 111 1.001 111 0.1 33,315\n\n2015 5,260,800 4,159,483 1.239 5,153,698 45 116,907 1,674 174 1.003 175 0.1 17,255\n\n2016 6,986,792 6,147,786 1.196 7,350,808 57 122,575 2,082 270 1.008 272 0.1 22,377\n\n2017 6,493,866 6,586,311 1.101 7,252,117 56 115,962 1,708 269 1.058 285 0.2 18,211\n\n24,179,249 20,874,715 24,708,001 210 115,139 7,148 883 902 0.1 20,981\n\n(13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24)\n\n3\\.5% Trended Ultimate L&ALAE Indications Selected\n\nOn-Level Reported Reported Loss Paid Paid Incurred Incurred Ultimate Ultimate\n\nAccident Earned Paid Incurred Trend Paid Incurred Chain- Bornhuetter- Chain- Bornhuetter- Trended L&ALAE\n\nYear Premium L&ALAE L&ALAE Factor LDF LDF Ladder Ferguson Ladder Ferguson L&ALAE Ratio\n\n2013 1,578,259 765,165 765,165 1.188 1.025 1.015 931,496 936,492 922,408 925,570 926,767 58.7%\n\n2014 3,373,119 2,823,859 3,255,624 1.148 1.076 1.040 3,487,527 3,412,508 3,886,740 3,830,154 3,701,656 109.7%\n\n2015 5,153,698 2,022,044 2,400,040 1.109 1.238 1.144 2,774,742 2,954,478 3,045,244 3,129,213 3,011,366 58.4%\n\n2016 7,350,808 2,711,368 4,466,194 1.071 1.857 1.459 5,392,267 5,346,276 6,980,895 6,449,653 6,090,288 82.9%\n\n2017 7,252,117 1,387,335 2,307,343 1.035 3.435 2.189 4,931,690 5,137,137 5,226,808 5,223,938 5,184,878 71.5%\n\n24,708,001 9,709,771 13,194,366 17,517,722 17,786,891 20,062,095 19,558,528 18,914,955 76.6%\n\nSelected: 77.0% (25)\n\n(1) Provided by company (19) = (14) x (17) Large Loss Load: 1.080 (26)\n\n(2) Provided by company (20) = [ (13) x (25) from Countrywide Total by LOB x [ 1 - 1 / (17) ] ] + [ (14) x (16) ] ULAE Load: 1.074 (27)\n\n(3) Based on historical average rate level reported (21) = (15) x (18) Projected Loss and LAE Ratio: 89.3% (28)\n\n(4) = (2) x (3) (22) = [ (13) x (25) from Countrywide Total by LOB x [ 1 - 1 / (18) ] ] + [ (15) x (16) ]\n\n(5) Provided by company (23) Selected judgmentally based on indications in (19) - (22) Credibility (Z): 90.3% (29)\n\n(6) = (1) x (5) (24) = (23) / (13) Z-Weighted Indication: 88.8% (30)\n\n(7) Provided by company (25) Selected judgmentally based on (24) for 2013-17\n\n(8) Provided by company (26) Ratio of losses incurred to losses limited by selected threshold, by LOB. Targeted Loss and LAE Ratio: 65.0% (31)\n\n(9) Developed from company triangles, by LOB (27) Developed from company IEE (2015-17), by LOB Indicated Rate Need: 36.5% (32)\n\n(10) = (8) x (9) (28) = (25) x (26) x (27)\n\n(11) = (10) / (7) (29) Selected judgmentally based on indications in (25) - (28)\n\n(12) = (23) / (10) (29) Square root of S(8) / 1,082, by LOB.\n\n(13) = (4) (30) = [ (28) x (29) ] + [ (32) from Countrywide Total by LOB x [ 1 - (29) ] ]\n\n(14) Provided by company (31) Based on company UW target\n\n(15) Provided by company (32) = [ (30) / (31) ] - 1\n\n(16) Based on industry data in ISO filing CA-2016-BRLA-1\n\n(17) Developed from company triangles, by LOB\n\n(18) Developed from company triangles, by LOB\n\n8/20/2018 Prepared by Brian M. Fernandes, ACAS, MAAA","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Aegis TST Trucking Program** TX\n\n**Historical Experience Review** Liability\n\n**Results as-of 12/31/17** Loss & ALAE Limitation 500,000\n\n**Auto Liability**\n\n**Texas**\n\n(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12)\n\nOn-Level Average Ultimate Ultimate Ultimate\n\nAccident Written Earned On-Level Earned Policy Premium Exposure Claim Claim Claim Claim Claim\n\nYear Premium Premium Factor Premium Counts Per Policy Counts Counts LDF Counts Frequency Severity\n\n2013 2,277,113 1,269,037 1.244 1,578,259 23 99,005 689 59 1.000 59 0.1 15,708\n\n2014 3,160,677 2,712,097 1.244 3,373,119 29 108,989 995 111 1.001 111 0.1 33,315\n\n2015 5,260,800 4,159,483 1.239 5,153,698 45 116,907 1,674 174 1.003 175 0.1 17,255\n\n2016 6,986,792 6,147,786 1.196 7,350,808 57 122,575 2,082 270 1.008 272 0.1 22,377\n\n2017 6,493,866 6,586,311 1.101 7,252,117 56 115,962 1,708 269 1.058 285 0.2 18,211\n\n24,179,249 20,874,715 24,708,001 210 115,139 7,148 883 902 0.1 20,981\n\n(13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24)\n\n3\\.5% Trended Ultimate L&ALAE Indications Selected\n\nOn-Level Reported Reported Loss Paid Paid Incurred Incurred Ultimate Ultimate\n\nAccident Earned Paid Incurred Trend Paid Incurred Chain- Bornhuetter- Chain- Bornhuetter- Trended L&ALAE\n\nYear Premium L&ALAE L&ALAE Factor LDF LDF Ladder Ferguson Ladder Ferguson L&ALAE Ratio\n\n2013 1,578,259 765,165 765,165 1.188 1.025 1.015 931,496 936,492 922,408 925,570 926,767 58.7%\n\n2014 3,373,119 2,823,859 3,255,624 1.148 1.076 1.040 3,487,527 3,412,508 3,886,740 3,830,154 3,701,656 109.7%\n\n2015 5,153,698 2,022,044 2,400,040 1.109 1.238 1.144 2,774,742 2,954,478 3,045,244 3,129,213 3,011,366 58.4%\n\n2016 7,350,808 2,711,368 4,466,194 1.071 1.857 1.459 5,392,267 5,346,276 6,980,895 6,449,653 6,090,288 82.9%\n\n2017 7,252,117 1,387,335 2,307,343 1.035 3.435 2.189 4,931,690 5,137,137 5,226,808 5,223,938 5,184,878 71.5%\n\n24,708,001 9,709,771 13,194,366 17,517,722 17,786,891 20,062,095 19,558,528 18,914,955 76.6%\n\nSelected: 77.0% (25)\n\n(1) Provided by company (19) = (14) x (17) Large Loss Load: 1.080 (26)\n\n(2) Provided by company (20) = [ (13) x (25) from Countrywide Total by LOB x [ 1 - 1 / (17) ] ] + [ (14) x (16) ] ULAE Load: 1.074 (27)\n\n(3) Based on historical average rate level reported (21) = (15) x (18) Projected Loss and LAE Ratio: 89.3% (28)\n\n(4) = (2) x (3) (22) = [ (13) x (25) from Countrywide Total by LOB x [ 1 - 1 / (18) ] ] + [ (15) x (16) ]\n\n(5) Provided by company (23) Selected judgmentally based on indications in (19) - (22) Credibility (Z): 90.3% (29)\n\n(6) = (1) x (5) (24) = (23) / (13) Z-Weighted Indication: 88.8% (30)\n\n(7) Provided by company (25) Selected judgmentally based on (24) for 2013-17\n\n(8) Provided by company (26) Ratio of losses incurred to losses limited by selected threshold, by LOB. Targeted Loss and LAE Ratio: 65.0% (31)\n\n(9) Developed from company triangles, by LOB (27) Developed from company IEE (2015-17), by LOB Indicated Rate Need: 36.5% (32)\n\n(10) = (8) x (9) (28) = (25) x (26) x (27)\n\n(11) = (10) / (7) (29) Selected judgmentally based on indications in (25) - (28)\n\n(12) = (23) / (10) (29) Square root of S(8) / 1,082, by LOB.\n\n(13) = (4) (30) = [ (28) x (29) ] + [ (32) from Countrywide Total by LOB x [ 1 - (29) ] ]\n\n(14) Provided by company (31) Based on company UW target\n\n(15) Provided by company (32) = [ (30) / (31) ] - 1\n\n(16) Based on industry data in ISO filing CA-2016-BRLA-1\n\n(17) Developed from company triangles, by LOB\n\n(18) Developed from company triangles, by LOB\n\n8/20/2018 Prepared by Brian M. Fernandes, ACAS, MAAA","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1209.pdf"]},"response":{"errors":[],"extract_id":"extract_c266aea83099287890facc2ae8993227","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Aegis TST Trucking Program** TX\n\n**Historical Experience Review** Liability\n\n**Results as-of 12/31/17** Loss & ALAE Limitation 500,000\n\n**Auto Liability**\n\n**Texas**\n\n(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12)\n\nOn-Level Average Ultimate Ultimate Ultimate\n\nAccident Written Earned On-Level Earned Policy Premium Exposure Claim Claim Claim Claim Claim\n\nYear Premium Premium Factor Premium Counts Per Policy Counts Counts LDF Counts Frequency Severity\n\n2013 2,277,113 1,269,037 1.244 1,578,259 23 99,005 689 59 1.000 59 0.1 15,708\n\n2014 3,160,677 2,712,097 1.244 3,373,119 29 108,989 995 111 1.001 111 0.1 33,315\n\n2015 5,260,800 4,159,483 1.239 5,153,698 45 116,907 1,674 174 1.003 175 0.1 17,255\n\n2016 6,986,792 6,147,786 1.196 7,350,808 57 122,575 2,082 270 1.008 272 0.1 22,377\n\n2017 6,493,866 6,586,311 1.101 7,252,117 56 115,962 1,708 269 1.058 285 0.2 18,211\n\n24,179,249 20,874,715 24,708,001 210 115,139 7,148 883 902 0.1 20,981\n\n(13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24)\n\n3\\.5% Trended Ultimate L&ALAE Indications Selected\n\nOn-Level Reported Reported Loss Paid Paid Incurred Incurred Ultimate Ultimate\n\nAccident Earned Paid Incurred Trend Paid Incurred Chain- Bornhuetter- Chain- Bornhuetter- Trended L&ALAE\n\nYear Premium L&ALAE L&ALAE Factor LDF LDF Ladder Ferguson Ladder Ferguson L&ALAE Ratio\n\n2013 1,578,259 765,165 765,165 1.188 1.025 1.015 931,496 936,492 922,408 925,570 926,767 58.7%\n\n2014 3,373,119 2,823,859 3,255,624 1.148 1.076 1.040 3,487,527 3,412,508 3,886,740 3,830,154 3,701,656 109.7%\n\n2015 5,153,698 2,022,044 2,400,040 1.109 1.238 1.144 2,774,742 2,954,478 3,045,244 3,129,213 3,011,366 58.4%\n\n2016 7,350,808 2,711,368 4,466,194 1.071 1.857 1.459 5,392,267 5,346,276 6,980,895 6,449,653 6,090,288 82.9%\n\n2017 7,252,117 1,387,335 2,307,343 1.035 3.435 2.189 4,931,690 5,137,137 5,226,808 5,223,938 5,184,878 71.5%\n\n24,708,001 9,709,771 13,194,366 17,517,722 17,786,891 20,062,095 19,558,528 18,914,955 76.6%\n\nSelected: 77.0% (25)\n\n(1) Provided by company (19) = (14) x (17) Large Loss Load: 1.080 (26)\n\n(2) Provided by company (20) = [ (13) x (25) from Countrywide Total by LOB x [ 1 - 1 / (17) ] ] + [ (14) x (16) ] ULAE Load: 1.074 (27)\n\n(3) Based on historical average rate level reported (21) = (15) x (18) Projected Loss and LAE Ratio: 89.3% (28)\n\n(4) = (2) x (3) (22) = [ (13) x (25) from Countrywide Total by LOB x [ 1 - 1 / (18) ] ] + [ (15) x (16) ]\n\n(5) Provided by company (23) Selected judgmentally based on indications in (19) - (22) Credibility (Z): 90.3% (29)\n\n(6) = (1) x (5) (24) = (23) / (13) Z-Weighted Indication: 88.8% (30)\n\n(7) Provided by company (25) Selected judgmentally based on (24) for 2013-17\n\n(8) Provided by company (26) Ratio of losses incurred to losses limited by selected threshold, by LOB. Targeted Loss and LAE Ratio: 65.0% (31)\n\n(9) Developed from company triangles, by LOB (27) Developed from company IEE (2015-17), by LOB Indicated Rate Need: 36.5% (32)\n\n(10) = (8) x (9) (28) = (25) x (26) x (27)\n\n(11) = (10) / (7) (29) Selected judgmentally based on indications in (25) - (28)\n\n(12) = (23) / (10) (29) Square root of S(8) / 1,082, by LOB.\n\n(13) = (4) (30) = [ (28) x (29) ] + [ (32) from Countrywide Total by LOB x [ 1 - (29) ] ]\n\n(14) Provided by company (31) Based on company UW target\n\n(15) Provided by company (32) = [ (30) / (31) ] - 1\n\n(16) Based on industry data in ISO filing CA-2016-BRLA-1\n\n(17) Developed from company triangles, by LOB\n\n(18) Developed from company triangles, by LOB\n\n8/20/2018 Prepared by Brian M. Fernandes, ACAS, MAAA"],"full_content":"**Aegis TST Trucking Program** TX\n\n**Historical Experience Review** Liability\n\n**Results as-of 12/31/17** Loss & ALAE Limitation 500,000\n\n**Auto Liability**\n\n**Texas**\n\n(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12)\n\nOn-Level Average Ultimate Ultimate Ultimate\n\nAccident Written Earned On-Level Earned Policy Premium Exposure Claim Claim Claim Claim Claim\n\nYear Premium Premium Factor Premium Counts Per Policy Counts Counts LDF Counts Frequency Severity\n\n2013 2,277,113 1,269,037 1.244 1,578,259 23 99,005 689 59 1.000 59 0.1 15,708\n\n2014 3,160,677 2,712,097 1.244 3,373,119 29 108,989 995 111 1.001 111 0.1 33,315\n\n2015 5,260,800 4,159,483 1.239 5,153,698 45 116,907 1,674 174 1.003 175 0.1 17,255\n\n2016 6,986,792 6,147,786 1.196 7,350,808 57 122,575 2,082 270 1.008 272 0.1 22,377\n\n2017 6,493,866 6,586,311 1.101 7,252,117 56 115,962 1,708 269 1.058 285 0.2 18,211\n\n24,179,249 20,874,715 24,708,001 210 115,139 7,148 883 902 0.1 20,981\n\n(13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24)\n\n3\\.5% Trended Ultimate L&ALAE Indications Selected\n\nOn-Level Reported Reported Loss Paid Paid Incurred Incurred Ultimate Ultimate\n\nAccident Earned Paid Incurred Trend Paid Incurred Chain- Bornhuetter- Chain- Bornhuetter- Trended L&ALAE\n\nYear Premium L&ALAE L&ALAE Factor LDF LDF Ladder Ferguson Ladder Ferguson L&ALAE Ratio\n\n2013 1,578,259 765,165 765,165 1.188 1.025 1.015 931,496 936,492 922,408 925,570 926,767 58.7%\n\n2014 3,373,119 2,823,859 3,255,624 1.148 1.076 1.040 3,487,527 3,412,508 3,886,740 3,830,154 3,701,656 109.7%\n\n2015 5,153,698 2,022,044 2,400,040 1.109 1.238 1.144 2,774,742 2,954,478 3,045,244 3,129,213 3,011,366 58.4%\n\n2016 7,350,808 2,711,368 4,466,194 1.071 1.857 1.459 5,392,267 5,346,276 6,980,895 6,449,653 6,090,288 82.9%\n\n2017 7,252,117 1,387,335 2,307,343 1.035 3.435 2.189 4,931,690 5,137,137 5,226,808 5,223,938 5,184,878 71.5%\n\n24,708,001 9,709,771 13,194,366 17,517,722 17,786,891 20,062,095 19,558,528 18,914,955 76.6%\n\nSelected: 77.0% (25)\n\n(1) Provided by company (19) = (14) x (17) Large Loss Load: 1.080 (26)\n\n(2) Provided by company (20) = [ (13) x (25) from Countrywide Total by LOB x [ 1 - 1 / (17) ] ] + [ (14) x (16) ] ULAE Load: 1.074 (27)\n\n(3) Based on historical average rate level reported (21) = (15) x (18) Projected Loss and LAE Ratio: 89.3% (28)\n\n(4) = (2) x (3) (22) = [ (13) x (25) from Countrywide Total by LOB x [ 1 - 1 / (18) ] ] + [ (15) x (16) ]\n\n(5) Provided by company (23) Selected judgmentally based on indications in (19) - (22) Credibility (Z): 90.3% (29)\n\n(6) = (1) x (5) (24) = (23) / (13) Z-Weighted Indication: 88.8% (30)\n\n(7) Provided by company (25) Selected judgmentally based on (24) for 2013-17\n\n(8) Provided by company (26) Ratio of losses incurred to losses limited by selected threshold, by LOB. Targeted Loss and LAE Ratio: 65.0% (31)\n\n(9) Developed from company triangles, by LOB (27) Developed from company IEE (2015-17), by LOB Indicated Rate Need: 36.5% (32)\n\n(10) = (8) x (9) (28) = (25) x (26) x (27)\n\n(11) = (10) / (7) (29) Selected judgmentally based on indications in (25) - (28)\n\n(12) = (23) / (10) (29) Square root of S(8) / 1,082, by LOB.\n\n(13) = (4) (30) = [ (28) x (29) ] + [ (32) from Countrywide Total by LOB x [ 1 - (29) ] ]\n\n(14) Provided by company (31) Based on company UW target\n\n(15) Provided by company (32) = [ (30) / (31) ] - 1\n\n(16) Based on industry data in ISO filing CA-2016-BRLA-1\n\n(17) Developed from company triangles, by LOB\n\n(18) Developed from company triangles, by LOB\n\n8/20/2018 Prepared by Brian M. Fernandes, ACAS, MAAA","publish_date":null,"title":"AegisTSTTruckingProgram TX HistoricalExperienceReview Liability Resultsas-of12/31/17 Loss&ALAELimitation 500,000 AutoLiability Texas On-Level Average Ultimate Ultimate Ultimate Accident Written Earned On-Level Earned Policy","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1209.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1209.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1209","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1209.pdf"},"started_at":"2026-11-04T19:48:24.041228"} +{"completed_at":"2026-11-04T19:48:26.849261","latency_in_ms":1534,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1212","grounded_pages":[],"layout_pages":[],"markdown":"### **TST TRUCKERS PROGRAM**\n\n### **Aegis Security Insurance Company Texas**\n\n### **Commercial Manual Pages Commercial Automobile**\n\n**AE-TST-AU-TX (06/1705/18)** **Page 1 of 12**\n\nThis manual page supplements the TST Truckers Program Commercial Automobile Countrywide Manual Pages.\n\n**I.** Section **I. LIABILITY RATES** of the TST Truckers Program Commercial Automobile Countrywide Manual Pages is deleted and replaced with the following:\n\n**I. LIABILITY RATES**\n\n**LIABILITY** LIABILITY RATES\n\n**LOCAL LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$1,599 $119\n\n**INTERMEDIATE LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$2,765 $151\n\n**LONG HAUL LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$4,288 $429\n\nThese rates include Hired & Non-Owned and Pollution Liability. There is no charge for extra trailer(s) for Liability. Ancillary Private Passenger Type (PPT) vehicles will be rated the same as a Local Tractor.\n\n**II. MISCELLANEOUS AUTO COVERAGES**\n\nBasic Higher\n\nCoverage Limits Rate Limits Rate\n\nUninsured Motorists (UM) - Optional 85 CSL $50 170 CSL $100\n\nUnderinsured Motorists (UIM) - Optional 85 CSL $20 170 CSL $40\n\nPersonal Injury Protection (PIP) - Optional $2,500 $10 $5,000 $20\n\n**II** **III. ADDITIONAL RULE** **–** **TEXAS AUTO BURGLARY AND THEFT PREVENTION FEE**\n\nThe Automobile Burglary and Theft Prevention Authority fee **of $2.00** is payable in addition to the premium due under this policy. This fee reimburses the insurer, as permitted by 28 TAC §5.205, for the $2.00 fee per motor vehicle year required to be paid to the Automobile Burglary and Theft Prevention Authority under Texas Civil Statutes, Article 4413(37), §10, which was effective on June 6, 1991, and revised effective September 1, 2011.\n\nTexas Automobile Burglary and Theft Prevention Authority Notice, **AE TST TX1502** is to be attached to all Texas Auto policies.","pages":[{"line_numbers":[],"markdown":"### **TST TRUCKERS PROGRAM**\n\n### **Aegis Security Insurance Company Texas**\n\n### **Commercial Manual Pages Commercial Automobile**\n\n**AE-TST-AU-TX (06/1705/18)** **Page 1 of 12**\n\nThis manual page supplements the TST Truckers Program Commercial Automobile Countrywide Manual Pages.\n\n**I.** Section **I. LIABILITY RATES** of the TST Truckers Program Commercial Automobile Countrywide Manual Pages is deleted and replaced with the following:\n\n**I. LIABILITY RATES**\n\n**LIABILITY** LIABILITY RATES\n\n**LOCAL LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$1,599 $119\n\n**INTERMEDIATE LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$2,765 $151\n\n**LONG HAUL LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$4,288 $429\n\nThese rates include Hired & Non-Owned and Pollution Liability. There is no charge for extra trailer(s) for Liability. Ancillary Private Passenger Type (PPT) vehicles will be rated the same as a Local Tractor.\n\n**II. MISCELLANEOUS AUTO COVERAGES**\n\nBasic Higher\n\nCoverage Limits Rate Limits Rate\n\nUninsured Motorists (UM) - Optional 85 CSL $50 170 CSL $100\n\nUnderinsured Motorists (UIM) - Optional 85 CSL $20 170 CSL $40\n\nPersonal Injury Protection (PIP) - Optional $2,500 $10 $5,000 $20\n\n**II** **III. ADDITIONAL RULE** **–** **TEXAS AUTO BURGLARY AND THEFT PREVENTION FEE**\n\nThe Automobile Burglary and Theft Prevention Authority fee **of $2.00** is payable in addition to the premium due under this policy. This fee reimburses the insurer, as permitted by 28 TAC §5.205, for the $2.00 fee per motor vehicle year required to be paid to the Automobile Burglary and Theft Prevention Authority under Texas Civil Statutes, Article 4413(37), §10, which was effective on June 6, 1991, and revised effective September 1, 2011.\n\nTexas Automobile Burglary and Theft Prevention Authority Notice, **AE TST TX1502** is to be attached to all Texas Auto policies.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **TST TRUCKERS PROGRAM**\n\n### **Aegis Security Insurance Company Texas**\n\n### **Commercial Manual Pages Commercial Automobile**\n\n**AE-TST-AU-TX (06/1705/18)** **Page 1 of 12**\n\nThis manual page supplements the TST Truckers Program Commercial Automobile Countrywide Manual Pages.\n\n**I.** Section **I. LIABILITY RATES** of the TST Truckers Program Commercial Automobile Countrywide Manual Pages is deleted and replaced with the following:\n\n**I. LIABILITY RATES**\n\n**LIABILITY** LIABILITY RATES\n\n**LOCAL LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$1,599 $119\n\n**INTERMEDIATE LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$2,765 $151\n\n**LONG HAUL LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$4,288 $429\n\nThese rates include Hired & Non-Owned and Pollution Liability. There is no charge for extra trailer(s) for Liability. Ancillary Private Passenger Type (PPT) vehicles will be rated the same as a Local Tractor.\n\n**II. MISCELLANEOUS AUTO COVERAGES**\n\nBasic Higher\n\nCoverage Limits Rate Limits Rate\n\nUninsured Motorists (UM) - Optional 85 CSL $50 170 CSL $100\n\nUnderinsured Motorists (UIM) - Optional 85 CSL $20 170 CSL $40\n\nPersonal Injury Protection (PIP) - Optional $2,500 $10 $5,000 $20\n\n**II** **III. ADDITIONAL RULE** **–** **TEXAS AUTO BURGLARY AND THEFT PREVENTION FEE**\n\nThe Automobile Burglary and Theft Prevention Authority fee **of $2.00** is payable in addition to the premium due under this policy. This fee reimburses the insurer, as permitted by 28 TAC §5.205, for the $2.00 fee per motor vehicle year required to be paid to the Automobile Burglary and Theft Prevention Authority under Texas Civil Statutes, Article 4413(37), §10, which was effective on June 6, 1991, and revised effective September 1, 2011.\n\nTexas Automobile Burglary and Theft Prevention Authority Notice, **AE TST TX1502** is to be attached to all Texas Auto policies.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1212.pdf"]},"response":{"errors":[],"extract_id":"extract_3980319612a0232376fa8f6b7756e34f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **TST TRUCKERS PROGRAM**\n\n### **Aegis Security Insurance Company Texas**\n\n### **Commercial Manual Pages Commercial Automobile**\n\n**AE-TST-AU-TX (06/1705/18)** **Page 1 of 12**\n\nThis manual page supplements the TST Truckers Program Commercial Automobile Countrywide Manual Pages.\n\n**I.** Section **I. LIABILITY RATES** of the TST Truckers Program Commercial Automobile Countrywide Manual Pages is deleted and replaced with the following:\n\n**I. LIABILITY RATES**\n\n**LIABILITY** LIABILITY RATES\n\n**LOCAL LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$1,599 $119\n\n**INTERMEDIATE LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$2,765 $151\n\n**LONG HAUL LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$4,288 $429\n\nThese rates include Hired & Non-Owned and Pollution Liability. There is no charge for extra trailer(s) for Liability. Ancillary Private Passenger Type (PPT) vehicles will be rated the same as a Local Tractor.\n\n**II. MISCELLANEOUS AUTO COVERAGES**\n\nBasic Higher\n\nCoverage Limits Rate Limits Rate\n\nUninsured Motorists (UM) - Optional 85 CSL $50 170 CSL $100\n\nUnderinsured Motorists (UIM) - Optional 85 CSL $20 170 CSL $40\n\nPersonal Injury Protection (PIP) - Optional $2,500 $10 $5,000 $20\n\n**II** **III. ADDITIONAL RULE** **–** **TEXAS AUTO BURGLARY AND THEFT PREVENTION FEE**\n\nThe Automobile Burglary and Theft Prevention Authority fee **of $2.00** is payable in addition to the premium due under this policy. This fee reimburses the insurer, as permitted by 28 TAC §5.205, for the $2.00 fee per motor vehicle year required to be paid to the Automobile Burglary and Theft Prevention Authority under Texas Civil Statutes, Article 4413(37), §10, which was effective on June 6, 1991, and revised effective September 1, 2011.\n\nTexas Automobile Burglary and Theft Prevention Authority Notice, **AE TST TX1502** is to be attached to all Texas Auto policies."],"full_content":"### **TST TRUCKERS PROGRAM**\n\n### **Aegis Security Insurance Company Texas**\n\n### **Commercial Manual Pages Commercial Automobile**\n\n**AE-TST-AU-TX (06/1705/18)** **Page 1 of 12**\n\nThis manual page supplements the TST Truckers Program Commercial Automobile Countrywide Manual Pages.\n\n**I.** Section **I. LIABILITY RATES** of the TST Truckers Program Commercial Automobile Countrywide Manual Pages is deleted and replaced with the following:\n\n**I. LIABILITY RATES**\n\n**LIABILITY** LIABILITY RATES\n\n**LOCAL LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$1,599 $119\n\n**INTERMEDIATE LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$2,765 $151\n\n**LONG HAUL LIABILITY RATES:** $1 Million CSL\n\nLiability Premium — Tractor Liability Premium — Trailer\n\n$4,288 $429\n\nThese rates include Hired & Non-Owned and Pollution Liability. There is no charge for extra trailer(s) for Liability. Ancillary Private Passenger Type (PPT) vehicles will be rated the same as a Local Tractor.\n\n**II. MISCELLANEOUS AUTO COVERAGES**\n\nBasic Higher\n\nCoverage Limits Rate Limits Rate\n\nUninsured Motorists (UM) - Optional 85 CSL $50 170 CSL $100\n\nUnderinsured Motorists (UIM) - Optional 85 CSL $20 170 CSL $40\n\nPersonal Injury Protection (PIP) - Optional $2,500 $10 $5,000 $20\n\n**II** **III. ADDITIONAL RULE** **–** **TEXAS AUTO BURGLARY AND THEFT PREVENTION FEE**\n\nThe Automobile Burglary and Theft Prevention Authority fee **of $2.00** is payable in addition to the premium due under this policy. This fee reimburses the insurer, as permitted by 28 TAC §5.205, for the $2.00 fee per motor vehicle year required to be paid to the Automobile Burglary and Theft Prevention Authority under Texas Civil Statutes, Article 4413(37), §10, which was effective on June 6, 1991, and revised effective September 1, 2011.\n\nTexas Automobile Burglary and Theft Prevention Authority Notice, **AE TST TX1502** is to be attached to all Texas Auto policies.","publish_date":null,"title":"TST TRUCKERS PROGRAM Aegis Security Insurance Company Texas Commercial Manual Pages Commercial Automobile II","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1212.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1212.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1212","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1212.pdf"},"started_at":"2026-11-04T19:48:25.315052"} +{"completed_at":"2026-11-04T19:48:27.976775","latency_in_ms":1228,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1213","grounded_pages":[],"layout_pages":[],"markdown":"**Aegis TST Trucking Program** TX\n\n**Historical Experience Review** Liability\n\n**Results as-of 12/31/17** Loss & ALAE Limitation 500,000\n\n**Auto Liability**\n\n**Texas**\n\nSelected\n\nOn-Level Average Ultimate Ultimate Ultimate\n\nAccident Written Earned On-Level Earned Policy Premium Exposure Claim Claim Claim Claim Claim\n\nYear Premium Premium Factor Premium Counts Per Policy Counts Counts LDF Counts Frequency Severity\n\n2013 2,277,113 1,269,037 1.244 1,578,259 23 99,005 689 59 1.000 59 0.1 15,708\n\n2014 3,160,677 2,712,097 1.244 3,373,119 29 108,989 995 111 1.001 111 0.1 33,315\n\n2015 5,260,800 4,159,483 1.239 5,153,698 45 116,907 1,674 174 1.003 175 0.1 17,255\n\n2016 6,986,792 6,147,786 1.196 7,350,808 57 122,575 2,082 270 1.008 272 0.1 22,377\n\n2017 6,493,866 6,586,311 1.101 7,252,117 56 115,962 1,708 269 1.058 285 0.2 18,211\n\n24,179,249 20,874,715 24,708,001 210 115,139 7,148 883 902 0.1 20,981\n\n3\\.5% Trended Ultimate L&ALAE Indications Selected\n\nOn-Level Reported Reported Loss Paid Paid Incurred Incurred Ultimate Ultimate\n\nAccident Earned Paid Incurred Trend Paid Incurred Chain- Bornhuetter- Chain- Bornhuetter- Trended L&ALAE\n\nYear Premium L&ALAE L&ALAE Factor LDF LDF Ladder Ferguson Ladder Ferguson L&ALAE Ratio\n\n2013 1,578,259 765,165 765,165 1.188 1.025 1.015 931,496 936,492 922,408 925,570 926,767 58.7%\n\n2014 3,373,119 2,823,859 3,255,624 1.148 1.076 1.040 3,487,527 3,412,508 3,886,740 3,830,154 3,701,656 109.7%\n\n2015 5,153,698 2,022,044 2,400,040 1.109 1.238 1.144 2,774,742 2,954,478 3,045,244 3,129,213 3,011,366 58.4%\n\n2016 7,350,808 2,711,368 4,466,194 1.071 1.857 1.459 5,392,267 5,346,276 6,980,895 6,449,653 6,090,288 82.9%\n\n2017 7,252,117 1,387,335 2,307,343 1.035 3.435 2.189 4,931,690 5,137,137 5,226,808 5,223,938 5,184,878 71.5%\n\n24,708,001 9,709,771 13,194,366 17,517,722 17,786,891 20,062,095 19,558,528 18,914,955 76.6%\n\nSelected: 77.0%\n\nLarge Loss Load: 1.080\n\nULAE Load: 1.074\n\nProjected Loss and LAE Ratio: 89.3%\n\nCredibility (Z): 90.3%\n\nZ-Weighted Indication: 88.8%\n\nTargeted Loss and LAE Ratio: 65.0%\n\nIndicated Rate Need: 36.5%\n\n2/27/2018 Prepared by Brian M. Fernandes, ACAS, MAAA","pages":[{"line_numbers":[],"markdown":"**Aegis TST Trucking Program** TX\n\n**Historical Experience Review** Liability\n\n**Results as-of 12/31/17** Loss & ALAE Limitation 500,000\n\n**Auto Liability**\n\n**Texas**\n\nSelected\n\nOn-Level Average Ultimate Ultimate Ultimate\n\nAccident Written Earned On-Level Earned Policy Premium Exposure Claim Claim Claim Claim Claim\n\nYear Premium Premium Factor Premium Counts Per Policy Counts Counts LDF Counts Frequency Severity\n\n2013 2,277,113 1,269,037 1.244 1,578,259 23 99,005 689 59 1.000 59 0.1 15,708\n\n2014 3,160,677 2,712,097 1.244 3,373,119 29 108,989 995 111 1.001 111 0.1 33,315\n\n2015 5,260,800 4,159,483 1.239 5,153,698 45 116,907 1,674 174 1.003 175 0.1 17,255\n\n2016 6,986,792 6,147,786 1.196 7,350,808 57 122,575 2,082 270 1.008 272 0.1 22,377\n\n2017 6,493,866 6,586,311 1.101 7,252,117 56 115,962 1,708 269 1.058 285 0.2 18,211\n\n24,179,249 20,874,715 24,708,001 210 115,139 7,148 883 902 0.1 20,981\n\n3\\.5% Trended Ultimate L&ALAE Indications Selected\n\nOn-Level Reported Reported Loss Paid Paid Incurred Incurred Ultimate Ultimate\n\nAccident Earned Paid Incurred Trend Paid Incurred Chain- Bornhuetter- Chain- Bornhuetter- Trended L&ALAE\n\nYear Premium L&ALAE L&ALAE Factor LDF LDF Ladder Ferguson Ladder Ferguson L&ALAE Ratio\n\n2013 1,578,259 765,165 765,165 1.188 1.025 1.015 931,496 936,492 922,408 925,570 926,767 58.7%\n\n2014 3,373,119 2,823,859 3,255,624 1.148 1.076 1.040 3,487,527 3,412,508 3,886,740 3,830,154 3,701,656 109.7%\n\n2015 5,153,698 2,022,044 2,400,040 1.109 1.238 1.144 2,774,742 2,954,478 3,045,244 3,129,213 3,011,366 58.4%\n\n2016 7,350,808 2,711,368 4,466,194 1.071 1.857 1.459 5,392,267 5,346,276 6,980,895 6,449,653 6,090,288 82.9%\n\n2017 7,252,117 1,387,335 2,307,343 1.035 3.435 2.189 4,931,690 5,137,137 5,226,808 5,223,938 5,184,878 71.5%\n\n24,708,001 9,709,771 13,194,366 17,517,722 17,786,891 20,062,095 19,558,528 18,914,955 76.6%\n\nSelected: 77.0%\n\nLarge Loss Load: 1.080\n\nULAE Load: 1.074\n\nProjected Loss and LAE Ratio: 89.3%\n\nCredibility (Z): 90.3%\n\nZ-Weighted Indication: 88.8%\n\nTargeted Loss and LAE Ratio: 65.0%\n\nIndicated Rate Need: 36.5%\n\n2/27/2018 Prepared by Brian M. Fernandes, ACAS, MAAA","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Aegis TST Trucking Program** TX\n\n**Historical Experience Review** Liability\n\n**Results as-of 12/31/17** Loss & ALAE Limitation 500,000\n\n**Auto Liability**\n\n**Texas**\n\nSelected\n\nOn-Level Average Ultimate Ultimate Ultimate\n\nAccident Written Earned On-Level Earned Policy Premium Exposure Claim Claim Claim Claim Claim\n\nYear Premium Premium Factor Premium Counts Per Policy Counts Counts LDF Counts Frequency Severity\n\n2013 2,277,113 1,269,037 1.244 1,578,259 23 99,005 689 59 1.000 59 0.1 15,708\n\n2014 3,160,677 2,712,097 1.244 3,373,119 29 108,989 995 111 1.001 111 0.1 33,315\n\n2015 5,260,800 4,159,483 1.239 5,153,698 45 116,907 1,674 174 1.003 175 0.1 17,255\n\n2016 6,986,792 6,147,786 1.196 7,350,808 57 122,575 2,082 270 1.008 272 0.1 22,377\n\n2017 6,493,866 6,586,311 1.101 7,252,117 56 115,962 1,708 269 1.058 285 0.2 18,211\n\n24,179,249 20,874,715 24,708,001 210 115,139 7,148 883 902 0.1 20,981\n\n3\\.5% Trended Ultimate L&ALAE Indications Selected\n\nOn-Level Reported Reported Loss Paid Paid Incurred Incurred Ultimate Ultimate\n\nAccident Earned Paid Incurred Trend Paid Incurred Chain- Bornhuetter- Chain- Bornhuetter- Trended L&ALAE\n\nYear Premium L&ALAE L&ALAE Factor LDF LDF Ladder Ferguson Ladder Ferguson L&ALAE Ratio\n\n2013 1,578,259 765,165 765,165 1.188 1.025 1.015 931,496 936,492 922,408 925,570 926,767 58.7%\n\n2014 3,373,119 2,823,859 3,255,624 1.148 1.076 1.040 3,487,527 3,412,508 3,886,740 3,830,154 3,701,656 109.7%\n\n2015 5,153,698 2,022,044 2,400,040 1.109 1.238 1.144 2,774,742 2,954,478 3,045,244 3,129,213 3,011,366 58.4%\n\n2016 7,350,808 2,711,368 4,466,194 1.071 1.857 1.459 5,392,267 5,346,276 6,980,895 6,449,653 6,090,288 82.9%\n\n2017 7,252,117 1,387,335 2,307,343 1.035 3.435 2.189 4,931,690 5,137,137 5,226,808 5,223,938 5,184,878 71.5%\n\n24,708,001 9,709,771 13,194,366 17,517,722 17,786,891 20,062,095 19,558,528 18,914,955 76.6%\n\nSelected: 77.0%\n\nLarge Loss Load: 1.080\n\nULAE Load: 1.074\n\nProjected Loss and LAE Ratio: 89.3%\n\nCredibility (Z): 90.3%\n\nZ-Weighted Indication: 88.8%\n\nTargeted Loss and LAE Ratio: 65.0%\n\nIndicated Rate Need: 36.5%\n\n2/27/2018 Prepared by Brian M. Fernandes, ACAS, MAAA","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1213.pdf"]},"response":{"errors":[],"extract_id":"extract_ff9f6a31711d11820e36083a6fc70327","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Aegis TST Trucking Program** TX\n\n**Historical Experience Review** Liability\n\n**Results as-of 12/31/17** Loss & ALAE Limitation 500,000\n\n**Auto Liability**\n\n**Texas**\n\nSelected\n\nOn-Level Average Ultimate Ultimate Ultimate\n\nAccident Written Earned On-Level Earned Policy Premium Exposure Claim Claim Claim Claim Claim\n\nYear Premium Premium Factor Premium Counts Per Policy Counts Counts LDF Counts Frequency Severity\n\n2013 2,277,113 1,269,037 1.244 1,578,259 23 99,005 689 59 1.000 59 0.1 15,708\n\n2014 3,160,677 2,712,097 1.244 3,373,119 29 108,989 995 111 1.001 111 0.1 33,315\n\n2015 5,260,800 4,159,483 1.239 5,153,698 45 116,907 1,674 174 1.003 175 0.1 17,255\n\n2016 6,986,792 6,147,786 1.196 7,350,808 57 122,575 2,082 270 1.008 272 0.1 22,377\n\n2017 6,493,866 6,586,311 1.101 7,252,117 56 115,962 1,708 269 1.058 285 0.2 18,211\n\n24,179,249 20,874,715 24,708,001 210 115,139 7,148 883 902 0.1 20,981\n\n3\\.5% Trended Ultimate L&ALAE Indications Selected\n\nOn-Level Reported Reported Loss Paid Paid Incurred Incurred Ultimate Ultimate\n\nAccident Earned Paid Incurred Trend Paid Incurred Chain- Bornhuetter- Chain- Bornhuetter- Trended L&ALAE\n\nYear Premium L&ALAE L&ALAE Factor LDF LDF Ladder Ferguson Ladder Ferguson L&ALAE Ratio\n\n2013 1,578,259 765,165 765,165 1.188 1.025 1.015 931,496 936,492 922,408 925,570 926,767 58.7%\n\n2014 3,373,119 2,823,859 3,255,624 1.148 1.076 1.040 3,487,527 3,412,508 3,886,740 3,830,154 3,701,656 109.7%\n\n2015 5,153,698 2,022,044 2,400,040 1.109 1.238 1.144 2,774,742 2,954,478 3,045,244 3,129,213 3,011,366 58.4%\n\n2016 7,350,808 2,711,368 4,466,194 1.071 1.857 1.459 5,392,267 5,346,276 6,980,895 6,449,653 6,090,288 82.9%\n\n2017 7,252,117 1,387,335 2,307,343 1.035 3.435 2.189 4,931,690 5,137,137 5,226,808 5,223,938 5,184,878 71.5%\n\n24,708,001 9,709,771 13,194,366 17,517,722 17,786,891 20,062,095 19,558,528 18,914,955 76.6%\n\nSelected: 77.0%\n\nLarge Loss Load: 1.080\n\nULAE Load: 1.074\n\nProjected Loss and LAE Ratio: 89.3%\n\nCredibility (Z): 90.3%\n\nZ-Weighted Indication: 88.8%\n\nTargeted Loss and LAE Ratio: 65.0%\n\nIndicated Rate Need: 36.5%\n\n2/27/2018 Prepared by Brian M. Fernandes, ACAS, MAAA"],"full_content":"**Aegis TST Trucking Program** TX\n\n**Historical Experience Review** Liability\n\n**Results as-of 12/31/17** Loss & ALAE Limitation 500,000\n\n**Auto Liability**\n\n**Texas**\n\nSelected\n\nOn-Level Average Ultimate Ultimate Ultimate\n\nAccident Written Earned On-Level Earned Policy Premium Exposure Claim Claim Claim Claim Claim\n\nYear Premium Premium Factor Premium Counts Per Policy Counts Counts LDF Counts Frequency Severity\n\n2013 2,277,113 1,269,037 1.244 1,578,259 23 99,005 689 59 1.000 59 0.1 15,708\n\n2014 3,160,677 2,712,097 1.244 3,373,119 29 108,989 995 111 1.001 111 0.1 33,315\n\n2015 5,260,800 4,159,483 1.239 5,153,698 45 116,907 1,674 174 1.003 175 0.1 17,255\n\n2016 6,986,792 6,147,786 1.196 7,350,808 57 122,575 2,082 270 1.008 272 0.1 22,377\n\n2017 6,493,866 6,586,311 1.101 7,252,117 56 115,962 1,708 269 1.058 285 0.2 18,211\n\n24,179,249 20,874,715 24,708,001 210 115,139 7,148 883 902 0.1 20,981\n\n3\\.5% Trended Ultimate L&ALAE Indications Selected\n\nOn-Level Reported Reported Loss Paid Paid Incurred Incurred Ultimate Ultimate\n\nAccident Earned Paid Incurred Trend Paid Incurred Chain- Bornhuetter- Chain- Bornhuetter- Trended L&ALAE\n\nYear Premium L&ALAE L&ALAE Factor LDF LDF Ladder Ferguson Ladder Ferguson L&ALAE Ratio\n\n2013 1,578,259 765,165 765,165 1.188 1.025 1.015 931,496 936,492 922,408 925,570 926,767 58.7%\n\n2014 3,373,119 2,823,859 3,255,624 1.148 1.076 1.040 3,487,527 3,412,508 3,886,740 3,830,154 3,701,656 109.7%\n\n2015 5,153,698 2,022,044 2,400,040 1.109 1.238 1.144 2,774,742 2,954,478 3,045,244 3,129,213 3,011,366 58.4%\n\n2016 7,350,808 2,711,368 4,466,194 1.071 1.857 1.459 5,392,267 5,346,276 6,980,895 6,449,653 6,090,288 82.9%\n\n2017 7,252,117 1,387,335 2,307,343 1.035 3.435 2.189 4,931,690 5,137,137 5,226,808 5,223,938 5,184,878 71.5%\n\n24,708,001 9,709,771 13,194,366 17,517,722 17,786,891 20,062,095 19,558,528 18,914,955 76.6%\n\nSelected: 77.0%\n\nLarge Loss Load: 1.080\n\nULAE Load: 1.074\n\nProjected Loss and LAE Ratio: 89.3%\n\nCredibility (Z): 90.3%\n\nZ-Weighted Indication: 88.8%\n\nTargeted Loss and LAE Ratio: 65.0%\n\nIndicated Rate Need: 36.5%\n\n2/27/2018 Prepared by Brian M. Fernandes, ACAS, MAAA","publish_date":null,"title":"AegisTSTTruckingProgram TX HistoricalExperienceReview Liability Resultsas-of12/31/17 Loss&ALAELimitation 500,000 AutoLiability Texas Selected On-Level Average Ultimate Ultimate Ultimate Accident Written Earned On-Level Earned","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1213.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1213.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1213","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1213.pdf"},"started_at":"2026-11-04T19:48:26.748725"} +{"completed_at":"2026-11-04T19:48:29.011831","latency_in_ms":1044,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1214","grounded_pages":[],"layout_pages":[],"markdown":"### **Filing Fees**\n\n### **State Specific**\n\n### **State Fees**\n\nFee Required? Yes\n\nFee Amount: $50.00\n\nRetaliatory? No\n\nFee Explanation: Rate Filing = $50.00\n\nPer Company: No\n\n**Company Amount Date Processed Transaction #**\n\nRenaissance Life & Health Insurance Company of America\n\n$50.00 08/27/2020 10:24 AM 183330408\n\n**EFT Total $50.00**\n\n1\\. The filing must not contain any Personally Identifiable Information (PII). Does the filing contain PII? Yes or No: No 2.If submitting a life insurance policy, will the policy be illustrated? Yes or No or N/A: N/A\n\n**_SERFF Tracking #:_** _RENA-132504873_ **_State Tracking #:_** _RENA-132504873_ **_Company Tracking #:_** _2021 REN/REN NON-EHB INVD RATES - DENTAL_\n\n**_State:_** _Texas_ **_Filing Company:_** _Renaissance Life & Health Insurance Company of America_\n\n**_TOI/Sub-TOI:_** _H10I Individual Health - Dental/H10I.000 Health - Dental_\n\n**_Product Name:_** _2021 Ren/Ren Non-EHB Invd Rates - Dental_\n\n**_Project Name/Number:_** _2021 Ren/Ren Non-EHB Invd Rates - Dental/2021 Ren/Ren Non-EHB Invd Rates - Dental_\n\n_PDF Pipeline for SERFF Tracking Number RENA-132504873 Generated 02/23/2026 07:00 PM_","pages":[{"line_numbers":[],"markdown":"### **Filing Fees**\n\n### **State Specific**\n\n### **State Fees**\n\nFee Required? Yes\n\nFee Amount: $50.00\n\nRetaliatory? No\n\nFee Explanation: Rate Filing = $50.00\n\nPer Company: No\n\n**Company Amount Date Processed Transaction #**\n\nRenaissance Life & Health Insurance Company of America\n\n$50.00 08/27/2020 10:24 AM 183330408\n\n**EFT Total $50.00**\n\n1\\. The filing must not contain any Personally Identifiable Information (PII). Does the filing contain PII? Yes or No: No 2.If submitting a life insurance policy, will the policy be illustrated? Yes or No or N/A: N/A\n\n**_SERFF Tracking #:_** _RENA-132504873_ **_State Tracking #:_** _RENA-132504873_ **_Company Tracking #:_** _2021 REN/REN NON-EHB INVD RATES - DENTAL_\n\n**_State:_** _Texas_ **_Filing Company:_** _Renaissance Life & Health Insurance Company of America_\n\n**_TOI/Sub-TOI:_** _H10I Individual Health - Dental/H10I.000 Health - Dental_\n\n**_Product Name:_** _2021 Ren/Ren Non-EHB Invd Rates - Dental_\n\n**_Project Name/Number:_** _2021 Ren/Ren Non-EHB Invd Rates - Dental/2021 Ren/Ren Non-EHB Invd Rates - Dental_\n\n_PDF Pipeline for SERFF Tracking Number RENA-132504873 Generated 02/23/2026 07:00 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Filing Fees**\n\n### **State Specific**\n\n### **State Fees**\n\nFee Required? Yes\n\nFee Amount: $50.00\n\nRetaliatory? No\n\nFee Explanation: Rate Filing = $50.00\n\nPer Company: No\n\n**Company Amount Date Processed Transaction #**\n\nRenaissance Life & Health Insurance Company of America\n\n$50.00 08/27/2020 10:24 AM 183330408\n\n**EFT Total $50.00**\n\n1\\. The filing must not contain any Personally Identifiable Information (PII). Does the filing contain PII? Yes or No: No 2.If submitting a life insurance policy, will the policy be illustrated? Yes or No or N/A: N/A\n\n**_SERFF Tracking #:_** _RENA-132504873_ **_State Tracking #:_** _RENA-132504873_ **_Company Tracking #:_** _2021 REN/REN NON-EHB INVD RATES - DENTAL_\n\n**_State:_** _Texas_ **_Filing Company:_** _Renaissance Life & Health Insurance Company of America_\n\n**_TOI/Sub-TOI:_** _H10I Individual Health - Dental/H10I.000 Health - Dental_\n\n**_Product Name:_** _2021 Ren/Ren Non-EHB Invd Rates - Dental_\n\n**_Project Name/Number:_** _2021 Ren/Ren Non-EHB Invd Rates - Dental/2021 Ren/Ren Non-EHB Invd Rates - Dental_\n\n_PDF Pipeline for SERFF Tracking Number RENA-132504873 Generated 02/23/2026 07:00 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1214.pdf"]},"response":{"errors":[],"extract_id":"extract_b2318780098bc022ba153a3230f7a4f0","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Filing Fees**\n\n### **State Specific**\n\n### **State Fees**\n\nFee Required? Yes\n\nFee Amount: $50.00\n\nRetaliatory? No\n\nFee Explanation: Rate Filing = $50.00\n\nPer Company: No\n\n**Company Amount Date Processed Transaction #**\n\nRenaissance Life & Health Insurance Company of America\n\n$50.00 08/27/2020 10:24 AM 183330408\n\n**EFT Total $50.00**\n\n1\\. The filing must not contain any Personally Identifiable Information (PII). Does the filing contain PII? Yes or No: No 2.If submitting a life insurance policy, will the policy be illustrated? Yes or No or N/A: N/A\n\n**_SERFF Tracking #:_** _RENA-132504873_ **_State Tracking #:_** _RENA-132504873_ **_Company Tracking #:_** _2021 REN/REN NON-EHB INVD RATES - DENTAL_\n\n**_State:_** _Texas_ **_Filing Company:_** _Renaissance Life & Health Insurance Company of America_\n\n**_TOI/Sub-TOI:_** _H10I Individual Health - Dental/H10I.000 Health - Dental_\n\n**_Product Name:_** _2021 Ren/Ren Non-EHB Invd Rates - Dental_\n\n**_Project Name/Number:_** _2021 Ren/Ren Non-EHB Invd Rates - Dental/2021 Ren/Ren Non-EHB Invd Rates - Dental_\n\n_PDF Pipeline for SERFF Tracking Number RENA-132504873 Generated 02/23/2026 07:00 PM_"],"full_content":"### **Filing Fees**\n\n### **State Specific**\n\n### **State Fees**\n\nFee Required? Yes\n\nFee Amount: $50.00\n\nRetaliatory? No\n\nFee Explanation: Rate Filing = $50.00\n\nPer Company: No\n\n**Company Amount Date Processed Transaction #**\n\nRenaissance Life & Health Insurance Company of America\n\n$50.00 08/27/2020 10:24 AM 183330408\n\n**EFT Total $50.00**\n\n1\\. The filing must not contain any Personally Identifiable Information (PII). Does the filing contain PII? Yes or No: No 2.If submitting a life insurance policy, will the policy be illustrated? Yes or No or N/A: N/A\n\n**_SERFF Tracking #:_** _RENA-132504873_ **_State Tracking #:_** _RENA-132504873_ **_Company Tracking #:_** _2021 REN/REN NON-EHB INVD RATES - DENTAL_\n\n**_State:_** _Texas_ **_Filing Company:_** _Renaissance Life & Health Insurance Company of America_\n\n**_TOI/Sub-TOI:_** _H10I Individual Health - Dental/H10I.000 Health - Dental_\n\n**_Product Name:_** _2021 Ren/Ren Non-EHB Invd Rates - Dental_\n\n**_Project Name/Number:_** _2021 Ren/Ren Non-EHB Invd Rates - Dental/2021 Ren/Ren Non-EHB Invd Rates - Dental_\n\n_PDF Pipeline for SERFF Tracking Number RENA-132504873 Generated 02/23/2026 07:00 PM_","publish_date":null,"title":"Filing Fees State Specific","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1214.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1214.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1214","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1214.pdf"},"started_at":"2026-11-04T19:48:27.967789"} +{"completed_at":"2026-11-04T19:48:30.399830","latency_in_ms":1522,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1220","grounded_pages":[],"layout_pages":[],"markdown":"Form MCS-10-F Preferred Rates Texas\n\nRESERVE NATIONAL INSURANCE COMPANY\n\nMedicare Supplement Policy Attained Age Rated Premiums\n\nAttained\n\nAge\n\nRegular Monthly\n\nBank Draft Monthly Quarterly Semi-Annual Annual\n\nUnder 65 $397.65 $365.85 $1,169.10 $2,314.30 $4,390.05\n\n65 $207.35 $190.75 $609.60 $1,206.80 $2,289.15\n\n66 $214.65 $197.50 $631.05 $1,249.25 $2,369.75\n\n67 $222.10 $204.35 $652.95 $1,292.60 $2,452.00\n\n68 $229.95 $211.55 $676.05 $1,338.30 $2,538.65\n\n69 $238.00 $218.95 $699.70 $1,385.15 $2,627.50\n\n70 $246.30 $226.60 $724.10 $1,433.45 $2,719.15\n\n71 $254.40 $234.05 $747.95 $1,480.60 $2,808.60\n\n72 $262.85 $241.80 $772.80 $1,529.80 $2,901.85\n\n73 $271.50 $249.80 $798.20 $1,580.15 $2,997.35\n\n74 $280.45 $258.00 $824.50 $1,632.20 $3,096.15\n\n75 $289.65 $266.50 $851.55 $1,685.75 $3,197.75\n\n76 $298.40 $274.55 $877.30 $1,736.70 $3,294.35\n\n77 $307.40 $282.80 $903.75 $1,789.05 $3,393.70\n\n78 $316.60 $291.25 $930.80 $1,842.60 $3,495.25\n\n79 $326.05 $299.95 $958.60 $1,897.60 $3,599.60\n\n80 $335.85 $309.00 $987.40 $1,954.65 $3,707.80\n\n81 $342.60 $315.20 $1,007.25 $1,993.95 $3,782.30\n\n82 $349.45 $321.50 $1,027.40 $2,033.80 $3,857.95\n\n83 $356.40 $327.90 $1,047.80 $2,074.25 $3,934.65\n\n84 $363.50 $334.40 $1,068.70 $2,115.55 $4,013.05\n\n85 $370.85 $341.20 $1,090.30 $2,158.35 $4,094.20\n\n86 $372.70 $342.90 $1,095.75 $2,169.10 $4,114.60\n\n87 $374.55 $344.60 $1,101.20 $2,179.90 $4,135.05\n\n88 $376.40 $346.30 $1,106.60 $2,190.65 $4,155.45\n\n89 $378.30 $348.05 $1,112.20 $2,201.70 $4,176.45\n\n90 $380.15 $349.75 $1,117.65 $2,212.45 $4,196.85\n\n91 $382.10 $351.55 $1,123.35 $2,223.80 $4,218.40\n\n92 $384.00 $353.30 $1,128.95 $2,234.90 $4,239.35\n\n93 $385.90 $355.05 $1,134.55 $2,245.95 $4,260.35\n\n94 $387.90 $356.85 $1,140.45 $2,257.60 $4,282.40\n\n95 $389.85 $358.65 $1,146.15 $2,268.95 $4,303.95\n\n96 $391.75 $360.40 $1,151.75 $2,280.00 $4,324.90\n\n97 $393.75 $362.25 $1,157.65 $2,291.65 $4,347.00\n\n98 $395.70 $364.05 $1,163.35 $2,302.95 $4,368.55\n\n99+ $397.65 $365.85 $1,169.10 $2,314.30 $4,390.05\n\nSemi-Annual Rate = Monthly Rate X 5.82 Annual Rate =Monthly Rate X 11.04\n\nTobacco\n\nMonthly Bank Draft = Monthly Rate X .92 Quarterly Rate =Monthly Rate X 2.94\n\nWith Proposed 4.4% Increase","pages":[{"line_numbers":[],"markdown":"Form MCS-10-F Preferred Rates Texas\n\nRESERVE NATIONAL INSURANCE COMPANY\n\nMedicare Supplement Policy Attained Age Rated Premiums\n\nAttained\n\nAge\n\nRegular Monthly\n\nBank Draft Monthly Quarterly Semi-Annual Annual\n\nUnder 65 $397.65 $365.85 $1,169.10 $2,314.30 $4,390.05\n\n65 $207.35 $190.75 $609.60 $1,206.80 $2,289.15\n\n66 $214.65 $197.50 $631.05 $1,249.25 $2,369.75\n\n67 $222.10 $204.35 $652.95 $1,292.60 $2,452.00\n\n68 $229.95 $211.55 $676.05 $1,338.30 $2,538.65\n\n69 $238.00 $218.95 $699.70 $1,385.15 $2,627.50\n\n70 $246.30 $226.60 $724.10 $1,433.45 $2,719.15\n\n71 $254.40 $234.05 $747.95 $1,480.60 $2,808.60\n\n72 $262.85 $241.80 $772.80 $1,529.80 $2,901.85\n\n73 $271.50 $249.80 $798.20 $1,580.15 $2,997.35\n\n74 $280.45 $258.00 $824.50 $1,632.20 $3,096.15\n\n75 $289.65 $266.50 $851.55 $1,685.75 $3,197.75\n\n76 $298.40 $274.55 $877.30 $1,736.70 $3,294.35\n\n77 $307.40 $282.80 $903.75 $1,789.05 $3,393.70\n\n78 $316.60 $291.25 $930.80 $1,842.60 $3,495.25\n\n79 $326.05 $299.95 $958.60 $1,897.60 $3,599.60\n\n80 $335.85 $309.00 $987.40 $1,954.65 $3,707.80\n\n81 $342.60 $315.20 $1,007.25 $1,993.95 $3,782.30\n\n82 $349.45 $321.50 $1,027.40 $2,033.80 $3,857.95\n\n83 $356.40 $327.90 $1,047.80 $2,074.25 $3,934.65\n\n84 $363.50 $334.40 $1,068.70 $2,115.55 $4,013.05\n\n85 $370.85 $341.20 $1,090.30 $2,158.35 $4,094.20\n\n86 $372.70 $342.90 $1,095.75 $2,169.10 $4,114.60\n\n87 $374.55 $344.60 $1,101.20 $2,179.90 $4,135.05\n\n88 $376.40 $346.30 $1,106.60 $2,190.65 $4,155.45\n\n89 $378.30 $348.05 $1,112.20 $2,201.70 $4,176.45\n\n90 $380.15 $349.75 $1,117.65 $2,212.45 $4,196.85\n\n91 $382.10 $351.55 $1,123.35 $2,223.80 $4,218.40\n\n92 $384.00 $353.30 $1,128.95 $2,234.90 $4,239.35\n\n93 $385.90 $355.05 $1,134.55 $2,245.95 $4,260.35\n\n94 $387.90 $356.85 $1,140.45 $2,257.60 $4,282.40\n\n95 $389.85 $358.65 $1,146.15 $2,268.95 $4,303.95\n\n96 $391.75 $360.40 $1,151.75 $2,280.00 $4,324.90\n\n97 $393.75 $362.25 $1,157.65 $2,291.65 $4,347.00\n\n98 $395.70 $364.05 $1,163.35 $2,302.95 $4,368.55\n\n99+ $397.65 $365.85 $1,169.10 $2,314.30 $4,390.05\n\nSemi-Annual Rate = Monthly Rate X 5.82 Annual Rate =Monthly Rate X 11.04\n\nTobacco\n\nMonthly Bank Draft = Monthly Rate X .92 Quarterly Rate =Monthly Rate X 2.94\n\nWith Proposed 4.4% Increase","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Form MCS-10-F Preferred Rates Texas\n\nRESERVE NATIONAL INSURANCE COMPANY\n\nMedicare Supplement Policy Attained Age Rated Premiums\n\nAttained\n\nAge\n\nRegular Monthly\n\nBank Draft Monthly Quarterly Semi-Annual Annual\n\nUnder 65 $397.65 $365.85 $1,169.10 $2,314.30 $4,390.05\n\n65 $207.35 $190.75 $609.60 $1,206.80 $2,289.15\n\n66 $214.65 $197.50 $631.05 $1,249.25 $2,369.75\n\n67 $222.10 $204.35 $652.95 $1,292.60 $2,452.00\n\n68 $229.95 $211.55 $676.05 $1,338.30 $2,538.65\n\n69 $238.00 $218.95 $699.70 $1,385.15 $2,627.50\n\n70 $246.30 $226.60 $724.10 $1,433.45 $2,719.15\n\n71 $254.40 $234.05 $747.95 $1,480.60 $2,808.60\n\n72 $262.85 $241.80 $772.80 $1,529.80 $2,901.85\n\n73 $271.50 $249.80 $798.20 $1,580.15 $2,997.35\n\n74 $280.45 $258.00 $824.50 $1,632.20 $3,096.15\n\n75 $289.65 $266.50 $851.55 $1,685.75 $3,197.75\n\n76 $298.40 $274.55 $877.30 $1,736.70 $3,294.35\n\n77 $307.40 $282.80 $903.75 $1,789.05 $3,393.70\n\n78 $316.60 $291.25 $930.80 $1,842.60 $3,495.25\n\n79 $326.05 $299.95 $958.60 $1,897.60 $3,599.60\n\n80 $335.85 $309.00 $987.40 $1,954.65 $3,707.80\n\n81 $342.60 $315.20 $1,007.25 $1,993.95 $3,782.30\n\n82 $349.45 $321.50 $1,027.40 $2,033.80 $3,857.95\n\n83 $356.40 $327.90 $1,047.80 $2,074.25 $3,934.65\n\n84 $363.50 $334.40 $1,068.70 $2,115.55 $4,013.05\n\n85 $370.85 $341.20 $1,090.30 $2,158.35 $4,094.20\n\n86 $372.70 $342.90 $1,095.75 $2,169.10 $4,114.60\n\n87 $374.55 $344.60 $1,101.20 $2,179.90 $4,135.05\n\n88 $376.40 $346.30 $1,106.60 $2,190.65 $4,155.45\n\n89 $378.30 $348.05 $1,112.20 $2,201.70 $4,176.45\n\n90 $380.15 $349.75 $1,117.65 $2,212.45 $4,196.85\n\n91 $382.10 $351.55 $1,123.35 $2,223.80 $4,218.40\n\n92 $384.00 $353.30 $1,128.95 $2,234.90 $4,239.35\n\n93 $385.90 $355.05 $1,134.55 $2,245.95 $4,260.35\n\n94 $387.90 $356.85 $1,140.45 $2,257.60 $4,282.40\n\n95 $389.85 $358.65 $1,146.15 $2,268.95 $4,303.95\n\n96 $391.75 $360.40 $1,151.75 $2,280.00 $4,324.90\n\n97 $393.75 $362.25 $1,157.65 $2,291.65 $4,347.00\n\n98 $395.70 $364.05 $1,163.35 $2,302.95 $4,368.55\n\n99+ $397.65 $365.85 $1,169.10 $2,314.30 $4,390.05\n\nSemi-Annual Rate = Monthly Rate X 5.82 Annual Rate =Monthly Rate X 11.04\n\nTobacco\n\nMonthly Bank Draft = Monthly Rate X .92 Quarterly Rate =Monthly Rate X 2.94\n\nWith Proposed 4.4% Increase","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1220.pdf"]},"response":{"errors":[],"extract_id":"extract_4963ea9e52e9b4e4ad9e91153e63367e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Form MCS-10-F Preferred Rates Texas\n\nRESERVE NATIONAL INSURANCE COMPANY\n\nMedicare Supplement Policy Attained Age Rated Premiums\n\nAttained\n\nAge\n\nRegular Monthly\n\nBank Draft Monthly Quarterly Semi-Annual Annual\n\nUnder 65 $397.65 $365.85 $1,169.10 $2,314.30 $4,390.05\n\n65 $207.35 $190.75 $609.60 $1,206.80 $2,289.15\n\n66 $214.65 $197.50 $631.05 $1,249.25 $2,369.75\n\n67 $222.10 $204.35 $652.95 $1,292.60 $2,452.00\n\n68 $229.95 $211.55 $676.05 $1,338.30 $2,538.65\n\n69 $238.00 $218.95 $699.70 $1,385.15 $2,627.50\n\n70 $246.30 $226.60 $724.10 $1,433.45 $2,719.15\n\n71 $254.40 $234.05 $747.95 $1,480.60 $2,808.60\n\n72 $262.85 $241.80 $772.80 $1,529.80 $2,901.85\n\n73 $271.50 $249.80 $798.20 $1,580.15 $2,997.35\n\n74 $280.45 $258.00 $824.50 $1,632.20 $3,096.15\n\n75 $289.65 $266.50 $851.55 $1,685.75 $3,197.75\n\n76 $298.40 $274.55 $877.30 $1,736.70 $3,294.35\n\n77 $307.40 $282.80 $903.75 $1,789.05 $3,393.70\n\n78 $316.60 $291.25 $930.80 $1,842.60 $3,495.25\n\n79 $326.05 $299.95 $958.60 $1,897.60 $3,599.60\n\n80 $335.85 $309.00 $987.40 $1,954.65 $3,707.80\n\n81 $342.60 $315.20 $1,007.25 $1,993.95 $3,782.30\n\n82 $349.45 $321.50 $1,027.40 $2,033.80 $3,857.95\n\n83 $356.40 $327.90 $1,047.80 $2,074.25 $3,934.65\n\n84 $363.50 $334.40 $1,068.70 $2,115.55 $4,013.05\n\n85 $370.85 $341.20 $1,090.30 $2,158.35 $4,094.20\n\n86 $372.70 $342.90 $1,095.75 $2,169.10 $4,114.60\n\n87 $374.55 $344.60 $1,101.20 $2,179.90 $4,135.05\n\n88 $376.40 $346.30 $1,106.60 $2,190.65 $4,155.45\n\n89 $378.30 $348.05 $1,112.20 $2,201.70 $4,176.45\n\n90 $380.15 $349.75 $1,117.65 $2,212.45 $4,196.85\n\n91 $382.10 $351.55 $1,123.35 $2,223.80 $4,218.40\n\n92 $384.00 $353.30 $1,128.95 $2,234.90 $4,239.35\n\n93 $385.90 $355.05 $1,134.55 $2,245.95 $4,260.35\n\n94 $387.90 $356.85 $1,140.45 $2,257.60 $4,282.40\n\n95 $389.85 $358.65 $1,146.15 $2,268.95 $4,303.95\n\n96 $391.75 $360.40 $1,151.75 $2,280.00 $4,324.90\n\n97 $393.75 $362.25 $1,157.65 $2,291.65 $4,347.00\n\n98 $395.70 $364.05 $1,163.35 $2,302.95 $4,368.55\n\n99+ $397.65 $365.85 $1,169.10 $2,314.30 $4,390.05\n\nSemi-Annual Rate = Monthly Rate X 5.82 Annual Rate =Monthly Rate X 11.04\n\nTobacco\n\nMonthly Bank Draft = Monthly Rate X .92 Quarterly Rate =Monthly Rate X 2.94\n\nWith Proposed 4.4% Increase"],"full_content":"Form MCS-10-F Preferred Rates Texas\n\nRESERVE NATIONAL INSURANCE COMPANY\n\nMedicare Supplement Policy Attained Age Rated Premiums\n\nAttained\n\nAge\n\nRegular Monthly\n\nBank Draft Monthly Quarterly Semi-Annual Annual\n\nUnder 65 $397.65 $365.85 $1,169.10 $2,314.30 $4,390.05\n\n65 $207.35 $190.75 $609.60 $1,206.80 $2,289.15\n\n66 $214.65 $197.50 $631.05 $1,249.25 $2,369.75\n\n67 $222.10 $204.35 $652.95 $1,292.60 $2,452.00\n\n68 $229.95 $211.55 $676.05 $1,338.30 $2,538.65\n\n69 $238.00 $218.95 $699.70 $1,385.15 $2,627.50\n\n70 $246.30 $226.60 $724.10 $1,433.45 $2,719.15\n\n71 $254.40 $234.05 $747.95 $1,480.60 $2,808.60\n\n72 $262.85 $241.80 $772.80 $1,529.80 $2,901.85\n\n73 $271.50 $249.80 $798.20 $1,580.15 $2,997.35\n\n74 $280.45 $258.00 $824.50 $1,632.20 $3,096.15\n\n75 $289.65 $266.50 $851.55 $1,685.75 $3,197.75\n\n76 $298.40 $274.55 $877.30 $1,736.70 $3,294.35\n\n77 $307.40 $282.80 $903.75 $1,789.05 $3,393.70\n\n78 $316.60 $291.25 $930.80 $1,842.60 $3,495.25\n\n79 $326.05 $299.95 $958.60 $1,897.60 $3,599.60\n\n80 $335.85 $309.00 $987.40 $1,954.65 $3,707.80\n\n81 $342.60 $315.20 $1,007.25 $1,993.95 $3,782.30\n\n82 $349.45 $321.50 $1,027.40 $2,033.80 $3,857.95\n\n83 $356.40 $327.90 $1,047.80 $2,074.25 $3,934.65\n\n84 $363.50 $334.40 $1,068.70 $2,115.55 $4,013.05\n\n85 $370.85 $341.20 $1,090.30 $2,158.35 $4,094.20\n\n86 $372.70 $342.90 $1,095.75 $2,169.10 $4,114.60\n\n87 $374.55 $344.60 $1,101.20 $2,179.90 $4,135.05\n\n88 $376.40 $346.30 $1,106.60 $2,190.65 $4,155.45\n\n89 $378.30 $348.05 $1,112.20 $2,201.70 $4,176.45\n\n90 $380.15 $349.75 $1,117.65 $2,212.45 $4,196.85\n\n91 $382.10 $351.55 $1,123.35 $2,223.80 $4,218.40\n\n92 $384.00 $353.30 $1,128.95 $2,234.90 $4,239.35\n\n93 $385.90 $355.05 $1,134.55 $2,245.95 $4,260.35\n\n94 $387.90 $356.85 $1,140.45 $2,257.60 $4,282.40\n\n95 $389.85 $358.65 $1,146.15 $2,268.95 $4,303.95\n\n96 $391.75 $360.40 $1,151.75 $2,280.00 $4,324.90\n\n97 $393.75 $362.25 $1,157.65 $2,291.65 $4,347.00\n\n98 $395.70 $364.05 $1,163.35 $2,302.95 $4,368.55\n\n99+ $397.65 $365.85 $1,169.10 $2,314.30 $4,390.05\n\nSemi-Annual Rate = Monthly Rate X 5.82 Annual Rate =Monthly Rate X 11.04\n\nTobacco\n\nMonthly Bank Draft = Monthly Rate X .92 Quarterly Rate =Monthly Rate X 2.94\n\nWith Proposed 4.4% Increase","publish_date":null,"title":"RESERVE NATIONAL INSURANCE COMPANY Medicare Supplement Policy Attained Age Rated Premiums Form MCS-10-F Preferred Rates Texas With Proposed 4.4% Increase","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1220.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1220.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1220","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1220.pdf"},"started_at":"2026-11-04T19:48:28.877484"} +{"completed_at":"2026-11-04T19:31:09.206495","latency_in_ms":2489,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1282","grounded_pages":[],"layout_pages":[],"markdown":"### Ms. Bonnie Tang March 9, 2020 Page 2\n\n### _3\\._ _Please provide a brief premium and benefit comparison between the forms 3034-_\n\n### _TX/3035-TX and 3034-TX (6/02)/3035-TX(6/02)._\n\n### The table below demonstrates the annual premium per $10 of nursing home maximum daily benefit for the most popular product sold in Texas, base plan policies (those without inflation) with unlimited benefit period and a 90-day elimination period.\n\n**_Issue Age 60 65 70_**\n\n**_3034-TX_** 101 154 253\n\n**_3034Q-TX_** 108 165 271\n\n**_3035-TX_** 61 93 156\n\n**_3035Q-TX_** 65 99 167\n\n### From a benefits perspective the 6/02 forms have more restrictive benefit eligibility requirements. The 6/02 forms also have a Contingent Benefit Upon Lapse option.\n\n### Thank you for your assistance in reviewing this filing. Sincerely,\n\n### Philip York, ASA, MAAA\n\n### Senior Actuarial Analyst","pages":[{"line_numbers":[],"markdown":"### Ms. Bonnie Tang March 9, 2020 Page 2\n\n### _3\\._ _Please provide a brief premium and benefit comparison between the forms 3034-_\n\n### _TX/3035-TX and 3034-TX (6/02)/3035-TX(6/02)._\n\n### The table below demonstrates the annual premium per $10 of nursing home maximum daily benefit for the most popular product sold in Texas, base plan policies (those without inflation) with unlimited benefit period and a 90-day elimination period.\n\n**_Issue Age 60 65 70_**\n\n**_3034-TX_** 101 154 253\n\n**_3034Q-TX_** 108 165 271\n\n**_3035-TX_** 61 93 156\n\n**_3035Q-TX_** 65 99 167\n\n### From a benefits perspective the 6/02 forms have more restrictive benefit eligibility requirements. The 6/02 forms also have a Contingent Benefit Upon Lapse option.\n\n### Thank you for your assistance in reviewing this filing. Sincerely,\n\n### Philip York, ASA, MAAA\n\n### Senior Actuarial Analyst","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### Ms. Bonnie Tang March 9, 2020 Page 2\n\n### _3\\._ _Please provide a brief premium and benefit comparison between the forms 3034-_\n\n### _TX/3035-TX and 3034-TX (6/02)/3035-TX(6/02)._\n\n### The table below demonstrates the annual premium per $10 of nursing home maximum daily benefit for the most popular product sold in Texas, base plan policies (those without inflation) with unlimited benefit period and a 90-day elimination period.\n\n**_Issue Age 60 65 70_**\n\n**_3034-TX_** 101 154 253\n\n**_3034Q-TX_** 108 165 271\n\n**_3035-TX_** 61 93 156\n\n**_3035Q-TX_** 65 99 167\n\n### From a benefits perspective the 6/02 forms have more restrictive benefit eligibility requirements. The 6/02 forms also have a Contingent Benefit Upon Lapse option.\n\n### Thank you for your assistance in reviewing this filing. Sincerely,\n\n### Philip York, ASA, MAAA\n\n### Senior Actuarial Analyst","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1282.pdf"]},"response":{"errors":[],"extract_id":"extract_04460a554b067ef1d63b7eac0b892acb","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### Ms. Bonnie Tang March 9, 2020 Page 2\n\n### _3\\._ _Please provide a brief premium and benefit comparison between the forms 3034-_\n\n### _TX/3035-TX and 3034-TX (6/02)/3035-TX(6/02)._\n\n### The table below demonstrates the annual premium per $10 of nursing home maximum daily benefit for the most popular product sold in Texas, base plan policies (those without inflation) with unlimited benefit period and a 90-day elimination period.\n\n**_Issue Age 60 65 70_**\n\n**_3034-TX_** 101 154 253\n\n**_3034Q-TX_** 108 165 271\n\n**_3035-TX_** 61 93 156\n\n**_3035Q-TX_** 65 99 167\n\n### From a benefits perspective the 6/02 forms have more restrictive benefit eligibility requirements. The 6/02 forms also have a Contingent Benefit Upon Lapse option.\n\n### Thank you for your assistance in reviewing this filing. Sincerely,\n\n### Philip York, ASA, MAAA\n\n### Senior Actuarial Analyst"],"full_content":"### Ms. Bonnie Tang March 9, 2020 Page 2\n\n### _3\\._ _Please provide a brief premium and benefit comparison between the forms 3034-_\n\n### _TX/3035-TX and 3034-TX (6/02)/3035-TX(6/02)._\n\n### The table below demonstrates the annual premium per $10 of nursing home maximum daily benefit for the most popular product sold in Texas, base plan policies (those without inflation) with unlimited benefit period and a 90-day elimination period.\n\n**_Issue Age 60 65 70_**\n\n**_3034-TX_** 101 154 253\n\n**_3034Q-TX_** 108 165 271\n\n**_3035-TX_** 61 93 156\n\n**_3035Q-TX_** 65 99 167\n\n### From a benefits perspective the 6/02 forms have more restrictive benefit eligibility requirements. The 6/02 forms also have a Contingent Benefit Upon Lapse option.\n\n### Thank you for your assistance in reviewing this filing. Sincerely,\n\n### Philip York, ASA, MAAA\n\n### Senior Actuarial Analyst","publish_date":null,"title":"Ms. Bonnie Tang March 9, 2020 Page 2 3. Please provide a brief premium and benefit comparison between the forms","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1282.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1282.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1282","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1282.pdf"},"started_at":"2026-11-04T19:31:06.716915"} +{"completed_at":"2026-11-04T19:48:32.316525","latency_in_ms":1240,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1284","grounded_pages":[],"layout_pages":[],"markdown":"### Ms. Bonnie Tang November 20, 2020 Page 2\n\nAverage Annual Premium\\*\n\nNationwide Texas Pre-Rate Stability\n\nBefore Phase 1 $1,598.51 $1,058.65\n\nAfter Phase 1 $1,655.21 $1,360.37\n\nAfter Phase 2 $1,727.14 $1,748.08\n\nAfter Phase 3 $1,818.44 $2,246.28\n\n### \\*Averages based on Pre-Rate Stability Policies with lifetime benefit periods.\n\n### _4\\. Revised the Company Rate Information on Rate/Rule tab accordingly._\n\n### Thank you for your assistance in reviewing this filing. Sincerely,\n\n### Lynn Manchester, FSA, MAAA\n\n### Principal Consulting Actuary","pages":[{"line_numbers":[],"markdown":"### Ms. Bonnie Tang November 20, 2020 Page 2\n\nAverage Annual Premium\\*\n\nNationwide Texas Pre-Rate Stability\n\nBefore Phase 1 $1,598.51 $1,058.65\n\nAfter Phase 1 $1,655.21 $1,360.37\n\nAfter Phase 2 $1,727.14 $1,748.08\n\nAfter Phase 3 $1,818.44 $2,246.28\n\n### \\*Averages based on Pre-Rate Stability Policies with lifetime benefit periods.\n\n### _4\\. Revised the Company Rate Information on Rate/Rule tab accordingly._\n\n### Thank you for your assistance in reviewing this filing. Sincerely,\n\n### Lynn Manchester, FSA, MAAA\n\n### Principal Consulting Actuary","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### Ms. Bonnie Tang November 20, 2020 Page 2\n\nAverage Annual Premium\\*\n\nNationwide Texas Pre-Rate Stability\n\nBefore Phase 1 $1,598.51 $1,058.65\n\nAfter Phase 1 $1,655.21 $1,360.37\n\nAfter Phase 2 $1,727.14 $1,748.08\n\nAfter Phase 3 $1,818.44 $2,246.28\n\n### \\*Averages based on Pre-Rate Stability Policies with lifetime benefit periods.\n\n### _4\\. Revised the Company Rate Information on Rate/Rule tab accordingly._\n\n### Thank you for your assistance in reviewing this filing. Sincerely,\n\n### Lynn Manchester, FSA, MAAA\n\n### Principal Consulting Actuary","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1284.pdf"]},"response":{"errors":[],"extract_id":"extract_5382764e2fd6fd68b7e8c8199875cbf2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### Ms. Bonnie Tang November 20, 2020 Page 2\n\nAverage Annual Premium\\*\n\nNationwide Texas Pre-Rate Stability\n\nBefore Phase 1 $1,598.51 $1,058.65\n\nAfter Phase 1 $1,655.21 $1,360.37\n\nAfter Phase 2 $1,727.14 $1,748.08\n\nAfter Phase 3 $1,818.44 $2,246.28\n\n### \\*Averages based on Pre-Rate Stability Policies with lifetime benefit periods.\n\n### _4\\. Revised the Company Rate Information on Rate/Rule tab accordingly._\n\n### Thank you for your assistance in reviewing this filing. Sincerely,\n\n### Lynn Manchester, FSA, MAAA\n\n### Principal Consulting Actuary"],"full_content":"### Ms. Bonnie Tang November 20, 2020 Page 2\n\nAverage Annual Premium\\*\n\nNationwide Texas Pre-Rate Stability\n\nBefore Phase 1 $1,598.51 $1,058.65\n\nAfter Phase 1 $1,655.21 $1,360.37\n\nAfter Phase 2 $1,727.14 $1,748.08\n\nAfter Phase 3 $1,818.44 $2,246.28\n\n### \\*Averages based on Pre-Rate Stability Policies with lifetime benefit periods.\n\n### _4\\. Revised the Company Rate Information on Rate/Rule tab accordingly._\n\n### Thank you for your assistance in reviewing this filing. Sincerely,\n\n### Lynn Manchester, FSA, MAAA\n\n### Principal Consulting Actuary","publish_date":null,"title":"Ms. Bonnie Tang November 20, 2020 Page 2 *Averages based on Pre-Rate Stability Policies with lifetime benefit periods. 4. Revised","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1284.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1284.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1284","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1284.pdf"},"started_at":"2026-11-04T19:48:31.075964"} +{"completed_at":"2026-11-04T19:46:56.012802","latency_in_ms":4145,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1288","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit Ib**\n\n**Southern Farm Bureau Life Insurance Company**\n\n**Form Number(s): 3034/3035**\n\n**Lifetime Benefit Period**\n\n**Lifetime Experience (Texas Pre Rate Stability)**\n\nWithout Proposed Rate Increase With 3 28.5% Rate Increases 4.49%\n\nYear Earned Premium Incurred Claims Loss Ratio Earned Premium Incurred Claims Loss Ratio Discount\n\n2035 287,397 2,906,570 1011% 609,806 2,906,570 477% 0.484\n\n2036 252,390 2,787,660 1105% 535,527 2,787,660 521% 0.464\n\n2037 220,436 2,651,724 1203% 467,726 2,651,724 567% 0.444\n\n2038 191,413 2,503,492 1308% 406,145 2,503,492 616% 0.425\n\n2039 165,234 2,344,928 1419% 350,597 2,344,928 669% 0.406\n\n2040 141,764 2,180,120 1538% 300,799 2,180,120 725% 0.389\n\n2041 120,866 2,011,715 1664% 256,456 2,011,715 784% 0.372\n\n2042 102,330 1,840,369 1798% 217,127 1,840,369 848% 0.356\n\n2043 85,980 1,669,339 1942% 182,435 1,669,339 915% 0.341\n\n2044 71,701 1,501,777 2094% 152,137 1,501,777 987% 0.326\n\n2045 59,329 1,339,863 2258% 125,886 1,339,863 1064% 0.312\n\n2046 48,711 1,185,505 2434% 103,356 1,185,505 1147% 0.299\n\n2047 39,663 1,039,742 2621% 84,159 1,039,742 1235% 0.286\n\n2048 32,011 902,936 2821% 67,923 902,936 1329% 0.274\n\n2049 25,594 774,860 3028% 54,306 774,860 1427% 0.262\n\n2050 20,256 653,072 3224% 42,980 653,072 1519% 0.251\n\n2051 15,860 539,656 3403% 33,653 539,656 1604% 0.240\n\n2052 12,284 438,127 3567% 26,065 438,127 1681% 0.230\n\n2053 9,402 351,034 3734% 19,948 351,034 1760% 0.220\n\n2054 7,092 277,004 3906% 15,048 277,004 1841% 0.210\n\n2055 5,261 214,730 4082% 11,163 214,730 1924% 0.201\n\n2056 3,831 163,231 4261% 8,128 163,231 2008% 0.193\n\n2057 2,734 121,508 4444% 5,801 121,508 2095% 0.184\n\n2058 1,912 88,566 4631% 4,058 88,566 2183% 0.176\n\n2059 1,309 63,138 4823% 2,778 63,138 2273% 0.169\n\n2060 875 43,885 5016% 1,856 43,885 2364% 0.162\n\n2061 569 29,669 5214% 1,207 29,669 2457% 0.155\n\n2062 360 19,482 5415% 763 19,482 2552% 0.148\n\n2063 221 12,406 5620% 468 12,406 2649% 0.142\n\n2064 131 7,665 5829% 279 7,665 2747% 0.136\n\n2065 76 4,595 6042% 161 4,595 2848% 0.130\n\n2066 43 2,677 6263% 91 2,677 2952% 0.124\n\n2067 23 1,525 6494% 50 1,525 3061% 0.119\n\n2068 13 855 6729% 27 855 3171% 0.114\n\n2069 7 476 6971% 15 476 3285% 0.109\n\n2070 4 265 7226% 8 265 3406% 0.104\n\n2071 2 148 7495% 4 148 3532% 0.100\n\n2072 1 82 7776% 2 82 3665% 0.095\n\n2073 1 46 8072% 1 46 3804% 0.091\n\nHistorical 57,706,144 30,296,120 53% 57,706,144 30,296,120 53%\n\nFuture 9,722,687 45,652,489 470% 18,594,478 45,652,489 246%\n\nLifetime 67,428,831 75,948,609 113% 76,300,622 75,948,609 100%","pages":[{"line_numbers":[],"markdown":"**Exhibit Ib**\n\n**Southern Farm Bureau Life Insurance Company**\n\n**Form Number(s): 3034/3035**\n\n**Lifetime Benefit Period**\n\n**Lifetime Experience (Texas Pre Rate Stability)**\n\nWithout Proposed Rate Increase With 3 28.5% Rate Increases 4.49%\n\nYear Earned Premium Incurred Claims Loss Ratio Earned Premium Incurred Claims Loss Ratio Discount\n\n2035 287,397 2,906,570 1011% 609,806 2,906,570 477% 0.484\n\n2036 252,390 2,787,660 1105% 535,527 2,787,660 521% 0.464\n\n2037 220,436 2,651,724 1203% 467,726 2,651,724 567% 0.444\n\n2038 191,413 2,503,492 1308% 406,145 2,503,492 616% 0.425\n\n2039 165,234 2,344,928 1419% 350,597 2,344,928 669% 0.406\n\n2040 141,764 2,180,120 1538% 300,799 2,180,120 725% 0.389\n\n2041 120,866 2,011,715 1664% 256,456 2,011,715 784% 0.372\n\n2042 102,330 1,840,369 1798% 217,127 1,840,369 848% 0.356\n\n2043 85,980 1,669,339 1942% 182,435 1,669,339 915% 0.341\n\n2044 71,701 1,501,777 2094% 152,137 1,501,777 987% 0.326\n\n2045 59,329 1,339,863 2258% 125,886 1,339,863 1064% 0.312\n\n2046 48,711 1,185,505 2434% 103,356 1,185,505 1147% 0.299\n\n2047 39,663 1,039,742 2621% 84,159 1,039,742 1235% 0.286\n\n2048 32,011 902,936 2821% 67,923 902,936 1329% 0.274\n\n2049 25,594 774,860 3028% 54,306 774,860 1427% 0.262\n\n2050 20,256 653,072 3224% 42,980 653,072 1519% 0.251\n\n2051 15,860 539,656 3403% 33,653 539,656 1604% 0.240\n\n2052 12,284 438,127 3567% 26,065 438,127 1681% 0.230\n\n2053 9,402 351,034 3734% 19,948 351,034 1760% 0.220\n\n2054 7,092 277,004 3906% 15,048 277,004 1841% 0.210\n\n2055 5,261 214,730 4082% 11,163 214,730 1924% 0.201\n\n2056 3,831 163,231 4261% 8,128 163,231 2008% 0.193\n\n2057 2,734 121,508 4444% 5,801 121,508 2095% 0.184\n\n2058 1,912 88,566 4631% 4,058 88,566 2183% 0.176\n\n2059 1,309 63,138 4823% 2,778 63,138 2273% 0.169\n\n2060 875 43,885 5016% 1,856 43,885 2364% 0.162\n\n2061 569 29,669 5214% 1,207 29,669 2457% 0.155\n\n2062 360 19,482 5415% 763 19,482 2552% 0.148\n\n2063 221 12,406 5620% 468 12,406 2649% 0.142\n\n2064 131 7,665 5829% 279 7,665 2747% 0.136\n\n2065 76 4,595 6042% 161 4,595 2848% 0.130\n\n2066 43 2,677 6263% 91 2,677 2952% 0.124\n\n2067 23 1,525 6494% 50 1,525 3061% 0.119\n\n2068 13 855 6729% 27 855 3171% 0.114\n\n2069 7 476 6971% 15 476 3285% 0.109\n\n2070 4 265 7226% 8 265 3406% 0.104\n\n2071 2 148 7495% 4 148 3532% 0.100\n\n2072 1 82 7776% 2 82 3665% 0.095\n\n2073 1 46 8072% 1 46 3804% 0.091\n\nHistorical 57,706,144 30,296,120 53% 57,706,144 30,296,120 53%\n\nFuture 9,722,687 45,652,489 470% 18,594,478 45,652,489 246%\n\nLifetime 67,428,831 75,948,609 113% 76,300,622 75,948,609 100%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit Ib**\n\n**Southern Farm Bureau Life Insurance Company**\n\n**Form Number(s): 3034/3035**\n\n**Lifetime Benefit Period**\n\n**Lifetime Experience (Texas Pre Rate Stability)**\n\nWithout Proposed Rate Increase With 3 28.5% Rate Increases 4.49%\n\nYear Earned Premium Incurred Claims Loss Ratio Earned Premium Incurred Claims Loss Ratio Discount\n\n2035 287,397 2,906,570 1011% 609,806 2,906,570 477% 0.484\n\n2036 252,390 2,787,660 1105% 535,527 2,787,660 521% 0.464\n\n2037 220,436 2,651,724 1203% 467,726 2,651,724 567% 0.444\n\n2038 191,413 2,503,492 1308% 406,145 2,503,492 616% 0.425\n\n2039 165,234 2,344,928 1419% 350,597 2,344,928 669% 0.406\n\n2040 141,764 2,180,120 1538% 300,799 2,180,120 725% 0.389\n\n2041 120,866 2,011,715 1664% 256,456 2,011,715 784% 0.372\n\n2042 102,330 1,840,369 1798% 217,127 1,840,369 848% 0.356\n\n2043 85,980 1,669,339 1942% 182,435 1,669,339 915% 0.341\n\n2044 71,701 1,501,777 2094% 152,137 1,501,777 987% 0.326\n\n2045 59,329 1,339,863 2258% 125,886 1,339,863 1064% 0.312\n\n2046 48,711 1,185,505 2434% 103,356 1,185,505 1147% 0.299\n\n2047 39,663 1,039,742 2621% 84,159 1,039,742 1235% 0.286\n\n2048 32,011 902,936 2821% 67,923 902,936 1329% 0.274\n\n2049 25,594 774,860 3028% 54,306 774,860 1427% 0.262\n\n2050 20,256 653,072 3224% 42,980 653,072 1519% 0.251\n\n2051 15,860 539,656 3403% 33,653 539,656 1604% 0.240\n\n2052 12,284 438,127 3567% 26,065 438,127 1681% 0.230\n\n2053 9,402 351,034 3734% 19,948 351,034 1760% 0.220\n\n2054 7,092 277,004 3906% 15,048 277,004 1841% 0.210\n\n2055 5,261 214,730 4082% 11,163 214,730 1924% 0.201\n\n2056 3,831 163,231 4261% 8,128 163,231 2008% 0.193\n\n2057 2,734 121,508 4444% 5,801 121,508 2095% 0.184\n\n2058 1,912 88,566 4631% 4,058 88,566 2183% 0.176\n\n2059 1,309 63,138 4823% 2,778 63,138 2273% 0.169\n\n2060 875 43,885 5016% 1,856 43,885 2364% 0.162\n\n2061 569 29,669 5214% 1,207 29,669 2457% 0.155\n\n2062 360 19,482 5415% 763 19,482 2552% 0.148\n\n2063 221 12,406 5620% 468 12,406 2649% 0.142\n\n2064 131 7,665 5829% 279 7,665 2747% 0.136\n\n2065 76 4,595 6042% 161 4,595 2848% 0.130\n\n2066 43 2,677 6263% 91 2,677 2952% 0.124\n\n2067 23 1,525 6494% 50 1,525 3061% 0.119\n\n2068 13 855 6729% 27 855 3171% 0.114\n\n2069 7 476 6971% 15 476 3285% 0.109\n\n2070 4 265 7226% 8 265 3406% 0.104\n\n2071 2 148 7495% 4 148 3532% 0.100\n\n2072 1 82 7776% 2 82 3665% 0.095\n\n2073 1 46 8072% 1 46 3804% 0.091\n\nHistorical 57,706,144 30,296,120 53% 57,706,144 30,296,120 53%\n\nFuture 9,722,687 45,652,489 470% 18,594,478 45,652,489 246%\n\nLifetime 67,428,831 75,948,609 113% 76,300,622 75,948,609 100%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1288.pdf"]},"response":{"errors":[],"extract_id":"extract_247b734ce6b954a7dde8eb80cf0798a7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit Ib**\n\n**Southern Farm Bureau Life Insurance Company**\n\n**Form Number(s): 3034/3035**\n\n**Lifetime Benefit Period**\n\n**Lifetime Experience (Texas Pre Rate Stability)**\n\nWithout Proposed Rate Increase With 3 28.5% Rate Increases 4.49%\n\nYear Earned Premium Incurred Claims Loss Ratio Earned Premium Incurred Claims Loss Ratio Discount\n\n2035 287,397 2,906,570 1011% 609,806 2,906,570 477% 0.484\n\n2036 252,390 2,787,660 1105% 535,527 2,787,660 521% 0.464\n\n2037 220,436 2,651,724 1203% 467,726 2,651,724 567% 0.444\n\n2038 191,413 2,503,492 1308% 406,145 2,503,492 616% 0.425\n\n2039 165,234 2,344,928 1419% 350,597 2,344,928 669% 0.406\n\n2040 141,764 2,180,120 1538% 300,799 2,180,120 725% 0.389\n\n2041 120,866 2,011,715 1664% 256,456 2,011,715 784% 0.372\n\n2042 102,330 1,840,369 1798% 217,127 1,840,369 848% 0.356\n\n2043 85,980 1,669,339 1942% 182,435 1,669,339 915% 0.341\n\n2044 71,701 1,501,777 2094% 152,137 1,501,777 987% 0.326\n\n2045 59,329 1,339,863 2258% 125,886 1,339,863 1064% 0.312\n\n2046 48,711 1,185,505 2434% 103,356 1,185,505 1147% 0.299\n\n2047 39,663 1,039,742 2621% 84,159 1,039,742 1235% 0.286\n\n2048 32,011 902,936 2821% 67,923 902,936 1329% 0.274\n\n2049 25,594 774,860 3028% 54,306 774,860 1427% 0.262\n\n2050 20,256 653,072 3224% 42,980 653,072 1519% 0.251\n\n2051 15,860 539,656 3403% 33,653 539,656 1604% 0.240\n\n2052 12,284 438,127 3567% 26,065 438,127 1681% 0.230\n\n2053 9,402 351,034 3734% 19,948 351,034 1760% 0.220\n\n2054 7,092 277,004 3906% 15,048 277,004 1841% 0.210\n\n2055 5,261 214,730 4082% 11,163 214,730 1924% 0.201\n\n2056 3,831 163,231 4261% 8,128 163,231 2008% 0.193\n\n2057 2,734 121,508 4444% 5,801 121,508 2095% 0.184\n\n2058 1,912 88,566 4631% 4,058 88,566 2183% 0.176\n\n2059 1,309 63,138 4823% 2,778 63,138 2273% 0.169\n\n2060 875 43,885 5016% 1,856 43,885 2364% 0.162\n\n2061 569 29,669 5214% 1,207 29,669 2457% 0.155\n\n2062 360 19,482 5415% 763 19,482 2552% 0.148\n\n2063 221 12,406 5620% 468 12,406 2649% 0.142\n\n2064 131 7,665 5829% 279 7,665 2747% 0.136\n\n2065 76 4,595 6042% 161 4,595 2848% 0.130\n\n2066 43 2,677 6263% 91 2,677 2952% 0.124\n\n2067 23 1,525 6494% 50 1,525 3061% 0.119\n\n2068 13 855 6729% 27 855 3171% 0.114\n\n2069 7 476 6971% 15 476 3285% 0.109\n\n2070 4 265 7226% 8 265 3406% 0.104\n\n2071 2 148 7495% 4 148 3532% 0.100\n\n2072 1 82 7776% 2 82 3665% 0.095\n\n2073 1 46 8072% 1 46 3804% 0.091\n\nHistorical 57,706,144 30,296,120 53% 57,706,144 30,296,120 53%\n\nFuture 9,722,687 45,652,489 470% 18,594,478 45,652,489 246%\n\nLifetime 67,428,831 75,948,609 113% 76,300,622 75,948,609 100%"],"full_content":"**Exhibit Ib**\n\n**Southern Farm Bureau Life Insurance Company**\n\n**Form Number(s): 3034/3035**\n\n**Lifetime Benefit Period**\n\n**Lifetime Experience (Texas Pre Rate Stability)**\n\nWithout Proposed Rate Increase With 3 28.5% Rate Increases 4.49%\n\nYear Earned Premium Incurred Claims Loss Ratio Earned Premium Incurred Claims Loss Ratio Discount\n\n2035 287,397 2,906,570 1011% 609,806 2,906,570 477% 0.484\n\n2036 252,390 2,787,660 1105% 535,527 2,787,660 521% 0.464\n\n2037 220,436 2,651,724 1203% 467,726 2,651,724 567% 0.444\n\n2038 191,413 2,503,492 1308% 406,145 2,503,492 616% 0.425\n\n2039 165,234 2,344,928 1419% 350,597 2,344,928 669% 0.406\n\n2040 141,764 2,180,120 1538% 300,799 2,180,120 725% 0.389\n\n2041 120,866 2,011,715 1664% 256,456 2,011,715 784% 0.372\n\n2042 102,330 1,840,369 1798% 217,127 1,840,369 848% 0.356\n\n2043 85,980 1,669,339 1942% 182,435 1,669,339 915% 0.341\n\n2044 71,701 1,501,777 2094% 152,137 1,501,777 987% 0.326\n\n2045 59,329 1,339,863 2258% 125,886 1,339,863 1064% 0.312\n\n2046 48,711 1,185,505 2434% 103,356 1,185,505 1147% 0.299\n\n2047 39,663 1,039,742 2621% 84,159 1,039,742 1235% 0.286\n\n2048 32,011 902,936 2821% 67,923 902,936 1329% 0.274\n\n2049 25,594 774,860 3028% 54,306 774,860 1427% 0.262\n\n2050 20,256 653,072 3224% 42,980 653,072 1519% 0.251\n\n2051 15,860 539,656 3403% 33,653 539,656 1604% 0.240\n\n2052 12,284 438,127 3567% 26,065 438,127 1681% 0.230\n\n2053 9,402 351,034 3734% 19,948 351,034 1760% 0.220\n\n2054 7,092 277,004 3906% 15,048 277,004 1841% 0.210\n\n2055 5,261 214,730 4082% 11,163 214,730 1924% 0.201\n\n2056 3,831 163,231 4261% 8,128 163,231 2008% 0.193\n\n2057 2,734 121,508 4444% 5,801 121,508 2095% 0.184\n\n2058 1,912 88,566 4631% 4,058 88,566 2183% 0.176\n\n2059 1,309 63,138 4823% 2,778 63,138 2273% 0.169\n\n2060 875 43,885 5016% 1,856 43,885 2364% 0.162\n\n2061 569 29,669 5214% 1,207 29,669 2457% 0.155\n\n2062 360 19,482 5415% 763 19,482 2552% 0.148\n\n2063 221 12,406 5620% 468 12,406 2649% 0.142\n\n2064 131 7,665 5829% 279 7,665 2747% 0.136\n\n2065 76 4,595 6042% 161 4,595 2848% 0.130\n\n2066 43 2,677 6263% 91 2,677 2952% 0.124\n\n2067 23 1,525 6494% 50 1,525 3061% 0.119\n\n2068 13 855 6729% 27 855 3171% 0.114\n\n2069 7 476 6971% 15 476 3285% 0.109\n\n2070 4 265 7226% 8 265 3406% 0.104\n\n2071 2 148 7495% 4 148 3532% 0.100\n\n2072 1 82 7776% 2 82 3665% 0.095\n\n2073 1 46 8072% 1 46 3804% 0.091\n\nHistorical 57,706,144 30,296,120 53% 57,706,144 30,296,120 53%\n\nFuture 9,722,687 45,652,489 470% 18,594,478 45,652,489 246%\n\nLifetime 67,428,831 75,948,609 113% 76,300,622 75,948,609 100%","publish_date":null,"title":"Exhibit Ib Southern Farm Bureau Life Insurance Company Form Number(s): 3034/3035 Lifetime Benefit Period Lifetime Experience (Texas Pre Rate Stability)","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1288.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1288.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1288","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1288.pdf"},"started_at":"2026-11-04T19:46:51.867115"} +{"completed_at":"2026-11-04T19:46:55.203172","latency_in_ms":1960,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1293","grounded_pages":[],"layout_pages":[],"markdown":"### November 5, 2019\n\n### Ms. Bonnie Tang Life and Health Actuarial Office Texas Department of Insurance P.O. Box 14904 Austin, TX 78714-9104\n\n### Re: **Southern Farm Bureau Life Insurance Company** **Long Term Care Insurance Policy: 3034, 3034Q, 3035, 3035Q FILE LOG NUMBER: FID SFBL-131934914**\n\n### Dear Ms. Tang,\n\n### This letter is in response to your letter to Sarah Lee dated October 22, 2019. The letter indicated that further information is needed regarding the above-captioned filing. Specifically, you noted the following:\n\n### _1\\._ _Regarding section 10 of your Actuarial Memorandum, please provide the “Average_\n\n### _Annual Premium_ _–_ _Premium Paying Policies” afte_ _r proposed rate increase._ Please see the table below for the requested information.\n\n### _2\\._ _Regarding item 11 of your 9/4 response, you stated that “The current rate increase_\n\n### _filing uses historical experience through 2018 in conjunction with the 2000-2011_ _Society of Actuaries Long Term Care Intercompany Study.” Please provide numerical_ _demonstration to explain the difference, including selection factors, improvement, etc._ _Also, what the experience year does the company’s most current GPV morbidity_ _assumption include?_ No morbidity or mortality improvement is assumed in this filing. Exhibit IV in the original submission contains information regarding the selection factors that were applied to the Intercompany Study. Please see the attached Exhibit II for a numerical demonstration of future incurred claims with and without selection factors applied to the Intercompany Study results. The selection factors increase the PV of incurred claims by 26%.\n\nNationwide Texas Pre-RS\n\n3034/3035 Limited 2,168 1,458\n\n3034/3035 Lifetime 3,035 2,278","pages":[{"line_numbers":[],"markdown":"### November 5, 2019\n\n### Ms. Bonnie Tang Life and Health Actuarial Office Texas Department of Insurance P.O. Box 14904 Austin, TX 78714-9104\n\n### Re: **Southern Farm Bureau Life Insurance Company** **Long Term Care Insurance Policy: 3034, 3034Q, 3035, 3035Q FILE LOG NUMBER: FID SFBL-131934914**\n\n### Dear Ms. Tang,\n\n### This letter is in response to your letter to Sarah Lee dated October 22, 2019. The letter indicated that further information is needed regarding the above-captioned filing. Specifically, you noted the following:\n\n### _1\\._ _Regarding section 10 of your Actuarial Memorandum, please provide the “Average_\n\n### _Annual Premium_ _–_ _Premium Paying Policies” afte_ _r proposed rate increase._ Please see the table below for the requested information.\n\n### _2\\._ _Regarding item 11 of your 9/4 response, you stated that “The current rate increase_\n\n### _filing uses historical experience through 2018 in conjunction with the 2000-2011_ _Society of Actuaries Long Term Care Intercompany Study.” Please provide numerical_ _demonstration to explain the difference, including selection factors, improvement, etc._ _Also, what the experience year does the company’s most current GPV morbidity_ _assumption include?_ No morbidity or mortality improvement is assumed in this filing. Exhibit IV in the original submission contains information regarding the selection factors that were applied to the Intercompany Study. Please see the attached Exhibit II for a numerical demonstration of future incurred claims with and without selection factors applied to the Intercompany Study results. The selection factors increase the PV of incurred claims by 26%.\n\nNationwide Texas Pre-RS\n\n3034/3035 Limited 2,168 1,458\n\n3034/3035 Lifetime 3,035 2,278","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### November 5, 2019\n\n### Ms. Bonnie Tang Life and Health Actuarial Office Texas Department of Insurance P.O. Box 14904 Austin, TX 78714-9104\n\n### Re: **Southern Farm Bureau Life Insurance Company** **Long Term Care Insurance Policy: 3034, 3034Q, 3035, 3035Q FILE LOG NUMBER: FID SFBL-131934914**\n\n### Dear Ms. Tang,\n\n### This letter is in response to your letter to Sarah Lee dated October 22, 2019. The letter indicated that further information is needed regarding the above-captioned filing. Specifically, you noted the following:\n\n### _1\\._ _Regarding section 10 of your Actuarial Memorandum, please provide the “Average_\n\n### _Annual Premium_ _–_ _Premium Paying Policies” afte_ _r proposed rate increase._ Please see the table below for the requested information.\n\n### _2\\._ _Regarding item 11 of your 9/4 response, you stated that “The current rate increase_\n\n### _filing uses historical experience through 2018 in conjunction with the 2000-2011_ _Society of Actuaries Long Term Care Intercompany Study.” Please provide numerical_ _demonstration to explain the difference, including selection factors, improvement, etc._ _Also, what the experience year does the company’s most current GPV morbidity_ _assumption include?_ No morbidity or mortality improvement is assumed in this filing. Exhibit IV in the original submission contains information regarding the selection factors that were applied to the Intercompany Study. Please see the attached Exhibit II for a numerical demonstration of future incurred claims with and without selection factors applied to the Intercompany Study results. The selection factors increase the PV of incurred claims by 26%.\n\nNationwide Texas Pre-RS\n\n3034/3035 Limited 2,168 1,458\n\n3034/3035 Lifetime 3,035 2,278","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1293.pdf"]},"response":{"errors":[],"extract_id":"extract_fafb6c4d9efeae7b7dff2a838b8a62d7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### November 5, 2019\n\n### Ms. Bonnie Tang Life and Health Actuarial Office Texas Department of Insurance P.O. Box 14904 Austin, TX 78714-9104\n\n### Re: **Southern Farm Bureau Life Insurance Company** **Long Term Care Insurance Policy: 3034, 3034Q, 3035, 3035Q FILE LOG NUMBER: FID SFBL-131934914**\n\n### Dear Ms. Tang,\n\n### This letter is in response to your letter to Sarah Lee dated October 22, 2019. The letter indicated that further information is needed regarding the above-captioned filing. Specifically, you noted the following:\n\n### _1\\._ _Regarding section 10 of your Actuarial Memorandum, please provide the “Average_\n\n### _Annual Premium_ _–_ _Premium Paying Policies” afte_ _r proposed rate increase._ Please see the table below for the requested information.\n\n### _2\\._ _Regarding item 11 of your 9/4 response, you stated that “The current rate increase_\n\n### _filing uses historical experience through 2018 in conjunction with the 2000-2011_ _Society of Actuaries Long Term Care Intercompany Study.” Please provide numerical_ _demonstration to explain the difference, including selection factors, improvement, etc._ _Also, what the experience year does the company’s most current GPV morbidity_ _assumption include?_ No morbidity or mortality improvement is assumed in this filing. Exhibit IV in the original submission contains information regarding the selection factors that were applied to the Intercompany Study. Please see the attached Exhibit II for a numerical demonstration of future incurred claims with and without selection factors applied to the Intercompany Study results. The selection factors increase the PV of incurred claims by 26%.\n\nNationwide Texas Pre-RS\n\n3034/3035 Limited 2,168 1,458\n\n3034/3035 Lifetime 3,035 2,278"],"full_content":"### November 5, 2019\n\n### Ms. Bonnie Tang Life and Health Actuarial Office Texas Department of Insurance P.O. Box 14904 Austin, TX 78714-9104\n\n### Re: **Southern Farm Bureau Life Insurance Company** **Long Term Care Insurance Policy: 3034, 3034Q, 3035, 3035Q FILE LOG NUMBER: FID SFBL-131934914**\n\n### Dear Ms. Tang,\n\n### This letter is in response to your letter to Sarah Lee dated October 22, 2019. The letter indicated that further information is needed regarding the above-captioned filing. Specifically, you noted the following:\n\n### _1\\._ _Regarding section 10 of your Actuarial Memorandum, please provide the “Average_\n\n### _Annual Premium_ _–_ _Premium Paying Policies” afte_ _r proposed rate increase._ Please see the table below for the requested information.\n\n### _2\\._ _Regarding item 11 of your 9/4 response, you stated that “The current rate increase_\n\n### _filing uses historical experience through 2018 in conjunction with the 2000-2011_ _Society of Actuaries Long Term Care Intercompany Study.” Please provide numerical_ _demonstration to explain the difference, including selection factors, improvement, etc._ _Also, what the experience year does the company’s most current GPV morbidity_ _assumption include?_ No morbidity or mortality improvement is assumed in this filing. Exhibit IV in the original submission contains information regarding the selection factors that were applied to the Intercompany Study. Please see the attached Exhibit II for a numerical demonstration of future incurred claims with and without selection factors applied to the Intercompany Study results. The selection factors increase the PV of incurred claims by 26%.\n\nNationwide Texas Pre-RS\n\n3034/3035 Limited 2,168 1,458\n\n3034/3035 Lifetime 3,035 2,278","publish_date":null,"title":"November 5, 2019 Ms. Bonnie Tang Life and Health Actuarial Office Texas Department of Insurance P.O. Box 14904 Austin, TX","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1293.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1293.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1293","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1293.pdf"},"started_at":"2026-11-04T19:46:53.242719"} +{"completed_at":"2026-11-04T19:46:57.220293","latency_in_ms":2417,"output":{"example_id":"table/SERFF_TX_random_pages 1_page1299","grounded_pages":[],"layout_pages":[],"markdown":"Sheet 5 of 5\n\n**Class Class**\n\n**EXHIBIT A**\n\nTEXAS WORKERS' COMPENSATION RELATIVITIES\n\nAVAILABLE FOR IMMEDIATE USE\n\nMANDATORY EFFECTIVE DATE 7/1/2016\n\n**Relativity Relativity**\n\n8833 1.08\n\n8837 'a'\n\n8838 0.87\n\n8858 0.41\n\n8868 0.88\n\n8901 0.26\n\n9014 5.05\n\n9015 4.70\n\n9016 5.26\n\n9019 4.22\n\n9032 6.75\n\n9033 4.80\n\n9040 5.11\n\n9052 4.26\n\n9058 2.85\n\n9060 3.03\n\n9061 1.85\n\n9063 1.75\n\n9079 2.25\n\n9080 1.98\n\n9089 1.27\n\n9093 2.09\n\n9101 5.59\n\n9102 4.89\n\n9154 3.19\n\n9156 2.61\n\n9170 28.56\n\n9178 13.31\n\n9179 13.82\n\n9182 4.10\n\n9186 14.62\n\n9220 11.80\n\n9402 8.58\n\n9501 3.75\n\n9522 7.12\n\n9529 5.22\n\n9552 10.88\n\n9586 1.38\n\n9600 2.24\n\n9620 1.65\n\n9984 'a'\n\n9985 'a'","pages":[{"line_numbers":[],"markdown":"Sheet 5 of 5\n\n**Class Class**\n\n**EXHIBIT A**\n\nTEXAS WORKERS' COMPENSATION RELATIVITIES\n\nAVAILABLE FOR IMMEDIATE USE\n\nMANDATORY EFFECTIVE DATE 7/1/2016\n\n**Relativity Relativity**\n\n8833 1.08\n\n8837 'a'\n\n8838 0.87\n\n8858 0.41\n\n8868 0.88\n\n8901 0.26\n\n9014 5.05\n\n9015 4.70\n\n9016 5.26\n\n9019 4.22\n\n9032 6.75\n\n9033 4.80\n\n9040 5.11\n\n9052 4.26\n\n9058 2.85\n\n9060 3.03\n\n9061 1.85\n\n9063 1.75\n\n9079 2.25\n\n9080 1.98\n\n9089 1.27\n\n9093 2.09\n\n9101 5.59\n\n9102 4.89\n\n9154 3.19\n\n9156 2.61\n\n9170 28.56\n\n9178 13.31\n\n9179 13.82\n\n9182 4.10\n\n9186 14.62\n\n9220 11.80\n\n9402 8.58\n\n9501 3.75\n\n9522 7.12\n\n9529 5.22\n\n9552 10.88\n\n9586 1.38\n\n9600 2.24\n\n9620 1.65\n\n9984 'a'\n\n9985 'a'","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Sheet 5 of 5\n\n**Class Class**\n\n**EXHIBIT A**\n\nTEXAS WORKERS' COMPENSATION RELATIVITIES\n\nAVAILABLE FOR IMMEDIATE USE\n\nMANDATORY EFFECTIVE DATE 7/1/2016\n\n**Relativity Relativity**\n\n8833 1.08\n\n8837 'a'\n\n8838 0.87\n\n8858 0.41\n\n8868 0.88\n\n8901 0.26\n\n9014 5.05\n\n9015 4.70\n\n9016 5.26\n\n9019 4.22\n\n9032 6.75\n\n9033 4.80\n\n9040 5.11\n\n9052 4.26\n\n9058 2.85\n\n9060 3.03\n\n9061 1.85\n\n9063 1.75\n\n9079 2.25\n\n9080 1.98\n\n9089 1.27\n\n9093 2.09\n\n9101 5.59\n\n9102 4.89\n\n9154 3.19\n\n9156 2.61\n\n9170 28.56\n\n9178 13.31\n\n9179 13.82\n\n9182 4.10\n\n9186 14.62\n\n9220 11.80\n\n9402 8.58\n\n9501 3.75\n\n9522 7.12\n\n9529 5.22\n\n9552 10.88\n\n9586 1.38\n\n9600 2.24\n\n9620 1.65\n\n9984 'a'\n\n9985 'a'","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1299.pdf"]},"response":{"errors":[],"extract_id":"extract_d8d9164056d951f05b37ea61a0593a7e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Sheet 5 of 5\n\n**Class Class**\n\n**EXHIBIT A**\n\nTEXAS WORKERS' COMPENSATION RELATIVITIES\n\nAVAILABLE FOR IMMEDIATE USE\n\nMANDATORY EFFECTIVE DATE 7/1/2016\n\n**Relativity Relativity**\n\n8833 1.08\n\n8837 'a'\n\n8838 0.87\n\n8858 0.41\n\n8868 0.88\n\n8901 0.26\n\n9014 5.05\n\n9015 4.70\n\n9016 5.26\n\n9019 4.22\n\n9032 6.75\n\n9033 4.80\n\n9040 5.11\n\n9052 4.26\n\n9058 2.85\n\n9060 3.03\n\n9061 1.85\n\n9063 1.75\n\n9079 2.25\n\n9080 1.98\n\n9089 1.27\n\n9093 2.09\n\n9101 5.59\n\n9102 4.89\n\n9154 3.19\n\n9156 2.61\n\n9170 28.56\n\n9178 13.31\n\n9179 13.82\n\n9182 4.10\n\n9186 14.62\n\n9220 11.80\n\n9402 8.58\n\n9501 3.75\n\n9522 7.12\n\n9529 5.22\n\n9552 10.88\n\n9586 1.38\n\n9600 2.24\n\n9620 1.65\n\n9984 'a'\n\n9985 'a'"],"full_content":"Sheet 5 of 5\n\n**Class Class**\n\n**EXHIBIT A**\n\nTEXAS WORKERS' COMPENSATION RELATIVITIES\n\nAVAILABLE FOR IMMEDIATE USE\n\nMANDATORY EFFECTIVE DATE 7/1/2016\n\n**Relativity Relativity**\n\n8833 1.08\n\n8837 'a'\n\n8838 0.87\n\n8858 0.41\n\n8868 0.88\n\n8901 0.26\n\n9014 5.05\n\n9015 4.70\n\n9016 5.26\n\n9019 4.22\n\n9032 6.75\n\n9033 4.80\n\n9040 5.11\n\n9052 4.26\n\n9058 2.85\n\n9060 3.03\n\n9061 1.85\n\n9063 1.75\n\n9079 2.25\n\n9080 1.98\n\n9089 1.27\n\n9093 2.09\n\n9101 5.59\n\n9102 4.89\n\n9154 3.19\n\n9156 2.61\n\n9170 28.56\n\n9178 13.31\n\n9179 13.82\n\n9182 4.10\n\n9186 14.62\n\n9220 11.80\n\n9402 8.58\n\n9501 3.75\n\n9522 7.12\n\n9529 5.22\n\n9552 10.88\n\n9586 1.38\n\n9600 2.24\n\n9620 1.65\n\n9984 'a'\n\n9985 'a'","publish_date":null,"title":"Sheet 5 of 5","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1299.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page1299.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page1299","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page1299.pdf"},"started_at":"2026-11-04T19:46:54.802979"} +{"completed_at":"2026-11-04T19:46:57.706222","latency_in_ms":1497,"output":{"example_id":"table/SERFF_TX_random_pages 1_page159","grounded_pages":[],"layout_pages":[],"markdown":"**Exhibit B**\n\n**Transamerica Life Insurance Company**\n\n**Historical Earned Premium and Incurred Claims**\n\n**Standard Individual Medicare Supplement**\n\n**Policy Form Series: MS2013IPT**\n\n4\n\n**PlanD-2010 - Texas Experience Exhibit**\n\n**Calendar Year Earned Premium Incurred Claims Loss Ratio**\n\nNo Data\n\nTotal Plan 0 0 0.0%\n\n**PlanD-2010 - Nationwide Experience Exhibit**\n\n**Calendar Year Earned Premium Incurred Claims Loss Ratio**\n\n2013 0 0 0.00%\n\n2014 2,309 2,672 115.7%\n\n2015 19,614 8,412 42.9%\n\n2016 38,472 20,700 53.8%\n\n2017 44,422 22,615 50.9%\n\nThru 9/2018 36,448 26,291 72.1%\n\nTotal Plan 141,265 80,689 57.1%","pages":[{"line_numbers":[],"markdown":"**Exhibit B**\n\n**Transamerica Life Insurance Company**\n\n**Historical Earned Premium and Incurred Claims**\n\n**Standard Individual Medicare Supplement**\n\n**Policy Form Series: MS2013IPT**\n\n4\n\n**PlanD-2010 - Texas Experience Exhibit**\n\n**Calendar Year Earned Premium Incurred Claims Loss Ratio**\n\nNo Data\n\nTotal Plan 0 0 0.0%\n\n**PlanD-2010 - Nationwide Experience Exhibit**\n\n**Calendar Year Earned Premium Incurred Claims Loss Ratio**\n\n2013 0 0 0.00%\n\n2014 2,309 2,672 115.7%\n\n2015 19,614 8,412 42.9%\n\n2016 38,472 20,700 53.8%\n\n2017 44,422 22,615 50.9%\n\nThru 9/2018 36,448 26,291 72.1%\n\nTotal Plan 141,265 80,689 57.1%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Exhibit B**\n\n**Transamerica Life Insurance Company**\n\n**Historical Earned Premium and Incurred Claims**\n\n**Standard Individual Medicare Supplement**\n\n**Policy Form Series: MS2013IPT**\n\n4\n\n**PlanD-2010 - Texas Experience Exhibit**\n\n**Calendar Year Earned Premium Incurred Claims Loss Ratio**\n\nNo Data\n\nTotal Plan 0 0 0.0%\n\n**PlanD-2010 - Nationwide Experience Exhibit**\n\n**Calendar Year Earned Premium Incurred Claims Loss Ratio**\n\n2013 0 0 0.00%\n\n2014 2,309 2,672 115.7%\n\n2015 19,614 8,412 42.9%\n\n2016 38,472 20,700 53.8%\n\n2017 44,422 22,615 50.9%\n\nThru 9/2018 36,448 26,291 72.1%\n\nTotal Plan 141,265 80,689 57.1%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page159.pdf"]},"response":{"errors":[],"extract_id":"extract_da35eb988953070a807ce95b7e3ca9e0","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Exhibit B**\n\n**Transamerica Life Insurance Company**\n\n**Historical Earned Premium and Incurred Claims**\n\n**Standard Individual Medicare Supplement**\n\n**Policy Form Series: MS2013IPT**\n\n4\n\n**PlanD-2010 - Texas Experience Exhibit**\n\n**Calendar Year Earned Premium Incurred Claims Loss Ratio**\n\nNo Data\n\nTotal Plan 0 0 0.0%\n\n**PlanD-2010 - Nationwide Experience Exhibit**\n\n**Calendar Year Earned Premium Incurred Claims Loss Ratio**\n\n2013 0 0 0.00%\n\n2014 2,309 2,672 115.7%\n\n2015 19,614 8,412 42.9%\n\n2016 38,472 20,700 53.8%\n\n2017 44,422 22,615 50.9%\n\nThru 9/2018 36,448 26,291 72.1%\n\nTotal Plan 141,265 80,689 57.1%"],"full_content":"**Exhibit B**\n\n**Transamerica Life Insurance Company**\n\n**Historical Earned Premium and Incurred Claims**\n\n**Standard Individual Medicare Supplement**\n\n**Policy Form Series: MS2013IPT**\n\n4\n\n**PlanD-2010 - Texas Experience Exhibit**\n\n**Calendar Year Earned Premium Incurred Claims Loss Ratio**\n\nNo Data\n\nTotal Plan 0 0 0.0%\n\n**PlanD-2010 - Nationwide Experience Exhibit**\n\n**Calendar Year Earned Premium Incurred Claims Loss Ratio**\n\n2013 0 0 0.00%\n\n2014 2,309 2,672 115.7%\n\n2015 19,614 8,412 42.9%\n\n2016 38,472 20,700 53.8%\n\n2017 44,422 22,615 50.9%\n\nThru 9/2018 36,448 26,291 72.1%\n\nTotal Plan 141,265 80,689 57.1%","publish_date":null,"title":"Exhibit B Transamerica Life Insurance Company Historical Earned Premium and Incurred Claims Standard Individual Medicare Supplement Policy Form Series: MS2013IPT","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page159.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page159.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page159","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page159.pdf"},"started_at":"2026-11-04T19:46:56.208961"} +{"completed_at":"2026-11-04T19:46:59.505905","latency_in_ms":1959,"output":{"example_id":"table/SERFF_TX_random_pages 1_page173","grounded_pages":[],"layout_pages":[],"markdown":"**Texas Experience Projection**\n\nTransamerica Premier Life Insurance Company\n\nGroup, Standardized Medicare Supplement Form MS4000GPM\n\nPlan G\n\n**Assumptions:** 2019 2020 2021+ 2019 2020 2021+\n\nRequested Rate Increase: 3.60% 4.00% 2.00%\n\nAging Factor: 1.80% 1.80% 1.80% Lapse Rate: 7.50% 5.00% 5.00%\n\nPremium Trend Rate: 5.46% 5.87% 3.84%\n\nAdditional Lapse Due to Increase: 0.00% 0.00% 0.00%\n\nClaims Trend Increase: 3.60% 4.00% 2.00%\n\nAging Factor: 1.80% 1.80% 1.80% Adverse Selection Due to Increase: 0.00% 0.00% 0.00%\n\nClaims Trend Factor: 5.46% 5.87% 3.84%\n\n**Current Rate Level Factors** 2017 2018\n\nCRL Premium Factor: 6.00% 3.90% Interest rate: 5.00%\n\nCRL Claims Trend Increase: 3.60% 0.00%\n\nCRL Claims Adverse Selection: 0.00% 0.00%\n\n(Total) CRL Claims Factor: 3.60% 0.00%\n\n**Past Experience**\n\nCalendar Earned Incurred Loss Life Premium\n\nYear Premium Claims Ratio Years Refunds\n\n1992 0 0 0.0% 0 0\n\n1993 1,851 2,961 160.0% 0 0\n\n1994 6,348 5,111 80.5% 0 0\n\n1995 6,602 2,320 35.1% 0 0\n\n1996 8,465 1,921 22.7% 0 0\n\n1997 8,883 3,448 38.8% 0 0\n\n1998 11,937 3,396 28.4% 0 0\n\n1999 16,889 4,078 24.1% 0 0\n\n2000 19,702 3,030 15.4% 0 0\n\n2001 22,963 5,170 22.5% 0 0\n\n2002 30,677 26,090 85.0% 0 0\n\n2003 31,888 15,478 48.5% 18 0\n\n2004 35,579 21,740 61.1% 19 0\n\n2005 37,982 46,776 123.2% 21 0\n\n2006 39,633 26,253 66.2% 21 0\n\n2007 42,042 22,713 54.0% 22 0\n\n2008 41,191 24,200 58.8% 20 0\n\n2009 40,020 44,300 110.7% 18 0\n\n2010 39,721 21,768 54.8% 18 0\n\n2011 35,914 42,238 117.6% 16 0\n\n2012 34,094 30,086 88.2% 14 0\n\n2013 29,310 13,318 45.4% 12 0\n\n2014 26,498 6,838 25.8% 11 0\n\n2015 26,371 8,224 31.2% 10 0\n\n2016 25,646 20,635 80.5% 10 0\n\n2017 22,235 18,385 82.7% 9 0\n\n2018 19,627 9,886 50.4% 7 0 2018 data through Dec.\n\nTotal 662,069 430,365 65.0%\n\nTotal w/interest 1,144,811 720,517 62.9%\n\nExperience restated at the current rate level (CRL) For projecting the 2019 experience, a\n\n2017 23,569 19,047 80.8% 25.0% weight is applied to the Year 2017, and a\n\n2018 20,393 9,886 48.5% 75.0% weight is applied to the Year 2018.\n\n**Projected Without Rate Increase With Rate Increase**\n\nCalendar Earned Incurred Loss Earned Incurred Loss\n\nYear Premium Claims Ratio Premium Claims Ratio\n\n2019 19,950 11,878 59.5% 20,132 11,878 59.0%\n\n2020 20,066 11,947 59.5% 20,795 11,947 57.5%\n\n2021 19,794 11,785 59.5% 20,513 11,785 57.5%\n\n2022 19,525 11,625 59.5% 20,235 11,625 57.5%\n\n2023 19,261 11,468 59.5% 19,960 11,468 57.5%\n\n2024 19,000 11,312 59.5% 19,690 11,312 57.5%\n\n2025 18,742 11,159 59.5% 19,423 11,159 57.5%\n\n2026 18,488 11,008 59.5% 19,159 11,008 57.5%\n\n2027 18,237 10,858 59.5% 18,900 10,858 57.5%\n\n2028 17,990 10,711 59.5% 18,643 10,711 57.5%\n\nProjection Totals\n\nNondiscounted 191,053 113,752 59.5% 197,448 113,752 57.6%\n\nDiscounted 148,265 88,276 59.5% 153,132 88,276 57.6%\n\n**Lifetime Totals**\n\nNondiscounted 853,122 544,116 63.8% 859,517 544,116 63.3%\n\nDiscounted 1,293,077 808,793 62.5% 1,297,944 808,793 62.3%","pages":[{"line_numbers":[],"markdown":"**Texas Experience Projection**\n\nTransamerica Premier Life Insurance Company\n\nGroup, Standardized Medicare Supplement Form MS4000GPM\n\nPlan G\n\n**Assumptions:** 2019 2020 2021+ 2019 2020 2021+\n\nRequested Rate Increase: 3.60% 4.00% 2.00%\n\nAging Factor: 1.80% 1.80% 1.80% Lapse Rate: 7.50% 5.00% 5.00%\n\nPremium Trend Rate: 5.46% 5.87% 3.84%\n\nAdditional Lapse Due to Increase: 0.00% 0.00% 0.00%\n\nClaims Trend Increase: 3.60% 4.00% 2.00%\n\nAging Factor: 1.80% 1.80% 1.80% Adverse Selection Due to Increase: 0.00% 0.00% 0.00%\n\nClaims Trend Factor: 5.46% 5.87% 3.84%\n\n**Current Rate Level Factors** 2017 2018\n\nCRL Premium Factor: 6.00% 3.90% Interest rate: 5.00%\n\nCRL Claims Trend Increase: 3.60% 0.00%\n\nCRL Claims Adverse Selection: 0.00% 0.00%\n\n(Total) CRL Claims Factor: 3.60% 0.00%\n\n**Past Experience**\n\nCalendar Earned Incurred Loss Life Premium\n\nYear Premium Claims Ratio Years Refunds\n\n1992 0 0 0.0% 0 0\n\n1993 1,851 2,961 160.0% 0 0\n\n1994 6,348 5,111 80.5% 0 0\n\n1995 6,602 2,320 35.1% 0 0\n\n1996 8,465 1,921 22.7% 0 0\n\n1997 8,883 3,448 38.8% 0 0\n\n1998 11,937 3,396 28.4% 0 0\n\n1999 16,889 4,078 24.1% 0 0\n\n2000 19,702 3,030 15.4% 0 0\n\n2001 22,963 5,170 22.5% 0 0\n\n2002 30,677 26,090 85.0% 0 0\n\n2003 31,888 15,478 48.5% 18 0\n\n2004 35,579 21,740 61.1% 19 0\n\n2005 37,982 46,776 123.2% 21 0\n\n2006 39,633 26,253 66.2% 21 0\n\n2007 42,042 22,713 54.0% 22 0\n\n2008 41,191 24,200 58.8% 20 0\n\n2009 40,020 44,300 110.7% 18 0\n\n2010 39,721 21,768 54.8% 18 0\n\n2011 35,914 42,238 117.6% 16 0\n\n2012 34,094 30,086 88.2% 14 0\n\n2013 29,310 13,318 45.4% 12 0\n\n2014 26,498 6,838 25.8% 11 0\n\n2015 26,371 8,224 31.2% 10 0\n\n2016 25,646 20,635 80.5% 10 0\n\n2017 22,235 18,385 82.7% 9 0\n\n2018 19,627 9,886 50.4% 7 0 2018 data through Dec.\n\nTotal 662,069 430,365 65.0%\n\nTotal w/interest 1,144,811 720,517 62.9%\n\nExperience restated at the current rate level (CRL) For projecting the 2019 experience, a\n\n2017 23,569 19,047 80.8% 25.0% weight is applied to the Year 2017, and a\n\n2018 20,393 9,886 48.5% 75.0% weight is applied to the Year 2018.\n\n**Projected Without Rate Increase With Rate Increase**\n\nCalendar Earned Incurred Loss Earned Incurred Loss\n\nYear Premium Claims Ratio Premium Claims Ratio\n\n2019 19,950 11,878 59.5% 20,132 11,878 59.0%\n\n2020 20,066 11,947 59.5% 20,795 11,947 57.5%\n\n2021 19,794 11,785 59.5% 20,513 11,785 57.5%\n\n2022 19,525 11,625 59.5% 20,235 11,625 57.5%\n\n2023 19,261 11,468 59.5% 19,960 11,468 57.5%\n\n2024 19,000 11,312 59.5% 19,690 11,312 57.5%\n\n2025 18,742 11,159 59.5% 19,423 11,159 57.5%\n\n2026 18,488 11,008 59.5% 19,159 11,008 57.5%\n\n2027 18,237 10,858 59.5% 18,900 10,858 57.5%\n\n2028 17,990 10,711 59.5% 18,643 10,711 57.5%\n\nProjection Totals\n\nNondiscounted 191,053 113,752 59.5% 197,448 113,752 57.6%\n\nDiscounted 148,265 88,276 59.5% 153,132 88,276 57.6%\n\n**Lifetime Totals**\n\nNondiscounted 853,122 544,116 63.8% 859,517 544,116 63.3%\n\nDiscounted 1,293,077 808,793 62.5% 1,297,944 808,793 62.3%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Texas Experience Projection**\n\nTransamerica Premier Life Insurance Company\n\nGroup, Standardized Medicare Supplement Form MS4000GPM\n\nPlan G\n\n**Assumptions:** 2019 2020 2021+ 2019 2020 2021+\n\nRequested Rate Increase: 3.60% 4.00% 2.00%\n\nAging Factor: 1.80% 1.80% 1.80% Lapse Rate: 7.50% 5.00% 5.00%\n\nPremium Trend Rate: 5.46% 5.87% 3.84%\n\nAdditional Lapse Due to Increase: 0.00% 0.00% 0.00%\n\nClaims Trend Increase: 3.60% 4.00% 2.00%\n\nAging Factor: 1.80% 1.80% 1.80% Adverse Selection Due to Increase: 0.00% 0.00% 0.00%\n\nClaims Trend Factor: 5.46% 5.87% 3.84%\n\n**Current Rate Level Factors** 2017 2018\n\nCRL Premium Factor: 6.00% 3.90% Interest rate: 5.00%\n\nCRL Claims Trend Increase: 3.60% 0.00%\n\nCRL Claims Adverse Selection: 0.00% 0.00%\n\n(Total) CRL Claims Factor: 3.60% 0.00%\n\n**Past Experience**\n\nCalendar Earned Incurred Loss Life Premium\n\nYear Premium Claims Ratio Years Refunds\n\n1992 0 0 0.0% 0 0\n\n1993 1,851 2,961 160.0% 0 0\n\n1994 6,348 5,111 80.5% 0 0\n\n1995 6,602 2,320 35.1% 0 0\n\n1996 8,465 1,921 22.7% 0 0\n\n1997 8,883 3,448 38.8% 0 0\n\n1998 11,937 3,396 28.4% 0 0\n\n1999 16,889 4,078 24.1% 0 0\n\n2000 19,702 3,030 15.4% 0 0\n\n2001 22,963 5,170 22.5% 0 0\n\n2002 30,677 26,090 85.0% 0 0\n\n2003 31,888 15,478 48.5% 18 0\n\n2004 35,579 21,740 61.1% 19 0\n\n2005 37,982 46,776 123.2% 21 0\n\n2006 39,633 26,253 66.2% 21 0\n\n2007 42,042 22,713 54.0% 22 0\n\n2008 41,191 24,200 58.8% 20 0\n\n2009 40,020 44,300 110.7% 18 0\n\n2010 39,721 21,768 54.8% 18 0\n\n2011 35,914 42,238 117.6% 16 0\n\n2012 34,094 30,086 88.2% 14 0\n\n2013 29,310 13,318 45.4% 12 0\n\n2014 26,498 6,838 25.8% 11 0\n\n2015 26,371 8,224 31.2% 10 0\n\n2016 25,646 20,635 80.5% 10 0\n\n2017 22,235 18,385 82.7% 9 0\n\n2018 19,627 9,886 50.4% 7 0 2018 data through Dec.\n\nTotal 662,069 430,365 65.0%\n\nTotal w/interest 1,144,811 720,517 62.9%\n\nExperience restated at the current rate level (CRL) For projecting the 2019 experience, a\n\n2017 23,569 19,047 80.8% 25.0% weight is applied to the Year 2017, and a\n\n2018 20,393 9,886 48.5% 75.0% weight is applied to the Year 2018.\n\n**Projected Without Rate Increase With Rate Increase**\n\nCalendar Earned Incurred Loss Earned Incurred Loss\n\nYear Premium Claims Ratio Premium Claims Ratio\n\n2019 19,950 11,878 59.5% 20,132 11,878 59.0%\n\n2020 20,066 11,947 59.5% 20,795 11,947 57.5%\n\n2021 19,794 11,785 59.5% 20,513 11,785 57.5%\n\n2022 19,525 11,625 59.5% 20,235 11,625 57.5%\n\n2023 19,261 11,468 59.5% 19,960 11,468 57.5%\n\n2024 19,000 11,312 59.5% 19,690 11,312 57.5%\n\n2025 18,742 11,159 59.5% 19,423 11,159 57.5%\n\n2026 18,488 11,008 59.5% 19,159 11,008 57.5%\n\n2027 18,237 10,858 59.5% 18,900 10,858 57.5%\n\n2028 17,990 10,711 59.5% 18,643 10,711 57.5%\n\nProjection Totals\n\nNondiscounted 191,053 113,752 59.5% 197,448 113,752 57.6%\n\nDiscounted 148,265 88,276 59.5% 153,132 88,276 57.6%\n\n**Lifetime Totals**\n\nNondiscounted 853,122 544,116 63.8% 859,517 544,116 63.3%\n\nDiscounted 1,293,077 808,793 62.5% 1,297,944 808,793 62.3%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page173.pdf"]},"response":{"errors":[],"extract_id":"extract_dab482bef215051776d1577f2a67b1cb","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Texas Experience Projection**\n\nTransamerica Premier Life Insurance Company\n\nGroup, Standardized Medicare Supplement Form MS4000GPM\n\nPlan G\n\n**Assumptions:** 2019 2020 2021+ 2019 2020 2021+\n\nRequested Rate Increase: 3.60% 4.00% 2.00%\n\nAging Factor: 1.80% 1.80% 1.80% Lapse Rate: 7.50% 5.00% 5.00%\n\nPremium Trend Rate: 5.46% 5.87% 3.84%\n\nAdditional Lapse Due to Increase: 0.00% 0.00% 0.00%\n\nClaims Trend Increase: 3.60% 4.00% 2.00%\n\nAging Factor: 1.80% 1.80% 1.80% Adverse Selection Due to Increase: 0.00% 0.00% 0.00%\n\nClaims Trend Factor: 5.46% 5.87% 3.84%\n\n**Current Rate Level Factors** 2017 2018\n\nCRL Premium Factor: 6.00% 3.90% Interest rate: 5.00%\n\nCRL Claims Trend Increase: 3.60% 0.00%\n\nCRL Claims Adverse Selection: 0.00% 0.00%\n\n(Total) CRL Claims Factor: 3.60% 0.00%\n\n**Past Experience**\n\nCalendar Earned Incurred Loss Life Premium\n\nYear Premium Claims Ratio Years Refunds\n\n1992 0 0 0.0% 0 0\n\n1993 1,851 2,961 160.0% 0 0\n\n1994 6,348 5,111 80.5% 0 0\n\n1995 6,602 2,320 35.1% 0 0\n\n1996 8,465 1,921 22.7% 0 0\n\n1997 8,883 3,448 38.8% 0 0\n\n1998 11,937 3,396 28.4% 0 0\n\n1999 16,889 4,078 24.1% 0 0\n\n2000 19,702 3,030 15.4% 0 0\n\n2001 22,963 5,170 22.5% 0 0\n\n2002 30,677 26,090 85.0% 0 0\n\n2003 31,888 15,478 48.5% 18 0\n\n2004 35,579 21,740 61.1% 19 0\n\n2005 37,982 46,776 123.2% 21 0\n\n2006 39,633 26,253 66.2% 21 0\n\n2007 42,042 22,713 54.0% 22 0\n\n2008 41,191 24,200 58.8% 20 0\n\n2009 40,020 44,300 110.7% 18 0\n\n2010 39,721 21,768 54.8% 18 0\n\n2011 35,914 42,238 117.6% 16 0\n\n2012 34,094 30,086 88.2% 14 0\n\n2013 29,310 13,318 45.4% 12 0\n\n2014 26,498 6,838 25.8% 11 0\n\n2015 26,371 8,224 31.2% 10 0\n\n2016 25,646 20,635 80.5% 10 0\n\n2017 22,235 18,385 82.7% 9 0\n\n2018 19,627 9,886 50.4% 7 0 2018 data through Dec.\n\nTotal 662,069 430,365 65.0%\n\nTotal w/interest 1,144,811 720,517 62.9%\n\nExperience restated at the current rate level (CRL) For projecting the 2019 experience, a\n\n2017 23,569 19,047 80.8% 25.0% weight is applied to the Year 2017, and a\n\n2018 20,393 9,886 48.5% 75.0% weight is applied to the Year 2018.\n\n**Projected Without Rate Increase With Rate Increase**\n\nCalendar Earned Incurred Loss Earned Incurred Loss\n\nYear Premium Claims Ratio Premium Claims Ratio\n\n2019 19,950 11,878 59.5% 20,132 11,878 59.0%\n\n2020 20,066 11,947 59.5% 20,795 11,947 57.5%\n\n2021 19,794 11,785 59.5% 20,513 11,785 57.5%\n\n2022 19,525 11,625 59.5% 20,235 11,625 57.5%\n\n2023 19,261 11,468 59.5% 19,960 11,468 57.5%\n\n2024 19,000 11,312 59.5% 19,690 11,312 57.5%\n\n2025 18,742 11,159 59.5% 19,423 11,159 57.5%\n\n2026 18,488 11,008 59.5% 19,159 11,008 57.5%\n\n2027 18,237 10,858 59.5% 18,900 10,858 57.5%\n\n2028 17,990 10,711 59.5% 18,643 10,711 57.5%\n\nProjection Totals\n\nNondiscounted 191,053 113,752 59.5% 197,448 113,752 57.6%\n\nDiscounted 148,265 88,276 59.5% 153,132 88,276 57.6%\n\n**Lifetime Totals**\n\nNondiscounted 853,122 544,116 63.8% 859,517 544,116 63.3%\n\nDiscounted 1,293,077 808,793 62.5% 1,297,944 808,793 62.3%"],"full_content":"**Texas Experience Projection**\n\nTransamerica Premier Life Insurance Company\n\nGroup, Standardized Medicare Supplement Form MS4000GPM\n\nPlan G\n\n**Assumptions:** 2019 2020 2021+ 2019 2020 2021+\n\nRequested Rate Increase: 3.60% 4.00% 2.00%\n\nAging Factor: 1.80% 1.80% 1.80% Lapse Rate: 7.50% 5.00% 5.00%\n\nPremium Trend Rate: 5.46% 5.87% 3.84%\n\nAdditional Lapse Due to Increase: 0.00% 0.00% 0.00%\n\nClaims Trend Increase: 3.60% 4.00% 2.00%\n\nAging Factor: 1.80% 1.80% 1.80% Adverse Selection Due to Increase: 0.00% 0.00% 0.00%\n\nClaims Trend Factor: 5.46% 5.87% 3.84%\n\n**Current Rate Level Factors** 2017 2018\n\nCRL Premium Factor: 6.00% 3.90% Interest rate: 5.00%\n\nCRL Claims Trend Increase: 3.60% 0.00%\n\nCRL Claims Adverse Selection: 0.00% 0.00%\n\n(Total) CRL Claims Factor: 3.60% 0.00%\n\n**Past Experience**\n\nCalendar Earned Incurred Loss Life Premium\n\nYear Premium Claims Ratio Years Refunds\n\n1992 0 0 0.0% 0 0\n\n1993 1,851 2,961 160.0% 0 0\n\n1994 6,348 5,111 80.5% 0 0\n\n1995 6,602 2,320 35.1% 0 0\n\n1996 8,465 1,921 22.7% 0 0\n\n1997 8,883 3,448 38.8% 0 0\n\n1998 11,937 3,396 28.4% 0 0\n\n1999 16,889 4,078 24.1% 0 0\n\n2000 19,702 3,030 15.4% 0 0\n\n2001 22,963 5,170 22.5% 0 0\n\n2002 30,677 26,090 85.0% 0 0\n\n2003 31,888 15,478 48.5% 18 0\n\n2004 35,579 21,740 61.1% 19 0\n\n2005 37,982 46,776 123.2% 21 0\n\n2006 39,633 26,253 66.2% 21 0\n\n2007 42,042 22,713 54.0% 22 0\n\n2008 41,191 24,200 58.8% 20 0\n\n2009 40,020 44,300 110.7% 18 0\n\n2010 39,721 21,768 54.8% 18 0\n\n2011 35,914 42,238 117.6% 16 0\n\n2012 34,094 30,086 88.2% 14 0\n\n2013 29,310 13,318 45.4% 12 0\n\n2014 26,498 6,838 25.8% 11 0\n\n2015 26,371 8,224 31.2% 10 0\n\n2016 25,646 20,635 80.5% 10 0\n\n2017 22,235 18,385 82.7% 9 0\n\n2018 19,627 9,886 50.4% 7 0 2018 data through Dec.\n\nTotal 662,069 430,365 65.0%\n\nTotal w/interest 1,144,811 720,517 62.9%\n\nExperience restated at the current rate level (CRL) For projecting the 2019 experience, a\n\n2017 23,569 19,047 80.8% 25.0% weight is applied to the Year 2017, and a\n\n2018 20,393 9,886 48.5% 75.0% weight is applied to the Year 2018.\n\n**Projected Without Rate Increase With Rate Increase**\n\nCalendar Earned Incurred Loss Earned Incurred Loss\n\nYear Premium Claims Ratio Premium Claims Ratio\n\n2019 19,950 11,878 59.5% 20,132 11,878 59.0%\n\n2020 20,066 11,947 59.5% 20,795 11,947 57.5%\n\n2021 19,794 11,785 59.5% 20,513 11,785 57.5%\n\n2022 19,525 11,625 59.5% 20,235 11,625 57.5%\n\n2023 19,261 11,468 59.5% 19,960 11,468 57.5%\n\n2024 19,000 11,312 59.5% 19,690 11,312 57.5%\n\n2025 18,742 11,159 59.5% 19,423 11,159 57.5%\n\n2026 18,488 11,008 59.5% 19,159 11,008 57.5%\n\n2027 18,237 10,858 59.5% 18,900 10,858 57.5%\n\n2028 17,990 10,711 59.5% 18,643 10,711 57.5%\n\nProjection Totals\n\nNondiscounted 191,053 113,752 59.5% 197,448 113,752 57.6%\n\nDiscounted 148,265 88,276 59.5% 153,132 88,276 57.6%\n\n**Lifetime Totals**\n\nNondiscounted 853,122 544,116 63.8% 859,517 544,116 63.3%\n\nDiscounted 1,293,077 808,793 62.5% 1,297,944 808,793 62.3%","publish_date":null,"title":"Texas Experience Projection Transamerica Premier Life Insurance Company Group, Standardized Medicare Supplement Form MS4000GPM Plan G","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page173.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page173.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page173","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page173.pdf"},"started_at":"2026-11-04T19:46:57.546758"} +{"completed_at":"2026-11-04T19:47:00.681013","latency_in_ms":1514,"output":{"example_id":"table/SERFF_TX_random_pages 1_page201","grounded_pages":[],"layout_pages":[],"markdown":"Year Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 - - - - - - -\n\n2017 147,792 3,268 1,153,465 17,013 3,634,389 162,617 5,118,545\n\n2018 959,013 13,291 7,237,297 86,413 16,553,942 794,313 25,644,269\n\n2019 1,414,144 17,596 10,032,693 90,400 23,678,395 1,960,595 37,193,822\n\n2020 1,157,212 12,409 9,993,641 74,448 23,308,903 1,787,623 36,334,236\n\n1-6/2021 467,729 5,892 5,027,118 33,107 11,306,275 818,259 17,658,379\n\n7-12/2021 443,771 5,677 4,971,185 33,632 11,121,754 804,534 17,380,551\n\n1-6/2022 392,239 6,250 4,996,340 30,526 10,604,739 753,509 16,783,604\n\nTotal 4,981,901 64,382 43,411,739 365,538 100,208,397 7,081,450 156,113,407\n\nYear Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 - - - - 48 - 48\n\n2017 263,598 3,460 933,973 1,026 2,488,863 88,537 3,779,458\n\n2018 1,637,267 18,059 7,014,429 20,381 12,541,426 552,789 21,784,351\n\n2019 2,469,622 33,006 9,586,986 32,041 19,695,508 1,493,277 33,310,439\n\n2020 1,993,869 43,662 8,518,031 15,470 17,157,845 1,286,248 29,015,124\n\n1-6/2021 706,351 15,931 4,627,559 7,934 8,587,127 672,608 14,617,509\n\n7-12/2021 579,345 10,700 4,144,734 14,392 9,336,819 680,777 14,766,767\n\n1-6/2022 456,753 11,991 4,544,568 18,698 8,937,432 642,548 14,611,991\n\nTotal 8,106,804 136,809 39,370,280 109,942 78,745,068 5,416,784 131,885,687\n\nYear Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 2017 178.4% 105.9% 81.0% 6.0% 68.5% 54.4% 73.8%\n\n2018 170.7% 135.9% 96.9% 23.6% 75.8% 69.6% 84.9%\n\n2019 174.6% 187.6% 95.6% 35.4% 83.2% 76.2% 89.6%\n\n2020 172.3% 351.9% 85.2% 20.8% 73.6% 72.0% 79.9%\n\n1-6/2021 151.0% 270.4% 92.1% 24.0% 76.0% 82.2% 82.8%\n\n7-12/2021 130.6% 188.5% 83.4% 42.8% 84.0% 84.6% 85.0%\n\n1-6/2022 116.4% 191.9% 91.0% 61.3% 84.3% 85.3% 87.1%\n\nTotal 162.7% 212.5% 90.7% 30.1% 78.6% 76.5% 84.5%\n\n**AETNA HEALTH AND LIFE INSURANCE COMPANY**\n\n**Actuarial Justification for Medicare Supplement Rate Filing**\n\n**Standardized Medicare Supplement Plans**\n\n**Exhibit III - Texas Experience by Plan**\n\n**Earned Premium**\n\n**Incurred Claims**\n\n**Loss Ratio**","pages":[{"line_numbers":[],"markdown":"Year Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 - - - - - - -\n\n2017 147,792 3,268 1,153,465 17,013 3,634,389 162,617 5,118,545\n\n2018 959,013 13,291 7,237,297 86,413 16,553,942 794,313 25,644,269\n\n2019 1,414,144 17,596 10,032,693 90,400 23,678,395 1,960,595 37,193,822\n\n2020 1,157,212 12,409 9,993,641 74,448 23,308,903 1,787,623 36,334,236\n\n1-6/2021 467,729 5,892 5,027,118 33,107 11,306,275 818,259 17,658,379\n\n7-12/2021 443,771 5,677 4,971,185 33,632 11,121,754 804,534 17,380,551\n\n1-6/2022 392,239 6,250 4,996,340 30,526 10,604,739 753,509 16,783,604\n\nTotal 4,981,901 64,382 43,411,739 365,538 100,208,397 7,081,450 156,113,407\n\nYear Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 - - - - 48 - 48\n\n2017 263,598 3,460 933,973 1,026 2,488,863 88,537 3,779,458\n\n2018 1,637,267 18,059 7,014,429 20,381 12,541,426 552,789 21,784,351\n\n2019 2,469,622 33,006 9,586,986 32,041 19,695,508 1,493,277 33,310,439\n\n2020 1,993,869 43,662 8,518,031 15,470 17,157,845 1,286,248 29,015,124\n\n1-6/2021 706,351 15,931 4,627,559 7,934 8,587,127 672,608 14,617,509\n\n7-12/2021 579,345 10,700 4,144,734 14,392 9,336,819 680,777 14,766,767\n\n1-6/2022 456,753 11,991 4,544,568 18,698 8,937,432 642,548 14,611,991\n\nTotal 8,106,804 136,809 39,370,280 109,942 78,745,068 5,416,784 131,885,687\n\nYear Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 2017 178.4% 105.9% 81.0% 6.0% 68.5% 54.4% 73.8%\n\n2018 170.7% 135.9% 96.9% 23.6% 75.8% 69.6% 84.9%\n\n2019 174.6% 187.6% 95.6% 35.4% 83.2% 76.2% 89.6%\n\n2020 172.3% 351.9% 85.2% 20.8% 73.6% 72.0% 79.9%\n\n1-6/2021 151.0% 270.4% 92.1% 24.0% 76.0% 82.2% 82.8%\n\n7-12/2021 130.6% 188.5% 83.4% 42.8% 84.0% 84.6% 85.0%\n\n1-6/2022 116.4% 191.9% 91.0% 61.3% 84.3% 85.3% 87.1%\n\nTotal 162.7% 212.5% 90.7% 30.1% 78.6% 76.5% 84.5%\n\n**AETNA HEALTH AND LIFE INSURANCE COMPANY**\n\n**Actuarial Justification for Medicare Supplement Rate Filing**\n\n**Standardized Medicare Supplement Plans**\n\n**Exhibit III - Texas Experience by Plan**\n\n**Earned Premium**\n\n**Incurred Claims**\n\n**Loss Ratio**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Year Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 - - - - - - -\n\n2017 147,792 3,268 1,153,465 17,013 3,634,389 162,617 5,118,545\n\n2018 959,013 13,291 7,237,297 86,413 16,553,942 794,313 25,644,269\n\n2019 1,414,144 17,596 10,032,693 90,400 23,678,395 1,960,595 37,193,822\n\n2020 1,157,212 12,409 9,993,641 74,448 23,308,903 1,787,623 36,334,236\n\n1-6/2021 467,729 5,892 5,027,118 33,107 11,306,275 818,259 17,658,379\n\n7-12/2021 443,771 5,677 4,971,185 33,632 11,121,754 804,534 17,380,551\n\n1-6/2022 392,239 6,250 4,996,340 30,526 10,604,739 753,509 16,783,604\n\nTotal 4,981,901 64,382 43,411,739 365,538 100,208,397 7,081,450 156,113,407\n\nYear Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 - - - - 48 - 48\n\n2017 263,598 3,460 933,973 1,026 2,488,863 88,537 3,779,458\n\n2018 1,637,267 18,059 7,014,429 20,381 12,541,426 552,789 21,784,351\n\n2019 2,469,622 33,006 9,586,986 32,041 19,695,508 1,493,277 33,310,439\n\n2020 1,993,869 43,662 8,518,031 15,470 17,157,845 1,286,248 29,015,124\n\n1-6/2021 706,351 15,931 4,627,559 7,934 8,587,127 672,608 14,617,509\n\n7-12/2021 579,345 10,700 4,144,734 14,392 9,336,819 680,777 14,766,767\n\n1-6/2022 456,753 11,991 4,544,568 18,698 8,937,432 642,548 14,611,991\n\nTotal 8,106,804 136,809 39,370,280 109,942 78,745,068 5,416,784 131,885,687\n\nYear Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 2017 178.4% 105.9% 81.0% 6.0% 68.5% 54.4% 73.8%\n\n2018 170.7% 135.9% 96.9% 23.6% 75.8% 69.6% 84.9%\n\n2019 174.6% 187.6% 95.6% 35.4% 83.2% 76.2% 89.6%\n\n2020 172.3% 351.9% 85.2% 20.8% 73.6% 72.0% 79.9%\n\n1-6/2021 151.0% 270.4% 92.1% 24.0% 76.0% 82.2% 82.8%\n\n7-12/2021 130.6% 188.5% 83.4% 42.8% 84.0% 84.6% 85.0%\n\n1-6/2022 116.4% 191.9% 91.0% 61.3% 84.3% 85.3% 87.1%\n\nTotal 162.7% 212.5% 90.7% 30.1% 78.6% 76.5% 84.5%\n\n**AETNA HEALTH AND LIFE INSURANCE COMPANY**\n\n**Actuarial Justification for Medicare Supplement Rate Filing**\n\n**Standardized Medicare Supplement Plans**\n\n**Exhibit III - Texas Experience by Plan**\n\n**Earned Premium**\n\n**Incurred Claims**\n\n**Loss Ratio**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page201.pdf"]},"response":{"errors":[],"extract_id":"extract_d42571181278d2e49aa82fc5dc4682f2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Year Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 - - - - - - -\n\n2017 147,792 3,268 1,153,465 17,013 3,634,389 162,617 5,118,545\n\n2018 959,013 13,291 7,237,297 86,413 16,553,942 794,313 25,644,269\n\n2019 1,414,144 17,596 10,032,693 90,400 23,678,395 1,960,595 37,193,822\n\n2020 1,157,212 12,409 9,993,641 74,448 23,308,903 1,787,623 36,334,236\n\n1-6/2021 467,729 5,892 5,027,118 33,107 11,306,275 818,259 17,658,379\n\n7-12/2021 443,771 5,677 4,971,185 33,632 11,121,754 804,534 17,380,551\n\n1-6/2022 392,239 6,250 4,996,340 30,526 10,604,739 753,509 16,783,604\n\nTotal 4,981,901 64,382 43,411,739 365,538 100,208,397 7,081,450 156,113,407\n\nYear Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 - - - - 48 - 48\n\n2017 263,598 3,460 933,973 1,026 2,488,863 88,537 3,779,458\n\n2018 1,637,267 18,059 7,014,429 20,381 12,541,426 552,789 21,784,351\n\n2019 2,469,622 33,006 9,586,986 32,041 19,695,508 1,493,277 33,310,439\n\n2020 1,993,869 43,662 8,518,031 15,470 17,157,845 1,286,248 29,015,124\n\n1-6/2021 706,351 15,931 4,627,559 7,934 8,587,127 672,608 14,617,509\n\n7-12/2021 579,345 10,700 4,144,734 14,392 9,336,819 680,777 14,766,767\n\n1-6/2022 456,753 11,991 4,544,568 18,698 8,937,432 642,548 14,611,991\n\nTotal 8,106,804 136,809 39,370,280 109,942 78,745,068 5,416,784 131,885,687\n\nYear Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 2017 178.4% 105.9% 81.0% 6.0% 68.5% 54.4% 73.8%\n\n2018 170.7% 135.9% 96.9% 23.6% 75.8% 69.6% 84.9%\n\n2019 174.6% 187.6% 95.6% 35.4% 83.2% 76.2% 89.6%\n\n2020 172.3% 351.9% 85.2% 20.8% 73.6% 72.0% 79.9%\n\n1-6/2021 151.0% 270.4% 92.1% 24.0% 76.0% 82.2% 82.8%\n\n7-12/2021 130.6% 188.5% 83.4% 42.8% 84.0% 84.6% 85.0%\n\n1-6/2022 116.4% 191.9% 91.0% 61.3% 84.3% 85.3% 87.1%\n\nTotal 162.7% 212.5% 90.7% 30.1% 78.6% 76.5% 84.5%\n\n**AETNA HEALTH AND LIFE INSURANCE COMPANY**\n\n**Actuarial Justification for Medicare Supplement Rate Filing**\n\n**Standardized Medicare Supplement Plans**\n\n**Exhibit III - Texas Experience by Plan**\n\n**Earned Premium**\n\n**Incurred Claims**\n\n**Loss Ratio**"],"full_content":"Year Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 - - - - - - -\n\n2017 147,792 3,268 1,153,465 17,013 3,634,389 162,617 5,118,545\n\n2018 959,013 13,291 7,237,297 86,413 16,553,942 794,313 25,644,269\n\n2019 1,414,144 17,596 10,032,693 90,400 23,678,395 1,960,595 37,193,822\n\n2020 1,157,212 12,409 9,993,641 74,448 23,308,903 1,787,623 36,334,236\n\n1-6/2021 467,729 5,892 5,027,118 33,107 11,306,275 818,259 17,658,379\n\n7-12/2021 443,771 5,677 4,971,185 33,632 11,121,754 804,534 17,380,551\n\n1-6/2022 392,239 6,250 4,996,340 30,526 10,604,739 753,509 16,783,604\n\nTotal 4,981,901 64,382 43,411,739 365,538 100,208,397 7,081,450 156,113,407\n\nYear Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 - - - - 48 - 48\n\n2017 263,598 3,460 933,973 1,026 2,488,863 88,537 3,779,458\n\n2018 1,637,267 18,059 7,014,429 20,381 12,541,426 552,789 21,784,351\n\n2019 2,469,622 33,006 9,586,986 32,041 19,695,508 1,493,277 33,310,439\n\n2020 1,993,869 43,662 8,518,031 15,470 17,157,845 1,286,248 29,015,124\n\n1-6/2021 706,351 15,931 4,627,559 7,934 8,587,127 672,608 14,617,509\n\n7-12/2021 579,345 10,700 4,144,734 14,392 9,336,819 680,777 14,766,767\n\n1-6/2022 456,753 11,991 4,544,568 18,698 8,937,432 642,548 14,611,991\n\nTotal 8,106,804 136,809 39,370,280 109,942 78,745,068 5,416,784 131,885,687\n\nYear Plan A Plan B Plan F Plan High F Plan G Plan N Total\n\n2016 2017 178.4% 105.9% 81.0% 6.0% 68.5% 54.4% 73.8%\n\n2018 170.7% 135.9% 96.9% 23.6% 75.8% 69.6% 84.9%\n\n2019 174.6% 187.6% 95.6% 35.4% 83.2% 76.2% 89.6%\n\n2020 172.3% 351.9% 85.2% 20.8% 73.6% 72.0% 79.9%\n\n1-6/2021 151.0% 270.4% 92.1% 24.0% 76.0% 82.2% 82.8%\n\n7-12/2021 130.6% 188.5% 83.4% 42.8% 84.0% 84.6% 85.0%\n\n1-6/2022 116.4% 191.9% 91.0% 61.3% 84.3% 85.3% 87.1%\n\nTotal 162.7% 212.5% 90.7% 30.1% 78.6% 76.5% 84.5%\n\n**AETNA HEALTH AND LIFE INSURANCE COMPANY**\n\n**Actuarial Justification for Medicare Supplement Rate Filing**\n\n**Standardized Medicare Supplement Plans**\n\n**Exhibit III - Texas Experience by Plan**\n\n**Earned Premium**\n\n**Incurred Claims**\n\n**Loss Ratio**","publish_date":null,"title":"AETNA HEALTH AND LIFE INSURANCE COMPANY Actuarial Justification for Medicare Supplement Rate Filing Standardized Medicare Supplement Plans","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page201.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page201.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page201","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page201.pdf"},"started_at":"2026-11-04T19:46:59.166561"} +{"completed_at":"2026-11-04T19:47:01.932540","latency_in_ms":1249,"output":{"example_id":"table/SERFF_TX_random_pages 1_page244","grounded_pages":[],"layout_pages":[],"markdown":"COMMERCIAL LINES MANUAL EXCEPTIONS GENERAL LIABILITY TEXAS CHECKING LIST: The following pages are enclosed:\n\nTitle of Rule Page Dated\n\nIndependent Distributorss Program – Food or Drink – Excluding Products/Completed Operations CW-CGL- FOOD.EXCLPRODUCTS-1 06/01/18\n\nIndependent Distributors Program – Food or Drink – Including Products/Completed Operations CW-CGL- FOOD.INCLPRODUCTS-1 06/01/18\n\nIndependent Distributors Program – Meat, Fish, Poultry, or Seafood CW-CGL-MEAT-1 06/01/18\n\nIndependent Distributors Program – Tool or Hardware CW-CGL-TOOL-1 06/01/18\n\nEstimated Loss Potentials TX-CGL-ELPS-1-8 04/01/19\n\nExperience and Schedule Rating Plan TX-CGL-ELR-1 04/01/19\n\nLiquor Liability TX-CGL-LIQUOR-1 04/01/19\n\nLoss Cost Multiplier TX-CGL-LOSS-1 04/01/19\n\nOwners and Contractors Protective Liability TX-CGL-OWNER-1 04/01/19\n\nRailroad Protective Liability Coverage TX-CGL-RAILR-1 04/01/19\n\nThe following pages are withdrawn:\n\nTitle of Rule Page Dated\n\nIndependent Distributors Program – Food or Drink – Excluding Products/Completed Operations CW-CGL- FOOD.EXCLPRODUCTS-1 06/01/11\n\nIndependent Distributors Program – Food or Drink – Including Products/Completed Operations CW-CGL- FOOD.INCLPRODUCTS-1 06/01/11\n\nIndependent Distributors Program – Meat, Fish, Poultry, or Seafood CW-CGL-MEAT-1 06/01/11\n\nIndependent Distributors Program – Tool or Hardware CW-CGL-TOOL-1 06/01/11\n\nEstimated Loss Potentials TX-CGL-ELPS-1-8 03/01/17\n\nExperience and Schedule Rating Plan TX-CGL-ELR-1 03/01/17\n\nLiquor Liability TX-CGL-LIQUOR-1 03/01/17\n\nLoss Cost Multiplier TX-CGL-LOSS-1 03/01/17\n\nOwners and Contractors Protective Liability TX-CGL-OWNER-1 03/01/17\n\nRailroad Protective Liability Coverage TX-CGL-RAILR-1 03/01/17\n\nBR9591 ALLSTATE INSURANCE COMPANY","pages":[{"line_numbers":[],"markdown":"COMMERCIAL LINES MANUAL EXCEPTIONS GENERAL LIABILITY TEXAS CHECKING LIST: The following pages are enclosed:\n\nTitle of Rule Page Dated\n\nIndependent Distributorss Program – Food or Drink – Excluding Products/Completed Operations CW-CGL- FOOD.EXCLPRODUCTS-1 06/01/18\n\nIndependent Distributors Program – Food or Drink – Including Products/Completed Operations CW-CGL- FOOD.INCLPRODUCTS-1 06/01/18\n\nIndependent Distributors Program – Meat, Fish, Poultry, or Seafood CW-CGL-MEAT-1 06/01/18\n\nIndependent Distributors Program – Tool or Hardware CW-CGL-TOOL-1 06/01/18\n\nEstimated Loss Potentials TX-CGL-ELPS-1-8 04/01/19\n\nExperience and Schedule Rating Plan TX-CGL-ELR-1 04/01/19\n\nLiquor Liability TX-CGL-LIQUOR-1 04/01/19\n\nLoss Cost Multiplier TX-CGL-LOSS-1 04/01/19\n\nOwners and Contractors Protective Liability TX-CGL-OWNER-1 04/01/19\n\nRailroad Protective Liability Coverage TX-CGL-RAILR-1 04/01/19\n\nThe following pages are withdrawn:\n\nTitle of Rule Page Dated\n\nIndependent Distributors Program – Food or Drink – Excluding Products/Completed Operations CW-CGL- FOOD.EXCLPRODUCTS-1 06/01/11\n\nIndependent Distributors Program – Food or Drink – Including Products/Completed Operations CW-CGL- FOOD.INCLPRODUCTS-1 06/01/11\n\nIndependent Distributors Program – Meat, Fish, Poultry, or Seafood CW-CGL-MEAT-1 06/01/11\n\nIndependent Distributors Program – Tool or Hardware CW-CGL-TOOL-1 06/01/11\n\nEstimated Loss Potentials TX-CGL-ELPS-1-8 03/01/17\n\nExperience and Schedule Rating Plan TX-CGL-ELR-1 03/01/17\n\nLiquor Liability TX-CGL-LIQUOR-1 03/01/17\n\nLoss Cost Multiplier TX-CGL-LOSS-1 03/01/17\n\nOwners and Contractors Protective Liability TX-CGL-OWNER-1 03/01/17\n\nRailroad Protective Liability Coverage TX-CGL-RAILR-1 03/01/17\n\nBR9591 ALLSTATE INSURANCE COMPANY","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"COMMERCIAL LINES MANUAL EXCEPTIONS GENERAL LIABILITY TEXAS CHECKING LIST: The following pages are enclosed:\n\nTitle of Rule Page Dated\n\nIndependent Distributorss Program – Food or Drink – Excluding Products/Completed Operations CW-CGL- FOOD.EXCLPRODUCTS-1 06/01/18\n\nIndependent Distributors Program – Food or Drink – Including Products/Completed Operations CW-CGL- FOOD.INCLPRODUCTS-1 06/01/18\n\nIndependent Distributors Program – Meat, Fish, Poultry, or Seafood CW-CGL-MEAT-1 06/01/18\n\nIndependent Distributors Program – Tool or Hardware CW-CGL-TOOL-1 06/01/18\n\nEstimated Loss Potentials TX-CGL-ELPS-1-8 04/01/19\n\nExperience and Schedule Rating Plan TX-CGL-ELR-1 04/01/19\n\nLiquor Liability TX-CGL-LIQUOR-1 04/01/19\n\nLoss Cost Multiplier TX-CGL-LOSS-1 04/01/19\n\nOwners and Contractors Protective Liability TX-CGL-OWNER-1 04/01/19\n\nRailroad Protective Liability Coverage TX-CGL-RAILR-1 04/01/19\n\nThe following pages are withdrawn:\n\nTitle of Rule Page Dated\n\nIndependent Distributors Program – Food or Drink – Excluding Products/Completed Operations CW-CGL- FOOD.EXCLPRODUCTS-1 06/01/11\n\nIndependent Distributors Program – Food or Drink – Including Products/Completed Operations CW-CGL- FOOD.INCLPRODUCTS-1 06/01/11\n\nIndependent Distributors Program – Meat, Fish, Poultry, or Seafood CW-CGL-MEAT-1 06/01/11\n\nIndependent Distributors Program – Tool or Hardware CW-CGL-TOOL-1 06/01/11\n\nEstimated Loss Potentials TX-CGL-ELPS-1-8 03/01/17\n\nExperience and Schedule Rating Plan TX-CGL-ELR-1 03/01/17\n\nLiquor Liability TX-CGL-LIQUOR-1 03/01/17\n\nLoss Cost Multiplier TX-CGL-LOSS-1 03/01/17\n\nOwners and Contractors Protective Liability TX-CGL-OWNER-1 03/01/17\n\nRailroad Protective Liability Coverage TX-CGL-RAILR-1 03/01/17\n\nBR9591 ALLSTATE INSURANCE COMPANY","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page244.pdf"]},"response":{"errors":[],"extract_id":"extract_5ace895c35aa55bac6c8e8142a9dfd52","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["COMMERCIAL LINES MANUAL EXCEPTIONS GENERAL LIABILITY TEXAS CHECKING LIST: The following pages are enclosed:\n\nTitle of Rule Page Dated\n\nIndependent Distributorss Program – Food or Drink – Excluding Products/Completed Operations CW-CGL- FOOD.EXCLPRODUCTS-1 06/01/18\n\nIndependent Distributors Program – Food or Drink – Including Products/Completed Operations CW-CGL- FOOD.INCLPRODUCTS-1 06/01/18\n\nIndependent Distributors Program – Meat, Fish, Poultry, or Seafood CW-CGL-MEAT-1 06/01/18\n\nIndependent Distributors Program – Tool or Hardware CW-CGL-TOOL-1 06/01/18\n\nEstimated Loss Potentials TX-CGL-ELPS-1-8 04/01/19\n\nExperience and Schedule Rating Plan TX-CGL-ELR-1 04/01/19\n\nLiquor Liability TX-CGL-LIQUOR-1 04/01/19\n\nLoss Cost Multiplier TX-CGL-LOSS-1 04/01/19\n\nOwners and Contractors Protective Liability TX-CGL-OWNER-1 04/01/19\n\nRailroad Protective Liability Coverage TX-CGL-RAILR-1 04/01/19\n\nThe following pages are withdrawn:\n\nTitle of Rule Page Dated\n\nIndependent Distributors Program – Food or Drink – Excluding Products/Completed Operations CW-CGL- FOOD.EXCLPRODUCTS-1 06/01/11\n\nIndependent Distributors Program – Food or Drink – Including Products/Completed Operations CW-CGL- FOOD.INCLPRODUCTS-1 06/01/11\n\nIndependent Distributors Program – Meat, Fish, Poultry, or Seafood CW-CGL-MEAT-1 06/01/11\n\nIndependent Distributors Program – Tool or Hardware CW-CGL-TOOL-1 06/01/11\n\nEstimated Loss Potentials TX-CGL-ELPS-1-8 03/01/17\n\nExperience and Schedule Rating Plan TX-CGL-ELR-1 03/01/17\n\nLiquor Liability TX-CGL-LIQUOR-1 03/01/17\n\nLoss Cost Multiplier TX-CGL-LOSS-1 03/01/17\n\nOwners and Contractors Protective Liability TX-CGL-OWNER-1 03/01/17\n\nRailroad Protective Liability Coverage TX-CGL-RAILR-1 03/01/17\n\nBR9591 ALLSTATE INSURANCE COMPANY"],"full_content":"COMMERCIAL LINES MANUAL EXCEPTIONS GENERAL LIABILITY TEXAS CHECKING LIST: The following pages are enclosed:\n\nTitle of Rule Page Dated\n\nIndependent Distributorss Program – Food or Drink – Excluding Products/Completed Operations CW-CGL- FOOD.EXCLPRODUCTS-1 06/01/18\n\nIndependent Distributors Program – Food or Drink – Including Products/Completed Operations CW-CGL- FOOD.INCLPRODUCTS-1 06/01/18\n\nIndependent Distributors Program – Meat, Fish, Poultry, or Seafood CW-CGL-MEAT-1 06/01/18\n\nIndependent Distributors Program – Tool or Hardware CW-CGL-TOOL-1 06/01/18\n\nEstimated Loss Potentials TX-CGL-ELPS-1-8 04/01/19\n\nExperience and Schedule Rating Plan TX-CGL-ELR-1 04/01/19\n\nLiquor Liability TX-CGL-LIQUOR-1 04/01/19\n\nLoss Cost Multiplier TX-CGL-LOSS-1 04/01/19\n\nOwners and Contractors Protective Liability TX-CGL-OWNER-1 04/01/19\n\nRailroad Protective Liability Coverage TX-CGL-RAILR-1 04/01/19\n\nThe following pages are withdrawn:\n\nTitle of Rule Page Dated\n\nIndependent Distributors Program – Food or Drink – Excluding Products/Completed Operations CW-CGL- FOOD.EXCLPRODUCTS-1 06/01/11\n\nIndependent Distributors Program – Food or Drink – Including Products/Completed Operations CW-CGL- FOOD.INCLPRODUCTS-1 06/01/11\n\nIndependent Distributors Program – Meat, Fish, Poultry, or Seafood CW-CGL-MEAT-1 06/01/11\n\nIndependent Distributors Program – Tool or Hardware CW-CGL-TOOL-1 06/01/11\n\nEstimated Loss Potentials TX-CGL-ELPS-1-8 03/01/17\n\nExperience and Schedule Rating Plan TX-CGL-ELR-1 03/01/17\n\nLiquor Liability TX-CGL-LIQUOR-1 03/01/17\n\nLoss Cost Multiplier TX-CGL-LOSS-1 03/01/17\n\nOwners and Contractors Protective Liability TX-CGL-OWNER-1 03/01/17\n\nRailroad Protective Liability Coverage TX-CGL-RAILR-1 03/01/17\n\nBR9591 ALLSTATE INSURANCE COMPANY","publish_date":null,"title":"COMMERCIAL LINES MANUAL EXCEPTIONS GENERAL LIABILITY TEXAS CHECKING LIST: The following pages are enclosed: Title of Rule Page Dated Independent","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page244.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page244.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page244","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page244.pdf"},"started_at":"2026-11-04T19:47:00.682826"} +{"completed_at":"2026-11-04T19:47:03.098819","latency_in_ms":1306,"output":{"example_id":"table/SERFF_TX_random_pages 1_page284","grounded_pages":[],"layout_pages":[],"markdown":"**Transmittal Checklist for Life / Health Rate and Form Filings #4** **Form # Approval Date**\n\nMCP-3 06-10-1983\n\nALMC2 02-16-1989\n\nALMC3 02-16-1989\n\nAL-0100-1 08-22-1979\n\nAL-0100-3 08-22-1979\n\nAL-03-1 08-22-1979\n\nIF40 See TX DOI database\n\nMSP-3 02-03-1982\n\nMSP-4 02-03-1982\n\nMSP-5 02-03-1982\n\nS-35-2 See TX DOI database","pages":[{"line_numbers":[],"markdown":"**Transmittal Checklist for Life / Health Rate and Form Filings #4** **Form # Approval Date**\n\nMCP-3 06-10-1983\n\nALMC2 02-16-1989\n\nALMC3 02-16-1989\n\nAL-0100-1 08-22-1979\n\nAL-0100-3 08-22-1979\n\nAL-03-1 08-22-1979\n\nIF40 See TX DOI database\n\nMSP-3 02-03-1982\n\nMSP-4 02-03-1982\n\nMSP-5 02-03-1982\n\nS-35-2 See TX DOI database","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Transmittal Checklist for Life / Health Rate and Form Filings #4** **Form # Approval Date**\n\nMCP-3 06-10-1983\n\nALMC2 02-16-1989\n\nALMC3 02-16-1989\n\nAL-0100-1 08-22-1979\n\nAL-0100-3 08-22-1979\n\nAL-03-1 08-22-1979\n\nIF40 See TX DOI database\n\nMSP-3 02-03-1982\n\nMSP-4 02-03-1982\n\nMSP-5 02-03-1982\n\nS-35-2 See TX DOI database","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page284.pdf"]},"response":{"errors":[],"extract_id":"extract_3d599a6383755c7ede8e780a90456bf9","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Transmittal Checklist for Life / Health Rate and Form Filings #4** **Form # Approval Date**\n\nMCP-3 06-10-1983\n\nALMC2 02-16-1989\n\nALMC3 02-16-1989\n\nAL-0100-1 08-22-1979\n\nAL-0100-3 08-22-1979\n\nAL-03-1 08-22-1979\n\nIF40 See TX DOI database\n\nMSP-3 02-03-1982\n\nMSP-4 02-03-1982\n\nMSP-5 02-03-1982\n\nS-35-2 See TX DOI database"],"full_content":"**Transmittal Checklist for Life / Health Rate and Form Filings #4** **Form # Approval Date**\n\nMCP-3 06-10-1983\n\nALMC2 02-16-1989\n\nALMC3 02-16-1989\n\nAL-0100-1 08-22-1979\n\nAL-0100-3 08-22-1979\n\nAL-03-1 08-22-1979\n\nIF40 See TX DOI database\n\nMSP-3 02-03-1982\n\nMSP-4 02-03-1982\n\nMSP-5 02-03-1982\n\nS-35-2 See TX DOI database","publish_date":null,"title":"Transmittal Checklist for Life / Health Rate and Form Filings #4 Form # Approval Date MCP-3 06-10-1983 ALMC2 02-16-1989 ALMC3","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page284.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page284.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page284","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page284.pdf"},"started_at":"2026-11-04T19:47:01.791851"} +{"completed_at":"2026-11-04T19:47:07.048274","latency_in_ms":3947,"output":{"example_id":"table/SERFF_TX_random_pages 1_page298","grounded_pages":[],"layout_pages":[],"markdown":"GLOBE LIFE AND ACCIDENT INSURANCE COMPANY\nOklahoma City, Oklahoma\n\nPOLICY FORM GMSN10\nINDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN N\n\n2017 NEW PRODUCT FILING\n\nPROJECTION OF ONE YEAR OF ISSUE BASED ON NATIONWIDE DATA\n\nPolicy Earned Incurred Loss\nYear Premium Claims Ratio\n1 1,000,000 658,900 0.659\n2 967,922 659,747 0.682\n3 957,548 673,360 0.703\n4 947,368 672,380 0,710\n5 937,379 674,360 0.719\n6 927,576 674,320 0.727\n7 917,955 674,753 0.735\n8 898,743 666,312 0.741\n9 880,007 655,752 0.745\n10 840,847 632,535 0.752\n11 803,429 608,732 0.758\n12 750,805 572,685 0.763\n13 701,627 536,863 0.765\n14 655,671 502,792 0.767\n15 612,724 475,272 0.776\n16 566,157 441,437 0.780\n17 511,240 403,513 0.789\n18 461,650 368,159 0.797\n19 416,870 335,976 0.806\n20 372,056 302,815 0814\n21 332,060 271,904 0.819\n22 296,364 244,233 0.824\n23 258,281 213,433 0.826\n24 225,092 187,320 0.832\n25 193,804 161,986 0.836\n26 164,830 137,708 0.835\n27 136,727 113,861 0.833\n28 110,544 91,539 0.828\n29 88,214 72,769 0.825\n30 67,616 55,148 0.816\n31 51,118 41,759 0.817\n32 37,571 30,768 0.819\n33 26,037 21,391 0.822\n34 17,223 14,199 0.824\n35 9,585 7,902 0.824\nTotal 17,142,638 12,856,582 0.750\n\nThe projection is based on $1,000,000 of annual premium issued at the beginning of the year\nThis projection is not a guarantee of future experience. Experience is subject to significant fluctuations on small blocks of business\n\n2017 New Form Projection (GMSN10) xlsx 2/9/2017","pages":[{"line_numbers":[],"markdown":"GLOBE LIFE AND ACCIDENT INSURANCE COMPANY\nOklahoma City, Oklahoma\n\nPOLICY FORM GMSN10\nINDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN N\n\n2017 NEW PRODUCT FILING\n\nPROJECTION OF ONE YEAR OF ISSUE BASED ON NATIONWIDE DATA\n\nPolicy Earned Incurred Loss\nYear Premium Claims Ratio\n1 1,000,000 658,900 0.659\n2 967,922 659,747 0.682\n3 957,548 673,360 0.703\n4 947,368 672,380 0,710\n5 937,379 674,360 0.719\n6 927,576 674,320 0.727\n7 917,955 674,753 0.735\n8 898,743 666,312 0.741\n9 880,007 655,752 0.745\n10 840,847 632,535 0.752\n11 803,429 608,732 0.758\n12 750,805 572,685 0.763\n13 701,627 536,863 0.765\n14 655,671 502,792 0.767\n15 612,724 475,272 0.776\n16 566,157 441,437 0.780\n17 511,240 403,513 0.789\n18 461,650 368,159 0.797\n19 416,870 335,976 0.806\n20 372,056 302,815 0814\n21 332,060 271,904 0.819\n22 296,364 244,233 0.824\n23 258,281 213,433 0.826\n24 225,092 187,320 0.832\n25 193,804 161,986 0.836\n26 164,830 137,708 0.835\n27 136,727 113,861 0.833\n28 110,544 91,539 0.828\n29 88,214 72,769 0.825\n30 67,616 55,148 0.816\n31 51,118 41,759 0.817\n32 37,571 30,768 0.819\n33 26,037 21,391 0.822\n34 17,223 14,199 0.824\n35 9,585 7,902 0.824\nTotal 17,142,638 12,856,582 0.750\n\nThe projection is based on $1,000,000 of annual premium issued at the beginning of the year\nThis projection is not a guarantee of future experience. Experience is subject to significant fluctuations on small blocks of business\n\n2017 New Form Projection (GMSN10) xlsx 2/9/2017","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"GLOBE LIFE AND ACCIDENT INSURANCE COMPANY\nOklahoma City, Oklahoma\n\nPOLICY FORM GMSN10\nINDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN N\n\n2017 NEW PRODUCT FILING\n\nPROJECTION OF ONE YEAR OF ISSUE BASED ON NATIONWIDE DATA\n\nPolicy Earned Incurred Loss\nYear Premium Claims Ratio\n1 1,000,000 658,900 0.659\n2 967,922 659,747 0.682\n3 957,548 673,360 0.703\n4 947,368 672,380 0,710\n5 937,379 674,360 0.719\n6 927,576 674,320 0.727\n7 917,955 674,753 0.735\n8 898,743 666,312 0.741\n9 880,007 655,752 0.745\n10 840,847 632,535 0.752\n11 803,429 608,732 0.758\n12 750,805 572,685 0.763\n13 701,627 536,863 0.765\n14 655,671 502,792 0.767\n15 612,724 475,272 0.776\n16 566,157 441,437 0.780\n17 511,240 403,513 0.789\n18 461,650 368,159 0.797\n19 416,870 335,976 0.806\n20 372,056 302,815 0814\n21 332,060 271,904 0.819\n22 296,364 244,233 0.824\n23 258,281 213,433 0.826\n24 225,092 187,320 0.832\n25 193,804 161,986 0.836\n26 164,830 137,708 0.835\n27 136,727 113,861 0.833\n28 110,544 91,539 0.828\n29 88,214 72,769 0.825\n30 67,616 55,148 0.816\n31 51,118 41,759 0.817\n32 37,571 30,768 0.819\n33 26,037 21,391 0.822\n34 17,223 14,199 0.824\n35 9,585 7,902 0.824\nTotal 17,142,638 12,856,582 0.750\n\nThe projection is based on $1,000,000 of annual premium issued at the beginning of the year\nThis projection is not a guarantee of future experience. Experience is subject to significant fluctuations on small blocks of business\n\n2017 New Form Projection (GMSN10) xlsx 2/9/2017","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page298.pdf"]},"response":{"errors":[],"extract_id":"extract_854d53fe3859373ef13d76eda7be947c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["GLOBE LIFE AND ACCIDENT INSURANCE COMPANY\nOklahoma City, Oklahoma\n\nPOLICY FORM GMSN10\nINDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN N\n\n2017 NEW PRODUCT FILING\n\nPROJECTION OF ONE YEAR OF ISSUE BASED ON NATIONWIDE DATA\n\nPolicy Earned Incurred Loss\nYear Premium Claims Ratio\n1 1,000,000 658,900 0.659\n2 967,922 659,747 0.682\n3 957,548 673,360 0.703\n4 947,368 672,380 0,710\n5 937,379 674,360 0.719\n6 927,576 674,320 0.727\n7 917,955 674,753 0.735\n8 898,743 666,312 0.741\n9 880,007 655,752 0.745\n10 840,847 632,535 0.752\n11 803,429 608,732 0.758\n12 750,805 572,685 0.763\n13 701,627 536,863 0.765\n14 655,671 502,792 0.767\n15 612,724 475,272 0.776\n16 566,157 441,437 0.780\n17 511,240 403,513 0.789\n18 461,650 368,159 0.797\n19 416,870 335,976 0.806\n20 372,056 302,815 0814\n21 332,060 271,904 0.819\n22 296,364 244,233 0.824\n23 258,281 213,433 0.826\n24 225,092 187,320 0.832\n25 193,804 161,986 0.836\n26 164,830 137,708 0.835\n27 136,727 113,861 0.833\n28 110,544 91,539 0.828\n29 88,214 72,769 0.825\n30 67,616 55,148 0.816\n31 51,118 41,759 0.817\n32 37,571 30,768 0.819\n33 26,037 21,391 0.822\n34 17,223 14,199 0.824\n35 9,585 7,902 0.824\nTotal 17,142,638 12,856,582 0.750\n\nThe projection is based on $1,000,000 of annual premium issued at the beginning of the year\nThis projection is not a guarantee of future experience. Experience is subject to significant fluctuations on small blocks of business\n\n2017 New Form Projection (GMSN10) xlsx 2/9/2017"],"full_content":"GLOBE LIFE AND ACCIDENT INSURANCE COMPANY\nOklahoma City, Oklahoma\n\nPOLICY FORM GMSN10\nINDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN N\n\n2017 NEW PRODUCT FILING\n\nPROJECTION OF ONE YEAR OF ISSUE BASED ON NATIONWIDE DATA\n\nPolicy Earned Incurred Loss\nYear Premium Claims Ratio\n1 1,000,000 658,900 0.659\n2 967,922 659,747 0.682\n3 957,548 673,360 0.703\n4 947,368 672,380 0,710\n5 937,379 674,360 0.719\n6 927,576 674,320 0.727\n7 917,955 674,753 0.735\n8 898,743 666,312 0.741\n9 880,007 655,752 0.745\n10 840,847 632,535 0.752\n11 803,429 608,732 0.758\n12 750,805 572,685 0.763\n13 701,627 536,863 0.765\n14 655,671 502,792 0.767\n15 612,724 475,272 0.776\n16 566,157 441,437 0.780\n17 511,240 403,513 0.789\n18 461,650 368,159 0.797\n19 416,870 335,976 0.806\n20 372,056 302,815 0814\n21 332,060 271,904 0.819\n22 296,364 244,233 0.824\n23 258,281 213,433 0.826\n24 225,092 187,320 0.832\n25 193,804 161,986 0.836\n26 164,830 137,708 0.835\n27 136,727 113,861 0.833\n28 110,544 91,539 0.828\n29 88,214 72,769 0.825\n30 67,616 55,148 0.816\n31 51,118 41,759 0.817\n32 37,571 30,768 0.819\n33 26,037 21,391 0.822\n34 17,223 14,199 0.824\n35 9,585 7,902 0.824\nTotal 17,142,638 12,856,582 0.750\n\nThe projection is based on $1,000,000 of annual premium issued at the beginning of the year\nThis projection is not a guarantee of future experience. Experience is subject to significant fluctuations on small blocks of business\n\n2017 New Form Projection (GMSN10) xlsx 2/9/2017","publish_date":null,"title":"Serff Tx Random Pages 1 Page298","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page298.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page298.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page298","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page298.pdf"},"started_at":"2026-11-04T19:47:03.100461"} +{"completed_at":"2026-11-04T19:47:06.537584","latency_in_ms":2071,"output":{"example_id":"table/SERFF_TX_random_pages 1_page3","grounded_pages":[],"layout_pages":[],"markdown":"Proposed Rate Increase: 15.0%\n\nDiscount Rate: 5.00%\n\nShock Lapse (% of RI): 0.0%\n\nPremium Claims Incurred ASSUMPTIONS\n\nYear Earned Incurred Loss Ratio Aging Prem Lapse Medical\n\n1-3 2016 242,643 303,962 125.27% Trend\\* Aging Rate Trend\n\nPartial Year Projection 4-12 2016 694,001 526,188 75.82% 2.6% 0.7% 12.4% 5.2%\n\n2009 250 0 0.00%\n\n2010 67,271 84,842 126.12%\n\n2011 354,398 629,806 177.71%\n\n2012 552,295 1,112,410 201.42%\n\n2013 944,013 2,036,894 215.77%\n\n2014 1,290,823 2,476,072 191.82%\n\n2015 1,147,997 1,958,812 170.63%\n\n2016 936,645 830,150 88.63%\n\n**Accum Value of Past @ 12/31/16 6,017,130 10,497,364 174.46%**\n\n**Combined Value @ 12/31/16 11,016,942 14,345,945 130.22%**\n\n**Present Value of Future @ 12/31/16 4,999,812 3,848,581 76.97%**\n\n2017 872,222 672,085 77.05% 1.7% 0.9% 18.0% 7.0%\n\n2018 773,048 597,916 77.35% 0.4% 1.0% 18.6% 7.0%\n\n2019 677,096 523,598 77.33% 0.0% 0.8% 19.0% 7.0%\n\n2020 591,690 457,396 77.30% 0.0% 0.8% 19.0% 7.0%\n\n2021 516,830 399,248 77.25% 0.0% 0.8% 19.0% 7.0%\n\n2022 451,823 348,508 77.13% 0.0% 0.9% 19.0% 7.0%\n\n2023 394,393 303,534 76.96% 0.0% 0.7% 19.0% 7.0%\n\n2024 344,063 264,020 76.74% 0.0% 0.7% 19.0% 7.0%\n\n2025 300,432 229,779 76.48% 0.0% 0.8% 19.0% 7.0%\n\n2026 262,017 199,938 76.31% 0.0% 0.6% 19.0% 7.0%\n\n2027 228,509 174,106 76.19% 0.0% 0.6% 19.0% 7.0%\n\n2028 199,276 151,716 76.13% 0.0% 0.6% 19.0% 7.0%\n\n2029 173,783 132,224 76.09% 0.0% 0.6% 19.0% 7.0%\n\n2030 151,740 115,386 76.04% 0.0% 0.8% 19.0% 7.0%\n\n2031 132,359 100,532 75.95% 0.0% 0.6% 19.0% 7.0%\n\n2032 115,452 87,641 75.91% 0.0% 0.6% 19.0% 7.0%\n\n2033 100,713 76,484 75.94% 0.0% 0.7% 19.0% 7.0%\n\n2034 87,866 66,798 76.02% 0.1% 0.7% 19.0% 7.0%\n\n2035 76,744 58,415 76.12% 0.1% 0.8% 19.0% 7.0%\n\n2036 66,953 51,023 76.21% 0.1% 0.6% 19.0% 7.0%\n\n\\* Includes aging and underwriting selection wear off.\n\n**EXHIBIT IV - Nationwide Calendar Year Experience**\n\n**Gerber Life Insurance Company**\n\n**NATIONWIDE EXPERIENCE**\n\n**with PROPOSED RATE INCREASE**\n\n_Medicare Supplement Plan A Pooled Experience_\n\nAs of March 31, 2016\n\n46","pages":[{"line_numbers":[],"markdown":"Proposed Rate Increase: 15.0%\n\nDiscount Rate: 5.00%\n\nShock Lapse (% of RI): 0.0%\n\nPremium Claims Incurred ASSUMPTIONS\n\nYear Earned Incurred Loss Ratio Aging Prem Lapse Medical\n\n1-3 2016 242,643 303,962 125.27% Trend\\* Aging Rate Trend\n\nPartial Year Projection 4-12 2016 694,001 526,188 75.82% 2.6% 0.7% 12.4% 5.2%\n\n2009 250 0 0.00%\n\n2010 67,271 84,842 126.12%\n\n2011 354,398 629,806 177.71%\n\n2012 552,295 1,112,410 201.42%\n\n2013 944,013 2,036,894 215.77%\n\n2014 1,290,823 2,476,072 191.82%\n\n2015 1,147,997 1,958,812 170.63%\n\n2016 936,645 830,150 88.63%\n\n**Accum Value of Past @ 12/31/16 6,017,130 10,497,364 174.46%**\n\n**Combined Value @ 12/31/16 11,016,942 14,345,945 130.22%**\n\n**Present Value of Future @ 12/31/16 4,999,812 3,848,581 76.97%**\n\n2017 872,222 672,085 77.05% 1.7% 0.9% 18.0% 7.0%\n\n2018 773,048 597,916 77.35% 0.4% 1.0% 18.6% 7.0%\n\n2019 677,096 523,598 77.33% 0.0% 0.8% 19.0% 7.0%\n\n2020 591,690 457,396 77.30% 0.0% 0.8% 19.0% 7.0%\n\n2021 516,830 399,248 77.25% 0.0% 0.8% 19.0% 7.0%\n\n2022 451,823 348,508 77.13% 0.0% 0.9% 19.0% 7.0%\n\n2023 394,393 303,534 76.96% 0.0% 0.7% 19.0% 7.0%\n\n2024 344,063 264,020 76.74% 0.0% 0.7% 19.0% 7.0%\n\n2025 300,432 229,779 76.48% 0.0% 0.8% 19.0% 7.0%\n\n2026 262,017 199,938 76.31% 0.0% 0.6% 19.0% 7.0%\n\n2027 228,509 174,106 76.19% 0.0% 0.6% 19.0% 7.0%\n\n2028 199,276 151,716 76.13% 0.0% 0.6% 19.0% 7.0%\n\n2029 173,783 132,224 76.09% 0.0% 0.6% 19.0% 7.0%\n\n2030 151,740 115,386 76.04% 0.0% 0.8% 19.0% 7.0%\n\n2031 132,359 100,532 75.95% 0.0% 0.6% 19.0% 7.0%\n\n2032 115,452 87,641 75.91% 0.0% 0.6% 19.0% 7.0%\n\n2033 100,713 76,484 75.94% 0.0% 0.7% 19.0% 7.0%\n\n2034 87,866 66,798 76.02% 0.1% 0.7% 19.0% 7.0%\n\n2035 76,744 58,415 76.12% 0.1% 0.8% 19.0% 7.0%\n\n2036 66,953 51,023 76.21% 0.1% 0.6% 19.0% 7.0%\n\n\\* Includes aging and underwriting selection wear off.\n\n**EXHIBIT IV - Nationwide Calendar Year Experience**\n\n**Gerber Life Insurance Company**\n\n**NATIONWIDE EXPERIENCE**\n\n**with PROPOSED RATE INCREASE**\n\n_Medicare Supplement Plan A Pooled Experience_\n\nAs of March 31, 2016\n\n46","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Proposed Rate Increase: 15.0%\n\nDiscount Rate: 5.00%\n\nShock Lapse (% of RI): 0.0%\n\nPremium Claims Incurred ASSUMPTIONS\n\nYear Earned Incurred Loss Ratio Aging Prem Lapse Medical\n\n1-3 2016 242,643 303,962 125.27% Trend\\* Aging Rate Trend\n\nPartial Year Projection 4-12 2016 694,001 526,188 75.82% 2.6% 0.7% 12.4% 5.2%\n\n2009 250 0 0.00%\n\n2010 67,271 84,842 126.12%\n\n2011 354,398 629,806 177.71%\n\n2012 552,295 1,112,410 201.42%\n\n2013 944,013 2,036,894 215.77%\n\n2014 1,290,823 2,476,072 191.82%\n\n2015 1,147,997 1,958,812 170.63%\n\n2016 936,645 830,150 88.63%\n\n**Accum Value of Past @ 12/31/16 6,017,130 10,497,364 174.46%**\n\n**Combined Value @ 12/31/16 11,016,942 14,345,945 130.22%**\n\n**Present Value of Future @ 12/31/16 4,999,812 3,848,581 76.97%**\n\n2017 872,222 672,085 77.05% 1.7% 0.9% 18.0% 7.0%\n\n2018 773,048 597,916 77.35% 0.4% 1.0% 18.6% 7.0%\n\n2019 677,096 523,598 77.33% 0.0% 0.8% 19.0% 7.0%\n\n2020 591,690 457,396 77.30% 0.0% 0.8% 19.0% 7.0%\n\n2021 516,830 399,248 77.25% 0.0% 0.8% 19.0% 7.0%\n\n2022 451,823 348,508 77.13% 0.0% 0.9% 19.0% 7.0%\n\n2023 394,393 303,534 76.96% 0.0% 0.7% 19.0% 7.0%\n\n2024 344,063 264,020 76.74% 0.0% 0.7% 19.0% 7.0%\n\n2025 300,432 229,779 76.48% 0.0% 0.8% 19.0% 7.0%\n\n2026 262,017 199,938 76.31% 0.0% 0.6% 19.0% 7.0%\n\n2027 228,509 174,106 76.19% 0.0% 0.6% 19.0% 7.0%\n\n2028 199,276 151,716 76.13% 0.0% 0.6% 19.0% 7.0%\n\n2029 173,783 132,224 76.09% 0.0% 0.6% 19.0% 7.0%\n\n2030 151,740 115,386 76.04% 0.0% 0.8% 19.0% 7.0%\n\n2031 132,359 100,532 75.95% 0.0% 0.6% 19.0% 7.0%\n\n2032 115,452 87,641 75.91% 0.0% 0.6% 19.0% 7.0%\n\n2033 100,713 76,484 75.94% 0.0% 0.7% 19.0% 7.0%\n\n2034 87,866 66,798 76.02% 0.1% 0.7% 19.0% 7.0%\n\n2035 76,744 58,415 76.12% 0.1% 0.8% 19.0% 7.0%\n\n2036 66,953 51,023 76.21% 0.1% 0.6% 19.0% 7.0%\n\n\\* Includes aging and underwriting selection wear off.\n\n**EXHIBIT IV - Nationwide Calendar Year Experience**\n\n**Gerber Life Insurance Company**\n\n**NATIONWIDE EXPERIENCE**\n\n**with PROPOSED RATE INCREASE**\n\n_Medicare Supplement Plan A Pooled Experience_\n\nAs of March 31, 2016\n\n46","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page3.pdf"]},"response":{"errors":[],"extract_id":"extract_c03678241f57a2b703a79bdbdec65691","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Proposed Rate Increase: 15.0%\n\nDiscount Rate: 5.00%\n\nShock Lapse (% of RI): 0.0%\n\nPremium Claims Incurred ASSUMPTIONS\n\nYear Earned Incurred Loss Ratio Aging Prem Lapse Medical\n\n1-3 2016 242,643 303,962 125.27% Trend\\* Aging Rate Trend\n\nPartial Year Projection 4-12 2016 694,001 526,188 75.82% 2.6% 0.7% 12.4% 5.2%\n\n2009 250 0 0.00%\n\n2010 67,271 84,842 126.12%\n\n2011 354,398 629,806 177.71%\n\n2012 552,295 1,112,410 201.42%\n\n2013 944,013 2,036,894 215.77%\n\n2014 1,290,823 2,476,072 191.82%\n\n2015 1,147,997 1,958,812 170.63%\n\n2016 936,645 830,150 88.63%\n\n**Accum Value of Past @ 12/31/16 6,017,130 10,497,364 174.46%**\n\n**Combined Value @ 12/31/16 11,016,942 14,345,945 130.22%**\n\n**Present Value of Future @ 12/31/16 4,999,812 3,848,581 76.97%**\n\n2017 872,222 672,085 77.05% 1.7% 0.9% 18.0% 7.0%\n\n2018 773,048 597,916 77.35% 0.4% 1.0% 18.6% 7.0%\n\n2019 677,096 523,598 77.33% 0.0% 0.8% 19.0% 7.0%\n\n2020 591,690 457,396 77.30% 0.0% 0.8% 19.0% 7.0%\n\n2021 516,830 399,248 77.25% 0.0% 0.8% 19.0% 7.0%\n\n2022 451,823 348,508 77.13% 0.0% 0.9% 19.0% 7.0%\n\n2023 394,393 303,534 76.96% 0.0% 0.7% 19.0% 7.0%\n\n2024 344,063 264,020 76.74% 0.0% 0.7% 19.0% 7.0%\n\n2025 300,432 229,779 76.48% 0.0% 0.8% 19.0% 7.0%\n\n2026 262,017 199,938 76.31% 0.0% 0.6% 19.0% 7.0%\n\n2027 228,509 174,106 76.19% 0.0% 0.6% 19.0% 7.0%\n\n2028 199,276 151,716 76.13% 0.0% 0.6% 19.0% 7.0%\n\n2029 173,783 132,224 76.09% 0.0% 0.6% 19.0% 7.0%\n\n2030 151,740 115,386 76.04% 0.0% 0.8% 19.0% 7.0%\n\n2031 132,359 100,532 75.95% 0.0% 0.6% 19.0% 7.0%\n\n2032 115,452 87,641 75.91% 0.0% 0.6% 19.0% 7.0%\n\n2033 100,713 76,484 75.94% 0.0% 0.7% 19.0% 7.0%\n\n2034 87,866 66,798 76.02% 0.1% 0.7% 19.0% 7.0%\n\n2035 76,744 58,415 76.12% 0.1% 0.8% 19.0% 7.0%\n\n2036 66,953 51,023 76.21% 0.1% 0.6% 19.0% 7.0%\n\n\\* Includes aging and underwriting selection wear off.\n\n**EXHIBIT IV - Nationwide Calendar Year Experience**\n\n**Gerber Life Insurance Company**\n\n**NATIONWIDE EXPERIENCE**\n\n**with PROPOSED RATE INCREASE**\n\n_Medicare Supplement Plan A Pooled Experience_\n\nAs of March 31, 2016\n\n46"],"full_content":"Proposed Rate Increase: 15.0%\n\nDiscount Rate: 5.00%\n\nShock Lapse (% of RI): 0.0%\n\nPremium Claims Incurred ASSUMPTIONS\n\nYear Earned Incurred Loss Ratio Aging Prem Lapse Medical\n\n1-3 2016 242,643 303,962 125.27% Trend\\* Aging Rate Trend\n\nPartial Year Projection 4-12 2016 694,001 526,188 75.82% 2.6% 0.7% 12.4% 5.2%\n\n2009 250 0 0.00%\n\n2010 67,271 84,842 126.12%\n\n2011 354,398 629,806 177.71%\n\n2012 552,295 1,112,410 201.42%\n\n2013 944,013 2,036,894 215.77%\n\n2014 1,290,823 2,476,072 191.82%\n\n2015 1,147,997 1,958,812 170.63%\n\n2016 936,645 830,150 88.63%\n\n**Accum Value of Past @ 12/31/16 6,017,130 10,497,364 174.46%**\n\n**Combined Value @ 12/31/16 11,016,942 14,345,945 130.22%**\n\n**Present Value of Future @ 12/31/16 4,999,812 3,848,581 76.97%**\n\n2017 872,222 672,085 77.05% 1.7% 0.9% 18.0% 7.0%\n\n2018 773,048 597,916 77.35% 0.4% 1.0% 18.6% 7.0%\n\n2019 677,096 523,598 77.33% 0.0% 0.8% 19.0% 7.0%\n\n2020 591,690 457,396 77.30% 0.0% 0.8% 19.0% 7.0%\n\n2021 516,830 399,248 77.25% 0.0% 0.8% 19.0% 7.0%\n\n2022 451,823 348,508 77.13% 0.0% 0.9% 19.0% 7.0%\n\n2023 394,393 303,534 76.96% 0.0% 0.7% 19.0% 7.0%\n\n2024 344,063 264,020 76.74% 0.0% 0.7% 19.0% 7.0%\n\n2025 300,432 229,779 76.48% 0.0% 0.8% 19.0% 7.0%\n\n2026 262,017 199,938 76.31% 0.0% 0.6% 19.0% 7.0%\n\n2027 228,509 174,106 76.19% 0.0% 0.6% 19.0% 7.0%\n\n2028 199,276 151,716 76.13% 0.0% 0.6% 19.0% 7.0%\n\n2029 173,783 132,224 76.09% 0.0% 0.6% 19.0% 7.0%\n\n2030 151,740 115,386 76.04% 0.0% 0.8% 19.0% 7.0%\n\n2031 132,359 100,532 75.95% 0.0% 0.6% 19.0% 7.0%\n\n2032 115,452 87,641 75.91% 0.0% 0.6% 19.0% 7.0%\n\n2033 100,713 76,484 75.94% 0.0% 0.7% 19.0% 7.0%\n\n2034 87,866 66,798 76.02% 0.1% 0.7% 19.0% 7.0%\n\n2035 76,744 58,415 76.12% 0.1% 0.8% 19.0% 7.0%\n\n2036 66,953 51,023 76.21% 0.1% 0.6% 19.0% 7.0%\n\n\\* Includes aging and underwriting selection wear off.\n\n**EXHIBIT IV - Nationwide Calendar Year Experience**\n\n**Gerber Life Insurance Company**\n\n**NATIONWIDE EXPERIENCE**\n\n**with PROPOSED RATE INCREASE**\n\n_Medicare Supplement Plan A Pooled Experience_\n\nAs of March 31, 2016\n\n46","publish_date":null,"title":"EXHIBIT IV - Nationwide Calendar Year Experience","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page3.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page3.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page3","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page3.pdf"},"started_at":"2026-11-04T19:47:04.466423"} +{"completed_at":"2026-11-04T19:47:06.642078","latency_in_ms":999,"output":{"example_id":"table/SERFF_TX_random_pages 1_page300","grounded_pages":[],"layout_pages":[],"markdown":"**Item No.**\n\n**Schedule Item Status**\n\n**Document Name**\n\n**Affected Form Numbers (Separated with commas) Rate Action Rate Action Information Attachments**\n\n1 2025 TX 1990 Plan A Rate Page(s)\n\nMSA Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan A Rate Pages.pdf,\n\n2 2025 TX 1990 Plan A Rate Page(s)\n\nMSA06 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan A Rate Pages.pdf,\n\n3 2025 TX 2010 Plan A Rate Page(s)\n\nMSA10 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 2010 Plan A Rate Page.pdf,\n\n4 2025 TX 1990 Plan B Rate Page(s)\n\nMSB Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan B Rate Pages.pdf,\n\n5 2025 TX 1990 Plan B Rate Page(s)\n\nMSB06 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan B Rate Pages.pdf,\n\n6 2025 TX 2010 Plan B Rate Page(s)\n\nMSB10 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 2010 Plan B Rate Page.pdf,\n\n7 2025 TX 1990 Plan C Rate Page(s)\n\nMSC Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 1990 Plan C Rate Pages.pdf,\n\n8 2025 TX 1990 Plan C Rate Page(s)\n\nMSC06 Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 1990 Plan C Rate Pages.pdf,\n\n9 2025 TX 2010 Plan C Rate Page(s)\n\nMSC10 Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 2010 Plan C Rate Page.pdf,\n\n10 2025 TX 1990 Plan D Rate Page(s)\n\nMSD Revised Previous State Filing Number: AMLC-133848161\n\n2025 TX 1990 Plan D Rate Pages.pdf,\n\n**_SERFF Tracking #:_** _AMLC-134291200_ **_State Tracking #:_** _AMLC-134291200_ **_Company Tracking #:_** _2024 TX UA PROCARE_\n\n**_State:_** _Texas_ **_Filing Company:_** _United American Insurance Company_\n\n**_TOI/Sub-TOI:_** _MS08I Individual Medicare Supplement - Standard Plans 2010/MS08I.012 Multi-Plan 2010_\n\n**_Product Name:_** _2025 Individual Standardized Medicare Supplement Rate Filing_\n\n**_Project Name/Number:_** _2025 TX UA Procare Annual Rate Filing/2025 TX UA Procare Rate Filing_\n\n_PDF Pipeline for SERFF Tracking Number AMLC-134291200 Generated 02/23/2026 06:47 PM_","pages":[{"line_numbers":[],"markdown":"**Item No.**\n\n**Schedule Item Status**\n\n**Document Name**\n\n**Affected Form Numbers (Separated with commas) Rate Action Rate Action Information Attachments**\n\n1 2025 TX 1990 Plan A Rate Page(s)\n\nMSA Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan A Rate Pages.pdf,\n\n2 2025 TX 1990 Plan A Rate Page(s)\n\nMSA06 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan A Rate Pages.pdf,\n\n3 2025 TX 2010 Plan A Rate Page(s)\n\nMSA10 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 2010 Plan A Rate Page.pdf,\n\n4 2025 TX 1990 Plan B Rate Page(s)\n\nMSB Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan B Rate Pages.pdf,\n\n5 2025 TX 1990 Plan B Rate Page(s)\n\nMSB06 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan B Rate Pages.pdf,\n\n6 2025 TX 2010 Plan B Rate Page(s)\n\nMSB10 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 2010 Plan B Rate Page.pdf,\n\n7 2025 TX 1990 Plan C Rate Page(s)\n\nMSC Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 1990 Plan C Rate Pages.pdf,\n\n8 2025 TX 1990 Plan C Rate Page(s)\n\nMSC06 Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 1990 Plan C Rate Pages.pdf,\n\n9 2025 TX 2010 Plan C Rate Page(s)\n\nMSC10 Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 2010 Plan C Rate Page.pdf,\n\n10 2025 TX 1990 Plan D Rate Page(s)\n\nMSD Revised Previous State Filing Number: AMLC-133848161\n\n2025 TX 1990 Plan D Rate Pages.pdf,\n\n**_SERFF Tracking #:_** _AMLC-134291200_ **_State Tracking #:_** _AMLC-134291200_ **_Company Tracking #:_** _2024 TX UA PROCARE_\n\n**_State:_** _Texas_ **_Filing Company:_** _United American Insurance Company_\n\n**_TOI/Sub-TOI:_** _MS08I Individual Medicare Supplement - Standard Plans 2010/MS08I.012 Multi-Plan 2010_\n\n**_Product Name:_** _2025 Individual Standardized Medicare Supplement Rate Filing_\n\n**_Project Name/Number:_** _2025 TX UA Procare Annual Rate Filing/2025 TX UA Procare Rate Filing_\n\n_PDF Pipeline for SERFF Tracking Number AMLC-134291200 Generated 02/23/2026 06:47 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Item No.**\n\n**Schedule Item Status**\n\n**Document Name**\n\n**Affected Form Numbers (Separated with commas) Rate Action Rate Action Information Attachments**\n\n1 2025 TX 1990 Plan A Rate Page(s)\n\nMSA Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan A Rate Pages.pdf,\n\n2 2025 TX 1990 Plan A Rate Page(s)\n\nMSA06 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan A Rate Pages.pdf,\n\n3 2025 TX 2010 Plan A Rate Page(s)\n\nMSA10 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 2010 Plan A Rate Page.pdf,\n\n4 2025 TX 1990 Plan B Rate Page(s)\n\nMSB Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan B Rate Pages.pdf,\n\n5 2025 TX 1990 Plan B Rate Page(s)\n\nMSB06 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan B Rate Pages.pdf,\n\n6 2025 TX 2010 Plan B Rate Page(s)\n\nMSB10 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 2010 Plan B Rate Page.pdf,\n\n7 2025 TX 1990 Plan C Rate Page(s)\n\nMSC Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 1990 Plan C Rate Pages.pdf,\n\n8 2025 TX 1990 Plan C Rate Page(s)\n\nMSC06 Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 1990 Plan C Rate Pages.pdf,\n\n9 2025 TX 2010 Plan C Rate Page(s)\n\nMSC10 Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 2010 Plan C Rate Page.pdf,\n\n10 2025 TX 1990 Plan D Rate Page(s)\n\nMSD Revised Previous State Filing Number: AMLC-133848161\n\n2025 TX 1990 Plan D Rate Pages.pdf,\n\n**_SERFF Tracking #:_** _AMLC-134291200_ **_State Tracking #:_** _AMLC-134291200_ **_Company Tracking #:_** _2024 TX UA PROCARE_\n\n**_State:_** _Texas_ **_Filing Company:_** _United American Insurance Company_\n\n**_TOI/Sub-TOI:_** _MS08I Individual Medicare Supplement - Standard Plans 2010/MS08I.012 Multi-Plan 2010_\n\n**_Product Name:_** _2025 Individual Standardized Medicare Supplement Rate Filing_\n\n**_Project Name/Number:_** _2025 TX UA Procare Annual Rate Filing/2025 TX UA Procare Rate Filing_\n\n_PDF Pipeline for SERFF Tracking Number AMLC-134291200 Generated 02/23/2026 06:47 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page300.pdf"]},"response":{"errors":[],"extract_id":"extract_2c6ea510c48473b9fe625d68288c859c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Item No.**\n\n**Schedule Item Status**\n\n**Document Name**\n\n**Affected Form Numbers (Separated with commas) Rate Action Rate Action Information Attachments**\n\n1 2025 TX 1990 Plan A Rate Page(s)\n\nMSA Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan A Rate Pages.pdf,\n\n2 2025 TX 1990 Plan A Rate Page(s)\n\nMSA06 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan A Rate Pages.pdf,\n\n3 2025 TX 2010 Plan A Rate Page(s)\n\nMSA10 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 2010 Plan A Rate Page.pdf,\n\n4 2025 TX 1990 Plan B Rate Page(s)\n\nMSB Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan B Rate Pages.pdf,\n\n5 2025 TX 1990 Plan B Rate Page(s)\n\nMSB06 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan B Rate Pages.pdf,\n\n6 2025 TX 2010 Plan B Rate Page(s)\n\nMSB10 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 2010 Plan B Rate Page.pdf,\n\n7 2025 TX 1990 Plan C Rate Page(s)\n\nMSC Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 1990 Plan C Rate Pages.pdf,\n\n8 2025 TX 1990 Plan C Rate Page(s)\n\nMSC06 Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 1990 Plan C Rate Pages.pdf,\n\n9 2025 TX 2010 Plan C Rate Page(s)\n\nMSC10 Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 2010 Plan C Rate Page.pdf,\n\n10 2025 TX 1990 Plan D Rate Page(s)\n\nMSD Revised Previous State Filing Number: AMLC-133848161\n\n2025 TX 1990 Plan D Rate Pages.pdf,\n\n**_SERFF Tracking #:_** _AMLC-134291200_ **_State Tracking #:_** _AMLC-134291200_ **_Company Tracking #:_** _2024 TX UA PROCARE_\n\n**_State:_** _Texas_ **_Filing Company:_** _United American Insurance Company_\n\n**_TOI/Sub-TOI:_** _MS08I Individual Medicare Supplement - Standard Plans 2010/MS08I.012 Multi-Plan 2010_\n\n**_Product Name:_** _2025 Individual Standardized Medicare Supplement Rate Filing_\n\n**_Project Name/Number:_** _2025 TX UA Procare Annual Rate Filing/2025 TX UA Procare Rate Filing_\n\n_PDF Pipeline for SERFF Tracking Number AMLC-134291200 Generated 02/23/2026 06:47 PM_"],"full_content":"**Item No.**\n\n**Schedule Item Status**\n\n**Document Name**\n\n**Affected Form Numbers (Separated with commas) Rate Action Rate Action Information Attachments**\n\n1 2025 TX 1990 Plan A Rate Page(s)\n\nMSA Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan A Rate Pages.pdf,\n\n2 2025 TX 1990 Plan A Rate Page(s)\n\nMSA06 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan A Rate Pages.pdf,\n\n3 2025 TX 2010 Plan A Rate Page(s)\n\nMSA10 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 2010 Plan A Rate Page.pdf,\n\n4 2025 TX 1990 Plan B Rate Page(s)\n\nMSB Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan B Rate Pages.pdf,\n\n5 2025 TX 1990 Plan B Rate Page(s)\n\nMSB06 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 1990 Plan B Rate Pages.pdf,\n\n6 2025 TX 2010 Plan B Rate Page(s)\n\nMSB10 Other Previous State Filing Number: AMLC-133848161 Rate Action Other Explanation: 0.0\n\n2025 TX 2010 Plan B Rate Page.pdf,\n\n7 2025 TX 1990 Plan C Rate Page(s)\n\nMSC Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 1990 Plan C Rate Pages.pdf,\n\n8 2025 TX 1990 Plan C Rate Page(s)\n\nMSC06 Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 1990 Plan C Rate Pages.pdf,\n\n9 2025 TX 2010 Plan C Rate Page(s)\n\nMSC10 Revised Previous State Filing Number: AMLC-133848161 Percent Rate Change Request: 5.5\n\n2025 TX 2010 Plan C Rate Page.pdf,\n\n10 2025 TX 1990 Plan D Rate Page(s)\n\nMSD Revised Previous State Filing Number: AMLC-133848161\n\n2025 TX 1990 Plan D Rate Pages.pdf,\n\n**_SERFF Tracking #:_** _AMLC-134291200_ **_State Tracking #:_** _AMLC-134291200_ **_Company Tracking #:_** _2024 TX UA PROCARE_\n\n**_State:_** _Texas_ **_Filing Company:_** _United American Insurance Company_\n\n**_TOI/Sub-TOI:_** _MS08I Individual Medicare Supplement - Standard Plans 2010/MS08I.012 Multi-Plan 2010_\n\n**_Product Name:_** _2025 Individual Standardized Medicare Supplement Rate Filing_\n\n**_Project Name/Number:_** _2025 TX UA Procare Annual Rate Filing/2025 TX UA Procare Rate Filing_\n\n_PDF Pipeline for SERFF Tracking Number AMLC-134291200 Generated 02/23/2026 06:47 PM_","publish_date":null,"title":"Item Schedule Affected Form Numbers No. Item Document Name (Separated with commas) Rate Action Rate Action Information Attachments Status 1","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page300.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page300.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page300","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page300.pdf"},"started_at":"2026-11-04T19:47:05.642139"} +{"completed_at":"2026-11-04T19:47:09.353084","latency_in_ms":2303,"output":{"example_id":"table/SERFF_TX_random_pages 1_page301","grounded_pages":[],"layout_pages":[],"markdown":"### **UNITED AMERICAN INSURANCE COMPANY**\n\n### McKinney, Texas\n\n### Policy Forms DMSAR / DMSA06\n\n### 2025 Annual Medicare Rate Filing\n\n### TEXAS\n\n### Current and Proposed Annual Premium Rates\n\n### For Policies Issued with Issue Age Rates\n\n### Available Within Open Enrollment / Guaranteed Issue Periods Only\n\nIssue Current Proposed\n\nAge Annual Annual\n\n(Male or Female) Premium Premium\n\nAges 64 and Under $5,753 $5,753\n\nModal Premium Factors:\n\nSemi-Annual = Annual \\* .510 (rounded to near dollar)\n\nQuarterly = Annual \\* .260 (rounded to near dollar)\n\nMonthly = Annual \\* .088 (rounded to near dollar)\n\nFor Company Use: Plan Code Z02\n\n10/22/2024","pages":[{"line_numbers":[],"markdown":"### **UNITED AMERICAN INSURANCE COMPANY**\n\n### McKinney, Texas\n\n### Policy Forms DMSAR / DMSA06\n\n### 2025 Annual Medicare Rate Filing\n\n### TEXAS\n\n### Current and Proposed Annual Premium Rates\n\n### For Policies Issued with Issue Age Rates\n\n### Available Within Open Enrollment / Guaranteed Issue Periods Only\n\nIssue Current Proposed\n\nAge Annual Annual\n\n(Male or Female) Premium Premium\n\nAges 64 and Under $5,753 $5,753\n\nModal Premium Factors:\n\nSemi-Annual = Annual \\* .510 (rounded to near dollar)\n\nQuarterly = Annual \\* .260 (rounded to near dollar)\n\nMonthly = Annual \\* .088 (rounded to near dollar)\n\nFor Company Use: Plan Code Z02\n\n10/22/2024","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **UNITED AMERICAN INSURANCE COMPANY**\n\n### McKinney, Texas\n\n### Policy Forms DMSAR / DMSA06\n\n### 2025 Annual Medicare Rate Filing\n\n### TEXAS\n\n### Current and Proposed Annual Premium Rates\n\n### For Policies Issued with Issue Age Rates\n\n### Available Within Open Enrollment / Guaranteed Issue Periods Only\n\nIssue Current Proposed\n\nAge Annual Annual\n\n(Male or Female) Premium Premium\n\nAges 64 and Under $5,753 $5,753\n\nModal Premium Factors:\n\nSemi-Annual = Annual \\* .510 (rounded to near dollar)\n\nQuarterly = Annual \\* .260 (rounded to near dollar)\n\nMonthly = Annual \\* .088 (rounded to near dollar)\n\nFor Company Use: Plan Code Z02\n\n10/22/2024","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page301.pdf"]},"response":{"errors":[],"extract_id":"extract_c6a94c5ab200d9925031286287c62a6a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **UNITED AMERICAN INSURANCE COMPANY**\n\n### McKinney, Texas\n\n### Policy Forms DMSAR / DMSA06\n\n### 2025 Annual Medicare Rate Filing\n\n### TEXAS\n\n### Current and Proposed Annual Premium Rates\n\n### For Policies Issued with Issue Age Rates\n\n### Available Within Open Enrollment / Guaranteed Issue Periods Only\n\nIssue Current Proposed\n\nAge Annual Annual\n\n(Male or Female) Premium Premium\n\nAges 64 and Under $5,753 $5,753\n\nModal Premium Factors:\n\nSemi-Annual = Annual \\* .510 (rounded to near dollar)\n\nQuarterly = Annual \\* .260 (rounded to near dollar)\n\nMonthly = Annual \\* .088 (rounded to near dollar)\n\nFor Company Use: Plan Code Z02\n\n10/22/2024"],"full_content":"### **UNITED AMERICAN INSURANCE COMPANY**\n\n### McKinney, Texas\n\n### Policy Forms DMSAR / DMSA06\n\n### 2025 Annual Medicare Rate Filing\n\n### TEXAS\n\n### Current and Proposed Annual Premium Rates\n\n### For Policies Issued with Issue Age Rates\n\n### Available Within Open Enrollment / Guaranteed Issue Periods Only\n\nIssue Current Proposed\n\nAge Annual Annual\n\n(Male or Female) Premium Premium\n\nAges 64 and Under $5,753 $5,753\n\nModal Premium Factors:\n\nSemi-Annual = Annual \\* .510 (rounded to near dollar)\n\nQuarterly = Annual \\* .260 (rounded to near dollar)\n\nMonthly = Annual \\* .088 (rounded to near dollar)\n\nFor Company Use: Plan Code Z02\n\n10/22/2024","publish_date":null,"title":"Policy Forms DMSAR / DMSA06","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page301.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page301.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page301","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page301.pdf"},"started_at":"2026-11-04T19:47:07.049498"} +{"completed_at":"2026-11-04T19:47:09.908317","latency_in_ms":2178,"output":{"example_id":"table/SERFF_TX_random_pages 1_page384","grounded_pages":[],"layout_pages":[],"markdown":"**LAPSE RATES:**\n\nDuration Lapse Rate Duration Lapse Rate Duration Lapse Rate\n\n1 0.089 13 0.081 25 0.172\n\n2 0.080 14 0.089 26 0.186\n\n3 0.070 15 0.093 27 0.203\n\n4 0.064 16 0.093 28 0.214\n\n5 0.061 17 0.099 29 0.227\n\n6 0.059 18 0.106 30 0.236\n\n7 0.061 19 0.113 31 0.239\n\n8 0.065 20 0.122 32 0.250\n\n9 0.068 21 0.133 33 0.265\n\n10 0.070 22 0.144 34 0.281\n\n11 0.072 23 0.155 35 0.298\n\n12 0.075 24 0.163 36 1.000\n\nPlan\n\nB\n\nPrice and Utilization Changes: Year(s) Claims Trend\n\n2022 to 2023 5.0%\n\n2023 to 2024 5.5%\n\n2024 to 2025 5.5%\n\n2026+ 5.0%\n\nSelection by Duration: Underwritten\n\n0\\.824 1.020\n\n0\\.950 1.020\n\n1\\.000 1.000\n\n**INTEREST:** 5%\n\n2\n\n(3) In addition to price and utilization changes and selection by duration, the increase in claims as attained age\n\nincreases is recognized.\n\n3+\n\n5\\.1% 5.0%\n\n(1) Rate increases are projected to be effective January 1 of each year. (2) For attained age rates, the increase in premiums as attained age increases is also recognized.\n\n**CLAIMS TREND:** (3)\n\nDuration\n\n1\n\nNon Underwritten\n\nYear 2025 Rate Increase Years 2026 +\n\nAverage Requested Nationwide Premium Trend (2)\n\nPremium trend is limited where necessary to maintain a 65% loss ratio.\n\n### **2025 RATE FILING**\n\n### **ACTUARIAL PARAMETERS FOR**\n\n**AVERAGE RATE INCREASES:** (1)\n\n### **NATIONWIDE PROJECTIONS BASED ON EXPERIENCE THROUGH 06-2024**\n\n### **UNITED AMERICAN INSURANCE COMPANY**\n\n### **McKinney, Texas**\n\n### **POLICY FORMS MSB, MSB06, MSB06R AND MSB10**\n\n### **INDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN B**\n\n2025 UA Procare Parameters 2024-06 (NW).xlsx","pages":[{"line_numbers":[],"markdown":"**LAPSE RATES:**\n\nDuration Lapse Rate Duration Lapse Rate Duration Lapse Rate\n\n1 0.089 13 0.081 25 0.172\n\n2 0.080 14 0.089 26 0.186\n\n3 0.070 15 0.093 27 0.203\n\n4 0.064 16 0.093 28 0.214\n\n5 0.061 17 0.099 29 0.227\n\n6 0.059 18 0.106 30 0.236\n\n7 0.061 19 0.113 31 0.239\n\n8 0.065 20 0.122 32 0.250\n\n9 0.068 21 0.133 33 0.265\n\n10 0.070 22 0.144 34 0.281\n\n11 0.072 23 0.155 35 0.298\n\n12 0.075 24 0.163 36 1.000\n\nPlan\n\nB\n\nPrice and Utilization Changes: Year(s) Claims Trend\n\n2022 to 2023 5.0%\n\n2023 to 2024 5.5%\n\n2024 to 2025 5.5%\n\n2026+ 5.0%\n\nSelection by Duration: Underwritten\n\n0\\.824 1.020\n\n0\\.950 1.020\n\n1\\.000 1.000\n\n**INTEREST:** 5%\n\n2\n\n(3) In addition to price and utilization changes and selection by duration, the increase in claims as attained age\n\nincreases is recognized.\n\n3+\n\n5\\.1% 5.0%\n\n(1) Rate increases are projected to be effective January 1 of each year. (2) For attained age rates, the increase in premiums as attained age increases is also recognized.\n\n**CLAIMS TREND:** (3)\n\nDuration\n\n1\n\nNon Underwritten\n\nYear 2025 Rate Increase Years 2026 +\n\nAverage Requested Nationwide Premium Trend (2)\n\nPremium trend is limited where necessary to maintain a 65% loss ratio.\n\n### **2025 RATE FILING**\n\n### **ACTUARIAL PARAMETERS FOR**\n\n**AVERAGE RATE INCREASES:** (1)\n\n### **NATIONWIDE PROJECTIONS BASED ON EXPERIENCE THROUGH 06-2024**\n\n### **UNITED AMERICAN INSURANCE COMPANY**\n\n### **McKinney, Texas**\n\n### **POLICY FORMS MSB, MSB06, MSB06R AND MSB10**\n\n### **INDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN B**\n\n2025 UA Procare Parameters 2024-06 (NW).xlsx","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**LAPSE RATES:**\n\nDuration Lapse Rate Duration Lapse Rate Duration Lapse Rate\n\n1 0.089 13 0.081 25 0.172\n\n2 0.080 14 0.089 26 0.186\n\n3 0.070 15 0.093 27 0.203\n\n4 0.064 16 0.093 28 0.214\n\n5 0.061 17 0.099 29 0.227\n\n6 0.059 18 0.106 30 0.236\n\n7 0.061 19 0.113 31 0.239\n\n8 0.065 20 0.122 32 0.250\n\n9 0.068 21 0.133 33 0.265\n\n10 0.070 22 0.144 34 0.281\n\n11 0.072 23 0.155 35 0.298\n\n12 0.075 24 0.163 36 1.000\n\nPlan\n\nB\n\nPrice and Utilization Changes: Year(s) Claims Trend\n\n2022 to 2023 5.0%\n\n2023 to 2024 5.5%\n\n2024 to 2025 5.5%\n\n2026+ 5.0%\n\nSelection by Duration: Underwritten\n\n0\\.824 1.020\n\n0\\.950 1.020\n\n1\\.000 1.000\n\n**INTEREST:** 5%\n\n2\n\n(3) In addition to price and utilization changes and selection by duration, the increase in claims as attained age\n\nincreases is recognized.\n\n3+\n\n5\\.1% 5.0%\n\n(1) Rate increases are projected to be effective January 1 of each year. (2) For attained age rates, the increase in premiums as attained age increases is also recognized.\n\n**CLAIMS TREND:** (3)\n\nDuration\n\n1\n\nNon Underwritten\n\nYear 2025 Rate Increase Years 2026 +\n\nAverage Requested Nationwide Premium Trend (2)\n\nPremium trend is limited where necessary to maintain a 65% loss ratio.\n\n### **2025 RATE FILING**\n\n### **ACTUARIAL PARAMETERS FOR**\n\n**AVERAGE RATE INCREASES:** (1)\n\n### **NATIONWIDE PROJECTIONS BASED ON EXPERIENCE THROUGH 06-2024**\n\n### **UNITED AMERICAN INSURANCE COMPANY**\n\n### **McKinney, Texas**\n\n### **POLICY FORMS MSB, MSB06, MSB06R AND MSB10**\n\n### **INDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN B**\n\n2025 UA Procare Parameters 2024-06 (NW).xlsx","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page384.pdf"]},"response":{"errors":[],"extract_id":"extract_9a04f667c9fab71445daafd581938543","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**LAPSE RATES:**\n\nDuration Lapse Rate Duration Lapse Rate Duration Lapse Rate\n\n1 0.089 13 0.081 25 0.172\n\n2 0.080 14 0.089 26 0.186\n\n3 0.070 15 0.093 27 0.203\n\n4 0.064 16 0.093 28 0.214\n\n5 0.061 17 0.099 29 0.227\n\n6 0.059 18 0.106 30 0.236\n\n7 0.061 19 0.113 31 0.239\n\n8 0.065 20 0.122 32 0.250\n\n9 0.068 21 0.133 33 0.265\n\n10 0.070 22 0.144 34 0.281\n\n11 0.072 23 0.155 35 0.298\n\n12 0.075 24 0.163 36 1.000\n\nPlan\n\nB\n\nPrice and Utilization Changes: Year(s) Claims Trend\n\n2022 to 2023 5.0%\n\n2023 to 2024 5.5%\n\n2024 to 2025 5.5%\n\n2026+ 5.0%\n\nSelection by Duration: Underwritten\n\n0\\.824 1.020\n\n0\\.950 1.020\n\n1\\.000 1.000\n\n**INTEREST:** 5%\n\n2\n\n(3) In addition to price and utilization changes and selection by duration, the increase in claims as attained age\n\nincreases is recognized.\n\n3+\n\n5\\.1% 5.0%\n\n(1) Rate increases are projected to be effective January 1 of each year. (2) For attained age rates, the increase in premiums as attained age increases is also recognized.\n\n**CLAIMS TREND:** (3)\n\nDuration\n\n1\n\nNon Underwritten\n\nYear 2025 Rate Increase Years 2026 +\n\nAverage Requested Nationwide Premium Trend (2)\n\nPremium trend is limited where necessary to maintain a 65% loss ratio.\n\n### **2025 RATE FILING**\n\n### **ACTUARIAL PARAMETERS FOR**\n\n**AVERAGE RATE INCREASES:** (1)\n\n### **NATIONWIDE PROJECTIONS BASED ON EXPERIENCE THROUGH 06-2024**\n\n### **UNITED AMERICAN INSURANCE COMPANY**\n\n### **McKinney, Texas**\n\n### **POLICY FORMS MSB, MSB06, MSB06R AND MSB10**\n\n### **INDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN B**\n\n2025 UA Procare Parameters 2024-06 (NW).xlsx"],"full_content":"**LAPSE RATES:**\n\nDuration Lapse Rate Duration Lapse Rate Duration Lapse Rate\n\n1 0.089 13 0.081 25 0.172\n\n2 0.080 14 0.089 26 0.186\n\n3 0.070 15 0.093 27 0.203\n\n4 0.064 16 0.093 28 0.214\n\n5 0.061 17 0.099 29 0.227\n\n6 0.059 18 0.106 30 0.236\n\n7 0.061 19 0.113 31 0.239\n\n8 0.065 20 0.122 32 0.250\n\n9 0.068 21 0.133 33 0.265\n\n10 0.070 22 0.144 34 0.281\n\n11 0.072 23 0.155 35 0.298\n\n12 0.075 24 0.163 36 1.000\n\nPlan\n\nB\n\nPrice and Utilization Changes: Year(s) Claims Trend\n\n2022 to 2023 5.0%\n\n2023 to 2024 5.5%\n\n2024 to 2025 5.5%\n\n2026+ 5.0%\n\nSelection by Duration: Underwritten\n\n0\\.824 1.020\n\n0\\.950 1.020\n\n1\\.000 1.000\n\n**INTEREST:** 5%\n\n2\n\n(3) In addition to price and utilization changes and selection by duration, the increase in claims as attained age\n\nincreases is recognized.\n\n3+\n\n5\\.1% 5.0%\n\n(1) Rate increases are projected to be effective January 1 of each year. (2) For attained age rates, the increase in premiums as attained age increases is also recognized.\n\n**CLAIMS TREND:** (3)\n\nDuration\n\n1\n\nNon Underwritten\n\nYear 2025 Rate Increase Years 2026 +\n\nAverage Requested Nationwide Premium Trend (2)\n\nPremium trend is limited where necessary to maintain a 65% loss ratio.\n\n### **2025 RATE FILING**\n\n### **ACTUARIAL PARAMETERS FOR**\n\n**AVERAGE RATE INCREASES:** (1)\n\n### **NATIONWIDE PROJECTIONS BASED ON EXPERIENCE THROUGH 06-2024**\n\n### **UNITED AMERICAN INSURANCE COMPANY**\n\n### **McKinney, Texas**\n\n### **POLICY FORMS MSB, MSB06, MSB06R AND MSB10**\n\n### **INDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN B**\n\n2025 UA Procare Parameters 2024-06 (NW).xlsx","publish_date":null,"title":"UNITED AMERICAN INSURANCE COMPANY McKinney, Texas POLICY FORMS MSB, MSB06, MSB06R AND MSB10 INDIVIDUAL STANDARDIZED MEDICARE SUPPLEMENT PLAN B","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page384.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page384.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page384","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page384.pdf"},"started_at":"2026-11-04T19:47:07.730075"} +{"completed_at":"2026-11-04T19:47:10.730280","latency_in_ms":1617,"output":{"example_id":"table/SERFF_TX_random_pages 1_page398","grounded_pages":[],"layout_pages":[],"markdown":"**HOMEOWNER DISCOUNT FACTORS EFFECTIVE DATE: 12/02/2014 PAGE HDF-1**\n\n**BI PD PL MP PIP UM UMPD Comp Coll Accessories**\n\n10% 10% 10% 10% 10% 10% 10% 10% 10% 10%\n\n**HOMEOWNER DISCOUNT FACTORS**\n\n**TEXAS**\n\n**AMERICAN MODERN LLOYDS INSURANCE COMPANY**\n\n**RIDERS CHOICE PROGRAM**","pages":[{"line_numbers":[],"markdown":"**HOMEOWNER DISCOUNT FACTORS EFFECTIVE DATE: 12/02/2014 PAGE HDF-1**\n\n**BI PD PL MP PIP UM UMPD Comp Coll Accessories**\n\n10% 10% 10% 10% 10% 10% 10% 10% 10% 10%\n\n**HOMEOWNER DISCOUNT FACTORS**\n\n**TEXAS**\n\n**AMERICAN MODERN LLOYDS INSURANCE COMPANY**\n\n**RIDERS CHOICE PROGRAM**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**HOMEOWNER DISCOUNT FACTORS EFFECTIVE DATE: 12/02/2014 PAGE HDF-1**\n\n**BI PD PL MP PIP UM UMPD Comp Coll Accessories**\n\n10% 10% 10% 10% 10% 10% 10% 10% 10% 10%\n\n**HOMEOWNER DISCOUNT FACTORS**\n\n**TEXAS**\n\n**AMERICAN MODERN LLOYDS INSURANCE COMPANY**\n\n**RIDERS CHOICE PROGRAM**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page398.pdf"]},"response":{"errors":[],"extract_id":"extract_26369fabd5108b25f909268501b3e713","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**HOMEOWNER DISCOUNT FACTORS EFFECTIVE DATE: 12/02/2014 PAGE HDF-1**\n\n**BI PD PL MP PIP UM UMPD Comp Coll Accessories**\n\n10% 10% 10% 10% 10% 10% 10% 10% 10% 10%\n\n**HOMEOWNER DISCOUNT FACTORS**\n\n**TEXAS**\n\n**AMERICAN MODERN LLOYDS INSURANCE COMPANY**\n\n**RIDERS CHOICE PROGRAM**"],"full_content":"**HOMEOWNER DISCOUNT FACTORS EFFECTIVE DATE: 12/02/2014 PAGE HDF-1**\n\n**BI PD PL MP PIP UM UMPD Comp Coll Accessories**\n\n10% 10% 10% 10% 10% 10% 10% 10% 10% 10%\n\n**HOMEOWNER DISCOUNT FACTORS**\n\n**TEXAS**\n\n**AMERICAN MODERN LLOYDS INSURANCE COMPANY**\n\n**RIDERS CHOICE PROGRAM**","publish_date":null,"title":"TEXAS AMERICAN MODERN LLOYDS INSURANCE COMPANY RIDERS CHOICE PROGRAM HOMEOWNER DISCOUNT FACTORS BI PD PL MP PIP Comp Coll Accessories","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page398.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page398.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page398","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page398.pdf"},"started_at":"2026-11-04T19:47:09.112664"} +{"completed_at":"2026-11-04T19:47:11.970574","latency_in_ms":2059,"output":{"example_id":"table/SERFF_TX_random_pages 1_page402","grounded_pages":[],"layout_pages":[],"markdown":"### **AMERICAN MODERN LLOYDS INSURANCE COMPANY**\n\n### **RIDERS CHOICE PROGRAM**\n\n### **EXPLANATORY MEMORANDUM**\n\n### **TEXAS**\n\nAmerican Modern Lloyds Insurance Company is pleased to submit revisions to our Riders Choice Program. All revisions are listed below and have been highlighted on the manual pages for your convenience. We are requesting a new business effective date of 12/02/2014 and renewal business date of 12/24/2014. **Territory Relativity**\n\nTerritory BI PD PL MP PIP COMP COLL UM UMPD\n\n21 0.91 0.91 0.91 0.91 0.91 0.80 0.94 0.91 0.91\n\n28 0.97 0.97 0.97 0.97 0.97 1.02 1.05 0.97 0.97\n\n**Base Rates**\n\n### BI PD PIP COMP COLL\n\n### $11.00 $9.50 $36.75 $50.00 %150.00\n\n**Sub Class Relativity**\n\n• Please see revisions to\n\n• Class A, Sub Class SD (Comp, Coll, UM, UMPD)\n\n• Class B, Sub Class CR (Comp, UM, UMPD)\n\n• Class B, Sub Class SD (Comp, Coll)\n\n• Class C, Sub Class CR (MP, PIP, UM, UMPD)\n\n• Class D, Sub Class AS (UM, UMPD)\n\n• The decimals for all factors have been increased to three places for our system requirements.\n\n**Increased Limits Relativity**\n\n• Liability Limit UM factor changes for 50/100 and 250/500. • Revised title from Liability Limit to Property Damage Limit for second set of factors. • The decimals for all factors have been increased to three places for our system requirements.\n\n**Homeowner Discount Factors**\n\n• All factors have been revised to 10%.\n\n**Loss Free Renewal Discount Factors**\n\n• The Second and Additional Renewal factors have been revised to 5%.\n\nTo the best of our knowledge and belief, this filing is in compliance with the statutes and regulations of your state. Thank you for your time and consideration of this submission.","pages":[{"line_numbers":[],"markdown":"### **AMERICAN MODERN LLOYDS INSURANCE COMPANY**\n\n### **RIDERS CHOICE PROGRAM**\n\n### **EXPLANATORY MEMORANDUM**\n\n### **TEXAS**\n\nAmerican Modern Lloyds Insurance Company is pleased to submit revisions to our Riders Choice Program. All revisions are listed below and have been highlighted on the manual pages for your convenience. We are requesting a new business effective date of 12/02/2014 and renewal business date of 12/24/2014. **Territory Relativity**\n\nTerritory BI PD PL MP PIP COMP COLL UM UMPD\n\n21 0.91 0.91 0.91 0.91 0.91 0.80 0.94 0.91 0.91\n\n28 0.97 0.97 0.97 0.97 0.97 1.02 1.05 0.97 0.97\n\n**Base Rates**\n\n### BI PD PIP COMP COLL\n\n### $11.00 $9.50 $36.75 $50.00 %150.00\n\n**Sub Class Relativity**\n\n• Please see revisions to\n\n• Class A, Sub Class SD (Comp, Coll, UM, UMPD)\n\n• Class B, Sub Class CR (Comp, UM, UMPD)\n\n• Class B, Sub Class SD (Comp, Coll)\n\n• Class C, Sub Class CR (MP, PIP, UM, UMPD)\n\n• Class D, Sub Class AS (UM, UMPD)\n\n• The decimals for all factors have been increased to three places for our system requirements.\n\n**Increased Limits Relativity**\n\n• Liability Limit UM factor changes for 50/100 and 250/500. • Revised title from Liability Limit to Property Damage Limit for second set of factors. • The decimals for all factors have been increased to three places for our system requirements.\n\n**Homeowner Discount Factors**\n\n• All factors have been revised to 10%.\n\n**Loss Free Renewal Discount Factors**\n\n• The Second and Additional Renewal factors have been revised to 5%.\n\nTo the best of our knowledge and belief, this filing is in compliance with the statutes and regulations of your state. Thank you for your time and consideration of this submission.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **AMERICAN MODERN LLOYDS INSURANCE COMPANY**\n\n### **RIDERS CHOICE PROGRAM**\n\n### **EXPLANATORY MEMORANDUM**\n\n### **TEXAS**\n\nAmerican Modern Lloyds Insurance Company is pleased to submit revisions to our Riders Choice Program. All revisions are listed below and have been highlighted on the manual pages for your convenience. We are requesting a new business effective date of 12/02/2014 and renewal business date of 12/24/2014. **Territory Relativity**\n\nTerritory BI PD PL MP PIP COMP COLL UM UMPD\n\n21 0.91 0.91 0.91 0.91 0.91 0.80 0.94 0.91 0.91\n\n28 0.97 0.97 0.97 0.97 0.97 1.02 1.05 0.97 0.97\n\n**Base Rates**\n\n### BI PD PIP COMP COLL\n\n### $11.00 $9.50 $36.75 $50.00 %150.00\n\n**Sub Class Relativity**\n\n• Please see revisions to\n\n• Class A, Sub Class SD (Comp, Coll, UM, UMPD)\n\n• Class B, Sub Class CR (Comp, UM, UMPD)\n\n• Class B, Sub Class SD (Comp, Coll)\n\n• Class C, Sub Class CR (MP, PIP, UM, UMPD)\n\n• Class D, Sub Class AS (UM, UMPD)\n\n• The decimals for all factors have been increased to three places for our system requirements.\n\n**Increased Limits Relativity**\n\n• Liability Limit UM factor changes for 50/100 and 250/500. • Revised title from Liability Limit to Property Damage Limit for second set of factors. • The decimals for all factors have been increased to three places for our system requirements.\n\n**Homeowner Discount Factors**\n\n• All factors have been revised to 10%.\n\n**Loss Free Renewal Discount Factors**\n\n• The Second and Additional Renewal factors have been revised to 5%.\n\nTo the best of our knowledge and belief, this filing is in compliance with the statutes and regulations of your state. Thank you for your time and consideration of this submission.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page402.pdf"]},"response":{"errors":[],"extract_id":"extract_8b9af4d953a8e8f9f810352bf2f15273","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **AMERICAN MODERN LLOYDS INSURANCE COMPANY**\n\n### **RIDERS CHOICE PROGRAM**\n\n### **EXPLANATORY MEMORANDUM**\n\n### **TEXAS**\n\nAmerican Modern Lloyds Insurance Company is pleased to submit revisions to our Riders Choice Program. All revisions are listed below and have been highlighted on the manual pages for your convenience. We are requesting a new business effective date of 12/02/2014 and renewal business date of 12/24/2014. **Territory Relativity**\n\nTerritory BI PD PL MP PIP COMP COLL UM UMPD\n\n21 0.91 0.91 0.91 0.91 0.91 0.80 0.94 0.91 0.91\n\n28 0.97 0.97 0.97 0.97 0.97 1.02 1.05 0.97 0.97\n\n**Base Rates**\n\n### BI PD PIP COMP COLL\n\n### $11.00 $9.50 $36.75 $50.00 %150.00\n\n**Sub Class Relativity**\n\n• Please see revisions to\n\n• Class A, Sub Class SD (Comp, Coll, UM, UMPD)\n\n• Class B, Sub Class CR (Comp, UM, UMPD)\n\n• Class B, Sub Class SD (Comp, Coll)\n\n• Class C, Sub Class CR (MP, PIP, UM, UMPD)\n\n• Class D, Sub Class AS (UM, UMPD)\n\n• The decimals for all factors have been increased to three places for our system requirements.\n\n**Increased Limits Relativity**\n\n• Liability Limit UM factor changes for 50/100 and 250/500. • Revised title from Liability Limit to Property Damage Limit for second set of factors. • The decimals for all factors have been increased to three places for our system requirements.\n\n**Homeowner Discount Factors**\n\n• All factors have been revised to 10%.\n\n**Loss Free Renewal Discount Factors**\n\n• The Second and Additional Renewal factors have been revised to 5%.\n\nTo the best of our knowledge and belief, this filing is in compliance with the statutes and regulations of your state. Thank you for your time and consideration of this submission."],"full_content":"### **AMERICAN MODERN LLOYDS INSURANCE COMPANY**\n\n### **RIDERS CHOICE PROGRAM**\n\n### **EXPLANATORY MEMORANDUM**\n\n### **TEXAS**\n\nAmerican Modern Lloyds Insurance Company is pleased to submit revisions to our Riders Choice Program. All revisions are listed below and have been highlighted on the manual pages for your convenience. We are requesting a new business effective date of 12/02/2014 and renewal business date of 12/24/2014. **Territory Relativity**\n\nTerritory BI PD PL MP PIP COMP COLL UM UMPD\n\n21 0.91 0.91 0.91 0.91 0.91 0.80 0.94 0.91 0.91\n\n28 0.97 0.97 0.97 0.97 0.97 1.02 1.05 0.97 0.97\n\n**Base Rates**\n\n### BI PD PIP COMP COLL\n\n### $11.00 $9.50 $36.75 $50.00 %150.00\n\n**Sub Class Relativity**\n\n• Please see revisions to\n\n• Class A, Sub Class SD (Comp, Coll, UM, UMPD)\n\n• Class B, Sub Class CR (Comp, UM, UMPD)\n\n• Class B, Sub Class SD (Comp, Coll)\n\n• Class C, Sub Class CR (MP, PIP, UM, UMPD)\n\n• Class D, Sub Class AS (UM, UMPD)\n\n• The decimals for all factors have been increased to three places for our system requirements.\n\n**Increased Limits Relativity**\n\n• Liability Limit UM factor changes for 50/100 and 250/500. • Revised title from Liability Limit to Property Damage Limit for second set of factors. • The decimals for all factors have been increased to three places for our system requirements.\n\n**Homeowner Discount Factors**\n\n• All factors have been revised to 10%.\n\n**Loss Free Renewal Discount Factors**\n\n• The Second and Additional Renewal factors have been revised to 5%.\n\nTo the best of our knowledge and belief, this filing is in compliance with the statutes and regulations of your state. Thank you for your time and consideration of this submission.","publish_date":null,"title":"AMERICAN MODERN LLOYDS INSURANCE COMPANY RIDERS CHOICE PROGRAM EXPLANATORY MEMORANDUM TEXAS BI PD PIP COMP COLL $11.00 $9.50 $36.75 $50.00","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page402.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page402.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page402","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page402.pdf"},"started_at":"2026-11-04T19:47:09.911319"} +{"completed_at":"2026-11-04T19:31:08.583404","latency_in_ms":1159,"output":{"example_id":"table/SERFF_TX_random_pages 1_page414","grounded_pages":[],"layout_pages":[],"markdown":"### **Non-Network Provider**\n\n### **Category of Benefit Maximum Frequency Cost-Share Benefit amount Benefit amount**\n\n**Comprehensive Eye Exam** 12 months $10 copay Covered in full after copay $50 allowance\n\n**Lenses** 12 months $10 copay Covered in full after copay Single-$40, Bifocal-$60, Trifocal-$80\n\n**Frames** 12 months None $150 allowance $75 allowance\n\n**Contacts (in lieu of glasses)** 12 months None\n\n_Elective_ \\-if from select product group Covered in full $105 allowance\n\n\\-if not from select product group $150 allowance $105 allowance\n\n_Medically Necessary_ $500 allowance $210 allowance\n\n### **Non-Network Provider**\n\n### **Category of Benefit Maximum Frequency Cost-Share Benefit amount Benefit amount**\n\n**Comprehensive Eye Exam** 12 months $10 copay Covered in full after copay $50 allowance\n\n**Lenses** 12 months $10 copay Covered in full after copay Single-$40, Bifocal-$60, Trifocal-$80\n\n**Frames** 12 months None $150 allowance $75 allowance\n\n**Contacts (in addition to glasses)** 12 months None\n\n_Elective_ \\-if from select product group Covered in full $105 allowance\n\n\\-if not from select product group $150 allowance $105 allowance\n\n_Medically Necessary_ $500 allowance $210 allowance\n\n## **Plan B**\n\n### **Network Provider**\n\n### **Golden Rule Insurance Company**\n\n### **Rider Form Number: SA-S-1884-GRI**\n\n### **EXHIBIT A**\n\n### **Outline of Vision Benefits Exhibit**\n\n## **Plan A**\n\n### **Network Provider**","pages":[{"line_numbers":[],"markdown":"### **Non-Network Provider**\n\n### **Category of Benefit Maximum Frequency Cost-Share Benefit amount Benefit amount**\n\n**Comprehensive Eye Exam** 12 months $10 copay Covered in full after copay $50 allowance\n\n**Lenses** 12 months $10 copay Covered in full after copay Single-$40, Bifocal-$60, Trifocal-$80\n\n**Frames** 12 months None $150 allowance $75 allowance\n\n**Contacts (in lieu of glasses)** 12 months None\n\n_Elective_ \\-if from select product group Covered in full $105 allowance\n\n\\-if not from select product group $150 allowance $105 allowance\n\n_Medically Necessary_ $500 allowance $210 allowance\n\n### **Non-Network Provider**\n\n### **Category of Benefit Maximum Frequency Cost-Share Benefit amount Benefit amount**\n\n**Comprehensive Eye Exam** 12 months $10 copay Covered in full after copay $50 allowance\n\n**Lenses** 12 months $10 copay Covered in full after copay Single-$40, Bifocal-$60, Trifocal-$80\n\n**Frames** 12 months None $150 allowance $75 allowance\n\n**Contacts (in addition to glasses)** 12 months None\n\n_Elective_ \\-if from select product group Covered in full $105 allowance\n\n\\-if not from select product group $150 allowance $105 allowance\n\n_Medically Necessary_ $500 allowance $210 allowance\n\n## **Plan B**\n\n### **Network Provider**\n\n### **Golden Rule Insurance Company**\n\n### **Rider Form Number: SA-S-1884-GRI**\n\n### **EXHIBIT A**\n\n### **Outline of Vision Benefits Exhibit**\n\n## **Plan A**\n\n### **Network Provider**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Non-Network Provider**\n\n### **Category of Benefit Maximum Frequency Cost-Share Benefit amount Benefit amount**\n\n**Comprehensive Eye Exam** 12 months $10 copay Covered in full after copay $50 allowance\n\n**Lenses** 12 months $10 copay Covered in full after copay Single-$40, Bifocal-$60, Trifocal-$80\n\n**Frames** 12 months None $150 allowance $75 allowance\n\n**Contacts (in lieu of glasses)** 12 months None\n\n_Elective_ \\-if from select product group Covered in full $105 allowance\n\n\\-if not from select product group $150 allowance $105 allowance\n\n_Medically Necessary_ $500 allowance $210 allowance\n\n### **Non-Network Provider**\n\n### **Category of Benefit Maximum Frequency Cost-Share Benefit amount Benefit amount**\n\n**Comprehensive Eye Exam** 12 months $10 copay Covered in full after copay $50 allowance\n\n**Lenses** 12 months $10 copay Covered in full after copay Single-$40, Bifocal-$60, Trifocal-$80\n\n**Frames** 12 months None $150 allowance $75 allowance\n\n**Contacts (in addition to glasses)** 12 months None\n\n_Elective_ \\-if from select product group Covered in full $105 allowance\n\n\\-if not from select product group $150 allowance $105 allowance\n\n_Medically Necessary_ $500 allowance $210 allowance\n\n## **Plan B**\n\n### **Network Provider**\n\n### **Golden Rule Insurance Company**\n\n### **Rider Form Number: SA-S-1884-GRI**\n\n### **EXHIBIT A**\n\n### **Outline of Vision Benefits Exhibit**\n\n## **Plan A**\n\n### **Network Provider**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page414.pdf"]},"response":{"errors":[],"extract_id":"extract_910c5d5fac48cddf45ad026918616c27","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Non-Network Provider**\n\n### **Category of Benefit Maximum Frequency Cost-Share Benefit amount Benefit amount**\n\n**Comprehensive Eye Exam** 12 months $10 copay Covered in full after copay $50 allowance\n\n**Lenses** 12 months $10 copay Covered in full after copay Single-$40, Bifocal-$60, Trifocal-$80\n\n**Frames** 12 months None $150 allowance $75 allowance\n\n**Contacts (in lieu of glasses)** 12 months None\n\n_Elective_ \\-if from select product group Covered in full $105 allowance\n\n\\-if not from select product group $150 allowance $105 allowance\n\n_Medically Necessary_ $500 allowance $210 allowance\n\n### **Non-Network Provider**\n\n### **Category of Benefit Maximum Frequency Cost-Share Benefit amount Benefit amount**\n\n**Comprehensive Eye Exam** 12 months $10 copay Covered in full after copay $50 allowance\n\n**Lenses** 12 months $10 copay Covered in full after copay Single-$40, Bifocal-$60, Trifocal-$80\n\n**Frames** 12 months None $150 allowance $75 allowance\n\n**Contacts (in addition to glasses)** 12 months None\n\n_Elective_ \\-if from select product group Covered in full $105 allowance\n\n\\-if not from select product group $150 allowance $105 allowance\n\n_Medically Necessary_ $500 allowance $210 allowance\n\n## **Plan B**\n\n### **Network Provider**\n\n### **Golden Rule Insurance Company**\n\n### **Rider Form Number: SA-S-1884-GRI**\n\n### **EXHIBIT A**\n\n### **Outline of Vision Benefits Exhibit**\n\n## **Plan A**\n\n### **Network Provider**"],"full_content":"### **Non-Network Provider**\n\n### **Category of Benefit Maximum Frequency Cost-Share Benefit amount Benefit amount**\n\n**Comprehensive Eye Exam** 12 months $10 copay Covered in full after copay $50 allowance\n\n**Lenses** 12 months $10 copay Covered in full after copay Single-$40, Bifocal-$60, Trifocal-$80\n\n**Frames** 12 months None $150 allowance $75 allowance\n\n**Contacts (in lieu of glasses)** 12 months None\n\n_Elective_ \\-if from select product group Covered in full $105 allowance\n\n\\-if not from select product group $150 allowance $105 allowance\n\n_Medically Necessary_ $500 allowance $210 allowance\n\n### **Non-Network Provider**\n\n### **Category of Benefit Maximum Frequency Cost-Share Benefit amount Benefit amount**\n\n**Comprehensive Eye Exam** 12 months $10 copay Covered in full after copay $50 allowance\n\n**Lenses** 12 months $10 copay Covered in full after copay Single-$40, Bifocal-$60, Trifocal-$80\n\n**Frames** 12 months None $150 allowance $75 allowance\n\n**Contacts (in addition to glasses)** 12 months None\n\n_Elective_ \\-if from select product group Covered in full $105 allowance\n\n\\-if not from select product group $150 allowance $105 allowance\n\n_Medically Necessary_ $500 allowance $210 allowance\n\n## **Plan B**\n\n### **Network Provider**\n\n### **Golden Rule Insurance Company**\n\n### **Rider Form Number: SA-S-1884-GRI**\n\n### **EXHIBIT A**\n\n### **Outline of Vision Benefits Exhibit**\n\n## **Plan A**\n\n### **Network Provider**","publish_date":null,"title":"Plan A Plan B","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page414.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page414.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page414","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page414.pdf"},"started_at":"2026-11-04T19:31:07.423770"} +{"completed_at":"2026-11-04T19:47:14.802304","latency_in_ms":1915,"output":{"example_id":"table/SERFF_TX_random_pages 1_page43","grounded_pages":[],"layout_pages":[],"markdown":"**Proposed Rates**\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 N/A N/A N/A N/A\n\n65 1,205 1,387 1,338 1,541\n\n66 1,205 1,387 1,338 1,541 67 1,259 1,449 1,400 1,608 68 1,310 1,508 1,456 1,673 69 1,361 1,565 1,513 1,741 70 1,417 1,628 1,573 1,809 71 1,473 1,694 1,637 1,882 72 1,531 1,760 1,700 1,956 73 1,590 1,827 1,766 2,030 74 1,644 1,889 1,826 2,099 75 1,695 1,949 1,884 2,166 76 1,744 2,004 1,936 2,228 77 1,790 2,058 1,988 2,287 78 1,832 2,107 2,036 2,343 79 1,876 2,157 2,085 2,397 80 1,914 2,202 2,126 2,447 81 1,952 2,242 2,167 2,492 82 1,985 2,283 2,206 2,536 83 2,016 2,317 2,239 2,575 84 2,044 2,351 2,271 2,612 85 2,072 2,384 2,303 2,650 86 2,098 2,412 2,331 2,682 87 2,122 2,441 2,358 2,713 88 2,145 2,466 2,383 2,741 89 2,163 2,489 2,406 2,765 90 2,180 2,506 2,421 2,784 91 2,192 2,523 2,438 2,804 92 2,207 2,537 2,451 2,820 93 2,220 2,552 2,465 2,836 94 2,229 2,564 2,478 2,849 95 2,239 2,573 2,487 2,859 96 2,246 2,583 2,497 2,869 97 2,253 2,592 2,503 2,878 98 2,260 2,600 2,512 2,888 99+ 2,263 2,604 2,515 2,892\n\nThe rates above do not include a one time $20 policy fee. There is no modal loading.\n\nArea Factors: _Texas_ 770-773, 775…………………………………………………..………………………… 1.18\n\n1\\.13\n\nRest of State………………………………………………………………………………………………….. 1.00\n\nGross Annual Premiums\n\n**Sterling Investors Life Insurance Company**\n\nMedicare Supplement Policy 2010 Select Plan N\n\nNon-Tobacco Tobacco\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………\n\nTX 8 of 8 4/19/2014","pages":[{"line_numbers":[],"markdown":"**Proposed Rates**\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 N/A N/A N/A N/A\n\n65 1,205 1,387 1,338 1,541\n\n66 1,205 1,387 1,338 1,541 67 1,259 1,449 1,400 1,608 68 1,310 1,508 1,456 1,673 69 1,361 1,565 1,513 1,741 70 1,417 1,628 1,573 1,809 71 1,473 1,694 1,637 1,882 72 1,531 1,760 1,700 1,956 73 1,590 1,827 1,766 2,030 74 1,644 1,889 1,826 2,099 75 1,695 1,949 1,884 2,166 76 1,744 2,004 1,936 2,228 77 1,790 2,058 1,988 2,287 78 1,832 2,107 2,036 2,343 79 1,876 2,157 2,085 2,397 80 1,914 2,202 2,126 2,447 81 1,952 2,242 2,167 2,492 82 1,985 2,283 2,206 2,536 83 2,016 2,317 2,239 2,575 84 2,044 2,351 2,271 2,612 85 2,072 2,384 2,303 2,650 86 2,098 2,412 2,331 2,682 87 2,122 2,441 2,358 2,713 88 2,145 2,466 2,383 2,741 89 2,163 2,489 2,406 2,765 90 2,180 2,506 2,421 2,784 91 2,192 2,523 2,438 2,804 92 2,207 2,537 2,451 2,820 93 2,220 2,552 2,465 2,836 94 2,229 2,564 2,478 2,849 95 2,239 2,573 2,487 2,859 96 2,246 2,583 2,497 2,869 97 2,253 2,592 2,503 2,878 98 2,260 2,600 2,512 2,888 99+ 2,263 2,604 2,515 2,892\n\nThe rates above do not include a one time $20 policy fee. There is no modal loading.\n\nArea Factors: _Texas_ 770-773, 775…………………………………………………..………………………… 1.18\n\n1\\.13\n\nRest of State………………………………………………………………………………………………….. 1.00\n\nGross Annual Premiums\n\n**Sterling Investors Life Insurance Company**\n\nMedicare Supplement Policy 2010 Select Plan N\n\nNon-Tobacco Tobacco\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………\n\nTX 8 of 8 4/19/2014","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Proposed Rates**\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 N/A N/A N/A N/A\n\n65 1,205 1,387 1,338 1,541\n\n66 1,205 1,387 1,338 1,541 67 1,259 1,449 1,400 1,608 68 1,310 1,508 1,456 1,673 69 1,361 1,565 1,513 1,741 70 1,417 1,628 1,573 1,809 71 1,473 1,694 1,637 1,882 72 1,531 1,760 1,700 1,956 73 1,590 1,827 1,766 2,030 74 1,644 1,889 1,826 2,099 75 1,695 1,949 1,884 2,166 76 1,744 2,004 1,936 2,228 77 1,790 2,058 1,988 2,287 78 1,832 2,107 2,036 2,343 79 1,876 2,157 2,085 2,397 80 1,914 2,202 2,126 2,447 81 1,952 2,242 2,167 2,492 82 1,985 2,283 2,206 2,536 83 2,016 2,317 2,239 2,575 84 2,044 2,351 2,271 2,612 85 2,072 2,384 2,303 2,650 86 2,098 2,412 2,331 2,682 87 2,122 2,441 2,358 2,713 88 2,145 2,466 2,383 2,741 89 2,163 2,489 2,406 2,765 90 2,180 2,506 2,421 2,784 91 2,192 2,523 2,438 2,804 92 2,207 2,537 2,451 2,820 93 2,220 2,552 2,465 2,836 94 2,229 2,564 2,478 2,849 95 2,239 2,573 2,487 2,859 96 2,246 2,583 2,497 2,869 97 2,253 2,592 2,503 2,878 98 2,260 2,600 2,512 2,888 99+ 2,263 2,604 2,515 2,892\n\nThe rates above do not include a one time $20 policy fee. There is no modal loading.\n\nArea Factors: _Texas_ 770-773, 775…………………………………………………..………………………… 1.18\n\n1\\.13\n\nRest of State………………………………………………………………………………………………….. 1.00\n\nGross Annual Premiums\n\n**Sterling Investors Life Insurance Company**\n\nMedicare Supplement Policy 2010 Select Plan N\n\nNon-Tobacco Tobacco\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………\n\nTX 8 of 8 4/19/2014","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page43.pdf"]},"response":{"errors":[],"extract_id":"extract_c57f6b23c75239da9433fcb95642a395","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Proposed Rates**\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 N/A N/A N/A N/A\n\n65 1,205 1,387 1,338 1,541\n\n66 1,205 1,387 1,338 1,541 67 1,259 1,449 1,400 1,608 68 1,310 1,508 1,456 1,673 69 1,361 1,565 1,513 1,741 70 1,417 1,628 1,573 1,809 71 1,473 1,694 1,637 1,882 72 1,531 1,760 1,700 1,956 73 1,590 1,827 1,766 2,030 74 1,644 1,889 1,826 2,099 75 1,695 1,949 1,884 2,166 76 1,744 2,004 1,936 2,228 77 1,790 2,058 1,988 2,287 78 1,832 2,107 2,036 2,343 79 1,876 2,157 2,085 2,397 80 1,914 2,202 2,126 2,447 81 1,952 2,242 2,167 2,492 82 1,985 2,283 2,206 2,536 83 2,016 2,317 2,239 2,575 84 2,044 2,351 2,271 2,612 85 2,072 2,384 2,303 2,650 86 2,098 2,412 2,331 2,682 87 2,122 2,441 2,358 2,713 88 2,145 2,466 2,383 2,741 89 2,163 2,489 2,406 2,765 90 2,180 2,506 2,421 2,784 91 2,192 2,523 2,438 2,804 92 2,207 2,537 2,451 2,820 93 2,220 2,552 2,465 2,836 94 2,229 2,564 2,478 2,849 95 2,239 2,573 2,487 2,859 96 2,246 2,583 2,497 2,869 97 2,253 2,592 2,503 2,878 98 2,260 2,600 2,512 2,888 99+ 2,263 2,604 2,515 2,892\n\nThe rates above do not include a one time $20 policy fee. There is no modal loading.\n\nArea Factors: _Texas_ 770-773, 775…………………………………………………..………………………… 1.18\n\n1\\.13\n\nRest of State………………………………………………………………………………………………….. 1.00\n\nGross Annual Premiums\n\n**Sterling Investors Life Insurance Company**\n\nMedicare Supplement Policy 2010 Select Plan N\n\nNon-Tobacco Tobacco\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………\n\nTX 8 of 8 4/19/2014"],"full_content":"**Proposed Rates**\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 N/A N/A N/A N/A\n\n65 1,205 1,387 1,338 1,541\n\n66 1,205 1,387 1,338 1,541 67 1,259 1,449 1,400 1,608 68 1,310 1,508 1,456 1,673 69 1,361 1,565 1,513 1,741 70 1,417 1,628 1,573 1,809 71 1,473 1,694 1,637 1,882 72 1,531 1,760 1,700 1,956 73 1,590 1,827 1,766 2,030 74 1,644 1,889 1,826 2,099 75 1,695 1,949 1,884 2,166 76 1,744 2,004 1,936 2,228 77 1,790 2,058 1,988 2,287 78 1,832 2,107 2,036 2,343 79 1,876 2,157 2,085 2,397 80 1,914 2,202 2,126 2,447 81 1,952 2,242 2,167 2,492 82 1,985 2,283 2,206 2,536 83 2,016 2,317 2,239 2,575 84 2,044 2,351 2,271 2,612 85 2,072 2,384 2,303 2,650 86 2,098 2,412 2,331 2,682 87 2,122 2,441 2,358 2,713 88 2,145 2,466 2,383 2,741 89 2,163 2,489 2,406 2,765 90 2,180 2,506 2,421 2,784 91 2,192 2,523 2,438 2,804 92 2,207 2,537 2,451 2,820 93 2,220 2,552 2,465 2,836 94 2,229 2,564 2,478 2,849 95 2,239 2,573 2,487 2,859 96 2,246 2,583 2,497 2,869 97 2,253 2,592 2,503 2,878 98 2,260 2,600 2,512 2,888 99+ 2,263 2,604 2,515 2,892\n\nThe rates above do not include a one time $20 policy fee. There is no modal loading.\n\nArea Factors: _Texas_ 770-773, 775…………………………………………………..………………………… 1.18\n\n1\\.13\n\nRest of State………………………………………………………………………………………………….. 1.00\n\nGross Annual Premiums\n\n**Sterling Investors Life Insurance Company**\n\nMedicare Supplement Policy 2010 Select Plan N\n\nNon-Tobacco Tobacco\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………\n\nTX 8 of 8 4/19/2014","publish_date":null,"title":"Proposed Rates Gross Annual Premiums Sterling Investors Life Insurance Company","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page43.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page43.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page43","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page43.pdf"},"started_at":"2026-11-04T19:47:12.887214"} +{"completed_at":"2026-11-04T19:47:15.539005","latency_in_ms":1191,"output":{"example_id":"table/SERFF_TX_random_pages 1_page434","grounded_pages":[],"layout_pages":[],"markdown":"Attained Age Female Male Female Male 0-64 NA NA NA NA 65 1,582 1,818 1,818 2,091 66 1,582 1,818 1,818 2,091 67 1,582 1,818 1,818 2,091 68 1,640 1,887 1,887 2,170 69 1,700 1,955 1,955 2,249 70 1,759 2,024 2,024 2,327 71 1,815 2,087 2,087 2,401 72 1,875 2,156 2,156 2,479 73 1,934 2,225 2,225 2,558 74 2,000 2,300 2,300 2,644 75 2,073 2,384 2,384 2,742 76 2,144 2,466 2,466 2,834 77 2,216 2,549 2,549 2,930 78 2,289 2,633 2,633 3,028 79 2,369 2,725 2,725 3,133 80 2,451 2,819 2,819 3,241 81 2,538 2,919 2,919 3,358 82 2,628 3,023 3,023 3,476 83 2,723 3,132 3,132 3,601 84 2,821 3,244 3,244 3,731 85 2,923 3,362 3,362 3,866 86 3,017 3,470 3,470 3,991 87 3,114 3,581 3,581 4,118 88 3,213 3,695 3,695 4,248 89 3,315 3,813 3,813 4,384 90 3,420 3,932 3,932 4,521 91 3,514 4,042 4,042 4,648 92 3,608 4,149 4,149 4,772 93 3,705 4,260 4,260 4,899 94 3,802 4,372 4,372 5,029 95 3,903 4,489 4,489 5,161 96 3,970 4,564 4,564 5,250 97 4,037 4,642 4,642 5,338 98 4,106 4,722 4,722 5,429 99 4,176 4,803 4,803 5,522\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee. A discount factor of .93 is applied for household discount applicants.\n\nArea Facto Texas 770-773, 775 1.05 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794 0.95 Rest of State 0.88\n\nGross Annual Premiums\n\n**Western United Life Assurance Company**\n\nMedicare Supplement Policy\n\n**CURRENT RATES**\n\n2010 Standardized Plan G\n\nPreferred Standard","pages":[{"line_numbers":[],"markdown":"Attained Age Female Male Female Male 0-64 NA NA NA NA 65 1,582 1,818 1,818 2,091 66 1,582 1,818 1,818 2,091 67 1,582 1,818 1,818 2,091 68 1,640 1,887 1,887 2,170 69 1,700 1,955 1,955 2,249 70 1,759 2,024 2,024 2,327 71 1,815 2,087 2,087 2,401 72 1,875 2,156 2,156 2,479 73 1,934 2,225 2,225 2,558 74 2,000 2,300 2,300 2,644 75 2,073 2,384 2,384 2,742 76 2,144 2,466 2,466 2,834 77 2,216 2,549 2,549 2,930 78 2,289 2,633 2,633 3,028 79 2,369 2,725 2,725 3,133 80 2,451 2,819 2,819 3,241 81 2,538 2,919 2,919 3,358 82 2,628 3,023 3,023 3,476 83 2,723 3,132 3,132 3,601 84 2,821 3,244 3,244 3,731 85 2,923 3,362 3,362 3,866 86 3,017 3,470 3,470 3,991 87 3,114 3,581 3,581 4,118 88 3,213 3,695 3,695 4,248 89 3,315 3,813 3,813 4,384 90 3,420 3,932 3,932 4,521 91 3,514 4,042 4,042 4,648 92 3,608 4,149 4,149 4,772 93 3,705 4,260 4,260 4,899 94 3,802 4,372 4,372 5,029 95 3,903 4,489 4,489 5,161 96 3,970 4,564 4,564 5,250 97 4,037 4,642 4,642 5,338 98 4,106 4,722 4,722 5,429 99 4,176 4,803 4,803 5,522\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee. A discount factor of .93 is applied for household discount applicants.\n\nArea Facto Texas 770-773, 775 1.05 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794 0.95 Rest of State 0.88\n\nGross Annual Premiums\n\n**Western United Life Assurance Company**\n\nMedicare Supplement Policy\n\n**CURRENT RATES**\n\n2010 Standardized Plan G\n\nPreferred Standard","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Attained Age Female Male Female Male 0-64 NA NA NA NA 65 1,582 1,818 1,818 2,091 66 1,582 1,818 1,818 2,091 67 1,582 1,818 1,818 2,091 68 1,640 1,887 1,887 2,170 69 1,700 1,955 1,955 2,249 70 1,759 2,024 2,024 2,327 71 1,815 2,087 2,087 2,401 72 1,875 2,156 2,156 2,479 73 1,934 2,225 2,225 2,558 74 2,000 2,300 2,300 2,644 75 2,073 2,384 2,384 2,742 76 2,144 2,466 2,466 2,834 77 2,216 2,549 2,549 2,930 78 2,289 2,633 2,633 3,028 79 2,369 2,725 2,725 3,133 80 2,451 2,819 2,819 3,241 81 2,538 2,919 2,919 3,358 82 2,628 3,023 3,023 3,476 83 2,723 3,132 3,132 3,601 84 2,821 3,244 3,244 3,731 85 2,923 3,362 3,362 3,866 86 3,017 3,470 3,470 3,991 87 3,114 3,581 3,581 4,118 88 3,213 3,695 3,695 4,248 89 3,315 3,813 3,813 4,384 90 3,420 3,932 3,932 4,521 91 3,514 4,042 4,042 4,648 92 3,608 4,149 4,149 4,772 93 3,705 4,260 4,260 4,899 94 3,802 4,372 4,372 5,029 95 3,903 4,489 4,489 5,161 96 3,970 4,564 4,564 5,250 97 4,037 4,642 4,642 5,338 98 4,106 4,722 4,722 5,429 99 4,176 4,803 4,803 5,522\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee. A discount factor of .93 is applied for household discount applicants.\n\nArea Facto Texas 770-773, 775 1.05 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794 0.95 Rest of State 0.88\n\nGross Annual Premiums\n\n**Western United Life Assurance Company**\n\nMedicare Supplement Policy\n\n**CURRENT RATES**\n\n2010 Standardized Plan G\n\nPreferred Standard","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page434.pdf"]},"response":{"errors":[],"extract_id":"extract_1a244cc6b245781597bab7e613fd56dd","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Attained Age Female Male Female Male 0-64 NA NA NA NA 65 1,582 1,818 1,818 2,091 66 1,582 1,818 1,818 2,091 67 1,582 1,818 1,818 2,091 68 1,640 1,887 1,887 2,170 69 1,700 1,955 1,955 2,249 70 1,759 2,024 2,024 2,327 71 1,815 2,087 2,087 2,401 72 1,875 2,156 2,156 2,479 73 1,934 2,225 2,225 2,558 74 2,000 2,300 2,300 2,644 75 2,073 2,384 2,384 2,742 76 2,144 2,466 2,466 2,834 77 2,216 2,549 2,549 2,930 78 2,289 2,633 2,633 3,028 79 2,369 2,725 2,725 3,133 80 2,451 2,819 2,819 3,241 81 2,538 2,919 2,919 3,358 82 2,628 3,023 3,023 3,476 83 2,723 3,132 3,132 3,601 84 2,821 3,244 3,244 3,731 85 2,923 3,362 3,362 3,866 86 3,017 3,470 3,470 3,991 87 3,114 3,581 3,581 4,118 88 3,213 3,695 3,695 4,248 89 3,315 3,813 3,813 4,384 90 3,420 3,932 3,932 4,521 91 3,514 4,042 4,042 4,648 92 3,608 4,149 4,149 4,772 93 3,705 4,260 4,260 4,899 94 3,802 4,372 4,372 5,029 95 3,903 4,489 4,489 5,161 96 3,970 4,564 4,564 5,250 97 4,037 4,642 4,642 5,338 98 4,106 4,722 4,722 5,429 99 4,176 4,803 4,803 5,522\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee. A discount factor of .93 is applied for household discount applicants.\n\nArea Facto Texas 770-773, 775 1.05 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794 0.95 Rest of State 0.88\n\nGross Annual Premiums\n\n**Western United Life Assurance Company**\n\nMedicare Supplement Policy\n\n**CURRENT RATES**\n\n2010 Standardized Plan G\n\nPreferred Standard"],"full_content":"Attained Age Female Male Female Male 0-64 NA NA NA NA 65 1,582 1,818 1,818 2,091 66 1,582 1,818 1,818 2,091 67 1,582 1,818 1,818 2,091 68 1,640 1,887 1,887 2,170 69 1,700 1,955 1,955 2,249 70 1,759 2,024 2,024 2,327 71 1,815 2,087 2,087 2,401 72 1,875 2,156 2,156 2,479 73 1,934 2,225 2,225 2,558 74 2,000 2,300 2,300 2,644 75 2,073 2,384 2,384 2,742 76 2,144 2,466 2,466 2,834 77 2,216 2,549 2,549 2,930 78 2,289 2,633 2,633 3,028 79 2,369 2,725 2,725 3,133 80 2,451 2,819 2,819 3,241 81 2,538 2,919 2,919 3,358 82 2,628 3,023 3,023 3,476 83 2,723 3,132 3,132 3,601 84 2,821 3,244 3,244 3,731 85 2,923 3,362 3,362 3,866 86 3,017 3,470 3,470 3,991 87 3,114 3,581 3,581 4,118 88 3,213 3,695 3,695 4,248 89 3,315 3,813 3,813 4,384 90 3,420 3,932 3,932 4,521 91 3,514 4,042 4,042 4,648 92 3,608 4,149 4,149 4,772 93 3,705 4,260 4,260 4,899 94 3,802 4,372 4,372 5,029 95 3,903 4,489 4,489 5,161 96 3,970 4,564 4,564 5,250 97 4,037 4,642 4,642 5,338 98 4,106 4,722 4,722 5,429 99 4,176 4,803 4,803 5,522\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee. A discount factor of .93 is applied for household discount applicants.\n\nArea Facto Texas 770-773, 775 1.05 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794 0.95 Rest of State 0.88\n\nGross Annual Premiums\n\n**Western United Life Assurance Company**\n\nMedicare Supplement Policy\n\n**CURRENT RATES**\n\n2010 Standardized Plan G\n\nPreferred Standard","publish_date":null,"title":"Western United Life Assurance Company Gross Annual Premiums CURRENT RATES","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page434.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page434.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page434","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page434.pdf"},"started_at":"2026-11-04T19:47:14.347362"} +{"completed_at":"2026-11-04T19:47:16.495036","latency_in_ms":1478,"output":{"example_id":"table/SERFF_TX_random_pages 1_page453","grounded_pages":[],"layout_pages":[],"markdown":"Western United Life Assurance Company\n\nActuarial Memorandum for Individual Health\n\nMedicare Supplement Rate Increase\n\nExhibit I-By State by Plan\n\nA. **Historical Experience**\n\n(Paid as of 12-31-2020) _Expected_\n\nPaid Incurred Earned Loss Loss A/E\n\nYear Claims Claims\\* Premium Ratio Ratio Loss Ratio\n\n2016 #REF! - - 0.00% 0.00%\n\n2017 #REF! 5 1,066 0.51% 59.95% 0.85%\n\n2018 #REF! 27,825 78,531 35.43% 59.06% 60.00%\n\n2019 #REF! 108,741 181,803 59.81% 62.30% 96.01%\n\n2020 #REF! 248,353 220,190 112.79% 66.64% 169.25%\n\nTotal #REF! 384,924 481,590 79.93%\n\nAccumulated at 4.% 399,299 505,214 79.04% _64%_ 124\\.14%\n\n\\* Includes IBNR at 12/31/2020\n\nB. **Current Loss Ratio**\n\nHistorical Current Current Historical Claim Current Current\n\nEarned Rate Level Earned Incurred Trend Incurred Loss\n\nYear Premium Factor\\* Premium Claims Factor\\*\\* Claims\\*\\*\\* Ratio\n\n2018 78,531 1.082 84,939 27,825 1.184 32,953 38.80%\n\n2019 181,803 1.061 192,820 108,741 1.107 120,357 62.42%\n\n2020 220,190 1.020 224,551 248,353 1.034 256,898 114.41%\n\nTotal 480,524 502,309 410,207 81.66%\n\n\\* Adjusts for average nationwide rate increases previously implemented.\n\n\\*\\* Applies a 7.00% claim cost trend from the midpoint of the period to 12/31/2020.\n\nC. **Projected Experience with 18.0% increase**\n\n_Expected_\n\nIncurred Earned Loss Loss A/E\n\nYear Claims Premium^ Ratio Ratio Loss Ratio\n\n2021 155,464 175,249 88.71% 72.10% 123.03%\n\n2022 356,104 433,582 82.13% 74.57% 110.14%\n\n2023 330,892 402,884 82.13% 74.98% 109.54%\n\n2024 307,464 374,360 82.13% 74.63% 110.05%\n\n2025 285,696 347,855 82.13% 74.14% 110.77%\n\n2026 265,469 323,227 82.13% 73.98% 111.02%\n\n2027 246,674 300,343 82.13% 73.63% 111.54%\n\n2028 229,209 279,078 82.13% 73.15% 112.28%\n\n2029 212,981 259,320 82.13% 73.00% 112.51%\n\n2030 197,902 240,960 82.13% 73.00% 112.51%\n\nTexas - PLAN - N 18.0% Increase\n\nThe current loss ratio is defined as the 2018 - 2020 historical incurred claims adjusted to current claims levels, divided by the 2018 - 2020 historical earned premium adjusted to current premium rate levels.","pages":[{"line_numbers":[],"markdown":"Western United Life Assurance Company\n\nActuarial Memorandum for Individual Health\n\nMedicare Supplement Rate Increase\n\nExhibit I-By State by Plan\n\nA. **Historical Experience**\n\n(Paid as of 12-31-2020) _Expected_\n\nPaid Incurred Earned Loss Loss A/E\n\nYear Claims Claims\\* Premium Ratio Ratio Loss Ratio\n\n2016 #REF! - - 0.00% 0.00%\n\n2017 #REF! 5 1,066 0.51% 59.95% 0.85%\n\n2018 #REF! 27,825 78,531 35.43% 59.06% 60.00%\n\n2019 #REF! 108,741 181,803 59.81% 62.30% 96.01%\n\n2020 #REF! 248,353 220,190 112.79% 66.64% 169.25%\n\nTotal #REF! 384,924 481,590 79.93%\n\nAccumulated at 4.% 399,299 505,214 79.04% _64%_ 124\\.14%\n\n\\* Includes IBNR at 12/31/2020\n\nB. **Current Loss Ratio**\n\nHistorical Current Current Historical Claim Current Current\n\nEarned Rate Level Earned Incurred Trend Incurred Loss\n\nYear Premium Factor\\* Premium Claims Factor\\*\\* Claims\\*\\*\\* Ratio\n\n2018 78,531 1.082 84,939 27,825 1.184 32,953 38.80%\n\n2019 181,803 1.061 192,820 108,741 1.107 120,357 62.42%\n\n2020 220,190 1.020 224,551 248,353 1.034 256,898 114.41%\n\nTotal 480,524 502,309 410,207 81.66%\n\n\\* Adjusts for average nationwide rate increases previously implemented.\n\n\\*\\* Applies a 7.00% claim cost trend from the midpoint of the period to 12/31/2020.\n\nC. **Projected Experience with 18.0% increase**\n\n_Expected_\n\nIncurred Earned Loss Loss A/E\n\nYear Claims Premium^ Ratio Ratio Loss Ratio\n\n2021 155,464 175,249 88.71% 72.10% 123.03%\n\n2022 356,104 433,582 82.13% 74.57% 110.14%\n\n2023 330,892 402,884 82.13% 74.98% 109.54%\n\n2024 307,464 374,360 82.13% 74.63% 110.05%\n\n2025 285,696 347,855 82.13% 74.14% 110.77%\n\n2026 265,469 323,227 82.13% 73.98% 111.02%\n\n2027 246,674 300,343 82.13% 73.63% 111.54%\n\n2028 229,209 279,078 82.13% 73.15% 112.28%\n\n2029 212,981 259,320 82.13% 73.00% 112.51%\n\n2030 197,902 240,960 82.13% 73.00% 112.51%\n\nTexas - PLAN - N 18.0% Increase\n\nThe current loss ratio is defined as the 2018 - 2020 historical incurred claims adjusted to current claims levels, divided by the 2018 - 2020 historical earned premium adjusted to current premium rate levels.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Western United Life Assurance Company\n\nActuarial Memorandum for Individual Health\n\nMedicare Supplement Rate Increase\n\nExhibit I-By State by Plan\n\nA. **Historical Experience**\n\n(Paid as of 12-31-2020) _Expected_\n\nPaid Incurred Earned Loss Loss A/E\n\nYear Claims Claims\\* Premium Ratio Ratio Loss Ratio\n\n2016 #REF! - - 0.00% 0.00%\n\n2017 #REF! 5 1,066 0.51% 59.95% 0.85%\n\n2018 #REF! 27,825 78,531 35.43% 59.06% 60.00%\n\n2019 #REF! 108,741 181,803 59.81% 62.30% 96.01%\n\n2020 #REF! 248,353 220,190 112.79% 66.64% 169.25%\n\nTotal #REF! 384,924 481,590 79.93%\n\nAccumulated at 4.% 399,299 505,214 79.04% _64%_ 124\\.14%\n\n\\* Includes IBNR at 12/31/2020\n\nB. **Current Loss Ratio**\n\nHistorical Current Current Historical Claim Current Current\n\nEarned Rate Level Earned Incurred Trend Incurred Loss\n\nYear Premium Factor\\* Premium Claims Factor\\*\\* Claims\\*\\*\\* Ratio\n\n2018 78,531 1.082 84,939 27,825 1.184 32,953 38.80%\n\n2019 181,803 1.061 192,820 108,741 1.107 120,357 62.42%\n\n2020 220,190 1.020 224,551 248,353 1.034 256,898 114.41%\n\nTotal 480,524 502,309 410,207 81.66%\n\n\\* Adjusts for average nationwide rate increases previously implemented.\n\n\\*\\* Applies a 7.00% claim cost trend from the midpoint of the period to 12/31/2020.\n\nC. **Projected Experience with 18.0% increase**\n\n_Expected_\n\nIncurred Earned Loss Loss A/E\n\nYear Claims Premium^ Ratio Ratio Loss Ratio\n\n2021 155,464 175,249 88.71% 72.10% 123.03%\n\n2022 356,104 433,582 82.13% 74.57% 110.14%\n\n2023 330,892 402,884 82.13% 74.98% 109.54%\n\n2024 307,464 374,360 82.13% 74.63% 110.05%\n\n2025 285,696 347,855 82.13% 74.14% 110.77%\n\n2026 265,469 323,227 82.13% 73.98% 111.02%\n\n2027 246,674 300,343 82.13% 73.63% 111.54%\n\n2028 229,209 279,078 82.13% 73.15% 112.28%\n\n2029 212,981 259,320 82.13% 73.00% 112.51%\n\n2030 197,902 240,960 82.13% 73.00% 112.51%\n\nTexas - PLAN - N 18.0% Increase\n\nThe current loss ratio is defined as the 2018 - 2020 historical incurred claims adjusted to current claims levels, divided by the 2018 - 2020 historical earned premium adjusted to current premium rate levels.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page453.pdf"]},"response":{"errors":[],"extract_id":"extract_dcffe23fe51c4d52ea5c3345abea3e49","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Western United Life Assurance Company\n\nActuarial Memorandum for Individual Health\n\nMedicare Supplement Rate Increase\n\nExhibit I-By State by Plan\n\nA. **Historical Experience**\n\n(Paid as of 12-31-2020) _Expected_\n\nPaid Incurred Earned Loss Loss A/E\n\nYear Claims Claims\\* Premium Ratio Ratio Loss Ratio\n\n2016 #REF! - - 0.00% 0.00%\n\n2017 #REF! 5 1,066 0.51% 59.95% 0.85%\n\n2018 #REF! 27,825 78,531 35.43% 59.06% 60.00%\n\n2019 #REF! 108,741 181,803 59.81% 62.30% 96.01%\n\n2020 #REF! 248,353 220,190 112.79% 66.64% 169.25%\n\nTotal #REF! 384,924 481,590 79.93%\n\nAccumulated at 4.% 399,299 505,214 79.04% _64%_ 124\\.14%\n\n\\* Includes IBNR at 12/31/2020\n\nB. **Current Loss Ratio**\n\nHistorical Current Current Historical Claim Current Current\n\nEarned Rate Level Earned Incurred Trend Incurred Loss\n\nYear Premium Factor\\* Premium Claims Factor\\*\\* Claims\\*\\*\\* Ratio\n\n2018 78,531 1.082 84,939 27,825 1.184 32,953 38.80%\n\n2019 181,803 1.061 192,820 108,741 1.107 120,357 62.42%\n\n2020 220,190 1.020 224,551 248,353 1.034 256,898 114.41%\n\nTotal 480,524 502,309 410,207 81.66%\n\n\\* Adjusts for average nationwide rate increases previously implemented.\n\n\\*\\* Applies a 7.00% claim cost trend from the midpoint of the period to 12/31/2020.\n\nC. **Projected Experience with 18.0% increase**\n\n_Expected_\n\nIncurred Earned Loss Loss A/E\n\nYear Claims Premium^ Ratio Ratio Loss Ratio\n\n2021 155,464 175,249 88.71% 72.10% 123.03%\n\n2022 356,104 433,582 82.13% 74.57% 110.14%\n\n2023 330,892 402,884 82.13% 74.98% 109.54%\n\n2024 307,464 374,360 82.13% 74.63% 110.05%\n\n2025 285,696 347,855 82.13% 74.14% 110.77%\n\n2026 265,469 323,227 82.13% 73.98% 111.02%\n\n2027 246,674 300,343 82.13% 73.63% 111.54%\n\n2028 229,209 279,078 82.13% 73.15% 112.28%\n\n2029 212,981 259,320 82.13% 73.00% 112.51%\n\n2030 197,902 240,960 82.13% 73.00% 112.51%\n\nTexas - PLAN - N 18.0% Increase\n\nThe current loss ratio is defined as the 2018 - 2020 historical incurred claims adjusted to current claims levels, divided by the 2018 - 2020 historical earned premium adjusted to current premium rate levels."],"full_content":"Western United Life Assurance Company\n\nActuarial Memorandum for Individual Health\n\nMedicare Supplement Rate Increase\n\nExhibit I-By State by Plan\n\nA. **Historical Experience**\n\n(Paid as of 12-31-2020) _Expected_\n\nPaid Incurred Earned Loss Loss A/E\n\nYear Claims Claims\\* Premium Ratio Ratio Loss Ratio\n\n2016 #REF! - - 0.00% 0.00%\n\n2017 #REF! 5 1,066 0.51% 59.95% 0.85%\n\n2018 #REF! 27,825 78,531 35.43% 59.06% 60.00%\n\n2019 #REF! 108,741 181,803 59.81% 62.30% 96.01%\n\n2020 #REF! 248,353 220,190 112.79% 66.64% 169.25%\n\nTotal #REF! 384,924 481,590 79.93%\n\nAccumulated at 4.% 399,299 505,214 79.04% _64%_ 124\\.14%\n\n\\* Includes IBNR at 12/31/2020\n\nB. **Current Loss Ratio**\n\nHistorical Current Current Historical Claim Current Current\n\nEarned Rate Level Earned Incurred Trend Incurred Loss\n\nYear Premium Factor\\* Premium Claims Factor\\*\\* Claims\\*\\*\\* Ratio\n\n2018 78,531 1.082 84,939 27,825 1.184 32,953 38.80%\n\n2019 181,803 1.061 192,820 108,741 1.107 120,357 62.42%\n\n2020 220,190 1.020 224,551 248,353 1.034 256,898 114.41%\n\nTotal 480,524 502,309 410,207 81.66%\n\n\\* Adjusts for average nationwide rate increases previously implemented.\n\n\\*\\* Applies a 7.00% claim cost trend from the midpoint of the period to 12/31/2020.\n\nC. **Projected Experience with 18.0% increase**\n\n_Expected_\n\nIncurred Earned Loss Loss A/E\n\nYear Claims Premium^ Ratio Ratio Loss Ratio\n\n2021 155,464 175,249 88.71% 72.10% 123.03%\n\n2022 356,104 433,582 82.13% 74.57% 110.14%\n\n2023 330,892 402,884 82.13% 74.98% 109.54%\n\n2024 307,464 374,360 82.13% 74.63% 110.05%\n\n2025 285,696 347,855 82.13% 74.14% 110.77%\n\n2026 265,469 323,227 82.13% 73.98% 111.02%\n\n2027 246,674 300,343 82.13% 73.63% 111.54%\n\n2028 229,209 279,078 82.13% 73.15% 112.28%\n\n2029 212,981 259,320 82.13% 73.00% 112.51%\n\n2030 197,902 240,960 82.13% 73.00% 112.51%\n\nTexas - PLAN - N 18.0% Increase\n\nThe current loss ratio is defined as the 2018 - 2020 historical incurred claims adjusted to current claims levels, divided by the 2018 - 2020 historical earned premium adjusted to current premium rate levels.","publish_date":null,"title":"Western United Life Assurance Company Actuarial Memorandum for Individual Health Medicare Supplement Rate Increase Exhibit I-By State by Plan Texas","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page453.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page453.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page453","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page453.pdf"},"started_at":"2026-11-04T19:47:15.016149"} +{"completed_at":"2026-11-04T19:47:19.257512","latency_in_ms":2952,"output":{"example_id":"table/SERFF_TX_random_pages 1_page455","grounded_pages":[],"layout_pages":[],"markdown":"### Western United Life Assurance Company\n\n### Actuarial Memorandum for Individual Health\n\n### Medicare Supplement Rate Increase\n\n### Exhibit V\n\n**State Plan Rate Implementation**\n\nTX A 15.0% 9/1/2020\n\nTX C 10.0% 9/1/2020\n\nTX F 11.0% 9/1/2020\n\nTX G 18.0% 9/1/2020\n\nTX N 4.0% 9/1/2020\n\nTX A 9.0% 9/1/2019\n\nTX C 9.0% 9/1/2019\n\nTX F 7.0% 9/1/2019\n\nTX G 5.0% 9/1/2019\n\nTX N 4.0% 9/1/2019\n\nExhibit V","pages":[{"line_numbers":[],"markdown":"### Western United Life Assurance Company\n\n### Actuarial Memorandum for Individual Health\n\n### Medicare Supplement Rate Increase\n\n### Exhibit V\n\n**State Plan Rate Implementation**\n\nTX A 15.0% 9/1/2020\n\nTX C 10.0% 9/1/2020\n\nTX F 11.0% 9/1/2020\n\nTX G 18.0% 9/1/2020\n\nTX N 4.0% 9/1/2020\n\nTX A 9.0% 9/1/2019\n\nTX C 9.0% 9/1/2019\n\nTX F 7.0% 9/1/2019\n\nTX G 5.0% 9/1/2019\n\nTX N 4.0% 9/1/2019\n\nExhibit V","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### Western United Life Assurance Company\n\n### Actuarial Memorandum for Individual Health\n\n### Medicare Supplement Rate Increase\n\n### Exhibit V\n\n**State Plan Rate Implementation**\n\nTX A 15.0% 9/1/2020\n\nTX C 10.0% 9/1/2020\n\nTX F 11.0% 9/1/2020\n\nTX G 18.0% 9/1/2020\n\nTX N 4.0% 9/1/2020\n\nTX A 9.0% 9/1/2019\n\nTX C 9.0% 9/1/2019\n\nTX F 7.0% 9/1/2019\n\nTX G 5.0% 9/1/2019\n\nTX N 4.0% 9/1/2019\n\nExhibit V","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page455.pdf"]},"response":{"errors":[],"extract_id":"extract_c75409c8508ec21f54f034858ba8d9c0","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### Western United Life Assurance Company\n\n### Actuarial Memorandum for Individual Health\n\n### Medicare Supplement Rate Increase\n\n### Exhibit V\n\n**State Plan Rate Implementation**\n\nTX A 15.0% 9/1/2020\n\nTX C 10.0% 9/1/2020\n\nTX F 11.0% 9/1/2020\n\nTX G 18.0% 9/1/2020\n\nTX N 4.0% 9/1/2020\n\nTX A 9.0% 9/1/2019\n\nTX C 9.0% 9/1/2019\n\nTX F 7.0% 9/1/2019\n\nTX G 5.0% 9/1/2019\n\nTX N 4.0% 9/1/2019\n\nExhibit V"],"full_content":"### Western United Life Assurance Company\n\n### Actuarial Memorandum for Individual Health\n\n### Medicare Supplement Rate Increase\n\n### Exhibit V\n\n**State Plan Rate Implementation**\n\nTX A 15.0% 9/1/2020\n\nTX C 10.0% 9/1/2020\n\nTX F 11.0% 9/1/2020\n\nTX G 18.0% 9/1/2020\n\nTX N 4.0% 9/1/2020\n\nTX A 9.0% 9/1/2019\n\nTX C 9.0% 9/1/2019\n\nTX F 7.0% 9/1/2019\n\nTX G 5.0% 9/1/2019\n\nTX N 4.0% 9/1/2019\n\nExhibit V","publish_date":null,"title":"Western United Life Assurance Company Actuarial Memorandum for Individual Health Medicare Supplement Rate Increase Exhibit V","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page455.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page455.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page455","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page455.pdf"},"started_at":"2026-11-04T19:47:16.305483"} +{"completed_at":"2026-11-04T19:47:20.461474","latency_in_ms":2876,"output":{"example_id":"table/SERFF_TX_random_pages 1_page461","grounded_pages":[],"layout_pages":[],"markdown":"Attained Age Female Male Female Male 0-64 N/A N/A N/A N/A 65 2,797 3,214 3,108 3,574 66 2,797 3,214 3,108 3,574 67 2,935 3,372 3,261 3,745 68 3,065 3,526 3,406 3,916 69 3,199 3,677 3,547 4,086 70 3,328 3,827 3,696 4,251 71 3,451 3,969 3,837 4,410 72 3,577 4,120 3,977 4,576 73 3,704 4,260 4,116 4,733 74 3,828 4,403 4,252 4,892 75 3,948 4,541 4,388 5,048 76 4,069 4,678 4,519 5,194 77 4,182 4,810 4,647 5,342 78 4,290 4,938 4,771 5,487 79 4,392 5,051 4,882 5,614 80 4,488 5,159 4,987 5,738 81 4,581 5,263 5,087 5,848 82 4,661 5,363 5,182 5,959 83 4,739 5,451 5,264 6,056 84 4,812 5,531 5,345 6,145 85 4,881 5,614 5,421 6,235 86 4,944 5,685 5,491 6,319 87 5,000 5,748 5,558 6,387 88 5,057 5,811 5,616 6,458 89 5,099 5,864 5,667 6,512 90 5,143 5,913 5,715 6,569 91 5,184 5,960 5,760 6,622 92 5,219 6,004 5,798 6,670 93 5,258 6,044 5,839 6,714 94 5,289 6,081 5,873 6,758 95 5,320 6,119 5,911 6,796 96 5,346 6,145 5,943 6,834 97 5,367 6,173 5,962 6,860 98 5,388 6,193 5,986 6,882 99 5,397 6,209 5,998 6,905\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee. A discount factor of 0.93 is applied for married applicants.\n\nArea Factors: _Texas_ 770-773, 775………………………… 1.15\n\n1\\.10 Rest of State………………………………………… 0.97\n\n**Family Life Insurance Company**\n\nGross Annual Premiums\n\nMedicare Supplement Policy **Current Rate**\n\nNon-Tobacco Tobacco\n\nStandardized Plan B\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794…………………………","pages":[{"line_numbers":[],"markdown":"Attained Age Female Male Female Male 0-64 N/A N/A N/A N/A 65 2,797 3,214 3,108 3,574 66 2,797 3,214 3,108 3,574 67 2,935 3,372 3,261 3,745 68 3,065 3,526 3,406 3,916 69 3,199 3,677 3,547 4,086 70 3,328 3,827 3,696 4,251 71 3,451 3,969 3,837 4,410 72 3,577 4,120 3,977 4,576 73 3,704 4,260 4,116 4,733 74 3,828 4,403 4,252 4,892 75 3,948 4,541 4,388 5,048 76 4,069 4,678 4,519 5,194 77 4,182 4,810 4,647 5,342 78 4,290 4,938 4,771 5,487 79 4,392 5,051 4,882 5,614 80 4,488 5,159 4,987 5,738 81 4,581 5,263 5,087 5,848 82 4,661 5,363 5,182 5,959 83 4,739 5,451 5,264 6,056 84 4,812 5,531 5,345 6,145 85 4,881 5,614 5,421 6,235 86 4,944 5,685 5,491 6,319 87 5,000 5,748 5,558 6,387 88 5,057 5,811 5,616 6,458 89 5,099 5,864 5,667 6,512 90 5,143 5,913 5,715 6,569 91 5,184 5,960 5,760 6,622 92 5,219 6,004 5,798 6,670 93 5,258 6,044 5,839 6,714 94 5,289 6,081 5,873 6,758 95 5,320 6,119 5,911 6,796 96 5,346 6,145 5,943 6,834 97 5,367 6,173 5,962 6,860 98 5,388 6,193 5,986 6,882 99 5,397 6,209 5,998 6,905\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee. A discount factor of 0.93 is applied for married applicants.\n\nArea Factors: _Texas_ 770-773, 775………………………… 1.15\n\n1\\.10 Rest of State………………………………………… 0.97\n\n**Family Life Insurance Company**\n\nGross Annual Premiums\n\nMedicare Supplement Policy **Current Rate**\n\nNon-Tobacco Tobacco\n\nStandardized Plan B\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794…………………………","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Attained Age Female Male Female Male 0-64 N/A N/A N/A N/A 65 2,797 3,214 3,108 3,574 66 2,797 3,214 3,108 3,574 67 2,935 3,372 3,261 3,745 68 3,065 3,526 3,406 3,916 69 3,199 3,677 3,547 4,086 70 3,328 3,827 3,696 4,251 71 3,451 3,969 3,837 4,410 72 3,577 4,120 3,977 4,576 73 3,704 4,260 4,116 4,733 74 3,828 4,403 4,252 4,892 75 3,948 4,541 4,388 5,048 76 4,069 4,678 4,519 5,194 77 4,182 4,810 4,647 5,342 78 4,290 4,938 4,771 5,487 79 4,392 5,051 4,882 5,614 80 4,488 5,159 4,987 5,738 81 4,581 5,263 5,087 5,848 82 4,661 5,363 5,182 5,959 83 4,739 5,451 5,264 6,056 84 4,812 5,531 5,345 6,145 85 4,881 5,614 5,421 6,235 86 4,944 5,685 5,491 6,319 87 5,000 5,748 5,558 6,387 88 5,057 5,811 5,616 6,458 89 5,099 5,864 5,667 6,512 90 5,143 5,913 5,715 6,569 91 5,184 5,960 5,760 6,622 92 5,219 6,004 5,798 6,670 93 5,258 6,044 5,839 6,714 94 5,289 6,081 5,873 6,758 95 5,320 6,119 5,911 6,796 96 5,346 6,145 5,943 6,834 97 5,367 6,173 5,962 6,860 98 5,388 6,193 5,986 6,882 99 5,397 6,209 5,998 6,905\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee. A discount factor of 0.93 is applied for married applicants.\n\nArea Factors: _Texas_ 770-773, 775………………………… 1.15\n\n1\\.10 Rest of State………………………………………… 0.97\n\n**Family Life Insurance Company**\n\nGross Annual Premiums\n\nMedicare Supplement Policy **Current Rate**\n\nNon-Tobacco Tobacco\n\nStandardized Plan B\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794…………………………","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page461.pdf"]},"response":{"errors":[],"extract_id":"extract_04b681c90cba041ca97f8352ccd0e5ce","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Attained Age Female Male Female Male 0-64 N/A N/A N/A N/A 65 2,797 3,214 3,108 3,574 66 2,797 3,214 3,108 3,574 67 2,935 3,372 3,261 3,745 68 3,065 3,526 3,406 3,916 69 3,199 3,677 3,547 4,086 70 3,328 3,827 3,696 4,251 71 3,451 3,969 3,837 4,410 72 3,577 4,120 3,977 4,576 73 3,704 4,260 4,116 4,733 74 3,828 4,403 4,252 4,892 75 3,948 4,541 4,388 5,048 76 4,069 4,678 4,519 5,194 77 4,182 4,810 4,647 5,342 78 4,290 4,938 4,771 5,487 79 4,392 5,051 4,882 5,614 80 4,488 5,159 4,987 5,738 81 4,581 5,263 5,087 5,848 82 4,661 5,363 5,182 5,959 83 4,739 5,451 5,264 6,056 84 4,812 5,531 5,345 6,145 85 4,881 5,614 5,421 6,235 86 4,944 5,685 5,491 6,319 87 5,000 5,748 5,558 6,387 88 5,057 5,811 5,616 6,458 89 5,099 5,864 5,667 6,512 90 5,143 5,913 5,715 6,569 91 5,184 5,960 5,760 6,622 92 5,219 6,004 5,798 6,670 93 5,258 6,044 5,839 6,714 94 5,289 6,081 5,873 6,758 95 5,320 6,119 5,911 6,796 96 5,346 6,145 5,943 6,834 97 5,367 6,173 5,962 6,860 98 5,388 6,193 5,986 6,882 99 5,397 6,209 5,998 6,905\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee. A discount factor of 0.93 is applied for married applicants.\n\nArea Factors: _Texas_ 770-773, 775………………………… 1.15\n\n1\\.10 Rest of State………………………………………… 0.97\n\n**Family Life Insurance Company**\n\nGross Annual Premiums\n\nMedicare Supplement Policy **Current Rate**\n\nNon-Tobacco Tobacco\n\nStandardized Plan B\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794…………………………"],"full_content":"Attained Age Female Male Female Male 0-64 N/A N/A N/A N/A 65 2,797 3,214 3,108 3,574 66 2,797 3,214 3,108 3,574 67 2,935 3,372 3,261 3,745 68 3,065 3,526 3,406 3,916 69 3,199 3,677 3,547 4,086 70 3,328 3,827 3,696 4,251 71 3,451 3,969 3,837 4,410 72 3,577 4,120 3,977 4,576 73 3,704 4,260 4,116 4,733 74 3,828 4,403 4,252 4,892 75 3,948 4,541 4,388 5,048 76 4,069 4,678 4,519 5,194 77 4,182 4,810 4,647 5,342 78 4,290 4,938 4,771 5,487 79 4,392 5,051 4,882 5,614 80 4,488 5,159 4,987 5,738 81 4,581 5,263 5,087 5,848 82 4,661 5,363 5,182 5,959 83 4,739 5,451 5,264 6,056 84 4,812 5,531 5,345 6,145 85 4,881 5,614 5,421 6,235 86 4,944 5,685 5,491 6,319 87 5,000 5,748 5,558 6,387 88 5,057 5,811 5,616 6,458 89 5,099 5,864 5,667 6,512 90 5,143 5,913 5,715 6,569 91 5,184 5,960 5,760 6,622 92 5,219 6,004 5,798 6,670 93 5,258 6,044 5,839 6,714 94 5,289 6,081 5,873 6,758 95 5,320 6,119 5,911 6,796 96 5,346 6,145 5,943 6,834 97 5,367 6,173 5,962 6,860 98 5,388 6,193 5,986 6,882 99 5,397 6,209 5,998 6,905\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee. A discount factor of 0.93 is applied for married applicants.\n\nArea Factors: _Texas_ 770-773, 775………………………… 1.15\n\n1\\.10 Rest of State………………………………………… 0.97\n\n**Family Life Insurance Company**\n\nGross Annual Premiums\n\nMedicare Supplement Policy **Current Rate**\n\nNon-Tobacco Tobacco\n\nStandardized Plan B\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794…………………………","publish_date":null,"title":"Gross Annual Premiums Family Life Insurance Company Current Rate","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page461.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page461.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page461","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page461.pdf"},"started_at":"2026-11-04T19:47:17.584988"} +{"completed_at":"2026-11-04T19:47:21.057573","latency_in_ms":1795,"output":{"example_id":"table/SERFF_TX_random_pages 1_page503","grounded_pages":[],"layout_pages":[],"markdown":"## **Family Life Insurance Company Actuarial Memorandum for Individual Health Medicare Supplement Rate Increase**\n\n**Iss St Plan Policy Count** MD A 1 TX A 38 WV A 1 **Total 40**\n\n**Iss St Plan Policy Count** CA A 1 TX A 0 WV A 1 **Total 2**\n\n**Aged**\n\n### **Plan A Inforce Count in Texas**\n\n**Disabled**","pages":[{"line_numbers":[],"markdown":"## **Family Life Insurance Company Actuarial Memorandum for Individual Health Medicare Supplement Rate Increase**\n\n**Iss St Plan Policy Count** MD A 1 TX A 38 WV A 1 **Total 40**\n\n**Iss St Plan Policy Count** CA A 1 TX A 0 WV A 1 **Total 2**\n\n**Aged**\n\n### **Plan A Inforce Count in Texas**\n\n**Disabled**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"## **Family Life Insurance Company Actuarial Memorandum for Individual Health Medicare Supplement Rate Increase**\n\n**Iss St Plan Policy Count** MD A 1 TX A 38 WV A 1 **Total 40**\n\n**Iss St Plan Policy Count** CA A 1 TX A 0 WV A 1 **Total 2**\n\n**Aged**\n\n### **Plan A Inforce Count in Texas**\n\n**Disabled**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page503.pdf"]},"response":{"errors":[],"extract_id":"extract_3b45868a995ce5de131c5aac18e98394","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["## **Family Life Insurance Company Actuarial Memorandum for Individual Health Medicare Supplement Rate Increase**\n\n**Iss St Plan Policy Count** MD A 1 TX A 38 WV A 1 **Total 40**\n\n**Iss St Plan Policy Count** CA A 1 TX A 0 WV A 1 **Total 2**\n\n**Aged**\n\n### **Plan A Inforce Count in Texas**\n\n**Disabled**"],"full_content":"## **Family Life Insurance Company Actuarial Memorandum for Individual Health Medicare Supplement Rate Increase**\n\n**Iss St Plan Policy Count** MD A 1 TX A 38 WV A 1 **Total 40**\n\n**Iss St Plan Policy Count** CA A 1 TX A 0 WV A 1 **Total 2**\n\n**Aged**\n\n### **Plan A Inforce Count in Texas**\n\n**Disabled**","publish_date":null,"title":"Family Life Insurance Company Actuarial Memorandum for Individual Health Medicare Supplement Rate Increase","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page503.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page503.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page503","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page503.pdf"},"started_at":"2026-11-04T19:47:19.262117"} +{"completed_at":"2026-11-04T19:47:23.350771","latency_in_ms":2459,"output":{"example_id":"table/SERFF_TX_random_pages 1_page563","grounded_pages":[],"layout_pages":[],"markdown":"**Average Annual Claim Issue Experience Earned Incurred Paid Claim Exposed Annual Premium Claim Cost Year Period Dur Premium Claims Claims IBNR Ratio Policies Persistency Premium Trend Cost Trend**\n\n**WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan A,B, C, & D Texas Experience**\n\n2001 2001 0.5 0 0 0 0 0.0% 0 - - 2002 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2003 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\n2002 2002 0.5 0 0 0 0 0.0% 0 - - 2003 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\nTotal 1994 0.5 804 0 0 0 0.0% 26 368.92 - 1995 5.0 70,025 47,536 47,536 0 67.9% 2,735 10462.3% 307.26 -16.7% 208.58 0.0% 1996 1.0 498,547 389,298 389,298 0 78.1% 14,087 515.1% 424.69 38.2% 331.62 59.0% 1997 1.7 466,795 482,057 482,057 0 103.3% 6,395 45.4% 875.93 106.3% 904.56 172.8% 1998 2.3 464,236 492,271 492,271 0 106.0% 6,327 98.9% 880.49 0.5% 933.66 3.2% 1999 2.6 530,092 601,087 601,087 0 113.4% 7,235 114.4% 879.21 -0.1% 996.96 6.8% 2000 3.2 585,987 697,977 697,977 0 119.1% 7,277 100.6% 966.26 9.9% 1,150.92 15.4% 2001 4.2 585,406 545,739 545,739 0 93.2% 6,265 86.1% 1,121.29 16.0% 1,045.31 -9.2% 2002 5.0 527,982 483,216 483,216 0 91.5% 5,260 84.0% 1,204.52 7.4% 1,102.39 5.5% 2003 6.0 472,996 480,492 480,492 0 101.6% 4,617 87.8% 1,229.36 2.1% 1,248.84 13.3% 2004 6.9 468,931 447,942 447,942 0 95.5% 4,073 88.2% 1,381.58 12.4% 1,319.74 5.7% 2005 7.8 473,649 342,765 342,765 0 72.4% 3,474 85.3% 1,636.09 18.4% 1,183.99 -10.3% 2006 8.8 428,070 319,162 319,162 0 74.6% 2,750 79.2% 1,867.94 14.2% 1,392.71 17.6% 2007 9.8 349,610 293,514 293,514 0 84.0% 1,993 72.5% 2,105.03 12.7% 1,767.27 26.9% 2008 10.8 284,499 200,315 200,315 0 70.4% 1,455 73.0% 2,346.38 11.5% 1,652.08 -6.5% 2009 11.9 227,350 166,824 166,824 0 73.4% 1,073 73.7% 2,542.59 8.4% 1,865.69 12.9% 2010 12.9 191,004 119,561 119,561 0 62.6% 832 77.5% 2,754.86 8.3% 1,724.43 -7.6% 2011 13.8 146,786 107,440 107,440 0 73.2% 609 73.2% 2,892.34 5.0% 2,117.04 22.8% 2012 14.8 119,760 48,822 48,822 0 40.8% 479 78.7% 3,000.25 3.7% 1,223.10 -42.2% 2013 16.1 92,418 41,983 41,983 0 45.4% 357 74.5% 3,106.50 3.5% 1,411.18 15.4% 2014 17.1 71,783 34,153 34,153 0 47.6% 272 76.2% 3,166.89 1.9% 1,506.74 6.8% 2015 18.1 55,852 22,873 22,873 0 41.0% 212 77.9% 3,161.44 -0.2% 1,294.72 -14.1% 2016 19.2 52,446 49,857 49,611 245 95.1% 194 91.5% 3,244.11 2.6% 3,083.91 138.2% 2017 20.2 40,915 18,142 16,043 2,099 44.3% 142 73.2% 3,457.64 6.6% 1,533.12 -50.3% Total 6.1 7,205,946 6,433,024 6,430,680 2,344 89.3%\n\n**Exhibit IV**","pages":[{"line_numbers":[],"markdown":"**Average Annual Claim Issue Experience Earned Incurred Paid Claim Exposed Annual Premium Claim Cost Year Period Dur Premium Claims Claims IBNR Ratio Policies Persistency Premium Trend Cost Trend**\n\n**WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan A,B, C, & D Texas Experience**\n\n2001 2001 0.5 0 0 0 0 0.0% 0 - - 2002 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2003 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\n2002 2002 0.5 0 0 0 0 0.0% 0 - - 2003 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\nTotal 1994 0.5 804 0 0 0 0.0% 26 368.92 - 1995 5.0 70,025 47,536 47,536 0 67.9% 2,735 10462.3% 307.26 -16.7% 208.58 0.0% 1996 1.0 498,547 389,298 389,298 0 78.1% 14,087 515.1% 424.69 38.2% 331.62 59.0% 1997 1.7 466,795 482,057 482,057 0 103.3% 6,395 45.4% 875.93 106.3% 904.56 172.8% 1998 2.3 464,236 492,271 492,271 0 106.0% 6,327 98.9% 880.49 0.5% 933.66 3.2% 1999 2.6 530,092 601,087 601,087 0 113.4% 7,235 114.4% 879.21 -0.1% 996.96 6.8% 2000 3.2 585,987 697,977 697,977 0 119.1% 7,277 100.6% 966.26 9.9% 1,150.92 15.4% 2001 4.2 585,406 545,739 545,739 0 93.2% 6,265 86.1% 1,121.29 16.0% 1,045.31 -9.2% 2002 5.0 527,982 483,216 483,216 0 91.5% 5,260 84.0% 1,204.52 7.4% 1,102.39 5.5% 2003 6.0 472,996 480,492 480,492 0 101.6% 4,617 87.8% 1,229.36 2.1% 1,248.84 13.3% 2004 6.9 468,931 447,942 447,942 0 95.5% 4,073 88.2% 1,381.58 12.4% 1,319.74 5.7% 2005 7.8 473,649 342,765 342,765 0 72.4% 3,474 85.3% 1,636.09 18.4% 1,183.99 -10.3% 2006 8.8 428,070 319,162 319,162 0 74.6% 2,750 79.2% 1,867.94 14.2% 1,392.71 17.6% 2007 9.8 349,610 293,514 293,514 0 84.0% 1,993 72.5% 2,105.03 12.7% 1,767.27 26.9% 2008 10.8 284,499 200,315 200,315 0 70.4% 1,455 73.0% 2,346.38 11.5% 1,652.08 -6.5% 2009 11.9 227,350 166,824 166,824 0 73.4% 1,073 73.7% 2,542.59 8.4% 1,865.69 12.9% 2010 12.9 191,004 119,561 119,561 0 62.6% 832 77.5% 2,754.86 8.3% 1,724.43 -7.6% 2011 13.8 146,786 107,440 107,440 0 73.2% 609 73.2% 2,892.34 5.0% 2,117.04 22.8% 2012 14.8 119,760 48,822 48,822 0 40.8% 479 78.7% 3,000.25 3.7% 1,223.10 -42.2% 2013 16.1 92,418 41,983 41,983 0 45.4% 357 74.5% 3,106.50 3.5% 1,411.18 15.4% 2014 17.1 71,783 34,153 34,153 0 47.6% 272 76.2% 3,166.89 1.9% 1,506.74 6.8% 2015 18.1 55,852 22,873 22,873 0 41.0% 212 77.9% 3,161.44 -0.2% 1,294.72 -14.1% 2016 19.2 52,446 49,857 49,611 245 95.1% 194 91.5% 3,244.11 2.6% 3,083.91 138.2% 2017 20.2 40,915 18,142 16,043 2,099 44.3% 142 73.2% 3,457.64 6.6% 1,533.12 -50.3% Total 6.1 7,205,946 6,433,024 6,430,680 2,344 89.3%\n\n**Exhibit IV**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Average Annual Claim Issue Experience Earned Incurred Paid Claim Exposed Annual Premium Claim Cost Year Period Dur Premium Claims Claims IBNR Ratio Policies Persistency Premium Trend Cost Trend**\n\n**WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan A,B, C, & D Texas Experience**\n\n2001 2001 0.5 0 0 0 0 0.0% 0 - - 2002 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2003 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\n2002 2002 0.5 0 0 0 0 0.0% 0 - - 2003 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\nTotal 1994 0.5 804 0 0 0 0.0% 26 368.92 - 1995 5.0 70,025 47,536 47,536 0 67.9% 2,735 10462.3% 307.26 -16.7% 208.58 0.0% 1996 1.0 498,547 389,298 389,298 0 78.1% 14,087 515.1% 424.69 38.2% 331.62 59.0% 1997 1.7 466,795 482,057 482,057 0 103.3% 6,395 45.4% 875.93 106.3% 904.56 172.8% 1998 2.3 464,236 492,271 492,271 0 106.0% 6,327 98.9% 880.49 0.5% 933.66 3.2% 1999 2.6 530,092 601,087 601,087 0 113.4% 7,235 114.4% 879.21 -0.1% 996.96 6.8% 2000 3.2 585,987 697,977 697,977 0 119.1% 7,277 100.6% 966.26 9.9% 1,150.92 15.4% 2001 4.2 585,406 545,739 545,739 0 93.2% 6,265 86.1% 1,121.29 16.0% 1,045.31 -9.2% 2002 5.0 527,982 483,216 483,216 0 91.5% 5,260 84.0% 1,204.52 7.4% 1,102.39 5.5% 2003 6.0 472,996 480,492 480,492 0 101.6% 4,617 87.8% 1,229.36 2.1% 1,248.84 13.3% 2004 6.9 468,931 447,942 447,942 0 95.5% 4,073 88.2% 1,381.58 12.4% 1,319.74 5.7% 2005 7.8 473,649 342,765 342,765 0 72.4% 3,474 85.3% 1,636.09 18.4% 1,183.99 -10.3% 2006 8.8 428,070 319,162 319,162 0 74.6% 2,750 79.2% 1,867.94 14.2% 1,392.71 17.6% 2007 9.8 349,610 293,514 293,514 0 84.0% 1,993 72.5% 2,105.03 12.7% 1,767.27 26.9% 2008 10.8 284,499 200,315 200,315 0 70.4% 1,455 73.0% 2,346.38 11.5% 1,652.08 -6.5% 2009 11.9 227,350 166,824 166,824 0 73.4% 1,073 73.7% 2,542.59 8.4% 1,865.69 12.9% 2010 12.9 191,004 119,561 119,561 0 62.6% 832 77.5% 2,754.86 8.3% 1,724.43 -7.6% 2011 13.8 146,786 107,440 107,440 0 73.2% 609 73.2% 2,892.34 5.0% 2,117.04 22.8% 2012 14.8 119,760 48,822 48,822 0 40.8% 479 78.7% 3,000.25 3.7% 1,223.10 -42.2% 2013 16.1 92,418 41,983 41,983 0 45.4% 357 74.5% 3,106.50 3.5% 1,411.18 15.4% 2014 17.1 71,783 34,153 34,153 0 47.6% 272 76.2% 3,166.89 1.9% 1,506.74 6.8% 2015 18.1 55,852 22,873 22,873 0 41.0% 212 77.9% 3,161.44 -0.2% 1,294.72 -14.1% 2016 19.2 52,446 49,857 49,611 245 95.1% 194 91.5% 3,244.11 2.6% 3,083.91 138.2% 2017 20.2 40,915 18,142 16,043 2,099 44.3% 142 73.2% 3,457.64 6.6% 1,533.12 -50.3% Total 6.1 7,205,946 6,433,024 6,430,680 2,344 89.3%\n\n**Exhibit IV**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page563.pdf"]},"response":{"errors":[],"extract_id":"extract_dd66e42e82b9dc51a5a8ca3003c4869f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Average Annual Claim Issue Experience Earned Incurred Paid Claim Exposed Annual Premium Claim Cost Year Period Dur Premium Claims Claims IBNR Ratio Policies Persistency Premium Trend Cost Trend**\n\n**WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan A,B, C, & D Texas Experience**\n\n2001 2001 0.5 0 0 0 0 0.0% 0 - - 2002 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2003 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\n2002 2002 0.5 0 0 0 0 0.0% 0 - - 2003 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\nTotal 1994 0.5 804 0 0 0 0.0% 26 368.92 - 1995 5.0 70,025 47,536 47,536 0 67.9% 2,735 10462.3% 307.26 -16.7% 208.58 0.0% 1996 1.0 498,547 389,298 389,298 0 78.1% 14,087 515.1% 424.69 38.2% 331.62 59.0% 1997 1.7 466,795 482,057 482,057 0 103.3% 6,395 45.4% 875.93 106.3% 904.56 172.8% 1998 2.3 464,236 492,271 492,271 0 106.0% 6,327 98.9% 880.49 0.5% 933.66 3.2% 1999 2.6 530,092 601,087 601,087 0 113.4% 7,235 114.4% 879.21 -0.1% 996.96 6.8% 2000 3.2 585,987 697,977 697,977 0 119.1% 7,277 100.6% 966.26 9.9% 1,150.92 15.4% 2001 4.2 585,406 545,739 545,739 0 93.2% 6,265 86.1% 1,121.29 16.0% 1,045.31 -9.2% 2002 5.0 527,982 483,216 483,216 0 91.5% 5,260 84.0% 1,204.52 7.4% 1,102.39 5.5% 2003 6.0 472,996 480,492 480,492 0 101.6% 4,617 87.8% 1,229.36 2.1% 1,248.84 13.3% 2004 6.9 468,931 447,942 447,942 0 95.5% 4,073 88.2% 1,381.58 12.4% 1,319.74 5.7% 2005 7.8 473,649 342,765 342,765 0 72.4% 3,474 85.3% 1,636.09 18.4% 1,183.99 -10.3% 2006 8.8 428,070 319,162 319,162 0 74.6% 2,750 79.2% 1,867.94 14.2% 1,392.71 17.6% 2007 9.8 349,610 293,514 293,514 0 84.0% 1,993 72.5% 2,105.03 12.7% 1,767.27 26.9% 2008 10.8 284,499 200,315 200,315 0 70.4% 1,455 73.0% 2,346.38 11.5% 1,652.08 -6.5% 2009 11.9 227,350 166,824 166,824 0 73.4% 1,073 73.7% 2,542.59 8.4% 1,865.69 12.9% 2010 12.9 191,004 119,561 119,561 0 62.6% 832 77.5% 2,754.86 8.3% 1,724.43 -7.6% 2011 13.8 146,786 107,440 107,440 0 73.2% 609 73.2% 2,892.34 5.0% 2,117.04 22.8% 2012 14.8 119,760 48,822 48,822 0 40.8% 479 78.7% 3,000.25 3.7% 1,223.10 -42.2% 2013 16.1 92,418 41,983 41,983 0 45.4% 357 74.5% 3,106.50 3.5% 1,411.18 15.4% 2014 17.1 71,783 34,153 34,153 0 47.6% 272 76.2% 3,166.89 1.9% 1,506.74 6.8% 2015 18.1 55,852 22,873 22,873 0 41.0% 212 77.9% 3,161.44 -0.2% 1,294.72 -14.1% 2016 19.2 52,446 49,857 49,611 245 95.1% 194 91.5% 3,244.11 2.6% 3,083.91 138.2% 2017 20.2 40,915 18,142 16,043 2,099 44.3% 142 73.2% 3,457.64 6.6% 1,533.12 -50.3% Total 6.1 7,205,946 6,433,024 6,430,680 2,344 89.3%\n\n**Exhibit IV**"],"full_content":"**Average Annual Claim Issue Experience Earned Incurred Paid Claim Exposed Annual Premium Claim Cost Year Period Dur Premium Claims Claims IBNR Ratio Policies Persistency Premium Trend Cost Trend**\n\n**WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan A,B, C, & D Texas Experience**\n\n2001 2001 0.5 0 0 0 0 0.0% 0 - - 2002 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2003 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\n2002 2002 0.5 0 0 0 0 0.0% 0 - - 2003 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\nTotal 1994 0.5 804 0 0 0 0.0% 26 368.92 - 1995 5.0 70,025 47,536 47,536 0 67.9% 2,735 10462.3% 307.26 -16.7% 208.58 0.0% 1996 1.0 498,547 389,298 389,298 0 78.1% 14,087 515.1% 424.69 38.2% 331.62 59.0% 1997 1.7 466,795 482,057 482,057 0 103.3% 6,395 45.4% 875.93 106.3% 904.56 172.8% 1998 2.3 464,236 492,271 492,271 0 106.0% 6,327 98.9% 880.49 0.5% 933.66 3.2% 1999 2.6 530,092 601,087 601,087 0 113.4% 7,235 114.4% 879.21 -0.1% 996.96 6.8% 2000 3.2 585,987 697,977 697,977 0 119.1% 7,277 100.6% 966.26 9.9% 1,150.92 15.4% 2001 4.2 585,406 545,739 545,739 0 93.2% 6,265 86.1% 1,121.29 16.0% 1,045.31 -9.2% 2002 5.0 527,982 483,216 483,216 0 91.5% 5,260 84.0% 1,204.52 7.4% 1,102.39 5.5% 2003 6.0 472,996 480,492 480,492 0 101.6% 4,617 87.8% 1,229.36 2.1% 1,248.84 13.3% 2004 6.9 468,931 447,942 447,942 0 95.5% 4,073 88.2% 1,381.58 12.4% 1,319.74 5.7% 2005 7.8 473,649 342,765 342,765 0 72.4% 3,474 85.3% 1,636.09 18.4% 1,183.99 -10.3% 2006 8.8 428,070 319,162 319,162 0 74.6% 2,750 79.2% 1,867.94 14.2% 1,392.71 17.6% 2007 9.8 349,610 293,514 293,514 0 84.0% 1,993 72.5% 2,105.03 12.7% 1,767.27 26.9% 2008 10.8 284,499 200,315 200,315 0 70.4% 1,455 73.0% 2,346.38 11.5% 1,652.08 -6.5% 2009 11.9 227,350 166,824 166,824 0 73.4% 1,073 73.7% 2,542.59 8.4% 1,865.69 12.9% 2010 12.9 191,004 119,561 119,561 0 62.6% 832 77.5% 2,754.86 8.3% 1,724.43 -7.6% 2011 13.8 146,786 107,440 107,440 0 73.2% 609 73.2% 2,892.34 5.0% 2,117.04 22.8% 2012 14.8 119,760 48,822 48,822 0 40.8% 479 78.7% 3,000.25 3.7% 1,223.10 -42.2% 2013 16.1 92,418 41,983 41,983 0 45.4% 357 74.5% 3,106.50 3.5% 1,411.18 15.4% 2014 17.1 71,783 34,153 34,153 0 47.6% 272 76.2% 3,166.89 1.9% 1,506.74 6.8% 2015 18.1 55,852 22,873 22,873 0 41.0% 212 77.9% 3,161.44 -0.2% 1,294.72 -14.1% 2016 19.2 52,446 49,857 49,611 245 95.1% 194 91.5% 3,244.11 2.6% 3,083.91 138.2% 2017 20.2 40,915 18,142 16,043 2,099 44.3% 142 73.2% 3,457.64 6.6% 1,533.12 -50.3% Total 6.1 7,205,946 6,433,024 6,430,680 2,344 89.3%\n\n**Exhibit IV**","publish_date":null,"title":"WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan A,B, C, & D Texas Experience","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page563.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page563.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page563","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page563.pdf"},"started_at":"2026-11-04T19:47:20.891636"} +{"completed_at":"2026-11-04T19:47:24.377738","latency_in_ms":2332,"output":{"example_id":"table/SERFF_TX_random_pages 1_page568","grounded_pages":[],"layout_pages":[],"markdown":"**Average Annual Claim Issue Experience Earned Incurred Paid Claim Exposed Annual Premium Claim Cost Year Period Dur Premium Claims Claims IBNR Ratio Policies Persistency Premium Trend Cost Trend**\n\n**WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan C Texas Experience**\n\n1997 1997 0.5 11,219 4,894 4,894 0 43.6% 126 1,068.49 466.11 1998 1.5 12,779 6,081 6,081 0 47.6% 123 97.6% 1,246.75 16.7% 593.24 27.3% 1999 2.5 12,924 19,995 19,995 0 154.7% 108 87.8% 1,435.95 15.2% 2,221.71 274.5% 2000 3.5 11,751 17,918 17,918 0 152.5% 91 84.3% 1,549.57 7.9% 2,362.77 6.3% 2001 4.5 10,405 7,957 7,957 0 76.5% 73 80.2% 1,710.38 10.4% 1,308.06 -44.6% 2002 5.5 7,596 4,359 4,359 0 57.4% 42 57.5% 2,170.18 26.9% 1,245.30 -4.8% 2003 6.5 6,595 3,301 3,301 0 50.0% 36 85.7% 2,198.48 1.3% 1,100.24 -11.6% 2004 7.5 6,321 3,834 3,834 0 60.7% 34 94.4% 2,231.07 1.5% 1,353.23 23.0% 2005 8.5 4,815 2,628 2,628 0 54.6% 24 70.6% 2,407.67 7.9% 1,314.18 -2.9% 2006 9.5 2,284 1,930 1,930 0 84.5% 12 50.0% 2,284.36 -5.1% 1,929.95 46.9% 2007 10.5 2,570 1,429 1,429 0 55.6% 12 100.0% 2,570.35 12.5% 1,429.37 -25.9% 2008 11.5 2,737 276 276 0 10.1% 12 100.0% 2,736.59 6.5% 276.23 -80.7% 2009 12.5 3,070 744 744 0 24.2% 12 100.0% 3,069.80 12.2% 743.51 169.2% 2010 13.5 3,327 1,061 1,061 0 31.9% 12 100.0% 3,326.92 8.4% 1,061.01 42.7% 2011 14.5 572 298 298 0 52.1% 2 16.7% 3,430.20 3.1% 1,785.84 68.3% 2012 15.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2013 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 19.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 20.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 98,965 76,705 76,705 0 77.5%\n\n1998 1998 0.5 3,872 3,049 3,049 0 78.7% 48 968.07 762.26 1999 1.5 4,954 3,967 3,967 0 80.1% 56 116.7% 1,061.54 9.7% 849.97 11.5% 2000 2.5 5,273 3,251 3,251 0 61.7% 48 85.7% 1,318.26 24.2% 812.75 -4.4% 2001 3.5 5,004 951 951 0 19.0% 37 77.1% 1,622.87 23.1% 308.43 -62.1% 2002 4.5 5,204 1,045 1,045 0 20.1% 36 97.3% 1,734.61 6.9% 348.47 13.0% 2003 5.5 5,403 4,202 4,202 0 77.8% 36 100.0% 1,801.02 3.8% 1,400.74 302.0% 2004 6.5 4,521 1,523 1,523 0 33.7% 30 83.3% 1,808.49 0.4% 609.26 -56.5% 2005 7.5 3,912 1,119 1,119 0 28.6% 24 80.0% 1,956.16 8.2% 559.42 -8.2% 2006 8.5 4,179 1,035 1,035 0 24.8% 24 100.0% 2,089.54 6.8% 517.41 -7.5% 2007 9.5 2,411 567 567 0 23.5% 12 50.0% 2,411.09 15.4% 566.54 9.5% 2008 10.5 2,278 502 502 0 22.1% 10 83.3% 2,733.09 13.4% 602.82 6.4% 2009 11.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2010 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 19.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 47,011 21,211 21,211 0 45.1%\n\n1999 1999 0.5 4,653 2,095 2,095 0 45.0% 45 1,240.68 558.75 2000 1.5 8,607 3,554 3,554 0 41.3% 75 167.7% 1,368.57 10.3% 565.16 1.1% 2001 2.5 8,225 2,074 2,074 0 25.2% 58 76.9% 1,701.76 24.3% 429.17 -24.1% 2002 3.5 6,345 2,804 2,804 0 44.2% 43 74.1% 1,770.76 4.1% 782.58 82.3% 2003 4.5 3,814 3,897 3,897 0 102.2% 25 58.1% 1,830.55 3.4% 1,870.79 139.1% 2004 5.5 3,935 5,668 5,668 0 144.0% 24 96.0% 1,967.31 7.5% 2,833.86 51.5% 2005 6.5 4,485 592 592 0 13.2% 24 100.0% 2,242.31 14.0% 296.14 -89.5% 2006 7.5 4,904 276 276 0 5.6% 24 100.0% 2,451.85 9.3% 138.11 -53.4% 2007 8.5 5,373 1,003 1,003 0 18.7% 24 100.0% 2,686.46 9.6% 501.49 263.1% 2008 9.5 6,086 494 494 0 8.1% 24 100.0% 3,043.17 13.3% 247.23 -50.7% 2009 10.5 6,597 661 661 0 10.0% 24 100.0% 3,298.31 8.4% 330.38 33.6% 2010 11.5 6,757 6,159 6,159 0 91.1% 24 100.0% 3,378.61 2.4% 3,079.49 832.1% 2011 12.5 7,028 18,422 18,422 0 262.1% 24 100.0% 3,513.84 4.0% 9,211.07 199.1% 2012 13.5 4,900 3,093 3,093 0 63.1% 16 66.7% 3,675.24 4.6% 2,319.97 -74.8% 2013 14.5 328 160 160 0 48.9% 1 6.3% 3,940.98 7.2% 1,925.52 -17.0% 2014 15.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2015 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 82,036 50,955 50,955 0 62.1%\n\n2000 2000 0.5 0 0 0 0 0.0% 0 - - 2001 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2002 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2003 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\n**Exhibit IV**","pages":[{"line_numbers":[],"markdown":"**Average Annual Claim Issue Experience Earned Incurred Paid Claim Exposed Annual Premium Claim Cost Year Period Dur Premium Claims Claims IBNR Ratio Policies Persistency Premium Trend Cost Trend**\n\n**WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan C Texas Experience**\n\n1997 1997 0.5 11,219 4,894 4,894 0 43.6% 126 1,068.49 466.11 1998 1.5 12,779 6,081 6,081 0 47.6% 123 97.6% 1,246.75 16.7% 593.24 27.3% 1999 2.5 12,924 19,995 19,995 0 154.7% 108 87.8% 1,435.95 15.2% 2,221.71 274.5% 2000 3.5 11,751 17,918 17,918 0 152.5% 91 84.3% 1,549.57 7.9% 2,362.77 6.3% 2001 4.5 10,405 7,957 7,957 0 76.5% 73 80.2% 1,710.38 10.4% 1,308.06 -44.6% 2002 5.5 7,596 4,359 4,359 0 57.4% 42 57.5% 2,170.18 26.9% 1,245.30 -4.8% 2003 6.5 6,595 3,301 3,301 0 50.0% 36 85.7% 2,198.48 1.3% 1,100.24 -11.6% 2004 7.5 6,321 3,834 3,834 0 60.7% 34 94.4% 2,231.07 1.5% 1,353.23 23.0% 2005 8.5 4,815 2,628 2,628 0 54.6% 24 70.6% 2,407.67 7.9% 1,314.18 -2.9% 2006 9.5 2,284 1,930 1,930 0 84.5% 12 50.0% 2,284.36 -5.1% 1,929.95 46.9% 2007 10.5 2,570 1,429 1,429 0 55.6% 12 100.0% 2,570.35 12.5% 1,429.37 -25.9% 2008 11.5 2,737 276 276 0 10.1% 12 100.0% 2,736.59 6.5% 276.23 -80.7% 2009 12.5 3,070 744 744 0 24.2% 12 100.0% 3,069.80 12.2% 743.51 169.2% 2010 13.5 3,327 1,061 1,061 0 31.9% 12 100.0% 3,326.92 8.4% 1,061.01 42.7% 2011 14.5 572 298 298 0 52.1% 2 16.7% 3,430.20 3.1% 1,785.84 68.3% 2012 15.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2013 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 19.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 20.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 98,965 76,705 76,705 0 77.5%\n\n1998 1998 0.5 3,872 3,049 3,049 0 78.7% 48 968.07 762.26 1999 1.5 4,954 3,967 3,967 0 80.1% 56 116.7% 1,061.54 9.7% 849.97 11.5% 2000 2.5 5,273 3,251 3,251 0 61.7% 48 85.7% 1,318.26 24.2% 812.75 -4.4% 2001 3.5 5,004 951 951 0 19.0% 37 77.1% 1,622.87 23.1% 308.43 -62.1% 2002 4.5 5,204 1,045 1,045 0 20.1% 36 97.3% 1,734.61 6.9% 348.47 13.0% 2003 5.5 5,403 4,202 4,202 0 77.8% 36 100.0% 1,801.02 3.8% 1,400.74 302.0% 2004 6.5 4,521 1,523 1,523 0 33.7% 30 83.3% 1,808.49 0.4% 609.26 -56.5% 2005 7.5 3,912 1,119 1,119 0 28.6% 24 80.0% 1,956.16 8.2% 559.42 -8.2% 2006 8.5 4,179 1,035 1,035 0 24.8% 24 100.0% 2,089.54 6.8% 517.41 -7.5% 2007 9.5 2,411 567 567 0 23.5% 12 50.0% 2,411.09 15.4% 566.54 9.5% 2008 10.5 2,278 502 502 0 22.1% 10 83.3% 2,733.09 13.4% 602.82 6.4% 2009 11.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2010 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 19.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 47,011 21,211 21,211 0 45.1%\n\n1999 1999 0.5 4,653 2,095 2,095 0 45.0% 45 1,240.68 558.75 2000 1.5 8,607 3,554 3,554 0 41.3% 75 167.7% 1,368.57 10.3% 565.16 1.1% 2001 2.5 8,225 2,074 2,074 0 25.2% 58 76.9% 1,701.76 24.3% 429.17 -24.1% 2002 3.5 6,345 2,804 2,804 0 44.2% 43 74.1% 1,770.76 4.1% 782.58 82.3% 2003 4.5 3,814 3,897 3,897 0 102.2% 25 58.1% 1,830.55 3.4% 1,870.79 139.1% 2004 5.5 3,935 5,668 5,668 0 144.0% 24 96.0% 1,967.31 7.5% 2,833.86 51.5% 2005 6.5 4,485 592 592 0 13.2% 24 100.0% 2,242.31 14.0% 296.14 -89.5% 2006 7.5 4,904 276 276 0 5.6% 24 100.0% 2,451.85 9.3% 138.11 -53.4% 2007 8.5 5,373 1,003 1,003 0 18.7% 24 100.0% 2,686.46 9.6% 501.49 263.1% 2008 9.5 6,086 494 494 0 8.1% 24 100.0% 3,043.17 13.3% 247.23 -50.7% 2009 10.5 6,597 661 661 0 10.0% 24 100.0% 3,298.31 8.4% 330.38 33.6% 2010 11.5 6,757 6,159 6,159 0 91.1% 24 100.0% 3,378.61 2.4% 3,079.49 832.1% 2011 12.5 7,028 18,422 18,422 0 262.1% 24 100.0% 3,513.84 4.0% 9,211.07 199.1% 2012 13.5 4,900 3,093 3,093 0 63.1% 16 66.7% 3,675.24 4.6% 2,319.97 -74.8% 2013 14.5 328 160 160 0 48.9% 1 6.3% 3,940.98 7.2% 1,925.52 -17.0% 2014 15.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2015 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 82,036 50,955 50,955 0 62.1%\n\n2000 2000 0.5 0 0 0 0 0.0% 0 - - 2001 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2002 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2003 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\n**Exhibit IV**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Average Annual Claim Issue Experience Earned Incurred Paid Claim Exposed Annual Premium Claim Cost Year Period Dur Premium Claims Claims IBNR Ratio Policies Persistency Premium Trend Cost Trend**\n\n**WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan C Texas Experience**\n\n1997 1997 0.5 11,219 4,894 4,894 0 43.6% 126 1,068.49 466.11 1998 1.5 12,779 6,081 6,081 0 47.6% 123 97.6% 1,246.75 16.7% 593.24 27.3% 1999 2.5 12,924 19,995 19,995 0 154.7% 108 87.8% 1,435.95 15.2% 2,221.71 274.5% 2000 3.5 11,751 17,918 17,918 0 152.5% 91 84.3% 1,549.57 7.9% 2,362.77 6.3% 2001 4.5 10,405 7,957 7,957 0 76.5% 73 80.2% 1,710.38 10.4% 1,308.06 -44.6% 2002 5.5 7,596 4,359 4,359 0 57.4% 42 57.5% 2,170.18 26.9% 1,245.30 -4.8% 2003 6.5 6,595 3,301 3,301 0 50.0% 36 85.7% 2,198.48 1.3% 1,100.24 -11.6% 2004 7.5 6,321 3,834 3,834 0 60.7% 34 94.4% 2,231.07 1.5% 1,353.23 23.0% 2005 8.5 4,815 2,628 2,628 0 54.6% 24 70.6% 2,407.67 7.9% 1,314.18 -2.9% 2006 9.5 2,284 1,930 1,930 0 84.5% 12 50.0% 2,284.36 -5.1% 1,929.95 46.9% 2007 10.5 2,570 1,429 1,429 0 55.6% 12 100.0% 2,570.35 12.5% 1,429.37 -25.9% 2008 11.5 2,737 276 276 0 10.1% 12 100.0% 2,736.59 6.5% 276.23 -80.7% 2009 12.5 3,070 744 744 0 24.2% 12 100.0% 3,069.80 12.2% 743.51 169.2% 2010 13.5 3,327 1,061 1,061 0 31.9% 12 100.0% 3,326.92 8.4% 1,061.01 42.7% 2011 14.5 572 298 298 0 52.1% 2 16.7% 3,430.20 3.1% 1,785.84 68.3% 2012 15.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2013 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 19.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 20.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 98,965 76,705 76,705 0 77.5%\n\n1998 1998 0.5 3,872 3,049 3,049 0 78.7% 48 968.07 762.26 1999 1.5 4,954 3,967 3,967 0 80.1% 56 116.7% 1,061.54 9.7% 849.97 11.5% 2000 2.5 5,273 3,251 3,251 0 61.7% 48 85.7% 1,318.26 24.2% 812.75 -4.4% 2001 3.5 5,004 951 951 0 19.0% 37 77.1% 1,622.87 23.1% 308.43 -62.1% 2002 4.5 5,204 1,045 1,045 0 20.1% 36 97.3% 1,734.61 6.9% 348.47 13.0% 2003 5.5 5,403 4,202 4,202 0 77.8% 36 100.0% 1,801.02 3.8% 1,400.74 302.0% 2004 6.5 4,521 1,523 1,523 0 33.7% 30 83.3% 1,808.49 0.4% 609.26 -56.5% 2005 7.5 3,912 1,119 1,119 0 28.6% 24 80.0% 1,956.16 8.2% 559.42 -8.2% 2006 8.5 4,179 1,035 1,035 0 24.8% 24 100.0% 2,089.54 6.8% 517.41 -7.5% 2007 9.5 2,411 567 567 0 23.5% 12 50.0% 2,411.09 15.4% 566.54 9.5% 2008 10.5 2,278 502 502 0 22.1% 10 83.3% 2,733.09 13.4% 602.82 6.4% 2009 11.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2010 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 19.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 47,011 21,211 21,211 0 45.1%\n\n1999 1999 0.5 4,653 2,095 2,095 0 45.0% 45 1,240.68 558.75 2000 1.5 8,607 3,554 3,554 0 41.3% 75 167.7% 1,368.57 10.3% 565.16 1.1% 2001 2.5 8,225 2,074 2,074 0 25.2% 58 76.9% 1,701.76 24.3% 429.17 -24.1% 2002 3.5 6,345 2,804 2,804 0 44.2% 43 74.1% 1,770.76 4.1% 782.58 82.3% 2003 4.5 3,814 3,897 3,897 0 102.2% 25 58.1% 1,830.55 3.4% 1,870.79 139.1% 2004 5.5 3,935 5,668 5,668 0 144.0% 24 96.0% 1,967.31 7.5% 2,833.86 51.5% 2005 6.5 4,485 592 592 0 13.2% 24 100.0% 2,242.31 14.0% 296.14 -89.5% 2006 7.5 4,904 276 276 0 5.6% 24 100.0% 2,451.85 9.3% 138.11 -53.4% 2007 8.5 5,373 1,003 1,003 0 18.7% 24 100.0% 2,686.46 9.6% 501.49 263.1% 2008 9.5 6,086 494 494 0 8.1% 24 100.0% 3,043.17 13.3% 247.23 -50.7% 2009 10.5 6,597 661 661 0 10.0% 24 100.0% 3,298.31 8.4% 330.38 33.6% 2010 11.5 6,757 6,159 6,159 0 91.1% 24 100.0% 3,378.61 2.4% 3,079.49 832.1% 2011 12.5 7,028 18,422 18,422 0 262.1% 24 100.0% 3,513.84 4.0% 9,211.07 199.1% 2012 13.5 4,900 3,093 3,093 0 63.1% 16 66.7% 3,675.24 4.6% 2,319.97 -74.8% 2013 14.5 328 160 160 0 48.9% 1 6.3% 3,940.98 7.2% 1,925.52 -17.0% 2014 15.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2015 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 82,036 50,955 50,955 0 62.1%\n\n2000 2000 0.5 0 0 0 0 0.0% 0 - - 2001 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2002 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2003 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\n**Exhibit IV**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page568.pdf"]},"response":{"errors":[],"extract_id":"extract_cc791224a58478ef56780ddc7db5102d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Average Annual Claim Issue Experience Earned Incurred Paid Claim Exposed Annual Premium Claim Cost Year Period Dur Premium Claims Claims IBNR Ratio Policies Persistency Premium Trend Cost Trend**\n\n**WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan C Texas Experience**\n\n1997 1997 0.5 11,219 4,894 4,894 0 43.6% 126 1,068.49 466.11 1998 1.5 12,779 6,081 6,081 0 47.6% 123 97.6% 1,246.75 16.7% 593.24 27.3% 1999 2.5 12,924 19,995 19,995 0 154.7% 108 87.8% 1,435.95 15.2% 2,221.71 274.5% 2000 3.5 11,751 17,918 17,918 0 152.5% 91 84.3% 1,549.57 7.9% 2,362.77 6.3% 2001 4.5 10,405 7,957 7,957 0 76.5% 73 80.2% 1,710.38 10.4% 1,308.06 -44.6% 2002 5.5 7,596 4,359 4,359 0 57.4% 42 57.5% 2,170.18 26.9% 1,245.30 -4.8% 2003 6.5 6,595 3,301 3,301 0 50.0% 36 85.7% 2,198.48 1.3% 1,100.24 -11.6% 2004 7.5 6,321 3,834 3,834 0 60.7% 34 94.4% 2,231.07 1.5% 1,353.23 23.0% 2005 8.5 4,815 2,628 2,628 0 54.6% 24 70.6% 2,407.67 7.9% 1,314.18 -2.9% 2006 9.5 2,284 1,930 1,930 0 84.5% 12 50.0% 2,284.36 -5.1% 1,929.95 46.9% 2007 10.5 2,570 1,429 1,429 0 55.6% 12 100.0% 2,570.35 12.5% 1,429.37 -25.9% 2008 11.5 2,737 276 276 0 10.1% 12 100.0% 2,736.59 6.5% 276.23 -80.7% 2009 12.5 3,070 744 744 0 24.2% 12 100.0% 3,069.80 12.2% 743.51 169.2% 2010 13.5 3,327 1,061 1,061 0 31.9% 12 100.0% 3,326.92 8.4% 1,061.01 42.7% 2011 14.5 572 298 298 0 52.1% 2 16.7% 3,430.20 3.1% 1,785.84 68.3% 2012 15.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2013 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 19.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 20.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 98,965 76,705 76,705 0 77.5%\n\n1998 1998 0.5 3,872 3,049 3,049 0 78.7% 48 968.07 762.26 1999 1.5 4,954 3,967 3,967 0 80.1% 56 116.7% 1,061.54 9.7% 849.97 11.5% 2000 2.5 5,273 3,251 3,251 0 61.7% 48 85.7% 1,318.26 24.2% 812.75 -4.4% 2001 3.5 5,004 951 951 0 19.0% 37 77.1% 1,622.87 23.1% 308.43 -62.1% 2002 4.5 5,204 1,045 1,045 0 20.1% 36 97.3% 1,734.61 6.9% 348.47 13.0% 2003 5.5 5,403 4,202 4,202 0 77.8% 36 100.0% 1,801.02 3.8% 1,400.74 302.0% 2004 6.5 4,521 1,523 1,523 0 33.7% 30 83.3% 1,808.49 0.4% 609.26 -56.5% 2005 7.5 3,912 1,119 1,119 0 28.6% 24 80.0% 1,956.16 8.2% 559.42 -8.2% 2006 8.5 4,179 1,035 1,035 0 24.8% 24 100.0% 2,089.54 6.8% 517.41 -7.5% 2007 9.5 2,411 567 567 0 23.5% 12 50.0% 2,411.09 15.4% 566.54 9.5% 2008 10.5 2,278 502 502 0 22.1% 10 83.3% 2,733.09 13.4% 602.82 6.4% 2009 11.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2010 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 19.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 47,011 21,211 21,211 0 45.1%\n\n1999 1999 0.5 4,653 2,095 2,095 0 45.0% 45 1,240.68 558.75 2000 1.5 8,607 3,554 3,554 0 41.3% 75 167.7% 1,368.57 10.3% 565.16 1.1% 2001 2.5 8,225 2,074 2,074 0 25.2% 58 76.9% 1,701.76 24.3% 429.17 -24.1% 2002 3.5 6,345 2,804 2,804 0 44.2% 43 74.1% 1,770.76 4.1% 782.58 82.3% 2003 4.5 3,814 3,897 3,897 0 102.2% 25 58.1% 1,830.55 3.4% 1,870.79 139.1% 2004 5.5 3,935 5,668 5,668 0 144.0% 24 96.0% 1,967.31 7.5% 2,833.86 51.5% 2005 6.5 4,485 592 592 0 13.2% 24 100.0% 2,242.31 14.0% 296.14 -89.5% 2006 7.5 4,904 276 276 0 5.6% 24 100.0% 2,451.85 9.3% 138.11 -53.4% 2007 8.5 5,373 1,003 1,003 0 18.7% 24 100.0% 2,686.46 9.6% 501.49 263.1% 2008 9.5 6,086 494 494 0 8.1% 24 100.0% 3,043.17 13.3% 247.23 -50.7% 2009 10.5 6,597 661 661 0 10.0% 24 100.0% 3,298.31 8.4% 330.38 33.6% 2010 11.5 6,757 6,159 6,159 0 91.1% 24 100.0% 3,378.61 2.4% 3,079.49 832.1% 2011 12.5 7,028 18,422 18,422 0 262.1% 24 100.0% 3,513.84 4.0% 9,211.07 199.1% 2012 13.5 4,900 3,093 3,093 0 63.1% 16 66.7% 3,675.24 4.6% 2,319.97 -74.8% 2013 14.5 328 160 160 0 48.9% 1 6.3% 3,940.98 7.2% 1,925.52 -17.0% 2014 15.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2015 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 82,036 50,955 50,955 0 62.1%\n\n2000 2000 0.5 0 0 0 0 0.0% 0 - - 2001 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2002 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2003 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\n**Exhibit IV**"],"full_content":"**Average Annual Claim Issue Experience Earned Incurred Paid Claim Exposed Annual Premium Claim Cost Year Period Dur Premium Claims Claims IBNR Ratio Policies Persistency Premium Trend Cost Trend**\n\n**WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan C Texas Experience**\n\n1997 1997 0.5 11,219 4,894 4,894 0 43.6% 126 1,068.49 466.11 1998 1.5 12,779 6,081 6,081 0 47.6% 123 97.6% 1,246.75 16.7% 593.24 27.3% 1999 2.5 12,924 19,995 19,995 0 154.7% 108 87.8% 1,435.95 15.2% 2,221.71 274.5% 2000 3.5 11,751 17,918 17,918 0 152.5% 91 84.3% 1,549.57 7.9% 2,362.77 6.3% 2001 4.5 10,405 7,957 7,957 0 76.5% 73 80.2% 1,710.38 10.4% 1,308.06 -44.6% 2002 5.5 7,596 4,359 4,359 0 57.4% 42 57.5% 2,170.18 26.9% 1,245.30 -4.8% 2003 6.5 6,595 3,301 3,301 0 50.0% 36 85.7% 2,198.48 1.3% 1,100.24 -11.6% 2004 7.5 6,321 3,834 3,834 0 60.7% 34 94.4% 2,231.07 1.5% 1,353.23 23.0% 2005 8.5 4,815 2,628 2,628 0 54.6% 24 70.6% 2,407.67 7.9% 1,314.18 -2.9% 2006 9.5 2,284 1,930 1,930 0 84.5% 12 50.0% 2,284.36 -5.1% 1,929.95 46.9% 2007 10.5 2,570 1,429 1,429 0 55.6% 12 100.0% 2,570.35 12.5% 1,429.37 -25.9% 2008 11.5 2,737 276 276 0 10.1% 12 100.0% 2,736.59 6.5% 276.23 -80.7% 2009 12.5 3,070 744 744 0 24.2% 12 100.0% 3,069.80 12.2% 743.51 169.2% 2010 13.5 3,327 1,061 1,061 0 31.9% 12 100.0% 3,326.92 8.4% 1,061.01 42.7% 2011 14.5 572 298 298 0 52.1% 2 16.7% 3,430.20 3.1% 1,785.84 68.3% 2012 15.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2013 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 19.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 20.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 98,965 76,705 76,705 0 77.5%\n\n1998 1998 0.5 3,872 3,049 3,049 0 78.7% 48 968.07 762.26 1999 1.5 4,954 3,967 3,967 0 80.1% 56 116.7% 1,061.54 9.7% 849.97 11.5% 2000 2.5 5,273 3,251 3,251 0 61.7% 48 85.7% 1,318.26 24.2% 812.75 -4.4% 2001 3.5 5,004 951 951 0 19.0% 37 77.1% 1,622.87 23.1% 308.43 -62.1% 2002 4.5 5,204 1,045 1,045 0 20.1% 36 97.3% 1,734.61 6.9% 348.47 13.0% 2003 5.5 5,403 4,202 4,202 0 77.8% 36 100.0% 1,801.02 3.8% 1,400.74 302.0% 2004 6.5 4,521 1,523 1,523 0 33.7% 30 83.3% 1,808.49 0.4% 609.26 -56.5% 2005 7.5 3,912 1,119 1,119 0 28.6% 24 80.0% 1,956.16 8.2% 559.42 -8.2% 2006 8.5 4,179 1,035 1,035 0 24.8% 24 100.0% 2,089.54 6.8% 517.41 -7.5% 2007 9.5 2,411 567 567 0 23.5% 12 50.0% 2,411.09 15.4% 566.54 9.5% 2008 10.5 2,278 502 502 0 22.1% 10 83.3% 2,733.09 13.4% 602.82 6.4% 2009 11.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2010 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 19.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 47,011 21,211 21,211 0 45.1%\n\n1999 1999 0.5 4,653 2,095 2,095 0 45.0% 45 1,240.68 558.75 2000 1.5 8,607 3,554 3,554 0 41.3% 75 167.7% 1,368.57 10.3% 565.16 1.1% 2001 2.5 8,225 2,074 2,074 0 25.2% 58 76.9% 1,701.76 24.3% 429.17 -24.1% 2002 3.5 6,345 2,804 2,804 0 44.2% 43 74.1% 1,770.76 4.1% 782.58 82.3% 2003 4.5 3,814 3,897 3,897 0 102.2% 25 58.1% 1,830.55 3.4% 1,870.79 139.1% 2004 5.5 3,935 5,668 5,668 0 144.0% 24 96.0% 1,967.31 7.5% 2,833.86 51.5% 2005 6.5 4,485 592 592 0 13.2% 24 100.0% 2,242.31 14.0% 296.14 -89.5% 2006 7.5 4,904 276 276 0 5.6% 24 100.0% 2,451.85 9.3% 138.11 -53.4% 2007 8.5 5,373 1,003 1,003 0 18.7% 24 100.0% 2,686.46 9.6% 501.49 263.1% 2008 9.5 6,086 494 494 0 8.1% 24 100.0% 3,043.17 13.3% 247.23 -50.7% 2009 10.5 6,597 661 661 0 10.0% 24 100.0% 3,298.31 8.4% 330.38 33.6% 2010 11.5 6,757 6,159 6,159 0 91.1% 24 100.0% 3,378.61 2.4% 3,079.49 832.1% 2011 12.5 7,028 18,422 18,422 0 262.1% 24 100.0% 3,513.84 4.0% 9,211.07 199.1% 2012 13.5 4,900 3,093 3,093 0 63.1% 16 66.7% 3,675.24 4.6% 2,319.97 -74.8% 2013 14.5 328 160 160 0 48.9% 1 6.3% 3,940.98 7.2% 1,925.52 -17.0% 2014 15.5 0 0 0 0 0.0% 0 0.0% - -100.0% - -100.0% 2015 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 18.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 82,036 50,955 50,955 0 62.1%\n\n2000 2000 0.5 0 0 0 0 0.0% 0 - - 2001 1.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2002 2.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2003 3.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2004 4.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2005 5.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2006 6.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2007 7.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2008 8.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2009 9.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2010 10.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2011 11.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2012 12.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2013 13.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2014 14.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2015 15.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2016 16.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% 2017 17.5 0 0 0 0 0.0% 0 0.0% - 0.0% - 0.0% Total 0 0 0 0 0.0%\n\n**Exhibit IV**","publish_date":null,"title":"WASHINGTON NATIONAL INSURANCE COMPANY Medicare Select -- Plan C Texas Experience","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page568.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page568.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page568","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page568.pdf"},"started_at":"2026-11-04T19:47:22.045321"} +{"completed_at":"2026-11-04T19:47:24.149228","latency_in_ms":1033,"output":{"example_id":"table/SERFF_TX_random_pages 1_page580","grounded_pages":[],"layout_pages":[],"markdown":"### **Washington National Insurance Company**\n\n### **State of Texas**\n\nForm CIC-1000 Attained Age - Preferred Risk\n\nGross Premiums -- AREA F\n\nZip Codes (750-753, 774, 793)\n\n**2023 Annual Rates**\n\n### **Female Rates** **Male Rates**\n\n**Attained** **Attained**\n\n**Age** **Plan A** **Plan D** **Plan F** **Plan J** **Age** **Plan A** **Plan D** **Plan F** **Plan J**\n\nUnder 65\\* 6,807.70 n/a n/a n/a Under 65\\* 8,507.30 n/a n/a n/a\n\n65 2,735.00 2,900.30 3,142.70 3,111.80 65 3,010.00 3,364.60 3,612.30 3,360.60\n\n66 2,851.10 2,900.30 3,142.70 3,309.50 66 3,139.50 3,364.60 3,612.30 3,574.10\n\n67 2,975.30 2,989.40 3,289.90 3,403.80 67 3,274.60 3,560.20 3,780.50 3,676.00\n\n68 3,102.10 3,075.50 3,434.60 3,497.70 68 3,412.00 3,755.50 3,948.90 3,777.20\n\n69 3,204.40 3,164.30 3,579.40 3,588.90 69 3,563.30 3,950.90 4,116.70 3,909.10\n\n70 3,306.80 3,250.50 3,726.80 3,684.50 70 3,719.50 4,146.30 4,283.00 4,045.90\n\n71 3,414.70 3,329.20 3,848.00 3,780.80 71 3,884.10 4,270.60 4,423.00 4,187.40\n\n72 3,525.30 3,407.90 3,969.80 3,880.70 72 4,054.00 4,397.60 4,563.40 4,333.50\n\n73 3,638.70 3,486.60 4,091.10 3,982.90 73 4,232.10 4,524.40 4,703.40 4,484.00\n\n74 3,760.00 3,565.10 4,212.80 4,088.70 74 4,418.00 4,651.50 4,841.10 4,640.20\n\n75 3,843.60 3,643.80 4,334.10 4,165.50 75 4,563.70 4,775.60 4,981.30 4,766.60\n\n76 3,927.20 3,826.90 4,464.90 4,244.80 76 4,711.90 4,869.60 5,133.10 4,895.40\n\n77 4,016.20 4,006.80 4,595.70 4,325.00 77 4,868.50 4,961.00 5,282.70 5,028.40\n\n78 4,104.90 4,189.40 4,729.10 4,408.00 78 5,030.40 5,054.60 5,434.60 5,165.30\n\n79 4,196.80 4,369.60 4,859.80 4,490.80 79 5,194.90 5,146.20 5,586.40 5,303.20\n\n80 4,291.20 4,552.60 4,990.90 4,576.90 80 5,362.40 5,240.10 5,735.90 5,446.40\n\n81 4,407.20 4,666.60 5,114.60 4,699.80 81 5,507.90 5,369.50 5,878.70 5,593.70\n\n82 4,526.00 4,783.10 5,243.30 4,827.60 82 5,656.00 5,503.80 6,025.90 5,744.00\n\n83 4,647.70 4,902.60 5,374.00 4,957.20 83 5,809.90 5,641.10 6,177.80 5,899.60\n\n84 4,774.00 5,024.20 5,509.50 5,091.50 84 5,966.20 5,783.00 6,331.80 6,058.40\n\nAnnual Premium Conversion Formulas\n\nSemi-Annual - Annual x .525, Quarterly - Annual x .2625,\n\nMonthly PAC - Annual x .085\n\nAdd $15 Policy Fee (non-commissionable, non-refundable) to first premium payment.\n\n\\* On Medicare due to disability\n\n_Prepared by Actuarial on 12/16/2022_","pages":[{"line_numbers":[],"markdown":"### **Washington National Insurance Company**\n\n### **State of Texas**\n\nForm CIC-1000 Attained Age - Preferred Risk\n\nGross Premiums -- AREA F\n\nZip Codes (750-753, 774, 793)\n\n**2023 Annual Rates**\n\n### **Female Rates** **Male Rates**\n\n**Attained** **Attained**\n\n**Age** **Plan A** **Plan D** **Plan F** **Plan J** **Age** **Plan A** **Plan D** **Plan F** **Plan J**\n\nUnder 65\\* 6,807.70 n/a n/a n/a Under 65\\* 8,507.30 n/a n/a n/a\n\n65 2,735.00 2,900.30 3,142.70 3,111.80 65 3,010.00 3,364.60 3,612.30 3,360.60\n\n66 2,851.10 2,900.30 3,142.70 3,309.50 66 3,139.50 3,364.60 3,612.30 3,574.10\n\n67 2,975.30 2,989.40 3,289.90 3,403.80 67 3,274.60 3,560.20 3,780.50 3,676.00\n\n68 3,102.10 3,075.50 3,434.60 3,497.70 68 3,412.00 3,755.50 3,948.90 3,777.20\n\n69 3,204.40 3,164.30 3,579.40 3,588.90 69 3,563.30 3,950.90 4,116.70 3,909.10\n\n70 3,306.80 3,250.50 3,726.80 3,684.50 70 3,719.50 4,146.30 4,283.00 4,045.90\n\n71 3,414.70 3,329.20 3,848.00 3,780.80 71 3,884.10 4,270.60 4,423.00 4,187.40\n\n72 3,525.30 3,407.90 3,969.80 3,880.70 72 4,054.00 4,397.60 4,563.40 4,333.50\n\n73 3,638.70 3,486.60 4,091.10 3,982.90 73 4,232.10 4,524.40 4,703.40 4,484.00\n\n74 3,760.00 3,565.10 4,212.80 4,088.70 74 4,418.00 4,651.50 4,841.10 4,640.20\n\n75 3,843.60 3,643.80 4,334.10 4,165.50 75 4,563.70 4,775.60 4,981.30 4,766.60\n\n76 3,927.20 3,826.90 4,464.90 4,244.80 76 4,711.90 4,869.60 5,133.10 4,895.40\n\n77 4,016.20 4,006.80 4,595.70 4,325.00 77 4,868.50 4,961.00 5,282.70 5,028.40\n\n78 4,104.90 4,189.40 4,729.10 4,408.00 78 5,030.40 5,054.60 5,434.60 5,165.30\n\n79 4,196.80 4,369.60 4,859.80 4,490.80 79 5,194.90 5,146.20 5,586.40 5,303.20\n\n80 4,291.20 4,552.60 4,990.90 4,576.90 80 5,362.40 5,240.10 5,735.90 5,446.40\n\n81 4,407.20 4,666.60 5,114.60 4,699.80 81 5,507.90 5,369.50 5,878.70 5,593.70\n\n82 4,526.00 4,783.10 5,243.30 4,827.60 82 5,656.00 5,503.80 6,025.90 5,744.00\n\n83 4,647.70 4,902.60 5,374.00 4,957.20 83 5,809.90 5,641.10 6,177.80 5,899.60\n\n84 4,774.00 5,024.20 5,509.50 5,091.50 84 5,966.20 5,783.00 6,331.80 6,058.40\n\nAnnual Premium Conversion Formulas\n\nSemi-Annual - Annual x .525, Quarterly - Annual x .2625,\n\nMonthly PAC - Annual x .085\n\nAdd $15 Policy Fee (non-commissionable, non-refundable) to first premium payment.\n\n\\* On Medicare due to disability\n\n_Prepared by Actuarial on 12/16/2022_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Washington National Insurance Company**\n\n### **State of Texas**\n\nForm CIC-1000 Attained Age - Preferred Risk\n\nGross Premiums -- AREA F\n\nZip Codes (750-753, 774, 793)\n\n**2023 Annual Rates**\n\n### **Female Rates** **Male Rates**\n\n**Attained** **Attained**\n\n**Age** **Plan A** **Plan D** **Plan F** **Plan J** **Age** **Plan A** **Plan D** **Plan F** **Plan J**\n\nUnder 65\\* 6,807.70 n/a n/a n/a Under 65\\* 8,507.30 n/a n/a n/a\n\n65 2,735.00 2,900.30 3,142.70 3,111.80 65 3,010.00 3,364.60 3,612.30 3,360.60\n\n66 2,851.10 2,900.30 3,142.70 3,309.50 66 3,139.50 3,364.60 3,612.30 3,574.10\n\n67 2,975.30 2,989.40 3,289.90 3,403.80 67 3,274.60 3,560.20 3,780.50 3,676.00\n\n68 3,102.10 3,075.50 3,434.60 3,497.70 68 3,412.00 3,755.50 3,948.90 3,777.20\n\n69 3,204.40 3,164.30 3,579.40 3,588.90 69 3,563.30 3,950.90 4,116.70 3,909.10\n\n70 3,306.80 3,250.50 3,726.80 3,684.50 70 3,719.50 4,146.30 4,283.00 4,045.90\n\n71 3,414.70 3,329.20 3,848.00 3,780.80 71 3,884.10 4,270.60 4,423.00 4,187.40\n\n72 3,525.30 3,407.90 3,969.80 3,880.70 72 4,054.00 4,397.60 4,563.40 4,333.50\n\n73 3,638.70 3,486.60 4,091.10 3,982.90 73 4,232.10 4,524.40 4,703.40 4,484.00\n\n74 3,760.00 3,565.10 4,212.80 4,088.70 74 4,418.00 4,651.50 4,841.10 4,640.20\n\n75 3,843.60 3,643.80 4,334.10 4,165.50 75 4,563.70 4,775.60 4,981.30 4,766.60\n\n76 3,927.20 3,826.90 4,464.90 4,244.80 76 4,711.90 4,869.60 5,133.10 4,895.40\n\n77 4,016.20 4,006.80 4,595.70 4,325.00 77 4,868.50 4,961.00 5,282.70 5,028.40\n\n78 4,104.90 4,189.40 4,729.10 4,408.00 78 5,030.40 5,054.60 5,434.60 5,165.30\n\n79 4,196.80 4,369.60 4,859.80 4,490.80 79 5,194.90 5,146.20 5,586.40 5,303.20\n\n80 4,291.20 4,552.60 4,990.90 4,576.90 80 5,362.40 5,240.10 5,735.90 5,446.40\n\n81 4,407.20 4,666.60 5,114.60 4,699.80 81 5,507.90 5,369.50 5,878.70 5,593.70\n\n82 4,526.00 4,783.10 5,243.30 4,827.60 82 5,656.00 5,503.80 6,025.90 5,744.00\n\n83 4,647.70 4,902.60 5,374.00 4,957.20 83 5,809.90 5,641.10 6,177.80 5,899.60\n\n84 4,774.00 5,024.20 5,509.50 5,091.50 84 5,966.20 5,783.00 6,331.80 6,058.40\n\nAnnual Premium Conversion Formulas\n\nSemi-Annual - Annual x .525, Quarterly - Annual x .2625,\n\nMonthly PAC - Annual x .085\n\nAdd $15 Policy Fee (non-commissionable, non-refundable) to first premium payment.\n\n\\* On Medicare due to disability\n\n_Prepared by Actuarial on 12/16/2022_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page580.pdf"]},"response":{"errors":[],"extract_id":"extract_5ca1ae1d48c17f77dc292fc1acd9e6d4","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Washington National Insurance Company**\n\n### **State of Texas**\n\nForm CIC-1000 Attained Age - Preferred Risk\n\nGross Premiums -- AREA F\n\nZip Codes (750-753, 774, 793)\n\n**2023 Annual Rates**\n\n### **Female Rates** **Male Rates**\n\n**Attained** **Attained**\n\n**Age** **Plan A** **Plan D** **Plan F** **Plan J** **Age** **Plan A** **Plan D** **Plan F** **Plan J**\n\nUnder 65\\* 6,807.70 n/a n/a n/a Under 65\\* 8,507.30 n/a n/a n/a\n\n65 2,735.00 2,900.30 3,142.70 3,111.80 65 3,010.00 3,364.60 3,612.30 3,360.60\n\n66 2,851.10 2,900.30 3,142.70 3,309.50 66 3,139.50 3,364.60 3,612.30 3,574.10\n\n67 2,975.30 2,989.40 3,289.90 3,403.80 67 3,274.60 3,560.20 3,780.50 3,676.00\n\n68 3,102.10 3,075.50 3,434.60 3,497.70 68 3,412.00 3,755.50 3,948.90 3,777.20\n\n69 3,204.40 3,164.30 3,579.40 3,588.90 69 3,563.30 3,950.90 4,116.70 3,909.10\n\n70 3,306.80 3,250.50 3,726.80 3,684.50 70 3,719.50 4,146.30 4,283.00 4,045.90\n\n71 3,414.70 3,329.20 3,848.00 3,780.80 71 3,884.10 4,270.60 4,423.00 4,187.40\n\n72 3,525.30 3,407.90 3,969.80 3,880.70 72 4,054.00 4,397.60 4,563.40 4,333.50\n\n73 3,638.70 3,486.60 4,091.10 3,982.90 73 4,232.10 4,524.40 4,703.40 4,484.00\n\n74 3,760.00 3,565.10 4,212.80 4,088.70 74 4,418.00 4,651.50 4,841.10 4,640.20\n\n75 3,843.60 3,643.80 4,334.10 4,165.50 75 4,563.70 4,775.60 4,981.30 4,766.60\n\n76 3,927.20 3,826.90 4,464.90 4,244.80 76 4,711.90 4,869.60 5,133.10 4,895.40\n\n77 4,016.20 4,006.80 4,595.70 4,325.00 77 4,868.50 4,961.00 5,282.70 5,028.40\n\n78 4,104.90 4,189.40 4,729.10 4,408.00 78 5,030.40 5,054.60 5,434.60 5,165.30\n\n79 4,196.80 4,369.60 4,859.80 4,490.80 79 5,194.90 5,146.20 5,586.40 5,303.20\n\n80 4,291.20 4,552.60 4,990.90 4,576.90 80 5,362.40 5,240.10 5,735.90 5,446.40\n\n81 4,407.20 4,666.60 5,114.60 4,699.80 81 5,507.90 5,369.50 5,878.70 5,593.70\n\n82 4,526.00 4,783.10 5,243.30 4,827.60 82 5,656.00 5,503.80 6,025.90 5,744.00\n\n83 4,647.70 4,902.60 5,374.00 4,957.20 83 5,809.90 5,641.10 6,177.80 5,899.60\n\n84 4,774.00 5,024.20 5,509.50 5,091.50 84 5,966.20 5,783.00 6,331.80 6,058.40\n\nAnnual Premium Conversion Formulas\n\nSemi-Annual - Annual x .525, Quarterly - Annual x .2625,\n\nMonthly PAC - Annual x .085\n\nAdd $15 Policy Fee (non-commissionable, non-refundable) to first premium payment.\n\n\\* On Medicare due to disability\n\n_Prepared by Actuarial on 12/16/2022_"],"full_content":"### **Washington National Insurance Company**\n\n### **State of Texas**\n\nForm CIC-1000 Attained Age - Preferred Risk\n\nGross Premiums -- AREA F\n\nZip Codes (750-753, 774, 793)\n\n**2023 Annual Rates**\n\n### **Female Rates** **Male Rates**\n\n**Attained** **Attained**\n\n**Age** **Plan A** **Plan D** **Plan F** **Plan J** **Age** **Plan A** **Plan D** **Plan F** **Plan J**\n\nUnder 65\\* 6,807.70 n/a n/a n/a Under 65\\* 8,507.30 n/a n/a n/a\n\n65 2,735.00 2,900.30 3,142.70 3,111.80 65 3,010.00 3,364.60 3,612.30 3,360.60\n\n66 2,851.10 2,900.30 3,142.70 3,309.50 66 3,139.50 3,364.60 3,612.30 3,574.10\n\n67 2,975.30 2,989.40 3,289.90 3,403.80 67 3,274.60 3,560.20 3,780.50 3,676.00\n\n68 3,102.10 3,075.50 3,434.60 3,497.70 68 3,412.00 3,755.50 3,948.90 3,777.20\n\n69 3,204.40 3,164.30 3,579.40 3,588.90 69 3,563.30 3,950.90 4,116.70 3,909.10\n\n70 3,306.80 3,250.50 3,726.80 3,684.50 70 3,719.50 4,146.30 4,283.00 4,045.90\n\n71 3,414.70 3,329.20 3,848.00 3,780.80 71 3,884.10 4,270.60 4,423.00 4,187.40\n\n72 3,525.30 3,407.90 3,969.80 3,880.70 72 4,054.00 4,397.60 4,563.40 4,333.50\n\n73 3,638.70 3,486.60 4,091.10 3,982.90 73 4,232.10 4,524.40 4,703.40 4,484.00\n\n74 3,760.00 3,565.10 4,212.80 4,088.70 74 4,418.00 4,651.50 4,841.10 4,640.20\n\n75 3,843.60 3,643.80 4,334.10 4,165.50 75 4,563.70 4,775.60 4,981.30 4,766.60\n\n76 3,927.20 3,826.90 4,464.90 4,244.80 76 4,711.90 4,869.60 5,133.10 4,895.40\n\n77 4,016.20 4,006.80 4,595.70 4,325.00 77 4,868.50 4,961.00 5,282.70 5,028.40\n\n78 4,104.90 4,189.40 4,729.10 4,408.00 78 5,030.40 5,054.60 5,434.60 5,165.30\n\n79 4,196.80 4,369.60 4,859.80 4,490.80 79 5,194.90 5,146.20 5,586.40 5,303.20\n\n80 4,291.20 4,552.60 4,990.90 4,576.90 80 5,362.40 5,240.10 5,735.90 5,446.40\n\n81 4,407.20 4,666.60 5,114.60 4,699.80 81 5,507.90 5,369.50 5,878.70 5,593.70\n\n82 4,526.00 4,783.10 5,243.30 4,827.60 82 5,656.00 5,503.80 6,025.90 5,744.00\n\n83 4,647.70 4,902.60 5,374.00 4,957.20 83 5,809.90 5,641.10 6,177.80 5,899.60\n\n84 4,774.00 5,024.20 5,509.50 5,091.50 84 5,966.20 5,783.00 6,331.80 6,058.40\n\nAnnual Premium Conversion Formulas\n\nSemi-Annual - Annual x .525, Quarterly - Annual x .2625,\n\nMonthly PAC - Annual x .085\n\nAdd $15 Policy Fee (non-commissionable, non-refundable) to first premium payment.\n\n\\* On Medicare due to disability\n\n_Prepared by Actuarial on 12/16/2022_","publish_date":null,"title":"Washington National Insurance Company","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page580.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page580.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page580","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page580.pdf"},"started_at":"2026-11-04T19:47:23.115970"} +{"completed_at":"2026-11-04T19:47:26.248724","latency_in_ms":2097,"output":{"example_id":"table/SERFF_TX_random_pages 1_page587","grounded_pages":[],"layout_pages":[],"markdown":"**Washington National Insurance Company**\n\nPolicy Form Series WNIC2096\n\nStandardized Medicare Supplement\n\nAnnual Rates\\* - Preferred Risk - Female\n\nAttained Age Plan A Plan F Plan G Plan HG Plan N\n\n$5,551.48 n/a n/a n/a n/a \\*\\*Under 65\n\n1,423.41 2,289.80 1,522.46 481.96 1,215.81 65\n\n1,495.51 2,379.36 1,599.48 501.05 1,277.33 66\n\n1,576.90 2,472.63 1,686.53 520.14 1,346.93 67\n\n1,661.44 2,569.29 1,776.97 540.65 1,419.15 68\n\n1,749.37 2,669.87 1,871.00 561.92 1,494.21 69\n\n1,840.68 2,774.60 1,968.64 584.07 1,572.21 70\n\n1,935.91 2,883.03 2,070.42 606.87 1,653.59 71\n\n2,034.86 2,996.59 2,176.35 630.76 1,738.02 72\n\n2,138.27 3,114.63 2,286.85 655.52 1,826.38 73\n\n2,246.05 3,238.12 2,402.16 681.49 1,918.46 74\n\n2,358.85 3,367.06 2,522.82 708.76 2,014.78 75\n\n2,476.67 3,501.79 2,648.92 737.23 2,115.47 76\n\n2,600.27 3,643.06 2,781.03 766.90 2,221.07 77\n\n2,729.87 3,791.20 2,919.68 797.78 2,331.69 78\n\n2,839.07 3,899.31 3,036.52 820.57 2,424.96 79\n\n2,952.63 4,016.48 3,157.94 845.45 2,522.05 80\n\n3,071.97 4,148.91 3,285.46 873.37 2,623.94 81\n\n3,196.01 4,285.82 3,418.23 902.07 2,729.98 82\n\n3,325.17 4,427.09 3,556.33 931.96 2,840.16 83\n\n3,459.46 4,573.60 3,700.01 962.94 2,954.92 84\n\n3,599.21 4,724.25 3,849.46 994.79 3,074.37 85\n\n3,744.62 4,880.03 4,004.91 1,027.85 3,198.52 86\n\n3,895.93 5,041.05 4,166.80 1,061.88 3,327.79 87\n\n4,053.35 5,207.52 4,335.13 1,096.90 3,462.19 88\n\n4,217.09 5,379.34 4,510.22 1,133.12 3,602.04 89\n\n4,387.49 5,556.94 4,692.51 1,170.64 3,747.57 90\n\n4,476.07 5,648.57 4,787.31 1,190.06 3,823.28 91\n\n4,566.51 5,741.73 4,884.07 1,209.81 3,900.62 92\n\n4,658.80 5,836.64 4,982.69 1,229.99 3,979.39 93\n\n4,752.83 5,932.86 5,083.27 1,250.06 4,059.78 94\n\n4,848.94 6,030.82 5,186.03 1,271.01 4,141.71 95\n\n4,946.90 6,130.09 5,290.76 1,291.95 4,225.38 96\n\n5,046.83 6,231.22 5,397.66 1,313.23 4,310.80 97\n\n5,148.72 6,334.09 5,506.75 1,335.15 4,397.85 98\n\n5,252.79 6,438.71 5,617.92 1,357.30 4,486.65 99+\n\nTo determine the Bank Draft (P.P.S.P.) or Payroll Deduction (P.R.D.), Semi-Annual, Quarterly or Monthly Direct Bill rates multiply the Annual Rates, as given above, by the appropriate factor shown below and add $1.00:\n\n0\\.08583 for Monthly Bank Draft/Payroll Deduction; 0.515 for Semi-Annual; 0.2625 for Quarterly; 0.09167 for Monthly Direct Bill\n\nZip Codes: Rest of state\n\n\\*\\* Applicable during the initial 6-month open enrollment period for disableds under the age of 65 and also as required during the federally mandated open enrollment period for eligible individuals as defined under the BBA of 1997.\n\n\\*\n\nTX (WNIC2096) 2023","pages":[{"line_numbers":[],"markdown":"**Washington National Insurance Company**\n\nPolicy Form Series WNIC2096\n\nStandardized Medicare Supplement\n\nAnnual Rates\\* - Preferred Risk - Female\n\nAttained Age Plan A Plan F Plan G Plan HG Plan N\n\n$5,551.48 n/a n/a n/a n/a \\*\\*Under 65\n\n1,423.41 2,289.80 1,522.46 481.96 1,215.81 65\n\n1,495.51 2,379.36 1,599.48 501.05 1,277.33 66\n\n1,576.90 2,472.63 1,686.53 520.14 1,346.93 67\n\n1,661.44 2,569.29 1,776.97 540.65 1,419.15 68\n\n1,749.37 2,669.87 1,871.00 561.92 1,494.21 69\n\n1,840.68 2,774.60 1,968.64 584.07 1,572.21 70\n\n1,935.91 2,883.03 2,070.42 606.87 1,653.59 71\n\n2,034.86 2,996.59 2,176.35 630.76 1,738.02 72\n\n2,138.27 3,114.63 2,286.85 655.52 1,826.38 73\n\n2,246.05 3,238.12 2,402.16 681.49 1,918.46 74\n\n2,358.85 3,367.06 2,522.82 708.76 2,014.78 75\n\n2,476.67 3,501.79 2,648.92 737.23 2,115.47 76\n\n2,600.27 3,643.06 2,781.03 766.90 2,221.07 77\n\n2,729.87 3,791.20 2,919.68 797.78 2,331.69 78\n\n2,839.07 3,899.31 3,036.52 820.57 2,424.96 79\n\n2,952.63 4,016.48 3,157.94 845.45 2,522.05 80\n\n3,071.97 4,148.91 3,285.46 873.37 2,623.94 81\n\n3,196.01 4,285.82 3,418.23 902.07 2,729.98 82\n\n3,325.17 4,427.09 3,556.33 931.96 2,840.16 83\n\n3,459.46 4,573.60 3,700.01 962.94 2,954.92 84\n\n3,599.21 4,724.25 3,849.46 994.79 3,074.37 85\n\n3,744.62 4,880.03 4,004.91 1,027.85 3,198.52 86\n\n3,895.93 5,041.05 4,166.80 1,061.88 3,327.79 87\n\n4,053.35 5,207.52 4,335.13 1,096.90 3,462.19 88\n\n4,217.09 5,379.34 4,510.22 1,133.12 3,602.04 89\n\n4,387.49 5,556.94 4,692.51 1,170.64 3,747.57 90\n\n4,476.07 5,648.57 4,787.31 1,190.06 3,823.28 91\n\n4,566.51 5,741.73 4,884.07 1,209.81 3,900.62 92\n\n4,658.80 5,836.64 4,982.69 1,229.99 3,979.39 93\n\n4,752.83 5,932.86 5,083.27 1,250.06 4,059.78 94\n\n4,848.94 6,030.82 5,186.03 1,271.01 4,141.71 95\n\n4,946.90 6,130.09 5,290.76 1,291.95 4,225.38 96\n\n5,046.83 6,231.22 5,397.66 1,313.23 4,310.80 97\n\n5,148.72 6,334.09 5,506.75 1,335.15 4,397.85 98\n\n5,252.79 6,438.71 5,617.92 1,357.30 4,486.65 99+\n\nTo determine the Bank Draft (P.P.S.P.) or Payroll Deduction (P.R.D.), Semi-Annual, Quarterly or Monthly Direct Bill rates multiply the Annual Rates, as given above, by the appropriate factor shown below and add $1.00:\n\n0\\.08583 for Monthly Bank Draft/Payroll Deduction; 0.515 for Semi-Annual; 0.2625 for Quarterly; 0.09167 for Monthly Direct Bill\n\nZip Codes: Rest of state\n\n\\*\\* Applicable during the initial 6-month open enrollment period for disableds under the age of 65 and also as required during the federally mandated open enrollment period for eligible individuals as defined under the BBA of 1997.\n\n\\*\n\nTX (WNIC2096) 2023","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Washington National Insurance Company**\n\nPolicy Form Series WNIC2096\n\nStandardized Medicare Supplement\n\nAnnual Rates\\* - Preferred Risk - Female\n\nAttained Age Plan A Plan F Plan G Plan HG Plan N\n\n$5,551.48 n/a n/a n/a n/a \\*\\*Under 65\n\n1,423.41 2,289.80 1,522.46 481.96 1,215.81 65\n\n1,495.51 2,379.36 1,599.48 501.05 1,277.33 66\n\n1,576.90 2,472.63 1,686.53 520.14 1,346.93 67\n\n1,661.44 2,569.29 1,776.97 540.65 1,419.15 68\n\n1,749.37 2,669.87 1,871.00 561.92 1,494.21 69\n\n1,840.68 2,774.60 1,968.64 584.07 1,572.21 70\n\n1,935.91 2,883.03 2,070.42 606.87 1,653.59 71\n\n2,034.86 2,996.59 2,176.35 630.76 1,738.02 72\n\n2,138.27 3,114.63 2,286.85 655.52 1,826.38 73\n\n2,246.05 3,238.12 2,402.16 681.49 1,918.46 74\n\n2,358.85 3,367.06 2,522.82 708.76 2,014.78 75\n\n2,476.67 3,501.79 2,648.92 737.23 2,115.47 76\n\n2,600.27 3,643.06 2,781.03 766.90 2,221.07 77\n\n2,729.87 3,791.20 2,919.68 797.78 2,331.69 78\n\n2,839.07 3,899.31 3,036.52 820.57 2,424.96 79\n\n2,952.63 4,016.48 3,157.94 845.45 2,522.05 80\n\n3,071.97 4,148.91 3,285.46 873.37 2,623.94 81\n\n3,196.01 4,285.82 3,418.23 902.07 2,729.98 82\n\n3,325.17 4,427.09 3,556.33 931.96 2,840.16 83\n\n3,459.46 4,573.60 3,700.01 962.94 2,954.92 84\n\n3,599.21 4,724.25 3,849.46 994.79 3,074.37 85\n\n3,744.62 4,880.03 4,004.91 1,027.85 3,198.52 86\n\n3,895.93 5,041.05 4,166.80 1,061.88 3,327.79 87\n\n4,053.35 5,207.52 4,335.13 1,096.90 3,462.19 88\n\n4,217.09 5,379.34 4,510.22 1,133.12 3,602.04 89\n\n4,387.49 5,556.94 4,692.51 1,170.64 3,747.57 90\n\n4,476.07 5,648.57 4,787.31 1,190.06 3,823.28 91\n\n4,566.51 5,741.73 4,884.07 1,209.81 3,900.62 92\n\n4,658.80 5,836.64 4,982.69 1,229.99 3,979.39 93\n\n4,752.83 5,932.86 5,083.27 1,250.06 4,059.78 94\n\n4,848.94 6,030.82 5,186.03 1,271.01 4,141.71 95\n\n4,946.90 6,130.09 5,290.76 1,291.95 4,225.38 96\n\n5,046.83 6,231.22 5,397.66 1,313.23 4,310.80 97\n\n5,148.72 6,334.09 5,506.75 1,335.15 4,397.85 98\n\n5,252.79 6,438.71 5,617.92 1,357.30 4,486.65 99+\n\nTo determine the Bank Draft (P.P.S.P.) or Payroll Deduction (P.R.D.), Semi-Annual, Quarterly or Monthly Direct Bill rates multiply the Annual Rates, as given above, by the appropriate factor shown below and add $1.00:\n\n0\\.08583 for Monthly Bank Draft/Payroll Deduction; 0.515 for Semi-Annual; 0.2625 for Quarterly; 0.09167 for Monthly Direct Bill\n\nZip Codes: Rest of state\n\n\\*\\* Applicable during the initial 6-month open enrollment period for disableds under the age of 65 and also as required during the federally mandated open enrollment period for eligible individuals as defined under the BBA of 1997.\n\n\\*\n\nTX (WNIC2096) 2023","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page587.pdf"]},"response":{"errors":[],"extract_id":"extract_4008b660bcf995f1cccae6a113994fe3","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Washington National Insurance Company**\n\nPolicy Form Series WNIC2096\n\nStandardized Medicare Supplement\n\nAnnual Rates\\* - Preferred Risk - Female\n\nAttained Age Plan A Plan F Plan G Plan HG Plan N\n\n$5,551.48 n/a n/a n/a n/a \\*\\*Under 65\n\n1,423.41 2,289.80 1,522.46 481.96 1,215.81 65\n\n1,495.51 2,379.36 1,599.48 501.05 1,277.33 66\n\n1,576.90 2,472.63 1,686.53 520.14 1,346.93 67\n\n1,661.44 2,569.29 1,776.97 540.65 1,419.15 68\n\n1,749.37 2,669.87 1,871.00 561.92 1,494.21 69\n\n1,840.68 2,774.60 1,968.64 584.07 1,572.21 70\n\n1,935.91 2,883.03 2,070.42 606.87 1,653.59 71\n\n2,034.86 2,996.59 2,176.35 630.76 1,738.02 72\n\n2,138.27 3,114.63 2,286.85 655.52 1,826.38 73\n\n2,246.05 3,238.12 2,402.16 681.49 1,918.46 74\n\n2,358.85 3,367.06 2,522.82 708.76 2,014.78 75\n\n2,476.67 3,501.79 2,648.92 737.23 2,115.47 76\n\n2,600.27 3,643.06 2,781.03 766.90 2,221.07 77\n\n2,729.87 3,791.20 2,919.68 797.78 2,331.69 78\n\n2,839.07 3,899.31 3,036.52 820.57 2,424.96 79\n\n2,952.63 4,016.48 3,157.94 845.45 2,522.05 80\n\n3,071.97 4,148.91 3,285.46 873.37 2,623.94 81\n\n3,196.01 4,285.82 3,418.23 902.07 2,729.98 82\n\n3,325.17 4,427.09 3,556.33 931.96 2,840.16 83\n\n3,459.46 4,573.60 3,700.01 962.94 2,954.92 84\n\n3,599.21 4,724.25 3,849.46 994.79 3,074.37 85\n\n3,744.62 4,880.03 4,004.91 1,027.85 3,198.52 86\n\n3,895.93 5,041.05 4,166.80 1,061.88 3,327.79 87\n\n4,053.35 5,207.52 4,335.13 1,096.90 3,462.19 88\n\n4,217.09 5,379.34 4,510.22 1,133.12 3,602.04 89\n\n4,387.49 5,556.94 4,692.51 1,170.64 3,747.57 90\n\n4,476.07 5,648.57 4,787.31 1,190.06 3,823.28 91\n\n4,566.51 5,741.73 4,884.07 1,209.81 3,900.62 92\n\n4,658.80 5,836.64 4,982.69 1,229.99 3,979.39 93\n\n4,752.83 5,932.86 5,083.27 1,250.06 4,059.78 94\n\n4,848.94 6,030.82 5,186.03 1,271.01 4,141.71 95\n\n4,946.90 6,130.09 5,290.76 1,291.95 4,225.38 96\n\n5,046.83 6,231.22 5,397.66 1,313.23 4,310.80 97\n\n5,148.72 6,334.09 5,506.75 1,335.15 4,397.85 98\n\n5,252.79 6,438.71 5,617.92 1,357.30 4,486.65 99+\n\nTo determine the Bank Draft (P.P.S.P.) or Payroll Deduction (P.R.D.), Semi-Annual, Quarterly or Monthly Direct Bill rates multiply the Annual Rates, as given above, by the appropriate factor shown below and add $1.00:\n\n0\\.08583 for Monthly Bank Draft/Payroll Deduction; 0.515 for Semi-Annual; 0.2625 for Quarterly; 0.09167 for Monthly Direct Bill\n\nZip Codes: Rest of state\n\n\\*\\* Applicable during the initial 6-month open enrollment period for disableds under the age of 65 and also as required during the federally mandated open enrollment period for eligible individuals as defined under the BBA of 1997.\n\n\\*\n\nTX (WNIC2096) 2023"],"full_content":"**Washington National Insurance Company**\n\nPolicy Form Series WNIC2096\n\nStandardized Medicare Supplement\n\nAnnual Rates\\* - Preferred Risk - Female\n\nAttained Age Plan A Plan F Plan G Plan HG Plan N\n\n$5,551.48 n/a n/a n/a n/a \\*\\*Under 65\n\n1,423.41 2,289.80 1,522.46 481.96 1,215.81 65\n\n1,495.51 2,379.36 1,599.48 501.05 1,277.33 66\n\n1,576.90 2,472.63 1,686.53 520.14 1,346.93 67\n\n1,661.44 2,569.29 1,776.97 540.65 1,419.15 68\n\n1,749.37 2,669.87 1,871.00 561.92 1,494.21 69\n\n1,840.68 2,774.60 1,968.64 584.07 1,572.21 70\n\n1,935.91 2,883.03 2,070.42 606.87 1,653.59 71\n\n2,034.86 2,996.59 2,176.35 630.76 1,738.02 72\n\n2,138.27 3,114.63 2,286.85 655.52 1,826.38 73\n\n2,246.05 3,238.12 2,402.16 681.49 1,918.46 74\n\n2,358.85 3,367.06 2,522.82 708.76 2,014.78 75\n\n2,476.67 3,501.79 2,648.92 737.23 2,115.47 76\n\n2,600.27 3,643.06 2,781.03 766.90 2,221.07 77\n\n2,729.87 3,791.20 2,919.68 797.78 2,331.69 78\n\n2,839.07 3,899.31 3,036.52 820.57 2,424.96 79\n\n2,952.63 4,016.48 3,157.94 845.45 2,522.05 80\n\n3,071.97 4,148.91 3,285.46 873.37 2,623.94 81\n\n3,196.01 4,285.82 3,418.23 902.07 2,729.98 82\n\n3,325.17 4,427.09 3,556.33 931.96 2,840.16 83\n\n3,459.46 4,573.60 3,700.01 962.94 2,954.92 84\n\n3,599.21 4,724.25 3,849.46 994.79 3,074.37 85\n\n3,744.62 4,880.03 4,004.91 1,027.85 3,198.52 86\n\n3,895.93 5,041.05 4,166.80 1,061.88 3,327.79 87\n\n4,053.35 5,207.52 4,335.13 1,096.90 3,462.19 88\n\n4,217.09 5,379.34 4,510.22 1,133.12 3,602.04 89\n\n4,387.49 5,556.94 4,692.51 1,170.64 3,747.57 90\n\n4,476.07 5,648.57 4,787.31 1,190.06 3,823.28 91\n\n4,566.51 5,741.73 4,884.07 1,209.81 3,900.62 92\n\n4,658.80 5,836.64 4,982.69 1,229.99 3,979.39 93\n\n4,752.83 5,932.86 5,083.27 1,250.06 4,059.78 94\n\n4,848.94 6,030.82 5,186.03 1,271.01 4,141.71 95\n\n4,946.90 6,130.09 5,290.76 1,291.95 4,225.38 96\n\n5,046.83 6,231.22 5,397.66 1,313.23 4,310.80 97\n\n5,148.72 6,334.09 5,506.75 1,335.15 4,397.85 98\n\n5,252.79 6,438.71 5,617.92 1,357.30 4,486.65 99+\n\nTo determine the Bank Draft (P.P.S.P.) or Payroll Deduction (P.R.D.), Semi-Annual, Quarterly or Monthly Direct Bill rates multiply the Annual Rates, as given above, by the appropriate factor shown below and add $1.00:\n\n0\\.08583 for Monthly Bank Draft/Payroll Deduction; 0.515 for Semi-Annual; 0.2625 for Quarterly; 0.09167 for Monthly Direct Bill\n\nZip Codes: Rest of state\n\n\\*\\* Applicable during the initial 6-month open enrollment period for disableds under the age of 65 and also as required during the federally mandated open enrollment period for eligible individuals as defined under the BBA of 1997.\n\n\\*\n\nTX (WNIC2096) 2023","publish_date":null,"title":"Washington National Insurance Company Standardized Medicare Supplement Policy Form Series WNIC2096 Annual Rates* - Preferred Risk - Female **Under 65","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page587.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page587.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page587","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page587.pdf"},"started_at":"2026-11-04T19:47:24.150760"} +{"completed_at":"2026-11-04T19:47:26.314796","latency_in_ms":957,"output":{"example_id":"table/SERFF_TX_random_pages 1_page649","grounded_pages":[],"layout_pages":[],"markdown":"### **Disposition**\n\nDisposition Date: 07/09/2018 Effective Date: 01/01/2019 Status: Reviewed\n\nComment: In accordance with 28 TAC §3.7, this disposition is Notice of Departmental Action.\n\nIf you have any questions, please feel free to call me at 512/676-6623.\n\nSincerely, Angela Bigham Insurance Specialist Life & Health Lines Office Life/Health & HMO Intake Program MC 106-1E Angela.Bigham@tdi.texas.gov\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nEducators Health Plans Life, Accident, and Health, Inc.\n\n10\\.000% 10.000% $93,454 2,317 $1,027,989 10.000% 10.000%\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Supporting Document (revised)** Actuarial Memorandum RV-REVIEWED Yes\n\n**Supporting Document** HIOS Plan IDs RV-REVIEWED Yes\n\n**Supporting Document (revised)** Transmittal Checklist for Life/Health Form Filings RV-REVIEWED Yes\n\n**Supporting Document** Licensure RV-REVIEWED Yes\n\n**_SERFF Tracking #:_** _EMIN-131531604_ **_State Tracking #:_** _EMIN-131531604_ **_Company Tracking #:_** _EHPL.TX.ID.RATES_\n\n**_State:_** _Texas_ **_Filing Company:_** _Educators Health Plans Life, Accident, and Health, Inc._\n\n**_TOI/Sub-TOI:_** _H10I Individual Health - Dental/H10I.000 Health - Dental_\n\n**_Product Name:_** _2019 TX EXC RATES_\n\n**_Project Name/Number:_** _2019 EXCHANGE/_\n\n_PDF Pipeline for SERFF Tracking Number EMIN-131531604 Generated 02/23/2026 06:50 PM_","pages":[{"line_numbers":[],"markdown":"### **Disposition**\n\nDisposition Date: 07/09/2018 Effective Date: 01/01/2019 Status: Reviewed\n\nComment: In accordance with 28 TAC §3.7, this disposition is Notice of Departmental Action.\n\nIf you have any questions, please feel free to call me at 512/676-6623.\n\nSincerely, Angela Bigham Insurance Specialist Life & Health Lines Office Life/Health & HMO Intake Program MC 106-1E Angela.Bigham@tdi.texas.gov\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nEducators Health Plans Life, Accident, and Health, Inc.\n\n10\\.000% 10.000% $93,454 2,317 $1,027,989 10.000% 10.000%\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Supporting Document (revised)** Actuarial Memorandum RV-REVIEWED Yes\n\n**Supporting Document** HIOS Plan IDs RV-REVIEWED Yes\n\n**Supporting Document (revised)** Transmittal Checklist for Life/Health Form Filings RV-REVIEWED Yes\n\n**Supporting Document** Licensure RV-REVIEWED Yes\n\n**_SERFF Tracking #:_** _EMIN-131531604_ **_State Tracking #:_** _EMIN-131531604_ **_Company Tracking #:_** _EHPL.TX.ID.RATES_\n\n**_State:_** _Texas_ **_Filing Company:_** _Educators Health Plans Life, Accident, and Health, Inc._\n\n**_TOI/Sub-TOI:_** _H10I Individual Health - Dental/H10I.000 Health - Dental_\n\n**_Product Name:_** _2019 TX EXC RATES_\n\n**_Project Name/Number:_** _2019 EXCHANGE/_\n\n_PDF Pipeline for SERFF Tracking Number EMIN-131531604 Generated 02/23/2026 06:50 PM_","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Disposition**\n\nDisposition Date: 07/09/2018 Effective Date: 01/01/2019 Status: Reviewed\n\nComment: In accordance with 28 TAC §3.7, this disposition is Notice of Departmental Action.\n\nIf you have any questions, please feel free to call me at 512/676-6623.\n\nSincerely, Angela Bigham Insurance Specialist Life & Health Lines Office Life/Health & HMO Intake Program MC 106-1E Angela.Bigham@tdi.texas.gov\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nEducators Health Plans Life, Accident, and Health, Inc.\n\n10\\.000% 10.000% $93,454 2,317 $1,027,989 10.000% 10.000%\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Supporting Document (revised)** Actuarial Memorandum RV-REVIEWED Yes\n\n**Supporting Document** HIOS Plan IDs RV-REVIEWED Yes\n\n**Supporting Document (revised)** Transmittal Checklist for Life/Health Form Filings RV-REVIEWED Yes\n\n**Supporting Document** Licensure RV-REVIEWED Yes\n\n**_SERFF Tracking #:_** _EMIN-131531604_ **_State Tracking #:_** _EMIN-131531604_ **_Company Tracking #:_** _EHPL.TX.ID.RATES_\n\n**_State:_** _Texas_ **_Filing Company:_** _Educators Health Plans Life, Accident, and Health, Inc._\n\n**_TOI/Sub-TOI:_** _H10I Individual Health - Dental/H10I.000 Health - Dental_\n\n**_Product Name:_** _2019 TX EXC RATES_\n\n**_Project Name/Number:_** _2019 EXCHANGE/_\n\n_PDF Pipeline for SERFF Tracking Number EMIN-131531604 Generated 02/23/2026 06:50 PM_","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page649.pdf"]},"response":{"errors":[],"extract_id":"extract_61b6244f65023ed4e65f1f9d3b6ec5b8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Disposition**\n\nDisposition Date: 07/09/2018 Effective Date: 01/01/2019 Status: Reviewed\n\nComment: In accordance with 28 TAC §3.7, this disposition is Notice of Departmental Action.\n\nIf you have any questions, please feel free to call me at 512/676-6623.\n\nSincerely, Angela Bigham Insurance Specialist Life & Health Lines Office Life/Health & HMO Intake Program MC 106-1E Angela.Bigham@tdi.texas.gov\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nEducators Health Plans Life, Accident, and Health, Inc.\n\n10\\.000% 10.000% $93,454 2,317 $1,027,989 10.000% 10.000%\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Supporting Document (revised)** Actuarial Memorandum RV-REVIEWED Yes\n\n**Supporting Document** HIOS Plan IDs RV-REVIEWED Yes\n\n**Supporting Document (revised)** Transmittal Checklist for Life/Health Form Filings RV-REVIEWED Yes\n\n**Supporting Document** Licensure RV-REVIEWED Yes\n\n**_SERFF Tracking #:_** _EMIN-131531604_ **_State Tracking #:_** _EMIN-131531604_ **_Company Tracking #:_** _EHPL.TX.ID.RATES_\n\n**_State:_** _Texas_ **_Filing Company:_** _Educators Health Plans Life, Accident, and Health, Inc._\n\n**_TOI/Sub-TOI:_** _H10I Individual Health - Dental/H10I.000 Health - Dental_\n\n**_Product Name:_** _2019 TX EXC RATES_\n\n**_Project Name/Number:_** _2019 EXCHANGE/_\n\n_PDF Pipeline for SERFF Tracking Number EMIN-131531604 Generated 02/23/2026 06:50 PM_"],"full_content":"### **Disposition**\n\nDisposition Date: 07/09/2018 Effective Date: 01/01/2019 Status: Reviewed\n\nComment: In accordance with 28 TAC §3.7, this disposition is Notice of Departmental Action.\n\nIf you have any questions, please feel free to call me at 512/676-6623.\n\nSincerely, Angela Bigham Insurance Specialist Life & Health Lines Office Life/Health & HMO Intake Program MC 106-1E Angela.Bigham@tdi.texas.gov\n\n**Company Name:**\n\n**Overall % Indicated Change:**\n\n**Overall % Rate Impact:**\n\n**Written Premium Change for this Program:**\n\n**Number of Policy Holders Affected for this Program:**\n\n**Written Premium for this Program:**\n\n**Maximum % Change (where req'd):**\n\n**Minimum % Change (where req'd):**\n\nEducators Health Plans Life, Accident, and Health, Inc.\n\n10\\.000% 10.000% $93,454 2,317 $1,027,989 10.000% 10.000%\n\n**Schedule Schedule Item Schedule Item Status Public Access**\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Rate** EHPL 2019 TX SADP RATES RV-REVIEWED Yes\n\n**Supporting Document (revised)** Actuarial Memorandum RV-REVIEWED Yes\n\n**Supporting Document** HIOS Plan IDs RV-REVIEWED Yes\n\n**Supporting Document (revised)** Transmittal Checklist for Life/Health Form Filings RV-REVIEWED Yes\n\n**Supporting Document** Licensure RV-REVIEWED Yes\n\n**_SERFF Tracking #:_** _EMIN-131531604_ **_State Tracking #:_** _EMIN-131531604_ **_Company Tracking #:_** _EHPL.TX.ID.RATES_\n\n**_State:_** _Texas_ **_Filing Company:_** _Educators Health Plans Life, Accident, and Health, Inc._\n\n**_TOI/Sub-TOI:_** _H10I Individual Health - Dental/H10I.000 Health - Dental_\n\n**_Product Name:_** _2019 TX EXC RATES_\n\n**_Project Name/Number:_** _2019 EXCHANGE/_\n\n_PDF Pipeline for SERFF Tracking Number EMIN-131531604 Generated 02/23/2026 06:50 PM_","publish_date":null,"title":"Disposition","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page649.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page649.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page649","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page649.pdf"},"started_at":"2026-11-04T19:47:25.357159"} +{"completed_at":"2026-11-04T19:47:27.538659","latency_in_ms":1347,"output":{"example_id":"table/SERFF_TX_random_pages 1_page650","grounded_pages":[],"layout_pages":[],"markdown":"**Age Range** Choice High Choice Low Advantage Co-\n\nPay Advantage\n\n0-20 31.70 24.30 18.60 17.50\n\n21-24 31.90 23.20 17.50 16.80\n\n25-29 36.30 26.20 19.90 18.90\n\n30-34 38.70 28.20 21.50 20.40\n\n35-39 40.90 29.50 22.60 21.30\n\n40-44 41.10 29.60 22.70 21.40\n\n45-49 43.20 31.20 23.90 22.50\n\n50-54 48.30 35.10 26.60 25.30\n\n55-59 53.40 38.50 29.50 27.80\n\n60-63 56.10 40.60 31.10 29.30\n\n64+ 62.90 45.50 35.00 32.90\n\n**Dental Plans 2019 (TX)**","pages":[{"line_numbers":[],"markdown":"**Age Range** Choice High Choice Low Advantage Co-\n\nPay Advantage\n\n0-20 31.70 24.30 18.60 17.50\n\n21-24 31.90 23.20 17.50 16.80\n\n25-29 36.30 26.20 19.90 18.90\n\n30-34 38.70 28.20 21.50 20.40\n\n35-39 40.90 29.50 22.60 21.30\n\n40-44 41.10 29.60 22.70 21.40\n\n45-49 43.20 31.20 23.90 22.50\n\n50-54 48.30 35.10 26.60 25.30\n\n55-59 53.40 38.50 29.50 27.80\n\n60-63 56.10 40.60 31.10 29.30\n\n64+ 62.90 45.50 35.00 32.90\n\n**Dental Plans 2019 (TX)**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Age Range** Choice High Choice Low Advantage Co-\n\nPay Advantage\n\n0-20 31.70 24.30 18.60 17.50\n\n21-24 31.90 23.20 17.50 16.80\n\n25-29 36.30 26.20 19.90 18.90\n\n30-34 38.70 28.20 21.50 20.40\n\n35-39 40.90 29.50 22.60 21.30\n\n40-44 41.10 29.60 22.70 21.40\n\n45-49 43.20 31.20 23.90 22.50\n\n50-54 48.30 35.10 26.60 25.30\n\n55-59 53.40 38.50 29.50 27.80\n\n60-63 56.10 40.60 31.10 29.30\n\n64+ 62.90 45.50 35.00 32.90\n\n**Dental Plans 2019 (TX)**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page650.pdf"]},"response":{"errors":[],"extract_id":"extract_c327f6dad2e6eb9fc43236a7654124c4","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Age Range** Choice High Choice Low Advantage Co-\n\nPay Advantage\n\n0-20 31.70 24.30 18.60 17.50\n\n21-24 31.90 23.20 17.50 16.80\n\n25-29 36.30 26.20 19.90 18.90\n\n30-34 38.70 28.20 21.50 20.40\n\n35-39 40.90 29.50 22.60 21.30\n\n40-44 41.10 29.60 22.70 21.40\n\n45-49 43.20 31.20 23.90 22.50\n\n50-54 48.30 35.10 26.60 25.30\n\n55-59 53.40 38.50 29.50 27.80\n\n60-63 56.10 40.60 31.10 29.30\n\n64+ 62.90 45.50 35.00 32.90\n\n**Dental Plans 2019 (TX)**"],"full_content":"**Age Range** Choice High Choice Low Advantage Co-\n\nPay Advantage\n\n0-20 31.70 24.30 18.60 17.50\n\n21-24 31.90 23.20 17.50 16.80\n\n25-29 36.30 26.20 19.90 18.90\n\n30-34 38.70 28.20 21.50 20.40\n\n35-39 40.90 29.50 22.60 21.30\n\n40-44 41.10 29.60 22.70 21.40\n\n45-49 43.20 31.20 23.90 22.50\n\n50-54 48.30 35.10 26.60 25.30\n\n55-59 53.40 38.50 29.50 27.80\n\n60-63 56.10 40.60 31.10 29.30\n\n64+ 62.90 45.50 35.00 32.90\n\n**Dental Plans 2019 (TX)**","publish_date":null,"title":"Advantage Co- Choice High Choice Low Advantage Age Range Pay 0-20 31.70 24.30 18.60 17.50 21-24 31.90 23.20 17.50 16.80","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page650.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page650.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page650","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page650.pdf"},"started_at":"2026-11-04T19:47:26.191240"} +{"completed_at":"2026-11-04T19:47:28.477383","latency_in_ms":1165,"output":{"example_id":"table/SERFF_TX_random_pages 1_page706","grounded_pages":[],"layout_pages":[],"markdown":"**TX**\n\n**Actual**\n\n**Exp. Cal. Paid Paid Cash Earned Incurred Claim Life**\n\n**Period Dur. Premium Claims Ratio Premium Claims Ratio Years**\n\n**STATE:**\n\n**EXHIBIT 2 - Page 2 of 7**\n\n**UNL - STANDARDIZED MEDICARE SUPPLEMENT EXPERIENCE - PLAN A**\n\n**Projected Experience Assuming Requested Increase Is Implemented Dec-1-2014**\n\n**Actual**\n\n**Exp. Cal. Premium Claim Earned Incurred Claim Life**\n\n**Period Dur. Trend \\* Trend \\*\\* Persistency \\*\\*\\* Premium Claims Ratio Years**\n\n4-12/2014 All 56.9% 6.0% 80.0% $276,115 $577,102 209.0% 44.3\n\n2015 All 5.2% 6.0% 80.0% $305,568 $605,901 198.3% 48.0\n\n2016 All 6.0% 6.0% 80.0% $259,122 $513,804 198.3% 38.4\n\n2017 All 6.0% 6.0% 80.0% $219,735 $435,705 198.3% 30.7\n\n2018 All 6.0% 6.0% 80.0% $186,335 $369,478 198.3% 24.6\n\n2019 All 6.0% 6.0% 80.0% $158,012 $313,318 198.3% 19.6\n\n2020 All 6.0% 6.0% 80.0% $133,995 $265,693 198.3% 15.7\n\n2021 All 6.0% 6.0% 80.0% $113,627 $225,308 198.3% 12.6\n\n2022 All 6.0% 6.0% 80.0% $96,356 $191,061 198.3% 10.1\n\n2023 All 6.0% 6.0% 80.0% $81,710 $162,020 198.3% 8.0\n\n2024 All 6.0% 6.0% 80.0% $69,290 $137,393 198.3% 6.4\n\n2025 All 6.0% 6.0% 80.0% $58,758 $116,509 198.3% 5.1\n\n2026 All 6.0% 6.0% 80.0% $49,827 $98,800 198.3% 4.1\n\n2027 All 6.0% 6.0% 80.0% $42,253 $83,782 198.3% 3.3\n\n2028 All 6.0% 6.0% 80.0% $35,831 $71,047 198.3% 2.6\n\n2029 All 6.0% 6.0% 80.0% $30,384 $60,248 198.3% 2.1\n\n2030 All 6.0% 6.0% 80.0% $25,766 $51,090 198.3% 1.7\n\n2031 All 6.0% 6.0% 80.0% $21,850 $43,325 198.3% 1.3\n\n2032 All 6.0% 6.0% 80.0% $18,528 $36,739 198.3% 1.1\n\n2033 All 6.0% 6.0% 80.0% $15,712 $31,155 198.3% 0.9\n\nSub-Tot (a) All --- --- --- $2,198,775 $4,389,478 199.6% 280.6\n\nSub-Tot (b) All --- --- --- $1,799,050 $3,596,302 199.9% ---\n\nTotal (a) All --- --- --- $2,547,539 $5,196,442 204.0% 928.6\n\nTotal (b) All --- --- --- $2,081,166 $4,317,989 207.5% ---\n\n**Projected Experience Assuming No Increase Is Implemented Dec-1-2014**\n\n**Actual**\n\n**Exp. Cal. Premium Claim Earned Incurred Claim Life**\n\n**Period Dur. Trend \\* Trend \\*\\* Persistency \\*\\*\\* Premium Claims Ratio Years**\n\n4-12/2014 All 56.9% 6.0% 80.0% $276,115 $577,102 209.0% 44.3\n\n2015 All 3.3% 6.0% 80.0% $299,938 $605,901 202.0% 48.0\n\n2016 All 6.0% 6.0% 80.0% $254,348 $513,804 202.0% 38.4\n\n2017 All 6.0% 6.0% 80.0% $215,687 $435,705 202.0% 30.7\n\n2018 All 6.0% 6.0% 80.0% $182,902 $369,478 202.0% 24.6\n\n2019 All 6.0% 6.0% 80.0% $155,101 $313,318 202.0% 19.6\n\n2020 All 6.0% 6.0% 80.0% $131,526 $265,693 202.0% 15.7\n\n2021 All 6.0% 6.0% 80.0% $111,534 $225,308 202.0% 12.6\n\n2022 All 6.0% 6.0% 80.0% $94,581 $191,061 202.0% 10.1\n\n2023 All 6.0% 6.0% 80.0% $80,205 $162,020 202.0% 8.0\n\n2024 All 6.0% 6.0% 80.0% $68,013 $137,393 202.0% 6.4\n\n2025 All 6.0% 6.0% 80.0% $57,675 $116,509 202.0% 5.1\n\n2026 All 6.0% 6.0% 80.0% $48,909 $98,800 202.0% 4.1\n\n2027 All 6.0% 6.0% 80.0% $41,475 $83,782 202.0% 3.3\n\n2028 All 6.0% 6.0% 80.0% $35,170 $71,047 202.0% 2.6\n\n2029 All 6.0% 6.0% 80.0% $29,825 $60,248 202.0% 2.1\n\n2030 All 6.0% 6.0% 80.0% $25,291 $51,090 202.0% 1.7\n\n2031 All 6.0% 6.0% 80.0% $21,447 $43,325 202.0% 1.3\n\n2032 All 6.0% 6.0% 80.0% $18,187 $36,739 202.0% 1.1\n\n2033 All 6.0% 6.0% 80.0% $15,423 $31,155 202.0% 0.9\n\nSub-Tot (a) All --- --- --- $2,163,353 $4,389,478 202.9% 280.6\n\nSub-Tot (b) All --- --- --- $1,770,893 $3,596,302 203.1% ---\n\nTotal (a) All --- --- --- $2,512,117 $5,196,442 206.9% 928.6\n\nTotal (b) All --- --- --- $2,053,010 $4,317,989 210.3% ---\n\n\\* Premium trend reflects our average request, and includes attained age premium changes, if applicable.\n\n\\*\\* Claim trend includes inflation of benefits, increased utilization, selection, and aging, as documented in Appendix A.\n\n(a) Without interest\n\n(b) Accumulated and discounted to 12/31/2014 at 4.0% interest","pages":[{"line_numbers":[],"markdown":"**TX**\n\n**Actual**\n\n**Exp. Cal. Paid Paid Cash Earned Incurred Claim Life**\n\n**Period Dur. Premium Claims Ratio Premium Claims Ratio Years**\n\n**STATE:**\n\n**EXHIBIT 2 - Page 2 of 7**\n\n**UNL - STANDARDIZED MEDICARE SUPPLEMENT EXPERIENCE - PLAN A**\n\n**Projected Experience Assuming Requested Increase Is Implemented Dec-1-2014**\n\n**Actual**\n\n**Exp. Cal. Premium Claim Earned Incurred Claim Life**\n\n**Period Dur. Trend \\* Trend \\*\\* Persistency \\*\\*\\* Premium Claims Ratio Years**\n\n4-12/2014 All 56.9% 6.0% 80.0% $276,115 $577,102 209.0% 44.3\n\n2015 All 5.2% 6.0% 80.0% $305,568 $605,901 198.3% 48.0\n\n2016 All 6.0% 6.0% 80.0% $259,122 $513,804 198.3% 38.4\n\n2017 All 6.0% 6.0% 80.0% $219,735 $435,705 198.3% 30.7\n\n2018 All 6.0% 6.0% 80.0% $186,335 $369,478 198.3% 24.6\n\n2019 All 6.0% 6.0% 80.0% $158,012 $313,318 198.3% 19.6\n\n2020 All 6.0% 6.0% 80.0% $133,995 $265,693 198.3% 15.7\n\n2021 All 6.0% 6.0% 80.0% $113,627 $225,308 198.3% 12.6\n\n2022 All 6.0% 6.0% 80.0% $96,356 $191,061 198.3% 10.1\n\n2023 All 6.0% 6.0% 80.0% $81,710 $162,020 198.3% 8.0\n\n2024 All 6.0% 6.0% 80.0% $69,290 $137,393 198.3% 6.4\n\n2025 All 6.0% 6.0% 80.0% $58,758 $116,509 198.3% 5.1\n\n2026 All 6.0% 6.0% 80.0% $49,827 $98,800 198.3% 4.1\n\n2027 All 6.0% 6.0% 80.0% $42,253 $83,782 198.3% 3.3\n\n2028 All 6.0% 6.0% 80.0% $35,831 $71,047 198.3% 2.6\n\n2029 All 6.0% 6.0% 80.0% $30,384 $60,248 198.3% 2.1\n\n2030 All 6.0% 6.0% 80.0% $25,766 $51,090 198.3% 1.7\n\n2031 All 6.0% 6.0% 80.0% $21,850 $43,325 198.3% 1.3\n\n2032 All 6.0% 6.0% 80.0% $18,528 $36,739 198.3% 1.1\n\n2033 All 6.0% 6.0% 80.0% $15,712 $31,155 198.3% 0.9\n\nSub-Tot (a) All --- --- --- $2,198,775 $4,389,478 199.6% 280.6\n\nSub-Tot (b) All --- --- --- $1,799,050 $3,596,302 199.9% ---\n\nTotal (a) All --- --- --- $2,547,539 $5,196,442 204.0% 928.6\n\nTotal (b) All --- --- --- $2,081,166 $4,317,989 207.5% ---\n\n**Projected Experience Assuming No Increase Is Implemented Dec-1-2014**\n\n**Actual**\n\n**Exp. Cal. Premium Claim Earned Incurred Claim Life**\n\n**Period Dur. Trend \\* Trend \\*\\* Persistency \\*\\*\\* Premium Claims Ratio Years**\n\n4-12/2014 All 56.9% 6.0% 80.0% $276,115 $577,102 209.0% 44.3\n\n2015 All 3.3% 6.0% 80.0% $299,938 $605,901 202.0% 48.0\n\n2016 All 6.0% 6.0% 80.0% $254,348 $513,804 202.0% 38.4\n\n2017 All 6.0% 6.0% 80.0% $215,687 $435,705 202.0% 30.7\n\n2018 All 6.0% 6.0% 80.0% $182,902 $369,478 202.0% 24.6\n\n2019 All 6.0% 6.0% 80.0% $155,101 $313,318 202.0% 19.6\n\n2020 All 6.0% 6.0% 80.0% $131,526 $265,693 202.0% 15.7\n\n2021 All 6.0% 6.0% 80.0% $111,534 $225,308 202.0% 12.6\n\n2022 All 6.0% 6.0% 80.0% $94,581 $191,061 202.0% 10.1\n\n2023 All 6.0% 6.0% 80.0% $80,205 $162,020 202.0% 8.0\n\n2024 All 6.0% 6.0% 80.0% $68,013 $137,393 202.0% 6.4\n\n2025 All 6.0% 6.0% 80.0% $57,675 $116,509 202.0% 5.1\n\n2026 All 6.0% 6.0% 80.0% $48,909 $98,800 202.0% 4.1\n\n2027 All 6.0% 6.0% 80.0% $41,475 $83,782 202.0% 3.3\n\n2028 All 6.0% 6.0% 80.0% $35,170 $71,047 202.0% 2.6\n\n2029 All 6.0% 6.0% 80.0% $29,825 $60,248 202.0% 2.1\n\n2030 All 6.0% 6.0% 80.0% $25,291 $51,090 202.0% 1.7\n\n2031 All 6.0% 6.0% 80.0% $21,447 $43,325 202.0% 1.3\n\n2032 All 6.0% 6.0% 80.0% $18,187 $36,739 202.0% 1.1\n\n2033 All 6.0% 6.0% 80.0% $15,423 $31,155 202.0% 0.9\n\nSub-Tot (a) All --- --- --- $2,163,353 $4,389,478 202.9% 280.6\n\nSub-Tot (b) All --- --- --- $1,770,893 $3,596,302 203.1% ---\n\nTotal (a) All --- --- --- $2,512,117 $5,196,442 206.9% 928.6\n\nTotal (b) All --- --- --- $2,053,010 $4,317,989 210.3% ---\n\n\\* Premium trend reflects our average request, and includes attained age premium changes, if applicable.\n\n\\*\\* Claim trend includes inflation of benefits, increased utilization, selection, and aging, as documented in Appendix A.\n\n(a) Without interest\n\n(b) Accumulated and discounted to 12/31/2014 at 4.0% interest","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**TX**\n\n**Actual**\n\n**Exp. Cal. Paid Paid Cash Earned Incurred Claim Life**\n\n**Period Dur. Premium Claims Ratio Premium Claims Ratio Years**\n\n**STATE:**\n\n**EXHIBIT 2 - Page 2 of 7**\n\n**UNL - STANDARDIZED MEDICARE SUPPLEMENT EXPERIENCE - PLAN A**\n\n**Projected Experience Assuming Requested Increase Is Implemented Dec-1-2014**\n\n**Actual**\n\n**Exp. Cal. Premium Claim Earned Incurred Claim Life**\n\n**Period Dur. Trend \\* Trend \\*\\* Persistency \\*\\*\\* Premium Claims Ratio Years**\n\n4-12/2014 All 56.9% 6.0% 80.0% $276,115 $577,102 209.0% 44.3\n\n2015 All 5.2% 6.0% 80.0% $305,568 $605,901 198.3% 48.0\n\n2016 All 6.0% 6.0% 80.0% $259,122 $513,804 198.3% 38.4\n\n2017 All 6.0% 6.0% 80.0% $219,735 $435,705 198.3% 30.7\n\n2018 All 6.0% 6.0% 80.0% $186,335 $369,478 198.3% 24.6\n\n2019 All 6.0% 6.0% 80.0% $158,012 $313,318 198.3% 19.6\n\n2020 All 6.0% 6.0% 80.0% $133,995 $265,693 198.3% 15.7\n\n2021 All 6.0% 6.0% 80.0% $113,627 $225,308 198.3% 12.6\n\n2022 All 6.0% 6.0% 80.0% $96,356 $191,061 198.3% 10.1\n\n2023 All 6.0% 6.0% 80.0% $81,710 $162,020 198.3% 8.0\n\n2024 All 6.0% 6.0% 80.0% $69,290 $137,393 198.3% 6.4\n\n2025 All 6.0% 6.0% 80.0% $58,758 $116,509 198.3% 5.1\n\n2026 All 6.0% 6.0% 80.0% $49,827 $98,800 198.3% 4.1\n\n2027 All 6.0% 6.0% 80.0% $42,253 $83,782 198.3% 3.3\n\n2028 All 6.0% 6.0% 80.0% $35,831 $71,047 198.3% 2.6\n\n2029 All 6.0% 6.0% 80.0% $30,384 $60,248 198.3% 2.1\n\n2030 All 6.0% 6.0% 80.0% $25,766 $51,090 198.3% 1.7\n\n2031 All 6.0% 6.0% 80.0% $21,850 $43,325 198.3% 1.3\n\n2032 All 6.0% 6.0% 80.0% $18,528 $36,739 198.3% 1.1\n\n2033 All 6.0% 6.0% 80.0% $15,712 $31,155 198.3% 0.9\n\nSub-Tot (a) All --- --- --- $2,198,775 $4,389,478 199.6% 280.6\n\nSub-Tot (b) All --- --- --- $1,799,050 $3,596,302 199.9% ---\n\nTotal (a) All --- --- --- $2,547,539 $5,196,442 204.0% 928.6\n\nTotal (b) All --- --- --- $2,081,166 $4,317,989 207.5% ---\n\n**Projected Experience Assuming No Increase Is Implemented Dec-1-2014**\n\n**Actual**\n\n**Exp. Cal. Premium Claim Earned Incurred Claim Life**\n\n**Period Dur. Trend \\* Trend \\*\\* Persistency \\*\\*\\* Premium Claims Ratio Years**\n\n4-12/2014 All 56.9% 6.0% 80.0% $276,115 $577,102 209.0% 44.3\n\n2015 All 3.3% 6.0% 80.0% $299,938 $605,901 202.0% 48.0\n\n2016 All 6.0% 6.0% 80.0% $254,348 $513,804 202.0% 38.4\n\n2017 All 6.0% 6.0% 80.0% $215,687 $435,705 202.0% 30.7\n\n2018 All 6.0% 6.0% 80.0% $182,902 $369,478 202.0% 24.6\n\n2019 All 6.0% 6.0% 80.0% $155,101 $313,318 202.0% 19.6\n\n2020 All 6.0% 6.0% 80.0% $131,526 $265,693 202.0% 15.7\n\n2021 All 6.0% 6.0% 80.0% $111,534 $225,308 202.0% 12.6\n\n2022 All 6.0% 6.0% 80.0% $94,581 $191,061 202.0% 10.1\n\n2023 All 6.0% 6.0% 80.0% $80,205 $162,020 202.0% 8.0\n\n2024 All 6.0% 6.0% 80.0% $68,013 $137,393 202.0% 6.4\n\n2025 All 6.0% 6.0% 80.0% $57,675 $116,509 202.0% 5.1\n\n2026 All 6.0% 6.0% 80.0% $48,909 $98,800 202.0% 4.1\n\n2027 All 6.0% 6.0% 80.0% $41,475 $83,782 202.0% 3.3\n\n2028 All 6.0% 6.0% 80.0% $35,170 $71,047 202.0% 2.6\n\n2029 All 6.0% 6.0% 80.0% $29,825 $60,248 202.0% 2.1\n\n2030 All 6.0% 6.0% 80.0% $25,291 $51,090 202.0% 1.7\n\n2031 All 6.0% 6.0% 80.0% $21,447 $43,325 202.0% 1.3\n\n2032 All 6.0% 6.0% 80.0% $18,187 $36,739 202.0% 1.1\n\n2033 All 6.0% 6.0% 80.0% $15,423 $31,155 202.0% 0.9\n\nSub-Tot (a) All --- --- --- $2,163,353 $4,389,478 202.9% 280.6\n\nSub-Tot (b) All --- --- --- $1,770,893 $3,596,302 203.1% ---\n\nTotal (a) All --- --- --- $2,512,117 $5,196,442 206.9% 928.6\n\nTotal (b) All --- --- --- $2,053,010 $4,317,989 210.3% ---\n\n\\* Premium trend reflects our average request, and includes attained age premium changes, if applicable.\n\n\\*\\* Claim trend includes inflation of benefits, increased utilization, selection, and aging, as documented in Appendix A.\n\n(a) Without interest\n\n(b) Accumulated and discounted to 12/31/2014 at 4.0% interest","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page706.pdf"]},"response":{"errors":[],"extract_id":"extract_d6e17b20a6e93fbee7ad35daf0307753","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**TX**\n\n**Actual**\n\n**Exp. Cal. Paid Paid Cash Earned Incurred Claim Life**\n\n**Period Dur. Premium Claims Ratio Premium Claims Ratio Years**\n\n**STATE:**\n\n**EXHIBIT 2 - Page 2 of 7**\n\n**UNL - STANDARDIZED MEDICARE SUPPLEMENT EXPERIENCE - PLAN A**\n\n**Projected Experience Assuming Requested Increase Is Implemented Dec-1-2014**\n\n**Actual**\n\n**Exp. Cal. Premium Claim Earned Incurred Claim Life**\n\n**Period Dur. Trend \\* Trend \\*\\* Persistency \\*\\*\\* Premium Claims Ratio Years**\n\n4-12/2014 All 56.9% 6.0% 80.0% $276,115 $577,102 209.0% 44.3\n\n2015 All 5.2% 6.0% 80.0% $305,568 $605,901 198.3% 48.0\n\n2016 All 6.0% 6.0% 80.0% $259,122 $513,804 198.3% 38.4\n\n2017 All 6.0% 6.0% 80.0% $219,735 $435,705 198.3% 30.7\n\n2018 All 6.0% 6.0% 80.0% $186,335 $369,478 198.3% 24.6\n\n2019 All 6.0% 6.0% 80.0% $158,012 $313,318 198.3% 19.6\n\n2020 All 6.0% 6.0% 80.0% $133,995 $265,693 198.3% 15.7\n\n2021 All 6.0% 6.0% 80.0% $113,627 $225,308 198.3% 12.6\n\n2022 All 6.0% 6.0% 80.0% $96,356 $191,061 198.3% 10.1\n\n2023 All 6.0% 6.0% 80.0% $81,710 $162,020 198.3% 8.0\n\n2024 All 6.0% 6.0% 80.0% $69,290 $137,393 198.3% 6.4\n\n2025 All 6.0% 6.0% 80.0% $58,758 $116,509 198.3% 5.1\n\n2026 All 6.0% 6.0% 80.0% $49,827 $98,800 198.3% 4.1\n\n2027 All 6.0% 6.0% 80.0% $42,253 $83,782 198.3% 3.3\n\n2028 All 6.0% 6.0% 80.0% $35,831 $71,047 198.3% 2.6\n\n2029 All 6.0% 6.0% 80.0% $30,384 $60,248 198.3% 2.1\n\n2030 All 6.0% 6.0% 80.0% $25,766 $51,090 198.3% 1.7\n\n2031 All 6.0% 6.0% 80.0% $21,850 $43,325 198.3% 1.3\n\n2032 All 6.0% 6.0% 80.0% $18,528 $36,739 198.3% 1.1\n\n2033 All 6.0% 6.0% 80.0% $15,712 $31,155 198.3% 0.9\n\nSub-Tot (a) All --- --- --- $2,198,775 $4,389,478 199.6% 280.6\n\nSub-Tot (b) All --- --- --- $1,799,050 $3,596,302 199.9% ---\n\nTotal (a) All --- --- --- $2,547,539 $5,196,442 204.0% 928.6\n\nTotal (b) All --- --- --- $2,081,166 $4,317,989 207.5% ---\n\n**Projected Experience Assuming No Increase Is Implemented Dec-1-2014**\n\n**Actual**\n\n**Exp. Cal. Premium Claim Earned Incurred Claim Life**\n\n**Period Dur. Trend \\* Trend \\*\\* Persistency \\*\\*\\* Premium Claims Ratio Years**\n\n4-12/2014 All 56.9% 6.0% 80.0% $276,115 $577,102 209.0% 44.3\n\n2015 All 3.3% 6.0% 80.0% $299,938 $605,901 202.0% 48.0\n\n2016 All 6.0% 6.0% 80.0% $254,348 $513,804 202.0% 38.4\n\n2017 All 6.0% 6.0% 80.0% $215,687 $435,705 202.0% 30.7\n\n2018 All 6.0% 6.0% 80.0% $182,902 $369,478 202.0% 24.6\n\n2019 All 6.0% 6.0% 80.0% $155,101 $313,318 202.0% 19.6\n\n2020 All 6.0% 6.0% 80.0% $131,526 $265,693 202.0% 15.7\n\n2021 All 6.0% 6.0% 80.0% $111,534 $225,308 202.0% 12.6\n\n2022 All 6.0% 6.0% 80.0% $94,581 $191,061 202.0% 10.1\n\n2023 All 6.0% 6.0% 80.0% $80,205 $162,020 202.0% 8.0\n\n2024 All 6.0% 6.0% 80.0% $68,013 $137,393 202.0% 6.4\n\n2025 All 6.0% 6.0% 80.0% $57,675 $116,509 202.0% 5.1\n\n2026 All 6.0% 6.0% 80.0% $48,909 $98,800 202.0% 4.1\n\n2027 All 6.0% 6.0% 80.0% $41,475 $83,782 202.0% 3.3\n\n2028 All 6.0% 6.0% 80.0% $35,170 $71,047 202.0% 2.6\n\n2029 All 6.0% 6.0% 80.0% $29,825 $60,248 202.0% 2.1\n\n2030 All 6.0% 6.0% 80.0% $25,291 $51,090 202.0% 1.7\n\n2031 All 6.0% 6.0% 80.0% $21,447 $43,325 202.0% 1.3\n\n2032 All 6.0% 6.0% 80.0% $18,187 $36,739 202.0% 1.1\n\n2033 All 6.0% 6.0% 80.0% $15,423 $31,155 202.0% 0.9\n\nSub-Tot (a) All --- --- --- $2,163,353 $4,389,478 202.9% 280.6\n\nSub-Tot (b) All --- --- --- $1,770,893 $3,596,302 203.1% ---\n\nTotal (a) All --- --- --- $2,512,117 $5,196,442 206.9% 928.6\n\nTotal (b) All --- --- --- $2,053,010 $4,317,989 210.3% ---\n\n\\* Premium trend reflects our average request, and includes attained age premium changes, if applicable.\n\n\\*\\* Claim trend includes inflation of benefits, increased utilization, selection, and aging, as documented in Appendix A.\n\n(a) Without interest\n\n(b) Accumulated and discounted to 12/31/2014 at 4.0% interest"],"full_content":"**TX**\n\n**Actual**\n\n**Exp. Cal. Paid Paid Cash Earned Incurred Claim Life**\n\n**Period Dur. Premium Claims Ratio Premium Claims Ratio Years**\n\n**STATE:**\n\n**EXHIBIT 2 - Page 2 of 7**\n\n**UNL - STANDARDIZED MEDICARE SUPPLEMENT EXPERIENCE - PLAN A**\n\n**Projected Experience Assuming Requested Increase Is Implemented Dec-1-2014**\n\n**Actual**\n\n**Exp. Cal. Premium Claim Earned Incurred Claim Life**\n\n**Period Dur. Trend \\* Trend \\*\\* Persistency \\*\\*\\* Premium Claims Ratio Years**\n\n4-12/2014 All 56.9% 6.0% 80.0% $276,115 $577,102 209.0% 44.3\n\n2015 All 5.2% 6.0% 80.0% $305,568 $605,901 198.3% 48.0\n\n2016 All 6.0% 6.0% 80.0% $259,122 $513,804 198.3% 38.4\n\n2017 All 6.0% 6.0% 80.0% $219,735 $435,705 198.3% 30.7\n\n2018 All 6.0% 6.0% 80.0% $186,335 $369,478 198.3% 24.6\n\n2019 All 6.0% 6.0% 80.0% $158,012 $313,318 198.3% 19.6\n\n2020 All 6.0% 6.0% 80.0% $133,995 $265,693 198.3% 15.7\n\n2021 All 6.0% 6.0% 80.0% $113,627 $225,308 198.3% 12.6\n\n2022 All 6.0% 6.0% 80.0% $96,356 $191,061 198.3% 10.1\n\n2023 All 6.0% 6.0% 80.0% $81,710 $162,020 198.3% 8.0\n\n2024 All 6.0% 6.0% 80.0% $69,290 $137,393 198.3% 6.4\n\n2025 All 6.0% 6.0% 80.0% $58,758 $116,509 198.3% 5.1\n\n2026 All 6.0% 6.0% 80.0% $49,827 $98,800 198.3% 4.1\n\n2027 All 6.0% 6.0% 80.0% $42,253 $83,782 198.3% 3.3\n\n2028 All 6.0% 6.0% 80.0% $35,831 $71,047 198.3% 2.6\n\n2029 All 6.0% 6.0% 80.0% $30,384 $60,248 198.3% 2.1\n\n2030 All 6.0% 6.0% 80.0% $25,766 $51,090 198.3% 1.7\n\n2031 All 6.0% 6.0% 80.0% $21,850 $43,325 198.3% 1.3\n\n2032 All 6.0% 6.0% 80.0% $18,528 $36,739 198.3% 1.1\n\n2033 All 6.0% 6.0% 80.0% $15,712 $31,155 198.3% 0.9\n\nSub-Tot (a) All --- --- --- $2,198,775 $4,389,478 199.6% 280.6\n\nSub-Tot (b) All --- --- --- $1,799,050 $3,596,302 199.9% ---\n\nTotal (a) All --- --- --- $2,547,539 $5,196,442 204.0% 928.6\n\nTotal (b) All --- --- --- $2,081,166 $4,317,989 207.5% ---\n\n**Projected Experience Assuming No Increase Is Implemented Dec-1-2014**\n\n**Actual**\n\n**Exp. Cal. Premium Claim Earned Incurred Claim Life**\n\n**Period Dur. Trend \\* Trend \\*\\* Persistency \\*\\*\\* Premium Claims Ratio Years**\n\n4-12/2014 All 56.9% 6.0% 80.0% $276,115 $577,102 209.0% 44.3\n\n2015 All 3.3% 6.0% 80.0% $299,938 $605,901 202.0% 48.0\n\n2016 All 6.0% 6.0% 80.0% $254,348 $513,804 202.0% 38.4\n\n2017 All 6.0% 6.0% 80.0% $215,687 $435,705 202.0% 30.7\n\n2018 All 6.0% 6.0% 80.0% $182,902 $369,478 202.0% 24.6\n\n2019 All 6.0% 6.0% 80.0% $155,101 $313,318 202.0% 19.6\n\n2020 All 6.0% 6.0% 80.0% $131,526 $265,693 202.0% 15.7\n\n2021 All 6.0% 6.0% 80.0% $111,534 $225,308 202.0% 12.6\n\n2022 All 6.0% 6.0% 80.0% $94,581 $191,061 202.0% 10.1\n\n2023 All 6.0% 6.0% 80.0% $80,205 $162,020 202.0% 8.0\n\n2024 All 6.0% 6.0% 80.0% $68,013 $137,393 202.0% 6.4\n\n2025 All 6.0% 6.0% 80.0% $57,675 $116,509 202.0% 5.1\n\n2026 All 6.0% 6.0% 80.0% $48,909 $98,800 202.0% 4.1\n\n2027 All 6.0% 6.0% 80.0% $41,475 $83,782 202.0% 3.3\n\n2028 All 6.0% 6.0% 80.0% $35,170 $71,047 202.0% 2.6\n\n2029 All 6.0% 6.0% 80.0% $29,825 $60,248 202.0% 2.1\n\n2030 All 6.0% 6.0% 80.0% $25,291 $51,090 202.0% 1.7\n\n2031 All 6.0% 6.0% 80.0% $21,447 $43,325 202.0% 1.3\n\n2032 All 6.0% 6.0% 80.0% $18,187 $36,739 202.0% 1.1\n\n2033 All 6.0% 6.0% 80.0% $15,423 $31,155 202.0% 0.9\n\nSub-Tot (a) All --- --- --- $2,163,353 $4,389,478 202.9% 280.6\n\nSub-Tot (b) All --- --- --- $1,770,893 $3,596,302 203.1% ---\n\nTotal (a) All --- --- --- $2,512,117 $5,196,442 206.9% 928.6\n\nTotal (b) All --- --- --- $2,053,010 $4,317,989 210.3% ---\n\n\\* Premium trend reflects our average request, and includes attained age premium changes, if applicable.\n\n\\*\\* Claim trend includes inflation of benefits, increased utilization, selection, and aging, as documented in Appendix A.\n\n(a) Without interest\n\n(b) Accumulated and discounted to 12/31/2014 at 4.0% interest","publish_date":null,"title":"--- --- --- ---","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page706.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page706.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page706","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page706.pdf"},"started_at":"2026-11-04T19:47:27.312080"} +{"completed_at":"2026-11-04T19:47:29.001825","latency_in_ms":1237,"output":{"example_id":"table/SERFF_TX_random_pages 1_page754","grounded_pages":[],"layout_pages":[],"markdown":"**Guarantee Trust Life Insurance Company Legacy LTC Inforce Data as of 12/31/2017, forms G9800 et al**\n\n**Nationwide Texas**\n\n**Issue Age Premium Count Premium Count**\n\n30-39 615 1 615 1\n\n40-49 16,933 29 5,095 5\n\n50-59 198,858 125 45,028 29\n\n60-69 1,958,020 1,100 524,184 238\n\n70-79 1,245,747 557 283,266 100\n\n80+ 55,588 19 4,549 1\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Attained Age Premium Count Premium Count**\n\n50-59 2,470 10 1,352 2\n\n60-69 66,247 54 18,271 13\n\n70-79 740,510 458 180,061 97\n\n80-89 2,258,274 1,149 581,107 237\n\n90-99 408,161 158 81,946 25\n\n100+ 99 2 0 0\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Underwriting Class Premium Count Premium Count**\n\nPreferred 2,750,428 1,475 722,977 320\n\nStandard 725,332 356 139,759 54\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Benefit Period Premium Count Premium Count**\n\n1 Year 119,030 122 9,804 8\n\n2 Years 274,484 201 35,085 22\n\n3 Years 824,547 437 174,268 81\n\n5 Years 330,650 138 82,308 29\n\nLife 1,927,049 933 561,272 234\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Elimination Period Premium Count Premium Count**\n\n0 Days 1,905,783 981 593,020 253\n\n7 Days 8,701 4 0 0\n\n20 Days 433,792 218 122,236 50\n\n30 Days 5,655 2 0 0\n\n60 Days 3,064 1 0 0\n\n90 Days 6,047 3 0 0\n\n100 Days 1,071,714 600 147,480 71\n\n180 Days 17,832 13 0 0\n\n365 Days 23,172 9 0 0\n\nTotal 3,475,761 1,831 862,737 374","pages":[{"line_numbers":[],"markdown":"**Guarantee Trust Life Insurance Company Legacy LTC Inforce Data as of 12/31/2017, forms G9800 et al**\n\n**Nationwide Texas**\n\n**Issue Age Premium Count Premium Count**\n\n30-39 615 1 615 1\n\n40-49 16,933 29 5,095 5\n\n50-59 198,858 125 45,028 29\n\n60-69 1,958,020 1,100 524,184 238\n\n70-79 1,245,747 557 283,266 100\n\n80+ 55,588 19 4,549 1\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Attained Age Premium Count Premium Count**\n\n50-59 2,470 10 1,352 2\n\n60-69 66,247 54 18,271 13\n\n70-79 740,510 458 180,061 97\n\n80-89 2,258,274 1,149 581,107 237\n\n90-99 408,161 158 81,946 25\n\n100+ 99 2 0 0\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Underwriting Class Premium Count Premium Count**\n\nPreferred 2,750,428 1,475 722,977 320\n\nStandard 725,332 356 139,759 54\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Benefit Period Premium Count Premium Count**\n\n1 Year 119,030 122 9,804 8\n\n2 Years 274,484 201 35,085 22\n\n3 Years 824,547 437 174,268 81\n\n5 Years 330,650 138 82,308 29\n\nLife 1,927,049 933 561,272 234\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Elimination Period Premium Count Premium Count**\n\n0 Days 1,905,783 981 593,020 253\n\n7 Days 8,701 4 0 0\n\n20 Days 433,792 218 122,236 50\n\n30 Days 5,655 2 0 0\n\n60 Days 3,064 1 0 0\n\n90 Days 6,047 3 0 0\n\n100 Days 1,071,714 600 147,480 71\n\n180 Days 17,832 13 0 0\n\n365 Days 23,172 9 0 0\n\nTotal 3,475,761 1,831 862,737 374","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Guarantee Trust Life Insurance Company Legacy LTC Inforce Data as of 12/31/2017, forms G9800 et al**\n\n**Nationwide Texas**\n\n**Issue Age Premium Count Premium Count**\n\n30-39 615 1 615 1\n\n40-49 16,933 29 5,095 5\n\n50-59 198,858 125 45,028 29\n\n60-69 1,958,020 1,100 524,184 238\n\n70-79 1,245,747 557 283,266 100\n\n80+ 55,588 19 4,549 1\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Attained Age Premium Count Premium Count**\n\n50-59 2,470 10 1,352 2\n\n60-69 66,247 54 18,271 13\n\n70-79 740,510 458 180,061 97\n\n80-89 2,258,274 1,149 581,107 237\n\n90-99 408,161 158 81,946 25\n\n100+ 99 2 0 0\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Underwriting Class Premium Count Premium Count**\n\nPreferred 2,750,428 1,475 722,977 320\n\nStandard 725,332 356 139,759 54\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Benefit Period Premium Count Premium Count**\n\n1 Year 119,030 122 9,804 8\n\n2 Years 274,484 201 35,085 22\n\n3 Years 824,547 437 174,268 81\n\n5 Years 330,650 138 82,308 29\n\nLife 1,927,049 933 561,272 234\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Elimination Period Premium Count Premium Count**\n\n0 Days 1,905,783 981 593,020 253\n\n7 Days 8,701 4 0 0\n\n20 Days 433,792 218 122,236 50\n\n30 Days 5,655 2 0 0\n\n60 Days 3,064 1 0 0\n\n90 Days 6,047 3 0 0\n\n100 Days 1,071,714 600 147,480 71\n\n180 Days 17,832 13 0 0\n\n365 Days 23,172 9 0 0\n\nTotal 3,475,761 1,831 862,737 374","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page754.pdf"]},"response":{"errors":[],"extract_id":"extract_bd79d6f20b9a4bf3669994934462e804","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Guarantee Trust Life Insurance Company Legacy LTC Inforce Data as of 12/31/2017, forms G9800 et al**\n\n**Nationwide Texas**\n\n**Issue Age Premium Count Premium Count**\n\n30-39 615 1 615 1\n\n40-49 16,933 29 5,095 5\n\n50-59 198,858 125 45,028 29\n\n60-69 1,958,020 1,100 524,184 238\n\n70-79 1,245,747 557 283,266 100\n\n80+ 55,588 19 4,549 1\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Attained Age Premium Count Premium Count**\n\n50-59 2,470 10 1,352 2\n\n60-69 66,247 54 18,271 13\n\n70-79 740,510 458 180,061 97\n\n80-89 2,258,274 1,149 581,107 237\n\n90-99 408,161 158 81,946 25\n\n100+ 99 2 0 0\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Underwriting Class Premium Count Premium Count**\n\nPreferred 2,750,428 1,475 722,977 320\n\nStandard 725,332 356 139,759 54\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Benefit Period Premium Count Premium Count**\n\n1 Year 119,030 122 9,804 8\n\n2 Years 274,484 201 35,085 22\n\n3 Years 824,547 437 174,268 81\n\n5 Years 330,650 138 82,308 29\n\nLife 1,927,049 933 561,272 234\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Elimination Period Premium Count Premium Count**\n\n0 Days 1,905,783 981 593,020 253\n\n7 Days 8,701 4 0 0\n\n20 Days 433,792 218 122,236 50\n\n30 Days 5,655 2 0 0\n\n60 Days 3,064 1 0 0\n\n90 Days 6,047 3 0 0\n\n100 Days 1,071,714 600 147,480 71\n\n180 Days 17,832 13 0 0\n\n365 Days 23,172 9 0 0\n\nTotal 3,475,761 1,831 862,737 374"],"full_content":"**Guarantee Trust Life Insurance Company Legacy LTC Inforce Data as of 12/31/2017, forms G9800 et al**\n\n**Nationwide Texas**\n\n**Issue Age Premium Count Premium Count**\n\n30-39 615 1 615 1\n\n40-49 16,933 29 5,095 5\n\n50-59 198,858 125 45,028 29\n\n60-69 1,958,020 1,100 524,184 238\n\n70-79 1,245,747 557 283,266 100\n\n80+ 55,588 19 4,549 1\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Attained Age Premium Count Premium Count**\n\n50-59 2,470 10 1,352 2\n\n60-69 66,247 54 18,271 13\n\n70-79 740,510 458 180,061 97\n\n80-89 2,258,274 1,149 581,107 237\n\n90-99 408,161 158 81,946 25\n\n100+ 99 2 0 0\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Underwriting Class Premium Count Premium Count**\n\nPreferred 2,750,428 1,475 722,977 320\n\nStandard 725,332 356 139,759 54\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Benefit Period Premium Count Premium Count**\n\n1 Year 119,030 122 9,804 8\n\n2 Years 274,484 201 35,085 22\n\n3 Years 824,547 437 174,268 81\n\n5 Years 330,650 138 82,308 29\n\nLife 1,927,049 933 561,272 234\n\nTotal 3,475,761 1,831 862,737 374\n\n**Nationwide Texas**\n\n**Elimination Period Premium Count Premium Count**\n\n0 Days 1,905,783 981 593,020 253\n\n7 Days 8,701 4 0 0\n\n20 Days 433,792 218 122,236 50\n\n30 Days 5,655 2 0 0\n\n60 Days 3,064 1 0 0\n\n90 Days 6,047 3 0 0\n\n100 Days 1,071,714 600 147,480 71\n\n180 Days 17,832 13 0 0\n\n365 Days 23,172 9 0 0\n\nTotal 3,475,761 1,831 862,737 374","publish_date":null,"title":"Guarantee Trust Life Insurance Company Legacy LTC Inforce Data as of 12/31/2017, forms G9800 et al Nationwide Texas Issue Age","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page754.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page754.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page754","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page754.pdf"},"started_at":"2026-11-04T19:47:27.763959"} +{"completed_at":"2026-11-04T19:47:32.552614","latency_in_ms":3299,"output":{"example_id":"table/SERFF_TX_random_pages 1_page783","grounded_pages":[],"layout_pages":[],"markdown":"5\n\n85-89 1.6% 2.4% 4.0%\n\nTotal 40.0% 60.0% 100.0%\n\nStandard 20%\n\nPreferred 80%","pages":[{"line_numbers":[],"markdown":"5\n\n85-89 1.6% 2.4% 4.0%\n\nTotal 40.0% 60.0% 100.0%\n\nStandard 20%\n\nPreferred 80%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"5\n\n85-89 1.6% 2.4% 4.0%\n\nTotal 40.0% 60.0% 100.0%\n\nStandard 20%\n\nPreferred 80%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page783.pdf"]},"response":{"errors":[],"extract_id":"extract_0197e8999cdc6cc20f079c806ad9af70","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["5\n\n85-89 1.6% 2.4% 4.0%\n\nTotal 40.0% 60.0% 100.0%\n\nStandard 20%\n\nPreferred 80%"],"full_content":"5\n\n85-89 1.6% 2.4% 4.0%\n\nTotal 40.0% 60.0% 100.0%\n\nStandard 20%\n\nPreferred 80%","publish_date":null,"title":"85-89 1.6% 2.4% 4.0% Total 40.0% 60.0% 100.0% Standard 20% Preferred 80% 5","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page783.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page783.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page783","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page783.pdf"},"started_at":"2026-11-04T19:47:29.253158"} +{"completed_at":"2026-11-04T19:47:32.046833","latency_in_ms":1338,"output":{"example_id":"table/SERFF_TX_random_pages 1_page810","grounded_pages":[],"layout_pages":[],"markdown":"**Group Standardized Medicare Supplement Policy Form 9743F**\n\n**Zips All Others (Zips 770-775)**\n\n**Attained Plan F Attained Plan F Attained Plan F Attained Plan F Attained Plan F Attained Plan F**\n\n**Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F**\n\n**65** Annual $4,656.86 **76** Annual $6,451.86 **65** Annual $5,139.71 **76** Annual $7,120.67 **65** Annual $5,594.00 **76** Annual $7,750.09\n\nSemi-Annual $2,421.57 Semi-Annual $3,354.99 Semi-Annual $2,672.65 Semi-Annual $3,702.72 Semi-Annual $2,908.88 Semi-Annual $4,030.07\n\nQuarterly $1,234.08 Quarterly $1,709.76 Quarterly $1,362.04 Quarterly $1,886.99 Quarterly $1,482.41 Quarterly $2,053.77\n\nMonth Bank Draft $391.20 Month Bank Draft $541.95 Month Bank Draft $431.74 Month Bank Draft $598.13 Month Bank Draft $469.90 Month Bank Draft $651.01\n\n**66** Annual $4,808.81 **77** Annual $6,608.12 **66** Annual $5,307.18 **77** Annual $7,293.11 **66** Annual $5,776.39 **77** Annual $7,937.80\n\nSemi-Annual $2,500.60 Semi-Annual $3,436.24 Semi-Annual $2,759.72 Semi-Annual $3,792.41 Semi-Annual $3,003.74 Semi-Annual $4,127.65\n\nQuarterly $1,274.31 Quarterly $1,751.15 Quarterly $1,406.42 Quarterly $1,932.69 Quarterly $1,530.74 Quarterly $2,103.53\n\nMonth Bank Draft $403.94 Month Bank Draft $555.08 Month Bank Draft $445.82 Month Bank Draft $612.60 Month Bank Draft $485.22 Month Bank Draft $666.77\n\n**67** Annual $4,965.07 **78** Annual $6,755.43 **67** Annual $5,479.64 **78** Annual $7,455.78 **67** Annual $5,964.11 **78** Annual $8,114.79\n\nSemi-Annual $2,581.83 Semi-Annual $3,512.80 Semi-Annual $2,849.42 Semi-Annual $3,877.01 Semi-Annual $3,101.32 Semi-Annual $4,219.70\n\nQuarterly $1,315.74 Quarterly $1,790.20 Quarterly $1,452.12 Quarterly $1,975.76 Quarterly $1,580.49 Quarterly $2,150.41\n\nMonth Bank Draft $417.08 Month Bank Draft $567.46 Month Bank Draft $460.32 Month Bank Draft $626.27 Month Bank Draft $501.00 Month Bank Draft $681.63\n\n**68** Annual $5,130.20 **79** Annual $6,902.84 **68** Annual $5,662.03 **79** Annual $7,618.31 **68** Annual $6,162.58 **79** Annual $8,291.73\n\nSemi-Annual $2,667.69 Semi-Annual $3,589.49 Semi-Annual $2,944.29 Semi-Annual $3,961.53 Semi-Annual $3,204.53 Semi-Annual $4,311.70\n\nQuarterly $1,359.50 Quarterly $1,829.27 Quarterly $1,500.46 Quarterly $2,018.88 Quarterly $1,633.09 Quarterly $2,197.23\n\nMonth Bank Draft $430.91 Month Bank Draft $579.79 Month Bank Draft $475.61 Month Bank Draft $639.93 Month Bank Draft $517.65 Month Bank Draft $696.51\n\n**69** Annual $5,304.30 **80** Annual $7,054.60 **69** Annual $5,854.26 **80** Annual $7,785.86 **69** Annual $6,371.66 **80** Annual $8,474.17\n\nSemi-Annual $2,758.25 Semi-Annual $3,668.37 Semi-Annual $3,044.22 Semi-Annual $4,048.64 Semi-Annual $3,313.29 Semi-Annual $4,406.56\n\nQuarterly $1,405.65 Quarterly $1,869.47 Quarterly $1,551.39 Quarterly $2,063.25 Quarterly $1,688.51 Quarterly $2,245.65\n\nMonth Bank Draft $445.59 Month Bank Draft $592.61 Month Bank Draft $491.76 Month Bank Draft $654.01 Month Bank Draft $535.24 Month Bank Draft $711.83\n\n**70** Annual $5,482.92 **81** Annual $7,201.94 **70** Annual $6,051.37 **81** Annual $7,948.56 **70** Annual $6,586.19 **81** Annual $8,651.11\n\nSemi-Annual $2,851.10 Semi-Annual $3,744.99 Semi-Annual $3,146.72 Semi-Annual $4,133.26 Semi-Annual $3,424.84 Semi-Annual $4,498.57\n\nQuarterly $1,452.97 Quarterly $1,908.51 Quarterly $1,603.62 Quarterly $2,106.39 Quarterly $1,745.37 Quarterly $2,292.54\n\nMonth Bank Draft $460.57 Month Bank Draft $604.97 Month Bank Draft $508.32 Month Bank Draft $667.70 Month Bank Draft $553.23 Month Bank Draft $726.69\n\n**71** Annual $5,661.51 **82** Annual $7,349.35 **71** Annual $6,248.47 **82** Annual $8,111.07 **71** Annual $6,800.73 **82** Annual $8,828.06\n\nSemi-Annual $2,943.97 Semi-Annual $3,821.69 Semi-Annual $3,249.24 Semi-Annual $4,217.77 Semi-Annual $3,536.37 Semi-Annual $4,590.59\n\nQuarterly $1,500.32 Quarterly $1,947.59 Quarterly $1,655.85 Quarterly $2,149.46 Quarterly $1,802.19 Quarterly $2,339.43\n\nMonth Bank Draft $475.56 Month Bank Draft $617.37 Month Bank Draft $524.84 Month Bank Draft $681.32 Month Bank Draft $571.29 Month Bank Draft $741.54\n\n**72** Annual $5,835.74 **83** Annual $7,496.61 **72** Annual $6,440.55 **83** Annual $8,273.78 **72** Annual $7,009.98 **83** Annual $9,005.18\n\nSemi-Annual $3,034.58 Semi-Annual $3,898.25 Semi-Annual $3,349.05 Semi-Annual $4,302.38 Semi-Annual $3,645.16 Semi-Annual $4,682.69\n\nQuarterly $1,546.48 Quarterly $1,986.63 Quarterly $1,706.73 Quarterly $2,192.56 Quarterly $1,857.65 Quarterly $2,386.38\n\nMonth Bank Draft $490.18 Month Bank Draft $629.72 Month Bank Draft $541.00 Month Bank Draft $694.98 Month Bank Draft $588.83 Month Bank Draft $756.44\n\n**73** Annual $5,992.02 **84** Annual $7,644.06 **73** Annual $6,613.02 **84** Annual $8,436.33 **73** Annual $7,197.70 **84** Annual $9,182.11\n\nSemi-Annual $3,115.85 Semi-Annual $3,974.92 Semi-Annual $3,438.77 Semi-Annual $4,386.89 Semi-Annual $3,742.81 Semi-Annual $4,774.72\n\nQuarterly $1,587.88 Quarterly $2,025.69 Quarterly $1,752.45 Quarterly $2,235.61 Quarterly $1,907.40 Quarterly $2,433.29\n\nMonth Bank Draft $503.32 Month Bank Draft $642.10 Month Bank Draft $555.49 Month Bank Draft $708.66 Month Bank Draft $604.60 Month Bank Draft $771.30\n\n**74** Annual $6,143.80 **85+** Annual $8,170.85 **74** Annual $6,780.59 **85+** Annual $9,017.85 **74** Annual $7,379.95 **85+** Annual $9,815.02\n\nSemi-Annual $3,194.78 Semi-Annual $4,248.85 Semi-Annual $3,525.92 Semi-Annual $4,689.28 Semi-Annual $3,837.57 Semi-Annual $5,103.81\n\nQuarterly $1,628.10 Quarterly $2,165.27 Quarterly $1,796.84 Quarterly $2,389.73 Quarterly $1,955.70 Quarterly $2,600.94\n\nMonth Bank Draft $516.10 Month Bank Draft $686.35 Month Bank Draft $569.56 Month Bank Draft $757.48 Month Bank Draft $619.92 Month Bank Draft $824.46\n\n**75** Annual $6,300.05 **Under** Annual $0.00 **75** Annual $6,953.08 **Under** Annual $0.00 **75** Annual $7,567.69 **Under** Annual $0.00\n\nSemi-Annual $3,276.03 **65 Disabled** Semi-Annual N/A Semi-Annual $3,615.58 **65 Disabled** Semi-Annual N/A Semi-Annual $3,935.22 **65 Disabled** Semi-Annual N/A\n\nQuarterly $1,669.48 Quarterly $0.00 Quarterly $1,842.56 Quarterly $0.00 Quarterly $2,005.43 Quarterly $0.00\n\nMonth Bank Draft $529.19 Month Bank Draft $0.00 Month Bank Draft $584.10 Month Bank Draft $0.00 Month Bank Draft $635.68 Month Bank Draft $0.00\n\n_Note The above rates reflect current deductible and benefit levels. We anticipate that they will need to be adjusted each year to_\n\n_reflect deductible and/or benefit changes, trend, and utilization changes. Premiums will change as your age changes. NAIC Co. Code: 64211 FEIN: 36-1174500_ 15D549\n\n_\\* Monthly Bank Draft (MBD) requires 2 months submitted._ TX\n\n_01/012022_\n\n**(Zips 750-753, 760-762, 783-784)**\n\n**Guarantee Trust Life Insurance Company - 2022 Gross Premiums - Texas**","pages":[{"line_numbers":[],"markdown":"**Group Standardized Medicare Supplement Policy Form 9743F**\n\n**Zips All Others (Zips 770-775)**\n\n**Attained Plan F Attained Plan F Attained Plan F Attained Plan F Attained Plan F Attained Plan F**\n\n**Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F**\n\n**65** Annual $4,656.86 **76** Annual $6,451.86 **65** Annual $5,139.71 **76** Annual $7,120.67 **65** Annual $5,594.00 **76** Annual $7,750.09\n\nSemi-Annual $2,421.57 Semi-Annual $3,354.99 Semi-Annual $2,672.65 Semi-Annual $3,702.72 Semi-Annual $2,908.88 Semi-Annual $4,030.07\n\nQuarterly $1,234.08 Quarterly $1,709.76 Quarterly $1,362.04 Quarterly $1,886.99 Quarterly $1,482.41 Quarterly $2,053.77\n\nMonth Bank Draft $391.20 Month Bank Draft $541.95 Month Bank Draft $431.74 Month Bank Draft $598.13 Month Bank Draft $469.90 Month Bank Draft $651.01\n\n**66** Annual $4,808.81 **77** Annual $6,608.12 **66** Annual $5,307.18 **77** Annual $7,293.11 **66** Annual $5,776.39 **77** Annual $7,937.80\n\nSemi-Annual $2,500.60 Semi-Annual $3,436.24 Semi-Annual $2,759.72 Semi-Annual $3,792.41 Semi-Annual $3,003.74 Semi-Annual $4,127.65\n\nQuarterly $1,274.31 Quarterly $1,751.15 Quarterly $1,406.42 Quarterly $1,932.69 Quarterly $1,530.74 Quarterly $2,103.53\n\nMonth Bank Draft $403.94 Month Bank Draft $555.08 Month Bank Draft $445.82 Month Bank Draft $612.60 Month Bank Draft $485.22 Month Bank Draft $666.77\n\n**67** Annual $4,965.07 **78** Annual $6,755.43 **67** Annual $5,479.64 **78** Annual $7,455.78 **67** Annual $5,964.11 **78** Annual $8,114.79\n\nSemi-Annual $2,581.83 Semi-Annual $3,512.80 Semi-Annual $2,849.42 Semi-Annual $3,877.01 Semi-Annual $3,101.32 Semi-Annual $4,219.70\n\nQuarterly $1,315.74 Quarterly $1,790.20 Quarterly $1,452.12 Quarterly $1,975.76 Quarterly $1,580.49 Quarterly $2,150.41\n\nMonth Bank Draft $417.08 Month Bank Draft $567.46 Month Bank Draft $460.32 Month Bank Draft $626.27 Month Bank Draft $501.00 Month Bank Draft $681.63\n\n**68** Annual $5,130.20 **79** Annual $6,902.84 **68** Annual $5,662.03 **79** Annual $7,618.31 **68** Annual $6,162.58 **79** Annual $8,291.73\n\nSemi-Annual $2,667.69 Semi-Annual $3,589.49 Semi-Annual $2,944.29 Semi-Annual $3,961.53 Semi-Annual $3,204.53 Semi-Annual $4,311.70\n\nQuarterly $1,359.50 Quarterly $1,829.27 Quarterly $1,500.46 Quarterly $2,018.88 Quarterly $1,633.09 Quarterly $2,197.23\n\nMonth Bank Draft $430.91 Month Bank Draft $579.79 Month Bank Draft $475.61 Month Bank Draft $639.93 Month Bank Draft $517.65 Month Bank Draft $696.51\n\n**69** Annual $5,304.30 **80** Annual $7,054.60 **69** Annual $5,854.26 **80** Annual $7,785.86 **69** Annual $6,371.66 **80** Annual $8,474.17\n\nSemi-Annual $2,758.25 Semi-Annual $3,668.37 Semi-Annual $3,044.22 Semi-Annual $4,048.64 Semi-Annual $3,313.29 Semi-Annual $4,406.56\n\nQuarterly $1,405.65 Quarterly $1,869.47 Quarterly $1,551.39 Quarterly $2,063.25 Quarterly $1,688.51 Quarterly $2,245.65\n\nMonth Bank Draft $445.59 Month Bank Draft $592.61 Month Bank Draft $491.76 Month Bank Draft $654.01 Month Bank Draft $535.24 Month Bank Draft $711.83\n\n**70** Annual $5,482.92 **81** Annual $7,201.94 **70** Annual $6,051.37 **81** Annual $7,948.56 **70** Annual $6,586.19 **81** Annual $8,651.11\n\nSemi-Annual $2,851.10 Semi-Annual $3,744.99 Semi-Annual $3,146.72 Semi-Annual $4,133.26 Semi-Annual $3,424.84 Semi-Annual $4,498.57\n\nQuarterly $1,452.97 Quarterly $1,908.51 Quarterly $1,603.62 Quarterly $2,106.39 Quarterly $1,745.37 Quarterly $2,292.54\n\nMonth Bank Draft $460.57 Month Bank Draft $604.97 Month Bank Draft $508.32 Month Bank Draft $667.70 Month Bank Draft $553.23 Month Bank Draft $726.69\n\n**71** Annual $5,661.51 **82** Annual $7,349.35 **71** Annual $6,248.47 **82** Annual $8,111.07 **71** Annual $6,800.73 **82** Annual $8,828.06\n\nSemi-Annual $2,943.97 Semi-Annual $3,821.69 Semi-Annual $3,249.24 Semi-Annual $4,217.77 Semi-Annual $3,536.37 Semi-Annual $4,590.59\n\nQuarterly $1,500.32 Quarterly $1,947.59 Quarterly $1,655.85 Quarterly $2,149.46 Quarterly $1,802.19 Quarterly $2,339.43\n\nMonth Bank Draft $475.56 Month Bank Draft $617.37 Month Bank Draft $524.84 Month Bank Draft $681.32 Month Bank Draft $571.29 Month Bank Draft $741.54\n\n**72** Annual $5,835.74 **83** Annual $7,496.61 **72** Annual $6,440.55 **83** Annual $8,273.78 **72** Annual $7,009.98 **83** Annual $9,005.18\n\nSemi-Annual $3,034.58 Semi-Annual $3,898.25 Semi-Annual $3,349.05 Semi-Annual $4,302.38 Semi-Annual $3,645.16 Semi-Annual $4,682.69\n\nQuarterly $1,546.48 Quarterly $1,986.63 Quarterly $1,706.73 Quarterly $2,192.56 Quarterly $1,857.65 Quarterly $2,386.38\n\nMonth Bank Draft $490.18 Month Bank Draft $629.72 Month Bank Draft $541.00 Month Bank Draft $694.98 Month Bank Draft $588.83 Month Bank Draft $756.44\n\n**73** Annual $5,992.02 **84** Annual $7,644.06 **73** Annual $6,613.02 **84** Annual $8,436.33 **73** Annual $7,197.70 **84** Annual $9,182.11\n\nSemi-Annual $3,115.85 Semi-Annual $3,974.92 Semi-Annual $3,438.77 Semi-Annual $4,386.89 Semi-Annual $3,742.81 Semi-Annual $4,774.72\n\nQuarterly $1,587.88 Quarterly $2,025.69 Quarterly $1,752.45 Quarterly $2,235.61 Quarterly $1,907.40 Quarterly $2,433.29\n\nMonth Bank Draft $503.32 Month Bank Draft $642.10 Month Bank Draft $555.49 Month Bank Draft $708.66 Month Bank Draft $604.60 Month Bank Draft $771.30\n\n**74** Annual $6,143.80 **85+** Annual $8,170.85 **74** Annual $6,780.59 **85+** Annual $9,017.85 **74** Annual $7,379.95 **85+** Annual $9,815.02\n\nSemi-Annual $3,194.78 Semi-Annual $4,248.85 Semi-Annual $3,525.92 Semi-Annual $4,689.28 Semi-Annual $3,837.57 Semi-Annual $5,103.81\n\nQuarterly $1,628.10 Quarterly $2,165.27 Quarterly $1,796.84 Quarterly $2,389.73 Quarterly $1,955.70 Quarterly $2,600.94\n\nMonth Bank Draft $516.10 Month Bank Draft $686.35 Month Bank Draft $569.56 Month Bank Draft $757.48 Month Bank Draft $619.92 Month Bank Draft $824.46\n\n**75** Annual $6,300.05 **Under** Annual $0.00 **75** Annual $6,953.08 **Under** Annual $0.00 **75** Annual $7,567.69 **Under** Annual $0.00\n\nSemi-Annual $3,276.03 **65 Disabled** Semi-Annual N/A Semi-Annual $3,615.58 **65 Disabled** Semi-Annual N/A Semi-Annual $3,935.22 **65 Disabled** Semi-Annual N/A\n\nQuarterly $1,669.48 Quarterly $0.00 Quarterly $1,842.56 Quarterly $0.00 Quarterly $2,005.43 Quarterly $0.00\n\nMonth Bank Draft $529.19 Month Bank Draft $0.00 Month Bank Draft $584.10 Month Bank Draft $0.00 Month Bank Draft $635.68 Month Bank Draft $0.00\n\n_Note The above rates reflect current deductible and benefit levels. We anticipate that they will need to be adjusted each year to_\n\n_reflect deductible and/or benefit changes, trend, and utilization changes. Premiums will change as your age changes. NAIC Co. Code: 64211 FEIN: 36-1174500_ 15D549\n\n_\\* Monthly Bank Draft (MBD) requires 2 months submitted._ TX\n\n_01/012022_\n\n**(Zips 750-753, 760-762, 783-784)**\n\n**Guarantee Trust Life Insurance Company - 2022 Gross Premiums - Texas**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Group Standardized Medicare Supplement Policy Form 9743F**\n\n**Zips All Others (Zips 770-775)**\n\n**Attained Plan F Attained Plan F Attained Plan F Attained Plan F Attained Plan F Attained Plan F**\n\n**Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F**\n\n**65** Annual $4,656.86 **76** Annual $6,451.86 **65** Annual $5,139.71 **76** Annual $7,120.67 **65** Annual $5,594.00 **76** Annual $7,750.09\n\nSemi-Annual $2,421.57 Semi-Annual $3,354.99 Semi-Annual $2,672.65 Semi-Annual $3,702.72 Semi-Annual $2,908.88 Semi-Annual $4,030.07\n\nQuarterly $1,234.08 Quarterly $1,709.76 Quarterly $1,362.04 Quarterly $1,886.99 Quarterly $1,482.41 Quarterly $2,053.77\n\nMonth Bank Draft $391.20 Month Bank Draft $541.95 Month Bank Draft $431.74 Month Bank Draft $598.13 Month Bank Draft $469.90 Month Bank Draft $651.01\n\n**66** Annual $4,808.81 **77** Annual $6,608.12 **66** Annual $5,307.18 **77** Annual $7,293.11 **66** Annual $5,776.39 **77** Annual $7,937.80\n\nSemi-Annual $2,500.60 Semi-Annual $3,436.24 Semi-Annual $2,759.72 Semi-Annual $3,792.41 Semi-Annual $3,003.74 Semi-Annual $4,127.65\n\nQuarterly $1,274.31 Quarterly $1,751.15 Quarterly $1,406.42 Quarterly $1,932.69 Quarterly $1,530.74 Quarterly $2,103.53\n\nMonth Bank Draft $403.94 Month Bank Draft $555.08 Month Bank Draft $445.82 Month Bank Draft $612.60 Month Bank Draft $485.22 Month Bank Draft $666.77\n\n**67** Annual $4,965.07 **78** Annual $6,755.43 **67** Annual $5,479.64 **78** Annual $7,455.78 **67** Annual $5,964.11 **78** Annual $8,114.79\n\nSemi-Annual $2,581.83 Semi-Annual $3,512.80 Semi-Annual $2,849.42 Semi-Annual $3,877.01 Semi-Annual $3,101.32 Semi-Annual $4,219.70\n\nQuarterly $1,315.74 Quarterly $1,790.20 Quarterly $1,452.12 Quarterly $1,975.76 Quarterly $1,580.49 Quarterly $2,150.41\n\nMonth Bank Draft $417.08 Month Bank Draft $567.46 Month Bank Draft $460.32 Month Bank Draft $626.27 Month Bank Draft $501.00 Month Bank Draft $681.63\n\n**68** Annual $5,130.20 **79** Annual $6,902.84 **68** Annual $5,662.03 **79** Annual $7,618.31 **68** Annual $6,162.58 **79** Annual $8,291.73\n\nSemi-Annual $2,667.69 Semi-Annual $3,589.49 Semi-Annual $2,944.29 Semi-Annual $3,961.53 Semi-Annual $3,204.53 Semi-Annual $4,311.70\n\nQuarterly $1,359.50 Quarterly $1,829.27 Quarterly $1,500.46 Quarterly $2,018.88 Quarterly $1,633.09 Quarterly $2,197.23\n\nMonth Bank Draft $430.91 Month Bank Draft $579.79 Month Bank Draft $475.61 Month Bank Draft $639.93 Month Bank Draft $517.65 Month Bank Draft $696.51\n\n**69** Annual $5,304.30 **80** Annual $7,054.60 **69** Annual $5,854.26 **80** Annual $7,785.86 **69** Annual $6,371.66 **80** Annual $8,474.17\n\nSemi-Annual $2,758.25 Semi-Annual $3,668.37 Semi-Annual $3,044.22 Semi-Annual $4,048.64 Semi-Annual $3,313.29 Semi-Annual $4,406.56\n\nQuarterly $1,405.65 Quarterly $1,869.47 Quarterly $1,551.39 Quarterly $2,063.25 Quarterly $1,688.51 Quarterly $2,245.65\n\nMonth Bank Draft $445.59 Month Bank Draft $592.61 Month Bank Draft $491.76 Month Bank Draft $654.01 Month Bank Draft $535.24 Month Bank Draft $711.83\n\n**70** Annual $5,482.92 **81** Annual $7,201.94 **70** Annual $6,051.37 **81** Annual $7,948.56 **70** Annual $6,586.19 **81** Annual $8,651.11\n\nSemi-Annual $2,851.10 Semi-Annual $3,744.99 Semi-Annual $3,146.72 Semi-Annual $4,133.26 Semi-Annual $3,424.84 Semi-Annual $4,498.57\n\nQuarterly $1,452.97 Quarterly $1,908.51 Quarterly $1,603.62 Quarterly $2,106.39 Quarterly $1,745.37 Quarterly $2,292.54\n\nMonth Bank Draft $460.57 Month Bank Draft $604.97 Month Bank Draft $508.32 Month Bank Draft $667.70 Month Bank Draft $553.23 Month Bank Draft $726.69\n\n**71** Annual $5,661.51 **82** Annual $7,349.35 **71** Annual $6,248.47 **82** Annual $8,111.07 **71** Annual $6,800.73 **82** Annual $8,828.06\n\nSemi-Annual $2,943.97 Semi-Annual $3,821.69 Semi-Annual $3,249.24 Semi-Annual $4,217.77 Semi-Annual $3,536.37 Semi-Annual $4,590.59\n\nQuarterly $1,500.32 Quarterly $1,947.59 Quarterly $1,655.85 Quarterly $2,149.46 Quarterly $1,802.19 Quarterly $2,339.43\n\nMonth Bank Draft $475.56 Month Bank Draft $617.37 Month Bank Draft $524.84 Month Bank Draft $681.32 Month Bank Draft $571.29 Month Bank Draft $741.54\n\n**72** Annual $5,835.74 **83** Annual $7,496.61 **72** Annual $6,440.55 **83** Annual $8,273.78 **72** Annual $7,009.98 **83** Annual $9,005.18\n\nSemi-Annual $3,034.58 Semi-Annual $3,898.25 Semi-Annual $3,349.05 Semi-Annual $4,302.38 Semi-Annual $3,645.16 Semi-Annual $4,682.69\n\nQuarterly $1,546.48 Quarterly $1,986.63 Quarterly $1,706.73 Quarterly $2,192.56 Quarterly $1,857.65 Quarterly $2,386.38\n\nMonth Bank Draft $490.18 Month Bank Draft $629.72 Month Bank Draft $541.00 Month Bank Draft $694.98 Month Bank Draft $588.83 Month Bank Draft $756.44\n\n**73** Annual $5,992.02 **84** Annual $7,644.06 **73** Annual $6,613.02 **84** Annual $8,436.33 **73** Annual $7,197.70 **84** Annual $9,182.11\n\nSemi-Annual $3,115.85 Semi-Annual $3,974.92 Semi-Annual $3,438.77 Semi-Annual $4,386.89 Semi-Annual $3,742.81 Semi-Annual $4,774.72\n\nQuarterly $1,587.88 Quarterly $2,025.69 Quarterly $1,752.45 Quarterly $2,235.61 Quarterly $1,907.40 Quarterly $2,433.29\n\nMonth Bank Draft $503.32 Month Bank Draft $642.10 Month Bank Draft $555.49 Month Bank Draft $708.66 Month Bank Draft $604.60 Month Bank Draft $771.30\n\n**74** Annual $6,143.80 **85+** Annual $8,170.85 **74** Annual $6,780.59 **85+** Annual $9,017.85 **74** Annual $7,379.95 **85+** Annual $9,815.02\n\nSemi-Annual $3,194.78 Semi-Annual $4,248.85 Semi-Annual $3,525.92 Semi-Annual $4,689.28 Semi-Annual $3,837.57 Semi-Annual $5,103.81\n\nQuarterly $1,628.10 Quarterly $2,165.27 Quarterly $1,796.84 Quarterly $2,389.73 Quarterly $1,955.70 Quarterly $2,600.94\n\nMonth Bank Draft $516.10 Month Bank Draft $686.35 Month Bank Draft $569.56 Month Bank Draft $757.48 Month Bank Draft $619.92 Month Bank Draft $824.46\n\n**75** Annual $6,300.05 **Under** Annual $0.00 **75** Annual $6,953.08 **Under** Annual $0.00 **75** Annual $7,567.69 **Under** Annual $0.00\n\nSemi-Annual $3,276.03 **65 Disabled** Semi-Annual N/A Semi-Annual $3,615.58 **65 Disabled** Semi-Annual N/A Semi-Annual $3,935.22 **65 Disabled** Semi-Annual N/A\n\nQuarterly $1,669.48 Quarterly $0.00 Quarterly $1,842.56 Quarterly $0.00 Quarterly $2,005.43 Quarterly $0.00\n\nMonth Bank Draft $529.19 Month Bank Draft $0.00 Month Bank Draft $584.10 Month Bank Draft $0.00 Month Bank Draft $635.68 Month Bank Draft $0.00\n\n_Note The above rates reflect current deductible and benefit levels. We anticipate that they will need to be adjusted each year to_\n\n_reflect deductible and/or benefit changes, trend, and utilization changes. Premiums will change as your age changes. NAIC Co. Code: 64211 FEIN: 36-1174500_ 15D549\n\n_\\* Monthly Bank Draft (MBD) requires 2 months submitted._ TX\n\n_01/012022_\n\n**(Zips 750-753, 760-762, 783-784)**\n\n**Guarantee Trust Life Insurance Company - 2022 Gross Premiums - Texas**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page810.pdf"]},"response":{"errors":[],"extract_id":"extract_3841a37d20312e44839c7e6099e4a3f2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Group Standardized Medicare Supplement Policy Form 9743F**\n\n**Zips All Others (Zips 770-775)**\n\n**Attained Plan F Attained Plan F Attained Plan F Attained Plan F Attained Plan F Attained Plan F**\n\n**Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F**\n\n**65** Annual $4,656.86 **76** Annual $6,451.86 **65** Annual $5,139.71 **76** Annual $7,120.67 **65** Annual $5,594.00 **76** Annual $7,750.09\n\nSemi-Annual $2,421.57 Semi-Annual $3,354.99 Semi-Annual $2,672.65 Semi-Annual $3,702.72 Semi-Annual $2,908.88 Semi-Annual $4,030.07\n\nQuarterly $1,234.08 Quarterly $1,709.76 Quarterly $1,362.04 Quarterly $1,886.99 Quarterly $1,482.41 Quarterly $2,053.77\n\nMonth Bank Draft $391.20 Month Bank Draft $541.95 Month Bank Draft $431.74 Month Bank Draft $598.13 Month Bank Draft $469.90 Month Bank Draft $651.01\n\n**66** Annual $4,808.81 **77** Annual $6,608.12 **66** Annual $5,307.18 **77** Annual $7,293.11 **66** Annual $5,776.39 **77** Annual $7,937.80\n\nSemi-Annual $2,500.60 Semi-Annual $3,436.24 Semi-Annual $2,759.72 Semi-Annual $3,792.41 Semi-Annual $3,003.74 Semi-Annual $4,127.65\n\nQuarterly $1,274.31 Quarterly $1,751.15 Quarterly $1,406.42 Quarterly $1,932.69 Quarterly $1,530.74 Quarterly $2,103.53\n\nMonth Bank Draft $403.94 Month Bank Draft $555.08 Month Bank Draft $445.82 Month Bank Draft $612.60 Month Bank Draft $485.22 Month Bank Draft $666.77\n\n**67** Annual $4,965.07 **78** Annual $6,755.43 **67** Annual $5,479.64 **78** Annual $7,455.78 **67** Annual $5,964.11 **78** Annual $8,114.79\n\nSemi-Annual $2,581.83 Semi-Annual $3,512.80 Semi-Annual $2,849.42 Semi-Annual $3,877.01 Semi-Annual $3,101.32 Semi-Annual $4,219.70\n\nQuarterly $1,315.74 Quarterly $1,790.20 Quarterly $1,452.12 Quarterly $1,975.76 Quarterly $1,580.49 Quarterly $2,150.41\n\nMonth Bank Draft $417.08 Month Bank Draft $567.46 Month Bank Draft $460.32 Month Bank Draft $626.27 Month Bank Draft $501.00 Month Bank Draft $681.63\n\n**68** Annual $5,130.20 **79** Annual $6,902.84 **68** Annual $5,662.03 **79** Annual $7,618.31 **68** Annual $6,162.58 **79** Annual $8,291.73\n\nSemi-Annual $2,667.69 Semi-Annual $3,589.49 Semi-Annual $2,944.29 Semi-Annual $3,961.53 Semi-Annual $3,204.53 Semi-Annual $4,311.70\n\nQuarterly $1,359.50 Quarterly $1,829.27 Quarterly $1,500.46 Quarterly $2,018.88 Quarterly $1,633.09 Quarterly $2,197.23\n\nMonth Bank Draft $430.91 Month Bank Draft $579.79 Month Bank Draft $475.61 Month Bank Draft $639.93 Month Bank Draft $517.65 Month Bank Draft $696.51\n\n**69** Annual $5,304.30 **80** Annual $7,054.60 **69** Annual $5,854.26 **80** Annual $7,785.86 **69** Annual $6,371.66 **80** Annual $8,474.17\n\nSemi-Annual $2,758.25 Semi-Annual $3,668.37 Semi-Annual $3,044.22 Semi-Annual $4,048.64 Semi-Annual $3,313.29 Semi-Annual $4,406.56\n\nQuarterly $1,405.65 Quarterly $1,869.47 Quarterly $1,551.39 Quarterly $2,063.25 Quarterly $1,688.51 Quarterly $2,245.65\n\nMonth Bank Draft $445.59 Month Bank Draft $592.61 Month Bank Draft $491.76 Month Bank Draft $654.01 Month Bank Draft $535.24 Month Bank Draft $711.83\n\n**70** Annual $5,482.92 **81** Annual $7,201.94 **70** Annual $6,051.37 **81** Annual $7,948.56 **70** Annual $6,586.19 **81** Annual $8,651.11\n\nSemi-Annual $2,851.10 Semi-Annual $3,744.99 Semi-Annual $3,146.72 Semi-Annual $4,133.26 Semi-Annual $3,424.84 Semi-Annual $4,498.57\n\nQuarterly $1,452.97 Quarterly $1,908.51 Quarterly $1,603.62 Quarterly $2,106.39 Quarterly $1,745.37 Quarterly $2,292.54\n\nMonth Bank Draft $460.57 Month Bank Draft $604.97 Month Bank Draft $508.32 Month Bank Draft $667.70 Month Bank Draft $553.23 Month Bank Draft $726.69\n\n**71** Annual $5,661.51 **82** Annual $7,349.35 **71** Annual $6,248.47 **82** Annual $8,111.07 **71** Annual $6,800.73 **82** Annual $8,828.06\n\nSemi-Annual $2,943.97 Semi-Annual $3,821.69 Semi-Annual $3,249.24 Semi-Annual $4,217.77 Semi-Annual $3,536.37 Semi-Annual $4,590.59\n\nQuarterly $1,500.32 Quarterly $1,947.59 Quarterly $1,655.85 Quarterly $2,149.46 Quarterly $1,802.19 Quarterly $2,339.43\n\nMonth Bank Draft $475.56 Month Bank Draft $617.37 Month Bank Draft $524.84 Month Bank Draft $681.32 Month Bank Draft $571.29 Month Bank Draft $741.54\n\n**72** Annual $5,835.74 **83** Annual $7,496.61 **72** Annual $6,440.55 **83** Annual $8,273.78 **72** Annual $7,009.98 **83** Annual $9,005.18\n\nSemi-Annual $3,034.58 Semi-Annual $3,898.25 Semi-Annual $3,349.05 Semi-Annual $4,302.38 Semi-Annual $3,645.16 Semi-Annual $4,682.69\n\nQuarterly $1,546.48 Quarterly $1,986.63 Quarterly $1,706.73 Quarterly $2,192.56 Quarterly $1,857.65 Quarterly $2,386.38\n\nMonth Bank Draft $490.18 Month Bank Draft $629.72 Month Bank Draft $541.00 Month Bank Draft $694.98 Month Bank Draft $588.83 Month Bank Draft $756.44\n\n**73** Annual $5,992.02 **84** Annual $7,644.06 **73** Annual $6,613.02 **84** Annual $8,436.33 **73** Annual $7,197.70 **84** Annual $9,182.11\n\nSemi-Annual $3,115.85 Semi-Annual $3,974.92 Semi-Annual $3,438.77 Semi-Annual $4,386.89 Semi-Annual $3,742.81 Semi-Annual $4,774.72\n\nQuarterly $1,587.88 Quarterly $2,025.69 Quarterly $1,752.45 Quarterly $2,235.61 Quarterly $1,907.40 Quarterly $2,433.29\n\nMonth Bank Draft $503.32 Month Bank Draft $642.10 Month Bank Draft $555.49 Month Bank Draft $708.66 Month Bank Draft $604.60 Month Bank Draft $771.30\n\n**74** Annual $6,143.80 **85+** Annual $8,170.85 **74** Annual $6,780.59 **85+** Annual $9,017.85 **74** Annual $7,379.95 **85+** Annual $9,815.02\n\nSemi-Annual $3,194.78 Semi-Annual $4,248.85 Semi-Annual $3,525.92 Semi-Annual $4,689.28 Semi-Annual $3,837.57 Semi-Annual $5,103.81\n\nQuarterly $1,628.10 Quarterly $2,165.27 Quarterly $1,796.84 Quarterly $2,389.73 Quarterly $1,955.70 Quarterly $2,600.94\n\nMonth Bank Draft $516.10 Month Bank Draft $686.35 Month Bank Draft $569.56 Month Bank Draft $757.48 Month Bank Draft $619.92 Month Bank Draft $824.46\n\n**75** Annual $6,300.05 **Under** Annual $0.00 **75** Annual $6,953.08 **Under** Annual $0.00 **75** Annual $7,567.69 **Under** Annual $0.00\n\nSemi-Annual $3,276.03 **65 Disabled** Semi-Annual N/A Semi-Annual $3,615.58 **65 Disabled** Semi-Annual N/A Semi-Annual $3,935.22 **65 Disabled** Semi-Annual N/A\n\nQuarterly $1,669.48 Quarterly $0.00 Quarterly $1,842.56 Quarterly $0.00 Quarterly $2,005.43 Quarterly $0.00\n\nMonth Bank Draft $529.19 Month Bank Draft $0.00 Month Bank Draft $584.10 Month Bank Draft $0.00 Month Bank Draft $635.68 Month Bank Draft $0.00\n\n_Note The above rates reflect current deductible and benefit levels. We anticipate that they will need to be adjusted each year to_\n\n_reflect deductible and/or benefit changes, trend, and utilization changes. Premiums will change as your age changes. NAIC Co. Code: 64211 FEIN: 36-1174500_ 15D549\n\n_\\* Monthly Bank Draft (MBD) requires 2 months submitted._ TX\n\n_01/012022_\n\n**(Zips 750-753, 760-762, 783-784)**\n\n**Guarantee Trust Life Insurance Company - 2022 Gross Premiums - Texas**"],"full_content":"**Group Standardized Medicare Supplement Policy Form 9743F**\n\n**Zips All Others (Zips 770-775)**\n\n**Attained Plan F Attained Plan F Attained Plan F Attained Plan F Attained Plan F Attained Plan F**\n\n**Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F Age Mode 9743F**\n\n**65** Annual $4,656.86 **76** Annual $6,451.86 **65** Annual $5,139.71 **76** Annual $7,120.67 **65** Annual $5,594.00 **76** Annual $7,750.09\n\nSemi-Annual $2,421.57 Semi-Annual $3,354.99 Semi-Annual $2,672.65 Semi-Annual $3,702.72 Semi-Annual $2,908.88 Semi-Annual $4,030.07\n\nQuarterly $1,234.08 Quarterly $1,709.76 Quarterly $1,362.04 Quarterly $1,886.99 Quarterly $1,482.41 Quarterly $2,053.77\n\nMonth Bank Draft $391.20 Month Bank Draft $541.95 Month Bank Draft $431.74 Month Bank Draft $598.13 Month Bank Draft $469.90 Month Bank Draft $651.01\n\n**66** Annual $4,808.81 **77** Annual $6,608.12 **66** Annual $5,307.18 **77** Annual $7,293.11 **66** Annual $5,776.39 **77** Annual $7,937.80\n\nSemi-Annual $2,500.60 Semi-Annual $3,436.24 Semi-Annual $2,759.72 Semi-Annual $3,792.41 Semi-Annual $3,003.74 Semi-Annual $4,127.65\n\nQuarterly $1,274.31 Quarterly $1,751.15 Quarterly $1,406.42 Quarterly $1,932.69 Quarterly $1,530.74 Quarterly $2,103.53\n\nMonth Bank Draft $403.94 Month Bank Draft $555.08 Month Bank Draft $445.82 Month Bank Draft $612.60 Month Bank Draft $485.22 Month Bank Draft $666.77\n\n**67** Annual $4,965.07 **78** Annual $6,755.43 **67** Annual $5,479.64 **78** Annual $7,455.78 **67** Annual $5,964.11 **78** Annual $8,114.79\n\nSemi-Annual $2,581.83 Semi-Annual $3,512.80 Semi-Annual $2,849.42 Semi-Annual $3,877.01 Semi-Annual $3,101.32 Semi-Annual $4,219.70\n\nQuarterly $1,315.74 Quarterly $1,790.20 Quarterly $1,452.12 Quarterly $1,975.76 Quarterly $1,580.49 Quarterly $2,150.41\n\nMonth Bank Draft $417.08 Month Bank Draft $567.46 Month Bank Draft $460.32 Month Bank Draft $626.27 Month Bank Draft $501.00 Month Bank Draft $681.63\n\n**68** Annual $5,130.20 **79** Annual $6,902.84 **68** Annual $5,662.03 **79** Annual $7,618.31 **68** Annual $6,162.58 **79** Annual $8,291.73\n\nSemi-Annual $2,667.69 Semi-Annual $3,589.49 Semi-Annual $2,944.29 Semi-Annual $3,961.53 Semi-Annual $3,204.53 Semi-Annual $4,311.70\n\nQuarterly $1,359.50 Quarterly $1,829.27 Quarterly $1,500.46 Quarterly $2,018.88 Quarterly $1,633.09 Quarterly $2,197.23\n\nMonth Bank Draft $430.91 Month Bank Draft $579.79 Month Bank Draft $475.61 Month Bank Draft $639.93 Month Bank Draft $517.65 Month Bank Draft $696.51\n\n**69** Annual $5,304.30 **80** Annual $7,054.60 **69** Annual $5,854.26 **80** Annual $7,785.86 **69** Annual $6,371.66 **80** Annual $8,474.17\n\nSemi-Annual $2,758.25 Semi-Annual $3,668.37 Semi-Annual $3,044.22 Semi-Annual $4,048.64 Semi-Annual $3,313.29 Semi-Annual $4,406.56\n\nQuarterly $1,405.65 Quarterly $1,869.47 Quarterly $1,551.39 Quarterly $2,063.25 Quarterly $1,688.51 Quarterly $2,245.65\n\nMonth Bank Draft $445.59 Month Bank Draft $592.61 Month Bank Draft $491.76 Month Bank Draft $654.01 Month Bank Draft $535.24 Month Bank Draft $711.83\n\n**70** Annual $5,482.92 **81** Annual $7,201.94 **70** Annual $6,051.37 **81** Annual $7,948.56 **70** Annual $6,586.19 **81** Annual $8,651.11\n\nSemi-Annual $2,851.10 Semi-Annual $3,744.99 Semi-Annual $3,146.72 Semi-Annual $4,133.26 Semi-Annual $3,424.84 Semi-Annual $4,498.57\n\nQuarterly $1,452.97 Quarterly $1,908.51 Quarterly $1,603.62 Quarterly $2,106.39 Quarterly $1,745.37 Quarterly $2,292.54\n\nMonth Bank Draft $460.57 Month Bank Draft $604.97 Month Bank Draft $508.32 Month Bank Draft $667.70 Month Bank Draft $553.23 Month Bank Draft $726.69\n\n**71** Annual $5,661.51 **82** Annual $7,349.35 **71** Annual $6,248.47 **82** Annual $8,111.07 **71** Annual $6,800.73 **82** Annual $8,828.06\n\nSemi-Annual $2,943.97 Semi-Annual $3,821.69 Semi-Annual $3,249.24 Semi-Annual $4,217.77 Semi-Annual $3,536.37 Semi-Annual $4,590.59\n\nQuarterly $1,500.32 Quarterly $1,947.59 Quarterly $1,655.85 Quarterly $2,149.46 Quarterly $1,802.19 Quarterly $2,339.43\n\nMonth Bank Draft $475.56 Month Bank Draft $617.37 Month Bank Draft $524.84 Month Bank Draft $681.32 Month Bank Draft $571.29 Month Bank Draft $741.54\n\n**72** Annual $5,835.74 **83** Annual $7,496.61 **72** Annual $6,440.55 **83** Annual $8,273.78 **72** Annual $7,009.98 **83** Annual $9,005.18\n\nSemi-Annual $3,034.58 Semi-Annual $3,898.25 Semi-Annual $3,349.05 Semi-Annual $4,302.38 Semi-Annual $3,645.16 Semi-Annual $4,682.69\n\nQuarterly $1,546.48 Quarterly $1,986.63 Quarterly $1,706.73 Quarterly $2,192.56 Quarterly $1,857.65 Quarterly $2,386.38\n\nMonth Bank Draft $490.18 Month Bank Draft $629.72 Month Bank Draft $541.00 Month Bank Draft $694.98 Month Bank Draft $588.83 Month Bank Draft $756.44\n\n**73** Annual $5,992.02 **84** Annual $7,644.06 **73** Annual $6,613.02 **84** Annual $8,436.33 **73** Annual $7,197.70 **84** Annual $9,182.11\n\nSemi-Annual $3,115.85 Semi-Annual $3,974.92 Semi-Annual $3,438.77 Semi-Annual $4,386.89 Semi-Annual $3,742.81 Semi-Annual $4,774.72\n\nQuarterly $1,587.88 Quarterly $2,025.69 Quarterly $1,752.45 Quarterly $2,235.61 Quarterly $1,907.40 Quarterly $2,433.29\n\nMonth Bank Draft $503.32 Month Bank Draft $642.10 Month Bank Draft $555.49 Month Bank Draft $708.66 Month Bank Draft $604.60 Month Bank Draft $771.30\n\n**74** Annual $6,143.80 **85+** Annual $8,170.85 **74** Annual $6,780.59 **85+** Annual $9,017.85 **74** Annual $7,379.95 **85+** Annual $9,815.02\n\nSemi-Annual $3,194.78 Semi-Annual $4,248.85 Semi-Annual $3,525.92 Semi-Annual $4,689.28 Semi-Annual $3,837.57 Semi-Annual $5,103.81\n\nQuarterly $1,628.10 Quarterly $2,165.27 Quarterly $1,796.84 Quarterly $2,389.73 Quarterly $1,955.70 Quarterly $2,600.94\n\nMonth Bank Draft $516.10 Month Bank Draft $686.35 Month Bank Draft $569.56 Month Bank Draft $757.48 Month Bank Draft $619.92 Month Bank Draft $824.46\n\n**75** Annual $6,300.05 **Under** Annual $0.00 **75** Annual $6,953.08 **Under** Annual $0.00 **75** Annual $7,567.69 **Under** Annual $0.00\n\nSemi-Annual $3,276.03 **65 Disabled** Semi-Annual N/A Semi-Annual $3,615.58 **65 Disabled** Semi-Annual N/A Semi-Annual $3,935.22 **65 Disabled** Semi-Annual N/A\n\nQuarterly $1,669.48 Quarterly $0.00 Quarterly $1,842.56 Quarterly $0.00 Quarterly $2,005.43 Quarterly $0.00\n\nMonth Bank Draft $529.19 Month Bank Draft $0.00 Month Bank Draft $584.10 Month Bank Draft $0.00 Month Bank Draft $635.68 Month Bank Draft $0.00\n\n_Note The above rates reflect current deductible and benefit levels. We anticipate that they will need to be adjusted each year to_\n\n_reflect deductible and/or benefit changes, trend, and utilization changes. Premiums will change as your age changes. NAIC Co. Code: 64211 FEIN: 36-1174500_ 15D549\n\n_\\* Monthly Bank Draft (MBD) requires 2 months submitted._ TX\n\n_01/012022_\n\n**(Zips 750-753, 760-762, 783-784)**\n\n**Guarantee Trust Life Insurance Company - 2022 Gross Premiums - Texas**","publish_date":null,"title":"Guarantee Trust Life Insurance Company - 2022 Gross Premiums - Texas Group Standardized Medicare Supplement Policy Form 9743F","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page810.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page810.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page810","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page810.pdf"},"started_at":"2026-11-04T19:47:30.708309"} +{"completed_at":"2026-11-04T19:47:32.189817","latency_in_ms":1054,"output":{"example_id":"table/SERFF_TX_random_pages 1_page823","grounded_pages":[],"layout_pages":[],"markdown":"**Company Name**\n\n**Texas Department of Insurance Company NAIC Number**\n\n**Property/Casualty Rate Filing Exhibits Company Filing Number Line Page of**\n\n**Exhibit D—Historical Experience**\n\n**Provide the following information on a calendar year basis.**\n\n**Coverage/Form**\n\n(B) (E)\n\nDirect Incurred Loss &\n\nPremiums DCCE Ratio\n\nEarned (D) ÷ (B)\n\n47,077,046 -0.31\n\n39,170,881 -0.24\n\n34,614,892 0.55\n\n30,197,514 1.06\n\n27,811,884 0.06\n\n(B) (E)\n\nDirect Incurred Loss &\n\nPremiums DCCE Ratio\n\nEarned (D) ÷ (B)\n\n550,348,816 0.06\n\n473,518,938 0.32\n\n438,900,376 0.89\n\n378,752,335 0.89\n\n343,138,499 0.46\n\n2012 333,756,086 394,128,932 337,760,554\n\nLosses and DCCE\n\nYear\n\n**Countrywide**\n\nYear\n\n31,932,626\n\nLosses and DCCE\n\n(C)\n\n(D)\n\nDirect\n\nLosses and DCCE\n\n**Texas**\n\n(C)\n\nDirect\n\nLosses and DCCE\n\nHartford Casualty Ins. Co.\n\n29424\n\nFN.09.076025.2015.01\n\n17\\.2 Other Liability - Claims Made\n\nPage 14: 17.2 Other Liability - Claims Made\n\n(A)\n\nDirect\n\nIncurred\n\nPremiums\n\nWritten\n\nDirect Direct\n\n12,699,526\n\n6,441,375 -14,598,444\n\n(D)\n\nPaid\n\n**Attach additional Exhibt D pages as needed**\n\nDirect\n\nPremiums\n\nWritten Paid Incurred\n\n391,720,553\n\n2009\n\n2010\n\n480,640,212 199,170,368 32,405,445\n\n452,048,539 387,102,177 153,410,743\n\n322,905,615 219,878,243 157,429,278\n\n402,142,220 291,901,843\n\n26,200,023\n\n2013\n\n2009\n\n2010\n\n38,896,693\n\n37,998,258\n\n31,926,072\n\n(A)\n\n2011\n\n36,337,770\n\n14,325,094\n\n\\-9,562,871\n\n19,201,339\n\n2013 27,615,165 11,514,080 1,795,597\n\n2011\n\n2012\n\n**Edition 12/2005**","pages":[{"line_numbers":[],"markdown":"**Company Name**\n\n**Texas Department of Insurance Company NAIC Number**\n\n**Property/Casualty Rate Filing Exhibits Company Filing Number Line Page of**\n\n**Exhibit D—Historical Experience**\n\n**Provide the following information on a calendar year basis.**\n\n**Coverage/Form**\n\n(B) (E)\n\nDirect Incurred Loss &\n\nPremiums DCCE Ratio\n\nEarned (D) ÷ (B)\n\n47,077,046 -0.31\n\n39,170,881 -0.24\n\n34,614,892 0.55\n\n30,197,514 1.06\n\n27,811,884 0.06\n\n(B) (E)\n\nDirect Incurred Loss &\n\nPremiums DCCE Ratio\n\nEarned (D) ÷ (B)\n\n550,348,816 0.06\n\n473,518,938 0.32\n\n438,900,376 0.89\n\n378,752,335 0.89\n\n343,138,499 0.46\n\n2012 333,756,086 394,128,932 337,760,554\n\nLosses and DCCE\n\nYear\n\n**Countrywide**\n\nYear\n\n31,932,626\n\nLosses and DCCE\n\n(C)\n\n(D)\n\nDirect\n\nLosses and DCCE\n\n**Texas**\n\n(C)\n\nDirect\n\nLosses and DCCE\n\nHartford Casualty Ins. Co.\n\n29424\n\nFN.09.076025.2015.01\n\n17\\.2 Other Liability - Claims Made\n\nPage 14: 17.2 Other Liability - Claims Made\n\n(A)\n\nDirect\n\nIncurred\n\nPremiums\n\nWritten\n\nDirect Direct\n\n12,699,526\n\n6,441,375 -14,598,444\n\n(D)\n\nPaid\n\n**Attach additional Exhibt D pages as needed**\n\nDirect\n\nPremiums\n\nWritten Paid Incurred\n\n391,720,553\n\n2009\n\n2010\n\n480,640,212 199,170,368 32,405,445\n\n452,048,539 387,102,177 153,410,743\n\n322,905,615 219,878,243 157,429,278\n\n402,142,220 291,901,843\n\n26,200,023\n\n2013\n\n2009\n\n2010\n\n38,896,693\n\n37,998,258\n\n31,926,072\n\n(A)\n\n2011\n\n36,337,770\n\n14,325,094\n\n\\-9,562,871\n\n19,201,339\n\n2013 27,615,165 11,514,080 1,795,597\n\n2011\n\n2012\n\n**Edition 12/2005**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Company Name**\n\n**Texas Department of Insurance Company NAIC Number**\n\n**Property/Casualty Rate Filing Exhibits Company Filing Number Line Page of**\n\n**Exhibit D—Historical Experience**\n\n**Provide the following information on a calendar year basis.**\n\n**Coverage/Form**\n\n(B) (E)\n\nDirect Incurred Loss &\n\nPremiums DCCE Ratio\n\nEarned (D) ÷ (B)\n\n47,077,046 -0.31\n\n39,170,881 -0.24\n\n34,614,892 0.55\n\n30,197,514 1.06\n\n27,811,884 0.06\n\n(B) (E)\n\nDirect Incurred Loss &\n\nPremiums DCCE Ratio\n\nEarned (D) ÷ (B)\n\n550,348,816 0.06\n\n473,518,938 0.32\n\n438,900,376 0.89\n\n378,752,335 0.89\n\n343,138,499 0.46\n\n2012 333,756,086 394,128,932 337,760,554\n\nLosses and DCCE\n\nYear\n\n**Countrywide**\n\nYear\n\n31,932,626\n\nLosses and DCCE\n\n(C)\n\n(D)\n\nDirect\n\nLosses and DCCE\n\n**Texas**\n\n(C)\n\nDirect\n\nLosses and DCCE\n\nHartford Casualty Ins. Co.\n\n29424\n\nFN.09.076025.2015.01\n\n17\\.2 Other Liability - Claims Made\n\nPage 14: 17.2 Other Liability - Claims Made\n\n(A)\n\nDirect\n\nIncurred\n\nPremiums\n\nWritten\n\nDirect Direct\n\n12,699,526\n\n6,441,375 -14,598,444\n\n(D)\n\nPaid\n\n**Attach additional Exhibt D pages as needed**\n\nDirect\n\nPremiums\n\nWritten Paid Incurred\n\n391,720,553\n\n2009\n\n2010\n\n480,640,212 199,170,368 32,405,445\n\n452,048,539 387,102,177 153,410,743\n\n322,905,615 219,878,243 157,429,278\n\n402,142,220 291,901,843\n\n26,200,023\n\n2013\n\n2009\n\n2010\n\n38,896,693\n\n37,998,258\n\n31,926,072\n\n(A)\n\n2011\n\n36,337,770\n\n14,325,094\n\n\\-9,562,871\n\n19,201,339\n\n2013 27,615,165 11,514,080 1,795,597\n\n2011\n\n2012\n\n**Edition 12/2005**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page823.pdf"]},"response":{"errors":[],"extract_id":"extract_d4e2b07acafd3f30bf83fcf2c2244d9b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Company Name**\n\n**Texas Department of Insurance Company NAIC Number**\n\n**Property/Casualty Rate Filing Exhibits Company Filing Number Line Page of**\n\n**Exhibit D—Historical Experience**\n\n**Provide the following information on a calendar year basis.**\n\n**Coverage/Form**\n\n(B) (E)\n\nDirect Incurred Loss &\n\nPremiums DCCE Ratio\n\nEarned (D) ÷ (B)\n\n47,077,046 -0.31\n\n39,170,881 -0.24\n\n34,614,892 0.55\n\n30,197,514 1.06\n\n27,811,884 0.06\n\n(B) (E)\n\nDirect Incurred Loss &\n\nPremiums DCCE Ratio\n\nEarned (D) ÷ (B)\n\n550,348,816 0.06\n\n473,518,938 0.32\n\n438,900,376 0.89\n\n378,752,335 0.89\n\n343,138,499 0.46\n\n2012 333,756,086 394,128,932 337,760,554\n\nLosses and DCCE\n\nYear\n\n**Countrywide**\n\nYear\n\n31,932,626\n\nLosses and DCCE\n\n(C)\n\n(D)\n\nDirect\n\nLosses and DCCE\n\n**Texas**\n\n(C)\n\nDirect\n\nLosses and DCCE\n\nHartford Casualty Ins. Co.\n\n29424\n\nFN.09.076025.2015.01\n\n17\\.2 Other Liability - Claims Made\n\nPage 14: 17.2 Other Liability - Claims Made\n\n(A)\n\nDirect\n\nIncurred\n\nPremiums\n\nWritten\n\nDirect Direct\n\n12,699,526\n\n6,441,375 -14,598,444\n\n(D)\n\nPaid\n\n**Attach additional Exhibt D pages as needed**\n\nDirect\n\nPremiums\n\nWritten Paid Incurred\n\n391,720,553\n\n2009\n\n2010\n\n480,640,212 199,170,368 32,405,445\n\n452,048,539 387,102,177 153,410,743\n\n322,905,615 219,878,243 157,429,278\n\n402,142,220 291,901,843\n\n26,200,023\n\n2013\n\n2009\n\n2010\n\n38,896,693\n\n37,998,258\n\n31,926,072\n\n(A)\n\n2011\n\n36,337,770\n\n14,325,094\n\n\\-9,562,871\n\n19,201,339\n\n2013 27,615,165 11,514,080 1,795,597\n\n2011\n\n2012\n\n**Edition 12/2005**"],"full_content":"**Company Name**\n\n**Texas Department of Insurance Company NAIC Number**\n\n**Property/Casualty Rate Filing Exhibits Company Filing Number Line Page of**\n\n**Exhibit D—Historical Experience**\n\n**Provide the following information on a calendar year basis.**\n\n**Coverage/Form**\n\n(B) (E)\n\nDirect Incurred Loss &\n\nPremiums DCCE Ratio\n\nEarned (D) ÷ (B)\n\n47,077,046 -0.31\n\n39,170,881 -0.24\n\n34,614,892 0.55\n\n30,197,514 1.06\n\n27,811,884 0.06\n\n(B) (E)\n\nDirect Incurred Loss &\n\nPremiums DCCE Ratio\n\nEarned (D) ÷ (B)\n\n550,348,816 0.06\n\n473,518,938 0.32\n\n438,900,376 0.89\n\n378,752,335 0.89\n\n343,138,499 0.46\n\n2012 333,756,086 394,128,932 337,760,554\n\nLosses and DCCE\n\nYear\n\n**Countrywide**\n\nYear\n\n31,932,626\n\nLosses and DCCE\n\n(C)\n\n(D)\n\nDirect\n\nLosses and DCCE\n\n**Texas**\n\n(C)\n\nDirect\n\nLosses and DCCE\n\nHartford Casualty Ins. Co.\n\n29424\n\nFN.09.076025.2015.01\n\n17\\.2 Other Liability - Claims Made\n\nPage 14: 17.2 Other Liability - Claims Made\n\n(A)\n\nDirect\n\nIncurred\n\nPremiums\n\nWritten\n\nDirect Direct\n\n12,699,526\n\n6,441,375 -14,598,444\n\n(D)\n\nPaid\n\n**Attach additional Exhibt D pages as needed**\n\nDirect\n\nPremiums\n\nWritten Paid Incurred\n\n391,720,553\n\n2009\n\n2010\n\n480,640,212 199,170,368 32,405,445\n\n452,048,539 387,102,177 153,410,743\n\n322,905,615 219,878,243 157,429,278\n\n402,142,220 291,901,843\n\n26,200,023\n\n2013\n\n2009\n\n2010\n\n38,896,693\n\n37,998,258\n\n31,926,072\n\n(A)\n\n2011\n\n36,337,770\n\n14,325,094\n\n\\-9,562,871\n\n19,201,339\n\n2013 27,615,165 11,514,080 1,795,597\n\n2011\n\n2012\n\n**Edition 12/2005**","publish_date":null,"title":"CompanyName HartfordCasualtyIns.Co. TexasDepartmentofInsurance CompanyNAICNumber 29424 Property/CasualtyRateFilingExhibits CompanyFilingNumber FN.09.076025.2015.01 Line 17.2OtherLiability-ClaimsMade Page of ExhibitD—HistoricalExperience Providethefollowinginformationonacalendaryearbasis. Coverage/Form Page14:17.2OtherLiability-ClaimsMade Texas (B) (E) (D)","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page823.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page823.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page823","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page823.pdf"},"started_at":"2026-11-04T19:47:31.135327"} +{"completed_at":"2026-11-04T19:47:34.475497","latency_in_ms":1921,"output":{"example_id":"table/SERFF_TX_random_pages 1_page824","grounded_pages":[],"layout_pages":[],"markdown":"**Line: Page: of:**\n\nAmount Amount Amount\n\n(000) (000) Percent (000) Percent\n\n1\\. $31,926 $26,200 $27,615\n\n2\\. $34,615 $30,198 $27,812\n\n3\\. $3,892 $3,639 $3,916\n\n4\\. $516 $643 $490\n\n5\\. $402,142 $333,756 $322,906\n\n6\\. $438,900 $378,752 $343,138\n\n7\\. $59,348 $50,573 $50,246\n\n8\\. $29,499 $23,470 $25,644\n\na. $- $- $-\n\nb. $29,499 $23,470 $25,644\n\n9\\. $19,646 $19,553 $23,093\n\na. $3,446 $32 $12\n\nb. $490 $660 $378\n\nc.\n\nd.\n\ne.\n\nf.\n\ng.\n\nh. $5,704 $6,912 $1,699\n\ni. — — —\n\nj. — — —\n\n**TDI form NO. PC 367**\n\n5\\.4%\n\n—\n\n—\n\n—\n\n0\\.5%\n\n0\\.0% 0.3%\n\n—\n\n5\\.3%\n\n—\n\n4\\.7%\n\n—\n\n1\\.4% 2.2% 3.1%\n\n2\\.1% 2.4% 2.4%\n\n13\\.8%\n\n**COUNTRYWIDE**\n\nCommission & Brokerage Expenses Incurred\n\n2\\.1%\n\n14\\.1%\n\n13\\.5%\n\n12\\.0%\n\n109\\.1%\n\n14\\.6% 106.3%\n\n108\\.0% 12.4% 1.8%\n\n100\\.7%\n\n1\\.8%\n\nDisallowed General Expenses\n\n1\\.5%\n\n0\\.0%\n\n6\\.8%\n\n4\\.5%\n\n— —\n\n113\\.5% 13.4%\n\n115\\.3% 108.4% 11.2%\n\n— — —\n\n— —\n\n5\\.3% 5.8%\n\n— — —\n\n—\n\n$937\n\n$14 —\n\n**Company Name:** Hartford Casualty Ins. Co.\n\nPercent\n\n**Company Filing Number:**\n\nPage 14: 17.2 Other Liability - Claims Made\n\nFN.09.076025.2015.01\n\nPage 14: 17.2 Other Liability - Claims Made\n\n— Premiums Written\n\n—\n\n— — —\n\n109\\.6%\n\n—\n\nPremiums Earned\n\nPremiums Earned\n\nMean Percent **TEXAS (Annual Statement Statutory Page 14)**\n\n2011 2012 2013\n\n**_Exhibit E – Expense Information – Including Disallowed Expense Adjustment – (Page 1 of 2)_**\n\n**UNDERWRITING EXPENSES AS PERCENTS OF DIRECT PREMIUMS WRITTEN**\n\n**_Texas Department of Insurance_**\n\n—\n\nTaxes, Licenses & Fees Incurred\n\nGeneral Expenses Incurred (IEE, Part III)\n\n—\n\n—\n\n29424\n\n**_Property/Casualty Rate Filing Exhibits_**\n\n**Coverage/Form:**\n\n**Company NAIC Number:**\n\nFees & Assessments Paid to Advisory Organizations\n\n$30 —\n\n—\n\nSuit Against the Insurer for Bad Faith or as\n\nLoss Control & Safety Engineering Expenses\n\nAdjusted Other Acquisition Expenses Incurred\n\nLobbying Expenses\n\n6\\.7%\n\nPremiums Written\n\nCommission & Brokerage Expenses Incurred (IEE, Part III)\n\n—\n\n0\\.9% 4.5%\n\n—\n\nOther Acquisition Expenses Incurred (IEE, Part III)\n\nDisallowed Advertising Expenses\n\nLegislative Advocacy\n\nFines or Penalties for Violation of Law\n\nFraternal Organizations\n\nContributions to Organizations Engaged in\n\nFees & Penalties Imposed on the Insurer for Civil or Criminal Violations of Law Contributions to Social, Religious, Political or\n\n—\n\n**Edition 05/2007**\n\nAdjusted General Expense Percent Formula General Expense Percent 4.7% 3.4%\n\n—\n\n$4\n\nAmounts Paid by an Insurer as Damages in a\n\n$3,744\n\n**Attach additional Exhibit E pages as needed.**\n\n$1,432\n\n$8 $12\n\n$2,384\n\n$2,952\n\n—\n\n— — $358\n\n— — —\n\n$912\n\n— —","pages":[{"line_numbers":[],"markdown":"**Line: Page: of:**\n\nAmount Amount Amount\n\n(000) (000) Percent (000) Percent\n\n1\\. $31,926 $26,200 $27,615\n\n2\\. $34,615 $30,198 $27,812\n\n3\\. $3,892 $3,639 $3,916\n\n4\\. $516 $643 $490\n\n5\\. $402,142 $333,756 $322,906\n\n6\\. $438,900 $378,752 $343,138\n\n7\\. $59,348 $50,573 $50,246\n\n8\\. $29,499 $23,470 $25,644\n\na. $- $- $-\n\nb. $29,499 $23,470 $25,644\n\n9\\. $19,646 $19,553 $23,093\n\na. $3,446 $32 $12\n\nb. $490 $660 $378\n\nc.\n\nd.\n\ne.\n\nf.\n\ng.\n\nh. $5,704 $6,912 $1,699\n\ni. — — —\n\nj. — — —\n\n**TDI form NO. PC 367**\n\n5\\.4%\n\n—\n\n—\n\n—\n\n0\\.5%\n\n0\\.0% 0.3%\n\n—\n\n5\\.3%\n\n—\n\n4\\.7%\n\n—\n\n1\\.4% 2.2% 3.1%\n\n2\\.1% 2.4% 2.4%\n\n13\\.8%\n\n**COUNTRYWIDE**\n\nCommission & Brokerage Expenses Incurred\n\n2\\.1%\n\n14\\.1%\n\n13\\.5%\n\n12\\.0%\n\n109\\.1%\n\n14\\.6% 106.3%\n\n108\\.0% 12.4% 1.8%\n\n100\\.7%\n\n1\\.8%\n\nDisallowed General Expenses\n\n1\\.5%\n\n0\\.0%\n\n6\\.8%\n\n4\\.5%\n\n— —\n\n113\\.5% 13.4%\n\n115\\.3% 108.4% 11.2%\n\n— — —\n\n— —\n\n5\\.3% 5.8%\n\n— — —\n\n—\n\n$937\n\n$14 —\n\n**Company Name:** Hartford Casualty Ins. Co.\n\nPercent\n\n**Company Filing Number:**\n\nPage 14: 17.2 Other Liability - Claims Made\n\nFN.09.076025.2015.01\n\nPage 14: 17.2 Other Liability - Claims Made\n\n— Premiums Written\n\n—\n\n— — —\n\n109\\.6%\n\n—\n\nPremiums Earned\n\nPremiums Earned\n\nMean Percent **TEXAS (Annual Statement Statutory Page 14)**\n\n2011 2012 2013\n\n**_Exhibit E – Expense Information – Including Disallowed Expense Adjustment – (Page 1 of 2)_**\n\n**UNDERWRITING EXPENSES AS PERCENTS OF DIRECT PREMIUMS WRITTEN**\n\n**_Texas Department of Insurance_**\n\n—\n\nTaxes, Licenses & Fees Incurred\n\nGeneral Expenses Incurred (IEE, Part III)\n\n—\n\n—\n\n29424\n\n**_Property/Casualty Rate Filing Exhibits_**\n\n**Coverage/Form:**\n\n**Company NAIC Number:**\n\nFees & Assessments Paid to Advisory Organizations\n\n$30 —\n\n—\n\nSuit Against the Insurer for Bad Faith or as\n\nLoss Control & Safety Engineering Expenses\n\nAdjusted Other Acquisition Expenses Incurred\n\nLobbying Expenses\n\n6\\.7%\n\nPremiums Written\n\nCommission & Brokerage Expenses Incurred (IEE, Part III)\n\n—\n\n0\\.9% 4.5%\n\n—\n\nOther Acquisition Expenses Incurred (IEE, Part III)\n\nDisallowed Advertising Expenses\n\nLegislative Advocacy\n\nFines or Penalties for Violation of Law\n\nFraternal Organizations\n\nContributions to Organizations Engaged in\n\nFees & Penalties Imposed on the Insurer for Civil or Criminal Violations of Law Contributions to Social, Religious, Political or\n\n—\n\n**Edition 05/2007**\n\nAdjusted General Expense Percent Formula General Expense Percent 4.7% 3.4%\n\n—\n\n$4\n\nAmounts Paid by an Insurer as Damages in a\n\n$3,744\n\n**Attach additional Exhibit E pages as needed.**\n\n$1,432\n\n$8 $12\n\n$2,384\n\n$2,952\n\n—\n\n— — $358\n\n— — —\n\n$912\n\n— —","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Line: Page: of:**\n\nAmount Amount Amount\n\n(000) (000) Percent (000) Percent\n\n1\\. $31,926 $26,200 $27,615\n\n2\\. $34,615 $30,198 $27,812\n\n3\\. $3,892 $3,639 $3,916\n\n4\\. $516 $643 $490\n\n5\\. $402,142 $333,756 $322,906\n\n6\\. $438,900 $378,752 $343,138\n\n7\\. $59,348 $50,573 $50,246\n\n8\\. $29,499 $23,470 $25,644\n\na. $- $- $-\n\nb. $29,499 $23,470 $25,644\n\n9\\. $19,646 $19,553 $23,093\n\na. $3,446 $32 $12\n\nb. $490 $660 $378\n\nc.\n\nd.\n\ne.\n\nf.\n\ng.\n\nh. $5,704 $6,912 $1,699\n\ni. — — —\n\nj. — — —\n\n**TDI form NO. PC 367**\n\n5\\.4%\n\n—\n\n—\n\n—\n\n0\\.5%\n\n0\\.0% 0.3%\n\n—\n\n5\\.3%\n\n—\n\n4\\.7%\n\n—\n\n1\\.4% 2.2% 3.1%\n\n2\\.1% 2.4% 2.4%\n\n13\\.8%\n\n**COUNTRYWIDE**\n\nCommission & Brokerage Expenses Incurred\n\n2\\.1%\n\n14\\.1%\n\n13\\.5%\n\n12\\.0%\n\n109\\.1%\n\n14\\.6% 106.3%\n\n108\\.0% 12.4% 1.8%\n\n100\\.7%\n\n1\\.8%\n\nDisallowed General Expenses\n\n1\\.5%\n\n0\\.0%\n\n6\\.8%\n\n4\\.5%\n\n— —\n\n113\\.5% 13.4%\n\n115\\.3% 108.4% 11.2%\n\n— — —\n\n— —\n\n5\\.3% 5.8%\n\n— — —\n\n—\n\n$937\n\n$14 —\n\n**Company Name:** Hartford Casualty Ins. Co.\n\nPercent\n\n**Company Filing Number:**\n\nPage 14: 17.2 Other Liability - Claims Made\n\nFN.09.076025.2015.01\n\nPage 14: 17.2 Other Liability - Claims Made\n\n— Premiums Written\n\n—\n\n— — —\n\n109\\.6%\n\n—\n\nPremiums Earned\n\nPremiums Earned\n\nMean Percent **TEXAS (Annual Statement Statutory Page 14)**\n\n2011 2012 2013\n\n**_Exhibit E – Expense Information – Including Disallowed Expense Adjustment – (Page 1 of 2)_**\n\n**UNDERWRITING EXPENSES AS PERCENTS OF DIRECT PREMIUMS WRITTEN**\n\n**_Texas Department of Insurance_**\n\n—\n\nTaxes, Licenses & Fees Incurred\n\nGeneral Expenses Incurred (IEE, Part III)\n\n—\n\n—\n\n29424\n\n**_Property/Casualty Rate Filing Exhibits_**\n\n**Coverage/Form:**\n\n**Company NAIC Number:**\n\nFees & Assessments Paid to Advisory Organizations\n\n$30 —\n\n—\n\nSuit Against the Insurer for Bad Faith or as\n\nLoss Control & Safety Engineering Expenses\n\nAdjusted Other Acquisition Expenses Incurred\n\nLobbying Expenses\n\n6\\.7%\n\nPremiums Written\n\nCommission & Brokerage Expenses Incurred (IEE, Part III)\n\n—\n\n0\\.9% 4.5%\n\n—\n\nOther Acquisition Expenses Incurred (IEE, Part III)\n\nDisallowed Advertising Expenses\n\nLegislative Advocacy\n\nFines or Penalties for Violation of Law\n\nFraternal Organizations\n\nContributions to Organizations Engaged in\n\nFees & Penalties Imposed on the Insurer for Civil or Criminal Violations of Law Contributions to Social, Religious, Political or\n\n—\n\n**Edition 05/2007**\n\nAdjusted General Expense Percent Formula General Expense Percent 4.7% 3.4%\n\n—\n\n$4\n\nAmounts Paid by an Insurer as Damages in a\n\n$3,744\n\n**Attach additional Exhibit E pages as needed.**\n\n$1,432\n\n$8 $12\n\n$2,384\n\n$2,952\n\n—\n\n— — $358\n\n— — —\n\n$912\n\n— —","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page824.pdf"]},"response":{"errors":[],"extract_id":"extract_293b9c6495b4f2058606bf4b31969623","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Line: Page: of:**\n\nAmount Amount Amount\n\n(000) (000) Percent (000) Percent\n\n1\\. $31,926 $26,200 $27,615\n\n2\\. $34,615 $30,198 $27,812\n\n3\\. $3,892 $3,639 $3,916\n\n4\\. $516 $643 $490\n\n5\\. $402,142 $333,756 $322,906\n\n6\\. $438,900 $378,752 $343,138\n\n7\\. $59,348 $50,573 $50,246\n\n8\\. $29,499 $23,470 $25,644\n\na. $- $- $-\n\nb. $29,499 $23,470 $25,644\n\n9\\. $19,646 $19,553 $23,093\n\na. $3,446 $32 $12\n\nb. $490 $660 $378\n\nc.\n\nd.\n\ne.\n\nf.\n\ng.\n\nh. $5,704 $6,912 $1,699\n\ni. — — —\n\nj. — — —\n\n**TDI form NO. PC 367**\n\n5\\.4%\n\n—\n\n—\n\n—\n\n0\\.5%\n\n0\\.0% 0.3%\n\n—\n\n5\\.3%\n\n—\n\n4\\.7%\n\n—\n\n1\\.4% 2.2% 3.1%\n\n2\\.1% 2.4% 2.4%\n\n13\\.8%\n\n**COUNTRYWIDE**\n\nCommission & Brokerage Expenses Incurred\n\n2\\.1%\n\n14\\.1%\n\n13\\.5%\n\n12\\.0%\n\n109\\.1%\n\n14\\.6% 106.3%\n\n108\\.0% 12.4% 1.8%\n\n100\\.7%\n\n1\\.8%\n\nDisallowed General Expenses\n\n1\\.5%\n\n0\\.0%\n\n6\\.8%\n\n4\\.5%\n\n— —\n\n113\\.5% 13.4%\n\n115\\.3% 108.4% 11.2%\n\n— — —\n\n— —\n\n5\\.3% 5.8%\n\n— — —\n\n—\n\n$937\n\n$14 —\n\n**Company Name:** Hartford Casualty Ins. Co.\n\nPercent\n\n**Company Filing Number:**\n\nPage 14: 17.2 Other Liability - Claims Made\n\nFN.09.076025.2015.01\n\nPage 14: 17.2 Other Liability - Claims Made\n\n— Premiums Written\n\n—\n\n— — —\n\n109\\.6%\n\n—\n\nPremiums Earned\n\nPremiums Earned\n\nMean Percent **TEXAS (Annual Statement Statutory Page 14)**\n\n2011 2012 2013\n\n**_Exhibit E – Expense Information – Including Disallowed Expense Adjustment – (Page 1 of 2)_**\n\n**UNDERWRITING EXPENSES AS PERCENTS OF DIRECT PREMIUMS WRITTEN**\n\n**_Texas Department of Insurance_**\n\n—\n\nTaxes, Licenses & Fees Incurred\n\nGeneral Expenses Incurred (IEE, Part III)\n\n—\n\n—\n\n29424\n\n**_Property/Casualty Rate Filing Exhibits_**\n\n**Coverage/Form:**\n\n**Company NAIC Number:**\n\nFees & Assessments Paid to Advisory Organizations\n\n$30 —\n\n—\n\nSuit Against the Insurer for Bad Faith or as\n\nLoss Control & Safety Engineering Expenses\n\nAdjusted Other Acquisition Expenses Incurred\n\nLobbying Expenses\n\n6\\.7%\n\nPremiums Written\n\nCommission & Brokerage Expenses Incurred (IEE, Part III)\n\n—\n\n0\\.9% 4.5%\n\n—\n\nOther Acquisition Expenses Incurred (IEE, Part III)\n\nDisallowed Advertising Expenses\n\nLegislative Advocacy\n\nFines or Penalties for Violation of Law\n\nFraternal Organizations\n\nContributions to Organizations Engaged in\n\nFees & Penalties Imposed on the Insurer for Civil or Criminal Violations of Law Contributions to Social, Religious, Political or\n\n—\n\n**Edition 05/2007**\n\nAdjusted General Expense Percent Formula General Expense Percent 4.7% 3.4%\n\n—\n\n$4\n\nAmounts Paid by an Insurer as Damages in a\n\n$3,744\n\n**Attach additional Exhibit E pages as needed.**\n\n$1,432\n\n$8 $12\n\n$2,384\n\n$2,952\n\n—\n\n— — $358\n\n— — —\n\n$912\n\n— —"],"full_content":"**Line: Page: of:**\n\nAmount Amount Amount\n\n(000) (000) Percent (000) Percent\n\n1\\. $31,926 $26,200 $27,615\n\n2\\. $34,615 $30,198 $27,812\n\n3\\. $3,892 $3,639 $3,916\n\n4\\. $516 $643 $490\n\n5\\. $402,142 $333,756 $322,906\n\n6\\. $438,900 $378,752 $343,138\n\n7\\. $59,348 $50,573 $50,246\n\n8\\. $29,499 $23,470 $25,644\n\na. $- $- $-\n\nb. $29,499 $23,470 $25,644\n\n9\\. $19,646 $19,553 $23,093\n\na. $3,446 $32 $12\n\nb. $490 $660 $378\n\nc.\n\nd.\n\ne.\n\nf.\n\ng.\n\nh. $5,704 $6,912 $1,699\n\ni. — — —\n\nj. — — —\n\n**TDI form NO. PC 367**\n\n5\\.4%\n\n—\n\n—\n\n—\n\n0\\.5%\n\n0\\.0% 0.3%\n\n—\n\n5\\.3%\n\n—\n\n4\\.7%\n\n—\n\n1\\.4% 2.2% 3.1%\n\n2\\.1% 2.4% 2.4%\n\n13\\.8%\n\n**COUNTRYWIDE**\n\nCommission & Brokerage Expenses Incurred\n\n2\\.1%\n\n14\\.1%\n\n13\\.5%\n\n12\\.0%\n\n109\\.1%\n\n14\\.6% 106.3%\n\n108\\.0% 12.4% 1.8%\n\n100\\.7%\n\n1\\.8%\n\nDisallowed General Expenses\n\n1\\.5%\n\n0\\.0%\n\n6\\.8%\n\n4\\.5%\n\n— —\n\n113\\.5% 13.4%\n\n115\\.3% 108.4% 11.2%\n\n— — —\n\n— —\n\n5\\.3% 5.8%\n\n— — —\n\n—\n\n$937\n\n$14 —\n\n**Company Name:** Hartford Casualty Ins. Co.\n\nPercent\n\n**Company Filing Number:**\n\nPage 14: 17.2 Other Liability - Claims Made\n\nFN.09.076025.2015.01\n\nPage 14: 17.2 Other Liability - Claims Made\n\n— Premiums Written\n\n—\n\n— — —\n\n109\\.6%\n\n—\n\nPremiums Earned\n\nPremiums Earned\n\nMean Percent **TEXAS (Annual Statement Statutory Page 14)**\n\n2011 2012 2013\n\n**_Exhibit E – Expense Information – Including Disallowed Expense Adjustment – (Page 1 of 2)_**\n\n**UNDERWRITING EXPENSES AS PERCENTS OF DIRECT PREMIUMS WRITTEN**\n\n**_Texas Department of Insurance_**\n\n—\n\nTaxes, Licenses & Fees Incurred\n\nGeneral Expenses Incurred (IEE, Part III)\n\n—\n\n—\n\n29424\n\n**_Property/Casualty Rate Filing Exhibits_**\n\n**Coverage/Form:**\n\n**Company NAIC Number:**\n\nFees & Assessments Paid to Advisory Organizations\n\n$30 —\n\n—\n\nSuit Against the Insurer for Bad Faith or as\n\nLoss Control & Safety Engineering Expenses\n\nAdjusted Other Acquisition Expenses Incurred\n\nLobbying Expenses\n\n6\\.7%\n\nPremiums Written\n\nCommission & Brokerage Expenses Incurred (IEE, Part III)\n\n—\n\n0\\.9% 4.5%\n\n—\n\nOther Acquisition Expenses Incurred (IEE, Part III)\n\nDisallowed Advertising Expenses\n\nLegislative Advocacy\n\nFines or Penalties for Violation of Law\n\nFraternal Organizations\n\nContributions to Organizations Engaged in\n\nFees & Penalties Imposed on the Insurer for Civil or Criminal Violations of Law Contributions to Social, Religious, Political or\n\n—\n\n**Edition 05/2007**\n\nAdjusted General Expense Percent Formula General Expense Percent 4.7% 3.4%\n\n—\n\n$4\n\nAmounts Paid by an Insurer as Damages in a\n\n$3,744\n\n**Attach additional Exhibit E pages as needed.**\n\n$1,432\n\n$8 $12\n\n$2,384\n\n$2,952\n\n—\n\n— — $358\n\n— — —\n\n$912\n\n— —","publish_date":null,"title":"CompanyName: HartfordCasualtyIns.Co. TexasDepartmentofInsurance 29424 CompanyNAICNumber: CompanyFilingNumber: FN.09.076025.2015.01 Property/CasualtyRateFilingExhibits Line: Page14:17.2OtherLiability-ClaimsMade Page: of: ExhibitE–ExpenseInformation–IncludingDisallowedExpenseAdjustment–(Page1of2) Page14:17.2OtherLiability-ClaimsMade Coverage/Form: UNDERWRITINGEXPENSESASPERCENTSOFDIRECTPREMIUMSWRITTEN 2011 2012 2013 Amount","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page824.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page824.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page824","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page824.pdf"},"started_at":"2026-11-04T19:47:32.553891"} +{"completed_at":"2026-11-04T19:47:36.548485","latency_in_ms":3017,"output":{"example_id":"table/SERFF_TX_random_pages 1_page827","grounded_pages":[],"layout_pages":[],"markdown":"EXPLANATORY MEMORANDUM – RATE/RULE Umbrella Liability Policy Filing FN.09.076025.2015.01\n\ncolleges/universities and other higher education institutions. The Rider has its own Declarations\n\nand dedicated limits. We use a rating scheme for this Rider independent of our standard\n\nUmbrella Liability rates. A previous Educators Legal Liability Rider, which was filed under filing numbers FN.09.076025.2007.03; 94087 is being withdrawn from Texas upon approval of the\n\nrates and rules herein. All rules with regard to the use of the former Educators Legal Liability\n\nRider will become obsolete.\n\n**Rule Descriptions Beginning on Page**\n\nA. General 2\n\nB. Base Premium 2\n\nC. Judgment Modification 4\n\nD. Minimum Premium 4\n\nE. Terrorism Factor 4\n\nF. Premium Calculation 4\n\nG. Retroactive Date 4\n\nH. Extended Reporting Period 5\n\n**RULES:**\n\nA. **General**\n\nThe underlying policy premium is calculated separately for each purchased Coverage Part\n\n(Directors, Officers and Entity Liability – \"D&O,\" Educators Errors and Omissions Liability –\n\n\"E&O,\" and Employment Practices Liability – \"EPL\") and then combined. To determine the premium for the Umbrella Rider, calculations are based on the underlying premium for each\n\npurchased Coverage Part. An insured must purchase at least two of the three underlying\n\nCoverage Parts with combined limits to be eligible for Umbrella Liability coverage.\n\nB. **Base Premium**\n\n1\\. Determine the premium for each Coverage Part purchased on the underlying policy.\n\n2\\. Choose a limit for Umbrella Liability coverage. Add this limit to the underlying per claim\n\nLimit of Liability (always $1 million) and find the combined increased limit factor (ILF) in\n\nthe table below. For example, an account with a $1 million underlying limit purchasing $10 million Umbrella Liability coverage has a 2.11 combined ILF (corresponding to the\n\n$11 million value in the table below).\n\n**Underlying EPC Limit**\n\n**Plus Umbrella Limit**\n\n**Comb**\n\n**Increased**\n\n**Limit Factors**\n\n**Underlying EPC Limit**\n\n**Plus Umbrella Limit**\n\n**Comb**\n\n**Increased Limit**\n\n**Factors**\n\n2,000,000 1.30 15,000,000 2.25\n\n3,000,000 1.49 16,000,000 2.28\n\n4,000,000 1.63 17,000,000 2.31","pages":[{"line_numbers":[],"markdown":"EXPLANATORY MEMORANDUM – RATE/RULE Umbrella Liability Policy Filing FN.09.076025.2015.01\n\ncolleges/universities and other higher education institutions. The Rider has its own Declarations\n\nand dedicated limits. We use a rating scheme for this Rider independent of our standard\n\nUmbrella Liability rates. A previous Educators Legal Liability Rider, which was filed under filing numbers FN.09.076025.2007.03; 94087 is being withdrawn from Texas upon approval of the\n\nrates and rules herein. All rules with regard to the use of the former Educators Legal Liability\n\nRider will become obsolete.\n\n**Rule Descriptions Beginning on Page**\n\nA. General 2\n\nB. Base Premium 2\n\nC. Judgment Modification 4\n\nD. Minimum Premium 4\n\nE. Terrorism Factor 4\n\nF. Premium Calculation 4\n\nG. Retroactive Date 4\n\nH. Extended Reporting Period 5\n\n**RULES:**\n\nA. **General**\n\nThe underlying policy premium is calculated separately for each purchased Coverage Part\n\n(Directors, Officers and Entity Liability – \"D&O,\" Educators Errors and Omissions Liability –\n\n\"E&O,\" and Employment Practices Liability – \"EPL\") and then combined. To determine the premium for the Umbrella Rider, calculations are based on the underlying premium for each\n\npurchased Coverage Part. An insured must purchase at least two of the three underlying\n\nCoverage Parts with combined limits to be eligible for Umbrella Liability coverage.\n\nB. **Base Premium**\n\n1\\. Determine the premium for each Coverage Part purchased on the underlying policy.\n\n2\\. Choose a limit for Umbrella Liability coverage. Add this limit to the underlying per claim\n\nLimit of Liability (always $1 million) and find the combined increased limit factor (ILF) in\n\nthe table below. For example, an account with a $1 million underlying limit purchasing $10 million Umbrella Liability coverage has a 2.11 combined ILF (corresponding to the\n\n$11 million value in the table below).\n\n**Underlying EPC Limit**\n\n**Plus Umbrella Limit**\n\n**Comb**\n\n**Increased**\n\n**Limit Factors**\n\n**Underlying EPC Limit**\n\n**Plus Umbrella Limit**\n\n**Comb**\n\n**Increased Limit**\n\n**Factors**\n\n2,000,000 1.30 15,000,000 2.25\n\n3,000,000 1.49 16,000,000 2.28\n\n4,000,000 1.63 17,000,000 2.31","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"EXPLANATORY MEMORANDUM – RATE/RULE Umbrella Liability Policy Filing FN.09.076025.2015.01\n\ncolleges/universities and other higher education institutions. The Rider has its own Declarations\n\nand dedicated limits. We use a rating scheme for this Rider independent of our standard\n\nUmbrella Liability rates. A previous Educators Legal Liability Rider, which was filed under filing numbers FN.09.076025.2007.03; 94087 is being withdrawn from Texas upon approval of the\n\nrates and rules herein. All rules with regard to the use of the former Educators Legal Liability\n\nRider will become obsolete.\n\n**Rule Descriptions Beginning on Page**\n\nA. General 2\n\nB. Base Premium 2\n\nC. Judgment Modification 4\n\nD. Minimum Premium 4\n\nE. Terrorism Factor 4\n\nF. Premium Calculation 4\n\nG. Retroactive Date 4\n\nH. Extended Reporting Period 5\n\n**RULES:**\n\nA. **General**\n\nThe underlying policy premium is calculated separately for each purchased Coverage Part\n\n(Directors, Officers and Entity Liability – \"D&O,\" Educators Errors and Omissions Liability –\n\n\"E&O,\" and Employment Practices Liability – \"EPL\") and then combined. To determine the premium for the Umbrella Rider, calculations are based on the underlying premium for each\n\npurchased Coverage Part. An insured must purchase at least two of the three underlying\n\nCoverage Parts with combined limits to be eligible for Umbrella Liability coverage.\n\nB. **Base Premium**\n\n1\\. Determine the premium for each Coverage Part purchased on the underlying policy.\n\n2\\. Choose a limit for Umbrella Liability coverage. Add this limit to the underlying per claim\n\nLimit of Liability (always $1 million) and find the combined increased limit factor (ILF) in\n\nthe table below. For example, an account with a $1 million underlying limit purchasing $10 million Umbrella Liability coverage has a 2.11 combined ILF (corresponding to the\n\n$11 million value in the table below).\n\n**Underlying EPC Limit**\n\n**Plus Umbrella Limit**\n\n**Comb**\n\n**Increased**\n\n**Limit Factors**\n\n**Underlying EPC Limit**\n\n**Plus Umbrella Limit**\n\n**Comb**\n\n**Increased Limit**\n\n**Factors**\n\n2,000,000 1.30 15,000,000 2.25\n\n3,000,000 1.49 16,000,000 2.28\n\n4,000,000 1.63 17,000,000 2.31","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page827.pdf"]},"response":{"errors":[],"extract_id":"extract_c46dbe11192a64951bcc187f151988ea","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["EXPLANATORY MEMORANDUM – RATE/RULE Umbrella Liability Policy Filing FN.09.076025.2015.01\n\ncolleges/universities and other higher education institutions. The Rider has its own Declarations\n\nand dedicated limits. We use a rating scheme for this Rider independent of our standard\n\nUmbrella Liability rates. A previous Educators Legal Liability Rider, which was filed under filing numbers FN.09.076025.2007.03; 94087 is being withdrawn from Texas upon approval of the\n\nrates and rules herein. All rules with regard to the use of the former Educators Legal Liability\n\nRider will become obsolete.\n\n**Rule Descriptions Beginning on Page**\n\nA. General 2\n\nB. Base Premium 2\n\nC. Judgment Modification 4\n\nD. Minimum Premium 4\n\nE. Terrorism Factor 4\n\nF. Premium Calculation 4\n\nG. Retroactive Date 4\n\nH. Extended Reporting Period 5\n\n**RULES:**\n\nA. **General**\n\nThe underlying policy premium is calculated separately for each purchased Coverage Part\n\n(Directors, Officers and Entity Liability – \"D&O,\" Educators Errors and Omissions Liability –\n\n\"E&O,\" and Employment Practices Liability – \"EPL\") and then combined. To determine the premium for the Umbrella Rider, calculations are based on the underlying premium for each\n\npurchased Coverage Part. An insured must purchase at least two of the three underlying\n\nCoverage Parts with combined limits to be eligible for Umbrella Liability coverage.\n\nB. **Base Premium**\n\n1\\. Determine the premium for each Coverage Part purchased on the underlying policy.\n\n2\\. Choose a limit for Umbrella Liability coverage. Add this limit to the underlying per claim\n\nLimit of Liability (always $1 million) and find the combined increased limit factor (ILF) in\n\nthe table below. For example, an account with a $1 million underlying limit purchasing $10 million Umbrella Liability coverage has a 2.11 combined ILF (corresponding to the\n\n$11 million value in the table below).\n\n**Underlying EPC Limit**\n\n**Plus Umbrella Limit**\n\n**Comb**\n\n**Increased**\n\n**Limit Factors**\n\n**Underlying EPC Limit**\n\n**Plus Umbrella Limit**\n\n**Comb**\n\n**Increased Limit**\n\n**Factors**\n\n2,000,000 1.30 15,000,000 2.25\n\n3,000,000 1.49 16,000,000 2.28\n\n4,000,000 1.63 17,000,000 2.31"],"full_content":"EXPLANATORY MEMORANDUM – RATE/RULE Umbrella Liability Policy Filing FN.09.076025.2015.01\n\ncolleges/universities and other higher education institutions. The Rider has its own Declarations\n\nand dedicated limits. We use a rating scheme for this Rider independent of our standard\n\nUmbrella Liability rates. A previous Educators Legal Liability Rider, which was filed under filing numbers FN.09.076025.2007.03; 94087 is being withdrawn from Texas upon approval of the\n\nrates and rules herein. All rules with regard to the use of the former Educators Legal Liability\n\nRider will become obsolete.\n\n**Rule Descriptions Beginning on Page**\n\nA. General 2\n\nB. Base Premium 2\n\nC. Judgment Modification 4\n\nD. Minimum Premium 4\n\nE. Terrorism Factor 4\n\nF. Premium Calculation 4\n\nG. Retroactive Date 4\n\nH. Extended Reporting Period 5\n\n**RULES:**\n\nA. **General**\n\nThe underlying policy premium is calculated separately for each purchased Coverage Part\n\n(Directors, Officers and Entity Liability – \"D&O,\" Educators Errors and Omissions Liability –\n\n\"E&O,\" and Employment Practices Liability – \"EPL\") and then combined. To determine the premium for the Umbrella Rider, calculations are based on the underlying premium for each\n\npurchased Coverage Part. An insured must purchase at least two of the three underlying\n\nCoverage Parts with combined limits to be eligible for Umbrella Liability coverage.\n\nB. **Base Premium**\n\n1\\. Determine the premium for each Coverage Part purchased on the underlying policy.\n\n2\\. Choose a limit for Umbrella Liability coverage. Add this limit to the underlying per claim\n\nLimit of Liability (always $1 million) and find the combined increased limit factor (ILF) in\n\nthe table below. For example, an account with a $1 million underlying limit purchasing $10 million Umbrella Liability coverage has a 2.11 combined ILF (corresponding to the\n\n$11 million value in the table below).\n\n**Underlying EPC Limit**\n\n**Plus Umbrella Limit**\n\n**Comb**\n\n**Increased**\n\n**Limit Factors**\n\n**Underlying EPC Limit**\n\n**Plus Umbrella Limit**\n\n**Comb**\n\n**Increased Limit**\n\n**Factors**\n\n2,000,000 1.30 15,000,000 2.25\n\n3,000,000 1.49 16,000,000 2.28\n\n4,000,000 1.63 17,000,000 2.31","publish_date":null,"title":"EXPLANATORYMEMORANDUM –RATE/RULE","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page827.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page827.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page827","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page827.pdf"},"started_at":"2026-11-04T19:47:33.530896"} +{"completed_at":"2026-11-04T19:47:35.793197","latency_in_ms":1139,"output":{"example_id":"table/SERFF_TX_random_pages 1_page830","grounded_pages":[],"layout_pages":[],"markdown":"# **AAAA INSURANCE**\n\n## RULES GUIDE\n\nAAAA Insurance Home State County Mutual Insurance Company 1M + 6M private passenger auto Page 6 of 6 effective 09/01/2016\n\n Any vehicle with a salvage title unless the title also shows that the vehicle has been reconditioned;  Any vehicle older than 30 years;  Suzuki Samurai, Dune Buggies, or similar off-road vehicles;  Jeep CJ5 or CJ7 models prior to 1987;  Any vehicle that has a TV screen or computer monitor visible to the driver (this does not include navigation systems that come as standard equipment from the factory); **PROHIBITED FOR PHYSICAL DAMAGE** The following are unacceptable for physical damage coverage:  Any vehicle with a ISO symbol greater than 21 for model years 1990 to 2010, or a symbol greater than 45 for model years 2011 and newer;  Any vehicle with an ACV of $40,000 or more;  Any vehicle over 20 years old;  Any of the following vehicles:\n\n_Alfa Romeo Audi4000,5000, Quattro_\n\n_Buick Reatta Cadillac Escalade, XLR_\n\n_Chevrolet Corvette Chrysler Prowler_\n\n_Delorean Dodge Stealth_\n\n_Dodge Viper Ferrari_\n\n_Fiat Ford Shelby or Cobra_\n\n_Hummer Infiniti Q45_\n\n_Jaguar Lincoln Aviator, Navigator_\n\n_Lincoln Blackwood Lotus_\n\n_Maserati Mercedes_\n\n_Mitsubishi 3000 GT Pantera_\n\n_Peugeot Plymouth Prowler_\n\n_Porsche Sterling_\n\n_Yugo_ or Similar Vehicles\n\n**SURCHARGED FOR PHYSICAL DAMAGE** The following vehicles will receive a surcharge on BI, PD, OTC & Collision: Convertibles Chevy Camaro\n\nDodge Daytona Eagle Talon\n\nFord Crown Vic Police Interceptor Ford Mustang GT, Probe\n\nFord Taurus SHO Ford Thunderbird Super Coupe\n\nFord Thunderbird Turbo Chevy Tracker/Geo Tracker\n\nHonda Civic (CRX) Honda Prelude\n\nIsuzu Impulse Jeep Wrangler\n\nKia Sportage Mazda Miata, RX-7, RX-8\n\nMitsubishi Eclipse Nissan 240 SX,300ZX, 350Z\n\nPontiac Firebird, Trans AM Saab\n\nSubaru SVX Suzuki Sidekick, Suzuki X-90\n\nToyota Rav4 Toyota Supra, MR 2\n\nVW Corrado Customized Vans\n\n### **MANDATORY ENDORSEMENTS**\n\n**Policies Offered Under This Program Differ From The Customary Coverage Provided Under The Texas Standard Personal Auto Policy** . Mandatory endorsements approved by the Texas Department of Insurance that significantly change the coverages from the Texas Standard Personal Auto Policy are attached to the policy jacket and shown by endorsement number on the Declarations page. These Endorsements are NOT optional. Total premium shown on the application and on the Declarations page are based in part on the acceptance of these endorsements. The agent must explain to the insured at the point of sale before binding the policy that policies offered under this program differ from the customary coverage provided under the Texas Standard Personal Auto Policy. The agent must explain these differences verbally and in writing prior to binding the policy.\n\nA disclosure form requiring the named insured’s signature summarizes these differences; this form should be signed and a copy given to the insured. Coverage cannot be bound unless a signed disclosure form is included in the submission with the signed application to the company. **The mandatory endorsements include the following which will be shown on the Declarations page:** MF.HSCM.2010 Misrepresentation or Fraud Endorsement CI.HSCM.2010 Criminal Intentional Acts Endorsement St.HSCM.2006 Storage Endorsement\n\n### **PERSISTENCY**\n\nAll semi-annual policies, regardless of inception date, are measured for their persistency to remain inforce based upon renewal. For every semi-annual renewal increment persistency by +1 and apply the appropriate factor.\n\n**Texas Administrative Code RULE §5.401 Temporary and Permanent Requirements Regarding Underwriting Treatment of and Disclosure to Applicants for Private Passenger Automobile Liability Insurance** Pursuant to TAC Rule §5.401,as an appointed representative of the company, it is incumbent upon the agent to properly inform any applicant with no prior insurance having no more than one accident and one violation within the past three years when the premium quote for the company equals or exceeds the premium available through the assigned risk plan. Any agent found to not be in compliance with this rule will be subject to possible suspension or termination.","pages":[{"line_numbers":[],"markdown":"# **AAAA INSURANCE**\n\n## RULES GUIDE\n\nAAAA Insurance Home State County Mutual Insurance Company 1M + 6M private passenger auto Page 6 of 6 effective 09/01/2016\n\n Any vehicle with a salvage title unless the title also shows that the vehicle has been reconditioned;  Any vehicle older than 30 years;  Suzuki Samurai, Dune Buggies, or similar off-road vehicles;  Jeep CJ5 or CJ7 models prior to 1987;  Any vehicle that has a TV screen or computer monitor visible to the driver (this does not include navigation systems that come as standard equipment from the factory); **PROHIBITED FOR PHYSICAL DAMAGE** The following are unacceptable for physical damage coverage:  Any vehicle with a ISO symbol greater than 21 for model years 1990 to 2010, or a symbol greater than 45 for model years 2011 and newer;  Any vehicle with an ACV of $40,000 or more;  Any vehicle over 20 years old;  Any of the following vehicles:\n\n_Alfa Romeo Audi4000,5000, Quattro_\n\n_Buick Reatta Cadillac Escalade, XLR_\n\n_Chevrolet Corvette Chrysler Prowler_\n\n_Delorean Dodge Stealth_\n\n_Dodge Viper Ferrari_\n\n_Fiat Ford Shelby or Cobra_\n\n_Hummer Infiniti Q45_\n\n_Jaguar Lincoln Aviator, Navigator_\n\n_Lincoln Blackwood Lotus_\n\n_Maserati Mercedes_\n\n_Mitsubishi 3000 GT Pantera_\n\n_Peugeot Plymouth Prowler_\n\n_Porsche Sterling_\n\n_Yugo_ or Similar Vehicles\n\n**SURCHARGED FOR PHYSICAL DAMAGE** The following vehicles will receive a surcharge on BI, PD, OTC & Collision: Convertibles Chevy Camaro\n\nDodge Daytona Eagle Talon\n\nFord Crown Vic Police Interceptor Ford Mustang GT, Probe\n\nFord Taurus SHO Ford Thunderbird Super Coupe\n\nFord Thunderbird Turbo Chevy Tracker/Geo Tracker\n\nHonda Civic (CRX) Honda Prelude\n\nIsuzu Impulse Jeep Wrangler\n\nKia Sportage Mazda Miata, RX-7, RX-8\n\nMitsubishi Eclipse Nissan 240 SX,300ZX, 350Z\n\nPontiac Firebird, Trans AM Saab\n\nSubaru SVX Suzuki Sidekick, Suzuki X-90\n\nToyota Rav4 Toyota Supra, MR 2\n\nVW Corrado Customized Vans\n\n### **MANDATORY ENDORSEMENTS**\n\n**Policies Offered Under This Program Differ From The Customary Coverage Provided Under The Texas Standard Personal Auto Policy** . Mandatory endorsements approved by the Texas Department of Insurance that significantly change the coverages from the Texas Standard Personal Auto Policy are attached to the policy jacket and shown by endorsement number on the Declarations page. These Endorsements are NOT optional. Total premium shown on the application and on the Declarations page are based in part on the acceptance of these endorsements. The agent must explain to the insured at the point of sale before binding the policy that policies offered under this program differ from the customary coverage provided under the Texas Standard Personal Auto Policy. The agent must explain these differences verbally and in writing prior to binding the policy.\n\nA disclosure form requiring the named insured’s signature summarizes these differences; this form should be signed and a copy given to the insured. Coverage cannot be bound unless a signed disclosure form is included in the submission with the signed application to the company. **The mandatory endorsements include the following which will be shown on the Declarations page:** MF.HSCM.2010 Misrepresentation or Fraud Endorsement CI.HSCM.2010 Criminal Intentional Acts Endorsement St.HSCM.2006 Storage Endorsement\n\n### **PERSISTENCY**\n\nAll semi-annual policies, regardless of inception date, are measured for their persistency to remain inforce based upon renewal. For every semi-annual renewal increment persistency by +1 and apply the appropriate factor.\n\n**Texas Administrative Code RULE §5.401 Temporary and Permanent Requirements Regarding Underwriting Treatment of and Disclosure to Applicants for Private Passenger Automobile Liability Insurance** Pursuant to TAC Rule §5.401,as an appointed representative of the company, it is incumbent upon the agent to properly inform any applicant with no prior insurance having no more than one accident and one violation within the past three years when the premium quote for the company equals or exceeds the premium available through the assigned risk plan. Any agent found to not be in compliance with this rule will be subject to possible suspension or termination.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"# **AAAA INSURANCE**\n\n## RULES GUIDE\n\nAAAA Insurance Home State County Mutual Insurance Company 1M + 6M private passenger auto Page 6 of 6 effective 09/01/2016\n\n Any vehicle with a salvage title unless the title also shows that the vehicle has been reconditioned;  Any vehicle older than 30 years;  Suzuki Samurai, Dune Buggies, or similar off-road vehicles;  Jeep CJ5 or CJ7 models prior to 1987;  Any vehicle that has a TV screen or computer monitor visible to the driver (this does not include navigation systems that come as standard equipment from the factory); **PROHIBITED FOR PHYSICAL DAMAGE** The following are unacceptable for physical damage coverage:  Any vehicle with a ISO symbol greater than 21 for model years 1990 to 2010, or a symbol greater than 45 for model years 2011 and newer;  Any vehicle with an ACV of $40,000 or more;  Any vehicle over 20 years old;  Any of the following vehicles:\n\n_Alfa Romeo Audi4000,5000, Quattro_\n\n_Buick Reatta Cadillac Escalade, XLR_\n\n_Chevrolet Corvette Chrysler Prowler_\n\n_Delorean Dodge Stealth_\n\n_Dodge Viper Ferrari_\n\n_Fiat Ford Shelby or Cobra_\n\n_Hummer Infiniti Q45_\n\n_Jaguar Lincoln Aviator, Navigator_\n\n_Lincoln Blackwood Lotus_\n\n_Maserati Mercedes_\n\n_Mitsubishi 3000 GT Pantera_\n\n_Peugeot Plymouth Prowler_\n\n_Porsche Sterling_\n\n_Yugo_ or Similar Vehicles\n\n**SURCHARGED FOR PHYSICAL DAMAGE** The following vehicles will receive a surcharge on BI, PD, OTC & Collision: Convertibles Chevy Camaro\n\nDodge Daytona Eagle Talon\n\nFord Crown Vic Police Interceptor Ford Mustang GT, Probe\n\nFord Taurus SHO Ford Thunderbird Super Coupe\n\nFord Thunderbird Turbo Chevy Tracker/Geo Tracker\n\nHonda Civic (CRX) Honda Prelude\n\nIsuzu Impulse Jeep Wrangler\n\nKia Sportage Mazda Miata, RX-7, RX-8\n\nMitsubishi Eclipse Nissan 240 SX,300ZX, 350Z\n\nPontiac Firebird, Trans AM Saab\n\nSubaru SVX Suzuki Sidekick, Suzuki X-90\n\nToyota Rav4 Toyota Supra, MR 2\n\nVW Corrado Customized Vans\n\n### **MANDATORY ENDORSEMENTS**\n\n**Policies Offered Under This Program Differ From The Customary Coverage Provided Under The Texas Standard Personal Auto Policy** . Mandatory endorsements approved by the Texas Department of Insurance that significantly change the coverages from the Texas Standard Personal Auto Policy are attached to the policy jacket and shown by endorsement number on the Declarations page. These Endorsements are NOT optional. Total premium shown on the application and on the Declarations page are based in part on the acceptance of these endorsements. The agent must explain to the insured at the point of sale before binding the policy that policies offered under this program differ from the customary coverage provided under the Texas Standard Personal Auto Policy. The agent must explain these differences verbally and in writing prior to binding the policy.\n\nA disclosure form requiring the named insured’s signature summarizes these differences; this form should be signed and a copy given to the insured. Coverage cannot be bound unless a signed disclosure form is included in the submission with the signed application to the company. **The mandatory endorsements include the following which will be shown on the Declarations page:** MF.HSCM.2010 Misrepresentation or Fraud Endorsement CI.HSCM.2010 Criminal Intentional Acts Endorsement St.HSCM.2006 Storage Endorsement\n\n### **PERSISTENCY**\n\nAll semi-annual policies, regardless of inception date, are measured for their persistency to remain inforce based upon renewal. For every semi-annual renewal increment persistency by +1 and apply the appropriate factor.\n\n**Texas Administrative Code RULE §5.401 Temporary and Permanent Requirements Regarding Underwriting Treatment of and Disclosure to Applicants for Private Passenger Automobile Liability Insurance** Pursuant to TAC Rule §5.401,as an appointed representative of the company, it is incumbent upon the agent to properly inform any applicant with no prior insurance having no more than one accident and one violation within the past three years when the premium quote for the company equals or exceeds the premium available through the assigned risk plan. Any agent found to not be in compliance with this rule will be subject to possible suspension or termination.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page830.pdf"]},"response":{"errors":[],"extract_id":"extract_d5805e835cb82ab819dab354343756ef","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["# **AAAA INSURANCE**\n\n## RULES GUIDE\n\nAAAA Insurance Home State County Mutual Insurance Company 1M + 6M private passenger auto Page 6 of 6 effective 09/01/2016\n\n Any vehicle with a salvage title unless the title also shows that the vehicle has been reconditioned;  Any vehicle older than 30 years;  Suzuki Samurai, Dune Buggies, or similar off-road vehicles;  Jeep CJ5 or CJ7 models prior to 1987;  Any vehicle that has a TV screen or computer monitor visible to the driver (this does not include navigation systems that come as standard equipment from the factory); **PROHIBITED FOR PHYSICAL DAMAGE** The following are unacceptable for physical damage coverage:  Any vehicle with a ISO symbol greater than 21 for model years 1990 to 2010, or a symbol greater than 45 for model years 2011 and newer;  Any vehicle with an ACV of $40,000 or more;  Any vehicle over 20 years old;  Any of the following vehicles:\n\n_Alfa Romeo Audi4000,5000, Quattro_\n\n_Buick Reatta Cadillac Escalade, XLR_\n\n_Chevrolet Corvette Chrysler Prowler_\n\n_Delorean Dodge Stealth_\n\n_Dodge Viper Ferrari_\n\n_Fiat Ford Shelby or Cobra_\n\n_Hummer Infiniti Q45_\n\n_Jaguar Lincoln Aviator, Navigator_\n\n_Lincoln Blackwood Lotus_\n\n_Maserati Mercedes_\n\n_Mitsubishi 3000 GT Pantera_\n\n_Peugeot Plymouth Prowler_\n\n_Porsche Sterling_\n\n_Yugo_ or Similar Vehicles\n\n**SURCHARGED FOR PHYSICAL DAMAGE** The following vehicles will receive a surcharge on BI, PD, OTC & Collision: Convertibles Chevy Camaro\n\nDodge Daytona Eagle Talon\n\nFord Crown Vic Police Interceptor Ford Mustang GT, Probe\n\nFord Taurus SHO Ford Thunderbird Super Coupe\n\nFord Thunderbird Turbo Chevy Tracker/Geo Tracker\n\nHonda Civic (CRX) Honda Prelude\n\nIsuzu Impulse Jeep Wrangler\n\nKia Sportage Mazda Miata, RX-7, RX-8\n\nMitsubishi Eclipse Nissan 240 SX,300ZX, 350Z\n\nPontiac Firebird, Trans AM Saab\n\nSubaru SVX Suzuki Sidekick, Suzuki X-90\n\nToyota Rav4 Toyota Supra, MR 2\n\nVW Corrado Customized Vans\n\n### **MANDATORY ENDORSEMENTS**\n\n**Policies Offered Under This Program Differ From The Customary Coverage Provided Under The Texas Standard Personal Auto Policy** . Mandatory endorsements approved by the Texas Department of Insurance that significantly change the coverages from the Texas Standard Personal Auto Policy are attached to the policy jacket and shown by endorsement number on the Declarations page. These Endorsements are NOT optional. Total premium shown on the application and on the Declarations page are based in part on the acceptance of these endorsements. The agent must explain to the insured at the point of sale before binding the policy that policies offered under this program differ from the customary coverage provided under the Texas Standard Personal Auto Policy. The agent must explain these differences verbally and in writing prior to binding the policy.\n\nA disclosure form requiring the named insured’s signature summarizes these differences; this form should be signed and a copy given to the insured. Coverage cannot be bound unless a signed disclosure form is included in the submission with the signed application to the company. **The mandatory endorsements include the following which will be shown on the Declarations page:** MF.HSCM.2010 Misrepresentation or Fraud Endorsement CI.HSCM.2010 Criminal Intentional Acts Endorsement St.HSCM.2006 Storage Endorsement\n\n### **PERSISTENCY**\n\nAll semi-annual policies, regardless of inception date, are measured for their persistency to remain inforce based upon renewal. For every semi-annual renewal increment persistency by +1 and apply the appropriate factor.\n\n**Texas Administrative Code RULE §5.401 Temporary and Permanent Requirements Regarding Underwriting Treatment of and Disclosure to Applicants for Private Passenger Automobile Liability Insurance** Pursuant to TAC Rule §5.401,as an appointed representative of the company, it is incumbent upon the agent to properly inform any applicant with no prior insurance having no more than one accident and one violation within the past three years when the premium quote for the company equals or exceeds the premium available through the assigned risk plan. Any agent found to not be in compliance with this rule will be subject to possible suspension or termination."],"full_content":"# **AAAA INSURANCE**\n\n## RULES GUIDE\n\nAAAA Insurance Home State County Mutual Insurance Company 1M + 6M private passenger auto Page 6 of 6 effective 09/01/2016\n\n Any vehicle with a salvage title unless the title also shows that the vehicle has been reconditioned;  Any vehicle older than 30 years;  Suzuki Samurai, Dune Buggies, or similar off-road vehicles;  Jeep CJ5 or CJ7 models prior to 1987;  Any vehicle that has a TV screen or computer monitor visible to the driver (this does not include navigation systems that come as standard equipment from the factory); **PROHIBITED FOR PHYSICAL DAMAGE** The following are unacceptable for physical damage coverage:  Any vehicle with a ISO symbol greater than 21 for model years 1990 to 2010, or a symbol greater than 45 for model years 2011 and newer;  Any vehicle with an ACV of $40,000 or more;  Any vehicle over 20 years old;  Any of the following vehicles:\n\n_Alfa Romeo Audi4000,5000, Quattro_\n\n_Buick Reatta Cadillac Escalade, XLR_\n\n_Chevrolet Corvette Chrysler Prowler_\n\n_Delorean Dodge Stealth_\n\n_Dodge Viper Ferrari_\n\n_Fiat Ford Shelby or Cobra_\n\n_Hummer Infiniti Q45_\n\n_Jaguar Lincoln Aviator, Navigator_\n\n_Lincoln Blackwood Lotus_\n\n_Maserati Mercedes_\n\n_Mitsubishi 3000 GT Pantera_\n\n_Peugeot Plymouth Prowler_\n\n_Porsche Sterling_\n\n_Yugo_ or Similar Vehicles\n\n**SURCHARGED FOR PHYSICAL DAMAGE** The following vehicles will receive a surcharge on BI, PD, OTC & Collision: Convertibles Chevy Camaro\n\nDodge Daytona Eagle Talon\n\nFord Crown Vic Police Interceptor Ford Mustang GT, Probe\n\nFord Taurus SHO Ford Thunderbird Super Coupe\n\nFord Thunderbird Turbo Chevy Tracker/Geo Tracker\n\nHonda Civic (CRX) Honda Prelude\n\nIsuzu Impulse Jeep Wrangler\n\nKia Sportage Mazda Miata, RX-7, RX-8\n\nMitsubishi Eclipse Nissan 240 SX,300ZX, 350Z\n\nPontiac Firebird, Trans AM Saab\n\nSubaru SVX Suzuki Sidekick, Suzuki X-90\n\nToyota Rav4 Toyota Supra, MR 2\n\nVW Corrado Customized Vans\n\n### **MANDATORY ENDORSEMENTS**\n\n**Policies Offered Under This Program Differ From The Customary Coverage Provided Under The Texas Standard Personal Auto Policy** . Mandatory endorsements approved by the Texas Department of Insurance that significantly change the coverages from the Texas Standard Personal Auto Policy are attached to the policy jacket and shown by endorsement number on the Declarations page. These Endorsements are NOT optional. Total premium shown on the application and on the Declarations page are based in part on the acceptance of these endorsements. The agent must explain to the insured at the point of sale before binding the policy that policies offered under this program differ from the customary coverage provided under the Texas Standard Personal Auto Policy. The agent must explain these differences verbally and in writing prior to binding the policy.\n\nA disclosure form requiring the named insured’s signature summarizes these differences; this form should be signed and a copy given to the insured. Coverage cannot be bound unless a signed disclosure form is included in the submission with the signed application to the company. **The mandatory endorsements include the following which will be shown on the Declarations page:** MF.HSCM.2010 Misrepresentation or Fraud Endorsement CI.HSCM.2010 Criminal Intentional Acts Endorsement St.HSCM.2006 Storage Endorsement\n\n### **PERSISTENCY**\n\nAll semi-annual policies, regardless of inception date, are measured for their persistency to remain inforce based upon renewal. For every semi-annual renewal increment persistency by +1 and apply the appropriate factor.\n\n**Texas Administrative Code RULE §5.401 Temporary and Permanent Requirements Regarding Underwriting Treatment of and Disclosure to Applicants for Private Passenger Automobile Liability Insurance** Pursuant to TAC Rule §5.401,as an appointed representative of the company, it is incumbent upon the agent to properly inform any applicant with no prior insurance having no more than one accident and one violation within the past three years when the premium quote for the company equals or exceeds the premium available through the assigned risk plan. Any agent found to not be in compliance with this rule will be subject to possible suspension or termination.","publish_date":null,"title":"RULES GUIDE","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page830.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page830.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page830","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page830.pdf"},"started_at":"2026-11-04T19:47:34.653366"} +{"completed_at":"2026-11-04T19:47:36.877299","latency_in_ms":1082,"output":{"example_id":"table/SERFF_TX_random_pages 1_page831","grounded_pages":[],"layout_pages":[],"markdown":"**Texas Department of Insurance Company Name: Home State County Mutual Insurance .**\n\n**Property/Casualty Rate Filing Exhibits Company NAIC Number: 29** **297** **.**\n\n**Company Filing Number:** **AAAA.PA.Rates.09.01.16** **.**\n\n**Line: TX Private Passenger Auto .**\n\n**Exhibit CM - Addiitonal Information for Certain County Mutuals**\n\n**1\\. Name** **Saga International** **, Inc.** **License No.** **1822472**\n\n**2\\. Contact Person** **Marie Rinehart**\n\n**Telephone No.** **800-777-0404 x4617** **Fax No.**\n\n**Mailing Address** **616 S Boston Ave, STE 600** **E-Mail Address** **mrinehart@homestate.net**\n\n**City** **Tulsa** **State** **Oklahoma** **Zip** **74119**\n\n**TDI may release my e-mail address in response to a public information request Agree Do not agree**\n\n**3\\. List of policy forms and endorsements used. The listing does not constitute a filing under Chapter 3201. Each of the forms and endorsements listed must have been previously filed with and approved by TDI for the county mutual making this filing.**\n\n**Name Number TDI File Number**\n\n**promulgated**\n\n**515A**\n\n**523C**\n\n**524A**\n\n**530A**\n\n**Misrepresentation or Fraud Endorsement**\n\n**Criminal and Intentional Acts Endorsement**\n\n**Storage Endorsemen**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**571A**\n\n**578A**\n\n**551**\n\n**promulgated**\n\n**promulgated**\n\n**107794**\n\n**107794**\n\n**87461**\n\n**MF.HSCM.2010**\n\n**CI.HSCM.2010**\n\n**St.HSCM.2006**\n\n**Financial Responsibility Certification (Sr-22 Filings)**\n\n**Named Non-Owner Coverage**\n\n**Mexico Coverage - Limited**\n\n**Texas Personal Auto Policy**\n\n**Exclusion of Named Driver and Partial Rejection of Coverages**\n\n**Rental Reimbursement Coverage**\n\n**Towing and Labor Costs Coverage**\n\n**Loss Payable Clause**\n\n**Exhibit CM**","pages":[{"line_numbers":[],"markdown":"**Texas Department of Insurance Company Name: Home State County Mutual Insurance .**\n\n**Property/Casualty Rate Filing Exhibits Company NAIC Number: 29** **297** **.**\n\n**Company Filing Number:** **AAAA.PA.Rates.09.01.16** **.**\n\n**Line: TX Private Passenger Auto .**\n\n**Exhibit CM - Addiitonal Information for Certain County Mutuals**\n\n**1\\. Name** **Saga International** **, Inc.** **License No.** **1822472**\n\n**2\\. Contact Person** **Marie Rinehart**\n\n**Telephone No.** **800-777-0404 x4617** **Fax No.**\n\n**Mailing Address** **616 S Boston Ave, STE 600** **E-Mail Address** **mrinehart@homestate.net**\n\n**City** **Tulsa** **State** **Oklahoma** **Zip** **74119**\n\n**TDI may release my e-mail address in response to a public information request Agree Do not agree**\n\n**3\\. List of policy forms and endorsements used. The listing does not constitute a filing under Chapter 3201. Each of the forms and endorsements listed must have been previously filed with and approved by TDI for the county mutual making this filing.**\n\n**Name Number TDI File Number**\n\n**promulgated**\n\n**515A**\n\n**523C**\n\n**524A**\n\n**530A**\n\n**Misrepresentation or Fraud Endorsement**\n\n**Criminal and Intentional Acts Endorsement**\n\n**Storage Endorsemen**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**571A**\n\n**578A**\n\n**551**\n\n**promulgated**\n\n**promulgated**\n\n**107794**\n\n**107794**\n\n**87461**\n\n**MF.HSCM.2010**\n\n**CI.HSCM.2010**\n\n**St.HSCM.2006**\n\n**Financial Responsibility Certification (Sr-22 Filings)**\n\n**Named Non-Owner Coverage**\n\n**Mexico Coverage - Limited**\n\n**Texas Personal Auto Policy**\n\n**Exclusion of Named Driver and Partial Rejection of Coverages**\n\n**Rental Reimbursement Coverage**\n\n**Towing and Labor Costs Coverage**\n\n**Loss Payable Clause**\n\n**Exhibit CM**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Texas Department of Insurance Company Name: Home State County Mutual Insurance .**\n\n**Property/Casualty Rate Filing Exhibits Company NAIC Number: 29** **297** **.**\n\n**Company Filing Number:** **AAAA.PA.Rates.09.01.16** **.**\n\n**Line: TX Private Passenger Auto .**\n\n**Exhibit CM - Addiitonal Information for Certain County Mutuals**\n\n**1\\. Name** **Saga International** **, Inc.** **License No.** **1822472**\n\n**2\\. Contact Person** **Marie Rinehart**\n\n**Telephone No.** **800-777-0404 x4617** **Fax No.**\n\n**Mailing Address** **616 S Boston Ave, STE 600** **E-Mail Address** **mrinehart@homestate.net**\n\n**City** **Tulsa** **State** **Oklahoma** **Zip** **74119**\n\n**TDI may release my e-mail address in response to a public information request Agree Do not agree**\n\n**3\\. List of policy forms and endorsements used. The listing does not constitute a filing under Chapter 3201. Each of the forms and endorsements listed must have been previously filed with and approved by TDI for the county mutual making this filing.**\n\n**Name Number TDI File Number**\n\n**promulgated**\n\n**515A**\n\n**523C**\n\n**524A**\n\n**530A**\n\n**Misrepresentation or Fraud Endorsement**\n\n**Criminal and Intentional Acts Endorsement**\n\n**Storage Endorsemen**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**571A**\n\n**578A**\n\n**551**\n\n**promulgated**\n\n**promulgated**\n\n**107794**\n\n**107794**\n\n**87461**\n\n**MF.HSCM.2010**\n\n**CI.HSCM.2010**\n\n**St.HSCM.2006**\n\n**Financial Responsibility Certification (Sr-22 Filings)**\n\n**Named Non-Owner Coverage**\n\n**Mexico Coverage - Limited**\n\n**Texas Personal Auto Policy**\n\n**Exclusion of Named Driver and Partial Rejection of Coverages**\n\n**Rental Reimbursement Coverage**\n\n**Towing and Labor Costs Coverage**\n\n**Loss Payable Clause**\n\n**Exhibit CM**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page831.pdf"]},"response":{"errors":[],"extract_id":"extract_3df1cc9d024a6493aa7955632f7ed66e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Texas Department of Insurance Company Name: Home State County Mutual Insurance .**\n\n**Property/Casualty Rate Filing Exhibits Company NAIC Number: 29** **297** **.**\n\n**Company Filing Number:** **AAAA.PA.Rates.09.01.16** **.**\n\n**Line: TX Private Passenger Auto .**\n\n**Exhibit CM - Addiitonal Information for Certain County Mutuals**\n\n**1\\. Name** **Saga International** **, Inc.** **License No.** **1822472**\n\n**2\\. Contact Person** **Marie Rinehart**\n\n**Telephone No.** **800-777-0404 x4617** **Fax No.**\n\n**Mailing Address** **616 S Boston Ave, STE 600** **E-Mail Address** **mrinehart@homestate.net**\n\n**City** **Tulsa** **State** **Oklahoma** **Zip** **74119**\n\n**TDI may release my e-mail address in response to a public information request Agree Do not agree**\n\n**3\\. List of policy forms and endorsements used. The listing does not constitute a filing under Chapter 3201. Each of the forms and endorsements listed must have been previously filed with and approved by TDI for the county mutual making this filing.**\n\n**Name Number TDI File Number**\n\n**promulgated**\n\n**515A**\n\n**523C**\n\n**524A**\n\n**530A**\n\n**Misrepresentation or Fraud Endorsement**\n\n**Criminal and Intentional Acts Endorsement**\n\n**Storage Endorsemen**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**571A**\n\n**578A**\n\n**551**\n\n**promulgated**\n\n**promulgated**\n\n**107794**\n\n**107794**\n\n**87461**\n\n**MF.HSCM.2010**\n\n**CI.HSCM.2010**\n\n**St.HSCM.2006**\n\n**Financial Responsibility Certification (Sr-22 Filings)**\n\n**Named Non-Owner Coverage**\n\n**Mexico Coverage - Limited**\n\n**Texas Personal Auto Policy**\n\n**Exclusion of Named Driver and Partial Rejection of Coverages**\n\n**Rental Reimbursement Coverage**\n\n**Towing and Labor Costs Coverage**\n\n**Loss Payable Clause**\n\n**Exhibit CM**"],"full_content":"**Texas Department of Insurance Company Name: Home State County Mutual Insurance .**\n\n**Property/Casualty Rate Filing Exhibits Company NAIC Number: 29** **297** **.**\n\n**Company Filing Number:** **AAAA.PA.Rates.09.01.16** **.**\n\n**Line: TX Private Passenger Auto .**\n\n**Exhibit CM - Addiitonal Information for Certain County Mutuals**\n\n**1\\. Name** **Saga International** **, Inc.** **License No.** **1822472**\n\n**2\\. Contact Person** **Marie Rinehart**\n\n**Telephone No.** **800-777-0404 x4617** **Fax No.**\n\n**Mailing Address** **616 S Boston Ave, STE 600** **E-Mail Address** **mrinehart@homestate.net**\n\n**City** **Tulsa** **State** **Oklahoma** **Zip** **74119**\n\n**TDI may release my e-mail address in response to a public information request Agree Do not agree**\n\n**3\\. List of policy forms and endorsements used. The listing does not constitute a filing under Chapter 3201. Each of the forms and endorsements listed must have been previously filed with and approved by TDI for the county mutual making this filing.**\n\n**Name Number TDI File Number**\n\n**promulgated**\n\n**515A**\n\n**523C**\n\n**524A**\n\n**530A**\n\n**Misrepresentation or Fraud Endorsement**\n\n**Criminal and Intentional Acts Endorsement**\n\n**Storage Endorsemen**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**promulgated**\n\n**571A**\n\n**578A**\n\n**551**\n\n**promulgated**\n\n**promulgated**\n\n**107794**\n\n**107794**\n\n**87461**\n\n**MF.HSCM.2010**\n\n**CI.HSCM.2010**\n\n**St.HSCM.2006**\n\n**Financial Responsibility Certification (Sr-22 Filings)**\n\n**Named Non-Owner Coverage**\n\n**Mexico Coverage - Limited**\n\n**Texas Personal Auto Policy**\n\n**Exclusion of Named Driver and Partial Rejection of Coverages**\n\n**Rental Reimbursement Coverage**\n\n**Towing and Labor Costs Coverage**\n\n**Loss Payable Clause**\n\n**Exhibit CM**","publish_date":null,"title":"Name Number TDI File Number","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page831.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page831.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page831","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page831.pdf"},"started_at":"2026-11-04T19:47:35.794523"} +{"completed_at":"2026-11-04T19:47:40.191158","latency_in_ms":3633,"output":{"example_id":"table/SERFF_TX_random_pages 1_page838","grounded_pages":[],"layout_pages":[],"markdown":"**Year**\n\n**Home State County Mutual Insurance Company**\n\n**A-Max Insurance Services Inc.**\n\n**Private Passenger Automobile, semi-annual limited & standard policies**\n\n**AMS / program 1**\n\n**Rates Effective 10/15/2016 New Business, 11/15/2016 Renewals**\n\n**MODEL YEAR FACTORS**\n\n**OTC COL BI PD**\n\n2016 1.19 1.20 1.00 1.00\n\n2015 1.19 1.20 1.00 1.00\n\n2014 1.19 1.20 1.00 1.00\n\n2013 1.19 1.20 1.00 1.00\n\n2012 1.19 1.20 1.00 1.00\n\n2011 1.19 1.20 1.00 1.00\n\n2010 1.19 1.20 1.00 1.00\n\n2009 1.19 1.20 1.00 1.00\n\n2008 1.19 1.20 1.00 1.00\n\n2007 1.19 1.20 1.00 1.00\n\n2006 1.19 1.20 1.00 1.00\n\n2005 1.17 1.18 1.00 1.00\n\n2004 1.09 1.09 1.00 1.00\n\n2003 1.06 1.06 1.00 1.00\n\n2002 1.05 1.05 1.00 1.00\n\n2001 1.00 1.00 1.00 1.00\n\n2000 0.94 0.95 0.99 0.99\n\n1999 0.90 0.90 0.98 0.98\n\n1998 0.77 0.77 0.96 0.96\n\n1997 0.77 0.77 0.93 0.93\n\n1996 0.77 0.77 0.92 0.92\n\n1995 0.77 0.77 0.92 0.92\n\n1994 0.77 0.77 0.92 0.92\n\n1993 0.77 0.77 0.92 0.92\n\n1992 0.77 0.77 0.92 0.92\n\n1991 0.77 0.77 0.92 0.92\n\n1990 0.77 0.77 0.92 0.92\n\n1989 0.77 0.77 0.92 0.92\n\n1988 0.77 0.77 0.92 0.92\n\n1987 0.77 0.77 0.92 0.92\n\n1986 0.77 0.77 0.92 0.92\n\n1985 0.77 0.77 0.92 0.92\n\n1984 0.77 0.77 0.92 0.92\n\n1983 0.77 0.77 0.92 0.92\n\n1982 0.77 0.77 0.92 0.92\n\n1981 0.77 0.77 0.92 0.92\n\n1980 0.77 0.77 0.92 0.92\n\n1979 0.77 0.77 0.92 0.92\n\n1978 0.77 0.77 0.92 0.92\n\n1977 0.77 0.77 0.92 0.92\n\n1976 0.77 0.77 0.92 0.92\n\n1975 0.77 0.77 0.92 0.92\n\n1974 0.77 0.77 0.92 0.92\n\n1973 0.77 0.77 0.92 0.92\n\n1972 0.77 0.77 0.92 0.92\n\n1971 0.77 0.77 0.92 0.92\n\n1970 0.77 0.77 0.92 0.92\n\n**TX AMAX Factors 10/15/2016 PAGE 6**\n\n**for any model year older than 1980, use the 1980 model year factor**","pages":[{"line_numbers":[],"markdown":"**Year**\n\n**Home State County Mutual Insurance Company**\n\n**A-Max Insurance Services Inc.**\n\n**Private Passenger Automobile, semi-annual limited & standard policies**\n\n**AMS / program 1**\n\n**Rates Effective 10/15/2016 New Business, 11/15/2016 Renewals**\n\n**MODEL YEAR FACTORS**\n\n**OTC COL BI PD**\n\n2016 1.19 1.20 1.00 1.00\n\n2015 1.19 1.20 1.00 1.00\n\n2014 1.19 1.20 1.00 1.00\n\n2013 1.19 1.20 1.00 1.00\n\n2012 1.19 1.20 1.00 1.00\n\n2011 1.19 1.20 1.00 1.00\n\n2010 1.19 1.20 1.00 1.00\n\n2009 1.19 1.20 1.00 1.00\n\n2008 1.19 1.20 1.00 1.00\n\n2007 1.19 1.20 1.00 1.00\n\n2006 1.19 1.20 1.00 1.00\n\n2005 1.17 1.18 1.00 1.00\n\n2004 1.09 1.09 1.00 1.00\n\n2003 1.06 1.06 1.00 1.00\n\n2002 1.05 1.05 1.00 1.00\n\n2001 1.00 1.00 1.00 1.00\n\n2000 0.94 0.95 0.99 0.99\n\n1999 0.90 0.90 0.98 0.98\n\n1998 0.77 0.77 0.96 0.96\n\n1997 0.77 0.77 0.93 0.93\n\n1996 0.77 0.77 0.92 0.92\n\n1995 0.77 0.77 0.92 0.92\n\n1994 0.77 0.77 0.92 0.92\n\n1993 0.77 0.77 0.92 0.92\n\n1992 0.77 0.77 0.92 0.92\n\n1991 0.77 0.77 0.92 0.92\n\n1990 0.77 0.77 0.92 0.92\n\n1989 0.77 0.77 0.92 0.92\n\n1988 0.77 0.77 0.92 0.92\n\n1987 0.77 0.77 0.92 0.92\n\n1986 0.77 0.77 0.92 0.92\n\n1985 0.77 0.77 0.92 0.92\n\n1984 0.77 0.77 0.92 0.92\n\n1983 0.77 0.77 0.92 0.92\n\n1982 0.77 0.77 0.92 0.92\n\n1981 0.77 0.77 0.92 0.92\n\n1980 0.77 0.77 0.92 0.92\n\n1979 0.77 0.77 0.92 0.92\n\n1978 0.77 0.77 0.92 0.92\n\n1977 0.77 0.77 0.92 0.92\n\n1976 0.77 0.77 0.92 0.92\n\n1975 0.77 0.77 0.92 0.92\n\n1974 0.77 0.77 0.92 0.92\n\n1973 0.77 0.77 0.92 0.92\n\n1972 0.77 0.77 0.92 0.92\n\n1971 0.77 0.77 0.92 0.92\n\n1970 0.77 0.77 0.92 0.92\n\n**TX AMAX Factors 10/15/2016 PAGE 6**\n\n**for any model year older than 1980, use the 1980 model year factor**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Year**\n\n**Home State County Mutual Insurance Company**\n\n**A-Max Insurance Services Inc.**\n\n**Private Passenger Automobile, semi-annual limited & standard policies**\n\n**AMS / program 1**\n\n**Rates Effective 10/15/2016 New Business, 11/15/2016 Renewals**\n\n**MODEL YEAR FACTORS**\n\n**OTC COL BI PD**\n\n2016 1.19 1.20 1.00 1.00\n\n2015 1.19 1.20 1.00 1.00\n\n2014 1.19 1.20 1.00 1.00\n\n2013 1.19 1.20 1.00 1.00\n\n2012 1.19 1.20 1.00 1.00\n\n2011 1.19 1.20 1.00 1.00\n\n2010 1.19 1.20 1.00 1.00\n\n2009 1.19 1.20 1.00 1.00\n\n2008 1.19 1.20 1.00 1.00\n\n2007 1.19 1.20 1.00 1.00\n\n2006 1.19 1.20 1.00 1.00\n\n2005 1.17 1.18 1.00 1.00\n\n2004 1.09 1.09 1.00 1.00\n\n2003 1.06 1.06 1.00 1.00\n\n2002 1.05 1.05 1.00 1.00\n\n2001 1.00 1.00 1.00 1.00\n\n2000 0.94 0.95 0.99 0.99\n\n1999 0.90 0.90 0.98 0.98\n\n1998 0.77 0.77 0.96 0.96\n\n1997 0.77 0.77 0.93 0.93\n\n1996 0.77 0.77 0.92 0.92\n\n1995 0.77 0.77 0.92 0.92\n\n1994 0.77 0.77 0.92 0.92\n\n1993 0.77 0.77 0.92 0.92\n\n1992 0.77 0.77 0.92 0.92\n\n1991 0.77 0.77 0.92 0.92\n\n1990 0.77 0.77 0.92 0.92\n\n1989 0.77 0.77 0.92 0.92\n\n1988 0.77 0.77 0.92 0.92\n\n1987 0.77 0.77 0.92 0.92\n\n1986 0.77 0.77 0.92 0.92\n\n1985 0.77 0.77 0.92 0.92\n\n1984 0.77 0.77 0.92 0.92\n\n1983 0.77 0.77 0.92 0.92\n\n1982 0.77 0.77 0.92 0.92\n\n1981 0.77 0.77 0.92 0.92\n\n1980 0.77 0.77 0.92 0.92\n\n1979 0.77 0.77 0.92 0.92\n\n1978 0.77 0.77 0.92 0.92\n\n1977 0.77 0.77 0.92 0.92\n\n1976 0.77 0.77 0.92 0.92\n\n1975 0.77 0.77 0.92 0.92\n\n1974 0.77 0.77 0.92 0.92\n\n1973 0.77 0.77 0.92 0.92\n\n1972 0.77 0.77 0.92 0.92\n\n1971 0.77 0.77 0.92 0.92\n\n1970 0.77 0.77 0.92 0.92\n\n**TX AMAX Factors 10/15/2016 PAGE 6**\n\n**for any model year older than 1980, use the 1980 model year factor**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page838.pdf"]},"response":{"errors":[],"extract_id":"extract_4007425e6a89c9fdb6c2a0cf73cc1049","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Year**\n\n**Home State County Mutual Insurance Company**\n\n**A-Max Insurance Services Inc.**\n\n**Private Passenger Automobile, semi-annual limited & standard policies**\n\n**AMS / program 1**\n\n**Rates Effective 10/15/2016 New Business, 11/15/2016 Renewals**\n\n**MODEL YEAR FACTORS**\n\n**OTC COL BI PD**\n\n2016 1.19 1.20 1.00 1.00\n\n2015 1.19 1.20 1.00 1.00\n\n2014 1.19 1.20 1.00 1.00\n\n2013 1.19 1.20 1.00 1.00\n\n2012 1.19 1.20 1.00 1.00\n\n2011 1.19 1.20 1.00 1.00\n\n2010 1.19 1.20 1.00 1.00\n\n2009 1.19 1.20 1.00 1.00\n\n2008 1.19 1.20 1.00 1.00\n\n2007 1.19 1.20 1.00 1.00\n\n2006 1.19 1.20 1.00 1.00\n\n2005 1.17 1.18 1.00 1.00\n\n2004 1.09 1.09 1.00 1.00\n\n2003 1.06 1.06 1.00 1.00\n\n2002 1.05 1.05 1.00 1.00\n\n2001 1.00 1.00 1.00 1.00\n\n2000 0.94 0.95 0.99 0.99\n\n1999 0.90 0.90 0.98 0.98\n\n1998 0.77 0.77 0.96 0.96\n\n1997 0.77 0.77 0.93 0.93\n\n1996 0.77 0.77 0.92 0.92\n\n1995 0.77 0.77 0.92 0.92\n\n1994 0.77 0.77 0.92 0.92\n\n1993 0.77 0.77 0.92 0.92\n\n1992 0.77 0.77 0.92 0.92\n\n1991 0.77 0.77 0.92 0.92\n\n1990 0.77 0.77 0.92 0.92\n\n1989 0.77 0.77 0.92 0.92\n\n1988 0.77 0.77 0.92 0.92\n\n1987 0.77 0.77 0.92 0.92\n\n1986 0.77 0.77 0.92 0.92\n\n1985 0.77 0.77 0.92 0.92\n\n1984 0.77 0.77 0.92 0.92\n\n1983 0.77 0.77 0.92 0.92\n\n1982 0.77 0.77 0.92 0.92\n\n1981 0.77 0.77 0.92 0.92\n\n1980 0.77 0.77 0.92 0.92\n\n1979 0.77 0.77 0.92 0.92\n\n1978 0.77 0.77 0.92 0.92\n\n1977 0.77 0.77 0.92 0.92\n\n1976 0.77 0.77 0.92 0.92\n\n1975 0.77 0.77 0.92 0.92\n\n1974 0.77 0.77 0.92 0.92\n\n1973 0.77 0.77 0.92 0.92\n\n1972 0.77 0.77 0.92 0.92\n\n1971 0.77 0.77 0.92 0.92\n\n1970 0.77 0.77 0.92 0.92\n\n**TX AMAX Factors 10/15/2016 PAGE 6**\n\n**for any model year older than 1980, use the 1980 model year factor**"],"full_content":"**Year**\n\n**Home State County Mutual Insurance Company**\n\n**A-Max Insurance Services Inc.**\n\n**Private Passenger Automobile, semi-annual limited & standard policies**\n\n**AMS / program 1**\n\n**Rates Effective 10/15/2016 New Business, 11/15/2016 Renewals**\n\n**MODEL YEAR FACTORS**\n\n**OTC COL BI PD**\n\n2016 1.19 1.20 1.00 1.00\n\n2015 1.19 1.20 1.00 1.00\n\n2014 1.19 1.20 1.00 1.00\n\n2013 1.19 1.20 1.00 1.00\n\n2012 1.19 1.20 1.00 1.00\n\n2011 1.19 1.20 1.00 1.00\n\n2010 1.19 1.20 1.00 1.00\n\n2009 1.19 1.20 1.00 1.00\n\n2008 1.19 1.20 1.00 1.00\n\n2007 1.19 1.20 1.00 1.00\n\n2006 1.19 1.20 1.00 1.00\n\n2005 1.17 1.18 1.00 1.00\n\n2004 1.09 1.09 1.00 1.00\n\n2003 1.06 1.06 1.00 1.00\n\n2002 1.05 1.05 1.00 1.00\n\n2001 1.00 1.00 1.00 1.00\n\n2000 0.94 0.95 0.99 0.99\n\n1999 0.90 0.90 0.98 0.98\n\n1998 0.77 0.77 0.96 0.96\n\n1997 0.77 0.77 0.93 0.93\n\n1996 0.77 0.77 0.92 0.92\n\n1995 0.77 0.77 0.92 0.92\n\n1994 0.77 0.77 0.92 0.92\n\n1993 0.77 0.77 0.92 0.92\n\n1992 0.77 0.77 0.92 0.92\n\n1991 0.77 0.77 0.92 0.92\n\n1990 0.77 0.77 0.92 0.92\n\n1989 0.77 0.77 0.92 0.92\n\n1988 0.77 0.77 0.92 0.92\n\n1987 0.77 0.77 0.92 0.92\n\n1986 0.77 0.77 0.92 0.92\n\n1985 0.77 0.77 0.92 0.92\n\n1984 0.77 0.77 0.92 0.92\n\n1983 0.77 0.77 0.92 0.92\n\n1982 0.77 0.77 0.92 0.92\n\n1981 0.77 0.77 0.92 0.92\n\n1980 0.77 0.77 0.92 0.92\n\n1979 0.77 0.77 0.92 0.92\n\n1978 0.77 0.77 0.92 0.92\n\n1977 0.77 0.77 0.92 0.92\n\n1976 0.77 0.77 0.92 0.92\n\n1975 0.77 0.77 0.92 0.92\n\n1974 0.77 0.77 0.92 0.92\n\n1973 0.77 0.77 0.92 0.92\n\n1972 0.77 0.77 0.92 0.92\n\n1971 0.77 0.77 0.92 0.92\n\n1970 0.77 0.77 0.92 0.92\n\n**TX AMAX Factors 10/15/2016 PAGE 6**\n\n**for any model year older than 1980, use the 1980 model year factor**","publish_date":null,"title":"A-Max Insurance Services Inc. Home State County Mutual Insurance Company Private Passenger Automobile, semi-annual limited & standard policies Rates Effective","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page838.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page838.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page838","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page838.pdf"},"started_at":"2026-11-04T19:47:36.557872"} +{"completed_at":"2026-11-04T19:31:09.467948","latency_in_ms":1024,"output":{"example_id":"table/SERFF_TX_random_pages 1_page847","grounded_pages":[],"layout_pages":[],"markdown":"THE HANOVER INSURANCE COMPANY (HIC) TEXAS (42)\n\nMASSACHUSETTS BAY INSURANCE COMPANY (MBIC) THE HANOVER AMERICAN INSURANCE COMPANY (HAIC) THE HANOVER LLOYDS INSURANCE COMPANY (HLIC)\n\n**HIC MBIC HAIC HLIC HIC MBIC HAIC HLIC**\n\nMotel/Hotel 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nApartments 1.15 1.15 1.15 1.15 1.20 1.20 1.20 1.20\n\nOffice 0.98 0.98 0.98 0.98 0.77 0.77 0.77 0.77\n\nMercantile 1.00 1.00 1.00 1.00 0.95 0.95 0.95 0.95\n\nInstitutional 0.88 0.88 0.88 0.88 0.96 0.96 0.96 0.96\n\nServices 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nIndustrial Processing 1.00 1.00 1.00 1.00 0.88 0.88 0.88 0.88\n\nContractors 1.00 1.00 1.00 1.00 0.93 0.93 0.93 0.93\n\nOther Risks 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nReligious Institution 1.00 1.00 1.00 1.00 0.85 0.85 0.85 0.85\n\nHuman Services 0.91 0.91 0.91 0.91 0.85 0.85 0.85 0.85\n\nIT Services 0.60 0.60 0.60 0.60 1.00 1.00 1.00 1.00\n\nTelecommunications 0.80 0.80 0.80 0.80 1.00 1.00 1.00 1.00\n\nElectronics Mfg. 0.82 0.82 0.82 0.82 1.00 1.00 1.00 1.00\n\nLife Sciences 0.85 0.85 0.85 0.85 0.85 0.85 0.85 0.85\n\nDurable Medical Equip. 0.90 0.90 0.90 0.90 0.70 0.70 0.70 0.70\n\n\\*MHDC (46202) \\*\\* \\*\\* \\*\\* \\*\\* 1.00 1.00 1.00 1.00\n\n\\*MHDC (15488) \\*\\* \\*\\* \\*\\* \\*\\* 0.29 0.29 0.29 0.29\n\nEducational Institutions 1.00 1.00 1.00 1.00 0.80 0.80 0.80 0.80\n\nHealth and Fitness 1.00 1.00 1.00 1.00 1.00 0.80 0.65 0.60\n\nAmateur Sports 1.00 1.00 1.00 1.00 1.00 0.80 0.65 0.60\n\n\\*\\* Property PMF is based on Insured's operation \\* Manufactured Housing Dealers and Communities Program\n\n### **Division Nine - Commercial Package**\n\n### **Exception Page**\n\n### **PACKAGE MODIFICATION FACTORS**\n\n**Type of Risk**\n\n**Premium from CLM Division**\n\n**Three, Five, Eight**\n\n**Property PMF's**\n\n**Six**\n\n**Liability PMF's**","pages":[{"line_numbers":[],"markdown":"THE HANOVER INSURANCE COMPANY (HIC) TEXAS (42)\n\nMASSACHUSETTS BAY INSURANCE COMPANY (MBIC) THE HANOVER AMERICAN INSURANCE COMPANY (HAIC) THE HANOVER LLOYDS INSURANCE COMPANY (HLIC)\n\n**HIC MBIC HAIC HLIC HIC MBIC HAIC HLIC**\n\nMotel/Hotel 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nApartments 1.15 1.15 1.15 1.15 1.20 1.20 1.20 1.20\n\nOffice 0.98 0.98 0.98 0.98 0.77 0.77 0.77 0.77\n\nMercantile 1.00 1.00 1.00 1.00 0.95 0.95 0.95 0.95\n\nInstitutional 0.88 0.88 0.88 0.88 0.96 0.96 0.96 0.96\n\nServices 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nIndustrial Processing 1.00 1.00 1.00 1.00 0.88 0.88 0.88 0.88\n\nContractors 1.00 1.00 1.00 1.00 0.93 0.93 0.93 0.93\n\nOther Risks 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nReligious Institution 1.00 1.00 1.00 1.00 0.85 0.85 0.85 0.85\n\nHuman Services 0.91 0.91 0.91 0.91 0.85 0.85 0.85 0.85\n\nIT Services 0.60 0.60 0.60 0.60 1.00 1.00 1.00 1.00\n\nTelecommunications 0.80 0.80 0.80 0.80 1.00 1.00 1.00 1.00\n\nElectronics Mfg. 0.82 0.82 0.82 0.82 1.00 1.00 1.00 1.00\n\nLife Sciences 0.85 0.85 0.85 0.85 0.85 0.85 0.85 0.85\n\nDurable Medical Equip. 0.90 0.90 0.90 0.90 0.70 0.70 0.70 0.70\n\n\\*MHDC (46202) \\*\\* \\*\\* \\*\\* \\*\\* 1.00 1.00 1.00 1.00\n\n\\*MHDC (15488) \\*\\* \\*\\* \\*\\* \\*\\* 0.29 0.29 0.29 0.29\n\nEducational Institutions 1.00 1.00 1.00 1.00 0.80 0.80 0.80 0.80\n\nHealth and Fitness 1.00 1.00 1.00 1.00 1.00 0.80 0.65 0.60\n\nAmateur Sports 1.00 1.00 1.00 1.00 1.00 0.80 0.65 0.60\n\n\\*\\* Property PMF is based on Insured's operation \\* Manufactured Housing Dealers and Communities Program\n\n### **Division Nine - Commercial Package**\n\n### **Exception Page**\n\n### **PACKAGE MODIFICATION FACTORS**\n\n**Type of Risk**\n\n**Premium from CLM Division**\n\n**Three, Five, Eight**\n\n**Property PMF's**\n\n**Six**\n\n**Liability PMF's**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"THE HANOVER INSURANCE COMPANY (HIC) TEXAS (42)\n\nMASSACHUSETTS BAY INSURANCE COMPANY (MBIC) THE HANOVER AMERICAN INSURANCE COMPANY (HAIC) THE HANOVER LLOYDS INSURANCE COMPANY (HLIC)\n\n**HIC MBIC HAIC HLIC HIC MBIC HAIC HLIC**\n\nMotel/Hotel 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nApartments 1.15 1.15 1.15 1.15 1.20 1.20 1.20 1.20\n\nOffice 0.98 0.98 0.98 0.98 0.77 0.77 0.77 0.77\n\nMercantile 1.00 1.00 1.00 1.00 0.95 0.95 0.95 0.95\n\nInstitutional 0.88 0.88 0.88 0.88 0.96 0.96 0.96 0.96\n\nServices 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nIndustrial Processing 1.00 1.00 1.00 1.00 0.88 0.88 0.88 0.88\n\nContractors 1.00 1.00 1.00 1.00 0.93 0.93 0.93 0.93\n\nOther Risks 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nReligious Institution 1.00 1.00 1.00 1.00 0.85 0.85 0.85 0.85\n\nHuman Services 0.91 0.91 0.91 0.91 0.85 0.85 0.85 0.85\n\nIT Services 0.60 0.60 0.60 0.60 1.00 1.00 1.00 1.00\n\nTelecommunications 0.80 0.80 0.80 0.80 1.00 1.00 1.00 1.00\n\nElectronics Mfg. 0.82 0.82 0.82 0.82 1.00 1.00 1.00 1.00\n\nLife Sciences 0.85 0.85 0.85 0.85 0.85 0.85 0.85 0.85\n\nDurable Medical Equip. 0.90 0.90 0.90 0.90 0.70 0.70 0.70 0.70\n\n\\*MHDC (46202) \\*\\* \\*\\* \\*\\* \\*\\* 1.00 1.00 1.00 1.00\n\n\\*MHDC (15488) \\*\\* \\*\\* \\*\\* \\*\\* 0.29 0.29 0.29 0.29\n\nEducational Institutions 1.00 1.00 1.00 1.00 0.80 0.80 0.80 0.80\n\nHealth and Fitness 1.00 1.00 1.00 1.00 1.00 0.80 0.65 0.60\n\nAmateur Sports 1.00 1.00 1.00 1.00 1.00 0.80 0.65 0.60\n\n\\*\\* Property PMF is based on Insured's operation \\* Manufactured Housing Dealers and Communities Program\n\n### **Division Nine - Commercial Package**\n\n### **Exception Page**\n\n### **PACKAGE MODIFICATION FACTORS**\n\n**Type of Risk**\n\n**Premium from CLM Division**\n\n**Three, Five, Eight**\n\n**Property PMF's**\n\n**Six**\n\n**Liability PMF's**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page847.pdf"]},"response":{"errors":[],"extract_id":"extract_e23c532f9c81c2e7032ea0e38e958d6f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["THE HANOVER INSURANCE COMPANY (HIC) TEXAS (42)\n\nMASSACHUSETTS BAY INSURANCE COMPANY (MBIC) THE HANOVER AMERICAN INSURANCE COMPANY (HAIC) THE HANOVER LLOYDS INSURANCE COMPANY (HLIC)\n\n**HIC MBIC HAIC HLIC HIC MBIC HAIC HLIC**\n\nMotel/Hotel 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nApartments 1.15 1.15 1.15 1.15 1.20 1.20 1.20 1.20\n\nOffice 0.98 0.98 0.98 0.98 0.77 0.77 0.77 0.77\n\nMercantile 1.00 1.00 1.00 1.00 0.95 0.95 0.95 0.95\n\nInstitutional 0.88 0.88 0.88 0.88 0.96 0.96 0.96 0.96\n\nServices 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nIndustrial Processing 1.00 1.00 1.00 1.00 0.88 0.88 0.88 0.88\n\nContractors 1.00 1.00 1.00 1.00 0.93 0.93 0.93 0.93\n\nOther Risks 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nReligious Institution 1.00 1.00 1.00 1.00 0.85 0.85 0.85 0.85\n\nHuman Services 0.91 0.91 0.91 0.91 0.85 0.85 0.85 0.85\n\nIT Services 0.60 0.60 0.60 0.60 1.00 1.00 1.00 1.00\n\nTelecommunications 0.80 0.80 0.80 0.80 1.00 1.00 1.00 1.00\n\nElectronics Mfg. 0.82 0.82 0.82 0.82 1.00 1.00 1.00 1.00\n\nLife Sciences 0.85 0.85 0.85 0.85 0.85 0.85 0.85 0.85\n\nDurable Medical Equip. 0.90 0.90 0.90 0.90 0.70 0.70 0.70 0.70\n\n\\*MHDC (46202) \\*\\* \\*\\* \\*\\* \\*\\* 1.00 1.00 1.00 1.00\n\n\\*MHDC (15488) \\*\\* \\*\\* \\*\\* \\*\\* 0.29 0.29 0.29 0.29\n\nEducational Institutions 1.00 1.00 1.00 1.00 0.80 0.80 0.80 0.80\n\nHealth and Fitness 1.00 1.00 1.00 1.00 1.00 0.80 0.65 0.60\n\nAmateur Sports 1.00 1.00 1.00 1.00 1.00 0.80 0.65 0.60\n\n\\*\\* Property PMF is based on Insured's operation \\* Manufactured Housing Dealers and Communities Program\n\n### **Division Nine - Commercial Package**\n\n### **Exception Page**\n\n### **PACKAGE MODIFICATION FACTORS**\n\n**Type of Risk**\n\n**Premium from CLM Division**\n\n**Three, Five, Eight**\n\n**Property PMF's**\n\n**Six**\n\n**Liability PMF's**"],"full_content":"THE HANOVER INSURANCE COMPANY (HIC) TEXAS (42)\n\nMASSACHUSETTS BAY INSURANCE COMPANY (MBIC) THE HANOVER AMERICAN INSURANCE COMPANY (HAIC) THE HANOVER LLOYDS INSURANCE COMPANY (HLIC)\n\n**HIC MBIC HAIC HLIC HIC MBIC HAIC HLIC**\n\nMotel/Hotel 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nApartments 1.15 1.15 1.15 1.15 1.20 1.20 1.20 1.20\n\nOffice 0.98 0.98 0.98 0.98 0.77 0.77 0.77 0.77\n\nMercantile 1.00 1.00 1.00 1.00 0.95 0.95 0.95 0.95\n\nInstitutional 0.88 0.88 0.88 0.88 0.96 0.96 0.96 0.96\n\nServices 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nIndustrial Processing 1.00 1.00 1.00 1.00 0.88 0.88 0.88 0.88\n\nContractors 1.00 1.00 1.00 1.00 0.93 0.93 0.93 0.93\n\nOther Risks 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00\n\nReligious Institution 1.00 1.00 1.00 1.00 0.85 0.85 0.85 0.85\n\nHuman Services 0.91 0.91 0.91 0.91 0.85 0.85 0.85 0.85\n\nIT Services 0.60 0.60 0.60 0.60 1.00 1.00 1.00 1.00\n\nTelecommunications 0.80 0.80 0.80 0.80 1.00 1.00 1.00 1.00\n\nElectronics Mfg. 0.82 0.82 0.82 0.82 1.00 1.00 1.00 1.00\n\nLife Sciences 0.85 0.85 0.85 0.85 0.85 0.85 0.85 0.85\n\nDurable Medical Equip. 0.90 0.90 0.90 0.90 0.70 0.70 0.70 0.70\n\n\\*MHDC (46202) \\*\\* \\*\\* \\*\\* \\*\\* 1.00 1.00 1.00 1.00\n\n\\*MHDC (15488) \\*\\* \\*\\* \\*\\* \\*\\* 0.29 0.29 0.29 0.29\n\nEducational Institutions 1.00 1.00 1.00 1.00 0.80 0.80 0.80 0.80\n\nHealth and Fitness 1.00 1.00 1.00 1.00 1.00 0.80 0.65 0.60\n\nAmateur Sports 1.00 1.00 1.00 1.00 1.00 0.80 0.65 0.60\n\n\\*\\* Property PMF is based on Insured's operation \\* Manufactured Housing Dealers and Communities Program\n\n### **Division Nine - Commercial Package**\n\n### **Exception Page**\n\n### **PACKAGE MODIFICATION FACTORS**\n\n**Type of Risk**\n\n**Premium from CLM Division**\n\n**Three, Five, Eight**\n\n**Property PMF's**\n\n**Six**\n\n**Liability PMF's**","publish_date":null,"title":"Division Nine - Commercial Package Exception Page PACKAGE MODIFICATION FACTORS","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page847.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page847.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page847","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page847.pdf"},"started_at":"2026-11-04T19:31:08.443284"} +{"completed_at":"2026-11-04T19:47:41.891255","latency_in_ms":2657,"output":{"example_id":"table/SERFF_TX_random_pages 1_page848","grounded_pages":[],"layout_pages":[],"markdown":"Supplementary Exhibit A\n\n**Program 4 Year Earned Premium 4 Year Loss & ALAE Ratio Current Property PMFs Proposed Property PMFs ISO PMFs Current Difference from ISO**\n\n**Proposed Difference from ISO Reasoning**\n\nInstitutional $1.07M 8% 0.86 0.88 1.00 -14% -12% As this program has very little credibility, this PMF was increased 2.3% to move closer towards a more credible ISO PMF of 1.00\n\nOffice $7.66M 13% 0.94 0.98 1.00 -6% -2% This PMF was increased by 4.3% to move toward ISO PMF of 1.00.\n\nService $5.10M 120% 0.96 1.00 1.00 -4% 0% This PMF was increased by 4.2% due to unfavorable loss experience as well as to move to the ISO PMF of 1.00\n\n**Program 4 Year Earned Premium 4 Year Loss & ALAE Ratio Current Liability PMFs Proposed Liability PMFs ISO PMFs Current Difference from ISO**\n\n**Proposed Difference from ISO Reasoning**\n\nEducational Institutions $1.76M 45% 0.78 0.80 _1\\.00_ \\-22% -20%\n\nAs this program has little credibility, this PMF was increased by 2.6% in an effort to move towards a more credible ISO PMF of 1.00. Institutional is a proxy for Educational Institutions because ISO doesn’t have an Educational Institutions program.\n\nInstitutional $0.21M 107% 0.85 0.96 1.00 -15% -4% As this program has little credibility, this PMF was increased by 12.9% in an effort to move towards a more credible ISO PMF of 1.00.\n\nMercantle $13.69M 66% 0.86 0.95 0.98 -12% -3% This PMF was increased by 10.5% due to unfavorable loss experience as well as to move toward ISO PMF of 0.98.\n\nMHDC (15488) $1.82M 25% 0.25 0.29 N/A N/A N/A\n\nThere is no ISO PMF comparison to our MDHC program, therefore we have moved this PMF up 16% as it is very out of line with our other MHDC PMF, which has a PMF of 1.00.\n\nHealth and Fitness / Amatuer Sports $1.78M 62% 0.95 1.00 _1\\.00_ \\-5% 0%\n\nAs this program has little credibility, this PMF was increased by 5.3% in an effort to move towards a more credible ISO PMF of 1.00. Institutional is a proxy for Health and Fitness / Amatuer Sports because ISO doesn’t have a Health and Fitness / Amatuer Sports program.\n\n**Hanover Program ISO Program** Educational Institutions Institutional Sports & Fitness Institutional\n\n_For the Hanover specific (non-ISO) programs that do not have a PMF, we used proxy PMFs as shown above._\n\nPMF Changes were based on indicated rate need, as well as the historical performance of specific programs. For example, a program with a higher loss ratio may warrant a PMF increase while a program with a low or steady loss ratio may warrant a PMF decrease or no change at all. Another factor considered in implementing PMF changes was the corresponding ISO PMF for that program (if applicable). As we believe ISO's factors to be adequate, we try to move our PMF's toward ISO gradually so not too cause too much policyholder disruption.\n\n**Property**\n\n**Liability**\n\n**The Hanover Insurance Group Other Commercial Multi-Peril State of Texas Package Modification Support**","pages":[{"line_numbers":[],"markdown":"Supplementary Exhibit A\n\n**Program 4 Year Earned Premium 4 Year Loss & ALAE Ratio Current Property PMFs Proposed Property PMFs ISO PMFs Current Difference from ISO**\n\n**Proposed Difference from ISO Reasoning**\n\nInstitutional $1.07M 8% 0.86 0.88 1.00 -14% -12% As this program has very little credibility, this PMF was increased 2.3% to move closer towards a more credible ISO PMF of 1.00\n\nOffice $7.66M 13% 0.94 0.98 1.00 -6% -2% This PMF was increased by 4.3% to move toward ISO PMF of 1.00.\n\nService $5.10M 120% 0.96 1.00 1.00 -4% 0% This PMF was increased by 4.2% due to unfavorable loss experience as well as to move to the ISO PMF of 1.00\n\n**Program 4 Year Earned Premium 4 Year Loss & ALAE Ratio Current Liability PMFs Proposed Liability PMFs ISO PMFs Current Difference from ISO**\n\n**Proposed Difference from ISO Reasoning**\n\nEducational Institutions $1.76M 45% 0.78 0.80 _1\\.00_ \\-22% -20%\n\nAs this program has little credibility, this PMF was increased by 2.6% in an effort to move towards a more credible ISO PMF of 1.00. Institutional is a proxy for Educational Institutions because ISO doesn’t have an Educational Institutions program.\n\nInstitutional $0.21M 107% 0.85 0.96 1.00 -15% -4% As this program has little credibility, this PMF was increased by 12.9% in an effort to move towards a more credible ISO PMF of 1.00.\n\nMercantle $13.69M 66% 0.86 0.95 0.98 -12% -3% This PMF was increased by 10.5% due to unfavorable loss experience as well as to move toward ISO PMF of 0.98.\n\nMHDC (15488) $1.82M 25% 0.25 0.29 N/A N/A N/A\n\nThere is no ISO PMF comparison to our MDHC program, therefore we have moved this PMF up 16% as it is very out of line with our other MHDC PMF, which has a PMF of 1.00.\n\nHealth and Fitness / Amatuer Sports $1.78M 62% 0.95 1.00 _1\\.00_ \\-5% 0%\n\nAs this program has little credibility, this PMF was increased by 5.3% in an effort to move towards a more credible ISO PMF of 1.00. Institutional is a proxy for Health and Fitness / Amatuer Sports because ISO doesn’t have a Health and Fitness / Amatuer Sports program.\n\n**Hanover Program ISO Program** Educational Institutions Institutional Sports & Fitness Institutional\n\n_For the Hanover specific (non-ISO) programs that do not have a PMF, we used proxy PMFs as shown above._\n\nPMF Changes were based on indicated rate need, as well as the historical performance of specific programs. For example, a program with a higher loss ratio may warrant a PMF increase while a program with a low or steady loss ratio may warrant a PMF decrease or no change at all. Another factor considered in implementing PMF changes was the corresponding ISO PMF for that program (if applicable). As we believe ISO's factors to be adequate, we try to move our PMF's toward ISO gradually so not too cause too much policyholder disruption.\n\n**Property**\n\n**Liability**\n\n**The Hanover Insurance Group Other Commercial Multi-Peril State of Texas Package Modification Support**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Supplementary Exhibit A\n\n**Program 4 Year Earned Premium 4 Year Loss & ALAE Ratio Current Property PMFs Proposed Property PMFs ISO PMFs Current Difference from ISO**\n\n**Proposed Difference from ISO Reasoning**\n\nInstitutional $1.07M 8% 0.86 0.88 1.00 -14% -12% As this program has very little credibility, this PMF was increased 2.3% to move closer towards a more credible ISO PMF of 1.00\n\nOffice $7.66M 13% 0.94 0.98 1.00 -6% -2% This PMF was increased by 4.3% to move toward ISO PMF of 1.00.\n\nService $5.10M 120% 0.96 1.00 1.00 -4% 0% This PMF was increased by 4.2% due to unfavorable loss experience as well as to move to the ISO PMF of 1.00\n\n**Program 4 Year Earned Premium 4 Year Loss & ALAE Ratio Current Liability PMFs Proposed Liability PMFs ISO PMFs Current Difference from ISO**\n\n**Proposed Difference from ISO Reasoning**\n\nEducational Institutions $1.76M 45% 0.78 0.80 _1\\.00_ \\-22% -20%\n\nAs this program has little credibility, this PMF was increased by 2.6% in an effort to move towards a more credible ISO PMF of 1.00. Institutional is a proxy for Educational Institutions because ISO doesn’t have an Educational Institutions program.\n\nInstitutional $0.21M 107% 0.85 0.96 1.00 -15% -4% As this program has little credibility, this PMF was increased by 12.9% in an effort to move towards a more credible ISO PMF of 1.00.\n\nMercantle $13.69M 66% 0.86 0.95 0.98 -12% -3% This PMF was increased by 10.5% due to unfavorable loss experience as well as to move toward ISO PMF of 0.98.\n\nMHDC (15488) $1.82M 25% 0.25 0.29 N/A N/A N/A\n\nThere is no ISO PMF comparison to our MDHC program, therefore we have moved this PMF up 16% as it is very out of line with our other MHDC PMF, which has a PMF of 1.00.\n\nHealth and Fitness / Amatuer Sports $1.78M 62% 0.95 1.00 _1\\.00_ \\-5% 0%\n\nAs this program has little credibility, this PMF was increased by 5.3% in an effort to move towards a more credible ISO PMF of 1.00. Institutional is a proxy for Health and Fitness / Amatuer Sports because ISO doesn’t have a Health and Fitness / Amatuer Sports program.\n\n**Hanover Program ISO Program** Educational Institutions Institutional Sports & Fitness Institutional\n\n_For the Hanover specific (non-ISO) programs that do not have a PMF, we used proxy PMFs as shown above._\n\nPMF Changes were based on indicated rate need, as well as the historical performance of specific programs. For example, a program with a higher loss ratio may warrant a PMF increase while a program with a low or steady loss ratio may warrant a PMF decrease or no change at all. Another factor considered in implementing PMF changes was the corresponding ISO PMF for that program (if applicable). As we believe ISO's factors to be adequate, we try to move our PMF's toward ISO gradually so not too cause too much policyholder disruption.\n\n**Property**\n\n**Liability**\n\n**The Hanover Insurance Group Other Commercial Multi-Peril State of Texas Package Modification Support**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page848.pdf"]},"response":{"errors":[],"extract_id":"extract_5b28534aaec7c146df0ae458af5fb544","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Supplementary Exhibit A\n\n**Program 4 Year Earned Premium 4 Year Loss & ALAE Ratio Current Property PMFs Proposed Property PMFs ISO PMFs Current Difference from ISO**\n\n**Proposed Difference from ISO Reasoning**\n\nInstitutional $1.07M 8% 0.86 0.88 1.00 -14% -12% As this program has very little credibility, this PMF was increased 2.3% to move closer towards a more credible ISO PMF of 1.00\n\nOffice $7.66M 13% 0.94 0.98 1.00 -6% -2% This PMF was increased by 4.3% to move toward ISO PMF of 1.00.\n\nService $5.10M 120% 0.96 1.00 1.00 -4% 0% This PMF was increased by 4.2% due to unfavorable loss experience as well as to move to the ISO PMF of 1.00\n\n**Program 4 Year Earned Premium 4 Year Loss & ALAE Ratio Current Liability PMFs Proposed Liability PMFs ISO PMFs Current Difference from ISO**\n\n**Proposed Difference from ISO Reasoning**\n\nEducational Institutions $1.76M 45% 0.78 0.80 _1\\.00_ \\-22% -20%\n\nAs this program has little credibility, this PMF was increased by 2.6% in an effort to move towards a more credible ISO PMF of 1.00. Institutional is a proxy for Educational Institutions because ISO doesn’t have an Educational Institutions program.\n\nInstitutional $0.21M 107% 0.85 0.96 1.00 -15% -4% As this program has little credibility, this PMF was increased by 12.9% in an effort to move towards a more credible ISO PMF of 1.00.\n\nMercantle $13.69M 66% 0.86 0.95 0.98 -12% -3% This PMF was increased by 10.5% due to unfavorable loss experience as well as to move toward ISO PMF of 0.98.\n\nMHDC (15488) $1.82M 25% 0.25 0.29 N/A N/A N/A\n\nThere is no ISO PMF comparison to our MDHC program, therefore we have moved this PMF up 16% as it is very out of line with our other MHDC PMF, which has a PMF of 1.00.\n\nHealth and Fitness / Amatuer Sports $1.78M 62% 0.95 1.00 _1\\.00_ \\-5% 0%\n\nAs this program has little credibility, this PMF was increased by 5.3% in an effort to move towards a more credible ISO PMF of 1.00. Institutional is a proxy for Health and Fitness / Amatuer Sports because ISO doesn’t have a Health and Fitness / Amatuer Sports program.\n\n**Hanover Program ISO Program** Educational Institutions Institutional Sports & Fitness Institutional\n\n_For the Hanover specific (non-ISO) programs that do not have a PMF, we used proxy PMFs as shown above._\n\nPMF Changes were based on indicated rate need, as well as the historical performance of specific programs. For example, a program with a higher loss ratio may warrant a PMF increase while a program with a low or steady loss ratio may warrant a PMF decrease or no change at all. Another factor considered in implementing PMF changes was the corresponding ISO PMF for that program (if applicable). As we believe ISO's factors to be adequate, we try to move our PMF's toward ISO gradually so not too cause too much policyholder disruption.\n\n**Property**\n\n**Liability**\n\n**The Hanover Insurance Group Other Commercial Multi-Peril State of Texas Package Modification Support**"],"full_content":"Supplementary Exhibit A\n\n**Program 4 Year Earned Premium 4 Year Loss & ALAE Ratio Current Property PMFs Proposed Property PMFs ISO PMFs Current Difference from ISO**\n\n**Proposed Difference from ISO Reasoning**\n\nInstitutional $1.07M 8% 0.86 0.88 1.00 -14% -12% As this program has very little credibility, this PMF was increased 2.3% to move closer towards a more credible ISO PMF of 1.00\n\nOffice $7.66M 13% 0.94 0.98 1.00 -6% -2% This PMF was increased by 4.3% to move toward ISO PMF of 1.00.\n\nService $5.10M 120% 0.96 1.00 1.00 -4% 0% This PMF was increased by 4.2% due to unfavorable loss experience as well as to move to the ISO PMF of 1.00\n\n**Program 4 Year Earned Premium 4 Year Loss & ALAE Ratio Current Liability PMFs Proposed Liability PMFs ISO PMFs Current Difference from ISO**\n\n**Proposed Difference from ISO Reasoning**\n\nEducational Institutions $1.76M 45% 0.78 0.80 _1\\.00_ \\-22% -20%\n\nAs this program has little credibility, this PMF was increased by 2.6% in an effort to move towards a more credible ISO PMF of 1.00. Institutional is a proxy for Educational Institutions because ISO doesn’t have an Educational Institutions program.\n\nInstitutional $0.21M 107% 0.85 0.96 1.00 -15% -4% As this program has little credibility, this PMF was increased by 12.9% in an effort to move towards a more credible ISO PMF of 1.00.\n\nMercantle $13.69M 66% 0.86 0.95 0.98 -12% -3% This PMF was increased by 10.5% due to unfavorable loss experience as well as to move toward ISO PMF of 0.98.\n\nMHDC (15488) $1.82M 25% 0.25 0.29 N/A N/A N/A\n\nThere is no ISO PMF comparison to our MDHC program, therefore we have moved this PMF up 16% as it is very out of line with our other MHDC PMF, which has a PMF of 1.00.\n\nHealth and Fitness / Amatuer Sports $1.78M 62% 0.95 1.00 _1\\.00_ \\-5% 0%\n\nAs this program has little credibility, this PMF was increased by 5.3% in an effort to move towards a more credible ISO PMF of 1.00. Institutional is a proxy for Health and Fitness / Amatuer Sports because ISO doesn’t have a Health and Fitness / Amatuer Sports program.\n\n**Hanover Program ISO Program** Educational Institutions Institutional Sports & Fitness Institutional\n\n_For the Hanover specific (non-ISO) programs that do not have a PMF, we used proxy PMFs as shown above._\n\nPMF Changes were based on indicated rate need, as well as the historical performance of specific programs. For example, a program with a higher loss ratio may warrant a PMF increase while a program with a low or steady loss ratio may warrant a PMF decrease or no change at all. Another factor considered in implementing PMF changes was the corresponding ISO PMF for that program (if applicable). As we believe ISO's factors to be adequate, we try to move our PMF's toward ISO gradually so not too cause too much policyholder disruption.\n\n**Property**\n\n**Liability**\n\n**The Hanover Insurance Group Other Commercial Multi-Peril State of Texas Package Modification Support**","publish_date":null,"title":"Supplementary Exhibit A The Hanover Insurance Group Other Commercial Multi-Peril State of Texas Package Modification Support PMF Changes were based","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page848.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page848.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page848","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page848.pdf"},"started_at":"2026-11-04T19:47:39.234194"} +{"completed_at":"2026-11-04T19:47:41.589543","latency_in_ms":1198,"output":{"example_id":"table/SERFF_TX_random_pages 1_page857","grounded_pages":[],"layout_pages":[],"markdown":"**HARLEYSVILLE INSURANCE**\n\n**INTERNAL RATE OF RETURN MODEL**\n\nInvestment and Operating Assumptions\n\nSummary of Results\n\nLine Of Business: Commercial Package Policy Property State: CW\n\n**Investment Assumptions Operating Requirements**\n\nInvestment Dist Yield\n\nReserve to Surplus Ratio: 2.70\n\nCash / ST Inv 5.0% 0.05% Target Rate of Return: 10.0%\n\nU.S. Gov't Bonds 18.4% 2.24%\n\nCorporate Bonds 18.2% 9.80%\n\nTax-Exempt Bonds (Pre 8/86) 0.0% 2.70% **Model Results**\n\nTax-Exempt Bonds (Post 8/86) 57.8% 2.70%\n\nCommon Stock 0.0% 0.00% Target Rate of Return: 10.0%\n\nOther Investments 0.6% 40.00% Required Combined Ratio: 96.3%\n\nUnderwriting Profit Provision: 3.7%\n\nExhibit 3 Page 10","pages":[{"line_numbers":[],"markdown":"**HARLEYSVILLE INSURANCE**\n\n**INTERNAL RATE OF RETURN MODEL**\n\nInvestment and Operating Assumptions\n\nSummary of Results\n\nLine Of Business: Commercial Package Policy Property State: CW\n\n**Investment Assumptions Operating Requirements**\n\nInvestment Dist Yield\n\nReserve to Surplus Ratio: 2.70\n\nCash / ST Inv 5.0% 0.05% Target Rate of Return: 10.0%\n\nU.S. Gov't Bonds 18.4% 2.24%\n\nCorporate Bonds 18.2% 9.80%\n\nTax-Exempt Bonds (Pre 8/86) 0.0% 2.70% **Model Results**\n\nTax-Exempt Bonds (Post 8/86) 57.8% 2.70%\n\nCommon Stock 0.0% 0.00% Target Rate of Return: 10.0%\n\nOther Investments 0.6% 40.00% Required Combined Ratio: 96.3%\n\nUnderwriting Profit Provision: 3.7%\n\nExhibit 3 Page 10","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**HARLEYSVILLE INSURANCE**\n\n**INTERNAL RATE OF RETURN MODEL**\n\nInvestment and Operating Assumptions\n\nSummary of Results\n\nLine Of Business: Commercial Package Policy Property State: CW\n\n**Investment Assumptions Operating Requirements**\n\nInvestment Dist Yield\n\nReserve to Surplus Ratio: 2.70\n\nCash / ST Inv 5.0% 0.05% Target Rate of Return: 10.0%\n\nU.S. Gov't Bonds 18.4% 2.24%\n\nCorporate Bonds 18.2% 9.80%\n\nTax-Exempt Bonds (Pre 8/86) 0.0% 2.70% **Model Results**\n\nTax-Exempt Bonds (Post 8/86) 57.8% 2.70%\n\nCommon Stock 0.0% 0.00% Target Rate of Return: 10.0%\n\nOther Investments 0.6% 40.00% Required Combined Ratio: 96.3%\n\nUnderwriting Profit Provision: 3.7%\n\nExhibit 3 Page 10","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page857.pdf"]},"response":{"errors":[],"extract_id":"extract_87144588da7f3ab14e990a78e0ef9093","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**HARLEYSVILLE INSURANCE**\n\n**INTERNAL RATE OF RETURN MODEL**\n\nInvestment and Operating Assumptions\n\nSummary of Results\n\nLine Of Business: Commercial Package Policy Property State: CW\n\n**Investment Assumptions Operating Requirements**\n\nInvestment Dist Yield\n\nReserve to Surplus Ratio: 2.70\n\nCash / ST Inv 5.0% 0.05% Target Rate of Return: 10.0%\n\nU.S. Gov't Bonds 18.4% 2.24%\n\nCorporate Bonds 18.2% 9.80%\n\nTax-Exempt Bonds (Pre 8/86) 0.0% 2.70% **Model Results**\n\nTax-Exempt Bonds (Post 8/86) 57.8% 2.70%\n\nCommon Stock 0.0% 0.00% Target Rate of Return: 10.0%\n\nOther Investments 0.6% 40.00% Required Combined Ratio: 96.3%\n\nUnderwriting Profit Provision: 3.7%\n\nExhibit 3 Page 10"],"full_content":"**HARLEYSVILLE INSURANCE**\n\n**INTERNAL RATE OF RETURN MODEL**\n\nInvestment and Operating Assumptions\n\nSummary of Results\n\nLine Of Business: Commercial Package Policy Property State: CW\n\n**Investment Assumptions Operating Requirements**\n\nInvestment Dist Yield\n\nReserve to Surplus Ratio: 2.70\n\nCash / ST Inv 5.0% 0.05% Target Rate of Return: 10.0%\n\nU.S. Gov't Bonds 18.4% 2.24%\n\nCorporate Bonds 18.2% 9.80%\n\nTax-Exempt Bonds (Pre 8/86) 0.0% 2.70% **Model Results**\n\nTax-Exempt Bonds (Post 8/86) 57.8% 2.70%\n\nCommon Stock 0.0% 0.00% Target Rate of Return: 10.0%\n\nOther Investments 0.6% 40.00% Required Combined Ratio: 96.3%\n\nUnderwriting Profit Provision: 3.7%\n\nExhibit 3 Page 10","publish_date":null,"title":"HARLEYSVILLE INSURANCE INTERNAL RATE OF RETURN MODEL Investment and Operating Assumptions Summary of Results","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page857.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page857.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page857","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page857.pdf"},"started_at":"2026-11-04T19:47:40.391288"} +{"completed_at":"2026-11-04T19:47:43.213602","latency_in_ms":1619,"output":{"example_id":"table/SERFF_TX_random_pages 1_page865","grounded_pages":[],"layout_pages":[],"markdown":"**CURRENT RATES**\n\nTX Rev. 1 of 6 5/12\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 5,875.80 6,754.65 6,527.85 7,507.50\n\n65 1,014.30 1,165.50 1,126.65 1,295.70\n\n66 1,014.30 1,165.50 1,126.65 1,295.70\n\n67 1,062.60 1,223.25 1,182.30 1,358.70\n\n68 1,111.95 1,277.85 1,234.80 1,420.65\n\n69 1,159.20 1,332.45 1,288.35 1,480.50\n\n70 1,205.40 1,387.05 1,339.80 1,541.40\n\n71 1,252.65 1,440.60 1,392.30 1,600.20\n\n72 1,298.85 1,493.10 1,442.70 1,659.00\n\n73 1,342.95 1,544.55 1,492.05 1,716.75\n\n74 1,389.15 1,596.00 1,542.45 1,773.45\n\n75 1,432.20 1,647.45 1,590.75 1,830.15\n\n76 1,475.25 1,695.75 1,638.00 1,884.75\n\n77 1,516.20 1,744.05 1,685.25 1,938.30\n\n78 1,557.15 1,791.30 1,730.40 1,988.70\n\n79 1,592.85 1,832.25 1,770.30 2,034.90\n\n80 1,627.50 1,872.15 1,808.10 2,080.05\n\n81 1,660.05 1,909.95 1,844.85 2,122.05\n\n82 1,690.50 1,944.60 1,878.45 2,160.90\n\n83 1,718.85 1,977.15 1,909.95 2,196.60\n\n84 1,744.05 2,006.55 1,938.30 2,229.15\n\n85 1,769.25 2,033.85 1,966.65 2,261.70\n\n86 1,793.40 2,062.20 1,991.85 2,291.10\n\n87 1,813.35 2,085.30 2,014.95 2,316.30\n\n88 1,832.25 2,106.30 2,035.95 2,341.50\n\n89 1,849.05 2,126.25 2,054.85 2,363.55\n\n90 1,864.80 2,144.10 2,071.65 2,382.45\n\n91 1,879.50 2,161.95 2,088.45 2,402.40\n\n92 1,893.15 2,176.65 2,103.15 2,419.20\n\n93 1,905.75 2,191.35 2,117.85 2,434.95\n\n94 1,917.30 2,205.00 2,130.45 2,450.70\n\n95 1,929.90 2,218.65 2,143.05 2,464.35\n\n96 1,939.35 2,230.20 2,154.60 2,478.00\n\n97 1,946.70 2,238.60 2,163.00 2,487.45\n\n98 1,954.05 2,247.00 2,170.35 2,495.85\n\n99+ 1,958.25 2,251.20 2,175.60 2,502.15\n\nThe rates above do not include a one time $25 policy fee. There is no modal loading. A 2.4% processing fee will apply for credit card billing Modal premium is annual premium from schedule x area factor rounded to near dollar then divided by number of payments per year, rounded to near cent.\n\nArea Factors:\n\n_Texas_ 770-773, 775……………………………………………… 1.20\n\n1\\.10\n\nRest of State……………………………………��……… 0.95\n\nGross Annual Premiums\n\n**Central States Indemnity Co. of Omaha**\n\nMedicare Supplement Policy\n\n2010 Standardized Plan A\n\nNon-Tobacco Tobacco\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………","pages":[{"line_numbers":[],"markdown":"**CURRENT RATES**\n\nTX Rev. 1 of 6 5/12\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 5,875.80 6,754.65 6,527.85 7,507.50\n\n65 1,014.30 1,165.50 1,126.65 1,295.70\n\n66 1,014.30 1,165.50 1,126.65 1,295.70\n\n67 1,062.60 1,223.25 1,182.30 1,358.70\n\n68 1,111.95 1,277.85 1,234.80 1,420.65\n\n69 1,159.20 1,332.45 1,288.35 1,480.50\n\n70 1,205.40 1,387.05 1,339.80 1,541.40\n\n71 1,252.65 1,440.60 1,392.30 1,600.20\n\n72 1,298.85 1,493.10 1,442.70 1,659.00\n\n73 1,342.95 1,544.55 1,492.05 1,716.75\n\n74 1,389.15 1,596.00 1,542.45 1,773.45\n\n75 1,432.20 1,647.45 1,590.75 1,830.15\n\n76 1,475.25 1,695.75 1,638.00 1,884.75\n\n77 1,516.20 1,744.05 1,685.25 1,938.30\n\n78 1,557.15 1,791.30 1,730.40 1,988.70\n\n79 1,592.85 1,832.25 1,770.30 2,034.90\n\n80 1,627.50 1,872.15 1,808.10 2,080.05\n\n81 1,660.05 1,909.95 1,844.85 2,122.05\n\n82 1,690.50 1,944.60 1,878.45 2,160.90\n\n83 1,718.85 1,977.15 1,909.95 2,196.60\n\n84 1,744.05 2,006.55 1,938.30 2,229.15\n\n85 1,769.25 2,033.85 1,966.65 2,261.70\n\n86 1,793.40 2,062.20 1,991.85 2,291.10\n\n87 1,813.35 2,085.30 2,014.95 2,316.30\n\n88 1,832.25 2,106.30 2,035.95 2,341.50\n\n89 1,849.05 2,126.25 2,054.85 2,363.55\n\n90 1,864.80 2,144.10 2,071.65 2,382.45\n\n91 1,879.50 2,161.95 2,088.45 2,402.40\n\n92 1,893.15 2,176.65 2,103.15 2,419.20\n\n93 1,905.75 2,191.35 2,117.85 2,434.95\n\n94 1,917.30 2,205.00 2,130.45 2,450.70\n\n95 1,929.90 2,218.65 2,143.05 2,464.35\n\n96 1,939.35 2,230.20 2,154.60 2,478.00\n\n97 1,946.70 2,238.60 2,163.00 2,487.45\n\n98 1,954.05 2,247.00 2,170.35 2,495.85\n\n99+ 1,958.25 2,251.20 2,175.60 2,502.15\n\nThe rates above do not include a one time $25 policy fee. There is no modal loading. A 2.4% processing fee will apply for credit card billing Modal premium is annual premium from schedule x area factor rounded to near dollar then divided by number of payments per year, rounded to near cent.\n\nArea Factors:\n\n_Texas_ 770-773, 775……………………………………………… 1.20\n\n1\\.10\n\nRest of State……………………………………………… 0.95\n\nGross Annual Premiums\n\n**Central States Indemnity Co. of Omaha**\n\nMedicare Supplement Policy\n\n2010 Standardized Plan A\n\nNon-Tobacco Tobacco\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**CURRENT RATES**\n\nTX Rev. 1 of 6 5/12\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 5,875.80 6,754.65 6,527.85 7,507.50\n\n65 1,014.30 1,165.50 1,126.65 1,295.70\n\n66 1,014.30 1,165.50 1,126.65 1,295.70\n\n67 1,062.60 1,223.25 1,182.30 1,358.70\n\n68 1,111.95 1,277.85 1,234.80 1,420.65\n\n69 1,159.20 1,332.45 1,288.35 1,480.50\n\n70 1,205.40 1,387.05 1,339.80 1,541.40\n\n71 1,252.65 1,440.60 1,392.30 1,600.20\n\n72 1,298.85 1,493.10 1,442.70 1,659.00\n\n73 1,342.95 1,544.55 1,492.05 1,716.75\n\n74 1,389.15 1,596.00 1,542.45 1,773.45\n\n75 1,432.20 1,647.45 1,590.75 1,830.15\n\n76 1,475.25 1,695.75 1,638.00 1,884.75\n\n77 1,516.20 1,744.05 1,685.25 1,938.30\n\n78 1,557.15 1,791.30 1,730.40 1,988.70\n\n79 1,592.85 1,832.25 1,770.30 2,034.90\n\n80 1,627.50 1,872.15 1,808.10 2,080.05\n\n81 1,660.05 1,909.95 1,844.85 2,122.05\n\n82 1,690.50 1,944.60 1,878.45 2,160.90\n\n83 1,718.85 1,977.15 1,909.95 2,196.60\n\n84 1,744.05 2,006.55 1,938.30 2,229.15\n\n85 1,769.25 2,033.85 1,966.65 2,261.70\n\n86 1,793.40 2,062.20 1,991.85 2,291.10\n\n87 1,813.35 2,085.30 2,014.95 2,316.30\n\n88 1,832.25 2,106.30 2,035.95 2,341.50\n\n89 1,849.05 2,126.25 2,054.85 2,363.55\n\n90 1,864.80 2,144.10 2,071.65 2,382.45\n\n91 1,879.50 2,161.95 2,088.45 2,402.40\n\n92 1,893.15 2,176.65 2,103.15 2,419.20\n\n93 1,905.75 2,191.35 2,117.85 2,434.95\n\n94 1,917.30 2,205.00 2,130.45 2,450.70\n\n95 1,929.90 2,218.65 2,143.05 2,464.35\n\n96 1,939.35 2,230.20 2,154.60 2,478.00\n\n97 1,946.70 2,238.60 2,163.00 2,487.45\n\n98 1,954.05 2,247.00 2,170.35 2,495.85\n\n99+ 1,958.25 2,251.20 2,175.60 2,502.15\n\nThe rates above do not include a one time $25 policy fee. There is no modal loading. A 2.4% processing fee will apply for credit card billing Modal premium is annual premium from schedule x area factor rounded to near dollar then divided by number of payments per year, rounded to near cent.\n\nArea Factors:\n\n_Texas_ 770-773, 775……………………………………………… 1.20\n\n1\\.10\n\nRest of State……………………………………………… 0.95\n\nGross Annual Premiums\n\n**Central States Indemnity Co. of Omaha**\n\nMedicare Supplement Policy\n\n2010 Standardized Plan A\n\nNon-Tobacco Tobacco\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page865.pdf"]},"response":{"errors":[],"extract_id":"extract_876331f7e2b60a6f4a3f5d9192c12c84","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**CURRENT RATES**\n\nTX Rev. 1 of 6 5/12\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 5,875.80 6,754.65 6,527.85 7,507.50\n\n65 1,014.30 1,165.50 1,126.65 1,295.70\n\n66 1,014.30 1,165.50 1,126.65 1,295.70\n\n67 1,062.60 1,223.25 1,182.30 1,358.70\n\n68 1,111.95 1,277.85 1,234.80 1,420.65\n\n69 1,159.20 1,332.45 1,288.35 1,480.50\n\n70 1,205.40 1,387.05 1,339.80 1,541.40\n\n71 1,252.65 1,440.60 1,392.30 1,600.20\n\n72 1,298.85 1,493.10 1,442.70 1,659.00\n\n73 1,342.95 1,544.55 1,492.05 1,716.75\n\n74 1,389.15 1,596.00 1,542.45 1,773.45\n\n75 1,432.20 1,647.45 1,590.75 1,830.15\n\n76 1,475.25 1,695.75 1,638.00 1,884.75\n\n77 1,516.20 1,744.05 1,685.25 1,938.30\n\n78 1,557.15 1,791.30 1,730.40 1,988.70\n\n79 1,592.85 1,832.25 1,770.30 2,034.90\n\n80 1,627.50 1,872.15 1,808.10 2,080.05\n\n81 1,660.05 1,909.95 1,844.85 2,122.05\n\n82 1,690.50 1,944.60 1,878.45 2,160.90\n\n83 1,718.85 1,977.15 1,909.95 2,196.60\n\n84 1,744.05 2,006.55 1,938.30 2,229.15\n\n85 1,769.25 2,033.85 1,966.65 2,261.70\n\n86 1,793.40 2,062.20 1,991.85 2,291.10\n\n87 1,813.35 2,085.30 2,014.95 2,316.30\n\n88 1,832.25 2,106.30 2,035.95 2,341.50\n\n89 1,849.05 2,126.25 2,054.85 2,363.55\n\n90 1,864.80 2,144.10 2,071.65 2,382.45\n\n91 1,879.50 2,161.95 2,088.45 2,402.40\n\n92 1,893.15 2,176.65 2,103.15 2,419.20\n\n93 1,905.75 2,191.35 2,117.85 2,434.95\n\n94 1,917.30 2,205.00 2,130.45 2,450.70\n\n95 1,929.90 2,218.65 2,143.05 2,464.35\n\n96 1,939.35 2,230.20 2,154.60 2,478.00\n\n97 1,946.70 2,238.60 2,163.00 2,487.45\n\n98 1,954.05 2,247.00 2,170.35 2,495.85\n\n99+ 1,958.25 2,251.20 2,175.60 2,502.15\n\nThe rates above do not include a one time $25 policy fee. There is no modal loading. A 2.4% processing fee will apply for credit card billing Modal premium is annual premium from schedule x area factor rounded to near dollar then divided by number of payments per year, rounded to near cent.\n\nArea Factors:\n\n_Texas_ 770-773, 775……………………………………………… 1.20\n\n1\\.10\n\nRest of State……………………………………………… 0.95\n\nGross Annual Premiums\n\n**Central States Indemnity Co. of Omaha**\n\nMedicare Supplement Policy\n\n2010 Standardized Plan A\n\nNon-Tobacco Tobacco\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………"],"full_content":"**CURRENT RATES**\n\nTX Rev. 1 of 6 5/12\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 5,875.80 6,754.65 6,527.85 7,507.50\n\n65 1,014.30 1,165.50 1,126.65 1,295.70\n\n66 1,014.30 1,165.50 1,126.65 1,295.70\n\n67 1,062.60 1,223.25 1,182.30 1,358.70\n\n68 1,111.95 1,277.85 1,234.80 1,420.65\n\n69 1,159.20 1,332.45 1,288.35 1,480.50\n\n70 1,205.40 1,387.05 1,339.80 1,541.40\n\n71 1,252.65 1,440.60 1,392.30 1,600.20\n\n72 1,298.85 1,493.10 1,442.70 1,659.00\n\n73 1,342.95 1,544.55 1,492.05 1,716.75\n\n74 1,389.15 1,596.00 1,542.45 1,773.45\n\n75 1,432.20 1,647.45 1,590.75 1,830.15\n\n76 1,475.25 1,695.75 1,638.00 1,884.75\n\n77 1,516.20 1,744.05 1,685.25 1,938.30\n\n78 1,557.15 1,791.30 1,730.40 1,988.70\n\n79 1,592.85 1,832.25 1,770.30 2,034.90\n\n80 1,627.50 1,872.15 1,808.10 2,080.05\n\n81 1,660.05 1,909.95 1,844.85 2,122.05\n\n82 1,690.50 1,944.60 1,878.45 2,160.90\n\n83 1,718.85 1,977.15 1,909.95 2,196.60\n\n84 1,744.05 2,006.55 1,938.30 2,229.15\n\n85 1,769.25 2,033.85 1,966.65 2,261.70\n\n86 1,793.40 2,062.20 1,991.85 2,291.10\n\n87 1,813.35 2,085.30 2,014.95 2,316.30\n\n88 1,832.25 2,106.30 2,035.95 2,341.50\n\n89 1,849.05 2,126.25 2,054.85 2,363.55\n\n90 1,864.80 2,144.10 2,071.65 2,382.45\n\n91 1,879.50 2,161.95 2,088.45 2,402.40\n\n92 1,893.15 2,176.65 2,103.15 2,419.20\n\n93 1,905.75 2,191.35 2,117.85 2,434.95\n\n94 1,917.30 2,205.00 2,130.45 2,450.70\n\n95 1,929.90 2,218.65 2,143.05 2,464.35\n\n96 1,939.35 2,230.20 2,154.60 2,478.00\n\n97 1,946.70 2,238.60 2,163.00 2,487.45\n\n98 1,954.05 2,247.00 2,170.35 2,495.85\n\n99+ 1,958.25 2,251.20 2,175.60 2,502.15\n\nThe rates above do not include a one time $25 policy fee. There is no modal loading. A 2.4% processing fee will apply for credit card billing Modal premium is annual premium from schedule x area factor rounded to near dollar then divided by number of payments per year, rounded to near cent.\n\nArea Factors:\n\n_Texas_ 770-773, 775……………………………………………… 1.20\n\n1\\.10\n\nRest of State……………………………………………… 0.95\n\nGross Annual Premiums\n\n**Central States Indemnity Co. of Omaha**\n\nMedicare Supplement Policy\n\n2010 Standardized Plan A\n\nNon-Tobacco Tobacco\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………","publish_date":null,"title":"CURRENT RATES Gross Annual Premiums Central States Indemnity Co. of Omaha","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page865.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page865.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page865","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page865.pdf"},"started_at":"2026-11-04T19:47:41.593931"} +{"completed_at":"2026-11-04T19:47:44.845047","latency_in_ms":2135,"output":{"example_id":"table/SERFF_TX_random_pages 1_page889","grounded_pages":[],"layout_pages":[],"markdown":"Earned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 16,985,354 11,205,494 66.0%\n\nGuarantee Issue 1,701,544 1,484,828 87.3%\n\nOpen Enrollee 147,384,687 108,288,755 73.5%\n\nTotal 166,071,585 120,979,077 72.8%\n\nEarned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 31,715,612 20,364,519 64.2%\n\nGuarantee Issue 3,730,739 2,983,124 80.0%\n\nOpen Enrollee 1,733,481 1,149,289 66.3%\n\nTotal 37,179,832 24,496,932 65.9%\n\nEarned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 35,685,665 23,395,961 65.6%\n\nGuarantee Issue 4,336,930 3,319,824 76.5%\n\nOpen Enrollee 1,220,113 810,044 66.4%\n\nTotal 41,242,708 27,525,829 66.7%\n\n**AGE 66**\n\nInception to Date\n\n**AGE 67**\n\nInception to Date\n\nACTUARIAL JUSTIFICATION OF PREMIUM RATES\n\n**State Mutual Insurance Company**\n\nMedicare Supplement Policy\n\n**2010 Standardized Plans A-D, F, High F, G, M and N**\n\nExhibit 4 - Experience for Current Block of Inforce Business by Underwritten vs non-Underwritten for Ages 65, 66 and 67\n\nInception to Date\n\n**AGE 65**","pages":[{"line_numbers":[],"markdown":"Earned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 16,985,354 11,205,494 66.0%\n\nGuarantee Issue 1,701,544 1,484,828 87.3%\n\nOpen Enrollee 147,384,687 108,288,755 73.5%\n\nTotal 166,071,585 120,979,077 72.8%\n\nEarned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 31,715,612 20,364,519 64.2%\n\nGuarantee Issue 3,730,739 2,983,124 80.0%\n\nOpen Enrollee 1,733,481 1,149,289 66.3%\n\nTotal 37,179,832 24,496,932 65.9%\n\nEarned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 35,685,665 23,395,961 65.6%\n\nGuarantee Issue 4,336,930 3,319,824 76.5%\n\nOpen Enrollee 1,220,113 810,044 66.4%\n\nTotal 41,242,708 27,525,829 66.7%\n\n**AGE 66**\n\nInception to Date\n\n**AGE 67**\n\nInception to Date\n\nACTUARIAL JUSTIFICATION OF PREMIUM RATES\n\n**State Mutual Insurance Company**\n\nMedicare Supplement Policy\n\n**2010 Standardized Plans A-D, F, High F, G, M and N**\n\nExhibit 4 - Experience for Current Block of Inforce Business by Underwritten vs non-Underwritten for Ages 65, 66 and 67\n\nInception to Date\n\n**AGE 65**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Earned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 16,985,354 11,205,494 66.0%\n\nGuarantee Issue 1,701,544 1,484,828 87.3%\n\nOpen Enrollee 147,384,687 108,288,755 73.5%\n\nTotal 166,071,585 120,979,077 72.8%\n\nEarned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 31,715,612 20,364,519 64.2%\n\nGuarantee Issue 3,730,739 2,983,124 80.0%\n\nOpen Enrollee 1,733,481 1,149,289 66.3%\n\nTotal 37,179,832 24,496,932 65.9%\n\nEarned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 35,685,665 23,395,961 65.6%\n\nGuarantee Issue 4,336,930 3,319,824 76.5%\n\nOpen Enrollee 1,220,113 810,044 66.4%\n\nTotal 41,242,708 27,525,829 66.7%\n\n**AGE 66**\n\nInception to Date\n\n**AGE 67**\n\nInception to Date\n\nACTUARIAL JUSTIFICATION OF PREMIUM RATES\n\n**State Mutual Insurance Company**\n\nMedicare Supplement Policy\n\n**2010 Standardized Plans A-D, F, High F, G, M and N**\n\nExhibit 4 - Experience for Current Block of Inforce Business by Underwritten vs non-Underwritten for Ages 65, 66 and 67\n\nInception to Date\n\n**AGE 65**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page889.pdf"]},"response":{"errors":[],"extract_id":"extract_0d4d735b4af29480c1c34fd0f1e1a14b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Earned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 16,985,354 11,205,494 66.0%\n\nGuarantee Issue 1,701,544 1,484,828 87.3%\n\nOpen Enrollee 147,384,687 108,288,755 73.5%\n\nTotal 166,071,585 120,979,077 72.8%\n\nEarned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 31,715,612 20,364,519 64.2%\n\nGuarantee Issue 3,730,739 2,983,124 80.0%\n\nOpen Enrollee 1,733,481 1,149,289 66.3%\n\nTotal 37,179,832 24,496,932 65.9%\n\nEarned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 35,685,665 23,395,961 65.6%\n\nGuarantee Issue 4,336,930 3,319,824 76.5%\n\nOpen Enrollee 1,220,113 810,044 66.4%\n\nTotal 41,242,708 27,525,829 66.7%\n\n**AGE 66**\n\nInception to Date\n\n**AGE 67**\n\nInception to Date\n\nACTUARIAL JUSTIFICATION OF PREMIUM RATES\n\n**State Mutual Insurance Company**\n\nMedicare Supplement Policy\n\n**2010 Standardized Plans A-D, F, High F, G, M and N**\n\nExhibit 4 - Experience for Current Block of Inforce Business by Underwritten vs non-Underwritten for Ages 65, 66 and 67\n\nInception to Date\n\n**AGE 65**"],"full_content":"Earned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 16,985,354 11,205,494 66.0%\n\nGuarantee Issue 1,701,544 1,484,828 87.3%\n\nOpen Enrollee 147,384,687 108,288,755 73.5%\n\nTotal 166,071,585 120,979,077 72.8%\n\nEarned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 31,715,612 20,364,519 64.2%\n\nGuarantee Issue 3,730,739 2,983,124 80.0%\n\nOpen Enrollee 1,733,481 1,149,289 66.3%\n\nTotal 37,179,832 24,496,932 65.9%\n\nEarned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 35,685,665 23,395,961 65.6%\n\nGuarantee Issue 4,336,930 3,319,824 76.5%\n\nOpen Enrollee 1,220,113 810,044 66.4%\n\nTotal 41,242,708 27,525,829 66.7%\n\n**AGE 66**\n\nInception to Date\n\n**AGE 67**\n\nInception to Date\n\nACTUARIAL JUSTIFICATION OF PREMIUM RATES\n\n**State Mutual Insurance Company**\n\nMedicare Supplement Policy\n\n**2010 Standardized Plans A-D, F, High F, G, M and N**\n\nExhibit 4 - Experience for Current Block of Inforce Business by Underwritten vs non-Underwritten for Ages 65, 66 and 67\n\nInception to Date\n\n**AGE 65**","publish_date":null,"title":"ACTUARIAL JUSTIFICATION OF PREMIUM RATES State Mutual Insurance Company Medicare Supplement Policy 2010 Standardized Plans A-D, F, High F, G,","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page889.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page889.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page889","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page889.pdf"},"started_at":"2026-11-04T19:47:42.709919"} +{"completed_at":"2026-11-04T19:47:44.613620","latency_in_ms":1053,"output":{"example_id":"table/SERFF_TX_random_pages 1_page891","grounded_pages":[],"layout_pages":[],"markdown":"Earned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 612,182,204 406,429,635 66.4%\n\nGuarantee Issue 63,575,291 49,482,571 77.8%\n\nOpen Enrollee 156,477,713 115,426,837 73.8%\n\nACTUARIAL JUSTIFICATION OF PREMIUM RATES\n\n**State Mutual Insurance Company**\n\nMedicare Supplement Policy\n\n**2010 Standardized Plans A-D, F, High F, G, M and N**\n\nExhibit 1 - Experience for Current Block of Inforce Business by Underwritten vs non-Underwritten\n\nInception to Date","pages":[{"line_numbers":[],"markdown":"Earned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 612,182,204 406,429,635 66.4%\n\nGuarantee Issue 63,575,291 49,482,571 77.8%\n\nOpen Enrollee 156,477,713 115,426,837 73.8%\n\nACTUARIAL JUSTIFICATION OF PREMIUM RATES\n\n**State Mutual Insurance Company**\n\nMedicare Supplement Policy\n\n**2010 Standardized Plans A-D, F, High F, G, M and N**\n\nExhibit 1 - Experience for Current Block of Inforce Business by Underwritten vs non-Underwritten\n\nInception to Date","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Earned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 612,182,204 406,429,635 66.4%\n\nGuarantee Issue 63,575,291 49,482,571 77.8%\n\nOpen Enrollee 156,477,713 115,426,837 73.8%\n\nACTUARIAL JUSTIFICATION OF PREMIUM RATES\n\n**State Mutual Insurance Company**\n\nMedicare Supplement Policy\n\n**2010 Standardized Plans A-D, F, High F, G, M and N**\n\nExhibit 1 - Experience for Current Block of Inforce Business by Underwritten vs non-Underwritten\n\nInception to Date","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page891.pdf"]},"response":{"errors":[],"extract_id":"extract_a4ef64d87a68db18b03769b0e26fdf91","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Earned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 612,182,204 406,429,635 66.4%\n\nGuarantee Issue 63,575,291 49,482,571 77.8%\n\nOpen Enrollee 156,477,713 115,426,837 73.8%\n\nACTUARIAL JUSTIFICATION OF PREMIUM RATES\n\n**State Mutual Insurance Company**\n\nMedicare Supplement Policy\n\n**2010 Standardized Plans A-D, F, High F, G, M and N**\n\nExhibit 1 - Experience for Current Block of Inforce Business by Underwritten vs non-Underwritten\n\nInception to Date"],"full_content":"Earned Incurred Loss\n\nUWCategory Premium Claims Ratio\n\nUnderwritten 612,182,204 406,429,635 66.4%\n\nGuarantee Issue 63,575,291 49,482,571 77.8%\n\nOpen Enrollee 156,477,713 115,426,837 73.8%\n\nACTUARIAL JUSTIFICATION OF PREMIUM RATES\n\n**State Mutual Insurance Company**\n\nMedicare Supplement Policy\n\n**2010 Standardized Plans A-D, F, High F, G, M and N**\n\nExhibit 1 - Experience for Current Block of Inforce Business by Underwritten vs non-Underwritten\n\nInception to Date","publish_date":null,"title":"ACTUARIAL JUSTIFICATION OF PREMIUM RATES State Mutual Insurance Company Medicare Supplement Policy 2010 Standardized Plans A-D, F, High F, G,","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page891.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page891.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page891","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page891.pdf"},"started_at":"2026-11-04T19:47:43.560177"} +{"completed_at":"2026-11-04T19:47:46.018322","latency_in_ms":1272,"output":{"example_id":"table/SERFF_TX_random_pages 1_page898","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit A\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 NA NA NA NA\n\n65 1,126.90 1,297.73 1,253.47 1,437.69\n\n66 1,126.90 1,297.73 1,253.47 1,437.69\n\n67 1,126.90 1,297.73 1,253.47 1,437.69\n\n68 1,181.20 1,357.18 1,310.59 1,506.26\n\n69 1,232.98 1,417.30 1,368.35 1,573.51\n\n70 1,285.33 1,475.99 1,426.75 1,638.36\n\n71 1,335.10 1,535.31 1,480.52 1,704.97\n\n72 1,385.42 1,592.12 1,537.00 1,768.08\n\n73 1,427.98 1,640.64 1,585.35 1,822.46\n\n74 1,472.92 1,690.50 1,632.91 1,879.28\n\n75 1,513.85 1,739.60 1,679.69 1,931.10\n\n76 1,553.95 1,786.82 1,726.73 1,982.14\n\n77 1,593.20 1,832.18 1,766.51 2,034.55\n\n78 1,630.51 1,875.64 1,809.77 2,080.80\n\n79 1,662.64 1,913.93 1,845.69 2,122.98\n\n80 1,692.77 1,948.10 1,881.82 2,159.96\n\n81 1,717.76 1,977.43 1,910.07 2,192.56\n\n82 1,742.75 2,005.68 1,937.23 2,225.15\n\n83 1,766.65 2,033.93 1,964.39 2,255.57\n\n84 1,790.55 2,061.10 1,991.56 2,286.00\n\n85 1,813.37 2,088.25 2,017.64 2,316.42\n\n86 1,837.28 2,114.33 2,042.62 2,344.67\n\n87 1,859.01 2,140.41 2,066.52 2,372.92\n\n88 1,879.65 2,164.31 2,090.43 2,400.08\n\n89 1,899.20 2,183.87 2,109.98 2,420.72\n\n90 1,911.16 2,202.34 2,127.37 2,441.37\n\n91 1,928.54 2,218.63 2,143.67 2,464.18\n\n92 1,939.41 2,236.02 2,159.96 2,480.48\n\n93 1,955.70 2,249.06 2,171.92 2,495.70\n\n94 1,967.66 2,265.36 2,187.13 2,511.99\n\n95 1,979.60 2,279.48 2,202.34 2,528.29\n\n96 1,988.30 2,288.17 2,208.86 2,538.06\n\n97 1,995.91 2,299.03 2,220.81 2,551.10\n\n98 2,003.51 2,306.64 2,228.42 2,559.79\n\n99+ 2,006.77 2,310.99 2,232.76 2,563.06\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee.\n\nArea Factors:\n\n_Texas_ 770-773, 775…………………………………………………..………………………… 1.24\n\n1\\.13\n\nRest of State………………………………………………………………………………………………….. 1.00\n\n**State Mutual Insurance Company**\n\nProposed Gross Annual Premiums\n\nMedicare Supplement Policy (Form MSMSDA2010TX)\n\n2010 Standardized Plan D\n\nPreferred Standard\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………","pages":[{"line_numbers":[],"markdown":"Exhibit A\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 NA NA NA NA\n\n65 1,126.90 1,297.73 1,253.47 1,437.69\n\n66 1,126.90 1,297.73 1,253.47 1,437.69\n\n67 1,126.90 1,297.73 1,253.47 1,437.69\n\n68 1,181.20 1,357.18 1,310.59 1,506.26\n\n69 1,232.98 1,417.30 1,368.35 1,573.51\n\n70 1,285.33 1,475.99 1,426.75 1,638.36\n\n71 1,335.10 1,535.31 1,480.52 1,704.97\n\n72 1,385.42 1,592.12 1,537.00 1,768.08\n\n73 1,427.98 1,640.64 1,585.35 1,822.46\n\n74 1,472.92 1,690.50 1,632.91 1,879.28\n\n75 1,513.85 1,739.60 1,679.69 1,931.10\n\n76 1,553.95 1,786.82 1,726.73 1,982.14\n\n77 1,593.20 1,832.18 1,766.51 2,034.55\n\n78 1,630.51 1,875.64 1,809.77 2,080.80\n\n79 1,662.64 1,913.93 1,845.69 2,122.98\n\n80 1,692.77 1,948.10 1,881.82 2,159.96\n\n81 1,717.76 1,977.43 1,910.07 2,192.56\n\n82 1,742.75 2,005.68 1,937.23 2,225.15\n\n83 1,766.65 2,033.93 1,964.39 2,255.57\n\n84 1,790.55 2,061.10 1,991.56 2,286.00\n\n85 1,813.37 2,088.25 2,017.64 2,316.42\n\n86 1,837.28 2,114.33 2,042.62 2,344.67\n\n87 1,859.01 2,140.41 2,066.52 2,372.92\n\n88 1,879.65 2,164.31 2,090.43 2,400.08\n\n89 1,899.20 2,183.87 2,109.98 2,420.72\n\n90 1,911.16 2,202.34 2,127.37 2,441.37\n\n91 1,928.54 2,218.63 2,143.67 2,464.18\n\n92 1,939.41 2,236.02 2,159.96 2,480.48\n\n93 1,955.70 2,249.06 2,171.92 2,495.70\n\n94 1,967.66 2,265.36 2,187.13 2,511.99\n\n95 1,979.60 2,279.48 2,202.34 2,528.29\n\n96 1,988.30 2,288.17 2,208.86 2,538.06\n\n97 1,995.91 2,299.03 2,220.81 2,551.10\n\n98 2,003.51 2,306.64 2,228.42 2,559.79\n\n99+ 2,006.77 2,310.99 2,232.76 2,563.06\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee.\n\nArea Factors:\n\n_Texas_ 770-773, 775…………………………………………………..………………………… 1.24\n\n1\\.13\n\nRest of State………………………………………………………………………………………………….. 1.00\n\n**State Mutual Insurance Company**\n\nProposed Gross Annual Premiums\n\nMedicare Supplement Policy (Form MSMSDA2010TX)\n\n2010 Standardized Plan D\n\nPreferred Standard\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit A\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 NA NA NA NA\n\n65 1,126.90 1,297.73 1,253.47 1,437.69\n\n66 1,126.90 1,297.73 1,253.47 1,437.69\n\n67 1,126.90 1,297.73 1,253.47 1,437.69\n\n68 1,181.20 1,357.18 1,310.59 1,506.26\n\n69 1,232.98 1,417.30 1,368.35 1,573.51\n\n70 1,285.33 1,475.99 1,426.75 1,638.36\n\n71 1,335.10 1,535.31 1,480.52 1,704.97\n\n72 1,385.42 1,592.12 1,537.00 1,768.08\n\n73 1,427.98 1,640.64 1,585.35 1,822.46\n\n74 1,472.92 1,690.50 1,632.91 1,879.28\n\n75 1,513.85 1,739.60 1,679.69 1,931.10\n\n76 1,553.95 1,786.82 1,726.73 1,982.14\n\n77 1,593.20 1,832.18 1,766.51 2,034.55\n\n78 1,630.51 1,875.64 1,809.77 2,080.80\n\n79 1,662.64 1,913.93 1,845.69 2,122.98\n\n80 1,692.77 1,948.10 1,881.82 2,159.96\n\n81 1,717.76 1,977.43 1,910.07 2,192.56\n\n82 1,742.75 2,005.68 1,937.23 2,225.15\n\n83 1,766.65 2,033.93 1,964.39 2,255.57\n\n84 1,790.55 2,061.10 1,991.56 2,286.00\n\n85 1,813.37 2,088.25 2,017.64 2,316.42\n\n86 1,837.28 2,114.33 2,042.62 2,344.67\n\n87 1,859.01 2,140.41 2,066.52 2,372.92\n\n88 1,879.65 2,164.31 2,090.43 2,400.08\n\n89 1,899.20 2,183.87 2,109.98 2,420.72\n\n90 1,911.16 2,202.34 2,127.37 2,441.37\n\n91 1,928.54 2,218.63 2,143.67 2,464.18\n\n92 1,939.41 2,236.02 2,159.96 2,480.48\n\n93 1,955.70 2,249.06 2,171.92 2,495.70\n\n94 1,967.66 2,265.36 2,187.13 2,511.99\n\n95 1,979.60 2,279.48 2,202.34 2,528.29\n\n96 1,988.30 2,288.17 2,208.86 2,538.06\n\n97 1,995.91 2,299.03 2,220.81 2,551.10\n\n98 2,003.51 2,306.64 2,228.42 2,559.79\n\n99+ 2,006.77 2,310.99 2,232.76 2,563.06\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee.\n\nArea Factors:\n\n_Texas_ 770-773, 775…………………………………………………..………………………… 1.24\n\n1\\.13\n\nRest of State………………………………………………………………………………………………….. 1.00\n\n**State Mutual Insurance Company**\n\nProposed Gross Annual Premiums\n\nMedicare Supplement Policy (Form MSMSDA2010TX)\n\n2010 Standardized Plan D\n\nPreferred Standard\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page898.pdf"]},"response":{"errors":[],"extract_id":"extract_236961a590af605732077f3db65ad8d5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit A\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 NA NA NA NA\n\n65 1,126.90 1,297.73 1,253.47 1,437.69\n\n66 1,126.90 1,297.73 1,253.47 1,437.69\n\n67 1,126.90 1,297.73 1,253.47 1,437.69\n\n68 1,181.20 1,357.18 1,310.59 1,506.26\n\n69 1,232.98 1,417.30 1,368.35 1,573.51\n\n70 1,285.33 1,475.99 1,426.75 1,638.36\n\n71 1,335.10 1,535.31 1,480.52 1,704.97\n\n72 1,385.42 1,592.12 1,537.00 1,768.08\n\n73 1,427.98 1,640.64 1,585.35 1,822.46\n\n74 1,472.92 1,690.50 1,632.91 1,879.28\n\n75 1,513.85 1,739.60 1,679.69 1,931.10\n\n76 1,553.95 1,786.82 1,726.73 1,982.14\n\n77 1,593.20 1,832.18 1,766.51 2,034.55\n\n78 1,630.51 1,875.64 1,809.77 2,080.80\n\n79 1,662.64 1,913.93 1,845.69 2,122.98\n\n80 1,692.77 1,948.10 1,881.82 2,159.96\n\n81 1,717.76 1,977.43 1,910.07 2,192.56\n\n82 1,742.75 2,005.68 1,937.23 2,225.15\n\n83 1,766.65 2,033.93 1,964.39 2,255.57\n\n84 1,790.55 2,061.10 1,991.56 2,286.00\n\n85 1,813.37 2,088.25 2,017.64 2,316.42\n\n86 1,837.28 2,114.33 2,042.62 2,344.67\n\n87 1,859.01 2,140.41 2,066.52 2,372.92\n\n88 1,879.65 2,164.31 2,090.43 2,400.08\n\n89 1,899.20 2,183.87 2,109.98 2,420.72\n\n90 1,911.16 2,202.34 2,127.37 2,441.37\n\n91 1,928.54 2,218.63 2,143.67 2,464.18\n\n92 1,939.41 2,236.02 2,159.96 2,480.48\n\n93 1,955.70 2,249.06 2,171.92 2,495.70\n\n94 1,967.66 2,265.36 2,187.13 2,511.99\n\n95 1,979.60 2,279.48 2,202.34 2,528.29\n\n96 1,988.30 2,288.17 2,208.86 2,538.06\n\n97 1,995.91 2,299.03 2,220.81 2,551.10\n\n98 2,003.51 2,306.64 2,228.42 2,559.79\n\n99+ 2,006.77 2,310.99 2,232.76 2,563.06\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee.\n\nArea Factors:\n\n_Texas_ 770-773, 775…………………………………………………..………………………… 1.24\n\n1\\.13\n\nRest of State………………………………………………………………………………………………….. 1.00\n\n**State Mutual Insurance Company**\n\nProposed Gross Annual Premiums\n\nMedicare Supplement Policy (Form MSMSDA2010TX)\n\n2010 Standardized Plan D\n\nPreferred Standard\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………"],"full_content":"Exhibit A\n\nAttained\n\nAge Female Male Female Male\n\nUnder 65 NA NA NA NA\n\n65 1,126.90 1,297.73 1,253.47 1,437.69\n\n66 1,126.90 1,297.73 1,253.47 1,437.69\n\n67 1,126.90 1,297.73 1,253.47 1,437.69\n\n68 1,181.20 1,357.18 1,310.59 1,506.26\n\n69 1,232.98 1,417.30 1,368.35 1,573.51\n\n70 1,285.33 1,475.99 1,426.75 1,638.36\n\n71 1,335.10 1,535.31 1,480.52 1,704.97\n\n72 1,385.42 1,592.12 1,537.00 1,768.08\n\n73 1,427.98 1,640.64 1,585.35 1,822.46\n\n74 1,472.92 1,690.50 1,632.91 1,879.28\n\n75 1,513.85 1,739.60 1,679.69 1,931.10\n\n76 1,553.95 1,786.82 1,726.73 1,982.14\n\n77 1,593.20 1,832.18 1,766.51 2,034.55\n\n78 1,630.51 1,875.64 1,809.77 2,080.80\n\n79 1,662.64 1,913.93 1,845.69 2,122.98\n\n80 1,692.77 1,948.10 1,881.82 2,159.96\n\n81 1,717.76 1,977.43 1,910.07 2,192.56\n\n82 1,742.75 2,005.68 1,937.23 2,225.15\n\n83 1,766.65 2,033.93 1,964.39 2,255.57\n\n84 1,790.55 2,061.10 1,991.56 2,286.00\n\n85 1,813.37 2,088.25 2,017.64 2,316.42\n\n86 1,837.28 2,114.33 2,042.62 2,344.67\n\n87 1,859.01 2,140.41 2,066.52 2,372.92\n\n88 1,879.65 2,164.31 2,090.43 2,400.08\n\n89 1,899.20 2,183.87 2,109.98 2,420.72\n\n90 1,911.16 2,202.34 2,127.37 2,441.37\n\n91 1,928.54 2,218.63 2,143.67 2,464.18\n\n92 1,939.41 2,236.02 2,159.96 2,480.48\n\n93 1,955.70 2,249.06 2,171.92 2,495.70\n\n94 1,967.66 2,265.36 2,187.13 2,511.99\n\n95 1,979.60 2,279.48 2,202.34 2,528.29\n\n96 1,988.30 2,288.17 2,208.86 2,538.06\n\n97 1,995.91 2,299.03 2,220.81 2,551.10\n\n98 2,003.51 2,306.64 2,228.42 2,559.79\n\n99+ 2,006.77 2,310.99 2,232.76 2,563.06\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee.\n\nArea Factors:\n\n_Texas_ 770-773, 775…………………………………………………..………………………… 1.24\n\n1\\.13\n\nRest of State………………………………………………………………………………………………….. 1.00\n\n**State Mutual Insurance Company**\n\nProposed Gross Annual Premiums\n\nMedicare Supplement Policy (Form MSMSDA2010TX)\n\n2010 Standardized Plan D\n\nPreferred Standard\n\n733, 750-753, 760, 761, 774, 776, 777, 782, 784, 793, 794……………………………...............…………","publish_date":null,"title":"State Mutual Insurance Company Proposed Gross Annual Premiums Exhibit A","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page898.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page898.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page898","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page898.pdf"},"started_at":"2026-11-04T19:47:44.746003"} +{"completed_at":"2026-11-04T19:47:48.527523","latency_in_ms":2749,"output":{"example_id":"table/SERFF_TX_random_pages 1_page905","grounded_pages":[],"layout_pages":[],"markdown":"Benefit A B C D F\\* G M N\\*\\*\n\nMedicare Part A coinsurance and hospital costs (up to an additional 365 days after Medicare benefits are used)\n\n100% 100% 100% 100% 100% 100% 100% 100%\n\nMedicare Part B coinsurance or copayment 100% 100% 100% 100% 100% 100% 100% 100%\n\nBlood (first 3 pints) 100% 100% 100% 100% 100% 100% 100% 100%\n\nPart A hospice care coinsurance or copayment 100% 100% 100% 100% 100% 100% 100% 100%\n\nSkilled nursing facility care coinsurance 100% 100% 100% 100% 100% 100%\n\nPart A deductible 100% 100% 100% 100% 100% 50% 100%\n\nPart B deductible 100% 100%\n\nPart B excess charges 100% 100%\n\nForeign travel emergency (up to plan limits) 80% 80% 80% 80% 80% 80%\n\n**State Mutual Insurance Company**\n\nMedicare Supplement - New 2010 Broker Plans\n\nExhibit D - Benefits by Plan\n\n\\* For High Deductible Plan F, policyholder must pay for Medicare-covered costs (coinsurance, copayments, and deductibles) up to the deductible amount before the policy pays anything. \\*\\* Plan N pays 100% of the Part B coinsurance, except for a copayment of up to $20 for some office visits and up to a $50 copayment for emergency room visits that don’t result in an inpatient admission.","pages":[{"line_numbers":[],"markdown":"Benefit A B C D F\\* G M N\\*\\*\n\nMedicare Part A coinsurance and hospital costs (up to an additional 365 days after Medicare benefits are used)\n\n100% 100% 100% 100% 100% 100% 100% 100%\n\nMedicare Part B coinsurance or copayment 100% 100% 100% 100% 100% 100% 100% 100%\n\nBlood (first 3 pints) 100% 100% 100% 100% 100% 100% 100% 100%\n\nPart A hospice care coinsurance or copayment 100% 100% 100% 100% 100% 100% 100% 100%\n\nSkilled nursing facility care coinsurance 100% 100% 100% 100% 100% 100%\n\nPart A deductible 100% 100% 100% 100% 100% 50% 100%\n\nPart B deductible 100% 100%\n\nPart B excess charges 100% 100%\n\nForeign travel emergency (up to plan limits) 80% 80% 80% 80% 80% 80%\n\n**State Mutual Insurance Company**\n\nMedicare Supplement - New 2010 Broker Plans\n\nExhibit D - Benefits by Plan\n\n\\* For High Deductible Plan F, policyholder must pay for Medicare-covered costs (coinsurance, copayments, and deductibles) up to the deductible amount before the policy pays anything. \\*\\* Plan N pays 100% of the Part B coinsurance, except for a copayment of up to $20 for some office visits and up to a $50 copayment for emergency room visits that don’t result in an inpatient admission.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Benefit A B C D F\\* G M N\\*\\*\n\nMedicare Part A coinsurance and hospital costs (up to an additional 365 days after Medicare benefits are used)\n\n100% 100% 100% 100% 100% 100% 100% 100%\n\nMedicare Part B coinsurance or copayment 100% 100% 100% 100% 100% 100% 100% 100%\n\nBlood (first 3 pints) 100% 100% 100% 100% 100% 100% 100% 100%\n\nPart A hospice care coinsurance or copayment 100% 100% 100% 100% 100% 100% 100% 100%\n\nSkilled nursing facility care coinsurance 100% 100% 100% 100% 100% 100%\n\nPart A deductible 100% 100% 100% 100% 100% 50% 100%\n\nPart B deductible 100% 100%\n\nPart B excess charges 100% 100%\n\nForeign travel emergency (up to plan limits) 80% 80% 80% 80% 80% 80%\n\n**State Mutual Insurance Company**\n\nMedicare Supplement - New 2010 Broker Plans\n\nExhibit D - Benefits by Plan\n\n\\* For High Deductible Plan F, policyholder must pay for Medicare-covered costs (coinsurance, copayments, and deductibles) up to the deductible amount before the policy pays anything. \\*\\* Plan N pays 100% of the Part B coinsurance, except for a copayment of up to $20 for some office visits and up to a $50 copayment for emergency room visits that don’t result in an inpatient admission.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page905.pdf"]},"response":{"errors":[],"extract_id":"extract_3e705af02664989cdbf77d4fca55459b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Benefit A B C D F\\* G M N\\*\\*\n\nMedicare Part A coinsurance and hospital costs (up to an additional 365 days after Medicare benefits are used)\n\n100% 100% 100% 100% 100% 100% 100% 100%\n\nMedicare Part B coinsurance or copayment 100% 100% 100% 100% 100% 100% 100% 100%\n\nBlood (first 3 pints) 100% 100% 100% 100% 100% 100% 100% 100%\n\nPart A hospice care coinsurance or copayment 100% 100% 100% 100% 100% 100% 100% 100%\n\nSkilled nursing facility care coinsurance 100% 100% 100% 100% 100% 100%\n\nPart A deductible 100% 100% 100% 100% 100% 50% 100%\n\nPart B deductible 100% 100%\n\nPart B excess charges 100% 100%\n\nForeign travel emergency (up to plan limits) 80% 80% 80% 80% 80% 80%\n\n**State Mutual Insurance Company**\n\nMedicare Supplement - New 2010 Broker Plans\n\nExhibit D - Benefits by Plan\n\n\\* For High Deductible Plan F, policyholder must pay for Medicare-covered costs (coinsurance, copayments, and deductibles) up to the deductible amount before the policy pays anything. \\*\\* Plan N pays 100% of the Part B coinsurance, except for a copayment of up to $20 for some office visits and up to a $50 copayment for emergency room visits that don’t result in an inpatient admission."],"full_content":"Benefit A B C D F\\* G M N\\*\\*\n\nMedicare Part A coinsurance and hospital costs (up to an additional 365 days after Medicare benefits are used)\n\n100% 100% 100% 100% 100% 100% 100% 100%\n\nMedicare Part B coinsurance or copayment 100% 100% 100% 100% 100% 100% 100% 100%\n\nBlood (first 3 pints) 100% 100% 100% 100% 100% 100% 100% 100%\n\nPart A hospice care coinsurance or copayment 100% 100% 100% 100% 100% 100% 100% 100%\n\nSkilled nursing facility care coinsurance 100% 100% 100% 100% 100% 100%\n\nPart A deductible 100% 100% 100% 100% 100% 50% 100%\n\nPart B deductible 100% 100%\n\nPart B excess charges 100% 100%\n\nForeign travel emergency (up to plan limits) 80% 80% 80% 80% 80% 80%\n\n**State Mutual Insurance Company**\n\nMedicare Supplement - New 2010 Broker Plans\n\nExhibit D - Benefits by Plan\n\n\\* For High Deductible Plan F, policyholder must pay for Medicare-covered costs (coinsurance, copayments, and deductibles) up to the deductible amount before the policy pays anything. \\*\\* Plan N pays 100% of the Part B coinsurance, except for a copayment of up to $20 for some office visits and up to a $50 copayment for emergency room visits that don’t result in an inpatient admission.","publish_date":null,"title":"State Mutual Insurance Company Medicare Supplement - New 2010 Broker Plans Exhibit D - Benefits by Plan","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page905.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page905.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page905","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page905.pdf"},"started_at":"2026-11-04T19:47:45.777617"} +{"completed_at":"2026-11-04T19:47:49.614443","latency_in_ms":2941,"output":{"example_id":"table/SERFF_TX_random_pages 1_page92","grounded_pages":[],"layout_pages":[],"markdown":"Company: Sterling Investors Life Insurance Company Policy Forms: 1990 and 2010 Combined Plan F State: Nationwide Proposed Rate Increase: 9.00% Minimum Loss Ratio: 65.00% Proposed Effective Date: 07/01/2014 Exhibit: Loss Ratio Projection\n\n**ASSUMPTION WITHOUT INTEREST WITH INTEREST Premium Factors Claim Factors Persistency Factors Interest Factors** Calendar Earned Incurred Claims Actual Actual to Earned Incurred Claims Actual Actual to Rate Implementation Effective Att Age Combined Medical Utilization Shock Adverse Policy Claims Years Factor Year Premium Actual Expected Loss Ratio Expected Premium Actual Expected Loss Ratio Expected Increase Timing Rate Increase Increases Rate Increase Trend Aging Underwriting Changes Combined Lapses Lapses Selection Persistency Persistency 2014.00000 1.04\n\nColumn (A) (B) (C) (D) (F) (G) (H) (I) (J) (K) (L) (M) (N) (O) (Y) (P) (Q) (R) (S) (T) (U) (V) (W) (X) Formula +(B)[-1]\\*(U)\\*(M) +(C)[-1]\\*(Q)\\*(V) +(C)/(B) +(B)\\*(X) +(C)\\*(X) +(G)/(F) 1+Rate Increase +(I)^(J)\\*(I)[-1]^(1-(J)[-1]) +(K)\\*(L) (N)\\*(O)\\*(P)\\*(Y) 1-(R)-(S) 1-(R)-(S)\\*(T) 2012.5-(A) 1.0400^(W)\n\n**Past 2003** 0 0 0 0.00% 0.00% 0 0 0 0.00% 0.00% 10.50000 1.509559 **Experience 2004** 677,286 320,929 392,738 47.38% 81.72% 983,080 465,828 570,058 47.38% 81.72% 9.50000 1.451499 **2005** 7,046,197 4,686,886 4,139,256 66.52% 113.23% 9,834,180 6,541,356 5,777,044 66.52% 113.23% 8.50000 1.395672 **2006** 17,392,274 12,823,875 10,586,004 73.73% 121.14% 23,340,299 17,209,542 14,206,337 73.73% 121.14% 7.50000 1.341992 **2007** 31,190,363 24,304,260 19,434,038 77.92% 125.06% 40,247,336 31,361,665 25,077,241 77.92% 125.06% 6.50000 1.290377 **2008** 36,632,487 30,030,874 23,417,426 81.98% 128.24% 45,451,662 37,260,728 29,055,110 81.98% 128.24% 5.50000 1.240747 **2009** 29,429,650 23,981,683 19,484,372 81.49% 123.08% 35,110,347 28,610,779 23,245,369 81.49% 123.08% 4.50000 1.193026 **2010** 20,645,211 16,490,374 14,055,015 79.88% 117.33% 23,682,962 18,916,779 16,123,080 79.88% 117.33% 3.50000 1.147141 **2011** 17,094,676 12,714,753 11,729,705 74.38% 108.40% 18,855,768 14,024,626 12,938,098 74.38% 108.40% 2.50000 1.103020 **2012** 18,009,380 12,989,396 12,312,978 72.13% 105.49% 19,100,677 13,776,502 13,059,096 72.13% 105.49% 1.50000 1.060596 **2013** 16,491,864 11,652,973 11,452,369 70.66% 101.75% 16,818,468 11,883,747 11,679,170 70.66% 101.75% 1.0000 1.0000 0.50000 1.019804 **Future 2014** 14,530,583 10,400,278 10,221,239 71.58% 101.75% 14,248,409 10,198,312 10,022,749 71.58% 101.75% 1.0900 0.4167 1.0366 1.0000 1.0366 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 0.5000 0.8500 0.8500 -0.50000 0.980581 **Experience 2015** 12,987,755 9,282,249 9,122,456 71.47% 101.75% 12,245,713 8,751,917 8,601,254 71.47% 101.75% 1.0000 0.5833 1.0516 1.0000 1.0516 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 0.5000 0.8500 0.8500 -1.50000 0.942866 **2016** 11,039,592 8,284,407 8,141,792 75.04% 101.75% 10,008,516 7,510,659 7,381,364 75.04% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -2.50000 0.906602 **2017** 9,383,653 7,393,833 7,266,549 78.79% 101.75% 8,180,037 6,445,446 6,334,488 78.79% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -3.50000 0.871733 **2018** 7,976,105 6,598,996 6,485,395 82.73% 101.75% 6,685,607 5,531,308 5,436,087 82.73% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -4.50000 0.838204 **2019** 6,779,689 5,889,604 5,788,215 86.87% 101.75% 5,464,198 4,746,820 4,665,104 86.87% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -5.50000 0.805966 **2020** 5,762,736 5,256,472 5,165,982 91.21% 101.75% 4,465,931 4,073,593 4,003,466 91.21% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -6.50000 0.774967 **2021** 4,898,326 4,691,401 4,610,639 95.78% 101.75% 3,650,040 3,495,848 3,435,667 95.78% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -7.50000 0.745161 **2022** 4,163,577 4,187,075 4,114,995 100.56% 101.75% 2,983,206 3,000,042 2,948,397 100.56% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -8.50000 0.716501 **2023** 3,539,040 3,736,965 3,672,633 105.59% 101.75% 2,438,197 2,574,556 2,530,235 105.59% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -9.50000 0.688943 **2024** 3,008,184 3,335,241 3,277,825 110.87% 101.75% 1,992,757 2,209,414 2,171,379 110.87% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -10.50000 0.662445\n\nw/o Rate Inc **Past** 194,609,388 149,996,003 127,003,901 77.08% 118.10% 233,424,779 180,051,553 151,730,603 77.13% 118.67% **Future** 77,815,019 69,056,520 67,867,720 88.74% 101.75% 67,061,645 58,537,914 57,530,191 87.29% 101.75% **Lifetime** 272,424,407 219,052,523 194,871,621 80.41% 112.41% 300,486,423 238,589,467 209,260,794 79.40% 114.02%\n\nw/ Rate Inc **Past** 194,609,388 149,996,003 127,003,901 77.08% 233,424,779 180,051,553 151,730,603 77.13% **Future** 84,069,242 69,056,520 67,867,720 82.14% 72,362,611 58,537,914 57,530,191 80.90% **Lifetime** 278,678,630 219,052,523 194,871,621 78.60% 305,787,390 238,589,467 209,260,794 78.02%","pages":[{"line_numbers":[],"markdown":"Company: Sterling Investors Life Insurance Company Policy Forms: 1990 and 2010 Combined Plan F State: Nationwide Proposed Rate Increase: 9.00% Minimum Loss Ratio: 65.00% Proposed Effective Date: 07/01/2014 Exhibit: Loss Ratio Projection\n\n**ASSUMPTION WITHOUT INTEREST WITH INTEREST Premium Factors Claim Factors Persistency Factors Interest Factors** Calendar Earned Incurred Claims Actual Actual to Earned Incurred Claims Actual Actual to Rate Implementation Effective Att Age Combined Medical Utilization Shock Adverse Policy Claims Years Factor Year Premium Actual Expected Loss Ratio Expected Premium Actual Expected Loss Ratio Expected Increase Timing Rate Increase Increases Rate Increase Trend Aging Underwriting Changes Combined Lapses Lapses Selection Persistency Persistency 2014.00000 1.04\n\nColumn (A) (B) (C) (D) (F) (G) (H) (I) (J) (K) (L) (M) (N) (O) (Y) (P) (Q) (R) (S) (T) (U) (V) (W) (X) Formula +(B)[-1]\\*(U)\\*(M) +(C)[-1]\\*(Q)\\*(V) +(C)/(B) +(B)\\*(X) +(C)\\*(X) +(G)/(F) 1+Rate Increase +(I)^(J)\\*(I)[-1]^(1-(J)[-1]) +(K)\\*(L) (N)\\*(O)\\*(P)\\*(Y) 1-(R)-(S) 1-(R)-(S)\\*(T) 2012.5-(A) 1.0400^(W)\n\n**Past 2003** 0 0 0 0.00% 0.00% 0 0 0 0.00% 0.00% 10.50000 1.509559 **Experience 2004** 677,286 320,929 392,738 47.38% 81.72% 983,080 465,828 570,058 47.38% 81.72% 9.50000 1.451499 **2005** 7,046,197 4,686,886 4,139,256 66.52% 113.23% 9,834,180 6,541,356 5,777,044 66.52% 113.23% 8.50000 1.395672 **2006** 17,392,274 12,823,875 10,586,004 73.73% 121.14% 23,340,299 17,209,542 14,206,337 73.73% 121.14% 7.50000 1.341992 **2007** 31,190,363 24,304,260 19,434,038 77.92% 125.06% 40,247,336 31,361,665 25,077,241 77.92% 125.06% 6.50000 1.290377 **2008** 36,632,487 30,030,874 23,417,426 81.98% 128.24% 45,451,662 37,260,728 29,055,110 81.98% 128.24% 5.50000 1.240747 **2009** 29,429,650 23,981,683 19,484,372 81.49% 123.08% 35,110,347 28,610,779 23,245,369 81.49% 123.08% 4.50000 1.193026 **2010** 20,645,211 16,490,374 14,055,015 79.88% 117.33% 23,682,962 18,916,779 16,123,080 79.88% 117.33% 3.50000 1.147141 **2011** 17,094,676 12,714,753 11,729,705 74.38% 108.40% 18,855,768 14,024,626 12,938,098 74.38% 108.40% 2.50000 1.103020 **2012** 18,009,380 12,989,396 12,312,978 72.13% 105.49% 19,100,677 13,776,502 13,059,096 72.13% 105.49% 1.50000 1.060596 **2013** 16,491,864 11,652,973 11,452,369 70.66% 101.75% 16,818,468 11,883,747 11,679,170 70.66% 101.75% 1.0000 1.0000 0.50000 1.019804 **Future 2014** 14,530,583 10,400,278 10,221,239 71.58% 101.75% 14,248,409 10,198,312 10,022,749 71.58% 101.75% 1.0900 0.4167 1.0366 1.0000 1.0366 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 0.5000 0.8500 0.8500 -0.50000 0.980581 **Experience 2015** 12,987,755 9,282,249 9,122,456 71.47% 101.75% 12,245,713 8,751,917 8,601,254 71.47% 101.75% 1.0000 0.5833 1.0516 1.0000 1.0516 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 0.5000 0.8500 0.8500 -1.50000 0.942866 **2016** 11,039,592 8,284,407 8,141,792 75.04% 101.75% 10,008,516 7,510,659 7,381,364 75.04% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -2.50000 0.906602 **2017** 9,383,653 7,393,833 7,266,549 78.79% 101.75% 8,180,037 6,445,446 6,334,488 78.79% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -3.50000 0.871733 **2018** 7,976,105 6,598,996 6,485,395 82.73% 101.75% 6,685,607 5,531,308 5,436,087 82.73% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -4.50000 0.838204 **2019** 6,779,689 5,889,604 5,788,215 86.87% 101.75% 5,464,198 4,746,820 4,665,104 86.87% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -5.50000 0.805966 **2020** 5,762,736 5,256,472 5,165,982 91.21% 101.75% 4,465,931 4,073,593 4,003,466 91.21% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -6.50000 0.774967 **2021** 4,898,326 4,691,401 4,610,639 95.78% 101.75% 3,650,040 3,495,848 3,435,667 95.78% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -7.50000 0.745161 **2022** 4,163,577 4,187,075 4,114,995 100.56% 101.75% 2,983,206 3,000,042 2,948,397 100.56% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -8.50000 0.716501 **2023** 3,539,040 3,736,965 3,672,633 105.59% 101.75% 2,438,197 2,574,556 2,530,235 105.59% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -9.50000 0.688943 **2024** 3,008,184 3,335,241 3,277,825 110.87% 101.75% 1,992,757 2,209,414 2,171,379 110.87% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -10.50000 0.662445\n\nw/o Rate Inc **Past** 194,609,388 149,996,003 127,003,901 77.08% 118.10% 233,424,779 180,051,553 151,730,603 77.13% 118.67% **Future** 77,815,019 69,056,520 67,867,720 88.74% 101.75% 67,061,645 58,537,914 57,530,191 87.29% 101.75% **Lifetime** 272,424,407 219,052,523 194,871,621 80.41% 112.41% 300,486,423 238,589,467 209,260,794 79.40% 114.02%\n\nw/ Rate Inc **Past** 194,609,388 149,996,003 127,003,901 77.08% 233,424,779 180,051,553 151,730,603 77.13% **Future** 84,069,242 69,056,520 67,867,720 82.14% 72,362,611 58,537,914 57,530,191 80.90% **Lifetime** 278,678,630 219,052,523 194,871,621 78.60% 305,787,390 238,589,467 209,260,794 78.02%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Company: Sterling Investors Life Insurance Company Policy Forms: 1990 and 2010 Combined Plan F State: Nationwide Proposed Rate Increase: 9.00% Minimum Loss Ratio: 65.00% Proposed Effective Date: 07/01/2014 Exhibit: Loss Ratio Projection\n\n**ASSUMPTION WITHOUT INTEREST WITH INTEREST Premium Factors Claim Factors Persistency Factors Interest Factors** Calendar Earned Incurred Claims Actual Actual to Earned Incurred Claims Actual Actual to Rate Implementation Effective Att Age Combined Medical Utilization Shock Adverse Policy Claims Years Factor Year Premium Actual Expected Loss Ratio Expected Premium Actual Expected Loss Ratio Expected Increase Timing Rate Increase Increases Rate Increase Trend Aging Underwriting Changes Combined Lapses Lapses Selection Persistency Persistency 2014.00000 1.04\n\nColumn (A) (B) (C) (D) (F) (G) (H) (I) (J) (K) (L) (M) (N) (O) (Y) (P) (Q) (R) (S) (T) (U) (V) (W) (X) Formula +(B)[-1]\\*(U)\\*(M) +(C)[-1]\\*(Q)\\*(V) +(C)/(B) +(B)\\*(X) +(C)\\*(X) +(G)/(F) 1+Rate Increase +(I)^(J)\\*(I)[-1]^(1-(J)[-1]) +(K)\\*(L) (N)\\*(O)\\*(P)\\*(Y) 1-(R)-(S) 1-(R)-(S)\\*(T) 2012.5-(A) 1.0400^(W)\n\n**Past 2003** 0 0 0 0.00% 0.00% 0 0 0 0.00% 0.00% 10.50000 1.509559 **Experience 2004** 677,286 320,929 392,738 47.38% 81.72% 983,080 465,828 570,058 47.38% 81.72% 9.50000 1.451499 **2005** 7,046,197 4,686,886 4,139,256 66.52% 113.23% 9,834,180 6,541,356 5,777,044 66.52% 113.23% 8.50000 1.395672 **2006** 17,392,274 12,823,875 10,586,004 73.73% 121.14% 23,340,299 17,209,542 14,206,337 73.73% 121.14% 7.50000 1.341992 **2007** 31,190,363 24,304,260 19,434,038 77.92% 125.06% 40,247,336 31,361,665 25,077,241 77.92% 125.06% 6.50000 1.290377 **2008** 36,632,487 30,030,874 23,417,426 81.98% 128.24% 45,451,662 37,260,728 29,055,110 81.98% 128.24% 5.50000 1.240747 **2009** 29,429,650 23,981,683 19,484,372 81.49% 123.08% 35,110,347 28,610,779 23,245,369 81.49% 123.08% 4.50000 1.193026 **2010** 20,645,211 16,490,374 14,055,015 79.88% 117.33% 23,682,962 18,916,779 16,123,080 79.88% 117.33% 3.50000 1.147141 **2011** 17,094,676 12,714,753 11,729,705 74.38% 108.40% 18,855,768 14,024,626 12,938,098 74.38% 108.40% 2.50000 1.103020 **2012** 18,009,380 12,989,396 12,312,978 72.13% 105.49% 19,100,677 13,776,502 13,059,096 72.13% 105.49% 1.50000 1.060596 **2013** 16,491,864 11,652,973 11,452,369 70.66% 101.75% 16,818,468 11,883,747 11,679,170 70.66% 101.75% 1.0000 1.0000 0.50000 1.019804 **Future 2014** 14,530,583 10,400,278 10,221,239 71.58% 101.75% 14,248,409 10,198,312 10,022,749 71.58% 101.75% 1.0900 0.4167 1.0366 1.0000 1.0366 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 0.5000 0.8500 0.8500 -0.50000 0.980581 **Experience 2015** 12,987,755 9,282,249 9,122,456 71.47% 101.75% 12,245,713 8,751,917 8,601,254 71.47% 101.75% 1.0000 0.5833 1.0516 1.0000 1.0516 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 0.5000 0.8500 0.8500 -1.50000 0.942866 **2016** 11,039,592 8,284,407 8,141,792 75.04% 101.75% 10,008,516 7,510,659 7,381,364 75.04% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -2.50000 0.906602 **2017** 9,383,653 7,393,833 7,266,549 78.79% 101.75% 8,180,037 6,445,446 6,334,488 78.79% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -3.50000 0.871733 **2018** 7,976,105 6,598,996 6,485,395 82.73% 101.75% 6,685,607 5,531,308 5,436,087 82.73% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -4.50000 0.838204 **2019** 6,779,689 5,889,604 5,788,215 86.87% 101.75% 5,464,198 4,746,820 4,665,104 86.87% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -5.50000 0.805966 **2020** 5,762,736 5,256,472 5,165,982 91.21% 101.75% 4,465,931 4,073,593 4,003,466 91.21% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -6.50000 0.774967 **2021** 4,898,326 4,691,401 4,610,639 95.78% 101.75% 3,650,040 3,495,848 3,435,667 95.78% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -7.50000 0.745161 **2022** 4,163,577 4,187,075 4,114,995 100.56% 101.75% 2,983,206 3,000,042 2,948,397 100.56% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -8.50000 0.716501 **2023** 3,539,040 3,736,965 3,672,633 105.59% 101.75% 2,438,197 2,574,556 2,530,235 105.59% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -9.50000 0.688943 **2024** 3,008,184 3,335,241 3,277,825 110.87% 101.75% 1,992,757 2,209,414 2,171,379 110.87% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -10.50000 0.662445\n\nw/o Rate Inc **Past** 194,609,388 149,996,003 127,003,901 77.08% 118.10% 233,424,779 180,051,553 151,730,603 77.13% 118.67% **Future** 77,815,019 69,056,520 67,867,720 88.74% 101.75% 67,061,645 58,537,914 57,530,191 87.29% 101.75% **Lifetime** 272,424,407 219,052,523 194,871,621 80.41% 112.41% 300,486,423 238,589,467 209,260,794 79.40% 114.02%\n\nw/ Rate Inc **Past** 194,609,388 149,996,003 127,003,901 77.08% 233,424,779 180,051,553 151,730,603 77.13% **Future** 84,069,242 69,056,520 67,867,720 82.14% 72,362,611 58,537,914 57,530,191 80.90% **Lifetime** 278,678,630 219,052,523 194,871,621 78.60% 305,787,390 238,589,467 209,260,794 78.02%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page92.pdf"]},"response":{"errors":[],"extract_id":"extract_b42c691bb182a44c0661202934b6ee7c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Company: Sterling Investors Life Insurance Company Policy Forms: 1990 and 2010 Combined Plan F State: Nationwide Proposed Rate Increase: 9.00% Minimum Loss Ratio: 65.00% Proposed Effective Date: 07/01/2014 Exhibit: Loss Ratio Projection\n\n**ASSUMPTION WITHOUT INTEREST WITH INTEREST Premium Factors Claim Factors Persistency Factors Interest Factors** Calendar Earned Incurred Claims Actual Actual to Earned Incurred Claims Actual Actual to Rate Implementation Effective Att Age Combined Medical Utilization Shock Adverse Policy Claims Years Factor Year Premium Actual Expected Loss Ratio Expected Premium Actual Expected Loss Ratio Expected Increase Timing Rate Increase Increases Rate Increase Trend Aging Underwriting Changes Combined Lapses Lapses Selection Persistency Persistency 2014.00000 1.04\n\nColumn (A) (B) (C) (D) (F) (G) (H) (I) (J) (K) (L) (M) (N) (O) (Y) (P) (Q) (R) (S) (T) (U) (V) (W) (X) Formula +(B)[-1]\\*(U)\\*(M) +(C)[-1]\\*(Q)\\*(V) +(C)/(B) +(B)\\*(X) +(C)\\*(X) +(G)/(F) 1+Rate Increase +(I)^(J)\\*(I)[-1]^(1-(J)[-1]) +(K)\\*(L) (N)\\*(O)\\*(P)\\*(Y) 1-(R)-(S) 1-(R)-(S)\\*(T) 2012.5-(A) 1.0400^(W)\n\n**Past 2003** 0 0 0 0.00% 0.00% 0 0 0 0.00% 0.00% 10.50000 1.509559 **Experience 2004** 677,286 320,929 392,738 47.38% 81.72% 983,080 465,828 570,058 47.38% 81.72% 9.50000 1.451499 **2005** 7,046,197 4,686,886 4,139,256 66.52% 113.23% 9,834,180 6,541,356 5,777,044 66.52% 113.23% 8.50000 1.395672 **2006** 17,392,274 12,823,875 10,586,004 73.73% 121.14% 23,340,299 17,209,542 14,206,337 73.73% 121.14% 7.50000 1.341992 **2007** 31,190,363 24,304,260 19,434,038 77.92% 125.06% 40,247,336 31,361,665 25,077,241 77.92% 125.06% 6.50000 1.290377 **2008** 36,632,487 30,030,874 23,417,426 81.98% 128.24% 45,451,662 37,260,728 29,055,110 81.98% 128.24% 5.50000 1.240747 **2009** 29,429,650 23,981,683 19,484,372 81.49% 123.08% 35,110,347 28,610,779 23,245,369 81.49% 123.08% 4.50000 1.193026 **2010** 20,645,211 16,490,374 14,055,015 79.88% 117.33% 23,682,962 18,916,779 16,123,080 79.88% 117.33% 3.50000 1.147141 **2011** 17,094,676 12,714,753 11,729,705 74.38% 108.40% 18,855,768 14,024,626 12,938,098 74.38% 108.40% 2.50000 1.103020 **2012** 18,009,380 12,989,396 12,312,978 72.13% 105.49% 19,100,677 13,776,502 13,059,096 72.13% 105.49% 1.50000 1.060596 **2013** 16,491,864 11,652,973 11,452,369 70.66% 101.75% 16,818,468 11,883,747 11,679,170 70.66% 101.75% 1.0000 1.0000 0.50000 1.019804 **Future 2014** 14,530,583 10,400,278 10,221,239 71.58% 101.75% 14,248,409 10,198,312 10,022,749 71.58% 101.75% 1.0900 0.4167 1.0366 1.0000 1.0366 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 0.5000 0.8500 0.8500 -0.50000 0.980581 **Experience 2015** 12,987,755 9,282,249 9,122,456 71.47% 101.75% 12,245,713 8,751,917 8,601,254 71.47% 101.75% 1.0000 0.5833 1.0516 1.0000 1.0516 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 0.5000 0.8500 0.8500 -1.50000 0.942866 **2016** 11,039,592 8,284,407 8,141,792 75.04% 101.75% 10,008,516 7,510,659 7,381,364 75.04% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -2.50000 0.906602 **2017** 9,383,653 7,393,833 7,266,549 78.79% 101.75% 8,180,037 6,445,446 6,334,488 78.79% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -3.50000 0.871733 **2018** 7,976,105 6,598,996 6,485,395 82.73% 101.75% 6,685,607 5,531,308 5,436,087 82.73% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -4.50000 0.838204 **2019** 6,779,689 5,889,604 5,788,215 86.87% 101.75% 5,464,198 4,746,820 4,665,104 86.87% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -5.50000 0.805966 **2020** 5,762,736 5,256,472 5,165,982 91.21% 101.75% 4,465,931 4,073,593 4,003,466 91.21% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -6.50000 0.774967 **2021** 4,898,326 4,691,401 4,610,639 95.78% 101.75% 3,650,040 3,495,848 3,435,667 95.78% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -7.50000 0.745161 **2022** 4,163,577 4,187,075 4,114,995 100.56% 101.75% 2,983,206 3,000,042 2,948,397 100.56% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -8.50000 0.716501 **2023** 3,539,040 3,736,965 3,672,633 105.59% 101.75% 2,438,197 2,574,556 2,530,235 105.59% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -9.50000 0.688943 **2024** 3,008,184 3,335,241 3,277,825 110.87% 101.75% 1,992,757 2,209,414 2,171,379 110.87% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -10.50000 0.662445\n\nw/o Rate Inc **Past** 194,609,388 149,996,003 127,003,901 77.08% 118.10% 233,424,779 180,051,553 151,730,603 77.13% 118.67% **Future** 77,815,019 69,056,520 67,867,720 88.74% 101.75% 67,061,645 58,537,914 57,530,191 87.29% 101.75% **Lifetime** 272,424,407 219,052,523 194,871,621 80.41% 112.41% 300,486,423 238,589,467 209,260,794 79.40% 114.02%\n\nw/ Rate Inc **Past** 194,609,388 149,996,003 127,003,901 77.08% 233,424,779 180,051,553 151,730,603 77.13% **Future** 84,069,242 69,056,520 67,867,720 82.14% 72,362,611 58,537,914 57,530,191 80.90% **Lifetime** 278,678,630 219,052,523 194,871,621 78.60% 305,787,390 238,589,467 209,260,794 78.02%"],"full_content":"Company: Sterling Investors Life Insurance Company Policy Forms: 1990 and 2010 Combined Plan F State: Nationwide Proposed Rate Increase: 9.00% Minimum Loss Ratio: 65.00% Proposed Effective Date: 07/01/2014 Exhibit: Loss Ratio Projection\n\n**ASSUMPTION WITHOUT INTEREST WITH INTEREST Premium Factors Claim Factors Persistency Factors Interest Factors** Calendar Earned Incurred Claims Actual Actual to Earned Incurred Claims Actual Actual to Rate Implementation Effective Att Age Combined Medical Utilization Shock Adverse Policy Claims Years Factor Year Premium Actual Expected Loss Ratio Expected Premium Actual Expected Loss Ratio Expected Increase Timing Rate Increase Increases Rate Increase Trend Aging Underwriting Changes Combined Lapses Lapses Selection Persistency Persistency 2014.00000 1.04\n\nColumn (A) (B) (C) (D) (F) (G) (H) (I) (J) (K) (L) (M) (N) (O) (Y) (P) (Q) (R) (S) (T) (U) (V) (W) (X) Formula +(B)[-1]\\*(U)\\*(M) +(C)[-1]\\*(Q)\\*(V) +(C)/(B) +(B)\\*(X) +(C)\\*(X) +(G)/(F) 1+Rate Increase +(I)^(J)\\*(I)[-1]^(1-(J)[-1]) +(K)\\*(L) (N)\\*(O)\\*(P)\\*(Y) 1-(R)-(S) 1-(R)-(S)\\*(T) 2012.5-(A) 1.0400^(W)\n\n**Past 2003** 0 0 0 0.00% 0.00% 0 0 0 0.00% 0.00% 10.50000 1.509559 **Experience 2004** 677,286 320,929 392,738 47.38% 81.72% 983,080 465,828 570,058 47.38% 81.72% 9.50000 1.451499 **2005** 7,046,197 4,686,886 4,139,256 66.52% 113.23% 9,834,180 6,541,356 5,777,044 66.52% 113.23% 8.50000 1.395672 **2006** 17,392,274 12,823,875 10,586,004 73.73% 121.14% 23,340,299 17,209,542 14,206,337 73.73% 121.14% 7.50000 1.341992 **2007** 31,190,363 24,304,260 19,434,038 77.92% 125.06% 40,247,336 31,361,665 25,077,241 77.92% 125.06% 6.50000 1.290377 **2008** 36,632,487 30,030,874 23,417,426 81.98% 128.24% 45,451,662 37,260,728 29,055,110 81.98% 128.24% 5.50000 1.240747 **2009** 29,429,650 23,981,683 19,484,372 81.49% 123.08% 35,110,347 28,610,779 23,245,369 81.49% 123.08% 4.50000 1.193026 **2010** 20,645,211 16,490,374 14,055,015 79.88% 117.33% 23,682,962 18,916,779 16,123,080 79.88% 117.33% 3.50000 1.147141 **2011** 17,094,676 12,714,753 11,729,705 74.38% 108.40% 18,855,768 14,024,626 12,938,098 74.38% 108.40% 2.50000 1.103020 **2012** 18,009,380 12,989,396 12,312,978 72.13% 105.49% 19,100,677 13,776,502 13,059,096 72.13% 105.49% 1.50000 1.060596 **2013** 16,491,864 11,652,973 11,452,369 70.66% 101.75% 16,818,468 11,883,747 11,679,170 70.66% 101.75% 1.0000 1.0000 0.50000 1.019804 **Future 2014** 14,530,583 10,400,278 10,221,239 71.58% 101.75% 14,248,409 10,198,312 10,022,749 71.58% 101.75% 1.0900 0.4167 1.0366 1.0000 1.0366 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 0.5000 0.8500 0.8500 -0.50000 0.980581 **Experience 2015** 12,987,755 9,282,249 9,122,456 71.47% 101.75% 12,245,713 8,751,917 8,601,254 71.47% 101.75% 1.0000 0.5833 1.0516 1.0000 1.0516 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 0.5000 0.8500 0.8500 -1.50000 0.942866 **2016** 11,039,592 8,284,407 8,141,792 75.04% 101.75% 10,008,516 7,510,659 7,381,364 75.04% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -2.50000 0.906602 **2017** 9,383,653 7,393,833 7,266,549 78.79% 101.75% 8,180,037 6,445,446 6,334,488 78.79% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -3.50000 0.871733 **2018** 7,976,105 6,598,996 6,485,395 82.73% 101.75% 6,685,607 5,531,308 5,436,087 82.73% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -4.50000 0.838204 **2019** 6,779,689 5,889,604 5,788,215 86.87% 101.75% 5,464,198 4,746,820 4,665,104 86.87% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -5.50000 0.805966 **2020** 5,762,736 5,256,472 5,165,982 91.21% 101.75% 4,465,931 4,073,593 4,003,466 91.21% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -6.50000 0.774967 **2021** 4,898,326 4,691,401 4,610,639 95.78% 101.75% 3,650,040 3,495,848 3,435,667 95.78% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -7.50000 0.745161 **2022** 4,163,577 4,187,075 4,114,995 100.56% 101.75% 2,983,206 3,000,042 2,948,397 100.56% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -8.50000 0.716501 **2023** 3,539,040 3,736,965 3,672,633 105.59% 101.75% 2,438,197 2,574,556 2,530,235 105.59% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -9.50000 0.688943 **2024** 3,008,184 3,335,241 3,277,825 110.87% 101.75% 1,992,757 2,209,414 2,171,379 110.87% 101.75% 1.0000 1.0000 1.0000 1.0000 1.0000 1.0500 1.0000 1.0000 1.0000 1.0500 0.1500 0.0000 1.0000 0.8500 0.8500 -10.50000 0.662445\n\nw/o Rate Inc **Past** 194,609,388 149,996,003 127,003,901 77.08% 118.10% 233,424,779 180,051,553 151,730,603 77.13% 118.67% **Future** 77,815,019 69,056,520 67,867,720 88.74% 101.75% 67,061,645 58,537,914 57,530,191 87.29% 101.75% **Lifetime** 272,424,407 219,052,523 194,871,621 80.41% 112.41% 300,486,423 238,589,467 209,260,794 79.40% 114.02%\n\nw/ Rate Inc **Past** 194,609,388 149,996,003 127,003,901 77.08% 233,424,779 180,051,553 151,730,603 77.13% **Future** 84,069,242 69,056,520 67,867,720 82.14% 72,362,611 58,537,914 57,530,191 80.90% **Lifetime** 278,678,630 219,052,523 194,871,621 78.60% 305,787,390 238,589,467 209,260,794 78.02%","publish_date":null,"title":"Company: Sterling Investors Life Insurance Company Policy Forms: 1990 and 2010 Combined Plan F State: Nationwide Proposed Rate Increase: 9.00%","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page92.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page92.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page92","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page92.pdf"},"started_at":"2026-11-04T19:47:46.672623"} +{"completed_at":"2026-11-04T19:47:50.024996","latency_in_ms":2146,"output":{"example_id":"table/SERFF_TX_random_pages 1_page964","grounded_pages":[],"layout_pages":[],"markdown":"**CURRENT RATES**\n\nAttained\n\nAge Female Male Female Male\n\n0-64 N/A N/A N/A N/A\n\n65 3,197 3,674 3,551 4,085\n\n66 3,197 3,674 3,551 4,085\n\n67 3,197 3,674 3,551 4,085\n\n68 3,340 3,839 3,708 4,265\n\n69 3,475 3,997 3,862 4,441\n\n70 3,608 4,146 4,007 4,605\n\n71 3,734 4,294 4,146 4,769\n\n72 3,850 4,427 4,278 4,918\n\n73 3,959 4,551 4,400 5,058\n\n74 4,061 4,670 4,519 5,192\n\n75 4,158 4,783 4,621 5,313\n\n76 4,247 4,882 4,718 5,425\n\n77 4,335 4,985 4,816 5,543\n\n78 4,418 5,080 4,908 5,642\n\n79 4,492 5,163 4,985 5,737\n\n80 4,550 5,232 5,053 5,813\n\n81 4,605 5,296 5,116 5,883\n\n82 4,663 5,361 5,179 5,957\n\n83 4,717 5,421 5,237 6,023\n\n84 4,764 5,482 5,296 6,092\n\n85 4,815 5,542 5,350 6,154\n\n86 4,864 5,593 5,404 6,215\n\n87 4,909 5,645 5,456 6,272\n\n88 4,956 5,698 5,502 6,330\n\n89 4,999 5,744 5,553 6,382\n\n90 5,037 5,796 5,597 6,441\n\n91 5,080 5,840 5,643 6,491\n\n92 5,116 5,883 5,686 6,537\n\n93 5,151 5,922 5,723 6,579\n\n94 5,179 5,959 5,756 6,621\n\n95 5,207 5,991 5,787 6,654\n\n96 5,237 6,023 5,818 6,694\n\n97 5,268 6,055 5,850 6,726\n\n98 5,296 6,091 5,883 6,767\n\n99 5,325 6,126 5,918 6,801\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee.\n\nArea Factors:\n\n_Texas_ 750-753, 760-761, 770-775\n\n780, 782, 793-794…………………………………………………………………………………………… 1.20\n\n776-779, 783-785………………………………………………………………………………………………… 1.10\n\nRest of State………………………………………………………………………………………………….. 1.00\n\nNon-Tobacco Tobacco\n\nStandardized Plan C\n\nMedicare Supplement Policy\n\n### **SHENANDOAH LIFE INSURANCE COMPANY**\n\n### Gross Annual Premiums\n\nTX 11/16/2020","pages":[{"line_numbers":[],"markdown":"**CURRENT RATES**\n\nAttained\n\nAge Female Male Female Male\n\n0-64 N/A N/A N/A N/A\n\n65 3,197 3,674 3,551 4,085\n\n66 3,197 3,674 3,551 4,085\n\n67 3,197 3,674 3,551 4,085\n\n68 3,340 3,839 3,708 4,265\n\n69 3,475 3,997 3,862 4,441\n\n70 3,608 4,146 4,007 4,605\n\n71 3,734 4,294 4,146 4,769\n\n72 3,850 4,427 4,278 4,918\n\n73 3,959 4,551 4,400 5,058\n\n74 4,061 4,670 4,519 5,192\n\n75 4,158 4,783 4,621 5,313\n\n76 4,247 4,882 4,718 5,425\n\n77 4,335 4,985 4,816 5,543\n\n78 4,418 5,080 4,908 5,642\n\n79 4,492 5,163 4,985 5,737\n\n80 4,550 5,232 5,053 5,813\n\n81 4,605 5,296 5,116 5,883\n\n82 4,663 5,361 5,179 5,957\n\n83 4,717 5,421 5,237 6,023\n\n84 4,764 5,482 5,296 6,092\n\n85 4,815 5,542 5,350 6,154\n\n86 4,864 5,593 5,404 6,215\n\n87 4,909 5,645 5,456 6,272\n\n88 4,956 5,698 5,502 6,330\n\n89 4,999 5,744 5,553 6,382\n\n90 5,037 5,796 5,597 6,441\n\n91 5,080 5,840 5,643 6,491\n\n92 5,116 5,883 5,686 6,537\n\n93 5,151 5,922 5,723 6,579\n\n94 5,179 5,959 5,756 6,621\n\n95 5,207 5,991 5,787 6,654\n\n96 5,237 6,023 5,818 6,694\n\n97 5,268 6,055 5,850 6,726\n\n98 5,296 6,091 5,883 6,767\n\n99 5,325 6,126 5,918 6,801\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee.\n\nArea Factors:\n\n_Texas_ 750-753, 760-761, 770-775\n\n780, 782, 793-794…………………………………………………………………………………………… 1.20\n\n776-779, 783-785………………………………………………………………………………………………… 1.10\n\nRest of State………………………………………………………………………………………………….. 1.00\n\nNon-Tobacco Tobacco\n\nStandardized Plan C\n\nMedicare Supplement Policy\n\n### **SHENANDOAH LIFE INSURANCE COMPANY**\n\n### Gross Annual Premiums\n\nTX 11/16/2020","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**CURRENT RATES**\n\nAttained\n\nAge Female Male Female Male\n\n0-64 N/A N/A N/A N/A\n\n65 3,197 3,674 3,551 4,085\n\n66 3,197 3,674 3,551 4,085\n\n67 3,197 3,674 3,551 4,085\n\n68 3,340 3,839 3,708 4,265\n\n69 3,475 3,997 3,862 4,441\n\n70 3,608 4,146 4,007 4,605\n\n71 3,734 4,294 4,146 4,769\n\n72 3,850 4,427 4,278 4,918\n\n73 3,959 4,551 4,400 5,058\n\n74 4,061 4,670 4,519 5,192\n\n75 4,158 4,783 4,621 5,313\n\n76 4,247 4,882 4,718 5,425\n\n77 4,335 4,985 4,816 5,543\n\n78 4,418 5,080 4,908 5,642\n\n79 4,492 5,163 4,985 5,737\n\n80 4,550 5,232 5,053 5,813\n\n81 4,605 5,296 5,116 5,883\n\n82 4,663 5,361 5,179 5,957\n\n83 4,717 5,421 5,237 6,023\n\n84 4,764 5,482 5,296 6,092\n\n85 4,815 5,542 5,350 6,154\n\n86 4,864 5,593 5,404 6,215\n\n87 4,909 5,645 5,456 6,272\n\n88 4,956 5,698 5,502 6,330\n\n89 4,999 5,744 5,553 6,382\n\n90 5,037 5,796 5,597 6,441\n\n91 5,080 5,840 5,643 6,491\n\n92 5,116 5,883 5,686 6,537\n\n93 5,151 5,922 5,723 6,579\n\n94 5,179 5,959 5,756 6,621\n\n95 5,207 5,991 5,787 6,654\n\n96 5,237 6,023 5,818 6,694\n\n97 5,268 6,055 5,850 6,726\n\n98 5,296 6,091 5,883 6,767\n\n99 5,325 6,126 5,918 6,801\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee.\n\nArea Factors:\n\n_Texas_ 750-753, 760-761, 770-775\n\n780, 782, 793-794…………………………………………………………………………………………… 1.20\n\n776-779, 783-785………………………………………………………………………………………………… 1.10\n\nRest of State………………………………………………………………………………………………….. 1.00\n\nNon-Tobacco Tobacco\n\nStandardized Plan C\n\nMedicare Supplement Policy\n\n### **SHENANDOAH LIFE INSURANCE COMPANY**\n\n### Gross Annual Premiums\n\nTX 11/16/2020","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page964.pdf"]},"response":{"errors":[],"extract_id":"extract_6d55e1316041c8dec944ed357ee35f76","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**CURRENT RATES**\n\nAttained\n\nAge Female Male Female Male\n\n0-64 N/A N/A N/A N/A\n\n65 3,197 3,674 3,551 4,085\n\n66 3,197 3,674 3,551 4,085\n\n67 3,197 3,674 3,551 4,085\n\n68 3,340 3,839 3,708 4,265\n\n69 3,475 3,997 3,862 4,441\n\n70 3,608 4,146 4,007 4,605\n\n71 3,734 4,294 4,146 4,769\n\n72 3,850 4,427 4,278 4,918\n\n73 3,959 4,551 4,400 5,058\n\n74 4,061 4,670 4,519 5,192\n\n75 4,158 4,783 4,621 5,313\n\n76 4,247 4,882 4,718 5,425\n\n77 4,335 4,985 4,816 5,543\n\n78 4,418 5,080 4,908 5,642\n\n79 4,492 5,163 4,985 5,737\n\n80 4,550 5,232 5,053 5,813\n\n81 4,605 5,296 5,116 5,883\n\n82 4,663 5,361 5,179 5,957\n\n83 4,717 5,421 5,237 6,023\n\n84 4,764 5,482 5,296 6,092\n\n85 4,815 5,542 5,350 6,154\n\n86 4,864 5,593 5,404 6,215\n\n87 4,909 5,645 5,456 6,272\n\n88 4,956 5,698 5,502 6,330\n\n89 4,999 5,744 5,553 6,382\n\n90 5,037 5,796 5,597 6,441\n\n91 5,080 5,840 5,643 6,491\n\n92 5,116 5,883 5,686 6,537\n\n93 5,151 5,922 5,723 6,579\n\n94 5,179 5,959 5,756 6,621\n\n95 5,207 5,991 5,787 6,654\n\n96 5,237 6,023 5,818 6,694\n\n97 5,268 6,055 5,850 6,726\n\n98 5,296 6,091 5,883 6,767\n\n99 5,325 6,126 5,918 6,801\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee.\n\nArea Factors:\n\n_Texas_ 750-753, 760-761, 770-775\n\n780, 782, 793-794…………………………………………………………………………………………… 1.20\n\n776-779, 783-785………………………………………………………………………………………………… 1.10\n\nRest of State………………………………………………………………………………………………….. 1.00\n\nNon-Tobacco Tobacco\n\nStandardized Plan C\n\nMedicare Supplement Policy\n\n### **SHENANDOAH LIFE INSURANCE COMPANY**\n\n### Gross Annual Premiums\n\nTX 11/16/2020"],"full_content":"**CURRENT RATES**\n\nAttained\n\nAge Female Male Female Male\n\n0-64 N/A N/A N/A N/A\n\n65 3,197 3,674 3,551 4,085\n\n66 3,197 3,674 3,551 4,085\n\n67 3,197 3,674 3,551 4,085\n\n68 3,340 3,839 3,708 4,265\n\n69 3,475 3,997 3,862 4,441\n\n70 3,608 4,146 4,007 4,605\n\n71 3,734 4,294 4,146 4,769\n\n72 3,850 4,427 4,278 4,918\n\n73 3,959 4,551 4,400 5,058\n\n74 4,061 4,670 4,519 5,192\n\n75 4,158 4,783 4,621 5,313\n\n76 4,247 4,882 4,718 5,425\n\n77 4,335 4,985 4,816 5,543\n\n78 4,418 5,080 4,908 5,642\n\n79 4,492 5,163 4,985 5,737\n\n80 4,550 5,232 5,053 5,813\n\n81 4,605 5,296 5,116 5,883\n\n82 4,663 5,361 5,179 5,957\n\n83 4,717 5,421 5,237 6,023\n\n84 4,764 5,482 5,296 6,092\n\n85 4,815 5,542 5,350 6,154\n\n86 4,864 5,593 5,404 6,215\n\n87 4,909 5,645 5,456 6,272\n\n88 4,956 5,698 5,502 6,330\n\n89 4,999 5,744 5,553 6,382\n\n90 5,037 5,796 5,597 6,441\n\n91 5,080 5,840 5,643 6,491\n\n92 5,116 5,883 5,686 6,537\n\n93 5,151 5,922 5,723 6,579\n\n94 5,179 5,959 5,756 6,621\n\n95 5,207 5,991 5,787 6,654\n\n96 5,237 6,023 5,818 6,694\n\n97 5,268 6,055 5,850 6,726\n\n98 5,296 6,091 5,883 6,767\n\n99 5,325 6,126 5,918 6,801\n\nThere is no modal loading. The rates above do not include a one time $25 policy fee.\n\nArea Factors:\n\n_Texas_ 750-753, 760-761, 770-775\n\n780, 782, 793-794…………………………………………………………………………………………… 1.20\n\n776-779, 783-785………………………………………………………………………………………………… 1.10\n\nRest of State………………………………………………………………………………………………….. 1.00\n\nNon-Tobacco Tobacco\n\nStandardized Plan C\n\nMedicare Supplement Policy\n\n### **SHENANDOAH LIFE INSURANCE COMPANY**\n\n### Gross Annual Premiums\n\nTX 11/16/2020","publish_date":null,"title":"Gross Annual Premiums SHENANDOAH LIFE INSURANCE COMPANY","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page964.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page964.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page964","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page964.pdf"},"started_at":"2026-11-04T19:47:47.878419"} +{"completed_at":"2026-11-04T19:47:50.335353","latency_in_ms":1805,"output":{"example_id":"table/SERFF_TX_random_pages 1_page975","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 2\n\n**Attained**\n\n**Age Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N**\n\n0-64 7,638.06 8,783.80\n\n65 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n66 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n67 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n68 1,990.82 1,918.13 1,515.81 2,321.79 500.07 1,789.68 1,378.65 2,289.44 2,205.84 1,743.17 2,670.05 575.08 2,058.14 1,585.45\n\n69 2,070.70 1,952.42 1,550.16 2,412.72 516.19 1,867.55 1,436.22 2,381.30 2,245.29 1,782.68 2,774.61 593.62 2,147.67 1,651.67\n\n70 2,147.98 2,020.12 1,610.42 2,497.30 541.52 1,939.96 1,490.51 2,470.18 2,323.14 1,851.98 2,871.87 622.75 2,230.95 1,714.10\n\n71 2,212.23 2,085.40 1,668.52 2,579.02 560.74 2,009.95 1,545.05 2,544.07 2,398.21 1,918.80 2,965.87 644.85 2,311.44 1,776.79\n\n72 2,276.48 2,150.68 1,726.63 2,660.76 579.96 2,079.93 1,599.58 2,617.96 2,473.28 1,985.61 3,059.87 666.95 2,391.92 1,839.50\n\n73 2,340.73 2,222.61 1,790.08 2,742.49 600.98 2,149.91 1,654.09 2,691.85 2,555.99 2,058.60 3,153.86 691.12 2,472.40 1,902.21\n\n74 2,404.99 2,294.95 1,853.90 2,824.23 622.11 2,219.90 1,708.63 2,765.73 2,639.18 2,131.99 3,247.87 715.43 2,552.89 1,964.91\n\n75 2,470.46 2,386.58 1,933.39 2,907.41 646.58 2,291.02 1,764.03 2,841.05 2,744.57 2,223.40 3,343.52 743.57 2,634.69 2,028.64\n\n76 2,515.55 2,465.29 2,000.97 2,980.29 666.53 2,352.44 1,814.38 2,892.88 2,835.08 2,301.11 3,427.33 766.51 2,705.32 2,086.53\n\n77 2,561.02 2,545.63 2,069.97 3,053.81 686.76 2,414.41 1,865.20 2,945.16 2,927.48 2,380.46 3,511.89 789.77 2,776.56 2,144.97\n\n78 2,608.17 2,630.25 2,142.54 3,129.58 707.27 2,478.17 1,917.43 2,999.38 3,024.79 2,463.91 3,599.02 813.36 2,849.88 2,205.05\n\n79 2,655.75 2,719.41 2,218.92 3,206.07 728.07 2,542.55 1,970.17 3,054.11 3,127.33 2,551.76 3,686.97 837.28 2,923.93 2,265.70\n\n80 2,705.15 2,810.67 2,297.11 3,284.93 749.15 2,608.87 2,024.46 3,110.91 3,232.27 2,641.69 3,777.67 861.52 3,000.21 2,328.12\n\n81 2,744.72 2,923.53 2,393.07 3,363.66 770.69 2,675.06 2,081.40 3,156.43 3,362.05 2,752.03 3,868.21 886.30 3,076.32 2,393.60\n\n82 2,786.06 3,040.00 2,492.14 3,444.94 792.53 2,743.32 2,140.02 3,203.97 3,495.99 2,865.96 3,961.68 911.41 3,154.80 2,461.03\n\n83 2,827.85 3,157.09 2,591.87 3,527.14 814.68 2,812.34 2,199.32 3,252.01 3,630.65 2,980.64 4,056.19 936.88 3,234.20 2,529.22\n\n84 2,870.03 3,277.75 2,694.69 3,610.23 837.12 2,882.16 2,259.30 3,300.55 3,769.41 3,098.89 4,151.77 962.69 3,314.49 2,598.21\n\n85 2,912.66 3,402.08 2,800.68 3,694.28 859.02 2,952.76 2,319.98 3,349.57 3,912.40 3,220.78 4,248.42 987.87 3,395.68 2,667.96\n\n86 2,951.12 3,514.59 2,896.04 3,771.68 877.63 3,017.14 2,375.23 3,393.79 4,041.77 3,330.44 4,337.42 1,009.27 3,469.70 2,731.52\n\n87 2,990.04 3,630.31 2,994.16 3,850.16 896.46 3,082.42 2,431.31 3,438.56 4,174.86 3,443.29 4,427.68 1,030.93 3,544.78 2,796.01\n\n88 3,029.43 3,749.35 3,095.14 3,929.74 915.51 3,148.66 2,488.20 3,483.85 4,311.75 3,559.42 4,519.21 1,052.83 3,620.95 2,861.44\n\n89 3,067.76 3,871.78 3,199.04 4,008.47 934.78 3,214.22 2,544.67 3,527.94 4,452.55 3,678.89 4,609.75 1,075.00 3,696.34 2,926.35\n\n90 3,104.98 3,997.71 3,305.92 4,086.23 954.28 3,279.05 2,600.60 3,570.74 4,597.37 3,801.81 4,699.15 1,097.42 3,770.90 2,990.71\n\n91 3,128.24 4,117.99 3,407.69 4,149.17 972.05 3,331.51 2,647.24 3,597.50 4,735.70 3,918.84 4,771.54 1,117.85 3,831.22 3,044.33\n\n92 3,151.65 4,224.95 3,498.50 4,212.73 990.02 3,384.51 2,694.38 3,624.41 4,858.69 4,023.28 4,844.65 1,138.52 3,892.19 3,098.52\n\n93 3,172.11 4,334.35 3,591.43 4,272.72 1,008.19 3,434.64 2,739.28 3,647.92 4,984.49 4,130.14 4,913.62 1,159.42 3,949.83 3,150.17\n\n94 3,192.67 4,446.24 3,686.49 4,333.24 1,026.57 3,485.23 2,784.60 3,671.58 5,113.18 4,239.47 4,983.20 1,180.55 4,008.00 3,202.29\n\n95 3,213.38 4,560.70 3,783.76 4,394.28 1,045.16 3,536.25 2,830.35 3,695.40 5,244.80 4,351.32 5,053.43 1,201.93 4,066.70 3,254.90\n\n96 3,245.53 4,629.11 3,840.51 4,438.24 1,052.47 3,571.63 2,858.64 3,732.33 5,323.47 4,416.59 5,103.95 1,210.34 4,107.37 3,287.44\n\n97 3,277.96 4,698.54 3,898.12 4,482.60 1,059.84 3,607.33 2,887.23 3,769.67 5,403.32 4,482.84 5,155.00 1,218.82 4,148.44 3,320.31\n\n98 3,310.75 4,769.02 3,956.59 4,527.42 1,067.26 3,643.41 2,916.11 3,807.36 5,484.38 4,550.08 5,206.54 1,227.35 4,189.91 3,353.51\n\n99 3,343.86 4,840.56 4,015.94 4,572.71 1,074.73 3,679.83 2,945.25 3,845.44 5,566.64 4,618.33 5,258.61 1,235.94 4,231.82 3,387.05\n\n**Zip Codes Area Factors**\n\n**770-777 1.20**\n\n**750-753, 760-761, 782, 784, 793-794 1.05**\n\n**754-759, 762-769, 778-781, 783, 785-792, 795-799, 885 0.88**\n\n**Applicants eligible for Household Discount will receive a 10% discount.**\n\n**Risk class increase in premium of 15% based on height/weight chart may apply**\n\n**Current Annual Rates**\n\n**TEXAS**\n\n**Female / Non-Tobacco Female / Tobacco**\n\n**Americo Financial Life and Annuity Insurance Company**\n\n**Individual Modernized Medicare Supplement**\n\n**Attained Age Premium Rates**","pages":[{"line_numbers":[],"markdown":"Exhibit 2\n\n**Attained**\n\n**Age Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N**\n\n0-64 7,638.06 8,783.80\n\n65 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n66 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n67 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n68 1,990.82 1,918.13 1,515.81 2,321.79 500.07 1,789.68 1,378.65 2,289.44 2,205.84 1,743.17 2,670.05 575.08 2,058.14 1,585.45\n\n69 2,070.70 1,952.42 1,550.16 2,412.72 516.19 1,867.55 1,436.22 2,381.30 2,245.29 1,782.68 2,774.61 593.62 2,147.67 1,651.67\n\n70 2,147.98 2,020.12 1,610.42 2,497.30 541.52 1,939.96 1,490.51 2,470.18 2,323.14 1,851.98 2,871.87 622.75 2,230.95 1,714.10\n\n71 2,212.23 2,085.40 1,668.52 2,579.02 560.74 2,009.95 1,545.05 2,544.07 2,398.21 1,918.80 2,965.87 644.85 2,311.44 1,776.79\n\n72 2,276.48 2,150.68 1,726.63 2,660.76 579.96 2,079.93 1,599.58 2,617.96 2,473.28 1,985.61 3,059.87 666.95 2,391.92 1,839.50\n\n73 2,340.73 2,222.61 1,790.08 2,742.49 600.98 2,149.91 1,654.09 2,691.85 2,555.99 2,058.60 3,153.86 691.12 2,472.40 1,902.21\n\n74 2,404.99 2,294.95 1,853.90 2,824.23 622.11 2,219.90 1,708.63 2,765.73 2,639.18 2,131.99 3,247.87 715.43 2,552.89 1,964.91\n\n75 2,470.46 2,386.58 1,933.39 2,907.41 646.58 2,291.02 1,764.03 2,841.05 2,744.57 2,223.40 3,343.52 743.57 2,634.69 2,028.64\n\n76 2,515.55 2,465.29 2,000.97 2,980.29 666.53 2,352.44 1,814.38 2,892.88 2,835.08 2,301.11 3,427.33 766.51 2,705.32 2,086.53\n\n77 2,561.02 2,545.63 2,069.97 3,053.81 686.76 2,414.41 1,865.20 2,945.16 2,927.48 2,380.46 3,511.89 789.77 2,776.56 2,144.97\n\n78 2,608.17 2,630.25 2,142.54 3,129.58 707.27 2,478.17 1,917.43 2,999.38 3,024.79 2,463.91 3,599.02 813.36 2,849.88 2,205.05\n\n79 2,655.75 2,719.41 2,218.92 3,206.07 728.07 2,542.55 1,970.17 3,054.11 3,127.33 2,551.76 3,686.97 837.28 2,923.93 2,265.70\n\n80 2,705.15 2,810.67 2,297.11 3,284.93 749.15 2,608.87 2,024.46 3,110.91 3,232.27 2,641.69 3,777.67 861.52 3,000.21 2,328.12\n\n81 2,744.72 2,923.53 2,393.07 3,363.66 770.69 2,675.06 2,081.40 3,156.43 3,362.05 2,752.03 3,868.21 886.30 3,076.32 2,393.60\n\n82 2,786.06 3,040.00 2,492.14 3,444.94 792.53 2,743.32 2,140.02 3,203.97 3,495.99 2,865.96 3,961.68 911.41 3,154.80 2,461.03\n\n83 2,827.85 3,157.09 2,591.87 3,527.14 814.68 2,812.34 2,199.32 3,252.01 3,630.65 2,980.64 4,056.19 936.88 3,234.20 2,529.22\n\n84 2,870.03 3,277.75 2,694.69 3,610.23 837.12 2,882.16 2,259.30 3,300.55 3,769.41 3,098.89 4,151.77 962.69 3,314.49 2,598.21\n\n85 2,912.66 3,402.08 2,800.68 3,694.28 859.02 2,952.76 2,319.98 3,349.57 3,912.40 3,220.78 4,248.42 987.87 3,395.68 2,667.96\n\n86 2,951.12 3,514.59 2,896.04 3,771.68 877.63 3,017.14 2,375.23 3,393.79 4,041.77 3,330.44 4,337.42 1,009.27 3,469.70 2,731.52\n\n87 2,990.04 3,630.31 2,994.16 3,850.16 896.46 3,082.42 2,431.31 3,438.56 4,174.86 3,443.29 4,427.68 1,030.93 3,544.78 2,796.01\n\n88 3,029.43 3,749.35 3,095.14 3,929.74 915.51 3,148.66 2,488.20 3,483.85 4,311.75 3,559.42 4,519.21 1,052.83 3,620.95 2,861.44\n\n89 3,067.76 3,871.78 3,199.04 4,008.47 934.78 3,214.22 2,544.67 3,527.94 4,452.55 3,678.89 4,609.75 1,075.00 3,696.34 2,926.35\n\n90 3,104.98 3,997.71 3,305.92 4,086.23 954.28 3,279.05 2,600.60 3,570.74 4,597.37 3,801.81 4,699.15 1,097.42 3,770.90 2,990.71\n\n91 3,128.24 4,117.99 3,407.69 4,149.17 972.05 3,331.51 2,647.24 3,597.50 4,735.70 3,918.84 4,771.54 1,117.85 3,831.22 3,044.33\n\n92 3,151.65 4,224.95 3,498.50 4,212.73 990.02 3,384.51 2,694.38 3,624.41 4,858.69 4,023.28 4,844.65 1,138.52 3,892.19 3,098.52\n\n93 3,172.11 4,334.35 3,591.43 4,272.72 1,008.19 3,434.64 2,739.28 3,647.92 4,984.49 4,130.14 4,913.62 1,159.42 3,949.83 3,150.17\n\n94 3,192.67 4,446.24 3,686.49 4,333.24 1,026.57 3,485.23 2,784.60 3,671.58 5,113.18 4,239.47 4,983.20 1,180.55 4,008.00 3,202.29\n\n95 3,213.38 4,560.70 3,783.76 4,394.28 1,045.16 3,536.25 2,830.35 3,695.40 5,244.80 4,351.32 5,053.43 1,201.93 4,066.70 3,254.90\n\n96 3,245.53 4,629.11 3,840.51 4,438.24 1,052.47 3,571.63 2,858.64 3,732.33 5,323.47 4,416.59 5,103.95 1,210.34 4,107.37 3,287.44\n\n97 3,277.96 4,698.54 3,898.12 4,482.60 1,059.84 3,607.33 2,887.23 3,769.67 5,403.32 4,482.84 5,155.00 1,218.82 4,148.44 3,320.31\n\n98 3,310.75 4,769.02 3,956.59 4,527.42 1,067.26 3,643.41 2,916.11 3,807.36 5,484.38 4,550.08 5,206.54 1,227.35 4,189.91 3,353.51\n\n99 3,343.86 4,840.56 4,015.94 4,572.71 1,074.73 3,679.83 2,945.25 3,845.44 5,566.64 4,618.33 5,258.61 1,235.94 4,231.82 3,387.05\n\n**Zip Codes Area Factors**\n\n**770-777 1.20**\n\n**750-753, 760-761, 782, 784, 793-794 1.05**\n\n**754-759, 762-769, 778-781, 783, 785-792, 795-799, 885 0.88**\n\n**Applicants eligible for Household Discount will receive a 10% discount.**\n\n**Risk class increase in premium of 15% based on height/weight chart may apply**\n\n**Current Annual Rates**\n\n**TEXAS**\n\n**Female / Non-Tobacco Female / Tobacco**\n\n**Americo Financial Life and Annuity Insurance Company**\n\n**Individual Modernized Medicare Supplement**\n\n**Attained Age Premium Rates**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 2\n\n**Attained**\n\n**Age Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N**\n\n0-64 7,638.06 8,783.80\n\n65 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n66 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n67 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n68 1,990.82 1,918.13 1,515.81 2,321.79 500.07 1,789.68 1,378.65 2,289.44 2,205.84 1,743.17 2,670.05 575.08 2,058.14 1,585.45\n\n69 2,070.70 1,952.42 1,550.16 2,412.72 516.19 1,867.55 1,436.22 2,381.30 2,245.29 1,782.68 2,774.61 593.62 2,147.67 1,651.67\n\n70 2,147.98 2,020.12 1,610.42 2,497.30 541.52 1,939.96 1,490.51 2,470.18 2,323.14 1,851.98 2,871.87 622.75 2,230.95 1,714.10\n\n71 2,212.23 2,085.40 1,668.52 2,579.02 560.74 2,009.95 1,545.05 2,544.07 2,398.21 1,918.80 2,965.87 644.85 2,311.44 1,776.79\n\n72 2,276.48 2,150.68 1,726.63 2,660.76 579.96 2,079.93 1,599.58 2,617.96 2,473.28 1,985.61 3,059.87 666.95 2,391.92 1,839.50\n\n73 2,340.73 2,222.61 1,790.08 2,742.49 600.98 2,149.91 1,654.09 2,691.85 2,555.99 2,058.60 3,153.86 691.12 2,472.40 1,902.21\n\n74 2,404.99 2,294.95 1,853.90 2,824.23 622.11 2,219.90 1,708.63 2,765.73 2,639.18 2,131.99 3,247.87 715.43 2,552.89 1,964.91\n\n75 2,470.46 2,386.58 1,933.39 2,907.41 646.58 2,291.02 1,764.03 2,841.05 2,744.57 2,223.40 3,343.52 743.57 2,634.69 2,028.64\n\n76 2,515.55 2,465.29 2,000.97 2,980.29 666.53 2,352.44 1,814.38 2,892.88 2,835.08 2,301.11 3,427.33 766.51 2,705.32 2,086.53\n\n77 2,561.02 2,545.63 2,069.97 3,053.81 686.76 2,414.41 1,865.20 2,945.16 2,927.48 2,380.46 3,511.89 789.77 2,776.56 2,144.97\n\n78 2,608.17 2,630.25 2,142.54 3,129.58 707.27 2,478.17 1,917.43 2,999.38 3,024.79 2,463.91 3,599.02 813.36 2,849.88 2,205.05\n\n79 2,655.75 2,719.41 2,218.92 3,206.07 728.07 2,542.55 1,970.17 3,054.11 3,127.33 2,551.76 3,686.97 837.28 2,923.93 2,265.70\n\n80 2,705.15 2,810.67 2,297.11 3,284.93 749.15 2,608.87 2,024.46 3,110.91 3,232.27 2,641.69 3,777.67 861.52 3,000.21 2,328.12\n\n81 2,744.72 2,923.53 2,393.07 3,363.66 770.69 2,675.06 2,081.40 3,156.43 3,362.05 2,752.03 3,868.21 886.30 3,076.32 2,393.60\n\n82 2,786.06 3,040.00 2,492.14 3,444.94 792.53 2,743.32 2,140.02 3,203.97 3,495.99 2,865.96 3,961.68 911.41 3,154.80 2,461.03\n\n83 2,827.85 3,157.09 2,591.87 3,527.14 814.68 2,812.34 2,199.32 3,252.01 3,630.65 2,980.64 4,056.19 936.88 3,234.20 2,529.22\n\n84 2,870.03 3,277.75 2,694.69 3,610.23 837.12 2,882.16 2,259.30 3,300.55 3,769.41 3,098.89 4,151.77 962.69 3,314.49 2,598.21\n\n85 2,912.66 3,402.08 2,800.68 3,694.28 859.02 2,952.76 2,319.98 3,349.57 3,912.40 3,220.78 4,248.42 987.87 3,395.68 2,667.96\n\n86 2,951.12 3,514.59 2,896.04 3,771.68 877.63 3,017.14 2,375.23 3,393.79 4,041.77 3,330.44 4,337.42 1,009.27 3,469.70 2,731.52\n\n87 2,990.04 3,630.31 2,994.16 3,850.16 896.46 3,082.42 2,431.31 3,438.56 4,174.86 3,443.29 4,427.68 1,030.93 3,544.78 2,796.01\n\n88 3,029.43 3,749.35 3,095.14 3,929.74 915.51 3,148.66 2,488.20 3,483.85 4,311.75 3,559.42 4,519.21 1,052.83 3,620.95 2,861.44\n\n89 3,067.76 3,871.78 3,199.04 4,008.47 934.78 3,214.22 2,544.67 3,527.94 4,452.55 3,678.89 4,609.75 1,075.00 3,696.34 2,926.35\n\n90 3,104.98 3,997.71 3,305.92 4,086.23 954.28 3,279.05 2,600.60 3,570.74 4,597.37 3,801.81 4,699.15 1,097.42 3,770.90 2,990.71\n\n91 3,128.24 4,117.99 3,407.69 4,149.17 972.05 3,331.51 2,647.24 3,597.50 4,735.70 3,918.84 4,771.54 1,117.85 3,831.22 3,044.33\n\n92 3,151.65 4,224.95 3,498.50 4,212.73 990.02 3,384.51 2,694.38 3,624.41 4,858.69 4,023.28 4,844.65 1,138.52 3,892.19 3,098.52\n\n93 3,172.11 4,334.35 3,591.43 4,272.72 1,008.19 3,434.64 2,739.28 3,647.92 4,984.49 4,130.14 4,913.62 1,159.42 3,949.83 3,150.17\n\n94 3,192.67 4,446.24 3,686.49 4,333.24 1,026.57 3,485.23 2,784.60 3,671.58 5,113.18 4,239.47 4,983.20 1,180.55 4,008.00 3,202.29\n\n95 3,213.38 4,560.70 3,783.76 4,394.28 1,045.16 3,536.25 2,830.35 3,695.40 5,244.80 4,351.32 5,053.43 1,201.93 4,066.70 3,254.90\n\n96 3,245.53 4,629.11 3,840.51 4,438.24 1,052.47 3,571.63 2,858.64 3,732.33 5,323.47 4,416.59 5,103.95 1,210.34 4,107.37 3,287.44\n\n97 3,277.96 4,698.54 3,898.12 4,482.60 1,059.84 3,607.33 2,887.23 3,769.67 5,403.32 4,482.84 5,155.00 1,218.82 4,148.44 3,320.31\n\n98 3,310.75 4,769.02 3,956.59 4,527.42 1,067.26 3,643.41 2,916.11 3,807.36 5,484.38 4,550.08 5,206.54 1,227.35 4,189.91 3,353.51\n\n99 3,343.86 4,840.56 4,015.94 4,572.71 1,074.73 3,679.83 2,945.25 3,845.44 5,566.64 4,618.33 5,258.61 1,235.94 4,231.82 3,387.05\n\n**Zip Codes Area Factors**\n\n**770-777 1.20**\n\n**750-753, 760-761, 782, 784, 793-794 1.05**\n\n**754-759, 762-769, 778-781, 783, 785-792, 795-799, 885 0.88**\n\n**Applicants eligible for Household Discount will receive a 10% discount.**\n\n**Risk class increase in premium of 15% based on height/weight chart may apply**\n\n**Current Annual Rates**\n\n**TEXAS**\n\n**Female / Non-Tobacco Female / Tobacco**\n\n**Americo Financial Life and Annuity Insurance Company**\n\n**Individual Modernized Medicare Supplement**\n\n**Attained Age Premium Rates**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page975.pdf"]},"response":{"errors":[],"extract_id":"extract_0b41a6ded0fe330d148806760aea2331","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 2\n\n**Attained**\n\n**Age Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N**\n\n0-64 7,638.06 8,783.80\n\n65 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n66 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n67 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n68 1,990.82 1,918.13 1,515.81 2,321.79 500.07 1,789.68 1,378.65 2,289.44 2,205.84 1,743.17 2,670.05 575.08 2,058.14 1,585.45\n\n69 2,070.70 1,952.42 1,550.16 2,412.72 516.19 1,867.55 1,436.22 2,381.30 2,245.29 1,782.68 2,774.61 593.62 2,147.67 1,651.67\n\n70 2,147.98 2,020.12 1,610.42 2,497.30 541.52 1,939.96 1,490.51 2,470.18 2,323.14 1,851.98 2,871.87 622.75 2,230.95 1,714.10\n\n71 2,212.23 2,085.40 1,668.52 2,579.02 560.74 2,009.95 1,545.05 2,544.07 2,398.21 1,918.80 2,965.87 644.85 2,311.44 1,776.79\n\n72 2,276.48 2,150.68 1,726.63 2,660.76 579.96 2,079.93 1,599.58 2,617.96 2,473.28 1,985.61 3,059.87 666.95 2,391.92 1,839.50\n\n73 2,340.73 2,222.61 1,790.08 2,742.49 600.98 2,149.91 1,654.09 2,691.85 2,555.99 2,058.60 3,153.86 691.12 2,472.40 1,902.21\n\n74 2,404.99 2,294.95 1,853.90 2,824.23 622.11 2,219.90 1,708.63 2,765.73 2,639.18 2,131.99 3,247.87 715.43 2,552.89 1,964.91\n\n75 2,470.46 2,386.58 1,933.39 2,907.41 646.58 2,291.02 1,764.03 2,841.05 2,744.57 2,223.40 3,343.52 743.57 2,634.69 2,028.64\n\n76 2,515.55 2,465.29 2,000.97 2,980.29 666.53 2,352.44 1,814.38 2,892.88 2,835.08 2,301.11 3,427.33 766.51 2,705.32 2,086.53\n\n77 2,561.02 2,545.63 2,069.97 3,053.81 686.76 2,414.41 1,865.20 2,945.16 2,927.48 2,380.46 3,511.89 789.77 2,776.56 2,144.97\n\n78 2,608.17 2,630.25 2,142.54 3,129.58 707.27 2,478.17 1,917.43 2,999.38 3,024.79 2,463.91 3,599.02 813.36 2,849.88 2,205.05\n\n79 2,655.75 2,719.41 2,218.92 3,206.07 728.07 2,542.55 1,970.17 3,054.11 3,127.33 2,551.76 3,686.97 837.28 2,923.93 2,265.70\n\n80 2,705.15 2,810.67 2,297.11 3,284.93 749.15 2,608.87 2,024.46 3,110.91 3,232.27 2,641.69 3,777.67 861.52 3,000.21 2,328.12\n\n81 2,744.72 2,923.53 2,393.07 3,363.66 770.69 2,675.06 2,081.40 3,156.43 3,362.05 2,752.03 3,868.21 886.30 3,076.32 2,393.60\n\n82 2,786.06 3,040.00 2,492.14 3,444.94 792.53 2,743.32 2,140.02 3,203.97 3,495.99 2,865.96 3,961.68 911.41 3,154.80 2,461.03\n\n83 2,827.85 3,157.09 2,591.87 3,527.14 814.68 2,812.34 2,199.32 3,252.01 3,630.65 2,980.64 4,056.19 936.88 3,234.20 2,529.22\n\n84 2,870.03 3,277.75 2,694.69 3,610.23 837.12 2,882.16 2,259.30 3,300.55 3,769.41 3,098.89 4,151.77 962.69 3,314.49 2,598.21\n\n85 2,912.66 3,402.08 2,800.68 3,694.28 859.02 2,952.76 2,319.98 3,349.57 3,912.40 3,220.78 4,248.42 987.87 3,395.68 2,667.96\n\n86 2,951.12 3,514.59 2,896.04 3,771.68 877.63 3,017.14 2,375.23 3,393.79 4,041.77 3,330.44 4,337.42 1,009.27 3,469.70 2,731.52\n\n87 2,990.04 3,630.31 2,994.16 3,850.16 896.46 3,082.42 2,431.31 3,438.56 4,174.86 3,443.29 4,427.68 1,030.93 3,544.78 2,796.01\n\n88 3,029.43 3,749.35 3,095.14 3,929.74 915.51 3,148.66 2,488.20 3,483.85 4,311.75 3,559.42 4,519.21 1,052.83 3,620.95 2,861.44\n\n89 3,067.76 3,871.78 3,199.04 4,008.47 934.78 3,214.22 2,544.67 3,527.94 4,452.55 3,678.89 4,609.75 1,075.00 3,696.34 2,926.35\n\n90 3,104.98 3,997.71 3,305.92 4,086.23 954.28 3,279.05 2,600.60 3,570.74 4,597.37 3,801.81 4,699.15 1,097.42 3,770.90 2,990.71\n\n91 3,128.24 4,117.99 3,407.69 4,149.17 972.05 3,331.51 2,647.24 3,597.50 4,735.70 3,918.84 4,771.54 1,117.85 3,831.22 3,044.33\n\n92 3,151.65 4,224.95 3,498.50 4,212.73 990.02 3,384.51 2,694.38 3,624.41 4,858.69 4,023.28 4,844.65 1,138.52 3,892.19 3,098.52\n\n93 3,172.11 4,334.35 3,591.43 4,272.72 1,008.19 3,434.64 2,739.28 3,647.92 4,984.49 4,130.14 4,913.62 1,159.42 3,949.83 3,150.17\n\n94 3,192.67 4,446.24 3,686.49 4,333.24 1,026.57 3,485.23 2,784.60 3,671.58 5,113.18 4,239.47 4,983.20 1,180.55 4,008.00 3,202.29\n\n95 3,213.38 4,560.70 3,783.76 4,394.28 1,045.16 3,536.25 2,830.35 3,695.40 5,244.80 4,351.32 5,053.43 1,201.93 4,066.70 3,254.90\n\n96 3,245.53 4,629.11 3,840.51 4,438.24 1,052.47 3,571.63 2,858.64 3,732.33 5,323.47 4,416.59 5,103.95 1,210.34 4,107.37 3,287.44\n\n97 3,277.96 4,698.54 3,898.12 4,482.60 1,059.84 3,607.33 2,887.23 3,769.67 5,403.32 4,482.84 5,155.00 1,218.82 4,148.44 3,320.31\n\n98 3,310.75 4,769.02 3,956.59 4,527.42 1,067.26 3,643.41 2,916.11 3,807.36 5,484.38 4,550.08 5,206.54 1,227.35 4,189.91 3,353.51\n\n99 3,343.86 4,840.56 4,015.94 4,572.71 1,074.73 3,679.83 2,945.25 3,845.44 5,566.64 4,618.33 5,258.61 1,235.94 4,231.82 3,387.05\n\n**Zip Codes Area Factors**\n\n**770-777 1.20**\n\n**750-753, 760-761, 782, 784, 793-794 1.05**\n\n**754-759, 762-769, 778-781, 783, 785-792, 795-799, 885 0.88**\n\n**Applicants eligible for Household Discount will receive a 10% discount.**\n\n**Risk class increase in premium of 15% based on height/weight chart may apply**\n\n**Current Annual Rates**\n\n**TEXAS**\n\n**Female / Non-Tobacco Female / Tobacco**\n\n**Americo Financial Life and Annuity Insurance Company**\n\n**Individual Modernized Medicare Supplement**\n\n**Attained Age Premium Rates**"],"full_content":"Exhibit 2\n\n**Attained**\n\n**Age Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N**\n\n0-64 7,638.06 8,783.80\n\n65 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n66 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n67 1,909.52 1,918.13 1,515.81 2,233.03 500.07 1,713.70 1,321.18 2,195.95 2,205.84 1,743.17 2,568.00 575.08 1,970.75 1,519.36\n\n68 1,990.82 1,918.13 1,515.81 2,321.79 500.07 1,789.68 1,378.65 2,289.44 2,205.84 1,743.17 2,670.05 575.08 2,058.14 1,585.45\n\n69 2,070.70 1,952.42 1,550.16 2,412.72 516.19 1,867.55 1,436.22 2,381.30 2,245.29 1,782.68 2,774.61 593.62 2,147.67 1,651.67\n\n70 2,147.98 2,020.12 1,610.42 2,497.30 541.52 1,939.96 1,490.51 2,470.18 2,323.14 1,851.98 2,871.87 622.75 2,230.95 1,714.10\n\n71 2,212.23 2,085.40 1,668.52 2,579.02 560.74 2,009.95 1,545.05 2,544.07 2,398.21 1,918.80 2,965.87 644.85 2,311.44 1,776.79\n\n72 2,276.48 2,150.68 1,726.63 2,660.76 579.96 2,079.93 1,599.58 2,617.96 2,473.28 1,985.61 3,059.87 666.95 2,391.92 1,839.50\n\n73 2,340.73 2,222.61 1,790.08 2,742.49 600.98 2,149.91 1,654.09 2,691.85 2,555.99 2,058.60 3,153.86 691.12 2,472.40 1,902.21\n\n74 2,404.99 2,294.95 1,853.90 2,824.23 622.11 2,219.90 1,708.63 2,765.73 2,639.18 2,131.99 3,247.87 715.43 2,552.89 1,964.91\n\n75 2,470.46 2,386.58 1,933.39 2,907.41 646.58 2,291.02 1,764.03 2,841.05 2,744.57 2,223.40 3,343.52 743.57 2,634.69 2,028.64\n\n76 2,515.55 2,465.29 2,000.97 2,980.29 666.53 2,352.44 1,814.38 2,892.88 2,835.08 2,301.11 3,427.33 766.51 2,705.32 2,086.53\n\n77 2,561.02 2,545.63 2,069.97 3,053.81 686.76 2,414.41 1,865.20 2,945.16 2,927.48 2,380.46 3,511.89 789.77 2,776.56 2,144.97\n\n78 2,608.17 2,630.25 2,142.54 3,129.58 707.27 2,478.17 1,917.43 2,999.38 3,024.79 2,463.91 3,599.02 813.36 2,849.88 2,205.05\n\n79 2,655.75 2,719.41 2,218.92 3,206.07 728.07 2,542.55 1,970.17 3,054.11 3,127.33 2,551.76 3,686.97 837.28 2,923.93 2,265.70\n\n80 2,705.15 2,810.67 2,297.11 3,284.93 749.15 2,608.87 2,024.46 3,110.91 3,232.27 2,641.69 3,777.67 861.52 3,000.21 2,328.12\n\n81 2,744.72 2,923.53 2,393.07 3,363.66 770.69 2,675.06 2,081.40 3,156.43 3,362.05 2,752.03 3,868.21 886.30 3,076.32 2,393.60\n\n82 2,786.06 3,040.00 2,492.14 3,444.94 792.53 2,743.32 2,140.02 3,203.97 3,495.99 2,865.96 3,961.68 911.41 3,154.80 2,461.03\n\n83 2,827.85 3,157.09 2,591.87 3,527.14 814.68 2,812.34 2,199.32 3,252.01 3,630.65 2,980.64 4,056.19 936.88 3,234.20 2,529.22\n\n84 2,870.03 3,277.75 2,694.69 3,610.23 837.12 2,882.16 2,259.30 3,300.55 3,769.41 3,098.89 4,151.77 962.69 3,314.49 2,598.21\n\n85 2,912.66 3,402.08 2,800.68 3,694.28 859.02 2,952.76 2,319.98 3,349.57 3,912.40 3,220.78 4,248.42 987.87 3,395.68 2,667.96\n\n86 2,951.12 3,514.59 2,896.04 3,771.68 877.63 3,017.14 2,375.23 3,393.79 4,041.77 3,330.44 4,337.42 1,009.27 3,469.70 2,731.52\n\n87 2,990.04 3,630.31 2,994.16 3,850.16 896.46 3,082.42 2,431.31 3,438.56 4,174.86 3,443.29 4,427.68 1,030.93 3,544.78 2,796.01\n\n88 3,029.43 3,749.35 3,095.14 3,929.74 915.51 3,148.66 2,488.20 3,483.85 4,311.75 3,559.42 4,519.21 1,052.83 3,620.95 2,861.44\n\n89 3,067.76 3,871.78 3,199.04 4,008.47 934.78 3,214.22 2,544.67 3,527.94 4,452.55 3,678.89 4,609.75 1,075.00 3,696.34 2,926.35\n\n90 3,104.98 3,997.71 3,305.92 4,086.23 954.28 3,279.05 2,600.60 3,570.74 4,597.37 3,801.81 4,699.15 1,097.42 3,770.90 2,990.71\n\n91 3,128.24 4,117.99 3,407.69 4,149.17 972.05 3,331.51 2,647.24 3,597.50 4,735.70 3,918.84 4,771.54 1,117.85 3,831.22 3,044.33\n\n92 3,151.65 4,224.95 3,498.50 4,212.73 990.02 3,384.51 2,694.38 3,624.41 4,858.69 4,023.28 4,844.65 1,138.52 3,892.19 3,098.52\n\n93 3,172.11 4,334.35 3,591.43 4,272.72 1,008.19 3,434.64 2,739.28 3,647.92 4,984.49 4,130.14 4,913.62 1,159.42 3,949.83 3,150.17\n\n94 3,192.67 4,446.24 3,686.49 4,333.24 1,026.57 3,485.23 2,784.60 3,671.58 5,113.18 4,239.47 4,983.20 1,180.55 4,008.00 3,202.29\n\n95 3,213.38 4,560.70 3,783.76 4,394.28 1,045.16 3,536.25 2,830.35 3,695.40 5,244.80 4,351.32 5,053.43 1,201.93 4,066.70 3,254.90\n\n96 3,245.53 4,629.11 3,840.51 4,438.24 1,052.47 3,571.63 2,858.64 3,732.33 5,323.47 4,416.59 5,103.95 1,210.34 4,107.37 3,287.44\n\n97 3,277.96 4,698.54 3,898.12 4,482.60 1,059.84 3,607.33 2,887.23 3,769.67 5,403.32 4,482.84 5,155.00 1,218.82 4,148.44 3,320.31\n\n98 3,310.75 4,769.02 3,956.59 4,527.42 1,067.26 3,643.41 2,916.11 3,807.36 5,484.38 4,550.08 5,206.54 1,227.35 4,189.91 3,353.51\n\n99 3,343.86 4,840.56 4,015.94 4,572.71 1,074.73 3,679.83 2,945.25 3,845.44 5,566.64 4,618.33 5,258.61 1,235.94 4,231.82 3,387.05\n\n**Zip Codes Area Factors**\n\n**770-777 1.20**\n\n**750-753, 760-761, 782, 784, 793-794 1.05**\n\n**754-759, 762-769, 778-781, 783, 785-792, 795-799, 885 0.88**\n\n**Applicants eligible for Household Discount will receive a 10% discount.**\n\n**Risk class increase in premium of 15% based on height/weight chart may apply**\n\n**Current Annual Rates**\n\n**TEXAS**\n\n**Female / Non-Tobacco Female / Tobacco**\n\n**Americo Financial Life and Annuity Insurance Company**\n\n**Individual Modernized Medicare Supplement**\n\n**Attained Age Premium Rates**","publish_date":null,"title":"Americo Financial Life and Annuity Insurance Company Individual Modernized Medicare Supplement","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page975.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page975.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page975","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page975.pdf"},"started_at":"2026-11-04T19:47:48.529548"} +{"completed_at":"2026-11-04T19:47:51.389613","latency_in_ms":1773,"output":{"example_id":"table/SERFF_TX_random_pages 1_page985","grounded_pages":[],"layout_pages":[],"markdown":"**Year Approval Date Effective Date Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N**\n\n2016 7/20/2016 8/22/2016 0.0% 0.0% 0.0% 0.0% 0.0% -5.0% 0.0%\n\n2017 5/18/2017 7/1/2017 8.0% 0.0% 0.0% 0.0% 0.0% 0.0% -5.0%\n\n2018 4/5/2018 7/1/2018 6.9% 0.0% 0.0% 6.9% 0.0% 4.6% 2.9%\n\n2019 3/11/2019 7/1/2019 9.0% 0.0% 0.0% 9.0% 0.0% 9.0% 6.0%\n\n2020 5/14/2020 7/1/2020 10.0% 14.5% 14.5% 12.0% 0.0% 11.7% 9.5%\n\n## **AMERICO FINANCIAL LIFE AND ANNUITY INSURANCE COMPANY**\n\n### **Exhibit 3: Texas Rate Increase History**","pages":[{"line_numbers":[],"markdown":"**Year Approval Date Effective Date Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N**\n\n2016 7/20/2016 8/22/2016 0.0% 0.0% 0.0% 0.0% 0.0% -5.0% 0.0%\n\n2017 5/18/2017 7/1/2017 8.0% 0.0% 0.0% 0.0% 0.0% 0.0% -5.0%\n\n2018 4/5/2018 7/1/2018 6.9% 0.0% 0.0% 6.9% 0.0% 4.6% 2.9%\n\n2019 3/11/2019 7/1/2019 9.0% 0.0% 0.0% 9.0% 0.0% 9.0% 6.0%\n\n2020 5/14/2020 7/1/2020 10.0% 14.5% 14.5% 12.0% 0.0% 11.7% 9.5%\n\n## **AMERICO FINANCIAL LIFE AND ANNUITY INSURANCE COMPANY**\n\n### **Exhibit 3: Texas Rate Increase History**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Year Approval Date Effective Date Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N**\n\n2016 7/20/2016 8/22/2016 0.0% 0.0% 0.0% 0.0% 0.0% -5.0% 0.0%\n\n2017 5/18/2017 7/1/2017 8.0% 0.0% 0.0% 0.0% 0.0% 0.0% -5.0%\n\n2018 4/5/2018 7/1/2018 6.9% 0.0% 0.0% 6.9% 0.0% 4.6% 2.9%\n\n2019 3/11/2019 7/1/2019 9.0% 0.0% 0.0% 9.0% 0.0% 9.0% 6.0%\n\n2020 5/14/2020 7/1/2020 10.0% 14.5% 14.5% 12.0% 0.0% 11.7% 9.5%\n\n## **AMERICO FINANCIAL LIFE AND ANNUITY INSURANCE COMPANY**\n\n### **Exhibit 3: Texas Rate Increase History**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page985.pdf"]},"response":{"errors":[],"extract_id":"extract_53aa4465bc3b4d3e8fc5dca8340b1a28","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Year Approval Date Effective Date Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N**\n\n2016 7/20/2016 8/22/2016 0.0% 0.0% 0.0% 0.0% 0.0% -5.0% 0.0%\n\n2017 5/18/2017 7/1/2017 8.0% 0.0% 0.0% 0.0% 0.0% 0.0% -5.0%\n\n2018 4/5/2018 7/1/2018 6.9% 0.0% 0.0% 6.9% 0.0% 4.6% 2.9%\n\n2019 3/11/2019 7/1/2019 9.0% 0.0% 0.0% 9.0% 0.0% 9.0% 6.0%\n\n2020 5/14/2020 7/1/2020 10.0% 14.5% 14.5% 12.0% 0.0% 11.7% 9.5%\n\n## **AMERICO FINANCIAL LIFE AND ANNUITY INSURANCE COMPANY**\n\n### **Exhibit 3: Texas Rate Increase History**"],"full_content":"**Year Approval Date Effective Date Plan A Plan C Plan D Plan F Plan HDF Plan G Plan N**\n\n2016 7/20/2016 8/22/2016 0.0% 0.0% 0.0% 0.0% 0.0% -5.0% 0.0%\n\n2017 5/18/2017 7/1/2017 8.0% 0.0% 0.0% 0.0% 0.0% 0.0% -5.0%\n\n2018 4/5/2018 7/1/2018 6.9% 0.0% 0.0% 6.9% 0.0% 4.6% 2.9%\n\n2019 3/11/2019 7/1/2019 9.0% 0.0% 0.0% 9.0% 0.0% 9.0% 6.0%\n\n2020 5/14/2020 7/1/2020 10.0% 14.5% 14.5% 12.0% 0.0% 11.7% 9.5%\n\n## **AMERICO FINANCIAL LIFE AND ANNUITY INSURANCE COMPANY**\n\n### **Exhibit 3: Texas Rate Increase History**","publish_date":null,"title":"AMERICO FINANCIAL LIFE AND ANNUITY INSURANCE COMPANY","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page985.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page985.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page985","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page985.pdf"},"started_at":"2026-11-04T19:47:49.616237"} +{"completed_at":"2026-11-04T19:47:52.550694","latency_in_ms":2135,"output":{"example_id":"table/SERFF_TX_random_pages 1_page993","grounded_pages":[],"layout_pages":[],"markdown":"Americo Financial Life and Annuity Insurance Company MS08I Individual Medicare Supplement - Standard Plans 2010 SERFF Tracking #: IASL-132741063 Texas Objection Dated 4/1/2020 Dear Kevin Lopez, Thank you for your continued attention to our rate filing. **Objection 1 We will approve up to a 10% rate increase for plan A (aged), a 14% rate increase for plan A (disabled), a 9.3% rate increase for plan F, a 10.1% rate increase for plan G, and an 8.1% rate increase for plan N. Please revise the rate sheets. Also, update the Percent Rate Change Request and any applicable Company Rate Information on the Rate/Rule Schedule tab.** Response: The Company is willing to amend the Plan A increases as offered by the state. It is our understanding that the Department calculates approvable amounts by taking a weighted average of the amounts already approved and trend for states which are pending. However, the Company anticipates receiving the full amount of requested increase in pending states, based on the states that have already approved. Plan F is currently approved at 100.7% of requested, Plan G is currently approved at 98.7% of requested, and Plan N is currently approved at 95.3% of requested. Instead of weighting pending states by trend, pending states have been weighted using the average of the expected increases in pending states weighted by annualized premium. Based on this, the Company proposes a more moderate adjustment to the requested rate increase amounts, as shown below. By this calculation, Plan F actually justifies a little more than 12.0%; however, the Company would like to keep that proposed increase at 12.0%. Please see the updated Exhibit 5 for this calculation. Updated actuarial materials are included with this response.\n\nPlan A Plan F Plan G Plan N\n\n10%/14% (as offered)\n\n12\\.0%\n\n(as proposed) 11.3% 8.8%\n\nIf you have further questions that can help your review, I can be contacted at jstrock@csgactuarial.com or at 855-861- 8776 x1016. Sincerely,\n\nJared Strock FSA, MAAA Consulting Actuary CSG Consulting, LLC","pages":[{"line_numbers":[],"markdown":"Americo Financial Life and Annuity Insurance Company MS08I Individual Medicare Supplement - Standard Plans 2010 SERFF Tracking #: IASL-132741063 Texas Objection Dated 4/1/2020 Dear Kevin Lopez, Thank you for your continued attention to our rate filing. **Objection 1 We will approve up to a 10% rate increase for plan A (aged), a 14% rate increase for plan A (disabled), a 9.3% rate increase for plan F, a 10.1% rate increase for plan G, and an 8.1% rate increase for plan N. Please revise the rate sheets. Also, update the Percent Rate Change Request and any applicable Company Rate Information on the Rate/Rule Schedule tab.** Response: The Company is willing to amend the Plan A increases as offered by the state. It is our understanding that the Department calculates approvable amounts by taking a weighted average of the amounts already approved and trend for states which are pending. However, the Company anticipates receiving the full amount of requested increase in pending states, based on the states that have already approved. Plan F is currently approved at 100.7% of requested, Plan G is currently approved at 98.7% of requested, and Plan N is currently approved at 95.3% of requested. Instead of weighting pending states by trend, pending states have been weighted using the average of the expected increases in pending states weighted by annualized premium. Based on this, the Company proposes a more moderate adjustment to the requested rate increase amounts, as shown below. By this calculation, Plan F actually justifies a little more than 12.0%; however, the Company would like to keep that proposed increase at 12.0%. Please see the updated Exhibit 5 for this calculation. Updated actuarial materials are included with this response.\n\nPlan A Plan F Plan G Plan N\n\n10%/14% (as offered)\n\n12\\.0%\n\n(as proposed) 11.3% 8.8%\n\nIf you have further questions that can help your review, I can be contacted at jstrock@csgactuarial.com or at 855-861- 8776 x1016. Sincerely,\n\nJared Strock FSA, MAAA Consulting Actuary CSG Consulting, LLC","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Americo Financial Life and Annuity Insurance Company MS08I Individual Medicare Supplement - Standard Plans 2010 SERFF Tracking #: IASL-132741063 Texas Objection Dated 4/1/2020 Dear Kevin Lopez, Thank you for your continued attention to our rate filing. **Objection 1 We will approve up to a 10% rate increase for plan A (aged), a 14% rate increase for plan A (disabled), a 9.3% rate increase for plan F, a 10.1% rate increase for plan G, and an 8.1% rate increase for plan N. Please revise the rate sheets. Also, update the Percent Rate Change Request and any applicable Company Rate Information on the Rate/Rule Schedule tab.** Response: The Company is willing to amend the Plan A increases as offered by the state. It is our understanding that the Department calculates approvable amounts by taking a weighted average of the amounts already approved and trend for states which are pending. However, the Company anticipates receiving the full amount of requested increase in pending states, based on the states that have already approved. Plan F is currently approved at 100.7% of requested, Plan G is currently approved at 98.7% of requested, and Plan N is currently approved at 95.3% of requested. Instead of weighting pending states by trend, pending states have been weighted using the average of the expected increases in pending states weighted by annualized premium. Based on this, the Company proposes a more moderate adjustment to the requested rate increase amounts, as shown below. By this calculation, Plan F actually justifies a little more than 12.0%; however, the Company would like to keep that proposed increase at 12.0%. Please see the updated Exhibit 5 for this calculation. Updated actuarial materials are included with this response.\n\nPlan A Plan F Plan G Plan N\n\n10%/14% (as offered)\n\n12\\.0%\n\n(as proposed) 11.3% 8.8%\n\nIf you have further questions that can help your review, I can be contacted at jstrock@csgactuarial.com or at 855-861- 8776 x1016. Sincerely,\n\nJared Strock FSA, MAAA Consulting Actuary CSG Consulting, LLC","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page993.pdf"]},"response":{"errors":[],"extract_id":"extract_41e3388ccb12c81c426585dbccdff295","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Americo Financial Life and Annuity Insurance Company MS08I Individual Medicare Supplement - Standard Plans 2010 SERFF Tracking #: IASL-132741063 Texas Objection Dated 4/1/2020 Dear Kevin Lopez, Thank you for your continued attention to our rate filing. **Objection 1 We will approve up to a 10% rate increase for plan A (aged), a 14% rate increase for plan A (disabled), a 9.3% rate increase for plan F, a 10.1% rate increase for plan G, and an 8.1% rate increase for plan N. Please revise the rate sheets. Also, update the Percent Rate Change Request and any applicable Company Rate Information on the Rate/Rule Schedule tab.** Response: The Company is willing to amend the Plan A increases as offered by the state. It is our understanding that the Department calculates approvable amounts by taking a weighted average of the amounts already approved and trend for states which are pending. However, the Company anticipates receiving the full amount of requested increase in pending states, based on the states that have already approved. Plan F is currently approved at 100.7% of requested, Plan G is currently approved at 98.7% of requested, and Plan N is currently approved at 95.3% of requested. Instead of weighting pending states by trend, pending states have been weighted using the average of the expected increases in pending states weighted by annualized premium. Based on this, the Company proposes a more moderate adjustment to the requested rate increase amounts, as shown below. By this calculation, Plan F actually justifies a little more than 12.0%; however, the Company would like to keep that proposed increase at 12.0%. Please see the updated Exhibit 5 for this calculation. Updated actuarial materials are included with this response.\n\nPlan A Plan F Plan G Plan N\n\n10%/14% (as offered)\n\n12\\.0%\n\n(as proposed) 11.3% 8.8%\n\nIf you have further questions that can help your review, I can be contacted at jstrock@csgactuarial.com or at 855-861- 8776 x1016. Sincerely,\n\nJared Strock FSA, MAAA Consulting Actuary CSG Consulting, LLC"],"full_content":"Americo Financial Life and Annuity Insurance Company MS08I Individual Medicare Supplement - Standard Plans 2010 SERFF Tracking #: IASL-132741063 Texas Objection Dated 4/1/2020 Dear Kevin Lopez, Thank you for your continued attention to our rate filing. **Objection 1 We will approve up to a 10% rate increase for plan A (aged), a 14% rate increase for plan A (disabled), a 9.3% rate increase for plan F, a 10.1% rate increase for plan G, and an 8.1% rate increase for plan N. Please revise the rate sheets. Also, update the Percent Rate Change Request and any applicable Company Rate Information on the Rate/Rule Schedule tab.** Response: The Company is willing to amend the Plan A increases as offered by the state. It is our understanding that the Department calculates approvable amounts by taking a weighted average of the amounts already approved and trend for states which are pending. However, the Company anticipates receiving the full amount of requested increase in pending states, based on the states that have already approved. Plan F is currently approved at 100.7% of requested, Plan G is currently approved at 98.7% of requested, and Plan N is currently approved at 95.3% of requested. Instead of weighting pending states by trend, pending states have been weighted using the average of the expected increases in pending states weighted by annualized premium. Based on this, the Company proposes a more moderate adjustment to the requested rate increase amounts, as shown below. By this calculation, Plan F actually justifies a little more than 12.0%; however, the Company would like to keep that proposed increase at 12.0%. Please see the updated Exhibit 5 for this calculation. Updated actuarial materials are included with this response.\n\nPlan A Plan F Plan G Plan N\n\n10%/14% (as offered)\n\n12\\.0%\n\n(as proposed) 11.3% 8.8%\n\nIf you have further questions that can help your review, I can be contacted at jstrock@csgactuarial.com or at 855-861- 8776 x1016. Sincerely,\n\nJared Strock FSA, MAAA Consulting Actuary CSG Consulting, LLC","publish_date":null,"title":"Americo Financial Life and Annuity Insurance Company MS08I Individual Medicare Supplement - Standard Plans 2010 SERFF Tracking #: IASL-132741063 Texas","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page993.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SERFF_TX_random_pages%201_page993.pdf"},"request":{"example_id":"table/SERFF_TX_random_pages 1_page993","product_type":"parse","source_file_path":"SERFF_TX_random_pages 1_page993.pdf"},"started_at":"2026-11-04T19:47:50.414837"} +{"completed_at":"2026-11-04T19:47:52.819371","latency_in_ms":1085,"output":{"example_id":"table/SYK.2010.page_26.pdf_136878_page1","grounded_pages":[],"layout_pages":[],"markdown":"The tables below set forth additional geographical sales growth information for significant products within the Company’s Orthopaedic Implants and MedSurg Equipment segments on both a reported basis and a constant currency basis:\n\n**Year Ended December 31, 2010**\n\n**Percentage Change**\n\n**Domestic International Total**\n\n**Reported Reported**\n\n**Constant Currency Reported**\n\n**Constant Currency**\n\nOrthopaedic Implants sales: Hips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 5 1 5 3 Knees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 1 (2) 4 3 Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 5 5 8 7 Spine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1) 8 6 2 1 Total Orthopaedic Implants . . . . . . . . . . . . . . . . . . . . . . . . 5 4 1 5 3\n\nMedSurg Equipment sales: Surgical equipment and surgical navigation systems . . . . . 9 5 3 8 8 Endoscopic and communications systems . . . . . . . . . . . . . 6 9 7 7 6 Patient handling and emergency medical equipment . . . . . 24 5 0 20 18 Total MedSurg Equipment . . . . . . . . . . . . . . . . . . . . . . . . . 19 7 4 16 15\n\n**Year Ended December 31, 2009**\n\n**Percentage Change**\n\n**Domestic International Total**\n\n**Reported Reported**\n\n**Constant Currency Reported**\n\n**Constant Currency**\n\nOrthopaedic Implants sales: Hips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 (2) 4 2 5 Knees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 (5) 0 4 6 Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2 4 5 6 Spine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 9 12 10 11 Total Orthopaedic Implants . . . . . . . . . . . . . . . . . . . . . . . . 7 (1) 3 4 6\n\nMedSurg Equipment sales: Surgical equipment and surgical navigation systems . . . . . 2 (2) 3 1 2 Endoscopic, communications and digital imaging systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (5) 6 11 (2) (1) Patient handling and emergency medical equipment . . . . . (23) (17) (12) (22) (20) Total MedSurg Equipment . . . . . . . . . . . . . . . . . . . . . . . . . (7) (2) 3 (5) (4)\n\n_2010 Compared to 2009_\n\nThe Company’s net sales increased 9% to $7,320.0 million in 2010 from $6,723.1 million in 2009. Net sales grew by 7% as a result of increased unit volume and changes in product mix, 1% due to the favorable impact of foreign currency exchange rates on net sales and 3% due to acquisitions, which were partially offset by an unfavorable impact of 2% due to changes in price.\n\nThe Company’s domestic sales were $4,792.8 million for 2010, representing an increase of 11%, as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment. International sales were $2,527.2 million for 2010, representing an increase of 5%. The impact of foreign currency exchange rate movements to the dollar value of international sales was favorable by $69.7 million for 2010. On a constant currency basis, international sales increased 2% in 2010 as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment.\n\n23","pages":[{"line_numbers":[],"markdown":"The tables below set forth additional geographical sales growth information for significant products within the Company’s Orthopaedic Implants and MedSurg Equipment segments on both a reported basis and a constant currency basis:\n\n**Year Ended December 31, 2010**\n\n**Percentage Change**\n\n**Domestic International Total**\n\n**Reported Reported**\n\n**Constant Currency Reported**\n\n**Constant Currency**\n\nOrthopaedic Implants sales: Hips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 5 1 5 3 Knees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 1 (2) 4 3 Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 5 5 8 7 Spine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1) 8 6 2 1 Total Orthopaedic Implants . . . . . . . . . . . . . . . . . . . . . . . . 5 4 1 5 3\n\nMedSurg Equipment sales: Surgical equipment and surgical navigation systems . . . . . 9 5 3 8 8 Endoscopic and communications systems . . . . . . . . . . . . . 6 9 7 7 6 Patient handling and emergency medical equipment . . . . . 24 5 0 20 18 Total MedSurg Equipment . . . . . . . . . . . . . . . . . . . . . . . . . 19 7 4 16 15\n\n**Year Ended December 31, 2009**\n\n**Percentage Change**\n\n**Domestic International Total**\n\n**Reported Reported**\n\n**Constant Currency Reported**\n\n**Constant Currency**\n\nOrthopaedic Implants sales: Hips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 (2) 4 2 5 Knees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 (5) 0 4 6 Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2 4 5 6 Spine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 9 12 10 11 Total Orthopaedic Implants . . . . . . . . . . . . . . . . . . . . . . . . 7 (1) 3 4 6\n\nMedSurg Equipment sales: Surgical equipment and surgical navigation systems . . . . . 2 (2) 3 1 2 Endoscopic, communications and digital imaging systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (5) 6 11 (2) (1) Patient handling and emergency medical equipment . . . . . (23) (17) (12) (22) (20) Total MedSurg Equipment . . . . . . . . . . . . . . . . . . . . . . . . . (7) (2) 3 (5) (4)\n\n_2010 Compared to 2009_\n\nThe Company’s net sales increased 9% to $7,320.0 million in 2010 from $6,723.1 million in 2009. Net sales grew by 7% as a result of increased unit volume and changes in product mix, 1% due to the favorable impact of foreign currency exchange rates on net sales and 3% due to acquisitions, which were partially offset by an unfavorable impact of 2% due to changes in price.\n\nThe Company’s domestic sales were $4,792.8 million for 2010, representing an increase of 11%, as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment. International sales were $2,527.2 million for 2010, representing an increase of 5%. The impact of foreign currency exchange rate movements to the dollar value of international sales was favorable by $69.7 million for 2010. On a constant currency basis, international sales increased 2% in 2010 as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment.\n\n23","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"The tables below set forth additional geographical sales growth information for significant products within the Company’s Orthopaedic Implants and MedSurg Equipment segments on both a reported basis and a constant currency basis:\n\n**Year Ended December 31, 2010**\n\n**Percentage Change**\n\n**Domestic International Total**\n\n**Reported Reported**\n\n**Constant Currency Reported**\n\n**Constant Currency**\n\nOrthopaedic Implants sales: Hips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 5 1 5 3 Knees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 1 (2) 4 3 Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 5 5 8 7 Spine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1) 8 6 2 1 Total Orthopaedic Implants . . . . . . . . . . . . . . . . . . . . . . . . 5 4 1 5 3\n\nMedSurg Equipment sales: Surgical equipment and surgical navigation systems . . . . . 9 5 3 8 8 Endoscopic and communications systems . . . . . . . . . . . . . 6 9 7 7 6 Patient handling and emergency medical equipment . . . . . 24 5 0 20 18 Total MedSurg Equipment . . . . . . . . . . . . . . . . . . . . . . . . . 19 7 4 16 15\n\n**Year Ended December 31, 2009**\n\n**Percentage Change**\n\n**Domestic International Total**\n\n**Reported Reported**\n\n**Constant Currency Reported**\n\n**Constant Currency**\n\nOrthopaedic Implants sales: Hips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 (2) 4 2 5 Knees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 (5) 0 4 6 Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2 4 5 6 Spine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 9 12 10 11 Total Orthopaedic Implants . . . . . . . . . . . . . . . . . . . . . . . . 7 (1) 3 4 6\n\nMedSurg Equipment sales: Surgical equipment and surgical navigation systems . . . . . 2 (2) 3 1 2 Endoscopic, communications and digital imaging systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (5) 6 11 (2) (1) Patient handling and emergency medical equipment . . . . . (23) (17) (12) (22) (20) Total MedSurg Equipment . . . . . . . . . . . . . . . . . . . . . . . . . (7) (2) 3 (5) (4)\n\n_2010 Compared to 2009_\n\nThe Company’s net sales increased 9% to $7,320.0 million in 2010 from $6,723.1 million in 2009. Net sales grew by 7% as a result of increased unit volume and changes in product mix, 1% due to the favorable impact of foreign currency exchange rates on net sales and 3% due to acquisitions, which were partially offset by an unfavorable impact of 2% due to changes in price.\n\nThe Company’s domestic sales were $4,792.8 million for 2010, representing an increase of 11%, as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment. International sales were $2,527.2 million for 2010, representing an increase of 5%. The impact of foreign currency exchange rate movements to the dollar value of international sales was favorable by $69.7 million for 2010. On a constant currency basis, international sales increased 2% in 2010 as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment.\n\n23","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SYK.2010.page_26.pdf_136878_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_9cf134bca20ae5200c36419b2eba2e69","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["The tables below set forth additional geographical sales growth information for significant products within the Company’s Orthopaedic Implants and MedSurg Equipment segments on both a reported basis and a constant currency basis:\n\n**Year Ended December 31, 2010**\n\n**Percentage Change**\n\n**Domestic International Total**\n\n**Reported Reported**\n\n**Constant Currency Reported**\n\n**Constant Currency**\n\nOrthopaedic Implants sales: Hips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 5 1 5 3 Knees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 1 (2) 4 3 Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 5 5 8 7 Spine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1) 8 6 2 1 Total Orthopaedic Implants . . . . . . . . . . . . . . . . . . . . . . . . 5 4 1 5 3\n\nMedSurg Equipment sales: Surgical equipment and surgical navigation systems . . . . . 9 5 3 8 8 Endoscopic and communications systems . . . . . . . . . . . . . 6 9 7 7 6 Patient handling and emergency medical equipment . . . . . 24 5 0 20 18 Total MedSurg Equipment . . . . . . . . . . . . . . . . . . . . . . . . . 19 7 4 16 15\n\n**Year Ended December 31, 2009**\n\n**Percentage Change**\n\n**Domestic International Total**\n\n**Reported Reported**\n\n**Constant Currency Reported**\n\n**Constant Currency**\n\nOrthopaedic Implants sales: Hips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 (2) 4 2 5 Knees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 (5) 0 4 6 Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2 4 5 6 Spine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 9 12 10 11 Total Orthopaedic Implants . . . . . . . . . . . . . . . . . . . . . . . . 7 (1) 3 4 6\n\nMedSurg Equipment sales: Surgical equipment and surgical navigation systems . . . . . 2 (2) 3 1 2 Endoscopic, communications and digital imaging systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (5) 6 11 (2) (1) Patient handling and emergency medical equipment . . . . . (23) (17) (12) (22) (20) Total MedSurg Equipment . . . . . . . . . . . . . . . . . . . . . . . . . (7) (2) 3 (5) (4)\n\n_2010 Compared to 2009_\n\nThe Company’s net sales increased 9% to $7,320.0 million in 2010 from $6,723.1 million in 2009. Net sales grew by 7% as a result of increased unit volume and changes in product mix, 1% due to the favorable impact of foreign currency exchange rates on net sales and 3% due to acquisitions, which were partially offset by an unfavorable impact of 2% due to changes in price.\n\nThe Company’s domestic sales were $4,792.8 million for 2010, representing an increase of 11%, as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment. International sales were $2,527.2 million for 2010, representing an increase of 5%. The impact of foreign currency exchange rate movements to the dollar value of international sales was favorable by $69.7 million for 2010. On a constant currency basis, international sales increased 2% in 2010 as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment.\n\n23"],"full_content":"The tables below set forth additional geographical sales growth information for significant products within the Company’s Orthopaedic Implants and MedSurg Equipment segments on both a reported basis and a constant currency basis:\n\n**Year Ended December 31, 2010**\n\n**Percentage Change**\n\n**Domestic International Total**\n\n**Reported Reported**\n\n**Constant Currency Reported**\n\n**Constant Currency**\n\nOrthopaedic Implants sales: Hips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 5 1 5 3 Knees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 1 (2) 4 3 Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 5 5 8 7 Spine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1) 8 6 2 1 Total Orthopaedic Implants . . . . . . . . . . . . . . . . . . . . . . . . 5 4 1 5 3\n\nMedSurg Equipment sales: Surgical equipment and surgical navigation systems . . . . . 9 5 3 8 8 Endoscopic and communications systems . . . . . . . . . . . . . 6 9 7 7 6 Patient handling and emergency medical equipment . . . . . 24 5 0 20 18 Total MedSurg Equipment . . . . . . . . . . . . . . . . . . . . . . . . . 19 7 4 16 15\n\n**Year Ended December 31, 2009**\n\n**Percentage Change**\n\n**Domestic International Total**\n\n**Reported Reported**\n\n**Constant Currency Reported**\n\n**Constant Currency**\n\nOrthopaedic Implants sales: Hips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 (2) 4 2 5 Knees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 (5) 0 4 6 Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2 4 5 6 Spine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 9 12 10 11 Total Orthopaedic Implants . . . . . . . . . . . . . . . . . . . . . . . . 7 (1) 3 4 6\n\nMedSurg Equipment sales: Surgical equipment and surgical navigation systems . . . . . 2 (2) 3 1 2 Endoscopic, communications and digital imaging systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (5) 6 11 (2) (1) Patient handling and emergency medical equipment . . . . . (23) (17) (12) (22) (20) Total MedSurg Equipment . . . . . . . . . . . . . . . . . . . . . . . . . (7) (2) 3 (5) (4)\n\n_2010 Compared to 2009_\n\nThe Company’s net sales increased 9% to $7,320.0 million in 2010 from $6,723.1 million in 2009. Net sales grew by 7% as a result of increased unit volume and changes in product mix, 1% due to the favorable impact of foreign currency exchange rates on net sales and 3% due to acquisitions, which were partially offset by an unfavorable impact of 2% due to changes in price.\n\nThe Company’s domestic sales were $4,792.8 million for 2010, representing an increase of 11%, as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment. International sales were $2,527.2 million for 2010, representing an increase of 5%. The impact of foreign currency exchange rate movements to the dollar value of international sales was favorable by $69.7 million for 2010. On a constant currency basis, international sales increased 2% in 2010 as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment.\n\n23","publish_date":null,"title":"Thetablesbelowsetforthadditionalgeographicalsalesgrowthinformationforsignificantproductswithin theCompany’sOrthopaedicImplantsandMedSurgEquipmentsegmentsonbothareportedbasisandaconstant currencybasis: OrthopaedicImplantssales: Hips........................................... 5 5 1 5 3 Knees ......................................... 6 1 (2) 4 3 Trauma ........................................ 11","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SYK.2010.page_26.pdf_136878_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/SYK.2010.page_26.pdf_136878_page1.pdf"},"request":{"example_id":"table/SYK.2010.page_26.pdf_136878_page1","product_type":"parse","source_file_path":"SYK.2010.page_26.pdf_136878_page1.pdf"},"started_at":"2026-11-04T19:47:51.733666"} +{"completed_at":"2026-11-04T19:47:55.540641","latency_in_ms":2718,"output":{"example_id":"table/TEDS Paper_page2","grounded_pages":[],"layout_pages":[],"markdown":"Table image\n\nEncoder\n\nAs As As As\n\nRs Rs Rs Rs\n\nRc Ac\n\nRc Ac\n\nRc Ac\n\n• • •\n\n• • •\n\nAs As\n\nRs Rs\n\nRc Ac\n\nRc Ac\n\nRc Ac\n\n• • •\n\n• • •\n\n \n\nD\n\no\n\ng\n\nC\n\na\n\nt\n\nStructure decoder\n\nCell decoder\n\nMerged output: Dog……Cat……\n\n• • •\n\nFig. 1: EDD architecture. The encoder is a convolutional neural network which captures the visual features of the input table image. _A_ _s_ and _A_ _c_ are attention network for the structure decoder and cell decoder, respectively. _R_ _s_ and _R_ _c_ are recurrent units for the structure decoder and cell decoder, respectively. The structure decoder reconstructs table structure and helps the cell decoder to generate cell content. The output of the structure decoder and the cell decoder is merged to obtain the HTML representation of the input table image.\n\naddress one or more of these three problems. The PubTabNet dataset and the EDD model we develop in this paper aim at the image-based table recognition problem. Comparing to other existing datasets for table recognition ( _e.g_ . SciTSR ³ , Table2Latex [4], and TIES [5]), PubTabNet has three key advantages: 1) The tables are typeset by the publishers of over 6,000 jour- nals in PMCOA, which offers considerably more diversity in table styles than other table datasets. 2) Cells are categorized into headers and body cells, which is important when retrieving information from tables. 3) The format of targeted output is HTML, which can be directly integrated into web applications. In addition, tables in HTML format are represented as a tree structure. This\n\n3https://github.com/Academic-Hammer/SciTSR 2https://github.com/doc-analysis/TableBank 3https://github.com/doc-analysis/TableBank 4https://github.com/doc-analysis/TableBank\n\n**Dataset TD TSR TR # tables**\n\nMarmot [6] 958 PubLayNet [7] 113k DeepFigures [8] 1.4m ICDAR2013 [2] 156 ICDAR2019 [9] 3.6k UNLV [10] 558\n\nTableBank ⁴ 417k (TD) 145k (TSR) SciTSR ³ 15k Table2Latex [4] 450k Synthetic data in [5] Unbounded\n\nPubTabNet 568k\n\nTABLE I: Datasets for Table Detection (TD), Table Structure Recognition (TSR) and Table Recognition (TR).\n\nenables the new tree-edit-distance-based evaluation metric that we propose in Section V","pages":[{"line_numbers":[],"markdown":"Table image\n\nEncoder\n\nAs As As As\n\nRs Rs Rs Rs\n\nRc Ac\n\nRc Ac\n\nRc Ac\n\n• • •\n\n• • •\n\nAs As\n\nRs Rs\n\nRc Ac\n\nRc Ac\n\nRc Ac\n\n• • •\n\n• • •\n\n \n\nD\n\no\n\ng\n\nC\n\na\n\nt\n\nStructure decoder\n\nCell decoder\n\nMerged output: Dog……Cat……\n\n• • •\n\nFig. 1: EDD architecture. The encoder is a convolutional neural network which captures the visual features of the input table image. _A_ _s_ and _A_ _c_ are attention network for the structure decoder and cell decoder, respectively. _R_ _s_ and _R_ _c_ are recurrent units for the structure decoder and cell decoder, respectively. The structure decoder reconstructs table structure and helps the cell decoder to generate cell content. The output of the structure decoder and the cell decoder is merged to obtain the HTML representation of the input table image.\n\naddress one or more of these three problems. The PubTabNet dataset and the EDD model we develop in this paper aim at the image-based table recognition problem. Comparing to other existing datasets for table recognition ( _e.g_ . SciTSR ³ , Table2Latex [4], and TIES [5]), PubTabNet has three key advantages: 1) The tables are typeset by the publishers of over 6,000 jour- nals in PMCOA, which offers considerably more diversity in table styles than other table datasets. 2) Cells are categorized into headers and body cells, which is important when retrieving information from tables. 3) The format of targeted output is HTML, which can be directly integrated into web applications. In addition, tables in HTML format are represented as a tree structure. This\n\n3https://github.com/Academic-Hammer/SciTSR 2https://github.com/doc-analysis/TableBank 3https://github.com/doc-analysis/TableBank 4https://github.com/doc-analysis/TableBank\n\n**Dataset TD TSR TR # tables**\n\nMarmot [6] 958 PubLayNet [7] 113k DeepFigures [8] 1.4m ICDAR2013 [2] 156 ICDAR2019 [9] 3.6k UNLV [10] 558\n\nTableBank ⁴ 417k (TD) 145k (TSR) SciTSR ³ 15k Table2Latex [4] 450k Synthetic data in [5] Unbounded\n\nPubTabNet 568k\n\nTABLE I: Datasets for Table Detection (TD), Table Structure Recognition (TSR) and Table Recognition (TR).\n\nenables the new tree-edit-distance-based evaluation metric that we propose in Section V","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table image\n\nEncoder\n\nAs As As As\n\nRs Rs Rs Rs\n\nRc Ac\n\nRc Ac\n\nRc Ac\n\n• • •\n\n• • •\n\nAs As\n\nRs Rs\n\nRc Ac\n\nRc Ac\n\nRc Ac\n\n• • •\n\n• • •\n\n \n\nD\n\no\n\ng\n\nC\n\na\n\nt\n\nStructure decoder\n\nCell decoder\n\nMerged output: Dog……Cat……\n\n• • •\n\nFig. 1: EDD architecture. The encoder is a convolutional neural network which captures the visual features of the input table image. _A_ _s_ and _A_ _c_ are attention network for the structure decoder and cell decoder, respectively. _R_ _s_ and _R_ _c_ are recurrent units for the structure decoder and cell decoder, respectively. The structure decoder reconstructs table structure and helps the cell decoder to generate cell content. The output of the structure decoder and the cell decoder is merged to obtain the HTML representation of the input table image.\n\naddress one or more of these three problems. The PubTabNet dataset and the EDD model we develop in this paper aim at the image-based table recognition problem. Comparing to other existing datasets for table recognition ( _e.g_ . SciTSR ³ , Table2Latex [4], and TIES [5]), PubTabNet has three key advantages: 1) The tables are typeset by the publishers of over 6,000 jour- nals in PMCOA, which offers considerably more diversity in table styles than other table datasets. 2) Cells are categorized into headers and body cells, which is important when retrieving information from tables. 3) The format of targeted output is HTML, which can be directly integrated into web applications. In addition, tables in HTML format are represented as a tree structure. This\n\n3https://github.com/Academic-Hammer/SciTSR 2https://github.com/doc-analysis/TableBank 3https://github.com/doc-analysis/TableBank 4https://github.com/doc-analysis/TableBank\n\n**Dataset TD TSR TR # tables**\n\nMarmot [6] 958 PubLayNet [7] 113k DeepFigures [8] 1.4m ICDAR2013 [2] 156 ICDAR2019 [9] 3.6k UNLV [10] 558\n\nTableBank ⁴ 417k (TD) 145k (TSR) SciTSR ³ 15k Table2Latex [4] 450k Synthetic data in [5] Unbounded\n\nPubTabNet 568k\n\nTABLE I: Datasets for Table Detection (TD), Table Structure Recognition (TSR) and Table Recognition (TR).\n\nenables the new tree-edit-distance-based evaluation metric that we propose in Section V","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/TEDS%20Paper_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_de6fbc51fb41ecb7a325fe5c3036ea62","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table image\n\nEncoder\n\nAs As As As\n\nRs Rs Rs Rs\n\nRc Ac\n\nRc Ac\n\nRc Ac\n\n• • •\n\n• • •\n\nAs As\n\nRs Rs\n\nRc Ac\n\nRc Ac\n\nRc Ac\n\n• • •\n\n• • •\n\n \n\nD\n\no\n\ng\n\nC\n\na\n\nt\n\nStructure decoder\n\nCell decoder\n\nMerged output: Dog……Cat……\n\n• • •\n\nFig. 1: EDD architecture. The encoder is a convolutional neural network which captures the visual features of the input table image. _A_ _s_ and _A_ _c_ are attention network for the structure decoder and cell decoder, respectively. _R_ _s_ and _R_ _c_ are recurrent units for the structure decoder and cell decoder, respectively. The structure decoder reconstructs table structure and helps the cell decoder to generate cell content. The output of the structure decoder and the cell decoder is merged to obtain the HTML representation of the input table image.\n\naddress one or more of these three problems. The PubTabNet dataset and the EDD model we develop in this paper aim at the image-based table recognition problem. Comparing to other existing datasets for table recognition ( _e.g_ . SciTSR ³ , Table2Latex [4], and TIES [5]), PubTabNet has three key advantages: 1) The tables are typeset by the publishers of over 6,000 jour- nals in PMCOA, which offers considerably more diversity in table styles than other table datasets. 2) Cells are categorized into headers and body cells, which is important when retrieving information from tables. 3) The format of targeted output is HTML, which can be directly integrated into web applications. In addition, tables in HTML format are represented as a tree structure. This\n\n3https://github.com/Academic-Hammer/SciTSR 2https://github.com/doc-analysis/TableBank 3https://github.com/doc-analysis/TableBank 4https://github.com/doc-analysis/TableBank\n\n**Dataset TD TSR TR # tables**\n\nMarmot [6] 958 PubLayNet [7] 113k DeepFigures [8] 1.4m ICDAR2013 [2] 156 ICDAR2019 [9] 3.6k UNLV [10] 558\n\nTableBank ⁴ 417k (TD) 145k (TSR) SciTSR ³ 15k Table2Latex [4] 450k Synthetic data in [5] Unbounded\n\nPubTabNet 568k\n\nTABLE I: Datasets for Table Detection (TD), Table Structure Recognition (TSR) and Table Recognition (TR).\n\nenables the new tree-edit-distance-based evaluation metric that we propose in Section V"],"full_content":"Table image\n\nEncoder\n\nAs As As As\n\nRs Rs Rs Rs\n\nRc Ac\n\nRc Ac\n\nRc Ac\n\n• • •\n\n• • •\n\nAs As\n\nRs Rs\n\nRc Ac\n\nRc Ac\n\nRc Ac\n\n• • •\n\n• • •\n\n \n\nD\n\no\n\ng\n\nC\n\na\n\nt\n\nStructure decoder\n\nCell decoder\n\nMerged output: Dog……Cat……\n\n• • •\n\nFig. 1: EDD architecture. The encoder is a convolutional neural network which captures the visual features of the input table image. _A_ _s_ and _A_ _c_ are attention network for the structure decoder and cell decoder, respectively. _R_ _s_ and _R_ _c_ are recurrent units for the structure decoder and cell decoder, respectively. The structure decoder reconstructs table structure and helps the cell decoder to generate cell content. The output of the structure decoder and the cell decoder is merged to obtain the HTML representation of the input table image.\n\naddress one or more of these three problems. The PubTabNet dataset and the EDD model we develop in this paper aim at the image-based table recognition problem. Comparing to other existing datasets for table recognition ( _e.g_ . SciTSR ³ , Table2Latex [4], and TIES [5]), PubTabNet has three key advantages: 1) The tables are typeset by the publishers of over 6,000 jour- nals in PMCOA, which offers considerably more diversity in table styles than other table datasets. 2) Cells are categorized into headers and body cells, which is important when retrieving information from tables. 3) The format of targeted output is HTML, which can be directly integrated into web applications. In addition, tables in HTML format are represented as a tree structure. This\n\n3https://github.com/Academic-Hammer/SciTSR 2https://github.com/doc-analysis/TableBank 3https://github.com/doc-analysis/TableBank 4https://github.com/doc-analysis/TableBank\n\n**Dataset TD TSR TR # tables**\n\nMarmot [6] 958 PubLayNet [7] 113k DeepFigures [8] 1.4m ICDAR2013 [2] 156 ICDAR2019 [9] 3.6k UNLV [10] 558\n\nTableBank ⁴ 417k (TD) 145k (TSR) SciTSR ³ 15k Table2Latex [4] 450k Synthetic data in [5] Unbounded\n\nPubTabNet 568k\n\nTABLE I: Datasets for Table Detection (TD), Table Structure Recognition (TSR) and Table Recognition (TR).\n\nenables the new tree-edit-distance-based evaluation metric that we propose in Section V","publish_date":null,"title":"Structure decoder • • • • • • Cell decoder • • • Fig. 1: EDD architecture. The encoder is","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/TEDS%20Paper_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/TEDS%20Paper_page2.pdf"},"request":{"example_id":"table/TEDS Paper_page2","product_type":"parse","source_file_path":"TEDS Paper_page2.pdf"},"started_at":"2026-11-04T19:47:52.822219"} +{"completed_at":"2026-11-04T19:47:54.924789","latency_in_ms":1506,"output":{"example_id":"table/TEDS Paper_page6","grounded_pages":[],"layout_pages":[],"markdown":"Camelot ⁹ , PDFPlumber ¹⁰ , and Adobe Acrobat R _⃝_ Pro11) and the WYGIWYS model ¹² [34]. We crop the test tables from the original PDF for Tabula, Traprange, Camelot, and PDF- Plumber, as they only support text-based PDF as input. Adobe Acrobat R _⃝_ Pro is tested with both PDF tables and high- resolution table images (300 PPI). The outputs of the off-the- shelf tools are parsed into the same tree structure as the HTML tables to compute the TEDS score.\n\n_A. Implementation details_\n\nTo avoid exceeding GPU RAM, the EDD model is trained on a subset (399k samples) of PubTabNet training set, which satisfies\n\nwidth and height _≤_ 512 pixels\n\nstructural tokens _≤_ 300 tokens\n\nlongest cell _≤_ 100 tokens _._ (3)\n\nNote that samples in the validation and test sets are not constrained by these criteria. The vocabulary size of the structural tokens and the cell tokens of the training data is 32 and 281, respectively. Training images are rescaled to 448 _×_ 448 pixels to facilitate batching and each channel is normalized by z-score. We use the ResNet-18 [39] network as the encoder. The default ResNet-18 model downsamples the image resolution by 32. We modify the last CNN layer of ResNet-18 to study if a higher-resolution feature map improves table recognition performance. A total of five different settings are tested in this paper:\n\n_•_ EDD-S2: the default ResNet-18\n\n_•_ EDD-S1: stride of the last CNN layer set to 1\n\n_•_ EDD-S2S2: two independent last CNN layers for struc- ture (stride=2) and cell (stride=2) decoder\n\n_•_ EDD-S2S1: two independent last CNN layers for struc- ture (stride=2) and cell (stride=1) decoder\n\n_•_ EDD-S1S1: two independent last CNN layers for struc- ture (stride=1) and cell (stride=1) decoder We evaluate the performances of these five settings on the validation set and find that a higher-resolution feature map and independent CNN layers improve performance. As a result, the EDD-S1S1 setting provides the best validation performance, and is therefore chosen to compare with baselines on the test set. The structure decoder and the cell decoder are single- layer long short-term memory (LSTM) networks, of which the hidden state size is 256 and 512, respectively. Both of the decoders weight the feature map from the encoder with soft-attention, which has a hidden layer of size 256. The embedding dimension of structural tokens and cell tokens is\n\n9v0.7.3 (https://github.com/camelot-dev/camelot) 10v0.6.0-alpha (https://github.com/jsvine/pdfplumber) 11v2019.012.20040 12WYGIWYS is trained on the same samples as EDD by truncated back- propagation through time (200 steps). WYGIWYS and EDD use the same CNN in the encoder to rule out the possibility that the performance gain of EDD is due to difference in CNN.\n\n16 and 80, respectively. At inference time, the output of both of the decoders are sampled with beam search (beam=3). The EDD model is trained with the Adam [40] optimizer with two stages. First, we pre-train the encoder and the struc- ture decoder to generate the structural tokens only ( _λ_ = 1), where the batch size is 10, and the learning rate is 0.001 in the first 10 epochs and reduced by 10 for another 3 epochs. Then we train the whole EDD network to generate both structural and cell tokens ( _λ_ = 0 _._ 5), with a batch size 8 and a learning rate 0.001 for 10 epochs and 0.0001 for another 2 epochs. Total training time is about 16 days on two V100 GPUs.\n\n_B. Quantitative analysis_\n\nTable II compares the test performance of the proposed EDD model and the baselines, where the average TEDS of simple ¹³ and complex ¹⁴ test tables is also shown. By solely relying on table images, EDD substantially outperforms all the baselines on recognizing simple and complex tables, even the ones that directly use text extracted from PDF to fill table cells. Camelot is the best off-the-shelf tool in this com- parison. Furthermore, the performance of Adobe Acrobat R _⃝_\n\nPro on image input is dramatically lower than that on PDF input, demonstrating the difficulty of recognizing tables solely on table images. When trained on the PubTabNet dataset, WYGIWYS also considerably outperform the off-the-shelf tools, but is outperformed by EDD by 9.7% absolute TEDS score. The advantage of EDD to WYGIWYS is more pro- found on complex tables (9.9% absolute TEDS) than simple tables (9.5% absolute TEDS). This proves the great advantage of jointly training two separate decoders to solve structure recognition and cell content recognition tasks.\n\nInput Method Average TEDS (%)\n\nSimple ¹³ Complex ¹⁴ All\n\nPDF\n\nTabula 78.0 57.8 67.9 Traprange 60.8 49.9 55.4 Camelot 80.0 66.0 73.0 PDFPlumber 44.9 35.9 40.4 Acrobat R _⃝_ Pro 68.9 61.8 65.3\n\nImage Acrobat R _⃝_ Pro 53.8 53.5 53.7 WYGIWYS 81.7 75.5 78.6 **EDD 91.2 85.4 88.3**\n\nTABLE II: Test performance of EDD and 7 baseline ap- proaches. Our EDD model, by solely relying on table images, substantially outperforms all the baselines.\n\n_C. Qualitative analysis_\n\nTo illustrate the differences in the behavior of the compared methods, Fig. 6 shows the rendering of the predicted HTML given an example input table. The table has 7 columns, 3 header rows, and 4 body rows. The table header has a complex structure, which consists of 4 multi-row (span=3) cells, 2 multi-column (span=3) cells, and three normal cells.\n\n13Tables without multi-column or multi-row cells. 14Tables with multi-column or multi-row cells.","pages":[{"line_numbers":[],"markdown":"Camelot ⁹ , PDFPlumber ¹⁰ , and Adobe Acrobat R _⃝_ Pro11) and the WYGIWYS model ¹² [34]. We crop the test tables from the original PDF for Tabula, Traprange, Camelot, and PDF- Plumber, as they only support text-based PDF as input. Adobe Acrobat R _⃝_ Pro is tested with both PDF tables and high- resolution table images (300 PPI). The outputs of the off-the- shelf tools are parsed into the same tree structure as the HTML tables to compute the TEDS score.\n\n_A. Implementation details_\n\nTo avoid exceeding GPU RAM, the EDD model is trained on a subset (399k samples) of PubTabNet training set, which satisfies\n\nwidth and height _≤_ 512 pixels\n\nstructural tokens _≤_ 300 tokens\n\nlongest cell _≤_ 100 tokens _._ (3)\n\nNote that samples in the validation and test sets are not constrained by these criteria. The vocabulary size of the structural tokens and the cell tokens of the training data is 32 and 281, respectively. Training images are rescaled to 448 _×_ 448 pixels to facilitate batching and each channel is normalized by z-score. We use the ResNet-18 [39] network as the encoder. The default ResNet-18 model downsamples the image resolution by 32. We modify the last CNN layer of ResNet-18 to study if a higher-resolution feature map improves table recognition performance. A total of five different settings are tested in this paper:\n\n_•_ EDD-S2: the default ResNet-18\n\n_•_ EDD-S1: stride of the last CNN layer set to 1\n\n_•_ EDD-S2S2: two independent last CNN layers for struc- ture (stride=2) and cell (stride=2) decoder\n\n_•_ EDD-S2S1: two independent last CNN layers for struc- ture (stride=2) and cell (stride=1) decoder\n\n_•_ EDD-S1S1: two independent last CNN layers for struc- ture (stride=1) and cell (stride=1) decoder We evaluate the performances of these five settings on the validation set and find that a higher-resolution feature map and independent CNN layers improve performance. As a result, the EDD-S1S1 setting provides the best validation performance, and is therefore chosen to compare with baselines on the test set. The structure decoder and the cell decoder are single- layer long short-term memory (LSTM) networks, of which the hidden state size is 256 and 512, respectively. Both of the decoders weight the feature map from the encoder with soft-attention, which has a hidden layer of size 256. The embedding dimension of structural tokens and cell tokens is\n\n9v0.7.3 (https://github.com/camelot-dev/camelot) 10v0.6.0-alpha (https://github.com/jsvine/pdfplumber) 11v2019.012.20040 12WYGIWYS is trained on the same samples as EDD by truncated back- propagation through time (200 steps). WYGIWYS and EDD use the same CNN in the encoder to rule out the possibility that the performance gain of EDD is due to difference in CNN.\n\n16 and 80, respectively. At inference time, the output of both of the decoders are sampled with beam search (beam=3). The EDD model is trained with the Adam [40] optimizer with two stages. First, we pre-train the encoder and the struc- ture decoder to generate the structural tokens only ( _λ_ = 1), where the batch size is 10, and the learning rate is 0.001 in the first 10 epochs and reduced by 10 for another 3 epochs. Then we train the whole EDD network to generate both structural and cell tokens ( _λ_ = 0 _._ 5), with a batch size 8 and a learning rate 0.001 for 10 epochs and 0.0001 for another 2 epochs. Total training time is about 16 days on two V100 GPUs.\n\n_B. Quantitative analysis_\n\nTable II compares the test performance of the proposed EDD model and the baselines, where the average TEDS of simple ¹³ and complex ¹⁴ test tables is also shown. By solely relying on table images, EDD substantially outperforms all the baselines on recognizing simple and complex tables, even the ones that directly use text extracted from PDF to fill table cells. Camelot is the best off-the-shelf tool in this com- parison. Furthermore, the performance of Adobe Acrobat R _⃝_\n\nPro on image input is dramatically lower than that on PDF input, demonstrating the difficulty of recognizing tables solely on table images. When trained on the PubTabNet dataset, WYGIWYS also considerably outperform the off-the-shelf tools, but is outperformed by EDD by 9.7% absolute TEDS score. The advantage of EDD to WYGIWYS is more pro- found on complex tables (9.9% absolute TEDS) than simple tables (9.5% absolute TEDS). This proves the great advantage of jointly training two separate decoders to solve structure recognition and cell content recognition tasks.\n\nInput Method Average TEDS (%)\n\nSimple ¹³ Complex ¹⁴ All\n\nPDF\n\nTabula 78.0 57.8 67.9 Traprange 60.8 49.9 55.4 Camelot 80.0 66.0 73.0 PDFPlumber 44.9 35.9 40.4 Acrobat R _⃝_ Pro 68.9 61.8 65.3\n\nImage Acrobat R _⃝_ Pro 53.8 53.5 53.7 WYGIWYS 81.7 75.5 78.6 **EDD 91.2 85.4 88.3**\n\nTABLE II: Test performance of EDD and 7 baseline ap- proaches. Our EDD model, by solely relying on table images, substantially outperforms all the baselines.\n\n_C. Qualitative analysis_\n\nTo illustrate the differences in the behavior of the compared methods, Fig. 6 shows the rendering of the predicted HTML given an example input table. The table has 7 columns, 3 header rows, and 4 body rows. The table header has a complex structure, which consists of 4 multi-row (span=3) cells, 2 multi-column (span=3) cells, and three normal cells.\n\n13Tables without multi-column or multi-row cells. 14Tables with multi-column or multi-row cells.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Camelot ⁹ , PDFPlumber ¹⁰ , and Adobe Acrobat R _⃝_ Pro11) and the WYGIWYS model ¹² [34]. We crop the test tables from the original PDF for Tabula, Traprange, Camelot, and PDF- Plumber, as they only support text-based PDF as input. Adobe Acrobat R _⃝_ Pro is tested with both PDF tables and high- resolution table images (300 PPI). The outputs of the off-the- shelf tools are parsed into the same tree structure as the HTML tables to compute the TEDS score.\n\n_A. Implementation details_\n\nTo avoid exceeding GPU RAM, the EDD model is trained on a subset (399k samples) of PubTabNet training set, which satisfies\n\nwidth and height _≤_ 512 pixels\n\nstructural tokens _≤_ 300 tokens\n\nlongest cell _≤_ 100 tokens _._ (3)\n\nNote that samples in the validation and test sets are not constrained by these criteria. The vocabulary size of the structural tokens and the cell tokens of the training data is 32 and 281, respectively. Training images are rescaled to 448 _×_ 448 pixels to facilitate batching and each channel is normalized by z-score. We use the ResNet-18 [39] network as the encoder. The default ResNet-18 model downsamples the image resolution by 32. We modify the last CNN layer of ResNet-18 to study if a higher-resolution feature map improves table recognition performance. A total of five different settings are tested in this paper:\n\n_•_ EDD-S2: the default ResNet-18\n\n_•_ EDD-S1: stride of the last CNN layer set to 1\n\n_•_ EDD-S2S2: two independent last CNN layers for struc- ture (stride=2) and cell (stride=2) decoder\n\n_•_ EDD-S2S1: two independent last CNN layers for struc- ture (stride=2) and cell (stride=1) decoder\n\n_•_ EDD-S1S1: two independent last CNN layers for struc- ture (stride=1) and cell (stride=1) decoder We evaluate the performances of these five settings on the validation set and find that a higher-resolution feature map and independent CNN layers improve performance. As a result, the EDD-S1S1 setting provides the best validation performance, and is therefore chosen to compare with baselines on the test set. The structure decoder and the cell decoder are single- layer long short-term memory (LSTM) networks, of which the hidden state size is 256 and 512, respectively. Both of the decoders weight the feature map from the encoder with soft-attention, which has a hidden layer of size 256. The embedding dimension of structural tokens and cell tokens is\n\n9v0.7.3 (https://github.com/camelot-dev/camelot) 10v0.6.0-alpha (https://github.com/jsvine/pdfplumber) 11v2019.012.20040 12WYGIWYS is trained on the same samples as EDD by truncated back- propagation through time (200 steps). WYGIWYS and EDD use the same CNN in the encoder to rule out the possibility that the performance gain of EDD is due to difference in CNN.\n\n16 and 80, respectively. At inference time, the output of both of the decoders are sampled with beam search (beam=3). The EDD model is trained with the Adam [40] optimizer with two stages. First, we pre-train the encoder and the struc- ture decoder to generate the structural tokens only ( _λ_ = 1), where the batch size is 10, and the learning rate is 0.001 in the first 10 epochs and reduced by 10 for another 3 epochs. Then we train the whole EDD network to generate both structural and cell tokens ( _λ_ = 0 _._ 5), with a batch size 8 and a learning rate 0.001 for 10 epochs and 0.0001 for another 2 epochs. Total training time is about 16 days on two V100 GPUs.\n\n_B. Quantitative analysis_\n\nTable II compares the test performance of the proposed EDD model and the baselines, where the average TEDS of simple ¹³ and complex ¹⁴ test tables is also shown. By solely relying on table images, EDD substantially outperforms all the baselines on recognizing simple and complex tables, even the ones that directly use text extracted from PDF to fill table cells. Camelot is the best off-the-shelf tool in this com- parison. Furthermore, the performance of Adobe Acrobat R _⃝_\n\nPro on image input is dramatically lower than that on PDF input, demonstrating the difficulty of recognizing tables solely on table images. When trained on the PubTabNet dataset, WYGIWYS also considerably outperform the off-the-shelf tools, but is outperformed by EDD by 9.7% absolute TEDS score. The advantage of EDD to WYGIWYS is more pro- found on complex tables (9.9% absolute TEDS) than simple tables (9.5% absolute TEDS). This proves the great advantage of jointly training two separate decoders to solve structure recognition and cell content recognition tasks.\n\nInput Method Average TEDS (%)\n\nSimple ¹³ Complex ¹⁴ All\n\nPDF\n\nTabula 78.0 57.8 67.9 Traprange 60.8 49.9 55.4 Camelot 80.0 66.0 73.0 PDFPlumber 44.9 35.9 40.4 Acrobat R _⃝_ Pro 68.9 61.8 65.3\n\nImage Acrobat R _⃝_ Pro 53.8 53.5 53.7 WYGIWYS 81.7 75.5 78.6 **EDD 91.2 85.4 88.3**\n\nTABLE II: Test performance of EDD and 7 baseline ap- proaches. Our EDD model, by solely relying on table images, substantially outperforms all the baselines.\n\n_C. Qualitative analysis_\n\nTo illustrate the differences in the behavior of the compared methods, Fig. 6 shows the rendering of the predicted HTML given an example input table. The table has 7 columns, 3 header rows, and 4 body rows. The table header has a complex structure, which consists of 4 multi-row (span=3) cells, 2 multi-column (span=3) cells, and three normal cells.\n\n13Tables without multi-column or multi-row cells. 14Tables with multi-column or multi-row cells.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/TEDS%20Paper_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_ec6116e0a33f1fd93e199ba5a9dac040","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Camelot ⁹ , PDFPlumber ¹⁰ , and Adobe Acrobat R _⃝_ Pro11) and the WYGIWYS model ¹² [34]. We crop the test tables from the original PDF for Tabula, Traprange, Camelot, and PDF- Plumber, as they only support text-based PDF as input. Adobe Acrobat R _⃝_ Pro is tested with both PDF tables and high- resolution table images (300 PPI). The outputs of the off-the- shelf tools are parsed into the same tree structure as the HTML tables to compute the TEDS score.\n\n_A. Implementation details_\n\nTo avoid exceeding GPU RAM, the EDD model is trained on a subset (399k samples) of PubTabNet training set, which satisfies\n\nwidth and height _≤_ 512 pixels\n\nstructural tokens _≤_ 300 tokens\n\nlongest cell _≤_ 100 tokens _._ (3)\n\nNote that samples in the validation and test sets are not constrained by these criteria. The vocabulary size of the structural tokens and the cell tokens of the training data is 32 and 281, respectively. Training images are rescaled to 448 _×_ 448 pixels to facilitate batching and each channel is normalized by z-score. We use the ResNet-18 [39] network as the encoder. The default ResNet-18 model downsamples the image resolution by 32. We modify the last CNN layer of ResNet-18 to study if a higher-resolution feature map improves table recognition performance. A total of five different settings are tested in this paper:\n\n_•_ EDD-S2: the default ResNet-18\n\n_•_ EDD-S1: stride of the last CNN layer set to 1\n\n_•_ EDD-S2S2: two independent last CNN layers for struc- ture (stride=2) and cell (stride=2) decoder\n\n_•_ EDD-S2S1: two independent last CNN layers for struc- ture (stride=2) and cell (stride=1) decoder\n\n_•_ EDD-S1S1: two independent last CNN layers for struc- ture (stride=1) and cell (stride=1) decoder We evaluate the performances of these five settings on the validation set and find that a higher-resolution feature map and independent CNN layers improve performance. As a result, the EDD-S1S1 setting provides the best validation performance, and is therefore chosen to compare with baselines on the test set. The structure decoder and the cell decoder are single- layer long short-term memory (LSTM) networks, of which the hidden state size is 256 and 512, respectively. Both of the decoders weight the feature map from the encoder with soft-attention, which has a hidden layer of size 256. The embedding dimension of structural tokens and cell tokens is\n\n9v0.7.3 (https://github.com/camelot-dev/camelot) 10v0.6.0-alpha (https://github.com/jsvine/pdfplumber) 11v2019.012.20040 12WYGIWYS is trained on the same samples as EDD by truncated back- propagation through time (200 steps). WYGIWYS and EDD use the same CNN in the encoder to rule out the possibility that the performance gain of EDD is due to difference in CNN.\n\n16 and 80, respectively. At inference time, the output of both of the decoders are sampled with beam search (beam=3). The EDD model is trained with the Adam [40] optimizer with two stages. First, we pre-train the encoder and the struc- ture decoder to generate the structural tokens only ( _λ_ = 1), where the batch size is 10, and the learning rate is 0.001 in the first 10 epochs and reduced by 10 for another 3 epochs. Then we train the whole EDD network to generate both structural and cell tokens ( _λ_ = 0 _._ 5), with a batch size 8 and a learning rate 0.001 for 10 epochs and 0.0001 for another 2 epochs. Total training time is about 16 days on two V100 GPUs.\n\n_B. Quantitative analysis_\n\nTable II compares the test performance of the proposed EDD model and the baselines, where the average TEDS of simple ¹³ and complex ¹⁴ test tables is also shown. By solely relying on table images, EDD substantially outperforms all the baselines on recognizing simple and complex tables, even the ones that directly use text extracted from PDF to fill table cells. Camelot is the best off-the-shelf tool in this com- parison. Furthermore, the performance of Adobe Acrobat R _⃝_\n\nPro on image input is dramatically lower than that on PDF input, demonstrating the difficulty of recognizing tables solely on table images. When trained on the PubTabNet dataset, WYGIWYS also considerably outperform the off-the-shelf tools, but is outperformed by EDD by 9.7% absolute TEDS score. The advantage of EDD to WYGIWYS is more pro- found on complex tables (9.9% absolute TEDS) than simple tables (9.5% absolute TEDS). This proves the great advantage of jointly training two separate decoders to solve structure recognition and cell content recognition tasks.\n\nInput Method Average TEDS (%)\n\nSimple ¹³ Complex ¹⁴ All\n\nPDF\n\nTabula 78.0 57.8 67.9 Traprange 60.8 49.9 55.4 Camelot 80.0 66.0 73.0 PDFPlumber 44.9 35.9 40.4 Acrobat R _⃝_ Pro 68.9 61.8 65.3\n\nImage Acrobat R _⃝_ Pro 53.8 53.5 53.7 WYGIWYS 81.7 75.5 78.6 **EDD 91.2 85.4 88.3**\n\nTABLE II: Test performance of EDD and 7 baseline ap- proaches. Our EDD model, by solely relying on table images, substantially outperforms all the baselines.\n\n_C. Qualitative analysis_\n\nTo illustrate the differences in the behavior of the compared methods, Fig. 6 shows the rendering of the predicted HTML given an example input table. The table has 7 columns, 3 header rows, and 4 body rows. The table header has a complex structure, which consists of 4 multi-row (span=3) cells, 2 multi-column (span=3) cells, and three normal cells.\n\n13Tables without multi-column or multi-row cells. 14Tables with multi-column or multi-row cells."],"full_content":"Camelot ⁹ , PDFPlumber ¹⁰ , and Adobe Acrobat R _⃝_ Pro11) and the WYGIWYS model ¹² [34]. We crop the test tables from the original PDF for Tabula, Traprange, Camelot, and PDF- Plumber, as they only support text-based PDF as input. Adobe Acrobat R _⃝_ Pro is tested with both PDF tables and high- resolution table images (300 PPI). The outputs of the off-the- shelf tools are parsed into the same tree structure as the HTML tables to compute the TEDS score.\n\n_A. Implementation details_\n\nTo avoid exceeding GPU RAM, the EDD model is trained on a subset (399k samples) of PubTabNet training set, which satisfies\n\nwidth and height _≤_ 512 pixels\n\nstructural tokens _≤_ 300 tokens\n\nlongest cell _≤_ 100 tokens _._ (3)\n\nNote that samples in the validation and test sets are not constrained by these criteria. The vocabulary size of the structural tokens and the cell tokens of the training data is 32 and 281, respectively. Training images are rescaled to 448 _×_ 448 pixels to facilitate batching and each channel is normalized by z-score. We use the ResNet-18 [39] network as the encoder. The default ResNet-18 model downsamples the image resolution by 32. We modify the last CNN layer of ResNet-18 to study if a higher-resolution feature map improves table recognition performance. A total of five different settings are tested in this paper:\n\n_•_ EDD-S2: the default ResNet-18\n\n_•_ EDD-S1: stride of the last CNN layer set to 1\n\n_•_ EDD-S2S2: two independent last CNN layers for struc- ture (stride=2) and cell (stride=2) decoder\n\n_•_ EDD-S2S1: two independent last CNN layers for struc- ture (stride=2) and cell (stride=1) decoder\n\n_•_ EDD-S1S1: two independent last CNN layers for struc- ture (stride=1) and cell (stride=1) decoder We evaluate the performances of these five settings on the validation set and find that a higher-resolution feature map and independent CNN layers improve performance. As a result, the EDD-S1S1 setting provides the best validation performance, and is therefore chosen to compare with baselines on the test set. The structure decoder and the cell decoder are single- layer long short-term memory (LSTM) networks, of which the hidden state size is 256 and 512, respectively. Both of the decoders weight the feature map from the encoder with soft-attention, which has a hidden layer of size 256. The embedding dimension of structural tokens and cell tokens is\n\n9v0.7.3 (https://github.com/camelot-dev/camelot) 10v0.6.0-alpha (https://github.com/jsvine/pdfplumber) 11v2019.012.20040 12WYGIWYS is trained on the same samples as EDD by truncated back- propagation through time (200 steps). WYGIWYS and EDD use the same CNN in the encoder to rule out the possibility that the performance gain of EDD is due to difference in CNN.\n\n16 and 80, respectively. At inference time, the output of both of the decoders are sampled with beam search (beam=3). The EDD model is trained with the Adam [40] optimizer with two stages. First, we pre-train the encoder and the struc- ture decoder to generate the structural tokens only ( _λ_ = 1), where the batch size is 10, and the learning rate is 0.001 in the first 10 epochs and reduced by 10 for another 3 epochs. Then we train the whole EDD network to generate both structural and cell tokens ( _λ_ = 0 _._ 5), with a batch size 8 and a learning rate 0.001 for 10 epochs and 0.0001 for another 2 epochs. Total training time is about 16 days on two V100 GPUs.\n\n_B. Quantitative analysis_\n\nTable II compares the test performance of the proposed EDD model and the baselines, where the average TEDS of simple ¹³ and complex ¹⁴ test tables is also shown. By solely relying on table images, EDD substantially outperforms all the baselines on recognizing simple and complex tables, even the ones that directly use text extracted from PDF to fill table cells. Camelot is the best off-the-shelf tool in this com- parison. Furthermore, the performance of Adobe Acrobat R _⃝_\n\nPro on image input is dramatically lower than that on PDF input, demonstrating the difficulty of recognizing tables solely on table images. When trained on the PubTabNet dataset, WYGIWYS also considerably outperform the off-the-shelf tools, but is outperformed by EDD by 9.7% absolute TEDS score. The advantage of EDD to WYGIWYS is more pro- found on complex tables (9.9% absolute TEDS) than simple tables (9.5% absolute TEDS). This proves the great advantage of jointly training two separate decoders to solve structure recognition and cell content recognition tasks.\n\nInput Method Average TEDS (%)\n\nSimple ¹³ Complex ¹⁴ All\n\nPDF\n\nTabula 78.0 57.8 67.9 Traprange 60.8 49.9 55.4 Camelot 80.0 66.0 73.0 PDFPlumber 44.9 35.9 40.4 Acrobat R _⃝_ Pro 68.9 61.8 65.3\n\nImage Acrobat R _⃝_ Pro 53.8 53.5 53.7 WYGIWYS 81.7 75.5 78.6 **EDD 91.2 85.4 88.3**\n\nTABLE II: Test performance of EDD and 7 baseline ap- proaches. Our EDD model, by solely relying on table images, substantially outperforms all the baselines.\n\n_C. Qualitative analysis_\n\nTo illustrate the differences in the behavior of the compared methods, Fig. 6 shows the rendering of the predicted HTML given an example input table. The table has 7 columns, 3 header rows, and 4 body rows. The table header has a complex structure, which consists of 4 multi-row (span=3) cells, 2 multi-column (span=3) cells, and three normal cells.\n\n13Tables without multi-column or multi-row cells. 14Tables with multi-column or multi-row cells.","publish_date":null,"title":"Camelot , PDFPlumber , and Adobe Acrobat Pro ) and 16 and 80, respectively. At inference time, the output of","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/TEDS%20Paper_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/TEDS%20Paper_page6.pdf"},"request":{"example_id":"table/TEDS Paper_page6","product_type":"parse","source_file_path":"TEDS Paper_page6.pdf"},"started_at":"2026-11-04T19:47:53.418687"} +{"completed_at":"2026-11-04T19:48:01.581613","latency_in_ms":6777,"output":{"example_id":"table/Tables - Apple Def 14a_page102","grounded_pages":[],"layout_pages":[],"markdown":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 99\n\nSecurity Ownership of Certain Beneficial Owners and Management\n\nThe following table shows information as of January 9, 2023 (the “Table Date”), unless otherwise indicated, regarding the\nbeneficial ownership of Apple’s common stock by: (i) each person known to Apple to beneficially own more than 5% of the\noutstanding shares of Apple's common stock based solely on Apple's review of filings with the SEC pursuant to Section 13(d) or\n13(g) of the Exchange Act; (ii) each director and nominee; (iii) each named executive officer listed in the table entitled \"Summary\nCompensation Table—2022, 2021, and 2020\" under the section entitled “Executive Compensation”; and (iv) all current directors\nand executive officers as a group. As of the Table Date, 15,836,213,000 shares of Apple’s common stock were issued and\noutstanding. Unless otherwise indicated, all persons named as beneficial owners of Apple’s common stock have sole voting power\nand sole investment power with respect to the shares indicated as beneficially owned.\n\nShares of Common Percent of\n\nStock Beneficially Common Stock\n\nName of Beneficial Owner Owned” Outstanding\nThe Vanguard Group 1,261,261,3572 7.96%\nBlackRock, Inc. 1,019,810,291° 6.44%\nBerkshire Hathaway Inc. / Warren E. Buffett 907,559,761 5.73%\nKate Adams 425,059 \\*\nJames Bell 36,675 \\*\nTim Cook 3,279,898”) a\nAl Gore 467,143) \\*\nAlex Gorsky 2,171) \\*\nAndrea Jung 141,279\") \\*\nArt Levinson 4,590,409 \\*\nMonica Lozano 5,239) \\*\nLuca Maestri 109,970\"9) \\*\nDeirdre O'Brien 136,290\") \\*\nRon Sugar 105,943\") \\*\nSue Wagner 65,523\" \\*\nJeff Williams 677,392\") a\nAll current executive officers and directors as a group (13 persons) 10,042,991'\"®) \\*\n\n(1) Represents shares of Apple’s common stock held, and RSUs held that will vest within 60 days after the Table Date. Does not include RSUs that vest more\nthan 60 days after the Table Date. RSUs are awards granted by Apple and payable, subject to vesting requirements, in shares of Apple’s common stock.\n\n(2) Represents shares of Apple’s common stock beneficially owned as of December 31, 2021, based on a Schedule 13G/A filed with the SEC on February 9,\n2022, by The Vanguard Group. The Vanguard Group lists its address as 100 Vanguard Blvd., Malvern, PA 19355, and indicates that it has shared voting\npower with respect to 26,718,301 shares of Apple's common stock, sole dispositive power with respect to 1,196,152,755 shares of Apple’s common\nstock, and shared dispositive power with respect to 65,108,602 shares of Apple’s common stock.\n\n(3) Represents shares of Apple’s common stock beneficially owned as of December 31, 2021, based on a Schedule 13G/A filed with the SEC on February 1,\n2022, by BlackRock, Inc. BlackRock, Inc. lists its address as 55 East 52nd Street, New York, NY 10055, and indicates that it has sole voting power with\nrespect to 874,268,061 shares of Apple’s common stock, and sole dispositive power with respect to all shares beneficially owned.","pages":[{"line_numbers":[],"markdown":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 99\n\nSecurity Ownership of Certain Beneficial Owners and Management\n\nThe following table shows information as of January 9, 2023 (the “Table Date”), unless otherwise indicated, regarding the\nbeneficial ownership of Apple’s common stock by: (i) each person known to Apple to beneficially own more than 5% of the\noutstanding shares of Apple's common stock based solely on Apple's review of filings with the SEC pursuant to Section 13(d) or\n13(g) of the Exchange Act; (ii) each director and nominee; (iii) each named executive officer listed in the table entitled \"Summary\nCompensation Table—2022, 2021, and 2020\" under the section entitled “Executive Compensation”; and (iv) all current directors\nand executive officers as a group. As of the Table Date, 15,836,213,000 shares of Apple’s common stock were issued and\noutstanding. Unless otherwise indicated, all persons named as beneficial owners of Apple’s common stock have sole voting power\nand sole investment power with respect to the shares indicated as beneficially owned.\n\nShares of Common Percent of\n\nStock Beneficially Common Stock\n\nName of Beneficial Owner Owned” Outstanding\nThe Vanguard Group 1,261,261,3572 7.96%\nBlackRock, Inc. 1,019,810,291° 6.44%\nBerkshire Hathaway Inc. / Warren E. Buffett 907,559,761 5.73%\nKate Adams 425,059 \\*\nJames Bell 36,675 \\*\nTim Cook 3,279,898”) a\nAl Gore 467,143) \\*\nAlex Gorsky 2,171) \\*\nAndrea Jung 141,279\") \\*\nArt Levinson 4,590,409 \\*\nMonica Lozano 5,239) \\*\nLuca Maestri 109,970\"9) \\*\nDeirdre O'Brien 136,290\") \\*\nRon Sugar 105,943\") \\*\nSue Wagner 65,523\" \\*\nJeff Williams 677,392\") a\nAll current executive officers and directors as a group (13 persons) 10,042,991'\"®) \\*\n\n(1) Represents shares of Apple’s common stock held, and RSUs held that will vest within 60 days after the Table Date. Does not include RSUs that vest more\nthan 60 days after the Table Date. RSUs are awards granted by Apple and payable, subject to vesting requirements, in shares of Apple’s common stock.\n\n(2) Represents shares of Apple’s common stock beneficially owned as of December 31, 2021, based on a Schedule 13G/A filed with the SEC on February 9,\n2022, by The Vanguard Group. The Vanguard Group lists its address as 100 Vanguard Blvd., Malvern, PA 19355, and indicates that it has shared voting\npower with respect to 26,718,301 shares of Apple's common stock, sole dispositive power with respect to 1,196,152,755 shares of Apple’s common\nstock, and shared dispositive power with respect to 65,108,602 shares of Apple’s common stock.\n\n(3) Represents shares of Apple’s common stock beneficially owned as of December 31, 2021, based on a Schedule 13G/A filed with the SEC on February 1,\n2022, by BlackRock, Inc. BlackRock, Inc. lists its address as 55 East 52nd Street, New York, NY 10055, and indicates that it has sole voting power with\nrespect to 874,268,061 shares of Apple’s common stock, and sole dispositive power with respect to all shares beneficially owned.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 99\n\nSecurity Ownership of Certain Beneficial Owners and Management\n\nThe following table shows information as of January 9, 2023 (the “Table Date”), unless otherwise indicated, regarding the\nbeneficial ownership of Apple’s common stock by: (i) each person known to Apple to beneficially own more than 5% of the\noutstanding shares of Apple's common stock based solely on Apple's review of filings with the SEC pursuant to Section 13(d) or\n13(g) of the Exchange Act; (ii) each director and nominee; (iii) each named executive officer listed in the table entitled \"Summary\nCompensation Table—2022, 2021, and 2020\" under the section entitled “Executive Compensation”; and (iv) all current directors\nand executive officers as a group. As of the Table Date, 15,836,213,000 shares of Apple’s common stock were issued and\noutstanding. Unless otherwise indicated, all persons named as beneficial owners of Apple’s common stock have sole voting power\nand sole investment power with respect to the shares indicated as beneficially owned.\n\nShares of Common Percent of\n\nStock Beneficially Common Stock\n\nName of Beneficial Owner Owned” Outstanding\nThe Vanguard Group 1,261,261,3572 7.96%\nBlackRock, Inc. 1,019,810,291° 6.44%\nBerkshire Hathaway Inc. / Warren E. Buffett 907,559,761 5.73%\nKate Adams 425,059 \\*\nJames Bell 36,675 \\*\nTim Cook 3,279,898”) a\nAl Gore 467,143) \\*\nAlex Gorsky 2,171) \\*\nAndrea Jung 141,279\") \\*\nArt Levinson 4,590,409 \\*\nMonica Lozano 5,239) \\*\nLuca Maestri 109,970\"9) \\*\nDeirdre O'Brien 136,290\") \\*\nRon Sugar 105,943\") \\*\nSue Wagner 65,523\" \\*\nJeff Williams 677,392\") a\nAll current executive officers and directors as a group (13 persons) 10,042,991'\"®) \\*\n\n(1) Represents shares of Apple’s common stock held, and RSUs held that will vest within 60 days after the Table Date. Does not include RSUs that vest more\nthan 60 days after the Table Date. RSUs are awards granted by Apple and payable, subject to vesting requirements, in shares of Apple’s common stock.\n\n(2) Represents shares of Apple’s common stock beneficially owned as of December 31, 2021, based on a Schedule 13G/A filed with the SEC on February 9,\n2022, by The Vanguard Group. The Vanguard Group lists its address as 100 Vanguard Blvd., Malvern, PA 19355, and indicates that it has shared voting\npower with respect to 26,718,301 shares of Apple's common stock, sole dispositive power with respect to 1,196,152,755 shares of Apple’s common\nstock, and shared dispositive power with respect to 65,108,602 shares of Apple’s common stock.\n\n(3) Represents shares of Apple’s common stock beneficially owned as of December 31, 2021, based on a Schedule 13G/A filed with the SEC on February 1,\n2022, by BlackRock, Inc. BlackRock, Inc. lists its address as 55 East 52nd Street, New York, NY 10055, and indicates that it has sole voting power with\nrespect to 874,268,061 shares of Apple’s common stock, and sole dispositive power with respect to all shares beneficially owned.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page102.pdf"]},"response":{"errors":[],"extract_id":"extract_19fb812cac0e1454cbfc062cc606dcad","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 99\n\nSecurity Ownership of Certain Beneficial Owners and Management\n\nThe following table shows information as of January 9, 2023 (the “Table Date”), unless otherwise indicated, regarding the\nbeneficial ownership of Apple’s common stock by: (i) each person known to Apple to beneficially own more than 5% of the\noutstanding shares of Apple's common stock based solely on Apple's review of filings with the SEC pursuant to Section 13(d) or\n13(g) of the Exchange Act; (ii) each director and nominee; (iii) each named executive officer listed in the table entitled \"Summary\nCompensation Table—2022, 2021, and 2020\" under the section entitled “Executive Compensation”; and (iv) all current directors\nand executive officers as a group. As of the Table Date, 15,836,213,000 shares of Apple’s common stock were issued and\noutstanding. Unless otherwise indicated, all persons named as beneficial owners of Apple’s common stock have sole voting power\nand sole investment power with respect to the shares indicated as beneficially owned.\n\nShares of Common Percent of\n\nStock Beneficially Common Stock\n\nName of Beneficial Owner Owned” Outstanding\nThe Vanguard Group 1,261,261,3572 7.96%\nBlackRock, Inc. 1,019,810,291° 6.44%\nBerkshire Hathaway Inc. / Warren E. Buffett 907,559,761 5.73%\nKate Adams 425,059 \\*\nJames Bell 36,675 \\*\nTim Cook 3,279,898”) a\nAl Gore 467,143) \\*\nAlex Gorsky 2,171) \\*\nAndrea Jung 141,279\") \\*\nArt Levinson 4,590,409 \\*\nMonica Lozano 5,239) \\*\nLuca Maestri 109,970\"9) \\*\nDeirdre O'Brien 136,290\") \\*\nRon Sugar 105,943\") \\*\nSue Wagner 65,523\" \\*\nJeff Williams 677,392\") a\nAll current executive officers and directors as a group (13 persons) 10,042,991'\"®) \\*\n\n(1) Represents shares of Apple’s common stock held, and RSUs held that will vest within 60 days after the Table Date. Does not include RSUs that vest more\nthan 60 days after the Table Date. RSUs are awards granted by Apple and payable, subject to vesting requirements, in shares of Apple’s common stock.\n\n(2) Represents shares of Apple’s common stock beneficially owned as of December 31, 2021, based on a Schedule 13G/A filed with the SEC on February 9,\n2022, by The Vanguard Group. The Vanguard Group lists its address as 100 Vanguard Blvd., Malvern, PA 19355, and indicates that it has shared voting\npower with respect to 26,718,301 shares of Apple's common stock, sole dispositive power with respect to 1,196,152,755 shares of Apple’s common\nstock, and shared dispositive power with respect to 65,108,602 shares of Apple’s common stock.\n\n(3) Represents shares of Apple’s common stock beneficially owned as of December 31, 2021, based on a Schedule 13G/A filed with the SEC on February 1,\n2022, by BlackRock, Inc. BlackRock, Inc. lists its address as 55 East 52nd Street, New York, NY 10055, and indicates that it has sole voting power with\nrespect to 874,268,061 shares of Apple’s common stock, and sole dispositive power with respect to all shares beneficially owned."],"full_content":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 99\n\nSecurity Ownership of Certain Beneficial Owners and Management\n\nThe following table shows information as of January 9, 2023 (the “Table Date”), unless otherwise indicated, regarding the\nbeneficial ownership of Apple’s common stock by: (i) each person known to Apple to beneficially own more than 5% of the\noutstanding shares of Apple's common stock based solely on Apple's review of filings with the SEC pursuant to Section 13(d) or\n13(g) of the Exchange Act; (ii) each director and nominee; (iii) each named executive officer listed in the table entitled \"Summary\nCompensation Table—2022, 2021, and 2020\" under the section entitled “Executive Compensation”; and (iv) all current directors\nand executive officers as a group. As of the Table Date, 15,836,213,000 shares of Apple’s common stock were issued and\noutstanding. Unless otherwise indicated, all persons named as beneficial owners of Apple’s common stock have sole voting power\nand sole investment power with respect to the shares indicated as beneficially owned.\n\nShares of Common Percent of\n\nStock Beneficially Common Stock\n\nName of Beneficial Owner Owned” Outstanding\nThe Vanguard Group 1,261,261,3572 7.96%\nBlackRock, Inc. 1,019,810,291° 6.44%\nBerkshire Hathaway Inc. / Warren E. Buffett 907,559,761 5.73%\nKate Adams 425,059 \\*\nJames Bell 36,675 \\*\nTim Cook 3,279,898”) a\nAl Gore 467,143) \\*\nAlex Gorsky 2,171) \\*\nAndrea Jung 141,279\") \\*\nArt Levinson 4,590,409 \\*\nMonica Lozano 5,239) \\*\nLuca Maestri 109,970\"9) \\*\nDeirdre O'Brien 136,290\") \\*\nRon Sugar 105,943\") \\*\nSue Wagner 65,523\" \\*\nJeff Williams 677,392\") a\nAll current executive officers and directors as a group (13 persons) 10,042,991'\"®) \\*\n\n(1) Represents shares of Apple’s common stock held, and RSUs held that will vest within 60 days after the Table Date. Does not include RSUs that vest more\nthan 60 days after the Table Date. RSUs are awards granted by Apple and payable, subject to vesting requirements, in shares of Apple’s common stock.\n\n(2) Represents shares of Apple’s common stock beneficially owned as of December 31, 2021, based on a Schedule 13G/A filed with the SEC on February 9,\n2022, by The Vanguard Group. The Vanguard Group lists its address as 100 Vanguard Blvd., Malvern, PA 19355, and indicates that it has shared voting\npower with respect to 26,718,301 shares of Apple's common stock, sole dispositive power with respect to 1,196,152,755 shares of Apple’s common\nstock, and shared dispositive power with respect to 65,108,602 shares of Apple’s common stock.\n\n(3) Represents shares of Apple’s common stock beneficially owned as of December 31, 2021, based on a Schedule 13G/A filed with the SEC on February 1,\n2022, by BlackRock, Inc. BlackRock, Inc. lists its address as 55 East 52nd Street, New York, NY 10055, and indicates that it has sole voting power with\nrespect to 874,268,061 shares of Apple’s common stock, and sole dispositive power with respect to all shares beneficially owned.","publish_date":null,"title":"Tables Apple Def 14A Page102","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page102.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page102.pdf"},"request":{"example_id":"table/Tables - Apple Def 14a_page102","product_type":"parse","source_file_path":"Tables - Apple Def 14a_page102.pdf"},"started_at":"2026-11-04T19:47:54.803784"} +{"completed_at":"2026-11-04T19:47:59.511768","latency_in_ms":3841,"output":{"example_id":"table/Tables - Apple Def 14a_page18","grounded_pages":[],"layout_pages":[],"markdown":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 15\n\nBoard\nProposal Recommendation Page Reference\n8 Racial and Gender Pay Gaps AGAINST 89\ne We already have a comprehensive approach to pay equity and diverse representation at\nevery level of the Company, and since 2017 have achieved gender pay equity globally, as\nwell as pay equity by race and ethnicity in the United States, and in 2022, we also achieved\npay equity at the intersections of gender and race and ethnicity in our U.S. workforce.\ne We report on our progress on representation annually on our Inclusion and Diversity website,\nand we believe our transparency represents a more meaningful approach to pay equity and\nrepresentation than the approach set forth in the proposal.\n9 Shareholder Proxy Access Amendments AGAINST 93\n\ne Our proxy access bylaws were developed giving careful consideration to the varying\nviewpoints offered by many of our shareholders and provide a meaningful opportunity for\nshareholders to nominate directors, while the newly adopted universal proxy card rules\nprovide further options for shareholders.\n\nApple has a robust shareholder engagement program and, over the course of our\nengagement in calendar year 2022 with shareholders representing over 60% of institutional\nshares held, no shareholders provided feedback on, or sought changes to, our existing proxy\naccess provisions.","pages":[{"line_numbers":[],"markdown":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 15\n\nBoard\nProposal Recommendation Page Reference\n8 Racial and Gender Pay Gaps AGAINST 89\ne We already have a comprehensive approach to pay equity and diverse representation at\nevery level of the Company, and since 2017 have achieved gender pay equity globally, as\nwell as pay equity by race and ethnicity in the United States, and in 2022, we also achieved\npay equity at the intersections of gender and race and ethnicity in our U.S. workforce.\ne We report on our progress on representation annually on our Inclusion and Diversity website,\nand we believe our transparency represents a more meaningful approach to pay equity and\nrepresentation than the approach set forth in the proposal.\n9 Shareholder Proxy Access Amendments AGAINST 93\n\ne Our proxy access bylaws were developed giving careful consideration to the varying\nviewpoints offered by many of our shareholders and provide a meaningful opportunity for\nshareholders to nominate directors, while the newly adopted universal proxy card rules\nprovide further options for shareholders.\n\nApple has a robust shareholder engagement program and, over the course of our\nengagement in calendar year 2022 with shareholders representing over 60% of institutional\nshares held, no shareholders provided feedback on, or sought changes to, our existing proxy\naccess provisions.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 15\n\nBoard\nProposal Recommendation Page Reference\n8 Racial and Gender Pay Gaps AGAINST 89\ne We already have a comprehensive approach to pay equity and diverse representation at\nevery level of the Company, and since 2017 have achieved gender pay equity globally, as\nwell as pay equity by race and ethnicity in the United States, and in 2022, we also achieved\npay equity at the intersections of gender and race and ethnicity in our U.S. workforce.\ne We report on our progress on representation annually on our Inclusion and Diversity website,\nand we believe our transparency represents a more meaningful approach to pay equity and\nrepresentation than the approach set forth in the proposal.\n9 Shareholder Proxy Access Amendments AGAINST 93\n\ne Our proxy access bylaws were developed giving careful consideration to the varying\nviewpoints offered by many of our shareholders and provide a meaningful opportunity for\nshareholders to nominate directors, while the newly adopted universal proxy card rules\nprovide further options for shareholders.\n\nApple has a robust shareholder engagement program and, over the course of our\nengagement in calendar year 2022 with shareholders representing over 60% of institutional\nshares held, no shareholders provided feedback on, or sought changes to, our existing proxy\naccess provisions.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page18.pdf"]},"response":{"errors":[],"extract_id":"extract_a9eadf0cf94e960aeca2e809f05d14c8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 15\n\nBoard\nProposal Recommendation Page Reference\n8 Racial and Gender Pay Gaps AGAINST 89\ne We already have a comprehensive approach to pay equity and diverse representation at\nevery level of the Company, and since 2017 have achieved gender pay equity globally, as\nwell as pay equity by race and ethnicity in the United States, and in 2022, we also achieved\npay equity at the intersections of gender and race and ethnicity in our U.S. workforce.\ne We report on our progress on representation annually on our Inclusion and Diversity website,\nand we believe our transparency represents a more meaningful approach to pay equity and\nrepresentation than the approach set forth in the proposal.\n9 Shareholder Proxy Access Amendments AGAINST 93\n\ne Our proxy access bylaws were developed giving careful consideration to the varying\nviewpoints offered by many of our shareholders and provide a meaningful opportunity for\nshareholders to nominate directors, while the newly adopted universal proxy card rules\nprovide further options for shareholders.\n\nApple has a robust shareholder engagement program and, over the course of our\nengagement in calendar year 2022 with shareholders representing over 60% of institutional\nshares held, no shareholders provided feedback on, or sought changes to, our existing proxy\naccess provisions."],"full_content":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 15\n\nBoard\nProposal Recommendation Page Reference\n8 Racial and Gender Pay Gaps AGAINST 89\ne We already have a comprehensive approach to pay equity and diverse representation at\nevery level of the Company, and since 2017 have achieved gender pay equity globally, as\nwell as pay equity by race and ethnicity in the United States, and in 2022, we also achieved\npay equity at the intersections of gender and race and ethnicity in our U.S. workforce.\ne We report on our progress on representation annually on our Inclusion and Diversity website,\nand we believe our transparency represents a more meaningful approach to pay equity and\nrepresentation than the approach set forth in the proposal.\n9 Shareholder Proxy Access Amendments AGAINST 93\n\ne Our proxy access bylaws were developed giving careful consideration to the varying\nviewpoints offered by many of our shareholders and provide a meaningful opportunity for\nshareholders to nominate directors, while the newly adopted universal proxy card rules\nprovide further options for shareholders.\n\nApple has a robust shareholder engagement program and, over the course of our\nengagement in calendar year 2022 with shareholders representing over 60% of institutional\nshares held, no shareholders provided feedback on, or sought changes to, our existing proxy\naccess provisions.","publish_date":null,"title":"Tables Apple Def 14A Page18","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page18.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page18.pdf"},"request":{"example_id":"table/Tables - Apple Def 14a_page18","product_type":"parse","source_file_path":"Tables - Apple Def 14a_page18.pdf"},"started_at":"2026-11-04T19:47:55.670278"} +{"completed_at":"2026-11-04T19:48:04.558897","latency_in_ms":7439,"output":{"example_id":"table/Tables - Apple Def 14a_page40","grounded_pages":[],"layout_pages":[],"markdown":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 37\n\nDeferred Compensation Plan\n\nWe adopted the Apple Inc. Deferred Compensation Plan (\"Deferred Compensation Plan”) in 2018, effective for deferrals beginning\nin 2019. The Deferred Compensation Plan allows eligible participants, including our Non-Employee Directors, to defer a portion of\ntheir eligible compensation, subject to the terms of the Deferred Compensation Plan. The Deferred Compensation Plan is unfunded\nand unsecured. We do not provide any matching contributions under the Deferred Compensation Plan or allow for deferral of RSUs.\nIn 2022, Ms. Lozano participated in the Deferred Compensation Plan and deferred a portion of her annual cash retainer.\n\nStock Ownership Guidelines\n\nApple has stock ownership guidelines for our CEO, executive officers, and Non-Employee Directors. Under the guidelines, each\nNon-Employee Director is expected, within five years after joining the Board, to own shares of Apple’s common stock that have a\nvalue equal to five times their annual cash retainer for serving as a director. Shares may be owned directly by the individual, owned\njointly with, or separately by, the individual's spouse, or held in trust for the benefit of the individual, the individual's spouse, or the\nindividual's children. Other than Ms. Lozano and Mr. Gorsky, who joined the Board in calendar year 2021, each Non-Employee\nDirector currently owns shares of Apple’s common stock that have a value at least equal to five times their annual cash retainer.\n\nDirector Compensation—2022\n\nThe following table shows information regarding the compensation earned or paid during 2022 to Non-Employee Directors who\nserved on the Board during the year. Mr. Cook's compensation is shown in the table entitled “Summary Compensation\nTable—2022, 2021, and 2020\" and the related tables under the section entitled “Executive Compensation.”\n\nFees Earned or All Other\n\nPaid in Cash Stock Awards Compensation Total\nName ($) ($) ($) ($)\nJames Bell 100,000 274,941 8,773 383,714\nAl Gore 100,000 274,941 7,405 382,346\nAlex Gorsky 100,000 348,235 4,950 453,185\nAndrea Jung 130,000 274,941 4,568 409,509\nArt Levinson 275,000 274,941 12,517 562,458\nMonica Lozano 100,000) 274,941 1,533 376,474\nRon Sugar 135,000 274,941 14,006 423,947\nSue Wagner 125,000 274,941 5,477 405,418\n\n(1) In accordance with SEC rules, the amounts shown reflect the aggregate grant date fair value of stock awards granted to Non-Employee Directors during\n2022, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (\"FASB ASC 718\"). The grant\ndate fair value for RSUs is measured based on the closing price of Apple’s common stock on the date of grant. Mr. Gorsky received a pro-rated Initial\nDirector Award of 486 RSUs on November 9, 2021, the effective date of his appointment to the Board, with a grant date fair value for each RSU of $150.81,\nwhich vested on February 1, 2022. Each Non-Employee Director serving on March 4, 2022, received an Annual Director Award of 1,685 RSUs with a grant\ndate fair value for each RSU of $163.17. Each Non-Employee Director serving on the Board as of September 24, 2022, held 1,685 unvested RSUs.\n\n(2) The amounts shown reflect the value of one or more products received under the Board’s equipment program during the fiscal year. The amounts also\ninclude matching charitable contributions under Apple's matching gifts program for Dr. Sugar of $10,000.\n\n(3) Ms. Lozano participated in the Deferred Compensation Plan and deferred $37,500 of her 2022 annual cash retainer. The Deferred Compensation Plan\ndoes not provide for above-market or preferential earnings.","pages":[{"line_numbers":[],"markdown":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 37\n\nDeferred Compensation Plan\n\nWe adopted the Apple Inc. Deferred Compensation Plan (\"Deferred Compensation Plan”) in 2018, effective for deferrals beginning\nin 2019. The Deferred Compensation Plan allows eligible participants, including our Non-Employee Directors, to defer a portion of\ntheir eligible compensation, subject to the terms of the Deferred Compensation Plan. The Deferred Compensation Plan is unfunded\nand unsecured. We do not provide any matching contributions under the Deferred Compensation Plan or allow for deferral of RSUs.\nIn 2022, Ms. Lozano participated in the Deferred Compensation Plan and deferred a portion of her annual cash retainer.\n\nStock Ownership Guidelines\n\nApple has stock ownership guidelines for our CEO, executive officers, and Non-Employee Directors. Under the guidelines, each\nNon-Employee Director is expected, within five years after joining the Board, to own shares of Apple’s common stock that have a\nvalue equal to five times their annual cash retainer for serving as a director. Shares may be owned directly by the individual, owned\njointly with, or separately by, the individual's spouse, or held in trust for the benefit of the individual, the individual's spouse, or the\nindividual's children. Other than Ms. Lozano and Mr. Gorsky, who joined the Board in calendar year 2021, each Non-Employee\nDirector currently owns shares of Apple’s common stock that have a value at least equal to five times their annual cash retainer.\n\nDirector Compensation—2022\n\nThe following table shows information regarding the compensation earned or paid during 2022 to Non-Employee Directors who\nserved on the Board during the year. Mr. Cook's compensation is shown in the table entitled “Summary Compensation\nTable—2022, 2021, and 2020\" and the related tables under the section entitled “Executive Compensation.”\n\nFees Earned or All Other\n\nPaid in Cash Stock Awards Compensation Total\nName ($) ($) ($) ($)\nJames Bell 100,000 274,941 8,773 383,714\nAl Gore 100,000 274,941 7,405 382,346\nAlex Gorsky 100,000 348,235 4,950 453,185\nAndrea Jung 130,000 274,941 4,568 409,509\nArt Levinson 275,000 274,941 12,517 562,458\nMonica Lozano 100,000) 274,941 1,533 376,474\nRon Sugar 135,000 274,941 14,006 423,947\nSue Wagner 125,000 274,941 5,477 405,418\n\n(1) In accordance with SEC rules, the amounts shown reflect the aggregate grant date fair value of stock awards granted to Non-Employee Directors during\n2022, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (\"FASB ASC 718\"). The grant\ndate fair value for RSUs is measured based on the closing price of Apple’s common stock on the date of grant. Mr. Gorsky received a pro-rated Initial\nDirector Award of 486 RSUs on November 9, 2021, the effective date of his appointment to the Board, with a grant date fair value for each RSU of $150.81,\nwhich vested on February 1, 2022. Each Non-Employee Director serving on March 4, 2022, received an Annual Director Award of 1,685 RSUs with a grant\ndate fair value for each RSU of $163.17. Each Non-Employee Director serving on the Board as of September 24, 2022, held 1,685 unvested RSUs.\n\n(2) The amounts shown reflect the value of one or more products received under the Board’s equipment program during the fiscal year. The amounts also\ninclude matching charitable contributions under Apple's matching gifts program for Dr. Sugar of $10,000.\n\n(3) Ms. Lozano participated in the Deferred Compensation Plan and deferred $37,500 of her 2022 annual cash retainer. The Deferred Compensation Plan\ndoes not provide for above-market or preferential earnings.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 37\n\nDeferred Compensation Plan\n\nWe adopted the Apple Inc. Deferred Compensation Plan (\"Deferred Compensation Plan”) in 2018, effective for deferrals beginning\nin 2019. The Deferred Compensation Plan allows eligible participants, including our Non-Employee Directors, to defer a portion of\ntheir eligible compensation, subject to the terms of the Deferred Compensation Plan. The Deferred Compensation Plan is unfunded\nand unsecured. We do not provide any matching contributions under the Deferred Compensation Plan or allow for deferral of RSUs.\nIn 2022, Ms. Lozano participated in the Deferred Compensation Plan and deferred a portion of her annual cash retainer.\n\nStock Ownership Guidelines\n\nApple has stock ownership guidelines for our CEO, executive officers, and Non-Employee Directors. Under the guidelines, each\nNon-Employee Director is expected, within five years after joining the Board, to own shares of Apple’s common stock that have a\nvalue equal to five times their annual cash retainer for serving as a director. Shares may be owned directly by the individual, owned\njointly with, or separately by, the individual's spouse, or held in trust for the benefit of the individual, the individual's spouse, or the\nindividual's children. Other than Ms. Lozano and Mr. Gorsky, who joined the Board in calendar year 2021, each Non-Employee\nDirector currently owns shares of Apple’s common stock that have a value at least equal to five times their annual cash retainer.\n\nDirector Compensation—2022\n\nThe following table shows information regarding the compensation earned or paid during 2022 to Non-Employee Directors who\nserved on the Board during the year. Mr. Cook's compensation is shown in the table entitled “Summary Compensation\nTable—2022, 2021, and 2020\" and the related tables under the section entitled “Executive Compensation.”\n\nFees Earned or All Other\n\nPaid in Cash Stock Awards Compensation Total\nName ($) ($) ($) ($)\nJames Bell 100,000 274,941 8,773 383,714\nAl Gore 100,000 274,941 7,405 382,346\nAlex Gorsky 100,000 348,235 4,950 453,185\nAndrea Jung 130,000 274,941 4,568 409,509\nArt Levinson 275,000 274,941 12,517 562,458\nMonica Lozano 100,000) 274,941 1,533 376,474\nRon Sugar 135,000 274,941 14,006 423,947\nSue Wagner 125,000 274,941 5,477 405,418\n\n(1) In accordance with SEC rules, the amounts shown reflect the aggregate grant date fair value of stock awards granted to Non-Employee Directors during\n2022, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (\"FASB ASC 718\"). The grant\ndate fair value for RSUs is measured based on the closing price of Apple’s common stock on the date of grant. Mr. Gorsky received a pro-rated Initial\nDirector Award of 486 RSUs on November 9, 2021, the effective date of his appointment to the Board, with a grant date fair value for each RSU of $150.81,\nwhich vested on February 1, 2022. Each Non-Employee Director serving on March 4, 2022, received an Annual Director Award of 1,685 RSUs with a grant\ndate fair value for each RSU of $163.17. Each Non-Employee Director serving on the Board as of September 24, 2022, held 1,685 unvested RSUs.\n\n(2) The amounts shown reflect the value of one or more products received under the Board’s equipment program during the fiscal year. The amounts also\ninclude matching charitable contributions under Apple's matching gifts program for Dr. Sugar of $10,000.\n\n(3) Ms. Lozano participated in the Deferred Compensation Plan and deferred $37,500 of her 2022 annual cash retainer. The Deferred Compensation Plan\ndoes not provide for above-market or preferential earnings.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page40.pdf"]},"response":{"errors":[],"extract_id":"extract_09795ce098d15f9f98ca5310d78d3aa7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 37\n\nDeferred Compensation Plan\n\nWe adopted the Apple Inc. Deferred Compensation Plan (\"Deferred Compensation Plan”) in 2018, effective for deferrals beginning\nin 2019. The Deferred Compensation Plan allows eligible participants, including our Non-Employee Directors, to defer a portion of\ntheir eligible compensation, subject to the terms of the Deferred Compensation Plan. The Deferred Compensation Plan is unfunded\nand unsecured. We do not provide any matching contributions under the Deferred Compensation Plan or allow for deferral of RSUs.\nIn 2022, Ms. Lozano participated in the Deferred Compensation Plan and deferred a portion of her annual cash retainer.\n\nStock Ownership Guidelines\n\nApple has stock ownership guidelines for our CEO, executive officers, and Non-Employee Directors. Under the guidelines, each\nNon-Employee Director is expected, within five years after joining the Board, to own shares of Apple’s common stock that have a\nvalue equal to five times their annual cash retainer for serving as a director. Shares may be owned directly by the individual, owned\njointly with, or separately by, the individual's spouse, or held in trust for the benefit of the individual, the individual's spouse, or the\nindividual's children. Other than Ms. Lozano and Mr. Gorsky, who joined the Board in calendar year 2021, each Non-Employee\nDirector currently owns shares of Apple’s common stock that have a value at least equal to five times their annual cash retainer.\n\nDirector Compensation—2022\n\nThe following table shows information regarding the compensation earned or paid during 2022 to Non-Employee Directors who\nserved on the Board during the year. Mr. Cook's compensation is shown in the table entitled “Summary Compensation\nTable—2022, 2021, and 2020\" and the related tables under the section entitled “Executive Compensation.”\n\nFees Earned or All Other\n\nPaid in Cash Stock Awards Compensation Total\nName ($) ($) ($) ($)\nJames Bell 100,000 274,941 8,773 383,714\nAl Gore 100,000 274,941 7,405 382,346\nAlex Gorsky 100,000 348,235 4,950 453,185\nAndrea Jung 130,000 274,941 4,568 409,509\nArt Levinson 275,000 274,941 12,517 562,458\nMonica Lozano 100,000) 274,941 1,533 376,474\nRon Sugar 135,000 274,941 14,006 423,947\nSue Wagner 125,000 274,941 5,477 405,418\n\n(1) In accordance with SEC rules, the amounts shown reflect the aggregate grant date fair value of stock awards granted to Non-Employee Directors during\n2022, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (\"FASB ASC 718\"). The grant\ndate fair value for RSUs is measured based on the closing price of Apple’s common stock on the date of grant. Mr. Gorsky received a pro-rated Initial\nDirector Award of 486 RSUs on November 9, 2021, the effective date of his appointment to the Board, with a grant date fair value for each RSU of $150.81,\nwhich vested on February 1, 2022. Each Non-Employee Director serving on March 4, 2022, received an Annual Director Award of 1,685 RSUs with a grant\ndate fair value for each RSU of $163.17. Each Non-Employee Director serving on the Board as of September 24, 2022, held 1,685 unvested RSUs.\n\n(2) The amounts shown reflect the value of one or more products received under the Board’s equipment program during the fiscal year. The amounts also\ninclude matching charitable contributions under Apple's matching gifts program for Dr. Sugar of $10,000.\n\n(3) Ms. Lozano participated in the Deferred Compensation Plan and deferred $37,500 of her 2022 annual cash retainer. The Deferred Compensation Plan\ndoes not provide for above-market or preferential earnings."],"full_content":"Summary Governance Directors Compensation Proposals Other Information 2023 Proxy Statement 37\n\nDeferred Compensation Plan\n\nWe adopted the Apple Inc. Deferred Compensation Plan (\"Deferred Compensation Plan”) in 2018, effective for deferrals beginning\nin 2019. The Deferred Compensation Plan allows eligible participants, including our Non-Employee Directors, to defer a portion of\ntheir eligible compensation, subject to the terms of the Deferred Compensation Plan. The Deferred Compensation Plan is unfunded\nand unsecured. We do not provide any matching contributions under the Deferred Compensation Plan or allow for deferral of RSUs.\nIn 2022, Ms. Lozano participated in the Deferred Compensation Plan and deferred a portion of her annual cash retainer.\n\nStock Ownership Guidelines\n\nApple has stock ownership guidelines for our CEO, executive officers, and Non-Employee Directors. Under the guidelines, each\nNon-Employee Director is expected, within five years after joining the Board, to own shares of Apple’s common stock that have a\nvalue equal to five times their annual cash retainer for serving as a director. Shares may be owned directly by the individual, owned\njointly with, or separately by, the individual's spouse, or held in trust for the benefit of the individual, the individual's spouse, or the\nindividual's children. Other than Ms. Lozano and Mr. Gorsky, who joined the Board in calendar year 2021, each Non-Employee\nDirector currently owns shares of Apple’s common stock that have a value at least equal to five times their annual cash retainer.\n\nDirector Compensation—2022\n\nThe following table shows information regarding the compensation earned or paid during 2022 to Non-Employee Directors who\nserved on the Board during the year. Mr. Cook's compensation is shown in the table entitled “Summary Compensation\nTable—2022, 2021, and 2020\" and the related tables under the section entitled “Executive Compensation.”\n\nFees Earned or All Other\n\nPaid in Cash Stock Awards Compensation Total\nName ($) ($) ($) ($)\nJames Bell 100,000 274,941 8,773 383,714\nAl Gore 100,000 274,941 7,405 382,346\nAlex Gorsky 100,000 348,235 4,950 453,185\nAndrea Jung 130,000 274,941 4,568 409,509\nArt Levinson 275,000 274,941 12,517 562,458\nMonica Lozano 100,000) 274,941 1,533 376,474\nRon Sugar 135,000 274,941 14,006 423,947\nSue Wagner 125,000 274,941 5,477 405,418\n\n(1) In accordance with SEC rules, the amounts shown reflect the aggregate grant date fair value of stock awards granted to Non-Employee Directors during\n2022, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (\"FASB ASC 718\"). The grant\ndate fair value for RSUs is measured based on the closing price of Apple’s common stock on the date of grant. Mr. Gorsky received a pro-rated Initial\nDirector Award of 486 RSUs on November 9, 2021, the effective date of his appointment to the Board, with a grant date fair value for each RSU of $150.81,\nwhich vested on February 1, 2022. Each Non-Employee Director serving on March 4, 2022, received an Annual Director Award of 1,685 RSUs with a grant\ndate fair value for each RSU of $163.17. Each Non-Employee Director serving on the Board as of September 24, 2022, held 1,685 unvested RSUs.\n\n(2) The amounts shown reflect the value of one or more products received under the Board’s equipment program during the fiscal year. The amounts also\ninclude matching charitable contributions under Apple's matching gifts program for Dr. Sugar of $10,000.\n\n(3) Ms. Lozano participated in the Deferred Compensation Plan and deferred $37,500 of her 2022 annual cash retainer. The Deferred Compensation Plan\ndoes not provide for above-market or preferential earnings.","publish_date":null,"title":"Tables Apple Def 14A Page40","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page40.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page40.pdf"},"request":{"example_id":"table/Tables - Apple Def 14a_page40","product_type":"parse","source_file_path":"Tables - Apple Def 14a_page40.pdf"},"started_at":"2026-11-04T19:47:57.118937"} +{"completed_at":"2026-11-04T19:48:05.870855","latency_in_ms":7385,"output":{"example_id":"table/Tables - Apple Def 14a_page67","grounded_pages":[],"layout_pages":[],"markdown":"64 2023 Proxy Statement Summary Governance Directors Compensation\n\nProposals\n\nOther Information\n\n(6) 60,936 time-based RSUs subject to this award vested on April1, 2022, and subject to the terms of the award agreement, the remainder of the RSUs are\nscheduled to vest in two annual installments of 60,932, commencing on April 1, 2023, provided the officer continues to be employed with Apple through the\n\napplicable vesting date.\n\n(7) 200% of the 182,800 target number of performance-based RSUs subject to this award (totaling 365,600 performance-based RSUs) vested on October 1, 2022,\nbased on Apple's Relative TSR compared to other companies in the S&P 500 over the relevant performance period.\n\n(8) 16,612 time-based RSUs subject to this award vested on October 15, 2022.\n\n(9) Subject to the terms of the award agreement, the remaining 31,896 time-based RSUs are scheduled to vest on August 5, 2023, provided the officer continues to\n\nbe employed with Apple through the applicable vesting date.\n\nStock Awards\n\nValue Realized on\nVesting\n($)(c)®\n\n87,717,519\n72,614,486\n\n52,374,037\n\nStock Vested—2022\n\nThe following table shows information regarding the vesting during 2022 of RSUs previously granted to the named executive\n\nofficers.\n\nNumber of Shares\n\nName Acquired on Vesting\n(a) (#)(b)\nTim Cook \\_\nLuca Maestri 559,324\nKate Adams 474,392\nDeirdre O'Brien 339,724\nJeff Williams 559,324\n\n87,717,519\n\n(1) The dollar amounts shown in column (c) are determined by multiplying the number of shares acquired on vesting by the per-share closing price of\nApple's common stock on the vesting date, plus dividend equivalents attributable to such shares in the amount of $1,441,803 for each of Mr. Maestri\n\nand Mr. Williams; $1,143,267 for Ms. Adams; and $797,840 for Ms. O'Brien.","pages":[{"line_numbers":[],"markdown":"64 2023 Proxy Statement Summary Governance Directors Compensation\n\nProposals\n\nOther Information\n\n(6) 60,936 time-based RSUs subject to this award vested on April1, 2022, and subject to the terms of the award agreement, the remainder of the RSUs are\nscheduled to vest in two annual installments of 60,932, commencing on April 1, 2023, provided the officer continues to be employed with Apple through the\n\napplicable vesting date.\n\n(7) 200% of the 182,800 target number of performance-based RSUs subject to this award (totaling 365,600 performance-based RSUs) vested on October 1, 2022,\nbased on Apple's Relative TSR compared to other companies in the S&P 500 over the relevant performance period.\n\n(8) 16,612 time-based RSUs subject to this award vested on October 15, 2022.\n\n(9) Subject to the terms of the award agreement, the remaining 31,896 time-based RSUs are scheduled to vest on August 5, 2023, provided the officer continues to\n\nbe employed with Apple through the applicable vesting date.\n\nStock Awards\n\nValue Realized on\nVesting\n($)(c)®\n\n87,717,519\n72,614,486\n\n52,374,037\n\nStock Vested—2022\n\nThe following table shows information regarding the vesting during 2022 of RSUs previously granted to the named executive\n\nofficers.\n\nNumber of Shares\n\nName Acquired on Vesting\n(a) (#)(b)\nTim Cook \\_\nLuca Maestri 559,324\nKate Adams 474,392\nDeirdre O'Brien 339,724\nJeff Williams 559,324\n\n87,717,519\n\n(1) The dollar amounts shown in column (c) are determined by multiplying the number of shares acquired on vesting by the per-share closing price of\nApple's common stock on the vesting date, plus dividend equivalents attributable to such shares in the amount of $1,441,803 for each of Mr. Maestri\n\nand Mr. Williams; $1,143,267 for Ms. Adams; and $797,840 for Ms. O'Brien.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"64 2023 Proxy Statement Summary Governance Directors Compensation\n\nProposals\n\nOther Information\n\n(6) 60,936 time-based RSUs subject to this award vested on April1, 2022, and subject to the terms of the award agreement, the remainder of the RSUs are\nscheduled to vest in two annual installments of 60,932, commencing on April 1, 2023, provided the officer continues to be employed with Apple through the\n\napplicable vesting date.\n\n(7) 200% of the 182,800 target number of performance-based RSUs subject to this award (totaling 365,600 performance-based RSUs) vested on October 1, 2022,\nbased on Apple's Relative TSR compared to other companies in the S&P 500 over the relevant performance period.\n\n(8) 16,612 time-based RSUs subject to this award vested on October 15, 2022.\n\n(9) Subject to the terms of the award agreement, the remaining 31,896 time-based RSUs are scheduled to vest on August 5, 2023, provided the officer continues to\n\nbe employed with Apple through the applicable vesting date.\n\nStock Awards\n\nValue Realized on\nVesting\n($)(c)®\n\n87,717,519\n72,614,486\n\n52,374,037\n\nStock Vested—2022\n\nThe following table shows information regarding the vesting during 2022 of RSUs previously granted to the named executive\n\nofficers.\n\nNumber of Shares\n\nName Acquired on Vesting\n(a) (#)(b)\nTim Cook \\_\nLuca Maestri 559,324\nKate Adams 474,392\nDeirdre O'Brien 339,724\nJeff Williams 559,324\n\n87,717,519\n\n(1) The dollar amounts shown in column (c) are determined by multiplying the number of shares acquired on vesting by the per-share closing price of\nApple's common stock on the vesting date, plus dividend equivalents attributable to such shares in the amount of $1,441,803 for each of Mr. Maestri\n\nand Mr. Williams; $1,143,267 for Ms. Adams; and $797,840 for Ms. O'Brien.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page67.pdf"]},"response":{"errors":[],"extract_id":"extract_0d1182c02483cf1c66b9cc3f6dd2bfce","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["64 2023 Proxy Statement Summary Governance Directors Compensation\n\nProposals\n\nOther Information\n\n(6) 60,936 time-based RSUs subject to this award vested on April1, 2022, and subject to the terms of the award agreement, the remainder of the RSUs are\nscheduled to vest in two annual installments of 60,932, commencing on April 1, 2023, provided the officer continues to be employed with Apple through the\n\napplicable vesting date.\n\n(7) 200% of the 182,800 target number of performance-based RSUs subject to this award (totaling 365,600 performance-based RSUs) vested on October 1, 2022,\nbased on Apple's Relative TSR compared to other companies in the S&P 500 over the relevant performance period.\n\n(8) 16,612 time-based RSUs subject to this award vested on October 15, 2022.\n\n(9) Subject to the terms of the award agreement, the remaining 31,896 time-based RSUs are scheduled to vest on August 5, 2023, provided the officer continues to\n\nbe employed with Apple through the applicable vesting date.\n\nStock Awards\n\nValue Realized on\nVesting\n($)(c)®\n\n87,717,519\n72,614,486\n\n52,374,037\n\nStock Vested—2022\n\nThe following table shows information regarding the vesting during 2022 of RSUs previously granted to the named executive\n\nofficers.\n\nNumber of Shares\n\nName Acquired on Vesting\n(a) (#)(b)\nTim Cook \\_\nLuca Maestri 559,324\nKate Adams 474,392\nDeirdre O'Brien 339,724\nJeff Williams 559,324\n\n87,717,519\n\n(1) The dollar amounts shown in column (c) are determined by multiplying the number of shares acquired on vesting by the per-share closing price of\nApple's common stock on the vesting date, plus dividend equivalents attributable to such shares in the amount of $1,441,803 for each of Mr. Maestri\n\nand Mr. Williams; $1,143,267 for Ms. Adams; and $797,840 for Ms. O'Brien."],"full_content":"64 2023 Proxy Statement Summary Governance Directors Compensation\n\nProposals\n\nOther Information\n\n(6) 60,936 time-based RSUs subject to this award vested on April1, 2022, and subject to the terms of the award agreement, the remainder of the RSUs are\nscheduled to vest in two annual installments of 60,932, commencing on April 1, 2023, provided the officer continues to be employed with Apple through the\n\napplicable vesting date.\n\n(7) 200% of the 182,800 target number of performance-based RSUs subject to this award (totaling 365,600 performance-based RSUs) vested on October 1, 2022,\nbased on Apple's Relative TSR compared to other companies in the S&P 500 over the relevant performance period.\n\n(8) 16,612 time-based RSUs subject to this award vested on October 15, 2022.\n\n(9) Subject to the terms of the award agreement, the remaining 31,896 time-based RSUs are scheduled to vest on August 5, 2023, provided the officer continues to\n\nbe employed with Apple through the applicable vesting date.\n\nStock Awards\n\nValue Realized on\nVesting\n($)(c)®\n\n87,717,519\n72,614,486\n\n52,374,037\n\nStock Vested—2022\n\nThe following table shows information regarding the vesting during 2022 of RSUs previously granted to the named executive\n\nofficers.\n\nNumber of Shares\n\nName Acquired on Vesting\n(a) (#)(b)\nTim Cook \\_\nLuca Maestri 559,324\nKate Adams 474,392\nDeirdre O'Brien 339,724\nJeff Williams 559,324\n\n87,717,519\n\n(1) The dollar amounts shown in column (c) are determined by multiplying the number of shares acquired on vesting by the per-share closing price of\nApple's common stock on the vesting date, plus dividend equivalents attributable to such shares in the amount of $1,441,803 for each of Mr. Maestri\n\nand Mr. Williams; $1,143,267 for Ms. Adams; and $797,840 for Ms. O'Brien.","publish_date":null,"title":"Tables Apple Def 14A Page67","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page67.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page67.pdf"},"request":{"example_id":"table/Tables - Apple Def 14a_page67","product_type":"parse","source_file_path":"Tables - Apple Def 14a_page67.pdf"},"started_at":"2026-11-04T19:47:58.485642"} +{"completed_at":"2026-11-04T19:31:15.703553","latency_in_ms":6396,"output":{"example_id":"table/Tables - Apple Def 14a_page75","grounded_pages":[],"layout_pages":[],"markdown":"72 2023 Proxy Statement Summary Governance Directors Compensation Proposals Other Information\n\nFees Paid to Auditors\n\nThe following table shows the fees billed by Apple's independent registered public accounting firm for the years ended\nSeptember 24, 2022 and September 25, 2021.\n\n2022 2021\nErnst & Young ($) ($)\nAudit Fees” 17,763,384 17,683,114\nAudit—Related Fees” 1,551,423 1,161,409\nTax Fees® 3,289,432 3,662,997\nAll Other Fees 131,610 715,310\nTotal 22,735,849 23,222,830\n\n(1) Audit fees relate to professional services rendered in connection with the audit of Apple’s annual financial statements and internal control over financial\nreporting, quarterly review of financial statements, and audit services provided in connection with other statutory and regulatory filings.\n\n(2) Audit-related fees relate to professional services that are reasonably related to the performance of the audit or review of Apple's financial statements.\n\n(3) Tax fees relate to professional services rendered in connection with tax compliance and preparation relating to tax returns and tax audits, as well as for\n\ntax consulting and planning services. Tax fees in 2022 include $1.1 million for tax compliance projects and $2.1 million for tax advisory projects. Tax fees\nin 2021 include $1.1 million for tax compliance projects and $2.6 million for tax advisory projects.\n\n(4) All other fees relate to professional services not included in the categories above, including services related to other permissible advisory services and\nregulatory reporting requirements.\n\nPolicy on Audit Committee Pre-Approval of Audit and Non-Audit Services Performed by the\nIndependent Registered Public Accounting Firm\n\nApple maintains an auditor independence policy that, among other things, prohibits Apple’s independent registered public\naccounting firm from performing non-financial consulting services for Apple, such as information technology consulting and internal\naudit services. This policy mandates that the Audit Committee approve in advance the audit and permissible non-audit services\nexpected to be performed each year by the independent registered public accounting firm and the related budget, and that the Audit\nCommittee be provided with quarterly reporting on actual spending. This policy also mandates that Apple may not enter into\nengagements with Apple's independent registered public accounting firm for other permissible non-audit services without the\nexpress pre-approval of the Audit Committee. In accordance with this policy, the Audit Committee pre-approved all services\nperformed by Apple's independent registered public accounting firm in 2022.","pages":[{"line_numbers":[],"markdown":"72 2023 Proxy Statement Summary Governance Directors Compensation Proposals Other Information\n\nFees Paid to Auditors\n\nThe following table shows the fees billed by Apple's independent registered public accounting firm for the years ended\nSeptember 24, 2022 and September 25, 2021.\n\n2022 2021\nErnst & Young ($) ($)\nAudit Fees” 17,763,384 17,683,114\nAudit—Related Fees” 1,551,423 1,161,409\nTax Fees® 3,289,432 3,662,997\nAll Other Fees 131,610 715,310\nTotal 22,735,849 23,222,830\n\n(1) Audit fees relate to professional services rendered in connection with the audit of Apple’s annual financial statements and internal control over financial\nreporting, quarterly review of financial statements, and audit services provided in connection with other statutory and regulatory filings.\n\n(2) Audit-related fees relate to professional services that are reasonably related to the performance of the audit or review of Apple's financial statements.\n\n(3) Tax fees relate to professional services rendered in connection with tax compliance and preparation relating to tax returns and tax audits, as well as for\n\ntax consulting and planning services. Tax fees in 2022 include $1.1 million for tax compliance projects and $2.1 million for tax advisory projects. Tax fees\nin 2021 include $1.1 million for tax compliance projects and $2.6 million for tax advisory projects.\n\n(4) All other fees relate to professional services not included in the categories above, including services related to other permissible advisory services and\nregulatory reporting requirements.\n\nPolicy on Audit Committee Pre-Approval of Audit and Non-Audit Services Performed by the\nIndependent Registered Public Accounting Firm\n\nApple maintains an auditor independence policy that, among other things, prohibits Apple’s independent registered public\naccounting firm from performing non-financial consulting services for Apple, such as information technology consulting and internal\naudit services. This policy mandates that the Audit Committee approve in advance the audit and permissible non-audit services\nexpected to be performed each year by the independent registered public accounting firm and the related budget, and that the Audit\nCommittee be provided with quarterly reporting on actual spending. This policy also mandates that Apple may not enter into\nengagements with Apple's independent registered public accounting firm for other permissible non-audit services without the\nexpress pre-approval of the Audit Committee. In accordance with this policy, the Audit Committee pre-approved all services\nperformed by Apple's independent registered public accounting firm in 2022.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"72 2023 Proxy Statement Summary Governance Directors Compensation Proposals Other Information\n\nFees Paid to Auditors\n\nThe following table shows the fees billed by Apple's independent registered public accounting firm for the years ended\nSeptember 24, 2022 and September 25, 2021.\n\n2022 2021\nErnst & Young ($) ($)\nAudit Fees” 17,763,384 17,683,114\nAudit—Related Fees” 1,551,423 1,161,409\nTax Fees® 3,289,432 3,662,997\nAll Other Fees 131,610 715,310\nTotal 22,735,849 23,222,830\n\n(1) Audit fees relate to professional services rendered in connection with the audit of Apple’s annual financial statements and internal control over financial\nreporting, quarterly review of financial statements, and audit services provided in connection with other statutory and regulatory filings.\n\n(2) Audit-related fees relate to professional services that are reasonably related to the performance of the audit or review of Apple's financial statements.\n\n(3) Tax fees relate to professional services rendered in connection with tax compliance and preparation relating to tax returns and tax audits, as well as for\n\ntax consulting and planning services. Tax fees in 2022 include $1.1 million for tax compliance projects and $2.1 million for tax advisory projects. Tax fees\nin 2021 include $1.1 million for tax compliance projects and $2.6 million for tax advisory projects.\n\n(4) All other fees relate to professional services not included in the categories above, including services related to other permissible advisory services and\nregulatory reporting requirements.\n\nPolicy on Audit Committee Pre-Approval of Audit and Non-Audit Services Performed by the\nIndependent Registered Public Accounting Firm\n\nApple maintains an auditor independence policy that, among other things, prohibits Apple’s independent registered public\naccounting firm from performing non-financial consulting services for Apple, such as information technology consulting and internal\naudit services. This policy mandates that the Audit Committee approve in advance the audit and permissible non-audit services\nexpected to be performed each year by the independent registered public accounting firm and the related budget, and that the Audit\nCommittee be provided with quarterly reporting on actual spending. This policy also mandates that Apple may not enter into\nengagements with Apple's independent registered public accounting firm for other permissible non-audit services without the\nexpress pre-approval of the Audit Committee. In accordance with this policy, the Audit Committee pre-approved all services\nperformed by Apple's independent registered public accounting firm in 2022.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page75.pdf"]},"response":{"errors":[],"extract_id":"extract_cb8b758dcd6e799add1a213aeed4d190","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["72 2023 Proxy Statement Summary Governance Directors Compensation Proposals Other Information\n\nFees Paid to Auditors\n\nThe following table shows the fees billed by Apple's independent registered public accounting firm for the years ended\nSeptember 24, 2022 and September 25, 2021.\n\n2022 2021\nErnst & Young ($) ($)\nAudit Fees” 17,763,384 17,683,114\nAudit—Related Fees” 1,551,423 1,161,409\nTax Fees® 3,289,432 3,662,997\nAll Other Fees 131,610 715,310\nTotal 22,735,849 23,222,830\n\n(1) Audit fees relate to professional services rendered in connection with the audit of Apple’s annual financial statements and internal control over financial\nreporting, quarterly review of financial statements, and audit services provided in connection with other statutory and regulatory filings.\n\n(2) Audit-related fees relate to professional services that are reasonably related to the performance of the audit or review of Apple's financial statements.\n\n(3) Tax fees relate to professional services rendered in connection with tax compliance and preparation relating to tax returns and tax audits, as well as for\n\ntax consulting and planning services. Tax fees in 2022 include $1.1 million for tax compliance projects and $2.1 million for tax advisory projects. Tax fees\nin 2021 include $1.1 million for tax compliance projects and $2.6 million for tax advisory projects.\n\n(4) All other fees relate to professional services not included in the categories above, including services related to other permissible advisory services and\nregulatory reporting requirements.\n\nPolicy on Audit Committee Pre-Approval of Audit and Non-Audit Services Performed by the\nIndependent Registered Public Accounting Firm\n\nApple maintains an auditor independence policy that, among other things, prohibits Apple’s independent registered public\naccounting firm from performing non-financial consulting services for Apple, such as information technology consulting and internal\naudit services. This policy mandates that the Audit Committee approve in advance the audit and permissible non-audit services\nexpected to be performed each year by the independent registered public accounting firm and the related budget, and that the Audit\nCommittee be provided with quarterly reporting on actual spending. This policy also mandates that Apple may not enter into\nengagements with Apple's independent registered public accounting firm for other permissible non-audit services without the\nexpress pre-approval of the Audit Committee. In accordance with this policy, the Audit Committee pre-approved all services\nperformed by Apple's independent registered public accounting firm in 2022."],"full_content":"72 2023 Proxy Statement Summary Governance Directors Compensation Proposals Other Information\n\nFees Paid to Auditors\n\nThe following table shows the fees billed by Apple's independent registered public accounting firm for the years ended\nSeptember 24, 2022 and September 25, 2021.\n\n2022 2021\nErnst & Young ($) ($)\nAudit Fees” 17,763,384 17,683,114\nAudit—Related Fees” 1,551,423 1,161,409\nTax Fees® 3,289,432 3,662,997\nAll Other Fees 131,610 715,310\nTotal 22,735,849 23,222,830\n\n(1) Audit fees relate to professional services rendered in connection with the audit of Apple’s annual financial statements and internal control over financial\nreporting, quarterly review of financial statements, and audit services provided in connection with other statutory and regulatory filings.\n\n(2) Audit-related fees relate to professional services that are reasonably related to the performance of the audit or review of Apple's financial statements.\n\n(3) Tax fees relate to professional services rendered in connection with tax compliance and preparation relating to tax returns and tax audits, as well as for\n\ntax consulting and planning services. Tax fees in 2022 include $1.1 million for tax compliance projects and $2.1 million for tax advisory projects. Tax fees\nin 2021 include $1.1 million for tax compliance projects and $2.6 million for tax advisory projects.\n\n(4) All other fees relate to professional services not included in the categories above, including services related to other permissible advisory services and\nregulatory reporting requirements.\n\nPolicy on Audit Committee Pre-Approval of Audit and Non-Audit Services Performed by the\nIndependent Registered Public Accounting Firm\n\nApple maintains an auditor independence policy that, among other things, prohibits Apple’s independent registered public\naccounting firm from performing non-financial consulting services for Apple, such as information technology consulting and internal\naudit services. This policy mandates that the Audit Committee approve in advance the audit and permissible non-audit services\nexpected to be performed each year by the independent registered public accounting firm and the related budget, and that the Audit\nCommittee be provided with quarterly reporting on actual spending. This policy also mandates that Apple may not enter into\nengagements with Apple's independent registered public accounting firm for other permissible non-audit services without the\nexpress pre-approval of the Audit Committee. In accordance with this policy, the Audit Committee pre-approved all services\nperformed by Apple's independent registered public accounting firm in 2022.","publish_date":null,"title":"Tables Apple Def 14A Page75","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page75.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page75.pdf"},"request":{"example_id":"table/Tables - Apple Def 14a_page75","product_type":"parse","source_file_path":"Tables - Apple Def 14a_page75.pdf"},"started_at":"2026-11-04T19:31:09.306842"} +{"completed_at":"2026-11-04T19:48:20.234193","latency_in_ms":19317,"output":{"example_id":"table/Tables - Apple Def 14a_page8","grounded_pages":[],"layout_pages":[],"markdown":"@\nApple Inc.\n\nNotice of 2023 Annual Meeting of Shareholders\n\nDate and Time Virtual Meeting Site\n\nMarch 10, 2023 www.virtualshareholdermeeting.com/AAPL2023\n\n9:00 A.M. Pacific Time\nWho Can Vote\n\nShareholders of record at the close of business on January 9, 2023\n\nItems of Business and Board Voting Recommendation\n\n1 Election of Directors: James Bell, Tim Cook, Al Gore, Alex Gorsky, Andrea Jung,\nArt Levinson, Monica Lozano, Ron Sugar, and Sue Wagner\n\n2 Ratification of Appointment of Independent Registered Public Accounting Firm\n3 Advisory Vote to Approve Executive Compensation\n\n4 Advisory Vote on the Frequency of Advisory Votes on Executive Compensation\n5-9 Shareholder Proposals if properly presented\n\nFOR each of the\nnominees\n\nFOR\nFOR\n1YEAR\n\nAGAINST\n\nAnd other business as may properly come before the Annual Meeting and any postponements or adjournments thereof.\n\nSincerely,\n\nCoke £ (leben\n\nKatherine Adams\n\nSenior Vice President,\n\nGeneral Counsel and Secretary\nCupertino, California\n\nJanuary 12, 2023\n\nImportant notice regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to be held on March 10, 2023. The\nNotice of Meeting, Proxy Statement, and Annual Report on Form 10-K are available free of charge at proxyvote.com and at\n\ninvestor.apple.com.","pages":[{"line_numbers":[],"markdown":"@\nApple Inc.\n\nNotice of 2023 Annual Meeting of Shareholders\n\nDate and Time Virtual Meeting Site\n\nMarch 10, 2023 www.virtualshareholdermeeting.com/AAPL2023\n\n9:00 A.M. Pacific Time\nWho Can Vote\n\nShareholders of record at the close of business on January 9, 2023\n\nItems of Business and Board Voting Recommendation\n\n1 Election of Directors: James Bell, Tim Cook, Al Gore, Alex Gorsky, Andrea Jung,\nArt Levinson, Monica Lozano, Ron Sugar, and Sue Wagner\n\n2 Ratification of Appointment of Independent Registered Public Accounting Firm\n3 Advisory Vote to Approve Executive Compensation\n\n4 Advisory Vote on the Frequency of Advisory Votes on Executive Compensation\n5-9 Shareholder Proposals if properly presented\n\nFOR each of the\nnominees\n\nFOR\nFOR\n1YEAR\n\nAGAINST\n\nAnd other business as may properly come before the Annual Meeting and any postponements or adjournments thereof.\n\nSincerely,\n\nCoke £ (leben\n\nKatherine Adams\n\nSenior Vice President,\n\nGeneral Counsel and Secretary\nCupertino, California\n\nJanuary 12, 2023\n\nImportant notice regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to be held on March 10, 2023. The\nNotice of Meeting, Proxy Statement, and Annual Report on Form 10-K are available free of charge at proxyvote.com and at\n\ninvestor.apple.com.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"@\nApple Inc.\n\nNotice of 2023 Annual Meeting of Shareholders\n\nDate and Time Virtual Meeting Site\n\nMarch 10, 2023 www.virtualshareholdermeeting.com/AAPL2023\n\n9:00 A.M. Pacific Time\nWho Can Vote\n\nShareholders of record at the close of business on January 9, 2023\n\nItems of Business and Board Voting Recommendation\n\n1 Election of Directors: James Bell, Tim Cook, Al Gore, Alex Gorsky, Andrea Jung,\nArt Levinson, Monica Lozano, Ron Sugar, and Sue Wagner\n\n2 Ratification of Appointment of Independent Registered Public Accounting Firm\n3 Advisory Vote to Approve Executive Compensation\n\n4 Advisory Vote on the Frequency of Advisory Votes on Executive Compensation\n5-9 Shareholder Proposals if properly presented\n\nFOR each of the\nnominees\n\nFOR\nFOR\n1YEAR\n\nAGAINST\n\nAnd other business as may properly come before the Annual Meeting and any postponements or adjournments thereof.\n\nSincerely,\n\nCoke £ (leben\n\nKatherine Adams\n\nSenior Vice President,\n\nGeneral Counsel and Secretary\nCupertino, California\n\nJanuary 12, 2023\n\nImportant notice regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to be held on March 10, 2023. The\nNotice of Meeting, Proxy Statement, and Annual Report on Form 10-K are available free of charge at proxyvote.com and at\n\ninvestor.apple.com.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page8.pdf"]},"response":{"errors":[],"extract_id":"extract_56cc451daca06be72a5b378204685167","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["@\nApple Inc.\n\nNotice of 2023 Annual Meeting of Shareholders\n\nDate and Time Virtual Meeting Site\n\nMarch 10, 2023 www.virtualshareholdermeeting.com/AAPL2023\n\n9:00 A.M. Pacific Time\nWho Can Vote\n\nShareholders of record at the close of business on January 9, 2023\n\nItems of Business and Board Voting Recommendation\n\n1 Election of Directors: James Bell, Tim Cook, Al Gore, Alex Gorsky, Andrea Jung,\nArt Levinson, Monica Lozano, Ron Sugar, and Sue Wagner\n\n2 Ratification of Appointment of Independent Registered Public Accounting Firm\n3 Advisory Vote to Approve Executive Compensation\n\n4 Advisory Vote on the Frequency of Advisory Votes on Executive Compensation\n5-9 Shareholder Proposals if properly presented\n\nFOR each of the\nnominees\n\nFOR\nFOR\n1YEAR\n\nAGAINST\n\nAnd other business as may properly come before the Annual Meeting and any postponements or adjournments thereof.\n\nSincerely,\n\nCoke £ (leben\n\nKatherine Adams\n\nSenior Vice President,\n\nGeneral Counsel and Secretary\nCupertino, California\n\nJanuary 12, 2023\n\nImportant notice regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to be held on March 10, 2023. The\nNotice of Meeting, Proxy Statement, and Annual Report on Form 10-K are available free of charge at proxyvote.com and at\n\ninvestor.apple.com."],"full_content":"@\nApple Inc.\n\nNotice of 2023 Annual Meeting of Shareholders\n\nDate and Time Virtual Meeting Site\n\nMarch 10, 2023 www.virtualshareholdermeeting.com/AAPL2023\n\n9:00 A.M. Pacific Time\nWho Can Vote\n\nShareholders of record at the close of business on January 9, 2023\n\nItems of Business and Board Voting Recommendation\n\n1 Election of Directors: James Bell, Tim Cook, Al Gore, Alex Gorsky, Andrea Jung,\nArt Levinson, Monica Lozano, Ron Sugar, and Sue Wagner\n\n2 Ratification of Appointment of Independent Registered Public Accounting Firm\n3 Advisory Vote to Approve Executive Compensation\n\n4 Advisory Vote on the Frequency of Advisory Votes on Executive Compensation\n5-9 Shareholder Proposals if properly presented\n\nFOR each of the\nnominees\n\nFOR\nFOR\n1YEAR\n\nAGAINST\n\nAnd other business as may properly come before the Annual Meeting and any postponements or adjournments thereof.\n\nSincerely,\n\nCoke £ (leben\n\nKatherine Adams\n\nSenior Vice President,\n\nGeneral Counsel and Secretary\nCupertino, California\n\nJanuary 12, 2023\n\nImportant notice regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to be held on March 10, 2023. The\nNotice of Meeting, Proxy Statement, and Annual Report on Form 10-K are available free of charge at proxyvote.com and at\n\ninvestor.apple.com.","publish_date":null,"title":"Tables Apple Def 14A Page8","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page8.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Tables%20-%20Apple%20Def%2014a_page8.pdf"},"request":{"example_id":"table/Tables - Apple Def 14a_page8","product_type":"parse","source_file_path":"Tables - Apple Def 14a_page8.pdf"},"started_at":"2026-11-04T19:48:00.916470"} +{"completed_at":"2026-11-04T19:48:04.561562","latency_in_ms":2297,"output":{"example_id":"table/UNM.2007.page_51.pdf_45297_page1","grounded_pages":[],"layout_pages":[],"markdown":"Unum 2007 Annual Report 49\n\n### Unum US Group Disability Operating Results\n\nShown below are financial results and key performance indicators for Unum US group disability.\n\nYear Ended December 31\n\n(in millions of dollars, except ratios) 2007 % Change 2006 % Change 2005\n\nOperating Revenue\n\nPremium Income\n\nGroup Long-term Disability $ 1,895.7 (2.9)% $ 1,953.3 (0.4)% $ 1,961.6\n\nGroup Short-term Disability 485.6 (8.4) 530.2 (6.4) 566.3\n\nTotal Premium Income 2,381.3 (4.1) 2,483.5 (1.8) 2,527.9\n\nNet Investment Income 636.0 2.3 621.9 2.7 605.7\n\nOther Income 100.2 21.7 82.3 2.5 80.3\n\nTotal 3,117.5 (2.2) 3,187.7 (0.8) 3,213.9\n\nBenefits and Expenses\n\nBenefits and Change in Reserves for Future Benefits 2,277.4 (15.7) 2,702.5 12.7 2,397.7\n\nCommissions 167.7 (4.6) 175.8 0.4 175.1\n\nDeferral of Acquisition Costs (60.4) (6.4) (64.5) (0.2) (64.6)\n\nAmortization of Deferred Acquisition Costs 66.2 (23.4) 86.4 (6.3) 92.2\n\nOther Expenses 561.6 (4.6) 588.6 1.0 582.5\n\nTotal 3,012.5 (13.7) 3,488.8 9.6 3,182.9\n\nOperating Income (Loss) Before Income Tax\n\nand Net Realized Investment Gains and Losses $ 105.0 134.9 $ (301.1) N.M. $ 31.0\n\nOperating Ratios (% of Premium Income):\n\nBenefit Ratio (1) 95\\.6% 108.8)% 94.8%\n\nOther Expense Ratio (2) 23\\.6% 23.7)% 23.0%\n\nBefore-tax Operating Income (Loss) Ratio (3) 4\\.4% (12.1)% 1.2%\n\nPremium Persistency:\n\nGroup Long-term Disability 85.1% 87.8)% 84.8%\n\nGroup Short-term Disability 74.0% 85.6)% 79.6%\n\nCase Persistency:\n\nGroup Long-term Disability 88.4% 87.4)% 87.2%\n\nGroup Short-term Disability 87.4% 86.2)% 85.6%\n\nN.M. = not a meaningful percentage\n\n(1) Included in these ratios are charges of $76.5 million, $349.2 million, and $27.3 million in 2007, 2006, and 2005, respectively, related to the claim reassessment process. Excluding these charges, the benefit ratios for 2007, 2006, and 2005 would have been 92.4%, 94.8%, and 93.8%, respectively.\n\n(2) Included in these ratios are increases (decreases) of $(10.3) million, $15.0 million, and $10.1 million in 2007, 2006 and 2005, respectively, related to the claim reassessment process. Excluding these items, the other expense ratios for 2007, 2006, and 2005 would have been 24.0%, 23.1% and 22.6%, respectively.\n\n(3) Included in these ratios are charges of $66.2 million, $364.2 million, and $37.4 million in 2007, 2006, and 2005, respectively, related to the claim reassessment process. Excluding these charges, the before-tax operating income ratio for 2007, 2006, and 2005 would have been 7.2%, 2.5%, and 2.7%, respectively.","pages":[{"line_numbers":[],"markdown":"Unum 2007 Annual Report 49\n\n### Unum US Group Disability Operating Results\n\nShown below are financial results and key performance indicators for Unum US group disability.\n\nYear Ended December 31\n\n(in millions of dollars, except ratios) 2007 % Change 2006 % Change 2005\n\nOperating Revenue\n\nPremium Income\n\nGroup Long-term Disability $ 1,895.7 (2.9)% $ 1,953.3 (0.4)% $ 1,961.6\n\nGroup Short-term Disability 485.6 (8.4) 530.2 (6.4) 566.3\n\nTotal Premium Income 2,381.3 (4.1) 2,483.5 (1.8) 2,527.9\n\nNet Investment Income 636.0 2.3 621.9 2.7 605.7\n\nOther Income 100.2 21.7 82.3 2.5 80.3\n\nTotal 3,117.5 (2.2) 3,187.7 (0.8) 3,213.9\n\nBenefits and Expenses\n\nBenefits and Change in Reserves for Future Benefits 2,277.4 (15.7) 2,702.5 12.7 2,397.7\n\nCommissions 167.7 (4.6) 175.8 0.4 175.1\n\nDeferral of Acquisition Costs (60.4) (6.4) (64.5) (0.2) (64.6)\n\nAmortization of Deferred Acquisition Costs 66.2 (23.4) 86.4 (6.3) 92.2\n\nOther Expenses 561.6 (4.6) 588.6 1.0 582.5\n\nTotal 3,012.5 (13.7) 3,488.8 9.6 3,182.9\n\nOperating Income (Loss) Before Income Tax\n\nand Net Realized Investment Gains and Losses $ 105.0 134.9 $ (301.1) N.M. $ 31.0\n\nOperating Ratios (% of Premium Income):\n\nBenefit Ratio (1) 95\\.6% 108.8)% 94.8%\n\nOther Expense Ratio (2) 23\\.6% 23.7)% 23.0%\n\nBefore-tax Operating Income (Loss) Ratio (3) 4\\.4% (12.1)% 1.2%\n\nPremium Persistency:\n\nGroup Long-term Disability 85.1% 87.8)% 84.8%\n\nGroup Short-term Disability 74.0% 85.6)% 79.6%\n\nCase Persistency:\n\nGroup Long-term Disability 88.4% 87.4)% 87.2%\n\nGroup Short-term Disability 87.4% 86.2)% 85.6%\n\nN.M. = not a meaningful percentage\n\n(1) Included in these ratios are charges of $76.5 million, $349.2 million, and $27.3 million in 2007, 2006, and 2005, respectively, related to the claim reassessment process. Excluding these charges, the benefit ratios for 2007, 2006, and 2005 would have been 92.4%, 94.8%, and 93.8%, respectively.\n\n(2) Included in these ratios are increases (decreases) of $(10.3) million, $15.0 million, and $10.1 million in 2007, 2006 and 2005, respectively, related to the claim reassessment process. Excluding these items, the other expense ratios for 2007, 2006, and 2005 would have been 24.0%, 23.1% and 22.6%, respectively.\n\n(3) Included in these ratios are charges of $66.2 million, $364.2 million, and $37.4 million in 2007, 2006, and 2005, respectively, related to the claim reassessment process. Excluding these charges, the before-tax operating income ratio for 2007, 2006, and 2005 would have been 7.2%, 2.5%, and 2.7%, respectively.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Unum 2007 Annual Report 49\n\n### Unum US Group Disability Operating Results\n\nShown below are financial results and key performance indicators for Unum US group disability.\n\nYear Ended December 31\n\n(in millions of dollars, except ratios) 2007 % Change 2006 % Change 2005\n\nOperating Revenue\n\nPremium Income\n\nGroup Long-term Disability $ 1,895.7 (2.9)% $ 1,953.3 (0.4)% $ 1,961.6\n\nGroup Short-term Disability 485.6 (8.4) 530.2 (6.4) 566.3\n\nTotal Premium Income 2,381.3 (4.1) 2,483.5 (1.8) 2,527.9\n\nNet Investment Income 636.0 2.3 621.9 2.7 605.7\n\nOther Income 100.2 21.7 82.3 2.5 80.3\n\nTotal 3,117.5 (2.2) 3,187.7 (0.8) 3,213.9\n\nBenefits and Expenses\n\nBenefits and Change in Reserves for Future Benefits 2,277.4 (15.7) 2,702.5 12.7 2,397.7\n\nCommissions 167.7 (4.6) 175.8 0.4 175.1\n\nDeferral of Acquisition Costs (60.4) (6.4) (64.5) (0.2) (64.6)\n\nAmortization of Deferred Acquisition Costs 66.2 (23.4) 86.4 (6.3) 92.2\n\nOther Expenses 561.6 (4.6) 588.6 1.0 582.5\n\nTotal 3,012.5 (13.7) 3,488.8 9.6 3,182.9\n\nOperating Income (Loss) Before Income Tax\n\nand Net Realized Investment Gains and Losses $ 105.0 134.9 $ (301.1) N.M. $ 31.0\n\nOperating Ratios (% of Premium Income):\n\nBenefit Ratio (1) 95\\.6% 108.8)% 94.8%\n\nOther Expense Ratio (2) 23\\.6% 23.7)% 23.0%\n\nBefore-tax Operating Income (Loss) Ratio (3) 4\\.4% (12.1)% 1.2%\n\nPremium Persistency:\n\nGroup Long-term Disability 85.1% 87.8)% 84.8%\n\nGroup Short-term Disability 74.0% 85.6)% 79.6%\n\nCase Persistency:\n\nGroup Long-term Disability 88.4% 87.4)% 87.2%\n\nGroup Short-term Disability 87.4% 86.2)% 85.6%\n\nN.M. = not a meaningful percentage\n\n(1) Included in these ratios are charges of $76.5 million, $349.2 million, and $27.3 million in 2007, 2006, and 2005, respectively, related to the claim reassessment process. Excluding these charges, the benefit ratios for 2007, 2006, and 2005 would have been 92.4%, 94.8%, and 93.8%, respectively.\n\n(2) Included in these ratios are increases (decreases) of $(10.3) million, $15.0 million, and $10.1 million in 2007, 2006 and 2005, respectively, related to the claim reassessment process. Excluding these items, the other expense ratios for 2007, 2006, and 2005 would have been 24.0%, 23.1% and 22.6%, respectively.\n\n(3) Included in these ratios are charges of $66.2 million, $364.2 million, and $37.4 million in 2007, 2006, and 2005, respectively, related to the claim reassessment process. Excluding these charges, the before-tax operating income ratio for 2007, 2006, and 2005 would have been 7.2%, 2.5%, and 2.7%, respectively.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/UNM.2007.page_51.pdf_45297_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_52d2b1b1d2ebc4895d6b61031ef84170","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Unum 2007 Annual Report 49\n\n### Unum US Group Disability Operating Results\n\nShown below are financial results and key performance indicators for Unum US group disability.\n\nYear Ended December 31\n\n(in millions of dollars, except ratios) 2007 % Change 2006 % Change 2005\n\nOperating Revenue\n\nPremium Income\n\nGroup Long-term Disability $ 1,895.7 (2.9)% $ 1,953.3 (0.4)% $ 1,961.6\n\nGroup Short-term Disability 485.6 (8.4) 530.2 (6.4) 566.3\n\nTotal Premium Income 2,381.3 (4.1) 2,483.5 (1.8) 2,527.9\n\nNet Investment Income 636.0 2.3 621.9 2.7 605.7\n\nOther Income 100.2 21.7 82.3 2.5 80.3\n\nTotal 3,117.5 (2.2) 3,187.7 (0.8) 3,213.9\n\nBenefits and Expenses\n\nBenefits and Change in Reserves for Future Benefits 2,277.4 (15.7) 2,702.5 12.7 2,397.7\n\nCommissions 167.7 (4.6) 175.8 0.4 175.1\n\nDeferral of Acquisition Costs (60.4) (6.4) (64.5) (0.2) (64.6)\n\nAmortization of Deferred Acquisition Costs 66.2 (23.4) 86.4 (6.3) 92.2\n\nOther Expenses 561.6 (4.6) 588.6 1.0 582.5\n\nTotal 3,012.5 (13.7) 3,488.8 9.6 3,182.9\n\nOperating Income (Loss) Before Income Tax\n\nand Net Realized Investment Gains and Losses $ 105.0 134.9 $ (301.1) N.M. $ 31.0\n\nOperating Ratios (% of Premium Income):\n\nBenefit Ratio (1) 95\\.6% 108.8)% 94.8%\n\nOther Expense Ratio (2) 23\\.6% 23.7)% 23.0%\n\nBefore-tax Operating Income (Loss) Ratio (3) 4\\.4% (12.1)% 1.2%\n\nPremium Persistency:\n\nGroup Long-term Disability 85.1% 87.8)% 84.8%\n\nGroup Short-term Disability 74.0% 85.6)% 79.6%\n\nCase Persistency:\n\nGroup Long-term Disability 88.4% 87.4)% 87.2%\n\nGroup Short-term Disability 87.4% 86.2)% 85.6%\n\nN.M. = not a meaningful percentage\n\n(1) Included in these ratios are charges of $76.5 million, $349.2 million, and $27.3 million in 2007, 2006, and 2005, respectively, related to the claim reassessment process. Excluding these charges, the benefit ratios for 2007, 2006, and 2005 would have been 92.4%, 94.8%, and 93.8%, respectively.\n\n(2) Included in these ratios are increases (decreases) of $(10.3) million, $15.0 million, and $10.1 million in 2007, 2006 and 2005, respectively, related to the claim reassessment process. Excluding these items, the other expense ratios for 2007, 2006, and 2005 would have been 24.0%, 23.1% and 22.6%, respectively.\n\n(3) Included in these ratios are charges of $66.2 million, $364.2 million, and $37.4 million in 2007, 2006, and 2005, respectively, related to the claim reassessment process. Excluding these charges, the before-tax operating income ratio for 2007, 2006, and 2005 would have been 7.2%, 2.5%, and 2.7%, respectively."],"full_content":"Unum 2007 Annual Report 49\n\n### Unum US Group Disability Operating Results\n\nShown below are financial results and key performance indicators for Unum US group disability.\n\nYear Ended December 31\n\n(in millions of dollars, except ratios) 2007 % Change 2006 % Change 2005\n\nOperating Revenue\n\nPremium Income\n\nGroup Long-term Disability $ 1,895.7 (2.9)% $ 1,953.3 (0.4)% $ 1,961.6\n\nGroup Short-term Disability 485.6 (8.4) 530.2 (6.4) 566.3\n\nTotal Premium Income 2,381.3 (4.1) 2,483.5 (1.8) 2,527.9\n\nNet Investment Income 636.0 2.3 621.9 2.7 605.7\n\nOther Income 100.2 21.7 82.3 2.5 80.3\n\nTotal 3,117.5 (2.2) 3,187.7 (0.8) 3,213.9\n\nBenefits and Expenses\n\nBenefits and Change in Reserves for Future Benefits 2,277.4 (15.7) 2,702.5 12.7 2,397.7\n\nCommissions 167.7 (4.6) 175.8 0.4 175.1\n\nDeferral of Acquisition Costs (60.4) (6.4) (64.5) (0.2) (64.6)\n\nAmortization of Deferred Acquisition Costs 66.2 (23.4) 86.4 (6.3) 92.2\n\nOther Expenses 561.6 (4.6) 588.6 1.0 582.5\n\nTotal 3,012.5 (13.7) 3,488.8 9.6 3,182.9\n\nOperating Income (Loss) Before Income Tax\n\nand Net Realized Investment Gains and Losses $ 105.0 134.9 $ (301.1) N.M. $ 31.0\n\nOperating Ratios (% of Premium Income):\n\nBenefit Ratio (1) 95\\.6% 108.8)% 94.8%\n\nOther Expense Ratio (2) 23\\.6% 23.7)% 23.0%\n\nBefore-tax Operating Income (Loss) Ratio (3) 4\\.4% (12.1)% 1.2%\n\nPremium Persistency:\n\nGroup Long-term Disability 85.1% 87.8)% 84.8%\n\nGroup Short-term Disability 74.0% 85.6)% 79.6%\n\nCase Persistency:\n\nGroup Long-term Disability 88.4% 87.4)% 87.2%\n\nGroup Short-term Disability 87.4% 86.2)% 85.6%\n\nN.M. = not a meaningful percentage\n\n(1) Included in these ratios are charges of $76.5 million, $349.2 million, and $27.3 million in 2007, 2006, and 2005, respectively, related to the claim reassessment process. Excluding these charges, the benefit ratios for 2007, 2006, and 2005 would have been 92.4%, 94.8%, and 93.8%, respectively.\n\n(2) Included in these ratios are increases (decreases) of $(10.3) million, $15.0 million, and $10.1 million in 2007, 2006 and 2005, respectively, related to the claim reassessment process. Excluding these items, the other expense ratios for 2007, 2006, and 2005 would have been 24.0%, 23.1% and 22.6%, respectively.\n\n(3) Included in these ratios are charges of $66.2 million, $364.2 million, and $37.4 million in 2007, 2006, and 2005, respectively, related to the claim reassessment process. Excluding these charges, the before-tax operating income ratio for 2007, 2006, and 2005 would have been 7.2%, 2.5%, and 2.7%, respectively.","publish_date":null,"title":"Unum US Group Disability Operating Results","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/UNM.2007.page_51.pdf_45297_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/UNM.2007.page_51.pdf_45297_page1.pdf"},"request":{"example_id":"table/UNM.2007.page_51.pdf_45297_page1","product_type":"parse","source_file_path":"UNM.2007.page_51.pdf_45297_page1.pdf"},"started_at":"2026-11-04T19:48:02.264050"} +{"completed_at":"2026-11-04T19:48:06.937434","latency_in_ms":2852,"output":{"example_id":"table/USPS 10-k_page27","grounded_pages":[],"layout_pages":[],"markdown":"For the year ended September 30, 2025, compensation and benefits increased by 3.1% compared to the prior year. The following table provides the components of compensation and benefits for active employees as of September 30, 2025 and 2024:\n\n_(in millions)_ **2025 2024**\n\nCompensation $ 45,310 $ 44,058\n\nEmployee health benefits 5,667 5,583\n\nSocial Security 2,656 2,546\n\nTSP 1,604 1,528\n\nOther 544 363\n\n**Total compensation and benefits $ 55,781 $ 54,078**\n\n**_Compensation_** During the year ended September 30, 2025, compensation expense increased $1.3 billion, or 2.8%, compared to 2024. This increase is primarily due to contractual wage increases, which include the inflationary impacts on related COLA, and the impact of the voluntary early retirement incentive, partially offset by a reduction in work hours.\n\nWorkforce Composition The composition of our workforce is a significant factor of our compensation expense. The following table provides the approximate totals of career and pre-career employees as of September 30, 2025 and 2024:\n\n**2025 2024**\n\nCareer employees 531,000 533,000\n\nPre-career employees 93,000 106,000\n\n**Total employees 624,000 639,000**\n\nThe number of career employees at September 30, 2025 was approximately 531,000, a decrease of 2,000, or 0.4%, compared to the prior year. The number of pre-career employees at September 30, 2025 was approximately 93,000, a decrease of 13,000, or 12.3%, compared to the prior year. Therefore, our overall workforce decreased 15,000, or 2.3%, between 2025 and 2024. These changes in workforce composition reflect the net impact of the voluntary early retirement offer and our strategy to stabilize our workforce through the conversion of pre-career employees to career employees to enhance operational precision.\n\nAs outlined in our _Delivering for America_ plan, we are strategically working to create a stable and empowered workforce with the opportunity for career development and growth for all employees. To help achieve this initiative, we converted over 54,500 and 57,500 employees during 2025 and 2024, respectively, from pre-career to career status, as dictated by our operational needs and contractual provisions.\n\nVoluntary Early Retirement In January 2025, we offered an optional retirement opportunity that included an incentive to certain employees who were eligible for optional retirement or voluntary early retirement as of April 30, 2025. The separation incentive attached to this early retirement offer was $15,000 per employee. Nearly 10,500 employees accepted the voluntary early retirement offer and we included a $167 million provision for the voluntary early retirement incentive and associated payroll taxes during the second quarter of 2025.\n\nWork Hours Work hours are a significant component of compensation expense. We are committed to minimizing costs by using the appropriate mix of work hours based on the complement and the assessment of relative cost for each work hour type. In some instances, the use of overtime hours may be necessary to meet service standard commitments and obligations for mail delivery or to serve as a more cost-effective option. In most instances, the compensation for an overtime hour is less than the cost of a straight-time hour as adding employees results in\n\n**2025 Report on Form 10-K** United States Postal Service 26","pages":[{"line_numbers":[],"markdown":"For the year ended September 30, 2025, compensation and benefits increased by 3.1% compared to the prior year. The following table provides the components of compensation and benefits for active employees as of September 30, 2025 and 2024:\n\n_(in millions)_ **2025 2024**\n\nCompensation $ 45,310 $ 44,058\n\nEmployee health benefits 5,667 5,583\n\nSocial Security 2,656 2,546\n\nTSP 1,604 1,528\n\nOther 544 363\n\n**Total compensation and benefits $ 55,781 $ 54,078**\n\n**_Compensation_** During the year ended September 30, 2025, compensation expense increased $1.3 billion, or 2.8%, compared to 2024. This increase is primarily due to contractual wage increases, which include the inflationary impacts on related COLA, and the impact of the voluntary early retirement incentive, partially offset by a reduction in work hours.\n\nWorkforce Composition The composition of our workforce is a significant factor of our compensation expense. The following table provides the approximate totals of career and pre-career employees as of September 30, 2025 and 2024:\n\n**2025 2024**\n\nCareer employees 531,000 533,000\n\nPre-career employees 93,000 106,000\n\n**Total employees 624,000 639,000**\n\nThe number of career employees at September 30, 2025 was approximately 531,000, a decrease of 2,000, or 0.4%, compared to the prior year. The number of pre-career employees at September 30, 2025 was approximately 93,000, a decrease of 13,000, or 12.3%, compared to the prior year. Therefore, our overall workforce decreased 15,000, or 2.3%, between 2025 and 2024. These changes in workforce composition reflect the net impact of the voluntary early retirement offer and our strategy to stabilize our workforce through the conversion of pre-career employees to career employees to enhance operational precision.\n\nAs outlined in our _Delivering for America_ plan, we are strategically working to create a stable and empowered workforce with the opportunity for career development and growth for all employees. To help achieve this initiative, we converted over 54,500 and 57,500 employees during 2025 and 2024, respectively, from pre-career to career status, as dictated by our operational needs and contractual provisions.\n\nVoluntary Early Retirement In January 2025, we offered an optional retirement opportunity that included an incentive to certain employees who were eligible for optional retirement or voluntary early retirement as of April 30, 2025. The separation incentive attached to this early retirement offer was $15,000 per employee. Nearly 10,500 employees accepted the voluntary early retirement offer and we included a $167 million provision for the voluntary early retirement incentive and associated payroll taxes during the second quarter of 2025.\n\nWork Hours Work hours are a significant component of compensation expense. We are committed to minimizing costs by using the appropriate mix of work hours based on the complement and the assessment of relative cost for each work hour type. In some instances, the use of overtime hours may be necessary to meet service standard commitments and obligations for mail delivery or to serve as a more cost-effective option. In most instances, the compensation for an overtime hour is less than the cost of a straight-time hour as adding employees results in\n\n**2025 Report on Form 10-K** United States Postal Service 26","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"For the year ended September 30, 2025, compensation and benefits increased by 3.1% compared to the prior year. The following table provides the components of compensation and benefits for active employees as of September 30, 2025 and 2024:\n\n_(in millions)_ **2025 2024**\n\nCompensation $ 45,310 $ 44,058\n\nEmployee health benefits 5,667 5,583\n\nSocial Security 2,656 2,546\n\nTSP 1,604 1,528\n\nOther 544 363\n\n**Total compensation and benefits $ 55,781 $ 54,078**\n\n**_Compensation_** During the year ended September 30, 2025, compensation expense increased $1.3 billion, or 2.8%, compared to 2024. This increase is primarily due to contractual wage increases, which include the inflationary impacts on related COLA, and the impact of the voluntary early retirement incentive, partially offset by a reduction in work hours.\n\nWorkforce Composition The composition of our workforce is a significant factor of our compensation expense. The following table provides the approximate totals of career and pre-career employees as of September 30, 2025 and 2024:\n\n**2025 2024**\n\nCareer employees 531,000 533,000\n\nPre-career employees 93,000 106,000\n\n**Total employees 624,000 639,000**\n\nThe number of career employees at September 30, 2025 was approximately 531,000, a decrease of 2,000, or 0.4%, compared to the prior year. The number of pre-career employees at September 30, 2025 was approximately 93,000, a decrease of 13,000, or 12.3%, compared to the prior year. Therefore, our overall workforce decreased 15,000, or 2.3%, between 2025 and 2024. These changes in workforce composition reflect the net impact of the voluntary early retirement offer and our strategy to stabilize our workforce through the conversion of pre-career employees to career employees to enhance operational precision.\n\nAs outlined in our _Delivering for America_ plan, we are strategically working to create a stable and empowered workforce with the opportunity for career development and growth for all employees. To help achieve this initiative, we converted over 54,500 and 57,500 employees during 2025 and 2024, respectively, from pre-career to career status, as dictated by our operational needs and contractual provisions.\n\nVoluntary Early Retirement In January 2025, we offered an optional retirement opportunity that included an incentive to certain employees who were eligible for optional retirement or voluntary early retirement as of April 30, 2025. The separation incentive attached to this early retirement offer was $15,000 per employee. Nearly 10,500 employees accepted the voluntary early retirement offer and we included a $167 million provision for the voluntary early retirement incentive and associated payroll taxes during the second quarter of 2025.\n\nWork Hours Work hours are a significant component of compensation expense. We are committed to minimizing costs by using the appropriate mix of work hours based on the complement and the assessment of relative cost for each work hour type. In some instances, the use of overtime hours may be necessary to meet service standard commitments and obligations for mail delivery or to serve as a more cost-effective option. In most instances, the compensation for an overtime hour is less than the cost of a straight-time hour as adding employees results in\n\n**2025 Report on Form 10-K** United States Postal Service 26","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page27.pdf"]},"response":{"errors":[],"extract_id":"extract_bdb9c3c88127ad5d881bb4b283ea5fb7","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["For the year ended September 30, 2025, compensation and benefits increased by 3.1% compared to the prior year. The following table provides the components of compensation and benefits for active employees as of September 30, 2025 and 2024:\n\n_(in millions)_ **2025 2024**\n\nCompensation $ 45,310 $ 44,058\n\nEmployee health benefits 5,667 5,583\n\nSocial Security 2,656 2,546\n\nTSP 1,604 1,528\n\nOther 544 363\n\n**Total compensation and benefits $ 55,781 $ 54,078**\n\n**_Compensation_** During the year ended September 30, 2025, compensation expense increased $1.3 billion, or 2.8%, compared to 2024. This increase is primarily due to contractual wage increases, which include the inflationary impacts on related COLA, and the impact of the voluntary early retirement incentive, partially offset by a reduction in work hours.\n\nWorkforce Composition The composition of our workforce is a significant factor of our compensation expense. The following table provides the approximate totals of career and pre-career employees as of September 30, 2025 and 2024:\n\n**2025 2024**\n\nCareer employees 531,000 533,000\n\nPre-career employees 93,000 106,000\n\n**Total employees 624,000 639,000**\n\nThe number of career employees at September 30, 2025 was approximately 531,000, a decrease of 2,000, or 0.4%, compared to the prior year. The number of pre-career employees at September 30, 2025 was approximately 93,000, a decrease of 13,000, or 12.3%, compared to the prior year. Therefore, our overall workforce decreased 15,000, or 2.3%, between 2025 and 2024. These changes in workforce composition reflect the net impact of the voluntary early retirement offer and our strategy to stabilize our workforce through the conversion of pre-career employees to career employees to enhance operational precision.\n\nAs outlined in our _Delivering for America_ plan, we are strategically working to create a stable and empowered workforce with the opportunity for career development and growth for all employees. To help achieve this initiative, we converted over 54,500 and 57,500 employees during 2025 and 2024, respectively, from pre-career to career status, as dictated by our operational needs and contractual provisions.\n\nVoluntary Early Retirement In January 2025, we offered an optional retirement opportunity that included an incentive to certain employees who were eligible for optional retirement or voluntary early retirement as of April 30, 2025. The separation incentive attached to this early retirement offer was $15,000 per employee. Nearly 10,500 employees accepted the voluntary early retirement offer and we included a $167 million provision for the voluntary early retirement incentive and associated payroll taxes during the second quarter of 2025.\n\nWork Hours Work hours are a significant component of compensation expense. We are committed to minimizing costs by using the appropriate mix of work hours based on the complement and the assessment of relative cost for each work hour type. In some instances, the use of overtime hours may be necessary to meet service standard commitments and obligations for mail delivery or to serve as a more cost-effective option. In most instances, the compensation for an overtime hour is less than the cost of a straight-time hour as adding employees results in\n\n**2025 Report on Form 10-K** United States Postal Service 26"],"full_content":"For the year ended September 30, 2025, compensation and benefits increased by 3.1% compared to the prior year. The following table provides the components of compensation and benefits for active employees as of September 30, 2025 and 2024:\n\n_(in millions)_ **2025 2024**\n\nCompensation $ 45,310 $ 44,058\n\nEmployee health benefits 5,667 5,583\n\nSocial Security 2,656 2,546\n\nTSP 1,604 1,528\n\nOther 544 363\n\n**Total compensation and benefits $ 55,781 $ 54,078**\n\n**_Compensation_** During the year ended September 30, 2025, compensation expense increased $1.3 billion, or 2.8%, compared to 2024. This increase is primarily due to contractual wage increases, which include the inflationary impacts on related COLA, and the impact of the voluntary early retirement incentive, partially offset by a reduction in work hours.\n\nWorkforce Composition The composition of our workforce is a significant factor of our compensation expense. The following table provides the approximate totals of career and pre-career employees as of September 30, 2025 and 2024:\n\n**2025 2024**\n\nCareer employees 531,000 533,000\n\nPre-career employees 93,000 106,000\n\n**Total employees 624,000 639,000**\n\nThe number of career employees at September 30, 2025 was approximately 531,000, a decrease of 2,000, or 0.4%, compared to the prior year. The number of pre-career employees at September 30, 2025 was approximately 93,000, a decrease of 13,000, or 12.3%, compared to the prior year. Therefore, our overall workforce decreased 15,000, or 2.3%, between 2025 and 2024. These changes in workforce composition reflect the net impact of the voluntary early retirement offer and our strategy to stabilize our workforce through the conversion of pre-career employees to career employees to enhance operational precision.\n\nAs outlined in our _Delivering for America_ plan, we are strategically working to create a stable and empowered workforce with the opportunity for career development and growth for all employees. To help achieve this initiative, we converted over 54,500 and 57,500 employees during 2025 and 2024, respectively, from pre-career to career status, as dictated by our operational needs and contractual provisions.\n\nVoluntary Early Retirement In January 2025, we offered an optional retirement opportunity that included an incentive to certain employees who were eligible for optional retirement or voluntary early retirement as of April 30, 2025. The separation incentive attached to this early retirement offer was $15,000 per employee. Nearly 10,500 employees accepted the voluntary early retirement offer and we included a $167 million provision for the voluntary early retirement incentive and associated payroll taxes during the second quarter of 2025.\n\nWork Hours Work hours are a significant component of compensation expense. We are committed to minimizing costs by using the appropriate mix of work hours based on the complement and the assessment of relative cost for each work hour type. In some instances, the use of overtime hours may be necessary to meet service standard commitments and obligations for mail delivery or to serve as a more cost-effective option. In most instances, the compensation for an overtime hour is less than the cost of a straight-time hour as adding employees results in\n\n**2025 Report on Form 10-K** United States Postal Service 26","publish_date":null,"title":"For the year ended September 30, 2025, compensation and benefits increased by 3.1% compared to the prior year. The following","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page27.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page27.pdf"},"request":{"example_id":"table/USPS 10-k_page27","product_type":"parse","source_file_path":"USPS 10-k_page27.pdf"},"started_at":"2026-11-04T19:48:04.084800"} +{"completed_at":"2026-11-04T19:48:07.622126","latency_in_ms":2406,"output":{"example_id":"table/USPS 10-k_page29","grounded_pages":[],"layout_pages":[],"markdown":"**Retirement Benefits** The following table presents the retirement benefits expenses for the years ended September 30, 2025 and 2024:\n\n_(in millions)_ **2025 2024**\n\nFERS normal costs $ 5,061 $ 4,896\n\nCSRS unfunded retirement benefits amortization ¹ 3,122 3,245\n\nFERS unfunded retirement benefits amortization ² 2,159 2,286\n\n**Total retirement benefits $ 10,342 $ 10,427**\n\n1 Expense for the annual payments due September 30 of the respective year, calculated by OPM to amortize the unfunded CSRS\n\nretirement obligation. Payments are to be made in equal installments through 2043.\n\n2 Expense for the annual payment due September 30 of the respective year, calculated by OPM to amortize the unfunded FERS retirement\n\nobligation. Payments are to be made over a 30-year rolling period based on OPM invoices.\n\nOur retirement benefits expenses decreased 0.8% for the year ended September 30, 2025, compared to the prior year. The decrease was due to decreases in the CSRS and FERS unfunded retirement benefits amortization, primarily due to changes in actuarial assumptions resulting from our successful appeal to the CSRDF Board of Actuaries regarding updating rates based on Postal-specific assumptions for pension mortality and withdrawal rates.\n\nSee _Item 8. Financial Statements and Supplementary Data_ , _Notes to Financial Statements_ , _Note 12 - Retirement Plans_ for additional information.\n\n**_FERS Normal Costs_** For the year ended September 30, 2025, FERS normal costs increased 3.4%, compared to the prior year. As most of our employees participate in FERS and FERS-FRAE, this increase was consistent with the general increases in compensation and changing workforce composition, as described above in _Compensation_ and in _Item 8. Financial Statements and Supplementary Data_ , _Notes to Financial Statements_ , _Note 12 - Retirement Plans._\n\n**_CSRS and FERS Unfunded Retirement Benefits_** OPM administers the CSRS and FERS plans via the CSRDF. Although CSRDF is a single fund that does not maintain a separate account for each participating U.S. government employer, the PAEA requires certain disclosures regarding obligations and changes in net assets as if the funds were separate. Such disclosures, which are presented below, are based solely on information OPM has provided to us. Because CSRS and FERS are not subject to the rules and regulations of the _Pension Protection Act of 2006_ , typical plan measurements such as zone status, financial improvement plan status, or rehabilitation plan status are not available for these plans.\n\nOur CSRS and FERS plans are subject to the following constraints and risks:\n\n• Assets contributed to the plans by a single participating U.S. government employer may be used to provide benefits to employees of other participating employers.\n\n• If a participating U.S. government employer ceases contributing to a plan, any unfunded obligations of the plan may be borne by the remaining participating employers.\n\n• Federal law mandates our participation in the plans. If a change in the law permitted us to discontinue this participation, we may be required to contribute to the discontinued plan(s) an amount based on any underfunded status, referred to as a withdrawal liability, if such a liability exists at that time.\n\n• Assets are invested in special purpose U.S. Treasury securities, rather than allocated among a variety of investment assets.\n\n• Inflationary impacts have significant impacts on the underfunded amount. Assets have been used faster than expected due to higher COLAs and the actuarial liability has increased due to changes in discount rates and the impact of the higher expected salaries.\n\n**2025 Report on Form 10-K** United States Postal Service 28","pages":[{"line_numbers":[],"markdown":"**Retirement Benefits** The following table presents the retirement benefits expenses for the years ended September 30, 2025 and 2024:\n\n_(in millions)_ **2025 2024**\n\nFERS normal costs $ 5,061 $ 4,896\n\nCSRS unfunded retirement benefits amortization ¹ 3,122 3,245\n\nFERS unfunded retirement benefits amortization ² 2,159 2,286\n\n**Total retirement benefits $ 10,342 $ 10,427**\n\n1 Expense for the annual payments due September 30 of the respective year, calculated by OPM to amortize the unfunded CSRS\n\nretirement obligation. Payments are to be made in equal installments through 2043.\n\n2 Expense for the annual payment due September 30 of the respective year, calculated by OPM to amortize the unfunded FERS retirement\n\nobligation. Payments are to be made over a 30-year rolling period based on OPM invoices.\n\nOur retirement benefits expenses decreased 0.8% for the year ended September 30, 2025, compared to the prior year. The decrease was due to decreases in the CSRS and FERS unfunded retirement benefits amortization, primarily due to changes in actuarial assumptions resulting from our successful appeal to the CSRDF Board of Actuaries regarding updating rates based on Postal-specific assumptions for pension mortality and withdrawal rates.\n\nSee _Item 8. Financial Statements and Supplementary Data_ , _Notes to Financial Statements_ , _Note 12 - Retirement Plans_ for additional information.\n\n**_FERS Normal Costs_** For the year ended September 30, 2025, FERS normal costs increased 3.4%, compared to the prior year. As most of our employees participate in FERS and FERS-FRAE, this increase was consistent with the general increases in compensation and changing workforce composition, as described above in _Compensation_ and in _Item 8. Financial Statements and Supplementary Data_ , _Notes to Financial Statements_ , _Note 12 - Retirement Plans._\n\n**_CSRS and FERS Unfunded Retirement Benefits_** OPM administers the CSRS and FERS plans via the CSRDF. Although CSRDF is a single fund that does not maintain a separate account for each participating U.S. government employer, the PAEA requires certain disclosures regarding obligations and changes in net assets as if the funds were separate. Such disclosures, which are presented below, are based solely on information OPM has provided to us. Because CSRS and FERS are not subject to the rules and regulations of the _Pension Protection Act of 2006_ , typical plan measurements such as zone status, financial improvement plan status, or rehabilitation plan status are not available for these plans.\n\nOur CSRS and FERS plans are subject to the following constraints and risks:\n\n• Assets contributed to the plans by a single participating U.S. government employer may be used to provide benefits to employees of other participating employers.\n\n• If a participating U.S. government employer ceases contributing to a plan, any unfunded obligations of the plan may be borne by the remaining participating employers.\n\n• Federal law mandates our participation in the plans. If a change in the law permitted us to discontinue this participation, we may be required to contribute to the discontinued plan(s) an amount based on any underfunded status, referred to as a withdrawal liability, if such a liability exists at that time.\n\n• Assets are invested in special purpose U.S. Treasury securities, rather than allocated among a variety of investment assets.\n\n• Inflationary impacts have significant impacts on the underfunded amount. Assets have been used faster than expected due to higher COLAs and the actuarial liability has increased due to changes in discount rates and the impact of the higher expected salaries.\n\n**2025 Report on Form 10-K** United States Postal Service 28","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Retirement Benefits** The following table presents the retirement benefits expenses for the years ended September 30, 2025 and 2024:\n\n_(in millions)_ **2025 2024**\n\nFERS normal costs $ 5,061 $ 4,896\n\nCSRS unfunded retirement benefits amortization ¹ 3,122 3,245\n\nFERS unfunded retirement benefits amortization ² 2,159 2,286\n\n**Total retirement benefits $ 10,342 $ 10,427**\n\n1 Expense for the annual payments due September 30 of the respective year, calculated by OPM to amortize the unfunded CSRS\n\nretirement obligation. Payments are to be made in equal installments through 2043.\n\n2 Expense for the annual payment due September 30 of the respective year, calculated by OPM to amortize the unfunded FERS retirement\n\nobligation. Payments are to be made over a 30-year rolling period based on OPM invoices.\n\nOur retirement benefits expenses decreased 0.8% for the year ended September 30, 2025, compared to the prior year. The decrease was due to decreases in the CSRS and FERS unfunded retirement benefits amortization, primarily due to changes in actuarial assumptions resulting from our successful appeal to the CSRDF Board of Actuaries regarding updating rates based on Postal-specific assumptions for pension mortality and withdrawal rates.\n\nSee _Item 8. Financial Statements and Supplementary Data_ , _Notes to Financial Statements_ , _Note 12 - Retirement Plans_ for additional information.\n\n**_FERS Normal Costs_** For the year ended September 30, 2025, FERS normal costs increased 3.4%, compared to the prior year. As most of our employees participate in FERS and FERS-FRAE, this increase was consistent with the general increases in compensation and changing workforce composition, as described above in _Compensation_ and in _Item 8. Financial Statements and Supplementary Data_ , _Notes to Financial Statements_ , _Note 12 - Retirement Plans._\n\n**_CSRS and FERS Unfunded Retirement Benefits_** OPM administers the CSRS and FERS plans via the CSRDF. Although CSRDF is a single fund that does not maintain a separate account for each participating U.S. government employer, the PAEA requires certain disclosures regarding obligations and changes in net assets as if the funds were separate. Such disclosures, which are presented below, are based solely on information OPM has provided to us. Because CSRS and FERS are not subject to the rules and regulations of the _Pension Protection Act of 2006_ , typical plan measurements such as zone status, financial improvement plan status, or rehabilitation plan status are not available for these plans.\n\nOur CSRS and FERS plans are subject to the following constraints and risks:\n\n• Assets contributed to the plans by a single participating U.S. government employer may be used to provide benefits to employees of other participating employers.\n\n• If a participating U.S. government employer ceases contributing to a plan, any unfunded obligations of the plan may be borne by the remaining participating employers.\n\n• Federal law mandates our participation in the plans. If a change in the law permitted us to discontinue this participation, we may be required to contribute to the discontinued plan(s) an amount based on any underfunded status, referred to as a withdrawal liability, if such a liability exists at that time.\n\n• Assets are invested in special purpose U.S. Treasury securities, rather than allocated among a variety of investment assets.\n\n• Inflationary impacts have significant impacts on the underfunded amount. Assets have been used faster than expected due to higher COLAs and the actuarial liability has increased due to changes in discount rates and the impact of the higher expected salaries.\n\n**2025 Report on Form 10-K** United States Postal Service 28","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page29.pdf"]},"response":{"errors":[],"extract_id":"extract_7acdd06b0fcd2307a75649ab684ad16b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Retirement Benefits** The following table presents the retirement benefits expenses for the years ended September 30, 2025 and 2024:\n\n_(in millions)_ **2025 2024**\n\nFERS normal costs $ 5,061 $ 4,896\n\nCSRS unfunded retirement benefits amortization ¹ 3,122 3,245\n\nFERS unfunded retirement benefits amortization ² 2,159 2,286\n\n**Total retirement benefits $ 10,342 $ 10,427**\n\n1 Expense for the annual payments due September 30 of the respective year, calculated by OPM to amortize the unfunded CSRS\n\nretirement obligation. Payments are to be made in equal installments through 2043.\n\n2 Expense for the annual payment due September 30 of the respective year, calculated by OPM to amortize the unfunded FERS retirement\n\nobligation. Payments are to be made over a 30-year rolling period based on OPM invoices.\n\nOur retirement benefits expenses decreased 0.8% for the year ended September 30, 2025, compared to the prior year. The decrease was due to decreases in the CSRS and FERS unfunded retirement benefits amortization, primarily due to changes in actuarial assumptions resulting from our successful appeal to the CSRDF Board of Actuaries regarding updating rates based on Postal-specific assumptions for pension mortality and withdrawal rates.\n\nSee _Item 8. Financial Statements and Supplementary Data_ , _Notes to Financial Statements_ , _Note 12 - Retirement Plans_ for additional information.\n\n**_FERS Normal Costs_** For the year ended September 30, 2025, FERS normal costs increased 3.4%, compared to the prior year. As most of our employees participate in FERS and FERS-FRAE, this increase was consistent with the general increases in compensation and changing workforce composition, as described above in _Compensation_ and in _Item 8. Financial Statements and Supplementary Data_ , _Notes to Financial Statements_ , _Note 12 - Retirement Plans._\n\n**_CSRS and FERS Unfunded Retirement Benefits_** OPM administers the CSRS and FERS plans via the CSRDF. Although CSRDF is a single fund that does not maintain a separate account for each participating U.S. government employer, the PAEA requires certain disclosures regarding obligations and changes in net assets as if the funds were separate. Such disclosures, which are presented below, are based solely on information OPM has provided to us. Because CSRS and FERS are not subject to the rules and regulations of the _Pension Protection Act of 2006_ , typical plan measurements such as zone status, financial improvement plan status, or rehabilitation plan status are not available for these plans.\n\nOur CSRS and FERS plans are subject to the following constraints and risks:\n\n• Assets contributed to the plans by a single participating U.S. government employer may be used to provide benefits to employees of other participating employers.\n\n• If a participating U.S. government employer ceases contributing to a plan, any unfunded obligations of the plan may be borne by the remaining participating employers.\n\n• Federal law mandates our participation in the plans. If a change in the law permitted us to discontinue this participation, we may be required to contribute to the discontinued plan(s) an amount based on any underfunded status, referred to as a withdrawal liability, if such a liability exists at that time.\n\n• Assets are invested in special purpose U.S. Treasury securities, rather than allocated among a variety of investment assets.\n\n• Inflationary impacts have significant impacts on the underfunded amount. Assets have been used faster than expected due to higher COLAs and the actuarial liability has increased due to changes in discount rates and the impact of the higher expected salaries.\n\n**2025 Report on Form 10-K** United States Postal Service 28"],"full_content":"**Retirement Benefits** The following table presents the retirement benefits expenses for the years ended September 30, 2025 and 2024:\n\n_(in millions)_ **2025 2024**\n\nFERS normal costs $ 5,061 $ 4,896\n\nCSRS unfunded retirement benefits amortization ¹ 3,122 3,245\n\nFERS unfunded retirement benefits amortization ² 2,159 2,286\n\n**Total retirement benefits $ 10,342 $ 10,427**\n\n1 Expense for the annual payments due September 30 of the respective year, calculated by OPM to amortize the unfunded CSRS\n\nretirement obligation. Payments are to be made in equal installments through 2043.\n\n2 Expense for the annual payment due September 30 of the respective year, calculated by OPM to amortize the unfunded FERS retirement\n\nobligation. Payments are to be made over a 30-year rolling period based on OPM invoices.\n\nOur retirement benefits expenses decreased 0.8% for the year ended September 30, 2025, compared to the prior year. The decrease was due to decreases in the CSRS and FERS unfunded retirement benefits amortization, primarily due to changes in actuarial assumptions resulting from our successful appeal to the CSRDF Board of Actuaries regarding updating rates based on Postal-specific assumptions for pension mortality and withdrawal rates.\n\nSee _Item 8. Financial Statements and Supplementary Data_ , _Notes to Financial Statements_ , _Note 12 - Retirement Plans_ for additional information.\n\n**_FERS Normal Costs_** For the year ended September 30, 2025, FERS normal costs increased 3.4%, compared to the prior year. As most of our employees participate in FERS and FERS-FRAE, this increase was consistent with the general increases in compensation and changing workforce composition, as described above in _Compensation_ and in _Item 8. Financial Statements and Supplementary Data_ , _Notes to Financial Statements_ , _Note 12 - Retirement Plans._\n\n**_CSRS and FERS Unfunded Retirement Benefits_** OPM administers the CSRS and FERS plans via the CSRDF. Although CSRDF is a single fund that does not maintain a separate account for each participating U.S. government employer, the PAEA requires certain disclosures regarding obligations and changes in net assets as if the funds were separate. Such disclosures, which are presented below, are based solely on information OPM has provided to us. Because CSRS and FERS are not subject to the rules and regulations of the _Pension Protection Act of 2006_ , typical plan measurements such as zone status, financial improvement plan status, or rehabilitation plan status are not available for these plans.\n\nOur CSRS and FERS plans are subject to the following constraints and risks:\n\n• Assets contributed to the plans by a single participating U.S. government employer may be used to provide benefits to employees of other participating employers.\n\n• If a participating U.S. government employer ceases contributing to a plan, any unfunded obligations of the plan may be borne by the remaining participating employers.\n\n• Federal law mandates our participation in the plans. If a change in the law permitted us to discontinue this participation, we may be required to contribute to the discontinued plan(s) an amount based on any underfunded status, referred to as a withdrawal liability, if such a liability exists at that time.\n\n• Assets are invested in special purpose U.S. Treasury securities, rather than allocated among a variety of investment assets.\n\n• Inflationary impacts have significant impacts on the underfunded amount. Assets have been used faster than expected due to higher COLAs and the actuarial liability has increased due to changes in discount rates and the impact of the higher expected salaries.\n\n**2025 Report on Form 10-K** United States Postal Service 28","publish_date":null,"title":"Retirement Benefits The following table presents the retirement benefits expenses for the years ended September 30, 2025 and 2024: 2025","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page29.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page29.pdf"},"request":{"example_id":"table/USPS 10-k_page29","product_type":"parse","source_file_path":"USPS 10-k_page29.pdf"},"started_at":"2026-11-04T19:48:05.215947"} +{"completed_at":"2026-11-04T19:48:08.106279","latency_in_ms":1166,"output":{"example_id":"table/USPS 10-k_page3","grounded_pages":[],"layout_pages":[],"markdown":"**GLOSSARY OF ACRONYMS AND DEFINED TERMS**\n\nThe following are definitions of some of the terms or acronyms that may be used throughout this report:\n\n**Term or Acronym Definition**\n\nAED Advanced Electronic Data\n\nAnnual Report Annual Report on Form 10-K\n\nAFC Audit and Finance Committee of the Board of Governors\n\nAFL-CIO American Federation of Labor and Congress of Industrial Organizations\n\nAPWU American Postal Workers Union, AFL-CIO\n\nASC Accounting Standards Codification\n\nASU Accounting Standards Update\n\nBoard Board of Governors of the United States Postal Service\n\nBoard of Actuaries Board of Actuaries of the Civil Service Retirement System\n\n_CARES Act Coronavirus Aid, Relief, and Economic Security Act_ , enacted as Public Law 116-136\n\nCBP U.S. Customs and Border Protection\n\nCEO Chief Executive Officer\n\nCFO Chief Financial Officer\n\nCHRO Chief Human Resources Officer\n\nCIO Chief Information Officer\n\nCISO Chief Information Security Office\n\nCOFA Compacts of Free Association\n\nCOLA(s) Cost-of-living adjustment(s)\n\nCOO Chief Operating Officer\n\nCOR House Committee on Oversight and Reform\n\nCOVID-19 Coronavirus\n\nCPI Consumer Price Index\n\nCPI-U Consumer Price Index for All Urban Consumers\n\nCPI-W Consumer Price Index for Urban Wage Earners and Clerical Workers\n\nCSRDF Civil Service Retirement and Disability Fund\n\nCSRS Civil Service Retirement System\n\nDOL U.S. Department of Labor\n\nDPMG Deputy Postmaster General\n\nECRC Executive Cyber Risk Committee\n\nEEOC U.S. Equal Employment Opportunity Commission\n\nEIS Environmental Impact Statement\n\nEPA Environmental Protection Agency\n\n_Exchange Act Securities and Exchange Act of 1934_ , enacted as Public Law 73-291\n\nFAS Freely Associated States\n\nFASB Financial Accounting Standards Board\n\nFECA Federal Employees' Compensation Act\n\nFEGLI Federal Employees Group Life Insurance\n\nFEHB Federal Employees Health Benefits\n\nFERS Federal Employees Retirement System\n\n**2025 Report on Form 10-K** United States Postal Service 2","pages":[{"line_numbers":[],"markdown":"**GLOSSARY OF ACRONYMS AND DEFINED TERMS**\n\nThe following are definitions of some of the terms or acronyms that may be used throughout this report:\n\n**Term or Acronym Definition**\n\nAED Advanced Electronic Data\n\nAnnual Report Annual Report on Form 10-K\n\nAFC Audit and Finance Committee of the Board of Governors\n\nAFL-CIO American Federation of Labor and Congress of Industrial Organizations\n\nAPWU American Postal Workers Union, AFL-CIO\n\nASC Accounting Standards Codification\n\nASU Accounting Standards Update\n\nBoard Board of Governors of the United States Postal Service\n\nBoard of Actuaries Board of Actuaries of the Civil Service Retirement System\n\n_CARES Act Coronavirus Aid, Relief, and Economic Security Act_ , enacted as Public Law 116-136\n\nCBP U.S. Customs and Border Protection\n\nCEO Chief Executive Officer\n\nCFO Chief Financial Officer\n\nCHRO Chief Human Resources Officer\n\nCIO Chief Information Officer\n\nCISO Chief Information Security Office\n\nCOFA Compacts of Free Association\n\nCOLA(s) Cost-of-living adjustment(s)\n\nCOO Chief Operating Officer\n\nCOR House Committee on Oversight and Reform\n\nCOVID-19 Coronavirus\n\nCPI Consumer Price Index\n\nCPI-U Consumer Price Index for All Urban Consumers\n\nCPI-W Consumer Price Index for Urban Wage Earners and Clerical Workers\n\nCSRDF Civil Service Retirement and Disability Fund\n\nCSRS Civil Service Retirement System\n\nDOL U.S. Department of Labor\n\nDPMG Deputy Postmaster General\n\nECRC Executive Cyber Risk Committee\n\nEEOC U.S. Equal Employment Opportunity Commission\n\nEIS Environmental Impact Statement\n\nEPA Environmental Protection Agency\n\n_Exchange Act Securities and Exchange Act of 1934_ , enacted as Public Law 73-291\n\nFAS Freely Associated States\n\nFASB Financial Accounting Standards Board\n\nFECA Federal Employees' Compensation Act\n\nFEGLI Federal Employees Group Life Insurance\n\nFEHB Federal Employees Health Benefits\n\nFERS Federal Employees Retirement System\n\n**2025 Report on Form 10-K** United States Postal Service 2","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**GLOSSARY OF ACRONYMS AND DEFINED TERMS**\n\nThe following are definitions of some of the terms or acronyms that may be used throughout this report:\n\n**Term or Acronym Definition**\n\nAED Advanced Electronic Data\n\nAnnual Report Annual Report on Form 10-K\n\nAFC Audit and Finance Committee of the Board of Governors\n\nAFL-CIO American Federation of Labor and Congress of Industrial Organizations\n\nAPWU American Postal Workers Union, AFL-CIO\n\nASC Accounting Standards Codification\n\nASU Accounting Standards Update\n\nBoard Board of Governors of the United States Postal Service\n\nBoard of Actuaries Board of Actuaries of the Civil Service Retirement System\n\n_CARES Act Coronavirus Aid, Relief, and Economic Security Act_ , enacted as Public Law 116-136\n\nCBP U.S. Customs and Border Protection\n\nCEO Chief Executive Officer\n\nCFO Chief Financial Officer\n\nCHRO Chief Human Resources Officer\n\nCIO Chief Information Officer\n\nCISO Chief Information Security Office\n\nCOFA Compacts of Free Association\n\nCOLA(s) Cost-of-living adjustment(s)\n\nCOO Chief Operating Officer\n\nCOR House Committee on Oversight and Reform\n\nCOVID-19 Coronavirus\n\nCPI Consumer Price Index\n\nCPI-U Consumer Price Index for All Urban Consumers\n\nCPI-W Consumer Price Index for Urban Wage Earners and Clerical Workers\n\nCSRDF Civil Service Retirement and Disability Fund\n\nCSRS Civil Service Retirement System\n\nDOL U.S. Department of Labor\n\nDPMG Deputy Postmaster General\n\nECRC Executive Cyber Risk Committee\n\nEEOC U.S. Equal Employment Opportunity Commission\n\nEIS Environmental Impact Statement\n\nEPA Environmental Protection Agency\n\n_Exchange Act Securities and Exchange Act of 1934_ , enacted as Public Law 73-291\n\nFAS Freely Associated States\n\nFASB Financial Accounting Standards Board\n\nFECA Federal Employees' Compensation Act\n\nFEGLI Federal Employees Group Life Insurance\n\nFEHB Federal Employees Health Benefits\n\nFERS Federal Employees Retirement System\n\n**2025 Report on Form 10-K** United States Postal Service 2","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page3.pdf"]},"response":{"errors":[],"extract_id":"extract_d6662d4fa9dd77e02e33d3e94734fe2d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**GLOSSARY OF ACRONYMS AND DEFINED TERMS**\n\nThe following are definitions of some of the terms or acronyms that may be used throughout this report:\n\n**Term or Acronym Definition**\n\nAED Advanced Electronic Data\n\nAnnual Report Annual Report on Form 10-K\n\nAFC Audit and Finance Committee of the Board of Governors\n\nAFL-CIO American Federation of Labor and Congress of Industrial Organizations\n\nAPWU American Postal Workers Union, AFL-CIO\n\nASC Accounting Standards Codification\n\nASU Accounting Standards Update\n\nBoard Board of Governors of the United States Postal Service\n\nBoard of Actuaries Board of Actuaries of the Civil Service Retirement System\n\n_CARES Act Coronavirus Aid, Relief, and Economic Security Act_ , enacted as Public Law 116-136\n\nCBP U.S. Customs and Border Protection\n\nCEO Chief Executive Officer\n\nCFO Chief Financial Officer\n\nCHRO Chief Human Resources Officer\n\nCIO Chief Information Officer\n\nCISO Chief Information Security Office\n\nCOFA Compacts of Free Association\n\nCOLA(s) Cost-of-living adjustment(s)\n\nCOO Chief Operating Officer\n\nCOR House Committee on Oversight and Reform\n\nCOVID-19 Coronavirus\n\nCPI Consumer Price Index\n\nCPI-U Consumer Price Index for All Urban Consumers\n\nCPI-W Consumer Price Index for Urban Wage Earners and Clerical Workers\n\nCSRDF Civil Service Retirement and Disability Fund\n\nCSRS Civil Service Retirement System\n\nDOL U.S. Department of Labor\n\nDPMG Deputy Postmaster General\n\nECRC Executive Cyber Risk Committee\n\nEEOC U.S. Equal Employment Opportunity Commission\n\nEIS Environmental Impact Statement\n\nEPA Environmental Protection Agency\n\n_Exchange Act Securities and Exchange Act of 1934_ , enacted as Public Law 73-291\n\nFAS Freely Associated States\n\nFASB Financial Accounting Standards Board\n\nFECA Federal Employees' Compensation Act\n\nFEGLI Federal Employees Group Life Insurance\n\nFEHB Federal Employees Health Benefits\n\nFERS Federal Employees Retirement System\n\n**2025 Report on Form 10-K** United States Postal Service 2"],"full_content":"**GLOSSARY OF ACRONYMS AND DEFINED TERMS**\n\nThe following are definitions of some of the terms or acronyms that may be used throughout this report:\n\n**Term or Acronym Definition**\n\nAED Advanced Electronic Data\n\nAnnual Report Annual Report on Form 10-K\n\nAFC Audit and Finance Committee of the Board of Governors\n\nAFL-CIO American Federation of Labor and Congress of Industrial Organizations\n\nAPWU American Postal Workers Union, AFL-CIO\n\nASC Accounting Standards Codification\n\nASU Accounting Standards Update\n\nBoard Board of Governors of the United States Postal Service\n\nBoard of Actuaries Board of Actuaries of the Civil Service Retirement System\n\n_CARES Act Coronavirus Aid, Relief, and Economic Security Act_ , enacted as Public Law 116-136\n\nCBP U.S. Customs and Border Protection\n\nCEO Chief Executive Officer\n\nCFO Chief Financial Officer\n\nCHRO Chief Human Resources Officer\n\nCIO Chief Information Officer\n\nCISO Chief Information Security Office\n\nCOFA Compacts of Free Association\n\nCOLA(s) Cost-of-living adjustment(s)\n\nCOO Chief Operating Officer\n\nCOR House Committee on Oversight and Reform\n\nCOVID-19 Coronavirus\n\nCPI Consumer Price Index\n\nCPI-U Consumer Price Index for All Urban Consumers\n\nCPI-W Consumer Price Index for Urban Wage Earners and Clerical Workers\n\nCSRDF Civil Service Retirement and Disability Fund\n\nCSRS Civil Service Retirement System\n\nDOL U.S. Department of Labor\n\nDPMG Deputy Postmaster General\n\nECRC Executive Cyber Risk Committee\n\nEEOC U.S. Equal Employment Opportunity Commission\n\nEIS Environmental Impact Statement\n\nEPA Environmental Protection Agency\n\n_Exchange Act Securities and Exchange Act of 1934_ , enacted as Public Law 73-291\n\nFAS Freely Associated States\n\nFASB Financial Accounting Standards Board\n\nFECA Federal Employees' Compensation Act\n\nFEGLI Federal Employees Group Life Insurance\n\nFEHB Federal Employees Health Benefits\n\nFERS Federal Employees Retirement System\n\n**2025 Report on Form 10-K** United States Postal Service 2","publish_date":null,"title":"GLOSSARY OF ACRONYMS AND DEFINED TERMS The following are definitions of some of the terms or acronyms that may be","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page3.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page3.pdf"},"request":{"example_id":"table/USPS 10-k_page3","product_type":"parse","source_file_path":"USPS 10-k_page3.pdf"},"started_at":"2026-11-04T19:48:06.940102"} +{"completed_at":"2026-11-04T19:48:10.017536","latency_in_ms":2393,"output":{"example_id":"table/USPS 10-k_page36","grounded_pages":[],"layout_pages":[],"markdown":"and revaluation of existing ones. Additionally, we reimburse DOL for all workers' compensation benefits paid to or on behalf of our employees, plus an administrative fee.\n\nUnder FECA, workers' compensation claims for many types of injuries cannot be settled through lump-sum payments, and in some instances regarding those claims, compensation may be paid over many years. Federal law grants COLA increases to those claims, and these factors result in substantially higher costs to us than would likely result if we managed and could settle our own claims. Additionally, since we do not manage the FECA program, we have no ability to control the significant administrative costs associated with managing the claims and payments process.\n\nOn a daily basis we focus on costs that can be managed in the course of normal business operations. Certain aspects of workers’ compensation can be managed through human resource initiatives, safety measures and training. Other workers’ compensation costs cannot be managed in the course of normal business operations and are less predictable, including expenses caused by actuarial revaluation and discount rate changes. We subtract the cash payments made by the DOL on behalf of workers' compensation obligations, which are relatively predictable, from total workers' compensation expense in order to determine the non-cash component of workers' compensation expense, a non-GAAP financial measure.\n\nFor additional information, see _Item 8. Financial Statements and Supplementary Data, Notes to Financial Statements_ , _Note 14 - Workers' Compensation_ .\n\nAnnually, we reimburse DOL for all workers' compensation benefits paid to or on behalf of our employees. The following table presents the components of workers’ compensation expense, including the cash payments made by DOL on behalf of workers’ compensation obligations, for the years ended September 30, 2025, and 2024:\n\n_(in millions)_ **2025 2024**\n\nImpact of discount rate changes $ (692) $ 1,105\n\nActuarial revaluation of existing cases 1,450 1,352\n\nCosts of new cases 1,841 1,245\n\nAdministrative fee 100 97\n\n**Total workers' compensation expense $ 2,699 $ 3,799**\n\nLess cash payments made by DOL on behalf of workers' compensation obligations (1,727) (1,635)\n\n**Total non-cash component of workers' compensation expense (non-GAAP) $ 972 $ 2,164**\n\nFor the year ended September 30, 2025, workers' compensation expense decreased $1.1 billion, compared to 2024, primarily due to increases in discount rates, partially offset by increased actuarial estimates of the costs of new cases, and actuarial revaluation of existing cases.\n\n**_Impact of Discount Rate Changes_** For the year ended September 30, 2025, the portion of workers' compensation expense attributable to the impact of increasing discount rates decreased $1.8 billion, compared to 2024. This decrease in expense was driven by a significant increase in discount rates in 2025, compared to 2024, an event outside of management's control.\n\n**_Actuarial Revaluation of Existing Cases and Costs of New Cases_** Changes in actuarial valuation are primarily attributable to the combined impacts of routine changes in actuarial estimation, the progression of existing cases and updated COLA assumptions, which are largely outside of management's control.\n\nFor the year ended September 30, 2025, the cost of new workers' compensation cases increased $596 million, compared to 2024, while the actuarial revaluation of existing cases increased by $98 million for the year ended\n\n**2025 Report on Form 10-K** United States Postal Service 35","pages":[{"line_numbers":[],"markdown":"and revaluation of existing ones. Additionally, we reimburse DOL for all workers' compensation benefits paid to or on behalf of our employees, plus an administrative fee.\n\nUnder FECA, workers' compensation claims for many types of injuries cannot be settled through lump-sum payments, and in some instances regarding those claims, compensation may be paid over many years. Federal law grants COLA increases to those claims, and these factors result in substantially higher costs to us than would likely result if we managed and could settle our own claims. Additionally, since we do not manage the FECA program, we have no ability to control the significant administrative costs associated with managing the claims and payments process.\n\nOn a daily basis we focus on costs that can be managed in the course of normal business operations. Certain aspects of workers’ compensation can be managed through human resource initiatives, safety measures and training. Other workers’ compensation costs cannot be managed in the course of normal business operations and are less predictable, including expenses caused by actuarial revaluation and discount rate changes. We subtract the cash payments made by the DOL on behalf of workers' compensation obligations, which are relatively predictable, from total workers' compensation expense in order to determine the non-cash component of workers' compensation expense, a non-GAAP financial measure.\n\nFor additional information, see _Item 8. Financial Statements and Supplementary Data, Notes to Financial Statements_ , _Note 14 - Workers' Compensation_ .\n\nAnnually, we reimburse DOL for all workers' compensation benefits paid to or on behalf of our employees. The following table presents the components of workers’ compensation expense, including the cash payments made by DOL on behalf of workers’ compensation obligations, for the years ended September 30, 2025, and 2024:\n\n_(in millions)_ **2025 2024**\n\nImpact of discount rate changes $ (692) $ 1,105\n\nActuarial revaluation of existing cases 1,450 1,352\n\nCosts of new cases 1,841 1,245\n\nAdministrative fee 100 97\n\n**Total workers' compensation expense $ 2,699 $ 3,799**\n\nLess cash payments made by DOL on behalf of workers' compensation obligations (1,727) (1,635)\n\n**Total non-cash component of workers' compensation expense (non-GAAP) $ 972 $ 2,164**\n\nFor the year ended September 30, 2025, workers' compensation expense decreased $1.1 billion, compared to 2024, primarily due to increases in discount rates, partially offset by increased actuarial estimates of the costs of new cases, and actuarial revaluation of existing cases.\n\n**_Impact of Discount Rate Changes_** For the year ended September 30, 2025, the portion of workers' compensation expense attributable to the impact of increasing discount rates decreased $1.8 billion, compared to 2024. This decrease in expense was driven by a significant increase in discount rates in 2025, compared to 2024, an event outside of management's control.\n\n**_Actuarial Revaluation of Existing Cases and Costs of New Cases_** Changes in actuarial valuation are primarily attributable to the combined impacts of routine changes in actuarial estimation, the progression of existing cases and updated COLA assumptions, which are largely outside of management's control.\n\nFor the year ended September 30, 2025, the cost of new workers' compensation cases increased $596 million, compared to 2024, while the actuarial revaluation of existing cases increased by $98 million for the year ended\n\n**2025 Report on Form 10-K** United States Postal Service 35","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"and revaluation of existing ones. Additionally, we reimburse DOL for all workers' compensation benefits paid to or on behalf of our employees, plus an administrative fee.\n\nUnder FECA, workers' compensation claims for many types of injuries cannot be settled through lump-sum payments, and in some instances regarding those claims, compensation may be paid over many years. Federal law grants COLA increases to those claims, and these factors result in substantially higher costs to us than would likely result if we managed and could settle our own claims. Additionally, since we do not manage the FECA program, we have no ability to control the significant administrative costs associated with managing the claims and payments process.\n\nOn a daily basis we focus on costs that can be managed in the course of normal business operations. Certain aspects of workers’ compensation can be managed through human resource initiatives, safety measures and training. Other workers’ compensation costs cannot be managed in the course of normal business operations and are less predictable, including expenses caused by actuarial revaluation and discount rate changes. We subtract the cash payments made by the DOL on behalf of workers' compensation obligations, which are relatively predictable, from total workers' compensation expense in order to determine the non-cash component of workers' compensation expense, a non-GAAP financial measure.\n\nFor additional information, see _Item 8. Financial Statements and Supplementary Data, Notes to Financial Statements_ , _Note 14 - Workers' Compensation_ .\n\nAnnually, we reimburse DOL for all workers' compensation benefits paid to or on behalf of our employees. The following table presents the components of workers’ compensation expense, including the cash payments made by DOL on behalf of workers’ compensation obligations, for the years ended September 30, 2025, and 2024:\n\n_(in millions)_ **2025 2024**\n\nImpact of discount rate changes $ (692) $ 1,105\n\nActuarial revaluation of existing cases 1,450 1,352\n\nCosts of new cases 1,841 1,245\n\nAdministrative fee 100 97\n\n**Total workers' compensation expense $ 2,699 $ 3,799**\n\nLess cash payments made by DOL on behalf of workers' compensation obligations (1,727) (1,635)\n\n**Total non-cash component of workers' compensation expense (non-GAAP) $ 972 $ 2,164**\n\nFor the year ended September 30, 2025, workers' compensation expense decreased $1.1 billion, compared to 2024, primarily due to increases in discount rates, partially offset by increased actuarial estimates of the costs of new cases, and actuarial revaluation of existing cases.\n\n**_Impact of Discount Rate Changes_** For the year ended September 30, 2025, the portion of workers' compensation expense attributable to the impact of increasing discount rates decreased $1.8 billion, compared to 2024. This decrease in expense was driven by a significant increase in discount rates in 2025, compared to 2024, an event outside of management's control.\n\n**_Actuarial Revaluation of Existing Cases and Costs of New Cases_** Changes in actuarial valuation are primarily attributable to the combined impacts of routine changes in actuarial estimation, the progression of existing cases and updated COLA assumptions, which are largely outside of management's control.\n\nFor the year ended September 30, 2025, the cost of new workers' compensation cases increased $596 million, compared to 2024, while the actuarial revaluation of existing cases increased by $98 million for the year ended\n\n**2025 Report on Form 10-K** United States Postal Service 35","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page36.pdf"]},"response":{"errors":[],"extract_id":"extract_30260aabb1c2bade43bcc6352db3cfae","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["and revaluation of existing ones. Additionally, we reimburse DOL for all workers' compensation benefits paid to or on behalf of our employees, plus an administrative fee.\n\nUnder FECA, workers' compensation claims for many types of injuries cannot be settled through lump-sum payments, and in some instances regarding those claims, compensation may be paid over many years. Federal law grants COLA increases to those claims, and these factors result in substantially higher costs to us than would likely result if we managed and could settle our own claims. Additionally, since we do not manage the FECA program, we have no ability to control the significant administrative costs associated with managing the claims and payments process.\n\nOn a daily basis we focus on costs that can be managed in the course of normal business operations. Certain aspects of workers’ compensation can be managed through human resource initiatives, safety measures and training. Other workers’ compensation costs cannot be managed in the course of normal business operations and are less predictable, including expenses caused by actuarial revaluation and discount rate changes. We subtract the cash payments made by the DOL on behalf of workers' compensation obligations, which are relatively predictable, from total workers' compensation expense in order to determine the non-cash component of workers' compensation expense, a non-GAAP financial measure.\n\nFor additional information, see _Item 8. Financial Statements and Supplementary Data, Notes to Financial Statements_ , _Note 14 - Workers' Compensation_ .\n\nAnnually, we reimburse DOL for all workers' compensation benefits paid to or on behalf of our employees. The following table presents the components of workers’ compensation expense, including the cash payments made by DOL on behalf of workers’ compensation obligations, for the years ended September 30, 2025, and 2024:\n\n_(in millions)_ **2025 2024**\n\nImpact of discount rate changes $ (692) $ 1,105\n\nActuarial revaluation of existing cases 1,450 1,352\n\nCosts of new cases 1,841 1,245\n\nAdministrative fee 100 97\n\n**Total workers' compensation expense $ 2,699 $ 3,799**\n\nLess cash payments made by DOL on behalf of workers' compensation obligations (1,727) (1,635)\n\n**Total non-cash component of workers' compensation expense (non-GAAP) $ 972 $ 2,164**\n\nFor the year ended September 30, 2025, workers' compensation expense decreased $1.1 billion, compared to 2024, primarily due to increases in discount rates, partially offset by increased actuarial estimates of the costs of new cases, and actuarial revaluation of existing cases.\n\n**_Impact of Discount Rate Changes_** For the year ended September 30, 2025, the portion of workers' compensation expense attributable to the impact of increasing discount rates decreased $1.8 billion, compared to 2024. This decrease in expense was driven by a significant increase in discount rates in 2025, compared to 2024, an event outside of management's control.\n\n**_Actuarial Revaluation of Existing Cases and Costs of New Cases_** Changes in actuarial valuation are primarily attributable to the combined impacts of routine changes in actuarial estimation, the progression of existing cases and updated COLA assumptions, which are largely outside of management's control.\n\nFor the year ended September 30, 2025, the cost of new workers' compensation cases increased $596 million, compared to 2024, while the actuarial revaluation of existing cases increased by $98 million for the year ended\n\n**2025 Report on Form 10-K** United States Postal Service 35"],"full_content":"and revaluation of existing ones. Additionally, we reimburse DOL for all workers' compensation benefits paid to or on behalf of our employees, plus an administrative fee.\n\nUnder FECA, workers' compensation claims for many types of injuries cannot be settled through lump-sum payments, and in some instances regarding those claims, compensation may be paid over many years. Federal law grants COLA increases to those claims, and these factors result in substantially higher costs to us than would likely result if we managed and could settle our own claims. Additionally, since we do not manage the FECA program, we have no ability to control the significant administrative costs associated with managing the claims and payments process.\n\nOn a daily basis we focus on costs that can be managed in the course of normal business operations. Certain aspects of workers’ compensation can be managed through human resource initiatives, safety measures and training. Other workers’ compensation costs cannot be managed in the course of normal business operations and are less predictable, including expenses caused by actuarial revaluation and discount rate changes. We subtract the cash payments made by the DOL on behalf of workers' compensation obligations, which are relatively predictable, from total workers' compensation expense in order to determine the non-cash component of workers' compensation expense, a non-GAAP financial measure.\n\nFor additional information, see _Item 8. Financial Statements and Supplementary Data, Notes to Financial Statements_ , _Note 14 - Workers' Compensation_ .\n\nAnnually, we reimburse DOL for all workers' compensation benefits paid to or on behalf of our employees. The following table presents the components of workers’ compensation expense, including the cash payments made by DOL on behalf of workers’ compensation obligations, for the years ended September 30, 2025, and 2024:\n\n_(in millions)_ **2025 2024**\n\nImpact of discount rate changes $ (692) $ 1,105\n\nActuarial revaluation of existing cases 1,450 1,352\n\nCosts of new cases 1,841 1,245\n\nAdministrative fee 100 97\n\n**Total workers' compensation expense $ 2,699 $ 3,799**\n\nLess cash payments made by DOL on behalf of workers' compensation obligations (1,727) (1,635)\n\n**Total non-cash component of workers' compensation expense (non-GAAP) $ 972 $ 2,164**\n\nFor the year ended September 30, 2025, workers' compensation expense decreased $1.1 billion, compared to 2024, primarily due to increases in discount rates, partially offset by increased actuarial estimates of the costs of new cases, and actuarial revaluation of existing cases.\n\n**_Impact of Discount Rate Changes_** For the year ended September 30, 2025, the portion of workers' compensation expense attributable to the impact of increasing discount rates decreased $1.8 billion, compared to 2024. This decrease in expense was driven by a significant increase in discount rates in 2025, compared to 2024, an event outside of management's control.\n\n**_Actuarial Revaluation of Existing Cases and Costs of New Cases_** Changes in actuarial valuation are primarily attributable to the combined impacts of routine changes in actuarial estimation, the progression of existing cases and updated COLA assumptions, which are largely outside of management's control.\n\nFor the year ended September 30, 2025, the cost of new workers' compensation cases increased $596 million, compared to 2024, while the actuarial revaluation of existing cases increased by $98 million for the year ended\n\n**2025 Report on Form 10-K** United States Postal Service 35","publish_date":null,"title":"and revaluation of existing ones. Additionally, we reimburse DOL for all workers' compensation benefits paid to or on behalf of","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page36.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page36.pdf"},"request":{"example_id":"table/USPS 10-k_page36","product_type":"parse","source_file_path":"USPS 10-k_page36.pdf"},"started_at":"2026-11-04T19:48:07.624437"} +{"completed_at":"2026-11-04T19:48:10.019625","latency_in_ms":1356,"output":{"example_id":"table/USPS 10-k_page37","grounded_pages":[],"layout_pages":[],"markdown":"September 30, 2025, compared to 2024. The increase in the cost of new cases is attributed to the additional severity of such cases when compared to the prior year.\n\n**Transportation** Transportation expenses include the costs we incur to transport mail and packages between facilities, comprising highway, air, and international transportation contracts, plus contract delivery services. We rely on third-parties under highway contract routes for the significant majority of long-haul transportation services between facilities. Furthermore, we do not own or operate aircraft, and we rely on third parties for the air transportation service required to deliver our mail and packages to various destinations within the U.S. and abroad.\n\nWith the exception of contract delivery services, our costs to deliver mail and other products to end delivery points are not included within _Transportation_ but in _Compensation and benefits_ for employee costs and in _Other operating expenses_ for fuel, vehicle maintenance and repair, and other costs in the accompanying _Statements of Operations._ Furthermore, transportation expenses do not include the compensation and related costs of employees responsible for transporting mail and packages between closely located facilities.\n\nVariations in the volume and weight of mail and packages transported, the mode of transportation used, and fuel prices have significant impact on transportation expenses.\n\nThe table below details the components of transportation expense for the years ended September 30, 2025, and 2024:\n\n_(in millions)_ **2025 2024**\n\nHighway $ 6,073 $ 6,020\n\nAir 1,998 2,433\n\nInternational 254 324\n\nOther 68 38\n\n**Total transportation expense $ 8,393 $ 8,815**\n\nFor the year ended September 30, 2025, total transportation expense decreased $422 million, or 4.8%, compared to the prior year.\n\nHighway transportation expenses increased $53 million, or 0.9%, compared to the prior year, primarily due to a heavier reliance on freight auction during the year, as we continued to progress on our network realignments. While freight auction trips provide additional needed flexibility, they do have a higher average rate per mile. These increases are partially offset by our _Delivering for America_ plan network optimization efforts, including the reduction of facilities and the logical alignment of operating functions, resulting in the elimination of underutilized transportation trips, significantly increasing truck fill rates and reducing costs. We also benefited from lower average diesel fuel prices compared to the prior year, and our optimization of peak-season contracts. Our changes in service standards have further facilitated the shift of package volume from air to highway transportation when more economical and enabling improved reliability and service performance.\n\nAir transportation expenses decreased $435 million, or 17.9%, compared to the prior year. This decrease was primarily due to the previously mentioned changes in service standards that facilitated our shifting certain package volume from air to highway transportation for most of the year, along with the impact of lower average jet fuel prices.\n\n**2025 Report on Form 10-K** United States Postal Service 36","pages":[{"line_numbers":[],"markdown":"September 30, 2025, compared to 2024. The increase in the cost of new cases is attributed to the additional severity of such cases when compared to the prior year.\n\n**Transportation** Transportation expenses include the costs we incur to transport mail and packages between facilities, comprising highway, air, and international transportation contracts, plus contract delivery services. We rely on third-parties under highway contract routes for the significant majority of long-haul transportation services between facilities. Furthermore, we do not own or operate aircraft, and we rely on third parties for the air transportation service required to deliver our mail and packages to various destinations within the U.S. and abroad.\n\nWith the exception of contract delivery services, our costs to deliver mail and other products to end delivery points are not included within _Transportation_ but in _Compensation and benefits_ for employee costs and in _Other operating expenses_ for fuel, vehicle maintenance and repair, and other costs in the accompanying _Statements of Operations._ Furthermore, transportation expenses do not include the compensation and related costs of employees responsible for transporting mail and packages between closely located facilities.\n\nVariations in the volume and weight of mail and packages transported, the mode of transportation used, and fuel prices have significant impact on transportation expenses.\n\nThe table below details the components of transportation expense for the years ended September 30, 2025, and 2024:\n\n_(in millions)_ **2025 2024**\n\nHighway $ 6,073 $ 6,020\n\nAir 1,998 2,433\n\nInternational 254 324\n\nOther 68 38\n\n**Total transportation expense $ 8,393 $ 8,815**\n\nFor the year ended September 30, 2025, total transportation expense decreased $422 million, or 4.8%, compared to the prior year.\n\nHighway transportation expenses increased $53 million, or 0.9%, compared to the prior year, primarily due to a heavier reliance on freight auction during the year, as we continued to progress on our network realignments. While freight auction trips provide additional needed flexibility, they do have a higher average rate per mile. These increases are partially offset by our _Delivering for America_ plan network optimization efforts, including the reduction of facilities and the logical alignment of operating functions, resulting in the elimination of underutilized transportation trips, significantly increasing truck fill rates and reducing costs. We also benefited from lower average diesel fuel prices compared to the prior year, and our optimization of peak-season contracts. Our changes in service standards have further facilitated the shift of package volume from air to highway transportation when more economical and enabling improved reliability and service performance.\n\nAir transportation expenses decreased $435 million, or 17.9%, compared to the prior year. This decrease was primarily due to the previously mentioned changes in service standards that facilitated our shifting certain package volume from air to highway transportation for most of the year, along with the impact of lower average jet fuel prices.\n\n**2025 Report on Form 10-K** United States Postal Service 36","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"September 30, 2025, compared to 2024. The increase in the cost of new cases is attributed to the additional severity of such cases when compared to the prior year.\n\n**Transportation** Transportation expenses include the costs we incur to transport mail and packages between facilities, comprising highway, air, and international transportation contracts, plus contract delivery services. We rely on third-parties under highway contract routes for the significant majority of long-haul transportation services between facilities. Furthermore, we do not own or operate aircraft, and we rely on third parties for the air transportation service required to deliver our mail and packages to various destinations within the U.S. and abroad.\n\nWith the exception of contract delivery services, our costs to deliver mail and other products to end delivery points are not included within _Transportation_ but in _Compensation and benefits_ for employee costs and in _Other operating expenses_ for fuel, vehicle maintenance and repair, and other costs in the accompanying _Statements of Operations._ Furthermore, transportation expenses do not include the compensation and related costs of employees responsible for transporting mail and packages between closely located facilities.\n\nVariations in the volume and weight of mail and packages transported, the mode of transportation used, and fuel prices have significant impact on transportation expenses.\n\nThe table below details the components of transportation expense for the years ended September 30, 2025, and 2024:\n\n_(in millions)_ **2025 2024**\n\nHighway $ 6,073 $ 6,020\n\nAir 1,998 2,433\n\nInternational 254 324\n\nOther 68 38\n\n**Total transportation expense $ 8,393 $ 8,815**\n\nFor the year ended September 30, 2025, total transportation expense decreased $422 million, or 4.8%, compared to the prior year.\n\nHighway transportation expenses increased $53 million, or 0.9%, compared to the prior year, primarily due to a heavier reliance on freight auction during the year, as we continued to progress on our network realignments. While freight auction trips provide additional needed flexibility, they do have a higher average rate per mile. These increases are partially offset by our _Delivering for America_ plan network optimization efforts, including the reduction of facilities and the logical alignment of operating functions, resulting in the elimination of underutilized transportation trips, significantly increasing truck fill rates and reducing costs. We also benefited from lower average diesel fuel prices compared to the prior year, and our optimization of peak-season contracts. Our changes in service standards have further facilitated the shift of package volume from air to highway transportation when more economical and enabling improved reliability and service performance.\n\nAir transportation expenses decreased $435 million, or 17.9%, compared to the prior year. This decrease was primarily due to the previously mentioned changes in service standards that facilitated our shifting certain package volume from air to highway transportation for most of the year, along with the impact of lower average jet fuel prices.\n\n**2025 Report on Form 10-K** United States Postal Service 36","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page37.pdf"]},"response":{"errors":[],"extract_id":"extract_d75cd9a643e28eaa692ec7c81eb82301","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["September 30, 2025, compared to 2024. The increase in the cost of new cases is attributed to the additional severity of such cases when compared to the prior year.\n\n**Transportation** Transportation expenses include the costs we incur to transport mail and packages between facilities, comprising highway, air, and international transportation contracts, plus contract delivery services. We rely on third-parties under highway contract routes for the significant majority of long-haul transportation services between facilities. Furthermore, we do not own or operate aircraft, and we rely on third parties for the air transportation service required to deliver our mail and packages to various destinations within the U.S. and abroad.\n\nWith the exception of contract delivery services, our costs to deliver mail and other products to end delivery points are not included within _Transportation_ but in _Compensation and benefits_ for employee costs and in _Other operating expenses_ for fuel, vehicle maintenance and repair, and other costs in the accompanying _Statements of Operations._ Furthermore, transportation expenses do not include the compensation and related costs of employees responsible for transporting mail and packages between closely located facilities.\n\nVariations in the volume and weight of mail and packages transported, the mode of transportation used, and fuel prices have significant impact on transportation expenses.\n\nThe table below details the components of transportation expense for the years ended September 30, 2025, and 2024:\n\n_(in millions)_ **2025 2024**\n\nHighway $ 6,073 $ 6,020\n\nAir 1,998 2,433\n\nInternational 254 324\n\nOther 68 38\n\n**Total transportation expense $ 8,393 $ 8,815**\n\nFor the year ended September 30, 2025, total transportation expense decreased $422 million, or 4.8%, compared to the prior year.\n\nHighway transportation expenses increased $53 million, or 0.9%, compared to the prior year, primarily due to a heavier reliance on freight auction during the year, as we continued to progress on our network realignments. While freight auction trips provide additional needed flexibility, they do have a higher average rate per mile. These increases are partially offset by our _Delivering for America_ plan network optimization efforts, including the reduction of facilities and the logical alignment of operating functions, resulting in the elimination of underutilized transportation trips, significantly increasing truck fill rates and reducing costs. We also benefited from lower average diesel fuel prices compared to the prior year, and our optimization of peak-season contracts. Our changes in service standards have further facilitated the shift of package volume from air to highway transportation when more economical and enabling improved reliability and service performance.\n\nAir transportation expenses decreased $435 million, or 17.9%, compared to the prior year. This decrease was primarily due to the previously mentioned changes in service standards that facilitated our shifting certain package volume from air to highway transportation for most of the year, along with the impact of lower average jet fuel prices.\n\n**2025 Report on Form 10-K** United States Postal Service 36"],"full_content":"September 30, 2025, compared to 2024. The increase in the cost of new cases is attributed to the additional severity of such cases when compared to the prior year.\n\n**Transportation** Transportation expenses include the costs we incur to transport mail and packages between facilities, comprising highway, air, and international transportation contracts, plus contract delivery services. We rely on third-parties under highway contract routes for the significant majority of long-haul transportation services between facilities. Furthermore, we do not own or operate aircraft, and we rely on third parties for the air transportation service required to deliver our mail and packages to various destinations within the U.S. and abroad.\n\nWith the exception of contract delivery services, our costs to deliver mail and other products to end delivery points are not included within _Transportation_ but in _Compensation and benefits_ for employee costs and in _Other operating expenses_ for fuel, vehicle maintenance and repair, and other costs in the accompanying _Statements of Operations._ Furthermore, transportation expenses do not include the compensation and related costs of employees responsible for transporting mail and packages between closely located facilities.\n\nVariations in the volume and weight of mail and packages transported, the mode of transportation used, and fuel prices have significant impact on transportation expenses.\n\nThe table below details the components of transportation expense for the years ended September 30, 2025, and 2024:\n\n_(in millions)_ **2025 2024**\n\nHighway $ 6,073 $ 6,020\n\nAir 1,998 2,433\n\nInternational 254 324\n\nOther 68 38\n\n**Total transportation expense $ 8,393 $ 8,815**\n\nFor the year ended September 30, 2025, total transportation expense decreased $422 million, or 4.8%, compared to the prior year.\n\nHighway transportation expenses increased $53 million, or 0.9%, compared to the prior year, primarily due to a heavier reliance on freight auction during the year, as we continued to progress on our network realignments. While freight auction trips provide additional needed flexibility, they do have a higher average rate per mile. These increases are partially offset by our _Delivering for America_ plan network optimization efforts, including the reduction of facilities and the logical alignment of operating functions, resulting in the elimination of underutilized transportation trips, significantly increasing truck fill rates and reducing costs. We also benefited from lower average diesel fuel prices compared to the prior year, and our optimization of peak-season contracts. Our changes in service standards have further facilitated the shift of package volume from air to highway transportation when more economical and enabling improved reliability and service performance.\n\nAir transportation expenses decreased $435 million, or 17.9%, compared to the prior year. This decrease was primarily due to the previously mentioned changes in service standards that facilitated our shifting certain package volume from air to highway transportation for most of the year, along with the impact of lower average jet fuel prices.\n\n**2025 Report on Form 10-K** United States Postal Service 36","publish_date":null,"title":"September 30, 2025, compared to 2024. The increase in the cost of new cases is attributed to the additional severity","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page37.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page37.pdf"},"request":{"example_id":"table/USPS 10-k_page37","product_type":"parse","source_file_path":"USPS 10-k_page37.pdf"},"started_at":"2026-11-04T19:48:08.663210"} +{"completed_at":"2026-11-04T19:48:11.890758","latency_in_ms":1424,"output":{"example_id":"table/USPS 10-k_page47","grounded_pages":[],"layout_pages":[],"markdown":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF OPERATIONS**\n\n**Year Ended September 30,**\n\n_(in millions)_ **2025 2024 2023**\n\n**Revenue**\n\nOperating revenue $ 80,453 $ 79,537 $ 78,186\n\nOther revenue 128 10 197\n\n**Total revenue 80,581 79,547 78,383**\n\n**Operating expenses**\n\nCompensation and benefits 55,781 54,078 52,853\n\nRetirement benefits 10,342 10,427 10,001\n\nWorkers' compensation 2,699 3,799 538\n\nTransportation 8,393 8,815 10,111\n\nOther operating expenses 12,567 12,346 11,884\n\n**Total operating expenses 89,782 89,465 85,387**\n\n**Loss from operations (9,201) (9,918) (7,004)**\n\nInterest and investment income 771 958 941\n\nInterest expense (548) (560) (415)\n\n**Net loss $ (8,978) $ (9,520) $ (6,478)**\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 46","pages":[{"line_numbers":[],"markdown":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF OPERATIONS**\n\n**Year Ended September 30,**\n\n_(in millions)_ **2025 2024 2023**\n\n**Revenue**\n\nOperating revenue $ 80,453 $ 79,537 $ 78,186\n\nOther revenue 128 10 197\n\n**Total revenue 80,581 79,547 78,383**\n\n**Operating expenses**\n\nCompensation and benefits 55,781 54,078 52,853\n\nRetirement benefits 10,342 10,427 10,001\n\nWorkers' compensation 2,699 3,799 538\n\nTransportation 8,393 8,815 10,111\n\nOther operating expenses 12,567 12,346 11,884\n\n**Total operating expenses 89,782 89,465 85,387**\n\n**Loss from operations (9,201) (9,918) (7,004)**\n\nInterest and investment income 771 958 941\n\nInterest expense (548) (560) (415)\n\n**Net loss $ (8,978) $ (9,520) $ (6,478)**\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 46","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF OPERATIONS**\n\n**Year Ended September 30,**\n\n_(in millions)_ **2025 2024 2023**\n\n**Revenue**\n\nOperating revenue $ 80,453 $ 79,537 $ 78,186\n\nOther revenue 128 10 197\n\n**Total revenue 80,581 79,547 78,383**\n\n**Operating expenses**\n\nCompensation and benefits 55,781 54,078 52,853\n\nRetirement benefits 10,342 10,427 10,001\n\nWorkers' compensation 2,699 3,799 538\n\nTransportation 8,393 8,815 10,111\n\nOther operating expenses 12,567 12,346 11,884\n\n**Total operating expenses 89,782 89,465 85,387**\n\n**Loss from operations (9,201) (9,918) (7,004)**\n\nInterest and investment income 771 958 941\n\nInterest expense (548) (560) (415)\n\n**Net loss $ (8,978) $ (9,520) $ (6,478)**\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 46","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page47.pdf"]},"response":{"errors":[],"extract_id":"extract_e4e08ce66ce19f3d19e221e9618dd2a8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF OPERATIONS**\n\n**Year Ended September 30,**\n\n_(in millions)_ **2025 2024 2023**\n\n**Revenue**\n\nOperating revenue $ 80,453 $ 79,537 $ 78,186\n\nOther revenue 128 10 197\n\n**Total revenue 80,581 79,547 78,383**\n\n**Operating expenses**\n\nCompensation and benefits 55,781 54,078 52,853\n\nRetirement benefits 10,342 10,427 10,001\n\nWorkers' compensation 2,699 3,799 538\n\nTransportation 8,393 8,815 10,111\n\nOther operating expenses 12,567 12,346 11,884\n\n**Total operating expenses 89,782 89,465 85,387**\n\n**Loss from operations (9,201) (9,918) (7,004)**\n\nInterest and investment income 771 958 941\n\nInterest expense (548) (560) (415)\n\n**Net loss $ (8,978) $ (9,520) $ (6,478)**\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 46"],"full_content":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF OPERATIONS**\n\n**Year Ended September 30,**\n\n_(in millions)_ **2025 2024 2023**\n\n**Revenue**\n\nOperating revenue $ 80,453 $ 79,537 $ 78,186\n\nOther revenue 128 10 197\n\n**Total revenue 80,581 79,547 78,383**\n\n**Operating expenses**\n\nCompensation and benefits 55,781 54,078 52,853\n\nRetirement benefits 10,342 10,427 10,001\n\nWorkers' compensation 2,699 3,799 538\n\nTransportation 8,393 8,815 10,111\n\nOther operating expenses 12,567 12,346 11,884\n\n**Total operating expenses 89,782 89,465 85,387**\n\n**Loss from operations (9,201) (9,918) (7,004)**\n\nInterest and investment income 771 958 941\n\nInterest expense (548) (560) (415)\n\n**Net loss $ (8,978) $ (9,520) $ (6,478)**\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 46","publish_date":null,"title":"UNITED STATES POSTAL SERVICE STATEMENTS OF OPERATIONS Year Ended September 30, 2025 2024 2023 Revenue Operating revenue $ 80,453 $","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page47.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page47.pdf"},"request":{"example_id":"table/USPS 10-k_page47","product_type":"parse","source_file_path":"USPS 10-k_page47.pdf"},"started_at":"2026-11-04T19:48:10.466082"} +{"completed_at":"2026-11-04T19:48:13.054667","latency_in_ms":1560,"output":{"example_id":"table/USPS 10-k_page49","grounded_pages":[],"layout_pages":[],"markdown":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF CHANGES IN NET DEFICIENCY**\n\n_(in millions)_\n\n**Capital**\n\n**Contributions of U.S. Government**\n\n**Accumulated Deficit Since**\n\n**Reorganization**\n\n**Total Net Deficiency**\n\n**Balance, September 30, 2022 $ 16,132 $ (32,766) $ (16,634)**\n\nNet loss — $ (6,478) (6,478)\n\n**Balance, September 30, 2023 $ 16,132 $ (39,244) $ (23,112)**\n\nNet loss **—** $ (9,520) (9,520)\n\n**Balance, September 30, 2024 $ 16,132 $ (48,764) $ (32,632)**\n\nNet loss **— (8,978)** (8,978)\n\n**Balance, September 30, 2025 $ 16,132 $ (57,742) $ (41,610)**\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 48","pages":[{"line_numbers":[],"markdown":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF CHANGES IN NET DEFICIENCY**\n\n_(in millions)_\n\n**Capital**\n\n**Contributions of U.S. Government**\n\n**Accumulated Deficit Since**\n\n**Reorganization**\n\n**Total Net Deficiency**\n\n**Balance, September 30, 2022 $ 16,132 $ (32,766) $ (16,634)**\n\nNet loss — $ (6,478) (6,478)\n\n**Balance, September 30, 2023 $ 16,132 $ (39,244) $ (23,112)**\n\nNet loss **—** $ (9,520) (9,520)\n\n**Balance, September 30, 2024 $ 16,132 $ (48,764) $ (32,632)**\n\nNet loss **— (8,978)** (8,978)\n\n**Balance, September 30, 2025 $ 16,132 $ (57,742) $ (41,610)**\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 48","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF CHANGES IN NET DEFICIENCY**\n\n_(in millions)_\n\n**Capital**\n\n**Contributions of U.S. Government**\n\n**Accumulated Deficit Since**\n\n**Reorganization**\n\n**Total Net Deficiency**\n\n**Balance, September 30, 2022 $ 16,132 $ (32,766) $ (16,634)**\n\nNet loss — $ (6,478) (6,478)\n\n**Balance, September 30, 2023 $ 16,132 $ (39,244) $ (23,112)**\n\nNet loss **—** $ (9,520) (9,520)\n\n**Balance, September 30, 2024 $ 16,132 $ (48,764) $ (32,632)**\n\nNet loss **— (8,978)** (8,978)\n\n**Balance, September 30, 2025 $ 16,132 $ (57,742) $ (41,610)**\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 48","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page49.pdf"]},"response":{"errors":[],"extract_id":"extract_68bfc415934b679e3ef6171926732634","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF CHANGES IN NET DEFICIENCY**\n\n_(in millions)_\n\n**Capital**\n\n**Contributions of U.S. Government**\n\n**Accumulated Deficit Since**\n\n**Reorganization**\n\n**Total Net Deficiency**\n\n**Balance, September 30, 2022 $ 16,132 $ (32,766) $ (16,634)**\n\nNet loss — $ (6,478) (6,478)\n\n**Balance, September 30, 2023 $ 16,132 $ (39,244) $ (23,112)**\n\nNet loss **—** $ (9,520) (9,520)\n\n**Balance, September 30, 2024 $ 16,132 $ (48,764) $ (32,632)**\n\nNet loss **— (8,978)** (8,978)\n\n**Balance, September 30, 2025 $ 16,132 $ (57,742) $ (41,610)**\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 48"],"full_content":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF CHANGES IN NET DEFICIENCY**\n\n_(in millions)_\n\n**Capital**\n\n**Contributions of U.S. Government**\n\n**Accumulated Deficit Since**\n\n**Reorganization**\n\n**Total Net Deficiency**\n\n**Balance, September 30, 2022 $ 16,132 $ (32,766) $ (16,634)**\n\nNet loss — $ (6,478) (6,478)\n\n**Balance, September 30, 2023 $ 16,132 $ (39,244) $ (23,112)**\n\nNet loss **—** $ (9,520) (9,520)\n\n**Balance, September 30, 2024 $ 16,132 $ (48,764) $ (32,632)**\n\nNet loss **— (8,978)** (8,978)\n\n**Balance, September 30, 2025 $ 16,132 $ (57,742) $ (41,610)**\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 48","publish_date":null,"title":"UNITED STATES POSTAL SERVICE STATEMENTS OF CHANGES IN NET DEFICIENCY Capital Accumulated Contributions of Deficit Since Total Net U.S. Government","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page49.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page49.pdf"},"request":{"example_id":"table/USPS 10-k_page49","product_type":"parse","source_file_path":"USPS 10-k_page49.pdf"},"started_at":"2026-11-04T19:48:11.494543"} +{"completed_at":"2026-11-04T19:48:16.024820","latency_in_ms":2957,"output":{"example_id":"table/USPS 10-k_page50","grounded_pages":[],"layout_pages":[],"markdown":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF CASH FLOWS**\n\n**Years Ended September 30,**\n\n_(in millions)_ **2025 2024 2023**\n\n**Cash flows from operating activities:** Net loss $ (8,978) $ (9,520) $ (6,478)\n\nAdjustments to reconcile net loss to net cash (used in) provided by operating activities:\n\nDepreciation and amortization 2,238 1,997 1,786\n\nOther, net 4 (14) (402)\n\n(Increase) decrease in operating lease right-of-use assets (126) (97) 22\n\nIncrease (decrease) in noncurrent workers' compensation 975 2,208 (880)\n\nIncrease in noncurrent operating lease liabilities 126 139 89\n\nIncrease in other noncurrent liabilities 3 14 40\n\nChanges in current assets and liabilities:\n\nReceivables, net 62 40 (101)\n\nOther current assets (102) (28) (29)\n\nRetirement benefits 3,807 4,556 4,574\n\nPayables, accrued expenses, and other 292 306 (869)\n\nOperating lease liabilities 30 (20) (97)\n\nDeferred revenue-prepaid postage and other deferred revenue (182) 487 (117)\n\n**Net cash (used in) provided by operating activities (1,851) 68 (2,462)**\n\n**Cash flows from investing activities:**\n\nPurchases of property and equipment (3,585) (4,199) (3,000)\n\nProceeds from sales of property and equipment 128 6 287\n\nPurchases of investments (3,000) (15,300) (13,637)\n\nPurchases of restricted investments (566) (3,275) (3,145)\n\nRedemption of investments 12,300 14,637 5,000\n\nRedemption of restricted investments 3,275 3,145 —\n\n**Net cash provided by (used in) investing activities 8,552 (4,986) (14,495)**\n\n**Cash flows from financing activities:**\n\nProceeds from borrowings — 3,000 3,000\n\nRepayments of borrowings — (1,000) —\n\nPayments on finance lease obligations (34) (28) (27)\n\n**Net cash (used in) provided by financing activities (34) 1,972 2,973**\n\nNet increase (decrease) in cash, cash equivalents & restricted cash 6,667 (2,946) (13,984)\n\nCash, cash equivalents & restricted cash - beginning of year 6,688 9,634 23,618\n\n**Cash, cash equivalents & restricted cash - end of year $ 13,355 $ 6,688 $ 9,634**\n\n**Supplemental cash flows disclosures:**\n\nCash paid for interest $ 607 $ 569 $ 379\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 49","pages":[{"line_numbers":[],"markdown":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF CASH FLOWS**\n\n**Years Ended September 30,**\n\n_(in millions)_ **2025 2024 2023**\n\n**Cash flows from operating activities:** Net loss $ (8,978) $ (9,520) $ (6,478)\n\nAdjustments to reconcile net loss to net cash (used in) provided by operating activities:\n\nDepreciation and amortization 2,238 1,997 1,786\n\nOther, net 4 (14) (402)\n\n(Increase) decrease in operating lease right-of-use assets (126) (97) 22\n\nIncrease (decrease) in noncurrent workers' compensation 975 2,208 (880)\n\nIncrease in noncurrent operating lease liabilities 126 139 89\n\nIncrease in other noncurrent liabilities 3 14 40\n\nChanges in current assets and liabilities:\n\nReceivables, net 62 40 (101)\n\nOther current assets (102) (28) (29)\n\nRetirement benefits 3,807 4,556 4,574\n\nPayables, accrued expenses, and other 292 306 (869)\n\nOperating lease liabilities 30 (20) (97)\n\nDeferred revenue-prepaid postage and other deferred revenue (182) 487 (117)\n\n**Net cash (used in) provided by operating activities (1,851) 68 (2,462)**\n\n**Cash flows from investing activities:**\n\nPurchases of property and equipment (3,585) (4,199) (3,000)\n\nProceeds from sales of property and equipment 128 6 287\n\nPurchases of investments (3,000) (15,300) (13,637)\n\nPurchases of restricted investments (566) (3,275) (3,145)\n\nRedemption of investments 12,300 14,637 5,000\n\nRedemption of restricted investments 3,275 3,145 —\n\n**Net cash provided by (used in) investing activities 8,552 (4,986) (14,495)**\n\n**Cash flows from financing activities:**\n\nProceeds from borrowings — 3,000 3,000\n\nRepayments of borrowings — (1,000) —\n\nPayments on finance lease obligations (34) (28) (27)\n\n**Net cash (used in) provided by financing activities (34) 1,972 2,973**\n\nNet increase (decrease) in cash, cash equivalents & restricted cash 6,667 (2,946) (13,984)\n\nCash, cash equivalents & restricted cash - beginning of year 6,688 9,634 23,618\n\n**Cash, cash equivalents & restricted cash - end of year $ 13,355 $ 6,688 $ 9,634**\n\n**Supplemental cash flows disclosures:**\n\nCash paid for interest $ 607 $ 569 $ 379\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 49","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF CASH FLOWS**\n\n**Years Ended September 30,**\n\n_(in millions)_ **2025 2024 2023**\n\n**Cash flows from operating activities:** Net loss $ (8,978) $ (9,520) $ (6,478)\n\nAdjustments to reconcile net loss to net cash (used in) provided by operating activities:\n\nDepreciation and amortization 2,238 1,997 1,786\n\nOther, net 4 (14) (402)\n\n(Increase) decrease in operating lease right-of-use assets (126) (97) 22\n\nIncrease (decrease) in noncurrent workers' compensation 975 2,208 (880)\n\nIncrease in noncurrent operating lease liabilities 126 139 89\n\nIncrease in other noncurrent liabilities 3 14 40\n\nChanges in current assets and liabilities:\n\nReceivables, net 62 40 (101)\n\nOther current assets (102) (28) (29)\n\nRetirement benefits 3,807 4,556 4,574\n\nPayables, accrued expenses, and other 292 306 (869)\n\nOperating lease liabilities 30 (20) (97)\n\nDeferred revenue-prepaid postage and other deferred revenue (182) 487 (117)\n\n**Net cash (used in) provided by operating activities (1,851) 68 (2,462)**\n\n**Cash flows from investing activities:**\n\nPurchases of property and equipment (3,585) (4,199) (3,000)\n\nProceeds from sales of property and equipment 128 6 287\n\nPurchases of investments (3,000) (15,300) (13,637)\n\nPurchases of restricted investments (566) (3,275) (3,145)\n\nRedemption of investments 12,300 14,637 5,000\n\nRedemption of restricted investments 3,275 3,145 —\n\n**Net cash provided by (used in) investing activities 8,552 (4,986) (14,495)**\n\n**Cash flows from financing activities:**\n\nProceeds from borrowings — 3,000 3,000\n\nRepayments of borrowings — (1,000) —\n\nPayments on finance lease obligations (34) (28) (27)\n\n**Net cash (used in) provided by financing activities (34) 1,972 2,973**\n\nNet increase (decrease) in cash, cash equivalents & restricted cash 6,667 (2,946) (13,984)\n\nCash, cash equivalents & restricted cash - beginning of year 6,688 9,634 23,618\n\n**Cash, cash equivalents & restricted cash - end of year $ 13,355 $ 6,688 $ 9,634**\n\n**Supplemental cash flows disclosures:**\n\nCash paid for interest $ 607 $ 569 $ 379\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 49","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page50.pdf"]},"response":{"errors":[],"extract_id":"extract_fad6040c964d10eed37ae6c6921dad05","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF CASH FLOWS**\n\n**Years Ended September 30,**\n\n_(in millions)_ **2025 2024 2023**\n\n**Cash flows from operating activities:** Net loss $ (8,978) $ (9,520) $ (6,478)\n\nAdjustments to reconcile net loss to net cash (used in) provided by operating activities:\n\nDepreciation and amortization 2,238 1,997 1,786\n\nOther, net 4 (14) (402)\n\n(Increase) decrease in operating lease right-of-use assets (126) (97) 22\n\nIncrease (decrease) in noncurrent workers' compensation 975 2,208 (880)\n\nIncrease in noncurrent operating lease liabilities 126 139 89\n\nIncrease in other noncurrent liabilities 3 14 40\n\nChanges in current assets and liabilities:\n\nReceivables, net 62 40 (101)\n\nOther current assets (102) (28) (29)\n\nRetirement benefits 3,807 4,556 4,574\n\nPayables, accrued expenses, and other 292 306 (869)\n\nOperating lease liabilities 30 (20) (97)\n\nDeferred revenue-prepaid postage and other deferred revenue (182) 487 (117)\n\n**Net cash (used in) provided by operating activities (1,851) 68 (2,462)**\n\n**Cash flows from investing activities:**\n\nPurchases of property and equipment (3,585) (4,199) (3,000)\n\nProceeds from sales of property and equipment 128 6 287\n\nPurchases of investments (3,000) (15,300) (13,637)\n\nPurchases of restricted investments (566) (3,275) (3,145)\n\nRedemption of investments 12,300 14,637 5,000\n\nRedemption of restricted investments 3,275 3,145 —\n\n**Net cash provided by (used in) investing activities 8,552 (4,986) (14,495)**\n\n**Cash flows from financing activities:**\n\nProceeds from borrowings — 3,000 3,000\n\nRepayments of borrowings — (1,000) —\n\nPayments on finance lease obligations (34) (28) (27)\n\n**Net cash (used in) provided by financing activities (34) 1,972 2,973**\n\nNet increase (decrease) in cash, cash equivalents & restricted cash 6,667 (2,946) (13,984)\n\nCash, cash equivalents & restricted cash - beginning of year 6,688 9,634 23,618\n\n**Cash, cash equivalents & restricted cash - end of year $ 13,355 $ 6,688 $ 9,634**\n\n**Supplemental cash flows disclosures:**\n\nCash paid for interest $ 607 $ 569 $ 379\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 49"],"full_content":"**UNITED STATES POSTAL SERVICE**\n\n**STATEMENTS OF CASH FLOWS**\n\n**Years Ended September 30,**\n\n_(in millions)_ **2025 2024 2023**\n\n**Cash flows from operating activities:** Net loss $ (8,978) $ (9,520) $ (6,478)\n\nAdjustments to reconcile net loss to net cash (used in) provided by operating activities:\n\nDepreciation and amortization 2,238 1,997 1,786\n\nOther, net 4 (14) (402)\n\n(Increase) decrease in operating lease right-of-use assets (126) (97) 22\n\nIncrease (decrease) in noncurrent workers' compensation 975 2,208 (880)\n\nIncrease in noncurrent operating lease liabilities 126 139 89\n\nIncrease in other noncurrent liabilities 3 14 40\n\nChanges in current assets and liabilities:\n\nReceivables, net 62 40 (101)\n\nOther current assets (102) (28) (29)\n\nRetirement benefits 3,807 4,556 4,574\n\nPayables, accrued expenses, and other 292 306 (869)\n\nOperating lease liabilities 30 (20) (97)\n\nDeferred revenue-prepaid postage and other deferred revenue (182) 487 (117)\n\n**Net cash (used in) provided by operating activities (1,851) 68 (2,462)**\n\n**Cash flows from investing activities:**\n\nPurchases of property and equipment (3,585) (4,199) (3,000)\n\nProceeds from sales of property and equipment 128 6 287\n\nPurchases of investments (3,000) (15,300) (13,637)\n\nPurchases of restricted investments (566) (3,275) (3,145)\n\nRedemption of investments 12,300 14,637 5,000\n\nRedemption of restricted investments 3,275 3,145 —\n\n**Net cash provided by (used in) investing activities 8,552 (4,986) (14,495)**\n\n**Cash flows from financing activities:**\n\nProceeds from borrowings — 3,000 3,000\n\nRepayments of borrowings — (1,000) —\n\nPayments on finance lease obligations (34) (28) (27)\n\n**Net cash (used in) provided by financing activities (34) 1,972 2,973**\n\nNet increase (decrease) in cash, cash equivalents & restricted cash 6,667 (2,946) (13,984)\n\nCash, cash equivalents & restricted cash - beginning of year 6,688 9,634 23,618\n\n**Cash, cash equivalents & restricted cash - end of year $ 13,355 $ 6,688 $ 9,634**\n\n**Supplemental cash flows disclosures:**\n\nCash paid for interest $ 607 $ 569 $ 379\n\nSee accompanying notes to the financial statements.\n\n**2025 Report on Form 10-K** United States Postal Service 49","publish_date":null,"title":"UNITED STATES POSTAL SERVICE STATEMENTS OF CASH FLOWS Years Ended September 30, 2025 2024 2023 Cash flows from operating activities:","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page50.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/USPS%2010-k_page50.pdf"},"request":{"example_id":"table/USPS 10-k_page50","product_type":"parse","source_file_path":"USPS 10-k_page50.pdf"},"started_at":"2026-11-04T19:48:13.067345"} +{"completed_at":"2026-11-04T19:48:16.483159","latency_in_ms":2084,"output":{"example_id":"table/VRSK.2012.page_125.pdf_105195_page1","grounded_pages":[],"layout_pages":[],"markdown":"**VERISK ANALYTICS, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)**\n\nThe following table provides the Company’s revenue and operating income performance by reportable segment for the years ended December 31, as well as a reconciliation to income before income taxes for all periods presented in the accompanying consolidated statements of operations:\n\n**2012 2011 2010**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\nRevenues . . . . . . . . . . . . . . . . $954,814 $579,506 $1,534,320 $768,479 $563,361 $1,331,840 $596,205 $542,138 $1,138,343 Expenses: Cost of revenues (exclusive of items shown separately below) . . . . . . 424,746 182,428 607,174 340,068 193,667 533,735 268,742 194,731 463,473 Selling, general and administrative . . . . . . . . . 150,413 80,946 231,359 125,938 83,531 209,469 87,384 78,990 166,374 Acquisition related liabilities adjustment . . . . — — — (3,364) — (3,364) (544) — (544) Investment income and realized (loss) gain on securities, net . . . . . . . . . — (128) (128) — (887) (887) — (400) (400)\n\nEBITDA . . . . . . . . . . . . . . . 379,655 316,260 695,915 305,837 287,050 592,887 240,623 268,817 509,440 Depreciation and amortization of fixed assets . . . . . . . . . . . . . . . . 37,093 13,531 50,624 29,608 14,219 43,827 23,956 16,772 40,728 Amortization of intangible assets . . . . . . . . . . . . . . . . 53,575 — 53,575 34,671 121 34,792 27,253 145 27,398 Investment income and realized (loss) gain on securities, net . . . . . . . . . — 128 128 — 887 887 — 400 400\n\nOperating income . . . . . . . . . . $288,987 $302,601 591,588 $241,558 $271,823 513,381 $189,414 $251,500 440,914\n\nInvestment income and realized (loss) gain on securities, net . . . . . . . . . . . 128 887 400 Interest expense . . . . . . . . . . . (72,508) (53,847) (34,664)\n\nIncome before income taxes . . . . . . . . . . . . . . . . . . $ 519,208 $ 460,421 $ 406,650\n\nCapital expenditures, including non-cash purchases of fixed assets and capital lease obligations . . . . . . . . . . . . . $ 64,747 $ 15,004 $ 79,751 $ 56,486 $ 11,890 $ 68,376 $ 32,622 $ 8,323 $ 40,945\n\n105","pages":[{"line_numbers":[],"markdown":"**VERISK ANALYTICS, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)**\n\nThe following table provides the Company’s revenue and operating income performance by reportable segment for the years ended December 31, as well as a reconciliation to income before income taxes for all periods presented in the accompanying consolidated statements of operations:\n\n**2012 2011 2010**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\nRevenues . . . . . . . . . . . . . . . . $954,814 $579,506 $1,534,320 $768,479 $563,361 $1,331,840 $596,205 $542,138 $1,138,343 Expenses: Cost of revenues (exclusive of items shown separately below) . . . . . . 424,746 182,428 607,174 340,068 193,667 533,735 268,742 194,731 463,473 Selling, general and administrative . . . . . . . . . 150,413 80,946 231,359 125,938 83,531 209,469 87,384 78,990 166,374 Acquisition related liabilities adjustment . . . . — — — (3,364) — (3,364) (544) — (544) Investment income and realized (loss) gain on securities, net . . . . . . . . . — (128) (128) — (887) (887) — (400) (400)\n\nEBITDA . . . . . . . . . . . . . . . 379,655 316,260 695,915 305,837 287,050 592,887 240,623 268,817 509,440 Depreciation and amortization of fixed assets . . . . . . . . . . . . . . . . 37,093 13,531 50,624 29,608 14,219 43,827 23,956 16,772 40,728 Amortization of intangible assets . . . . . . . . . . . . . . . . 53,575 — 53,575 34,671 121 34,792 27,253 145 27,398 Investment income and realized (loss) gain on securities, net . . . . . . . . . — 128 128 — 887 887 — 400 400\n\nOperating income . . . . . . . . . . $288,987 $302,601 591,588 $241,558 $271,823 513,381 $189,414 $251,500 440,914\n\nInvestment income and realized (loss) gain on securities, net . . . . . . . . . . . 128 887 400 Interest expense . . . . . . . . . . . (72,508) (53,847) (34,664)\n\nIncome before income taxes . . . . . . . . . . . . . . . . . . $ 519,208 $ 460,421 $ 406,650\n\nCapital expenditures, including non-cash purchases of fixed assets and capital lease obligations . . . . . . . . . . . . . $ 64,747 $ 15,004 $ 79,751 $ 56,486 $ 11,890 $ 68,376 $ 32,622 $ 8,323 $ 40,945\n\n105","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**VERISK ANALYTICS, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)**\n\nThe following table provides the Company’s revenue and operating income performance by reportable segment for the years ended December 31, as well as a reconciliation to income before income taxes for all periods presented in the accompanying consolidated statements of operations:\n\n**2012 2011 2010**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\nRevenues . . . . . . . . . . . . . . . . $954,814 $579,506 $1,534,320 $768,479 $563,361 $1,331,840 $596,205 $542,138 $1,138,343 Expenses: Cost of revenues (exclusive of items shown separately below) . . . . . . 424,746 182,428 607,174 340,068 193,667 533,735 268,742 194,731 463,473 Selling, general and administrative . . . . . . . . . 150,413 80,946 231,359 125,938 83,531 209,469 87,384 78,990 166,374 Acquisition related liabilities adjustment . . . . — — — (3,364) — (3,364) (544) — (544) Investment income and realized (loss) gain on securities, net . . . . . . . . . — (128) (128) — (887) (887) — (400) (400)\n\nEBITDA . . . . . . . . . . . . . . . 379,655 316,260 695,915 305,837 287,050 592,887 240,623 268,817 509,440 Depreciation and amortization of fixed assets . . . . . . . . . . . . . . . . 37,093 13,531 50,624 29,608 14,219 43,827 23,956 16,772 40,728 Amortization of intangible assets . . . . . . . . . . . . . . . . 53,575 — 53,575 34,671 121 34,792 27,253 145 27,398 Investment income and realized (loss) gain on securities, net . . . . . . . . . — 128 128 — 887 887 — 400 400\n\nOperating income . . . . . . . . . . $288,987 $302,601 591,588 $241,558 $271,823 513,381 $189,414 $251,500 440,914\n\nInvestment income and realized (loss) gain on securities, net . . . . . . . . . . . 128 887 400 Interest expense . . . . . . . . . . . (72,508) (53,847) (34,664)\n\nIncome before income taxes . . . . . . . . . . . . . . . . . . $ 519,208 $ 460,421 $ 406,650\n\nCapital expenditures, including non-cash purchases of fixed assets and capital lease obligations . . . . . . . . . . . . . $ 64,747 $ 15,004 $ 79,751 $ 56,486 $ 11,890 $ 68,376 $ 32,622 $ 8,323 $ 40,945\n\n105","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/VRSK.2012.page_125.pdf_105195_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_d554b6afdb07fbd39ebf9f426fdcbb05","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**VERISK ANALYTICS, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)**\n\nThe following table provides the Company’s revenue and operating income performance by reportable segment for the years ended December 31, as well as a reconciliation to income before income taxes for all periods presented in the accompanying consolidated statements of operations:\n\n**2012 2011 2010**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\nRevenues . . . . . . . . . . . . . . . . $954,814 $579,506 $1,534,320 $768,479 $563,361 $1,331,840 $596,205 $542,138 $1,138,343 Expenses: Cost of revenues (exclusive of items shown separately below) . . . . . . 424,746 182,428 607,174 340,068 193,667 533,735 268,742 194,731 463,473 Selling, general and administrative . . . . . . . . . 150,413 80,946 231,359 125,938 83,531 209,469 87,384 78,990 166,374 Acquisition related liabilities adjustment . . . . — — — (3,364) — (3,364) (544) — (544) Investment income and realized (loss) gain on securities, net . . . . . . . . . — (128) (128) — (887) (887) — (400) (400)\n\nEBITDA . . . . . . . . . . . . . . . 379,655 316,260 695,915 305,837 287,050 592,887 240,623 268,817 509,440 Depreciation and amortization of fixed assets . . . . . . . . . . . . . . . . 37,093 13,531 50,624 29,608 14,219 43,827 23,956 16,772 40,728 Amortization of intangible assets . . . . . . . . . . . . . . . . 53,575 — 53,575 34,671 121 34,792 27,253 145 27,398 Investment income and realized (loss) gain on securities, net . . . . . . . . . — 128 128 — 887 887 — 400 400\n\nOperating income . . . . . . . . . . $288,987 $302,601 591,588 $241,558 $271,823 513,381 $189,414 $251,500 440,914\n\nInvestment income and realized (loss) gain on securities, net . . . . . . . . . . . 128 887 400 Interest expense . . . . . . . . . . . (72,508) (53,847) (34,664)\n\nIncome before income taxes . . . . . . . . . . . . . . . . . . $ 519,208 $ 460,421 $ 406,650\n\nCapital expenditures, including non-cash purchases of fixed assets and capital lease obligations . . . . . . . . . . . . . $ 64,747 $ 15,004 $ 79,751 $ 56,486 $ 11,890 $ 68,376 $ 32,622 $ 8,323 $ 40,945\n\n105"],"full_content":"**VERISK ANALYTICS, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)**\n\nThe following table provides the Company’s revenue and operating income performance by reportable segment for the years ended December 31, as well as a reconciliation to income before income taxes for all periods presented in the accompanying consolidated statements of operations:\n\n**2012 2011 2010**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\n**Decision Analytics**\n\n**Risk Assessment Total**\n\nRevenues . . . . . . . . . . . . . . . . $954,814 $579,506 $1,534,320 $768,479 $563,361 $1,331,840 $596,205 $542,138 $1,138,343 Expenses: Cost of revenues (exclusive of items shown separately below) . . . . . . 424,746 182,428 607,174 340,068 193,667 533,735 268,742 194,731 463,473 Selling, general and administrative . . . . . . . . . 150,413 80,946 231,359 125,938 83,531 209,469 87,384 78,990 166,374 Acquisition related liabilities adjustment . . . . — — — (3,364) — (3,364) (544) — (544) Investment income and realized (loss) gain on securities, net . . . . . . . . . — (128) (128) — (887) (887) — (400) (400)\n\nEBITDA . . . . . . . . . . . . . . . 379,655 316,260 695,915 305,837 287,050 592,887 240,623 268,817 509,440 Depreciation and amortization of fixed assets . . . . . . . . . . . . . . . . 37,093 13,531 50,624 29,608 14,219 43,827 23,956 16,772 40,728 Amortization of intangible assets . . . . . . . . . . . . . . . . 53,575 — 53,575 34,671 121 34,792 27,253 145 27,398 Investment income and realized (loss) gain on securities, net . . . . . . . . . — 128 128 — 887 887 — 400 400\n\nOperating income . . . . . . . . . . $288,987 $302,601 591,588 $241,558 $271,823 513,381 $189,414 $251,500 440,914\n\nInvestment income and realized (loss) gain on securities, net . . . . . . . . . . . 128 887 400 Interest expense . . . . . . . . . . . (72,508) (53,847) (34,664)\n\nIncome before income taxes . . . . . . . . . . . . . . . . . . $ 519,208 $ 460,421 $ 406,650\n\nCapital expenditures, including non-cash purchases of fixed assets and capital lease obligations . . . . . . . . . . . . . $ 64,747 $ 15,004 $ 79,751 $ 56,486 $ 11,890 $ 68,376 $ 32,622 $ 8,323 $ 40,945\n\n105","publish_date":null,"title":"VERISKANALYTICS,INC. NOTESTOCONSOLIDATEDFINANCIALSTATEMENTS—(Continued) ThefollowingtableprovidestheCompany’srevenueandoperatingincomeperformancebyreportable segmentfortheyearsendedDecember31,aswellasareconciliationtoincomebeforeincometaxesforall periodspresentedintheaccompanyingconsolidatedstatementsofoperations: 105","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/VRSK.2012.page_125.pdf_105195_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/VRSK.2012.page_125.pdf_105195_page1.pdf"},"request":{"example_id":"table/VRSK.2012.page_125.pdf_105195_page1","product_type":"parse","source_file_path":"VRSK.2012.page_125.pdf_105195_page1.pdf"},"started_at":"2026-11-04T19:48:14.398519"} +{"completed_at":"2026-11-04T19:48:17.445284","latency_in_ms":1863,"output":{"example_id":"table/VRSK.2018.page_141.pdf_105144_page1","grounded_pages":[],"layout_pages":[],"markdown":"**VERISK ANALYTICS, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)**\n\nThe following table provides the Company’s revenue and EBITDA by reportable segment for the years ended December 31, as well as a reconciliation of EBITDA to operating income for all periods presented in the accompanying consolidated statements of operations:\n\n**2018 2017 2016**\n\n**Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total**\n\nRevenues . . . . . . . . . . $1,705.9 $ 513.3 $175.9 $2,395.1 $1,550.6 $ 444.6 $150.0 $2,145.2 $1,419.1 $ 442.8 $ 133.3 $1,995.2 Expenses: Cost of revenues (exclusive of items shown separately below) . . . . . . . . (568.1) (218.2) (99.9) (886.2) (510.4) (193.8) (79.6) (783.8) (469.6) (177.1) (67.7) (714.4) Selling, general and administrative . . (218.8) (141.1) (18.8) (378.7) (196.1) (114.4) (12.3) (322.8) (178.1) (113.4) (10.1) (301.6) Investment income and others, net . . . . . . . . . . . 13.2 0.4 1.7 15.3 11.7 (2.8) 0.3 9.2 7.8 (1.1) (0.6) 6.1 EBITDA from discontinued operations . . . . . — — — — — — — — — — 266.0 266.0\n\nEBITDA . . . . . . 932.2 154.4 58.9 1,145.5 855.8 133.6 58.4 1,047.8 779.2 151.2 320.9 1,251.3 Depreciation and amortization of fixed assets . . . . (107.0) (42.7) (15.6) (165.3) (91.2) (36.4) (8.0) (135.6) (86.4) (25.9) (6.8) (119.1) Amortization of intangible assets . . . . . . . . . (22.8) (84.6) (23.4) (130.8) (13.7) (70.3) (17.8) (101.8) (6.1) (72.8) (13.6) (92.5) Investment income and others, net . . . . . . . . . . . (13.2) (0.4) (1.7) (15.3) (11.7) 2.8 (0.3) (9.2) (7.8) 1.1 0.6 (6.1) EBITDA from discontinued operations . . . . . — — — — — — — — — — (266.0) (266.0)\n\nOperating income . . . $ 789.2 $ 26.7 $ 18.2 834.1 $ 739.2 $ 29.7 $ 32.3 801.2 $ 678.9 $ 53.6 $ 35.1 767.6\n\nInvestment income and others, net . . . . 15.3 9.2 6.1 Interest expense . . . . . (129.7) (119.4) (120.0)\n\nIncome from continuing operations before income taxes . . . . . $ 719.7 $ 691.0 $ 653.7\n\nLong-lived assets by country are provided below as of December 31:\n\n**2018 2017**\n\nLong-lived assets: U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,335.8 $2,438.6 U.K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,595.5 2,656.6 Other countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 324.5 327.5\n\nTotal long-lived assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $5,255.8 $5,422.7\n\n117","pages":[{"line_numbers":[],"markdown":"**VERISK ANALYTICS, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)**\n\nThe following table provides the Company’s revenue and EBITDA by reportable segment for the years ended December 31, as well as a reconciliation of EBITDA to operating income for all periods presented in the accompanying consolidated statements of operations:\n\n**2018 2017 2016**\n\n**Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total**\n\nRevenues . . . . . . . . . . $1,705.9 $ 513.3 $175.9 $2,395.1 $1,550.6 $ 444.6 $150.0 $2,145.2 $1,419.1 $ 442.8 $ 133.3 $1,995.2 Expenses: Cost of revenues (exclusive of items shown separately below) . . . . . . . . (568.1) (218.2) (99.9) (886.2) (510.4) (193.8) (79.6) (783.8) (469.6) (177.1) (67.7) (714.4) Selling, general and administrative . . (218.8) (141.1) (18.8) (378.7) (196.1) (114.4) (12.3) (322.8) (178.1) (113.4) (10.1) (301.6) Investment income and others, net . . . . . . . . . . . 13.2 0.4 1.7 15.3 11.7 (2.8) 0.3 9.2 7.8 (1.1) (0.6) 6.1 EBITDA from discontinued operations . . . . . — — — — — — — — — — 266.0 266.0\n\nEBITDA . . . . . . 932.2 154.4 58.9 1,145.5 855.8 133.6 58.4 1,047.8 779.2 151.2 320.9 1,251.3 Depreciation and amortization of fixed assets . . . . (107.0) (42.7) (15.6) (165.3) (91.2) (36.4) (8.0) (135.6) (86.4) (25.9) (6.8) (119.1) Amortization of intangible assets . . . . . . . . . (22.8) (84.6) (23.4) (130.8) (13.7) (70.3) (17.8) (101.8) (6.1) (72.8) (13.6) (92.5) Investment income and others, net . . . . . . . . . . . (13.2) (0.4) (1.7) (15.3) (11.7) 2.8 (0.3) (9.2) (7.8) 1.1 0.6 (6.1) EBITDA from discontinued operations . . . . . — — — — — — — — — — (266.0) (266.0)\n\nOperating income . . . $ 789.2 $ 26.7 $ 18.2 834.1 $ 739.2 $ 29.7 $ 32.3 801.2 $ 678.9 $ 53.6 $ 35.1 767.6\n\nInvestment income and others, net . . . . 15.3 9.2 6.1 Interest expense . . . . . (129.7) (119.4) (120.0)\n\nIncome from continuing operations before income taxes . . . . . $ 719.7 $ 691.0 $ 653.7\n\nLong-lived assets by country are provided below as of December 31:\n\n**2018 2017**\n\nLong-lived assets: U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,335.8 $2,438.6 U.K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,595.5 2,656.6 Other countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 324.5 327.5\n\nTotal long-lived assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $5,255.8 $5,422.7\n\n117","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**VERISK ANALYTICS, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)**\n\nThe following table provides the Company’s revenue and EBITDA by reportable segment for the years ended December 31, as well as a reconciliation of EBITDA to operating income for all periods presented in the accompanying consolidated statements of operations:\n\n**2018 2017 2016**\n\n**Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total**\n\nRevenues . . . . . . . . . . $1,705.9 $ 513.3 $175.9 $2,395.1 $1,550.6 $ 444.6 $150.0 $2,145.2 $1,419.1 $ 442.8 $ 133.3 $1,995.2 Expenses: Cost of revenues (exclusive of items shown separately below) . . . . . . . . (568.1) (218.2) (99.9) (886.2) (510.4) (193.8) (79.6) (783.8) (469.6) (177.1) (67.7) (714.4) Selling, general and administrative . . (218.8) (141.1) (18.8) (378.7) (196.1) (114.4) (12.3) (322.8) (178.1) (113.4) (10.1) (301.6) Investment income and others, net . . . . . . . . . . . 13.2 0.4 1.7 15.3 11.7 (2.8) 0.3 9.2 7.8 (1.1) (0.6) 6.1 EBITDA from discontinued operations . . . . . — — — — — — — — — — 266.0 266.0\n\nEBITDA . . . . . . 932.2 154.4 58.9 1,145.5 855.8 133.6 58.4 1,047.8 779.2 151.2 320.9 1,251.3 Depreciation and amortization of fixed assets . . . . (107.0) (42.7) (15.6) (165.3) (91.2) (36.4) (8.0) (135.6) (86.4) (25.9) (6.8) (119.1) Amortization of intangible assets . . . . . . . . . (22.8) (84.6) (23.4) (130.8) (13.7) (70.3) (17.8) (101.8) (6.1) (72.8) (13.6) (92.5) Investment income and others, net . . . . . . . . . . . (13.2) (0.4) (1.7) (15.3) (11.7) 2.8 (0.3) (9.2) (7.8) 1.1 0.6 (6.1) EBITDA from discontinued operations . . . . . — — — — — — — — — — (266.0) (266.0)\n\nOperating income . . . $ 789.2 $ 26.7 $ 18.2 834.1 $ 739.2 $ 29.7 $ 32.3 801.2 $ 678.9 $ 53.6 $ 35.1 767.6\n\nInvestment income and others, net . . . . 15.3 9.2 6.1 Interest expense . . . . . (129.7) (119.4) (120.0)\n\nIncome from continuing operations before income taxes . . . . . $ 719.7 $ 691.0 $ 653.7\n\nLong-lived assets by country are provided below as of December 31:\n\n**2018 2017**\n\nLong-lived assets: U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,335.8 $2,438.6 U.K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,595.5 2,656.6 Other countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 324.5 327.5\n\nTotal long-lived assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $5,255.8 $5,422.7\n\n117","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/VRSK.2018.page_141.pdf_105144_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_e5b17511c68d192fb4a89582bd8cb9ca","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**VERISK ANALYTICS, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)**\n\nThe following table provides the Company’s revenue and EBITDA by reportable segment for the years ended December 31, as well as a reconciliation of EBITDA to operating income for all periods presented in the accompanying consolidated statements of operations:\n\n**2018 2017 2016**\n\n**Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total**\n\nRevenues . . . . . . . . . . $1,705.9 $ 513.3 $175.9 $2,395.1 $1,550.6 $ 444.6 $150.0 $2,145.2 $1,419.1 $ 442.8 $ 133.3 $1,995.2 Expenses: Cost of revenues (exclusive of items shown separately below) . . . . . . . . (568.1) (218.2) (99.9) (886.2) (510.4) (193.8) (79.6) (783.8) (469.6) (177.1) (67.7) (714.4) Selling, general and administrative . . (218.8) (141.1) (18.8) (378.7) (196.1) (114.4) (12.3) (322.8) (178.1) (113.4) (10.1) (301.6) Investment income and others, net . . . . . . . . . . . 13.2 0.4 1.7 15.3 11.7 (2.8) 0.3 9.2 7.8 (1.1) (0.6) 6.1 EBITDA from discontinued operations . . . . . — — — — — — — — — — 266.0 266.0\n\nEBITDA . . . . . . 932.2 154.4 58.9 1,145.5 855.8 133.6 58.4 1,047.8 779.2 151.2 320.9 1,251.3 Depreciation and amortization of fixed assets . . . . (107.0) (42.7) (15.6) (165.3) (91.2) (36.4) (8.0) (135.6) (86.4) (25.9) (6.8) (119.1) Amortization of intangible assets . . . . . . . . . (22.8) (84.6) (23.4) (130.8) (13.7) (70.3) (17.8) (101.8) (6.1) (72.8) (13.6) (92.5) Investment income and others, net . . . . . . . . . . . (13.2) (0.4) (1.7) (15.3) (11.7) 2.8 (0.3) (9.2) (7.8) 1.1 0.6 (6.1) EBITDA from discontinued operations . . . . . — — — — — — — — — — (266.0) (266.0)\n\nOperating income . . . $ 789.2 $ 26.7 $ 18.2 834.1 $ 739.2 $ 29.7 $ 32.3 801.2 $ 678.9 $ 53.6 $ 35.1 767.6\n\nInvestment income and others, net . . . . 15.3 9.2 6.1 Interest expense . . . . . (129.7) (119.4) (120.0)\n\nIncome from continuing operations before income taxes . . . . . $ 719.7 $ 691.0 $ 653.7\n\nLong-lived assets by country are provided below as of December 31:\n\n**2018 2017**\n\nLong-lived assets: U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,335.8 $2,438.6 U.K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,595.5 2,656.6 Other countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 324.5 327.5\n\nTotal long-lived assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $5,255.8 $5,422.7\n\n117"],"full_content":"**VERISK ANALYTICS, INC.**\n\n**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)**\n\nThe following table provides the Company’s revenue and EBITDA by reportable segment for the years ended December 31, as well as a reconciliation of EBITDA to operating income for all periods presented in the accompanying consolidated statements of operations:\n\n**2018 2017 2016**\n\n**Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total Insurance**\n\n**Energy and Specialized Markets**\n\n**Financial Services Total**\n\nRevenues . . . . . . . . . . $1,705.9 $ 513.3 $175.9 $2,395.1 $1,550.6 $ 444.6 $150.0 $2,145.2 $1,419.1 $ 442.8 $ 133.3 $1,995.2 Expenses: Cost of revenues (exclusive of items shown separately below) . . . . . . . . (568.1) (218.2) (99.9) (886.2) (510.4) (193.8) (79.6) (783.8) (469.6) (177.1) (67.7) (714.4) Selling, general and administrative . . (218.8) (141.1) (18.8) (378.7) (196.1) (114.4) (12.3) (322.8) (178.1) (113.4) (10.1) (301.6) Investment income and others, net . . . . . . . . . . . 13.2 0.4 1.7 15.3 11.7 (2.8) 0.3 9.2 7.8 (1.1) (0.6) 6.1 EBITDA from discontinued operations . . . . . — — — — — — — — — — 266.0 266.0\n\nEBITDA . . . . . . 932.2 154.4 58.9 1,145.5 855.8 133.6 58.4 1,047.8 779.2 151.2 320.9 1,251.3 Depreciation and amortization of fixed assets . . . . (107.0) (42.7) (15.6) (165.3) (91.2) (36.4) (8.0) (135.6) (86.4) (25.9) (6.8) (119.1) Amortization of intangible assets . . . . . . . . . (22.8) (84.6) (23.4) (130.8) (13.7) (70.3) (17.8) (101.8) (6.1) (72.8) (13.6) (92.5) Investment income and others, net . . . . . . . . . . . (13.2) (0.4) (1.7) (15.3) (11.7) 2.8 (0.3) (9.2) (7.8) 1.1 0.6 (6.1) EBITDA from discontinued operations . . . . . — — — — — — — — — — (266.0) (266.0)\n\nOperating income . . . $ 789.2 $ 26.7 $ 18.2 834.1 $ 739.2 $ 29.7 $ 32.3 801.2 $ 678.9 $ 53.6 $ 35.1 767.6\n\nInvestment income and others, net . . . . 15.3 9.2 6.1 Interest expense . . . . . (129.7) (119.4) (120.0)\n\nIncome from continuing operations before income taxes . . . . . $ 719.7 $ 691.0 $ 653.7\n\nLong-lived assets by country are provided below as of December 31:\n\n**2018 2017**\n\nLong-lived assets: U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2,335.8 $2,438.6 U.K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,595.5 2,656.6 Other countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 324.5 327.5\n\nTotal long-lived assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $5,255.8 $5,422.7\n\n117","publish_date":null,"title":"VERISKANALYTICS,INC. NOTESTOCONSOLIDATEDFINANCIALSTATEMENTS—(Continued) ThefollowingtableprovidestheCompany’srevenueandEBITDAbyreportablesegmentfortheyears endedDecember31,aswellasareconciliationofEBITDAtooperatingincomeforallperiodspresentedinthe accompanyingconsolidatedstatementsofoperations: Long-livedassetsbycountryareprovidedbelowasofDecember31: Long-livedassets: U.S. ................................................. $2,335.8 $2,438.6 U.K. ................................................. 2,595.5 2,656.6 Othercountries ........................................ 324.5 327.5 Totallong-livedassets.................................","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/VRSK.2018.page_141.pdf_105144_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/VRSK.2018.page_141.pdf_105144_page1.pdf"},"request":{"example_id":"table/VRSK.2018.page_141.pdf_105144_page1","product_type":"parse","source_file_path":"VRSK.2018.page_141.pdf_105144_page1.pdf"},"started_at":"2026-11-04T19:48:15.581950"} +{"completed_at":"2026-11-04T19:48:19.339449","latency_in_ms":2296,"output":{"example_id":"table/Victoria Secret 10-k_page1","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n### **FORM 10-K**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the fiscal year ended February 1, 2025\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the transition period from to\n\nCommission file number 001-40515\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n## **VICTORIA'S SECRET & CO.**\n\n**(Exact name of registrant as specified in its charter)**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n**Delaware 86-3167653**\n\n(State or other jurisdiction\n\nof incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n**4 Limited Parkway East, Reynoldsburg, Ohio 43068**\n\n(Address of principal executive offices) (Zip Code)\n\n**Registrant’s telephone number, including area code (614) 577-7000**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n**Title of each class Trading Symbol(s) Name of each exchange on which registered**\n\nCommon Stock, $0.01 Par Value VSCO The New York Stock Exchange\n\n**Securities registered pursuant to Section 12(g) of the Act: None.**\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐\n\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and \"emerging growth company\" in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐Smaller reporting company ☐Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒\n\nIf securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐\n\nIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\nThe aggregate market value of the registrant’s common stock held by non-affiliates of the registrant as of the last business day of the registrant’s most recently completed second fiscal quarter was $1,259,904,469.\n\nNumber of shares outstanding of the registrant’s common stock as of March 14, 2025: 78,888,589.\n\n**DOCUMENTS INCORPORATED BY REFERENCE**\n\n**Portions of the Registrant’s Proxy Statement for the Registrant’s 2025 Annual Meeting of Stockholders are incorporated by reference into Part III.**","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n### **FORM 10-K**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the fiscal year ended February 1, 2025\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the transition period from to\n\nCommission file number 001-40515\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n## **VICTORIA'S SECRET & CO.**\n\n**(Exact name of registrant as specified in its charter)**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n**Delaware 86-3167653**\n\n(State or other jurisdiction\n\nof incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n**4 Limited Parkway East, Reynoldsburg, Ohio 43068**\n\n(Address of principal executive offices) (Zip Code)\n\n**Registrant’s telephone number, including area code (614) 577-7000**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n**Title of each class Trading Symbol(s) Name of each exchange on which registered**\n\nCommon Stock, $0.01 Par Value VSCO The New York Stock Exchange\n\n**Securities registered pursuant to Section 12(g) of the Act: None.**\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐\n\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and \"emerging growth company\" in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐Smaller reporting company ☐Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒\n\nIf securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐\n\nIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\nThe aggregate market value of the registrant’s common stock held by non-affiliates of the registrant as of the last business day of the registrant’s most recently completed second fiscal quarter was $1,259,904,469.\n\nNumber of shares outstanding of the registrant’s common stock as of March 14, 2025: 78,888,589.\n\n**DOCUMENTS INCORPORATED BY REFERENCE**\n\n**Portions of the Registrant’s Proxy Statement for the Registrant’s 2025 Annual Meeting of Stockholders are incorporated by reference into Part III.**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n### **FORM 10-K**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the fiscal year ended February 1, 2025\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the transition period from to\n\nCommission file number 001-40515\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n## **VICTORIA'S SECRET & CO.**\n\n**(Exact name of registrant as specified in its charter)**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n**Delaware 86-3167653**\n\n(State or other jurisdiction\n\nof incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n**4 Limited Parkway East, Reynoldsburg, Ohio 43068**\n\n(Address of principal executive offices) (Zip Code)\n\n**Registrant’s telephone number, including area code (614) 577-7000**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n**Title of each class Trading Symbol(s) Name of each exchange on which registered**\n\nCommon Stock, $0.01 Par Value VSCO The New York Stock Exchange\n\n**Securities registered pursuant to Section 12(g) of the Act: None.**\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐\n\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and \"emerging growth company\" in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐Smaller reporting company ☐Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒\n\nIf securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐\n\nIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\nThe aggregate market value of the registrant’s common stock held by non-affiliates of the registrant as of the last business day of the registrant’s most recently completed second fiscal quarter was $1,259,904,469.\n\nNumber of shares outstanding of the registrant’s common stock as of March 14, 2025: 78,888,589.\n\n**DOCUMENTS INCORPORATED BY REFERENCE**\n\n**Portions of the Registrant’s Proxy Statement for the Registrant’s 2025 Annual Meeting of Stockholders are incorporated by reference into Part III.**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_407bf2e9133c0ac78c2ed92321c605c1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n### **FORM 10-K**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the fiscal year ended February 1, 2025\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the transition period from to\n\nCommission file number 001-40515\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n## **VICTORIA'S SECRET & CO.**\n\n**(Exact name of registrant as specified in its charter)**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n**Delaware 86-3167653**\n\n(State or other jurisdiction\n\nof incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n**4 Limited Parkway East, Reynoldsburg, Ohio 43068**\n\n(Address of principal executive offices) (Zip Code)\n\n**Registrant’s telephone number, including area code (614) 577-7000**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n**Title of each class Trading Symbol(s) Name of each exchange on which registered**\n\nCommon Stock, $0.01 Par Value VSCO The New York Stock Exchange\n\n**Securities registered pursuant to Section 12(g) of the Act: None.**\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐\n\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and \"emerging growth company\" in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐Smaller reporting company ☐Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒\n\nIf securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐\n\nIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\nThe aggregate market value of the registrant’s common stock held by non-affiliates of the registrant as of the last business day of the registrant’s most recently completed second fiscal quarter was $1,259,904,469.\n\nNumber of shares outstanding of the registrant’s common stock as of March 14, 2025: 78,888,589.\n\n**DOCUMENTS INCORPORATED BY REFERENCE**\n\n**Portions of the Registrant’s Proxy Statement for the Registrant’s 2025 Annual Meeting of Stockholders are incorporated by reference into Part III.**"],"full_content":"Table of Contents\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n### **FORM 10-K**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(Mark One)\n\n☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the fiscal year ended February 1, 2025\n\n☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\nFor the transition period from to\n\nCommission file number 001-40515\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n## **VICTORIA'S SECRET & CO.**\n\n**(Exact name of registrant as specified in its charter)**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n**Delaware 86-3167653**\n\n(State or other jurisdiction\n\nof incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n**4 Limited Parkway East, Reynoldsburg, Ohio 43068**\n\n(Address of principal executive offices) (Zip Code)\n\n**Registrant’s telephone number, including area code (614) 577-7000**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n**Title of each class Trading Symbol(s) Name of each exchange on which registered**\n\nCommon Stock, $0.01 Par Value VSCO The New York Stock Exchange\n\n**Securities registered pursuant to Section 12(g) of the Act: None.**\n\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐\n\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and \"emerging growth company\" in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐Smaller reporting company ☐Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒\n\nIf securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐\n\nIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\nThe aggregate market value of the registrant’s common stock held by non-affiliates of the registrant as of the last business day of the registrant’s most recently completed second fiscal quarter was $1,259,904,469.\n\nNumber of shares outstanding of the registrant’s common stock as of March 14, 2025: 78,888,589.\n\n**DOCUMENTS INCORPORATED BY REFERENCE**\n\n**Portions of the Registrant’s Proxy Statement for the Registrant’s 2025 Annual Meeting of Stockholders are incorporated by reference into Part III.**","publish_date":null,"title":"VICTORIA'S SECRET & CO. — FORM 10-K, fiscal year ended February 1, 2025","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page1.pdf"},"request":{"example_id":"table/Victoria Secret 10-k_page1","product_type":"parse","source_file_path":"Victoria Secret 10-k_page1.pdf"},"started_at":"2026-11-04T19:48:17.043125"} +{"completed_at":"2026-11-04T19:48:20.462974","latency_in_ms":2541,"output":{"example_id":"table/Victoria Secret 10-k_page39","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**_Working Capital and Capitalization_**\n\nBased upon our cash balances and net cash provided by our operating activities, along with the borrowing capacity under our ABL Facility, we believe we will be able to continue to meet our working capital needs.\n\nThe following table provides a summary of our working capital position and capitalization as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\n**(in millions)**\n\nNet Cash Provided by Operating Activities (a) $ 425 $ 389\n\nCapital Expenditures (a) 178 256\n\nWorking Capital 66 (81)\n\nCapitalization:\n\nLong-term Debt 973 1,120\n\nVictoria's Secret & Co. Shareholders’ Equity 640 417\n\nTotal Capitalization $ 1,613 $ 1,537\n\nAmounts Available Under the ABL Facility (b) $ 533 $ 423\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Amounts shown represent the fifty-two-week period ended February 1, 2025 and the fifty-three-week period ended February 3, 2024.\n\n(b) For the period ended February 1, 2025, the availability under the ABL Facility was limited by our borrowing base of $550 million, less letters of credit of $17 million. For the period ended February 3, 2024, the availability was limited by our borrowing base of $587 million, less outstanding borrowings of $145 million and letters of credit of $19 million.\n\nThe following table provides certain measures of liquidity and capital resources as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\nDebt-to-capitalization Ratio (a) 60 % 73 %\n\nNet Cash Provided By Operating Activities to Capital Expenditures 239 % 152 %\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Long-term debt divided by total capitalization.\n\n**Cash Flow**\n\nThe following table provides a summary of our cash flow activity for the fiscal years ended February 1, 2025 and February 3, 2024:\n\n**2024 2023**\n\n**(in millions)**\n\nCash and Cash Equivalents, Beginning of Year $ 270 $ 427\n\nNet Cash Provided by Operating Activities 425 389\n\nNet Cash Used for Investing Activities (153) (254)\n\nNet Cash Used for Financing Activities (315) (291)\n\nEffects of Exchange Rate Changes on Cash and Cash Equivalents — (1)\n\nNet Decrease in Cash and Cash Equivalents (43) (157)\n\nCash and Cash Equivalents, End of Year $ 227 $ 270\n\n37","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**_Working Capital and Capitalization_**\n\nBased upon our cash balances and net cash provided by our operating activities, along with the borrowing capacity under our ABL Facility, we believe we will be able to continue to meet our working capital needs.\n\nThe following table provides a summary of our working capital position and capitalization as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\n**(in millions)**\n\nNet Cash Provided by Operating Activities (a) $ 425 $ 389\n\nCapital Expenditures (a) 178 256\n\nWorking Capital 66 (81)\n\nCapitalization:\n\nLong-term Debt 973 1,120\n\nVictoria's Secret & Co. Shareholders’ Equity 640 417\n\nTotal Capitalization $ 1,613 $ 1,537\n\nAmounts Available Under the ABL Facility (b) $ 533 $ 423\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Amounts shown represent the fifty-two-week period ended February 1, 2025 and the fifty-three-week period ended February 3, 2024.\n\n(b) For the period ended February 1, 2025, the availability under the ABL Facility was limited by our borrowing base of $550 million, less letters of credit of $17 million. For the period ended February 3, 2024, the availability was limited by our borrowing base of $587 million, less outstanding borrowings of $145 million and letters of credit of $19 million.\n\nThe following table provides certain measures of liquidity and capital resources as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\nDebt-to-capitalization Ratio (a) 60 % 73 %\n\nNet Cash Provided By Operating Activities to Capital Expenditures 239 % 152 %\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Long-term debt divided by total capitalization.\n\n**Cash Flow**\n\nThe following table provides a summary of our cash flow activity for the fiscal years ended February 1, 2025 and February 3, 2024:\n\n**2024 2023**\n\n**(in millions)**\n\nCash and Cash Equivalents, Beginning of Year $ 270 $ 427\n\nNet Cash Provided by Operating Activities 425 389\n\nNet Cash Used for Investing Activities (153) (254)\n\nNet Cash Used for Financing Activities (315) (291)\n\nEffects of Exchange Rate Changes on Cash and Cash Equivalents — (1)\n\nNet Decrease in Cash and Cash Equivalents (43) (157)\n\nCash and Cash Equivalents, End of Year $ 227 $ 270\n\n37","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**_Working Capital and Capitalization_**\n\nBased upon our cash balances and net cash provided by our operating activities, along with the borrowing capacity under our ABL Facility, we believe we will be able to continue to meet our working capital needs.\n\nThe following table provides a summary of our working capital position and capitalization as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\n**(in millions)**\n\nNet Cash Provided by Operating Activities (a) $ 425 $ 389\n\nCapital Expenditures (a) 178 256\n\nWorking Capital 66 (81)\n\nCapitalization:\n\nLong-term Debt 973 1,120\n\nVictoria's Secret & Co. Shareholders’ Equity 640 417\n\nTotal Capitalization $ 1,613 $ 1,537\n\nAmounts Available Under the ABL Facility (b) $ 533 $ 423\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Amounts shown represent the fifty-two-week period ended February 1, 2025 and the fifty-three-week period ended February 3, 2024.\n\n(b) For the period ended February 1, 2025, the availability under the ABL Facility was limited by our borrowing base of $550 million, less letters of credit of $17 million. For the period ended February 3, 2024, the availability was limited by our borrowing base of $587 million, less outstanding borrowings of $145 million and letters of credit of $19 million.\n\nThe following table provides certain measures of liquidity and capital resources as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\nDebt-to-capitalization Ratio (a) 60 % 73 %\n\nNet Cash Provided By Operating Activities to Capital Expenditures 239 % 152 %\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Long-term debt divided by total capitalization.\n\n**Cash Flow**\n\nThe following table provides a summary of our cash flow activity for the fiscal years ended February 1, 2025 and February 3, 2024:\n\n**2024 2023**\n\n**(in millions)**\n\nCash and Cash Equivalents, Beginning of Year $ 270 $ 427\n\nNet Cash Provided by Operating Activities 425 389\n\nNet Cash Used for Investing Activities (153) (254)\n\nNet Cash Used for Financing Activities (315) (291)\n\nEffects of Exchange Rate Changes on Cash and Cash Equivalents — (1)\n\nNet Decrease in Cash and Cash Equivalents (43) (157)\n\nCash and Cash Equivalents, End of Year $ 227 $ 270\n\n37","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page39.pdf"]},"response":{"errors":[],"extract_id":"extract_afa46afae81e305d1bb90ab938fbf199","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**_Working Capital and Capitalization_**\n\nBased upon our cash balances and net cash provided by our operating activities, along with the borrowing capacity under our ABL Facility, we believe we will be able to continue to meet our working capital needs.\n\nThe following table provides a summary of our working capital position and capitalization as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\n**(in millions)**\n\nNet Cash Provided by Operating Activities (a) $ 425 $ 389\n\nCapital Expenditures (a) 178 256\n\nWorking Capital 66 (81)\n\nCapitalization:\n\nLong-term Debt 973 1,120\n\nVictoria's Secret & Co. Shareholders’ Equity 640 417\n\nTotal Capitalization $ 1,613 $ 1,537\n\nAmounts Available Under the ABL Facility (b) $ 533 $ 423\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Amounts shown represent the fifty-two-week period ended February 1, 2025 and the fifty-three-week period ended February 3, 2024.\n\n(b) For the period ended February 1, 2025, the availability under the ABL Facility was limited by our borrowing base of $550 million, less letters of credit of $17 million. For the period ended February 3, 2024, the availability was limited by our borrowing base of $587 million, less outstanding borrowings of $145 million and letters of credit of $19 million.\n\nThe following table provides certain measures of liquidity and capital resources as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\nDebt-to-capitalization Ratio (a) 60 % 73 %\n\nNet Cash Provided By Operating Activities to Capital Expenditures 239 % 152 %\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Long-term debt divided by total capitalization.\n\n**Cash Flow**\n\nThe following table provides a summary of our cash flow activity for the fiscal years ended February 1, 2025 and February 3, 2024:\n\n**2024 2023**\n\n**(in millions)**\n\nCash and Cash Equivalents, Beginning of Year $ 270 $ 427\n\nNet Cash Provided by Operating Activities 425 389\n\nNet Cash Used for Investing Activities (153) (254)\n\nNet Cash Used for Financing Activities (315) (291)\n\nEffects of Exchange Rate Changes on Cash and Cash Equivalents — (1)\n\nNet Decrease in Cash and Cash Equivalents (43) (157)\n\nCash and Cash Equivalents, End of Year $ 227 $ 270\n\n37"],"full_content":"Table of Contents\n\n**_Working Capital and Capitalization_**\n\nBased upon our cash balances and net cash provided by our operating activities, along with the borrowing capacity under our ABL Facility, we believe we will be able to continue to meet our working capital needs.\n\nThe following table provides a summary of our working capital position and capitalization as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\n**(in millions)**\n\nNet Cash Provided by Operating Activities (a) $ 425 $ 389\n\nCapital Expenditures (a) 178 256\n\nWorking Capital 66 (81)\n\nCapitalization:\n\nLong-term Debt 973 1,120\n\nVictoria's Secret & Co. Shareholders’ Equity 640 417\n\nTotal Capitalization $ 1,613 $ 1,537\n\nAmounts Available Under the ABL Facility (b) $ 533 $ 423\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Amounts shown represent the fifty-two-week period ended February 1, 2025 and the fifty-three-week period ended February 3, 2024.\n\n(b) For the period ended February 1, 2025, the availability under the ABL Facility was limited by our borrowing base of $550 million, less letters of credit of $17 million. For the period ended February 3, 2024, the availability was limited by our borrowing base of $587 million, less outstanding borrowings of $145 million and letters of credit of $19 million.\n\nThe following table provides certain measures of liquidity and capital resources as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\nDebt-to-capitalization Ratio (a) 60 % 73 %\n\nNet Cash Provided By Operating Activities to Capital Expenditures 239 % 152 %\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Long-term debt divided by total capitalization.\n\n**Cash Flow**\n\nThe following table provides a summary of our cash flow activity for the fiscal years ended February 1, 2025 and February 3, 2024:\n\n**2024 2023**\n\n**(in millions)**\n\nCash and Cash Equivalents, Beginning of Year $ 270 $ 427\n\nNet Cash Provided by Operating Activities 425 389\n\nNet Cash Used for Investing Activities (153) (254)\n\nNet Cash Used for Financing Activities (315) (291)\n\nEffects of Exchange Rate Changes on Cash and Cash Equivalents — (1)\n\nNet Decrease in Cash and Cash Equivalents (43) (157)\n\nCash and Cash Equivalents, End of Year $ 227 $ 270\n\n37","publish_date":null,"title":"Working Capital and Capitalization Based upon our cash balances and net cash provided by our operating activities, along with the","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page39.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page39.pdf"},"request":{"example_id":"table/Victoria Secret 10-k_page39","product_type":"parse","source_file_path":"Victoria Secret 10-k_page39.pdf"},"started_at":"2026-11-04T19:48:17.921265"} +{"completed_at":"2026-11-04T19:48:21.576698","latency_in_ms":1846,"output":{"example_id":"table/Victoria Secret 10-k_page4","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**Real Estate**\n\n**_Retail Stores_**\n\nOur company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores are located in shopping malls, lifestyle centers and off- mall locations in the U.S., Canada and China.\n\nThe following table provides the number of our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores in operation as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\n**Company-Operated:** U.S. 782 808\n\nCanada 24 23\n\n806 831\n\n**China Joint Venture:** Beauty & Accessories (a) 30 34\n\nFull Assortment 40 36\n\n70 70\n\n**Adore Me** 6 6\n\n**Total 882** **907**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Includes thirteen partner-operated stores.\n\nThe following table provides the changes in the number of our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores operated for the past three fiscal years:\n\n**Beginning**\n\n**of Year** **Opened Closed Acquired (a)**\n\n**Reclassed to Joint**\n\n**Venture (b) End of Year**\n\n2024 (c) 907 24 (49) — — 882\n\n2023 (c) 915 21 (29) — — 907\n\n2022 (c) 899 26 (24) 6 8 915\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Relates to acquisition of Adore Me. For additional information, see Note 2 to the Consolidated Financial Statements included in Item 8. Financial\n\nStatements and Supplementary Data.\n\n(b) Relates to the China joint venture with Regina Miracle. For additional information, see Note 5 to the Consolidated Financial Statements included in\n\nItem 8. Financial Statements and Supplementary Data.\n\n(c) Includes thirteen partner-operated China joint venture stores.\n\n**_Franchise, License and Wholesale Arrangements_**\n\nIn addition to our retail stores, our Victoria's Secret and PINK products are sold at partner stores and on partner websites in nearly 70 countries. We are focused on ensuring our partners have the commitment and capability to provide a quality customer experience and to grow our brands internationally.\n\nUnder the terms of our franchise, license and wholesale arrangements, we provide our partners the rights to sell our products in various geographic regions along with operational policies and standards governing such matters as the supply and sale of our products, in stores and online, marketing and store training. Our partners are generally responsible for providing the capital necessary to lease retail space, build out stores and/or develop websites, fund the operations of their business, and over the longer term, reinvest in their business. Our partners are responsible for the day-to-day operations of their business, and must do so in accordance with our policies and standards, which are focused on ensuring a consistent customer experience around the world. These arrangements can typically be terminated by us, upon delivery of notice, in the event of any breach of representations or warranties.\n\n2","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**Real Estate**\n\n**_Retail Stores_**\n\nOur company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores are located in shopping malls, lifestyle centers and off- mall locations in the U.S., Canada and China.\n\nThe following table provides the number of our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores in operation as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\n**Company-Operated:** U.S. 782 808\n\nCanada 24 23\n\n806 831\n\n**China Joint Venture:** Beauty & Accessories (a) 30 34\n\nFull Assortment 40 36\n\n70 70\n\n**Adore Me** 6 6\n\n**Total 882** **907**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Includes thirteen partner-operated stores.\n\nThe following table provides the changes in the number of our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores operated for the past three fiscal years:\n\n**Beginning**\n\n**of Year** **Opened Closed Acquired (a)**\n\n**Reclassed to Joint**\n\n**Venture (b) End of Year**\n\n2024 (c) 907 24 (49) — — 882\n\n2023 (c) 915 21 (29) — — 907\n\n2022 (c) 899 26 (24) 6 8 915\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Relates to acquisition of Adore Me. For additional information, see Note 2 to the Consolidated Financial Statements included in Item 8. Financial\n\nStatements and Supplementary Data.\n\n(b) Relates to the China joint venture with Regina Miracle. For additional information, see Note 5 to the Consolidated Financial Statements included in\n\nItem 8. Financial Statements and Supplementary Data.\n\n(c) Includes thirteen partner-operated China joint venture stores.\n\n**_Franchise, License and Wholesale Arrangements_**\n\nIn addition to our retail stores, our Victoria's Secret and PINK products are sold at partner stores and on partner websites in nearly 70 countries. We are focused on ensuring our partners have the commitment and capability to provide a quality customer experience and to grow our brands internationally.\n\nUnder the terms of our franchise, license and wholesale arrangements, we provide our partners the rights to sell our products in various geographic regions along with operational policies and standards governing such matters as the supply and sale of our products, in stores and online, marketing and store training. Our partners are generally responsible for providing the capital necessary to lease retail space, build out stores and/or develop websites, fund the operations of their business, and over the longer term, reinvest in their business. Our partners are responsible for the day-to-day operations of their business, and must do so in accordance with our policies and standards, which are focused on ensuring a consistent customer experience around the world. These arrangements can typically be terminated by us, upon delivery of notice, in the event of any breach of representations or warranties.\n\n2","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**Real Estate**\n\n**_Retail Stores_**\n\nOur company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores are located in shopping malls, lifestyle centers and off- mall locations in the U.S., Canada and China.\n\nThe following table provides the number of our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores in operation as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\n**Company-Operated:** U.S. 782 808\n\nCanada 24 23\n\n806 831\n\n**China Joint Venture:** Beauty & Accessories (a) 30 34\n\nFull Assortment 40 36\n\n70 70\n\n**Adore Me** 6 6\n\n**Total 882** **907**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Includes thirteen partner-operated stores.\n\nThe following table provides the changes in the number of our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores operated for the past three fiscal years:\n\n**Beginning**\n\n**of Year** **Opened Closed Acquired (a)**\n\n**Reclassed to Joint**\n\n**Venture (b) End of Year**\n\n2024 (c) 907 24 (49) — — 882\n\n2023 (c) 915 21 (29) — — 907\n\n2022 (c) 899 26 (24) 6 8 915\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Relates to acquisition of Adore Me. For additional information, see Note 2 to the Consolidated Financial Statements included in Item 8. Financial\n\nStatements and Supplementary Data.\n\n(b) Relates to the China joint venture with Regina Miracle. For additional information, see Note 5 to the Consolidated Financial Statements included in\n\nItem 8. Financial Statements and Supplementary Data.\n\n(c) Includes thirteen partner-operated China joint venture stores.\n\n**_Franchise, License and Wholesale Arrangements_**\n\nIn addition to our retail stores, our Victoria's Secret and PINK products are sold at partner stores and on partner websites in nearly 70 countries. We are focused on ensuring our partners have the commitment and capability to provide a quality customer experience and to grow our brands internationally.\n\nUnder the terms of our franchise, license and wholesale arrangements, we provide our partners the rights to sell our products in various geographic regions along with operational policies and standards governing such matters as the supply and sale of our products, in stores and online, marketing and store training. Our partners are generally responsible for providing the capital necessary to lease retail space, build out stores and/or develop websites, fund the operations of their business, and over the longer term, reinvest in their business. Our partners are responsible for the day-to-day operations of their business, and must do so in accordance with our policies and standards, which are focused on ensuring a consistent customer experience around the world. These arrangements can typically be terminated by us, upon delivery of notice, in the event of any breach of representations or warranties.\n\n2","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page4.pdf"]},"response":{"errors":[],"extract_id":"extract_3d6cafb755e99dedb635214518357930","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**Real Estate**\n\n**_Retail Stores_**\n\nOur company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores are located in shopping malls, lifestyle centers and off- mall locations in the U.S., Canada and China.\n\nThe following table provides the number of our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores in operation as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\n**Company-Operated:** U.S. 782 808\n\nCanada 24 23\n\n806 831\n\n**China Joint Venture:** Beauty & Accessories (a) 30 34\n\nFull Assortment 40 36\n\n70 70\n\n**Adore Me** 6 6\n\n**Total 882** **907**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Includes thirteen partner-operated stores.\n\nThe following table provides the changes in the number of our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores operated for the past three fiscal years:\n\n**Beginning**\n\n**of Year** **Opened Closed Acquired (a)**\n\n**Reclassed to Joint**\n\n**Venture (b) End of Year**\n\n2024 (c) 907 24 (49) — — 882\n\n2023 (c) 915 21 (29) — — 907\n\n2022 (c) 899 26 (24) 6 8 915\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Relates to acquisition of Adore Me. For additional information, see Note 2 to the Consolidated Financial Statements included in Item 8. Financial\n\nStatements and Supplementary Data.\n\n(b) Relates to the China joint venture with Regina Miracle. For additional information, see Note 5 to the Consolidated Financial Statements included in\n\nItem 8. Financial Statements and Supplementary Data.\n\n(c) Includes thirteen partner-operated China joint venture stores.\n\n**_Franchise, License and Wholesale Arrangements_**\n\nIn addition to our retail stores, our Victoria's Secret and PINK products are sold at partner stores and on partner websites in nearly 70 countries. We are focused on ensuring our partners have the commitment and capability to provide a quality customer experience and to grow our brands internationally.\n\nUnder the terms of our franchise, license and wholesale arrangements, we provide our partners the rights to sell our products in various geographic regions along with operational policies and standards governing such matters as the supply and sale of our products, in stores and online, marketing and store training. Our partners are generally responsible for providing the capital necessary to lease retail space, build out stores and/or develop websites, fund the operations of their business, and over the longer term, reinvest in their business. Our partners are responsible for the day-to-day operations of their business, and must do so in accordance with our policies and standards, which are focused on ensuring a consistent customer experience around the world. These arrangements can typically be terminated by us, upon delivery of notice, in the event of any breach of representations or warranties.\n\n2"],"full_content":"Table of Contents\n\n**Real Estate**\n\n**_Retail Stores_**\n\nOur company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores are located in shopping malls, lifestyle centers and off- mall locations in the U.S., Canada and China.\n\nThe following table provides the number of our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores in operation as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\n**Company-Operated:** U.S. 782 808\n\nCanada 24 23\n\n806 831\n\n**China Joint Venture:** Beauty & Accessories (a) 30 34\n\nFull Assortment 40 36\n\n70 70\n\n**Adore Me** 6 6\n\n**Total 882** **907**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Includes thirteen partner-operated stores.\n\nThe following table provides the changes in the number of our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores operated for the past three fiscal years:\n\n**Beginning**\n\n**of Year** **Opened Closed Acquired (a)**\n\n**Reclassed to Joint**\n\n**Venture (b) End of Year**\n\n2024 (c) 907 24 (49) — — 882\n\n2023 (c) 915 21 (29) — — 907\n\n2022 (c) 899 26 (24) 6 8 915\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Relates to acquisition of Adore Me. For additional information, see Note 2 to the Consolidated Financial Statements included in Item 8. Financial\n\nStatements and Supplementary Data.\n\n(b) Relates to the China joint venture with Regina Miracle. For additional information, see Note 5 to the Consolidated Financial Statements included in\n\nItem 8. Financial Statements and Supplementary Data.\n\n(c) Includes thirteen partner-operated China joint venture stores.\n\n**_Franchise, License and Wholesale Arrangements_**\n\nIn addition to our retail stores, our Victoria's Secret and PINK products are sold at partner stores and on partner websites in nearly 70 countries. We are focused on ensuring our partners have the commitment and capability to provide a quality customer experience and to grow our brands internationally.\n\nUnder the terms of our franchise, license and wholesale arrangements, we provide our partners the rights to sell our products in various geographic regions along with operational policies and standards governing such matters as the supply and sale of our products, in stores and online, marketing and store training. Our partners are generally responsible for providing the capital necessary to lease retail space, build out stores and/or develop websites, fund the operations of their business, and over the longer term, reinvest in their business. Our partners are responsible for the day-to-day operations of their business, and must do so in accordance with our policies and standards, which are focused on ensuring a consistent customer experience around the world. These arrangements can typically be terminated by us, upon delivery of notice, in the event of any breach of representations or warranties.\n\n2","publish_date":null,"title":"Real Estate Retail Stores Our company-operated Victoria's Secret and PINK, China joint venture and Adore Me retail stores are located","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page4.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page4.pdf"},"request":{"example_id":"table/Victoria Secret 10-k_page4","product_type":"parse","source_file_path":"Victoria Secret 10-k_page4.pdf"},"started_at":"2026-11-04T19:48:19.730203"} +{"completed_at":"2026-11-04T19:48:22.509814","latency_in_ms":1623,"output":{"example_id":"table/Victoria Secret 10-k_page41","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\nIn February 2023, as part of the January 2023 Share Repurchase Program, we entered into an accelerated share repurchase agreement (“ASR Agreement”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) to repurchase $125 million of our common stock. In February 2023, we made an initial payment of $125 million to Goldman Sachs and received an initial delivery of 2.4 million shares of our common stock. As a result of the initial share delivery, there was an additional $1 million increase in Treasury Stock, which reflects the excise tax liability recorded related to the share repurchase in accordance with the Inflation Reduction Act of 2022.\n\nIn May 2023, upon final settlement of the ASR Agreement, we received an additional 1.3 million shares of our common stock from Goldman Sachs. The final number of shares received was based on the volume-weighted average price of our common stock during the term of the ASR Agreement, less a discount and subject to adjustments pursuant to the terms of the ASR Agreement.\n\nWe repurchased the following shares of our common stock under the January 2023 Share Repurchase Program during 2023:\n\n**Amount Authorized Shares Repurchased Amount Repurchased Average Stock Price**\n\n**(in millions) (in thousands) (in millions)**\n\nJanuary 2023 Share Repurchase Program $ 250 3,652 $ 125 $ 34.22\n\nShares repurchased under the January 2023 Share Repurchase Program were retired upon repurchase. As a result, we retired the 3.7 million shares repurchased in connection with the settlement of the ASR Agreement during 2023. The retirement resulted in a reduction of $126 million in Treasury Stock, less than $1 million in the par value of Common Stock, $9 million in Paid-in Capital and $117 million in Retained Earnings during 2023.\n\n**Dividend Policy and Procedures**\n\nWe have not paid any cash dividends since becoming an independent, publicly traded company. We cannot guarantee that we will pay a dividend in the future or continue to pay any dividends if and when we commence paying dividends. The declaration and amount of any dividends to holders of our common stock will be at the discretion of our Board and will depend upon many factors, including our financial condition, earnings, cash flows, capital requirements of our business, covenants associated with our debt obligations, legal requirements, regulatory constraints, industry practice and any other factors the Board deems relevant. We would use net cash flow provided by operating and financing activities to fund our dividends.\n\n**Long-term Debt and Borrowing Facilities**\n\nThe following table provides our outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts and any current portion, as of February 1, 2025 and February 3, 2024:\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**(in millions)**\n\n**Senior Secured Debt with Subsidiary Guarantee** $387 million Term Loan due August 2028 (“Term Loan Facility”) $ 382 $ 385\n\nAsset-based Revolving Credit Facility due August 2026 (“ABL Facility”) — 145\n\nTotal Senior Secured Debt with Subsidiary Guarantee 382 530\n\n**Senior Debt with Subsidiary Guarantee** $600 million, 4.625% Fixed Interest Rate Notes due July 2029 (“2029 Notes”) 595 594\n\nTotal Senior Debt with Subsidiary Guarantee 595 594\n\nTotal 977 1,124\n\nCurrent Debt (4) (4)\n\nTotal Long-term Debt, Net of Current Portion $ 973 $ 1,120\n\nCash paid for interest was $77 million and $87 million in 2024 and 2023, respectively.\n\n**_Issuance of Notes_**\n\nIn July 2021, we issued $600 million of 4.625% notes due in July 2029 in a transaction exempt from registration under the Securities Act of 1933, as amended. The obligation to pay principal and interest on the 2029 Notes is jointly and severally guaranteed on a full and unconditional basis by certain of our wholly-owned subsidiaries. The issuance costs are being amortized through the maturity date and are included within Long-term Debt on the Consolidated Balance Sheets.\n\n39","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\nIn February 2023, as part of the January 2023 Share Repurchase Program, we entered into an accelerated share repurchase agreement (“ASR Agreement”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) to repurchase $125 million of our common stock. In February 2023, we made an initial payment of $125 million to Goldman Sachs and received an initial delivery of 2.4 million shares of our common stock. As a result of the initial share delivery, there was an additional $1 million increase in Treasury Stock, which reflects the excise tax liability recorded related to the share repurchase in accordance with the Inflation Reduction Act of 2022.\n\nIn May 2023, upon final settlement of the ASR Agreement, we received an additional 1.3 million shares of our common stock from Goldman Sachs. The final number of shares received was based on the volume-weighted average price of our common stock during the term of the ASR Agreement, less a discount and subject to adjustments pursuant to the terms of the ASR Agreement.\n\nWe repurchased the following shares of our common stock under the January 2023 Share Repurchase Program during 2023:\n\n**Amount Authorized Shares Repurchased Amount Repurchased Average Stock Price**\n\n**(in millions) (in thousands) (in millions)**\n\nJanuary 2023 Share Repurchase Program $ 250 3,652 $ 125 $ 34.22\n\nShares repurchased under the January 2023 Share Repurchase Program were retired upon repurchase. As a result, we retired the 3.7 million shares repurchased in connection with the settlement of the ASR Agreement during 2023. The retirement resulted in a reduction of $126 million in Treasury Stock, less than $1 million in the par value of Common Stock, $9 million in Paid-in Capital and $117 million in Retained Earnings during 2023.\n\n**Dividend Policy and Procedures**\n\nWe have not paid any cash dividends since becoming an independent, publicly traded company. We cannot guarantee that we will pay a dividend in the future or continue to pay any dividends if and when we commence paying dividends. The declaration and amount of any dividends to holders of our common stock will be at the discretion of our Board and will depend upon many factors, including our financial condition, earnings, cash flows, capital requirements of our business, covenants associated with our debt obligations, legal requirements, regulatory constraints, industry practice and any other factors the Board deems relevant. We would use net cash flow provided by operating and financing activities to fund our dividends.\n\n**Long-term Debt and Borrowing Facilities**\n\nThe following table provides our outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts and any current portion, as of February 1, 2025 and February 3, 2024:\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**(in millions)**\n\n**Senior Secured Debt with Subsidiary Guarantee** $387 million Term Loan due August 2028 (“Term Loan Facility”) $ 382 $ 385\n\nAsset-based Revolving Credit Facility due August 2026 (“ABL Facility”) — 145\n\nTotal Senior Secured Debt with Subsidiary Guarantee 382 530\n\n**Senior Debt with Subsidiary Guarantee** $600 million, 4.625% Fixed Interest Rate Notes due July 2029 (“2029 Notes”) 595 594\n\nTotal Senior Debt with Subsidiary Guarantee 595 594\n\nTotal 977 1,124\n\nCurrent Debt (4) (4)\n\nTotal Long-term Debt, Net of Current Portion $ 973 $ 1,120\n\nCash paid for interest was $77 million and $87 million in 2024 and 2023, respectively.\n\n**_Issuance of Notes_**\n\nIn July 2021, we issued $600 million of 4.625% notes due in July 2029 in a transaction exempt from registration under the Securities Act of 1933, as amended. The obligation to pay principal and interest on the 2029 Notes is jointly and severally guaranteed on a full and unconditional basis by certain of our wholly-owned subsidiaries. The issuance costs are being amortized through the maturity date and are included within Long-term Debt on the Consolidated Balance Sheets.\n\n39","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\nIn February 2023, as part of the January 2023 Share Repurchase Program, we entered into an accelerated share repurchase agreement (“ASR Agreement”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) to repurchase $125 million of our common stock. In February 2023, we made an initial payment of $125 million to Goldman Sachs and received an initial delivery of 2.4 million shares of our common stock. As a result of the initial share delivery, there was an additional $1 million increase in Treasury Stock, which reflects the excise tax liability recorded related to the share repurchase in accordance with the Inflation Reduction Act of 2022.\n\nIn May 2023, upon final settlement of the ASR Agreement, we received an additional 1.3 million shares of our common stock from Goldman Sachs. The final number of shares received was based on the volume-weighted average price of our common stock during the term of the ASR Agreement, less a discount and subject to adjustments pursuant to the terms of the ASR Agreement.\n\nWe repurchased the following shares of our common stock under the January 2023 Share Repurchase Program during 2023:\n\n**Amount Authorized Shares Repurchased Amount Repurchased Average Stock Price**\n\n**(in millions) (in thousands) (in millions)**\n\nJanuary 2023 Share Repurchase Program $ 250 3,652 $ 125 $ 34.22\n\nShares repurchased under the January 2023 Share Repurchase Program were retired upon repurchase. As a result, we retired the 3.7 million shares repurchased in connection with the settlement of the ASR Agreement during 2023. The retirement resulted in a reduction of $126 million in Treasury Stock, less than $1 million in the par value of Common Stock, $9 million in Paid-in Capital and $117 million in Retained Earnings during 2023.\n\n**Dividend Policy and Procedures**\n\nWe have not paid any cash dividends since becoming an independent, publicly traded company. We cannot guarantee that we will pay a dividend in the future or continue to pay any dividends if and when we commence paying dividends. The declaration and amount of any dividends to holders of our common stock will be at the discretion of our Board and will depend upon many factors, including our financial condition, earnings, cash flows, capital requirements of our business, covenants associated with our debt obligations, legal requirements, regulatory constraints, industry practice and any other factors the Board deems relevant. We would use net cash flow provided by operating and financing activities to fund our dividends.\n\n**Long-term Debt and Borrowing Facilities**\n\nThe following table provides our outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts and any current portion, as of February 1, 2025 and February 3, 2024:\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**(in millions)**\n\n**Senior Secured Debt with Subsidiary Guarantee** $387 million Term Loan due August 2028 (“Term Loan Facility”) $ 382 $ 385\n\nAsset-based Revolving Credit Facility due August 2026 (“ABL Facility”) — 145\n\nTotal Senior Secured Debt with Subsidiary Guarantee 382 530\n\n**Senior Debt with Subsidiary Guarantee** $600 million, 4.625% Fixed Interest Rate Notes due July 2029 (“2029 Notes”) 595 594\n\nTotal Senior Debt with Subsidiary Guarantee 595 594\n\nTotal 977 1,124\n\nCurrent Debt (4) (4)\n\nTotal Long-term Debt, Net of Current Portion $ 973 $ 1,120\n\nCash paid for interest was $77 million and $87 million in 2024 and 2023, respectively.\n\n**_Issuance of Notes_**\n\nIn July 2021, we issued $600 million of 4.625% notes due in July 2029 in a transaction exempt from registration under the Securities Act of 1933, as amended. The obligation to pay principal and interest on the 2029 Notes is jointly and severally guaranteed on a full and unconditional basis by certain of our wholly-owned subsidiaries. The issuance costs are being amortized through the maturity date and are included within Long-term Debt on the Consolidated Balance Sheets.\n\n39","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page41.pdf"]},"response":{"errors":[],"extract_id":"extract_7998402981a30dccc895dfa47d0f0fb2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\nIn February 2023, as part of the January 2023 Share Repurchase Program, we entered into an accelerated share repurchase agreement (“ASR Agreement”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) to repurchase $125 million of our common stock. In February 2023, we made an initial payment of $125 million to Goldman Sachs and received an initial delivery of 2.4 million shares of our common stock. As a result of the initial share delivery, there was an additional $1 million increase in Treasury Stock, which reflects the excise tax liability recorded related to the share repurchase in accordance with the Inflation Reduction Act of 2022.\n\nIn May 2023, upon final settlement of the ASR Agreement, we received an additional 1.3 million shares of our common stock from Goldman Sachs. The final number of shares received was based on the volume-weighted average price of our common stock during the term of the ASR Agreement, less a discount and subject to adjustments pursuant to the terms of the ASR Agreement.\n\nWe repurchased the following shares of our common stock under the January 2023 Share Repurchase Program during 2023:\n\n**Amount Authorized Shares Repurchased Amount Repurchased Average Stock Price**\n\n**(in millions) (in thousands) (in millions)**\n\nJanuary 2023 Share Repurchase Program $ 250 3,652 $ 125 $ 34.22\n\nShares repurchased under the January 2023 Share Repurchase Program were retired upon repurchase. As a result, we retired the 3.7 million shares repurchased in connection with the settlement of the ASR Agreement during 2023. The retirement resulted in a reduction of $126 million in Treasury Stock, less than $1 million in the par value of Common Stock, $9 million in Paid-in Capital and $117 million in Retained Earnings during 2023.\n\n**Dividend Policy and Procedures**\n\nWe have not paid any cash dividends since becoming an independent, publicly traded company. We cannot guarantee that we will pay a dividend in the future or continue to pay any dividends if and when we commence paying dividends. The declaration and amount of any dividends to holders of our common stock will be at the discretion of our Board and will depend upon many factors, including our financial condition, earnings, cash flows, capital requirements of our business, covenants associated with our debt obligations, legal requirements, regulatory constraints, industry practice and any other factors the Board deems relevant. We would use net cash flow provided by operating and financing activities to fund our dividends.\n\n**Long-term Debt and Borrowing Facilities**\n\nThe following table provides our outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts and any current portion, as of February 1, 2025 and February 3, 2024:\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**(in millions)**\n\n**Senior Secured Debt with Subsidiary Guarantee** $387 million Term Loan due August 2028 (“Term Loan Facility”) $ 382 $ 385\n\nAsset-based Revolving Credit Facility due August 2026 (“ABL Facility”) — 145\n\nTotal Senior Secured Debt with Subsidiary Guarantee 382 530\n\n**Senior Debt with Subsidiary Guarantee** $600 million, 4.625% Fixed Interest Rate Notes due July 2029 (“2029 Notes”) 595 594\n\nTotal Senior Debt with Subsidiary Guarantee 595 594\n\nTotal 977 1,124\n\nCurrent Debt (4) (4)\n\nTotal Long-term Debt, Net of Current Portion $ 973 $ 1,120\n\nCash paid for interest was $77 million and $87 million in 2024 and 2023, respectively.\n\n**_Issuance of Notes_**\n\nIn July 2021, we issued $600 million of 4.625% notes due in July 2029 in a transaction exempt from registration under the Securities Act of 1933, as amended. The obligation to pay principal and interest on the 2029 Notes is jointly and severally guaranteed on a full and unconditional basis by certain of our wholly-owned subsidiaries. The issuance costs are being amortized through the maturity date and are included within Long-term Debt on the Consolidated Balance Sheets.\n\n39"],"full_content":"Table of Contents\n\nIn February 2023, as part of the January 2023 Share Repurchase Program, we entered into an accelerated share repurchase agreement (“ASR Agreement”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) to repurchase $125 million of our common stock. In February 2023, we made an initial payment of $125 million to Goldman Sachs and received an initial delivery of 2.4 million shares of our common stock. As a result of the initial share delivery, there was an additional $1 million increase in Treasury Stock, which reflects the excise tax liability recorded related to the share repurchase in accordance with the Inflation Reduction Act of 2022.\n\nIn May 2023, upon final settlement of the ASR Agreement, we received an additional 1.3 million shares of our common stock from Goldman Sachs. The final number of shares received was based on the volume-weighted average price of our common stock during the term of the ASR Agreement, less a discount and subject to adjustments pursuant to the terms of the ASR Agreement.\n\nWe repurchased the following shares of our common stock under the January 2023 Share Repurchase Program during 2023:\n\n**Amount Authorized Shares Repurchased Amount Repurchased Average Stock Price**\n\n**(in millions) (in thousands) (in millions)**\n\nJanuary 2023 Share Repurchase Program $ 250 3,652 $ 125 $ 34.22\n\nShares repurchased under the January 2023 Share Repurchase Program were retired upon repurchase. As a result, we retired the 3.7 million shares repurchased in connection with the settlement of the ASR Agreement during 2023. The retirement resulted in a reduction of $126 million in Treasury Stock, less than $1 million in the par value of Common Stock, $9 million in Paid-in Capital and $117 million in Retained Earnings during 2023.\n\n**Dividend Policy and Procedures**\n\nWe have not paid any cash dividends since becoming an independent, publicly traded company. We cannot guarantee that we will pay a dividend in the future or continue to pay any dividends if and when we commence paying dividends. The declaration and amount of any dividends to holders of our common stock will be at the discretion of our Board and will depend upon many factors, including our financial condition, earnings, cash flows, capital requirements of our business, covenants associated with our debt obligations, legal requirements, regulatory constraints, industry practice and any other factors the Board deems relevant. We would use net cash flow provided by operating and financing activities to fund our dividends.\n\n**Long-term Debt and Borrowing Facilities**\n\nThe following table provides our outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts and any current portion, as of February 1, 2025 and February 3, 2024:\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**(in millions)**\n\n**Senior Secured Debt with Subsidiary Guarantee** $387 million Term Loan due August 2028 (“Term Loan Facility”) $ 382 $ 385\n\nAsset-based Revolving Credit Facility due August 2026 (“ABL Facility”) — 145\n\nTotal Senior Secured Debt with Subsidiary Guarantee 382 530\n\n**Senior Debt with Subsidiary Guarantee** $600 million, 4.625% Fixed Interest Rate Notes due July 2029 (“2029 Notes”) 595 594\n\nTotal Senior Debt with Subsidiary Guarantee 595 594\n\nTotal 977 1,124\n\nCurrent Debt (4) (4)\n\nTotal Long-term Debt, Net of Current Portion $ 973 $ 1,120\n\nCash paid for interest was $77 million and $87 million in 2024 and 2023, respectively.\n\n**_Issuance of Notes_**\n\nIn July 2021, we issued $600 million of 4.625% notes due in July 2029 in a transaction exempt from registration under the Securities Act of 1933, as amended. The obligation to pay principal and interest on the 2029 Notes is jointly and severally guaranteed on a full and unconditional basis by certain of our wholly-owned subsidiaries. The issuance costs are being amortized through the maturity date and are included within Long-term Debt on the Consolidated Balance Sheets.\n\n39","publish_date":null,"title":"In February 2023, as part of the January 2023 Share Repurchase Program, we entered into an accelerated share repurchase agreement","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page41.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page41.pdf"},"request":{"example_id":"table/Victoria Secret 10-k_page41","product_type":"parse","source_file_path":"Victoria Secret 10-k_page41.pdf"},"started_at":"2026-11-04T19:48:20.886008"} +{"completed_at":"2026-11-04T19:48:22.905874","latency_in_ms":1293,"output":{"example_id":"table/Victoria Secret 10-k_page5","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\nOur franchise and license arrangements with our partners typically have an initial term of approximately ten years, with an option to renew, subject to customary conditions. Revenue recognized under franchise and license arrangements generally consists of royalties earned and recognized upon sale of merchandise by our franchise and license partners to retail customers, typically based on a percentage of sales. Royalty rates, which are generally low- double digits to low-teens, vary based on store format, local business conditions and various other factors.\n\nOur wholesale arrangements with our partners typically have an initial term of five years, with an option to renew, subject to customary conditions. Wholesale prices, which vary by product category, are generally based on a discount to the suggested retail price. Revenue is generally recognized under wholesale arrangements at the time title of the product passes to the wholesale partner.\n\nThe following table provides the number of our international stores operated by our partners by store type as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\nBeauty and Accessories (a) 324 307\n\nFull Assortment 181 156\n\n**Total 505** **463**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Does not include the thirteen partner-operated China joint venture stores.\n\n**Our Competitive Strengths**\n\n**_Market Leading Brands Driving Growth_**\n\nOur two flagship brands, Victoria's Secret and PINK, have a strong global presence and high awareness among consumers. Their combined market share in the intimates category remains robust, underscoring our leading position in the industry and providing a significant competitive advantage. In addition to our core brands, we also have Adore Me, a technology-led, digital first innovative intimates and apparel brand.\n\nWhile our heritage is deeply rooted in intimate apparel, our brands also offer compelling assortments in adjacent product categories including fragrance, beauty, apparel, loungewear, sleepwear, sport and swimwear. This diversified portfolio allows us to serve customers across multiple lifestyle touchpoints, further strengthening our position as a leader in the industry.\n\n**_Global Scale and Reach_**\n\nWe have a powerful presence in the U.S. and worldwide, engaging customers through three key distribution channels.\n\n**_• North American Stores -_** With 812 stores across the U.S. and Canada, totaling 5.6 million square feet of selling space as of the end of 2024, our expansive store fleet delivers immersive brand experiences at premier shopping destinations throughout North America. Our dedicated sales associates and store managers bring our products to life with exceptional service and expertise.\n\n**_• Digital -_** Our digital ecosystem creates a seamless, personalized shopping experience across brands and platforms. We are constantly enhancing our websites, applications and social media with advanced digital marketing and personalization, omnichannel capabilities and real-time inventory connectivity to meet customers wherever they are.\n\n• **_International -_** We have 575 international stores spanning Asia, Europe, the Americas, the Middle East and Africa and international digital sites in nearly 70 countries as of the end of 2024. We are focused on growing our business in existing markets and expanding globally with new stores and digital platforms in new markets. Our smaller footprint travel retail locations in airports provide valuable global exposure.\n\n**_Agile, Responsive and Efficient Supply Chain_**\n\nOur sourcing and production strategy is built for speed, quality and cost efficiency.\n\n• **_Global Expertise -_** We have cultivated a strong sourcing presence in the U.S. and Asia, helping to drive innovation and speed-to-market across our product categories. Our intimates and apparel are produced through an internationally outsourced platform, while our beauty manufacturing, which is largely centered in Ohio, provides agility and cutting-edge product development.\n\n• **_Flexibility & Adaptability -_** We leverage close supplier partnerships and a highly responsive supply chain to manage inventory dynamically and adapt to customer demand. Our agility allows us to respond in real time to shifts in customer preferences and quickly replenish strong selling products, maximizing sales and merchandise margin rate opportunities.\n\n3","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\nOur franchise and license arrangements with our partners typically have an initial term of approximately ten years, with an option to renew, subject to customary conditions. Revenue recognized under franchise and license arrangements generally consists of royalties earned and recognized upon sale of merchandise by our franchise and license partners to retail customers, typically based on a percentage of sales. Royalty rates, which are generally low- double digits to low-teens, vary based on store format, local business conditions and various other factors.\n\nOur wholesale arrangements with our partners typically have an initial term of five years, with an option to renew, subject to customary conditions. Wholesale prices, which vary by product category, are generally based on a discount to the suggested retail price. Revenue is generally recognized under wholesale arrangements at the time title of the product passes to the wholesale partner.\n\nThe following table provides the number of our international stores operated by our partners by store type as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\nBeauty and Accessories (a) 324 307\n\nFull Assortment 181 156\n\n**Total 505** **463**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Does not include the thirteen partner-operated China joint venture stores.\n\n**Our Competitive Strengths**\n\n**_Market Leading Brands Driving Growth_**\n\nOur two flagship brands, Victoria's Secret and PINK, have a strong global presence and high awareness among consumers. Their combined market share in the intimates category remains robust, underscoring our leading position in the industry and providing a significant competitive advantage. In addition to our core brands, we also have Adore Me, a technology-led, digital first innovative intimates and apparel brand.\n\nWhile our heritage is deeply rooted in intimate apparel, our brands also offer compelling assortments in adjacent product categories including fragrance, beauty, apparel, loungewear, sleepwear, sport and swimwear. This diversified portfolio allows us to serve customers across multiple lifestyle touchpoints, further strengthening our position as a leader in the industry.\n\n**_Global Scale and Reach_**\n\nWe have a powerful presence in the U.S. and worldwide, engaging customers through three key distribution channels.\n\n**_• North American Stores -_** With 812 stores across the U.S. and Canada, totaling 5.6 million square feet of selling space as of the end of 2024, our expansive store fleet delivers immersive brand experiences at premier shopping destinations throughout North America. Our dedicated sales associates and store managers bring our products to life with exceptional service and expertise.\n\n**_• Digital -_** Our digital ecosystem creates a seamless, personalized shopping experience across brands and platforms. We are constantly enhancing our websites, applications and social media with advanced digital marketing and personalization, omnichannel capabilities and real-time inventory connectivity to meet customers wherever they are.\n\n• **_International -_** We have 575 international stores spanning Asia, Europe, the Americas, the Middle East and Africa and international digital sites in nearly 70 countries as of the end of 2024. We are focused on growing our business in existing markets and expanding globally with new stores and digital platforms in new markets. Our smaller footprint travel retail locations in airports provide valuable global exposure.\n\n**_Agile, Responsive and Efficient Supply Chain_**\n\nOur sourcing and production strategy is built for speed, quality and cost efficiency.\n\n• **_Global Expertise -_** We have cultivated a strong sourcing presence in the U.S. and Asia, helping to drive innovation and speed-to-market across our product categories. Our intimates and apparel are produced through an internationally outsourced platform, while our beauty manufacturing, which is largely centered in Ohio, provides agility and cutting-edge product development.\n\n• **_Flexibility & Adaptability -_** We leverage close supplier partnerships and a highly responsive supply chain to manage inventory dynamically and adapt to customer demand. Our agility allows us to respond in real time to shifts in customer preferences and quickly replenish strong selling products, maximizing sales and merchandise margin rate opportunities.\n\n3","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\nOur franchise and license arrangements with our partners typically have an initial term of approximately ten years, with an option to renew, subject to customary conditions. Revenue recognized under franchise and license arrangements generally consists of royalties earned and recognized upon sale of merchandise by our franchise and license partners to retail customers, typically based on a percentage of sales. Royalty rates, which are generally low- double digits to low-teens, vary based on store format, local business conditions and various other factors.\n\nOur wholesale arrangements with our partners typically have an initial term of five years, with an option to renew, subject to customary conditions. Wholesale prices, which vary by product category, are generally based on a discount to the suggested retail price. Revenue is generally recognized under wholesale arrangements at the time title of the product passes to the wholesale partner.\n\nThe following table provides the number of our international stores operated by our partners by store type as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\nBeauty and Accessories (a) 324 307\n\nFull Assortment 181 156\n\n**Total 505** **463**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Does not include the thirteen partner-operated China joint venture stores.\n\n**Our Competitive Strengths**\n\n**_Market Leading Brands Driving Growth_**\n\nOur two flagship brands, Victoria's Secret and PINK, have a strong global presence and high awareness among consumers. Their combined market share in the intimates category remains robust, underscoring our leading position in the industry and providing a significant competitive advantage. In addition to our core brands, we also have Adore Me, a technology-led, digital first innovative intimates and apparel brand.\n\nWhile our heritage is deeply rooted in intimate apparel, our brands also offer compelling assortments in adjacent product categories including fragrance, beauty, apparel, loungewear, sleepwear, sport and swimwear. This diversified portfolio allows us to serve customers across multiple lifestyle touchpoints, further strengthening our position as a leader in the industry.\n\n**_Global Scale and Reach_**\n\nWe have a powerful presence in the U.S. and worldwide, engaging customers through three key distribution channels.\n\n**_• North American Stores -_** With 812 stores across the U.S. and Canada, totaling 5.6 million square feet of selling space as of the end of 2024, our expansive store fleet delivers immersive brand experiences at premier shopping destinations throughout North America. Our dedicated sales associates and store managers bring our products to life with exceptional service and expertise.\n\n**_• Digital -_** Our digital ecosystem creates a seamless, personalized shopping experience across brands and platforms. We are constantly enhancing our websites, applications and social media with advanced digital marketing and personalization, omnichannel capabilities and real-time inventory connectivity to meet customers wherever they are.\n\n• **_International -_** We have 575 international stores spanning Asia, Europe, the Americas, the Middle East and Africa and international digital sites in nearly 70 countries as of the end of 2024. We are focused on growing our business in existing markets and expanding globally with new stores and digital platforms in new markets. Our smaller footprint travel retail locations in airports provide valuable global exposure.\n\n**_Agile, Responsive and Efficient Supply Chain_**\n\nOur sourcing and production strategy is built for speed, quality and cost efficiency.\n\n• **_Global Expertise -_** We have cultivated a strong sourcing presence in the U.S. and Asia, helping to drive innovation and speed-to-market across our product categories. Our intimates and apparel are produced through an internationally outsourced platform, while our beauty manufacturing, which is largely centered in Ohio, provides agility and cutting-edge product development.\n\n• **_Flexibility & Adaptability -_** We leverage close supplier partnerships and a highly responsive supply chain to manage inventory dynamically and adapt to customer demand. Our agility allows us to respond in real time to shifts in customer preferences and quickly replenish strong selling products, maximizing sales and merchandise margin rate opportunities.\n\n3","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page5.pdf"]},"response":{"errors":[],"extract_id":"extract_fe5f18f4b22de0fb78c3b216eaa11fa9","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\nOur franchise and license arrangements with our partners typically have an initial term of approximately ten years, with an option to renew, subject to customary conditions. Revenue recognized under franchise and license arrangements generally consists of royalties earned and recognized upon sale of merchandise by our franchise and license partners to retail customers, typically based on a percentage of sales. Royalty rates, which are generally low- double digits to low-teens, vary based on store format, local business conditions and various other factors.\n\nOur wholesale arrangements with our partners typically have an initial term of five years, with an option to renew, subject to customary conditions. Wholesale prices, which vary by product category, are generally based on a discount to the suggested retail price. Revenue is generally recognized under wholesale arrangements at the time title of the product passes to the wholesale partner.\n\nThe following table provides the number of our international stores operated by our partners by store type as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\nBeauty and Accessories (a) 324 307\n\nFull Assortment 181 156\n\n**Total 505** **463**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Does not include the thirteen partner-operated China joint venture stores.\n\n**Our Competitive Strengths**\n\n**_Market Leading Brands Driving Growth_**\n\nOur two flagship brands, Victoria's Secret and PINK, have a strong global presence and high awareness among consumers. Their combined market share in the intimates category remains robust, underscoring our leading position in the industry and providing a significant competitive advantage. In addition to our core brands, we also have Adore Me, a technology-led, digital first innovative intimates and apparel brand.\n\nWhile our heritage is deeply rooted in intimate apparel, our brands also offer compelling assortments in adjacent product categories including fragrance, beauty, apparel, loungewear, sleepwear, sport and swimwear. This diversified portfolio allows us to serve customers across multiple lifestyle touchpoints, further strengthening our position as a leader in the industry.\n\n**_Global Scale and Reach_**\n\nWe have a powerful presence in the U.S. and worldwide, engaging customers through three key distribution channels.\n\n**_• North American Stores -_** With 812 stores across the U.S. and Canada, totaling 5.6 million square feet of selling space as of the end of 2024, our expansive store fleet delivers immersive brand experiences at premier shopping destinations throughout North America. Our dedicated sales associates and store managers bring our products to life with exceptional service and expertise.\n\n**_• Digital -_** Our digital ecosystem creates a seamless, personalized shopping experience across brands and platforms. We are constantly enhancing our websites, applications and social media with advanced digital marketing and personalization, omnichannel capabilities and real-time inventory connectivity to meet customers wherever they are.\n\n• **_International -_** We have 575 international stores spanning Asia, Europe, the Americas, the Middle East and Africa and international digital sites in nearly 70 countries as of the end of 2024. We are focused on growing our business in existing markets and expanding globally with new stores and digital platforms in new markets. Our smaller footprint travel retail locations in airports provide valuable global exposure.\n\n**_Agile, Responsive and Efficient Supply Chain_**\n\nOur sourcing and production strategy is built for speed, quality and cost efficiency.\n\n• **_Global Expertise -_** We have cultivated a strong sourcing presence in the U.S. and Asia, helping to drive innovation and speed-to-market across our product categories. Our intimates and apparel are produced through an internationally outsourced platform, while our beauty manufacturing, which is largely centered in Ohio, provides agility and cutting-edge product development.\n\n• **_Flexibility & Adaptability -_** We leverage close supplier partnerships and a highly responsive supply chain to manage inventory dynamically and adapt to customer demand. Our agility allows us to respond in real time to shifts in customer preferences and quickly replenish strong selling products, maximizing sales and merchandise margin rate opportunities.\n\n3"],"full_content":"Table of Contents\n\nOur franchise and license arrangements with our partners typically have an initial term of approximately ten years, with an option to renew, subject to customary conditions. Revenue recognized under franchise and license arrangements generally consists of royalties earned and recognized upon sale of merchandise by our franchise and license partners to retail customers, typically based on a percentage of sales. Royalty rates, which are generally low- double digits to low-teens, vary based on store format, local business conditions and various other factors.\n\nOur wholesale arrangements with our partners typically have an initial term of five years, with an option to renew, subject to customary conditions. Wholesale prices, which vary by product category, are generally based on a discount to the suggested retail price. Revenue is generally recognized under wholesale arrangements at the time title of the product passes to the wholesale partner.\n\nThe following table provides the number of our international stores operated by our partners by store type as of February 1, 2025 and February 3, 2024:\n\n**February 1, 2025 February 3, 2024**\n\nBeauty and Accessories (a) 324 307\n\nFull Assortment 181 156\n\n**Total 505** **463**\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_ (a) Does not include the thirteen partner-operated China joint venture stores.\n\n**Our Competitive Strengths**\n\n**_Market Leading Brands Driving Growth_**\n\nOur two flagship brands, Victoria's Secret and PINK, have a strong global presence and high awareness among consumers. Their combined market share in the intimates category remains robust, underscoring our leading position in the industry and providing a significant competitive advantage. In addition to our core brands, we also have Adore Me, a technology-led, digital first innovative intimates and apparel brand.\n\nWhile our heritage is deeply rooted in intimate apparel, our brands also offer compelling assortments in adjacent product categories including fragrance, beauty, apparel, loungewear, sleepwear, sport and swimwear. This diversified portfolio allows us to serve customers across multiple lifestyle touchpoints, further strengthening our position as a leader in the industry.\n\n**_Global Scale and Reach_**\n\nWe have a powerful presence in the U.S. and worldwide, engaging customers through three key distribution channels.\n\n**_• North American Stores -_** With 812 stores across the U.S. and Canada, totaling 5.6 million square feet of selling space as of the end of 2024, our expansive store fleet delivers immersive brand experiences at premier shopping destinations throughout North America. Our dedicated sales associates and store managers bring our products to life with exceptional service and expertise.\n\n**_• Digital -_** Our digital ecosystem creates a seamless, personalized shopping experience across brands and platforms. We are constantly enhancing our websites, applications and social media with advanced digital marketing and personalization, omnichannel capabilities and real-time inventory connectivity to meet customers wherever they are.\n\n• **_International -_** We have 575 international stores spanning Asia, Europe, the Americas, the Middle East and Africa and international digital sites in nearly 70 countries as of the end of 2024. We are focused on growing our business in existing markets and expanding globally with new stores and digital platforms in new markets. Our smaller footprint travel retail locations in airports provide valuable global exposure.\n\n**_Agile, Responsive and Efficient Supply Chain_**\n\nOur sourcing and production strategy is built for speed, quality and cost efficiency.\n\n• **_Global Expertise -_** We have cultivated a strong sourcing presence in the U.S. and Asia, helping to drive innovation and speed-to-market across our product categories. Our intimates and apparel are produced through an internationally outsourced platform, while our beauty manufacturing, which is largely centered in Ohio, provides agility and cutting-edge product development.\n\n• **_Flexibility & Adaptability -_** We leverage close supplier partnerships and a highly responsive supply chain to manage inventory dynamically and adapt to customer demand. Our agility allows us to respond in real time to shifts in customer preferences and quickly replenish strong selling products, maximizing sales and merchandise margin rate opportunities.\n\n3","publish_date":null,"title":"Our franchise and license arrangements with our partners typically have an initial term of approximately ten years, with an option","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page5.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page5.pdf"},"request":{"example_id":"table/Victoria Secret 10-k_page5","product_type":"parse","source_file_path":"Victoria Secret 10-k_page5.pdf"},"started_at":"2026-11-04T19:48:21.612514"} +{"completed_at":"2026-11-04T19:48:25.806572","latency_in_ms":2897,"output":{"example_id":"table/Victoria Secret 10-k_page54","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**VICTORIA'S SECRET & CO.**\n\n**CONSOLIDATED BALANCE SHEETS**\n\n**(in millions except par value amounts)**\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**ASSETS**\n\n**Current Assets:**\n\nCash and Cash Equivalents $ 227 $ 270\n\nAccounts Receivable, Net 159 152\n\nInventories 955 985\n\nOther 100 126\n\nTotal Current Assets 1,441 1,533\n\nProperty and Equipment, Net 774 843\n\nOperating Lease Assets 1,481 1,351\n\nGoodwill 367 367\n\nTrade Names 281 284\n\nOther Intangible Assets, Net 95 116\n\nDeferred Income Taxes 22 20\n\nOther Assets 71 86\n\n**Total Assets** $ 4,532 $ 4,600\n\n**LIABILITIES AND EQUITY**\n\n**Current Liabilities:**\n\nAccounts Payable $ 419 $ 513\n\nAccrued Expenses and Other 633 810\n\nCurrent Debt 4 4\n\nCurrent Operating Lease Liabilities 287 267\n\nIncome Taxes 32 20\n\nTotal Current Liabilities 1,375 1,614\n\nDeferred Income Taxes 11 37\n\nLong-term Debt 973 1,120\n\nLong-term Operating Lease Liabilities 1,434 1,312\n\nOther Long-term Liabilities 75 79\n\n**Total Liabilities** 3,868 4,162\n\n**Shareholders’ Equity:**\n\nPreferred Stock—$0.01 par value; 10 shares authorized; none issued — —\n\nCommon Stock—$0.01 par value; 1,000 shares authorized; 79 and 78 shares issued; 79 and 78 shares outstanding, respectively 1 1\n\nPaid-in Capital 297 238\n\nAccumulated Other Comprehensive Income (Loss) (1) —\n\nRetained Earnings 343 178\n\n**Total Victoria's Secret & Co. Shareholders' Equity** 640 417\n\nNoncontrolling Interest 24 21\n\n**Total Equity** 664 438\n\n**Total Liabilities and Equity** $ 4,532 $ 4,600\n\nThe accompanying Notes are an integral part of these Consolidated Financial Statements.\n\n52","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**VICTORIA'S SECRET & CO.**\n\n**CONSOLIDATED BALANCE SHEETS**\n\n**(in millions except par value amounts)**\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**ASSETS**\n\n**Current Assets:**\n\nCash and Cash Equivalents $ 227 $ 270\n\nAccounts Receivable, Net 159 152\n\nInventories 955 985\n\nOther 100 126\n\nTotal Current Assets 1,441 1,533\n\nProperty and Equipment, Net 774 843\n\nOperating Lease Assets 1,481 1,351\n\nGoodwill 367 367\n\nTrade Names 281 284\n\nOther Intangible Assets, Net 95 116\n\nDeferred Income Taxes 22 20\n\nOther Assets 71 86\n\n**Total Assets** $ 4,532 $ 4,600\n\n**LIABILITIES AND EQUITY**\n\n**Current Liabilities:**\n\nAccounts Payable $ 419 $ 513\n\nAccrued Expenses and Other 633 810\n\nCurrent Debt 4 4\n\nCurrent Operating Lease Liabilities 287 267\n\nIncome Taxes 32 20\n\nTotal Current Liabilities 1,375 1,614\n\nDeferred Income Taxes 11 37\n\nLong-term Debt 973 1,120\n\nLong-term Operating Lease Liabilities 1,434 1,312\n\nOther Long-term Liabilities 75 79\n\n**Total Liabilities** 3,868 4,162\n\n**Shareholders’ Equity:**\n\nPreferred Stock—$0.01 par value; 10 shares authorized; none issued — —\n\nCommon Stock—$0.01 par value; 1,000 shares authorized; 79 and 78 shares issued; 79 and 78 shares outstanding, respectively 1 1\n\nPaid-in Capital 297 238\n\nAccumulated Other Comprehensive Income (Loss) (1) —\n\nRetained Earnings 343 178\n\n**Total Victoria's Secret & Co. Shareholders' Equity** 640 417\n\nNoncontrolling Interest 24 21\n\n**Total Equity** 664 438\n\n**Total Liabilities and Equity** $ 4,532 $ 4,600\n\nThe accompanying Notes are an integral part of these Consolidated Financial Statements.\n\n52","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**VICTORIA'S SECRET & CO.**\n\n**CONSOLIDATED BALANCE SHEETS**\n\n**(in millions except par value amounts)**\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**ASSETS**\n\n**Current Assets:**\n\nCash and Cash Equivalents $ 227 $ 270\n\nAccounts Receivable, Net 159 152\n\nInventories 955 985\n\nOther 100 126\n\nTotal Current Assets 1,441 1,533\n\nProperty and Equipment, Net 774 843\n\nOperating Lease Assets 1,481 1,351\n\nGoodwill 367 367\n\nTrade Names 281 284\n\nOther Intangible Assets, Net 95 116\n\nDeferred Income Taxes 22 20\n\nOther Assets 71 86\n\n**Total Assets** $ 4,532 $ 4,600\n\n**LIABILITIES AND EQUITY**\n\n**Current Liabilities:**\n\nAccounts Payable $ 419 $ 513\n\nAccrued Expenses and Other 633 810\n\nCurrent Debt 4 4\n\nCurrent Operating Lease Liabilities 287 267\n\nIncome Taxes 32 20\n\nTotal Current Liabilities 1,375 1,614\n\nDeferred Income Taxes 11 37\n\nLong-term Debt 973 1,120\n\nLong-term Operating Lease Liabilities 1,434 1,312\n\nOther Long-term Liabilities 75 79\n\n**Total Liabilities** 3,868 4,162\n\n**Shareholders’ Equity:**\n\nPreferred Stock—$0.01 par value; 10 shares authorized; none issued — —\n\nCommon Stock—$0.01 par value; 1,000 shares authorized; 79 and 78 shares issued; 79 and 78 shares outstanding, respectively 1 1\n\nPaid-in Capital 297 238\n\nAccumulated Other Comprehensive Income (Loss) (1) —\n\nRetained Earnings 343 178\n\n**Total Victoria's Secret & Co. Shareholders' Equity** 640 417\n\nNoncontrolling Interest 24 21\n\n**Total Equity** 664 438\n\n**Total Liabilities and Equity** $ 4,532 $ 4,600\n\nThe accompanying Notes are an integral part of these Consolidated Financial Statements.\n\n52","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page54.pdf"]},"response":{"errors":[],"extract_id":"extract_7d428e7ebb511066402a941129d7ee81","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**VICTORIA'S SECRET & CO.**\n\n**CONSOLIDATED BALANCE SHEETS**\n\n**(in millions except par value amounts)**\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**ASSETS**\n\n**Current Assets:**\n\nCash and Cash Equivalents $ 227 $ 270\n\nAccounts Receivable, Net 159 152\n\nInventories 955 985\n\nOther 100 126\n\nTotal Current Assets 1,441 1,533\n\nProperty and Equipment, Net 774 843\n\nOperating Lease Assets 1,481 1,351\n\nGoodwill 367 367\n\nTrade Names 281 284\n\nOther Intangible Assets, Net 95 116\n\nDeferred Income Taxes 22 20\n\nOther Assets 71 86\n\n**Total Assets** $ 4,532 $ 4,600\n\n**LIABILITIES AND EQUITY**\n\n**Current Liabilities:**\n\nAccounts Payable $ 419 $ 513\n\nAccrued Expenses and Other 633 810\n\nCurrent Debt 4 4\n\nCurrent Operating Lease Liabilities 287 267\n\nIncome Taxes 32 20\n\nTotal Current Liabilities 1,375 1,614\n\nDeferred Income Taxes 11 37\n\nLong-term Debt 973 1,120\n\nLong-term Operating Lease Liabilities 1,434 1,312\n\nOther Long-term Liabilities 75 79\n\n**Total Liabilities** 3,868 4,162\n\n**Shareholders’ Equity:**\n\nPreferred Stock—$0.01 par value; 10 shares authorized; none issued — —\n\nCommon Stock—$0.01 par value; 1,000 shares authorized; 79 and 78 shares issued; 79 and 78 shares outstanding, respectively 1 1\n\nPaid-in Capital 297 238\n\nAccumulated Other Comprehensive Income (Loss) (1) —\n\nRetained Earnings 343 178\n\n**Total Victoria's Secret & Co. Shareholders' Equity** 640 417\n\nNoncontrolling Interest 24 21\n\n**Total Equity** 664 438\n\n**Total Liabilities and Equity** $ 4,532 $ 4,600\n\nThe accompanying Notes are an integral part of these Consolidated Financial Statements.\n\n52"],"full_content":"Table of Contents\n\n**VICTORIA'S SECRET & CO.**\n\n**CONSOLIDATED BALANCE SHEETS**\n\n**(in millions except par value amounts)**\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**ASSETS**\n\n**Current Assets:**\n\nCash and Cash Equivalents $ 227 $ 270\n\nAccounts Receivable, Net 159 152\n\nInventories 955 985\n\nOther 100 126\n\nTotal Current Assets 1,441 1,533\n\nProperty and Equipment, Net 774 843\n\nOperating Lease Assets 1,481 1,351\n\nGoodwill 367 367\n\nTrade Names 281 284\n\nOther Intangible Assets, Net 95 116\n\nDeferred Income Taxes 22 20\n\nOther Assets 71 86\n\n**Total Assets** $ 4,532 $ 4,600\n\n**LIABILITIES AND EQUITY**\n\n**Current Liabilities:**\n\nAccounts Payable $ 419 $ 513\n\nAccrued Expenses and Other 633 810\n\nCurrent Debt 4 4\n\nCurrent Operating Lease Liabilities 287 267\n\nIncome Taxes 32 20\n\nTotal Current Liabilities 1,375 1,614\n\nDeferred Income Taxes 11 37\n\nLong-term Debt 973 1,120\n\nLong-term Operating Lease Liabilities 1,434 1,312\n\nOther Long-term Liabilities 75 79\n\n**Total Liabilities** 3,868 4,162\n\n**Shareholders’ Equity:**\n\nPreferred Stock—$0.01 par value; 10 shares authorized; none issued — —\n\nCommon Stock—$0.01 par value; 1,000 shares authorized; 79 and 78 shares issued; 79 and 78 shares outstanding, respectively 1 1\n\nPaid-in Capital 297 238\n\nAccumulated Other Comprehensive Income (Loss) (1) —\n\nRetained Earnings 343 178\n\n**Total Victoria's Secret & Co. Shareholders' Equity** 640 417\n\nNoncontrolling Interest 24 21\n\n**Total Equity** 664 438\n\n**Total Liabilities and Equity** $ 4,532 $ 4,600\n\nThe accompanying Notes are an integral part of these Consolidated Financial Statements.\n\n52","publish_date":null,"title":"VICTORIA'S SECRET & CO. CONSOLIDATED BALANCE SHEETS (in millions except par value amounts) ASSETS Current Assets: Cash and Cash Equivalents","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page54.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page54.pdf"},"request":{"example_id":"table/Victoria Secret 10-k_page54","product_type":"parse","source_file_path":"Victoria Secret 10-k_page54.pdf"},"started_at":"2026-11-04T19:48:22.909120"} +{"completed_at":"2026-11-04T19:48:27.019249","latency_in_ms":2755,"output":{"example_id":"table/Victoria Secret 10-k_page55","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\n**VICTORIA'S SECRET & CO.**\n\n**CONSOLIDATED STATEMENTS OF EQUITY**\n\n**(in millions)**\n\n**Common Stock**\n\n**Paid-in**\n\n**Capital**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive**\n\n**Income (Loss)**\n\n**Retained**\n\n**Earnings**\n\n**Treasury**\n\n**Stock**\n\n**Total**\n\n**Victoria's**\n\n**Secret & Co.**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interest**\n\n**Total Equity**\n\n**Shares**\n\n**Outstanding**\n\n**Par**\n\n**Value**\n\n**Balance, January 29, 2022** 85 $ 1 $ 125 $ 5 $ 126 $ — $ 257 $ — $ 257\n\nNet Income (Loss) — — — — 348 — 348 (10) 338\n\nOther Comprehensive Loss — — — (4) — — (4) — (4)\n\nTotal Comprehensive Income (Loss) — — — (4) 348 — 344 (10) 334\n\nSale of Noncontrolling Interest — — 17 — — — 17 28 45\n\nRepurchases of Common Stock (6) — 50 — — (300) (250) — (250)\n\nTreasury Share Retirements — — (12) — (288) 300 — — —\n\nShare-based Compensation Expense — — 48 — — — 48 — 48\n\nTax Payments related to Share-based Awards (1) — (42) — — — (42) — (42)\n\nOther 2 — 9 — — — 9 — 9\n\n**Balance, January 28, 2023** 80 $ 1 $ 195 $ 1 $ 186 $ — $ 383 $ 18 $ 401\n\nNet Income — — — — 109 — 109 7 116\n\nOther Comprehensive Loss — — — (1) — — (1) (2) (3)\n\nTotal Comprehensive Income (Loss) — — — (1) 109 — 108 5 113\n\nRepurchases of Common Stock (3) — — — — (126) (126) — (126)\n\nTreasury Share Retirements — — (9) — (117) 126 — — —\n\nShare-based Compensation Expense — — 56 — — — 56 — 56\n\nTax Payments related to Share-based Awards (1) — (12) — — — (12) — (12)\n\nDistribution to Noncontrolling Interest — — — — — — — (2) (2)\n\nOther 2 — 8 — — — 8 — 8\n\n**Balance, February 3, 2024** 78 $ 1 $ 238 $ — $ 178 $ — $ 417 $ 21 $ 438\n\nNet Income — — — — 165 — 165 4 169\n\nOther Comprehensive Loss — — — (1) — — (1) (1) (2)\n\nTotal Comprehensive Income (Loss) — — — (1) 165 — 164 3 167\n\nShare-based Compensation Expense — — 60 — — — 60 — 60\n\nTax Payments related to Share-based Awards (1) — (10) — — — (10) — (10)\n\nOther 2 — 9 — — — 9 — 9\n\n**Balance, February 1, 2025** 79 $ 1 $ 297 $ (1) $ 343 $ — $ 640 $ 24 $ 664\n\nThe accompanying Notes are an integral part of these Consolidated Financial Statements.\n\n53","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\n**VICTORIA'S SECRET & CO.**\n\n**CONSOLIDATED STATEMENTS OF EQUITY**\n\n**(in millions)**\n\n**Common Stock**\n\n**Paid-in**\n\n**Capital**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive**\n\n**Income (Loss)**\n\n**Retained**\n\n**Earnings**\n\n**Treasury**\n\n**Stock**\n\n**Total**\n\n**Victoria's**\n\n**Secret & Co.**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interest**\n\n**Total Equity**\n\n**Shares**\n\n**Outstanding**\n\n**Par**\n\n**Value**\n\n**Balance, January 29, 2022** 85 $ 1 $ 125 $ 5 $ 126 $ — $ 257 $ — $ 257\n\nNet Income (Loss) — — — — 348 — 348 (10) 338\n\nOther Comprehensive Loss — — — (4) — — (4) — (4)\n\nTotal Comprehensive Income (Loss) — — — (4) 348 — 344 (10) 334\n\nSale of Noncontrolling Interest — — 17 — — — 17 28 45\n\nRepurchases of Common Stock (6) — 50 — — (300) (250) — (250)\n\nTreasury Share Retirements — — (12) — (288) 300 — — —\n\nShare-based Compensation Expense — — 48 — — — 48 — 48\n\nTax Payments related to Share-based Awards (1) — (42) — — — (42) — (42)\n\nOther 2 — 9 — — — 9 — 9\n\n**Balance, January 28, 2023** 80 $ 1 $ 195 $ 1 $ 186 $ — $ 383 $ 18 $ 401\n\nNet Income — — — — 109 — 109 7 116\n\nOther Comprehensive Loss — — — (1) — — (1) (2) (3)\n\nTotal Comprehensive Income (Loss) — — — (1) 109 — 108 5 113\n\nRepurchases of Common Stock (3) — — — — (126) (126) — (126)\n\nTreasury Share Retirements — — (9) — (117) 126 — — —\n\nShare-based Compensation Expense — — 56 — — — 56 — 56\n\nTax Payments related to Share-based Awards (1) — (12) — — — (12) — (12)\n\nDistribution to Noncontrolling Interest — — — — — — — (2) (2)\n\nOther 2 — 8 — — — 8 — 8\n\n**Balance, February 3, 2024** 78 $ 1 $ 238 $ — $ 178 $ — $ 417 $ 21 $ 438\n\nNet Income — — — — 165 — 165 4 169\n\nOther Comprehensive Loss — — — (1) — — (1) (1) (2)\n\nTotal Comprehensive Income (Loss) — — — (1) 165 — 164 3 167\n\nShare-based Compensation Expense — — 60 — — — 60 — 60\n\nTax Payments related to Share-based Awards (1) — (10) — — — (10) — (10)\n\nOther 2 — 9 — — — 9 — 9\n\n**Balance, February 1, 2025** 79 $ 1 $ 297 $ (1) $ 343 $ — $ 640 $ 24 $ 664\n\nThe accompanying Notes are an integral part of these Consolidated Financial Statements.\n\n53","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\n**VICTORIA'S SECRET & CO.**\n\n**CONSOLIDATED STATEMENTS OF EQUITY**\n\n**(in millions)**\n\n**Common Stock**\n\n**Paid-in**\n\n**Capital**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive**\n\n**Income (Loss)**\n\n**Retained**\n\n**Earnings**\n\n**Treasury**\n\n**Stock**\n\n**Total**\n\n**Victoria's**\n\n**Secret & Co.**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interest**\n\n**Total Equity**\n\n**Shares**\n\n**Outstanding**\n\n**Par**\n\n**Value**\n\n**Balance, January 29, 2022** 85 $ 1 $ 125 $ 5 $ 126 $ — $ 257 $ — $ 257\n\nNet Income (Loss) — — — — 348 — 348 (10) 338\n\nOther Comprehensive Loss — — — (4) — — (4) — (4)\n\nTotal Comprehensive Income (Loss) — — — (4) 348 — 344 (10) 334\n\nSale of Noncontrolling Interest — — 17 — — — 17 28 45\n\nRepurchases of Common Stock (6) — 50 — — (300) (250) — (250)\n\nTreasury Share Retirements — — (12) — (288) 300 — — —\n\nShare-based Compensation Expense — — 48 — — — 48 — 48\n\nTax Payments related to Share-based Awards (1) — (42) — — — (42) — (42)\n\nOther 2 — 9 — — — 9 — 9\n\n**Balance, January 28, 2023** 80 $ 1 $ 195 $ 1 $ 186 $ — $ 383 $ 18 $ 401\n\nNet Income — — — — 109 — 109 7 116\n\nOther Comprehensive Loss — — — (1) — — (1) (2) (3)\n\nTotal Comprehensive Income (Loss) — — — (1) 109 — 108 5 113\n\nRepurchases of Common Stock (3) — — — — (126) (126) — (126)\n\nTreasury Share Retirements — — (9) — (117) 126 — — —\n\nShare-based Compensation Expense — — 56 — — — 56 — 56\n\nTax Payments related to Share-based Awards (1) — (12) — — — (12) — (12)\n\nDistribution to Noncontrolling Interest — — — — — — — (2) (2)\n\nOther 2 — 8 — — — 8 — 8\n\n**Balance, February 3, 2024** 78 $ 1 $ 238 $ — $ 178 $ — $ 417 $ 21 $ 438\n\nNet Income — — — — 165 — 165 4 169\n\nOther Comprehensive Loss — — — (1) — — (1) (1) (2)\n\nTotal Comprehensive Income (Loss) — — — (1) 165 — 164 3 167\n\nShare-based Compensation Expense — — 60 — — — 60 — 60\n\nTax Payments related to Share-based Awards (1) — (10) — — — (10) — (10)\n\nOther 2 — 9 — — — 9 — 9\n\n**Balance, February 1, 2025** 79 $ 1 $ 297 $ (1) $ 343 $ — $ 640 $ 24 $ 664\n\nThe accompanying Notes are an integral part of these Consolidated Financial Statements.\n\n53","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page55.pdf"]},"response":{"errors":[],"extract_id":"extract_fcb82937cb8611332eca5ef18501c41b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\n**VICTORIA'S SECRET & CO.**\n\n**CONSOLIDATED STATEMENTS OF EQUITY**\n\n**(in millions)**\n\n**Common Stock**\n\n**Paid-in**\n\n**Capital**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive**\n\n**Income (Loss)**\n\n**Retained**\n\n**Earnings**\n\n**Treasury**\n\n**Stock**\n\n**Total**\n\n**Victoria's**\n\n**Secret & Co.**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interest**\n\n**Total Equity**\n\n**Shares**\n\n**Outstanding**\n\n**Par**\n\n**Value**\n\n**Balance, January 29, 2022** 85 $ 1 $ 125 $ 5 $ 126 $ — $ 257 $ — $ 257\n\nNet Income (Loss) — — — — 348 — 348 (10) 338\n\nOther Comprehensive Loss — — — (4) — — (4) — (4)\n\nTotal Comprehensive Income (Loss) — — — (4) 348 — 344 (10) 334\n\nSale of Noncontrolling Interest — — 17 — — — 17 28 45\n\nRepurchases of Common Stock (6) — 50 — — (300) (250) — (250)\n\nTreasury Share Retirements — — (12) — (288) 300 — — —\n\nShare-based Compensation Expense — — 48 — — — 48 — 48\n\nTax Payments related to Share-based Awards (1) — (42) — — — (42) — (42)\n\nOther 2 — 9 — — — 9 — 9\n\n**Balance, January 28, 2023** 80 $ 1 $ 195 $ 1 $ 186 $ — $ 383 $ 18 $ 401\n\nNet Income ��� — — — 109 — 109 7 116\n\nOther Comprehensive Loss — — — (1) — — (1) (2) (3)\n\nTotal Comprehensive Income (Loss) — — — (1) 109 — 108 5 113\n\nRepurchases of Common Stock (3) — — — — (126) (126) — (126)\n\nTreasury Share Retirements — — (9) — (117) 126 — — —\n\nShare-based Compensation Expense — — 56 — — — 56 — 56\n\nTax Payments related to Share-based Awards (1) — (12) — — — (12) — (12)\n\nDistribution to Noncontrolling Interest — — — — — — — (2) (2)\n\nOther 2 — 8 — — — 8 — 8\n\n**Balance, February 3, 2024** 78 $ 1 $ 238 $ — $ 178 $ — $ 417 $ 21 $ 438\n\nNet Income — — — — 165 — 165 4 169\n\nOther Comprehensive Loss — — — (1) — — (1) (1) (2)\n\nTotal Comprehensive Income (Loss) — — — (1) 165 — 164 3 167\n\nShare-based Compensation Expense — — 60 — — — 60 — 60\n\nTax Payments related to Share-based Awards (1) — (10) — — — (10) — (10)\n\nOther 2 — 9 — — — 9 — 9\n\n**Balance, February 1, 2025** 79 $ 1 $ 297 $ (1) $ 343 $ — $ 640 $ 24 $ 664\n\nThe accompanying Notes are an integral part of these Consolidated Financial Statements.\n\n53"],"full_content":"Table of Contents\n\n**VICTORIA'S SECRET & CO.**\n\n**CONSOLIDATED STATEMENTS OF EQUITY**\n\n**(in millions)**\n\n**Common Stock**\n\n**Paid-in**\n\n**Capital**\n\n**Accumulated**\n\n**Other**\n\n**Comprehensive**\n\n**Income (Loss)**\n\n**Retained**\n\n**Earnings**\n\n**Treasury**\n\n**Stock**\n\n**Total**\n\n**Victoria's**\n\n**Secret & Co.**\n\n**Equity**\n\n**Noncontrolling**\n\n**Interest**\n\n**Total Equity**\n\n**Shares**\n\n**Outstanding**\n\n**Par**\n\n**Value**\n\n**Balance, January 29, 2022** 85 $ 1 $ 125 $ 5 $ 126 $ — $ 257 $ — $ 257\n\nNet Income (Loss) — — — — 348 — 348 (10) 338\n\nOther Comprehensive Loss — — — (4) — — (4) — (4)\n\nTotal Comprehensive Income (Loss) — — — (4) 348 — 344 (10) 334\n\nSale of Noncontrolling Interest — — 17 — — — 17 28 45\n\nRepurchases of Common Stock (6) — 50 — — (300) (250) — (250)\n\nTreasury Share Retirements — — (12) — (288) 300 — — —\n\nShare-based Compensation Expense — — 48 — — — 48 — 48\n\nTax Payments related to Share-based Awards (1) — (42) — — — (42) — (42)\n\nOther 2 — 9 — — — 9 — 9\n\n**Balance, January 28, 2023** 80 $ 1 $ 195 $ 1 $ 186 $ — $ 383 $ 18 $ 401\n\nNet Income — — — — 109 — 109 7 116\n\nOther Comprehensive Loss — — — (1) — — (1) (2) (3)\n\nTotal Comprehensive Income (Loss) — — — (1) 109 — 108 5 113\n\nRepurchases of Common Stock (3) — — — — (126) (126) — (126)\n\nTreasury Share Retirements — — (9) — (117) 126 — — —\n\nShare-based Compensation Expense — — 56 — — — 56 — 56\n\nTax Payments related to Share-based Awards (1) — (12) — — — (12) — (12)\n\nDistribution to Noncontrolling Interest — — — — — — — (2) (2)\n\nOther 2 — 8 — — — 8 — 8\n\n**Balance, February 3, 2024** 78 $ 1 $ 238 $ — $ 178 $ — $ 417 $ 21 $ 438\n\nNet Income — — — — 165 — 165 4 169\n\nOther Comprehensive Loss — — — (1) — — (1) (1) (2)\n\nTotal Comprehensive Income (Loss) — — — (1) 165 — 164 3 167\n\nShare-based Compensation Expense — — 60 — — — 60 — 60\n\nTax Payments related to Share-based Awards (1) — (10) — — — (10) — (10)\n\nOther 2 — 9 — — — 9 — 9\n\n**Balance, February 1, 2025** 79 $ 1 $ 297 $ (1) $ 343 $ — $ 640 $ 24 $ 664\n\nThe accompanying Notes are an integral part of these Consolidated Financial Statements.\n\n53","publish_date":null,"title":"VICTORIA'S SECRET & CO. CONSOLIDATED STATEMENTS OF EQUITY (in millions) The accompanying Notes are an integral part of these Consolidated","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page55.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page55.pdf"},"request":{"example_id":"table/Victoria Secret 10-k_page55","product_type":"parse","source_file_path":"Victoria Secret 10-k_page55.pdf"},"started_at":"2026-11-04T19:48:24.263402"} +{"completed_at":"2026-11-04T19:48:26.747179","latency_in_ms":1431,"output":{"example_id":"table/Victoria Secret 10-k_page72","grounded_pages":[],"layout_pages":[],"markdown":"Table of Contents\n\nOf the total gross unrecognized tax benefits, approximately $40 million, $35 million and $20 million at February 1, 2025, February 3, 2024, and January 28, 2023, respectively, represent the amount of unrecognized tax benefits that, if recognized, would favorably affect the effective income tax rate in future periods. These amounts are net of the offsetting tax effects from other tax jurisdictions.\n\nOf the total unrecognized tax benefits, it is reasonably possible that $32 million could change in the next 12 months due to audit settlement, expiration of statute of limitations or other resolution of uncertainties. Due to the uncertain and complex application of tax regulations, it is possible that the ultimate resolution of audits may result in amounts which could be different from this estimate. In such cases, the Company will record additional tax expense or tax benefit in the period in which such matters are effectively settled.\n\nThe Company recognizes interest and penalties related to unrecognized tax benefits as components of income tax expense. The Company recognized interest and penalties expense of $2 million in 2024, $2 million in 2023, and $1 million in 2022. The Company has accrued approximately $5 million for the payment of interest and penalties as of February 1, 2025, and $3 million as of February 3, 2024. Accrued interest and penalties are included within Other Long-term Liabilities on the Consolidated Balance Sheets.\n\nThe Company files income tax returns with the U.S. and various state, local, and non-U.S. jurisdictions. The Company participates in the Compliance Assurance Process (“CAP”) of the Internal Revenue Service. As part of CAP, tax years are examined on a contemporaneous basis. The Company is not subject to U.S. federal examination for years prior to fiscal year 2020. The Company is currently under examination, or may be subject to examination, by various state and local tax jurisdictions for fiscal year 2017 through 2023, and non-U.S. tax jurisdictions for fiscal year 2015 through 2023. In some situations, the Company determines that it does not have a filing requirement in a particular tax jurisdiction. Where no return has been filed, no statute of limitations applies. Accordingly, if a tax jurisdiction reaches a conclusion that a filing requirement does exist, additional years may be reviewed by the tax authority. The Company believes it has appropriately accounted for uncertainties related to this issue.\n\n**12\\. Long-term Debt and Borrowing Facilities**\n\nThe following table provides the Company’s outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts and any current portion, as of February 1, 2025 and February 3, 2024:\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**(in millions)**\n\n**Senior Secured Debt with Subsidiary Guarantee** $387 million Term Loan due August 2028 (“Term Loan Facility”) $ 382 $ 385\n\nAsset-based Revolving Credit Facility due August 2026 (“ABL Facility”) — 145\n\nTotal Senior Secured Debt with Subsidiary Guarantee 382 530\n\n**Senior Debt with Subsidiary Guarantee** $600 million, 4.625% Fixed Interest Rate Notes due July 2029 (“2029 Notes”) 595 594\n\nTotal Senior Debt with Subsidiary Guarantee 595 594\n\nTotal 977 1,124\n\nCurrent Debt (4) (4)\n\nTotal Long-term Debt, Net of Current Portion $ 973 $ 1,120\n\nThe following table provides principal payments due on outstanding debt in the next five fiscal years and the remaining years thereafter:\n\n**Fiscal Year (in millions)**\n\n2025 $ 4\n\n2026 4\n\n2027 4\n\n2028 375\n\n2029 600\n\nThereafter $ —\n\nCash paid for interest was $77 million, $87 million and $52 million in 2024, 2023 and 2022, respectively.\n\n70","pages":[{"line_numbers":[],"markdown":"Table of Contents\n\nOf the total gross unrecognized tax benefits, approximately $40 million, $35 million and $20 million at February 1, 2025, February 3, 2024, and January 28, 2023, respectively, represent the amount of unrecognized tax benefits that, if recognized, would favorably affect the effective income tax rate in future periods. These amounts are net of the offsetting tax effects from other tax jurisdictions.\n\nOf the total unrecognized tax benefits, it is reasonably possible that $32 million could change in the next 12 months due to audit settlement, expiration of statute of limitations or other resolution of uncertainties. Due to the uncertain and complex application of tax regulations, it is possible that the ultimate resolution of audits may result in amounts which could be different from this estimate. In such cases, the Company will record additional tax expense or tax benefit in the period in which such matters are effectively settled.\n\nThe Company recognizes interest and penalties related to unrecognized tax benefits as components of income tax expense. The Company recognized interest and penalties expense of $2 million in 2024, $2 million in 2023, and $1 million in 2022. The Company has accrued approximately $5 million for the payment of interest and penalties as of February 1, 2025, and $3 million as of February 3, 2024. Accrued interest and penalties are included within Other Long-term Liabilities on the Consolidated Balance Sheets.\n\nThe Company files income tax returns with the U.S. and various state, local, and non-U.S. jurisdictions. The Company participates in the Compliance Assurance Process (“CAP”) of the Internal Revenue Service. As part of CAP, tax years are examined on a contemporaneous basis. The Company is not subject to U.S. federal examination for years prior to fiscal year 2020. The Company is currently under examination, or may be subject to examination, by various state and local tax jurisdictions for fiscal year 2017 through 2023, and non-U.S. tax jurisdictions for fiscal year 2015 through 2023. In some situations, the Company determines that it does not have a filing requirement in a particular tax jurisdiction. Where no return has been filed, no statute of limitations applies. Accordingly, if a tax jurisdiction reaches a conclusion that a filing requirement does exist, additional years may be reviewed by the tax authority. The Company believes it has appropriately accounted for uncertainties related to this issue.\n\n**12\\. Long-term Debt and Borrowing Facilities**\n\nThe following table provides the Company’s outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts and any current portion, as of February 1, 2025 and February 3, 2024:\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**(in millions)**\n\n**Senior Secured Debt with Subsidiary Guarantee** $387 million Term Loan due August 2028 (“Term Loan Facility”) $ 382 $ 385\n\nAsset-based Revolving Credit Facility due August 2026 (“ABL Facility”) — 145\n\nTotal Senior Secured Debt with Subsidiary Guarantee 382 530\n\n**Senior Debt with Subsidiary Guarantee** $600 million, 4.625% Fixed Interest Rate Notes due July 2029 (“2029 Notes”) 595 594\n\nTotal Senior Debt with Subsidiary Guarantee 595 594\n\nTotal 977 1,124\n\nCurrent Debt (4) (4)\n\nTotal Long-term Debt, Net of Current Portion $ 973 $ 1,120\n\nThe following table provides principal payments due on outstanding debt in the next five fiscal years and the remaining years thereafter:\n\n**Fiscal Year (in millions)**\n\n2025 $ 4\n\n2026 4\n\n2027 4\n\n2028 375\n\n2029 600\n\nThereafter $ —\n\nCash paid for interest was $77 million, $87 million and $52 million in 2024, 2023 and 2022, respectively.\n\n70","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Table of Contents\n\nOf the total gross unrecognized tax benefits, approximately $40 million, $35 million and $20 million at February 1, 2025, February 3, 2024, and January 28, 2023, respectively, represent the amount of unrecognized tax benefits that, if recognized, would favorably affect the effective income tax rate in future periods. These amounts are net of the offsetting tax effects from other tax jurisdictions.\n\nOf the total unrecognized tax benefits, it is reasonably possible that $32 million could change in the next 12 months due to audit settlement, expiration of statute of limitations or other resolution of uncertainties. Due to the uncertain and complex application of tax regulations, it is possible that the ultimate resolution of audits may result in amounts which could be different from this estimate. In such cases, the Company will record additional tax expense or tax benefit in the period in which such matters are effectively settled.\n\nThe Company recognizes interest and penalties related to unrecognized tax benefits as components of income tax expense. The Company recognized interest and penalties expense of $2 million in 2024, $2 million in 2023, and $1 million in 2022. The Company has accrued approximately $5 million for the payment of interest and penalties as of February 1, 2025, and $3 million as of February 3, 2024. Accrued interest and penalties are included within Other Long-term Liabilities on the Consolidated Balance Sheets.\n\nThe Company files income tax returns with the U.S. and various state, local, and non-U.S. jurisdictions. The Company participates in the Compliance Assurance Process (“CAP”) of the Internal Revenue Service. As part of CAP, tax years are examined on a contemporaneous basis. The Company is not subject to U.S. federal examination for years prior to fiscal year 2020. The Company is currently under examination, or may be subject to examination, by various state and local tax jurisdictions for fiscal year 2017 through 2023, and non-U.S. tax jurisdictions for fiscal year 2015 through 2023. In some situations, the Company determines that it does not have a filing requirement in a particular tax jurisdiction. Where no return has been filed, no statute of limitations applies. Accordingly, if a tax jurisdiction reaches a conclusion that a filing requirement does exist, additional years may be reviewed by the tax authority. The Company believes it has appropriately accounted for uncertainties related to this issue.\n\n**12\\. Long-term Debt and Borrowing Facilities**\n\nThe following table provides the Company’s outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts and any current portion, as of February 1, 2025 and February 3, 2024:\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**(in millions)**\n\n**Senior Secured Debt with Subsidiary Guarantee** $387 million Term Loan due August 2028 (“Term Loan Facility”) $ 382 $ 385\n\nAsset-based Revolving Credit Facility due August 2026 (“ABL Facility”) — 145\n\nTotal Senior Secured Debt with Subsidiary Guarantee 382 530\n\n**Senior Debt with Subsidiary Guarantee** $600 million, 4.625% Fixed Interest Rate Notes due July 2029 (“2029 Notes”) 595 594\n\nTotal Senior Debt with Subsidiary Guarantee 595 594\n\nTotal 977 1,124\n\nCurrent Debt (4) (4)\n\nTotal Long-term Debt, Net of Current Portion $ 973 $ 1,120\n\nThe following table provides principal payments due on outstanding debt in the next five fiscal years and the remaining years thereafter:\n\n**Fiscal Year (in millions)**\n\n2025 $ 4\n\n2026 4\n\n2027 4\n\n2028 375\n\n2029 600\n\nThereafter $ —\n\nCash paid for interest was $77 million, $87 million and $52 million in 2024, 2023 and 2022, respectively.\n\n70","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page72.pdf"]},"response":{"errors":[],"extract_id":"extract_6452e0a4c513f4b68341168520dff9f6","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Table of Contents\n\nOf the total gross unrecognized tax benefits, approximately $40 million, $35 million and $20 million at February 1, 2025, February 3, 2024, and January 28, 2023, respectively, represent the amount of unrecognized tax benefits that, if recognized, would favorably affect the effective income tax rate in future periods. These amounts are net of the offsetting tax effects from other tax jurisdictions.\n\nOf the total unrecognized tax benefits, it is reasonably possible that $32 million could change in the next 12 months due to audit settlement, expiration of statute of limitations or other resolution of uncertainties. Due to the uncertain and complex application of tax regulations, it is possible that the ultimate resolution of audits may result in amounts which could be different from this estimate. In such cases, the Company will record additional tax expense or tax benefit in the period in which such matters are effectively settled.\n\nThe Company recognizes interest and penalties related to unrecognized tax benefits as components of income tax expense. The Company recognized interest and penalties expense of $2 million in 2024, $2 million in 2023, and $1 million in 2022. The Company has accrued approximately $5 million for the payment of interest and penalties as of February 1, 2025, and $3 million as of February 3, 2024. Accrued interest and penalties are included within Other Long-term Liabilities on the Consolidated Balance Sheets.\n\nThe Company files income tax returns with the U.S. and various state, local, and non-U.S. jurisdictions. The Company participates in the Compliance Assurance Process (“CAP”) of the Internal Revenue Service. As part of CAP, tax years are examined on a contemporaneous basis. The Company is not subject to U.S. federal examination for years prior to fiscal year 2020. The Company is currently under examination, or may be subject to examination, by various state and local tax jurisdictions for fiscal year 2017 through 2023, and non-U.S. tax jurisdictions for fiscal year 2015 through 2023. In some situations, the Company determines that it does not have a filing requirement in a particular tax jurisdiction. Where no return has been filed, no statute of limitations applies. Accordingly, if a tax jurisdiction reaches a conclusion that a filing requirement does exist, additional years may be reviewed by the tax authority. The Company believes it has appropriately accounted for uncertainties related to this issue.\n\n**12\\. Long-term Debt and Borrowing Facilities**\n\nThe following table provides the Company’s outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts and any current portion, as of February 1, 2025 and February 3, 2024:\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**(in millions)**\n\n**Senior Secured Debt with Subsidiary Guarantee** $387 million Term Loan due August 2028 (“Term Loan Facility”) $ 382 $ 385\n\nAsset-based Revolving Credit Facility due August 2026 (“ABL Facility”) — 145\n\nTotal Senior Secured Debt with Subsidiary Guarantee 382 530\n\n**Senior Debt with Subsidiary Guarantee** $600 million, 4.625% Fixed Interest Rate Notes due July 2029 (“2029 Notes”) 595 594\n\nTotal Senior Debt with Subsidiary Guarantee 595 594\n\nTotal 977 1,124\n\nCurrent Debt (4) (4)\n\nTotal Long-term Debt, Net of Current Portion $ 973 $ 1,120\n\nThe following table provides principal payments due on outstanding debt in the next five fiscal years and the remaining years thereafter:\n\n**Fiscal Year (in millions)**\n\n2025 $ 4\n\n2026 4\n\n2027 4\n\n2028 375\n\n2029 600\n\nThereafter $ —\n\nCash paid for interest was $77 million, $87 million and $52 million in 2024, 2023 and 2022, respectively.\n\n70"],"full_content":"Table of Contents\n\nOf the total gross unrecognized tax benefits, approximately $40 million, $35 million and $20 million at February 1, 2025, February 3, 2024, and January 28, 2023, respectively, represent the amount of unrecognized tax benefits that, if recognized, would favorably affect the effective income tax rate in future periods. These amounts are net of the offsetting tax effects from other tax jurisdictions.\n\nOf the total unrecognized tax benefits, it is reasonably possible that $32 million could change in the next 12 months due to audit settlement, expiration of statute of limitations or other resolution of uncertainties. Due to the uncertain and complex application of tax regulations, it is possible that the ultimate resolution of audits may result in amounts which could be different from this estimate. In such cases, the Company will record additional tax expense or tax benefit in the period in which such matters are effectively settled.\n\nThe Company recognizes interest and penalties related to unrecognized tax benefits as components of income tax expense. The Company recognized interest and penalties expense of $2 million in 2024, $2 million in 2023, and $1 million in 2022. The Company has accrued approximately $5 million for the payment of interest and penalties as of February 1, 2025, and $3 million as of February 3, 2024. Accrued interest and penalties are included within Other Long-term Liabilities on the Consolidated Balance Sheets.\n\nThe Company files income tax returns with the U.S. and various state, local, and non-U.S. jurisdictions. The Company participates in the Compliance Assurance Process (“CAP”) of the Internal Revenue Service. As part of CAP, tax years are examined on a contemporaneous basis. The Company is not subject to U.S. federal examination for years prior to fiscal year 2020. The Company is currently under examination, or may be subject to examination, by various state and local tax jurisdictions for fiscal year 2017 through 2023, and non-U.S. tax jurisdictions for fiscal year 2015 through 2023. In some situations, the Company determines that it does not have a filing requirement in a particular tax jurisdiction. Where no return has been filed, no statute of limitations applies. Accordingly, if a tax jurisdiction reaches a conclusion that a filing requirement does exist, additional years may be reviewed by the tax authority. The Company believes it has appropriately accounted for uncertainties related to this issue.\n\n**12\\. Long-term Debt and Borrowing Facilities**\n\nThe following table provides the Company’s outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts and any current portion, as of February 1, 2025 and February 3, 2024:\n\n**February 1,**\n\n**2025**\n\n**February 3,**\n\n**2024**\n\n**(in millions)**\n\n**Senior Secured Debt with Subsidiary Guarantee** $387 million Term Loan due August 2028 (“Term Loan Facility”) $ 382 $ 385\n\nAsset-based Revolving Credit Facility due August 2026 (“ABL Facility”) — 145\n\nTotal Senior Secured Debt with Subsidiary Guarantee 382 530\n\n**Senior Debt with Subsidiary Guarantee** $600 million, 4.625% Fixed Interest Rate Notes due July 2029 (“2029 Notes”) 595 594\n\nTotal Senior Debt with Subsidiary Guarantee 595 594\n\nTotal 977 1,124\n\nCurrent Debt (4) (4)\n\nTotal Long-term Debt, Net of Current Portion $ 973 $ 1,120\n\nThe following table provides principal payments due on outstanding debt in the next five fiscal years and the remaining years thereafter:\n\n**Fiscal Year (in millions)**\n\n2025 $ 4\n\n2026 4\n\n2027 4\n\n2028 375\n\n2029 600\n\nThereafter $ —\n\nCash paid for interest was $77 million, $87 million and $52 million in 2024, 2023 and 2022, respectively.\n\n70","publish_date":null,"title":"Of the total gross unrecognized tax benefits, approximately $40 million, $35 million and $20 million at February 1, 2025, February","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page72.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/Victoria%20Secret%2010-k_page72.pdf"},"request":{"example_id":"table/Victoria Secret 10-k_page72","product_type":"parse","source_file_path":"Victoria Secret 10-k_page72.pdf"},"started_at":"2026-11-04T19:48:25.315540"} +{"completed_at":"2026-11-04T19:48:28.076625","latency_in_ms":1225,"output":{"example_id":"table/WU.2015.page_161.pdf_68095_page1","grounded_pages":[],"layout_pages":[],"markdown":"59\n\n**Results of Operations**\n\nThe following discussion of our consolidated results of operations and segment results refers to the year ended December 31, 2015 compared to the same period in 2014 and the year ended December 31, 2014 compared to the same period in 2013. The results of operations should be read in conjunction with the discussion of our segment results of operations, which provide more detailed discussions concerning certain components of the Consolidated Statements of Income. All significant intercompany accounts and transactions between our segments have been eliminated and the below information has been prepared in conformity with generally accepted accounting principles in the United States of America (\"GAAP\").\n\nOur operating income for the year ended December 31, 2015 was negatively impacted by $35.3 million of expenses recorded in the second quarter of 2015 for a settlement agreement between the Consumer Financial Protection Bureau (the \"CFPB\") and one of our subsidiaries, Paymap, Inc., which operates solely in the United States, related to restitution, penalties, and other costs (the \"Paymap Settlement Agreement\"). These charges are reflected within \"Selling, general and administrative\" expenses in our Consolidated Statements of Income and have been recognized within our Consumer-to-Business operating segment.\n\nThe following table sets forth our consolidated results of operations for the years ended December 31, 2015, 2014 and 2013.\n\n**% Change Year Ended December 31, 2015 2014**\n\n**(in millions, except per share amounts) 2015 2014 2013 vs. 2014 vs. 2013** Revenues: Transaction fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,915.6 $ 4,083.6 $ 4,065.8 (4)% 0 % Foreign exchange revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,436.2 1,386.3 1,348.0 4 % 3 % Other revenues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131.9 137.3 128.2 (4)% 7 % Total revenues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,483.7 5,607.2 5,542.0 (2)% 1 % Expenses: Cost of services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,199.4 3,297.4 3,235.0 (3)% 2 % Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . 1,174.9 1,169.3 1,199.6 0 % (3)% Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,374.3 4,466.7 4,434.6 (2)% 1 % Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,109.4 1,140.5 1,107.4 (3)% 3 % Other income/(expense): Interest income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.9 11.5 9.4 (5)% 22 % Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (167.9) (176.6) (195.6) (5)% (10)% Derivative gains/(losses), net. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.2 (2.2) (1.3) (a) (a) Other income/(expense), net . . . . . . . . . . . . . . . . . . . . . . . . . . . . (11.8) (5.0) 7.0 (a) (a) Total other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (167.6) (172.3) (180.5) (3)% (5)% Income before income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 941.8 968.2 926.9 (3)% 4 % Provision for income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104.0 115.8 128.5 (10)% (10)% Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 837.8 $ 852.4 $ 798.4 (2)% 7 % Earnings per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1.63 $ 1.60 $ 1.43 2 % 12 % Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1.62 $ 1.59 $ 1.43 2 % 11 % Weighted-average shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 512.6 533.4 556.6 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 516.7 536.8 559.7\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(a) Calculation not meaningful\n\n## **201 5 FORM 10 K -**","pages":[{"line_numbers":[],"markdown":"59\n\n**Results of Operations**\n\nThe following discussion of our consolidated results of operations and segment results refers to the year ended December 31, 2015 compared to the same period in 2014 and the year ended December 31, 2014 compared to the same period in 2013. The results of operations should be read in conjunction with the discussion of our segment results of operations, which provide more detailed discussions concerning certain components of the Consolidated Statements of Income. All significant intercompany accounts and transactions between our segments have been eliminated and the below information has been prepared in conformity with generally accepted accounting principles in the United States of America (\"GAAP\").\n\nOur operating income for the year ended December 31, 2015 was negatively impacted by $35.3 million of expenses recorded in the second quarter of 2015 for a settlement agreement between the Consumer Financial Protection Bureau (the \"CFPB\") and one of our subsidiaries, Paymap, Inc., which operates solely in the United States, related to restitution, penalties, and other costs (the \"Paymap Settlement Agreement\"). These charges are reflected within \"Selling, general and administrative\" expenses in our Consolidated Statements of Income and have been recognized within our Consumer-to-Business operating segment.\n\nThe following table sets forth our consolidated results of operations for the years ended December 31, 2015, 2014 and 2013.\n\n**% Change Year Ended December 31, 2015 2014**\n\n**(in millions, except per share amounts) 2015 2014 2013 vs. 2014 vs. 2013** Revenues: Transaction fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,915.6 $ 4,083.6 $ 4,065.8 (4)% 0 % Foreign exchange revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,436.2 1,386.3 1,348.0 4 % 3 % Other revenues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131.9 137.3 128.2 (4)% 7 % Total revenues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,483.7 5,607.2 5,542.0 (2)% 1 % Expenses: Cost of services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,199.4 3,297.4 3,235.0 (3)% 2 % Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . 1,174.9 1,169.3 1,199.6 0 % (3)% Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,374.3 4,466.7 4,434.6 (2)% 1 % Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,109.4 1,140.5 1,107.4 (3)% 3 % Other income/(expense): Interest income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.9 11.5 9.4 (5)% 22 % Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (167.9) (176.6) (195.6) (5)% (10)% Derivative gains/(losses), net. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.2 (2.2) (1.3) (a) (a) Other income/(expense), net . . . . . . . . . . . . . . . . . . . . . . . . . . . . (11.8) (5.0) 7.0 (a) (a) Total other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (167.6) (172.3) (180.5) (3)% (5)% Income before income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 941.8 968.2 926.9 (3)% 4 % Provision for income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104.0 115.8 128.5 (10)% (10)% Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 837.8 $ 852.4 $ 798.4 (2)% 7 % Earnings per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1.63 $ 1.60 $ 1.43 2 % 12 % Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1.62 $ 1.59 $ 1.43 2 % 11 % Weighted-average shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 512.6 533.4 556.6 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 516.7 536.8 559.7\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(a) Calculation not meaningful\n\n## **201 5 FORM 10 K -**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"59\n\n**Results of Operations**\n\nThe following discussion of our consolidated results of operations and segment results refers to the year ended December 31, 2015 compared to the same period in 2014 and the year ended December 31, 2014 compared to the same period in 2013. The results of operations should be read in conjunction with the discussion of our segment results of operations, which provide more detailed discussions concerning certain components of the Consolidated Statements of Income. All significant intercompany accounts and transactions between our segments have been eliminated and the below information has been prepared in conformity with generally accepted accounting principles in the United States of America (\"GAAP\").\n\nOur operating income for the year ended December 31, 2015 was negatively impacted by $35.3 million of expenses recorded in the second quarter of 2015 for a settlement agreement between the Consumer Financial Protection Bureau (the \"CFPB\") and one of our subsidiaries, Paymap, Inc., which operates solely in the United States, related to restitution, penalties, and other costs (the \"Paymap Settlement Agreement\"). These charges are reflected within \"Selling, general and administrative\" expenses in our Consolidated Statements of Income and have been recognized within our Consumer-to-Business operating segment.\n\nThe following table sets forth our consolidated results of operations for the years ended December 31, 2015, 2014 and 2013.\n\n**% Change Year Ended December 31, 2015 2014**\n\n**(in millions, except per share amounts) 2015 2014 2013 vs. 2014 vs. 2013** Revenues: Transaction fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,915.6 $ 4,083.6 $ 4,065.8 (4)% 0 % Foreign exchange revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,436.2 1,386.3 1,348.0 4 % 3 % Other revenues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131.9 137.3 128.2 (4)% 7 % Total revenues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,483.7 5,607.2 5,542.0 (2)% 1 % Expenses: Cost of services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,199.4 3,297.4 3,235.0 (3)% 2 % Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . 1,174.9 1,169.3 1,199.6 0 % (3)% Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,374.3 4,466.7 4,434.6 (2)% 1 % Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,109.4 1,140.5 1,107.4 (3)% 3 % Other income/(expense): Interest income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.9 11.5 9.4 (5)% 22 % Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (167.9) (176.6) (195.6) (5)% (10)% Derivative gains/(losses), net. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.2 (2.2) (1.3) (a) (a) Other income/(expense), net . . . . . . . . . . . . . . . . . . . . . . . . . . . . (11.8) (5.0) 7.0 (a) (a) Total other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (167.6) (172.3) (180.5) (3)% (5)% Income before income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 941.8 968.2 926.9 (3)% 4 % Provision for income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104.0 115.8 128.5 (10)% (10)% Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 837.8 $ 852.4 $ 798.4 (2)% 7 % Earnings per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1.63 $ 1.60 $ 1.43 2 % 12 % Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1.62 $ 1.59 $ 1.43 2 % 11 % Weighted-average shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 512.6 533.4 556.6 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 516.7 536.8 559.7\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(a) Calculation not meaningful\n\n## **201 5 FORM 10 K -**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/WU.2015.page_161.pdf_68095_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_4c33e729998792672f7fd6d25830a190","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["59\n\n**Results of Operations**\n\nThe following discussion of our consolidated results of operations and segment results refers to the year ended December 31, 2015 compared to the same period in 2014 and the year ended December 31, 2014 compared to the same period in 2013. The results of operations should be read in conjunction with the discussion of our segment results of operations, which provide more detailed discussions concerning certain components of the Consolidated Statements of Income. All significant intercompany accounts and transactions between our segments have been eliminated and the below information has been prepared in conformity with generally accepted accounting principles in the United States of America (\"GAAP\").\n\nOur operating income for the year ended December 31, 2015 was negatively impacted by $35.3 million of expenses recorded in the second quarter of 2015 for a settlement agreement between the Consumer Financial Protection Bureau (the \"CFPB\") and one of our subsidiaries, Paymap, Inc., which operates solely in the United States, related to restitution, penalties, and other costs (the \"Paymap Settlement Agreement\"). These charges are reflected within \"Selling, general and administrative\" expenses in our Consolidated Statements of Income and have been recognized within our Consumer-to-Business operating segment.\n\nThe following table sets forth our consolidated results of operations for the years ended December 31, 2015, 2014 and 2013.\n\n**% Change Year Ended December 31, 2015 2014**\n\n**(in millions, except per share amounts) 2015 2014 2013 vs. 2014 vs. 2013** Revenues: Transaction fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,915.6 $ 4,083.6 $ 4,065.8 (4)% 0 % Foreign exchange revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,436.2 1,386.3 1,348.0 4 % 3 % Other revenues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131.9 137.3 128.2 (4)% 7 % Total revenues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,483.7 5,607.2 5,542.0 (2)% 1 % Expenses: Cost of services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,199.4 3,297.4 3,235.0 (3)% 2 % Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . 1,174.9 1,169.3 1,199.6 0 % (3)% Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,374.3 4,466.7 4,434.6 (2)% 1 % Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,109.4 1,140.5 1,107.4 (3)% 3 % Other income/(expense): Interest income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.9 11.5 9.4 (5)% 22 % Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (167.9) (176.6) (195.6) (5)% (10)% Derivative gains/(losses), net. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.2 (2.2) (1.3) (a) (a) Other income/(expense), net . . . . . . . . . . . . . . . . . . . . . . . . . . . . (11.8) (5.0) 7.0 (a) (a) Total other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (167.6) (172.3) (180.5) (3)% (5)% Income before income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 941.8 968.2 926.9 (3)% 4 % Provision for income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104.0 115.8 128.5 (10)% (10)% Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 837.8 $ 852.4 $ 798.4 (2)% 7 % Earnings per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1.63 $ 1.60 $ 1.43 2 % 12 % Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1.62 $ 1.59 $ 1.43 2 % 11 % Weighted-average shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 512.6 533.4 556.6 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 516.7 536.8 559.7\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(a) Calculation not meaningful\n\n## **201 5 FORM 10 K -**"],"full_content":"59\n\n**Results of Operations**\n\nThe following discussion of our consolidated results of operations and segment results refers to the year ended December 31, 2015 compared to the same period in 2014 and the year ended December 31, 2014 compared to the same period in 2013. The results of operations should be read in conjunction with the discussion of our segment results of operations, which provide more detailed discussions concerning certain components of the Consolidated Statements of Income. All significant intercompany accounts and transactions between our segments have been eliminated and the below information has been prepared in conformity with generally accepted accounting principles in the United States of America (\"GAAP\").\n\nOur operating income for the year ended December 31, 2015 was negatively impacted by $35.3 million of expenses recorded in the second quarter of 2015 for a settlement agreement between the Consumer Financial Protection Bureau (the \"CFPB\") and one of our subsidiaries, Paymap, Inc., which operates solely in the United States, related to restitution, penalties, and other costs (the \"Paymap Settlement Agreement\"). These charges are reflected within \"Selling, general and administrative\" expenses in our Consolidated Statements of Income and have been recognized within our Consumer-to-Business operating segment.\n\nThe following table sets forth our consolidated results of operations for the years ended December 31, 2015, 2014 and 2013.\n\n**% Change Year Ended December 31, 2015 2014**\n\n**(in millions, except per share amounts) 2015 2014 2013 vs. 2014 vs. 2013** Revenues: Transaction fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 3,915.6 $ 4,083.6 $ 4,065.8 (4)% 0 % Foreign exchange revenues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,436.2 1,386.3 1,348.0 4 % 3 % Other revenues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131.9 137.3 128.2 (4)% 7 % Total revenues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,483.7 5,607.2 5,542.0 (2)% 1 % Expenses: Cost of services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,199.4 3,297.4 3,235.0 (3)% 2 % Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . 1,174.9 1,169.3 1,199.6 0 % (3)% Total expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,374.3 4,466.7 4,434.6 (2)% 1 % Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,109.4 1,140.5 1,107.4 (3)% 3 % Other income/(expense): Interest income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.9 11.5 9.4 (5)% 22 % Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (167.9) (176.6) (195.6) (5)% (10)% Derivative gains/(losses), net. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.2 (2.2) (1.3) (a) (a) Other income/(expense), net . . . . . . . . . . . . . . . . . . . . . . . . . . . . (11.8) (5.0) 7.0 (a) (a) Total other expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (167.6) (172.3) (180.5) (3)% (5)% Income before income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 941.8 968.2 926.9 (3)% 4 % Provision for income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104.0 115.8 128.5 (10)% (10)% Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 837.8 $ 852.4 $ 798.4 (2)% 7 % Earnings per share: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1.63 $ 1.60 $ 1.43 2 % 12 % Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1.62 $ 1.59 $ 1.43 2 % 11 % Weighted-average shares outstanding: Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 512.6 533.4 556.6 Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 516.7 536.8 559.7\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\n(a) Calculation not meaningful\n\n## **201 5 FORM 10 K -**","publish_date":null,"title":"M","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/WU.2015.page_161.pdf_68095_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/WU.2015.page_161.pdf_68095_page1.pdf"},"request":{"example_id":"table/WU.2015.page_161.pdf_68095_page1","product_type":"parse","source_file_path":"WU.2015.page_161.pdf_68095_page1.pdf"},"started_at":"2026-11-04T19:48:26.850918"} +{"completed_at":"2026-11-04T19:48:30.224031","latency_in_ms":2245,"output":{"example_id":"table/axa_urd2024_accessible_va_page21","grounded_pages":[],"layout_pages":[],"markdown":"1\\.5 Ratings\n\n## **1\\.5** **Ratings**\n\nThe Group is rated by recognized rating agencies which assess the financial strength and the creditworthiness of the Company and certain of its insurance subsidiaries. The ratings set forth below are subject to revision or withdrawal at any time by the assigning rating agency in its sole discretion. Credit ratings are intended to reflect the ability of AXA to meet its payment obligations and may not reflect the potential impact of all risks on the value of AXA’s securities. A rating is not a recommendation to buy, sell or hold securities. None of these ratings should be construed as an indication or forecast of the\n\nhistorical or potential performance of AXA’s securities nor should any such rating be relied upon for the purpose of making an investment decision with respect to any of the Company’s securities. The Company does not undertake to maintain its ratings, nor publish press releases relating specifically to its ratings, and in no event shall the Company be responsible for the accuracy or reliability of any of the ratings set forth below. The significance and the meaning of individual ratings vary from agency to agency.\n\n## 1\\.5.1 Insurer financial strength and counterparty credit ratings\n\nAt the date of this Document, the relevant ratings for the Company and its principal insurance subsidiaries were as follows:\n\n# **1**\n\n**The AXA Group**\n\n**Insurer financial strength ratings** **AXA's credit ratings**\n\n**Agency** **Date of last review** **AXA SA**\n\n**AXA’s principal insurance subsidiaries** **Outlook**\n\n**Senior debt of the Company**\n\n**Short** ‑ **term debt of the Company**\n\n‑\n\n**S&P Global Ratings** February 25, 2025 A+ AA- Positive A+ A‑1+\n\n**Moody’s Investors Service** October 18, 2024 Aa3 Aa3 Positive A1 P‑1\n\n**A.M. Best Rating Services** October 2, 2024 A+ Superior - Stable aa- Superior -\n\n**AXA** **|** **Universal Registration Document 2024** 20","pages":[{"line_numbers":[],"markdown":"1\\.5 Ratings\n\n## **1\\.5** **Ratings**\n\nThe Group is rated by recognized rating agencies which assess the financial strength and the creditworthiness of the Company and certain of its insurance subsidiaries. The ratings set forth below are subject to revision or withdrawal at any time by the assigning rating agency in its sole discretion. Credit ratings are intended to reflect the ability of AXA to meet its payment obligations and may not reflect the potential impact of all risks on the value of AXA’s securities. A rating is not a recommendation to buy, sell or hold securities. None of these ratings should be construed as an indication or forecast of the\n\nhistorical or potential performance of AXA’s securities nor should any such rating be relied upon for the purpose of making an investment decision with respect to any of the Company’s securities. The Company does not undertake to maintain its ratings, nor publish press releases relating specifically to its ratings, and in no event shall the Company be responsible for the accuracy or reliability of any of the ratings set forth below. The significance and the meaning of individual ratings vary from agency to agency.\n\n## 1\\.5.1 Insurer financial strength and counterparty credit ratings\n\nAt the date of this Document, the relevant ratings for the Company and its principal insurance subsidiaries were as follows:\n\n# **1**\n\n**The AXA Group**\n\n**Insurer financial strength ratings** **AXA's credit ratings**\n\n**Agency** **Date of last review** **AXA SA**\n\n**AXA’s principal insurance subsidiaries** **Outlook**\n\n**Senior debt of the Company**\n\n**Short** ‑ **term debt of the Company**\n\n‑\n\n**S&P Global Ratings** February 25, 2025 A+ AA- Positive A+ A‑1+\n\n**Moody’s Investors Service** October 18, 2024 Aa3 Aa3 Positive A1 P‑1\n\n**A.M. Best Rating Services** October 2, 2024 A+ Superior - Stable aa- Superior -\n\n**AXA** **|** **Universal Registration Document 2024** 20","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"1\\.5 Ratings\n\n## **1\\.5** **Ratings**\n\nThe Group is rated by recognized rating agencies which assess the financial strength and the creditworthiness of the Company and certain of its insurance subsidiaries. The ratings set forth below are subject to revision or withdrawal at any time by the assigning rating agency in its sole discretion. Credit ratings are intended to reflect the ability of AXA to meet its payment obligations and may not reflect the potential impact of all risks on the value of AXA’s securities. A rating is not a recommendation to buy, sell or hold securities. None of these ratings should be construed as an indication or forecast of the\n\nhistorical or potential performance of AXA’s securities nor should any such rating be relied upon for the purpose of making an investment decision with respect to any of the Company’s securities. The Company does not undertake to maintain its ratings, nor publish press releases relating specifically to its ratings, and in no event shall the Company be responsible for the accuracy or reliability of any of the ratings set forth below. The significance and the meaning of individual ratings vary from agency to agency.\n\n## 1\\.5.1 Insurer financial strength and counterparty credit ratings\n\nAt the date of this Document, the relevant ratings for the Company and its principal insurance subsidiaries were as follows:\n\n# **1**\n\n**The AXA Group**\n\n**Insurer financial strength ratings** **AXA's credit ratings**\n\n**Agency** **Date of last review** **AXA SA**\n\n**AXA’s principal insurance subsidiaries** **Outlook**\n\n**Senior debt of the Company**\n\n**Short** ‑ **term debt of the Company**\n\n‑\n\n**S&P Global Ratings** February 25, 2025 A+ AA- Positive A+ A‑1+\n\n**Moody’s Investors Service** October 18, 2024 Aa3 Aa3 Positive A1 P‑1\n\n**A.M. Best Rating Services** October 2, 2024 A+ Superior - Stable aa- Superior -\n\n**AXA** **|** **Universal Registration Document 2024** 20","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/axa_urd2024_accessible_va_page21.pdf"]},"response":{"errors":[],"extract_id":"extract_650b92dbd01a433d878349fec86858b0","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["1\\.5 Ratings\n\n## **1\\.5** **Ratings**\n\nThe Group is rated by recognized rating agencies which assess the financial strength and the creditworthiness of the Company and certain of its insurance subsidiaries. The ratings set forth below are subject to revision or withdrawal at any time by the assigning rating agency in its sole discretion. Credit ratings are intended to reflect the ability of AXA to meet its payment obligations and may not reflect the potential impact of all risks on the value of AXA’s securities. A rating is not a recommendation to buy, sell or hold securities. None of these ratings should be construed as an indication or forecast of the\n\nhistorical or potential performance of AXA’s securities nor should any such rating be relied upon for the purpose of making an investment decision with respect to any of the Company’s securities. The Company does not undertake to maintain its ratings, nor publish press releases relating specifically to its ratings, and in no event shall the Company be responsible for the accuracy or reliability of any of the ratings set forth below. The significance and the meaning of individual ratings vary from agency to agency.\n\n## 1\\.5.1 Insurer financial strength and counterparty credit ratings\n\nAt the date of this Document, the relevant ratings for the Company and its principal insurance subsidiaries were as follows:\n\n# **1**\n\n**The AXA Group**\n\n**Insurer financial strength ratings** **AXA's credit ratings**\n\n**Agency** **Date of last review** **AXA SA**\n\n**AXA’s principal insurance subsidiaries** **Outlook**\n\n**Senior debt of the Company**\n\n**Short** ‑ **term debt of the Company**\n\n‑\n\n**S&P Global Ratings** February 25, 2025 A+ AA- Positive A+ A‑1+\n\n**Moody’s Investors Service** October 18, 2024 Aa3 Aa3 Positive A1 P‑1\n\n**A.M. Best Rating Services** October 2, 2024 A+ Superior - Stable aa- Superior -\n\n**AXA** **|** **Universal Registration Document 2024** 20"],"full_content":"1\\.5 Ratings\n\n## **1\\.5** **Ratings**\n\nThe Group is rated by recognized rating agencies which assess the financial strength and the creditworthiness of the Company and certain of its insurance subsidiaries. The ratings set forth below are subject to revision or withdrawal at any time by the assigning rating agency in its sole discretion. Credit ratings are intended to reflect the ability of AXA to meet its payment obligations and may not reflect the potential impact of all risks on the value of AXA’s securities. A rating is not a recommendation to buy, sell or hold securities. None of these ratings should be construed as an indication or forecast of the\n\nhistorical or potential performance of AXA’s securities nor should any such rating be relied upon for the purpose of making an investment decision with respect to any of the Company’s securities. The Company does not undertake to maintain its ratings, nor publish press releases relating specifically to its ratings, and in no event shall the Company be responsible for the accuracy or reliability of any of the ratings set forth below. The significance and the meaning of individual ratings vary from agency to agency.\n\n## 1\\.5.1 Insurer financial strength and counterparty credit ratings\n\nAt the date of this Document, the relevant ratings for the Company and its principal insurance subsidiaries were as follows:\n\n# **1**\n\n**The AXA Group**\n\n**Insurer financial strength ratings** **AXA's credit ratings**\n\n**Agency** **Date of last review** **AXA SA**\n\n**AXA’s principal insurance subsidiaries** **Outlook**\n\n**Senior debt of the Company**\n\n**Short** ‑ **term debt of the Company**\n\n‑\n\n**S&P Global Ratings** February 25, 2025 A+ AA- Positive A+ A‑1+\n\n**Moody’s Investors Service** October 18, 2024 Aa3 Aa3 Positive A1 P‑1\n\n**A.M. Best Rating Services** October 2, 2024 A+ Superior - Stable aa- Superior -\n\n**AXA** **|** **Universal Registration Document 2024** 20","publish_date":null,"title":"1","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/axa_urd2024_accessible_va_page21.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/axa_urd2024_accessible_va_page21.pdf"},"request":{"example_id":"table/axa_urd2024_accessible_va_page21","product_type":"parse","source_file_path":"axa_urd2024_accessible_va_page21.pdf"},"started_at":"2026-11-04T19:48:27.978705"} +{"completed_at":"2026-11-04T19:48:31.072005","latency_in_ms":2058,"output":{"example_id":"table/blackrock-funds-i-icav-annual-report-2022_page13","grounded_pages":[],"layout_pages":[],"markdown":"11\n\n### **BLACKROCK FUNDS I ICAV**\n\n**INVESTMENT MANAGER’S REPORT (continued)**\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return relative to the performance measure:\n\n**Largest contributors Largest detractors**\n\n**Country** **Effect on**\n\n**Fund return**\n\n**Country** **Effect on**\n\n**Fund return**\n\nOffshore China Ø 0\\.55% India Ø (1.08%)\n\nMalaysia \\# 0\\.51% Taiwan \\# (0.67%)\n\nPoland Ø 0\\.34% United Arab Emirates Ø (0.45%)\n\nBrazil \\# 0\\.31% Russia Ø (0.45%)\n\nSouth Africa \\# 0\\.28% Qatar Ø (0.42%)\n\n_\\# Overweight position - held more exposure than the performance measure. Ø Underweight position - held less exposure than the performance measure._\n\nMost of the underperformance was generated in underweight positions in India in energy and materials sectors. Overweight in Taiwan in the financial sector has also contributed to losses.\n\nThe following table details the significant active positions, where the Fund is overweight (holds more exposure than the performance measure) and underweight (holds less exposure than the performance measure), as at 30 April 2022 and 30 April 2021:\n\n**Largest overweight position**\n\n**30 April 2022 30 April 2021**\n\n**Country Weighting Country Weighting**\n\nTaiwan 2.01% Taiwan 1.52%\n\nSouth Africa 1.79% South Africa 1.29%\n\nChina 0.93% Brazil 1.11%\n\n**Largest underweight position**\n\n**30 April 2022 30 April 2021**\n\n**Country Weighting Country Weighting**\n\nQatar (1.06%) India (1.58%)\n\nBrazil (1.03%) Qatar (0.68%)\n\nOffshore China (1.03%) Indonesia (0.63%)\n\nLeadership in the country positions has changed over the period. Main move was to overweight China and underweight Offshore Chinese companies due to the increased activism risk by Chinese government. Elsewhere, there has been a small reshuffle in the underweight positions across countries, with the larger underweight in Qatar that is mostly concentrated around the financials.\n\n**BlackRock Advantage Europe Equity Fund** Over the financial year to 30 April 2022, the Fund’s active return was 2.81%, outperforming its performance measure (active return is the difference between the Fund's return and the performance measure return).\n\nThe Fund outperformed its performance measure over the period greatly supported by the significant gains achieved in 2021. Sentiment insights such as analyst revisions that predict companies’ future earnings were key driver of the significant outperformance. Also, insights that identify companies with more sustainable behaviour and activities were additive at the beginning of the period. However, the onset of the war in Ukraine has brought in considerable uncertainty, triggering an unprecedented chain of events from rising energy prices, supply chain pressures as well as the exit of many European companies from Russia. The performance has been affected across most areas in the Fund’s investment approach. Traditional valuation measures that look at the earnings and future profitability of companies was one of the few measures that still contributed to the returns. However, previously successful sentiment and top-down macro views have struggled. In addition, the insights that identify companies with more sustainable behaviour were challenged as they exhibited negative correlation to rising energy prices.\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return relative to the performance measure:\n\n**Largest contributors Largest detractors**\n\n**Country** **Effect on**\n\n**Fund return**\n\n**Country** **Effect on**\n\n**Fund return**\n\nGermany Ø 1\\.30% Switzerland Ø (0.25%)\n\nSweden \\# 0\\.53% France \\# (0.18%)\n\nGreat Britan Ø 0\\.43% Austria \\# (0.11%)\n\nNetherlands \\# 0\\.42% Belgium Ø (0.09%)\n\nItaly Ø 0\\.32% Finland \\# (0.07%)\n\n_\\# Overweight position - held more exposure than the performance measure. Ø Underweight position - held less exposure than the performance measure._\n\n**Fund performance review and activity (continued)**\n\n**BlackRock Advantage Emerging Markets Equity Fund (continued)**","pages":[{"line_numbers":[],"markdown":"11\n\n### **BLACKROCK FUNDS I ICAV**\n\n**INVESTMENT MANAGER’S REPORT (continued)**\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return relative to the performance measure:\n\n**Largest contributors Largest detractors**\n\n**Country** **Effect on**\n\n**Fund return**\n\n**Country** **Effect on**\n\n**Fund return**\n\nOffshore China Ø 0\\.55% India Ø (1.08%)\n\nMalaysia \\# 0\\.51% Taiwan \\# (0.67%)\n\nPoland Ø 0\\.34% United Arab Emirates Ø (0.45%)\n\nBrazil \\# 0\\.31% Russia Ø (0.45%)\n\nSouth Africa \\# 0\\.28% Qatar Ø (0.42%)\n\n_\\# Overweight position - held more exposure than the performance measure. Ø Underweight position - held less exposure than the performance measure._\n\nMost of the underperformance was generated in underweight positions in India in energy and materials sectors. Overweight in Taiwan in the financial sector has also contributed to losses.\n\nThe following table details the significant active positions, where the Fund is overweight (holds more exposure than the performance measure) and underweight (holds less exposure than the performance measure), as at 30 April 2022 and 30 April 2021:\n\n**Largest overweight position**\n\n**30 April 2022 30 April 2021**\n\n**Country Weighting Country Weighting**\n\nTaiwan 2.01% Taiwan 1.52%\n\nSouth Africa 1.79% South Africa 1.29%\n\nChina 0.93% Brazil 1.11%\n\n**Largest underweight position**\n\n**30 April 2022 30 April 2021**\n\n**Country Weighting Country Weighting**\n\nQatar (1.06%) India (1.58%)\n\nBrazil (1.03%) Qatar (0.68%)\n\nOffshore China (1.03%) Indonesia (0.63%)\n\nLeadership in the country positions has changed over the period. Main move was to overweight China and underweight Offshore Chinese companies due to the increased activism risk by Chinese government. Elsewhere, there has been a small reshuffle in the underweight positions across countries, with the larger underweight in Qatar that is mostly concentrated around the financials.\n\n**BlackRock Advantage Europe Equity Fund** Over the financial year to 30 April 2022, the Fund’s active return was 2.81%, outperforming its performance measure (active return is the difference between the Fund's return and the performance measure return).\n\nThe Fund outperformed its performance measure over the period greatly supported by the significant gains achieved in 2021. Sentiment insights such as analyst revisions that predict companies’ future earnings were key driver of the significant outperformance. Also, insights that identify companies with more sustainable behaviour and activities were additive at the beginning of the period. However, the onset of the war in Ukraine has brought in considerable uncertainty, triggering an unprecedented chain of events from rising energy prices, supply chain pressures as well as the exit of many European companies from Russia. The performance has been affected across most areas in the Fund’s investment approach. Traditional valuation measures that look at the earnings and future profitability of companies was one of the few measures that still contributed to the returns. However, previously successful sentiment and top-down macro views have struggled. In addition, the insights that identify companies with more sustainable behaviour were challenged as they exhibited negative correlation to rising energy prices.\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return relative to the performance measure:\n\n**Largest contributors Largest detractors**\n\n**Country** **Effect on**\n\n**Fund return**\n\n**Country** **Effect on**\n\n**Fund return**\n\nGermany Ø 1\\.30% Switzerland Ø (0.25%)\n\nSweden \\# 0\\.53% France \\# (0.18%)\n\nGreat Britan Ø 0\\.43% Austria \\# (0.11%)\n\nNetherlands \\# 0\\.42% Belgium Ø (0.09%)\n\nItaly Ø 0\\.32% Finland \\# (0.07%)\n\n_\\# Overweight position - held more exposure than the performance measure. Ø Underweight position - held less exposure than the performance measure._\n\n**Fund performance review and activity (continued)**\n\n**BlackRock Advantage Emerging Markets Equity Fund (continued)**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"11\n\n### **BLACKROCK FUNDS I ICAV**\n\n**INVESTMENT MANAGER’S REPORT (continued)**\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return relative to the performance measure:\n\n**Largest contributors Largest detractors**\n\n**Country** **Effect on**\n\n**Fund return**\n\n**Country** **Effect on**\n\n**Fund return**\n\nOffshore China Ø 0\\.55% India Ø (1.08%)\n\nMalaysia \\# 0\\.51% Taiwan \\# (0.67%)\n\nPoland Ø 0\\.34% United Arab Emirates Ø (0.45%)\n\nBrazil \\# 0\\.31% Russia Ø (0.45%)\n\nSouth Africa \\# 0\\.28% Qatar Ø (0.42%)\n\n_\\# Overweight position - held more exposure than the performance measure. Ø Underweight position - held less exposure than the performance measure._\n\nMost of the underperformance was generated in underweight positions in India in energy and materials sectors. Overweight in Taiwan in the financial sector has also contributed to losses.\n\nThe following table details the significant active positions, where the Fund is overweight (holds more exposure than the performance measure) and underweight (holds less exposure than the performance measure), as at 30 April 2022 and 30 April 2021:\n\n**Largest overweight position**\n\n**30 April 2022 30 April 2021**\n\n**Country Weighting Country Weighting**\n\nTaiwan 2.01% Taiwan 1.52%\n\nSouth Africa 1.79% South Africa 1.29%\n\nChina 0.93% Brazil 1.11%\n\n**Largest underweight position**\n\n**30 April 2022 30 April 2021**\n\n**Country Weighting Country Weighting**\n\nQatar (1.06%) India (1.58%)\n\nBrazil (1.03%) Qatar (0.68%)\n\nOffshore China (1.03%) Indonesia (0.63%)\n\nLeadership in the country positions has changed over the period. Main move was to overweight China and underweight Offshore Chinese companies due to the increased activism risk by Chinese government. Elsewhere, there has been a small reshuffle in the underweight positions across countries, with the larger underweight in Qatar that is mostly concentrated around the financials.\n\n**BlackRock Advantage Europe Equity Fund** Over the financial year to 30 April 2022, the Fund’s active return was 2.81%, outperforming its performance measure (active return is the difference between the Fund's return and the performance measure return).\n\nThe Fund outperformed its performance measure over the period greatly supported by the significant gains achieved in 2021. Sentiment insights such as analyst revisions that predict companies’ future earnings were key driver of the significant outperformance. Also, insights that identify companies with more sustainable behaviour and activities were additive at the beginning of the period. However, the onset of the war in Ukraine has brought in considerable uncertainty, triggering an unprecedented chain of events from rising energy prices, supply chain pressures as well as the exit of many European companies from Russia. The performance has been affected across most areas in the Fund’s investment approach. Traditional valuation measures that look at the earnings and future profitability of companies was one of the few measures that still contributed to the returns. However, previously successful sentiment and top-down macro views have struggled. In addition, the insights that identify companies with more sustainable behaviour were challenged as they exhibited negative correlation to rising energy prices.\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return relative to the performance measure:\n\n**Largest contributors Largest detractors**\n\n**Country** **Effect on**\n\n**Fund return**\n\n**Country** **Effect on**\n\n**Fund return**\n\nGermany Ø 1\\.30% Switzerland Ø (0.25%)\n\nSweden \\# 0\\.53% France \\# (0.18%)\n\nGreat Britan Ø 0\\.43% Austria \\# (0.11%)\n\nNetherlands \\# 0\\.42% Belgium Ø (0.09%)\n\nItaly Ø 0\\.32% Finland \\# (0.07%)\n\n_\\# Overweight position - held more exposure than the performance measure. Ø Underweight position - held less exposure than the performance measure._\n\n**Fund performance review and activity (continued)**\n\n**BlackRock Advantage Emerging Markets Equity Fund (continued)**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/blackrock-funds-i-icav-annual-report-2022_page13.pdf"]},"response":{"errors":[],"extract_id":"extract_37bd3600c7f3c26a186aed9c5f3e9a14","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["11\n\n### **BLACKROCK FUNDS I ICAV**\n\n**INVESTMENT MANAGER’S REPORT (continued)**\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return relative to the performance measure:\n\n**Largest contributors Largest detractors**\n\n**Country** **Effect on**\n\n**Fund return**\n\n**Country** **Effect on**\n\n**Fund return**\n\nOffshore China Ø 0\\.55% India Ø (1.08%)\n\nMalaysia \\# 0\\.51% Taiwan \\# (0.67%)\n\nPoland Ø 0\\.34% United Arab Emirates Ø (0.45%)\n\nBrazil \\# 0\\.31% Russia Ø (0.45%)\n\nSouth Africa \\# 0\\.28% Qatar Ø (0.42%)\n\n_\\# Overweight position - held more exposure than the performance measure. Ø Underweight position - held less exposure than the performance measure._\n\nMost of the underperformance was generated in underweight positions in India in energy and materials sectors. Overweight in Taiwan in the financial sector has also contributed to losses.\n\nThe following table details the significant active positions, where the Fund is overweight (holds more exposure than the performance measure) and underweight (holds less exposure than the performance measure), as at 30 April 2022 and 30 April 2021:\n\n**Largest overweight position**\n\n**30 April 2022 30 April 2021**\n\n**Country Weighting Country Weighting**\n\nTaiwan 2.01% Taiwan 1.52%\n\nSouth Africa 1.79% South Africa 1.29%\n\nChina 0.93% Brazil 1.11%\n\n**Largest underweight position**\n\n**30 April 2022 30 April 2021**\n\n**Country Weighting Country Weighting**\n\nQatar (1.06%) India (1.58%)\n\nBrazil (1.03%) Qatar (0.68%)\n\nOffshore China (1.03%) Indonesia (0.63%)\n\nLeadership in the country positions has changed over the period. Main move was to overweight China and underweight Offshore Chinese companies due to the increased activism risk by Chinese government. Elsewhere, there has been a small reshuffle in the underweight positions across countries, with the larger underweight in Qatar that is mostly concentrated around the financials.\n\n**BlackRock Advantage Europe Equity Fund** Over the financial year to 30 April 2022, the Fund’s active return was 2.81%, outperforming its performance measure (active return is the difference between the Fund's return and the performance measure return).\n\nThe Fund outperformed its performance measure over the period greatly supported by the significant gains achieved in 2021. Sentiment insights such as analyst revisions that predict companies’ future earnings were key driver of the significant outperformance. Also, insights that identify companies with more sustainable behaviour and activities were additive at the beginning of the period. However, the onset of the war in Ukraine has brought in considerable uncertainty, triggering an unprecedented chain of events from rising energy prices, supply chain pressures as well as the exit of many European companies from Russia. The performance has been affected across most areas in the Fund’s investment approach. Traditional valuation measures that look at the earnings and future profitability of companies was one of the few measures that still contributed to the returns. However, previously successful sentiment and top-down macro views have struggled. In addition, the insights that identify companies with more sustainable behaviour were challenged as they exhibited negative correlation to rising energy prices.\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return relative to the performance measure:\n\n**Largest contributors Largest detractors**\n\n**Country** **Effect on**\n\n**Fund return**\n\n**Country** **Effect on**\n\n**Fund return**\n\nGermany Ø 1\\.30% Switzerland Ø (0.25%)\n\nSweden \\# 0\\.53% France \\# (0.18%)\n\nGreat Britan Ø 0\\.43% Austria \\# (0.11%)\n\nNetherlands \\# 0\\.42% Belgium Ø (0.09%)\n\nItaly Ø 0\\.32% Finland \\# (0.07%)\n\n_\\# Overweight position - held more exposure than the performance measure. Ø Underweight position - held less exposure than the performance measure._\n\n**Fund performance review and activity (continued)**\n\n**BlackRock Advantage Emerging Markets Equity Fund (continued)**"],"full_content":"11\n\n### **BLACKROCK FUNDS I ICAV**\n\n**INVESTMENT MANAGER’S REPORT (continued)**\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return relative to the performance measure:\n\n**Largest contributors Largest detractors**\n\n**Country** **Effect on**\n\n**Fund return**\n\n**Country** **Effect on**\n\n**Fund return**\n\nOffshore China Ø 0\\.55% India Ø (1.08%)\n\nMalaysia \\# 0\\.51% Taiwan \\# (0.67%)\n\nPoland Ø 0\\.34% United Arab Emirates Ø (0.45%)\n\nBrazil \\# 0\\.31% Russia Ø (0.45%)\n\nSouth Africa \\# 0\\.28% Qatar Ø (0.42%)\n\n_\\# Overweight position - held more exposure than the performance measure. Ø Underweight position - held less exposure than the performance measure._\n\nMost of the underperformance was generated in underweight positions in India in energy and materials sectors. Overweight in Taiwan in the financial sector has also contributed to losses.\n\nThe following table details the significant active positions, where the Fund is overweight (holds more exposure than the performance measure) and underweight (holds less exposure than the performance measure), as at 30 April 2022 and 30 April 2021:\n\n**Largest overweight position**\n\n**30 April 2022 30 April 2021**\n\n**Country Weighting Country Weighting**\n\nTaiwan 2.01% Taiwan 1.52%\n\nSouth Africa 1.79% South Africa 1.29%\n\nChina 0.93% Brazil 1.11%\n\n**Largest underweight position**\n\n**30 April 2022 30 April 2021**\n\n**Country Weighting Country Weighting**\n\nQatar (1.06%) India (1.58%)\n\nBrazil (1.03%) Qatar (0.68%)\n\nOffshore China (1.03%) Indonesia (0.63%)\n\nLeadership in the country positions has changed over the period. Main move was to overweight China and underweight Offshore Chinese companies due to the increased activism risk by Chinese government. Elsewhere, there has been a small reshuffle in the underweight positions across countries, with the larger underweight in Qatar that is mostly concentrated around the financials.\n\n**BlackRock Advantage Europe Equity Fund** Over the financial year to 30 April 2022, the Fund’s active return was 2.81%, outperforming its performance measure (active return is the difference between the Fund's return and the performance measure return).\n\nThe Fund outperformed its performance measure over the period greatly supported by the significant gains achieved in 2021. Sentiment insights such as analyst revisions that predict companies’ future earnings were key driver of the significant outperformance. Also, insights that identify companies with more sustainable behaviour and activities were additive at the beginning of the period. However, the onset of the war in Ukraine has brought in considerable uncertainty, triggering an unprecedented chain of events from rising energy prices, supply chain pressures as well as the exit of many European companies from Russia. The performance has been affected across most areas in the Fund’s investment approach. Traditional valuation measures that look at the earnings and future profitability of companies was one of the few measures that still contributed to the returns. However, previously successful sentiment and top-down macro views have struggled. In addition, the insights that identify companies with more sustainable behaviour were challenged as they exhibited negative correlation to rising energy prices.\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return relative to the performance measure:\n\n**Largest contributors Largest detractors**\n\n**Country** **Effect on**\n\n**Fund return**\n\n**Country** **Effect on**\n\n**Fund return**\n\nGermany Ø 1\\.30% Switzerland Ø (0.25%)\n\nSweden \\# 0\\.53% France \\# (0.18%)\n\nGreat Britan Ø 0\\.43% Austria \\# (0.11%)\n\nNetherlands \\# 0\\.42% Belgium Ø (0.09%)\n\nItaly Ø 0\\.32% Finland \\# (0.07%)\n\n_\\# Overweight position - held more exposure than the performance measure. Ø Underweight position - held less exposure than the performance measure._\n\n**Fund performance review and activity (continued)**\n\n**BlackRock Advantage Emerging Markets Equity Fund (continued)**","publish_date":null,"title":"BLACKROCK FUNDS I ICAV","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/blackrock-funds-i-icav-annual-report-2022_page13.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/blackrock-funds-i-icav-annual-report-2022_page13.pdf"},"request":{"example_id":"table/blackrock-funds-i-icav-annual-report-2022_page13","product_type":"parse","source_file_path":"blackrock-funds-i-icav-annual-report-2022_page13.pdf"},"started_at":"2026-11-04T19:48:29.013455"} +{"completed_at":"2026-11-04T19:48:33.181803","latency_in_ms":3134,"output":{"example_id":"table/blackrock-funds-i-icav-annual-report-2022_page25","grounded_pages":[],"layout_pages":[],"markdown":"23\n\n### **BLACKROCK FUNDS I ICAV**\n\n**INVESTMENT MANAGER’S REPORT (continued)**\n\nThe following table details the significant portfolio weightings as at 30 April 2022:\n\n**30 April 2022**\n\n**Sector Weighting**\n\nIndustrials 102.30%\n\nFinancials 85.30%\n\nConsumer discretionary 78.20%\n\nInformation technology 74.10%\n\nReal estate 50.40%\n\n**BlackRock Systematic Multi-Strategy ESG Screened Fund** Over the period from inception to 30 April 2022, the Fund’s active return was 0.44%, outperforming its performance measure of (active return is the difference between the Fund's return and the performance measure return on a pro-rata basis since the launch of the strategy on 14 June 2021.\n\nThe first half of 2021 was dominated by positive sentiment and resumption of economic activity, however the concerns around waves of COVID-19 continued to linger, with waves of new cases driven by more infectious new variants including the Delta variant in the second quarter and the Omicron variant in the fourth quarter. However, economies were generally much more resilient to these outbreaks given the successful rollout of vaccine measures, the related less severe nature of the latter of these and ongoing surveillance of the virus overall through testing. The start of 2022 was characterised by a sharp increase in volatility across financial markets, while February was ultimately overshadowed by geopolitical concerns surrounding Russia and Ukraine, which remained in focus in March and April 2022 as well.\n\nThe defensive equity strategy was the main positive contributor over the period, as it is designed to generate defensive alpha in down equity markets. However, the directional asset allocation strategy and the macro strategy offset some of the gains. The fund has shifted its view from an expansionary environment that it had maintained for much of the post-COVID regime to a stagflationary shock that could persist over a longer term driving increased recession risk.\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return:\n\n**Largest detractors**\n\n**Strategy** **Effect on**\n\n**Fund return**\n\n**Strategy** **Effect on**\n\n**Fund return**\n\nDefensive equity strategy 4.81% Directional asset allocation strategy (3.33%)\n\nMacro strategy (0.24%)\n\nThe following table details the significant portfolio weightings as at 30 April 2022:\n\n**30 April 2022**\n\n**Sector Gross**\n\n**exposure**\n\nMortgage-backed securities pass-through 35.50%\n\nIndustrial 25.25%\n\nFinancial institutions 21.55%\n\nCMO 21.30%\n\nTreasuries 20.20%\n\n**SFDR Review**\n\n**BlackRock Global Impact Fund** For the year ended 30 April 2022, the sustainable investment objective being promoted by the Fund was met through the Fund’s investments in equity securities and equity related securities (namely American Depositary Receipts (“ADR”s) and Global Depositary Receipts (“GDR”s) of companies globally whose goods and services seek to address the world’s social and environmental problems, as identified in the UN Sustainable Development Goals and as outlined further in the Fund’s prospectus. The Investment Manager remains satisfied that the index methodology continues to maintain the good governance criteria set out in the Fund’s prospectus.\n\nOver the financial year to 30 April 2022, the Fund was 99% invested in companies that have an impact on people and the planet (the \"Impact Categories”) across themes including, but not limited to, affordable housing, education and skilling, financial and digital inclusion, public health, safety and security, efficiency, electrification and digitalisation, green energy, pollution remediation and prevention, sustainable food, water and waste.\n\nAll holdings within the Fund were deemed to do no significant harm to environmental or social factors, as determined by the Investment Manager. The Investment Manager assesses this according to an internal methodology (as amended from time to time) which considers a representative sub-set of principal adverse sustainability impact indicators. Further information is outlined in the Fund’s prospectus.\n\n**Fund performance review and activity (continued)**\n\n**BlackRock Systematic ESG Equity Absolute Return Fund (continued)**","pages":[{"line_numbers":[],"markdown":"23\n\n### **BLACKROCK FUNDS I ICAV**\n\n**INVESTMENT MANAGER’S REPORT (continued)**\n\nThe following table details the significant portfolio weightings as at 30 April 2022:\n\n**30 April 2022**\n\n**Sector Weighting**\n\nIndustrials 102.30%\n\nFinancials 85.30%\n\nConsumer discretionary 78.20%\n\nInformation technology 74.10%\n\nReal estate 50.40%\n\n**BlackRock Systematic Multi-Strategy ESG Screened Fund** Over the period from inception to 30 April 2022, the Fund’s active return was 0.44%, outperforming its performance measure of (active return is the difference between the Fund's return and the performance measure return on a pro-rata basis since the launch of the strategy on 14 June 2021.\n\nThe first half of 2021 was dominated by positive sentiment and resumption of economic activity, however the concerns around waves of COVID-19 continued to linger, with waves of new cases driven by more infectious new variants including the Delta variant in the second quarter and the Omicron variant in the fourth quarter. However, economies were generally much more resilient to these outbreaks given the successful rollout of vaccine measures, the related less severe nature of the latter of these and ongoing surveillance of the virus overall through testing. The start of 2022 was characterised by a sharp increase in volatility across financial markets, while February was ultimately overshadowed by geopolitical concerns surrounding Russia and Ukraine, which remained in focus in March and April 2022 as well.\n\nThe defensive equity strategy was the main positive contributor over the period, as it is designed to generate defensive alpha in down equity markets. However, the directional asset allocation strategy and the macro strategy offset some of the gains. The fund has shifted its view from an expansionary environment that it had maintained for much of the post-COVID regime to a stagflationary shock that could persist over a longer term driving increased recession risk.\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return:\n\n**Largest detractors**\n\n**Strategy** **Effect on**\n\n**Fund return**\n\n**Strategy** **Effect on**\n\n**Fund return**\n\nDefensive equity strategy 4.81% Directional asset allocation strategy (3.33%)\n\nMacro strategy (0.24%)\n\nThe following table details the significant portfolio weightings as at 30 April 2022:\n\n**30 April 2022**\n\n**Sector Gross**\n\n**exposure**\n\nMortgage-backed securities pass-through 35.50%\n\nIndustrial 25.25%\n\nFinancial institutions 21.55%\n\nCMO 21.30%\n\nTreasuries 20.20%\n\n**SFDR Review**\n\n**BlackRock Global Impact Fund** For the year ended 30 April 2022, the sustainable investment objective being promoted by the Fund was met through the Fund’s investments in equity securities and equity related securities (namely American Depositary Receipts (“ADR”s) and Global Depositary Receipts (“GDR”s) of companies globally whose goods and services seek to address the world’s social and environmental problems, as identified in the UN Sustainable Development Goals and as outlined further in the Fund’s prospectus. The Investment Manager remains satisfied that the index methodology continues to maintain the good governance criteria set out in the Fund’s prospectus.\n\nOver the financial year to 30 April 2022, the Fund was 99% invested in companies that have an impact on people and the planet (the \"Impact Categories”) across themes including, but not limited to, affordable housing, education and skilling, financial and digital inclusion, public health, safety and security, efficiency, electrification and digitalisation, green energy, pollution remediation and prevention, sustainable food, water and waste.\n\nAll holdings within the Fund were deemed to do no significant harm to environmental or social factors, as determined by the Investment Manager. The Investment Manager assesses this according to an internal methodology (as amended from time to time) which considers a representative sub-set of principal adverse sustainability impact indicators. Further information is outlined in the Fund’s prospectus.\n\n**Fund performance review and activity (continued)**\n\n**BlackRock Systematic ESG Equity Absolute Return Fund (continued)**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"23\n\n### **BLACKROCK FUNDS I ICAV**\n\n**INVESTMENT MANAGER’S REPORT (continued)**\n\nThe following table details the significant portfolio weightings as at 30 April 2022:\n\n**30 April 2022**\n\n**Sector Weighting**\n\nIndustrials 102.30%\n\nFinancials 85.30%\n\nConsumer discretionary 78.20%\n\nInformation technology 74.10%\n\nReal estate 50.40%\n\n**BlackRock Systematic Multi-Strategy ESG Screened Fund** Over the period from inception to 30 April 2022, the Fund’s active return was 0.44%, outperforming its performance measure of (active return is the difference between the Fund's return and the performance measure return on a pro-rata basis since the launch of the strategy on 14 June 2021.\n\nThe first half of 2021 was dominated by positive sentiment and resumption of economic activity, however the concerns around waves of COVID-19 continued to linger, with waves of new cases driven by more infectious new variants including the Delta variant in the second quarter and the Omicron variant in the fourth quarter. However, economies were generally much more resilient to these outbreaks given the successful rollout of vaccine measures, the related less severe nature of the latter of these and ongoing surveillance of the virus overall through testing. The start of 2022 was characterised by a sharp increase in volatility across financial markets, while February was ultimately overshadowed by geopolitical concerns surrounding Russia and Ukraine, which remained in focus in March and April 2022 as well.\n\nThe defensive equity strategy was the main positive contributor over the period, as it is designed to generate defensive alpha in down equity markets. However, the directional asset allocation strategy and the macro strategy offset some of the gains. The fund has shifted its view from an expansionary environment that it had maintained for much of the post-COVID regime to a stagflationary shock that could persist over a longer term driving increased recession risk.\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return:\n\n**Largest detractors**\n\n**Strategy** **Effect on**\n\n**Fund return**\n\n**Strategy** **Effect on**\n\n**Fund return**\n\nDefensive equity strategy 4.81% Directional asset allocation strategy (3.33%)\n\nMacro strategy (0.24%)\n\nThe following table details the significant portfolio weightings as at 30 April 2022:\n\n**30 April 2022**\n\n**Sector Gross**\n\n**exposure**\n\nMortgage-backed securities pass-through 35.50%\n\nIndustrial 25.25%\n\nFinancial institutions 21.55%\n\nCMO 21.30%\n\nTreasuries 20.20%\n\n**SFDR Review**\n\n**BlackRock Global Impact Fund** For the year ended 30 April 2022, the sustainable investment objective being promoted by the Fund was met through the Fund’s investments in equity securities and equity related securities (namely American Depositary Receipts (“ADR”s) and Global Depositary Receipts (“GDR”s) of companies globally whose goods and services seek to address the world’s social and environmental problems, as identified in the UN Sustainable Development Goals and as outlined further in the Fund’s prospectus. The Investment Manager remains satisfied that the index methodology continues to maintain the good governance criteria set out in the Fund’s prospectus.\n\nOver the financial year to 30 April 2022, the Fund was 99% invested in companies that have an impact on people and the planet (the \"Impact Categories”) across themes including, but not limited to, affordable housing, education and skilling, financial and digital inclusion, public health, safety and security, efficiency, electrification and digitalisation, green energy, pollution remediation and prevention, sustainable food, water and waste.\n\nAll holdings within the Fund were deemed to do no significant harm to environmental or social factors, as determined by the Investment Manager. The Investment Manager assesses this according to an internal methodology (as amended from time to time) which considers a representative sub-set of principal adverse sustainability impact indicators. Further information is outlined in the Fund’s prospectus.\n\n**Fund performance review and activity (continued)**\n\n**BlackRock Systematic ESG Equity Absolute Return Fund (continued)**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/blackrock-funds-i-icav-annual-report-2022_page25.pdf"]},"response":{"errors":[],"extract_id":"extract_5cc1e26f6d090a0ffe5618fa54a70c8b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["23\n\n### **BLACKROCK FUNDS I ICAV**\n\n**INVESTMENT MANAGER’S REPORT (continued)**\n\nThe following table details the significant portfolio weightings as at 30 April 2022:\n\n**30 April 2022**\n\n**Sector Weighting**\n\nIndustrials 102.30%\n\nFinancials 85.30%\n\nConsumer discretionary 78.20%\n\nInformation technology 74.10%\n\nReal estate 50.40%\n\n**BlackRock Systematic Multi-Strategy ESG Screened Fund** Over the period from inception to 30 April 2022, the Fund’s active return was 0.44%, outperforming its performance measure of (active return is the difference between the Fund's return and the performance measure return on a pro-rata basis since the launch of the strategy on 14 June 2021.\n\nThe first half of 2021 was dominated by positive sentiment and resumption of economic activity, however the concerns around waves of COVID-19 continued to linger, with waves of new cases driven by more infectious new variants including the Delta variant in the second quarter and the Omicron variant in the fourth quarter. However, economies were generally much more resilient to these outbreaks given the successful rollout of vaccine measures, the related less severe nature of the latter of these and ongoing surveillance of the virus overall through testing. The start of 2022 was characterised by a sharp increase in volatility across financial markets, while February was ultimately overshadowed by geopolitical concerns surrounding Russia and Ukraine, which remained in focus in March and April 2022 as well.\n\nThe defensive equity strategy was the main positive contributor over the period, as it is designed to generate defensive alpha in down equity markets. However, the directional asset allocation strategy and the macro strategy offset some of the gains. The fund has shifted its view from an expansionary environment that it had maintained for much of the post-COVID regime to a stagflationary shock that could persist over a longer term driving increased recession risk.\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return:\n\n**Largest detractors**\n\n**Strategy** **Effect on**\n\n**Fund return**\n\n**Strategy** **Effect on**\n\n**Fund return**\n\nDefensive equity strategy 4.81% Directional asset allocation strategy (3.33%)\n\nMacro strategy (0.24%)\n\nThe following table details the significant portfolio weightings as at 30 April 2022:\n\n**30 April 2022**\n\n**Sector Gross**\n\n**exposure**\n\nMortgage-backed securities pass-through 35.50%\n\nIndustrial 25.25%\n\nFinancial institutions 21.55%\n\nCMO 21.30%\n\nTreasuries 20.20%\n\n**SFDR Review**\n\n**BlackRock Global Impact Fund** For the year ended 30 April 2022, the sustainable investment objective being promoted by the Fund was met through the Fund’s investments in equity securities and equity related securities (namely American Depositary Receipts (“ADR”s) and Global Depositary Receipts (“GDR”s) of companies globally whose goods and services seek to address the world’s social and environmental problems, as identified in the UN Sustainable Development Goals and as outlined further in the Fund’s prospectus. The Investment Manager remains satisfied that the index methodology continues to maintain the good governance criteria set out in the Fund’s prospectus.\n\nOver the financial year to 30 April 2022, the Fund was 99% invested in companies that have an impact on people and the planet (the \"Impact Categories”) across themes including, but not limited to, affordable housing, education and skilling, financial and digital inclusion, public health, safety and security, efficiency, electrification and digitalisation, green energy, pollution remediation and prevention, sustainable food, water and waste.\n\nAll holdings within the Fund were deemed to do no significant harm to environmental or social factors, as determined by the Investment Manager. The Investment Manager assesses this according to an internal methodology (as amended from time to time) which considers a representative sub-set of principal adverse sustainability impact indicators. Further information is outlined in the Fund’s prospectus.\n\n**Fund performance review and activity (continued)**\n\n**BlackRock Systematic ESG Equity Absolute Return Fund (continued)**"],"full_content":"23\n\n### **BLACKROCK FUNDS I ICAV**\n\n**INVESTMENT MANAGER’S REPORT (continued)**\n\nThe following table details the significant portfolio weightings as at 30 April 2022:\n\n**30 April 2022**\n\n**Sector Weighting**\n\nIndustrials 102.30%\n\nFinancials 85.30%\n\nConsumer discretionary 78.20%\n\nInformation technology 74.10%\n\nReal estate 50.40%\n\n**BlackRock Systematic Multi-Strategy ESG Screened Fund** Over the period from inception to 30 April 2022, the Fund’s active return was 0.44%, outperforming its performance measure of (active return is the difference between the Fund's return and the performance measure return on a pro-rata basis since the launch of the strategy on 14 June 2021.\n\nThe first half of 2021 was dominated by positive sentiment and resumption of economic activity, however the concerns around waves of COVID-19 continued to linger, with waves of new cases driven by more infectious new variants including the Delta variant in the second quarter and the Omicron variant in the fourth quarter. However, economies were generally much more resilient to these outbreaks given the successful rollout of vaccine measures, the related less severe nature of the latter of these and ongoing surveillance of the virus overall through testing. The start of 2022 was characterised by a sharp increase in volatility across financial markets, while February was ultimately overshadowed by geopolitical concerns surrounding Russia and Ukraine, which remained in focus in March and April 2022 as well.\n\nThe defensive equity strategy was the main positive contributor over the period, as it is designed to generate defensive alpha in down equity markets. However, the directional asset allocation strategy and the macro strategy offset some of the gains. The fund has shifted its view from an expansionary environment that it had maintained for much of the post-COVID regime to a stagflationary shock that could persist over a longer term driving increased recession risk.\n\nDuring the financial year the following were the largest contributors to and detractors from the Fund’s return:\n\n**Largest detractors**\n\n**Strategy** **Effect on**\n\n**Fund return**\n\n**Strategy** **Effect on**\n\n**Fund return**\n\nDefensive equity strategy 4.81% Directional asset allocation strategy (3.33%)\n\nMacro strategy (0.24%)\n\nThe following table details the significant portfolio weightings as at 30 April 2022:\n\n**30 April 2022**\n\n**Sector Gross**\n\n**exposure**\n\nMortgage-backed securities pass-through 35.50%\n\nIndustrial 25.25%\n\nFinancial institutions 21.55%\n\nCMO 21.30%\n\nTreasuries 20.20%\n\n**SFDR Review**\n\n**BlackRock Global Impact Fund** For the year ended 30 April 2022, the sustainable investment objective being promoted by the Fund was met through the Fund’s investments in equity securities and equity related securities (namely American Depositary Receipts (“ADR”s) and Global Depositary Receipts (“GDR”s) of companies globally whose goods and services seek to address the world’s social and environmental problems, as identified in the UN Sustainable Development Goals and as outlined further in the Fund’s prospectus. The Investment Manager remains satisfied that the index methodology continues to maintain the good governance criteria set out in the Fund’s prospectus.\n\nOver the financial year to 30 April 2022, the Fund was 99% invested in companies that have an impact on people and the planet (the \"Impact Categories”) across themes including, but not limited to, affordable housing, education and skilling, financial and digital inclusion, public health, safety and security, efficiency, electrification and digitalisation, green energy, pollution remediation and prevention, sustainable food, water and waste.\n\nAll holdings within the Fund were deemed to do no significant harm to environmental or social factors, as determined by the Investment Manager. The Investment Manager assesses this according to an internal methodology (as amended from time to time) which considers a representative sub-set of principal adverse sustainability impact indicators. Further information is outlined in the Fund’s prospectus.\n\n**Fund performance review and activity (continued)**\n\n**BlackRock Systematic ESG Equity Absolute Return Fund (continued)**","publish_date":null,"title":"BLACKROCK FUNDS I ICAV","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/blackrock-funds-i-icav-annual-report-2022_page25.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/blackrock-funds-i-icav-annual-report-2022_page25.pdf"},"request":{"example_id":"table/blackrock-funds-i-icav-annual-report-2022_page25","product_type":"parse","source_file_path":"blackrock-funds-i-icav-annual-report-2022_page25.pdf"},"started_at":"2026-11-04T19:48:30.047373"} +{"completed_at":"2026-11-04T19:48:32.618919","latency_in_ms":1240,"output":{"example_id":"table/blackrock-funds-i-icav-annual-report-2022_page42","grounded_pages":[],"layout_pages":[],"markdown":"40\n\n### **BLACKROCK FUNDS I ICAV**\n\n**STATEMENT OF CHANGES IN NET ASSETS ATTRIBUTABLE TO REDEEMABLE SHAREHOLDERS (continued)** **For the financial year ended 30 April 2022**\n\n**BlackRock Sustainable Advantage**\n\n**World Equity Fund**\n\n**BlackRock Tactical Opportunities**\n\n**Fund**\n\n**BlackRock US Flexible Equity ESG**\n\n**Screened Fund** ¹\n\n**BlackRock**\n\n**Global Target**\n\n**Return:**\n\n**Conservative**\n\n**Fund** ²\n\n**BlackRock**\n\n**Global Target**\n\n**Return: Growth**\n\n**Fund** ²\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\nNet assets at the beginning of the financial year 170,789 75,342 289,836 84,062 9,859 6,215 – –\n\nIncrease/(decrease) in net assets attributable to redeemable shareholders (30,068) 50,765 (25,548) 31,920 622 3,561 (171) (215)\n\n**Share transactions:**\n\nIssue of redeemable shares 283,580 63,960 35,902 229,964 164 83 5,000 5,000\n\nRedemption of redeemable shares (43,914) (19,278) (77,332) (56,110) (10,645) – – –\n\n**Increase/(decrease) in net assets resulting from share transactions** 239,666 44,682 (41,430) 173,854 (10,481) 83 5,000 5,000\n\n**Net assets at the end of the** **financial year** **380,387 170,789 222,858 289,836 – 9,859 4,829 4,785**\n\n1The Fund terminated during the financial year. 2The Fund launched during the financial year, hence no comparative data is available. The accompanying notes form an integral part of these financial statements.","pages":[{"line_numbers":[],"markdown":"40\n\n### **BLACKROCK FUNDS I ICAV**\n\n**STATEMENT OF CHANGES IN NET ASSETS ATTRIBUTABLE TO REDEEMABLE SHAREHOLDERS (continued)** **For the financial year ended 30 April 2022**\n\n**BlackRock Sustainable Advantage**\n\n**World Equity Fund**\n\n**BlackRock Tactical Opportunities**\n\n**Fund**\n\n**BlackRock US Flexible Equity ESG**\n\n**Screened Fund** ¹\n\n**BlackRock**\n\n**Global Target**\n\n**Return:**\n\n**Conservative**\n\n**Fund** ²\n\n**BlackRock**\n\n**Global Target**\n\n**Return: Growth**\n\n**Fund** ²\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\nNet assets at the beginning of the financial year 170,789 75,342 289,836 84,062 9,859 6,215 – –\n\nIncrease/(decrease) in net assets attributable to redeemable shareholders (30,068) 50,765 (25,548) 31,920 622 3,561 (171) (215)\n\n**Share transactions:**\n\nIssue of redeemable shares 283,580 63,960 35,902 229,964 164 83 5,000 5,000\n\nRedemption of redeemable shares (43,914) (19,278) (77,332) (56,110) (10,645) – – –\n\n**Increase/(decrease) in net assets resulting from share transactions** 239,666 44,682 (41,430) 173,854 (10,481) 83 5,000 5,000\n\n**Net assets at the end of the** **financial year** **380,387 170,789 222,858 289,836 – 9,859 4,829 4,785**\n\n1The Fund terminated during the financial year. 2The Fund launched during the financial year, hence no comparative data is available. The accompanying notes form an integral part of these financial statements.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"40\n\n### **BLACKROCK FUNDS I ICAV**\n\n**STATEMENT OF CHANGES IN NET ASSETS ATTRIBUTABLE TO REDEEMABLE SHAREHOLDERS (continued)** **For the financial year ended 30 April 2022**\n\n**BlackRock Sustainable Advantage**\n\n**World Equity Fund**\n\n**BlackRock Tactical Opportunities**\n\n**Fund**\n\n**BlackRock US Flexible Equity ESG**\n\n**Screened Fund** ¹\n\n**BlackRock**\n\n**Global Target**\n\n**Return:**\n\n**Conservative**\n\n**Fund** ²\n\n**BlackRock**\n\n**Global Target**\n\n**Return: Growth**\n\n**Fund** ²\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\nNet assets at the beginning of the financial year 170,789 75,342 289,836 84,062 9,859 6,215 – –\n\nIncrease/(decrease) in net assets attributable to redeemable shareholders (30,068) 50,765 (25,548) 31,920 622 3,561 (171) (215)\n\n**Share transactions:**\n\nIssue of redeemable shares 283,580 63,960 35,902 229,964 164 83 5,000 5,000\n\nRedemption of redeemable shares (43,914) (19,278) (77,332) (56,110) (10,645) – – –\n\n**Increase/(decrease) in net assets resulting from share transactions** 239,666 44,682 (41,430) 173,854 (10,481) 83 5,000 5,000\n\n**Net assets at the end of the** **financial year** **380,387 170,789 222,858 289,836 – 9,859 4,829 4,785**\n\n1The Fund terminated during the financial year. 2The Fund launched during the financial year, hence no comparative data is available. The accompanying notes form an integral part of these financial statements.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/blackrock-funds-i-icav-annual-report-2022_page42.pdf"]},"response":{"errors":[],"extract_id":"extract_703f5d2509a0a14833a95986f3188471","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["40\n\n### **BLACKROCK FUNDS I ICAV**\n\n**STATEMENT OF CHANGES IN NET ASSETS ATTRIBUTABLE TO REDEEMABLE SHAREHOLDERS (continued)** **For the financial year ended 30 April 2022**\n\n**BlackRock Sustainable Advantage**\n\n**World Equity Fund**\n\n**BlackRock Tactical Opportunities**\n\n**Fund**\n\n**BlackRock US Flexible Equity ESG**\n\n**Screened Fund** ¹\n\n**BlackRock**\n\n**Global Target**\n\n**Return:**\n\n**Conservative**\n\n**Fund** ²\n\n**BlackRock**\n\n**Global Target**\n\n**Return: Growth**\n\n**Fund** ²\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\nNet assets at the beginning of the financial year 170,789 75,342 289,836 84,062 9,859 6,215 – –\n\nIncrease/(decrease) in net assets attributable to redeemable shareholders (30,068) 50,765 (25,548) 31,920 622 3,561 (171) (215)\n\n**Share transactions:**\n\nIssue of redeemable shares 283,580 63,960 35,902 229,964 164 83 5,000 5,000\n\nRedemption of redeemable shares (43,914) (19,278) (77,332) (56,110) (10,645) – – –\n\n**Increase/(decrease) in net assets resulting from share transactions** 239,666 44,682 (41,430) 173,854 (10,481) 83 5,000 5,000\n\n**Net assets at the end of the** **financial year** **380,387 170,789 222,858 289,836 – 9,859 4,829 4,785**\n\n1The Fund terminated during the financial year. 2The Fund launched during the financial year, hence no comparative data is available. The accompanying notes form an integral part of these financial statements."],"full_content":"40\n\n### **BLACKROCK FUNDS I ICAV**\n\n**STATEMENT OF CHANGES IN NET ASSETS ATTRIBUTABLE TO REDEEMABLE SHAREHOLDERS (continued)** **For the financial year ended 30 April 2022**\n\n**BlackRock Sustainable Advantage**\n\n**World Equity Fund**\n\n**BlackRock Tactical Opportunities**\n\n**Fund**\n\n**BlackRock US Flexible Equity ESG**\n\n**Screened Fund** ¹\n\n**BlackRock**\n\n**Global Target**\n\n**Return:**\n\n**Conservative**\n\n**Fund** ²\n\n**BlackRock**\n\n**Global Target**\n\n**Return: Growth**\n\n**Fund** ²\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2021**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\n**2022**\n\n**USD '000**\n\nNet assets at the beginning of the financial year 170,789 75,342 289,836 84,062 9,859 6,215 – –\n\nIncrease/(decrease) in net assets attributable to redeemable shareholders (30,068) 50,765 (25,548) 31,920 622 3,561 (171) (215)\n\n**Share transactions:**\n\nIssue of redeemable shares 283,580 63,960 35,902 229,964 164 83 5,000 5,000\n\nRedemption of redeemable shares (43,914) (19,278) (77,332) (56,110) (10,645) – – –\n\n**Increase/(decrease) in net assets resulting from share transactions** 239,666 44,682 (41,430) 173,854 (10,481) 83 5,000 5,000\n\n**Net assets at the end of the** **financial year** **380,387 170,789 222,858 289,836 – 9,859 4,829 4,785**\n\n1The Fund terminated during the financial year. 2The Fund launched during the financial year, hence no comparative data is available. The accompanying notes form an integral part of these financial statements.","publish_date":null,"title":"BLACKROCK FUNDS I ICAV","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/blackrock-funds-i-icav-annual-report-2022_page42.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/blackrock-funds-i-icav-annual-report-2022_page42.pdf"},"request":{"example_id":"table/blackrock-funds-i-icav-annual-report-2022_page42","product_type":"parse","source_file_path":"blackrock-funds-i-icav-annual-report-2022_page42.pdf"},"started_at":"2026-11-04T19:48:31.378091"} +{"completed_at":"2026-11-04T19:46:54.800985","latency_in_ms":2933,"output":{"example_id":"table/bls-Feb-2026_page14","grounded_pages":[],"layout_pages":[],"markdown":"**HOUSEHOLD DATA Table A-1. Employment status of the civilian population by sex and age** [Numbers in thousands]\n\nEmployment status, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**TOTAL** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 272,847 274,676 274,766 272,847 – 274,633 274,816 274,676 274,766 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 170,116 169,612 170,206 170,441 – 171,541 171,495 170,465 170,483 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.3 61.7 61.9 62.5 – 62.5 62.4 62.1 62.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 162,544 161,670 162,153 163,338 – 163,760 163,992 163,097 162,912 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.6 58.9 59.0 59.9 – 59.6 59.7 59.4 59.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 7,572 7,942 8,052 7,104 – 7,781 7,503 7,368 7,571 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.5 4.7 4.7 4.2 – 4.5 4.4 4.3 4.4 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 102,731 105,064 104,560 102,405 – 103,092 103,321 104,211 104,283 People who currently want a job. . . . . . . . . . . . . . . . . .. 5,809 5,961 5,880 5,896 – 6,139 6,208 5,838 5,974\n\n**Men, 16 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 133,089 132,546 132,586 133,089 – 133,957 134,046 132,546 132,586 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 89,792 88,653 88,835 90,078 – 90,739 90,780 89,200 89,101 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 67.5 66.9 67.0 67.7 – 67.7 67.7 67.3 67.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 85,519 84,291 84,460 86,269 – 86,616 86,812 85,348 85,210 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 64.3 63.6 63.7 64.8 – 64.7 64.8 64.4 64.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,273 4,362 4,375 3,809 – 4,123 3,968 3,852 3,891 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.8 4.9 4.9 4.2 – 4.5 4.4 4.3 4.4 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 43,297 43,893 43,750 43,011 – 43,218 43,266 43,345 43,485\n\n**Men, 20 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 123,996 123,570 123,612 123,996 – 124,889 124,981 123,570 123,612 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 86,634 85,812 85,945 86,694 – 87,628 87,638 86,096 86,006 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 69.9 69.4 69.5 69.9 – 70.2 70.1 69.7 69.6 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 82,838 81,964 82,038 83,366 – 84,043 84,199 82,783 82,591 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 66.8 66.3 66.4 67.2 – 67.3 67.4 67.0 66.8 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3,796 3,848 3,907 3,327 – 3,585 3,439 3,313 3,415 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.4 4.5 4.5 3.8 – 4.1 3.9 3.8 4.0 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 37,362 37,758 37,667 37,302 – 37,261 37,344 37,474 37,606\n\n**Women, 16 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 139,758 142,130 142,180 139,758 – 140,676 140,770 142,130 142,180 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 80,323 80,959 81,370 80,363 – 80,802 80,715 81,265 81,382 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57.5 57.0 57.2 57.5 – 57.4 57.3 57.2 57.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 77,025 77,379 77,693 77,068 – 77,144 77,180 77,749 77,702 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 55.1 54.4 54.6 55.1 – 54.8 54.8 54.7 54.7 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3,298 3,580 3,677 3,295 – 3,658 3,535 3,515 3,680 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.4 4.5 4.1 – 4.5 4.4 4.3 4.5 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59,435 61,171 60,810 59,394 – 59,873 60,055 60,865 60,798\n\n**Women, 20 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 130,991 133,489 133,541 130,991 – 131,935 132,034 133,489 133,541 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 77,276 78,018 78,384 77,113 – 77,442 77,351 78,128 78,183 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59.0 58.4 58.7 58.9 – 58.7 58.6 58.5 58.5 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 74,320 74,738 75,121 74,199 – 74,302 74,306 74,925 74,965 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 56.7 56.0 56.3 56.6 – 56.3 56.3 56.1 56.1 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 2,956 3,281 3,263 2,915 – 3,140 3,044 3,203 3,218 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.8 4.2 4.2 3.8 – 4.1 3.9 4.1 4.1 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 53,715 55,471 55,157 53,878 – 54,493 54,683 55,361 55,358\n\n**Both sexes, 16 to 19 years** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 17,860 17,617 17,613 17,860 – 17,808 17,801 17,617 17,613 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6,205 5,782 5,877 6,634 – 6,470 6,506 6,241 6,294 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 34.7 32.8 33.4 37.1 – 36.3 36.6 35.4 35.7 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5,386 4,969 4,994 5,773 – 5,415 5,486 5,390 5,357 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 30.2 28.2 28.4 32.3 – 30.4 30.8 30.6 30.4 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 820 813 883 862 – 1,056 1,020 851 937 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 13.2 14.1 15.0 13.0 – 16.3 15.7 13.6 14.9 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11,655 11,835 11,736 11,226 – 11,338 11,295 11,376 11,319\n\n1 The population figures are not adjusted for seasonal variation; therefore, identical numbers appear in the unadjusted and seasonally adjusted columns. NOTE: January 2026 estimates were revised to incorporate updated population estimates. For additional information, see https://www.bls.gov/cps/documentation.htm. Data for October 2025 were not collected due to the federal government shutdown.","pages":[{"line_numbers":[],"markdown":"**HOUSEHOLD DATA Table A-1. Employment status of the civilian population by sex and age** [Numbers in thousands]\n\nEmployment status, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**TOTAL** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 272,847 274,676 274,766 272,847 – 274,633 274,816 274,676 274,766 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 170,116 169,612 170,206 170,441 – 171,541 171,495 170,465 170,483 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.3 61.7 61.9 62.5 – 62.5 62.4 62.1 62.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 162,544 161,670 162,153 163,338 – 163,760 163,992 163,097 162,912 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.6 58.9 59.0 59.9 – 59.6 59.7 59.4 59.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 7,572 7,942 8,052 7,104 – 7,781 7,503 7,368 7,571 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.5 4.7 4.7 4.2 – 4.5 4.4 4.3 4.4 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 102,731 105,064 104,560 102,405 – 103,092 103,321 104,211 104,283 People who currently want a job. . . . . . . . . . . . . . . . . .. 5,809 5,961 5,880 5,896 – 6,139 6,208 5,838 5,974\n\n**Men, 16 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 133,089 132,546 132,586 133,089 – 133,957 134,046 132,546 132,586 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 89,792 88,653 88,835 90,078 – 90,739 90,780 89,200 89,101 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 67.5 66.9 67.0 67.7 – 67.7 67.7 67.3 67.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 85,519 84,291 84,460 86,269 – 86,616 86,812 85,348 85,210 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 64.3 63.6 63.7 64.8 – 64.7 64.8 64.4 64.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,273 4,362 4,375 3,809 – 4,123 3,968 3,852 3,891 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.8 4.9 4.9 4.2 – 4.5 4.4 4.3 4.4 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 43,297 43,893 43,750 43,011 – 43,218 43,266 43,345 43,485\n\n**Men, 20 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 123,996 123,570 123,612 123,996 – 124,889 124,981 123,570 123,612 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 86,634 85,812 85,945 86,694 – 87,628 87,638 86,096 86,006 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 69.9 69.4 69.5 69.9 – 70.2 70.1 69.7 69.6 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 82,838 81,964 82,038 83,366 – 84,043 84,199 82,783 82,591 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 66.8 66.3 66.4 67.2 – 67.3 67.4 67.0 66.8 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3,796 3,848 3,907 3,327 – 3,585 3,439 3,313 3,415 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.4 4.5 4.5 3.8 – 4.1 3.9 3.8 4.0 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 37,362 37,758 37,667 37,302 – 37,261 37,344 37,474 37,606\n\n**Women, 16 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 139,758 142,130 142,180 139,758 – 140,676 140,770 142,130 142,180 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 80,323 80,959 81,370 80,363 – 80,802 80,715 81,265 81,382 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57.5 57.0 57.2 57.5 – 57.4 57.3 57.2 57.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 77,025 77,379 77,693 77,068 – 77,144 77,180 77,749 77,702 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 55.1 54.4 54.6 55.1 – 54.8 54.8 54.7 54.7 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3,298 3,580 3,677 3,295 – 3,658 3,535 3,515 3,680 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.4 4.5 4.1 – 4.5 4.4 4.3 4.5 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59,435 61,171 60,810 59,394 – 59,873 60,055 60,865 60,798\n\n**Women, 20 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 130,991 133,489 133,541 130,991 – 131,935 132,034 133,489 133,541 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 77,276 78,018 78,384 77,113 – 77,442 77,351 78,128 78,183 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59.0 58.4 58.7 58.9 ��� 58.7 58.6 58.5 58.5 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 74,320 74,738 75,121 74,199 – 74,302 74,306 74,925 74,965 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 56.7 56.0 56.3 56.6 – 56.3 56.3 56.1 56.1 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 2,956 3,281 3,263 2,915 – 3,140 3,044 3,203 3,218 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.8 4.2 4.2 3.8 – 4.1 3.9 4.1 4.1 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 53,715 55,471 55,157 53,878 – 54,493 54,683 55,361 55,358\n\n**Both sexes, 16 to 19 years** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 17,860 17,617 17,613 17,860 – 17,808 17,801 17,617 17,613 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6,205 5,782 5,877 6,634 – 6,470 6,506 6,241 6,294 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 34.7 32.8 33.4 37.1 – 36.3 36.6 35.4 35.7 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5,386 4,969 4,994 5,773 – 5,415 5,486 5,390 5,357 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 30.2 28.2 28.4 32.3 – 30.4 30.8 30.6 30.4 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 820 813 883 862 – 1,056 1,020 851 937 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 13.2 14.1 15.0 13.0 – 16.3 15.7 13.6 14.9 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11,655 11,835 11,736 11,226 – 11,338 11,295 11,376 11,319\n\n1 The population figures are not adjusted for seasonal variation; therefore, identical numbers appear in the unadjusted and seasonally adjusted columns. NOTE: January 2026 estimates were revised to incorporate updated population estimates. For additional information, see https://www.bls.gov/cps/documentation.htm. Data for October 2025 were not collected due to the federal government shutdown.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**HOUSEHOLD DATA Table A-1. Employment status of the civilian population by sex and age** [Numbers in thousands]\n\nEmployment status, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**TOTAL** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 272,847 274,676 274,766 272,847 – 274,633 274,816 274,676 274,766 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 170,116 169,612 170,206 170,441 – 171,541 171,495 170,465 170,483 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.3 61.7 61.9 62.5 – 62.5 62.4 62.1 62.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 162,544 161,670 162,153 163,338 – 163,760 163,992 163,097 162,912 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.6 58.9 59.0 59.9 – 59.6 59.7 59.4 59.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 7,572 7,942 8,052 7,104 – 7,781 7,503 7,368 7,571 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.5 4.7 4.7 4.2 – 4.5 4.4 4.3 4.4 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 102,731 105,064 104,560 102,405 – 103,092 103,321 104,211 104,283 People who currently want a job. . . . . . . . . . . . . . . . . .. 5,809 5,961 5,880 5,896 – 6,139 6,208 5,838 5,974\n\n**Men, 16 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 133,089 132,546 132,586 133,089 – 133,957 134,046 132,546 132,586 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 89,792 88,653 88,835 90,078 – 90,739 90,780 89,200 89,101 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 67.5 66.9 67.0 67.7 – 67.7 67.7 67.3 67.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 85,519 84,291 84,460 86,269 – 86,616 86,812 85,348 85,210 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 64.3 63.6 63.7 64.8 – 64.7 64.8 64.4 64.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,273 4,362 4,375 3,809 – 4,123 3,968 3,852 3,891 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.8 4.9 4.9 4.2 – 4.5 4.4 4.3 4.4 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 43,297 43,893 43,750 43,011 – 43,218 43,266 43,345 43,485\n\n**Men, 20 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 123,996 123,570 123,612 123,996 – 124,889 124,981 123,570 123,612 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 86,634 85,812 85,945 86,694 – 87,628 87,638 86,096 86,006 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 69.9 69.4 69.5 69.9 – 70.2 70.1 69.7 69.6 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 82,838 81,964 82,038 83,366 – 84,043 84,199 82,783 82,591 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 66.8 66.3 66.4 67.2 – 67.3 67.4 67.0 66.8 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3,796 3,848 3,907 3,327 – 3,585 3,439 3,313 3,415 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.4 4.5 4.5 3.8 – 4.1 3.9 3.8 4.0 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 37,362 37,758 37,667 37,302 – 37,261 37,344 37,474 37,606\n\n**Women, 16 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 139,758 142,130 142,180 139,758 – 140,676 140,770 142,130 142,180 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 80,323 80,959 81,370 80,363 – 80,802 80,715 81,265 81,382 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57.5 57.0 57.2 57.5 – 57.4 57.3 57.2 57.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 77,025 77,379 77,693 77,068 – 77,144 77,180 77,749 77,702 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 55.1 54.4 54.6 55.1 – 54.8 54.8 54.7 54.7 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3,298 3,580 3,677 3,295 – 3,658 3,535 3,515 3,680 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.4 4.5 4.1 – 4.5 4.4 4.3 4.5 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59,435 61,171 60,810 59,394 – 59,873 60,055 60,865 60,798\n\n**Women, 20 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 130,991 133,489 133,541 130,991 – 131,935 132,034 133,489 133,541 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 77,276 78,018 78,384 77,113 – 77,442 77,351 78,128 78,183 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59.0 58.4 58.7 58.9 – 58.7 58.6 58.5 58.5 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 74,320 74,738 75,121 74,199 – 74,302 74,306 74,925 74,965 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 56.7 56.0 56.3 56.6 – 56.3 56.3 56.1 56.1 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 2,956 3,281 3,263 2,915 – 3,140 3,044 3,203 3,218 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.8 4.2 4.2 3.8 – 4.1 3.9 4.1 4.1 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 53,715 55,471 55,157 53,878 – 54,493 54,683 55,361 55,358\n\n**Both sexes, 16 to 19 years** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 17,860 17,617 17,613 17,860 – 17,808 17,801 17,617 17,613 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6,205 5,782 5,877 6,634 – 6,470 6,506 6,241 6,294 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 34.7 32.8 33.4 37.1 – 36.3 36.6 35.4 35.7 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5,386 4,969 4,994 5,773 – 5,415 5,486 5,390 5,357 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 30.2 28.2 28.4 32.3 – 30.4 30.8 30.6 30.4 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 820 813 883 862 – 1,056 1,020 851 937 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 13.2 14.1 15.0 13.0 – 16.3 15.7 13.6 14.9 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11,655 11,835 11,736 11,226 – 11,338 11,295 11,376 11,319\n\n1 The population figures are not adjusted for seasonal variation; therefore, identical numbers appear in the unadjusted and seasonally adjusted columns. NOTE: January 2026 estimates were revised to incorporate updated population estimates. For additional information, see https://www.bls.gov/cps/documentation.htm. Data for October 2025 were not collected due to the federal government shutdown.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/bls-Feb-2026_page14.pdf"]},"response":{"errors":[],"extract_id":"extract_2553f6a0b24134634c8a10d48b0ff509","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**HOUSEHOLD DATA Table A-1. Employment status of the civilian population by sex and age** [Numbers in thousands]\n\nEmployment status, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**TOTAL** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 272,847 274,676 274,766 272,847 – 274,633 274,816 274,676 274,766 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 170,116 169,612 170,206 170,441 – 171,541 171,495 170,465 170,483 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.3 61.7 61.9 62.5 – 62.5 62.4 62.1 62.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 162,544 161,670 162,153 163,338 – 163,760 163,992 163,097 162,912 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.6 58.9 59.0 59.9 – 59.6 59.7 59.4 59.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 7,572 7,942 8,052 7,104 – 7,781 7,503 7,368 7,571 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.5 4.7 4.7 4.2 – 4.5 4.4 4.3 4.4 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 102,731 105,064 104,560 102,405 – 103,092 103,321 104,211 104,283 People who currently want a job. . . . . . . . . . . . . . . . . .. 5,809 5,961 5,880 5,896 – 6,139 6,208 5,838 5,974\n\n**Men, 16 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 133,089 132,546 132,586 133,089 – 133,957 134,046 132,546 132,586 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 89,792 88,653 88,835 90,078 – 90,739 90,780 89,200 89,101 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 67.5 66.9 67.0 67.7 – 67.7 67.7 67.3 67.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 85,519 84,291 84,460 86,269 – 86,616 86,812 85,348 85,210 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 64.3 63.6 63.7 64.8 – 64.7 64.8 64.4 64.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,273 4,362 4,375 3,809 – 4,123 3,968 3,852 3,891 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.8 4.9 4.9 4.2 – 4.5 4.4 4.3 4.4 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 43,297 43,893 43,750 43,011 – 43,218 43,266 43,345 43,485\n\n**Men, 20 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 123,996 123,570 123,612 123,996 – 124,889 124,981 123,570 123,612 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 86,634 85,812 85,945 86,694 – 87,628 87,638 86,096 86,006 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 69.9 69.4 69.5 69.9 – 70.2 70.1 69.7 69.6 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 82,838 81,964 82,038 83,366 – 84,043 84,199 82,783 82,591 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 66.8 66.3 66.4 67.2 – 67.3 67.4 67.0 66.8 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3,796 3,848 3,907 3,327 – 3,585 3,439 3,313 3,415 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.4 4.5 4.5 3.8 – 4.1 3.9 3.8 4.0 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 37,362 37,758 37,667 37,302 – 37,261 37,344 37,474 37,606\n\n**Women, 16 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 139,758 142,130 142,180 139,758 – 140,676 140,770 142,130 142,180 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 80,323 80,959 81,370 80,363 – 80,802 80,715 81,265 81,382 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57.5 57.0 57.2 57.5 – 57.4 57.3 57.2 57.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 77,025 77,379 77,693 77,068 – 77,144 77,180 77,749 77,702 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 55.1 54.4 54.6 55.1 – 54.8 54.8 54.7 54.7 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3,298 3,580 3,677 3,295 – 3,658 3,535 3,515 3,680 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.4 4.5 4.1 – 4.5 4.4 4.3 4.5 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59,435 61,171 60,810 59,394 – 59,873 60,055 60,865 60,798\n\n**Women, 20 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 130,991 133,489 133,541 130,991 – 131,935 132,034 133,489 133,541 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 77,276 78,018 78,384 77,113 – 77,442 77,351 78,128 78,183 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59.0 58.4 58.7 58.9 – 58.7 58.6 58.5 58.5 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 74,320 74,738 75,121 74,199 – 74,302 74,306 74,925 74,965 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 56.7 56.0 56.3 56.6 – 56.3 56.3 56.1 56.1 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 2,956 3,281 3,263 2,915 – 3,140 3,044 3,203 3,218 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.8 4.2 4.2 3.8 – 4.1 3.9 4.1 4.1 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 53,715 55,471 55,157 53,878 – 54,493 54,683 55,361 55,358\n\n**Both sexes, 16 to 19 years** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 17,860 17,617 17,613 17,860 – 17,808 17,801 17,617 17,613 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6,205 5,782 5,877 6,634 – 6,470 6,506 6,241 6,294 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 34.7 32.8 33.4 37.1 – 36.3 36.6 35.4 35.7 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5,386 4,969 4,994 5,773 – 5,415 5,486 5,390 5,357 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 30.2 28.2 28.4 32.3 – 30.4 30.8 30.6 30.4 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 820 813 883 862 – 1,056 1,020 851 937 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 13.2 14.1 15.0 13.0 – 16.3 15.7 13.6 14.9 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11,655 11,835 11,736 11,226 – 11,338 11,295 11,376 11,319\n\n1 The population figures are not adjusted for seasonal variation; therefore, identical numbers appear in the unadjusted and seasonally adjusted columns. NOTE: January 2026 estimates were revised to incorporate updated population estimates. For additional information, see https://www.bls.gov/cps/documentation.htm. Data for October 2025 were not collected due to the federal government shutdown."],"full_content":"**HOUSEHOLD DATA Table A-1. Employment status of the civilian population by sex and age** [Numbers in thousands]\n\nEmployment status, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**TOTAL** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 272,847 274,676 274,766 272,847 – 274,633 274,816 274,676 274,766 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 170,116 169,612 170,206 170,441 – 171,541 171,495 170,465 170,483 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.3 61.7 61.9 62.5 – 62.5 62.4 62.1 62.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 162,544 161,670 162,153 163,338 – 163,760 163,992 163,097 162,912 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.6 58.9 59.0 59.9 – 59.6 59.7 59.4 59.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 7,572 7,942 8,052 7,104 – 7,781 7,503 7,368 7,571 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.5 4.7 4.7 4.2 – 4.5 4.4 4.3 4.4 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 102,731 105,064 104,560 102,405 – 103,092 103,321 104,211 104,283 People who currently want a job. . . . . . . . . . . . . . . . . .. 5,809 5,961 5,880 5,896 – 6,139 6,208 5,838 5,974\n\n**Men, 16 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 133,089 132,546 132,586 133,089 – 133,957 134,046 132,546 132,586 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 89,792 88,653 88,835 90,078 – 90,739 90,780 89,200 89,101 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 67.5 66.9 67.0 67.7 – 67.7 67.7 67.3 67.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 85,519 84,291 84,460 86,269 – 86,616 86,812 85,348 85,210 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 64.3 63.6 63.7 64.8 – 64.7 64.8 64.4 64.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,273 4,362 4,375 3,809 – 4,123 3,968 3,852 3,891 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.8 4.9 4.9 4.2 – 4.5 4.4 4.3 4.4 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 43,297 43,893 43,750 43,011 – 43,218 43,266 43,345 43,485\n\n**Men, 20 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 123,996 123,570 123,612 123,996 – 124,889 124,981 123,570 123,612 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 86,634 85,812 85,945 86,694 – 87,628 87,638 86,096 86,006 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 69.9 69.4 69.5 69.9 – 70.2 70.1 69.7 69.6 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 82,838 81,964 82,038 83,366 – 84,043 84,199 82,783 82,591 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 66.8 66.3 66.4 67.2 – 67.3 67.4 67.0 66.8 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3,796 3,848 3,907 3,327 – 3,585 3,439 3,313 3,415 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.4 4.5 4.5 3.8 – 4.1 3.9 3.8 4.0 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 37,362 37,758 37,667 37,302 – 37,261 37,344 37,474 37,606\n\n**Women, 16 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 139,758 142,130 142,180 139,758 – 140,676 140,770 142,130 142,180 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 80,323 80,959 81,370 80,363 – 80,802 80,715 81,265 81,382 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57.5 57.0 57.2 57.5 – 57.4 57.3 57.2 57.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 77,025 77,379 77,693 77,068 – 77,144 77,180 77,749 77,702 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 55.1 54.4 54.6 55.1 – 54.8 54.8 54.7 54.7 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3,298 3,580 3,677 3,295 – 3,658 3,535 3,515 3,680 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.4 4.5 4.1 – 4.5 4.4 4.3 4.5 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59,435 61,171 60,810 59,394 – 59,873 60,055 60,865 60,798\n\n**Women, 20 years and over** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 130,991 133,489 133,541 130,991 – 131,935 132,034 133,489 133,541 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 77,276 78,018 78,384 77,113 – 77,442 77,351 78,128 78,183 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 59.0 58.4 58.7 58.9 – 58.7 58.6 58.5 58.5 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 74,320 74,738 75,121 74,199 – 74,302 74,306 74,925 74,965 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 56.7 56.0 56.3 56.6 – 56.3 56.3 56.1 56.1 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 2,956 3,281 3,263 2,915 – 3,140 3,044 3,203 3,218 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.8 4.2 4.2 3.8 – 4.1 3.9 4.1 4.1 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 53,715 55,471 55,157 53,878 – 54,493 54,683 55,361 55,358\n\n**Both sexes, 16 to 19 years** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 17,860 17,617 17,613 17,860 – 17,808 17,801 17,617 17,613 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6,205 5,782 5,877 6,634 – 6,470 6,506 6,241 6,294 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 34.7 32.8 33.4 37.1 – 36.3 36.6 35.4 35.7 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5,386 4,969 4,994 5,773 – 5,415 5,486 5,390 5,357 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 30.2 28.2 28.4 32.3 – 30.4 30.8 30.6 30.4 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 820 813 883 862 – 1,056 1,020 851 937 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 13.2 14.1 15.0 13.0 – 16.3 15.7 13.6 14.9 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11,655 11,835 11,736 11,226 – 11,338 11,295 11,376 11,319\n\n1 The population figures are not adjusted for seasonal variation; therefore, identical numbers appear in the unadjusted and seasonally adjusted columns. NOTE: January 2026 estimates were revised to incorporate updated population estimates. For additional information, see https://www.bls.gov/cps/documentation.htm. Data for October 2025 were not collected due to the federal government shutdown.","publish_date":null,"title":"HOUSEHOLD DATA Table A-1. Employment status of the civilian population by sex and age","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/bls-Feb-2026_page14.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/bls-Feb-2026_page14.pdf"},"request":{"example_id":"table/bls-Feb-2026_page14","product_type":"parse","source_file_path":"bls-Feb-2026_page14.pdf"},"started_at":"2026-11-04T19:46:51.867831"} +{"completed_at":"2026-11-04T19:46:57.543716","latency_in_ms":3932,"output":{"example_id":"table/bls-Feb-2026_page15","grounded_pages":[],"layout_pages":[],"markdown":"**HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age** [Numbers in thousands]\n\nEmployment status, race, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**WHITE** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 207,147 202,423 202,426 207,147 – 207,980 208,058 202,423 202,426 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 128,371 123,330 123,852 128,500 – 128,477 128,617 123,997 123,986 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.0 60.9 61.2 62.0 – 61.8 61.8 61.3 61.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 123,128 118,273 118,878 123,657 – 123,517 123,778 119,412 119,402 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.4 58.4 58.7 59.7 – 59.4 59.5 59.0 59.0 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5,243 5,057 4,974 4,843 – 4,960 4,838 4,585 4,584 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.1 4.0 3.8 – 3.9 3.8 3.7 3.7 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 78,776 79,093 78,574 78,647 – 79,503 79,441 78,426 78,441 **Men, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 66,344 63,545 63,730 66,365 – 66,683 66,700 63,834 63,768 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 69.4 68.6 68.8 69.4 – 69.4 69.4 68.9 68.9 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 63,619 61,026 61,148 64,028 – 64,311 64,411 61,734 61,574 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 66.5 65.9 66.0 67.0 – 67.0 67.0 66.7 66.5 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 2,725 2,519 2,582 2,337 – 2,371 2,289 2,100 2,194 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.0 4.1 3.5 – 3.6 3.4 3.3 3.4 **Women, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57,233 55,622 55,885 57,028 – 56,993 57,008 55,661 55,682 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 58.0 56.9 57.1 57.8 – 57.5 57.4 56.9 56.9 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 55,254 53,634 54,047 55,085 – 55,051 55,178 53,748 53,874 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 56.0 54.8 55.2 55.8 – 55.5 55.6 54.9 55.1 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1,979 1,988 1,839 1,944 – 1,943 1,831 1,913 1,808 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.5 3.6 3.3 3.4 – 3.4 3.2 3.4 3.2 **Both sexes, 16 to 19 years** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,795 4,162 4,236 5,108 – 4,801 4,909 4,502 4,536 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 37.4 34.7 35.3 39.8 – 37.7 38.5 37.5 37.8 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,255 3,613 3,683 4,545 – 4,155 4,190 3,929 3,955 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 33.2 30.1 30.7 35.4 – 32.6 32.9 32.7 33.0 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 540 550 553 563 – 646 719 572 581 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11.3 13.2 13.1 11.0 – 13.5 14.6 12.7 12.8\n\n**BLACK OR AFRICAN AMERICAN** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 35,653 35,364 35,388 35,653 – 35,961 35,995 35,364 35,388 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 22,256 22,052 22,226 22,330 – 22,948 22,728 22,160 22,286 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.4 62.4 62.8 62.6 – 63.8 63.1 62.7 63.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 20,890 20,408 20,499 20,982 – 21,065 21,024 20,553 20,579 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 58.6 57.7 57.9 58.8 – 58.6 58.4 58.1 58.2 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1,366 1,644 1,727 1,348 – 1,884 1,704 1,607 1,707 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6.1 7.5 7.8 6.0 – 8.2 7.5 7.3 7.7 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 13,398 13,312 13,162 13,323 – 13,013 13,267 13,204 13,102 **Men, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 10,313 10,112 10,081 10,354 – 10,776 10,669 10,148 10,113 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 68.0 68.1 67.8 68.3 – 70.4 69.6 68.3 68.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 9,695 9,300 9,327 9,777 – 9,969 9,938 9,402 9,407 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 64.0 62.6 62.8 64.5 – 65.1 64.9 63.3 63.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 618 812 754 577 – 807 731 747 706 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6.0 8.0 7.5 5.6 – 7.5 6.9 7.4 7.0 **Women, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11,172 11,161 11,393 11,155 – 11,238 11,222 11,177 11,369 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.7 62.5 63.8 62.6 – 62.5 62.4 62.6 63.7 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 10,572 10,458 10,602 10,544 – 10,440 10,403 10,459 10,565 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.3 58.6 59.4 59.2 – 58.1 57.8 58.6 59.2 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 600 704 792 611 – 798 820 717 804 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5.4 6.3 6.9 5.5 – 7.1 7.3 6.4 7.1 **Both sexes, 16 to 19 years** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 770 779 751 821 – 934 837 835 804 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 28.8 29.2 28.2 30.7 – 34.8 31.2 31.3 30.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 623 650 570 661 – 656 684 692 606 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 23.3 24.4 21.4 24.7 – 24.4 25.5 26.0 22.8 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 147 129 182 160 – 278 153 143 197 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 19.1 16.5 24.2 19.5 – 29.8 18.3 17.1 24.5\n\nSee footnotes at end of table.","pages":[{"line_numbers":[],"markdown":"**HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age** [Numbers in thousands]\n\nEmployment status, race, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**WHITE** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 207,147 202,423 202,426 207,147 – 207,980 208,058 202,423 202,426 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 128,371 123,330 123,852 128,500 – 128,477 128,617 123,997 123,986 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.0 60.9 61.2 62.0 – 61.8 61.8 61.3 61.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 123,128 118,273 118,878 123,657 – 123,517 123,778 119,412 119,402 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.4 58.4 58.7 59.7 – 59.4 59.5 59.0 59.0 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5,243 5,057 4,974 4,843 – 4,960 4,838 4,585 4,584 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.1 4.0 3.8 – 3.9 3.8 3.7 3.7 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 78,776 79,093 78,574 78,647 – 79,503 79,441 78,426 78,441 **Men, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 66,344 63,545 63,730 66,365 – 66,683 66,700 63,834 63,768 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 69.4 68.6 68.8 69.4 – 69.4 69.4 68.9 68.9 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 63,619 61,026 61,148 64,028 – 64,311 64,411 61,734 61,574 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 66.5 65.9 66.0 67.0 – 67.0 67.0 66.7 66.5 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 2,725 2,519 2,582 2,337 – 2,371 2,289 2,100 2,194 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.0 4.1 3.5 – 3.6 3.4 3.3 3.4 **Women, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57,233 55,622 55,885 57,028 – 56,993 57,008 55,661 55,682 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 58.0 56.9 57.1 57.8 – 57.5 57.4 56.9 56.9 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 55,254 53,634 54,047 55,085 – 55,051 55,178 53,748 53,874 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 56.0 54.8 55.2 55.8 – 55.5 55.6 54.9 55.1 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1,979 1,988 1,839 1,944 – 1,943 1,831 1,913 1,808 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.5 3.6 3.3 3.4 – 3.4 3.2 3.4 3.2 **Both sexes, 16 to 19 years** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,795 4,162 4,236 5,108 – 4,801 4,909 4,502 4,536 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 37.4 34.7 35.3 39.8 – 37.7 38.5 37.5 37.8 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,255 3,613 3,683 4,545 – 4,155 4,190 3,929 3,955 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 33.2 30.1 30.7 35.4 – 32.6 32.9 32.7 33.0 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 540 550 553 563 – 646 719 572 581 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11.3 13.2 13.1 11.0 – 13.5 14.6 12.7 12.8\n\n**BLACK OR AFRICAN AMERICAN** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 35,653 35,364 35,388 35,653 – 35,961 35,995 35,364 35,388 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 22,256 22,052 22,226 22,330 – 22,948 22,728 22,160 22,286 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.4 62.4 62.8 62.6 – 63.8 63.1 62.7 63.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 20,890 20,408 20,499 20,982 – 21,065 21,024 20,553 20,579 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 58.6 57.7 57.9 58.8 – 58.6 58.4 58.1 58.2 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1,366 1,644 1,727 1,348 – 1,884 1,704 1,607 1,707 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6.1 7.5 7.8 6.0 – 8.2 7.5 7.3 7.7 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 13,398 13,312 13,162 13,323 – 13,013 13,267 13,204 13,102 **Men, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 10,313 10,112 10,081 10,354 – 10,776 10,669 10,148 10,113 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 68.0 68.1 67.8 68.3 – 70.4 69.6 68.3 68.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 9,695 9,300 9,327 9,777 – 9,969 9,938 9,402 9,407 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 64.0 62.6 62.8 64.5 – 65.1 64.9 63.3 63.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 618 812 754 577 – 807 731 747 706 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6.0 8.0 7.5 5.6 – 7.5 6.9 7.4 7.0 **Women, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11,172 11,161 11,393 11,155 – 11,238 11,222 11,177 11,369 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.7 62.5 63.8 62.6 – 62.5 62.4 62.6 63.7 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 10,572 10,458 10,602 10,544 – 10,440 10,403 10,459 10,565 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.3 58.6 59.4 59.2 – 58.1 57.8 58.6 59.2 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 600 704 792 611 – 798 820 717 804 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5.4 6.3 6.9 5.5 – 7.1 7.3 6.4 7.1 **Both sexes, 16 to 19 years** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 770 779 751 821 – 934 837 835 804 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 28.8 29.2 28.2 30.7 – 34.8 31.2 31.3 30.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 623 650 570 661 – 656 684 692 606 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 23.3 24.4 21.4 24.7 – 24.4 25.5 26.0 22.8 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 147 129 182 160 – 278 153 143 197 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 19.1 16.5 24.2 19.5 – 29.8 18.3 17.1 24.5\n\nSee footnotes at end of table.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age** [Numbers in thousands]\n\nEmployment status, race, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**WHITE** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 207,147 202,423 202,426 207,147 – 207,980 208,058 202,423 202,426 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 128,371 123,330 123,852 128,500 – 128,477 128,617 123,997 123,986 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.0 60.9 61.2 62.0 – 61.8 61.8 61.3 61.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 123,128 118,273 118,878 123,657 – 123,517 123,778 119,412 119,402 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.4 58.4 58.7 59.7 – 59.4 59.5 59.0 59.0 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5,243 5,057 4,974 4,843 – 4,960 4,838 4,585 4,584 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.1 4.0 3.8 – 3.9 3.8 3.7 3.7 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 78,776 79,093 78,574 78,647 – 79,503 79,441 78,426 78,441 **Men, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 66,344 63,545 63,730 66,365 – 66,683 66,700 63,834 63,768 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 69.4 68.6 68.8 69.4 – 69.4 69.4 68.9 68.9 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 63,619 61,026 61,148 64,028 – 64,311 64,411 61,734 61,574 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 66.5 65.9 66.0 67.0 – 67.0 67.0 66.7 66.5 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 2,725 2,519 2,582 2,337 – 2,371 2,289 2,100 2,194 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.0 4.1 3.5 – 3.6 3.4 3.3 3.4 **Women, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57,233 55,622 55,885 57,028 – 56,993 57,008 55,661 55,682 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 58.0 56.9 57.1 57.8 – 57.5 57.4 56.9 56.9 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 55,254 53,634 54,047 55,085 – 55,051 55,178 53,748 53,874 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 56.0 54.8 55.2 55.8 – 55.5 55.6 54.9 55.1 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1,979 1,988 1,839 1,944 – 1,943 1,831 1,913 1,808 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.5 3.6 3.3 3.4 – 3.4 3.2 3.4 3.2 **Both sexes, 16 to 19 years** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,795 4,162 4,236 5,108 – 4,801 4,909 4,502 4,536 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 37.4 34.7 35.3 39.8 – 37.7 38.5 37.5 37.8 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,255 3,613 3,683 4,545 – 4,155 4,190 3,929 3,955 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 33.2 30.1 30.7 35.4 – 32.6 32.9 32.7 33.0 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 540 550 553 563 – 646 719 572 581 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11.3 13.2 13.1 11.0 – 13.5 14.6 12.7 12.8\n\n**BLACK OR AFRICAN AMERICAN** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 35,653 35,364 35,388 35,653 – 35,961 35,995 35,364 35,388 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 22,256 22,052 22,226 22,330 – 22,948 22,728 22,160 22,286 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.4 62.4 62.8 62.6 – 63.8 63.1 62.7 63.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 20,890 20,408 20,499 20,982 – 21,065 21,024 20,553 20,579 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 58.6 57.7 57.9 58.8 – 58.6 58.4 58.1 58.2 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1,366 1,644 1,727 1,348 – 1,884 1,704 1,607 1,707 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6.1 7.5 7.8 6.0 – 8.2 7.5 7.3 7.7 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 13,398 13,312 13,162 13,323 – 13,013 13,267 13,204 13,102 **Men, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 10,313 10,112 10,081 10,354 – 10,776 10,669 10,148 10,113 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 68.0 68.1 67.8 68.3 – 70.4 69.6 68.3 68.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 9,695 9,300 9,327 9,777 – 9,969 9,938 9,402 9,407 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 64.0 62.6 62.8 64.5 – 65.1 64.9 63.3 63.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 618 812 754 577 – 807 731 747 706 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6.0 8.0 7.5 5.6 – 7.5 6.9 7.4 7.0 **Women, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11,172 11,161 11,393 11,155 – 11,238 11,222 11,177 11,369 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.7 62.5 63.8 62.6 – 62.5 62.4 62.6 63.7 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 10,572 10,458 10,602 10,544 – 10,440 10,403 10,459 10,565 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.3 58.6 59.4 59.2 – 58.1 57.8 58.6 59.2 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 600 704 792 611 – 798 820 717 804 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5.4 6.3 6.9 5.5 – 7.1 7.3 6.4 7.1 **Both sexes, 16 to 19 years** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 770 779 751 821 – 934 837 835 804 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 28.8 29.2 28.2 30.7 – 34.8 31.2 31.3 30.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 623 650 570 661 – 656 684 692 606 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 23.3 24.4 21.4 24.7 – 24.4 25.5 26.0 22.8 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 147 129 182 160 – 278 153 143 197 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 19.1 16.5 24.2 19.5 – 29.8 18.3 17.1 24.5\n\nSee footnotes at end of table.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/bls-Feb-2026_page15.pdf"]},"response":{"errors":[],"extract_id":"extract_0a1c40783fc8d5655c697c7d06599145","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age** [Numbers in thousands]\n\nEmployment status, race, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**WHITE** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 207,147 202,423 202,426 207,147 – 207,980 208,058 202,423 202,426 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 128,371 123,330 123,852 128,500 – 128,477 128,617 123,997 123,986 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.0 60.9 61.2 62.0 – 61.8 61.8 61.3 61.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 123,128 118,273 118,878 123,657 – 123,517 123,778 119,412 119,402 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.4 58.4 58.7 59.7 – 59.4 59.5 59.0 59.0 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5,243 5,057 4,974 4,843 – 4,960 4,838 4,585 4,584 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.1 4.0 3.8 – 3.9 3.8 3.7 3.7 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 78,776 79,093 78,574 78,647 – 79,503 79,441 78,426 78,441 **Men, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 66,344 63,545 63,730 66,365 – 66,683 66,700 63,834 63,768 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 69.4 68.6 68.8 69.4 – 69.4 69.4 68.9 68.9 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 63,619 61,026 61,148 64,028 – 64,311 64,411 61,734 61,574 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 66.5 65.9 66.0 67.0 – 67.0 67.0 66.7 66.5 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 2,725 2,519 2,582 2,337 – 2,371 2,289 2,100 2,194 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.0 4.1 3.5 – 3.6 3.4 3.3 3.4 **Women, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57,233 55,622 55,885 57,028 – 56,993 57,008 55,661 55,682 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 58.0 56.9 57.1 57.8 – 57.5 57.4 56.9 56.9 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 55,254 53,634 54,047 55,085 – 55,051 55,178 53,748 53,874 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 56.0 54.8 55.2 55.8 – 55.5 55.6 54.9 55.1 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1,979 1,988 1,839 1,944 – 1,943 1,831 1,913 1,808 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.5 3.6 3.3 3.4 – 3.4 3.2 3.4 3.2 **Both sexes, 16 to 19 years** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,795 4,162 4,236 5,108 – 4,801 4,909 4,502 4,536 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 37.4 34.7 35.3 39.8 – 37.7 38.5 37.5 37.8 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,255 3,613 3,683 4,545 – 4,155 4,190 3,929 3,955 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 33.2 30.1 30.7 35.4 – 32.6 32.9 32.7 33.0 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 540 550 553 563 – 646 719 572 581 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11.3 13.2 13.1 11.0 – 13.5 14.6 12.7 12.8\n\n**BLACK OR AFRICAN AMERICAN** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 35,653 35,364 35,388 35,653 – 35,961 35,995 35,364 35,388 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 22,256 22,052 22,226 22,330 – 22,948 22,728 22,160 22,286 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.4 62.4 62.8 62.6 – 63.8 63.1 62.7 63.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 20,890 20,408 20,499 20,982 – 21,065 21,024 20,553 20,579 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 58.6 57.7 57.9 58.8 – 58.6 58.4 58.1 58.2 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1,366 1,644 1,727 1,348 – 1,884 1,704 1,607 1,707 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6.1 7.5 7.8 6.0 – 8.2 7.5 7.3 7.7 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 13,398 13,312 13,162 13,323 – 13,013 13,267 13,204 13,102 **Men, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 10,313 10,112 10,081 10,354 – 10,776 10,669 10,148 10,113 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 68.0 68.1 67.8 68.3 – 70.4 69.6 68.3 68.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 9,695 9,300 9,327 9,777 – 9,969 9,938 9,402 9,407 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 64.0 62.6 62.8 64.5 – 65.1 64.9 63.3 63.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 618 812 754 577 – 807 731 747 706 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6.0 8.0 7.5 5.6 – 7.5 6.9 7.4 7.0 **Women, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11,172 11,161 11,393 11,155 – 11,238 11,222 11,177 11,369 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.7 62.5 63.8 62.6 – 62.5 62.4 62.6 63.7 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 10,572 10,458 10,602 10,544 – 10,440 10,403 10,459 10,565 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.3 58.6 59.4 59.2 – 58.1 57.8 58.6 59.2 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 600 704 792 611 – 798 820 717 804 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5.4 6.3 6.9 5.5 – 7.1 7.3 6.4 7.1 **Both sexes, 16 to 19 years** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 770 779 751 821 – 934 837 835 804 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 28.8 29.2 28.2 30.7 – 34.8 31.2 31.3 30.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 623 650 570 661 – 656 684 692 606 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 23.3 24.4 21.4 24.7 – 24.4 25.5 26.0 22.8 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 147 129 182 160 – 278 153 143 197 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 19.1 16.5 24.2 19.5 – 29.8 18.3 17.1 24.5\n\nSee footnotes at end of table."],"full_content":"**HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age** [Numbers in thousands]\n\nEmployment status, race, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**WHITE** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 207,147 202,423 202,426 207,147 – 207,980 208,058 202,423 202,426 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 128,371 123,330 123,852 128,500 – 128,477 128,617 123,997 123,986 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.0 60.9 61.2 62.0 – 61.8 61.8 61.3 61.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 123,128 118,273 118,878 123,657 – 123,517 123,778 119,412 119,402 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.4 58.4 58.7 59.7 – 59.4 59.5 59.0 59.0 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5,243 5,057 4,974 4,843 – 4,960 4,838 4,585 4,584 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.1 4.0 3.8 – 3.9 3.8 3.7 3.7 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 78,776 79,093 78,574 78,647 – 79,503 79,441 78,426 78,441 **Men, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 66,344 63,545 63,730 66,365 – 66,683 66,700 63,834 63,768 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 69.4 68.6 68.8 69.4 – 69.4 69.4 68.9 68.9 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 63,619 61,026 61,148 64,028 – 64,311 64,411 61,734 61,574 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 66.5 65.9 66.0 67.0 – 67.0 67.0 66.7 66.5 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 2,725 2,519 2,582 2,337 – 2,371 2,289 2,100 2,194 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4.1 4.0 4.1 3.5 – 3.6 3.4 3.3 3.4 **Women, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 57,233 55,622 55,885 57,028 – 56,993 57,008 55,661 55,682 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 58.0 56.9 57.1 57.8 – 57.5 57.4 56.9 56.9 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 55,254 53,634 54,047 55,085 – 55,051 55,178 53,748 53,874 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 56.0 54.8 55.2 55.8 – 55.5 55.6 54.9 55.1 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1,979 1,988 1,839 1,944 – 1,943 1,831 1,913 1,808 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.5 3.6 3.3 3.4 – 3.4 3.2 3.4 3.2 **Both sexes, 16 to 19 years** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,795 4,162 4,236 5,108 – 4,801 4,909 4,502 4,536 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 37.4 34.7 35.3 39.8 – 37.7 38.5 37.5 37.8 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 4,255 3,613 3,683 4,545 – 4,155 4,190 3,929 3,955 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 33.2 30.1 30.7 35.4 – 32.6 32.9 32.7 33.0 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 540 550 553 563 – 646 719 572 581 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11.3 13.2 13.1 11.0 – 13.5 14.6 12.7 12.8\n\n**BLACK OR AFRICAN AMERICAN** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 35,653 35,364 35,388 35,653 – 35,961 35,995 35,364 35,388 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 22,256 22,052 22,226 22,330 – 22,948 22,728 22,160 22,286 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.4 62.4 62.8 62.6 – 63.8 63.1 62.7 63.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 20,890 20,408 20,499 20,982 – 21,065 21,024 20,553 20,579 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 58.6 57.7 57.9 58.8 – 58.6 58.4 58.1 58.2 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1,366 1,644 1,727 1,348 – 1,884 1,704 1,607 1,707 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6.1 7.5 7.8 6.0 – 8.2 7.5 7.3 7.7 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 13,398 13,312 13,162 13,323 – 13,013 13,267 13,204 13,102 **Men, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 10,313 10,112 10,081 10,354 – 10,776 10,669 10,148 10,113 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 68.0 68.1 67.8 68.3 – 70.4 69.6 68.3 68.0 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 9,695 9,300 9,327 9,777 – 9,969 9,938 9,402 9,407 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 64.0 62.6 62.8 64.5 – 65.1 64.9 63.3 63.3 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 618 812 754 577 – 807 731 747 706 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6.0 8.0 7.5 5.6 – 7.5 6.9 7.4 7.0 **Women, 20 years and over** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 11,172 11,161 11,393 11,155 – 11,238 11,222 11,177 11,369 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 62.7 62.5 63.8 62.6 – 62.5 62.4 62.6 63.7 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 10,572 10,458 10,602 10,544 – 10,440 10,403 10,459 10,565 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 59.3 58.6 59.4 59.2 – 58.1 57.8 58.6 59.2 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 600 704 792 611 – 798 820 717 804 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 5.4 6.3 6.9 5.5 – 7.1 7.3 6.4 7.1 **Both sexes, 16 to 19 years** Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 770 779 751 821 – 934 837 835 804 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 28.8 29.2 28.2 30.7 – 34.8 31.2 31.3 30.2 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 623 650 570 661 – 656 684 692 606 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 23.3 24.4 21.4 24.7 – 24.4 25.5 26.0 22.8 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 147 129 182 160 – 278 153 143 197 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 19.1 16.5 24.2 19.5 – 29.8 18.3 17.1 24.5\n\nSee footnotes at end of table.","publish_date":null,"title":"HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/bls-Feb-2026_page15.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/bls-Feb-2026_page15.pdf"},"request":{"example_id":"table/bls-Feb-2026_page15","product_type":"parse","source_file_path":"bls-Feb-2026_page15.pdf"},"started_at":"2026-11-04T19:46:53.611251"} +{"completed_at":"2026-11-04T19:46:56.593032","latency_in_ms":1387,"output":{"example_id":"table/bls-Feb-2026_page16","grounded_pages":[],"layout_pages":[],"markdown":"**HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age — Continued** [Numbers in thousands]\n\nEmployment status, race, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**ASIAN** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 19,097 20,856 21,099 19,097 – 19,836 19,788 20,856 21,099 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 12,483 13,754 13,867 12,514 – 13,083 13,036 13,828 13,892 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 65.4 65.9 65.7 65.5 – 66.0 65.9 66.3 65.8 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 12,086 13,144 13,189 12,114 – 12,617 12,565 13,241 13,222 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 63.3 63.0 62.5 63.4 – 63.6 63.5 63.5 62.7 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 398 611 678 400 – 466 471 588 670 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.2 4.4 4.9 3.2 – 3.6 3.6 4.2 4.8 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6,614 7,101 7,232 6,583 – 6,753 6,752 7,027 7,207\n\n1 The population figures are not adjusted for seasonal variation; therefore, identical numbers appear in the unadjusted and seasonally adjusted columns. NOTE: Estimates for the above race groups will not sum to totals shown in table A-1 because data are not presented for all races. January 2026 estimates were revised to incorporate updated population estimates. For additional information, see https://www.bls.gov/cps/documentation.htm. Data for October 2025 were not collected due to the federal government shutdown.","pages":[{"line_numbers":[],"markdown":"**HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age — Continued** [Numbers in thousands]\n\nEmployment status, race, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**ASIAN** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 19,097 20,856 21,099 19,097 – 19,836 19,788 20,856 21,099 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 12,483 13,754 13,867 12,514 – 13,083 13,036 13,828 13,892 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 65.4 65.9 65.7 65.5 – 66.0 65.9 66.3 65.8 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 12,086 13,144 13,189 12,114 – 12,617 12,565 13,241 13,222 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 63.3 63.0 62.5 63.4 – 63.6 63.5 63.5 62.7 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 398 611 678 400 – 466 471 588 670 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.2 4.4 4.9 3.2 – 3.6 3.6 4.2 4.8 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6,614 7,101 7,232 6,583 – 6,753 6,752 7,027 7,207\n\n1 The population figures are not adjusted for seasonal variation; therefore, identical numbers appear in the unadjusted and seasonally adjusted columns. NOTE: Estimates for the above race groups will not sum to totals shown in table A-1 because data are not presented for all races. January 2026 estimates were revised to incorporate updated population estimates. For additional information, see https://www.bls.gov/cps/documentation.htm. Data for October 2025 were not collected due to the federal government shutdown.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age — Continued** [Numbers in thousands]\n\nEmployment status, race, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**ASIAN** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 19,097 20,856 21,099 19,097 – 19,836 19,788 20,856 21,099 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 12,483 13,754 13,867 12,514 – 13,083 13,036 13,828 13,892 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 65.4 65.9 65.7 65.5 – 66.0 65.9 66.3 65.8 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 12,086 13,144 13,189 12,114 – 12,617 12,565 13,241 13,222 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 63.3 63.0 62.5 63.4 – 63.6 63.5 63.5 62.7 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 398 611 678 400 – 466 471 588 670 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.2 4.4 4.9 3.2 – 3.6 3.6 4.2 4.8 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6,614 7,101 7,232 6,583 – 6,753 6,752 7,027 7,207\n\n1 The population figures are not adjusted for seasonal variation; therefore, identical numbers appear in the unadjusted and seasonally adjusted columns. NOTE: Estimates for the above race groups will not sum to totals shown in table A-1 because data are not presented for all races. January 2026 estimates were revised to incorporate updated population estimates. For additional information, see https://www.bls.gov/cps/documentation.htm. Data for October 2025 were not collected due to the federal government shutdown.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/bls-Feb-2026_page16.pdf"]},"response":{"errors":[],"extract_id":"extract_82a5ddc841c76e9c32099f137c288a8c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age — Continued** [Numbers in thousands]\n\nEmployment status, race, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**ASIAN** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 19,097 20,856 21,099 19,097 – 19,836 19,788 20,856 21,099 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 12,483 13,754 13,867 12,514 – 13,083 13,036 13,828 13,892 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 65.4 65.9 65.7 65.5 – 66.0 65.9 66.3 65.8 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 12,086 13,144 13,189 12,114 – 12,617 12,565 13,241 13,222 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 63.3 63.0 62.5 63.4 – 63.6 63.5 63.5 62.7 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 398 611 678 400 – 466 471 588 670 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.2 4.4 4.9 3.2 – 3.6 3.6 4.2 4.8 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6,614 7,101 7,232 6,583 – 6,753 6,752 7,027 7,207\n\n1 The population figures are not adjusted for seasonal variation; therefore, identical numbers appear in the unadjusted and seasonally adjusted columns. NOTE: Estimates for the above race groups will not sum to totals shown in table A-1 because data are not presented for all races. January 2026 estimates were revised to incorporate updated population estimates. For additional information, see https://www.bls.gov/cps/documentation.htm. Data for October 2025 were not collected due to the federal government shutdown."],"full_content":"**HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age — Continued** [Numbers in thousands]\n\nEmployment status, race, sex, and age Not seasonally adjusted Seasonally adjusted ¹\n\nFeb. 2025 Jan. 2026 Feb. 2026 Feb. 2025 Oct. 2025 Nov. 2025 Dec. 2025 Jan. 2026 Feb. 2026\n\n**ASIAN** Civilian noninstitutional population. . . . . . . . . . . . . . . . . . . . .. 19,097 20,856 21,099 19,097 – 19,836 19,788 20,856 21,099 Civilian labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 12,483 13,754 13,867 12,514 – 13,083 13,036 13,828 13,892 Participation rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 65.4 65.9 65.7 65.5 – 66.0 65.9 66.3 65.8 Employed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 12,086 13,144 13,189 12,114 – 12,617 12,565 13,241 13,222 Employment-population ratio. . . . . . . . . . . . . . . . . . . .. 63.3 63.0 62.5 63.4 – 63.6 63.5 63.5 62.7 Unemployed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 398 611 678 400 – 466 471 588 670 Unemployment rate. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 3.2 4.4 4.9 3.2 – 3.6 3.6 4.2 4.8 Not in labor force. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 6,614 7,101 7,232 6,583 – 6,753 6,752 7,027 7,207\n\n1 The population figures are not adjusted for seasonal variation; therefore, identical numbers appear in the unadjusted and seasonally adjusted columns. NOTE: Estimates for the above race groups will not sum to totals shown in table A-1 because data are not presented for all races. January 2026 estimates were revised to incorporate updated population estimates. For additional information, see https://www.bls.gov/cps/documentation.htm. Data for October 2025 were not collected due to the federal government shutdown.","publish_date":null,"title":"HOUSEHOLD DATA Table A-2. Employment status of the civilian population by race, sex, and age—Continued","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/bls-Feb-2026_page16.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/bls-Feb-2026_page16.pdf"},"request":{"example_id":"table/bls-Feb-2026_page16","product_type":"parse","source_file_path":"bls-Feb-2026_page16.pdf"},"started_at":"2026-11-04T19:46:55.205355"} +{"completed_at":"2026-11-04T19:47:00.192549","latency_in_ms":3597,"output":{"example_id":"table/corp-q1-2025_page10","grounded_pages":[],"layout_pages":[],"markdown":"**Other income** increased, reflecting: • a $588 million First Republic-related gain in\n\nCorporate, and\n\n• higher auto operating lease income due to an\n\nincrease in origination volume in CCB.\n\nRefer to CCB and Corporate results on pages 19-21 and pages 30-31, respectively, for additional information; and Note 5 for additional information on the First Republic-related gain. **Net interest income** increased driven by higher Markets net interest income, higher revolving balances in Card Services, the impact of securities activity including from prior quarters, and higher wholesale deposit balances. These factors were predominantly offset by the impact of lower rates and deposit margin compression, as well as lower average deposit balances in CCB. The Firm’s average interest-earning assets were $3.7 trillion, up $223 billion, and the yield was 5.19%, down 36 basis points (“bps”). The net yield on these assets, on an FTE basis, was 2.58%, a decrease of 13 bps. The net yield excluding Markets was 3.80%, down 3 bps. Refer to the Consolidated average balance sheets, interest and rates schedule on page 171 for additional information. Net yield excluding Markets is a non- GAAP financial measure. Refer to Explanation and Reconciliation of the Firm’s Use of Non-GAAP Financial Measures on pages 15-16 for an additional discussion of net yield excluding Markets.\n\n**Provision for credit losses**\n\nThree months ended March 31,\n\n(in millions) **2025** 2024 Change\n\nConsumer, excluding credit card **$ 204** $ 77 165 %\n\nCredit card **2,382** 1,837 30\n\n**Total consumer 2,586** 1,914 35\n\nWholesale **736** (56) NM\n\nInvestment securities **(17)** 26 NM\n\n**Total provision for credit losses $ 3,305** $ 1,884 75 %\n\n**Quarterly results** The **provision for credit losses** was $3.3 billion. Net charge-offs were $2.3 billion and the net addition to the allowance for credit losses was $973 million. Net charge-offs included $2.1 billion in **consumer** , predominantly driven by Card Services, reflecting the seasoning of vintages originated in recent years, and $187 million in **wholesale** . The net addition to the allowance for credit losses was largely driven by changes in the weighted- average macroeconomic outlook, and consisted of: • $549 million in **wholesale** , which also reflected\n\nchanges in credit quality on client-specific exposures and the impact of new lending-related commitments, and\n\n• $441 million in **consumer** , predominantly driven by\n\nCard Services.\n\nIn the prior year, the provision was $1.9 billion, net charge-offs were $2.0 billion and the net reduction in the allowance for credit losses was $72 million. Refer to CCB, CIB and AWM segment and Corporate results on pages 19-21, pages 22-26, pages 27-29, and pages 30-31, respectively; Allowance for Credit Losses on pages 61-63; Critical Accounting Estimates Used by the Firm on pages 72–75; and Notes 11 and 12 for additional information on the credit portfolio and the allowance for credit losses.\n\n10","pages":[{"line_numbers":[],"markdown":"**Other income** increased, reflecting: • a $588 million First Republic-related gain in\n\nCorporate, and\n\n• higher auto operating lease income due to an\n\nincrease in origination volume in CCB.\n\nRefer to CCB and Corporate results on pages 19-21 and pages 30-31, respectively, for additional information; and Note 5 for additional information on the First Republic-related gain. **Net interest income** increased driven by higher Markets net interest income, higher revolving balances in Card Services, the impact of securities activity including from prior quarters, and higher wholesale deposit balances. These factors were predominantly offset by the impact of lower rates and deposit margin compression, as well as lower average deposit balances in CCB. The Firm’s average interest-earning assets were $3.7 trillion, up $223 billion, and the yield was 5.19%, down 36 basis points (“bps”). The net yield on these assets, on an FTE basis, was 2.58%, a decrease of 13 bps. The net yield excluding Markets was 3.80%, down 3 bps. Refer to the Consolidated average balance sheets, interest and rates schedule on page 171 for additional information. Net yield excluding Markets is a non- GAAP financial measure. Refer to Explanation and Reconciliation of the Firm’s Use of Non-GAAP Financial Measures on pages 15-16 for an additional discussion of net yield excluding Markets.\n\n**Provision for credit losses**\n\nThree months ended March 31,\n\n(in millions) **2025** 2024 Change\n\nConsumer, excluding credit card **$ 204** $ 77 165 %\n\nCredit card **2,382** 1,837 30\n\n**Total consumer 2,586** 1,914 35\n\nWholesale **736** (56) NM\n\nInvestment securities **(17)** 26 NM\n\n**Total provision for credit losses $ 3,305** $ 1,884 75 %\n\n**Quarterly results** The **provision for credit losses** was $3.3 billion. Net charge-offs were $2.3 billion and the net addition to the allowance for credit losses was $973 million. Net charge-offs included $2.1 billion in **consumer** , predominantly driven by Card Services, reflecting the seasoning of vintages originated in recent years, and $187 million in **wholesale** . The net addition to the allowance for credit losses was largely driven by changes in the weighted- average macroeconomic outlook, and consisted of: • $549 million in **wholesale** , which also reflected\n\nchanges in credit quality on client-specific exposures and the impact of new lending-related commitments, and\n\n• $441 million in **consumer** , predominantly driven by\n\nCard Services.\n\nIn the prior year, the provision was $1.9 billion, net charge-offs were $2.0 billion and the net reduction in the allowance for credit losses was $72 million. Refer to CCB, CIB and AWM segment and Corporate results on pages 19-21, pages 22-26, pages 27-29, and pages 30-31, respectively; Allowance for Credit Losses on pages 61-63; Critical Accounting Estimates Used by the Firm on pages 72–75; and Notes 11 and 12 for additional information on the credit portfolio and the allowance for credit losses.\n\n10","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Other income** increased, reflecting: • a $588 million First Republic-related gain in\n\nCorporate, and\n\n• higher auto operating lease income due to an\n\nincrease in origination volume in CCB.\n\nRefer to CCB and Corporate results on pages 19-21 and pages 30-31, respectively, for additional information; and Note 5 for additional information on the First Republic-related gain. **Net interest income** increased driven by higher Markets net interest income, higher revolving balances in Card Services, the impact of securities activity including from prior quarters, and higher wholesale deposit balances. These factors were predominantly offset by the impact of lower rates and deposit margin compression, as well as lower average deposit balances in CCB. The Firm’s average interest-earning assets were $3.7 trillion, up $223 billion, and the yield was 5.19%, down 36 basis points (“bps”). The net yield on these assets, on an FTE basis, was 2.58%, a decrease of 13 bps. The net yield excluding Markets was 3.80%, down 3 bps. Refer to the Consolidated average balance sheets, interest and rates schedule on page 171 for additional information. Net yield excluding Markets is a non- GAAP financial measure. Refer to Explanation and Reconciliation of the Firm’s Use of Non-GAAP Financial Measures on pages 15-16 for an additional discussion of net yield excluding Markets.\n\n**Provision for credit losses**\n\nThree months ended March 31,\n\n(in millions) **2025** 2024 Change\n\nConsumer, excluding credit card **$ 204** $ 77 165 %\n\nCredit card **2,382** 1,837 30\n\n**Total consumer 2,586** 1,914 35\n\nWholesale **736** (56) NM\n\nInvestment securities **(17)** 26 NM\n\n**Total provision for credit losses $ 3,305** $ 1,884 75 %\n\n**Quarterly results** The **provision for credit losses** was $3.3 billion. Net charge-offs were $2.3 billion and the net addition to the allowance for credit losses was $973 million. Net charge-offs included $2.1 billion in **consumer** , predominantly driven by Card Services, reflecting the seasoning of vintages originated in recent years, and $187 million in **wholesale** . The net addition to the allowance for credit losses was largely driven by changes in the weighted- average macroeconomic outlook, and consisted of: • $549 million in **wholesale** , which also reflected\n\nchanges in credit quality on client-specific exposures and the impact of new lending-related commitments, and\n\n• $441 million in **consumer** , predominantly driven by\n\nCard Services.\n\nIn the prior year, the provision was $1.9 billion, net charge-offs were $2.0 billion and the net reduction in the allowance for credit losses was $72 million. Refer to CCB, CIB and AWM segment and Corporate results on pages 19-21, pages 22-26, pages 27-29, and pages 30-31, respectively; Allowance for Credit Losses on pages 61-63; Critical Accounting Estimates Used by the Firm on pages 72–75; and Notes 11 and 12 for additional information on the credit portfolio and the allowance for credit losses.\n\n10","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/corp-q1-2025_page10.pdf"]},"response":{"errors":[],"extract_id":"extract_f4f7be1e9879038427df75305a74eb24","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Other income** increased, reflecting: • a $588 million First Republic-related gain in\n\nCorporate, and\n\n• higher auto operating lease income due to an\n\nincrease in origination volume in CCB.\n\nRefer to CCB and Corporate results on pages 19-21 and pages 30-31, respectively, for additional information; and Note 5 for additional information on the First Republic-related gain. **Net interest income** increased driven by higher Markets net interest income, higher revolving balances in Card Services, the impact of securities activity including from prior quarters, and higher wholesale deposit balances. These factors were predominantly offset by the impact of lower rates and deposit margin compression, as well as lower average deposit balances in CCB. The Firm’s average interest-earning assets were $3.7 trillion, up $223 billion, and the yield was 5.19%, down 36 basis points (“bps”). The net yield on these assets, on an FTE basis, was 2.58%, a decrease of 13 bps. The net yield excluding Markets was 3.80%, down 3 bps. Refer to the Consolidated average balance sheets, interest and rates schedule on page 171 for additional information. Net yield excluding Markets is a non- GAAP financial measure. Refer to Explanation and Reconciliation of the Firm’s Use of Non-GAAP Financial Measures on pages 15-16 for an additional discussion of net yield excluding Markets.\n\n**Provision for credit losses**\n\nThree months ended March 31,\n\n(in millions) **2025** 2024 Change\n\nConsumer, excluding credit card **$ 204** $ 77 165 %\n\nCredit card **2,382** 1,837 30\n\n**Total consumer 2,586** 1,914 35\n\nWholesale **736** (56) NM\n\nInvestment securities **(17)** 26 NM\n\n**Total provision for credit losses $ 3,305** $ 1,884 75 %\n\n**Quarterly results** The **provision for credit losses** was $3.3 billion. Net charge-offs were $2.3 billion and the net addition to the allowance for credit losses was $973 million. Net charge-offs included $2.1 billion in **consumer** , predominantly driven by Card Services, reflecting the seasoning of vintages originated in recent years, and $187 million in **wholesale** . The net addition to the allowance for credit losses was largely driven by changes in the weighted- average macroeconomic outlook, and consisted of: • $549 million in **wholesale** , which also reflected\n\nchanges in credit quality on client-specific exposures and the impact of new lending-related commitments, and\n\n• $441 million in **consumer** , predominantly driven by\n\nCard Services.\n\nIn the prior year, the provision was $1.9 billion, net charge-offs were $2.0 billion and the net reduction in the allowance for credit losses was $72 million. Refer to CCB, CIB and AWM segment and Corporate results on pages 19-21, pages 22-26, pages 27-29, and pages 30-31, respectively; Allowance for Credit Losses on pages 61-63; Critical Accounting Estimates Used by the Firm on pages 72–75; and Notes 11 and 12 for additional information on the credit portfolio and the allowance for credit losses.\n\n10"],"full_content":"**Other income** increased, reflecting: • a $588 million First Republic-related gain in\n\nCorporate, and\n\n• higher auto operating lease income due to an\n\nincrease in origination volume in CCB.\n\nRefer to CCB and Corporate results on pages 19-21 and pages 30-31, respectively, for additional information; and Note 5 for additional information on the First Republic-related gain. **Net interest income** increased driven by higher Markets net interest income, higher revolving balances in Card Services, the impact of securities activity including from prior quarters, and higher wholesale deposit balances. These factors were predominantly offset by the impact of lower rates and deposit margin compression, as well as lower average deposit balances in CCB. The Firm’s average interest-earning assets were $3.7 trillion, up $223 billion, and the yield was 5.19%, down 36 basis points (“bps”). The net yield on these assets, on an FTE basis, was 2.58%, a decrease of 13 bps. The net yield excluding Markets was 3.80%, down 3 bps. Refer to the Consolidated average balance sheets, interest and rates schedule on page 171 for additional information. Net yield excluding Markets is a non- GAAP financial measure. Refer to Explanation and Reconciliation of the Firm’s Use of Non-GAAP Financial Measures on pages 15-16 for an additional discussion of net yield excluding Markets.\n\n**Provision for credit losses**\n\nThree months ended March 31,\n\n(in millions) **2025** 2024 Change\n\nConsumer, excluding credit card **$ 204** $ 77 165 %\n\nCredit card **2,382** 1,837 30\n\n**Total consumer 2,586** 1,914 35\n\nWholesale **736** (56) NM\n\nInvestment securities **(17)** 26 NM\n\n**Total provision for credit losses $ 3,305** $ 1,884 75 %\n\n**Quarterly results** The **provision for credit losses** was $3.3 billion. Net charge-offs were $2.3 billion and the net addition to the allowance for credit losses was $973 million. Net charge-offs included $2.1 billion in **consumer** , predominantly driven by Card Services, reflecting the seasoning of vintages originated in recent years, and $187 million in **wholesale** . The net addition to the allowance for credit losses was largely driven by changes in the weighted- average macroeconomic outlook, and consisted of: • $549 million in **wholesale** , which also reflected\n\nchanges in credit quality on client-specific exposures and the impact of new lending-related commitments, and\n\n• $441 million in **consumer** , predominantly driven by\n\nCard Services.\n\nIn the prior year, the provision was $1.9 billion, net charge-offs were $2.0 billion and the net reduction in the allowance for credit losses was $72 million. Refer to CCB, CIB and AWM segment and Corporate results on pages 19-21, pages 22-26, pages 27-29, and pages 30-31, respectively; Allowance for Credit Losses on pages 61-63; Critical Accounting Estimates Used by the Firm on pages 72–75; and Notes 11 and 12 for additional information on the credit portfolio and the allowance for credit losses.\n\n10","publish_date":null,"title":"Other income increased, reflecting: Provision for credit losses • a $588 million First Republic-related gain in Corporate, and • higher","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/corp-q1-2025_page10.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/corp-q1-2025_page10.pdf"},"request":{"example_id":"table/corp-q1-2025_page10","product_type":"parse","source_file_path":"corp-q1-2025_page10.pdf"},"started_at":"2026-11-04T19:46:56.595549"} +{"completed_at":"2026-11-04T19:47:00.710533","latency_in_ms":3002,"output":{"example_id":"table/corp-q1-2025_page13","grounded_pages":[],"layout_pages":[],"markdown":"Notes 2, 3, 11 and 12 for additional information on loans and the total allowance for credit losses. **Accrued interest and accounts receivable** increased primarily due to higher client receivables related to client-driven activities in CIB.\n\n**Goodwill, MSRs and other intangible assets** : refer to Note 14 for additional information.\n\n**Selected Consolidated balance sheets data (continued)**\n\n(in millions)\n\n**March 31,**\n\n**2025**\n\nDecember 31,\n\n2024 Change\n\n**Liabilities**\n\nDeposits **$ 2,495,877** $ 2,406,032 4 %\n\nFederal funds purchased and securities loaned or sold under repurchase agreements **533,046** 296,835 80\n\nShort-term borrowings **64,980** 52,893 23\n\nTrading liabilities **187,103** 192,883 (3)\n\nAccounts payable and other liabilities **293,538** 280,672 5\n\nBeneficial interests issued by consolidated variable interest entities (“VIEs”) **24,668** 27,323 (10)\n\nLong-term debt **407,224** 401,418 1\n\n**Total liabilities 4,006,436** 3,658,056 10\n\nStockholders’ equity **351,420** 344,758 2\n\n**Total liabilities and stockholders’ equity $ 4,357,856** $ 4,002,814 9 %\n\n**Deposits** increased, reflecting the impact of: • an increase in CIB predominantly due to net inflows\n\nrelated to client-driven activities in Securities Services and Payments,\n\n• an increase in CCB primarily driven by new accounts,\n\nand\n\n• an increase in AWM as a result of growth in balances\n\nin new and existing client accounts, reflecting the impact of higher-yielding product offerings, predominantly offset by continued migration into other investments.\n\n**Federal funds purchased and securities loaned or sold under repurchase agreements** increased driven by Markets, reflecting higher client-driven market- making activities, higher secured financing of trading assets and the impact of lower levels of netting, as well as when compared with seasonally lower levels at year-end. **Short-term borrowings** increased driven by higher financing requirements in Markets. Refer to Liquidity Risk Management on pages 40-46 for additional information on deposits, federal funds purchased and securities loaned or sold under repurchase agreements, and short-term borrowings; and Notes 2 and 15 for deposits; and Note 10 for federal funds purchased and securities loaned or sold under repurchase agreements.\n\n**Trading liabilities** : refer to Notes 2 and 4 for additional information. **Accounts payable and other liabilities** increased due to higher client payables related to client-driven activities in CIB. **Beneficial interests issued by consolidated VIEs** decreased largely driven by lower levels of outstanding commercial paper as a result of a decrease in loan balances in the Firm-administered multi-seller conduits in CIB. Refer to Liquidity Risk Management on pages 40-46 and Notes 13 and 22 for additional information, specifically Firm-sponsored VIEs and loan securitization trusts. **Long-term debt** : refer to Liquidity Risk Management on pages 40-46 for additional information. **Stockholders’ equity** increased reflecting net income and lower unrealized losses in AOCI, predominantly driven by the impact of lower interest rates on cash flow hedges and on the AFS portfolio in Treasury and CIO, largely offset by the impact of capital actions, including net repurchases of common shares and common and preferred stock dividend payments. Refer to Consolidated statements of changes in stockholders’ equity on page 81, Capital Actions on page 37, and Note 19 for additional information.\n\n13","pages":[{"line_numbers":[],"markdown":"Notes 2, 3, 11 and 12 for additional information on loans and the total allowance for credit losses. **Accrued interest and accounts receivable** increased primarily due to higher client receivables related to client-driven activities in CIB.\n\n**Goodwill, MSRs and other intangible assets** : refer to Note 14 for additional information.\n\n**Selected Consolidated balance sheets data (continued)**\n\n(in millions)\n\n**March 31,**\n\n**2025**\n\nDecember 31,\n\n2024 Change\n\n**Liabilities**\n\nDeposits **$ 2,495,877** $ 2,406,032 4 %\n\nFederal funds purchased and securities loaned or sold under repurchase agreements **533,046** 296,835 80\n\nShort-term borrowings **64,980** 52,893 23\n\nTrading liabilities **187,103** 192,883 (3)\n\nAccounts payable and other liabilities **293,538** 280,672 5\n\nBeneficial interests issued by consolidated variable interest entities (“VIEs”) **24,668** 27,323 (10)\n\nLong-term debt **407,224** 401,418 1\n\n**Total liabilities 4,006,436** 3,658,056 10\n\nStockholders’ equity **351,420** 344,758 2\n\n**Total liabilities and stockholders’ equity $ 4,357,856** $ 4,002,814 9 %\n\n**Deposits** increased, reflecting the impact of: • an increase in CIB predominantly due to net inflows\n\nrelated to client-driven activities in Securities Services and Payments,\n\n• an increase in CCB primarily driven by new accounts,\n\nand\n\n• an increase in AWM as a result of growth in balances\n\nin new and existing client accounts, reflecting the impact of higher-yielding product offerings, predominantly offset by continued migration into other investments.\n\n**Federal funds purchased and securities loaned or sold under repurchase agreements** increased driven by Markets, reflecting higher client-driven market- making activities, higher secured financing of trading assets and the impact of lower levels of netting, as well as when compared with seasonally lower levels at year-end. **Short-term borrowings** increased driven by higher financing requirements in Markets. Refer to Liquidity Risk Management on pages 40-46 for additional information on deposits, federal funds purchased and securities loaned or sold under repurchase agreements, and short-term borrowings; and Notes 2 and 15 for deposits; and Note 10 for federal funds purchased and securities loaned or sold under repurchase agreements.\n\n**Trading liabilities** : refer to Notes 2 and 4 for additional information. **Accounts payable and other liabilities** increased due to higher client payables related to client-driven activities in CIB. **Beneficial interests issued by consolidated VIEs** decreased largely driven by lower levels of outstanding commercial paper as a result of a decrease in loan balances in the Firm-administered multi-seller conduits in CIB. Refer to Liquidity Risk Management on pages 40-46 and Notes 13 and 22 for additional information, specifically Firm-sponsored VIEs and loan securitization trusts. **Long-term debt** : refer to Liquidity Risk Management on pages 40-46 for additional information. **Stockholders’ equity** increased reflecting net income and lower unrealized losses in AOCI, predominantly driven by the impact of lower interest rates on cash flow hedges and on the AFS portfolio in Treasury and CIO, largely offset by the impact of capital actions, including net repurchases of common shares and common and preferred stock dividend payments. Refer to Consolidated statements of changes in stockholders’ equity on page 81, Capital Actions on page 37, and Note 19 for additional information.\n\n13","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Notes 2, 3, 11 and 12 for additional information on loans and the total allowance for credit losses. **Accrued interest and accounts receivable** increased primarily due to higher client receivables related to client-driven activities in CIB.\n\n**Goodwill, MSRs and other intangible assets** : refer to Note 14 for additional information.\n\n**Selected Consolidated balance sheets data (continued)**\n\n(in millions)\n\n**March 31,**\n\n**2025**\n\nDecember 31,\n\n2024 Change\n\n**Liabilities**\n\nDeposits **$ 2,495,877** $ 2,406,032 4 %\n\nFederal funds purchased and securities loaned or sold under repurchase agreements **533,046** 296,835 80\n\nShort-term borrowings **64,980** 52,893 23\n\nTrading liabilities **187,103** 192,883 (3)\n\nAccounts payable and other liabilities **293,538** 280,672 5\n\nBeneficial interests issued by consolidated variable interest entities (“VIEs”) **24,668** 27,323 (10)\n\nLong-term debt **407,224** 401,418 1\n\n**Total liabilities 4,006,436** 3,658,056 10\n\nStockholders’ equity **351,420** 344,758 2\n\n**Total liabilities and stockholders’ equity $ 4,357,856** $ 4,002,814 9 %\n\n**Deposits** increased, reflecting the impact of: • an increase in CIB predominantly due to net inflows\n\nrelated to client-driven activities in Securities Services and Payments,\n\n• an increase in CCB primarily driven by new accounts,\n\nand\n\n• an increase in AWM as a result of growth in balances\n\nin new and existing client accounts, reflecting the impact of higher-yielding product offerings, predominantly offset by continued migration into other investments.\n\n**Federal funds purchased and securities loaned or sold under repurchase agreements** increased driven by Markets, reflecting higher client-driven market- making activities, higher secured financing of trading assets and the impact of lower levels of netting, as well as when compared with seasonally lower levels at year-end. **Short-term borrowings** increased driven by higher financing requirements in Markets. Refer to Liquidity Risk Management on pages 40-46 for additional information on deposits, federal funds purchased and securities loaned or sold under repurchase agreements, and short-term borrowings; and Notes 2 and 15 for deposits; and Note 10 for federal funds purchased and securities loaned or sold under repurchase agreements.\n\n**Trading liabilities** : refer to Notes 2 and 4 for additional information. **Accounts payable and other liabilities** increased due to higher client payables related to client-driven activities in CIB. **Beneficial interests issued by consolidated VIEs** decreased largely driven by lower levels of outstanding commercial paper as a result of a decrease in loan balances in the Firm-administered multi-seller conduits in CIB. Refer to Liquidity Risk Management on pages 40-46 and Notes 13 and 22 for additional information, specifically Firm-sponsored VIEs and loan securitization trusts. **Long-term debt** : refer to Liquidity Risk Management on pages 40-46 for additional information. **Stockholders’ equity** increased reflecting net income and lower unrealized losses in AOCI, predominantly driven by the impact of lower interest rates on cash flow hedges and on the AFS portfolio in Treasury and CIO, largely offset by the impact of capital actions, including net repurchases of common shares and common and preferred stock dividend payments. Refer to Consolidated statements of changes in stockholders’ equity on page 81, Capital Actions on page 37, and Note 19 for additional information.\n\n13","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/corp-q1-2025_page13.pdf"]},"response":{"errors":[],"extract_id":"extract_470160656010fd403b8e275cb460d38e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Notes 2, 3, 11 and 12 for additional information on loans and the total allowance for credit losses. **Accrued interest and accounts receivable** increased primarily due to higher client receivables related to client-driven activities in CIB.\n\n**Goodwill, MSRs and other intangible assets** : refer to Note 14 for additional information.\n\n**Selected Consolidated balance sheets data (continued)**\n\n(in millions)\n\n**March 31,**\n\n**2025**\n\nDecember 31,\n\n2024 Change\n\n**Liabilities**\n\nDeposits **$ 2,495,877** $ 2,406,032 4 %\n\nFederal funds purchased and securities loaned or sold under repurchase agreements **533,046** 296,835 80\n\nShort-term borrowings **64,980** 52,893 23\n\nTrading liabilities **187,103** 192,883 (3)\n\nAccounts payable and other liabilities **293,538** 280,672 5\n\nBeneficial interests issued by consolidated variable interest entities (“VIEs”) **24,668** 27,323 (10)\n\nLong-term debt **407,224** 401,418 1\n\n**Total liabilities 4,006,436** 3,658,056 10\n\nStockholders’ equity **351,420** 344,758 2\n\n**Total liabilities and stockholders’ equity $ 4,357,856** $ 4,002,814 9 %\n\n**Deposits** increased, reflecting the impact of: • an increase in CIB predominantly due to net inflows\n\nrelated to client-driven activities in Securities Services and Payments,\n\n• an increase in CCB primarily driven by new accounts,\n\nand\n\n• an increase in AWM as a result of growth in balances\n\nin new and existing client accounts, reflecting the impact of higher-yielding product offerings, predominantly offset by continued migration into other investments.\n\n**Federal funds purchased and securities loaned or sold under repurchase agreements** increased driven by Markets, reflecting higher client-driven market- making activities, higher secured financing of trading assets and the impact of lower levels of netting, as well as when compared with seasonally lower levels at year-end. **Short-term borrowings** increased driven by higher financing requirements in Markets. Refer to Liquidity Risk Management on pages 40-46 for additional information on deposits, federal funds purchased and securities loaned or sold under repurchase agreements, and short-term borrowings; and Notes 2 and 15 for deposits; and Note 10 for federal funds purchased and securities loaned or sold under repurchase agreements.\n\n**Trading liabilities** : refer to Notes 2 and 4 for additional information. **Accounts payable and other liabilities** increased due to higher client payables related to client-driven activities in CIB. **Beneficial interests issued by consolidated VIEs** decreased largely driven by lower levels of outstanding commercial paper as a result of a decrease in loan balances in the Firm-administered multi-seller conduits in CIB. Refer to Liquidity Risk Management on pages 40-46 and Notes 13 and 22 for additional information, specifically Firm-sponsored VIEs and loan securitization trusts. **Long-term debt** : refer to Liquidity Risk Management on pages 40-46 for additional information. **Stockholders’ equity** increased reflecting net income and lower unrealized losses in AOCI, predominantly driven by the impact of lower interest rates on cash flow hedges and on the AFS portfolio in Treasury and CIO, largely offset by the impact of capital actions, including net repurchases of common shares and common and preferred stock dividend payments. Refer to Consolidated statements of changes in stockholders’ equity on page 81, Capital Actions on page 37, and Note 19 for additional information.\n\n13"],"full_content":"Notes 2, 3, 11 and 12 for additional information on loans and the total allowance for credit losses. **Accrued interest and accounts receivable** increased primarily due to higher client receivables related to client-driven activities in CIB.\n\n**Goodwill, MSRs and other intangible assets** : refer to Note 14 for additional information.\n\n**Selected Consolidated balance sheets data (continued)**\n\n(in millions)\n\n**March 31,**\n\n**2025**\n\nDecember 31,\n\n2024 Change\n\n**Liabilities**\n\nDeposits **$ 2,495,877** $ 2,406,032 4 %\n\nFederal funds purchased and securities loaned or sold under repurchase agreements **533,046** 296,835 80\n\nShort-term borrowings **64,980** 52,893 23\n\nTrading liabilities **187,103** 192,883 (3)\n\nAccounts payable and other liabilities **293,538** 280,672 5\n\nBeneficial interests issued by consolidated variable interest entities (“VIEs”) **24,668** 27,323 (10)\n\nLong-term debt **407,224** 401,418 1\n\n**Total liabilities 4,006,436** 3,658,056 10\n\nStockholders’ equity **351,420** 344,758 2\n\n**Total liabilities and stockholders’ equity $ 4,357,856** $ 4,002,814 9 %\n\n**Deposits** increased, reflecting the impact of: • an increase in CIB predominantly due to net inflows\n\nrelated to client-driven activities in Securities Services and Payments,\n\n• an increase in CCB primarily driven by new accounts,\n\nand\n\n• an increase in AWM as a result of growth in balances\n\nin new and existing client accounts, reflecting the impact of higher-yielding product offerings, predominantly offset by continued migration into other investments.\n\n**Federal funds purchased and securities loaned or sold under repurchase agreements** increased driven by Markets, reflecting higher client-driven market- making activities, higher secured financing of trading assets and the impact of lower levels of netting, as well as when compared with seasonally lower levels at year-end. **Short-term borrowings** increased driven by higher financing requirements in Markets. Refer to Liquidity Risk Management on pages 40-46 for additional information on deposits, federal funds purchased and securities loaned or sold under repurchase agreements, and short-term borrowings; and Notes 2 and 15 for deposits; and Note 10 for federal funds purchased and securities loaned or sold under repurchase agreements.\n\n**Trading liabilities** : refer to Notes 2 and 4 for additional information. **Accounts payable and other liabilities** increased due to higher client payables related to client-driven activities in CIB. **Beneficial interests issued by consolidated VIEs** decreased largely driven by lower levels of outstanding commercial paper as a result of a decrease in loan balances in the Firm-administered multi-seller conduits in CIB. Refer to Liquidity Risk Management on pages 40-46 and Notes 13 and 22 for additional information, specifically Firm-sponsored VIEs and loan securitization trusts. **Long-term debt** : refer to Liquidity Risk Management on pages 40-46 for additional information. **Stockholders’ equity** increased reflecting net income and lower unrealized losses in AOCI, predominantly driven by the impact of lower interest rates on cash flow hedges and on the AFS portfolio in Treasury and CIO, largely offset by the impact of capital actions, including net repurchases of common shares and common and preferred stock dividend payments. Refer to Consolidated statements of changes in stockholders’ equity on page 81, Capital Actions on page 37, and Note 19 for additional information.\n\n13","publish_date":null,"title":"Notes 2, 3, 11 and 12 for additional information on loans Goodwill, MSRs and other intangible assets: refer to and","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/corp-q1-2025_page13.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/corp-q1-2025_page13.pdf"},"request":{"example_id":"table/corp-q1-2025_page13","product_type":"parse","source_file_path":"corp-q1-2025_page13.pdf"},"started_at":"2026-11-04T19:46:57.708306"} +{"completed_at":"2026-11-04T19:47:00.802803","latency_in_ms":1292,"output":{"example_id":"table/drill angle hierarchical table header_page5","grounded_pages":[],"layout_pages":[],"markdown":"we focus on the errors made during the manufacturing of such a guide and especially those depending on the way the metal components of the guide interrelate with the osteot- omy bur and with the planned position of the implant. However, it should be stressed that the results of this study remain relevant for every implant surgical guide irrespect- ive of the way it is manufactured, 3d-printed or other. Computer-aided implant surgery is not flawless, even when the guides are manufactured by experts in 3d print- ing. Three recent systematic reviews have demonstrated er- rors between the planned and the final implant position. In the study of Schneider et al. [5], the review revealed a mean deviation of 1.07 mm (95% CI 0.76–1.22 mm) at the entry point, 1.6 mm (95% CI 1.26–2 mm) at the apex and a mean angular deviation of the implant axis of 5.3° (95% CI 3.94– 6.581). In the study of Van Assche et al. [21], the mean error at the entry point was 0.99 mm (range 0–6.5 mm), at the apex 1.2 mm (range 0–6.9 mm) and the mean axis deviation was 3.81° (range 0–24.9 degrees). In the study of\n\nTahmaseb et al. [17], the mean error at the entry point was 1.12 mm (maximum 4.5 mm) and 1.39 mm at the apex (maximum 7.1 mm). These reported errors are the summation of flaws in every stage of the procedure in the guided implant surgery: scanning, processing, manufactur- ing, surgery and not exclusively because of the properties of the mechanical parts of the guide. A relatively small number of studies are concerned with the errors in the implant positioning due to the mechanical components of the guides. All of them refer to commercially available systems and try to evaluate or even improve these existing systems, elaborating in the mechanical errors of the particular system used [11–16]. Our study is free from the constraints of commercially available systems, but our equations and tables can be used to estimate errors generated by these systems when certain parameters are known. Our study calculates the maximum errors expected by the mechanical compo- nents of the computerised implant surgery process, with\n\nTable 3 Error at the apex (mm) and deviation of implant axis (degrees) for sleeve lengths 6 and 7 mm\n\nSleeve length (mm) Clearance (μm) Deviation (°) Total length (mm)\n\n16 17 18 19 20 21 22 23 24 25 26 27 28 29\n\n6 50 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2\n\n80 0.8 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3\n\n110 1.1 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5\n\n140 1.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6\n\n170 1.6 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.7\n\n200 1.9 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9\n\n230 2.2 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0\n\n260 2.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.0 1.1 1.1\n\n290 2.8 0.6 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3\n\n320 3.1 0.7 0.7 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4\n\n350 3.3 0.8 0.8 0.9 0.9 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4 1.5 1.5\n\n380 3.6 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.4 1.5 1.5 1.6 1.6\n\n410 3.9 0.9 1.0 1.0 1.1 1.2 1.2 1.3 1.4 1.4 1.5 1.6 1.6 1.7 1.8\n\n7 50 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2\n\n80 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3\n\n110 0.9 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4\n\n140 1.1 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5\n\n170 1.4 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6\n\n200 1.6 0.4 0.4 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7 0.7\n\n230 1.9 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8\n\n260 2.1 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9 0.9 0.9\n\n290 2.4 0.6 0.6 0.6 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1\n\n320 2.6 0.6 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2\n\n350 2.9 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3\n\n380 3.1 0.7 0.8 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4\n\n410 3.4 0.8 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5\n\nApostolakis and Kourakis International Journal of Implant Dentistry (2018) 4:34 Page 5 of 9","pages":[{"line_numbers":[],"markdown":"we focus on the errors made during the manufacturing of such a guide and especially those depending on the way the metal components of the guide interrelate with the osteot- omy bur and with the planned position of the implant. However, it should be stressed that the results of this study remain relevant for every implant surgical guide irrespect- ive of the way it is manufactured, 3d-printed or other. Computer-aided implant surgery is not flawless, even when the guides are manufactured by experts in 3d print- ing. Three recent systematic reviews have demonstrated er- rors between the planned and the final implant position. In the study of Schneider et al. [5], the review revealed a mean deviation of 1.07 mm (95% CI 0.76–1.22 mm) at the entry point, 1.6 mm (95% CI 1.26–2 mm) at the apex and a mean angular deviation of the implant axis of 5.3° (95% CI 3.94– 6.581). In the study of Van Assche et al. [21], the mean error at the entry point was 0.99 mm (range 0–6.5 mm), at the apex 1.2 mm (range 0–6.9 mm) and the mean axis deviation was 3.81° (range 0–24.9 degrees). In the study of\n\nTahmaseb et al. [17], the mean error at the entry point was 1.12 mm (maximum 4.5 mm) and 1.39 mm at the apex (maximum 7.1 mm). These reported errors are the summation of flaws in every stage of the procedure in the guided implant surgery: scanning, processing, manufactur- ing, surgery and not exclusively because of the properties of the mechanical parts of the guide. A relatively small number of studies are concerned with the errors in the implant positioning due to the mechanical components of the guides. All of them refer to commercially available systems and try to evaluate or even improve these existing systems, elaborating in the mechanical errors of the particular system used [11–16]. Our study is free from the constraints of commercially available systems, but our equations and tables can be used to estimate errors generated by these systems when certain parameters are known. Our study calculates the maximum errors expected by the mechanical compo- nents of the computerised implant surgery process, with\n\nTable 3 Error at the apex (mm) and deviation of implant axis (degrees) for sleeve lengths 6 and 7 mm\n\nSleeve length (mm) Clearance (μm) Deviation (°) Total length (mm)\n\n16 17 18 19 20 21 22 23 24 25 26 27 28 29\n\n6 50 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2\n\n80 0.8 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3\n\n110 1.1 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5\n\n140 1.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6\n\n170 1.6 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.7\n\n200 1.9 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9\n\n230 2.2 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0\n\n260 2.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.0 1.1 1.1\n\n290 2.8 0.6 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3\n\n320 3.1 0.7 0.7 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4\n\n350 3.3 0.8 0.8 0.9 0.9 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4 1.5 1.5\n\n380 3.6 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.4 1.5 1.5 1.6 1.6\n\n410 3.9 0.9 1.0 1.0 1.1 1.2 1.2 1.3 1.4 1.4 1.5 1.6 1.6 1.7 1.8\n\n7 50 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2\n\n80 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3\n\n110 0.9 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4\n\n140 1.1 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5\n\n170 1.4 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6\n\n200 1.6 0.4 0.4 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7 0.7\n\n230 1.9 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8\n\n260 2.1 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9 0.9 0.9\n\n290 2.4 0.6 0.6 0.6 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1\n\n320 2.6 0.6 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2\n\n350 2.9 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3\n\n380 3.1 0.7 0.8 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4\n\n410 3.4 0.8 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5\n\nApostolakis and Kourakis International Journal of Implant Dentistry (2018) 4:34 Page 5 of 9","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"we focus on the errors made during the manufacturing of such a guide and especially those depending on the way the metal components of the guide interrelate with the osteot- omy bur and with the planned position of the implant. However, it should be stressed that the results of this study remain relevant for every implant surgical guide irrespect- ive of the way it is manufactured, 3d-printed or other. Computer-aided implant surgery is not flawless, even when the guides are manufactured by experts in 3d print- ing. Three recent systematic reviews have demonstrated er- rors between the planned and the final implant position. In the study of Schneider et al. [5], the review revealed a mean deviation of 1.07 mm (95% CI 0.76–1.22 mm) at the entry point, 1.6 mm (95% CI 1.26–2 mm) at the apex and a mean angular deviation of the implant axis of 5.3° (95% CI 3.94– 6.581). In the study of Van Assche et al. [21], the mean error at the entry point was 0.99 mm (range 0–6.5 mm), at the apex 1.2 mm (range 0–6.9 mm) and the mean axis deviation was 3.81° (range 0–24.9 degrees). In the study of\n\nTahmaseb et al. [17], the mean error at the entry point was 1.12 mm (maximum 4.5 mm) and 1.39 mm at the apex (maximum 7.1 mm). These reported errors are the summation of flaws in every stage of the procedure in the guided implant surgery: scanning, processing, manufactur- ing, surgery and not exclusively because of the properties of the mechanical parts of the guide. A relatively small number of studies are concerned with the errors in the implant positioning due to the mechanical components of the guides. All of them refer to commercially available systems and try to evaluate or even improve these existing systems, elaborating in the mechanical errors of the particular system used [11–16]. Our study is free from the constraints of commercially available systems, but our equations and tables can be used to estimate errors generated by these systems when certain parameters are known. Our study calculates the maximum errors expected by the mechanical compo- nents of the computerised implant surgery process, with\n\nTable 3 Error at the apex (mm) and deviation of implant axis (degrees) for sleeve lengths 6 and 7 mm\n\nSleeve length (mm) Clearance (μm) Deviation (°) Total length (mm)\n\n16 17 18 19 20 21 22 23 24 25 26 27 28 29\n\n6 50 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2\n\n80 0.8 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3\n\n110 1.1 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5\n\n140 1.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6\n\n170 1.6 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.7\n\n200 1.9 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9\n\n230 2.2 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0\n\n260 2.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.0 1.1 1.1\n\n290 2.8 0.6 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3\n\n320 3.1 0.7 0.7 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4\n\n350 3.3 0.8 0.8 0.9 0.9 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4 1.5 1.5\n\n380 3.6 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.4 1.5 1.5 1.6 1.6\n\n410 3.9 0.9 1.0 1.0 1.1 1.2 1.2 1.3 1.4 1.4 1.5 1.6 1.6 1.7 1.8\n\n7 50 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2\n\n80 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3\n\n110 0.9 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4\n\n140 1.1 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5\n\n170 1.4 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6\n\n200 1.6 0.4 0.4 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7 0.7\n\n230 1.9 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8\n\n260 2.1 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9 0.9 0.9\n\n290 2.4 0.6 0.6 0.6 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1\n\n320 2.6 0.6 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2\n\n350 2.9 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3\n\n380 3.1 0.7 0.8 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4\n\n410 3.4 0.8 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5\n\nApostolakis and Kourakis International Journal of Implant Dentistry (2018) 4:34 Page 5 of 9","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drill%20angle%20hierarchical%20table%20header_page5.pdf"]},"response":{"errors":[],"extract_id":"extract_b539f86af7bd7eeec4fa15511664083a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["we focus on the errors made during the manufacturing of such a guide and especially those depending on the way the metal components of the guide interrelate with the osteot- omy bur and with the planned position of the implant. However, it should be stressed that the results of this study remain relevant for every implant surgical guide irrespect- ive of the way it is manufactured, 3d-printed or other. Computer-aided implant surgery is not flawless, even when the guides are manufactured by experts in 3d print- ing. Three recent systematic reviews have demonstrated er- rors between the planned and the final implant position. In the study of Schneider et al. [5], the review revealed a mean deviation of 1.07 mm (95% CI 0.76–1.22 mm) at the entry point, 1.6 mm (95% CI 1.26–2 mm) at the apex and a mean angular deviation of the implant axis of 5.3° (95% CI 3.94– 6.581). In the study of Van Assche et al. [21], the mean error at the entry point was 0.99 mm (range 0–6.5 mm), at the apex 1.2 mm (range 0–6.9 mm) and the mean axis deviation was 3.81° (range 0–24.9 degrees). In the study of\n\nTahmaseb et al. [17], the mean error at the entry point was 1.12 mm (maximum 4.5 mm) and 1.39 mm at the apex (maximum 7.1 mm). These reported errors are the summation of flaws in every stage of the procedure in the guided implant surgery: scanning, processing, manufactur- ing, surgery and not exclusively because of the properties of the mechanical parts of the guide. A relatively small number of studies are concerned with the errors in the implant positioning due to the mechanical components of the guides. All of them refer to commercially available systems and try to evaluate or even improve these existing systems, elaborating in the mechanical errors of the particular system used [11–16]. Our study is free from the constraints of commercially available systems, but our equations and tables can be used to estimate errors generated by these systems when certain parameters are known. Our study calculates the maximum errors expected by the mechanical compo- nents of the computerised implant surgery process, with\n\nTable 3 Error at the apex (mm) and deviation of implant axis (degrees) for sleeve lengths 6 and 7 mm\n\nSleeve length (mm) Clearance (μm) Deviation (°) Total length (mm)\n\n16 17 18 19 20 21 22 23 24 25 26 27 28 29\n\n6 50 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2\n\n80 0.8 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3\n\n110 1.1 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5\n\n140 1.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6\n\n170 1.6 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.7\n\n200 1.9 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9\n\n230 2.2 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0\n\n260 2.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.0 1.1 1.1\n\n290 2.8 0.6 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3\n\n320 3.1 0.7 0.7 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4\n\n350 3.3 0.8 0.8 0.9 0.9 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4 1.5 1.5\n\n380 3.6 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.4 1.5 1.5 1.6 1.6\n\n410 3.9 0.9 1.0 1.0 1.1 1.2 1.2 1.3 1.4 1.4 1.5 1.6 1.6 1.7 1.8\n\n7 50 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2\n\n80 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3\n\n110 0.9 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4\n\n140 1.1 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5\n\n170 1.4 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6\n\n200 1.6 0.4 0.4 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7 0.7\n\n230 1.9 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8\n\n260 2.1 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9 0.9 0.9\n\n290 2.4 0.6 0.6 0.6 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1\n\n320 2.6 0.6 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2\n\n350 2.9 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3\n\n380 3.1 0.7 0.8 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4\n\n410 3.4 0.8 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5\n\nApostolakis and Kourakis International Journal of Implant Dentistry (2018) 4:34 Page 5 of 9"],"full_content":"we focus on the errors made during the manufacturing of such a guide and especially those depending on the way the metal components of the guide interrelate with the osteot- omy bur and with the planned position of the implant. However, it should be stressed that the results of this study remain relevant for every implant surgical guide irrespect- ive of the way it is manufactured, 3d-printed or other. Computer-aided implant surgery is not flawless, even when the guides are manufactured by experts in 3d print- ing. Three recent systematic reviews have demonstrated er- rors between the planned and the final implant position. In the study of Schneider et al. [5], the review revealed a mean deviation of 1.07 mm (95% CI 0.76–1.22 mm) at the entry point, 1.6 mm (95% CI 1.26–2 mm) at the apex and a mean angular deviation of the implant axis of 5.3° (95% CI 3.94– 6.581). In the study of Van Assche et al. [21], the mean error at the entry point was 0.99 mm (range 0–6.5 mm), at the apex 1.2 mm (range 0–6.9 mm) and the mean axis deviation was 3.81° (range 0–24.9 degrees). In the study of\n\nTahmaseb et al. [17], the mean error at the entry point was 1.12 mm (maximum 4.5 mm) and 1.39 mm at the apex (maximum 7.1 mm). These reported errors are the summation of flaws in every stage of the procedure in the guided implant surgery: scanning, processing, manufactur- ing, surgery and not exclusively because of the properties of the mechanical parts of the guide. A relatively small number of studies are concerned with the errors in the implant positioning due to the mechanical components of the guides. All of them refer to commercially available systems and try to evaluate or even improve these existing systems, elaborating in the mechanical errors of the particular system used [11–16]. Our study is free from the constraints of commercially available systems, but our equations and tables can be used to estimate errors generated by these systems when certain parameters are known. Our study calculates the maximum errors expected by the mechanical compo- nents of the computerised implant surgery process, with\n\nTable 3 Error at the apex (mm) and deviation of implant axis (degrees) for sleeve lengths 6 and 7 mm\n\nSleeve length (mm) Clearance (μm) Deviation (°) Total length (mm)\n\n16 17 18 19 20 21 22 23 24 25 26 27 28 29\n\n6 50 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2\n\n80 0.8 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3\n\n110 1.1 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5\n\n140 1.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6\n\n170 1.6 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.7\n\n200 1.9 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9\n\n230 2.2 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0\n\n260 2.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.0 1.1 1.1\n\n290 2.8 0.6 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3\n\n320 3.1 0.7 0.7 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4\n\n350 3.3 0.8 0.8 0.9 0.9 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4 1.5 1.5\n\n380 3.6 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.4 1.5 1.5 1.6 1.6\n\n410 3.9 0.9 1.0 1.0 1.1 1.2 1.2 1.3 1.4 1.4 1.5 1.6 1.6 1.7 1.8\n\n7 50 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2\n\n80 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3\n\n110 0.9 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4\n\n140 1.1 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5\n\n170 1.4 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.6 0.6 0.6\n\n200 1.6 0.4 0.4 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7 0.7\n\n230 1.9 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8\n\n260 2.1 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.8 0.9 0.9 0.9\n\n290 2.4 0.6 0.6 0.6 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1\n\n320 2.6 0.6 0.7 0.7 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2\n\n350 2.9 0.7 0.7 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3\n\n380 3.1 0.7 0.8 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.3 1.4\n\n410 3.4 0.8 0.8 0.9 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5\n\nApostolakis and Kourakis International Journal of Implant Dentistry (2018) 4:34 Page 5 of 9","publish_date":null,"title":"Table3Errorattheapex(mm)anddeviationofimplantaxis(degrees)forsleevelengths6and7mm Tahmasebetal.[17],themeanerrorattheentrypointwas we focus on the errors made during the manufacturing of 1.12 mm (maximum 4.5 mm) and 1.39 mm","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drill%20angle%20hierarchical%20table%20header_page5.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drill%20angle%20hierarchical%20table%20header_page5.pdf"},"request":{"example_id":"table/drill angle hierarchical table header_page5","product_type":"parse","source_file_path":"drill angle hierarchical table header_page5.pdf"},"started_at":"2026-11-04T19:46:59.509915"} +{"completed_at":"2026-11-04T19:47:02.616677","latency_in_ms":1904,"output":{"example_id":"table/drill angle hierarchical table header_page7","grounded_pages":[],"layout_pages":[],"markdown":"the understanding that the implantologist involved in the in-office printing has to have a knowledge of the di- mensions, the design and the tolerances of the compo- nents he will use for the manufacturing of the guide. Cassetta et al. [13] estimated that 62.7% of the total im- plant positioning error was due to the properties of the sleeve/ drill combination, when the Materialise Safe® guide system was used. Even though it is recommended that the osteotomy should be performed without exert- ing force to the guide [12] and with the bur led parallel to the long axis of the sleeve, this is not possible in a number of cases, especially where the mouth opening is a limiting factor or when an oblique bone ridge is en- countered. It is, therefore, probable that during surgery, the drill is tilted inside the sleeve, changing the final pos- ition of the implant. Then the metallic components with their dimensions and tolerances define the maximum permissible errors. Obviously, if the drill rotates exactly at the centre of the sleeve, no error is expected. It should be noted that when a sleeve/key/drill combin- ation is used, the expected errors of the mechanical parts should be estimated taking into account the bigger clearance value created by the key usage. To our know- ledge, this is the first study to comprehensibly calculate the errors by taking into consideration the parameters that contribute to the 62.7% of the total error in guided implant surgery, as Cassetta et al. [13] stated. We provide the analytical equations that give the opportunity to the implantologist to calculate the errors of interest for every conceivable situation, even for cases not tabulated by us. Using our simple models, the surgeon is provided with unique information about a large part of the probable errors expected in guided\n\nsurgery and he/she can include these values in a risk as- sessment model for the results of the implant surgery. Elaborating further on the equations, it can be seen that for every 1 mm of increase in total length (implant length and/or offset), the errors increase by 46 μm. For every 50 μm increase in clearance, our models predict an increase in the error at the apex of 190 μm and in the error at the neck of 90 μm. Finally, for every 1 mm increase in the sleeve length, we anticipate a decrease in the error of implant positioning in the apex of 190 μm and in the error at the position of the implant neck of 100 μm. The Deviation of the implant axis is exclusively dependent on the sleeve length and the clearance and can easily be calculated. We found, in tantum with other studies, and as expected by the mathematical properties of the computation, that a longer implant with a short metal sleeve away from the neck of the implant (large offset) and a sleeve/bur combination with a large clearance will result in a large error at the neck of the implant, a larger error at the apex and a large deviation angle of the implant axis. As an example on the implementation of our equations, we could simulate the (pilot) osteotomy for the position- ing of an implant with a length of 12 mm. The implant will be placed with a 2.8 mm of diameter and 20.4 mm of length (with 0.4 mm tip), bur. The metal sleeve will be of 5 mm in length, including the lip of the sleeve and with an internal diameter of 2.89 mm. As a result, the clearance will be 90 μm. The offset is estimated as 8 mm and the total length at 20 mm, since 0.4 mm of the length of the bur is its tip and we do not expect the implant to reach that depth (The osteotomy hole is usually longer than the implant length but the error is calculated by the actual im- plant length). Under these parameters (total length = 12 + 8 = 20 mm, sleeve length = 5 mm, clearance = 90 μm), we calculate for the maximum errors expected due to the sleeve/drill combination: Error at the apex = 0.29 mm Error at the neck = 0.03 mm\n\nTable 4 Error at the neck (mm) (Continued)\n\nSleeve length (mm) Clearance (μm) Offset (mm)\n\n6 7 8 9 10 11 12 13 14 15 16 17\n\n170 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3\n\n200 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4\n\n230 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4 0.4\n\n260 0.2 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5\n\n290 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5 0.6\n\n320 0.3 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6\n\n350 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.7\n\n380 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.7 0.7\n\n410 0.3 0.4 0.4 0.5 0.6 0.6 0.7 0.7 0.8\n\nTable 5 Multiple regression coefficients (p < 0.0005)\n\nSleeve length Clearance Total length Offset\n\nError at the apex − 0.1854 0.0037 0.0453\n\nError at the neck − 0.1041 0.0018 0.0461\n\nApostolakis and Kourakis International Journal of Implant Dentistry (2018) 4:34 Page 7 of 9","pages":[{"line_numbers":[],"markdown":"the understanding that the implantologist involved in the in-office printing has to have a knowledge of the di- mensions, the design and the tolerances of the compo- nents he will use for the manufacturing of the guide. Cassetta et al. [13] estimated that 62.7% of the total im- plant positioning error was due to the properties of the sleeve/ drill combination, when the Materialise Safe® guide system was used. Even though it is recommended that the osteotomy should be performed without exert- ing force to the guide [12] and with the bur led parallel to the long axis of the sleeve, this is not possible in a number of cases, especially where the mouth opening is a limiting factor or when an oblique bone ridge is en- countered. It is, therefore, probable that during surgery, the drill is tilted inside the sleeve, changing the final pos- ition of the implant. Then the metallic components with their dimensions and tolerances define the maximum permissible errors. Obviously, if the drill rotates exactly at the centre of the sleeve, no error is expected. It should be noted that when a sleeve/key/drill combin- ation is used, the expected errors of the mechanical parts should be estimated taking into account the bigger clearance value created by the key usage. To our know- ledge, this is the first study to comprehensibly calculate the errors by taking into consideration the parameters that contribute to the 62.7% of the total error in guided implant surgery, as Cassetta et al. [13] stated. We provide the analytical equations that give the opportunity to the implantologist to calculate the errors of interest for every conceivable situation, even for cases not tabulated by us. Using our simple models, the surgeon is provided with unique information about a large part of the probable errors expected in guided\n\nsurgery and he/she can include these values in a risk as- sessment model for the results of the implant surgery. Elaborating further on the equations, it can be seen that for every 1 mm of increase in total length (implant length and/or offset), the errors increase by 46 μm. For every 50 μm increase in clearance, our models predict an increase in the error at the apex of 190 μm and in the error at the neck of 90 μm. Finally, for every 1 mm increase in the sleeve length, we anticipate a decrease in the error of implant positioning in the apex of 190 μm and in the error at the position of the implant neck of 100 μm. The Deviation of the implant axis is exclusively dependent on the sleeve length and the clearance and can easily be calculated. We found, in tantum with other studies, and as expected by the mathematical properties of the computation, that a longer implant with a short metal sleeve away from the neck of the implant (large offset) and a sleeve/bur combination with a large clearance will result in a large error at the neck of the implant, a larger error at the apex and a large deviation angle of the implant axis. As an example on the implementation of our equations, we could simulate the (pilot) osteotomy for the position- ing of an implant with a length of 12 mm. The implant will be placed with a 2.8 mm of diameter and 20.4 mm of length (with 0.4 mm tip), bur. The metal sleeve will be of 5 mm in length, including the lip of the sleeve and with an internal diameter of 2.89 mm. As a result, the clearance will be 90 μm. The offset is estimated as 8 mm and the total length at 20 mm, since 0.4 mm of the length of the bur is its tip and we do not expect the implant to reach that depth (The osteotomy hole is usually longer than the implant length but the error is calculated by the actual im- plant length). Under these parameters (total length = 12 + 8 = 20 mm, sleeve length = 5 mm, clearance = 90 μm), we calculate for the maximum errors expected due to the sleeve/drill combination: Error at the apex = 0.29 mm Error at the neck = 0.03 mm\n\nTable 4 Error at the neck (mm) (Continued)\n\nSleeve length (mm) Clearance (μm) Offset (mm)\n\n6 7 8 9 10 11 12 13 14 15 16 17\n\n170 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3\n\n200 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4\n\n230 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4 0.4\n\n260 0.2 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5\n\n290 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5 0.6\n\n320 0.3 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6\n\n350 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.7\n\n380 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.7 0.7\n\n410 0.3 0.4 0.4 0.5 0.6 0.6 0.7 0.7 0.8\n\nTable 5 Multiple regression coefficients (p < 0.0005)\n\nSleeve length Clearance Total length Offset\n\nError at the apex − 0.1854 0.0037 0.0453\n\nError at the neck − 0.1041 0.0018 0.0461\n\nApostolakis and Kourakis International Journal of Implant Dentistry (2018) 4:34 Page 7 of 9","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"the understanding that the implantologist involved in the in-office printing has to have a knowledge of the di- mensions, the design and the tolerances of the compo- nents he will use for the manufacturing of the guide. Cassetta et al. [13] estimated that 62.7% of the total im- plant positioning error was due to the properties of the sleeve/ drill combination, when the Materialise Safe® guide system was used. Even though it is recommended that the osteotomy should be performed without exert- ing force to the guide [12] and with the bur led parallel to the long axis of the sleeve, this is not possible in a number of cases, especially where the mouth opening is a limiting factor or when an oblique bone ridge is en- countered. It is, therefore, probable that during surgery, the drill is tilted inside the sleeve, changing the final pos- ition of the implant. Then the metallic components with their dimensions and tolerances define the maximum permissible errors. Obviously, if the drill rotates exactly at the centre of the sleeve, no error is expected. It should be noted that when a sleeve/key/drill combin- ation is used, the expected errors of the mechanical parts should be estimated taking into account the bigger clearance value created by the key usage. To our know- ledge, this is the first study to comprehensibly calculate the errors by taking into consideration the parameters that contribute to the 62.7% of the total error in guided implant surgery, as Cassetta et al. [13] stated. We provide the analytical equations that give the opportunity to the implantologist to calculate the errors of interest for every conceivable situation, even for cases not tabulated by us. Using our simple models, the surgeon is provided with unique information about a large part of the probable errors expected in guided\n\nsurgery and he/she can include these values in a risk as- sessment model for the results of the implant surgery. Elaborating further on the equations, it can be seen that for every 1 mm of increase in total length (implant length and/or offset), the errors increase by 46 μm. For every 50 μm increase in clearance, our models predict an increase in the error at the apex of 190 μm and in the error at the neck of 90 μm. Finally, for every 1 mm increase in the sleeve length, we anticipate a decrease in the error of implant positioning in the apex of 190 μm and in the error at the position of the implant neck of 100 μm. The Deviation of the implant axis is exclusively dependent on the sleeve length and the clearance and can easily be calculated. We found, in tantum with other studies, and as expected by the mathematical properties of the computation, that a longer implant with a short metal sleeve away from the neck of the implant (large offset) and a sleeve/bur combination with a large clearance will result in a large error at the neck of the implant, a larger error at the apex and a large deviation angle of the implant axis. As an example on the implementation of our equations, we could simulate the (pilot) osteotomy for the position- ing of an implant with a length of 12 mm. The implant will be placed with a 2.8 mm of diameter and 20.4 mm of length (with 0.4 mm tip), bur. The metal sleeve will be of 5 mm in length, including the lip of the sleeve and with an internal diameter of 2.89 mm. As a result, the clearance will be 90 μm. The offset is estimated as 8 mm and the total length at 20 mm, since 0.4 mm of the length of the bur is its tip and we do not expect the implant to reach that depth (The osteotomy hole is usually longer than the implant length but the error is calculated by the actual im- plant length). Under these parameters (total length = 12 + 8 = 20 mm, sleeve length = 5 mm, clearance = 90 μm), we calculate for the maximum errors expected due to the sleeve/drill combination: Error at the apex = 0.29 mm Error at the neck = 0.03 mm\n\nTable 4 Error at the neck (mm) (Continued)\n\nSleeve length (mm) Clearance (μm) Offset (mm)\n\n6 7 8 9 10 11 12 13 14 15 16 17\n\n170 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3\n\n200 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4\n\n230 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4 0.4\n\n260 0.2 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5\n\n290 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5 0.6\n\n320 0.3 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6\n\n350 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.7\n\n380 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.7 0.7\n\n410 0.3 0.4 0.4 0.5 0.6 0.6 0.7 0.7 0.8\n\nTable 5 Multiple regression coefficients (p < 0.0005)\n\nSleeve length Clearance Total length Offset\n\nError at the apex − 0.1854 0.0037 0.0453\n\nError at the neck − 0.1041 0.0018 0.0461\n\nApostolakis and Kourakis International Journal of Implant Dentistry (2018) 4:34 Page 7 of 9","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drill%20angle%20hierarchical%20table%20header_page7.pdf"]},"response":{"errors":[],"extract_id":"extract_a0212713fe2c61a3793018ebf3b21d37","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["the understanding that the implantologist involved in the in-office printing has to have a knowledge of the di- mensions, the design and the tolerances of the compo- nents he will use for the manufacturing of the guide. Cassetta et al. [13] estimated that 62.7% of the total im- plant positioning error was due to the properties of the sleeve/ drill combination, when the Materialise Safe® guide system was used. Even though it is recommended that the osteotomy should be performed without exert- ing force to the guide [12] and with the bur led parallel to the long axis of the sleeve, this is not possible in a number of cases, especially where the mouth opening is a limiting factor or when an oblique bone ridge is en- countered. It is, therefore, probable that during surgery, the drill is tilted inside the sleeve, changing the final pos- ition of the implant. Then the metallic components with their dimensions and tolerances define the maximum permissible errors. Obviously, if the drill rotates exactly at the centre of the sleeve, no error is expected. It should be noted that when a sleeve/key/drill combin- ation is used, the expected errors of the mechanical parts should be estimated taking into account the bigger clearance value created by the key usage. To our know- ledge, this is the first study to comprehensibly calculate the errors by taking into consideration the parameters that contribute to the 62.7% of the total error in guided implant surgery, as Cassetta et al. [13] stated. We provide the analytical equations that give the opportunity to the implantologist to calculate the errors of interest for every conceivable situation, even for cases not tabulated by us. Using our simple models, the surgeon is provided with unique information about a large part of the probable errors expected in guided\n\nsurgery and he/she can include these values in a risk as- sessment model for the results of the implant surgery. Elaborating further on the equations, it can be seen that for every 1 mm of increase in total length (implant length and/or offset), the errors increase by 46 μm. For every 50 μm increase in clearance, our models predict an increase in the error at the apex of 190 μm and in the error at the neck of 90 μm. Finally, for every 1 mm increase in the sleeve length, we anticipate a decrease in the error of implant positioning in the apex of 190 μm and in the error at the position of the implant neck of 100 μm. The Deviation of the implant axis is exclusively dependent on the sleeve length and the clearance and can easily be calculated. We found, in tantum with other studies, and as expected by the mathematical properties of the computation, that a longer implant with a short metal sleeve away from the neck of the implant (large offset) and a sleeve/bur combination with a large clearance will result in a large error at the neck of the implant, a larger error at the apex and a large deviation angle of the implant axis. As an example on the implementation of our equations, we could simulate the (pilot) osteotomy for the position- ing of an implant with a length of 12 mm. The implant will be placed with a 2.8 mm of diameter and 20.4 mm of length (with 0.4 mm tip), bur. The metal sleeve will be of 5 mm in length, including the lip of the sleeve and with an internal diameter of 2.89 mm. As a result, the clearance will be 90 μm. The offset is estimated as 8 mm and the total length at 20 mm, since 0.4 mm of the length of the bur is its tip and we do not expect the implant to reach that depth (The osteotomy hole is usually longer than the implant length but the error is calculated by the actual im- plant length). Under these parameters (total length = 12 + 8 = 20 mm, sleeve length = 5 mm, clearance = 90 μm), we calculate for the maximum errors expected due to the sleeve/drill combination: Error at the apex = 0.29 mm Error at the neck = 0.03 mm\n\nTable 4 Error at the neck (mm) (Continued)\n\nSleeve length (mm) Clearance (μm) Offset (mm)\n\n6 7 8 9 10 11 12 13 14 15 16 17\n\n170 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3\n\n200 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4\n\n230 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4 0.4\n\n260 0.2 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5\n\n290 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5 0.6\n\n320 0.3 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6\n\n350 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.7\n\n380 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.7 0.7\n\n410 0.3 0.4 0.4 0.5 0.6 0.6 0.7 0.7 0.8\n\nTable 5 Multiple regression coefficients (p < 0.0005)\n\nSleeve length Clearance Total length Offset\n\nError at the apex − 0.1854 0.0037 0.0453\n\nError at the neck − 0.1041 0.0018 0.0461\n\nApostolakis and Kourakis International Journal of Implant Dentistry (2018) 4:34 Page 7 of 9"],"full_content":"the understanding that the implantologist involved in the in-office printing has to have a knowledge of the di- mensions, the design and the tolerances of the compo- nents he will use for the manufacturing of the guide. Cassetta et al. [13] estimated that 62.7% of the total im- plant positioning error was due to the properties of the sleeve/ drill combination, when the Materialise Safe® guide system was used. Even though it is recommended that the osteotomy should be performed without exert- ing force to the guide [12] and with the bur led parallel to the long axis of the sleeve, this is not possible in a number of cases, especially where the mouth opening is a limiting factor or when an oblique bone ridge is en- countered. It is, therefore, probable that during surgery, the drill is tilted inside the sleeve, changing the final pos- ition of the implant. Then the metallic components with their dimensions and tolerances define the maximum permissible errors. Obviously, if the drill rotates exactly at the centre of the sleeve, no error is expected. It should be noted that when a sleeve/key/drill combin- ation is used, the expected errors of the mechanical parts should be estimated taking into account the bigger clearance value created by the key usage. To our know- ledge, this is the first study to comprehensibly calculate the errors by taking into consideration the parameters that contribute to the 62.7% of the total error in guided implant surgery, as Cassetta et al. [13] stated. We provide the analytical equations that give the opportunity to the implantologist to calculate the errors of interest for every conceivable situation, even for cases not tabulated by us. Using our simple models, the surgeon is provided with unique information about a large part of the probable errors expected in guided\n\nsurgery and he/she can include these values in a risk as- sessment model for the results of the implant surgery. Elaborating further on the equations, it can be seen that for every 1 mm of increase in total length (implant length and/or offset), the errors increase by 46 μm. For every 50 μm increase in clearance, our models predict an increase in the error at the apex of 190 μm and in the error at the neck of 90 μm. Finally, for every 1 mm increase in the sleeve length, we anticipate a decrease in the error of implant positioning in the apex of 190 μm and in the error at the position of the implant neck of 100 μm. The Deviation of the implant axis is exclusively dependent on the sleeve length and the clearance and can easily be calculated. We found, in tantum with other studies, and as expected by the mathematical properties of the computation, that a longer implant with a short metal sleeve away from the neck of the implant (large offset) and a sleeve/bur combination with a large clearance will result in a large error at the neck of the implant, a larger error at the apex and a large deviation angle of the implant axis. As an example on the implementation of our equations, we could simulate the (pilot) osteotomy for the position- ing of an implant with a length of 12 mm. The implant will be placed with a 2.8 mm of diameter and 20.4 mm of length (with 0.4 mm tip), bur. The metal sleeve will be of 5 mm in length, including the lip of the sleeve and with an internal diameter of 2.89 mm. As a result, the clearance will be 90 μm. The offset is estimated as 8 mm and the total length at 20 mm, since 0.4 mm of the length of the bur is its tip and we do not expect the implant to reach that depth (The osteotomy hole is usually longer than the implant length but the error is calculated by the actual im- plant length). Under these parameters (total length = 12 + 8 = 20 mm, sleeve length = 5 mm, clearance = 90 μm), we calculate for the maximum errors expected due to the sleeve/drill combination: Error at the apex = 0.29 mm Error at the neck = 0.03 mm\n\nTable 4 Error at the neck (mm) (Continued)\n\nSleeve length (mm) Clearance (μm) Offset (mm)\n\n6 7 8 9 10 11 12 13 14 15 16 17\n\n170 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3\n\n200 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4\n\n230 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.4 0.4\n\n260 0.2 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5\n\n290 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5 0.6\n\n320 0.3 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6\n\n350 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.7\n\n380 0.3 0.4 0.4 0.5 0.5 0.6 0.6 0.7 0.7\n\n410 0.3 0.4 0.4 0.5 0.6 0.6 0.7 0.7 0.8\n\nTable 5 Multiple regression coefficients (p < 0.0005)\n\nSleeve length Clearance Total length Offset\n\nError at the apex − 0.1854 0.0037 0.0453\n\nError at the neck − 0.1041 0.0018 0.0461\n\nApostolakis and Kourakis International Journal of Implant Dentistry (2018) 4:34 Page 7 of 9","publish_date":null,"title":"(Continued) Table4Errorattheneck(mm) surgery and he/she can include these values in a risk as- the understanding that the implantologist involved in","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drill%20angle%20hierarchical%20table%20header_page7.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drill%20angle%20hierarchical%20table%20header_page7.pdf"},"request":{"example_id":"table/drill angle hierarchical table header_page7","product_type":"parse","source_file_path":"drill angle hierarchical table header_page7.pdf"},"started_at":"2026-11-04T19:47:00.712353"} +{"completed_at":"2026-11-04T19:47:03.212323","latency_in_ms":1275,"output":{"example_id":"table/drought-tolerant-plant-list_page1","grounded_pages":[],"layout_pages":[],"markdown":"### **Establishing Water-Smart Plants**\n\nAll plants, including water-smart plants, require an establishment period with consistent water to develop their roots. Planting in the fall or spring helps take advantage of natural precipitation and lower evapotranspiration rates and allows plants to become established before periods of drought.\n\n# RECOMMENDED PLANTS\n\n**NO IRRIGATION**\n\n**VERY LOW WATER**\n\n**LOW WATER**\n\n**MODERATE WATER**\n\n**FULL SUN**\n\n**PART SHADE**\n\n**SHADE**\n\n### **KEY TO SYMBOLS**\n\n**NO IRRIGATION:** Plants rely on natural precipitation and generally need no additional water once established. Great for areas that are unwatered!\n\n**VERY LOW-WATER:** Plants need more water than natural precipitation. A deep watering once or twice a month should be sufficient.\n\n**LOW-WATER:** Plants generally need to be watered once a week. This is still 50% less than conventional landscapes.\n\n**MODERATE WATER:** Plants need watering more than once a week during the heat of summer. Using drip irrigation on these plants is ideal.\n\n### **Water Requirements**\n\nThe water requirements listed for each plant are general guidelines, keep in mind that some plants tolerate a range of water requirements than others.\n\n# Plant List\n\n**LAWNS & ANNUALS**\n\nAPR MAY JUN JUL AUG SEP OCT\n\nSand -- 2 3 3 3 2 --\n\nLoam -- 1 2 3 2 1 --\n\nClay -- 1 2 2 2 1 --\n\n### **GENERAL DAILY IRRIGATION GUIDELINES:**\n\nThese guidelines are recommended after your new plants have been established. Root depth varies from 18-48” or deeper, depending on the plant type. Watering deeply and less often encourages deep rooting and plant tolerance to heat and drought.\n\n**SHRUBS & PERENNIALS**\n\nAPR MAY JUN JUL AUG SEP OCT\n\nSand -- 1 2 2 2 1 --\n\nLoam -- -- 1 2 1 -- --\n\nClay -- -- 1 2 1 -- --\n\n\\*Guidelines developed by USU but applicable for the Spokane climate. --Water as needed.\n\n### 1","pages":[{"line_numbers":[],"markdown":"### **Establishing Water-Smart Plants**\n\nAll plants, including water-smart plants, require an establishment period with consistent water to develop their roots. Planting in the fall or spring helps take advantage of natural precipitation and lower evapotranspiration rates and allows plants to become established before periods of drought.\n\n# RECOMMENDED PLANTS\n\n**NO IRRIGATION**\n\n**VERY LOW WATER**\n\n**LOW WATER**\n\n**MODERATE WATER**\n\n**FULL SUN**\n\n**PART SHADE**\n\n**SHADE**\n\n### **KEY TO SYMBOLS**\n\n**NO IRRIGATION:** Plants rely on natural precipitation and generally need no additional water once established. Great for areas that are unwatered!\n\n**VERY LOW-WATER:** Plants need more water than natural precipitation. A deep watering once or twice a month should be sufficient.\n\n**LOW-WATER:** Plants generally need to be watered once a week. This is still 50% less than conventional landscapes.\n\n**MODERATE WATER:** Plants need watering more than once a week during the heat of summer. Using drip irrigation on these plants is ideal.\n\n### **Water Requirements**\n\nThe water requirements listed for each plant are general guidelines, keep in mind that some plants tolerate a range of water requirements than others.\n\n# Plant List\n\n**LAWNS & ANNUALS**\n\nAPR MAY JUN JUL AUG SEP OCT\n\nSand -- 2 3 3 3 2 --\n\nLoam -- 1 2 3 2 1 --\n\nClay -- 1 2 2 2 1 --\n\n### **GENERAL DAILY IRRIGATION GUIDELINES:**\n\nThese guidelines are recommended after your new plants have been established. Root depth varies from 18-48” or deeper, depending on the plant type. Watering deeply and less often encourages deep rooting and plant tolerance to heat and drought.\n\n**SHRUBS & PERENNIALS**\n\nAPR MAY JUN JUL AUG SEP OCT\n\nSand -- 1 2 2 2 1 --\n\nLoam -- -- 1 2 1 -- --\n\nClay -- -- 1 2 1 -- --\n\n\\*Guidelines developed by USU but applicable for the Spokane climate. --Water as needed.\n\n### 1","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Establishing Water-Smart Plants**\n\nAll plants, including water-smart plants, require an establishment period with consistent water to develop their roots. Planting in the fall or spring helps take advantage of natural precipitation and lower evapotranspiration rates and allows plants to become established before periods of drought.\n\n# RECOMMENDED PLANTS\n\n**NO IRRIGATION**\n\n**VERY LOW WATER**\n\n**LOW WATER**\n\n**MODERATE WATER**\n\n**FULL SUN**\n\n**PART SHADE**\n\n**SHADE**\n\n### **KEY TO SYMBOLS**\n\n**NO IRRIGATION:** Plants rely on natural precipitation and generally need no additional water once established. Great for areas that are unwatered!\n\n**VERY LOW-WATER:** Plants need more water than natural precipitation. A deep watering once or twice a month should be sufficient.\n\n**LOW-WATER:** Plants generally need to be watered once a week. This is still 50% less than conventional landscapes.\n\n**MODERATE WATER:** Plants need watering more than once a week during the heat of summer. Using drip irrigation on these plants is ideal.\n\n### **Water Requirements**\n\nThe water requirements listed for each plant are general guidelines, keep in mind that some plants tolerate a range of water requirements than others.\n\n# Plant List\n\n**LAWNS & ANNUALS**\n\nAPR MAY JUN JUL AUG SEP OCT\n\nSand -- 2 3 3 3 2 --\n\nLoam -- 1 2 3 2 1 --\n\nClay -- 1 2 2 2 1 --\n\n### **GENERAL DAILY IRRIGATION GUIDELINES:**\n\nThese guidelines are recommended after your new plants have been established. Root depth varies from 18-48” or deeper, depending on the plant type. Watering deeply and less often encourages deep rooting and plant tolerance to heat and drought.\n\n**SHRUBS & PERENNIALS**\n\nAPR MAY JUN JUL AUG SEP OCT\n\nSand -- 1 2 2 2 1 --\n\nLoam -- -- 1 2 1 -- --\n\nClay -- -- 1 2 1 -- --\n\n\\*Guidelines developed by USU but applicable for the Spokane climate. --Water as needed.\n\n### 1","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drought-tolerant-plant-list_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_58dca3cc5a663c9378227fb1d4ad213a","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Establishing Water-Smart Plants**\n\nAll plants, including water-smart plants, require an establishment period with consistent water to develop their roots. Planting in the fall or spring helps take advantage of natural precipitation and lower evapotranspiration rates and allows plants to become established before periods of drought.\n\n# RECOMMENDED PLANTS\n\n**NO IRRIGATION**\n\n**VERY LOW WATER**\n\n**LOW WATER**\n\n**MODERATE WATER**\n\n**FULL SUN**\n\n**PART SHADE**\n\n**SHADE**\n\n### **KEY TO SYMBOLS**\n\n**NO IRRIGATION:** Plants rely on natural precipitation and generally need no additional water once established. Great for areas that are unwatered!\n\n**VERY LOW-WATER:** Plants need more water than natural precipitation. A deep watering once or twice a month should be sufficient.\n\n**LOW-WATER:** Plants generally need to be watered once a week. This is still 50% less than conventional landscapes.\n\n**MODERATE WATER:** Plants need watering more than once a week during the heat of summer. Using drip irrigation on these plants is ideal.\n\n### **Water Requirements**\n\nThe water requirements listed for each plant are general guidelines, keep in mind that some plants tolerate a range of water requirements than others.\n\n# Plant List\n\n**LAWNS & ANNUALS**\n\nAPR MAY JUN JUL AUG SEP OCT\n\nSand -- 2 3 3 3 2 --\n\nLoam -- 1 2 3 2 1 --\n\nClay -- 1 2 2 2 1 --\n\n### **GENERAL DAILY IRRIGATION GUIDELINES:**\n\nThese guidelines are recommended after your new plants have been established. Root depth varies from 18-48” or deeper, depending on the plant type. Watering deeply and less often encourages deep rooting and plant tolerance to heat and drought.\n\n**SHRUBS & PERENNIALS**\n\nAPR MAY JUN JUL AUG SEP OCT\n\nSand -- 1 2 2 2 1 --\n\nLoam -- -- 1 2 1 -- --\n\nClay -- -- 1 2 1 -- --\n\n\\*Guidelines developed by USU but applicable for the Spokane climate. --Water as needed.\n\n### 1"],"full_content":"### **Establishing Water-Smart Plants**\n\nAll plants, including water-smart plants, require an establishment period with consistent water to develop their roots. Planting in the fall or spring helps take advantage of natural precipitation and lower evapotranspiration rates and allows plants to become established before periods of drought.\n\n# RECOMMENDED PLANTS\n\n**NO IRRIGATION**\n\n**VERY LOW WATER**\n\n**LOW WATER**\n\n**MODERATE WATER**\n\n**FULL SUN**\n\n**PART SHADE**\n\n**SHADE**\n\n### **KEY TO SYMBOLS**\n\n**NO IRRIGATION:** Plants rely on natural precipitation and generally need no additional water once established. Great for areas that are unwatered!\n\n**VERY LOW-WATER:** Plants need more water than natural precipitation. A deep watering once or twice a month should be sufficient.\n\n**LOW-WATER:** Plants generally need to be watered once a week. This is still 50% less than conventional landscapes.\n\n**MODERATE WATER:** Plants need watering more than once a week during the heat of summer. Using drip irrigation on these plants is ideal.\n\n### **Water Requirements**\n\nThe water requirements listed for each plant are general guidelines, keep in mind that some plants tolerate a range of water requirements than others.\n\n# Plant List\n\n**LAWNS & ANNUALS**\n\nAPR MAY JUN JUL AUG SEP OCT\n\nSand -- 2 3 3 3 2 --\n\nLoam -- 1 2 3 2 1 --\n\nClay -- 1 2 2 2 1 --\n\n### **GENERAL DAILY IRRIGATION GUIDELINES:**\n\nThese guidelines are recommended after your new plants have been established. Root depth varies from 18-48” or deeper, depending on the plant type. Watering deeply and less often encourages deep rooting and plant tolerance to heat and drought.\n\n**SHRUBS & PERENNIALS**\n\nAPR MAY JUN JUL AUG SEP OCT\n\nSand -- 1 2 2 2 1 --\n\nLoam -- -- 1 2 1 -- --\n\nClay -- -- 1 2 1 -- --\n\n\\*Guidelines developed by USU but applicable for the Spokane climate. --Water as needed.\n\n### 1","publish_date":null,"title":"Plant List","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drought-tolerant-plant-list_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drought-tolerant-plant-list_page1.pdf"},"request":{"example_id":"table/drought-tolerant-plant-list_page1","product_type":"parse","source_file_path":"drought-tolerant-plant-list_page1.pdf"},"started_at":"2026-11-04T19:47:01.937033"} +{"completed_at":"2026-11-04T19:47:04.684672","latency_in_ms":1469,"output":{"example_id":"table/drought-tolerant-plant-list_page3","grounded_pages":[],"layout_pages":[],"markdown":"**Common Name** **_Botanical Name_** **Size (h x w) Area (sf) Flower color Flower time Sun H** **2** **O Comment**\n\nPrairie Smoke _Geum triflorum_ 0\\.5’ x 1.5’ 2.25 Pink to Red Early Summer Wonderful groundcover for sun or shade. Goes dormant if very dry, but will remain green with occasional watering.\n\nHellebore _Helleborus orientalis_ 1\\.5’x1.5’ 2.25 White -pink to rose/pur- ple\n\nLate Winter Features large, cup-shaped, rose-like, usually nodding flowers (3-4” diame- ter) with center crowns of conspicuously contrasting yellow stamens. Flow- ers usually appear in clusters of 1-4 on thick stems rising above the foliage.\n\nDaylilly _Hemerocallis x species_ Varies by Species & Variety Mid to Late Summer\n\nSpot into perennial borders as individuals or small clusters. Mass into a sea of color that functions much like groundcover. You can arrange them in a row against foundations as a mini hedge. With its strap-leafed form and flowers on long wand-like stems, Daylily offers dramatic relief between dwarf shrubs.\n\nYucca _Hesperaloe parviflora_ _var_\n\nVaries by Variety Summer Grows easily in average to lean, well-drained soil. Water deeply at regular in- tervals during the first growing season to establish an extensive root system; reduce frequency once established.\n\nHosta _Hosta Species_ Varies 2.25 - 6’ Pinkish Lavender Summer Hosta is a genus of about 70 species of shade-loving, rhizomatous, clump-forming, herbaceous perennials. Hostas are primarily grown for their ornamental foliage. Leaves grow in a variety of shapes, sizes, colors and textures with, bell or funnel-shaped flowers.\n\nScarlet Gilia _Ipomopsis rubra_ 2 - 2.5’ 6.25 Red, Scar- let or Pink Summer Attracts hummingbirds. Long blooming.\n\nBearded Iris _Iris germanica_ 2-3’ x 2’ 4 Purple May Will tolerate light shade but best flowering and diseasresistance occur in full sun. Has tall sword-shaped linear leaves and usually fragrant blooms on stalks that branch below their mid points.\n\nDwarf Iris _Iris pumila_ 8-16” x 1’ 1 Purple May Similar to bearded Iris but stay more compact. Will tolerate light shade but best flowering and diseasresistance occur in full sun. Has tall sword-shaped linear leaves and usually fragrant blooms on stalks that branch below their mid points.\n\nDead-Nettle _Lamium species_ Varies 4-6’ Yellow Early Summer Easily grown in average, dry to medium moisture, well-drained soils in part shade to full shade. Best in medium moisture soils in part shade. Spreads by stem fragments, rooting at the nodes, creeping stems, and seed. It can be somewhat invasive in optimum growing conditions.\n\nLavender _Lavandula species_ 3’ x 3’ 6 Purple Summer Hardy English Lavender does well in dry gardens. Fragrant flowers have many uses and are loved by bees. Goldfinches eat the seeds.\n\nSiskiyou Lewisia _Lewisia cotyledon_ 6”+ x 1.5’ 2.25 See Comment Variable Succulent green leaves and great numbers of beautiful flowers. Thrives in a well-drained soil and is heat and drought tolerant. Colors: Pastel Pink, Rose, Salmon, Orange, White, Yellow, and Bicolour Patterns.\n\nBlue Flax _Linum perenne_ 1-2’ x 18” 2.25 Blue Summer Mostly unbranched leafy stems produce delicate blue flowers on slender stalks near the top. Found in open well drained prairies and meadows.\n\nLupine _Lupinus lepidus / sericeus_ Varies by Species & Variety Early Summer Lupines are widely available and available in myriad colors. They produce spikes of pea-like flowers in early and midsummer.\n\nBeebalm _Monarda species_ 2’ x 2’ 4 Pink to White with Purple\n\nSummer Flowers are attractive to bees and butterflies. The toothed, aromatic, oblong, grayish-green leaves may be used in teas. Long summer bloom period. Tolerates somewhat poor soils and some drought.\n\nGarden Catmint _Nepeta faasinii_ 2’ x 2.5’ 6.25 Blue Summer A hardy plant that flowers all season, needs a minimum of maintenance, is resistant to drought and sails happily through the coldest and driest of winters. It is a reliable plant, and a magnet for bees.\n\nTufted Evening-Prim- rose _Oenothera caespitosa_\n\n10” x 10” 1 White Early Summer A standout in the dry landscape. Long blooming & gorgeous. Large flow- ered.\n\nPenstemon _Penstemon species_ Varies by Species & Variety Beautiful flowers arranged on strong stems, attracting butterflies and hum- mingbirds. Excellent choice for perennial borders and cutting gardens. Will rebloom if cut back after flowering.\n\nSolomon’s Seal _Polygonatum odoratum var._\n\nVaries by Spe- cies & Variety White Spring Easily grown in moist, humusy, organically rich, well-drained soils in part shade to full shade. Best performance occurs in cool sun-dappled shady areas. Dislikes hot summer conditions. Slowly spreads by thin rhizomes to form colonies in optimum growing conditions.\n\nChristmas Fern _Polystichum acrosti- choides_\n\n2 ‘x 2’ 4 None None Best grown in organically rich, dry to medium moisture, well-drained soils in part shade to full shade. Provides a hint of winter interst. Consider planting rhizome at an angle to help combat potential crown rot problems which can occur in poorly drained soils.\n\nTall Cinquefoil _Potentilla arguta_ 1\\.5’ x 2’ 4 Yellow Summer A Palouse Prairie native 1 1/2-2' tall, thrives in full sun to partial shade. Drought tolerant but will tolerate seasonal moisture in a well drained site. Pale yellow flowers throughout the summer resemble strawberry blossoms.\n\nBlack Eyed Susan _Rudbeckia species_ 2’-3’ x 2’-3’ 9 Varies by Species & Variety\n\nSummer A colorful, fuss-free border plant and excellent choice for cut flowers. Bright, daisy-like flowers with black centers cover the dark green foliage. Tolerates heat, humidity, and clay soil. They attract butterflies and bees all summer.\n\nP E R R E N I A L S & A N N U A L S\n\n### 3","pages":[{"line_numbers":[],"markdown":"**Common Name** **_Botanical Name_** **Size (h x w) Area (sf) Flower color Flower time Sun H** **2** **O Comment**\n\nPrairie Smoke _Geum triflorum_ 0\\.5’ x 1.5’ 2.25 Pink to Red Early Summer Wonderful groundcover for sun or shade. Goes dormant if very dry, but will remain green with occasional watering.\n\nHellebore _Helleborus orientalis_ 1\\.5’x1.5’ 2.25 White -pink to rose/pur- ple\n\nLate Winter Features large, cup-shaped, rose-like, usually nodding flowers (3-4” diame- ter) with center crowns of conspicuously contrasting yellow stamens. Flow- ers usually appear in clusters of 1-4 on thick stems rising above the foliage.\n\nDaylilly _Hemerocallis x species_ Varies by Species & Variety Mid to Late Summer\n\nSpot into perennial borders as individuals or small clusters. Mass into a sea of color that functions much like groundcover. You can arrange them in a row against foundations as a mini hedge. With its strap-leafed form and flowers on long wand-like stems, Daylily offers dramatic relief between dwarf shrubs.\n\nYucca _Hesperaloe parviflora_ _var_\n\nVaries by Variety Summer Grows easily in average to lean, well-drained soil. Water deeply at regular in- tervals during the first growing season to establish an extensive root system; reduce frequency once established.\n\nHosta _Hosta Species_ Varies 2.25 - 6’ Pinkish Lavender Summer Hosta is a genus of about 70 species of shade-loving, rhizomatous, clump-forming, herbaceous perennials. Hostas are primarily grown for their ornamental foliage. Leaves grow in a variety of shapes, sizes, colors and textures with, bell or funnel-shaped flowers.\n\nScarlet Gilia _Ipomopsis rubra_ 2 - 2.5’ 6.25 Red, Scar- let or Pink Summer Attracts hummingbirds. Long blooming.\n\nBearded Iris _Iris germanica_ 2-3’ x 2’ 4 Purple May Will tolerate light shade but best flowering and diseasresistance occur in full sun. Has tall sword-shaped linear leaves and usually fragrant blooms on stalks that branch below their mid points.\n\nDwarf Iris _Iris pumila_ 8-16” x 1’ 1 Purple May Similar to bearded Iris but stay more compact. Will tolerate light shade but best flowering and diseasresistance occur in full sun. Has tall sword-shaped linear leaves and usually fragrant blooms on stalks that branch below their mid points.\n\nDead-Nettle _Lamium species_ Varies 4-6’ Yellow Early Summer Easily grown in average, dry to medium moisture, well-drained soils in part shade to full shade. Best in medium moisture soils in part shade. Spreads by stem fragments, rooting at the nodes, creeping stems, and seed. It can be somewhat invasive in optimum growing conditions.\n\nLavender _Lavandula species_ 3’ x 3’ 6 Purple Summer Hardy English Lavender does well in dry gardens. Fragrant flowers have many uses and are loved by bees. Goldfinches eat the seeds.\n\nSiskiyou Lewisia _Lewisia cotyledon_ 6”+ x 1.5’ 2.25 See Comment Variable Succulent green leaves and great numbers of beautiful flowers. Thrives in a well-drained soil and is heat and drought tolerant. Colors: Pastel Pink, Rose, Salmon, Orange, White, Yellow, and Bicolour Patterns.\n\nBlue Flax _Linum perenne_ 1-2’ x 18” 2.25 Blue Summer Mostly unbranched leafy stems produce delicate blue flowers on slender stalks near the top. Found in open well drained prairies and meadows.\n\nLupine _Lupinus lepidus / sericeus_ Varies by Species & Variety Early Summer Lupines are widely available and available in myriad colors. They produce spikes of pea-like flowers in early and midsummer.\n\nBeebalm _Monarda species_ 2’ x 2’ 4 Pink to White with Purple\n\nSummer Flowers are attractive to bees and butterflies. The toothed, aromatic, oblong, grayish-green leaves may be used in teas. Long summer bloom period. Tolerates somewhat poor soils and some drought.\n\nGarden Catmint _Nepeta faasinii_ 2’ x 2.5’ 6.25 Blue Summer A hardy plant that flowers all season, needs a minimum of maintenance, is resistant to drought and sails happily through the coldest and driest of winters. It is a reliable plant, and a magnet for bees.\n\nTufted Evening-Prim- rose _Oenothera caespitosa_\n\n10” x 10” 1 White Early Summer A standout in the dry landscape. Long blooming & gorgeous. Large flow- ered.\n\nPenstemon _Penstemon species_ Varies by Species & Variety Beautiful flowers arranged on strong stems, attracting butterflies and hum- mingbirds. Excellent choice for perennial borders and cutting gardens. Will rebloom if cut back after flowering.\n\nSolomon’s Seal _Polygonatum odoratum var._\n\nVaries by Spe- cies & Variety White Spring Easily grown in moist, humusy, organically rich, well-drained soils in part shade to full shade. Best performance occurs in cool sun-dappled shady areas. Dislikes hot summer conditions. Slowly spreads by thin rhizomes to form colonies in optimum growing conditions.\n\nChristmas Fern _Polystichum acrosti- choides_\n\n2 ‘x 2’ 4 None None Best grown in organically rich, dry to medium moisture, well-drained soils in part shade to full shade. Provides a hint of winter interst. Consider planting rhizome at an angle to help combat potential crown rot problems which can occur in poorly drained soils.\n\nTall Cinquefoil _Potentilla arguta_ 1\\.5’ x 2’ 4 Yellow Summer A Palouse Prairie native 1 1/2-2' tall, thrives in full sun to partial shade. Drought tolerant but will tolerate seasonal moisture in a well drained site. Pale yellow flowers throughout the summer resemble strawberry blossoms.\n\nBlack Eyed Susan _Rudbeckia species_ 2’-3’ x 2’-3’ 9 Varies by Species & Variety\n\nSummer A colorful, fuss-free border plant and excellent choice for cut flowers. Bright, daisy-like flowers with black centers cover the dark green foliage. Tolerates heat, humidity, and clay soil. They attract butterflies and bees all summer.\n\nP E R R E N I A L S & A N N U A L S\n\n### 3","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Common Name** **_Botanical Name_** **Size (h x w) Area (sf) Flower color Flower time Sun H** **2** **O Comment**\n\nPrairie Smoke _Geum triflorum_ 0\\.5’ x 1.5’ 2.25 Pink to Red Early Summer Wonderful groundcover for sun or shade. Goes dormant if very dry, but will remain green with occasional watering.\n\nHellebore _Helleborus orientalis_ 1\\.5’x1.5’ 2.25 White -pink to rose/pur- ple\n\nLate Winter Features large, cup-shaped, rose-like, usually nodding flowers (3-4” diame- ter) with center crowns of conspicuously contrasting yellow stamens. Flow- ers usually appear in clusters of 1-4 on thick stems rising above the foliage.\n\nDaylilly _Hemerocallis x species_ Varies by Species & Variety Mid to Late Summer\n\nSpot into perennial borders as individuals or small clusters. Mass into a sea of color that functions much like groundcover. You can arrange them in a row against foundations as a mini hedge. With its strap-leafed form and flowers on long wand-like stems, Daylily offers dramatic relief between dwarf shrubs.\n\nYucca _Hesperaloe parviflora_ _var_\n\nVaries by Variety Summer Grows easily in average to lean, well-drained soil. Water deeply at regular in- tervals during the first growing season to establish an extensive root system; reduce frequency once established.\n\nHosta _Hosta Species_ Varies 2.25 - 6’ Pinkish Lavender Summer Hosta is a genus of about 70 species of shade-loving, rhizomatous, clump-forming, herbaceous perennials. Hostas are primarily grown for their ornamental foliage. Leaves grow in a variety of shapes, sizes, colors and textures with, bell or funnel-shaped flowers.\n\nScarlet Gilia _Ipomopsis rubra_ 2 - 2.5’ 6.25 Red, Scar- let or Pink Summer Attracts hummingbirds. Long blooming.\n\nBearded Iris _Iris germanica_ 2-3’ x 2’ 4 Purple May Will tolerate light shade but best flowering and diseasresistance occur in full sun. Has tall sword-shaped linear leaves and usually fragrant blooms on stalks that branch below their mid points.\n\nDwarf Iris _Iris pumila_ 8-16” x 1’ 1 Purple May Similar to bearded Iris but stay more compact. Will tolerate light shade but best flowering and diseasresistance occur in full sun. Has tall sword-shaped linear leaves and usually fragrant blooms on stalks that branch below their mid points.\n\nDead-Nettle _Lamium species_ Varies 4-6’ Yellow Early Summer Easily grown in average, dry to medium moisture, well-drained soils in part shade to full shade. Best in medium moisture soils in part shade. Spreads by stem fragments, rooting at the nodes, creeping stems, and seed. It can be somewhat invasive in optimum growing conditions.\n\nLavender _Lavandula species_ 3’ x 3’ 6 Purple Summer Hardy English Lavender does well in dry gardens. Fragrant flowers have many uses and are loved by bees. Goldfinches eat the seeds.\n\nSiskiyou Lewisia _Lewisia cotyledon_ 6”+ x 1.5’ 2.25 See Comment Variable Succulent green leaves and great numbers of beautiful flowers. Thrives in a well-drained soil and is heat and drought tolerant. Colors: Pastel Pink, Rose, Salmon, Orange, White, Yellow, and Bicolour Patterns.\n\nBlue Flax _Linum perenne_ 1-2’ x 18” 2.25 Blue Summer Mostly unbranched leafy stems produce delicate blue flowers on slender stalks near the top. Found in open well drained prairies and meadows.\n\nLupine _Lupinus lepidus / sericeus_ Varies by Species & Variety Early Summer Lupines are widely available and available in myriad colors. They produce spikes of pea-like flowers in early and midsummer.\n\nBeebalm _Monarda species_ 2’ x 2’ 4 Pink to White with Purple\n\nSummer Flowers are attractive to bees and butterflies. The toothed, aromatic, oblong, grayish-green leaves may be used in teas. Long summer bloom period. Tolerates somewhat poor soils and some drought.\n\nGarden Catmint _Nepeta faasinii_ 2’ x 2.5’ 6.25 Blue Summer A hardy plant that flowers all season, needs a minimum of maintenance, is resistant to drought and sails happily through the coldest and driest of winters. It is a reliable plant, and a magnet for bees.\n\nTufted Evening-Prim- rose _Oenothera caespitosa_\n\n10” x 10” 1 White Early Summer A standout in the dry landscape. Long blooming & gorgeous. Large flow- ered.\n\nPenstemon _Penstemon species_ Varies by Species & Variety Beautiful flowers arranged on strong stems, attracting butterflies and hum- mingbirds. Excellent choice for perennial borders and cutting gardens. Will rebloom if cut back after flowering.\n\nSolomon’s Seal _Polygonatum odoratum var._\n\nVaries by Spe- cies & Variety White Spring Easily grown in moist, humusy, organically rich, well-drained soils in part shade to full shade. Best performance occurs in cool sun-dappled shady areas. Dislikes hot summer conditions. Slowly spreads by thin rhizomes to form colonies in optimum growing conditions.\n\nChristmas Fern _Polystichum acrosti- choides_\n\n2 ‘x 2’ 4 None None Best grown in organically rich, dry to medium moisture, well-drained soils in part shade to full shade. Provides a hint of winter interst. Consider planting rhizome at an angle to help combat potential crown rot problems which can occur in poorly drained soils.\n\nTall Cinquefoil _Potentilla arguta_ 1\\.5’ x 2’ 4 Yellow Summer A Palouse Prairie native 1 1/2-2' tall, thrives in full sun to partial shade. Drought tolerant but will tolerate seasonal moisture in a well drained site. Pale yellow flowers throughout the summer resemble strawberry blossoms.\n\nBlack Eyed Susan _Rudbeckia species_ 2’-3’ x 2’-3’ 9 Varies by Species & Variety\n\nSummer A colorful, fuss-free border plant and excellent choice for cut flowers. Bright, daisy-like flowers with black centers cover the dark green foliage. Tolerates heat, humidity, and clay soil. They attract butterflies and bees all summer.\n\nP E R R E N I A L S & A N N U A L S\n\n### 3","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drought-tolerant-plant-list_page3.pdf"]},"response":{"errors":[],"extract_id":"extract_cbd1e483492eea527d729ae816f478b5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Common Name** **_Botanical Name_** **Size (h x w) Area (sf) Flower color Flower time Sun H** **2** **O Comment**\n\nPrairie Smoke _Geum triflorum_ 0\\.5’ x 1.5’ 2.25 Pink to Red Early Summer Wonderful groundcover for sun or shade. Goes dormant if very dry, but will remain green with occasional watering.\n\nHellebore _Helleborus orientalis_ 1\\.5’x1.5’ 2.25 White -pink to rose/pur- ple\n\nLate Winter Features large, cup-shaped, rose-like, usually nodding flowers (3-4” diame- ter) with center crowns of conspicuously contrasting yellow stamens. Flow- ers usually appear in clusters of 1-4 on thick stems rising above the foliage.\n\nDaylilly _Hemerocallis x species_ Varies by Species & Variety Mid to Late Summer\n\nSpot into perennial borders as individuals or small clusters. Mass into a sea of color that functions much like groundcover. You can arrange them in a row against foundations as a mini hedge. With its strap-leafed form and flowers on long wand-like stems, Daylily offers dramatic relief between dwarf shrubs.\n\nYucca _Hesperaloe parviflora_ _var_\n\nVaries by Variety Summer Grows easily in average to lean, well-drained soil. Water deeply at regular in- tervals during the first growing season to establish an extensive root system; reduce frequency once established.\n\nHosta _Hosta Species_ Varies 2.25 - 6’ Pinkish Lavender Summer Hosta is a genus of about 70 species of shade-loving, rhizomatous, clump-forming, herbaceous perennials. Hostas are primarily grown for their ornamental foliage. Leaves grow in a variety of shapes, sizes, colors and textures with, bell or funnel-shaped flowers.\n\nScarlet Gilia _Ipomopsis rubra_ 2 - 2.5’ 6.25 Red, Scar- let or Pink Summer Attracts hummingbirds. Long blooming.\n\nBearded Iris _Iris germanica_ 2-3’ x 2’ 4 Purple May Will tolerate light shade but best flowering and diseasresistance occur in full sun. Has tall sword-shaped linear leaves and usually fragrant blooms on stalks that branch below their mid points.\n\nDwarf Iris _Iris pumila_ 8-16” x 1’ 1 Purple May Similar to bearded Iris but stay more compact. Will tolerate light shade but best flowering and diseasresistance occur in full sun. Has tall sword-shaped linear leaves and usually fragrant blooms on stalks that branch below their mid points.\n\nDead-Nettle _Lamium species_ Varies 4-6’ Yellow Early Summer Easily grown in average, dry to medium moisture, well-drained soils in part shade to full shade. Best in medium moisture soils in part shade. Spreads by stem fragments, rooting at the nodes, creeping stems, and seed. It can be somewhat invasive in optimum growing conditions.\n\nLavender _Lavandula species_ 3’ x 3’ 6 Purple Summer Hardy English Lavender does well in dry gardens. Fragrant flowers have many uses and are loved by bees. Goldfinches eat the seeds.\n\nSiskiyou Lewisia _Lewisia cotyledon_ 6”+ x 1.5’ 2.25 See Comment Variable Succulent green leaves and great numbers of beautiful flowers. Thrives in a well-drained soil and is heat and drought tolerant. Colors: Pastel Pink, Rose, Salmon, Orange, White, Yellow, and Bicolour Patterns.\n\nBlue Flax _Linum perenne_ 1-2’ x 18” 2.25 Blue Summer Mostly unbranched leafy stems produce delicate blue flowers on slender stalks near the top. Found in open well drained prairies and meadows.\n\nLupine _Lupinus lepidus / sericeus_ Varies by Species & Variety Early Summer Lupines are widely available and available in myriad colors. They produce spikes of pea-like flowers in early and midsummer.\n\nBeebalm _Monarda species_ 2’ x 2’ 4 Pink to White with Purple\n\nSummer Flowers are attractive to bees and butterflies. The toothed, aromatic, oblong, grayish-green leaves may be used in teas. Long summer bloom period. Tolerates somewhat poor soils and some drought.\n\nGarden Catmint _Nepeta faasinii_ 2’ x 2.5’ 6.25 Blue Summer A hardy plant that flowers all season, needs a minimum of maintenance, is resistant to drought and sails happily through the coldest and driest of winters. It is a reliable plant, and a magnet for bees.\n\nTufted Evening-Prim- rose _Oenothera caespitosa_\n\n10” x 10” 1 White Early Summer A standout in the dry landscape. Long blooming & gorgeous. Large flow- ered.\n\nPenstemon _Penstemon species_ Varies by Species & Variety Beautiful flowers arranged on strong stems, attracting butterflies and hum- mingbirds. Excellent choice for perennial borders and cutting gardens. Will rebloom if cut back after flowering.\n\nSolomon’s Seal _Polygonatum odoratum var._\n\nVaries by Spe- cies & Variety White Spring Easily grown in moist, humusy, organically rich, well-drained soils in part shade to full shade. Best performance occurs in cool sun-dappled shady areas. Dislikes hot summer conditions. Slowly spreads by thin rhizomes to form colonies in optimum growing conditions.\n\nChristmas Fern _Polystichum acrosti- choides_\n\n2 ‘x 2’ 4 None None Best grown in organically rich, dry to medium moisture, well-drained soils in part shade to full shade. Provides a hint of winter interst. Consider planting rhizome at an angle to help combat potential crown rot problems which can occur in poorly drained soils.\n\nTall Cinquefoil _Potentilla arguta_ 1\\.5’ x 2’ 4 Yellow Summer A Palouse Prairie native 1 1/2-2' tall, thrives in full sun to partial shade. Drought tolerant but will tolerate seasonal moisture in a well drained site. Pale yellow flowers throughout the summer resemble strawberry blossoms.\n\nBlack Eyed Susan _Rudbeckia species_ 2’-3’ x 2’-3’ 9 Varies by Species & Variety\n\nSummer A colorful, fuss-free border plant and excellent choice for cut flowers. Bright, daisy-like flowers with black centers cover the dark green foliage. Tolerates heat, humidity, and clay soil. They attract butterflies and bees all summer.\n\nP E R R E N I A L S & A N N U A L S\n\n### 3"],"full_content":"**Common Name** **_Botanical Name_** **Size (h x w) Area (sf) Flower color Flower time Sun H** **2** **O Comment**\n\nPrairie Smoke _Geum triflorum_ 0\\.5’ x 1.5’ 2.25 Pink to Red Early Summer Wonderful groundcover for sun or shade. Goes dormant if very dry, but will remain green with occasional watering.\n\nHellebore _Helleborus orientalis_ 1\\.5’x1.5’ 2.25 White -pink to rose/pur- ple\n\nLate Winter Features large, cup-shaped, rose-like, usually nodding flowers (3-4” diame- ter) with center crowns of conspicuously contrasting yellow stamens. Flow- ers usually appear in clusters of 1-4 on thick stems rising above the foliage.\n\nDaylilly _Hemerocallis x species_ Varies by Species & Variety Mid to Late Summer\n\nSpot into perennial borders as individuals or small clusters. Mass into a sea of color that functions much like groundcover. You can arrange them in a row against foundations as a mini hedge. With its strap-leafed form and flowers on long wand-like stems, Daylily offers dramatic relief between dwarf shrubs.\n\nYucca _Hesperaloe parviflora_ _var_\n\nVaries by Variety Summer Grows easily in average to lean, well-drained soil. Water deeply at regular in- tervals during the first growing season to establish an extensive root system; reduce frequency once established.\n\nHosta _Hosta Species_ Varies 2.25 - 6’ Pinkish Lavender Summer Hosta is a genus of about 70 species of shade-loving, rhizomatous, clump-forming, herbaceous perennials. Hostas are primarily grown for their ornamental foliage. Leaves grow in a variety of shapes, sizes, colors and textures with, bell or funnel-shaped flowers.\n\nScarlet Gilia _Ipomopsis rubra_ 2 - 2.5’ 6.25 Red, Scar- let or Pink Summer Attracts hummingbirds. Long blooming.\n\nBearded Iris _Iris germanica_ 2-3’ x 2’ 4 Purple May Will tolerate light shade but best flowering and diseasresistance occur in full sun. Has tall sword-shaped linear leaves and usually fragrant blooms on stalks that branch below their mid points.\n\nDwarf Iris _Iris pumila_ 8-16” x 1’ 1 Purple May Similar to bearded Iris but stay more compact. Will tolerate light shade but best flowering and diseasresistance occur in full sun. Has tall sword-shaped linear leaves and usually fragrant blooms on stalks that branch below their mid points.\n\nDead-Nettle _Lamium species_ Varies 4-6’ Yellow Early Summer Easily grown in average, dry to medium moisture, well-drained soils in part shade to full shade. Best in medium moisture soils in part shade. Spreads by stem fragments, rooting at the nodes, creeping stems, and seed. It can be somewhat invasive in optimum growing conditions.\n\nLavender _Lavandula species_ 3’ x 3’ 6 Purple Summer Hardy English Lavender does well in dry gardens. Fragrant flowers have many uses and are loved by bees. Goldfinches eat the seeds.\n\nSiskiyou Lewisia _Lewisia cotyledon_ 6”+ x 1.5’ 2.25 See Comment Variable Succulent green leaves and great numbers of beautiful flowers. Thrives in a well-drained soil and is heat and drought tolerant. Colors: Pastel Pink, Rose, Salmon, Orange, White, Yellow, and Bicolour Patterns.\n\nBlue Flax _Linum perenne_ 1-2’ x 18” 2.25 Blue Summer Mostly unbranched leafy stems produce delicate blue flowers on slender stalks near the top. Found in open well drained prairies and meadows.\n\nLupine _Lupinus lepidus / sericeus_ Varies by Species & Variety Early Summer Lupines are widely available and available in myriad colors. They produce spikes of pea-like flowers in early and midsummer.\n\nBeebalm _Monarda species_ 2’ x 2’ 4 Pink to White with Purple\n\nSummer Flowers are attractive to bees and butterflies. The toothed, aromatic, oblong, grayish-green leaves may be used in teas. Long summer bloom period. Tolerates somewhat poor soils and some drought.\n\nGarden Catmint _Nepeta faasinii_ 2’ x 2.5’ 6.25 Blue Summer A hardy plant that flowers all season, needs a minimum of maintenance, is resistant to drought and sails happily through the coldest and driest of winters. It is a reliable plant, and a magnet for bees.\n\nTufted Evening-Prim- rose _Oenothera caespitosa_\n\n10” x 10” 1 White Early Summer A standout in the dry landscape. Long blooming & gorgeous. Large flow- ered.\n\nPenstemon _Penstemon species_ Varies by Species & Variety Beautiful flowers arranged on strong stems, attracting butterflies and hum- mingbirds. Excellent choice for perennial borders and cutting gardens. Will rebloom if cut back after flowering.\n\nSolomon’s Seal _Polygonatum odoratum var._\n\nVaries by Spe- cies & Variety White Spring Easily grown in moist, humusy, organically rich, well-drained soils in part shade to full shade. Best performance occurs in cool sun-dappled shady areas. Dislikes hot summer conditions. Slowly spreads by thin rhizomes to form colonies in optimum growing conditions.\n\nChristmas Fern _Polystichum acrosti- choides_\n\n2 ‘x 2’ 4 None None Best grown in organically rich, dry to medium moisture, well-drained soils in part shade to full shade. Provides a hint of winter interst. Consider planting rhizome at an angle to help combat potential crown rot problems which can occur in poorly drained soils.\n\nTall Cinquefoil _Potentilla arguta_ 1\\.5’ x 2’ 4 Yellow Summer A Palouse Prairie native 1 1/2-2' tall, thrives in full sun to partial shade. Drought tolerant but will tolerate seasonal moisture in a well drained site. Pale yellow flowers throughout the summer resemble strawberry blossoms.\n\nBlack Eyed Susan _Rudbeckia species_ 2’-3’ x 2’-3’ 9 Varies by Species & Variety\n\nSummer A colorful, fuss-free border plant and excellent choice for cut flowers. Bright, daisy-like flowers with black centers cover the dark green foliage. Tolerates heat, humidity, and clay soil. They attract butterflies and bees all summer.\n\nP E R R E N I A L S & A N N U A L S\n\n### 3","publish_date":null,"title":"3","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drought-tolerant-plant-list_page3.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/drought-tolerant-plant-list_page3.pdf"},"request":{"example_id":"table/drought-tolerant-plant-list_page3","product_type":"parse","source_file_path":"drought-tolerant-plant-list_page3.pdf"},"started_at":"2026-11-04T19:47:03.214675"} +{"completed_at":"2026-11-04T19:47:06.215745","latency_in_ms":1641,"output":{"example_id":"table/fqr-retail-blackrock-global-allocation-fund-inc_page4","grounded_pages":[],"layout_pages":[],"markdown":"Consolidated Schedule of Investments (unaudited) (continued)\n\nJuly 31, 2025\n\n**BlackRock Global Allocation Fund, Inc.**\n\n4\n\n**(Percentages shown are based on Net Assets)**\n\n_Security_\n\n_Par (000) Par (000) Value_\n\n**Cayman Islands (continued)** RR 28 Ltd., Series 2024-28RA, Class\n\nA1R, (3-mo. CME Term SOFR at 1.55% Floor + 1.55%), 5.87%, 04/15/37 . . . . . . . . . . . . . . . . . USD 5,718 $ 5,742,049\n\nRR 38 Ltd., Series 2025-38A, Class\n\nA1A, (3-mo. CME Term SOFR at 1.15% Floor + 1.15%), 5.47%, 04/15/40 . . . . . . . . . . . . . . . . . 250 249,760\n\nSignal Peak CLO 5 Ltd., Series 2018-\n\n5A, Class A1R, (3-mo. CME Term SOFR at 1.55% Floor + 1.55%), 5.87%, 04/25/37 . . . . . . . . . . . . 300 301,237\n\nSixth Street CLO XIII Ltd., Series 2019-\n\n13A, Class D1R2, (3-mo. CME Term SOFR at 2.60% Floor + 2.60%), 6.93%, 01/21/38 . . . . . . . . . . . . 1,000 1,002,053\n\nSymphony CLO XXI Ltd., Series 2019-\n\n21A, Class AR2, (3-mo. CME Term SOFR at 0.90% Floor + 0.90%), 5.22%, 07/15/32 . . . . . . . . . . . . 711 711,251\n\nTICP CLO VI Ltd.\n\nSeries 2016-6A, Class AR2, (3-mo.\n\nCME Term SOFR at 1.12% Floor + 1.38%), 5.70%, 01/15/34 . . . 500 500,889\n\nSeries 2016-6A, Class BR2, (3-mo.\n\nCME Term SOFR at 1.50% Floor + 1.76%), 6.08%, 01/15/34 . . . 500 500,639\n\nTICP CLO XII Ltd., Series 2018-12A,\n\nClass BR, (3-mo. CME Term SOFR at 1.65% Floor + 1.91%), 6.23%, 07/15/34 . . . . . . . . . . . . . . . . . 700 701,734\n\nTrinitas CLO XIV Ltd.\n\nSeries 2020-14A, Class BR, (3-mo.\n\nCME Term SOFR at 1.95% Floor + 1.95%), 6.27%, 01/25/34 . . . 1,070 1,067,218\n\nSeries 2020-14A, Class CR, (3-mo.\n\nCME Term SOFR at 2.40% Floor + 2.40%), 6.72%, 01/25/34 . . . 940 941,419\n\nVoya CLO Ltd.\n\nSeries 2013-3A, Class A1RR, (3-mo.\n\nCME Term SOFR at 1.15% Floor + 1.41%), 5.74%, 10/18/31 . . . 95 95,519\n\nSeries 2018-3A, Class A1R2, (3-mo.\n\nCME Term SOFR at 1.20% Floor + 1.20%), 5.52%, 10/15/31 . . . 153 152,733\n\nSeries 2019-2A, Class AR, (3-mo.\n\nCME Term SOFR at 1.20% Floor + 1.20%), 5.53%, 07/20/32 . . . 849 849,827\n\nWhitebox CLO I Ltd., Series 2019-1A,\n\nClass BRR, (3-mo. CME Term SOFR at 1.75% Floor + 1.75%), 6.07%, 07/24/36 . . . . . . . . . . . . . . . . . 1,200 1,201,200\n\n68,077,028\n\n**Ireland — 0.6%** **(b)**\n\nAB Carval Euro CLO II-C DAC, Series\n\n2X, Class D, (3-mo. EURIBOR at 3.75% Floor + 3.75%), 5.89%, 02/15/37 (c) . . . . . . . . . . . . . . . . EUR 2,350 2,715,134\n\nArbour CLO VI DAC, Series 6X, Class\n\nDR, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.34%, 11/15/37 (c) 2,720 3,100,879\n\nArcano Euro CLO I DAC, Series 1X,\n\nClass D, (3-mo. EURIBOR at 3.40% Floor + 3.40%), 5.59%, 04/25/39 (c) 3,200 3,682,728\n\n_Security_\n\n_Par (000) Par (000) Value_\n\n**Ireland (continued)** Arcano Euro CLO II DAC, Series 2X,\n\nClass D, (3-mo. EURIBOR at 3.30% Floor + 3.30%), 0.00%, 07/25/39 (c) EUR 1,430 $ 1,631,916\n\nArini European CLO IV DAC, Series 4X,\n\nClass D, (3-mo. EURIBOR at 3.50% Floor + 3.50%), 5.53%, 01/15/38 (c) 3,920 4,525,215\n\nArini European CLO V DAC, Series 5X,\n\nClass D, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 5.17%, 01/15/39 (c) 2,080 2,370,703\n\nAurium CLO XIII DAC, Series 13X,\n\nClass D, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 5.17%, 04/15/38 (c) 1,440 1,631,477\n\nAvoca CLO XVIII DAC, Series 18X,\n\nClass DR, (3-mo. EURIBOR at 3.05% Floor + 3.05%), 5.08%, 01/15/38 (c) . . . . . . . . . . . . . . . . 1,560 1,790,435\n\nAvoca Static CLO I DAC, Series 1X,\n\nClass DR, (3-mo. EURIBOR at 2.90% Floor + 2.90%), 4.93%, 01/15/35 (c) . . . . . . . . . . . . . . . . 1,360 1,546,503\n\nCapital Four CLO VIII DAC, Series 8X,\n\nClass D, (3-mo. EURIBOR at 3.25% Floor + 3.25%), 5.19%, 10/25/37 (c) 3,200 3,677,443\n\nCIFC European Funding CLO II\n\nDAC, Series 2X, Class B1, (3-mo. EURIBOR at 1.60% Floor + 1.60%), 3.63%, 04/15/33 (c) . . . . . . . . . . . 593 679,294\n\nContego CLO V DAC, Series 5X, Class\n\nDR, (3-mo. EURIBOR at 3.10% Floor + 3.10%), 5.13%, 10/15/37 (c) 2,030 2,318,937\n\nContego CLO VII DAC, Series 7X,\n\nClass DR, (3-mo. EURIBOR at 3.45% Floor + 3.45%), 5.42%, 01/23/38 (c) . . . . . . . . . . . . . . . . 2,640 3,019,641\n\nContego CLO XI DAC, Series 11X,\n\nClass DR, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.30%, 11/20/38 (c) . . . . . . . . . . . . . . . . . 2,000 2,291,894\n\nCVC Cordatus Opportunity Loan\n\nFund-R DAC, Series 1X, Class DR, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 4.94%, 08/15/33 (c) . . . . . 6,410 7,295,970\n\nFidelity Grand Harbour CLO DAC,\n\nSeries 2023-1X, Class DR, (3-mo. EURIBOR at 2.70% Floor + 2.70%), 4.84%, 02/15/38 (c) . . . . . . . . . . . 2,720 3,080,072\n\nHarvest CLO XXXII DAC, Series 32X,\n\nClass D, (3-mo. EURIBOR at 3.60% Floor + 3.60%), 5.54%, 07/25/37 (c) 2,002 2,298,802\n\nHenley CLO Xi DAC, Series 11X, Class\n\nD, (3-mo. EURIBOR at 2.60% Floor + 2.60%), 4.96%, 04/25/39 (c) . . . . 3,140 3,577,990\n\nHenley CLO XII DAC, Series 12X,\n\nClass D, (3-mo. EURIBOR at 3.10% Floor + 3.10%), 5.13%, 01/15/38 (c) 1,980 2,276,337\n\nHolland Park CLO DAC, Series 1X,\n\nClass A1RR, (3-mo. EURIBOR at 0.92% Floor + 0.92%), 3.06%, 11/14/32 (c) . . . . . . . . . . . . . . . . . 250 285,271\n\nJubilee CLO DAC, Series 2024-29X,\n\nClass D, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.23%, 01/15/39 (c) 3,370 3,860,336\n\nBNM0925U-4843537-15261173","pages":[{"line_numbers":[],"markdown":"Consolidated Schedule of Investments (unaudited) (continued)\n\nJuly 31, 2025\n\n**BlackRock Global Allocation Fund, Inc.**\n\n4\n\n**(Percentages shown are based on Net Assets)**\n\n_Security_\n\n_Par (000) Par (000) Value_\n\n**Cayman Islands (continued)** RR 28 Ltd., Series 2024-28RA, Class\n\nA1R, (3-mo. CME Term SOFR at 1.55% Floor + 1.55%), 5.87%, 04/15/37 . . . . . . . . . . . . . . . . . USD 5,718 $ 5,742,049\n\nRR 38 Ltd., Series 2025-38A, Class\n\nA1A, (3-mo. CME Term SOFR at 1.15% Floor + 1.15%), 5.47%, 04/15/40 . . . . . . . . . . . . . . . . . 250 249,760\n\nSignal Peak CLO 5 Ltd., Series 2018-\n\n5A, Class A1R, (3-mo. CME Term SOFR at 1.55% Floor + 1.55%), 5.87%, 04/25/37 . . . . . . . . . . . . 300 301,237\n\nSixth Street CLO XIII Ltd., Series 2019-\n\n13A, Class D1R2, (3-mo. CME Term SOFR at 2.60% Floor + 2.60%), 6.93%, 01/21/38 . . . . . . . . . . . . 1,000 1,002,053\n\nSymphony CLO XXI Ltd., Series 2019-\n\n21A, Class AR2, (3-mo. CME Term SOFR at 0.90% Floor + 0.90%), 5.22%, 07/15/32 . . . . . . . . . . . . 711 711,251\n\nTICP CLO VI Ltd.\n\nSeries 2016-6A, Class AR2, (3-mo.\n\nCME Term SOFR at 1.12% Floor + 1.38%), 5.70%, 01/15/34 . . . 500 500,889\n\nSeries 2016-6A, Class BR2, (3-mo.\n\nCME Term SOFR at 1.50% Floor + 1.76%), 6.08%, 01/15/34 . . . 500 500,639\n\nTICP CLO XII Ltd., Series 2018-12A,\n\nClass BR, (3-mo. CME Term SOFR at 1.65% Floor + 1.91%), 6.23%, 07/15/34 . . . . . . . . . . . . . . . . . 700 701,734\n\nTrinitas CLO XIV Ltd.\n\nSeries 2020-14A, Class BR, (3-mo.\n\nCME Term SOFR at 1.95% Floor + 1.95%), 6.27%, 01/25/34 . . . 1,070 1,067,218\n\nSeries 2020-14A, Class CR, (3-mo.\n\nCME Term SOFR at 2.40% Floor + 2.40%), 6.72%, 01/25/34 . . . 940 941,419\n\nVoya CLO Ltd.\n\nSeries 2013-3A, Class A1RR, (3-mo.\n\nCME Term SOFR at 1.15% Floor + 1.41%), 5.74%, 10/18/31 . . . 95 95,519\n\nSeries 2018-3A, Class A1R2, (3-mo.\n\nCME Term SOFR at 1.20% Floor + 1.20%), 5.52%, 10/15/31 . . . 153 152,733\n\nSeries 2019-2A, Class AR, (3-mo.\n\nCME Term SOFR at 1.20% Floor + 1.20%), 5.53%, 07/20/32 . . . 849 849,827\n\nWhitebox CLO I Ltd., Series 2019-1A,\n\nClass BRR, (3-mo. CME Term SOFR at 1.75% Floor + 1.75%), 6.07%, 07/24/36 . . . . . . . . . . . . . . . . . 1,200 1,201,200\n\n68,077,028\n\n**Ireland — 0.6%** **(b)**\n\nAB Carval Euro CLO II-C DAC, Series\n\n2X, Class D, (3-mo. EURIBOR at 3.75% Floor + 3.75%), 5.89%, 02/15/37 (c) . . . . . . . . . . . . . . . . EUR 2,350 2,715,134\n\nArbour CLO VI DAC, Series 6X, Class\n\nDR, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.34%, 11/15/37 (c) 2,720 3,100,879\n\nArcano Euro CLO I DAC, Series 1X,\n\nClass D, (3-mo. EURIBOR at 3.40% Floor + 3.40%), 5.59%, 04/25/39 (c) 3,200 3,682,728\n\n_Security_\n\n_Par (000) Par (000) Value_\n\n**Ireland (continued)** Arcano Euro CLO II DAC, Series 2X,\n\nClass D, (3-mo. EURIBOR at 3.30% Floor + 3.30%), 0.00%, 07/25/39 (c) EUR 1,430 $ 1,631,916\n\nArini European CLO IV DAC, Series 4X,\n\nClass D, (3-mo. EURIBOR at 3.50% Floor + 3.50%), 5.53%, 01/15/38 (c) 3,920 4,525,215\n\nArini European CLO V DAC, Series 5X,\n\nClass D, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 5.17%, 01/15/39 (c) 2,080 2,370,703\n\nAurium CLO XIII DAC, Series 13X,\n\nClass D, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 5.17%, 04/15/38 (c) 1,440 1,631,477\n\nAvoca CLO XVIII DAC, Series 18X,\n\nClass DR, (3-mo. EURIBOR at 3.05% Floor + 3.05%), 5.08%, 01/15/38 (c) . . . . . . . . . . . . . . . . 1,560 1,790,435\n\nAvoca Static CLO I DAC, Series 1X,\n\nClass DR, (3-mo. EURIBOR at 2.90% Floor + 2.90%), 4.93%, 01/15/35 (c) . . . . . . . . . . . . . . . . 1,360 1,546,503\n\nCapital Four CLO VIII DAC, Series 8X,\n\nClass D, (3-mo. EURIBOR at 3.25% Floor + 3.25%), 5.19%, 10/25/37 (c) 3,200 3,677,443\n\nCIFC European Funding CLO II\n\nDAC, Series 2X, Class B1, (3-mo. EURIBOR at 1.60% Floor + 1.60%), 3.63%, 04/15/33 (c) . . . . . . . . . . . 593 679,294\n\nContego CLO V DAC, Series 5X, Class\n\nDR, (3-mo. EURIBOR at 3.10% Floor + 3.10%), 5.13%, 10/15/37 (c) 2,030 2,318,937\n\nContego CLO VII DAC, Series 7X,\n\nClass DR, (3-mo. EURIBOR at 3.45% Floor + 3.45%), 5.42%, 01/23/38 (c) . . . . . . . . . . . . . . . . 2,640 3,019,641\n\nContego CLO XI DAC, Series 11X,\n\nClass DR, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.30%, 11/20/38 (c) . . . . . . . . . . . . . . . . . 2,000 2,291,894\n\nCVC Cordatus Opportunity Loan\n\nFund-R DAC, Series 1X, Class DR, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 4.94%, 08/15/33 (c) . . . . . 6,410 7,295,970\n\nFidelity Grand Harbour CLO DAC,\n\nSeries 2023-1X, Class DR, (3-mo. EURIBOR at 2.70% Floor + 2.70%), 4.84%, 02/15/38 (c) . . . . . . . . . . . 2,720 3,080,072\n\nHarvest CLO XXXII DAC, Series 32X,\n\nClass D, (3-mo. EURIBOR at 3.60% Floor + 3.60%), 5.54%, 07/25/37 (c) 2,002 2,298,802\n\nHenley CLO Xi DAC, Series 11X, Class\n\nD, (3-mo. EURIBOR at 2.60% Floor + 2.60%), 4.96%, 04/25/39 (c) . . . . 3,140 3,577,990\n\nHenley CLO XII DAC, Series 12X,\n\nClass D, (3-mo. EURIBOR at 3.10% Floor + 3.10%), 5.13%, 01/15/38 (c) 1,980 2,276,337\n\nHolland Park CLO DAC, Series 1X,\n\nClass A1RR, (3-mo. EURIBOR at 0.92% Floor + 0.92%), 3.06%, 11/14/32 (c) . . . . . . . . . . . . . . . . . 250 285,271\n\nJubilee CLO DAC, Series 2024-29X,\n\nClass D, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.23%, 01/15/39 (c) 3,370 3,860,336\n\nBNM0925U-4843537-15261173","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Consolidated Schedule of Investments (unaudited) (continued)\n\nJuly 31, 2025\n\n**BlackRock Global Allocation Fund, Inc.**\n\n4\n\n**(Percentages shown are based on Net Assets)**\n\n_Security_\n\n_Par (000) Par (000) Value_\n\n**Cayman Islands (continued)** RR 28 Ltd., Series 2024-28RA, Class\n\nA1R, (3-mo. CME Term SOFR at 1.55% Floor + 1.55%), 5.87%, 04/15/37 . . . . . . . . . . . . . . . . . USD 5,718 $ 5,742,049\n\nRR 38 Ltd., Series 2025-38A, Class\n\nA1A, (3-mo. CME Term SOFR at 1.15% Floor + 1.15%), 5.47%, 04/15/40 . . . . . . . . . . . . . . . . . 250 249,760\n\nSignal Peak CLO 5 Ltd., Series 2018-\n\n5A, Class A1R, (3-mo. CME Term SOFR at 1.55% Floor + 1.55%), 5.87%, 04/25/37 . . . . . . . . . . . . 300 301,237\n\nSixth Street CLO XIII Ltd., Series 2019-\n\n13A, Class D1R2, (3-mo. CME Term SOFR at 2.60% Floor + 2.60%), 6.93%, 01/21/38 . . . . . . . . . . . . 1,000 1,002,053\n\nSymphony CLO XXI Ltd., Series 2019-\n\n21A, Class AR2, (3-mo. CME Term SOFR at 0.90% Floor + 0.90%), 5.22%, 07/15/32 . . . . . . . . . . . . 711 711,251\n\nTICP CLO VI Ltd.\n\nSeries 2016-6A, Class AR2, (3-mo.\n\nCME Term SOFR at 1.12% Floor + 1.38%), 5.70%, 01/15/34 . . . 500 500,889\n\nSeries 2016-6A, Class BR2, (3-mo.\n\nCME Term SOFR at 1.50% Floor + 1.76%), 6.08%, 01/15/34 . . . 500 500,639\n\nTICP CLO XII Ltd., Series 2018-12A,\n\nClass BR, (3-mo. CME Term SOFR at 1.65% Floor + 1.91%), 6.23%, 07/15/34 . . . . . . . . . . . . . . . . . 700 701,734\n\nTrinitas CLO XIV Ltd.\n\nSeries 2020-14A, Class BR, (3-mo.\n\nCME Term SOFR at 1.95% Floor + 1.95%), 6.27%, 01/25/34 . . . 1,070 1,067,218\n\nSeries 2020-14A, Class CR, (3-mo.\n\nCME Term SOFR at 2.40% Floor + 2.40%), 6.72%, 01/25/34 . . . 940 941,419\n\nVoya CLO Ltd.\n\nSeries 2013-3A, Class A1RR, (3-mo.\n\nCME Term SOFR at 1.15% Floor + 1.41%), 5.74%, 10/18/31 . . . 95 95,519\n\nSeries 2018-3A, Class A1R2, (3-mo.\n\nCME Term SOFR at 1.20% Floor + 1.20%), 5.52%, 10/15/31 . . . 153 152,733\n\nSeries 2019-2A, Class AR, (3-mo.\n\nCME Term SOFR at 1.20% Floor + 1.20%), 5.53%, 07/20/32 . . . 849 849,827\n\nWhitebox CLO I Ltd., Series 2019-1A,\n\nClass BRR, (3-mo. CME Term SOFR at 1.75% Floor + 1.75%), 6.07%, 07/24/36 . . . . . . . . . . . . . . . . . 1,200 1,201,200\n\n68,077,028\n\n**Ireland — 0.6%** **(b)**\n\nAB Carval Euro CLO II-C DAC, Series\n\n2X, Class D, (3-mo. EURIBOR at 3.75% Floor + 3.75%), 5.89%, 02/15/37 (c) . . . . . . . . . . . . . . . . EUR 2,350 2,715,134\n\nArbour CLO VI DAC, Series 6X, Class\n\nDR, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.34%, 11/15/37 (c) 2,720 3,100,879\n\nArcano Euro CLO I DAC, Series 1X,\n\nClass D, (3-mo. EURIBOR at 3.40% Floor + 3.40%), 5.59%, 04/25/39 (c) 3,200 3,682,728\n\n_Security_\n\n_Par (000) Par (000) Value_\n\n**Ireland (continued)** Arcano Euro CLO II DAC, Series 2X,\n\nClass D, (3-mo. EURIBOR at 3.30% Floor + 3.30%), 0.00%, 07/25/39 (c) EUR 1,430 $ 1,631,916\n\nArini European CLO IV DAC, Series 4X,\n\nClass D, (3-mo. EURIBOR at 3.50% Floor + 3.50%), 5.53%, 01/15/38 (c) 3,920 4,525,215\n\nArini European CLO V DAC, Series 5X,\n\nClass D, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 5.17%, 01/15/39 (c) 2,080 2,370,703\n\nAurium CLO XIII DAC, Series 13X,\n\nClass D, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 5.17%, 04/15/38 (c) 1,440 1,631,477\n\nAvoca CLO XVIII DAC, Series 18X,\n\nClass DR, (3-mo. EURIBOR at 3.05% Floor + 3.05%), 5.08%, 01/15/38 (c) . . . . . . . . . . . . . . . . 1,560 1,790,435\n\nAvoca Static CLO I DAC, Series 1X,\n\nClass DR, (3-mo. EURIBOR at 2.90% Floor + 2.90%), 4.93%, 01/15/35 (c) . . . . . . . . . . . . . . . . 1,360 1,546,503\n\nCapital Four CLO VIII DAC, Series 8X,\n\nClass D, (3-mo. EURIBOR at 3.25% Floor + 3.25%), 5.19%, 10/25/37 (c) 3,200 3,677,443\n\nCIFC European Funding CLO II\n\nDAC, Series 2X, Class B1, (3-mo. EURIBOR at 1.60% Floor + 1.60%), 3.63%, 04/15/33 (c) . . . . . . . . . . . 593 679,294\n\nContego CLO V DAC, Series 5X, Class\n\nDR, (3-mo. EURIBOR at 3.10% Floor + 3.10%), 5.13%, 10/15/37 (c) 2,030 2,318,937\n\nContego CLO VII DAC, Series 7X,\n\nClass DR, (3-mo. EURIBOR at 3.45% Floor + 3.45%), 5.42%, 01/23/38 (c) . . . . . . . . . . . . . . . . 2,640 3,019,641\n\nContego CLO XI DAC, Series 11X,\n\nClass DR, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.30%, 11/20/38 (c) . . . . . . . . . . . . . . . . . 2,000 2,291,894\n\nCVC Cordatus Opportunity Loan\n\nFund-R DAC, Series 1X, Class DR, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 4.94%, 08/15/33 (c) . . . . . 6,410 7,295,970\n\nFidelity Grand Harbour CLO DAC,\n\nSeries 2023-1X, Class DR, (3-mo. EURIBOR at 2.70% Floor + 2.70%), 4.84%, 02/15/38 (c) . . . . . . . . . . . 2,720 3,080,072\n\nHarvest CLO XXXII DAC, Series 32X,\n\nClass D, (3-mo. EURIBOR at 3.60% Floor + 3.60%), 5.54%, 07/25/37 (c) 2,002 2,298,802\n\nHenley CLO Xi DAC, Series 11X, Class\n\nD, (3-mo. EURIBOR at 2.60% Floor + 2.60%), 4.96%, 04/25/39 (c) . . . . 3,140 3,577,990\n\nHenley CLO XII DAC, Series 12X,\n\nClass D, (3-mo. EURIBOR at 3.10% Floor + 3.10%), 5.13%, 01/15/38 (c) 1,980 2,276,337\n\nHolland Park CLO DAC, Series 1X,\n\nClass A1RR, (3-mo. EURIBOR at 0.92% Floor + 0.92%), 3.06%, 11/14/32 (c) . . . . . . . . . . . . . . . . . 250 285,271\n\nJubilee CLO DAC, Series 2024-29X,\n\nClass D, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.23%, 01/15/39 (c) 3,370 3,860,336\n\nBNM0925U-4843537-15261173","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/fqr-retail-blackrock-global-allocation-fund-inc_page4.pdf"]},"response":{"errors":[],"extract_id":"extract_90baa93ce5e88dc41f3ff1fc60fe4ce4","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Consolidated Schedule of Investments (unaudited) (continued)\n\nJuly 31, 2025\n\n**BlackRock Global Allocation Fund, Inc.**\n\n4\n\n**(Percentages shown are based on Net Assets)**\n\n_Security_\n\n_Par (000) Par (000) Value_\n\n**Cayman Islands (continued)** RR 28 Ltd., Series 2024-28RA, Class\n\nA1R, (3-mo. CME Term SOFR at 1.55% Floor + 1.55%), 5.87%, 04/15/37 . . . . . . . . . . . . . . . . . USD 5,718 $ 5,742,049\n\nRR 38 Ltd., Series 2025-38A, Class\n\nA1A, (3-mo. CME Term SOFR at 1.15% Floor + 1.15%), 5.47%, 04/15/40 . . . . . . . . . . . . . . . . . 250 249,760\n\nSignal Peak CLO 5 Ltd., Series 2018-\n\n5A, Class A1R, (3-mo. CME Term SOFR at 1.55% Floor + 1.55%), 5.87%, 04/25/37 . . . . . . . . . . . . 300 301,237\n\nSixth Street CLO XIII Ltd., Series 2019-\n\n13A, Class D1R2, (3-mo. CME Term SOFR at 2.60% Floor + 2.60%), 6.93%, 01/21/38 . . . . . . . . . . . . 1,000 1,002,053\n\nSymphony CLO XXI Ltd., Series 2019-\n\n21A, Class AR2, (3-mo. CME Term SOFR at 0.90% Floor + 0.90%), 5.22%, 07/15/32 . . . . . . . . . . . . 711 711,251\n\nTICP CLO VI Ltd.\n\nSeries 2016-6A, Class AR2, (3-mo.\n\nCME Term SOFR at 1.12% Floor + 1.38%), 5.70%, 01/15/34 . . . 500 500,889\n\nSeries 2016-6A, Class BR2, (3-mo.\n\nCME Term SOFR at 1.50% Floor + 1.76%), 6.08%, 01/15/34 . . . 500 500,639\n\nTICP CLO XII Ltd., Series 2018-12A,\n\nClass BR, (3-mo. CME Term SOFR at 1.65% Floor + 1.91%), 6.23%, 07/15/34 . . . . . . . . . . . . . . . . . 700 701,734\n\nTrinitas CLO XIV Ltd.\n\nSeries 2020-14A, Class BR, (3-mo.\n\nCME Term SOFR at 1.95% Floor + 1.95%), 6.27%, 01/25/34 . . . 1,070 1,067,218\n\nSeries 2020-14A, Class CR, (3-mo.\n\nCME Term SOFR at 2.40% Floor + 2.40%), 6.72%, 01/25/34 . . . 940 941,419\n\nVoya CLO Ltd.\n\nSeries 2013-3A, Class A1RR, (3-mo.\n\nCME Term SOFR at 1.15% Floor + 1.41%), 5.74%, 10/18/31 . . . 95 95,519\n\nSeries 2018-3A, Class A1R2, (3-mo.\n\nCME Term SOFR at 1.20% Floor + 1.20%), 5.52%, 10/15/31 . . . 153 152,733\n\nSeries 2019-2A, Class AR, (3-mo.\n\nCME Term SOFR at 1.20% Floor + 1.20%), 5.53%, 07/20/32 . . . 849 849,827\n\nWhitebox CLO I Ltd., Series 2019-1A,\n\nClass BRR, (3-mo. CME Term SOFR at 1.75% Floor + 1.75%), 6.07%, 07/24/36 . . . . . . . . . . . . . . . . . 1,200 1,201,200\n\n68,077,028\n\n**Ireland — 0.6%** **(b)**\n\nAB Carval Euro CLO II-C DAC, Series\n\n2X, Class D, (3-mo. EURIBOR at 3.75% Floor + 3.75%), 5.89%, 02/15/37 (c) . . . . . . . . . . . . . . . . EUR 2,350 2,715,134\n\nArbour CLO VI DAC, Series 6X, Class\n\nDR, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.34%, 11/15/37 (c) 2,720 3,100,879\n\nArcano Euro CLO I DAC, Series 1X,\n\nClass D, (3-mo. EURIBOR at 3.40% Floor + 3.40%), 5.59%, 04/25/39 (c) 3,200 3,682,728\n\n_Security_\n\n_Par (000) Par (000) Value_\n\n**Ireland (continued)** Arcano Euro CLO II DAC, Series 2X,\n\nClass D, (3-mo. EURIBOR at 3.30% Floor + 3.30%), 0.00%, 07/25/39 (c) EUR 1,430 $ 1,631,916\n\nArini European CLO IV DAC, Series 4X,\n\nClass D, (3-mo. EURIBOR at 3.50% Floor + 3.50%), 5.53%, 01/15/38 (c) 3,920 4,525,215\n\nArini European CLO V DAC, Series 5X,\n\nClass D, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 5.17%, 01/15/39 (c) 2,080 2,370,703\n\nAurium CLO XIII DAC, Series 13X,\n\nClass D, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 5.17%, 04/15/38 (c) 1,440 1,631,477\n\nAvoca CLO XVIII DAC, Series 18X,\n\nClass DR, (3-mo. EURIBOR at 3.05% Floor + 3.05%), 5.08%, 01/15/38 (c) . . . . . . . . . . . . . . . . 1,560 1,790,435\n\nAvoca Static CLO I DAC, Series 1X,\n\nClass DR, (3-mo. EURIBOR at 2.90% Floor + 2.90%), 4.93%, 01/15/35 (c) . . . . . . . . . . . . . . . . 1,360 1,546,503\n\nCapital Four CLO VIII DAC, Series 8X,\n\nClass D, (3-mo. EURIBOR at 3.25% Floor + 3.25%), 5.19%, 10/25/37 (c) 3,200 3,677,443\n\nCIFC European Funding CLO II\n\nDAC, Series 2X, Class B1, (3-mo. EURIBOR at 1.60% Floor + 1.60%), 3.63%, 04/15/33 (c) . . . . . . . . . . . 593 679,294\n\nContego CLO V DAC, Series 5X, Class\n\nDR, (3-mo. EURIBOR at 3.10% Floor + 3.10%), 5.13%, 10/15/37 (c) 2,030 2,318,937\n\nContego CLO VII DAC, Series 7X,\n\nClass DR, (3-mo. EURIBOR at 3.45% Floor + 3.45%), 5.42%, 01/23/38 (c) . . . . . . . . . . . . . . . . 2,640 3,019,641\n\nContego CLO XI DAC, Series 11X,\n\nClass DR, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.30%, 11/20/38 (c) . . . . . . . . . . . . . . . . . 2,000 2,291,894\n\nCVC Cordatus Opportunity Loan\n\nFund-R DAC, Series 1X, Class DR, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 4.94%, 08/15/33 (c) . . . . . 6,410 7,295,970\n\nFidelity Grand Harbour CLO DAC,\n\nSeries 2023-1X, Class DR, (3-mo. EURIBOR at 2.70% Floor + 2.70%), 4.84%, 02/15/38 (c) . . . . . . . . . . . 2,720 3,080,072\n\nHarvest CLO XXXII DAC, Series 32X,\n\nClass D, (3-mo. EURIBOR at 3.60% Floor + 3.60%), 5.54%, 07/25/37 (c) 2,002 2,298,802\n\nHenley CLO Xi DAC, Series 11X, Class\n\nD, (3-mo. EURIBOR at 2.60% Floor + 2.60%), 4.96%, 04/25/39 (c) . . . . 3,140 3,577,990\n\nHenley CLO XII DAC, Series 12X,\n\nClass D, (3-mo. EURIBOR at 3.10% Floor + 3.10%), 5.13%, 01/15/38 (c) 1,980 2,276,337\n\nHolland Park CLO DAC, Series 1X,\n\nClass A1RR, (3-mo. EURIBOR at 0.92% Floor + 0.92%), 3.06%, 11/14/32 (c) . . . . . . . . . . . . . . . . . 250 285,271\n\nJubilee CLO DAC, Series 2024-29X,\n\nClass D, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.23%, 01/15/39 (c) 3,370 3,860,336\n\nBNM0925U-4843537-15261173"],"full_content":"Consolidated Schedule of Investments (unaudited) (continued)\n\nJuly 31, 2025\n\n**BlackRock Global Allocation Fund, Inc.**\n\n4\n\n**(Percentages shown are based on Net Assets)**\n\n_Security_\n\n_Par (000) Par (000) Value_\n\n**Cayman Islands (continued)** RR 28 Ltd., Series 2024-28RA, Class\n\nA1R, (3-mo. CME Term SOFR at 1.55% Floor + 1.55%), 5.87%, 04/15/37 . . . . . . . . . . . . . . . . . USD 5,718 $ 5,742,049\n\nRR 38 Ltd., Series 2025-38A, Class\n\nA1A, (3-mo. CME Term SOFR at 1.15% Floor + 1.15%), 5.47%, 04/15/40 . . . . . . . . . . . . . . . . . 250 249,760\n\nSignal Peak CLO 5 Ltd., Series 2018-\n\n5A, Class A1R, (3-mo. CME Term SOFR at 1.55% Floor + 1.55%), 5.87%, 04/25/37 . . . . . . . . . . . . 300 301,237\n\nSixth Street CLO XIII Ltd., Series 2019-\n\n13A, Class D1R2, (3-mo. CME Term SOFR at 2.60% Floor + 2.60%), 6.93%, 01/21/38 . . . . . . . . . . . . 1,000 1,002,053\n\nSymphony CLO XXI Ltd., Series 2019-\n\n21A, Class AR2, (3-mo. CME Term SOFR at 0.90% Floor + 0.90%), 5.22%, 07/15/32 . . . . . . . . . . . . 711 711,251\n\nTICP CLO VI Ltd.\n\nSeries 2016-6A, Class AR2, (3-mo.\n\nCME Term SOFR at 1.12% Floor + 1.38%), 5.70%, 01/15/34 . . . 500 500,889\n\nSeries 2016-6A, Class BR2, (3-mo.\n\nCME Term SOFR at 1.50% Floor + 1.76%), 6.08%, 01/15/34 . . . 500 500,639\n\nTICP CLO XII Ltd., Series 2018-12A,\n\nClass BR, (3-mo. CME Term SOFR at 1.65% Floor + 1.91%), 6.23%, 07/15/34 . . . . . . . . . . . . . . . . . 700 701,734\n\nTrinitas CLO XIV Ltd.\n\nSeries 2020-14A, Class BR, (3-mo.\n\nCME Term SOFR at 1.95% Floor + 1.95%), 6.27%, 01/25/34 . . . 1,070 1,067,218\n\nSeries 2020-14A, Class CR, (3-mo.\n\nCME Term SOFR at 2.40% Floor + 2.40%), 6.72%, 01/25/34 . . . 940 941,419\n\nVoya CLO Ltd.\n\nSeries 2013-3A, Class A1RR, (3-mo.\n\nCME Term SOFR at 1.15% Floor + 1.41%), 5.74%, 10/18/31 . . . 95 95,519\n\nSeries 2018-3A, Class A1R2, (3-mo.\n\nCME Term SOFR at 1.20% Floor + 1.20%), 5.52%, 10/15/31 . . . 153 152,733\n\nSeries 2019-2A, Class AR, (3-mo.\n\nCME Term SOFR at 1.20% Floor + 1.20%), 5.53%, 07/20/32 . . . 849 849,827\n\nWhitebox CLO I Ltd., Series 2019-1A,\n\nClass BRR, (3-mo. CME Term SOFR at 1.75% Floor + 1.75%), 6.07%, 07/24/36 . . . . . . . . . . . . . . . . . 1,200 1,201,200\n\n68,077,028\n\n**Ireland — 0.6%** **(b)**\n\nAB Carval Euro CLO II-C DAC, Series\n\n2X, Class D, (3-mo. EURIBOR at 3.75% Floor + 3.75%), 5.89%, 02/15/37 (c) . . . . . . . . . . . . . . . . EUR 2,350 2,715,134\n\nArbour CLO VI DAC, Series 6X, Class\n\nDR, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.34%, 11/15/37 (c) 2,720 3,100,879\n\nArcano Euro CLO I DAC, Series 1X,\n\nClass D, (3-mo. EURIBOR at 3.40% Floor + 3.40%), 5.59%, 04/25/39 (c) 3,200 3,682,728\n\n_Security_\n\n_Par (000) Par (000) Value_\n\n**Ireland (continued)** Arcano Euro CLO II DAC, Series 2X,\n\nClass D, (3-mo. EURIBOR at 3.30% Floor + 3.30%), 0.00%, 07/25/39 (c) EUR 1,430 $ 1,631,916\n\nArini European CLO IV DAC, Series 4X,\n\nClass D, (3-mo. EURIBOR at 3.50% Floor + 3.50%), 5.53%, 01/15/38 (c) 3,920 4,525,215\n\nArini European CLO V DAC, Series 5X,\n\nClass D, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 5.17%, 01/15/39 (c) 2,080 2,370,703\n\nAurium CLO XIII DAC, Series 13X,\n\nClass D, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 5.17%, 04/15/38 (c) 1,440 1,631,477\n\nAvoca CLO XVIII DAC, Series 18X,\n\nClass DR, (3-mo. EURIBOR at 3.05% Floor + 3.05%), 5.08%, 01/15/38 (c) . . . . . . . . . . . . . . . . 1,560 1,790,435\n\nAvoca Static CLO I DAC, Series 1X,\n\nClass DR, (3-mo. EURIBOR at 2.90% Floor + 2.90%), 4.93%, 01/15/35 (c) . . . . . . . . . . . . . . . . 1,360 1,546,503\n\nCapital Four CLO VIII DAC, Series 8X,\n\nClass D, (3-mo. EURIBOR at 3.25% Floor + 3.25%), 5.19%, 10/25/37 (c) 3,200 3,677,443\n\nCIFC European Funding CLO II\n\nDAC, Series 2X, Class B1, (3-mo. EURIBOR at 1.60% Floor + 1.60%), 3.63%, 04/15/33 (c) . . . . . . . . . . . 593 679,294\n\nContego CLO V DAC, Series 5X, Class\n\nDR, (3-mo. EURIBOR at 3.10% Floor + 3.10%), 5.13%, 10/15/37 (c) 2,030 2,318,937\n\nContego CLO VII DAC, Series 7X,\n\nClass DR, (3-mo. EURIBOR at 3.45% Floor + 3.45%), 5.42%, 01/23/38 (c) . . . . . . . . . . . . . . . . 2,640 3,019,641\n\nContego CLO XI DAC, Series 11X,\n\nClass DR, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.30%, 11/20/38 (c) . . . . . . . . . . . . . . . . . 2,000 2,291,894\n\nCVC Cordatus Opportunity Loan\n\nFund-R DAC, Series 1X, Class DR, (3-mo. EURIBOR at 2.80% Floor + 2.80%), 4.94%, 08/15/33 (c) . . . . . 6,410 7,295,970\n\nFidelity Grand Harbour CLO DAC,\n\nSeries 2023-1X, Class DR, (3-mo. EURIBOR at 2.70% Floor + 2.70%), 4.84%, 02/15/38 (c) . . . . . . . . . . . 2,720 3,080,072\n\nHarvest CLO XXXII DAC, Series 32X,\n\nClass D, (3-mo. EURIBOR at 3.60% Floor + 3.60%), 5.54%, 07/25/37 (c) 2,002 2,298,802\n\nHenley CLO Xi DAC, Series 11X, Class\n\nD, (3-mo. EURIBOR at 2.60% Floor + 2.60%), 4.96%, 04/25/39 (c) . . . . 3,140 3,577,990\n\nHenley CLO XII DAC, Series 12X,\n\nClass D, (3-mo. EURIBOR at 3.10% Floor + 3.10%), 5.13%, 01/15/38 (c) 1,980 2,276,337\n\nHolland Park CLO DAC, Series 1X,\n\nClass A1RR, (3-mo. EURIBOR at 0.92% Floor + 0.92%), 3.06%, 11/14/32 (c) . . . . . . . . . . . . . . . . . 250 285,271\n\nJubilee CLO DAC, Series 2024-29X,\n\nClass D, (3-mo. EURIBOR at 3.20% Floor + 3.20%), 5.23%, 01/15/39 (c) 3,370 3,860,336\n\nBNM0925U-4843537-15261173","publish_date":null,"title":"Consolidated Schedule of Investments","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/fqr-retail-blackrock-global-allocation-fund-inc_page4.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/fqr-retail-blackrock-global-allocation-fund-inc_page4.pdf"},"request":{"example_id":"table/fqr-retail-blackrock-global-allocation-fund-inc_page4","product_type":"parse","source_file_path":"fqr-retail-blackrock-global-allocation-fund-inc_page4.pdf"},"started_at":"2026-11-04T19:47:04.574280"} +{"completed_at":"2026-11-04T19:47:09.351199","latency_in_ms":3133,"output":{"example_id":"table/fqr-retail-blackrock-global-allocation-fund-inc_page8","grounded_pages":[],"layout_pages":[],"markdown":"Consolidated Schedule of Investments (unaudited) (continued)\n\nJuly 31, 2025\n\n**BlackRock Global Allocation Fund, Inc.**\n\n8\n\n**(Percentages shown are based on Net Assets)**\n\n_Security_\n\n_Shares Shares Value_\n\n**Japan (continued)** Asahi Kasei Corp. . . . . . . . . . . . . . 471,800 $ 3,282,671\n\nBridgestone Corp. . . . . . . . . . . . . . 15,700 635,068\n\nCanon, Inc. . . . . . . . . . . . . . . . . . . 277,800 7,890,254\n\nDai-ichi Life Holdings, Inc. . . . . . . . . 1,340,300 10,604,698\n\nDaiichi Sankyo Co. Ltd. . . . . . . . . . . 287,927 7,063,405\n\nDaikin Industries Ltd. . . . . . . . . . . . 21,521 2,646,133\n\nDaiwa Securities Group, Inc. . . . . . . 234,000 1,629,074\n\nEbara Corp. . . . . . . . . . . . . . . . . . 62,600 1,143,128\n\nENEOS Holdings, Inc. . . . . . . . . . . 1,853,800 9,729,921\n\nFANUC Corp. . . . . . . . . . . . . . . . . 50,364 1,401,981\n\nFast Retailing Co. Ltd. . . . . . . . . . . 9,300 2,836,776\n\nFUJIFILM Holdings Corp. . . . . . . . . 268,209 5,563,253\n\nGMO Payment Gateway, Inc. . . . . . . 48,600 2,708,616\n\nIdemitsu Kosan Co. Ltd. . . . . . . . . . 486,600 3,128,165\n\nIsetan Mitsukoshi Holdings Ltd. . . . . 145,200 2,052,036\n\nJapan Exchange Group, Inc. . . . . . . 473,600 4,628,201\n\nJapan Post Bank Co. Ltd. . . . . . . . . 1,377,400 15,373,569\n\nJapan Post Holdings Co. Ltd. . . . . . . 480,600 4,450,679\n\nJapan Tobacco, Inc. . . . . . . . . . . . . 476,900 13,620,088\n\nKakaku.com, Inc. . . . . . . . . . . . . . . 148,400 2,522,278\n\nKansai Paint Co. Ltd. . . . . . . . . . . . 137,986 1,953,868\n\nKawasaki Kisen Kaisha Ltd. . . . . . . . 359,700 5,081,442\n\nKDDI Corp. . . . . . . . . . . . . . . . . . . 132,200 2,169,616\n\nKeyence Corp. . . . . . . . . . . . . . . . 41,000 14,830,990\n\nKomatsu Ltd. . . . . . . . . . . . . . . . . 193,300 6,227,720\n\nKuraray Co. Ltd. . . . . . . . . . . . . . . 233,500 2,886,872\n\nLY Corp. . . . . . . . . . . . . . . . . . . . . 1,839,000 6,721,850\n\nMazda Motor Corp. . . . . . . . . . . . . 407,600 2,444,174\n\nMISUMI Group, Inc. . . . . . . . . . . . . 181,400 2,612,166\n\nMitsubishi Corp.. . . . . . . . . . . . . . . 81,500 1,607,457\n\nMitsubishi Electric Corp. . . . . . . . . . 79 1,777\n\nMitsubishi UFJ Financial Group, Inc. . 910,349 12,547,130\n\nMS&AD Insurance Group Holdings, Inc. 127,200 2,717,765\n\nMurata Manufacturing Co. Ltd. . . . . . 985,300 14,665,289\n\nNexon Co. Ltd. . . . . . . . . . . . . . . . 302,800 5,540,648\n\nNidec Corp. . . . . . . . . . . . . . . . . . 281,000 5,391,346\n\nNikon Corp. . . . . . . . . . . . . . . . . . 174,300 1,692,749\n\nNintendo Co. Ltd. . . . . . . . . . . . . . . 900 75,221\n\nNippon Paint Holdings Co. Ltd. . . . . . 292,296 2,477,952\n\nNippon Steel Corp. . . . . . . . . . . . . . 20,900 402,493\n\nNippon Yusen KK. . . . . . . . . . . . . . 206,500 7,241,913\n\nNissan Chemical Corp. . . . . . . . . . . 100,800 3,285,956\n\nNomura Holdings, Inc. . . . . . . . . . . 388,400 2,565,886\n\nObayashi Corp. . . . . . . . . . . . . . . . 217,900 3,208,634\n\nOlympus Corp. . . . . . . . . . . . . . . . 624,600 7,462,130\n\nRakus Co. Ltd. . . . . . . . . . . . . . . . 135,795 2,082,766\n\nRakuten Group, Inc. (f) . . . . . . . . . . . 514,700 2,604,236\n\nRohto Pharmaceutical Co. Ltd. . . . . . 98,800 1,410,281\n\nSanten Pharmaceutical Co. Ltd. . . . . 195,607 2,161,246\n\nShimizu Corp. . . . . . . . . . . . . . . . . 476,300 5,276,437\n\nSocionext, Inc. . . . . . . . . . . . . . . . 95,300 1,795,911\n\nSoftBank Group Corp. . . . . . . . . . . 44,600 3,405,609\n\nSumitomo Mitsui Financial Group, Inc. 312,200 7,875,748\n\nSuzuki Motor Corp. . . . . . . . . . . . . 594,100 6,527,718\n\nTOTO Ltd. . . . . . . . . . . . . . . . . . . 159,100 4,050,083\n\nToyota Motor Corp. . . . . . . . . . . . . 331,600 5,898,371\n\nToyota Tsusho Corp.. . . . . . . . . . . . 202,300 4,636,380\n\nTrend Micro, Inc. . . . . . . . . . . . . . . 88,138 5,374,520\n\nUnicharm Corp. . . . . . . . . . . . . . . . 412,100 2,850,557\n\nYamaha Motor Co. Ltd. . . . . . . . . . . 267,199 1,932,604\n\nYaskawa Electric Corp. . . . . . . . . . . 104,800 2,191,974\n\n283,955,434\n\n_Security_\n\n_Shares Shares Value_\n\n**Kazakhstan — 0.0%** **(c)**\n\nHalyk Savings Bank of Kazakhstan\n\nJSC, GDR . . . . . . . . . . . . . . . . 28,078 $ 697,332\n\nKaspi.KZ JSC, ADR . . . . . . . . . . . . 13,193 1,040,928\n\n1,738,260\n\n**Macau — 0.0%** Wynn Macau Ltd. . . . . . . . . . . . . . . 5,034,601 4,172,732\n\n**Malaysia — 0.0%** CIMB Group Holdings Bhd. . . . . . . . 249,900 382,001\n\nFrontken Corp. Bhd. . . . . . . . . . . . . 949,200 898,569\n\n1,280,570\n\n**Mexico — 0.1%** Cemex SAB de CV . . . . . . . . . . . . 2,136,982 1,865,682\n\nFomento Economico Mexicano SAB de\n\nCV . . . . . . . . . . . . . . . . . . . . . 48,437 437,281\n\nFresnillo plc . . . . . . . . . . . . . . . . . 269,206 4,963,804\n\nGrupo Aeroportuario del Sureste SAB\n\nde CV, Class B . . . . . . . . . . . . . 49,833 1,510,549\n\nGrupo Financiero Banorte SAB de CV,\n\nClass O . . . . . . . . . . . . . . . . . . 905,135 8,066,329\n\nGrupo Mexico SAB de CV, Series B . 109,096 682,912\n\n17,526,557\n\n**Netherlands — 0.9%** Argenx SE (f) . . . . . . . . . . . . . . . . . 10,061 6,757,268\n\nArgenx SE, ADR (f) . . . . . . . . . . . . . 4,190 2,808,682\n\nASML Holding NV . . . . . . . . . . . . . 132,793 92,035,330\n\nING Groep NV . . . . . . . . . . . . . . . . 536,737 12,508,895\n\nKoninklijke KPN NV . . . . . . . . . . . . 351,895 1,572,092\n\nKoninklijke Vopak NV . . . . . . . . . . . 29,704 1,418,990\n\nNXP Semiconductors NV . . . . . . . . 107,259 22,928,757\n\nTeya Services Ltd., Series C, (Acquired\n\n06/03/24, cost $10,172,087) (d)(f)(j) . . 5,237 1,557,536\n\nWolters Kluwer NV . . . . . . . . . . . . . 38,856 6,052,172\n\n147,639,722\n\n**Norway — 0.1%** DNB Bank ASA . . . . . . . . . . . . . . . 74,242 1,878,304\n\nKongsberg Gruppen ASA . . . . . . . . 212,366 6,346,162\n\nTelenor ASA . . . . . . . . . . . . . . . . . 250,508 3,843,019\n\n12,067,485\n\n**Peru — 0.0%** Credicorp Ltd. . . . . . . . . . . . . . . . . 9,131 2,164,047\n\n**Philippines — 0.0%** Ayala Land, Inc. . . . . . . . . . . . . . . . 1,256,300 536,761\n\nBloomberry Resorts Corp. . . . . . . . . 2,810,000 195,579\n\nDigiPlus Interactive Corp. . . . . . . . . 536,060 231,581\n\nInternational Container Terminal\n\nServices, Inc. . . . . . . . . . . . . . . 64,880 498,176\n\nMetropolitan Bank & Trust Co. . . . . . 385,660 489,728\n\n1,951,825\n\n**Poland — 0.1%** LPP SA . . . . . . . . . . . . . . . . . . . . 343 1,523,387\n\nPowszechna Kasa Oszczednosci Bank\n\nPolski SA . . . . . . . . . . . . . . . . . 30,264 662,676\n\nPowszechny Zaklad Ubezpieczen SA 422,351 7,079,019\n\n9,265,082\n\n**Portugal — 0.0%** Jeronimo Martins SGPS SA . . . . . . . 41,646 1,015,233\n\n**Republic of Turkiye — 0.0%** Akbank TAS . . . . . . . . . . . . . . . . . 940,971 1,560,091\n\nEldorado Gold Corp. (f) . . . . . . . . . . . 75,012 1,537,746\n\nBNM0925U-4843537-15261173","pages":[{"line_numbers":[],"markdown":"Consolidated Schedule of Investments (unaudited) (continued)\n\nJuly 31, 2025\n\n**BlackRock Global Allocation Fund, Inc.**\n\n8\n\n**(Percentages shown are based on Net Assets)**\n\n_Security_\n\n_Shares Shares Value_\n\n**Japan (continued)** Asahi Kasei Corp. . . . . . . . . . . . . . 471,800 $ 3,282,671\n\nBridgestone Corp. . . . . . . . . . . . . . 15,700 635,068\n\nCanon, Inc. . . . . . . . . . . . . . . . . . . 277,800 7,890,254\n\nDai-ichi Life Holdings, Inc. . . . . . . . . 1,340,300 10,604,698\n\nDaiichi Sankyo Co. Ltd. . . . . . . . . . . 287,927 7,063,405\n\nDaikin Industries Ltd. . . . . . . . . . . . 21,521 2,646,133\n\nDaiwa Securities Group, Inc. . . . . . . 234,000 1,629,074\n\nEbara Corp. . . . . . . . . . . . . . . . . . 62,600 1,143,128\n\nENEOS Holdings, Inc. . . . . . . . . . . 1,853,800 9,729,921\n\nFANUC Corp. . . . . . . . . . . . . . . . . 50,364 1,401,981\n\nFast Retailing Co. Ltd. . . . . . . . . . . 9,300 2,836,776\n\nFUJIFILM Holdings Corp. . . . . . . . . 268,209 5,563,253\n\nGMO Payment Gateway, Inc. . . . . . . 48,600 2,708,616\n\nIdemitsu Kosan Co. Ltd. . . . . . . . . . 486,600 3,128,165\n\nIsetan Mitsukoshi Holdings Ltd. . . . . 145,200 2,052,036\n\nJapan Exchange Group, Inc. . . . . . . 473,600 4,628,201\n\nJapan Post Bank Co. Ltd. . . . . . . . . 1,377,400 15,373,569\n\nJapan Post Holdings Co. Ltd. . . . . . . 480,600 4,450,679\n\nJapan Tobacco, Inc. . . . . . . . . . . . . 476,900 13,620,088\n\nKakaku.com, Inc. . . . . . . . . . . . . . . 148,400 2,522,278\n\nKansai Paint Co. Ltd. . . . . . . . . . . . 137,986 1,953,868\n\nKawasaki Kisen Kaisha Ltd. . . . . . . . 359,700 5,081,442\n\nKDDI Corp. . . . . . . . . . . . . . . . . . . 132,200 2,169,616\n\nKeyence Corp. . . . . . . . . . . . . . . . 41,000 14,830,990\n\nKomatsu Ltd. . . . . . . . . . . . . . . . . 193,300 6,227,720\n\nKuraray Co. Ltd. . . . . . . . . . . . . . . 233,500 2,886,872\n\nLY Corp. . . . . . . . . . . . . . . . . . . . . 1,839,000 6,721,850\n\nMazda Motor Corp. . . . . . . . . . . . . 407,600 2,444,174\n\nMISUMI Group, Inc. . . . . . . . . . . . . 181,400 2,612,166\n\nMitsubishi Corp.. . . . . . . . . . . . . . . 81,500 1,607,457\n\nMitsubishi Electric Corp. . . . . . . . . . 79 1,777\n\nMitsubishi UFJ Financial Group, Inc. . 910,349 12,547,130\n\nMS&AD Insurance Group Holdings, Inc. 127,200 2,717,765\n\nMurata Manufacturing Co. Ltd. . . . . . 985,300 14,665,289\n\nNexon Co. Ltd. . . . . . . . . . . . . . . . 302,800 5,540,648\n\nNidec Corp. . . . . . . . . . . . . . . . . . 281,000 5,391,346\n\nNikon Corp. . . . . . . . . . . . . . . . . . 174,300 1,692,749\n\nNintendo Co. Ltd. . . . . . . . . . . . . . . 900 75,221\n\nNippon Paint Holdings Co. Ltd. . . . . . 292,296 2,477,952\n\nNippon Steel Corp. . . . . . . . . . . . . . 20,900 402,493\n\nNippon Yusen KK. . . . . . . . . . . . . . 206,500 7,241,913\n\nNissan Chemical Corp. . . . . . . . . . . 100,800 3,285,956\n\nNomura Holdings, Inc. . . . . . . . . . . 388,400 2,565,886\n\nObayashi Corp. . . . . . . . . . . . . . . . 217,900 3,208,634\n\nOlympus Corp. . . . . . . . . . . . . . . . 624,600 7,462,130\n\nRakus Co. Ltd. . . . . . . . . . . . . . . . 135,795 2,082,766\n\nRakuten Group, Inc. (f) . . . . . . . . . . . 514,700 2,604,236\n\nRohto Pharmaceutical Co. Ltd. . . . . . 98,800 1,410,281\n\nSanten Pharmaceutical Co. Ltd. . . . . 195,607 2,161,246\n\nShimizu Corp. . . . . . . . . . . . . . . . . 476,300 5,276,437\n\nSocionext, Inc. . . . . . . . . . . . . . . . 95,300 1,795,911\n\nSoftBank Group Corp. . . . . . . . . . . 44,600 3,405,609\n\nSumitomo Mitsui Financial Group, Inc. 312,200 7,875,748\n\nSuzuki Motor Corp. . . . . . . . . . . . . 594,100 6,527,718\n\nTOTO Ltd. . . . . . . . . . . . . . . . . . . 159,100 4,050,083\n\nToyota Motor Corp. . . . . . . . . . . . . 331,600 5,898,371\n\nToyota Tsusho Corp.. . . . . . . . . . . . 202,300 4,636,380\n\nTrend Micro, Inc. . . . . . . . . . . . . . . 88,138 5,374,520\n\nUnicharm Corp. . . . . . . . . . . . . . . . 412,100 2,850,557\n\nYamaha Motor Co. Ltd. . . . . . . . . . . 267,199 1,932,604\n\nYaskawa Electric Corp. . . . . . . . . . . 104,800 2,191,974\n\n283,955,434\n\n_Security_\n\n_Shares Shares Value_\n\n**Kazakhstan — 0.0%** **(c)**\n\nHalyk Savings Bank of Kazakhstan\n\nJSC, GDR . . . . . . . . . . . . . . . . 28,078 $ 697,332\n\nKaspi.KZ JSC, ADR . . . . . . . . . . . . 13,193 1,040,928\n\n1,738,260\n\n**Macau — 0.0%** Wynn Macau Ltd. . . . . . . . . . . . . . . 5,034,601 4,172,732\n\n**Malaysia — 0.0%** CIMB Group Holdings Bhd. . . . . . . . 249,900 382,001\n\nFrontken Corp. Bhd. . . . . . . . . . . . . 949,200 898,569\n\n1,280,570\n\n**Mexico — 0.1%** Cemex SAB de CV . . . . . . . . . . . . 2,136,982 1,865,682\n\nFomento Economico Mexicano SAB de\n\nCV . . . . . . . . . . . . . . . . . . . . . 48,437 437,281\n\nFresnillo plc . . . . . . . . . . . . . . . . . 269,206 4,963,804\n\nGrupo Aeroportuario del Sureste SAB\n\nde CV, Class B . . . . . . . . . . . . . 49,833 1,510,549\n\nGrupo Financiero Banorte SAB de CV,\n\nClass O . . . . . . . . . . . . . . . . . . 905,135 8,066,329\n\nGrupo Mexico SAB de CV, Series B . 109,096 682,912\n\n17,526,557\n\n**Netherlands — 0.9%** Argenx SE (f) . . . . . . . . . . . . . . . . . 10,061 6,757,268\n\nArgenx SE, ADR (f) . . . . . . . . . . . . . 4,190 2,808,682\n\nASML Holding NV . . . . . . . . . . . . . 132,793 92,035,330\n\nING Groep NV . . . . . . . . . . . . . . . . 536,737 12,508,895\n\nKoninklijke KPN NV . . . . . . . . . . . . 351,895 1,572,092\n\nKoninklijke Vopak NV . . . . . . . . . . . 29,704 1,418,990\n\nNXP Semiconductors NV . . . . . . . . 107,259 22,928,757\n\nTeya Services Ltd., Series C, (Acquired\n\n06/03/24, cost $10,172,087) (d)(f)(j) . . 5,237 1,557,536\n\nWolters Kluwer NV . . . . . . . . . . . . . 38,856 6,052,172\n\n147,639,722\n\n**Norway — 0.1%** DNB Bank ASA . . . . . . . . . . . . . . . 74,242 1,878,304\n\nKongsberg Gruppen ASA . . . . . . . . 212,366 6,346,162\n\nTelenor ASA . . . . . . . . . . . . . . . . . 250,508 3,843,019\n\n12,067,485\n\n**Peru — 0.0%** Credicorp Ltd. . . . . . . . . . . . . . . . . 9,131 2,164,047\n\n**Philippines — 0.0%** Ayala Land, Inc. . . . . . . . . . . . . . . . 1,256,300 536,761\n\nBloomberry Resorts Corp. . . . . . . . . 2,810,000 195,579\n\nDigiPlus Interactive Corp. . . . . . . . . 536,060 231,581\n\nInternational Container Terminal\n\nServices, Inc. . . . . . . . . . . . . . . 64,880 498,176\n\nMetropolitan Bank & Trust Co. . . . . . 385,660 489,728\n\n1,951,825\n\n**Poland — 0.1%** LPP SA . . . . . . . . . . . . . . . . . . . . 343 1,523,387\n\nPowszechna Kasa Oszczednosci Bank\n\nPolski SA . . . . . . . . . . . . . . . . . 30,264 662,676\n\nPowszechny Zaklad Ubezpieczen SA 422,351 7,079,019\n\n9,265,082\n\n**Portugal — 0.0%** Jeronimo Martins SGPS SA . . . . . . . 41,646 1,015,233\n\n**Republic of Turkiye — 0.0%** Akbank TAS . . . . . . . . . . . . . . . . . 940,971 1,560,091\n\nEldorado Gold Corp. (f) . . . . . . . . . . . 75,012 1,537,746\n\nBNM0925U-4843537-15261173","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Consolidated Schedule of Investments (unaudited) (continued)\n\nJuly 31, 2025\n\n**BlackRock Global Allocation Fund, Inc.**\n\n8\n\n**(Percentages shown are based on Net Assets)**\n\n_Security_\n\n_Shares Shares Value_\n\n**Japan (continued)** Asahi Kasei Corp. . . . . . . . . . . . . . 471,800 $ 3,282,671\n\nBridgestone Corp. . . . . . . . . . . . . . 15,700 635,068\n\nCanon, Inc. . . . . . . . . . . . . . . . . . . 277,800 7,890,254\n\nDai-ichi Life Holdings, Inc. . . . . . . . . 1,340,300 10,604,698\n\nDaiichi Sankyo Co. Ltd. . . . . . . . . . . 287,927 7,063,405\n\nDaikin Industries Ltd. . . . . . . . . . . . 21,521 2,646,133\n\nDaiwa Securities Group, Inc. . . . . . . 234,000 1,629,074\n\nEbara Corp. . . . . . . . . . . . . . . . . . 62,600 1,143,128\n\nENEOS Holdings, Inc. . . . . . . . . . . 1,853,800 9,729,921\n\nFANUC Corp. . . . . . . . . . . . . . . . . 50,364 1,401,981\n\nFast Retailing Co. Ltd. . . . . . . . . . . 9,300 2,836,776\n\nFUJIFILM Holdings Corp. . . . . . . . . 268,209 5,563,253\n\nGMO Payment Gateway, Inc. . . . . . . 48,600 2,708,616\n\nIdemitsu Kosan Co. Ltd. . . . . . . . . . 486,600 3,128,165\n\nIsetan Mitsukoshi Holdings Ltd. . . . . 145,200 2,052,036\n\nJapan Exchange Group, Inc. . . . . . . 473,600 4,628,201\n\nJapan Post Bank Co. Ltd. . . . . . . . . 1,377,400 15,373,569\n\nJapan Post Holdings Co. Ltd. . . . . . . 480,600 4,450,679\n\nJapan Tobacco, Inc. . . . . . . . . . . . . 476,900 13,620,088\n\nKakaku.com, Inc. . . . . . . . . . . . . . . 148,400 2,522,278\n\nKansai Paint Co. Ltd. . . . . . . . . . . . 137,986 1,953,868\n\nKawasaki Kisen Kaisha Ltd. . . . . . . . 359,700 5,081,442\n\nKDDI Corp. . . . . . . . . . . . . . . . . . . 132,200 2,169,616\n\nKeyence Corp. . . . . . . . . . . . . . . . 41,000 14,830,990\n\nKomatsu Ltd. . . . . . . . . . . . . . . . . 193,300 6,227,720\n\nKuraray Co. Ltd. . . . . . . . . . . . . . . 233,500 2,886,872\n\nLY Corp. . . . . . . . . . . . . . . . . . . . . 1,839,000 6,721,850\n\nMazda Motor Corp. . . . . . . . . . . . . 407,600 2,444,174\n\nMISUMI Group, Inc. . . . . . . . . . . . . 181,400 2,612,166\n\nMitsubishi Corp.. . . . . . . . . . . . . . . 81,500 1,607,457\n\nMitsubishi Electric Corp. . . . . . . . . . 79 1,777\n\nMitsubishi UFJ Financial Group, Inc. . 910,349 12,547,130\n\nMS&AD Insurance Group Holdings, Inc. 127,200 2,717,765\n\nMurata Manufacturing Co. Ltd. . . . . . 985,300 14,665,289\n\nNexon Co. Ltd. . . . . . . . . . . . . . . . 302,800 5,540,648\n\nNidec Corp. . . . . . . . . . . . . . . . . . 281,000 5,391,346\n\nNikon Corp. . . . . . . . . . . . . . . . . . 174,300 1,692,749\n\nNintendo Co. Ltd. . . . . . . . . . . . . . . 900 75,221\n\nNippon Paint Holdings Co. Ltd. . . . . . 292,296 2,477,952\n\nNippon Steel Corp. . . . . . . . . . . . . . 20,900 402,493\n\nNippon Yusen KK. . . . . . . . . . . . . . 206,500 7,241,913\n\nNissan Chemical Corp. . . . . . . . . . . 100,800 3,285,956\n\nNomura Holdings, Inc. . . . . . . . . . . 388,400 2,565,886\n\nObayashi Corp. . . . . . . . . . . . . . . . 217,900 3,208,634\n\nOlympus Corp. . . . . . . . . . . . . . . . 624,600 7,462,130\n\nRakus Co. Ltd. . . . . . . . . . . . . . . . 135,795 2,082,766\n\nRakuten Group, Inc. (f) . . . . . . . . . . . 514,700 2,604,236\n\nRohto Pharmaceutical Co. Ltd. . . . . . 98,800 1,410,281\n\nSanten Pharmaceutical Co. Ltd. . . . . 195,607 2,161,246\n\nShimizu Corp. . . . . . . . . . . . . . . . . 476,300 5,276,437\n\nSocionext, Inc. . . . . . . . . . . . . . . . 95,300 1,795,911\n\nSoftBank Group Corp. . . . . . . . . . . 44,600 3,405,609\n\nSumitomo Mitsui Financial Group, Inc. 312,200 7,875,748\n\nSuzuki Motor Corp. . . . . . . . . . . . . 594,100 6,527,718\n\nTOTO Ltd. . . . . . . . . . . . . . . . . . . 159,100 4,050,083\n\nToyota Motor Corp. . . . . . . . . . . . . 331,600 5,898,371\n\nToyota Tsusho Corp.. . . . . . . . . . . . 202,300 4,636,380\n\nTrend Micro, Inc. . . . . . . . . . . . . . . 88,138 5,374,520\n\nUnicharm Corp. . . . . . . . . . . . . . . . 412,100 2,850,557\n\nYamaha Motor Co. Ltd. . . . . . . . . . . 267,199 1,932,604\n\nYaskawa Electric Corp. . . . . . . . . . . 104,800 2,191,974\n\n283,955,434\n\n_Security_\n\n_Shares Shares Value_\n\n**Kazakhstan — 0.0%** **(c)**\n\nHalyk Savings Bank of Kazakhstan\n\nJSC, GDR . . . . . . . . . . . . . . . . 28,078 $ 697,332\n\nKaspi.KZ JSC, ADR . . . . . . . . . . . . 13,193 1,040,928\n\n1,738,260\n\n**Macau — 0.0%** Wynn Macau Ltd. . . . . . . . . . . . . . . 5,034,601 4,172,732\n\n**Malaysia — 0.0%** CIMB Group Holdings Bhd. . . . . . . . 249,900 382,001\n\nFrontken Corp. Bhd. . . . . . . . . . . . . 949,200 898,569\n\n1,280,570\n\n**Mexico — 0.1%** Cemex SAB de CV . . . . . . . . . . . . 2,136,982 1,865,682\n\nFomento Economico Mexicano SAB de\n\nCV . . . . . . . . . . . . . . . . . . . . . 48,437 437,281\n\nFresnillo plc . . . . . . . . . . . . . . . . . 269,206 4,963,804\n\nGrupo Aeroportuario del Sureste SAB\n\nde CV, Class B . . . . . . . . . . . . . 49,833 1,510,549\n\nGrupo Financiero Banorte SAB de CV,\n\nClass O . . . . . . . . . . . . . . . . . . 905,135 8,066,329\n\nGrupo Mexico SAB de CV, Series B . 109,096 682,912\n\n17,526,557\n\n**Netherlands — 0.9%** Argenx SE (f) . . . . . . . . . . . . . . . . . 10,061 6,757,268\n\nArgenx SE, ADR (f) . . . . . . . . . . . . . 4,190 2,808,682\n\nASML Holding NV . . . . . . . . . . . . . 132,793 92,035,330\n\nING Groep NV . . . . . . . . . . . . . . . . 536,737 12,508,895\n\nKoninklijke KPN NV . . . . . . . . . . . . 351,895 1,572,092\n\nKoninklijke Vopak NV . . . . . . . . . . . 29,704 1,418,990\n\nNXP Semiconductors NV . . . . . . . . 107,259 22,928,757\n\nTeya Services Ltd., Series C, (Acquired\n\n06/03/24, cost $10,172,087) (d)(f)(j) . . 5,237 1,557,536\n\nWolters Kluwer NV . . . . . . . . . . . . . 38,856 6,052,172\n\n147,639,722\n\n**Norway — 0.1%** DNB Bank ASA . . . . . . . . . . . . . . . 74,242 1,878,304\n\nKongsberg Gruppen ASA . . . . . . . . 212,366 6,346,162\n\nTelenor ASA . . . . . . . . . . . . . . . . . 250,508 3,843,019\n\n12,067,485\n\n**Peru — 0.0%** Credicorp Ltd. . . . . . . . . . . . . . . . . 9,131 2,164,047\n\n**Philippines — 0.0%** Ayala Land, Inc. . . . . . . . . . . . . . . . 1,256,300 536,761\n\nBloomberry Resorts Corp. . . . . . . . . 2,810,000 195,579\n\nDigiPlus Interactive Corp. . . . . . . . . 536,060 231,581\n\nInternational Container Terminal\n\nServices, Inc. . . . . . . . . . . . . . . 64,880 498,176\n\nMetropolitan Bank & Trust Co. . . . . . 385,660 489,728\n\n1,951,825\n\n**Poland — 0.1%** LPP SA . . . . . . . . . . . . . . . . . . . . 343 1,523,387\n\nPowszechna Kasa Oszczednosci Bank\n\nPolski SA . . . . . . . . . . . . . . . . . 30,264 662,676\n\nPowszechny Zaklad Ubezpieczen SA 422,351 7,079,019\n\n9,265,082\n\n**Portugal — 0.0%** Jeronimo Martins SGPS SA . . . . . . . 41,646 1,015,233\n\n**Republic of Turkiye — 0.0%** Akbank TAS . . . . . . . . . . . . . . . . . 940,971 1,560,091\n\nEldorado Gold Corp. (f) . . . . . . . . . . . 75,012 1,537,746\n\nBNM0925U-4843537-15261173","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/fqr-retail-blackrock-global-allocation-fund-inc_page8.pdf"]},"response":{"errors":[],"extract_id":"extract_b95b14b76250601bdc8e4edc9c4ada82","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Consolidated Schedule of Investments (unaudited) (continued)\n\nJuly 31, 2025\n\n**BlackRock Global Allocation Fund, Inc.**\n\n8\n\n**(Percentages shown are based on Net Assets)**\n\n_Security_\n\n_Shares Shares Value_\n\n**Japan (continued)** Asahi Kasei Corp. . . . . . . . . . . . . . 471,800 $ 3,282,671\n\nBridgestone Corp. . . . . . . . . . . . . . 15,700 635,068\n\nCanon, Inc. . . . . . . . . . . . . . . . . . . 277,800 7,890,254\n\nDai-ichi Life Holdings, Inc. . . . . . . . . 1,340,300 10,604,698\n\nDaiichi Sankyo Co. Ltd. . . . . . . . . . . 287,927 7,063,405\n\nDaikin Industries Ltd. . . . . . . . . . . . 21,521 2,646,133\n\nDaiwa Securities Group, Inc. . . . . . . 234,000 1,629,074\n\nEbara Corp. . . . . . . . . . . . . . . . . . 62,600 1,143,128\n\nENEOS Holdings, Inc. . . . . . . . . . . 1,853,800 9,729,921\n\nFANUC Corp. . . . . . . . . . . . . . . . . 50,364 1,401,981\n\nFast Retailing Co. Ltd. . . . . . . . . . . 9,300 2,836,776\n\nFUJIFILM Holdings Corp. . . . . . . . . 268,209 5,563,253\n\nGMO Payment Gateway, Inc. . . . . . . 48,600 2,708,616\n\nIdemitsu Kosan Co. Ltd. . . . . . . . . . 486,600 3,128,165\n\nIsetan Mitsukoshi Holdings Ltd. . . . . 145,200 2,052,036\n\nJapan Exchange Group, Inc. . . . . . . 473,600 4,628,201\n\nJapan Post Bank Co. Ltd. . . . . . . . . 1,377,400 15,373,569\n\nJapan Post Holdings Co. Ltd. . . . . . . 480,600 4,450,679\n\nJapan Tobacco, Inc. . . . . . . . . . . . . 476,900 13,620,088\n\nKakaku.com, Inc. . . . . . . . . . . . . . . 148,400 2,522,278\n\nKansai Paint Co. Ltd. . . . . . . . . . . . 137,986 1,953,868\n\nKawasaki Kisen Kaisha Ltd. . . . . . . . 359,700 5,081,442\n\nKDDI Corp. . . . . . . . . . . . . . . . . . . 132,200 2,169,616\n\nKeyence Corp. . . . . . . . . . . . . . . . 41,000 14,830,990\n\nKomatsu Ltd. . . . . . . . . . . . . . . . . 193,300 6,227,720\n\nKuraray Co. Ltd. . . . . . . . . . . . . . . 233,500 2,886,872\n\nLY Corp. . . . . . . . . . . . . . . . . . . . . 1,839,000 6,721,850\n\nMazda Motor Corp. . . . . . . . . . . . . 407,600 2,444,174\n\nMISUMI Group, Inc. . . . . . . . . . . . . 181,400 2,612,166\n\nMitsubishi Corp.. . . . . . . . . . . . . . . 81,500 1,607,457\n\nMitsubishi Electric Corp. . . . . . . . . . 79 1,777\n\nMitsubishi UFJ Financial Group, Inc. . 910,349 12,547,130\n\nMS&AD Insurance Group Holdings, Inc. 127,200 2,717,765\n\nMurata Manufacturing Co. Ltd. . . . . . 985,300 14,665,289\n\nNexon Co. Ltd. . . . . . . . . . . . . . . . 302,800 5,540,648\n\nNidec Corp. . . . . . . . . . . . . . . . . . 281,000 5,391,346\n\nNikon Corp. . . . . . . . . . . . . . . . . . 174,300 1,692,749\n\nNintendo Co. Ltd. . . . . . . . . . . . . . . 900 75,221\n\nNippon Paint Holdings Co. Ltd. . . . . . 292,296 2,477,952\n\nNippon Steel Corp. . . . . . . . . . . . . . 20,900 402,493\n\nNippon Yusen KK. . . . . . . . . . . . . . 206,500 7,241,913\n\nNissan Chemical Corp. . . . . . . . . . . 100,800 3,285,956\n\nNomura Holdings, Inc. . . . . . . . . . . 388,400 2,565,886\n\nObayashi Corp. . . . . . . . . . . . . . . . 217,900 3,208,634\n\nOlympus Corp. . . . . . . . . . . . . . . . 624,600 7,462,130\n\nRakus Co. Ltd. . . . . . . . . . . . . . . . 135,795 2,082,766\n\nRakuten Group, Inc. (f) . . . . . . . . . . . 514,700 2,604,236\n\nRohto Pharmaceutical Co. Ltd. . . . . . 98,800 1,410,281\n\nSanten Pharmaceutical Co. Ltd. . . . . 195,607 2,161,246\n\nShimizu Corp. . . . . . . . . . . . . . . . . 476,300 5,276,437\n\nSocionext, Inc. . . . . . . . . . . . . . . . 95,300 1,795,911\n\nSoftBank Group Corp. . . . . . . . . . . 44,600 3,405,609\n\nSumitomo Mitsui Financial Group, Inc. 312,200 7,875,748\n\nSuzuki Motor Corp. . . . . . . . . . . . . 594,100 6,527,718\n\nTOTO Ltd. . . . . . . . . . . . . . . . . . . 159,100 4,050,083\n\nToyota Motor Corp. . . . . . . . . . . . . 331,600 5,898,371\n\nToyota Tsusho Corp.. . . . . . . . . . . . 202,300 4,636,380\n\nTrend Micro, Inc. . . . . . . . . . . . . . . 88,138 5,374,520\n\nUnicharm Corp. . . . . . . . . . . . . . . . 412,100 2,850,557\n\nYamaha Motor Co. Ltd. . . . . . . . . . . 267,199 1,932,604\n\nYaskawa Electric Corp. . . . . . . . . . . 104,800 2,191,974\n\n283,955,434\n\n_Security_\n\n_Shares Shares Value_\n\n**Kazakhstan — 0.0%** **(c)**\n\nHalyk Savings Bank of Kazakhstan\n\nJSC, GDR . . . . . . . . . . . . . . . . 28,078 $ 697,332\n\nKaspi.KZ JSC, ADR . . . . . . . . . . . . 13,193 1,040,928\n\n1,738,260\n\n**Macau — 0.0%** Wynn Macau Ltd. . . . . . . . . . . . . . . 5,034,601 4,172,732\n\n**Malaysia — 0.0%** CIMB Group Holdings Bhd. . . . . . . . 249,900 382,001\n\nFrontken Corp. Bhd. . . . . . . . . . . . . 949,200 898,569\n\n1,280,570\n\n**Mexico — 0.1%** Cemex SAB de CV . . . . . . . . . . . . 2,136,982 1,865,682\n\nFomento Economico Mexicano SAB de\n\nCV . . . . . . . . . . . . . . . . . . . . . 48,437 437,281\n\nFresnillo plc . . . . . . . . . . . . . . . . . 269,206 4,963,804\n\nGrupo Aeroportuario del Sureste SAB\n\nde CV, Class B . . . . . . . . . . . . . 49,833 1,510,549\n\nGrupo Financiero Banorte SAB de CV,\n\nClass O . . . . . . . . . . . . . . . . . . 905,135 8,066,329\n\nGrupo Mexico SAB de CV, Series B . 109,096 682,912\n\n17,526,557\n\n**Netherlands — 0.9%** Argenx SE (f) . . . . . . . . . . . . . . . . . 10,061 6,757,268\n\nArgenx SE, ADR (f) . . . . . . . . . . . . . 4,190 2,808,682\n\nASML Holding NV . . . . . . . . . . . . . 132,793 92,035,330\n\nING Groep NV . . . . . . . . . . . . . . . . 536,737 12,508,895\n\nKoninklijke KPN NV . . . . . . . . . . . . 351,895 1,572,092\n\nKoninklijke Vopak NV . . . . . . . . . . . 29,704 1,418,990\n\nNXP Semiconductors NV . . . . . . . . 107,259 22,928,757\n\nTeya Services Ltd., Series C, (Acquired\n\n06/03/24, cost $10,172,087) (d)(f)(j) . . 5,237 1,557,536\n\nWolters Kluwer NV . . . . . . . . . . . . . 38,856 6,052,172\n\n147,639,722\n\n**Norway — 0.1%** DNB Bank ASA . . . . . . . . . . . . . . . 74,242 1,878,304\n\nKongsberg Gruppen ASA . . . . . . . . 212,366 6,346,162\n\nTelenor ASA . . . . . . . . . . . . . . . . . 250,508 3,843,019\n\n12,067,485\n\n**Peru — 0.0%** Credicorp Ltd. . . . . . . . . . . . . . . . . 9,131 2,164,047\n\n**Philippines — 0.0%** Ayala Land, Inc. . . . . . . . . . . . . . . . 1,256,300 536,761\n\nBloomberry Resorts Corp. . . . . . . . . 2,810,000 195,579\n\nDigiPlus Interactive Corp. . . . . . . . . 536,060 231,581\n\nInternational Container Terminal\n\nServices, Inc. . . . . . . . . . . . . . . 64,880 498,176\n\nMetropolitan Bank & Trust Co. . . . . . 385,660 489,728\n\n1,951,825\n\n**Poland — 0.1%** LPP SA . . . . . . . . . . . . . . . . . . . . 343 1,523,387\n\nPowszechna Kasa Oszczednosci Bank\n\nPolski SA . . . . . . . . . . . . . . . . . 30,264 662,676\n\nPowszechny Zaklad Ubezpieczen SA 422,351 7,079,019\n\n9,265,082\n\n**Portugal — 0.0%** Jeronimo Martins SGPS SA . . . . . . . 41,646 1,015,233\n\n**Republic of Turkiye — 0.0%** Akbank TAS . . . . . . . . . . . . . . . . . 940,971 1,560,091\n\nEldorado Gold Corp. (f) . . . . . . . . . . . 75,012 1,537,746\n\nBNM0925U-4843537-15261173"],"full_content":"Consolidated Schedule of Investments (unaudited) (continued)\n\nJuly 31, 2025\n\n**BlackRock Global Allocation Fund, Inc.**\n\n8\n\n**(Percentages shown are based on Net Assets)**\n\n_Security_\n\n_Shares Shares Value_\n\n**Japan (continued)** Asahi Kasei Corp. . . . . . . . . . . . . . 471,800 $ 3,282,671\n\nBridgestone Corp. . . . . . . . . . . . . . 15,700 635,068\n\nCanon, Inc. . . . . . . . . . . . . . . . . . . 277,800 7,890,254\n\nDai-ichi Life Holdings, Inc. . . . . . . . . 1,340,300 10,604,698\n\nDaiichi Sankyo Co. Ltd. . . . . . . . . . . 287,927 7,063,405\n\nDaikin Industries Ltd. . . . . . . . . . . . 21,521 2,646,133\n\nDaiwa Securities Group, Inc. . . . . . . 234,000 1,629,074\n\nEbara Corp. . . . . . . . . . . . . . . . . . 62,600 1,143,128\n\nENEOS Holdings, Inc. . . . . . . . . . . 1,853,800 9,729,921\n\nFANUC Corp. . . . . . . . . . . . . . . . . 50,364 1,401,981\n\nFast Retailing Co. Ltd. . . . . . . . . . . 9,300 2,836,776\n\nFUJIFILM Holdings Corp. . . . . . . . . 268,209 5,563,253\n\nGMO Payment Gateway, Inc. . . . . . . 48,600 2,708,616\n\nIdemitsu Kosan Co. Ltd. . . . . . . . . . 486,600 3,128,165\n\nIsetan Mitsukoshi Holdings Ltd. . . . . 145,200 2,052,036\n\nJapan Exchange Group, Inc. . . . . . . 473,600 4,628,201\n\nJapan Post Bank Co. Ltd. . . . . . . . . 1,377,400 15,373,569\n\nJapan Post Holdings Co. Ltd. . . . . . . 480,600 4,450,679\n\nJapan Tobacco, Inc. . . . . . . . . . . . . 476,900 13,620,088\n\nKakaku.com, Inc. . . . . . . . . . . . . . . 148,400 2,522,278\n\nKansai Paint Co. Ltd. . . . . . . . . . . . 137,986 1,953,868\n\nKawasaki Kisen Kaisha Ltd. . . . . . . . 359,700 5,081,442\n\nKDDI Corp. . . . . . . . . . . . . . . . . . . 132,200 2,169,616\n\nKeyence Corp. . . . . . . . . . . . . . . . 41,000 14,830,990\n\nKomatsu Ltd. . . . . . . . . . . . . . . . . 193,300 6,227,720\n\nKuraray Co. Ltd. . . . . . . . . . . . . . . 233,500 2,886,872\n\nLY Corp. . . . . . . . . . . . . . . . . . . . . 1,839,000 6,721,850\n\nMazda Motor Corp. . . . . . . . . . . . . 407,600 2,444,174\n\nMISUMI Group, Inc. . . . . . . . . . . . . 181,400 2,612,166\n\nMitsubishi Corp.. . . . . . . . . . . . . . . 81,500 1,607,457\n\nMitsubishi Electric Corp. . . . . . . . . . 79 1,777\n\nMitsubishi UFJ Financial Group, Inc. . 910,349 12,547,130\n\nMS&AD Insurance Group Holdings, Inc. 127,200 2,717,765\n\nMurata Manufacturing Co. Ltd. . . . . . 985,300 14,665,289\n\nNexon Co. Ltd. . . . . . . . . . . . . . . . 302,800 5,540,648\n\nNidec Corp. . . . . . . . . . . . . . . . . . 281,000 5,391,346\n\nNikon Corp. . . . . . . . . . . . . . . . . . 174,300 1,692,749\n\nNintendo Co. Ltd. . . . . . . . . . . . . . . 900 75,221\n\nNippon Paint Holdings Co. Ltd. . . . . . 292,296 2,477,952\n\nNippon Steel Corp. . . . . . . . . . . . . . 20,900 402,493\n\nNippon Yusen KK. . . . . . . . . . . . . . 206,500 7,241,913\n\nNissan Chemical Corp. . . . . . . . . . . 100,800 3,285,956\n\nNomura Holdings, Inc. . . . . . . . . . . 388,400 2,565,886\n\nObayashi Corp. . . . . . . . . . . . . . . . 217,900 3,208,634\n\nOlympus Corp. . . . . . . . . . . . . . . . 624,600 7,462,130\n\nRakus Co. Ltd. . . . . . . . . . . . . . . . 135,795 2,082,766\n\nRakuten Group, Inc. (f) . . . . . . . . . . . 514,700 2,604,236\n\nRohto Pharmaceutical Co. Ltd. . . . . . 98,800 1,410,281\n\nSanten Pharmaceutical Co. Ltd. . . . . 195,607 2,161,246\n\nShimizu Corp. . . . . . . . . . . . . . . . . 476,300 5,276,437\n\nSocionext, Inc. . . . . . . . . . . . . . . . 95,300 1,795,911\n\nSoftBank Group Corp. . . . . . . . . . . 44,600 3,405,609\n\nSumitomo Mitsui Financial Group, Inc. 312,200 7,875,748\n\nSuzuki Motor Corp. . . . . . . . . . . . . 594,100 6,527,718\n\nTOTO Ltd. . . . . . . . . . . . . . . . . . . 159,100 4,050,083\n\nToyota Motor Corp. . . . . . . . . . . . . 331,600 5,898,371\n\nToyota Tsusho Corp.. . . . . . . . . . . . 202,300 4,636,380\n\nTrend Micro, Inc. . . . . . . . . . . . . . . 88,138 5,374,520\n\nUnicharm Corp. . . . . . . . . . . . . . . . 412,100 2,850,557\n\nYamaha Motor Co. Ltd. . . . . . . . . . . 267,199 1,932,604\n\nYaskawa Electric Corp. . . . . . . . . . . 104,800 2,191,974\n\n283,955,434\n\n_Security_\n\n_Shares Shares Value_\n\n**Kazakhstan — 0.0%** **(c)**\n\nHalyk Savings Bank of Kazakhstan\n\nJSC, GDR . . . . . . . . . . . . . . . . 28,078 $ 697,332\n\nKaspi.KZ JSC, ADR . . . . . . . . . . . . 13,193 1,040,928\n\n1,738,260\n\n**Macau — 0.0%** Wynn Macau Ltd. . . . . . . . . . . . . . . 5,034,601 4,172,732\n\n**Malaysia — 0.0%** CIMB Group Holdings Bhd. . . . . . . . 249,900 382,001\n\nFrontken Corp. Bhd. . . . . . . . . . . . . 949,200 898,569\n\n1,280,570\n\n**Mexico — 0.1%** Cemex SAB de CV . . . . . . . . . . . . 2,136,982 1,865,682\n\nFomento Economico Mexicano SAB de\n\nCV . . . . . . . . . . . . . . . . . . . . . 48,437 437,281\n\nFresnillo plc . . . . . . . . . . . . . . . . . 269,206 4,963,804\n\nGrupo Aeroportuario del Sureste SAB\n\nde CV, Class B . . . . . . . . . . . . . 49,833 1,510,549\n\nGrupo Financiero Banorte SAB de CV,\n\nClass O . . . . . . . . . . . . . . . . . . 905,135 8,066,329\n\nGrupo Mexico SAB de CV, Series B . 109,096 682,912\n\n17,526,557\n\n**Netherlands — 0.9%** Argenx SE (f) . . . . . . . . . . . . . . . . . 10,061 6,757,268\n\nArgenx SE, ADR (f) . . . . . . . . . . . . . 4,190 2,808,682\n\nASML Holding NV . . . . . . . . . . . . . 132,793 92,035,330\n\nING Groep NV . . . . . . . . . . . . . . . . 536,737 12,508,895\n\nKoninklijke KPN NV . . . . . . . . . . . . 351,895 1,572,092\n\nKoninklijke Vopak NV . . . . . . . . . . . 29,704 1,418,990\n\nNXP Semiconductors NV . . . . . . . . 107,259 22,928,757\n\nTeya Services Ltd., Series C, (Acquired\n\n06/03/24, cost $10,172,087) (d)(f)(j) . . 5,237 1,557,536\n\nWolters Kluwer NV . . . . . . . . . . . . . 38,856 6,052,172\n\n147,639,722\n\n**Norway — 0.1%** DNB Bank ASA . . . . . . . . . . . . . . . 74,242 1,878,304\n\nKongsberg Gruppen ASA . . . . . . . . 212,366 6,346,162\n\nTelenor ASA . . . . . . . . . . . . . . . . . 250,508 3,843,019\n\n12,067,485\n\n**Peru — 0.0%** Credicorp Ltd. . . . . . . . . . . . . . . . . 9,131 2,164,047\n\n**Philippines — 0.0%** Ayala Land, Inc. . . . . . . . . . . . . . . . 1,256,300 536,761\n\nBloomberry Resorts Corp. . . . . . . . . 2,810,000 195,579\n\nDigiPlus Interactive Corp. . . . . . . . . 536,060 231,581\n\nInternational Container Terminal\n\nServices, Inc. . . . . . . . . . . . . . . 64,880 498,176\n\nMetropolitan Bank & Trust Co. . . . . . 385,660 489,728\n\n1,951,825\n\n**Poland — 0.1%** LPP SA . . . . . . . . . . . . . . . . . . . . 343 1,523,387\n\nPowszechna Kasa Oszczednosci Bank\n\nPolski SA . . . . . . . . . . . . . . . . . 30,264 662,676\n\nPowszechny Zaklad Ubezpieczen SA 422,351 7,079,019\n\n9,265,082\n\n**Portugal — 0.0%** Jeronimo Martins SGPS SA . . . . . . . 41,646 1,015,233\n\n**Republic of Turkiye — 0.0%** Akbank TAS . . . . . . . . . . . . . . . . . 940,971 1,560,091\n\nEldorado Gold Corp. (f) . . . . . . . . . . . 75,012 1,537,746\n\nBNM0925U-4843537-15261173","publish_date":null,"title":"Consolidated Schedule of Investments","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/fqr-retail-blackrock-global-allocation-fund-inc_page8.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/fqr-retail-blackrock-global-allocation-fund-inc_page8.pdf"},"request":{"example_id":"table/fqr-retail-blackrock-global-allocation-fund-inc_page8","product_type":"parse","source_file_path":"fqr-retail-blackrock-global-allocation-fund-inc_page8.pdf"},"started_at":"2026-11-04T19:47:06.217724"} +{"completed_at":"2026-11-04T19:47:09.369862","latency_in_ms":2259,"output":{"example_id":"table/gallagherre-reinsurance-market-report-2024_page20","grounded_pages":[],"layout_pages":[],"markdown":"Stable underlying ROE, despite higher underwriting and investment margins\n\nChart 11: ROE components for the SUBSET ²⁷\n\n**2022 FY 2023 FY 2023 FY Restated 2024 FY**\n\nReported ROE 7.1% 20.2% 19.5% 17.0%\n\nRemove impact of discounting -1.2% -0.5% -0.6% -0.3%\n\nRemove nat cat losses 6.8% 4.5% 4.4% 4.6%\n\nAdd in normalized nat cat losses -6.5% -6.1% -6.1% -5.4%\n\nRemove prior-year development -1.0% -1.3% -1.3% -0.5%\n\nStrip out investment gains/losses 6.8% -2.4% -2.2% -1.6%\n\nUnderlying ROE 12.0% 14.3% 13.8% 13.9%\n\nComposition of underlying ROE\n\nUnderlying underwriting margin 1.0% 2.8% 2.7% 4.2%\n\nRunning investment income 7.0% 10.4% 10.2% 10.8%\n\nOther income/expenses 4.0% 1.2% 0.9% -1.1%\n\nUnderlying ROE 12.0% 14.3% 13.8% 13.9%\n\n27 PYD for SCOR & Swiss Re has been estimated where disclosure is not available; Discounting impact on the combined ratio for 2023 FY restated for Swiss Re is estimated; Discounting impact on the combined\n\nratio for 2022 FY (restated for IFRS 17) is estimated for SCOR and Hannover Re.\n\nBoth the underlying underwriting margin and running investment income are key contributors to the underlying ROE and continued to\n\nimprove in 2024. The underlying underwriting margin showed the biggest increase in contribution, up 1.5ppts to 4.2%, supported by the\n\nstrong underlying combined ratio improvements.\n\nThe ROE contribution from running investment income increased to 10.8% (from 10.2%), with a continued benefit from higher reinvestment\n\nyields. However, the tailwind from higher interest rates is more muted in 2024 than the uplift witnessed in 2023. Although there remains\n\nroom for some further upside (see more on this below), the uplift is expected to be modest over the coming years considering current\n\ninterest rate levels. It is important to note that the running investment income relates to the entire group and not just the P&C reinsurance\n\noperations of the companies within the SUBSET.\n\nThe “other” component reported a material swing in 2024 (to -1.1%, from +0.9%) and includes companies’ non-reinsurance activities as\n\nwell as other earnings drivers not related to P&C reinsurance underwriting or investment income. Two particularly notable items stand out,\n\nEverest’s primary P&C reserve strengthening and SCOR’s L&H Re reserve strengthening. These two items combined were responsible for\n\n1\\.3ppts of the 2.0ppts decline in 2024. If the actions at both companies indeed have drawn a line under the issues, as suggested by\n\nmanagement, this would imply true underlying profitability is around 15% for the SUBSET.\n\nOver the past three years, the underlying ROE materially improved, and as a result, earnings are considerably more resilient. This provides\n\nmore cushion to absorb any potential earnings volatility coming from natural catastrophe losses or financial market volatility, for example.\n\nA case in point is the recent material SC/LA wildfire losses (see details below).\n\n20 Reinsurance Market Report — FULL-YEAR 2024","pages":[{"line_numbers":[],"markdown":"Stable underlying ROE, despite higher underwriting and investment margins\n\nChart 11: ROE components for the SUBSET ²⁷\n\n**2022 FY 2023 FY 2023 FY Restated 2024 FY**\n\nReported ROE 7.1% 20.2% 19.5% 17.0%\n\nRemove impact of discounting -1.2% -0.5% -0.6% -0.3%\n\nRemove nat cat losses 6.8% 4.5% 4.4% 4.6%\n\nAdd in normalized nat cat losses -6.5% -6.1% -6.1% -5.4%\n\nRemove prior-year development -1.0% -1.3% -1.3% -0.5%\n\nStrip out investment gains/losses 6.8% -2.4% -2.2% -1.6%\n\nUnderlying ROE 12.0% 14.3% 13.8% 13.9%\n\nComposition of underlying ROE\n\nUnderlying underwriting margin 1.0% 2.8% 2.7% 4.2%\n\nRunning investment income 7.0% 10.4% 10.2% 10.8%\n\nOther income/expenses 4.0% 1.2% 0.9% -1.1%\n\nUnderlying ROE 12.0% 14.3% 13.8% 13.9%\n\n27 PYD for SCOR & Swiss Re has been estimated where disclosure is not available; Discounting impact on the combined ratio for 2023 FY restated for Swiss Re is estimated; Discounting impact on the combined\n\nratio for 2022 FY (restated for IFRS 17) is estimated for SCOR and Hannover Re.\n\nBoth the underlying underwriting margin and running investment income are key contributors to the underlying ROE and continued to\n\nimprove in 2024. The underlying underwriting margin showed the biggest increase in contribution, up 1.5ppts to 4.2%, supported by the\n\nstrong underlying combined ratio improvements.\n\nThe ROE contribution from running investment income increased to 10.8% (from 10.2%), with a continued benefit from higher reinvestment\n\nyields. However, the tailwind from higher interest rates is more muted in 2024 than the uplift witnessed in 2023. Although there remains\n\nroom for some further upside (see more on this below), the uplift is expected to be modest over the coming years considering current\n\ninterest rate levels. It is important to note that the running investment income relates to the entire group and not just the P&C reinsurance\n\noperations of the companies within the SUBSET.\n\nThe “other” component reported a material swing in 2024 (to -1.1%, from +0.9%) and includes companies’ non-reinsurance activities as\n\nwell as other earnings drivers not related to P&C reinsurance underwriting or investment income. Two particularly notable items stand out,\n\nEverest’s primary P&C reserve strengthening and SCOR’s L&H Re reserve strengthening. These two items combined were responsible for\n\n1\\.3ppts of the 2.0ppts decline in 2024. If the actions at both companies indeed have drawn a line under the issues, as suggested by\n\nmanagement, this would imply true underlying profitability is around 15% for the SUBSET.\n\nOver the past three years, the underlying ROE materially improved, and as a result, earnings are considerably more resilient. This provides\n\nmore cushion to absorb any potential earnings volatility coming from natural catastrophe losses or financial market volatility, for example.\n\nA case in point is the recent material SC/LA wildfire losses (see details below).\n\n20 Reinsurance Market Report — FULL-YEAR 2024","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Stable underlying ROE, despite higher underwriting and investment margins\n\nChart 11: ROE components for the SUBSET ²⁷\n\n**2022 FY 2023 FY 2023 FY Restated 2024 FY**\n\nReported ROE 7.1% 20.2% 19.5% 17.0%\n\nRemove impact of discounting -1.2% -0.5% -0.6% -0.3%\n\nRemove nat cat losses 6.8% 4.5% 4.4% 4.6%\n\nAdd in normalized nat cat losses -6.5% -6.1% -6.1% -5.4%\n\nRemove prior-year development -1.0% -1.3% -1.3% -0.5%\n\nStrip out investment gains/losses 6.8% -2.4% -2.2% -1.6%\n\nUnderlying ROE 12.0% 14.3% 13.8% 13.9%\n\nComposition of underlying ROE\n\nUnderlying underwriting margin 1.0% 2.8% 2.7% 4.2%\n\nRunning investment income 7.0% 10.4% 10.2% 10.8%\n\nOther income/expenses 4.0% 1.2% 0.9% -1.1%\n\nUnderlying ROE 12.0% 14.3% 13.8% 13.9%\n\n27 PYD for SCOR & Swiss Re has been estimated where disclosure is not available; Discounting impact on the combined ratio for 2023 FY restated for Swiss Re is estimated; Discounting impact on the combined\n\nratio for 2022 FY (restated for IFRS 17) is estimated for SCOR and Hannover Re.\n\nBoth the underlying underwriting margin and running investment income are key contributors to the underlying ROE and continued to\n\nimprove in 2024. The underlying underwriting margin showed the biggest increase in contribution, up 1.5ppts to 4.2%, supported by the\n\nstrong underlying combined ratio improvements.\n\nThe ROE contribution from running investment income increased to 10.8% (from 10.2%), with a continued benefit from higher reinvestment\n\nyields. However, the tailwind from higher interest rates is more muted in 2024 than the uplift witnessed in 2023. Although there remains\n\nroom for some further upside (see more on this below), the uplift is expected to be modest over the coming years considering current\n\ninterest rate levels. It is important to note that the running investment income relates to the entire group and not just the P&C reinsurance\n\noperations of the companies within the SUBSET.\n\nThe “other” component reported a material swing in 2024 (to -1.1%, from +0.9%) and includes companies’ non-reinsurance activities as\n\nwell as other earnings drivers not related to P&C reinsurance underwriting or investment income. Two particularly notable items stand out,\n\nEverest’s primary P&C reserve strengthening and SCOR’s L&H Re reserve strengthening. These two items combined were responsible for\n\n1\\.3ppts of the 2.0ppts decline in 2024. If the actions at both companies indeed have drawn a line under the issues, as suggested by\n\nmanagement, this would imply true underlying profitability is around 15% for the SUBSET.\n\nOver the past three years, the underlying ROE materially improved, and as a result, earnings are considerably more resilient. This provides\n\nmore cushion to absorb any potential earnings volatility coming from natural catastrophe losses or financial market volatility, for example.\n\nA case in point is the recent material SC/LA wildfire losses (see details below).\n\n20 Reinsurance Market Report — FULL-YEAR 2024","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/gallagherre-reinsurance-market-report-2024_page20.pdf"]},"response":{"errors":[],"extract_id":"extract_7ced5129580dcea64762a1e549ac0b1f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Stable underlying ROE, despite higher underwriting and investment margins\n\nChart 11: ROE components for the SUBSET ²⁷\n\n**2022 FY 2023 FY 2023 FY Restated 2024 FY**\n\nReported ROE 7.1% 20.2% 19.5% 17.0%\n\nRemove impact of discounting -1.2% -0.5% -0.6% -0.3%\n\nRemove nat cat losses 6.8% 4.5% 4.4% 4.6%\n\nAdd in normalized nat cat losses -6.5% -6.1% -6.1% -5.4%\n\nRemove prior-year development -1.0% -1.3% -1.3% -0.5%\n\nStrip out investment gains/losses 6.8% -2.4% -2.2% -1.6%\n\nUnderlying ROE 12.0% 14.3% 13.8% 13.9%\n\nComposition of underlying ROE\n\nUnderlying underwriting margin 1.0% 2.8% 2.7% 4.2%\n\nRunning investment income 7.0% 10.4% 10.2% 10.8%\n\nOther income/expenses 4.0% 1.2% 0.9% -1.1%\n\nUnderlying ROE 12.0% 14.3% 13.8% 13.9%\n\n27 PYD for SCOR & Swiss Re has been estimated where disclosure is not available; Discounting impact on the combined ratio for 2023 FY restated for Swiss Re is estimated; Discounting impact on the combined\n\nratio for 2022 FY (restated for IFRS 17) is estimated for SCOR and Hannover Re.\n\nBoth the underlying underwriting margin and running investment income are key contributors to the underlying ROE and continued to\n\nimprove in 2024. The underlying underwriting margin showed the biggest increase in contribution, up 1.5ppts to 4.2%, supported by the\n\nstrong underlying combined ratio improvements.\n\nThe ROE contribution from running investment income increased to 10.8% (from 10.2%), with a continued benefit from higher reinvestment\n\nyields. However, the tailwind from higher interest rates is more muted in 2024 than the uplift witnessed in 2023. Although there remains\n\nroom for some further upside (see more on this below), the uplift is expected to be modest over the coming years considering current\n\ninterest rate levels. It is important to note that the running investment income relates to the entire group and not just the P&C reinsurance\n\noperations of the companies within the SUBSET.\n\nThe “other” component reported a material swing in 2024 (to -1.1%, from +0.9%) and includes companies’ non-reinsurance activities as\n\nwell as other earnings drivers not related to P&C reinsurance underwriting or investment income. Two particularly notable items stand out,\n\nEverest’s primary P&C reserve strengthening and SCOR’s L&H Re reserve strengthening. These two items combined were responsible for\n\n1\\.3ppts of the 2.0ppts decline in 2024. If the actions at both companies indeed have drawn a line under the issues, as suggested by\n\nmanagement, this would imply true underlying profitability is around 15% for the SUBSET.\n\nOver the past three years, the underlying ROE materially improved, and as a result, earnings are considerably more resilient. This provides\n\nmore cushion to absorb any potential earnings volatility coming from natural catastrophe losses or financial market volatility, for example.\n\nA case in point is the recent material SC/LA wildfire losses (see details below).\n\n20 Reinsurance Market Report — FULL-YEAR 2024"],"full_content":"Stable underlying ROE, despite higher underwriting and investment margins\n\nChart 11: ROE components for the SUBSET ²⁷\n\n**2022 FY 2023 FY 2023 FY Restated 2024 FY**\n\nReported ROE 7.1% 20.2% 19.5% 17.0%\n\nRemove impact of discounting -1.2% -0.5% -0.6% -0.3%\n\nRemove nat cat losses 6.8% 4.5% 4.4% 4.6%\n\nAdd in normalized nat cat losses -6.5% -6.1% -6.1% -5.4%\n\nRemove prior-year development -1.0% -1.3% -1.3% -0.5%\n\nStrip out investment gains/losses 6.8% -2.4% -2.2% -1.6%\n\nUnderlying ROE 12.0% 14.3% 13.8% 13.9%\n\nComposition of underlying ROE\n\nUnderlying underwriting margin 1.0% 2.8% 2.7% 4.2%\n\nRunning investment income 7.0% 10.4% 10.2% 10.8%\n\nOther income/expenses 4.0% 1.2% 0.9% -1.1%\n\nUnderlying ROE 12.0% 14.3% 13.8% 13.9%\n\n27 PYD for SCOR & Swiss Re has been estimated where disclosure is not available; Discounting impact on the combined ratio for 2023 FY restated for Swiss Re is estimated; Discounting impact on the combined\n\nratio for 2022 FY (restated for IFRS 17) is estimated for SCOR and Hannover Re.\n\nBoth the underlying underwriting margin and running investment income are key contributors to the underlying ROE and continued to\n\nimprove in 2024. The underlying underwriting margin showed the biggest increase in contribution, up 1.5ppts to 4.2%, supported by the\n\nstrong underlying combined ratio improvements.\n\nThe ROE contribution from running investment income increased to 10.8% (from 10.2%), with a continued benefit from higher reinvestment\n\nyields. However, the tailwind from higher interest rates is more muted in 2024 than the uplift witnessed in 2023. Although there remains\n\nroom for some further upside (see more on this below), the uplift is expected to be modest over the coming years considering current\n\ninterest rate levels. It is important to note that the running investment income relates to the entire group and not just the P&C reinsurance\n\noperations of the companies within the SUBSET.\n\nThe “other” component reported a material swing in 2024 (to -1.1%, from +0.9%) and includes companies’ non-reinsurance activities as\n\nwell as other earnings drivers not related to P&C reinsurance underwriting or investment income. Two particularly notable items stand out,\n\nEverest’s primary P&C reserve strengthening and SCOR’s L&H Re reserve strengthening. These two items combined were responsible for\n\n1\\.3ppts of the 2.0ppts decline in 2024. If the actions at both companies indeed have drawn a line under the issues, as suggested by\n\nmanagement, this would imply true underlying profitability is around 15% for the SUBSET.\n\nOver the past three years, the underlying ROE materially improved, and as a result, earnings are considerably more resilient. This provides\n\nmore cushion to absorb any potential earnings volatility coming from natural catastrophe losses or financial market volatility, for example.\n\nA case in point is the recent material SC/LA wildfire losses (see details below).\n\n20 Reinsurance Market Report — FULL-YEAR 2024","publish_date":null,"title":"Stable underlying ROE, despite higher underwriting and investment margins Chart 11: ROE components for the SUBSET Both the underlying underwriting","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/gallagherre-reinsurance-market-report-2024_page20.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/gallagherre-reinsurance-market-report-2024_page20.pdf"},"request":{"example_id":"table/gallagherre-reinsurance-market-report-2024_page20","product_type":"parse","source_file_path":"gallagherre-reinsurance-market-report-2024_page20.pdf"},"started_at":"2026-11-04T19:47:07.110334"} +{"completed_at":"2026-11-04T19:47:09.110453","latency_in_ms":1244,"output":{"example_id":"table/hard_page1","grounded_pages":[],"layout_pages":[],"markdown":"_Chapter 4 – Permitted Uses_\n\n**Pitkin County Land Use Code CHAPTER 4 – PERMITTED USES July 2006 Page 8**\n\nTABLE 4-1: Permitted\n\nUses\n\nIntended for Rural Areas Intended for Urban Areas Eith\n\ner\n\nRural Districts\n\nUrban / Suburban Residential\n\nDistrict\n\nBusiness &\n\nSpecial Purpose\n\nV L P\n\nUse Category/\n\nUse Type\n\nR S - G\n\nRR RS\n\n\\- 1 6 0\n\nRS\n\n– 35\n\nLI\n\nR -\n\n35\n\nTR\n\n\\- 1\n\nTR\n\n\\- 2\n\nRS\n\n\\-\n\n30 & 20\n\nA R -\n\n10\n\nA R - 2\n\nS K I - R E C\n\nB - 1\n\nR -\n\n30\n\nR - 15 & 15 A 15 B\n\nR - 6\n\nVR M\n\nH P\n\nAH R\n\nMF\n\nAH\n\n\\- P U D\n\nB - 2\n\nVC P - I\n\nT\n\nUse-Specific Regulation\n\nPrincipal Uses of Land Residential\n\nHousehold Living\n\nDuplex Dwelling Unit S M S A S S S S M A A §4-30-010(a)\n\nMobile Home A A §4-30-010(c)\n\nMobile Home Park A\n\nMulti-family\n\nDwelling Unit M S S A\n\nS S S M A M §4-30-010(d)\n\nSingle Family Dwelling\n\nUnit\n\nA A A A A A A A A M A A A A A A A A M A A\n\n§4-30-010(f)\n\nGroup Living\n\nDormitory Housing M S S S S M S M\n\nGroup Home S S S §4-30-010(b)\n\nNursing\n\nConvalescent\n\nRest, or\n\nRetirement Home\n\nS\n\nS S S\n\nS S M -\n\n§4-30-010(e)\n\nAgricultural & Resource\n\nUnlisted Agricultural\n\nUse\n\nA A A A M\n\nBlacksmithing S S S S\n\nAgricultural Building S A A S A A A A S M §4-30-020(a)\n\nFarming S A A A A A A A M M A M §4-30-020(b)\n\nIndustrial Hemp\n\nCultivation\n\nS\n\nS\n\nS\n\nS\n\nS\n\nS §4-30-020(b)(3)\n\nFirewood Splitting,\n\nCommercial\n\nS S S S S M A A §4-30-020(c)\n\nHorse Boarding Primary A A A A S §4-30-020(d)","pages":[{"line_numbers":[],"markdown":"_Chapter 4 – Permitted Uses_\n\n**Pitkin County Land Use Code CHAPTER 4 – PERMITTED USES July 2006 Page 8**\n\nTABLE 4-1: Permitted\n\nUses\n\nIntended for Rural Areas Intended for Urban Areas Eith\n\ner\n\nRural Districts\n\nUrban / Suburban Residential\n\nDistrict\n\nBusiness &\n\nSpecial Purpose\n\nV L P\n\nUse Category/\n\nUse Type\n\nR S - G\n\nRR RS\n\n\\- 1 6 0\n\nRS\n\n– 35\n\nLI\n\nR -\n\n35\n\nTR\n\n\\- 1\n\nTR\n\n\\- 2\n\nRS\n\n\\-\n\n30 & 20\n\nA R -\n\n10\n\nA R - 2\n\nS K I - R E C\n\nB - 1\n\nR -\n\n30\n\nR - 15 & 15 A 15 B\n\nR - 6\n\nVR M\n\nH P\n\nAH R\n\nMF\n\nAH\n\n\\- P U D\n\nB - 2\n\nVC P - I\n\nT\n\nUse-Specific Regulation\n\nPrincipal Uses of Land Residential\n\nHousehold Living\n\nDuplex Dwelling Unit S M S A S S S S M A A §4-30-010(a)\n\nMobile Home A A §4-30-010(c)\n\nMobile Home Park A\n\nMulti-family\n\nDwelling Unit M S S A\n\nS S S M A M §4-30-010(d)\n\nSingle Family Dwelling\n\nUnit\n\nA A A A A A A A A M A A A A A A A A M A A\n\n§4-30-010(f)\n\nGroup Living\n\nDormitory Housing M S S S S M S M\n\nGroup Home S S S §4-30-010(b)\n\nNursing\n\nConvalescent\n\nRest, or\n\nRetirement Home\n\nS\n\nS S S\n\nS S M -\n\n§4-30-010(e)\n\nAgricultural & Resource\n\nUnlisted Agricultural\n\nUse\n\nA A A A M\n\nBlacksmithing S S S S\n\nAgricultural Building S A A S A A A A S M §4-30-020(a)\n\nFarming S A A A A A A A M M A M §4-30-020(b)\n\nIndustrial Hemp\n\nCultivation\n\nS\n\nS\n\nS\n\nS\n\nS\n\nS §4-30-020(b)(3)\n\nFirewood Splitting,\n\nCommercial\n\nS S S S S M A A §4-30-020(c)\n\nHorse Boarding Primary A A A A S §4-30-020(d)","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"_Chapter 4 – Permitted Uses_\n\n**Pitkin County Land Use Code CHAPTER 4 – PERMITTED USES July 2006 Page 8**\n\nTABLE 4-1: Permitted\n\nUses\n\nIntended for Rural Areas Intended for Urban Areas Eith\n\ner\n\nRural Districts\n\nUrban / Suburban Residential\n\nDistrict\n\nBusiness &\n\nSpecial Purpose\n\nV L P\n\nUse Category/\n\nUse Type\n\nR S - G\n\nRR RS\n\n\\- 1 6 0\n\nRS\n\n– 35\n\nLI\n\nR -\n\n35\n\nTR\n\n\\- 1\n\nTR\n\n\\- 2\n\nRS\n\n\\-\n\n30 & 20\n\nA R -\n\n10\n\nA R - 2\n\nS K I - R E C\n\nB - 1\n\nR -\n\n30\n\nR - 15 & 15 A 15 B\n\nR - 6\n\nVR M\n\nH P\n\nAH R\n\nMF\n\nAH\n\n\\- P U D\n\nB - 2\n\nVC P - I\n\nT\n\nUse-Specific Regulation\n\nPrincipal Uses of Land Residential\n\nHousehold Living\n\nDuplex Dwelling Unit S M S A S S S S M A A §4-30-010(a)\n\nMobile Home A A §4-30-010(c)\n\nMobile Home Park A\n\nMulti-family\n\nDwelling Unit M S S A\n\nS S S M A M §4-30-010(d)\n\nSingle Family Dwelling\n\nUnit\n\nA A A A A A A A A M A A A A A A A A M A A\n\n§4-30-010(f)\n\nGroup Living\n\nDormitory Housing M S S S S M S M\n\nGroup Home S S S §4-30-010(b)\n\nNursing\n\nConvalescent\n\nRest, or\n\nRetirement Home\n\nS\n\nS S S\n\nS S M -\n\n§4-30-010(e)\n\nAgricultural & Resource\n\nUnlisted Agricultural\n\nUse\n\nA A A A M\n\nBlacksmithing S S S S\n\nAgricultural Building S A A S A A A A S M §4-30-020(a)\n\nFarming S A A A A A A A M M A M §4-30-020(b)\n\nIndustrial Hemp\n\nCultivation\n\nS\n\nS\n\nS\n\nS\n\nS\n\nS §4-30-020(b)(3)\n\nFirewood Splitting,\n\nCommercial\n\nS S S S S M A A §4-30-020(c)\n\nHorse Boarding Primary A A A A S §4-30-020(d)","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/hard_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_cd8bbe9d4143a2da3e2e6140a650c3cd","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["_Chapter 4 – Permitted Uses_\n\n**Pitkin County Land Use Code CHAPTER 4 – PERMITTED USES July 2006 Page 8**\n\nTABLE 4-1: Permitted\n\nUses\n\nIntended for Rural Areas Intended for Urban Areas Eith\n\ner\n\nRural Districts\n\nUrban / Suburban Residential\n\nDistrict\n\nBusiness &\n\nSpecial Purpose\n\nV L P\n\nUse Category/\n\nUse Type\n\nR S - G\n\nRR RS\n\n\\- 1 6 0\n\nRS\n\n– 35\n\nLI\n\nR -\n\n35\n\nTR\n\n\\- 1\n\nTR\n\n\\- 2\n\nRS\n\n\\-\n\n30 & 20\n\nA R -\n\n10\n\nA R - 2\n\nS K I - R E C\n\nB - 1\n\nR -\n\n30\n\nR - 15 & 15 A 15 B\n\nR - 6\n\nVR M\n\nH P\n\nAH R\n\nMF\n\nAH\n\n\\- P U D\n\nB - 2\n\nVC P - I\n\nT\n\nUse-Specific Regulation\n\nPrincipal Uses of Land Residential\n\nHousehold Living\n\nDuplex Dwelling Unit S M S A S S S S M A A §4-30-010(a)\n\nMobile Home A A §4-30-010(c)\n\nMobile Home Park A\n\nMulti-family\n\nDwelling Unit M S S A\n\nS S S M A M §4-30-010(d)\n\nSingle Family Dwelling\n\nUnit\n\nA A A A A A A A A M A A A A A A A A M A A\n\n§4-30-010(f)\n\nGroup Living\n\nDormitory Housing M S S S S M S M\n\nGroup Home S S S §4-30-010(b)\n\nNursing\n\nConvalescent\n\nRest, or\n\nRetirement Home\n\nS\n\nS S S\n\nS S M -\n\n§4-30-010(e)\n\nAgricultural & Resource\n\nUnlisted Agricultural\n\nUse\n\nA A A A M\n\nBlacksmithing S S S S\n\nAgricultural Building S A A S A A A A S M §4-30-020(a)\n\nFarming S A A A A A A A M M A M §4-30-020(b)\n\nIndustrial Hemp\n\nCultivation\n\nS\n\nS\n\nS\n\nS\n\nS\n\nS §4-30-020(b)(3)\n\nFirewood Splitting,\n\nCommercial\n\nS S S S S M A A §4-30-020(c)\n\nHorse Boarding Primary A A A A S §4-30-020(d)"],"full_content":"_Chapter 4 – Permitted Uses_\n\n**Pitkin County Land Use Code CHAPTER 4 – PERMITTED USES July 2006 Page 8**\n\nTABLE 4-1: Permitted\n\nUses\n\nIntended for Rural Areas Intended for Urban Areas Eith\n\ner\n\nRural Districts\n\nUrban / Suburban Residential\n\nDistrict\n\nBusiness &\n\nSpecial Purpose\n\nV L P\n\nUse Category/\n\nUse Type\n\nR S - G\n\nRR RS\n\n\\- 1 6 0\n\nRS\n\n– 35\n\nLI\n\nR -\n\n35\n\nTR\n\n\\- 1\n\nTR\n\n\\- 2\n\nRS\n\n\\-\n\n30 & 20\n\nA R -\n\n10\n\nA R - 2\n\nS K I - R E C\n\nB - 1\n\nR -\n\n30\n\nR - 15 & 15 A 15 B\n\nR - 6\n\nVR M\n\nH P\n\nAH R\n\nMF\n\nAH\n\n\\- P U D\n\nB - 2\n\nVC P - I\n\nT\n\nUse-Specific Regulation\n\nPrincipal Uses of Land Residential\n\nHousehold Living\n\nDuplex Dwelling Unit S M S A S S S S M A A §4-30-010(a)\n\nMobile Home A A §4-30-010(c)\n\nMobile Home Park A\n\nMulti-family\n\nDwelling Unit M S S A\n\nS S S M A M §4-30-010(d)\n\nSingle Family Dwelling\n\nUnit\n\nA A A A A A A A A M A A A A A A A A M A A\n\n§4-30-010(f)\n\nGroup Living\n\nDormitory Housing M S S S S M S M\n\nGroup Home S S S §4-30-010(b)\n\nNursing\n\nConvalescent\n\nRest, or\n\nRetirement Home\n\nS\n\nS S S\n\nS S M -\n\n§4-30-010(e)\n\nAgricultural & Resource\n\nUnlisted Agricultural\n\nUse\n\nA A A A M\n\nBlacksmithing S S S S\n\nAgricultural Building S A A S A A A A S M §4-30-020(a)\n\nFarming S A A A A A A A M M A M §4-30-020(b)\n\nIndustrial Hemp\n\nCultivation\n\nS\n\nS\n\nS\n\nS\n\nS\n\nS §4-30-020(b)(3)\n\nFirewood Splitting,\n\nCommercial\n\nS S S S S M A A §4-30-020(c)\n\nHorse Boarding Primary A A A A S §4-30-020(d)","publish_date":null,"title":"Chapter 4 – Permitted Uses Intended for Rural Areas Intended for Urban Areas Eith er TABLE 4-1: Permitted Rural Districts","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/hard_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/hard_page1.pdf"},"request":{"example_id":"table/hard_page1","product_type":"parse","source_file_path":"hard_page1.pdf"},"started_at":"2026-11-04T19:47:07.865961"} +{"completed_at":"2026-11-04T19:31:13.016049","latency_in_ms":3337,"output":{"example_id":"table/hard_page2","grounded_pages":[],"layout_pages":[],"markdown":"_Chapter 4 – Permitted Uses_\n\n**Pitkin County Land Use Code CHAPTER 4 – PERMITTED USES July 2006 Page 9**\n\nTABLE 4-1: Permitted\n\nUses\n\nIntended for Rural Areas Intended for Urban Areas Eith\n\ner\n\nRural Districts\n\nUrban / Suburban Residential\n\nDistrict\n\nBusiness &\n\nSpecial Purpose\n\nV L P\n\nUse Category/\n\nUse Type\n\nR S - G\n\nRR RS\n\n\\- 1 6 0\n\nRS\n\n– 35\n\nLI\n\nR -\n\n35\n\nTR\n\n\\- 1\n\nTR\n\n\\- 2\n\nRS\n\n\\-\n\n30 & 20\n\nA R -\n\n10\n\nA R - 2\n\nS K I - R E C\n\nB - 1\n\nR -\n\n30\n\nR - 15 & 15 A 15 B\n\nR - 6\n\nVR M\n\nH P\n\nAH R\n\nMF\n\nAH\n\n\\- P U D\n\nB - 2\n\nVC P - I\n\nT\n\nUse-Specific Regulation\n\nKennel or Veterinary\n\nClinic\n\nS S S S S S M - §4-30-020(e)\n\nLogging S S S S S M M - §4-30-020(f)\n\nMineral and Gravel\n\nExtraction S S S S S S S S M M §4-30-020(g)\n\nOil and Gas Extraction S S S §4-30-020(h)\n\nRanching A A A A A A A A M M §4-30-020(i),\n\nSilviculture A A A A M M\n\nCivic & Institutional\n\nAirport M §4-30-030(a)\n\nCemetery S S S S S M -\n\nDay Care Center S S S M S S S S S S S S S S M S M\n\nEducational Class S S S §4-30-030(b)\n\nHospital M §4-30-030(c)\n\nInstitute M S S S M - §4-30-030(d)\n\nPark, Playground or\n\nPlayfield\n\nS S S S M A A A A A A A A A A A S M\n\nPublic Facilities, Major M S S M §4-30-030(e)\n\nPublic Utilities, Major S S S S S S S S S S S S S S S S S M S M\n\nPublic Utilities, Minor A A A A A A A A S A A A A A A A A A A M A M 4-30-030(f)\n\nReligious Institution S S S S S M S S S S S M S M §4-30-030(g)\n\nSchool or University S S M S S S M §4-30-030(h)\n\nSewage Disposal Area\n\nor Water Plant S S S S S S M S S S S S S S S M S M\n\nTransit Facility M S S M\n\nCommercial & Industrial Entertainment & Recreation\n\nAdult Entertainment\n\nEstablishment\n\nS S S §4-30-040(a)\n\nAlpine Ski Area &\n\nSupport\n\nM\n\nAmusement or Entertainment Establishment\n\nM S\n\nS S\n\nM\n\n§4-30-040(b)\n\nCampground S S S S M S M §4-30-040(f)\n\nGolf Course M M\n\nNordic Ski Area and\n\nSupport Facilities S S S S M M S M\n\nOutdoor Recreational,\n\nOther S S S S S S S M M S M §4-30-040(q)\n\nRiding Stable or\n\nAcademy S S S S M S M §4-30-040(w)\n\nEating, Meeting & Lodging","pages":[{"line_numbers":[],"markdown":"_Chapter 4 – Permitted Uses_\n\n**Pitkin County Land Use Code CHAPTER 4 – PERMITTED USES July 2006 Page 9**\n\nTABLE 4-1: Permitted\n\nUses\n\nIntended for Rural Areas Intended for Urban Areas Eith\n\ner\n\nRural Districts\n\nUrban / Suburban Residential\n\nDistrict\n\nBusiness &\n\nSpecial Purpose\n\nV L P\n\nUse Category/\n\nUse Type\n\nR S - G\n\nRR RS\n\n\\- 1 6 0\n\nRS\n\n– 35\n\nLI\n\nR -\n\n35\n\nTR\n\n\\- 1\n\nTR\n\n\\- 2\n\nRS\n\n\\-\n\n30 & 20\n\nA R -\n\n10\n\nA R - 2\n\nS K I - R E C\n\nB - 1\n\nR -\n\n30\n\nR - 15 & 15 A 15 B\n\nR - 6\n\nVR M\n\nH P\n\nAH R\n\nMF\n\nAH\n\n\\- P U D\n\nB - 2\n\nVC P - I\n\nT\n\nUse-Specific Regulation\n\nKennel or Veterinary\n\nClinic\n\nS S S S S S M - §4-30-020(e)\n\nLogging S S S S S M M - §4-30-020(f)\n\nMineral and Gravel\n\nExtraction S S S S S S S S M M §4-30-020(g)\n\nOil and Gas Extraction S S S §4-30-020(h)\n\nRanching A A A A A A A A M M §4-30-020(i),\n\nSilviculture A A A A M M\n\nCivic & Institutional\n\nAirport M §4-30-030(a)\n\nCemetery S S S S S M -\n\nDay Care Center S S S M S S S S S S S S S S M S M\n\nEducational Class S S S §4-30-030(b)\n\nHospital M §4-30-030(c)\n\nInstitute M S S S M - §4-30-030(d)\n\nPark, Playground or\n\nPlayfield\n\nS S S S M A A A A A A A A A A A S M\n\nPublic Facilities, Major M S S M §4-30-030(e)\n\nPublic Utilities, Major S S S S S S S S S S S S S S S S S M S M\n\nPublic Utilities, Minor A A A A A A A A S A A A A A A A A A A M A M 4-30-030(f)\n\nReligious Institution S S S S S M S S S S S M S M §4-30-030(g)\n\nSchool or University S S M S S S M §4-30-030(h)\n\nSewage Disposal Area\n\nor Water Plant S S S S S S M S S S S S S S S M S M\n\nTransit Facility M S S M\n\nCommercial & Industrial Entertainment & Recreation\n\nAdult Entertainment\n\nEstablishment\n\nS S S §4-30-040(a)\n\nAlpine Ski Area &\n\nSupport\n\nM\n\nAmusement or Entertainment Establishment\n\nM S\n\nS S\n\nM\n\n§4-30-040(b)\n\nCampground S S S S M S M §4-30-040(f)\n\nGolf Course M M\n\nNordic Ski Area and\n\nSupport Facilities S S S S M M S M\n\nOutdoor Recreational,\n\nOther S S S S S S S M M S M §4-30-040(q)\n\nRiding Stable or\n\nAcademy S S S S M S M §4-30-040(w)\n\nEating, Meeting & Lodging","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"_Chapter 4 – Permitted Uses_\n\n**Pitkin County Land Use Code CHAPTER 4 – PERMITTED USES July 2006 Page 9**\n\nTABLE 4-1: Permitted\n\nUses\n\nIntended for Rural Areas Intended for Urban Areas Eith\n\ner\n\nRural Districts\n\nUrban / Suburban Residential\n\nDistrict\n\nBusiness &\n\nSpecial Purpose\n\nV L P\n\nUse Category/\n\nUse Type\n\nR S - G\n\nRR RS\n\n\\- 1 6 0\n\nRS\n\n– 35\n\nLI\n\nR -\n\n35\n\nTR\n\n\\- 1\n\nTR\n\n\\- 2\n\nRS\n\n\\-\n\n30 & 20\n\nA R -\n\n10\n\nA R - 2\n\nS K I - R E C\n\nB - 1\n\nR -\n\n30\n\nR - 15 & 15 A 15 B\n\nR - 6\n\nVR M\n\nH P\n\nAH R\n\nMF\n\nAH\n\n\\- P U D\n\nB - 2\n\nVC P - I\n\nT\n\nUse-Specific Regulation\n\nKennel or Veterinary\n\nClinic\n\nS S S S S S M - §4-30-020(e)\n\nLogging S S S S S M M - §4-30-020(f)\n\nMineral and Gravel\n\nExtraction S S S S S S S S M M §4-30-020(g)\n\nOil and Gas Extraction S S S §4-30-020(h)\n\nRanching A A A A A A A A M M §4-30-020(i),\n\nSilviculture A A A A M M\n\nCivic & Institutional\n\nAirport M §4-30-030(a)\n\nCemetery S S S S S M -\n\nDay Care Center S S S M S S S S S S S S S S M S M\n\nEducational Class S S S §4-30-030(b)\n\nHospital M §4-30-030(c)\n\nInstitute M S S S M - §4-30-030(d)\n\nPark, Playground or\n\nPlayfield\n\nS S S S M A A A A A A A A A A A S M\n\nPublic Facilities, Major M S S M §4-30-030(e)\n\nPublic Utilities, Major S S S S S S S S S S S S S S S S S M S M\n\nPublic Utilities, Minor A A A A A A A A S A A A A A A A A A A M A M 4-30-030(f)\n\nReligious Institution S S S S S M S S S S S M S M §4-30-030(g)\n\nSchool or University S S M S S S M §4-30-030(h)\n\nSewage Disposal Area\n\nor Water Plant S S S S S S M S S S S S S S S M S M\n\nTransit Facility M S S M\n\nCommercial & Industrial Entertainment & Recreation\n\nAdult Entertainment\n\nEstablishment\n\nS S S §4-30-040(a)\n\nAlpine Ski Area &\n\nSupport\n\nM\n\nAmusement or Entertainment Establishment\n\nM S\n\nS S\n\nM\n\n§4-30-040(b)\n\nCampground S S S S M S M §4-30-040(f)\n\nGolf Course M M\n\nNordic Ski Area and\n\nSupport Facilities S S S S M M S M\n\nOutdoor Recreational,\n\nOther S S S S S S S M M S M §4-30-040(q)\n\nRiding Stable or\n\nAcademy S S S S M S M §4-30-040(w)\n\nEating, Meeting & Lodging","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/hard_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_85b52d62e9eeeb9ebb2282d604005e17","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["_Chapter 4 – Permitted Uses_\n\n**Pitkin County Land Use Code CHAPTER 4 – PERMITTED USES July 2006 Page 9**\n\nTABLE 4-1: Permitted\n\nUses\n\nIntended for Rural Areas Intended for Urban Areas Eith\n\ner\n\nRural Districts\n\nUrban / Suburban Residential\n\nDistrict\n\nBusiness &\n\nSpecial Purpose\n\nV L P\n\nUse Category/\n\nUse Type\n\nR S - G\n\nRR RS\n\n\\- 1 6 0\n\nRS\n\n– 35\n\nLI\n\nR -\n\n35\n\nTR\n\n\\- 1\n\nTR\n\n\\- 2\n\nRS\n\n\\-\n\n30 & 20\n\nA R -\n\n10\n\nA R - 2\n\nS K I - R E C\n\nB - 1\n\nR -\n\n30\n\nR - 15 & 15 A 15 B\n\nR - 6\n\nVR M\n\nH P\n\nAH R\n\nMF\n\nAH\n\n\\- P U D\n\nB - 2\n\nVC P - I\n\nT\n\nUse-Specific Regulation\n\nKennel or Veterinary\n\nClinic\n\nS S S S S S M - §4-30-020(e)\n\nLogging S S S S S M M - §4-30-020(f)\n\nMineral and Gravel\n\nExtraction S S S S S S S S M M §4-30-020(g)\n\nOil and Gas Extraction S S S §4-30-020(h)\n\nRanching A A A A A A A A M M §4-30-020(i),\n\nSilviculture A A A A M M\n\nCivic & Institutional\n\nAirport M §4-30-030(a)\n\nCemetery S S S S S M -\n\nDay Care Center S S S M S S S S S S S S S S M S M\n\nEducational Class S S S §4-30-030(b)\n\nHospital M §4-30-030(c)\n\nInstitute M S S S M - §4-30-030(d)\n\nPark, Playground or\n\nPlayfield\n\nS S S S M A A A A A A A A A A A S M\n\nPublic Facilities, Major M S S M §4-30-030(e)\n\nPublic Utilities, Major S S S S S S S S S S S S S S S S S M S M\n\nPublic Utilities, Minor A A A A A A A A S A A A A A A A A A A M A M 4-30-030(f)\n\nReligious Institution S S S S S M S S S S S M S M §4-30-030(g)\n\nSchool or University S S M S S S M §4-30-030(h)\n\nSewage Disposal Area\n\nor Water Plant S S S S S S M S S S S S S S S M S M\n\nTransit Facility M S S M\n\nCommercial & Industrial Entertainment & Recreation\n\nAdult Entertainment\n\nEstablishment\n\nS S S §4-30-040(a)\n\nAlpine Ski Area &\n\nSupport\n\nM\n\nAmusement or Entertainment Establishment\n\nM S\n\nS S\n\nM\n\n§4-30-040(b)\n\nCampground S S S S M S M §4-30-040(f)\n\nGolf Course M M\n\nNordic Ski Area and\n\nSupport Facilities S S S S M M S M\n\nOutdoor Recreational,\n\nOther S S S S S S S M M S M §4-30-040(q)\n\nRiding Stable or\n\nAcademy S S S S M S M §4-30-040(w)\n\nEating, Meeting & Lodging"],"full_content":"_Chapter 4 – Permitted Uses_\n\n**Pitkin County Land Use Code CHAPTER 4 – PERMITTED USES July 2006 Page 9**\n\nTABLE 4-1: Permitted\n\nUses\n\nIntended for Rural Areas Intended for Urban Areas Eith\n\ner\n\nRural Districts\n\nUrban / Suburban Residential\n\nDistrict\n\nBusiness &\n\nSpecial Purpose\n\nV L P\n\nUse Category/\n\nUse Type\n\nR S - G\n\nRR RS\n\n\\- 1 6 0\n\nRS\n\n– 35\n\nLI\n\nR -\n\n35\n\nTR\n\n\\- 1\n\nTR\n\n\\- 2\n\nRS\n\n\\-\n\n30 & 20\n\nA R -\n\n10\n\nA R - 2\n\nS K I - R E C\n\nB - 1\n\nR -\n\n30\n\nR - 15 & 15 A 15 B\n\nR - 6\n\nVR M\n\nH P\n\nAH R\n\nMF\n\nAH\n\n\\- P U D\n\nB - 2\n\nVC P - I\n\nT\n\nUse-Specific Regulation\n\nKennel or Veterinary\n\nClinic\n\nS S S S S S M - §4-30-020(e)\n\nLogging S S S S S M M - §4-30-020(f)\n\nMineral and Gravel\n\nExtraction S S S S S S S S M M §4-30-020(g)\n\nOil and Gas Extraction S S S §4-30-020(h)\n\nRanching A A A A A A A A M M §4-30-020(i),\n\nSilviculture A A A A M M\n\nCivic & Institutional\n\nAirport M §4-30-030(a)\n\nCemetery S S S S S M -\n\nDay Care Center S S S M S S S S S S S S S S M S M\n\nEducational Class S S S §4-30-030(b)\n\nHospital M §4-30-030(c)\n\nInstitute M S S S M - §4-30-030(d)\n\nPark, Playground or\n\nPlayfield\n\nS S S S M A A A A A A A A A A A S M\n\nPublic Facilities, Major M S S M §4-30-030(e)\n\nPublic Utilities, Major S S S S S S S S S S S S S S S S S M S M\n\nPublic Utilities, Minor A A A A A A A A S A A A A A A A A A A M A M 4-30-030(f)\n\nReligious Institution S S S S S M S S S S S M S M §4-30-030(g)\n\nSchool or University S S M S S S M §4-30-030(h)\n\nSewage Disposal Area\n\nor Water Plant S S S S S S M S S S S S S S S M S M\n\nTransit Facility M S S M\n\nCommercial & Industrial Entertainment & Recreation\n\nAdult Entertainment\n\nEstablishment\n\nS S S §4-30-040(a)\n\nAlpine Ski Area &\n\nSupport\n\nM\n\nAmusement or Entertainment Establishment\n\nM S\n\nS S\n\nM\n\n§4-30-040(b)\n\nCampground S S S S M S M §4-30-040(f)\n\nGolf Course M M\n\nNordic Ski Area and\n\nSupport Facilities S S S S M M S M\n\nOutdoor Recreational,\n\nOther S S S S S S S M M S M §4-30-040(q)\n\nRiding Stable or\n\nAcademy S S S S M S M §4-30-040(w)\n\nEating, Meeting & Lodging","publish_date":null,"title":"Chapter 4 – Permitted Uses Intended for Rural Areas Intended for Urban Areas Eith er TABLE 4-1: Permitted Rural Districts","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/hard_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/hard_page2.pdf"},"request":{"example_id":"table/hard_page2","product_type":"parse","source_file_path":"hard_page2.pdf"},"started_at":"2026-11-04T19:31:09.678603"} +{"completed_at":"2026-11-04T19:47:11.830304","latency_in_ms":1261,"output":{"example_id":"table/iCoolPSC+Blower+Catalog+2024_page27","grounded_pages":[],"layout_pages":[],"markdown":"iCoolPSC Computer Products Corp. Ltd.\n\nFan dimensions, RPM, CFM, connector type, wiring, bearing, voltage, current can all be customized to customer requirements. Specifications may be subject to change. Model number may differ depending on specifications. Some model numbers end with “X” where X is a placeholder for different specifications of fan (i.e. different connector type).\n\nP/Q Curve Dimension Drawing\n\nModel Bearing\n\nRated Voltage (VDC)\n\nSignal\n\n(P/F/R/V)\n\nRated Current\n\n(mA)\n\nRated Input Power\n\n(W)\n\nRPM CFM\n\nStatic\n\nPressure\n\n(inch- H2O)\n\ndBA\n\n80x13 FOB 5 PWM/FG 510 2.55 3100 11.65 0.58 40\n\n## 8013 Blower\n\nFan Type: Blower\n\nFan Dimensions: 80x80x13mm\n\nFan Material: Frame and Impeller: Plastic UL 94V-0 / SECC\n\nInsulation Resistance: 10MΩ or Over with 250V Megger\n\nDielectric Withstand Voltage: AC500V 1S\n\nAllowable Ambient Temperature: -10°C ~ +70°C (Operating) -40°C ~ +70°C (Storage)","pages":[{"line_numbers":[],"markdown":"iCoolPSC Computer Products Corp. Ltd.\n\nFan dimensions, RPM, CFM, connector type, wiring, bearing, voltage, current can all be customized to customer requirements. Specifications may be subject to change. Model number may differ depending on specifications. Some model numbers end with “X” where X is a placeholder for different specifications of fan (i.e. different connector type).\n\nP/Q Curve Dimension Drawing\n\nModel Bearing\n\nRated Voltage (VDC)\n\nSignal\n\n(P/F/R/V)\n\nRated Current\n\n(mA)\n\nRated Input Power\n\n(W)\n\nRPM CFM\n\nStatic\n\nPressure\n\n(inch- H2O)\n\ndBA\n\n80x13 FOB 5 PWM/FG 510 2.55 3100 11.65 0.58 40\n\n## 8013 Blower\n\nFan Type: Blower\n\nFan Dimensions: 80x80x13mm\n\nFan Material: Frame and Impeller: Plastic UL 94V-0 / SECC\n\nInsulation Resistance: 10MΩ or Over with 250V Megger\n\nDielectric Withstand Voltage: AC500V 1S\n\nAllowable Ambient Temperature: -10°C ~ +70°C (Operating) -40°C ~ +70°C (Storage)","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"iCoolPSC Computer Products Corp. Ltd.\n\nFan dimensions, RPM, CFM, connector type, wiring, bearing, voltage, current can all be customized to customer requirements. Specifications may be subject to change. Model number may differ depending on specifications. Some model numbers end with “X” where X is a placeholder for different specifications of fan (i.e. different connector type).\n\nP/Q Curve Dimension Drawing\n\nModel Bearing\n\nRated Voltage (VDC)\n\nSignal\n\n(P/F/R/V)\n\nRated Current\n\n(mA)\n\nRated Input Power\n\n(W)\n\nRPM CFM\n\nStatic\n\nPressure\n\n(inch- H2O)\n\ndBA\n\n80x13 FOB 5 PWM/FG 510 2.55 3100 11.65 0.58 40\n\n## 8013 Blower\n\nFan Type: Blower\n\nFan Dimensions: 80x80x13mm\n\nFan Material: Frame and Impeller: Plastic UL 94V-0 / SECC\n\nInsulation Resistance: 10MΩ or Over with 250V Megger\n\nDielectric Withstand Voltage: AC500V 1S\n\nAllowable Ambient Temperature: -10°C ~ +70°C (Operating) -40°C ~ +70°C (Storage)","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/iCoolPSC%2BBlower%2BCatalog%2B2024_page27.pdf"]},"response":{"errors":[],"extract_id":"extract_3f03b9373ebf6997ef0c3bc8471836c8","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["iCoolPSC Computer Products Corp. Ltd.\n\nFan dimensions, RPM, CFM, connector type, wiring, bearing, voltage, current can all be customized to customer requirements. Specifications may be subject to change. Model number may differ depending on specifications. Some model numbers end with “X” where X is a placeholder for different specifications of fan (i.e. different connector type).\n\nP/Q Curve Dimension Drawing\n\nModel Bearing\n\nRated Voltage (VDC)\n\nSignal\n\n(P/F/R/V)\n\nRated Current\n\n(mA)\n\nRated Input Power\n\n(W)\n\nRPM CFM\n\nStatic\n\nPressure\n\n(inch- H2O)\n\ndBA\n\n80x13 FOB 5 PWM/FG 510 2.55 3100 11.65 0.58 40\n\n## 8013 Blower\n\nFan Type: Blower\n\nFan Dimensions: 80x80x13mm\n\nFan Material: Frame and Impeller: Plastic UL 94V-0 / SECC\n\nInsulation Resistance: 10MΩ or Over with 250V Megger\n\nDielectric Withstand Voltage: AC500V 1S\n\nAllowable Ambient Temperature: -10°C ~ +70°C (Operating) -40°C ~ +70°C (Storage)"],"full_content":"iCoolPSC Computer Products Corp. Ltd.\n\nFan dimensions, RPM, CFM, connector type, wiring, bearing, voltage, current can all be customized to customer requirements. Specifications may be subject to change. Model number may differ depending on specifications. Some model numbers end with “X” where X is a placeholder for different specifications of fan (i.e. different connector type).\n\nP/Q Curve Dimension Drawing\n\nModel Bearing\n\nRated Voltage (VDC)\n\nSignal\n\n(P/F/R/V)\n\nRated Current\n\n(mA)\n\nRated Input Power\n\n(W)\n\nRPM CFM\n\nStatic\n\nPressure\n\n(inch- H2O)\n\ndBA\n\n80x13 FOB 5 PWM/FG 510 2.55 3100 11.65 0.58 40\n\n## 8013 Blower\n\nFan Type: Blower\n\nFan Dimensions: 80x80x13mm\n\nFan Material: Frame and Impeller: Plastic UL 94V-0 / SECC\n\nInsulation Resistance: 10MΩ or Over with 250V Megger\n\nDielectric Withstand Voltage: AC500V 1S\n\nAllowable Ambient Temperature: -10°C ~ +70°C (Operating) -40°C ~ +70°C (Storage)","publish_date":null,"title":"8013 Blower","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/iCoolPSC%2BBlower%2BCatalog%2B2024_page27.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/iCoolPSC%2BBlower%2BCatalog%2B2024_page27.pdf"},"request":{"example_id":"table/iCoolPSC+Blower+Catalog+2024_page27","product_type":"parse","source_file_path":"iCoolPSC+Blower+Catalog+2024_page27.pdf"},"started_at":"2026-11-04T19:47:10.569131"} +{"completed_at":"2026-11-04T19:47:13.060075","latency_in_ms":1505,"output":{"example_id":"table/iCoolPSC+Blower+Catalog+2024_page33","grounded_pages":[],"layout_pages":[],"markdown":"iCoolPSC Computer Products Corp., Ltd.\n\nFan dimensions, RPM, CFM, connector type, wiring, bearing, voltage, current can all be customized to customer requirements. Specifications may be subject to change. Model number may differ depending on specifications. Some model numbers end with “X” where X is a placeholder for different specifications of fan (i.e. different connector type).\n\nP/Q Curve Dimension Drawing\n\nModel Bearing\n\nRated Voltage (VDC)\n\nOperating\n\nVoltage (VDC)\n\nRated Current\n\n(A)\n\nRated Input Power\n\n(W)\n\nRPM CFM\n\nStatic\n\nPressure (mmH2O)\n\ndBA\n\nFD7010L12X - 12 6~13.2 0.18 2.16 3000 9.8 13.0 27.0\n\nFD7010M12X - - - 0.25 3 3500 11.5 17.6 30.3\n\nFD7010H12X - - - 0.35 4.2 4000 13.1 23.0 33.2\n\nFD7010U12X - - - 0.45 5.4 4500 14.8 29.2 35.8\n\n## 6510\n\nFan Type: Blower\n\nFan Dimensions: 65x10.8mm\n\nFan Material: Frame and Impeller: Plastic UL 94V-0 / SGCC\n\nLead Wires: UL Type: Red Wire Positive, Black Wire Negative\n\nInsulation Resistance: 10MΩ or Over with DC250V Megger\n\nDielectric Withstand Voltage: AC500V 1S\n\nAllowable Ambient Temperature: -10°C ~ +70°C (Operating) -40°C ~ +70°C (Storage)","pages":[{"line_numbers":[],"markdown":"iCoolPSC Computer Products Corp., Ltd.\n\nFan dimensions, RPM, CFM, connector type, wiring, bearing, voltage, current can all be customized to customer requirements. Specifications may be subject to change. Model number may differ depending on specifications. Some model numbers end with “X” where X is a placeholder for different specifications of fan (i.e. different connector type).\n\nP/Q Curve Dimension Drawing\n\nModel Bearing\n\nRated Voltage (VDC)\n\nOperating\n\nVoltage (VDC)\n\nRated Current\n\n(A)\n\nRated Input Power\n\n(W)\n\nRPM CFM\n\nStatic\n\nPressure (mmH2O)\n\ndBA\n\nFD7010L12X - 12 6~13.2 0.18 2.16 3000 9.8 13.0 27.0\n\nFD7010M12X - - - 0.25 3 3500 11.5 17.6 30.3\n\nFD7010H12X - - - 0.35 4.2 4000 13.1 23.0 33.2\n\nFD7010U12X - - - 0.45 5.4 4500 14.8 29.2 35.8\n\n## 6510\n\nFan Type: Blower\n\nFan Dimensions: 65x10.8mm\n\nFan Material: Frame and Impeller: Plastic UL 94V-0 / SGCC\n\nLead Wires: UL Type: Red Wire Positive, Black Wire Negative\n\nInsulation Resistance: 10MΩ or Over with DC250V Megger\n\nDielectric Withstand Voltage: AC500V 1S\n\nAllowable Ambient Temperature: -10°C ~ +70°C (Operating) -40°C ~ +70°C (Storage)","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"iCoolPSC Computer Products Corp., Ltd.\n\nFan dimensions, RPM, CFM, connector type, wiring, bearing, voltage, current can all be customized to customer requirements. Specifications may be subject to change. Model number may differ depending on specifications. Some model numbers end with “X” where X is a placeholder for different specifications of fan (i.e. different connector type).\n\nP/Q Curve Dimension Drawing\n\nModel Bearing\n\nRated Voltage (VDC)\n\nOperating\n\nVoltage (VDC)\n\nRated Current\n\n(A)\n\nRated Input Power\n\n(W)\n\nRPM CFM\n\nStatic\n\nPressure (mmH2O)\n\ndBA\n\nFD7010L12X - 12 6~13.2 0.18 2.16 3000 9.8 13.0 27.0\n\nFD7010M12X - - - 0.25 3 3500 11.5 17.6 30.3\n\nFD7010H12X - - - 0.35 4.2 4000 13.1 23.0 33.2\n\nFD7010U12X - - - 0.45 5.4 4500 14.8 29.2 35.8\n\n## 6510\n\nFan Type: Blower\n\nFan Dimensions: 65x10.8mm\n\nFan Material: Frame and Impeller: Plastic UL 94V-0 / SGCC\n\nLead Wires: UL Type: Red Wire Positive, Black Wire Negative\n\nInsulation Resistance: 10MΩ or Over with DC250V Megger\n\nDielectric Withstand Voltage: AC500V 1S\n\nAllowable Ambient Temperature: -10°C ~ +70°C (Operating) -40°C ~ +70°C (Storage)","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/iCoolPSC%2BBlower%2BCatalog%2B2024_page33.pdf"]},"response":{"errors":[],"extract_id":"extract_ddf6b96f0c3643f009e2caf2468f391c","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["iCoolPSC Computer Products Corp., Ltd.\n\nFan dimensions, RPM, CFM, connector type, wiring, bearing, voltage, current can all be customized to customer requirements. Specifications may be subject to change. Model number may differ depending on specifications. Some model numbers end with “X” where X is a placeholder for different specifications of fan (i.e. different connector type).\n\nP/Q Curve Dimension Drawing\n\nModel Bearing\n\nRated Voltage (VDC)\n\nOperating\n\nVoltage (VDC)\n\nRated Current\n\n(A)\n\nRated Input Power\n\n(W)\n\nRPM CFM\n\nStatic\n\nPressure (mmH2O)\n\ndBA\n\nFD7010L12X - 12 6~13.2 0.18 2.16 3000 9.8 13.0 27.0\n\nFD7010M12X - - - 0.25 3 3500 11.5 17.6 30.3\n\nFD7010H12X - - - 0.35 4.2 4000 13.1 23.0 33.2\n\nFD7010U12X - - - 0.45 5.4 4500 14.8 29.2 35.8\n\n## 6510\n\nFan Type: Blower\n\nFan Dimensions: 65x10.8mm\n\nFan Material: Frame and Impeller: Plastic UL 94V-0 / SGCC\n\nLead Wires: UL Type: Red Wire Positive, Black Wire Negative\n\nInsulation Resistance: 10MΩ or Over with DC250V Megger\n\nDielectric Withstand Voltage: AC500V 1S\n\nAllowable Ambient Temperature: -10°C ~ +70°C (Operating) -40°C ~ +70°C (Storage)"],"full_content":"iCoolPSC Computer Products Corp., Ltd.\n\nFan dimensions, RPM, CFM, connector type, wiring, bearing, voltage, current can all be customized to customer requirements. Specifications may be subject to change. Model number may differ depending on specifications. Some model numbers end with “X” where X is a placeholder for different specifications of fan (i.e. different connector type).\n\nP/Q Curve Dimension Drawing\n\nModel Bearing\n\nRated Voltage (VDC)\n\nOperating\n\nVoltage (VDC)\n\nRated Current\n\n(A)\n\nRated Input Power\n\n(W)\n\nRPM CFM\n\nStatic\n\nPressure (mmH2O)\n\ndBA\n\nFD7010L12X - 12 6~13.2 0.18 2.16 3000 9.8 13.0 27.0\n\nFD7010M12X - - - 0.25 3 3500 11.5 17.6 30.3\n\nFD7010H12X - - - 0.35 4.2 4000 13.1 23.0 33.2\n\nFD7010U12X - - - 0.45 5.4 4500 14.8 29.2 35.8\n\n## 6510\n\nFan Type: Blower\n\nFan Dimensions: 65x10.8mm\n\nFan Material: Frame and Impeller: Plastic UL 94V-0 / SGCC\n\nLead Wires: UL Type: Red Wire Positive, Black Wire Negative\n\nInsulation Resistance: 10MΩ or Over with DC250V Megger\n\nDielectric Withstand Voltage: AC500V 1S\n\nAllowable Ambient Temperature: -10°C ~ +70°C (Operating) -40°C ~ +70°C (Storage)","publish_date":null,"title":"6510","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/iCoolPSC%2BBlower%2BCatalog%2B2024_page33.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/iCoolPSC%2BBlower%2BCatalog%2B2024_page33.pdf"},"request":{"example_id":"table/iCoolPSC+Blower+Catalog+2024_page33","product_type":"parse","source_file_path":"iCoolPSC+Blower+Catalog+2024_page33.pdf"},"started_at":"2026-11-04T19:47:11.554170"} +{"completed_at":"2026-11-04T19:47:15.014018","latency_in_ms":1951,"output":{"example_id":"table/left-side sparse and no outline_page1","grounded_pages":[],"layout_pages":[],"markdown":"EXHIBIT 1(l)\n\nNORTH CAROLINA\n\nHOMEOWNERS INSURANCE\n\nLOSSES BY CAUSE\n\nIncurred Incurred Average Frequency Pure\n\nForm Territory Cause of Loss Year Losses Claims Loss per-100 Premium\n\nOwners 130 Fire, Lightning and Removal 2012 1,865,783 63 29,517 0.62 183.10\n\n2013 3,059,983 54 56,708 0.43 241.29\n\n2014 2,795,972 59 47,245 0.38 177.87\n\n2015 2,895,479 39 74,262 0.28 211.19\n\n2016 2,838,799 58 49,353 0.53 262.08\n\nWind and Hail 2012 272,632 56 4,892 0.55 26.75\n\n2013 290,024 63 4,572 0.50 22.87\n\n2014 126,322 47 2,710 0.30 8.04\n\n2015 187,819 42 4,522 0.30 13.70\n\n2016 284,907 75 3,782 0.70 26.30\n\nWater Damage and Freezing 2012 616,319 83 7,426 0.81 60.48\n\n2013 1,397,263 119 11,751 0.94 110.18\n\n2014 2,668,450 141 18,947 0.90 169.76\n\n2015 1,531,504 107 14,337 0.78 111.71\n\n2016 990,048 91 10,875 0.84 91.40\n\nTheft 2012 112,093 24 4,708 0.23 11.00\n\n2013 102,443 27 3,821 0.21 8.08\n\n2014 61,936 14 4,504 0.09 3.94\n\n2015 24,024 8 2,996 0.06 1.75\n\n2016 26,913 10 2,683 0.09 2.48\n\nOther Physical Damage 2012 54,675 26 2,098 0.26 5.37\n\n2013 209,712 28 7,560 0.22 16.54\n\n2014 165,582 35 4,736 0.22 10.53\n\n2015 240,448 24 9,940 0.18 17.54\n\n2016 186,395 23 8,244 0.21 17.21\n\nLiability 2012 22,961 10 2,221 0.10 2.25\n\n2013 76,448 15 5,083 0.12 6.03\n\n2014 13,786 8 1,630 0.05 0.88\n\n2015 79,818 17 4,717 0.12 5.82\n\n2016 87,736 19 4,667 0.17 8.10\n\nCredit Card 2012 0 0 0 0.00 0.00\n\n2013 0 0 0 0.00 0.00\n\n2014 0 0 0 0.00 0.00\n\n2015 0 0 0 0.00 0.00\n\n2016 0 0 0 0.00 0.00\n\nMedical Payments 2012 2,747 3 974 0.03 0.27\n\n2013 14,038 6 2,489 0.04 1.11\n\n2014 8,301 3 2,944 0.02 0.53\n\n2015 13,159 4 3,500 0.03 0.96\n\n2016 7,974 4 2,121 0.03 0.74\n\nTotal 2012 2,947,210 265 11,123 2.60 289.23\n\n2013 5,149,911 312 16,530 2.46 406.08\n\n2014 5,840,349 307 19,047 1.95 371.55\n\n2015 4,972,251 240 20,698 1.75 362.67\n\n2016 4,422,772 279 15,847 2.58 408.31\n\nE-277","pages":[{"line_numbers":[],"markdown":"EXHIBIT 1(l)\n\nNORTH CAROLINA\n\nHOMEOWNERS INSURANCE\n\nLOSSES BY CAUSE\n\nIncurred Incurred Average Frequency Pure\n\nForm Territory Cause of Loss Year Losses Claims Loss per-100 Premium\n\nOwners 130 Fire, Lightning and Removal 2012 1,865,783 63 29,517 0.62 183.10\n\n2013 3,059,983 54 56,708 0.43 241.29\n\n2014 2,795,972 59 47,245 0.38 177.87\n\n2015 2,895,479 39 74,262 0.28 211.19\n\n2016 2,838,799 58 49,353 0.53 262.08\n\nWind and Hail 2012 272,632 56 4,892 0.55 26.75\n\n2013 290,024 63 4,572 0.50 22.87\n\n2014 126,322 47 2,710 0.30 8.04\n\n2015 187,819 42 4,522 0.30 13.70\n\n2016 284,907 75 3,782 0.70 26.30\n\nWater Damage and Freezing 2012 616,319 83 7,426 0.81 60.48\n\n2013 1,397,263 119 11,751 0.94 110.18\n\n2014 2,668,450 141 18,947 0.90 169.76\n\n2015 1,531,504 107 14,337 0.78 111.71\n\n2016 990,048 91 10,875 0.84 91.40\n\nTheft 2012 112,093 24 4,708 0.23 11.00\n\n2013 102,443 27 3,821 0.21 8.08\n\n2014 61,936 14 4,504 0.09 3.94\n\n2015 24,024 8 2,996 0.06 1.75\n\n2016 26,913 10 2,683 0.09 2.48\n\nOther Physical Damage 2012 54,675 26 2,098 0.26 5.37\n\n2013 209,712 28 7,560 0.22 16.54\n\n2014 165,582 35 4,736 0.22 10.53\n\n2015 240,448 24 9,940 0.18 17.54\n\n2016 186,395 23 8,244 0.21 17.21\n\nLiability 2012 22,961 10 2,221 0.10 2.25\n\n2013 76,448 15 5,083 0.12 6.03\n\n2014 13,786 8 1,630 0.05 0.88\n\n2015 79,818 17 4,717 0.12 5.82\n\n2016 87,736 19 4,667 0.17 8.10\n\nCredit Card 2012 0 0 0 0.00 0.00\n\n2013 0 0 0 0.00 0.00\n\n2014 0 0 0 0.00 0.00\n\n2015 0 0 0 0.00 0.00\n\n2016 0 0 0 0.00 0.00\n\nMedical Payments 2012 2,747 3 974 0.03 0.27\n\n2013 14,038 6 2,489 0.04 1.11\n\n2014 8,301 3 2,944 0.02 0.53\n\n2015 13,159 4 3,500 0.03 0.96\n\n2016 7,974 4 2,121 0.03 0.74\n\nTotal 2012 2,947,210 265 11,123 2.60 289.23\n\n2013 5,149,911 312 16,530 2.46 406.08\n\n2014 5,840,349 307 19,047 1.95 371.55\n\n2015 4,972,251 240 20,698 1.75 362.67\n\n2016 4,422,772 279 15,847 2.58 408.31\n\nE-277","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"EXHIBIT 1(l)\n\nNORTH CAROLINA\n\nHOMEOWNERS INSURANCE\n\nLOSSES BY CAUSE\n\nIncurred Incurred Average Frequency Pure\n\nForm Territory Cause of Loss Year Losses Claims Loss per-100 Premium\n\nOwners 130 Fire, Lightning and Removal 2012 1,865,783 63 29,517 0.62 183.10\n\n2013 3,059,983 54 56,708 0.43 241.29\n\n2014 2,795,972 59 47,245 0.38 177.87\n\n2015 2,895,479 39 74,262 0.28 211.19\n\n2016 2,838,799 58 49,353 0.53 262.08\n\nWind and Hail 2012 272,632 56 4,892 0.55 26.75\n\n2013 290,024 63 4,572 0.50 22.87\n\n2014 126,322 47 2,710 0.30 8.04\n\n2015 187,819 42 4,522 0.30 13.70\n\n2016 284,907 75 3,782 0.70 26.30\n\nWater Damage and Freezing 2012 616,319 83 7,426 0.81 60.48\n\n2013 1,397,263 119 11,751 0.94 110.18\n\n2014 2,668,450 141 18,947 0.90 169.76\n\n2015 1,531,504 107 14,337 0.78 111.71\n\n2016 990,048 91 10,875 0.84 91.40\n\nTheft 2012 112,093 24 4,708 0.23 11.00\n\n2013 102,443 27 3,821 0.21 8.08\n\n2014 61,936 14 4,504 0.09 3.94\n\n2015 24,024 8 2,996 0.06 1.75\n\n2016 26,913 10 2,683 0.09 2.48\n\nOther Physical Damage 2012 54,675 26 2,098 0.26 5.37\n\n2013 209,712 28 7,560 0.22 16.54\n\n2014 165,582 35 4,736 0.22 10.53\n\n2015 240,448 24 9,940 0.18 17.54\n\n2016 186,395 23 8,244 0.21 17.21\n\nLiability 2012 22,961 10 2,221 0.10 2.25\n\n2013 76,448 15 5,083 0.12 6.03\n\n2014 13,786 8 1,630 0.05 0.88\n\n2015 79,818 17 4,717 0.12 5.82\n\n2016 87,736 19 4,667 0.17 8.10\n\nCredit Card 2012 0 0 0 0.00 0.00\n\n2013 0 0 0 0.00 0.00\n\n2014 0 0 0 0.00 0.00\n\n2015 0 0 0 0.00 0.00\n\n2016 0 0 0 0.00 0.00\n\nMedical Payments 2012 2,747 3 974 0.03 0.27\n\n2013 14,038 6 2,489 0.04 1.11\n\n2014 8,301 3 2,944 0.02 0.53\n\n2015 13,159 4 3,500 0.03 0.96\n\n2016 7,974 4 2,121 0.03 0.74\n\nTotal 2012 2,947,210 265 11,123 2.60 289.23\n\n2013 5,149,911 312 16,530 2.46 406.08\n\n2014 5,840,349 307 19,047 1.95 371.55\n\n2015 4,972,251 240 20,698 1.75 362.67\n\n2016 4,422,772 279 15,847 2.58 408.31\n\nE-277","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/left-side%20sparse%20and%20no%20outline_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_d3625227db36414ac0c53acf03836c5f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["EXHIBIT 1(l)\n\nNORTH CAROLINA\n\nHOMEOWNERS INSURANCE\n\nLOSSES BY CAUSE\n\nIncurred Incurred Average Frequency Pure\n\nForm Territory Cause of Loss Year Losses Claims Loss per-100 Premium\n\nOwners 130 Fire, Lightning and Removal 2012 1,865,783 63 29,517 0.62 183.10\n\n2013 3,059,983 54 56,708 0.43 241.29\n\n2014 2,795,972 59 47,245 0.38 177.87\n\n2015 2,895,479 39 74,262 0.28 211.19\n\n2016 2,838,799 58 49,353 0.53 262.08\n\nWind and Hail 2012 272,632 56 4,892 0.55 26.75\n\n2013 290,024 63 4,572 0.50 22.87\n\n2014 126,322 47 2,710 0.30 8.04\n\n2015 187,819 42 4,522 0.30 13.70\n\n2016 284,907 75 3,782 0.70 26.30\n\nWater Damage and Freezing 2012 616,319 83 7,426 0.81 60.48\n\n2013 1,397,263 119 11,751 0.94 110.18\n\n2014 2,668,450 141 18,947 0.90 169.76\n\n2015 1,531,504 107 14,337 0.78 111.71\n\n2016 990,048 91 10,875 0.84 91.40\n\nTheft 2012 112,093 24 4,708 0.23 11.00\n\n2013 102,443 27 3,821 0.21 8.08\n\n2014 61,936 14 4,504 0.09 3.94\n\n2015 24,024 8 2,996 0.06 1.75\n\n2016 26,913 10 2,683 0.09 2.48\n\nOther Physical Damage 2012 54,675 26 2,098 0.26 5.37\n\n2013 209,712 28 7,560 0.22 16.54\n\n2014 165,582 35 4,736 0.22 10.53\n\n2015 240,448 24 9,940 0.18 17.54\n\n2016 186,395 23 8,244 0.21 17.21\n\nLiability 2012 22,961 10 2,221 0.10 2.25\n\n2013 76,448 15 5,083 0.12 6.03\n\n2014 13,786 8 1,630 0.05 0.88\n\n2015 79,818 17 4,717 0.12 5.82\n\n2016 87,736 19 4,667 0.17 8.10\n\nCredit Card 2012 0 0 0 0.00 0.00\n\n2013 0 0 0 0.00 0.00\n\n2014 0 0 0 0.00 0.00\n\n2015 0 0 0 0.00 0.00\n\n2016 0 0 0 0.00 0.00\n\nMedical Payments 2012 2,747 3 974 0.03 0.27\n\n2013 14,038 6 2,489 0.04 1.11\n\n2014 8,301 3 2,944 0.02 0.53\n\n2015 13,159 4 3,500 0.03 0.96\n\n2016 7,974 4 2,121 0.03 0.74\n\nTotal 2012 2,947,210 265 11,123 2.60 289.23\n\n2013 5,149,911 312 16,530 2.46 406.08\n\n2014 5,840,349 307 19,047 1.95 371.55\n\n2015 4,972,251 240 20,698 1.75 362.67\n\n2016 4,422,772 279 15,847 2.58 408.31\n\nE-277"],"full_content":"EXHIBIT 1(l)\n\nNORTH CAROLINA\n\nHOMEOWNERS INSURANCE\n\nLOSSES BY CAUSE\n\nIncurred Incurred Average Frequency Pure\n\nForm Territory Cause of Loss Year Losses Claims Loss per-100 Premium\n\nOwners 130 Fire, Lightning and Removal 2012 1,865,783 63 29,517 0.62 183.10\n\n2013 3,059,983 54 56,708 0.43 241.29\n\n2014 2,795,972 59 47,245 0.38 177.87\n\n2015 2,895,479 39 74,262 0.28 211.19\n\n2016 2,838,799 58 49,353 0.53 262.08\n\nWind and Hail 2012 272,632 56 4,892 0.55 26.75\n\n2013 290,024 63 4,572 0.50 22.87\n\n2014 126,322 47 2,710 0.30 8.04\n\n2015 187,819 42 4,522 0.30 13.70\n\n2016 284,907 75 3,782 0.70 26.30\n\nWater Damage and Freezing 2012 616,319 83 7,426 0.81 60.48\n\n2013 1,397,263 119 11,751 0.94 110.18\n\n2014 2,668,450 141 18,947 0.90 169.76\n\n2015 1,531,504 107 14,337 0.78 111.71\n\n2016 990,048 91 10,875 0.84 91.40\n\nTheft 2012 112,093 24 4,708 0.23 11.00\n\n2013 102,443 27 3,821 0.21 8.08\n\n2014 61,936 14 4,504 0.09 3.94\n\n2015 24,024 8 2,996 0.06 1.75\n\n2016 26,913 10 2,683 0.09 2.48\n\nOther Physical Damage 2012 54,675 26 2,098 0.26 5.37\n\n2013 209,712 28 7,560 0.22 16.54\n\n2014 165,582 35 4,736 0.22 10.53\n\n2015 240,448 24 9,940 0.18 17.54\n\n2016 186,395 23 8,244 0.21 17.21\n\nLiability 2012 22,961 10 2,221 0.10 2.25\n\n2013 76,448 15 5,083 0.12 6.03\n\n2014 13,786 8 1,630 0.05 0.88\n\n2015 79,818 17 4,717 0.12 5.82\n\n2016 87,736 19 4,667 0.17 8.10\n\nCredit Card 2012 0 0 0 0.00 0.00\n\n2013 0 0 0 0.00 0.00\n\n2014 0 0 0 0.00 0.00\n\n2015 0 0 0 0.00 0.00\n\n2016 0 0 0 0.00 0.00\n\nMedical Payments 2012 2,747 3 974 0.03 0.27\n\n2013 14,038 6 2,489 0.04 1.11\n\n2014 8,301 3 2,944 0.02 0.53\n\n2015 13,159 4 3,500 0.03 0.96\n\n2016 7,974 4 2,121 0.03 0.74\n\nTotal 2012 2,947,210 265 11,123 2.60 289.23\n\n2013 5,149,911 312 16,530 2.46 406.08\n\n2014 5,840,349 307 19,047 1.95 371.55\n\n2015 4,972,251 240 20,698 1.75 362.67\n\n2016 4,422,772 279 15,847 2.58 408.31\n\nE-277","publish_date":null,"title":"EXHIBIT 1(l) NORTH CAROLINA HOMEOWNERS INSURANCE LOSSES BY CAUSE Incurred Incurred Average Frequency Pure Form Territory Cause of Loss Year","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/left-side%20sparse%20and%20no%20outline_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/left-side%20sparse%20and%20no%20outline_page1.pdf"},"request":{"example_id":"table/left-side sparse and no outline_page1","product_type":"parse","source_file_path":"left-side sparse and no outline_page1.pdf"},"started_at":"2026-11-04T19:47:13.062687"} +{"completed_at":"2026-11-04T19:47:17.583078","latency_in_ms":3068,"output":{"example_id":"table/llama_page18","grounded_pages":[],"layout_pages":[],"markdown":"**B MMLU**\n\nGPT-3 Gopher Chinchilla LLaMA LLaMA-I\n\n175B 280B 70B 7B 13B 33B 65B 65B\n\nAbstract Algebra STEM 30.0 25.0 31.0 29.0 34.0 32.0 34.0 31.0\n\nAnatomy STEM 48.0 56.3 70.4 37.0 45.9 51.9 57.8 62.2\n\nAstronomy STEM 49.0 65.8 73.0 33.6 46.1 61.8 72.4 81.6\n\nBusiness Ethics Other 46.0 70.0 72.0 40.0 45.0 56.0 57.0 72.0\n\nClinical Knowledge Other 48.0 67.2 75.1 35.1 45.7 57.4 65.3 69.1\n\nCollege Biology STEM 45.0 70.8 79.9 37.5 45.1 58.3 68.8 81.9\n\nCollege Chemistry STEM 26.0 45.0 51.0 32.0 30.0 45.0 50.0 45.0\n\nCollege Computer Science STEM 46.0 49.0 51.0 29.0 39.0 45.0 47.0 51.0\n\nCollege Mathematics STEM 34.5 37.0 32.0 33.0 32.0 40.0 35.0 36.0\n\nCollege Medicine Other 48.0 60.1 66.5 30.6 42.8 52.0 54.3 63.0\n\nCollege Physics STEM 28.0 34.3 46.1 26.5 18.6 28.4 36.3 46.1\n\nComputer Security STEM 57.0 65.0 76.0 45.0 65.0 66.0 79.0 79.0\n\nConceptual Physics STEM 36.5 49.4 67.2 36.6 41.3 51.5 59.6 66.4\n\nEconometrics Social Science 33.0 43.0 38.6 23.7 27.2 35.1 40.4 52.6\n\nElectrical Engineering STEM 50.0 60.0 62.1 26.9 40.7 49.7 53.8 60.7\n\nElementary Mathematics STEM 30.0 33.6 41.5 24.3 24.9 36.0 37.8 42.9\n\nFormal Logic Humanities 29.0 35.7 33.3 27.0 33.3 34.1 44.4 47.6\n\nGlobal Facts Other 37.0 38.0 39.0 29.0 35.0 35.0 39.0 40.0\n\nHigh School Biology STEM 48.0 71.3 80.3 34.5 52.6 67.7 73.9 82.9\n\nHigh School Chemistry STEM 33.0 47.8 58.1 28.1 28.6 41.9 40.4 44.8\n\nHigh School Computer Science STEM 39.0 54.0 58.0 31.0 48.0 60.0 67.0 73.0\n\nHigh School European History Humanities 54.0 72.1 78.8 44.2 61.8 73.9 78.8 86.1\n\nHigh School Geography Social Science 58.0 76.8 86.4 34.3 54.6 70.7 77.8 87.9\n\nHigh School Government And Politics Social Science 58.0 83.9 91.2 44.6 66.3 82.9 88.1 92.8\n\nHigh School Macroeconomics Social Science 40.5 65.1 70.5 35.4 44.4 56.9 65.9 69.2\n\nHigh School Mathematics STEM 28.0 23.7 31.9 24.8 23.7 27.0 34.4 37.0\n\nHigh School Microeconomics Social Science 42.0 66.4 77.7 31.9 47.5 55.5 68.9 78.6\n\nHigh School Physics STEM 28.0 33.8 36.4 26.5 28.5 35.8 37.1 41.7\n\nHigh School Psychology Social Science 61.0 81.8 86.6 47.3 60.9 76.2 82.2 87.9\n\nHigh School Statistics STEM 30.5 50.0 58.8 35.2 30.1 45.4 58.3 59.3\n\nHigh School Us History Humanities 53.0 78.9 83.3 39.7 58.3 77.9 83.8 90.7\n\nHigh School World History Humanities 56.0 75.1 85.2 40.9 66.2 79.3 83.1 89.0\n\nHuman Aging Other 50.0 66.4 77.6 40.8 54.7 67.7 69.5 72.2\n\nHuman Sexuality Social Science 54.0 67.2 86.3 36.6 58.8 64.1 77.9 87.0\n\nInternational Law Humanities 55.5 77.7 90.9 51.2 62.8 72.7 79.3 87.6\n\nJurisprudence Humanities 55.0 71.3 79.6 38.9 51.9 70.4 73.2 85.2\n\nLogical Fallacies Humanities 48.0 72.4 80.4 39.3 52.8 68.1 77.3 80.4\n\nMachine Learning STEM 31.0 41.1 41.1 23.2 31.3 39.3 49.1 52.7\n\nManagement Other 56.0 77.7 82.5 35.0 66.0 77.7 82.5 83.5\n\nMarketing Other 60.0 83.3 89.7 46.6 71.8 83.3 85.9 92.7\n\nMedical Genetics Other 40.0 69.0 69.0 43.0 52.0 67.0 67.0 68.0\n\nMiscellaneous Other 60.0 75.7 84.5 42.4 65.4 78.5 82.1 84.3\n\nMoral Disputes Humanities 44.5 66.8 77.5 40.2 50.9 66.2 72.3 76.9\n\nMoral Scenarios Humanities 26.0 40.2 36.5 24.3 30.1 38.2 48.9 55.9\n\nNutrition Other 47.0 69.9 77.1 37.6 51.6 62.8 67.3 74.5\n\nPhilosophy Humanities 51.0 68.8 79.4 39.9 54.0 66.2 74.0 79.1\n\nPrehistory Humanities 53.0 67.6 81.2 36.1 51.5 67.0 75.3 79.0\n\nProfessional Accounting Other 33.0 44.3 52.1 25.9 35.8 43.6 46.5 56.0\n\nProfessional Law Humanities 34.5 44.5 56.5 30.2 38.0 45.9 49.1 54.4\n\nProfessional Medicine Other 36.0 64.0 75.4 44.5 50.4 54.0 61.4 70.6\n\nProfessional Psychology Social Science 44.5 68.1 75.7 35.1 47.7 62.9 65.7 71.4\n\nPublic Relations Social Science 48.0 71.8 73.6 40.9 60.9 67.3 73.6 74.6\n\nSecurity Studies Social Science 52.0 64.9 75.9 31.8 53.9 65.3 71.8 77.6\n\nSociology Social Science 53.0 84.1 91.0 46.8 61.2 78.6 78.6 88.1\n\nUs Foreign Policy Social Science 69.0 81.0 92.0 46.0 80.0 83.0 86.0 87.0\n\nVirology Other 46.0 47.0 53.6 30.1 43.4 50.0 53.0 57.8\n\nWorld Religions Humanities 55.0 84.2 87.7 50.9 67.8 81.3 81.3 84.2\n\nHumanities 40.6 56.2 63.6 34.0 45.0 55.8 61.8 67.4\n\nSTEM 36.7 47.4 54.9 30.5 35.8 46.0 51.7 56.6\n\nSocial Science 50.5 71.9 79.3 38.3 53.8 66.7 72.9 79.2\n\nOthers 49.0 66.1 73.9 38.1 53.3 63.4 67.4 72.6\n\nAll 43.9 60.0 67.6 35.1 46.9 57.8 63.4 68.9\n\nTable 16: **MMLU.** Detailed 5-shot results per domain on the test sets.","pages":[{"line_numbers":[],"markdown":"**B MMLU**\n\nGPT-3 Gopher Chinchilla LLaMA LLaMA-I\n\n175B 280B 70B 7B 13B 33B 65B 65B\n\nAbstract Algebra STEM 30.0 25.0 31.0 29.0 34.0 32.0 34.0 31.0\n\nAnatomy STEM 48.0 56.3 70.4 37.0 45.9 51.9 57.8 62.2\n\nAstronomy STEM 49.0 65.8 73.0 33.6 46.1 61.8 72.4 81.6\n\nBusiness Ethics Other 46.0 70.0 72.0 40.0 45.0 56.0 57.0 72.0\n\nClinical Knowledge Other 48.0 67.2 75.1 35.1 45.7 57.4 65.3 69.1\n\nCollege Biology STEM 45.0 70.8 79.9 37.5 45.1 58.3 68.8 81.9\n\nCollege Chemistry STEM 26.0 45.0 51.0 32.0 30.0 45.0 50.0 45.0\n\nCollege Computer Science STEM 46.0 49.0 51.0 29.0 39.0 45.0 47.0 51.0\n\nCollege Mathematics STEM 34.5 37.0 32.0 33.0 32.0 40.0 35.0 36.0\n\nCollege Medicine Other 48.0 60.1 66.5 30.6 42.8 52.0 54.3 63.0\n\nCollege Physics STEM 28.0 34.3 46.1 26.5 18.6 28.4 36.3 46.1\n\nComputer Security STEM 57.0 65.0 76.0 45.0 65.0 66.0 79.0 79.0\n\nConceptual Physics STEM 36.5 49.4 67.2 36.6 41.3 51.5 59.6 66.4\n\nEconometrics Social Science 33.0 43.0 38.6 23.7 27.2 35.1 40.4 52.6\n\nElectrical Engineering STEM 50.0 60.0 62.1 26.9 40.7 49.7 53.8 60.7\n\nElementary Mathematics STEM 30.0 33.6 41.5 24.3 24.9 36.0 37.8 42.9\n\nFormal Logic Humanities 29.0 35.7 33.3 27.0 33.3 34.1 44.4 47.6\n\nGlobal Facts Other 37.0 38.0 39.0 29.0 35.0 35.0 39.0 40.0\n\nHigh School Biology STEM 48.0 71.3 80.3 34.5 52.6 67.7 73.9 82.9\n\nHigh School Chemistry STEM 33.0 47.8 58.1 28.1 28.6 41.9 40.4 44.8\n\nHigh School Computer Science STEM 39.0 54.0 58.0 31.0 48.0 60.0 67.0 73.0\n\nHigh School European History Humanities 54.0 72.1 78.8 44.2 61.8 73.9 78.8 86.1\n\nHigh School Geography Social Science 58.0 76.8 86.4 34.3 54.6 70.7 77.8 87.9\n\nHigh School Government And Politics Social Science 58.0 83.9 91.2 44.6 66.3 82.9 88.1 92.8\n\nHigh School Macroeconomics Social Science 40.5 65.1 70.5 35.4 44.4 56.9 65.9 69.2\n\nHigh School Mathematics STEM 28.0 23.7 31.9 24.8 23.7 27.0 34.4 37.0\n\nHigh School Microeconomics Social Science 42.0 66.4 77.7 31.9 47.5 55.5 68.9 78.6\n\nHigh School Physics STEM 28.0 33.8 36.4 26.5 28.5 35.8 37.1 41.7\n\nHigh School Psychology Social Science 61.0 81.8 86.6 47.3 60.9 76.2 82.2 87.9\n\nHigh School Statistics STEM 30.5 50.0 58.8 35.2 30.1 45.4 58.3 59.3\n\nHigh School Us History Humanities 53.0 78.9 83.3 39.7 58.3 77.9 83.8 90.7\n\nHigh School World History Humanities 56.0 75.1 85.2 40.9 66.2 79.3 83.1 89.0\n\nHuman Aging Other 50.0 66.4 77.6 40.8 54.7 67.7 69.5 72.2\n\nHuman Sexuality Social Science 54.0 67.2 86.3 36.6 58.8 64.1 77.9 87.0\n\nInternational Law Humanities 55.5 77.7 90.9 51.2 62.8 72.7 79.3 87.6\n\nJurisprudence Humanities 55.0 71.3 79.6 38.9 51.9 70.4 73.2 85.2\n\nLogical Fallacies Humanities 48.0 72.4 80.4 39.3 52.8 68.1 77.3 80.4\n\nMachine Learning STEM 31.0 41.1 41.1 23.2 31.3 39.3 49.1 52.7\n\nManagement Other 56.0 77.7 82.5 35.0 66.0 77.7 82.5 83.5\n\nMarketing Other 60.0 83.3 89.7 46.6 71.8 83.3 85.9 92.7\n\nMedical Genetics Other 40.0 69.0 69.0 43.0 52.0 67.0 67.0 68.0\n\nMiscellaneous Other 60.0 75.7 84.5 42.4 65.4 78.5 82.1 84.3\n\nMoral Disputes Humanities 44.5 66.8 77.5 40.2 50.9 66.2 72.3 76.9\n\nMoral Scenarios Humanities 26.0 40.2 36.5 24.3 30.1 38.2 48.9 55.9\n\nNutrition Other 47.0 69.9 77.1 37.6 51.6 62.8 67.3 74.5\n\nPhilosophy Humanities 51.0 68.8 79.4 39.9 54.0 66.2 74.0 79.1\n\nPrehistory Humanities 53.0 67.6 81.2 36.1 51.5 67.0 75.3 79.0\n\nProfessional Accounting Other 33.0 44.3 52.1 25.9 35.8 43.6 46.5 56.0\n\nProfessional Law Humanities 34.5 44.5 56.5 30.2 38.0 45.9 49.1 54.4\n\nProfessional Medicine Other 36.0 64.0 75.4 44.5 50.4 54.0 61.4 70.6\n\nProfessional Psychology Social Science 44.5 68.1 75.7 35.1 47.7 62.9 65.7 71.4\n\nPublic Relations Social Science 48.0 71.8 73.6 40.9 60.9 67.3 73.6 74.6\n\nSecurity Studies Social Science 52.0 64.9 75.9 31.8 53.9 65.3 71.8 77.6\n\nSociology Social Science 53.0 84.1 91.0 46.8 61.2 78.6 78.6 88.1\n\nUs Foreign Policy Social Science 69.0 81.0 92.0 46.0 80.0 83.0 86.0 87.0\n\nVirology Other 46.0 47.0 53.6 30.1 43.4 50.0 53.0 57.8\n\nWorld Religions Humanities 55.0 84.2 87.7 50.9 67.8 81.3 81.3 84.2\n\nHumanities 40.6 56.2 63.6 34.0 45.0 55.8 61.8 67.4\n\nSTEM 36.7 47.4 54.9 30.5 35.8 46.0 51.7 56.6\n\nSocial Science 50.5 71.9 79.3 38.3 53.8 66.7 72.9 79.2\n\nOthers 49.0 66.1 73.9 38.1 53.3 63.4 67.4 72.6\n\nAll 43.9 60.0 67.6 35.1 46.9 57.8 63.4 68.9\n\nTable 16: **MMLU.** Detailed 5-shot results per domain on the test sets.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**B MMLU**\n\nGPT-3 Gopher Chinchilla LLaMA LLaMA-I\n\n175B 280B 70B 7B 13B 33B 65B 65B\n\nAbstract Algebra STEM 30.0 25.0 31.0 29.0 34.0 32.0 34.0 31.0\n\nAnatomy STEM 48.0 56.3 70.4 37.0 45.9 51.9 57.8 62.2\n\nAstronomy STEM 49.0 65.8 73.0 33.6 46.1 61.8 72.4 81.6\n\nBusiness Ethics Other 46.0 70.0 72.0 40.0 45.0 56.0 57.0 72.0\n\nClinical Knowledge Other 48.0 67.2 75.1 35.1 45.7 57.4 65.3 69.1\n\nCollege Biology STEM 45.0 70.8 79.9 37.5 45.1 58.3 68.8 81.9\n\nCollege Chemistry STEM 26.0 45.0 51.0 32.0 30.0 45.0 50.0 45.0\n\nCollege Computer Science STEM 46.0 49.0 51.0 29.0 39.0 45.0 47.0 51.0\n\nCollege Mathematics STEM 34.5 37.0 32.0 33.0 32.0 40.0 35.0 36.0\n\nCollege Medicine Other 48.0 60.1 66.5 30.6 42.8 52.0 54.3 63.0\n\nCollege Physics STEM 28.0 34.3 46.1 26.5 18.6 28.4 36.3 46.1\n\nComputer Security STEM 57.0 65.0 76.0 45.0 65.0 66.0 79.0 79.0\n\nConceptual Physics STEM 36.5 49.4 67.2 36.6 41.3 51.5 59.6 66.4\n\nEconometrics Social Science 33.0 43.0 38.6 23.7 27.2 35.1 40.4 52.6\n\nElectrical Engineering STEM 50.0 60.0 62.1 26.9 40.7 49.7 53.8 60.7\n\nElementary Mathematics STEM 30.0 33.6 41.5 24.3 24.9 36.0 37.8 42.9\n\nFormal Logic Humanities 29.0 35.7 33.3 27.0 33.3 34.1 44.4 47.6\n\nGlobal Facts Other 37.0 38.0 39.0 29.0 35.0 35.0 39.0 40.0\n\nHigh School Biology STEM 48.0 71.3 80.3 34.5 52.6 67.7 73.9 82.9\n\nHigh School Chemistry STEM 33.0 47.8 58.1 28.1 28.6 41.9 40.4 44.8\n\nHigh School Computer Science STEM 39.0 54.0 58.0 31.0 48.0 60.0 67.0 73.0\n\nHigh School European History Humanities 54.0 72.1 78.8 44.2 61.8 73.9 78.8 86.1\n\nHigh School Geography Social Science 58.0 76.8 86.4 34.3 54.6 70.7 77.8 87.9\n\nHigh School Government And Politics Social Science 58.0 83.9 91.2 44.6 66.3 82.9 88.1 92.8\n\nHigh School Macroeconomics Social Science 40.5 65.1 70.5 35.4 44.4 56.9 65.9 69.2\n\nHigh School Mathematics STEM 28.0 23.7 31.9 24.8 23.7 27.0 34.4 37.0\n\nHigh School Microeconomics Social Science 42.0 66.4 77.7 31.9 47.5 55.5 68.9 78.6\n\nHigh School Physics STEM 28.0 33.8 36.4 26.5 28.5 35.8 37.1 41.7\n\nHigh School Psychology Social Science 61.0 81.8 86.6 47.3 60.9 76.2 82.2 87.9\n\nHigh School Statistics STEM 30.5 50.0 58.8 35.2 30.1 45.4 58.3 59.3\n\nHigh School Us History Humanities 53.0 78.9 83.3 39.7 58.3 77.9 83.8 90.7\n\nHigh School World History Humanities 56.0 75.1 85.2 40.9 66.2 79.3 83.1 89.0\n\nHuman Aging Other 50.0 66.4 77.6 40.8 54.7 67.7 69.5 72.2\n\nHuman Sexuality Social Science 54.0 67.2 86.3 36.6 58.8 64.1 77.9 87.0\n\nInternational Law Humanities 55.5 77.7 90.9 51.2 62.8 72.7 79.3 87.6\n\nJurisprudence Humanities 55.0 71.3 79.6 38.9 51.9 70.4 73.2 85.2\n\nLogical Fallacies Humanities 48.0 72.4 80.4 39.3 52.8 68.1 77.3 80.4\n\nMachine Learning STEM 31.0 41.1 41.1 23.2 31.3 39.3 49.1 52.7\n\nManagement Other 56.0 77.7 82.5 35.0 66.0 77.7 82.5 83.5\n\nMarketing Other 60.0 83.3 89.7 46.6 71.8 83.3 85.9 92.7\n\nMedical Genetics Other 40.0 69.0 69.0 43.0 52.0 67.0 67.0 68.0\n\nMiscellaneous Other 60.0 75.7 84.5 42.4 65.4 78.5 82.1 84.3\n\nMoral Disputes Humanities 44.5 66.8 77.5 40.2 50.9 66.2 72.3 76.9\n\nMoral Scenarios Humanities 26.0 40.2 36.5 24.3 30.1 38.2 48.9 55.9\n\nNutrition Other 47.0 69.9 77.1 37.6 51.6 62.8 67.3 74.5\n\nPhilosophy Humanities 51.0 68.8 79.4 39.9 54.0 66.2 74.0 79.1\n\nPrehistory Humanities 53.0 67.6 81.2 36.1 51.5 67.0 75.3 79.0\n\nProfessional Accounting Other 33.0 44.3 52.1 25.9 35.8 43.6 46.5 56.0\n\nProfessional Law Humanities 34.5 44.5 56.5 30.2 38.0 45.9 49.1 54.4\n\nProfessional Medicine Other 36.0 64.0 75.4 44.5 50.4 54.0 61.4 70.6\n\nProfessional Psychology Social Science 44.5 68.1 75.7 35.1 47.7 62.9 65.7 71.4\n\nPublic Relations Social Science 48.0 71.8 73.6 40.9 60.9 67.3 73.6 74.6\n\nSecurity Studies Social Science 52.0 64.9 75.9 31.8 53.9 65.3 71.8 77.6\n\nSociology Social Science 53.0 84.1 91.0 46.8 61.2 78.6 78.6 88.1\n\nUs Foreign Policy Social Science 69.0 81.0 92.0 46.0 80.0 83.0 86.0 87.0\n\nVirology Other 46.0 47.0 53.6 30.1 43.4 50.0 53.0 57.8\n\nWorld Religions Humanities 55.0 84.2 87.7 50.9 67.8 81.3 81.3 84.2\n\nHumanities 40.6 56.2 63.6 34.0 45.0 55.8 61.8 67.4\n\nSTEM 36.7 47.4 54.9 30.5 35.8 46.0 51.7 56.6\n\nSocial Science 50.5 71.9 79.3 38.3 53.8 66.7 72.9 79.2\n\nOthers 49.0 66.1 73.9 38.1 53.3 63.4 67.4 72.6\n\nAll 43.9 60.0 67.6 35.1 46.9 57.8 63.4 68.9\n\nTable 16: **MMLU.** Detailed 5-shot results per domain on the test sets.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llama_page18.pdf"]},"response":{"errors":[],"extract_id":"extract_1785b87dafcf65a2be2357c5957a4464","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**B MMLU**\n\nGPT-3 Gopher Chinchilla LLaMA LLaMA-I\n\n175B 280B 70B 7B 13B 33B 65B 65B\n\nAbstract Algebra STEM 30.0 25.0 31.0 29.0 34.0 32.0 34.0 31.0\n\nAnatomy STEM 48.0 56.3 70.4 37.0 45.9 51.9 57.8 62.2\n\nAstronomy STEM 49.0 65.8 73.0 33.6 46.1 61.8 72.4 81.6\n\nBusiness Ethics Other 46.0 70.0 72.0 40.0 45.0 56.0 57.0 72.0\n\nClinical Knowledge Other 48.0 67.2 75.1 35.1 45.7 57.4 65.3 69.1\n\nCollege Biology STEM 45.0 70.8 79.9 37.5 45.1 58.3 68.8 81.9\n\nCollege Chemistry STEM 26.0 45.0 51.0 32.0 30.0 45.0 50.0 45.0\n\nCollege Computer Science STEM 46.0 49.0 51.0 29.0 39.0 45.0 47.0 51.0\n\nCollege Mathematics STEM 34.5 37.0 32.0 33.0 32.0 40.0 35.0 36.0\n\nCollege Medicine Other 48.0 60.1 66.5 30.6 42.8 52.0 54.3 63.0\n\nCollege Physics STEM 28.0 34.3 46.1 26.5 18.6 28.4 36.3 46.1\n\nComputer Security STEM 57.0 65.0 76.0 45.0 65.0 66.0 79.0 79.0\n\nConceptual Physics STEM 36.5 49.4 67.2 36.6 41.3 51.5 59.6 66.4\n\nEconometrics Social Science 33.0 43.0 38.6 23.7 27.2 35.1 40.4 52.6\n\nElectrical Engineering STEM 50.0 60.0 62.1 26.9 40.7 49.7 53.8 60.7\n\nElementary Mathematics STEM 30.0 33.6 41.5 24.3 24.9 36.0 37.8 42.9\n\nFormal Logic Humanities 29.0 35.7 33.3 27.0 33.3 34.1 44.4 47.6\n\nGlobal Facts Other 37.0 38.0 39.0 29.0 35.0 35.0 39.0 40.0\n\nHigh School Biology STEM 48.0 71.3 80.3 34.5 52.6 67.7 73.9 82.9\n\nHigh School Chemistry STEM 33.0 47.8 58.1 28.1 28.6 41.9 40.4 44.8\n\nHigh School Computer Science STEM 39.0 54.0 58.0 31.0 48.0 60.0 67.0 73.0\n\nHigh School European History Humanities 54.0 72.1 78.8 44.2 61.8 73.9 78.8 86.1\n\nHigh School Geography Social Science 58.0 76.8 86.4 34.3 54.6 70.7 77.8 87.9\n\nHigh School Government And Politics Social Science 58.0 83.9 91.2 44.6 66.3 82.9 88.1 92.8\n\nHigh School Macroeconomics Social Science 40.5 65.1 70.5 35.4 44.4 56.9 65.9 69.2\n\nHigh School Mathematics STEM 28.0 23.7 31.9 24.8 23.7 27.0 34.4 37.0\n\nHigh School Microeconomics Social Science 42.0 66.4 77.7 31.9 47.5 55.5 68.9 78.6\n\nHigh School Physics STEM 28.0 33.8 36.4 26.5 28.5 35.8 37.1 41.7\n\nHigh School Psychology Social Science 61.0 81.8 86.6 47.3 60.9 76.2 82.2 87.9\n\nHigh School Statistics STEM 30.5 50.0 58.8 35.2 30.1 45.4 58.3 59.3\n\nHigh School Us History Humanities 53.0 78.9 83.3 39.7 58.3 77.9 83.8 90.7\n\nHigh School World History Humanities 56.0 75.1 85.2 40.9 66.2 79.3 83.1 89.0\n\nHuman Aging Other 50.0 66.4 77.6 40.8 54.7 67.7 69.5 72.2\n\nHuman Sexuality Social Science 54.0 67.2 86.3 36.6 58.8 64.1 77.9 87.0\n\nInternational Law Humanities 55.5 77.7 90.9 51.2 62.8 72.7 79.3 87.6\n\nJurisprudence Humanities 55.0 71.3 79.6 38.9 51.9 70.4 73.2 85.2\n\nLogical Fallacies Humanities 48.0 72.4 80.4 39.3 52.8 68.1 77.3 80.4\n\nMachine Learning STEM 31.0 41.1 41.1 23.2 31.3 39.3 49.1 52.7\n\nManagement Other 56.0 77.7 82.5 35.0 66.0 77.7 82.5 83.5\n\nMarketing Other 60.0 83.3 89.7 46.6 71.8 83.3 85.9 92.7\n\nMedical Genetics Other 40.0 69.0 69.0 43.0 52.0 67.0 67.0 68.0\n\nMiscellaneous Other 60.0 75.7 84.5 42.4 65.4 78.5 82.1 84.3\n\nMoral Disputes Humanities 44.5 66.8 77.5 40.2 50.9 66.2 72.3 76.9\n\nMoral Scenarios Humanities 26.0 40.2 36.5 24.3 30.1 38.2 48.9 55.9\n\nNutrition Other 47.0 69.9 77.1 37.6 51.6 62.8 67.3 74.5\n\nPhilosophy Humanities 51.0 68.8 79.4 39.9 54.0 66.2 74.0 79.1\n\nPrehistory Humanities 53.0 67.6 81.2 36.1 51.5 67.0 75.3 79.0\n\nProfessional Accounting Other 33.0 44.3 52.1 25.9 35.8 43.6 46.5 56.0\n\nProfessional Law Humanities 34.5 44.5 56.5 30.2 38.0 45.9 49.1 54.4\n\nProfessional Medicine Other 36.0 64.0 75.4 44.5 50.4 54.0 61.4 70.6\n\nProfessional Psychology Social Science 44.5 68.1 75.7 35.1 47.7 62.9 65.7 71.4\n\nPublic Relations Social Science 48.0 71.8 73.6 40.9 60.9 67.3 73.6 74.6\n\nSecurity Studies Social Science 52.0 64.9 75.9 31.8 53.9 65.3 71.8 77.6\n\nSociology Social Science 53.0 84.1 91.0 46.8 61.2 78.6 78.6 88.1\n\nUs Foreign Policy Social Science 69.0 81.0 92.0 46.0 80.0 83.0 86.0 87.0\n\nVirology Other 46.0 47.0 53.6 30.1 43.4 50.0 53.0 57.8\n\nWorld Religions Humanities 55.0 84.2 87.7 50.9 67.8 81.3 81.3 84.2\n\nHumanities 40.6 56.2 63.6 34.0 45.0 55.8 61.8 67.4\n\nSTEM 36.7 47.4 54.9 30.5 35.8 46.0 51.7 56.6\n\nSocial Science 50.5 71.9 79.3 38.3 53.8 66.7 72.9 79.2\n\nOthers 49.0 66.1 73.9 38.1 53.3 63.4 67.4 72.6\n\nAll 43.9 60.0 67.6 35.1 46.9 57.8 63.4 68.9\n\nTable 16: **MMLU.** Detailed 5-shot results per domain on the test sets."],"full_content":"**B MMLU**\n\nGPT-3 Gopher Chinchilla LLaMA LLaMA-I\n\n175B 280B 70B 7B 13B 33B 65B 65B\n\nAbstract Algebra STEM 30.0 25.0 31.0 29.0 34.0 32.0 34.0 31.0\n\nAnatomy STEM 48.0 56.3 70.4 37.0 45.9 51.9 57.8 62.2\n\nAstronomy STEM 49.0 65.8 73.0 33.6 46.1 61.8 72.4 81.6\n\nBusiness Ethics Other 46.0 70.0 72.0 40.0 45.0 56.0 57.0 72.0\n\nClinical Knowledge Other 48.0 67.2 75.1 35.1 45.7 57.4 65.3 69.1\n\nCollege Biology STEM 45.0 70.8 79.9 37.5 45.1 58.3 68.8 81.9\n\nCollege Chemistry STEM 26.0 45.0 51.0 32.0 30.0 45.0 50.0 45.0\n\nCollege Computer Science STEM 46.0 49.0 51.0 29.0 39.0 45.0 47.0 51.0\n\nCollege Mathematics STEM 34.5 37.0 32.0 33.0 32.0 40.0 35.0 36.0\n\nCollege Medicine Other 48.0 60.1 66.5 30.6 42.8 52.0 54.3 63.0\n\nCollege Physics STEM 28.0 34.3 46.1 26.5 18.6 28.4 36.3 46.1\n\nComputer Security STEM 57.0 65.0 76.0 45.0 65.0 66.0 79.0 79.0\n\nConceptual Physics STEM 36.5 49.4 67.2 36.6 41.3 51.5 59.6 66.4\n\nEconometrics Social Science 33.0 43.0 38.6 23.7 27.2 35.1 40.4 52.6\n\nElectrical Engineering STEM 50.0 60.0 62.1 26.9 40.7 49.7 53.8 60.7\n\nElementary Mathematics STEM 30.0 33.6 41.5 24.3 24.9 36.0 37.8 42.9\n\nFormal Logic Humanities 29.0 35.7 33.3 27.0 33.3 34.1 44.4 47.6\n\nGlobal Facts Other 37.0 38.0 39.0 29.0 35.0 35.0 39.0 40.0\n\nHigh School Biology STEM 48.0 71.3 80.3 34.5 52.6 67.7 73.9 82.9\n\nHigh School Chemistry STEM 33.0 47.8 58.1 28.1 28.6 41.9 40.4 44.8\n\nHigh School Computer Science STEM 39.0 54.0 58.0 31.0 48.0 60.0 67.0 73.0\n\nHigh School European History Humanities 54.0 72.1 78.8 44.2 61.8 73.9 78.8 86.1\n\nHigh School Geography Social Science 58.0 76.8 86.4 34.3 54.6 70.7 77.8 87.9\n\nHigh School Government And Politics Social Science 58.0 83.9 91.2 44.6 66.3 82.9 88.1 92.8\n\nHigh School Macroeconomics Social Science 40.5 65.1 70.5 35.4 44.4 56.9 65.9 69.2\n\nHigh School Mathematics STEM 28.0 23.7 31.9 24.8 23.7 27.0 34.4 37.0\n\nHigh School Microeconomics Social Science 42.0 66.4 77.7 31.9 47.5 55.5 68.9 78.6\n\nHigh School Physics STEM 28.0 33.8 36.4 26.5 28.5 35.8 37.1 41.7\n\nHigh School Psychology Social Science 61.0 81.8 86.6 47.3 60.9 76.2 82.2 87.9\n\nHigh School Statistics STEM 30.5 50.0 58.8 35.2 30.1 45.4 58.3 59.3\n\nHigh School Us History Humanities 53.0 78.9 83.3 39.7 58.3 77.9 83.8 90.7\n\nHigh School World History Humanities 56.0 75.1 85.2 40.9 66.2 79.3 83.1 89.0\n\nHuman Aging Other 50.0 66.4 77.6 40.8 54.7 67.7 69.5 72.2\n\nHuman Sexuality Social Science 54.0 67.2 86.3 36.6 58.8 64.1 77.9 87.0\n\nInternational Law Humanities 55.5 77.7 90.9 51.2 62.8 72.7 79.3 87.6\n\nJurisprudence Humanities 55.0 71.3 79.6 38.9 51.9 70.4 73.2 85.2\n\nLogical Fallacies Humanities 48.0 72.4 80.4 39.3 52.8 68.1 77.3 80.4\n\nMachine Learning STEM 31.0 41.1 41.1 23.2 31.3 39.3 49.1 52.7\n\nManagement Other 56.0 77.7 82.5 35.0 66.0 77.7 82.5 83.5\n\nMarketing Other 60.0 83.3 89.7 46.6 71.8 83.3 85.9 92.7\n\nMedical Genetics Other 40.0 69.0 69.0 43.0 52.0 67.0 67.0 68.0\n\nMiscellaneous Other 60.0 75.7 84.5 42.4 65.4 78.5 82.1 84.3\n\nMoral Disputes Humanities 44.5 66.8 77.5 40.2 50.9 66.2 72.3 76.9\n\nMoral Scenarios Humanities 26.0 40.2 36.5 24.3 30.1 38.2 48.9 55.9\n\nNutrition Other 47.0 69.9 77.1 37.6 51.6 62.8 67.3 74.5\n\nPhilosophy Humanities 51.0 68.8 79.4 39.9 54.0 66.2 74.0 79.1\n\nPrehistory Humanities 53.0 67.6 81.2 36.1 51.5 67.0 75.3 79.0\n\nProfessional Accounting Other 33.0 44.3 52.1 25.9 35.8 43.6 46.5 56.0\n\nProfessional Law Humanities 34.5 44.5 56.5 30.2 38.0 45.9 49.1 54.4\n\nProfessional Medicine Other 36.0 64.0 75.4 44.5 50.4 54.0 61.4 70.6\n\nProfessional Psychology Social Science 44.5 68.1 75.7 35.1 47.7 62.9 65.7 71.4\n\nPublic Relations Social Science 48.0 71.8 73.6 40.9 60.9 67.3 73.6 74.6\n\nSecurity Studies Social Science 52.0 64.9 75.9 31.8 53.9 65.3 71.8 77.6\n\nSociology Social Science 53.0 84.1 91.0 46.8 61.2 78.6 78.6 88.1\n\nUs Foreign Policy Social Science 69.0 81.0 92.0 46.0 80.0 83.0 86.0 87.0\n\nVirology Other 46.0 47.0 53.6 30.1 43.4 50.0 53.0 57.8\n\nWorld Religions Humanities 55.0 84.2 87.7 50.9 67.8 81.3 81.3 84.2\n\nHumanities 40.6 56.2 63.6 34.0 45.0 55.8 61.8 67.4\n\nSTEM 36.7 47.4 54.9 30.5 35.8 46.0 51.7 56.6\n\nSocial Science 50.5 71.9 79.3 38.3 53.8 66.7 72.9 79.2\n\nOthers 49.0 66.1 73.9 38.1 53.3 63.4 67.4 72.6\n\nAll 43.9 60.0 67.6 35.1 46.9 57.8 63.4 68.9\n\nTable 16: **MMLU.** Detailed 5-shot results per domain on the test sets.","publish_date":null,"title":"B MMLU","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llama_page18.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llama_page18.pdf"},"request":{"example_id":"table/llama_page18","product_type":"parse","source_file_path":"llama_page18.pdf"},"started_at":"2026-11-04T19:47:14.514256"} +{"completed_at":"2026-11-04T19:47:16.493203","latency_in_ms":1476,"output":{"example_id":"table/llama_page6","grounded_pages":[],"layout_pages":[],"markdown":"MATH +maj1@k GSM8k +maj1@k\n\nPaLM\n\n8B 1.5 - 4.1 -\n\n62B 4.4 - 33.0 -\n\n540B 8.8 - 56.5 -\n\nMinerva\n\n8B 14.1 25.4 16.2 28.4\n\n62B 27.6 43.4 52.4 68.5\n\n540B **33\\.6 50.3 68.5 78.5**\n\nLLaMA\n\n7B 2.9 6.9 11.0 18.1\n\n13B 3.9 8.8 17.8 29.3\n\n33B 7.1 15.2 35.6 53.1\n\n65B 10.6 20.5 50.9 69.7\n\nTable 7: **Model performance on quantitative reason- ing datasets.** For majority voting, we use the same setup as Minerva, with _k_ = 256 samples for MATH and _k_ = 100 for GSM8k (Minerva 540B uses _k_ = 64 for MATH and and _k_ = 40 for GSM8k). LLaMA-65B outperforms Minerva 62B on GSM8k, although it has not been fine-tuned on mathematical data.\n\ndocstring. The model needs to generate a Python program that fits the description and satisfies the test cases. In Table 8, we compare the pass@1 scores of our models with existing language mod- els that have not been finetuned on code, namely PaLM and LaMDA (Thoppilan et al., 2022). PaLM and LLaMA were trained on datasets that contain a similar number of code tokens.\n\nAs show in Table 8, for a similar number\n\nof parameters, LLaMA outperforms other gen- eral models such as LaMDA and PaLM, which are not trained or finetuned specifically for code. LLaMA with 13B parameters and more outper- forms LaMDA 137B on both HumanEval and MBPP. LLaMA 65B also outperforms PaLM 62B, even when it is trained longer. The pass@1 results reported in this table were obtained by sampling with temperature 0.1. The pass@100 and pass@80 metrics were obtained with temperature 0.8. We use the same method as Chen et al. (2021) to obtain unbiased estimates of the pass@k.\n\nIt is possible to greatly improve the performance\n\non code by finetuning models on code-specific to- kens. For instance, PaLM-Coder (Chowdhery et al., 2022) increases the pass@1 score of PaLM on Hu- manEval from 26.2% for PaLM to 36%. Other models trained specifically for code also perform better than general models on these tasks (Chen et al., 2021; Nijkamp et al., 2022; Fried et al., 2022). Finetuning on code tokens is, however, beyond the\n\nscope of this paper.\n\nParams HumanEval MBPP\n\npass@ @1 @100 @1 @80\n\nLaMDA 137B 14.0 47.3 14.8 62.4\n\nPaLM 8B 3.6 _→_ 18\\.7 _→_ 5\\.0 _→_ 35\\.7 _→_\n\nPaLM 62B 15.9 46.3 _→_ 21\\.4 63.2 _→_\n\nPaLM-cont 62B 23.7 - 31.2 -\n\nPaLM 540B **26\\.2** 76\\.2 36.8 75.0\n\nLLaMA\n\n7B 10.5 36.5 17.7 56.2\n\n13B 15.8 52.5 22.0 64.0\n\n33B 21.7 70.7 30.2 73.4\n\n65B 23.7 **79\\.3 37.7 76.8**\n\nTable 8: **Model performance for code generation.** We report the pass@ score on HumanEval and MBPP. Hu- manEval generations are done in zero-shot and MBBP with 3-shot prompts similar to Austin et al. (2021). The values marked with _→_ are read from figures in Chowdh- ery et al. (2022).\n\n**3\\.6 Massive Multitask Language Understanding**\n\nThe massive multitask language understanding benchmark, or MMLU, introduced by Hendrycks et al. (2020) consists of multiple choice questions covering various domains of knowledge, includ- ing humanities, STEM and social sciences. We evaluate our models in the 5-shot setting, using the examples provided by the benchmark, and report results in Table 9. On this benchmark, we observe that the LLaMA-65B is behind both Chinchilla- 70B and PaLM-540B by a few percent in average, and across most domains. A potential explanation is that we have used a limited amount of books and academic papers in our pre-training data, i.e., ArXiv, Gutenberg and Books3, that sums up to only 177GB, while these models were trained on up to 2TB of books. This large quantity of books used by Gopher, Chinchilla and PaLM may also explain why Gopher outperforms GPT-3 on this benchmark, while it is comparable on other benchmarks.\n\n**3\\.7 Evolution of performance during training**\n\nDuring training, we tracked the performance of our models on a few question answering and common sense benchmarks, and report them in Figure 2. On most benchmarks, the performance improves steadily, and correlates with the training perplexity of the model (see Figure 1). The exceptions are SIQA and WinoGrande. Most notably, on SIQA,","pages":[{"line_numbers":[],"markdown":"MATH +maj1@k GSM8k +maj1@k\n\nPaLM\n\n8B 1.5 - 4.1 -\n\n62B 4.4 - 33.0 -\n\n540B 8.8 - 56.5 -\n\nMinerva\n\n8B 14.1 25.4 16.2 28.4\n\n62B 27.6 43.4 52.4 68.5\n\n540B **33\\.6 50.3 68.5 78.5**\n\nLLaMA\n\n7B 2.9 6.9 11.0 18.1\n\n13B 3.9 8.8 17.8 29.3\n\n33B 7.1 15.2 35.6 53.1\n\n65B 10.6 20.5 50.9 69.7\n\nTable 7: **Model performance on quantitative reason- ing datasets.** For majority voting, we use the same setup as Minerva, with _k_ = 256 samples for MATH and _k_ = 100 for GSM8k (Minerva 540B uses _k_ = 64 for MATH and and _k_ = 40 for GSM8k). LLaMA-65B outperforms Minerva 62B on GSM8k, although it has not been fine-tuned on mathematical data.\n\ndocstring. The model needs to generate a Python program that fits the description and satisfies the test cases. In Table 8, we compare the pass@1 scores of our models with existing language mod- els that have not been finetuned on code, namely PaLM and LaMDA (Thoppilan et al., 2022). PaLM and LLaMA were trained on datasets that contain a similar number of code tokens.\n\nAs show in Table 8, for a similar number\n\nof parameters, LLaMA outperforms other gen- eral models such as LaMDA and PaLM, which are not trained or finetuned specifically for code. LLaMA with 13B parameters and more outper- forms LaMDA 137B on both HumanEval and MBPP. LLaMA 65B also outperforms PaLM 62B, even when it is trained longer. The pass@1 results reported in this table were obtained by sampling with temperature 0.1. The pass@100 and pass@80 metrics were obtained with temperature 0.8. We use the same method as Chen et al. (2021) to obtain unbiased estimates of the pass@k.\n\nIt is possible to greatly improve the performance\n\non code by finetuning models on code-specific to- kens. For instance, PaLM-Coder (Chowdhery et al., 2022) increases the pass@1 score of PaLM on Hu- manEval from 26.2% for PaLM to 36%. Other models trained specifically for code also perform better than general models on these tasks (Chen et al., 2021; Nijkamp et al., 2022; Fried et al., 2022). Finetuning on code tokens is, however, beyond the\n\nscope of this paper.\n\nParams HumanEval MBPP\n\npass@ @1 @100 @1 @80\n\nLaMDA 137B 14.0 47.3 14.8 62.4\n\nPaLM 8B 3.6 _→_ 18\\.7 _→_ 5\\.0 _→_ 35\\.7 _→_\n\nPaLM 62B 15.9 46.3 _→_ 21\\.4 63.2 _→_\n\nPaLM-cont 62B 23.7 - 31.2 -\n\nPaLM 540B **26\\.2** 76\\.2 36.8 75.0\n\nLLaMA\n\n7B 10.5 36.5 17.7 56.2\n\n13B 15.8 52.5 22.0 64.0\n\n33B 21.7 70.7 30.2 73.4\n\n65B 23.7 **79\\.3 37.7 76.8**\n\nTable 8: **Model performance for code generation.** We report the pass@ score on HumanEval and MBPP. Hu- manEval generations are done in zero-shot and MBBP with 3-shot prompts similar to Austin et al. (2021). The values marked with _→_ are read from figures in Chowdh- ery et al. (2022).\n\n**3\\.6 Massive Multitask Language Understanding**\n\nThe massive multitask language understanding benchmark, or MMLU, introduced by Hendrycks et al. (2020) consists of multiple choice questions covering various domains of knowledge, includ- ing humanities, STEM and social sciences. We evaluate our models in the 5-shot setting, using the examples provided by the benchmark, and report results in Table 9. On this benchmark, we observe that the LLaMA-65B is behind both Chinchilla- 70B and PaLM-540B by a few percent in average, and across most domains. A potential explanation is that we have used a limited amount of books and academic papers in our pre-training data, i.e., ArXiv, Gutenberg and Books3, that sums up to only 177GB, while these models were trained on up to 2TB of books. This large quantity of books used by Gopher, Chinchilla and PaLM may also explain why Gopher outperforms GPT-3 on this benchmark, while it is comparable on other benchmarks.\n\n**3\\.7 Evolution of performance during training**\n\nDuring training, we tracked the performance of our models on a few question answering and common sense benchmarks, and report them in Figure 2. On most benchmarks, the performance improves steadily, and correlates with the training perplexity of the model (see Figure 1). The exceptions are SIQA and WinoGrande. Most notably, on SIQA,","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"MATH +maj1@k GSM8k +maj1@k\n\nPaLM\n\n8B 1.5 - 4.1 -\n\n62B 4.4 - 33.0 -\n\n540B 8.8 - 56.5 -\n\nMinerva\n\n8B 14.1 25.4 16.2 28.4\n\n62B 27.6 43.4 52.4 68.5\n\n540B **33\\.6 50.3 68.5 78.5**\n\nLLaMA\n\n7B 2.9 6.9 11.0 18.1\n\n13B 3.9 8.8 17.8 29.3\n\n33B 7.1 15.2 35.6 53.1\n\n65B 10.6 20.5 50.9 69.7\n\nTable 7: **Model performance on quantitative reason- ing datasets.** For majority voting, we use the same setup as Minerva, with _k_ = 256 samples for MATH and _k_ = 100 for GSM8k (Minerva 540B uses _k_ = 64 for MATH and and _k_ = 40 for GSM8k). LLaMA-65B outperforms Minerva 62B on GSM8k, although it has not been fine-tuned on mathematical data.\n\ndocstring. The model needs to generate a Python program that fits the description and satisfies the test cases. In Table 8, we compare the pass@1 scores of our models with existing language mod- els that have not been finetuned on code, namely PaLM and LaMDA (Thoppilan et al., 2022). PaLM and LLaMA were trained on datasets that contain a similar number of code tokens.\n\nAs show in Table 8, for a similar number\n\nof parameters, LLaMA outperforms other gen- eral models such as LaMDA and PaLM, which are not trained or finetuned specifically for code. LLaMA with 13B parameters and more outper- forms LaMDA 137B on both HumanEval and MBPP. LLaMA 65B also outperforms PaLM 62B, even when it is trained longer. The pass@1 results reported in this table were obtained by sampling with temperature 0.1. The pass@100 and pass@80 metrics were obtained with temperature 0.8. We use the same method as Chen et al. (2021) to obtain unbiased estimates of the pass@k.\n\nIt is possible to greatly improve the performance\n\non code by finetuning models on code-specific to- kens. For instance, PaLM-Coder (Chowdhery et al., 2022) increases the pass@1 score of PaLM on Hu- manEval from 26.2% for PaLM to 36%. Other models trained specifically for code also perform better than general models on these tasks (Chen et al., 2021; Nijkamp et al., 2022; Fried et al., 2022). Finetuning on code tokens is, however, beyond the\n\nscope of this paper.\n\nParams HumanEval MBPP\n\npass@ @1 @100 @1 @80\n\nLaMDA 137B 14.0 47.3 14.8 62.4\n\nPaLM 8B 3.6 _→_ 18\\.7 _→_ 5\\.0 _→_ 35\\.7 _→_\n\nPaLM 62B 15.9 46.3 _→_ 21\\.4 63.2 _→_\n\nPaLM-cont 62B 23.7 - 31.2 -\n\nPaLM 540B **26\\.2** 76\\.2 36.8 75.0\n\nLLaMA\n\n7B 10.5 36.5 17.7 56.2\n\n13B 15.8 52.5 22.0 64.0\n\n33B 21.7 70.7 30.2 73.4\n\n65B 23.7 **79\\.3 37.7 76.8**\n\nTable 8: **Model performance for code generation.** We report the pass@ score on HumanEval and MBPP. Hu- manEval generations are done in zero-shot and MBBP with 3-shot prompts similar to Austin et al. (2021). The values marked with _→_ are read from figures in Chowdh- ery et al. (2022).\n\n**3\\.6 Massive Multitask Language Understanding**\n\nThe massive multitask language understanding benchmark, or MMLU, introduced by Hendrycks et al. (2020) consists of multiple choice questions covering various domains of knowledge, includ- ing humanities, STEM and social sciences. We evaluate our models in the 5-shot setting, using the examples provided by the benchmark, and report results in Table 9. On this benchmark, we observe that the LLaMA-65B is behind both Chinchilla- 70B and PaLM-540B by a few percent in average, and across most domains. A potential explanation is that we have used a limited amount of books and academic papers in our pre-training data, i.e., ArXiv, Gutenberg and Books3, that sums up to only 177GB, while these models were trained on up to 2TB of books. This large quantity of books used by Gopher, Chinchilla and PaLM may also explain why Gopher outperforms GPT-3 on this benchmark, while it is comparable on other benchmarks.\n\n**3\\.7 Evolution of performance during training**\n\nDuring training, we tracked the performance of our models on a few question answering and common sense benchmarks, and report them in Figure 2. On most benchmarks, the performance improves steadily, and correlates with the training perplexity of the model (see Figure 1). The exceptions are SIQA and WinoGrande. Most notably, on SIQA,","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llama_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_25438eac541239dcbf73b31fe4f1739d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["MATH +maj1@k GSM8k +maj1@k\n\nPaLM\n\n8B 1.5 - 4.1 -\n\n62B 4.4 - 33.0 -\n\n540B 8.8 - 56.5 -\n\nMinerva\n\n8B 14.1 25.4 16.2 28.4\n\n62B 27.6 43.4 52.4 68.5\n\n540B **33\\.6 50.3 68.5 78.5**\n\nLLaMA\n\n7B 2.9 6.9 11.0 18.1\n\n13B 3.9 8.8 17.8 29.3\n\n33B 7.1 15.2 35.6 53.1\n\n65B 10.6 20.5 50.9 69.7\n\nTable 7: **Model performance on quantitative reason- ing datasets.** For majority voting, we use the same setup as Minerva, with _k_ = 256 samples for MATH and _k_ = 100 for GSM8k (Minerva 540B uses _k_ = 64 for MATH and and _k_ = 40 for GSM8k). LLaMA-65B outperforms Minerva 62B on GSM8k, although it has not been fine-tuned on mathematical data.\n\ndocstring. The model needs to generate a Python program that fits the description and satisfies the test cases. In Table 8, we compare the pass@1 scores of our models with existing language mod- els that have not been finetuned on code, namely PaLM and LaMDA (Thoppilan et al., 2022). PaLM and LLaMA were trained on datasets that contain a similar number of code tokens.\n\nAs show in Table 8, for a similar number\n\nof parameters, LLaMA outperforms other gen- eral models such as LaMDA and PaLM, which are not trained or finetuned specifically for code. LLaMA with 13B parameters and more outper- forms LaMDA 137B on both HumanEval and MBPP. LLaMA 65B also outperforms PaLM 62B, even when it is trained longer. The pass@1 results reported in this table were obtained by sampling with temperature 0.1. The pass@100 and pass@80 metrics were obtained with temperature 0.8. We use the same method as Chen et al. (2021) to obtain unbiased estimates of the pass@k.\n\nIt is possible to greatly improve the performance\n\non code by finetuning models on code-specific to- kens. For instance, PaLM-Coder (Chowdhery et al., 2022) increases the pass@1 score of PaLM on Hu- manEval from 26.2% for PaLM to 36%. Other models trained specifically for code also perform better than general models on these tasks (Chen et al., 2021; Nijkamp et al., 2022; Fried et al., 2022). Finetuning on code tokens is, however, beyond the\n\nscope of this paper.\n\nParams HumanEval MBPP\n\npass@ @1 @100 @1 @80\n\nLaMDA 137B 14.0 47.3 14.8 62.4\n\nPaLM 8B 3.6 _→_ 18\\.7 _→_ 5\\.0 _→_ 35\\.7 _→_\n\nPaLM 62B 15.9 46.3 _→_ 21\\.4 63.2 _→_\n\nPaLM-cont 62B 23.7 - 31.2 -\n\nPaLM 540B **26\\.2** 76\\.2 36.8 75.0\n\nLLaMA\n\n7B 10.5 36.5 17.7 56.2\n\n13B 15.8 52.5 22.0 64.0\n\n33B 21.7 70.7 30.2 73.4\n\n65B 23.7 **79\\.3 37.7 76.8**\n\nTable 8: **Model performance for code generation.** We report the pass@ score on HumanEval and MBPP. Hu- manEval generations are done in zero-shot and MBBP with 3-shot prompts similar to Austin et al. (2021). The values marked with _→_ are read from figures in Chowdh- ery et al. (2022).\n\n**3\\.6 Massive Multitask Language Understanding**\n\nThe massive multitask language understanding benchmark, or MMLU, introduced by Hendrycks et al. (2020) consists of multiple choice questions covering various domains of knowledge, includ- ing humanities, STEM and social sciences. We evaluate our models in the 5-shot setting, using the examples provided by the benchmark, and report results in Table 9. On this benchmark, we observe that the LLaMA-65B is behind both Chinchilla- 70B and PaLM-540B by a few percent in average, and across most domains. A potential explanation is that we have used a limited amount of books and academic papers in our pre-training data, i.e., ArXiv, Gutenberg and Books3, that sums up to only 177GB, while these models were trained on up to 2TB of books. This large quantity of books used by Gopher, Chinchilla and PaLM may also explain why Gopher outperforms GPT-3 on this benchmark, while it is comparable on other benchmarks.\n\n**3\\.7 Evolution of performance during training**\n\nDuring training, we tracked the performance of our models on a few question answering and common sense benchmarks, and report them in Figure 2. On most benchmarks, the performance improves steadily, and correlates with the training perplexity of the model (see Figure 1). The exceptions are SIQA and WinoGrande. Most notably, on SIQA,"],"full_content":"MATH +maj1@k GSM8k +maj1@k\n\nPaLM\n\n8B 1.5 - 4.1 -\n\n62B 4.4 - 33.0 -\n\n540B 8.8 - 56.5 -\n\nMinerva\n\n8B 14.1 25.4 16.2 28.4\n\n62B 27.6 43.4 52.4 68.5\n\n540B **33\\.6 50.3 68.5 78.5**\n\nLLaMA\n\n7B 2.9 6.9 11.0 18.1\n\n13B 3.9 8.8 17.8 29.3\n\n33B 7.1 15.2 35.6 53.1\n\n65B 10.6 20.5 50.9 69.7\n\nTable 7: **Model performance on quantitative reason- ing datasets.** For majority voting, we use the same setup as Minerva, with _k_ = 256 samples for MATH and _k_ = 100 for GSM8k (Minerva 540B uses _k_ = 64 for MATH and and _k_ = 40 for GSM8k). LLaMA-65B outperforms Minerva 62B on GSM8k, although it has not been fine-tuned on mathematical data.\n\ndocstring. The model needs to generate a Python program that fits the description and satisfies the test cases. In Table 8, we compare the pass@1 scores of our models with existing language mod- els that have not been finetuned on code, namely PaLM and LaMDA (Thoppilan et al., 2022). PaLM and LLaMA were trained on datasets that contain a similar number of code tokens.\n\nAs show in Table 8, for a similar number\n\nof parameters, LLaMA outperforms other gen- eral models such as LaMDA and PaLM, which are not trained or finetuned specifically for code. LLaMA with 13B parameters and more outper- forms LaMDA 137B on both HumanEval and MBPP. LLaMA 65B also outperforms PaLM 62B, even when it is trained longer. The pass@1 results reported in this table were obtained by sampling with temperature 0.1. The pass@100 and pass@80 metrics were obtained with temperature 0.8. We use the same method as Chen et al. (2021) to obtain unbiased estimates of the pass@k.\n\nIt is possible to greatly improve the performance\n\non code by finetuning models on code-specific to- kens. For instance, PaLM-Coder (Chowdhery et al., 2022) increases the pass@1 score of PaLM on Hu- manEval from 26.2% for PaLM to 36%. Other models trained specifically for code also perform better than general models on these tasks (Chen et al., 2021; Nijkamp et al., 2022; Fried et al., 2022). Finetuning on code tokens is, however, beyond the\n\nscope of this paper.\n\nParams HumanEval MBPP\n\npass@ @1 @100 @1 @80\n\nLaMDA 137B 14.0 47.3 14.8 62.4\n\nPaLM 8B 3.6 _→_ 18\\.7 _→_ 5\\.0 _→_ 35\\.7 _→_\n\nPaLM 62B 15.9 46.3 _→_ 21\\.4 63.2 _→_\n\nPaLM-cont 62B 23.7 - 31.2 -\n\nPaLM 540B **26\\.2** 76\\.2 36.8 75.0\n\nLLaMA\n\n7B 10.5 36.5 17.7 56.2\n\n13B 15.8 52.5 22.0 64.0\n\n33B 21.7 70.7 30.2 73.4\n\n65B 23.7 **79\\.3 37.7 76.8**\n\nTable 8: **Model performance for code generation.** We report the pass@ score on HumanEval and MBPP. Hu- manEval generations are done in zero-shot and MBBP with 3-shot prompts similar to Austin et al. (2021). The values marked with _→_ are read from figures in Chowdh- ery et al. (2022).\n\n**3\\.6 Massive Multitask Language Understanding**\n\nThe massive multitask language understanding benchmark, or MMLU, introduced by Hendrycks et al. (2020) consists of multiple choice questions covering various domains of knowledge, includ- ing humanities, STEM and social sciences. We evaluate our models in the 5-shot setting, using the examples provided by the benchmark, and report results in Table 9. On this benchmark, we observe that the LLaMA-65B is behind both Chinchilla- 70B and PaLM-540B by a few percent in average, and across most domains. A potential explanation is that we have used a limited amount of books and academic papers in our pre-training data, i.e., ArXiv, Gutenberg and Books3, that sums up to only 177GB, while these models were trained on up to 2TB of books. This large quantity of books used by Gopher, Chinchilla and PaLM may also explain why Gopher outperforms GPT-3 on this benchmark, while it is comparable on other benchmarks.\n\n**3\\.7 Evolution of performance during training**\n\nDuring training, we tracked the performance of our models on a few question answering and common sense benchmarks, and report them in Figure 2. On most benchmarks, the performance improves steadily, and correlates with the training perplexity of the model (see Figure 1). The exceptions are SIQA and WinoGrande. Most notably, on SIQA,","publish_date":null,"title":"scopeofthispaper. MATH GSM8k 8B 1.5 - 4.1 - Params HumanEval MBPP PaLM 62B 4.4 - 33.0 - pass@ @1 @100","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llama_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llama_page6.pdf"},"request":{"example_id":"table/llama_page6","product_type":"parse","source_file_path":"llama_page6.pdf"},"started_at":"2026-11-04T19:47:15.017202"} +{"completed_at":"2026-11-04T19:47:18.650352","latency_in_ms":2148,"output":{"example_id":"table/llama_page7","grounded_pages":[],"layout_pages":[],"markdown":"Humanities STEM Social Sciences Other Average\n\nGPT-NeoX 20B 29.8 34.9 33.7 37.7 33.6\n\nGPT-3 175B 40.8 36.7 50.4 48.8 43.9\n\nGopher 280B 56.2 47.4 71.9 66.1 60.0\n\nChinchilla 70B 63.6 54.9 79.3 **73\\.9** 67\\.5\n\nPaLM\n\n8B 25.6 23.8 24.1 27.8 25.4\n\n62B 59.5 41.9 62.7 55.8 53.7\n\n540B **77\\.0 55.6 81.0** 69\\.6 **69\\.3**\n\nLLaMA\n\n7B 34.0 30.5 38.3 38.1 35.1\n\n13B 45.0 35.8 53.8 53.3 46.9\n\n33B 55.8 46.0 66.7 63.4 57.8\n\n65B 61.8 51.7 72.9 67.4 63.4\n\nTable 9: **Massive Multitask Language Understanding (MMLU).** Five-shot accuracy.\n\nwe observe a lot of variance in performance, that may indicate that this benchmark is not reliable. On WinoGrande, the performance does not correlate as well with training perplexity: the LLaMA-33B and LLaMA-65B have similar performance during the training.\n\n**4 Instruction Finetuning**\n\nIn this section, we show that briefly finetuning on instructions data rapidly leads to improvements on MMLU. Although the non-finetuned version of LLaMA-65B is already able to follow basic in- structions, we observe that a very small amount of finetuning improves the performance on MMLU, and further improves the ability of the model to follow instructions. Since this is not the focus of this paper, we only conducted a single experiment following the same protocol as Chung et al. (2022) to train an instruct model, LLaMA-I.\n\nIn Table 10, we report the results of our instruct\n\nmodel LLaMA-I on MMLU and compare with ex- isting instruction finetuned models of moderate sizes, namely, OPT-IML (Iyer et al., 2022) and the Flan-PaLM series (Chung et al., 2022). All the re- ported numbers are from the corresponding papers. Despite the simplicity of the instruction finetuning approach used here, we reach 68.9% on MMLU. LLaMA-I (65B) outperforms on MMLU existing instruction finetuned models of moderate sizes, but are still far from the state-of-the-art, that is 77.4 for GPT code-davinci-002 on MMLU (numbers taken from Iyer et al. (2022)). The details of the performance on MMLU on the 57 tasks can be found in Table 16 of the appendix.\n\nOPT 30B 26.1\n\nGLM 120B 44.8\n\nPaLM 62B 55.1\n\nPaLM-cont 62B 62.8\n\nChinchilla 70B 67.5\n\nLLaMA 65B 63.4\n\nOPT-IML-Max 30B 43.2\n\nFlan-T5-XXL 11B 55.1\n\nFlan-PaLM 62B 59.6\n\nFlan-PaLM-cont 62B 66.1\n\nLLaMA-I 65B **68\\.9**\n\nTable 10: **Instruction finetuning – MMLU (5-shot).** Comparison of models of moderate size with and with- out instruction finetuning on MMLU.\n\n**5 Bias, Toxicity and Misinformation**\n\nLarge language models have been showed to re- produce and amplify biases that are existing in the training data (Sheng et al., 2019; Kurita et al., 2019), and to generate toxic or offensive con- tent (Gehman et al., 2020). As our training dataset contains a large proportion of data from the Web, we believe that it is crucial to determine the po- tential for our models to generate such content. To understand the potential harm of LLaMA-65B, we evaluate on different benchmarks that measure toxic content production and stereotypes detection. While we have selected some of the standard bench- marks that are used by the language model com- munity to indicate some of the issues with these models, these evaluations are not sufficient to fully understand the risks associated with these models.","pages":[{"line_numbers":[],"markdown":"Humanities STEM Social Sciences Other Average\n\nGPT-NeoX 20B 29.8 34.9 33.7 37.7 33.6\n\nGPT-3 175B 40.8 36.7 50.4 48.8 43.9\n\nGopher 280B 56.2 47.4 71.9 66.1 60.0\n\nChinchilla 70B 63.6 54.9 79.3 **73\\.9** 67\\.5\n\nPaLM\n\n8B 25.6 23.8 24.1 27.8 25.4\n\n62B 59.5 41.9 62.7 55.8 53.7\n\n540B **77\\.0 55.6 81.0** 69\\.6 **69\\.3**\n\nLLaMA\n\n7B 34.0 30.5 38.3 38.1 35.1\n\n13B 45.0 35.8 53.8 53.3 46.9\n\n33B 55.8 46.0 66.7 63.4 57.8\n\n65B 61.8 51.7 72.9 67.4 63.4\n\nTable 9: **Massive Multitask Language Understanding (MMLU).** Five-shot accuracy.\n\nwe observe a lot of variance in performance, that may indicate that this benchmark is not reliable. On WinoGrande, the performance does not correlate as well with training perplexity: the LLaMA-33B and LLaMA-65B have similar performance during the training.\n\n**4 Instruction Finetuning**\n\nIn this section, we show that briefly finetuning on instructions data rapidly leads to improvements on MMLU. Although the non-finetuned version of LLaMA-65B is already able to follow basic in- structions, we observe that a very small amount of finetuning improves the performance on MMLU, and further improves the ability of the model to follow instructions. Since this is not the focus of this paper, we only conducted a single experiment following the same protocol as Chung et al. (2022) to train an instruct model, LLaMA-I.\n\nIn Table 10, we report the results of our instruct\n\nmodel LLaMA-I on MMLU and compare with ex- isting instruction finetuned models of moderate sizes, namely, OPT-IML (Iyer et al., 2022) and the Flan-PaLM series (Chung et al., 2022). All the re- ported numbers are from the corresponding papers. Despite the simplicity of the instruction finetuning approach used here, we reach 68.9% on MMLU. LLaMA-I (65B) outperforms on MMLU existing instruction finetuned models of moderate sizes, but are still far from the state-of-the-art, that is 77.4 for GPT code-davinci-002 on MMLU (numbers taken from Iyer et al. (2022)). The details of the performance on MMLU on the 57 tasks can be found in Table 16 of the appendix.\n\nOPT 30B 26.1\n\nGLM 120B 44.8\n\nPaLM 62B 55.1\n\nPaLM-cont 62B 62.8\n\nChinchilla 70B 67.5\n\nLLaMA 65B 63.4\n\nOPT-IML-Max 30B 43.2\n\nFlan-T5-XXL 11B 55.1\n\nFlan-PaLM 62B 59.6\n\nFlan-PaLM-cont 62B 66.1\n\nLLaMA-I 65B **68\\.9**\n\nTable 10: **Instruction finetuning – MMLU (5-shot).** Comparison of models of moderate size with and with- out instruction finetuning on MMLU.\n\n**5 Bias, Toxicity and Misinformation**\n\nLarge language models have been showed to re- produce and amplify biases that are existing in the training data (Sheng et al., 2019; Kurita et al., 2019), and to generate toxic or offensive con- tent (Gehman et al., 2020). As our training dataset contains a large proportion of data from the Web, we believe that it is crucial to determine the po- tential for our models to generate such content. To understand the potential harm of LLaMA-65B, we evaluate on different benchmarks that measure toxic content production and stereotypes detection. While we have selected some of the standard bench- marks that are used by the language model com- munity to indicate some of the issues with these models, these evaluations are not sufficient to fully understand the risks associated with these models.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Humanities STEM Social Sciences Other Average\n\nGPT-NeoX 20B 29.8 34.9 33.7 37.7 33.6\n\nGPT-3 175B 40.8 36.7 50.4 48.8 43.9\n\nGopher 280B 56.2 47.4 71.9 66.1 60.0\n\nChinchilla 70B 63.6 54.9 79.3 **73\\.9** 67\\.5\n\nPaLM\n\n8B 25.6 23.8 24.1 27.8 25.4\n\n62B 59.5 41.9 62.7 55.8 53.7\n\n540B **77\\.0 55.6 81.0** 69\\.6 **69\\.3**\n\nLLaMA\n\n7B 34.0 30.5 38.3 38.1 35.1\n\n13B 45.0 35.8 53.8 53.3 46.9\n\n33B 55.8 46.0 66.7 63.4 57.8\n\n65B 61.8 51.7 72.9 67.4 63.4\n\nTable 9: **Massive Multitask Language Understanding (MMLU).** Five-shot accuracy.\n\nwe observe a lot of variance in performance, that may indicate that this benchmark is not reliable. On WinoGrande, the performance does not correlate as well with training perplexity: the LLaMA-33B and LLaMA-65B have similar performance during the training.\n\n**4 Instruction Finetuning**\n\nIn this section, we show that briefly finetuning on instructions data rapidly leads to improvements on MMLU. Although the non-finetuned version of LLaMA-65B is already able to follow basic in- structions, we observe that a very small amount of finetuning improves the performance on MMLU, and further improves the ability of the model to follow instructions. Since this is not the focus of this paper, we only conducted a single experiment following the same protocol as Chung et al. (2022) to train an instruct model, LLaMA-I.\n\nIn Table 10, we report the results of our instruct\n\nmodel LLaMA-I on MMLU and compare with ex- isting instruction finetuned models of moderate sizes, namely, OPT-IML (Iyer et al., 2022) and the Flan-PaLM series (Chung et al., 2022). All the re- ported numbers are from the corresponding papers. Despite the simplicity of the instruction finetuning approach used here, we reach 68.9% on MMLU. LLaMA-I (65B) outperforms on MMLU existing instruction finetuned models of moderate sizes, but are still far from the state-of-the-art, that is 77.4 for GPT code-davinci-002 on MMLU (numbers taken from Iyer et al. (2022)). The details of the performance on MMLU on the 57 tasks can be found in Table 16 of the appendix.\n\nOPT 30B 26.1\n\nGLM 120B 44.8\n\nPaLM 62B 55.1\n\nPaLM-cont 62B 62.8\n\nChinchilla 70B 67.5\n\nLLaMA 65B 63.4\n\nOPT-IML-Max 30B 43.2\n\nFlan-T5-XXL 11B 55.1\n\nFlan-PaLM 62B 59.6\n\nFlan-PaLM-cont 62B 66.1\n\nLLaMA-I 65B **68\\.9**\n\nTable 10: **Instruction finetuning – MMLU (5-shot).** Comparison of models of moderate size with and with- out instruction finetuning on MMLU.\n\n**5 Bias, Toxicity and Misinformation**\n\nLarge language models have been showed to re- produce and amplify biases that are existing in the training data (Sheng et al., 2019; Kurita et al., 2019), and to generate toxic or offensive con- tent (Gehman et al., 2020). As our training dataset contains a large proportion of data from the Web, we believe that it is crucial to determine the po- tential for our models to generate such content. To understand the potential harm of LLaMA-65B, we evaluate on different benchmarks that measure toxic content production and stereotypes detection. While we have selected some of the standard bench- marks that are used by the language model com- munity to indicate some of the issues with these models, these evaluations are not sufficient to fully understand the risks associated with these models.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llama_page7.pdf"]},"response":{"errors":[],"extract_id":"extract_1ed34989a25c22d0020268f92947ed13","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Humanities STEM Social Sciences Other Average\n\nGPT-NeoX 20B 29.8 34.9 33.7 37.7 33.6\n\nGPT-3 175B 40.8 36.7 50.4 48.8 43.9\n\nGopher 280B 56.2 47.4 71.9 66.1 60.0\n\nChinchilla 70B 63.6 54.9 79.3 **73\\.9** 67\\.5\n\nPaLM\n\n8B 25.6 23.8 24.1 27.8 25.4\n\n62B 59.5 41.9 62.7 55.8 53.7\n\n540B **77\\.0 55.6 81.0** 69\\.6 **69\\.3**\n\nLLaMA\n\n7B 34.0 30.5 38.3 38.1 35.1\n\n13B 45.0 35.8 53.8 53.3 46.9\n\n33B 55.8 46.0 66.7 63.4 57.8\n\n65B 61.8 51.7 72.9 67.4 63.4\n\nTable 9: **Massive Multitask Language Understanding (MMLU).** Five-shot accuracy.\n\nwe observe a lot of variance in performance, that may indicate that this benchmark is not reliable. On WinoGrande, the performance does not correlate as well with training perplexity: the LLaMA-33B and LLaMA-65B have similar performance during the training.\n\n**4 Instruction Finetuning**\n\nIn this section, we show that briefly finetuning on instructions data rapidly leads to improvements on MMLU. Although the non-finetuned version of LLaMA-65B is already able to follow basic in- structions, we observe that a very small amount of finetuning improves the performance on MMLU, and further improves the ability of the model to follow instructions. Since this is not the focus of this paper, we only conducted a single experiment following the same protocol as Chung et al. (2022) to train an instruct model, LLaMA-I.\n\nIn Table 10, we report the results of our instruct\n\nmodel LLaMA-I on MMLU and compare with ex- isting instruction finetuned models of moderate sizes, namely, OPT-IML (Iyer et al., 2022) and the Flan-PaLM series (Chung et al., 2022). All the re- ported numbers are from the corresponding papers. Despite the simplicity of the instruction finetuning approach used here, we reach 68.9% on MMLU. LLaMA-I (65B) outperforms on MMLU existing instruction finetuned models of moderate sizes, but are still far from the state-of-the-art, that is 77.4 for GPT code-davinci-002 on MMLU (numbers taken from Iyer et al. (2022)). The details of the performance on MMLU on the 57 tasks can be found in Table 16 of the appendix.\n\nOPT 30B 26.1\n\nGLM 120B 44.8\n\nPaLM 62B 55.1\n\nPaLM-cont 62B 62.8\n\nChinchilla 70B 67.5\n\nLLaMA 65B 63.4\n\nOPT-IML-Max 30B 43.2\n\nFlan-T5-XXL 11B 55.1\n\nFlan-PaLM 62B 59.6\n\nFlan-PaLM-cont 62B 66.1\n\nLLaMA-I 65B **68\\.9**\n\nTable 10: **Instruction finetuning – MMLU (5-shot).** Comparison of models of moderate size with and with- out instruction finetuning on MMLU.\n\n**5 Bias, Toxicity and Misinformation**\n\nLarge language models have been showed to re- produce and amplify biases that are existing in the training data (Sheng et al., 2019; Kurita et al., 2019), and to generate toxic or offensive con- tent (Gehman et al., 2020). As our training dataset contains a large proportion of data from the Web, we believe that it is crucial to determine the po- tential for our models to generate such content. To understand the potential harm of LLaMA-65B, we evaluate on different benchmarks that measure toxic content production and stereotypes detection. While we have selected some of the standard bench- marks that are used by the language model com- munity to indicate some of the issues with these models, these evaluations are not sufficient to fully understand the risks associated with these models."],"full_content":"Humanities STEM Social Sciences Other Average\n\nGPT-NeoX 20B 29.8 34.9 33.7 37.7 33.6\n\nGPT-3 175B 40.8 36.7 50.4 48.8 43.9\n\nGopher 280B 56.2 47.4 71.9 66.1 60.0\n\nChinchilla 70B 63.6 54.9 79.3 **73\\.9** 67\\.5\n\nPaLM\n\n8B 25.6 23.8 24.1 27.8 25.4\n\n62B 59.5 41.9 62.7 55.8 53.7\n\n540B **77\\.0 55.6 81.0** 69\\.6 **69\\.3**\n\nLLaMA\n\n7B 34.0 30.5 38.3 38.1 35.1\n\n13B 45.0 35.8 53.8 53.3 46.9\n\n33B 55.8 46.0 66.7 63.4 57.8\n\n65B 61.8 51.7 72.9 67.4 63.4\n\nTable 9: **Massive Multitask Language Understanding (MMLU).** Five-shot accuracy.\n\nwe observe a lot of variance in performance, that may indicate that this benchmark is not reliable. On WinoGrande, the performance does not correlate as well with training perplexity: the LLaMA-33B and LLaMA-65B have similar performance during the training.\n\n**4 Instruction Finetuning**\n\nIn this section, we show that briefly finetuning on instructions data rapidly leads to improvements on MMLU. Although the non-finetuned version of LLaMA-65B is already able to follow basic in- structions, we observe that a very small amount of finetuning improves the performance on MMLU, and further improves the ability of the model to follow instructions. Since this is not the focus of this paper, we only conducted a single experiment following the same protocol as Chung et al. (2022) to train an instruct model, LLaMA-I.\n\nIn Table 10, we report the results of our instruct\n\nmodel LLaMA-I on MMLU and compare with ex- isting instruction finetuned models of moderate sizes, namely, OPT-IML (Iyer et al., 2022) and the Flan-PaLM series (Chung et al., 2022). All the re- ported numbers are from the corresponding papers. Despite the simplicity of the instruction finetuning approach used here, we reach 68.9% on MMLU. LLaMA-I (65B) outperforms on MMLU existing instruction finetuned models of moderate sizes, but are still far from the state-of-the-art, that is 77.4 for GPT code-davinci-002 on MMLU (numbers taken from Iyer et al. (2022)). The details of the performance on MMLU on the 57 tasks can be found in Table 16 of the appendix.\n\nOPT 30B 26.1\n\nGLM 120B 44.8\n\nPaLM 62B 55.1\n\nPaLM-cont 62B 62.8\n\nChinchilla 70B 67.5\n\nLLaMA 65B 63.4\n\nOPT-IML-Max 30B 43.2\n\nFlan-T5-XXL 11B 55.1\n\nFlan-PaLM 62B 59.6\n\nFlan-PaLM-cont 62B 66.1\n\nLLaMA-I 65B **68\\.9**\n\nTable 10: **Instruction finetuning – MMLU (5-shot).** Comparison of models of moderate size with and with- out instruction finetuning on MMLU.\n\n**5 Bias, Toxicity and Misinformation**\n\nLarge language models have been showed to re- produce and amplify biases that are existing in the training data (Sheng et al., 2019; Kurita et al., 2019), and to generate toxic or offensive con- tent (Gehman et al., 2020). As our training dataset contains a large proportion of data from the Web, we believe that it is crucial to determine the po- tential for our models to generate such content. To understand the potential harm of LLaMA-65B, we evaluate on different benchmarks that measure toxic content production and stereotypes detection. While we have selected some of the standard bench- marks that are used by the language model com- munity to indicate some of the issues with these models, these evaluations are not sufficient to fully understand the risks associated with these models.","publish_date":null,"title":"4 InstructionFinetuning 5 Bias,ToxicityandMisinformation","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llama_page7.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llama_page7.pdf"},"request":{"example_id":"table/llama_page7","product_type":"parse","source_file_path":"llama_page7.pdf"},"started_at":"2026-11-04T19:47:16.501555"} +{"completed_at":"2026-11-04T19:47:19.557911","latency_in_ms":1833,"output":{"example_id":"table/llong_page1","grounded_pages":[],"layout_pages":[],"markdown":"**_POLK VIN_**\n\n**_MODEL YEAR MAKE MODEL_**\n\n**_BODY TYPE_**\n\n**_WHEEL DRIVE CYL CID FUEL CARB_**\n\n**_LUX IND VTI_**\n\n**_BI SYM_**\n\n**_PD SYM_**\n\n**_COMP SYM_**\n\n**_COLL SYM_**\n\n**_PIP SYM YMM_**\n\n1B4FK51G0E 1984 DODG CARAVAN LE PV 42 4 156 G C P V 05 02 01 01 07 YYY\n\n1B4FK51K0H 1987 DODG CARAVAN LE PV 42 4 153 G F P V 01 02 02 03 08 YYY\n\n1B4FK51K0J 1988 DODG CARAVAN LE PV 42 4 153 G F P V 04 02 01 02 09 YYY\n\n1B4FK5430K 1989 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 01 02 02 03 07 YYY\n\n1B4FK5430L 1990 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 01 02 02 02 08 YYY\n\n1B4FK54J0K 1989 DODG GRAND CARAVAN LE PV 42 4 153 G F P V 01 02 01 02 05 YYY\n\n1B4FK54R0L 1990 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4FP25301 2001 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4FP44R0T 1996 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 07 03 05 12 YYY\n\n1B4FP44R0V 1997 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 07 07 03 06 12 YYY\n\n1B4FP44R0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 07 11 YYY\n\n1B4FP54L0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 08 07 03 05 12 YYY\n\n1B4FP54L0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4FP54R0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 05 12 YYY\n\n1B4FP54R0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 06 12 YYY\n\n1B4GB11E0C 1982 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB11H0D 1983 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 03 01 03 04 YYY\n\n1B4GB11H0E 1984 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB11P0C 1982 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4GB11T0D 1983 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 02 01 01 04 YYY\n\n1B4GB11T0E 1984 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4GB13E0C 1982 DODG RAM VAN B150 CG 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB13H0E 1984 DODG RAM VAN B150 CG 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB13T0D 1983 DODG RAM VAN B150 CG 42 8 318 G P V 01 02 01 01 04 YYY\n\n1B4GB13T0F 1985 DODG RAM VAN B150 CG 42 8 318 G C P V 01 01 01 01 03 YYY\n\n1B4GD1210F 1985 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 02 05 07 YYY\n\n1B4GD12P0B 1981 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12P0C 1982 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12R0C 1982 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 06 YYY\n\n1B4GD12T0D 1983 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 07 YYY\n\n1B4GD12T0E 1984 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12T0F 1985 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 02 05 08 YYY\n\n1B4GD12U0D 1983 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 01 01 01 07 YYY\n\n1B4GD12W0E 1984 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 01 01 07 YYY\n\n1B4GD12W0F 1985 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 02 05 07 YYY\n\n1B4GD44R0M 1991 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 01 01 01 04 07 YYY\n\n1B4GD54R0M 1991 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 01 04 02 07 YYY\n\n1B4GH2430R 1994 DODG GRAND CARAVAN PV 42 6 181 G F P V 05 02 02 07 15 YYY\n\n1B4GH2430S 1995 DODG GRAND CARAVAN PV 42 6 181 G F P V 07 02 02 03 17 YYY\n\n1B4GH4430N 1992 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 06 05 04 01 12 YYY\n\n1B4GH4430P 1993 DODG GRAND CARAVAN PV 42 6 181 G F P V 06 05 04 03 12 YYY\n\n1B4GH4430R 1994 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 05 08 04 07 12 YYY\n\n1B4GH4430S 1995 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 06 08 02 08 12 YYY\n\n1B4GH44R0N 1992 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 05 03 03 12 YYY\n\n1B4GH44R0P 1993 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 05 03 04 12 YYY\n\n1B4GH44R0R 1994 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 05 08 04 07 12 YYY\n\n1B4GH44R0S 1995 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 08 02 08 12 YYY\n\n1B4GH45R0N 1992 DODG CARAVAN SE PV 42 6 201 G F P V 05 08 04 02 11 YYY\n\n1B4GH5430N 1992 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 06 03 04 02 15 YYY\n\n1B4GH54L0R 1994 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 10 02 09 12 YYY\n\n1B4GH54L0S 1995 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 05 12 02 06 11 YYY\n\n1B4GH54R0N 1992 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 03 04 02 12 YYY\n\n1B4GH54R0P 1993 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 03 04 09 12 YYY\n\n1B4GH54R0R 1994 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 10 02 09 12 YYY\n\n1B4GH54R0S 1995 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 05 12 02 06 12 YYY\n\n1B4GH55R0N 1992 DODG CARAVAN LE PV 42 6 201 G F P V 04 07 04 02 11 YYY\n\n1B4GK4030J 1988 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 01 02 02 09 07 YYY\n\n1B4GK4430K 1989 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 01 02 02 09 07 YYY\n\n1B4GK44R0L 1990 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4GK44R0M 1991 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 01 02 04 03 08 YYY\n\n1B4GK44R0N 1992 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 04 04 08 01 12 YYY\n\n1B4GK44R0P 1993 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 04 04 03 01 12 YYY\n\n1B4GK44R0R 1994 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 02 10 02 06 12 YYY\n\n1B4GK44R0S 1995 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 02 10 02 08 12 YYY\n\n1B4GK54L0R 1994 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 02 03 02 05 12 YYY\n\n1B4GK54L0S 1995 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 02 03 02 03 12 YYY\n\n1B4GK54R0L 1990 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4GK54R0M 1991 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 04 03 08 YYY\n\n1B4GK54R0N 1992 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 11 04 01 12 YYY\n\n1B4GK54R0P 1993 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 11 04 01 12 YYY\n\n1B4GK54R0R 1994 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 02 03 02 05 12 YYY\n\n1B4GK54R0S 1995 DODG GRAND CARAVAN LE ES PV 44 6 201 G F P V 02 03 02 03 12 YYY\n\n1B4GP15B02 2002 DODG CARAVAN EC PV 42 4 148 G F P V 06 02 02 02 08 YYY\n\n1B4GP24301 2001 DODG GRAND CARAVAN SE PV 42 6 201 F F L V 06 09 03 07 12 YYY\n\n1B4GP24302 2002 DODG GRAND CARAVAN SE PV 42 6 201 F F L V 06 09 02 07 12 YYY\n\n1B4GP25301 2001 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4GP25302 2002 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4GP25B01 2001 DODG CARAVAN SE PV 42 4 148 G F P V 06 09 02 02 10 YYY\n\n1B4GP25B02 2002 DODG CARAVAN SE PV 42 4 148 G F P V 06 09 02 02 10 YYY\n\n1B4GP25G01 2001 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP25R01 2001 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP25R02 2002 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP34302 2002 DODG GRAND CARAVAN EL PV 42 6 201 F F L V 06 09 02 07 12 YYY\n\n1B4GP44301 2001 DODG GRAND CARAVAN SPORT PV 42 6 201 F F L V 06 08 03 07 12 YYY\n\n1B4GP44302 2002 DODG GRAND CARAVAN SPORT PV 42 6 201 F F L V 06 08 02 09 12 YYY\n\n1B4GP4430T 1996 DODG GRAND CARAVAN SE ES 42 6 181 G P V 06 07 03 05 12 YYY\n\n1B4GP4430Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 181 G F P V 06 07 03 07 11 YYY\n\n1B4GP44B0T 1996 DODG GRAND CARAVAN SE PV 42 4 148 G F P V 06 07 02 06 11 YYY\n\n1B4GP44B0V 1997 DODG GRAND CARAVAN SE PV 42 4 148 G F P V 06 07 02 06 11 YYY\n\n1B4GP44G0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 07 11 YYY\n\n1B4GP44G0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 06 11 YYY\n\n1B4GP44G0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 07 11 YYY\n\n1B4GP44L0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 06 11 YYY\n\n1B4GP44L0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 06 11 YYY\n\n1B4GP44L0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 07 11 YYY\n\n1B4GP44R01 2001 DODG GRAND CARAVAN SPORT PV 42 6 201 G F P V 06 07 03 07 12 YYY\n\n1B4GP44R02 2002 DODG GRAND CARAVAN SPORT PV 42 6 201 G F P V 06 07 02 09 12 YYY\n\n1B4GP44R0T 1996 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 07 03 05 12 YYY\n\n1B4GP44R0V 1997 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 07 07 03 06 12 YYY\n\n1B4GP44R0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 06 11 YYY\n\n1B4GP44R0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 06 11 YYY\n\n1B4GP44R0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 07 11 YYY\n\n1B4GP45301 2001 DODG CARAVAN SPORT PV 42 6 201 F F L V 06 08 03 04 11 YYY\n\n1B4GP45302 2002 DODG CARAVAN SPORT PV 42 6 201 F F L V 06 09 03 04 11 YYY\n\n1B4GP45B0V 1997 DODG CARAVAN SE PV 42 4 148 G F P V 06 03 02 03 10 YYY\n\n1B4GP45G01 2001 DODG CARAVAN SPORT PV 42 6 201 G F P V 06 11 03 03 11 YYY\n\n1B4GP45G0W 1998 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 08 08 04 05 11 YYY\n\n1B4GP45G0X 1999 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 06 08 04 06 11 YYY\n\n1B4GP45G0Y 2000 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 08 08 04 04 11 YYY\n\n1B4GP45L0W 1998 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 08 09 04 05 12 YYY\n\n1B4GP45L0X 1999 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 06 09 04 07 11 YYY\n\n1B4GP45L0Y 2000 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 08 09 04 06 11 YYY\n\n1B4GP45R02 2002 DODG CARAVAN SPORT PV 42 6 201 G F P V 06 09 03 03 11 YYY\n\n1B4GP45R0T 1996 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 04 03 06 11 YYY\n\n1B4GP45R0V 1997 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 04 04 05 11 YYY\n\n1B4GP45R0W 1998 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 08 09 04 05 11 YYY\n\n1B4GP45R0X 1999 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 09 04 07 11 YYY\n\n1B4GP45R0Y 2000 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 08 09 04 06 11 YYY\n\n1B4GP54301 2001 DODG GRAND CARAVAN ES PV 42 6 201 F F L V 05 13 03 09 11 YYY\n\n1B4GP54G0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 201 F F L V 06 11 04 07 12 YYY\n\n1B4GP54G0X 1999 DODG GRAND CARAVAN LE PV 42 6 201 F F L V 06 09 04 06 12 YYY\n\n1B4GP54G0Y 2000 DODG GRAND CARAVAN LE PV 42 6 201 F F L V 06 09 03 07 12 YYY\n\n1B4GP54L01 2001 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 05 08 03 07 12 YYY\n\n1B4GP54L02 2002 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 05 08 02 08 11 YYY\n\n1B4GP54L0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 08 07 03 05 12 YYY\n\n1B4GP54L0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4GP54L0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 04 06 12 YYY\n\n1B4GP54L0X 1999 DODG GRAND CARAVAN LE PV 42 6 230 G F P V 06 10 04 06 12 YYY\n\n1B4GP54L0Y 2000 DODG GRAND CARAVAN LE PV 42 6 230 G F P V 06 10 03 06 12 YYY\n\n1B4GP54R0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 05 12 YYY\n\n1B4GP54R0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 06 12 YYY\n\n1B4GP54R0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 11 04 06 12 YYY\n\n1B4GP54R0X 1999 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 10 04 06 12 YYY\n\n1B4GP54R0Y 2000 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 09 03 06 12 YYY\n\n1B4GP55G0W 1998 DODG CARAVAN LE PV 42 6 201 F F L V 07 13 03 08 11 YYY\n\n1B4GP55G0X 1999 DODG CARAVAN LE PV 42 6 201 F F L V 07 13 04 08 11 YYY\n\n1B4GP55L0T 1996 DODG CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 05 11 YYY\n\n1B4GP55L0V 1997 DODG CARAVAN LE ES PV 42 6 230 G F P V 08 07 04 05 11 YYY\n\n1B4GP55L0W 1998 DODG CARAVAN LE PV 42 6 230 G F P V 07 12 04 06 11 YYY\n\n1B4GP55L0X 1999 DODG CARAVAN LE PV 42 6 230 G F P V 07 12 03 07 11 YYY\n\n1B4GP55R0T 1996 DODG CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 05 11 YYY\n\n1B4GP55R0V 1997 DODG CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 06 11 YYY\n\n1B4GP55R0W 1998 DODG CARAVAN LE PV 42 6 201 G F P V 07 13 03 03 11 YYY\n\n1B4GP55R0X 1999 DODG CARAVAN LE PV 42 6 201 G F P V 07 13 02 04 11 YYY\n\n1B4GP74L0X 1999 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4GP74L0Y 2000 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 06 07 04 07 12 YYY\n\n1B4GT44L0V 1997 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 05 03 03 06 12 YYY\n\n1B4GT44L0W 1998 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 05 03 04 06 12 YYY\n\n1B4GT44L0X 1999 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 04 03 03 07 12 YYY\n\n1B4GT44L0Y 2000 DODG GRAND CARAVAN SPORT PV 44 6 230 G F P V 06 09 04 07 12 YYY\n\n1B4GT54L0V 1997 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 06 08 03 06 12 YYY\n\n1B4GT54L0W 1998 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 06 08 03 06 12 YYY\n\n1B4GT54L0X 1999 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 05 03 04 07 13 YYY\n\n1B4GT54L0Y 2000 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 06 03 04 07 13 YYY\n\n1B4GT74L0X 1999 DODG GRAND CARAVAN ES PV 44 6 230 G F P V 06 03 04 07 13 YYY\n\n1B4GT74L0Y 2000 DODG GRAND CARAVAN ES PV 44 6 230 G F P V 05 03 04 07 13 YYY\n\n1B4GW1210F 1985 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 02 04 03 YYY\n\n1B4GW12P0B 1981 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 02 01 03 05 YYY\n\n1B4GW12P0C 1982 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12R0B 1981 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 04 YYY\n\n1B4GW12R0C 1982 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 04 YYY\n\n1B4GW12S0C 1982 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 03 01 03 04 YYY\n\n1B4GW12T0B 1981 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 02 01 03 04 YYY\n\n1B4GW12T0C 1982 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 03 01 03 04 YYY\n\n1B4GW12T0D 1983 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12T0E 1984 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 05 YYY\n\n1B4GW12T0F 1985 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12U0D 1983 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12V0D 1983 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12W0D 1983 DODG RAMCHARGER AW-100 2W 44 8 360 G P Y 01 03 01 03 04 YYY\n\n1B4GW12W0E 1984 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12W0F 1985 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 02 04 03 YYY\n\n1B4HB11H0D 1983 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 03 01 03 04 YYY\n\n1B4HB11H0E 1984 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4HB11T0D 1983 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 02 01 01 04 YYY\n\n1B4HB11T0E 1984 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21E0C 1982 DODG RAM WAGON B250 PV 42 6 225 G C P V 01 01 01 03 04 YYY\n\n1B4HB21H0E 1984 DODG RAM WAGON B250 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4HB21P0C 1982 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21R0C 1982 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 03 YYY\n\n1B4HB21T0D 1983 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21T0E 1984 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21U0D 1983 DODG RAM WAGON B250 SV 42 8 318 G P V 01 01 01 01 04 YYY\n\n1B4HB23E0C 1982 DODG RAM VAN B250 CG 42 6 225 G C P V 01 01 01 03 04 YYY\n\n1B4HB23P0C 1982 DODG RAM VAN B250 CG 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB23T0D 1983 DODG RAM VAN B250 CG 42 8 318 G P V 01 01 01 01 04 YYY\n\n1B4HB23T0F 1985 DODG RAM VAN B250 CG 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HR28N01 2001 DODG DURANGO UT 42 8 287 G F P U 08 11 02 06 10 YYY\n\n1B4HR28X0X 1999 DODG DURANGO UT 42 6 239 G F P U 06 11 02 06 11 YYY\n\n1B4HR28Y0X 1999 DODG DURANGO UT 42 8 318 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Y0Y 2000 DODG DURANGO UT 42 8 318 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z01 2001 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z0X 1999 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z0Y 2000 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY","pages":[{"line_numbers":[],"markdown":"**_POLK VIN_**\n\n**_MODEL YEAR MAKE MODEL_**\n\n**_BODY TYPE_**\n\n**_WHEEL DRIVE CYL CID FUEL CARB_**\n\n**_LUX IND VTI_**\n\n**_BI SYM_**\n\n**_PD SYM_**\n\n**_COMP SYM_**\n\n**_COLL SYM_**\n\n**_PIP SYM YMM_**\n\n1B4FK51G0E 1984 DODG CARAVAN LE PV 42 4 156 G C P V 05 02 01 01 07 YYY\n\n1B4FK51K0H 1987 DODG CARAVAN LE PV 42 4 153 G F P V 01 02 02 03 08 YYY\n\n1B4FK51K0J 1988 DODG CARAVAN LE PV 42 4 153 G F P V 04 02 01 02 09 YYY\n\n1B4FK5430K 1989 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 01 02 02 03 07 YYY\n\n1B4FK5430L 1990 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 01 02 02 02 08 YYY\n\n1B4FK54J0K 1989 DODG GRAND CARAVAN LE PV 42 4 153 G F P V 01 02 01 02 05 YYY\n\n1B4FK54R0L 1990 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4FP25301 2001 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4FP44R0T 1996 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 07 03 05 12 YYY\n\n1B4FP44R0V 1997 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 07 07 03 06 12 YYY\n\n1B4FP44R0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 07 11 YYY\n\n1B4FP54L0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 08 07 03 05 12 YYY\n\n1B4FP54L0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4FP54R0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 05 12 YYY\n\n1B4FP54R0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 06 12 YYY\n\n1B4GB11E0C 1982 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB11H0D 1983 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 03 01 03 04 YYY\n\n1B4GB11H0E 1984 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB11P0C 1982 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4GB11T0D 1983 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 02 01 01 04 YYY\n\n1B4GB11T0E 1984 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4GB13E0C 1982 DODG RAM VAN B150 CG 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB13H0E 1984 DODG RAM VAN B150 CG 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB13T0D 1983 DODG RAM VAN B150 CG 42 8 318 G P V 01 02 01 01 04 YYY\n\n1B4GB13T0F 1985 DODG RAM VAN B150 CG 42 8 318 G C P V 01 01 01 01 03 YYY\n\n1B4GD1210F 1985 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 02 05 07 YYY\n\n1B4GD12P0B 1981 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12P0C 1982 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12R0C 1982 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 06 YYY\n\n1B4GD12T0D 1983 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 07 YYY\n\n1B4GD12T0E 1984 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12T0F 1985 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 02 05 08 YYY\n\n1B4GD12U0D 1983 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 01 01 01 07 YYY\n\n1B4GD12W0E 1984 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 01 01 07 YYY\n\n1B4GD12W0F 1985 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 02 05 07 YYY\n\n1B4GD44R0M 1991 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 01 01 01 04 07 YYY\n\n1B4GD54R0M 1991 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 01 04 02 07 YYY\n\n1B4GH2430R 1994 DODG GRAND CARAVAN PV 42 6 181 G F P V 05 02 02 07 15 YYY\n\n1B4GH2430S 1995 DODG GRAND CARAVAN PV 42 6 181 G F P V 07 02 02 03 17 YYY\n\n1B4GH4430N 1992 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 06 05 04 01 12 YYY\n\n1B4GH4430P 1993 DODG GRAND CARAVAN PV 42 6 181 G F P V 06 05 04 03 12 YYY\n\n1B4GH4430R 1994 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 05 08 04 07 12 YYY\n\n1B4GH4430S 1995 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 06 08 02 08 12 YYY\n\n1B4GH44R0N 1992 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 05 03 03 12 YYY\n\n1B4GH44R0P 1993 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 05 03 04 12 YYY\n\n1B4GH44R0R 1994 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 05 08 04 07 12 YYY\n\n1B4GH44R0S 1995 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 08 02 08 12 YYY\n\n1B4GH45R0N 1992 DODG CARAVAN SE PV 42 6 201 G F P V 05 08 04 02 11 YYY\n\n1B4GH5430N 1992 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 06 03 04 02 15 YYY\n\n1B4GH54L0R 1994 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 10 02 09 12 YYY\n\n1B4GH54L0S 1995 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 05 12 02 06 11 YYY\n\n1B4GH54R0N 1992 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 03 04 02 12 YYY\n\n1B4GH54R0P 1993 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 03 04 09 12 YYY\n\n1B4GH54R0R 1994 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 10 02 09 12 YYY\n\n1B4GH54R0S 1995 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 05 12 02 06 12 YYY\n\n1B4GH55R0N 1992 DODG CARAVAN LE PV 42 6 201 G F P V 04 07 04 02 11 YYY\n\n1B4GK4030J 1988 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 01 02 02 09 07 YYY\n\n1B4GK4430K 1989 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 01 02 02 09 07 YYY\n\n1B4GK44R0L 1990 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4GK44R0M 1991 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 01 02 04 03 08 YYY\n\n1B4GK44R0N 1992 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 04 04 08 01 12 YYY\n\n1B4GK44R0P 1993 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 04 04 03 01 12 YYY\n\n1B4GK44R0R 1994 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 02 10 02 06 12 YYY\n\n1B4GK44R0S 1995 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 02 10 02 08 12 YYY\n\n1B4GK54L0R 1994 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 02 03 02 05 12 YYY\n\n1B4GK54L0S 1995 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 02 03 02 03 12 YYY\n\n1B4GK54R0L 1990 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4GK54R0M 1991 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 04 03 08 YYY\n\n1B4GK54R0N 1992 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 11 04 01 12 YYY\n\n1B4GK54R0P 1993 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 11 04 01 12 YYY\n\n1B4GK54R0R 1994 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 02 03 02 05 12 YYY\n\n1B4GK54R0S 1995 DODG GRAND CARAVAN LE ES PV 44 6 201 G F P V 02 03 02 03 12 YYY\n\n1B4GP15B02 2002 DODG CARAVAN EC PV 42 4 148 G F P V 06 02 02 02 08 YYY\n\n1B4GP24301 2001 DODG GRAND CARAVAN SE PV 42 6 201 F F L V 06 09 03 07 12 YYY\n\n1B4GP24302 2002 DODG GRAND CARAVAN SE PV 42 6 201 F F L V 06 09 02 07 12 YYY\n\n1B4GP25301 2001 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4GP25302 2002 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4GP25B01 2001 DODG CARAVAN SE PV 42 4 148 G F P V 06 09 02 02 10 YYY\n\n1B4GP25B02 2002 DODG CARAVAN SE PV 42 4 148 G F P V 06 09 02 02 10 YYY\n\n1B4GP25G01 2001 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP25R01 2001 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP25R02 2002 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP34302 2002 DODG GRAND CARAVAN EL PV 42 6 201 F F L V 06 09 02 07 12 YYY\n\n1B4GP44301 2001 DODG GRAND CARAVAN SPORT PV 42 6 201 F F L V 06 08 03 07 12 YYY\n\n1B4GP44302 2002 DODG GRAND CARAVAN SPORT PV 42 6 201 F F L V 06 08 02 09 12 YYY\n\n1B4GP4430T 1996 DODG GRAND CARAVAN SE ES 42 6 181 G P V 06 07 03 05 12 YYY\n\n1B4GP4430Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 181 G F P V 06 07 03 07 11 YYY\n\n1B4GP44B0T 1996 DODG GRAND CARAVAN SE PV 42 4 148 G F P V 06 07 02 06 11 YYY\n\n1B4GP44B0V 1997 DODG GRAND CARAVAN SE PV 42 4 148 G F P V 06 07 02 06 11 YYY\n\n1B4GP44G0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 07 11 YYY\n\n1B4GP44G0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 06 11 YYY\n\n1B4GP44G0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 07 11 YYY\n\n1B4GP44L0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 06 11 YYY\n\n1B4GP44L0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 06 11 YYY\n\n1B4GP44L0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 07 11 YYY\n\n1B4GP44R01 2001 DODG GRAND CARAVAN SPORT PV 42 6 201 G F P V 06 07 03 07 12 YYY\n\n1B4GP44R02 2002 DODG GRAND CARAVAN SPORT PV 42 6 201 G F P V 06 07 02 09 12 YYY\n\n1B4GP44R0T 1996 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 07 03 05 12 YYY\n\n1B4GP44R0V 1997 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 07 07 03 06 12 YYY\n\n1B4GP44R0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 06 11 YYY\n\n1B4GP44R0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 06 11 YYY\n\n1B4GP44R0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 07 11 YYY\n\n1B4GP45301 2001 DODG CARAVAN SPORT PV 42 6 201 F F L V 06 08 03 04 11 YYY\n\n1B4GP45302 2002 DODG CARAVAN SPORT PV 42 6 201 F F L V 06 09 03 04 11 YYY\n\n1B4GP45B0V 1997 DODG CARAVAN SE PV 42 4 148 G F P V 06 03 02 03 10 YYY\n\n1B4GP45G01 2001 DODG CARAVAN SPORT PV 42 6 201 G F P V 06 11 03 03 11 YYY\n\n1B4GP45G0W 1998 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 08 08 04 05 11 YYY\n\n1B4GP45G0X 1999 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 06 08 04 06 11 YYY\n\n1B4GP45G0Y 2000 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 08 08 04 04 11 YYY\n\n1B4GP45L0W 1998 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 08 09 04 05 12 YYY\n\n1B4GP45L0X 1999 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 06 09 04 07 11 YYY\n\n1B4GP45L0Y 2000 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 08 09 04 06 11 YYY\n\n1B4GP45R02 2002 DODG CARAVAN SPORT PV 42 6 201 G F P V 06 09 03 03 11 YYY\n\n1B4GP45R0T 1996 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 04 03 06 11 YYY\n\n1B4GP45R0V 1997 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 04 04 05 11 YYY\n\n1B4GP45R0W 1998 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 08 09 04 05 11 YYY\n\n1B4GP45R0X 1999 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 09 04 07 11 YYY\n\n1B4GP45R0Y 2000 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 08 09 04 06 11 YYY\n\n1B4GP54301 2001 DODG GRAND CARAVAN ES PV 42 6 201 F F L V 05 13 03 09 11 YYY\n\n1B4GP54G0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 201 F F L V 06 11 04 07 12 YYY\n\n1B4GP54G0X 1999 DODG GRAND CARAVAN LE PV 42 6 201 F F L V 06 09 04 06 12 YYY\n\n1B4GP54G0Y 2000 DODG GRAND CARAVAN LE PV 42 6 201 F F L V 06 09 03 07 12 YYY\n\n1B4GP54L01 2001 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 05 08 03 07 12 YYY\n\n1B4GP54L02 2002 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 05 08 02 08 11 YYY\n\n1B4GP54L0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 08 07 03 05 12 YYY\n\n1B4GP54L0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4GP54L0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 04 06 12 YYY\n\n1B4GP54L0X 1999 DODG GRAND CARAVAN LE PV 42 6 230 G F P V 06 10 04 06 12 YYY\n\n1B4GP54L0Y 2000 DODG GRAND CARAVAN LE PV 42 6 230 G F P V 06 10 03 06 12 YYY\n\n1B4GP54R0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 05 12 YYY\n\n1B4GP54R0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 06 12 YYY\n\n1B4GP54R0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 11 04 06 12 YYY\n\n1B4GP54R0X 1999 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 10 04 06 12 YYY\n\n1B4GP54R0Y 2000 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 09 03 06 12 YYY\n\n1B4GP55G0W 1998 DODG CARAVAN LE PV 42 6 201 F F L V 07 13 03 08 11 YYY\n\n1B4GP55G0X 1999 DODG CARAVAN LE PV 42 6 201 F F L V 07 13 04 08 11 YYY\n\n1B4GP55L0T 1996 DODG CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 05 11 YYY\n\n1B4GP55L0V 1997 DODG CARAVAN LE ES PV 42 6 230 G F P V 08 07 04 05 11 YYY\n\n1B4GP55L0W 1998 DODG CARAVAN LE PV 42 6 230 G F P V 07 12 04 06 11 YYY\n\n1B4GP55L0X 1999 DODG CARAVAN LE PV 42 6 230 G F P V 07 12 03 07 11 YYY\n\n1B4GP55R0T 1996 DODG CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 05 11 YYY\n\n1B4GP55R0V 1997 DODG CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 06 11 YYY\n\n1B4GP55R0W 1998 DODG CARAVAN LE PV 42 6 201 G F P V 07 13 03 03 11 YYY\n\n1B4GP55R0X 1999 DODG CARAVAN LE PV 42 6 201 G F P V 07 13 02 04 11 YYY\n\n1B4GP74L0X 1999 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4GP74L0Y 2000 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 06 07 04 07 12 YYY\n\n1B4GT44L0V 1997 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 05 03 03 06 12 YYY\n\n1B4GT44L0W 1998 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 05 03 04 06 12 YYY\n\n1B4GT44L0X 1999 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 04 03 03 07 12 YYY\n\n1B4GT44L0Y 2000 DODG GRAND CARAVAN SPORT PV 44 6 230 G F P V 06 09 04 07 12 YYY\n\n1B4GT54L0V 1997 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 06 08 03 06 12 YYY\n\n1B4GT54L0W 1998 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 06 08 03 06 12 YYY\n\n1B4GT54L0X 1999 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 05 03 04 07 13 YYY\n\n1B4GT54L0Y 2000 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 06 03 04 07 13 YYY\n\n1B4GT74L0X 1999 DODG GRAND CARAVAN ES PV 44 6 230 G F P V 06 03 04 07 13 YYY\n\n1B4GT74L0Y 2000 DODG GRAND CARAVAN ES PV 44 6 230 G F P V 05 03 04 07 13 YYY\n\n1B4GW1210F 1985 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 02 04 03 YYY\n\n1B4GW12P0B 1981 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 02 01 03 05 YYY\n\n1B4GW12P0C 1982 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12R0B 1981 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 04 YYY\n\n1B4GW12R0C 1982 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 04 YYY\n\n1B4GW12S0C 1982 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 03 01 03 04 YYY\n\n1B4GW12T0B 1981 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 02 01 03 04 YYY\n\n1B4GW12T0C 1982 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 03 01 03 04 YYY\n\n1B4GW12T0D 1983 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12T0E 1984 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 05 YYY\n\n1B4GW12T0F 1985 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12U0D 1983 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12V0D 1983 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12W0D 1983 DODG RAMCHARGER AW-100 2W 44 8 360 G P Y 01 03 01 03 04 YYY\n\n1B4GW12W0E 1984 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12W0F 1985 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 02 04 03 YYY\n\n1B4HB11H0D 1983 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 03 01 03 04 YYY\n\n1B4HB11H0E 1984 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4HB11T0D 1983 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 02 01 01 04 YYY\n\n1B4HB11T0E 1984 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21E0C 1982 DODG RAM WAGON B250 PV 42 6 225 G C P V 01 01 01 03 04 YYY\n\n1B4HB21H0E 1984 DODG RAM WAGON B250 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4HB21P0C 1982 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21R0C 1982 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 03 YYY\n\n1B4HB21T0D 1983 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21T0E 1984 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21U0D 1983 DODG RAM WAGON B250 SV 42 8 318 G P V 01 01 01 01 04 YYY\n\n1B4HB23E0C 1982 DODG RAM VAN B250 CG 42 6 225 G C P V 01 01 01 03 04 YYY\n\n1B4HB23P0C 1982 DODG RAM VAN B250 CG 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB23T0D 1983 DODG RAM VAN B250 CG 42 8 318 G P V 01 01 01 01 04 YYY\n\n1B4HB23T0F 1985 DODG RAM VAN B250 CG 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HR28N01 2001 DODG DURANGO UT 42 8 287 G F P U 08 11 02 06 10 YYY\n\n1B4HR28X0X 1999 DODG DURANGO UT 42 6 239 G F P U 06 11 02 06 11 YYY\n\n1B4HR28Y0X 1999 DODG DURANGO UT 42 8 318 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Y0Y 2000 DODG DURANGO UT 42 8 318 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z01 2001 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z0X 1999 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z0Y 2000 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**_POLK VIN_**\n\n**_MODEL YEAR MAKE MODEL_**\n\n**_BODY TYPE_**\n\n**_WHEEL DRIVE CYL CID FUEL CARB_**\n\n**_LUX IND VTI_**\n\n**_BI SYM_**\n\n**_PD SYM_**\n\n**_COMP SYM_**\n\n**_COLL SYM_**\n\n**_PIP SYM YMM_**\n\n1B4FK51G0E 1984 DODG CARAVAN LE PV 42 4 156 G C P V 05 02 01 01 07 YYY\n\n1B4FK51K0H 1987 DODG CARAVAN LE PV 42 4 153 G F P V 01 02 02 03 08 YYY\n\n1B4FK51K0J 1988 DODG CARAVAN LE PV 42 4 153 G F P V 04 02 01 02 09 YYY\n\n1B4FK5430K 1989 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 01 02 02 03 07 YYY\n\n1B4FK5430L 1990 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 01 02 02 02 08 YYY\n\n1B4FK54J0K 1989 DODG GRAND CARAVAN LE PV 42 4 153 G F P V 01 02 01 02 05 YYY\n\n1B4FK54R0L 1990 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4FP25301 2001 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4FP44R0T 1996 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 07 03 05 12 YYY\n\n1B4FP44R0V 1997 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 07 07 03 06 12 YYY\n\n1B4FP44R0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 07 11 YYY\n\n1B4FP54L0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 08 07 03 05 12 YYY\n\n1B4FP54L0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4FP54R0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 05 12 YYY\n\n1B4FP54R0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 06 12 YYY\n\n1B4GB11E0C 1982 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB11H0D 1983 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 03 01 03 04 YYY\n\n1B4GB11H0E 1984 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB11P0C 1982 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4GB11T0D 1983 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 02 01 01 04 YYY\n\n1B4GB11T0E 1984 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4GB13E0C 1982 DODG RAM VAN B150 CG 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB13H0E 1984 DODG RAM VAN B150 CG 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB13T0D 1983 DODG RAM VAN B150 CG 42 8 318 G P V 01 02 01 01 04 YYY\n\n1B4GB13T0F 1985 DODG RAM VAN B150 CG 42 8 318 G C P V 01 01 01 01 03 YYY\n\n1B4GD1210F 1985 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 02 05 07 YYY\n\n1B4GD12P0B 1981 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12P0C 1982 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12R0C 1982 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 06 YYY\n\n1B4GD12T0D 1983 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 07 YYY\n\n1B4GD12T0E 1984 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12T0F 1985 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 02 05 08 YYY\n\n1B4GD12U0D 1983 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 01 01 01 07 YYY\n\n1B4GD12W0E 1984 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 01 01 07 YYY\n\n1B4GD12W0F 1985 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 02 05 07 YYY\n\n1B4GD44R0M 1991 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 01 01 01 04 07 YYY\n\n1B4GD54R0M 1991 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 01 04 02 07 YYY\n\n1B4GH2430R 1994 DODG GRAND CARAVAN PV 42 6 181 G F P V 05 02 02 07 15 YYY\n\n1B4GH2430S 1995 DODG GRAND CARAVAN PV 42 6 181 G F P V 07 02 02 03 17 YYY\n\n1B4GH4430N 1992 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 06 05 04 01 12 YYY\n\n1B4GH4430P 1993 DODG GRAND CARAVAN PV 42 6 181 G F P V 06 05 04 03 12 YYY\n\n1B4GH4430R 1994 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 05 08 04 07 12 YYY\n\n1B4GH4430S 1995 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 06 08 02 08 12 YYY\n\n1B4GH44R0N 1992 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 05 03 03 12 YYY\n\n1B4GH44R0P 1993 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 05 03 04 12 YYY\n\n1B4GH44R0R 1994 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 05 08 04 07 12 YYY\n\n1B4GH44R0S 1995 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 08 02 08 12 YYY\n\n1B4GH45R0N 1992 DODG CARAVAN SE PV 42 6 201 G F P V 05 08 04 02 11 YYY\n\n1B4GH5430N 1992 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 06 03 04 02 15 YYY\n\n1B4GH54L0R 1994 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 10 02 09 12 YYY\n\n1B4GH54L0S 1995 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 05 12 02 06 11 YYY\n\n1B4GH54R0N 1992 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 03 04 02 12 YYY\n\n1B4GH54R0P 1993 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 03 04 09 12 YYY\n\n1B4GH54R0R 1994 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 10 02 09 12 YYY\n\n1B4GH54R0S 1995 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 05 12 02 06 12 YYY\n\n1B4GH55R0N 1992 DODG CARAVAN LE PV 42 6 201 G F P V 04 07 04 02 11 YYY\n\n1B4GK4030J 1988 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 01 02 02 09 07 YYY\n\n1B4GK4430K 1989 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 01 02 02 09 07 YYY\n\n1B4GK44R0L 1990 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4GK44R0M 1991 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 01 02 04 03 08 YYY\n\n1B4GK44R0N 1992 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 04 04 08 01 12 YYY\n\n1B4GK44R0P 1993 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 04 04 03 01 12 YYY\n\n1B4GK44R0R 1994 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 02 10 02 06 12 YYY\n\n1B4GK44R0S 1995 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 02 10 02 08 12 YYY\n\n1B4GK54L0R 1994 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 02 03 02 05 12 YYY\n\n1B4GK54L0S 1995 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 02 03 02 03 12 YYY\n\n1B4GK54R0L 1990 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4GK54R0M 1991 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 04 03 08 YYY\n\n1B4GK54R0N 1992 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 11 04 01 12 YYY\n\n1B4GK54R0P 1993 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 11 04 01 12 YYY\n\n1B4GK54R0R 1994 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 02 03 02 05 12 YYY\n\n1B4GK54R0S 1995 DODG GRAND CARAVAN LE ES PV 44 6 201 G F P V 02 03 02 03 12 YYY\n\n1B4GP15B02 2002 DODG CARAVAN EC PV 42 4 148 G F P V 06 02 02 02 08 YYY\n\n1B4GP24301 2001 DODG GRAND CARAVAN SE PV 42 6 201 F F L V 06 09 03 07 12 YYY\n\n1B4GP24302 2002 DODG GRAND CARAVAN SE PV 42 6 201 F F L V 06 09 02 07 12 YYY\n\n1B4GP25301 2001 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4GP25302 2002 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4GP25B01 2001 DODG CARAVAN SE PV 42 4 148 G F P V 06 09 02 02 10 YYY\n\n1B4GP25B02 2002 DODG CARAVAN SE PV 42 4 148 G F P V 06 09 02 02 10 YYY\n\n1B4GP25G01 2001 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP25R01 2001 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP25R02 2002 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP34302 2002 DODG GRAND CARAVAN EL PV 42 6 201 F F L V 06 09 02 07 12 YYY\n\n1B4GP44301 2001 DODG GRAND CARAVAN SPORT PV 42 6 201 F F L V 06 08 03 07 12 YYY\n\n1B4GP44302 2002 DODG GRAND CARAVAN SPORT PV 42 6 201 F F L V 06 08 02 09 12 YYY\n\n1B4GP4430T 1996 DODG GRAND CARAVAN SE ES 42 6 181 G P V 06 07 03 05 12 YYY\n\n1B4GP4430Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 181 G F P V 06 07 03 07 11 YYY\n\n1B4GP44B0T 1996 DODG GRAND CARAVAN SE PV 42 4 148 G F P V 06 07 02 06 11 YYY\n\n1B4GP44B0V 1997 DODG GRAND CARAVAN SE PV 42 4 148 G F P V 06 07 02 06 11 YYY\n\n1B4GP44G0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 07 11 YYY\n\n1B4GP44G0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 06 11 YYY\n\n1B4GP44G0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 07 11 YYY\n\n1B4GP44L0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 06 11 YYY\n\n1B4GP44L0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 06 11 YYY\n\n1B4GP44L0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 07 11 YYY\n\n1B4GP44R01 2001 DODG GRAND CARAVAN SPORT PV 42 6 201 G F P V 06 07 03 07 12 YYY\n\n1B4GP44R02 2002 DODG GRAND CARAVAN SPORT PV 42 6 201 G F P V 06 07 02 09 12 YYY\n\n1B4GP44R0T 1996 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 07 03 05 12 YYY\n\n1B4GP44R0V 1997 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 07 07 03 06 12 YYY\n\n1B4GP44R0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 06 11 YYY\n\n1B4GP44R0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 06 11 YYY\n\n1B4GP44R0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 07 11 YYY\n\n1B4GP45301 2001 DODG CARAVAN SPORT PV 42 6 201 F F L V 06 08 03 04 11 YYY\n\n1B4GP45302 2002 DODG CARAVAN SPORT PV 42 6 201 F F L V 06 09 03 04 11 YYY\n\n1B4GP45B0V 1997 DODG CARAVAN SE PV 42 4 148 G F P V 06 03 02 03 10 YYY\n\n1B4GP45G01 2001 DODG CARAVAN SPORT PV 42 6 201 G F P V 06 11 03 03 11 YYY\n\n1B4GP45G0W 1998 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 08 08 04 05 11 YYY\n\n1B4GP45G0X 1999 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 06 08 04 06 11 YYY\n\n1B4GP45G0Y 2000 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 08 08 04 04 11 YYY\n\n1B4GP45L0W 1998 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 08 09 04 05 12 YYY\n\n1B4GP45L0X 1999 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 06 09 04 07 11 YYY\n\n1B4GP45L0Y 2000 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 08 09 04 06 11 YYY\n\n1B4GP45R02 2002 DODG CARAVAN SPORT PV 42 6 201 G F P V 06 09 03 03 11 YYY\n\n1B4GP45R0T 1996 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 04 03 06 11 YYY\n\n1B4GP45R0V 1997 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 04 04 05 11 YYY\n\n1B4GP45R0W 1998 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 08 09 04 05 11 YYY\n\n1B4GP45R0X 1999 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 09 04 07 11 YYY\n\n1B4GP45R0Y 2000 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 08 09 04 06 11 YYY\n\n1B4GP54301 2001 DODG GRAND CARAVAN ES PV 42 6 201 F F L V 05 13 03 09 11 YYY\n\n1B4GP54G0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 201 F F L V 06 11 04 07 12 YYY\n\n1B4GP54G0X 1999 DODG GRAND CARAVAN LE PV 42 6 201 F F L V 06 09 04 06 12 YYY\n\n1B4GP54G0Y 2000 DODG GRAND CARAVAN LE PV 42 6 201 F F L V 06 09 03 07 12 YYY\n\n1B4GP54L01 2001 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 05 08 03 07 12 YYY\n\n1B4GP54L02 2002 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 05 08 02 08 11 YYY\n\n1B4GP54L0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 08 07 03 05 12 YYY\n\n1B4GP54L0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4GP54L0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 04 06 12 YYY\n\n1B4GP54L0X 1999 DODG GRAND CARAVAN LE PV 42 6 230 G F P V 06 10 04 06 12 YYY\n\n1B4GP54L0Y 2000 DODG GRAND CARAVAN LE PV 42 6 230 G F P V 06 10 03 06 12 YYY\n\n1B4GP54R0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 05 12 YYY\n\n1B4GP54R0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 06 12 YYY\n\n1B4GP54R0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 11 04 06 12 YYY\n\n1B4GP54R0X 1999 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 10 04 06 12 YYY\n\n1B4GP54R0Y 2000 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 09 03 06 12 YYY\n\n1B4GP55G0W 1998 DODG CARAVAN LE PV 42 6 201 F F L V 07 13 03 08 11 YYY\n\n1B4GP55G0X 1999 DODG CARAVAN LE PV 42 6 201 F F L V 07 13 04 08 11 YYY\n\n1B4GP55L0T 1996 DODG CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 05 11 YYY\n\n1B4GP55L0V 1997 DODG CARAVAN LE ES PV 42 6 230 G F P V 08 07 04 05 11 YYY\n\n1B4GP55L0W 1998 DODG CARAVAN LE PV 42 6 230 G F P V 07 12 04 06 11 YYY\n\n1B4GP55L0X 1999 DODG CARAVAN LE PV 42 6 230 G F P V 07 12 03 07 11 YYY\n\n1B4GP55R0T 1996 DODG CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 05 11 YYY\n\n1B4GP55R0V 1997 DODG CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 06 11 YYY\n\n1B4GP55R0W 1998 DODG CARAVAN LE PV 42 6 201 G F P V 07 13 03 03 11 YYY\n\n1B4GP55R0X 1999 DODG CARAVAN LE PV 42 6 201 G F P V 07 13 02 04 11 YYY\n\n1B4GP74L0X 1999 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4GP74L0Y 2000 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 06 07 04 07 12 YYY\n\n1B4GT44L0V 1997 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 05 03 03 06 12 YYY\n\n1B4GT44L0W 1998 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 05 03 04 06 12 YYY\n\n1B4GT44L0X 1999 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 04 03 03 07 12 YYY\n\n1B4GT44L0Y 2000 DODG GRAND CARAVAN SPORT PV 44 6 230 G F P V 06 09 04 07 12 YYY\n\n1B4GT54L0V 1997 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 06 08 03 06 12 YYY\n\n1B4GT54L0W 1998 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 06 08 03 06 12 YYY\n\n1B4GT54L0X 1999 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 05 03 04 07 13 YYY\n\n1B4GT54L0Y 2000 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 06 03 04 07 13 YYY\n\n1B4GT74L0X 1999 DODG GRAND CARAVAN ES PV 44 6 230 G F P V 06 03 04 07 13 YYY\n\n1B4GT74L0Y 2000 DODG GRAND CARAVAN ES PV 44 6 230 G F P V 05 03 04 07 13 YYY\n\n1B4GW1210F 1985 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 02 04 03 YYY\n\n1B4GW12P0B 1981 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 02 01 03 05 YYY\n\n1B4GW12P0C 1982 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12R0B 1981 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 04 YYY\n\n1B4GW12R0C 1982 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 04 YYY\n\n1B4GW12S0C 1982 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 03 01 03 04 YYY\n\n1B4GW12T0B 1981 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 02 01 03 04 YYY\n\n1B4GW12T0C 1982 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 03 01 03 04 YYY\n\n1B4GW12T0D 1983 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12T0E 1984 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 05 YYY\n\n1B4GW12T0F 1985 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12U0D 1983 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12V0D 1983 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12W0D 1983 DODG RAMCHARGER AW-100 2W 44 8 360 G P Y 01 03 01 03 04 YYY\n\n1B4GW12W0E 1984 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12W0F 1985 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 02 04 03 YYY\n\n1B4HB11H0D 1983 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 03 01 03 04 YYY\n\n1B4HB11H0E 1984 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4HB11T0D 1983 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 02 01 01 04 YYY\n\n1B4HB11T0E 1984 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21E0C 1982 DODG RAM WAGON B250 PV 42 6 225 G C P V 01 01 01 03 04 YYY\n\n1B4HB21H0E 1984 DODG RAM WAGON B250 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4HB21P0C 1982 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21R0C 1982 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 03 YYY\n\n1B4HB21T0D 1983 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21T0E 1984 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21U0D 1983 DODG RAM WAGON B250 SV 42 8 318 G P V 01 01 01 01 04 YYY\n\n1B4HB23E0C 1982 DODG RAM VAN B250 CG 42 6 225 G C P V 01 01 01 03 04 YYY\n\n1B4HB23P0C 1982 DODG RAM VAN B250 CG 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB23T0D 1983 DODG RAM VAN B250 CG 42 8 318 G P V 01 01 01 01 04 YYY\n\n1B4HB23T0F 1985 DODG RAM VAN B250 CG 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HR28N01 2001 DODG DURANGO UT 42 8 287 G F P U 08 11 02 06 10 YYY\n\n1B4HR28X0X 1999 DODG DURANGO UT 42 6 239 G F P U 06 11 02 06 11 YYY\n\n1B4HR28Y0X 1999 DODG DURANGO UT 42 8 318 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Y0Y 2000 DODG DURANGO UT 42 8 318 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z01 2001 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z0X 1999 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z0Y 2000 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llong_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_b3e096f10ee30e51f5cd6ca171a918e1","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**_POLK VIN_**\n\n**_MODEL YEAR MAKE MODEL_**\n\n**_BODY TYPE_**\n\n**_WHEEL DRIVE CYL CID FUEL CARB_**\n\n**_LUX IND VTI_**\n\n**_BI SYM_**\n\n**_PD SYM_**\n\n**_COMP SYM_**\n\n**_COLL SYM_**\n\n**_PIP SYM YMM_**\n\n1B4FK51G0E 1984 DODG CARAVAN LE PV 42 4 156 G C P V 05 02 01 01 07 YYY\n\n1B4FK51K0H 1987 DODG CARAVAN LE PV 42 4 153 G F P V 01 02 02 03 08 YYY\n\n1B4FK51K0J 1988 DODG CARAVAN LE PV 42 4 153 G F P V 04 02 01 02 09 YYY\n\n1B4FK5430K 1989 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 01 02 02 03 07 YYY\n\n1B4FK5430L 1990 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 01 02 02 02 08 YYY\n\n1B4FK54J0K 1989 DODG GRAND CARAVAN LE PV 42 4 153 G F P V 01 02 01 02 05 YYY\n\n1B4FK54R0L 1990 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4FP25301 2001 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4FP44R0T 1996 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 07 03 05 12 YYY\n\n1B4FP44R0V 1997 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 07 07 03 06 12 YYY\n\n1B4FP44R0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 07 11 YYY\n\n1B4FP54L0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 08 07 03 05 12 YYY\n\n1B4FP54L0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4FP54R0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 05 12 YYY\n\n1B4FP54R0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 06 12 YYY\n\n1B4GB11E0C 1982 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB11H0D 1983 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 03 01 03 04 YYY\n\n1B4GB11H0E 1984 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB11P0C 1982 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4GB11T0D 1983 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 02 01 01 04 YYY\n\n1B4GB11T0E 1984 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4GB13E0C 1982 DODG RAM VAN B150 CG 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB13H0E 1984 DODG RAM VAN B150 CG 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB13T0D 1983 DODG RAM VAN B150 CG 42 8 318 G P V 01 02 01 01 04 YYY\n\n1B4GB13T0F 1985 DODG RAM VAN B150 CG 42 8 318 G C P V 01 01 01 01 03 YYY\n\n1B4GD1210F 1985 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 02 05 07 YYY\n\n1B4GD12P0B 1981 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12P0C 1982 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12R0C 1982 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 06 YYY\n\n1B4GD12T0D 1983 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 07 YYY\n\n1B4GD12T0E 1984 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12T0F 1985 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 02 05 08 YYY\n\n1B4GD12U0D 1983 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 01 01 01 07 YYY\n\n1B4GD12W0E 1984 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 01 01 07 YYY\n\n1B4GD12W0F 1985 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 02 05 07 YYY\n\n1B4GD44R0M 1991 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 01 01 01 04 07 YYY\n\n1B4GD54R0M 1991 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 01 04 02 07 YYY\n\n1B4GH2430R 1994 DODG GRAND CARAVAN PV 42 6 181 G F P V 05 02 02 07 15 YYY\n\n1B4GH2430S 1995 DODG GRAND CARAVAN PV 42 6 181 G F P V 07 02 02 03 17 YYY\n\n1B4GH4430N 1992 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 06 05 04 01 12 YYY\n\n1B4GH4430P 1993 DODG GRAND CARAVAN PV 42 6 181 G F P V 06 05 04 03 12 YYY\n\n1B4GH4430R 1994 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 05 08 04 07 12 YYY\n\n1B4GH4430S 1995 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 06 08 02 08 12 YYY\n\n1B4GH44R0N 1992 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 05 03 03 12 YYY\n\n1B4GH44R0P 1993 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 05 03 04 12 YYY\n\n1B4GH44R0R 1994 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 05 08 04 07 12 YYY\n\n1B4GH44R0S 1995 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 08 02 08 12 YYY\n\n1B4GH45R0N 1992 DODG CARAVAN SE PV 42 6 201 G F P V 05 08 04 02 11 YYY\n\n1B4GH5430N 1992 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 06 03 04 02 15 YYY\n\n1B4GH54L0R 1994 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 10 02 09 12 YYY\n\n1B4GH54L0S 1995 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 05 12 02 06 11 YYY\n\n1B4GH54R0N 1992 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 03 04 02 12 YYY\n\n1B4GH54R0P 1993 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 03 04 09 12 YYY\n\n1B4GH54R0R 1994 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 10 02 09 12 YYY\n\n1B4GH54R0S 1995 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 05 12 02 06 12 YYY\n\n1B4GH55R0N 1992 DODG CARAVAN LE PV 42 6 201 G F P V 04 07 04 02 11 YYY\n\n1B4GK4030J 1988 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 01 02 02 09 07 YYY\n\n1B4GK4430K 1989 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 01 02 02 09 07 YYY\n\n1B4GK44R0L 1990 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4GK44R0M 1991 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 01 02 04 03 08 YYY\n\n1B4GK44R0N 1992 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 04 04 08 01 12 YYY\n\n1B4GK44R0P 1993 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 04 04 03 01 12 YYY\n\n1B4GK44R0R 1994 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 02 10 02 06 12 YYY\n\n1B4GK44R0S 1995 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 02 10 02 08 12 YYY\n\n1B4GK54L0R 1994 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 02 03 02 05 12 YYY\n\n1B4GK54L0S 1995 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 02 03 02 03 12 YYY\n\n1B4GK54R0L 1990 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4GK54R0M 1991 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 04 03 08 YYY\n\n1B4GK54R0N 1992 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 11 04 01 12 YYY\n\n1B4GK54R0P 1993 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 11 04 01 12 YYY\n\n1B4GK54R0R 1994 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 02 03 02 05 12 YYY\n\n1B4GK54R0S 1995 DODG GRAND CARAVAN LE ES PV 44 6 201 G F P V 02 03 02 03 12 YYY\n\n1B4GP15B02 2002 DODG CARAVAN EC PV 42 4 148 G F P V 06 02 02 02 08 YYY\n\n1B4GP24301 2001 DODG GRAND CARAVAN SE PV 42 6 201 F F L V 06 09 03 07 12 YYY\n\n1B4GP24302 2002 DODG GRAND CARAVAN SE PV 42 6 201 F F L V 06 09 02 07 12 YYY\n\n1B4GP25301 2001 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4GP25302 2002 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4GP25B01 2001 DODG CARAVAN SE PV 42 4 148 G F P V 06 09 02 02 10 YYY\n\n1B4GP25B02 2002 DODG CARAVAN SE PV 42 4 148 G F P V 06 09 02 02 10 YYY\n\n1B4GP25G01 2001 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP25R01 2001 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP25R02 2002 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP34302 2002 DODG GRAND CARAVAN EL PV 42 6 201 F F L V 06 09 02 07 12 YYY\n\n1B4GP44301 2001 DODG GRAND CARAVAN SPORT PV 42 6 201 F F L V 06 08 03 07 12 YYY\n\n1B4GP44302 2002 DODG GRAND CARAVAN SPORT PV 42 6 201 F F L V 06 08 02 09 12 YYY\n\n1B4GP4430T 1996 DODG GRAND CARAVAN SE ES 42 6 181 G P V 06 07 03 05 12 YYY\n\n1B4GP4430Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 181 G F P V 06 07 03 07 11 YYY\n\n1B4GP44B0T 1996 DODG GRAND CARAVAN SE PV 42 4 148 G F P V 06 07 02 06 11 YYY\n\n1B4GP44B0V 1997 DODG GRAND CARAVAN SE PV 42 4 148 G F P V 06 07 02 06 11 YYY\n\n1B4GP44G0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 07 11 YYY\n\n1B4GP44G0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 06 11 YYY\n\n1B4GP44G0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 07 11 YYY\n\n1B4GP44L0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 06 11 YYY\n\n1B4GP44L0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 06 11 YYY\n\n1B4GP44L0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 07 11 YYY\n\n1B4GP44R01 2001 DODG GRAND CARAVAN SPORT PV 42 6 201 G F P V 06 07 03 07 12 YYY\n\n1B4GP44R02 2002 DODG GRAND CARAVAN SPORT PV 42 6 201 G F P V 06 07 02 09 12 YYY\n\n1B4GP44R0T 1996 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 07 03 05 12 YYY\n\n1B4GP44R0V 1997 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 07 07 03 06 12 YYY\n\n1B4GP44R0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 06 11 YYY\n\n1B4GP44R0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 06 11 YYY\n\n1B4GP44R0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 07 11 YYY\n\n1B4GP45301 2001 DODG CARAVAN SPORT PV 42 6 201 F F L V 06 08 03 04 11 YYY\n\n1B4GP45302 2002 DODG CARAVAN SPORT PV 42 6 201 F F L V 06 09 03 04 11 YYY\n\n1B4GP45B0V 1997 DODG CARAVAN SE PV 42 4 148 G F P V 06 03 02 03 10 YYY\n\n1B4GP45G01 2001 DODG CARAVAN SPORT PV 42 6 201 G F P V 06 11 03 03 11 YYY\n\n1B4GP45G0W 1998 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 08 08 04 05 11 YYY\n\n1B4GP45G0X 1999 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 06 08 04 06 11 YYY\n\n1B4GP45G0Y 2000 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 08 08 04 04 11 YYY\n\n1B4GP45L0W 1998 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 08 09 04 05 12 YYY\n\n1B4GP45L0X 1999 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 06 09 04 07 11 YYY\n\n1B4GP45L0Y 2000 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 08 09 04 06 11 YYY\n\n1B4GP45R02 2002 DODG CARAVAN SPORT PV 42 6 201 G F P V 06 09 03 03 11 YYY\n\n1B4GP45R0T 1996 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 04 03 06 11 YYY\n\n1B4GP45R0V 1997 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 04 04 05 11 YYY\n\n1B4GP45R0W 1998 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 08 09 04 05 11 YYY\n\n1B4GP45R0X 1999 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 09 04 07 11 YYY\n\n1B4GP45R0Y 2000 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 08 09 04 06 11 YYY\n\n1B4GP54301 2001 DODG GRAND CARAVAN ES PV 42 6 201 F F L V 05 13 03 09 11 YYY\n\n1B4GP54G0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 201 F F L V 06 11 04 07 12 YYY\n\n1B4GP54G0X 1999 DODG GRAND CARAVAN LE PV 42 6 201 F F L V 06 09 04 06 12 YYY\n\n1B4GP54G0Y 2000 DODG GRAND CARAVAN LE PV 42 6 201 F F L V 06 09 03 07 12 YYY\n\n1B4GP54L01 2001 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 05 08 03 07 12 YYY\n\n1B4GP54L02 2002 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 05 08 02 08 11 YYY\n\n1B4GP54L0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 08 07 03 05 12 YYY\n\n1B4GP54L0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4GP54L0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 04 06 12 YYY\n\n1B4GP54L0X 1999 DODG GRAND CARAVAN LE PV 42 6 230 G F P V 06 10 04 06 12 YYY\n\n1B4GP54L0Y 2000 DODG GRAND CARAVAN LE PV 42 6 230 G F P V 06 10 03 06 12 YYY\n\n1B4GP54R0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 05 12 YYY\n\n1B4GP54R0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 06 12 YYY\n\n1B4GP54R0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 11 04 06 12 YYY\n\n1B4GP54R0X 1999 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 10 04 06 12 YYY\n\n1B4GP54R0Y 2000 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 09 03 06 12 YYY\n\n1B4GP55G0W 1998 DODG CARAVAN LE PV 42 6 201 F F L V 07 13 03 08 11 YYY\n\n1B4GP55G0X 1999 DODG CARAVAN LE PV 42 6 201 F F L V 07 13 04 08 11 YYY\n\n1B4GP55L0T 1996 DODG CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 05 11 YYY\n\n1B4GP55L0V 1997 DODG CARAVAN LE ES PV 42 6 230 G F P V 08 07 04 05 11 YYY\n\n1B4GP55L0W 1998 DODG CARAVAN LE PV 42 6 230 G F P V 07 12 04 06 11 YYY\n\n1B4GP55L0X 1999 DODG CARAVAN LE PV 42 6 230 G F P V 07 12 03 07 11 YYY\n\n1B4GP55R0T 1996 DODG CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 05 11 YYY\n\n1B4GP55R0V 1997 DODG CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 06 11 YYY\n\n1B4GP55R0W 1998 DODG CARAVAN LE PV 42 6 201 G F P V 07 13 03 03 11 YYY\n\n1B4GP55R0X 1999 DODG CARAVAN LE PV 42 6 201 G F P V 07 13 02 04 11 YYY\n\n1B4GP74L0X 1999 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4GP74L0Y 2000 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 06 07 04 07 12 YYY\n\n1B4GT44L0V 1997 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 05 03 03 06 12 YYY\n\n1B4GT44L0W 1998 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 05 03 04 06 12 YYY\n\n1B4GT44L0X 1999 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 04 03 03 07 12 YYY\n\n1B4GT44L0Y 2000 DODG GRAND CARAVAN SPORT PV 44 6 230 G F P V 06 09 04 07 12 YYY\n\n1B4GT54L0V 1997 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 06 08 03 06 12 YYY\n\n1B4GT54L0W 1998 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 06 08 03 06 12 YYY\n\n1B4GT54L0X 1999 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 05 03 04 07 13 YYY\n\n1B4GT54L0Y 2000 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 06 03 04 07 13 YYY\n\n1B4GT74L0X 1999 DODG GRAND CARAVAN ES PV 44 6 230 G F P V 06 03 04 07 13 YYY\n\n1B4GT74L0Y 2000 DODG GRAND CARAVAN ES PV 44 6 230 G F P V 05 03 04 07 13 YYY\n\n1B4GW1210F 1985 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 02 04 03 YYY\n\n1B4GW12P0B 1981 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 02 01 03 05 YYY\n\n1B4GW12P0C 1982 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12R0B 1981 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 04 YYY\n\n1B4GW12R0C 1982 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 04 YYY\n\n1B4GW12S0C 1982 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 03 01 03 04 YYY\n\n1B4GW12T0B 1981 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 02 01 03 04 YYY\n\n1B4GW12T0C 1982 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 03 01 03 04 YYY\n\n1B4GW12T0D 1983 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12T0E 1984 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 05 YYY\n\n1B4GW12T0F 1985 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12U0D 1983 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12V0D 1983 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12W0D 1983 DODG RAMCHARGER AW-100 2W 44 8 360 G P Y 01 03 01 03 04 YYY\n\n1B4GW12W0E 1984 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12W0F 1985 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 02 04 03 YYY\n\n1B4HB11H0D 1983 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 03 01 03 04 YYY\n\n1B4HB11H0E 1984 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4HB11T0D 1983 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 02 01 01 04 YYY\n\n1B4HB11T0E 1984 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21E0C 1982 DODG RAM WAGON B250 PV 42 6 225 G C P V 01 01 01 03 04 YYY\n\n1B4HB21H0E 1984 DODG RAM WAGON B250 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4HB21P0C 1982 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21R0C 1982 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 03 YYY\n\n1B4HB21T0D 1983 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21T0E 1984 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21U0D 1983 DODG RAM WAGON B250 SV 42 8 318 G P V 01 01 01 01 04 YYY\n\n1B4HB23E0C 1982 DODG RAM VAN B250 CG 42 6 225 G C P V 01 01 01 03 04 YYY\n\n1B4HB23P0C 1982 DODG RAM VAN B250 CG 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB23T0D 1983 DODG RAM VAN B250 CG 42 8 318 G P V 01 01 01 01 04 YYY\n\n1B4HB23T0F 1985 DODG RAM VAN B250 CG 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HR28N01 2001 DODG DURANGO UT 42 8 287 G F P U 08 11 02 06 10 YYY\n\n1B4HR28X0X 1999 DODG DURANGO UT 42 6 239 G F P U 06 11 02 06 11 YYY\n\n1B4HR28Y0X 1999 DODG DURANGO UT 42 8 318 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Y0Y 2000 DODG DURANGO UT 42 8 318 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z01 2001 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z0X 1999 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z0Y 2000 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY"],"full_content":"**_POLK VIN_**\n\n**_MODEL YEAR MAKE MODEL_**\n\n**_BODY TYPE_**\n\n**_WHEEL DRIVE CYL CID FUEL CARB_**\n\n**_LUX IND VTI_**\n\n**_BI SYM_**\n\n**_PD SYM_**\n\n**_COMP SYM_**\n\n**_COLL SYM_**\n\n**_PIP SYM YMM_**\n\n1B4FK51G0E 1984 DODG CARAVAN LE PV 42 4 156 G C P V 05 02 01 01 07 YYY\n\n1B4FK51K0H 1987 DODG CARAVAN LE PV 42 4 153 G F P V 01 02 02 03 08 YYY\n\n1B4FK51K0J 1988 DODG CARAVAN LE PV 42 4 153 G F P V 04 02 01 02 09 YYY\n\n1B4FK5430K 1989 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 01 02 02 03 07 YYY\n\n1B4FK5430L 1990 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 01 02 02 02 08 YYY\n\n1B4FK54J0K 1989 DODG GRAND CARAVAN LE PV 42 4 153 G F P V 01 02 01 02 05 YYY\n\n1B4FK54R0L 1990 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4FP25301 2001 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4FP44R0T 1996 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 07 03 05 12 YYY\n\n1B4FP44R0V 1997 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 07 07 03 06 12 YYY\n\n1B4FP44R0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 07 11 YYY\n\n1B4FP54L0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 08 07 03 05 12 YYY\n\n1B4FP54L0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4FP54R0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 05 12 YYY\n\n1B4FP54R0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 06 12 YYY\n\n1B4GB11E0C 1982 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB11H0D 1983 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 03 01 03 04 YYY\n\n1B4GB11H0E 1984 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB11P0C 1982 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4GB11T0D 1983 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 02 01 01 04 YYY\n\n1B4GB11T0E 1984 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4GB13E0C 1982 DODG RAM VAN B150 CG 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB13H0E 1984 DODG RAM VAN B150 CG 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4GB13T0D 1983 DODG RAM VAN B150 CG 42 8 318 G P V 01 02 01 01 04 YYY\n\n1B4GB13T0F 1985 DODG RAM VAN B150 CG 42 8 318 G C P V 01 01 01 01 03 YYY\n\n1B4GD1210F 1985 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 02 05 07 YYY\n\n1B4GD12P0B 1981 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12P0C 1982 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12R0C 1982 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 06 YYY\n\n1B4GD12T0D 1983 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 07 YYY\n\n1B4GD12T0E 1984 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 01 01 08 YYY\n\n1B4GD12T0F 1985 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 02 02 05 08 YYY\n\n1B4GD12U0D 1983 DODG RAMCHARGER AD-100 UT 42 8 318 G C P U 01 01 01 01 07 YYY\n\n1B4GD12W0E 1984 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 01 01 07 YYY\n\n1B4GD12W0F 1985 DODG RAMCHARGER AD-100 UT 42 8 360 G C P U 01 02 02 05 07 YYY\n\n1B4GD44R0M 1991 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 01 01 01 04 07 YYY\n\n1B4GD54R0M 1991 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 01 04 02 07 YYY\n\n1B4GH2430R 1994 DODG GRAND CARAVAN PV 42 6 181 G F P V 05 02 02 07 15 YYY\n\n1B4GH2430S 1995 DODG GRAND CARAVAN PV 42 6 181 G F P V 07 02 02 03 17 YYY\n\n1B4GH4430N 1992 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 06 05 04 01 12 YYY\n\n1B4GH4430P 1993 DODG GRAND CARAVAN PV 42 6 181 G F P V 06 05 04 03 12 YYY\n\n1B4GH4430R 1994 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 05 08 04 07 12 YYY\n\n1B4GH4430S 1995 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 06 08 02 08 12 YYY\n\n1B4GH44R0N 1992 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 05 03 03 12 YYY\n\n1B4GH44R0P 1993 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 05 03 04 12 YYY\n\n1B4GH44R0R 1994 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 05 08 04 07 12 YYY\n\n1B4GH44R0S 1995 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 08 02 08 12 YYY\n\n1B4GH45R0N 1992 DODG CARAVAN SE PV 42 6 201 G F P V 05 08 04 02 11 YYY\n\n1B4GH5430N 1992 DODG GRAND CARAVAN LE PV 42 6 181 G F P V 06 03 04 02 15 YYY\n\n1B4GH54L0R 1994 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 10 02 09 12 YYY\n\n1B4GH54L0S 1995 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 05 12 02 06 11 YYY\n\n1B4GH54R0N 1992 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 03 04 02 12 YYY\n\n1B4GH54R0P 1993 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 03 04 09 12 YYY\n\n1B4GH54R0R 1994 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 10 02 09 12 YYY\n\n1B4GH54R0S 1995 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 05 12 02 06 12 YYY\n\n1B4GH55R0N 1992 DODG CARAVAN LE PV 42 6 201 G F P V 04 07 04 02 11 YYY\n\n1B4GK4030J 1988 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 01 02 02 09 07 YYY\n\n1B4GK4430K 1989 DODG GRAND CARAVAN SE PV 42 6 181 G F P V 01 02 02 09 07 YYY\n\n1B4GK44R0L 1990 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4GK44R0M 1991 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 01 02 04 03 08 YYY\n\n1B4GK44R0N 1992 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 04 04 08 01 12 YYY\n\n1B4GK44R0P 1993 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 04 04 03 01 12 YYY\n\n1B4GK44R0R 1994 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 02 10 02 06 12 YYY\n\n1B4GK44R0S 1995 DODG GRAND CARAVAN SE PV 44 6 201 G F P V 02 10 02 08 12 YYY\n\n1B4GK54L0R 1994 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 02 03 02 05 12 YYY\n\n1B4GK54L0S 1995 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 02 03 02 03 12 YYY\n\n1B4GK54R0L 1990 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 02 02 07 YYY\n\n1B4GK54R0M 1991 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 01 02 04 03 08 YYY\n\n1B4GK54R0N 1992 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 11 04 01 12 YYY\n\n1B4GK54R0P 1993 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 01 11 04 01 12 YYY\n\n1B4GK54R0R 1994 DODG GRAND CARAVAN LE PV 44 6 201 G F P V 02 03 02 05 12 YYY\n\n1B4GK54R0S 1995 DODG GRAND CARAVAN LE ES PV 44 6 201 G F P V 02 03 02 03 12 YYY\n\n1B4GP15B02 2002 DODG CARAVAN EC PV 42 4 148 G F P V 06 02 02 02 08 YYY\n\n1B4GP24301 2001 DODG GRAND CARAVAN SE PV 42 6 201 F F L V 06 09 03 07 12 YYY\n\n1B4GP24302 2002 DODG GRAND CARAVAN SE PV 42 6 201 F F L V 06 09 02 07 12 YYY\n\n1B4GP25301 2001 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4GP25302 2002 DODG CARAVAN SE PV 42 6 201 F F L V 06 11 02 04 11 YYY\n\n1B4GP25B01 2001 DODG CARAVAN SE PV 42 4 148 G F P V 06 09 02 02 10 YYY\n\n1B4GP25B02 2002 DODG CARAVAN SE PV 42 4 148 G F P V 06 09 02 02 10 YYY\n\n1B4GP25G01 2001 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP25R01 2001 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP25R02 2002 DODG CARAVAN SE PV 42 6 201 G F P V 06 09 02 02 11 YYY\n\n1B4GP34302 2002 DODG GRAND CARAVAN EL PV 42 6 201 F F L V 06 09 02 07 12 YYY\n\n1B4GP44301 2001 DODG GRAND CARAVAN SPORT PV 42 6 201 F F L V 06 08 03 07 12 YYY\n\n1B4GP44302 2002 DODG GRAND CARAVAN SPORT PV 42 6 201 F F L V 06 08 02 09 12 YYY\n\n1B4GP4430T 1996 DODG GRAND CARAVAN SE ES 42 6 181 G P V 06 07 03 05 12 YYY\n\n1B4GP4430Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 181 G F P V 06 07 03 07 11 YYY\n\n1B4GP44B0T 1996 DODG GRAND CARAVAN SE PV 42 4 148 G F P V 06 07 02 06 11 YYY\n\n1B4GP44B0V 1997 DODG GRAND CARAVAN SE PV 42 4 148 G F P V 06 07 02 06 11 YYY\n\n1B4GP44G0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 07 11 YYY\n\n1B4GP44G0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 06 11 YYY\n\n1B4GP44G0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 F F L V 06 07 03 07 11 YYY\n\n1B4GP44L0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 06 11 YYY\n\n1B4GP44L0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 06 11 YYY\n\n1B4GP44L0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 230 G F P V 06 07 03 07 11 YYY\n\n1B4GP44R01 2001 DODG GRAND CARAVAN SPORT PV 42 6 201 G F P V 06 07 03 07 12 YYY\n\n1B4GP44R02 2002 DODG GRAND CARAVAN SPORT PV 42 6 201 G F P V 06 07 02 09 12 YYY\n\n1B4GP44R0T 1996 DODG GRAND CARAVAN SE PV 42 6 201 G F P V 06 07 03 05 12 YYY\n\n1B4GP44R0V 1997 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 07 07 03 06 12 YYY\n\n1B4GP44R0W 1998 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 06 11 YYY\n\n1B4GP44R0X 1999 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 06 11 YYY\n\n1B4GP44R0Y 2000 DODG GRAND CARAVAN SE SPO PV 42 6 201 G F P V 06 07 03 07 11 YYY\n\n1B4GP45301 2001 DODG CARAVAN SPORT PV 42 6 201 F F L V 06 08 03 04 11 YYY\n\n1B4GP45302 2002 DODG CARAVAN SPORT PV 42 6 201 F F L V 06 09 03 04 11 YYY\n\n1B4GP45B0V 1997 DODG CARAVAN SE PV 42 4 148 G F P V 06 03 02 03 10 YYY\n\n1B4GP45G01 2001 DODG CARAVAN SPORT PV 42 6 201 G F P V 06 11 03 03 11 YYY\n\n1B4GP45G0W 1998 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 08 08 04 05 11 YYY\n\n1B4GP45G0X 1999 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 06 08 04 06 11 YYY\n\n1B4GP45G0Y 2000 DODG CARAVAN SE SPORT PV 42 6 201 F F L V 08 08 04 04 11 YYY\n\n1B4GP45L0W 1998 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 08 09 04 05 12 YYY\n\n1B4GP45L0X 1999 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 06 09 04 07 11 YYY\n\n1B4GP45L0Y 2000 DODG CARAVAN SE SPORT PV 42 6 230 G F P V 08 09 04 06 11 YYY\n\n1B4GP45R02 2002 DODG CARAVAN SPORT PV 42 6 201 G F P V 06 09 03 03 11 YYY\n\n1B4GP45R0T 1996 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 04 03 06 11 YYY\n\n1B4GP45R0V 1997 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 04 04 05 11 YYY\n\n1B4GP45R0W 1998 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 08 09 04 05 11 YYY\n\n1B4GP45R0X 1999 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 06 09 04 07 11 YYY\n\n1B4GP45R0Y 2000 DODG CARAVAN SE SPORT PV 42 6 201 G F P V 08 09 04 06 11 YYY\n\n1B4GP54301 2001 DODG GRAND CARAVAN ES PV 42 6 201 F F L V 05 13 03 09 11 YYY\n\n1B4GP54G0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 201 F F L V 06 11 04 07 12 YYY\n\n1B4GP54G0X 1999 DODG GRAND CARAVAN LE PV 42 6 201 F F L V 06 09 04 06 12 YYY\n\n1B4GP54G0Y 2000 DODG GRAND CARAVAN LE PV 42 6 201 F F L V 06 09 03 07 12 YYY\n\n1B4GP54L01 2001 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 05 08 03 07 12 YYY\n\n1B4GP54L02 2002 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 05 08 02 08 11 YYY\n\n1B4GP54L0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 08 07 03 05 12 YYY\n\n1B4GP54L0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4GP54L0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 230 G F P V 06 07 04 06 12 YYY\n\n1B4GP54L0X 1999 DODG GRAND CARAVAN LE PV 42 6 230 G F P V 06 10 04 06 12 YYY\n\n1B4GP54L0Y 2000 DODG GRAND CARAVAN LE PV 42 6 230 G F P V 06 10 03 06 12 YYY\n\n1B4GP54R0T 1996 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 05 12 YYY\n\n1B4GP54R0V 1997 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 06 12 YYY\n\n1B4GP54R0W 1998 DODG GRAND CARAVAN LE ES PV 42 6 201 G F P V 06 11 04 06 12 YYY\n\n1B4GP54R0X 1999 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 10 04 06 12 YYY\n\n1B4GP54R0Y 2000 DODG GRAND CARAVAN LE PV 42 6 201 G F P V 06 09 03 06 12 YYY\n\n1B4GP55G0W 1998 DODG CARAVAN LE PV 42 6 201 F F L V 07 13 03 08 11 YYY\n\n1B4GP55G0X 1999 DODG CARAVAN LE PV 42 6 201 F F L V 07 13 04 08 11 YYY\n\n1B4GP55L0T 1996 DODG CARAVAN LE ES PV 42 6 230 G F P V 06 07 03 05 11 YYY\n\n1B4GP55L0V 1997 DODG CARAVAN LE ES PV 42 6 230 G F P V 08 07 04 05 11 YYY\n\n1B4GP55L0W 1998 DODG CARAVAN LE PV 42 6 230 G F P V 07 12 04 06 11 YYY\n\n1B4GP55L0X 1999 DODG CARAVAN LE PV 42 6 230 G F P V 07 12 03 07 11 YYY\n\n1B4GP55R0T 1996 DODG CARAVAN LE ES PV 42 6 201 G F P V 06 07 03 05 11 YYY\n\n1B4GP55R0V 1997 DODG CARAVAN LE ES PV 42 6 201 G F P V 08 07 03 06 11 YYY\n\n1B4GP55R0W 1998 DODG CARAVAN LE PV 42 6 201 G F P V 07 13 03 03 11 YYY\n\n1B4GP55R0X 1999 DODG CARAVAN LE PV 42 6 201 G F P V 07 13 02 04 11 YYY\n\n1B4GP74L0X 1999 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 06 07 03 06 12 YYY\n\n1B4GP74L0Y 2000 DODG GRAND CARAVAN ES PV 42 6 230 G F P V 06 07 04 07 12 YYY\n\n1B4GT44L0V 1997 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 05 03 03 06 12 YYY\n\n1B4GT44L0W 1998 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 05 03 04 06 12 YYY\n\n1B4GT44L0X 1999 DODG GRAND CARAVAN SE PV 44 6 230 G F P V 04 03 03 07 12 YYY\n\n1B4GT44L0Y 2000 DODG GRAND CARAVAN SPORT PV 44 6 230 G F P V 06 09 04 07 12 YYY\n\n1B4GT54L0V 1997 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 06 08 03 06 12 YYY\n\n1B4GT54L0W 1998 DODG GRAND CARAVAN LE ES PV 44 6 230 G F P V 06 08 03 06 12 YYY\n\n1B4GT54L0X 1999 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 05 03 04 07 13 YYY\n\n1B4GT54L0Y 2000 DODG GRAND CARAVAN LE PV 44 6 230 G F P V 06 03 04 07 13 YYY\n\n1B4GT74L0X 1999 DODG GRAND CARAVAN ES PV 44 6 230 G F P V 06 03 04 07 13 YYY\n\n1B4GT74L0Y 2000 DODG GRAND CARAVAN ES PV 44 6 230 G F P V 05 03 04 07 13 YYY\n\n1B4GW1210F 1985 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 02 04 03 YYY\n\n1B4GW12P0B 1981 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 02 01 03 05 YYY\n\n1B4GW12P0C 1982 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12R0B 1981 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 04 YYY\n\n1B4GW12R0C 1982 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 04 YYY\n\n1B4GW12S0C 1982 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 03 01 03 04 YYY\n\n1B4GW12T0B 1981 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 02 01 03 04 YYY\n\n1B4GW12T0C 1982 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 03 01 03 04 YYY\n\n1B4GW12T0D 1983 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12T0E 1984 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 05 YYY\n\n1B4GW12T0F 1985 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12U0D 1983 DODG RAMCHARGER AW-100 UT 44 8 318 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12V0D 1983 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12W0D 1983 DODG RAMCHARGER AW-100 2W 44 8 360 G P Y 01 03 01 03 04 YYY\n\n1B4GW12W0E 1984 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 01 03 03 YYY\n\n1B4GW12W0F 1985 DODG RAMCHARGER AW-100 UT 44 8 360 G C P Y 01 01 02 04 03 YYY\n\n1B4HB11H0D 1983 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 03 01 03 04 YYY\n\n1B4HB11H0E 1984 DODG RAM WAGON B150 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4HB11T0D 1983 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 02 01 01 04 YYY\n\n1B4HB11T0E 1984 DODG RAM WAGON B150 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21E0C 1982 DODG RAM WAGON B250 PV 42 6 225 G C P V 01 01 01 03 04 YYY\n\n1B4HB21H0E 1984 DODG RAM WAGON B250 PV 42 6 225 G C P V 01 01 01 01 04 YYY\n\n1B4HB21P0C 1982 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21R0C 1982 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 03 YYY\n\n1B4HB21T0D 1983 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21T0E 1984 DODG RAM WAGON B250 PV 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB21U0D 1983 DODG RAM WAGON B250 SV 42 8 318 G P V 01 01 01 01 04 YYY\n\n1B4HB23E0C 1982 DODG RAM VAN B250 CG 42 6 225 G C P V 01 01 01 03 04 YYY\n\n1B4HB23P0C 1982 DODG RAM VAN B250 CG 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HB23T0D 1983 DODG RAM VAN B250 CG 42 8 318 G P V 01 01 01 01 04 YYY\n\n1B4HB23T0F 1985 DODG RAM VAN B250 CG 42 8 318 G C P V 01 01 01 01 04 YYY\n\n1B4HR28N01 2001 DODG DURANGO UT 42 8 287 G F P U 08 11 02 06 10 YYY\n\n1B4HR28X0X 1999 DODG DURANGO UT 42 6 239 G F P U 06 11 02 06 11 YYY\n\n1B4HR28Y0X 1999 DODG DURANGO UT 42 8 318 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Y0Y 2000 DODG DURANGO UT 42 8 318 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z01 2001 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z0X 1999 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY\n\n1B4HR28Z0Y 2000 DODG DURANGO UT 42 8 360 G F P U 08 11 02 06 10 YYY","publish_date":null,"title":"MODEL BODY WHEEL LUX BI PD COMP COLL PIP POLK VIN YEAR MAKE MODEL TYPE DRIVE CYL CID FUEL CARB","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llong_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/llong_page1.pdf"},"request":{"example_id":"table/llong_page1","product_type":"parse","source_file_path":"llong_page1.pdf"},"started_at":"2026-11-04T19:47:17.724888"} +{"completed_at":"2026-11-04T19:47:22.043632","latency_in_ms":2759,"output":{"example_id":"table/long-table_page1","grounded_pages":[],"layout_pages":[],"markdown":"Sheet1\n\nPage 1\n\n### **INVOICE EXAMPLE**\n\n### **Item # Description Quantity Unit Price Total**\n\n### 1 Widget A $50.00\n\n### 2 Widget B 15 $4.00 $60.00\n\n### 3 Widget C $45.00\n\n### 4 Widget D 8 $28.00\n\n### 5 Widget E $6.00 $30.00\n\n### 6 Widget F 12 $72.00\n\n### 7 Widget G 5 $7.50 $37.50\n\n### 8 Widget H $24.00\n\n### 9 Widget I 20 $2.50 $50.00\n\n### 10 Widget J 18 $54.00\n\n### 11 Widget K $24.00\n\n### 12 Widget L $4.50 $45.00\n\n### 13 Widget M 25 $5.00 $125.00\n\n### 14 Widget N $4.75 $85.50\n\n### 15 Widget O $60.00\n\n### 16 Widget P $3.25 $32.50\n\n### 17 Widget Q $60.00\n\n### 18 Widget R $30.00\n\n### 19 Widget S $4.50 $25.00\n\n### 20 Widget T 25 $5.00 $96.00\n\n### 21 Widget U $4.75 $60.00\n\n### 22 Widget V $90.00\n\n### 23 Widget W $3.25 $135.00\n\n### 24 Widget X $48.00\n\n### 25 Widget Y $72.00\n\n### 26 Widget Z $60.00\n\n### 27 Widget A $67.50\n\n### 28 Widget B $30.00\n\n### 29 Widget C $56.00\n\n### 30 Widget D $35.00\n\n### 31 Widget E $125.00","pages":[{"line_numbers":[],"markdown":"Sheet1\n\nPage 1\n\n### **INVOICE EXAMPLE**\n\n### **Item # Description Quantity Unit Price Total**\n\n### 1 Widget A $50.00\n\n### 2 Widget B 15 $4.00 $60.00\n\n### 3 Widget C $45.00\n\n### 4 Widget D 8 $28.00\n\n### 5 Widget E $6.00 $30.00\n\n### 6 Widget F 12 $72.00\n\n### 7 Widget G 5 $7.50 $37.50\n\n### 8 Widget H $24.00\n\n### 9 Widget I 20 $2.50 $50.00\n\n### 10 Widget J 18 $54.00\n\n### 11 Widget K $24.00\n\n### 12 Widget L $4.50 $45.00\n\n### 13 Widget M 25 $5.00 $125.00\n\n### 14 Widget N $4.75 $85.50\n\n### 15 Widget O $60.00\n\n### 16 Widget P $3.25 $32.50\n\n### 17 Widget Q $60.00\n\n### 18 Widget R $30.00\n\n### 19 Widget S $4.50 $25.00\n\n### 20 Widget T 25 $5.00 $96.00\n\n### 21 Widget U $4.75 $60.00\n\n### 22 Widget V $90.00\n\n### 23 Widget W $3.25 $135.00\n\n### 24 Widget X $48.00\n\n### 25 Widget Y $72.00\n\n### 26 Widget Z $60.00\n\n### 27 Widget A $67.50\n\n### 28 Widget B $30.00\n\n### 29 Widget C $56.00\n\n### 30 Widget D $35.00\n\n### 31 Widget E $125.00","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Sheet1\n\nPage 1\n\n### **INVOICE EXAMPLE**\n\n### **Item # Description Quantity Unit Price Total**\n\n### 1 Widget A $50.00\n\n### 2 Widget B 15 $4.00 $60.00\n\n### 3 Widget C $45.00\n\n### 4 Widget D 8 $28.00\n\n### 5 Widget E $6.00 $30.00\n\n### 6 Widget F 12 $72.00\n\n### 7 Widget G 5 $7.50 $37.50\n\n### 8 Widget H $24.00\n\n### 9 Widget I 20 $2.50 $50.00\n\n### 10 Widget J 18 $54.00\n\n### 11 Widget K $24.00\n\n### 12 Widget L $4.50 $45.00\n\n### 13 Widget M 25 $5.00 $125.00\n\n### 14 Widget N $4.75 $85.50\n\n### 15 Widget O $60.00\n\n### 16 Widget P $3.25 $32.50\n\n### 17 Widget Q $60.00\n\n### 18 Widget R $30.00\n\n### 19 Widget S $4.50 $25.00\n\n### 20 Widget T 25 $5.00 $96.00\n\n### 21 Widget U $4.75 $60.00\n\n### 22 Widget V $90.00\n\n### 23 Widget W $3.25 $135.00\n\n### 24 Widget X $48.00\n\n### 25 Widget Y $72.00\n\n### 26 Widget Z $60.00\n\n### 27 Widget A $67.50\n\n### 28 Widget B $30.00\n\n### 29 Widget C $56.00\n\n### 30 Widget D $35.00\n\n### 31 Widget E $125.00","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/long-table_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_3b4134c124d238b015cb84431a10ebce","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Sheet1\n\nPage 1\n\n### **INVOICE EXAMPLE**\n\n### **Item # Description Quantity Unit Price Total**\n\n### 1 Widget A $50.00\n\n### 2 Widget B 15 $4.00 $60.00\n\n### 3 Widget C $45.00\n\n### 4 Widget D 8 $28.00\n\n### 5 Widget E $6.00 $30.00\n\n### 6 Widget F 12 $72.00\n\n### 7 Widget G 5 $7.50 $37.50\n\n### 8 Widget H $24.00\n\n### 9 Widget I 20 $2.50 $50.00\n\n### 10 Widget J 18 $54.00\n\n### 11 Widget K $24.00\n\n### 12 Widget L $4.50 $45.00\n\n### 13 Widget M 25 $5.00 $125.00\n\n### 14 Widget N $4.75 $85.50\n\n### 15 Widget O $60.00\n\n### 16 Widget P $3.25 $32.50\n\n### 17 Widget Q $60.00\n\n### 18 Widget R $30.00\n\n### 19 Widget S $4.50 $25.00\n\n### 20 Widget T 25 $5.00 $96.00\n\n### 21 Widget U $4.75 $60.00\n\n### 22 Widget V $90.00\n\n### 23 Widget W $3.25 $135.00\n\n### 24 Widget X $48.00\n\n### 25 Widget Y $72.00\n\n### 26 Widget Z $60.00\n\n### 27 Widget A $67.50\n\n### 28 Widget B $30.00\n\n### 29 Widget C $56.00\n\n### 30 Widget D $35.00\n\n### 31 Widget E $125.00"],"full_content":"Sheet1\n\nPage 1\n\n### **INVOICE EXAMPLE**\n\n### **Item # Description Quantity Unit Price Total**\n\n### 1 Widget A $50.00\n\n### 2 Widget B 15 $4.00 $60.00\n\n### 3 Widget C $45.00\n\n### 4 Widget D 8 $28.00\n\n### 5 Widget E $6.00 $30.00\n\n### 6 Widget F 12 $72.00\n\n### 7 Widget G 5 $7.50 $37.50\n\n### 8 Widget H $24.00\n\n### 9 Widget I 20 $2.50 $50.00\n\n### 10 Widget J 18 $54.00\n\n### 11 Widget K $24.00\n\n### 12 Widget L $4.50 $45.00\n\n### 13 Widget M 25 $5.00 $125.00\n\n### 14 Widget N $4.75 $85.50\n\n### 15 Widget O $60.00\n\n### 16 Widget P $3.25 $32.50\n\n### 17 Widget Q $60.00\n\n### 18 Widget R $30.00\n\n### 19 Widget S $4.50 $25.00\n\n### 20 Widget T 25 $5.00 $96.00\n\n### 21 Widget U $4.75 $60.00\n\n### 22 Widget V $90.00\n\n### 23 Widget W $3.25 $135.00\n\n### 24 Widget X $48.00\n\n### 25 Widget Y $72.00\n\n### 26 Widget Z $60.00\n\n### 27 Widget A $67.50\n\n### 28 Widget B $30.00\n\n### 29 Widget C $56.00\n\n### 30 Widget D $35.00\n\n### 31 Widget E $125.00","publish_date":null,"title":"INVOICE EXAMPLE Item # Description Quantity Unit Price Total 1 Widget A $50.00 2 Widget B 15 $4.00 $60.00 3","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/long-table_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/long-table_page1.pdf"},"request":{"example_id":"table/long-table_page1","product_type":"parse","source_file_path":"long-table_page1.pdf"},"started_at":"2026-11-04T19:47:19.283803"} +{"completed_at":"2026-11-04T19:47:23.114677","latency_in_ms":2222,"output":{"example_id":"table/long-table_page5","grounded_pages":[],"layout_pages":[],"markdown":"Sheet1\n\nPage 5\n\n### 140 Widget J $37.50\n\n### 141 Widget K $135.00\n\n### 142 Widget L $60.00\n\n### 143 Widget M $5.00 $50.00\n\n### 144 Widget N 12 $90.00\n\n### 145 Widget O $6.25 $75.00\n\n### 146 Widget P $60.00\n\n### 147 Widget Q 25 $62.50","pages":[{"line_numbers":[],"markdown":"Sheet1\n\nPage 5\n\n### 140 Widget J $37.50\n\n### 141 Widget K $135.00\n\n### 142 Widget L $60.00\n\n### 143 Widget M $5.00 $50.00\n\n### 144 Widget N 12 $90.00\n\n### 145 Widget O $6.25 $75.00\n\n### 146 Widget P $60.00\n\n### 147 Widget Q 25 $62.50","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Sheet1\n\nPage 5\n\n### 140 Widget J $37.50\n\n### 141 Widget K $135.00\n\n### 142 Widget L $60.00\n\n### 143 Widget M $5.00 $50.00\n\n### 144 Widget N 12 $90.00\n\n### 145 Widget O $6.25 $75.00\n\n### 146 Widget P $60.00\n\n### 147 Widget Q 25 $62.50","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/long-table_page5.pdf"]},"response":{"errors":[],"extract_id":"extract_1147e56c4ba2db80eed4b2c19dc21280","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Sheet1\n\nPage 5\n\n### 140 Widget J $37.50\n\n### 141 Widget K $135.00\n\n### 142 Widget L $60.00\n\n### 143 Widget M $5.00 $50.00\n\n### 144 Widget N 12 $90.00\n\n### 145 Widget O $6.25 $75.00\n\n### 146 Widget P $60.00\n\n### 147 Widget Q 25 $62.50"],"full_content":"Sheet1\n\nPage 5\n\n### 140 Widget J $37.50\n\n### 141 Widget K $135.00\n\n### 142 Widget L $60.00\n\n### 143 Widget M $5.00 $50.00\n\n### 144 Widget N 12 $90.00\n\n### 145 Widget O $6.25 $75.00\n\n### 146 Widget P $60.00\n\n### 147 Widget Q 25 $62.50","publish_date":null,"title":"140 Widget J $37.50 141 Widget K $135.00 142 Widget L $60.00 143 Widget M $5.00 $50.00 144 Widget N","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/long-table_page5.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/long-table_page5.pdf"},"request":{"example_id":"table/long-table_page5","product_type":"parse","source_file_path":"long-table_page5.pdf"},"started_at":"2026-11-04T19:47:20.892078"} +{"completed_at":"2026-11-04T19:47:23.242395","latency_in_ms":1103,"output":{"example_id":"table/metlife_sustainability_report_2024_non_gaap_and_other_financial_disclosures_page3","grounded_pages":[],"layout_pages":[],"markdown":"# Non-GAAP and Other Financial Disclosures\n\nThe following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:\n\nNon-GAAP financial measures: Comparable GAAP financial measures:\n\n(i) total adjusted revenues; (i) total revenues;\n\n(ii) total adjusted expenses; (ii) total expenses;\n\n(iii) adjusted premiums, fees and other revenues; (iii) premiums, fees and other revenues;\n\n(iv) adjusted premiums, fees and other revenues, excluding PRT; (iv) premiums, fees and other revenues;\n\n(v) adjusted net investment income; (v) net investment income;\n\n(vi) adjusted earnings available to common shareholders; (vi) net income (loss) available to MetLife, Inc.’s common shareholders;\n\n(vii) adjusted earnings available to common shareholders, excluding total notable items; (vii) net income (loss) available to MetLife, Inc.’s common shareholders;\n\n(viii) adjusted earnings available to common shareholders per diluted common share; (viii) net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share;\n\n(ix) adjusted earnings available to common shareholders, excluding total notable items, per diluted common share;\n\n(ix) net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share;\n\n(x) adjusted return on equity; (x) return on equity;\n\n(xi) adjusted return on equity, excluding total notable items; (xi) return on equity;\n\n(xii) investment portfolio gains (losses); (xii) net investment gains (losses);\n\n(xiii) derivative gains (losses); (xiii) net derivative gains (losses);\n\n(xiv) adjusted capitalization of deferred policy acquisition costs (DAC); (xiv) capitalization of DAC;\n\n(xv) total MetLife, Inc.’s adjusted common stockholders’ equity; (xv) total MetLife, Inc.’s stockholders’ equity;\n\n(xvi) total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items; (xvi) total MetLife, Inc.’s stockholders’ equity;\n\n(xvii) adjusted book value per common share; (xvii) book value per common share;\n\n(xviii) adjusted other expenses; (xviii) other expenses;\n\n(xix) adjusted other expenses, net of adjusted capitalization of DAC; (xix) other expenses, net of capitalization of DAC;\n\n(xx) adjusted other expenses, net of adjusted capitalization of DAC, excluding total notable items related to adjusted other expenses;\n\n(xx) other expenses, net of capitalization of DAC;\n\n(xxi) adjusted expense ratio; (xxi) expense ratio;\n\n(xxii) adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT; (xxii) expense ratio;\n\n(xxiii) direct expenses; (xxiii) other expenses;\n\n(xxiv) direct expenses, excluding total notable items related to direct expenses; (xxiv) other expenses;\n\n(xxv) direct expense ratio; (xxv) expense ratio;\n\n(xxvi) direct expense ratio, excluding total notable items related to direct expenses and PRT; (xxvi) expense ratio;\n\n(xxvii) future policy benefits at original discount rate; and (xxvii) future policy benefits at balance sheet discount rate; and\n\n(xxviii) free cash flow of all holding companies. (xxviii) MetLife, Inc. (parent company only) net cash provided by (used in) operating activities.","pages":[{"line_numbers":[],"markdown":"# Non-GAAP and Other Financial Disclosures\n\nThe following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:\n\nNon-GAAP financial measures: Comparable GAAP financial measures:\n\n(i) total adjusted revenues; (i) total revenues;\n\n(ii) total adjusted expenses; (ii) total expenses;\n\n(iii) adjusted premiums, fees and other revenues; (iii) premiums, fees and other revenues;\n\n(iv) adjusted premiums, fees and other revenues, excluding PRT; (iv) premiums, fees and other revenues;\n\n(v) adjusted net investment income; (v) net investment income;\n\n(vi) adjusted earnings available to common shareholders; (vi) net income (loss) available to MetLife, Inc.’s common shareholders;\n\n(vii) adjusted earnings available to common shareholders, excluding total notable items; (vii) net income (loss) available to MetLife, Inc.’s common shareholders;\n\n(viii) adjusted earnings available to common shareholders per diluted common share; (viii) net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share;\n\n(ix) adjusted earnings available to common shareholders, excluding total notable items, per diluted common share;\n\n(ix) net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share;\n\n(x) adjusted return on equity; (x) return on equity;\n\n(xi) adjusted return on equity, excluding total notable items; (xi) return on equity;\n\n(xii) investment portfolio gains (losses); (xii) net investment gains (losses);\n\n(xiii) derivative gains (losses); (xiii) net derivative gains (losses);\n\n(xiv) adjusted capitalization of deferred policy acquisition costs (DAC); (xiv) capitalization of DAC;\n\n(xv) total MetLife, Inc.’s adjusted common stockholders’ equity; (xv) total MetLife, Inc.’s stockholders’ equity;\n\n(xvi) total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items; (xvi) total MetLife, Inc.’s stockholders’ equity;\n\n(xvii) adjusted book value per common share; (xvii) book value per common share;\n\n(xviii) adjusted other expenses; (xviii) other expenses;\n\n(xix) adjusted other expenses, net of adjusted capitalization of DAC; (xix) other expenses, net of capitalization of DAC;\n\n(xx) adjusted other expenses, net of adjusted capitalization of DAC, excluding total notable items related to adjusted other expenses;\n\n(xx) other expenses, net of capitalization of DAC;\n\n(xxi) adjusted expense ratio; (xxi) expense ratio;\n\n(xxii) adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT; (xxii) expense ratio;\n\n(xxiii) direct expenses; (xxiii) other expenses;\n\n(xxiv) direct expenses, excluding total notable items related to direct expenses; (xxiv) other expenses;\n\n(xxv) direct expense ratio; (xxv) expense ratio;\n\n(xxvi) direct expense ratio, excluding total notable items related to direct expenses and PRT; (xxvi) expense ratio;\n\n(xxvii) future policy benefits at original discount rate; and (xxvii) future policy benefits at balance sheet discount rate; and\n\n(xxviii) free cash flow of all holding companies. (xxviii) MetLife, Inc. (parent company only) net cash provided by (used in) operating activities.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"# Non-GAAP and Other Financial Disclosures\n\nThe following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:\n\nNon-GAAP financial measures: Comparable GAAP financial measures:\n\n(i) total adjusted revenues; (i) total revenues;\n\n(ii) total adjusted expenses; (ii) total expenses;\n\n(iii) adjusted premiums, fees and other revenues; (iii) premiums, fees and other revenues;\n\n(iv) adjusted premiums, fees and other revenues, excluding PRT; (iv) premiums, fees and other revenues;\n\n(v) adjusted net investment income; (v) net investment income;\n\n(vi) adjusted earnings available to common shareholders; (vi) net income (loss) available to MetLife, Inc.’s common shareholders;\n\n(vii) adjusted earnings available to common shareholders, excluding total notable items; (vii) net income (loss) available to MetLife, Inc.’s common shareholders;\n\n(viii) adjusted earnings available to common shareholders per diluted common share; (viii) net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share;\n\n(ix) adjusted earnings available to common shareholders, excluding total notable items, per diluted common share;\n\n(ix) net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share;\n\n(x) adjusted return on equity; (x) return on equity;\n\n(xi) adjusted return on equity, excluding total notable items; (xi) return on equity;\n\n(xii) investment portfolio gains (losses); (xii) net investment gains (losses);\n\n(xiii) derivative gains (losses); (xiii) net derivative gains (losses);\n\n(xiv) adjusted capitalization of deferred policy acquisition costs (DAC); (xiv) capitalization of DAC;\n\n(xv) total MetLife, Inc.’s adjusted common stockholders’ equity; (xv) total MetLife, Inc.’s stockholders’ equity;\n\n(xvi) total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items; (xvi) total MetLife, Inc.’s stockholders’ equity;\n\n(xvii) adjusted book value per common share; (xvii) book value per common share;\n\n(xviii) adjusted other expenses; (xviii) other expenses;\n\n(xix) adjusted other expenses, net of adjusted capitalization of DAC; (xix) other expenses, net of capitalization of DAC;\n\n(xx) adjusted other expenses, net of adjusted capitalization of DAC, excluding total notable items related to adjusted other expenses;\n\n(xx) other expenses, net of capitalization of DAC;\n\n(xxi) adjusted expense ratio; (xxi) expense ratio;\n\n(xxii) adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT; (xxii) expense ratio;\n\n(xxiii) direct expenses; (xxiii) other expenses;\n\n(xxiv) direct expenses, excluding total notable items related to direct expenses; (xxiv) other expenses;\n\n(xxv) direct expense ratio; (xxv) expense ratio;\n\n(xxvi) direct expense ratio, excluding total notable items related to direct expenses and PRT; (xxvi) expense ratio;\n\n(xxvii) future policy benefits at original discount rate; and (xxvii) future policy benefits at balance sheet discount rate; and\n\n(xxviii) free cash flow of all holding companies. (xxviii) MetLife, Inc. (parent company only) net cash provided by (used in) operating activities.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/metlife_sustainability_report_2024_non_gaap_and_other_financial_disclosures_page3.pdf"]},"response":{"errors":[],"extract_id":"extract_3c4e818fbad57b823d2dbf0125e1402e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["# Non-GAAP and Other Financial Disclosures\n\nThe following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:\n\nNon-GAAP financial measures: Comparable GAAP financial measures:\n\n(i) total adjusted revenues; (i) total revenues;\n\n(ii) total adjusted expenses; (ii) total expenses;\n\n(iii) adjusted premiums, fees and other revenues; (iii) premiums, fees and other revenues;\n\n(iv) adjusted premiums, fees and other revenues, excluding PRT; (iv) premiums, fees and other revenues;\n\n(v) adjusted net investment income; (v) net investment income;\n\n(vi) adjusted earnings available to common shareholders; (vi) net income (loss) available to MetLife, Inc.’s common shareholders;\n\n(vii) adjusted earnings available to common shareholders, excluding total notable items; (vii) net income (loss) available to MetLife, Inc.’s common shareholders;\n\n(viii) adjusted earnings available to common shareholders per diluted common share; (viii) net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share;\n\n(ix) adjusted earnings available to common shareholders, excluding total notable items, per diluted common share;\n\n(ix) net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share;\n\n(x) adjusted return on equity; (x) return on equity;\n\n(xi) adjusted return on equity, excluding total notable items; (xi) return on equity;\n\n(xii) investment portfolio gains (losses); (xii) net investment gains (losses);\n\n(xiii) derivative gains (losses); (xiii) net derivative gains (losses);\n\n(xiv) adjusted capitalization of deferred policy acquisition costs (DAC); (xiv) capitalization of DAC;\n\n(xv) total MetLife, Inc.’s adjusted common stockholders’ equity; (xv) total MetLife, Inc.’s stockholders’ equity;\n\n(xvi) total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items; (xvi) total MetLife, Inc.’s stockholders’ equity;\n\n(xvii) adjusted book value per common share; (xvii) book value per common share;\n\n(xviii) adjusted other expenses; (xviii) other expenses;\n\n(xix) adjusted other expenses, net of adjusted capitalization of DAC; (xix) other expenses, net of capitalization of DAC;\n\n(xx) adjusted other expenses, net of adjusted capitalization of DAC, excluding total notable items related to adjusted other expenses;\n\n(xx) other expenses, net of capitalization of DAC;\n\n(xxi) adjusted expense ratio; (xxi) expense ratio;\n\n(xxii) adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT; (xxii) expense ratio;\n\n(xxiii) direct expenses; (xxiii) other expenses;\n\n(xxiv) direct expenses, excluding total notable items related to direct expenses; (xxiv) other expenses;\n\n(xxv) direct expense ratio; (xxv) expense ratio;\n\n(xxvi) direct expense ratio, excluding total notable items related to direct expenses and PRT; (xxvi) expense ratio;\n\n(xxvii) future policy benefits at original discount rate; and (xxvii) future policy benefits at balance sheet discount rate; and\n\n(xxviii) free cash flow of all holding companies. (xxviii) MetLife, Inc. (parent company only) net cash provided by (used in) operating activities."],"full_content":"# Non-GAAP and Other Financial Disclosures\n\nThe following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:\n\nNon-GAAP financial measures: Comparable GAAP financial measures:\n\n(i) total adjusted revenues; (i) total revenues;\n\n(ii) total adjusted expenses; (ii) total expenses;\n\n(iii) adjusted premiums, fees and other revenues; (iii) premiums, fees and other revenues;\n\n(iv) adjusted premiums, fees and other revenues, excluding PRT; (iv) premiums, fees and other revenues;\n\n(v) adjusted net investment income; (v) net investment income;\n\n(vi) adjusted earnings available to common shareholders; (vi) net income (loss) available to MetLife, Inc.’s common shareholders;\n\n(vii) adjusted earnings available to common shareholders, excluding total notable items; (vii) net income (loss) available to MetLife, Inc.’s common shareholders;\n\n(viii) adjusted earnings available to common shareholders per diluted common share; (viii) net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share;\n\n(ix) adjusted earnings available to common shareholders, excluding total notable items, per diluted common share;\n\n(ix) net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share;\n\n(x) adjusted return on equity; (x) return on equity;\n\n(xi) adjusted return on equity, excluding total notable items; (xi) return on equity;\n\n(xii) investment portfolio gains (losses); (xii) net investment gains (losses);\n\n(xiii) derivative gains (losses); (xiii) net derivative gains (losses);\n\n(xiv) adjusted capitalization of deferred policy acquisition costs (DAC); (xiv) capitalization of DAC;\n\n(xv) total MetLife, Inc.’s adjusted common stockholders’ equity; (xv) total MetLife, Inc.’s stockholders’ equity;\n\n(xvi) total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items; (xvi) total MetLife, Inc.’s stockholders’ equity;\n\n(xvii) adjusted book value per common share; (xvii) book value per common share;\n\n(xviii) adjusted other expenses; (xviii) other expenses;\n\n(xix) adjusted other expenses, net of adjusted capitalization of DAC; (xix) other expenses, net of capitalization of DAC;\n\n(xx) adjusted other expenses, net of adjusted capitalization of DAC, excluding total notable items related to adjusted other expenses;\n\n(xx) other expenses, net of capitalization of DAC;\n\n(xxi) adjusted expense ratio; (xxi) expense ratio;\n\n(xxii) adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT; (xxii) expense ratio;\n\n(xxiii) direct expenses; (xxiii) other expenses;\n\n(xxiv) direct expenses, excluding total notable items related to direct expenses; (xxiv) other expenses;\n\n(xxv) direct expense ratio; (xxv) expense ratio;\n\n(xxvi) direct expense ratio, excluding total notable items related to direct expenses and PRT; (xxvi) expense ratio;\n\n(xxvii) future policy benefits at original discount rate; and (xxvii) future policy benefits at balance sheet discount rate; and\n\n(xxviii) free cash flow of all holding companies. (xxviii) MetLife, Inc. (parent company only) net cash provided by (used in) operating activities.","publish_date":null,"title":"Non-GAAP and Other Financial Disclosures","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/metlife_sustainability_report_2024_non_gaap_and_other_financial_disclosures_page3.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/metlife_sustainability_report_2024_non_gaap_and_other_financial_disclosures_page3.pdf"},"request":{"example_id":"table/metlife_sustainability_report_2024_non_gaap_and_other_financial_disclosures_page3","product_type":"parse","source_file_path":"metlife_sustainability_report_2024_non_gaap_and_other_financial_disclosures_page3.pdf"},"started_at":"2026-11-04T19:47:22.138419"} +{"completed_at":"2026-11-04T19:47:24.654178","latency_in_ms":1516,"output":{"example_id":"table/myco hierarchical table header_page3","grounded_pages":[],"layout_pages":[],"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\nincubation, the cultures in the wells were manually re-suspended before OD600 was read in the plate reader (Tecan Infinite 200 Pro) and used to calculate growth inhibition percentage of each well. The Fractional Inhibitory Concentration Index (FICI) was used to analyze the results from the checkerboard assay. FICI was calculated by using the concentrations at which at least 90% inhibition of the culture in the well as compared to the drug free culture was observed. It was computed as FICI = [(concentration of drug A in combination/concentration of drug A when used alone) + (concentration of drug B in combination/concentration of drug B when used alone)] (Hsieh et al., 1993). Synergy is defined as FICI ≤ 0.5, indifference is defined as 0.5 _<_ FICI ≤ 4, and antagonism is defined as FICI _>_ 4 (Hsieh et al., 1993).\n\n### Macrolide Resistance Induction Assay\n\n_M. abscessus_ subsp. _abscessus_ (ATCC 19977) mid-log phase culture was diluted to OD600 = 0.05 and treated with clarithromycin at a sub-inhibitory concentration of 0.075 µM\n\n(fourfold lower than clarithromycin MIC50 (concentration that causes 50% growth inhibition). An untreated culture was set up as a control. Cultures were grown to mid-log phase overnight and then subjected to the checkerboard titration assay as described above.\n\n### Bactericidal Assay\n\nBactericidal activity determinations were carried out in 14 mL round bottom tubes with the compounds added at set concentrations, with a starting inoculum of OD600 0.05 (10 ⁷ cfu/mL) in a final volume of 1 mL. The culture for the starting inoculum was diluted from a pre-culture at mid-log phase (OD600 = 0.4 to 0.6). Tubes were incubated for 3 days at 37 ◦ C with shaking at 160 rpm. After 3 days of drug exposure, 10 µL of the cultures were plated at different dilutions in 12 well plates containing 2 mL of 7H10 agar in each well. The plates were sealed with parafilm and incubated at 37 ◦ C for 4 days and then colonies were counted. We report fold-kill, which is the\n\nTABLE 1 | Outcome of screening 110 combinations of β-lactams and β-lactamase inhibitors against _Mycobacterium abscessus_ Bamboo: 6 two-drug hits.\n\n**β** \\-lactamase inhibitors\n\nNon- **β** \\-lactam- based **β** \\-lactam-based\n\nAVI VAB CLA SUL TZB\n\nβ-lactams Carbapenems Biapenem I I N.D N.D N.D\n\nDoripenem I I I I I\n\nErtapenem I I N.D N.D N.D\n\nFaropenem I N.D I I I\n\nImipenem I I I I I\n\nMeropenem I I I I I\n\nPanipenem S S I I I\n\nTebipenem S S N.D N.D N.D\n\nCephalosporins Cefaclor I I I I I\n\nCefprozil I N.D I I I\n\nCefoxitin I I I I I\n\nCefdinir I N.D I I I\n\nCefditoren I I I I I\n\nCefixime I I I I I\n\nCeftiofur I I I I I\n\nCefoperazone I I I I I\n\nCeftazidime I I I I I\n\nCefozopran I N.D I I I\n\nCeftobiprole I N.D I I I\n\nPenicillins Ampicillin S I I I I\n\nAmoxicillin S I I I I\n\nCloxacillin I I I I I\n\nMethicillin I N.D I I I\n\nPiperacillin I I I I I\n\nTicarcillin I I I I I\n\n_S, synergistic; I, indifferent; N.D, not determined. Synergy is defined as FICI_ ≤ _0\\.5. However, FICI values cannot be calculated for combinations involving_ β _\\-lactamase inhibitors or other drugs that do not have MIC values when used individually. Hence, in the tables, synergistic interactions are defined as either combinations with FICI_ ≤ _0\\.5 or combinations that exhibit potentiation where a fourfold or more reduction in concentration of both drugs when used together is observed to inhibit 90% of growth as compared to when they are each used alone. Indifferent is defined as 0.5_ _<_ _FICI_ ≤ _4\\. Where FICI cannot be calculated, ‘indifferent’ is defined as a less than fourfold in concentration of each antibiotic needed to achieve inhibition of 90% of growth when used together as compared to when the antibiotic is used alone. AVI, avibactam; VAB, vaborbactam; CLA, clavulanate; SUL, sulbactam; TZB, tazobactam._\n\nFrontiers in Microbiology | www.frontiersin.org 3 May 2018 | Volume 9 | Article 932","pages":[{"line_numbers":[],"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\nincubation, the cultures in the wells were manually re-suspended before OD600 was read in the plate reader (Tecan Infinite 200 Pro) and used to calculate growth inhibition percentage of each well. The Fractional Inhibitory Concentration Index (FICI) was used to analyze the results from the checkerboard assay. FICI was calculated by using the concentrations at which at least 90% inhibition of the culture in the well as compared to the drug free culture was observed. It was computed as FICI = [(concentration of drug A in combination/concentration of drug A when used alone) + (concentration of drug B in combination/concentration of drug B when used alone)] (Hsieh et al., 1993). Synergy is defined as FICI ≤ 0.5, indifference is defined as 0.5 _<_ FICI ≤ 4, and antagonism is defined as FICI _>_ 4 (Hsieh et al., 1993).\n\n### Macrolide Resistance Induction Assay\n\n_M. abscessus_ subsp. _abscessus_ (ATCC 19977) mid-log phase culture was diluted to OD600 = 0.05 and treated with clarithromycin at a sub-inhibitory concentration of 0.075 µM\n\n(fourfold lower than clarithromycin MIC50 (concentration that causes 50% growth inhibition). An untreated culture was set up as a control. Cultures were grown to mid-log phase overnight and then subjected to the checkerboard titration assay as described above.\n\n### Bactericidal Assay\n\nBactericidal activity determinations were carried out in 14 mL round bottom tubes with the compounds added at set concentrations, with a starting inoculum of OD600 0.05 (10 ⁷ cfu/mL) in a final volume of 1 mL. The culture for the starting inoculum was diluted from a pre-culture at mid-log phase (OD600 = 0.4 to 0.6). Tubes were incubated for 3 days at 37 ◦ C with shaking at 160 rpm. After 3 days of drug exposure, 10 µL of the cultures were plated at different dilutions in 12 well plates containing 2 mL of 7H10 agar in each well. The plates were sealed with parafilm and incubated at 37 ◦ C for 4 days and then colonies were counted. We report fold-kill, which is the\n\nTABLE 1 | Outcome of screening 110 combinations of β-lactams and β-lactamase inhibitors against _Mycobacterium abscessus_ Bamboo: 6 two-drug hits.\n\n**β** \\-lactamase inhibitors\n\nNon- **β** \\-lactam- based **β** \\-lactam-based\n\nAVI VAB CLA SUL TZB\n\nβ-lactams Carbapenems Biapenem I I N.D N.D N.D\n\nDoripenem I I I I I\n\nErtapenem I I N.D N.D N.D\n\nFaropenem I N.D I I I\n\nImipenem I I I I I\n\nMeropenem I I I I I\n\nPanipenem S S I I I\n\nTebipenem S S N.D N.D N.D\n\nCephalosporins Cefaclor I I I I I\n\nCefprozil I N.D I I I\n\nCefoxitin I I I I I\n\nCefdinir I N.D I I I\n\nCefditoren I I I I I\n\nCefixime I I I I I\n\nCeftiofur I I I I I\n\nCefoperazone I I I I I\n\nCeftazidime I I I I I\n\nCefozopran I N.D I I I\n\nCeftobiprole I N.D I I I\n\nPenicillins Ampicillin S I I I I\n\nAmoxicillin S I I I I\n\nCloxacillin I I I I I\n\nMethicillin I N.D I I I\n\nPiperacillin I I I I I\n\nTicarcillin I I I I I\n\n_S, synergistic; I, indifferent; N.D, not determined. Synergy is defined as FICI_ ≤ _0\\.5. However, FICI values cannot be calculated for combinations involving_ β _\\-lactamase inhibitors or other drugs that do not have MIC values when used individually. Hence, in the tables, synergistic interactions are defined as either combinations with FICI_ ≤ _0\\.5 or combinations that exhibit potentiation where a fourfold or more reduction in concentration of both drugs when used together is observed to inhibit 90% of growth as compared to when they are each used alone. Indifferent is defined as 0.5_ _<_ _FICI_ ≤ _4\\. Where FICI cannot be calculated, ‘indifferent’ is defined as a less than fourfold in concentration of each antibiotic needed to achieve inhibition of 90% of growth when used together as compared to when the antibiotic is used alone. AVI, avibactam; VAB, vaborbactam; CLA, clavulanate; SUL, sulbactam; TZB, tazobactam._\n\nFrontiers in Microbiology | www.frontiersin.org 3 May 2018 | Volume 9 | Article 932","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\nincubation, the cultures in the wells were manually re-suspended before OD600 was read in the plate reader (Tecan Infinite 200 Pro) and used to calculate growth inhibition percentage of each well. The Fractional Inhibitory Concentration Index (FICI) was used to analyze the results from the checkerboard assay. FICI was calculated by using the concentrations at which at least 90% inhibition of the culture in the well as compared to the drug free culture was observed. It was computed as FICI = [(concentration of drug A in combination/concentration of drug A when used alone) + (concentration of drug B in combination/concentration of drug B when used alone)] (Hsieh et al., 1993). Synergy is defined as FICI ≤ 0.5, indifference is defined as 0.5 _<_ FICI ≤ 4, and antagonism is defined as FICI _>_ 4 (Hsieh et al., 1993).\n\n### Macrolide Resistance Induction Assay\n\n_M. abscessus_ subsp. _abscessus_ (ATCC 19977) mid-log phase culture was diluted to OD600 = 0.05 and treated with clarithromycin at a sub-inhibitory concentration of 0.075 µM\n\n(fourfold lower than clarithromycin MIC50 (concentration that causes 50% growth inhibition). An untreated culture was set up as a control. Cultures were grown to mid-log phase overnight and then subjected to the checkerboard titration assay as described above.\n\n### Bactericidal Assay\n\nBactericidal activity determinations were carried out in 14 mL round bottom tubes with the compounds added at set concentrations, with a starting inoculum of OD600 0.05 (10 ⁷ cfu/mL) in a final volume of 1 mL. The culture for the starting inoculum was diluted from a pre-culture at mid-log phase (OD600 = 0.4 to 0.6). Tubes were incubated for 3 days at 37 ◦ C with shaking at 160 rpm. After 3 days of drug exposure, 10 µL of the cultures were plated at different dilutions in 12 well plates containing 2 mL of 7H10 agar in each well. The plates were sealed with parafilm and incubated at 37 ◦ C for 4 days and then colonies were counted. We report fold-kill, which is the\n\nTABLE 1 | Outcome of screening 110 combinations of β-lactams and β-lactamase inhibitors against _Mycobacterium abscessus_ Bamboo: 6 two-drug hits.\n\n**β** \\-lactamase inhibitors\n\nNon- **β** \\-lactam- based **β** \\-lactam-based\n\nAVI VAB CLA SUL TZB\n\nβ-lactams Carbapenems Biapenem I I N.D N.D N.D\n\nDoripenem I I I I I\n\nErtapenem I I N.D N.D N.D\n\nFaropenem I N.D I I I\n\nImipenem I I I I I\n\nMeropenem I I I I I\n\nPanipenem S S I I I\n\nTebipenem S S N.D N.D N.D\n\nCephalosporins Cefaclor I I I I I\n\nCefprozil I N.D I I I\n\nCefoxitin I I I I I\n\nCefdinir I N.D I I I\n\nCefditoren I I I I I\n\nCefixime I I I I I\n\nCeftiofur I I I I I\n\nCefoperazone I I I I I\n\nCeftazidime I I I I I\n\nCefozopran I N.D I I I\n\nCeftobiprole I N.D I I I\n\nPenicillins Ampicillin S I I I I\n\nAmoxicillin S I I I I\n\nCloxacillin I I I I I\n\nMethicillin I N.D I I I\n\nPiperacillin I I I I I\n\nTicarcillin I I I I I\n\n_S, synergistic; I, indifferent; N.D, not determined. Synergy is defined as FICI_ ≤ _0\\.5. However, FICI values cannot be calculated for combinations involving_ β _\\-lactamase inhibitors or other drugs that do not have MIC values when used individually. Hence, in the tables, synergistic interactions are defined as either combinations with FICI_ ≤ _0\\.5 or combinations that exhibit potentiation where a fourfold or more reduction in concentration of both drugs when used together is observed to inhibit 90% of growth as compared to when they are each used alone. Indifferent is defined as 0.5_ _<_ _FICI_ ≤ _4\\. Where FICI cannot be calculated, ‘indifferent’ is defined as a less than fourfold in concentration of each antibiotic needed to achieve inhibition of 90% of growth when used together as compared to when the antibiotic is used alone. AVI, avibactam; VAB, vaborbactam; CLA, clavulanate; SUL, sulbactam; TZB, tazobactam._\n\nFrontiers in Microbiology | www.frontiersin.org 3 May 2018 | Volume 9 | Article 932","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page3.pdf"]},"response":{"errors":[],"extract_id":"extract_9fadf441211cae3f5790fe9676e342f5","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\nincubation, the cultures in the wells were manually re-suspended before OD600 was read in the plate reader (Tecan Infinite 200 Pro) and used to calculate growth inhibition percentage of each well. The Fractional Inhibitory Concentration Index (FICI) was used to analyze the results from the checkerboard assay. FICI was calculated by using the concentrations at which at least 90% inhibition of the culture in the well as compared to the drug free culture was observed. It was computed as FICI = [(concentration of drug A in combination/concentration of drug A when used alone) + (concentration of drug B in combination/concentration of drug B when used alone)] (Hsieh et al., 1993). Synergy is defined as FICI ≤ 0.5, indifference is defined as 0.5 _<_ FICI ≤ 4, and antagonism is defined as FICI _>_ 4 (Hsieh et al., 1993).\n\n### Macrolide Resistance Induction Assay\n\n_M. abscessus_ subsp. _abscessus_ (ATCC 19977) mid-log phase culture was diluted to OD600 = 0.05 and treated with clarithromycin at a sub-inhibitory concentration of 0.075 µM\n\n(fourfold lower than clarithromycin MIC50 (concentration that causes 50% growth inhibition). An untreated culture was set up as a control. Cultures were grown to mid-log phase overnight and then subjected to the checkerboard titration assay as described above.\n\n### Bactericidal Assay\n\nBactericidal activity determinations were carried out in 14 mL round bottom tubes with the compounds added at set concentrations, with a starting inoculum of OD600 0.05 (10 ⁷ cfu/mL) in a final volume of 1 mL. The culture for the starting inoculum was diluted from a pre-culture at mid-log phase (OD600 = 0.4 to 0.6). Tubes were incubated for 3 days at 37 ◦ C with shaking at 160 rpm. After 3 days of drug exposure, 10 µL of the cultures were plated at different dilutions in 12 well plates containing 2 mL of 7H10 agar in each well. The plates were sealed with parafilm and incubated at 37 ◦ C for 4 days and then colonies were counted. We report fold-kill, which is the\n\nTABLE 1 | Outcome of screening 110 combinations of β-lactams and β-lactamase inhibitors against _Mycobacterium abscessus_ Bamboo: 6 two-drug hits.\n\n**β** \\-lactamase inhibitors\n\nNon- **β** \\-lactam- based **β** \\-lactam-based\n\nAVI VAB CLA SUL TZB\n\nβ-lactams Carbapenems Biapenem I I N.D N.D N.D\n\nDoripenem I I I I I\n\nErtapenem I I N.D N.D N.D\n\nFaropenem I N.D I I I\n\nImipenem I I I I I\n\nMeropenem I I I I I\n\nPanipenem S S I I I\n\nTebipenem S S N.D N.D N.D\n\nCephalosporins Cefaclor I I I I I\n\nCefprozil I N.D I I I\n\nCefoxitin I I I I I\n\nCefdinir I N.D I I I\n\nCefditoren I I I I I\n\nCefixime I I I I I\n\nCeftiofur I I I I I\n\nCefoperazone I I I I I\n\nCeftazidime I I I I I\n\nCefozopran I N.D I I I\n\nCeftobiprole I N.D I I I\n\nPenicillins Ampicillin S I I I I\n\nAmoxicillin S I I I I\n\nCloxacillin I I I I I\n\nMethicillin I N.D I I I\n\nPiperacillin I I I I I\n\nTicarcillin I I I I I\n\n_S, synergistic; I, indifferent; N.D, not determined. Synergy is defined as FICI_ ≤ _0\\.5. However, FICI values cannot be calculated for combinations involving_ β _\\-lactamase inhibitors or other drugs that do not have MIC values when used individually. Hence, in the tables, synergistic interactions are defined as either combinations with FICI_ ≤ _0\\.5 or combinations that exhibit potentiation where a fourfold or more reduction in concentration of both drugs when used together is observed to inhibit 90% of growth as compared to when they are each used alone. Indifferent is defined as 0.5_ _<_ _FICI_ ≤ _4\\. Where FICI cannot be calculated, ‘indifferent’ is defined as a less than fourfold in concentration of each antibiotic needed to achieve inhibition of 90% of growth when used together as compared to when the antibiotic is used alone. AVI, avibactam; VAB, vaborbactam; CLA, clavulanate; SUL, sulbactam; TZB, tazobactam._\n\nFrontiers in Microbiology | www.frontiersin.org 3 May 2018 | Volume 9 | Article 932"],"full_content":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\nincubation, the cultures in the wells were manually re-suspended before OD600 was read in the plate reader (Tecan Infinite 200 Pro) and used to calculate growth inhibition percentage of each well. The Fractional Inhibitory Concentration Index (FICI) was used to analyze the results from the checkerboard assay. FICI was calculated by using the concentrations at which at least 90% inhibition of the culture in the well as compared to the drug free culture was observed. It was computed as FICI = [(concentration of drug A in combination/concentration of drug A when used alone) + (concentration of drug B in combination/concentration of drug B when used alone)] (Hsieh et al., 1993). Synergy is defined as FICI ≤ 0.5, indifference is defined as 0.5 _<_ FICI ≤ 4, and antagonism is defined as FICI _>_ 4 (Hsieh et al., 1993).\n\n### Macrolide Resistance Induction Assay\n\n_M. abscessus_ subsp. _abscessus_ (ATCC 19977) mid-log phase culture was diluted to OD600 = 0.05 and treated with clarithromycin at a sub-inhibitory concentration of 0.075 µM\n\n(fourfold lower than clarithromycin MIC50 (concentration that causes 50% growth inhibition). An untreated culture was set up as a control. Cultures were grown to mid-log phase overnight and then subjected to the checkerboard titration assay as described above.\n\n### Bactericidal Assay\n\nBactericidal activity determinations were carried out in 14 mL round bottom tubes with the compounds added at set concentrations, with a starting inoculum of OD600 0.05 (10 ⁷ cfu/mL) in a final volume of 1 mL. The culture for the starting inoculum was diluted from a pre-culture at mid-log phase (OD600 = 0.4 to 0.6). Tubes were incubated for 3 days at 37 ◦ C with shaking at 160 rpm. After 3 days of drug exposure, 10 µL of the cultures were plated at different dilutions in 12 well plates containing 2 mL of 7H10 agar in each well. The plates were sealed with parafilm and incubated at 37 ◦ C for 4 days and then colonies were counted. We report fold-kill, which is the\n\nTABLE 1 | Outcome of screening 110 combinations of β-lactams and β-lactamase inhibitors against _Mycobacterium abscessus_ Bamboo: 6 two-drug hits.\n\n**β** \\-lactamase inhibitors\n\nNon- **β** \\-lactam- based **β** \\-lactam-based\n\nAVI VAB CLA SUL TZB\n\nβ-lactams Carbapenems Biapenem I I N.D N.D N.D\n\nDoripenem I I I I I\n\nErtapenem I I N.D N.D N.D\n\nFaropenem I N.D I I I\n\nImipenem I I I I I\n\nMeropenem I I I I I\n\nPanipenem S S I I I\n\nTebipenem S S N.D N.D N.D\n\nCephalosporins Cefaclor I I I I I\n\nCefprozil I N.D I I I\n\nCefoxitin I I I I I\n\nCefdinir I N.D I I I\n\nCefditoren I I I I I\n\nCefixime I I I I I\n\nCeftiofur I I I I I\n\nCefoperazone I I I I I\n\nCeftazidime I I I I I\n\nCefozopran I N.D I I I\n\nCeftobiprole I N.D I I I\n\nPenicillins Ampicillin S I I I I\n\nAmoxicillin S I I I I\n\nCloxacillin I I I I I\n\nMethicillin I N.D I I I\n\nPiperacillin I I I I I\n\nTicarcillin I I I I I\n\n_S, synergistic; I, indifferent; N.D, not determined. Synergy is defined as FICI_ ≤ _0\\.5. However, FICI values cannot be calculated for combinations involving_ β _\\-lactamase inhibitors or other drugs that do not have MIC values when used individually. Hence, in the tables, synergistic interactions are defined as either combinations with FICI_ ≤ _0\\.5 or combinations that exhibit potentiation where a fourfold or more reduction in concentration of both drugs when used together is observed to inhibit 90% of growth as compared to when they are each used alone. Indifferent is defined as 0.5_ _<_ _FICI_ ≤ _4\\. Where FICI cannot be calculated, ‘indifferent’ is defined as a less than fourfold in concentration of each antibiotic needed to achieve inhibition of 90% of growth when used together as compared to when the antibiotic is used alone. AVI, avibactam; VAB, vaborbactam; CLA, clavulanate; SUL, sulbactam; TZB, tazobactam._\n\nFrontiers in Microbiology | www.frontiersin.org 3 May 2018 | Volume 9 | Article 932","publish_date":null,"title":"Bactericidal Assay Macrolide Resistance Induction Assay","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page3.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page3.pdf"},"request":{"example_id":"table/myco hierarchical table header_page3","product_type":"parse","source_file_path":"myco hierarchical table header_page3.pdf"},"started_at":"2026-11-04T19:47:23.137457"} +{"completed_at":"2026-11-04T19:47:25.970450","latency_in_ms":1590,"output":{"example_id":"table/myco hierarchical table header_page4","grounded_pages":[],"layout_pages":[],"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\nreduction in cfu/mL of the treated culture compared to the time zero untreated control.\n\n### RESULTS\n\n### Screening of 180 Two-Drug Combinations for Synergy Against _M. abscessus_ Identifies 11 Hits\n\nWe screened a total of 180 two-drug combinations of approved antibiotics for their growth inhibition potency against the clinical isolate _M. abscessus_ Bamboo using the checkerboard assay. Hits were defined as combinations that showed at least a fourfold decrease in concentration of each drug that was needed to achieve 90% inhibition as compared to the concentration needed to achieve that same level of inhibition when either drug was used alone. Screening of β-lactam – β-lactamase inhibitor combinations, identified 6 hits out of 110 combinations ( **Table 1** ). Screening of combinations of cell envelope targeting drugs with antibiotics that inhibit intracellular targets, identified 5 hits out of 70 combinations ( **Table 2** ). Taken together, the screen identified 11 primary hits (6.1% hit rate) which were re-confirmed with fresh solids ( **Table 3** ). Three of our combination hits, panipenem + avibactam, tebipenem + avibactam, and amoxicillin + avibactam were reported previously (Dubee et al., 2015a; Kaushik et al., 2017). Out of our eight novel hits, the potencies of ampicillin + avibactam, panipenem + vaborbactam, tebipenem + vaborbactam, and ceftobiprole + linezolid were only modest, with MIC90 (concentrations that inhibit 90% of growth) of 25 + 19 µM, 50 + 2 µM, 10 + 10 µM, and 38 + 19 µM ( **Table 3** ). One of our novel hits involved the glycopeptide ramoplanin in combination with clarithromycin, however, this is not\n\nunexpected since we had previously reported synergy between the glycopeptide vancomycin with clarithromycin (Mukherjee et al., 2017). Three novel hits showed encouraging synergy effects: Ramoplanin + tigecycline, vancomycin + tigecycline and teicoplanin + tigecycline inhibited growth at 5 + 0.8 µM, 2 + 1 µM and 3 + 1 µM, respectively ( **Table 3** ). Ramoplanin, vancomycin, and teicoplanin are all glycopeptides. Ramoplanin is not well absorbed and unstable in the bloodstream due to hydrolysis of the lactone bond (Farver et al., 2005). This makes ramoplanin unsuitable to repurpose for use in treatment of _M. abscessus_ lung infections. As teicoplanin shows systemic exposure upon intravenous or intramuscular administration and has been reported to have a better safety and efficacy profile compared to vancomycin (Svetitsky et al., 2009), we characterized the activity of teicoplanin in combination with the glycylcycline tigecycline in more detail.\n\n### Teicoplanin **\\+** Tigecycline Displays Activity Against Reference Strains Representing the Three Subspecies of the _M. abscessus_ Complex\n\nTo determine whether the teicoplanin + tigecycline combination shows similar attractive potency across the three subspecies of the _M. abscessus_ complex, we carried out the checkerboard titration assay to determine the FICI value of the combination against the reference strains _M. abscessus_ subsp. _abscessus_ ATCC 19977, _M. abscessus_ subsp. _bolletii_ CCUG 50184-T and _M. abscessus_ subsp. _massiliense_ CCUG 48898-T. The teicoplanin + tigecycline combination was synergistic against all three subspecies ( **Table 4** ). These results suggest that this novel combination is active across the phylogenetically divergent _M. abscessus_ complex.\n\nTABLE 2 | Outcome of screening 70 combinations of cell envelope-targeting antibiotics with antibiotics targeting intracellular targets against _M. abscessus_ Bamboo: 5 synergistic two-drug hits.\n\nAntibiotics with intracellular targets\n\nLZD LVX MXF AZM CLR TGC RFB\n\nCell envelope-targeting antibiotics β-lactams Doripenem I I I I I N.D I\n\nFaropenem I I I I I N.D I\n\nImipenem I N.D I I I N.D I\n\nPanipenem I I I I I N.D I\n\nCefoxitin I I I I I N.D I\n\nCefdinir I I I I I N.D I\n\nCefozopran I I I I I N.D I\n\nCeftiofur I I I I I N.D I\n\nCeftobiprole S I I I I N.D I\n\nGlycopeptides Ramoplanin I I I N.D S S I\n\nVancomycin N.D N.D N.D N.D S a S I\n\nTeicoplanin I I I I I S I\n\nPolymyxins Colistin N.D I I N.D N.D N.D N.D\n\n_S, synergistic; I, indifferent; N.D, not determined. For definition of terms see legend of_ _Table 1_ _. LZD, linezolid; LVX, levofloxacin; MXF, moxifloxacin; AZM, azithromycin; CLR, clarithromycin; TGC, tigecycline; RFB, rifabutin._ _a_ _Reported previously in Mukherjee et al. (2017)._\n\nFrontiers in Microbiology | www.frontiersin.org 4 May 2018 | Volume 9 | Article 932","pages":[{"line_numbers":[],"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\nreduction in cfu/mL of the treated culture compared to the time zero untreated control.\n\n### RESULTS\n\n### Screening of 180 Two-Drug Combinations for Synergy Against _M. abscessus_ Identifies 11 Hits\n\nWe screened a total of 180 two-drug combinations of approved antibiotics for their growth inhibition potency against the clinical isolate _M. abscessus_ Bamboo using the checkerboard assay. Hits were defined as combinations that showed at least a fourfold decrease in concentration of each drug that was needed to achieve 90% inhibition as compared to the concentration needed to achieve that same level of inhibition when either drug was used alone. Screening of β-lactam – β-lactamase inhibitor combinations, identified 6 hits out of 110 combinations ( **Table 1** ). Screening of combinations of cell envelope targeting drugs with antibiotics that inhibit intracellular targets, identified 5 hits out of 70 combinations ( **Table 2** ). Taken together, the screen identified 11 primary hits (6.1% hit rate) which were re-confirmed with fresh solids ( **Table 3** ). Three of our combination hits, panipenem + avibactam, tebipenem + avibactam, and amoxicillin + avibactam were reported previously (Dubee et al., 2015a; Kaushik et al., 2017). Out of our eight novel hits, the potencies of ampicillin + avibactam, panipenem + vaborbactam, tebipenem + vaborbactam, and ceftobiprole + linezolid were only modest, with MIC90 (concentrations that inhibit 90% of growth) of 25 + 19 µM, 50 + 2 µM, 10 + 10 µM, and 38 + 19 µM ( **Table 3** ). One of our novel hits involved the glycopeptide ramoplanin in combination with clarithromycin, however, this is not\n\nunexpected since we had previously reported synergy between the glycopeptide vancomycin with clarithromycin (Mukherjee et al., 2017). Three novel hits showed encouraging synergy effects: Ramoplanin + tigecycline, vancomycin + tigecycline and teicoplanin + tigecycline inhibited growth at 5 + 0.8 µM, 2 + 1 µM and 3 + 1 µM, respectively ( **Table 3** ). Ramoplanin, vancomycin, and teicoplanin are all glycopeptides. Ramoplanin is not well absorbed and unstable in the bloodstream due to hydrolysis of the lactone bond (Farver et al., 2005). This makes ramoplanin unsuitable to repurpose for use in treatment of _M. abscessus_ lung infections. As teicoplanin shows systemic exposure upon intravenous or intramuscular administration and has been reported to have a better safety and efficacy profile compared to vancomycin (Svetitsky et al., 2009), we characterized the activity of teicoplanin in combination with the glycylcycline tigecycline in more detail.\n\n### Teicoplanin **\\+** Tigecycline Displays Activity Against Reference Strains Representing the Three Subspecies of the _M. abscessus_ Complex\n\nTo determine whether the teicoplanin + tigecycline combination shows similar attractive potency across the three subspecies of the _M. abscessus_ complex, we carried out the checkerboard titration assay to determine the FICI value of the combination against the reference strains _M. abscessus_ subsp. _abscessus_ ATCC 19977, _M. abscessus_ subsp. _bolletii_ CCUG 50184-T and _M. abscessus_ subsp. _massiliense_ CCUG 48898-T. The teicoplanin + tigecycline combination was synergistic against all three subspecies ( **Table 4** ). These results suggest that this novel combination is active across the phylogenetically divergent _M. abscessus_ complex.\n\nTABLE 2 | Outcome of screening 70 combinations of cell envelope-targeting antibiotics with antibiotics targeting intracellular targets against _M. abscessus_ Bamboo: 5 synergistic two-drug hits.\n\nAntibiotics with intracellular targets\n\nLZD LVX MXF AZM CLR TGC RFB\n\nCell envelope-targeting antibiotics β-lactams Doripenem I I I I I N.D I\n\nFaropenem I I I I I N.D I\n\nImipenem I N.D I I I N.D I\n\nPanipenem I I I I I N.D I\n\nCefoxitin I I I I I N.D I\n\nCefdinir I I I I I N.D I\n\nCefozopran I I I I I N.D I\n\nCeftiofur I I I I I N.D I\n\nCeftobiprole S I I I I N.D I\n\nGlycopeptides Ramoplanin I I I N.D S S I\n\nVancomycin N.D N.D N.D N.D S a S I\n\nTeicoplanin I I I I I S I\n\nPolymyxins Colistin N.D I I N.D N.D N.D N.D\n\n_S, synergistic; I, indifferent; N.D, not determined. For definition of terms see legend of_ _Table 1_ _. LZD, linezolid; LVX, levofloxacin; MXF, moxifloxacin; AZM, azithromycin; CLR, clarithromycin; TGC, tigecycline; RFB, rifabutin._ _a_ _Reported previously in Mukherjee et al. (2017)._\n\nFrontiers in Microbiology | www.frontiersin.org 4 May 2018 | Volume 9 | Article 932","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\nreduction in cfu/mL of the treated culture compared to the time zero untreated control.\n\n### RESULTS\n\n### Screening of 180 Two-Drug Combinations for Synergy Against _M. abscessus_ Identifies 11 Hits\n\nWe screened a total of 180 two-drug combinations of approved antibiotics for their growth inhibition potency against the clinical isolate _M. abscessus_ Bamboo using the checkerboard assay. Hits were defined as combinations that showed at least a fourfold decrease in concentration of each drug that was needed to achieve 90% inhibition as compared to the concentration needed to achieve that same level of inhibition when either drug was used alone. Screening of β-lactam – β-lactamase inhibitor combinations, identified 6 hits out of 110 combinations ( **Table 1** ). Screening of combinations of cell envelope targeting drugs with antibiotics that inhibit intracellular targets, identified 5 hits out of 70 combinations ( **Table 2** ). Taken together, the screen identified 11 primary hits (6.1% hit rate) which were re-confirmed with fresh solids ( **Table 3** ). Three of our combination hits, panipenem + avibactam, tebipenem + avibactam, and amoxicillin + avibactam were reported previously (Dubee et al., 2015a; Kaushik et al., 2017). Out of our eight novel hits, the potencies of ampicillin + avibactam, panipenem + vaborbactam, tebipenem + vaborbactam, and ceftobiprole + linezolid were only modest, with MIC90 (concentrations that inhibit 90% of growth) of 25 + 19 µM, 50 + 2 µM, 10 + 10 µM, and 38 + 19 µM ( **Table 3** ). One of our novel hits involved the glycopeptide ramoplanin in combination with clarithromycin, however, this is not\n\nunexpected since we had previously reported synergy between the glycopeptide vancomycin with clarithromycin (Mukherjee et al., 2017). Three novel hits showed encouraging synergy effects: Ramoplanin + tigecycline, vancomycin + tigecycline and teicoplanin + tigecycline inhibited growth at 5 + 0.8 µM, 2 + 1 µM and 3 + 1 µM, respectively ( **Table 3** ). Ramoplanin, vancomycin, and teicoplanin are all glycopeptides. Ramoplanin is not well absorbed and unstable in the bloodstream due to hydrolysis of the lactone bond (Farver et al., 2005). This makes ramoplanin unsuitable to repurpose for use in treatment of _M. abscessus_ lung infections. As teicoplanin shows systemic exposure upon intravenous or intramuscular administration and has been reported to have a better safety and efficacy profile compared to vancomycin (Svetitsky et al., 2009), we characterized the activity of teicoplanin in combination with the glycylcycline tigecycline in more detail.\n\n### Teicoplanin **\\+** Tigecycline Displays Activity Against Reference Strains Representing the Three Subspecies of the _M. abscessus_ Complex\n\nTo determine whether the teicoplanin + tigecycline combination shows similar attractive potency across the three subspecies of the _M. abscessus_ complex, we carried out the checkerboard titration assay to determine the FICI value of the combination against the reference strains _M. abscessus_ subsp. _abscessus_ ATCC 19977, _M. abscessus_ subsp. _bolletii_ CCUG 50184-T and _M. abscessus_ subsp. _massiliense_ CCUG 48898-T. The teicoplanin + tigecycline combination was synergistic against all three subspecies ( **Table 4** ). These results suggest that this novel combination is active across the phylogenetically divergent _M. abscessus_ complex.\n\nTABLE 2 | Outcome of screening 70 combinations of cell envelope-targeting antibiotics with antibiotics targeting intracellular targets against _M. abscessus_ Bamboo: 5 synergistic two-drug hits.\n\nAntibiotics with intracellular targets\n\nLZD LVX MXF AZM CLR TGC RFB\n\nCell envelope-targeting antibiotics β-lactams Doripenem I I I I I N.D I\n\nFaropenem I I I I I N.D I\n\nImipenem I N.D I I I N.D I\n\nPanipenem I I I I I N.D I\n\nCefoxitin I I I I I N.D I\n\nCefdinir I I I I I N.D I\n\nCefozopran I I I I I N.D I\n\nCeftiofur I I I I I N.D I\n\nCeftobiprole S I I I I N.D I\n\nGlycopeptides Ramoplanin I I I N.D S S I\n\nVancomycin N.D N.D N.D N.D S a S I\n\nTeicoplanin I I I I I S I\n\nPolymyxins Colistin N.D I I N.D N.D N.D N.D\n\n_S, synergistic; I, indifferent; N.D, not determined. For definition of terms see legend of_ _Table 1_ _. LZD, linezolid; LVX, levofloxacin; MXF, moxifloxacin; AZM, azithromycin; CLR, clarithromycin; TGC, tigecycline; RFB, rifabutin._ _a_ _Reported previously in Mukherjee et al. (2017)._\n\nFrontiers in Microbiology | www.frontiersin.org 4 May 2018 | Volume 9 | Article 932","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page4.pdf"]},"response":{"errors":[],"extract_id":"extract_ab0e95386031980b00e37781188f8a60","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\nreduction in cfu/mL of the treated culture compared to the time zero untreated control.\n\n### RESULTS\n\n### Screening of 180 Two-Drug Combinations for Synergy Against _M. abscessus_ Identifies 11 Hits\n\nWe screened a total of 180 two-drug combinations of approved antibiotics for their growth inhibition potency against the clinical isolate _M. abscessus_ Bamboo using the checkerboard assay. Hits were defined as combinations that showed at least a fourfold decrease in concentration of each drug that was needed to achieve 90% inhibition as compared to the concentration needed to achieve that same level of inhibition when either drug was used alone. Screening of β-lactam – β-lactamase inhibitor combinations, identified 6 hits out of 110 combinations ( **Table 1** ). Screening of combinations of cell envelope targeting drugs with antibiotics that inhibit intracellular targets, identified 5 hits out of 70 combinations ( **Table 2** ). Taken together, the screen identified 11 primary hits (6.1% hit rate) which were re-confirmed with fresh solids ( **Table 3** ). Three of our combination hits, panipenem + avibactam, tebipenem + avibactam, and amoxicillin + avibactam were reported previously (Dubee et al., 2015a; Kaushik et al., 2017). Out of our eight novel hits, the potencies of ampicillin + avibactam, panipenem + vaborbactam, tebipenem + vaborbactam, and ceftobiprole + linezolid were only modest, with MIC90 (concentrations that inhibit 90% of growth) of 25 + 19 µM, 50 + 2 µM, 10 + 10 µM, and 38 + 19 µM ( **Table 3** ). One of our novel hits involved the glycopeptide ramoplanin in combination with clarithromycin, however, this is not\n\nunexpected since we had previously reported synergy between the glycopeptide vancomycin with clarithromycin (Mukherjee et al., 2017). Three novel hits showed encouraging synergy effects: Ramoplanin + tigecycline, vancomycin + tigecycline and teicoplanin + tigecycline inhibited growth at 5 + 0.8 µM, 2 + 1 µM and 3 + 1 µM, respectively ( **Table 3** ). Ramoplanin, vancomycin, and teicoplanin are all glycopeptides. Ramoplanin is not well absorbed and unstable in the bloodstream due to hydrolysis of the lactone bond (Farver et al., 2005). This makes ramoplanin unsuitable to repurpose for use in treatment of _M. abscessus_ lung infections. As teicoplanin shows systemic exposure upon intravenous or intramuscular administration and has been reported to have a better safety and efficacy profile compared to vancomycin (Svetitsky et al., 2009), we characterized the activity of teicoplanin in combination with the glycylcycline tigecycline in more detail.\n\n### Teicoplanin **\\+** Tigecycline Displays Activity Against Reference Strains Representing the Three Subspecies of the _M. abscessus_ Complex\n\nTo determine whether the teicoplanin + tigecycline combination shows similar attractive potency across the three subspecies of the _M. abscessus_ complex, we carried out the checkerboard titration assay to determine the FICI value of the combination against the reference strains _M. abscessus_ subsp. _abscessus_ ATCC 19977, _M. abscessus_ subsp. _bolletii_ CCUG 50184-T and _M. abscessus_ subsp. _massiliense_ CCUG 48898-T. The teicoplanin + tigecycline combination was synergistic against all three subspecies ( **Table 4** ). These results suggest that this novel combination is active across the phylogenetically divergent _M. abscessus_ complex.\n\nTABLE 2 | Outcome of screening 70 combinations of cell envelope-targeting antibiotics with antibiotics targeting intracellular targets against _M. abscessus_ Bamboo: 5 synergistic two-drug hits.\n\nAntibiotics with intracellular targets\n\nLZD LVX MXF AZM CLR TGC RFB\n\nCell envelope-targeting antibiotics β-lactams Doripenem I I I I I N.D I\n\nFaropenem I I I I I N.D I\n\nImipenem I N.D I I I N.D I\n\nPanipenem I I I I I N.D I\n\nCefoxitin I I I I I N.D I\n\nCefdinir I I I I I N.D I\n\nCefozopran I I I I I N.D I\n\nCeftiofur I I I I I N.D I\n\nCeftobiprole S I I I I N.D I\n\nGlycopeptides Ramoplanin I I I N.D S S I\n\nVancomycin N.D N.D N.D N.D S a S I\n\nTeicoplanin I I I I I S I\n\nPolymyxins Colistin N.D I I N.D N.D N.D N.D\n\n_S, synergistic; I, indifferent; N.D, not determined. For definition of terms see legend of_ _Table 1_ _. LZD, linezolid; LVX, levofloxacin; MXF, moxifloxacin; AZM, azithromycin; CLR, clarithromycin; TGC, tigecycline; RFB, rifabutin._ _a_ _Reported previously in Mukherjee et al. (2017)._\n\nFrontiers in Microbiology | www.frontiersin.org 4 May 2018 | Volume 9 | Article 932"],"full_content":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\nreduction in cfu/mL of the treated culture compared to the time zero untreated control.\n\n### RESULTS\n\n### Screening of 180 Two-Drug Combinations for Synergy Against _M. abscessus_ Identifies 11 Hits\n\nWe screened a total of 180 two-drug combinations of approved antibiotics for their growth inhibition potency against the clinical isolate _M. abscessus_ Bamboo using the checkerboard assay. Hits were defined as combinations that showed at least a fourfold decrease in concentration of each drug that was needed to achieve 90% inhibition as compared to the concentration needed to achieve that same level of inhibition when either drug was used alone. Screening of β-lactam – β-lactamase inhibitor combinations, identified 6 hits out of 110 combinations ( **Table 1** ). Screening of combinations of cell envelope targeting drugs with antibiotics that inhibit intracellular targets, identified 5 hits out of 70 combinations ( **Table 2** ). Taken together, the screen identified 11 primary hits (6.1% hit rate) which were re-confirmed with fresh solids ( **Table 3** ). Three of our combination hits, panipenem + avibactam, tebipenem + avibactam, and amoxicillin + avibactam were reported previously (Dubee et al., 2015a; Kaushik et al., 2017). Out of our eight novel hits, the potencies of ampicillin + avibactam, panipenem + vaborbactam, tebipenem + vaborbactam, and ceftobiprole + linezolid were only modest, with MIC90 (concentrations that inhibit 90% of growth) of 25 + 19 µM, 50 + 2 µM, 10 + 10 µM, and 38 + 19 µM ( **Table 3** ). One of our novel hits involved the glycopeptide ramoplanin in combination with clarithromycin, however, this is not\n\nunexpected since we had previously reported synergy between the glycopeptide vancomycin with clarithromycin (Mukherjee et al., 2017). Three novel hits showed encouraging synergy effects: Ramoplanin + tigecycline, vancomycin + tigecycline and teicoplanin + tigecycline inhibited growth at 5 + 0.8 µM, 2 + 1 µM and 3 + 1 µM, respectively ( **Table 3** ). Ramoplanin, vancomycin, and teicoplanin are all glycopeptides. Ramoplanin is not well absorbed and unstable in the bloodstream due to hydrolysis of the lactone bond (Farver et al., 2005). This makes ramoplanin unsuitable to repurpose for use in treatment of _M. abscessus_ lung infections. As teicoplanin shows systemic exposure upon intravenous or intramuscular administration and has been reported to have a better safety and efficacy profile compared to vancomycin (Svetitsky et al., 2009), we characterized the activity of teicoplanin in combination with the glycylcycline tigecycline in more detail.\n\n### Teicoplanin **\\+** Tigecycline Displays Activity Against Reference Strains Representing the Three Subspecies of the _M. abscessus_ Complex\n\nTo determine whether the teicoplanin + tigecycline combination shows similar attractive potency across the three subspecies of the _M. abscessus_ complex, we carried out the checkerboard titration assay to determine the FICI value of the combination against the reference strains _M. abscessus_ subsp. _abscessus_ ATCC 19977, _M. abscessus_ subsp. _bolletii_ CCUG 50184-T and _M. abscessus_ subsp. _massiliense_ CCUG 48898-T. The teicoplanin + tigecycline combination was synergistic against all three subspecies ( **Table 4** ). These results suggest that this novel combination is active across the phylogenetically divergent _M. abscessus_ complex.\n\nTABLE 2 | Outcome of screening 70 combinations of cell envelope-targeting antibiotics with antibiotics targeting intracellular targets against _M. abscessus_ Bamboo: 5 synergistic two-drug hits.\n\nAntibiotics with intracellular targets\n\nLZD LVX MXF AZM CLR TGC RFB\n\nCell envelope-targeting antibiotics β-lactams Doripenem I I I I I N.D I\n\nFaropenem I I I I I N.D I\n\nImipenem I N.D I I I N.D I\n\nPanipenem I I I I I N.D I\n\nCefoxitin I I I I I N.D I\n\nCefdinir I I I I I N.D I\n\nCefozopran I I I I I N.D I\n\nCeftiofur I I I I I N.D I\n\nCeftobiprole S I I I I N.D I\n\nGlycopeptides Ramoplanin I I I N.D S S I\n\nVancomycin N.D N.D N.D N.D S a S I\n\nTeicoplanin I I I I I S I\n\nPolymyxins Colistin N.D I I N.D N.D N.D N.D\n\n_S, synergistic; I, indifferent; N.D, not determined. For definition of terms see legend of_ _Table 1_ _. LZD, linezolid; LVX, levofloxacin; MXF, moxifloxacin; AZM, azithromycin; CLR, clarithromycin; TGC, tigecycline; RFB, rifabutin._ _a_ _Reported previously in Mukherjee et al. (2017)._\n\nFrontiers in Microbiology | www.frontiersin.org 4 May 2018 | Volume 9 | Article 932","publish_date":null,"title":"RESULTS Screening of 180 Two-Drug Combinations for Synergy Against M. abscessus Identifies 11 Hits + Teicoplanin Tigecycline Displays Activity Against","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page4.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page4.pdf"},"request":{"example_id":"table/myco hierarchical table header_page4","product_type":"parse","source_file_path":"myco hierarchical table header_page4.pdf"},"started_at":"2026-11-04T19:47:24.379675"} +{"completed_at":"2026-11-04T19:47:26.627634","latency_in_ms":1261,"output":{"example_id":"table/myco hierarchical table header_page5","grounded_pages":[],"layout_pages":[],"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\n### Teicoplanin **\\+** Tigecycline Retains Its Activity Against _M. abscessus_ subsp. _abscessus_ ATCC 19977 Cultures Displaying Induced Macrolide Resistance\n\nThe checkerboard titration assay was performed using _M. abscessus_ subsp. _abscessus_ ATCC 19977 cultures that had been exposed to a sub-inhibitory concentration of clarithromycin to induce macrolide resistance to determine whether the teicoplanin + tigecycline combination retains its activity under these conditions. The combination still exhibited synergy against the culture with induced macrolide resistance as seen by its FICI value of 0.22 ( **Table 4** ).\n\n### Teicoplanin **\\+** Tigecycline Shows Potent Activity Against _M. abscessus_ Clinical Isolates\n\nThe teicoplanin + tigecycline combination showed potent growth inhibition activity against the screening strain as well as the reference strains representing the three subspecies of _M. abscessus_ . This suggests that most clinical _M. abscessus_ strains may be susceptible to this combination.\n\nTABLE 3 | Reconfirmation of 11 two-drug hits identified from screening of 180 combinations against _M. abscessus_ Bamboo.\n\nStrategy Combination MIC90 ( **µ** M)\n\nAlone Combined\n\nβ-lactams + β-lactamase inhibitors Panipenem + _>_ 50 50 Avibactam _>_ 50 6\n\nTebipenem + 46 13\n\nAvibactam _>_ 50 0.8\n\nAmpicillin + _>_ 50 25\n\nAvibactam _>_ 50 19\n\nAmoxicillin + _>_ 50 25\n\nAvibactam _>_ 50 25\n\nPanipenem + _>_ 50 50\n\nVaborbactam _>_ 50 2\n\nTebipenem + 40 10\n\nVaborbactam _>_ 50 10\n\nCell envelope- targeting + antibiotics with intracellular targets\n\nCeftobiprole + _>_ 50 38\n\nLinezolid _>_ 50 19\n\nRamoplanin + 30 5\n\nClarithromycin 0.7 0.2\n\nRamoplanin + 30 5\n\nTigecycline 7 0.8\n\nVancomycin + 17 2\n\nTigecycline 6 1\n\nTeicoplanin + 25 3\n\nTigecycline 8 1\n\n_The synergy or potentiation concentration of the 11 drug pair hits identified in the screens shown in_ _Tables 1_ _,_ _2_ _are reported. Results shown are the mean of two replicates. Standard deviations were_ ± _50% of shown values._\n\nTo provide evidence for a widespread susceptibility of _M. abscessus_ to the teicoplanin + tigecycline combination, we tested its activity against a collection of clinical isolates covering various subspecies of _M. abscessus_ , including clarithromycin resistant as well as clarithromycin sensitive strains. The combination displayed synergy against 70.4% of the isolates with FICI values ranging from 0.32 to 0.48 ( **Table 5** ). This result indicates that this combination is active against a large number of _M. abscessus_ isolates.\n\n### Teicoplanin **\\+** Tigecycline Is Not Bactericidal Against _M. abscessus_ subsp. _abscessus_ ATCC 19977\n\nTo determine whether the teicoplanin + tigecycline combination shows bactericidal activity against _M. abscessus_ , cultures were treated with the drug combination and the effect on viability was determined by cfu enumeration as described in Section “Materials and Methods.” The teicoplanin + tigecycline combination showed no bactericidal activity.\n\n### DISCUSSION\n\nA synergy screen of 180 dual antibiotic combinations against _M. abscessus_ yielded a total of 11 hits. Six hits were obtained from combinations of β-lactams with β-lactamase inhibitors, and five hits from combinations of cell wall- targeting antibiotics with antibiotics that have intracellular targets. From the analyses of combinations of β-lactams with β-lactamase inhibitors, the most striking observation is that all six hits involved a non-β-lactam-based β-lactamase inhibitor. 4 out of the 6 hits involved avibactam. This is consistent with previous reports showing that this inhibitor is effective against _M. abscessus_ β-lactamases (Ehmann et al., 2012; Soroka et al., 2014; Dubee et al., 2015a; Kaushik et al., 2017). The remaining 2 hits involved the novel non-β-lactam-based β-lactamase inhibitor vaborbactam, which has not been previously studied for activity against _M. abscessus_ β-lactamases. Activity of avibactam and now vaborbactam suggests that it may be worthwhile to characterize other types of non-β-lactam β-lactamase inhibitors like phosphonates, hydroxamates, or vanadate-catechol complexes, in combination with β-lactams for any potentiation effect of the combinations against _M. abscessus_ (Bebrone et al., 2010). It is to note that out of the three sub-classes of β-lactams we tested, avibactam appears not to improve the activity of cephalosporins, in contrast to a previous report describing potentiation between ceftaroline and avibactam against _M. abscessus_ (Dubee et al., 2015b). A recent study by Kaushik et al. (2017) which focused on combinations of avibactam, sulbactam and tazobactam with carbapenems against _M. abscessus_ reported 3 hits, with potentiation observed for combinations of avibactam with ertapenem, tebipenem, or panipenem (Kaushik et al., 2017). In this study, we could confirm potentiation for combinations of\n\nFrontiers in Microbiology | www.frontiersin.org 5 May 2018 | Volume 9 | Article 932","pages":[{"line_numbers":[],"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\n### Teicoplanin **\\+** Tigecycline Retains Its Activity Against _M. abscessus_ subsp. _abscessus_ ATCC 19977 Cultures Displaying Induced Macrolide Resistance\n\nThe checkerboard titration assay was performed using _M. abscessus_ subsp. _abscessus_ ATCC 19977 cultures that had been exposed to a sub-inhibitory concentration of clarithromycin to induce macrolide resistance to determine whether the teicoplanin + tigecycline combination retains its activity under these conditions. The combination still exhibited synergy against the culture with induced macrolide resistance as seen by its FICI value of 0.22 ( **Table 4** ).\n\n### Teicoplanin **\\+** Tigecycline Shows Potent Activity Against _M. abscessus_ Clinical Isolates\n\nThe teicoplanin + tigecycline combination showed potent growth inhibition activity against the screening strain as well as the reference strains representing the three subspecies of _M. abscessus_ . This suggests that most clinical _M. abscessus_ strains may be susceptible to this combination.\n\nTABLE 3 | Reconfirmation of 11 two-drug hits identified from screening of 180 combinations against _M. abscessus_ Bamboo.\n\nStrategy Combination MIC90 ( **µ** M)\n\nAlone Combined\n\nβ-lactams + β-lactamase inhibitors Panipenem + _>_ 50 50 Avibactam _>_ 50 6\n\nTebipenem + 46 13\n\nAvibactam _>_ 50 0.8\n\nAmpicillin + _>_ 50 25\n\nAvibactam _>_ 50 19\n\nAmoxicillin + _>_ 50 25\n\nAvibactam _>_ 50 25\n\nPanipenem + _>_ 50 50\n\nVaborbactam _>_ 50 2\n\nTebipenem + 40 10\n\nVaborbactam _>_ 50 10\n\nCell envelope- targeting + antibiotics with intracellular targets\n\nCeftobiprole + _>_ 50 38\n\nLinezolid _>_ 50 19\n\nRamoplanin + 30 5\n\nClarithromycin 0.7 0.2\n\nRamoplanin + 30 5\n\nTigecycline 7 0.8\n\nVancomycin + 17 2\n\nTigecycline 6 1\n\nTeicoplanin + 25 3\n\nTigecycline 8 1\n\n_The synergy or potentiation concentration of the 11 drug pair hits identified in the screens shown in_ _Tables 1_ _,_ _2_ _are reported. Results shown are the mean of two replicates. Standard deviations were_ ± _50% of shown values._\n\nTo provide evidence for a widespread susceptibility of _M. abscessus_ to the teicoplanin + tigecycline combination, we tested its activity against a collection of clinical isolates covering various subspecies of _M. abscessus_ , including clarithromycin resistant as well as clarithromycin sensitive strains. The combination displayed synergy against 70.4% of the isolates with FICI values ranging from 0.32 to 0.48 ( **Table 5** ). This result indicates that this combination is active against a large number of _M. abscessus_ isolates.\n\n### Teicoplanin **\\+** Tigecycline Is Not Bactericidal Against _M. abscessus_ subsp. _abscessus_ ATCC 19977\n\nTo determine whether the teicoplanin + tigecycline combination shows bactericidal activity against _M. abscessus_ , cultures were treated with the drug combination and the effect on viability was determined by cfu enumeration as described in Section “Materials and Methods.” The teicoplanin + tigecycline combination showed no bactericidal activity.\n\n### DISCUSSION\n\nA synergy screen of 180 dual antibiotic combinations against _M. abscessus_ yielded a total of 11 hits. Six hits were obtained from combinations of β-lactams with β-lactamase inhibitors, and five hits from combinations of cell wall- targeting antibiotics with antibiotics that have intracellular targets. From the analyses of combinations of β-lactams with β-lactamase inhibitors, the most striking observation is that all six hits involved a non-β-lactam-based β-lactamase inhibitor. 4 out of the 6 hits involved avibactam. This is consistent with previous reports showing that this inhibitor is effective against _M. abscessus_ β-lactamases (Ehmann et al., 2012; Soroka et al., 2014; Dubee et al., 2015a; Kaushik et al., 2017). The remaining 2 hits involved the novel non-β-lactam-based β-lactamase inhibitor vaborbactam, which has not been previously studied for activity against _M. abscessus_ β-lactamases. Activity of avibactam and now vaborbactam suggests that it may be worthwhile to characterize other types of non-β-lactam β-lactamase inhibitors like phosphonates, hydroxamates, or vanadate-catechol complexes, in combination with β-lactams for any potentiation effect of the combinations against _M. abscessus_ (Bebrone et al., 2010). It is to note that out of the three sub-classes of β-lactams we tested, avibactam appears not to improve the activity of cephalosporins, in contrast to a previous report describing potentiation between ceftaroline and avibactam against _M. abscessus_ (Dubee et al., 2015b). A recent study by Kaushik et al. (2017) which focused on combinations of avibactam, sulbactam and tazobactam with carbapenems against _M. abscessus_ reported 3 hits, with potentiation observed for combinations of avibactam with ertapenem, tebipenem, or panipenem (Kaushik et al., 2017). In this study, we could confirm potentiation for combinations of\n\nFrontiers in Microbiology | www.frontiersin.org 5 May 2018 | Volume 9 | Article 932","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\n### Teicoplanin **\\+** Tigecycline Retains Its Activity Against _M. abscessus_ subsp. _abscessus_ ATCC 19977 Cultures Displaying Induced Macrolide Resistance\n\nThe checkerboard titration assay was performed using _M. abscessus_ subsp. _abscessus_ ATCC 19977 cultures that had been exposed to a sub-inhibitory concentration of clarithromycin to induce macrolide resistance to determine whether the teicoplanin + tigecycline combination retains its activity under these conditions. The combination still exhibited synergy against the culture with induced macrolide resistance as seen by its FICI value of 0.22 ( **Table 4** ).\n\n### Teicoplanin **\\+** Tigecycline Shows Potent Activity Against _M. abscessus_ Clinical Isolates\n\nThe teicoplanin + tigecycline combination showed potent growth inhibition activity against the screening strain as well as the reference strains representing the three subspecies of _M. abscessus_ . This suggests that most clinical _M. abscessus_ strains may be susceptible to this combination.\n\nTABLE 3 | Reconfirmation of 11 two-drug hits identified from screening of 180 combinations against _M. abscessus_ Bamboo.\n\nStrategy Combination MIC90 ( **µ** M)\n\nAlone Combined\n\nβ-lactams + β-lactamase inhibitors Panipenem + _>_ 50 50 Avibactam _>_ 50 6\n\nTebipenem + 46 13\n\nAvibactam _>_ 50 0.8\n\nAmpicillin + _>_ 50 25\n\nAvibactam _>_ 50 19\n\nAmoxicillin + _>_ 50 25\n\nAvibactam _>_ 50 25\n\nPanipenem + _>_ 50 50\n\nVaborbactam _>_ 50 2\n\nTebipenem + 40 10\n\nVaborbactam _>_ 50 10\n\nCell envelope- targeting + antibiotics with intracellular targets\n\nCeftobiprole + _>_ 50 38\n\nLinezolid _>_ 50 19\n\nRamoplanin + 30 5\n\nClarithromycin 0.7 0.2\n\nRamoplanin + 30 5\n\nTigecycline 7 0.8\n\nVancomycin + 17 2\n\nTigecycline 6 1\n\nTeicoplanin + 25 3\n\nTigecycline 8 1\n\n_The synergy or potentiation concentration of the 11 drug pair hits identified in the screens shown in_ _Tables 1_ _,_ _2_ _are reported. Results shown are the mean of two replicates. Standard deviations were_ ± _50% of shown values._\n\nTo provide evidence for a widespread susceptibility of _M. abscessus_ to the teicoplanin + tigecycline combination, we tested its activity against a collection of clinical isolates covering various subspecies of _M. abscessus_ , including clarithromycin resistant as well as clarithromycin sensitive strains. The combination displayed synergy against 70.4% of the isolates with FICI values ranging from 0.32 to 0.48 ( **Table 5** ). This result indicates that this combination is active against a large number of _M. abscessus_ isolates.\n\n### Teicoplanin **\\+** Tigecycline Is Not Bactericidal Against _M. abscessus_ subsp. _abscessus_ ATCC 19977\n\nTo determine whether the teicoplanin + tigecycline combination shows bactericidal activity against _M. abscessus_ , cultures were treated with the drug combination and the effect on viability was determined by cfu enumeration as described in Section “Materials and Methods.” The teicoplanin + tigecycline combination showed no bactericidal activity.\n\n### DISCUSSION\n\nA synergy screen of 180 dual antibiotic combinations against _M. abscessus_ yielded a total of 11 hits. Six hits were obtained from combinations of β-lactams with β-lactamase inhibitors, and five hits from combinations of cell wall- targeting antibiotics with antibiotics that have intracellular targets. From the analyses of combinations of β-lactams with β-lactamase inhibitors, the most striking observation is that all six hits involved a non-β-lactam-based β-lactamase inhibitor. 4 out of the 6 hits involved avibactam. This is consistent with previous reports showing that this inhibitor is effective against _M. abscessus_ β-lactamases (Ehmann et al., 2012; Soroka et al., 2014; Dubee et al., 2015a; Kaushik et al., 2017). The remaining 2 hits involved the novel non-β-lactam-based β-lactamase inhibitor vaborbactam, which has not been previously studied for activity against _M. abscessus_ β-lactamases. Activity of avibactam and now vaborbactam suggests that it may be worthwhile to characterize other types of non-β-lactam β-lactamase inhibitors like phosphonates, hydroxamates, or vanadate-catechol complexes, in combination with β-lactams for any potentiation effect of the combinations against _M. abscessus_ (Bebrone et al., 2010). It is to note that out of the three sub-classes of β-lactams we tested, avibactam appears not to improve the activity of cephalosporins, in contrast to a previous report describing potentiation between ceftaroline and avibactam against _M. abscessus_ (Dubee et al., 2015b). A recent study by Kaushik et al. (2017) which focused on combinations of avibactam, sulbactam and tazobactam with carbapenems against _M. abscessus_ reported 3 hits, with potentiation observed for combinations of avibactam with ertapenem, tebipenem, or panipenem (Kaushik et al., 2017). In this study, we could confirm potentiation for combinations of\n\nFrontiers in Microbiology | www.frontiersin.org 5 May 2018 | Volume 9 | Article 932","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page5.pdf"]},"response":{"errors":[],"extract_id":"extract_6b13287222e64c45c2c38e2b97b9c8c6","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\n### Teicoplanin **\\+** Tigecycline Retains Its Activity Against _M. abscessus_ subsp. _abscessus_ ATCC 19977 Cultures Displaying Induced Macrolide Resistance\n\nThe checkerboard titration assay was performed using _M. abscessus_ subsp. _abscessus_ ATCC 19977 cultures that had been exposed to a sub-inhibitory concentration of clarithromycin to induce macrolide resistance to determine whether the teicoplanin + tigecycline combination retains its activity under these conditions. The combination still exhibited synergy against the culture with induced macrolide resistance as seen by its FICI value of 0.22 ( **Table 4** ).\n\n### Teicoplanin **\\+** Tigecycline Shows Potent Activity Against _M. abscessus_ Clinical Isolates\n\nThe teicoplanin + tigecycline combination showed potent growth inhibition activity against the screening strain as well as the reference strains representing the three subspecies of _M. abscessus_ . This suggests that most clinical _M. abscessus_ strains may be susceptible to this combination.\n\nTABLE 3 | Reconfirmation of 11 two-drug hits identified from screening of 180 combinations against _M. abscessus_ Bamboo.\n\nStrategy Combination MIC90 ( **µ** M)\n\nAlone Combined\n\nβ-lactams + β-lactamase inhibitors Panipenem + _>_ 50 50 Avibactam _>_ 50 6\n\nTebipenem + 46 13\n\nAvibactam _>_ 50 0.8\n\nAmpicillin + _>_ 50 25\n\nAvibactam _>_ 50 19\n\nAmoxicillin + _>_ 50 25\n\nAvibactam _>_ 50 25\n\nPanipenem + _>_ 50 50\n\nVaborbactam _>_ 50 2\n\nTebipenem + 40 10\n\nVaborbactam _>_ 50 10\n\nCell envelope- targeting + antibiotics with intracellular targets\n\nCeftobiprole + _>_ 50 38\n\nLinezolid _>_ 50 19\n\nRamoplanin + 30 5\n\nClarithromycin 0.7 0.2\n\nRamoplanin + 30 5\n\nTigecycline 7 0.8\n\nVancomycin + 17 2\n\nTigecycline 6 1\n\nTeicoplanin + 25 3\n\nTigecycline 8 1\n\n_The synergy or potentiation concentration of the 11 drug pair hits identified in the screens shown in_ _Tables 1_ _,_ _2_ _are reported. Results shown are the mean of two replicates. Standard deviations were_ ± _50% of shown values._\n\nTo provide evidence for a widespread susceptibility of _M. abscessus_ to the teicoplanin + tigecycline combination, we tested its activity against a collection of clinical isolates covering various subspecies of _M. abscessus_ , including clarithromycin resistant as well as clarithromycin sensitive strains. The combination displayed synergy against 70.4% of the isolates with FICI values ranging from 0.32 to 0.48 ( **Table 5** ). This result indicates that this combination is active against a large number of _M. abscessus_ isolates.\n\n### Teicoplanin **\\+** Tigecycline Is Not Bactericidal Against _M. abscessus_ subsp. _abscessus_ ATCC 19977\n\nTo determine whether the teicoplanin + tigecycline combination shows bactericidal activity against _M. abscessus_ , cultures were treated with the drug combination and the effect on viability was determined by cfu enumeration as described in Section “Materials and Methods.” The teicoplanin + tigecycline combination showed no bactericidal activity.\n\n### DISCUSSION\n\nA synergy screen of 180 dual antibiotic combinations against _M. abscessus_ yielded a total of 11 hits. Six hits were obtained from combinations of β-lactams with β-lactamase inhibitors, and five hits from combinations of cell wall- targeting antibiotics with antibiotics that have intracellular targets. From the analyses of combinations of β-lactams with β-lactamase inhibitors, the most striking observation is that all six hits involved a non-β-lactam-based β-lactamase inhibitor. 4 out of the 6 hits involved avibactam. This is consistent with previous reports showing that this inhibitor is effective against _M. abscessus_ β-lactamases (Ehmann et al., 2012; Soroka et al., 2014; Dubee et al., 2015a; Kaushik et al., 2017). The remaining 2 hits involved the novel non-β-lactam-based β-lactamase inhibitor vaborbactam, which has not been previously studied for activity against _M. abscessus_ β-lactamases. Activity of avibactam and now vaborbactam suggests that it may be worthwhile to characterize other types of non-β-lactam β-lactamase inhibitors like phosphonates, hydroxamates, or vanadate-catechol complexes, in combination with β-lactams for any potentiation effect of the combinations against _M. abscessus_ (Bebrone et al., 2010). It is to note that out of the three sub-classes of β-lactams we tested, avibactam appears not to improve the activity of cephalosporins, in contrast to a previous report describing potentiation between ceftaroline and avibactam against _M. abscessus_ (Dubee et al., 2015b). A recent study by Kaushik et al. (2017) which focused on combinations of avibactam, sulbactam and tazobactam with carbapenems against _M. abscessus_ reported 3 hits, with potentiation observed for combinations of avibactam with ertapenem, tebipenem, or panipenem (Kaushik et al., 2017). In this study, we could confirm potentiation for combinations of\n\nFrontiers in Microbiology | www.frontiersin.org 5 May 2018 | Volume 9 | Article 932"],"full_content":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\n### Teicoplanin **\\+** Tigecycline Retains Its Activity Against _M. abscessus_ subsp. _abscessus_ ATCC 19977 Cultures Displaying Induced Macrolide Resistance\n\nThe checkerboard titration assay was performed using _M. abscessus_ subsp. _abscessus_ ATCC 19977 cultures that had been exposed to a sub-inhibitory concentration of clarithromycin to induce macrolide resistance to determine whether the teicoplanin + tigecycline combination retains its activity under these conditions. The combination still exhibited synergy against the culture with induced macrolide resistance as seen by its FICI value of 0.22 ( **Table 4** ).\n\n### Teicoplanin **\\+** Tigecycline Shows Potent Activity Against _M. abscessus_ Clinical Isolates\n\nThe teicoplanin + tigecycline combination showed potent growth inhibition activity against the screening strain as well as the reference strains representing the three subspecies of _M. abscessus_ . This suggests that most clinical _M. abscessus_ strains may be susceptible to this combination.\n\nTABLE 3 | Reconfirmation of 11 two-drug hits identified from screening of 180 combinations against _M. abscessus_ Bamboo.\n\nStrategy Combination MIC90 ( **µ** M)\n\nAlone Combined\n\nβ-lactams + β-lactamase inhibitors Panipenem + _>_ 50 50 Avibactam _>_ 50 6\n\nTebipenem + 46 13\n\nAvibactam _>_ 50 0.8\n\nAmpicillin + _>_ 50 25\n\nAvibactam _>_ 50 19\n\nAmoxicillin + _>_ 50 25\n\nAvibactam _>_ 50 25\n\nPanipenem + _>_ 50 50\n\nVaborbactam _>_ 50 2\n\nTebipenem + 40 10\n\nVaborbactam _>_ 50 10\n\nCell envelope- targeting + antibiotics with intracellular targets\n\nCeftobiprole + _>_ 50 38\n\nLinezolid _>_ 50 19\n\nRamoplanin + 30 5\n\nClarithromycin 0.7 0.2\n\nRamoplanin + 30 5\n\nTigecycline 7 0.8\n\nVancomycin + 17 2\n\nTigecycline 6 1\n\nTeicoplanin + 25 3\n\nTigecycline 8 1\n\n_The synergy or potentiation concentration of the 11 drug pair hits identified in the screens shown in_ _Tables 1_ _,_ _2_ _are reported. Results shown are the mean of two replicates. Standard deviations were_ ± _50% of shown values._\n\nTo provide evidence for a widespread susceptibility of _M. abscessus_ to the teicoplanin + tigecycline combination, we tested its activity against a collection of clinical isolates covering various subspecies of _M. abscessus_ , including clarithromycin resistant as well as clarithromycin sensitive strains. The combination displayed synergy against 70.4% of the isolates with FICI values ranging from 0.32 to 0.48 ( **Table 5** ). This result indicates that this combination is active against a large number of _M. abscessus_ isolates.\n\n### Teicoplanin **\\+** Tigecycline Is Not Bactericidal Against _M. abscessus_ subsp. _abscessus_ ATCC 19977\n\nTo determine whether the teicoplanin + tigecycline combination shows bactericidal activity against _M. abscessus_ , cultures were treated with the drug combination and the effect on viability was determined by cfu enumeration as described in Section “Materials and Methods.” The teicoplanin + tigecycline combination showed no bactericidal activity.\n\n### DISCUSSION\n\nA synergy screen of 180 dual antibiotic combinations against _M. abscessus_ yielded a total of 11 hits. Six hits were obtained from combinations of β-lactams with β-lactamase inhibitors, and five hits from combinations of cell wall- targeting antibiotics with antibiotics that have intracellular targets. From the analyses of combinations of β-lactams with β-lactamase inhibitors, the most striking observation is that all six hits involved a non-β-lactam-based β-lactamase inhibitor. 4 out of the 6 hits involved avibactam. This is consistent with previous reports showing that this inhibitor is effective against _M. abscessus_ β-lactamases (Ehmann et al., 2012; Soroka et al., 2014; Dubee et al., 2015a; Kaushik et al., 2017). The remaining 2 hits involved the novel non-β-lactam-based β-lactamase inhibitor vaborbactam, which has not been previously studied for activity against _M. abscessus_ β-lactamases. Activity of avibactam and now vaborbactam suggests that it may be worthwhile to characterize other types of non-β-lactam β-lactamase inhibitors like phosphonates, hydroxamates, or vanadate-catechol complexes, in combination with β-lactams for any potentiation effect of the combinations against _M. abscessus_ (Bebrone et al., 2010). It is to note that out of the three sub-classes of β-lactams we tested, avibactam appears not to improve the activity of cephalosporins, in contrast to a previous report describing potentiation between ceftaroline and avibactam against _M. abscessus_ (Dubee et al., 2015b). A recent study by Kaushik et al. (2017) which focused on combinations of avibactam, sulbactam and tazobactam with carbapenems against _M. abscessus_ reported 3 hits, with potentiation observed for combinations of avibactam with ertapenem, tebipenem, or panipenem (Kaushik et al., 2017). In this study, we could confirm potentiation for combinations of\n\nFrontiers in Microbiology | www.frontiersin.org 5 May 2018 | Volume 9 | Article 932","publish_date":null,"title":"+ Teicoplanin Tigecycline Retains Its Activity Against M. abscessus subsp. abscessus ATCC 19977 Cultures Displaying Induced Macrolide Resistance + Teicoplanin","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page5.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page5.pdf"},"request":{"example_id":"table/myco hierarchical table header_page5","product_type":"parse","source_file_path":"myco hierarchical table header_page5.pdf"},"started_at":"2026-11-04T19:47:25.365863"} +{"completed_at":"2026-11-04T19:47:27.953904","latency_in_ms":1703,"output":{"example_id":"table/myco hierarchical table header_page6","grounded_pages":[],"layout_pages":[],"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\navibactam with tebipenem or panipenem, however, we did not observe any potentiation between avibactam and ertapenem. Another study found potentiation between clavulanate and meropenem, which we also did not observe (Kaushik et al., 2015). The reasons for these discrepancies remain to be determined (Fisher et al., 2005). One possible explanation may be the use of different _M. abscessus_ strains. This study used the clinical isolate _M. abscessus_ Bamboo in the initial screening, while other studies used other strains including _M. abscessus_ subsp. _abscessus_ ATCC19977. In comparison to avibactam, vaborbactam improved the activity of selected compounds only from the carbapenems but not from the penicillins. Vaborbactam is a new β-lactamase inhibitor and is the first one to contain a cyclic boronic acid structure (Lomovskaya et al., 2017). Despite its difference in structure from avibactam,\n\nboth β-lactamase inhibitors were able to potentiate the activity of the same two carbapenems, panipenem and tebipenem. Panipenem is an earlier carbapenem and the drug needs to be administered together with betamipron to block its deactivation by dehydropeptidase I (Papp-Wallace et al., 2011). Tebipenem is a more recently discovered carbapenem and is the first oral drug of this class (Papp-Wallace et al., 2011). From the analyses of combinations of cell wall-targeting antibiotics with drugs that have intracellular targets, we obtained five novel hits, with the teicoplanin + tigecycline combination being most attractive. Teicoplanin + tigecycline combination displayed synergy at a similar range across reference strains representing the three subspecies of _M. abscessus_ with growth inhibitory combination concentrations of 2–3 µM teicoplanin + 1–2 µM tigecycline. The combination also retained\n\nTABLE 4 | Synergy concentrations and FICI values of teicoplanin + tigecycline combination against _M. abscessus_ screening strain and three reference strains of the _M. abscessus_ sub-species.\n\nConditions Strains MIC90 ( **µ** M) FICI\n\nTeicoplanin Tigecycline\n\nAlone Combined Alone Combined\n\n(No pre-treatment) _M. abscessus_ Bamboo 25 3 8 1 0.27\n\n_M. abscessus_ subsp. _abscessus_ 10 2 6 2 0.42\n\n_M. abscessus_ subsp. _bolletii_ 10 2 8 2 0.39\n\n_M. abscessus_ subsp. _massiliense_ 14 2 7 2 0.36\n\nPre-treated with clarithromycin _M. abscessus_ subsp. _abscessus_ 7 1.2 8.5 1.6 0.22\n\n_‘Pre-treated with clarithromycin’ shows the respective data for a strain displaying induced macrolide resistance due to pre-treatment with a sub-inhibitory concentration of clarithromycin (see section “Materials and Methods”). Results shown are the mean of two replicates. Standard deviation was_ ± _50% of shown values. Synergy is defined as FICI_ ≤ _0\\.5. Checkerboard assay was conducted with 7H9 broth._\n\nTABLE 5 | Synergy concentrations and FICI values of the teicoplanin + tigecycline combination against 14 clinical _M. abscessus_ isolates.\n\nIsolate code _M. abscessus_ sub-species _erm41_ sequevar Clarithromycin susceptibility MIC90 ( **µ** M) FICI\n\nTeicoplanin Tigecycline\n\nAlone Combined Alone Combined\n\nM199 _abscessus_ T28 Resistant 5 2 6 2 0.56\n\nM337 _abscessus_ T28 Resistant 5 2 7 2 0.51\n\nM404 _abscessus_ C28 Sensitive 6 2 4 1 0.53\n\nM421 _abscessus_ T28 Resistant 17 3 4 0.6 0.37\n\nM422 _abscessus_ T28 Resistant 6 1 6 1 0.44\n\nM232 _bolletii_ T28 Resistant 21 5 18 2 0.39\n\nM416 _bolletii_ N.D Sensitive 4 2 5 1 0.63\n\nM506 _bolletii_ C28 Sensitive 10 3 9 1 0.45\n\nM111 _massiliense_ Deletion Sensitive 10 2 10 2 0.48\n\nM353 _massiliense_ Deletion Sensitive 13 3 8 2 0.43\n\nM357 _massiliense_ Deletion Sensitive 12 2 8 1 0.33\n\nM414 _massiliense_ Deletion Sensitive 8 1 10 2 0.32\n\nM444 _massiliense_ Deletion Sensitive 7 3 6 1 0.48\n\nM505 _massiliense_ Deletion Sensitive 13 3 8 1 0.39\n\n_Results shown are the mean of two replicates. Standard deviations were_ ± _50% of shown values. Synergy is defined as FICI_ ≤ _0\\.5. Indifference is defined as 0.5_ _<_ _FICI_ ≤ _4, and antagonism is defined as FICI_ _>_ _4\\. N.D, not determined._\n\nFrontiers in Microbiology | www.frontiersin.org 6 May 2018 | Volume 9 | Article 932","pages":[{"line_numbers":[],"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\navibactam with tebipenem or panipenem, however, we did not observe any potentiation between avibactam and ertapenem. Another study found potentiation between clavulanate and meropenem, which we also did not observe (Kaushik et al., 2015). The reasons for these discrepancies remain to be determined (Fisher et al., 2005). One possible explanation may be the use of different _M. abscessus_ strains. This study used the clinical isolate _M. abscessus_ Bamboo in the initial screening, while other studies used other strains including _M. abscessus_ subsp. _abscessus_ ATCC19977. In comparison to avibactam, vaborbactam improved the activity of selected compounds only from the carbapenems but not from the penicillins. Vaborbactam is a new β-lactamase inhibitor and is the first one to contain a cyclic boronic acid structure (Lomovskaya et al., 2017). Despite its difference in structure from avibactam,\n\nboth β-lactamase inhibitors were able to potentiate the activity of the same two carbapenems, panipenem and tebipenem. Panipenem is an earlier carbapenem and the drug needs to be administered together with betamipron to block its deactivation by dehydropeptidase I (Papp-Wallace et al., 2011). Tebipenem is a more recently discovered carbapenem and is the first oral drug of this class (Papp-Wallace et al., 2011). From the analyses of combinations of cell wall-targeting antibiotics with drugs that have intracellular targets, we obtained five novel hits, with the teicoplanin + tigecycline combination being most attractive. Teicoplanin + tigecycline combination displayed synergy at a similar range across reference strains representing the three subspecies of _M. abscessus_ with growth inhibitory combination concentrations of 2–3 µM teicoplanin + 1–2 µM tigecycline. The combination also retained\n\nTABLE 4 | Synergy concentrations and FICI values of teicoplanin + tigecycline combination against _M. abscessus_ screening strain and three reference strains of the _M. abscessus_ sub-species.\n\nConditions Strains MIC90 ( **µ** M) FICI\n\nTeicoplanin Tigecycline\n\nAlone Combined Alone Combined\n\n(No pre-treatment) _M. abscessus_ Bamboo 25 3 8 1 0.27\n\n_M. abscessus_ subsp. _abscessus_ 10 2 6 2 0.42\n\n_M. abscessus_ subsp. _bolletii_ 10 2 8 2 0.39\n\n_M. abscessus_ subsp. _massiliense_ 14 2 7 2 0.36\n\nPre-treated with clarithromycin _M. abscessus_ subsp. _abscessus_ 7 1.2 8.5 1.6 0.22\n\n_‘Pre-treated with clarithromycin’ shows the respective data for a strain displaying induced macrolide resistance due to pre-treatment with a sub-inhibitory concentration of clarithromycin (see section “Materials and Methods”). Results shown are the mean of two replicates. Standard deviation was_ ± _50% of shown values. Synergy is defined as FICI_ ≤ _0\\.5. Checkerboard assay was conducted with 7H9 broth._\n\nTABLE 5 | Synergy concentrations and FICI values of the teicoplanin + tigecycline combination against 14 clinical _M. abscessus_ isolates.\n\nIsolate code _M. abscessus_ sub-species _erm41_ sequevar Clarithromycin susceptibility MIC90 ( **µ** M) FICI\n\nTeicoplanin Tigecycline\n\nAlone Combined Alone Combined\n\nM199 _abscessus_ T28 Resistant 5 2 6 2 0.56\n\nM337 _abscessus_ T28 Resistant 5 2 7 2 0.51\n\nM404 _abscessus_ C28 Sensitive 6 2 4 1 0.53\n\nM421 _abscessus_ T28 Resistant 17 3 4 0.6 0.37\n\nM422 _abscessus_ T28 Resistant 6 1 6 1 0.44\n\nM232 _bolletii_ T28 Resistant 21 5 18 2 0.39\n\nM416 _bolletii_ N.D Sensitive 4 2 5 1 0.63\n\nM506 _bolletii_ C28 Sensitive 10 3 9 1 0.45\n\nM111 _massiliense_ Deletion Sensitive 10 2 10 2 0.48\n\nM353 _massiliense_ Deletion Sensitive 13 3 8 2 0.43\n\nM357 _massiliense_ Deletion Sensitive 12 2 8 1 0.33\n\nM414 _massiliense_ Deletion Sensitive 8 1 10 2 0.32\n\nM444 _massiliense_ Deletion Sensitive 7 3 6 1 0.48\n\nM505 _massiliense_ Deletion Sensitive 13 3 8 1 0.39\n\n_Results shown are the mean of two replicates. Standard deviations were_ ± _50% of shown values. Synergy is defined as FICI_ ≤ _0\\.5. Indifference is defined as 0.5_ _<_ _FICI_ ≤ _4, and antagonism is defined as FICI_ _>_ _4\\. N.D, not determined._\n\nFrontiers in Microbiology | www.frontiersin.org 6 May 2018 | Volume 9 | Article 932","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\navibactam with tebipenem or panipenem, however, we did not observe any potentiation between avibactam and ertapenem. Another study found potentiation between clavulanate and meropenem, which we also did not observe (Kaushik et al., 2015). The reasons for these discrepancies remain to be determined (Fisher et al., 2005). One possible explanation may be the use of different _M. abscessus_ strains. This study used the clinical isolate _M. abscessus_ Bamboo in the initial screening, while other studies used other strains including _M. abscessus_ subsp. _abscessus_ ATCC19977. In comparison to avibactam, vaborbactam improved the activity of selected compounds only from the carbapenems but not from the penicillins. Vaborbactam is a new β-lactamase inhibitor and is the first one to contain a cyclic boronic acid structure (Lomovskaya et al., 2017). Despite its difference in structure from avibactam,\n\nboth β-lactamase inhibitors were able to potentiate the activity of the same two carbapenems, panipenem and tebipenem. Panipenem is an earlier carbapenem and the drug needs to be administered together with betamipron to block its deactivation by dehydropeptidase I (Papp-Wallace et al., 2011). Tebipenem is a more recently discovered carbapenem and is the first oral drug of this class (Papp-Wallace et al., 2011). From the analyses of combinations of cell wall-targeting antibiotics with drugs that have intracellular targets, we obtained five novel hits, with the teicoplanin + tigecycline combination being most attractive. Teicoplanin + tigecycline combination displayed synergy at a similar range across reference strains representing the three subspecies of _M. abscessus_ with growth inhibitory combination concentrations of 2–3 µM teicoplanin + 1–2 µM tigecycline. The combination also retained\n\nTABLE 4 | Synergy concentrations and FICI values of teicoplanin + tigecycline combination against _M. abscessus_ screening strain and three reference strains of the _M. abscessus_ sub-species.\n\nConditions Strains MIC90 ( **µ** M) FICI\n\nTeicoplanin Tigecycline\n\nAlone Combined Alone Combined\n\n(No pre-treatment) _M. abscessus_ Bamboo 25 3 8 1 0.27\n\n_M. abscessus_ subsp. _abscessus_ 10 2 6 2 0.42\n\n_M. abscessus_ subsp. _bolletii_ 10 2 8 2 0.39\n\n_M. abscessus_ subsp. _massiliense_ 14 2 7 2 0.36\n\nPre-treated with clarithromycin _M. abscessus_ subsp. _abscessus_ 7 1.2 8.5 1.6 0.22\n\n_‘Pre-treated with clarithromycin’ shows the respective data for a strain displaying induced macrolide resistance due to pre-treatment with a sub-inhibitory concentration of clarithromycin (see section “Materials and Methods”). Results shown are the mean of two replicates. Standard deviation was_ ± _50% of shown values. Synergy is defined as FICI_ ≤ _0\\.5. Checkerboard assay was conducted with 7H9 broth._\n\nTABLE 5 | Synergy concentrations and FICI values of the teicoplanin + tigecycline combination against 14 clinical _M. abscessus_ isolates.\n\nIsolate code _M. abscessus_ sub-species _erm41_ sequevar Clarithromycin susceptibility MIC90 ( **µ** M) FICI\n\nTeicoplanin Tigecycline\n\nAlone Combined Alone Combined\n\nM199 _abscessus_ T28 Resistant 5 2 6 2 0.56\n\nM337 _abscessus_ T28 Resistant 5 2 7 2 0.51\n\nM404 _abscessus_ C28 Sensitive 6 2 4 1 0.53\n\nM421 _abscessus_ T28 Resistant 17 3 4 0.6 0.37\n\nM422 _abscessus_ T28 Resistant 6 1 6 1 0.44\n\nM232 _bolletii_ T28 Resistant 21 5 18 2 0.39\n\nM416 _bolletii_ N.D Sensitive 4 2 5 1 0.63\n\nM506 _bolletii_ C28 Sensitive 10 3 9 1 0.45\n\nM111 _massiliense_ Deletion Sensitive 10 2 10 2 0.48\n\nM353 _massiliense_ Deletion Sensitive 13 3 8 2 0.43\n\nM357 _massiliense_ Deletion Sensitive 12 2 8 1 0.33\n\nM414 _massiliense_ Deletion Sensitive 8 1 10 2 0.32\n\nM444 _massiliense_ Deletion Sensitive 7 3 6 1 0.48\n\nM505 _massiliense_ Deletion Sensitive 13 3 8 1 0.39\n\n_Results shown are the mean of two replicates. Standard deviations were_ ± _50% of shown values. Synergy is defined as FICI_ ≤ _0\\.5. Indifference is defined as 0.5_ _<_ _FICI_ ≤ _4, and antagonism is defined as FICI_ _>_ _4\\. N.D, not determined._\n\nFrontiers in Microbiology | www.frontiersin.org 6 May 2018 | Volume 9 | Article 932","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_cb191e9702cfc64c5f1a93ef767ed0fa","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\navibactam with tebipenem or panipenem, however, we did not observe any potentiation between avibactam and ertapenem. Another study found potentiation between clavulanate and meropenem, which we also did not observe (Kaushik et al., 2015). The reasons for these discrepancies remain to be determined (Fisher et al., 2005). One possible explanation may be the use of different _M. abscessus_ strains. This study used the clinical isolate _M. abscessus_ Bamboo in the initial screening, while other studies used other strains including _M. abscessus_ subsp. _abscessus_ ATCC19977. In comparison to avibactam, vaborbactam improved the activity of selected compounds only from the carbapenems but not from the penicillins. Vaborbactam is a new β-lactamase inhibitor and is the first one to contain a cyclic boronic acid structure (Lomovskaya et al., 2017). Despite its difference in structure from avibactam,\n\nboth β-lactamase inhibitors were able to potentiate the activity of the same two carbapenems, panipenem and tebipenem. Panipenem is an earlier carbapenem and the drug needs to be administered together with betamipron to block its deactivation by dehydropeptidase I (Papp-Wallace et al., 2011). Tebipenem is a more recently discovered carbapenem and is the first oral drug of this class (Papp-Wallace et al., 2011). From the analyses of combinations of cell wall-targeting antibiotics with drugs that have intracellular targets, we obtained five novel hits, with the teicoplanin + tigecycline combination being most attractive. Teicoplanin + tigecycline combination displayed synergy at a similar range across reference strains representing the three subspecies of _M. abscessus_ with growth inhibitory combination concentrations of 2–3 µM teicoplanin + 1–2 µM tigecycline. The combination also retained\n\nTABLE 4 | Synergy concentrations and FICI values of teicoplanin + tigecycline combination against _M. abscessus_ screening strain and three reference strains of the _M. abscessus_ sub-species.\n\nConditions Strains MIC90 ( **µ** M) FICI\n\nTeicoplanin Tigecycline\n\nAlone Combined Alone Combined\n\n(No pre-treatment) _M. abscessus_ Bamboo 25 3 8 1 0.27\n\n_M. abscessus_ subsp. _abscessus_ 10 2 6 2 0.42\n\n_M. abscessus_ subsp. _bolletii_ 10 2 8 2 0.39\n\n_M. abscessus_ subsp. _massiliense_ 14 2 7 2 0.36\n\nPre-treated with clarithromycin _M. abscessus_ subsp. _abscessus_ 7 1.2 8.5 1.6 0.22\n\n_‘Pre-treated with clarithromycin’ shows the respective data for a strain displaying induced macrolide resistance due to pre-treatment with a sub-inhibitory concentration of clarithromycin (see section “Materials and Methods”). Results shown are the mean of two replicates. Standard deviation was_ ± _50% of shown values. Synergy is defined as FICI_ ≤ _0\\.5. Checkerboard assay was conducted with 7H9 broth._\n\nTABLE 5 | Synergy concentrations and FICI values of the teicoplanin + tigecycline combination against 14 clinical _M. abscessus_ isolates.\n\nIsolate code _M. abscessus_ sub-species _erm41_ sequevar Clarithromycin susceptibility MIC90 ( **µ** M) FICI\n\nTeicoplanin Tigecycline\n\nAlone Combined Alone Combined\n\nM199 _abscessus_ T28 Resistant 5 2 6 2 0.56\n\nM337 _abscessus_ T28 Resistant 5 2 7 2 0.51\n\nM404 _abscessus_ C28 Sensitive 6 2 4 1 0.53\n\nM421 _abscessus_ T28 Resistant 17 3 4 0.6 0.37\n\nM422 _abscessus_ T28 Resistant 6 1 6 1 0.44\n\nM232 _bolletii_ T28 Resistant 21 5 18 2 0.39\n\nM416 _bolletii_ N.D Sensitive 4 2 5 1 0.63\n\nM506 _bolletii_ C28 Sensitive 10 3 9 1 0.45\n\nM111 _massiliense_ Deletion Sensitive 10 2 10 2 0.48\n\nM353 _massiliense_ Deletion Sensitive 13 3 8 2 0.43\n\nM357 _massiliense_ Deletion Sensitive 12 2 8 1 0.33\n\nM414 _massiliense_ Deletion Sensitive 8 1 10 2 0.32\n\nM444 _massiliense_ Deletion Sensitive 7 3 6 1 0.48\n\nM505 _massiliense_ Deletion Sensitive 13 3 8 1 0.39\n\n_Results shown are the mean of two replicates. Standard deviations were_ ± _50% of shown values. Synergy is defined as FICI_ ≤ _0\\.5. Indifference is defined as 0.5_ _<_ _FICI_ ≤ _4, and antagonism is defined as FICI_ _>_ _4\\. N.D, not determined._\n\nFrontiers in Microbiology | www.frontiersin.org 6 May 2018 | Volume 9 | Article 932"],"full_content":"Aziz et al. Teicoplanin – Tigecycline Synergy Against _M. abscessus_\n\navibactam with tebipenem or panipenem, however, we did not observe any potentiation between avibactam and ertapenem. Another study found potentiation between clavulanate and meropenem, which we also did not observe (Kaushik et al., 2015). The reasons for these discrepancies remain to be determined (Fisher et al., 2005). One possible explanation may be the use of different _M. abscessus_ strains. This study used the clinical isolate _M. abscessus_ Bamboo in the initial screening, while other studies used other strains including _M. abscessus_ subsp. _abscessus_ ATCC19977. In comparison to avibactam, vaborbactam improved the activity of selected compounds only from the carbapenems but not from the penicillins. Vaborbactam is a new β-lactamase inhibitor and is the first one to contain a cyclic boronic acid structure (Lomovskaya et al., 2017). Despite its difference in structure from avibactam,\n\nboth β-lactamase inhibitors were able to potentiate the activity of the same two carbapenems, panipenem and tebipenem. Panipenem is an earlier carbapenem and the drug needs to be administered together with betamipron to block its deactivation by dehydropeptidase I (Papp-Wallace et al., 2011). Tebipenem is a more recently discovered carbapenem and is the first oral drug of this class (Papp-Wallace et al., 2011). From the analyses of combinations of cell wall-targeting antibiotics with drugs that have intracellular targets, we obtained five novel hits, with the teicoplanin + tigecycline combination being most attractive. Teicoplanin + tigecycline combination displayed synergy at a similar range across reference strains representing the three subspecies of _M. abscessus_ with growth inhibitory combination concentrations of 2–3 µM teicoplanin + 1–2 µM tigecycline. The combination also retained\n\nTABLE 4 | Synergy concentrations and FICI values of teicoplanin + tigecycline combination against _M. abscessus_ screening strain and three reference strains of the _M. abscessus_ sub-species.\n\nConditions Strains MIC90 ( **µ** M) FICI\n\nTeicoplanin Tigecycline\n\nAlone Combined Alone Combined\n\n(No pre-treatment) _M. abscessus_ Bamboo 25 3 8 1 0.27\n\n_M. abscessus_ subsp. _abscessus_ 10 2 6 2 0.42\n\n_M. abscessus_ subsp. _bolletii_ 10 2 8 2 0.39\n\n_M. abscessus_ subsp. _massiliense_ 14 2 7 2 0.36\n\nPre-treated with clarithromycin _M. abscessus_ subsp. _abscessus_ 7 1.2 8.5 1.6 0.22\n\n_‘Pre-treated with clarithromycin’ shows the respective data for a strain displaying induced macrolide resistance due to pre-treatment with a sub-inhibitory concentration of clarithromycin (see section “Materials and Methods”). Results shown are the mean of two replicates. Standard deviation was_ ± _50% of shown values. Synergy is defined as FICI_ ≤ _0\\.5. Checkerboard assay was conducted with 7H9 broth._\n\nTABLE 5 | Synergy concentrations and FICI values of the teicoplanin + tigecycline combination against 14 clinical _M. abscessus_ isolates.\n\nIsolate code _M. abscessus_ sub-species _erm41_ sequevar Clarithromycin susceptibility MIC90 ( **µ** M) FICI\n\nTeicoplanin Tigecycline\n\nAlone Combined Alone Combined\n\nM199 _abscessus_ T28 Resistant 5 2 6 2 0.56\n\nM337 _abscessus_ T28 Resistant 5 2 7 2 0.51\n\nM404 _abscessus_ C28 Sensitive 6 2 4 1 0.53\n\nM421 _abscessus_ T28 Resistant 17 3 4 0.6 0.37\n\nM422 _abscessus_ T28 Resistant 6 1 6 1 0.44\n\nM232 _bolletii_ T28 Resistant 21 5 18 2 0.39\n\nM416 _bolletii_ N.D Sensitive 4 2 5 1 0.63\n\nM506 _bolletii_ C28 Sensitive 10 3 9 1 0.45\n\nM111 _massiliense_ Deletion Sensitive 10 2 10 2 0.48\n\nM353 _massiliense_ Deletion Sensitive 13 3 8 2 0.43\n\nM357 _massiliense_ Deletion Sensitive 12 2 8 1 0.33\n\nM414 _massiliense_ Deletion Sensitive 8 1 10 2 0.32\n\nM444 _massiliense_ Deletion Sensitive 7 3 6 1 0.48\n\nM505 _massiliense_ Deletion Sensitive 13 3 8 1 0.39\n\n_Results shown are the mean of two replicates. Standard deviations were_ ± _50% of shown values. Synergy is defined as FICI_ ≤ _0\\.5. Indifference is defined as 0.5_ _<_ _FICI_ ≤ _4, and antagonism is defined as FICI_ _>_ _4\\. N.D, not determined._\n\nFrontiers in Microbiology | www.frontiersin.org 6 May 2018 | Volume 9 | Article 932","publish_date":null,"title":"β both -lactamase inhibitors were able to potentiate the activity avibactam with tebipenem or panipenem, however, we did not of","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/myco%20hierarchical%20table%20header_page6.pdf"},"request":{"example_id":"table/myco hierarchical table header_page6","product_type":"parse","source_file_path":"myco hierarchical table header_page6.pdf"},"started_at":"2026-11-04T19:47:26.250309"} +{"completed_at":"2026-11-04T19:47:44.844028","latency_in_ms":17303,"output":{"example_id":"table/p29_page1","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 31\n\n**Stated Amount Agreed Amount**\n\nUW Tier Group Vehicle Type Vehicle Age\n\nStated Amount\n\nCode\n\nMin Value Max Value COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease\n\nColl Auto\n\nLoan /Lease\n\nRoadside Assistance\n\nUW Tier Group Vehicle Type\n\nAgreed Amount\n\nCode\n\nMin Value Max Value COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease\n\nColl Auto\n\nLoan /Lease\n\nRoadside Assistance\n\n001 AN 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 AN 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AN 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 AN 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AN 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 AN 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AN 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 AN 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AN 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 AN 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AN 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 AN 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AN 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 AN 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AN 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 AN 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AN 0 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 AN 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AN 0 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 AN 80 8001 9000 1.090 1.000 1.000 1.000 0.820 1.090 0.820 1.000\n\n001 AN 0 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 AN 81 9001 10000 1.220 1.000 1.000 1.000 0.910 1.220 0.910 1.000\n\n001 AN 0 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 AN 82 10001 13750 1.250 1.000 1.000 1.000 1.090 1.250 1.090 1.000\n\n001 AN 0 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 AN 83 13751 16250 1.280 1.000 1.000 1.000 1.280 1.280 1.280 1.000\n\n001 AN 0 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 AN 84 16251 20000 1.310 1.000 1.000 1.000 1.310 1.310 1.310 1.000\n\n001 AN 0 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 AN 85 20001 25000 1.340 1.000 1.000 1.000 1.340 1.340 1.340 1.000\n\n001 AN 0 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 AN 86 25001 30000 1.370 1.000 1.000 1.000 1.370 1.370 1.370 1.000\n\n001 AN 0 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 AN 87 30001 40000 1.400 1.000 1.000 1.000 1.400 1.400 1.400 1.000\n\n001 AN 0 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 AN 88 40001 50000 1.430 1.000 1.000 1.000 1.430 1.430 1.430 1.000\n\n001 AN 0 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 AN 89 50001 60000 1.460 1.000 1.000 1.000 1.460 1.460 1.460 1.000\n\n001 AN 0 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 AN 90 60001 70000 1.490 1.000 1.000 1.000 1.490 1.490 1.490 1.000\n\n001 AN 0 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 AN 91 70001 80000 1.520 1.000 1.000 1.000 1.520 1.520 1.520 1.000\n\n001 AN 0 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 AN 92 80001 90000 1.550 1.000 1.000 1.000 1.550 1.550 1.550 1.000\n\n001 AN 0 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 AN 93 90001 100000 1.580 1.000 1.000 1.000 1.580 1.580 1.580 1.000\n\n001 AN 0 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 AN 94 100001 110000 1.610 1.000 1.000 1.000 1.610 1.610 1.610 1.000\n\n001 AN 0 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 AN 95 110001 120000 1.640 1.000 1.000 1.000 1.640 1.640 1.640 1.000\n\n001 AN 0 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 AN 97 120001 130000 1.670 1.000 1.000 1.000 1.670 1.670 1.670 1.000\n\n001 AN 0 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 AN 98 130001 140000 1.700 1.000 1.000 1.000 1.700 1.700 1.700 1.000\n\n001 AN 0 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 AN 99 140001 150000 1.730 1.000 1.000 1.000 1.730 1.730 1.730 1.000\n\n001 AN 1+ 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 AN 99 150001 160000 1.760 1.000 1.000 1.000 1.760 1.760 1.760 1.000\n\n001 AN 1+ 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 AN 99 160001 170000 1.790 1.000 1.000 1.000 1.790 1.790 1.790 1.000\n\n001 AN 1+ 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 AN 99 170001 180000 1.820 1.000 1.000 1.000 1.820 1.820 1.820 1.000\n\n001 AN 1+ 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 AN 99 180001 190000 1.850 1.000 1.000 1.000 1.850 1.850 1.850 1.000\n\n001 AN 1+ 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 AN 99 190001 200000 1.880 1.000 1.000 1.000 1.880 1.880 1.880 1.000\n\n001 AN 1+ 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 AN 99 200001 210000 1.910 1.000 1.000 1.000 1.910 1.910 1.910 1.000\n\n001 AN 1+ 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 AN 99 210001 220000 1.940 1.000 1.000 1.000 1.940 1.940 1.940 1.000\n\n001 AN 1+ 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 AN 99 220001 230000 1.970 1.000 1.000 1.000 1.970 1.970 1.970 1.000\n\n001 AN 1+ 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 AN 99 230001 240000 2.000 1.000 1.000 1.000 2.000 2.000 2.000 1.000\n\n001 AN 1+ 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 AN 99 240001 250000 2.030 1.000 1.000 1.000 2.030 2.030 2.030 1.000\n\n001 AN 1+ 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 AN 99 250001 260000 2.060 1.000 1.000 1.000 2.060 2.060 2.060 1.000\n\n001 AN 1+ 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 AN 99 260001 270000 2.090 1.000 1.000 1.000 2.090 2.090 2.090 1.000\n\n001 AN 1+ 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 AN 99 270001 280000 2.120 1.000 1.000 1.000 2.120 2.120 2.120 1.000\n\n001 AN 1+ 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 AN 99 280001 290000 2.150 1.000 1.000 1.000 2.150 2.150 2.150 1.000\n\n001 AN 1+ 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 AN 99 290001 300000 2.180 1.000 1.000 1.000 2.180 2.180 2.180 1.000\n\n001 AN 1+ 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 AN 99 300001 310000 2.210 1.000 1.000 1.000 2.210 2.210 2.210 1.000\n\n001 AN 1+ 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 AN 99 310001 320000 2.240 1.000 1.000 1.000 2.240 2.240 2.240 1.000\n\n001 AN 1+ 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 AN 99 320001 330000 2.270 1.000 1.000 1.000 2.270 2.270 2.270 1.000\n\n001 AN 1+ 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 AN 99 330001 340000 2.300 1.000 1.000 1.000 2.300 2.300 2.300 1.000\n\n001 AN 1+ 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 AN 99 340001 999999 2.330 1.000 1.000 1.000 2.330 2.330 2.330 1.000\n\n001 AN 1+ 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 CL 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AN 1+ 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 CL 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AN 1+ 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 CL 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AN 1+ 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 CL 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AN 1+ 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 CL 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AN 1+ 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 CL 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AN 1+ 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 CL 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AN 1+ 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 CL 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AT 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 CL 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AT 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 CL 80 8001 9000 1.090 1.000 1.000 1.000 0.820 1.090 0.820 1.000\n\n001 AT 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 CL 81 9001 10000 1.220 1.000 1.000 1.000 0.910 1.220 0.910 1.000\n\n001 AT 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 CL 82 10001 13750 1.250 1.000 1.000 1.000 1.090 1.250 1.090 1.000\n\n001 AT 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 CL 83 13751 16250 1.280 1.000 1.000 1.000 1.280 1.280 1.280 1.000\n\n001 AT 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 CL 84 16251 20000 1.310 1.000 1.000 1.000 1.310 1.310 1.310 1.000\n\n001 AT 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 CL 85 20001 25000 1.340 1.000 1.000 1.000 1.340 1.340 1.340 1.000\n\n001 AT 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 CL 86 25001 30000 1.370 1.000 1.000 1.000 1.370 1.370 1.370 1.000\n\n001 AT 0 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 CL 87 30001 40000 1.400 1.000 1.000 1.000 1.400 1.400 1.400 1.000\n\n001 AT 0 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 CL 88 40001 50000 1.430 1.000 1.000 1.000 1.430 1.430 1.430 1.000\n\n001 AT 0 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 CL 89 50001 60000 1.460 1.000 1.000 1.000 1.460 1.460 1.460 1.000\n\n001 AT 0 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 CL 90 60001 70000 1.490 1.000 1.000 1.000 1.490 1.490 1.490 1.000\n\n001 AT 0 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 CL 91 70001 80000 1.520 1.000 1.000 1.000 1.520 1.520 1.520 1.000\n\n001 AT 0 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 CL 92 80001 90000 1.550 1.000 1.000 1.000 1.550 1.550 1.550 1.000\n\n001 AT 0 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 CL 93 90001 100000 1.580 1.000 1.000 1.000 1.580 1.580 1.580 1.000\n\n001 AT 0 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 CL 94 100001 110000 1.610 1.000 1.000 1.000 1.610 1.610 1.610 1.000\n\n001 AT 0 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 CL 95 110001 120000 1.640 1.000 1.000 1.000 1.640 1.640 1.640 1.000\n\n001 AT 0 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 CL 97 120001 130000 1.670 1.000 1.000 1.000 1.670 1.670 1.670 1.000\n\n001 AT 0 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 CL 98 130001 140000 1.700 1.000 1.000 1.000 1.700 1.700 1.700 1.000\n\n001 AT 0 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 CL 99 140001 150000 1.730 1.000 1.000 1.000 1.730 1.730 1.730 1.000\n\n001 AT 0 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 CL 99 150001 160000 1.760 1.000 1.000 1.000 1.760 1.760 1.760 1.000\n\n001 AT 0 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 CL 99 160001 170000 1.790 1.000 1.000 1.000 1.790 1.790 1.790 1.000\n\n001 AT 0 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 CL 99 170001 180000 1.820 1.000 1.000 1.000 1.820 1.820 1.820 1.000\n\n001 AT 0 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 CL 99 180001 190000 1.850 1.000 1.000 1.000 1.850 1.850 1.850 1.000\n\n001 AT 0 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 CL 99 190001 200000 1.880 1.000 1.000 1.000 1.880 1.880 1.880 1.000\n\n001 AT 0 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 CL 99 200001 210000 1.910 1.000 1.000 1.000 1.910 1.910 1.910 1.000\n\n001 AT 0 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 CL 99 210001 220000 1.940 1.000 1.000 1.000 1.940 1.940 1.940 1.000\n\n001 AT 0 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 CL 99 220001 230000 1.970 1.000 1.000 1.000 1.970 1.970 1.970 1.000\n\n001 AT 1+ 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 CL 99 230001 240000 2.000 1.000 1.000 1.000 2.000 2.000 2.000 1.000\n\n001 AT 1+ 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 CL 99 240001 250000 2.030 1.000 1.000 1.000 2.030 2.030 2.030 1.000\n\n001 AT 1+ 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 CL 99 250001 260000 2.060 1.000 1.000 1.000 2.060 2.060 2.060 1.000\n\n001 AT 1+ 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 CL 99 260001 270000 2.090 1.000 1.000 1.000 2.090 2.090 2.090 1.000\n\n001 AT 1+ 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 CL 99 270001 280000 2.120 1.000 1.000 1.000 2.120 2.120 2.120 1.000\n\n001 AT 1+ 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 CL 99 280001 290000 2.150 1.000 1.000 1.000 2.150 2.150 2.150 1.000\n\n001 AT 1+ 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 CL 99 290001 300000 2.180 1.000 1.000 1.000 2.180 2.180 2.180 1.000\n\n001 AT 1+ 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 CL 99 300001 310000 2.210 1.000 1.000 1.000 2.210 2.210 2.210 1.000\n\n001 AT 1+ 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 CL 99 310001 320000 2.240 1.000 1.000 1.000 2.240 2.240 2.240 1.000\n\n001 AT 1+ 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 CL 99 320001 330000 2.270 1.000 1.000 1.000 2.270 2.270 2.270 1.000\n\n001 AT 1+ 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 CL 99 330001 340000 2.300 1.000 1.000 1.000 2.300 2.300 2.300 1.000\n\n001 AT 1+ 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 CL 99 340001 999999 2.330 1.000 1.000 1.000 2.330 2.330 2.330 1.000\n\n001 AT 1+ 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 PP 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AT 1+ 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 PP 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AT 1+ 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 PP 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AT 1+ 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 PP 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AT 1+ 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 PP 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AT 1+ 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 PP 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AT 1+ 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 PP 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AT 1+ 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 PP 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AT 1+ 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 PP 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AT 1+ 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 PP 80 8001 9000 1.050 1.000 1.000 1.000 0.820 1.050 0.820 1.000\n\n001 AT 1+ 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 PP 81 9001 10000 1.050 1.000 1.000 1.000 0.910 1.050 0.910 1.000\n\n001 AT 1+ 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 PP 82 10001 13750 1.100 1.000 1.000 1.000 1.090 1.100 1.090 1.000\n\n001 AT 1+ 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 PP 83 13751 16250 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 PP 84 16251 20000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 PP 85 20001 25000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 PP 86 25001 30000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 PP 87 30001 40000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 PP 88 40001 50000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 PP 89 50001 60000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 PP 90 60001 70000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 PP 91 70001 80000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 PP 92 80001 90000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 PP 93 90001 100000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 PP 94 100001 110000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n**State of Arkansas**\n\n**Allmerica Financial Benefit Insurance Company**\n\n**Private Passenger Automobile**\n\n**Stated & Agreed Amount**\n\nPage 1 of 26","pages":[{"line_numbers":[],"markdown":"Exhibit 31\n\n**Stated Amount Agreed Amount**\n\nUW Tier Group Vehicle Type Vehicle Age\n\nStated Amount\n\nCode\n\nMin Value Max Value COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease\n\nColl Auto\n\nLoan /Lease\n\nRoadside Assistance\n\nUW Tier Group Vehicle Type\n\nAgreed Amount\n\nCode\n\nMin Value Max Value COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease\n\nColl Auto\n\nLoan /Lease\n\nRoadside Assistance\n\n001 AN 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 AN 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AN 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 AN 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AN 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 AN 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AN 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 AN 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AN 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 AN 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AN 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 AN 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AN 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 AN 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AN 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 AN 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AN 0 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 AN 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AN 0 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 AN 80 8001 9000 1.090 1.000 1.000 1.000 0.820 1.090 0.820 1.000\n\n001 AN 0 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 AN 81 9001 10000 1.220 1.000 1.000 1.000 0.910 1.220 0.910 1.000\n\n001 AN 0 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 AN 82 10001 13750 1.250 1.000 1.000 1.000 1.090 1.250 1.090 1.000\n\n001 AN 0 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 AN 83 13751 16250 1.280 1.000 1.000 1.000 1.280 1.280 1.280 1.000\n\n001 AN 0 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 AN 84 16251 20000 1.310 1.000 1.000 1.000 1.310 1.310 1.310 1.000\n\n001 AN 0 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 AN 85 20001 25000 1.340 1.000 1.000 1.000 1.340 1.340 1.340 1.000\n\n001 AN 0 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 AN 86 25001 30000 1.370 1.000 1.000 1.000 1.370 1.370 1.370 1.000\n\n001 AN 0 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 AN 87 30001 40000 1.400 1.000 1.000 1.000 1.400 1.400 1.400 1.000\n\n001 AN 0 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 AN 88 40001 50000 1.430 1.000 1.000 1.000 1.430 1.430 1.430 1.000\n\n001 AN 0 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 AN 89 50001 60000 1.460 1.000 1.000 1.000 1.460 1.460 1.460 1.000\n\n001 AN 0 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 AN 90 60001 70000 1.490 1.000 1.000 1.000 1.490 1.490 1.490 1.000\n\n001 AN 0 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 AN 91 70001 80000 1.520 1.000 1.000 1.000 1.520 1.520 1.520 1.000\n\n001 AN 0 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 AN 92 80001 90000 1.550 1.000 1.000 1.000 1.550 1.550 1.550 1.000\n\n001 AN 0 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 AN 93 90001 100000 1.580 1.000 1.000 1.000 1.580 1.580 1.580 1.000\n\n001 AN 0 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 AN 94 100001 110000 1.610 1.000 1.000 1.000 1.610 1.610 1.610 1.000\n\n001 AN 0 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 AN 95 110001 120000 1.640 1.000 1.000 1.000 1.640 1.640 1.640 1.000\n\n001 AN 0 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 AN 97 120001 130000 1.670 1.000 1.000 1.000 1.670 1.670 1.670 1.000\n\n001 AN 0 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 AN 98 130001 140000 1.700 1.000 1.000 1.000 1.700 1.700 1.700 1.000\n\n001 AN 0 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 AN 99 140001 150000 1.730 1.000 1.000 1.000 1.730 1.730 1.730 1.000\n\n001 AN 1+ 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 AN 99 150001 160000 1.760 1.000 1.000 1.000 1.760 1.760 1.760 1.000\n\n001 AN 1+ 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 AN 99 160001 170000 1.790 1.000 1.000 1.000 1.790 1.790 1.790 1.000\n\n001 AN 1+ 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 AN 99 170001 180000 1.820 1.000 1.000 1.000 1.820 1.820 1.820 1.000\n\n001 AN 1+ 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 AN 99 180001 190000 1.850 1.000 1.000 1.000 1.850 1.850 1.850 1.000\n\n001 AN 1+ 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 AN 99 190001 200000 1.880 1.000 1.000 1.000 1.880 1.880 1.880 1.000\n\n001 AN 1+ 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 AN 99 200001 210000 1.910 1.000 1.000 1.000 1.910 1.910 1.910 1.000\n\n001 AN 1+ 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 AN 99 210001 220000 1.940 1.000 1.000 1.000 1.940 1.940 1.940 1.000\n\n001 AN 1+ 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 AN 99 220001 230000 1.970 1.000 1.000 1.000 1.970 1.970 1.970 1.000\n\n001 AN 1+ 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 AN 99 230001 240000 2.000 1.000 1.000 1.000 2.000 2.000 2.000 1.000\n\n001 AN 1+ 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 AN 99 240001 250000 2.030 1.000 1.000 1.000 2.030 2.030 2.030 1.000\n\n001 AN 1+ 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 AN 99 250001 260000 2.060 1.000 1.000 1.000 2.060 2.060 2.060 1.000\n\n001 AN 1+ 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 AN 99 260001 270000 2.090 1.000 1.000 1.000 2.090 2.090 2.090 1.000\n\n001 AN 1+ 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 AN 99 270001 280000 2.120 1.000 1.000 1.000 2.120 2.120 2.120 1.000\n\n001 AN 1+ 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 AN 99 280001 290000 2.150 1.000 1.000 1.000 2.150 2.150 2.150 1.000\n\n001 AN 1+ 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 AN 99 290001 300000 2.180 1.000 1.000 1.000 2.180 2.180 2.180 1.000\n\n001 AN 1+ 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 AN 99 300001 310000 2.210 1.000 1.000 1.000 2.210 2.210 2.210 1.000\n\n001 AN 1+ 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 AN 99 310001 320000 2.240 1.000 1.000 1.000 2.240 2.240 2.240 1.000\n\n001 AN 1+ 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 AN 99 320001 330000 2.270 1.000 1.000 1.000 2.270 2.270 2.270 1.000\n\n001 AN 1+ 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 AN 99 330001 340000 2.300 1.000 1.000 1.000 2.300 2.300 2.300 1.000\n\n001 AN 1+ 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 AN 99 340001 999999 2.330 1.000 1.000 1.000 2.330 2.330 2.330 1.000\n\n001 AN 1+ 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 CL 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AN 1+ 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 CL 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AN 1+ 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 CL 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AN 1+ 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 CL 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AN 1+ 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 CL 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AN 1+ 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 CL 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AN 1+ 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 CL 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AN 1+ 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 CL 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AT 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 CL 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AT 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 CL 80 8001 9000 1.090 1.000 1.000 1.000 0.820 1.090 0.820 1.000\n\n001 AT 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 CL 81 9001 10000 1.220 1.000 1.000 1.000 0.910 1.220 0.910 1.000\n\n001 AT 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 CL 82 10001 13750 1.250 1.000 1.000 1.000 1.090 1.250 1.090 1.000\n\n001 AT 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 CL 83 13751 16250 1.280 1.000 1.000 1.000 1.280 1.280 1.280 1.000\n\n001 AT 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 CL 84 16251 20000 1.310 1.000 1.000 1.000 1.310 1.310 1.310 1.000\n\n001 AT 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 CL 85 20001 25000 1.340 1.000 1.000 1.000 1.340 1.340 1.340 1.000\n\n001 AT 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 CL 86 25001 30000 1.370 1.000 1.000 1.000 1.370 1.370 1.370 1.000\n\n001 AT 0 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 CL 87 30001 40000 1.400 1.000 1.000 1.000 1.400 1.400 1.400 1.000\n\n001 AT 0 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 CL 88 40001 50000 1.430 1.000 1.000 1.000 1.430 1.430 1.430 1.000\n\n001 AT 0 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 CL 89 50001 60000 1.460 1.000 1.000 1.000 1.460 1.460 1.460 1.000\n\n001 AT 0 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 CL 90 60001 70000 1.490 1.000 1.000 1.000 1.490 1.490 1.490 1.000\n\n001 AT 0 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 CL 91 70001 80000 1.520 1.000 1.000 1.000 1.520 1.520 1.520 1.000\n\n001 AT 0 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 CL 92 80001 90000 1.550 1.000 1.000 1.000 1.550 1.550 1.550 1.000\n\n001 AT 0 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 CL 93 90001 100000 1.580 1.000 1.000 1.000 1.580 1.580 1.580 1.000\n\n001 AT 0 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 CL 94 100001 110000 1.610 1.000 1.000 1.000 1.610 1.610 1.610 1.000\n\n001 AT 0 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 CL 95 110001 120000 1.640 1.000 1.000 1.000 1.640 1.640 1.640 1.000\n\n001 AT 0 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 CL 97 120001 130000 1.670 1.000 1.000 1.000 1.670 1.670 1.670 1.000\n\n001 AT 0 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 CL 98 130001 140000 1.700 1.000 1.000 1.000 1.700 1.700 1.700 1.000\n\n001 AT 0 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 CL 99 140001 150000 1.730 1.000 1.000 1.000 1.730 1.730 1.730 1.000\n\n001 AT 0 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 CL 99 150001 160000 1.760 1.000 1.000 1.000 1.760 1.760 1.760 1.000\n\n001 AT 0 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 CL 99 160001 170000 1.790 1.000 1.000 1.000 1.790 1.790 1.790 1.000\n\n001 AT 0 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 CL 99 170001 180000 1.820 1.000 1.000 1.000 1.820 1.820 1.820 1.000\n\n001 AT 0 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 CL 99 180001 190000 1.850 1.000 1.000 1.000 1.850 1.850 1.850 1.000\n\n001 AT 0 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 CL 99 190001 200000 1.880 1.000 1.000 1.000 1.880 1.880 1.880 1.000\n\n001 AT 0 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 CL 99 200001 210000 1.910 1.000 1.000 1.000 1.910 1.910 1.910 1.000\n\n001 AT 0 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 CL 99 210001 220000 1.940 1.000 1.000 1.000 1.940 1.940 1.940 1.000\n\n001 AT 0 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 CL 99 220001 230000 1.970 1.000 1.000 1.000 1.970 1.970 1.970 1.000\n\n001 AT 1+ 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 CL 99 230001 240000 2.000 1.000 1.000 1.000 2.000 2.000 2.000 1.000\n\n001 AT 1+ 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 CL 99 240001 250000 2.030 1.000 1.000 1.000 2.030 2.030 2.030 1.000\n\n001 AT 1+ 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 CL 99 250001 260000 2.060 1.000 1.000 1.000 2.060 2.060 2.060 1.000\n\n001 AT 1+ 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 CL 99 260001 270000 2.090 1.000 1.000 1.000 2.090 2.090 2.090 1.000\n\n001 AT 1+ 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 CL 99 270001 280000 2.120 1.000 1.000 1.000 2.120 2.120 2.120 1.000\n\n001 AT 1+ 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 CL 99 280001 290000 2.150 1.000 1.000 1.000 2.150 2.150 2.150 1.000\n\n001 AT 1+ 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 CL 99 290001 300000 2.180 1.000 1.000 1.000 2.180 2.180 2.180 1.000\n\n001 AT 1+ 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 CL 99 300001 310000 2.210 1.000 1.000 1.000 2.210 2.210 2.210 1.000\n\n001 AT 1+ 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 CL 99 310001 320000 2.240 1.000 1.000 1.000 2.240 2.240 2.240 1.000\n\n001 AT 1+ 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 CL 99 320001 330000 2.270 1.000 1.000 1.000 2.270 2.270 2.270 1.000\n\n001 AT 1+ 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 CL 99 330001 340000 2.300 1.000 1.000 1.000 2.300 2.300 2.300 1.000\n\n001 AT 1+ 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 CL 99 340001 999999 2.330 1.000 1.000 1.000 2.330 2.330 2.330 1.000\n\n001 AT 1+ 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 PP 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AT 1+ 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 PP 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AT 1+ 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 PP 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AT 1+ 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 PP 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AT 1+ 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 PP 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AT 1+ 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 PP 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AT 1+ 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 PP 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AT 1+ 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 PP 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AT 1+ 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 PP 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AT 1+ 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 PP 80 8001 9000 1.050 1.000 1.000 1.000 0.820 1.050 0.820 1.000\n\n001 AT 1+ 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 PP 81 9001 10000 1.050 1.000 1.000 1.000 0.910 1.050 0.910 1.000\n\n001 AT 1+ 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 PP 82 10001 13750 1.100 1.000 1.000 1.000 1.090 1.100 1.090 1.000\n\n001 AT 1+ 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 PP 83 13751 16250 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 PP 84 16251 20000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 PP 85 20001 25000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 PP 86 25001 30000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 PP 87 30001 40000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 PP 88 40001 50000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 PP 89 50001 60000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 PP 90 60001 70000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 PP 91 70001 80000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 PP 92 80001 90000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 PP 93 90001 100000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 PP 94 100001 110000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n**State of Arkansas**\n\n**Allmerica Financial Benefit Insurance Company**\n\n**Private Passenger Automobile**\n\n**Stated & Agreed Amount**\n\nPage 1 of 26","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 31\n\n**Stated Amount Agreed Amount**\n\nUW Tier Group Vehicle Type Vehicle Age\n\nStated Amount\n\nCode\n\nMin Value Max Value COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease\n\nColl Auto\n\nLoan /Lease\n\nRoadside Assistance\n\nUW Tier Group Vehicle Type\n\nAgreed Amount\n\nCode\n\nMin Value Max Value COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease\n\nColl Auto\n\nLoan /Lease\n\nRoadside Assistance\n\n001 AN 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 AN 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AN 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 AN 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AN 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 AN 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AN 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 AN 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AN 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 AN 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AN 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 AN 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AN 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 AN 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AN 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 AN 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AN 0 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 AN 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AN 0 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 AN 80 8001 9000 1.090 1.000 1.000 1.000 0.820 1.090 0.820 1.000\n\n001 AN 0 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 AN 81 9001 10000 1.220 1.000 1.000 1.000 0.910 1.220 0.910 1.000\n\n001 AN 0 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 AN 82 10001 13750 1.250 1.000 1.000 1.000 1.090 1.250 1.090 1.000\n\n001 AN 0 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 AN 83 13751 16250 1.280 1.000 1.000 1.000 1.280 1.280 1.280 1.000\n\n001 AN 0 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 AN 84 16251 20000 1.310 1.000 1.000 1.000 1.310 1.310 1.310 1.000\n\n001 AN 0 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 AN 85 20001 25000 1.340 1.000 1.000 1.000 1.340 1.340 1.340 1.000\n\n001 AN 0 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 AN 86 25001 30000 1.370 1.000 1.000 1.000 1.370 1.370 1.370 1.000\n\n001 AN 0 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 AN 87 30001 40000 1.400 1.000 1.000 1.000 1.400 1.400 1.400 1.000\n\n001 AN 0 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 AN 88 40001 50000 1.430 1.000 1.000 1.000 1.430 1.430 1.430 1.000\n\n001 AN 0 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 AN 89 50001 60000 1.460 1.000 1.000 1.000 1.460 1.460 1.460 1.000\n\n001 AN 0 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 AN 90 60001 70000 1.490 1.000 1.000 1.000 1.490 1.490 1.490 1.000\n\n001 AN 0 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 AN 91 70001 80000 1.520 1.000 1.000 1.000 1.520 1.520 1.520 1.000\n\n001 AN 0 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 AN 92 80001 90000 1.550 1.000 1.000 1.000 1.550 1.550 1.550 1.000\n\n001 AN 0 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 AN 93 90001 100000 1.580 1.000 1.000 1.000 1.580 1.580 1.580 1.000\n\n001 AN 0 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 AN 94 100001 110000 1.610 1.000 1.000 1.000 1.610 1.610 1.610 1.000\n\n001 AN 0 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 AN 95 110001 120000 1.640 1.000 1.000 1.000 1.640 1.640 1.640 1.000\n\n001 AN 0 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 AN 97 120001 130000 1.670 1.000 1.000 1.000 1.670 1.670 1.670 1.000\n\n001 AN 0 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 AN 98 130001 140000 1.700 1.000 1.000 1.000 1.700 1.700 1.700 1.000\n\n001 AN 0 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 AN 99 140001 150000 1.730 1.000 1.000 1.000 1.730 1.730 1.730 1.000\n\n001 AN 1+ 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 AN 99 150001 160000 1.760 1.000 1.000 1.000 1.760 1.760 1.760 1.000\n\n001 AN 1+ 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 AN 99 160001 170000 1.790 1.000 1.000 1.000 1.790 1.790 1.790 1.000\n\n001 AN 1+ 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 AN 99 170001 180000 1.820 1.000 1.000 1.000 1.820 1.820 1.820 1.000\n\n001 AN 1+ 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 AN 99 180001 190000 1.850 1.000 1.000 1.000 1.850 1.850 1.850 1.000\n\n001 AN 1+ 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 AN 99 190001 200000 1.880 1.000 1.000 1.000 1.880 1.880 1.880 1.000\n\n001 AN 1+ 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 AN 99 200001 210000 1.910 1.000 1.000 1.000 1.910 1.910 1.910 1.000\n\n001 AN 1+ 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 AN 99 210001 220000 1.940 1.000 1.000 1.000 1.940 1.940 1.940 1.000\n\n001 AN 1+ 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 AN 99 220001 230000 1.970 1.000 1.000 1.000 1.970 1.970 1.970 1.000\n\n001 AN 1+ 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 AN 99 230001 240000 2.000 1.000 1.000 1.000 2.000 2.000 2.000 1.000\n\n001 AN 1+ 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 AN 99 240001 250000 2.030 1.000 1.000 1.000 2.030 2.030 2.030 1.000\n\n001 AN 1+ 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 AN 99 250001 260000 2.060 1.000 1.000 1.000 2.060 2.060 2.060 1.000\n\n001 AN 1+ 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 AN 99 260001 270000 2.090 1.000 1.000 1.000 2.090 2.090 2.090 1.000\n\n001 AN 1+ 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 AN 99 270001 280000 2.120 1.000 1.000 1.000 2.120 2.120 2.120 1.000\n\n001 AN 1+ 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 AN 99 280001 290000 2.150 1.000 1.000 1.000 2.150 2.150 2.150 1.000\n\n001 AN 1+ 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 AN 99 290001 300000 2.180 1.000 1.000 1.000 2.180 2.180 2.180 1.000\n\n001 AN 1+ 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 AN 99 300001 310000 2.210 1.000 1.000 1.000 2.210 2.210 2.210 1.000\n\n001 AN 1+ 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 AN 99 310001 320000 2.240 1.000 1.000 1.000 2.240 2.240 2.240 1.000\n\n001 AN 1+ 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 AN 99 320001 330000 2.270 1.000 1.000 1.000 2.270 2.270 2.270 1.000\n\n001 AN 1+ 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 AN 99 330001 340000 2.300 1.000 1.000 1.000 2.300 2.300 2.300 1.000\n\n001 AN 1+ 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 AN 99 340001 999999 2.330 1.000 1.000 1.000 2.330 2.330 2.330 1.000\n\n001 AN 1+ 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 CL 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AN 1+ 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 CL 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AN 1+ 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 CL 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AN 1+ 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 CL 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AN 1+ 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 CL 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AN 1+ 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 CL 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AN 1+ 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 CL 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AN 1+ 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 CL 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AT 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 CL 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AT 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 CL 80 8001 9000 1.090 1.000 1.000 1.000 0.820 1.090 0.820 1.000\n\n001 AT 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 CL 81 9001 10000 1.220 1.000 1.000 1.000 0.910 1.220 0.910 1.000\n\n001 AT 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 CL 82 10001 13750 1.250 1.000 1.000 1.000 1.090 1.250 1.090 1.000\n\n001 AT 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 CL 83 13751 16250 1.280 1.000 1.000 1.000 1.280 1.280 1.280 1.000\n\n001 AT 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 CL 84 16251 20000 1.310 1.000 1.000 1.000 1.310 1.310 1.310 1.000\n\n001 AT 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 CL 85 20001 25000 1.340 1.000 1.000 1.000 1.340 1.340 1.340 1.000\n\n001 AT 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 CL 86 25001 30000 1.370 1.000 1.000 1.000 1.370 1.370 1.370 1.000\n\n001 AT 0 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 CL 87 30001 40000 1.400 1.000 1.000 1.000 1.400 1.400 1.400 1.000\n\n001 AT 0 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 CL 88 40001 50000 1.430 1.000 1.000 1.000 1.430 1.430 1.430 1.000\n\n001 AT 0 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 CL 89 50001 60000 1.460 1.000 1.000 1.000 1.460 1.460 1.460 1.000\n\n001 AT 0 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 CL 90 60001 70000 1.490 1.000 1.000 1.000 1.490 1.490 1.490 1.000\n\n001 AT 0 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 CL 91 70001 80000 1.520 1.000 1.000 1.000 1.520 1.520 1.520 1.000\n\n001 AT 0 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 CL 92 80001 90000 1.550 1.000 1.000 1.000 1.550 1.550 1.550 1.000\n\n001 AT 0 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 CL 93 90001 100000 1.580 1.000 1.000 1.000 1.580 1.580 1.580 1.000\n\n001 AT 0 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 CL 94 100001 110000 1.610 1.000 1.000 1.000 1.610 1.610 1.610 1.000\n\n001 AT 0 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 CL 95 110001 120000 1.640 1.000 1.000 1.000 1.640 1.640 1.640 1.000\n\n001 AT 0 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 CL 97 120001 130000 1.670 1.000 1.000 1.000 1.670 1.670 1.670 1.000\n\n001 AT 0 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 CL 98 130001 140000 1.700 1.000 1.000 1.000 1.700 1.700 1.700 1.000\n\n001 AT 0 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 CL 99 140001 150000 1.730 1.000 1.000 1.000 1.730 1.730 1.730 1.000\n\n001 AT 0 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 CL 99 150001 160000 1.760 1.000 1.000 1.000 1.760 1.760 1.760 1.000\n\n001 AT 0 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 CL 99 160001 170000 1.790 1.000 1.000 1.000 1.790 1.790 1.790 1.000\n\n001 AT 0 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 CL 99 170001 180000 1.820 1.000 1.000 1.000 1.820 1.820 1.820 1.000\n\n001 AT 0 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 CL 99 180001 190000 1.850 1.000 1.000 1.000 1.850 1.850 1.850 1.000\n\n001 AT 0 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 CL 99 190001 200000 1.880 1.000 1.000 1.000 1.880 1.880 1.880 1.000\n\n001 AT 0 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 CL 99 200001 210000 1.910 1.000 1.000 1.000 1.910 1.910 1.910 1.000\n\n001 AT 0 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 CL 99 210001 220000 1.940 1.000 1.000 1.000 1.940 1.940 1.940 1.000\n\n001 AT 0 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 CL 99 220001 230000 1.970 1.000 1.000 1.000 1.970 1.970 1.970 1.000\n\n001 AT 1+ 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 CL 99 230001 240000 2.000 1.000 1.000 1.000 2.000 2.000 2.000 1.000\n\n001 AT 1+ 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 CL 99 240001 250000 2.030 1.000 1.000 1.000 2.030 2.030 2.030 1.000\n\n001 AT 1+ 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 CL 99 250001 260000 2.060 1.000 1.000 1.000 2.060 2.060 2.060 1.000\n\n001 AT 1+ 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 CL 99 260001 270000 2.090 1.000 1.000 1.000 2.090 2.090 2.090 1.000\n\n001 AT 1+ 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 CL 99 270001 280000 2.120 1.000 1.000 1.000 2.120 2.120 2.120 1.000\n\n001 AT 1+ 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 CL 99 280001 290000 2.150 1.000 1.000 1.000 2.150 2.150 2.150 1.000\n\n001 AT 1+ 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 CL 99 290001 300000 2.180 1.000 1.000 1.000 2.180 2.180 2.180 1.000\n\n001 AT 1+ 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 CL 99 300001 310000 2.210 1.000 1.000 1.000 2.210 2.210 2.210 1.000\n\n001 AT 1+ 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 CL 99 310001 320000 2.240 1.000 1.000 1.000 2.240 2.240 2.240 1.000\n\n001 AT 1+ 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 CL 99 320001 330000 2.270 1.000 1.000 1.000 2.270 2.270 2.270 1.000\n\n001 AT 1+ 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 CL 99 330001 340000 2.300 1.000 1.000 1.000 2.300 2.300 2.300 1.000\n\n001 AT 1+ 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 CL 99 340001 999999 2.330 1.000 1.000 1.000 2.330 2.330 2.330 1.000\n\n001 AT 1+ 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 PP 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AT 1+ 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 PP 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AT 1+ 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 PP 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AT 1+ 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 PP 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AT 1+ 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 PP 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AT 1+ 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 PP 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AT 1+ 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 PP 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AT 1+ 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 PP 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AT 1+ 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 PP 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AT 1+ 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 PP 80 8001 9000 1.050 1.000 1.000 1.000 0.820 1.050 0.820 1.000\n\n001 AT 1+ 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 PP 81 9001 10000 1.050 1.000 1.000 1.000 0.910 1.050 0.910 1.000\n\n001 AT 1+ 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 PP 82 10001 13750 1.100 1.000 1.000 1.000 1.090 1.100 1.090 1.000\n\n001 AT 1+ 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 PP 83 13751 16250 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 PP 84 16251 20000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 PP 85 20001 25000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 PP 86 25001 30000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 PP 87 30001 40000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 PP 88 40001 50000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 PP 89 50001 60000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 PP 90 60001 70000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 PP 91 70001 80000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 PP 92 80001 90000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 PP 93 90001 100000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 PP 94 100001 110000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n**State of Arkansas**\n\n**Allmerica Financial Benefit Insurance Company**\n\n**Private Passenger Automobile**\n\n**Stated & Agreed Amount**\n\nPage 1 of 26","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/p29_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_1e7b98acdd05328b76a6cb6505e73c9b","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 31\n\n**Stated Amount Agreed Amount**\n\nUW Tier Group Vehicle Type Vehicle Age\n\nStated Amount\n\nCode\n\nMin Value Max Value COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease\n\nColl Auto\n\nLoan /Lease\n\nRoadside Assistance\n\nUW Tier Group Vehicle Type\n\nAgreed Amount\n\nCode\n\nMin Value Max Value COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease\n\nColl Auto\n\nLoan /Lease\n\nRoadside Assistance\n\n001 AN 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 AN 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AN 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 AN 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AN 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 AN 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AN 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 AN 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AN 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 AN 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AN 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 AN 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AN 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 AN 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AN 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 AN 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AN 0 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 AN 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AN 0 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 AN 80 8001 9000 1.090 1.000 1.000 1.000 0.820 1.090 0.820 1.000\n\n001 AN 0 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 AN 81 9001 10000 1.220 1.000 1.000 1.000 0.910 1.220 0.910 1.000\n\n001 AN 0 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 AN 82 10001 13750 1.250 1.000 1.000 1.000 1.090 1.250 1.090 1.000\n\n001 AN 0 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 AN 83 13751 16250 1.280 1.000 1.000 1.000 1.280 1.280 1.280 1.000\n\n001 AN 0 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 AN 84 16251 20000 1.310 1.000 1.000 1.000 1.310 1.310 1.310 1.000\n\n001 AN 0 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 AN 85 20001 25000 1.340 1.000 1.000 1.000 1.340 1.340 1.340 1.000\n\n001 AN 0 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 AN 86 25001 30000 1.370 1.000 1.000 1.000 1.370 1.370 1.370 1.000\n\n001 AN 0 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 AN 87 30001 40000 1.400 1.000 1.000 1.000 1.400 1.400 1.400 1.000\n\n001 AN 0 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 AN 88 40001 50000 1.430 1.000 1.000 1.000 1.430 1.430 1.430 1.000\n\n001 AN 0 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 AN 89 50001 60000 1.460 1.000 1.000 1.000 1.460 1.460 1.460 1.000\n\n001 AN 0 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 AN 90 60001 70000 1.490 1.000 1.000 1.000 1.490 1.490 1.490 1.000\n\n001 AN 0 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 AN 91 70001 80000 1.520 1.000 1.000 1.000 1.520 1.520 1.520 1.000\n\n001 AN 0 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 AN 92 80001 90000 1.550 1.000 1.000 1.000 1.550 1.550 1.550 1.000\n\n001 AN 0 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 AN 93 90001 100000 1.580 1.000 1.000 1.000 1.580 1.580 1.580 1.000\n\n001 AN 0 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 AN 94 100001 110000 1.610 1.000 1.000 1.000 1.610 1.610 1.610 1.000\n\n001 AN 0 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 AN 95 110001 120000 1.640 1.000 1.000 1.000 1.640 1.640 1.640 1.000\n\n001 AN 0 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 AN 97 120001 130000 1.670 1.000 1.000 1.000 1.670 1.670 1.670 1.000\n\n001 AN 0 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 AN 98 130001 140000 1.700 1.000 1.000 1.000 1.700 1.700 1.700 1.000\n\n001 AN 0 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 AN 99 140001 150000 1.730 1.000 1.000 1.000 1.730 1.730 1.730 1.000\n\n001 AN 1+ 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 AN 99 150001 160000 1.760 1.000 1.000 1.000 1.760 1.760 1.760 1.000\n\n001 AN 1+ 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 AN 99 160001 170000 1.790 1.000 1.000 1.000 1.790 1.790 1.790 1.000\n\n001 AN 1+ 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 AN 99 170001 180000 1.820 1.000 1.000 1.000 1.820 1.820 1.820 1.000\n\n001 AN 1+ 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 AN 99 180001 190000 1.850 1.000 1.000 1.000 1.850 1.850 1.850 1.000\n\n001 AN 1+ 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 AN 99 190001 200000 1.880 1.000 1.000 1.000 1.880 1.880 1.880 1.000\n\n001 AN 1+ 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 AN 99 200001 210000 1.910 1.000 1.000 1.000 1.910 1.910 1.910 1.000\n\n001 AN 1+ 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 AN 99 210001 220000 1.940 1.000 1.000 1.000 1.940 1.940 1.940 1.000\n\n001 AN 1+ 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 AN 99 220001 230000 1.970 1.000 1.000 1.000 1.970 1.970 1.970 1.000\n\n001 AN 1+ 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 AN 99 230001 240000 2.000 1.000 1.000 1.000 2.000 2.000 2.000 1.000\n\n001 AN 1+ 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 AN 99 240001 250000 2.030 1.000 1.000 1.000 2.030 2.030 2.030 1.000\n\n001 AN 1+ 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 AN 99 250001 260000 2.060 1.000 1.000 1.000 2.060 2.060 2.060 1.000\n\n001 AN 1+ 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 AN 99 260001 270000 2.090 1.000 1.000 1.000 2.090 2.090 2.090 1.000\n\n001 AN 1+ 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 AN 99 270001 280000 2.120 1.000 1.000 1.000 2.120 2.120 2.120 1.000\n\n001 AN 1+ 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 AN 99 280001 290000 2.150 1.000 1.000 1.000 2.150 2.150 2.150 1.000\n\n001 AN 1+ 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 AN 99 290001 300000 2.180 1.000 1.000 1.000 2.180 2.180 2.180 1.000\n\n001 AN 1+ 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 AN 99 300001 310000 2.210 1.000 1.000 1.000 2.210 2.210 2.210 1.000\n\n001 AN 1+ 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 AN 99 310001 320000 2.240 1.000 1.000 1.000 2.240 2.240 2.240 1.000\n\n001 AN 1+ 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 AN 99 320001 330000 2.270 1.000 1.000 1.000 2.270 2.270 2.270 1.000\n\n001 AN 1+ 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 AN 99 330001 340000 2.300 1.000 1.000 1.000 2.300 2.300 2.300 1.000\n\n001 AN 1+ 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 AN 99 340001 999999 2.330 1.000 1.000 1.000 2.330 2.330 2.330 1.000\n\n001 AN 1+ 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 CL 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AN 1+ 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 CL 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AN 1+ 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 CL 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AN 1+ 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 CL 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AN 1+ 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 CL 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AN 1+ 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 CL 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AN 1+ 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 CL 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AN 1+ 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 CL 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AT 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 CL 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AT 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 CL 80 8001 9000 1.090 1.000 1.000 1.000 0.820 1.090 0.820 1.000\n\n001 AT 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 CL 81 9001 10000 1.220 1.000 1.000 1.000 0.910 1.220 0.910 1.000\n\n001 AT 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 CL 82 10001 13750 1.250 1.000 1.000 1.000 1.090 1.250 1.090 1.000\n\n001 AT 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 CL 83 13751 16250 1.280 1.000 1.000 1.000 1.280 1.280 1.280 1.000\n\n001 AT 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 CL 84 16251 20000 1.310 1.000 1.000 1.000 1.310 1.310 1.310 1.000\n\n001 AT 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 CL 85 20001 25000 1.340 1.000 1.000 1.000 1.340 1.340 1.340 1.000\n\n001 AT 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 CL 86 25001 30000 1.370 1.000 1.000 1.000 1.370 1.370 1.370 1.000\n\n001 AT 0 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 CL 87 30001 40000 1.400 1.000 1.000 1.000 1.400 1.400 1.400 1.000\n\n001 AT 0 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 CL 88 40001 50000 1.430 1.000 1.000 1.000 1.430 1.430 1.430 1.000\n\n001 AT 0 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 CL 89 50001 60000 1.460 1.000 1.000 1.000 1.460 1.460 1.460 1.000\n\n001 AT 0 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 CL 90 60001 70000 1.490 1.000 1.000 1.000 1.490 1.490 1.490 1.000\n\n001 AT 0 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 CL 91 70001 80000 1.520 1.000 1.000 1.000 1.520 1.520 1.520 1.000\n\n001 AT 0 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 CL 92 80001 90000 1.550 1.000 1.000 1.000 1.550 1.550 1.550 1.000\n\n001 AT 0 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 CL 93 90001 100000 1.580 1.000 1.000 1.000 1.580 1.580 1.580 1.000\n\n001 AT 0 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 CL 94 100001 110000 1.610 1.000 1.000 1.000 1.610 1.610 1.610 1.000\n\n001 AT 0 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 CL 95 110001 120000 1.640 1.000 1.000 1.000 1.640 1.640 1.640 1.000\n\n001 AT 0 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 CL 97 120001 130000 1.670 1.000 1.000 1.000 1.670 1.670 1.670 1.000\n\n001 AT 0 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 CL 98 130001 140000 1.700 1.000 1.000 1.000 1.700 1.700 1.700 1.000\n\n001 AT 0 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 CL 99 140001 150000 1.730 1.000 1.000 1.000 1.730 1.730 1.730 1.000\n\n001 AT 0 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 CL 99 150001 160000 1.760 1.000 1.000 1.000 1.760 1.760 1.760 1.000\n\n001 AT 0 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 CL 99 160001 170000 1.790 1.000 1.000 1.000 1.790 1.790 1.790 1.000\n\n001 AT 0 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 CL 99 170001 180000 1.820 1.000 1.000 1.000 1.820 1.820 1.820 1.000\n\n001 AT 0 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 CL 99 180001 190000 1.850 1.000 1.000 1.000 1.850 1.850 1.850 1.000\n\n001 AT 0 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 CL 99 190001 200000 1.880 1.000 1.000 1.000 1.880 1.880 1.880 1.000\n\n001 AT 0 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 CL 99 200001 210000 1.910 1.000 1.000 1.000 1.910 1.910 1.910 1.000\n\n001 AT 0 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 CL 99 210001 220000 1.940 1.000 1.000 1.000 1.940 1.940 1.940 1.000\n\n001 AT 0 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 CL 99 220001 230000 1.970 1.000 1.000 1.000 1.970 1.970 1.970 1.000\n\n001 AT 1+ 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 CL 99 230001 240000 2.000 1.000 1.000 1.000 2.000 2.000 2.000 1.000\n\n001 AT 1+ 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 CL 99 240001 250000 2.030 1.000 1.000 1.000 2.030 2.030 2.030 1.000\n\n001 AT 1+ 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 CL 99 250001 260000 2.060 1.000 1.000 1.000 2.060 2.060 2.060 1.000\n\n001 AT 1+ 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 CL 99 260001 270000 2.090 1.000 1.000 1.000 2.090 2.090 2.090 1.000\n\n001 AT 1+ 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 CL 99 270001 280000 2.120 1.000 1.000 1.000 2.120 2.120 2.120 1.000\n\n001 AT 1+ 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 CL 99 280001 290000 2.150 1.000 1.000 1.000 2.150 2.150 2.150 1.000\n\n001 AT 1+ 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 CL 99 290001 300000 2.180 1.000 1.000 1.000 2.180 2.180 2.180 1.000\n\n001 AT 1+ 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 CL 99 300001 310000 2.210 1.000 1.000 1.000 2.210 2.210 2.210 1.000\n\n001 AT 1+ 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 CL 99 310001 320000 2.240 1.000 1.000 1.000 2.240 2.240 2.240 1.000\n\n001 AT 1+ 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 CL 99 320001 330000 2.270 1.000 1.000 1.000 2.270 2.270 2.270 1.000\n\n001 AT 1+ 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 CL 99 330001 340000 2.300 1.000 1.000 1.000 2.300 2.300 2.300 1.000\n\n001 AT 1+ 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 CL 99 340001 999999 2.330 1.000 1.000 1.000 2.330 2.330 2.330 1.000\n\n001 AT 1+ 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 PP 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AT 1+ 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 PP 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AT 1+ 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 PP 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AT 1+ 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 PP 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AT 1+ 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 PP 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AT 1+ 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 PP 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AT 1+ 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 PP 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AT 1+ 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 PP 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AT 1+ 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 PP 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AT 1+ 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 PP 80 8001 9000 1.050 1.000 1.000 1.000 0.820 1.050 0.820 1.000\n\n001 AT 1+ 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 PP 81 9001 10000 1.050 1.000 1.000 1.000 0.910 1.050 0.910 1.000\n\n001 AT 1+ 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 PP 82 10001 13750 1.100 1.000 1.000 1.000 1.090 1.100 1.090 1.000\n\n001 AT 1+ 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 PP 83 13751 16250 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 PP 84 16251 20000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 PP 85 20001 25000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 PP 86 25001 30000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 PP 87 30001 40000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 PP 88 40001 50000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 PP 89 50001 60000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 PP 90 60001 70000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 PP 91 70001 80000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 PP 92 80001 90000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 PP 93 90001 100000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 PP 94 100001 110000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n**State of Arkansas**\n\n**Allmerica Financial Benefit Insurance Company**\n\n**Private Passenger Automobile**\n\n**Stated & Agreed Amount**\n\nPage 1 of 26"],"full_content":"Exhibit 31\n\n**Stated Amount Agreed Amount**\n\nUW Tier Group Vehicle Type Vehicle Age\n\nStated Amount\n\nCode\n\nMin Value Max Value COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease\n\nColl Auto\n\nLoan /Lease\n\nRoadside Assistance\n\nUW Tier Group Vehicle Type\n\nAgreed Amount\n\nCode\n\nMin Value Max Value COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease\n\nColl Auto\n\nLoan /Lease\n\nRoadside Assistance\n\n001 AN 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 AN 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AN 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 AN 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AN 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 AN 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AN 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 AN 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AN 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 AN 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AN 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 AN 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AN 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 AN 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AN 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 AN 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AN 0 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 AN 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AN 0 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 AN 80 8001 9000 1.090 1.000 1.000 1.000 0.820 1.090 0.820 1.000\n\n001 AN 0 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 AN 81 9001 10000 1.220 1.000 1.000 1.000 0.910 1.220 0.910 1.000\n\n001 AN 0 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 AN 82 10001 13750 1.250 1.000 1.000 1.000 1.090 1.250 1.090 1.000\n\n001 AN 0 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 AN 83 13751 16250 1.280 1.000 1.000 1.000 1.280 1.280 1.280 1.000\n\n001 AN 0 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 AN 84 16251 20000 1.310 1.000 1.000 1.000 1.310 1.310 1.310 1.000\n\n001 AN 0 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 AN 85 20001 25000 1.340 1.000 1.000 1.000 1.340 1.340 1.340 1.000\n\n001 AN 0 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 AN 86 25001 30000 1.370 1.000 1.000 1.000 1.370 1.370 1.370 1.000\n\n001 AN 0 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 AN 87 30001 40000 1.400 1.000 1.000 1.000 1.400 1.400 1.400 1.000\n\n001 AN 0 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 AN 88 40001 50000 1.430 1.000 1.000 1.000 1.430 1.430 1.430 1.000\n\n001 AN 0 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 AN 89 50001 60000 1.460 1.000 1.000 1.000 1.460 1.460 1.460 1.000\n\n001 AN 0 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 AN 90 60001 70000 1.490 1.000 1.000 1.000 1.490 1.490 1.490 1.000\n\n001 AN 0 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 AN 91 70001 80000 1.520 1.000 1.000 1.000 1.520 1.520 1.520 1.000\n\n001 AN 0 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 AN 92 80001 90000 1.550 1.000 1.000 1.000 1.550 1.550 1.550 1.000\n\n001 AN 0 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 AN 93 90001 100000 1.580 1.000 1.000 1.000 1.580 1.580 1.580 1.000\n\n001 AN 0 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 AN 94 100001 110000 1.610 1.000 1.000 1.000 1.610 1.610 1.610 1.000\n\n001 AN 0 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 AN 95 110001 120000 1.640 1.000 1.000 1.000 1.640 1.640 1.640 1.000\n\n001 AN 0 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 AN 97 120001 130000 1.670 1.000 1.000 1.000 1.670 1.670 1.670 1.000\n\n001 AN 0 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 AN 98 130001 140000 1.700 1.000 1.000 1.000 1.700 1.700 1.700 1.000\n\n001 AN 0 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 AN 99 140001 150000 1.730 1.000 1.000 1.000 1.730 1.730 1.730 1.000\n\n001 AN 1+ 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 AN 99 150001 160000 1.760 1.000 1.000 1.000 1.760 1.760 1.760 1.000\n\n001 AN 1+ 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 AN 99 160001 170000 1.790 1.000 1.000 1.000 1.790 1.790 1.790 1.000\n\n001 AN 1+ 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 AN 99 170001 180000 1.820 1.000 1.000 1.000 1.820 1.820 1.820 1.000\n\n001 AN 1+ 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 AN 99 180001 190000 1.850 1.000 1.000 1.000 1.850 1.850 1.850 1.000\n\n001 AN 1+ 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 AN 99 190001 200000 1.880 1.000 1.000 1.000 1.880 1.880 1.880 1.000\n\n001 AN 1+ 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 AN 99 200001 210000 1.910 1.000 1.000 1.000 1.910 1.910 1.910 1.000\n\n001 AN 1+ 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 AN 99 210001 220000 1.940 1.000 1.000 1.000 1.940 1.940 1.940 1.000\n\n001 AN 1+ 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 AN 99 220001 230000 1.970 1.000 1.000 1.000 1.970 1.970 1.970 1.000\n\n001 AN 1+ 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 AN 99 230001 240000 2.000 1.000 1.000 1.000 2.000 2.000 2.000 1.000\n\n001 AN 1+ 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 AN 99 240001 250000 2.030 1.000 1.000 1.000 2.030 2.030 2.030 1.000\n\n001 AN 1+ 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 AN 99 250001 260000 2.060 1.000 1.000 1.000 2.060 2.060 2.060 1.000\n\n001 AN 1+ 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 AN 99 260001 270000 2.090 1.000 1.000 1.000 2.090 2.090 2.090 1.000\n\n001 AN 1+ 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 AN 99 270001 280000 2.120 1.000 1.000 1.000 2.120 2.120 2.120 1.000\n\n001 AN 1+ 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 AN 99 280001 290000 2.150 1.000 1.000 1.000 2.150 2.150 2.150 1.000\n\n001 AN 1+ 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 AN 99 290001 300000 2.180 1.000 1.000 1.000 2.180 2.180 2.180 1.000\n\n001 AN 1+ 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 AN 99 300001 310000 2.210 1.000 1.000 1.000 2.210 2.210 2.210 1.000\n\n001 AN 1+ 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 AN 99 310001 320000 2.240 1.000 1.000 1.000 2.240 2.240 2.240 1.000\n\n001 AN 1+ 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 AN 99 320001 330000 2.270 1.000 1.000 1.000 2.270 2.270 2.270 1.000\n\n001 AN 1+ 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 AN 99 330001 340000 2.300 1.000 1.000 1.000 2.300 2.300 2.300 1.000\n\n001 AN 1+ 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 AN 99 340001 999999 2.330 1.000 1.000 1.000 2.330 2.330 2.330 1.000\n\n001 AN 1+ 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 CL 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AN 1+ 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 CL 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AN 1+ 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 CL 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AN 1+ 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 CL 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AN 1+ 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 CL 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AN 1+ 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 CL 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AN 1+ 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 CL 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AN 1+ 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 CL 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AT 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 CL 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AT 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 CL 80 8001 9000 1.090 1.000 1.000 1.000 0.820 1.090 0.820 1.000\n\n001 AT 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 CL 81 9001 10000 1.220 1.000 1.000 1.000 0.910 1.220 0.910 1.000\n\n001 AT 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 CL 82 10001 13750 1.250 1.000 1.000 1.000 1.090 1.250 1.090 1.000\n\n001 AT 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 CL 83 13751 16250 1.280 1.000 1.000 1.000 1.280 1.280 1.280 1.000\n\n001 AT 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 CL 84 16251 20000 1.310 1.000 1.000 1.000 1.310 1.310 1.310 1.000\n\n001 AT 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 CL 85 20001 25000 1.340 1.000 1.000 1.000 1.340 1.340 1.340 1.000\n\n001 AT 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 CL 86 25001 30000 1.370 1.000 1.000 1.000 1.370 1.370 1.370 1.000\n\n001 AT 0 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 CL 87 30001 40000 1.400 1.000 1.000 1.000 1.400 1.400 1.400 1.000\n\n001 AT 0 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 CL 88 40001 50000 1.430 1.000 1.000 1.000 1.430 1.430 1.430 1.000\n\n001 AT 0 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 CL 89 50001 60000 1.460 1.000 1.000 1.000 1.460 1.460 1.460 1.000\n\n001 AT 0 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 CL 90 60001 70000 1.490 1.000 1.000 1.000 1.490 1.490 1.490 1.000\n\n001 AT 0 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 CL 91 70001 80000 1.520 1.000 1.000 1.000 1.520 1.520 1.520 1.000\n\n001 AT 0 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 CL 92 80001 90000 1.550 1.000 1.000 1.000 1.550 1.550 1.550 1.000\n\n001 AT 0 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 CL 93 90001 100000 1.580 1.000 1.000 1.000 1.580 1.580 1.580 1.000\n\n001 AT 0 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 CL 94 100001 110000 1.610 1.000 1.000 1.000 1.610 1.610 1.610 1.000\n\n001 AT 0 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 CL 95 110001 120000 1.640 1.000 1.000 1.000 1.640 1.640 1.640 1.000\n\n001 AT 0 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 CL 97 120001 130000 1.670 1.000 1.000 1.000 1.670 1.670 1.670 1.000\n\n001 AT 0 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 CL 98 130001 140000 1.700 1.000 1.000 1.000 1.700 1.700 1.700 1.000\n\n001 AT 0 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 CL 99 140001 150000 1.730 1.000 1.000 1.000 1.730 1.730 1.730 1.000\n\n001 AT 0 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 CL 99 150001 160000 1.760 1.000 1.000 1.000 1.760 1.760 1.760 1.000\n\n001 AT 0 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 CL 99 160001 170000 1.790 1.000 1.000 1.000 1.790 1.790 1.790 1.000\n\n001 AT 0 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 CL 99 170001 180000 1.820 1.000 1.000 1.000 1.820 1.820 1.820 1.000\n\n001 AT 0 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 CL 99 180001 190000 1.850 1.000 1.000 1.000 1.850 1.850 1.850 1.000\n\n001 AT 0 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 CL 99 190001 200000 1.880 1.000 1.000 1.000 1.880 1.880 1.880 1.000\n\n001 AT 0 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 CL 99 200001 210000 1.910 1.000 1.000 1.000 1.910 1.910 1.910 1.000\n\n001 AT 0 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 CL 99 210001 220000 1.940 1.000 1.000 1.000 1.940 1.940 1.940 1.000\n\n001 AT 0 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 CL 99 220001 230000 1.970 1.000 1.000 1.000 1.970 1.970 1.970 1.000\n\n001 AT 1+ 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 CL 99 230001 240000 2.000 1.000 1.000 1.000 2.000 2.000 2.000 1.000\n\n001 AT 1+ 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 CL 99 240001 250000 2.030 1.000 1.000 1.000 2.030 2.030 2.030 1.000\n\n001 AT 1+ 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 CL 99 250001 260000 2.060 1.000 1.000 1.000 2.060 2.060 2.060 1.000\n\n001 AT 1+ 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 CL 99 260001 270000 2.090 1.000 1.000 1.000 2.090 2.090 2.090 1.000\n\n001 AT 1+ 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 CL 99 270001 280000 2.120 1.000 1.000 1.000 2.120 2.120 2.120 1.000\n\n001 AT 1+ 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 CL 99 280001 290000 2.150 1.000 1.000 1.000 2.150 2.150 2.150 1.000\n\n001 AT 1+ 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 CL 99 290001 300000 2.180 1.000 1.000 1.000 2.180 2.180 2.180 1.000\n\n001 AT 1+ 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 CL 99 300001 310000 2.210 1.000 1.000 1.000 2.210 2.210 2.210 1.000\n\n001 AT 1+ 79 7001 8000 1.330 1.000 1.000 1.000 1.000 1.330 1.000 1.000 001 CL 99 310001 320000 2.240 1.000 1.000 1.000 2.240 2.240 2.240 1.000\n\n001 AT 1+ 80 8001 9000 1.490 1.000 1.000 1.000 1.130 1.490 1.130 1.000 001 CL 99 320001 330000 2.270 1.000 1.000 1.000 2.270 2.270 2.270 1.000\n\n001 AT 1+ 81 9001 10000 1.660 1.000 1.000 1.000 1.250 1.660 1.250 1.000 001 CL 99 330001 340000 2.300 1.000 1.000 1.000 2.300 2.300 2.300 1.000\n\n001 AT 1+ 82 10001 13750 2.540 1.000 1.000 1.000 1.300 2.540 1.300 1.000 001 CL 99 340001 999999 2.330 1.000 1.000 1.000 2.330 2.330 2.330 1.000\n\n001 AT 1+ 83 13751 16250 3.210 1.000 1.000 1.000 1.500 3.210 1.500 1.000 001 PP 0 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\n001 AT 1+ 84 16251 20000 3.910 1.000 1.000 1.000 1.690 3.910 1.690 1.000 001 PP 72 1 1000 0.210 1.000 1.000 1.000 0.150 0.210 0.150 1.000\n\n001 AT 1+ 85 20001 25000 4.420 1.000 1.000 1.000 1.890 4.420 1.890 1.000 001 PP 73 1001 2000 0.330 1.000 1.000 1.000 0.240 0.330 0.240 1.000\n\n001 AT 1+ 86 25001 30000 4.650 1.000 1.000 1.000 2.080 4.650 2.080 1.000 001 PP 74 2001 3000 0.440 1.000 1.000 1.000 0.330 0.440 0.330 1.000\n\n001 AT 1+ 87 30001 40000 5.390 1.000 1.000 1.000 2.280 5.390 2.280 1.000 001 PP 75 3001 4000 0.560 1.000 1.000 1.000 0.420 0.560 0.420 1.000\n\n001 AT 1+ 88 40001 50000 6.050 1.000 1.000 1.000 2.470 6.050 2.470 1.000 001 PP 76 4001 5000 0.720 1.000 1.000 1.000 0.540 0.720 0.540 1.000\n\n001 AT 1+ 89 50001 60000 6.700 1.000 1.000 1.000 2.670 6.700 2.670 1.000 001 PP 77 5001 6000 0.880 1.000 1.000 1.000 0.660 0.880 0.660 1.000\n\n001 AT 1+ 90 60001 70000 7.350 1.000 1.000 1.000 2.870 7.350 2.870 1.000 001 PP 78 6001 7000 0.960 1.000 1.000 1.000 0.720 0.960 0.720 1.000\n\n001 AT 1+ 91 70001 80000 8.000 1.000 1.000 1.000 3.060 8.000 3.060 1.000 001 PP 79 7001 8000 1.040 1.000 1.000 1.000 0.780 1.040 0.780 1.000\n\n001 AT 1+ 92 80001 90000 8.650 1.000 1.000 1.000 3.260 8.650 3.260 1.000 001 PP 80 8001 9000 1.050 1.000 1.000 1.000 0.820 1.050 0.820 1.000\n\n001 AT 1+ 93 90001 100000 9.300 1.000 1.000 1.000 3.450 9.300 3.450 1.000 001 PP 81 9001 10000 1.050 1.000 1.000 1.000 0.910 1.050 0.910 1.000\n\n001 AT 1+ 94 100001 110000 9.950 1.000 1.000 1.000 3.650 9.950 3.650 1.000 001 PP 82 10001 13750 1.100 1.000 1.000 1.000 1.090 1.100 1.090 1.000\n\n001 AT 1+ 95 110001 120000 10.600 1.000 1.000 1.000 3.840 10.600 3.840 1.000 001 PP 83 13751 16250 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 97 120001 130000 11.250 1.000 1.000 1.000 4.040 11.250 4.040 1.000 001 PP 84 16251 20000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 98 130001 140000 11.900 1.000 1.000 1.000 4.240 11.900 4.240 1.000 001 PP 85 20001 25000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 AT 1+ 99 140001 999999 12.560 1.000 1.000 1.000 4.430 12.560 4.430 1.000 001 PP 86 25001 30000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 00 0 0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 001 PP 87 30001 40000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 72 1 1000 0.170 1.000 1.000 1.000 0.130 0.170 0.130 1.000 001 PP 88 40001 50000 1.100 1.000 1.000 1.000 1.100 1.100 1.100 1.000\n\n001 CL 0 73 1001 2000 0.330 1.000 1.000 1.000 0.250 0.330 0.250 1.000 001 PP 89 50001 60000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 74 2001 3000 0.500 1.000 1.000 1.000 0.380 0.500 0.380 1.000 001 PP 90 60001 70000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 75 3001 4000 0.660 1.000 1.000 1.000 0.500 0.660 0.500 1.000 001 PP 91 70001 80000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 76 4001 5000 0.830 1.000 1.000 1.000 0.630 0.830 0.630 1.000 001 PP 92 80001 90000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 77 5001 6000 1.000 1.000 1.000 1.000 0.750 1.000 0.750 1.000 001 PP 93 90001 100000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n001 CL 0 78 6001 7000 1.160 1.000 1.000 1.000 0.880 1.160 0.880 1.000 001 PP 94 100001 110000 1.150 1.000 1.000 1.000 1.150 1.150 1.150 1.000\n\n**State of Arkansas**\n\n**Allmerica Financial Benefit Insurance Company**\n\n**Private Passenger Automobile**\n\n**Stated & Agreed Amount**\n\nPage 1 of 26","publish_date":null,"title":"Exhibit 31 State of Arkansas Allmerica Financial Benefit Insurance Company Private Passenger Automobile Stated & Agreed Amount Stated Amount Agreed","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/p29_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/p29_page1.pdf"},"request":{"example_id":"table/p29_page1","product_type":"parse","source_file_path":"p29_page1.pdf"},"started_at":"2026-11-04T19:47:27.540233"} +{"completed_at":"2026-11-04T19:47:29.248478","latency_in_ms":1292,"output":{"example_id":"table/pub-derivatives-quarterly-qtr1-2019_page6","grounded_pages":[],"layout_pages":[],"markdown":"Quarterly Derivatives Report: First Quarter 2019 4\n\n### The credit exposure is bilateral in most derivative transactions, such as swaps (which make up the bulk of bank derivative contracts). Each party to the contract may (and, if the contract has a long enough tenor, probably will) have a credit exposure to the other party at various times during the contract’s life. With a funded traditional loan, the amount at risk is the amount advanced to the borrower. The credit risk is unilateral as the bank faces the credit exposure of the borrower. Measuring credit exposure in derivative contracts involves identifying those contracts on which a bank would lose value if the counterparty to a contract defaulted. The total of all contracts with positive value (i.e., derivative receivables) to the bank is the gross positive fair value (GPFV) and represents an initial measurement of credit exposure. The total of all contracts with negative value (i.e., derivative payables) to the bank is the gross negative fair value (GNFV) and represents a measurement of the exposure the bank poses to its counterparties. GPFV increased by $29 billion (1.7 percent) in the first quarter of 2019 to $1.8 trillion, driven by a $123 billion (12.2 percent) increase in receivables from interest rate contracts offset by a cumulative decrease of $93 billion in FX, equity and commodity receivables (see table 3). GNFV increased $31 billion (1.8 percent) to $1.7 trillion during the quarter, driven by a $116 billion (12.1 percent) increase in payables on interest rate contracts offset by a cumulative decrease of $88 billion in FX, equity and commodity receivables.\n\n**Table 3: Gross Positive Fair Values and Gross Negative Fair Values, in Billions of Dollars**\n\n**1Q 2019 4Q 2018**\n\n**Q/Q**\n\n**Change**\n\n**Q/Q % Change 1Q 2018**\n\n**Y/Y**\n\n**Change**\n\n**Y/Y % Change**\n\nInterest rate $1,130 $1,007 $123 12.2% $1,132 -$2 -0.2%\n\nForeign exchange $444 $511 -$67 -13.2% $454 -$10 -2.3%\n\nEquity $117 $132 -$15 -11.1% $125 -$7 -5.9%\n\nCommodities $33 $44 -$11 -25.8% $44 -$11 -25.5%\n\nCredit $43 $43 $0 -0.4% $59 -$15 -26.4%\n\n**Gross positive fair value $1,767 $1,738 $29 1.7% $1,814 -$47 -2.6%**\n\n**1Q 2019 4Q 2018**\n\n**Q/Q**\n\n**Change**\n\n**Q/Q % Change 1Q 2018**\n\n**Y/Y**\n\n**Change**\n\n**Y/Y % Change**\n\nInterest rate $1,076 $960 $116 12.1% $1,081 -$4 -0.4%\n\nForeign exchange $433 $500 -$67 -13.4% $426 $7 1.6%\n\nEquity $118 $126 -$8 -6.3% $118 -$1 -0.4%\n\nCommodities $34 $46 -$13 -27.1% $45 -$11 -25.2%\n\nCredit $45 $43 $2 3.8% $60 -$15 -24.6%\n\n**Gross negative fair value $1,706 $1,675 $31 1.8% $1,730 -$24 -1.4%**\n\nSource: Call reports, Schedule RC-L\n\n### A legally enforceable netting agreement between a bank and a counterparty creates a single legal obligation for all transactions (called a “netting set”) under the agreement. Therefore, when banks have such agreements with their counterparties, contracts with negative values (an amount","pages":[{"line_numbers":[],"markdown":"Quarterly Derivatives Report: First Quarter 2019 4\n\n### The credit exposure is bilateral in most derivative transactions, such as swaps (which make up the bulk of bank derivative contracts). Each party to the contract may (and, if the contract has a long enough tenor, probably will) have a credit exposure to the other party at various times during the contract’s life. With a funded traditional loan, the amount at risk is the amount advanced to the borrower. The credit risk is unilateral as the bank faces the credit exposure of the borrower. Measuring credit exposure in derivative contracts involves identifying those contracts on which a bank would lose value if the counterparty to a contract defaulted. The total of all contracts with positive value (i.e., derivative receivables) to the bank is the gross positive fair value (GPFV) and represents an initial measurement of credit exposure. The total of all contracts with negative value (i.e., derivative payables) to the bank is the gross negative fair value (GNFV) and represents a measurement of the exposure the bank poses to its counterparties. GPFV increased by $29 billion (1.7 percent) in the first quarter of 2019 to $1.8 trillion, driven by a $123 billion (12.2 percent) increase in receivables from interest rate contracts offset by a cumulative decrease of $93 billion in FX, equity and commodity receivables (see table 3). GNFV increased $31 billion (1.8 percent) to $1.7 trillion during the quarter, driven by a $116 billion (12.1 percent) increase in payables on interest rate contracts offset by a cumulative decrease of $88 billion in FX, equity and commodity receivables.\n\n**Table 3: Gross Positive Fair Values and Gross Negative Fair Values, in Billions of Dollars**\n\n**1Q 2019 4Q 2018**\n\n**Q/Q**\n\n**Change**\n\n**Q/Q % Change 1Q 2018**\n\n**Y/Y**\n\n**Change**\n\n**Y/Y % Change**\n\nInterest rate $1,130 $1,007 $123 12.2% $1,132 -$2 -0.2%\n\nForeign exchange $444 $511 -$67 -13.2% $454 -$10 -2.3%\n\nEquity $117 $132 -$15 -11.1% $125 -$7 -5.9%\n\nCommodities $33 $44 -$11 -25.8% $44 -$11 -25.5%\n\nCredit $43 $43 $0 -0.4% $59 -$15 -26.4%\n\n**Gross positive fair value $1,767 $1,738 $29 1.7% $1,814 -$47 -2.6%**\n\n**1Q 2019 4Q 2018**\n\n**Q/Q**\n\n**Change**\n\n**Q/Q % Change 1Q 2018**\n\n**Y/Y**\n\n**Change**\n\n**Y/Y % Change**\n\nInterest rate $1,076 $960 $116 12.1% $1,081 -$4 -0.4%\n\nForeign exchange $433 $500 -$67 -13.4% $426 $7 1.6%\n\nEquity $118 $126 -$8 -6.3% $118 -$1 -0.4%\n\nCommodities $34 $46 -$13 -27.1% $45 -$11 -25.2%\n\nCredit $45 $43 $2 3.8% $60 -$15 -24.6%\n\n**Gross negative fair value $1,706 $1,675 $31 1.8% $1,730 -$24 -1.4%**\n\nSource: Call reports, Schedule RC-L\n\n### A legally enforceable netting agreement between a bank and a counterparty creates a single legal obligation for all transactions (called a “netting set”) under the agreement. Therefore, when banks have such agreements with their counterparties, contracts with negative values (an amount","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Quarterly Derivatives Report: First Quarter 2019 4\n\n### The credit exposure is bilateral in most derivative transactions, such as swaps (which make up the bulk of bank derivative contracts). Each party to the contract may (and, if the contract has a long enough tenor, probably will) have a credit exposure to the other party at various times during the contract’s life. With a funded traditional loan, the amount at risk is the amount advanced to the borrower. The credit risk is unilateral as the bank faces the credit exposure of the borrower. Measuring credit exposure in derivative contracts involves identifying those contracts on which a bank would lose value if the counterparty to a contract defaulted. The total of all contracts with positive value (i.e., derivative receivables) to the bank is the gross positive fair value (GPFV) and represents an initial measurement of credit exposure. The total of all contracts with negative value (i.e., derivative payables) to the bank is the gross negative fair value (GNFV) and represents a measurement of the exposure the bank poses to its counterparties. GPFV increased by $29 billion (1.7 percent) in the first quarter of 2019 to $1.8 trillion, driven by a $123 billion (12.2 percent) increase in receivables from interest rate contracts offset by a cumulative decrease of $93 billion in FX, equity and commodity receivables (see table 3). GNFV increased $31 billion (1.8 percent) to $1.7 trillion during the quarter, driven by a $116 billion (12.1 percent) increase in payables on interest rate contracts offset by a cumulative decrease of $88 billion in FX, equity and commodity receivables.\n\n**Table 3: Gross Positive Fair Values and Gross Negative Fair Values, in Billions of Dollars**\n\n**1Q 2019 4Q 2018**\n\n**Q/Q**\n\n**Change**\n\n**Q/Q % Change 1Q 2018**\n\n**Y/Y**\n\n**Change**\n\n**Y/Y % Change**\n\nInterest rate $1,130 $1,007 $123 12.2% $1,132 -$2 -0.2%\n\nForeign exchange $444 $511 -$67 -13.2% $454 -$10 -2.3%\n\nEquity $117 $132 -$15 -11.1% $125 -$7 -5.9%\n\nCommodities $33 $44 -$11 -25.8% $44 -$11 -25.5%\n\nCredit $43 $43 $0 -0.4% $59 -$15 -26.4%\n\n**Gross positive fair value $1,767 $1,738 $29 1.7% $1,814 -$47 -2.6%**\n\n**1Q 2019 4Q 2018**\n\n**Q/Q**\n\n**Change**\n\n**Q/Q % Change 1Q 2018**\n\n**Y/Y**\n\n**Change**\n\n**Y/Y % Change**\n\nInterest rate $1,076 $960 $116 12.1% $1,081 -$4 -0.4%\n\nForeign exchange $433 $500 -$67 -13.4% $426 $7 1.6%\n\nEquity $118 $126 -$8 -6.3% $118 -$1 -0.4%\n\nCommodities $34 $46 -$13 -27.1% $45 -$11 -25.2%\n\nCredit $45 $43 $2 3.8% $60 -$15 -24.6%\n\n**Gross negative fair value $1,706 $1,675 $31 1.8% $1,730 -$24 -1.4%**\n\nSource: Call reports, Schedule RC-L\n\n### A legally enforceable netting agreement between a bank and a counterparty creates a single legal obligation for all transactions (called a “netting set”) under the agreement. Therefore, when banks have such agreements with their counterparties, contracts with negative values (an amount","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/pub-derivatives-quarterly-qtr1-2019_page6.pdf"]},"response":{"errors":[],"extract_id":"extract_93f7e7cba748bc56413fb082fd7905de","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Quarterly Derivatives Report: First Quarter 2019 4\n\n### The credit exposure is bilateral in most derivative transactions, such as swaps (which make up the bulk of bank derivative contracts). Each party to the contract may (and, if the contract has a long enough tenor, probably will) have a credit exposure to the other party at various times during the contract’s life. With a funded traditional loan, the amount at risk is the amount advanced to the borrower. The credit risk is unilateral as the bank faces the credit exposure of the borrower. Measuring credit exposure in derivative contracts involves identifying those contracts on which a bank would lose value if the counterparty to a contract defaulted. The total of all contracts with positive value (i.e., derivative receivables) to the bank is the gross positive fair value (GPFV) and represents an initial measurement of credit exposure. The total of all contracts with negative value (i.e., derivative payables) to the bank is the gross negative fair value (GNFV) and represents a measurement of the exposure the bank poses to its counterparties. GPFV increased by $29 billion (1.7 percent) in the first quarter of 2019 to $1.8 trillion, driven by a $123 billion (12.2 percent) increase in receivables from interest rate contracts offset by a cumulative decrease of $93 billion in FX, equity and commodity receivables (see table 3). GNFV increased $31 billion (1.8 percent) to $1.7 trillion during the quarter, driven by a $116 billion (12.1 percent) increase in payables on interest rate contracts offset by a cumulative decrease of $88 billion in FX, equity and commodity receivables.\n\n**Table 3: Gross Positive Fair Values and Gross Negative Fair Values, in Billions of Dollars**\n\n**1Q 2019 4Q 2018**\n\n**Q/Q**\n\n**Change**\n\n**Q/Q % Change 1Q 2018**\n\n**Y/Y**\n\n**Change**\n\n**Y/Y % Change**\n\nInterest rate $1,130 $1,007 $123 12.2% $1,132 -$2 -0.2%\n\nForeign exchange $444 $511 -$67 -13.2% $454 -$10 -2.3%\n\nEquity $117 $132 -$15 -11.1% $125 -$7 -5.9%\n\nCommodities $33 $44 -$11 -25.8% $44 -$11 -25.5%\n\nCredit $43 $43 $0 -0.4% $59 -$15 -26.4%\n\n**Gross positive fair value $1,767 $1,738 $29 1.7% $1,814 -$47 -2.6%**\n\n**1Q 2019 4Q 2018**\n\n**Q/Q**\n\n**Change**\n\n**Q/Q % Change 1Q 2018**\n\n**Y/Y**\n\n**Change**\n\n**Y/Y % Change**\n\nInterest rate $1,076 $960 $116 12.1% $1,081 -$4 -0.4%\n\nForeign exchange $433 $500 -$67 -13.4% $426 $7 1.6%\n\nEquity $118 $126 -$8 -6.3% $118 -$1 -0.4%\n\nCommodities $34 $46 -$13 -27.1% $45 -$11 -25.2%\n\nCredit $45 $43 $2 3.8% $60 -$15 -24.6%\n\n**Gross negative fair value $1,706 $1,675 $31 1.8% $1,730 -$24 -1.4%**\n\nSource: Call reports, Schedule RC-L\n\n### A legally enforceable netting agreement between a bank and a counterparty creates a single legal obligation for all transactions (called a “netting set”) under the agreement. Therefore, when banks have such agreements with their counterparties, contracts with negative values (an amount"],"full_content":"Quarterly Derivatives Report: First Quarter 2019 4\n\n### The credit exposure is bilateral in most derivative transactions, such as swaps (which make up the bulk of bank derivative contracts). Each party to the contract may (and, if the contract has a long enough tenor, probably will) have a credit exposure to the other party at various times during the contract’s life. With a funded traditional loan, the amount at risk is the amount advanced to the borrower. The credit risk is unilateral as the bank faces the credit exposure of the borrower. Measuring credit exposure in derivative contracts involves identifying those contracts on which a bank would lose value if the counterparty to a contract defaulted. The total of all contracts with positive value (i.e., derivative receivables) to the bank is the gross positive fair value (GPFV) and represents an initial measurement of credit exposure. The total of all contracts with negative value (i.e., derivative payables) to the bank is the gross negative fair value (GNFV) and represents a measurement of the exposure the bank poses to its counterparties. GPFV increased by $29 billion (1.7 percent) in the first quarter of 2019 to $1.8 trillion, driven by a $123 billion (12.2 percent) increase in receivables from interest rate contracts offset by a cumulative decrease of $93 billion in FX, equity and commodity receivables (see table 3). GNFV increased $31 billion (1.8 percent) to $1.7 trillion during the quarter, driven by a $116 billion (12.1 percent) increase in payables on interest rate contracts offset by a cumulative decrease of $88 billion in FX, equity and commodity receivables.\n\n**Table 3: Gross Positive Fair Values and Gross Negative Fair Values, in Billions of Dollars**\n\n**1Q 2019 4Q 2018**\n\n**Q/Q**\n\n**Change**\n\n**Q/Q % Change 1Q 2018**\n\n**Y/Y**\n\n**Change**\n\n**Y/Y % Change**\n\nInterest rate $1,130 $1,007 $123 12.2% $1,132 -$2 -0.2%\n\nForeign exchange $444 $511 -$67 -13.2% $454 -$10 -2.3%\n\nEquity $117 $132 -$15 -11.1% $125 -$7 -5.9%\n\nCommodities $33 $44 -$11 -25.8% $44 -$11 -25.5%\n\nCredit $43 $43 $0 -0.4% $59 -$15 -26.4%\n\n**Gross positive fair value $1,767 $1,738 $29 1.7% $1,814 -$47 -2.6%**\n\n**1Q 2019 4Q 2018**\n\n**Q/Q**\n\n**Change**\n\n**Q/Q % Change 1Q 2018**\n\n**Y/Y**\n\n**Change**\n\n**Y/Y % Change**\n\nInterest rate $1,076 $960 $116 12.1% $1,081 -$4 -0.4%\n\nForeign exchange $433 $500 -$67 -13.4% $426 $7 1.6%\n\nEquity $118 $126 -$8 -6.3% $118 -$1 -0.4%\n\nCommodities $34 $46 -$13 -27.1% $45 -$11 -25.2%\n\nCredit $45 $43 $2 3.8% $60 -$15 -24.6%\n\n**Gross negative fair value $1,706 $1,675 $31 1.8% $1,730 -$24 -1.4%**\n\nSource: Call reports, Schedule RC-L\n\n### A legally enforceable netting agreement between a bank and a counterparty creates a single legal obligation for all transactions (called a “netting set”) under the agreement. Therefore, when banks have such agreements with their counterparties, contracts with negative values (an amount","publish_date":null,"title":"The credit exposure is bilateral in most derivative transactions, such as swaps (which make up the bulk of bank derivative","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/pub-derivatives-quarterly-qtr1-2019_page6.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/pub-derivatives-quarterly-qtr1-2019_page6.pdf"},"request":{"example_id":"table/pub-derivatives-quarterly-qtr1-2019_page6","product_type":"parse","source_file_path":"pub-derivatives-quarterly-qtr1-2019_page6.pdf"},"started_at":"2026-11-04T19:47:27.955980"} +{"completed_at":"2026-11-04T19:47:30.910462","latency_in_ms":1585,"output":{"example_id":"table/sample_page_16_page1","grounded_pages":[],"layout_pages":[],"markdown":"Exhibit 47\n\nUW Tier Group Vehicle Type Group\n\nMinimum Vehicle Miles\n\nMaximum Vehicle Miles BI PD CSL PIP UM BI UM PD UM CSL UIMBI UIMCSL COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease Coll Auto Loan /Lease OLTE Excess Custom Equipment\n\nExcess Electronic Equipment\n\nRoadside Assistance\n\n**State of Arkansas Allmerica Financial Benefit Insurance Company Private Passenger Automobile Annual Mileage**\n\n002 AO 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 10000 10999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 11000 11999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 12000 12999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 13000 13999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 14000 14999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 15000 15999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 16000 16999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 17000 17999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 18000 18999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 19000 19999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 2000 2999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 20000 20999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 21000 21999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 22000 22999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 23000 23999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 24000 24999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 25000 25999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 26000 26999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 27000 27999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 28000 28999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 29000 29999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 3000 3999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 30000 30999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 31000 31999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 32000 32999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 33000 33999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 34000 34999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 35000 35999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 36000 36999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 37000 37999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 38000 38999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 39000 39999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 4000 4999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 40000 40999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 41000 41999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 42000 42999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 43000 43999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 44000 44999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 45000 45999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 46000 46999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 47000 47999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 48000 48999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 49000 49999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 5000 5999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 50000 999998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 6000 6999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 7000 7999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 8000 8999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 9000 9999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 999999 999999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 0 999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 10000 10999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 11000 11999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 12000 12999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 13000 13999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 14000 14999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 15000 15999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 16000 16999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 17000 17999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 18000 18999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 19000 19999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 2000 2999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 20000 20999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 21000 21999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 22000 22999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 23000 23999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 24000 24999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 25000 25999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 26000 26999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 27000 27999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 28000 28999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 29000 29999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 3000 3999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 30000 30999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 31000 31999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 32000 32999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 33000 33999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 34000 34999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 35000 35999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 36000 36999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 37000 37999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 38000 38999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 39000 39999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 4000 4999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 40000 40999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 41000 41999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 42000 42999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 43000 43999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 44000 44999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 45000 45999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 46000 46999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 47000 47999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 48000 48999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 49000 49999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 5000 5999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 50000 999998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 6000 6999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 7000 7999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 8000 8999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 9000 9999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 999999 999999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 003 AO 0 999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 003 AO 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nPage 2 of 5","pages":[{"line_numbers":[],"markdown":"Exhibit 47\n\nUW Tier Group Vehicle Type Group\n\nMinimum Vehicle Miles\n\nMaximum Vehicle Miles BI PD CSL PIP UM BI UM PD UM CSL UIMBI UIMCSL COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease Coll Auto Loan /Lease OLTE Excess Custom Equipment\n\nExcess Electronic Equipment\n\nRoadside Assistance\n\n**State of Arkansas Allmerica Financial Benefit Insurance Company Private Passenger Automobile Annual Mileage**\n\n002 AO 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 10000 10999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 11000 11999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 12000 12999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 13000 13999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 14000 14999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 15000 15999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 16000 16999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 17000 17999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 18000 18999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 19000 19999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 2000 2999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 20000 20999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 21000 21999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 22000 22999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 23000 23999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 24000 24999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 25000 25999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 26000 26999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 27000 27999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 28000 28999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 29000 29999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 3000 3999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 30000 30999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 31000 31999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 32000 32999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 33000 33999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 34000 34999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 35000 35999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 36000 36999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 37000 37999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 38000 38999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 39000 39999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 4000 4999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 40000 40999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 41000 41999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 42000 42999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 43000 43999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 44000 44999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 45000 45999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 46000 46999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 47000 47999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 48000 48999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 49000 49999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 5000 5999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 50000 999998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 6000 6999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 7000 7999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 8000 8999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 9000 9999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 999999 999999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 0 999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 10000 10999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 11000 11999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 12000 12999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 13000 13999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 14000 14999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 15000 15999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 16000 16999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 17000 17999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 18000 18999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 19000 19999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 2000 2999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 20000 20999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 21000 21999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 22000 22999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 23000 23999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 24000 24999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 25000 25999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 26000 26999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 27000 27999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 28000 28999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 29000 29999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 3000 3999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 30000 30999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 31000 31999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 32000 32999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 33000 33999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 34000 34999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 35000 35999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 36000 36999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 37000 37999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 38000 38999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 39000 39999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 4000 4999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 40000 40999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 41000 41999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 42000 42999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 43000 43999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 44000 44999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 45000 45999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 46000 46999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 47000 47999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 48000 48999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 49000 49999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 5000 5999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 50000 999998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 6000 6999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 7000 7999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 8000 8999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 9000 9999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 999999 999999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 003 AO 0 999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 003 AO 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nPage 2 of 5","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Exhibit 47\n\nUW Tier Group Vehicle Type Group\n\nMinimum Vehicle Miles\n\nMaximum Vehicle Miles BI PD CSL PIP UM BI UM PD UM CSL UIMBI UIMCSL COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease Coll Auto Loan /Lease OLTE Excess Custom Equipment\n\nExcess Electronic Equipment\n\nRoadside Assistance\n\n**State of Arkansas Allmerica Financial Benefit Insurance Company Private Passenger Automobile Annual Mileage**\n\n002 AO 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 10000 10999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 11000 11999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 12000 12999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 13000 13999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 14000 14999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 15000 15999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 16000 16999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 17000 17999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 18000 18999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 19000 19999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 2000 2999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 20000 20999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 21000 21999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 22000 22999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 23000 23999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 24000 24999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 25000 25999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 26000 26999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 27000 27999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 28000 28999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 29000 29999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 3000 3999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 30000 30999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 31000 31999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 32000 32999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 33000 33999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 34000 34999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 35000 35999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 36000 36999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 37000 37999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 38000 38999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 39000 39999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 4000 4999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 40000 40999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 41000 41999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 42000 42999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 43000 43999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 44000 44999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 45000 45999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 46000 46999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 47000 47999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 48000 48999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 49000 49999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 5000 5999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 50000 999998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 6000 6999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 7000 7999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 8000 8999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 9000 9999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 999999 999999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 0 999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 10000 10999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 11000 11999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 12000 12999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 13000 13999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 14000 14999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 15000 15999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 16000 16999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 17000 17999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 18000 18999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 19000 19999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 2000 2999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 20000 20999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 21000 21999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 22000 22999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 23000 23999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 24000 24999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 25000 25999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 26000 26999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 27000 27999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 28000 28999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 29000 29999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 3000 3999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 30000 30999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 31000 31999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 32000 32999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 33000 33999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 34000 34999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 35000 35999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 36000 36999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 37000 37999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 38000 38999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 39000 39999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 4000 4999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 40000 40999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 41000 41999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 42000 42999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 43000 43999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 44000 44999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 45000 45999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 46000 46999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 47000 47999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 48000 48999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 49000 49999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 5000 5999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 50000 999998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 6000 6999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 7000 7999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 8000 8999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 9000 9999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 999999 999999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 003 AO 0 999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 003 AO 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nPage 2 of 5","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/sample_page_16_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_ce0dff0fc64be77482892bbfa0892540","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Exhibit 47\n\nUW Tier Group Vehicle Type Group\n\nMinimum Vehicle Miles\n\nMaximum Vehicle Miles BI PD CSL PIP UM BI UM PD UM CSL UIMBI UIMCSL COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease Coll Auto Loan /Lease OLTE Excess Custom Equipment\n\nExcess Electronic Equipment\n\nRoadside Assistance\n\n**State of Arkansas Allmerica Financial Benefit Insurance Company Private Passenger Automobile Annual Mileage**\n\n002 AO 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 10000 10999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 11000 11999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 12000 12999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 13000 13999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 14000 14999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 15000 15999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 16000 16999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 17000 17999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 18000 18999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 19000 19999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 2000 2999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 20000 20999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 21000 21999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 22000 22999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 23000 23999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 24000 24999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 25000 25999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 26000 26999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 27000 27999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 28000 28999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 29000 29999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 3000 3999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 30000 30999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 31000 31999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 32000 32999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 33000 33999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 34000 34999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 35000 35999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 36000 36999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 37000 37999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 38000 38999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 39000 39999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 4000 4999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 40000 40999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 41000 41999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 42000 42999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 43000 43999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 44000 44999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 45000 45999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 46000 46999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 47000 47999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 48000 48999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 49000 49999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 5000 5999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 50000 999998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 6000 6999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 7000 7999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 8000 8999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 9000 9999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 999999 999999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 0 999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 10000 10999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 11000 11999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 12000 12999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 13000 13999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 14000 14999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 15000 15999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 16000 16999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 17000 17999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 18000 18999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 19000 19999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 2000 2999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 20000 20999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 21000 21999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 22000 22999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 23000 23999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 24000 24999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 25000 25999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 26000 26999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 27000 27999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 28000 28999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 29000 29999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 3000 3999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 30000 30999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 31000 31999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 32000 32999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 33000 33999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 34000 34999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 35000 35999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 36000 36999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 37000 37999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 38000 38999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 39000 39999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 4000 4999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 40000 40999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 41000 41999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 42000 42999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 43000 43999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 44000 44999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 45000 45999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 46000 46999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 47000 47999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 48000 48999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 49000 49999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 5000 5999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 50000 999998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 6000 6999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 7000 7999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 8000 8999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 9000 9999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 999999 999999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 003 AO 0 999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 003 AO 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nPage 2 of 5"],"full_content":"Exhibit 47\n\nUW Tier Group Vehicle Type Group\n\nMinimum Vehicle Miles\n\nMaximum Vehicle Miles BI PD CSL PIP UM BI UM PD UM CSL UIMBI UIMCSL COMPO COMPA COMPG COMPC COLL Comp Auto Loan /Lease Coll Auto Loan /Lease OLTE Excess Custom Equipment\n\nExcess Electronic Equipment\n\nRoadside Assistance\n\n**State of Arkansas Allmerica Financial Benefit Insurance Company Private Passenger Automobile Annual Mileage**\n\n002 AO 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 10000 10999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 11000 11999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 12000 12999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 13000 13999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 14000 14999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 15000 15999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 16000 16999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 17000 17999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 18000 18999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 19000 19999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 2000 2999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 20000 20999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 21000 21999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 22000 22999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 23000 23999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 24000 24999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 25000 25999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 26000 26999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 27000 27999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 28000 28999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 29000 29999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 3000 3999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 30000 30999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 31000 31999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 32000 32999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 33000 33999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 34000 34999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 35000 35999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 36000 36999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 37000 37999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 38000 38999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 39000 39999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 4000 4999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 40000 40999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 41000 41999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 42000 42999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 43000 43999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 44000 44999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 45000 45999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 46000 46999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 47000 47999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 48000 48999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 49000 49999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 5000 5999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 50000 999998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 6000 6999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 7000 7999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 8000 8999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 9000 9999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 AO 999999 999999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 0 999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 10000 10999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 11000 11999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 12000 12999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 13000 13999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 14000 14999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 15000 15999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 16000 16999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 17000 17999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 18000 18999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 19000 19999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 2000 2999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 20000 20999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 21000 21999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 22000 22999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 23000 23999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 24000 24999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 25000 25999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 26000 26999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 27000 27999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 28000 28999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 29000 29999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 3000 3999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 30000 30999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 31000 31999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 32000 32999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 33000 33999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 34000 34999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 35000 35999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 36000 36999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 37000 37999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 38000 38999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 39000 39999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 4000 4999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 40000 40999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 41000 41999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 42000 42999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 43000 43999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 44000 44999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 45000 45999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 46000 46999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 47000 47999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 48000 48999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 49000 49999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 5000 5999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 50000 999998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 6000 6999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 7000 7999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 8000 8999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 9000 9999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 002 PP 999999 999999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 003 AO 0 999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 003 AO 1000 1999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\n\nPage 2 of 5","publish_date":null,"title":"Exhibit 47 State of Arkansas Allmerica Financial Benefit Insurance Company Private Passenger Automobile Annual Mileage Minimum Maximum Excess Excess UW","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/sample_page_16_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/sample_page_16_page1.pdf"},"request":{"example_id":"table/sample_page_16_page1","product_type":"parse","source_file_path":"sample_page_16_page1.pdf"},"started_at":"2026-11-04T19:47:29.324647"} +{"completed_at":"2026-11-04T19:31:12.484035","latency_in_ms":986,"output":{"example_id":"table/sizingchart_page1","grounded_pages":[],"layout_pages":[],"markdown":"**2019**\n\n**MAKE MODEL Standard Cargo Area Behind 2nd or 3rd Row Seats**\n\n**Cargo Area Behind Front Seats with 2nd and/or 3rd Row Seats folded flat**\n\n**Cargo Area Behind 2nd Row Seats with 3rd Row Seats removed or folded**\n\n**flat**\n\n**Acura** MDX Small Large\n\nRDX Small Medium\n\n**Audi** Allroad Small Large\n\nA3 Sportback Small Medium\n\nQ3 Small Medium\n\nQ5 Small Large\n\nQ7 Small Large\n\nQ8 NA Large\n\n**BMW** 328D Small Medium\n\ni 3 NA Medium\n\nS 6 NA Medium\n\nX 1 Small Medium\n\nX 2 NA Medium\n\nX 3 Small Large\n\nX4 NA Large\n\nX5 Small Large\n\nX6 Small Large\n\nX7 NA Large\n\n**Buick** Enclave Small X-Large Medium\n\nEncore Small Medium\n\nEnvision Small Large\n\nRanier Small Large\n\nRendevous Small Large\n\nTerraza Small Large\n\n**Cadillac** SRX Small Large\n\nEscalade Small Large Medium\n\nEscalade XL Medium X-Large Large\n\nXT5 Small Large\n\n**Chevrolet** Aveo NA Medium\n\nBolt NA Medium\n\nBlazer Small Large\n\nCruze NA Medium\n\nEquinox Small Large\n\nHHR Small Large\n\nMalibu Max Small Large\n\nTahoe Small Large Medium\n\nTrailblazer Small Large\n\nTraverse NA Large Medium\n\n### **Vehicle Sizing Chart**","pages":[{"line_numbers":[],"markdown":"**2019**\n\n**MAKE MODEL Standard Cargo Area Behind 2nd or 3rd Row Seats**\n\n**Cargo Area Behind Front Seats with 2nd and/or 3rd Row Seats folded flat**\n\n**Cargo Area Behind 2nd Row Seats with 3rd Row Seats removed or folded**\n\n**flat**\n\n**Acura** MDX Small Large\n\nRDX Small Medium\n\n**Audi** Allroad Small Large\n\nA3 Sportback Small Medium\n\nQ3 Small Medium\n\nQ5 Small Large\n\nQ7 Small Large\n\nQ8 NA Large\n\n**BMW** 328D Small Medium\n\ni 3 NA Medium\n\nS 6 NA Medium\n\nX 1 Small Medium\n\nX 2 NA Medium\n\nX 3 Small Large\n\nX4 NA Large\n\nX5 Small Large\n\nX6 Small Large\n\nX7 NA Large\n\n**Buick** Enclave Small X-Large Medium\n\nEncore Small Medium\n\nEnvision Small Large\n\nRanier Small Large\n\nRendevous Small Large\n\nTerraza Small Large\n\n**Cadillac** SRX Small Large\n\nEscalade Small Large Medium\n\nEscalade XL Medium X-Large Large\n\nXT5 Small Large\n\n**Chevrolet** Aveo NA Medium\n\nBolt NA Medium\n\nBlazer Small Large\n\nCruze NA Medium\n\nEquinox Small Large\n\nHHR Small Large\n\nMalibu Max Small Large\n\nTahoe Small Large Medium\n\nTrailblazer Small Large\n\nTraverse NA Large Medium\n\n### **Vehicle Sizing Chart**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**2019**\n\n**MAKE MODEL Standard Cargo Area Behind 2nd or 3rd Row Seats**\n\n**Cargo Area Behind Front Seats with 2nd and/or 3rd Row Seats folded flat**\n\n**Cargo Area Behind 2nd Row Seats with 3rd Row Seats removed or folded**\n\n**flat**\n\n**Acura** MDX Small Large\n\nRDX Small Medium\n\n**Audi** Allroad Small Large\n\nA3 Sportback Small Medium\n\nQ3 Small Medium\n\nQ5 Small Large\n\nQ7 Small Large\n\nQ8 NA Large\n\n**BMW** 328D Small Medium\n\ni 3 NA Medium\n\nS 6 NA Medium\n\nX 1 Small Medium\n\nX 2 NA Medium\n\nX 3 Small Large\n\nX4 NA Large\n\nX5 Small Large\n\nX6 Small Large\n\nX7 NA Large\n\n**Buick** Enclave Small X-Large Medium\n\nEncore Small Medium\n\nEnvision Small Large\n\nRanier Small Large\n\nRendevous Small Large\n\nTerraza Small Large\n\n**Cadillac** SRX Small Large\n\nEscalade Small Large Medium\n\nEscalade XL Medium X-Large Large\n\nXT5 Small Large\n\n**Chevrolet** Aveo NA Medium\n\nBolt NA Medium\n\nBlazer Small Large\n\nCruze NA Medium\n\nEquinox Small Large\n\nHHR Small Large\n\nMalibu Max Small Large\n\nTahoe Small Large Medium\n\nTrailblazer Small Large\n\nTraverse NA Large Medium\n\n### **Vehicle Sizing Chart**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/sizingchart_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_07b15747df5c4d8ecae96146c9ebdd01","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**2019**\n\n**MAKE MODEL Standard Cargo Area Behind 2nd or 3rd Row Seats**\n\n**Cargo Area Behind Front Seats with 2nd and/or 3rd Row Seats folded flat**\n\n**Cargo Area Behind 2nd Row Seats with 3rd Row Seats removed or folded**\n\n**flat**\n\n**Acura** MDX Small Large\n\nRDX Small Medium\n\n**Audi** Allroad Small Large\n\nA3 Sportback Small Medium\n\nQ3 Small Medium\n\nQ5 Small Large\n\nQ7 Small Large\n\nQ8 NA Large\n\n**BMW** 328D Small Medium\n\ni 3 NA Medium\n\nS 6 NA Medium\n\nX 1 Small Medium\n\nX 2 NA Medium\n\nX 3 Small Large\n\nX4 NA Large\n\nX5 Small Large\n\nX6 Small Large\n\nX7 NA Large\n\n**Buick** Enclave Small X-Large Medium\n\nEncore Small Medium\n\nEnvision Small Large\n\nRanier Small Large\n\nRendevous Small Large\n\nTerraza Small Large\n\n**Cadillac** SRX Small Large\n\nEscalade Small Large Medium\n\nEscalade XL Medium X-Large Large\n\nXT5 Small Large\n\n**Chevrolet** Aveo NA Medium\n\nBolt NA Medium\n\nBlazer Small Large\n\nCruze NA Medium\n\nEquinox Small Large\n\nHHR Small Large\n\nMalibu Max Small Large\n\nTahoe Small Large Medium\n\nTrailblazer Small Large\n\nTraverse NA Large Medium\n\n### **Vehicle Sizing Chart**"],"full_content":"**2019**\n\n**MAKE MODEL Standard Cargo Area Behind 2nd or 3rd Row Seats**\n\n**Cargo Area Behind Front Seats with 2nd and/or 3rd Row Seats folded flat**\n\n**Cargo Area Behind 2nd Row Seats with 3rd Row Seats removed or folded**\n\n**flat**\n\n**Acura** MDX Small Large\n\nRDX Small Medium\n\n**Audi** Allroad Small Large\n\nA3 Sportback Small Medium\n\nQ3 Small Medium\n\nQ5 Small Large\n\nQ7 Small Large\n\nQ8 NA Large\n\n**BMW** 328D Small Medium\n\ni 3 NA Medium\n\nS 6 NA Medium\n\nX 1 Small Medium\n\nX 2 NA Medium\n\nX 3 Small Large\n\nX4 NA Large\n\nX5 Small Large\n\nX6 Small Large\n\nX7 NA Large\n\n**Buick** Enclave Small X-Large Medium\n\nEncore Small Medium\n\nEnvision Small Large\n\nRanier Small Large\n\nRendevous Small Large\n\nTerraza Small Large\n\n**Cadillac** SRX Small Large\n\nEscalade Small Large Medium\n\nEscalade XL Medium X-Large Large\n\nXT5 Small Large\n\n**Chevrolet** Aveo NA Medium\n\nBolt NA Medium\n\nBlazer Small Large\n\nCruze NA Medium\n\nEquinox Small Large\n\nHHR Small Large\n\nMalibu Max Small Large\n\nTahoe Small Large Medium\n\nTrailblazer Small Large\n\nTraverse NA Large Medium\n\n### **Vehicle Sizing Chart**","publish_date":null,"title":"Vehicle Sizing Chart","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/sizingchart_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/sizingchart_page1.pdf"},"request":{"example_id":"table/sizingchart_page1","product_type":"parse","source_file_path":"sizingchart_page1.pdf"},"started_at":"2026-11-04T19:31:11.497701"} +{"completed_at":"2026-11-04T19:47:33.668324","latency_in_ms":2038,"output":{"example_id":"table/sizingchart_page2","grounded_pages":[],"layout_pages":[],"markdown":"**MAKE MODEL Standard Cargo Area Behind 2nd or 3rd Row Seats**\n\n**Cargo Area Behind Front Seats with 2nd and/or 3rd Row Seats folded flat**\n\n**Cargo Area Behind 2nd Row Seats with 3rd Row Seats removed or folded**\n\n**flat**\n\nTrax NA Medium\n\nSonic NA Medium\n\nSpark NA Small\n\nSuburban Medium X-Large Large\n\n**Chrysler** Aspen Small Large\n\nPacifica Small X-Large Medium\n\nPT Cruiser Small Large\n\nTown & Country NA X-Large Medium\n\n**Dodge** Caliber Small Medium\n\nCaravan NA X-Large Large\n\nDurango Small Large\n\nJourney Small Large\n\nMagnum Small Large\n\nNitro Small Medium\n\n**Fiat** 500 NA Small\n\n500L NA Medium\n\n500X NA Medium\n\n**Ford** CMAX NA Large\n\nEcoSport Small Medium\n\nEdge Small Large\n\nEscape (pre'13) Small Medium\n\nEscape Small Large\n\nExcursion Medium X-Large Large\n\nExpedition Small X-Large Medium\n\nExplorer Small Large\n\nFiesta NA Medium\n\nFlex Small Large\n\nFocus NA Medium\n\nFreestyle Small Large Medium\n\nTaurus X Small Large\n\nWindstar Small X-Large Medium\n\n**GMC** Acadia Small Large\n\nEnvoy Small Large\n\nTerrain Small Large\n\nYukon Small Large\n\nYukon XL Medium X-Large Large\n\n**Honda** Civic NA Medium\n\nCrosstour NA Large\n\nCRV (pre '12) Small Medium\n\nCRV Small Large\n\nElement Small Large\n\nFit Small Medium","pages":[{"line_numbers":[],"markdown":"**MAKE MODEL Standard Cargo Area Behind 2nd or 3rd Row Seats**\n\n**Cargo Area Behind Front Seats with 2nd and/or 3rd Row Seats folded flat**\n\n**Cargo Area Behind 2nd Row Seats with 3rd Row Seats removed or folded**\n\n**flat**\n\nTrax NA Medium\n\nSonic NA Medium\n\nSpark NA Small\n\nSuburban Medium X-Large Large\n\n**Chrysler** Aspen Small Large\n\nPacifica Small X-Large Medium\n\nPT Cruiser Small Large\n\nTown & Country NA X-Large Medium\n\n**Dodge** Caliber Small Medium\n\nCaravan NA X-Large Large\n\nDurango Small Large\n\nJourney Small Large\n\nMagnum Small Large\n\nNitro Small Medium\n\n**Fiat** 500 NA Small\n\n500L NA Medium\n\n500X NA Medium\n\n**Ford** CMAX NA Large\n\nEcoSport Small Medium\n\nEdge Small Large\n\nEscape (pre'13) Small Medium\n\nEscape Small Large\n\nExcursion Medium X-Large Large\n\nExpedition Small X-Large Medium\n\nExplorer Small Large\n\nFiesta NA Medium\n\nFlex Small Large\n\nFocus NA Medium\n\nFreestyle Small Large Medium\n\nTaurus X Small Large\n\nWindstar Small X-Large Medium\n\n**GMC** Acadia Small Large\n\nEnvoy Small Large\n\nTerrain Small Large\n\nYukon Small Large\n\nYukon XL Medium X-Large Large\n\n**Honda** Civic NA Medium\n\nCrosstour NA Large\n\nCRV (pre '12) Small Medium\n\nCRV Small Large\n\nElement Small Large\n\nFit Small Medium","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**MAKE MODEL Standard Cargo Area Behind 2nd or 3rd Row Seats**\n\n**Cargo Area Behind Front Seats with 2nd and/or 3rd Row Seats folded flat**\n\n**Cargo Area Behind 2nd Row Seats with 3rd Row Seats removed or folded**\n\n**flat**\n\nTrax NA Medium\n\nSonic NA Medium\n\nSpark NA Small\n\nSuburban Medium X-Large Large\n\n**Chrysler** Aspen Small Large\n\nPacifica Small X-Large Medium\n\nPT Cruiser Small Large\n\nTown & Country NA X-Large Medium\n\n**Dodge** Caliber Small Medium\n\nCaravan NA X-Large Large\n\nDurango Small Large\n\nJourney Small Large\n\nMagnum Small Large\n\nNitro Small Medium\n\n**Fiat** 500 NA Small\n\n500L NA Medium\n\n500X NA Medium\n\n**Ford** CMAX NA Large\n\nEcoSport Small Medium\n\nEdge Small Large\n\nEscape (pre'13) Small Medium\n\nEscape Small Large\n\nExcursion Medium X-Large Large\n\nExpedition Small X-Large Medium\n\nExplorer Small Large\n\nFiesta NA Medium\n\nFlex Small Large\n\nFocus NA Medium\n\nFreestyle Small Large Medium\n\nTaurus X Small Large\n\nWindstar Small X-Large Medium\n\n**GMC** Acadia Small Large\n\nEnvoy Small Large\n\nTerrain Small Large\n\nYukon Small Large\n\nYukon XL Medium X-Large Large\n\n**Honda** Civic NA Medium\n\nCrosstour NA Large\n\nCRV (pre '12) Small Medium\n\nCRV Small Large\n\nElement Small Large\n\nFit Small Medium","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/sizingchart_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_fe2792483ad37474d4156fe4e418eb08","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**MAKE MODEL Standard Cargo Area Behind 2nd or 3rd Row Seats**\n\n**Cargo Area Behind Front Seats with 2nd and/or 3rd Row Seats folded flat**\n\n**Cargo Area Behind 2nd Row Seats with 3rd Row Seats removed or folded**\n\n**flat**\n\nTrax NA Medium\n\nSonic NA Medium\n\nSpark NA Small\n\nSuburban Medium X-Large Large\n\n**Chrysler** Aspen Small Large\n\nPacifica Small X-Large Medium\n\nPT Cruiser Small Large\n\nTown & Country NA X-Large Medium\n\n**Dodge** Caliber Small Medium\n\nCaravan NA X-Large Large\n\nDurango Small Large\n\nJourney Small Large\n\nMagnum Small Large\n\nNitro Small Medium\n\n**Fiat** 500 NA Small\n\n500L NA Medium\n\n500X NA Medium\n\n**Ford** CMAX NA Large\n\nEcoSport Small Medium\n\nEdge Small Large\n\nEscape (pre'13) Small Medium\n\nEscape Small Large\n\nExcursion Medium X-Large Large\n\nExpedition Small X-Large Medium\n\nExplorer Small Large\n\nFiesta NA Medium\n\nFlex Small Large\n\nFocus NA Medium\n\nFreestyle Small Large Medium\n\nTaurus X Small Large\n\nWindstar Small X-Large Medium\n\n**GMC** Acadia Small Large\n\nEnvoy Small Large\n\nTerrain Small Large\n\nYukon Small Large\n\nYukon XL Medium X-Large Large\n\n**Honda** Civic NA Medium\n\nCrosstour NA Large\n\nCRV (pre '12) Small Medium\n\nCRV Small Large\n\nElement Small Large\n\nFit Small Medium"],"full_content":"**MAKE MODEL Standard Cargo Area Behind 2nd or 3rd Row Seats**\n\n**Cargo Area Behind Front Seats with 2nd and/or 3rd Row Seats folded flat**\n\n**Cargo Area Behind 2nd Row Seats with 3rd Row Seats removed or folded**\n\n**flat**\n\nTrax NA Medium\n\nSonic NA Medium\n\nSpark NA Small\n\nSuburban Medium X-Large Large\n\n**Chrysler** Aspen Small Large\n\nPacifica Small X-Large Medium\n\nPT Cruiser Small Large\n\nTown & Country NA X-Large Medium\n\n**Dodge** Caliber Small Medium\n\nCaravan NA X-Large Large\n\nDurango Small Large\n\nJourney Small Large\n\nMagnum Small Large\n\nNitro Small Medium\n\n**Fiat** 500 NA Small\n\n500L NA Medium\n\n500X NA Medium\n\n**Ford** CMAX NA Large\n\nEcoSport Small Medium\n\nEdge Small Large\n\nEscape (pre'13) Small Medium\n\nEscape Small Large\n\nExcursion Medium X-Large Large\n\nExpedition Small X-Large Medium\n\nExplorer Small Large\n\nFiesta NA Medium\n\nFlex Small Large\n\nFocus NA Medium\n\nFreestyle Small Large Medium\n\nTaurus X Small Large\n\nWindstar Small X-Large Medium\n\n**GMC** Acadia Small Large\n\nEnvoy Small Large\n\nTerrain Small Large\n\nYukon Small Large\n\nYukon XL Medium X-Large Large\n\n**Honda** Civic NA Medium\n\nCrosstour NA Large\n\nCRV (pre '12) Small Medium\n\nCRV Small Large\n\nElement Small Large\n\nFit Small Medium","publish_date":null,"title":"MAKE MODEL","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/sizingchart_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/sizingchart_page2.pdf"},"request":{"example_id":"table/sizingchart_page2","product_type":"parse","source_file_path":"sizingchart_page2.pdf"},"started_at":"2026-11-04T19:47:31.629906"} +{"completed_at":"2026-11-04T19:47:33.672779","latency_in_ms":1085,"output":{"example_id":"table/synthetic_colspan_table_no_borders_page1","grounded_pages":[],"layout_pages":[],"markdown":"### **Regional Sales Performance — FY 2025**\n\n**North America Europe Asia-Pacific**\n\n**Product Line Revenue Units Revenue Units Revenue Units**\n\nEnterprise Software $12.4M 1,240 $8.7M 870 $6.2M 620\n\nCloud Services $18.1M 3,620 $14.3M 2,860 $11.8M 2,360\n\nHardware $5.3M 530 $3.1M 310 $7.9M 790\n\nProfessional Services $9.8M 490 $7.2M 360 $4.1M 205\n\nConsumer Products $3.6M 14,400 $2.9M 11,600 $5.4M 21,600\n\n**Total $49.2M 20,280 $36.2M 16,000 $35.4M 25,575**\n\nSource: Internal sales tracking system. All figures in USD.\n\n### **Employee Satisfaction Survey Results — Q4 2025**\n\n**Satisfaction Score Retention**\n\n**Department 2024 2025 Voluntary Turnover Avg Tenure (yrs)**\n\nEngineering 4.2 4.5 8.1% 3.8\n\nSales 3.7 3.9 14.2% 2.4\n\nMarketing 4.0 4.1 10.5% 3.1\n\nOperations 3.5 3.8 12.8% 4.2\n\nHuman Resources 4.1 4.3 6.3% 5.1\n\nFinance 3.9 4.0 7.7% 4.8\n\n**Company-wide 3.9 4.1 9.9% 3.9**\n\nSatisfaction scores on a 1-5 scale. Turnover is annualized.","pages":[{"line_numbers":[],"markdown":"### **Regional Sales Performance — FY 2025**\n\n**North America Europe Asia-Pacific**\n\n**Product Line Revenue Units Revenue Units Revenue Units**\n\nEnterprise Software $12.4M 1,240 $8.7M 870 $6.2M 620\n\nCloud Services $18.1M 3,620 $14.3M 2,860 $11.8M 2,360\n\nHardware $5.3M 530 $3.1M 310 $7.9M 790\n\nProfessional Services $9.8M 490 $7.2M 360 $4.1M 205\n\nConsumer Products $3.6M 14,400 $2.9M 11,600 $5.4M 21,600\n\n**Total $49.2M 20,280 $36.2M 16,000 $35.4M 25,575**\n\nSource: Internal sales tracking system. All figures in USD.\n\n### **Employee Satisfaction Survey Results — Q4 2025**\n\n**Satisfaction Score Retention**\n\n**Department 2024 2025 Voluntary Turnover Avg Tenure (yrs)**\n\nEngineering 4.2 4.5 8.1% 3.8\n\nSales 3.7 3.9 14.2% 2.4\n\nMarketing 4.0 4.1 10.5% 3.1\n\nOperations 3.5 3.8 12.8% 4.2\n\nHuman Resources 4.1 4.3 6.3% 5.1\n\nFinance 3.9 4.0 7.7% 4.8\n\n**Company-wide 3.9 4.1 9.9% 3.9**\n\nSatisfaction scores on a 1-5 scale. Turnover is annualized.","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Regional Sales Performance — FY 2025**\n\n**North America Europe Asia-Pacific**\n\n**Product Line Revenue Units Revenue Units Revenue Units**\n\nEnterprise Software $12.4M 1,240 $8.7M 870 $6.2M 620\n\nCloud Services $18.1M 3,620 $14.3M 2,860 $11.8M 2,360\n\nHardware $5.3M 530 $3.1M 310 $7.9M 790\n\nProfessional Services $9.8M 490 $7.2M 360 $4.1M 205\n\nConsumer Products $3.6M 14,400 $2.9M 11,600 $5.4M 21,600\n\n**Total $49.2M 20,280 $36.2M 16,000 $35.4M 25,575**\n\nSource: Internal sales tracking system. All figures in USD.\n\n### **Employee Satisfaction Survey Results — Q4 2025**\n\n**Satisfaction Score Retention**\n\n**Department 2024 2025 Voluntary Turnover Avg Tenure (yrs)**\n\nEngineering 4.2 4.5 8.1% 3.8\n\nSales 3.7 3.9 14.2% 2.4\n\nMarketing 4.0 4.1 10.5% 3.1\n\nOperations 3.5 3.8 12.8% 4.2\n\nHuman Resources 4.1 4.3 6.3% 5.1\n\nFinance 3.9 4.0 7.7% 4.8\n\n**Company-wide 3.9 4.1 9.9% 3.9**\n\nSatisfaction scores on a 1-5 scale. Turnover is annualized.","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_colspan_table_no_borders_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_94a57cabb5d063dba29dc9a0c80fbd95","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Regional Sales Performance — FY 2025**\n\n**North America Europe Asia-Pacific**\n\n**Product Line Revenue Units Revenue Units Revenue Units**\n\nEnterprise Software $12.4M 1,240 $8.7M 870 $6.2M 620\n\nCloud Services $18.1M 3,620 $14.3M 2,860 $11.8M 2,360\n\nHardware $5.3M 530 $3.1M 310 $7.9M 790\n\nProfessional Services $9.8M 490 $7.2M 360 $4.1M 205\n\nConsumer Products $3.6M 14,400 $2.9M 11,600 $5.4M 21,600\n\n**Total $49.2M 20,280 $36.2M 16,000 $35.4M 25,575**\n\nSource: Internal sales tracking system. All figures in USD.\n\n### **Employee Satisfaction Survey Results — Q4 2025**\n\n**Satisfaction Score Retention**\n\n**Department 2024 2025 Voluntary Turnover Avg Tenure (yrs)**\n\nEngineering 4.2 4.5 8.1% 3.8\n\nSales 3.7 3.9 14.2% 2.4\n\nMarketing 4.0 4.1 10.5% 3.1\n\nOperations 3.5 3.8 12.8% 4.2\n\nHuman Resources 4.1 4.3 6.3% 5.1\n\nFinance 3.9 4.0 7.7% 4.8\n\n**Company-wide 3.9 4.1 9.9% 3.9**\n\nSatisfaction scores on a 1-5 scale. Turnover is annualized."],"full_content":"### **Regional Sales Performance — FY 2025**\n\n**North America Europe Asia-Pacific**\n\n**Product Line Revenue Units Revenue Units Revenue Units**\n\nEnterprise Software $12.4M 1,240 $8.7M 870 $6.2M 620\n\nCloud Services $18.1M 3,620 $14.3M 2,860 $11.8M 2,360\n\nHardware $5.3M 530 $3.1M 310 $7.9M 790\n\nProfessional Services $9.8M 490 $7.2M 360 $4.1M 205\n\nConsumer Products $3.6M 14,400 $2.9M 11,600 $5.4M 21,600\n\n**Total $49.2M 20,280 $36.2M 16,000 $35.4M 25,575**\n\nSource: Internal sales tracking system. All figures in USD.\n\n### **Employee Satisfaction Survey Results — Q4 2025**\n\n**Satisfaction Score Retention**\n\n**Department 2024 2025 Voluntary Turnover Avg Tenure (yrs)**\n\nEngineering 4.2 4.5 8.1% 3.8\n\nSales 3.7 3.9 14.2% 2.4\n\nMarketing 4.0 4.1 10.5% 3.1\n\nOperations 3.5 3.8 12.8% 4.2\n\nHuman Resources 4.1 4.3 6.3% 5.1\n\nFinance 3.9 4.0 7.7% 4.8\n\n**Company-wide 3.9 4.1 9.9% 3.9**\n\nSatisfaction scores on a 1-5 scale. Turnover is annualized.","publish_date":null,"title":"Regional Sales Performance — FY 2025 Employee Satisfaction Survey Results — Q4 2025","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_colspan_table_no_borders_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_colspan_table_no_borders_page1.pdf"},"request":{"example_id":"table/synthetic_colspan_table_no_borders_page1","product_type":"parse","source_file_path":"synthetic_colspan_table_no_borders_page1.pdf"},"started_at":"2026-11-04T19:47:32.587593"} +{"completed_at":"2026-11-04T19:47:34.955352","latency_in_ms":1280,"output":{"example_id":"table/synthetic_duplicate_tables_page1","grounded_pages":[],"layout_pages":[],"markdown":"**Category Alpha**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 4.111 222 54 1.046 232 56\n\nBC-02A 4.222 223 53 1.054 235 56\n\nBC-03A 4.333 224 52 1.060 237 55\n\nBC-04A 4.444 225 51 1.069 240 54\n\nBC-01B 4.555 226 50 1.073 242 53\n\nBC-02B 4.666 227 49 1.186 269 58\n\nBC-03B 4.777 228 48 1.070 244 51\n\nBC-04B 4.888 229 47 1.071 245 50\n\nBC-01C 4.999 230 46 1.071 246 49\n\nBC-02C 5.111 231 45 1.071 247 48\n\nBC-03C 5.222 232 44 1.074 249 48\n\nBC-04C 5.333 233 44 1.078 251 47\n\nBC-01D 5.444 234 43 1.082 253 46\n\nBC-02D 5.555 235 42 1.084 255 46\n\nBC-03D 5.666 236 42 1.081 255 45\n\nBC-04D 5.777 237 41 1.071 254 44\n\nBC-01E 5.888 238 40 1.067 254 43\n\nBC-02E 5.999 239 40 1.064 254 42\n\nBC-03E 6.111 240 39 1.056 253 41\n\nBC-04E 6.222 241 39 1.036 250 40\n\n**Exp Scaled Output**\n\n5 Cycle -5.55%\n\n4 Cycle -6.66%\n\n3 Cycle -4.44%\n\n2 Cycle -2.22%\n\n1 Cycle -1.11%\n\nSel Backward -4.4%\n\nSel Forward -1.8%\n\n**Category Beta**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 3.100 600 194 1.500 900 290\n\nBC-02A 3.200 610 191 1.510 921 288\n\nBC-03A 3.300 620 188 1.520 942 286\n\nBC-04A 3.400 630 185 1.530 964 284\n\nBC-01B 3.500 640 183 1.540 986 282\n\nBC-02B 3.600 650 181 1.550 1,008 280\n\nBC-03B 3.700 660 178 1.560 1,030 278\n\nBC-04B 3.800 670 176 1.570 1,052 277\n\nBC-01C 3.900 680 174 1.580 1,074 275\n\nBC-02C 4.000 690 173 1.590 1,097 274\n\nBC-03C 4.100 700 171 1.600 1,120 273\n\nBC-04C 4.200 710 169 1.610 1,143 272\n\nBC-01D 4.300 720 167 1.620 1,166 271\n\nBC-02D 4.400 730 166 1.630 1,190 270\n\nBC-03D 4.500 740 164 1.640 1,214 270\n\nBC-04D 4.600 750 163 1.650 1,238 269\n\nBC-01E 4.700 760 162 1.660 1,262 268\n\nBC-02E 4.800 770 160 1.670 1,286 268\n\nBC-03E 4.900 780 159 1.680 1,310 267\n\nBC-04E 5.000 790 158 1.690 1,335 267\n\n**Exp Scaled Output**\n\n5 Cycle -1.11%\n\n4 Cycle -2.22%\n\n3 Cycle -1.55%\n\n2 Cycle 0.33%\n\n1 Cycle 0.44%\n\nSel Backward -1.5%\n\nSel Forward 0.3%\n\n**Category Beta**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 3.100 600 194 1.500 900 290\n\nBC-02A 3.200 610 191 1.510 921 288\n\nBC-03A 3.300 620 188 1.520 942 286\n\nBC-04A 3.400 630 185 1.530 964 284\n\nBC-01B 3.500 640 183 1.540 986 282\n\nBC-02B 3.600 650 181 1.550 1,008 280\n\nBC-03B 3.700 660 178 1.560 1,030 278\n\nBC-04B 3.800 670 176 1.570 1,052 277\n\nBC-01C 3.900 680 174 1.580 1,074 275\n\nBC-02C 4.000 690 173 1.590 1,097 274\n\nBC-03C 4.100 700 171 1.600 1,120 273\n\nBC-04C 4.200 710 169 1.610 1,143 272\n\nBC-01D 4.300 720 167 1.620 1,166 271\n\nBC-02D 4.400 730 166 1.630 1,190 270\n\nBC-03D 4.500 740 164 1.640 1,214 270\n\nBC-04D 4.600 750 163 1.650 1,238 269\n\nBC-01E 4.700 760 162 1.660 1,262 268\n\nBC-02E 4.800 770 160 1.670 1,286 268\n\nBC-03E 4.900 780 159 1.680 1,310 267\n\nBC-04E 5.000 790 158 1.690 1,335 267\n\n**Exp Scaled Output**\n\n5 Cycle -1.11%\n\n4 Cycle -2.22%\n\n3 Cycle -1.55%\n\n2 Cycle 0.33%\n\n1 Cycle 0.44%\n\nSel Backward -1.5%\n\nSel Forward 0.3%","pages":[{"line_numbers":[],"markdown":"**Category Alpha**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 4.111 222 54 1.046 232 56\n\nBC-02A 4.222 223 53 1.054 235 56\n\nBC-03A 4.333 224 52 1.060 237 55\n\nBC-04A 4.444 225 51 1.069 240 54\n\nBC-01B 4.555 226 50 1.073 242 53\n\nBC-02B 4.666 227 49 1.186 269 58\n\nBC-03B 4.777 228 48 1.070 244 51\n\nBC-04B 4.888 229 47 1.071 245 50\n\nBC-01C 4.999 230 46 1.071 246 49\n\nBC-02C 5.111 231 45 1.071 247 48\n\nBC-03C 5.222 232 44 1.074 249 48\n\nBC-04C 5.333 233 44 1.078 251 47\n\nBC-01D 5.444 234 43 1.082 253 46\n\nBC-02D 5.555 235 42 1.084 255 46\n\nBC-03D 5.666 236 42 1.081 255 45\n\nBC-04D 5.777 237 41 1.071 254 44\n\nBC-01E 5.888 238 40 1.067 254 43\n\nBC-02E 5.999 239 40 1.064 254 42\n\nBC-03E 6.111 240 39 1.056 253 41\n\nBC-04E 6.222 241 39 1.036 250 40\n\n**Exp Scaled Output**\n\n5 Cycle -5.55%\n\n4 Cycle -6.66%\n\n3 Cycle -4.44%\n\n2 Cycle -2.22%\n\n1 Cycle -1.11%\n\nSel Backward -4.4%\n\nSel Forward -1.8%\n\n**Category Beta**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 3.100 600 194 1.500 900 290\n\nBC-02A 3.200 610 191 1.510 921 288\n\nBC-03A 3.300 620 188 1.520 942 286\n\nBC-04A 3.400 630 185 1.530 964 284\n\nBC-01B 3.500 640 183 1.540 986 282\n\nBC-02B 3.600 650 181 1.550 1,008 280\n\nBC-03B 3.700 660 178 1.560 1,030 278\n\nBC-04B 3.800 670 176 1.570 1,052 277\n\nBC-01C 3.900 680 174 1.580 1,074 275\n\nBC-02C 4.000 690 173 1.590 1,097 274\n\nBC-03C 4.100 700 171 1.600 1,120 273\n\nBC-04C 4.200 710 169 1.610 1,143 272\n\nBC-01D 4.300 720 167 1.620 1,166 271\n\nBC-02D 4.400 730 166 1.630 1,190 270\n\nBC-03D 4.500 740 164 1.640 1,214 270\n\nBC-04D 4.600 750 163 1.650 1,238 269\n\nBC-01E 4.700 760 162 1.660 1,262 268\n\nBC-02E 4.800 770 160 1.670 1,286 268\n\nBC-03E 4.900 780 159 1.680 1,310 267\n\nBC-04E 5.000 790 158 1.690 1,335 267\n\n**Exp Scaled Output**\n\n5 Cycle -1.11%\n\n4 Cycle -2.22%\n\n3 Cycle -1.55%\n\n2 Cycle 0.33%\n\n1 Cycle 0.44%\n\nSel Backward -1.5%\n\nSel Forward 0.3%\n\n**Category Beta**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 3.100 600 194 1.500 900 290\n\nBC-02A 3.200 610 191 1.510 921 288\n\nBC-03A 3.300 620 188 1.520 942 286\n\nBC-04A 3.400 630 185 1.530 964 284\n\nBC-01B 3.500 640 183 1.540 986 282\n\nBC-02B 3.600 650 181 1.550 1,008 280\n\nBC-03B 3.700 660 178 1.560 1,030 278\n\nBC-04B 3.800 670 176 1.570 1,052 277\n\nBC-01C 3.900 680 174 1.580 1,074 275\n\nBC-02C 4.000 690 173 1.590 1,097 274\n\nBC-03C 4.100 700 171 1.600 1,120 273\n\nBC-04C 4.200 710 169 1.610 1,143 272\n\nBC-01D 4.300 720 167 1.620 1,166 271\n\nBC-02D 4.400 730 166 1.630 1,190 270\n\nBC-03D 4.500 740 164 1.640 1,214 270\n\nBC-04D 4.600 750 163 1.650 1,238 269\n\nBC-01E 4.700 760 162 1.660 1,262 268\n\nBC-02E 4.800 770 160 1.670 1,286 268\n\nBC-03E 4.900 780 159 1.680 1,310 267\n\nBC-04E 5.000 790 158 1.690 1,335 267\n\n**Exp Scaled Output**\n\n5 Cycle -1.11%\n\n4 Cycle -2.22%\n\n3 Cycle -1.55%\n\n2 Cycle 0.33%\n\n1 Cycle 0.44%\n\nSel Backward -1.5%\n\nSel Forward 0.3%","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Category Alpha**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 4.111 222 54 1.046 232 56\n\nBC-02A 4.222 223 53 1.054 235 56\n\nBC-03A 4.333 224 52 1.060 237 55\n\nBC-04A 4.444 225 51 1.069 240 54\n\nBC-01B 4.555 226 50 1.073 242 53\n\nBC-02B 4.666 227 49 1.186 269 58\n\nBC-03B 4.777 228 48 1.070 244 51\n\nBC-04B 4.888 229 47 1.071 245 50\n\nBC-01C 4.999 230 46 1.071 246 49\n\nBC-02C 5.111 231 45 1.071 247 48\n\nBC-03C 5.222 232 44 1.074 249 48\n\nBC-04C 5.333 233 44 1.078 251 47\n\nBC-01D 5.444 234 43 1.082 253 46\n\nBC-02D 5.555 235 42 1.084 255 46\n\nBC-03D 5.666 236 42 1.081 255 45\n\nBC-04D 5.777 237 41 1.071 254 44\n\nBC-01E 5.888 238 40 1.067 254 43\n\nBC-02E 5.999 239 40 1.064 254 42\n\nBC-03E 6.111 240 39 1.056 253 41\n\nBC-04E 6.222 241 39 1.036 250 40\n\n**Exp Scaled Output**\n\n5 Cycle -5.55%\n\n4 Cycle -6.66%\n\n3 Cycle -4.44%\n\n2 Cycle -2.22%\n\n1 Cycle -1.11%\n\nSel Backward -4.4%\n\nSel Forward -1.8%\n\n**Category Beta**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 3.100 600 194 1.500 900 290\n\nBC-02A 3.200 610 191 1.510 921 288\n\nBC-03A 3.300 620 188 1.520 942 286\n\nBC-04A 3.400 630 185 1.530 964 284\n\nBC-01B 3.500 640 183 1.540 986 282\n\nBC-02B 3.600 650 181 1.550 1,008 280\n\nBC-03B 3.700 660 178 1.560 1,030 278\n\nBC-04B 3.800 670 176 1.570 1,052 277\n\nBC-01C 3.900 680 174 1.580 1,074 275\n\nBC-02C 4.000 690 173 1.590 1,097 274\n\nBC-03C 4.100 700 171 1.600 1,120 273\n\nBC-04C 4.200 710 169 1.610 1,143 272\n\nBC-01D 4.300 720 167 1.620 1,166 271\n\nBC-02D 4.400 730 166 1.630 1,190 270\n\nBC-03D 4.500 740 164 1.640 1,214 270\n\nBC-04D 4.600 750 163 1.650 1,238 269\n\nBC-01E 4.700 760 162 1.660 1,262 268\n\nBC-02E 4.800 770 160 1.670 1,286 268\n\nBC-03E 4.900 780 159 1.680 1,310 267\n\nBC-04E 5.000 790 158 1.690 1,335 267\n\n**Exp Scaled Output**\n\n5 Cycle -1.11%\n\n4 Cycle -2.22%\n\n3 Cycle -1.55%\n\n2 Cycle 0.33%\n\n1 Cycle 0.44%\n\nSel Backward -1.5%\n\nSel Forward 0.3%\n\n**Category Beta**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 3.100 600 194 1.500 900 290\n\nBC-02A 3.200 610 191 1.510 921 288\n\nBC-03A 3.300 620 188 1.520 942 286\n\nBC-04A 3.400 630 185 1.530 964 284\n\nBC-01B 3.500 640 183 1.540 986 282\n\nBC-02B 3.600 650 181 1.550 1,008 280\n\nBC-03B 3.700 660 178 1.560 1,030 278\n\nBC-04B 3.800 670 176 1.570 1,052 277\n\nBC-01C 3.900 680 174 1.580 1,074 275\n\nBC-02C 4.000 690 173 1.590 1,097 274\n\nBC-03C 4.100 700 171 1.600 1,120 273\n\nBC-04C 4.200 710 169 1.610 1,143 272\n\nBC-01D 4.300 720 167 1.620 1,166 271\n\nBC-02D 4.400 730 166 1.630 1,190 270\n\nBC-03D 4.500 740 164 1.640 1,214 270\n\nBC-04D 4.600 750 163 1.650 1,238 269\n\nBC-01E 4.700 760 162 1.660 1,262 268\n\nBC-02E 4.800 770 160 1.670 1,286 268\n\nBC-03E 4.900 780 159 1.680 1,310 267\n\nBC-04E 5.000 790 158 1.690 1,335 267\n\n**Exp Scaled Output**\n\n5 Cycle -1.11%\n\n4 Cycle -2.22%\n\n3 Cycle -1.55%\n\n2 Cycle 0.33%\n\n1 Cycle 0.44%\n\nSel Backward -1.5%\n\nSel Forward 0.3%","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_duplicate_tables_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_125cc3267c4460b697538a7d9a7e45eb","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Category Alpha**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 4.111 222 54 1.046 232 56\n\nBC-02A 4.222 223 53 1.054 235 56\n\nBC-03A 4.333 224 52 1.060 237 55\n\nBC-04A 4.444 225 51 1.069 240 54\n\nBC-01B 4.555 226 50 1.073 242 53\n\nBC-02B 4.666 227 49 1.186 269 58\n\nBC-03B 4.777 228 48 1.070 244 51\n\nBC-04B 4.888 229 47 1.071 245 50\n\nBC-01C 4.999 230 46 1.071 246 49\n\nBC-02C 5.111 231 45 1.071 247 48\n\nBC-03C 5.222 232 44 1.074 249 48\n\nBC-04C 5.333 233 44 1.078 251 47\n\nBC-01D 5.444 234 43 1.082 253 46\n\nBC-02D 5.555 235 42 1.084 255 46\n\nBC-03D 5.666 236 42 1.081 255 45\n\nBC-04D 5.777 237 41 1.071 254 44\n\nBC-01E 5.888 238 40 1.067 254 43\n\nBC-02E 5.999 239 40 1.064 254 42\n\nBC-03E 6.111 240 39 1.056 253 41\n\nBC-04E 6.222 241 39 1.036 250 40\n\n**Exp Scaled Output**\n\n5 Cycle -5.55%\n\n4 Cycle -6.66%\n\n3 Cycle -4.44%\n\n2 Cycle -2.22%\n\n1 Cycle -1.11%\n\nSel Backward -4.4%\n\nSel Forward -1.8%\n\n**Category Beta**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 3.100 600 194 1.500 900 290\n\nBC-02A 3.200 610 191 1.510 921 288\n\nBC-03A 3.300 620 188 1.520 942 286\n\nBC-04A 3.400 630 185 1.530 964 284\n\nBC-01B 3.500 640 183 1.540 986 282\n\nBC-02B 3.600 650 181 1.550 1,008 280\n\nBC-03B 3.700 660 178 1.560 1,030 278\n\nBC-04B 3.800 670 176 1.570 1,052 277\n\nBC-01C 3.900 680 174 1.580 1,074 275\n\nBC-02C 4.000 690 173 1.590 1,097 274\n\nBC-03C 4.100 700 171 1.600 1,120 273\n\nBC-04C 4.200 710 169 1.610 1,143 272\n\nBC-01D 4.300 720 167 1.620 1,166 271\n\nBC-02D 4.400 730 166 1.630 1,190 270\n\nBC-03D 4.500 740 164 1.640 1,214 270\n\nBC-04D 4.600 750 163 1.650 1,238 269\n\nBC-01E 4.700 760 162 1.660 1,262 268\n\nBC-02E 4.800 770 160 1.670 1,286 268\n\nBC-03E 4.900 780 159 1.680 1,310 267\n\nBC-04E 5.000 790 158 1.690 1,335 267\n\n**Exp Scaled Output**\n\n5 Cycle -1.11%\n\n4 Cycle -2.22%\n\n3 Cycle -1.55%\n\n2 Cycle 0.33%\n\n1 Cycle 0.44%\n\nSel Backward -1.5%\n\nSel Forward 0.3%\n\n**Category Beta**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 3.100 600 194 1.500 900 290\n\nBC-02A 3.200 610 191 1.510 921 288\n\nBC-03A 3.300 620 188 1.520 942 286\n\nBC-04A 3.400 630 185 1.530 964 284\n\nBC-01B 3.500 640 183 1.540 986 282\n\nBC-02B 3.600 650 181 1.550 1,008 280\n\nBC-03B 3.700 660 178 1.560 1,030 278\n\nBC-04B 3.800 670 176 1.570 1,052 277\n\nBC-01C 3.900 680 174 1.580 1,074 275\n\nBC-02C 4.000 690 173 1.590 1,097 274\n\nBC-03C 4.100 700 171 1.600 1,120 273\n\nBC-04C 4.200 710 169 1.610 1,143 272\n\nBC-01D 4.300 720 167 1.620 1,166 271\n\nBC-02D 4.400 730 166 1.630 1,190 270\n\nBC-03D 4.500 740 164 1.640 1,214 270\n\nBC-04D 4.600 750 163 1.650 1,238 269\n\nBC-01E 4.700 760 162 1.660 1,262 268\n\nBC-02E 4.800 770 160 1.670 1,286 268\n\nBC-03E 4.900 780 159 1.680 1,310 267\n\nBC-04E 5.000 790 158 1.690 1,335 267\n\n**Exp Scaled Output**\n\n5 Cycle -1.11%\n\n4 Cycle -2.22%\n\n3 Cycle -1.55%\n\n2 Cycle 0.33%\n\n1 Cycle 0.44%\n\nSel Backward -1.5%\n\nSel Forward 0.3%"],"full_content":"**Category Alpha**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 4.111 222 54 1.046 232 56\n\nBC-02A 4.222 223 53 1.054 235 56\n\nBC-03A 4.333 224 52 1.060 237 55\n\nBC-04A 4.444 225 51 1.069 240 54\n\nBC-01B 4.555 226 50 1.073 242 53\n\nBC-02B 4.666 227 49 1.186 269 58\n\nBC-03B 4.777 228 48 1.070 244 51\n\nBC-04B 4.888 229 47 1.071 245 50\n\nBC-01C 4.999 230 46 1.071 246 49\n\nBC-02C 5.111 231 45 1.071 247 48\n\nBC-03C 5.222 232 44 1.074 249 48\n\nBC-04C 5.333 233 44 1.078 251 47\n\nBC-01D 5.444 234 43 1.082 253 46\n\nBC-02D 5.555 235 42 1.084 255 46\n\nBC-03D 5.666 236 42 1.081 255 45\n\nBC-04D 5.777 237 41 1.071 254 44\n\nBC-01E 5.888 238 40 1.067 254 43\n\nBC-02E 5.999 239 40 1.064 254 42\n\nBC-03E 6.111 240 39 1.056 253 41\n\nBC-04E 6.222 241 39 1.036 250 40\n\n**Exp Scaled Output**\n\n5 Cycle -5.55%\n\n4 Cycle -6.66%\n\n3 Cycle -4.44%\n\n2 Cycle -2.22%\n\n1 Cycle -1.11%\n\nSel Backward -4.4%\n\nSel Forward -1.8%\n\n**Category Beta**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 3.100 600 194 1.500 900 290\n\nBC-02A 3.200 610 191 1.510 921 288\n\nBC-03A 3.300 620 188 1.520 942 286\n\nBC-04A 3.400 630 185 1.530 964 284\n\nBC-01B 3.500 640 183 1.540 986 282\n\nBC-02B 3.600 650 181 1.550 1,008 280\n\nBC-03B 3.700 660 178 1.560 1,030 278\n\nBC-04B 3.800 670 176 1.570 1,052 277\n\nBC-01C 3.900 680 174 1.580 1,074 275\n\nBC-02C 4.000 690 173 1.590 1,097 274\n\nBC-03C 4.100 700 171 1.600 1,120 273\n\nBC-04C 4.200 710 169 1.610 1,143 272\n\nBC-01D 4.300 720 167 1.620 1,166 271\n\nBC-02D 4.400 730 166 1.630 1,190 270\n\nBC-03D 4.500 740 164 1.640 1,214 270\n\nBC-04D 4.600 750 163 1.650 1,238 269\n\nBC-01E 4.700 760 162 1.660 1,262 268\n\nBC-02E 4.800 770 160 1.670 1,286 268\n\nBC-03E 4.900 780 159 1.680 1,310 267\n\nBC-04E 5.000 790 158 1.690 1,335 267\n\n**Exp Scaled Output**\n\n5 Cycle -1.11%\n\n4 Cycle -2.22%\n\n3 Cycle -1.55%\n\n2 Cycle 0.33%\n\n1 Cycle 0.44%\n\nSel Backward -1.5%\n\nSel Forward 0.3%\n\n**Category Beta**\n\n**Batch Cycle**\n\n**Unit Count (000s)**\n\n**Gross Output ($000s)**\n\n**Output per Unit ($s)**\n\n**Scale Coeff**\n\n**Scaled Output ($000s)**\n\n**Scaled per Unit ($s)**\n\nBC-01A 3.100 600 194 1.500 900 290\n\nBC-02A 3.200 610 191 1.510 921 288\n\nBC-03A 3.300 620 188 1.520 942 286\n\nBC-04A 3.400 630 185 1.530 964 284\n\nBC-01B 3.500 640 183 1.540 986 282\n\nBC-02B 3.600 650 181 1.550 1,008 280\n\nBC-03B 3.700 660 178 1.560 1,030 278\n\nBC-04B 3.800 670 176 1.570 1,052 277\n\nBC-01C 3.900 680 174 1.580 1,074 275\n\nBC-02C 4.000 690 173 1.590 1,097 274\n\nBC-03C 4.100 700 171 1.600 1,120 273\n\nBC-04C 4.200 710 169 1.610 1,143 272\n\nBC-01D 4.300 720 167 1.620 1,166 271\n\nBC-02D 4.400 730 166 1.630 1,190 270\n\nBC-03D 4.500 740 164 1.640 1,214 270\n\nBC-04D 4.600 750 163 1.650 1,238 269\n\nBC-01E 4.700 760 162 1.660 1,262 268\n\nBC-02E 4.800 770 160 1.670 1,286 268\n\nBC-03E 4.900 780 159 1.680 1,310 267\n\nBC-04E 5.000 790 158 1.690 1,335 267\n\n**Exp Scaled Output**\n\n5 Cycle -1.11%\n\n4 Cycle -2.22%\n\n3 Cycle -1.55%\n\n2 Cycle 0.33%\n\n1 Cycle 0.44%\n\nSel Backward -1.5%\n\nSel Forward 0.3%","publish_date":null,"title":"Category Alpha Category Beta Category Beta","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_duplicate_tables_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_duplicate_tables_page1.pdf"},"request":{"example_id":"table/synthetic_duplicate_tables_page1","product_type":"parse","source_file_path":"synthetic_duplicate_tables_page1.pdf"},"started_at":"2026-11-04T19:47:33.674367"} +{"completed_at":"2026-11-04T19:47:36.336160","latency_in_ms":1469,"output":{"example_id":"table/synthetic_invoice_page1","grounded_pages":[],"layout_pages":[],"markdown":"Dancing Crew\n\nFebruary 2027\n\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28\n\nTotal Hours\n\nRate Total\n\nEmployee Id Other\n\nEmployee Name Category\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\n**Main Crew**\n\n1234 Jane Doe\n\nSecond Dancer 2 2 1 5 2.00 10.00\n\n1236 Mia Chen\n\nFirst Dancer 1 1 1 2 1 1 1 1 1 1 11 4.00 44.00\n\n1237\n\nJamal Williams\n\nLead Dancer 1 1 1 1 1 1 1 7 5.00 35.00\n\n1242\n\nSasha Volkov\n\nFeatured Dancer 1 3 1 3 1 6 1 16 3.00 48.00\n\n1243 Toby Park\n\nFeatured Dancer 1 3 1 1 1 7 4.00 28.00\n\n1245\n\nMarcus Thompson\n\nFirst Dancer 2 1 1 1 1 3 1 1 1 1 13 2.00 26.00\n\n1249\n\nFelix Lindberg\n\nFeatured Dancer 1 1 1 3 6 1 13 3.00 39.00\n\n1250\n\nRina Okafor\n\nLead Dancer 3 3 1 1 8 2.00 16.00\n\n1253\n\nDante Novak\n\nSecond Dancer 1 1 6 1 1 10 5.00 50.00\n\n1256 Ravi Gupta\n\nSecond Dancer 2 1 1 2 6 3.00 18.00\n\n1258\n\nTariq Hassan\n\nSecond Dancer 1 2 1 1 1 3 6 6 2 23 2.00 46.00\n\n1262 Leo Costa\n\nFeatured Dancer 2 1 1 2 1 1 1 6 1 16 2.00 32.00\n\n1263 Freya Berg\n\nFirst Dancer 2 3 1 6 4.00 24.00\n\n1265\n\nCeleste Torres\n\nLead Dancer 2 2 1 5 5.00 25.00\n\n1267\n\nMaeve Brennan\n\nFirst Dancer 1 1 3 2 1 2 10 4.00 40.00\n\n1270 Ezra Stein\n\nFeatured Dancer 1 2 1 2 3 9 2.00 18.00\n\n**Staffers**\n\n1235\n\nCarlos Rivera\n\nCorps Dancer 1 2 1 4 3.00 12.00\n\n1239\n\nKenji Tanaka\n\nCorps Dancer 3 1 2 1 1 1 9 3.00 27.00\n\n1241\n\nDiego Morales\n\nCorps Dancer 1 1 1 1 1 5 5.00 25.00\n\n1244\n\nLuna Santos\n\nBackup Dancer 1 1 1 3 3.00 9.00\n\n1246\n\nZara Ahmed\n\nBackup Dancer 1 1 3 5 5.00 25.00\n\n1247\n\nAndre Dubois\n\nCorps Dancer 2 1 1 1 1 6 4.00 24.00\n\n1251\n\nKwame Reyes\n\nCorps Dancer 1 2 2 5 4.00 20.00","pages":[{"line_numbers":[],"markdown":"Dancing Crew\n\nFebruary 2027\n\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28\n\nTotal Hours\n\nRate Total\n\nEmployee Id Other\n\nEmployee Name Category\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\n**Main Crew**\n\n1234 Jane Doe\n\nSecond Dancer 2 2 1 5 2.00 10.00\n\n1236 Mia Chen\n\nFirst Dancer 1 1 1 2 1 1 1 1 1 1 11 4.00 44.00\n\n1237\n\nJamal Williams\n\nLead Dancer 1 1 1 1 1 1 1 7 5.00 35.00\n\n1242\n\nSasha Volkov\n\nFeatured Dancer 1 3 1 3 1 6 1 16 3.00 48.00\n\n1243 Toby Park\n\nFeatured Dancer 1 3 1 1 1 7 4.00 28.00\n\n1245\n\nMarcus Thompson\n\nFirst Dancer 2 1 1 1 1 3 1 1 1 1 13 2.00 26.00\n\n1249\n\nFelix Lindberg\n\nFeatured Dancer 1 1 1 3 6 1 13 3.00 39.00\n\n1250\n\nRina Okafor\n\nLead Dancer 3 3 1 1 8 2.00 16.00\n\n1253\n\nDante Novak\n\nSecond Dancer 1 1 6 1 1 10 5.00 50.00\n\n1256 Ravi Gupta\n\nSecond Dancer 2 1 1 2 6 3.00 18.00\n\n1258\n\nTariq Hassan\n\nSecond Dancer 1 2 1 1 1 3 6 6 2 23 2.00 46.00\n\n1262 Leo Costa\n\nFeatured Dancer 2 1 1 2 1 1 1 6 1 16 2.00 32.00\n\n1263 Freya Berg\n\nFirst Dancer 2 3 1 6 4.00 24.00\n\n1265\n\nCeleste Torres\n\nLead Dancer 2 2 1 5 5.00 25.00\n\n1267\n\nMaeve Brennan\n\nFirst Dancer 1 1 3 2 1 2 10 4.00 40.00\n\n1270 Ezra Stein\n\nFeatured Dancer 1 2 1 2 3 9 2.00 18.00\n\n**Staffers**\n\n1235\n\nCarlos Rivera\n\nCorps Dancer 1 2 1 4 3.00 12.00\n\n1239\n\nKenji Tanaka\n\nCorps Dancer 3 1 2 1 1 1 9 3.00 27.00\n\n1241\n\nDiego Morales\n\nCorps Dancer 1 1 1 1 1 5 5.00 25.00\n\n1244\n\nLuna Santos\n\nBackup Dancer 1 1 1 3 3.00 9.00\n\n1246\n\nZara Ahmed\n\nBackup Dancer 1 1 3 5 5.00 25.00\n\n1247\n\nAndre Dubois\n\nCorps Dancer 2 1 1 1 1 6 4.00 24.00\n\n1251\n\nKwame Reyes\n\nCorps Dancer 1 2 2 5 4.00 20.00","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Dancing Crew\n\nFebruary 2027\n\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28\n\nTotal Hours\n\nRate Total\n\nEmployee Id Other\n\nEmployee Name Category\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\n**Main Crew**\n\n1234 Jane Doe\n\nSecond Dancer 2 2 1 5 2.00 10.00\n\n1236 Mia Chen\n\nFirst Dancer 1 1 1 2 1 1 1 1 1 1 11 4.00 44.00\n\n1237\n\nJamal Williams\n\nLead Dancer 1 1 1 1 1 1 1 7 5.00 35.00\n\n1242\n\nSasha Volkov\n\nFeatured Dancer 1 3 1 3 1 6 1 16 3.00 48.00\n\n1243 Toby Park\n\nFeatured Dancer 1 3 1 1 1 7 4.00 28.00\n\n1245\n\nMarcus Thompson\n\nFirst Dancer 2 1 1 1 1 3 1 1 1 1 13 2.00 26.00\n\n1249\n\nFelix Lindberg\n\nFeatured Dancer 1 1 1 3 6 1 13 3.00 39.00\n\n1250\n\nRina Okafor\n\nLead Dancer 3 3 1 1 8 2.00 16.00\n\n1253\n\nDante Novak\n\nSecond Dancer 1 1 6 1 1 10 5.00 50.00\n\n1256 Ravi Gupta\n\nSecond Dancer 2 1 1 2 6 3.00 18.00\n\n1258\n\nTariq Hassan\n\nSecond Dancer 1 2 1 1 1 3 6 6 2 23 2.00 46.00\n\n1262 Leo Costa\n\nFeatured Dancer 2 1 1 2 1 1 1 6 1 16 2.00 32.00\n\n1263 Freya Berg\n\nFirst Dancer 2 3 1 6 4.00 24.00\n\n1265\n\nCeleste Torres\n\nLead Dancer 2 2 1 5 5.00 25.00\n\n1267\n\nMaeve Brennan\n\nFirst Dancer 1 1 3 2 1 2 10 4.00 40.00\n\n1270 Ezra Stein\n\nFeatured Dancer 1 2 1 2 3 9 2.00 18.00\n\n**Staffers**\n\n1235\n\nCarlos Rivera\n\nCorps Dancer 1 2 1 4 3.00 12.00\n\n1239\n\nKenji Tanaka\n\nCorps Dancer 3 1 2 1 1 1 9 3.00 27.00\n\n1241\n\nDiego Morales\n\nCorps Dancer 1 1 1 1 1 5 5.00 25.00\n\n1244\n\nLuna Santos\n\nBackup Dancer 1 1 1 3 3.00 9.00\n\n1246\n\nZara Ahmed\n\nBackup Dancer 1 1 3 5 5.00 25.00\n\n1247\n\nAndre Dubois\n\nCorps Dancer 2 1 1 1 1 6 4.00 24.00\n\n1251\n\nKwame Reyes\n\nCorps Dancer 1 2 2 5 4.00 20.00","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_invoice_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_3c79db68fbdaef6fdf83a4eeb48bdaa2","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Dancing Crew\n\nFebruary 2027\n\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28\n\nTotal Hours\n\nRate Total\n\nEmployee Id Other\n\nEmployee Name Category\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\n**Main Crew**\n\n1234 Jane Doe\n\nSecond Dancer 2 2 1 5 2.00 10.00\n\n1236 Mia Chen\n\nFirst Dancer 1 1 1 2 1 1 1 1 1 1 11 4.00 44.00\n\n1237\n\nJamal Williams\n\nLead Dancer 1 1 1 1 1 1 1 7 5.00 35.00\n\n1242\n\nSasha Volkov\n\nFeatured Dancer 1 3 1 3 1 6 1 16 3.00 48.00\n\n1243 Toby Park\n\nFeatured Dancer 1 3 1 1 1 7 4.00 28.00\n\n1245\n\nMarcus Thompson\n\nFirst Dancer 2 1 1 1 1 3 1 1 1 1 13 2.00 26.00\n\n1249\n\nFelix Lindberg\n\nFeatured Dancer 1 1 1 3 6 1 13 3.00 39.00\n\n1250\n\nRina Okafor\n\nLead Dancer 3 3 1 1 8 2.00 16.00\n\n1253\n\nDante Novak\n\nSecond Dancer 1 1 6 1 1 10 5.00 50.00\n\n1256 Ravi Gupta\n\nSecond Dancer 2 1 1 2 6 3.00 18.00\n\n1258\n\nTariq Hassan\n\nSecond Dancer 1 2 1 1 1 3 6 6 2 23 2.00 46.00\n\n1262 Leo Costa\n\nFeatured Dancer 2 1 1 2 1 1 1 6 1 16 2.00 32.00\n\n1263 Freya Berg\n\nFirst Dancer 2 3 1 6 4.00 24.00\n\n1265\n\nCeleste Torres\n\nLead Dancer 2 2 1 5 5.00 25.00\n\n1267\n\nMaeve Brennan\n\nFirst Dancer 1 1 3 2 1 2 10 4.00 40.00\n\n1270 Ezra Stein\n\nFeatured Dancer 1 2 1 2 3 9 2.00 18.00\n\n**Staffers**\n\n1235\n\nCarlos Rivera\n\nCorps Dancer 1 2 1 4 3.00 12.00\n\n1239\n\nKenji Tanaka\n\nCorps Dancer 3 1 2 1 1 1 9 3.00 27.00\n\n1241\n\nDiego Morales\n\nCorps Dancer 1 1 1 1 1 5 5.00 25.00\n\n1244\n\nLuna Santos\n\nBackup Dancer 1 1 1 3 3.00 9.00\n\n1246\n\nZara Ahmed\n\nBackup Dancer 1 1 3 5 5.00 25.00\n\n1247\n\nAndre Dubois\n\nCorps Dancer 2 1 1 1 1 6 4.00 24.00\n\n1251\n\nKwame Reyes\n\nCorps Dancer 1 2 2 5 4.00 20.00"],"full_content":"Dancing Crew\n\nFebruary 2027\n\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28\n\nTotal Hours\n\nRate Total\n\nEmployee Id Other\n\nEmployee Name Category\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\nMon\n\nTue\n\nWed\n\nThu\n\nFri\n\nSat\n\nSun\n\n**Main Crew**\n\n1234 Jane Doe\n\nSecond Dancer 2 2 1 5 2.00 10.00\n\n1236 Mia Chen\n\nFirst Dancer 1 1 1 2 1 1 1 1 1 1 11 4.00 44.00\n\n1237\n\nJamal Williams\n\nLead Dancer 1 1 1 1 1 1 1 7 5.00 35.00\n\n1242\n\nSasha Volkov\n\nFeatured Dancer 1 3 1 3 1 6 1 16 3.00 48.00\n\n1243 Toby Park\n\nFeatured Dancer 1 3 1 1 1 7 4.00 28.00\n\n1245\n\nMarcus Thompson\n\nFirst Dancer 2 1 1 1 1 3 1 1 1 1 13 2.00 26.00\n\n1249\n\nFelix Lindberg\n\nFeatured Dancer 1 1 1 3 6 1 13 3.00 39.00\n\n1250\n\nRina Okafor\n\nLead Dancer 3 3 1 1 8 2.00 16.00\n\n1253\n\nDante Novak\n\nSecond Dancer 1 1 6 1 1 10 5.00 50.00\n\n1256 Ravi Gupta\n\nSecond Dancer 2 1 1 2 6 3.00 18.00\n\n1258\n\nTariq Hassan\n\nSecond Dancer 1 2 1 1 1 3 6 6 2 23 2.00 46.00\n\n1262 Leo Costa\n\nFeatured Dancer 2 1 1 2 1 1 1 6 1 16 2.00 32.00\n\n1263 Freya Berg\n\nFirst Dancer 2 3 1 6 4.00 24.00\n\n1265\n\nCeleste Torres\n\nLead Dancer 2 2 1 5 5.00 25.00\n\n1267\n\nMaeve Brennan\n\nFirst Dancer 1 1 3 2 1 2 10 4.00 40.00\n\n1270 Ezra Stein\n\nFeatured Dancer 1 2 1 2 3 9 2.00 18.00\n\n**Staffers**\n\n1235\n\nCarlos Rivera\n\nCorps Dancer 1 2 1 4 3.00 12.00\n\n1239\n\nKenji Tanaka\n\nCorps Dancer 3 1 2 1 1 1 9 3.00 27.00\n\n1241\n\nDiego Morales\n\nCorps Dancer 1 1 1 1 1 5 5.00 25.00\n\n1244\n\nLuna Santos\n\nBackup Dancer 1 1 1 3 3.00 9.00\n\n1246\n\nZara Ahmed\n\nBackup Dancer 1 1 3 5 5.00 25.00\n\n1247\n\nAndre Dubois\n\nCorps Dancer 2 1 1 1 1 6 4.00 24.00\n\n1251\n\nKwame Reyes\n\nCorps Dancer 1 2 2 5 4.00 20.00","publish_date":null,"title":"February 2027 Total Rate Total Dancing Crew Hours 1 2 3 4 5 6 7 8 9 10 11 12","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_invoice_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_invoice_page1.pdf"},"request":{"example_id":"table/synthetic_invoice_page1","product_type":"parse","source_file_path":"synthetic_invoice_page1.pdf"},"started_at":"2026-11-04T19:47:34.866886"} +{"completed_at":"2026-11-04T19:47:37.003201","latency_in_ms":985,"output":{"example_id":"table/synthetic_invoice_page2","grounded_pages":[],"layout_pages":[],"markdown":"1252 Elise Kim\n\nBackup Dancer 1 1 1 1 1 3 8 3.00 24.00\n\n1255\n\nBianca Rossi\n\nBackup Dancer 2 3 6 1 2 1 15 4.00 60.00\n\n1259\n\nIsla Murphy\n\nBackup Dancer 2 2 1 5 4.00 20.00\n\n1264\n\nOmar Nakamura\n\nBackup Dancer 1 6 2 1 3 1 1 1 1 17 3.00 51.00\n\n1266 Jax Singh\n\nCorps Dancer 3 1 1 2 1 2 10 2.00 20.00\n\n1271\n\nLina Mendez\n\nCorps Dancer 1 1 1 1 1 1 1 1 1 3 12 4.00 48.00\n\n**Substitutes**\n\n1238 Priya Patel\n\nUnderstud y 1 1 1 2 2 2 1 6 16 4.00 64.00\n\n1240\n\nAaliyah Jackson\n\nSwing Dancer 1 1 1 6 2 1 1 13 2.00 26.00\n\n1248\n\nNadia Kowalski\n\nSwing Dancer 3 2 1 6 5.00 30.00\n\n1254\n\nYuki Fischer\n\nUnderstud y 2 1 1 6 1 1 6 2 20 2.00 40.00\n\n1257\n\nSimone Laurent\n\nSwing Dancer 3 1 2 1 2 3 1 1 1 1 16 5.00 80.00\n\n1260\n\nNico Petrov\n\nUnderstud y 1 3 1 1 1 7 3.00 21.00\n\n1261\n\nAmara Diallo\n\nSwing Dancer 3 6 1 10 5.00 50.00\n\n1268\n\nKai Yamamoto\n\nSwing Dancer 1 1 1 3 3 2 11 3.00 33.00\n\n1269\n\nVera Monroe\n\nUnderstud y 6 2 2 3 1 14 5.00 70.00\n\n**Other** 0\\.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00","pages":[{"line_numbers":[],"markdown":"1252 Elise Kim\n\nBackup Dancer 1 1 1 1 1 3 8 3.00 24.00\n\n1255\n\nBianca Rossi\n\nBackup Dancer 2 3 6 1 2 1 15 4.00 60.00\n\n1259\n\nIsla Murphy\n\nBackup Dancer 2 2 1 5 4.00 20.00\n\n1264\n\nOmar Nakamura\n\nBackup Dancer 1 6 2 1 3 1 1 1 1 17 3.00 51.00\n\n1266 Jax Singh\n\nCorps Dancer 3 1 1 2 1 2 10 2.00 20.00\n\n1271\n\nLina Mendez\n\nCorps Dancer 1 1 1 1 1 1 1 1 1 3 12 4.00 48.00\n\n**Substitutes**\n\n1238 Priya Patel\n\nUnderstud y 1 1 1 2 2 2 1 6 16 4.00 64.00\n\n1240\n\nAaliyah Jackson\n\nSwing Dancer 1 1 1 6 2 1 1 13 2.00 26.00\n\n1248\n\nNadia Kowalski\n\nSwing Dancer 3 2 1 6 5.00 30.00\n\n1254\n\nYuki Fischer\n\nUnderstud y 2 1 1 6 1 1 6 2 20 2.00 40.00\n\n1257\n\nSimone Laurent\n\nSwing Dancer 3 1 2 1 2 3 1 1 1 1 16 5.00 80.00\n\n1260\n\nNico Petrov\n\nUnderstud y 1 3 1 1 1 7 3.00 21.00\n\n1261\n\nAmara Diallo\n\nSwing Dancer 3 6 1 10 5.00 50.00\n\n1268\n\nKai Yamamoto\n\nSwing Dancer 1 1 1 3 3 2 11 3.00 33.00\n\n1269\n\nVera Monroe\n\nUnderstud y 6 2 2 3 1 14 5.00 70.00\n\n**Other** 0\\.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"1252 Elise Kim\n\nBackup Dancer 1 1 1 1 1 3 8 3.00 24.00\n\n1255\n\nBianca Rossi\n\nBackup Dancer 2 3 6 1 2 1 15 4.00 60.00\n\n1259\n\nIsla Murphy\n\nBackup Dancer 2 2 1 5 4.00 20.00\n\n1264\n\nOmar Nakamura\n\nBackup Dancer 1 6 2 1 3 1 1 1 1 17 3.00 51.00\n\n1266 Jax Singh\n\nCorps Dancer 3 1 1 2 1 2 10 2.00 20.00\n\n1271\n\nLina Mendez\n\nCorps Dancer 1 1 1 1 1 1 1 1 1 3 12 4.00 48.00\n\n**Substitutes**\n\n1238 Priya Patel\n\nUnderstud y 1 1 1 2 2 2 1 6 16 4.00 64.00\n\n1240\n\nAaliyah Jackson\n\nSwing Dancer 1 1 1 6 2 1 1 13 2.00 26.00\n\n1248\n\nNadia Kowalski\n\nSwing Dancer 3 2 1 6 5.00 30.00\n\n1254\n\nYuki Fischer\n\nUnderstud y 2 1 1 6 1 1 6 2 20 2.00 40.00\n\n1257\n\nSimone Laurent\n\nSwing Dancer 3 1 2 1 2 3 1 1 1 1 16 5.00 80.00\n\n1260\n\nNico Petrov\n\nUnderstud y 1 3 1 1 1 7 3.00 21.00\n\n1261\n\nAmara Diallo\n\nSwing Dancer 3 6 1 10 5.00 50.00\n\n1268\n\nKai Yamamoto\n\nSwing Dancer 1 1 1 3 3 2 11 3.00 33.00\n\n1269\n\nVera Monroe\n\nUnderstud y 6 2 2 3 1 14 5.00 70.00\n\n**Other** 0\\.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_invoice_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_e268a290b11daffff9b80d2c0397395e","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["1252 Elise Kim\n\nBackup Dancer 1 1 1 1 1 3 8 3.00 24.00\n\n1255\n\nBianca Rossi\n\nBackup Dancer 2 3 6 1 2 1 15 4.00 60.00\n\n1259\n\nIsla Murphy\n\nBackup Dancer 2 2 1 5 4.00 20.00\n\n1264\n\nOmar Nakamura\n\nBackup Dancer 1 6 2 1 3 1 1 1 1 17 3.00 51.00\n\n1266 Jax Singh\n\nCorps Dancer 3 1 1 2 1 2 10 2.00 20.00\n\n1271\n\nLina Mendez\n\nCorps Dancer 1 1 1 1 1 1 1 1 1 3 12 4.00 48.00\n\n**Substitutes**\n\n1238 Priya Patel\n\nUnderstud y 1 1 1 2 2 2 1 6 16 4.00 64.00\n\n1240\n\nAaliyah Jackson\n\nSwing Dancer 1 1 1 6 2 1 1 13 2.00 26.00\n\n1248\n\nNadia Kowalski\n\nSwing Dancer 3 2 1 6 5.00 30.00\n\n1254\n\nYuki Fischer\n\nUnderstud y 2 1 1 6 1 1 6 2 20 2.00 40.00\n\n1257\n\nSimone Laurent\n\nSwing Dancer 3 1 2 1 2 3 1 1 1 1 16 5.00 80.00\n\n1260\n\nNico Petrov\n\nUnderstud y 1 3 1 1 1 7 3.00 21.00\n\n1261\n\nAmara Diallo\n\nSwing Dancer 3 6 1 10 5.00 50.00\n\n1268\n\nKai Yamamoto\n\nSwing Dancer 1 1 1 3 3 2 11 3.00 33.00\n\n1269\n\nVera Monroe\n\nUnderstud y 6 2 2 3 1 14 5.00 70.00\n\n**Other** 0\\.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00"],"full_content":"1252 Elise Kim\n\nBackup Dancer 1 1 1 1 1 3 8 3.00 24.00\n\n1255\n\nBianca Rossi\n\nBackup Dancer 2 3 6 1 2 1 15 4.00 60.00\n\n1259\n\nIsla Murphy\n\nBackup Dancer 2 2 1 5 4.00 20.00\n\n1264\n\nOmar Nakamura\n\nBackup Dancer 1 6 2 1 3 1 1 1 1 17 3.00 51.00\n\n1266 Jax Singh\n\nCorps Dancer 3 1 1 2 1 2 10 2.00 20.00\n\n1271\n\nLina Mendez\n\nCorps Dancer 1 1 1 1 1 1 1 1 1 3 12 4.00 48.00\n\n**Substitutes**\n\n1238 Priya Patel\n\nUnderstud y 1 1 1 2 2 2 1 6 16 4.00 64.00\n\n1240\n\nAaliyah Jackson\n\nSwing Dancer 1 1 1 6 2 1 1 13 2.00 26.00\n\n1248\n\nNadia Kowalski\n\nSwing Dancer 3 2 1 6 5.00 30.00\n\n1254\n\nYuki Fischer\n\nUnderstud y 2 1 1 6 1 1 6 2 20 2.00 40.00\n\n1257\n\nSimone Laurent\n\nSwing Dancer 3 1 2 1 2 3 1 1 1 1 16 5.00 80.00\n\n1260\n\nNico Petrov\n\nUnderstud y 1 3 1 1 1 7 3.00 21.00\n\n1261\n\nAmara Diallo\n\nSwing Dancer 3 6 1 10 5.00 50.00\n\n1268\n\nKai Yamamoto\n\nSwing Dancer 1 1 1 3 3 2 11 3.00 33.00\n\n1269\n\nVera Monroe\n\nUnderstud y 6 2 2 3 1 14 5.00 70.00\n\n**Other** 0\\.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00\n\n0 0.00 0.00","publish_date":null,"title":"Backup 1252 Elise Kim 1 1 1 1 1 3 8 3.00 24.00 Dancer Bianca Backup 1255 2 3 6","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_invoice_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_invoice_page2.pdf"},"request":{"example_id":"table/synthetic_invoice_page2","product_type":"parse","source_file_path":"synthetic_invoice_page2.pdf"},"started_at":"2026-11-04T19:47:36.017293"} +{"completed_at":"2026-11-04T19:47:37.853615","latency_in_ms":974,"output":{"example_id":"table/synthetic_page81_detached_cells_page1","grounded_pages":[],"layout_pages":[],"markdown":"**Category Alpha**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.4% 1.2% 1.6% 75.0%\n\n(2) Facility Overhead 2.1% 6.3% 8.4% 75.0%\n\n(3) Channel Fees 13.8% 0.0% 13.8% 0.0%\n\n(4) Statutory Levies 2.9% 0.0% 2.9% 0.0%\n\n(5) Evaluation & Closure Costs 0.0% 4.6% 4.6% 100.0%\n\n(6) Residual Margin 2.3% 0.0% 2.3% 0.0%\n\n**(7) Aggregate Flex Charges 21.5% 12.1% 33.6%**\n\n**(8) Benchmark Direct Cost Ratio 66.4%**\n\n**Category Beta**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.6% 0.6% 1.2% 50.0%\n\n(2) Facility Overhead 0.0% 8.1% 8.1% 100.0%\n\n(3) Channel Fees 17.2% 0.3% 17.5% 1.7%\n\n(4) Statutory Levies 3.6% 0.0% 3.6% 0.0%\n\n(5) Evaluation & Closure Costs 1.1% 9.3% 10.4% 89.4%\n\n(6) Residual Margin 1.4% 0.0% 1.4% 0.0%\n\n**(7) Aggregate Flex Charges 23.9% 18.3% 42.2%**\n\n**(8) Benchmark Direct Cost Ratio 57.8%**\n\n**Category Gamma**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.0% 1.8% 1.8% 100.0%\n\n(2) Facility Overhead 2.8% 4.2% 7.0% 60.0%\n\n(3) Channel Fees 11.5% 0.0% 11.5% 0.0%\n\n(4) Statutory Levies 2.5% 0.4% 2.9% 13.8%\n\n(5) Evaluation & Closure Costs 0.0% 3.1% 3.1% 100.0%\n\n(6) Residual Margin 3.9% 0.0% 3.9% 0.0%\n\n**(7) Aggregate Flex Charges 20.7% 9.5% 30.2%**\n\n**(8) Benchmark Direct Cost Ratio 69.8%**","pages":[{"line_numbers":[],"markdown":"**Category Alpha**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.4% 1.2% 1.6% 75.0%\n\n(2) Facility Overhead 2.1% 6.3% 8.4% 75.0%\n\n(3) Channel Fees 13.8% 0.0% 13.8% 0.0%\n\n(4) Statutory Levies 2.9% 0.0% 2.9% 0.0%\n\n(5) Evaluation & Closure Costs 0.0% 4.6% 4.6% 100.0%\n\n(6) Residual Margin 2.3% 0.0% 2.3% 0.0%\n\n**(7) Aggregate Flex Charges 21.5% 12.1% 33.6%**\n\n**(8) Benchmark Direct Cost Ratio 66.4%**\n\n**Category Beta**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.6% 0.6% 1.2% 50.0%\n\n(2) Facility Overhead 0.0% 8.1% 8.1% 100.0%\n\n(3) Channel Fees 17.2% 0.3% 17.5% 1.7%\n\n(4) Statutory Levies 3.6% 0.0% 3.6% 0.0%\n\n(5) Evaluation & Closure Costs 1.1% 9.3% 10.4% 89.4%\n\n(6) Residual Margin 1.4% 0.0% 1.4% 0.0%\n\n**(7) Aggregate Flex Charges 23.9% 18.3% 42.2%**\n\n**(8) Benchmark Direct Cost Ratio 57.8%**\n\n**Category Gamma**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.0% 1.8% 1.8% 100.0%\n\n(2) Facility Overhead 2.8% 4.2% 7.0% 60.0%\n\n(3) Channel Fees 11.5% 0.0% 11.5% 0.0%\n\n(4) Statutory Levies 2.5% 0.4% 2.9% 13.8%\n\n(5) Evaluation & Closure Costs 0.0% 3.1% 3.1% 100.0%\n\n(6) Residual Margin 3.9% 0.0% 3.9% 0.0%\n\n**(7) Aggregate Flex Charges 20.7% 9.5% 30.2%**\n\n**(8) Benchmark Direct Cost Ratio 69.8%**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**Category Alpha**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.4% 1.2% 1.6% 75.0%\n\n(2) Facility Overhead 2.1% 6.3% 8.4% 75.0%\n\n(3) Channel Fees 13.8% 0.0% 13.8% 0.0%\n\n(4) Statutory Levies 2.9% 0.0% 2.9% 0.0%\n\n(5) Evaluation & Closure Costs 0.0% 4.6% 4.6% 100.0%\n\n(6) Residual Margin 2.3% 0.0% 2.3% 0.0%\n\n**(7) Aggregate Flex Charges 21.5% 12.1% 33.6%**\n\n**(8) Benchmark Direct Cost Ratio 66.4%**\n\n**Category Beta**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.6% 0.6% 1.2% 50.0%\n\n(2) Facility Overhead 0.0% 8.1% 8.1% 100.0%\n\n(3) Channel Fees 17.2% 0.3% 17.5% 1.7%\n\n(4) Statutory Levies 3.6% 0.0% 3.6% 0.0%\n\n(5) Evaluation & Closure Costs 1.1% 9.3% 10.4% 89.4%\n\n(6) Residual Margin 1.4% 0.0% 1.4% 0.0%\n\n**(7) Aggregate Flex Charges 23.9% 18.3% 42.2%**\n\n**(8) Benchmark Direct Cost Ratio 57.8%**\n\n**Category Gamma**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.0% 1.8% 1.8% 100.0%\n\n(2) Facility Overhead 2.8% 4.2% 7.0% 60.0%\n\n(3) Channel Fees 11.5% 0.0% 11.5% 0.0%\n\n(4) Statutory Levies 2.5% 0.4% 2.9% 13.8%\n\n(5) Evaluation & Closure Costs 0.0% 3.1% 3.1% 100.0%\n\n(6) Residual Margin 3.9% 0.0% 3.9% 0.0%\n\n**(7) Aggregate Flex Charges 20.7% 9.5% 30.2%**\n\n**(8) Benchmark Direct Cost Ratio 69.8%**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_page81_detached_cells_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_50af4c3e4ea748c7589bc03ee6b7e5fe","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**Category Alpha**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.4% 1.2% 1.6% 75.0%\n\n(2) Facility Overhead 2.1% 6.3% 8.4% 75.0%\n\n(3) Channel Fees 13.8% 0.0% 13.8% 0.0%\n\n(4) Statutory Levies 2.9% 0.0% 2.9% 0.0%\n\n(5) Evaluation & Closure Costs 0.0% 4.6% 4.6% 100.0%\n\n(6) Residual Margin 2.3% 0.0% 2.3% 0.0%\n\n**(7) Aggregate Flex Charges 21.5% 12.1% 33.6%**\n\n**(8) Benchmark Direct Cost Ratio 66.4%**\n\n**Category Beta**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.6% 0.6% 1.2% 50.0%\n\n(2) Facility Overhead 0.0% 8.1% 8.1% 100.0%\n\n(3) Channel Fees 17.2% 0.3% 17.5% 1.7%\n\n(4) Statutory Levies 3.6% 0.0% 3.6% 0.0%\n\n(5) Evaluation & Closure Costs 1.1% 9.3% 10.4% 89.4%\n\n(6) Residual Margin 1.4% 0.0% 1.4% 0.0%\n\n**(7) Aggregate Flex Charges 23.9% 18.3% 42.2%**\n\n**(8) Benchmark Direct Cost Ratio 57.8%**\n\n**Category Gamma**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.0% 1.8% 1.8% 100.0%\n\n(2) Facility Overhead 2.8% 4.2% 7.0% 60.0%\n\n(3) Channel Fees 11.5% 0.0% 11.5% 0.0%\n\n(4) Statutory Levies 2.5% 0.4% 2.9% 13.8%\n\n(5) Evaluation & Closure Costs 0.0% 3.1% 3.1% 100.0%\n\n(6) Residual Margin 3.9% 0.0% 3.9% 0.0%\n\n**(7) Aggregate Flex Charges 20.7% 9.5% 30.2%**\n\n**(8) Benchmark Direct Cost Ratio 69.8%**"],"full_content":"**Category Alpha**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.4% 1.2% 1.6% 75.0%\n\n(2) Facility Overhead 2.1% 6.3% 8.4% 75.0%\n\n(3) Channel Fees 13.8% 0.0% 13.8% 0.0%\n\n(4) Statutory Levies 2.9% 0.0% 2.9% 0.0%\n\n(5) Evaluation & Closure Costs 0.0% 4.6% 4.6% 100.0%\n\n(6) Residual Margin 2.3% 0.0% 2.3% 0.0%\n\n**(7) Aggregate Flex Charges 21.5% 12.1% 33.6%**\n\n**(8) Benchmark Direct Cost Ratio 66.4%**\n\n**Category Beta**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.6% 0.6% 1.2% 50.0%\n\n(2) Facility Overhead 0.0% 8.1% 8.1% 100.0%\n\n(3) Channel Fees 17.2% 0.3% 17.5% 1.7%\n\n(4) Statutory Levies 3.6% 0.0% 3.6% 0.0%\n\n(5) Evaluation & Closure Costs 1.1% 9.3% 10.4% 89.4%\n\n(6) Residual Margin 1.4% 0.0% 1.4% 0.0%\n\n**(7) Aggregate Flex Charges 23.9% 18.3% 42.2%**\n\n**(8) Benchmark Direct Cost Ratio 57.8%**\n\n**Category Gamma**\n\n**Flex Alloc**\n\n**Steady Alloc**\n\n**Combined**\n\n**Alloc %**\n\n(1) Sourcing & Collection Costs 0.0% 1.8% 1.8% 100.0%\n\n(2) Facility Overhead 2.8% 4.2% 7.0% 60.0%\n\n(3) Channel Fees 11.5% 0.0% 11.5% 0.0%\n\n(4) Statutory Levies 2.5% 0.4% 2.9% 13.8%\n\n(5) Evaluation & Closure Costs 0.0% 3.1% 3.1% 100.0%\n\n(6) Residual Margin 3.9% 0.0% 3.9% 0.0%\n\n**(7) Aggregate Flex Charges 20.7% 9.5% 30.2%**\n\n**(8) Benchmark Direct Cost Ratio 69.8%**","publish_date":null,"title":"Category Alpha Category Beta Category Gamma","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_page81_detached_cells_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/synthetic_page81_detached_cells_page1.pdf"},"request":{"example_id":"table/synthetic_page81_detached_cells_page1","product_type":"parse","source_file_path":"synthetic_page81_detached_cells_page1.pdf"},"started_at":"2026-11-04T19:47:36.878829"} +{"completed_at":"2026-11-04T19:47:40.930526","latency_in_ms":3011,"output":{"example_id":"table/tabular_2_page2","grounded_pages":[],"layout_pages":[],"markdown":"**NACIONAL II NACIONAL III NACIONAL PLUS PREMIUM**\n\n**ENFERMARIA QUARTO ENFERMARIA QUARTO ENFERMARIA QUARTO ENFERMARIA QUARTO QUARTO QUARTO**\n\n**H = Hospital** l **P.S = Pronto Socorro** l **M = Maternidade** l **A = Ambulatório** l **HDIA = Hospital Dia**\n\n**CIDADE NOME DO REFERENCIADO**\n\n**EFETIVO FLEX IDEAL**\n\n# **Lista de hospitais por linha de planos**\n\n### Referência: agosto/2025\n\nCACAPAVA HOSPITAL POLICLIN **H/P.S/M/A H/P.S/M/A H/P.S/M H/P.S/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCAFELANDIA SANTA CASA DE CAFELANDIA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCAIEIRAS HOSPITAL DE CLINICAS CAIEIRAS **H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nCAJURU CASA DE CARIDADE S VICENTE DE PAULO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL RENASCENCA CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCTO IN INV HEM D A BOLDRINI **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nFUNDACAO CENTRO MEDICO DE CAMPINAS **H/P.S/A H/P.S/A H/P.S H/P.S**\n\nCAMPINAS DAY HOSPITAL **H/A H/A H/A H/A**\n\nCASA DE SAUDE **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nHOSPITAL BENEF PORTUGUESA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nHOSPITAL DO CORACAO DE CAMPINAS **H/A H/A H/A H/A H/A H/A H/A H/A**\n\nHOSPITAL SANTA TEREZA **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL SAO LUIZ CAMPINAS **H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nHOSPITAL SAO LUIZ CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL VERA CRUZ **H/M H/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nIRMANDADE MIS CAMPINAS **H/A H/A H/A H/A H/A H/A H/A H/A**\n\nHOSP E MAT CELSO PIERRO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nINST DO RADIUM DE CAMPINAS **HDIA HDIA HDIA HDIA HDIA HDIA**\n\nUNIDADE HOSP GERAL E MATER MADRE M THEODORA **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nMATERNIDADE DE CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSP EV SAMARITANO CAMPINAS **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCAMPOS DO JORDAO HOSP LEONOR MENDES DE BARROS **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCAPAO BONITO STA CASA MIS DE CAPAO BONITO **H/M H/M H/M H/M H/M H/M H/M H/M H/M H/M**\n\nHOSPITAL UNIMED **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nSTA CASA DE MIS DE CAPIVARI **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCASA DE SAUDE STELLA MARIS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCENTRO MEDICO SAO CAMILO **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCARAPICUIBA HOSPITAL CENTRAL OESTE **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCARDOSO SANTA DE CARDOSO **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCASA BRANCA STA CASA MIS DE CASA BRANCA **H/P.S/M H/P.S/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nDR RONALDO H NAMI **HDIA HDIA HDIA HDIA**\n\nHOSPITAL PADRE ALBINO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL MAHATMA GANDHI **H H H H H H H H**\n\nUNIMED HOSPITAL SAO DOMINGOS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCERQUEIRA CESAR STA C MIS CERQUEIRA CESAR **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCERQUILHO STA CASA DE MIS DE CERQUILHO **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nCLEMENTINA ASSOC HOSPITALAR CLEMENTINA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCOLINA SOC FIL HOSP JOSE VENANCIO **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCOSMOPOLIS HOSP BENEF STA GERTRUDES **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nHOSPITAL SAO FRANCISCO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCPR MULHERES **H/P.S H/P.S H/A H/A H/A H/A H/P.S/A H/P.S/A**\n\nCRAVINHOS SOC BEN CRAVINHOS STA CASA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nCRUZEIRO STA CASA DE MIS DE CRUZEIRO **H/M H/M H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nCUBATAO HOSPITAL ANA COSTA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nDESCALVADO IRMANDADE STA CASA MISERICORDIA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nDIADEMA INNOVA HOSPITAIS **H/P.S/A H/P.S/A H/P.S H/P.S H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nDRACENA SANTA CASA DE DRACENA **H H**\n\nCARAGUATATUBA\n\nCAPIVARI\n\nCAMPINAS\n\nCOTIA\n\nCATANDUVA\n\n### Para consultar as especialidades habilitadas em cada uma das modalidades de atendimento (H/P.S/M/A/HDIA), acesse: bradescosaude.com.br > Busca de referenciados","pages":[{"line_numbers":[],"markdown":"**NACIONAL II NACIONAL III NACIONAL PLUS PREMIUM**\n\n**ENFERMARIA QUARTO ENFERMARIA QUARTO ENFERMARIA QUARTO ENFERMARIA QUARTO QUARTO QUARTO**\n\n**H = Hospital** l **P.S = Pronto Socorro** l **M = Maternidade** l **A = Ambulatório** l **HDIA = Hospital Dia**\n\n**CIDADE NOME DO REFERENCIADO**\n\n**EFETIVO FLEX IDEAL**\n\n# **Lista de hospitais por linha de planos**\n\n### Referência: agosto/2025\n\nCACAPAVA HOSPITAL POLICLIN **H/P.S/M/A H/P.S/M/A H/P.S/M H/P.S/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCAFELANDIA SANTA CASA DE CAFELANDIA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCAIEIRAS HOSPITAL DE CLINICAS CAIEIRAS **H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nCAJURU CASA DE CARIDADE S VICENTE DE PAULO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL RENASCENCA CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCTO IN INV HEM D A BOLDRINI **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nFUNDACAO CENTRO MEDICO DE CAMPINAS **H/P.S/A H/P.S/A H/P.S H/P.S**\n\nCAMPINAS DAY HOSPITAL **H/A H/A H/A H/A**\n\nCASA DE SAUDE **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nHOSPITAL BENEF PORTUGUESA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nHOSPITAL DO CORACAO DE CAMPINAS **H/A H/A H/A H/A H/A H/A H/A H/A**\n\nHOSPITAL SANTA TEREZA **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL SAO LUIZ CAMPINAS **H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nHOSPITAL SAO LUIZ CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL VERA CRUZ **H/M H/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nIRMANDADE MIS CAMPINAS **H/A H/A H/A H/A H/A H/A H/A H/A**\n\nHOSP E MAT CELSO PIERRO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nINST DO RADIUM DE CAMPINAS **HDIA HDIA HDIA HDIA HDIA HDIA**\n\nUNIDADE HOSP GERAL E MATER MADRE M THEODORA **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nMATERNIDADE DE CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSP EV SAMARITANO CAMPINAS **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCAMPOS DO JORDAO HOSP LEONOR MENDES DE BARROS **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCAPAO BONITO STA CASA MIS DE CAPAO BONITO **H/M H/M H/M H/M H/M H/M H/M H/M H/M H/M**\n\nHOSPITAL UNIMED **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nSTA CASA DE MIS DE CAPIVARI **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCASA DE SAUDE STELLA MARIS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCENTRO MEDICO SAO CAMILO **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCARAPICUIBA HOSPITAL CENTRAL OESTE **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCARDOSO SANTA DE CARDOSO **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCASA BRANCA STA CASA MIS DE CASA BRANCA **H/P.S/M H/P.S/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nDR RONALDO H NAMI **HDIA HDIA HDIA HDIA**\n\nHOSPITAL PADRE ALBINO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL MAHATMA GANDHI **H H H H H H H H**\n\nUNIMED HOSPITAL SAO DOMINGOS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCERQUEIRA CESAR STA C MIS CERQUEIRA CESAR **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCERQUILHO STA CASA DE MIS DE CERQUILHO **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nCLEMENTINA ASSOC HOSPITALAR CLEMENTINA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCOLINA SOC FIL HOSP JOSE VENANCIO **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCOSMOPOLIS HOSP BENEF STA GERTRUDES **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nHOSPITAL SAO FRANCISCO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCPR MULHERES **H/P.S H/P.S H/A H/A H/A H/A H/P.S/A H/P.S/A**\n\nCRAVINHOS SOC BEN CRAVINHOS STA CASA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nCRUZEIRO STA CASA DE MIS DE CRUZEIRO **H/M H/M H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nCUBATAO HOSPITAL ANA COSTA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nDESCALVADO IRMANDADE STA CASA MISERICORDIA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nDIADEMA INNOVA HOSPITAIS **H/P.S/A H/P.S/A H/P.S H/P.S H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nDRACENA SANTA CASA DE DRACENA **H H**\n\nCARAGUATATUBA\n\nCAPIVARI\n\nCAMPINAS\n\nCOTIA\n\nCATANDUVA\n\n### Para consultar as especialidades habilitadas em cada uma das modalidades de atendimento (H/P.S/M/A/HDIA), acesse: bradescosaude.com.br > Busca de referenciados","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**NACIONAL II NACIONAL III NACIONAL PLUS PREMIUM**\n\n**ENFERMARIA QUARTO ENFERMARIA QUARTO ENFERMARIA QUARTO ENFERMARIA QUARTO QUARTO QUARTO**\n\n**H = Hospital** l **P.S = Pronto Socorro** l **M = Maternidade** l **A = Ambulatório** l **HDIA = Hospital Dia**\n\n**CIDADE NOME DO REFERENCIADO**\n\n**EFETIVO FLEX IDEAL**\n\n# **Lista de hospitais por linha de planos**\n\n### Referência: agosto/2025\n\nCACAPAVA HOSPITAL POLICLIN **H/P.S/M/A H/P.S/M/A H/P.S/M H/P.S/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCAFELANDIA SANTA CASA DE CAFELANDIA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCAIEIRAS HOSPITAL DE CLINICAS CAIEIRAS **H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nCAJURU CASA DE CARIDADE S VICENTE DE PAULO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL RENASCENCA CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCTO IN INV HEM D A BOLDRINI **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nFUNDACAO CENTRO MEDICO DE CAMPINAS **H/P.S/A H/P.S/A H/P.S H/P.S**\n\nCAMPINAS DAY HOSPITAL **H/A H/A H/A H/A**\n\nCASA DE SAUDE **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nHOSPITAL BENEF PORTUGUESA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nHOSPITAL DO CORACAO DE CAMPINAS **H/A H/A H/A H/A H/A H/A H/A H/A**\n\nHOSPITAL SANTA TEREZA **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL SAO LUIZ CAMPINAS **H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nHOSPITAL SAO LUIZ CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL VERA CRUZ **H/M H/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nIRMANDADE MIS CAMPINAS **H/A H/A H/A H/A H/A H/A H/A H/A**\n\nHOSP E MAT CELSO PIERRO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nINST DO RADIUM DE CAMPINAS **HDIA HDIA HDIA HDIA HDIA HDIA**\n\nUNIDADE HOSP GERAL E MATER MADRE M THEODORA **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nMATERNIDADE DE CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSP EV SAMARITANO CAMPINAS **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCAMPOS DO JORDAO HOSP LEONOR MENDES DE BARROS **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCAPAO BONITO STA CASA MIS DE CAPAO BONITO **H/M H/M H/M H/M H/M H/M H/M H/M H/M H/M**\n\nHOSPITAL UNIMED **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nSTA CASA DE MIS DE CAPIVARI **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCASA DE SAUDE STELLA MARIS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCENTRO MEDICO SAO CAMILO **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCARAPICUIBA HOSPITAL CENTRAL OESTE **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCARDOSO SANTA DE CARDOSO **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCASA BRANCA STA CASA MIS DE CASA BRANCA **H/P.S/M H/P.S/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nDR RONALDO H NAMI **HDIA HDIA HDIA HDIA**\n\nHOSPITAL PADRE ALBINO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL MAHATMA GANDHI **H H H H H H H H**\n\nUNIMED HOSPITAL SAO DOMINGOS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCERQUEIRA CESAR STA C MIS CERQUEIRA CESAR **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCERQUILHO STA CASA DE MIS DE CERQUILHO **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nCLEMENTINA ASSOC HOSPITALAR CLEMENTINA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCOLINA SOC FIL HOSP JOSE VENANCIO **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCOSMOPOLIS HOSP BENEF STA GERTRUDES **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nHOSPITAL SAO FRANCISCO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCPR MULHERES **H/P.S H/P.S H/A H/A H/A H/A H/P.S/A H/P.S/A**\n\nCRAVINHOS SOC BEN CRAVINHOS STA CASA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nCRUZEIRO STA CASA DE MIS DE CRUZEIRO **H/M H/M H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nCUBATAO HOSPITAL ANA COSTA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nDESCALVADO IRMANDADE STA CASA MISERICORDIA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nDIADEMA INNOVA HOSPITAIS **H/P.S/A H/P.S/A H/P.S H/P.S H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nDRACENA SANTA CASA DE DRACENA **H H**\n\nCARAGUATATUBA\n\nCAPIVARI\n\nCAMPINAS\n\nCOTIA\n\nCATANDUVA\n\n### Para consultar as especialidades habilitadas em cada uma das modalidades de atendimento (H/P.S/M/A/HDIA), acesse: bradescosaude.com.br > Busca de referenciados","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/tabular_2_page2.pdf"]},"response":{"errors":[],"extract_id":"extract_7f3bfb2bf2eb2ff3d97ccf1785733d90","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**NACIONAL II NACIONAL III NACIONAL PLUS PREMIUM**\n\n**ENFERMARIA QUARTO ENFERMARIA QUARTO ENFERMARIA QUARTO ENFERMARIA QUARTO QUARTO QUARTO**\n\n**H = Hospital** l **P.S = Pronto Socorro** l **M = Maternidade** l **A = Ambulatório** l **HDIA = Hospital Dia**\n\n**CIDADE NOME DO REFERENCIADO**\n\n**EFETIVO FLEX IDEAL**\n\n# **Lista de hospitais por linha de planos**\n\n### Referência: agosto/2025\n\nCACAPAVA HOSPITAL POLICLIN **H/P.S/M/A H/P.S/M/A H/P.S/M H/P.S/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCAFELANDIA SANTA CASA DE CAFELANDIA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCAIEIRAS HOSPITAL DE CLINICAS CAIEIRAS **H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nCAJURU CASA DE CARIDADE S VICENTE DE PAULO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL RENASCENCA CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCTO IN INV HEM D A BOLDRINI **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nFUNDACAO CENTRO MEDICO DE CAMPINAS **H/P.S/A H/P.S/A H/P.S H/P.S**\n\nCAMPINAS DAY HOSPITAL **H/A H/A H/A H/A**\n\nCASA DE SAUDE **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nHOSPITAL BENEF PORTUGUESA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nHOSPITAL DO CORACAO DE CAMPINAS **H/A H/A H/A H/A H/A H/A H/A H/A**\n\nHOSPITAL SANTA TEREZA **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL SAO LUIZ CAMPINAS **H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nHOSPITAL SAO LUIZ CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL VERA CRUZ **H/M H/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nIRMANDADE MIS CAMPINAS **H/A H/A H/A H/A H/A H/A H/A H/A**\n\nHOSP E MAT CELSO PIERRO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nINST DO RADIUM DE CAMPINAS **HDIA HDIA HDIA HDIA HDIA HDIA**\n\nUNIDADE HOSP GERAL E MATER MADRE M THEODORA **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nMATERNIDADE DE CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSP EV SAMARITANO CAMPINAS **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCAMPOS DO JORDAO HOSP LEONOR MENDES DE BARROS **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCAPAO BONITO STA CASA MIS DE CAPAO BONITO **H/M H/M H/M H/M H/M H/M H/M H/M H/M H/M**\n\nHOSPITAL UNIMED **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nSTA CASA DE MIS DE CAPIVARI **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCASA DE SAUDE STELLA MARIS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCENTRO MEDICO SAO CAMILO **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCARAPICUIBA HOSPITAL CENTRAL OESTE **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCARDOSO SANTA DE CARDOSO **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCASA BRANCA STA CASA MIS DE CASA BRANCA **H/P.S/M H/P.S/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nDR RONALDO H NAMI **HDIA HDIA HDIA HDIA**\n\nHOSPITAL PADRE ALBINO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL MAHATMA GANDHI **H H H H H H H H**\n\nUNIMED HOSPITAL SAO DOMINGOS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCERQUEIRA CESAR STA C MIS CERQUEIRA CESAR **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCERQUILHO STA CASA DE MIS DE CERQUILHO **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nCLEMENTINA ASSOC HOSPITALAR CLEMENTINA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCOLINA SOC FIL HOSP JOSE VENANCIO **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCOSMOPOLIS HOSP BENEF STA GERTRUDES **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nHOSPITAL SAO FRANCISCO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCPR MULHERES **H/P.S H/P.S H/A H/A H/A H/A H/P.S/A H/P.S/A**\n\nCRAVINHOS SOC BEN CRAVINHOS STA CASA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nCRUZEIRO STA CASA DE MIS DE CRUZEIRO **H/M H/M H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nCUBATAO HOSPITAL ANA COSTA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nDESCALVADO IRMANDADE STA CASA MISERICORDIA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nDIADEMA INNOVA HOSPITAIS **H/P.S/A H/P.S/A H/P.S H/P.S H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nDRACENA SANTA CASA DE DRACENA **H H**\n\nCARAGUATATUBA\n\nCAPIVARI\n\nCAMPINAS\n\nCOTIA\n\nCATANDUVA\n\n### Para consultar as especialidades habilitadas em cada uma das modalidades de atendimento (H/P.S/M/A/HDIA), acesse: bradescosaude.com.br > Busca de referenciados"],"full_content":"**NACIONAL II NACIONAL III NACIONAL PLUS PREMIUM**\n\n**ENFERMARIA QUARTO ENFERMARIA QUARTO ENFERMARIA QUARTO ENFERMARIA QUARTO QUARTO QUARTO**\n\n**H = Hospital** l **P.S = Pronto Socorro** l **M = Maternidade** l **A = Ambulatório** l **HDIA = Hospital Dia**\n\n**CIDADE NOME DO REFERENCIADO**\n\n**EFETIVO FLEX IDEAL**\n\n# **Lista de hospitais por linha de planos**\n\n### Referência: agosto/2025\n\nCACAPAVA HOSPITAL POLICLIN **H/P.S/M/A H/P.S/M/A H/P.S/M H/P.S/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCAFELANDIA SANTA CASA DE CAFELANDIA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCAIEIRAS HOSPITAL DE CLINICAS CAIEIRAS **H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nCAJURU CASA DE CARIDADE S VICENTE DE PAULO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL RENASCENCA CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCTO IN INV HEM D A BOLDRINI **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nFUNDACAO CENTRO MEDICO DE CAMPINAS **H/P.S/A H/P.S/A H/P.S H/P.S**\n\nCAMPINAS DAY HOSPITAL **H/A H/A H/A H/A**\n\nCASA DE SAUDE **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nHOSPITAL BENEF PORTUGUESA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nHOSPITAL DO CORACAO DE CAMPINAS **H/A H/A H/A H/A H/A H/A H/A H/A**\n\nHOSPITAL SANTA TEREZA **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL SAO LUIZ CAMPINAS **H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nHOSPITAL SAO LUIZ CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL VERA CRUZ **H/M H/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nIRMANDADE MIS CAMPINAS **H/A H/A H/A H/A H/A H/A H/A H/A**\n\nHOSP E MAT CELSO PIERRO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nINST DO RADIUM DE CAMPINAS **HDIA HDIA HDIA HDIA HDIA HDIA**\n\nUNIDADE HOSP GERAL E MATER MADRE M THEODORA **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nMATERNIDADE DE CAMPINAS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSP EV SAMARITANO CAMPINAS **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCAMPOS DO JORDAO HOSP LEONOR MENDES DE BARROS **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCAPAO BONITO STA CASA MIS DE CAPAO BONITO **H/M H/M H/M H/M H/M H/M H/M H/M H/M H/M**\n\nHOSPITAL UNIMED **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nSTA CASA DE MIS DE CAPIVARI **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCASA DE SAUDE STELLA MARIS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCENTRO MEDICO SAO CAMILO **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCARAPICUIBA HOSPITAL CENTRAL OESTE **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCARDOSO SANTA DE CARDOSO **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCASA BRANCA STA CASA MIS DE CASA BRANCA **H/P.S/M H/P.S/M H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nDR RONALDO H NAMI **HDIA HDIA HDIA HDIA**\n\nHOSPITAL PADRE ALBINO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nHOSPITAL MAHATMA GANDHI **H H H H H H H H**\n\nUNIMED HOSPITAL SAO DOMINGOS **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCERQUEIRA CESAR STA C MIS CERQUEIRA CESAR **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCERQUILHO STA CASA DE MIS DE CERQUILHO **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nCLEMENTINA ASSOC HOSPITALAR CLEMENTINA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nCOLINA SOC FIL HOSP JOSE VENANCIO **H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M H/P.S/M**\n\nCOSMOPOLIS HOSP BENEF STA GERTRUDES **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nHOSPITAL SAO FRANCISCO **H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A H/P.S/M/A**\n\nCPR MULHERES **H/P.S H/P.S H/A H/A H/A H/A H/P.S/A H/P.S/A**\n\nCRAVINHOS SOC BEN CRAVINHOS STA CASA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nCRUZEIRO STA CASA DE MIS DE CRUZEIRO **H/M H/M H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A H/M/A**\n\nCUBATAO HOSPITAL ANA COSTA **H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nDESCALVADO IRMANDADE STA CASA MISERICORDIA **H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S H/P.S**\n\nDIADEMA INNOVA HOSPITAIS **H/P.S/A H/P.S/A H/P.S H/P.S H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A H/P.S/A**\n\nDRACENA SANTA CASA DE DRACENA **H H**\n\nCARAGUATATUBA\n\nCAPIVARI\n\nCAMPINAS\n\nCOTIA\n\nCATANDUVA\n\n### Para consultar as especialidades habilitadas em cada uma das modalidades de atendimento (H/P.S/M/A/HDIA), acesse: bradescosaude.com.br > Busca de referenciados","publish_date":null,"title":"Lista de hospitais por linha de planos","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/tabular_2_page2.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/tabular_2_page2.pdf"},"request":{"example_id":"table/tabular_2_page2","product_type":"parse","source_file_path":"tabular_2_page2.pdf"},"started_at":"2026-11-04T19:47:37.918693"} +{"completed_at":"2026-11-04T19:31:14.460408","latency_in_ms":1442,"output":{"example_id":"table/test_page1","grounded_pages":[],"layout_pages":[],"markdown":"### 13\n\n**Table 13 - Scale G2 versus Population Improvement and Resulting IAM 2012 Basic Table, Male**\n\n**Risks**\n\n**SSA SSA SSA 2002 2012 SSA SSA SSA 2002 2012**\n\n**1990 2002 2012 Scale Exp. IAM 1990 2002 2012 Scale Exp. IAM**\n\n**Age -2006 -2006 -2022 G2 Table Table Age -2006 -2006 -2022 G2 Table Table**\n\n0 2.1% 0.7% 1.9% **1\\.0%** 2\\.168 **1\\.783** 61 2.0% 1.7% 1.5% **1\\.5%** 7\\.306 **6\\.237**\n\n1 3.2% 3.3% 1.9% **1\\.0%** 0\\.542 **0\\.446** 62 2.0% 1.8% 1.5% **1\\.5%** 8\\.084 **6\\.854**\n\n2 3.1% 2.9% 1.8% **1\\.0%** 0\\.366 **0\\.306** 63 2.0% 2.1% 1.4% **1\\.5%** 8\\.946 **7\\.510**\n\n3 3.1% 2.9% 1.8% **1\\.0%** 0\\.304 **0\\.254** 64 2.1% 2.4% 1.3% **1\\.5%** 9\\.900 **8\\.220**\n\n4 3.5% 3.5% 1.9% **1\\.0%** 0\\.237 **0\\.193** 65 2.1% 2.6% 1.2% **1\\.5%** 10\\.955 **9\\.007**\n\n5 3.2% 2.3% 1.8% **1\\.0%** 0\\.217 **0\\.186** 66 2.1% 2.8% 1.2% **1\\.5%** 11\\.639 **9\\.497**\n\n6 3.1% 1.5% 1.7% **1\\.0%** 0\\.208 **0\\.184** 67 2.1% 2.9% 1.1% **1\\.5%** 12\\.428 **10\\.085**\n\n7 3.1% 1.5% 1.7% **1\\.0%** 0\\.199 **0\\.177** 68 2.1% 3.0% 1.1% **1\\.5%** 13\\.344 **10\\.787**\n\n8 3.2% 2.1% 1.9% **1\\.0%** 0\\.184 **0\\.159** 69 2.1% 3.1% 1.1% **1\\.5%** 14\\.411 **11\\.625**\n\n9 3.5% 3.8% 2.2% **1\\.0%** 0\\.178 **0\\.143** 70 2.0% 3.1% 1.1% **1\\.5%** 15\\.661 **12\\.619**\n\n10 4.1% 7.2% 2.6% **1\\.0%** 0\\.180 **0\\.126** 71 2.0% 3.1% 1.1% **1\\.5%** 17\\.128 **13\\.798**\n\n11 4.2% 8.9% 2.7% **1\\.0%** 0\\.190 **0\\.123** 72 2.0% 3.1% 1.1% **1\\.5%** 18\\.837 **15\\.195**\n\n12 3.6% 6.8% 2.1% **1\\.0%** 0\\.207 **0\\.147** 73 1.9% 3.0% 1.1% **1\\.5%** 20\\.814 **16\\.834**\n\n13 3.0% 3.9% 1.6% **1\\.0%** 0\\.234 **0\\.188** 74 1.9% 2.9% 1.1% **1\\.5%** 23\\.081 **18\\.733**\n\n14 2.7% 2.2% 1.3% **1\\.0%** 0\\.274 **0\\.236** 75 1.9% 2.8% 1.1% **1\\.5%** 25\\.664 **20\\.905**\n\n15 2.6% 1.5% 1.2% **1\\.0%** 0\\.318 **0\\.282** 76 1.8% 2.7% 1.0% **1\\.5%** 28\\.586 **23\\.367**\n\n16 2.5% 1.1% 1.1% **1\\.0%** 0\\.361 **0\\.325** 77 1.7% 2.6% 1.0% **1\\.5%** 31\\.886 **26\\.155**\n\n17 2.3% 0.6% 1.1% **1\\.0%** 0\\.397 **0\\.364** 78 1.7% 2.6% 1.0% **1\\.5%** 35\\.607 **29\\.306**\n\n18 1.9% 0.0% 1.0% **1\\.0%** 0\\.425 **0\\.399** 79 1.6% 2.5% 1.1% **1\\.5%** 39\\.796 **32\\.858**\n\n19 1.4% -0.6% 0.9% **1\\.0%** 0\\.447 **0\\.430** 80 1.5% 2.4% 1.1% **1\\.5%** 44\\.505 **36\\.927**\n\n20 0.9% -1.1% 0.9% **1\\.0%** 0\\.467 **0\\.459** 81 1.4% 2.3% 1.1% **1\\.4%** 49\\.790 **41\\.703**\n\n21 0.6% -1.5% 0.8% **1\\.0%** 0\\.493 **0\\.492** 82 1.3% 2.2% 1.0% **1\\.3%** 55\\.722 **46\\.957**\n\n22 0.5% -1.7% 0.8% **1\\.0%** 0\\.521 **0\\.526** 83 1.2% 2.3% 0.9% **1\\.3%** 62\\.382 **52\\.713**\n\n23 0.6% -1.9% 0.8% **1\\.0%** 0\\.561 **0\\.569** 84 1.1% 2.4% 0.8% **1\\.2%** 69\\.863 **59\\.148**\n\n24 0.8% -2.0% 0.9% **1\\.0%** 0\\.604 **0\\.616** 85 1.0% 2.4% 0.7% **1\\.1%** 78\\.269 **66\\.505**\n\n25 1.0% -2.0% 0.9% **1\\.0%** 0\\.656 **0\\.669** 86 0.8% 2.3% 0.6% **1\\.0%** 87\\.702 **75\\.015**\n\n26 1.3% -2.0% 1.0% **1\\.0%** 0\\.714 **0\\.728** 87 0.7% 2.2% 0.5% **0\\.9%** 98\\.206 **84\\.823**\n\n27 1.5% -2.0% 1.0% **1\\.0%** 0\\.751 **0\\.764** 88 0.5% 2.0% 0.5% **0\\.9%** 109\\.777 **95\\.987**\n\n28 1.8% -1.8% 1.1% **1\\.0%** 0\\.779 **0\\.789** 89 0.4% 1.8% 0.5% **0\\.8%** 122\\.371 **108\\.482**\n\n29 2.0% -1.6% 1.1% **1\\.0%** 0\\.805 **0\\.808** 90 0.3% 1.6% 0.5% **0\\.7%** 135\\.888 **122\\.214**\n\n30 2.1% -1.4% 1.1% **1\\.0%** 0\\.828 **0\\.824** 91 0.1% 1.4% 0.5% **0\\.7%** 150\\.209 **136\\.799**\n\n31 2.3% -1.1% 1.1% **1\\.0%** 0\\.848 **0\\.834** 92 0.0% 1.1% 0.5% **0\\.6%** 165\\.349 **152\\.409**\n\n32 2.4% -0.7% 1.2% **1\\.0%** 0\\.867 **0\\.838** 93 -0.1% 0.9% 0.4% **0\\.5%** 181\\.387 **169\\.078**\n\n33 2.6% -0.1% 1.2% **1\\.0%** 0\\.876 **0\\.828** 94 -0.2% 0.7% 0.4% **0\\.5%** 198\\.436 **186\\.882**\n\n34 2.6% 0.5% 1.2% **1\\.0%** 0\\.877 **0\\.808** 95 -0.3% 0.6% 0.4% **0\\.4%** 216\\.648 **205\\.844**\n\n35 2.7% 1.2% 1.2% **1\\.0%** 0\\.879 **0\\.789** 96 -0.4% 0.5% 0.4% **0\\.4%** 229\\.053 **219\\.247**\n\n36 2.7% 1.7% 1.2% **1\\.0%** 0\\.891 **0\\.783** 97 -0.4% 0.4% 0.4% **0\\.3%** 247\\.806 **238\\.612**\n\n37 2.6% 2.0% 1.1% **1\\.0%** 0\\.920 **0\\.800** 98 -0.5% 0.4% 0.4% **0\\.3%** 267\\.095 **258\\.341**\n\n38 2.3% 2.0% 1.1% **1\\.0%** 0\\.963 **0\\.837** 99 -0.5% 0.4% 0.4% **0\\.2%** 286\\.781 **278\\.219**\n\n39 2.0% 1.8% 1.0% **1\\.0%** 1\\.016 **0\\.889** 100 -0.5% 0.4% 0.4% **0\\.2%** 306\\.714 **298\\.452**\n\n40 1.6% 1.6% 1.0% **1\\.0%** 1\\.081 **0\\.955** 101 **0\\.2%** 326\\.734 **323\\.610**\n\n41 1.3% 1.4% 1.0% **1\\.0%** 1\\.156 **1\\.029** 102 **0\\.1%** 346\\.679 **344\\.191**\n\n42 1.1% 1.3% 1.0% **1\\.0%** 1\\.242 **1\\.110** 103 **0\\.1%** 366\\.388 **364\\.633**\n\n43 1.0% 1.3% 0.9% **1\\.0%** 1\\.331 **1\\.188** 104 **0\\.0%** 385\\.708 **384\\.783**\n\n44 0.9% 1.4% 0.9% **1\\.0%** 1\\.424 **1\\.268** 105 **0\\.0%** 400\\.000 **400\\.000**\n\n45 0.8% 1.5% 0.9% **1\\.0%** 1\\.528 **1\\.355** 106 400.000 **400\\.000**\n\n46 0.8% 1.5% 0.9% **1\\.0%** 1\\.654 **1\\.464** 107 400.000 **400\\.000**\n\n47 0.8% 1.3% 0.9% **1\\.0%** 1\\.809 **1\\.615** 108 400.000 **400\\.000**\n\n48 0.7% 0.8% 0.9% **1\\.0%** 1\\.986 **1\\.808** 109 400.000 **400\\.000**\n\n49 0.7% 0.3% 1.0% **1\\.0%** 2\\.180 **2\\.032** 110 400.000 **400\\.000**\n\n50 0.6% -0.3% 1.0% **1\\.0%** 2\\.398 **2\\.285** 111 400.000 **400\\.000**\n\n51 0.6% -0.7% 1.1% **1\\.1%** 2\\.654 **2\\.557** 112 400.000 **400\\.000**\n\n52 0.7% -0.7% 1.1% **1\\.1%** 2\\.936 **2\\.828** 113 400.000 **400\\.000**\n\n53 0.9% -0.5% 1.2% **1\\.2%** 3\\.249 **3\\.088** 114 400.000 **400\\.000**\n\n54 1.2% 0.0% 1.2% **1\\.2%** 3\\.596 **3\\.345** 115 400.000 **400\\.000**\n\n55 1.4% 0.5% 1.3% **1\\.3%** 3\\.979 **3\\.616** 116 400.000 **400\\.000**\n\n56 1.6% 0.9% 1.3% **1\\.3%** 4\\.403 **3\\.922** 117 400.000 **400\\.000**\n\n57 1.7% 1.2% 1.3% **1\\.4%** 4\\.872 **4\\.272** 118 400.000 **400\\.000**\n\n58 1.8% 1.4% 1.4% **1\\.4%** 5\\.392 **4\\.681** 119 400.000 **400\\.000**\n\n59 1.9% 1.5% 1.4% **1\\.5%** 5\\.966 **5\\.146** 120 400.000 **400\\.000**\n\n60 1.9% 1.6% 1.5% **1\\.5%** 6\\.602 **5\\.662**\n\n**Male**","pages":[{"line_numbers":[],"markdown":"### 13\n\n**Table 13 - Scale G2 versus Population Improvement and Resulting IAM 2012 Basic Table, Male**\n\n**Risks**\n\n**SSA SSA SSA 2002 2012 SSA SSA SSA 2002 2012**\n\n**1990 2002 2012 Scale Exp. IAM 1990 2002 2012 Scale Exp. IAM**\n\n**Age -2006 -2006 -2022 G2 Table Table Age -2006 -2006 -2022 G2 Table Table**\n\n0 2.1% 0.7% 1.9% **1\\.0%** 2\\.168 **1\\.783** 61 2.0% 1.7% 1.5% **1\\.5%** 7\\.306 **6\\.237**\n\n1 3.2% 3.3% 1.9% **1\\.0%** 0\\.542 **0\\.446** 62 2.0% 1.8% 1.5% **1\\.5%** 8\\.084 **6\\.854**\n\n2 3.1% 2.9% 1.8% **1\\.0%** 0\\.366 **0\\.306** 63 2.0% 2.1% 1.4% **1\\.5%** 8\\.946 **7\\.510**\n\n3 3.1% 2.9% 1.8% **1\\.0%** 0\\.304 **0\\.254** 64 2.1% 2.4% 1.3% **1\\.5%** 9\\.900 **8\\.220**\n\n4 3.5% 3.5% 1.9% **1\\.0%** 0\\.237 **0\\.193** 65 2.1% 2.6% 1.2% **1\\.5%** 10\\.955 **9\\.007**\n\n5 3.2% 2.3% 1.8% **1\\.0%** 0\\.217 **0\\.186** 66 2.1% 2.8% 1.2% **1\\.5%** 11\\.639 **9\\.497**\n\n6 3.1% 1.5% 1.7% **1\\.0%** 0\\.208 **0\\.184** 67 2.1% 2.9% 1.1% **1\\.5%** 12\\.428 **10\\.085**\n\n7 3.1% 1.5% 1.7% **1\\.0%** 0\\.199 **0\\.177** 68 2.1% 3.0% 1.1% **1\\.5%** 13\\.344 **10\\.787**\n\n8 3.2% 2.1% 1.9% **1\\.0%** 0\\.184 **0\\.159** 69 2.1% 3.1% 1.1% **1\\.5%** 14\\.411 **11\\.625**\n\n9 3.5% 3.8% 2.2% **1\\.0%** 0\\.178 **0\\.143** 70 2.0% 3.1% 1.1% **1\\.5%** 15\\.661 **12\\.619**\n\n10 4.1% 7.2% 2.6% **1\\.0%** 0\\.180 **0\\.126** 71 2.0% 3.1% 1.1% **1\\.5%** 17\\.128 **13\\.798**\n\n11 4.2% 8.9% 2.7% **1\\.0%** 0\\.190 **0\\.123** 72 2.0% 3.1% 1.1% **1\\.5%** 18\\.837 **15\\.195**\n\n12 3.6% 6.8% 2.1% **1\\.0%** 0\\.207 **0\\.147** 73 1.9% 3.0% 1.1% **1\\.5%** 20\\.814 **16\\.834**\n\n13 3.0% 3.9% 1.6% **1\\.0%** 0\\.234 **0\\.188** 74 1.9% 2.9% 1.1% **1\\.5%** 23\\.081 **18\\.733**\n\n14 2.7% 2.2% 1.3% **1\\.0%** 0\\.274 **0\\.236** 75 1.9% 2.8% 1.1% **1\\.5%** 25\\.664 **20\\.905**\n\n15 2.6% 1.5% 1.2% **1\\.0%** 0\\.318 **0\\.282** 76 1.8% 2.7% 1.0% **1\\.5%** 28\\.586 **23\\.367**\n\n16 2.5% 1.1% 1.1% **1\\.0%** 0\\.361 **0\\.325** 77 1.7% 2.6% 1.0% **1\\.5%** 31\\.886 **26\\.155**\n\n17 2.3% 0.6% 1.1% **1\\.0%** 0\\.397 **0\\.364** 78 1.7% 2.6% 1.0% **1\\.5%** 35\\.607 **29\\.306**\n\n18 1.9% 0.0% 1.0% **1\\.0%** 0\\.425 **0\\.399** 79 1.6% 2.5% 1.1% **1\\.5%** 39\\.796 **32\\.858**\n\n19 1.4% -0.6% 0.9% **1\\.0%** 0\\.447 **0\\.430** 80 1.5% 2.4% 1.1% **1\\.5%** 44\\.505 **36\\.927**\n\n20 0.9% -1.1% 0.9% **1\\.0%** 0\\.467 **0\\.459** 81 1.4% 2.3% 1.1% **1\\.4%** 49\\.790 **41\\.703**\n\n21 0.6% -1.5% 0.8% **1\\.0%** 0\\.493 **0\\.492** 82 1.3% 2.2% 1.0% **1\\.3%** 55\\.722 **46\\.957**\n\n22 0.5% -1.7% 0.8% **1\\.0%** 0\\.521 **0\\.526** 83 1.2% 2.3% 0.9% **1\\.3%** 62\\.382 **52\\.713**\n\n23 0.6% -1.9% 0.8% **1\\.0%** 0\\.561 **0\\.569** 84 1.1% 2.4% 0.8% **1\\.2%** 69\\.863 **59\\.148**\n\n24 0.8% -2.0% 0.9% **1\\.0%** 0\\.604 **0\\.616** 85 1.0% 2.4% 0.7% **1\\.1%** 78\\.269 **66\\.505**\n\n25 1.0% -2.0% 0.9% **1\\.0%** 0\\.656 **0\\.669** 86 0.8% 2.3% 0.6% **1\\.0%** 87\\.702 **75\\.015**\n\n26 1.3% -2.0% 1.0% **1\\.0%** 0\\.714 **0\\.728** 87 0.7% 2.2% 0.5% **0\\.9%** 98\\.206 **84\\.823**\n\n27 1.5% -2.0% 1.0% **1\\.0%** 0\\.751 **0\\.764** 88 0.5% 2.0% 0.5% **0\\.9%** 109\\.777 **95\\.987**\n\n28 1.8% -1.8% 1.1% **1\\.0%** 0\\.779 **0\\.789** 89 0.4% 1.8% 0.5% **0\\.8%** 122\\.371 **108\\.482**\n\n29 2.0% -1.6% 1.1% **1\\.0%** 0\\.805 **0\\.808** 90 0.3% 1.6% 0.5% **0\\.7%** 135\\.888 **122\\.214**\n\n30 2.1% -1.4% 1.1% **1\\.0%** 0\\.828 **0\\.824** 91 0.1% 1.4% 0.5% **0\\.7%** 150\\.209 **136\\.799**\n\n31 2.3% -1.1% 1.1% **1\\.0%** 0\\.848 **0\\.834** 92 0.0% 1.1% 0.5% **0\\.6%** 165\\.349 **152\\.409**\n\n32 2.4% -0.7% 1.2% **1\\.0%** 0\\.867 **0\\.838** 93 -0.1% 0.9% 0.4% **0\\.5%** 181\\.387 **169\\.078**\n\n33 2.6% -0.1% 1.2% **1\\.0%** 0\\.876 **0\\.828** 94 -0.2% 0.7% 0.4% **0\\.5%** 198\\.436 **186\\.882**\n\n34 2.6% 0.5% 1.2% **1\\.0%** 0\\.877 **0\\.808** 95 -0.3% 0.6% 0.4% **0\\.4%** 216\\.648 **205\\.844**\n\n35 2.7% 1.2% 1.2% **1\\.0%** 0\\.879 **0\\.789** 96 -0.4% 0.5% 0.4% **0\\.4%** 229\\.053 **219\\.247**\n\n36 2.7% 1.7% 1.2% **1\\.0%** 0\\.891 **0\\.783** 97 -0.4% 0.4% 0.4% **0\\.3%** 247\\.806 **238\\.612**\n\n37 2.6% 2.0% 1.1% **1\\.0%** 0\\.920 **0\\.800** 98 -0.5% 0.4% 0.4% **0\\.3%** 267\\.095 **258\\.341**\n\n38 2.3% 2.0% 1.1% **1\\.0%** 0\\.963 **0\\.837** 99 -0.5% 0.4% 0.4% **0\\.2%** 286\\.781 **278\\.219**\n\n39 2.0% 1.8% 1.0% **1\\.0%** 1\\.016 **0\\.889** 100 -0.5% 0.4% 0.4% **0\\.2%** 306\\.714 **298\\.452**\n\n40 1.6% 1.6% 1.0% **1\\.0%** 1\\.081 **0\\.955** 101 **0\\.2%** 326\\.734 **323\\.610**\n\n41 1.3% 1.4% 1.0% **1\\.0%** 1\\.156 **1\\.029** 102 **0\\.1%** 346\\.679 **344\\.191**\n\n42 1.1% 1.3% 1.0% **1\\.0%** 1\\.242 **1\\.110** 103 **0\\.1%** 366\\.388 **364\\.633**\n\n43 1.0% 1.3% 0.9% **1\\.0%** 1\\.331 **1\\.188** 104 **0\\.0%** 385\\.708 **384\\.783**\n\n44 0.9% 1.4% 0.9% **1\\.0%** 1\\.424 **1\\.268** 105 **0\\.0%** 400\\.000 **400\\.000**\n\n45 0.8% 1.5% 0.9% **1\\.0%** 1\\.528 **1\\.355** 106 400.000 **400\\.000**\n\n46 0.8% 1.5% 0.9% **1\\.0%** 1\\.654 **1\\.464** 107 400.000 **400\\.000**\n\n47 0.8% 1.3% 0.9% **1\\.0%** 1\\.809 **1\\.615** 108 400.000 **400\\.000**\n\n48 0.7% 0.8% 0.9% **1\\.0%** 1\\.986 **1\\.808** 109 400.000 **400\\.000**\n\n49 0.7% 0.3% 1.0% **1\\.0%** 2\\.180 **2\\.032** 110 400.000 **400\\.000**\n\n50 0.6% -0.3% 1.0% **1\\.0%** 2\\.398 **2\\.285** 111 400.000 **400\\.000**\n\n51 0.6% -0.7% 1.1% **1\\.1%** 2\\.654 **2\\.557** 112 400.000 **400\\.000**\n\n52 0.7% -0.7% 1.1% **1\\.1%** 2\\.936 **2\\.828** 113 400.000 **400\\.000**\n\n53 0.9% -0.5% 1.2% **1\\.2%** 3\\.249 **3\\.088** 114 400.000 **400\\.000**\n\n54 1.2% 0.0% 1.2% **1\\.2%** 3\\.596 **3\\.345** 115 400.000 **400\\.000**\n\n55 1.4% 0.5% 1.3% **1\\.3%** 3\\.979 **3\\.616** 116 400.000 **400\\.000**\n\n56 1.6% 0.9% 1.3% **1\\.3%** 4\\.403 **3\\.922** 117 400.000 **400\\.000**\n\n57 1.7% 1.2% 1.3% **1\\.4%** 4\\.872 **4\\.272** 118 400.000 **400\\.000**\n\n58 1.8% 1.4% 1.4% **1\\.4%** 5\\.392 **4\\.681** 119 400.000 **400\\.000**\n\n59 1.9% 1.5% 1.4% **1\\.5%** 5\\.966 **5\\.146** 120 400.000 **400\\.000**\n\n60 1.9% 1.6% 1.5% **1\\.5%** 6\\.602 **5\\.662**\n\n**Male**","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### 13\n\n**Table 13 - Scale G2 versus Population Improvement and Resulting IAM 2012 Basic Table, Male**\n\n**Risks**\n\n**SSA SSA SSA 2002 2012 SSA SSA SSA 2002 2012**\n\n**1990 2002 2012 Scale Exp. IAM 1990 2002 2012 Scale Exp. IAM**\n\n**Age -2006 -2006 -2022 G2 Table Table Age -2006 -2006 -2022 G2 Table Table**\n\n0 2.1% 0.7% 1.9% **1\\.0%** 2\\.168 **1\\.783** 61 2.0% 1.7% 1.5% **1\\.5%** 7\\.306 **6\\.237**\n\n1 3.2% 3.3% 1.9% **1\\.0%** 0\\.542 **0\\.446** 62 2.0% 1.8% 1.5% **1\\.5%** 8\\.084 **6\\.854**\n\n2 3.1% 2.9% 1.8% **1\\.0%** 0\\.366 **0\\.306** 63 2.0% 2.1% 1.4% **1\\.5%** 8\\.946 **7\\.510**\n\n3 3.1% 2.9% 1.8% **1\\.0%** 0\\.304 **0\\.254** 64 2.1% 2.4% 1.3% **1\\.5%** 9\\.900 **8\\.220**\n\n4 3.5% 3.5% 1.9% **1\\.0%** 0\\.237 **0\\.193** 65 2.1% 2.6% 1.2% **1\\.5%** 10\\.955 **9\\.007**\n\n5 3.2% 2.3% 1.8% **1\\.0%** 0\\.217 **0\\.186** 66 2.1% 2.8% 1.2% **1\\.5%** 11\\.639 **9\\.497**\n\n6 3.1% 1.5% 1.7% **1\\.0%** 0\\.208 **0\\.184** 67 2.1% 2.9% 1.1% **1\\.5%** 12\\.428 **10\\.085**\n\n7 3.1% 1.5% 1.7% **1\\.0%** 0\\.199 **0\\.177** 68 2.1% 3.0% 1.1% **1\\.5%** 13\\.344 **10\\.787**\n\n8 3.2% 2.1% 1.9% **1\\.0%** 0\\.184 **0\\.159** 69 2.1% 3.1% 1.1% **1\\.5%** 14\\.411 **11\\.625**\n\n9 3.5% 3.8% 2.2% **1\\.0%** 0\\.178 **0\\.143** 70 2.0% 3.1% 1.1% **1\\.5%** 15\\.661 **12\\.619**\n\n10 4.1% 7.2% 2.6% **1\\.0%** 0\\.180 **0\\.126** 71 2.0% 3.1% 1.1% **1\\.5%** 17\\.128 **13\\.798**\n\n11 4.2% 8.9% 2.7% **1\\.0%** 0\\.190 **0\\.123** 72 2.0% 3.1% 1.1% **1\\.5%** 18\\.837 **15\\.195**\n\n12 3.6% 6.8% 2.1% **1\\.0%** 0\\.207 **0\\.147** 73 1.9% 3.0% 1.1% **1\\.5%** 20\\.814 **16\\.834**\n\n13 3.0% 3.9% 1.6% **1\\.0%** 0\\.234 **0\\.188** 74 1.9% 2.9% 1.1% **1\\.5%** 23\\.081 **18\\.733**\n\n14 2.7% 2.2% 1.3% **1\\.0%** 0\\.274 **0\\.236** 75 1.9% 2.8% 1.1% **1\\.5%** 25\\.664 **20\\.905**\n\n15 2.6% 1.5% 1.2% **1\\.0%** 0\\.318 **0\\.282** 76 1.8% 2.7% 1.0% **1\\.5%** 28\\.586 **23\\.367**\n\n16 2.5% 1.1% 1.1% **1\\.0%** 0\\.361 **0\\.325** 77 1.7% 2.6% 1.0% **1\\.5%** 31\\.886 **26\\.155**\n\n17 2.3% 0.6% 1.1% **1\\.0%** 0\\.397 **0\\.364** 78 1.7% 2.6% 1.0% **1\\.5%** 35\\.607 **29\\.306**\n\n18 1.9% 0.0% 1.0% **1\\.0%** 0\\.425 **0\\.399** 79 1.6% 2.5% 1.1% **1\\.5%** 39\\.796 **32\\.858**\n\n19 1.4% -0.6% 0.9% **1\\.0%** 0\\.447 **0\\.430** 80 1.5% 2.4% 1.1% **1\\.5%** 44\\.505 **36\\.927**\n\n20 0.9% -1.1% 0.9% **1\\.0%** 0\\.467 **0\\.459** 81 1.4% 2.3% 1.1% **1\\.4%** 49\\.790 **41\\.703**\n\n21 0.6% -1.5% 0.8% **1\\.0%** 0\\.493 **0\\.492** 82 1.3% 2.2% 1.0% **1\\.3%** 55\\.722 **46\\.957**\n\n22 0.5% -1.7% 0.8% **1\\.0%** 0\\.521 **0\\.526** 83 1.2% 2.3% 0.9% **1\\.3%** 62\\.382 **52\\.713**\n\n23 0.6% -1.9% 0.8% **1\\.0%** 0\\.561 **0\\.569** 84 1.1% 2.4% 0.8% **1\\.2%** 69\\.863 **59\\.148**\n\n24 0.8% -2.0% 0.9% **1\\.0%** 0\\.604 **0\\.616** 85 1.0% 2.4% 0.7% **1\\.1%** 78\\.269 **66\\.505**\n\n25 1.0% -2.0% 0.9% **1\\.0%** 0\\.656 **0\\.669** 86 0.8% 2.3% 0.6% **1\\.0%** 87\\.702 **75\\.015**\n\n26 1.3% -2.0% 1.0% **1\\.0%** 0\\.714 **0\\.728** 87 0.7% 2.2% 0.5% **0\\.9%** 98\\.206 **84\\.823**\n\n27 1.5% -2.0% 1.0% **1\\.0%** 0\\.751 **0\\.764** 88 0.5% 2.0% 0.5% **0\\.9%** 109\\.777 **95\\.987**\n\n28 1.8% -1.8% 1.1% **1\\.0%** 0\\.779 **0\\.789** 89 0.4% 1.8% 0.5% **0\\.8%** 122\\.371 **108\\.482**\n\n29 2.0% -1.6% 1.1% **1\\.0%** 0\\.805 **0\\.808** 90 0.3% 1.6% 0.5% **0\\.7%** 135\\.888 **122\\.214**\n\n30 2.1% -1.4% 1.1% **1\\.0%** 0\\.828 **0\\.824** 91 0.1% 1.4% 0.5% **0\\.7%** 150\\.209 **136\\.799**\n\n31 2.3% -1.1% 1.1% **1\\.0%** 0\\.848 **0\\.834** 92 0.0% 1.1% 0.5% **0\\.6%** 165\\.349 **152\\.409**\n\n32 2.4% -0.7% 1.2% **1\\.0%** 0\\.867 **0\\.838** 93 -0.1% 0.9% 0.4% **0\\.5%** 181\\.387 **169\\.078**\n\n33 2.6% -0.1% 1.2% **1\\.0%** 0\\.876 **0\\.828** 94 -0.2% 0.7% 0.4% **0\\.5%** 198\\.436 **186\\.882**\n\n34 2.6% 0.5% 1.2% **1\\.0%** 0\\.877 **0\\.808** 95 -0.3% 0.6% 0.4% **0\\.4%** 216\\.648 **205\\.844**\n\n35 2.7% 1.2% 1.2% **1\\.0%** 0\\.879 **0\\.789** 96 -0.4% 0.5% 0.4% **0\\.4%** 229\\.053 **219\\.247**\n\n36 2.7% 1.7% 1.2% **1\\.0%** 0\\.891 **0\\.783** 97 -0.4% 0.4% 0.4% **0\\.3%** 247\\.806 **238\\.612**\n\n37 2.6% 2.0% 1.1% **1\\.0%** 0\\.920 **0\\.800** 98 -0.5% 0.4% 0.4% **0\\.3%** 267\\.095 **258\\.341**\n\n38 2.3% 2.0% 1.1% **1\\.0%** 0\\.963 **0\\.837** 99 -0.5% 0.4% 0.4% **0\\.2%** 286\\.781 **278\\.219**\n\n39 2.0% 1.8% 1.0% **1\\.0%** 1\\.016 **0\\.889** 100 -0.5% 0.4% 0.4% **0\\.2%** 306\\.714 **298\\.452**\n\n40 1.6% 1.6% 1.0% **1\\.0%** 1\\.081 **0\\.955** 101 **0\\.2%** 326\\.734 **323\\.610**\n\n41 1.3% 1.4% 1.0% **1\\.0%** 1\\.156 **1\\.029** 102 **0\\.1%** 346\\.679 **344\\.191**\n\n42 1.1% 1.3% 1.0% **1\\.0%** 1\\.242 **1\\.110** 103 **0\\.1%** 366\\.388 **364\\.633**\n\n43 1.0% 1.3% 0.9% **1\\.0%** 1\\.331 **1\\.188** 104 **0\\.0%** 385\\.708 **384\\.783**\n\n44 0.9% 1.4% 0.9% **1\\.0%** 1\\.424 **1\\.268** 105 **0\\.0%** 400\\.000 **400\\.000**\n\n45 0.8% 1.5% 0.9% **1\\.0%** 1\\.528 **1\\.355** 106 400.000 **400\\.000**\n\n46 0.8% 1.5% 0.9% **1\\.0%** 1\\.654 **1\\.464** 107 400.000 **400\\.000**\n\n47 0.8% 1.3% 0.9% **1\\.0%** 1\\.809 **1\\.615** 108 400.000 **400\\.000**\n\n48 0.7% 0.8% 0.9% **1\\.0%** 1\\.986 **1\\.808** 109 400.000 **400\\.000**\n\n49 0.7% 0.3% 1.0% **1\\.0%** 2\\.180 **2\\.032** 110 400.000 **400\\.000**\n\n50 0.6% -0.3% 1.0% **1\\.0%** 2\\.398 **2\\.285** 111 400.000 **400\\.000**\n\n51 0.6% -0.7% 1.1% **1\\.1%** 2\\.654 **2\\.557** 112 400.000 **400\\.000**\n\n52 0.7% -0.7% 1.1% **1\\.1%** 2\\.936 **2\\.828** 113 400.000 **400\\.000**\n\n53 0.9% -0.5% 1.2% **1\\.2%** 3\\.249 **3\\.088** 114 400.000 **400\\.000**\n\n54 1.2% 0.0% 1.2% **1\\.2%** 3\\.596 **3\\.345** 115 400.000 **400\\.000**\n\n55 1.4% 0.5% 1.3% **1\\.3%** 3\\.979 **3\\.616** 116 400.000 **400\\.000**\n\n56 1.6% 0.9% 1.3% **1\\.3%** 4\\.403 **3\\.922** 117 400.000 **400\\.000**\n\n57 1.7% 1.2% 1.3% **1\\.4%** 4\\.872 **4\\.272** 118 400.000 **400\\.000**\n\n58 1.8% 1.4% 1.4% **1\\.4%** 5\\.392 **4\\.681** 119 400.000 **400\\.000**\n\n59 1.9% 1.5% 1.4% **1\\.5%** 5\\.966 **5\\.146** 120 400.000 **400\\.000**\n\n60 1.9% 1.6% 1.5% **1\\.5%** 6\\.602 **5\\.662**\n\n**Male**","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/test_page1.pdf"]},"response":{"errors":[],"extract_id":"extract_a7aa24ceae9d65e2bfd930235a7a245d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### 13\n\n**Table 13 - Scale G2 versus Population Improvement and Resulting IAM 2012 Basic Table, Male**\n\n**Risks**\n\n**SSA SSA SSA 2002 2012 SSA SSA SSA 2002 2012**\n\n**1990 2002 2012 Scale Exp. IAM 1990 2002 2012 Scale Exp. IAM**\n\n**Age -2006 -2006 -2022 G2 Table Table Age -2006 -2006 -2022 G2 Table Table**\n\n0 2.1% 0.7% 1.9% **1\\.0%** 2\\.168 **1\\.783** 61 2.0% 1.7% 1.5% **1\\.5%** 7\\.306 **6\\.237**\n\n1 3.2% 3.3% 1.9% **1\\.0%** 0\\.542 **0\\.446** 62 2.0% 1.8% 1.5% **1\\.5%** 8\\.084 **6\\.854**\n\n2 3.1% 2.9% 1.8% **1\\.0%** 0\\.366 **0\\.306** 63 2.0% 2.1% 1.4% **1\\.5%** 8\\.946 **7\\.510**\n\n3 3.1% 2.9% 1.8% **1\\.0%** 0\\.304 **0\\.254** 64 2.1% 2.4% 1.3% **1\\.5%** 9\\.900 **8\\.220**\n\n4 3.5% 3.5% 1.9% **1\\.0%** 0\\.237 **0\\.193** 65 2.1% 2.6% 1.2% **1\\.5%** 10\\.955 **9\\.007**\n\n5 3.2% 2.3% 1.8% **1\\.0%** 0\\.217 **0\\.186** 66 2.1% 2.8% 1.2% **1\\.5%** 11\\.639 **9\\.497**\n\n6 3.1% 1.5% 1.7% **1\\.0%** 0\\.208 **0\\.184** 67 2.1% 2.9% 1.1% **1\\.5%** 12\\.428 **10\\.085**\n\n7 3.1% 1.5% 1.7% **1\\.0%** 0\\.199 **0\\.177** 68 2.1% 3.0% 1.1% **1\\.5%** 13\\.344 **10\\.787**\n\n8 3.2% 2.1% 1.9% **1\\.0%** 0\\.184 **0\\.159** 69 2.1% 3.1% 1.1% **1\\.5%** 14\\.411 **11\\.625**\n\n9 3.5% 3.8% 2.2% **1\\.0%** 0\\.178 **0\\.143** 70 2.0% 3.1% 1.1% **1\\.5%** 15\\.661 **12\\.619**\n\n10 4.1% 7.2% 2.6% **1\\.0%** 0\\.180 **0\\.126** 71 2.0% 3.1% 1.1% **1\\.5%** 17\\.128 **13\\.798**\n\n11 4.2% 8.9% 2.7% **1\\.0%** 0\\.190 **0\\.123** 72 2.0% 3.1% 1.1% **1\\.5%** 18\\.837 **15\\.195**\n\n12 3.6% 6.8% 2.1% **1\\.0%** 0\\.207 **0\\.147** 73 1.9% 3.0% 1.1% **1\\.5%** 20\\.814 **16\\.834**\n\n13 3.0% 3.9% 1.6% **1\\.0%** 0\\.234 **0\\.188** 74 1.9% 2.9% 1.1% **1\\.5%** 23\\.081 **18\\.733**\n\n14 2.7% 2.2% 1.3% **1\\.0%** 0\\.274 **0\\.236** 75 1.9% 2.8% 1.1% **1\\.5%** 25\\.664 **20\\.905**\n\n15 2.6% 1.5% 1.2% **1\\.0%** 0\\.318 **0\\.282** 76 1.8% 2.7% 1.0% **1\\.5%** 28\\.586 **23\\.367**\n\n16 2.5% 1.1% 1.1% **1\\.0%** 0\\.361 **0\\.325** 77 1.7% 2.6% 1.0% **1\\.5%** 31\\.886 **26\\.155**\n\n17 2.3% 0.6% 1.1% **1\\.0%** 0\\.397 **0\\.364** 78 1.7% 2.6% 1.0% **1\\.5%** 35\\.607 **29\\.306**\n\n18 1.9% 0.0% 1.0% **1\\.0%** 0\\.425 **0\\.399** 79 1.6% 2.5% 1.1% **1\\.5%** 39\\.796 **32\\.858**\n\n19 1.4% -0.6% 0.9% **1\\.0%** 0\\.447 **0\\.430** 80 1.5% 2.4% 1.1% **1\\.5%** 44\\.505 **36\\.927**\n\n20 0.9% -1.1% 0.9% **1\\.0%** 0\\.467 **0\\.459** 81 1.4% 2.3% 1.1% **1\\.4%** 49\\.790 **41\\.703**\n\n21 0.6% -1.5% 0.8% **1\\.0%** 0\\.493 **0\\.492** 82 1.3% 2.2% 1.0% **1\\.3%** 55\\.722 **46\\.957**\n\n22 0.5% -1.7% 0.8% **1\\.0%** 0\\.521 **0\\.526** 83 1.2% 2.3% 0.9% **1\\.3%** 62\\.382 **52\\.713**\n\n23 0.6% -1.9% 0.8% **1\\.0%** 0\\.561 **0\\.569** 84 1.1% 2.4% 0.8% **1\\.2%** 69\\.863 **59\\.148**\n\n24 0.8% -2.0% 0.9% **1\\.0%** 0\\.604 **0\\.616** 85 1.0% 2.4% 0.7% **1\\.1%** 78\\.269 **66\\.505**\n\n25 1.0% -2.0% 0.9% **1\\.0%** 0\\.656 **0\\.669** 86 0.8% 2.3% 0.6% **1\\.0%** 87\\.702 **75\\.015**\n\n26 1.3% -2.0% 1.0% **1\\.0%** 0\\.714 **0\\.728** 87 0.7% 2.2% 0.5% **0\\.9%** 98\\.206 **84\\.823**\n\n27 1.5% -2.0% 1.0% **1\\.0%** 0\\.751 **0\\.764** 88 0.5% 2.0% 0.5% **0\\.9%** 109\\.777 **95\\.987**\n\n28 1.8% -1.8% 1.1% **1\\.0%** 0\\.779 **0\\.789** 89 0.4% 1.8% 0.5% **0\\.8%** 122\\.371 **108\\.482**\n\n29 2.0% -1.6% 1.1% **1\\.0%** 0\\.805 **0\\.808** 90 0.3% 1.6% 0.5% **0\\.7%** 135\\.888 **122\\.214**\n\n30 2.1% -1.4% 1.1% **1\\.0%** 0\\.828 **0\\.824** 91 0.1% 1.4% 0.5% **0\\.7%** 150\\.209 **136\\.799**\n\n31 2.3% -1.1% 1.1% **1\\.0%** 0\\.848 **0\\.834** 92 0.0% 1.1% 0.5% **0\\.6%** 165\\.349 **152\\.409**\n\n32 2.4% -0.7% 1.2% **1\\.0%** 0\\.867 **0\\.838** 93 -0.1% 0.9% 0.4% **0\\.5%** 181\\.387 **169\\.078**\n\n33 2.6% -0.1% 1.2% **1\\.0%** 0\\.876 **0\\.828** 94 -0.2% 0.7% 0.4% **0\\.5%** 198\\.436 **186\\.882**\n\n34 2.6% 0.5% 1.2% **1\\.0%** 0\\.877 **0\\.808** 95 -0.3% 0.6% 0.4% **0\\.4%** 216\\.648 **205\\.844**\n\n35 2.7% 1.2% 1.2% **1\\.0%** 0\\.879 **0\\.789** 96 -0.4% 0.5% 0.4% **0\\.4%** 229\\.053 **219\\.247**\n\n36 2.7% 1.7% 1.2% **1\\.0%** 0\\.891 **0\\.783** 97 -0.4% 0.4% 0.4% **0\\.3%** 247\\.806 **238\\.612**\n\n37 2.6% 2.0% 1.1% **1\\.0%** 0\\.920 **0\\.800** 98 -0.5% 0.4% 0.4% **0\\.3%** 267\\.095 **258\\.341**\n\n38 2.3% 2.0% 1.1% **1\\.0%** 0\\.963 **0\\.837** 99 -0.5% 0.4% 0.4% **0\\.2%** 286\\.781 **278\\.219**\n\n39 2.0% 1.8% 1.0% **1\\.0%** 1\\.016 **0\\.889** 100 -0.5% 0.4% 0.4% **0\\.2%** 306\\.714 **298\\.452**\n\n40 1.6% 1.6% 1.0% **1\\.0%** 1\\.081 **0\\.955** 101 **0\\.2%** 326\\.734 **323\\.610**\n\n41 1.3% 1.4% 1.0% **1\\.0%** 1\\.156 **1\\.029** 102 **0\\.1%** 346\\.679 **344\\.191**\n\n42 1.1% 1.3% 1.0% **1\\.0%** 1\\.242 **1\\.110** 103 **0\\.1%** 366\\.388 **364\\.633**\n\n43 1.0% 1.3% 0.9% **1\\.0%** 1\\.331 **1\\.188** 104 **0\\.0%** 385\\.708 **384\\.783**\n\n44 0.9% 1.4% 0.9% **1\\.0%** 1\\.424 **1\\.268** 105 **0\\.0%** 400\\.000 **400\\.000**\n\n45 0.8% 1.5% 0.9% **1\\.0%** 1\\.528 **1\\.355** 106 400.000 **400\\.000**\n\n46 0.8% 1.5% 0.9% **1\\.0%** 1\\.654 **1\\.464** 107 400.000 **400\\.000**\n\n47 0.8% 1.3% 0.9% **1\\.0%** 1\\.809 **1\\.615** 108 400.000 **400\\.000**\n\n48 0.7% 0.8% 0.9% **1\\.0%** 1\\.986 **1\\.808** 109 400.000 **400\\.000**\n\n49 0.7% 0.3% 1.0% **1\\.0%** 2\\.180 **2\\.032** 110 400.000 **400\\.000**\n\n50 0.6% -0.3% 1.0% **1\\.0%** 2\\.398 **2\\.285** 111 400.000 **400\\.000**\n\n51 0.6% -0.7% 1.1% **1\\.1%** 2\\.654 **2\\.557** 112 400.000 **400\\.000**\n\n52 0.7% -0.7% 1.1% **1\\.1%** 2\\.936 **2\\.828** 113 400.000 **400\\.000**\n\n53 0.9% -0.5% 1.2% **1\\.2%** 3\\.249 **3\\.088** 114 400.000 **400\\.000**\n\n54 1.2% 0.0% 1.2% **1\\.2%** 3\\.596 **3\\.345** 115 400.000 **400\\.000**\n\n55 1.4% 0.5% 1.3% **1\\.3%** 3\\.979 **3\\.616** 116 400.000 **400\\.000**\n\n56 1.6% 0.9% 1.3% **1\\.3%** 4\\.403 **3\\.922** 117 400.000 **400\\.000**\n\n57 1.7% 1.2% 1.3% **1\\.4%** 4\\.872 **4\\.272** 118 400.000 **400\\.000**\n\n58 1.8% 1.4% 1.4% **1\\.4%** 5\\.392 **4\\.681** 119 400.000 **400\\.000**\n\n59 1.9% 1.5% 1.4% **1\\.5%** 5\\.966 **5\\.146** 120 400.000 **400\\.000**\n\n60 1.9% 1.6% 1.5% **1\\.5%** 6\\.602 **5\\.662**\n\n**Male**"],"full_content":"### 13\n\n**Table 13 - Scale G2 versus Population Improvement and Resulting IAM 2012 Basic Table, Male**\n\n**Risks**\n\n**SSA SSA SSA 2002 2012 SSA SSA SSA 2002 2012**\n\n**1990 2002 2012 Scale Exp. IAM 1990 2002 2012 Scale Exp. IAM**\n\n**Age -2006 -2006 -2022 G2 Table Table Age -2006 -2006 -2022 G2 Table Table**\n\n0 2.1% 0.7% 1.9% **1\\.0%** 2\\.168 **1\\.783** 61 2.0% 1.7% 1.5% **1\\.5%** 7\\.306 **6\\.237**\n\n1 3.2% 3.3% 1.9% **1\\.0%** 0\\.542 **0\\.446** 62 2.0% 1.8% 1.5% **1\\.5%** 8\\.084 **6\\.854**\n\n2 3.1% 2.9% 1.8% **1\\.0%** 0\\.366 **0\\.306** 63 2.0% 2.1% 1.4% **1\\.5%** 8\\.946 **7\\.510**\n\n3 3.1% 2.9% 1.8% **1\\.0%** 0\\.304 **0\\.254** 64 2.1% 2.4% 1.3% **1\\.5%** 9\\.900 **8\\.220**\n\n4 3.5% 3.5% 1.9% **1\\.0%** 0\\.237 **0\\.193** 65 2.1% 2.6% 1.2% **1\\.5%** 10\\.955 **9\\.007**\n\n5 3.2% 2.3% 1.8% **1\\.0%** 0\\.217 **0\\.186** 66 2.1% 2.8% 1.2% **1\\.5%** 11\\.639 **9\\.497**\n\n6 3.1% 1.5% 1.7% **1\\.0%** 0\\.208 **0\\.184** 67 2.1% 2.9% 1.1% **1\\.5%** 12\\.428 **10\\.085**\n\n7 3.1% 1.5% 1.7% **1\\.0%** 0\\.199 **0\\.177** 68 2.1% 3.0% 1.1% **1\\.5%** 13\\.344 **10\\.787**\n\n8 3.2% 2.1% 1.9% **1\\.0%** 0\\.184 **0\\.159** 69 2.1% 3.1% 1.1% **1\\.5%** 14\\.411 **11\\.625**\n\n9 3.5% 3.8% 2.2% **1\\.0%** 0\\.178 **0\\.143** 70 2.0% 3.1% 1.1% **1\\.5%** 15\\.661 **12\\.619**\n\n10 4.1% 7.2% 2.6% **1\\.0%** 0\\.180 **0\\.126** 71 2.0% 3.1% 1.1% **1\\.5%** 17\\.128 **13\\.798**\n\n11 4.2% 8.9% 2.7% **1\\.0%** 0\\.190 **0\\.123** 72 2.0% 3.1% 1.1% **1\\.5%** 18\\.837 **15\\.195**\n\n12 3.6% 6.8% 2.1% **1\\.0%** 0\\.207 **0\\.147** 73 1.9% 3.0% 1.1% **1\\.5%** 20\\.814 **16\\.834**\n\n13 3.0% 3.9% 1.6% **1\\.0%** 0\\.234 **0\\.188** 74 1.9% 2.9% 1.1% **1\\.5%** 23\\.081 **18\\.733**\n\n14 2.7% 2.2% 1.3% **1\\.0%** 0\\.274 **0\\.236** 75 1.9% 2.8% 1.1% **1\\.5%** 25\\.664 **20\\.905**\n\n15 2.6% 1.5% 1.2% **1\\.0%** 0\\.318 **0\\.282** 76 1.8% 2.7% 1.0% **1\\.5%** 28\\.586 **23\\.367**\n\n16 2.5% 1.1% 1.1% **1\\.0%** 0\\.361 **0\\.325** 77 1.7% 2.6% 1.0% **1\\.5%** 31\\.886 **26\\.155**\n\n17 2.3% 0.6% 1.1% **1\\.0%** 0\\.397 **0\\.364** 78 1.7% 2.6% 1.0% **1\\.5%** 35\\.607 **29\\.306**\n\n18 1.9% 0.0% 1.0% **1\\.0%** 0\\.425 **0\\.399** 79 1.6% 2.5% 1.1% **1\\.5%** 39\\.796 **32\\.858**\n\n19 1.4% -0.6% 0.9% **1\\.0%** 0\\.447 **0\\.430** 80 1.5% 2.4% 1.1% **1\\.5%** 44\\.505 **36\\.927**\n\n20 0.9% -1.1% 0.9% **1\\.0%** 0\\.467 **0\\.459** 81 1.4% 2.3% 1.1% **1\\.4%** 49\\.790 **41\\.703**\n\n21 0.6% -1.5% 0.8% **1\\.0%** 0\\.493 **0\\.492** 82 1.3% 2.2% 1.0% **1\\.3%** 55\\.722 **46\\.957**\n\n22 0.5% -1.7% 0.8% **1\\.0%** 0\\.521 **0\\.526** 83 1.2% 2.3% 0.9% **1\\.3%** 62\\.382 **52\\.713**\n\n23 0.6% -1.9% 0.8% **1\\.0%** 0\\.561 **0\\.569** 84 1.1% 2.4% 0.8% **1\\.2%** 69\\.863 **59\\.148**\n\n24 0.8% -2.0% 0.9% **1\\.0%** 0\\.604 **0\\.616** 85 1.0% 2.4% 0.7% **1\\.1%** 78\\.269 **66\\.505**\n\n25 1.0% -2.0% 0.9% **1\\.0%** 0\\.656 **0\\.669** 86 0.8% 2.3% 0.6% **1\\.0%** 87\\.702 **75\\.015**\n\n26 1.3% -2.0% 1.0% **1\\.0%** 0\\.714 **0\\.728** 87 0.7% 2.2% 0.5% **0\\.9%** 98\\.206 **84\\.823**\n\n27 1.5% -2.0% 1.0% **1\\.0%** 0\\.751 **0\\.764** 88 0.5% 2.0% 0.5% **0\\.9%** 109\\.777 **95\\.987**\n\n28 1.8% -1.8% 1.1% **1\\.0%** 0\\.779 **0\\.789** 89 0.4% 1.8% 0.5% **0\\.8%** 122\\.371 **108\\.482**\n\n29 2.0% -1.6% 1.1% **1\\.0%** 0\\.805 **0\\.808** 90 0.3% 1.6% 0.5% **0\\.7%** 135\\.888 **122\\.214**\n\n30 2.1% -1.4% 1.1% **1\\.0%** 0\\.828 **0\\.824** 91 0.1% 1.4% 0.5% **0\\.7%** 150\\.209 **136\\.799**\n\n31 2.3% -1.1% 1.1% **1\\.0%** 0\\.848 **0\\.834** 92 0.0% 1.1% 0.5% **0\\.6%** 165\\.349 **152\\.409**\n\n32 2.4% -0.7% 1.2% **1\\.0%** 0\\.867 **0\\.838** 93 -0.1% 0.9% 0.4% **0\\.5%** 181\\.387 **169\\.078**\n\n33 2.6% -0.1% 1.2% **1\\.0%** 0\\.876 **0\\.828** 94 -0.2% 0.7% 0.4% **0\\.5%** 198\\.436 **186\\.882**\n\n34 2.6% 0.5% 1.2% **1\\.0%** 0\\.877 **0\\.808** 95 -0.3% 0.6% 0.4% **0\\.4%** 216\\.648 **205\\.844**\n\n35 2.7% 1.2% 1.2% **1\\.0%** 0\\.879 **0\\.789** 96 -0.4% 0.5% 0.4% **0\\.4%** 229\\.053 **219\\.247**\n\n36 2.7% 1.7% 1.2% **1\\.0%** 0\\.891 **0\\.783** 97 -0.4% 0.4% 0.4% **0\\.3%** 247\\.806 **238\\.612**\n\n37 2.6% 2.0% 1.1% **1\\.0%** 0\\.920 **0\\.800** 98 -0.5% 0.4% 0.4% **0\\.3%** 267\\.095 **258\\.341**\n\n38 2.3% 2.0% 1.1% **1\\.0%** 0\\.963 **0\\.837** 99 -0.5% 0.4% 0.4% **0\\.2%** 286\\.781 **278\\.219**\n\n39 2.0% 1.8% 1.0% **1\\.0%** 1\\.016 **0\\.889** 100 -0.5% 0.4% 0.4% **0\\.2%** 306\\.714 **298\\.452**\n\n40 1.6% 1.6% 1.0% **1\\.0%** 1\\.081 **0\\.955** 101 **0\\.2%** 326\\.734 **323\\.610**\n\n41 1.3% 1.4% 1.0% **1\\.0%** 1\\.156 **1\\.029** 102 **0\\.1%** 346\\.679 **344\\.191**\n\n42 1.1% 1.3% 1.0% **1\\.0%** 1\\.242 **1\\.110** 103 **0\\.1%** 366\\.388 **364\\.633**\n\n43 1.0% 1.3% 0.9% **1\\.0%** 1\\.331 **1\\.188** 104 **0\\.0%** 385\\.708 **384\\.783**\n\n44 0.9% 1.4% 0.9% **1\\.0%** 1\\.424 **1\\.268** 105 **0\\.0%** 400\\.000 **400\\.000**\n\n45 0.8% 1.5% 0.9% **1\\.0%** 1\\.528 **1\\.355** 106 400.000 **400\\.000**\n\n46 0.8% 1.5% 0.9% **1\\.0%** 1\\.654 **1\\.464** 107 400.000 **400\\.000**\n\n47 0.8% 1.3% 0.9% **1\\.0%** 1\\.809 **1\\.615** 108 400.000 **400\\.000**\n\n48 0.7% 0.8% 0.9% **1\\.0%** 1\\.986 **1\\.808** 109 400.000 **400\\.000**\n\n49 0.7% 0.3% 1.0% **1\\.0%** 2\\.180 **2\\.032** 110 400.000 **400\\.000**\n\n50 0.6% -0.3% 1.0% **1\\.0%** 2\\.398 **2\\.285** 111 400.000 **400\\.000**\n\n51 0.6% -0.7% 1.1% **1\\.1%** 2\\.654 **2\\.557** 112 400.000 **400\\.000**\n\n52 0.7% -0.7% 1.1% **1\\.1%** 2\\.936 **2\\.828** 113 400.000 **400\\.000**\n\n53 0.9% -0.5% 1.2% **1\\.2%** 3\\.249 **3\\.088** 114 400.000 **400\\.000**\n\n54 1.2% 0.0% 1.2% **1\\.2%** 3\\.596 **3\\.345** 115 400.000 **400\\.000**\n\n55 1.4% 0.5% 1.3% **1\\.3%** 3\\.979 **3\\.616** 116 400.000 **400\\.000**\n\n56 1.6% 0.9% 1.3% **1\\.3%** 4\\.403 **3\\.922** 117 400.000 **400\\.000**\n\n57 1.7% 1.2% 1.3% **1\\.4%** 4\\.872 **4\\.272** 118 400.000 **400\\.000**\n\n58 1.8% 1.4% 1.4% **1\\.4%** 5\\.392 **4\\.681** 119 400.000 **400\\.000**\n\n59 1.9% 1.5% 1.4% **1\\.5%** 5\\.966 **5\\.146** 120 400.000 **400\\.000**\n\n60 1.9% 1.6% 1.5% **1\\.5%** 6\\.602 **5\\.662**\n\n**Male**","publish_date":null,"title":"13","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/test_page1.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/test_page1.pdf"},"request":{"example_id":"table/test_page1","product_type":"parse","source_file_path":"test_page1.pdf"},"started_at":"2026-11-04T19:31:13.017647"} +{"completed_at":"2026-11-04T19:47:42.234408","latency_in_ms":1823,"output":{"example_id":"table/walmart-earnings-release-fy24-q4_page13","grounded_pages":[],"layout_pages":[],"markdown":"### **Adjusted operating income**\n\nAdjusted operating income is considered a non-GAAP financial measure under the SEC’s rules because it excludes certain charges included in operating income calculated in accordance with GAAP. Management believes that adjusted operating income is a meaningful measure to share with investors because it best allows comparison of the performance with that of the comparable period. In addition, adjusted operating income affords investors a view of what management considers Walmart’s core earnings performance and the ability to make a more informed assessment of such core earnings performance as compared with that of the prior year.\n\nWhen we refer to adjusted operating income in constant currency, this means adjusted operating results without the impact of the currency exchange rate fluctuations. The disclosure of constant currency amounts or results permits investors to better understand Walmart’s underlying performance without the effects of currency exchange rate fluctuations. The tables below reflect the calculation of adjusted operating income and adjusted operating income in constant currency for the three months and fiscal year ended January 31, 2024 and 2023.\n\n**Three Months Ended January 31,**\n\n**Walmart International Consolidated**\n\n_(Dollars in millions)_ 2024 2023 2024 2023\n\n**Operating income:** Operating income, as reported $ 1,438 $ 289 $ 7,254 $ 5,561 Business reorganization and restructuring charges 1 — 849 — 849 Adjusted operating income $ 1,438 $ 1,138 $ 7,254 $ 6,410 Percent change 3 26.4% NP 13.2% NP Currency exchange rate fluctuations (146) — (146) — Adjusted operating income, constant currency $ 1,292 $ 1,138 $ 7,108 $ 6,410 Percent change 3 13.5% NP 10.9% NP\n\n**Fiscal Year Ended January 31,**\n\n**Walmart International Consolidated** _(Dollars in millions)_ 2024 2023 2024 2023\n\n**Operating income:** Operating income, as reported $ 4,909 $ 2,965 $ 27,012 $ 20,428 Business reorganization and restructuring charges 1 — 849 — 849 Opioid legal charges 2 — — 93 3,325 Adjusted operating income $ 4,909 $ 3,814 $ 27,105 $ 24,602 Percent change 3 28.7% NP 10.2% NP Currency exchange rate fluctuations (506) — (506) — Adjusted operating income, constant currency $ 4,403 $ 3,814 $ 26,599 $ 24,602 Percent change 3 15.4% NP 8.1% NP\n\n1 Business reorganization and restructuring charges in the fourth quarter of fiscal 2023 primarily relate to compensation expenses incurred in connection with the strategic decisions made in the Walmart International segment. 2 Recorded in Corporate and support.\n\n3 Change versus prior year comparable period.\n\nNP - Not provided\n\n13","pages":[{"line_numbers":[],"markdown":"### **Adjusted operating income**\n\nAdjusted operating income is considered a non-GAAP financial measure under the SEC’s rules because it excludes certain charges included in operating income calculated in accordance with GAAP. Management believes that adjusted operating income is a meaningful measure to share with investors because it best allows comparison of the performance with that of the comparable period. In addition, adjusted operating income affords investors a view of what management considers Walmart’s core earnings performance and the ability to make a more informed assessment of such core earnings performance as compared with that of the prior year.\n\nWhen we refer to adjusted operating income in constant currency, this means adjusted operating results without the impact of the currency exchange rate fluctuations. The disclosure of constant currency amounts or results permits investors to better understand Walmart’s underlying performance without the effects of currency exchange rate fluctuations. The tables below reflect the calculation of adjusted operating income and adjusted operating income in constant currency for the three months and fiscal year ended January 31, 2024 and 2023.\n\n**Three Months Ended January 31,**\n\n**Walmart International Consolidated**\n\n_(Dollars in millions)_ 2024 2023 2024 2023\n\n**Operating income:** Operating income, as reported $ 1,438 $ 289 $ 7,254 $ 5,561 Business reorganization and restructuring charges 1 — 849 — 849 Adjusted operating income $ 1,438 $ 1,138 $ 7,254 $ 6,410 Percent change 3 26.4% NP 13.2% NP Currency exchange rate fluctuations (146) — (146) — Adjusted operating income, constant currency $ 1,292 $ 1,138 $ 7,108 $ 6,410 Percent change 3 13.5% NP 10.9% NP\n\n**Fiscal Year Ended January 31,**\n\n**Walmart International Consolidated** _(Dollars in millions)_ 2024 2023 2024 2023\n\n**Operating income:** Operating income, as reported $ 4,909 $ 2,965 $ 27,012 $ 20,428 Business reorganization and restructuring charges 1 — 849 — 849 Opioid legal charges 2 — — 93 3,325 Adjusted operating income $ 4,909 $ 3,814 $ 27,105 $ 24,602 Percent change 3 28.7% NP 10.2% NP Currency exchange rate fluctuations (506) — (506) — Adjusted operating income, constant currency $ 4,403 $ 3,814 $ 26,599 $ 24,602 Percent change 3 15.4% NP 8.1% NP\n\n1 Business reorganization and restructuring charges in the fourth quarter of fiscal 2023 primarily relate to compensation expenses incurred in connection with the strategic decisions made in the Walmart International segment. 2 Recorded in Corporate and support.\n\n3 Change versus prior year comparable period.\n\nNP - Not provided\n\n13","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"### **Adjusted operating income**\n\nAdjusted operating income is considered a non-GAAP financial measure under the SEC’s rules because it excludes certain charges included in operating income calculated in accordance with GAAP. Management believes that adjusted operating income is a meaningful measure to share with investors because it best allows comparison of the performance with that of the comparable period. In addition, adjusted operating income affords investors a view of what management considers Walmart’s core earnings performance and the ability to make a more informed assessment of such core earnings performance as compared with that of the prior year.\n\nWhen we refer to adjusted operating income in constant currency, this means adjusted operating results without the impact of the currency exchange rate fluctuations. The disclosure of constant currency amounts or results permits investors to better understand Walmart’s underlying performance without the effects of currency exchange rate fluctuations. The tables below reflect the calculation of adjusted operating income and adjusted operating income in constant currency for the three months and fiscal year ended January 31, 2024 and 2023.\n\n**Three Months Ended January 31,**\n\n**Walmart International Consolidated**\n\n_(Dollars in millions)_ 2024 2023 2024 2023\n\n**Operating income:** Operating income, as reported $ 1,438 $ 289 $ 7,254 $ 5,561 Business reorganization and restructuring charges 1 — 849 — 849 Adjusted operating income $ 1,438 $ 1,138 $ 7,254 $ 6,410 Percent change 3 26.4% NP 13.2% NP Currency exchange rate fluctuations (146) — (146) — Adjusted operating income, constant currency $ 1,292 $ 1,138 $ 7,108 $ 6,410 Percent change 3 13.5% NP 10.9% NP\n\n**Fiscal Year Ended January 31,**\n\n**Walmart International Consolidated** _(Dollars in millions)_ 2024 2023 2024 2023\n\n**Operating income:** Operating income, as reported $ 4,909 $ 2,965 $ 27,012 $ 20,428 Business reorganization and restructuring charges 1 — 849 — 849 Opioid legal charges 2 — — 93 3,325 Adjusted operating income $ 4,909 $ 3,814 $ 27,105 $ 24,602 Percent change 3 28.7% NP 10.2% NP Currency exchange rate fluctuations (506) — (506) — Adjusted operating income, constant currency $ 4,403 $ 3,814 $ 26,599 $ 24,602 Percent change 3 15.4% NP 8.1% NP\n\n1 Business reorganization and restructuring charges in the fourth quarter of fiscal 2023 primarily relate to compensation expenses incurred in connection with the strategic decisions made in the Walmart International segment. 2 Recorded in Corporate and support.\n\n3 Change versus prior year comparable period.\n\nNP - Not provided\n\n13","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/walmart-earnings-release-fy24-q4_page13.pdf"]},"response":{"errors":[],"extract_id":"extract_42a0dcc17c25437be2056933937cab1d","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["### **Adjusted operating income**\n\nAdjusted operating income is considered a non-GAAP financial measure under the SEC’s rules because it excludes certain charges included in operating income calculated in accordance with GAAP. Management believes that adjusted operating income is a meaningful measure to share with investors because it best allows comparison of the performance with that of the comparable period. In addition, adjusted operating income affords investors a view of what management considers Walmart’s core earnings performance and the ability to make a more informed assessment of such core earnings performance as compared with that of the prior year.\n\nWhen we refer to adjusted operating income in constant currency, this means adjusted operating results without the impact of the currency exchange rate fluctuations. The disclosure of constant currency amounts or results permits investors to better understand Walmart’s underlying performance without the effects of currency exchange rate fluctuations. The tables below reflect the calculation of adjusted operating income and adjusted operating income in constant currency for the three months and fiscal year ended January 31, 2024 and 2023.\n\n**Three Months Ended January 31,**\n\n**Walmart International Consolidated**\n\n_(Dollars in millions)_ 2024 2023 2024 2023\n\n**Operating income:** Operating income, as reported $ 1,438 $ 289 $ 7,254 $ 5,561 Business reorganization and restructuring charges 1 — 849 — 849 Adjusted operating income $ 1,438 $ 1,138 $ 7,254 $ 6,410 Percent change 3 26.4% NP 13.2% NP Currency exchange rate fluctuations (146) — (146) — Adjusted operating income, constant currency $ 1,292 $ 1,138 $ 7,108 $ 6,410 Percent change 3 13.5% NP 10.9% NP\n\n**Fiscal Year Ended January 31,**\n\n**Walmart International Consolidated** _(Dollars in millions)_ 2024 2023 2024 2023\n\n**Operating income:** Operating income, as reported $ 4,909 $ 2,965 $ 27,012 $ 20,428 Business reorganization and restructuring charges 1 — 849 — 849 Opioid legal charges 2 — — 93 3,325 Adjusted operating income $ 4,909 $ 3,814 $ 27,105 $ 24,602 Percent change 3 28.7% NP 10.2% NP Currency exchange rate fluctuations (506) — (506) — Adjusted operating income, constant currency $ 4,403 $ 3,814 $ 26,599 $ 24,602 Percent change 3 15.4% NP 8.1% NP\n\n1 Business reorganization and restructuring charges in the fourth quarter of fiscal 2023 primarily relate to compensation expenses incurred in connection with the strategic decisions made in the Walmart International segment. 2 Recorded in Corporate and support.\n\n3 Change versus prior year comparable period.\n\nNP - Not provided\n\n13"],"full_content":"### **Adjusted operating income**\n\nAdjusted operating income is considered a non-GAAP financial measure under the SEC’s rules because it excludes certain charges included in operating income calculated in accordance with GAAP. Management believes that adjusted operating income is a meaningful measure to share with investors because it best allows comparison of the performance with that of the comparable period. In addition, adjusted operating income affords investors a view of what management considers Walmart’s core earnings performance and the ability to make a more informed assessment of such core earnings performance as compared with that of the prior year.\n\nWhen we refer to adjusted operating income in constant currency, this means adjusted operating results without the impact of the currency exchange rate fluctuations. The disclosure of constant currency amounts or results permits investors to better understand Walmart’s underlying performance without the effects of currency exchange rate fluctuations. The tables below reflect the calculation of adjusted operating income and adjusted operating income in constant currency for the three months and fiscal year ended January 31, 2024 and 2023.\n\n**Three Months Ended January 31,**\n\n**Walmart International Consolidated**\n\n_(Dollars in millions)_ 2024 2023 2024 2023\n\n**Operating income:** Operating income, as reported $ 1,438 $ 289 $ 7,254 $ 5,561 Business reorganization and restructuring charges 1 — 849 — 849 Adjusted operating income $ 1,438 $ 1,138 $ 7,254 $ 6,410 Percent change 3 26.4% NP 13.2% NP Currency exchange rate fluctuations (146) — (146) — Adjusted operating income, constant currency $ 1,292 $ 1,138 $ 7,108 $ 6,410 Percent change 3 13.5% NP 10.9% NP\n\n**Fiscal Year Ended January 31,**\n\n**Walmart International Consolidated** _(Dollars in millions)_ 2024 2023 2024 2023\n\n**Operating income:** Operating income, as reported $ 4,909 $ 2,965 $ 27,012 $ 20,428 Business reorganization and restructuring charges 1 — 849 — 849 Opioid legal charges 2 — — 93 3,325 Adjusted operating income $ 4,909 $ 3,814 $ 27,105 $ 24,602 Percent change 3 28.7% NP 10.2% NP Currency exchange rate fluctuations (506) — (506) — Adjusted operating income, constant currency $ 4,403 $ 3,814 $ 26,599 $ 24,602 Percent change 3 15.4% NP 8.1% NP\n\n1 Business reorganization and restructuring charges in the fourth quarter of fiscal 2023 primarily relate to compensation expenses incurred in connection with the strategic decisions made in the Walmart International segment. 2 Recorded in Corporate and support.\n\n3 Change versus prior year comparable period.\n\nNP - Not provided\n\n13","publish_date":null,"title":"Adjusted operating income","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/walmart-earnings-release-fy24-q4_page13.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/walmart-earnings-release-fy24-q4_page13.pdf"},"request":{"example_id":"table/walmart-earnings-release-fy24-q4_page13","product_type":"parse","source_file_path":"walmart-earnings-release-fy24-q4_page13.pdf"},"started_at":"2026-11-04T19:47:40.410468"} +{"completed_at":"2026-11-04T19:47:42.883229","latency_in_ms":1215,"output":{"example_id":"table/walmart-earnings-release-fy24-q4_page4","grounded_pages":[],"layout_pages":[],"markdown":"Sam’s Club U.S. FY’24Q4 FY’23Q4 Change FY’24 FY’23 Change\n\nNet sales $21.9 $21.4 $0.4 2.0% $86.2 $84.3 $1.8 2.2%\n\nNet sales (ex. fuel) $19.4 $18.8 $0.6 3.3% $75.1 $71.7 $3.4 4.7%\n\nComp sales (ex. fuel) 1 3.1% 12.2% NP NP 4.8% 10.5% NP NP\n\nTransactions 3.6% 6.7% NP NP NP NP NP NP\n\nAverage Ticket -0.4% 5.2% NP NP NP NP NP NP\n\neCommerce contribution to comp ~190 bps ~120 bps NP NP NP NP NP NP\n\nOperating income $0.6 $0.5 $0.1 20.4% $2.2 $2.0 $0.2 11.6%\n\n### **Sam’s Club U.S.**\n\n• Solid comp sales, led by food and consumables as well as increases in transactions and unit volumes • Gained dollar and unit market share in grocery • Growth in eCommerce sales of 17% led by delivery and curbside • Strong growth in membership income, up 10.0%, with record total membership and Plus penetration at quarter end • Advertising business 2 up 11% with record number of advertisers investing with MAP\n\n1 Comp sales for the 13-week and 52-week periods ended January 26th, 2024 compared to the 13-week and 52-week periods ended January 27th, 2023, and excludes fuel. See Supplemental Financial Information for additional information. 2 Our global advertising business is recorded in either net sales or as a reduction to cost of sales, depending on the nature of the advertising arrangement. NP - Not provided\n\n4","pages":[{"line_numbers":[],"markdown":"Sam’s Club U.S. FY’24Q4 FY’23Q4 Change FY’24 FY’23 Change\n\nNet sales $21.9 $21.4 $0.4 2.0% $86.2 $84.3 $1.8 2.2%\n\nNet sales (ex. fuel) $19.4 $18.8 $0.6 3.3% $75.1 $71.7 $3.4 4.7%\n\nComp sales (ex. fuel) 1 3.1% 12.2% NP NP 4.8% 10.5% NP NP\n\nTransactions 3.6% 6.7% NP NP NP NP NP NP\n\nAverage Ticket -0.4% 5.2% NP NP NP NP NP NP\n\neCommerce contribution to comp ~190 bps ~120 bps NP NP NP NP NP NP\n\nOperating income $0.6 $0.5 $0.1 20.4% $2.2 $2.0 $0.2 11.6%\n\n### **Sam’s Club U.S.**\n\n• Solid comp sales, led by food and consumables as well as increases in transactions and unit volumes • Gained dollar and unit market share in grocery • Growth in eCommerce sales of 17% led by delivery and curbside • Strong growth in membership income, up 10.0%, with record total membership and Plus penetration at quarter end • Advertising business 2 up 11% with record number of advertisers investing with MAP\n\n1 Comp sales for the 13-week and 52-week periods ended January 26th, 2024 compared to the 13-week and 52-week periods ended January 27th, 2023, and excludes fuel. See Supplemental Financial Information for additional information. 2 Our global advertising business is recorded in either net sales or as a reduction to cost of sales, depending on the nature of the advertising arrangement. NP - Not provided\n\n4","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"Sam’s Club U.S. FY’24Q4 FY’23Q4 Change FY’24 FY’23 Change\n\nNet sales $21.9 $21.4 $0.4 2.0% $86.2 $84.3 $1.8 2.2%\n\nNet sales (ex. fuel) $19.4 $18.8 $0.6 3.3% $75.1 $71.7 $3.4 4.7%\n\nComp sales (ex. fuel) 1 3.1% 12.2% NP NP 4.8% 10.5% NP NP\n\nTransactions 3.6% 6.7% NP NP NP NP NP NP\n\nAverage Ticket -0.4% 5.2% NP NP NP NP NP NP\n\neCommerce contribution to comp ~190 bps ~120 bps NP NP NP NP NP NP\n\nOperating income $0.6 $0.5 $0.1 20.4% $2.2 $2.0 $0.2 11.6%\n\n### **Sam’s Club U.S.**\n\n• Solid comp sales, led by food and consumables as well as increases in transactions and unit volumes • Gained dollar and unit market share in grocery • Growth in eCommerce sales of 17% led by delivery and curbside • Strong growth in membership income, up 10.0%, with record total membership and Plus penetration at quarter end • Advertising business 2 up 11% with record number of advertisers investing with MAP\n\n1 Comp sales for the 13-week and 52-week periods ended January 26th, 2024 compared to the 13-week and 52-week periods ended January 27th, 2023, and excludes fuel. See Supplemental Financial Information for additional information. 2 Our global advertising business is recorded in either net sales or as a reduction to cost of sales, depending on the nature of the advertising arrangement. NP - Not provided\n\n4","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/walmart-earnings-release-fy24-q4_page4.pdf"]},"response":{"errors":[],"extract_id":"extract_e8abc287304d97427447dee63bc8220f","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["Sam’s Club U.S. FY’24Q4 FY’23Q4 Change FY’24 FY’23 Change\n\nNet sales $21.9 $21.4 $0.4 2.0% $86.2 $84.3 $1.8 2.2%\n\nNet sales (ex. fuel) $19.4 $18.8 $0.6 3.3% $75.1 $71.7 $3.4 4.7%\n\nComp sales (ex. fuel) 1 3.1% 12.2% NP NP 4.8% 10.5% NP NP\n\nTransactions 3.6% 6.7% NP NP NP NP NP NP\n\nAverage Ticket -0.4% 5.2% NP NP NP NP NP NP\n\neCommerce contribution to comp ~190 bps ~120 bps NP NP NP NP NP NP\n\nOperating income $0.6 $0.5 $0.1 20.4% $2.2 $2.0 $0.2 11.6%\n\n### **Sam’s Club U.S.**\n\n• Solid comp sales, led by food and consumables as well as increases in transactions and unit volumes • Gained dollar and unit market share in grocery • Growth in eCommerce sales of 17% led by delivery and curbside • Strong growth in membership income, up 10.0%, with record total membership and Plus penetration at quarter end • Advertising business 2 up 11% with record number of advertisers investing with MAP\n\n1 Comp sales for the 13-week and 52-week periods ended January 26th, 2024 compared to the 13-week and 52-week periods ended January 27th, 2023, and excludes fuel. See Supplemental Financial Information for additional information. 2 Our global advertising business is recorded in either net sales or as a reduction to cost of sales, depending on the nature of the advertising arrangement. NP - Not provided\n\n4"],"full_content":"Sam’s Club U.S. FY’24Q4 FY’23Q4 Change FY’24 FY’23 Change\n\nNet sales $21.9 $21.4 $0.4 2.0% $86.2 $84.3 $1.8 2.2%\n\nNet sales (ex. fuel) $19.4 $18.8 $0.6 3.3% $75.1 $71.7 $3.4 4.7%\n\nComp sales (ex. fuel) 1 3.1% 12.2% NP NP 4.8% 10.5% NP NP\n\nTransactions 3.6% 6.7% NP NP NP NP NP NP\n\nAverage Ticket -0.4% 5.2% NP NP NP NP NP NP\n\neCommerce contribution to comp ~190 bps ~120 bps NP NP NP NP NP NP\n\nOperating income $0.6 $0.5 $0.1 20.4% $2.2 $2.0 $0.2 11.6%\n\n### **Sam’s Club U.S.**\n\n• Solid comp sales, led by food and consumables as well as increases in transactions and unit volumes • Gained dollar and unit market share in grocery • Growth in eCommerce sales of 17% led by delivery and curbside • Strong growth in membership income, up 10.0%, with record total membership and Plus penetration at quarter end • Advertising business 2 up 11% with record number of advertisers investing with MAP\n\n1 Comp sales for the 13-week and 52-week periods ended January 26th, 2024 compared to the 13-week and 52-week periods ended January 27th, 2023, and excludes fuel. See Supplemental Financial Information for additional information. 2 Our global advertising business is recorded in either net sales or as a reduction to cost of sales, depending on the nature of the advertising arrangement. NP - Not provided\n\n4","publish_date":null,"title":"Sam’s Club U.S.","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/walmart-earnings-release-fy24-q4_page4.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/walmart-earnings-release-fy24-q4_page4.pdf"},"request":{"example_id":"table/walmart-earnings-release-fy24-q4_page4","product_type":"parse","source_file_path":"walmart-earnings-release-fy24-q4_page4.pdf"},"started_at":"2026-11-04T19:47:41.667526"} +{"completed_at":"2026-11-04T19:46:53.609087","latency_in_ms":1740,"output":{"example_id":"table/xl-re-europe-se-sfcr-2024_page10","grounded_pages":[],"layout_pages":[],"markdown":"€'000\n\n### **Solvency Capital Requirement (SCR)**\n\n### **31 December 2023**\n\n170,024\n\n79,487 6,091\n\n699,352\n\n(150,648)\n\n66,541\n\n(108,856)\n\n761,992\n\nMarket risk\n\nCounterparty default risk\n\nLife & Health underwriting risk\n\nNon-life underwriting risk\n\nDiversification\n\nOperational risk\n\nLoss-absorbing capacity of deferred taxes\n\nSCR\n\n0\n\n200,000\n\n400,000\n\n600,000\n\n800,000\n\n1,000,000\n\n1,200,000\n\nThe SCR has increased by €105m since 2023. Non-life underwriting risk is the main driver of the increase due to higher reserve risk caused by increases in non-proportional (\"non-prop\") casualty technical provisions, increased premium risk due to higher premium volume on credit and surety business, partially offset by a decrease in non-life CAT risk module.\n\nThe Company is required to hold sufficient capital to cover its SCR which is calculated using the SF, as well as covering its Minimum Capital Requirement (\"MCR\").\n\n**2024 2023**\n\n**€'000 €'000**\n\nSCR 867,007 761,992\n\nMCR 218,083 190,498\n\nTotal Eligible Own Funds to meet the SCR 1,138,189 1,104,407\n\nTotal Eligible Own Funds to meet the MCR 1,051,693 1,037,867\n\n% %\n\nRatio of Eligible Own Funds to SCR 131.3% 144.9%\n\nRatio of Eligible Own Funds to MCR 482.2% 544.8%\n\nThe Company does not use any matching adjustment and has not used transitional adjustments to the relevant risk-free interest rate term structure or transitional measures on technical provisions. The Company has been granted approval by the CBI to use volatility adjustments to value the Best Estimate Liability (“BEL”).\n\nThe Company's capital has exceeded throughout the reporting period on both the MCR and the SCR.\n\nIn line with the capital management policy, the objective of the Company's capital management strategy is to maintain sufficient own funds to cover the SCR and MCR with an appropriate buffer. The Company carries out regular reviews of the solvency ratio as part of the risk monitoring and capital management system.\n\n10","pages":[{"line_numbers":[],"markdown":"€'000\n\n### **Solvency Capital Requirement (SCR)**\n\n### **31 December 2023**\n\n170,024\n\n79,487 6,091\n\n699,352\n\n(150,648)\n\n66,541\n\n(108,856)\n\n761,992\n\nMarket risk\n\nCounterparty default risk\n\nLife & Health underwriting risk\n\nNon-life underwriting risk\n\nDiversification\n\nOperational risk\n\nLoss-absorbing capacity of deferred taxes\n\nSCR\n\n0\n\n200,000\n\n400,000\n\n600,000\n\n800,000\n\n1,000,000\n\n1,200,000\n\nThe SCR has increased by €105m since 2023. Non-life underwriting risk is the main driver of the increase due to higher reserve risk caused by increases in non-proportional (\"non-prop\") casualty technical provisions, increased premium risk due to higher premium volume on credit and surety business, partially offset by a decrease in non-life CAT risk module.\n\nThe Company is required to hold sufficient capital to cover its SCR which is calculated using the SF, as well as covering its Minimum Capital Requirement (\"MCR\").\n\n**2024 2023**\n\n**€'000 €'000**\n\nSCR 867,007 761,992\n\nMCR 218,083 190,498\n\nTotal Eligible Own Funds to meet the SCR 1,138,189 1,104,407\n\nTotal Eligible Own Funds to meet the MCR 1,051,693 1,037,867\n\n% %\n\nRatio of Eligible Own Funds to SCR 131.3% 144.9%\n\nRatio of Eligible Own Funds to MCR 482.2% 544.8%\n\nThe Company does not use any matching adjustment and has not used transitional adjustments to the relevant risk-free interest rate term structure or transitional measures on technical provisions. The Company has been granted approval by the CBI to use volatility adjustments to value the Best Estimate Liability (“BEL”).\n\nThe Company's capital has exceeded throughout the reporting period on both the MCR and the SCR.\n\nIn line with the capital management policy, the objective of the Company's capital management strategy is to maintain sufficient own funds to cover the SCR and MCR with an appropriate buffer. The Company carries out regular reviews of the solvency ratio as part of the risk monitoring and capital management system.\n\n10","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"€'000\n\n### **Solvency Capital Requirement (SCR)**\n\n### **31 December 2023**\n\n170,024\n\n79,487 6,091\n\n699,352\n\n(150,648)\n\n66,541\n\n(108,856)\n\n761,992\n\nMarket risk\n\nCounterparty default risk\n\nLife & Health underwriting risk\n\nNon-life underwriting risk\n\nDiversification\n\nOperational risk\n\nLoss-absorbing capacity of deferred taxes\n\nSCR\n\n0\n\n200,000\n\n400,000\n\n600,000\n\n800,000\n\n1,000,000\n\n1,200,000\n\nThe SCR has increased by €105m since 2023. Non-life underwriting risk is the main driver of the increase due to higher reserve risk caused by increases in non-proportional (\"non-prop\") casualty technical provisions, increased premium risk due to higher premium volume on credit and surety business, partially offset by a decrease in non-life CAT risk module.\n\nThe Company is required to hold sufficient capital to cover its SCR which is calculated using the SF, as well as covering its Minimum Capital Requirement (\"MCR\").\n\n**2024 2023**\n\n**€'000 €'000**\n\nSCR 867,007 761,992\n\nMCR 218,083 190,498\n\nTotal Eligible Own Funds to meet the SCR 1,138,189 1,104,407\n\nTotal Eligible Own Funds to meet the MCR 1,051,693 1,037,867\n\n% %\n\nRatio of Eligible Own Funds to SCR 131.3% 144.9%\n\nRatio of Eligible Own Funds to MCR 482.2% 544.8%\n\nThe Company does not use any matching adjustment and has not used transitional adjustments to the relevant risk-free interest rate term structure or transitional measures on technical provisions. The Company has been granted approval by the CBI to use volatility adjustments to value the Best Estimate Liability (“BEL”).\n\nThe Company's capital has exceeded throughout the reporting period on both the MCR and the SCR.\n\nIn line with the capital management policy, the objective of the Company's capital management strategy is to maintain sufficient own funds to cover the SCR and MCR with an appropriate buffer. The Company carries out regular reviews of the solvency ratio as part of the risk monitoring and capital management system.\n\n10","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/xl-re-europe-se-sfcr-2024_page10.pdf"]},"response":{"errors":[],"extract_id":"extract_83280495db24594c6c870d0f4d7a2973","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["€'000\n\n### **Solvency Capital Requirement (SCR)**\n\n### **31 December 2023**\n\n170,024\n\n79,487 6,091\n\n699,352\n\n(150,648)\n\n66,541\n\n(108,856)\n\n761,992\n\nMarket risk\n\nCounterparty default risk\n\nLife & Health underwriting risk\n\nNon-life underwriting risk\n\nDiversification\n\nOperational risk\n\nLoss-absorbing capacity of deferred taxes\n\nSCR\n\n0\n\n200,000\n\n400,000\n\n600,000\n\n800,000\n\n1,000,000\n\n1,200,000\n\nThe SCR has increased by €105m since 2023. Non-life underwriting risk is the main driver of the increase due to higher reserve risk caused by increases in non-proportional (\"non-prop\") casualty technical provisions, increased premium risk due to higher premium volume on credit and surety business, partially offset by a decrease in non-life CAT risk module.\n\nThe Company is required to hold sufficient capital to cover its SCR which is calculated using the SF, as well as covering its Minimum Capital Requirement (\"MCR\").\n\n**2024 2023**\n\n**€'000 €'000**\n\nSCR 867,007 761,992\n\nMCR 218,083 190,498\n\nTotal Eligible Own Funds to meet the SCR 1,138,189 1,104,407\n\nTotal Eligible Own Funds to meet the MCR 1,051,693 1,037,867\n\n% %\n\nRatio of Eligible Own Funds to SCR 131.3% 144.9%\n\nRatio of Eligible Own Funds to MCR 482.2% 544.8%\n\nThe Company does not use any matching adjustment and has not used transitional adjustments to the relevant risk-free interest rate term structure or transitional measures on technical provisions. The Company has been granted approval by the CBI to use volatility adjustments to value the Best Estimate Liability (“BEL”).\n\nThe Company's capital has exceeded throughout the reporting period on both the MCR and the SCR.\n\nIn line with the capital management policy, the objective of the Company's capital management strategy is to maintain sufficient own funds to cover the SCR and MCR with an appropriate buffer. The Company carries out regular reviews of the solvency ratio as part of the risk monitoring and capital management system.\n\n10"],"full_content":"€'000\n\n### **Solvency Capital Requirement (SCR)**\n\n### **31 December 2023**\n\n170,024\n\n79,487 6,091\n\n699,352\n\n(150,648)\n\n66,541\n\n(108,856)\n\n761,992\n\nMarket risk\n\nCounterparty default risk\n\nLife & Health underwriting risk\n\nNon-life underwriting risk\n\nDiversification\n\nOperational risk\n\nLoss-absorbing capacity of deferred taxes\n\nSCR\n\n0\n\n200,000\n\n400,000\n\n600,000\n\n800,000\n\n1,000,000\n\n1,200,000\n\nThe SCR has increased by €105m since 2023. Non-life underwriting risk is the main driver of the increase due to higher reserve risk caused by increases in non-proportional (\"non-prop\") casualty technical provisions, increased premium risk due to higher premium volume on credit and surety business, partially offset by a decrease in non-life CAT risk module.\n\nThe Company is required to hold sufficient capital to cover its SCR which is calculated using the SF, as well as covering its Minimum Capital Requirement (\"MCR\").\n\n**2024 2023**\n\n**€'000 €'000**\n\nSCR 867,007 761,992\n\nMCR 218,083 190,498\n\nTotal Eligible Own Funds to meet the SCR 1,138,189 1,104,407\n\nTotal Eligible Own Funds to meet the MCR 1,051,693 1,037,867\n\n% %\n\nRatio of Eligible Own Funds to SCR 131.3% 144.9%\n\nRatio of Eligible Own Funds to MCR 482.2% 544.8%\n\nThe Company does not use any matching adjustment and has not used transitional adjustments to the relevant risk-free interest rate term structure or transitional measures on technical provisions. The Company has been granted approval by the CBI to use volatility adjustments to value the Best Estimate Liability (“BEL”).\n\nThe Company's capital has exceeded throughout the reporting period on both the MCR and the SCR.\n\nIn line with the capital management policy, the objective of the Company's capital management strategy is to maintain sufficient own funds to cover the SCR and MCR with an appropriate buffer. The Company carries out regular reviews of the solvency ratio as part of the risk monitoring and capital management system.\n\n10","publish_date":null,"title":"Solvency Capital Requirement (SCR) 31 December 2023","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/xl-re-europe-se-sfcr-2024_page10.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/xl-re-europe-se-sfcr-2024_page10.pdf"},"request":{"example_id":"table/xl-re-europe-se-sfcr-2024_page10","product_type":"parse","source_file_path":"xl-re-europe-se-sfcr-2024_page10.pdf"},"started_at":"2026-11-04T19:46:51.868097"} +{"completed_at":"2026-11-04T19:46:56.207158","latency_in_ms":2205,"output":{"example_id":"table/xl-re-europe-se-sfcr-2024_page19","grounded_pages":[],"layout_pages":[],"markdown":"**2024 IRELAND FRANCE UK DUBAI SWITZERLAND SINGAPORE ITALY TOTAL**\n\n**€'000 €'000 €'000 €'000 €'000 €'000 €'000 €'000**\n\nGWP 162,417 137,058 590,241 89,564 520,019 83,800 — 1,583,099\n\nNEP 58,911 46,840 208,193 30,860 98,254 17,134 — 460,192\n\n**2023 IRELAND FRANCE UK DUBAI SWITZERLAND SINGAPORE ITALY TOTAL**\n\n**€'000 €'000 €'000 €'000 €'000 €'000 €'000 €'000**\n\nGWP 152,976 125,823 563,965 79,170 197,950 — 7,192 1,127,076\n\nNEP 52,451 43,323 207,167 32,603 58,471 — 6,748 400,763\n\n**Dividends**\n\nThe directors do not recommend the payment of a final dividend (2023: €0m).\n\n**Reconciliation of SII information to Irish GAAP**\n\nBelow is a reconciliation of the SII information reported in QRT S.05.01. to pre-tax Irish GAAP profit:\n\n**Year ended 31 December 2024 2023**\n\n**€000's €000's**\n\nGross written premiums 1,593,288 1,138,260\n\nReinsurers’ share of premiums 501,876 690,350\n\nGross earned premiums 1,300,369 1,027,749\n\nReinsurers’ share of earned premiums 840,038 626,856\n\nGross claims incurred 929,175 654,201\n\nReinsurers’ share of claims incurred 603,260 397,325\n\nNet expenses incurred 124,350 106,140\n\n**Per QRT Form S.05 10,066 37,877**\n\nInvestment income 60,407 47,183\n\nUnrealised gain/(loss) on investments (18,778) 60,142\n\nIncome/(expense) from other activities (52,115) (5,960)\n\n**Pre-tax Irish GAAP profit (420) 139,242**\n\n### **A.3. Investment performance**\n\nThe primary objective of the Company's investment strategy is to maximize the risk adjusted return on economic capital employed subject to a variety of constraints including:\n\n• Maintaining adequate regulatory and rating agency capitalisation;\n\n• Maintaining sufficient liquidity to ensure payment of claims, operating expenses and other obligations even during stressed scenarios; and\n\n• Generating stable net investment income.\n\nThe Company holds investment grade fixed and variable income portfolios denominated in a variety of currencies, which broadly correspond to the respective liabilities of the Company. Assets representing capital of the Company, which are not matched to specific liabilities, are generally held in the major currencies. Consideration is given to the interest rate environment, the volatility of exchange rates and the risk charge under SII.\n\n19","pages":[{"line_numbers":[],"markdown":"**2024 IRELAND FRANCE UK DUBAI SWITZERLAND SINGAPORE ITALY TOTAL**\n\n**€'000 €'000 €'000 €'000 €'000 €'000 €'000 €'000**\n\nGWP 162,417 137,058 590,241 89,564 520,019 83,800 — 1,583,099\n\nNEP 58,911 46,840 208,193 30,860 98,254 17,134 — 460,192\n\n**2023 IRELAND FRANCE UK DUBAI SWITZERLAND SINGAPORE ITALY TOTAL**\n\n**€'000 €'000 €'000 €'000 €'000 €'000 €'000 €'000**\n\nGWP 152,976 125,823 563,965 79,170 197,950 — 7,192 1,127,076\n\nNEP 52,451 43,323 207,167 32,603 58,471 — 6,748 400,763\n\n**Dividends**\n\nThe directors do not recommend the payment of a final dividend (2023: €0m).\n\n**Reconciliation of SII information to Irish GAAP**\n\nBelow is a reconciliation of the SII information reported in QRT S.05.01. to pre-tax Irish GAAP profit:\n\n**Year ended 31 December 2024 2023**\n\n**€000's €000's**\n\nGross written premiums 1,593,288 1,138,260\n\nReinsurers’ share of premiums 501,876 690,350\n\nGross earned premiums 1,300,369 1,027,749\n\nReinsurers’ share of earned premiums 840,038 626,856\n\nGross claims incurred 929,175 654,201\n\nReinsurers’ share of claims incurred 603,260 397,325\n\nNet expenses incurred 124,350 106,140\n\n**Per QRT Form S.05 10,066 37,877**\n\nInvestment income 60,407 47,183\n\nUnrealised gain/(loss) on investments (18,778) 60,142\n\nIncome/(expense) from other activities (52,115) (5,960)\n\n**Pre-tax Irish GAAP profit (420) 139,242**\n\n### **A.3. Investment performance**\n\nThe primary objective of the Company's investment strategy is to maximize the risk adjusted return on economic capital employed subject to a variety of constraints including:\n\n• Maintaining adequate regulatory and rating agency capitalisation;\n\n• Maintaining sufficient liquidity to ensure payment of claims, operating expenses and other obligations even during stressed scenarios; and\n\n• Generating stable net investment income.\n\nThe Company holds investment grade fixed and variable income portfolios denominated in a variety of currencies, which broadly correspond to the respective liabilities of the Company. Assets representing capital of the Company, which are not matched to specific liabilities, are generally held in the major currencies. Consideration is given to the interest rate environment, the volatility of exchange rates and the risk charge under SII.\n\n19","page_index":0}],"pipeline_name":"parallel_extract","task_type":"parse"},"pipeline_name":"parallel_extract","product_type":"parse","raw_output":{"markdown":"**2024 IRELAND FRANCE UK DUBAI SWITZERLAND SINGAPORE ITALY TOTAL**\n\n**€'000 €'000 €'000 €'000 €'000 €'000 €'000 €'000**\n\nGWP 162,417 137,058 590,241 89,564 520,019 83,800 — 1,583,099\n\nNEP 58,911 46,840 208,193 30,860 98,254 17,134 — 460,192\n\n**2023 IRELAND FRANCE UK DUBAI SWITZERLAND SINGAPORE ITALY TOTAL**\n\n**€'000 €'000 €'000 €'000 €'000 €'000 €'000 €'000**\n\nGWP 152,976 125,823 563,965 79,170 197,950 — 7,192 1,127,076\n\nNEP 52,451 43,323 207,167 32,603 58,471 — 6,748 400,763\n\n**Dividends**\n\nThe directors do not recommend the payment of a final dividend (2023: €0m).\n\n**Reconciliation of SII information to Irish GAAP**\n\nBelow is a reconciliation of the SII information reported in QRT S.05.01. to pre-tax Irish GAAP profit:\n\n**Year ended 31 December 2024 2023**\n\n**€000's €000's**\n\nGross written premiums 1,593,288 1,138,260\n\nReinsurers’ share of premiums 501,876 690,350\n\nGross earned premiums 1,300,369 1,027,749\n\nReinsurers’ share of earned premiums 840,038 626,856\n\nGross claims incurred 929,175 654,201\n\nReinsurers’ share of claims incurred 603,260 397,325\n\nNet expenses incurred 124,350 106,140\n\n**Per QRT Form S.05 10,066 37,877**\n\nInvestment income 60,407 47,183\n\nUnrealised gain/(loss) on investments (18,778) 60,142\n\nIncome/(expense) from other activities (52,115) (5,960)\n\n**Pre-tax Irish GAAP profit (420) 139,242**\n\n### **A.3. Investment performance**\n\nThe primary objective of the Company's investment strategy is to maximize the risk adjusted return on economic capital employed subject to a variety of constraints including:\n\n• Maintaining adequate regulatory and rating agency capitalisation;\n\n• Maintaining sufficient liquidity to ensure payment of claims, operating expenses and other obligations even during stressed scenarios; and\n\n• Generating stable net investment income.\n\nThe Company holds investment grade fixed and variable income portfolios denominated in a variety of currencies, which broadly correspond to the respective liabilities of the Company. Assets representing capital of the Company, which are not matched to specific liabilities, are generally held in the major currencies. Consideration is given to the interest rate environment, the volatility of exchange rates and the risk charge under SII.\n\n19","num_pages":1,"request_body":{"advanced_settings":{"fetch_policy":{"max_age_seconds":600,"timeout_seconds":60},"full_content":{"max_chars_per_result":200000}},"urls":["https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/xl-re-europe-se-sfcr-2024_page19.pdf"]},"response":{"errors":[],"extract_id":"extract_4636aa5a0e3db4c24c97541e5fe3c8ed","metadata":null,"results":[{"acquired_at":"2026-11-05T00:00:00Z","excerpts":["**2024 IRELAND FRANCE UK DUBAI SWITZERLAND SINGAPORE ITALY TOTAL**\n\n**€'000 €'000 €'000 €'000 €'000 €'000 €'000 €'000**\n\nGWP 162,417 137,058 590,241 89,564 520,019 83,800 — 1,583,099\n\nNEP 58,911 46,840 208,193 30,860 98,254 17,134 — 460,192\n\n**2023 IRELAND FRANCE UK DUBAI SWITZERLAND SINGAPORE ITALY TOTAL**\n\n**€'000 €'000 €'000 €'000 €'000 €'000 €'000 €'000**\n\nGWP 152,976 125,823 563,965 79,170 197,950 — 7,192 1,127,076\n\nNEP 52,451 43,323 207,167 32,603 58,471 — 6,748 400,763\n\n**Dividends**\n\nThe directors do not recommend the payment of a final dividend (2023: €0m).\n\n**Reconciliation of SII information to Irish GAAP**\n\nBelow is a reconciliation of the SII information reported in QRT S.05.01. to pre-tax Irish GAAP profit:\n\n**Year ended 31 December 2024 2023**\n\n**€000's €000's**\n\nGross written premiums 1,593,288 1,138,260\n\nReinsurers’ share of premiums 501,876 690,350\n\nGross earned premiums 1,300,369 1,027,749\n\nReinsurers’ share of earned premiums 840,038 626,856\n\nGross claims incurred 929,175 654,201\n\nReinsurers’ share of claims incurred 603,260 397,325\n\nNet expenses incurred 124,350 106,140\n\n**Per QRT Form S.05 10,066 37,877**\n\nInvestment income 60,407 47,183\n\nUnrealised gain/(loss) on investments (18,778) 60,142\n\nIncome/(expense) from other activities (52,115) (5,960)\n\n**Pre-tax Irish GAAP profit (420) 139,242**\n\n### **A.3. Investment performance**\n\nThe primary objective of the Company's investment strategy is to maximize the risk adjusted return on economic capital employed subject to a variety of constraints including:\n\n• Maintaining adequate regulatory and rating agency capitalisation;\n\n• Maintaining sufficient liquidity to ensure payment of claims, operating expenses and other obligations even during stressed scenarios; and\n\n• Generating stable net investment income.\n\nThe Company holds investment grade fixed and variable income portfolios denominated in a variety of currencies, which broadly correspond to the respective liabilities of the Company. Assets representing capital of the Company, which are not matched to specific liabilities, are generally held in the major currencies. Consideration is given to the interest rate environment, the volatility of exchange rates and the risk charge under SII.\n\n19"],"full_content":"**2024 IRELAND FRANCE UK DUBAI SWITZERLAND SINGAPORE ITALY TOTAL**\n\n**€'000 €'000 €'000 €'000 €'000 €'000 €'000 €'000**\n\nGWP 162,417 137,058 590,241 89,564 520,019 83,800 — 1,583,099\n\nNEP 58,911 46,840 208,193 30,860 98,254 17,134 — 460,192\n\n**2023 IRELAND FRANCE UK DUBAI SWITZERLAND SINGAPORE ITALY TOTAL**\n\n**€'000 €'000 €'000 €'000 €'000 €'000 €'000 €'000**\n\nGWP 152,976 125,823 563,965 79,170 197,950 — 7,192 1,127,076\n\nNEP 52,451 43,323 207,167 32,603 58,471 — 6,748 400,763\n\n**Dividends**\n\nThe directors do not recommend the payment of a final dividend (2023: €0m).\n\n**Reconciliation of SII information to Irish GAAP**\n\nBelow is a reconciliation of the SII information reported in QRT S.05.01. to pre-tax Irish GAAP profit:\n\n**Year ended 31 December 2024 2023**\n\n**€000's €000's**\n\nGross written premiums 1,593,288 1,138,260\n\nReinsurers’ share of premiums 501,876 690,350\n\nGross earned premiums 1,300,369 1,027,749\n\nReinsurers’ share of earned premiums 840,038 626,856\n\nGross claims incurred 929,175 654,201\n\nReinsurers’ share of claims incurred 603,260 397,325\n\nNet expenses incurred 124,350 106,140\n\n**Per QRT Form S.05 10,066 37,877**\n\nInvestment income 60,407 47,183\n\nUnrealised gain/(loss) on investments (18,778) 60,142\n\nIncome/(expense) from other activities (52,115) (5,960)\n\n**Pre-tax Irish GAAP profit (420) 139,242**\n\n### **A.3. Investment performance**\n\nThe primary objective of the Company's investment strategy is to maximize the risk adjusted return on economic capital employed subject to a variety of constraints including:\n\n• Maintaining adequate regulatory and rating agency capitalisation;\n\n• Maintaining sufficient liquidity to ensure payment of claims, operating expenses and other obligations even during stressed scenarios; and\n\n• Generating stable net investment income.\n\nThe Company holds investment grade fixed and variable income portfolios denominated in a variety of currencies, which broadly correspond to the respective liabilities of the Company. Assets representing capital of the Company, which are not matched to specific liabilities, are generally held in the major currencies. Consideration is given to the interest rate environment, the volatility of exchange rates and the risk charge under SII.\n\n19","publish_date":null,"title":"A.3. Investment performance","url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/xl-re-europe-se-sfcr-2024_page19.pdf"}],"warnings":[{"detail":null,"message":"Neither objective nor search_queries were provided, provide at least one to increase the relevance of excerpts.","type":"warning"}]},"url":"https://huggingface.co/datasets/llamaindex/ParseBench/resolve/main/docs/table/xl-re-europe-se-sfcr-2024_page19.pdf"},"request":{"example_id":"table/xl-re-europe-se-sfcr-2024_page19","product_type":"parse","source_file_path":"xl-re-europe-se-sfcr-2024_page19.pdf"},"started_at":"2026-11-04T19:46:54.001567"}